PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Gaffaney, JD; Dunning, FM; Wang, Z; Hui, E; Chapman, ER				Gaffaney, Jon D.; Dunning, F. Mark; Wang, Zhao; Hui, Enfu; Chapman, Edwin R.			Synaptotagmin C2B Domain Regulates Ca2+-triggered Fusion in Vitro CRITICAL RESIDUES REVEALED BY SCANNING ALANINE MUTAGENESIS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEMBRANE-PENETRATION ACTIVITY; CRACKED PC12 CELLS; NEUROTRANSMITTER RELEASE; SNARE INTERACTIONS; PLASMA-MEMBRANE; CA2+ BINDING; T-SNARE; SYNAPTIC-TRANSMISSION; VESICLE EXOCYTOSIS; LIPID-COMPOSITION	Synaptotagmin (syt) 1 is localized to synaptic vesicles, binds Ca2+, and regulates neuronal exocytosis. Syt 1 harbors two Ca2+-binding motifs referred to as C2A and C2B. In this study we examine the function of the isolated C2 domains of Syt 1 using a reconstituted, SNARE (soluble N-ethylmaleimide-sensitive factor attachment receptor)-mediated, fusion assay. We report that inclusion of phosphatidylethanolamine into reconstituted SNARE vesicles enabled isolated C2B, but not C2A, to regulate Ca2+-triggered fusion. The isolated C2B domain had a 6-fold lower EC50 for Ca2+-activated fusion than the intact cytosolic domain of Syt 1 (C2AB). Phosphatidylethanolamine increased both the rate and efficiency of C2AB- and C2B-regulated fusion without affecting their abilities to bind membrane-embedded syntaxin-SNAP-25 (t-SNARE) complexes. At equimolar concentrations, the isolated C2A domain was an effective inhibitor of C2B-, but not C2AB-regulated fusion; hence, C2A has markedly different effects in the fusion assay depending on whether it is tethered to C2B. Finally, scanning alanine mutagenesis of C2AB revealed four distinct groups of mutations within the C2B domain that play roles in the regulation of SNARE-mediated fusion. Surprisingly, substitution of Arg-398 with alanine, which lies on the opposite end of C2B from the Ca2+/membrane-binding loops, decreases C2AB t-SNARE binding and Ca2+-triggered fusion in vitro without affecting Ca(2+-)triggered interactions with phosphatidylserine or vesicle aggregation. In addition, some mutations uncouple the clamping and stimulatory functions of syt 1, suggesting that these two activities are mediated by distinct structural determinants in C2B.	Univ Wisconsin, Dept Physiol, Madison, WI 53706 USA; Univ Wisconsin, Howard Hughes Med Inst, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; Howard Hughes Medical Institute; University of Wisconsin System; University of Wisconsin Madison	Chapman, ER (corresponding author), 1300 Univ Ave,129 SMI, Madison, WI 53706 USA.	chapman@physiology.wisc.edu	Hui, Enfu/C-2806-2012; Wang, Zhao/C-2168-2014	Chapman, Edwin/0000-0001-9787-8140; WANG, ZHAO/0000-0002-4233-9884	National Institutes of Health [GM 56827, MH 61876]; American Heart Association [0440168N]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056827] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH061876] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported, in whole or in part, by National Institutes of Health Grants GM 56827 and MH 61876. This work was also supported by American Heart Association Grant 0440168N.	Bai JH, 2004, NEURON, V41, P929, DOI 10.1016/S0896-6273(04)00117-5; Bai JH, 2002, P NATL ACAD SCI USA, V99, P1665, DOI 10.1073/pnas.032541099; Bai JH, 2004, NAT STRUCT MOL BIOL, V11, P36, DOI 10.1038/nsmb709; Bhalla A, 2005, MOL BIOL CELL, V16, P4755, DOI 10.1091/mbc.E05-04-0277; Bhalla A, 2006, NAT STRUCT MOL BIOL, V13, P323, DOI 10.1038/nsmb1076; Bowen ME, 2005, BIOPHYS J, V89, P690, DOI 10.1529/biophysj.104.054064; BRECKENRIDGE WC, 1973, BIOCHIM BIOPHYS ACTA, V320, P681, DOI 10.1016/0304-4165(73)90148-7; BRECKENRIDGE WC, 1972, BIOCHIM BIOPHYS ACTA, V266, P695, DOI 10.1016/0005-2736(72)90365-3; Chapman ER, 2008, ANNU REV BIOCHEM, V77, P615, DOI 10.1146/annurev.biochem.77.062005.101135; Chapman ER, 1996, J BIOL CHEM, V271, P5844, DOI 10.1074/jbc.271.10.5844; Chapman ER, 1998, J BIOL CHEM, V273, P13995, DOI 10.1074/jbc.273.22.13995; CHAPMAN ER, 1995, J BIOL CHEM, V270, P23667, DOI 10.1074/jbc.270.40.23667; Chernomordik LV, 2003, ANNU REV BIOCHEM, V72, P175, DOI 10.1146/annurev.biochem.72.121801.161504; Chicka MC, 2008, NAT STRUCT MOL BIOL, V15, P827, DOI 10.1038/nsmb.1463; Dai H, 2007, J MOL BIOL, V367, P848, DOI 10.1016/j.jmb.2007.01.040; Desai RC, 2000, J CELL BIOL, V150, P1125, DOI 10.1083/jcb.150.5.1125; Fernandez I, 1998, CELL, V94, P841, DOI 10.1016/S0092-8674(00)81742-0; FONTAINE RN, 1980, J NEUROCHEM, V34, P269, DOI 10.1111/j.1471-4159.1980.tb06592.x; Fuson KL, 2007, BIOCHEMISTRY-US, V46, P13041, DOI 10.1021/bi701651k; Jackson MB, 2006, ANNU REV BIOPH BIOM, V35, P135, DOI 10.1146/annurev.biophys.35.040405.101958; KATZ B, 1965, PROC R SOC SER B-BIO, V161, P496, DOI 10.1098/rspb.1965.0017; Li LY, 2006, J BIOL CHEM, V281, P15845, DOI 10.1074/jbc.M600888200; LITTLETON JT, 1994, P NATL ACAD SCI USA, V91, P10888, DOI 10.1073/pnas.91.23.10888; Loewen CA, 2006, MOL BIOL CELL, V17, P5211, DOI 10.1091/mbc.E06-07-0622; Lynch KL, 2007, MOL BIOL CELL, V18, P4957, DOI 10.1091/mbc.E07-04-0368; Mackler JM, 2002, NATURE, V418, P340, DOI 10.1038/nature00846; Martens S, 2007, SCIENCE, V316, P1205, DOI 10.1126/science.1142614; Nalefski EA, 1996, PROTEIN SCI, V5, P2375, DOI 10.1002/pro.5560051201; Nishiki T, 2004, J NEUROSCI, V24, P8542, DOI 10.1523/JNEUROSCI.2545-04.2004; PERIN MS, 1991, J BIOL CHEM, V266, P623; Rickman C, 2003, J BIOL CHEM, V278, P5501, DOI 10.1074/jbc.C200692200; Robinson IM, 2002, NATURE, V418, P336, DOI 10.1038/nature00915; ROTHMAN JE, 1994, NATURE, V372, P55, DOI 10.1038/372055a0; Schiavo G, 1997, P NATL ACAD SCI USA, V94, P997, DOI 10.1073/pnas.94.3.997; Shao XG, 1997, NEURON, V18, P133, DOI 10.1016/S0896-6273(01)80052-0; Shin OH, 2004, P NATL ACAD SCI USA, V101, P2554, DOI 10.1073/pnas.0308477100; Shin OH, 2003, NEURON, V37, P99, DOI 10.1016/S0896-6273(02)01145-5; Shin OH, 2002, NAT NEUROSCI, V5, P649, DOI 10.1038/nn869; Stein A, 2007, NAT STRUCT MOL BIOL, V14, P904, DOI 10.1038/nsmb1305; Stevens CF, 2003, NEURON, V39, P299, DOI 10.1016/S0896-6273(03)00432-X; Sutton RB, 1998, NATURE, V395, P347, DOI 10.1038/26412; SUTTON RB, 1995, CELL, V80, P929, DOI 10.1016/0092-8674(95)90296-1; SZOKA F, 1980, ANNU REV BIOPHYS BIO, V9, P467, DOI 10.1146/annurev.bb.09.060180.002343; Tucker WC, 2004, SCIENCE, V304, P435, DOI 10.1126/science.1097196; Tucker WC, 2003, J CELL BIOL, V162, P199, DOI 10.1083/jcb.200302060; Wang P, 2003, J BIOL CHEM, V278, P47030, DOI 10.1074/jbc.M306728200; Weber T, 1998, CELL, V92, P759, DOI 10.1016/S0092-8674(00)81404-X	47	55	56	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 14	2008	283	46					31763	31775		10.1074/jbc.M803355200	http://dx.doi.org/10.1074/jbc.M803355200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	370KJ	18784080	hybrid, Green Published			2022-12-27	WOS:000260760800059
J	Cherry, J; Jones, H; Karschner, VA; Pekala, PH				Cherry, Joy; Jones, Heath; Karschner, Vesna A.; Pekala, Phillip H.			Post-transcriptional Control of CCAAT/Enhancer-binding Protein beta (C/EBP beta) Expression FORMATION OF A NUCLEAR HuR-C/EBP beta mRNA COMPLEX DETERMINES THE AMOUNT OF MESSAGE REACHING THE CYTOSOL	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MITOTIC CLONAL EXPANSION; 3'-UNTRANSLATED REGION; PPAR-GAMMA; GENE; ELEMENT; ALPHA; STABILIZATION; CELL; DIFFERENTIATION; ADIPOGENESIS	In 3T3-L1 cells, HuR is constitutively expressed and prior to induction of differentiation localized predominantly to the nucleus. Within minutes of induction of differentiation, nuclear HuR binds to its target ligand mRNAs, and the complexes appear to move to the cytosol. One ligand mRNA is the CCAAT/enhancer-binding protein beta (C/EBP beta) message. To examine the function and importance of the HuR-C/EBP beta interaction, retroviral expression constructs were created in which the HuR binding site was altered by deletion (beta del) or deletion and substitution (beta d/s). Expression of these constructs in murine embryonic fibroblasts resulted in significant adipose conversion relative to those cells expressing wild type C/EBP beta. C/EBP beta protein content was increased markedly in both beta del and beta d/s, which correlated with the acquisition of the adipocyte phenotype. Analysis of the beta d/s cell line demonstrated a robust expression of C/EBP alpha coincident with peroxisome proliferator-activated receptor gamma expression. Total C/EBP beta mRNA accumulation indicated no difference between cells harboring either the wild type C/EBP beta cDNA or beta d/s construct. However, cytosolic C/EBP beta mRNA in the cells expressing the beta d/s construct was maintained at levels between 2- and 7-fold greater than in the cells expressing the wild type construct. Alteration in mRNA half-life was not responsible for the increased accumulation. Mechanistically, these data suggest that HuR binding results in nuclear retention of the C/EBP beta mRNA and is consistent with HuR control, at least in part, of mRNA processing.	[Cherry, Joy; Jones, Heath; Karschner, Vesna A.; Pekala, Phillip H.] E Carolina Univ, Brody Sch Med, Dept Biochem & Mol Biol, Greenville, NC 27858 USA	University of North Carolina; East Carolina University	Pekala, PH (corresponding author), E Carolina Univ, Brody Sch Med, Dept Biochem & Mol Biol, Greenville, NC 27858 USA.	pekalap@ecu.edu			National Institutes of Health [DK55169]; American Diabetes Association [7-03-RA-76]; Brody Brothers Foundation [MT7753]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association(American Diabetes Association); Brody Brothers Foundation	This work was supported, in whole or in part, by National Institutes of Health Grant DK55169. This work was also supported by American Diabetes Association Grant 7-03-RA-76 and Brody Brothers Foundation Grant MT7753. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked " advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Antic D, 1999, GENE DEV, V13, P449, DOI 10.1101/gad.13.4.449; Brennan CM, 2000, J CELL BIOL, V151, P1, DOI 10.1083/jcb.151.1.1; Dean JLE, 2001, MOL CELL BIOL, V21, P721, DOI 10.1128/MCB.21.3.721-730.2001; Di Marco S, 2001, NUCLEIC ACIDS RES, V29, P863, DOI 10.1093/nar/29.4.863; Dixon DA, 2001, J CLIN INVEST, V108, P1657, DOI 10.1172/JCI200112973; Fan XHC, 1998, EMBO J, V17, P3448, DOI 10.1093/emboj/17.12.3448; FORD LP, 2001, EMBO J, V20, P1134; Gallouzi IE, 2000, P NATL ACAD SCI USA, V97, P3073, DOI 10.1073/pnas.97.7.3073; Gallouzi IE, 2001, SCIENCE, V294, P1895, DOI 10.1126/science.1064693; Gantt K, 2005, J BIOL CHEM, V280, P24768, DOI 10.1074/jbc.M502011200; Gantt KR, 2006, J CELL BIOCHEM, V99, P565, DOI 10.1002/jcb.20950; Gantt KR, 2004, BIOCHEM BIOPH RES CO, V313, P619, DOI 10.1016/j.bbrc.2003.11.162; Goldberg-Cohen I, 2002, J BIOL CHEM, V277, P13635, DOI 10.1074/jbc.M108703200; GONZALEZ GA, 1989, CELL, V59, P675, DOI 10.1016/0092-8674(89)90013-5; Hamm JK, 2001, J BIOL CHEM, V276, P18464, DOI 10.1074/jbc.M100797200; HUARTE J, 1992, CELL, V69, P1021, DOI 10.1016/0092-8674(92)90620-R; Jain RG, 1997, MOL CELL BIOL, V17, P954, DOI 10.1128/MCB.17.2.954; Jones H, 2007, BIOCHEM BIOPH RES CO, V355, P217, DOI 10.1016/j.bbrc.2007.01.136; Keene JD, 1999, P NATL ACAD SCI USA, V96, P5, DOI 10.1073/pnas.96.1.5; King PH, 2000, GENE, V242, P125, DOI 10.1016/S0378-1119(99)00537-5; Kirigiti P, 2001, MOL PHARMACOL, V60, P1308, DOI 10.1124/mol.60.6.1308; Klemm DJ, 1998, J BIOL CHEM, V273, P917, DOI 10.1074/jbc.273.2.917; Levy NS, 1998, J BIOL CHEM, V273, P6417, DOI 10.1074/jbc.273.11.6417; Loflin P, 2001, FEBS LETT, V509, P267, DOI 10.1016/S0014-5793(01)03176-3; Ma WJ, 1996, J BIOL CHEM, V271, P8144, DOI 10.1074/jbc.271.14.8144; Morrison RF, 1999, J BIOL CHEM, V274, P17088, DOI 10.1074/jbc.274.24.17088; Myer VE, 1997, EMBO J, V16, P2130, DOI 10.1093/emboj/16.8.2130; Neal JW, 2003, J BIOL CHEM, V278, P17246, DOI 10.1074/jbc.M300528200; Otto TC, 2005, CRIT REV BIOCHEM MOL, V40, P229, DOI 10.1080/10409230591008189; Peng SSY, 1998, EMBO J, V17, P3461, DOI 10.1093/emboj/17.12.3461; ROBINOW S, 1988, SCIENCE, V242, P1570, DOI 10.1126/science.3144044; STEPHENS JM, 1993, MOL CELL BIOCHEM, V123, P63, DOI 10.1007/BF01076476; Tang QQ, 2003, P NATL ACAD SCI USA, V100, P850, DOI 10.1073/pnas.0337434100; Wu ZD, 1998, J CLIN INVEST, V101, P22, DOI 10.1172/JCI1244; Zhang JW, 2004, P NATL ACAD SCI USA, V101, P43, DOI 10.1073/pnas.0307229101; Zhang JW, 2004, J BIOL CHEM, V279, P4471, DOI 10.1074/jbc.M311327200; Zhu H, 2008, MOL CELL BIOL, V28, P1240, DOI 10.1128/MCB.01509-07; Zhu H, 2007, J BIOL CHEM, V282, P2203, DOI 10.1074/jbc.M609349200; Zhu H, 2006, MOL BIOL CELL, V17, P5105, DOI 10.1091/mbc.E06-02-0099; Zuo Y, 2006, J BIOL CHEM, V281, P7960, DOI 10.1074/jbc.M510682200	40	14	14	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 7	2008	283	45					30812	30820		10.1074/jbc.M805659200	http://dx.doi.org/10.1074/jbc.M805659200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	367ID	18678862	Green Published, hybrid			2022-12-27	WOS:000260544800036
J	Liu, HY; Wen, GB; Han, JM; Hong, T; Zhuo, DG; Liu, ZQ; Cao, WH				Liu, Hui-Yu; Wen, Ge-Bo; Han, Jianmin; Hong, Tao; Zhuo, Degen; Liu, Zhenqi; Cao, Wenhong			Inhibition of Gluconeogenesis in Primary Hepatocytes by Stromal Cell-derived Factor-1 (SDF-1) through a c-Src/Akt-dependent Signaling Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTOR FOXO1; HEPATIC GLUCOSE-PRODUCTION; CHEMOKINE RECEPTOR CXCR4; MICE LACKING; MIGRATION; EXPRESSION; KINASES; LIVER; ACTIVATION; CANCER	Hepatic gluconeogenesis is elevated in diabetes and a major contributor to hyperglycemia. Stromal cell-derived factor-1 (SDF-1) is a chemokine and an activator of Akt. In this study, we tested the hypothesis that SDF-1 suppresses hepatic gluconeogenesis through Akt. Our results from isolated primary hepatocytes show that SDF-1 alpha and SDF-1 beta inhibited glucose production via gluconeogenesis and reduced transcript levels of key gluconeogenic genes glucose-6-phosphatase (G6Pase) and phosphoenolpyruvate carboxykinase (PEPCK). Additionally, SDF-1 alpha and SDF-1 beta both inhibited activation of the PEPCK promoter. In examining the mechanism by which SDF-1 inhibits gluconeogenesis, we found that SDF-1 promoted phosphorylation of Akt, FoxO1, and c-Src, but did not activate insulin receptor substrate-1-like insulin. Blockade of Akt activation by LY294002, FoxO1 translocation by constitutively nuclear FoxO1 mutant, or c-Src activation by the chemical inhibitor PP2, respectively, blunted SDF-1 suppression of gluconeogenesis. Finally, our results show that knocking down the level of SDF-1 receptor CXCR4 mRNA blocked SDF-1 suppression of gluconeogenesis. Together, our results demonstrate that SDF-1 is capable of inhibiting gluconeogenesis in primary hepatocytes through a signaling pathway distinct from the insulin signaling.	[Liu, Hui-Yu; Han, Jianmin; Hong, Tao; Zhuo, Degen; Cao, Wenhong] Hamner Inst Hlth Sci, Div Translat Biol, Res Triangle Pk, NC 27709 USA; [Wen, Ge-Bo; Hong, Tao] Univ S China, Hengyang 421001, Hunan, Peoples R China; [Liu, Zhenqi] Univ Virginia, Dept Med Endocrinol, Charlottesville, VA 22908 USA; [Cao, Wenhong] Duke Univ, Med Ctr, Dept Med Endocrinol, Durham, NC 27710 USA	The Hamner Institutes for Health Sciences; University of South China; University of Virginia; Duke University	Cao, WH (corresponding author), 6 Davis Dr, Res Triangle Pk, NC 27709 USA.	hliu@thehamner.org; wcao@thehamner.org			National Institutes of Health NIDDK [R01DK076039]; Hamner Institutes for Health Sciences; American Heart Association [SDG-0530244N]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK076039] Funding Source: NIH RePORTER	National Institutes of Health NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Hamner Institutes for Health Sciences; American Heart Association(American Heart Association); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health NIDDK Grant R01DK076039 (to W. C.). This work was also supported by the Investigator Development Fund from the Hamner Institutes for Health Sciences (to W. C.) and American Heart Association Grant SDG-0530244N (to W. C.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Accili D, 2004, DIABETES, V53, P1633, DOI 10.2337/diabetes.53.7.1633; Accili D, 1996, NAT GENET, V12, P106, DOI 10.1038/ng0196-106; An J, 2004, NAT MED, V10, P268, DOI 10.1038/nm995; Barbieri F, 2007, J MOL ENDOCRINOL, V38, P383, DOI 10.1677/JME-06-0014; Braunersreuther V, 2007, THROMB HAEMOSTASIS, V97, P714, DOI 10.1160/TH07-01-0036; Broxmeyer HE, 2008, CURR OPIN HEMATOL, V15, P49, DOI 10.1097/MOH.0b013e3282f29012; Burger JA, 2007, BRIT J HAEMATOL, V137, P288, DOI 10.1111/j.1365-2141.2007.06590.x; Busillo JM, 2007, BBA-BIOMEMBRANES, V1768, P952, DOI 10.1016/j.bbamem.2006.11.002; Cameron AJ, 2007, BIOCHEM SOC T, V35, P1013, DOI 10.1042/BST0351013; Cao WH, 2005, J BIOL CHEM, V280, P42731, DOI 10.1074/jbc.M506223200; Cassuto H, 2005, J BIOL CHEM, V280, P33873, DOI 10.1074/jbc.M504119200; Chang YC, 2007, CELL TRANSPLANT, V16, P171; Choudhury GG, 2006, CELL SIGNAL, V18, P1854, DOI 10.1016/j.cellsig.2006.02.003; Collins QF, 2007, J BIOL CHEM, V282, P30143, DOI 10.1074/jbc.M702390200; Collins QF, 2006, J BIOL CHEM, V281, P24336, DOI 10.1074/jbc.M602177200; De Paepe B, 2008, FRONT BIOSCI-LANDMRK, V13, P2548, DOI 10.2741/2866; Frescas D, 2005, J BIOL CHEM, V280, P20589, DOI 10.1074/jbc.M412357200; Gronthos S, 2007, TRENDS ENDOCRIN MET, V18, P108, DOI 10.1016/j.tem.2007.02.002; Gross DN, 2008, ONCOGENE, V27, P2320, DOI 10.1038/onc.2008.25; Han W, 2006, CELL RES, V16, P189, DOI 10.1038/sj.cr.7310026; Huang HJ, 2007, J CELL SCI, V120, P2479, DOI 10.1242/jcs.001222; Huang YC, 2007, BIOCHEM PHARMACOL, V74, P1702, DOI 10.1016/j.bcp.2007.08.025; Kayali AG, 2003, J CELL BIOL, V163, P859, DOI 10.1083/jcb.200304153; Kitamura T, 2002, J CLIN INVEST, V110, P1839, DOI 10.1172/JCI200216857; Koizumi K, 2007, CANCER SCI, V98, P1652, DOI 10.1111/j.1349-7006.2007.00606.x; Levinson NM, 2008, CELL, V134, P124, DOI 10.1016/j.cell.2008.05.051; Liu HY, 2008, J BIOL CHEM, V283, P12056, DOI 10.1074/jbc.M801033200; Liu HY, 2007, J BIOL CHEM, V282, P14205, DOI 10.1074/jbc.M609701200; Liu HY, 2005, J BIOL CHEM, V280, P19461, DOI 10.1074/jbc.M500313200; Ma Q, 1998, P NATL ACAD SCI USA, V95, P9448, DOI 10.1073/pnas.95.16.9448; Matin K, 2002, IMMUNOLOGY, V107, P222, DOI 10.1046/j.1365-2567.2002.01478.x; Matsumoto M, 2007, CELL METAB, V6, P208, DOI 10.1016/j.cmet.2007.08.006; MCGARRIGLE D, 2007, SCI STKE, pPE35, DOI DOI 10.1126/STKE.3922007PE35; Mendes-Da-Cruz DA, 2008, J IMMUNOL, V180, P4639, DOI 10.4049/jimmunol.180.7.4639; Nagasawa T, 1996, NATURE, V382, P635, DOI 10.1038/382635a0; Nakae J, 2001, J CLIN INVEST, V108, P1359, DOI 10.1172/JCI200112876; Odemis V, 2007, J CELL SCI, V120, P4050, DOI 10.1242/jcs.010009; Ono H, 2003, DIABETES, V52, P2905, DOI 10.2337/diabetes.52.12.2905; Poggi A, 2007, CURR MED CHEM, V14, P3166, DOI 10.2174/092986707782793835; Schober A, 2007, THROMB HAEMOSTASIS, V97, P730, DOI 10.1160/TH07-02-0085; Shao JH, 2005, DIABETES, V54, P976, DOI 10.2337/diabetes.54.4.976; Shibuta K, 2002, JPN J CANCER RES, V93, P789, DOI 10.1111/j.1349-7006.2002.tb01321.x; Stumm R, 2007, J MOL ENDOCRINOL, V38, P377, DOI 10.1677/JME-06-0032; Sutton A, 2007, MOL CANCER RES, V5, P21, DOI 10.1158/1541-7786.MCR-06-0103; TASHIRO K, 1993, SCIENCE, V261, P600, DOI 10.1126/science.8342023; Tsutsumi H, 2007, BIOPOLYMERS, V88, P279, DOI 10.1002/bip.20653; vanBiesen T, 1996, ENDOCR REV, V17, P698, DOI 10.1210/er.17.6.698; Warmuth M, 2003, CURR PHARM DESIGN, V9, P2043, DOI 10.2174/1381612033454126; Whiteman EL, 2002, TRENDS ENDOCRIN MET, V13, P444, DOI 10.1016/S1043-2760(02)00662-8; Wu MH, 2008, J CELL BIOCHEM, V103, P245, DOI 10.1002/jcb.21400; Xiong Y, 2007, J BIOL CHEM, V282, P4975, DOI 10.1074/jbc.M606742200; Yano T, 2007, DIABETES, V56, P2946, DOI 10.2337/db07-0291; Zhu W, 2007, J BIOL CHEM, V282, P18676, DOI 10.1074/jbc.M610232200; Zou YR, 1998, NATURE, V393, P595, DOI 10.1038/31269	54	20	22	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 7	2008	283	45					30642	30649		10.1074/jbc.M803698200	http://dx.doi.org/10.1074/jbc.M803698200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	367ID	18786922	Green Published, hybrid			2022-12-27	WOS:000260544800021
J	Ehteshami, M; Scarth, BJ; Tchesnokov, EP; Dash, C; Le Grice, SFJ; Hallenberger, S; Jochmans, D; Gotte, M				Ehteshami, Maryam; Scarth, Brian J.; Tchesnokov, Egor P.; Dash, Chandravanu; Le Grice, Stuart F. J.; Hallenberger, Sabine; Jochmans, Dirk; Goette, Matthias			Mutations M184V and Y115F in HIV-1 Reverse Transcriptase Discriminate against "Nucleotide-competing Reverse Transcriptase Inhibitors"	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLYMERASE TRANSLOCATION; DRUG-RESISTANCE; RT INHIBITORS; DNA-SYNTHESIS; SUBSTITUTIONS; MECHANISM; ABACAVIR; SUSCEPTIBILITY; REPLICATION; APHIDICOLIN	Indolopyridones are potent inhibitors of reverse transcriptase (RT) of the human immunodeficiency virus type 1 (HIV-1). Although the structure of these compounds differs from established nucleoside analogue RT inhibitors (NRTIs), previous studies suggest that the prototype compound INDOPY-1 may bind in close proximity to the polymerase active site. NRTI-associated mutations that are clustered around the active site confer decreased, e. g. M184V and Y115F, or increased, e. g. K65R, susceptibility to INDOPY-1. Here we have studied the underlying biochemical mechanism. RT enzymes containing the isolated mutations M184V and Y115F cause 2-3-fold increases in IC50 values, while the combination of the two mutations causes a > 15-fold increase. K65R can partially counteract these effects. Binding studies revealed that the M184V change reduces the affinity to INDOPY-1, while Y115F facilitates binding of the natural nucleotide substrate and the combined effects enhance the ability of the enzyme to discriminate against the inhibitor. Studies with other strategic mutations at residues Phe-61 and Ala-62, as well as the use of chemically modified templates shed further light on the putative binding site of the inhibitor and ternary complex formation. An abasic site residue at position n, i. e. opposite the 3'-end of the primer, prevents binding of INDOPY-1, while an abasic site at the adjacent position n + 1 has no effect. Collectively, our findings provide strong evidence to suggest that INDOPY-1 can compete with natural deoxynucleoside triphosphates (dNTPs). We therefore propose to refer to members of this class of compounds as "nucleotide-competing RT inhibitors" (NcRTIs).	[Ehteshami, Maryam; Scarth, Brian J.; Tchesnokov, Egor P.; Goette, Matthias] McGill Univ, Dept Microbiol & Immunol, Montreal, PQ H3A 2B4, Canada; [Goette, Matthias] McGill Univ, Dept Med, Montreal, PQ H3A 2B4, Canada; [Goette, Matthias] McGill Univ, Dept Biochem, Montreal, PQ H3A 2B4, Canada; [Dash, Chandravanu; Le Grice, Stuart F. J.] NCI, RT Biochem Sect, HIV Drug Resistance Program, NIH, Frederick, MD 21702 USA; [Hallenberger, Sabine; Jochmans, Dirk] Tibotec BVBA, B-2800 Mechelen, Belgium	McGill University; McGill University; McGill University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Johnson & Johnson	Gotte, M (corresponding author), McGill Univ, Dept Microbiol & Immunol, Duff Med Bldg D-6,3775 Univ St, Montreal, PQ H3A 2B4, Canada.	matthias.gotte@mcgill.ca	; JOCHMANS, DIRK/T-6223-2017	Dash, Chandravanu/0000-0003-4466-8355; JOCHMANS, DIRK/0000-0002-9265-6028	Center for Cancer Research, NCI, National Institutes of Health; Tibotec; Canadian Institutes of Health Research (CIHR); NATIONAL CANCER INSTITUTE [ZIABC010495, ZIABC010494] Funding Source: NIH RePORTER	Center for Cancer Research, NCI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Tibotec; Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by the intramural research program of the Center for Cancer Research, NCI, National Institutes of Health (to S. L. G.). This work was also funded in part by Tibotec and a grant from the Canadian Institutes of Health Research (CIHR) (to M. G.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	ARTS EJ, 1994, J BIOL CHEM, V269, P14672; Basavapathruni A, 2007, FASEB J, V21, P3795, DOI 10.1096/fj.07-8697rev; CHENG CH, 1993, BIOCHEMISTRY-US, V32, P8568, DOI 10.1021/bi00084a025; Fisher TS, 2003, J MOL BIOL, V325, P443, DOI 10.1016/S0022-2836(02)01225-1; Fisher TS, 2002, J BIOL CHEM, V277, P22345, DOI 10.1074/jbc.M200282200; Goldschmidt V, 2004, INT J BIOCHEM CELL B, V36, P1687, DOI 10.1016/j.biocel.2004.02.028; Huang HF, 1998, SCIENCE, V282, P1669, DOI 10.1126/science.282.5394.1669; JOCHMANS D, 2006, C RETR OPP INF DENV; JOCHMANS D, 2005, C RETR OPP INF BOST; JOCHMANS D, 2007, C RETR OPP INF LOS A; Jochmans D, 2008, VIRUS RES, V134, P171, DOI 10.1016/j.virusres.2008.01.003; Jochmans D, 2006, J VIROL, V80, P12283, DOI 10.1128/JVI.00889-06; Lanier ER, 2004, HIV MED, V5, P394, DOI 10.1111/j.1468-1293.2004.00243.x; LEGRICE SFJ, 1990, EUR J BIOCHEM, V187, P307, DOI 10.1111/j.1432-1033.1990.tb15306.x; Mandal D, 2006, NUCLEIC ACIDS RES, V34, P2853, DOI 10.1093/nar/gkl360; Marchand B, 2003, J BIOL CHEM, V278, P35362, DOI 10.1074/jbc.M304262200; Marchand B, 2007, J BIOL CHEM, V282, P3337, DOI 10.1074/jbc.M607710200; MartinHernandez AM, 1996, EMBO J, V15, P4434, DOI 10.1002/j.1460-2075.1996.tb00816.x; Menendez-Arias L, 2008, VIRUS RES, V134, P124, DOI 10.1016/j.virusres.2007.12.015; Miller MD, 2004, AIDS REV, V6, P22; Miller V, 2000, AIDS, V14, P163, DOI 10.1097/00002030-200001280-00012; Ray AS, 2002, J BIOL CHEM, V277, P40479, DOI 10.1074/jbc.M205303200; Sarafianos SG, 2002, EMBO J, V21, P6614, DOI 10.1093/emboj/cdf637; SHEAFF R, 1991, BIOCHEMISTRY-US, V30, P8590, DOI 10.1021/bi00099a014; Silverman AP, 2008, BIOCHEMISTRY-US, V47, P4800, DOI 10.1021/bi702427y; Sluis-Cremer N, 2000, BIOCHEM J, V348, P77, DOI 10.1042/0264-6021:3480077; Sluis-Cremer N, 2008, VIRUS RES, V134, P147, DOI 10.1016/j.virusres.2008.01.002; Sluis-Cremer N, 2007, ANTIMICROB AGENTS CH, V51, P48, DOI 10.1128/AAC.00683-06; Tong WJ, 1997, BIOCHEMISTRY-US, V36, P5749, DOI 10.1021/bi962410z; Tuske S, 2004, NAT STRUCT MOL BIOL, V11, P469, DOI 10.1038/nsmb760; Wainberg MA, 1999, ANTIVIR THER, V4, P87; Zhang ZJ, 2006, ANTIMICROB AGENTS CH, V50, P2772, DOI 10.1128/AAC.00127-06	32	42	44	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 31	2008	283	44					29904	29911		10.1074/jbc.M804882200	http://dx.doi.org/10.1074/jbc.M804882200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	364WS	18728003	hybrid, Green Published			2022-12-27	WOS:000260366900035
J	Lo, WY; Botzolakis, EJ; Tang, X; Macdonald, RL				Lo, Wen-yi; Botzolakis, Emmanuel J.; Tang, Xin; Macdonald, Robert L.			A Conserved Cys-loop Receptor Aspartate Residue in the M3-M4 Cytoplasmic Loop Is Required for GABA(A) Receptor Assembly	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NICOTINIC ACETYLCHOLINE-RECEPTORS; ENDOPLASMIC-RETICULUM; EPILEPSY MUTATION; FEBRILE SEIZURES; ALPHA-1 SUBUNIT; BETA-SUBUNITS; CELL-SURFACE; GLYCINE RECEPTOR; GAMMA-2 SUBUNIT; A RECEPTORS	Members of the Cys-loop superfamily of ligand-gated ion channels, which mediate fast synaptic transmission in the nervous system, are assembled as heteropentamers from a large repertoire of neuronal subunits. Although several motifs in subunit N-terminal domains are known to be important for subunit assembly, increasing evidence points toward a role for C-terminal domains. Using a combination of flow cytometry, patch clamp recording, endoglycosidase H digestion, brefeldin A treatment, and analytic centrifugation, we identified a highly conserved aspartate residue at the boundary of the M3-M4 loop and the M4 domain that was required for binary and ternary gamma-aminobutyric acid type A receptor surface expression. Mutation of this residue caused mutant and partnering subunits to be retained in the endoplasmic reticulum, reflecting impaired forward trafficking. Interestingly although mutant and partnering wild type subunits could be coimmunoprecipitated, analytic centrifugation studies demonstrated decreased formation of pentameric receptors, suggesting that this residue played an important role in later steps of subunit oligomerization. We thus conclude that C-terminal motifs are also important determinants of Cys-loop receptor assembly.	[Macdonald, Robert L.] Vanderbilt Univ, Med Ctr, Dept Neurol, Nashville, TN 37232 USA; [Lo, Wen-yi; Botzolakis, Emmanuel J.; Tang, Xin] Vanderbilt Univ, Program Neurosci, Nashville, TN 37232 USA; [Macdonald, Robert L.] Vanderbilt Univ, Dept Physiol & Mol Biophys, Nashville, TN 37232 USA; [Macdonald, Robert L.] Vanderbilt Univ, Dept Pharmacol, Nashville, TN 37232 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University	Macdonald, RL (corresponding author), Vanderbilt Univ, Med Ctr, Dept Neurol, 6140 Med Res Bldg 3,465 21st Ave, Nashville, TN 37232 USA.	macdonald@vanderbilt.edu			National Institutes of Health [NS33300]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS033300] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant NS33300 to (R. L. M.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Beck M, 2002, J BIOL CHEM, V277, P30079, DOI 10.1074/jbc.M200438200; BULLER AL, 1994, MOL PHARMACOL, V46, P858; Charych EI, 2004, J NEUROCHEM, V90, P173, DOI 10.1111/j.1471-4159.2004.02481.x; Connolly CN, 1999, MOL CELL NEUROSCI, V13, P259, DOI 10.1006/mcne.1999.0746; Connolly CN, 1996, J BIOL CHEM, V271, P89, DOI 10.1074/jbc.271.1.89; CORPET F, 1988, NUCLEIC ACIDS RES, V16, P10881, DOI 10.1093/nar/16.22.10881; Frugier G, 2007, J BIOL CHEM, V282, P3819, DOI 10.1074/jbc.M608910200; FUJIWARA T, 1988, J BIOL CHEM, V263, P18545; Gallagher MJ, 2007, P NATL ACAD SCI USA, V104, P12999, DOI 10.1073/pnas.0700163104; Gallagher MJ, 2005, J BIOL CHEM, V280, P37995, DOI 10.1074/jbc.M508305200; Gallagher MJ, 2004, J NEUROSCI, V24, P5570, DOI 10.1523/JNEUROSCI.1301-04.2004; GELMAN MS, 1995, J BIOL CHEM, V270, P15085, DOI 10.1074/jbc.270.25.15085; Gorrie GH, 1997, J NEUROSCI, V17, P6587; GREEN WN, 1993, CELL, V74, P57, DOI 10.1016/0092-8674(93)90294-Z; Hales TG, 2005, MOL CELL NEUROSCI, V29, P120, DOI 10.1016/j.mcn.2005.01.002; Harkin LA, 2002, AM J HUM GENET, V70, P530, DOI 10.1086/338710; Helenius A, 2004, ANNU REV BIOCHEM, V73, P1019, DOI 10.1146/annurev.biochem.73.011303.073752; Hinkle DJ, 2003, BIOTECHNIQUES, V35, P472; Kang JQ, 2006, J NEUROSCI, V26, P2590, DOI 10.1523/JNEUROSCI.4243-05.2006; Kang JQ, 2004, J NEUROSCI, V24, P8672, DOI 10.1523/JNEUROSCI.2717-04.2004; Kittler JT, 2000, J NEUROSCI, V20, P7972; Klausberger T, 2001, J NEUROSCI, V21, P9124, DOI 10.1523/JNEUROSCI.21-23-09124.2001; Lagrange AH, 2007, J PHYSIOL-LONDON, V578, P655, DOI 10.1113/jphysiol.2006.122135; Le Novere N, 1999, NUCLEIC ACIDS RES, V27, P340, DOI 10.1093/nar/27.1.340; Leite JF, 2000, J BIOL CHEM, V275, P13683, DOI 10.1074/jbc.275.18.13683; Lynch JW, 2004, PHYSIOL REV, V84, P1051, DOI 10.1152/physrev.00042.2003; MACDONALD RL, 1994, ANNU REV NEUROSCI, V17, P569, DOI 10.1146/annurev.neuro.17.1.569; Maus ADJ, 1998, MOL PHARMACOL, V54, P779, DOI 10.1124/mol.54.5.779; McKernan RM, 1996, TRENDS NEUROSCI, V19, P139, DOI 10.1016/S0166-2236(96)80023-3; Millar NS, 2003, BIOCHEM SOC T, V31, P869, DOI 10.1042/BST0310869; Niesler B, 2001, PHARMACOGENETICS, V11, P471, DOI 10.1097/00008571-200108000-00002; OU WJ, 1995, J BIOL CHEM, V270, P18051, DOI 10.1074/jbc.270.30.18051; Pratt MB, 2000, J BIOL CHEM, V275, P29441, DOI 10.1074/jbc.M004710200; Quiram PA, 1999, J CLIN INVEST, V104, P1403, DOI 10.1172/JCI8179; Roccamo AM, 2007, J NEUROSCI RES, V85, P285, DOI 10.1002/jnr.21123; Shen XM, 2005, BRAIN, V128, P345, DOI 10.1093/brain/awh364; Skok MV, 2003, MOL PHARMACOL, V64, P885, DOI 10.1124/mol.64.4.885; SMITH MM, 1987, J BIOL CHEM, V262, P4367; Taylor PM, 2000, J NEUROSCI, V20, P1297; Taylor PM, 1999, J NEUROSCI, V19, P6360; Unwin N, 2005, J MOL BIOL, V346, P967, DOI 10.1016/j.jmb.2004.12.031; Wanamaker CP, 2007, J BIOL CHEM, V282, P31113, DOI 10.1074/jbc.M705369200; Wang JM, 2002, NAT NEUROSCI, V5, P963, DOI 10.1038/nn918	43	33	33	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 31	2008	283	44					29740	29752		10.1074/jbc.M802856200	http://dx.doi.org/10.1074/jbc.M802856200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	364WS	18723504	Green Published, hybrid			2022-12-27	WOS:000260366900018
J	Masia, R; Nichols, CG				Masia, Ricard; Nichols, Colin G.			Functional Clustering of Mutations in the Dimer Interface of the Nucleotide Binding Folds of the Sulfonylurea Receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							K-ATP CHANNEL; NEONATAL DIABETES-MELLITUS; ABC TRANSPORTER; INSULIN-SECRETION; SUR1; SUBUNIT; DOMAIN; MGADP; PHOSPHORYLATION; TRAFFICKING	ATP-sensitive K+ (K-ATP) channels modulate their activity as a function of inhibitory ATP and stimulatory Mg-nucleotides. They are constituted by two proteins: a pore-forming K+ channel subunit (Kir6.1, Kir6.2) and a regulatory sulfonylurea receptor (SUR) subunit, an ATP-binding cassette (ABC) transporter that confers MgADP stimulation to the channel. Channel regulation by MgADP is dependent on nucleotide interaction with the cytoplasmic nucleotide binding folds (NBF1 and NBF2) of the SUR subunit. Crystal structures of bacterial ABC proteins indicate that NBFs form as dimers, suggesting that NBF1-NBF2 heterodimers may form in SUR and other eukaryotic ABC proteins. We have modeled SUR1 NBF1 and NBF2 as a heterodimer, and tested the validity of the predicted dimer interface by systematic mutagenesis. Engineered cysteine mutations in this region have significant effects, both positive and negative, on MgADP stimulation of K-ATP channels in excised patches and on macroscopic channel activity in intact cells. Additionally, the mutations cluster in the model structure according to their functional effect, such that patterns of alteration emerge. Of note, three gain-of-function mutations, leading to MgADP hyperstimulation of the channel, are located in the D-loop region at the center of the predicted dimer interface. Overall, the data support the idea that SUR1 NBFs assemble as heterodimers and that this interaction is functionally critical.	[Masia, Ricard; Nichols, Colin G.] Washington Univ, Sch Med, Dept Cell Biol & Physiol, St Louis, MO 63110 USA	Washington University (WUSTL)	Nichols, CG (corresponding author), Washington Univ, Sch Med, Dept Cell Biol & Physiol, St Louis, MO 63110 USA.	cnichols@wustl.edu	Nichols, Colin/D-6336-2012		American Diabetes Association; American Heart Association	American Diabetes Association(American Diabetes Association); American Heart Association(American Heart Association)	This work was supported by an American Diabetes Association Grant in Aid ( to C. G. N.) and a predoctoral fellowship from the American Heart Association ( Heartland Affiliate, to R. M.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	AGUILARBRYAN L, 1995, SCIENCE, V268, P423, DOI 10.1126/science.7716547; Ashcroft FM, 2005, J CLIN INVEST, V115, P2047, DOI 10.1172/JCI25495; Babenko AP, 2006, NEW ENGL J MED, V355, P456, DOI 10.1056/NEJMoa055068; Babenko AP, 2003, J BIOL CHEM, V278, P41577, DOI 10.1074/jbc.C300363200; Bienengraeber M, 2000, FASEB J, V14, P1943, DOI 10.1096/fj.00-0027com; Campbell JD, 2004, DIABETES, V53, pS123, DOI 10.2337/diabetes.53.suppl_3.S123; Campbell JD, 2003, EMBO REP, V4, P1038, DOI 10.1038/sj.embor.7400003; Cartier EA, 2003, J BIOL CHEM, V278, P7081, DOI 10.1074/jbc.M211395200; Chan KW, 2003, EMBO J, V22, P3833, DOI 10.1093/emboj/cdg376; Dawson RJP, 2006, NATURE, V443, P180, DOI 10.1038/nature05155; de Wet H, 2008, EMBO REP, V9, P648, DOI 10.1038/embor.2008.71; de Wet H, 2007, P NATL ACAD SCI USA, V104, P18988, DOI 10.1073/pnas.0707428104; de Wet H, 2007, FEBS J, V274, P3532, DOI 10.1111/j.1742-4658.2007.05879.x; DeLano WL, 2002, PYMOL USERS MANUAL; Diederichs K, 2000, EMBO J, V19, P5951, DOI 10.1093/emboj/19.22.5951; Gribble FM, 1997, J PHYSIOL-LONDON, V504, P35, DOI 10.1111/j.1469-7793.1997.00035.x; Gribble FM, 1997, EMBO J, V16, P1145, DOI 10.1093/emboj/16.6.1145; Gribble FM, 1998, P NATL ACAD SCI USA, V95, P7185, DOI 10.1073/pnas.95.12.7185; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Hopfner KP, 2000, CELL, V101, P789, DOI 10.1016/S0092-8674(00)80890-9; Hough E, 2002, BIOCHEM BIOPH RES CO, V294, P191, DOI 10.1016/S0006-291X(02)00454-0; INAGAKI N, 1995, SCIENCE, V270, P1166, DOI 10.1126/science.270.5239.1166; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LEDERER WJ, 1989, J PHYSIOL-LONDON, V419, P193, DOI 10.1113/jphysiol.1989.sp017869; Locher KP, 2002, SCIENCE, V296, P1091, DOI 10.1126/science.1071142; Masia R, 2005, J MOL CELL CARDIOL, V39, P491, DOI 10.1016/j.yjmcc.2005.03.009; Masia R, 2007, DIABETES, V56, P1357, DOI 10.2337/db06-1746; Matsuo M, 2000, J BIOL CHEM, V275, P28757, DOI 10.1074/jbc.M004818200; Matsuo M, 1999, J BIOL CHEM, V274, P37479, DOI 10.1074/jbc.274.52.37479; Mense M, 2006, EMBO J, V25, P4728, DOI 10.1038/sj.emboj.7601373; Mikhailov MV, 2005, EMBO J, V24, P4166, DOI 10.1038/sj.emboj.7600877; Mikhailov MV, 2000, J BIOL CHEM, V275, P3360, DOI 10.1074/jbc.275.5.3360; Moody JE, 2002, J BIOL CHEM, V277, P21111, DOI 10.1074/jbc.C200228200; Nichols CG, 1996, SCIENCE, V272, P1785, DOI 10.1126/science.272.5269.1785; Nichols CG, 2006, NATURE, V440, P470, DOI 10.1038/nature04711; Oloo EO, 2006, J BIOL CHEM, V281, P28397, DOI 10.1074/jbc.M513614200; Proks P, 2007, HUM MOL GENET, V16, P2011, DOI 10.1093/hmg/ddm149; Proks P, 2006, HUM MOL GENET, V15, P1793, DOI 10.1093/hmg/ddl101; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Schwanstecher M, 1998, EMBO J, V17, P5529, DOI 10.1093/emboj/17.19.5529; Shi Y, 2008, J BIOL CHEM, V283, P7523, DOI 10.1074/jbc.M709941200; Shyng SL, 1998, DIABETES, V47, P1145, DOI 10.2337/diabetes.47.7.1145; Shyng SL, 1997, J GEN PHYSIOL, V110, P643, DOI 10.1085/jgp.110.6.643; SIPPL MJ, 1993, PROTEINS, V17, P355, DOI 10.1002/prot.340170404; Smith PC, 2002, MOL CELL, V10, P139, DOI 10.1016/S1097-2765(02)00576-2; Tanabe K, 1999, J BIOL CHEM, V274, P3931, DOI 10.1074/jbc.274.7.3931; Tucker SJ, 1997, NATURE, V387, P179, DOI 10.1038/387179a0; Ueda K, 1999, P NATL ACAD SCI USA, V96, P1268, DOI 10.1073/pnas.96.4.1268; Ueda K, 1997, J BIOL CHEM, V272, P22983, DOI 10.1074/jbc.272.37.22983; Zaitseva J, 2005, EMBO J, V24, P1901, DOI 10.1038/sj.emboj.7600657; Zaitseva J, 2006, EMBO J, V25, P3432, DOI 10.1038/sj.emboj.7601208; Zingman LV, 2001, NEURON, V31, P233, DOI 10.1016/S0896-6273(01)00356-7	52	26	26	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 31	2008	283	44					30322	30329		10.1074/jbc.M804318200	http://dx.doi.org/10.1074/jbc.M804318200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	364WS	18715873	Green Published, hybrid			2022-12-27	WOS:000260366900076
J	Satoh, Y; Matsumura, I; Tanaka, H; Ezoe, S; Fukushima, K; Tokunaga, M; Yasumi, M; Shibayama, H; Mizuki, M; Era, T; Okuda, T; Kanakura, Y				Satoh, Yusuke; Matsumura, Itaru; Tanaka, Hirokazu; Ezoe, Sachiko; Fukushima, Kentaro; Tokunaga, Masahiro; Yasumi, Masato; Shibayama, Hirohiko; Mizuki, Masao; Era, Takumi; Okuda, Tsukasa; Kanakura, Yuzuru			AML1/RUNX1 Works as a Negative Regulator of c-Mpl in Hematopoietic Stem Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACUTE MYELOID-LEUKEMIA; ACUTE MYELOGENOUS LEUKEMIA; MULTIPLE CHROMOSOMAL TRANSLOCATIONS; FAMILIAL PLATELET DISORDER; FETAL LIVER HEMATOPOIESIS; BINDING-FACTOR-BETA; MYELODYSPLASTIC SYNDROME; POINT MUTATIONS; TRANSCRIPTION FACTOR; AML1/PEBP2-ALPHA-B GENE	In this study, we analyzed the roles for AML1/RUNX1 in the regulation of the c-mpl promoter. Wild-type AML1 activated the c-mpl promoter through the proximal AML-binding site in luciferase assays using 293T and HeLa cells. In accord with this result, electrophoretic mobility shift assay and chromatin immunoprecipitation assays demonstrated that AML1 bound to this site. Next, we analyzed the function of AML1 using a mutant of AML1 lacking the C terminus (AML1dC), which was originally found in a patient with myelodysplastic syndromes. AML1dC dominant-negatively suppressed transcriptional activity of wild-type AML1. However, unexpectedly, AML1dC-transduced murine c-Kit(+)Sca1(+)Lineage(-) cells expressed c-mpl mRNA and c-Mpl protein more abundantly than mock-transduced cells, which led to the enhanced thrombopoietin-mediated proliferation. Moreover, when AML1dC was induced to express during the development of hematopoietic cells from embryonic stem (ES) cells, AML1dC augmented the c-Mpl expression on hematopoietic stem/progenitor cells. Furthermore, we found that early hematopoietic cells that derived from AML1(-/-) ES cells expressed c-Mpl more intensely than those that developed from wild-type ES cells. In contrast, AML1dC hardly affected c-Mpl expression and maturation of megakaryocytes. As for the mechanism of the different roles of AML1 in the regulation of the c-mpl promoter, we found that AML1 forms a complex with a transcription repressor mSin3A on the c-mpl promoter in hematopoietic stem/progenitor cells, although it forms a complex with a transcription activator p300 on the same promoter in megakaryocytic cells. Together, these data indicate that AML1 can regulate the c-mpl promoter both positively and negatively by changing the binding partner according to cell types.	[Satoh, Yusuke; Matsumura, Itaru; Tanaka, Hirokazu; Ezoe, Sachiko; Fukushima, Kentaro; Tokunaga, Masahiro; Yasumi, Masato; Shibayama, Hirohiko; Mizuki, Masao; Kanakura, Yuzuru] Osaka Univ, Grad Sch Med, Dept Hematol & Oncol, Suita, Osaka 5650871, Japan; [Era, Takumi] Kumamoto Univ, Div Mol Neurobiol, Inst Mol Embryol & Genet, Kumamoto 8600811, Japan; [Okuda, Tsukasa] Kyoto Prefectural Univ Med, Dept Biochem & Mol Biol, Kyoto 6028566, Japan	Osaka University; Kumamoto University; Kyoto Prefectural University of Medicine	Matsumura, I (corresponding author), Osaka Univ, Grad Sch Med, Dept Hematol & Oncol, 2-2 Yamada Oka, Suita, Osaka 5650871, Japan.	matumura@bldon.med.osaka-u.ac.jp			Ministry of Education, Science, Sports, and Culture and Technology of Japan; Sankyo Foundation of Life Science	Ministry of Education, Science, Sports, and Culture and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Sankyo Foundation of Life Science	This work was supported by grants from the Ministry of Education, Science, Sports, and Culture and Technology of Japan and the Sankyo Foundation of Life Science.	Akashi K, 2000, NATURE, V404, P193, DOI 10.1038/35004599; Bernardin-Fried F, 2004, J BIOL CHEM, V279, P15678, DOI 10.1074/jbc.M310023200; CAMERON S, 1994, BLOOD, V83, P2851, DOI 10.1182/blood.V83.10.2851.2851; Elagib KE, 2007, CRIT REV EUKAR GENE, V17, P271, DOI 10.1615/CritRevEukarGeneExpr.v17.i4.20; Elagib KE, 2003, BLOOD, V101, P4333, DOI 10.1182/blood-2002-09-2708; Era T, 2000, P NATL ACAD SCI USA, V97, P1737, DOI 10.1073/pnas.97.4.1737; Fox N, 2002, J CLIN INVEST, V110, P389, DOI 10.1172/JCI200215430; GOLUB TR, 1995, P NATL ACAD SCI USA, V92, P4917, DOI 10.1073/pnas.92.11.4917; Growney JD, 2005, BLOOD, V106, P494, DOI 10.1182/blood-2004-08-3280; Gu TL, 2000, MOL CELL BIOL, V20, P91, DOI 10.1128/MCB.20.1.91-103.2000; Harada H, 2004, BLOOD, V103, P2316, DOI 10.1182/blood-2003-09-3074; Harada H, 2003, BLOOD, V101, P673, DOI 10.1182/blood-2002-04-1010; Heller PG, 2005, BLOOD, V105, P4664, DOI 10.1182/blood-2005-01-0050; Hirai H, 2003, JPN J CLIN ONCOL, V33, P153, DOI 10.1093/jjco/hyg037; Ichikawa M, 2004, NAT MED, V10, P299, DOI 10.1038/nm997; Jalvy S, 2007, CIRC RES, V100, P1292, DOI 10.1161/01.RES.0000266609.28312.de; Jiang HM, 2005, MOL CELL BIOL, V25, P10675, DOI 10.1128/MCB.25.24.10675-10683.2005; KAUSHANSKY K, 1994, NATURE, V369, P568, DOI 10.1038/369568a0; Kimura S, 1998, P NATL ACAD SCI USA, V95, P1195, DOI 10.1073/pnas.95.3.1195; Kitabayashi I, 2001, EMBO J, V20, P7184, DOI 10.1093/emboj/20.24.7184; Lutterbach B, 2000, J BIOL CHEM, V275, P651, DOI 10.1074/jbc.275.1.651; Matsumura I, 1999, EMBO J, V18, P1367, DOI 10.1093/emboj/18.5.1367; MEYERS S, 1993, MOL CELL BIOL, V13, P6336, DOI 10.1128/MCB.13.10.6336; Michaud J, 2002, BLOOD, V99, P1364, DOI 10.1182/blood.V99.4.1364; MIYOSHI H, 1991, P NATL ACAD SCI USA, V88, P10431, DOI 10.1073/pnas.88.23.10431; NAKANO T, 1994, SCIENCE, V265, P1098, DOI 10.1126/science.8066449; Nakata S, 2004, J BIOL CHEM, V279, P55578, DOI 10.1074/jbc.M408238200; Niki M, 1997, P NATL ACAD SCI USA, V94, P5697, DOI 10.1073/pnas.94.11.5697; Niwa H, 1998, GENE DEV, V12, P2048, DOI 10.1101/gad.12.13.2048; North TE, 2002, IMMUNITY, V16, P661, DOI 10.1016/S1074-7613(02)00296-0; Okuda T, 2000, MOL CELL BIOL, V20, P319, DOI 10.1128/MCB.20.1.319-328.2000; Okuda T, 1996, CELL, V84, P321, DOI 10.1016/S0092-8674(00)80986-1; Osato M, 2004, ONCOGENE, V23, P4284, DOI 10.1038/sj.onc.1207779; Osato M, 1999, BLOOD, V93, P1817, DOI 10.1182/blood.V93.6.1817.406k36_1817_1824; Osato M, 2001, INT J HEMATOL, V74, P245, DOI 10.1007/BF02982056; Otto F, 2003, J CELL BIOCHEM, V89, P9, DOI 10.1002/jcb.10491; PAQUETTE RL, 1993, BLOOD, V82, P590, DOI 10.1182/blood.V82.2.590.bloodjournal822590; Preudhomme C, 2000, BLOOD, V96, P2862, DOI 10.1182/blood.V96.8.2862.h8002862_2862_2869; Quesnel B, 1998, BLOOD, V91, P2985, DOI 10.1182/blood.V91.8.2985.2985_2985_2990; RUSSELL M, 1994, BLOOD, V84, P1243, DOI 10.1182/blood.V84.4.1243.bloodjournal8441243; Sasaki K, 1996, P NATL ACAD SCI USA, V93, P12359, DOI 10.1073/pnas.93.22.12359; Satoh Y, 2004, J BIOL CHEM, V279, P24986, DOI 10.1074/jbc.M400407200; Shimizu K, 2000, BLOOD, V96, P288, DOI 10.1182/blood.V96.1.288.013k05_288_296; Solar GP, 1998, BLOOD, V92, P4, DOI 10.1182/blood.V92.1.4.413k38_4_10; Song WJ, 1999, NAT GENET, V23, P166, DOI 10.1038/13793; SUGIMOTO K, 1993, BLOOD, V81, P3022; TAKAHASHI A, 1995, BLOOD, V86, P607, DOI 10.1182/blood.V86.2.607.bloodjournal862607; Taniuchi I, 2002, CELL, V111, P621, DOI 10.1016/S0092-8674(02)01111-X; Uchida T, 1997, BLOOD, V90, P1403, DOI 10.1182/blood.V90.4.1403.1403_1403_1409; Vangala RK, 2003, BLOOD, V101, P270, DOI 10.1182/blood-2002-04-1288; Wang Q, 1996, CELL, V87, P697, DOI 10.1016/S0092-8674(00)81389-6; Wei XL, 2007, CANCER RES, V67, P1853, DOI 10.1158/0008-5472.CAN-06-3063; WILLMAN CL, 1993, SCIENCE, V259, P968, DOI 10.1126/science.8438156; Woolf E, 2003, P NATL ACAD SCI USA, V100, P7731, DOI 10.1073/pnas.1232420100; Yokota S, 1997, LEUKEMIA, V11, P1605, DOI 10.1038/sj.leu.2400812; YonedaKato N, 1996, ONCOGENE, V12, P265; ZHANG DE, 1994, MOL CELL BIOL, V14, P8085, DOI 10.1128/MCB.14.12.8085	57	38	39	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 31	2008	283	44					30045	30056		10.1074/jbc.M804768200	http://dx.doi.org/10.1074/jbc.M804768200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	364WS	18687690	Green Published, hybrid			2022-12-27	WOS:000260366900049
J	Austermann, J; Nazmi, AR; Muller-Tidow, C; Gerke, V				Austermann, Judith; Nazmi, Ali Reza; Mueller-Tidow, Carsten; Gerke, Volker			Characterization of the Ca2+-regulated Ezrin-S100P Interaction and Its Role in Tumor Cell Migration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ERM PROTEINS; CRYSTAL-STRUCTURE; ACTIN-BINDING; FERM DOMAIN; EZRIN; METASTASIS; S100; FAMILY; CANCER; MERLIN	Ezrin is a multidomain protein providing regulated membrane-cytoskeleton contacts that play a role in cell differentiation, adhesion, and migration. Within the cytosol of resting cells ezrin resides in an autoinhibited conformation in which the Nand C-terminal ezrin/radixin/moesin (ERM) association domains (ERMADs) interact with one another. Activation of the ezrin membrane-cytoskeleton linker function requires an opening of this interdomain association that can result from phosphatidylinositol 4,5-bisphosphate binding to the N-ERMAD and threonine 567 phosphorylation in the C-ERMAD. We have shown that ezrin can also be activated by Ca2+-dependent binding of the EF-hand protein S100P. We now provide a quantitative analysis of this interaction and map the respective binding sites to the F2 lobe in the ezrin N-ERMAD and a stretch of hydrophobic residues in the C-terminal extension of S100P. Phospholipid binding assays reveal that S100P and phosphatidylinositol 4,5-bisphosphate compete to some extent for at least partially overlapping binding sites in N-ERMAD. Using interaction-competent as well as interaction-incompetent S100P derivatives and permanently active ezrin mutants, we also show that the protein interaction and a resulting activation of ezrin promote the transendothelial migration of tumor cells. Thus, a prometastatic role of ezrin and S100P that had been proposed based on their overexpression in highly metastatic cancers is probably due to a direct interaction between the two proteins and the S100P-mediated activation of ezrin.	[Austermann, Judith; Nazmi, Ali Reza; Gerke, Volker] Univ Munster, Ctr Mol Biol Inflammat, Inst Med Biochem, D-48149 Munster, Germany; [Mueller-Tidow, Carsten] Univ Munster, Dept Med Hematol & Oncol, D-48149 Munster, Germany	University of Munster; University of Munster	Gerke, V (corresponding author), Univ Munster, Ctr Mol Biol Inflammat, Inst Med Biochem, Esmarch Str 56, D-48149 Munster, Germany.	gerke@uni-muenster.de	Müller-Tidow, Carsten/O-7207-2018; Müller-Tidow, Carsten CMT/B-5257-2014	Müller-Tidow, Carsten/0000-0002-7166-5232; Nazmi, Ali Reza/0000-0003-1262-5078	Deutsche Forschungsgemeinschaft [Ge 514/5-2]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by a Deutsche Forschungsgemeinschaft Grant Ge 514/5-2). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Barret C, 2000, J CELL BIOL, V151, P1067, DOI 10.1083/jcb.151.5.1067; Bretscher A, 2002, NAT REV MOL CELL BIO, V3, P586, DOI 10.1038/nrm882; Bretscher A, 2000, ANNU REV CELL DEV BI, V16, P113, DOI 10.1146/annurev.cellbio.16.1.113; Curto M, 2004, CANCER CELL, V5, P113, DOI 10.1016/S1535-6108(04)00031-5; Diederichs S, 2004, CANCER RES, V64, P5564, DOI 10.1158/0008-5472.CAN-04-2004; Donato R, 2001, INT J BIOCHEM CELL B, V33, P637, DOI 10.1016/S1357-2725(01)00046-2; Fievet B, 2007, BBA-MOL CELL RES, V1773, P653, DOI 10.1016/j.bbamcr.2006.06.013; Garrett SC, 2006, J BIOL CHEM, V281, P677, DOI 10.1074/jbc.R500017200; GUERREIRO DS, 2000, INT J ONCOL, V16, P231; Helfman DM, 2005, BRIT J CANCER, V92, P1955, DOI 10.1038/sj.bjc.6602613; Hughes SC, 2007, CURR OPIN CELL BIOL, V19, P51, DOI 10.1016/j.ceb.2006.12.004; Ivetic A, 2004, IMMUNOLOGY, V112, P165, DOI 10.1111/j.1365-2567.2004.01882.x; Janke M, 2008, BIOCHEMISTRY-US, V47, P3762, DOI 10.1021/bi702542s; JOHNSSON N, 1988, EMBO J, V7, P2435, DOI 10.1002/j.1460-2075.1988.tb03089.x; Khanna C, 2004, NAT MED, V10, P182, DOI 10.1038/nm982; Kielbassa-Schnepp K, 2001, CELL CALCIUM, V30, P29, DOI 10.1054/ceca.2001.0210; Koltzscher M, 2003, MOL BIOL CELL, V14, P2372, DOI 10.1091/mbc.E02-09-0553; KUBE E, 1992, J BIOL CHEM, V267, P14175; Lee JH, 2004, J CELL BIOL, V167, P327, DOI 10.1083/jcb.200403091; Mangeat P, 1999, TRENDS CELL BIOL, V9, P187, DOI 10.1016/S0962-8924(99)01544-5; Marenholz I, 2004, BIOCHEM BIOPH RES CO, V322, P1111, DOI 10.1016/j.bbrc.2004.07.096; McClatchey AI, 2003, NAT REV CANCER, V3, P877, DOI 10.1038/nrc1213; Monni R, 2008, BLOOD, V111, P3163, DOI 10.1182/blood-2007-09-110510; Ng T, 2001, EMBO J, V20, P2723, DOI 10.1093/emboj/20.11.2723; Pearson MA, 2000, CELL, V101, P259, DOI 10.1016/S0092-8674(00)80836-3; Rescher U, 2004, J CELL SCI, V117, P3473, DOI 10.1242/jcs.01208; Rety S, 2000, STRUCTURE, V8, P175, DOI 10.1016/S0969-2126(00)00093-9; Rety S, 1999, NAT STRUCT BIOL, V6, P89; Rossy J, 2007, EXP CELL RES, V313, P1106, DOI 10.1016/j.yexcr.2006.12.023; Sahai E, 2003, NAT CELL BIOL, V5, P711, DOI 10.1038/ncb1019; Seemann J, 1996, BIOCHEM J, V319, P123, DOI 10.1042/bj3190123; Smith WJ, 2003, J BIOL CHEM, V278, P4949, DOI 10.1074/jbc.M210601200; Smith WJ, 2002, ACTA CRYSTALLOGR D, V58, P1359, DOI [10.1107/S0907444902010004, 10.1107/S0907444902009162]; Wang GZ, 2006, CANCER RES, V66, P1199, DOI 10.1158/0008-5472.CAN-05-2605; Wick W, 2001, J NEUROSCI, V21, P3360, DOI 10.1523/JNEUROSCI.21-10-03360.2001; Yoshinaga-Ohara N, 2002, EXP CELL RES, V278, P112, DOI 10.1006/excr.2002.5571; Yu YL, 2004, NAT MED, V10, P175, DOI 10.1038/nm966; Zhang HM, 2003, J MOL BIOL, V325, P785, DOI 10.1016/S0022-2836(02)01278-0	38	59	64	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 24	2008	283	43					29331	29340		10.1074/jbc.M806145200	http://dx.doi.org/10.1074/jbc.M806145200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	362EB	18725408	Green Published, hybrid			2022-12-27	WOS:000260179900060
J	Guidetti, GF; Lova, P; Bernardi, B; Campus, F; Baldanzi, G; Graziani, A; Balduini, C; Torti, M				Guidetti, Gianni F.; Lova, Paolo; Bernardi, Bruno; Campus, Francesca; Baldanzi, Gianluca; Graziani, Andrea; Balduini, Cesare; Torti, Mauro			The G(i)-coupled P2Y12 Receptor Regulates Diacylglycerol-mediated Signaling in Human Platelets	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTORS; SMALL GTPASE RAP1B; INTEGRIN ALPHA(IIB)BETA(3); CROSS-TALK; ANTITHROMBOTIC DRUGS; P2Y(12) RECEPTOR; PHOSPHOLIPASE-C; GLYCOPROTEIN-VI; ACTIVATION; AGGREGATION	Stimulation of G(q)-coupled receptors activates phospholipase C and is supposed to promote both intracellular Ca2+ mobilization and protein kinase C (PKC) activation. We found that ADP-induced phosphorylation of pleckstrin, the main platelet substrate for PKC, was completely inhibited not only by an antagonist of the G(q)-coupled P2Y1 receptor but also upon blockade of the G(i)-coupled P2Y12 receptor. The role of G(i) on PKC regulation required stimulation of phosphatidylinositol 3-kinase rather than inhibition of adenylyl cyclase. P2Y12 antagonists also inhibited pleckstrin phosphorylation, Rap1b activation, and platelet aggregation induced upon G(q) stimulation by the thromboxane A(2) analogue U46619. Importantly, activation of phospholipase C and intracellular Ca2+ mobilization occurred normally. Phorbol 12-myristate 13-acetate overcame the inhibitory effect of P2Y12 receptor blockade on PKC activation but not on Rap1b activation and platelet aggregation. By contrast, inhibition of diacylglycerol kinase restored both PKC and Rap1b activity and caused platelet aggregation. Stimulation of P2Y12 receptor or direct inhibition of diacylglycerol kinase potentiated the effect of membrane-permeable sn-1,2-dioctanoylglycerol on platelet aggregation and pleckstrin phosphorylation, in association with inhibition of its phosphorylation to phosphatidic acid. These results reveal a novel and unexpected role of the G(i)-coupled P2Y12 receptor in the regulation of diacylglycerol-mediated events in activated platelets.	[Guidetti, Gianni F.; Lova, Paolo; Bernardi, Bruno; Campus, Francesca; Balduini, Cesare; Torti, Mauro] Univ Pavia, Dept Chem, Ctr Excellence Appl Biol, I-27100 Pavia, Italy; [Baldanzi, Gianluca; Graziani, Andrea] Univ Amedeo Avogadro, Dept Clin & Expt Med, I-28100 Novara, Italy	University of Pavia; University of Eastern Piedmont Amedeo Avogadro	Torti, M (corresponding author), Univ Pavia, Dept Chem, Ctr Excellence Appl Biol, Via Bassi 21, I-27100 Pavia, Italy.	mtorti@unipv.it	Baldanzi, Gianluca/AAO-7673-2021; Graziani, Andrea/AAB-6301-2022; graziani, andrea/B-2554-2009	Baldanzi, Gianluca/0000-0002-1370-9903; Graziani, Andrea/0000-0002-6302-2317; graziani, andrea/0000-0002-6302-2317	Ministero dell'Istruzione, Universita e Ricerca Scientifica (MIUR) [PRIN 2006]; University of Pavia; Consorzio Interuniversitario Biotecnologie	Ministero dell'Istruzione, Universita e Ricerca Scientifica (MIUR)(Ministry of Education, Universities and Research (MIUR)); University of Pavia; Consorzio Interuniversitario Biotecnologie	This work was supported by grants from the Ministero dell'Istruzione, Universita e Ricerca Scientifica (MIUR, PRIN 2006), from the University of Pavia, and from the Consorzio Interuniversitario Biotecnologie. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Baldanzi G, 2008, ONCOGENE, V27, P942, DOI 10.1038/sj.onc.1210717; Bernardi B, 2006, BLOOD, V107, P2728, DOI 10.1182/blood-2005-07-3023; Bertoni A, 2002, J BIOL CHEM, V277, P25715, DOI 10.1074/jbc.M202791200; BISHOP WR, 1986, J BIOL CHEM, V261, P2513; Campus F, 2005, J BIOL CHEM, V280, P24386, DOI 10.1074/jbc.M501174200; Cosemans JMEM, 2006, BLOOD, V108, P3045, DOI 10.1182/blood-2006-03-006338; Crittenden JR, 2004, NAT MED, V10, P982, DOI 10.1038/nm1098; Dangelmaier C, 2001, THROMB HAEMOSTASIS, V85, P341, DOI 10.1055/s-0037-1615690; Daniel JL, 1999, THROMB HAEMOSTASIS, V82, P1322; Dorsam RT, 2004, J CLIN INVEST, V113, P340, DOI 10.1172/JCI200420986; Eckly A, 2001, THROMB HAEMOSTASIS, V85, P694, DOI 10.1055/s-0037-1615655; Foster CJ, 2001, J CLIN INVEST, V107, P1591, DOI 10.1172/JCI12242; Gachet C, 2008, THROMB HAEMOSTASIS, V99, P466, DOI 10.1160/TH07-11-0673; Hardy AR, 2004, BLOOD, V104, P1745, DOI 10.1182/blood-2004-02-0534; Hirsch E, 2001, FASEB J, V15, P2019, DOI 10.1096/fj.00-0810fje; Hollopeter G, 2001, NATURE, V409, P202, DOI 10.1038/35051599; Jackson SP, 2005, NAT MED, V11, P507, DOI 10.1038/nm1232; Jin JG, 1998, P NATL ACAD SCI USA, V95, P8070, DOI 10.1073/pnas.95.14.8070; Kauffenstein G, 2001, FEBS LETT, V505, P281, DOI 10.1016/S0014-5793(01)02824-1; Larson MK, 2003, BLOOD, V101, P1409, DOI 10.1182/blood-2002-05-1533; Lova P, 2004, J BIOL CHEM, V279, P25299, DOI 10.1074/jbc.M313199200; Lova P, 2003, J BIOL CHEM, V278, P131, DOI 10.1074/jbc.M204821200; Lova P, 2002, J BIOL CHEM, V277, P12009, DOI 10.1074/jbc.M111803200; Luo B, 2004, CELL SIGNAL, V16, P983, DOI 10.1016/j.cellsig.2004.03.016; Merida I, 2008, BIOCHEM J, V409, P1, DOI 10.1042/BJ20071040; Nieswandt B, 2001, BLOOD, V97, P3829, DOI 10.1182/blood.V97.12.3829; NUNN DL, 1987, BIOCHEM J, V243, P809, DOI 10.1042/bj2430809; Offermanns S, 1997, NATURE, V389, P183, DOI 10.1038/38284; PACKHAM MA, 1993, BIOCHEM J, V209, P849; Paul BZS, 1999, J BIOL CHEM, V274, P29108, DOI 10.1074/jbc.274.41.29108; Rhee SG, 2001, ANNU REV BIOCHEM, V70, P281, DOI 10.1146/annurev.biochem.70.1.281; Sage SO, 2000, CELL CALCIUM, V28, P119, DOI 10.1054/ceca.2000.0139; TORTI M, 1992, CELL BIOCHEM FUNCT, V10, P53, DOI 10.1002/cbf.290100109; TYERS M, 1988, NATURE, V333, P470, DOI 10.1038/333470a0; VICKERS JD, 1990, EUR J BIOCHEM, V193, P521, DOI 10.1111/j.1432-1033.1990.tb19367.x; Woulfe D, 2002, J BIOL CHEM, V277, P23382, DOI 10.1074/jbc.M202212200; Woulfe DS, 2005, J THROMB HAEMOST, V3, P2193, DOI 10.1111/j.1538-7836.2005.01338.x; YADA Y, 1990, J BIOL CHEM, V265, P19237; Yang J, 2000, P NATL ACAD SCI USA, V97, P9984, DOI 10.1073/pnas.180194597	39	46	49	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 24	2008	283	43					28795	28805		10.1074/jbc.M801588200	http://dx.doi.org/10.1074/jbc.M801588200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	362EB	18755689	Green Published, hybrid			2022-12-27	WOS:000260179900004
J	Sahoo, A; Jung, YM; Kwon, HK; Yi, HJ; Lee, S; Chang, S; Park, ZY; Hwang, KC; Im, SH				Sahoo, Anupama; Jung, Yun Min; Kwon, Ho-Keun; Yi, Hwa-Jung; Lee, Suho; Chang, Sunghoe; Park, Zee-Yong; Hwang, Ki-Chul; Im, Sin-Hyeog			A Novel Splicing Variant of Mouse Interleukin (IL)-24 Antagonizes IL-24-induced Apoptosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DIFFERENTIATION-ASSOCIATED GENE; HUMAN-MELANOMA DIFFERENTIATION; CELL-SPECIFIC APOPTOSIS; TUMOR-SUPPRESSOR; SELECTIVE APOPTOSIS; MESSENGER-RNA; CYTOKINE GENE; ER STRESS; MDA-7/IL-24; MDA-7	Alternative splicing of mRNA enables functionally diverse protein isoforms to be expressed from a single gene, allowing transcriptome diversification. Interleukin (IL)-24/MDA-7 is a member of the IL-10 gene family, and FISP (IL-4-induced secreted protein), its murine homologue, is selectively expressed and secreted by T helper 2 lymphocytes. A novel splice variant of mouse IL-24/FISP, designated FISP-sp, lacks 29 nucleotides from the 5'-end of exon 4 of FISP. The level of FISP-sp expression is 10% of the level of total primary FISP transcription. Unlike FISP, FISP-sp does not induce growth inhibition and apoptosis. FISP-sp is exclusively localized in endoplasmic reticulum, and its expression is up-regulated by endoplasmic reticulum stress. Our results suggest that the novel splicing variant FISP-sp dimerizes with FISP and blocks its secretion and inhibits FISP-induced apoptosis in vivo.	[Sahoo, Anupama; Jung, Yun Min; Kwon, Ho-Keun; Yi, Hwa-Jung; Lee, Suho; Chang, Sunghoe; Park, Zee-Yong; Im, Sin-Hyeog] Gwangju Inst Sci & Technol, Dept Life Sci, Kwangju 500712, South Korea; [Hwang, Ki-Chul] Yonsei Univ, Coll Med, Div Cardiol, Cardiovasc Res Inst, Seoul 120752, South Korea; [Im, Sin-Hyeog] Gwangju Inst Sci & Technol, Ctr Distributed Sensor Network, Kwangju 500712, South Korea	Gwangju Institute of Science & Technology (GIST); Yonsei University; Yonsei University Health System; Gwangju Institute of Science & Technology (GIST)	Im, SH (corresponding author), Gwangju Inst Sci & Technol, Dept Life Sci, 1 Oryong Dong, Kwangju 500712, South Korea.	imsh@gist.ac.kr	Im, Sin-Hyeog/E-6811-2013; Chang, Sunghoe/J-2784-2012; Im, Sin-Hyeog/AAM-9586-2021	Im, Sin-Hyeog/0000-0002-3173-1856; Im, Sin-Hyeog/0000-0002-3173-1856; Sahoo, Anupama/0000-0002-0928-958X	21st Century Frontier Functional Human Genome Project; Korea Health 21 R D Project; Ministry of Health and Welfare [A050533]; KBRDG Initiative Research Program; Regional Technology Innovation Program of the MOCIE [RTI05-01-01]; Gwangju Institute of Science and Technology	21st Century Frontier Functional Human Genome Project(Ministry of Education, Science & Technology (MEST), Republic of Korea); Korea Health 21 R D Project; Ministry of Health and Welfare(Ministry of Health, Labour and Welfare, Japan); KBRDG Initiative Research Program; Regional Technology Innovation Program of the MOCIE(Ministry of Trade, Industry & Energy (MOTIE), Republic of Korea); Gwangju Institute of Science and Technology	This work was supported by grants from the 21st Century Frontier Functional Human Genome Project, Korea Health 21 R & D Project, Ministry of Health and Welfare Grant A050533, the KBRDG Initiative Research Program, Grant RTI05-01-01 from the Regional Technology Innovation Program of the MOCIE, and a Systems Biology Infrastructure Establishment grant provided by Gwangju Institute of Science and Technology in 2008. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Agarwal S, 1998, IMMUNITY, V9, P765, DOI 10.1016/S1074-7613(00)80642-1; Allen M, 2004, J INVEST DERMATOL, V123, P583, DOI 10.1111/j.0022-202X.2004.23321.x; Ast G, 2004, NAT REV GENET, V5, P773, DOI 10.1038/nrg1451; Bert AG, 2000, PLASMID, V44, P173, DOI 10.1006/plas.2000.1474; Caudell EG, 2002, J IMMUNOL, V168, P6041, DOI 10.4049/jimmunol.168.12.6041; Chada S, 2004, MOL THER, V10, P1085, DOI 10.1016/j.ymthe.2004.08.020; Chada S, 2004, INT IMMUNOPHARMACOL, V4, P649, DOI 10.1016/j.intimp.2004.01.017; Chen WY, 2005, GENES IMMUN, V6, P493, DOI 10.1038/sj.gene.6364233; Chung CH, 1999, BIOCHEM BIOPH RES CO, V266, P633, DOI 10.1006/bbrc.1999.1880; Ciechanover A, 2000, BIOESSAYS, V22, P442, DOI 10.1002/(SICI)1521-1878(200005)22:5<442::AID-BIES6>3.0.CO;2-Q; Elton TS, 2003, TRENDS ENDOCRIN MET, V14, P66, DOI 10.1016/S1043-2760(02)00038-3; Fisher PB, 2003, CANCER BIOL THER, V2, pS23; Gupta P, 2006, CANCER RES, V66, P8182, DOI 10.1158/0008-5472.CAN-06-0577; Gupta P, 2006, PHARMACOL THERAPEUT, V111, P596, DOI 10.1016/j.pharmthera.2005.11.005; HERSHKO A, 1982, ANNU REV BIOCHEM, V51, P335, DOI 10.1146/annurev.bi.51.070182.002003; Huang EY, 2001, ONCOGENE, V20, P7051, DOI 10.1038/sj.onc.1204897; Im SH, 2004, J BIOL CHEM, V279, P46818, DOI 10.1074/jbc.M401722200; Iwawaki T, 2001, NAT CELL BIOL, V3, P158, DOI 10.1038/35055065; Jiang HP, 1995, ONCOGENE, V11, P2477; Jiang HP, 1996, P NATL ACAD SCI USA, V93, P9160, DOI 10.1073/pnas.93.17.9160; KERR JFR, 1972, BRIT J CANCER, V26, P239, DOI 10.1038/bjc.1972.33; Kriventseva EV, 2003, TRENDS GENET, V19, P124, DOI 10.1016/S0168-9525(03)00023-4; Lebedeva IV, 2003, SEMIN CANCER BIOL, V13, P169, DOI 10.1016/S1044-579X(02)00134-7; Lebedeva IV, 2005, MOL THER, V11, P4, DOI 10.1016/j.ymthe.2004.08.012; Lebedeva IV, 2002, ONCOGENE, V21, P708, DOI 10.1038/sj.onc.1205116; Macian F, 2002, CELL, V109, P719, DOI 10.1016/S0092-8674(02)00767-5; Madireddi MT, 2000, ADV EXP MED BIOL, V465, P239; Maquat LE, 2002, CURR BIOL, V12, pR196, DOI 10.1016/S0960-9822(02)00747-9; Mhashilkar AM, 2001, MOL MED, V7, P271, DOI 10.1007/BF03401847; Philips AV, 2000, CELL MOL LIFE SCI, V57, P235, DOI 10.1007/PL00000687; Ramesh R, 2003, CANCER RES, V63, P5105; Sarkar D, 2005, CANCER RES, V65, P9056, DOI 10.1158/0008-5472.CAN-05-1261; Sarkar D, 2002, P NATL ACAD SCI USA, V99, P10054, DOI 10.1073/pnas.152327199; Sarkar D, 2002, BIOTECHNIQUES, P30; Sauane M, 2004, CANCER RES, V64, P2988, DOI 10.1158/0008-5472.CAN-04-0200; Sauane M, 2003, J CELL PHYSIOL, V196, P334, DOI 10.1002/jcp.10309; Sauane M, 2003, CYTOKINE GROWTH F R, V14, P35, DOI 10.1016/S1359-6101(02)00074-6; Sauane M, 2006, CANCER RES, V66, P11869, DOI 10.1158/0008-5472.CAN-06-1887; Schaefer G, 2001, J IMMUNOL, V166, P5859, DOI 10.4049/jimmunol.166.10.5859; Schroder M, 2005, MUTAT RES-FUND MOL M, V569, P29, DOI 10.1016/j.mrfmmm.2004.06.056; Sieger KA, 2004, MOL THER, V9, P355, DOI 10.1016/j.ymthe.2003.11.014; Soo C, 1999, J CELL BIOCHEM, V74, P1; Stamm S, 2005, GENE, V344, P1, DOI 10.1016/j.gene.2004.10.022; Su ZZ, 2005, P NATL ACAD SCI USA, V102, P1059, DOI 10.1073/pnas.0409141102; Woodman PG, 2003, J CELL SCI, V116, P4283, DOI 10.1242/jcs.00817; WYLLIE AH, 1992, CANCER METAST REV, V11, P95, DOI 10.1007/BF00048057; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0; Zhao LL, 2005, HUM GENE THER, V16, P845, DOI 10.1089/hum.2005.16.845	48	19	21	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 24	2008	283	43					28860	28872		10.1074/jbc.M802510200	http://dx.doi.org/10.1074/jbc.M802510200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	362EB	18708357	Green Published, hybrid			2022-12-27	WOS:000260179900011
J	Wu, SC; Chang, SC; Wu, HY; Liao, PJ; Chang, MF				Wu, Shun-Chi; Chang, Shin C.; Wu, Hung-Yi; Liao, Pei-Ju; Chang, Ming-Fu			Hepatitis C Virus NS5A Protein Down-regulates the Expression of Spindle Gene Aspm through PKR-p38 Signaling Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NONSTRUCTURAL 5A PROTEIN; HEPATOCELLULAR-CARCINOMA; CELL-GROWTH; BRAIN SIZE; KINASE; RNA; HCV; PHOSPHORYLATION; ORGANIZATION; DETERMINANT	Hepatitis C virus often causes persistent infection and hepatocellular carcinoma. Studies have demonstrated the roles of viral nonstructural protein 5A (NS5A) in the induction of chromosome aneuploidy, but the molecular mechanisms are not clear. In this study, hydrodynamics-based in vivo transfection was applied to a mouse system. Mouse hepatocytes that successfully expressed NS5A protein were isolated by laser capture microdissection. Gene expression profiles of the NS5A-expressing hepatocytes were examined by an Affymetrix oligonucleotide microarray system. Aspm (abnormal spindle-like, microcephaly associated), which encodes the mitotic spindle protein ASPM, was identified to be differentially expressed in the absence and the presence of NS5A. The down-regulation of Aspm mRNA and ASPM protein was confirmed by real time polymerase chain reaction and Western blot analysis, respectively, both in mouse model systems and in viral subgenomic replicon and in vitro transfection culturing systems. In addition, cultured cells that constitutively expressed NS5A protein showed G(2)/M cell cycle block and chromosome aneuploidy. Overexpression of ASPM relieved the G(2)/M cell cycle block. Furthermore, NS5A protein repressed the promoter activity of Aspm gene in a dose-dependent manner. The regulatory effect was abolished when amino acid substitutions P2209L, T2214A, and T2217G known to interrupt the NS5A-PKR interaction were introduced into the NS5A protein. This indicates that the down-regulation of Aspm expression is via the PKR-p38 signaling pathway. These results suggest that NS5A protein down-regulates the expression of the mitotic spindle protein ASPM and induces aberrant mitotic cell cycle associated with chromosome instability and hepatocellular carcinoma.	[Wu, Shun-Chi; Wu, Hung-Yi; Chang, Ming-Fu] Natl Taiwan Univ, Coll Med, Inst Biochem & Mol Biol, Taipei, Taiwan; [Chang, Shin C.; Liao, Pei-Ju] Natl Taiwan Univ, Coll Med, Inst Microbiol, Taipei, Taiwan	National Taiwan University; National Taiwan University	Chang, SC (corresponding author), Natl Taiwan Univ, Coll Med, Inst Microbiol, 1 Jen Ai Rd,1st Sect, Taipei, Taiwan.	scchang093@ntu.edu.tw; mfchang@ntu.edu.tw		CHANG, MING-FU/0000-0001-7062-3578	National Science Council of the Republic of China [NSC 93-3112-B-002-025-Y, NSC 95-2752-B-002-009-PAE, NSC 96-2752-B-002-009-PAE, NSC 96-3112-B-002-028]	National Science Council of the Republic of China(Ministry of Science and Technology, Taiwan)	This work was supported in part by Research Grants NSC 93-3112-B-002025- Y, NSC 95-2752-B-002-009-PAE, NSC 96-2752-B-002-009-PAE and NSC 96-3112-B-002-028 from the National Science Council of the Republic of China. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Arima N, 2001, J BIOL CHEM, V276, P12675, DOI 10.1074/jbc.M008329200; Baek KH, 2006, J MOL BIOL, V359, P22, DOI 10.1016/j.jmb.2006.03.020; Bond J, 2003, AM J HUM GENET, V73, P1170, DOI 10.1086/379085; Bond J, 2002, NAT GENET, V32, P316, DOI 10.1038/ng995; CHANG MF, 1993, J VIROL, V67, P2529, DOI 10.1128/JVI.67.5.2529-2536.1993; Cheng JC, 1999, J VIROL, V73, P7044, DOI 10.1128/JVI.73.8.7044-7049.1999; CHOO QL, 1991, P NATL ACAD SCI USA, V88, P2451, DOI 10.1073/pnas.88.6.2451; Clute P, 1999, NAT CELL BIOL, V1, P82, DOI 10.1038/10049; Cuenda A, 2007, BBA-MOL CELL RES, V1773, P1358, DOI 10.1016/j.bbamcr.2007.03.010; De Mitri MS, 2002, J HEPATOL, V36, P116, DOI 10.1016/S0168-8278(01)00235-5; ENOMOTO N, 1995, J CLIN INVEST, V96, P224, DOI 10.1172/JCI118025; Fish JL, 2006, P NATL ACAD SCI USA, V103, P10438, DOI 10.1073/pnas.0604066103; Gale M, 1998, MOL CELL BIOL, V18, P5208, DOI 10.1128/MCB.18.9.5208; Gale MJ, 1998, CLIN DIAGN VIROL, V10, P157; Ghosh AK, 1999, J GEN VIROL, V80, P1179, DOI 10.1099/0022-1317-80-5-1179; He YP, 2002, J VIROL, V76, P9207, DOI 10.1128/JVI.76.18.9207-9217.2002; He YP, 2001, J VIROL, V75, P5090, DOI 10.1128/JVI.75.11.5090-5098.2001; HOPF U, 1990, J HEPATOL, V10, P69, DOI 10.1016/0168-8278(90)90075-3; Horvath S, 2006, P NATL ACAD SCI USA, V103, P17402, DOI 10.1073/pnas.0608396103; Hsieh PK, 2005, J VIROL, V79, P13848, DOI 10.1128/JVI.79.22.13848-13855.2005; KANEKO T, 1994, BIOCHEM BIOPH RES CO, V205, P320, DOI 10.1006/bbrc.1994.2667; Kou YH, 2007, J VIROL, V81, P7999, DOI 10.1128/JVI.00348-07; Kouprina N, 2005, HUM MOL GENET, V14, P2155, DOI 10.1093/hmg/ddi220; Kumar A, 2002, J BIOSCIENCES, V27, P629, DOI 10.1007/BF02708369; Kuo LY, 2006, J CELL PHYSIOL, V207, P729, DOI 10.1002/jcp.20616; Lai CF, 2001, J BIOL CHEM, V276, P14443, DOI 10.1074/jbc.M010021200; Mekel-Bobrov N, 2005, SCIENCE, V309, P1720, DOI 10.1126/science.1116815; Nishise Y, 2007, J INFECT DIS, V196, P1006, DOI 10.1086/521309; Park KJ, 2003, J BIOL CHEM, V278, P30711, DOI 10.1074/jbc.M209623200; Rennefahrt U, 2004, CANCER LETT, V215, P113, DOI 10.1016/j.canlet.2004.05.015; Sevinsky JR, 2004, MOL CELL BIOL, V24, P4534, DOI 10.1128/MCB.24.10.4534-4545.2004; Silva AM, 2004, J BIOL CHEM, V279, P37670, DOI 10.1074/jbc.M406554200; Tagger A, 1999, INT J CANCER, V81, P695, DOI 10.1002/(SICI)1097-0215(19990531)81:5<695::AID-IJC4>3.3.CO;2-N; Takao Y, 2007, MED MICROBIOL IMMUN, V196, P157, DOI 10.1007/s00430-007-0038-1; Tan SL, 1999, P NATL ACAD SCI USA, V96, P5533, DOI 10.1073/pnas.96.10.5533; Tang WL, 2007, AM J PATHOL, V171, P1831, DOI 10.2353/ajpath.2007.070413; Towatari M, 2004, HEMATOL J, V5, P262, DOI 10.1038/sj.thj.6200345; Wakefield JG, 2001, J CELL BIOL, V153, P637, DOI 10.1083/jcb.153.4.637; Yu YL, 2005, J BIOL CHEM, V280, P29533, DOI 10.1074/jbc.M506514200; Zhong XY, 2005, CELL CYCLE, V4, P1227, DOI 10.4161/cc.4.9.2029	40	45	45	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 24	2008	283	43					29396	29404		10.1074/jbc.M802821200	http://dx.doi.org/10.1074/jbc.M802821200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	362EB	18728014	Green Published, hybrid			2022-12-27	WOS:000260179900066
J	Woo, EJ; Lee, S; Cha, H; Park, JT; Yoon, SM; Song, HN; Park, KH				Woo, Eui-Jeon; Lee, Seungjae; Cha, Hyunju; Park, Jong-Tae; Yoon, Sei-Mee; Song, Hyung-Nam; Park, Kwan-Hwa			Structural insight into the bifunctional mechanism of the glycogen-debranching enzyme TreX from the archaeon Sulfolobus solfataricus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALPHA-AMYLASE FAMILY; ARTHROBACTER SP Q36; MALTOGENIC AMYLASE; CRYSTAL-STRUCTURE; TREHALOSE BIOSYNTHESIS; SPECIFICITY; ACARBOSE; 4-ALPHA-GLUCANOTRANSFERASE; NEOPULLULANASE; CYCLODEXTRIN	TreX is an archaeal glycogen-debranching enzyme that exists in two oligomeric states in solution, as a dimer and tetramer. Unlike its homologs, TreX from Sulfolobus solfataricus shows dual activities for alpha-1,4-transferase and alpha-1,6-glucosidase. To understand this bifunctional mechanism, we determined the crystal structure of TreX in complex with an acarbose ligand. The acarbose intermediate was covalently bound to Asp(363), occupying subsites -1 to -3. Although generally similar to the monomeric structure of isoamylase, TreX exhibits two different active-site configurations depending on its oligomeric state. The N terminus of one subunit is located at the active site of the other molecule, resulting in a reshaping of the active site in the tetramer. This is accompanied by a large shift in the "flexible loop" (amino acids 399-416), creating connected holes inside the tetramer. Mutations in the N-terminal region result in a sharp increase in alpha-1,4-transferase activity and a reduced level of alpha-1,6-glucosidase activity. On the basis of geometrical analysis of the active site and mutational study, we suggest that the structural lid (acids 99-97) at the active site generated by the tetramerization is closely associated with the bifunctionality and in particular with the alpha-1,4-transferase activity. These results provide a structural basis for the modulation of activities upon TreX oligomerization that may represent a common mode of action for other glycogen-debranching enzymes in higher organisms.	[Woo, Eui-Jeon; Yoon, Sei-Mee; Song, Hyung-Nam] Korea Res Inst Biosci & Biotechnol, Translat Res Ctr, Taejon 305806, South Korea; [Lee, Seungjae; Cha, Hyunju; Park, Jong-Tae; Park, Kwan-Hwa] Seoul Natl Univ, Ctr Agr Biomat, Seoul 151192, South Korea; [Lee, Seungjae; Cha, Hyunju; Park, Jong-Tae; Park, Kwan-Hwa] Seoul Natl Univ, Dept Food Sci & Biotechnol, Seoul 151192, South Korea	Korea Research Institute of Bioscience & Biotechnology (KRIBB); Seoul National University (SNU); Seoul National University (SNU)	Woo, EJ (corresponding author), Korea Res Inst Biosci & Biotechnol, Translat Res Ctr, 111 Gwahangno, Taejon 305806, South Korea.	ejwoo@kribb.re.kr; parkkh@plaza.snu.ac.kr		Woo, Eui-Jeon/0000-0001-6983-0270; Lee, Seungjae/0000-0001-9081-2835; Park, Jong-Tae/0000-0002-0650-6948	Korea Research Institute of Bioscience and Biotechnology Research Initiative; Ministry of Marine Affairs and Fisheries, Republic of Korea; Korea Research Foundation Grant [KRF-2006-005-J04703]	Korea Research Institute of Bioscience and Biotechnology Research Initiative; Ministry of Marine Affairs and Fisheries, Republic of Korea; Korea Research Foundation Grant(National Research Foundation of Korea)	This work was supported by a grant from the Korea Research Institute of Bioscience and Biotechnology Research Initiative, by the Marine and Extreme Genome Research Center Program, Ministry of Marine Affairs and Fisheries, Republic of Korea, and in part by Korea Research Foundation Grant KRF-2006-005-J04703. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Barends TRM, 2007, J BIOL CHEM, V282, P17242, DOI 10.1074/jbc.M701444200; BATES EJ, 1975, FEBS LETT, V58, P181, DOI 10.1016/0014-5793(75)80254-7; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cheong KA, 2002, BIOTECHNOL APPL BIOC, V35, P27, DOI 10.1042/BA20010052; Collaborative Computational Project, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI DOI 10.1107/S0907444994003112; Davies GJ, 1997, BIOCHEM J, V321, P557, DOI 10.1042/bj3210557; Delano W.L, 2002, PYMOL USERS MANUAL; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FOX JD, 1991, ANAL BIOCHEM, V195, P93, DOI 10.1016/0003-2697(91)90300-I; Hondoh H, 2003, J MOL BIOL, V326, P177, DOI 10.1016/S0022-2836(02)01402-X; Imamura H, 2003, J BIOL CHEM, V278, P19378, DOI 10.1074/jbc.M213134200; Kim JS, 1999, J BIOL CHEM, V274, P26279, DOI 10.1074/jbc.274.37.26279; Kim TJ, 1999, APPL ENVIRON MICROB, V65, P1644; LASKOWSKI RA, 1993, J MOL BIOL, V231, P1049, DOI 10.1006/jmbi.1993.1351; Lee HS, 2002, J BIOL CHEM, V277, P21891, DOI 10.1074/jbc.M201623200; LIU W, 1991, BIOCHEMISTRY-US, V30, P1419, DOI 10.1021/bi00219a036; MacGregor EA, 2001, BBA-PROTEIN STRUCT M, V1546, P1, DOI 10.1016/S0167-4838(00)00302-2; Maruta K, 2000, BBA-PROTEIN STRUCT M, V1476, P377, DOI 10.1016/S0167-4838(99)00253-8; Maruta K, 1996, BBA-GEN SUBJECTS, V1291, P177, DOI 10.1016/S0304-4165(96)00082-7; Maruta K, 1996, BBA-GEN SUBJECTS, V1289, P10, DOI 10.1016/0304-4165(95)00139-5; Mikami B, 2006, J MOL BIOL, V359, P690, DOI 10.1016/j.jmb.2006.03.058; MILLER GL, 1959, ANAL CHEM, V31, P426, DOI 10.1021/ac60147a030; Nakayama A, 2001, J BIOL CHEM, V276, P28824, DOI 10.1074/jbc.M102192200; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Park HS, 2007, BIOSCI BIOTECH BIOCH, V71, P1348, DOI 10.1271/bbb.70016; Park JT, 2008, BIOCATAL BIOTRANSFOR, V26, P76, DOI 10.1080/10242420701806652; Park KH, 2000, BBA-PROTEIN STRUCT M, V1478, P165, DOI 10.1016/S0167-4838(00)00041-8; Przylas I, 2000, EUR J BIOCHEM, V267, P6903, DOI 10.1046/j.1432-1033.2000.01790.x; Roujeinikova A, 2002, J MOL BIOL, V321, P149, DOI 10.1016/S0022-2836(02)00570-3; Schmidt AK, 1998, BIOCHEMISTRY-US, V37, P5909, DOI 10.1021/bi9729918; Stam MR, 2006, PROTEIN ENG DES SEL, V19, P555, DOI 10.1093/protein/gzl044; Strokopytov B, 1996, BIOCHEMISTRY-US, V35, P4241, DOI 10.1021/bi952339h; Watanabe Y, 2006, J BIOCHEM, V140, P135, DOI 10.1093/jb/mvj129; Yokota T, 2001, BIOSCI BIOTECH BIOCH, V65, P401, DOI 10.1271/bbb.65.401	34	38	40	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 17	2008	283	42					28641	28648		10.1074/jbc.M802560200	http://dx.doi.org/10.1074/jbc.M802560200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	359EN	18703518	Green Published, hybrid			2022-12-27	WOS:000259969300066
J	Kitagawa, H; Tsutsumi, K; Ikegami-Kuzuhara, A; Nadanaka, S; Goto, F; Ogawa, T; Sugahara, K				Kitagawa, Hiroshi; Tsutsumi, Kae; Ikegami-Kuzuhara, Akemi; Nadanaka, Satomi; Goto, Fumitaka; Ogawa, Tomoya; Sugahara, Kazuyuki			Sulfation of the galactose residues in the glycosaminoglycan-protein linkage region by recombinant human chondroitin 6-O-sulfotransferase-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLECULAR-CLONING; HEPARAN-SULFATE; SHARK CARTILAGE; PROTEOGLYCANS; EXPRESSION; BIOSYNTHESIS; 4-SULFATE; BRAIN	6-O-Sulfated galactose residues have been demonstrated in the glycosaminoglycan-protein linkage region GlcUA beta 1-3Gal beta 1-3Gal-4Xyl beta 1-O-Ser isolated from shark cartilage chondroitin 6-sulfate (Sugahara, K., Ohi, Y., Harada, T., de Waard, P., and Vliegenthart, J. F. G. ( 1992) J. Biol. Chem. 267, 6027-6035). In this study, we investigated whether a recombinant human chondroitin 6-sulfotransferase-1 (C6ST-1) catalyzes the sulfation of C6 on both galactose residues in the linkage region using structurally defined acceptor substrates. The C6ST-1 was expressed as a soluble protein A chimeric form in COS-1 cells and purified using IgG-Sepharose. The purified C6ST-1 utilized the linkage tri-, tetra-, penta-, and hexasaccharide-serines and hexasaccharide alditols, including GlcUA beta 1-3GalNAc(4-O-sulfate)beta 1-4GlcUA beta 1-3Gal(4-O-sulfate) beta 1-3Gal beta 1-4Xy1 beta 1-O-Ser and Delta GlcUA beta 1-3Gal-NAc(6-O-sulfate)beta 1-4GlcUA beta 1-3Gal beta 1-3Gal(6-O-sulfate)beta 1-4Xyl-ol. Identification of the reaction products obtained with the linkage tetra-, penta-, and hexasaccharideserines revealed that the C6ST-1 catalyzed the sulfation of C6 on both galactose residues in the linkage region. Notably, the linkage tetrasaccharide-peptide GlcUA beta 1-3Gal beta 1-3Gal beta 1-4Xyl beta 1-O-(Gly)Ser-(Gly-Glu) was a good acceptor substrate for the C6ST-1, suggesting that the sulfation of the galactose residues can occur before the transfer of the first N-acetylhexosamine residue to the linkage tetrasaccharide. In contrast, no incorporation was observed into Delta GlcUA beta 1 3GalNAc(4-O-sulfate)beta 1-4GlcUA beta 1-3Gal(4-O-sulfate)beta 1-3Gal beta 1-4Xyl-ol, indicating that an intact xylose is necessary for the transfer of a sulfate to the second sugar residue Gal from the reducing end. These findings clearly demonstrated that the recombinant C6ST-1 catalyzes the sulfation of C6 on both galactose residues in the linkage region in vitro. This is the first identification of the sulfotransferase responsible for the sulfation of galactose residues in the glycosaminoglycan-protein linkage region.	[Kitagawa, Hiroshi; Tsutsumi, Kae; Ikegami-Kuzuhara, Akemi; Nadanaka, Satomi; Sugahara, Kazuyuki] Kobe Pharmaceut Univ, Dept Biochem, Higashinada Ku, Kobe, Hyogo 6588558, Japan; [Goto, Fumitaka; Ogawa, Tomoya] RIKEN, Inst Phys & Chem Res, Wako, Saitama 35101, Japan; [Sugahara, Kazuyuki] Hokkaido Univ, Frontier Res Ctr Post Genom Sci & Technol, Grad Sch Life Sci, Lab Proteoglycan Signaling & Therapeut, Sapporo, Hokkaido 0010021, Japan	Kobe Pharmaceutical University; RIKEN; Hokkaido University	Kitagawa, H (corresponding author), Kobe Pharmaceut Univ, Dept Biochem, Higashinada Ku, 4-19-1 Motoyamakita Machi, Kobe, Hyogo 6588558, Japan.	kitagawa@kobepharma-u.ac.jp; k-sugar@sci.hokudai.ac.jp	Kitagawa, Hiroshi/AAJ-1344-2020	Kitagawa, Hiroshi/0000-0002-9307-7079	Japan Private School Promotion Foundation [19390025, 18390030]; Ministry of Education, Culture, Sports, Science, and Technology (MEXT) [14082207]; Takeda Science Foundation; Japan Science and Technology Agency; MEXT	Japan Private School Promotion Foundation; Ministry of Education, Culture, Sports, Science, and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Takeda Science Foundation(Takeda Science Foundation (TSF)); Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	The work was supported in part by the Scientific Research Promotion Fund from the Japan Private School Promotion Foundation, Grants-in-aid for Scientific Research-B 19390025 (to H. K.) and 18390030 (to K. S.), and Grant-in-aid for Scientific Research on Priority Areas 14082207 (to K. S.) from the Ministry of Education, Culture, Sports, Science, and Technology (MEXT), the Takeda Science Foundation (to H. K.), the Core Research for Evolutional Science and Technology program of the Japan Science and Technology Agency (to H. K. and K. S.), and a National Project "Knowledge Cluster Initiative" (2nd Stage "Sapporo Bio-cluster Bio-S") from MEXT. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Akita K, 2008, STEM CELLS, V26, P798, DOI 10.1634/stemcells.2007-0448; Deepa SS, 2002, J BIOL CHEM, V277, P43707, DOI 10.1074/jbc.M207105200; DEWAARD P, 1992, J BIOL CHEM, V267, P6036; FUKUTA M, 1995, J BIOL CHEM, V270, P18575, DOI 10.1074/jbc.270.31.18575; Fukuta M, 1998, BBA-GENE STRUCT EXPR, V1399, P57, DOI 10.1016/S0167-4781(98)00089-X; GOTO F, 1992, TETRAHEDRON LETT, V33, P6841, DOI 10.1016/S0040-4039(00)61790-2; GOTO F, 1992, TETRAHEDRON LETT, V33, P5099, DOI 10.1016/S0040-4039(00)61200-5; GOTO F, 1993, PURE APPL CHEM, V65, P793, DOI 10.1351/pac199365040793; Kitagawa H, 2000, J BIOL CHEM, V275, P21075, DOI 10.1074/jbc.M002101200; Kitagawa H, 1997, GLYCOBIOLOGY, V7, P531, DOI 10.1093/glycob/7.4.531; Li FC, 2007, J BIOL CHEM, V282, P2956, DOI 10.1074/jbc.M609296200; Moses J, 1999, EUR J BIOCHEM, V260, P879, DOI 10.1046/j.1432-1327.1999.00228.x; SUGAHARA K, 1992, EUR J BIOCHEM, V204, P401, DOI 10.1111/j.1432-1033.1992.tb16649.x; SUGAHARA K, 1995, J BIOL CHEM, V270, P7204, DOI 10.1074/jbc.270.13.7204; SUGAHARA K, 1994, GLYCOBIOLOGY, V4, P535, DOI 10.1093/glycob/4.4.535; SUGAHARA K, 1991, EUR J BIOCHEM, V202, P805, DOI 10.1111/j.1432-1033.1991.tb16436.x; SUGAHARA K, 1992, J BIOL CHEM, V267, P6027; SUGAHARA K, 1988, J BIOL CHEM, V263, P10168; Sugahara K, 2000, CURR OPIN STRUC BIOL, V10, P518, DOI 10.1016/S0959-440X(00)00125-1; SUGAHARA K, 1989, BIOCHEM BIOPH RES CO, V162, P189, DOI 10.1016/0006-291X(89)91980-3; SUGAHARA K, 1992, J BIOL CHEM, V267, P1528; Sugahara K, 2003, CURR OPIN STRUC BIOL, V13, P612, DOI 10.1016/j.sbi.2003.09.011; Sugahara K, 2007, CURR OPIN STRUC BIOL, V17, P536, DOI 10.1016/j.sbi.2007.08.015; Sugumaran G, 1998, BIOCHEM J, V329, P203, DOI 10.1042/bj3290203; Thiele H, 2004, P NATL ACAD SCI USA, V101, P10155, DOI 10.1073/pnas.0400334101; Tone Y, 2008, J BIOL CHEM, V283, P16801, DOI 10.1074/jbc.M709556200; Tsutsumi K, 1998, FEBS LETT, V441, P235, DOI 10.1016/S0014-5793(98)01532-4; Uchimura K, 1998, GLYCOBIOLOGY, V8, P489, DOI 10.1093/glycob/8.5.489; Uyama T., 2007, COMPR GLYCOSCI, V3, P79; van Roij MHH, 2008, AM J MED GENET A, V146A, P2376, DOI 10.1002/ajmg.a.32482	30	27	27	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 10	2008	283	41					27438	27443		10.1074/jbc.M803279200	http://dx.doi.org/10.1074/jbc.M803279200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	355OW	18697746	hybrid			2022-12-27	WOS:000259719200013
J	Duser, MG; Bi, YM; Zarrabi, N; Dunn, SD; Borsch, M				Dueser, Monika G.; Bi, Yumin; Zarrabi, Nawid; Dunn, Stanley D.; Boersch, Michael			The Proton-translocating a Subunit of F0F1-ATP Synthase Is Allocated Asymmetrically to the Peripheral Stalk	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COLI ATP SYNTHASE; GREEN FLUORESCENT PROTEIN; SINGLE-MOLECULE SPECTROSCOPY; RESONANCE ENERGY-TRANSFER; ESCHERICHIA-COLI; EPSILON-SUBUNIT; CONFORMATIONAL DYNAMICS; GAMMA-SUBUNIT; B-SUBUNIT; MEMBRANE	The position of the a subunit of the membrane-integral F-0 sector of Escherichia coli ATP synthase was investigated by single molecule fluorescence resonance energy transfer studies utilizing a fusion of enhanced green fluorescent protein to the C terminus of the a subunit and fluorescent labels attached to specific positions of the epsilon or gamma subunits. Three fluorescence resonance energy transfer levels were observed during rotation driven by ATP hydrolysis corresponding to the three resting positions of the rotor subunits, gamma or epsilon, relative to the a subunit of the stator. Comparison of these positions of the rotor sites with those previously determined relative to the b subunit dimer indicates the position of a as adjacent to the b dimer on its counterclockwise side when the enzyme is viewed from the cytoplasm. This relationship provides stability to the membrane interface between a and b(2), allowing it to withstand the torque imparted by the rotor during ATP synthesis as well as ATP hydrolysis.	[Dueser, Monika G.; Zarrabi, Nawid; Boersch, Michael] Univ Stuttgart, Inst Phys 3, D-70550 Stuttgart, Germany; [Bi, Yumin; Dunn, Stanley D.] Univ Western Ontario, Dept Biochem, London, ON N6A 5C1, Canada	University of Stuttgart; Western University (University of Western Ontario)	Borsch, M (corresponding author), Univ Stuttgart, Inst Phys 3, Pfaffenwaldring 57, D-70550 Stuttgart, Germany.	m.boersch@physik.uni-stuttgart.de	Dunn, Stanley/D-3418-2013	Borsch, Michael/0000-0002-0634-2963	Deutsche Forschungsgemeinschaft [BO 1891/8-1]; Canadian Institutes of Health Research [MT-10237]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported in part by Deutsche Forschungsgemeinschaft Grant BO 1891/8-1 (to M. B.) and by Canadian Institutes of Health Research Grant MT-10237 (to S. D.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	AGGELER R, 1992, J BIOL CHEM, V267, P21355; Aggeler R, 1997, J BIOL CHEM, V272, P19621, DOI 10.1074/jbc.272.31.19621; Alemdaroglu FE, 2008, ANGEW CHEM INT EDIT, V47, P974, DOI 10.1002/anie.200703466; Andrecka J, 2008, P NATL ACAD SCI USA, V105, P135, DOI 10.1073/pnas.0703815105; Angevine CM, 2003, P NATL ACAD SCI USA, V100, P13179, DOI 10.1073/pnas.2234364100; Antonik M, 2006, J PHYS CHEM B, V110, P6970, DOI 10.1021/jp057257+; Borsch M, 2002, FEBS LETT, V527, P147, DOI 10.1016/S0014-5793(02)03198-8; Bottcher B, 2000, J MOL BIOL, V296, P449, DOI 10.1006/jmbi.1999.3435; Boyer PD, 1997, ANNU REV BIOCHEM, V66, P717, DOI 10.1146/annurev.biochem.66.1.717; Cotlet M, 2006, CHEMPHYSCHEM, V7, P250, DOI 10.1002/cphc.200500247; Del Rizzo PA, 2002, BIOCHEMISTRY-US, V41, P6875, DOI 10.1021/bi025736i; Deniz AA, 2001, ANNU REV PHYS CHEM, V52, P233, DOI 10.1146/annurev.physchem.52.1.233; Dickson VK, 2006, EMBO J, V25, P2911, DOI 10.1038/sj.emboj.7601177; Diez M, 2004, NAT STRUCT MOL BIOL, V11, P135, DOI 10.1038/nsmb718; Ding K, 2007, ANGEW CHEM INT EDIT, V46, P1172, DOI 10.1002/anie.200603064; Dmitriev O, 1999, J BIOL CHEM, V274, P15598, DOI 10.1074/jbc.274.22.15598; Dmitriev OY, 2008, BBA-BIOENERGETICS, V1777, P227, DOI 10.1016/j.bbabio.2007.11.011; DUSER MG, 2006, P SOC PHOTOOPT INSTR, V6092; Fillingame RH, 2000, J EXP BIOL, V203, P9; Fischer S, 1999, FEBS LETT, V457, P327, DOI 10.1016/S0014-5793(99)01060-1; FORSTER T, 1948, ANN PHYS-BERLIN, V2, P55, DOI 10.1002/andp.19484370105; GOGOL EP, 1989, BIOCHEMISTRY-US, V28, P4709, DOI 10.1021/bi00437a030; Ha T, 1999, BIOPHYS J, V76, pA386; Heitkamp T, 2008, BIOCHEMISTRY-US, V47, P3564, DOI 10.1021/bi702038e; Krebstakies T, 2005, J BIOL CHEM, V280, P33338, DOI 10.1074/jbc.M506251200; KUMAMOTO CA, 1987, J BIOL CHEM, V262, P3060; KUMAMOTO CA, 1986, J BIOL CHEM, V261, P37; Kuo PH, 1998, FEBS LETT, V426, P217, DOI 10.1016/S0014-5793(98)00337-8; McKinney SA, 2006, BIOPHYS J, V91, P1941, DOI 10.1529/biophysj.106.082487; McLachlin DT, 2000, J BIOL CHEM, V275, P17571, DOI 10.1074/jbc.M000375200; Meier T, 2005, SCIENCE, V308, P659, DOI 10.1126/science.1111199; Mellwig C, 2003, J BIOL CHEM, V278, P18544, DOI 10.1074/jbc.M212852200; Myong S, 2006, STRUCTURE, V14, P633, DOI 10.1016/j.str.2006.02.005; Nakanishi-Matsui M, 2006, J BIOL CHEM, V281, P4126, DOI 10.1074/jbc.M510090200; Ormo M, 1996, SCIENCE, V273, P1392, DOI 10.1126/science.273.5280.1392; Panchuk-Voloshina N, 1999, J HISTOCHEM CYTOCHEM, V47, P1179, DOI 10.1177/002215549904700910; Panke O, 1999, BBA-BIOENERGETICS, V1412, P118, DOI 10.1016/S0005-2728(99)00059-6; Peneva K, 2008, J AM CHEM SOC, V130, P5398, DOI 10.1021/ja711322g; Rodgers AJW, 2000, NAT STRUCT BIOL, V7, P1051; Rubinstein JL, 2003, EMBO J, V22, P6182, DOI 10.1093/emboj/cdg608; Rubinstein JL, 2002, J MOL BIOL, V321, P613, DOI 10.1016/S0022-2836(02)00671-X; Stalz WD, 2003, J BIOL CHEM, V278, P27068, DOI 10.1074/jbc.M302027200; STRYER L, 1967, P NATL ACAD SCI USA, V58, P719, DOI 10.1073/pnas.58.2.719; Tsien RY, 1998, ANNU REV BIOCHEM, V67, P509, DOI 10.1146/annurev.biochem.67.1.509; Valiyaveetil FI, 1998, J BIOL CHEM, V273, P16241, DOI 10.1074/jbc.273.26.16241; Weber J, 1997, BBA-BIOENERGETICS, V1319, P19, DOI 10.1016/S0005-2728(96)00121-1; Yasuda R, 2001, NATURE, V410, P898, DOI 10.1038/35073513; Zarrabi N, 2005, PROC SPIE, V5699, P175, DOI 10.1117/12.597967; ZARRABI N, 2007, P SOC PHOTOOPT INSTR, V6771; ZARRABI N, 2007, P SOC PHOTOOPT INSTR, V6444; Zimmermann B, 2005, EMBO J, V24, P2053, DOI 10.1038/sj.emboj.7600682; Zimmermann B, 2006, BBA-BIOENERGETICS, V1757, P311, DOI 10.1016/j.bbabio.2006.03.020	52	54	54	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 28	2008	283	48					33602	33610		10.1074/jbc.M805170200	http://dx.doi.org/10.1074/jbc.M805170200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	376KY	18786919	hybrid, Green Published			2022-12-27	WOS:000261183700066
J	Cuneo, MJ; Changela, A; Miklos, AE; Beese, LS; Krueger, JK; Hellinga, HW				Cuneo, Matthew J.; Changela, Anita; Miklos, Aleksandr E.; Beese, Lorena S.; Krueger, Joanna K.; Hellinga, Homme W.			Structural Analysis of a Periplasmic Binding Protein in the Tripartite ATP-independent Transporter Family Reveals a Tetrameric Assembly That May Have a Role in Ligand Transport	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EXTRACYTOPLASMIC-SOLUTE-RECEPTOR; ESCHERICHIA-COLI; CRYSTAL-STRUCTURES; THERMODYNAMIC STABILITY; MALTOSE TRANSPORT; TRAP TRANSPORTERS; MECHANISM; SEQUENCE; DCTP; PURIFICATION	Several bacterial solute transport mechanisms involve members of the periplasmic binding protein (PBP) superfamily that bind and deliver ligand to integral membrane transport proteins in the ATP-binding cassette, tripartite tricarboxylate transporter, or tripartite ATP-independent (TRAP) families. PBPs involved in ATP-binding cassette transport systems have been well characterized, but only a few PBPs involved in TRAP transport have been studied. We have measured the thermal stability, determined the oligomerization state by small angle x-ray scattering, and solved the x-ray crystal structure to 1.9 angstrom resolution of a TRAP-PBP (open reading frame tm0322) from the hyperthermophilic bacterium Thermotoga maritima (TM0322). The overall fold of TM0322 is similar to other TRAP transport related PBPs, although the structural similarity of backbone atoms (2.5-3.1 angstrom root mean square deviation) is unusually low for PBPs within the same group. Individual monomers within the tetrameric asymmetric unit of TM0322 exhibit high root mean square deviation (0.9 angstrom) to each other as a consequence of conformational heterogeneity in their binding pockets. The gel filtration elution profile and the small angle x-ray scattering analysis indicate that TM0322 assembles as dimers in solution that in turn assemble into a dimer of dimers in the crystallographic asymmetric unit. Tetramerization has been previously observed in another TRAP-PBP (the Rhodobacter sphaeroides alpha-keto acid-binding protein) where quaternary structure formation is postulated to be an important requisite for the transmembrane transport process.	[Cuneo, Matthew J.; Changela, Anita; Miklos, Aleksandr E.; Beese, Lorena S.; Hellinga, Homme W.] Duke Univ, Med Ctr, Dept Biochem, Durham, NC 27710 USA; [Krueger, Joanna K.] Univ N Carolina, Dept Chem, Charlotte, NC 28213 USA	Duke University; University of North Carolina; University of North Carolina Charlotte	Hellinga, HW (corresponding author), 415 Nanaline Duke Bldg,Res Dr, Durham, NC 27710 USA.	hwh@biochem.duke.edu	Krueger, Joanna/A-3110-2011; beese, lorena/G-4993-2010	Miklos, Aleksandr/0000-0001-6375-2304; Cuneo, Matthew/0000-0002-1475-6656	National Institutes of Health [5 DP1 OD000122-02]; Homeland Security Advanced Research Projects Agency [W81XWH-05-C-0161]; National Science Foundation ADVANCE [SBE-0548401]; United States Department of Energy, Office of Science, Office of Basic Energy Sciences [DE-AC02-98CH10886]; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD000122] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Homeland Security Advanced Research Projects Agency; National Science Foundation ADVANCE(National Science Foundation (NSF)); United States Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported, in whole or in part, by National Institutes of Health Grant 5 DP1 OD000122-02 ( to H. W. H.). This work was also supported by Homeland Security Advanced Research Projects Agency Grant W81XWH-05-C-0161 ( to H. W. H.), a National Institutes of Health sponsored biological chemistry training grant (to M.J.C.), Bonnie Cone Fellowship National Science Foundation ADVANCE Grant SBE-0548401 (to J.K.K.), and United States Department of Energy, Office of Science, Office of Basic Energy Sciences Contract DE-AC02-98CH10886.	Ashish, 2008, J BIOL CHEM, V283, P2761, DOI 10.1074/jbc.M708325200; Bjorkman AJ, 1998, J MOL BIOL, V279, P651, DOI 10.1006/jmbi.1998.1785; Chen J, 2001, P NATL ACAD SCI USA, V98, P1525, DOI 10.1073/pnas.041542498; Clarke TE, 2002, J BIOL CHEM, V277, P13966, DOI 10.1074/jbc.M109385200; COHEN DS, 1994, PROTEIN SCI, V3, P1253, DOI 10.1002/pro.5560030811; Cuneo MJ, 2006, J MOL BIOL, V362, P259, DOI 10.1016/j.jmb.2006.06.084; DAVIDSON AL, 1992, P NATL ACAD SCI USA, V89, P2360, DOI 10.1073/pnas.89.6.2360; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fukami-Kobayashi K, 1999, J MOL BIOL, V286, P279, DOI 10.1006/jmbi.1998.2454; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; Gonin S, 2007, BMC STRUCT BIOL, V7, DOI 10.1186/1472-6807-7-11; HENDRICKSON WA, 1985, METHOD ENZYMOL, V115, P41; HOLM L, 1993, J MOL BIOL, V233, P123, DOI 10.1006/jmbi.1993.1489; HOR LI, 1993, J MOL BIOL, V233, P659, DOI 10.1006/jmbi.1993.1543; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Karpowich NK, 2003, J BIOL CHEM, V278, P8429, DOI 10.1074/jbc.M212239200; Kelly DJ, 2001, FEMS MICROBIOL REV, V25, P405, DOI 10.1111/j.1574-6976.2001.tb00584.x; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Kozin MB, 2001, J APPL CRYSTALLOGR, V34, P33, DOI 10.1107/S0021889800014126; KRIGBAUM WR, 1970, BIOCHEMISTRY-US, V9, P1216, DOI 10.1021/bi00807a024; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Matulis D, 2005, BIOCHEMISTRY-US, V44, P5258, DOI 10.1021/bi048135v; Muller A, 2006, J BIOL CHEM, V281, P22212, DOI 10.1074/jbc.M603463200; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nakai K, 1999, TRENDS BIOCHEM SCI, V24, P34, DOI 10.1016/S0968-0004(98)01336-X; Nelson KE, 1999, NATURE, V399, P323, DOI 10.1038/20601; NIKAIDO H, 1994, FEBS LETT, V346, P55, DOI 10.1016/0014-5793(94)00315-7; O Glatter, 1982, SMALL ANGLE XRAY SCA, P18; Perrakis A, 2001, ACTA CRYSTALLOGR D, V57, P1445, DOI 10.1107/S0907444901014007; Rabus R, 1999, MICROBIOL-SGM, V145, P3431, DOI 10.1099/00221287-145-12-3431; Rucktooa P, 2007, J MOL BIOL, V370, P93, DOI 10.1016/j.jmb.2007.04.047; SCHELLMAN JA, 1987, ANNU REV BIOPHYS BIO, V16, P115, DOI 10.1146/annurev.bb.16.060187.000555; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; Severi E, 2005, MOL MICROBIOL, V58, P1173, DOI 10.1111/j.1365-2958.2005.04901.x; SHAW JG, 1991, MOL MICROBIOL, V5, P3055, DOI 10.1111/j.1365-2958.1991.tb01865.x; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Svergun DI, 2001, BIOPHYS J, V80, P2946, DOI 10.1016/S0006-3495(01)76260-1; TAM R, 1993, MICROBIOL REV, V57, P320, DOI 10.1128/MMBR.57.2.320-346.1993; Terwilliger TC, 2000, ACTA CRYSTALLOGR D, V56, P965, DOI 10.1107/S0907444900005072; Tetsch L, 2002, FEMS MICROBIOL LETT, V211, P213, DOI 10.1111/j.1574-6968.2002.tb11227.x; Thomas GH, 2006, MICROBIOL-SGM, V152, P187, DOI 10.1099/MIC.0.28334-0; WALMSLEY AR, 1992, J BIOL CHEM, V267, P8064; WIDENHORN KA, 1988, J BACTERIOL, V170, P883, DOI 10.1128/jb.170.2.883-888.1988; Winnen B, 2003, RES MICROBIOL, V154, P457, DOI 10.1016/S0923-2508(03)00126-8; Yip Tai-Tung, 2004, Methods Mol Biol, V244, P179; Zeng G, 1998, BIOTECHNIQUES, V25, P206, DOI 10.2144/98252bm05	48	22	23	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 21	2008	283	47					32812	32820		10.1074/jbc.M803595200	http://dx.doi.org/10.1074/jbc.M803595200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	372HW	18723845	Green Published, hybrid			2022-12-27	WOS:000260893700070
J	Bartonova, V; Igonet, S; Sticht, J; Glass, B; Habermann, A; Vaney, MC; Sehr, P; Lewis, J; Rey, FA; Krausslich, HG				Bartonova, Vanda; Igonet, Sebastien; Sticht, Jana; Glass, Baerbel; Habermann, Anja; Vaney, Marie-Christine; Sehr, Peter; Lewis, Joe; Rey, Felix A.; Kraeusslich, Hans-Georg			Residues in the HIV-1 Capsid Assembly Inhibitor Binding Site Are Essential for Maintaining the Assembly-competent Quaternary Structure of the Capsid Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							C-TERMINAL DOMAIN; DIMERIZATION DOMAIN; PEPTIDE INHIBITOR; GAG PROTEIN; VIRUS; ORGANIZATION; MEMBRANE; REVEALS; VIRIONS; COMPLEX	Morphogenesis of infectious HIV-1 involves budding of immature virions followed by proteolytic disassembly of the Gag protein shell and subsequent assembly of processed capsid proteins (CA) into the mature HIV-1 core. The dimeric interface between C-terminal domains of CA (C-CA) has been shown to be important for both immature and mature assemblies. We previously reported a CA-binding peptide (CAI) that blocks both assembly steps in vitro. The three-dimensional structure of the C-CA/CAI complex revealed an allosteric effect of CAI that alters the C-CA dimer interface. Based on this structure, we now investigated the phenotypes of mutations in the binding pocket. CA variants carrying mutations Y169A, L211A, or L211S had a reduced affinity for CAI and were unable to form mature-like particles in vitro. These mutations also blocked morphological conversion to mature virions in tissue culture and abolished infectivity. X-ray crystallographic analyses of the variant C-CA domains revealed that these alterations induced the same allosteric change at the dimer interface observed in the C-CA/CAI complex. These results point to a role of key interactions between conserved amino acids in the CAI binding pocket of C-CA in maintaining the correct conformation necessary for mature core assembly.	[Bartonova, Vanda; Sticht, Jana; Glass, Baerbel; Habermann, Anja; Kraeusslich, Hans-Georg] Univ Klinikum Heidelberg, Dept Virol, D-69120 Heidelberg, Germany; [Igonet, Sebastien; Vaney, Marie-Christine; Rey, Felix A.] Inst Pasteur, CNRS URA 3015, Struct Virol Unit, F-75724 Paris 15, France; [Sticht, Jana] Leibniz Inst Mol Pharmacol, Prot Engn Grp, D-13125 Berlin, Germany; [Sehr, Peter; Lewis, Joe] European Mol Biol Lab, Chem Biol Core Facil, D-69117 Heidelberg, Germany	Ruprecht Karls University Heidelberg; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Leibniz Forschungsinstitut furr Molekulare Pharmakologie (FMP); European Molecular Biology Laboratory (EMBL)	Krausslich, HG (corresponding author), Univ Klinikum Heidelberg, Dept Virol, Neuenheimer Feld 324, D-69120 Heidelberg, Germany.	hans-georg.kraeusslich@med.uni-heidelberg.de	Rey, Felix/B-6497-2012	Habermann, Anja/0000-0003-3686-9050; Lux, Vanda/0000-0002-0184-8076; Sehr, Peter/0000-0002-4348-5066; Rey, Felix/0000-0002-9953-7988	Deutsche Forschungsgemeinschaft [SFB544, B11]; European Union (HIV-ACE)	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); European Union (HIV-ACE)(European Commission)	This work was supported by grants from the Deutsche Forschungsgemeinschaft (SFB544, B11) (to H.-G. K.) and the FP7 program of the European Union (HIV-ACE) (to H.-G. K. and F. R.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	ADACHI A, 1986, J VIROL, V59, P284, DOI 10.1128/JVI.59.2.284-291.1986; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bhattacharya S, 2008, J BIOL CHEM, V283, P16274, DOI 10.1074/jbc.C800048200; Briggs JAG, 2006, J MOL BIOL, V355, P157, DOI 10.1016/j.jmb.2005.10.025; Briggs JAG, 2004, NAT STRUCT MOL BIOL, V11, P672, DOI 10.1038/nsmb785; Briggs JAG, 2003, EMBO J, V22, P1707, DOI 10.1093/emboj/cdg143; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gamble TR, 1997, SCIENCE, V278, P849, DOI 10.1126/science.278.5339.849; Ganser BK, 1999, SCIENCE, V283, P80, DOI 10.1126/science.283.5398.80; Ganser-Pornillos BK, 2007, CELL, V131, P70, DOI 10.1016/j.cell.2007.08.018; Gitti RK, 1996, SCIENCE, V273, P231, DOI 10.1126/science.273.5272.231; Gottlinger HG, 2001, AIDS, V15, pS13; Gross I, 1998, J VIROL, V72, P4798, DOI 10.1128/JVI.72.6.4798-4810.1998; Gross I, 1997, EUR J BIOCHEM, V249, P592, DOI 10.1111/j.1432-1033.1997.t01-1-00592.x; Gross I, 2000, EMBO J, V19, P103, DOI 10.1093/emboj/19.1.103; Hawkes RA, 1979, DIAGNOSTIC PROCEDURE, P32; Hill CP, 1996, P NATL ACAD SCI USA, V93, P3099, DOI 10.1073/pnas.93.7.3099; Lanman J, 2004, NAT STRUCT MOL BIOL, V11, P676, DOI 10.1038/nsmb790; Lanman J, 2003, J MOL BIOL, V325, P759, DOI 10.1016/S0022-2836(02)01245-7; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Li S, 2000, NATURE, V407, P409, DOI 10.1038/35030177; MASSIAH MA, 1994, J MOL BIOL, V244, P198, DOI 10.1006/jmbi.1994.1719; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mortuza GB, 2004, NATURE, V431, P481, DOI 10.1038/nature02915; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Navaza J, 1997, METHOD ENZYMOL, V276, P581, DOI 10.1016/S0076-6879(97)76079-8; Nermut MV, 1998, J STRUCT BIOL, V123, P143, DOI 10.1006/jsbi.1998.4024; RATNER L, 1987, AIDS RES HUM RETROV, V3, P57, DOI 10.1089/aid.1987.3.57; Saad JS, 2006, P NATL ACAD SCI USA, V103, P11364, DOI 10.1073/pnas.0602818103; Sticht J, 2005, NAT STRUCT MOL BIOL, V12, P671, DOI 10.1038/nsmb964; Ternois F, 2005, NAT STRUCT MOL BIOL, V12, P678, DOI 10.1038/nsmb967; von Schwedler UK, 2003, J VIROL, V77, P5439, DOI 10.1128/JVI.77.9.5439-5450.2003; Wiegers K, 1998, J VIROL, V72, P2846, DOI 10.1128/JVI.72.4.2846-2854.1998; Wilk T, 2001, J VIROL, V75, P759, DOI 10.1128/JVI.75.2.759-771.2001; Worthylake DK, 1999, ACTA CRYSTALLOGR D, V55, P85, DOI 10.1107/S0907444998007689; Wright ER, 2007, EMBO J, V26, P2218, DOI 10.1038/sj.emboj.7601664; Zhang H, 2008, J MOL BIOL, V378, P565, DOI 10.1016/j.jmb.2008.02.066	37	68	71	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 14	2008	283	46					32024	32033		10.1074/jbc.M804230200	http://dx.doi.org/10.1074/jbc.M804230200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	370KJ	18772135	Green Published, hybrid			2022-12-27	WOS:000260760800084
J	Caines, MEC; Zhu, HZ; Vuckovic, M; Willis, LM; Withers, SG; Wakarchuk, WW; Strynadka, NCJ				Caines, Matthew E. C.; Zhu, Haizhong; Vuckovic, Marija; Willis, Lisa M.; Withers, Stephen G.; Wakarchuk, Warren W.; Strynadka, Natalie C. J.			The Structural Basis for T-antigen Hydrolysis by Streptococcus pneumoniae A TARGET FOR STRUCTURE-BASED VACCINE DESIGN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CARBOHYDRATE-BINDING MODULES; CRYSTAL-STRUCTURE; MOLECULAR-BASIS; ALPHA-AMYLASE; PROTEIN; IDENTIFICATION; CRYSTALLOGRAPHY; RECOGNITION; MECHANISM; REVEALS	Streptococcus pneumoniae endo-alpha-N-acetylgalactosaminidase is a cell surface-anchored glycoside hydrolase from family GH101 involved in the breakdown of mucin type O-linked glycans. The 189-kDa mature enzyme specifically hydrolyzes the T-antigen disaccharide from extracellular host glycoproteins and is representative of a broadly important class of virulence factors that have remained structurally uncharacterized due to their large size and highly modular nature. Here we report a 2.9 angstrom resolution crystal structure that remarkably captures the multidomain architecture and characterizes a catalytic center unexpectedly resembling that of alpha-amylases. Our analysis presents a complete model of glycoprotein recognition and provides a basis for the structure-based design of novel Streptococcus vaccines and therapeutics.	[Caines, Matthew E. C.; Zhu, Haizhong; Vuckovic, Marija; Withers, Stephen G.; Strynadka, Natalie C. J.] Univ British Columbia, Dept Biochem & Mol Biol, Vancouver, BC V6T 1Z3, Canada; [Caines, Matthew E. C.; Zhu, Haizhong; Vuckovic, Marija; Strynadka, Natalie C. J.] Univ British Columbia, Ctr Blood Res, Vancouver, BC V6T 1Z3, Canada; [Withers, Stephen G.] Univ British Columbia, Dept Chem, Vancouver, BC V6T 1Z3, Canada; [Willis, Lisa M.; Wakarchuk, Warren W.] Natl Res Council Canada, Inst Biol Sci, Ottawa, ON K1A 0R6, Canada	University of British Columbia; University of British Columbia; University of British Columbia; National Research Council Canada	Strynadka, NCJ (corresponding author), Univ British Columbia, Dept Biochem & Mol Biol, 2350 Hlth Sci Mall, Vancouver, BC V6T 1Z3, Canada.	natalie@byron.biochem.ubc.ca	Wakarchuk, Warren/AAO-2774-2020; Wakarchuk, Warren/Q-9514-2017	Wakarchuk, Warren/0000-0002-1539-1679; Wakarchuk, Warren/0000-0002-1539-1679; Willis, Lisa/0000-0001-6204-033X	Howard Hughes Medical Institute; Canadian Institutes of Health Research; Michael Smith Foundation for Health Research; Canada Foundation for Innovation	Howard Hughes Medical Institute(Howard Hughes Medical Institute); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Michael Smith Foundation for Health Research(Michael Smith Foundation for Health Research); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR)	This work was funded by the Howard Hughes Medical Institute, Canadian Institutes of Health Research, Michael Smith Foundation for Health Research, and Canada Foundation for Innovation. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Abe A, 2005, FEBS J, V272, P6145, DOI 10.1111/j.1742-4658.2005.05013.x; Abrahams JP, 1996, ACTA CRYSTALLOGR D, V52, P30, DOI 10.1107/S0907444995008754; Adam D, 2002, J ANTIMICROB CHEMOTH, V50, P1, DOI 10.1093/jac/dkf801; Afonine P., 2005, CCP4 NEWSLETTER, V42; Bae B, 2008, J BIOL CHEM, V283, P12415, DOI 10.1074/jbc.M706513200; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Bogaert D, 2004, LANCET INFECT DIS, V4, P144, DOI 10.1016/S1473-3099(04)00938-7; Bogaert D, 2004, VACCINE, V22, P2209, DOI 10.1016/j.vaccine.2003.11.038; Boraston AB, 2002, J MOL BIOL, V319, P1143, DOI 10.1016/S0022-2836(02)00374-1; Boraston AB, 2004, BIOCHEM J, V382, P769, DOI 10.1042/BJ20040892; Brux C, 2006, J MOL BIOL, V359, P97, DOI 10.1016/j.jmb.2006.03.005; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Burnaugh AM, 2008, J BACTERIOL, V190, P221, DOI 10.1128/JB.01251-07; Carlson CB, 2008, J BIOL CHEM, V283, P20069, DOI 10.1074/jbc.M800223200; Charnock SJ, 2000, BIOCHEMISTRY-US, V39, P5013, DOI 10.1021/bi992821q; CRENNELL S, 1994, STRUCTURE, V2, P535, DOI 10.1016/S0969-2126(00)00053-8; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; DeLano W.L, PYMOL MOL GRAPHICS S; Desvaux M, 2006, FEMS MICROBIOL LETT, V256, P1, DOI 10.1111/j.1574-6968.2006.00122.x; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fujita K, 2005, J BIOL CHEM, V280, P37415, DOI 10.1074/jbc.M506874200; Giefing C, 2008, J EXP MED, V205, P117, DOI 10.1084/jem.20071168; GLASGOW LR, 1977, J BIOL CHEM, V252, P8615; Harding MM, 2006, ACTA CRYSTALLOGR D, V62, P678, DOI 10.1107/S0907444906014594; Holm L, 1996, SCIENCE, V273, P595, DOI 10.1126/science.273.5275.595; Kharat AS, 2003, INFECT IMMUN, V71, P2758, DOI 10.1128/IAI.71.5.2758-2765.2003; Lee HS, 2002, J BIOL CHEM, V277, P21891, DOI 10.1074/jbc.M201623200; Leslie AGW, 1992, JOINT CCP4 ESF EAMCB, V26; Levy SB, 2004, NAT MED, V10, pS122, DOI 10.1038/nm1145; Moreno FBMB, 2008, J STRUCT BIOL, V161, P133, DOI 10.1016/j.jsb.2007.10.002; Mizuno M, 2004, EUR J BIOCHEM, V271, P2530, DOI 10.1111/j.1432-1033.2004.04183.x; Mizushima T, 2007, P NATL ACAD SCI USA, V104, P5777, DOI 10.1073/pnas.0610312104; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nahoum V, 1999, ACTA CRYSTALLOGR D, V55, P360, DOI 10.1107/S0907444998010701; Ravaud S, 2008, J BIOL CHEM, V283, P9350, DOI 10.1074/jbc.M710493200; Santi I, 2007, MOL MICROBIOL, V63, P754, DOI 10.1111/j.1365-2958.2006.05555.x; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Simpson PJ, 2002, BIOCHEMISTRY-US, V41, P5712, DOI 10.1021/bi012093i; Song JH, 2005, MOL CELLS, V19, P365; Sulzenbacher G, 2004, J BIOL CHEM, V279, P13119, DOI 10.1074/jbc.M313783200; Thoden JB, 2004, J BIOL CHEM, V279, P23431, DOI 10.1074/jbc.M402347200; Vonrhein Clemens, 2007, Methods Mol Biol, V364, P215, DOI 10.1385/1-59745-266-1:215; WAKARCHUK WW, 1994, PROTEIN SCI, V3, P467; Xie HF, 2001, BIOCHEMISTRY-US, V40, P9167, DOI 10.1021/bi0106742; Yamasaki M, 2004, J BIOL CHEM, V279, P31863, DOI 10.1074/jbc.M402466200; Zechel DL, 2000, ACCOUNTS CHEM RES, V33, P11, DOI 10.1021/ar970172+	48	36	38	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 14	2008	283	46					31279	31283		10.1074/jbc.C800150200	http://dx.doi.org/10.1074/jbc.C800150200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	370KJ	18784084	hybrid			2022-12-27	WOS:000260760800003
J	Attia, RR; Gardner, LA; Mahrous, E; Taxman, DJ; LeGros, L; Rowe, S; Ting, JPY; Geller, A; Kotb, M				Attia, Ramy R.; Gardner, Lidia A.; Mahrous, Engy; Taxman, Debra J.; LeGros, Leighton; Rowe, Sarah; Ting, Jenny P. -Y.; Geller, Arthur; Kotb, Malak			Selective Targeting of Leukemic Cell Growth in Vivo and in Vitro Using a Gene Silencing Approach to Diminish S-Adenosylmethionine Synthesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADENOSYL-L-METHIONINE; ACUTE LYMPHOBLASTIC-LEUKEMIA; CONFORMATIONAL ANALOGS; ENZYMATIC-SYNTHESIS; HUMAN-LYMPHOCYTES; AMINO-ACIDS; RAT-LIVER; ADENOSYLTRANSFERASE; INHIBITORS; SYNTHETASE	We exploited the fact that leukemic cells utilize significantly higher levels of S-adenosylmethionine (SAMe) than normal lymphocytes and developed tools that selectively diminished their survival under physiologic conditions. Using RNA interference gene silencing technology, we modulated the kinetics of methionine adenosyltransferase-II (MAT-II), which catalyzes SAMe synthesis from ATP and L-Met. Specifically, we silenced the expression of the regulatory MAT-II beta subunit in Jurkat cells and accordingly shifted the K-m (L-Met) of the enzyme 10-15-fold above the physiologic levels of L-Met, thereby reducing enzyme activity and SAMe pools, inducing excessive apoptosis and diminishing leukemic cell growth in vitro and in vivo. These effects were reversed at unphysiologically high L-Met (>50 mu M), indicating that diminished leukemic cell growth at physiologic L-Met levels was a direct result of the increase in MAT-II K-m (L-Met) due to MAT-II beta ablation and the consequent reduction in SAMe synthesis. In our NOD/Scid IL-2R gamma(null) humanized mouse model of leukemia, control shRNA-transduced Jurkat cells exhibited heightened engraftment, whereas cells lacking MAT-II beta failed to engraft for up to 5 weeks post-transplant. These stark differences in malignant cell survival, effected by MAT-II beta ablation, suggest that it may be possible to use this approach to disadvantage leukemic cell survival in vivo with little to no harm to normal cells.	[Geller, Arthur; Kotb, Malak] Univ Cincinnati, Coll Med, Dept Mol Genet Biochem & Microbiol, Cincinnati, OH 45267 USA; [Attia, Ramy R.; Gardner, Lidia A.; Mahrous, Engy; Geller, Arthur; Kotb, Malak] Univ Tennessee, Hlth Sci Ctr, Memphis, TN 38104 USA; [Attia, Ramy R.; Gardner, Lidia A.; LeGros, Leighton; Rowe, Sarah; Kotb, Malak] Vet Affairs Med Ctr, Res Serv, Memphis, TN 38104 USA; [Taxman, Debra J.; Ting, Jenny P. -Y.] Univ N Carolina, Dept Microbiol & Immunol, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA	University System of Ohio; University of Cincinnati; University of Tennessee System; University of Tennessee Health Science Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); Memphis VA Medical Center; University of North Carolina; University of North Carolina Chapel Hill	Kotb, M (corresponding author), Univ Cincinnati, Coll Med, Dept Mol Genet Biochem & Microbiol, 231 Albert Sabin Way,POB 670524,2938 CVC Mail Loc, Cincinnati, OH 45267 USA.	mscbskotb@gmail.com	Mahrous, Engy/AAG-6127-2021; Mahrous, Engy/AAG-9883-2021	Mahrous, Engy/0000-0001-8355-6984; 	National Institutes of Health [R01CA108792]; Veterans Affairs Merit Review Award; Senior Research Career Scientist Award; NATIONAL CANCER INSTITUTE [R01CA108792] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veterans Affairs Merit Review Award(US Department of Veterans Affairs); Senior Research Career Scientist Award; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01CA108792. This work was also supported by a Veterans Affairs Merit Review Award and a Senior Research Career Scientist Award (to M. K.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked " advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Baric I, 2004, P NATL ACAD SCI USA, V101, P4234, DOI 10.1073/pnas.0400658101; BREILLOUT F, 1990, J NATL CANCER I, V82, P1628, DOI 10.1093/jnci/82.20.1628; BUTRON K, 1956, BIOCHEM J, V62, P315; CANTONI GL, 1953, J BIOL CHEM, V204, P403; Chiang PK, 1996, FASEB J, V10, P471, DOI 10.1096/fasebj.10.4.8647346; Coffield VM, 2004, J EXP MED, V200, P1315, DOI 10.1084/jem.20040944; COULTER AW, 1974, MOL PHARMACOL, V10, P319; Cunningham L, 2007, EXPERT OPIN PHARMACO, V8, P2519, DOI 10.1517/14656566.8.15.2519; DELAROSA J, 1992, J BIOL CHEM, V267, P10699; DELAROSA J, 1992, CANCER RES, V52, P3361; FEDERICI MM, 1979, BIOCHEM PHARMACOL, V28, P1689, DOI 10.1016/0006-2952(79)90187-4; Finkelstein JD, 2006, J NUTR, V136, p1750S, DOI 10.1093/jn/136.6.1750S; FINKELSTEIN JD, 1990, J NUTR BIOCHEM, V1, P228, DOI 10.1016/0955-2863(90)90070-2; Fronhoffs S, 2002, MOL CELL PROBE, V16, P99, DOI 10.1006/mcpr.2002.0405; Garcia-Trevijano ER, 2000, FASEB J, V14, P2511, DOI 10.1096/fj.00-0121com; GOSEKI N, 1995, JPN J CANCER RES, V86, P484, DOI 10.1111/j.1349-7006.1995.tb03082.x; GUO HY, 1993, CANCER RES, V53, P5676; Halim AB, 1999, J BIOL CHEM, V274, P29720, DOI 10.1074/jbc.274.42.29720; HOFFMAN JL, 1983, METHOD ENZYMOL, V94, P223; KAPPLER F, 1988, J MED CHEM, V31, P384, DOI 10.1021/jm00397a020; Kokkinakis DM, 2006, MOL CANCER RES, V4, P575, DOI 10.1158/1541-7786.MCR-05-0240; KOTB M, 1985, J BIOL CHEM, V260, P3923; KOTB M, 1990, BIOCHIM BIOPHYS ACTA, V1040, P137, DOI 10.1016/0167-4838(90)90068-Q; Kotb M, 1997, TRENDS GENET, V13, P51, DOI 10.1016/S0168-9525(97)01013-5; KOTB M, 1993, PHARMACOL THERAPEUT, V59, P125, DOI 10.1016/0163-7258(93)90042-C; KOTB M, 2004, Patent No. 6696279; Lavrador K, 1998, J ENZYM INHIB, V13, P361, DOI 10.3109/14756369809021481; LeGros HL, 1997, J BIOL CHEM, V272, P16040, DOI 10.1074/jbc.272.25.16040; LeGros HL, 2000, J BIOL CHEM, V275, P2359, DOI 10.1074/jbc.275.4.2359; Loehrer FMT, 1997, J PHARMACOL EXP THER, V282, P845; Loenen WAM, 2006, BIOCHEM SOC T, V34, P330, DOI 10.1042/BST0340330; LOMBARDINI JB, 1983, BIOCHEM PHARMACOL, V32, P489, DOI 10.1016/0006-2952(83)90528-2; Martinez-Chantar ML, 2003, GASTROENTEROLOGY, V124, P940, DOI 10.1053/gast.2003.50151; Mato JM, 1997, PHARMACOL THERAPEUT, V73, P265, DOI 10.1016/S0163-7258(96)00197-0; Mato JM, 2002, FASEB J, V16, P15, DOI 10.1096/fj.01-0401rev; PEAR WS, 1993, P NATL ACAD SCI USA, V90, P8392, DOI 10.1073/pnas.90.18.8392; Pui CH, 2007, NAT REV DRUG DISCOV, V6, P149, DOI 10.1038/nrd2240; Sanz A, 2006, FASEB J, V20, P1064, DOI 10.1096/fj.05-5568com; Shultz LD, 2005, J IMMUNOL, V174, P6477, DOI 10.4049/jimmunol.174.10.6477; SUFRIN JR, 1993, BIOCHIM BIOPHYS ACTA, V1202, P87, DOI 10.1016/0167-4838(93)90067-2; SUFRIN JR, 1979, MOL PHARMACOL, V15, P661; SUMA Y, 1986, J BIOCHEM, V100, P67, DOI 10.1093/oxfordjournals.jbchem.a121707; Sun X, 2003, CANCER RES, V63, P8377; TABOR CW, 1984, ANNU REV BIOCHEM, V53, P749, DOI 10.1146/annurev.bi.53.070184.003533; TABOR CW, 1984, ADV ENZYMOL RAMB, V56, P251; Taxman DJ, 2006, BMC BIOTECHNOL, V6, DOI 10.1186/1472-6750-6-7; VRUDHULA VM, 1989, J MED CHEM, V32, P885, DOI 10.1021/jm00124a026; Wong AW, 2003, NAT IMMUNOL, V4, P891, DOI 10.1038/ni960; Yang HP, 2008, GASTROENTEROLOGY, V134, P281, DOI 10.1053/j.gastro.2007.10.027; Zhang ML, 2004, CANCER RES, V64, P5825, DOI 10.1158/0008-5472.CAN-04-1088	50	15	16	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 7	2008	283	45					30788	30795		10.1074/jbc.M804159200	http://dx.doi.org/10.1074/jbc.M804159200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	367ID	18753136	Green Submitted, hybrid, Green Published			2022-12-27	WOS:000260544800033
J	Green, JL; Rees-Channer, RR; Howell, SA; Martin, SR; Knuepfer, E; Taylor, HM; Grainger, M; Holder, AA				Green, Judith L.; Rees-Channer, Roxanne R.; Howell, Stephen A.; Martin, Stephen R.; Knuepfer, Ellen; Taylor, Helen M.; Grainger, Munira; Holder, Anthony A.			The Motor Complex of Plasmodium falciparum PHOSPHORYLATION BY A CALCIUM-DEPENDENT PROTEIN KINASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MALARIA PARASITE; ERYTHROCYTE INVASION; GLIDING MOTILITY; MYOSIN; MEROZOITE; SURFACE; CALMODULIN; BIOSYNTHESIS; EXPRESSION; VACUOLE	Calcium-dependent protein kinases (CDPKs) of Apicomplexan parasites are crucial for the survival of the parasite throughout its life cycle. CDPK1 is expressed in the asexual blood stages of the parasite, particularly late stage schizonts. We have identified two substrates of Plasmodium falciparum CDPK1: myosin A tail domain-interacting protein (MTIP) and glideosome-associated protein 45 (GAP45), both of which are components of the motor complex that generates the force required by the parasite to actively invade host cells. Indirect immunofluorescence shows that CDPK1 localizes to the periphery of P. falciparum merozoites and is therefore suitably located to act on MTIP and GAP45 at the inner membrane complex. A proportion of both GAP45 and MTIP is phosphorylated in schizonts, and we demonstrate that both proteins can be efficiently phosphorylated by CDPK1 in vitro. A primary phosphorylation of MTIP occurs at serine 47, whereas GAP45 is phosphorylated at two sites, one of which could also be detected in phosphopeptides purified from parasite lysates. Both CDPK1 activity and host cell invasion can be inhibited by the kinase inhibitor K252a, suggesting that CDPK1 is a suitable target for antimalarial drug development.	[Green, Judith L.; Rees-Channer, Roxanne R.; Knuepfer, Ellen; Grainger, Munira; Holder, Anthony A.] Natl Inst Med Res, MRC, Div Parasitol, London NW7 1AA, England; [Howell, Stephen A.] Natl Inst Med Res, MRC, Div Mol Struct, London NW7 1AA, England; [Rees-Channer, Roxanne R.; Martin, Stephen R.] Natl Inst Med Res, MRC, Div Phys Biochem, London NW7 1AA, England; [Taylor, Helen M.] Univ Glasgow, Glasgow Biomed Res Ctr, Wellcome Ctr Mol Parasitol, Glasgow G12 8TA, Lanark, Scotland	MRC National Institute for Medical Research; MRC National Institute for Medical Research; MRC National Institute for Medical Research; University of Glasgow	Green, JL (corresponding author), Natl Inst Med Res, MRC, Div Parasitol, Ridgeway, London NW7 1AA, England.	green@nimr.mrc.ac.uk	Holder, Anthony A/A-7554-2013	Holder, Anthony A/0000-0002-8490-6058; Green, Judith/0000-0001-6825-9404; Knuepfer, Ellen/0000-0002-6090-1877	National Institutes of Health [0600370P7601176]; United Kingdom Medical Research Council; Wellcome Trust [066742]; Medical Research Council [MC_U117570592, MC_U117532067] Funding Source: researchfish; MRC [MC_U117570592, MC_U117532067] Funding Source: UKRI	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United Kingdom Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported, in whole or in part, by National Institutes of Health Grant 0600370P7601176. This work was also supported by the United Kingdom Medical Research Council and Wellcome Trust Grant 066742.	Abr?moff M.D., 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Bannister LH, 2003, J CELL SCI, V116, P3825, DOI 10.1242/jcs.00665; Baum J, 2006, J BIOL CHEM, V281, P5197, DOI 10.1074/jbc.M509807200; Bergman LW, 2003, J CELL SCI, V116, P39, DOI 10.1242/jcs.00194; Bergmann-Leitner ES, 2006, AM J TROP MED HYG, V75, P437, DOI 10.4269/ajtmh.2006.75.437; Billker O, 2004, CELL, V117, P503, DOI 10.1016/S0092-8674(04)00449-0; BLACKMAN MJ, 1992, MOL BIOCHEM PARASIT, V50, P307, DOI 10.1016/0166-6851(92)90228-C; Bosch J, 2007, J MOL BIOL, V372, P77, DOI 10.1016/j.jmb.2007.06.016; Bozdech Z, 2003, PLOS BIOL, V1, P85, DOI 10.1371/journal.pbio.0000005; COOK PF, 1982, BIOCHEMISTRY-US, V21, P5794, DOI 10.1021/bi00266a011; Fidock DA, 2000, MOL BIOCHEM PARASIT, V110, P1, DOI 10.1016/S0166-6851(00)00249-8; Fidock DA, 2000, MOL CELL, V6, P861, DOI 10.1016/S1097-2765(05)00077-8; Gaskins E, 2004, J CELL BIOL, V165, P383, DOI 10.1083/jcb.200311137; Green JL, 2006, J MOL BIOL, V355, P933, DOI 10.1016/j.jmb.2005.11.027; Green JL, 2006, MOL BIOCHEM PARASIT, V150, P114, DOI 10.1016/j.molbiopara.2006.06.010; HARPER JF, 2005, J MOL BIOL, V357, P400; Hastie CJ, 2006, NAT PROTOC, V1, P968, DOI 10.1038/nprot.2006.149; Hirano K, 2003, MOL CELL BIOCHEM, V248, P105, DOI 10.1023/A:1024180101032; HOLDER AA, 1982, J EXP MED, V156, P1528, DOI 10.1084/jem.156.5.1528; HUFF CG, 1960, J BIOPHYS BIOCHEM CY, V7, P93, DOI 10.1083/jcb.7.1.93; Ishino T, 2006, MOL MICROBIOL, V59, P1175, DOI 10.1111/j.1365-2958.2005.05014.x; Jewett TJ, 2003, MOL CELL, V11, P885, DOI 10.1016/S1097-2765(03)00113-8; Kato N, 2008, NAT CHEM BIOL, V4, P347, DOI 10.1038/nchembio.87; Kieschnick H, 2001, J BIOL CHEM, V276, P12369, DOI 10.1074/jbc.M011045200; Kugelstadt D, 2007, MOL BIOCHEM PARASIT, V151, P111, DOI 10.1016/j.molbiopara.2006.10.012; Lovett JL, 2003, J CELL SCI, V116, P3009, DOI 10.1242/jcs.00596; MATSUMOTO Y, 1987, EUR J CELL BIOL, V45, P36; Moskes C, 2004, MOL MICROBIOL, V54, P676, DOI 10.1111/j.1365-2958.2004.04313.x; Pachebat JA, 2007, MOL BIOCHEM PARASIT, V151, P59, DOI 10.1016/j.molbiopara.2006.10.006; Pinder JC, 1998, J CELL SCI, V111, P1831; Rees-Channer RR, 2006, MOL BIOCHEM PARASIT, V149, P113, DOI 10.1016/j.molbiopara.2006.04.008; Ryder JW, 2007, J BIOL CHEM, V282, P20447, DOI 10.1074/jbc.M702927200; Siden-Kiamos I, 2006, MOL MICROBIOL, V60, P1355, DOI 10.1111/j.1365-2958.2006.05189.x; SWEENEY HL, 1986, AM J PHYSIOL, V250, pC657, DOI 10.1152/ajpcell.1986.250.4.C657; Vaid A, 2008, J BIOL CHEM, V283, P5589, DOI 10.1074/jbc.M708465200; VORM O, 1994, BIOL MASS SPECTROM, V23, P734, DOI 10.1002/bms.1200231204; WARD GE, 1994, EXP PARASITOL, V79, P480, DOI 10.1006/expr.1994.1109; Ward P, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-79; Wasserman M, 1996, PARASITOL RES, V82, P102, DOI 10.1007/s004360050078; ZHAO Y, 1993, J BIOL CHEM, V268, P4347	40	133	139	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 7	2008	283	45					30980	30989		10.1074/jbc.M803129200	http://dx.doi.org/10.1074/jbc.M803129200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	367ID	18768477	Green Published, hybrid			2022-12-27	WOS:000260544800053
J	Hopper, ED; Pittman, AMC; Fitzgerald, MC; Tucker, CL				Hopper, Erin D.; Pittman, Adrianne M. C.; Fitzgerald, Michael C.; Tucker, Chandra L.			In Vivo and in Vitro Examination of Stability of Primary Hyperoxaluria-associated Human Alanine: Glyoxylate Aminotransferase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							THROUGHPUT SCREENING ASSAY; PROMOTE PROTEIN STABILITY; THERMAL SHIFT ASSAYS; ESCHERICHIA-COLI; PYRIDOXAL 5'-PHOSPHATE; SERINE HYDROXYMETHYLTRANSFERASE; SACCHAROMYCES-CEREVISIAE; SUBCELLULAR-DISTRIBUTION; TRAFFICKING DEFECT; DRUG DISCOVERY	Primary hyperoxaluria type I is a severe kidney stone disease caused by mutations in the protein alanine: glyoxylate aminotransferase (AGT). Many patients have mutations in AGT that are not deleterious alone but act synergistically with a common minor allele polymorphic variant to impair protein folding, dimerization, or localization. Although studies suggest that the minor allele variant itself is destabilized, no direct stability studies have been carried out. In this report, we analyze AGT function and stability using three approaches. First, we describe a yeast complementation growth assay for AGT, in which we show that human AGT can substitute for function of yeast Agx1 and that mutations associated with disease in humans show reduced growth in yeast. The reduced growth of minor allele mutants reflects reduced protein levels, indicating that these proteins are less stable than wild-type AGT in yeast. We further examine stability of AGT alleles in vitro using two direct methods, a mass spectrometry-based technique (stability of unpurified proteins from rates of H/D exchange) and differential scanning fluorimetry. We also examine the effect of known ligands pyridoxal 5'-phosphate and aminooxyacetic acid on stability. Our work establishes that the minor allele is destabilized and that pyridoxal 5'-phosphate and aminooxyacetic acid binding significantly stabilizes both alleles. To our knowledge, this is the first work that directly measures relative stabilities of AGT variants and ligand complexes. Because previous studies suggest that stabilizing compounds (i.e. pharmacological chaperones) may be effective for treatment of primary hyperoxaluria, we propose that the methods described here can be used in high throughput screens for compounds that stabilize AGT mutants.	[Pittman, Adrianne M. C.; Tucker, Chandra L.] Duke Univ, Dept Biol, Durham, NC 27708 USA; [Hopper, Erin D.; Fitzgerald, Michael C.] Duke Univ, Dept Chem, Durham, NC 27708 USA	Duke University; Duke University	Tucker, CL (corresponding author), Duke Univ, Dept Biol, Box 90338, Durham, NC 27708 USA.	chandra@duke.edu	Fitzgerald, Michael/E-3392-2010; Tucker, Chandra/F-6842-2011	Tucker, Chandra/0000-0003-3033-1786	National Institutes of Health [R21 DK075291-01A1]; Oxalosis and Hyperoxaluria Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK081584, R21DK075291] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Oxalosis and Hyperoxaluria Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant R21 DK075291-01A1 (to C. L. T.). This work was also supported by a grant from the Oxalosis and Hyperoxaluria Foundation. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Baum EZ, 2007, ANTIMICROB AGENTS CH, V51, P4420, DOI 10.1128/AAC.00845-07; Bedalov A, 2001, P NATL ACAD SCI USA, V98, P15113, DOI 10.1073/pnas.261574398; BEELER T, 1976, J BIOL CHEM, V251, P5267; Bettati S, 2000, J BIOL CHEM, V275, P40244, DOI 10.1074/jbc.M007015200; CAI K, 1995, J BIOL CHEM, V270, P19294, DOI 10.1074/jbc.270.33.19294; Cellini B, 2008, PROTEIN PEPTIDE LETT, V15, P153; Chen CH, 1998, ARCH BIOCHEM BIOPHYS, V349, P175, DOI 10.1006/abbi.1997.0457; Coulter-Mackie MB, 2006, MOL GENET METAB, V89, P349, DOI 10.1016/j.ymgme.2006.07.013; Coulter-Mackie MB, 2005, PROTEIN EXPRES PURIF, V41, P18, DOI 10.1016/j.pep.2004.11.004; Coulter-Mackie MB, 2004, MOL GENET METAB, V83, P38, DOI 10.1016/j.ymgme.2004.08.009; Danpure CJ, 2006, BBA-MOL CELL RES, V1763, P1776, DOI 10.1016/j.bbamcr.2006.08.021; DANPURE CJ, 1994, EUR J CELL BIOL, V64, P295; Danpure CJ, 2005, AM J NEPHROL, V25, P303, DOI 10.1159/000086362; DANPURE CJ, 1990, J CELL SCI, V97, P669; DOMINICI P, 1993, BIOCHEM J, V295, P493, DOI 10.1042/bj2950493; Ehrnhoefer DE, 2006, HUM MOL GENET, V15, P2743, DOI 10.1093/hmg/ddl210; Epps DE, 2001, ANAL BIOCHEM, V292, P40, DOI 10.1006/abio.2001.5047; Fan JQ, 1999, NAT MED, V5, P112, DOI 10.1038/4801; Fan JQ, 2003, TRENDS PHARMACOL SCI, V24, P355, DOI 10.1016/S0165-6147(03)00158-5; Ghaemmaghami S, 2000, P NATL ACAD SCI USA, V97, P8296, DOI 10.1073/pnas.140111397; Grasberger BL, 2005, J MED CHEM, V48, P909, DOI 10.1021/jm049137g; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Liu WS, 2004, BIOCHEMISTRY-US, V43, P10896, DOI 10.1021/bi049218e; Lo MC, 2004, ANAL BIOCHEM, V332, P153, DOI 10.1016/j.ab.2004.04.031; Lumb MJ, 2003, BIOCHEM J, V374, P79, DOI 10.1042/BJ20030371; Lumb MJ, 1999, J BIOL CHEM, V274, P20587, DOI 10.1074/jbc.274.29.20587; Lumb MJ, 2000, J BIOL CHEM, V275, P36415, DOI 10.1074/jbc.M006693200; Monico CG, 2005, AM J NEPHROL, V25, P183, DOI 10.1159/000085411; Morello JP, 2000, J CLIN INVEST, V105, P887, DOI 10.1172/JCI8688; Niesen FH, 2007, NAT PROTOC, V2, P2212, DOI 10.1038/nprot.2007.321; NISHIYAMA K, 1991, BIOCHEM BIOPH RES CO, V176, P1093, DOI 10.1016/0006-291X(91)90396-O; Nozaki Y, 1972, Methods Enzymol, V26, P43; Pantoliano MW, 2001, J BIOMOL SCREEN, V6, P429, DOI 10.1089/108705701753364922; Poklar N, 1997, BIOCHEMISTRY-US, V36, P14345, DOI 10.1021/bi971719v; Powell KD, 2004, J COMB CHEM, V6, P262, DOI 10.1021/cc034051e; Powell KD, 2003, BIOCHEMISTRY-US, V42, P4962, DOI 10.1021/bi034096w; Powell KD, 2002, PROTEIN SCI, V11, P841, DOI 10.1110/ps.3820102; Powell KD, 2002, J AM CHEM SOC, V124, P10256, DOI 10.1021/ja026574g; PURDUE PE, 1991, P NATL ACAD SCI USA, V88, P10900, DOI 10.1073/pnas.88.23.10900; PURDUE PE, 1990, J CELL BIOL, V111, P2341, DOI 10.1083/jcb.111.6.2341; Rowlands MG, 2004, ANAL BIOCHEM, V327, P176, DOI 10.1016/j.ab.2003.10.038; Rumsby G, 1997, ANN CLIN BIOCHEM, V34, P400, DOI 10.1177/000456329703400411; Santana A, 2003, P NATL ACAD SCI USA, V100, P7277, DOI 10.1073/pnas.1131968100; Schlosser T, 2004, YEAST, V21, P63, DOI 10.1002/yea.1058; SEIFERT T, 1985, BIOCHEMISTRY-US, V24, P339, DOI 10.1021/bi00323a016; Stolz J, 2003, J BIOL CHEM, V278, P18990, DOI 10.1074/jbc.M300949200; Vedadi M, 2006, P NATL ACAD SCI USA, V103, P15835, DOI 10.1073/pnas.0605224103; Venkatesha B, 1998, BBA-PROTEIN STRUCT M, V1384, P141, DOI 10.1016/S0167-4838(98)00013-2; Williams E, 2007, CLIN CHEM, V53, P1216, DOI 10.1373/clinchem.2006.084434; Wu TH, 2003, BBA-PROTEINS PROTEOM, V1647, P315, DOI 10.1016/S1570-9639(03)00081-5; Yam GHF, 2005, FASEB J, V19, P12, DOI 10.1096/fj.04-2375com; ZETINA CR, 1980, J BIOL CHEM, V255, P4381; Zhang XQ, 2005, P NATL ACAD SCI USA, V102, P892, DOI 10.1073/pnas.0408936102; Zhang XX, 2003, J MOL BIOL, V331, P643, DOI 10.1016/S0022-2836(03)00791-5; ZOLLNER H, 1989, HDB ENZYME INHIBITOR	55	45	45	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 7	2008	283	45					30493	30502		10.1074/jbc.M803525200	http://dx.doi.org/10.1074/jbc.M803525200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	367ID	18782763	Green Published, hybrid			2022-12-27	WOS:000260544800007
J	Fujimoto, M; Oshima, K; Shinkawa, T; Wang, BB; Inouye, S; Hayashida, N; Takii, R; Nakai, A				Fujimoto, Mitsuaki; Oshima, Koji; Shinkawa, Toyohide; Wang, Bei Bei; Inouye, Sachiye; Hayashida, Naoki; Takii, Ryosuke; Nakai, Akira			Analysis of HSF4 Binding Regions Reveals Its Necessity for Gene Regulation during Development and Heat Shock Response in Mouse Lenses	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENOME-WIDE ANALYSIS; TRANSCRIPTION FACTOR-1; MOLECULAR CHAPERONES; FACTOR-I; TARGETED DISRUPTION; EXPRESSION; STRESS; MICE; ACTIVATOR; THERMOTOLERANCE	Heat shock transcription factors (HSFs) regulate gene expression in response to heat shock and in physiological conditions. In mammals, HSF1 is required for heat-mediated induction of classic heat shock genes; however, we do not know the molecular mechanisms by which HSF4 regulates gene expression or the biological consequences of its binding to chromatin. Here, we identified that HSF4 binds to various genomic regions, including the introns and distal parts of protein-coding genes in vivo in mouse lenses, and a substantial numbers of the regions were also occupied by HSF1 and HSF2. HSF4 regulated expression of some genes at a developmental stage when HSF1 and HSF2 expression decreased. Although HSF4 binding did not affect expression of many genes, it induces demethylated status of histone H3K9 on the binding regions. Unexpectedly, a lot of HSF4 targets were induced by heat shock treatment, and HSF4 is required for induction of a set of non-classic heat shock genes in response to heat shock, in part by facilitating HSF1 binding through chromatin modification. These results suggest novel mechanisms of gene regulation controlled by HSF4 in non-classic heat shock response and in lens development.	[Nakai, Akira] Yamaguchi Univ, Sch Med, Dept Biochem, Ube, Yamaguchi 7558505, Japan; Yamaguchi Univ, Sch Med, Dept Mol Biol, Ube, Yamaguchi 7558505, Japan	Yamaguchi University; Yamaguchi University	Nakai, A (corresponding author), Yamaguchi Univ, Sch Med, Dept Biochem, Minami Kogushi 1-1-1, Ube, Yamaguchi 7558505, Japan.	anakai@yamaguchi-u.ac.jp	Hayashida, Naoki/HGA-3453-2022	Hayashida, Naoki/0000-0002-8785-8012	Ministry of Education, Culture, Sports, Science and Technology, Japan; Uehara Foundation; NOVARTIS Foundation; Nakatomi Foundation; Kao Foundation for Arts and Sciences; Mochida Foundation	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Uehara Foundation(Uehara Memorial Foundation); NOVARTIS Foundation(Novartis); Nakatomi Foundation; Kao Foundation for Arts and Sciences; Mochida Foundation	This work was supported in part by Grants-in-Aid for Scientific Research and on Priority Area-a Nuclear System of DECODE, from the Ministry of Education, Culture, Sports, Science and Technology, Japan, the Uehara Foundation, the NOVARTIS Foundation, the Nakatomi Foundation, the Kao Foundation for Arts and Sciences, and the Mochida Foundation. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Agger K, 2008, CURR OPIN GENET DEV, V18, P159, DOI 10.1016/j.gde.2007.12.003; AMIN J, 1988, MOL CELL BIOL, V8, P3761, DOI 10.1128/MCB.8.9.3761; Balch WE, 2008, SCIENCE, V319, P916, DOI 10.1126/science.1141448; Baruch A, 2001, J BIOL CHEM, V276, P28999, DOI 10.1074/jbc.M103628200; Bu L, 2002, NAT GENET, V31, P276, DOI 10.1038/ng921; Chang YH, 2006, GENE DEV, V20, P836, DOI 10.1101/gad.366906; Christians E, 2000, NATURE, V407, P693, DOI 10.1038/35037669; Corey LL, 2003, GENE DEV, V17, P1392, DOI 10.1101/gad.1071803; Dai C, 2007, CELL, V130, P1005, DOI 10.1016/j.cell.2007.07.020; Fernandes M., 1994, BIOL HEAT SHOCK PROT, P375; Fujimoto M, 2004, EMBO J, V23, P4297, DOI 10.1038/sj.emboj.7600435; Fujimoto M, 2005, J BIOL CHEM, V280, P34908, DOI 10.1074/jbc.M506288200; Hahn JS, 2004, MOL CELL BIOL, V24, P5249, DOI 10.1128/MCB.24.12.5249-5256.2004; Hayashida N, 2006, EMBO J, V25, P4773, DOI 10.1038/sj.emboj.7601370; He HY, 2003, J BIOL CHEM, V278, P35465, DOI 10.1074/jbc.M304663200; Hsu AL, 2003, SCIENCE, V300, P1142, DOI 10.1126/science.1083701; Hu ZZ, 2007, NAT GENET, V39, P683, DOI 10.1038/ng2012; Inouye S, 2004, J BIOL CHEM, V279, P38701, DOI 10.1074/jbc.M405986200; Inouye S, 2003, MOL CELL BIOL, V23, P5882, DOI 10.1128/MCB.23.16.5882-5895.2003; Inouye S, 2007, J BIOL CHEM, V282, P33210, DOI 10.1074/jbc.M704471200; Jedlicka P, 1997, EMBO J, V16, P2452, DOI 10.1093/emboj/16.9.2452; Kallio M, 2002, EMBO J, V21, P2591, DOI 10.1093/emboj/21.11.2591; KROEGER PE, 1994, MOL CELL BIOL, V14, P7592, DOI 10.1128/MCB.14.11.7592; KROEGER PE, 1993, MOL CELL BIOL, V13, P3370, DOI 10.1128/MCB.13.6.3370; Lan F, 2008, CURR OPIN CELL BIOL, V20, P316, DOI 10.1016/j.ceb.2008.03.004; Li LP, 1997, HUM GENE THER, V8, P1695, DOI 10.1089/hum.1997.8.14-1695; McAvoy JW, 1999, EYE, V13, P425, DOI 10.1038/eye.1999.117; McMillan DR, 1998, J BIOL CHEM, V273, P7523, DOI 10.1074/jbc.273.13.7523; Min JN, 2007, ONCOGENE, V26, P5086, DOI 10.1038/sj.onc.1210317; Min JN, 2004, GENESIS, V40, P205, DOI 10.1002/gene.20087; Morimoto RI, 1998, GENE DEV, V12, P3788, DOI 10.1101/gad.12.24.3788; Morita S, 2000, GENE THER, V7, P1063, DOI 10.1038/sj.gt.3301206; Morley JF, 2004, MOL BIOL CELL, V15, P657, DOI 10.1091/mbc.E03-07-0532; Nakai A, 1997, MOL CELL BIOL, V17, P469, DOI 10.1128/MCB.17.1.469; Nakai A, 1999, CELL STRESS CHAPERON, V4, P86, DOI 10.1054/csac.1998.0002; Nakai A, 2000, EMBO J, V19, P1545, DOI 10.1093/emboj/19.7.1545; NAKAI A, 1995, MOL CELL BIOL, V15, P5268; Ostling P, 2007, J BIOL CHEM, V282, P7077, DOI 10.1074/jbc.M607556200; Page TJ, 2006, MOL BIOSYST, V2, P627, DOI 10.1039/b606129j; PARSELL DA, 1993, ANNU REV GENET, V27, P437, DOI 10.1146/annurev.ge.27.120193.002253; Pirkkala L, 2001, FASEB J, V15, P1118, DOI 10.1096/fj00-0294rev; Rallu M, 1997, P NATL ACAD SCI USA, V94, P2392, DOI 10.1073/pnas.94.6.2392; Sakamoto M, 2006, CIRC RES, V99, P1411, DOI 10.1161/01.RES.0000252345.80198.97; Santoro N, 1998, MOL CELL BIOL, V18, P6340, DOI 10.1128/MCB.18.11.6340; Santos SD, 2004, NEUROSCIENCE, V126, P657, DOI 10.1016/j.neuroscience.2004.03.023; SISTONEN L, 1994, MOL CELL BIOL, V14, P2087, DOI 10.1128/MCB.14.3.2087; SISTONEN L, 1992, MOL CELL BIOL, V12, P4104, DOI 10.1128/MCB.12.9.4104; Smith ST, 2004, NAT CELL BIOL, V6, P162, DOI 10.1038/ncb1088; Somasundaram T, 2004, J BIOL CHEM, V279, P44497, DOI 10.1074/jbc.M405813200; Takaki E, 2006, J BIOL CHEM, V281, P4931, DOI 10.1074/jbc.M506911200; Takaki E, 2007, J BIOL CHEM, V282, P37285, DOI 10.1074/jbc.M704562200; Tanabe M, 1998, EMBO J, V17, P1750, DOI 10.1093/emboj/17.6.1750; Tanabe M, 1999, J BIOL CHEM, V274, P27845, DOI 10.1074/jbc.274.39.27845; Tanaka KI, 2007, J BIOL CHEM, V282, P23240, DOI 10.1074/jbc.M704081200; Thomson S, 2004, MOL CELL, V15, P585, DOI 10.1016/j.molcel.2004.08.002; Trinklein ND, 2004, MOL BIOL CELL, V15, P1254, DOI 10.1091/mbc.E03-10-0738; Wang GH, 2004, GENESIS, V38, P66, DOI 10.1002/gene.20005; Westerheide SD, 2005, J BIOL CHEM, V280, P33097, DOI 10.1074/jbc.R500010200; WESTWOOD JT, 1991, NATURE, V353, P822, DOI 10.1038/353822a0; Wu C, 1995, ANNU REV CELL DEV BI, V11, P441, DOI 10.1146/annurev.cellbio.11.1.441; XIAO H, 1988, SCIENCE, V239, P1139, DOI 10.1126/science.3125608; Xing HY, 2005, SCIENCE, V307, P421, DOI 10.1126/science.1106478; Yao J, 2006, NATURE, V442, P1050, DOI 10.1038/nature05025; Zhang Y, 2002, J CELL BIOCHEM, V86, P376, DOI 10.1002/jcb.10232; Zheng H, 2004, J IMMUNOL, V173, P5929, DOI 10.4049/jimmunol.173.10.5929	65	52	52	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 31	2008	283	44					29961	29970		10.1074/jbc.M804629200	http://dx.doi.org/10.1074/jbc.M804629200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	364WS	18755693	Green Published, hybrid			2022-12-27	WOS:000260366900041
J	Glabe, CG				Glabe, Charles G.			Structural Classification of Toxic Amyloid Oligomers	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							A-BETA OLIGOMERS; ALZHEIMERS-DISEASE; ULTRASTRUCTURALLY LOCALIZE; COMMON MECHANISM; ALPHA-SYNUCLEIN; MOLECULAR-BASIS; CELL PROCESSES; IN-VIVO; PROTEIN; FIBRILS	Amyloid oligomers are believed to play important causal roles in many types of amyloid-related degenerative diseases. Many different laboratories have reported amyloid oligomers that differ in size, morphology, toxicity, and method of preparation or purification, raising the question of the structural relationships among these oligomer preparations. The structural plasticity that has been reported to occur in amyloids formed from the same protein sequence indicates that it is quite possible that different oligomer preparations may represent distinct structural variants. In view of the difficulty in determining the precise structure of amyloids, conformation- and epitope-specific antibodies may provide a facile means of classifying amyloid oligomer structures. Conformation-dependent antibodies that recognize generic epitopes that are specifically associated with distinct aggregation states of many different amyloid-forming sequences indicate that there are at least two fundamentally distinct types of amyloid oligomers: fibrillar and prefibrillar oligomers. Classification of amyloid oligomers according to their underlying structures may be a more useful and rational approach than relying on differences in size and morphology.	Univ Calif Irvine, Dept Mol Biol & Biochem, Irvine, CA 92697 USA	University of California System; University of California Irvine	Glabe, CG (corresponding author), Univ Calif Irvine, Dept Mol Biol & Biochem, Irvine, CA 92697 USA.	cglabe@uci.edu			National Institutes of Health [NS31230, AG00538]; Cure Alzheimer Fund; Larry L. Hillblom Foundation; NATIONAL INSTITUTE ON AGING [P01AG000538] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cure Alzheimer Fund; Larry L. Hillblom Foundation; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in part or in whole, by National Institutes of Health Grants NS31230 and AG00538 and grants from the Cure Alzheimer Fund and the Larry L. Hillblom Foundation. This is the fifth article of eleven in the Thematic Minireview Series on the Molecular Basis of Alzheimer Disease. This minireview will be reprinted in the 2008 Minireview Compendium, which will be available in January, 2009.	Anguiano M, 2002, BIOCHEMISTRY-US, V41, P11338, DOI 10.1021/bi020314u; Armen RS, 2004, P NATL ACAD SCI USA, V101, P11622, DOI 10.1073/pnas.0401781101; Baglioni S, 2006, J NEUROSCI, V26, P8160, DOI 10.1523/JNEUROSCI.4809-05.2006; Barghorn S, 2005, J NEUROCHEM, V95, P834, DOI 10.1111/j.1471-4159.2005.03407.x; Billings LM, 2005, NEURON, V45, P675, DOI 10.1016/j.neuron.2005.01.040; Bitan G, 2003, P NATL ACAD SCI USA, V100, P330, DOI 10.1073/pnas.222681699; Bucciantini M, 2002, NATURE, V416, P507, DOI 10.1038/416507a; BURDICK D, 1992, J BIOL CHEM, V267, P546; Chiti F, 2003, NATURE, V424, P805, DOI 10.1038/nature01891; Cleary JP, 2005, NAT NEUROSCI, V8, P79, DOI 10.1038/nn1372; Conway KA, 2000, BIOCHEMISTRY-US, V39, P2552, DOI 10.1021/bi991447r; Der-Sarkissian A, 2003, J BIOL CHEM, V278, P37530, DOI 10.1074/jbc.M305266200; Deshpande A, 2006, J NEUROSCI, V26, P6011, DOI 10.1523/JNEUROSCI.1189-06.2006; GarzonRodriguez W, 1997, J BIOL CHEM, V272, P21037, DOI 10.1074/jbc.272.34.21037; Georganopoulou DG, 2005, P NATL ACAD SCI USA, V102, P2273, DOI 10.1073/pnas.0409336102; Gong YS, 2003, P NATL ACAD SCI USA, V100, P10417, DOI 10.1073/pnas.1834302100; Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Harper JD, 1997, CHEM BIOL, V4, P119, DOI 10.1016/S1074-5521(97)90255-6; HILBICH C, 1991, J MOL BIOL, V218, P149, DOI 10.1016/0022-2836(91)90881-6; Hoshi M, 2003, P NATL ACAD SCI USA, V100, P6370, DOI 10.1073/pnas.1237107100; Hrncic R, 2000, AM J PATHOL, V157, P1239, DOI 10.1016/S0002-9440(10)64639-1; Janson J, 1999, DIABETES, V48, P491, DOI 10.2337/diabetes.48.3.491; Jayasinghe SA, 2004, J BIOL CHEM, V279, P48420, DOI 10.1074/jbc.M406853200; JURNAK F, 1994, CURR OPIN STRUC BIOL, V4, P802, DOI 10.1016/0959-440X(94)90259-3; Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469; Kayed R, 2007, MOL NEURODEGENER, V2, DOI 10.1186/1750-1326-2-18; KIRSCHNER DA, 1986, P NATL ACAD SCI USA, V83, P503, DOI 10.1073/pnas.83.2.503; Klyubin I, 2005, NAT MED, V11, P556, DOI 10.1038/nm1234; Kokubo H, 2005, BRAIN RES, V1045, P224, DOI 10.1016/j.brainres.2005.03.017; Kokubo H, 2005, BRAIN RES, V1031, P222, DOI 10.1016/j.brainres.2004.10.041; Lacor PN, 2004, J NEUROSCI, V24, P10191, DOI 10.1523/JNEUROSCI.3432-04.2004; Lambert MP, 2007, J NEUROCHEM, V100, P23, DOI 10.1111/j.1471-4159.2006.04157.x; Lambert MP, 2001, J NEUROCHEM, V79, P595, DOI 10.1046/j.1471-4159.2001.00592.x; Lambert MP, 1998, P NATL ACAD SCI USA, V95, P6448, DOI 10.1073/pnas.95.11.6448; Lashuel HA, 2002, NATURE, V418, P291, DOI 10.1038/418291a; Lesne S, 2006, NATURE, V440, P352, DOI 10.1038/nature04533; Lomakin A, 1997, P NATL ACAD SCI USA, V94, P7942, DOI 10.1073/pnas.94.15.7942; Luhrs T, 2005, P NATL ACAD SCI USA, V102, P17342, DOI 10.1073/pnas.0506723102; Margittai M, 2004, P NATL ACAD SCI USA, V101, P10278, DOI 10.1073/pnas.0401911101; Morales R, 2007, BBA-MOL BASIS DIS, V1772, P681, DOI 10.1016/j.bbadis.2006.12.006; Moretto N, 2007, J BIOL CHEM, V282, P11436, DOI 10.1074/jbc.M609690200; Necula M, 2007, J BIOL CHEM, V282, P10311, DOI 10.1074/jbc.M608207200; Nelson R, 2005, NATURE, V435, P773, DOI 10.1038/nature03680; Nimmrich V, 2008, J NEUROSCI, V28, P788, DOI 10.1523/JNEUROSCI.4771-07.2008; Novitskaya V, 2006, J BIOL CHEM, V281, P15536, DOI 10.1074/jbc.M601349200; O'Nuallain B, 2002, P NATL ACAD SCI USA, V99, P1485, DOI 10.1073/pnas.022662599; Petkova AT, 2005, SCIENCE, V307, P262, DOI 10.1126/science.1105850; Petkova AT, 2002, P NATL ACAD SCI USA, V99, P16742, DOI 10.1073/pnas.262663499; Sawaya MR, 2007, NATURE, V447, P453, DOI 10.1038/nature05695; SOREGHAN B, 1994, J BIOL CHEM, V269, P28551; Terry RD, 1996, J NEUROPATH EXP NEUR, V55, P1023, DOI 10.1097/00005072-199655100-00001; Toyama BH, 2007, NATURE, V449, P233, DOI 10.1038/nature06108; Walsh DM, 1997, J BIOL CHEM, V272, P22364, DOI 10.1074/jbc.272.35.22364; Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a; Westerman MA, 2002, J NEUROSCI, V22, P1858, DOI 10.1523/JNEUROSCI.22-05-01858.2002; Wisniewski HM, 1973, PROGR NEUROPATHOLOGY, V2, P1; Yamamoto N, 2007, J BIOL CHEM, V282, P2646, DOI 10.1074/jbc.M606202200	60	619	631	4	152	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 31	2008	283	44					29639	29643		10.1074/jbc.R800016200	http://dx.doi.org/10.1074/jbc.R800016200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	364WS	18723507	hybrid, Green Published			2022-12-27	WOS:000260366900006
J	Jin, W; Chen, Y; Di, GH; Miron, P; Hou, YF; Gao, H; Shao, ZM				Jin, Wei; Chen, Ying; Di, Gen-hong; Miron, Penelope; Hou, Yi-feng; Gao, Hui; Shao, Zhi-ming			Estrogen Receptor (ER)beta or p53 Attenuates ER alpha-mediated Transcriptional Activation on the BRCA2 Promoter	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SPORADIC BREAST-CANCER; GENE-EXPRESSION; MESSENGER-RNA; CARCINOMAS; MUTATIONS; P300; BETA; CBP; SUSCEPTIBILITY; COREGULATORS	BRCA2 is closely related to the pathogenesis of breast cancer. In the present study, we found that estrogen can activate BRCA2 transcription, which is estrogen receptor (ER) alpha-dependent. During estrogen treatment, ER alpha interacted with CREB-binding protein/p300, p68/p72, and MyoD and formed an activating transcriptional complex that could bind to many Sp1 sites on the BRCA2 promoter and activate its transcription by inducing histone acetylations. MyoD is a new component of ER alpha complex. ER beta or p53 attenuated ER alpha-mediated transcriptional activation by preventing the recruitment of ER alpha transcriptional complex and histone acetylations on the BRCA2 promoter. ER beta interacted with ER alpha and CREB-binding protein/p300 and formed a weak activating transcriptional complex that competed for binding to Sp1 sites with ER alpha transcriptional complex and slightly attenuated BRCA2 transcription. Different from ER beta, p53 interacted with HDAC1 and CtBP1 and formed an inhibiting transcriptional complex that could compete for binding to Sp1 sites with ER alpha transcriptional complex and inhibit BRCA2 transcription more significantly.	[Jin, Wei; Chen, Ying; Di, Gen-hong; Hou, Yi-feng; Shao, Zhi-ming] Fudan Univ, Breast Canc Inst, Canc Hosp, Dept Oncol,Shanghai Med Coll,Inst Biomed Sci, Shanghai 200032, Peoples R China; [Jin, Wei; Gao, Hui] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Canc Inst New Jersey, New Brunswick, NJ 08901 USA; [Miron, Penelope] Harvard Univ, Dept Canc Biol, Dana Farber Canc Inst, Boston, MA 02115 USA	Fudan University; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers Cancer Institute of New Jersey; Harvard University; Dana-Farber Cancer Institute	Shao, ZM (corresponding author), Fudan Univ, Dept Breast Surg, Breast Canc Inst, Canc Hosp Canc Inst, 270 Dong Rd, Shanghai 200032, Peoples R China.	zhimingshao@yahoo.com		Di, Genhong/0000-0003-1171-7907	National Natural Science Foundation of China [30371580, 30572109]; Shanghai Science and Technology Committee [03J14019, 06DJ14004, 06DZ19504]; Cancer Hospital/Cancer Institute of Fudan University [YJ200604]; Shanghai Pujiang Program;  [2006CB0D0901]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Science and Technology Committee(Shanghai Science & Technology Committee); Cancer Hospital/Cancer Institute of Fudan University; Shanghai Pujiang Program(Shanghai Pujiang Program); 	This work was supported in part by 973 (Grant 2006CB0D0901), the National Natural Science Foundation of China (Grants 30371580 and 30572109), the Shanghai Science and Technology Committee (Grants 03J14019, 06DJ14004, and 06DZ19504); the Cancer Hospital/Cancer Institute of Fudan University (Grant YJ200604), and the Shanghai Pujiang Program. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Abba MC, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-37; Angele S, 2000, CLIN CANCER RES, V6, P3536; Bannister AJ, 1996, NATURE, V384, P641, DOI 10.1038/384641a0; Bieche I, 2001, ONCOGENE, V20, P8109, DOI 10.1038/sj.onc.1204917; Blobel GA, 2002, J LEUKOCYTE BIOL, V71, P545; Caretti G, 2006, DEV CELL, V11, P547, DOI 10.1016/j.devcel.2006.08.003; COLES C, 1992, CANCER RES, V52, P5291; Couse JF, 1999, ENDOCR REV, V20, P358, DOI 10.1210/er.20.3.358; FUTREAL PA, 1994, SCIENCE, V266, P120, DOI 10.1126/science.7939630; Gayther SA, 1999, AM J HUM GENET, V65, P1021, DOI 10.1086/302583; Kato S, 2000, GENES CELLS, V5, P593, DOI 10.1046/j.1365-2443.2000.00354.x; Mueller CR, 2003, BREAST CANCER RES, V5, P45, DOI 10.1186/bcr557; Nilsson S, 2001, PHYSIOL REV, V81, P1535, DOI 10.1152/physrev.2001.81.4.1535; Ogawa S, 1998, BIOCHEM BIOPH RES CO, V243, P122, DOI 10.1006/bbrc.1997.7893; Ogryzko VV, 1996, CELL, V87, P953, DOI 10.1016/S0092-8674(00)82001-2; Pettersson K, 2001, ANNU REV PHYSIOL, V63, P165, DOI 10.1146/annurev.physiol.63.1.165; SHEK LL, 1989, EUR J CANCER CLIN ON, V25, P243, DOI 10.1016/0277-5379(89)90015-1; Shi YJ, 2003, NATURE, V422, P735, DOI 10.1038/nature01550; Sourvinos G, 1998, BIOCHEM BIOPH RES CO, V245, P75, DOI 10.1006/bbrc.1998.8379; Spillman MA, 1996, ONCOGENE, V13, P1639; Thakur S, 1999, J BIOL CHEM, V274, P8837, DOI 10.1074/jbc.274.13.8837; THOMPSON ME, 1995, NAT GENET, V9, P444, DOI 10.1038/ng0495-444; Turner N, 2004, NAT REV CANCER, V4, P814, DOI 10.1038/nrc1457; Venkitaraman AR, 2002, CELL, V108, P171, DOI 10.1016/S0092-8674(02)00615-3; Vo N, 2001, J BIOL CHEM, V276, P13505, DOI 10.1074/jbc.R000025200; Watanabe M, 2001, EMBO J, V20, P1341, DOI 10.1093/emboj/20.6.1341; Wilson CA, 1999, NAT GENET, V21, P236, DOI 10.1038/6029; Wu K, 2000, J BIOL CHEM, V275, P35548, DOI 10.1074/jbc.M004390200; Wu KJ, 2003, J BIOL CHEM, V278, P15652, DOI 10.1074/jbc.M211297200	29	24	27	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 31	2008	283	44					29671	29680		10.1074/jbc.M802785200	http://dx.doi.org/10.1074/jbc.M802785200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	364WS	18765668	hybrid, Green Published			2022-12-27	WOS:000260366900010
J	Larade, K; Jiang, ZG; Zhang, YZ; Wang, WF; Bonner-Weir, S; Zhu, H; Bunn, HF				Larade, Kevin; Jiang, Zhigang; Zhang, Yongzhao; Wang, WenFang; Bonner-Weir, Susan; Zhu, Hao; Bunn, H. Franklin			Loss of Ncb5or Results in Impaired Fatty Acid Desaturation, Lipoatrophy, and Diabetes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STEAROYL-COA DESATURASE-1; PANCREATIC BETA-CELLS; ENDOPLASMIC-RETICULUM STRESS; COENZYME-A DESATURASE; BREAST-CANCER CELLS; FACTOR-KAPPA-B; CONGENITAL METHEMOGLOBINEMIA; CYTOCHROME-B5 REDUCTASE; GENERALIZED DEFICIENCY; MENTAL-RETARDATION	Targeted ablation of the novel flavoheme reductase Ncb5or knock-out (KO) results in progressive loss of pancreatic beta-cells and white adipose tissue over time. Lipoatrophy persisted in KO animals in which the confounding metabolic effects of diabetes were eliminated by islet transplantation (transplanted knockout (TKO)). Lipid profiles in livers prepared from TKO animals were markedly deficient in triglycerides and diacylglycerides. Despite enhanced expression of stearoyl-Co-A desaturase-1, levels of palmitoleic and oleic acids (Delta 9 fatty acid desaturation) were decreased in TKO relative to wild type controls. Treatment of KO hepatocytes with palmitic acid reduced cell viability and increased apoptosis, a response blunted by coincubation with oleic acid. The results presented here support the hypothesis that Ncb5or supplies electrons for fatty acid desaturation, offer new insight into the regulation of a crucial step in fatty acid biosynthesis, and provide a plausible explanation for both the diabetic and the lipoatrophic phenotype in Ncb5or(-/-) mice.	[Larade, Kevin; Jiang, Zhigang; Zhang, Yongzhao; Bunn, H. Franklin] Harvard Univ, Brigham & Womens Hosp, Sch Med, Boston, MA 02115 USA; [Wang, WenFang; Zhu, Hao] Univ Kansas, Med Ctr, Sch Allied Hlth, Kansas City, KS 66160 USA; [Bonner-Weir, Susan] Harvard Univ, Sch Med, Joslin Diabet Ctr, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; University of Kansas; University of Kansas Medical Center; Harvard University; Harvard Medical School; Joslin Diabetes Center, Inc.	Bunn, HF (corresponding author), CHRB 5-215,75 Francis St, Boston, MA 02115 USA.	hfbunn@rics.bwh.harvard.edu		Bonner-Weir, Susan/0000-0003-4682-0656	National Institutes of Health [DK067355, AI56374]; Juvenile Diabetes Research Foundation [1-2005-121, 3-2005-232]; American Diabetes Association [7-04-RA-15]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI056374] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK067355] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); American Diabetes Association(American Diabetes Association); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK067355 and AI56374. This work was also supported by Juvenile Diabetes Research Foundation Grants 1-2005-121 and 3-2005-232 and American Diabetes Association Grant 7-04-RA-15. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked " advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Bulbarelli A, 1998, BLOOD, V92, P310, DOI 10.1182/blood.V92.1.310.413k24_310_319; Busch AK, 2005, DIABETES, V54, P2917, DOI 10.2337/diabetes.54.10.2917; Cho HP, 1999, J BIOL CHEM, V274, P471, DOI 10.1074/jbc.274.1.471; Cho HP, 1999, J BIOL CHEM, V274, P37335, DOI 10.1074/jbc.274.52.37335; Christianson JL, 2008, J BIOL CHEM, V283, P2906, DOI 10.1074/jbc.M705656200; Cnop M, 2005, DIABETES, V54, pS97, DOI 10.2337/diabetes.54.suppl_2.S97; Cnop M, 2001, DIABETES, V50, P1771, DOI 10.2337/diabetes.50.8.1771; Cohen P, 2002, SCIENCE, V297, P240, DOI 10.1126/science.1071527; Diakogiannaki E, 2007, J ENDOCRINOL, V194, P283, DOI 10.1677/JOE-07-0082; Donath MY, 2005, DIABETES, V54, pS108, DOI 10.2337/diabetes.54.suppl_2.S108; El-Assaad W, 2003, ENDOCRINOLOGY, V144, P4154, DOI 10.1210/en.2003-0410; Finck BN, 2006, J CLIN INVEST, V116, P615, DOI 10.1172/JCI27794; Flowers JB, 2007, DIABETES, V56, P1228, DOI 10.2337/db06-1142; GIORDANO SJ, 1991, BIOCHEM BIOPH RES CO, V178, P38, DOI 10.1016/0006-291X(91)91776-9; Hardy S, 2000, CANCER RES, V60, P6353; Hardy S, 2003, J BIOL CHEM, V278, P31861, DOI 10.1074/jbc.M300190200; HIRONO H, 1984, LIPIDS, V19, P60, DOI 10.1007/BF02534610; HIRONO H, 1980, LIPIDS, V15, P272, DOI 10.1007/BF02535839; HIRONO H, 1983, TOHOKU J EXP MED, V140, P391, DOI 10.1620/tjem.140.391; HOLLOWAY PW, 1972, BIOCHEMISTRY-US, V11, P3689, DOI 10.1021/bi00770a005; Iizuka K, 2002, BBA-MOL BASIS DIS, V1586, P23, DOI 10.1016/S0925-4439(01)00082-5; Kharroubi I, 2004, ENDOCRINOLOGY, V145, P5087, DOI 10.1210/en.2004-0478; Kim ND, 2006, TOXICOL SCI, V90, P586, DOI 10.1093/toxsci/kfj111; KIMURA S, 1984, FEBS LETT, V169, P143, DOI 10.1016/0014-5793(84)80306-3; Larade K, 2007, BIOCHEM J, V404, P467, DOI 10.1042/BJ20061859; Leonard AE, 2000, BIOCHEM J, V347, P719, DOI 10.1042/0264-6021:3470719; Lin JD, 2005, CELL METAB, V1, P361, DOI 10.1016/j.cmet.2005.05.004; Listenberger LL, 2003, P NATL ACAD SCI USA, V100, P3077, DOI 10.1073/pnas.0630588100; Maedler K, 2003, DIABETES, V52, P726, DOI 10.2337/diabetes.52.3.726; Maedler K, 2001, DIABETES, V50, P69, DOI 10.2337/diabetes.50.1.69; Malhi H, 2007, GUT, V56, P1124, DOI 10.1136/gut.2006.118059; McGarry JD, 1999, DIABETOLOGIA, V42, P128, DOI 10.1007/s001250051130; Ntambi JM, 2002, P NATL ACAD SCI USA, V99, P11482, DOI 10.1073/pnas.132384699; OSHINO N, 1971, J BIOCHEM, V69, P155, DOI 10.1093/oxfordjournals.jbchem.a129444; PIETRINI G, 1992, J CELL BIOL, V117, P975, DOI 10.1083/jcb.117.5.975; Prentki M, 1996, DIABETES, V45, P273, DOI 10.2337/diabetes.45.3.273; Rahman SM, 2003, P NATL ACAD SCI USA, V100, P11110, DOI 10.1073/pnas.1934571100; RICHIERI GV, 1993, BIOCHEMISTRY-US, V32, P7574, DOI 10.1021/bi00080a032; Roche E, 1999, DIABETES, V48, P2007, DOI 10.2337/diabetes.48.10.2007; Schenkman JB, 2003, PHARMACOL THERAPEUT, V97, P139, DOI 10.1016/S0163-7258(02)00327-3; Schrauwen P, 2004, DIABETES, V53, P1412, DOI 10.2337/diabetes.53.6.1412; Shimabukuro M, 1998, P NATL ACAD SCI USA, V95, P2498, DOI 10.1073/pnas.95.5.2498; Sperling P, 2001, EUR J LIPID SCI TECH, V103, P158, DOI 10.1002/1438-9312(200103)103:3<158::AID-EJLT158>3.0.CO;2-1; St-Pierre J, 2006, CELL, V127, P397, DOI 10.1016/j.cell.2006.09.024; Staiger K, 2006, DIABETES, V55, P3121, DOI 10.2337/db06-0188; STRITTMATTER P, 1974, P NATL ACAD SCI USA, V71, P4565, DOI 10.1073/pnas.71.11.4565; VIEIRA LM, 1994, EUR J BIOCHEM, V220, P729, DOI 10.1111/j.1432-1033.1994.tb18673.x; Wei YR, 2006, AM J PHYSIOL-ENDOC M, V291, pE275, DOI 10.1152/ajpendo.00644.2005; Weir GC, 2001, DIABETES, V50, pS154, DOI 10.2337/diabetes.50.2007.S154; Xie JX, 2004, P NATL ACAD SCI USA, V101, P10750, DOI 10.1073/pnas.0404044101; Zhu H, 2004, J BIOL CHEM, V279, P30316, DOI 10.1074/jbc.M402664200; Zhu H, 1999, P NATL ACAD SCI USA, V96, P14742, DOI 10.1073/pnas.96.26.14742	52	29	29	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 24	2008	283	43					29285	29291		10.1074/jbc.M804645200	http://dx.doi.org/10.1074/jbc.M804645200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	362EB	18682384	Green Published, hybrid			2022-12-27	WOS:000260179900055
J	Lineberry, N; Su, L; Soares, L; Fathman, CG				Lineberry, Neil; Su, Leon; Soares, Luis; Fathman, C. Garrison			The single subunit transmembrane E3 ligase gene related to anergy in lymphocytes (GRAIL) captures and then ubiquitinates transmembrane proteins across the cell membrane	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSFERRIN RECEPTOR; DOWN-REGULATION; DEGRADATION; SUBSTRATE; SUPERFAMILY; DOMAIN; TETRASPANINS; REGULATORS; INTEGRINS; COMPLEXES	The ubiquitin E3 ligase gene related to anergy in lymphocytes (GRAIL) (Rnf128) is a type 1 transmembrane protein that induces T cell anergy through the ubiquitination activity of its cytosolic RING finger. GRAIL also contains an equally large luminal region consisting primarily of an uncharacterized protease-associated (PA) domain. Using two-hybrid technology to screen for proteins that bound the PA domain we identified CD151, a member of the tetraspanin family of membrane proteins. GRAIL bound to the luminal/extracellular portion of both CD151 and the related tetraspanin CD81 using its PA domain, which promoted ubiquitination of cytosolic lysine residues. GRAIL exhibited specificity for lysines only within the tetraspanin amino terminus even in the presence of other cytosolic lysine residues in the substrate. GRAIL-mediated ubiquitination promoted proteasomal degradation and cell surface down-regulation of tetraspanins via Lys-48 linkages. As a result, the juxtaposition of PA and RING finger domains across a lipid bilayer facilitates the capture of transmembrane substrates for subsequent ubiquitination. These findings identify for the first time a single subunit E3 ligase containing a substrate-binding domain spatially restricted by a membrane from its E2 recruitment domain as well as an E3 ligase for members of the tetraspanin family.	[Lineberry, Neil; Su, Leon; Soares, Luis; Fathman, C. Garrison] Stanford Univ, Sch Med, Div Rheumatol & Immunol, Dept Med, Stanford, CA 94305 USA	Stanford University	Fathman, CG (corresponding author), Stanford Univ, Sch Med, Div Rheumatol & Immunol, Dept Med, CCSR Bldg Rm 2225, Stanford, CA 94305 USA.	cfathman@stanford.edu		Su, Leon/0000-0001-7654-9997	National Institutes of Health [CA 65237-17, T32-AI07290-21]; Tom and Susan Ford Fellowship; NATIONAL CANCER INSTITUTE [R01CA065237] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007290] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Tom and Susan Ford Fellowship; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants CA 65237-17 and T32-AI07290-21 (both to N. L.). This work was also supported by the Tom and Susan Ford Fellowship (to N. L.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Anandasabapathy N, 2003, IMMUNITY, V18, P535, DOI 10.1016/S1074-7613(03)00084-0; Bartee E, 2004, J VIROL, V78, P1109, DOI 10.1128/JVI.78.3.1109-1120.2004; Berditchevski F, 1999, J CELL BIOL, V146, P477, DOI 10.1083/jcb.146.2.477; Berditchevski F, 2001, J CELL SCI, V114, P4143; BRUINENBERG PG, 1994, PROTEIN ENG, V7, P991, DOI 10.1093/protein/7.8.991; Fitter S, 1999, BIOCHEM J, V338, P61, DOI 10.1042/0264-6021:3380061; Geetha T, 2005, MOL CELL, V20, P301, DOI 10.1016/j.molcel.2005.09.014; Guais A, 2006, GENE, V374, P112, DOI 10.1016/j.gene.2006.01.028; Heissmeyer V, 2004, NAT IMMUNOL, V5, P255, DOI 10.1038/ni1047; Hemler ME, 2001, J CELL BIOL, V155, P1103, DOI 10.1083/jcb.200108061; Hershko A, 2000, NAT MED, V6, P1073, DOI 10.1038/80384; Hicke L, 2003, ANNU REV CELL DEV BI, V19, P141, DOI 10.1146/annurev.cellbio.19.110701.154617; Hirao K, 2006, J BIOL CHEM, V281, P9650, DOI 10.1074/jbc.M512191200; Jackson PK, 2002, MOL CELL, V9, P923, DOI 10.1016/S1097-2765(02)00538-5; Jackson PK, 2000, TRENDS CELL BIOL, V10, P429, DOI 10.1016/S0962-8924(00)01834-1; Kim JH, 2003, J BIOCHEM, V134, P9, DOI 10.1093/jb/mvg107; Laney JD, 1999, CELL, V97, P427, DOI 10.1016/S0092-8674(00)80752-7; Lawrence CM, 1999, SCIENCE, V286, P779, DOI 10.1126/science.286.5440.779; Lehner PJ, 2005, IMMUNOL REV, V207, P112, DOI 10.1111/j.0105-2896.2005.00314.x; Mahon P, 2000, PROTEIN SCI, V9, P1930, DOI 10.1110/ps.9.10.1930; Ohmura-Hoshino M, 2006, J BIOCHEM, V140, P147, DOI 10.1093/jb/mvj160; Pickart CM, 2004, CURR OPIN CHEM BIOL, V8, P610, DOI 10.1016/j.cbpa.2004.09.009; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; Reggiori F, 2002, NAT CELL BIOL, V4, P117, DOI 10.1038/ncb743; Richly H, 2005, CELL, V120, P73, DOI 10.1016/j.cell.2004.11.013; Safford M, 2005, NAT IMMUNOL, V6, P472, DOI 10.1038/ni1193; Sanderfoot AA, 1998, P NATL ACAD SCI USA, V95, P9920, DOI 10.1073/pnas.95.17.9920; SCHERER DC, 1995, P NATL ACAD SCI USA, V92, P11259, DOI 10.1073/pnas.92.24.11259; Seigneuret M, 2006, BIOPHYS J, V90, P212, DOI 10.1529/biophysj.105.069666; Seigneuret M, 2001, J BIOL CHEM, V276, P40055, DOI 10.1074/jbc.M105557200; Stimpson HEM, 2006, EMBO J, V25, P662, DOI 10.1038/sj.emboj.7600984; Stipp CS, 2003, TRENDS BIOCHEM SCI, V28, P106, DOI 10.1016/S0968-0004(02)00014-2; Su L, 2006, J IMMUNOL, V177, P7559, DOI 10.4049/jimmunol.177.11.7559; Valdez-Taubas J, 2005, EMBO J, V24, P2524, DOI 10.1038/sj.emboj.7600724; WRIGHT MD, 1994, IMMUNOL TODAY, V15, P588, DOI 10.1016/0167-5699(94)90222-4; Yauch RL, 1998, MOL BIOL CELL, V9, P2751, DOI 10.1091/mbc.9.10.2751	36	57	57	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 17	2008	283	42					28497	28505		10.1074/jbc.M805092200	http://dx.doi.org/10.1074/jbc.M805092200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	359EN	18713730	hybrid, Green Published			2022-12-27	WOS:000259969300052
J	Mark, JK; Aubin, RA; Smith, S; Hefford, MA				Mark, John K.; Aubin, Remy A.; Smith, Sophie; Hefford, Mary Alice			Inhibition of mitogen-activated protein kinase phosphatase 3 activity by interdomain binding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAP-KINASE PHOSPHATASE; SECONDARY STRUCTURE; CATALYTIC ACTIVATION; DOMAIN; MKP3; EXPRESSION; ERK2; MECHANISM; PYST1/MKP3; DICHROWEB	Mitogen-activated protein (MAP) kinase phosphatase 3 (MKP3) is a cytoplasmic dual specificity phosphatase that functions to attenuate signaling via dephosphorylation and subsequent deactivation of its substrate and allosteric regulator, extracellular signal-regulated protein kinase 2 (ERK2). Expression of MKP3 has been shown to be under the control of ERK2, thus providing an elegant feedback mechanism for regulating the rate and duration of proliferative signals. Previously published studies suggest that MKP3 might serve as a tumor suppressor; however, significantly elevated, rather than reduced, levels of this protein have been reported in early lesions. Because overexpression of this phosphatase is counterintuitive to a proposed tumor suppressor function, the observed cellular tolerance suggested a self-inactivation mechanism. Using surface plasmon resonance, we have provided direct evidence of physical interaction between the N-and C-terminal domains. Kinetic analysis using dimethyl sulfoxide to activate the C-terminal fragment in the absence of ERK2 showed that the isolated C-terminal domain had higher catalytic efficiency than the similarly activated full-length protein. Furthermore, when the isolated N-terminal domain was added to the activated C-terminal domain, a dose-dependant inhibition of catalytic activity was observed. The similarity between the K-I and K-D values obtained indicate that interdomain binding stabilizes the inactive conformation of the catalytic site and implies that the N-terminal domain functions as an allosteric inhibitor of phosphatase activity. Finally, we have provided evidence for oligomerization of MKP3 in pancreatic cancer cells expressing elevated levels of this phosphatase.	[Mark, John K.; Aubin, Remy A.; Smith, Sophie; Hefford, Mary Alice] Hlth Canada, Biol Res Ctr, Biol & Genet Therapies Directorate, Ottawa, ON K1A 0L2, Canada	Health Canada	Hefford, MA (corresponding author), Hlth Canada, Biol Res Ctr, Biol & Genet Therapies Directorate, 251 Sir Frederick Banting Driveway, Ottawa, ON K1A 0L2, Canada.	Mary_Hefford@hc-sc.gc.ca						BENNETT MJ, 1995, PROTEIN SCI, V4, P2455, DOI 10.1002/pro.5560041202; Camps M, 1998, SCIENCE, V280, P1262, DOI 10.1126/science.280.5367.1262; Dickinson RJ, 2002, MECH DEVELOP, V113, P193, DOI 10.1016/S0925-4773(02)00024-2; Eblaghie MC, 2003, CURR BIOL, V13, P1009, DOI 10.1016/S0960-9822(03)00381-6; Echevarria D, 2005, DEV BIOL, V277, P114, DOI 10.1016/j.ydbio.2004.09.011; Evans DRH, 1998, NATURE, V394, P23, DOI 10.1038/27782; Farooq A, 2001, J BIOMOL NMR, V19, P195, DOI 10.1023/A:1008344405731; Farooq A, 2001, MOL CELL, V7, P387, DOI 10.1016/S1097-2765(01)00186-1; Fjeld CC, 2000, J BIOL CHEM, V275, P6749, DOI 10.1074/jbc.275.10.6749; Furukawa T, 2006, ONCOGENE, V25, P4831, DOI 10.1038/sj.onc.1209494; Furukawa T, 2006, CANCER SCI, V97, P1, DOI 10.1111/j.1349-7006.2005.00134.x; Furukawa T, 2005, MODERN PATHOL, V18, P1034, DOI 10.1038/modpathol.3800383; Furukawa T, 2004, PANCREAS, V28, P253, DOI 10.1097/00006676-200404000-00007; Furukawa T, 1998, CYTOGENET CELL GENET, V82, P156, DOI 10.1159/000015091; Furukawa T, 2003, AM J PATHOL, V162, P1807, DOI 10.1016/S0002-9440(10)64315-5; Groom LA, 1996, EMBO J, V15, P3621, DOI 10.1002/j.1460-2075.1996.tb00731.x; Hafen E, 1998, SCIENCE, V280, P1212, DOI 10.1126/science.280.5367.1212; Itoh M, 1998, J HUM GENET, V43, P9, DOI 10.1007/s100380050030; Jiang GQ, 2000, MOL CELL BIOL, V20, P5917, DOI 10.1128/MCB.20.16.5917-5929.2000; Kawakami Y, 2003, NAT CELL BIOL, V5, P513, DOI 10.1038/ncb989; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Liu Y, 2002, PROTEIN SCI, V11, P1285, DOI 10.1110/ps.0201402; Lobley A, 2002, BIOINFORMATICS, V18, P211, DOI 10.1093/bioinformatics/18.1.211; Mark JK, 2007, PROTEIN EXPRES PURIF, V54, P253, DOI 10.1016/j.pep.2007.03.004; Muda M, 1996, J BIOL CHEM, V271, P27205, DOI 10.1074/jbc.271.44.27205; Muda M, 1998, J BIOL CHEM, V273, P9323, DOI 10.1074/jbc.273.15.9323; Mustelin T, 2002, FRONT BIOSCI-LANDMRK, V7, pD85, DOI 10.2741/mustelin; Pouyssegur J, 2002, BIOCHEM PHARMACOL, V64, P755, DOI 10.1016/S0006-2952(02)01135-8; Rigas JD, 2001, BIOCHEMISTRY-US, V40, P4398, DOI 10.1021/bi002951v; Schlessinger J, 2003, SCIENCE, V300, P750, DOI 10.1126/science.1082024; Smith TG, 2005, DEVELOPMENT, V132, P1305, DOI 10.1242/dev.01699; Sreerama N, 2000, ANAL BIOCHEM, V287, P252, DOI 10.1006/abio.2000.4880; Stewart AE, 1999, NAT STRUCT BIOL, V6, P174; Theodosiou A, 2002, GENOME BIOL, V3; Tonks NK, 2006, NAT REV MOL CELL BIO, V7, P833, DOI 10.1038/nrm2039; Tsang M, 2004, DEVELOPMENT, V131, P2769, DOI 10.1242/dev.01157; Vivier E, 2004, SCIENCE, V306, P1517, DOI 10.1126/science.1103478; Wang J, 1997, BIOCHEMISTRY-US, V36, P2993, DOI 10.1021/bi9611873; Whitmore L, 2004, NUCLEIC ACIDS RES, V32, pW668, DOI 10.1093/nar/gkh371; Yin YX, 2003, NATURE, V422, P527, DOI 10.1038/nature01519; Yoshida E, 2004, MOL BRAIN RES, V131, P33, DOI 10.1016/j.molbrainres.2004.08.023; Zhang JL, 2003, J BIOL CHEM, V278, P29901, DOI 10.1074/jbc.M303909200; Zhou B, 1999, J BIOL CHEM, V274, P35526, DOI 10.1074/jbc.274.50.35526	43	13	13	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 17	2008	283	42					28574	28583		10.1074/jbc.M801747200	http://dx.doi.org/10.1074/jbc.M801747200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	359EN	18694935	Green Published, hybrid			2022-12-27	WOS:000259969300060
J	Monk, CE; Pearson, BM; Mulholland, F; Smith, HK; Poole, RK				Monk, Claire E.; Pearson, Bruce M.; Mulholland, Francis; Smith, Holly K.; Poole, Robert K.			Oxygen- and NssR-dependent globin expression and enhanced iron acquisition in the response of Campylobacter to nitrosative stress	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENTERICA SEROVAR TYPHIMURIUM; CULTURED ESCHERICHIA-COLI; SINGLE-DOMAIN HEMOGLOBIN; NITRIC-OXIDE; GENE-EXPRESSION; TRUNCATED HEMOGLOBIN; S-NITROSOGLUTATHIONE; HELICOBACTER-PYLORI; TRANSCRIPTIONAL RESPONSES; FUNCTIONAL-PROPERTIES	Pathogenic bacteria experience nitrosative stress from NO generated in the host and from nitrosating species such as S-nitrosoglutathione. The food-borne pathogen Campylobacter jejuni responds by activating gene expression from a small regulon under the control of the NO-sensitive regulator, NssR. Here, we describe the full extent of the S-nitrosoglutathione response using transcriptomic and proteomic analysis of batch- and chemostat-cultured C. jejuni. In addition to the NssR regulon, which includes two hemoglobins (Cgb and Ctb), we identify more than 90 other up-regulated genes, notably those encoding heat shock proteins and proteins involved in oxidative stress tolerance and iron metabolism/transport. Up-regulation of a subset of these genes, including cgb, is also elicited by NO-releasing compounds. Mutation of the iron-responsive regulator Fur results in insensitivity of growth to NO, suggesting that derepression of iron-regulated genes and augmentation of iron acquisition is a physiological response to nitrosative damage. We describe the effect of oxygen availability on nitrosative stress tolerance; cells cultured at higher rates of oxygen diffusion have elevated levels of hemoglobins, are more resistant to inhibition by NO of both growth and respiration, and consume NO more rapidly. The oxygen response is mediated by NssR. Thus, in addition to NO detoxification catalyzed by the hemoglobins Cgb and possibly Ctb, C. jejuni mounts an extensive stress response. We suggest that inhibition of respiration by NO may increase availability of oxygen for Cgb synthesis and function.	[Monk, Claire E.; Smith, Holly K.; Poole, Robert K.] Univ Sheffield, Dept Mol Biol & Biotechnol, Sheffield S10 2TN, S Yorkshire, England; [Pearson, Bruce M.; Mulholland, Francis] AFRC, Inst Food Res, Norwich NR4 7UA, Norfolk, England	University of Sheffield; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center; Quadram Institute; University of East Anglia	Poole, RK (corresponding author), Univ Sheffield, Dept Mol Biol & Biotechnol, Sheffield S10 2TN, S Yorkshire, England.	r.poole@sheffield.ac.uk		Pearson, Bruce/0000-0002-9223-7712	Biotechnology and Biological Sciences Research Council, Swindon, United Kingdom; Biotechnology and Biological Sciences Research Council [BB/E010504/1, BBS/E/F/00042291] Funding Source: researchfish; BBSRC [BB/E010504/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council, Swindon, United Kingdom(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the Biotechnology and Biological Sciences Research Council, Swindon, United Kingdom. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Allan E, 2001, MICROBIOL-SGM, V147, P2285, DOI 10.1099/00221287-147-8-2285; Baillon MLA, 1999, J BACTERIOL, V181, P4798, DOI 10.1128/JB.181.16.4798-4804.1999; Baker LMS, 2001, J BACTERIOL, V183, P1961, DOI 10.1128/JB.183.6.1961-1973.2001; Bang IS, 2006, J BIOL CHEM, V281, P28039, DOI 10.1074/jbc.M605174200; Bodenmiller DM, 2006, J BACTERIOL, V188, P874, DOI 10.1128/JB.188.3.874-881.2006; Bryk R, 2000, NATURE, V407, P211, DOI 10.1038/35025109; Clark RW, 2006, P NATL ACAD SCI USA, V103, P891, DOI 10.1073/pnas.0505919103; Comtois SL, 2003, MICROBIOL-SGM, V149, P121, DOI 10.1099/mic.0.25896-0; Cruz-Ramos H, 2002, EMBO J, V21, P3235, DOI 10.1093/emboj/cdf339; D'Autreaux B, 2002, P NATL ACAD SCI USA, V99, P16619, DOI 10.1073/pnas.252591299; D'Autreaux B, 2005, NATURE, V437, P769, DOI 10.1038/nature03953; DEGROOTE MA, 1995, P NATL ACAD SCI USA, V92, P6399, DOI 10.1073/pnas.92.14.6399; Delgado-Nixon VM, 2000, BIOCHEMISTRY-US, V39, P2685, DOI 10.1021/bi991911s; Ding HG, 2000, P NATL ACAD SCI USA, V97, P5146, DOI 10.1073/pnas.97.10.5146; Donzelli S, 2006, FREE RADICAL BIO MED, V40, P1056, DOI 10.1016/j.freeradbiomed.2005.10.058; Duetz WA, 2000, APPL ENVIRON MICROB, V66, P2641, DOI 10.1128/AEM.66.6.2641-2646.2000; Elvers KT, 2004, J BACTERIOL, V186, P5332, DOI 10.1128/JB.186.16.5332-5341.2004; Elvers KT, 2005, MOL MICROBIOL, V57, P735, DOI 10.1111/j.1365-2958.2005.04723.x; Flatley J, 2005, J BIOL CHEM, V280, P10065, DOI 10.1074/jbc.M410393200; Friedman C.R., 2000, CAMPYLOBACTER, P121; Gardner AM, 2002, J BIOL CHEM, V277, P8172, DOI 10.1074/jbc.M110471200; Gilberthorpe NJ, 2007, MICROBIOL-SGM, V153, P1756, DOI 10.1099/mic.0.2006/003731-0; Gomes CM, 2002, J BIOL CHEM, V277, P25273, DOI 10.1074/jbc.M203886200; GOODHEW CF, 1988, BIOCHIM BIOPHYS ACTA, V933, P114, DOI 10.1016/0005-2728(88)90061-8; Guerry P, 1997, J BACTERIOL, V179, P3997, DOI 10.1128/jb.179.12.3997-4002.1997; Hagen T, 2003, SCIENCE, V302, P1975, DOI 10.1126/science.1088805; HART TW, 1985, TETRAHEDRON LETT, V26, P2013, DOI 10.1016/S0040-4039(00)98368-0; Hausladen A, 2001, P NATL ACAD SCI USA, V98, P10108, DOI 10.1073/pnas.181199698; Hernandez-Urzua E, 2007, ARCH MICROBIOL, V187, P67, DOI 10.1007/s00203-006-0175-8; Hess DT, 2005, NAT REV MOL CELL BIO, V6, P150, DOI 10.1038/nrm1569; Holmes K, 2005, MICROBIOL-SGM, V151, P243, DOI 10.1099/mic.0.27412-0; Homuth G, 2000, J BACTERIOL, V182, P4257, DOI 10.1128/JB.182.15.4257-4263.2000; HUGHES MN, 1991, J GEN MICROBIOL, V137, P725, DOI 10.1099/00221287-137-4-725; Hyduke DR, 2007, P NATL ACAD SCI USA, V104, P8484, DOI 10.1073/pnas.0610888104; Iovine NM, 2008, INFECT IMMUN, V76, P986, DOI 10.1128/IAI.01063-07; Janvier B, 1998, RES MICROBIOL, V149, P95, DOI 10.1016/S0923-2508(98)80025-9; Jarboe LR, 2008, J BIOL CHEM, V283, P5148, DOI 10.1074/jbc.M706018200; Justino MC, 2005, J BIOL CHEM, V280, P2636, DOI 10.1074/jbc.M411070200; Konkel ME, 1998, INFECT IMMUN, V66, P3666, DOI 10.1128/IAI.66.8.3666-3672.1998; Lai Y, 2005, J NEUROCHEM, V94, P360, DOI 10.1111/j.1471-4159.2005.03212.x; Lee LJ, 2005, J BACTERIOL, V187, P1124, DOI 10.1128/JB.187.3.1124-1134.2005; Lu CY, 2007, J BIOL CHEM, V282, P25917, DOI 10.1074/jbc.M704415200; Lu CY, 2007, J BIOL CHEM, V282, P13627, DOI 10.1074/jbc.M609397200; Lundberg JO, 2004, NAT REV MICROBIOL, V2, P593, DOI 10.1038/nrmicro929; Mason MG, 2006, P NATL ACAD SCI USA, V103, P708, DOI 10.1073/pnas.0506562103; Membrillo-Hernandez J, 1998, MOL MICROBIOL, V29, P1101, DOI 10.1046/j.1365-2958.1998.01000.x; Membrillo-Hernandez J, 1999, J BIOL CHEM, V274, P748, DOI 10.1074/jbc.274.2.748; Mills CE, 2001, BIOCHEM J, V353, P207, DOI 10.1042/0264-6021:3530207; Moncada S, 2002, NAT REV MOL CELL BIO, V3, P214, DOI 10.1038/nrm762; Moore CM, 2004, J BACTERIOL, V186, P4655, DOI 10.1128/JB.186.14.4655-4664.2004; Mukhopadhyay P, 2004, P NATL ACAD SCI USA, V101, P745, DOI 10.1073/pnas.0307741100; Nakano MM, 2006, J BACTERIOL, V188, P5878, DOI 10.1128/JB.00486-06; Narberhaus F, 1999, MOL MICROBIOL, V31, P1, DOI 10.1046/j.1365-2958.1999.01166.x; Nioche P, 2004, SCIENCE, V306, P1550, DOI 10.1126/science.1103596; Olczak AA, 2003, INFECT IMMUN, V71, P580, DOI 10.1128/IAI.71.1.580-583.2003; Parkhill J, 2000, NATURE, V403, P665, DOI 10.1038/35001088; PIRT SJ, 1985, PRINCIPLES MICROBE C, P81; Poole RK, 1996, J BACTERIOL, V178, P5487, DOI 10.1128/jb.178.18.5487-5492.1996; Poole RK, 2000, MOL MICROBIOL, V36, P775, DOI 10.1046/j.1365-2958.2000.01889.x; Poole RK, 2005, BIOCHEM SOC T, V33, P176, DOI 10.1042/BST0330176; Pullan ST, 2008, METHOD ENZYMOL, V437, P499, DOI 10.1016/S0076-6879(07)37025-0; Pullan ST, 2007, J BACTERIOL, V189, P1845, DOI 10.1128/JB.01354-06; Raphael BH, 2003, CAN J MICROBIOL, V49, P727, DOI 10.1139/W03-086; Reid AN, 2008, APPL ENVIRON MICROB, V74, P1598, DOI 10.1128/AEM.01508-07; Richardson AR, 2006, MOL MICROBIOL, V61, P927, DOI 10.1111/j.1365-2958.2006.05290.x; Ridley KA, 2006, J BACTERIOL, V188, P7862, DOI 10.1128/JB.00994-06; Roos V, 2006, INFECT IMMUN, V74, P3565, DOI 10.1128/IAI.01959-05; Schmalisch M, 2002, J MOL MICROB BIOTECH, V4, P495; Sebbane F, 2006, P NATL ACAD SCI USA, V103, P11766, DOI 10.1073/pnas.0601182103; Shiloh MU, 2000, CURR OPIN MICROBIOL, V3, P35, DOI 10.1016/S1369-5274(99)00048-X; Stehr M, 2001, J BIOL CHEM, V276, P35836, DOI 10.1074/jbc.M105094200; Stevanin TM, 2007, GENE, V398, P62, DOI 10.1016/j.gene.2007.03.021; Stevanin TM, 2002, INFECT IMMUN, V70, P4399, DOI 10.1128/IAI.70.8.4399-4405.2002; Stevanin TM, 2000, J BIOL CHEM, V275, P35868, DOI 10.1074/jbc.M002471200; Stintzi A, 2003, J BACTERIOL, V185, P2009, DOI 10.1128/JB.185.6.2009-2016.2003; THORUPANDERSEN M, 2005, MICROBIOLOGY, V151, P905; van Vliet AHM, 1999, J BACTERIOL, V181, P6371, DOI 10.1128/JB.181.20.6371-6376.1999; van Vliet AHM, 2000, FEMS MICROBIOL LETT, V188, P115, DOI 10.1016/S0378-1097(00)00222-6; van Vliet AHM, 2002, FEMS MICROBIOL REV, V26, P173, DOI 10.1111/j.1574-6976.2002.tb00609.x; van Vliet AHM, 1998, J BACTERIOL, V180, P5291, DOI 10.1128/JB.180.20.5291-5298.1998; Velayudhan J, 2004, INFECT IMMUN, V72, P260, DOI 10.1128/IAI.72.1.260-268.2004; VOLKER U, 1994, MICROBIOL-UK, V140, P741, DOI 10.1099/00221287-140-4-741; Wainwright LM, 2006, BIOCHEMISTRY-US, V45, P6003, DOI 10.1021/bi052247k; Wainwright LM, 2005, MICROBIOL-SGM, V151, P4079, DOI 10.1099/mic.0.28266-0; Wan XY, 1997, FEBS LETT, V407, P32, DOI 10.1016/S0014-5793(97)00302-5; Weaver J, 2005, BBA-GEN SUBJECTS, V1726, P302, DOI 10.1016/j.bbagen.2005.08.012; Yu H, 1997, FEBS LETT, V409, P161, DOI 10.1016/S0014-5793(97)00494-8	87	27	27	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 17	2008	283	42					28413	28425		10.1074/jbc.M801016200	http://dx.doi.org/10.1074/jbc.M801016200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	359EN	18682395	Green Published, hybrid			2022-12-27	WOS:000259969300043
J	Yamano, T; Mizukami, S; Murata, S; Chiba, T; Tanaka, K; Udono, H				Yamano, Taketoshi; Mizukami, Shusaku; Murata, Shigeo; Chiba, Tomoki; Tanaka, Keiji; Udono, Heiichiro			Hsp90-mediated assembly of the 26 S proteasome is involved in major histocompatibility complex class I antigen processing	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MHC-CLASS-I; CYTOTOXIC T-LYMPHOCYTES; PEPTIDES; PROTEINS; IDENTIFICATION; GENERATION; DEGRADATION; MOLECULES; HSP90; CELLS	Heat shock protein 90 (hsp90) and the proteasome activator PA28 stimulate major histocompatibility complex (MHC) class I antigen processing. It is unknown whether hsp90 influences the proteasome activity to produce T cell epitopes, although association of PA28 with the 20 S proteasome stimulates the enzyme activity. Here, we show that hsp90 is essential in assembly of the 26 S proteasome and as a result, is involved in epitope production. Addition of recombinant hsp90 alpha to cell lysate enhanced chymotrypsinlike activity of the 26 S proteasome in an ATP-dependent manner as determined by an in-gel hydrolysis assay. We successfully pulled down histidine-tagged hsp90 alpha- and PA28 alpha-induced, newly assembled 26 S proteasomes from the cell extracts for in vitro epitope production assay, and we found these structures to be sensitive to geldanamycin, an hsp90 inhibitor. We found a cleaved epitope unique to the proteasome pulled down by both hsp90 alpha and PA28 alpha, whereas two different epitopes were identified in the hsp90 alpha- and PA28 alpha-pulldowns, respectively. Processing of these respective peptides in vivo was enhanced faithfully by the protein combinations used for the proteasome pulldowns. Inhibition of hsp90 in vivo by geldanamycin partly disrupted the 26 S proteasome structure, consistent with down-regulated MHC class I expression. Our results indicate that hsp90 facilitates MHC class I antigen processing through epitope production in a complex of the 26 S proteasome.	[Yamano, Taketoshi; Mizukami, Shusaku; Udono, Heiichiro] RIKEN Yokohama Inst, RCAI, Lab Immunochaperones, Tsurumi Ku, Yokohama, Kanagawa 2300045, Japan; [Murata, Shigeo] Univ Tokyo, Grad Sch Pharmaceut Sci, Lab Prot Metab, Bunkyo Ku, Tokyo 1130033, Japan; [Chiba, Tomoki] Univ Tsukuba, Grad Sch Life & Environm Sci, Tsukuba, Ibaraki 3058572, Japan; [Tanaka, Keiji] Tokyo Metropolitan Inst Med Sci, Lab Frontier Sci, Bunkyo Ku, Tokyo 1138613, Japan	RIKEN; University of Tokyo; University of Tsukuba; Tokyo Metropolitan Institute of Medical Science	Udono, H (corresponding author), 1-7-22 Suehiro Cho,Tsurumi Ku, Yokohama, Kanagawa 2300045, Japan.	udonoh@rcai.riken.jp	Mizukami, Shusaku/AAR-7291-2021; Murata, Shigeo/A-1426-2010	Mizukami, Shusaku/0000-0002-7722-4884; Murata, Shigeo/0000-0002-3177-3503	RIKEN RCAI; Ministry of Education, Science, Sports and Culture, Japan	RIKEN RCAI; Ministry of Education, Science, Sports and Culture, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by RIKEN RCAI and by a grant-in-aid for scientific research priority areas from the Ministry of Education, Science, Sports and Culture, Japan. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Babbitt SE, 2005, CELL, V121, P553, DOI 10.1016/j.cell.2005.03.028; Binder RJ, 2001, J BIOL CHEM, V276, P17163, DOI 10.1074/jbc.M011547200; Bloom MB, 1997, J EXP MED, V185, P453, DOI 10.1084/jem.185.3.453; Callahan MK, 2008, P NATL ACAD SCI USA, V105, P1662, DOI 10.1073/pnas.0711365105; Cascio P, 2002, EMBO J, V21, P2636, DOI 10.1093/emboj/21.11.2636; FALK K, 1991, NATURE, V351, P290, DOI 10.1038/351290a0; FEHLING HJ, 1994, SCIENCE, V265, P1234, DOI 10.1126/science.8066463; Glickman MH, 1998, MOL CELL BIOL, V18, P3149, DOI 10.1128/MCB.18.6.3149; Ishii T, 1999, J IMMUNOL, V162, P1303; Kloetzel PM, 2004, CURR OPIN IMMUNOL, V16, P76, DOI 10.1016/j.coi.2003.11.004; Kunisawa J, 2006, IMMUNITY, V24, P523, DOI 10.1016/j.immuni.2006.03.015; Pamer E, 1998, ANNU REV IMMUNOL, V16, P323, DOI 10.1146/annurev.immunol.16.1.323; Rock KL, 1999, ANNU REV IMMUNOL, V17, P739, DOI 10.1146/annurev.immunol.17.1.739; ROTZSCHKE O, 1990, NATURE, V348, P252, DOI 10.1038/348252a0; Schubert U, 2000, NATURE, V404, P770, DOI 10.1038/35008096; Seifert U, 2003, NAT IMMUNOL, V4, P375, DOI 10.1038/ni905; Udono H, 2001, INT IMMUNOL, V13, P1233, DOI 10.1093/intimm/13.10.1233; UENAKA A, 1994, J EXP MED, V180, P1599, DOI 10.1084/jem.180.5.1599; VAN KL, 1994, IMMUNITY, V1, P533; Verma R, 2000, MOL BIOL CELL, V11, P3425, DOI 10.1091/mbc.11.10.3425; WEISS WR, 1990, J EXP MED, V171, P763, DOI 10.1084/jem.171.3.763; Yamano T, 2002, J EXP MED, V196, P185, DOI 10.1084/jem.20011922	22	30	34	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 17	2008	283	42					28060	28065		10.1074/jbc.M803077200	http://dx.doi.org/10.1074/jbc.M803077200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	359EN	18703510	hybrid, Green Published			2022-12-27	WOS:000259969300007
J	Lee, CB; Swatek, KN; McClure, B				Lee, Christopher B.; Swatek, Kirby N.; McClure, Bruce			Pollen proteins bind to the C-terminal domain of Nicotiana alata pistil arabinogalactan proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUBE GROWTH; SELF-INCOMPATIBILITY; S-RNASE; UBIQUITIN LIGASE; IN-VITRO; 120-KDA GLYCOPROTEIN; SIGNALING PATHWAYS; IDENTIFICATION; SYNAPTOTAGMIN; ENDOCYTOSIS	Pollen tube growth is influenced by interaction between pollen proteins and the pistil extracellular matrix. The transmitting tract-specific glycoprotein (NaTTS) and 120-kDa glycoprotein (120K) are two pistil arabinogalactan proteins (AGPs) that share a conserved C-terminal domain (CTD) and directly influence pollen tubes in Nicotiana alata. 120K and other extracellular matrix proteins are taken up and transported to vacuoles of growing pollen tubes. We hypothesize that signaling and trafficking processes inside pollen tubes are important for controlling pollen tube growth. We performed a yeast two-hybrid screen of pollen cDNAs using sequences from 120K and NaTTS as baits. We found that an S-RNase-binding protein (SBP1), a C2 domain-containing protein (NaPCCP), and a putative cysteine protease bound to the AGP baits. SBP1 from Petunia hybrida and Solanum chacoense is a putative E3 ubiquitin ligase that binds to S-RNase and other proteins. C2 domain-containing proteins bind lipids and can regulate myriad cellular processes. Cysteine proteases are often associated with the degradation of vacuolar proteins. Expression analysis revealed that transcripts for these proteins are expressed in mature pollen. NaPCCP and NaSBP1 were characterized further because of their potential roles in signaling and trafficking. In vitro pull-down assays verified binding between maltose-binding protein (MBP) fusions, MBP:: NaPCCP or MBP:: NaSBP1 and glutathione S-transferase (GST), GST:: AGP CTD fusions. NaSBP1 binds to the AGP CTDs through its helical and RING domains. NaPCCP binds through its C-terminal region. Binding between NaPCCP and NaSBP1 and the pistil AGPs may contribute to signaling and trafficking inside pollen tubes growing in planta.	[Swatek, Kirby N.; McClure, Bruce] Univ Missouri, Div Biochem, Interdisciplinary Plant Grp, Christopher S Bond Life Sci Ctr, Columbia, MO 65211 USA; [Lee, Christopher B.] Univ Missouri, Div Biol Sci, Interdisciplinary Plant Grp, Christopher S Bond Life Sci Ctr, Columbia, MO 65211 USA	University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia	McClure, B (corresponding author), Univ Missouri, Div Biochem, Interdisciplinary Plant Grp, Christopher S Bond Life Sci Ctr, 240A Life Sci Ctr,1201 E Rollins St, Columbia, MO 65211 USA.	mcclureb@missouri.edu			National Science Foundation [IOB 0614962]	National Science Foundation(National Science Foundation (NSF))	This work was supported by National Science Foundation Grant IOB 0614962. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	BEECHER BS, 1999, THESIS U MISSOURI CO; Ben-Naim O, 2006, PLANT J, V46, P462, DOI 10.1111/j.1365-313X.2006.02706.x; BROSE N, 1992, SCIENCE, V256, P1021, DOI 10.1126/science.1589771; Camacho L, 2003, J EXP BOT, V54, P83, DOI 10.1093/jxb/54.380.83; Cheung AY, 2007, J EXP BOT, V58, P75, DOI 10.1093/jxb/erl122; CHEUNG AY, 1995, CELL, V82, P383, DOI 10.1016/0092-8674(95)90427-1; Cheung AY, 2000, ANN BOT-LONDON, V85, P29, DOI 10.1006/anbo.1999.1016; CLARK JD, 1991, CELL, V65, P1043, DOI 10.1016/0092-8674(91)90556-E; CORNISH EC, 1987, NATURE, V326, P99, DOI 10.1038/326099a0; COUSSENS L, 1986, SCIENCE, V233, P859, DOI 10.1126/science.3755548; Cruz-Garcia F, 2005, PLANT J, V42, P295, DOI 10.1111/j.1365-313X.2005.02375.x; CULLEN PJ, 1995, NATURE, V376, P527, DOI 10.1038/376527a0; DAMER CK, 1994, J BIOL CHEM, V269, P31115; Deblandre GA, 2001, DEV CELL, V1, P795, DOI 10.1016/S1534-5807(01)00091-0; Deshaies RJ, 1999, ANNU REV CELL DEV BI, V15, P435, DOI 10.1146/annurev.cellbio.15.1.435; Dunn R, 2004, J CELL BIOL, V165, P135, DOI 10.1083/jcb.200309026; FUKUDA M, 1994, J BIOL CHEM, V269, P29206; Galan JM, 2001, MOL CELL BIOL, V21, P3105, DOI 10.1128/MCB.21.9.3105-3117.2001; Goldraij A, 2006, NATURE, V439, P805, DOI 10.1038/nature04491; Gu Y, 2005, J CELL BIOL, V169, P127, DOI 10.1083/jcb.200409140; Gu Y, 2003, J EXP BOT, V54, P93, DOI 10.1093/jxb/54.380.93; Hancock CN, 2005, PLANT J, V43, P716, DOI 10.1111/j.1365-313X.2005.02490.x; Hepler PK, 2001, ANNU REV CELL DEV BI, V17, P159, DOI 10.1146/annurev.cellbio.17.1.159; Hicke L, 2003, ANNU REV CELL DEV BI, V19, P141, DOI 10.1146/annurev.cellbio.19.110701.154617; Holdaway-Clarke TL, 2003, NEW PHYTOL, V159, P539, DOI 10.1046/j.1469-8137.2003.00847.x; Hua ZH, 2006, PLANT CELL, V18, P2531, DOI 10.1105/tpc.106.041061; Johnson ML, 2006, PROCESSING AND FABRICATION OF ADVANCED MATERIALS XV, P223, DOI 10.1007/7089_051; JORGENSEN L, 1995, BIOTECHNOL TECH, V9, P477, DOI 10.1007/BF00159561; Katzmann DJ, 2004, MOL BIOL CELL, V15, P468, DOI 10.1091/mbc.E03-07-0473; Kim S, 2003, P NATL ACAD SCI USA, V100, P16125, DOI 10.1073/pnas.2533800100; Kim ST, 2006, PLANT PHYSIOL, V142, P1397, DOI 10.1104/pp.106.086801; Lai EC, 2001, P NATL ACAD SCI USA, V98, P5637, DOI 10.1073/pnas.101135498; Li ST, 2007, PLANT PHYSIOL, V145, P236, DOI 10.1104/pp.107.101741; Lind JL, 1996, SEX PLANT REPROD, V9, P75, DOI 10.1007/BF02153054; Marin-Vicente C, 2005, MOL BIOL CELL, V16, P2848, DOI 10.1091/mbc.E05-01-0067; MCCLURE BA, 1990, NATURE, V347, P757, DOI 10.1038/347757a0; Moscatelli A, 2007, J CELL SCI, V120, P3804, DOI 10.1242/jcs.012138; Murfett J, 1996, PLANT CELL, V8, P943, DOI 10.1105/tpc.8.6.943; Nettancourt, 2001, INCOMPATIBILITY INCO; O'Brien M, 2004, SEX PLANT REPROD, V17, P81, DOI 10.1007/s00497-004-0218-8; Pavlopoulos E, 2001, DEV CELL, V1, P807, DOI 10.1016/S1534-5807(01)00093-4; Rape M, 2004, BBA-MOL CELL RES, V1695, P209, DOI 10.1016/j.bbamcr.2004.09.022; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P379; Schneider BL, 1998, NATURE, V395, P86, DOI 10.1038/25774; Schopfer CR, 2000, PLANT PHYSIOL, V124, P935, DOI 10.1104/pp.124.3.935; Sijacic P, 2004, NATURE, V429, P302, DOI 10.1038/nature02523; Sims TL, 2001, PLANT MOL BIOL, V47, P771, DOI 10.1023/A:1013639528858; Stone SL, 2005, PLANT PHYSIOL, V137, P13, DOI 10.1104/pp.104.052423; Sze H, 2006, PLANT CELL MONOGR, V3, P71, DOI 10.1007/7089_044; Tang WH, 2004, PLANT J, V39, P343, DOI 10.1111/j.1365-313X.2004.02139.x; Taylor LP, 1997, ANNU REV PLANT PHYS, V48, P461, DOI 10.1146/annurev.arplant.48.1.461; Wiederkehr A, 2000, J CELL BIOL, V149, P397, DOI 10.1083/jcb.149.2.397; Willems AR, 2004, BBA-MOL CELL RES, V1695, P133, DOI 10.1016/j.bbamcr.2004.09.027; Wu HM, 2000, PLANT J, V22, P165, DOI 10.1046/j.1365-313x.2000.00731.x; WU HM, 1995, CELL, V82, P395, DOI 10.1016/0092-8674(95)90428-X; Zonia L, 2008, J EXP BOT, V59, P861, DOI 10.1093/jxb/ern007	57	36	41	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 3	2008	283	40					26965	26973		10.1074/jbc.M804410200	http://dx.doi.org/10.1074/jbc.M804410200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	353RT	18678868	hybrid			2022-12-27	WOS:000259586600017
J	Song, KS; Lee, TJ; Kim, K; Chung, KC; Yoon, JH				Song, Kyoung Seob; Lee, Tae-Jin; Kim, Kyubo; Chung, Kwang Chul; Yoon, Joo-Heon			cAMP-responding element-binding protein and c-Ets1 interact in the regulation of ATP-dependent MUC5AC gene expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PURINERGIC RECEPTORS; DNA-BINDING; ACTIVATION; ETS-1; MUCIN; INTERLEUKIN-1-BETA; NUCLEOTIDES; RELEASE; DOMAIN; CELLS	Exogenous ATP activates purinoreceptors on the cell surface that regulate diverse cellular functions, including mucous cell secretion in the respiratory epithelium. In this study, ATP increased MUC5AC mRNA in primary human nasal epithelial cells and in NCI-H292 pulmonary adenocarcinoma cells in vitro. ATP-induced MUC5AC mRNA was mediated by phospholipase C beta 3. Adominant-negative mutation in the PDZ binding domain of PLC beta 3 inhibited ATP-induced MUC5AC gene expression. ATP sequentially activated the phosphorylation of Akt, ERK1/2, p38, RSK1, and cAMP-responding element-binding protein (CREB) in a protein kinase C-independent manner. ATP-induced MUC5AC mRNA levels were regulated by CREB via direct interaction with c-Ets1 on the MUC5AC gene promoter (located - 938 to - 930). Effects of CREB and c-Ets1 were additive. Inhibition of either CREB or c-Ets1 inhibited ATP-induced MUC5AC gene expression. Stimulation with ATP caused the direct binding of CREB and c-Ets1 to the MUC5AC promoter, increasing the phosphorylation of c-Ets1. Chromatin immunoprecipitation assays demonstrated that in the presence of ATP, both c-Ets1 and CREB bound to the MUC5AC promoter. The effects of exogenous ATP on MUC5AC gene expression are mediated by a complex regulatory cascade controlling interactions between CREB and c-Ets1 that bind to a promoter element in the MUC5AC gene enhancing MUC5AC gene transcription. ATP-dependent activation of MUC5AC gene expression via CREB-c-Ets1 may contribute to mucous cell hypersecretion associated with common respiratory disorders.	[Song, Kyoung Seob; Yoon, Joo-Heon] Yonsei Univ, Coll Med, Airway Mucus Inst, Seoul 120752, South Korea; [Kim, Kyubo; Yoon, Joo-Heon] Yonsei Univ, Coll Med, Dept Otorhinolaryngol, Seoul 120752, South Korea; [Yoon, Joo-Heon] Yonsei Univ, Coll Med, Brain Korea Med Sci 21, Seoul 120752, South Korea; [Yoon, Joo-Heon] Yonsei Univ, Coll Med, Res Ctr Human Nat Def Syst, Seoul 120752, South Korea; [Lee, Tae-Jin] Yeungnam Univ, Coll Med, Dept Anat, Taegu 705717, South Korea; [Chung, Kwang Chul] Yonsei Univ, Coll Sci, Dept Biol, Seoul 120749, South Korea	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yeungnam University; Yonsei University	Yoon, JH (corresponding author), 134 Shinchon Dong, Seoul 120752, South Korea.	jhyoon@yuhs.ac	Yoon, Joo-Heon/E-5781-2016; rchnds, rchnds/D-7595-2016	Yoon, Joo-Heon/0000-0003-2404-7156	Korea Science and Engineering Foundation [R11-2007-040-02001-0]; Korea Research Foundation [KRF-2005-050-C00005]	Korea Science and Engineering Foundation(Korea Science and Engineering Foundation); Korea Research Foundation(National Research Foundation of Korea)	This work was supported by Korea Science and Engineering Foundation Grant R11-2007-040-02001-0 funded by the Korean Government (MOST) (to J.H.Y.) and Korea Research Foundation Grant KRF-2005-050-C00005 (to K. S. S.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	BERSTEIN G, 1992, J BIOL CHEM, V267, P8081; Chen Y, 2001, AM J RESP CELL MOL, V25, P409, DOI 10.1165/ajrcmb.25.4.4413; COADE SB, 1989, CIRC RES, V65, P531, DOI 10.1161/01.RES.65.3.531; Cowley DO, 2000, GENE DEV, V14, P366; Di Virgilio F, 2001, BLOOD, V97, P587, DOI 10.1182/blood.V97.3.587; Dittmer Jurgen, 2003, Mol Cancer, V2, P29, DOI 10.1186/1476-4598-2-29; Fauquette V, 2005, BIOCHEM J, V386, P35, DOI 10.1042/BJ20040706; Feng YM, 2004, GENE, V330, P75, DOI 10.1016/j.gene.2004.01.006; Ferrari D, 2006, J LEUKOCYTE BIOL, V79, P7, DOI 10.1189/jlb.0505286; Foulds CE, 2004, MOL CELL BIOL, V24, P10954, DOI 10.1128/MCB.24.24.10954-10964.2004; Hwang JI, 2000, J BIOL CHEM, V275, P16632, DOI 10.1074/jbc.M001410200; Hwang JI, 2005, J BIOL CHEM, V280, P12467, DOI 10.1074/jbc.M410740200; Idzko M, 2003, BRIT J PHARMACOL, V138, P1244, DOI 10.1038/sj.bjp.0705145; Idzko M, 2007, NAT MED, V13, P913, DOI 10.1038/nm1617; Jayaraman G, 1999, J BIOL CHEM, V274, P17342, DOI 10.1074/jbc.274.24.17342; JHON DY, 1993, J BIOL CHEM, V268, P6654; Kim CG, 1996, J BIOL CHEM, V271, P21187, DOI 10.1074/jbc.271.35.21187; Kim CH, 2004, AM J PHYSIOL-LUNG C, V287, pL835, DOI 10.1152/ajplung.00285.2003; KORNAU HC, 1995, SCIENCE, V269, P1737, DOI 10.1126/science.7569905; Kreda SM, 2007, J PHYSIOL-LONDON, V584, P245, DOI 10.1113/jphysiol.2007.139840; Li RZ, 2000, ONCOGENE, V19, P6514, DOI 10.1038/sj.onc.1204035; Marziali G, 2002, ONCOGENE, V21, P7933, DOI 10.1038/sj.onc.1205925; NYE JA, 1992, GENE DEV, V6, P975, DOI 10.1101/gad.6.6.975; Rose MC, 2006, PHYSIOL REV, V86, P245, DOI 10.1152/physrev.00010.2005; Sheng M, 2001, ANNU REV NEUROSCI, V24, P1, DOI 10.1146/annurev.neuro.24.1.1; Song KS, 2003, J BIOL CHEM, V278, P34890, DOI 10.1074/jbc.M303911200; Song KS, 2003, J BIOL CHEM, V278, P23243, DOI 10.1074/jbc.M300096200; Tang XW, 2002, J BIOL CHEM, V277, P338, DOI 10.1074/jbc.M108927200; Yang C, 1998, MOL CELL BIOL, V18, P2218, DOI 10.1128/MCB.18.4.2218; Yoon JH, 2000, ANN OTO RHINOL LARYN, V109, P594, DOI 10.1177/000348940010900612; Zhu Y, 2008, J PHYSIOL-LONDON, V586, P1977, DOI 10.1113/jphysiol.2007.149310	31	25	25	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 3	2008	283	40					26869	26878		10.1074/jbc.M802507200	http://dx.doi.org/10.1074/jbc.M802507200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	353RT	18676374	Green Published, hybrid			2022-12-27	WOS:000259586600006
J	Varshavsky, A				Varshavsky, Alexander			Discovery of Cellular Regulation by Protein Degradation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							N-END RULE; DNA TOPOISOMERASE-II; UBIQUITIN-CONJUGATING ENZYME; TEMPERATURE-SENSITIVE MUTANT; INTERTWINED CATENATED DIMERS; SISTER-CHROMATID SEPARATION; ATP-DEPENDENT PROTEOLYSIS; HEAT-INDUCIBLE DEGRON; SHORT-LIVED PROTEIN; SACCHAROMYCES-CEREVISIAE		CALTECH, Div Biol, Pasadena, CA 91125 USA	California Institute of Technology	Varshavsky, A (corresponding author), CALTECH, Div Biol, Pasadena, CA 91125 USA.				National Institutes of Health; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM031530] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Our studies are supported by the National Institutes of Health and by private foundations. I am most grateful to the past and present colleagues in my laboratory for their contributions, many of which are mentioned above. I also thank C. Brower, Z. Chang, W. Dunphy, R. Deshaies, M. Hochstrasser, A. Shemorry, O. Sundin, and W. Tansey for helpful comments on the paper.	ALAGRAMAM K, 1995, MOL MICROBIOL, V15, P225, DOI 10.1111/j.1365-2958.1995.tb02237.x; ALFAGEMIE CR, 1980, CHROMOSOMA, V78, P1; An JY, 2006, P NATL ACAD SCI USA, V103, P6212, DOI 10.1073/pnas.0601700103; Aulner N, 2002, MOL CELL BIOL, V22, P1218, DOI 10.1128/MCB.22.4.1218-1232.2002; BACHMAIR A, 1989, CELL, V56, P1019, DOI 10.1016/0092-8674(89)90635-1; BACHMAIR A, 1986, SCIENCE, V234, P179, DOI 10.1126/science.3018930; BAKAYEV VV, 1975, NUCLEIC ACIDS RES, V2, P1401, DOI 10.1093/nar/2.8.1401; BAKER RT, 1995, J BIOL CHEM, V270, P12065, DOI 10.1074/jbc.270.20.12065; BAKER RT, 1992, J BIOL CHEM, V267, P23364; BALZI E, 1990, J BIOL CHEM, V265, P7464; BARSOUM J, 1983, P NATL ACAD SCI-BIOL, V80, P5330, DOI 10.1073/pnas.80.17.5330; BARTEL B, 1990, EMBO J, V9, P3179, DOI 10.1002/j.1460-2075.1990.tb07516.x; BARTEL B, 1988, CELL, V52, P935, DOI 10.1016/0092-8674(88)90435-7; Blattes R, 2006, EMBO J, V25, P2397, DOI 10.1038/sj.emboj.7601125; Byrd C, 1998, EMBO J, V17, P269, DOI 10.1093/emboj/17.1.269; CHAU V, 1989, SCIENCE, V243, P1576, DOI 10.1126/science.2538923; CIECHANOVER A, 1984, CELL, V37, P57, DOI 10.1016/0092-8674(84)90300-3; CIECHANOVER A, 1982, J BIOL CHEM, V257, P2537; CIECHANOVER A, 1978, BIOCHEM BIOPH RES CO, V81, P1100, DOI 10.1016/0006-291X(78)91249-4; Clarke DJ, 2006, CELL CYCLE, V5, P1925, DOI 10.4161/cc.5.17.3200; Coelho PA, 2003, J CELL SCI, V116, P4763, DOI 10.1242/jcs.00799; D'Ambrosio C, 2008, CURR BIOL, V18, P1084, DOI 10.1016/j.cub.2008.06.058; Damelin M, 2007, BRIT J CANCER, V96, P201, DOI 10.1038/sj.bjc.6603537; Davydov IV, 2000, J BIOL CHEM, V275, P22931, DOI 10.1074/jbc.M001605200; DEMARTINO GN, 2007, CELL, V129, P747; Deming PB, 2001, P NATL ACAD SCI USA, V98, P12044, DOI 10.1073/pnas.221430898; DINARDO S, 1984, P NATL ACAD SCI-BIOL, V81, P2616, DOI 10.1073/pnas.81.9.2616; Ditzel M, 2003, NAT CELL BIOL, V5, P467, DOI 10.1038/ncb984; DOHMEN RJ, 1991, P NATL ACAD SCI USA, V88, P7351, DOI 10.1073/pnas.88.16.7351; Dohmen RJ, 2005, METHOD ENZYMOL, V399, P799, DOI 10.1016/S0076-6879(05)99052-6; DOHMEN RJ, 1994, SCIENCE, V263, P1273, DOI 10.1126/science.8122109; Du FY, 2002, P NATL ACAD SCI USA, V99, P14110, DOI 10.1073/pnas.172527399; Dunnwald M, 1999, MOL BIOL CELL, V10, P329, DOI 10.1091/mbc.10.2.329; EVANS T, 1983, CELL, V33, P389, DOI 10.1016/0092-8674(83)90420-8; FERBER S, 1987, NATURE, V326, P808, DOI 10.1038/326808a0; FINLEY D, 1987, CELL, V48, P1035, DOI 10.1016/0092-8674(87)90711-2; FINLEY D, 1984, CELL, V37, P43, DOI 10.1016/0092-8674(84)90299-X; FINLEY D, 1989, NATURE, V338, P394, DOI 10.1038/338394a0; FRIED M, 1981, NUCLEIC ACIDS RES, V9, P6505, DOI 10.1093/nar/9.23.6505; GARNER MM, 1981, NUCLEIC ACIDS RES, V9, P3047, DOI 10.1093/nar/9.13.3047; Geiss-Friedlander R, 2007, NAT REV MOL CELL BIO, V8, P947, DOI 10.1038/nrm2293; Gisler SM, 2008, MOL CELL PROTEOMICS, V7, P1362, DOI 10.1074/mcp.M800079-MCP200; GLOTZER M, 1991, NATURE, V349, P132, DOI 10.1038/349132a0; GOEBL MG, 1988, SCIENCE, V241, P1331, DOI 10.1126/science.2842867; GOLDKNOPF IL, 1977, P NATL ACAD SCI USA, V74, P864, DOI 10.1073/pnas.74.3.864; GONDA DK, 1989, J BIOL CHEM, V264, P16700; GOTO T, 1982, J BIOL CHEM, V257, P5866; Graciet E, 2006, P NATL ACAD SCI USA, V103, P3078, DOI 10.1073/pnas.0511224103; Grigoryev S, 1996, J BIOL CHEM, V271, P28521, DOI 10.1074/jbc.271.45.28521; Haering CH, 2008, NATURE, V454, P297, DOI 10.1038/nature07098; Haggarty SJ, 2003, CHEM BIOL, V10, P1267, DOI 10.1016/j.chembiol.2003.11.014; Hanna J, 2007, FEBS LETT, V581, P2854, DOI 10.1016/j.febslet.2007.03.053; Harper JW, 2006, CELL, V124, P1133, DOI 10.1016/j.cell.2006.03.009; Hauf S, 2001, SCIENCE, V293, P1320, DOI 10.1126/science.1061376; HERSHKO A, 1991, J BIOL CHEM, V266, P16376; Hershko A, 2000, NAT MED, V6, P1073, DOI 10.1038/80384; HERSHKO A, 1980, P NATL ACAD SCI-BIOL, V77, P1783, DOI 10.1073/pnas.77.4.1783; HERSHKO A, 1983, J BIOL CHEM, V258, P8206; HERSHKO A, 1984, P NATL ACAD SCI-BIOL, V81, P1619, DOI 10.1073/pnas.81.6.1619; Hicke L, 1996, CELL, V84, P277, DOI 10.1016/S0092-8674(00)80982-4; HOCHSTRASSER M, 1990, CELL, V61, P697, DOI 10.1016/0092-8674(90)90481-S; HOCHSTRASSER M, 1991, P NATL ACAD SCI USA, V88, P4606, DOI 10.1073/pnas.88.11.4606; HOLM C, 1985, CELL, V41, P553, DOI 10.1016/S0092-8674(85)80028-3; Hou JY, 2008, NAT STRUCT MOL BIOL, V15, P288, DOI 10.1038/nsmb.1392; Hu RG, 2005, NATURE, V437, P981, DOI 10.1038/nature04027; Hu RG, 2008, P NATL ACAD SCI USA, V105, P76, DOI 10.1073/pnas.0710568105; Hu RG, 2006, J BIOL CHEM, V281, P32559, DOI 10.1074/jbc.M604355200; Huang CE, 2005, PHILOS T ROY SOC B, V360, P537, DOI 10.1098/rstb.2004.1609; Hunter T, 2007, MOL CELL, V28, P730, DOI 10.1016/j.molcel.2007.11.019; Inobe T, 2008, CURR OPIN STRUC BIOL, V18, P43, DOI 10.1016/j.sbi.2007.12.014; JENTSCH S, 1987, NATURE, V329, P131, DOI 10.1038/329131a0; JOHNSON ES, 1990, NATURE, V346, P287, DOI 10.1038/346287a0; JOHNSON ES, 1992, EMBO J, V11, P497, DOI 10.1002/j.1460-2075.1992.tb05080.x; JOHNSON ES, 1995, J BIOL CHEM, V270, P17442, DOI 10.1074/jbc.270.29.17442; JOHNSSON N, 1994, EMBO J, V13, P2686, DOI 10.1002/j.1460-2075.1994.tb06559.x; JOHNSSON N, 1994, P NATL ACAD SCI USA, V91, P10340, DOI 10.1073/pnas.91.22.10340; KAIJI H, 1963, BIOCHIM BIOPHYS ACTA, V76, P474; Kerppola TK, 2008, ANNU REV BIOPHYS, V37, P465, DOI 10.1146/annurev.biophys.37.032807.125842; Kerscher O, 2006, ANNU REV CELL DEV BI, V22, P159, DOI 10.1146/annurev.cellbio.22.010605.093503; KORNBERG RD, 1974, SCIENCE, V184, P868, DOI 10.1126/science.184.4139.868; Kwon YT, 2003, MOL CELL BIOL, V23, P8255, DOI 10.1128/MCB.23.22.8255-8271.2003; Kwon YT, 2000, MOL CELL BIOL, V20, P4135, DOI 10.1128/MCB.20.11.4135-4148.2000; Kwon YT, 1999, MOL CELL BIOL, V19, P182; Kwon YT, 2002, SCIENCE, V297, P96, DOI 10.1126/science.1069531; Kwon YT, 2001, MOL CELL BIOL, V21, P8007, DOI 10.1128/MCB.21.23.8007-8021.2001; Lee MJ, 2005, P NATL ACAD SCI USA, V102, P15030, DOI 10.1073/pnas.0507533102; LEVINGER L, 1980, P NATL ACAD SCI-BIOL, V77, P3244, DOI 10.1073/pnas.77.6.3244; LEVINGER L, 1982, CELL, V28, P375, DOI 10.1016/0092-8674(82)90355-5; LEVINGER L, 1981, J MOL BIOL, V146, P287, DOI 10.1016/0022-2836(81)90389-2; LEVINGER L, 1982, P NATL ACAD SCI-BIOL, V79, P7152, DOI 10.1073/pnas.79.23.7152; Levy F, 1996, P NATL ACAD SCI USA, V93, P4907, DOI 10.1073/pnas.93.10.4907; Li TK, 2001, ANNU REV PHARMACOL, V41, P53, DOI 10.1146/annurev.pharmtox.41.1.53; Lou ZK, 2005, NAT STRUCT MOL BIOL, V12, P589, DOI 10.1038/nsmb953; MARUNOUCHI T, 1980, BIOCHEM BIOPH RES CO, V95, P126, DOI 10.1016/0006-291X(80)90713-5; MATSUMOTO Y, 1983, FEBS LETT, V151, P139, DOI 10.1016/0014-5793(83)80359-7; MCGRATH JP, 1991, EMBO J, V10, P227, DOI 10.1002/j.1460-2075.1991.tb07940.x; Meyer-Almes FJ, 1998, BIOPHYS CHEM, V75, P151, DOI 10.1016/S0301-4622(98)00203-8; Milutinovich M, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030012; Minsky N, 2008, NAT CELL BIOL, V10, P483, DOI 10.1038/ncb1712; Mogk A, 2007, TRENDS CELL BIOL, V17, P165, DOI 10.1016/j.tcb.2007.02.001; Mukhopadhyay D, 2007, SCIENCE, V315, P201, DOI 10.1126/science.1127085; Nasmyth K, 2005, ANNU REV BIOCHEM, V74, P595, DOI 10.1146/annurev.biochem.74.082803.133219; OZKAYNAK E, 1984, NATURE, V312, P663, DOI 10.1038/312663a0; OZKAYNAK E, 1987, EMBO J, V6, P1429, DOI 10.1002/j.1460-2075.1987.tb02384.x; Peters JM, 2006, NAT REV MOL CELL BIO, V7, P644, DOI 10.1038/nrm1988; Pickart CM, 2004, CELL, V116, P181, DOI 10.1016/S0092-8674(03)01074-2; Rao H, 2001, NATURE, V410, P955, DOI 10.1038/35073627; RONINSON IB, 1984, NATURE, V309, P626, DOI 10.1038/309626a0; Rubinsztein DC, 2006, NATURE, V443, P780, DOI 10.1038/nature05291; Rumpf S, 2006, MOL CELL, V21, P261, DOI 10.1016/j.molcel.2005.12.014; Sasaki T, 2006, MOL CELL, V24, P63, DOI 10.1016/j.molcel.2006.08.005; SHAMU CE, 1992, J CELL BIOL, V117, P921, DOI 10.1083/jcb.117.5.921; Sheng J, 2002, EMBO J, V21, P6061, DOI 10.1093/emboj/cdf626; Shintomi K, 2007, TRENDS BIOCHEM SCI, V32, P154, DOI 10.1016/j.tibs.2007.02.002; SHRADER TE, 1993, J BACTERIOL, V175, P4364, DOI 10.1128/JB.175.14.4364-4374.1993; Skoufias DA, 2004, MOL CELL, V15, P977, DOI 10.1016/j.molcel.2004.08.018; SOFFER RL, 1980, TRANSFER RNA BIOL AS, P493; SOLOMON MJ, 1988, CELL, V53, P937, DOI 10.1016/S0092-8674(88)90469-2; STECK TR, 1984, CELL, V36, P1081, DOI 10.1016/0092-8674(84)90058-8; STRAUSS F, 1984, CELL, V37, P889, DOI 10.1016/0092-8674(84)90424-0; SUNDIN O, 1980, CELL, V21, P103, DOI 10.1016/0092-8674(80)90118-X; SUNDIN O, 1981, CELL, V25, P659, DOI 10.1016/0092-8674(81)90173-2; Suzuki T, 1999, EMBO J, V18, P6017, DOI 10.1093/emboj/18.21.6017; Tarassov K, 2008, SCIENCE, V320, P1465, DOI 10.1126/science.1153878; Tasaki T, 2005, MOL CELL BIOL, V25, P7120, DOI 10.1128/MCB.25.16.7120-7136.2005; Tasaki T, 2007, TRENDS BIOCHEM SCI, V32, P520, DOI 10.1016/j.tibs.2007.08.010; TOBIAS JW, 1991, SCIENCE, V254, P1374, DOI 10.1126/science.1962196; Turner GC, 2000, SCIENCE, V289, P2117, DOI 10.1126/science.289.5487.2117; Turner GC, 2000, NATURE, V405, P579, DOI 10.1038/35014629; UEMURA T, 1987, CELL, V50, P917, DOI 10.1016/0092-8674(87)90518-6; Uhlmann F, 1999, NATURE, V400, P37, DOI 10.1038/21831; VARSHAVSKY A, 1991, CELL, V64, P13, DOI 10.1016/0092-8674(91)90202-A; Varshavsky A, 1996, P NATL ACAD SCI USA, V93, P12142, DOI 10.1073/pnas.93.22.12142; Varshavsky A, 2005, METHOD ENZYMOL, V399, P777, DOI 10.1016/S0076-6879(05)99051-4; Varshavsky A, 2004, CURR BIOL, V14, pR181, DOI 10.1016/j.cub.2004.02.014; Varshavsky A, 1987, Methods Enzymol, V151, P551, DOI 10.1016/S0076-6879(87)51044-8; VARSHAVSKY A, 1981, CELL, V25, P561, DOI 10.1016/0092-8674(81)90074-X; Varshavsky A, 1983, Cold Spring Harb Symp Quant Biol, V47 Pt 1, P511; Varshavsky A, 1998, P NATL ACAD SCI USA, V95, P2094, DOI 10.1073/pnas.95.5.2094; VARSHAVSKY A, 1995, P NATL ACAD SCI USA, V92, P3663, DOI 10.1073/pnas.92.9.3663; VARSHAVSKY A, 2006, CANDID SCI, V6, P311; VARSHAVSKY AJ, 1976, NUCLEIC ACIDS RES, V3, P477, DOI 10.1093/nar/3.2.477; VARSHAVSKY AJ, 1979, CELL, V16, P453, DOI 10.1016/0092-8674(79)90021-7; VARSHAVSKY AJ, 1978, NUCLEIC ACIDS RES, V5, P3469, DOI 10.1093/nar/5.10.3469; VARSHAVSKY AJ, 1974, BIOCHIM BIOPHYS ACTA, V340, P207, DOI 10.1016/0005-2787(74)90114-2; Varshavsky A, 2007, P NATL ACAD SCI USA, V104, P14935, DOI 10.1073/pnas.0706546104; Varshavsky AV, 2006, PROTEIN SCI, V15, P647, DOI 10.1110/ps.052012306; Wang LHC, 2008, CHROMOSOMA, V117, P123, DOI 10.1007/s00412-007-0131-7; WILKINSON KD, 1980, J BIOL CHEM, V255, P7529; WINTER E, 1989, EMBO J, V8, P1867, DOI 10.1002/j.1460-2075.1989.tb03583.x; Wittke S, 2002, MOL BIOL CELL, V13, P2223, DOI 10.1091/mbc.01-10-0518; Woelk T, 2007, CELL DIV, V2, DOI 10.1186/1747-1028-2-11; Xia ZX, 2008, J BIOL CHEM, V283, P24011, DOI 10.1074/jbc.M802583200; Xie YM, 2000, P NATL ACAD SCI USA, V97, P2497, DOI 10.1073/pnas.060025497; Xie YM, 2002, NAT CELL BIOL, V4, P1003, DOI 10.1038/ncb889; Yi JJ, 2007, PHARMACOL REV, V59, P14, DOI 10.1124/pr.59.1.4; Zenker M, 2005, NAT GENET, V37, P1345, DOI 10.1038/ng1681	157	73	73	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 12	2008	283	50					34469	34489		10.1074/jbc.X800009200	http://dx.doi.org/10.1074/jbc.X800009200			21	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	380MF	18708349	hybrid, Green Published, Green Submitted, Green Accepted			2022-12-27	WOS:000261469100001
J	Bergin, DA; Greene, CM; Sterchi, EE; Kenna, C; Geraghty, P; Belaaouaj, A; Taggart, CC; O'Neill, SJ; McElvaney, NG				Bergin, David A.; Greene, Catherine M.; Sterchi, Erwin E.; Kenna, Cliona; Geraghty, Patrick; Belaaouaj, Abderazzaq; Taggart, Clifford C.; O'Neill, Shane J.; McElvaney, Noel G.			Activation of the Epidermal Growth Factor Receptor (EGFR) by a Novel Metalloprotease Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN MEPRIN-ALPHA; NEUTROPHIL ELASTASE; MUCIN EXPRESSION; COLORECTAL-CANCER; EPITHELIAL-CELLS; PROTEASES; INFLAMMATION; RESPONSES; MEMBRANE; PROTEINS	Neutrophil Elastase (NE) is a pro-inflammatory protease present at higher than normal levels in the lung during inflammatory disease. NE regulates IL-8 production from airway epithelial cells and can activate both EGFR and TLR4. TACE/ADAM17 has been reported to trans-activate EGFR in response to NE. Here, using 16HBE14o-human bronchial epithelial cells we demonstrate anew mechanism by which NE regulates both of these events. A high molecular weight soluble metalloprotease activity detectable only in supernatants from NE-treated cells by gelatin and casein zymography was confirmed to be meprin alpha by Western immunoblotting. In vitro studies demonstrated the ability of NE to activate meprin alpha, which in turn could release soluble TGF alpha and induce IL-8 production from 16HBE14o-cells. These effects were abrogated by actinonin, a specific meprin inhibitor. NE-induced IL-8 expression was also inhibited by meprin alpha siRNA. Immunoprecipitation studies detected EGFR/TLR4 complexes in NE-stimulated cells overexpressing these receptors. Confocal studies confirmed colocalization of EGFR and TLR4 in 16HBE14o-cells stimulated with meprin alpha. NF kappa B was also activated via MyD88 in these cells by meprin alpha. In bronchoalveolar lavage fluid from NE knock-out mice infected intra-tracheally with Pseudomonas aeruginosa meprin alpha was significantly decreased compared with control mice, and was significantly increased and correlated with NE activity, in bronchoalveolar lavage fluid from individuals with cystic fibrosis but not healthy controls. The data describe a previously unidentified lung metalloprotease meprin alpha, and its role in NE-induced EGFR and TLR4 activation and IL-8 production.	[Bergin, David A.; Greene, Catherine M.; Kenna, Cliona; Geraghty, Patrick; Taggart, Clifford C.; O'Neill, Shane J.; McElvaney, Noel G.] Royal Coll Surgeons Ireland, Resp Res Div, Educ & Res Ctr, Beaumont Hosp,Dept Med, Dublin 9, Ireland; [Sterchi, Erwin E.] Univ Bern, Inst Biochem & Mol Med, CH-3012 Bern, Switzerland; [Belaaouaj, Abderazzaq] CHU Reimis, Hosp Maison Blanche, UMR514, INSERM,IFR 53, Reims, France	Royal College of Surgeons - Ireland; University of Bern; CHU de Reims; Institut National de la Sante et de la Recherche Medicale (Inserm)	Greene, CM (corresponding author), Royal Coll Surgeons Ireland, Resp Res Div, Educ & Res Ctr, Beaumont Hosp,Dept Med, Dublin 9, Ireland.	cmgreene@rcsi.ie; c.taggart@qub.ac.uk	McElvaney, Noel/A-6809-2010; A, Bentaher/F-6531-2018; Greene, Catherine M/D-3513-2012; Bentaher, Abderrazzaq/M-4424-2017; Taggart, Clifford C/G-4492-2014	A, Bentaher/0000-0001-6001-5456; Greene, Catherine M/0000-0003-2549-2569; Geraghty, Patrick/0000-0003-1647-5505; mcelvaney, Noel/0000-0002-0152-4370; Taggart, Clifford/0000-0002-9930-2978	The Alpha One Foundation; The Medical Research Charities Group/Health Research Board; The Children's Research Centre; Crumlin Hospital; The Swiss National Science Foundation	The Alpha One Foundation; The Medical Research Charities Group/Health Research Board; The Children's Research Centre; Crumlin Hospital; The Swiss National Science Foundation(Swiss National Science Foundation (SNSF))	This work was supported by The Alpha One Foundation, The Medical Research Charities Group/Health Research Board, The Children's Research Centre, Crumlin Hospital, and The Swiss National Science Foundation.	ABE H, 1994, J LAB CLIN MED, V123, P874; Becker C, 2003, BIOL CHEM, V384, P825, DOI 10.1515/BC.2003.092; Becker-Pauly C, 2007, J INVEST DERMATOL, V127, P1115, DOI 10.1038/sj.jid.5700675; Belaaouaj A, 1998, NAT MED, V4, P615, DOI 10.1038/nm0598-615; Bertenshaw GP, 2001, J BIOL CHEM, V276, P13248, DOI 10.1074/jbc.M011414200; BRACHMANN R, 1989, CELL, V56, P691, DOI 10.1016/0092-8674(89)90591-6; Carden D, 1998, AM J PHYSIOL-HEART C, V275, pH385, DOI 10.1152/ajpheart.1998.275.2.H385; Carroll TP, 2005, J IMMUNOL, V175, P7594, DOI 10.4049/jimmunol.175.11.7594; CHOUDRY Y, 1991, BIOCHEM J, V280, P57, DOI 10.1042/bj2800057; CRAIG SS, 1991, J HISTOCHEM CYTOCHEM, V39, P123, DOI 10.1177/39.1.1701182; Crisman JM, 2004, J IMMUNOL, V172, P4510, DOI 10.4049/jimmunol.172.7.4510; Devaney JM, 2003, FEBS LETT, V544, P129, DOI 10.1016/S0014-5793(03)00482-4; DiCamillo SJ, 2002, J BIOL CHEM, V277, P18938, DOI 10.1074/jbc.M200243200; DORING G, 1994, AM J RESP CRIT CARE, V150, pS114; Greene CM, 2005, J IMMUNOL, V174, P1638, DOI 10.4049/jimmunol.174.3.1638; Griffin S, 2007, CELL MICROBIOL, V9, P670, DOI 10.1111/j.1462-5822.2006.00819.x; Grogan A, 1997, J CELL SCI, V110, P3071; Hamilton LM, 2003, CLIN EXP ALLERGY, V33, P233, DOI 10.1046/j.1365-2222.2003.01593.x; Hardie WD, 1999, PEDIATR DEVEL PATHOL, V2, P415, DOI 10.1007/s100249900144; Herbst RS, 2004, INT J RADIAT ONCOL, V59, P21, DOI 10.1016/j.ijrobp.2003.11.041; Herzog C, 2005, CYTOKINE, V31, P394, DOI 10.1016/j.cyto.2005.06.012; HIBBS MS, 1987, J CLIN INVEST, V80, P1644, DOI 10.1172/JCI113253; Hirano M, 2005, J IMMUNOL, V175, P3177, DOI 10.4049/jimmunol.175.5.3177; Hirche TO, 2004, AM J RESP CELL MOL, V30, P576, DOI 10.1165/rcmb.2003-0253OC; JANOFF A, 1968, J EXP MED, V128, P1137, DOI 10.1084/jem.128.5.1137; KLINGEMANN HG, 1982, THROMB RES, V28, P793, DOI 10.1016/0049-3848(82)90105-0; Koff JL, 2008, AM J PHYSIOL-LUNG C, V294, pL1068, DOI 10.1152/ajplung.00025.2008; Kohri K, 2002, AM J PHYSIOL-LUNG C, V283, pL531, DOI 10.1152/ajplung.00455.2001; Kruse MN, 2004, BIOCHEM J, V378, P383, DOI 10.1042/BJ20031163; Kuwahara I, 2006, AM J PHYSIOL-LUNG C, V291, pL407, DOI 10.1152/ajplung.00471.2005; Lemjabbar H, 2002, NAT MED, V8, P41, DOI 10.1038/nm0102-41; Liau DF, 1996, BBA-LIPID LIPID MET, V1302, P117, DOI 10.1016/0005-2760(96)00042-2; Lottaz D, 1999, CANCER RES, V59, P1127; Lottaz D, 1999, EUR J BIOCHEM, V259, P496, DOI 10.1046/j.1432-1327.1999.00071.x; Matters GL, 1999, MOL CARCINOGEN, V25, P169, DOI 10.1002/(SICI)1098-2744(199907)25:3<169::AID-MC3>3.0.CO;2-Y; Matters GL, 2005, CLIN EXP METASTAS, V22, P331, DOI 10.1007/s10585-005-0660-5; Merlos-Suarez A, 2001, J BIOL CHEM, V276, P48510, DOI 10.1074/jbc.M103488200; Pham CTN, 2006, NAT REV IMMUNOL, V6, P541, DOI 10.1038/nri1841; Prenzel N, 2001, ENDOCR-RELAT CANCER, V8, P11, DOI 10.1677/erc.0.0080011; Rafiq K, 2008, CIRC RES, V102, P32, DOI 10.1161/CIRCRESAHA.107.150573; Reeves EP, 2002, NATURE, V416, P291, DOI 10.1038/416291a; Rosmann S, 2002, J BIOL CHEM, V277, P40650, DOI 10.1074/jbc.M206203200; Rouhani F, 2000, CHEST, V117, p250S, DOI 10.1378/chest.117.5_suppl_1.250S; SALO T, 1991, J BIOL CHEM, V266, P11436; Schlondorff J, 2001, J BIOL CHEM, V276, P14665, DOI 10.1074/jbc.M010741200; Shao MXG, 2005, P NATL ACAD SCI USA, V102, P767, DOI 10.1073/pnas.0408932102; Shao MXG, 2003, P NATL ACAD SCI USA, V100, P11618, DOI 10.1073/pnas.1534804100; STERCHI EE, 1988, ARCH BIOCHEM BIOPHYS, V265, P105, DOI 10.1016/0003-9861(88)90376-1; STROUPE ST, 1991, AM J PHYSIOL, V261, pE354, DOI 10.1152/ajpendo.1991.261.3.E354; Takayama J, 2007, BIOL PHARM BULL, V30, P1905, DOI 10.1248/bpb.30.1905; Walsh DE, 2001, J BIOL CHEM, V276, P35494, DOI 10.1074/jbc.M103543200; Wan YS, 2001, CELL SIGNAL, V13, P139, DOI 10.1016/S0898-6568(00)00146-7; WOLZ RL, 1994, ARCH BIOCHEM BIOPHYS, V310, P144, DOI 10.1006/abbi.1994.1150; Yao PM, 1996, J BIOL CHEM, V271, P15580, DOI 10.1074/jbc.271.26.15580	54	85	85	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 14	2008	283	46					31736	31744		10.1074/jbc.M803732200	http://dx.doi.org/10.1074/jbc.M803732200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	370KJ	18772136	hybrid, Green Published			2022-12-27	WOS:000260760800056
J	Jeganathan, S; Hascher, A; Chinnathambi, S; Biernat, J; Mandelkow, EM; Mandelkow, E				Jeganathan, Sadasivam; Hascher, Antje; Chinnathambi, Subashchandrabose; Biernat, Jacek; Mandelkow, Eva-Maria; Mandelkow, Eckhard			Proline-directed Pseudo-phosphorylation at AT8 and PHF1 Epitopes Induces a Compaction of the Paperclip Folding of Tau and Generates a Pathological (MC-1) Conformation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PAIRED HELICAL FILAMENTS; GLYCOGEN-SYNTHASE KINASE-3-BETA; ALZHEIMER-LIKE STATE; PROTEIN-KINASE; MICROTUBULES; BINDING; SERINE; SITES; RECOGNIZES; POLYMERIZATION	Tau, a neuronal microtubule-associated protein that aggregates in Alzheimer disease is a natively unfolded protein. In solution, Tau adopts a "paperclip" conformation, whereby the N- and C-terminal domains approach each other and the repeat domain (Jeganathan, S., von Bergen, M., Brutlach, H., Steinhoff, H. J., and Mandelkow, E. (2006) Biochemistry 45, 2283-2293). In AD, Tau is in a hyperphosphorylated state. The consequences for microtubule binding or aggregation are a matter of debate. We therefore tested whether phosphorylation alters the conformation of Tau. To avoid the ambiguities of heterogeneous phosphorylation we cloned "pseudophosphorylation" mutants of Tau where combinations of Ser or Thr residues were converted into Glu. These mutations were combined with FRET pairs inserted in different locations to allow distance measurements. The results show that the paperclip conformation becomes tighter or looser, depending on the pseudo-phosphorylation state. In particular, pseudo-phosphorylation at the epitope of the diagnostic antibody AT8* (S199E + S202E + T205E) moves the N- terminal domain away from the C-terminal domain. Pseudo-phosphorylation at the PHF1 epitope (S396E + S404E) moves the C-terminal domain away from the repeat domain. In both cases the paperclip conformation is opened up. By contrast, the combination of AT8* and PHF1 sites leads to compaction of the paperclip, such that the N- terminus approaches the repeat domain. The compaction becomes even stronger by combining pseudo-phosphorylated AT8*, AT100, and PHF1 epitopes. This is accompanied by a strong increase in the reaction with conformation-dependent antibody MC1, suggesting the generation of a pathological conformation characteristic for Tau in AD. Furthermore, the compact paperclip conformation enhances the aggregation to paired helical filaments but has little influence on microtubule interactions. The data provide a framework for the global folding of Tau dependent on proline-directed phosphorylation in the domains flanking the repeats and the consequences for pathological properties of Tau.	[Jeganathan, Sadasivam; Hascher, Antje; Chinnathambi, Subashchandrabose; Biernat, Jacek; Mandelkow, Eva-Maria; Mandelkow, Eckhard] Max Planck Unit Struct Mol Biol, D-22607 Hamburg, Germany	Max Planck Society	Mandelkow, E (corresponding author), Max Planck Unit Struct Mol Biol, Notkestr 85, D-22607 Hamburg, Germany.	mand@mpasmb.desy.de	Chinnathambi, Subashchandrabose/T-8471-2019	Jeganathan, Sadasivam/0000-0002-2811-2595; Chinnathambi, Subashchandrabose/0000-0002-5468-2129	Deutsche Forschungsgemeinschaft (DFG); Volkswagen (VW) Foundation	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Volkswagen (VW) Foundation(Volkswagen)	This work was supported by grants from the Deutsche Forschungsgemeinschaft (DFG) and the Volkswagen (VW) Foundation. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	Augustinack JC, 2002, ACTA NEUROPATHOL, V103, P26, DOI 10.1007/s004010100423; Barghorn Stefan, 2004, V299, P35; BAUMANN K, 1993, FEBS LETT, V336, P417, DOI 10.1016/0014-5793(93)80849-P; Berry RW, 2003, BIOCHEMISTRY-US, V42, P8325, DOI 10.1021/bi027348m; Bhaskar K, 2005, J BIOL CHEM, V280, P35119, DOI 10.1074/jbc.M505895200; BIERNAT J, 1992, EMBO J, V11, P1593, DOI 10.1002/j.1460-2075.1992.tb05204.x; BIERNAT J, 1993, NEURON, V11, P153, DOI 10.1016/0896-6273(93)90279-Z; Binder LI, 2005, BBA-MOL BASIS DIS, V1739, P216, DOI 10.1016/j.bbadis.2004.08.014; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; BRANDT R, 1994, J BIOL CHEM, V269, P11776; Carmel G, 1996, J BIOL CHEM, V271, P32789, DOI 10.1074/jbc.271.51.32789; CHEN J, 1992, NATURE, V360, P674, DOI 10.1038/360674a0; Cho JH, 2003, J BIOL CHEM, V278, P187, DOI 10.1074/jbc.M206236200; Derkinderen P, 2005, J NEUROSCI, V25, P6584, DOI 10.1523/JNEUROSCI.1487-05.2005; DICKSON DW, 1995, NEUROBIOL AGING, V16, P285, DOI 10.1016/0197-4580(95)00013-5; Dobson CM, 1999, TRENDS BIOCHEM SCI, V24, P329, DOI 10.1016/S0968-0004(99)01445-0; DREWES G, 1995, J BIOL CHEM, V270, P7679, DOI 10.1074/jbc.270.13.7679; Drewes G, 1997, CELL, V89, P297, DOI 10.1016/S0092-8674(00)80208-1; DREWES G, 1992, EMBO J, V11, P2131, DOI 10.1002/j.1460-2075.1992.tb05272.x; DRUBIN DG, 1986, J CELL BIOL, V103, P2739, DOI 10.1083/jcb.103.6.2739; EFTINK MR, 1991, METHOD BIOCHEM ANAL, V35, P127; Fitzkee NC, 2004, P NATL ACAD SCI USA, V101, P12497, DOI 10.1073/pnas.0404236101; Gamblin TC, 2003, BIOCHEMISTRY-US, V42, P15009, DOI 10.1021/bi035722s; Garcia ML, 2001, CURR OPIN CELL BIOL, V13, P41, DOI 10.1016/S0955-0674(00)00172-1; Ghoshal N, 2001, J NEUROCHEM, V77, P1372, DOI 10.1046/j.1471-4159.2001.00346.x; GOEDERT M, 1995, NEUROSCI LETT, V189, P167, DOI 10.1016/0304-3940(95)11484-E; GOEDERT M, 1989, NEURON, V3, P519, DOI 10.1016/0896-6273(89)90210-9; Gong CX, 2005, J NEURAL TRANSM, V112, P813, DOI 10.1007/s00702-004-0221-0; GREENBERG SG, 1992, J BIOL CHEM, V267, P564; Haase C, 2004, J NEUROCHEM, V88, P1509, DOI 10.1046/j.1471-4159.2003.02287.x; HANGER DP, 1992, NEUROSCI LETT, V147, P58, DOI 10.1016/0304-3940(92)90774-2; HIROKAWA N, 1988, J CELL BIOL, V107, P1449, DOI 10.1083/jcb.107.4.1449; Hirokawa N, 2005, NAT REV NEUROSCI, V6, P201, DOI 10.1038/nrn1624; Hoffmann R, 1997, BIOCHEMISTRY-US, V36, P8114, DOI 10.1021/bi970380+; HUANG WD, 1994, P NATL ACAD SCI USA, V91, P8960, DOI 10.1073/pnas.91.19.8960; HUDSON EN, 1973, BIOCHEMISTRY-US, V12, P4154, DOI 10.1021/bi00745a019; Illenberger S, 1998, MOL BIOL CELL, V9, P1495, DOI 10.1091/mbc.9.6.1495; Jeganathan S, 2006, BIOCHEMISTRY-US, V45, P2283, DOI 10.1021/bi0521543; Jicha GA, 1997, J NEUROSCI RES, V48, P128, DOI 10.1002/(SICI)1097-4547(19970415)48:2<128::AID-JNR5>3.0.CO;2-E; Johnson GVW, 2004, J CELL SCI, V117, P5721, DOI 10.1242/jcs.01558; Kampers T, 1999, FEBS LETT, V451, P39, DOI 10.1016/S0014-5793(99)00522-0; Kim YG, 2008, BIOCONJUGATE CHEM, V19, P786, DOI 10.1021/bc7002499; Kishi M, 2005, SCIENCE, V307, P929, DOI 10.1126/science.1107403; LEE G, 1988, SCIENCE, V239, P285, DOI 10.1126/science.3122323; Leger J, 1997, J BIOL CHEM, V272, P8441, DOI 10.1074/jbc.272.13.8441; LICHTENBERGKRAAG B, 1992, P NATL ACAD SCI USA, V89, P5384, DOI 10.1073/pnas.89.12.5384; Magnani E, 2007, EMBO J, V26, P4546, DOI 10.1038/sj.emboj.7601878; Mandelkow E, 2007, BRAIN PATHOL, V17, P83, DOI 10.1111/j.1750-3639.2007.00053.x; MANDELKOW EM, 1992, FEBS LETT, V314, P315, DOI 10.1016/0014-5793(92)81496-9; MATSUMOTO S, 1975, BIOCHEMISTRY-US, V14, P214, DOI 10.1021/bi00673a004; Mukrasch MD, 2007, J BIOL CHEM, V282, P12230, DOI 10.1074/jbc.M607159200; Mukrasch MD, 2005, J BIOL CHEM, V280, P24978, DOI 10.1074/jbc.M501565200; OTVOS L, 1994, J NEUROSCI RES, V39, P669, DOI 10.1002/jnr.490390607; Porzig R, 2007, BIOCHEM BIOPH RES CO, V358, P644, DOI 10.1016/j.bbrc.2007.04.187; Schneider A, 1999, BIOCHEMISTRY-US, V38, P3549, DOI 10.1021/bi981874p; Schuler B, 2002, NATURE, V419, P743, DOI 10.1038/nature01060; SCHWEERS O, 1994, J BIOL CHEM, V269, P24290; Skrabana R, 2004, FEBS LETT, V568, P178, DOI 10.1016/j.febslet.2004.04.098; Smet C, 2004, BIOCHEMISTRY-US, V43, P2032, DOI 10.1021/bi035479x; Sontag E, 1999, J BIOL CHEM, V274, P25490, DOI 10.1074/jbc.274.36.25490; Uversky VN, 2007, J NEUROCHEM, V103, P17, DOI 10.1111/j.1471-4159.2007.04764.x; von Bergen M, 2000, P NATL ACAD SCI USA, V97, P5129, DOI 10.1073/pnas.97.10.5129; WILLE H, 1992, J CELL BIOL, V118, P573, DOI 10.1083/jcb.118.3.573; Zheng-Fischhofer QY, 1998, EUR J BIOCHEM, V252, P542, DOI 10.1046/j.1432-1327.1998.2520542.x	64	171	177	1	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 14	2008	283	46					32066	32076		10.1074/jbc.M805300200	http://dx.doi.org/10.1074/jbc.M805300200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	370KJ	18725412	hybrid			2022-12-27	WOS:000260760800088
J	Dumez, ME; Teller, N; Mercier, F; Tanaka, T; Vandenberghe, I; Vandenbranden, M; Devreese, B; Luxen, A; Frere, JM; Matagne, A; Jacquet, A; Galleni, M; Chevigne, A				Dumez, Marie-Eve; Teller, Nathalie; Mercier, Frederic; Tanaka, Tetsuya; Vandenberghe, Isabel; Vandenbranden, Michel; Devreese, Bart; Luxen, Andre; Frere, Jean-Marie; Matagne, Andre; Jacquet, Alain; Galleni, Moreno; Chevigne, Andy			Activation mechanism of recombinant Der p 3 allergen zymogen - Contribution of cysteine protease Der p 1 and effect of propeptide glycosylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DUST-MITE ALLERGEN; HUMAN CATIONIC TRYPSINOGEN; GROUP-III ALLERGEN; DERMATOPHAGOIDES-PTERONYSSINUS; SERINE-PROTEASE; SLOW-BINDING; CATHEPSIN-B; CLONING; PURIFICATION; INHIBITION	The trypsin-like protease Der p 3, a major allergen of the house dust mite Dermatophagoides pteronyssinus, is synthesized as a zymogen, termed proDer p 3. No recombinant source of Der p 3 has been described yet, and the zymogen maturation mechanism remains to be elucidated. The Der p 3 zymogen was produced in Pichia pastoris. We demonstrated that the recombinant zymogen is glycosylated at the level of its propeptide. We showed that the activation mechanism of proDer p 3 is intermolecular and is mediated by the house dust mite cysteine protease Der p 1. The primary structure of the proDer p 3 propeptide is associated with a unique zymogen activation mechanism, which is different from those described for the trypsin-like family and relies on the house dust mite papain-like protease Der p 1. This is the first report of a recombinant source of Der p 3, with the same enzymatic activity as the natural enzyme and trypsin. Glycosylation of the propeptide was found to decrease the rate of maturation. Finally, we showed that recombinant Der p 3 is inhibited by the free modified prosequence TP1R.	[Tanaka, Tetsuya; Jacquet, Alain; Chevigne, Andy] Free Univ Brussels, Lab Allergol Expt, Inst Biol & Med Mol, Brussels, Belgium; [Dumez, Marie-Eve; Frere, Jean-Marie; Matagne, Andre; Galleni, Moreno; Chevigne, Andy] Univ Liege, Ctr Prot Engn, Lab Enzymol, B-4000 Liege, Belgium; [Teller, Nathalie; Mercier, Frederic; Luxen, Andre] Univ Liege, Ctr Rech Cyclotron, B-4000 Liege, Belgium; [Vandenberghe, Isabel; Devreese, Bart] Lab Prot Biochem & Prot Engn, B-9000 Ghent, Belgium; [Vandenbranden, Michel] Free Univ Brussels, Lab Struct & Fonct Membranes Biol, B-1050 Brussels, Belgium; [Dumez, Marie-Eve] Fonds Rech Ind & Agr, Brussels, Belgium; [Matagne, Andre; Chevigne, Andy] Natl Fund Sci Res, Brussels, Belgium	Universite Libre de Bruxelles; Vrije Universiteit Brussel; University of Liege; University of Liege; Universite Libre de Bruxelles; Vrije Universiteit Brussel; Fonds de la Recherche Scientifique - FNRS	Jacquet, A (corresponding author), Free Univ Brussels, Lab Allergol Expt, Inst Biol & Med Mol, Gosselies Charleroi 6041, Brussels, Belgium.	alain.jacquet@ulb.ac.be; mgalleni@ulg.ac.be	Devreese, Bart/B-2011-2009; Jacquet, Alain/T-8611-2019; Jacquet, Alain/GQI-0546-2022; luxen, andre/C-2116-2009; Devreese, Bart/K-2841-2019	Devreese, Bart/0000-0002-9764-2581; Jacquet, Alain/0000-0002-0980-9741; Jacquet, Alain/0000-0002-0980-9741; Devreese, Bart/0000-0002-9764-2581; Chevigne, Andy/0000-0003-4768-6743; Matagne, Andre/0000-0001-6417-6791	Fonds de la Recherche Fondamentale et Collective [2.4550.05, 2.4511.06, 1.5.209.07, 2.4561.07]	Fonds de la Recherche Fondamentale et Collective(Fonds de la Recherche Scientifique - FNRS)	This work was supported in part by Fonds de la Recherche Fondamentale et Collective Grants 2.4561.07, 1.5.209.07, 2.4511.06 and 2.4550.05 by the Direction Generale des Technologies de la Recherche et de l'Energie, Region Wallonne, and by GlaxoSmithKline Biologicals (Rixensart, Belgium). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. section 1734 solely to indicate this fact.	ANDO T, 1993, CLIN EXP ALLERGY, V23, P777, DOI 10.1111/j.1365-2222.1993.tb00366.x; Arrondo JLR, 1999, PROG BIOPHYS MOL BIO, V72, P367, DOI 10.1016/S0079-6107(99)00007-3; Bennett BJ, 1996, CLIN EXP ALLERGY, V26, P1150, DOI 10.1111/j.1365-2222.1996.tb00501.x; BRODRICK JW, 1978, J BIOL CHEM, V253, P2732; BRUNGER AT, 1987, BIOCHEMISTRY-US, V26, P5153; CHA S, 1975, BIOCHEM PHARMACOL, V24, P2177, DOI 10.1016/0006-2952(75)90050-7; Chen JM, 2003, MOL BIOL EVOL, V20, P1767, DOI 10.1093/molbev/msg183; Cheong N, 2003, ALLERGY, V58, P352, DOI 10.1034/j.1398-9995.2003.00033.x; Chevigne A, 2007, J MOL BIOL, V374, P170, DOI 10.1016/j.jmb.2007.08.025; FEHLHAMMER H, 1977, J MOL BIOL, V111, P415, DOI 10.1016/S0022-2836(77)80062-4; Frick TW, 1997, GUT, V41, P339, DOI 10.1136/gut.41.3.339; Gombos L, 2008, BIOCHEMISTRY-US, V47, P1675, DOI 10.1021/bi701454e; GREENBAUM LM, 1959, J BIOL CHEM, V234, P2885; Halangk W, 2000, J CLIN INVEST, V106, P773, DOI 10.1172/JCI9411; Hales BJ, 2006, J ALLERGY CLIN IMMUN, V118, P361, DOI 10.1016/j.jaci.2006.04.001; HALFON S, 2004, HDB PROTEOLYTIC ENZY, P1483; Harris J, 2004, CHEM BIOL, V11, P1361, DOI 10.1016/j.chembiol.2004.08.008; Hedstrom L, 1996, BIOCHEMISTRY-US, V35, P4515, DOI 10.1021/bi951928k; HUBER R, 1978, ACCOUNTS CHEM RES, V11, P114, DOI 10.1021/ar50123a006; Jacquet A, 2002, CLIN EXP ALLERGY, V32, P1048, DOI 10.1046/j.1365-2222.2002.01437.x; KAY J, 1971, J BIOL CHEM, V246, P6661; King C, 1996, J ALLERGY CLIN IMMUN, V98, P739, DOI 10.1016/S0091-6749(96)70121-5; Kukor Z, 2003, EUR J BIOCHEM, V270, P2047, DOI 10.1046/j.1432-1033.2003.03581.x; Kukor Z, 2002, J BIOL CHEM, V277, P6111, DOI 10.1074/jbc.M110959200; Lazure C, 2002, CURR PHARM DESIGN, V8, P511, DOI 10.2174/1381612023395691; Lund O., 2002, CASP5 C, pA102; Maruo K, 1997, J ALLERGY CLIN IMMUN, V100, P253, DOI 10.1016/S0091-6749(97)70233-1; Menard R, 1998, J BIOL CHEM, V273, P4478, DOI 10.1074/jbc.273.8.4478; Morrison J.F., 1985, COMMENTS MOL CELL BI, V2, P347; MORRISON JF, 1988, ADV ENZYMOL RAMB, V61, P201; MORRISON JF, 1982, TRENDS BIOCHEM SCI, V7, P102, DOI 10.1016/0968-0004(82)90157-8; MORRISON JF, 1969, BIOCHIM BIOPHYS ACTA, V185, P269, DOI 10.1016/0005-2744(69)90420-3; Nishiyama C, 1995, FEBS LETT, V377, P62, DOI 10.1016/0014-5793(95)01291-5; Pasternak A, 1998, BIOCHEMISTRY-US, V37, P16201, DOI 10.1021/bi980951d; PLATTSMILLS TAE, 1987, J ALLERGY CLIN IMMUN, V80, P755, DOI 10.1016/S0091-6749(87)80261-0; Quraishi O, 2001, J BIOL CHEM, V276, P8118, DOI 10.1074/jbc.M005851200; SCHECHTER I, 1967, BIOCHEM BIOPH RES CO, V27, P157, DOI 10.1016/S0006-291X(67)80055-X; Schulz O, 1998, J CLIN PATHOL-MOL PA, V51, P222, DOI 10.1136/mp.51.4.222; Smith WA, 1996, INT ARCH ALLERGY IMM, V109, P133, DOI 10.1159/000237212; SMITH WA, 1994, CLIN EXP ALLERGY, V24, P220, DOI 10.1111/j.1365-2222.1994.tb00223.x; STEWART GA, 1989, LANCET, V2, P154, DOI 10.1016/S0140-6736(89)90203-1; STEWART GA, 1992, IMMUNOLOGY, V75, P29; STEWART GA, 1989, LANCET, V2, P462; STEWART GA, 1994, ALLERGY, V49, P553, DOI 10.1111/j.1398-9995.1994.tb01128.x; Sun G, 2001, J IMMUNOL, V167, P1014, DOI 10.4049/jimmunol.167.2.1014; Szilagyi L, 2001, J BIOL CHEM, V276, P24574, DOI 10.1074/jbc.M011374200; Takai T, 2006, INT ARCH ALLERGY IMM, V139, P181, DOI 10.1159/000091163; Thomas WR, 2002, INT ARCH ALLERGY IMM, V129, P1, DOI 10.1159/000065179; VANSTOKKUM IHM, 1995, BIOCHEMISTRY-US, V34, P10508, DOI 10.1021/bi00033a024; Vernon HM, 1914, BIOCHEM J, V8, P494, DOI 10.1042/bj0080494; Whitcomb DC, 1996, NAT GENET, V14, P141, DOI 10.1038/ng1096-141; YASUEDA H, 1993, CLIN EXP ALLERGY, V23, P384, DOI 10.1111/j.1365-2222.1993.tb00343.x	52	19	20	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 7	2008	283	45					30606	30617		10.1074/jbc.M803041200	http://dx.doi.org/10.1074/jbc.M803041200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	367ID	18725410	Green Published, hybrid			2022-12-27	WOS:000260544800084
J	Kosloff, M; Alexov, E; Arshavsky, VY; Honig, B				Kosloff, Mickey; Alexov, Emil; Arshavsky, Vadim Y.; Honig, Barry			Electrostatic and Lipid Anchor Contributions to the Interaction of Transducin with Membranes MECHANISTIC IMPLICATIONS FOR ACTIVATION AND TRANSLOCATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTOR; LIGHT-DRIVEN TRANSLOCATION; BETA-GAMMA; ALPHA-SUBUNIT; CRYSTAL-STRUCTURE; FATTY ACYLATION; AMINO-TERMINUS; BASIC PEPTIDES; ACIDIC LIPIDS; ROD	The heterotrimeric G protein transducin is a key component of the vertebrate phototransduction cascade. Transducin is peripherally attached to membranes of the rod outer segment, where it interacts with other proteins at the membrane-cytosol interface. However, upon sustained activation by light, the dissociated G(t)alpha and G beta(1)gamma(1) subunits of transducin translocate from the outer segment to other parts of the rod cell. Here we used a computational approach to analyze the interaction strength of transducin and its subunits with acidic lipid bilayers, as well as the range of orientations that they are allowed to occupy on the membrane surface. Our results suggest that the combined constraints of electrostatics and lipid anchors substantially limit the rotational degrees of freedom of the membrane-bound transducin heterotrimer. This may contribute to a faster transducin activation rate by accelerating transducin-rhodopsin complex formation. Notably, the membrane interactions of the dissociated transducin subunits are very different from those of the heterotrimer. As shown previously, G beta(1)gamma(1) experiences significant attractive interactions with negatively charged membranes, whereas our new results suggest that G(t)alpha is electrostatically repelled by such membranes. We suggest that this repulsion could facilitate the membrane dissociation and intracellular translocation of G(t)alpha. Moreover, based on similarities in sequence and electrostatic properties, we propose that the properties described for transducin are common to its homologs within the G(i) subfamily. In a broader view, this work exemplifies how the activity-dependent association and dissociation of a G protein can change both the affinity for membranes and the range of allowed orientations, thereby modulating G protein function.	[Arshavsky, Vadim Y.] Duke Univ, Med Ctr, AERI, Durham, NC 27710 USA; [Kosloff, Mickey; Alexov, Emil; Honig, Barry] Columbia Univ, Dept Biochem & Mol Biophys, Ctr Computat Biol & Bioinformat, New York, NY 10032 USA; [Alexov, Emil; Honig, Barry] Columbia Univ, Howard Hughes Med Inst, New York, NY 10032 USA	Duke University; Columbia University; Columbia University; Howard Hughes Medical Institute	Arshavsky, VY (corresponding author), Duke Univ, Med Ctr, AERI, 2351 Erwin Rd,Box 3802, Durham, NC 27710 USA.	vadim.arshavsky@duke.edu; bh6@columbia.edu	Kosloff, Mickey/B-5962-2008	Kosloff, Mickey/0000-0003-1807-4000	National Institutes of Health [EY10336]; National Science Foundation [MCB-0416708]; Human Frontier Science Program; NATIONAL EYE INSTITUTE [R01EY010336] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); Human Frontier Science Program(Human Frontier Science Program); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported, in whole or in part, by National Institutes of Health Grant EY10336 (to V.Y.A.). This work was also supported by National Science Foundation Grant MCB-0416708 (to B.H.) and a long term postdoctoral fellowship from the Human Frontier Science Program (to M.K.).	ANDERSON RE, 1970, BIOCHEMISTRY-US, V9, P3624, DOI 10.1021/bi00820a019; Arshavsky VY, 2002, ANNU REV PHYSIOL, V64, P153, DOI 10.1146/annurev.physiol.64.082701.102229; ARSHAVSKY VY, 1987, RETINAL PROTEINS, P497; Artemyev NO, 2008, MOL NEUROBIOL, V37, P44, DOI 10.1007/s12035-008-8015-2; BAEHR W, 1982, J BIOL CHEM, V257, P6452; BenTal N, 1997, BIOPHYS J, V73, P1717, DOI 10.1016/S0006-3495(97)78203-1; BenTal N, 1996, BIOPHYS J, V71, P561, DOI 10.1016/S0006-3495(96)79280-9; BIGAY J, 1994, METHOD ENZYMOL, V237, P139; BIGAY J, 1994, BIOCHEMISTRY-US, V33, P14081, DOI 10.1021/bi00251a017; BOESZEBATTAGLIA K, 1994, EXP EYE RES, V58, P293, DOI 10.1006/exer.1994.1020; Bohm A, 1997, CURR OPIN BIOTECH, V8, P480, DOI 10.1016/S0958-1669(97)80072-9; BORGGREVEN JM, 1970, BIOCHIM BIOPHYS ACTA, V202, P374, DOI 10.1016/0005-2760(70)90201-8; Bourne HR, 1997, CURR OPIN CELL BIOL, V9, P134, DOI 10.1016/S0955-0674(97)80054-3; BRANN MR, 1987, SCIENCE, V235, P585, DOI 10.1126/science.3101175; Burns ME, 2001, ANNU REV NEUROSCI, V24, P779, DOI 10.1146/annurev.neuro.24.1.779; Burns ME, 2005, NEURON, V48, P387, DOI 10.1016/j.neuron.2005.10.014; Cabrera-Vera TM, 2003, ENDOCR REV, V24, P765, DOI 10.1210/er.2000-0026; Calvert PD, 2001, NATURE, V411, P90, DOI 10.1038/35075083; Calvert PD, 2006, TRENDS CELL BIOL, V16, P560, DOI 10.1016/j.tcb.2006.09.001; Chabre M, 2005, BIOCHEMISTRY-US, V44, P9395, DOI 10.1021/bi050720o; Cherfils J, 2003, TRENDS BIOCHEM SCI, V28, P13, DOI 10.1016/S0968-0004(02)00006-3; Crouthamel M, 2008, CELL SIGNAL, V20, P1900, DOI 10.1016/j.cellsig.2008.06.019; Ernst OP, 2007, P NATL ACAD SCI USA, V104, P10859, DOI 10.1073/pnas.0701967104; Fain GL, 2006, BIOESSAYS, V28, P344, DOI 10.1002/bies.20382; Filipek S, 2004, PHOTOCH PHOTOBIO SCI, V3, P628, DOI 10.1039/b315661c; FLIESLER SJ, 1983, PROG LIPID RES, V22, P79; Ford CE, 1998, SCIENCE, V280, P1271, DOI 10.1126/science.280.5367.1271; FUKADA Y, 1990, NATURE, V346, P658, DOI 10.1038/346658a0; FUNG BKK, 1981, P NATL ACAD SCI-BIOL, V78, P152, DOI 10.1073/pnas.78.1.152; Gaudet R, 1996, CELL, V87, P577, DOI 10.1016/S0092-8674(00)81376-8; Gurevich VV, 2008, TRENDS NEUROSCI, V31, P74, DOI 10.1016/j.tins.2007.11.007; Hamm HE, 1998, J BIOL CHEM, V273, P669, DOI 10.1074/jbc.273.2.669; Heck M, 2001, J BIOL CHEM, V276, P10000, DOI 10.1074/jbc.M009475200; Hessel E, 2003, J BIOL CHEM, V278, P22853, DOI 10.1074/jbc.M302747200; HONIG B, 1995, SCIENCE, V268, P1144, DOI 10.1126/science.7761829; HUBBELL WL, 1990, BIOPHYS J, V57, P99, DOI 10.1016/S0006-3495(90)82510-8; JOHNSON RS, 1994, J BIOL CHEM, V269, P21067; Kassai H, 2005, NEURON, V47, P529, DOI 10.1016/j.neuron.2005.07.025; Kerov V, 2007, J NEUROSCI, V27, P10270, DOI 10.1523/JNEUROSCI.2494-07.2007; KOKAME K, 1992, NATURE, V359, P749, DOI 10.1038/359749a0; Kosloff M, 2003, EMBO J, V22, P459, DOI 10.1093/emboj/cdg054; Kosloff M, 2002, BIOCHEMISTRY-US, V41, P14518, DOI 10.1021/bi026729x; KUHN H, 1980, NATURE, V283, P587, DOI 10.1038/283587a0; LAI RK, 1990, P NATL ACAD SCI USA, V87, P7673, DOI 10.1073/pnas.87.19.7673; LAMBRIGHT DG, 1994, NATURE, V369, P621, DOI 10.1038/369621a0; Lambright DG, 1996, NATURE, V379, P311, DOI 10.1038/379311a0; Leskov IB, 2000, NEURON, V27, P525, DOI 10.1016/S0896-6273(00)00063-5; Lobanova ES, 2007, J NEUROSCI, V27, P1151, DOI 10.1523/JNEUROSCI.5010-06.2007; Loew A, 1998, STRUCT FOLD DES, V6, P1007, DOI 10.1016/S0969-2126(98)00102-6; Marrari Y, 2007, BIOCHEMISTRY-US, V46, P7665, DOI 10.1021/bi700338m; MATSUDA T, 1994, J BIOL CHEM, V269, P30358; MIXON MB, 1995, SCIENCE, V270, P954, DOI 10.1126/science.270.5238.954; Murray D, 1999, BIOPHYS J, V77, P3176, DOI 10.1016/S0006-3495(99)77148-1; Murray D, 1998, BIOCHEMISTRY-US, V37, P2145, DOI 10.1021/bi972012b; Murray D, 2002, MOL CELL, V9, P145, DOI 10.1016/S1097-2765(01)00426-9; Murray D, 1997, STRUCTURE, V5, P985, DOI 10.1016/S0969-2126(97)00251-7; Murray D, 2001, J BIOL CHEM, V276, P45153, DOI 10.1074/jbc.M101784200; Murray PS, 2005, STRUCTURE, V13, P1521, DOI 10.1016/j.str.2005.07.010; Nair KS, 2005, NEURON, V46, P555, DOI 10.1016/j.neuron.2005.03.023; NEUBERT TA, 1992, J BIOL CHEM, V267, P18274; Neubert TA, 1998, FEBS LETT, V422, P343, DOI 10.1016/S0014-5793(98)00037-4; Onrust R, 1997, SCIENCE, V275, P381, DOI 10.1126/science.275.5298.381; Pedone KH, 2007, J BIOL CHEM, V282, P25199, DOI 10.1074/jbc.M610297200; PEITZSCH RM, 1993, BIOCHEMISTRY-US, V32, P10436, DOI 10.1021/bi00090a020; PEITZSCH RM, 1995, BIOPHYS J, V68, P729, DOI 10.1016/S0006-3495(95)80253-5; Petrey D, 2003, PROTEINS, V53, P430, DOI 10.1002/prot.10550; PHILP NJ, 1987, FEBS LETT, V225, P127, DOI 10.1016/0014-5793(87)81144-4; Preininger AM, 2003, BIOCHEMISTRY-US, V42, P7931, DOI 10.1021/bi0345438; Pugh E.N., 2000, HDB BIOL PHYS, V3, P183, DOI DOI 10.1016/S1383-8121(00)80008-1; Resh MD, 1999, BBA-MOL CELL RES, V1451, P1, DOI 10.1016/S0167-4889(99)00075-0; Ridge KD, 2003, TRENDS BIOCHEM SCI, V28, P479, DOI 10.1016/S0968-0004(03)00172-5; Rosenzweig DH, 2007, J NEUROSCI, V27, P5484, DOI 10.1523/JNEUROSCI.1421-07.2007; Seitz HR, 1999, BIOCHEMISTRY-US, V38, P7950, DOI 10.1021/bi990298+; SILVIUS JR, 1994, BIOCHEMISTRY-US, V33, P3014, DOI 10.1021/bi00176a034; Sokolov M, 2004, J BIOL CHEM, V279, P19149, DOI 10.1074/jbc.M311058200; Sokolov M, 2002, NEURON, V34, P95, DOI 10.1016/S0896-6273(02)00636-0; TSUI FC, 1990, BIOPHYS J, V57, P85, DOI 10.1016/S0006-3495(90)82509-1; WALL MA, 1995, CELL, V83, P1047, DOI 10.1016/0092-8674(95)90220-1; Wall MA, 1998, STRUCTURE, V6, P1169, DOI 10.1016/S0969-2126(98)00117-8; Wang JY, 2004, BIOPHYS J, V86, P1969, DOI 10.1016/S0006-3495(04)74260-5; WHELAN JP, 1988, J NEUROSCI RES, V20, P263, DOI 10.1002/jnr.490200216; Xiang ZX, 2001, J MOL BIOL, V311, P421, DOI 10.1006/jmbi.2001.4865; Zhang ZX, 2004, J BIOL CHEM, V279, P33937, DOI 10.1074/jbc.M403404200	83	30	30	0	6	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 7	2008	283	45					31197	31207		10.1074/jbc.M803799200	http://dx.doi.org/10.1074/jbc.M803799200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	367ID	18782760	Green Published, hybrid			2022-12-27	WOS:000260544800073
J	Mariappan, MM; Shetty, M; Sataranatarajan, K; Choudhury, GG; Kasinath, BS				Mariappan, Meenalakshmi M.; Shetty, Megan; Sataranatarajan, Kavithalakshmi; Choudhury, Goutam Ghosh; Kasinath, Balakuntalam S.			Glycogen Synthase Kinase 3 beta Is a Novel Regulator of High Glucose- and High Insulin-induced Extracellular Matrix Protein Synthesis in Renal Proximal Tubular Epithelial Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESSENGER-RNA TRANSLATION; SIGNAL-TRANSDUCTION PATHWAYS; SKELETAL-MUSCLE; GROWTH-FACTOR; CARDIAC-HYPERTROPHY; DIABETIC-NEPHROPATHY; GENE-EXPRESSION; POTENTIAL ROLE; PHOSPHORYLATION; KINASE-3-BETA	High glucose (30 mM) and high insulin (1 nM), pathogenic factors of type 2 diabetes, increased mRNA expression and synthesis of laminin beta 1 and fibronectin after 24 h of incubation in kidney proximal tubular epithelial (MCT) cells. We tested the hypothesis that inactivation of glycogen synthase kinase 3 beta(GSK3 beta) by high glucose and high insulin induces increase in synthesis of laminin beta 1 via activation of eIF2B epsilon. Both high glucose and high insulin induced Ser-9 phosphorylation and inactivation of GSK3 beta at 2 h that lasted for up to 48 h. This was associated with dephosphorylation of eIF2B epsilon and eEF2, and increase in phosphorylation of 4E-BP1 and eIF4E. Expression of the kinase-dead mutant of GSK3 beta or constitutively active kinase led to increased and diminished laminin beta 1 synthesis, respectively. Incubation with selective kinase inhibitors showed that high glucose- and high insulin-induced laminin beta 1 synthesis and phosphorylation of GSK3 beta were dependent on PI 3-kinase, Erk, and mTOR. High glucose and high insulin augmented activation of Akt, Erk, and p70S6 kinase. Dominant negative Akt, but not dominant negative p70S6 kinase, inhibited GSK3 beta phosphorylation induced by high glucose and high insulin, suggesting Akt but not p70S6 kinase was upstream of GSK3 beta. Status of GSK3 beta was examined in vivo in renal cortex of db/db mice with type 2 diabetes at 2 weeks and 2 months of diabetes. Diabetic mice showed increased phosphorylation of renal cortical GSK3 beta and decreased phosphorylation of eIF2B epsilon, which correlated with renal hypertrophy at 2 weeks, and increased laminin beta 1 and fibronectin protein content at 2 months. GSK3 beta and eIF2B epsilon play a role in augmented protein synthesis associated with high glucose- and high insulin-stimulated hypertrophy and matrix accumulation in renal disease in type 2 diabetes.	[Mariappan, Meenalakshmi M.; Shetty, Megan; Sataranatarajan, Kavithalakshmi; Choudhury, Goutam Ghosh; Kasinath, Balakuntalam S.] Univ Texas Hlth Sci Ctr San Antonio, Dept Med, Div Nephrol, OBrien Kidney Res Ctr, San Antonio, TX 78229 USA; [Choudhury, Goutam Ghosh; Kasinath, Balakuntalam S.] S Texas Vet Hlth Care Syst, San Antonio, TX 78229 USA	University of Texas System; University of Texas Health San Antonio; US Department of Veterans Affairs; Veterans Health Administration (VHA); Audie L. Murphy Memorial Veterans Hospital	Kasinath, BS (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Dept Med MC7882, 7703 Floyd Curl Dr, San Antonio, TX 78229 USA.	Kasinath@uthscsa.edu			National Institutes of Health [DK061597, DK077295, DK050190]; Juvenile Diabetes Research Foundation [3-2007-245, 1-2008-185]; American Diabetes Association [7-05-RA-60]; Veterans Administration Research Service; American Heart Association [SDG 0630283N]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R29DK050190, R01DK050190, P50DK061597, R01DK077295] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); American Diabetes Association(American Diabetes Association); Veterans Administration Research Service(US Department of Veterans Affairs); American Heart Association(American Heart Association); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK061597 and DK077295 (to B. S. K.) and DK050190 (to G. G. C.). These studies were also supported by Juvenile Diabetes Research Foundation Grants 3-2007-245 (to M. M. M. and B. S. K.) and 1-2008-185 (to G. G. C.), American Diabetes Association Grant 7-05-RA-60 (to B. S. K.), the Veterans Administration Research Service (to B. S. K. and G. G. C.), and American Heart Association Grant SDG 0630283N (to D. F.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Altomare DA, 2004, ONCOGENE, V23, P5853, DOI 10.1038/sj.onc.1207721; Antos CL, 2002, P NATL ACAD SCI USA, V99, P907, DOI 10.1073/pnas.231619298; Beurel E, 2004, EXP CELL RES, V300, P354, DOI 10.1016/j.yexcr.2004.08.001; Bhandari BK, 2001, KIDNEY INT, V59, P866; Chen JC, 2006, J AM SOC NEPHROL, V17, P1615, DOI 10.1681/ASN.2005111163; Choudhury GG, 2001, J BIOL CHEM, V276, P35636, DOI 10.1074/jbc.M100946200; Cohen P, 2001, NAT REV MOL CELL BIO, V2, P769, DOI 10.1038/35096075; Cordes N, 2003, BRIT J CANCER, V88, P1470, DOI 10.1038/sj.bjc.6600912; CROSS DAE, 1994, BIOCHEM J, V303, P21, DOI 10.1042/bj3030021; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; Cui H, 1998, DEV BRAIN RES, V111, P177, DOI 10.1016/S0165-3806(98)00136-9; DAMSBO P, 1991, DIABETOLOGIA, V34, P239, DOI 10.1007/BF00405082; De Servi B, 2005, ONCOGENE, V24, P4946, DOI 10.1038/sj.onc.1208676; DENG H, 2008, J BIOL CHEM; Diehl JA, 1998, GENE DEV, V12, P3499, DOI 10.1101/gad.12.22.3499; Dorn GW, 2005, J CLIN INVEST, V115, P527, DOI 10.1172/JCI200524178; Eldar-Finkelman H, 1999, DIABETES, V48, P1662, DOI 10.2337/diabetes.48.8.1662; ELDARFINKELMAN H, 1995, J BIOL CHEM, V270, P987, DOI 10.1074/jbc.270.3.987; EMBI N, 1980, EUR J BIOCHEM, V107, P519, DOI 10.1111/j.1432-1033.1980.tb06059.x; Feliers D, 2001, KIDNEY INT, V60, P495, DOI 10.1046/j.1523-1755.2001.060002495.x; Gingras AC, 1999, GENE DEV, V13, P1422, DOI 10.1101/gad.13.11.1422; Ha TS, 1999, J AM SOC NEPHROL, V10, P1931; Hagen T, 2006, J BIOL CHEM, V281, P35021, DOI 10.1074/jbc.M607003200; HANGER DP, 1992, NEUROSCI LETT, V147, P58, DOI 10.1016/0304-3940(92)90774-2; Haq S, 2000, J CELL BIOL, V151, P117, DOI 10.1083/jcb.151.1.117; Hardt SE, 2002, CIRC RES, V90, P1055, DOI 10.1161/01.RES.0000018952.70505.F1; HAVERTY TP, 1988, J CELL BIOL, V107, P1359, DOI 10.1083/jcb.107.4.1359; Jope RS, 2004, TRENDS BIOCHEM SCI, V29, P95, DOI 10.1016/j.tibs.2003.12.004; Kasinath B. S., 2003, CONT DIABETES DIABET, P97; Kasinath BS, 2006, J AM SOC NEPHROL, V17, P3281, DOI 10.1681/ASN.2006050488; Kerkela R, 2007, TRENDS CARDIOVAS MED, V17, P91, DOI 10.1016/j.tcm.2007.01.004; King WG, 1997, MOL CELL BIOL, V17, P4406, DOI 10.1128/MCB.17.8.4406; LAUGHLIN MR, 1990, AM J PHYSIOL, V258, pE184, DOI 10.1152/ajpendo.1990.258.1.E184; Lee MJ, 2007, AM J PHYSIOL-RENAL, V292, pF617, DOI 10.1152/ajprenal.00278.2006; Linseman DA, 2004, J NEUROSCI, V24, P9993, DOI 10.1523/JNEUROSCI.2057-04.2004; Lloberas N, 2006, J AM SOC NEPHROL, V17, P1395, DOI 10.1681/ASN.2005050549; Mariappan MM, 2007, DIABETES, V56, P476, DOI 10.2337/db05-1334; Mariappan MM, 2005, J BIOL CHEM, V280, P28402, DOI 10.1074/jbc.M504861200; Nikoulina SE, 2000, DIABETES, V49, P263, DOI 10.2337/diabetes.49.2.263; Nikoulina SE, 1997, DIABETES, V46, P1017, DOI 10.2337/diabetes.46.6.1017; Ossipova O, 2003, NAT CELL BIOL, V5, P889, DOI 10.1038/ncb1048; Proud CG, 2007, BIOCHEM J, V403, P217, DOI 10.1042/BJ20070024; REDPATH NT, 1993, EUR J BIOCHEM, V213, P689, DOI 10.1111/j.1432-1033.1993.tb17809.x; Rhoads RE, 1999, J BIOL CHEM, V274, P30337, DOI 10.1074/jbc.274.43.30337; Sakaguchi M, 2006, BIOCHEM BIOPH RES CO, V340, P296, DOI 10.1016/j.bbrc.2005.12.012; Sataranatarajan K, 2007, AM J PATHOL, V171, P1733, DOI 10.2353/ajpath.2007.070412; Schalm SS, 2002, CURR BIOL, V12, P632, DOI 10.1016/S0960-9822(02)00762-5; Senthil D, 2003, KIDNEY INT, V64, P468, DOI 10.1046/j.1523-1755.2003.00135.x; Senthil D, 2002, BIOCHEM J, V368, P49, DOI 10.1042/BJ20020137; Senthil D, 2002, AM J PHYSIOL-RENAL, V283, pF1226, DOI 10.1152/ajprenal.00109.2002; Senthil D, 2001, BIOCHEM J, V360, P87, DOI 10.1042/0264-6021:3600087; STAMBOLIC V, 1994, BIOCHEM J, V303, P701, DOI 10.1042/bj3030701; Thornton S, 2003, J MOL MED, V81, P536, DOI 10.1007/s00109-003-0461-8; Trivedi CM, 2007, NAT MED, V13, P324, DOI 10.1038/nm1552; van der Velden JLJ, 2006, AM J PHYSIOL-CELL PH, V290, pC453, DOI 10.1152/ajpcell.00068.2005; Wang XW, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng154; Welsh GI, 1998, FEBS LETT, V421, P125, DOI 10.1016/S0014-5793(97)01548-2; Zhang HH, 2006, MOL CELL, V24, P185, DOI 10.1016/j.molcel.2006.09.019	58	56	60	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 7	2008	283	45					30566	30575		10.1074/jbc.M801756200	http://dx.doi.org/10.1074/jbc.M801756200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	367ID	18701453	hybrid, Green Published			2022-12-27	WOS:000260544800015
J	Dines, M; Sendersky, E; David, L; Schwarz, R; Adir, N				Dines, Monica; Sendersky, Eleonora; David, Liron; Schwarz, Rakefet; Adir, Noam			Structural, Functional, and Mutational Analysis of the NblA Protein Provides Insight into Possible Modes of Interaction with the Phycobilisome	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYANOBACTERIUM SYNECHOCOCCUS-VULCANUS; CRYSTAL-STRUCTURE ANALYSIS; ANABAENA SP PCC-7120; 2.2 ANGSTROM; THERMAL-STABILITY; C-PHYCOCYANIN; DEGRADATION; CRYSTALLIZATION; EXPRESSION; NITROGEN	The enormous macromolecular phycobilisome antenna complex (>4 MDa) in cyanobacteria and red algae undergoes controlled degradation during certain forms of nutrient starvation. The NblA protein (similar to 6 kDa) has been identified as an essential component in this process. We have used structural, biochemical, and genetic methods to obtain molecular details on the mode of action of the NblA protein. We have determined the three-dimensional structure of the NblA protein from both the thermophilic cyanobacterium Thermosynechococcus vulcanus and the mesophilic cyanobacterium Synechococcus elongatus sp. PCC 7942. The NblA monomer has a helix-loop-helix motif which dimerizes into an open, four-helical bundle, identical to the previously determined NblA structure from Anabaena. Previous studies indicated that mutations to NblA residues near the C terminus impaired its binding to phycobilisome proteins in vitro, whereas the only mutation known to affect NblA function in vivo is located near the protein N terminus. We performed random mutagenesis of the S. elongatus nblA gene which enabled the identification of four additional amino acids crucial for NblA function in vivo. This data shows that essential amino acids are not confined to the protein termini. We also show that expression of the Anabaena nblA gene complements phycobilisome degradation in an S. elongatus NblA-null mutant despite the low homology between NblAs of these cyanobacteria. We propose that the NblA interacts with the phycobilisome via "structural mimicry" due to similarity in structural motifs found in all phycobiliproteins. This suggestion leads to a new model for the mode of NblA action which involves the entire NblA protein.	[Sendersky, Eleonora; Schwarz, Rakefet] Bar Ilan Univ, Mina & Everard Goodman Fac Life Sci, IL-52900 Ramat Gan, Israel; [Dines, Monica; David, Liron; Adir, Noam] Technion Israel Inst Technol, Schulich Fac Chem, IL-32000 Technion, Haifa, Israel; [Dines, Monica; David, Liron; Adir, Noam] Technion Israel Inst Technol, Inst Catalysis Sci & Technol, IL-32000 Technion, Haifa, Israel	Bar Ilan University; Technion Israel Institute of Technology; Technion Israel Institute of Technology	Schwarz, R (corresponding author), Bar Ilan Univ, Mina & Everard Goodman Fac Life Sci, IL-52900 Ramat Gan, Israel.	schwarr2@mail.biu.ac.il; nadir@tx.technion.ac.il	Adir, Noam/ABE-6990-2020		Israel Science Foundation [1045/06, 683/03-17.1]; German Israel Foundation [I-729-27.9/2002]	Israel Science Foundation(Israel Science Foundation); German Israel Foundation(German-Israeli Foundation for Scientific Research and Development)	This work was supported by the Israel Science Foundation founded by the Israel Academy of Sciences and Humanities (Grants 1045/06 and 683/03-17.1 (to N. A. and R. S., respectively) and German Israel Foundation Grant I-729-27.9/2002 (to R. S.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Adir N, 2005, PHOTOSYNTH RES, V85, P15, DOI 10.1007/s11120-004-2143-y; Adir N, 2002, BBA-BIOENERGETICS, V1556, P168, DOI 10.1016/S0005-2728(02)00359-6; Adir N, 2001, J MOL BIOL, V313, P71, DOI 10.1006/jmbi.2001.5030; ADIR N, 2006, MICROBIOLOGY MONOGRA, P47; APT KE, 1995, J MOL BIOL, V248, P79, DOI 10.1006/jmbi.1995.0203; Baier K, 2004, MICROBIOL-SGM, V150, P2739, DOI 10.1099/mic.0.27153-0; Baier K, 2001, FEMS MICROBIOL LETT, V195, P35, DOI 10.1111/j.1574-6968.2001.tb10494.x; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bienert R, 2006, J BIOL CHEM, V281, P5216, DOI 10.1074/jbc.M507243200; BREJC K, 1995, J MOL BIOL, V249, P424, DOI 10.1006/jmbi.1995.0307; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; COLLIER JL, 1992, J BACTERIOL, V174, P4718, DOI 10.1128/JB.174.14.4718-4726.1992; Contreras-Martel C, 2001, ACTA CRYSTALLOGR D, V57, P52, DOI 10.1107/S0907444900015274; de Alda JAGO, 2004, MICROBIOL-SGM, V150, P1377, DOI 10.1099/mic.0.26992-0; Dines M, 2007, J STRUCT BIOL, V158, P116, DOI 10.1016/j.jsb.2006.10.021; Dolganov N, 1999, J BACTERIOL, V181, P610, DOI 10.1128/JB.181.2.610-617.1999; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FICNER R, 1992, J MOL BIOL, V228, P935, DOI 10.1016/0022-2836(92)90876-L; GLAZER AN, 1989, J BIOL CHEM, V264, P1; GROSSMAN AR, 1993, MICROBIOL REV, V57, P725, DOI 10.1128/MMBR.57.3.725-749.1993; Lahmi R, 2006, J BACTERIOL, V188, P5258, DOI 10.1128/JB.00209-06; Leslie AGW, 1992, JOINT CCP4 ESF EAMCB, V26; Li H, 2002, ARCH MICROBIOL, V178, P256, DOI 10.1007/s00203-002-0446-y; Liu LN, 2005, BBA-BIOENERGETICS, V1708, P133, DOI 10.1016/j.bbabio.2005.04.001; Luque I, 2003, MOL MICROBIOL, V50, P1043, DOI 10.1046/j.1365-2958.2003.03768.x; MacColl R, 1998, J STRUCT BIOL, V124, P311, DOI 10.1006/jsbi.1998.4062; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; MCREE DE, 1999, PRACTICAL PROTEIN CH, P2; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; OTWINOWSKI Z, 1993, DATA COLLECTION PROC; Parbel A, 2000, INT J PHOTOENERGY, V2, P31, DOI 10.1155/S1110662X00000052; Perelman A, 2004, BIOTECHNIQUES, V36, P948, DOI 10.2144/04366BM05; Reuter W, 1999, P NATL ACAD SCI USA, V96, P1363, DOI 10.1073/pnas.96.4.1363; Richaud C, 2001, J BACTERIOL, V183, P2989, DOI 10.1128/JB.183.10.2989-2994.2001; Ritter S, 1999, J STRUCT BIOL, V126, P86, DOI 10.1006/jsbi.1999.4106; Schmidt M, 2006, BBA-PROTEINS PROTEOM, V1764, P55, DOI 10.1016/j.bbapap.2005.10.022; Schuermann JP, 2003, ACTA CRYSTALLOGR D, V59, P1731, DOI 10.1107/S0907444903015725; Schwarz R, 1998, P NATL ACAD SCI USA, V95, P11008, DOI 10.1073/pnas.95.18.11008; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; Sendersky E, 2005, MOL MICROBIOL, V58, P659, DOI 10.1111/j.1365-2958.2005.04844.x; Sheldrick GM, 1998, NATO ADV SCI I C-MAT, V507, P131; Strauss H, 2002, EUR J BIOCHEM, V269, P4617, DOI 10.1046/j.1432-1033.2002.03161.x; van Waasbergen LG, 2002, J BACTERIOL, V184, P2481, DOI 10.1128/JB.184.9.2481-2490.2002; Yeates TO, 1997, METHOD ENZYMOL, V276, P344, DOI 10.1016/S0076-6879(97)76068-3	45	26	27	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 31	2008	283	44					30330	30340		10.1074/jbc.M804241200	http://dx.doi.org/10.1074/jbc.M804241200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	364WS	18718907	hybrid, Green Published			2022-12-27	WOS:000260366900077
J	Lee, JY; Mogen, JL; Chavez, A; Johnson, FB				Lee, Julia Y.; Mogen, Jonathan L.; Chavez, Alejandro; Johnson, F. Brad			Sgs1 RecQ Helicase Inhibits Survival of Saccharomyces cerevisiae Cells Lacking Telomerase and Homologous Recombination	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							WERNERS-SYNDROME GENES; LARGE DNA PALINDROME; BUDDING YEAST; GENOMIC INSTABILITY; REPLICATION FORKS; SYNDROME PROTEIN; STRAND SYNTHESIS; BLOOMS-SYNDROME; MAINTENANCE; SENESCENCE	In yeast telomerase mutants, the Sgs1 RecQ helicase slows the rate of senescence and also facilitates the appearance of certain types of survivors of critical telomere shortening via mechanisms dependent on Rad52-dependent homologous recombination (HR). Here we describe a third function for Sgs1 in telomerase-deficient cells, inhibition of survivors that grow independent of Rad52. Unlike tlc1 rad52 double mutants, which do not form survivors of telomere dysfunction, tlc1 rad52 sgs1 triple mutants readily generated survivors. After emerging from growth crisis, the triple mutants progressively lost telomeric and subtelomeric sequences, yet grew for more than 1 year. Analysis of cloned chromosome termini and of copy number changes of loci genome-wide using tiling arrays revealed terminal deletions extending up to 57 kb, as well as changes in Ty retrotransposon copy numbers. Amplification of the remaining terminal sequences generated large palindromes at some chromosome termini. Sgs1 helicase activity but not checkpoint function was essential for inhibiting the appearance of the survivors, and the continued absence of Sgs1 was required for the growth of the established survivors. Thus, in addition to facilitating the maintenance of telomere repeat sequences via HR-dependent mechanisms, a RecQ helicase can prevent the adoption of HR-independent mechanisms that stabilize chromosome termini without the use of natural telomere sequences. This provides a novel mechanism by which RecQ helicases may help maintain genome integrity and thus prevent age-related diseases and cancer.	[Lee, Julia Y.; Mogen, Jonathan L.; Chavez, Alejandro; Johnson, F. Brad] Univ Penn, Sch Med, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; [Lee, Julia Y.] St Josephs Univ, Dept Biol, Philadelphia, PA 19131 USA	University of Pennsylvania; Saint Joseph's University	Johnson, FB (corresponding author), Univ Penn, Sch Med, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA.	johnsonb@mail.med.upenn.edu			National Institutes of Health [5R01AG021521]; Ruth L. Kirschstein National Research Service Award [F32 AG22769-01]; NATIONAL INSTITUTE ON AGING [R01AG021521, F32AG022769] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ruth L. Kirschstein National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grant 5R01AG021521 (National Institute on Aging) (to F. B. J.). This work was also supported by Ruth L. Kirschstein National Research Service Award F32 AG22769-01 (to J. Y. L.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	AMBERG DC, 2005, METHODS YEAST GENETI, P43; Azam M, 2006, NUCLEIC ACIDS RES, V34, P506, DOI 10.1093/nar/gkj452; BATEMAN AJ, 1975, NATURE, V253, P379, DOI 10.1038/253379a0; Beamish H, 2002, J BIOL CHEM, V277, P30515, DOI 10.1074/jbc.M203801200; Bennett RJ, 1999, J MOL BIOL, V289, P235, DOI 10.1006/jmbi.1999.2739; Bertuch AA, 2006, CURR OPIN CELL BIOL, V18, P247, DOI 10.1016/j.ceb.2006.04.005; Bjergbaek L, 2005, EMBO J, V24, P405, DOI 10.1038/sj.emboj.7600511; Blackburn EH, 2001, CELL, V106, P661, DOI 10.1016/S0092-8674(01)00492-5; Brosh RM, 2007, NUCLEIC ACIDS RES, V35, P7527, DOI 10.1093/nar/gkm1008; Bryk M, 2001, MOL CELL BIOL, V21, P5374, DOI 10.1128/MCB.21.16.5374-5388.2001; Bucholc M, 2001, MOL CELL BIOL, V21, P6559, DOI 10.1128/MCB.21.19.6559-6573.2001; Butler DK, 1996, CELL, V87, P1115, DOI 10.1016/S0092-8674(00)81805-X; BUTLER DK, 1995, MOL CELL BIOL, V15, P7117; Callen E, 2007, CELL, V130, P63, DOI 10.1016/j.cell.2007.06.016; Campisi J, 2008, AGING CELL, V7, P281, DOI 10.1111/j.1474-9726.2008.00383.x; CAVALIER.T, 1974, NATURE, V250, P467, DOI 10.1038/250467a0; Cesare AJ, 2008, MECH AGEING DEV, V129, P99, DOI 10.1016/j.mad.2007.11.006; Chang S, 2004, NAT GENET, V36, P877, DOI 10.1038/ng1389; Cohen H, 2001, P NATL ACAD SCI USA, V98, P3174, DOI 10.1073/pnas.061579598; Crabbe L, 2004, SCIENCE, V306, P1951, DOI 10.1126/science.1103619; Crabbe L, 2007, P NATL ACAD SCI USA, V104, P2205, DOI 10.1073/pnas.0609410104; DADDA DF, 2003, NATURE, V426, P194, DOI DOI 10.1038/NATURE02118; Dionne I, 1996, P NATL ACAD SCI USA, V93, P13902, DOI 10.1073/pnas.93.24.13902; Doe CL, 2002, J BIOL CHEM, V277, P32753, DOI 10.1074/jbc.M202120200; Du XB, 2004, MOL CELL BIOL, V24, P8437, DOI 10.1128/MCB.24.19.8437-8446.2004; Fabre F, 2002, P NATL ACAD SCI USA, V99, P16887, DOI 10.1073/pnas.252652399; Forstemann K, 2000, NUCLEIC ACIDS RES, V28, P2690, DOI 10.1093/nar/28.14.2690; Frei C, 2000, GENE DEV, V14, P81; Gaskell LJ, 2007, EMBO J, V26, P1891, DOI 10.1038/sj.emboj.7601645; GERRING SL, 1991, METHOD ENZYMOL, V194, P57; Han FP, 2006, P NATL ACAD SCI USA, V103, P3238, DOI 10.1073/pnas.0509650103; Hayashi N, 2002, MOL GENET GENOMICS, V267, P806, DOI 10.1007/s00438-002-0712-3; Huang PH, 2001, CURR BIOL, V11, P125, DOI 10.1016/S0960-9822(01)00021-5; Huber MD, 2002, NUCLEIC ACIDS RES, V30, P3954, DOI 10.1093/nar/gkf530; Johnson FB, 2001, EMBO J, V20, P905, DOI 10.1093/emboj/20.4.905; Kaneko H, 1999, CLIN EXP IMMUNOL, V118, P285; Kim JM, 1998, GENOME RES, V8, P464, DOI 10.1101/gr.8.5.464; Laud PR, 2005, GENE DEV, V19, P2560, DOI 10.1101/gad.1321305; Lee JY, 2007, PLOS BIOL, V5, P1334, DOI 10.1371/journal.pbio.0050160; Lemoine FJ, 2005, CELL, V120, P587, DOI 10.1016/j.cell.2004.12.039; Lillard-Wetherell K, 2005, CANCER RES, V65, P5520, DOI 10.1158/0008-5472.CAN-05-0632; Liu CL, 2003, BMC GENOMICS, V4, DOI 10.1186/1471-2164-4-19; LUNDBLAD V, 1989, CELL, V57, P633, DOI 10.1016/0092-8674(89)90132-3; LUNDBLAD V, 1993, CELL, V73, P347, DOI 10.1016/0092-8674(93)90234-H; Maringele L, 2004, GENE DEV, V18, P2663, DOI 10.1101/gad.316504; Maringele L, 2004, GENETICS, V166, P1641, DOI 10.1534/genetics.166.4.1641; Maxwell PH, 2007, GENE DEV, V21, P3308, DOI 10.1101/gad.1604707; Maxwell PH, 2004, MOL CELL BIOL, V24, P9887, DOI 10.1128/MCB.24.22.9887-9898.2004; McVey M, 2001, GENETICS, V157, P1531; MERCHLINSKY M, 1990, J VIROL, V64, P3437, DOI 10.1128/JVI.64.7.3437-3446.1990; Moore JK, 1996, MOL CELL BIOL, V16, P2164, DOI 10.1128/mcb.16.5.2164; Morrish TA, 2007, NATURE, V446, P208, DOI 10.1038/nature05560; Mullen JR, 2000, GENETICS, V154, P1101; OLOVNIKOV AM, 1973, J THEOR BIOL, V41, P181, DOI 10.1016/0022-5193(73)90198-7; Onoda F, 2004, DNA REPAIR, V3, P1355, DOI 10.1016/j.dnarep.2004.05.008; Opresko PL, 2008, MECH AGEING DEV, V129, P79, DOI 10.1016/j.mad.2007.10.007; Opresko PL, 2004, MOL CELL, V14, P763, DOI 10.1016/j.molcel.2004.05.023; Osman F, 2007, DNA REPAIR, V6, P1004, DOI 10.1016/j.dnarep.2007.02.019; Palaniyar N, 1999, J MOL BIOL, V287, P9, DOI 10.1006/jmbi.1999.2586; Pardue ML, 2005, CHROMOSOME RES, V13, P443, DOI 10.1007/s10577-005-0993-6; POCHART P, 1993, NUCLEIC ACIDS RES, V21, P3513, DOI 10.1093/nar/21.15.3513; Qin ZJ, 2000, GENE DEV, V14, P1789; RILEY J, 1990, NUCLEIC ACIDS RES, V18, P2887, DOI 10.1093/nar/18.10.2887; Schmidt KH, 2006, MOL CELL BIOL, V26, P5406, DOI 10.1128/MCB.00161-06; Scholes DT, 2003, P NATL ACAD SCI USA, V100, P15736, DOI 10.1073/pnas.2136609100; SINGER MS, 1994, SCIENCE, V266, P404, DOI 10.1126/science.7545955; Smogorzewska A, 2004, ANNU REV BIOCHEM, V73, P177, DOI 10.1146/annurev.biochem.73.071403.160049; Stavropoulos DJ, 2002, HUM MOL GENET, V11, P3135, DOI 10.1093/hmg/11.25.3135; Takai H, 2003, CURR BIOL, V13, P1549, DOI 10.1016/S0960-9822(03)00542-6; Tanaka Hisashi, 2006, Hum Cell, V19, P17, DOI 10.1111/j.1749-0774.2005.00003.x; Tanaka H, 2007, MOL CELL BIOL, V27, P1993, DOI 10.1128/MCB.01313-06; Teng SC, 1999, MOL CELL BIOL, V19, P8083; VONZGLINICKI T, 1995, EXP CELL RES, V220, P186, DOI 10.1006/excr.1995.1305; VOYTAS DF, 2001, MOBILE DNA, V2, P631; Watt PM, 1996, GENETICS, V144, P935; Yamagata K, 1998, P NATL ACAD SCI USA, V95, P8733, DOI 10.1073/pnas.95.15.8733; Yankiwski V, 2000, P NATL ACAD SCI USA, V97, P5214, DOI 10.1073/pnas.090525897; Yu X, 1999, MOL CELL, V4, P873, DOI 10.1016/S1097-2765(00)80397-4; Zhang ZH, 2007, GENOME RES, V17, P503, DOI 10.1101/gr.6049107	79	20	20	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 31	2008	283	44					29847	29858		10.1074/jbc.M804760200	http://dx.doi.org/10.1074/jbc.M804760200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	364WS	18757364	Green Published, hybrid			2022-12-27	WOS:000260366900029
J	Sanders, C; Turkarslan, S; Lee, DW; Onder, O; Kranz, RG; Daldal, F				Sanders, Carsten; Turkarslan, Serdar; Lee, Dong-Woo; Onder, Ozlem; Kranz, Robert G.; Daldal, Fevzi			The Cytochrome c Maturation Components CcmF, CcmH, and CcmI Form a Membrane-integral Multisubunit Heme Ligation Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RHODOBACTER-CAPSULATUS; RHODOPSEUDOMONAS-CAPSULATA; APOCYTOCHROME-C; PHOTOSYNTHETIC GROWTH; BIOGENESIS DEFECT; NULL MUTANTS; PROTEIN; SPHAEROIDES; PATHWAY; MITOCHONDRIA	Cytochrome c maturation (Ccm) is a post-translational and post-export protein modification process that involves ten (CcmABCDEFGHI and CcdA or DsbD) components in most Gram-negative bacteria. The absence of any of these components abolishes the ability of cells to form cytochrome c, leading in the case of Rhodobacter capsulatus to the loss of photosynthetic proficiency and respiratory cytochrome oxidase activity. Based on earlier molecular genetic studies, we inferred that R. capsulatus CcmF, CcmH, and CcmI interact with each other to perform heme-apocytochrome c ligation. Here, using functional epitope-tagged derivatives of these components coproduced in appropriate mutant strains, we determined protein-protein interactions between them in detergent-dispersed membranes. Reciprocal affinity purification as well as tandem size exclusion and affinity chromatography analyses provided the first biochemical evidence that CcmF, CcmH, and CcmI associate stably with each other, indicating that these Ccm components form a membrane-integral complex. Under the conditions used, the CcmFHI complex does not contain CcmG, suggesting that the latter thio-reduction component is not always associated with the heme ligation components. The findings are discussed with respect to defining the obligatory components of a minimalistic heme-apocytochrome c ligation complex in R. capsulatus.	[Sanders, Carsten; Turkarslan, Serdar; Lee, Dong-Woo; Onder, Ozlem; Daldal, Fevzi] Univ Penn, Dept Biol, Philadelphia, PA 19104 USA; [Kranz, Robert G.] Washington Univ, Dept Biol, St Louis, MO 63130 USA	University of Pennsylvania; Washington University (WUSTL)	Daldal, F (corresponding author), 433 S Univ Ave 103B Lynch Bldg, Philadelphia, PA 19104 USA.	fdaldal@sas.upenn.edu	Onder, Ozlem/AAA-5301-2020	Onder, Ozlem/0000-0003-0850-1216	National Institutes of Health [GM38237, GM47909]; Department of Energy [91ER20052]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM047909, R01GM038237, R55GM047909] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Energy(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	fThis work was supported, in whole or in part, by National Institutes of Health Grant GM38237 (to F. D.) and GM47909 (to R. G. K.). This work was also supported by Department of Energy Grant 91ER20052 (to F. D.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; BENNING C, 1992, J BACTERIOL, V174, P2352, DOI 10.1128/JB.174.7.2352-2360.1992; Blatch GL, 1999, BIOESSAYS, V21, P932, DOI 10.1002/(SICI)1521-1878(199911)21:11<932::AID-BIES5>3.0.CO;2-N; Collet JF, 2002, MOL MICROBIOL, V44, P1, DOI 10.1046/j.1365-2958.2002.02851.x; DALDAL F, 1986, P NATL ACAD SCI USA, V83, P2012, DOI 10.1073/pnas.83.7.2012; Deshmukh M, 2003, J BACTERIOL, V185, P3361, DOI 10.1128/JB.185.11.3361-3372.2003; Deshmukh M, 2002, MOL MICROBIOL, V46, P1069, DOI 10.1046/j.1365-2958.2002.03212.x; Di Matteo A, 2007, J BIOL CHEM, V282, P27012, DOI 10.1074/jbc.M702702200; DITTA G, 1985, PLASMID, V13, P149, DOI 10.1016/0147-619X(85)90068-X; Erlendsson LS, 2003, J BIOL CHEM, V278, P17852, DOI 10.1074/jbc.M300103200; Erlendsson LS, 2002, J BACTERIOL, V184, P1423, DOI 10.1128/JB.184.5.1423-1429.2002; Fabianek RA, 1999, ARCH MICROBIOL, V171, P92, DOI 10.1007/s002030050683; Feissner RE, 2006, MOL MICROBIOL, V61, P219, DOI 10.1111/j.1365-2958.2006.05221.x; Giege P, 2004, FEBS LETT, V563, P165, DOI 10.1016/S0014-5793(04)00291-1; Goldman BS, 1998, P NATL ACAD SCI USA, V95, P5003, DOI 10.1073/pnas.95.9.5003; Han D, 2008, PROTEINS, V70, P900, DOI 10.1002/prot.21597; JENNEY FE, 1993, EMBO J, V12, P1283, DOI 10.1002/j.1460-2075.1993.tb05773.x; Kadokura H, 2003, ANNU REV BIOCHEM, V72, P111, DOI 10.1146/annurev.biochem.72.121801.161459; KEEN NT, 1988, GENE, V70, P1991; Koch HG, 1998, METHOD ENZYMOL, V297, P81; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lang SE, 1996, J BACTERIOL, V178, P5279, DOI 10.1128/jb.178.17.5279-5290.1996; Lee JH, 2007, BBA-BIOMEMBRANES, V1768, P2164, DOI 10.1016/j.bbamem.2007.04.022; Meyer EH, 2005, P NATL ACAD SCI USA, V102, P16113, DOI 10.1073/pnas.0503473102; Monika EM, 1997, J MOL BIOL, V271, P679, DOI 10.1006/jmbi.1997.1227; Myllykallio H, 1999, P NATL ACAD SCI USA, V96, P4348, DOI 10.1073/pnas.96.8.4348; Pettigrew G.W., 1987, CYTOCHROMES C BIOL A; Ren Q, 2002, J BIOL CHEM, V277, P7657, DOI 10.1074/jbc.M110979200; Sambrook J., 2001, MOL CLONING LAB MANU; Sanders C, 2005, J BACTERIOL, V187, P4245, DOI 10.1128/JB.187.12.4245-4256.2005; Sanders C, 2001, MOL MICROBIOL, V41, P241, DOI 10.1046/j.1365-2958.2001.02514.x; SANDERS C, 2008, PURPLE PHOTOTROPHIC, P407; SANDERS C, 2005, PHOTOSYNTHESIS FUNDA, P421; Sanders C, 2007, J BACTERIOL, V189, P789, DOI 10.1128/JB.01441-06; SCOLNIK PA, 1980, J BIOL CHEM, V255, P2427; SISTROM WR, 1960, J GEN MICROBIOL, V22, P778, DOI 10.1099/00221287-22-3-778; Turkarslan S, 2006, MOL MICROBIOL, V60, P537, DOI 10.1111/j.1365-2958.2006.05148.x; Turkarslan S, 2008, MOL MICROBIOL, V70, P652, DOI 10.1111/j.1365-2958.2008.06441.x; YEN HC, 1979, J MOL BIOL, V131, P157, DOI 10.1016/0022-2836(79)90071-8	39	35	35	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 31	2008	283	44					29715	29722		10.1074/jbc.M805413200	http://dx.doi.org/10.1074/jbc.M805413200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	364WS	18753134	hybrid, Green Published			2022-12-27	WOS:000260366900015
J	Bocharov, EV; Mayzel, ML; Volynsky, PE; Goncharuk, MV; Ermolyuk, YS; Schulga, AA; Artemenko, EO; Efremov, RG; Arseniev, AS				Bocharov, Eduard V.; Mayzel, Maxim L.; Volynsky, Pavel E.; Goncharuk, Marina V.; Ermolyuk, Yaroslav S.; Schulga, Alexey A.; Artemenko, Elena O.; Efremov, Roman G.; Arseniev, Alexander S.			Spatial Structure and pH-dependent Conformational Diversity of Dimeric Transmembrane Domain of the Receptor Tyrosine Kinase EphA1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR RECEPTOR; HUMAN SKIN; PROTEIN; ACTIVATION; EXPRESSION; HYPOXIA; EPHRINS; STABILITY; SEQUENCE; BICELLES	Eph receptors are found in a wide variety of cells in developing and mature tissues and represent the largest family of receptor tyrosine kinases, regulating cell shape, movements, and attachment. The receptor tyrosine kinases conduct biochemical signals across plasma membrane via lateral dimerization in which their transmembrane domains play an important role. Structural-dynamic properties of the homodimeric transmembrane domain of the EphA1 receptor were investigated with the aid of solution NMR in lipid bicelles and molecular dynamics in explicit lipid bilayer. EphA1 transmembrane segments associate in a right-handed parallel alpha-helical bundle, region (544-569)(2), through the N-terminal glycine zipper motif A(550)X(3)G(554)X(3)G(558). Under acidic conditions, the N terminus of the transmembrane helix is stabilized by an N-capping box formed by the uncharged carboxyl group of Glu(547), whereas its deprotonation results in a rearrangement of hydrogen bonds, fractional unfolding of the helix, and a realignment of the helix-helix packing with appearance of additional minor dimer conformation utilizing seemingly the C-terminal GG4-like dimerization motif A(560)X(3)G(564). This can be interpreted as the ability of the EphA1 receptor to adjust its response to ligand binding according to extracellular pH. The dependence of the pK(a) value of Glu(547) and the dimer conformational equilibrium on the lipid head charge suggests that both local environment and membrane surface potential can modulate dimerization and activation of the receptor. This makes the EphA1 receptor unique among the Eph family, implying its possible physiological role as an "extracellular pH sensor," and can have relevant physiological implications.	[Bocharov, Eduard V.; Mayzel, Maxim L.; Volynsky, Pavel E.; Artemenko, Elena O.; Efremov, Roman G.; Arseniev, Alexander S.] Russian Acad Sci, Shemyakin Ovchinnikov Inst Bioorgan Chem, Div Struct Biol, Moscow 117997, Russia; [Goncharuk, Marina V.; Ermolyuk, Yaroslav S.; Schulga, Alexey A.] Russian Acad Sci, Shemyakin Ovchinnikov Inst Bioorgan Chem, Lab Prot Engn, Moscow 117997, Russia	Russian Academy of Sciences; Pushchino Scientific Center for Biological Research (PSCBI) of the Russian Academy of Sciences; Institute of Bioorganic Chemistry of the Russian Academy of Sciences; Russian Academy of Sciences; Pushchino Scientific Center for Biological Research (PSCBI) of the Russian Academy of Sciences; Institute of Bioorganic Chemistry of the Russian Academy of Sciences	Bocharov, EV (corresponding author), Russian Acad Sci, Shemyakin Ovchinnikov Inst Bioorgan Chem, Div Struct Biol, Ul Miklukho Maklaya 16-10, Moscow 117997, Russia.	bon@nmr.ru; aars@nmr.ru	Volynsky, Pavel/A-8360-2014; Mayzel, Maksim/AAM-1393-2020; Goncharuk, Marina/V-1558-2018; Schulga, Alexey/T-3856-2018; Roman, Efremov/A-7460-2014	Volynsky, Pavel/0000-0002-0471-4188; Schulga, Alexey/0000-0003-3425-0828; Roman, Efremov/0000-0002-5474-4721	Russian Foundation for Basic Research [06-04-49740, 07-04-01514, 08-04-01372]; Russian Federation Federal Agency for Science and Innovations [02.512.12.0019]; Russian Funds Investment Group	Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); Russian Federation Federal Agency for Science and Innovations(Federal Agency for Science & Innovations (FASI)); Russian Funds Investment Group	This work was supported by the Russian Foundation for Basic Research (Grant 06-04-49740 and in part by Grants 07-04-01514 and 08-04-01372), the Russian Federation Federal Agency for Science and Innovations (State Contract 02.512.12.0019), and the Russian Funds Investment Group. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Aasheim HC, 2005, BLOOD, V105, P2869, DOI 10.1182/blood-2004-08-2981; [Anonymous], 1997, Cell, V90, P403; ARSENIEV AS, 1984, FEBS LETT, V165, P57, DOI 10.1016/0014-5793(84)80014-9; Artemenko EO, 2008, BBA-BIOMEMBRANES, V1778, P2361, DOI 10.1016/j.bbamem.2008.06.003; BAKER EN, 1984, PROG BIOPHYS MOL BIO, V44, P97, DOI 10.1016/0079-6107(84)90007-5; Bocharov EV, 2008, J BIOL CHEM, V283, P6950, DOI 10.1074/jbc.M709202200; Bocharov EV, 2007, J BIOL CHEM, V282, P16256, DOI 10.1074/jbc.M701745200; Bocharov EV, 2002, J BIOL CHEM, V277, P46273, DOI 10.1074/jbc.M206274200; Cavanagh J, 2007, PROTEIN NMR SPECTROSCOPY: PRINCIPLES AND PRACTICE, 2ND EDITION, P1; CHAKRABARTI P, 1975, BIOCHEMISTRY-US, V14, P5021, DOI 10.1021/bi00694a001; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; Coulthard MG, 2001, GROWTH FACTORS, V18, P303, DOI 10.3109/08977190109029118; Daragan VA, 1997, PROG NUCL MAG RES SP, V31, P63, DOI 10.1016/S0079-6565(97)00006-X; DeLano W.L, PYMOL MOL GRAPHICS S; Doig AJ, 2002, BIOPHYS CHEM, V101, P281, DOI 10.1016/S0301-4622(02)00170-9; EFREMOV RG, 1995, J PHYS CHEM-US, V99, P10658, DOI 10.1021/j100026a033; Fleishman SJ, 2002, P NATL ACAD SCI USA, V99, P15937, DOI 10.1073/pnas.252640799; Fonseca NA, 2008, PROTEINS, V70, P188, DOI 10.1002/prot.21525; Gauthier LR, 2003, LIFE SCI, V74, P207, DOI 10.1016/j.lfs.2003.09.029; Gerlai R, 2001, NAT REV NEUROSCI, V2, P205, DOI 10.1038/35058582; Guntert P, 2003, PROG NUCL MAG RES SP, V43, P105, DOI 10.1016/S0079-6565(03)00021-9; Hafner C, 2006, MODERN PATHOL, V19, P1369, DOI 10.1038/modpathol.3800660; Halloran MC, 2006, CURR OPIN CELL BIOL, V18, P533, DOI 10.1016/j.ceb.2006.08.010; Himanen JP, 2007, CURR OPIN CELL BIOL, V19, P534, DOI 10.1016/j.ceb.2007.08.004; HIRAI H, 1987, SCIENCE, V238, P1717, DOI 10.1126/science.2825356; Hofmann K., 1993, BIOL CHEM H-S, V374, P166, DOI DOI 10.1515/BCHM3.1993.374.1-6.143; Iqbalsyah TM, 2004, PROTEIN SCI, V13, P32, DOI 10.1110/ps.03341804; Ivanov AI, 2006, IUBMB LIFE, V58, P389, DOI 10.1080/15216540600756004; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Kellum JA, 2004, CRIT CARE, V8, P331, DOI 10.1186/cc2900; Kim S, 2005, P NATL ACAD SCI USA, V102, P14278, DOI 10.1073/pnas.0501234102; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Kullander K, 2002, NAT REV MOL CELL BIO, V3, P475, DOI 10.1038/nrm856; Lackmann M, 2008, SCI SIGNAL, V1, DOI 10.1126/stke.115re2; Langosch D, 1998, PROTEINS, V31, P150, DOI 10.1002/(SICI)1097-0134(19980501)31:2<150::AID-PROT5>3.0.CO;2-Q; Lardner A, 2001, J LEUKOCYTE BIOL, V69, P522; Li E, 2006, BIOCHEMISTRY-US, V45, P6241, DOI 10.1021/bi060609y; Liao D, 2007, CANCER METAST REV, V26, P281, DOI 10.1007/s10555-007-9066-y; Lindahl E, 2001, J MOL MODEL, V7, P306, DOI 10.1007/s008940100045; MacKenzie KR, 2006, CHEM REV, V106, P1931, DOI 10.1021/cr0404388; MacKenzie KR, 1997, SCIENCE, V276, P131, DOI 10.1126/science.276.5309.131; MARKLEY JL, 1975, ACCOUNTS CHEM RES, V8, P70, DOI 10.1021/ar50086a004; Masuda J, 2008, J BIOL CHEM, V283, P13148, DOI 10.1074/jbc.M702164200; Moriki T, 2001, J MOL BIOL, V311, P1011, DOI 10.1006/jmbi.2001.4923; Murai KK, 2002, NEURON, V33, P159, DOI 10.1016/S0896-6273(02)00565-2; Orekhov VY, 1995, APPL MAGN RESON, V9, P581, DOI 10.1007/BF03162365; Pabbisetty KB, 2007, PROTEIN SCI, V16, P355, DOI 10.1110/ps.062608807; Palmer MJ, 2003, J NEUROSCI, V23, P11332; Pasquale EB, 2005, NAT REV MOL CELL BIO, V6, P462, DOI 10.1038/nrm1662; Prosser RS, 2006, BIOCHEMISTRY-US, V45, P8453, DOI 10.1021/bi060615u; Raghunand N, 2003, BRIT J RADIOL, V76, pS11, DOI 10.1259/bjr/12913493; Sattler M, 1999, PROG NUCL MAG RES SP, V34, P93, DOI 10.1016/S0079-6565(98)00025-9; Schlessinger J, 2000, CELL, V103, P211, DOI 10.1016/j.cell.2010.06.011; Schmid-Wendtner MH, 2006, SKIN PHARMACOL PHYS, V19, P296, DOI 10.1159/000094670; Smith SO, 1996, NAT STRUCT BIOL, V3, P252, DOI 10.1038/nsb0396-252; Struppe J, 2000, BIOPHYS J, V78, P281, DOI 10.1016/S0006-3495(00)76591-X; Stubbs M, 2000, MOL MED TODAY, V6, P15, DOI 10.1016/S1357-4310(99)01615-9; Surawska H, 2004, CYTOKINE GROWTH F R, V15, P419, DOI 10.1016/j.cytogfr.2004.09.002; SZYPERSKI T, 1994, BIOCHEMISTRY-US, V33, P9303, DOI 10.1021/bi00197a034; Vearing CJ, 2005, GROWTH FACTORS, V23, P67, DOI 10.1080/08977190500055869; Vihanto MM, 2005, FASEB J, V19, P1689, DOI 10.1096/fj.04-3647fje; WAGNER G, 1983, J AM CHEM SOC, V105, P5948, DOI 10.1021/ja00356a056; Wagner H, 2003, EUR J PHARM BIOPHARM, V55, P57, DOI 10.1016/S0939-6411(02)00125-X; Wimmer-Kleikamp SH, 2004, J CELL BIOL, V164, P661, DOI 10.1083/jcb.200312001; Xu K, 2006, J APPL PHYSIOL, V100, P725, DOI 10.1152/japplphysiol.00940.2005; Zhu HJ, 2003, GROWTH FACTORS, V21, P15, DOI 10.1080/0897719031000096424; Zwahlen C, 1997, J AM CHEM SOC, V119, P6711, DOI 10.1021/ja970224q	67	93	95	2	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 24	2008	283	43					29385	29395		10.1074/jbc.M803089200	http://dx.doi.org/10.1074/jbc.M803089200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	362EB	18728013	Green Published, hybrid			2022-12-27	WOS:000260179900065
J	Flannery, AR; Stevens, TH				Flannery, Andrew R.; Stevens, Tom H.			Functional Characterization of the N-terminal Domain of Subunit H (Vma13p) of the Yeast Vacuolar ATPase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLECULAR CHARACTERIZATION; MUTATIONAL ANALYSIS; PROTON PUMPS; ACIDIFICATION; MEMBRANE; ENCODES; COMPLEX; CELLS; PCR	The yeast Saccharomyces cerevisiae vacuolar H+-ATPase (V-ATPase) is a multisubunit complex responsible for acidifying intracellular organelles and is highly regulated. One of the regulatory subunits, subunit H, is encoded by the VMA13 gene in yeast and is composed of two domains, the N-terminal domain (amino acids (aa) 1-352) and the C-terminal domain (aa 353 478). The N-terminal domain is required for the activation of the complex, whereas the C-terminal domain is required for coupling ATP hydrolysis to proton translocation (Liu, M., Tarsio, M., Charsky, C. M., and Kane, P. M. (2005) J. Biol. Chem. 280, 36978-36985). Experiments with epitope-tagged copies of Vma13p revealed that there is only one copy of Vma13p/subunit H per V-ATPase complex. Analysis of the N-terminal domain shows that the first 179 amino acids are not required for the activation and full function of the V-ATPase complex and that the minimal region of Vma13p/subunit H capable of activating the V-ATPase is aa 180-353 of the N-terminal domain. Subunit H is expressed as two splice variants in mammals, and deletion of 18 amino acids in yeast Vma13p corresponding to the mammalian subunit H beta isoform results in reduced V-ATPase activity and significantly lower coupling of ATPase hydrolysis to proton translocation. Intriguingly, the yeast Vma13p mimicking the mammalian subunit H beta isoform is functionally equivalent to Vma13p lacking the entire C-terminal domain. These results suggest that the mammalian V-ATPase complexes with subunit H splice variant SFD-alpha or SFD-beta are likely to have different activities and may perform distinct cellular functions.	[Stevens, Tom H.] Univ Oregon, Dept Chem, Eugene, OR 97403 USA; [Stevens, Tom H.] Univ Oregon, Inst Mol Biol, Eugene, OR 97403 USA; [Flannery, Andrew R.] Yale Univ, Sch Med, Sect Microbial Pathogenesis, New Haven, CT 06536 USA	University of Oregon; University of Oregon; Yale University	Stevens, TH (corresponding author), Univ Oregon, Dept Chem, Eugene, OR 97403 USA.	stevens@molbio.uoregon.edu		Stevens, Tom/0000-0001-6427-6848	National Institutes of Health [GM38006];  [5 T32 GM007759-30]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007759, R01GM038006] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM38006 (to T. H. S.) and Training Grant 5 T32 GM007759-30 (to A. R. F.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Bowers K, 2000, MOL BIOL CELL, V11, P4277, DOI 10.1091/mbc.11.12.4277; Conibear E, 2002, METHOD ENZYMOL, V351, P408; Conibear E, 2000, MOL BIOL CELL, V11, P305, DOI 10.1091/mbc.11.1.305; Curtis KK, 2002, J BIOL CHEM, V277, P8979, DOI 10.1074/jbc.M111708200; Davis-Kaplan SR, 2006, J BIOL CHEM, V281, P32025, DOI 10.1074/jbc.M606451200; FENG Y, 1992, J BIOL CHEM, V267, P5817; Flannery AR, 2004, J BIOL CHEM, V279, P39856, DOI 10.1074/jbc.M406767200; Forgac M, 2007, NAT REV MOL CELL BIO, V8, P917, DOI 10.1038/nrm2272; Graham LA, 2003, J BIOENERG BIOMEMBR, V35, P301, DOI 10.1023/A:1025772730586; Groves MR, 1999, CURR OPIN STRUC BIOL, V9, P383, DOI 10.1016/S0959-440X(99)80052-9; HO MN, 1993, J BIOL CHEM, V268, P18286; Hui DQ, 1999, MAMM GENOME, V10, P266, DOI 10.1007/s003359900984; ITO H, 1983, J BACTERIOL, V153, P163, DOI 10.1128/JB.153.1.163-168.1983; Jefferies KC, 2008, J BIOL CHEM, V283, P4512, DOI 10.1074/jbc.M707144200; Kane PA, 2006, MICROBIOL MOL BIOL R, V70, P177, DOI 10.1128/MMBR.70.1.177-191.2006; Kitagawa N, 2008, J BIOL CHEM, V283, P3329, DOI 10.1074/jbc.M707924200; Liu JZ, 1996, BIOCHEMISTRY-US, V35, P10938, DOI 10.1021/bi9608065; Liu ML, 2005, J BIOL CHEM, V280, P36978, DOI 10.1074/jbc.M505296200; MARKWELL MAK, 1978, ANAL BIOCHEM, V87, P206, DOI 10.1016/0003-2697(78)90586-9; NOTHWEHR SF, 1995, J CELL BIOL, V129, P35, DOI 10.1083/jcb.129.1.35; Parra KJ, 2000, J BIOL CHEM, V275, P21761, DOI 10.1074/jbc.M002305200; Powell B, 2000, J BIOL CHEM, V275, P23654, DOI 10.1074/jbc.M004440200; Rizzo JM, 2007, J BIOL CHEM, V282, P8521, DOI 10.1074/jbc.M607092200; Sagermann M, 2001, P NATL ACAD SCI USA, V98, P7134, DOI 10.1073/pnas.131192798; SIKORSKI RS, 1989, GENETICS, V122, P19; Smith AN, 2005, J AM SOC NEPHROL, V16, P1245, DOI 10.1681/ASN.2004090761; Sun-Wada GH, 2003, J BIOENERG BIOMEMBR, V35, P347, DOI 10.1023/A:1025780932403; UCHIDA E, 1985, J BIOL CHEM, V260, P1090; WACH A, 1994, YEAST, V10, P1793, DOI 10.1002/yea.320101310; XIE XS, 1994, J BIOL CHEM, V269, P25809; Xu YF, 1999, BIOTECHNIQUES, V26, P639, DOI 10.2144/99264bm10; Zhou ZM, 1999, J BIOL CHEM, V274, P15913, DOI 10.1074/jbc.274.22.15913; Zhou ZM, 1998, J BIOL CHEM, V273, P5878, DOI 10.1074/jbc.273.10.5878	33	9	9	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 24	2008	283	43					29099	29108		10.1074/jbc.M803280200	http://dx.doi.org/10.1074/jbc.M803280200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	362EB	18708638	Green Published, hybrid			2022-12-27	WOS:000260179900037
J	Grimsey, N; Han, GS; O'Hara, L; Rochford, JJ; Carman, GM; Siniossoglou, S				Grimsey, Neil; Han, Gil-Soo; O'Hara, Laura; Rochford, Justin J.; Carman, George M.; Siniossoglou, Symeon			Temporal and Spatial Regulation of the Phosphatidate Phosphatases Lipin 1 and 2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHOLIPID BIOSYNTHESIS; ADIPOCYTE DIFFERENTIATION; SUBCELLULAR-LOCALIZATION; GENE; LIPODYSTROPHY; EXPRESSION; ADIPOGENESIS; BIOGENESIS; PROTEINS; PATHWAY	Lipins are the founding members of a novel family of Mg2+-dependent phosphatidate phosphatases (PAP1 enzymes) that play key roles in fat metabolism and lipid biosynthesis. Despite their importance, there is still little information on how their activity is regulated. Here we demonstrate that the functions of lipin 1 and 2 are evolutionarily conserved from unicellular eukaryotes to mammals. The two lipins display distinct intracellular localization in HeLa M cells, with a pool of lipin 2 exhibiting a tight membrane association. Small interfering RNA-mediated silencing of lipin 1 leads to a dramatic decrease of the cellular PAP1 activity in HeLaM cells, whereas silencing of lipin 2 leads to an increase of lipin 1 levels and PAP1 activity. Consistent with their distinct functions in HeLa M cells, lipin 1 and 2 exhibit reciprocal patterns of protein expression in differentiating 3T3-L1 adipocytes. Lipin 2 levels increase in lipin 1-depleted 3T3-L1 cells without rescuing the adipogenic defects, whereas depletion of lipin 2 does not inhibit adipogenesis. Finally, we show that the PAP1 activity of both lipins is inhibited by phosphorylation during mitosis, leading to a decrease in the cellular PAP1 activity during cell division. We propose that distinct and non-redundant functions of lipin 1 and 2 regulate lipid production during the cell cycle and adipocyte differentiation.	[Grimsey, Neil; O'Hara, Laura; Siniossoglou, Symeon] Univ Cambridge, Cambridge Inst Med Res, Cambridge CB2 0XY, England; [Han, Gil-Soo; Carman, George M.] Rutgers State Univ, Dept Food Sci, New Brunswick, NJ 08901 USA; [Han, Gil-Soo; Carman, George M.] Rutgers State Univ, Rutgers Ctr Lipid Res, New Brunswick, NJ 08901 USA; [Rochford, Justin J.] Univ Cambridge, Dept Clin Biochem, Cambridge CB2 2QR, England	University of Cambridge; Rutgers State University New Brunswick; Rutgers State University New Brunswick; University of Cambridge	Siniossoglou, S (corresponding author), Univ Cambridge, Cambridge Inst Med Res, Wellcome Trust MRC Bldg,Hills Rd, Cambridge CB2 0XY, England.	ss560@cam.ac.uk	Grimsey, Neil/B-1634-2015; Grimsey, Neil/AAB-9153-2020	Grimsey, Neil/0000-0002-0481-4920; Grimsey, Neil/0000-0002-0481-4920; O'Hara, Laura/0000-0001-7790-9261; Rochford, Justin/0000-0002-5020-4939	National Institutes of Health [GM-28140]; Wellcome Trust; United States Public Health Service; British Heart Foundation; MRC [G0701446] Funding Source: UKRI; Medical Research Council [G0701446] Funding Source: researchfish; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM028140, R37GM028140] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wellcome Trust(Wellcome TrustEuropean Commission); United States Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); British Heart Foundation(British Heart Foundation); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM-28140 (to G. M. C.). This work was also supported by a Wellcome Trust career development fellowship (to S. S.), by the United States Public Health Service, and by a British Heart Foundation intermediate fellowship (to J. J. R.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Athenstaedt K, 2006, CELL MOL LIFE SCI, V63, P1355, DOI 10.1007/s00018-006-6016-8; Brindley DN, 2004, J CELL BIOCHEM, V92, P900, DOI 10.1002/jcb.20126; Coleman RA, 2004, PROG LIPID RES, V43, P134, DOI 10.1016/S0163-7827(03)00051-1; DAVIS FM, 1983, P NATL ACAD SCI-BIOL, V80, P2926, DOI 10.1073/pnas.80.10.2926; Donkor J, 2007, J BIOL CHEM, V282, P3450, DOI 10.1074/jbc.M610745200; Fagone P, 2007, J BIOL CHEM, V282, P7591, DOI 10.1074/jbc.M608175200; Finck BN, 2006, CELL METAB, V4, P199, DOI 10.1016/j.cmet.2006.08.005; GOMEZMUNOZ A, 1992, FEBS LETT, V301, P103, DOI 10.1016/0014-5793(92)80219-7; Han GS, 2006, J BIOL CHEM, V281, P9210, DOI 10.1074/jbc.M600425200; Harris TE, 2007, J BIOL CHEM, V282, P277, DOI 10.1074/jbc.M609537200; JACKOWSKI S, 1994, J BIOL CHEM, V269, P3858; Kim YJ, 2007, P NATL ACAD SCI USA, V104, P6596, DOI 10.1073/pnas.0702099104; Lykidis A, 2001, PROG NUCLEIC ACID RE, V65, P361; Payne VA, 2008, DIABETES, V57, P2055, DOI 10.2337/db08-0184; Peterfy M, 2005, J BIOL CHEM, V280, P32883, DOI 10.1074/jbc.M503885200; Peterfy M, 2001, NAT GENET, V27, P121, DOI 10.1038/83685; Phan J, 2005, CELL METAB, V1, P73, DOI 10.1016/j.cmet.2004.12.002; Rochford JJ, 2004, MOL CELL BIOL, V24, P9863, DOI 10.1128/MCB.24.22.9863-9872.2004; Rosen ED, 2006, NAT REV MOL CELL BIO, V7, P885, DOI 10.1038/nrm2066; Santos-Rosa H, 2005, EMBO J, V24, P1931, DOI 10.1038/sj.emboj.7600672; Siniossoglou S, 1998, EMBO J, V17, P6449, DOI 10.1093/emboj/17.22.6449; Sriburi R, 2007, J BIOL CHEM, V282, P7024, DOI 10.1074/jbc.M609490200; van Meer G, 2008, NAT REV MOL CELL BIO, V9, P112, DOI 10.1038/nrm2330; WALTON PA, 1984, BIOCHIM BIOPHYS ACTA, V796, P364, DOI 10.1016/0005-2760(84)90139-5; Wymann MP, 2008, NAT REV MOL CELL BIO, V9, P162, DOI 10.1038/nrm2335	25	85	90	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 24	2008	283	43					29166	29174		10.1074/jbc.M804278200	http://dx.doi.org/10.1074/jbc.M804278200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	362EB	18694939	Green Published, hybrid			2022-12-27	WOS:000260179900044
J	Lin, KT; Sloniowski, S; Ethell, DW; Ethell, IM				Lin, Kai-Ti; Sloniowski, Slawomir; Ethell, Douglas W.; Ethell, Iryna M.			Ephrin-B2-induced Cleavage of EphB2 Receptor Is Mediated by Matrix Metalloproteinases to Trigger Cell Repulsion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DENDRITIC SPINE MORPHOGENESIS; TYROSINE-PHOSPHATASE; R-RAS; ACTIVATION; KINASE; NOTCH; MATRIX-METALLOPROTEINASE-9; RHO; PROTEOLYSIS; ENDOCYTOSIS	EphB receptors provide crucial adhesive and repulsive signals during cell migration and axon guidance, but it is unclear how they switch between these opposing responses. Here we provide evidence of an important role for matrix metalloproteinases (MMPs) in repulsive EphB2 signaling. We found that EphB2 is cleaved by MMPs both in vitro and in vivo, and that this cleavage is induced by interaction with its ligand ephrin-B2. Our findings demonstrate that MMP-2/MMP-9-specific inhibition or cleavage-resistant mutations in the ectodomain of EphB2 can prevent EphB2-mediated cell-cell repulsion in HEK293 cells, and block ephrin-B1-induced growth cone withdrawal in cultured hippocampal neurons. Transient expression of wtEphB2, but not noncleavable EphB2-4/5 mutant, restored ephrin-B1-induced growth cone collapse and withdrawal in EphB-deficient neurons. The inhibition of EphB2 cleavage also had potent regulatory effects on EphB2 activity. This study provides the first evidence that MMP-mediated cleavage of EphB2 is induced by receptor-ligand interactions at the cell surface and that this event triggers cell-repulsive responses.	[Lin, Kai-Ti; Sloniowski, Slawomir; Ethell, Douglas W.; Ethell, Iryna M.] Univ Calif Riverside, Div Biomed Sci, Riverside, CA 92521 USA	University of California System; University of California Riverside	Ethell, IM (corresponding author), Univ Calif Riverside, Div Biomed Sci, 900 Univ Ave, Riverside, CA 92521 USA.	iryna.ethell@ucr.edu	Lin, Kai-Ti/B-3840-2016	Lin, Kai-Ti/0000-0001-8656-5755; Ethell, Iryna/0000-0002-1324-6611; Ethell, Douglas/0000-0002-9237-0265	National Institutes of Health [MH67121]; Dorothy M. Pease Fund for Cancer Research; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH067121] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Dorothy M. Pease Fund for Cancer Research; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported, in whole or in part, by National Institutes of Health Grant MH67121 (to I. E.). This work was also supported by the Dorothy M. Pease Fund for Cancer Research (to K. L.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Bilousova TV, 2006, J NEUROCHEM, V97, P44, DOI 10.1111/j.1471-4159.2006.03701.x; Cokol M, 2000, EMBO REP, V1, P411, DOI 10.1093/embo-reports/kvd092; Dail M, 2006, J CELL SCI, V119, P1244, DOI 10.1242/jcs.02842; Ethell IM, 2001, NEURON, V31, P1001, DOI 10.1016/S0896-6273(01)00440-8; Ethell IM, 2007, J NEUROSCI RES, V85, P2813, DOI 10.1002/jnr.21273; Flanagan JG, 1998, ANNU REV NEUROSCI, V21, P309, DOI 10.1146/annurev.neuro.21.1.309; Georgakopoulos A, 2006, EMBO J, V25, P1242, DOI 10.1038/sj.emboj.7601031; Gu ZZ, 2005, J NEUROSCI, V25, P6401, DOI 10.1523/JNEUROSCI.1563-05.2005; Hartmann D, 2002, HUM MOL GENET, V11, P2615, DOI 10.1093/hmg/11.21.2615; Hattori M, 2000, SCIENCE, V289, P1360, DOI 10.1126/science.289.5483.1360; Henkemeyer M, 2003, J CELL BIOL, V163, P1313, DOI 10.1083/jcb.200306033; Ikejiri M, 2005, J BIOL CHEM, V280, P33992, DOI 10.1074/jbc.M504303200; Janes PW, 2005, CELL, V123, P291, DOI 10.1016/j.cell.2005.08.014; Jiang M, 2006, NAT PROTOC, V1, P695, DOI 10.1038/nprot.2006.86; KOPAN R, 1994, DEVELOPMENT, V120, P2385; Kullander K, 2002, NAT REV MOL CELL BIO, V3, P475, DOI 10.1038/nrm856; Lawrenson ID, 2002, J CELL SCI, V115, P1059; Lieber T, 2002, GENE DEV, V16, P209, DOI 10.1101/gad.942302; Litterst C, 2007, J BIOL CHEM, V282, P16155, DOI 10.1074/jbc.M611449200; Luo LQ, 2000, NAT REV NEUROSCI, V1, P173, DOI 10.1038/35044547; Marston DJ, 2003, NAT CELL BIOL, V5, P879, DOI 10.1038/ncb1044; Meighan SE, 2006, J NEUROCHEM, V96, P1227, DOI 10.1111/j.1471-4159.2005.03565.x; Miao H, 2001, NAT CELL BIOL, V3, P527, DOI 10.1038/35074604; Moeller ML, 2006, J BIOL CHEM, V281, P1587, DOI 10.1074/jbc.M511756200; Mott JD, 2004, CURR OPIN CELL BIOL, V16, P558, DOI 10.1016/j.ceb.2004.07.010; Mumm JS, 2000, MOL CELL, V5, P197, DOI 10.1016/S1097-2765(00)80416-5; Nagy V, 2006, J NEUROSCI, V26, P1923, DOI 10.1523/JNEUROSCI.4359-05.2006; Parri M, 2005, J BIOL CHEM, V280, P34008, DOI 10.1074/jbc.M502879200; PASQUALE EB, 1991, CELL REGUL, V2, P523, DOI 10.1091/mbc.2.7.523; Pasquale EB, 2008, CELL, V133, P38, DOI 10.1016/j.cell.2008.03.011; Poliakov A, 2004, DEV CELL, V7, P465, DOI 10.1016/j.devcel.2004.09.006; Selkoe D, 2003, ANNU REV NEUROSCI, V26, P565, DOI 10.1146/annurev.neuro.26.041002.131334; Shintani T, 2006, NAT NEUROSCI, V9, P761, DOI 10.1038/nn1697; Stein E, 1998, GENE DEV, V12, P667, DOI 10.1101/gad.12.5.667; Turk BE, 2001, NAT BIOTECHNOL, V19, P661, DOI 10.1038/90273; Ulrich R, 2005, DEV NEUROSCI-BASEL, V27, P408, DOI 10.1159/000088455; Wahl S, 2000, J CELL BIOL, V149, P263, DOI 10.1083/jcb.149.2.263; Williams SE, 2003, NEURON, V39, P919, DOI 10.1016/j.neuron.2003.08.017; Yong VW, 2007, NEUROTHERAPEUTICS, V4, P580, DOI 10.1016/j.nurt.2007.07.005; Yong VW, 2005, NAT REV NEUROSCI, V6, P931, DOI 10.1038/nrn1807; Zimmer M, 2003, NAT CELL BIOL, V5, P869, DOI 10.1038/ncb1045; Zou JX, 1999, P NATL ACAD SCI USA, V96, P13813, DOI 10.1073/pnas.96.24.13813	42	82	86	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 24	2008	283	43					28969	28979		10.1074/jbc.M804401200	http://dx.doi.org/10.1074/jbc.M804401200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	362EB	18713744	Green Published, hybrid			2022-12-27	WOS:000260179900022
J	Makino, CL; Peshenko, IV; Wen, XH; Olshevskaya, EV; Barrett, R; Dizhoor, AM				Makino, Clint L.; Peshenko, Igor V.; Wen, Xiao-Hong; Olshevskaya, Elena V.; Barrett, Ronald; Dizhoor, Alexander M.			A Role for GCAP2 in Regulating the Photoresponse GUANYLYL CYCLASE ACTIVATION AND ROD ELECTROPHYSIOLOGY IN GUCA1B KNOCK-OUT MICE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOTOTRANSDUCTION CASCADE; PROTEINS GCAPS; CALCIUM; EXPRESSION; CGMP; CLONING; RETGC; CA2+; PHOSPHODIESTERASE; INACTIVATION	Cyclic GMP serves as the second messenger in visual transduction, linking photon absorption by rhodopsin to the activity of ion channels. Synthesis of cGMP in photoreceptors is supported by a pair of retina-specific guanylyl cyclases, retGC1 and -2. Two neuronal calcium sensors, GCAP1 and GCAP2, confer Ca2+ sensitivity to guanylyl cyclase activity, but the importance and the contribution of each GCAP is controversial. To explore this issue, the gene GUCA1B, coding for GCAP2, was disrupted in mice, and the capacity for knock-out rods to regulate retGC and generate photoresponses was tested. The knock-out did not compromise rod viability or alter outer segment ultrastructure. Levels of retGC1, retGC2, and GCAP-1 expression did not undergo compensatory changes, but the absence of GCAP2 affected guanylyl cyclase activity in two ways; (a) the maximal rate of cGMP synthesis at low [Ca2+] dropped 2-fold and (b) the half-maximal rate of cGMP synthesis was attained at a higher than normal [Ca2+]. The addition of an antibody raised against mouse GCAP2 produced similar effects on the guanylyl cyclase activity in wild type retinas. Flash responses of GCAP2 knockout rods recovered more slowly than normal. Knock-out rods became more sensitive to flashes and to steps of illumination but tended to saturate at lower intensities, as compared with wild type rods. Therefore, GCAP2 regulation of guanylyl cyclase activity quickens the recovery of flash and step responses and adjusts the operating range of rods to higher intensities of ambient illumination.	[Peshenko, Igor V.; Olshevskaya, Elena V.; Dizhoor, Alexander M.] Salus Univ, PA Coll Optometry, Basic Sci & Hafter Res Labs, Elkins Pk, PA 19027 USA; [Makino, Clint L.; Wen, Xiao-Hong] Harvard Univ, Sch Med, Boston, MA 02114 USA; [Makino, Clint L.; Wen, Xiao-Hong] Massachusetts Eye & Ear Infirm, Dept Ophthalmol, Boston, MA 02114 USA; [Barrett, Ronald] Wayne State Univ, Dept Anat & Cell Biol, Detroit, MI 48201 USA	Harvard University; Harvard Medical School; Harvard University; Massachusetts Eye & Ear Infirmary; Wayne State University	Dizhoor, AM (corresponding author), Salus Univ, PA Coll Optometry, Basic Sci & Hafter Res Labs, 8360 Old York Rd, Elkins Pk, PA 19027 USA.	adizhoor@salus.edu	Makino, Clint Lawrence/H-8428-2019	Makino, Clint Lawrence/0000-0002-6005-9069; Dizhoor, Alexander/0000-0001-6770-9186	National Institutes of Health [EY11522, EY011358, EY014104]; Massachusetts Lions Eye Research Fund; Pennsylvania Lions Sight Conservation and Eye Research Foundation; Pennsylvania Department of Health; NATIONAL EYE INSTITUTE [P30EY014104, R01EY011358, R29EY011358, R01EY011522] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Massachusetts Lions Eye Research Fund; Pennsylvania Lions Sight Conservation and Eye Research Foundation; Pennsylvania Department of Health; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported, in whole or in part, by National Institutes of Health Grants EY11522, EY011358, and EY014104. This work was also supported by the Massachusetts Lions Eye Research Fund, the Pennsylvania Lions Sight Conservation and Eye Research Foundation, and the Pennsylvania Department of Health. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Burns ME, 2002, NEURON, V36, P81, DOI 10.1016/S0896-6273(02)00911-X; BUSH RA, 2006, NEURONAL CALCIUM SEN, P153; Calvert PD, 2002, ADV EXP MED BIOL, V514, P37; Chen CH, 2003, J PHYSIOL-LONDON, V553, P125, DOI 10.1113/jphysiol.2003.053280; Detwiler PB, 2000, BIOPHYS J, V79, P2801, DOI 10.1016/S0006-3495(00)76519-2; Dizhoor AM, 1998, J BIOL CHEM, V273, P17311, DOI 10.1074/jbc.273.28.17311; DIZHOOR AM, 1995, J BIOL CHEM, V270, P25200, DOI 10.1074/jbc.270.42.25200; DIZHOOR AM, 1994, NEURON, V12, P1345, DOI 10.1016/0896-6273(94)90449-9; Dizhoor AM, 1996, J BIOL CHEM, V271, P19346, DOI 10.1074/jbc.271.32.19346; Duda T, 2005, BIOCHEMISTRY-US, V44, P7336, DOI 10.1021/bi050068x; Fu YB, 2007, PFLUG ARCH EUR J PHY, V454, P805, DOI 10.1007/s00424-006-0194-y; Garbers DL, 1999, METHODS, V19, P477, DOI 10.1006/meth.1999.0890; GILLESPIE PG, 1989, P NATL ACAD SCI USA, V86, P4311, DOI 10.1073/pnas.86.11.4311; GORCZYCA WA, 1995, J BIOL CHEM, V270, P22029, DOI 10.1074/jbc.270.37.22029; GORCZYCA WA, 1994, P NATL ACAD SCI USA, V91, P4014, DOI 10.1073/pnas.91.9.4014; HODGKIN AL, 1988, J PHYSIOL-LONDON, V403, P439, DOI 10.1113/jphysiol.1988.sp017258; Howes KA, 2002, EMBO J, V21, P1545, DOI 10.1093/emboj/21.7.1545; Hurley JB, 2000, METHOD ENZYMOL, V315, P708; Hwang JY, 2003, EUR J BIOCHEM, V270, P3814, DOI 10.1046/j.1432-1033.2003.03770.x; Hwang JY, 2002, BIOCHEMISTRY-US, V41, P13021, DOI 10.1021/bi026618y; Imanishi Y, 2002, EUR J NEUROSCI, V15, P63, DOI 10.1046/j.0953-816x.2001.01835.x; Jeon CJ, 1998, J NEUROSCI, V18, P8936; KOCH KW, 1988, NATURE, V334, P64, DOI 10.1038/334064a0; KOUTALOS Y, 1995, J GEN PHYSIOL, V106, P891, DOI 10.1085/jgp.106.5.891; Krispel CM, 2006, NEURON, V51, P409, DOI 10.1016/j.neuron.2006.07.010; Laura RP, 1996, J BIOL CHEM, V271, P11646, DOI 10.1074/jbc.271.20.11646; Laura RP, 1998, BIOCHEMISTRY-US, V37, P11264, DOI 10.1021/bi9809674; Liu XQ, 2004, P NATL ACAD SCI USA, V101, P13903, DOI 10.1073/pnas.0405160101; LOWE DG, 1995, P NATL ACAD SCI USA, V92, P5535, DOI 10.1073/pnas.92.12.5535; Lyubarsky A, 1996, J GEN PHYSIOL, V107, P19, DOI 10.1085/jgp.107.1.19; Ma JX, 2001, NEURON, V32, P451, DOI 10.1016/S0896-6273(01)00482-2; Makino CL, 2004, J GEN PHYSIOL, V123, P729, DOI 10.1085/jgp.200308994; Makino CL, 2003, CURR OPIN NEUROBIOL, V13, P404, DOI 10.1016/S0959-4388(03)00091-6; Mendez A, 2001, P NATL ACAD SCI USA, V98, P9948, DOI 10.1073/pnas.171308998; Moriondo A, 2003, PHOTOCH PHOTOBIO SCI, V2, P1292, DOI 10.1039/b303871h; Nikonov S, 1998, J GEN PHYSIOL, V111, P7, DOI 10.1085/jgp.111.1.7; Olshevskaya EV, 1997, J BIOL CHEM, V272, P14327, DOI 10.1074/jbc.272.22.14327; Olshevskaya EV, 2004, J NEUROSCI, V24, P6078, DOI 10.1523/JNEUROSCI.0963-04.2004; PALCZEWSKI K, 1994, NEURON, V13, P395, DOI 10.1016/0896-6273(94)90355-7; PEPPERBERG DR, 1992, VISUAL NEUROSCI, V8, P9, DOI 10.1017/S0952523800006441; Peshenko IV, 2007, J BIOL CHEM, V282, P21645, DOI 10.1074/jbc.M702368200; Peshenko IV, 2006, J BIOL CHEM, V281, P23830, DOI 10.1074/jbc.M600257200; Peshenko IV, 2004, J BIOL CHEM, V279, P16903, DOI 10.1074/jbc.C400065200; Philippov PP, 2006, NEURONAL CALCIUM SEN, P139; Sagoo MS, 1997, NATURE, V389, P392, DOI 10.1038/38750; SITARAMAYYA A, 1986, BIOCHEMISTRY-US, V25, P651, DOI 10.1021/bi00351a021; Tucker CL, 1999, P NATL ACAD SCI USA, V96, P9039, DOI 10.1073/pnas.96.16.9039; TYBULEWICZ VLJ, 1991, CELL, V65, P1153, DOI 10.1016/0092-8674(91)90011-M; Woodruff ML, 2008, J NEUROSCI, V28, P2064, DOI 10.1523/JNEUROSCI.2973-07.2008; Woodruff ML, 2007, J NEUROSCI, V27, P8805, DOI 10.1523/JNEUROSCI.2751-07.2007; Woodruff ML, 2002, J PHYSIOL-LONDON, V542, P843, DOI 10.1113/jphysiol.2001.013987; YANG RB, 1995, P NATL ACAD SCI USA, V92, P602, DOI 10.1073/pnas.92.2.602	52	68	68	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 24	2008	283	43					29135	29143		10.1074/jbc.M804445200	http://dx.doi.org/10.1074/jbc.M804445200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	362EB	18723510	Green Published, hybrid			2022-12-27	WOS:000260179900041
J	Manchekar, M; Richardson, PE; Sun, Z; Liu, Y; Segrest, JP; Dashti, N				Manchekar, Medha; Richardson, Paul E.; Sun, Zhihuan; Liu, Yanwen; Segrest, Jere P.; Dashti, Nassrin			Charged Amino Acid Residues 997-1000 of Human Apolipoprotein B100 Are Critical for the Initiation of Lipoprotein Assembly and the Formation of a Stable Lipidated Primordial Particle in McA-RH7777 Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LOW-DENSITY LIPOPROTEINS; TRIGLYCERIDE TRANSFER PROTEIN; B-CONTAINING LIPOPROTEINS; RAT HEPATOMA-CELLS; HEP G2 CELLS; ENDOPLASMIC-RETICULUM; APO-B; INTRACELLULAR DEGRADATION; CRYOELECTRON MICROSCOPY; SECRETORY PATHWAY	We previously demonstrated that a portion, or perhaps all, of the residues between 931 and 1000 of apolipoprotein (apo) B100 are required for the initiation of apoB-containing particle assembly. Based on our structural model of the first 1000 residues of apoB (designated as apoB:1000), we hypothesized that this domain folds into a three-sided lipovitellin-like "lipid pocket" via a hairpinbridge mechanism.We proposed that salt bridges are formed between four tandem charged residues 717-720 in the turn of the hairpin bridge and four tandem complementary residues 997-1000 located at the C-terminal end of the model. To identify the specific motif within residues 931 and 1000 that is critical for apoB particle assembly, apoB:956 and apoB:986 were produced. To test the hairpin-bridge hypothesis, the following mutations were made: 1) residues 997-1000 deletion (apoB:996), 2) residues 717-720 deletion (apoB:1000 Delta 717-720), and 3) substitution of charged residues 997-1000 with alanines(apoB:996+4Ala). Characterization of particles secreted by stable transformants of McA-RH7777 cells demonstrated the following. 1) ApoB:956 did not form stable particles and was secreted as large lipid-rich aggregates. 2) ApoB:986 formed both a lipidated particle that was denser than HDL3 and large lipid-rich aggregates. 3) Compared with wild-type apoB:1000, apoB:1000 Delta 717-720 displayed the following: (i) significantly diminished capacity to form intact lipidated particles and (ii) increased propensity to form large lipid-rich aggregates. 4) Instriking contrast to wild-type apoB:1000, (i) apoB:996 and apoB:996+4Ala were highly susceptible to intracellular degradation, (ii) only a small proportion of the secreted proteins formed stable HDL3-like lipoproteins, and (iii) a majority of the secreted proteins formed large lipid-rich aggregates. We conclude that the first 1000 amino acid residues of human apoB100 are required for the initiation of nascent apoB-containing lipoprotein assembly, and residues 717-720 and 997-1000 play key roles in this process, perhaps via a hairpinbridge mechanism.	[Manchekar, Medha; Sun, Zhihuan; Liu, Yanwen; Segrest, Jere P.; Dashti, Nassrin] Univ Alabama Birmingham, Atherosclerosis Res Unit, Basic Sci Sect, Dept Med, Birmingham, AL 35294 USA; [Segrest, Jere P.] Univ Alabama Birmingham, Med Ctr, Dept Biochem & Mol Genet, Birmingham, AL 35294 USA; [Dashti, Nassrin] Univ Alabama Birmingham, Med Ctr, Dept Cell Biol, Birmingham, AL 35294 USA; [Richardson, Paul E.] Coastal Carolina Univ, Dept Chem & Phys, Conway, SC 29528 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; Coastal Carolina University	Dashti, N (corresponding author), Univ Alabama Birmingham, Dept Med, 1808 7th Ave S,BDB-D680, Birmingham, AL 35292 USA.	ndashti@uab.edu			National Institutes of Health [HL084685, PO1 HL34343]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL084685, P01HL034343] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL084685 and PO1 HL34343. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Anderson TA, 1998, STRUCT FOLD DES, V6, P895, DOI 10.1016/S0969-2126(98)00091-4; ATKINSON D, 1977, P NATL ACAD SCI USA, V74, P1042, DOI 10.1073/pnas.74.3.1042; BAKER ME, 1988, BIOCHEM J, V255, P1057, DOI 10.1042/bj2551057; BORCHARDT RA, 1987, J BIOL CHEM, V262, P16394; BOSTROM K, 1986, J BIOL CHEM, V261, P3800; BURNETTE WN, 1981, ANAL BIOCHEM, V112, P195, DOI 10.1016/0003-2697(81)90281-5; Cardozo C, 2002, BIOCHEMISTRY-US, V41, P10105, DOI 10.1021/bi025749w; Carraway M, 2000, BIOCHEMISTRY-US, V39, P9737, DOI 10.1021/bi000791h; Cavallo D, 1998, J BIOL CHEM, V273, P33397, DOI 10.1074/jbc.273.50.33397; Cavallo D, 1999, J BIOL CHEM, V274, P23135, DOI 10.1074/jbc.274.33.23135; CHATTERTON JE, 1995, J LIPID RES, V36, P2027; CHEN GC, 1989, BIOCHEMISTRY-US, V28, P2477, DOI 10.1021/bi00432a019; CHEN SH, 1986, J BIOL CHEM, V261, P2918; CHUNG BH, 1986, METHOD ENZYMOL, V128, P181; CLADARAS C, 1986, EMBO J, V5, P3495, DOI 10.1002/j.1460-2075.1986.tb04675.x; Coux O, 1996, ANNU REV BIOCHEM, V65, P801, DOI 10.1146/annurev.bi.65.070196.004101; Dashti N, 2002, BIOCHEMISTRY-US, V41, P6978, DOI 10.1021/bi011757l; Dashti N, 2002, J NUTR, V132, P2651, DOI 10.1093/jn/132.9.2651; DASHTI N, 1992, J BIOL CHEM, V267, P7160; Dashti N, 2007, J BIOL CHEM, V282, P28597, DOI 10.1074/jbc.M700229200; DECKELBAUM RJ, 1977, J BIOL CHEM, V252, P744; DECKELBAUM RJ, 1975, SCIENCE, V190, P392, DOI 10.1126/science.170681; DELOOF H, 1987, J LIPID RES, V28, P1455; Dixon JL, 2002, J HISTOCHEM CYTOCHEM, V50, P629, DOI 10.1177/002215540205000504; DIXON JL, 1993, J LIPID RES, V34, P167; DIXON JL, 1991, J BIOL CHEM, V266, P5080; Ellgaard L, 1999, SCIENCE, V286, P1882, DOI 10.1126/science.286.5446.1882; ELOVSON J, 1988, J LIPID RES, V29, P1461; Fisher EA, 2002, J BIOL CHEM, V277, P17377, DOI 10.1074/jbc.R100068200; Fisher EA, 2001, J BIOL CHEM, V276, P27855, DOI 10.1074/jbc.M008885200; Fisher EA, 1997, J BIOL CHEM, V272, P20427, DOI 10.1074/jbc.272.33.20427; FOLCH J, 1957, J BIOL CHEM, V226, P497; Gantz DL, 2000, J LIPID RES, V41, P1464; Gordon DA, 1997, CURR OPIN LIPIDOL, V8, P131, DOI 10.1097/00041433-199706000-00002; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Johs A, 2006, J BIOL CHEM, V281, P19732, DOI 10.1074/jbc.M601688200; KANE JP, 1983, ANNU REV PHYSIOL, V45, P637, DOI 10.1146/annurev.ph.45.030183.003225; KNOTT TJ, 1986, NATURE, V323, P734, DOI 10.1038/323734a0; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Liao W, 1998, J BIOL CHEM, V273, P27225, DOI 10.1074/jbc.273.42.27225; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Manchekar M, 2004, J BIOL CHEM, V279, P39757, DOI 10.1074/jbc.M406302200; MILLER AD, 1993, METHOD ENZYMOL, V217, P581; Mitchell DM, 1998, P NATL ACAD SCI USA, V95, P14733, DOI 10.1073/pnas.95.25.14733; Orlova EV, 1999, P NATL ACAD SCI USA, V96, P8420, DOI 10.1073/pnas.96.15.8420; Pan MH, 2004, J CLIN INVEST, V113, P1277, DOI 10.1172/JCI200419197; PULLINGER CR, 1989, J LIPID RES, V30, P1065; RAAG R, 1988, J MOL BIOL, V200, P553, DOI 10.1016/0022-2836(88)90542-6; Richardson PE, 2005, BIOPHYS J, V88, P2789, DOI 10.1529/biophysj.104.046235; SCHUMAKER VN, 1994, ADV PROTEIN CHEM, V45, P205; Segrest JP, 1998, J LIPID RES, V39, P85; Segrest JP, 1999, J LIPID RES, V40, P1401; SEGREST JP, 1994, ADV PROTEIN CHEM, V45, P303; Segrest JP, 2001, J LIPID RES, V42, P1346; SEGREST JP, 1994, ARTERIOSCLER THROMB, V14, P1674, DOI 10.1161/01.ATV.14.10.1674; SHARROCK WJ, 1992, J MOL BIOL, V226, P903, DOI 10.1016/0022-2836(92)90642-W; Shelness GS, 2003, J BIOL CHEM, V278, P44702, DOI 10.1074/jbc.M307562200; SHOULDERS CC, 1994, NAT STRUCT BIOL, V1, P285, DOI 10.1038/nsb0594-285; SPARKS JD, 1990, J BIOL CHEM, V265, P8854; SPIN JM, 1995, BIOPHYS J, V68, P2115, DOI 10.1016/S0006-3495(95)80392-9; van Antwerpen R, 1999, J LIPID RES, V40, P1827; WANG CN, 1995, J BIOL CHEM, V270, P24924, DOI 10.1074/jbc.270.42.24924; WHITE AL, 1992, J BIOL CHEM, V267, P15657; Yamaguchi J, 2006, J BIOL CHEM, V281, P27063, DOI 10.1074/jbc.M606809200; YANG CY, 1989, ARTERIOSCLEROSIS, V9, P96, DOI 10.1161/01.ATV.9.1.96; YAO ZM, 1992, J BIOL CHEM, V267, P1175; Yeung SJ, 1996, BIOCHEMISTRY-US, V35, P13843, DOI 10.1021/bi9618777; Zhou MY, 1998, J BIOL CHEM, V273, P24649, DOI 10.1074/jbc.273.38.24649	68	8	8	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 24	2008	283	43					29251	29265		10.1074/jbc.M804912200	http://dx.doi.org/10.1074/jbc.M804912200			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	362EB	18725409	Green Published, hybrid			2022-12-27	WOS:000260179900052
J	Dodd, R; Peracchia, C; Stolady, D; Torok, K				Dodd, Ryan; Peracchia, Camillo; Stolady, Daniel; Torok, Katalin			Calmodulin association with connexin32-derived peptides suggests trans-domain interaction in chemical gating of gap junction channels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CALCIUM; BINDING; ACTIVATION; MECHANISMS; CA2+/CALMODULIN; PERMEABILITY; CONDUCTANCE; DIVERSITY; PROTEINS; KINASE	Calmodulin plays a key role in the chemical gating of gap junction channels. Two calmodulin-binding regions have previously been identified in connexin32 gap junction protein, one in the N-terminal and another in the C-terminal cytoplasmic tail of the molecule. The aim of this study was to better understand how calmodulin interacts with the connexin32-binding domains. Lobe-specific interactions of calmodulin with connexin32 peptides were studied by stopped flow kinetics, using Ca2+ binding-deficient mutants. Peptides corresponding to the N-terminal tail (residues 1-22) of connexin32 engaged both the N- and C-terminal lobes (N- and C-lobes) of calmodulin, binding with higher affinity to the C-lobe of calmodulin (Ca2+ dissociation rate constants k(3,4), 1.7 +/- 0.5 s(-1)) than to the N-lobe (k(1,2), 10.8 +/- 1.3 s(-1)). In contrast, peptides representing the C-terminal tail domain (residues 208 - 227) of connexin32 bound either the Cor the N- lobe but only one calmodulin lobe at a time (k(3,4), 2.6 +/- 0.1 s(-1) or k(1), 13.8 +/- 0.5 s(-1) and k(2), 1000 s(-1)). The calmodulin-binding domains of the N- and C-terminal tails of connexin32 were best defined as residues 1 - 21 and 216 - 227, respectively. Our data, showing separate functions of the N- and C-lobes of calmodulin in the interactions with connexin32, suggest trans-domain or trans-subunit bridging by calmodulin as a possible mechanism of gap junction gating.	[Dodd, Ryan; Stolady, Daniel; Torok, Katalin] Univ London, Div Basic Med Sci, London SW17 0RE, England; [Peracchia, Camillo] Univ Rochester, Sch Med & Dent, Dept Physiol & Pharmacol, Rochester, NY 14627 USA	University of London; University of Rochester	Torok, K (corresponding author), SGUL, BMS, Cranmer Terrace, London SW17 0RE, England.	k.torok@sgul.ac.uk		Peracchia, Camillo/0000-0001-7405-1271; Torok, Katalin/0000-0002-3107-4534	National Institutes of Health [GM20113]; Wellcome Trust; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM020113] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wellcome Trust(Wellcome TrustEuropean Commission); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM20113. This work was also supported by long term support of research in the laboratory on CaM probes and stopped flow kinetics from the Wellcome Trust. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Alan R., 1988, GAP JUNCTIONS, V7, P267; [Anonymous], 1996, CIRCULAR DICHROISM C; Bennett M V, 1992, Semin Cell Biol, V3, P29; Bruzzone R, 1996, EUR J BIOCHEM, V238, P1, DOI 10.1111/j.1432-1033.1996.0001q.x; Bukauskas FF, 2004, BBA-BIOMEMBRANES, V1662, P42, DOI 10.1016/j.bbamem.2004.01.008; Bukauskas FF, 1997, BIOPHYS J, V72, P2137, DOI 10.1016/S0006-3495(97)78856-8; Burr GS, 2005, BIOCHEM BIOPH RES CO, V335, P1191, DOI 10.1016/j.bbrc.2005.08.007; Chin D, 2000, TRENDS CELL BIOL, V10, P322, DOI 10.1016/S0962-8924(00)01800-6; De Vuyst E, 2006, EMBO J, V25, P34, DOI 10.1038/sj.emboj.7600908; Evans WH, 2002, MOL MEMBR BIOL, V19, P121, DOI 10.1080/09687680210139839; Grabarek Z, 2006, J MOL BIOL, V359, P509, DOI 10.1016/j.jmb.2006.03.066; Harris AL, 2001, Q REV BIOPHYS, V34, P325, DOI 10.1017/S0033583501003705; Harris AL, 2007, PROG BIOPHYS MOL BIO, V94, P120, DOI 10.1016/j.pbiomolbio.2007.03.011; Hoeflich KP, 2002, CELL, V108, P739, DOI 10.1016/S0092-8674(02)00682-7; IKURA M, 1992, SCIENCE, V256, P632, DOI 10.1126/science.1585175; MARTIN SR, 1985, EUR J BIOCHEM, V151, P543, DOI 10.1111/j.1432-1033.1985.tb09137.x; PERACCHIA C, 1983, PFLUG ARCH EUR J PHY, V399, P152, DOI 10.1007/BF00663912; Peracchia C, 2004, BBA-BIOMEMBRANES, V1662, P61, DOI 10.1016/j.bbamem.2003.10.020; Peracchia C, 2000, J BIOL CHEM, V275, P26220, DOI 10.1074/jbc.M004007200; Peracchia C., 2000, GAP JUNCTIONS MOL BA, P271; Schumacher MA, 2001, NATURE, V410, P1120, DOI 10.1038/35074145; Sorensen BR, 2002, BIOCHEMISTRY-US, V41, P15, DOI 10.1021/bi011718+; SPRAY DC, 1985, AM J PHYSIOL, V248, pH753, DOI 10.1152/ajpheart.1985.248.6.H753; Torok K, 1997, BIOCHEM J, V326, P479; TOROK K, 1994, BIOCHEMISTRY-US, V33, P12807, DOI 10.1021/bi00209a012; Torok K, 2001, BIOCHEMISTRY-US, V40, P14878, DOI 10.1021/bi010920+; Tzortzopoulos A, 2004, BIOCHEMISTRY-US, V43, P6270, DOI 10.1021/bi035449u; VEENSTRA RD, 1995, CIRC RES, V77, P1156, DOI 10.1161/01.RES.77.6.1156; WANG X, 1997, BIOPHYS J, V271, pC1743; Wang XG, 1996, PFLUG ARCH EUR J PHY, V431, P844; WERNER R, 1991, P ROY SOC B-BIOL SCI, V243, P5, DOI 10.1098/rspb.1991.0002; Yeager M, 2007, CURR OPIN CELL BIOL, V19, P521, DOI 10.1016/j.ceb.2007.09.001; Zhou YB, 2007, J BIOL CHEM, V282, P35005, DOI 10.1074/jbc.M707728200	33	36	36	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 3	2008	283	40					26911	26920		10.1074/jbc.M801434200	http://dx.doi.org/10.1074/jbc.M801434200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	353RT	18676375	Green Published, Green Accepted, hybrid			2022-12-27	WOS:000259586600011
J	Rigbers, O; Li, SM				Rigbers, Ole; Li, Shu-Ming			Ergot alkaloid biosynthesis in Aspergillus fumigatus - Overproduction and biochemical characterization of a 4-dimethylallyltryptophan N-methyltransferase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PRENYLATED INDOLE-DERIVATIVES; FUNGUS CLAVICEPS-PURPUREA; FUMIGACLAVINE-C; DIMETHYLALLYLTRYPTOPHAN SYNTHASE; CHEMOENZYMATIC SYNTHESIS; DNA METHYLATION; GENE-CLUSTER; EVOLUTION; TOOLS; STEP	The putative gene fgaMT was identified in the biosynthetic gene cluster of fumigaclavines in Aspergillus fumigatus. The coding region of fgaMT was amplified by PCR from a cDNA library, cloned into pQE60, and overexpressed in Escherichia coli. FgaMT comprises 339 amino acids with a molecular mass of about 38.1 kDa. The soluble dimeric His(6)-FgaMT was purified to near homogeneity and characterized biochemically. FgaMT was found to catalyze the N-methylation of 4-dimethylallyltryptophan in the presence of S-adenosylmethionine, resulting in the formation of 4-dimethylallyl-L-abrine, which was identified by NMR and mass spectrometry analysis. Therefore, FgaMT represents the second pathway-specific enzyme in the biosynthesis of ergot alkaloids. The enzyme did not require metal ions for its enzymatic reaction and showed a relatively high specificity toward the prenyl moiety at position C-4 of the indole ring. 4-Dimethylallyltryptophan derivatives with modification at the indole ring were also accepted by FgaMT as substrates. Km values for 4-dimethylallyltryptophan and S-adenosylmethionine were determined at 0.12 and 2.4 mM, respectively. The turnover number was 2.0 s(-1).	[Li, Shu-Ming] Univ Dusseldorf, Inst Pharmazeut Biol & Biotechnol, D-40225 Dusseldorf, Germany; Univ Marburg, Inst Pharmazeut Biol, D-35037 Marburg, Germany	Heinrich Heine University Dusseldorf; Philipps University Marburg	Li, SM (corresponding author), Univ Dusseldorf, Inst Pharmazeut Biol & Biotechnol, Univ Str 1, D-40225 Dusseldorf, Germany.	shu-ming.li@staff.uni-marburg.de			Deutsche Forschungsgemeinschaft	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by a grant from the Deutsche Forschungsgemeinschaft (to S.-M. L.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Ashihara H, 2008, PHYTOCHEMISTRY, V69, P841, DOI 10.1016/j.phytochem.2007.10.029; Blixt O, 2006, METHOD ENZYMOL, V415, P137, DOI 10.1016/S0076-6879(06)15009-0; Buskas T, 2006, GLYCOBIOLOGY, V16, p113R, DOI 10.1093/glycob/cwj125; Coyle CM, 2005, APPL ENVIRON MICROB, V71, P3112, DOI 10.1128/AEM.71.6.3112-3118.2005; Ding YS, 2008, J BIOL CHEM, V283, P16068, DOI 10.1074/jbc.M801991200; Fleetwood DJ, 2007, APPL ENVIRON MICROB, V73, P2571, DOI 10.1128/AEM.00257-07; Flieger M, 1997, FOLIA MICROBIOL, V42, P3, DOI 10.1007/BF02898641; Floss HG, 2006, J BIOTECHNOL, V124, P242, DOI 10.1016/j.jbiotec.2005.12.001; FLOSS HG, 1976, TETRAHEDRON, V32, P873, DOI 10.1016/0040-4020(76)85047-8; Galm U, 2004, CHEM BIOL, V11, P173, DOI 10.1016/j.chembiol.2004.01.012; Groger D., 1998, ALKALOIDS CHEM PHARM, V50, P171; Grunewald J, 2006, MICROBIOL MOL BIOL R, V70, P121, DOI 10.1128/MMBR.70.1.121-146.2006; Haarmann T, 2006, CHEMBIOCHEM, V7, P645, DOI 10.1002/cbic.200500487; Jeltsch A, 2002, CHEMBIOCHEM, V3, P275, DOI 10.1002/1439-7633(20020402)3:4<274::AID-CBIC274>3.0.CO;2-S; KAGAN RM, 1994, ARCH BIOCHEM BIOPHYS, V310, P417, DOI 10.1006/abbi.1994.1187; Kodama Y, 2008, BIOCHIMIE, V90, P547, DOI 10.1016/j.biochi.2007.10.001; Kozbial PZ, 2005, BMC STRUCT BIOL, V5, DOI 10.1186/1472-6807-5-19; Krause CD, 2007, PHARMACOL THERAPEUT, V113, P50, DOI 10.1016/j.pharmthera.2006.06.007; Kremer A, 2008, APPL MICROBIOL BIOT, V79, P951, DOI 10.1007/s00253-008-1505-3; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lam KC, 2007, GENOME, V50, P1001, DOI 10.1139/G07-077; Langenhan JM, 2005, J NAT PROD, V68, P1696, DOI 10.1021/np0502084; Li SM, 2006, PLANTA MED, V72, P1117, DOI 10.1055/s-2006-947195; Liscombe DK, 2007, J BIOL CHEM, V282, P14741, DOI 10.1074/jbc.M611908200; Lorenz N, 2007, APPL ENVIRON MICROB, V73, P7185, DOI 10.1128/AEM.01040-07; Ma HY, 2006, PLANTA MED, V72, P387, DOI 10.1055/s-2005-916235; Markert A, 2008, PLANT PHYSIOL, V147, P296, DOI 10.1104/pp.108.116699; Miranda TB, 2007, J CELL PHYSIOL, V213, P384, DOI 10.1002/jcp.21224; OTSUKA H, 1980, PLANTA MED, V40, P109, DOI 10.1055/s-2008-1074947; Paik WK, 2007, TRENDS BIOCHEM SCI, V32, P146, DOI 10.1016/j.tibs.2007.01.006; Riederer B, 1996, J BIOL CHEM, V271, P27524, DOI 10.1074/jbc.271.44.27524; Rohde B, 2008, PLANT J, V53, P541, DOI 10.1111/j.1365-313X.2007.03360.x; Rupprath C, 2005, CURR MED CHEM, V12, P1637, DOI 10.2174/0929867054367167; Sambrook J., 2001, MOL CLONING LAB MANU; Schardl CL, 2006, ALKALOIDS-CHEM BIOL, V63, P45, DOI 10.1016/S1099-4831(06)63002-2; Steffan N, 2007, CHEMBIOCHEM, V8, P1298, DOI 10.1002/cbic.200700107; Sulewska A, 2007, FOLIA HISTOCHEM CYTO, V45, P149; Teuber M, 2007, PLANT MOL BIOL, V63, P787, DOI 10.1007/s11103-006-9126-7; TSAI HF, 1995, BIOCHEM BIOPH RES CO, V216, P119, DOI 10.1006/bbrc.1995.2599; Tudzynski P, 1999, MOL GEN GENET, V261, P133, DOI 10.1007/s004380050950; Unsold IA, 2006, CHEMBIOCHEM, V7, P158, DOI 10.1002/cbic.200500318; Unsold IA, 2005, MICROBIOL-SGM, V151, P1499, DOI 10.1099/mic.0.27759-0; Walsh CT, 2001, CURR OPIN CHEM BIOL, V5, P525, DOI 10.1016/S1367-5931(00)00235-0; Walzel B, 1997, CHEM BIOL, V4, P223, DOI 10.1016/S1074-5521(97)90292-1; Wang JH, 2004, FUNGAL GENET BIOL, V41, P189, DOI 10.1016/j.fgb.2003.10.002; Weissman KJ, 2007, TRENDS BIOTECHNOL, V25, P139, DOI 10.1016/j.tibtech.2007.02.004; Weist S, 2005, APPL MICROBIOL BIOT, V68, P141, DOI 10.1007/s00253-005-1891-8; Williams RM, 2000, TOP CURR CHEM, V209, P97; WOODSIDE AB, 1988, ORG SYNTH, V66, P211; Wu XF, 2005, INT IMMUNOPHARMACOL, V5, P1543, DOI 10.1016/j.intimp.2005.04.014; Zhao Y, 2004, J PHARM PHARMACOL, V56, P775, DOI 10.1211/0022357023592	51	56	60	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 3	2008	283	40					26859	26868		10.1074/jbc.M804979200	http://dx.doi.org/10.1074/jbc.M804979200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	353RT	18678866	hybrid			2022-12-27	WOS:000259586600005
J	Dilda, PJ; Ramsay, EE; Corti, A; Pompella, A; Hogg, PJ				Dilda, Pierre J.; Ramsay, Emma E.; Corti, Alessandro; Pompella, Alfonso; Hogg, Philip J.			Metabolism of the Tumor Angiogenesis Inhibitor 4-(N-(S-Glutathionylacetyl)amino) phenylarsonous Acid	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PERMEABILITY TRANSITION PORE; GAMMA-GLUTAMYL-TRANSPEPTIDASE; MEMBRANE; FAMILY; CELLS; TRANSFERASE; INVOLVEMENT; CONJUGATE; MECHANISM; TRANSPORT	4-(N-(S-glutathionylacetyl)amino) phenylarsonous acid (GSAO) is a small, synthetic mitochondrial poison that targets angiogenic endothelial cells and is currently being tested in a Phase I/IIa clinical trial. The trivalent arsenical of GSAO reacts with and perturbs adenine nucleotide translocase of the inner mitochondrial membrane of endothelial cells, which leads to proliferation arrest. Three observations indicated that the gamma-glutamyl residue of GSAO is cleaved at the endothelial cell surface by gamma-glutamyl transpeptidase (gamma GT). GSAO was found to be an efficient substrate for gamma GT, endothelial cell accumulation and antiproliferative activity of GSAO was blunted by a competitive substrate and an active site inhibitor of gamma GT, and the level of cell surface gamma GT correlated strongly with the sensitivity of cells to GSAO. Using transport inhibitors, it was revealed that the resulting metabolite of GSAO cleavage by gamma GT, 4-(N-(S-cysteinylglycylacetyl) amino) phenylarsonous acid (GCAO), was transported across the plasma membrane by an organic anion transporter. Furthermore, GCAO is likely processed by dipeptidases in the cytosol to 4-(N-(S-cysteinylacetyl) amino) phenylarsonous acid (CAO), and it is this metabolite that reacts with mitochondrial adenine nucleotide translocase. Taken together, our findings indicate that gamma GT processing of GSAO at the cell surface is the rate-limiting step in its antiangiogenic activity. This information can explain the kidney toxicity at high doses of GSAO noted in preclinical studies and will aid in the anticipation of potential side effects in humans and in the design of better antimitochondrial cancer drugs.	[Dilda, Pierre J.; Ramsay, Emma E.; Pompella, Alfonso; Hogg, Philip J.] Univ New S Wales, Ctr Canc Res, Sydney, NSW 2052, Australia; [Corti, Alessandro] Univ Pisa, Sch Med, I-56126 Pisa, Italy; [Hogg, Philip J.] Childrens Canc Inst Australia Med Res, Randwick, NSW 2031, Australia	University of New South Wales Sydney; University of Pisa; Children's Cancer Institute	Hogg, PJ (corresponding author), Univ New S Wales, Ctr Canc Res, Sydney, NSW 2052, Australia.	p.hogg@unsw.edu.au	Pompella, Alfonso/G-6785-2012	Pompella, Alfonso/0000-0002-6435-9325; Hogg, Philip/0000-0001-6486-2863; Ramsay, Emma/0000-0001-7273-5397	National Health and Medical Research Council of Australia; Cancer Council New South Wales (NSW); Cancer Institute NSW and the Istituto Toscano Tumori (Firenze, Italy)	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Cancer Council New South Wales (NSW)(Cancer Council New South Wales); Cancer Institute NSW and the Istituto Toscano Tumori (Firenze, Italy)	This study was supported by grants from the National Health and Medical Research Council of Australia, the Cancer Council New South Wales (NSW), the Cancer Institute NSW and the Istituto Toscano Tumori (Firenze, Italy). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Belzacq AS, 2001, ONCOGENE, V20, P7579, DOI 10.1038/sj.onc.1204953; Cannon VT, 2000, J AM SOC NEPHROL, V11, P394, DOI 10.1681/ASN.V113394; Daniel H, 2004, PFLUG ARCH EUR J PHY, V447, P610, DOI 10.1007/s00424-003-1101-4; Dilda PJ, 2005, CANCER RES, V65, P11729, DOI 10.1158/0008-5472.CAN-05-2797; Dilda PJ, 2005, JNCI-J NATL CANCER I, V97, P1539, DOI 10.1093/jnci/dji316; Don AS, 2004, TRENDS MOL MED, V10, P372, DOI 10.1016/j.molmed.2004.06.005; Don AS, 2003, CANCER CELL, V3, P497, DOI 10.1016/S1535-6108(03)00109-0; Donoghue N, 2000, PROTEIN SCI, V9, P2436, DOI 10.1110/ps.9.12.2436; Enoiu M, 2002, ARCH BIOCHEM BIOPHYS, V397, P18, DOI 10.1006/abbi.2001.2633; Franzini M, 2006, EUR J CANCER, V42, P2623, DOI 10.1016/j.ejca.2006.04.016; Hagenbuch B, 2003, BBA-BIOMEMBRANES, V1609, P1, DOI 10.1016/S0005-2736(02)00633-8; Halestrap AP, 2002, BIOCHIMIE, V84, P153, DOI 10.1016/S0300-9084(02)01375-5; Hanigan MH, 1996, J HISTOCHEM CYTOCHEM, V44, P1101, DOI 10.1177/44.10.8813074; HORIUCHI S, 1978, EUR J BIOCHEM, V87, P429, DOI 10.1111/j.1432-1033.1978.tb12392.x; HUSEBY NE, 1974, SCAND J CLIN LAB INV, V34, P357, DOI 10.3109/00365517409049892; Josch C, 1998, BIOCHEM PHARMACOL, V56, P763, DOI 10.1016/S0006-2952(98)00065-3; Kobayashi D, 2003, J PHARMACOL EXP THER, V306, P703, DOI 10.1124/jpet.103.051300; Kruh GD, 2003, ONCOGENE, V22, P7537, DOI 10.1038/sj.onc.1206953; Larochette N, 1999, EXP CELL RES, V249, P413, DOI 10.1006/excr.1999.4519; Lee W, 2005, J BIOL CHEM, V280, P9610, DOI 10.1074/jbc.M411092200; McStay GP, 2002, BIOCHEM J, V367, P541, DOI 10.1042/BJ20011672; Pajor AM, 2006, PFLUG ARCH EUR J PHY, V451, P597, DOI 10.1007/s00424-005-1487-2; Pebay-Peyroula E, 2003, NATURE, V426, P39, DOI 10.1038/nature02056	23	33	35	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 19	2008	283	51					35428	35434		10.1074/jbc.M804470200	http://dx.doi.org/10.1074/jbc.M804470200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	383QH	18723877	hybrid			2022-12-27	WOS:000261687900014
J	Mahajan, B; Selvapandiyan, A; Gerald, NJ; Majam, V; Zheng, H; Wickramarachchi, T; Tiwari, J; Fujioka, H; Moch, JK; Kumar, N; Aravind, L; Nakhasi, HL; Kumar, S				Mahajan, Babita; Selvapandiyan, Angamuthu; Gerald, Noel J.; Majam, Victoria; Zheng, Hong; Wickramarachchi, Thilan; Tiwari, Jawahar; Fujioka, Hisashi; Moch, J. Kathleen; Kumar, Nirbhay; Aravind, L.; Nakhasi, Hira L.; Kumar, Sanjai			Centrins, Cell Cycle Regulation Proteins in Human Malaria Parasite Plasmodium falciparum	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CALCIUM-BINDING; CHLAMYDOMONAS-REINHARDTII; SACCHAROMYCES-CEREVISIAE; BODY DUPLICATION; MURINE CENTRIN; GENE; CENTROSOME; LOCALIZATION; EXPRESSION; ULTRASTRUCTURE	Molecules and cellular mechanisms that regulate the process of cell division in malaria parasites remain poorly understood. In this study we isolate and characterize the four Plasmodium falciparum centrins (PfCENs) and, by growth complementation studies, provide evidence for their involvement in cell division. Centrins are cytoskeleton proteins with key roles in cell division, including centrosome duplication, and possess four Ca2+-binding EF hand domains. By means of phylogenetic analysis, we were able to decipher the evolutionary history of centrins in eukaryotes with particular emphasis on the situation in apicomplexans and other alveolates. Plasmodium possesses orthologs of four distinct centrin paralogs traceable to the ancestral alveolate, including two that are unique to alveolates. By real time PCR and/or immunofluorescence, we determined the expression of PfCEN mRNA or protein in sporozoites, asexual blood forms, gametocytes, and in the oocysts developing inside mosquito mid-gut. Immunoelectron microscopy studies showed that centrin is expressed in close proximity with the nucleus of sporozoites and asexual schizonts. Furthermore, confocal and widefield microscopy using the double staining with alpha-tubulin and centrin antibodies strongly suggested that centrin is associated with the parasite centrosome. Following the episomal expression of the four PfCENs in a centrin knock-out Leishmania donovani parasite line that exhibited a severe growth defect, one of the PfCENs was able to partially restore Leishmania growth rate and overcome the defect in cytokinesis in such mutant cell line. To our knowledge, this study is the first characterization of a Plasmodium molecule that is involved in the process of cell division. These results provide the opportunity to further explore the role of centrins in cell division in malaria parasites and suggest novel targets to construct genetically modified, live attenuated malaria vaccines.	[Kumar, Sanjai] US FDA, CBER, DETTD, OBRR, Rockville, MD 20852 USA; [Tiwari, Jawahar] US FDA, Ctr Biol Evaluat & Res, Div Biostat, Rockville, MD 20852 USA; [Fujioka, Hisashi] Case Western Reserve Univ, Dept Pharmacol, Cleveland, OH 44106 USA; [Moch, J. Kathleen] Walter Reed Army Inst Res, Dept Immunol, Silver Spring, MD 20910 USA; [Kumar, Nirbhay] Bloomberg Sch Publ Hlth, Dept Mol Microbiol & Immunol, Baltimore, MD 21205 USA; [Aravind, L.] Natl Lib Med, Natl Ctr Biotechnol Informat, NIH, Bethesda, MD 20892 USA	US Food & Drug Administration (FDA); US Food & Drug Administration (FDA); Case Western Reserve University; United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR); Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; National Institutes of Health (NIH) - USA; NIH National Library of Medicine (NLM)	Kumar, S (corresponding author), US FDA, CBER, DETTD, OBRR, 1401 Rockville Pike HFM-313, Rockville, MD 20852 USA.	sanjai.kumar@fda.hhs.gov	Selvapandiyan, Angamuthu/AAY-2556-2021; Selvapandiyan, Angamuthu/AAA-8602-2021	Selvapandiyan, Angamuthu/0000-0002-2194-1534; Aravind, L/0000-0003-0771-253X				AIKAWA M, 1978, J CELL BIOL, V77, P72, DOI 10.1083/jcb.77.1.72; Arnot DE, 1998, ANN TROP MED PARASIT, V92, P361, DOI 10.1080/00034989859357; Bannister LH, 2000, PARASITOLOGY, V121, P273, DOI 10.1017/S0031182099006320; BANNISTER LH, 1986, PARASITOLOGY, V92, P291, DOI 10.1017/S0031182000064064; BARON AT, 1991, CELL MOTIL CYTOSKEL, V18, P1, DOI 10.1002/cm.970180102; BAUM P, 1988, MOL CELL BIOL, V8, P5386, DOI 10.1128/MCB.8.12.5386; BAUM P, 1986, P NATL ACAD SCI USA, V83, P5512, DOI 10.1073/pnas.83.15.5512; Black MW, 2000, MICROBIOL MOL BIOL R, V64, P607, DOI 10.1128/MMBR.64.3.607-623.2000; Brinkley BR, 2001, TRENDS CELL BIOL, V11, P18, DOI 10.1016/S0962-8924(00)01872-9; CHELSKY D, 1989, MOL CELL BIOL, V9, P2487, DOI 10.1128/MCB.9.6.2487; Chook YM, 2001, CURR OPIN STRUC BIOL, V11, P703, DOI 10.1016/S0959-440X(01)00264-0; Christophe D, 2000, CELL SIGNAL, V12, P337, DOI 10.1016/S0898-6568(00)00077-2; Dubremetz JF, 1998, INT J PARASITOL, V28, P1007, DOI 10.1016/S0020-7519(98)00076-9; FREEDMAN DJ, 1993, MOL BIOCHEM PARASIT, V62, P37, DOI 10.1016/0166-6851(93)90175-W; Gavet O, 2003, MOL BIOL CELL, V14, P1818, DOI 10.1091/mbc.E02-11-0709; Gerald NJ, 2007, MOL MICROBIOL, V63, P962, DOI 10.1111/j.1365-2958.2006.05487.x; GILBERT W, 1987, COLD SPRING HARB SYM, V52, P901, DOI 10.1101/SQB.1987.052.01.098; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hart PE, 1999, GENOMICS, V60, P111, DOI 10.1006/geno.1999.5880; Hart PE, 2001, GENE, V264, P205, DOI 10.1016/S0378-1119(01)00342-0; Haynes J David, 2002, Methods Mol Med, V72, P489, DOI 10.1385/1-59259-271-6:489; He CY, 2005, SCIENCE, V310, P1196, DOI 10.1126/science.1119969; Hinchcliffe EH, 2001, SCIENCE, V291, P1547, DOI 10.1126/science.1056866; Hu K, 2006, PLOS PATHOG, V2, P121, DOI 10.1371/journal.ppat.0020013; JAIKARIA NS, 1993, MOL BIOCHEM PARASIT, V57, P269, DOI 10.1016/0166-6851(93)90203-A; Kats LM, 2006, TRENDS PARASITOL, V22, P269, DOI 10.1016/j.pt.2006.04.001; Khodjakov A, 2001, J CELL BIOL, V153, P237, DOI 10.1083/jcb.153.1.237; Koblenz B, 2003, J CELL SCI, V116, P2635, DOI 10.1242/jcs.00497; Kramer A, 2002, LEUKEMIA, V16, P767, DOI 10.1038/sj.leu.2402454; Kretsinger RH, 1996, NAT STRUCT BIOL, V3, P12, DOI 10.1038/nsb0196-12; KUCHKA MR, 1982, J CELL BIOL, V92, P170, DOI 10.1083/jcb.92.1.170; KUMAR N, 1991, MOL BIOCHEM PARASIT, V48, P47, DOI 10.1016/0166-6851(91)90163-Z; KUMAR N, 1988, P NATL ACAD SCI USA, V85, P6277, DOI 10.1073/pnas.85.17.6277; Lassmann T, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-298; Le Roch KG, 2003, SCIENCE, V301, P1503, DOI 10.1126/science.1087025; Leander BS, 2003, TRENDS ECOL EVOL, V18, P395, DOI 10.1016/S0169-5347(03)00152-6; LEE VD, 1993, P NATL ACAD SCI USA, V90, P11039, DOI 10.1073/pnas.90.23.11039; LINSE S, 1991, J BIOL CHEM, V266, P8050; Lutz W, 2001, J BIOL CHEM, V276, P20774, DOI 10.1074/jbc.M101324200; Middendorp S, 1997, P NATL ACAD SCI USA, V94, P9141, DOI 10.1073/pnas.94.17.9141; Middendorp S, 2000, J CELL BIOL, V148, P405, DOI 10.1083/jcb.148.3.405; MONCRIEF ND, 1990, J MOL EVOL, V30, P522, DOI 10.1007/BF02101108; Morrissette NS, 2002, MICROBIOL MOL BIOL R, V66, P21, DOI 10.1128/MMBR.66.1.21-38.2002; Nguyen TV, 2001, J BIOL CHEM, V276, P26724, DOI 10.1074/jbc.M103375200; PIELOU E C, 1969, P286; READ M, 1993, PARASITOLOGY, V106, P223, DOI 10.1017/S0031182000075041; Salanti A, 2003, MOL MICROBIOL, V49, P179, DOI 10.1046/j.1365-2958.2003.03570.x; Salisbury JL, 2002, CURR BIOL, V12, P1287, DOI 10.1016/S0960-9822(02)01019-9; SALISBURY JL, 1984, J CELL BIOL, V99, P962, DOI 10.1083/jcb.99.3.962; SANDERS MA, 1994, J CELL BIOL, V124, P795, DOI 10.1083/jcb.124.5.795; SCHATTEN G, 1994, DEV BIOL, V165, P299, DOI 10.1006/dbio.1994.1256; Schmidt HA, 2002, BIOINFORMATICS, V18, P502, DOI 10.1093/bioinformatics/18.3.502; SCHOFIELD L, 1986, MOL BIOCHEM PARASIT, V18, P183, DOI 10.1016/0166-6851(86)90037-X; SCHREVEL J, 1977, J ULTRA MOL STRUCT R, V59, P332, DOI 10.1016/S0022-5320(77)90043-0; Selvapandiyan A, 2004, J BIOL CHEM, V279, P25703, DOI 10.1074/jbc.M402794200; Selvapandiyan A, 2001, J BIOL CHEM, V276, P43253, DOI 10.1074/jbc.M106806200; Selvapandiyan A, 2007, MOL BIOL CELL, V18, P3290, DOI 10.1091/mbc.E07-01-0022; SPANG A, 1993, J CELL BIOL, V123, P405, DOI 10.1083/jcb.123.2.405; Striepen B, 2007, PLOS PATHOG, V3, P691, DOI 10.1371/journal.ppat.0030078; STRYNADKA NCJ, 1989, ANNU REV BIOCHEM, V58, P951, DOI 10.1146/annurev.bi.58.070189.004511; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; VAVRA J, 1969, J PROTOZOOL, V16, P745, DOI 10.1111/j.1550-7408.1969.tb02338.x; Wolfrum U, 1998, EXP CELL RES, V242, P10, DOI 10.1006/excr.1998.4038; WRIGHT RL, 1985, J CELL BIOL, V101, P1903, DOI 10.1083/jcb.101.5.1903	64	43	44	0	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 14	2008	283	46					31871	31883		10.1074/jbc.M800028200	http://dx.doi.org/10.1074/jbc.M800028200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	370KJ	18693242	hybrid			2022-12-27	WOS:000260760800070
J	Domsic, JF; Avvaru, BS; Kim, CU; Gruner, SM; Agbandje-McKenna, M; Silverman, DN; Mckenna, R				Domsic, John F.; Avvaru, Balendu Sankara; Kim, Chae Un; Gruner, Sol M.; Agbandje-McKenna, Mavis; Silverman, David N.; Mckenna, Robert			Entrapment of Carbon Dioxide in the Active Site of Carbonic Anhydrase II	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTON-TRANSFER; HYDROPHOBIC POCKET; CATALYTIC MECHANISM; MOLECULAR-DYNAMICS; BINDING; SUBSTRATE; CO2; CRYSTAL; HCO3; ZINC	The visualization at near atomic resolution of transient substrates in the active site of enzymes is fundamental to fully understanding their mechanism of action. Here we show the application of using CO2-pressurized, cryo-cooled crystals to capture the first step of CO2 hydration catalyzed by the zinc-metalloenzyme human carbonic anhydrase II, the binding of substrate CO2, for both the holo and the apo (without zinc) enzyme to 1.1 angstrom resolution. Until now, the feasibility of such a study was thought to be technically too challenging because of the low solubility of CO2 and the fast turnover to bicarbonate by the enzyme (Liang, J. Y., and Lipscomb, W. N. (1990) Proc. Natl. Acad. Sci. U. S. A. 87, 3675-3679). These structures provide insight into the long hypothesized binding of CO2 in a hydrophobic pocket at the active site and demonstrate that the zinc does not play a critical role in the binding or orientation of CO2. This method may also have a much broader implication for the study of other enzymes for which CO2 is a substrate or product and for the capturing of transient substrates and revealing hydrophobic pockets in proteins.	[Domsic, John F.; Avvaru, Balendu Sankara; Agbandje-McKenna, Mavis; Silverman, David N.; Mckenna, Robert] Univ Florida, Coll Med, Dept Biochem & Mol Biol, Gainesville, FL 32610 USA; [Silverman, David N.] Univ Florida, Coll Med, Dept Pharmacol & Therapeut, Gainesville, FL 32610 USA; [Kim, Chae Un; Gruner, Sol M.] Cornell Univ, Cornell High Energy Synchrotron Source, Ithaca, NY 14853 USA; [Gruner, Sol M.] Cornell Univ, Dept Phys, Ithaca, NY 14853 USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; Cornell University; Cornell University	Mckenna, R (corresponding author), 1600 SW Archer Rd,POB 100245, Gainesville, FL 32610 USA.	rmckenna@ufl.edu	Gruner, Sol/G-2924-2010; Kim, Chae Un/D-2956-2014	Gruner, Sol/0000-0002-1171-4426; 	National Institutes of Health [GM25154, RR001646]; MacCHESS; Thomas Maren Foundation; U. S. Department of Energy [DE-FG02-97ER62443]; CHESS; U. S. National Science Foundation (NSF); National Institutes of Health-NIGMS [DMR-0225180]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR001646] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM025154] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MacCHESS; Thomas Maren Foundation; U. S. Department of Energy(United States Department of Energy (DOE)); CHESS(Defence Research & Development Organisation (DRDO)); U. S. National Science Foundation (NSF)(National Science Foundation (NSF)); National Institutes of Health-NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM25154 (to D. N. S. and R. M.) and the MacCHESS grant (National Institutes of Health Grant RR001646). This work was also supported by grants from the Thomas Maren Foundation (to R. M.), U. S. Department of Energy Grant DE-FG02-97ER62443, and CHESS, which is supported by the U. S. National Science Foundation (NSF) and National Institutes of Health-NIGMS through NSF grant DMR-0225180. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked " advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	ALEXANDER RS, 1991, BIOCHEMISTRY-US, V30, P11064, DOI 10.1021/bi00110a008; BERTINI I, 1987, J AM CHEM SOC, V109, P7855, DOI 10.1021/ja00259a038; BERTINI I, 1992, INORG CHEM, V31, P3975, DOI 10.1021/ic00045a022; BRUNGER AT, 1992, NATURE, V355, P472, DOI 10.1038/355472a0; BUTLER JN, 1982, CARBON DIOXIDE EQUIL, P15; Chegwidden W. R., 2000, CARBONIC ANHYDRASES, DOI [10.1007/978-3-0348-8446-4_9, DOI 10.1007/978-3-0348-8446-4_9]; Christianson DW, 1996, ACCOUNTS CHEM RES, V29, P331, DOI 10.1021/ar9501232; DAVENPORT HW, 1984, ANN NY ACAD SCI, V429, P4, DOI 10.1111/j.1749-6632.1984.tb12310.x; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FIERKE CA, 1991, BIOCHEMISTRY-US, V30, P11054, DOI 10.1021/bi00110a007; Fisher SZ, 2007, BIOCHEMISTRY-US, V46, P2930, DOI 10.1021/bi062066y; FORSMAN C, 1988, ACTA CHEM SCAND B, V42, P314, DOI 10.3891/acta.chem.scand.42b-0314; HAKANSSON K, 1992, J MOL BIOL, V227, P1192, DOI 10.1016/0022-2836(92)90531-N; Jonasson P, 1997, BIOCHEMISTRY-US, V36, P5142, DOI 10.1021/bi961882a; KHALIFAH RG, 1977, BIOCHEMISTRY-US, V16, P2241, DOI 10.1021/bi00629a031; Kim CU, 2005, ACTA CRYSTALLOGR D, V61, P881, DOI 10.1107/S090744490500836X; KREBS JF, 1993, BIOCHEMISTRY-US, V32, P4496, DOI 10.1021/bi00068a004; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LIANG JY, 1990, P NATL ACAD SCI USA, V87, P3675, DOI 10.1073/pnas.87.10.3675; LIANG JY, 1987, BIOCHEMISTRY-US, V26, P5293, DOI 10.1021/bi00391a012; LINDAHL M, 1993, PROTEINS, V15, P177, DOI 10.1002/prot.340150207; Lindskog S, 1997, PHARMACOL THERAPEUT, V74, P1, DOI 10.1016/S0163-7258(96)00198-2; Lindskog S., 1983, ZINC ENZYMES, P78; McPherson A, 1982, PREPARATION ANAL PRO; MERZ KM, 1991, J AM CHEM SOC, V113, P406, DOI 10.1021/ja00002a004; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Roy A, 2007, J PHYS CHEM B, V111, P10563, DOI 10.1021/jp073499t; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Silverman DN, 2007, ACCOUNTS CHEM RES, V40, P669, DOI 10.1021/ar7000588; SILVERMAN DN, 1988, ACCOUNTS CHEM RES, V21, P30, DOI 10.1021/ar00145a005; TU CK, 1989, BIOCHEMISTRY-US, V28, P7913, DOI 10.1021/bi00445a054; WILLIAMS TJ, 1985, BIOCHEMISTRY-US, V24, P2459, DOI 10.1021/bi00331a010; Xu Y, 2008, NATURE, V452, P56, DOI 10.1038/nature06636; XUE YF, 1993, PROTEINS, V15, P80, DOI 10.1002/prot.340150110	34	169	173	1	48	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 7	2008	283	45					30766	30771		10.1074/jbc.M805353200	http://dx.doi.org/10.1074/jbc.M805353200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	367ID	18768466	Green Submitted, Green Published, hybrid			2022-12-27	WOS:000260544800031
J	Haaning, S; Radutoiu, S; Hoffmann, SV; Dittmer, J; Giehm, L; Otzen, DE; Stougaard, J				Haaning, Svend; Radutoiu, Simona; Hoffmann, Soren V.; Dittmer, Jens; Giehm, Lise; Otzen, Daniel E.; Stougaard, Jens			An Unusual Intrinsically Disordered Protein from the Model Legume Lotus japonicus Stabilizes Proteins in Vitro	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EMBRYOGENESIS ABUNDANT PROTEIN; NATIVELY UNFOLDED PROTEINS; SECONDARY STRUCTURE; STRUCTURAL DISORDER; REACTIVE OXYGEN; TERMINAL DOMAIN; CHAPERONE; EXPRESSION; STRESS; GENE	Intrinsic structural disorder is a prevalent feature of proteins with chaperone activity. Using a complementary set of techniques, we have structurally characterized LjIDP1 (intrinsically disordered protein 1) from the model legume Lotus japonicus, and our results provide the first structural characterization of a member of the Lea5 protein family (PF03242). Contrary to in silico predictions, we show that LjIDP1 is intrinsically disordered and probably exists as an ensemble of conformations with limited residual beta-sheet, turn/loop, and polyproline II secondary structure. Furthermore, we show that LjIDP1 has an inherent propensity to undergo a large conformational shift, adopting a largely alpha-helical structure when it is dehydrated and in the presence of different detergents and alcohols. This is consistent with an overrepresentation of order-promoting residues in LjIDP1 compared with the average of intrinsically disordered proteins. In line with functioning as a chaperone, we show that LjIDP1 effectively prevents inactivation of two model enzymes under conditions that promote protein misfolding and aggregation. The LjIdp1 gene is expressed in all L. japonicus tissues tested. A higher expression level was found in the root tip proximal zone, in roots inoculated with compatible endosymbiotic M. loti, and in functional nitrogen-fixing root nodules. We suggest that the ability of LjIDP1 to prevent protein misfolding and aggregation may play a significant role in tissues, such as symbiotic root nodules, which are characterized by high metabolic activity.	[Haaning, Svend; Radutoiu, Simona; Stougaard, Jens] Univ Aarhus, Ctr Carbohydrate Recognit & Signalling, Dept Mol Biol, DK-8000 Aarhus, Denmark; [Hoffmann, Soren V.] Univ Aarhus, Inst Storage Ring Facil, DK-8000 Aarhus, Denmark; [Dittmer, Jens] Univ Aarhus, Dept Chem, DK-8000 Aarhus, Denmark; [Giehm, Lise; Otzen, Daniel E.] Univ Aarhus, Interdisciplinary Nanosci Ctr, DK-8000 Aarhus, Denmark	Aarhus University; Aarhus University; Aarhus University; Aarhus University	Stougaard, J (corresponding author), Gustav Wieds Vej 10, DK-8000 Aarhus, Denmark.	stougaard@mb.au.dk	Dittmer, Jens/B-2020-2014	Dittmer, Jens/0000-0001-5038-6077; Hoffmann, Soren Vronning/0000-0002-8018-5433; Stougaard, Jens/0000-0002-9312-2685; Haaning, Svend/0000-0001-8417-2579; Otzen, Daniel/0000-0002-2918-8989	Danish Biotech Research Academy (DBRA); Danish National Research Foundation (Research Centre CARB); Danish Research Science Foundation; Villum Kann Rasmussen Foundation; Danish National Research Foundation	Danish Biotech Research Academy (DBRA); Danish National Research Foundation (Research Centre CARB)(Danmarks Grundforskningsfond); Danish Research Science Foundation; Villum Kann Rasmussen Foundation(Villum Fonden); Danish National Research Foundation(Danmarks Grundforskningsfond)	Supported by the Danish Biotech Research Academy (DBRA) and the Danish National Research Foundation (Research Centre CARB).; Supported by the Danish National Research Foundation (Research Centre CARB).; Supported by the Danish Research Science Foundation (Research Centre in SPIN) and the Villum Kann Rasmussen Foundation (Research Centre BioNET).; Supported by the Danish National Research Foundation (Research Centre CARB).	Alesandrini F, 2003, NEW PHYTOL, V158, P131, DOI 10.1046/j.1469-8137.2003.00720.x; Bhattacharyya J, 1999, J BIOL CHEM, V274, P15505, DOI 10.1074/jbc.274.22.15505; Bhattacharyya J, 2006, BIOCHEMISTRY-US, V45, P3069, DOI 10.1021/bi0518141; Chatellier J, 1998, P NATL ACAD SCI USA, V95, P9861, DOI 10.1073/pnas.95.17.9861; Chiti F, 2003, NATURE, V424, P805, DOI 10.1038/nature01891; Colebatch G, 2004, PLANT J, V39, P487, DOI 10.1111/j.1365-313X.2004.02150.x; COMPTON LA, 1986, ANAL BIOCHEM, V155, P155, DOI 10.1016/0003-2697(86)90241-1; Crowe JH, 2001, CRYOBIOLOGY, V43, P89, DOI 10.1006/cryo.2001.2353; Dunker A K, 2000, Genome Inform Ser Workshop Genome Inform, V11, P161; Dyson HJ, 2005, NAT REV MOL CELL BIO, V6, P197, DOI 10.1038/nrm1589; Dyson HJ, 2002, CURR OPIN STRUC BIOL, V12, P54, DOI 10.1016/S0959-440X(02)00289-0; Fuxreiter M, 2004, J MOL BIOL, V338, P1015, DOI 10.1016/j.jmb.2004.03.017; GALAU GA, 1993, PLANT PHYSIOL, V101, P695, DOI 10.1104/pp.101.2.695; GOSTI F, 1995, MOL GEN GENET, V246, P10, DOI 10.1007/BF00290128; Goyal K, 2005, BIOCHEM J, V388, P151, DOI 10.1042/BJ20041931; Goyal K, 2003, J BIOL CHEM, V278, P12977, DOI 10.1074/jbc.M212007200; Grelet J, 2005, PLANT PHYSIOL, V137, P157, DOI 10.1104/pp.104.052480; Jewett AI, 2006, J MOL BIOL, V363, P945, DOI 10.1016/j.jmb.2006.08.040; JIRGENSON B, 1961, ARCH BIOCHEM BIOPHYS, V94, P59, DOI 10.1016/0003-9861(61)90011-X; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; Karlin D, 2002, VIROLOGY, V296, P251, DOI 10.1006/viro.2001.1296; Kay BK, 2000, FASEB J, V14, P231, DOI 10.1096/fasebj.14.2.231; Lees JG, 2004, ANAL BIOCHEM, V332, P285, DOI 10.1016/j.ab.2004.06.002; LEHRMAN SR, 1990, BIOCHEMISTRY-US, V29, P5590, DOI 10.1021/bi00475a025; Longhi S, 2003, J BIOL CHEM, V278, P18638, DOI 10.1074/jbc.M300518200; Miles AJ, 2006, CHEM SOC REV, V35, P39, DOI 10.1039/b316168b; Mohan A, 2008, MOL BIOSYST, V4, P328, DOI 10.1039/b719168e; Mouillon JM, 2006, PLANT PHYSIOL, V141, P638, DOI 10.1104/pp.106.079848; Mowla SB, 2006, PLANT J, V48, P743, DOI 10.1111/j.1365-313X.2006.02911.x; NAOT D, 1995, PLANT MOL BIOL, V27, P619, DOI 10.1007/BF00019327; NELSON J W, 1986, Proteins Structure Function and Genetics, V1, P211, DOI 10.1002/prot.340010303; Obradovic Z, 2005, PROTEINS, V61, P176, DOI 10.1002/prot.20735; Oldfield CJ, 2005, BIOCHEMISTRY-US, V44, P1989, DOI 10.1021/bi047993o; Otzen DE, 2005, PROTEIN SCI, V14, P1396, DOI 10.1110/ps.041285605; Pauly N, 2006, J EXP BOT, V57, P1769, DOI 10.1093/jxb/erj184; Petrella EC, 1996, BIOCHEMISTRY-US, V35, P16535, DOI 10.1021/bi961498d; PLADYS D, 1993, PLANT PHYSIOL, V103, P379, DOI 10.1104/pp.103.2.379; Poduslo JF, 1999, J NEUROBIOL, V39, P371, DOI 10.1002/(SICI)1097-4695(19990605)39:3<371::AID-NEU4>3.3.CO;2-5; Pouchkina-Stantcheva NN, 2007, SCIENCE, V318, P268, DOI 10.1126/science.1144363; Prilusky J, 2005, BIOINFORMATICS, V21, P3435, DOI 10.1093/bioinformatics/bti537; Radivojac P, 2007, BIOPHYS J, V92, P1439, DOI 10.1529/biophysj.106.094045; Ramu SK, 2002, MOL PLANT MICROBE IN, V15, P522, DOI 10.1094/MPMI.2002.15.6.522; Rinaldi C, 2007, PLANT PHYSIOL, V144, P347, DOI 10.1104/pp.106.094987; Romero P, 2001, PROTEINS, V42, P38, DOI 10.1002/1097-0134(20010101)42:1<38::AID-PROT50>3.0.CO;2-3; Rost B, 2004, NUCLEIC ACIDS RES, V32, pW321, DOI 10.1093/nar/gkh377; Rousseau F, 2006, J MOL BIOL, V355, P1037, DOI 10.1016/j.jmb.2005.11.035; Santarius KA, 1998, CRYO-LETT, V19, P37; Santos R, 2001, MOL PLANT MICROBE IN, V14, P86, DOI 10.1094/MPMI.2001.14.1.86; Sickmeier M, 2007, NUCLEIC ACIDS RES, V35, pD786, DOI 10.1093/nar/gkl893; SONNICHSEN FD, 1992, BIOCHEMISTRY-US, V31, P8790, DOI 10.1021/bi00152a015; SRERE PA, 1966, J BIOL CHEM, V241, P2157; Stacey G, 2006, PLANT PHYSIOL, V141, P1473, DOI 10.1104/pp.106.080986; Stan G, 2005, J MOL BIOL, V350, P817, DOI 10.1016/j.jmb.2005.05.012; Sugase K, 2007, NATURE, V447, P1021, DOI 10.1038/nature05858; TAMIYA T, 1985, CRYOBIOLOGY, V22, P446, DOI 10.1016/0011-2240(85)90156-7; Tian R, 2004, NEUROCHEM RES, V29, P1863, DOI 10.1023/B:NERE.0000042213.68600.65; Tolleter D, 2007, PLANT CELL, V19, P1580, DOI 10.1105/tpc.107.050104; Tompa P, 2005, TRENDS BIOCHEM SCI, V30, P484, DOI 10.1016/j.tibs.2005.07.008; Tompa P, 2004, FASEB J, V18, P1169, DOI 10.1096/fj.04-1584rev; Tompa P, 2005, FEBS LETT, V579, P3346, DOI 10.1016/j.febslet.2005.03.072; Tsai CJ, 2002, PROTEIN SCI, V11, P1753, DOI 10.1110/ps.4100102; Tunnacliffe A, 2007, NATURWISSENSCHAFTEN, V94, P791, DOI 10.1007/s00114-007-0254-y; Uversky VN, 2008, ANNU REV BIOPHYS, V37, P215, DOI 10.1146/annurev.biophys.37.032807.125924; Uversky VN, 2002, EUR J BIOCHEM, V269, P2, DOI 10.1046/j.0014-2956.2001.02649.x; Uversky VN, 2000, PROTEINS, V41, P415, DOI 10.1002/1097-0134(20001115)41:3<415::AID-PROT130>3.3.CO;2-Z; Uversky VN, 2002, PROTEIN SCI, V11, P739, DOI 10.1110/ps.4210102; Vacic V, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-211; VASSE J, 1993, PLANT J, V4, P555, DOI 10.1046/j.1365-313X.1993.04030555.x; WALSH KB, 1987, PLANT PHYSIOL, V85, P137, DOI 10.1104/pp.85.1.137; Wang YC, 2006, PLANT SCI, V171, P655, DOI 10.1016/j.plantsci.2006.06.011; Weaver LM, 1998, PLANT MOL BIOL, V37, P455, DOI 10.1023/A:1005934428906; Whitehead A, 2004, ATLA-ALTERN LAB ANIM, V32, P73, DOI 10.1177/026119290403202s15; Zhang XF, 2005, INT J BIOCHEM CELL B, V37, P1232, DOI 10.1016/j.biocel.2004.12.004	73	34	35	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 7	2008	283	45					31142	31152		10.1074/jbc.M805024200	http://dx.doi.org/10.1074/jbc.M805024200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	367ID	18779323	Green Published, hybrid			2022-12-27	WOS:000260544800068
J	Olsen, JD; Tucker, JD; Timney, JA; Qian, P; Vassilev, C; Hunter, CN				Olsen, John D.; Tucker, Jaimey D.; Timney, John A.; Qian, Pu; Vassilev, Cvetelin; Hunter, C. Neil			The Organization of LH2 Complexes in Membranes from Rhodobacter sphaeroides	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ATOMIC-FORCE MICROSCOPY; LIGHT-HARVESTING COMPLEX; CRYSTAL-STRUCTURE; ENERGY-TRANSFER; PHOTOSYNTHETIC APPARATUS; RHODOSPIRILLUM-PHOTOMETRICUM; RHODOPSEUDOMONAS-VIRIDIS; ANGSTROM RESOLUTION; ANTENNA COMPLEXES; NATIVE MEMBRANES	The mapping of the photosynthetic membrane of Rhodobacter sphaeroides by atomic force microscopy (AFM) revealed a unique organization of arrays of dimeric reaction center-light harvesting I-PufX (RC-LH1-PufX) core complexes surrounded and interconnected by light-harvesting LH2 complexes (Baha-tyrova, S., Frese, R. N., Siebert, C. A., Olsen, J. D., van der Werf, K. O., van Grondelle, R., Niederman, R. A., Bullough, P. A., Otto, C., and Hunter, C. N. (2004) Nature 430, 1058-1062). However, membrane regions consisting solely of LH2 complexes were under-represented in these images because these small, highly curved areas of membrane rendered them difficult to image even using gentle tapping mode AFM and impossible with contact mode AFM. We report AFM imaging of membranes prepared from a mutant of R. sphaeroides, DPF2G, that synthesizes only the LH2 complexes, which assembles spherical intracytoplasmic membrane vesicles of similar to 53 nm diameter in vivo. By opening these vesicles and adsorbing them onto mica to form small, <= 120 nm, largely flat sheets we have been able to visualize the organization of these LH2-only membranes for the first time. The transition from highly curved vesicle to the planar sheet is accompanied by a change in the packing of the LH2 complexes such that approximately half of the complexes are raised off the mica surface by similar to 1 nm relative to the rest. This vertical displacement produces a very regular corrugated appearance of the planar membrane sheets. Analysis of the topographs was used to measure the distances and angles between the complexes. These data are used to model the organization of LH2 complexes in the original, curved membrane. The implications of this architecture for the light harvesting function and diffusion of quinones in native membranes of R. sphaeroides are discussed.	[Olsen, John D.; Tucker, Jaimey D.; Timney, John A.; Qian, Pu; Hunter, C. Neil] Univ Sheffield, Dept Mol Biol & Biotechnol, Sheffield S10 2TH, S Yorkshire, England; [Vassilev, Cvetelin] Univ Sheffield, Dept Phys & Astron, Sheffield S10 2TH, S Yorkshire, England	University of Sheffield; University of Sheffield	Olsen, JD (corresponding author), Univ Sheffield, Dept Mol Biol & Biotechnol, Western Bank, Sheffield S10 2TH, S Yorkshire, England.	j.olsen@sheffield.ac.uk	Qian, Pu/GZM-2400-2022; Vasilev, Cvetelin/B-3937-2016	Vasilev, Cvetelin/0000-0002-0536-882X	Biotechnology and Biological Sciences Research Council UK; Engineering and Physical Sciences Research Council UK; EPSRC [EP/F027591/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/F027591/1] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council UK(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Engineering and Physical Sciences Research Council UK(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This work was supported by funding from the Biotechnology and Biological Sciences Research Council UK (to J. D. O., J. D. T., P. Q., J. A. T., and C. N. H.) and from the Engineering and Physical Sciences Research Council UK(to C. V.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Abramson J, 2003, SCIENCE, V301, P610, DOI 10.1126/science.1088196; Agarwal R, 2002, J PHYS CHEM A, V106, P7573, DOI 10.1021/jp014054m; Bahatyrova S, 2004, J BIOL CHEM, V279, P21327, DOI 10.1074/jbc.M313039200; Bahatyrova S, 2004, NATURE, V430, P1058, DOI 10.1038/nature02823; Bass RB, 2002, SCIENCE, V298, P1582, DOI 10.1126/science.1077945; BRUNISHOLZ RA, 1992, J PHOTOCH PHOTOBIO B, V15, P113, DOI 10.1016/1011-1344(92)87010-7; Goncalves RP, 2005, J STRUCT BIOL, V152, P221, DOI 10.1016/j.jsb.2005.10.002; Hess S, 1995, P NATL ACAD SCI USA, V92, P12333, DOI 10.1073/pnas.92.26.12333; HUNTER CN, 1988, BIOCHEMISTRY-US, V27, P3459, DOI 10.1021/bi00409a050; Jordan P, 2001, NATURE, V411, P909, DOI 10.1038/35082000; Jungas C, 1999, EMBO J, V18, P534, DOI 10.1093/emboj/18.3.534; Liu LN, 2008, FEBS J, V275, P3157, DOI 10.1111/j.1742-4658.2008.06469.x; LOMMEN MAJ, 1978, J BACTERIOL, V136, P730, DOI 10.1128/JB.136.2.730-741.1978; MCDERMOTT G, 1995, NATURE, V374, P517, DOI 10.1038/374517a0; MICHEL H, 1986, EMBO J, V5, P2445, DOI 10.1002/j.1460-2075.1986.tb04520.x; Muller DJ, 2003, J MOL BIOL, V327, P925, DOI 10.1016/S0022-2836(03)00206-7; Nagarajan V, 1997, BIOCHEMISTRY-US, V36, P2300, DOI 10.1021/bi962534b; Noy D, 2006, BBA-BIOENERGETICS, V1757, P90, DOI 10.1016/j.bbabio.2005.11.010; OLSEN JD, 1994, P NATL ACAD SCI USA, V91, P7124, DOI 10.1073/pnas.91.15.7124; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Qian P, 2008, J BIOL CHEM, V283, P14002, DOI 10.1074/jbc.M800625200; Scheuring S, 2006, J MOL BIOL, V358, P83, DOI 10.1016/j.jmb.2006.01.085; Scheuring S, 2004, EMBO J, V23, P4127, DOI 10.1038/sj.emboj.7600429; Scheuring S, 2005, J BIOL CHEM, V280, P1426, DOI 10.1074/jbc.M411334200; Scheuring S, 2003, P NATL ACAD SCI USA, V100, P1690, DOI 10.1073/pnas.0437992100; Scheuring S, 2003, J MOL BIOL, V325, P569, DOI 10.1016/S0022-2836(02)01241-X; Scheuring S, 2001, EMBO J, V20, P3029, DOI 10.1093/emboj/20.12.3029; Scheuring S, 2006, BIOPHYS J, V91, P3707, DOI 10.1529/biophysj.106.083709; SENER MK, 2008, P NATL ACAD SCI USA, V104, P15273; Siebert CA, 2004, EMBO J, V23, P690, DOI 10.1038/sj.emboj.7600092; Sturgis JN, 2008, PHOTOSYNTH RES, V95, P269, DOI 10.1007/s11120-007-9239-0; Timpmann K, 2000, J PHYS CHEM B, V104, P9769, DOI 10.1021/jp001993q; Walz T, 1998, J MOL BIOL, V282, P833, DOI 10.1006/jmbi.1998.2050; Xia D, 1997, SCIENCE, V277, P60, DOI 10.1126/science.277.5322.60; Zouni A, 2001, NATURE, V409, P739, DOI 10.1038/35055589	35	53	55	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 7	2008	283	45					30772	30779		10.1074/jbc.M804824200	http://dx.doi.org/10.1074/jbc.M804824200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	367ID	18723509	Green Published, hybrid			2022-12-27	WOS:000260544800032
J	Cucinotta, M; Visalli, M; Aguennouz, M; Valenti, A; Loddo, S; Altucci, L; Teti, D				Cucinotta, Maria; Visalli, Maria; Aguennouz, Mohamed; Valenti, Andrea; Loddo, Saverio; Altucci, Lucia; Teti, Diana			Regulation of Interleukin-8 Gene at a Distinct Site of Its Promoter by CCAAT Enhancer-binding Protein Homologous Protein in Prostaglandin E-2-treated Human T Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTORS C/EBP; AMINO-ACID LIMITATION; GROWTH ARREST; CHOP GADD153; ACTIVATION; EXPRESSION; DIFFERENTIATION; STRESS; BETA; IDENTIFICATION	For a long period of time, the transcription factor CCAAT/enhancer-binding protein homologous protein (CHOP) has been thought to inhibit transcriptional activity for its ability to interact with CCAAT enhancer-binding protein family factors, thus preventing their binding to DNA. We have previously shown that in human T lymphocytes the CHOP phosphorylation induced by prostaglandin E-2 (PGE(2))-increased interleukin-8 ( IL-8) gene expression. Given the CHOP positive role in the regulation of transcription, here we have investigated the molecular mechanism(s) by which CHOP increases IL-8 gene activity under PGE2 stimulus. Transfection experiments with mutants showed both that the CHOP transactivation domain is essential for IL-8 transcription and that the IL-8/activator protein 1 (AP-1) promoter mutated in NF-kappa B and NF-IL-6, but not in the AP-1 site, harbors essential CHOP-responsive elements. CHOP silencing confirmed its role in the IL- 8 transcriptional regulation and protein production, whereas c-Jun small interfering RNA experiments showed that the PGE(2)-induced activation of IL- 8 promoter is mainly c-Jun-independent. Moreover, PGE2 induced CHOP-DNA complexes only when the entire IL-8/AP-1 promoter or the wild type sequences encompassing the AP-1 upstream region were employed. Mutations introduced in these sequences prevented the DNA-CHOP complex formation. The IL-8/AP-1 mutant promoter lacking the sequence immediately upstream the AP-1 site is PGE2-unresponsive. Finally, chromatin immunoprecipitation data confirmed in vivo that PGE2 induces CHOP binding to the IL- 8 promoter. Taken together, our results suggest that the increased expression of CHOP in response to PGE2 exerts a positive transcriptional regulation of the IL- 8 promoter mediated by direct binding to a novel consensus site.	[Cucinotta, Maria; Visalli, Maria; Valenti, Andrea; Loddo, Saverio; Teti, Diana] Univ Messina, Dept Expt Pathol & Microbiol, I-98100 Messina, Italy; [Aguennouz, Mohamed] Univ Messina, Dept Neurosci Psychiat & Anaesthesiol, I-98100 Messina, Italy; [Altucci, Lucia] Univ Naples 2, Dept Gen Pathol, I-80138 Naples, Italy	University of Messina; University of Messina; Universita della Campania Vanvitelli	Teti, D (corresponding author), Torre Biol IV P, Dept Expt Pathol & Microbiol, Policlin Univ Via Consolare Valeria 1, I-98125 Messina, Italy.	dteti@unime.it	Altucci, Lucia/S-8031-2019; Loddo, Saverio/I-7397-2012; Aguennouz, M'hammed/U-7420-2017	Loddo, Saverio/0000-0002-3338-9599; Aguennouz, M'hammed/0000-0003-0440-0354; altucci, lucia/0000-0002-7312-5387	Dottorato di Ricerca in Patologia della proliferazione cellulare e del differenziamento; Progetto di Ricerca di Ateneo; School of Specialization in Clinical Pathology (University of Messina)	Dottorato di Ricerca in Patologia della proliferazione cellulare e del differenziamento; Progetto di Ricerca di Ateneo; School of Specialization in Clinical Pathology (University of Messina)	This work was supported by grants from the Dottorato di Ricerca in Patologia della proliferazione cellulare e del differenziamento, the Progetto di Ricerca di Ateneo (to D. T.), and the School of Specialization in Clinical Pathology (University of Messina). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	BARTLETT JD, 1992, J BIOL CHEM, V267, P20465; Bruhat A, 1997, J BIOL CHEM, V272, P17588, DOI 10.1074/jbc.272.28.17588; Caristi S, 2005, J BIOL CHEM, V280, P14433, DOI 10.1074/jbc.M410725200; CARLSON SG, 1993, MOL CELL BIOL, V13, P4736, DOI 10.1128/MCB.13.8.4736; CHEN Q, 1992, J BIOL CHEM, V267, P8207; Chipitsyna G, 2006, J CELL PHYSIOL, V207, P605, DOI 10.1002/jcp.20612; Cui KY, 2000, J BIOL CHEM, V275, P7591, DOI 10.1074/jbc.275.11.7591; Fawcett TW, 1996, J BIOL CHEM, V271, P14285, DOI 10.1074/jbc.271.24.14285; FORNACE AJ, 1989, MOL CELL BIOL, V9, P4196, DOI 10.1128/MCB.9.10.4196; FRIEDMAN AD, 1990, GENE DEV, V4, P1416, DOI 10.1101/gad.4.8.1416; Friedman AD, 1996, CANCER RES, V56, P3250; Hattori T, 2003, FEBS LETT, V541, P33, DOI 10.1016/S0014-5793(03)00283-7; Hattori T, 2001, J INTERF CYTOK RES, V21, P323, DOI 10.1089/107999001300177510; Kodama K, 2005, AM J PHYSIOL-CELL PH, V289, pC582, DOI 10.1152/ajpcell.00558.2004; MARTEN NW, 1994, FASEB J, V8, P538, DOI 10.1096/fasebj.8.8.8181673; Maytin EV, 1998, J INVEST DERMATOL, V110, P238, DOI 10.1046/j.1523-1747.1998.00123.x; Monici MC, 2003, NEUROLOGY, V60, P993, DOI 10.1212/01.WNL.0000049913.27181.51; Pereira RC, 2004, ENDOCRINOLOGY, V145, P1952, DOI 10.1210/en.2003-0868; PRICE BD, 1992, CANCER RES, V52, P3814; RON D, 1992, GENE DEV, V6, P439, DOI 10.1101/gad.6.3.439; Sauter K, 2005, J BIOL CHEM, V280, P33566, DOI 10.1074/jbc.M503482200; Schmitt-Ney M, 2000, J BIOL CHEM, V275, P40839, DOI 10.1074/jbc.M007440200; Shirakawa K, 2006, MOL CELL BIOL, V26, P6105, DOI 10.1128/MCB.02429-05; Tang QQ, 2000, P NATL ACAD SCI USA, V97, P12446, DOI 10.1073/pnas.220425597; Ubeda M, 1999, MOL CELL BIOL, V19, P7589; Ubeda M, 1996, MOL CELL BIOL, V16, P1479; Vij N, 2008, AM J RESP CELL MOL, V38, P176, DOI 10.1165/rcmb.2007-0197OC; Vij N, 2006, J BIOL CHEM, V281, P17369, DOI 10.1074/jbc.M600509200; Weinmann AS, 2002, METHODS, V26, P37, DOI 10.1016/S1046-2023(02)00006-3; Zhao Q, 2002, EMBO J, V21, P4411, DOI 10.1093/emboj/cdf445	30	14	14	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 31	2008	283	44					29760	29769		10.1074/jbc.M803145200	http://dx.doi.org/10.1074/jbc.M803145200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	364WS	18772138	Green Published, hybrid			2022-12-27	WOS:000260366900020
J	Lancellotti, S; Rutella, S; De Filippis, V; Pozzi, N; Rocca, B; De Cristofaro, R				Lancellotti, Stefano; Rutella, Sergio; De Filippis, Vincenzo; Pozzi, Nicola; Rocca, Bianca; De Cristofaro, Raimondo			Fibrinogen-elongated gamma Chain Inhibits Thrombin-induced Platelet Response, Hindering the Interaction with Different Receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLYCOPROTEIN IB-ALPHA; VON-WILLEBRAND-FACTOR; BLOOD-COAGULATION PROTEINASES; PEPTIDE CHLOROMETHYL KETONES; II-BINDING INHIBITOR; CRYSTAL-STRUCTURE; EXOSITE-II; FRAGMENT-D; MYOCARDIAL-INFARCTION; PROTHROMBIN FRAGMENT-2	The expression of the elongated fibrinogen gamma chain, termed gamma', derives from alternative splicing of mRNA and causes an insertion sequence of 20 amino acids. This insertion domain interacts with the anion-binding exosite (ABE)-II of thrombin. This study investigated whether and how gamma' chain binding to ABE-II affects thrombin interaction with its platelet receptors, i.e. glycoprotein Ib alpha (GpIb alpha), protease-activated receptor (PAR) 1, and PAR4. Both synthetic gamma' peptide and fibrinogen fragment D*, containing the elongated gamma' chain, inhibited thrombin-induced platelet aggregation up to 70%, with IC50 values of 42 +/- 3.5 and 0.47 +/- 0.03 mu M, respectively. Solid-phase binding and spectrofluorimetric assays showed that both fragment D* and the synthetic gamma' peptide specifically bind to thrombin ABE-II and competitively inhibit the thrombin binding to GpIb alpha with a mean K-i approximate to 0.5 and approximate to 35 mu M, respectively. Both these gamma' chain-containing ligands allosterically inhibited thrombin cleavage of a synthetic PAR1 peptide, of native PAR1 molecules on intact platelets, and of the synthetic chromogenic peptide D-Phe-pipecolyl-Arg-p-nitroanilide. PAR4 cleavage was unaffected. In summary, fibrinogen gamma' chain binds with high affinity to thrombin and inhibits with combined mechanisms the platelet response to thrombin. Thus, its variations in vivo may affect the hemostatic balance in arterial circulation.	[Lancellotti, Stefano; De Cristofaro, Raimondo] Catholic Univ, Sch Med, Haemostasis Res Ctr, Inst Internal Med & Geriatr, I-00168 Rome, Italy; [Rutella, Sergio] Catholic Univ, Sch Med, Immunol Lab, Dept Hematol, I-00168 Rome, Italy; [De Filippis, Vincenzo; Pozzi, Nicola] Univ Padua, Dept Pharmaceut Sci, I-35131 Padua, Italy; [Rocca, Bianca] Catholic Univ, Sch Med, Inst Pharmacol, I-00168 Rome, Italy	Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; University of Padua; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli	De Cristofaro, R (corresponding author), Catholic Univ, Sch Med, Haemostasis Res Ctr, Inst Internal Med & Geriatr, Largo F Vito 1, I-00168 Rome, Italy.	rdecristofaro@rm.unicatt.it	LANCELLOTTI, Stefano/AAA-2950-2022; Pozzi, Nicola/AAV-4876-2021; De Cristofaro, Raimondo/K-3942-2018; Rutella, Sergio/AAF-9187-2020; Lancellotti, Stefano/K-3939-2018; Pozzi, Nicola/AAE-4910-2020; Rutella, Sergio/AAF-9210-2020; rocca, bianca/K-3922-2018	LANCELLOTTI, Stefano/0000-0002-8090-9040; Pozzi, Nicola/0000-0003-2309-7100; De Cristofaro, Raimondo/0000-0002-8066-8849; Rutella, Sergio/0000-0003-1970-7375; 	Italian Ministry of University [PRIN-2005]	Italian Ministry of University(Ministry of Education, Universities and Research (MIUR))	This work was supported by Italian Ministry of University "PRIN-2005." The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	ARNI RK, 1993, BIOCHEMISTRY-US, V32, P4727, DOI 10.1021/bi00069a006; Atherton E., 1990, SOLID PHASE PEPTIDE; Bah A, 2007, P NATL ACAD SCI USA, V104, P11603, DOI 10.1073/pnas.0704409104; BOCK PE, 1992, J BIOL CHEM, V267, P14963; BOCK PE, 1992, J BIOL CHEM, V267, P14974; Carter WJ, 2005, J BIOL CHEM, V280, P2745, DOI 10.1074/jbc.M411606200; Celikel R, 2003, SCIENCE, V301, P218, DOI 10.1126/science.1084183; Cheung EYL, 2008, STROKE, V39, P1033, DOI 10.1161/STROKEAHA.107.495499; Chung DW, 2002, BIOCHEMISTRY-US, V41, P11065, DOI 10.1021/bi0204692; Cleary DB, 2002, ARCH BIOCHEM BIOPHYS, V403, P179, DOI 10.1016/S0003-9861(02)00220-5; Cooper AV, 2003, BLOOD, V102, P535, DOI 10.1182/blood-2002-10-3150; De Candia E, 2001, J BIOL CHEM, V276, P4692, DOI 10.1074/jbc.M008160200; De Cristofaro R, 2000, J BIOL CHEM, V275, P3887, DOI 10.1074/jbc.275.6.3887; De Cristofaro R, 2005, J BIOL CHEM, V280, P23295, DOI 10.1074/jbc.M501143200; De Cristofaro R, 2003, BIOCHEM J, V373, P593, DOI 10.1042/BJ20030167; de Willige SU, 2005, BLOOD, V106, P4176, DOI 10.1182/blood-2005-05-2180; DECRISTOFARO R, 1993, BIOCHEM J, V289, P475, DOI 10.1042/bj2890475; Drouet L, 1999, Blood Coagul Fibrinolysis, V10 Suppl 1, pS35; Duan HO, 2003, J BIOL CHEM, V278, P41270, DOI 10.1074/jbc.M304210200; Dumas JJ, 2003, SCIENCE, V301, P222, DOI 10.1126/science.1083917; EVERSE SJ, 1995, PROTEIN SCI, V4, P1013; Falls LA, 1997, J BIOL CHEM, V272, P14251, DOI 10.1074/jbc.272.22.14251; FARRELL DH, 1991, BIOCHEMISTRY-US, V30, P9414, DOI 10.1021/bi00103a004; Faruqi TR, 2000, J BIOL CHEM, V275, P19728, DOI 10.1074/jbc.M909960199; Fredenburgh JC, 2008, J BIOL CHEM, V283, P2470, DOI 10.1074/jbc.M707710200; Fredenburgh JC, 1997, J BIOL CHEM, V272, P25493, DOI 10.1074/jbc.272.41.25493; Furlan M, 1996, BLOOD, V87, P4223, DOI 10.1182/blood.V87.10.4223.bloodjournal87104223; Henry BL, 2007, J BIOL CHEM, V282, P31891, DOI 10.1074/jbc.M704257200; Jacques SL, 2003, BIOCHEM J, V376, P733, DOI 10.1042/BJ20030954; Jacques SL, 2000, J BIOL CHEM, V275, P40671, DOI 10.1074/jbc.M004544200; JANDROTPERRUS M, 1992, BLOOD, V80, P2781; KIRSCHBAUM NE, 1992, BLOOD, V79, P2643; Kostelansky MS, 2002, BIOCHEMISTRY-US, V41, P12124, DOI 10.1021/bi0261894; KUYAS C, 1982, J BIOL CHEM, V257, P1107; Lakowicz JR, 1999, PRINCIPLES FLUORESCE; LANCELLOTTI S, 2008, CARDIOVASCU IN PRESS; LIU LW, 1991, J BIOL CHEM, V266, P16977; Lovely RS, 2007, BRIT J HAEMATOL, V139, P494, DOI 10.1111/j.1365-2141.2007.06825.x; Lovely RS, 2002, THROMB HAEMOSTASIS, V88, P26; Mannila MN, 2007, J THROMB HAEMOST, V5, P766, DOI 10.1111/j.1538-7836.2007.02406.x; Mannila MN, 2007, J INTERN MED, V261, P138, DOI 10.1111/j.1365-2796.2006.01749.x; Mannila MN, 2005, THROMB HAEMOSTASIS, V93, P570, DOI 10.1160/TH04-10-0698; MATHEWS II, 1994, BIOCHEMISTRY-US, V33, P3266, DOI 10.1021/bi00177a018; MAYO KH, 1990, BIOCHEMISTRY-US, V29, P3277, DOI 10.1021/bi00465a019; Meh DA, 1996, J BIOL CHEM, V271, P23121, DOI 10.1074/jbc.271.38.23121; Mosesson MW, 2003, J THROMB HAEMOST, V1, P231, DOI 10.1046/j.1538-7836.2003.00063.x; PACE CN, 1995, PROTEIN SCI, V4, P2411, DOI 10.1002/pro.5560041120; Pineda AO, 2007, BIOPHYS CHEM, V125, P556, DOI 10.1016/j.bpc.2006.08.005; Richardson JL, 2000, EMBO J, V19, P5650, DOI 10.1093/emboj/19.21.5650; Richardson JL, 2002, BIOCHEMISTRY-US, V41, P2535, DOI 10.1021/bi011605q; RYDEL TJ, 1991, J MOL BIOL, V221, P583, DOI 10.1016/0022-2836(91)80074-5; Sabo TM, 2006, BIOCHEMISTRY-US, V45, P7434, DOI 10.1021/bi060360k; SEEGERS WH, 1945, SCIENCE, V101, P520, DOI 10.1126/science.101.2629.520; Soslau G, 2001, J BIOL CHEM, V276, P21173, DOI 10.1074/jbc.M008249200; Spraggon G, 1997, NATURE, V389, P455, DOI 10.1038/38947; Tasset DM, 1997, J MOL BIOL, V272, P688, DOI 10.1006/jmbi.1997.1275; Thomas DP, 1997, ANN INTERN MED, V126, P638, DOI 10.7326/0003-4819-126-8-199704150-00009; Verhamme IM, 2002, J BIOL CHEM, V277, P6788, DOI 10.1074/jbc.M110257200; VIJAYALAKSHMI J, 1994, PROTEIN SCI, V3, P2254, DOI 10.1002/pro.5560031211; WYMAN J, 1990, BINDING LINKAGE FUNC, P33; Yee VC, 1997, STRUCTURE, V5, P125, DOI 10.1016/S0969-2126(97)00171-8	61	34	35	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 31	2008	283	44					30193	30204		10.1074/jbc.M803659200	http://dx.doi.org/10.1074/jbc.M803659200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	364WS	18779330	hybrid, Green Accepted, Green Published			2022-12-27	WOS:000260366900064
J	Lum, R; Niggemann, M; Glover, JR				Lum, Ronnie; Niggemann, Monika; Glover, John R.			Peptide and Protein Binding in the Axial Channel of Hsp104 INSIGHTS INTO THE MECHANISM OF PROTEIN UNFOLDING	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEAT-SHOCK-PROTEIN; N-TERMINAL DOMAIN; ATP-DEPENDENT PROTEASE; MOLECULAR CHAPERONE; SUBSTRATE RECOGNITION; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; SACCHAROMYCES-CEREVISIAE; PRION PROPAGATION; CENTRAL PORE	The AAA+ molecular chaperone Hsp104 mediates the extraction of proteins from aggregates by unfolding and threading them through its axial channel in an ATP-driven process. An Hsp104-binding peptide selected from solid phase arrays enhanced the refolding of a firefly luciferase-peptide fusion protein. Analysis of peptide binding using tryptophan fluorescence revealed two distinct binding sites, one in each AAA+ module of Hsp104. As a further indication of the relevance of peptide binding to the Hsp104 mechanism, we found that it competes with the binding of a model unfolded protein, reduced carboxymethylated alpha-lactalbumin. Inactivation of the pore loops in either AAA+ module prevented stable peptide and protein binding. However, when the loop in the first AAA+ was inactivated, stimulation of ATPase turnover in the second AAA+ module of this mutant was abolished. Drawing on these data, we propose a detailed mechanistic model of protein unfolding by Hsp104 in which an initial unstable interaction involving the loop in the first AAA+ module simultaneously promotes penetration of the substrate into the second axial channel binding site and activates ATP turnover in the second AAA+ module.	[Lum, Ronnie; Niggemann, Monika; Glover, John R.] Univ Toronto, Dept Biochem, Toronto, ON M5S 1A8, Canada	University of Toronto	Glover, JR (corresponding author), Univ Toronto, Dept Biochem, Rm 5302,Med Sci Bldg,1 Kings Coll Circle, Toronto, ON M5S 1A8, Canada.	john.glover@utoronto.ca			Canadian Institutes for Health Research; Ontario Graduate Scholarship; National Sciences and Engineering Research Council of Canada	Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Ontario Graduate Scholarship(Ontario Graduate Scholarship); National Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported in part by the Canadian Institutes for Health Research. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.; Supported by an Ontario Graduate Scholarship and a National Sciences and Engineering Research Council of Canada Postgraduate Scholarship.	Barnett ME, 2005, J BIOL CHEM, V280, P34940, DOI 10.1074/jbc.M505653200; Bochtler M, 2000, NATURE, V403, P800, DOI 10.1038/35001629; Bosl B, 2005, J BIOL CHEM, V280, P38170, DOI 10.1074/jbc.M506149200; CHERNOFF YO, 1995, SCIENCE, V268, P880, DOI 10.1126/science.7754373; Cunningham F, 2007, METHODS, V41, P370, DOI 10.1016/j.ymeth.2006.07.003; CYR DM, 1992, J BIOL CHEM, V267, P20927; Derkatch IL, 1997, GENETICS, V147, P507; Doyle SM, 2007, NAT STRUCT MOL BIOL, V14, P114, DOI 10.1038/nsmb1198; Flynn JM, 2003, MOL CELL, V11, P671, DOI 10.1016/S1097-2765(03)00060-1; Glover JR, 1998, CELL, V94, P73, DOI 10.1016/S0092-8674(00)81223-4; Goloubinoff P, 1999, P NATL ACAD SCI USA, V96, P13732, DOI 10.1073/pnas.96.24.13732; Gottesman S, 1998, GENE DEV, V12, P1338, DOI 10.1101/gad.12.9.1338; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Guo FS, 2002, J BIOL CHEM, V277, P46743, DOI 10.1074/jbc.M207796200; Haebel PW, 2004, CURR OPIN STRUC BIOL, V14, P58, DOI 10.1016/j.sbi.2004.01.010; Haslberger T, 2008, NAT STRUCT MOL BIOL, V15, P641, DOI 10.1038/nsmb.1425; Haslberger T, 2007, MOL CELL, V25, P247, DOI 10.1016/j.molcel.2006.11.008; Hattendorf DA, 2002, EMBO J, V21, P12, DOI 10.1093/emboj/21.1.12; HAYERHARTL MK, 1994, EMBO J, V13, P3192, DOI 10.1002/j.1460-2075.1994.tb06618.x; Hinnerwisch J, 2005, CELL, V121, P1029, DOI 10.1016/j.cell.2005.04.012; Hoskins JR, 2000, J BIOL CHEM, V275, P35361, DOI 10.1074/jbc.M006288200; Hung GC, 2006, GENETICS, V173, P611, DOI 10.1534/genetics.106.056820; Ishikawa T, 2001, P NATL ACAD SCI USA, V98, P4328, DOI 10.1073/pnas.081543698; Kern R, 2003, BIOCHEM J, V371, P965, DOI 10.1042/BJ20030093; Kim DY, 2003, J BIOL CHEM, V278, P50664, DOI 10.1074/jbc.M305882200; Kim YI, 2000, MOL CELL, V5, P639, DOI 10.1016/S1097-2765(00)80243-9; Kong CG, 2004, MOL CELL, V14, P233, DOI 10.1016/S1097-2765(04)00206-0; Kurahashi H, 2007, MOL MICROBIOL, V63, P1669, DOI 10.1111/j.1365-2958.2007.05629.x; Lee S, 2003, CELL, V115, P229, DOI 10.1016/S0092-8674(03)00807-9; Lee S, 2007, MOL CELL, V25, P261, DOI 10.1016/j.molcel.2007.01.002; Liu ZH, 2002, J MOL BIOL, V321, P111, DOI 10.1016/S0022-2836(02)00591-0; Lu Z, 1998, J BIOL CHEM, V273, P27824, DOI 10.1074/jbc.273.43.27824; Lum R, 2004, J BIOL CHEM, V279, P29139, DOI 10.1074/jbc.M403777200; Moriyama H, 2000, MOL CELL BIOL, V20, P8916, DOI 10.1128/MCB.20.23.8916-8922.2000; NORBY JG, 1988, METHOD ENZYMOL, V156, P116; Ortega J, 2000, MOL CELL, V6, P1515, DOI 10.1016/S1097-2765(00)00148-9; Park EY, 2005, J BIOL CHEM, V280, P22892, DOI 10.1074/jbc.M500035200; PARSELL DA, 1994, NATURE, V372, P475, DOI 10.1038/372475a0; Reid BG, 2001, P NATL ACAD SCI USA, V98, P3768, DOI 10.1073/pnas.071043698; Schaupp A, 2007, J MOL BIOL, V370, P674, DOI 10.1016/j.jmb.2007.04.070; Schlieker C, 2004, NAT STRUCT MOL BIOL, V11, P607, DOI 10.1038/nsmb787; Scholz C, 1997, EMBO J, V16, P54, DOI 10.1093/emboj/16.1.54; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; Shorter J, 2006, MOL CELL, V23, P425, DOI 10.1016/j.molcel.2006.05.042; Siddiqui SM, 2004, GENE DEV, V18, P369, DOI 10.1101/gad.1170304; Singer MA, 1998, MOL CELL, V1, P639, DOI 10.1016/S1097-2765(00)80064-7; Singh SK, 2000, P NATL ACAD SCI USA, V97, P8898, DOI 10.1073/pnas.97.16.8898; Sousa MC, 2000, CELL, V103, P633, DOI 10.1016/S0092-8674(00)00166-5; Tanaka N, 2004, PROTEIN SCI, V13, P3214, DOI 10.1110/ps.04780704; Tessarz P, 2008, MOL MICROBIOL, V68, P87, DOI 10.1111/j.1365-2958.2008.06135.x; Thibault G, 2006, P NATL ACAD SCI USA, V103, P17724, DOI 10.1073/pnas.0601505103; Tkach JM, 2004, J BIOL CHEM, V279, P35692, DOI 10.1074/jbc.M400782200; Tkach JM, 2006, TOP CURR GENET, V16, P65; Wang J, 2001, STRUCTURE, V9, P177, DOI 10.1016/S0969-2126(01)00570-6; WAWRZYNOW A, 1995, EMBO J, V14, P1867, DOI 10.1002/j.1460-2075.1995.tb07179.x; Weber-Ban EU, 1999, NATURE, V401, P90, DOI 10.1038/43481; Weibezahn J, 2004, CELL, V119, P653, DOI 10.1016/j.cell.2004.11.027; Weibezahn J, 2003, J BIOL CHEM, V278, P32608, DOI 10.1074/jbc.M303653200; Wendler P, 2007, CELL, V131, P1366, DOI 10.1016/j.cell.2007.10.047; Werbeck ND, 2008, J MOL BIOL, V378, P178, DOI 10.1016/j.jmb.2008.02.026; WICKNER S, 1994, P NATL ACAD SCI USA, V91, P12218, DOI 10.1073/pnas.91.25.12218; Zietkiewicz S, 2006, J BIOL CHEM, V281, P7022, DOI 10.1074/jbc.M507893200	62	66	66	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 31	2008	283	44					30139	30150		10.1074/jbc.M804849200	http://dx.doi.org/10.1074/jbc.M804849200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	364WS	18755692	Green Published, hybrid			2022-12-27	WOS:000260366900059
J	Chen, Y; Pan, XJ; Tang, Y; Quan, S; Tai, PC; Sui, SF				Chen, Yong; Pan, Xijiang; Tang, Ying; Quan, Shu; Tai, Phang C.; Sui, Sen-Fang			Full-length Escherichia coli SecA Dimerizes in a Closed Conformation in Solution as Determined by Cryo-electron Microscopy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSLOCATION ATPASE SECA; BACILLUS-SUBTILIS SECA; PLASMA-MEMBRANE; PROTEIN TRANSLOCATION; PRECURSOR PROTEIN; CRYSTAL-STRUCTURE; BINDING; VESICLES; COMPLEX; EXISTS	SecA is an obligatory component of the Escherichia coli general secretion pathway. However, the oligomeric structure of SecA and SecA conformational changes during translocation processes are still unclear. Here we obtained the three-dimensional structure of E. coli wild-type full-length SecA in solution by single particle cryo-electron microscopy and determined its oligomeric organization. In this structure, SecA occurs as a dimer in which the two protomers are arranged in an antiparallel mode, with a novel electrostatic interface, and both protomers are in closed conformation. The system developed here may provide a promising technique for studying dynamic structural changes in SecA.	[Chen, Yong; Pan, Xijiang; Tang, Ying; Quan, Shu; Sui, Sen-Fang] Tsinghua Univ, State Key Lab Biomembrane & Membrane Biotechnol, Dept Biol Sci & Biotechnol, Beijing 100084, Peoples R China; [Tai, Phang C.] Georgia State Univ, Dept Biol, Atlanta, GA 30303 USA	Tsinghua University; University System of Georgia; Georgia State University	Sui, SF (corresponding author), Tsinghua Univ, State Key Lab Biomembrane & Membrane Biotechnol, Dept Biol Sci & Biotechnol, Beijing 100084, Peoples R China.	suisf@mail.tsinghua.edu.cn	Chen, Yong/AAF-9915-2020; Quan, Shu/O-4562-2015; chen, Yong/F-3938-2010	Chen, Yong/0000-0001-5857-6086; Quan, Shu/0000-0002-6672-4947; Sui, Sen-Fang/0000-0001-5253-2592	National Nature Science Foundation of China; National Basic Research Program 973 of China [2004 CB720005]; National Institutes of Health [34766]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program 973 of China(National Basic Research Program of China); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by research grants from the National Nature Science Foundation of China and the National Basic Research Program 973 of China (Grant 2004 CB720005). This work was also supported in part by National Institutes of Health Grant 34766 (to P. C. T.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	AKITA M, 1991, BIOCHEM BIOPH RES CO, V174, P211, DOI 10.1016/0006-291X(91)90507-4; Benach J, 2003, J BIOL CHEM, V278, P3628, DOI 10.1074/jbc.M205992200; CABELLI RJ, 1988, CELL, V55, P683, DOI 10.1016/0092-8674(88)90227-9; Chen XC, 1996, J BIOL CHEM, V271, P29698, DOI 10.1074/jbc.271.47.29698; Chen Y, 2007, J STRUCT BIOL, V159, P149, DOI 10.1016/j.jsb.2007.01.015; CUNNINGHAM K, 1989, EMBO J, V8, P955, DOI 10.1002/j.1460-2075.1989.tb03457.x; de Keyzer J, 2003, CELL MOL LIFE SCI, V60, P2034, DOI 10.1007/s00018-003-3006-y; Ding HY, 2003, BIOCHEMISTRY-US, V42, P8729, DOI 10.1021/bi0342057; DRIESSEN AJM, 1993, BIOCHEMISTRY-US, V32, P13190, DOI 10.1021/bi00211a030; Frank J, 1996, J STRUCT BIOL, V116, P190, DOI 10.1006/jsbi.1996.0030; Gelis I, 2007, CELL, V131, P756, DOI 10.1016/j.cell.2007.09.039; HARTL FU, 1990, CELL, V63, P269, DOI 10.1016/0092-8674(90)90160-G; HENDRICK JP, 1991, J BIOL CHEM, V266, P24596; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Hunt JF, 2002, SCIENCE, V297, P2018, DOI 10.1126/science.1074424; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; Manting EH, 2000, MOL MICROBIOL, V37, P226, DOI 10.1046/j.1365-2958.2000.01980.x; OLIVER DB, 1981, CELL, V25, P765, DOI 10.1016/0092-8674(81)90184-7; Or E, 2002, EMBO J, V21, P4470, DOI 10.1093/emboj/cdf471; Osborne AR, 2004, P NATL ACAD SCI USA, V101, P10937, DOI 10.1073/pnas.0401742101; PAN XJ, 2005, TSINGHUA SCI TECHNOL, V10, P445; Papanikolau Y, 2007, J MOL BIOL, V366, P1545, DOI 10.1016/j.jmb.2006.12.049; Sharma V, 2003, P NATL ACAD SCI USA, V100, P2243, DOI 10.1073/pnas.0538077100; van der Wolk JPW, 1997, EMBO J, V16, P7297, DOI 10.1093/emboj/16.24.7297; Vassylyev DG, 2006, J MOL BIOL, V364, P248, DOI 10.1016/j.jmb.2006.09.061; Wang HW, 2003, P NATL ACAD SCI USA, V100, P4221, DOI 10.1073/pnas.0737415100; WATANABE M, 1993, P NATL ACAD SCI USA, V90, P9011, DOI 10.1073/pnas.90.19.9011; Wickner W, 1996, J BIOL CHEM, V271, P29514, DOI 10.1074/jbc.271.47.29514; Woodbury RL, 2000, J BIOL CHEM, V275, P24191, DOI 10.1074/jbc.M002885200; Woodbury RL, 2002, PROTEIN SCI, V11, P875, DOI 10.1110/ps.4090102; Wriggers W, 2001, STRUCTURE, V9, P779, DOI 10.1016/S0969-2126(01)00648-7; Zimmer J, 2006, J MOL BIOL, V364, P259, DOI 10.1016/j.jmb.2006.08.044	32	20	20	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 24	2008	283	43					28783	28787		10.1074/jbc.C800160200	http://dx.doi.org/10.1074/jbc.C800160200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	362EB	18772144	Green Published, hybrid			2022-12-27	WOS:000260179900002
J	Noberini, R; Koolpe, M; Peddibhotla, S; Dahl, R; Su, Y; Cosford, NDP; Roth, GP; Pasquale, EB				Noberini, Roberta; Koolpe, Mitchell; Peddibhotla, Satyamaheshwar; Dahl, Russell; Su, Ying; Cosford, Nicholas D. P.; Roth, Gregory P.; Pasquale, Elena B.			Small Molecules Can Selectively Inhibit Ephrin Binding to the EphA4 and EphA2 Receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FACTOR-ALPHA INDUCTION; TYROSINE KINASE; ENDOTHELIAL-CELLS; VISUAL-SYSTEM; TUMOR NEOVASCULARIZATION; VASCULOGENIC MIMICRY; INDUCED ANGIOGENESIS; PROTEIN INTERACTIONS; NERVOUS-SYSTEM; CANCER-THERAPY	The erythropoietin-producing hepatocellular (Eph) family of receptor tyrosine kinases regulates a multitude of physiological and pathological processes. Despite the numerous possible research and therapeutic applications of agents capable of modulating Eph receptor function, no small molecule inhibitors targeting the extracellular domain of these receptors have been identified. We have performed a high throughput screen to search for small molecules that inhibit ligand binding to the extracellular domain of the EphA4 receptor. This yielded a 2,5-dimethylpyrrolyl benzoic acid derivative able to inhibit the interaction of EphA4 with a peptide ligand as well as the natural ephrin ligands. Evaluation of a series of analogs identified an isomer with similar inhibitory properties and other less potent compounds. The two isomeric compounds act as competitive inhibitors, suggesting that they target the high affinity ligand-binding pocket of EphA4 and inhibit ephrin-A5 binding to EphA4 with K-i values of 7 and 9 mu M in enzyme-linked immunosorbent assays. Interestingly, despite the ability of each ephrin ligand to promiscuously bind many Eph receptors, the two compounds selectively target EphA4 and the closely related EphA2 receptor. The compounds also inhibit ephrin-induced phosphorylation of EphA4 and EphA2 in cells, without affecting cell viability or the phosphorylation of other receptor tyrosine kinases. Furthermore, the compounds inhibit EphA4-mediated growth cone collapse in retinal explants and EphA2-dependent retraction of the cell periphery in prostate cancer cells. These data demonstrate that the Eph receptor-ephrin interface can be targeted by inhibitory small molecules and suggest that the two compounds identified will be useful to discriminate the activities of EphA4 and EphA2 from those of other co-expressed Eph receptors that are activated by the same ephrin ligands. Furthermore, the newly identified inhibitors represent possible leads for the development of therapies to treat pathologies in which EphA4 and EphA2 are involved, including nerve injuries and cancer.	[Noberini, Roberta; Koolpe, Mitchell; Dahl, Russell; Su, Ying; Cosford, Nicholas D. P.; Pasquale, Elena B.] Burnham Inst Med Res, La Jolla, CA 92037 USA; [Noberini, Roberta] Univ Parma, Dept Biochem & Mol Biol, I-43100 Parma, Italy; [Peddibhotla, Satyamaheshwar; Roth, Gregory P.] Burnham Inst Med Res Lake Nona, Orlando, FL 32819 USA; [Pasquale, Elena B.] Univ Calif San Diego, Dept Pathol, La Jolla, CA 92093 USA	Sanford Burnham Prebys Medical Discovery Institute; University of Parma; Sanford Burnham Prebys Medical Discovery Institute; University of California System; University of California San Diego	Pasquale, EB (corresponding author), Burnham Inst Med Res, 10901 N Torrey Pines Rd, La Jolla, CA 92037 USA.	elenap@burnham.org	Noberini, Roberta/AAP-4527-2020	Cosford, Nic/0000-0001-7228-4709; Dahl, Russell/0000-0002-2939-1004; Noberini, Roberta/0000-0002-7267-1079	National Institutes of Health; Department of Defense	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense)	This work was supported, in whole or in part, by a National Institutes of Health grant (to E. B. P.). This work was also supported by the Department of Defense (to E. B. P.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Adams RH, 2002, SEMIN CELL DEV BIOL, V13, P55, DOI 10.1006/scdb.2001.0289; Ashida S, 2004, CANCER RES, V64, P5963, DOI 10.1158/0008-5472.CAN-04-0020; Baldwin C, 2006, AM J PHYSIOL-RENAL, V291, pF960, DOI 10.1152/ajprenal.00020.2006; Benson MD, 2005, P NATL ACAD SCI USA, V102, P10694, DOI 10.1073/pnas.0504021102; Brantley DM, 2002, ONCOGENE, V21, P7011, DOI 10.1038/sj.onc.1205679; Brantley-Sieders DM, 2006, CANCER RES, V66, P10315, DOI 10.1158/0008-5472.CAN-06-1560; Brantley-Sieders Dana M., 2004, Angiogenesis, V7, P17, DOI 10.1023/B:AGEN.0000037340.33788.87; Brantley-Sieders DM, 2005, FASEB J, V19, P1884, DOI 10.1096/fj.05-4038fje; Brantley-Sieders DM, 2004, J CELL SCI, V117, P2037, DOI 10.1242/jcs.01061; Caligiuri M, 2006, CHEM BIOL, V13, P711, DOI 10.1016/j.chembiol.2006.05.008; Chen J, 2006, EXP EYE RES, V82, P664, DOI 10.1016/j.exer.2005.09.004; CHENG HJ, 1994, CELL, V79, P157, DOI 10.1016/0092-8674(94)90408-1; Cheng N, 2002, MOL CANCER RES, V1, P2; Cheng N, 2003, NEOPLASIA, V5, P445, DOI 10.1016/S1476-5586(03)80047-7; Cheng N, 2001, J BIOL CHEM, V276, P13771, DOI 10.1074/jbc.M009147200; CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; Chrencik JE, 2006, STRUCTURE, V14, P321, DOI 10.1016/j.str.2005.11.011; Chrencik JE, 2007, J BIOL CHEM, V282, P36505, DOI 10.1074/jbc.M706340200; Connor RJ, 1998, DEV BIOL, V193, P21, DOI 10.1006/dbio.1997.8786; Dail M, 2006, J CELL SCI, V119, P1244, DOI 10.1242/jcs.02842; Dickson BJ, 2002, SCIENCE, V298, P1959, DOI 10.1126/science.1072165; DIXIT VM, 1990, J BIOL CHEM, V265, P2973; Du J, 2007, CURR PHARM DESIGN, V13, P2507; Easty DJ, 1997, INT J CANCER, V71, P1061, DOI 10.1002/(SICI)1097-0215(19970611)71:6<1061::AID-IJC24>3.0.CO;2-F; Egea J, 2007, TRENDS CELL BIOL, V17, P230, DOI 10.1016/j.tcb.2007.03.004; Fabes J, 2006, EUR J NEUROSCI, V23, P1721, DOI 10.1111/j.1460-9568.2006.04704.x; Fabes J, 2007, EUR J NEUROSCI, V26, P2496, DOI 10.1111/j.1460-9568.2007.05859.x; Flanagan JG, 2000, METHOD ENZYMOL, V327, P19, DOI 10.1016/S0076-6879(00)27264-9; Fox BP, 2006, BIOCHEM BIOPH RES CO, V342, P1263, DOI 10.1016/j.bbrc.2006.02.099; Fry DC, 2005, J MOL MED, V83, P955, DOI 10.1007/s00109-005-0705-x; Goldshmit Y, 2004, J NEUROSCI, V24, P10064, DOI 10.1523/JNEUROSCI.2981-04.2004; Heroult M, 2006, EXP CELL RES, V312, P642, DOI 10.1016/j.yexcr.2005.10.028; Hess AR, 2006, CANCER BIOL THER, V5, P228, DOI 10.4161/cbt.5.2.2510; Hess AR, 2001, CANCER RES, V61, P3250; Himanen JP, 2001, NATURE, V414, P933, DOI 10.1038/414933a; Himanen JP, 2007, CURR OPIN CELL BIOL, V19, P534, DOI 10.1016/j.ceb.2007.08.004; Holash JA, 1995, DEV BIOL, V172, P683, DOI 10.1006/dbio.1995.8039; Hornberger MR, 1999, NEURON, V22, P731, DOI 10.1016/S0896-6273(00)80732-1; Hunter SG, 2006, MOL CELL BIOL, V26, P4830, DOI 10.1128/MCB.02215-05; Iiizumi M, 2006, CANCER SCI, V97, P1211, DOI 10.1111/j.1349-7006.2006.00313.x; Ireton RC, 2005, CURR CANCER DRUG TAR, V5, P149, DOI 10.2174/1568009053765780; Karaman MW, 2008, NAT BIOTECHNOL, V26, P127, DOI 10.1038/nbt1358; Klein R, 2004, CURR OPIN CELL BIOL, V16, P580, DOI 10.1016/j.ceb.2004.07.002; Kolb P, 2008, PROTEINS, V73, P11, DOI 10.1002/prot.22028; Koolpe M, 2005, J BIOL CHEM, V280, P17301, DOI 10.1074/jbc.M500363200; Koolpe M, 2002, J BIOL CHEM, V277, P46974, DOI 10.1074/jbc.M208495200; Landen CN, 2005, EXPERT OPIN THER TAR, V9, P1179, DOI 10.1517/14728222.9.6.1179; Li YH, 1997, NEURON, V19, P453, DOI 10.1016/S0896-6273(00)80953-8; Liang YC, 1997, J CELL BIOCHEM, V67, P55, DOI 10.1002/(SICI)1097-4644(19971001)67:1<55::AID-JCB6>3.0.CO;2-V; Luo LQ, 2007, NEURON, V56, P284, DOI 10.1016/j.neuron.2007.10.014; Macrae M, 2005, CANCER CELL, V8, P111, DOI 10.1016/j.ccr.2005.07.005; Menzel P, 2001, DEV BIOL, V230, P74, DOI 10.1006/dbio.2000.0109; Miao H, 2000, NAT CELL BIOL, V2, P62, DOI 10.1038/35000008; Miyazaki Y, 2008, BIOORG MED CHEM LETT, V18, P1967, DOI 10.1016/j.bmcl.2008.01.113; Monschau B, 1997, EMBO J, V16, P1258, DOI 10.1093/emboj/16.6.1258; Murai KK, 2003, MOL CELL NEUROSCI, V24, P1000, DOI 10.1016/j.mcn.2003.08.006; Murai KK, 2003, NAT NEUROSCI, V6, P153, DOI 10.1038/nn994; Noren NK, 2007, CANCER RES, V67, P3994, DOI 10.1158/0008-5472.CAN-07-0525; Ogawa K, 2000, ONCOGENE, V19, P6043, DOI 10.1038/sj.onc.1204004; PANDEY A, 1995, SCIENCE, V268, P567, DOI 10.1126/science.7536959; Pasquale EB, 2005, NAT REV MOL CELL BIO, V6, P462, DOI 10.1038/nrm1662; Pasquale EB, 2004, NAT NEUROSCI, V7, P417, DOI 10.1038/nn0504-417; Pasquale EB, 2008, CELL, V133, P38, DOI 10.1016/j.cell.2008.03.011; Prevost N, 2005, P NATL ACAD SCI USA, V102, P9820, DOI 10.1073/pnas.0404065102; Qin HN, 2008, J BIOL CHEM, V283, P29473, DOI 10.1074/jbc.M804114200; Smith FM, 2004, J BIOL CHEM, V279, P9522, DOI 10.1074/jbc.M309326200; SOANS C, 1994, ONCOGENE, V9, P3353; Tang FY, 2007, J NUTR BIOCHEM, V18, P391, DOI 10.1016/j.jnutbio.2006.07.004; Walker-Daniels J, 2002, MOL CANCER RES, V1, P79; Wen ZX, 2006, CURR OPIN NEUROBIOL, V16, P52, DOI 10.1016/j.conb.2005.12.005; Wimmer-Kleikamp SH, 2005, IUBMB LIFE, V57, P421, DOI 10.1080/15216540500138337; Yamaguchi Y, 2004, CURR OPIN NEUROBIOL, V14, P288, DOI 10.1016/j.conb.2004.04.003; Yamashita T, 2008, J BIOL CHEM, V283, P18926, DOI 10.1074/jbc.M709133200; Yao VJ, 2005, AM J PATHOL, V166, P625, DOI 10.1016/S0002-9440(10)62283-3	74	116	124	2	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 24	2008	283	43					29461	29472		10.1074/jbc.M804103200	http://dx.doi.org/10.1074/jbc.M804103200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	362EB	18728010	Green Published, hybrid			2022-12-27	WOS:000260179900072
J	Whiteford, JR; Ko, S; Lee, W; Couchman, JR				Whiteford, James R.; Ko, Sunggeon; Lee, Weontae; Couchman, John R.			Structural and Cell Adhesion Properties of Zebrafish Syndecan-4 Are Shared with Higher Vertebrates	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEPARAN-SULFATE PROTEOGLYCAN; COMBINATORIAL EXPRESSION PATTERNS; PROTEIN-KINASE-C; CYTOPLASMIC DOMAIN; PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE; DIRECTIONAL MIGRATION; NMR-SPECTROSCOPY; BINDING DOMAIN; PDZ PROTEIN; SULFOTRANSFERASES	The syndecan proteoglycans are an ancient class of receptor, bearing heparan sulfate chains that interact with numerous potential ligands including growth factors, morphogens, and extracellular matrix molecules. The single syndecan of invertebrates appears not to have cell adhesion roles, but these have been described for mammalian paralogues, especially syndecan-4. This member is best understood in terms of interactions, signaling, and structure of its cytoplasmic domain. The zebrafish homologue of syndecan-4 has been genetically linked to cell adhesion and migration in zebrafish embryos, but no molecular and cellular studies have been reported. Here it is demonstrated that key functional attributes of syndecan-4 are common to both zebrafish and mammalian homologues. These include glycosaminoglycan substitution, a NXIP motif in the extracellular domain that promotes integrin-mediated cell adhesion, and a transmembrane GXXXG motif that promotes dimer formation. In addition, despite some amino acid substitutions in the cytoplasmic domain, its ability to form twisted clamp dimers is preserved, as revealed by nuclear magnetic resonance spectroscopy. This technique also showed that phosphatidylinositol 4,5-bisphosphate can interact with the zebrafish syndecan-4 cytoplasmic domain, and that the molecule in its entirety supports focal adhesion formation, and complements the murine null cells to restore a normal actin cytoskeleton identically to the rat homologue. Therefore, the cell adhesion properties of syndecan-4 are consistent across the vertebrate spectrum and reflect an early acquisition of specialization after syndecan gene duplication events at the invertebrate/early chordate boundary.	[Whiteford, James R.; Couchman, John R.] Univ Copenhagen, Inst Biomed, Bioctr, DK-2200 Copenhagen N, Denmark; [Ko, Sunggeon; Lee, Weontae] Yonsei Univ, Coll Life Sci & Biotechnol, Dept Biochem, Seoul 120749, South Korea; [Ko, Sunggeon; Lee, Weontae] Yonsei Univ, Coll Life Sci & Biotechnol, Mol Biophys Lab, Seoul 120749, South Korea	University of Copenhagen; Yonsei University; Yonsei University	Couchman, JR (corresponding author), Univ Copenhagen, Inst Biomed, Bioctr, Ole Maaloes Vej 5, DK-2200 Copenhagen N, Denmark.	john.couchman@bric.dk	LEE, WEON TAE/AAQ-9088-2021	Lee, Weontae/0000-0003-2347-1262; Whiteford, James/0000-0002-8967-7389	Wellcome Trust Programme [065940]; Korea Science and Engineering Foundation (KOSEF) [R01-2007-000-10161-0]; Korea government (MOST)	Wellcome Trust Programme(Wellcome Trust); Korea Science and Engineering Foundation (KOSEF)(Korea Science and Engineering Foundation); Korea government (MOST)(Ministry of Science & Technology (MOST), Republic of KoreaKorean Government)	This work was supported in part by Wellcome Trust Programme Grant 065940 (to J. R. C.). This work was also supported by a Korea Science and Engineering Foundation (KOSEF) Grant R01-2007-000-10161-0 funded by the Korea government (MOST) (to W. L.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked " advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Alexopoulou AN, 2007, INT J BIOCHEM CELL B, V39, P505, DOI 10.1016/j.biocel.2006.10.014; Bass MD, 2007, J CELL BIOL, V177, P527, DOI 10.1083/jcb.200610076; BAX A, 1985, J MAGN RESON, V65, P355, DOI 10.1016/0022-2364(85)90018-6; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cadwallader AB, 2007, DEV DYNAM, V236, P581, DOI 10.1002/dvdy.21051; Cadwallader AB, 2006, DEV DYNAM, V235, P3432, DOI 10.1002/dvdy.20990; Cadwallader AB, 2006, DEV DYNAM, V235, P3423, DOI 10.1002/dvdy.20991; Chakravarti R, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-83; Chen E, 2004, BLOOD, V103, P1710, DOI 10.1182/blood-2003-06-1783; Chen YL, 2005, AM J PATHOL, V167, P1699, DOI 10.1016/S0002-9440(10)61252-7; Choi S, 2005, J BIOL CHEM, V280, P42573, DOI 10.1074/jbc.M509238200; Couchman JR, 2003, NAT REV MOL CELL BIO, V4, P926, DOI 10.1038/nrm1257; Couchman JR, 2002, J BIOL CHEM, V277, P49296, DOI 10.1074/jbc.M209679200; DAVID G, 1992, J CELL BIOL, V118, P961, DOI 10.1083/jcb.118.4.961; Dews IC, 2007, P NATL ACAD SCI USA, V104, P20782, DOI 10.1073/pnas.0708909105; Dovas A, 2006, J CELL SCI, V119, P2837, DOI 10.1242/jcs.03020; Gao YH, 2000, J CELL PHYSIOL, V184, P373, DOI 10.1002/1097-4652(200009)184:3<373::AID-JCP12>3.0.CO;2-I; Greene DK, 2003, J BIOL CHEM, V278, P7617, DOI 10.1074/jbc.M207123200; Grootjans JJ, 1997, P NATL ACAD SCI USA, V94, P13683, DOI 10.1073/pnas.94.25.13683; Horowitz A, 1999, BIOCHEMISTRY-US, V38, P15871, DOI 10.1021/bi991363i; Hsueh YP, 1998, J CELL BIOL, V142, P139, DOI 10.1083/jcb.142.1.139; Ishiguro K, 2000, J BIOL CHEM, V275, P5249, DOI 10.1074/jbc.275.8.5249; JEENER J, 1979, J CHEM PHYS, V71, P4546, DOI 10.1063/1.438208; Koo BK, 2006, J MOL BIOL, V355, P651, DOI 10.1016/j.jmb.2005.09.087; Kramer KL, 2002, DEV CELL, V2, P115, DOI 10.1016/S1534-5807(01)00107-1; Lee D, 1998, J BIOL CHEM, V273, P13022, DOI 10.1074/jbc.273.21.13022; LEE WT, 1994, NAT STRUCT BIOL, V1, P877, DOI 10.1038/nsb1294-877; Liu ML, 1998, J MAGN RESON, V132, P125, DOI 10.1006/jmre.1998.1405; Longley RL, 1999, J CELL SCI, V112, P3421; Markley JL, 1998, J MOL BIOL, V280, P933, DOI 10.1006/jmbi.1998.1852; Matthews HK, 2008, DEVELOPMENT, V135, P1771, DOI 10.1242/dev.017350; McFall AJ, 1998, J BIOL CHEM, V273, P28270, DOI 10.1074/jbc.273.43.28270; Mehrotra B, 1997, J BIOL CHEM, V272, P4237, DOI 10.1074/jbc.272.7.4237; Morgan MR, 2007, NAT REV MOL CELL BIO, V8, P957, DOI 10.1038/nrm2289; Munoz R, 2006, NAT CELL BIOL, V8, P492, DOI 10.1038/ncb1399; Oh ES, 1998, J BIOL CHEM, V273, P10624, DOI 10.1074/jbc.273.17.10624; Saoncella S, 1999, P NATL ACAD SCI USA, V96, P2805, DOI 10.1073/pnas.96.6.2805; Shin J, 2001, BIOCHEMISTRY-US, V40, P8471, DOI 10.1021/bi002750r; Siekmann AF, 2005, DEV DYNAM, V232, P498, DOI 10.1002/dvdy.20248; SPRING J, 1994, P NATL ACAD SCI USA, V91, P3334, DOI 10.1073/pnas.91.8.3334; Whiteford JR, 2007, EXP CELL RES, V313, P3902, DOI 10.1016/j.yexcr.2007.08.002; Whiteford JR, 2006, J BIOL CHEM, V281, P32156, DOI 10.1074/jbc.M605553200; WOODS A, 1994, MOL BIOL CELL, V5, P183, DOI 10.1091/mbc.5.2.183; Woods A, 2000, ARCH BIOCHEM BIOPHYS, V374, P66, DOI 10.1006/abbi.1999.1607; WUTHRICH K, 1983, J MOL BIOL, V169, P949, DOI 10.1016/S0022-2836(83)80144-2; ZHANG LJ, 1994, J BIOL CHEM, V269, P19295	46	30	30	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 24	2008	283	43					29322	29330		10.1074/jbc.M803505200	http://dx.doi.org/10.1074/jbc.M803505200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	362EB	18753130	hybrid, Green Published			2022-12-27	WOS:000260179900059
J	Zhang, YM; Frank, MW; Zhu, K; Mayasundari, A; Rock, CO				Zhang, Yong-Mei; Frank, Matthew W.; Zhu, Kun; Mayasundari, Anand; Rock, Charles O.			PqsD Is Responsible for the Synthesis of 2,4-Dihydroxyquinoline, an Extracellular Metabolite Produced by Pseudomonas aeruginosa	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACYL CARRIER PROTEIN; FATTY-ACID BIOSYNTHESIS; TO-CELL COMMUNICATION; ESCHERICHIA-COLI; COENZYME-A; ROLES; MOLECULES; SYNTHASES; MUTANTS; REVEALS	2,4-Dihydroxyquinoline (DHQ) is an abundant extracellular metabolite of the opportunistic pathogen Pseudomonas aeruginosa that is secreted into growth medium in stationary phase to concentrations comparable with those of the Pseudomonas quinolone signal. Using a combination of biochemical and genetic approaches, we show that PqsD, a condensing enzyme in the pqs operon that is essential for Pseudomonas quinolone signal synthesis, accounts for DHQ formation in vivo. First, the anthraniloyl moiety is transferred to the active-site Cys of PqsD to form an anthraniloyl-PqsD intermediate, which then condenses with either malonyl-CoA or malonyl-acyl carrier protein to produce 3-(2-aminophenyl)-3-oxopropanoyl-CoA. This short-lived intermediate undergoes an intramolecular rearrangement to form DHQ. DHQ was produced by Escherichia coli coexpressing PqsA and PqsD, illustrating that these two proteins are the only factors necessary for DHQ synthesis. Thus, PqsD is responsible for the production of DHQ in P. aeruginosa.	[Zhang, Yong-Mei] St Jude Childrens Hosp, Dept Infect Dis, Prot Sci Div, Memphis, TN 38105 USA; [Mayasundari, Anand] St Jude Childrens Hosp, Dept Chem Biol & Therapeut, Memphis, TN 38105 USA	St Jude Children's Research Hospital; St Jude Children's Research Hospital	Zhang, YM (corresponding author), St Jude Childrens Hosp, Dept Infect Dis, Prot Sci Div, 332 N Lauderdale, Memphis, TN 38105 USA.	yongmei.zhang@stjude.org		Frank, Matthew/0000-0002-4914-1440	National Institutes of Health [GM 34496]; Cancer Center CORE Support [CA 21765]; American Lebanese Syrian Associated Charities; NATIONAL CANCER INSTITUTE [P30CA021765] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM034496, R01GM034496] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Center CORE Support; American Lebanese Syrian Associated Charities(American Lebanese Syrian Associated Charities (ALSAC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM 34496 and Cancer Center CORE Support Grant CA 21765. This work was also supported by the American Lebanese Syrian Associated Charities. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Bredenbruch F, 2005, J BACTERIOL, V187, P3630, DOI 10.1128/JB.187.11.3630-3635.2005; Choi KH, 2005, BMC MICROBIOL, V5, DOI 10.1186/1471-2180-5-30; Coleman JP, 2008, J BACTERIOL, V190, P1247, DOI 10.1128/JB.01140-07; D'Argenio DA, 2002, J BACTERIOL, V184, P6481, DOI 10.1128/JB.184.23.6481-6489.2002; Davies C, 2000, STRUCTURE, V8, P185, DOI 10.1016/S0969-2126(00)00094-0; Deziel E, 2004, P NATL ACAD SCI USA, V101, P1339, DOI 10.1073/pnas.0307694100; Dietrich LEP, 2006, MOL MICROBIOL, V61, P1308, DOI 10.1111/j.1365-2958.2006.05306.x; Diggle SP, 2006, INT J MED MICROBIOL, V296, P83, DOI 10.1016/j.ijmm.2006.01.038; Diggle SP, 2007, CHEM BIOL, V14, P87, DOI 10.1016/j.chembiol.2006.11.014; Diggle SP, 2006, CHEM BIOL, V13, P701, DOI 10.1016/j.chembiol.2006.05.006; Gallagher LA, 2002, J BACTERIOL, V184, P6472, DOI 10.1128/JB.184.23.6472-6480.2002; HEATH RJ, 1995, J BIOL CHEM, V270, P15531, DOI 10.1074/jbc.270.26.15531; Heath RJ, 1996, J BIOL CHEM, V271, P27795, DOI 10.1074/jbc.271.44.27795; Heath RJ, 2002, NAT PROD REP, V19, P581, DOI 10.1039/b110221b; Hirota Morihiko, 2006, Journal of Toxicological Sciences, V31, P149, DOI 10.2131/jts.31.149; Hutchinson CR, 1999, P NATL ACAD SCI USA, V96, P3336, DOI 10.1073/pnas.96.7.3336; JACKOWSKI S, 1986, J BACTERIOL, V166, P866, DOI 10.1128/jb.166.3.866-871.1986; JACKOWSKI S, 1981, J BACTERIOL, V148, P926, DOI 10.1128/JB.148.3.926-932.1981; Lepine F, 2007, BIOL CHEM, V388, P839, DOI 10.1515/BC.2007.100; MACHAN ZA, 1992, J ANTIMICROB CHEMOTH, V30, P615, DOI 10.1093/jac/30.5.615; Pesci EC, 1999, P NATL ACAD SCI USA, V96, P11229, DOI 10.1073/pnas.96.20.11229; Swift S, 2001, ADV MICROB PHYSIOL, V45, P199, DOI 10.1016/S0065-2911(01)45005-3; VALLARI DS, 1987, J BIOL CHEM, V262, P2468; White SW, 2005, ANNU REV BIOCHEM, V74, P791, DOI 10.1146/annurev.biochem.74.082803.133524; Zhang YM, 2006, J BIOL CHEM, V281, P17390, DOI 10.1074/jbc.M513199200; Zhou H, 2008, P NATL ACAD SCI USA, V105, P6249, DOI 10.1073/pnas.0800657105; Zhu K, 2006, MOL MICROBIOL, V60, P260, DOI 10.1111/j.1365-2958.2006.05088.x	27	63	69	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 24	2008	283	43					28788	28794		10.1074/jbc.M804555200	http://dx.doi.org/10.1074/jbc.M804555200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	362EB	18728009	hybrid, Green Published			2022-12-27	WOS:000260179900003
J	Bae, D; Lu, S; Taglienti, CA; Mercurio, AM				Bae, Donggoo; Lu, Shaolei; Taglienti, Cherie A.; Mercurio, Arthur M.			Metabolic stress induces the lysosomal degradation of neuropilin-1 but not neuropilin-2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOTHELIAL GROWTH-FACTOR; TUMOR-CELLS; CARCINOMA CELLS; SEMAPHORIN-III; BREAST-CANCER; PROGRESSION; RECEPTOR; ANGIOGENESIS; EXPRESSION; PROTEINS	The neuropilins-1 and -2 (NRP1 and NRP2) function as receptors for both the semaphorins and vascular endothelial growth factor. In addition to their contribution to the development of the nervous system, NRP1 and NRP2 have been implicated in angiogenesis and tumor progression. Given their importance to cancer and endothelial biology and their potential as therapeutic targets, an important issue that has not been addressed is the impact of metabolic stress conditions characteristic of the tumor microenvironment on their expression and function. Here, we demonstrate that hypoxia and nutrient deprivation stimulate the rapid loss of NRP1 expression in both endothelial and carcinoma cells. NRP2 expression, in contrast, is maintained under these conditions. The lysosomal inhibitors chloroquine and bafilomycin A1 prevented the loss of NRP1 expression, but proteasomal inhibitors had no effect. The hypothesis that NRP1 is degraded by autophagy is supported by the findings that its expression is lost rapidly in response to metabolic stress, prevented with 3-methyladenine and induced by rapamycin. Targeted depletion of NRP2 using small hairpin RNA revealed that NRP2 can function in the absence of NRP1 to mediate endothelial tube formation in hypoxia. Studies aimed at assessing NRP function and targeted therapy in cancer and angiogenesis should consider the impact of metabolic stress.	[Mercurio, Arthur M.] Univ Massachusetts, Sch Med, Dept Canc Biol, Worcester, MA 01605 USA; Univ Massachusetts, Sch Med, Ctr Canc, Worcester, MA 01605 USA	University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester	Mercurio, AM (corresponding author), Univ Massachusetts, Sch Med, Dept Canc Biol, LRB-408,364 Plantat St, Worcester, MA 01605 USA.	arthur.mercurio@umassmed.edu		Lu, Shaolei/0000-0003-2870-5793	National Institutes of Health [CA89209]; NATIONAL CANCER INSTITUTE [R01CA089209] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA89209. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Abramow-Newerly M, 2006, CELL SIGNAL, V18, P579, DOI 10.1016/j.cellsig.2005.08.010; Bachelder RE, 2001, CANCER RES, V61, P5736; Bachelder RE, 2002, CANCER RES, V62, P7203; Bielenberg DR, 2007, CANCER METAST REV, V26, P421, DOI 10.1007/s10555-007-9097-4; Bielenberg DR, 2006, EXP CELL RES, V312, P584, DOI 10.1016/j.yexcr.2005.11.024; BOWMAN EJ, 1988, P NATL ACAD SCI USA, V85, P7972, DOI 10.1073/pnas.85.21.7972; Brown JM, 1999, CANCER RES, V59, P5863; Calvani M, 2006, BLOOD, V107, P2705, DOI 10.1182/blood-2005-09-3541; Castro-Rivera E, 2004, P NATL ACAD SCI USA, V101, P11432, DOI 10.1073/pnas.0403969101; Caunt M, 2008, CANCER CELL, V13, P331, DOI 10.1016/j.ccr.2008.01.029; Chen H, 2000, NEURON, V25, P43, DOI 10.1016/S0896-6273(00)80870-3; Cuervo AM, 1998, J MOL MED-JMM, V76, P6, DOI 10.1007/s109-1998-8099-y; De Vries L, 1998, P NATL ACAD SCI USA, V95, P12340, DOI 10.1073/pnas.95.21.12340; FURUCHI T, 1993, J BIOL CHEM, V268, P27345; GERARD KW, 1988, J BIOL CHEM, V263, P18886; Gray MJ, 2008, J NATL CANCER I, V100, P109, DOI 10.1093/jnci/djm279; Gray MJ, 2005, CANCER RES, V65, P3664, DOI 10.1158/0008-5472.CAN-04-2229; Guttmann-Raviv N, 2006, CANCER LETT, V231, P1, DOI 10.1016/j.canlet.2004.12.047; He ZG, 1997, CELL, V90, P739, DOI 10.1016/S0092-8674(00)80534-6; Hong TM, 2007, CLIN CANCER RES, V13, P4759, DOI 10.1158/1078-0432.CCR-07-0001; Hu B, 2007, ONCOGENE, V26, P5577, DOI 10.1038/sj.onc.1210348; Ishihama H, 2001, INVEST OPHTH VIS SCI, V42, P1172; Kolodkin AL, 1997, CELL, V90, P753, DOI 10.1016/S0092-8674(00)80535-8; Lee DH, 1998, TRENDS CELL BIOL, V8, P397, DOI 10.1016/S0962-8924(98)01346-4; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Mathupala SP, 2001, J BIOL CHEM, V276, P43407, DOI 10.1074/jbc.M108181200; Matsushita A, 2007, CANCER RES, V67, P10309, DOI 10.1158/0008-5472.CAN-07-3256; Miao HQ, 2000, FASEB J, V14, P2532, DOI 10.1096/fj.00-0250com; Miao HQ, 1999, J CELL BIOL, V146, P233, DOI 10.1083/jcb.146.1.233; Narazaki M, 2008, BLOOD, V111, P4126, DOI 10.1182/blood-2007-09-112474; Neufeld G, 2002, ADV EXP MED BIOL, V515, P81; Pan Q, 2007, CANCER CELL, V11, P53, DOI 10.1016/j.ccr.2006.10.018; Parikh AA, 2004, AM J PATHOL, V164, P2139, DOI 10.1016/S0002-9440(10)63772-8; Pellet-Many C, 2008, BIOCHEM J, V411, P211, DOI 10.1042/BJ20071639; Pennacchietti S, 2003, CANCER CELL, V3, P347, DOI 10.1016/S1535-6108(03)00085-0; Santos SCR, 2007, EXP CELL RES, V313, P1561, DOI 10.1016/j.yexcr.2007.02.020; SEGLEN PO, 1982, P NATL ACAD SCI-BIOL, V79, P1889, DOI 10.1073/pnas.79.6.1889; Soker S, 1998, CELL, V92, P735, DOI 10.1016/S0092-8674(00)81402-6; Stephenson JM, 2002, INT J CANCER, V101, P409, DOI 10.1002/ijc.10611; Sulpice E, 2008, BLOOD, V111, P2036, DOI 10.1182/blood-2007-04-084269; SUTHERLAND RM, 1988, SCIENCE, V240, P177, DOI 10.1126/science.2451290; Wang L, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001161	42	37	38	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 17	2008	283	42					28074	28080		10.1074/jbc.M804203200	http://dx.doi.org/10.1074/jbc.M804203200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	359EN	18708346	Green Published, hybrid			2022-12-27	WOS:000259969300009
J	Yang, SQ; Ma, HW; Yu, L; Yu, CA				Yang, Shaoqing; Ma, He-Wen; Yu, Linda; Yu, Chang-An			On the mechanism of quinol oxidation at the Q(P) site in the cytochrome bc(1) complex - Studied using mutants lacking cytochrome b(L) or b(H)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IRON-SULFUR PROTEIN; BOVINE HEART-MITOCHONDRIA; RHODOBACTER-SPHAEROIDES; Q-CYCLE; ELECTRON-TRANSFER; DOMAIN MOVEMENT; BC1 COMPLEX; C REDUCTASE; Q(O) SITE; SUPEROXIDE-PRODUCTION	To elucidate the mechanism of bifurcated oxidation of quinol in the cytochrome bc(1) complex, Rhodobacter sphaeroides mutants, H198N and H111N, lacking heme b(L) and heme b(H), respectively, were constructed and characterized. Purified mutant complexes have the same subunit composition as that of the wild-type complex, but have only 9-11% of the electron transfer activity, which is sensitive to stigmatellin or myxothiazol. The E-m values for hemes bL and bH in the H111N and H198N complexes are -95 and -35 mV, respectively. The pseudo first-order reduction rate constants for hemes b(L) and b(H) in H111N and H198N, by ubiquiniol, are 16.3 and 12.4 s(-1), respectively. These indicate that the Q(P) site in the H111N mutant complex is similar to that in the wild-type complex. Pre-steady state reduction rates of heme c(1) by these two mutant complexes decrease to a similar extent of their activity, suggesting that the decrease in electron transfer activity is due to impairment of movement of the head domain of reduced iron-sulfur protein, caused by disruption of electron transfer from heme b(L) to heme b(H). Both mutant complexes produce as much superoxide as does antimycin A-treated wild-type complex. Ascorbate eliminates all superoxide generating activity in the intact or antimycin inhibited wild-type or mutant complexes.	[Yang, Shaoqing; Ma, He-Wen; Yu, Linda; Yu, Chang-An] Oklahoma State Univ, Dept Biochem & Mol Biol, Stillwater, OK 74078 USA	Oklahoma State University System; Oklahoma State University - Stillwater	Yu, CA (corresponding author), Oklahoma State Univ, Dept Biochem & Mol Biol, Stillwater, OK 74078 USA.	cayuq@okstate.edu	yang, shaoqing/C-9761-2012		NIGMS NIH HHS [GM30721] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM030721, R01GM030721] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALEXANDRE A, 1979, J BIOL CHEM, V254, P1555; BERRY EA, 1987, ANAL BIOCHEM, V161, P1, DOI 10.1016/0003-2697(87)90643-9; BRANDT U, 1991, J BIOL CHEM, V266, P19958; BRANDT U, 1991, EUR J BIOCHEM, V195, P163, DOI 10.1111/j.1432-1033.1991.tb15690.x; BRANDT U, 1994, CRIT REV BIOCHEM MOL, V29, P165, DOI 10.3109/10409239409086800; Cape JL, 2007, P NATL ACAD SCI USA, V104, P7887, DOI 10.1073/pnas.0702621104; Cen XW, 2008, FEBS LETT, V582, P523, DOI 10.1016/j.febslet.2008.01.016; Covian R, 2004, J BIOL CHEM, V279, P15040, DOI 10.1074/jbc.M400193200; Crofts AR, 2008, BBA-BIOENERGETICS, V1777, P1001, DOI 10.1016/j.bbabio.2008.04.037; Crofts AR, 1999, BIOCHEMISTRY-US, V38, P15827, DOI 10.1021/bi990963e; Crofts AR, 2004, ANNU REV PHYSIOL, V66, P689, DOI 10.1146/annurev.physiol.66.032102.150251; Crofts AR, 2003, J BIOL CHEM, V278, P36191, DOI 10.1074/jbc.M305461200; Darrouzet E, 2000, P NATL ACAD SCI USA, V97, P4567, DOI 10.1073/pnas.97.9.4567; Darrouzet E, 2002, J BIOL CHEM, V277, P3471, DOI 10.1074/jbc.M107974200; Darrouzet E, 2000, BIOCHEMISTRY-US, V39, P15475, DOI 10.1021/bi000750l; DENICOLA A, 1995, FREE RADICAL BIO MED, V19, P11, DOI 10.1016/0891-5849(94)00239-G; DEVRIES S, 1981, J BIOL CHEM, V256, P1996; DEVRIES S, 1983, BIOCHIM BIOPHYS ACTA, V723, P91, DOI 10.1016/0005-2728(83)90013-0; DEVRIES S, 1982, BIOCHIM BIOPHYS ACTA, V681, P41, DOI 10.1016/0005-2728(82)90276-6; Dutton P L, 1978, Methods Enzymol, V54, P411; Elberry M, 2006, BBA-BIOENERGETICS, V1757, P835, DOI 10.1016/j.bbabio.2006.05.031; ERECINSKA M, 1972, P NATL ACAD SCI USA, V69, P50, DOI 10.1073/pnas.69.1.50; Esser L, 2008, J BIOL CHEM, V283, P2846, DOI 10.1074/jbc.M708608200; Forquer I, 2006, J BIOL CHEM, V281, P38459, DOI 10.1074/jbc.M605119200; Gong X, 2005, J BIOL CHEM, V280, P9251, DOI 10.1074/jbc.M409994200; Hunte C, 2001, FEBS LETT, V504, P126, DOI 10.1016/S0014-5793(01)02744-2; Iwata S, 1998, SCIENCE, V281, P64, DOI 10.1126/science.281.5373.64; Junemann S, 1998, J BIOL CHEM, V273, P21603, DOI 10.1074/jbc.273.34.21603; Kim H, 1998, P NATL ACAD SCI USA, V95, P8026, DOI 10.1073/pnas.95.14.8026; KING TE, 1975, ELECTRON TRANSFER CH, P105; Lange C, 2002, P NATL ACAD SCI USA, V99, P2800, DOI 10.1073/pnas.052704699; Link TA, 1997, FEBS LETT, V412, P257, DOI 10.1016/S0014-5793(97)00772-2; Liu XY, 2004, J BIOL CHEM, V279, P47363, DOI 10.1074/jbc.M406497200; MATHER MW, 1995, J BIOL CHEM, V270, P28668, DOI 10.1074/jbc.270.48.28668; MITCHELL P, 1976, J THEOR BIOL, V62, P327, DOI 10.1016/0022-5193(76)90124-7; Muller F, 2002, BIOCHEMISTRY-US, V41, P7866, DOI 10.1021/bi025581e; NAKANO M, 1990, METHOD ENZYMOL, V186, P585; NOHL H, 1986, BIOCHEM BIOPH RES CO, V138, P533, DOI 10.1016/S0006-291X(86)80529-0; Rotsaert FAJ, 2008, BBA-BIOENERGETICS, V1777, P211, DOI 10.1016/j.bbabio.2007.10.011; Snyder CH, 1999, J BIOL CHEM, V274, P31209, DOI 10.1074/jbc.274.44.31209; Snyder CH, 2000, J BIOL CHEM, V275, P13535, DOI 10.1074/jbc.275.18.13535; Sun H, 2003, ARCH BIOCHEM BIOPHYS, V419, P198, DOI 10.1016/j.abb.2003.08.028; Tian H, 1999, J BIOL CHEM, V274, P7146, DOI 10.1074/jbc.274.11.7146; Tian H, 1998, J BIOL CHEM, V273, P27953, DOI 10.1074/jbc.273.43.27953; TRUMPOWER BL, 1994, ANNU REV BIOCHEM, V63, P675, DOI 10.1146/annurev.bi.63.070194.003331; TURRENS JF, 1985, ARCH BIOCHEM BIOPHYS, V237, P408, DOI 10.1016/0003-9861(85)90293-0; WIKSTROM MK, 1972, BIOCHIM BIOPHYS ACTA, V283, P403, DOI 10.1016/0005-2728(72)90258-7; Xia D, 1997, SCIENCE, V277, P60, DOI 10.1126/science.277.5322.60; Xia D, 2007, PHOTOSYNTH RES, V92, P17, DOI 10.1007/s11120-007-9155-3; Xiao KH, 2004, BIOCHEMISTRY-US, V43, P1488, DOI 10.1021/bi035378z; Xiao KH, 2000, J BIOL CHEM, V275, P38597, DOI 10.1074/jbc.M007444200; YU C, 1980, BIOCHIM BIOPHYS ACTA, V591, P409, DOI 10.1016/0005-2728(80)90172-3; YU CA, 1982, BIOCHEMISTRY-US, V21, P4096, DOI 10.1021/bi00260a028; Yu CA, 2008, BBA-BIOENERGETICS, V1777, P1038, DOI 10.1016/j.bbabio.2008.03.033; YU L, 1984, J BIOL CHEM, V259, P5752; YUN CH, 1991, BIOCHEMISTRY-US, V30, P6747, DOI 10.1021/bi00241a017; Zhang HB, 2007, BBA-BIOENERGETICS, V1767, P883, DOI 10.1016/j.bbabio.2007.04.004; Zhang L, 1998, J BIOL CHEM, V273, P33972, DOI 10.1074/jbc.273.51.33972; Zhang ZL, 1998, NATURE, V392, P677, DOI 10.1038/33612; Zhu J, 2007, P NATL ACAD SCI USA, V104, P4864, DOI 10.1073/pnas.0607812104	60	20	20	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 17	2008	283	42					28767	28776		10.1074/jbc.M803013200	http://dx.doi.org/10.1074/jbc.M803013200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	359EN	18713733	Green Published, hybrid			2022-12-27	WOS:000259969300079
J	Gjymishka, A; Palii, SS; Shan, J; Kilberg, MS				Gjymishka, Altin; Palii, Stela S.; Shan, Jixiu; Kilberg, Michael S.			Despite increased ATF4 binding at the C/EBP-ATF composite site following activation of the unfolded protein response, system A transporter 2 (SNAT2) transcription activity is repressed in HepG2 cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMINO-ACID DEPRIVATION; ASPARAGINE SYNTHETASE GENE; TRANSLATIONAL CONTROL; MASTER REGULATOR; EXPRESSION; ELEMENT; KINASE; REINITIATION; ATF6-ALPHA; RESISTANCE	The activated amino acid response (AAR) and unfolded protein response (UPR) stress signaling pathways converge at the phosphorylation of translation initiation factor eIF2 alpha. This eIF2 alpha modification suppresses global protein synthesis but enhances translation of selected mRNAs such as that for activating transcription factor 4 (ATF4). An ATF4 target gene, SNAT2 (systemAsodium-dependent neutral amino acid transporter 2), contains a C/EBP-ATF site that binds ATF4 and triggers increased transcription during the AAR. However, the present studies show that despite increased ATF4 binding to the SNAT2 gene during UPR activation in HepG2 human hepatoma cells, transcription activity was not enhanced. Hyperacetylation of histone H3 and recruitment of the general transcription factors at the HepG2 SNAT2 promoter occurred in response to the AAR but not the UPR. In contrast, the UPR did enhance transcription from a plasmid-based reporter gene driven by a SNAT2 genomic fragment containing the C/EBP-ATF site. Simultaneous activation of the AAR and the UPR pathways revealed that the UPR actually suppressed the increased SNAT2 transcription by the AAR pathway, demonstrating that the UPR pathway generates a repressive signal that acts downstream of ATF4 binding.	[Kilberg, Michael S.] Univ Florida, Coll Med, Dept Biochem & Mol Biol, Shands Canc Ctr,Genet Inst, Gainesville, FL 32610 USA; Univ Florida, Coll Med, Ctr Nutr Sci, Gainesville, FL 32610 USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida	Kilberg, MS (corresponding author), Univ Florida, Coll Med, Dept Biochem & Mol Biol, Shands Canc Ctr,Genet Inst, Box 100245, Gainesville, FL 32610 USA.	mkilberg@ufl.edu			National Institutes of Health [DK-59315, DK-52064]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK052064, R01DK059315] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK-59315 and DK-52064 (NIDDK) (to M. S. K.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Ameri K, 2008, INT J BIOCHEM CELL B, V40, P14, DOI 10.1016/j.biocel.2007.01.020; Bain PJ, 2002, J NUTR, V132, P3023, DOI 10.1093/jn/131.10.3023; BARBER EF, 1982, J BIOL CHEM, V257, P4960; Barbosa-Tessmann IP, 1999, BIOCHEM J, V339, P151, DOI 10.1042/0264-6021:3390151; Barbosa-Tessmann IP, 2000, J BIOL CHEM, V275, P26976; Chen C, 2005, BIOCHEM J, V391, P649, DOI 10.1042/BJ20050882; Chen H, 2004, J BIOL CHEM, V279, P50829, DOI 10.1074/jbc.M409173200; De Angelis R, 2003, FEBS LETT, V547, P15, DOI 10.1016/S0014-5793(03)00659-8; den Boer ML, 1998, BLOOD, V91, P2092, DOI 10.1182/blood.V91.6.2092.2092_2092_2098; Fawcett TW, 1999, BIOCHEM J, V339, P135, DOI 10.1042/0264-6021:3390135; Fraser P, 2006, GENE DEV, V20, P1379, DOI 10.1101/gad.1438106; HANSEN BS, 1972, J BIOL CHEM, V247, P3854; Harding HP, 2000, MOL CELL, V5, P897, DOI 10.1016/S1097-2765(00)80330-5; Harding HP, 2000, MOL CELL, V6, P1099, DOI 10.1016/S1097-2765(00)00108-8; Harding HP, 2003, MOL CELL, V11, P619, DOI 10.1016/S1097-2765(03)00105-9; Hinnebusch AG, 2002, EUKARYOT CELL, V1, P22, DOI 10.1128/EC.01.1.22-32.2002; HUTSON RG, 1994, BIOCHEM J, V304, P745, DOI 10.1042/bj3040745; Jousse C, 1999, FEBS LETT, V448, P211, DOI 10.1016/S0014-5793(99)00373-7; Kilberg M, 2002, J NUTR, V132, P1801, DOI 10.1093/jn/132.7.1801; Kilberg MS, 2005, ANNU REV NUTR, V25, P59, DOI 10.1146/annurev.nutr.24.012003.132145; KILBERG MS, 1993, ANNU REV NUTR, V13, P137, DOI 10.1146/annurev.nu.13.070193.001033; Liang GS, 1997, J BIOL CHEM, V272, P24088, DOI 10.1074/jbc.272.38.24088; LIPSON KE, 1989, P NATL ACAD SCI USA, V86, P9774, DOI 10.1073/pnas.86.24.9774; Lu PD, 2004, J CELL BIOL, V167, P27, DOI 10.1083/jcb.200408003; Ma YJ, 2004, J BIOL CHEM, V279, P13792, DOI 10.1074/jbc.M313724200; Ma YJ, 2002, J MOL BIOL, V318, P1351, DOI 10.1016/S0022-2836(02)00234-6; Mackenzie B, 2004, PFLUG ARCH EUR J PHY, V447, P784, DOI 10.1007/s00424-003-1117-9; MCGIVAN JD, 1994, BIOCHEM J, V299, P321, DOI 10.1042/bj2990321; Natarajan K, 2001, MOL CELL BIOL, V21, P4347, DOI 10.1128/MCB.21.13.4347-4368.2001; Palii SS, 2006, BIOCHEM J, V395, P517, DOI 10.1042/BJ20051867; Palii SS, 2004, J BIOL CHEM, V279, P3463, DOI 10.1074/jbc.M310483200; Pan YX, 2007, BIOCHEM J, V401, P299, DOI 10.1042/BJ20061261; Pan YX, 2003, J BIOL CHEM, V278, P38402, DOI 10.1074/jbc.M304574200; Pirot P, 2007, DIABETES, V56, P1069, DOI 10.2337/db06-1253; Ragoczy T, 2006, GENE DEV, V20, P1447, DOI 10.1101/gad.1419506; Ron D, 2002, J CLIN INVEST, V110, P1383, DOI 10.1172/JCI200216784; Roy B, 1999, NUCLEIC ACIDS RES, V27, P1437, DOI 10.1093/nar/27.6.1437; Rutkowski DT, 2004, TRENDS CELL BIOL, V14, P20, DOI 10.1016/j.tcb.2003.11.001; SAIER MH, 1988, J MEMBRANE BIOL, V104, P1, DOI 10.1007/BF01871898; Schroder M, 2005, ANNU REV BIOCHEM, V74, P739, DOI 10.1146/annurev.biochem.73.011303.074134; Siu F, 2002, J BIOL CHEM, V277, P24120, DOI 10.1074/jbc.M201959200; Sood R, 2000, GENETICS, V154, P787; Thiaville MM, 2008, BIOCHEM J, V410, P473, DOI 10.1042/BJ20071252; Thuerauf DJ, 2007, J BIOL CHEM, V282, P22865, DOI 10.1074/jbc.M701213200; van Huizen R, 2003, J BIOL CHEM, V278, P15558, DOI 10.1074/jbc.M212074200; Vattem KM, 2004, P NATL ACAD SCI USA, V101, P11269, DOI 10.1073/pnas.0400541101; Wek RC, 2007, ANTIOXID REDOX SIGN, V9, P2357, DOI 10.1089/ars.2007.1764; Yamamoto K, 2004, J BIOCHEM, V136, P343, DOI 10.1093/jb/mvh122; Yamamoto K, 2007, DEV CELL, V13, P365, DOI 10.1016/j.devcel.2007.07.018; Yang XG, 2004, CELL, V117, P387, DOI 10.1016/S0092-8674(04)00344-7; Yoshida H, 2000, MOL CELL BIOL, V20, P6755, DOI 10.1128/MCB.20.18.6755-6767.2000; Yoshida H, 1998, J BIOL CHEM, V273, P33741, DOI 10.1074/jbc.273.50.33741; Zhang PC, 2002, MOL CELL BIOL, V22, P6681, DOI 10.1128/MCB.22.19.6681-6688.2002; Zhong C, 2003, BIOCHEM J, V372, P603, DOI 10.1042/BJ20030076	54	30	30	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 10	2008	283	41					27736	27747		10.1074/jbc.M803781200	http://dx.doi.org/10.1074/jbc.M803781200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	355OW	18697751	hybrid, Green Published			2022-12-27	WOS:000259719200045
J	Anzai, N; Ichida, K; Jutabha, P; Kimura, T; Babu, E; Jin, CJ; Srivastava, S; Kitamura, K; Hisatome, I; Endou, H; Sakurai, H				Anzai, Naohiko; Ichida, Kimiyoshi; Jutabha, Promsuk; Kimura, Toru; Babu, Ellappan; Jin, Chun Ji; Srivastava, Sunena; Kitamura, Kenichiro; Hisatome, Ichiro; Endou, Hitoshi; Sakurai, Hiroyuki			Plasma urate level is directly regulated by a voltage-driven urate efflux transporter URATv1 (SLC2A9) in humans	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RENAL HYPOURICEMIA; URIC-ACID; APICAL MEMBRANE; IDENTIFICATION; FAMILY; EXCRETION; GLUT9; FACILITATORS; EXPRESSION; CLONING	Hyperuricemia is a significant factor in a variety of diseases, including gout and cardiovascular diseases. Although renal excretion largely determines plasma urate concentration, the molecular mechanism of renal urate handling remains elusive. Previously, we identified a major urate reabsorptive transporter, URAT1 (SLC22A12), on the apical side of the renal proximal tubular cells. However, it is not known how urate taken up by URAT1 exits from the tubular cell to the systemic circulation. Here, we report that a sugar transport facilitator family member protein GLUT9 (SLC2A9) functions as an efflux transporter of urate from the tubular cell. GLUT9-expressed Xenopus oocytes mediated saturable urate transport (K-m: 365 +/- 42 mu m). The transport was Na+-independent and enhanced at high concentrations of extracellular potassium favoring negative to positive potential direction. Substrate specificity and pyrazinoate sensitivity of GLUT9 was distinct from those of URAT1. The in vivo role of GLUT9 is supported by the fact that a renal hypouricemia patient without any mutations in SLC22A12 was found to have a missense mutation in SLC2A9, which reduced urate transport activity in vitro. Based on these data, we propose a novel model of transcellular urate transport in the kidney; Remunurate is taken up via apically located URAT1 and exits the cell via basolaterally located GLUT9, which we suggest be renamed URATv1 (voltage-driven urate transporter 1).	[Anzai, Naohiko; Kimura, Toru; Babu, Ellappan; Jin, Chun Ji; Srivastava, Sunena; Endou, Hitoshi; Sakurai, Hiroyuki] Kyorin Univ, Dept Pharmacol & Toxicol, Sch Med, Tokyo 1818611, Japan; [Ichida, Kimiyoshi] Tokyo Univ Pharm & Life Sci, Dept Pathophysiol, Tokyo 1930392, Japan; [Jutabha, Promsuk; Endou, Hitoshi] Fuji Biomedix Co Ltd, Kobuchisawa Res Labs, Yamanashi 4080044, Japan; [Kitamura, Kenichiro] Kumamoto Univ, Grad Sch Med & Pharmaceut Sci, Dept Nephrol, Kumamoto 8608556, Japan; [Hisatome, Ichiro] Tottori Univ, Fac Med, Dept Cardiovasc Med, Tottori 6808550, Japan; [Endou, Hitoshi] J Pharma Co Ltd, Tokyo 1600022, Japan	Kyorin University; Tokyo University of Pharmacy & Life Sciences; Kumamoto University; Tottori University	Anzai, N (corresponding author), 6-20-2 Shinkawa, Mitaka, Tokyo 1818611, Japan.	anzai@ks.kyorin-u.ac.jp	Jutabha, Promsuk/AAE-9872-2022; Jutabha, Promsuk/AFF-4363-2022; ANZAI, NAOHIKO/K-9492-2017	ANZAI, NAOHIKO/0000-0003-0605-0458	Ministry of Education, Culture, Sports, Science and Technology of Japan; Japan Society for the Promotion of Science; Takeda Science Foundation; Salt Science Research Foundation [0721]; Gout Research Foundation of Japan; Shimabara Foundation and Kyorin University School of Medicine	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Takeda Science Foundation(Takeda Science Foundation (TSF)); Salt Science Research Foundation; Gout Research Foundation of Japan(Gout Research Foundation of Japan); Shimabara Foundation and Kyorin University School of Medicine	This work was supported by grants from the Ministry of Education, Culture, Sports, Science and Technology of Japan, the Japan Society for the Promotion of Science, the Takeda Science Foundation, the Salt Science Research Foundation (Grant 0721), the Gout Research Foundation of Japan, and the Shimabara Foundation and Kyorin University School of Medicine (Collaborative Project 2008). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Anzai N, 2005, J PHARMACOL EXP THER, V315, P534, DOI 10.1124/jpet.105.088583; Anzai N, 2007, CURR OPIN RHEUMATOL, V19, P151, DOI 10.1097/BOR.0b013e328032781a; Anzai Naohiko, 2005, Curr Rheumatol Rep, V7, P227, DOI 10.1007/s11926-996-0044-0; Augustin R, 2004, J BIOL CHEM, V279, P16229, DOI 10.1074/jbc.M312226200; Bahn A, 2008, J BIOL CHEM, V283, P16332, DOI 10.1074/jbc.M800737200; Becker MA, 2006, RHEUM DIS CLIN N AM, V32, P275, DOI 10.1016/j.rdc.2006.02.005; Cha SH, 2000, J BIOL CHEM, V275, P4507, DOI 10.1074/jbc.275.6.4507; Doege H, 2000, BIOCHEM J, V350, P771, DOI 10.1042/0264-6021:3500771; Doring A, 2008, NAT GENET, V40, P430, DOI 10.1038/ng.107; Emmerson BT, 1996, NEW ENGL J MED, V334, P445, DOI 10.1056/NEJM199602153340707; Enomoto A, 2002, NATURE, V417, P447, DOI 10.1038/nature742; Eraly SA, 2008, PHYSIOL GENOMICS, V33, P180, DOI 10.1152/physiolgenomics.00207.2007; Hediger MA, 2005, PHYSIOLOGY, V20, P125, DOI 10.1152/physiol.00039.2004; Ichida K, 2004, J AM SOC NEPHROL, V15, P164, DOI 10.1097/01.ASN.0000105320.04395.D0; Islam R, 2008, J PHARMACOL SCI, V106, P525, DOI 10.1254/jphs.SC0070291; Joost HG, 2001, MOL MEMBR BIOL, V18, P247, DOI 10.1080/09687680110090456; Jutabha P, 2003, J BIOL CHEM, V278, P27930, DOI 10.1074/jbc.M303210200; Kutzing MK, 2008, J PHARMACOL EXP THER, V324, P1, DOI 10.1124/jpet.107.129031; Li S, 2007, PLOS GENET, V3, P2156, DOI 10.1371/journal.pgen.0030194; Mori K, 1997, FEBS LETT, V417, P371, DOI 10.1016/S0014-5793(97)01325-2; Mount DB, 2006, RHEUM DIS CLIN N AM, V32, P313, DOI 10.1016/j.rdc.2006.02.006; Phay JE, 2000, GENOMICS, V66, P217, DOI 10.1006/geno.2000.6195; Rafey MA, 2003, CURR OPIN NEPHROL HY, V12, P511, DOI 10.1097/00041552-200309000-00005; Sakata T, 2004, BIOCHEM BIOPH RES CO, V313, P789, DOI 10.1016/j.bbrc.2003.11.175; Sica DA, 2000, KIDNEY, P680; Sperling O, 2006, MOL GENET METAB, V89, P14, DOI 10.1016/j.ymgme.2006.03.015; Uldry M, 2004, PFLUG ARCH EUR J PHY, V447, P480, DOI 10.1007/s00424-003-1085-0; Vitart V, 2008, NAT GENET, V40, P437, DOI 10.1038/ng.106; Wakida N, 2005, J CLIN ENDOCR METAB, V90, P2169, DOI 10.1210/jc.2004-1111; Yokoyama H, 2008, CELL PHYSIOL BIOCHEM, V21, P269, DOI 10.1159/000129385	30	255	282	1	27	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	OCT 3	2008	283	40					26834	26838		10.1074/jbc.C800156200	http://dx.doi.org/10.1074/jbc.C800156200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	353RT	18701466	hybrid			2022-12-27	WOS:000259586600002
J	Kunos, G; Osei-Hyiaman, D; Liu, J; Godlewski, G; Batkai, S				Kunos, George; Osei-Hyiaman, Douglas; Liu, Jie; Godlewski, Gregorz; Batkai, Sandor			Endocannabinoids and the Control of Energy Homeostasis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							STEAROYL-COA DESATURASE-1; CANNABINOID-1 RECEPTOR BLOCKER; HEPATIC CB1 RECEPTORS; ADIPOSE-TISSUE; RISK-FACTORS; ANTAGONIST SR141716; OVERWEIGHT PATIENTS; INDUCED OBESITY; GLUCOSE-UPTAKE; BODY-WEIGHT	Endocannabinoids (ECBs) are ubiquitous lipid mediators that act through the same G protein-coupled receptors (CB1 and CB2) that recognize plant-derived cannabinoids. As regulators of metabolism, ECBs are anabolic: they increase the intake, promote the storage, and decrease the expenditure of energy. Recent work indicates that activation of peripheral CB1 receptors by ECBs plays a key role in the hormonal/metabolic changes associated with obesity/metabolic syndrome and may be targeted for its pharmacotherapy.	[Kunos, George; Osei-Hyiaman, Douglas; Liu, Jie; Godlewski, Gregorz; Batkai, Sandor] NIAAA, Lab Physiol Studies, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)	Kunos, G (corresponding author), NIAAA, Lab Physiol Studies, Bethesda, MD 20892 USA.	gkunos@mail.nih.gov	Batkai, Sandor/G-3889-2010; Batkai, Sandor/H-7983-2014	Osei-Hyiaman, Douglas/0000-0002-2725-5519	National Institutes of Health staff; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [ZIAAA000350, Z01AA000350] Funding Source: NIH RePORTER	National Institutes of Health staff(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was authored, in whole or in part, by National Institutes of Health staff. This minireview will be reprinted in the 2008 Minireview Compendium, which will be available in January, 2009.	Arnone M, 1997, PSYCHOPHARMACOLOGY, V132, P104, DOI 10.1007/s002130050326; Bensaid M, 2003, MOL PHARMACOL, V63, P908, DOI 10.1124/mol.63.4.908; Berdyshev EV, 2001, FASEB J, V15, P2171, DOI 10.1096/fj.01-0181com; Biddinger SB, 2005, DIABETES, V54, P1314, DOI 10.2337/diabetes.54.5.1314; Biecker E, 2004, EUR J CLIN INVEST, V34, P283, DOI 10.1111/j.1365-2362.2004.01331.x; Bluher M, 2006, DIABETES, V55, P3053, DOI 10.2337/db06-0812; Buettner C, 2008, NAT MED, V14, P667, DOI 10.1038/nm1775; Cohen P, 2002, SCIENCE, V297, P240, DOI 10.1126/science.1071527; Colombo G, 1998, LIFE SCI, V63, pPL113, DOI 10.1016/S0024-3205(98)00322-1; Cota D, 2003, J CLIN INVEST, V112, P423, DOI 10.1172/JCI17725; De Morrow S, 2008, AM J PHYSIOL-GASTR L, V294, pG506, DOI 10.1152/ajpgi.00304.2007; Despres JP, 2005, NEW ENGL J MED, V353, P2121, DOI 10.1056/NEJMoa044537; DEVANE WA, 1992, SCIENCE, V258, P1946, DOI 10.1126/science.1470919; Di Marzo V, 2001, NATURE, V410, P822, DOI 10.1038/35071088; diMarzo V, 1996, BIOCHEM J, V316, P977, DOI 10.1042/bj3160977; Dinh TP, 2002, P NATL ACAD SCI USA, V99, P10819, DOI 10.1073/pnas.152334899; Engeli S, 2005, DIABETES, V54, P2838, DOI 10.2337/diabetes.54.10.2838; Gary-Bobo M, 2007, HEPATOLOGY, V46, P122, DOI 10.1002/hep.21641; GREENBERG I, 1976, PSYCHOPHARMACOLOGY, V49, P79; Hezode C, 2008, GASTROENTEROLOGY, V134, P432, DOI 10.1053/j.gastro.2007.11.039; HOLLISTER LE, 1974, CLIN PHARMACOL THER, V16, P297; Ishac EJN, 1996, BRIT J PHARMACOL, V118, P2023, DOI 10.1111/j.1476-5381.1996.tb15639.x; Jamshidi N, 2001, BRIT J PHARMACOL, V134, P1151, DOI 10.1038/sj.bjp.0704379; Jbilo O, 2005, FASEB J, V19, P1567, DOI 10.1096/fj.04-3177fje; Jeong WI, 2008, CELL METAB, V7, P227, DOI 10.1016/j.cmet.2007.12.007; Jo YH, 2005, NEURON, V48, P1055, DOI 10.1016/j.neuron.2005.10.021; Julien B, 2005, GASTROENTEROLOGY, V128, P742, DOI 10.1053/j.gastro.2004.12.050; Kanda H, 2006, J CLIN INVEST, V116, P1494, DOI 10.1172/JCI26498; Kempf K, 2007, HORM METAB RES, V39, P596, DOI 10.1055/s-2007-984459; Kuo LE, 2007, NAT MED, V13, P803, DOI 10.1038/nm1611; Lin JD, 2005, CELL, V120, P261, DOI 10.1016/j.cell.2004.11.043; Liu J, 2003, J BIOL CHEM, V278, P45034, DOI 10.1074/jbc.M306062200; Liu YL, 2005, INT J OBESITY, V29, P183, DOI 10.1038/sj.ijo.0802847; Lumeng CN, 2007, J CLIN INVEST, V117, P175, DOI 10.1172/JCI29881; Matias I, 2006, J CLIN ENDOCR METAB, V91, P3171, DOI 10.1210/jc.2005-2679; McKinney MK, 2005, ANNU REV BIOCHEM, V74, P411, DOI 10.1146/annurev.biochem.74.082803.133450; Melis T, 2007, NEUROSCI LETT, V419, P231, DOI 10.1016/j.neulet.2007.04.012; Michalopoulos GK, 2003, GENE EXPRESSION, V11, P55, DOI 10.3727/000000003108748964; Miller CC, 2004, PHYSIOL BEHAV, V80, P611, DOI 10.1016/j.physbeh.2003.10.019; Moezi L, 2006, BRIT J PHARMACOL, V149, P898, DOI 10.1038/sj.bjp.0706928; Nakata M, 2008, REGUL PEPTIDES, V145, P49, DOI 10.1016/j.regpep.2007.08.009; Obici S, 2003, ENDOCRINOLOGY, V144, P5172, DOI 10.1210/en.2003-0999; Osei-Hyiaman D, 2005, J CLIN INVEST, V115, P1298, DOI 10.1172/JCI200523057; Osei-Hyiaman D, 2008, J CLIN INVEST, V118, P3160, DOI 10.1172/JCI34827; Pacher P, 2006, PHARMACOL REV, V58, P389, DOI 10.1124/pr.58.3.2; Pagano C, 2007, J CLIN ENDOCR METAB, V92, P4810, DOI 10.1210/jc.2007-0768; Pagotto U, 2006, ENDOCR REV, V27, P73, DOI 10.1210/er.2005-0009; Palmiter RD, 1998, RECENT PROG HORM RES, V53, P163; Pi-Sunyer F, 2006, JAMA-J AM MED ASSOC, V295, P761, DOI 10.1001/jama.295.7.761; Poirier B, 2005, DIABETES OBES METAB, V7, P65, DOI 10.1111/j.1463-1326.2004.00374.x; RINALDICARMONA M, 1994, FEBS LETT, V350, P240, DOI 10.1016/0014-5793(94)00773-X; Ryberg E, 2007, BRIT J PHARMACOL, V152, P1092, DOI 10.1038/sj.bjp.0707460; Sampath H, 2007, J BIOL CHEM, V282, P2483, DOI 10.1074/jbc.M610158200; Scheen AJ, 2006, LANCET, V368, P1660, DOI 10.1016/S0140-6736(06)69571-8; Siegmund SV, 2007, FASEB J, V21, P2798, DOI 10.1096/fj.06-7717com; Simiand J, 1998, BEHAV PHARMACOL, V9, P179; Starowicz K, 2007, PHARMACOL THERAPEUT, V114, P13, DOI 10.1016/j.pharmthera.2007.01.005; Teixeira-Clerc F, 2006, NAT MED, V12, P671, DOI 10.1038/nm1421; Trillou CR, 2003, AM J PHYSIOL-REG I, V284, pR345, DOI 10.1152/ajpregu.00545.2002; Trillou CR, 2004, INT J OBESITY, V28, P640, DOI 10.1038/sj.ijo.0802583; Van Gaal LF, 2005, LANCET, V365, P1389, DOI 10.1016/S0140-6736(05)66374-X; Vickers SP, 2003, PSYCHOPHARMACOLOGY, V167, P103, DOI 10.1007/s00213-002-1384-8; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451; Xu XD, 2006, CANCER GENET CYTOGEN, V171, P31, DOI 10.1016/j.cancergencyto.2006.06.014	64	74	78	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 28	2008	283	48					33021	33025		10.1074/jbc.R800012200	http://dx.doi.org/10.1074/jbc.R800012200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	376KY	18694938	Green Published, hybrid			2022-12-27	WOS:000261183700001
J	Adle, DJ; Lee, J				Adle, David J.; Lee, Jaekwon			Expressional Control of a Cadmium-transporting P-1B-type ATPase by a Metal Sensing Degradation Signal	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							WILSONS-DISEASE PROTEIN; BINDING SITES; FERRICHROME TRANSPORTER; CANDIDA-ALBICANS; COPPER-BINDING; YEAST; DOMAIN; RESISTANCE; INSIGHTS; ATP7B	Cadmium is a highly toxic environmental contaminant implicated in various diseases. Our previous data demonstrated that Pca1, a P-1B-type ATPase, plays a critical role in cadmium resistance in yeast S. cerevisiae by extruding intracellular cadmium. This illustrates the first cadmium-specific efflux pump in eukaryotes. In response to cadmium, yeast cells rapidly enhance expression of Pca1 by a post-transcriptional mechanism. To gain mechanistic insights into the cadmium-dependent control of Pca1 expression, we have characterized the pathway for Pca1 turnover and the mechanism of cadmium sensing that leads to up-regulation of Pca1. Pca1 is a short-lived protein (t(1/2) < 5 min) and is subject to ubiquitination when cells are growing in media lacking cadmium. Distinct from many plasma membrane transporters targeted to the vacuole for degradation via endocytosis, cells defective in this pathway did not stabilize Pca1. Rather, Pca1 turnover was dependent on the proteasome. These data suggest that, in the absence of cadmium, Pca1 is targeted for degradation before reaching the plasma membrane. Mapping of the N terminus of Pca1 identified a metal-responding degradation signal encompassing amino acids 250-350. Fusion of this domain to a stable protein demonstrated that it functions autonomously in a metal-responsive manner. Cadmium sensing by cysteine residues within this domain circumvents ubiquitination and degradation of Pca1. These data reveal a new mechanism for substrate-mediated control of P-1B-type ATPase expression. Cells have likely evolved this mode of regulation for a rapid and specific cellular response to cadmium.	[Adle, David J.; Lee, Jaekwon] Univ Nebraska, Dept Biochem, Redox Biol Ctr, Lincoln, NE 68588 USA	University of Nebraska System; University of Nebraska Lincoln	Lee, J (corresponding author), Univ Nebraska, Dept Biochem, Redox Biol Ctr, N210 Beadle Ctr, Lincoln, NE 68588 USA.	jlee7@unlnotes.unl.edu			National Institutes of Health [DK79209, P20RR-17657]; Hatch Act in the University of Nebraska Research Division; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK079209] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES016337] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Hatch Act in the University of Nebraska Research Division; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grants DK79209 (to J. L.) and P20RR-17657 (to the Nebraska Redox Biology Center). This work was also supported by funds provided through the Hatch Act in the University of Nebraska Research Division. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Achila D, 2006, P NATL ACAD SCI USA, V103, P5729, DOI 10.1073/pnas.0504472103; Adle DJ, 2007, J BIOL CHEM, V282, P947, DOI 10.1074/jbc.M609535200; *AG TOX SUBST DIS, 1999, 7440439 CAS AG TOX S; ALLOWAY BJ, 1990, SCI TOTAL ENVIRON, V91, P223, DOI 10.1016/0048-9697(90)90300-J; AMMERER G, 1986, MOL CELL BIOL, V6, P2490, DOI 10.1128/MCB.6.7.2490; AUSUBEL FM, 1999, SHORT PROTOCOLS MOL; Babst M, 1997, EMBO J, V16, P1820, DOI 10.1093/emboj/16.8.1820; Brennan RJ, 1996, MUTAT RES-FUND MOL M, V356, P171, DOI 10.1016/0027-5107(96)00051-6; Bressler JP, 2004, ANN NY ACAD SCI, V1012, P142, DOI 10.1196/annals.1306.011; Cater MA, 2007, BIOCHEM J, V401, P143, DOI 10.1042/BJ20061055; Chaney RL, 1997, CURR OPIN BIOTECH, V8, P279, DOI 10.1016/S0958-1669(97)80004-3; Cobbett C, 2002, ANNU REV PLANT BIOL, V53, P159, DOI 10.1146/annurev.arplant.53.100301.135154; Dalton TP, 2005, P NATL ACAD SCI USA, V102, P3401, DOI 10.1073/pnas.0406085102; de Bie P, 2007, GASTROENTEROLOGY, V133, P1316, DOI 10.1053/j.gastro.2007.07.020; De Domenico I, 2008, NAT REV MOL CELL BIO, V9, P72, DOI 10.1038/nrm2295; Ercal Nuran, 2001, Current Topics in Medicinal Chemistry, V1, P529, DOI 10.2174/1568026013394831; Eren E, 2006, J BIOL CHEM, V281, P33881, DOI 10.1074/jbc.M605218200; Fauchon M, 2002, MOL CELL, V9, P713, DOI 10.1016/S1097-2765(02)00500-2; Felice MR, 2005, J BIOL CHEM, V280, P22181, DOI 10.1074/jbc.M414663200; Fleming JA, 2002, P NATL ACAD SCI USA, V99, P1461, DOI 10.1073/pnas.032516399; GIETZ RD, 1995, YEAST, V11, P355, DOI 10.1002/yea.320110408; Gilon T, 1998, EMBO J, V17, P2759, DOI 10.1093/emboj/17.10.2759; Gitan RS, 2003, J BIOL CHEM, V278, P39558, DOI 10.1074/jbc.M302760200; Gomes DS, 2002, BBA-GEN SUBJECTS, V1573, P21, DOI 10.1016/S0304-4165(02)00324-0; Hampton RY, 2002, ANNU REV CELL DEV BI, V18, P345, DOI 10.1146/annurev.cellbio.18.032002.131219; HEINEMEYER W, 1993, J BIOL CHEM, V268, P5115; Henson MC, 2004, EXP BIOL MED, V229, P383, DOI 10.1177/153537020422900506; Horak J, 2003, BBA-BIOMEMBRANES, V1614, P139, DOI 10.1016/S0005-2736(03)00195-0; Huster D, 2003, J BIOL CHEM, V278, P32212, DOI 10.1074/jbc.M305408200; Jarup Lars, 1998, Scandinavian Journal of Work Environment and Health, V24, P1; Jin YH, 2003, NAT GENET, V34, P326, DOI 10.1038/ng1172; Johnson MD, 2003, NAT MED, V9, P1081, DOI 10.1038/nm902; Kim Y, 2005, EMBO J, V24, P952, DOI 10.1038/sj.emboj.7600579; Kim Y, 2002, EMBO J, V21, P3632, DOI 10.1093/emboj/cdf382; Klaassen CD, 1999, ANNU REV PHARMACOL, V39, P267, DOI 10.1146/annurev.pharmtox.39.1.267; Ko JH, 2006, J CELL BIOCHEM, V99, P719, DOI 10.1002/jcb.20980; Lemmon SK, 2000, CURR OPIN CELL BIOL, V12, P457, DOI 10.1016/S0955-0674(00)00117-4; Leslie EM, 2006, MOL PHARMACOL, V69, P629, DOI 10.1124/mol.105.014241; Li ZS, 1997, P NATL ACAD SCI USA, V94, P42, DOI 10.1073/pnas.94.1.42; Lim CM, 2006, BIOCHEM BIOPH RES CO, V348, P428, DOI 10.1016/j.bbrc.2006.07.067; Liu XF, 1999, J BIOL CHEM, V274, P4863, DOI 10.1074/jbc.274.8.4863; Lutsenko S, 2003, J MEMBRANE BIOL, V191, P1, DOI 10.1007/s00232-002-1040-6; Lutsenko S, 2007, PHYSIOL REV, V87, P1011, DOI 10.1152/physrev.00004.2006; Mana-Capelli S, 2003, J BIOL CHEM, V278, P40534, DOI 10.1074/jbc.M306907200; Mandal AK, 2003, BIOCHEMISTRY-US, V42, P11040, DOI 10.1021/bi034806y; MUMBERG D, 1995, GENE, V156, P119, DOI 10.1016/0378-1119(95)00037-7; Nies DH, 1999, APPL MICROBIOL BIOT, V51, P730, DOI 10.1007/s002530051457; Overton MC, 2002, J BIOL CHEM, V277, P41463, DOI 10.1074/jbc.M205368200; Perfus-Barbeoch L, 2002, PLANT J, V32, P539, DOI 10.1046/j.1365-313X.2002.01442.x; RATHS S, 1993, J CELL BIOL, V120, P55, DOI 10.1083/jcb.120.1.55; Rebbeor JF, 1998, J BIOL CHEM, V273, P33449, DOI 10.1074/jbc.273.50.33449; Rechsteiner M, 1996, TRENDS BIOCHEM SCI, V21, P267, DOI 10.1016/S0968-0004(96)10031-1; Riggle PJ, 2000, J BACTERIOL, V182, P4899, DOI 10.1128/JB.182.17.4899-4905.2000; Roberg KJ, 1997, J CELL BIOL, V137, P1469, DOI 10.1083/jcb.137.7.1469; Safe S, 2003, NAT MED, V9, P1000, DOI 10.1038/nm0803-1000; Satarug S, 2004, ENVIRON HEALTH PERSP, V112, P1099, DOI 10.1289/ehp.6751; Sayeed A, 2005, CRIT REV BIOCHEM MOL, V40, P75, DOI 10.1080/10409230590918685; Silver S, 1996, ANNU REV MICROBIOL, V50, P753, DOI 10.1146/annurev.micro.50.1.753; SINGHAL RK, 1987, FASEB J, V1, P220, DOI 10.1096/fasebj.1.3.2887478; Springael JY, 1998, MOL BIOL CELL, V9, P1253, DOI 10.1091/mbc.9.6.1253; Strausak D, 1999, J BIOL CHEM, V274, P11170, DOI 10.1074/jbc.274.16.11170; Tao TY, 2003, HEPATOLOGY, V37, P1241, DOI 10.1053/jhep.2003.50281; Toyoshima C, 2004, ANNU REV BIOCHEM, V73, P269, DOI 10.1146/annurev.biochem.73.011303.073700; Varshavsky A, 1996, P NATL ACAD SCI USA, V93, P12142, DOI 10.1073/pnas.93.22.12142; Verret F, 2005, FEBS LETT, V579, P1515, DOI 10.1016/j.febslet.2005.01.065; Vido K, 2001, J BIOL CHEM, V276, P8469, DOI 10.1074/jbc.M008708200; Walker JM, 2004, J BIOL CHEM, V279, P15376, DOI 10.1074/jbc.M400053200; Walker JM, 2002, J BIOL CHEM, V277, P27953, DOI 10.1074/jbc.M203845200; Weissman Z, 2000, P NATL ACAD SCI USA, V97, P3520, DOI 10.1073/pnas.97.7.3520; Williams LE, 2005, TRENDS PLANT SCI, V10, P491, DOI 10.1016/j.tplants.2005.08.008; Wimmer U, 2005, NUCLEIC ACIDS RES, V33, P5715, DOI 10.1093/nar/gki881; Yang Y, 2007, BBA-BIOMEMBRANES, V1768, P495, DOI 10.1016/j.bbamem.2006.09.013; Zhang FX, 2003, CELL, V115, P715, DOI 10.1016/S0092-8674(03)00974-7; ZHOU PB, 1993, BIOFACTORS, V4, P105	74	25	26	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 14	2008	283	46					31460	31468		10.1074/jbc.M806054200	http://dx.doi.org/10.1074/jbc.M806054200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	370KJ	18753133	hybrid, Green Published			2022-12-27	WOS:000260760800025
J	Guizzetti, M; Moore, NH; Giordano, G; Costa, LG				Guizzetti, Marina; Moore, Nadia H.; Giordano, Gennaro; Costa, Lucio G.			Modulation of Neuritogenesis by Astrocyte Muscarinic Receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; NEURITE OUTGROWTH; HIPPOCAMPAL-NEURONS; DNA-SYNTHESIS; GLIAL-CELLS; NEUROTRANSMITTER REGULATION; ASTROGLIAL CELLS; N-CADHERIN; ACETYLCHOLINE; GROWTH	Astrocytes have been shown to release factors that have promoting or inhibiting effects on neuronal development. However, mechanisms controlling the release of such factors from astrocytes are not well established. Astrocytes express muscarinic receptors whose activation stimulates a robust intracellular signaling, although the role of these receptors in glial cells is not well understood. Acetylcholine and acetylcholine receptors are present in the brain before synaptogenesis occurs and are believed to be involved in neuronal maturation. The present study was undertaken to investigate whether stimulation of muscarinic receptors in astrocytes would modulate neurite outgrowth in hippocampal neurons. Rat hippocampal neurons, cocultured with rat cortical astrocytes previously exposed to the cholinergic agonist carbachol, displayed longer neurites. The effect of carbachol in astrocytes was due to the activation of M3 muscarinic receptors. Exposure of astrocytes to carbachol increased the expression of the extracellular matrix proteins fibronectin and laminin-1 in these cells. This effect was mediated in part by an increase in laminin-1 and fibronectin mRNA levels and in part by the up-regulation of the production and release of plasminogen activator inhibitor-1, an inhibitor of the proteolytic degradation of the extracellular matrix. The inhibition of fibronectin activity strongly reduced the effect of carbachol on the elongation of all the neurites, whereas inhibition of laminin-1 activity reduced the elongation of minor neurites only. Plasminogen activator inhibitor-1 also induced neurite elongation through a direct effect on neurons. Taken together, these results demonstrate that cholinergic muscarinic stimulation of astrocytes induces the release of permissive factors that accelerate neuronal development.	[Guizzetti, Marina; Moore, Nadia H.; Giordano, Gennaro; Costa, Lucio G.] Univ Washington, Dept Environm & Occupat Hlth Sci, Seattle, WA 98105 USA; [Costa, Lucio G.] Univ Parma, Sch Med, Dept Human Anat Pharmacol & Forens Sci, I-43100 Parma, Italy	University of Washington; University of Washington Seattle; University of Parma	Guizzetti, M (corresponding author), Univ Washington, Dept Environm & Occupat Hlth Sci, 4225 Roosevelt Way NE 100, Seattle, WA 98105 USA.	marinag@u.washington.edu			National Institutes of Health [AA-08154, ES-07033]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [T32ES007032, P30ES007033] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA008154] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported, in whole or in part, by National Institutes of Health Grants AA-08154 and ES-07033.	Araque A, 2002, J NEUROSCI, V22, P2443, DOI 10.1523/JNEUROSCI.22-07-02443.2002; ARMSTRONG DM, 1987, DEV BRAIN RES, V36, P249, DOI 10.1016/0165-3806(87)90028-9; Asher RA, 2000, J NEUROSCI, V20, P2427; ASHKENAZI A, 1989, NATURE, V340, P146, DOI 10.1038/340146a0; BARTUS RT, 1982, SCIENCE, V217, P408, DOI 10.1126/science.7046051; Berger-Sweeney J, 2003, NEUROSCI BIOBEHAV R, V27, P401, DOI 10.1016/S0149-7634(03)00070-8; Blondel O, 2000, J NEUROSCI, V20, P8012; Booth GE, 2000, DEVELOPMENT, V127, P237; BREWER GJ, 1993, J NEUROSCI RES, V35, P567, DOI 10.1002/jnr.490350513; BUZNIKOV GA, 1984, PHARMACOL THERAPEUT, V25, P23, DOI 10.1016/0163-7258(84)90023-8; Catlin MC, 2000, CYTOMETRY, V41, P123; Chotard C, 2004, TRENDS NEUROSCI, V27, P655, DOI 10.1016/j.tins.2004.09.001; Costa LG, 2001, GROWTH FACTORS, V18, P227, DOI 10.3109/08977190109029112; DAUBAS P, 1990, NEURON, V5, P49, DOI 10.1016/0896-6273(90)90032-B; Dellas C, 2005, THROMB HAEMOSTASIS, V93, P631, DOI 10.1160/TH05-01-0033; DOTTI CG, 1988, J NEUROSCI, V8, P1454; Giau R, 2005, J NEUROSCI, V25, P8995, DOI 10.1523/JNEUROSCI.2430-05.2005; Gilmour DT, 2002, NEURON, V34, P577, DOI 10.1016/S0896-6273(02)00683-9; Guizzetti M, 1998, EUR J PHARMACOL, V359, P223, DOI 10.1016/S0014-2999(98)00620-7; Guizzetti M, 2000, BIOCHEM PHARMACOL, V60, P1457, DOI 10.1016/S0006-2952(00)00468-8; Guizzetti M, 2003, NEUROSCIENCE, V120, P941, DOI 10.1016/S0306-4522(03)00401-9; Guizzetti M, 1996, EUR J PHARMACOL, V297, P265, DOI 10.1016/0014-2999(95)00746-6; GUSTAFSON T, 1970, EXP CELL RES, V62, P102, DOI 10.1016/0014-4827(79)90512-3; Hamel MG, 2005, J NEUROCHEM, V93, P1533, DOI 10.1111/j.1471-4159.2005.03144.x; Higgins D, 1997, CURR OPIN NEUROBIOL, V7, P599, DOI 10.1016/S0959-4388(97)80078-5; Hohmann CF, 2003, NEUROSCI BIOBEHAV R, V27, P351, DOI 10.1016/S0149-7634(03)00066-6; HUNTER DD, 1992, J COMP NEUROL, V323, P238, DOI 10.1002/cne.903230208; Irigoyen JP, 1999, CELL MOL LIFE SCI, V56, P104, DOI 10.1007/PL00000615; Karczmar Alexander G., 2007, P1; KINNEY HC, 1993, NEUROSCIENCE, V55, P1127, DOI 10.1016/0306-4522(93)90326-B; Kiryushko D, 2004, ANN NY ACAD SCI, V1014, P140, DOI 10.1196/annals.1294.015; LAASBERG T, 1990, COMP BIOCHEM PHYS C, V97, P9, DOI 10.1016/0742-8413(90)90164-5; LANDER AD, 1985, P NATL ACAD SCI USA, V82, P2183, DOI 10.1073/pnas.82.7.2183; Lauder JM, 1999, ENVIRON HEALTH PERSP, V107, P65, DOI 10.2307/3434473; Lein PJ, 2002, J NEUROSCI, V22, P10377; LIESI P, 1986, EXP CELL RES, V163, P175, DOI 10.1016/0014-4827(86)90570-7; LIPTON SA, 1989, TRENDS NEUROSCI, V12, P265, DOI 10.1016/0166-2236(89)90026-X; Lohmann C, 2002, NATURE, V418, P177, DOI 10.1038/nature00850; Marin O, 2003, ANNU REV NEUROSCI, V26, P441, DOI 10.1146/annurev.neuro.26.041002.131058; Martinez R, 2002, J BIOL CHEM, V277, P49311, DOI 10.1074/jbc.M209284200; Masaki T, 2001, ACTA NEUROPATHOL, V101, P174; MATTHIESSEN HP, 1989, GLIA, V2, P177, DOI 10.1002/glia.440020307; MULLER HW, 1995, PHARMACOL THERAPEUT, V65, P1, DOI 10.1016/0163-7258(94)00047-7; NEUGEBAUER KM, 1988, J CELL BIOL, V107, P1177, DOI 10.1083/jcb.107.3.1177; Nguyen L, 2001, CELL TISSUE RES, V305, P187, DOI 10.1007/s004410000343; Pfrieger FW, 1997, SCIENCE, V277, P1684, DOI 10.1126/science.277.5332.1684; Porter JT, 1997, PROG NEUROBIOL, V51, P439, DOI 10.1016/S0301-0082(96)00068-8; PRICE J, 1985, J NEUROSCI, V5, P2205; Richards LJ, 2002, BRAZ J MED BIOL RES, V35, P1431, DOI 10.1590/S0100-879X2002001200004; Riethmacher D, 1997, NATURE, V389, P725, DOI 10.1038/39593; ROGERS SL, 1983, DEV BIOL, V98, P212, DOI 10.1016/0012-1606(83)90350-0; ROGERS SL, 1989, DEV NEUROSCI-BASEL, V11, P248, DOI 10.1159/000111904; SCHAMBRA UB, 1989, J COMP NEUROL, V288, P101, DOI 10.1002/cne.902880109; SCHLUMPF M, 1991, NEUROSCIENCE, V45, P347, DOI 10.1016/0306-4522(91)90232-D; SCHMIDT H, 1981, HISTOCHEMISTRY, V71, P89, DOI 10.1007/BF00592573; Schwamborn JC, 2006, METHOD ENZYMOL, V406, P715, DOI 10.1016/S0076-6879(06)06056-3; Seigneur J, 2006, CEREB CORTEX, V16, P655, DOI 10.1093/cercor/bhj011; Smit M, 2003, BIOTECHNIQUES, V35, P254, DOI 10.2144/03352bm01; SNOW DM, 1990, EXP NEUROL, V109, P111, DOI 10.1016/S0014-4886(05)80013-5; Soeda S, 2006, NEUROSCIENCE, V141, P101, DOI 10.1016/j.neuroscience.2006.03.026; SUN YA, 1987, P NATL ACAD SCI USA, V84, P2540, DOI 10.1073/pnas.84.8.2540; Tom VJ, 2004, J NEUROSCI, V24, P9282, DOI 10.1523/JNEUROSCI.2120-04.2004; TOMASELLI KJ, 1988, NEURON, V1, P33, DOI 10.1016/0896-6273(88)90207-3; Ullian EM, 2001, SCIENCE, V291, P657, DOI 10.1126/science.291.5504.657; VASSALLI JD, 1991, J CLIN INVEST, V88, P1067, DOI 10.1172/JCI115405; Viviani B, 1998, TOXICOL APPL PHARM, V150, P271, DOI 10.1006/taap.1998.8406; WEE EL, 1980, J EMBRYOL EXP MORPH, V58, P177; Weiss ER, 1998, PERSPECT DEV NEUROBI, V5, P323; Wong WT, 2001, NAT NEUROSCI, V4, P351, DOI 10.1038/85987; Wong WT, 2000, J NEUROSCI, V20, P5024; WUJEK JR, 1990, DEV BRAIN RES, V55, P237, DOI 10.1016/0165-3806(90)90205-D; XIE ZP, 1986, P NATL ACAD SCI USA, V83, P7069, DOI 10.1073/pnas.83.18.7069; Yagle K, 2001, GLIA, V35, P111, DOI 10.1002/glia.1076; Yamada H, 1997, J NEUROSCI, V17, P7784; Yao WD, 2000, J NEUROSCI, V20, P2626	75	67	67	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 14	2008	283	46					31884	31897		10.1074/jbc.M801316200	http://dx.doi.org/10.1074/jbc.M801316200			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	370KJ	18755690	Green Published, hybrid			2022-12-27	WOS:000260760800071
J	Kim, IY; Li, CX; Liang, D; Chen, XZ; Coffy, RJ; Ma, J; Zhao, P; Wu, GQ				Kim, Ingyu; Li, Cunxi; Liang, Dan; Chen, Xing-Zhen; Coffy, Robert J.; Ma, Jie; Zhao, Ping; Wu, Guanqing			Polycystin-2 Expression Is Regulated by a PC2-binding Domain in the Intracellular Portion of Fibrocystin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KIDNEY-DISEASE ARPKD; AUTOSOMAL-DOMINANT; PRIMARY CILIA; TRP CHANNELS; PROTEIN; GENE; PKHD1; ENCODES; PKD2; INACTIVATION	Autosomal dominant (ADPKD) and autosomal recessive (ARPKD) polycystic kidney disease are caused by mutations in Pkd1/Pkd2 and Pkhd1, which encode polycystins (PCs) and fibrocystin/ polyductin (FPC). Our recent study reported that a deficiency in FPC increases the severity of cystic disease in Pkd2 mutantsanddown-regulates PC2 in vivo, buttheprecisemolecular mechanism of these effects is unknown (Kim, I., Fu, Y., Hui, K., Moeckel, G., Mai, W., Li, C., Liang, D., Zhao, P., Ma, J., Chen, X.-Z., George, A. L., Jr., Coffey, R. J., Feng, Z. P., and Wu, G. (2008) J. Am. Soc. Nephrol. 19, 455 - 468). In this study, through the use of deletion and mutagenesis strategies, we identified a PC2-binding domain in the intracellular C terminus of FPC and an FPC-binding domain in the intracellular N terminus of PC2. These binding domains provide a molecular basis for the physical interaction between PC2 and FPC. In addition, we also found that physical interaction between the binding domains of PC2 and FPC is able to prevent down-regulation of PC2 induced by loss of FPC. In vivo, we generated a mouse model of ADPKD with hypomorphic Pkd2 alleles (Pkd2(nf3/nf3)) and show that PC2 down-regulation is accompanied by a phenotype similar to that of Pkhd1(-/)-mice. These findings demonstrate a common mechanism underlying cystogenesis in ADPKD and ARPKD and provide insight into the molecular relationship between PC2 and FPC.	[Kim, Ingyu; Li, Cunxi; Liang, Dan; Coffy, Robert J.; Wu, Guanqing] Vanderbilt Univ, Dept Cell & Dev Biol, Nashville, TN 37232 USA; [Chen, Xing-Zhen] Univ Alberta, Dept Physiol, Edmonton, AB T6G 2H7, Canada; [Kim, Ingyu; Li, Cunxi; Liang, Dan; Coffy, Robert J.; Wu, Guanqing] Vanderbilt Univ, Dept Med, Nashville, TN 37232 USA; [Ma, Jie; Zhao, Ping; Wu, Guanqing] Chinese Acad Med Sci, Canc Hosp & Inst, Div Translat Canc Res & Therapy, Beijing 100021, Peoples R China	Vanderbilt University; University of Alberta; Vanderbilt University; Chinese Academy of Medical Sciences - Peking Union Medical College	Wu, GQ (corresponding author), Vanderbilt Univ, Dept Med, 539 Light Hall,2215 Garland Ave, Nashville, TN 37232 USA.	guanqing.wu@vanderbilt.edu			National Institutes of Health [DK062373, DK071090]; Yangzhi scholarship, China; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK062373, R01DK071090] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Yangzhi scholarship, China; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK062373 and DK071090. This work was also supported by a Yangzhi scholarship, China (to G. W.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	BURN TC, 1995, HUM MOL GENET, V4, P575, DOI 10.1093/hmg/4.4.575; Capisonda R, 2003, PEDIATR NEPHROL, V18, P119, DOI 10.1007/s00467-002-1021-0; Fischer E, 2006, NAT GENET, V38, P21, DOI 10.1038/ng1701; Garcia-Gonzalez MA, 2007, HUM MOL GENET, V16, P1940, DOI 10.1093/hmg/ddm141; Guay-Woodford LM, 2003, PEDIATRICS, V111, P1072, DOI 10.1542/peds.111.5.1072; Hossain Z, 2007, P NATL ACAD SCI USA, V104, P1631, DOI 10.1073/pnas.0605266104; Igarashi P, 2002, J AM SOC NEPHROL, V13, P2384, DOI 10.1097/01.ASN.0000028643.17901.42; Kaimori JY, 2008, J AM SOC NEPHROL, V19, P416, DOI 10.1681/ASN.2008010033; Kaimori JY, 2007, HUM MOL GENET, V16, P942, DOI 10.1093/hmg/ddm039; Kim IY, 2008, J AM SOC NEPHROL, V19, P455, DOI 10.1681/ASN.2007070770; Li Z, 2003, CELL, V114, P215, DOI 10.1016/S0092-8674(03)00559-2; Lilova MI, 2001, PEDIATR NEPHROL, V16, P1030, DOI 10.1007/s004670100019; Losekoot M, 2005, HUM GENET, V118, P185, DOI 10.1007/s00439-005-0027-7; Mai WY, 2005, MOL BIOL CELL, V16, P4398, DOI 10.1091/mbc.E04-11-1019; Mochizuki T, 1996, SCIENCE, V272, P1339, DOI 10.1126/science.272.5266.1339; Montell C, 2002, CELL, V108, P595, DOI 10.1016/S0092-8674(02)00670-0; O'Connell BC, 2007, CURR OPIN CELL BIOL, V19, P206, DOI 10.1016/j.ceb.2007.02.014; Onuchic LF, 2002, AM J HUM GENET, V70, P1305, DOI 10.1086/340448; Qamar S, 2007, BIOCHEM SOC T, V35, P124, DOI 10.1042/BST0350124; Qian F, 1996, CELL, V87, P979, DOI 10.1016/S0092-8674(00)81793-6; Qian F, 1997, NAT GENET, V16, P179, DOI 10.1038/ng0697-179; Rodova M, 2002, J BIOL CHEM, V277, P29577, DOI 10.1074/jbc.M203570200; Rossetti S, 2003, KIDNEY INT, V64, P391, DOI 10.1046/j.1523-1755.2003.00111.x; Rossetti S, 2007, J AM SOC NEPHROL, V18, P2143, DOI 10.1681/ASN.2006121387; Sharp AM, 2005, J MED GENET, V42, P336, DOI 10.1136/jmg.2004.024489; Tian Y, 2007, MOL CELL BIOL, V27, P6383, DOI 10.1128/MCB.00254-07; Torres VE, 2006, NAT CLIN PRACT NEPHR, V2, P40, DOI 10.1038/ncpneph0070; Wang SX, 2007, MOL CELL BIOL, V27, P3241, DOI 10.1128/MCB.00072-07; Wang SX, 2004, J AM SOC NEPHROL, V15, P592, DOI 10.1097/01.ASN.0000113793.12558.1D; Ward CJ, 2002, NAT GENET, V30, P259, DOI 10.1038/ng833; Ward CJ, 2003, HUM MOL GENET, V12, P2703, DOI 10.1093/hmg/ddg274; WARD CJ, 1994, CELL, V77, P881; Wildenberg GA, 2006, CELL, V127, P1027, DOI 10.1016/j.cell.2006.09.046; Wilson PD, 2004, NEW ENGL J MED, V350, P151, DOI 10.1056/NEJMra022161; Wu GQ, 2002, HUM MOL GENET, V11, P1845, DOI 10.1093/hmg/11.16.1845; Wu GQ, 1998, CELL, V93, P177, DOI 10.1016/S0092-8674(00)81570-6; Wu YL, 2006, HUM MOL GENET, V15, P3280, DOI 10.1093/hmg/ddl404; Xiong HQ, 2002, GENOMICS, V80, P96, DOI 10.1006/geno.2002.6802; Yu SQ, 2007, P NATL ACAD SCI USA, V104, P18688, DOI 10.1073/pnas.0708217104; Zerres K, 1996, Adv Nephrol Necker Hosp, V25, P147; Zerres K, 2003, J NEPHROL, V16, P453; Zhang MZ, 2004, P NATL ACAD SCI USA, V101, P2311, DOI 10.1073/pnas.0400073101	42	52	54	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 14	2008	283	46					31559	31566		10.1074/jbc.M805452200	http://dx.doi.org/10.1074/jbc.M805452200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	370KJ	18782757	Green Published, hybrid			2022-12-27	WOS:000260760800035
J	Andre, H; Pereira, TS				Andre, Helder; Pereira, Teresa S.			Identification of an Alternative Mechanism of Degradation of the Hypoxia-inducible Factor-1 alpha	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-SUPPRESSOR PROTEIN; UBIQUITIN-PROTEASOME PATHWAY; HIPPEL-LINDAU PROTEIN; FACTOR-ALPHA; FACTOR 1-ALPHA; HYPOXIA-INDUCIBLE-FACTOR-1-ALPHA HIF-1-ALPHA; PROLINE HYDROXYLATION; PROLYL HYDROXYLATION; DIRECT BINDING; HIF-ALPHA	The hypoxia-inducible factor-1 alpha (HIF-1 alpha) is a master regulator of the cellular response to decreased oxygen levels. This transcription factor is highly unstable at normal oxygen concentrations and is rapidly stabilized by hypoxia. At normoxia two specific proline residues (Pro(402) and Pro(563)) of mHIF-1 alpha are hydroxylated and recognized by the von Hippel-Lindau E3 ubiquitin ligase (pVHL) complex, which upon binding mediates degradation of the protein. Previous studies have demonstrated that these two proline residues are critical for high affinity binding to pVHL. We have performed a detailed analysis of a mutant form of HIF-1 alpha, where both these proline residues have been mutated, and we have uncovered a novel degradation pathway, to which the HIF-1 alpha mutant protein is not resistant. Our results show that the HIF-1 alpha double proline mutant undergoes ubiquitination and proteasome-dependent degradation, and retains the ability to be stabilized in response to hypoxia and CoCl2 treatment. However in contrast to the wild-type protein, stabilization of the mutant was only observed within short periods of hypoxia exposure (1-2 h). Degradation assays in the presence of the expressed prolyl hydroxylases (PHDs) 1-3 showed that, unlike the wild-type protein, the HIF-1 alpha mutant was resistant to these hydroxylases. However, experiments knocking-down expression of pVHL by RNA interference showed that the HIF-1 alpha mutant is degraded and ubiquitinated by a pVHL-mediated mechanism. In conclusion, we show the first evidence of a novel mechanism of degradation of HIF-1 alpha at normoxia that involves pVHL but is not mediated by PHDs 1-3 or by degradation boxes surrounding Pro(402) and Pro(563).	[Andre, Helder; Pereira, Teresa S.] Karolinska Inst, Dept Cell & Mol Biol, S-17177 Stockholm, Sweden	Karolinska Institutet	Pereira, TS (corresponding author), Karolinska Inst, Dept Cell & Mol Biol, S-17177 Stockholm, Sweden.	teresa.pereira@ki.se	Pereira, Teresa/AAP-8197-2020; Andre, Helder/AAC-5220-2019	Pereira, Teresa/0000-0001-8654-2385; Andre, Helder/0000-0002-2926-2376	Swedish Medical Research Council; the Swedish Cancer Society; the European Union; Karolinska Institutet	Swedish Medical Research Council(Swedish Medical Research Council (SMRC)); the Swedish Cancer Society(Swedish Cancer Society); the European Union(European Commission); Karolinska Institutet(Karolinska Institutet)	This study was supported by grants from the Swedish Medical Research Council, the Swedish Cancer Society, the European Union, and Karolinska Institutet. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Baek JH, 2005, MOL CELL, V17, P503, DOI 10.1016/j.molcel.2005.01.011; Baek JH, 2007, J BIOL CHEM, V282, P23572, DOI 10.1074/jbc.M703504200; Berra E, 2006, EMBO REP, V7, P41, DOI 10.1038/sj.embor.7400598; Berra E, 2003, EMBO J, V22, P4082, DOI 10.1093/emboj/cdg392; Biju MP, 2004, MOL CELL BIOL, V24, P9038, DOI 10.1128/MCB.24.20.9038-9047.2004; Bruick RK, 2001, SCIENCE, V294, P1337, DOI 10.1126/science.1066373; Cheng J, 2007, CELL, V131, P584, DOI 10.1016/j.cell.2007.08.045; Cockman ME, 2000, J BIOL CHEM, V275, P25733, DOI 10.1074/jbc.M002740200; D'Angelo G, 2003, J BIOL CHEM, V278, P38183, DOI 10.1074/jbc.M302244200; Epstein ACR, 2001, CELL, V107, P43, DOI 10.1016/S0092-8674(01)00507-4; Grabmaier K, 2004, ONCOGENE, V23, P5624, DOI 10.1038/sj.onc.1207764; Haase VH, 2005, SEMIN CELL DEV BIOL, V16, P564, DOI 10.1016/j.semcdb.2005.03.006; Hirsila M, 2005, FASEB J, V19, P1308, DOI 10.1096/fj.04-3399fje; Hu CJ, 2003, MOL CELL BIOL, V23, P9361, DOI 10.1128/MCB.23.24.9361-9374.2003; Huang LE, 1998, P NATL ACAD SCI USA, V95, P7987, DOI 10.1073/pnas.95.14.7987; Ivan M, 2001, SCIENCE, V292, P464, DOI 10.1126/science.1059817; Iyer NV, 1998, GENE DEV, V12, P149, DOI 10.1101/gad.12.2.149; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; Kallio PJ, 1999, J BIOL CHEM, V274, P6519, DOI 10.1074/jbc.274.10.6519; Kamura T, 2000, P NATL ACAD SCI USA, V97, P10430, DOI 10.1073/pnas.190332597; Kanaya K, 2003, BIOCHEM BIOPH RES CO, V306, P750, DOI 10.1016/S0006-291X(03)01041-6; Kim WY, 2006, EMBO J, V25, P4650, DOI 10.1038/sj.emboj.7601300; Lando D, 2002, GENE DEV, V16, P1466, DOI 10.1101/gad.991402; Lando D, 2002, SCIENCE, V295, P858, DOI 10.1126/science.1068592; Marxsen JH, 2004, BIOCHEM J, V381, P761, DOI 10.1042/BJ20040620; Masson N, 2001, EMBO J, V20, P5197, DOI 10.1093/emboj/20.18.5197; Maynard MA, 2004, AM J NEPHROL, V24, P1, DOI 10.1159/000075346; Metzen E, 2003, J CELL SCI, V116, P1319, DOI 10.1242/jcs.00318; Ohh M, 2000, NAT CELL BIOL, V2, P423, DOI 10.1038/35017054; Pereira T, 2003, J BIOL CHEM, V278, P6816, DOI 10.1074/jbc.M209297200; Pfander D, 2004, DEVELOPMENT, V131, P2497, DOI 10.1242/dev.01138; Ruas JL, 2002, J BIOL CHEM, V277, P38723, DOI 10.1074/jbc.M205051200; Stiehl DP, 2006, J BIOL CHEM, V281, P23482, DOI 10.1074/jbc.M601719200; Tanimoto K, 2000, EMBO J, V19, P4298, DOI 10.1093/emboj/19.16.4298; Triantafyllou A, 2006, FREE RADICAL RES, V40, P847, DOI 10.1080/10715760600730810; Yu F, 2001, P NATL ACAD SCI USA, V98, P9630, DOI 10.1073/pnas.181341498; Yuan Y, 2003, J BIOL CHEM, V278, P15911, DOI 10.1074/jbc.M300463200	37	18	19	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 24	2008	283	43					29375	29384		10.1074/jbc.M805919200	http://dx.doi.org/10.1074/jbc.M805919200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	362EB	18694926	Green Published, hybrid			2022-12-27	WOS:000260179900064
J	Chen, H; Lin, AS; Li, YH; Reiter, CEN; Ver, MR; Quon, MJ				Chen, Hui; Lin, Alice Seraphina; Li, Yunhua; Reiter, Chad E. N.; Ver, Maria R.; Quon, Michael J.			Dehydroepiandrosterone Stimulates Phosphorylation of FoxO1 in Vascular Endothelial Cells via Phosphatidylinositol 3-Kinase- and Protein Kinase A-dependent Signaling Pathways to Regulate ET-1 Synthesis and Secretion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CARDIOVASCULAR-DISEASE RISK; NITRIC-OXIDE; TRANSCRIPTION FACTOR; INSULIN SENSITIVITY; IN-VITRO; CIRCULATING DEHYDROEPIANDROSTERONE; SERUM CONCENTRATIONS; ESTROGEN-RECEPTORS; TUMOR SUPPRESSION; PLASMA-MEMBRANE	Dehydroepiandrosterone (DHEA) is an endogenous adrenal steroid hormone with controversial actions in humans. We previously reported that DHEA has opposing actions in endothelial cells to stimulate phosphatidylinositol (PI) 3-kinase/Akt/endothelial nitric-oxide synthase leading to increased production of nitric oxide while simultaneously stimulating MAPK-dependent secretion of the vasoconstrictor ET-1. In the present study we hypothesized that DHEA may stimulate PI 3-kinase-dependent phosphorylation of FoxO1 in endothelial cells to help regulate endothelial function. In bovine or human aortic endothelial cells (BAEC and HAEC), treatment with DHEA(100 nM) acutely enhanced phosphorylation of FoxO1. DHEA-stimulated phosphorylation of FoxO1 was inhibited by pretreatment of cells with wortmannin (PI 3-kinase inhibitor) or H89 (protein kinase A (PKA) inhibitor) but not ICI182780 (estrogen receptor blocker), or PD98059 (MEK (MAPK/extracellular signal-regulated kinase kinase) inhibitor). Small interfering RNA knockdown of PKA inhibited DHEA-stimulated phosphorylation of FoxO1. DHEA promoted nuclear exclusion of FoxO1 that was blocked by pretreatment of cells with wortmannin, H89, or by small interfering RNA knockdown of PKA. DHEA treatment of endothelial cells increased PKA activity and intracellular cAMP concentrations. Transfection of BAEC with a constitutively nuclear FoxO1 mutant transactivated a co-transfected ET-1 promoter luciferase reporter. Treatment of BAEC with DHEA inhibited transactivation of the ET-1 promoter reporter in cells overexpressing FoxO1. ET-1 promoter activity and secretion in response to DHEA treatment was augmented by PI 3-kinase blockade and inhibited by MAPK blockade. We conclude that DHEA stimulates phosphorylation of FoxO1 via PI 3-kinase and PKA-dependent pathways in endothelial cells that negatively regulates ET-1 promoter activity and secretion. Balance between PI 3-kinase-dependent inhibition and MAPK-dependent stimulation of ET-1 secretion in response to DHEA may determine whether DHEA supplementation improves or worsens cardiovascular and metabolic function.	[Chen, Hui; Lin, Alice Seraphina; Li, Yunhua; Reiter, Chad E. N.; Ver, Maria R.; Quon, Michael J.] NIH, Diabet Unit, NCCAM, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Center for Complementary & Alternative Medicine	Quon, MJ (corresponding author), NIH, Diabet Unit, NCCAM, 9 Mem Dr,Bldg 9,Rm 1N-105, Bethesda, MD 20892 USA.	quonm@nih.gov		QUON, MICHAEL/0000-0002-5289-3707; Quon, Michael/0000-0002-9601-9915	National Institutes of Health; American Diabetes Association; NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE [Z02AT000001, Z01AT000001, ZIAAT000001] Funding Source: NIH RePORTER; National Center for Complementary & Integrative Health [ZIFAT000001] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association(American Diabetes Association); NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); National Center for Complementary & Integrative Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported, in part, by the National Institutes of Health (Intramural Research Program, NCCAM) and by a Mentor-based award from the American Diabetes Association (to M. J. Q.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Accili D, 2004, CELL, V117, P421, DOI 10.1016/S0092-8674(04)00452-0; Aitsebaomo J, 2001, J BIOL CHEM, V276, P39197, DOI 10.1074/jbc.M105166200; Aoki K, 1999, DIABETES, V48, P1579, DOI 10.2337/diabetes.48.8.1579; Armoni M, 2006, J BIOL CHEM, V281, P19881, DOI 10.1074/jbc.M600320200; Barnhart KT, 1999, J CLIN ENDOCR METAB, V84, P3896, DOI 10.1210/jc.84.11.3896; BarrettConnor E, 1995, ANN NY ACAD SCI, V774, P259, DOI 10.1111/j.1749-6632.1995.tb17386.x-i1; BARRETTCONNOR E, 1986, NEW ENGL J MED, V315, P1519, DOI 10.1056/NEJM198612113152405; BELANGER A, 1994, J CLIN ENDOCR METAB, V79, P1086; Biggs WH, 1999, P NATL ACAD SCI USA, V96, P7421, DOI 10.1073/pnas.96.13.7421; Chen F, 2005, ENDOCRINOLOGY, V146, P4568, DOI 10.1210/en.2005-0368; Chen H, 2003, J BIOL CHEM, V278, P45021, DOI 10.1074/jbc.M307878200; Chen JH, 2005, NAT MED, V11, P1188, DOI 10.1038/nm1307; Cusi K, 2000, J CLIN INVEST, V105, P311, DOI 10.1172/JCI7535; Daly C, 2006, P NATL ACAD SCI USA, V103, P15491, DOI 10.1073/pnas.0607538103; Dejana E, 2007, BBA-REV CANCER, V1775, P298, DOI 10.1016/j.bbcan.2007.05.003; DEPERETTI E, 1978, J CLIN ENDOCR METAB, V47, P572, DOI 10.1210/jcem-47-3-572; ELBeltagy K, 2007, FERTIL STERIL, V88, P1135, DOI 10.1016/j.fertnstert.2007.01.008; Fisslthaler B, 2007, CIRC RES, V100, pE12, DOI 10.1161/01.RES.0000257747.74358.1c; Formoso G, 2006, MOL ENDOCRINOL, V20, P1153, DOI 10.1210/me.2005-0266; Furuyama T, 2004, J BIOL CHEM, V279, P34741, DOI 10.1074/jbc.M314214200; Giachini FRC, 2008, EXPERT OPIN THER TAR, V12, P327, DOI 10.1517/14728222.12.3.327; GORDON GB, 1988, J CLIN INVEST, V82, P712, DOI 10.1172/JCI113652; Greer EL, 2005, ONCOGENE, V24, P7410, DOI 10.1038/sj.onc.1209086; Hosaka T, 2004, P NATL ACAD SCI USA, V101, P2975, DOI 10.1073/pnas.0400093101; Huang H, 2005, P NATL ACAD SCI USA, V102, P1649, DOI 10.1073/pnas.0406789102; Iglarz M, 2007, J CARDIOVASC PHARM, V50, P621, DOI 10.1097/FJC.0b013e31813c6cc3; Iruthayanathan M, 2005, ENDOCRINOLOGY, V146, P5176, DOI 10.1210/en.2005-0811; Ishizuka T, 2007, ACTA DIABETOL, V44, P219, DOI 10.1007/s00592-007-0009-4; Johannes CB, 1999, J CLIN EPIDEMIOL, V52, P95, DOI 10.1016/S0895-4356(98)00144-9; KALIMI M, 1994, MOL CELL BIOCHEM, V131, P99, DOI 10.1007/BF00925945; Kawano H, 2003, J CLIN ENDOCR METAB, V88, P3190, DOI 10.1210/jc.2002-021603; Kim JA, 2006, CIRCULATION, V113, P1888, DOI 10.1161/CIRCULATIONAHA.105.563213; Kops GJPL, 1999, J MOL MED-JMM, V77, P656, DOI 10.1007/s001099900050; Labrie F, 1997, J CLIN ENDOCR METAB, V82, P2396, DOI 10.1210/jc.82.8.2396; Lasley BL, 2002, J CLIN ENDOCR METAB, V87, P3760, DOI 10.1210/jc.87.8.3760; LEITER EH, 1987, METABOLISM, V36, P863, DOI 10.1016/0026-0495(87)90095-3; Liu DM, 2002, J BIOL CHEM, V277, P21379, DOI 10.1074/jbc.M200491200; Liu DM, 2004, STEROIDS, V69, P279, DOI 10.1016/j.steroids.2004.02.004; Liu DM, 2007, ENDOCRINOLOGY, V148, P3068, DOI 10.1210/en.2006-1378; Matsuzaki H, 2003, P NATL ACAD SCI USA, V100, P11285, DOI 10.1073/pnas.1934283100; Mazat L, 2001, P NATL ACAD SCI USA, V98, P8145, DOI 10.1073/pnas.121177998; MORALES AJ, 1994, J CLIN ENDOCR METAB, V78, P1360, DOI 10.1210/jc.78.6.1360; Muniyappa R, 2007, ENDOCR REV, V28, P463, DOI 10.1210/er.2007-0006; Nair KS, 2006, NEW ENGL J MED, V355, P1647, DOI 10.1056/NEJMoa054629; Nakai J, 2002, NAT GENET, V32, P245, DOI 10.1038/ng890; Nakazora H, 2005, INTERNAL MED, V44, P1247, DOI 10.2169/internalmedicine.44.1247; Narushima I, 1999, N-S ARCH PHARMACOL, V360, P639, DOI 10.1007/s002109900137; Percheron G, 2003, ARCH INTERN MED, V163, P720, DOI 10.1001/archinte.163.6.720; Perrini S, 2004, DIABETES, V53, P41, DOI 10.2337/diabetes.53.1.41; Porter LP, 2000, MICROCIRCULATION, V7, P347, DOI 10.1038/sj.mn.7300120; Potente M, 2005, J CLIN INVEST, V115, P2382, DOI 10.1172/JCI23126; Potente M, 2003, J BIOL CHEM, V278, P29619, DOI 10.1074/jbc.M305385200; Potenza MA, 2005, AM J PHYSIOL-HEART C, V289, pH813, DOI 10.1152/ajpheart.00092.2005; Potenza MA, 2007, AM J PHYSIOL-ENDOC M, V292, pE1378, DOI 10.1152/ajpendo.00698.2006; Potenza MA, 2006, DIABETES, V55, P3594, DOI 10.2337/db06-0667; Reiter C, 2007, DIABETES, V56, pA14; SCHRIOCK ED, 1988, J CLIN ENDOCR METAB, V66, P1329, DOI 10.1210/jcem-66-6-1329; Simoncini T, 2003, ENDOCRINOLOGY, V144, P3449, DOI 10.1210/en.2003-0044; SLOWINSKASRZEDNICKA J, 1991, J INTERN MED, V230, P551; Stomati M, 2000, GYNECOL ENDOCRINOL, V14, P342, DOI 10.3109/09513590009167703; Tamler R, 2007, ENDOCRIN METAB CLIN, V36, P533, DOI 10.1016/j.ecl.2007.03.005; Tang ED, 1999, J BIOL CHEM, V274, P16741, DOI 10.1074/jbc.274.24.16741; Tchernof A, 2004, EUR J ENDOCRINOL, V151, P1, DOI 10.1530/eje.0.1510001; USISKIN KS, 1990, INT J OBESITY, V14, P457; Valenti G, 2004, J GERONTOL A-BIOL, V59, P466; van der Heide LP, 2004, BIOCHEM J, V380, P297, DOI 10.1042/BJ20040167; Villareal DT, 2000, CLIN ENDOCRINOL, V53, P561, DOI 10.1046/j.1365-2265.2000.01131.x; WELLE S, 1990, J CLIN ENDOCR METAB, V71, P1259, DOI 10.1210/jcem-71-5-1259; Williams JR, 2000, LIPIDS, V35, P325, DOI 10.1007/s11745-000-0529-7; Williams MRI, 2004, J CLIN ENDOCR METAB, V89, P4708, DOI 10.1210/jc.2003-031560; YANAGISAWA M, 1988, NATURE, V332, P411, DOI 10.1038/332411a0; Yen SSC, 2001, P NATL ACAD SCI USA, V98, P8167, DOI 10.1073/pnas.161278698	72	40	40	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 24	2008	283	43					29228	29238		10.1074/jbc.M802906200	http://dx.doi.org/10.1074/jbc.M802906200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	362EB	18718910	Green Published, hybrid			2022-12-27	WOS:000260179900050
J	Oku, T; Kaneko, Y; Murofushi, K; Seyama, Y; Toyoshima, S; Tsuji, T				Oku, Teruaki; Kaneko, Yutaka; Murofushi, Koki; Seyama, Yoshiyuki; Toyoshima, Satoshi; Tsuji, Tsutomu			Phorbol Ester-dependent Phosphorylation Regulates the Association of p57/Coronin-1 with the Actin Cytoskeleton	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LEUCINE-ZIPPER MOTIF; PROTEIN-KINASE-C; BINDING-PROTEIN; CORONIN FAMILY; MYCOBACTERIUM-TUBERCULOSIS; TRANSIENT ASSOCIATION; CELL MOTILITY; DICTYOSTELIUM; PHAGOSOMES; DYNAMICS	The p57/coronin-1 protein is a member of the coronin family of actin-binding proteins, which are characterized by the presence of WD (tryptophan/aspartic acid) repeats and a coiled-coil motif in the molecule. It is selectively expressed in immune cells and has been suggested to play crucial roles in leukocyte functions, including cell migration and phagocytosis. In this study we examined the effects of p57/coronin-1 phosphorylation on the association of the protein with actin. Treatment of HL60 human leukemic cells or p57/coronin-1-transfected HEK293 cells with phorbol 12-myristate 13-acetate (PMA) reduced the association of p57/coronin-1 with the actin cytoskeleton, as indicated by cell fractionation experiments and by fluorescence microscopic observation. Two-dimensional gel electrophoresis of HL60 cell lysate revealed that p57/coronin-1 was phosphorylated upon PMA stimulation of the cells, giving two major and two minor spots of phosphorylated forms, each with distinct isoelectric points. The p57/coronin-1 molecules associated with the cytoskeleton in PMA-treated HL60 cells were phosphorylated at lower levels than those recovered in the cytosolic fraction. In addition, p57/coronin-1 co-sedimented with F-actin polymerized in vitro had lower phosphorylation levels than the molecules remaining in the supernatant. By affinity chromatographic analysis using anti-p57/coronin-1 antibody-conjugated Sepharose, p57/coronin-1 derived from PMA-treated HL60 cells showed lower affinity for actin than that from untreated cells. Finally, recovery of p57/coronin-1 in the actin cytoskeleton-rich fraction from neutrophil-like differentiated HL60 cells decreased during phagocytosis, concomitant with enhanced phosphorylation of p57/coronin-1. These results strongly suggest that the phosphorylation of p57/coronin-1 down-regulates its association with actin and modulates the reorganization of actin-containing cytoskeleton.	[Tsuji, Tsutomu] Hoshi Univ, Sch Pharm & Pharmaceut Sci, Dept Microbiol, Shinagawa Ku, Tokyo 1428501, Japan; [Seyama, Yoshiyuki] Hoshi Univ, Sch Pharm & Pharmaceut Sci, Dept Clin Chem, Tokyo 1428501, Japan; [Toyoshima, Satoshi] Pharmaceut & Med Devices Agcy, Tokyo 1000013, Japan	Hoshi University; Hoshi University	Tsuji, T (corresponding author), Hoshi Univ, Sch Pharm & Pharmaceut Sci, Dept Microbiol, Shinagawa Ku, 2-4-41 Ebara, Tokyo 1428501, Japan.	tsuji@hoshi.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology of Japan; Open Research Center Project	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Open Research Center Project(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This study was supported by the Ministry of Education, Culture, Sports, Science, and Technology of Japan and by the Open Research Center Project. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Allen LAH, 1999, BLOOD, V93, P3521, DOI 10.1182/blood.V93.10.3521.410k21_3521_3530; Cai L, 2005, J BIOL CHEM, V280, P31913, DOI 10.1074/jbc.M504146200; de Hostos EL, 1999, TRENDS CELL BIOL, V9, P345, DOI 10.1016/S0962-8924(99)01620-7; DEHOSTOS EL, 1991, EMBO J, V10, P4097, DOI 10.1002/j.1460-2075.1991.tb04986.x; DEHOSTOS EL, 1993, J CELL BIOL, V120, P163, DOI 10.1083/jcb.120.1.163; Ferrari G, 1999, CELL, V97, P435, DOI 10.1016/S0092-8674(00)80754-0; Foger N, 2006, SCIENCE, V313, P839, DOI 10.1126/science.1130563; Fukui Y, 1999, CELL MOTIL CYTOSKEL, V42, P204, DOI 10.1002/(SICI)1097-0169(1999)42:3<204::AID-CM4>3.0.CO;2-L; Fukui Y, 1997, BIOL BULL, V193, P224, DOI 10.1086/BBLv193n2p224; Gatfield J, 2005, MOL BIOL CELL, V16, P2786, DOI 10.1091/mbc.E05-01-0042; GERISCH G, 1995, CURR BIOL, V5, P1280, DOI 10.1016/S0960-9822(95)00254-5; Hacker U, 1997, J CELL SCI, V110, P105; Itoh S, 2002, BIOL PHARM BULL, V25, P837, DOI 10.1248/bpb.25.837; Jayachandran R, 2007, CELL, V130, P37, DOI 10.1016/j.cell.2007.04.043; Koul A, 2000, J BACTERIOL, V182, P5425, DOI 10.1128/JB.182.19.5425-5432.2000; MANIAK M, 1995, CELL, V83, P915, DOI 10.1016/0092-8674(95)90207-4; Oku T, 2005, BIOCHEM J, V387, P325, DOI 10.1042/BJ20041020; Oku T, 2003, BIOL PHARM BULL, V26, P409; Singh R, 2003, MOL MICROBIOL, V50, P751, DOI 10.1046/j.1365-2958.2003.03712.x; SPECTOR I, 1989, CELL MOTIL CYTOSKEL, V13, P127, DOI 10.1002/cm.970130302; SUZUKI K, 1995, FEBS LETT, V364, P283, DOI 10.1016/0014-5793(95)00393-N; Uetrecht AC, 2006, TRENDS CELL BIOL, V16, P421, DOI 10.1016/j.tcb.2006.06.002; Yan M, 2005, MOL BIOL CELL, V16, P3077, DOI 10.1091/mbc.E04-11-0989; Yan M, 2007, J IMMUNOL, V178, P5769, DOI 10.4049/jimmunol.178.9.5769	24	12	12	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 24	2008	283	43					28918	28925		10.1074/jbc.M709990200	http://dx.doi.org/10.1074/jbc.M709990200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	362EB	18693254	hybrid, Green Published			2022-12-27	WOS:000260179900017
J	Zhu, JM; Zhu, SS; Guzzo, CM; Ellis, NA; Sung, KS; Choi, CY; Matunis, MJ				Zhu, Jianmei; Zhu, Shanshan; Guzzo, Catherine M.; Ellis, Nathan A.; Sung, Ki Sa; Choi, Cheol Yong; Matunis, Michael J.			Small Ubiquitin-related Modifier (SUMO) Binding Determines Substrate Recognition and Paralog-selective SUMO Modification	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GTPASE-ACTIVATING PROTEIN; NUCLEAR-PORE COMPLEX; CONJUGATING ENZYME; BLM HELICASE; CLEFT-LIP; UBC9; MOTIF; MONOUBIQUITINATION; IDENTIFICATION; TRAFFICKING	Small ubiquitin-related modifiers (SUMOs) regulate diverse cellular processes through their covalent attachment to target proteins. Vertebrates express three SUMO paralogs: SUMO-1, SUMO-2, and SUMO-3 (SUMO-2 and SUMO-3 are similar to 96% identical and referred to as SUMO-2/3). SUMO-1 and SUMO-2/3 are conjugated, at least in part, to unique subsets of proteins and thus regulate distinct cellular pathways. However, how different proteins are selectively modified by SUMO-1 and SUMO-2/3 is unknown. We demonstrate that BLM, the RecQ DNA helicase mutated in Bloom syndrome, is preferentially modified by SUMO-2/3 both in vitro and in vivo. Our findings indicate that non-covalent interactions between SUMO and BLM are required for modification at non-consensus sites and that preferential SUMO-2/3 modification is determined by preferential SUMO-2/3 binding. We also present evidence that sumoylation of a C-terminal fragment of HIPK2 is dependent on SUMO binding, indicating that non-covalent interactions between SUMO and target proteins provide a general mechanism for SUMO substrate selection and possible paralogselective modification.	[Zhu, Jianmei; Zhu, Shanshan; Guzzo, Catherine M.; Matunis, Michael J.] Johns Hopkins Univ, Dept Biochem & Mol Biol, Bloomberg Sch Publ Hlth, Baltimore, MD 21205 USA; [Ellis, Nathan A.] Univ Chicago, Dept Med, Chicago, IL 60637 USA; [Sung, Ki Sa; Choi, Cheol Yong] Sungkyunkwan Univ, Dept Biol Sci, Suwon 440746, South Korea	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University of Chicago; Sungkyunkwan University (SKKU)	Matunis, MJ (corresponding author), Johns Hopkins Univ, Dept Biochem & Mol Biol, Bloomberg Sch Publ Hlth, 615 N Wolfe St,Rm W8041, Baltimore, MD 21205 USA.	mmatunis@jhsph.edu		Matunis, Michael/0000-0002-9350-6611; Zhu, Jianmei/0000-0001-6172-7180	National Institutes of Health [GM060980, U54RR020839]; NATIONAL CENTER FOR RESEARCH RESOURCES [U54RR020839] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM060980] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM060980 and U54RR020839. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Alkuraya FS, 2006, SCIENCE, V313, P1751, DOI 10.1126/science.1128406; Ayaydin F, 2004, MOL BIOL CELL, V15, P5208, DOI 10.1091/mbc.E04-07-0589; Azuma Y, 2003, J CELL BIOL, V163, P477, DOI 10.1083/jcb.200304088; Beresten SF, 1999, PROTEIN EXPRES PURIF, V17, P239, DOI 10.1006/prep.1999.1135; Bernier-Villamor V, 2002, CELL, V108, P345, DOI 10.1016/S0092-8674(02)00630-X; Capili AD, 2007, J MOL BIOL, V369, P608, DOI 10.1016/j.jmb.2007.04.006; Cheok CF, 2005, BIOCHEM SOC T, V33, P1456, DOI 10.1042/BST0331456; Desterro JMP, 1997, FEBS LETT, V417, P297, DOI 10.1016/S0014-5793(97)01305-7; Desterro JMP, 1999, J BIOL CHEM, V274, P10618, DOI 10.1074/jbc.274.15.10618; Di Fiore PP, 2003, NAT REV MOL CELL BIO, V4, P491, DOI 10.1038/nrm1124; Eladad S, 2005, HUM MOL GENET, V14, P1351, DOI 10.1093/hmg/ddi145; ELLIS NA, 1995, CELL, V83, P655, DOI 10.1016/0092-8674(95)90105-1; Fallon L, 2006, NAT CELL BIOL, V8, P834, DOI 10.1038/ncb1441; Geiss-Friedlander R, 2007, NAT REV MOL CELL BIO, V8, P947, DOI 10.1038/nrm2293; Hecker CM, 2006, J BIOL CHEM, V281, P16117, DOI 10.1074/jbc.M512757200; Hoeller D, 2006, NAT CELL BIOL, V8, P163, DOI 10.1038/ncb1354; Hoeller D, 2007, MOL CELL, V26, P891, DOI 10.1016/j.molcel.2007.05.014; Johnson ES, 2004, ANNU REV BIOCHEM, V73, P355, DOI 10.1146/annurev.biochem.73.011303.074118; Johnson ES, 1997, J BIOL CHEM, V272, P26799, DOI 10.1074/jbc.272.43.26799; Johnson ES, 1997, EMBO J, V16, P5509, DOI 10.1093/emboj/16.18.5509; Kerscher O, 2007, EMBO REP, V8, P550, DOI 10.1038/sj.embor.7400980; Knipscheer P, 2007, EMBO J, V26, P2797, DOI 10.1038/sj.emboj.7601711; Lee GW, 1998, J BIOL CHEM, V273, P6503, DOI 10.1074/jbc.273.11.6503; Lin DY, 2006, MOL CELL, V24, P341, DOI 10.1016/j.molcel.2006.10.019; Matunis MJ, 2006, DEV CELL, V11, P596, DOI 10.1016/j.devcel.2006.10.011; Matunis MJ, 1998, J CELL BIOL, V140, P499, DOI 10.1083/jcb.140.3.499; Minty A, 2000, J BIOL CHEM, V275, P36316, DOI 10.1074/jbc.M004293200; Pauws E, 2007, TRENDS GENET, V23, P631, DOI 10.1016/j.tig.2007.09.002; Reverter D, 2005, NATURE, V435, P687, DOI 10.1038/nature03588; Rodriguez MS, 2001, J BIOL CHEM, V276, P12654, DOI 10.1074/jbc.M009476200; Rosas-Acosta G, 2005, MOL CELL PROTEOMICS, V4, P56, DOI 10.1074/mcp.M400149-MCP200; Saitoh H, 2000, J BIOL CHEM, V275, P6252, DOI 10.1074/jbc.275.9.6252; Sampson DA, 2001, J BIOL CHEM, V276, P21664, DOI 10.1074/jbc.M100006200; Shen TH, 2006, MOL CELL, V24, P331, DOI 10.1016/j.molcel.2006.09.013; Song J, 2004, P NATL ACAD SCI USA, V101, P14373, DOI 10.1073/pnas.0403498101; Sun H, 2007, EMBO J, V26, P4102, DOI 10.1038/sj.emboj.7601839; Sung P, 2006, NAT REV MOL CELL BIO, V7, P739, DOI 10.1038/nrm2008; Takahashi H, 2005, J BIOL CHEM, V280, P5611, DOI 10.1074/jbc.M408130200; Tatham MH, 2005, NAT STRUCT MOL BIOL, V12, P67, DOI 10.1038/nsmb878; Tatham MH, 2003, BIOCHEMISTRY-US, V42, P9959, DOI 10.1021/bi0345283; Vertegaal ACO, 2006, MOL CELL PROTEOMICS, V5, P2298, DOI 10.1074/mcp.M600212-MCP200; Woelk T, 2006, NAT CELL BIOL, V8, P1246, DOI 10.1038/ncb1484; Wu L, 2007, DNA REPAIR, V6, P936, DOI 10.1016/j.dnarep.2007.02.007; Yang W, 2008, J CEREBR BLOOD F MET, V28, P269, DOI 10.1038/sj.jcbfm.9600523; Zhang H, 2002, MOL CELL BIOL, V22, P6498, DOI 10.1128/MCB.22.18.6498-6508.2002; Zhang XD, 2008, MOL CELL, V29, P729, DOI 10.1016/j.molcel.2008.01.013	46	104	107	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 24	2008	283	43					29405	29415		10.1074/jbc.M803632200	http://dx.doi.org/10.1074/jbc.M803632200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	362EB	18708356	Green Published, hybrid			2022-12-27	WOS:000260179900067
J	Johnson, ET; Schmidt-Dannert, C				Johnson, Ethan T.; Schmidt-Dannert, Claudia			Characterization of three homologs of the large subunit of the magnesium chelatase from Chlorobaculum tepidum and interaction with the magnesium protoporphyrin IX methyltransferase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GREEN-SULFUR BACTERIUM; COMPLETE GENOME SEQUENCE; ADENOSYL-L-METHIONINE; CHLOROPHYLL BIOSYNTHESIS; CHLOROBIUM-TEPIDUM; RHODOBACTER-CAPSULATUS; ESCHERICHIA-COLI; RHODOPSEUDOMONAS-SPHEROIDES; SYNECHOCYSTIS PCC6803; ATPASE ACTIVITY	Green bacteria synthesize several types of (bacterio) chlorophylls for the assembly of functional photosynthetic reaction centers and antenna complexes. A distinctive feature of green bacteria compared with other photosynthetic microbes is that their genomes contain multiple homologs of the large subunit (BchH) of the magnesium chelatase which is a three-subunit enzyme complex (BchH, BchD, and BchI) that inserts magnesium into protoporphyrin IX as the first committed step of (bacterio) chlorophyll biosynthesis. There is speculation that the additional BchH homologs may regulate the biosynthesis of each type of chlorophyll, although the biochemical properties of the different magnesium chelatase complexes from a single species of green bacteria have not yet been compared. In this study, we investigated the activities of all three chelatase complexes from the green sulfur bacterium Chlorobaculum tepidum and interactions with the next enzyme in the pathway, magnesium protoporphyrin IX methyltransferase (BchM). Although all three chelatase complexes insert magnesium into protoporphyrin IX, the activities range by a factor of 10(5). Further, there are differences in the interactions between the BchH homologs and BchM; two of the subunits increase the methyltransferase activity by 30-60%, and the third decreases it by 30%. Expression of the chelatase complexes alone and together with BchM in Escherichia coli overproducing protoporphyrin IX suggests that the chelatase is the rate-limiting enzyme. We observed that BchM uses protoporphyrin IX without bound metal as a substrate. Our results conflict with expectations generated by previous gene inactivation studies and suggest a complex regulation of chlorophyll biosynthesis in green bacteria.	[Johnson, Ethan T.; Schmidt-Dannert, Claudia] Univ Minnesota, Dept Biochem Mol Biol & Biophys, St Paul, MN 55108 USA	University of Minnesota System; University of Minnesota Twin Cities	Schmidt-Dannert, C (corresponding author), Univ Minnesota, Dept Biochem Mol Biol & Biophys, 1479 Gortner Ave, St Paul, MN 55108 USA.	schmi232@umn.edu			David and Lucile Packard Foundation; University of Minnesota; National Science Foundation [CBET-0756296]	David and Lucile Packard Foundation(The David & Lucile Packard Foundation); University of Minnesota(University of Minnesota System); National Science Foundation(National Science Foundation (NSF))	This research was supported by the David and Lucile Packard Foundation, the Institute on the Environment of the University of Minnesota, and National Science Foundation Grant CBET-0756296. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Alawady A, 2005, PLANT MOL BIOL, V57, P679, DOI 10.1007/s11103-005-1427-8; Anderson KS, 1999, METHOD ENZYMOL, V308, P111; Axelsson E, 2006, PLANT CELL, V18, P3606, DOI 10.1105/tpc.106.042374; Balaban TS, 2005, TOP CURR CHEM, V258, P1, DOI 10.1007/b137480; Blankenship RE, 1995, ANOXYGENIC PHOTOSYNT, V2, P399, DOI DOI 10.1007/0-306-47954-0; Bollivar DW, 2006, PHOTOSYNTH RES, V90, P173, DOI 10.1007/s11120-006-9076-6; Borrego CM, 1999, PHOTOSYNTH RES, V59, P159, DOI 10.1023/A:1006161302838; CHANCE B, 1956, ADV ENZYMOL REL S BI, V17, P65; Eisen JA, 2002, P NATL ACAD SCI USA, V99, P9509, DOI 10.1073/pnas.132181499; FALK JE, 1964, PORPHYRINS METALLOPO; Frigaard NU, 2004, ARCH MICROBIOL, V182, P265, DOI 10.1007/s00203-004-0718-9; Frigaard NU, 2003, PHOTOSYNTH RES, V78, P93, DOI 10.1023/B:PRES.0000004310.96189.b4; Geck MK, 1999, BIOCHEMISTRY-US, V38, P8032, DOI 10.1021/bi983029c; GIBSON KD, 1963, BIOCHEM J, V88, P325, DOI 10.1042/bj0880325; Gibson LCD, 1999, BIOCHEM J, V337, P243, DOI 10.1042/0264-6021:3370243; GIBSON LCD, 1995, P NATL ACAD SCI USA, V92, P1941, DOI 10.1073/pnas.92.6.1941; GORCHEIN A, 1972, BIOCHEM J, V127, P97, DOI 10.1042/bj1270097; GRANICK S, 1961, J BIOL CHEM, V236, P1168; GUNTER EW, 1989, CLIN CHEM, V35, P1601; Hinchigeri SB, 1997, FEBS LETT, V407, P337, DOI 10.1016/S0014-5793(97)00371-2; Huang XY, 2001, ANNU REV BIOCHEM, V70, P149, DOI 10.1146/annurev.biochem.70.1.149; Jensen PE, 1998, BIOCHEM J, V334, P335, DOI 10.1042/bj3340335; Karger GA, 2001, BIOCHEMISTRY-US, V40, P9291, DOI 10.1021/bi010562a; Kwon SJ, 2003, APPL ENVIRON MICROB, V69, P4875, DOI 10.1128/AEM.69.8.4875-4883.2003; Maqueo Chew AG, 2007, ANNU REV MICROBIOL, V61, P113, DOI 10.1146/annurev.micro.61.080706.093242; Milani M, 2003, BIOCHEM MOL BIOL EDU, V31, P228, DOI 10.1002/bmb.2003.494031040239; OHHAMA T, 1982, BIOCHEM BIOPH RES CO, V105, P647, DOI 10.1016/0006-291X(82)91483-8; Olson JM, 1998, PHOTOCHEM PHOTOBIOL, V67, P61, DOI 10.1111/j.1751-1097.1998.tb05166.x; Petersen BL, 1998, J BACTERIOL, V180, P699, DOI 10.1128/JB.180.3.699-704.1998; PORRA RJ, 1983, EUR J BIOCHEM, V130, P509, DOI 10.1111/j.1432-1033.1983.tb07179.x; Reid JD, 2004, J BIOL CHEM, V279, P26893, DOI 10.1074/jbc.M400958200; Sambrook J., 2001, MOL CLONING LAB MANU; Sawicki A, 2007, BIOCHEM J, V406, P469, DOI 10.1042/BJ20070284; Schmidt-Dannert C, 2000, NAT BIOTECHNOL, V18, P750, DOI 10.1038/77319; Shepherd M, 2005, FEBS J, V272, P4532, DOI 10.1111/j.1742-4658.2005.04873.x; Shepherd M, 2004, BIOCHEM J, V382, P1009, DOI 10.1042/BJ20040661; Shepherd M, 2003, BIOCHEM J, V371, P351, DOI 10.1042/BJ20021394; Sirijovski N, 2006, BIOCHEM J, V400, P477, DOI 10.1042/BJ20061103; Sirijovski N, 2008, J BIOL CHEM, V283, P11652, DOI 10.1074/jbc.M709172200; Spivey HO, 1999, METHODS, V19, P306, DOI 10.1006/meth.1999.0858; SRERE PA, 1987, ANNU REV BIOCHEM, V56, P89, DOI 10.1146/annurev.bi.56.070187.000513; Viney J, 2007, BIOCHEMISTRY-US, V46, P12788, DOI 10.1021/bi701515y; WAHLUND TM, 1991, ARCH MICROBIOL, V156, P81, DOI 10.1007/BF00290978; Willows RD, 1998, J BIOL CHEM, V273, P34206, DOI 10.1074/jbc.273.51.34206; Willows RD, 2003, NAT PROD REP, V20, P327, DOI 10.1039/b110549n	45	19	19	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 10	2008	283	41					27776	27784		10.1074/jbc.M804486200	http://dx.doi.org/10.1074/jbc.M804486200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	355OW	18693239	hybrid			2022-12-27	WOS:000259719200049
J	Cohen, S				Cohen, Stanley			Origins of Growth Factors: NGF and EGF	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Editorial Material							FACTOR RECEPTOR-KINASE; CARCINOMA-CELLS A-431; CHICK EMBRYO EPIDERMIS; DEPENDENT 35-KILODALTON SUBSTRATE; TYROSINE PHOSPHORYLATION; PROTEIN-KINASE; HUMAN FIBROBLASTS; MOUSE-LIVER; BIOLOGICAL-PROPERTIES; SUBMAXILLARY GLAND		Vanderbilt Univ, Sch Med, Dept Biochem, Nashville, TN 37232 USA	Vanderbilt University	Cohen, S (corresponding author), Vanderbilt Univ, Sch Med, Dept Biochem, 221 Kirkland Hall, Nashville, TN 37232 USA.	stancohen@earthlink.net						BREYER JA, 1990, J BIOL CHEM, V265, P16564; BUHROW SA, 1982, J BIOL CHEM, V257, P4019; BUHROW SA, 1983, J BIOL CHEM, V258, P7824; CARPENTER G, 1975, J BIOL CHEM, V250, P4297; CARPENTER G, 1976, J CELL BIOL, V71, P159, DOI 10.1083/jcb.71.1.159; CARPENTER G, 1979, J BIOL CHEM, V254, P4884; CHINKERS M, 1981, NATURE, V290, P516, DOI 10.1038/290516a0; CHINKERS M, 1979, J CELL BIOL, V83, P260, DOI 10.1083/jcb.83.1.260; COHEN S, 1982, J BIOL CHEM, V257, P1523; COHEN S, 1963, J INVEST DERMATOL, V40, P1; COHEN S, 1959, J BIOL CHEM, V234, P1129; COHEN S, 1968, BIOCHIM BIOPHYS ACTA, V166, P427, DOI 10.1016/0005-2787(68)90231-1; COHEN S, 1965, DEV BIOL, V12, P394; COHEN S, 1980, J BIOL CHEM, V255, P4834; COHEN S, 1960, P NATL ACAD SCI USA, V46, P302, DOI 10.1073/pnas.46.3.302; COHEN S, 1957, CANCER RES, V17, P15; COHEN S, 1950, J BIOL CHEM, V184, P479; COHEN S, 1954, J BIOL CHEM, V211, P337; COHEN S, 1962, J BIOL CHEM, V237, P1555; COHEN S, 1985, J BIOL CHEM, V260, P2351; COHEN S, 1975, P NATL ACAD SCI USA, V72, P1317, DOI 10.1073/pnas.72.4.1317; DE BK, 1986, J BIOL CHEM, V261, P3784; DONALDSON RW, 1991, J BIOL CHEM, V266, P3162; DONALDSON RW, 1992, P NATL ACAD SCI USA, V89, P8477, DOI 10.1073/pnas.89.18.8477; ERNEUX C, 1983, J BIOL CHEM, V258, P4137; FAVA RA, 1984, J BIOL CHEM, V259, P2636; Furge LL, 1999, J BIOL CHEM, V274, P33504, DOI 10.1074/jbc.274.47.33504; GIUGNI TD, 1988, J BIOL CHEM, V263, P18988; GORDEN P, 1978, P NATL ACAD SCI USA, V75, P5025, DOI 10.1073/pnas.75.10.5025; HAIGLER H, 1978, P NATL ACAD SCI USA, V75, P3317, DOI 10.1073/pnas.75.7.3317; HAIGLER HT, 1979, J CELL BIOL, V81, P382, DOI 10.1083/jcb.81.2.382; HAIGLER HT, 1979, J CELL BIOL, V83, P82, DOI 10.1083/jcb.83.1.82; HOOBER JK, 1967, BIOCHIM BIOPHYS ACTA, V138, P357, DOI 10.1016/0005-2787(67)90496-0; HOOBER JK, 1967, BIOCHIM BIOPHYS ACTA, V138, P347, DOI 10.1016/0005-2787(67)90495-9; KING LE, 1980, BIOCHEMISTRY-US, V19, P1524, DOI 10.1021/bi00548a040; LEVIMONTALCINI R, 1956, P NATL ACAD SCI USA, V42, P695, DOI 10.1073/pnas.42.9.695; LEVIMONTALCINI R, 1960, ANN NY ACAD SCI, V85, P324; MCKANNA JA, 1979, P NATL ACAD SCI USA, V76, P5689, DOI 10.1073/pnas.76.11.5689; MCKANNA JA, 1989, SCIENCE, V243, P1477, DOI 10.1126/science.2928781; MROCZKOWSKI B, 1989, MOL CELL BIOL, V9, P2771, DOI 10.1128/MCB.9.7.2771; MROCZKOWSKI B, 1988, P NATL ACAD SCI USA, V85, P126, DOI 10.1073/pnas.85.1.126; PARRIES G, 1995, J BIOL CHEM, V270, P27954, DOI 10.1074/jbc.270.46.27954; QUELLE FW, 1995, J BIOL CHEM, V270, P20775, DOI 10.1074/jbc.270.35.20775; Ruff SJ, 1997, J BIOL CHEM, V272, P1263, DOI 10.1074/jbc.272.2.1263; RUFFJAMISON S, 1993, J BIOL CHEM, V268, P7610; RUFFJAMISON S, 1994, J BIOL CHEM, V269, P21933; RUFFJAMISON S, 1995, P NATL ACAD SCI USA, V92, P4215, DOI 10.1073/pnas.92.10.4215; RUSSO MW, 1985, J BIOL CHEM, V260, P5205; SAVAGE CR, 1972, J BIOL CHEM, V247, P7612; SAVAGE CR, 1973, J BIOL CHEM, V248, P7669; SAWYER ST, 1985, J BIOL CHEM, V260, P8233; SAWYER ST, 1981, BIOCHEMISTRY-US, V20, P6280, DOI 10.1021/bi00524a057; STARKEY RH, 1975, SCIENCE, V189, P800, DOI 10.1126/science.1172293; STASTNY M, 1970, BIOCHIM BIOPHYS ACTA, V204, P578, DOI 10.1016/0005-2787(70)90177-2; SWARUP G, 1982, BIOCHEM BIOPH RES CO, V107, P1104, DOI 10.1016/0006-291X(82)90635-0; TAYLOR JM, 1972, J BIOL CHEM, V247, P5928; USHIRO H, 1980, J BIOL CHEM, V255, P8363	57	21	28	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 5	2008	283	49					33793	33797		10.1074/jbc.X800008200	http://dx.doi.org/10.1074/jbc.X800008200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	377UY	18697735	hybrid, Green Published			2022-12-27	WOS:000261277700001
J	Pan, YF; Wansa, KDSA; Liu, MH; Zhao, B; Hong, SZ; Tan, PY; Lim, KS; Bourque, G; Liu, ET; Cheung, E				Pan, You Fu; Wansa, K. D. Senali Abayratna; Liu, Mei Hui; Zhao, Bing; Hong, Shu Zhen; Tan, Peck Yean; Lim, Kar Sian; Bourque, Guillaume; Liu, Edison T.; Cheung, Edwin			Regulation of Estrogen Receptor-mediated Long Range Transcription via Evolutionarily Conserved Distal Response Elements	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLOBIN LOCUS REQUIRES; CANCER CELL-LINE; CHROMOSOME CONFORMATION; INTRACHROMOSOMAL INTERACTIONS; 1,25-DIHYDROXYVITAMIN D-3; ANDROGEN RECEPTOR; BINDING-SITES; ALPHA BINDING; PS2 GENE; ORGANIZATION	Nuclear signaling by estrogens rapidly induces the global recruitment of estrogen receptors (ERs) to thousands of highly specific locations in the genome. Here, we have examined whether ER binding sites that are located distal from the transcription start sites of estrogen target genes are functionally relevant. Similar to ER binding sites near the proximal promoter region, ER binding sites located at distal locations are occupied by ERs after estrogen stimulation. And, like proximal bound ERs, ERs occupied at distal sites can recruit coactivators and the RNA polymerase transcription machinery and mediate specific structural changes to chromatin. Furthermore, ERs occupied at the distal sites are capable of communicating with ERs bound at the promoter region, possibly via long range chromosome looping. In functional analysis, disruption of the response elements in the distal ER binding sites abrogated ER binding and significantly reduced transcriptional response. Finally, sequence comparison of the response elements at the distal sites suggests a high level of conservation across different species. Together, our data indicate that distal ER binding sites are bona fide transcriptional enhancers that are involved in long range chromosomal interaction, transcription complex formation, and distinct structural modifications of chromatin across large genomic spans.	[Pan, You Fu; Wansa, K. D. Senali Abayratna; Liu, Mei Hui; Zhao, Bing; Hong, Shu Zhen; Tan, Peck Yean; Lim, Kar Sian; Bourque, Guillaume; Liu, Edison T.; Cheung, Edwin] ASTAR, Genome Inst Singapore, Singapore 138672, Singapore; [Cheung, Edwin] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Biochem, Singapore 117543, Singapore; [Cheung, Edwin] Nanyang Technol Univ, Sch Biol Sci, Singapore 637551, Singapore	Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); National University of Singapore; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	Cheung, E (corresponding author), ASTAR, Genome Inst Singapore, 60 Biopolis St,02-01, Singapore 138672, Singapore.	cheungcwe@gis.a-star.edu.sg	Liu, Edison/C-4141-2008; Liu, Mei Hui/J-9750-2013; Bourque, Guillaume/AFR-2927-2022	Bourque, Guillaume/0000-0002-3933-9656; Liu, Mei Hui/0000-0001-7405-7008; Pan, You-Fu/0000-0002-9996-8892	Biomedical Research Council/Science and Engineering Research Council of A*STAR (Agency for Science, Technology and Research), Singapore	Biomedical Research Council/Science and Engineering Research Council of A*STAR (Agency for Science, Technology and Research), Singapore(Agency for Science Technology & Research (A*STAR))	This work was supported in part by the Biomedical Research Council/Science and Engineering Research Council of A*STAR (Agency for Science, Technology and Research), Singapore. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact. 1 Supported by an A*STAR graduate scholarship.	Bauer UM, 2002, EMBO REP, V3, P39, DOI 10.1093/embo-reports/kvf013; BERRY M, 1989, P NATL ACAD SCI USA, V86, P1218, DOI 10.1073/pnas.86.4.1218; Bhaumik SR, 2007, NAT STRUCT MOL BIOL, V14, P1008, DOI 10.1038/nsmb1337; Carroll JS, 2006, NAT GENET, V38, P1289, DOI 10.1038/ng1901; Carroll JS, 2005, CELL, V122, P33, DOI 10.1016/j.cell.2005.05.008; Cheung E, 2003, EMBO J, V22, P600, DOI 10.1093/emboj/cdg037; Dekker J, 2002, SCIENCE, V295, P1306, DOI 10.1126/science.1067799; Dostie J, 2006, GENOME RES, V16, P1299, DOI 10.1101/gr.5571506; Drissen R, 2004, GENE DEV, V18, P2485, DOI 10.1101/gad.317004; Green KA, 2007, NAT REV CANCER, V7, P713, DOI 10.1038/nrc2211; Hagege H, 2007, NAT PROTOC, V2, P1722, DOI 10.1038/nprot.2007.243; Heldring N, 2007, PHYSIOL REV, V87, P905, DOI 10.1152/physrev.00026.2006; JAKOWLEW SB, 1984, NUCLEIC ACIDS RES, V12, P2861, DOI 10.1093/nar/12.6.2861; Jing HI, 2008, MOL CELL, V29, P232, DOI 10.1016/j.molcel.2007.11.020; Kim S, 2006, MOL CELL BIOL, V26, P6469, DOI 10.1128/MCB.00353-06; Kininis Miltiadis, 2008, Nucl Recept Signal, V6, pe005, DOI 10.1621/nrs.06005; Klinge CM, 2001, NUCLEIC ACIDS RES, V29, P2905, DOI 10.1093/nar/29.14.2905; KRAUS WL, 1994, MOL ENDOCRINOL, V8, P952, DOI 10.1210/me.8.8.952; Latham JA, 2007, NAT STRUCT MOL BIOL, V14, P1017, DOI 10.1038/nsmb1307; Levasseur DN, 2008, GENE DEV, V22, P575, DOI 10.1101/gad.1606308; Lin CY, 2007, PLOS GENET, V3, P867, DOI 10.1371/journal.pgen.0030087; Mao C, 2008, J BIOL CHEM, V283, P12819, DOI 10.1074/jbc.M709936200; MASIAKOWSKI P, 1982, NUCLEIC ACIDS RES, V10, P7895, DOI 10.1093/nar/10.24.7895; Metivier R, 2003, CELL, V115, P751, DOI 10.1016/S0092-8674(03)00934-6; Nilsson S, 2001, PHYSIOL REV, V81, P1535, DOI 10.1152/physrev.2001.81.4.1535; NUNEZ AM, 1989, EMBO J, V8, P823, DOI 10.1002/j.1460-2075.1989.tb03443.x; Shang YF, 2000, CELL, V103, P843, DOI 10.1016/S0092-8674(00)00188-4; Simonis M, 2006, NAT GENET, V38, P1348, DOI 10.1038/ng1896; Spilianakis CG, 2004, NAT IMMUNOL, V5, P1017, DOI 10.1038/ni1115; Tsytsykova AV, 2007, P NATL ACAD SCI USA, V104, P16850, DOI 10.1073/pnas.0708210104; Vakoc CR, 2005, MOL CELL, V17, P453, DOI 10.1016/j.molcel.2004.12.028; Wang QB, 2005, MOL CELL, V19, P631, DOI 10.1016/j.molcel.2005.07.018; Wang QB, 2007, MOL CELL, V27, P380, DOI 10.1016/j.molcel.2007.05.041; Zella LA, 2006, MOL ENDOCRINOL, V20, P1231, DOI 10.1210/me.2006-0015; Zhao Z, 2006, NAT GENET, V38, P1341, DOI 10.1038/ng1891	35	71	72	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 21	2008	283	47					32977	32988		10.1074/jbc.M802024200	http://dx.doi.org/10.1074/jbc.M802024200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	372HW	18728018	hybrid			2022-12-27	WOS:000260893700086
J	Prasad, V; Bodi, I; Meyer, JW; Wang, YG; Ashraf, M; Engle, SJ; Doetschman, T; Sisco, K; Nieman, ML; Miller, ML; Lorenz, JN; Shull, GE				Prasad, Vikram; Bodi, Ilona; Meyer, Jamie W.; Wang, Yigang; Ashraf, Muhammad; Engle, Sandra J.; Doetschman, Thomas; Sisco, Karena; Nieman, Michelle L.; Miller, Marian L.; Lorenz, John N.; Shull, Gary E.			Impaired Cardiac Contractility in Mice Lacking Both the AE3 Cl-/HCO3- Exchanger and the NKCC1 Na+-K+-2Cl(-) Cotransporter EFFECTS ON Ca2+ HANDLING AND PROTEIN PHOSPHATASES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							2A CATALYTIC SUBUNIT; NA+-H+ EXCHANGER; TARGETED DISRUPTION; SARCOPLASMIC-RETICULUM; CARBOXYL METHYLATION; NA+-CA2+ EXCHANGE; ANGIOTENSIN-II; NULL MUTATION; BRUSH-BORDER; HEART	To analyze the cardiac functions of AE3, we disrupted its gene (Slc4a3) in mice. Cl-/HCO3- exchange coupled with Na+-dependent acid extrusion can mediate pH-neutral Na+ uptake, potentially affecting Ca2+ handling via effects on Na+/Ca2+ exchange. AE3 null mice appeared normal, however, and AE3 ablation had no effect on ischemia-reperfusion injury in isolated hearts or cardiac performance in vivo. The NKCC1 Na+-K+-2Cl(-) cotransporter also mediates Na+ uptake, and loss of NKCC1 alone does not impair contractility. To further stress the AE3-deficient myocardium, we combined the AE3 and NKCC1 knock-outs. Double knock-outs had impaired contraction and relaxation both in vivo and in isolated ventricular myocytes. Ca2+ transients revealed an apparent increase in Ca2+ clearance in double null cells. This was unlikely to result from increased Ca2+ sequestration, since the ratio of phosphorylated phospholamban to total phospholamban was sharply reduced in all three mutant hearts. Instead, Na+/Ca2+ exchanger activity was found to be enhanced in double null cells. Systolic Ca2+ was unaltered, however, suggesting more direct effects on the contractile apparatus of double null myocytes. Expression of the catalytic subunit of protein phosphatase 1 was increased in all mutant hearts. There was also a dramatic reversal, between single null and double null hearts, in the carboxymethylation and localization to the myofibrillar fraction, of the catalytic subunit of protein phosphatase 2A, which corresponded to the loss of normal contractility in double null hearts. These data show that AE3 and NKCC1 affect Ca2+ handling, PLN regulation, and expression and localization of major cardiac phosphatases and that their combined loss impairs cardiac function.	[Prasad, Vikram; Meyer, Jamie W.; Engle, Sandra J.; Doetschman, Thomas; Shull, Gary E.] Univ Cincinnati, Coll Med, Dept Mol Genet Biochem & Microbiol, Cincinnati, OH 45267 USA; [Wang, Yigang; Ashraf, Muhammad] Univ Cincinnati, Coll Med, Dept Lab Med, Cincinnati, OH 45267 USA; [Sisco, Karena; Nieman, Michelle L.; Lorenz, John N.] Univ Cincinnati, Coll Med, Dept Mol & Cellular Biol, Cincinnati, OH 45267 USA; [Miller, Marian L.] Univ Cincinnati, Coll Med, Dept Environm Hlth, Cincinnati, OH 45267 USA; [Bodi, Ilona] Univ Cincinnati, Coll Med, Inst Mol Pharmacol & Biophys, Cincinnati, OH 45267 USA	University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati	Shull, GE (corresponding author), Univ Cincinnati, Coll Med, Dept Mol Genet Biochem & Microbiol, 231 Albert Sabin Way, Cincinnati, OH 45267 USA.	shullge@ucmail.uc.edu	Ashraf, Muhammad/ABB-3463-2021		National Institutes of Health [HL61974, DK50594, DK57552, HL081859, HL080686]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007382, R01HL092508, R01HL081859, R01HL061974] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK057552, R37DK050594, R01DK050594] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants HL61974, DK50594, DK57552, HL081859, and HL080686. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	AdachiAkahane S, 1997, J GEN PHYSIOL, V109, P717, DOI 10.1085/jgp.109.6.717; Alvarez BV, 2004, J PHYSIOL-LONDON, V561, P721, DOI 10.1113/jphysiol.2004.077339; Alvarez BV, 2001, CIRC RES, V89, P1246, DOI 10.1161/hh2401.101907; Baartscheer A, 2003, CARDIOVASC RES, V57, P1015, DOI 10.1016/S0008-6363(02)00809-X; Baartscheer A, 2003, CARDIOVASC RES, V57, P986, DOI 10.1016/S0008-6363(02)00848-9; Bers DM, 2003, CARDIOVASC RES, V57, P897, DOI 10.1016/S0008-6363(02)00656-9; Braz JC, 2004, NAT MED, V10, P248, DOI 10.1038/nm1000; Brittsan AG, 2000, J BIOL CHEM, V275, P12129, DOI 10.1074/jbc.275.16.12129; Carr AN, 2002, MOL CELL BIOL, V22, P4124, DOI 10.1128/MCB.22.12.4124-4135.2002; Choi I, 2000, NATURE, V405, P571, DOI 10.1038/35014615; Cingolani HE, 2002, CIRC RES, V90, P751, DOI 10.1161/01.RES.0000016836.24179.AE; de Hurtado MCC, 1998, CIRC RES, V82, P473, DOI 10.1161/01.RES.82.4.473; Ennis IL, 1998, HYPERTENSION, V31, P961, DOI 10.1161/01.HYP.31.4.961; Flagella M, 1999, J BIOL CHEM, V274, P26946, DOI 10.1074/jbc.274.38.26946; FRELIN C, 1986, BIOCHEM BIOPH RES CO, V134, P326, DOI 10.1016/0006-291X(86)90566-8; Gawenis LR, 2005, GASTROENTEROLOGY, V128, pA44; Gawenis LR, 2005, J BIOL CHEM, V280, P12781, DOI 10.1074/jbc.M414118200; Gawenis LR, 2004, J BIOL CHEM, V279, P30531, DOI 10.1074/jbc.M403779200; Golenhofen N, 1998, AM J PHYSIOL-HEART C, V274, pH1457, DOI 10.1152/ajpheart.1998.274.5.H1457; Grubb BR, 2000, AM J PHYSIOL-GASTR L, V279, pG707, DOI 10.1152/ajpgi.2000.279.4.G707; Hentschke M, 2006, MOL CELL BIOL, V26, P182, DOI 10.1128/MCB.26.1.182-191.2006; Ji Y, 2006, AM J PHYSIOL-HEART C, V290, pH599, DOI 10.1152/ajpheart.00214.2005; Jiang LW, 1997, AM J PHYSIOL-CELL PH, V272, pC191, DOI 10.1152/ajpcell.1997.272.1.C191; Kadambi VJ, 1996, J CLIN INVEST, V97, P533, DOI 10.1172/JCI118446; Karmazyn M, 1999, CIRC RES, V85, P777, DOI 10.1161/01.RES.85.9.777; Kawasaki H, 2001, EUR J PHARMACOL, V411, P35, DOI 10.1016/S0014-2999(00)00893-1; Khandoudi N, 2001, CARDIOVASC RES, V52, P387, DOI 10.1016/S0008-6363(01)00430-8; Kirchhefer U, 2005, CARDIOVASC RES, V68, P98, DOI 10.1016/j.cardiores.2005.05.019; Knauf F, 2001, P NATL ACAD SCI USA, V98, P9425, DOI 10.1073/pnas.141241098; KNICKELBEIN R, 1985, AM J PHYSIOL, V249, pG236, DOI 10.1152/ajpgi.1985.249.2.G236; KOPITO RR, 1989, CELL, V59, P927, DOI 10.1016/0092-8674(89)90615-6; KUDRYCKI KE, 1990, J BIOL CHEM, V265, P462; Lai ZF, 1998, AM J PHYSIOL-HEART C, V275, pH1613, DOI 10.1152/ajpheart.1998.275.5.H1613; Lenart B, 2004, J NEUROSCI, V24, P9585, DOI 10.1523/JNEUROSCI.2569-04.2004; LINN SC, 1992, J BIOL CHEM, V267, P7927; LINN SC, 1995, CIRC RES, V76, P584, DOI 10.1161/01.RES.76.4.584; Liu QH, 2003, AM J PHYSIOL-HEART C, V285, pH97, DOI 10.1152/ajpheart.00956.2002; Liu QH, 2002, AM J PHYSIOL-HEART C, V283, pH1314, DOI 10.1152/ajpheart.00343.2002; Lorenz JN, 1997, AM J PHYSIOL-HEART C, V272, pH1137, DOI 10.1152/ajpheart.1997.272.3.H1137; MACDOUGALL LK, 1991, EUR J BIOCHEM, V196, P725, DOI 10.1111/j.1432-1033.1991.tb15871.x; MacLennan DH, 2003, NAT REV MOL CELL BIO, V4, P566, DOI 10.1038/nrm1151; Mattiazzi A, 1997, AM J PHYSIOL-HEART C, V272, pH1131, DOI 10.1152/ajpheart.1997.272.3.H1131; Melvin JE, 1999, J BIOL CHEM, V274, P22855, DOI 10.1074/jbc.274.32.22855; Melvin JE, 2005, ANNU REV PHYSIOL, V67, P445, DOI 10.1146/annurev.physiol.67.041703.084745; Meyer JW, 2002, AM J PHYSIOL-HEART C, V283, pH1846, DOI 10.1152/ajpheart.00083.2002; Mihailidou AS, 1998, AM J PHYSIOL-CELL PH, V274, pC175, DOI 10.1152/ajpcell.1998.274.1.C175; Mumby M., 2001, SCI STKE, pe1; Pathak A, 2005, CIRC RES, V96, P756, DOI 10.1161/01.RES.0000161256.85833.fa; Perez NG, 2001, CIRC RES, V88, P376; Periasamy M, 1999, J BIOL CHEM, V274, P2556, DOI 10.1074/jbc.274.4.2556; Pieske B, 2003, CARDIOVASC RES, V57, P874, DOI 10.1016/S0008-6363(02)00841-6; Pieske B, 2003, CARDIOVASC RES, V57, P871, DOI 10.1016/S0008-6363(02)00849-0; Pushkin A, 2000, IUBMB LIFE, V50, P13; Richards SM, 1999, J CELL SCI, V112, P1519; Romero MF, 1998, AM J PHYSIOL-RENAL, V274, pF425, DOI 10.1152/ajprenal.1998.274.2.F425; Schafer C, 2000, AM J PHYSIOL-HEART C, V278, pH1457, DOI 10.1152/ajpheart.2000.278.5.H1457; Sheehan KA, 2007, AM J PHYSIOL-REG I, V293, pR963, DOI 10.1152/ajpregu.00253.2007; SOLARO RJ, 2001, HDB PHYSL 2, V1, P264; STEENAART NAE, 1992, ARCH BIOCHEM BIOPHYS, V293, P17, DOI 10.1016/0003-9861(92)90359-5; Takahashi N, 2000, P NATL ACAD SCI USA, V97, P5434, DOI 10.1073/pnas.090091297; Terracciano CMN, 1998, J PHYSIOL-LONDON, V512, P651, DOI 10.1111/j.1469-7793.1998.651bd.x; Tikh EI, 2008, J CELL PHYSIOL, V216, P83, DOI 10.1002/jcp.21375; Tolstykh T, 2000, EMBO J, V19, P5682, DOI 10.1093/emboj/19.21.5682; Walker NM, 2002, GASTROENTEROLOGY, V123, P531, DOI 10.1053/gast.2002.34757; Wang YG, 2003, CIRC RES, V93, P776, DOI 10.1161/01.RES.0000094746.24774.DC; Wang ZH, 2002, AM J PHYSIOL-GASTR L, V282, pG573, DOI 10.1152/ajpgi.00338.2001; Wei HJ, 2001, J BIOL CHEM, V276, P1570, DOI 10.1074/jbc.M008694200; Wu J, 2000, EMBO J, V19, P5672, DOI 10.1093/emboj/19.21.5672; Yamamoto T, 2007, AM J PHYSIOL-HEART C, V293, pH1254, DOI 10.1152/ajpheart.00964.2006; Yao AS, 1998, CIRC RES, V82, P657, DOI 10.1161/01.RES.82.6.657; Yoo SJS, 2007, ARCH BIOCHEM BIOPHYS, V461, P186, DOI 10.1016/j.abb.2007.02.019; Yu XX, 2001, MOL BIOL CELL, V12, P185, DOI 10.1091/mbc.12.1.185; Zhou YY, 2000, AM J PHYSIOL-HEART C, V279, pH429	73	25	25	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 14	2008	283	46					31303	31314		10.1074/jbc.M803706200	http://dx.doi.org/10.1074/jbc.M803706200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	370KJ	18779325	Green Published			2022-12-27	WOS:000260760800007
J	He, LL; Yang, H; Ma, YH; Pledger, WJ; Cress, WD; Cheng, JQ				He, Lili; Yang, Hua; Ma, Yihong; Pledger, W. Jack; Cress, W. Douglas; Cheng, Jin Q.			Identification of Aurora-A as a Direct Target of E2F3 during G(2)/M Cell Cycle Progression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN BLADDER-CANCER; TRANSCRIPTION FACTOR; GENE-EXPRESSION; OVARIAN-CANCER; DNA-REPLICATION; KINASE GENE; S-PHASE; FAMILY; OVEREXPRESSION; ACTIVATION	Aurora-A is a centrosome kinase and plays a pivotal role in G(2)/M cell cycle progression. Expression of Aurora-A is cell cycle-dependent. Levels of Aurora-A mRNA and protein are low in G(1)/S, accumulate during G(2)/M, and decrease rapidly after mitosis. Previous studies have shown regulation of the Aurora-A protein level during the cell cycle through the ubiquitin-proteasome pathway. However, the mechanism of transcriptional regulation of Aurora-A remains largely unknown. Here, we demonstrated that E2F3 modulates Aurora-A mRNA expression during the cell cycle. Ectopic expression of E2F3 induces Aurora-A expression. Stable knockdown of E2F3 decreases mRNA and protein levels of Aurora-A and delays G(2)/M entry. Further, E2F3 directly binds to Aurora-A promoter and stimulates the promoter activity. Deletion and mutation analyses of the Aurora-A promoter revealed that a region located 96-bp upstream of the transcription initiation site is critical for the activation of the promoter by E2F3. In addition, expression of E2F3 positively correlates with the protein level of Aurora-A in human ovarian cancer examined. These results indicate for the first time that Aurora-A is transcriptionally regulated by E2F3 during the cell cycle and that E2F3 is a causal factor for up-regulation of Aurora-A in a subset of human ovarian cancer. Thus, the E2F3-Aurora-A axis could be an important target for cancer intervention.	[He, Lili; Yang, Hua; Ma, Yihong; Pledger, W. Jack; Cress, W. Douglas; Cheng, Jin Q.] Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Dept Mol Oncol, Tampa, FL 33612 USA	H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida	Cheng, JQ (corresponding author), Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Dept Mol Oncol, 12902 Magnolia Dr, Tampa, FL 33612 USA.	jin.cheng@moffitt.org	He, Lili/A-6356-2012		National Institutes of Health [CA77935, CA107078]; Department of Defense [DAMD17-02-1-0671]; Bankhead-Coley [07BB-01]; NATIONAL CANCER INSTITUTE [R29CA077935, R01CA077935] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); Bankhead-Coley; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants CA77935 and CA107078. This work was also supported by Department of Defense Grant DAMD17-02-1-0671 and Bankhead-Coley Grant 07BB-01.	Attwooll C, 2004, EMBO J, V23, P4709, DOI 10.1038/sj.emboj.7600481; Bischoff JR, 1998, EMBO J, V17, P3052, DOI 10.1093/emboj/17.11.3052; Black EP, 2005, P NATL ACAD SCI USA, V102, P15948, DOI 10.1073/pnas.0504300102; CHAN CSM, 1993, GENETICS, V135, P677; CHENG JQ, 1992, P NATL ACAD SCI USA, V89, P9267, DOI 10.1073/pnas.89.19.9267; Cheng JQ, 1997, ONCOGENE, V14, P2793, DOI 10.1038/sj.onc.1201121; Cooper CS, 2006, LUNG CANCER, V54, P155, DOI 10.1016/j.lungcan.2006.07.005; DeGregori J, 1997, P NATL ACAD SCI USA, V94, P7245, DOI 10.1073/pnas.94.14.7245; Dyson N, 1998, GENE DEV, V12, P2245, DOI 10.1101/gad.12.15.2245; Feber A, 2004, ONCOGENE, V23, P1627, DOI 10.1038/sj.onc.1207274; Foster CS, 2004, ONCOGENE, V23, P5871, DOI 10.1038/sj.onc.1207800; Gritsko TM, 2003, CLIN CANCER RES, V9, P1420; He YW, 2000, ONCOGENE, V19, P3422, DOI 10.1038/sj.onc.1203682; Hutterer A, 2006, DEV CELL, V11, P147, DOI 10.1016/j.devcel.2006.06.002; Ishida S, 2001, MOL CELL BIOL, V21, P4684, DOI 10.1128/MCB.21.14.4684-4699.2001; Kufer TA, 2002, J CELL BIOL, V158, P617, DOI 10.1083/jcb.200204155; Leone G, 1998, GENE DEV, V12, P2120, DOI 10.1101/gad.12.14.2120; Leone G, 2000, MOL CELL BIOL, V20, P3626, DOI 10.1128/MCB.20.10.3626-3632.2000; Li DH, 2003, CLIN CANCER RES, V9, P991; Logan N, 2005, ONCOGENE, V24, P5000, DOI 10.1038/sj.onc.1208703; Lu KH, 2004, CLIN CANCER RES, V10, P3291, DOI 10.1158/1078-0432.CCR-03-0409; Lukas J, 1996, MOL CELL BIOL, V16, P1047; Marumoto T, 2005, NAT REV CANCER, V5, P42, DOI 10.1038/nrc1526; Miyoshi Y, 2001, INT J CANCER, V92, P370, DOI 10.1002/ijc.1200; Neufeld TP, 1998, CELL, V93, P1183, DOI 10.1016/S0092-8674(00)81462-2; Nevins JR, 1998, CELL GROWTH DIFFER, V9, P585; Ogawa H, 2002, SCIENCE, V296, P1132, DOI 10.1126/science.1069861; Polager S, 2002, ONCOGENE, V21, P437, DOI 10.1038/sj.onc.1205102; Pugacheva EN, 2005, NAT CELL BIOL, V7, P937, DOI 10.1038/ncb1309; Ren B, 2002, GENE DEV, V16, P245, DOI 10.1101/gad.949802; Sakakura C, 2001, BRIT J CANCER, V84, P824, DOI 10.1054/bjoc.2000.1684; Sen S, 2002, JNCI-J NATL CANCER I, V94, P1320; Tanaka M, 2002, J BIOL CHEM, V277, P10719, DOI 10.1074/jbc.M108252200; Tanner MM, 2000, CLIN CANCER RES, V6, P1833; Udayakumar TS, 2006, J BIOL CHEM, V281, P14691, DOI 10.1074/jbc.M600163200; Wells J, 2002, METHODS, V26, P48, DOI 10.1016/S1046-2023(02)00007-5; XU GF, 1995, P NATL ACAD SCI USA, V92, P1357, DOI 10.1073/pnas.92.5.1357; Yuan ZQ, 2003, J BIOL CHEM, V278, P23432, DOI 10.1074/jbc.M302674200; Zhou HY, 1998, NAT GENET, V20, P189, DOI 10.1038/2496; Zhu WC, 2004, EMBO J, V23, P4615, DOI 10.1038/sj.emboj.7600459	40	36	38	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 7	2008	283	45					31012	31020		10.1074/jbc.M803547200	http://dx.doi.org/10.1074/jbc.M803547200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	367ID	18776222	Green Published, hybrid			2022-12-27	WOS:000260544800056
J	Kartsogiannis, V; Sims, NA; Quinn, JMW; Ly, C; Cipetic, M; Poulton, IJ; Walker, EC; Saleh, H; McGregor, NE; Wallace, ME; Smyth, MJ; Martin, TJ; Zhou, H; Ng, KW; Gillespie, MT				Kartsogiannis, Vicky; Sims, Natalie A.; Quinn, Julian M. W.; Ly, Chi; Cipetic, Mirijana; Poulton, Ingrid J.; Walker, Emma C.; Saleh, Hasnawati; McGregor, Narelle E.; Wallace, Morgan E.; Smyth, Mark J.; Martin, T. John; Zhou, Hong; Ng, Kong Wah; Gillespie, Matthew T.			Osteoclast Inhibitory Lectin, an Immune Cell Product That Is Required for Normal Bone Physiology in Vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							C-TYPE LECTIN; FAMILY; DIFFERENTIATION; RECEPTORS; GENE; OSTEOIMMUNOLOGY; EXPRESSION; VITRO; LINE	Osteoclast inhibitory lectin (OCIL or clrb) is a member of the natural killer cell C-type lectins that have a described role mostly in autoimmune cell function. OCIL was originally identified as an osteoblast-derived inhibitor of osteoclast formation in vitro. To determine the physiological function(s) of OCIL, we generated ocil(-/-) mice. These mice appeared healthy and were fertile, with no apparent immune function defect, and phenotypic abnormalities were limited to bone. Histomorphometric analysis revealed a significantly lower tibial trabecular bone volume and trabecular number in the 10- and 16-week-old male ocil(-/-) mice compared with wild type mice. Furthermore, ocil(-/-) mice showed reduced bone formation rate in the 10-week-old females and 16-week-old males while Static markers of bone formation showed no significant changes in male or female ocil(-/-) mice. Examination of bone resorption markers in the long bones of ocil(-/-) mice indicated a transient increase in osteoclast number per unit bone perimeter. Enhanced osteoclast formation was also observed when either bone marrow or splenic cultures were generated in vitro from ocil(-/-) mice relative to wild type control cultures. Loss of ocil therefore resulted in osteopenia in adult mice primarily as a result of increased osteoclast formation and/or decreased bone formation. The enhanced osteoclastic activity led to elevated serum calcium levels, which resulted in the suppression of circulating parathyroid hormone in 10-week-old ocil(-/-) mice compared with wild type control mice. Collectively, our data suggest that OCIL is a physiological negative regulator of bone.	[Kartsogiannis, Vicky; Sims, Natalie A.; Quinn, Julian M. W.; Ly, Chi; Cipetic, Mirijana; Poulton, Ingrid J.; Walker, Emma C.; Saleh, Hasnawati; McGregor, Narelle E.; Martin, T. John; Zhou, Hong; Gillespie, Matthew T.] St Vincents Inst Med Res, Fitzroy, Vic 3065, Australia; [Sims, Natalie A.; Quinn, Julian M. W.; Saleh, Hasnawati; Martin, T. John; Gillespie, Matthew T.] Univ Melbourne, Dept Med, St Vincents Hosp, Fitzroy, Vic 3065, Australia; [Wallace, Morgan E.; Smyth, Mark J.] Peter MacCallum Canc Ctr, Canc Immunol Program, Melbourne, Vic 8006, Australia; [Ng, Kong Wah] Univ Melbourne, St Vincents Hosp, Dept Endocrinol & Diabet, Fitzroy, Vic 3065, Australia	St. Vincent's Institute of Medical Research; St Vincent's Hospital Melbourne; University of Melbourne; Peter Maccallum Cancer Center; St Vincent's Hospital Melbourne; University of Melbourne	Gillespie, MT (corresponding author), Prince Henrys Inst, POB 5152, Clayton, Vic 3168, Australia.	Matthew.Gillespie@princehenrys.org	Sims, Natalie Ann/A-7192-2012; Wallace, Morgan/AAG-5451-2019; Smyth, Mark J/H-8709-2014	Sims, Natalie Ann/0000-0003-1421-8468; Wallace, Morgan/0000-0002-0744-6895; Smyth, Mark J/0000-0001-7098-7240; Gillespie, Matthew/0000-0001-6543-8909; Zhou, Hong/0000-0001-5899-9660	National Health and Medical Research Council of Australia [345401, 454569]	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by Program Grant 345401 (to M.T.G., T.J.M., N. A.S., and K.W.N.) and Program Grant 454569 (to M.J.S.) from the National Health and Medical Research Council of Australia. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked " advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Allan EH, 2003, J CELL BIOCHEM, V90, P158, DOI 10.1002/jcb.10614; Carlyle JR, 2004, P NATL ACAD SCI USA, V101, P3527, DOI 10.1073/pnas.0308304101; Gange CT, 2004, J BIOL CHEM, V279, P29043, DOI 10.1074/jbc.M312518200; Gillespie MT, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2141; Horwood NJ, 1998, J CLIN INVEST, V101, P595, DOI 10.1172/JCI1333; Horwood NJ, 2001, J IMMUNOL, V166, P4915, DOI 10.4049/jimmunol.166.8.4915; Hu YS, 2004, J BONE MINER RES, V19, P89, DOI 10.1359/JBMR.0301215; Iizuka K, 2003, NAT IMMUNOL, V4, P801, DOI 10.1038/ni954; Katsu Y, 2003, ENDOCRINOLOGY, V144, P2597, DOI 10.1210/en.2002-220980; Kim D, 2000, J EXP MED, V192, P1467, DOI 10.1084/jem.192.10.1467; KONTGEN F, 1993, INT IMMUNOL, V5, P957, DOI 10.1093/intimm/5.8.957; LEARY NO, 1992, CLIN CHEM, V38, P904; Nakamura A, 2007, BONE, V40, P305, DOI 10.1016/j.bone.2006.09.001; PARFITT AM, 1987, J BONE MINER RES, V2, P595, DOI 10.1002/jbmr.5650020617; PARKINSON IH, 1991, J HISTOTECHNOL, V14, P81, DOI 10.1179/his.1991.14.2.81; Pineda B, 2008, CALCIFIED TISSUE INT, V82, P348, DOI 10.1007/s00223-008-9135-4; Plougastel B, 2001, IMMUNOGENETICS, V53, P209, DOI 10.1007/s002510100319; Quinn JMW, 2005, BIOCHEM BIOPH RES CO, V328, P739, DOI 10.1016/j.bbrc.2004.11.076; Schmidt C, 2003, J BONE MINER RES, V18, P1486, DOI 10.1359/jbmr.2003.18.8.1486; Sims NA, 2002, BONE, V30, P18, DOI 10.1016/S8756-3282(01)00643-3; Sims NA, 2006, AM J PHYSIOL-ENDOC M, V290, pE456, DOI 10.1152/ajpendo.00311.2005; Takayanagi H, 2007, NAT REV IMMUNOL, V7, P292, DOI 10.1038/nri2062; Tian WZ, 2005, CELL IMMUNOL, V234, P39, DOI 10.1016/j.cellimm.2005.04.021; UMEZAWA A, 1992, J CELL PHYSIOL, V151, P197, DOI 10.1002/jcp.1041510125; VREMEC D, 1992, J EXP MED, V176, P47, DOI 10.1084/jem.176.1.47; Walsh MC, 2006, ANNU REV IMMUNOL, V24, P33, DOI 10.1146/annurev.immunol.24.021605.090646; Yokoyama WM, 2003, NAT REV IMMUNOL, V3, P304, DOI 10.1038/nri1055; Zhou H, 2001, J BIOL CHEM, V276, P14916, DOI 10.1074/jbc.M011554200; Zhou H, 2002, J BIOL CHEM, V277, P48808, DOI 10.1074/jbc.M209059200	29	23	25	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 7	2008	283	45					30850	30860		10.1074/jbc.M801761200	http://dx.doi.org/10.1074/jbc.M801761200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	367ID	18782774	Green Published, hybrid			2022-12-27	WOS:000260544800040
J	Pyo, JO; Nah, J; Kim, HJ; Chang, JW; Song, YW; Yang, DK; Jo, DG; Kim, HR; Chae, HJ; Chae, SW; Hwang, SY; Kim, SJ; Kim, HJ; Cho, C; Oh, CG; Park, WJ; Jung, YK				Pyo, Jong-Ok; Nah, Jihoon; Kim, Hyo-Jin; Chang, Jae-Woong; Song, Young-Wha; Yang, Dong-Kwon; Jo, Dong-Gyu; Kim, Hyung-Ryong; Chae, Han-Jung; Chae, Soo-Wan; Hwang, Seung-Yong; Kim, Seung-Jun; Kim, Hyo-Joon; Cho, Chunghee; Oh, Chang-Gyu; Park, Woo Jin; Jung, Yong-Keun			Protection of Cardiomyocytes from Ischemic/Hypoxic Cell Death via Drbp1 and pMe(2)GlyDH in Cardio-specific ARC Transgenic Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CASPASE RECRUITMENT DOMAIN; APOPTOSIS REPRESSOR; REPERFUSION INJURY; ACTIVATED AKT; KINASE; HEART; CARDIOPROTECTION; CARDIOMYOPATHY; MITOCHONDRIA; EXPRESSION	The ischemic death of cardiomyocytes is associated in heart disease and heart failure. However, the molecular mechanism underlying ischemic cell death is not well defined. To examine the function of apoptosis repressor with a caspase recruitment domain (ARC) in the ischemic/hypoxic damage of cardiomyocytes, we generated cardio-specific ARC transgenic mice using a mouse alpha-myosin heavy chain promoter. Compared with the control, the hearts of ARC transgenic mice showed a 3-fold overexpression of ARC. Langendoff preparation showed that the hearts isolated from ARC transgenic mice exhibited improved recovery of contractile performance during reperfusion. The cardiomyocytes cultured from neonatal ARC transgenic mice were significantly resistant to hypoxic cell death. Furthermore, the ARC C-terminal calcium-binding domain was as potent to protect cardiomyocytes from hypoxic cell death as ARC. Genome-wide RNA expression profiling uncovered a list of genes whose expression was changed (>2-fold) in ARC transgenic mice. Among them, expressional regulation of developmentally regulated RNA-binding protein 1 (Drbp1) or the dimethylglycine dehydrogenase precursor (pMe(2)GlyDH) affected hypoxic death of cardiomyocytes. These results suggest that ARC may protect cardiomyocytes from hypoxic cell death by regulating its downstream, Drbp1 and pMe2GlyDH, shedding new insights into the protection of heart from hypoxic damages.	[Pyo, Jong-Ok; Nah, Jihoon; Kim, Hyo-Jin; Chang, Jae-Woong; Jung, Yong-Keun] Seoul Natl Univ, Creat Res Initiat Accelerat Res, Seoul 151747, South Korea; [Song, Young-Wha; Yang, Dong-Kwon; Cho, Chunghee; Park, Woo Jin; Jung, Yong-Keun] Gwangju Inst Sci & Technol, Dept Life Sci, Kwangju 500712, South Korea; [Jo, Dong-Gyu] Sungkyunkwan Univ, Coll Pharm, Seoul 440746, South Korea; [Kim, Hyung-Ryong] Wonkwang Univ, Sch Dent, Dept Dent Pharmacol, Chonbuk 570749, South Korea; [Chae, Han-Jung; Chae, Soo-Wan] Chonbuk Natl Univ, Sch Med, Dept Pharmacol, Jeonju 560180, Chonbuk, South Korea; [Hwang, Seung-Yong; Kim, Seung-Jun; Kim, Hyo-Joon] Hanyang Univ, Dept Biochem, Ansan 428791, South Korea; [Hwang, Seung-Yong; Kim, Seung-Jun; Kim, Hyo-Joon] Genocheck Co Ltd, Ansan 428791, South Korea; [Oh, Chang-Gyu] Macrogen Inc, World Merdian Venture Ctr, Seoul 153023, South Korea	Seoul National University (SNU); Gwangju Institute of Science & Technology (GIST); Sungkyunkwan University (SKKU); Wonkwang University; Jeonbuk National University; Hanyang University; GenoCheck Co. Ltd; Macrogen, Inc.	Jung, YK (corresponding author), Seoul Natl Univ, Creat Res Initiat Accelerat Res, Shillim Dong, Seoul 151747, South Korea.	ykjung@snu.ac.kr	Nah, Jihoon/ABC-5145-2020; Nah, Jihoon/ABB-4363-2021; Kim, Seung Jun/N-5248-2019; Jo, Dong-Gyu/AAN-9278-2021	Nah, Jihoon/0000-0003-2254-2233; Nah, Jihoon/0000-0003-2254-2233; Kim, Seung Jun/0000-0002-6913-6358; Jo, Dong-Gyu/0000-0003-2271-1076; Jung, Yong-Keun/0000-0002-9686-3120; Chae, Han-Jung/0000-0003-4190-9889	Brain Research Center; Korea Science and Engineering Foundation	Brain Research Center; Korea Science and Engineering Foundation(Korea Science and Engineering Foundation)	This work was supported in part by the Brain Research Center of 21C Frontier, Ubiquitome, CRI of the Korea Science and Engineering Foundation, and a Basic Science grant of the Korean Research Foundation (to Y. K. J.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked " advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Abmayr S, 2004, HUM MOL GENET, V13, P213, DOI 10.1093/hmg/ddh018; Aoki H, 2002, J BIOL CHEM, V277, P10244, DOI 10.1074/jbc.M112355200; Bishopric Nanette H., 2001, Current Opinion in Pharmacology, V1, P141, DOI 10.1016/S1471-4892(01)00032-7; Brar BK, 2001, CYTOKINE, V16, P93, DOI 10.1006/cyto.2001.0951; Bueno OF, 2002, CIRC RES, V91, P776, DOI 10.1161/01.RES.0000038488.38975.1A; Chatterjee S, 2003, J THORAC CARDIOV SUR, V125, P1461, DOI 10.1016/S0022-5223(02)73229-7; Dawn B, 2002, ANN NY ACAD SCI, V962, P18, DOI 10.1111/j.1749-6632.2002.tb04053.x; Donath S, 2006, CIRCULATION, V113, P1203, DOI 10.1161/CIRCULATIONAHA.105.576785; Ekhterae D, 1999, CIRC RES, V85, pE70; GULICK J, 1991, J BIOL CHEM, V266, P9180; Gustafsson AB, 2002, CIRCULATION, V106, P735, DOI 10.1161/01.CIR.0000023943.50821.F7; Hamacher-Brady A, 2007, CELL DEATH DIFFER, V14, P146, DOI 10.1038/sj.cdd.4401936; Hofer T, 2003, BLOOD, V101, P348, DOI 10.1182/blood-2002-03-0773; Irizarry RA, 2005, NAT METHODS, V2, P345, DOI 10.1038/nmeth756; Jo DG, 2004, MOL CELL BIOL, V24, P9763, DOI 10.1128/MCB.24.22.9763-9770.2004; Jo DG, 2004, J NEUROCHEM, V88, P604, DOI 10.1046/j.1471-4159.2003.02159.x; Khan AA, 2006, P NATL ACAD SCI USA, V103, P17944, DOI 10.1073/pnas.0607497103; Koseki T, 1998, P NATL ACAD SCI USA, V95, P5156, DOI 10.1073/pnas.95.9.5156; Matsui T, 2002, J BIOL CHEM, V277, P22896, DOI 10.1074/jbc.M200347200; MEGURO K, 1995, BLOOD, V86, P940; Miao WF, 2000, J MOL CELL CARDIOL, V32, P2397, DOI 10.1006/jmcc.2000.1283; NAKAMURA TY, 1993, CIRC RES, V73, P758, DOI 10.1161/01.RES.73.4.758; Otto A, 1998, CLIN EXP IMMUNOL, V111, P541; Serviddio G, 2005, FASEB J, V19, P354, DOI 10.1096/fj.04-2338com; Tamada H, 2002, BIOCHEM BIOPH RES CO, V297, P96, DOI 10.1016/S0006-291X(02)02132-0; THOMPSON CB, 1995, SCIENCE, V267, P1456, DOI 10.1126/science.7878464; Tian R, 1999, P NATL ACAD SCI USA, V96, P13536, DOI 10.1073/pnas.96.23.13536; Yamashita K, 2001, CIRC RES, V88, P609, DOI 10.1161/01.RES.88.6.609; Yet SF, 2001, CIRC RES, V89, P168, DOI 10.1161/hh1401.093314; Zhang Z, 2005, CIRCULATION, V112, P1936, DOI 10.1161/CIRCULATIONAHA.105.540070	30	20	22	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 7	2008	283	45					30707	30714		10.1074/jbc.M804209200	http://dx.doi.org/10.1074/jbc.M804209200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	367ID	18782777	Green Published, hybrid			2022-12-27	WOS:000260544800026
J	Hunt, J; Bracher, MG; Shi, J; Fleury, S; Dombrowicz, D; Gould, HJ; Sutton, BJ; Beavil, AJ				Hunt, James; Bracher, Marguerite G.; Shi, Jianguo; Fleury, Sebastien; Dombrowicz, David; Gould, Hannah J.; Sutton, Brian J.; Beavil, Andrew J.			Attenuation of IgE Affinity for Fc epsilon RI Radically Reduces the Allergic Response in Vitro and in Vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-IMMUNOGLOBULIN-E; PROTEIN INTERFACES; HOT-SPOTS; RECEPTOR; BINDING; FRAGMENT; ALPHA; ANAPHYLAXIS; FLEXIBILITY; ANTIBODIES	The high affinity of IgE for its receptor, Fc epsilon RI (K-a similar to 10(10)M(-1)), is responsible for the persistence of mast cell sensitization. Crosslinking of Fc epsilon RI-bound IgE by multivalent allergen leads to cellular activation and release of pro-inflammatory mediators responsible for the symptoms of allergic disease. We previously demonstrated that limiting the IgE-Fc epsilon RI interaction to just one of the two C epsilon 3 domains in IgE-Fc, which together constitute the high affinity binding site, results in 1000-fold reduced affinity. Such attenuation, effected by a small molecule binding to part of the IgE: Fc epsilon RI interface or a distant allosteric site, rather than complete blocking of the interaction, may represent a viable approach to the treatment of allergic disease. However, the degree to which the interaction would need to be disrupted is unclear, because the importance of high affinity for immediate hypersensitivity has never been investigated. We have incorporated into human IgE a mutation, R334S, previously characterized in IgE-Fc, which reduces its affinity for Fc epsilon RI similar to 50- fold. We have compared the ability of wild type and R334S IgE to stimulate allergen-induced mast cell activation in vitro and in vivo. We confirmed the expected difference in affinity between wild type and mutant IgE for Fc epsilon RI (similar to 50-fold) and found that, in vitro, mast cell degranulation was reduced proportionately. The effect in vivo was also marked, with a 75% reduction in the passive cutaneous anaphylaxis response. We have therefore demonstrated that the high affinity of IgE for Fc epsilon RI is critical to the allergic response, and that even moderate attenuation of this affinity has a substantial effect in vivo.	[Hunt, James; Bracher, Marguerite G.; Shi, Jianguo; Gould, Hannah J.; Sutton, Brian J.; Beavil, Andrew J.] Kings Coll London, Randall Div Cell & Mol Biophys, Med Res Council, London SE1 1UL, England; [Hunt, James; Bracher, Marguerite G.; Shi, Jianguo; Gould, Hannah J.; Sutton, Brian J.; Beavil, Andrew J.] Kings Coll London, Randall Div Cell & Mol Biophys, Asthma UK Ctr Allerg Mech Asthma, London SE1 1UL, England; [Hunt, James; Bracher, Marguerite G.; Shi, Jianguo; Gould, Hannah J.; Sutton, Brian J.; Beavil, Andrew J.] Kings Coll London, Div Asthma Allergy & Lung Biol, London SE1 1UL, England; [Fleury, Sebastien; Dombrowicz, David] Univ Lille 2, Inst Pasteur, INSERM, U547, F-59019 Lille, France	UK Research & Innovation (UKRI); Medical Research Council UK (MRC); University of London; King's College London; University of London; King's College London; University of London; King's College London; Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Universite de Lille	Beavil, AJ (corresponding author), Kings Coll London, Randall Div Cell & Mol Biophys, Med Res Council, New Hunts House,Guys Campus, London SE1 1UL, England.	andrew.beavil@kcl.ac.uk	Beavil, Andrew/B-5624-2009; Dombrowicz, David/F-7044-2013	Beavil, Andrew/0000-0002-0768-122X; Dombrowicz, David/0000-0002-0485-8923; Gould, Hannah/0000-0003-0411-688X; Fleury, Sebastien/0000-0002-0679-3086	Asthma UK, Biotechnology and Biological Sciences Research Council (UK); Medical Research Council (UK); Marie Curie Cancer Care; Medical Research Council [G0400503B, G0501494] Funding Source: researchfish; Asthma UK [05/061] Funding Source: researchfish; MRC [G0501494] Funding Source: UKRI	Asthma UK, Biotechnology and Biological Sciences Research Council (UK)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council (UK)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Marie Curie Cancer Care; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Asthma UK; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by Asthma UK, Biotechnology and Biological Sciences Research Council (UK), Medical Research Council (UK), and Marie Curie Cancer Care. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Bogan AA, 1998, J MOL BIOL, V280, P1, DOI 10.1006/jmbi.1998.1843; BRUGGEMANN M, 1987, J EXP MED, V166, P1351, DOI 10.1084/jem.166.5.1351; Chang TW, 2000, NAT BIOTECHNOL, V18, P157, DOI 10.1038/72601; Cheng AC, 2007, NAT BIOTECHNOL, V25, P71, DOI 10.1038/nbt1273; Dombrowicz D, 1996, J IMMUNOL, V157, P1645; DOMBROWICZ D, 1993, CELL, V75, P969, DOI 10.1016/0092-8674(93)90540-7; Garman SC, 2000, NATURE, V406, P259, DOI 10.1038/35018500; Garman SC, 2001, J MOL BIOL, V311, P1049, DOI 10.1006/jmbi.2001.4929; GEHA RS, 1985, NATURE, V315, P577, DOI 10.1038/315577a0; Gould HJ, 2008, NAT REV IMMUNOL, V8, P205, DOI 10.1038/nri2273; Hammond G., 2006, CELL BIOL, P221; Harwood NE, 2007, BIOMED PHARMACOTHER, V61, P61, DOI 10.1016/j.biopha.2006.11.004; Henry AJ, 1997, BIOCHEMISTRY-US, V36, P15568, DOI 10.1021/bi971299+; Hunt J, 2005, J BIOL CHEM, V280, P16808, DOI 10.1074/jbc.M500965200; Ishizaka K., 1971, PROGR IMMUNOLOGY, V1st, P859; MacGlashan D, 1999, J ALLERGY CLIN IMMUN, V104, P492, DOI 10.1016/S0091-6749(99)70399-4; MacGlashan D, 2005, ANN NY ACAD SCI, V1050, P73, DOI 10.1196/annals.1313.009; McCloskey N, 2007, J BIOL CHEM, V282, P24083, DOI 10.1074/jbc.M703195200; MILLER L, 1989, SCIENCE, V244, P334, DOI 10.1126/science.2523561; Moreira IS, 2007, PROTEINS, V68, P803, DOI 10.1002/prot.21396; Myszka DG, 2000, METHOD ENZYMOL, V323, P325; Shi JG, 1997, BIOCHEMISTRY-US, V36, P2112, DOI 10.1021/bi961231e; TADA T, 1975, INT ARCH ALLER A IMM, V48, P116, DOI 10.1159/000231297; Wan T, 2002, NAT IMMUNOL, V3, P681, DOI 10.1038/ni811; Wells JA, 2007, NATURE, V450, P1001, DOI 10.1038/nature06526; Wiegand TW, 1996, J IMMUNOL, V157, P221; Wurzburg BA, 2000, IMMUNITY, V13, P375, DOI 10.1016/S1074-7613(00)00037-6; Yamasaki S, 2004, BLOOD, V103, P3093, DOI 10.1182/blood-2003-08-2944	28	9	10	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 31	2008	283	44					29882	29887		10.1074/jbc.M804742200	http://dx.doi.org/10.1074/jbc.M804742200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	364WS	18703499	hybrid, Green Published			2022-12-27	WOS:000260366900032
J	Johnson, CM; Chichili, GR; Rodgers, W				Johnson, Corey M.; Chichili, Gurunadh R.; Rodgers, William			Compartmentalization of Phosphatidylinositol 4,5-Bisphosphate Signaling Evidenced Using Targeted Phosphatases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENRICHED MEMBRANE DOMAINS; T-CELL-ACTIVATION; PLECKSTRIN HOMOLOGY DOMAINS; FC-EPSILON-RI; PLASMA-MEMBRANE; ACTIN CYTOSKELETON; LIPID RAFTS; CRITICAL REEVALUATION; KINASE SUBSTRATE; PHOSPHOINOSITIDES	Phosphatidylinositol 4,5-bisphosphate (PIP2) is a prevalent phosphoinositide in cell membranes, with important functions in cell signaling and activation. A large fraction of PIP2 associates with the detergent-resistant membrane "raft" fraction, but the functional significance of this association remains controversial. To measure the properties of raft and nonraft PIP2 in cell signaling, we targeted the PIP2-specific phosphatase Inp54p to either the raft or nonraft membrane fraction using minimal membrane anchors. Interestingly, we observed that targeting Inp54p to the nonraft fraction resulted in an enrichment of raft-associated PIP2 and striking changes in cell morphology, including a wortmannin-sensitive increase in cell filopodia and cell spreading. In contrast, raft-targeted Inp54p depleted the raft pool of PIP2 and produced smooth T cells void of membrane ruffling and filopodia. Furthermore, raft-targeted Inp54p inhibited capping in T cells stimulated by cross-linking the T cell receptor, but without affecting the T cell receptor-dependent Ca2+ flux. Altogether, these results provide evidence of compartmentalization of PIP2-dependent signaling in cell membranes such as predicted by the membrane raft model.	[Johnson, Corey M.; Chichili, Gurunadh R.; Rodgers, William] Oklahoma Med Res Fdn, Cardiovasc Biol Res Program, Oklahoma City, OK 73104 USA; [Rodgers, William] Univ Oklahoma, Hlth Sci Ctr, Dept Pathol, Oklahoma City, OK 73104 USA; [Rodgers, William] Univ Oklahoma, Hlth Sci Ctr, Dept Microbiol & Immunol, Oklahoma City, OK 73104 USA	Oklahoma Medical Research Foundation; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center	Rodgers, W (corresponding author), Oklahoma Med Res Fdn, Cardiovasc Biol Res Program, 825 NE 13th St,MS 45, Oklahoma City, OK 73104 USA.	william-rodgers@omrf.org		Johnson, Corey/0000-0002-0536-0449	National Institutes of Health [RO1 GM070001]; American Heart Association [0625648Z]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM070001] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant RO1 GM070001. This work was also supported by American Heart Association Grant 0625648Z. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Acuto O, 2000, ANNU REV IMMUNOL, V18, P165, DOI 10.1146/annurev.immunol.18.1.165; Arrieumerlou C, 2000, J IMMUNOL, V165, P3182, DOI 10.4049/jimmunol.165.6.3182; Caroni P, 2001, EMBO J, V20, P4332, DOI 10.1093/emboj/20.16.4332; Charras GT, 2006, J CELL BIOL, V175, P477, DOI 10.1083/jcb.200602085; Chichili GR, 2007, J BIOL CHEM, V282, P36682, DOI 10.1074/jbc.M702959200; Di Paolo G, 2006, NATURE, V443, P651, DOI 10.1038/nature05185; Engelman DM, 2005, NATURE, V438, P578, DOI 10.1038/nature04394; FIELD KA, 1995, P NATL ACAD SCI USA, V92, P9201, DOI 10.1073/pnas.92.20.9201; GABEV E, 1989, BIOCHIM BIOPHYS ACTA, V979, P105, DOI 10.1016/0005-2736(89)90529-4; Golub T, 2005, J CELL BIOL, V169, P151, DOI 10.1083/jcb.200407058; Hancock JF, 2006, NAT REV MOL CELL BIO, V7, P456, DOI 10.1038/nrm1925; Heerklotz H, 2002, BIOPHYS J, V83, P2693, DOI 10.1016/S0006-3495(02)75278-8; Heerklotz H, 2003, J MOL BIOL, V329, P793, DOI 10.1016/S0022-2836(03)00504-7; Huang SH, 2004, MOL CELL BIOL, V24, P9102, DOI 10.1128/MCB.24.20.9102-9123.2004; Ilani T, 2007, J CELL BIOL, V179, P733, DOI 10.1083/jcb.200707199; Jacobson K, 2007, NAT CELL BIOL, V9, P7, DOI 10.1038/ncb0107-7; Jaffe AB, 2005, ANNU REV CELL DEV BI, V21, P247, DOI 10.1146/annurev.cellbio.21.020604.150721; Jordan S, 2003, J IMMUNOL, V171, P78, DOI 10.4049/jimmunol.171.1.78; Kwik J, 2003, P NATL ACAD SCI USA, V100, P13964, DOI 10.1073/pnas.2336102100; Laux T, 2000, J CELL BIOL, V149, P1455, DOI 10.1083/jcb.149.7.1455; Lemmon MA, 2001, BIOCHEM SOC T, V29, P377, DOI 10.1042/BST0290377; MAJERUS PW, 1986, SCIENCE, V234, P1519, DOI 10.1126/science.3024320; McLaughlin S, 2002, ANNU REV BIOPH BIOM, V31, P151, DOI 10.1146/annurev.biophys.31.082901.134259; Parmryd I, 2003, EXP CELL RES, V285, P27, DOI 10.1016/S0014-4827(02)00048-4; Penninger JM, 1999, CELL, V96, P9, DOI 10.1016/S0092-8674(00)80954-X; Pettitt TR, 2006, J LIPID RES, V47, P1588, DOI 10.1194/jlr.D600004-JLR200; Pike LJ, 1996, J BIOL CHEM, V271, P26453, DOI 10.1074/jbc.271.43.26453; Pike LJ, 1998, J BIOL CHEM, V273, P22298, DOI 10.1074/jbc.273.35.22298; Pizzo P, 2002, EUR J IMMUNOL, V32, P3082, DOI 10.1002/1521-4141(200211)32:11<3082::AID-IMMU3082>3.0.CO;2-2; Rameh LE, 1999, J BIOL CHEM, V274, P8347, DOI 10.1074/jbc.274.13.8347; Raucher D, 2000, CELL, V100, P221, DOI 10.1016/S0092-8674(00)81560-3; RESH MD, 1994, CELL, V76, P411, DOI 10.1016/0092-8674(94)90104-X; Rodgers W, 2005, TRENDS IMMUNOL, V26, P97, DOI 10.1016/j.it.2004.11.016; Rodgers W, 2002, BIOTECHNIQUES, V32, P1044, DOI 10.2144/02325st05; Rodgers W, 1996, J CELL BIOL, V135, P1515, DOI 10.1083/jcb.135.6.1515; Rodgers W, 2001, EXP CELL RES, V267, P173, DOI 10.1006/excr.2001.5253; ROELANTS G, 1973, J EXP MED, V137, P1060, DOI 10.1084/jem.137.4.1060; Rozelle AL, 2000, CURR BIOL, V10, P311, DOI 10.1016/S0960-9822(00)00384-5; Shan XC, 2000, MOL CELL BIOL, V20, P6945, DOI 10.1128/MCB.20.18.6945-6957.2000; Stauffer TP, 1998, CURR BIOL, V8, P343, DOI 10.1016/S0960-9822(98)70135-6; Stossel TP, 2001, NAT REV MOL CELL BIO, V2, P138, DOI 10.1038/35052082; Takenawa T, 2007, NAT REV MOL CELL BIO, V8, P37, DOI 10.1038/nrm2069; Tian TH, 2007, NAT CELL BIOL, V9, P905, DOI 10.1038/ncb1615; Tong J, 2008, BIOPHYS J, V94, P125, DOI 10.1529/biophysj.107.110536; van Rheenen J, 2005, EMBO J, V24, P1664, DOI 10.1038/sj.emboj.7600655; Varnai P, 1998, J CELL BIOL, V143, P501, DOI 10.1083/jcb.143.2.501; Varnai P, 2002, J BIOL CHEM, V277, P27412, DOI 10.1074/jbc.M109672200; Villalba M, 2001, J CELL BIOL, V155, P331, DOI 10.1083/jcb.200107080; Wang JY, 2001, J BIOL CHEM, V276, P5012, DOI 10.1074/jbc.M008355200; Wiradjaja F, 2001, J BIOL CHEM, V276, P7643, DOI 10.1074/jbc.M010471200; Young RM, 2005, J BIOL CHEM, V280, P1230, DOI 10.1074/jbc.M408339200; Zhang WG, 1999, INT IMMUNOL, V11, P943, DOI 10.1093/intimm/11.6.943; Zhang WG, 1998, IMMUNITY, V9, P239, DOI 10.1016/S1074-7613(00)80606-8; Zhang WG, 1998, CELL, V92, P83, DOI 10.1016/S0092-8674(00)80901-0; Zhu MH, 2005, J IMMUNOL, V174, P31, DOI 10.4049/jimmunol.174.1.31	55	55	56	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 31	2008	283	44					29920	29928		10.1074/jbc.M805921200	http://dx.doi.org/10.1074/jbc.M805921200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	364WS	18723502	hybrid, Green Published			2022-12-27	WOS:000260366900037
J	Ju, JS; Miller, SE; Hanson, PI; Weihl, CC				Ju, Jeong-Sun; Miller, Sara E.; Hanson, Phyllis I.; Weihl, Conrad C.			Impaired Protein Aggregate Handling and Clearance Underlie the Pathogenesis of p97/VCP-associated Disease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VALOSIN-CONTAINING-PROTEIN; FRONTOTEMPORAL DEMENTIA; AUTOPHAGIC CLEARANCE; DEGRADATION; AGGRESOMES; MUTATIONS; INCLUSIONS; ROLES; CELLS; HDAC6	Mutations in p97/VCP cause the multisystem disease inclusion body myopathy, Paget disease of the bone and frontotemporal dementia (IBMPFD). p97/VCP is a member of the AAA+ (ATPase associated with a variety of activities) protein family and has been implicated in multiple cellular processes. One pathologic feature in IBMPFD is ubiquitinated inclusions, suggesting that mutations in p97/VCP may affect protein degradation. The present study shows that IBMPFD mutant expression increases ubiquitinated proteins and susceptibility to proteasome inhibition. Co-expression of an aggregate prone protein such as expanded polyglutamine in IBMPFD mutant cells results in an increase in aggregated protein that localizes to small inclusions instead of a single perinuclear aggresome. These small inclusions fail to co-localize with autophagic machinery. IBMPFD mutants avidly bind to these small inclusions and may not allow them to traffic to an aggresome. This is rescued by HDAC6, a p97/VCP-binding protein that facilitates the autophagic degradation of protein aggregates. Expression of HDAC6 improves aggresome formation and protects IBMPFD mutant cells from polyglutamine-induced cell death. Our study emphasizes the importance of protein aggregate trafficking to inclusion bodies in degenerative diseases and the therapeutic benefit of inclusion body formation.	[Ju, Jeong-Sun; Miller, Sara E.; Weihl, Conrad C.] Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA; [Hanson, Phyllis I.] Washington Univ, Sch Med, Dept Cell Biol & Physiol, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL)	Weihl, CC (corresponding author), Box 8111,660 S Euclid Ave, St Louis, MO 63110 USA.	weihlc@neuro.wustl.edu	Hanson, Phyllis/E-9420-2012	Ju, Jeong-sun/0000-0001-7276-9941	National Institutes of Health [K08 AG026271]; National Institutes of Health Neuroscience Blueprint Core [P30 NS057105]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS057105] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [K08AG026271, R01AG031867] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health Neuroscience Blueprint Core(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grant K08 AG026271 (to C. C. W.). This work was also supported by National Institutes of Health Neuroscience Blueprint Core Grant P30 NS057105 to Washington University. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Bjorkoy G, 2005, J CELL BIOL, V171, P603, DOI 10.1083/jcb.200507002; Boyault C, 2006, EMBO J, V25, P3357, DOI 10.1038/sj.emboj.7601210; Dalal S, 2004, MOL BIOL CELL, V15, P637, DOI 10.1091/mbc.E03-02-0097; Ding WX, 2007, AM J PATHOL, V171, P513, DOI 10.2353/ajpath.2007.070188; Filimonenko M, 2007, J CELL BIOL, V179, P485, DOI 10.1083/jcb.200702115; Forman MS, 2006, J NEUROPATH EXP NEUR, V65, P571, DOI 10.1097/00005072-200606000-00005; Halawani D, 2006, MOL CELL, V22, P713, DOI 10.1016/j.molcel.2006.06.003; Hara T, 2006, NATURE, V441, P885, DOI 10.1038/nature04724; Hirabayashi M, 2001, CELL DEATH DIFFER, V8, P977, DOI 10.1038/sj.cdd.4400907; Hocking LJ, 2002, HUM MOL GENET, V11, P2735, DOI 10.1093/hmg/11.22.2735; Hubbers CU, 2007, BRAIN, V130, P381, DOI 10.1093/brain/awl238; Ishigaki S, 2004, J BIOL CHEM, V279, P51376, DOI 10.1074/jbc.M406683200; Iwata A, 2005, J BIOL CHEM, V280, P40282, DOI 10.1074/jbc.M508786200; Janiesch PC, 2007, NAT CELL BIOL, V9, P379, DOI 10.1038/ncb1554; Johnston JA, 1998, J CELL BIOL, V143, P1883, DOI 10.1083/jcb.143.7.1883; Kawaguchi Y, 2003, CELL, V115, P727, DOI 10.1016/S0092-8674(03)00939-5; Kitada T, 1998, NATURE, V392, P605, DOI 10.1038/33416; Kitami MI, 2006, FEBS LETT, V580, P474, DOI 10.1016/j.febslet.2005.12.044; Kobayashi T, 2007, GENES CELLS, V12, P889, DOI 10.1111/j.1365-2443.2007.01099.x; Kopito RR, 2000, TRENDS CELL BIOL, V10, P524, DOI 10.1016/S0962-8924(00)01852-3; Lee CS, 2004, J NEUROCHEM, V91, P996, DOI 10.1111/j.1471-4159.2004.02813.x; Lee JA, 2007, CURR BIOL, V17, P1561, DOI 10.1016/j.cub.2007.07.029; Nishino Ichizo, 2003, Curr Neurol Neurosci Rep, V3, P64, DOI 10.1007/s11910-003-0040-y; Olzmann JA, 2007, J CELL BIOL, V178, P1025, DOI 10.1083/jcb.200611128; Pandey UB, 2007, NATURE, V447, P859, DOI 10.1038/nature05853; Pankiv S, 2007, J BIOL CHEM, V282, P24131, DOI 10.1074/jbc.M702824200; Pye VE, 2007, P NATL ACAD SCI USA, V104, P467, DOI 10.1073/pnas.0603408104; Rubinsztein DC, 2006, NATURE, V443, P780, DOI 10.1038/nature05291; Schroder R, 2005, ANN NEUROL, V57, P457, DOI 10.1002/ana.20407; Schwartz AL, 1999, ANNU REV MED, V50, P57; Seigneurin-Berny D, 2001, MOL CELL BIOL, V21, P8035, DOI 10.1128/MCB.21.23.8035-8044.2001; Skibinski G, 2005, NAT GENET, V37, P806, DOI 10.1038/ng1609; Song CC, 2008, TOXICOL APPL PHARM, V228, P351, DOI 10.1016/j.taap.2007.12.026; Tan JMM, 2008, HUM MOL GENET, V17, P431, DOI 10.1093/hmg/ddm320; Taylor JP, 2003, HUM MOL GENET, V12, P749, DOI 10.1093/hmg/ddg074; Watts GDJ, 2004, NAT GENET, V36, P377, DOI 10.1038/ng1332; Weihl CC, 2006, HUM MOL GENET, V15, P189, DOI 10.1093/hmg/ddi426; Weihl CC, 2007, HUM MOL GENET, V16, P919, DOI 10.1093/hmg/ddm037; Wojcik C, 2004, J CELL SCI, V117, P281, DOI 10.1242/jcs.00841; Wojcik C, 2006, MOL BIOL CELL, V17, P4606, DOI 10.1091/mbc.E06-05-0432; Yamanaka K, 2004, J STRUCT BIOL, V146, P242, DOI 10.1016/j.jsb.2003.11.017; Yang H, 2007, EXP CELL RES, V313, P538, DOI 10.1016/j.yexcr.2006.10.031	42	99	100	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 31	2008	283	44					30289	30299		10.1074/jbc.M805517200	http://dx.doi.org/10.1074/jbc.M805517200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	364WS	18715868	Green Published, hybrid			2022-12-27	WOS:000260366900073
J	Gin, P; Yin, LY; Davies, BSJ; Weinstein, MM; Ryan, RO; Bensadoun, A; Fong, LG; Young, SG; Beigneux, AP				Gin, Peter; Yin, Liya; Davies, Brandon S. J.; Weinstein, Michael M.; Ryan, Robert O.; Bensadoun, Andre; Fong, Loren G.; Young, Stephen G.; Beigneux, Anne P.			The Acidic Domain of GPIHBP1 Is Important for the Binding of Lipoprotein Lipase and Chylomicrons	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							APOLIPOPROTEIN-A-V; SITE-DIRECTED MUTAGENESIS; PLASMINOGEN-ACTIVATOR; HEPARIN-BINDING; TERMINAL DOMAIN; CLEARING FACTOR; LIGAND-BINDING; RECEPTOR GENE; IDENTIFICATION; RESIDUES	GPIHBP1, a glycosylphosphatidylinositol-anchored endothelial cell protein of the lymphocyte antigen 6 (Ly6) family, plays a key role in the lipolysis of triglyceride-rich lipoproteins (e. g. chylomicrons). GPIHBP1 is expressed along the luminal surface of endothelial cells of heart, skeletal muscle, and adipose tissue, and GPIHBP1-expressing cells bind lipoprotein lipase (LPL) and chylomicrons avidly. GPIHBP1 contains an aminoterminal acidic domain (amino acids 24-48) that is enriched in aspartate and glutamate residues, and we previously speculated that this domain might be important in binding ligands. To explore the functional importance of the acidic domain, we tested the ability of polyaspartate or polyglutamate peptides to block the binding of ligands to pgsA-745 Chinese hamster ovary cells that overexpress GPIHBP1. Both polyaspartate and polyglutamate blocked LPL and chylomicron binding to GPIHBP1. Also, a rabbit antiserum against the acidic domain of GPIHBP1 blocked LPL and chylomicron binding to GPIHBP1-expressing cells. Replacing the acidic amino acids within GPIHBP1 residues 38-48 with alanine eliminated the ability of GPIHBP1 to bind LPL and chylomicrons. Finally, mutation of the positively charged heparin-binding domains within LPL and apolipoprotein AV abolished the ability of these proteins to bind to GPIHBP1. These studies indicate that the acidic domain of GPIHBP1 is important and that electrostatic interactions play a key role in ligand binding.	[Gin, Peter; Yin, Liya; Davies, Brandon S. J.; Weinstein, Michael M.; Fong, Loren G.; Young, Stephen G.; Beigneux, Anne P.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Los Angeles, CA 90095 USA; [Weinstein, Michael M.; Young, Stephen G.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Human Genet, Los Angeles, CA 90095 USA; [Bensadoun, Andre] Cornell Univ, Div Nutr Sci, Ithaca, NY 14853 USA; [Ryan, Robert O.] Childrens Hosp, Oakland Res Inst, Oakland, CA 94609 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Cornell University; Children's Hospital Los Angeles; Children's Hospital Oakland Research Institute	Beigneux, AP (corresponding author), 675 Charles E Young Dr S, Los Angeles, CA 90095 USA.	abeigneux@mednet.ucla.edu		Davies, Brandon/0000-0002-7168-8522; Young, Stephen/0000-0001-7270-3176	Scientist Development Award; American Heart Association, National Office; BayGenomics [HL66621, HL66600, R01HL087228]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL073061, U01HL066600, R01HL087228, U01HL066621] Funding Source: NIH RePORTER	Scientist Development Award; American Heart Association, National Office(American Heart Association); BayGenomics; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by a Scientist Development Award from the American Heart Association, National Office ( to A. P. B.), BayGenomics Grants HL66621 and HL66600, R01HL087228( to S. G. Y.), and HL073061( to R. O. R.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Beckstead JA, 2003, BIOCHEMISTRY-US, V42, P9416, DOI 10.1021/bi034509t; BEHRENDT N, 1991, J BIOL CHEM, V266, P7842; Beigneux AP, 2007, CELL METAB, V5, P279, DOI 10.1016/j.cmet.2007.02.002; Ben-Zeev O, 2002, J BIOL CHEM, V277, P10727, DOI 10.1074/jbc.M108128200; Bensadoun A, 1999, METH MOL B, V109, P145; BERRYMAN DE, 1993, J BIOL CHEM, V268, P3272; BRAGDON JH, 1954, SCIENCE, V120, P113, DOI 10.1126/science.120.3107.113-a; CISAR LA, 1989, J BIOL CHEM, V264, P1767; ESKO JD, 1985, P NATL ACAD SCI USA, V82, P3197, DOI 10.1073/pnas.82.10.3197; Hahn PF, 1943, SCIENCE, V98, P19, DOI 10.1126/science.98.2531.19; HATA A, 1993, J BIOL CHEM, V268, P8447; HULTIN M, 1994, BIOCHEM J, V304, P959, DOI 10.1042/bj3040959; Ioka RX, 2003, J BIOL CHEM, V278, P7344, DOI 10.1074/jbc.M211932200; KORN ED, 1955, J BIOL CHEM, V215, P1; KORN ED, 1955, J BIOL CHEM, V215, P15; LECLAIR KP, 1987, P NATL ACAD SCI USA, V84, P1638, DOI 10.1073/pnas.84.6.1638; Llinas P, 2005, EMBO J, V24, P1655, DOI 10.1038/sj.emboj.7600635; Lookene A, 2005, J BIOL CHEM, V280, P25383, DOI 10.1074/jbc.M501589200; Lookene A, 2000, BIOCHEM BIOPH RES CO, V271, P15, DOI 10.1006/bbrc.2000.2530; LOW MG, 1992, PHOSPHOLIPASES DEGRA; MA YH, 1994, J LIPID RES, V35, P2049; Nilsson SK, 2007, BIOCHEMISTRY-US, V46, P3896, DOI 10.1021/bi7000533; Ploug M, 1998, BIOCHEMISTRY-US, V37, P16494, DOI 10.1021/bi981203r; Sendak RA, 1998, J LIPID RES, V39, P1310; WANG Y, 1995, EUR J BIOCHEM, V227, P116, DOI 10.1111/j.1432-1033.1995.tb20366.x; Young SG, 2007, CURR OPIN LIPIDOL, V18, P389, DOI 10.1097/MOL.0b013e3281527914	26	66	70	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 24	2008	283	43					29554	29562		10.1074/jbc.M802579200	http://dx.doi.org/10.1074/jbc.M802579200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	362EB	18713736	Green Published, hybrid			2022-12-27	WOS:000260179900081
J	Valant, C; Gregory, KJ; Hall, NE; Scammells, PJ; Lew, MJ; Sexton, PM; Christopoulos, A				Valant, Celine; Gregory, Karen J.; Hall, Nathan E.; Scammells, Peter J.; Lew, Michael J.; Sexton, Patrick M.; Christopoulos, Arthur			A Novel Mechanism of G Protein-coupled Receptor Functional Selectivity MUSCARINIC PARTIAL AGONIST McN-A-343 AS A BITOPIC ORTHOSTERIC/ALLOSTERIC LIGAND	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACETYLCHOLINE-RECEPTORS; CRYSTAL-STRUCTURE; BINDING-SITE; PHARMACOLOGY; MUTAGENESIS; MODULATORS; EFFICACY; DRUGS; MODE	Many G protein-coupled receptors (GPCRs) possess allosteric binding sites distinct from the orthosteric site utilized by their cognate ligands, but most GPCR allosteric modulators reported to date lack signaling efficacy in their own right. McN-A-343 (4-(N-(3-chlorophenyl)carbamoyloxy)-2-butynyltrimethylammonium chloride) is a functionally selective muscarinic acetylcholine receptor (mAChR) partial agonist that can also interact allosterically at the M-2 mAChR. We hypothesized that this molecule simultaneously utilizes both an allosteric and the orthosteric site on the M-2 mAChR to mediate these effects. By synthesizing progressively truncated McN-A-343 derivatives, we identified two, which minimally contain 3- chlorophenylcarbamate, as pure allosteric modulators. These compounds were positive modulators of the orthosteric antagonist N-[H-3] methylscopolamine, but in functional assays of M-2 mAChR-mediated ERK1/2 phosphorylation and guanosine 5'-3-O-([S-35]thio)triphosphate binding, they were negative modulators of agonist efficacy. This negative allosteric effect was diminished upon mutation of Y177A in the second extracellular (E2) loop of the M(2)mAChR that is known to reduce prototypical allosteric modulator potency. Our results are consistent with McN-A-343 being a bitopic orthosteric/allosteric ligand with the allosteric moiety engendering partial agonism and functional selectivity. This finding suggests a novel and largely unappreciated mechanism of "directed efficacy" whereby functional selectivity may be engendered in a GPCR by utilizing an allosteric ligand to direct the signaling of an orthosteric ligand encoded within the same molecule.	[Sexton, Patrick M.] Monash Univ, Dept Pharmacol, Drug Discovery Biol Lab, Clayton, Vic 3800, Australia; [Scammells, Peter J.] Monash Inst Pharmaceut Sci, Dept Med Chem, Parkville, Vic 3052, Australia; [Lew, Michael J.] Univ Melbourne, Dept Pharmacol, Melbourne, Vic 3010, Australia; [Valant, Celine; Gregory, Karen J.; Hall, Nathan E.; Sexton, Patrick M.; Christopoulos, Arthur] Monash Inst Pharmaceut Sci, Drug Discovery Biol Lab, Parkville, Vic 3052, Australia	Monash University; University of Melbourne	Christopoulos, A (corresponding author), Monash Univ, Dept Pharmacol, Drug Discovery Biol Lab, Clayton, Vic 3800, Australia.	arthur.christopoulos@med.monash.edu.au	Lew, Michael/E-1247-2012; Sexton, Patrick M/B-1319-2008; Christopoulos, Arthur/B-6207-2013	Sexton, Patrick M/0000-0001-8902-2473; Christopoulos, Arthur/0000-0003-4442-3294; Valant, Celine/0000-0002-2509-7465; Scammells, Peter/0000-0003-2930-895X; Hall, Nathan/0000-0001-8942-0498; Gregory, Karen/0000-0002-3833-2137; Lew, Michael/0000-0002-2523-7990	National Health and Medical Research Council (NHMRC) of Australia [400134]; Australian Research Council Discovery [DP0877497]	National Health and Medical Research Council (NHMRC) of Australia(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council Discovery(Australian Research Council)	This work was supported in part by National Health and Medical Research Council (NHMRC) of Australia Grant 400134 and Australian Research Council Discovery Grant DP0877497. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked " advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	ABAGYAN R, 1994, J MOL BIOL, V235, P983, DOI 10.1006/jmbi.1994.1052; Avlani VA, 2007, J BIOL CHEM, V282, P25677, DOI 10.1074/jbc.M702311200; BIRDSALL NJM, 1983, BRIT J PHARMACOL, V78, P257, DOI 10.1111/j.1476-5381.1983.tb09388.x; BLACK J, 1989, SCIENCE, V245, P486, DOI 10.1126/science.2569237; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Caulfield MP, 1998, PHARMACOL REV, V50, P279; CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; Cherezov V, 2007, SCIENCE, V318, P1258, DOI 10.1126/science.1150577; Christopoulos A, 1999, BIOCHEM PHARMACOL, V58, P735, DOI 10.1016/S0006-2952(99)00087-8; Christopoulos A, 1997, EUR J PHARMACOL, V339, P153, DOI 10.1016/S0014-2999(97)01379-4; Christopoulos A, 2000, J PHARMACOL TOXICOL, V43, P55, DOI 10.1016/S1056-8719(00)00078-2; Christopoulos A, 1998, TRENDS PHARMACOL SCI, V19, P351, DOI 10.1016/S0165-6147(98)01240-1; Christopoulos A, 2002, PHARMACOL REV, V54, P323, DOI 10.1124/pr.54.2.323; Griffin MT, 2007, J PHARMACOL EXP THER, V321, P1193, DOI 10.1124/jpet.107.120857; Heitz F, 1999, EUR J PHARMACOL, V380, P183, DOI 10.1016/S0014-2999(99)00439-2; JAKUBIK J, 1995, J PHARMACOL EXP THER, V274, P1077; Kostenis E, 1996, EUR J PHARMACOL, V314, P385, DOI 10.1016/S0014-2999(96)00568-7; Kristiansen K, 2004, PHARMACOL THERAPEUT, V103, P21, DOI 10.1016/j.pharmthera.2004.05.002; Lagerstrom MC, 2008, NAT REV DRUG DISCOV, V7, P339, DOI 10.1038/nrd2518; Langmead CJ, 2006, TRENDS PHARMACOL SCI, V27, P475, DOI 10.1016/j.tips.2006.07.009; LAZARENO S, 1995, MOL PHARMACOL, V48, P362; Leach K, 2007, TRENDS PHARMACOL SCI, V28, P382, DOI 10.1016/j.tips.2007.06.004; LEFF P, 1993, BRIT J PHARMACOL, V110, P239, DOI 10.1111/j.1476-5381.1993.tb13799.x; Lu ZL, 2002, TRENDS PHARMACOL SCI, V23, P140, DOI 10.1016/S0165-6147(00)01973-8; May LT, 2007, MOL PHARMACOL, V72, P463, DOI 10.1124/mol.107.037630; May LT, 2007, ANNU REV PHARMACOL, V47, P1, DOI 10.1146/annurev.pharmtox.47.120505.105159; MELLIN C, 1989, J MED CHEM, V32, P1590, DOI 10.1021/jm00127a031; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; ROSZKOWSKI A, 1961, J PHARMACOL EXP THER, V132, P156; ROSZKOWSKI AP, 1967, J PHARMACOL EXP THER, V156, P238; SCHWARZ RD, 1995, LIFE SCI, V56, P923, DOI 10.1016/0024-3205(95)00029-6; Sur C, 2003, P NATL ACAD SCI USA, V100, P13674, DOI 10.1073/pnas.1835612100; Swaminath G, 2005, J BIOL CHEM, V280, P22165, DOI 10.1074/jbc.M502352200; Urban JD, 2007, J PHARMACOL EXP THER, V320, P1, DOI 10.1124/jpet.106.104463; WAELBROECK M, 1994, MOL PHARMACOL, V46, P685; Wess J, 2005, MOL PHARMACOL, V68, P1506, DOI 10.1124/mol.105.019141	36	142	144	1	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 24	2008	283	43					29312	29321		10.1074/jbc.M803801200	http://dx.doi.org/10.1074/jbc.M803801200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	362EB	18723515	Green Published, hybrid			2022-12-27	WOS:000260179900058
J	Gurung, B; Yu, L; Yu, CA				Gurung, Buddha; Yu, Linda; Yu, Chang-An			Stigmatellin induces reduction of iron-sulfur protein in the oxidized cytochrome bc(1) complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MITOCHONDRIAL ELECTRON-TRANSFER; BOVINE HEART-MITOCHONDRIA; OXYGEN-EVOLVING SYSTEM; Q-CYCLE MECHANISM; DOMAIN MOVEMENT; UBIQUINOL OXIDATION; SACCHAROMYCES-CEREVISIAE; SUPEROXIDE FORMATION; YEAST MITOCHONDRIA; HYDROGEN-PEROXIDE	Stigmatellin, a Q(P) site inhibitor, inhibits electron transfer from iron-sulfur protein (ISP) to cytochrome c(1) in the bc(1) complex. Stigmatellin raises the midpoint potential of ISP from 290 mV to 540 mV. The binding of stigmatellin to the fully oxidized complex, oxidized completely by catalytic amounts of cytochrome c oxidase and cytochrome c, results in ISP reduction. The extent of ISP reduction is proportional to the amount of inhibitor used and reaches a maximum when the ratio of inhibitor to enzyme complex reaches unity. A g = 2.005 EPR peak, characteristic of an organic free radical, is also observed when stigmatellin is added to the oxidized complex, and its signal intensity depends on the amount of stigmatellin. Addition of ferricyanide, a strong oxidant, to the oxidized complex also generates a g = 2.005 EPR peak that is oxidant concentration-dependent. Oxygen radicals are generated when stigmatellin is added to the oxidized complex in the absence of the exogenous substrate, ubiquinol. The amount of oxygen radical formed is proportional to the amount of stigmatellin added. Oxygen radicals are not generated when stigmatellin is added to a mutant bc1 complex lacking the Rieske iron-sulfur cluster. Based on these results, it is proposed that ISP becomes a strong oxidant upon stigmatellin binding, extracting electrons from an organic compound, likely an amino acid residue. This results in the reduction of ISP and generation of organic radicals.	[Gurung, Buddha; Yu, Linda; Yu, Chang-An] Oklahoma State Univ, Dept Biochem & Mol Biol, Stillwater, OK 74078 USA	Oklahoma State University System; Oklahoma State University - Stillwater	Yu, CA (corresponding author), Oklahoma State Univ, Dept Biochem & Mol Biol, 255A NRC-D, Stillwater, OK 74078 USA.	cayuq@okstate.edu			National Institutes of Health [GM 30721]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM030721, R01GM030721] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM 30721 (to C.-A. Y.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	BARRY BA, 1987, P NATL ACAD SCI USA, V84, P7099, DOI 10.1073/pnas.84.20.7099; BERDEN JA, 1970, BIOCHIM BIOPHYS ACTA, V216, P237, DOI 10.1016/0005-2728(70)90215-X; Berry EA, 2000, ANNU REV BIOCHEM, V69, P1005, DOI 10.1146/annurev.biochem.69.1.1005; BOVERIS A, 1972, BIOCHEM J, V128, P617, DOI 10.1042/bj1280617; Brandt U, 1997, BIOCHEMISTRY-US, V36, P11234, DOI 10.1021/bi970968g; CADENAS E, 1977, ARCH BIOCHEM BIOPHYS, V180, P248, DOI 10.1016/0003-9861(77)90035-2; Chen YR, 2004, J BIOL CHEM, V279, P18054, DOI 10.1074/jbc.M307706200; Covian R, 2004, J BIOL CHEM, V279, P15040, DOI 10.1074/jbc.M400193200; Crofts AR, 2004, BBA-BIOENERGETICS, V1655, P77, DOI 10.1016/j.bbabio.2003.10.012; CROFTS AR, 1983, BIOCHIM BIOPHYS ACTA, V723, P202, DOI 10.1016/0005-2728(83)90120-2; Darrouzet E, 2000, P NATL ACAD SCI USA, V97, P4567, DOI 10.1073/pnas.97.9.4567; DEBUS RJ, 1988, P NATL ACAD SCI USA, V85, P427, DOI 10.1073/pnas.85.2.427; DENICOLA A, 1995, FREE RADICAL BIO MED, V19, P11, DOI 10.1016/0891-5849(94)00239-G; Esser L, 2004, J MOL BIOL, V341, P281, DOI 10.1016/j.jmb.2004.05.065; Gao XG, 2003, BIOCHEMISTRY-US, V42, P9067, DOI 10.1021/bi0341814; Ghosh M, 2001, BIOCHEMISTRY-US, V40, P327, DOI 10.1021/bi001708t; Gurung B, 2005, J BIOL CHEM, V280, P24895, DOI 10.1074/jbc.M503319200; Gutierrez-Cirlos EB, 2002, J BIOL CHEM, V277, P1195, DOI 10.1074/jbc.M109097200; Hunte C, 2000, STRUCTURE, V8, P669, DOI 10.1016/S0969-2126(00)00152-0; Hunte C, 2001, FEBS LETT, V504, P126, DOI 10.1016/S0014-5793(01)02744-2; Iwata S, 1998, SCIENCE, V281, P64, DOI 10.1126/science.281.5373.64; Junemann S, 1998, J BIOL CHEM, V273, P21603, DOI 10.1074/jbc.273.34.21603; KAGAWA Y, 1971, J BIOL CHEM, V246, P5477; Kim H, 1998, P NATL ACAD SCI USA, V95, P8026, DOI 10.1073/pnas.95.14.8026; Kurisu G, 2003, SCIENCE, V302, P1009, DOI 10.1126/science.1090165; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Link TA, 1997, FEBS LETT, V412, P257, DOI 10.1016/S0014-5793(97)00772-2; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MCCURLEY JP, 1990, BIOCHIM BIOPHYS ACTA, V1020, P176, DOI 10.1016/0005-2728(90)90049-A; MIKI T, 1992, ARCH BIOCHEM BIOPHYS, V293, P61, DOI 10.1016/0003-9861(92)90365-4; MITCHELL P, 1976, J THEOR BIOL, V62, P327, DOI 10.1016/0022-5193(76)90124-7; Nett JH, 2000, EUR J BIOCHEM, V267, P5777, DOI 10.1046/j.1432-1327.2000.01650.x; NOHL H, 1986, BIOCHEM BIOPH RES CO, V138, P533, DOI 10.1016/S0006-291X(86)80529-0; Obungu VH, 2000, BBA-BIOENERGETICS, V1457, P36, DOI 10.1016/S0005-2728(99)00116-4; ORMEJOHNSON NR, 1974, BIOCHEM BIOPH RES CO, V45, P871; Osyczka A, 2004, NATURE, V427, P607, DOI 10.1038/nature02242; PUMPHREY AM, 1960, BIOCHEM J, V76, P61, DOI 10.1042/bj0760061; Ritter M, 2004, BIOCHEMISTRY-US, V43, P8439, DOI 10.1021/bi049649x; Snyder CH, 1999, J BIOENERG BIOMEMBR, V31, P235, DOI 10.1023/A:1005419712731; Snyder CH, 2000, J BIOL CHEM, V275, P13535, DOI 10.1074/jbc.275.18.13535; Stroebel D, 2003, NATURE, V426, P413, DOI 10.1038/nature02155; THIERBACH G, 1984, BIOCHIM BIOPHYS ACTA, V765, P227, DOI 10.1016/0005-2728(84)90017-3; Tian H, 1999, J BIOL CHEM, V274, P7146, DOI 10.1074/jbc.274.11.7146; Tian H, 1998, J BIOL CHEM, V273, P27953, DOI 10.1074/jbc.273.43.27953; TRUMPOWER BL, 1994, ANNU REV BIOCHEM, V63, P675, DOI 10.1146/annurev.bi.63.070194.003331; TURRENS JF, 1980, BIOCHEM J, V191, P421, DOI 10.1042/bj1910421; TURRENS JF, 1985, ARCH BIOCHEM BIOPHYS, V237, P408, DOI 10.1016/0003-9861(85)90293-0; VONJAGOW G, 1985, FEBS LETT, V185, P311, DOI 10.1016/0014-5793(85)80929-7; Xia D, 1997, SCIENCE, V277, P60, DOI 10.1126/science.277.5322.60; Xiao KH, 2000, J BIOL CHEM, V275, P38597, DOI 10.1074/jbc.M007444200; YU CA, 1978, BIOCHEM BIOPH RES CO, V82, P1070, DOI 10.1016/0006-291X(78)90296-6; YU L, 1978, J BIOL CHEM, V253, P2657; YU L, 1986, BIOCHIM BIOPHYS ACTA, V852, P203, DOI 10.1016/0005-2728(86)90225-2; Zhang ZL, 1998, NATURE, V392, P677, DOI 10.1038/33612	54	13	13	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 17	2008	283	42					28087	28094		10.1074/jbc.M804229200	http://dx.doi.org/10.1074/jbc.M804229200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	359EN	18701458	Green Published, hybrid			2022-12-27	WOS:000259969300011
J	Tauxe, C; Xie, X; Joffraud, M; Martinez, M; Schapira, M; Spertini, O				Tauxe, Caroline; Xie, Xun; Joffraud, Magali; Martinez, Manuel; Schapira, Marc; Spertini, Olivier			P-selectin glycoprotein ligand-1 decameric repeats regulate selectin-dependent rolling under flow conditions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VWF TETHER BOND; IN-VIVO; LEUKOCYTE ADHESION; TYROSINE SULFATION; PLATELET-ADHESION; MOLECULAR-BASIS; CELL-ADHESION; CATCH BONDS; IB-ALPHA; PSGL-1	P-selectin glycoprotein ligand-1 ( PSGL-1) interacts with selectins to support leukocyte rolling along vascular wall. L-and P-selectin bind to N-terminal tyrosine sulfate residues and to core-2 O-glycans attached to Thr-57, whereas tyrosine sulfation is not required for E-selectin binding. PSGL-1 extracellular domain contains decameric repeats, which extend L-and P-selectin binding sites far above the plasma membrane. We hypothesized that decamers may play a role in regulating PSGL-1 interactions with selectins. Chinese hamster ovary cells expressing wild-type PSGL-1 or PSGL-1 molecules exhibiting deletion or substitution of decamers with the tandem repeats of platelet glycoprotein Ib alpha were compared in their ability to roll on selectins and to bind soluble L-or P-selectin. Deletion of decamers abrogated soluble L-selectin binding and cell rolling on L-selectin, whereas their substitution partially reversed these diminutions. P-selectin-dependent interactions with PSGL-1 were less affected by decamer deletion. Videomicroscopy analysis showed that decamers are required to stabilize L-selectin-dependent rolling. Importantly, adhesion assays performed on recombinant decamers demonstrated that they directly bind to E-selectin and promote slow rolling. Our results indicate that the role of decamers is to extend PSGL-1 N terminus far above the cell surface to support and stabilize leukocyte rolling on L-or P-selectin. In addition, they function as a cell adhesion receptor, which supports similar to 80% of E-selectin-dependent rolling.	[Tauxe, Caroline; Xie, Xun; Joffraud, Magali; Martinez, Manuel; Schapira, Marc; Spertini, Olivier] CHU Vaudois, Cent Hematol Lab, CH-1011 Lausanne, Switzerland	University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV)	Spertini, O (corresponding author), CHU Vaudois, Cent Hematol Lab, Rue Bugnon 46, CH-1011 Lausanne, Switzerland.	Olivier.Spertini@chuv.ch			Swiss National Foundation for Scientific Research [3200B0-105593]	Swiss National Foundation for Scientific Research(Swiss National Science Foundation (SNSF))	This work was supported by the Swiss National Foundation for Scientific Research (Grant 3200B0-105593). The authors have no conflict of interest disclosures. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked " advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Afshar-Kharghan V, 2001, BLOOD, V97, P3306, DOI 10.1182/blood.V97.10.3306; Baisse B, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-166; Bernimoulin MP, 2003, J BIOL CHEM, V278, P37, DOI 10.1074/jbc.M204360200; Bugert P, 2004, CLIN CHEM LAB MED, V42, P997, DOI 10.1515/CCLM.2004.202; Doggett TA, 2003, BLOOD, V102, P152, DOI 10.1182/blood-2003-01-0072; Doggett TA, 2002, BIOPHYS J, V83, P194, DOI 10.1016/S0006-3495(02)75161-8; Finger EB, 1996, NATURE, V379, P266, DOI 10.1038/379266a0; Fong AM, 2000, J BIOL CHEM, V275, P3781, DOI 10.1074/jbc.275.6.3781; Fukuda M, 1999, J CELL BIOL, V147, P467, DOI 10.1083/jcb.147.3.467; Goetz DJ, 1997, J CELL BIOL, V137, P509, DOI 10.1083/jcb.137.2.509; GOLDSTEIN JL, 1985, ANNU REV CELL BIOL, V1, P1, DOI 10.1146/annurev.cb.01.110185.000245; Hidalgo A, 2007, IMMUNITY, V26, P477, DOI 10.1016/j.immuni.2007.03.011; Lawrence MB, 1997, J CELL BIOL, V136, P717, DOI 10.1083/jcb.136.3.717; Leppanen A, 2003, J BIOL CHEM, V278, P26391, DOI 10.1074/jbc.M303551200; Leppanen A, 2000, J BIOL CHEM, V275, P39569, DOI 10.1074/jbc.M005005200; Ley K, 2003, TRENDS MOL MED, V9, P263, DOI 10.1016/S1471-4914(03)00071-6; LEY K, 1995, J EXP MED, V181, P669, DOI 10.1084/jem.181.2.669; Li FG, 1996, J BIOL CHEM, V271, P6342, DOI 10.1074/jbc.271.11.6342; Li FG, 1996, J BIOL CHEM, V271, P3255, DOI 10.1074/jbc.271.6.3255; Liu W, 1998, J BIOL CHEM, V273, P7078, DOI 10.1074/jbc.273.12.7078; LOPEZ JA, 1992, J BIOL CHEM, V267, P10055; Lowe JB, 2003, CURR OPIN CELL BIOL, V15, P531, DOI 10.1016/j.ceb.2003.08.002; Lozano ML, 2001, BRIT J HAEMATOL, V115, P969, DOI 10.1046/j.1365-2141.2001.03151.x; MARCHESE P, 1995, J BIOL CHEM, V270, P9571, DOI 10.1074/jbc.270.16.9571; Martinez M, 2005, J BIOL CHEM, V280, P5378, DOI 10.1074/jbc.M410899200; McEver RP, 2002, CURR OPIN CELL BIOL, V14, P581, DOI 10.1016/S0955-0674(02)00367-8; MOORE KL, 1992, J CELL BIOL, V118, P445, DOI 10.1083/jcb.118.2.445; NORMAN KE, 1995, BLOOD, V86, P4417, DOI 10.1182/blood.V86.12.4417.bloodjournal86124417; Norman KE, 2000, BLOOD, V96, P3585; Ozben B, 2007, J THROMB THROMBOLYS, V23, P181, DOI 10.1007/s11239-006-9020-9; POUYANI T, 1995, CELL, V83, P333, DOI 10.1016/0092-8674(95)90174-4; Ramachandran V, 1999, P NATL ACAD SCI USA, V96, P13771, DOI 10.1073/pnas.96.24.13771; Romo GM, 1999, J EXP MED, V190, P803, DOI 10.1084/jem.190.6.803; ROSEN SD, 1994, CURR OPIN CELL BIOL, V6, P663, DOI 10.1016/0955-0674(94)90092-2; SAKO D, 1993, CELL, V75, P1179, DOI 10.1016/0092-8674(93)90327-M; Sarangapani KK, 2004, J BIOL CHEM, V279, P2291, DOI 10.1074/jbc.M310396200; Somers WS, 2000, CELL, V103, P467, DOI 10.1016/S0092-8674(00)00138-0; Sperandio M, 2003, J EXP MED, V197, P1355, DOI 10.1084/jem.20021854; Spertini O, 1996, J CELL BIOL, V135, P523, DOI 10.1083/jcb.135.2.523; Tregouet DA, 2003, ANN HUM GENET, V67, P504, DOI 10.1046/j.1529-8817.2003.00053.x; Xie X, 2000, J BIOL CHEM, V275, P34818, DOI 10.1074/jbc.M001257200; Yago T, 2004, J CELL BIOL, V166, P913, DOI 10.1083/jcb.200403144; Zhu C, 2005, BIORHEOLOGY, V42, P443	43	11	12	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 17	2008	283	42					28536	28545		10.1074/jbc.M802865200	http://dx.doi.org/10.1074/jbc.M802865200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	359EN	18713749	Green Published, hybrid			2022-12-27	WOS:000259969300057
J	Schwarzer, C; Fu, Z; Fischer, H; Machen, TE				Schwarzer, Christian; Fu, Zhu; Fischer, Horst; Machen, Terry E.			Redox-independent activation of NF-kappa B by Pseudomonas aeruginosa pyocyanin in a cystic fibrosis airway epithelial cell line	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FLUORESCENT PROTEIN INDICATORS; TNF-ALPHA; EXPRESSION; FLAGELLIN; INHIBITION; RESPONSES; ACID; LOCALIZATION; INFLAMMATION; GLUTATHIONE	The roles of the Pseudomonas aeruginosa-derived pigment pyocyanin (PYO) as an oxidant and activator of the proinflammatory transcription factor NF-kappa B were tested in a cystic fibrosis (CF) airway epithelial cell line, CF15.100 mu M PYO on its own had no effect or only small effects to activate NF-kappa B (< 1.5-fold), but PYO synergized with the TLR5 agonist flagellin. Flagellin activated NF-kappa B 4-20-fold, and PYO increased these activations > 2.5- fold. PYO could have synergized with flagellin to activate NF-kappa B by redox cycling with NADPH, generating superoxide (O-2(.-).), hydrogen peroxide (H2O2), and hydroxyl radical (HO center dot). Cytosol-targeted, redox-sensitive roGFP1 and imaging microscopy showed that 1-100 mu M PYO oxidized CF15 cytosol redox potential (psi(cyto)) from -325mV(control) to -285 mV. O-2(.-) (derived from KO2.- or xanthine + xanthine oxidase) or H2O2 oxidized psi(cyto) dose-dependently but did not activate NF-kappa B, even in the presence of flagellin, and 400 mu M H2O2 inhibited NF-kappa B. Overexpressing intracellular catalase decreased effects of PYO and H2O2 on psi(cyto) but did not affect flagellin + PYO-activated NF-kappa B. Catalase also reversed the inhibitory effects of H2O2 on NF-kappa B. The HO center dot scavenger DMSO did not alter the effects of PYO on psi(cyto) and NF-kappa B. The synergistic NF-kappa B activation was calcium-independent. Thus, in the presence of flagellin, PYO activated NF-kappa B through a redox and calcium-independent effect.	[Schwarzer, Christian; Fu, Zhu; Machen, Terry E.] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Fischer, Horst] Childrens Hosp, Oakland Res Inst, Oakland, CA 94609 USA	University of California System; University of California Berkeley; Children's Hospital Los Angeles; Children's Hospital Oakland Research Institute	Machen, TE (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, 231 LSA, Berkeley, CA 94720 USA.	tmachen@berkeley.edu			National Institutes of Health [R01 DK51799]; Cystic Fibrosis Foundation [MACH03, MACH07, FISCHE07, SCHWA01]; Cystic Fibrosis Research Inc., and the Hawn Fund; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK051799] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cystic Fibrosis Foundation(Italian Cystic Fibrosis Research Foundation); Cystic Fibrosis Research Inc., and the Hawn Fund; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 DK51799. This work was also supported by Cystic Fibrosis Foundation Grants MACH03, MACH07, FISCHE07, and SCHWA01, Cystic Fibrosis Research Inc., and the Hawn Fund (University of California, Berkeley). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Akira S, 2001, ADV IMMUNOL, V78, P1, DOI 10.1016/S0065-2776(01)78001-7; Cao H, 2001, P NATL ACAD SCI USA, V98, P14613, DOI 10.1073/pnas.251465298; de Oliveira-Marques V, 2007, J IMMUNOL, V178, P3893, DOI 10.4049/jimmunol.178.6.3893; Denning GM, 1998, INFECT IMMUN, V66, P5777, DOI 10.1128/IAI.66.12.5777-5784.1998; Denning GM, 1998, AM J PHYSIOL-LUNG C, V274, pL893, DOI 10.1152/ajplung.1998.274.6.L893; Dooley CT, 2004, J BIOL CHEM, V279, P22284, DOI 10.1074/jbc.M312847200; Flohe L, 1997, FREE RADICAL BIO MED, V22, P1115, DOI 10.1016/S0891-5849(96)00501-1; Fu Z, 2007, AM J PHYSIOL-LUNG C, V292, pL353, DOI 10.1152/ajplung.00042.2006; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Hanson GT, 2004, J BIOL CHEM, V279, P13044, DOI 10.1074/jbc.M312846200; Hayakawa M, 2003, EMBO J, V22, P3356, DOI 10.1093/emboj/cdg332; Hughes G, 2005, BIOCHEM J, V389, P83, DOI 10.1042/bj20050078; Hybiske K, 2004, CELL MICROBIOL, V6, P49, DOI 10.1046/j.1462-5822.2003.00342.x; Jacob T, 2002, INFECT IMMUN, V70, P6399, DOI 10.1128/IAI.70.11.6399-6408.2002; JEFFERSON DM, 1990, AM J PHYSIOL, V259, pL496, DOI 10.1152/ajplung.1990.259.6.L496; Kaileh M, 2007, J BIOL CHEM, V282, P4253, DOI 10.1074/jbc.M606728200; Kong FS, 2006, CELL MICROBIOL, V8, P1121, DOI 10.1111/j.1462-5822.2006.00696.x; Lau GW, 2004, INFECT IMMUN, V72, P4275, DOI 10.1128/IAI.72.7.4275-4278.2004; Look DC, 2005, J IMMUNOL, V175, P4017, DOI 10.4049/jimmunol.175.6.4017; Lyczak JB, 2002, CLIN MICROBIOL REV, V15, P194, DOI 10.1128/CMR.15.2.194-222.2002; Mahajan-Miklos S, 1999, CELL, V96, P47, DOI 10.1016/S0092-8674(00)80958-7; Mavrodi DV, 2001, J BACTERIOL, V183, P6454, DOI 10.1128/JB.183.21.6454-6465.2001; Muller M, 2002, FREE RADICAL BIO MED, V33, P1527, DOI 10.1016/S0891-5849(02)01087-0; Na HJ, 2006, INT IMMUNOPHARMACOL, V6, P1597, DOI 10.1016/j.intimp.2006.06.004; O'Malley YQ, 2004, FREE RADICAL BIO MED, V36, P90, DOI 10.1016/j.freeradbiomed.2003.09.021; O'Malley YQ, 2004, AM J PHYSIOL-LUNG C, V287, pL94, DOI 10.1152/ajplung.00025.2004; O'Malley YQ, 2003, AM J PHYSIOL-LUNG C, V284, pL420, DOI 10.1152/ajplung.00316.2002; O'Malley YXQ, 2003, AM J PHYSIOL-LUNG C, V285, pL1077, DOI 10.1152/ajplung.00198.2003; Olson JC, 1999, INFECT IMMUN, V67, P2847, DOI 10.1128/IAI.67.6.2847-2854.1999; Pahl HL, 1997, TRENDS BIOCHEM SCI, V22, P63, DOI 10.1016/S0968-0004(96)10073-6; Pan NY, 2006, RESP MED, V100, P1614, DOI 10.1016/j.rmed.2005.12.003; Pederson KJ, 1999, MOL MICROBIOL, V32, P393, DOI 10.1046/j.1365-2958.1999.01359.x; Ran HM, 2003, P NATL ACAD SCI USA, V100, P14315, DOI 10.1073/pnas.2332354100; Reszka KJ, 2004, FREE RADICAL BIO MED, V36, P1448, DOI 10.1016/j.freeradbiomed.2004.03.011; Sandur SK, 2007, CARCINOGENESIS, V28, P1765, DOI 10.1093/carcin/bgm123; Sanlioglu S, 2001, J BIOL CHEM, V276, P30188, DOI 10.1074/jbc.M102061200; Sato H, 2004, MOL MICROBIOL, V53, P1279, DOI 10.1111/j.1365-2958.2004.04194.x; SCHRECK R, 1991, EMBO J, V10, P2247, DOI 10.1002/j.1460-2075.1991.tb07761.x; Schwarzer C, 2007, FREE RADICAL BIO MED, V43, P300, DOI 10.1016/j.freeradbiomed.2007.04.015; Tseng J, 2006, AM J PHYSIOL-CELL PH, V290, pC678, DOI 10.1152/ajpcell.00166.2005; WASIL M, 1987, BIOCHEM J, V243, P867, DOI 10.1042/bj2430867; WILSON R, 1987, J CLIN INVEST, V79, P221, DOI 10.1172/JCI112787; WILSON R, 1988, INFECT IMMUN, V56, P2515, DOI 10.1128/IAI.56.9.2515-2517.1988; Zhang Z, 2005, INFECT IMMUN, V73, P7151, DOI 10.1128/IAI.73.11.7151-7160.2005	44	17	18	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 3	2008	283	40					27144	27153		10.1074/jbc.M709693200	http://dx.doi.org/10.1074/jbc.M709693200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	353RT	18682396	Green Published, hybrid			2022-12-27	WOS:000259586600035
J	Demene, H; Ducat, T; De Guillen, K; Birck, C; Aymerich, S; Kochoyan, M; Declerck, N				Demene, Helene; Ducat, Thierry; De Guillen, Karine; Birck, Catherine; Aymerich, Stephane; Kochoyan, Michel; Declerck, Nathalie			Structural Mechanism of Signal Transduction between the RNA-binding Domain and the Phosphotransferase System Regulation Domain of the LicT Antiterminator	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CIRCULAR-DICHROISM; BACILLUS-SUBTILIS; TRANSCRIPTIONAL ANTITERMINATOR; SECONDARY STRUCTURE; RESPONSE REGULATOR; SPECIFICITY DETERMINANTS; CATABOLITE REPRESSION; BACKBONE DYNAMICS; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI	LicT belongs to a family of bacterial transcriptional antiterminators, which control the expression of sugar-metabolizing operons in response to phosphorylations by the phosphoenolpyruvate: sugar phosphotransferase system (PTS). Previous studies of LicT have revealed the structural basis of RNA recognition by the dimeric N-terminal co-antiterminator (CAT) domain on the one hand and the conformational changes undergone by the duplicated regulation domain (PRD1 and PRD2) upon activation on the other hand. To investigate the mechanism of signal transduction between the effector and regulation modules, we have undertaken the characterization of a fragment, including the CAT and PRD1 domains and the linker in-between. Comparative experiments, including RNA binding assays, NMR spectroscopy, limited proteolysis, analytical ultracentrifugation, and circular dichroism, were conducted on native CAT-PRD1 and on a constitutively active CAT-PRD1 mutant carrying a D99N substitution in PRD1. We show that in the native state, CAT-PRD1 behaves as a rather unstable RNA-binding deficient dimer, in which the CAT dimer interface is significantly altered and the linker region is folded as a trypsin-resistant helix. In the activated mutant form, the CAT-PRD1 linker becomes protease-sensitive, and the helix content decreases, and the CAT module adopts the same dimeric conformation as in isolated CAT, thereby restoring the affinity for RNA. From these results, we propose that a helix-to-coil transition in the linker acts as the structural relay triggered by the regulatory domain for remodeling the effector dimer interface. In essence, the structural mechanism modulating the LicT RNA antitermination activity is thus similar to that controlling the DNA binding activity of dimeric transcriptional regulators.	[Demene, Helene; Ducat, Thierry; De Guillen, Karine; Kochoyan, Michel; Declerck, Nathalie] Univ Montpellier I, Ctr Biochim Struct, F-34090 Montpellier, France; [Demene, Helene; Ducat, Thierry; De Guillen, Karine; Kochoyan, Michel; Declerck, Nathalie] Univ Montpellier 2, Ctr Biochim Struct, F-34090 Montpellier, France; [Demene, Helene; Ducat, Thierry; De Guillen, Karine; Kochoyan, Michel; Declerck, Nathalie] INSERM, U554, F-34090 Montpellier, France; [Demene, Helene; Ducat, Thierry; De Guillen, Karine; Kochoyan, Michel; Declerck, Nathalie] CNRS, UMR 5048, F-34090 Montpellier, France; [Birck, Catherine] Univ Strasbourg 1, Dept Biol & Genet Struct, Inst Genet & Biol Mol & Cellulaire, F-67404 Illkirch Cu Strasbourg, France; [Birck, Catherine] INSERM, U596, F-67404 Illkirch Cu Strasbourg, France; [Aymerich, Stephane] INRA, UMR1238, F-78850 Thiverval Grignon, France; [Aymerich, Stephane] CNRS, UMR2585, F-78850 Thiverval Grignon, France; [Aymerich, Stephane] AgroParisTech, F-78850 Thiverval Grignon, France; [Birck, Catherine] CNRS, UMR 7104, F-67404 Illkirch Cu Strasbourg, France	Universite de Montpellier; Universite de Montpellier; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Montpellier; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Institut National de la Sante et de la Recherche Medicale (Inserm); INRAE; UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); AgroParisTech; UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB)	Demene, H (corresponding author), Univ Montpellier I, Ctr Biochim Struct, 29 Rue Navacelles, F-34090 Montpellier, France.	helene.demene@cbs.cnrs.fr	Déméné, Hélène/AAZ-1691-2021	Déméné, Hélène/0000-0002-7531-4309; de Guillen, Karine/0000-0002-5037-2115; Declerck, Nathalie/0000-0003-1551-1607				ANDRADE MA, 1993, PROTEIN ENG, V6, P383, DOI 10.1093/protein/6.4.383; Antson AA, 1999, NATURE, V401, P235, DOI 10.1038/45730; AYMERICH S, 1992, P NATL ACAD SCI USA, V89, P10410, DOI 10.1073/pnas.89.21.10410; Beglova N, 2001, BIOCHEMISTRY-US, V40, P2808, DOI 10.1021/bi0027276; Ben-Zeev E, 2005, J MOL BIOL, V347, P693, DOI 10.1016/j.jmb.2005.01.068; Christen S, 2006, J BIOL CHEM, V281, P23129, DOI 10.1074/jbc.M603486200; Declerck N, 2001, J MOL BIOL, V314, P671, DOI 10.1006/jmbi.2001.5185; Declerck N, 1999, J MOL BIOL, V294, P389, DOI 10.1006/jmbi.1999.3256; Deutscher J, 2006, MICROBIOL MOL BIOL R, V70, P939, DOI 10.1128/MMBR.00024-06; Dosset P, 2000, J BIOMOL NMR, V16, P23, DOI 10.1023/A:1008305808620; Dosset P, 2001, J BIOMOL NMR, V20, P223, DOI 10.1023/A:1011206132740; Ducat T, 2002, J BIOMOL NMR, V23, P325, DOI 10.1023/A:1020264611438; Farmer BT, 1996, NAT STRUCT BIOL, V3, P995, DOI 10.1038/nsb1296-995; FARROW NA, 1994, BIOCHEMISTRY-US, V33, P5984, DOI 10.1021/bi00185a040; Graille M, 2005, J BIOL CHEM, V280, P14780, DOI 10.1074/jbc.M414642200; Huffman JL, 2002, CURR OPIN STRUC BIOL, V12, P98, DOI 10.1016/S0959-440X(02)00295-6; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; Kumarevel T, 2005, NATURE, V434, P183, DOI 10.1038/nature03355; Lindner C, 2002, J BACTERIOL, V184, P4819, DOI 10.1128/JB.184.17.4819-4828.2002; Lindner C, 1999, MOL MICROBIOL, V31, P995, DOI 10.1046/j.1365-2958.1999.01262.x; MAHADEVAN S, 1987, CELL, V50, P485, DOI 10.1016/0092-8674(87)90502-2; Manival X, 1997, EMBO J, V16, P5019, DOI 10.1093/emboj/16.16.5019; McElroy C, 2002, J MOL BIOL, V323, P463, DOI 10.1016/S0022-2836(02)00940-3; McGuffin LJ, 2000, BIOINFORMATICS, V16, P404, DOI 10.1093/bioinformatics/16.4.404; Miles AJ, 2005, PROTEIN SCI, V14, P368, DOI 10.1110/ps.041019905; MINTON AP, 1994, CONSERVATION SIGNAL; MUCHMORE DC, 1989, METHOD ENZYMOL, V177, P44; Nowak E, 2006, J BIOL CHEM, V281, P9659, DOI 10.1074/jbc.M512004200; PERCZEL A, 1992, ANAL BIOCHEM, V203, P83, DOI 10.1016/0003-2697(92)90046-A; Perron-Savard P, 2005, MICROBIOL-SGM, V151, P3979, DOI 10.1099/mic.0.28236-0; Pons JL, 1996, J BIOMOL NMR, V8, P445, DOI 10.1007/BF00228146; POSTMA PW, 1993, MICROBIOL REV, V57, P543, DOI 10.1128/MMBR.57.3.543-594.1993; Rhee JE, 2008, J BIOL CHEM, V283, P8664, DOI 10.1074/jbc.M705550200; ROYER CA, 1992, METHOD ENZYMOL, V210, P481; Ruckert M, 2000, J AM CHEM SOC, V122, P7793, DOI 10.1021/ja001068h; Schilling O, 2006, NUCLEIC ACIDS RES, V34, P6102, DOI 10.1093/nar/gkl733; Schnetz K, 1996, J BACTERIOL, V178, P1971, DOI 10.1128/jb.178.7.1971-1979.1996; Schumacher MA, 2002, EMBO J, V21, P1210, DOI 10.1093/emboj/21.5.1210; Spitzfaden C, 1997, J MOL BIOL, V265, P565, DOI 10.1006/jmbi.1996.0736; Sreerama N, 1999, PROTEIN SCI, V8, P370; STEVENS FJ, 1980, P NATL ACAD SCI-BIOL, V77, P1144, DOI 10.1073/pnas.77.2.1144; Stulke J, 1998, MOL MICROBIOL, V28, P865, DOI 10.1046/j.1365-2958.1998.00839.x; Tortosa P, 2001, MOL MICROBIOL, V41, P1381, DOI 10.1046/j.1365-2958.2001.02608.x; van Tilbeurgh H, 2001, EMBO J, V20, P3789, DOI 10.1093/emboj/20.14.3789; vanTilbeurgh H, 1997, EMBO J, V16, P5030, DOI 10.1093/emboj/16.16.5030; Vistica J, 2004, ANAL BIOCHEM, V326, P234, DOI 10.1016/j.ab.2003.12.014; WISHART DS, 1992, BIOCHEMISTRY-US, V31, P1647, DOI 10.1021/bi00121a010; YANG JT, 1986, METHOD ENZYMOL, V130, P208; Yang YS, 2002, EMBO J, V21, P1987, DOI 10.1093/emboj/21.8.1987; Zweckstetter M, 2008, NAT PROTOC, V3, P679, DOI 10.1038/nprot.2008.36	50	15	15	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 7	2008	283	45					30838	30849		10.1074/jbc.M805955200	http://dx.doi.org/10.1074/jbc.M805955200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	367ID	18682383	Green Published, hybrid			2022-12-27	WOS:000260544800039
J	Elorza, A; Hyde, B; Mikkola, HK; Collins, S; Shirihai, OS				Elorza, Alvaro; Hyde, Brigham; Mikkola, Hanna K.; Collins, Sheila; Shirihai, Orian S.			UCP2 Modulates Cell Proliferation through the MAPK/ERK Pathway during Erythropoiesis and Has No Effect on Heme Biosynthesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MITOCHONDRIAL UNCOUPLING PROTEIN-2; OXIDATIVE STRESS; REACTIVE OXYGEN; ERYTHROID-DIFFERENTIATION; SUPEROXIDE-DISMUTASE; INSULIN-SECRETION; SIGNALING PATHWAYS; PROGENITOR CELLS; BETA-CELLS; LIFE-SPAN	UCP2, an inner membrane mitochondrial protein, has been implicated in bioenergetics and reactive oxygen species (ROS) modulation. High levels of UCP2 mRNA were recently found in erythroid cells where UCP2 is hypothesized to function as a facilitator of heme synthesis and iron metabolism by reducing ROS production. We examined UCP2 protein expression and role in mice erythropoiesis in vivo. UCP2 was mainly expressed at early stages of erythroid maturation when cells are not fully committed in heme synthesis. Iron incorporation into heme was unaltered in reticulocytes from UCP2-deficient mice. Although heme synthesis was not influenced by UCP2 deficiency, mice lacking UCP2 had a delayed recovery from chemically induced hemolytic anemia. Analysis of progenitor cells from bone marrow and fetal liver both in vitro and in vivo revealed that UCP2 deficiency results in a significant decrease in cell proliferation at the erythropoietin-dependent phase of erythropoiesis. This was accompanied by reduction in the phosphorylated form of ERK, a ROS-dependent cytosolic regulator of cell proliferation. Analysis of ROS in UCP2 null erythroid cells revealed altered distribution of ROS, resulting in decreased cytosolic and increased mitochondrial ROS. Restoration of the cytosol oxidative state of erythroid progenitor cells by the pro-oxidant Paraquat reversed the effect of UCP2 deficiency on cell proliferation in in vitro differentiation assays. Together, these results indicate that UCP2 is a regulator of erythropoiesis and suggests that inhibition of UCP2 function may contribute to the development of anemia.	[Elorza, Alvaro; Hyde, Brigham; Shirihai, Orian S.] Boston Univ, Evans Biomed Res Ctr, Boston, MA 02118 USA; [Elorza, Alvaro; Hyde, Brigham; Shirihai, Orian S.] Tufts Univ, Sch Med, Dept Pharmacol & Expt Therapeut, Boston, MA 02111 USA; [Mikkola, Hanna K.] Univ Calif Los Angeles, Dept Mol Cell & Dev Biol, Los Angeles, CA 90095 USA; [Mikkola, Hanna K.; Collins, Sheila] Hamner Inst Hlth Sci, Res Triangle Pk, NC 27709 USA	Boston University; Tufts University; University of California System; University of California Los Angeles; The Hamner Institutes for Health Sciences	Shirihai, OS (corresponding author), Boston Univ, Evans Biomed Res Ctr, 650 Albany St, Boston, MA 02118 USA.	Shirihai@bu.edu		Shirihai, Orian/0000-0002-9502-2661; Elorza, Alvaro A./0000-0003-1570-9832	National Institutes of Health [1-R01-DK-074778-01, 5-R01-HL-071629-03, R01-DK-54024]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL071629] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK054024, R01DK074778] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants 1-R01-DK-074778-01 and 5-R01-HL-071629-03. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.; Supported by National Institutes of Health Grant 5-R01-HL-071629-03.; Supported by National Institutes of Health Grant R01-DK-54024.	Arsenijevic D, 2000, NAT GENET, V26, P435, DOI 10.1038/82565; BAAS AS, 1995, CIRC RES, V77, P29, DOI 10.1161/01.RES.77.1.29; Bai Y, 2005, J BIOL CHEM, V280, P19062, DOI 10.1074/jbc.M500566200; Beauchemin H, 2004, J BIOL CHEM, V279, P19471, DOI 10.1074/jbc.M309989200; Blanc J, 2003, CIRCULATION, V107, P388, DOI 10.1161/01.CIR.0000051722.66074.60; Brand MD, 2004, FREE RADICAL BIO MED, V37, P755, DOI 10.1016/j.freeradbiomed.2004.05.034; Bugarski D, 2007, EXP BIOL MED, V232, P156; Cakir Y, 2005, ANTIOXID REDOX SIGN, V7, P726, DOI 10.1089/ars.2005.7.726; Chen JJ, 2007, BLOOD, V109, P2693, DOI 10.1182/blood-2006-08-041830; Conti B, 2005, J NEUROCHEM, V93, P493, DOI 10.1111/j.1471-4159.2005.03052.x; Craven SE, 2005, BLOOD, V105, P3528, DOI 10.1182/blood-2004-03-1089; DE BF, 2004, J NEUROCHEM, V89, P1283; Echtay KS, 2002, J BIOL CHEM, V277, P47129, DOI 10.1074/jbc.M208262200; Emre Y, 2007, BIOCHEM J, V402, P271, DOI 10.1042/BJ20061430; Esteves TC, 2005, BBA-BIOENERGETICS, V1709, P35, DOI 10.1016/j.bbabio.2005.06.002; Flachs P, 2007, FEBS LETT, V581, P1093, DOI 10.1016/j.febslet.2007.02.012; Fleury C, 1997, NAT GENET, V15, P269, DOI 10.1038/ng0397-269; Fontenay M, 2006, ONCOGENE, V25, P4757, DOI 10.1038/sj.onc.1209606; Fridell YWC, 2005, CELL METAB, V1, P145, DOI 10.1016/j.cmet.2005.01.005; Friedman JS, 2004, BLOOD, V104, P2565, DOI 10.1182/blood-2003-11-3858; Friedman JS, 2001, J EXP MED, V193, P925, DOI 10.1084/jem.193.8.925; Greenberg Peter L, 2002, Hematology Am Soc Hematol Educ Program, P136; Gregory T, 1999, BLOOD, V94, P87, DOI 10.1182/blood.V94.1.87.413k41_87_96; Iiyama M, 2006, CELL SIGNAL, V18, P174, DOI 10.1016/j.cellsig.2005.04.002; Kefaloyianni E, 2006, CELL SIGNAL, V18, P2238, DOI 10.1016/j.cellsig.2006.05.004; Khanna R, 2002, P NATL ACAD SCI USA, V99, P6637, DOI 10.1073/pnas.052155999; KOURY MJ, 1988, J CELL PHYSIOL, V137, P65, DOI 10.1002/jcp.1041370108; Krauss S, 2005, NAT REV MOL CELL BIO, V6, P248, DOI 10.1038/nrm1592; Lebovitz RM, 1996, P NATL ACAD SCI USA, V93, P9782, DOI 10.1073/pnas.93.18.9782; Lee TH, 2003, BLOOD, V101, P5033, DOI 10.1182/blood-2002-08-2548; Li LX, 2001, BIOCHEM BIOPH RES CO, V282, P273, DOI 10.1006/bbrc.2001.4577; LI YB, 1995, NAT GENET, V11, P376, DOI 10.1038/ng1295-376; Martin FM, 2006, ANTIOXID REDOX SIGN, V8, P1217, DOI 10.1089/ars.2006.8.1217; MARTINEZ.J, 1972, BIOCHIM BIOPHYS ACTA, V264, P272, DOI 10.1016/0304-4165(72)90291-7; Mattiasson G, 2003, NAT MED, V9, P1062, DOI 10.1038/nm903; MUTA K, 1995, BLOOD, V86, P572, DOI 10.1182/blood.V86.2.572.bloodjournal862572; NAGRESALVAYRE A, 1997, FASEB J, V11, P809; Nicholls DG, 2006, BBA-BIOENERGETICS, V1757, P459, DOI 10.1016/j.bbabio.2006.02.005; Nishio K, 2005, J MOL HISTOL, V36, P35, DOI 10.1007/s10735-004-2915-x; Paradis E, 2003, TRENDS MOL MED, V9, P522, DOI 10.1016/j.molmed.2003.10.009; Pecqueur C, 2001, J MOL MED, V79, P48, DOI 10.1007/s001090000150; Pecqueur C, 2001, J BIOL CHEM, V276, P8705, DOI 10.1074/jbc.M006938200; Pecqueur C, 2008, FASEB J, V22, P9, DOI 10.1096/fj.07-8945com; Polonsky KS, 2001, CELL, V105, P705, DOI 10.1016/S0092-8674(01)00389-0; Richard D, 2001, BIOCHEM SOC T, V29, P812, DOI 10.1042/BST0290812; Ricquier D., 2000, INT J OBES RELAT S2, V24, P86; Rooke HM, 2006, BLOOD, V107, P3527, DOI 10.1182/blood-2005-10-4309; Rossi R, 2006, BLOOD CELL MOL DIS, V37, P180, DOI 10.1016/j.bcmd.2006.09.003; Rubiolo C, 2006, BLOOD, V108, P152, DOI 10.1182/blood-2005-09-3866; Ryter SW, 2000, FREE RADICAL BIO MED, V28, P289, DOI 10.1016/S0891-5849(99)00223-3; Sattler M, 1999, BLOOD, V93, P2928; Sears RC, 2002, J BIOL CHEM, V277, P11617, DOI 10.1074/jbc.R100063200; Shirihai OS, 2000, EMBO J, V19, P2492, DOI 10.1093/emboj/19.11.2492; Sluse FE, 2006, BBA-BIOENERGETICS, V1757, P480, DOI 10.1016/j.bbabio.2006.02.004; Socolovsky M, 2001, BLOOD, V98, P3261, DOI 10.1182/blood.V98.12.3261; Suh YH, 2004, J ENDOCRINOL, V183, P133, DOI 10.1677/joe.1.05675; Teshima Y, 2003, CIRC RES, V93, P192, DOI 10.1161/01.RES.0000085581.60197.4D; Thakur V, 2006, J LEUKOCYTE BIOL, V79, P1348, DOI 10.1189/jlb.1005613; VESGUERRA MC, 2003, J BIOL CHEM, V278, P42307; WU H, 1995, NATURE, V377, P242, DOI 10.1038/377242a0; Zhang AS, 2005, BLOOD, V105, P368, DOI 10.1182/blood-2004-06-2226; Zhang CY, 2001, CELL, V105, P745, DOI 10.1016/S0092-8674(01)00378-6; Zhang J, 2004, BLOOD, V104, P1679, DOI 10.1182/blood-2004-04-1362; Zhang J, 2003, BLOOD, V102, P3938, DOI 10.1182/blood-2003-05-1479	64	28	28	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 7	2008	283	45					30461	30470		10.1074/jbc.M805400200	http://dx.doi.org/10.1074/jbc.M805400200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	367ID	18687678	Green Published, hybrid			2022-12-27	WOS:000260544800004
J	Lee, WC; Reniere, ML; Skaar, EP; Murphy, MEP				Lee, Woo Cheol; Reniere, Michelle L.; Skaar, Eric P.; Murphy, Michael E. P.			Ruffling of Metalloporphyrins Bound to IsdG and IsdI, Two Heme-degrading Enzymes in Staphylococcus aureus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEISSERIA-MENINGITIDIS; CRYSTAL-STRUCTURES; IRON; OXYGENASE; BINDING; PROTEIN; METABOLISM; MECHANISM; PROGRAM	IsdG and IsdI are paralogous proteins that are intracellular components of a complex heme uptake system in Staphylococcus aureus. IsdG and IsdI were shown previously to reductively degrade hemin. Crystal structures of the apoproteins show that these proteins belong to a newly identified heme degradation family distinct from canonical eukaryotic and prokaryotic heme oxygenases. Here we report the crystal structures of an inactive N7A variant of IsdG in complex with Fe3+ -protoporphyrin IX (IsdG-hemin) and of IsdI in complex with cobalt protoporphyrin IX (IsdI-CoPPIX) to 1.8 angstrom or better resolution. These structures show that the metalloporphyrins are buried into similar deep clefts such that the propionic acids form salt bridges to two Arg residues. His(77) (IsdG) or His(76) (IsdI), a critical residue required for activity, is coordinated to the Fe3+ or Co3+ atoms, respectively. The bound porphyrin rings form extensive steric interactions in the binding cleft such that the rings are highly distorted from the plane. This distortion is best described as ruffled and places the beta- and delta-meso carbons proximal to the distal oxygen-binding site. In the IsdG-hemin structure, Fe3+ is pentacoordinate, and the distal side is occluded by the side chain of Ile(55). However, in the structure of IsdI-CoPPIX, the distal side of the CoPPIX accommodates a chloride ion in a cavity formed through a conformational change in Ile(55). The chloride ion participates in a hydrogen bond to the side chain amide of Asn(6). Together the structures suggest a reaction mechanism in which a reactive peroxide intermediate proceeds with nucleophilic oxidation at the beta- or delta- meso carbon of the hemin.	[Lee, Woo Cheol; Murphy, Michael E. P.] Univ British Columbia, Dept Microbiol & Immunol, Inst Life Sci, Vancouver, BC V6T 1Z3, Canada; [Reniere, Michelle L.; Skaar, Eric P.] Vanderbilt Univ, Med Ctr, Dept Microbiol & Immunol, Nashville, TN 37232 USA	University of British Columbia; Vanderbilt University	Murphy, MEP (corresponding author), Univ British Columbia, Dept Microbiol & Immunol, Inst Life Sci, Vancouver, BC V6T 1Z3, Canada.	Michael.Murphy@ubc.ca	Murphy, Michael/R-6805-2017	Murphy, Michael/0000-0003-2589-0014; Reniere, Michelle/0000-0002-0770-7784	National Institutes of Health [Al69233, 5 T32 HL07751]; Canadian Institutes of Health Research Operating [MOP-49597]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007751] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI069233] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institutes of Health Research Operating(Canadian Institutes of Health Research (CIHR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant Al69233 (USPHS from NIAID) (to E. P. S.) and Grant 5 T32 HL07751 (training grant) (to M. L. R.). This work was also supported by Canadian Institutes of Health Research Operating Grant MOP-49597 (to M. E. P. M.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked " advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Andreeva A, 2004, NUCLEIC ACIDS RES, V32, pD226, DOI 10.1093/nar/gkh039; Binkowski TA, 2003, NUCLEIC ACIDS RES, V31, P3352, DOI 10.1093/nar/gkg512; Bozja J, 2004, INT J ANTIMICROB AG, V24, P578, DOI 10.1016/j.ijantimicag.2004.06.008; BRANTLEY RE, 1993, J BIOL CHEM, V268, P6995; Brucker EA, 1996, J BIOL CHEM, V271, P25419, DOI 10.1074/jbc.271.41.25419; Chan ACK, 2006, J MOL BIOL, V362, P1108, DOI 10.1016/j.jmb.2006.08.001; *COLL COMP PROJ 4, 1995, ACTA CRYSTALLOGR D, V50, P760; DeLano W.L, PYMOL MOL GRAPHICS S; Friedman J, 2003, J BIOL CHEM, V278, P34654, DOI 10.1074/jbc.M302985200; Friedman J, 2007, J BIOL CHEM, V282, P1066, DOI 10.1074/jbc.M609112200; Grigg JC, 2007, J BIOL CHEM, V282, P28815, DOI 10.1074/jbc.M704602200; Grigg JC, 2007, MOL MICROBIOL, V63, P139, DOI 10.1111/j.1365-2958.2006.05502.x; Jentzen W, 1998, BIOPHYS J, V74, P753, DOI 10.1016/S0006-3495(98)74000-7; Jentzen W, 1997, J PHYS CHEM B, V101, P1684, DOI 10.1021/jp963142h; LEE B, 1971, J MOL BIOL, V55, P379, DOI 10.1016/0022-2836(71)90324-X; Ma JG, 1998, BIOCHEMISTRY-US, V37, P12431, DOI 10.1021/bi981189i; Mack J, 2004, BIOCHEM BIOPH RES CO, V320, P781, DOI 10.1016/j.bbrc.2004.06.025; Mazmanian SK, 2003, SCIENCE, V299, P906, DOI 10.1126/science.1081147; McRee DE, 1999, J STRUCT BIOL, V125, P156, DOI 10.1006/jsbi.1999.4094; Murphy ER, 2002, INFECT IMMUN, V70, P5390, DOI 10.1128/IAI.70.10.5390-5403.2002; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Pellicena P, 2004, P NATL ACAD SCI USA, V101, P12854, DOI 10.1073/pnas.0405188101; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; Puri S, 2006, J BACTERIOL, V188, P6476, DOI 10.1128/JB.00737-06; Radtke AL, 2006, CELL MICROBIOL, V8, P1720, DOI 10.1111/j.1462-5822.2006.00795.x; Ratledge C, 2000, ANNU REV MICROBIOL, V54, P881, DOI 10.1146/annurev.micro.54.1.881; Reniere ML, 2007, BIOMETALS, V20, P333, DOI 10.1007/s10534-006-9032-0; Roeser D, 2006, P NATL ACAD SCI USA, V103, P81, DOI 10.1073/pnas.0507592102; Sciara G, 2003, EMBO J, V22, P205, DOI 10.1093/emboj/cdg031; Shokhireva TK, 2003, P NATL ACAD SCI USA, V100, P3778, DOI 10.1073/pnas.0536641100; Skaar EP, 2004, MICROBES INFECT, V6, P390, DOI 10.1016/j.micinf.2003.12.008; Skaar EP, 2004, SCIENCE, V305, P1626, DOI 10.1126/science.1099930; Skaar EP, 2004, J BIOL CHEM, V279, P436, DOI 10.1074/jbc.M307952200; Skaar EP, 2006, J BACTERIOL, V188, P1071, DOI 10.1128/JB.188.3.1071-1080.2006; Sono M, 1996, CHEM REV, V96, P2841, DOI 10.1021/cr9500500; Stojiljkovic I, 2002, DNA CELL BIOL, V21, P281, DOI 10.1089/104454902753759708; STOJILJKOVIC I, 1995, MOL MICROBIOL, V15, P531, DOI 10.1111/j.1365-2958.1995.tb02266.x; Stojiljkovic I, 1999, MOL MICROBIOL, V31, P429, DOI 10.1046/j.1365-2958.1999.01175.x; Suits MDL, 2006, J BIOL CHEM, V281, P36776, DOI 10.1074/jbc.M607684200; Unno M, 2004, J BIOL CHEM, V279, P21055, DOI 10.1074/jbc.M400491200; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Vermeiren CL, 2006, BIOCHEMISTRY-US, V45, P12867, DOI 10.1021/bi0607711; Wandersman C, 2004, ANNU REV MICROBIOL, V58, P611, DOI 10.1146/annurev.micro.58.030603.123811; Weems JJ, 2001, POSTGRAD MED, V110, P24, DOI 10.3810/pgm.2001.10.1042; Wegele R, 2004, J BIOL CHEM, V279, P45791, DOI 10.1074/jbc.M408303200; WILKS A, 1993, J BIOL CHEM, V268, P22357; Wu RY, 2005, J BIOL CHEM, V280, P2840, DOI 10.1074/jbc.M409526200; Zeller John L, 2007, JAMA, V298, P1826, DOI 10.1001/jama.298.15.1826	48	89	92	3	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 7	2008	283	45					30957	30963		10.1074/jbc.M709486200	http://dx.doi.org/10.1074/jbc.M709486200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	367ID	18713745	Green Published, hybrid			2022-12-27	WOS:000260544800050
J	Lin, WW; Wu, J; Dong, HQ; Bouck, D; Zeng, FY; Chen, TS				Lin, Wenwei; Wu, Jing; Dong, Hanqing; Bouck, David; Zeng, Fu-Yue; Chen, Taosheng			Cyclin-dependent Kinase 2 Negatively Regulates Human Pregnane X Receptor-mediated CYP3A4 Gene Expression in HepG2 Liver Carcinoma Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE; XENOBIOTIC RECEPTOR; HUMAN HEPATOCYTES; DRUG-METABOLISM; PXR; ACTIVATION; INDUCTION; PHOSPHORYLATION; REPRESSION; RESISTANCE	The human pregnane X receptor (hPXR) regulates the expression of critical drug metabolism enzymes. One of such enzymes, cytochrome P450 3A4 (CYP3A4), plays critical roles in drug metabolism in hepatocytes that are either quiescent or passing through the cell cycle. It has been well established that the expression of P450, such as CYP3A4, is markedly reduced during liver development or regeneration. Numerous studies have implicated cellular signaling pathways in modulating the functions of nuclear receptors, including hPXR. Here we report that inhibition of cyclin-dependent kinases (Cdks) by kenpaullone and roscovitine (two small molecule inhibitors of Cdks that we identified in a screen for compounds that activate hPXR) leads to activation of hPXR-mediated CYP3A4 gene expression in HepG2 human liver carcinoma cells. Consistent with this finding, activation of Cdk2 attenuates the activation of CYP3A4 gene expression. In vitro kinase assays revealed that Cdk2 directly phosphorylates hPXR. A phosphomimetic mutation of a putative Cdk phosphorylation site, Ser(350), significantly impairs the function of hPXR, whereas a phosphorylation-deficient mutation confers resistance to Cdk2. Using HepG2 that has been stably transfected with hPXR and the CYP3A4-luciferase reporter, enriched in different phases of the cell cycle, we found that hPXR-mediated CYP3A4 expression is greatly reduced in the S phase. Our results indicate for the first time that Cdk2 negatively regulates the activity of hPXR, and suggest an important role for Cdk2 in regulating hPXR activity and CYP3A4 expression in hepatocytes passing through the cell cycle, such as those in fetal or regenerating adult liver.	[Lin, Wenwei; Wu, Jing; Dong, Hanqing; Bouck, David; Zeng, Fu-Yue; Chen, Taosheng] St Jude Childrens Res Hosp, Dept Chem Biol & Therapeut, Memphis, TN 38105 USA	St Jude Children's Research Hospital	Chen, TS (corresponding author), 262 Danny Thomas Pl, Memphis, TN 38105 USA.	taosheng.chen@stjude.org	Chen, Taosheng/I-6351-2013; Lin, Wenwei/D-9241-2018; Dong, Hanqing/F-6075-2013	Chen, Taosheng/0000-0001-6420-3809; Lin, Wenwei/0000-0001-8754-6150; Bouck, David/0000-0002-6281-2544	American Lebanese Syrian Associated Charities; St. Jude Children's Research Hospital	American Lebanese Syrian Associated Charities(American Lebanese Syrian Associated Charities (ALSAC)); St. Jude Children's Research Hospital	This work was supported by the American Lebanese Syrian Associated Charities and St. Jude Children's Research Hospital. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	BAES M, 1994, MOL CELL BIOL, V14, P1544, DOI 10.1128/MCB.14.3.1544; Berthet C, 2007, ONCOGENE, V26, P4469, DOI 10.1038/sj.onc.1210243; Blake MJ, 2007, CLIN PHARMACOL THER, V81, P510, DOI 10.1038/sj.clpt.6100101; Blumberg B, 1998, GENE DEV, V12, P3195, DOI 10.1101/gad.12.20.3195; Boylan JM, 2005, BIOCHEM BIOPH RES CO, V330, P722, DOI 10.1016/j.bbrc.2005.03.042; Chen TS, 2008, CURR OPIN CHEM BIOL, V12, P418, DOI 10.1016/j.cbpa.2008.07.001; Chen TS, 1999, CANCER RES, V59, P213; Chen TS, 2000, CANCER RES, V60, P2132; Chen Y, 2007, CANCER RES, V67, P10361, DOI 10.1158/0008-5472.CAN-06-4758; Ding XS, 2005, BIOCHEM PHARMACOL, V69, P867, DOI 10.1016/j.bcp.2004.11.025; Ding XS, 2005, J PHARMACOL EXP THER, V312, P849, DOI 10.1124/jpet.104.076331; Donato MT, 1998, J PHARMACOL EXP THER, V284, P760; Fausto N, 2006, HEPATOLOGY, V43, pS45, DOI 10.1002/hep.20969; Favre C, 1998, J HEPATOL, V28, P700, DOI 10.1016/S0168-8278(98)80295-X; Gong HB, 2005, METHOD ENZYMOL, V400, P598, DOI 10.1016/S0076-6879(05)00034-0; Goodwin B, 1999, MOL PHARMACOL, V56, P1329, DOI 10.1124/mol.56.6.1329; Hines RN, 2007, J BIOCHEM MOL TOXIC, V21, P169, DOI 10.1002/jbt.20179; Huang HJ, 2006, SCIENCE, V314, P294, DOI 10.1126/science.1130512; Kliewer SA, 1998, CELL, V92, P73, DOI 10.1016/S0092-8674(00)80900-9; Luo G, 2002, DRUG METAB DISPOS, V30, P795, DOI 10.1124/dmd.30.7.795; Martinez ED, 2002, J BIOL CHEM, V277, P29719, DOI 10.1074/jbc.M112134200; Masuyama H, 2007, MOL PHARMACOL, V72, P1045, DOI 10.1124/mol.107.037937; Meijer L, 1997, EUR J BIOCHEM, V243, P527, DOI 10.1111/j.1432-1033.1997.t01-2-00527.x; Mensah-Osman EJ, 2007, CANCER-AM CANCER SOC, V109, P957, DOI 10.1002/cncr.22479; Michalopoulos GK, 2007, J CELL PHYSIOL, V213, P286, DOI 10.1002/jcp.21172; Michalopoulos GK, 1997, SCIENCE, V276, P60, DOI 10.1126/science.276.5309.60; Moore NL, 2007, STEROIDS, V72, P202, DOI 10.1016/j.steroids.2006.11.025; MORENO S, 1990, CELL, V61, P549, DOI 10.1016/0092-8674(90)90463-O; Myers JS, 2007, CANCER RES, V67, P6685, DOI 10.1158/0008-5472.CAN-07-0495; Narayanan R, 2005, MOL CELL BIOL, V25, P2885, DOI 10.1128/MCB.25.8.2885-2898.2005; Narayanan R, 2005, MOL CELL BIOL, V25, P264, DOI 10.1128/MCB.25.1.264-277.2005; Saradhi M, 2005, BBA-MOL CELL RES, V1746, P85, DOI 10.1016/j.bbamcr.2005.10.004; Saradhi M, 2005, CELL RES, V15, P785, DOI 10.1038/sj.cr.7290348; Sinz M, 2006, CURR DRUG METAB, V7, P375, DOI 10.2174/138920006776873535; Thasler WE, 2006, J PHARMACOL EXP THER, V316, P822, DOI 10.1124/jpet.105.094201; Timsit YE, 2007, STEROIDS, V72, P231, DOI 10.1016/j.steroids.2006.12.006; Whitfield ML, 2002, MOL BIOL CELL, V13, P1977, DOI 10.1091/mbc.02-02-0030; Whitfield ML, 2000, MOL CELL BIOL, V20, P4188, DOI 10.1128/MCB.20.12.4188-4198.2000; Zaharevitz DW, 1999, CANCER RES, V59, P2566; Zhou SF, 2008, CURR DRUG METAB, V9, P310, DOI 10.2174/138920008784220664; Zhu ZR, 2004, J BIOMOL SCREEN, V9, P533, DOI 10.1177/1087057104264902	41	74	78	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 7	2008	283	45					30650	30657		10.1074/jbc.M806132200	http://dx.doi.org/10.1074/jbc.M806132200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	367ID	18784074	hybrid, Green Published			2022-12-27	WOS:000260544800022
J	Sandoval, FJ; Zhang, Y; Roje, S				Sandoval, Francisco J.; Zhang, Yi; Roje, Sanja			Flavin Nucleotide Metabolism in Plants MONOFUNCTIONAL ENZYMES SYNTHESIZE FAD IN PLASTIDS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADENINE-DINUCLEOTIDE SYNTHETASE; SACCHAROMYCES-CEREVISIAE MITOCHONDRIA; RIBOFLAVIN KINASE REVEALS; WEIGHT ACID-PHOSPHATASE; RAT-LIVER MITOCHONDRIA; PARTIAL-PURIFICATION; BACILLUS-SUBTILIS; ESCHERICHIA-COLI; CONFORMATIONAL-CHANGES; SUBSTRATE-SPECIFICITY	FAD synthetases (EC 2.7.7.2) catalyze biosynthesis of FAD from FMN and ATP. Monofunctional FAD synthetases are known to exist in mammals and yeast; bifunctional enzymes also catalyzing phosphorylation of riboflavin to FMN are known to exist in bacteria. Previously known eukaryotic enzymes with FAD synthetase activity have no sequence similarity to prokaryotic enzymes with riboflavin kinase and FAD synthetase activities. Proteins homologous to bacterial bifunctional FAD synthetases, yet shorter and lacking amino acid motifs at the C terminus, were found by bioinformatic analyses in vascular plant genomes, suggesting that plants contain a type of FAD synthetase previously known to exist only in prokaryotes. The Arabidopsis thaliana genome encodes two of such proteins. Both proteins, which we named AtRibF1 and AtRibF2, carry N-terminal extensions with characteristics of organellar targeting peptides. AtRibF1 and AtRibF2 cDNAs were cloned by reverse transcription-PCR. Only FAD synthetase activity was detected in the recombinant enzymes produced in Escherichia coli. FMN and ATP inhibited both enzymes. Kinetic parameters of AtRibF1 and AtRibF2 for the two substrates were similar. Confocal microscopy of protoplasts transformed with enhanced green fluorescence protein-fused proteins showed that AtRibF1 and AtRibF2 are targeted to plastids. In agreement with subcellular localization to plastids, Percoll-isolated chloroplasts from pea (Pisum sativum) synthesized FAD from imported riboflavin. Riboflavin kinase, FMN hydrolase, and FAD pyrophosphatase activities were detected in Percoll-isolated chloroplasts and mitochondria from pea. We propose from these new findings a model for subcellular distribution of enzymes that synthesize and hydrolyze flavin nucleotides in plants.	[Sandoval, Francisco J.; Roje, Sanja] Washington State Univ, Inst Biol Chem, Pullman, WA 99164 USA; [Zhang, Yi; Roje, Sanja] Washington State Univ, Grad Program Mol Plant Sci, Pullman, WA 99164 USA	Washington State University; Washington State University	Roje, S (corresponding author), Washington State Univ, Inst Biol Chem, Pullman, WA 99164 USA.	sanja@wsu.edu		Roje, Sanja/0000-0002-6302-5382; Zhang, Yi/0000-0002-1566-098X	United States Department of Agriculture National Research Initiative [2007-03559]; Murdoch Foundation	United States Department of Agriculture National Research Initiative(United States Department of Agriculture (USDA)); Murdoch Foundation	This work was supported by United States Department of Agriculture National Research Initiative Grant 2007-03559 (to S. R.) and the Murdoch Foundation. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked " advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	[Anonymous], 2005, PHYLIP PHYLOGENY INF; ARNON DI, 1949, PLANT PHYSIOL, V24, P15; Bafunno V, 2004, J BIOL CHEM, V279, P95, DOI 10.1074/jbc.M308230200; BALAKRISHNAN CV, 1977, EUR J BIOCHEM, V78, P95, DOI 10.1111/j.1432-1033.1977.tb11717.x; Barile M, 1997, EUR J BIOCHEM, V249, P777, DOI 10.1111/j.1432-1033.1997.00777.x; BARILE M, 1993, ARCH BIOCHEM BIOPHYS, V305, P442, DOI 10.1006/abbi.1993.1444; Barile M, 2000, EUR J BIOCHEM, V267, P4888, DOI 10.1046/j.1432-1327.2000.01552.x; Bauer S, 2003, J MOL BIOL, V326, P1463, DOI 10.1016/S0022-2836(03)00059-7; BOWERSKOMRO DM, 1989, BIOCHEMISTRY-US, V28, P8439, DOI 10.1021/bi00447a025; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brizio C, 2006, BIOCHEM BIOPH RES CO, V344, P1008, DOI 10.1016/j.bbrc.2006.04.003; BYRD JC, 1985, J BIOL CHEM, V260, P7474; Clarebout G, 2001, ANTIMICROB AGENTS CH, V45, P2280, DOI 10.1128/AAC.45.8.2280-2286.2001; CLINE K, 1986, J BIOL CHEM, V261, P4804; DELUCA C, 1958, BIOCHIM BIOPHYS ACTA, V30, P6, DOI 10.1016/0006-3002(58)90233-6; DOUCE R, 1987, METHOD ENZYMOL, V148, P403; Efimov I, 1998, BIOCHEMISTRY-US, V37, P9716, DOI 10.1021/bi972817j; Fischer M, 2006, PHYSIOL PLANTARUM, V126, P304, DOI 10.1111/j.1399-3054.2006.00607.x; Fischer M, 2004, J BIOL CHEM, V279, P36299, DOI 10.1074/jbc.M404406200; FUCHS KR, 1992, BIOCHEM BIOPH RES CO, V189, P1598, DOI 10.1016/0006-291X(92)90259-N; Galluccio M, 2007, PROTEIN EXPRES PURIF, V52, P175, DOI 10.1016/j.pep.2006.09.002; Garcia NAT, 2004, PLANT PHYSIOL BIOCH, V42, P585, DOI 10.1016/j.plaphy.2004.04.004; GIRI KV, 1957, NATURE, V179, P1134, DOI 10.1038/1791134b0; GIRI KV, 1960, BIOCHEM J, V75, P381, DOI 10.1042/bj0750381; Granjeiro JM, 1997, BIOCHEM MOL BIOL INT, V41, P1201; Herz S, 2000, PHYTOCHEMISTRY, V53, P723, DOI 10.1016/S0031-9422(00)00013-3; Jordan DB, 1999, J BIOL CHEM, V274, P22114, DOI 10.1074/jbc.274.31.22114; Karimi M, 2002, TRENDS PLANT SCI, V7, P193, DOI 10.1016/S1360-1385(02)02251-3; Karthikeyan S, 2003, BIOCHEMISTRY-US, V42, P12532, DOI 10.1021/bi035450t; Karthikeyan S, 2003, STRUCTURE, V11, P265, DOI 10.1016/S0969-2126(03)00024-8; KEARNEY EB, 1979, J BIOL CHEM, V254, P9551; KORNBERG A, 1950, J BIOL CHEM, V186, P763; KUMAR SA, 1965, ARCH BIOCHEM BIOPHYS, V111, P646, DOI 10.1016/0003-9861(65)90246-8; LEE RSF, 1988, J BIOL CHEM, V263, P14878; Mack M, 1998, J BACTERIOL, V180, P950, DOI 10.1128/JB.180.4.950-955.1998; MANSTEIN DJ, 1986, J BIOL CHEM, V261, P6169; Mayhew S G, 1980, Methods Enzymol, V66, P323; MERRILL AH, 1980, J BIOL CHEM, V255, P1335; Meyer S. L., 1975, DATA ANAL SCI ENG, P39; MITSUDA H, 1970, J VITAMINOL, V16, P52, DOI 10.5925/jnsv1954.16.52; MITSUDA H, 1965, J VITAMINOL, V11, P20, DOI 10.5925/jnsv1954.11.20; MITSUDA H, 1970, J VITAMINOL, V16, P31; NAKANO H, 1991, J BIOL CHEM, V266, P22125; OKA M, 1987, J BIOL CHEM, V262, P7418; Pallotta ML, 1998, FEBS LETT, V428, P245, DOI 10.1016/S0014-5793(98)00544-4; Quinlivan EP, 2003, J BIOL CHEM, V278, P20731, DOI 10.1074/jbc.M302894200; RAVINDRANATH SD, 1969, ARCH BIOCHEM BIOPHYS, V133, P54, DOI 10.1016/0003-9861(69)90487-1; Roje S, 2002, J BIOL CHEM, V277, P42748, DOI 10.1074/jbc.M205632200; SADASIVAM S, 1966, ENZYMOLOGIA, V31, P203; Sandoval FJ, 2005, J BIOL CHEM, V280, P38337, DOI 10.1074/jbc.M500350200; Santos MA, 2000, J BIOL CHEM, V275, P28618, DOI 10.1074/jbc.M004621200; SENSABAUGH GF, 1978, AM J HUM GENET, V30, P553; SHIN H, 1988, ARCH BIOCHEM BIOPHYS, V267, P95, DOI 10.1016/0003-9861(88)90012-4; SOBHANADITYA J, 1981, BIOCHEM J, V197, P227, DOI 10.1042/bj1970227; Solovieva IM, 1999, MICROBIOL-SGM, V145, P67, DOI 10.1099/13500872-145-1-67; TAGA EM, 1982, ARCH BIOCHEM BIOPHYS, V214, P505, DOI 10.1016/0003-9861(82)90054-6; WIRTZ W, 1980, PLANT PHYSIOL, V66, P187, DOI 10.1104/pp.66.1.187; WU M, 1995, MOL CELL BIOL, V15, P264, DOI 10.1128/MCB.15.1.264; YAMADA Y, 1990, ARCH BIOCHEM BIOPHYS, V278, P125, DOI 10.1016/0003-9861(90)90240-Y; ZHANG ZY, 1990, ARCH BIOCHEM BIOPHYS, V282, P39, DOI 10.1016/0003-9861(90)90084-C; Zimmermann P, 2004, PLANT PHYSIOL, V136, P2621, DOI 10.1104/pp.104.046367	61	56	61	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 7	2008	283	45					30890	30900		10.1074/jbc.M803416200	http://dx.doi.org/10.1074/jbc.M803416200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	367ID	18713732	hybrid, Green Published			2022-12-27	WOS:000260544800044
J	Tiao, JY; Bradaia, A; Biermann, B; Kaupmann, K; Metz, M; Haller, C; Rolink, AG; Pless, E; Barlow, PN; Gassmann, M; Bettler, B				Tiao, Jim Y.; Bradaia, Amyaouch; Biermann, Barbara; Kaupmann, Klemens; Metz, Michaela; Haller, Corinne; Rolink, Antonius G.; Pless, Elin; Barlow, Paul N.; Gassmann, Martin; Bettler, Bernhard			The Sushi Domains of Secreted GABA(B1) Isoforms Selectively Impair GABA(B) Heteroreceptor Function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMINOBUTYRIC-ACID RECEPTOR; PRESYNAPTIC INHIBITION; SENSORY NEURONS; RAT-BRAIN; PROTEIN; EXPRESSION; CELLS; MICE; TRANSMISSION; MODULATION	GABA(B) receptors are the G-protein-coupled receptors for gamma-aminobutyric acid (GAB(A)), the main inhibitory neurotransmitter in the brain. GABA(B) receptors are promising drug targets for a wide spectrum of psychiatric and neurological disorders. Receptor subtypes exhibit no pharmacological differences and are based on the subunit isoforms GABA(B1a) and GABA(B1b). GABA(B1a) differs from GABA(B1b) in its ectodomain by the presence of a pair of conserved protein binding motifs, the sushi domains (SDs). Previous work showed that selectively GABA(B1a) contributes to heteroreceptors at glutamatergic terminals, whereas both GABA(B1a) and GABA(B1b) contribute to autoreceptors at GABAergic terminals or to postsynaptic receptors. Here, we describe GABA(B1j), a secreted GABA(B1) isoform comprising the two SDs. We show that the two SDs, when expressed as a soluble protein, bind to neuronal membranes with low nanomolar affinity. Soluble SD protein, when added at nanomolar concentrations to dissociated hippocampal neurons or to acute hippocampal slices, impairs the inhibitory effect of GABA(B) heteroreceptors on evoked and spontaneous glutamate release. In contrast, soluble SD protein neither impairs the activity of GABA(B) autoreceptors nor impairs the activity of postsynaptic GABA(B) receptors. We propose that soluble SD protein scavenges an extracellular binding partner that retains GABA(B1a)-containing heteroreceptors in proximity of the presynaptic release machinery. Soluble GABA(B1) isoforms like GABAB(1j) may therefore act as dominant-negative inhibitors of heteroreceptors and control the level of GABA(B)-mediated inhibition at glutamatergic terminals. Of importance for drug discovery, our data also demonstrate that it is possible to selectively impair GABA(B) heteroreceptors by targeting their SDs.	[Tiao, Jim Y.; Bradaia, Amyaouch; Biermann, Barbara; Metz, Michaela; Haller, Corinne; Gassmann, Martin; Bettler, Bernhard] Univ Basel, Dept Biomed, Pharmazentrum, Inst Physiol, CH-4056 Basel, Switzerland; [Kaupmann, Klemens] Novartis Pharma AG, Novartis Inst BioMed Res, CH-4002 Basel, Switzerland; [Rolink, Antonius G.] Univ Basel, Dept Biomed Dev & Mol Immunol, CH-4058 Basel, Switzerland; [Pless, Elin; Barlow, Paul N.] Univ Edinburgh, Edinburgh Biomol NMR Unit, Edinburgh EH9 3JJ, Midlothian, Scotland	University of Basel; Novartis; University of Basel; University of Edinburgh	Bettler, B (corresponding author), Univ Basel, Dept Biomed, Pharmazentrum, Inst Physiol, Klingelbergstr 50-70, CH-4056 Basel, Switzerland.	bernhard.bettler@unibas.ch	bettler, bernhard/AAO-8018-2020; Barlow, Paul N/G-2853-2011	Tiao, Jim/0000-0001-6692-9697; Kaupmann, Klemens/0000-0001-8903-2508; BRADAIA, Amyaouch/0000-0001-9664-4641; Bettler, Bernhard/0000-0003-0842-8207	European Community's Seventh Framework Programme [FP7/2007-2013]; Swiss Science Foundation [3100-067100.01]; Novartis Pharma AG;  [201714]	European Community's Seventh Framework Programme; Swiss Science Foundation(Swiss National Science Foundation (SNSF)); Novartis Pharma AG; 	This work was supported by a grant from the European Community's Seventh Framework Programme (FP7/2007-2013) under Grant Agreement 201714. This study was also supported by the Swiss Science Foundation (Grant 3100-067100.01) and a grant from Novartis Pharma AG.	Bettler B, 2004, PHYSIOL REV, V84, P835, DOI 10.1152/physrev.00036.2003; Bischoff S, 1999, J COMP NEUROL, V412, P1; Blein S, 2004, J BIOL CHEM, V279, P48292, DOI 10.1074/jbc.M406540200; Bowery NG, 2002, PHARMACOL REV, V54, P247, DOI 10.1124/pr.54.2.247; Bulanova E, 2007, J BIOL CHEM, V282, P13167, DOI 10.1074/jbc.M610036200; Couve A, 2000, MOL CELL NEUROSCI, V16, P296, DOI 10.1006/mcne.2000.0908; DUNLAP K, 1981, BRIT J PHARMACOL, V74, P579, DOI 10.1111/j.1476-5381.1981.tb10467.x; DUNLAP K, 1981, J PHYSIOL-LONDON, V317, P519, DOI 10.1113/jphysiol.1981.sp013841; Fairfax BP, 2004, J BIOL CHEM, V279, P12565, DOI 10.1074/jbc.M311389200; Froestl W, 2004, BIOCHEM PHARMACOL, V68, P1479, DOI 10.1016/j.bcp.2004.07.030; Gally C, 2004, NATURE, V431, P578, DOI 10.1038/nature02893; Gassmann M, 2004, J NEUROSCI, V24, P6086, DOI 10.1523/JNEUROSCI.5635-03.2004; Goslin K., 1998, CULTURING NERVE CELL, P339; Grace CRR, 2004, P NATL ACAD SCI USA, V101, P12836, DOI 10.1073/pnas.0404702101; Hawrot E, 1998, FEBS LETT, V432, P103, DOI 10.1016/S0014-5793(98)00794-7; Holter J, 2005, J MOL NEUROSCI, V26, P99, DOI 10.1385/JMN:26:1:099; Jarolimek W, 1997, J NEUROSCI, V17, P1025; Kaupmann K, 1997, NATURE, V386, P239, DOI 10.1038/386239a0; Lei SB, 2003, J PHYSIOL-LONDON, V546, P439, DOI 10.1113/jphysiol.2002.034017; Luscher C, 1997, NEURON, V19, P687, DOI 10.1016/S0896-6273(00)80381-5; Marshall FH, 1999, TRENDS PHARMACOL SCI, V20, P396, DOI 10.1016/S0165-6147(99)01383-8; MOSLEY B, 1989, CELL, V59, P335, DOI 10.1016/0092-8674(89)90295-X; Pagano A, 2001, J NEUROSCI, V21, P1189; Prosser HM, 2001, MOL CELL NEUROSCI, V17, P1059, DOI 10.1006/mcne.2001.0995; Rolink AG, 1998, EUR J IMMUNOL, V28, P3738, DOI 10.1002/(SICI)1521-4141(199811)28:11<3738::AID-IMMU3738>3.0.CO;2-Q; Saglietti L, 2007, NEURON, V54, P461, DOI 10.1016/j.neuron.2007.04.012; Sakaba T, 2003, NATURE, V424, P775, DOI 10.1038/nature01859; SCANZIANI M, 1992, NEURON, V9, P919, DOI 10.1016/0896-6273(92)90244-8; SCHAERENWIEMERS N, 1993, HISTOCHEMISTRY, V100, P431, DOI 10.1007/BF00267823; Schuler V, 2001, NEURON, V31, P47, DOI 10.1016/S0896-6273(01)00345-2; Schwarz DA, 2000, J BIOL CHEM, V275, P32174, DOI 10.1074/jbc.M005333200; Shaban H, 2006, NAT NEUROSCI, V9, P1028, DOI 10.1038/nn1732; Sia GM, 2007, NEURON, V55, P87, DOI 10.1016/j.neuron.2007.06.020; Soares DC, 2005, STRUCTURAL BIOLOGY OF THE COMPLEMENT SYSTEM, P19; Steiger JL, 2004, J NEUROSCI, V24, P6115, DOI 10.1523/JNEUROSCI.1200-04.2004; Ulrich D, 2007, CURR OPIN NEUROBIOL, V17, P298, DOI 10.1016/j.conb.2007.04.001; Vigot R, 2006, NEURON, V50, P589, DOI 10.1016/j.neuron.2006.04.014; Wei KR, 2001, MOL BRAIN RES, V89, P103, DOI 10.1016/S0169-328X(01)00068-7; Yamada J, 1999, NEUROPHARMACOLOGY, V38, P1743, DOI 10.1016/S0028-3908(99)00126-4	39	35	37	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 7	2008	283	45					31005	31011		10.1074/jbc.M804464200	http://dx.doi.org/10.1074/jbc.M804464200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	367ID	18765663	Green Published, hybrid			2022-12-27	WOS:000260544800055
J	Doni, A; Mantovani, G; Porta, C; Tuckermann, J; Reichardt, HM; Kleiman, A; Sironi, M; Rubino, L; Pasqualini, F; Nebuloni, M; Signorini, S; Peri, G; Sica, A; Beck-Peccoz, P; Bottazzi, B; Mantovani, A				Doni, Andrea; Mantovani, Giovanna; Porta, Chiara; Tuckermann, Jan; Reichardt, Holger M.; Kleiman, Anna; Sironi, Marina; Rubino, Luca; Pasqualini, Fabio; Nebuloni, Manuela; Signorini, Stefano; Peri, Giuseppe; Sica, Antonio; Beck-Peccoz, Paolo; Bottazzi, Barbara; Mantovani, Alberto			Cell-specific Regulation of PTX3 by Glucocorticoid Hormones in Hematopoietic and Nonhematopoietic Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LONG PENTRAXIN PTX3; C-REACTIVE PROTEIN; ACUTE MYOCARDIAL-INFARCTION; RECOGNITION RECEPTOR PTX3; HUMORAL INNATE IMMUNITY; PITUITARY-ADRENAL AXIS; ACUTE PHASE PROTEINS; AMYLOID-P COMPONENT; DENDRITIC CELLS; FEMALE FERTILITY	PTX3 (prototypic long pentraxin 3) is a fluid phase pattern recognition receptor, which plays nonredundant roles in the resistance against diverse pathogens, in the assembly of a hyaluronic acid-rich extracellular matrix, and in female fertility. Inflammatory signals induce production of PTX3 in diverse cell types, including myeloid dendritic cells(DC), fibroblasts, and endothelial cells(EC). The present study was designed to explore the effect of glucocorticoid hormones (GC) on PTX3 production in different cellular contexts. In myeloid DC, GC inhibited the PTX3 production. In contrast, in fibroblasts and EC, GC alone induced and, under inflammatory conditions, enhanced and extended PTX3 production. In vivo administration of GC augmented the blood levels of PTX3 in mice and humans. Moreover, patients with Cushing syndrome had increased levels of circulating PTX3, whereas PTX3 levels were decreased in subjects affected by iatrogenic hypocortisolism. In nonhematopoietic cells, GC receptor (GR) functioned as a ligand-dependent transcription factor (dimerization-dependent) to induce PTX3 gene expression. In contrast, in hematopoietic cells, GR repressed PTX3 gene transcription by interfering (dimerization-independent) with the action of other signaling pathways, probably NF kappa B and AP-1. Thus, divergent effects of GC were found to be due to different GR mechanisms. The results presented here indicate that GC have divergent effects on PTX3 production in hematopoietic (DC and macrophages) and nonhematopoietic (fibroblasts and EC) cells. The divergent effects of GC on PTX3 production probably reflect the different functions of this multifunctional molecule in innate immunity and in the construction of the extracellular matrix.	[Doni, Andrea; Porta, Chiara; Sironi, Marina; Rubino, Luca; Pasqualini, Fabio; Peri, Giuseppe; Sica, Antonio; Bottazzi, Barbara; Mantovani, Alberto] IRCCS, Ist Clin Humanitas, Dept Immunol & Inflammat, I-20089 Milan, Italy; [Mantovani, Giovanna; Beck-Peccoz, Paolo] Univ Milan, IRCCS, Fdn Policlin, Endocrine Unit,Dept Med Sci, Milan, Italy; [Tuckermann, Jan; Kleiman, Anna] Leibniz Inst Age Res Fritz Lipmann, Jena, Germany; [Reichardt, Holger M.] Univ Goettingen, Dept Cellular & Mol Immunol, Gottingen, Germany; [Signorini, Stefano] Hosp Desio, Dept Lab Med, Milan, Italy; [Nebuloni, Manuela] Univ Milan, Luigi Sacco Dept Clin Sci, Pathol Unit, Milan, Italy; [Mantovani, Alberto] Univ Milan, Inst Gen Pathol, Milan, Italy	IRCCS Humanitas Research Hospital; University of Milan; Leibniz Institut fur Alternsforschung - Fritz-Lipmann-Institut (FLI); University of Gottingen; University of Milan; Luigi Sacco Hospital; University of Milan	Mantovani, A (corresponding author), IRCCS, Ist Clin Humanitas, Dept Immunol & Inflammat, Via Manzoni 56, I-20089 Milan, Italy.	alberto.mantovani@humanitas.it	Mantovani, Alberto/HCI-7449-2022; Sica, Antonio/AAB-9546-2020; Reichardt, Holger/AAF-3048-2020; bottazzi, barbara/ABH-9274-2020; Pasqualini, Fabio/G-5610-2018; sironi, marina/AAB-5757-2020; NEBULONI, MANUELA/L-3969-2017; Mantovani, Giovanna/A-2378-2014	Mantovani, Alberto/0000-0001-5578-236X; Reichardt, Holger/0000-0003-4647-057X; bottazzi, barbara/0000-0002-1930-9257; Pasqualini, Fabio/0000-0003-4852-3794; sironi, marina/0000-0002-3342-1149; NEBULONI, MANUELA/0000-0002-2773-734X; PORTA, Chiara/0000-0002-7183-5561; Doni, Andrea/0000-0001-9203-5814; Mantovani, Giovanna/0000-0002-9065-3886	Associazione Italiana per la Ricerca sul Cancro; Ministero Istruzione, Universita e Ricerca; European Commission Mugen [005203]; Muvapred [503240]; DC-Thera [512074]	Associazione Italiana per la Ricerca sul Cancro; Ministero Istruzione, Universita e Ricerca(Fondazione AIRC per la ricerca sul cancro); European Commission Mugen(European CommissionEuropean Commission Joint Research Centre); Muvapred; DC-Thera	This work was supported by Associazione Italiana per la Ricerca sul Cancro; Ministero Istruzione, Universita e Ricerca; and European Commission Mugen Grant 005203, Muvapred Grant 503240, and DC-Thera Grant 512074. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Abraham SM, 2006, J EXP MED, V203, P1883, DOI 10.1084/jem.20060336; ALLES VV, 1994, BLOOD, V84, P3483; ALTMEYER A, 1995, J BIOL CHEM, V270, P25584, DOI 10.1074/jbc.270.43.25584; Aranda A, 2001, PHYSIOL REV, V81, P1269, DOI 10.1152/physrev.2001.81.3.1269; Ashwell JD, 2000, ANNU REV IMMUNOL, V18, P309, DOI 10.1146/annurev.immunol.18.1.309; Baruah P, 2006, BLOOD, V107, P151, DOI 10.1182/blood-2005-03-1112; Baruah P, 2006, J LEUKOCYTE BIOL, V80, P87, DOI 10.1189/jlb.0805445; Basile A, 1997, J BIOL CHEM, V272, P8172, DOI 10.1074/jbc.272.13.8172; BAUMANN H, 1994, IMMUNOL TODAY, V15, P74, DOI 10.1016/0167-5699(94)90137-6; Bottazzi B, 2006, CURR OPIN IMMUNOL, V18, P10, DOI 10.1016/j.coi.2005.11.009; Bottazzi B, 1997, J BIOL CHEM, V272, P32817, DOI 10.1074/jbc.272.52.32817; Bottazzi B, 2006, J LEUKOCYTE BIOL, V79, P909, DOI 10.1189/jlb.1005557; BREVIARIO F, 1992, J BIOL CHEM, V267, P22190; CHROUSOS GP, 1995, NEW ENGL J MED, V332, P1351, DOI 10.1056/NEJM199505183322008; De Bosscher K, 2003, ENDOCR REV, V24, P488, DOI 10.1210/er.2002-0006; Dias AAM, 2001, J LEUKOCYTE BIOL, V69, P928; Diniz SN, 2004, J LEUKOCYTE BIOL, V75, P649, DOI 10.1189/jlb.0803371; Doni A, 2003, EUR J IMMUNOL, V33, P2886, DOI 10.1002/eji.200324390; Doni A, 2006, J LEUKOCYTE BIOL, V79, P797, DOI 10.1189/jlb.0905493; Du Clos TW, 2004, IMMUNOL RES, V30, P261, DOI 10.1385/IR:30:3:261; Duan HO, 2006, J BIOL CHEM, V281, P12451, DOI 10.1074/jbc.M600294200; Franchimont D, 2004, ANN NY ACAD SCI, V1024, P124, DOI 10.1196/annals.1321.009; Galon J, 2002, FASEB J, V16, P61, DOI 10.1096/fj.01-0245com; Garlanda C, 2002, NATURE, V420, P182, DOI 10.1038/nature01195; Garlanda C, 2005, ANNU REV IMMUNOL, V23, P337, DOI 10.1146/annurev.immunol.23.021704.115756; Han B, 2005, J IMMUNOL, V175, P8303, DOI 10.4049/jimmunol.175.12.8303; Herr I, 2007, APOPTOSIS, V12, P271, DOI 10.1007/s10495-006-0624-5; Imasato A, 2002, J BIOL CHEM, V277, P47444, DOI 10.1074/jbc.M208140200; Inoue K, 2007, ARTERIOSCL THROM VAS, V27, P161, DOI 10.1161/01.ATV.0000252126.48375.d5; Jeannin P, 2005, IMMUNITY, V22, P551, DOI 10.1016/j.immuni.2005.03.008; Kim SW, 2004, MOL ENDOCRINOL, V18, P2924, DOI 10.1210/me.2004-0255; KURODA M, 1995, AM J PATHOL, V147, P1221; Latini R, 2004, CIRCULATION, V110, P2349, DOI 10.1161/01.CIR.0000145167.30987.2E; LEE GW, 1993, J IMMUNOL, V150, P1804; Liberman AC, 2007, FASEB J, V21, P1177, DOI 10.1096/fj.06-7452com; Mantovani A, 2008, J CLIN IMMUNOL, V28, P1, DOI 10.1007/s10875-007-9126-7; Muller B, 2001, CRIT CARE MED, V29, P1404, DOI 10.1097/00003246-200107000-00017; Napoleone E, 1997, BLOOD, V89, P541, DOI 10.1182/blood.V89.2.541; Nauta AJ, 2003, EUR J IMMUNOL, V33, P465, DOI 10.1002/immu.200310022; PEPYS MB, 1983, ADV IMMUNOL, V34, P141, DOI 10.1016/S0065-2776(08)60379-X; Peri G, 2000, CIRCULATION, V102, P636, DOI 10.1161/01.CIR.102.6.636; PRESTRIDGE DS, 1991, COMPUT APPL BIOSCI, V7, P203; Ravizza T, 2001, NEUROSCIENCE, V105, P43, DOI 10.1016/S0306-4522(01)00177-4; Reichardt HM, 1998, CELL, V93, P531, DOI 10.1016/S0092-8674(00)81183-6; Reichardt HM, 2004, CURR PHARM DESIGN, V10, P2797, DOI 10.2174/1381612043383575; Rovere P, 2000, BLOOD, V96, P4300; Salio M, 2008, CIRCULATION, V117, P1055, DOI 10.1161/CIRCULATIONAHA.107.749234; Salustri A, 2004, DEVELOPMENT, V131, P1577, DOI 10.1242/dev.01056; Schioppa T, 2003, J EXP MED, V198, P1391, DOI 10.1084/jem.20030267; Silverstein R, 2003, J LEUKOCYTE BIOL, V73, P417, DOI 10.1189/jlb.0702379; Souza DG, 2002, AM J PATHOL, V160, P1755, DOI 10.1016/S0002-9440(10)61122-4; Sternberg EM, 2006, NAT REV IMMUNOL, V6, P318, DOI 10.1038/nri1810; Thorn CF, 2003, EUR J IMMUNOL, V33, P2630, DOI 10.1002/eji.200323985; Varani S, 2002, MOL ENDOCRINOL, V16, P1154, DOI 10.1210/me.16.6.1154; Vizzardelli C, 2006, EUR J IMMUNOL, V36, P1504, DOI 10.1002/eji.200535488; Webster JI, 2004, J ENDOCRINOL, V181, P207, DOI 10.1677/joe.0.1810207; Willeke F, 2006, EUR J CANCER, V42, P2639, DOI 10.1016/j.ejca.2006.05.035	57	69	71	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 31	2008	283	44					29983	29992		10.1074/jbc.M805631200	http://dx.doi.org/10.1074/jbc.M805631200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	364WS	18703503	Green Published, hybrid			2022-12-27	WOS:000260366900043
J	Sim, JA; Broomhead, HE; North, RA				Sim, Joan A.; Broomhead, Helen E.; North, R. Alan			Ectodomain Lysines and Suramin Block of P2X(1) Receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EXCITATORY JUNCTION POTENTIALS; ATP BINDING; POTENCY ANTAGONIST; VAS-DEFERENS; AMINO-ACIDS; ACTIVATION; P2-PURINOCEPTOR; INHIBITOR; PLATELET; SUBUNITS	P2X(1) receptors belong to a family of cation channels gated by extracellular ATP; they are found inter alia in smooth muscle, platelets, and immune cells. Suramin has been widely used as an antagonist at P2X receptors, and its analog 4,4',4 '',4 '''-[carbonylbis((imino-5,1,3-benzenetriylbis(carbonylimino))] tetrakis-benzene-1,3- disulfonic acid (NF449) is selective for the P2X(1) subtype. Human and mouse P2X(1) receptors were expressed in human embryonic kidney cells, and membrane currents evoked by ATP were recorded. ATP (10 nM to 100 mu M) was applied only once to each cell, to avoid the profound desensitization exhibited by P2X(1) receptors. Suramin (10 mu M) and NF449 (3-300 nM)effectively blocked the human receptor. Suramin had little effect on the mouse receptor. Suramin and NF449 are polysulfonates, with six and eight negative charges, respectively. We hypothesized that species differences might result from differences in positive residues presented by the large receptor ectodomain. Four lysines in the human sequence (Lys(111), Lys(127), Lys(138), and Lys(148)) were changed individually and together to their counterparts in the mouse sequence. The substitution K138E, either alone or together with K111Q, K127Q, and K148N, reduced the sensitivity to block by both suramin and NF449. Conversely, when lysine was introduced into the mouse receptor, the sensitivity to block by suramin and NF449 was much increased for E138K, but not for Q111K, Q127K, or N148K. The results explain the marked species difference in antagonist sensitivity and identify an ectodomain lysine residue that plays a key role in the binding of both suramin and NF449 to P2X(1) receptors.	[Sim, Joan A.; Broomhead, Helen E.; North, R. Alan] Univ Manchester, Fac Life Sci, Manchester M13 9PT, Lancs, England	University of Manchester	Sim, JA (corresponding author), Univ Manchester, Fac Life Sci, Michael Smith Bldg,Oxford Rd, Manchester M13 9PT, Lancs, England.	joan.sim@manchester.ac.uk	North, Richard/GQA-6156-2022		Wellcome Trust	Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by the Wellcome Trust. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Braun K, 2001, N-S ARCH PHARMACOL, V364, P285, DOI 10.1007/s002100100463; Buell G, 1996, EMBO J, V15, P55, DOI 10.1002/j.1460-2075.1996.tb00333.x; BURNSTOCK G, 1985, GEN PHARMACOL, V16, P433, DOI 10.1016/0306-3623(85)90001-1; DECLERCQ E, 1979, CANCER LETT, V8, P9, DOI 10.1016/0304-3835(79)90017-X; DUNN PM, 1988, BRIT J PHARMACOL, V93, P243, DOI 10.1111/j.1476-5381.1988.tb11427.x; Ennion S, 2000, J BIOL CHEM, V275, P29361, DOI 10.1074/jbc.M003637200; EVANS RJ, 1995, MOL PHARM, V48, P17; Fung CYE, 2007, J THROMB HAEMOST, V5, P910, DOI 10.1111/j.1538-7836.2007.02525.x; Hulsmann M, 2003, EUR J PHARMACOL, V470, P1, DOI 10.1016/S0014-2999(03)01761-8; Ikeda M, 2007, THROMB RES, V119, P343, DOI 10.1016/j.thromres.2006.03.007; LAYTON D, 1974, BIOCHEM BIOPH RES CO, V59, P322, DOI 10.1016/S0006-291X(74)80209-3; Le KT, 1999, J BIOL CHEM, V274, P15415, DOI 10.1074/jbc.274.22.15415; LOMOMINSKI I, 1961, NATURE, V192, P683; Mahaut-Smith MP, 2004, PLATELETS, V15, P131, DOI 10.1080/09537100410001682788; Marquez-Klaka B, 2007, J NEUROSCI, V27, P1456, DOI 10.1523/JNEUROSCI.3105-06.2007; Mulryan K, 2000, NATURE, V403, P86, DOI 10.1038/47495; North RA, 2000, ANNU REV PHARMACOL, V40, P563, DOI 10.1146/annurev.pharmtox.40.1.563; North RA, 2002, PHYSIOL REV, V82, P1013, DOI 10.1152/physrev.00015.2002; Rettinger J, 2003, J GEN PHYSIOL, V121, P451, DOI 10.1085/jgp.200208730; Roberts JA, 2004, J BIOL CHEM, V279, P9043, DOI 10.1074/jbc.M308964200; Roberts JA, 2007, J NEUROSCI, V27, P4072, DOI 10.1523/JNEUROSCI.2310-06.2007; Roberts JA, 2006, PFLUG ARCH EUR J PHY, V452, P486, DOI 10.1007/s00424-006-0073-6; Sim JA, 2007, BRIT J PHARMACOL, V152, P1283, DOI 10.1038/sj.bjp.0707504; SMOLEN JE, 1978, BIOCHIM BIOPHYS ACTA, V512, P525, DOI 10.1016/0005-2736(78)90162-1; SNEDDON P, 1992, BRIT J PHARMACOL, V107, P101, DOI 10.1111/j.1476-5381.1992.tb14469.x; Soto F, 1996, P NATL ACAD SCI USA, V93, P3684, DOI 10.1073/pnas.93.8.3684; Surprenant A, 2000, J AUTONOM NERV SYST, V81, P249, DOI 10.1016/S0165-1838(00)00123-5; TOWN BW, 1950, BIOCHEM J, V47, P149, DOI 10.1042/bj0470149; TOWN BW, 1949, NATURE, V163, P735, DOI 10.1038/163735a0; VALERA S, 1994, NATURE, V371, P519; Wilkinson WJ, 2006, MOL PHARMACOL, V70, P1159, DOI 10.1124/mol.106.026658	31	27	28	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 31	2008	283	44					29841	29846		10.1074/jbc.M802523200	http://dx.doi.org/10.1074/jbc.M802523200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	364WS	18765669	Green Published, hybrid			2022-12-27	WOS:000260366900028
J	Foy, RL; Song, IY; Chitalia, VC; Cohen, HT; Saksouk, N; Cayrou, C; Vaziri, C; Cote, J; Panchenko, MV				Foy, Rebecca L.; song, Ihn Young; Chitalia, Vipul C.; Cohen, Herbert T.; Saksouk, Nehme; Cayrou, Christelle; Vaziri, Cyrus; Cote, Jacques; Panchenko, Maria V.			Role of Jade-1 in the Histone Acetyltransferase (HAT) HBO1 Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHD FINGER; TUMOR-SUPPRESSOR; DNA-REPLICATION; LYSINE-4 METHYLATION; HOMEODOMAIN PROTEIN; H4 ACETYLATION; ZINC-FINGER; CHROMATIN; DOMAIN; TRANSCRIPTION	Regulation of global chromatin acetylation is important for chromatin remodeling. A small family of Jade proteins includes Jade-1L, Jade-2, and Jade-3, each bearing two mid-molecule tandem plant homology domain (PHD) zinc fingers. We previously demonstrated that the short isoform of Jade-1L protein, Jade-1, is associated with endogenous histone acetyltransferase (HAT) activity. It has been found that Jade-1L/2/3 proteins co-purify with a novel HAT complex, consisting of HBO1, ING4/5, and Eaf6. We investigated a role for Jade-1/1L in the HBO1 complex. When overexpressed individually, neither Jade-1/1L nor HBO1 affected histone acetylation. However, co-expression of Jade1/1L and HBO1 increased acetylation of the bulk of endogenous histone H4 in epithelial cells in a synergistic manner, suggesting that Jade1/1L positively regulates HBO1 HAT activity. Conversely, small interfering RNA-mediated depletion of endogenous Jade resulted in reduced levels of H4 acetylation. Moreover, HBO1-mediated H4 acetylation activity was enhanced severalfold by the presence of Jade-1/1L in vitro. The removal of PHD fingers affected neither binding nor mutual Jade-1-HBO1 stabilization but completely abrogated the synergistic Jade-1/1L- and HBO1-mediated histone H4 acetylation in live cells and in vitro with reconstituted oligonucleosome substrates. Therefore, PHDs are necessary for Jade-1/1L- induced acetylation of nucleosomal histones by HBO1. In contrast to Jade-1/1L, the PHD zinc finger protein ING4/5 failed to synergize with HBO1 to promote histone acetylation. The physical interaction of ING4/5 with HBO1 occurred in the presence of Jade-1L or Jade-3 but not with the Jade-1 short isoform. In summary, this study demonstrates that Jade-1/1L are crucial co-factors for HBO1-mediated histone H4 acetylation.	[song, Ihn Young; Vaziri, Cyrus; Panchenko, Maria V.] Boston Univ, Sch Med, Dept Pathol & Lab Med, Boston, MA 02118 USA; [Foy, Rebecca L.; Chitalia, Vipul C.; Cohen, Herbert T.; Panchenko, Maria V.] Boston Univ, Sch Med, Dept Med, Nephrol Sect, Boston, MA 02118 USA; [song, Ihn Young; Vaziri, Cyrus; Panchenko, Maria V.] Evans Biomed Res Ctr, Med Ctr, Boston, MA 02118 USA; [Saksouk, Nehme; Cayrou, Christelle; Cote, Jacques] Univ Laval, Canc Res Ctr, Hotel Dieu Quebec, CHU Quebec, Quebec City, PQ G1R 2J6, Canada	Boston University; Boston University; Laval University	Panchenko, MV (corresponding author), Boston Univ, Sch Med, Dept Pathol & Lab Med, 670 Albany St,Rm 416, Boston, MA 02118 USA.	mpanch@bu.edu	SAKSOUK, NEHME/ABA-4057-2021; Cote, Jacques/I-8901-2014	SAKSOUK, NEHME/0000-0001-5592-6298; Cote, Jacques/0000-0001-6751-555X; Cayrou, Christelle/0000-0002-6910-8023; Cohen, Herbert/0000-0003-1900-8718; Panchenko, Maria/0000-0001-6247-6598; Chitalia, Vipul/0000-0002-6663-6058	American Heart Association [SDG 0535485T]; American Cancer Society [IRG-72-001-32-IRG]; NIEHS [RO1 ES12917, R01 CA79830, R01 DK67569]; NATIONAL CANCER INSTITUTE [R01CA079830] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK067569, K08DK080946, R01DK087910] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES012917] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); American Cancer Society(American Cancer Society); NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by American Heart Association Grant SDG 0535485T and American Cancer Society Grant IRG-72-001-32-IRG (to M. V. P.). This work was supported, in whole or in part, by National Institutes of Health Grants RO1 ES12917 from the NIEHS ( to C. V.) and Grants R01 CA79830 and R01 DK67569 ( to H. T. C.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	AASLAND R, 1995, TRENDS BIOCHEM SCI, V20, P56, DOI 10.1016/S0968-0004(00)88957-4; Agalioti T, 2002, CELL, V111, P381, DOI 10.1016/S0092-8674(02)01077-2; Allis CD, 2007, CELL, V131, P633, DOI 10.1016/j.cell.2007.10.039; ANNUNZIATO AT, 1983, J BIOL CHEM, V258, P2675; Bell SP, 2002, ANNU REV BIOCHEM, V71, P333, DOI 10.1146/annurev.biochem.71.110601.135425; Bienz M, 2006, TRENDS BIOCHEM SCI, V31, P35, DOI 10.1016/j.tibs.2005.11.001; Bordoli L, 2001, NUCLEIC ACIDS RES, V29, P4462, DOI 10.1093/nar/29.21.4462; Burke TW, 2001, J BIOL CHEM, V276, P15397, DOI 10.1074/jbc.M011556200; Carruthers LM, 2007, BIOCHEM J, V405, P541, DOI 10.1042/BJ20061347; Choy JS, 2001, J BIOL CHEM, V276, P43653, DOI 10.1074/jbc.M102531200; Cimini D, 2003, MOL BIOL CELL, V14, P3821, DOI 10.1091/mbc.E03-01-0860; Doyon Y, 2006, MOL CELL, V21, P51, DOI 10.1016/j.molcel.2005.12.007; GASHLER AL, 1993, MOL CELL BIOL, V13, P4556, DOI 10.1128/MCB.13.8.4556; Georgiakaki M, 2006, MOL ENDOCRINOL, V20, P2122, DOI 10.1210/me.2005-0149; Iizuka M, 2006, MOL CELL BIOL, V26, P1098, DOI 10.1128/MCB.26.3.1098-1108.2006; Iizuka M, 1999, J BIOL CHEM, V274, P23027, DOI 10.1074/jbc.274.33.23027; Jasencakova Z, 2000, PLANT CELL, V12, P2087, DOI 10.1105/tpc.12.11.2087; Johmura Y, 2008, J BIOL CHEM, V283, P2265, DOI 10.1074/jbc.M707880200; Kalkhoven E, 2002, MOL CELL BIOL, V22, P1961, DOI 10.1128/MCB.22.7.1961-1970.2002; Katan-Khaykovich Y, 2002, GENE DEV, V16, P743, DOI 10.1101/gad.967302; Krebs JE, 2000, CELL, V102, P587, DOI 10.1016/S0092-8674(00)00081-7; Kruhlak MJ, 2001, J BIOL CHEM, V276, P38307; Kuo MH, 1998, BIOESSAYS, V20, P615, DOI 10.1002/(SICI)1521-1878(199808)20:8<615::AID-BIES4>3.0.CO;2-H; Li HT, 2006, NATURE, V442, P91, DOI 10.1038/nature04802; Linder B, 2000, J MOL BIOL, V299, P369, DOI 10.1006/jmbi.2000.3766; Martin DGE, 2006, MOL CELL BIOL, V26, P7871, DOI 10.1128/MCB.00573-06; MEGEE PC, 1995, GENE DEV, V9, P1716, DOI 10.1101/gad.9.14.1716; Narlikar GJ, 2002, CELL, V108, P475, DOI 10.1016/S0092-8674(02)00654-2; Ng HH, 2003, MOL CELL, V11, P709, DOI 10.1016/S1097-2765(03)00092-3; Panchenko MV, 2004, J BIOL CHEM, V279, P56032, DOI 10.1074/jbc.M410487200; Ragvin A, 2004, J MOL BIOL, V337, P773, DOI 10.1016/j.jmb.2004.01.051; RUIZCARRILLO A, 1975, SCIENCE, V190, P117, DOI 10.1126/science.1166303; SAHA V, 1995, P NATL ACAD SCI USA, V92, P9737, DOI 10.1073/pnas.92.21.9737; Santos-Rosa H, 2002, NATURE, V419, P407, DOI 10.1038/nature01080; SCHINDLER U, 1993, PLANT J, V4, P137, DOI 10.1046/j.1365-313X.1993.04010137.x; Schneider R, 2004, NAT CELL BIOL, V6, P73, DOI 10.1038/ncb1076; Sharma M, 2000, J BIOL CHEM, V275, P35200, DOI 10.1074/jbc.M004838200; Shi XB, 2006, NATURE, V442, P96, DOI 10.1038/nature04835; Stedman W, 2004, J VIROL, V78, P12566, DOI 10.1128/JVI.78.22.12566-12575.2004; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Szelci J, 2000, J STEROID BIOCHEM, V72, P89, DOI 10.1016/S0960-0760(00)00025-X; Taverna SD, 2006, MOL CELL, V24, P785, DOI 10.1016/j.molcel.2006.10.026; Turner BM, 2000, BIOESSAYS, V22, P836, DOI 10.1002/1521-1878(200009)22:9<836::AID-BIES9>3.0.CO;2-X; Tyler JK, 1999, NATURE, V402, P555, DOI 10.1038/990147; Tzouanacou E, 2003, MOL CELL BIOL, V23, P8553, DOI 10.1128/MCB.23.23.8553-8562.2003; Utley RT, 2003, CURR TOP MICROBIOL, V274, P203; VAQUERO A, 2003, SCI AGING KNOWLEDGE, pRE4, DOI DOI 10.1126/SAGEKE.2003.14.RE4; Verreault A, 2000, GENE DEV, V14, P1430; Vogelauer M, 2002, MOL CELL, V10, P1223, DOI 10.1016/S1097-2765(02)00702-5; Wysocka J, 2006, NATURE, V442, P86, DOI 10.1038/nature04815; Zhou MI, 2005, P NATL ACAD SCI USA, V102, P11035, DOI 10.1073/pnas.0500757102; Zhou MI, 2002, J BIOL CHEM, V277, P39887, DOI 10.1074/jbc.M205040200	52	50	50	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 24	2008	283	43					28817	28826		10.1074/jbc.M801407200	http://dx.doi.org/10.1074/jbc.M801407200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	362EB	18684714	Green Published, hybrid			2022-12-27	WOS:000260179900006
J	Ohrtman, J; Ritter, B; Polster, A; Beam, KG; Papadopoulos, S				Ohrtman, Joshua; Ritter, Barbara; Polster, Alexander; Beam, Kurt G.; Papadopoulos, Symeon			Sequence Differences in the IQ Motifs of Ca(v)1.1 and Ca(v)1.2 Strongly Impact Calmodulin Binding and Calcium-dependent Inactivation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							II-III LOOP; CA2+ CHANNELS; DIHYDROPYRIDINE-RECEPTOR; CA2+-SENSITIVE INACTIVATION; CA2+-DEPENDENT INACTIVATION; ALPHA(1C) SUBUNIT; SITES; CURRENTS; DOMAIN; DETERMINANTS	The proximal C terminus of the cardiac L-type calcium channel (Ca(V)1.2) contains structural elements important for the binding of calmodulin (CaM) and calcium-dependent inactivation, and exhibits extensive sequence conservation with the corresponding region of the skeletal L-type channel (Ca(V)1.1). However, there are several Ca(V)1.1 residues that are both identical in six species and are non-conservatively changed from the corresponding Ca(V)1.2 residues, including three of the "IQ motif." To investigate the functional significance of these residue differences, we used native gel electrophoresis and expression in intact myotubes to compare the binding of CaM to extended regions (up to 300 residues) of the C termini of Ca(V)1.1 and Ca(V)1.2. We found that in the presence of Ca2+ (either millimolar or that in resting myotubes), CaM bound strongly to C termini of Ca(V)1.2 but not of Ca(V)1.1. Furthermore, replacement of two residues (Tyr(1657) and Lys(1662)) within the IQ motif of a C-terminal Ca(V)1.2 construct with the divergent residues of Ca(V)1.1 (His(1532) and Met(1537)) led to a weakening of CaM binding (native gels), whereas the reciprocal substitution in Ca(V)1.1 caused a gain of CaM binding. In full-length Ca(V)1.2, substitution of these same two divergent residues with those of Ca(V)1.1 (Y1657H, K1662M) eliminated calcium-dependent inactivation of the heterologously expressed channel. Thus, our results reveal that a conserved difference between the IQ motifs of Ca(V)1.2 and Ca(V)1.1 has a profound effect on both CaM binding and calcium-dependent inactivation.	[Ritter, Barbara; Polster, Alexander; Papadopoulos, Symeon] Hannover Med Sch, OE 4200, Dept Physiol, D-30625 Hannover, Germany; [Ohrtman, Joshua; Beam, Kurt G.] Univ Colorado, Hlth Sci Ctr, Dept Physiol & Biophys, Aurora, CO 80045 USA	Hannover Medical School; University of Colorado System; University of Colorado Anschutz Medical Campus	Papadopoulos, S (corresponding author), Carl Neuberg Str 1, D-30625 Hannover, Germany.	symeon@mh-hannover.de			National Institutes of Health [NS24444]; Deutsche Forschungsgemeinschaft; Deutscher Akademischer Austauschdienst; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD041697] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS024444] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Deutscher Akademischer Austauschdienst(Deutscher Akademischer Austausch Dienst (DAAD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant NS24444 (to K. G. B.). This work was also supported by grants from the Deutsche Forschungsgemeinschaft and Deutscher Akademischer Austauschdienst (DAAD) (to S. P.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Adams B, 1997, J GEN PHYSIOL, V110, P379, DOI 10.1085/jgp.110.4.379; Alseikhan BA, 2002, P NATL ACAD SCI USA, V99, P17185, DOI 10.1073/pnas.262372999; ARMSTRONG CM, 1972, BIOCHIM BIOPHYS ACTA, V267, P605, DOI 10.1016/0005-2728(72)90194-6; Beam KG, 1997, METHOD CELL BIOL, V52, P283, DOI 10.1016/S0091-679X(08)60384-2; BEAM KG, 1988, J GEN PHYSIOL, V91, P781, DOI 10.1085/jgp.91.6.781; BEAM KG, 2004, MYOLOGY, P257; Bernatchez G, 1998, BIOPHYS J, V75, P1727, DOI 10.1016/S0006-3495(98)77614-3; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BREHM P, 1978, SCIENCE, V202, P1203, DOI 10.1126/science.103199; Budde T, 2002, NAT REV NEUROSCI, V3, P873, DOI 10.1038/nrn959; CAVALIE A, 1983, PFLUG ARCH EUR J PHY, V398, P284, DOI 10.1007/BF00657238; Cens T, 2005, MOL B INT U, P95; Cens T, 2006, PROG BIOPHYS MOL BIO, V90, P104, DOI 10.1016/j.pbiomolbio.2005.05.013; CHIARANDINI DJ, 1980, J PHYSIOL-LONDON, V303, P153, DOI 10.1113/jphysiol.1980.sp013277; DASCAL N, 1986, SCIENCE, V231, P1147, DOI 10.1126/science.2418503; De Marco V, 2004, BIOCHEM BIOPH RES CO, V322, P766, DOI 10.1016/j.bbrc.2004.07.189; DELEON M, 1995, SCIENCE, V270, P1502, DOI 10.1126/science.270.5241.1502; Erickson MG, 2001, NEURON, V31, P973, DOI 10.1016/S0896-6273(01)00438-X; Erickson MG, 2003, NEURON, V39, P97, DOI 10.1016/S0896-6273(03)00395-7; Fallon JL, 2005, STRUCTURE, V13, P1881, DOI 10.1016/j.str.2005.09.021; Grabner M, 1998, P NATL ACAD SCI USA, V95, P1903, DOI 10.1073/pnas.95.4.1903; HALLING DB, 2006, SCI STKE, V318, pER1; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; Hulme JT, 2005, P NATL ACAD SCI USA, V102, P5274, DOI 10.1073/pnas.0409885102; IMREDY JP, 1994, NEURON, V12, P1301, DOI 10.1016/0896-6273(94)90446-4; Johnston JA, 1998, J CELL BIOL, V143, P1883, DOI 10.1083/jcb.143.7.1883; KASS RS, 1984, J GEN PHYSIOL, V84, P705, DOI 10.1085/jgp.84.5.705; Kim J, 2004, NEURON, V41, P745, DOI 10.1016/S0896-6273(04)00081-9; KNUDSON CM, 1989, J BIOL CHEM, V264, P1345; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lee A, 2003, P NATL ACAD SCI USA, V100, P16059, DOI 10.1073/pnas.2237000100; Lee A, 1999, NATURE, V399, P155, DOI 10.1038/20194; Lorenzon NM, 2007, J GEN PHYSIOL, V130, P379, DOI 10.1085/jgp.200609730; Lorenzon NM, 2004, J BIOL CHEM, V279, P44057, DOI 10.1074/jbc.M405318200; MIKAMI A, 1989, NATURE, V340, P230, DOI 10.1038/340230a0; Mouton J, 2001, J BIOL CHEM, V276, P22359, DOI 10.1074/jbc.M100755200; Nakai J, 1998, J BIOL CHEM, V273, P24983, DOI 10.1074/jbc.273.39.24983; Nguyen AW, 2005, NAT BIOTECHNOL, V23, P355, DOI 10.1038/nbt1066; Papadopoulos S, 2004, J BIOL CHEM, V279, P44046, DOI 10.1074/jbc.M405317200; Pate P, 2000, J BIOL CHEM, V275, P39786, DOI 10.1074/jbc.M007158200; Persechini A, 2002, TRENDS CARDIOVAS MED, V12, P32, DOI 10.1016/S1050-1738(01)00144-X; Peterson BZ, 1999, NEURON, V22, P549, DOI 10.1016/S0896-6273(00)80709-6; Pitt GS, 2001, J BIOL CHEM, V276, P30794, DOI 10.1074/jbc.M104959200; Rhoads AR, 1997, FASEB J, V11, P331, DOI 10.1096/fasebj.11.5.9141499; ROMANIN C, 1992, PFLUG ARCH EUR J PHY, V421, P516, DOI 10.1007/BF00370266; Romanin C, 2000, FEBS LETT, V487, P301, DOI 10.1016/S0014-5793(00)02361-9; Schredelseker J, 2005, P NATL ACAD SCI USA, V102, P17219, DOI 10.1073/pnas.0508710102; Sencer S, 2001, J BIOL CHEM, V276, P38237; Soldatov MM, 2003, TRENDS PHARMACOL SCI, V24, P167, DOI 10.1016/S0165-6147(03)00065-8; Soldatov NM, 1997, J BIOL CHEM, V272, P3560, DOI 10.1074/jbc.272.6.3560; Stroffekova K, 2008, PFLUG ARCH EUR J PHY, V455, P873, DOI 10.1007/s00424-007-0344-x; TANABE T, 1990, NATURE, V346, P567, DOI 10.1038/346567a0; Tang W, 2003, BIOPHYS J, V85, P1538, DOI 10.1016/S0006-3495(03)74586-X; Van Petegem F, 2005, NAT STRUCT MOL BIOL, V12, P1108, DOI 10.1038/nsmb1027; Wilkens CM, 2003, J MUSCLE RES CELL M, V24, P99, DOI 10.1023/A:1024830132118; Zhou JM, 1997, P NATL ACAD SCI USA, V94, P2301, DOI 10.1073/pnas.94.6.2301; Zuhlke RD, 2000, J BIOL CHEM, V275, P21121, DOI 10.1074/jbc.M002986200; Zuhlke RD, 1998, P NATL ACAD SCI USA, V95, P3287, DOI 10.1073/pnas.95.6.3287; Zuhlke RD, 1999, NATURE, V399, P159, DOI 10.1038/20200	59	19	21	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 24	2008	283	43					29301	29311		10.1074/jbc.M805152200	http://dx.doi.org/10.1074/jbc.M805152200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	362EB	18718913	Green Published, hybrid			2022-12-27	WOS:000260179900057
J	Qin, HN; Shi, JH; Noberini, R; Pasquale, EB; Song, JX				Qin, Haina; Shi, Jiahai; Noberini, Roberta; Pasquale, Elena B.; Song, Jianxing			Crystal Structure and NMR Binding Reveal That Two Small Molecule Antagonists Target the High Affinity Ephrin-binding Channel of the EphA4 Receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN; SPECIFICITY; SYSTEM; CRYSTALLOGRAPHY; DETERMINANTS; ANGIOGENESIS; INHIBITORS; EXPRESSION; DIVERSITY; SOFTWARE	The Eph receptor tyrosine kinases regulate a variety of physiological and pathological processes not only during development but also in adult organs, and therefore they represent a promising class of drug targets. The EphA4 receptor plays important roles in the inhibition of the regeneration of injured axons, synaptic plasticity, platelet aggregation, and likely in certain types of cancer. Here we report the first crystal structure of the EphA4 ligand-binding domain, which adopts the same jellyroll beta-sandwich architecture as shown previously for EphB2 and EphB4. The similarity with EphB receptors is high in the core beta-stranded regions, whereas large variations exist in the loops, particularly the D-E and J-K loops, which form the high affinity ephrin binding channel. We also used isothermal titration calorimetry, NMR spectroscopy, and computational docking to characterize the binding to EphA4 of two small molecules, 4- and 5-(2,5 dimethyl-pyrrol-1-yl)-2-hydroxybenzoic acid which antagonize ephrin-induced effects in EphA4-expressing cells. We show that the two molecules bind to the EphA4 ligand-binding domain with K-d values of 20.4 and 26.4 mu M, respectively. NMR heteronuclear single quantum coherence titrations revealed that upon binding, both molecules significantly perturb EphA4 residues Ile(31)-Met(32) in the D-E loop, Gln(43) in the E beta-strand, and Ile(131)-Gly(132) in the J-K loop. Molecular docking shows that they can occupy a cavity in the high affinity ephrin binding channel of EphA4 in a similar manner, by interacting mainly with the EphA4 residues in the E strand and D-E and J-K loops. However, many of the interactions observed in Eph receptor-ephrin complexes are absent, which is consistent with the small size of the two molecules and may account for their relatively weak binding affinity. Thus, our studies provide the first receptor of the A subclass. Furthermore, the results demonstrate that the high affinity ephrin binding channel of the Eph receptors is amenable to targeting with small molecule antagonists and suggest avenues for further optimization.	[Qin, Haina; Shi, Jiahai; Song, Jianxing] Natl Univ Singapore, Fac Sci, Dept Biol Sci, Singapore 11926, Singapore; [Noberini, Roberta; Pasquale, Elena B.] Burnham Inst Med Res, La Jolla, CA 92037 USA; [Noberini, Roberta] Univ Parma, Dept Biochem & Mol Biol, I-43100 Parma, Italy; [Pasquale, Elena B.] Univ Calif San Diego, Dept Pathol, La Jolla, CA 92093 USA; [Song, Jianxing] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Biochem, Singapore 11926, Singapore	National University of Singapore; Sanford Burnham Prebys Medical Discovery Institute; University of Parma; University of California System; University of California San Diego; National University of Singapore	Song, JX (corresponding author), Natl Univ Singapore, Fac Sci, Dept Biol Sci, Singapore 11926, Singapore.	bchsj@nus.edu.sg	Qin, Haina/AAB-7486-2020; Shi, Jiahai/AAH-1103-2019; Song, Jianxing/J-3617-2013; Song, Jianxing/H-8026-2012; Noberini, Roberta/AAP-4527-2020; shi, jiahai/D-7650-2013	Shi, Jiahai/0000-0002-6467-8289; shi, jiahai/0000-0002-6467-8289; Song, Jianxing/0000-0003-0224-6322; Haina, Qin/0000-0002-9175-8014; Noberini, Roberta/0000-0002-7267-1079	National Medical Research Council of Singapore [R-154-000-382-213]	National Medical Research Council of Singapore(National Medical Research Council, Singapore)	This work was supported by National Medical Research Council of Singapore Grant R-154-000-382-213 (to J. S.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Adams RH, 2002, SEMIN CELL DEV BIOL, V13, P55, DOI 10.1006/scdb.2001.0289; Ashida S, 2004, CANCER RES, V64, P5963, DOI 10.1158/0008-5472.CAN-04-0020; Benson MD, 2005, P NATL ACAD SCI USA, V102, P10694, DOI 10.1073/pnas.0504021102; Bourgin C, 2007, J CELL BIOL, V178, P1295, DOI 10.1083/jcb.200610139; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Caligiuri M, 2006, CHEM BIOL, V13, P711, DOI 10.1016/j.chembiol.2006.05.008; Chrencik JE, 2006, STRUCTURE, V14, P321, DOI 10.1016/j.str.2005.11.011; Chrencik JE, 2007, J BIOL CHEM, V282, P36505, DOI 10.1074/jbc.M706340200; Chrencik JE, 2006, J BIOL CHEM, V281, P28185, DOI 10.1074/jbc.M605766200; Cowan CA, 2001, NATURE, V413, P174, DOI 10.1038/35093123; De Vries SJ, 2007, PROTEINS, V69, P726, DOI 10.1002/prot.21723; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dominguez C, 2003, J AM CHEM SOC, V125, P1731, DOI 10.1021/ja026939x; Du J, 2007, CURR PHARM DESIGN, V13, P2507; Easty DJ, 1997, INT J CANCER, V71, P1061, DOI 10.1002/(SICI)1097-0215(19970611)71:6<1061::AID-IJC24>3.0.CO;2-F; Egea J, 2007, TRENDS CELL BIOL, V17, P230, DOI 10.1016/j.tcb.2007.03.004; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gallarda BW, 2008, SCIENCE, V320, P233, DOI 10.1126/science.1153758; Goldshmit Y, 2004, J NEUROSCI, V24, P10064, DOI 10.1523/JNEUROSCI.2981-04.2004; Heroult M, 2006, EXP CELL RES, V312, P642, DOI 10.1016/j.yexcr.2005.10.028; Himanen JP, 1998, NATURE, V396, P486, DOI 10.1038/24904; Himanen JP, 2004, NAT NEUROSCI, V7, P501, DOI 10.1038/nn1237; Himanen JP, 2001, NATURE, V414, P933, DOI 10.1038/414933a; Himanen JP, 2007, CURR OPIN CELL BIOL, V19, P534, DOI 10.1016/j.ceb.2007.08.004; Iiizumi M, 2006, CANCER SCI, V97, P1211, DOI 10.1111/j.1349-7006.2006.00313.x; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; Karaman MW, 2008, NAT BIOTECHNOL, V26, P127, DOI 10.1038/nbt1358; Klein R, 2004, CURR OPIN CELL BIOL, V16, P580, DOI 10.1016/j.ceb.2004.07.002; Kolb P, 2008, PROTEINS, V73, P11, DOI 10.1002/prot.22028; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Liu JX, 2006, BIOCHEMISTRY-US, V45, P7171, DOI 10.1021/bi060091y; Luo LQ, 2007, NEURON, V56, P284, DOI 10.1016/j.neuron.2007.10.014; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; Miyazaki Y, 2008, BIOORG MED CHEM LETT, V18, P1967, DOI 10.1016/j.bmcl.2008.01.113; Noberini R, 2008, J BIOL CHEM, V283, P29461, DOI 10.1074/jbc.M804103200; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PACE CN, 1995, PROTEIN SCI, V4, P2411, DOI 10.1002/pro.5560041120; Pasquale EB, 2005, NAT REV MOL CELL BIO, V6, P462, DOI 10.1038/nrm1662; Pasquale EB, 2004, NAT NEUROSCI, V7, P417, DOI 10.1038/nn0504-417; Pasquale EB, 2008, CELL, V133, P38, DOI 10.1016/j.cell.2008.03.011; Prevost N, 2005, P NATL ACAD SCI USA, V102, P9820, DOI 10.1073/pnas.0404065102; Ran XY, 2008, PROTEINS, V72, P1019, DOI 10.1002/prot.21999; Ran XY, 2005, J BIOL CHEM, V280, P19205, DOI 10.1074/jbc.M500330200; Richter M, 2007, J NEUROSCI, V27, P14205, DOI 10.1523/JNEUROSCI.2746-07.2007; Sattler M, 1999, PROG NUCL MAG RES SP, V34, P93, DOI 10.1016/S0079-6565(98)00025-9; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Shi JH, 2008, J VIROL, V82, P4620, DOI 10.1128/JVI.02680-07; Shi JH, 2008, BIOMATERIALS, V29, P2820, DOI 10.1016/j.biomaterials.2008.03.020; Song JX, 2003, J BIOL CHEM, V278, P24714, DOI 10.1074/jbc.M210625200; Tang FY, 2007, J NUTR BIOCHEM, V18, P391, DOI 10.1016/j.jnutbio.2006.07.004; Yamaguchi Y, 2004, CURR OPIN NEUROBIOL, V14, P288, DOI 10.1016/j.conb.2004.04.003; Yao VJ, 2005, AM J PATHOL, V166, P625, DOI 10.1016/S0002-9440(10)62283-3; Zhang NX, 2006, J MOL BIOL, V363, P188, DOI 10.1016/j.jmb.2006.08.026	54	54	55	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 24	2008	283	43					29473	29484		10.1074/jbc.M804114200	http://dx.doi.org/10.1074/jbc.M804114200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	362EB	18708347	hybrid, Green Published			2022-12-27	WOS:000260179900073
J	Xia, ZX; Turner, GC; Hwang, CS; Byrd, C; Varshavsky, A				Xia, Zanxian; Turner, Glenn C.; Hwang, Cheol-Sang; Byrd, Christopher; Varshavsky, Alexander			Amino Acids Induce Peptide Uptake via Accelerated Degradation of CUP9, the Transcriptional Repressor of the PTR2 Peptide Transporter	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							END RULE PATHWAY; PERMEASE GENE BAP2; SACCHAROMYCES-CEREVISIAE; UBIQUITIN LIGASE; IN-VIVO; ENDOPROTEOLYTIC ACTIVATION; PROTEOLYTIC PATHWAY; PLASMA-MEMBRANE; YEAST; PROTEIN	Multiple pathways link expression of PTR2, the transporter of di- and tripeptides in the yeast Saccharomyces cerevisiae, to the availability and quality of nitrogen sources. Previous work has shown that induction of PTR2 by extracellular amino acids requires, in particular, SSY1 and PTR3. SSY1 is structurally similar to amino acid transporters but functions as a sensor of amino acids. PTR3 acts downstream of SSY1. Expression of the PTR2 peptide transporter is induced not only by amino acids but also by dipeptides with destabilizing N-terminal residues. These dipeptides bind to UBR1, the ubiquitin ligase of the N-end rule pathway, and allosterically accelerate the UBR1-dependent degradation of CUP9, a transcriptional repressor of PTR2. UBR1 targets CUP9 through its internal degron. Here we demonstrate that the repression of PTR2 by CUP9 requires TUP1 and SSN6, the corepressor proteins that form a complex with CUP9. We also show that the induction of PTR2 by amino acids is mediated by the UBR1-dependent acceleration of CUP9 degradation that requires both SSY1 and PTR3. The acceleration of CUP9 degradation is shown to be attained without increasing the activity of the N-end rule pathway toward substrates with destabilizing N-terminal residues. We also found that GAP1, a general amino acid transporter, strongly contributes to the induction of PTR2 by Trp. Although several aspects of this complex circuit remain to be understood, our findings establish new functional links between the amino acids-sensing SPS system, the CUP9-TUP1-SSN6 repressor complex, the PTR2 peptide transporter, and the UBR1-dependent N-end rule pathway.	[Xia, Zanxian; Hwang, Cheol-Sang; Varshavsky, Alexander] CALTECH, Div Biol, Pasadena, CA 91125 USA; [Turner, Glenn C.] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; [Byrd, Christopher] Wilson Sonsini Goodrich & Rosati, Palo Alto, CA 94304 USA	California Institute of Technology; Cold Spring Harbor Laboratory	Varshavsky, A (corresponding author), CALTECH, Div Biol, Pasadena, CA 91125 USA.	avarsh@caltech.edu	Hwang, Cheol-Sang/Q-7391-2019	Hwang, Cheol-Sang/0000-0002-0105-5957; Turner, Glenn/0000-0002-5341-2784	National Institutes of Health [DK39520, GM31530]; Sandler Program for Asthma Research; Ellison Medical Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK039520, R37DK039520, R56DK039520] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM031530] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Sandler Program for Asthma Research; Ellison Medical Foundation(Lawrence Ellison Foundation); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants DK39520 and GM31530 ( to A. V.). This work was also supported by the Sandler Program for Asthma Research, and from the Ellison Medical Foundation. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Abdel-Sater F, 2004, MOL CELL BIOL, V24, P9771, DOI 10.1128/MCB.24.22.9771-9785.2004; Abdel-Sater F, 2004, GENETICS, V166, P1727, DOI 10.1534/genetics.166.4.1727; ALAGRAMAM K, 1995, MOL MICROBIOL, V15, P225, DOI 10.1111/j.1365-2958.1995.tb02237.x; Andreasson C, 2002, GENE DEV, V16, P3158, DOI 10.1101/gad.239202; Andreasson C, 2006, GENE DEV, V20, P1563, DOI 10.1101/gad.374206; BACHMAIR A, 1989, CELL, V56, P1019, DOI 10.1016/0092-8674(89)90635-1; Bernard F, 2001, FEBS LETT, V496, P81, DOI 10.1016/S0014-5793(01)02412-7; Boban M, 2007, GENETICS, V176, P2087, DOI 10.1534/genetics.107.075077; Boles E, 2004, TOP CURR GENET, V9, P121; Byrd C, 1998, EMBO J, V17, P269, DOI 10.1093/emboj/17.1.269; Cai HJ, 2006, GENETICS, V172, P1459, DOI 10.1534/genetics.105.053041; Cai HJ, 2007, EUKARYOT CELL, V6, P1805, DOI 10.1128/EC.00257-06; CHEN XH, 1994, MOL GEN GENET, V244, P260, DOI 10.1007/BF00285453; Ditzel M, 2003, NAT CELL BIOL, V5, P467, DOI 10.1038/ncb984; Du FY, 2002, P NATL ACAD SCI USA, V99, P14110, DOI 10.1073/pnas.172527399; FOSBERG H, 2001, CURR GENET, V40, P91; FROMMER WB, 1994, FEBS LETT, V347, P185, DOI 10.1016/0014-5793(94)00533-8; Ghislain M, 1996, EMBO J, V15, P4884, DOI 10.1002/j.1460-2075.1996.tb00869.x; Godard P, 2007, MOL CELL BIOL, V27, P3065, DOI 10.1128/MCB.01084-06; Graciet E, 2006, P NATL ACAD SCI USA, V103, P3078, DOI 10.1073/pnas.0511224103; Holsbeeks I, 2004, TRENDS BIOCHEM SCI, V29, P556, DOI 10.1016/j.tibs.2004.08.010; Homann OR, 2005, PLOS GENET, V1, P715, DOI 10.1371/journal.pgen.0010080; Hou JY, 2008, NAT STRUCT MOL BIOL, V15, P288, DOI 10.1038/nsmb.1392; Hu RG, 2005, NATURE, V437, P981, DOI 10.1038/nature04027; Hu RG, 2008, P NATL ACAD SCI USA, V105, P76, DOI 10.1073/pnas.0710568105; Hu RG, 2006, J BIOL CHEM, V281, P32559, DOI 10.1074/jbc.M604355200; Inobe T, 2008, CURR OPIN STRUC BIOL, V18, P43, DOI 10.1016/j.sbi.2007.12.014; ISLAND MD, 1987, J BACTERIOL, V169, P2132, DOI 10.1128/jb.169.5.2132-2136.1987; JOHNSON ES, 1995, J BIOL CHEM, V270, P17442, DOI 10.1074/jbc.270.29.17442; Jorgensen MU, 1997, CURR GENET, V31, P241, DOI 10.1007/s002940050201; Klasson H, 1999, MOL CELL BIOL, V19, P5405; Kwon YT, 2003, MOL CELL BIOL, V23, P8255, DOI 10.1128/MCB.23.22.8255-8271.2003; Kwon YT, 2002, SCIENCE, V297, P96, DOI 10.1126/science.1069531; Laney JD, 2006, MOL CELL BIOL, V26, P371, DOI 10.1128/MCB.26.1.371-380.2006; Lee MJ, 2005, P NATL ACAD SCI USA, V102, P15030, DOI 10.1073/pnas.0507533102; Liu ZC, 2008, MOL CELL BIOL, V28, P551, DOI 10.1128/MCB.00929-07; Malave TM, 2006, BIOCHEM CELL BIOL, V84, P437, DOI 10.1139/O06-073; Mogk A, 2007, TRENDS CELL BIOL, V17, P165, DOI 10.1016/j.tcb.2007.02.001; Nielsen PS, 2001, MOL GEN GENET, V264, P613, DOI 10.1007/s004380000347; Rao H, 2001, NATURE, V410, P955, DOI 10.1038/35073627; Roosen J, 2005, MOL MICROBIOL, V55, P862, DOI 10.1111/j.1365-2958.2004.04429.x; Sasaki T, 2006, MOL CELL, V24, P63, DOI 10.1016/j.molcel.2006.08.005; SCHNEIDER BL, 1995, YEAST, V11, P1265, DOI 10.1002/yea.320111306; SIKORSKI RS, 1989, GENETICS, V122, P19; Spielewoy N, 2004, MOL CELL BIOL, V24, P8994, DOI 10.1128/MCB.24.20.8994-9005.2004; Suzuki T, 1999, EMBO J, V18, P6017, DOI 10.1093/emboj/18.21.6017; Tasaki T, 2005, MOL CELL BIOL, V25, P7120, DOI 10.1128/MCB.25.16.7120-7136.2005; Tasaki T, 2007, TRENDS BIOCHEM SCI, V32, P520, DOI 10.1016/j.tibs.2007.08.010; Tasaki T, 2007, J BIOL CHEM, V282, P18510, DOI 10.1074/jbc.M701894200; Turner GC, 2000, SCIENCE, V289, P2117, DOI 10.1126/science.289.5487.2117; Turner GC, 2000, NATURE, V405, P579, DOI 10.1038/35014629; Varshavsky A, 1996, P NATL ACAD SCI USA, V93, P12142, DOI 10.1073/pnas.93.22.12142; Varshavsky A, 2005, METHOD ENZYMOL, V399, P777, DOI 10.1016/S0076-6879(05)99051-4; Varshavsky A, 2004, CURR BIOL, V14, pR181, DOI 10.1016/j.cub.2004.02.014; Wiles AM, 2006, MICROBIOL-SGM, V152, P3133, DOI 10.1099/mic.0.29055-0; Wu BQ, 2006, J CELL BIOL, V173, P327, DOI 10.1083/jcb.200602089; Xia ZX, 2008, J BIOL CHEM, V283, P24011, DOI 10.1074/jbc.M802583200; Xie YM, 1999, EMBO J, V18, P6832, DOI 10.1093/emboj/18.23.6832; Zenker M, 2005, NAT GENET, V37, P1345, DOI 10.1038/ng1681	59	36	36	2	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 24	2008	283	43					28958	28968		10.1074/jbc.M803980200	http://dx.doi.org/10.1074/jbc.M803980200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	362EB	18708352	Green Published, Green Accepted, hybrid			2022-12-27	WOS:000260179900021
J	Carlson, CB; Gunderson, KA; Mosher, DF				Carlson, C. Britt; Gunderson, Kristin A.; Mosher, Deane F.			Mutations targeting intermodular interfaces or calcium binding destabilize the thrombospondin-2 signature domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OLIGOMERIC MATRIX PROTEIN; MULTIPLE EPIPHYSEAL DYSPLASIA; PSEUDOACHONDROPLASIA CHONDROCYTES; ENDOPLASMIC-RETICULUM; TYPE-3 REPEATS; CA2+ BINDING; CELL-DEATH; COMP; EXPRESSION; APOPTOSIS	Thrombospondins (THBSs) are a family of secreted calcium-binding glycoproteins with roles in angiogenesis, cell motility, apoptosis, cytoskeletal organization, and extracellular matrix organization. The THBS-2 signature domain (three epidermal growth factor (EGF)-like modules, a wire module with 13 calcium-binding repeats, and a lectin-like module) binds 30 calcium ions and forms extensive interactions among its parts. We explored the significance of these structural elements by examining the impact of 10 different mutations known to result in pseudoachondrodysplasia or multiple epiphyseal dysplasia when found in the homologous wire and lectin-like modules of thrombospondin-5 (THBS-5). A variety of observations indicate that the mutations result in unstable THBS-5 proteins that aggregate in the endoplasmic reticulum. We introduced the mutations into homologous sites of a THBS-2 construct, for which the crystal structure is known, and determined the effects of the mutations on structure as assayed by differential scanning calorimetry and expression of the epitope for the 4B6.13 conformation-sensitive antibody. Abnormalities were found in one or more of several readouts: stability of interactions between the wire and lectin-like modules, stabilities of the EGF-like and wire modules, expression of the 4B6.13 epitope in soluble protein, and expression of the 4B6.13 epitope in substrate-adsorbed protein at different calcium concentrations. The patterns of abnormalities support the idea that the EGF-like, wire, and lectin-like modules constitute a dynamic and interactive calcium-sensitive structure in which a distortion at one site is transmitted to distal sites, leading to global changes in the protein.	[Mosher, Deane F.] Univ Wisconsin, Dept Med, Madison, WI 53706 USA; Univ Wisconsin, Dept Biomol Chem, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Mosher, DF (corresponding author), Univ Wisconsin, Dept Med, 4285 Med Sci Ctr,1300 Univ Ave, Madison, WI 53706 USA.	dfmosher@wisc.edu			National Institutes of Health [HL54462, HL07899]; University of Wisconsin-Madison Biophysics Instrumentation Facility [S10 RR13790]; National Science Foundation [BIR-9512577]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR013790] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL054462] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Wisconsin-Madison Biophysics Instrumentation Facility; National Science Foundation(National Science Foundation (NSF)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL54462 (to D.F.M.) and S10 RR13790 (to the University of Wisconsin-Madison Biophysics Instrumentation Facility). This work was also supported by National Science Foundation Grant BIR-9512577 (to the University of Wisconsin-Madison Biophysics Instrumentation Facility). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact. 1 Supported by National Institutes of Health Training Grant HL07899.	Adams J, 2004, INT J BIOCHEM CELL B, V36, P960, DOI 10.1016/j.biocel.2004.02.009; Annis DS, 2007, J BIOL CHEM, V282, P27067, DOI 10.1074/jbc.M703804200; Carlson CB, 2008, CELL MOL LIFE SCI, V65, P672, DOI 10.1007/s00018-007-7484-1; Carlson CB, 2008, J BIOL CHEM, V283, P20069, DOI 10.1074/jbc.M800223200; Carlson CB, 2005, NAT STRUCT MOL BIOL, V12, P910, DOI 10.1038/nsmb997; Chen H, 2000, J BIOL CHEM, V275, P26538, DOI 10.1074/jbc.M909780199; Chen TLL, 2008, J CELL BIOCHEM, V103, P778, DOI 10.1002/jcb.21445; Delano W.L., 2002, DELANO SCI; Dinser R, 2002, J CLIN INVEST, V110, P505, DOI 10.1172/JCI200214386; Duke J, 2003, APOPTOSIS, V8, P191, DOI 10.1023/A:1022926811397; Hannah BLA, 2004, J BIOL CHEM, V279, P51915, DOI 10.1074/jbc.M409632200; Hashimoto Y, 2003, AM J PATHOL, V163, P101, DOI 10.1016/S0002-9440(10)63634-6; Hecht JT, 1998, MATRIX BIOL, V17, P269, DOI 10.1016/S0945-053X(98)90080-4; Hecht JT, 1998, MATRIX BIOL, V17, P625, DOI 10.1016/S0945-053X(98)90113-5; Hecht JT, 2001, MATRIX BIOL, V20, P251, DOI 10.1016/S0945-053X(01)00136-6; Hou J, 2000, CELL CALCIUM, V27, P309, DOI 10.1054/ceca.2000.0125; Karen LP, 2004, INT J BIOCHEM CELL B, V36, P1005, DOI 10.1016/j.biocel.2004.01.011; Kennedy J, 2005, EUR J HUM GENET, V13, P547, DOI 10.1038/sj.ejhg.5201374; Kleerekoper Q, 2002, J BIOL CHEM, V277, P10581, DOI 10.1074/jbc.M109944200; Kondrashov AS, 2002, P NATL ACAD SCI USA, V99, P14878, DOI 10.1073/pnas.232565499; Kvansakul M, 2004, EMBO J, V23, P1223, DOI 10.1038/sj.emboj.7600166; MACH H, 1992, ANAL BIOCHEM, V200, P74, DOI 10.1016/0003-2697(92)90279-G; Maddox BK, 2000, J BIOL CHEM, V275, P11412, DOI 10.1074/jbc.275.15.11412; Merritt TM, 2007, AM J PATHOL, V170, P293, DOI 10.2353/ajpath.2007.060530; Merritt TM, 2006, J ORTHOP RES, V24, P700, DOI 10.1002/jor.20100; Misenheimer TM, 2005, J BIOL CHEM, V280, P41229, DOI 10.1074/JBC.M504696200; Misenheimer TM, 2003, BIOCHEMISTRY-US, V42, P5125, DOI 10.1021/bi026983p; Mosher DF, 2002, METHOD CELL BIOL, V69, P69, DOI 10.1016/S0091-679X(02)69008-9; Pirog-Garcia KA, 2007, HUM MOL GENET, V16, P2072, DOI 10.1093/hmg/ddm155; Posey KL, 2008, CELL MOL LIFE SCI, V65, P687, DOI 10.1007/s00018-007-7485-0; Schmitz M, 2008, MATRIX BIOL, V27, P67, DOI 10.1016/j.matbio.2007.08.001; Svensson L, 2002, MOL CELL BIOL, V22, P4366, DOI 10.1128/MCB.22.12.4366-4371.2002; Thur J, 2001, J BIOL CHEM, V276, P6083, DOI 10.1074/jbc.M009512200; Tooney PA, 1998, MATRIX BIOL, V17, P131, DOI 10.1016/S0945-053X(98)90026-9; Vranka J, 2001, MATRIX BIOL, V20, P439, DOI 10.1016/S0945-053X(01)00148-2; Weirich C, 2007, MATRIX BIOL, V26, P314, DOI 10.1016/j.matbio.2007.01.004	36	9	9	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 3	2008	283	40					27089	27099		10.1074/jbc.M803842200	http://dx.doi.org/10.1074/jbc.M803842200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	353RT	18682400	Green Published, hybrid			2022-12-27	WOS:000259586600030
J	Dai, RP; Yu, FX; Goh, SR; Chng, HW; Tan, YL; Fu, JL; Zheng, L; Luo, Y				Dai, Ru-Ping; Yu, Fa-Xing; Goh, Shuang-Ru; Chng, Hsiao-Wee; Tan, Ya-Li; Fu, Jian-Lin; Zheng, Lei; Luo, Yan			Histone 2B (H2B) expression is confined to a proper NAD(+)/NADH redox status	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAMMALIAN GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE; CELL-CYCLE REGULATION; COACTIVATOR OCA-B; GENE-TRANSCRIPTION; METABOLIC ENZYMES; PHOSPHORYLATION; DEGENERATION; ACTIVATION; COMPLEX; PROTEIN	S-phase transcription of the histone 2B (H2B) gene is dependent on Octamer-binding factor 1 (Oct-1) and Oct-1 Co-Activator in S-phase (OCA-S), a protein complex comprising glyceraldehyde-3-phosphate dehydrogenase and lactate dehydrogenase (p38/GAPDH and p36/LDH) along with other components. H2B transcription in vitro is modulated by NAD(H). This potentially links the cellular redox status to histone expression. Here, we show that H2B transcription requires a proper NAD(+)/NADH redox status in vitro and in vivo. Therefore, perturbing a properly balanced redox impairs H2B transcription. A redox-modulated direct p38/GAPDH-Oct-1 interaction nucleates the occupancy of the H2B promoter by the OCA-S complex, in which p36/LDH plays a critical role in the hierarchical organization of the complex. As for p38/GAPDH, p36/LDH is essential for the OCA-S function in vivo, and OCA-S-associated p36/LDH possesses an LDH enzyme activity that impacts H2B transcription. These studies suggest that the cellular redox status (metabolic states) can directly feedback to gene switching in higher eukaryotes as is commonly observed in prokaryotes.	[Zheng, Lei] Johns Hopkins Univ, Sch Med, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD 21230 USA; [Dai, Ru-Ping; Yu, Fa-Xing; Goh, Shuang-Ru; Chng, Hsiao-Wee; Tan, Ya-Li; Fu, Jian-Lin; Luo, Yan] Inst Mol & Cell Biol, Singapore 138673, Singapore	Johns Hopkins University; Johns Hopkins Medicine; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB)	Zheng, L (corresponding author), Johns Hopkins Univ, Sch Med, Sidney Kimmel Comprehens Canc Ctr, 1650 Orleans St,CRB 186, Baltimore, MD 21230 USA.	lzheng6@jhmi.edu; yluo@imcb.a-star.edu.sg	Fu, Jianlin/T-6132-2019	Yu, Fa-Xing/0000-0003-4834-9335	Agency for Science, Technology, and Research (A* STAR), Singapore	Agency for Science, Technology, and Research (A* STAR), Singapore(Agency for Science Technology & Research (A*STAR))	This work was supported by the Agency for Science, Technology, and Research (A* STAR), Singapore. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Araki T, 2004, SCIENCE, V305, P1010, DOI 10.1126/science.1098014; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Ewen ME, 2000, GENE DEV, V14, P2265, DOI 10.1101/gad.842100; FLETCHER C, 1987, CELL, V51, P773, DOI 10.1016/0092-8674(87)90100-0; Fulco M, 2003, MOL CELL, V12, P51, DOI 10.1016/S1097-2765(03)00226-0; Kim MY, 2005, GENE DEV, V19, P1951, DOI 10.1101/gad.1331805; LABELLA F, 1988, GENE DEV, V2, P32, DOI 10.1101/gad.2.1.32; LUO Y, 1995, MOL CELL BIOL, V15, P4115; Luo Y, 1999, COLD SPRING HARB SYM, V64, P119, DOI 10.1101/sqb.1999.64.119; Ma TL, 2000, GENE DEV, V14, P2298, DOI 10.1101/gad.829500; Mack TGA, 2001, NAT NEUROSCI, V4, P1199, DOI 10.1038/nn770; Marzluff WF, 2002, CURR OPIN CELL BIOL, V14, P692, DOI 10.1016/S0955-0674(02)00387-3; McKnight S, 2003, CELL, V114, P150, DOI 10.1016/S0092-8674(03)00563-4; MORGENEGG G, 1986, J NEUROCHEM, V47, P54; Nelson DM, 2002, MOL CELL BIOL, V22, P7459, DOI 10.1128/MCB.22.21.7459-7472.2002; OSLEY MA, 1991, ANNU REV BIOCHEM, V60, P827, DOI 10.1146/annurev.biochem.60.1.827; PASSONNEAU JV, 1993, ENZYMATIC ANAL PRACT, P85; Rongvaux A, 2003, BIOESSAYS, V25, P683, DOI 10.1002/bies.10297; SEGIL N, 1991, SCIENCE, V254, P1814, DOI 10.1126/science.1684878; Shi YJ, 2004, TRENDS GENET, V20, P445, DOI 10.1016/j.tig.2004.07.004; Shi YJ, 2003, NATURE, V422, P735, DOI 10.1038/nature01550; Sirover MA, 1999, BBA-PROTEIN STRUCT M, V1432, P159, DOI 10.1016/S0167-4838(99)00119-3; Su C, 2004, EMBO J, V23, P1133, DOI 10.1038/sj.emboj.7600120; Svedruzic ZM, 2006, PROTEINS, V63, P501, DOI 10.1002/prot.20862; VEECH RL, 1969, BIOCHEM J, V115, P609, DOI 10.1042/bj1150609a; Zhang QH, 2002, SCIENCE, V295, P1895; Zhao JY, 2000, GENE DEV, V14, P2283, DOI 10.1101/gad.827700; Zheng L, 2003, CELL, V114, P255, DOI 10.1016/S0092-8674(03)00552-X	28	56	61	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 3	2008	283	40					26894	26901		10.1074/jbc.M804307200	http://dx.doi.org/10.1074/jbc.M804307200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	353RT	18682386	hybrid			2022-12-27	WOS:000259586600009
J	Butterworth, MB; Weisz, OA; Johnson, JP				Butterworth, Michael B.; Weisz, Ora A.; Johnson, John P.			Some Assembly Required: Putting the Epithelial Sodium Channel Together	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							SUBUNIT MESSENGER-RNAS; ENAC SUBUNITS; NA+ CHANNEL; SURFACE EXPRESSION; NONCOORDINATE REGULATION; APICAL MEMBRANE; ALPHA; KIDNEY; BETA; ENDOCYTOSIS		[Butterworth, Michael B.; Weisz, Ora A.; Johnson, John P.] Univ Pittsburgh, Dept Cell Biol & Physiol, Pittsburgh, PA 15261 USA; [Weisz, Ora A.; Johnson, John P.] Univ Pittsburgh, Dept Med, Pittsburgh, PA 15261 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Johnson, JP (corresponding author), Univ Pittsburgh, Dept Cell Biol & Physiol, Pittsburgh, PA 15261 USA.	johnson@dom.pitt.edu		Butterworth, Michael/0000-0002-2173-8333	National Institutes of Health [DK078917, DK064613, DK057718]; Cystic Fibrosis Foundation [BUTTER06G0]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK057718, R01DK064613, K99DK078917, R00DK078917] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cystic Fibrosis Foundation(Italian Cystic Fibrosis Research Foundation); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK078917 (to M. B. B.), DK064613 (to O.A.W.), and DK057718 (to J.P.J.). This work was also supported by Cystic Fibrosis Foundation Grant BUTTER06G0 ( to M. B. B.). This minireview will be reprinted in the 2008 Minireview Compendium, which will be available in January, 2009.	Bonifacino JS, 2006, NAT REV MOL CELL BIO, V7, P568, DOI 10.1038/nrm1985; Bruns JB, 2007, J BIOL CHEM, V282, P6153, DOI 10.1074/jbc.M610636200; Butterworth MB, 2005, J GEN PHYSIOL, V125, P81, DOI 10.1085/jgp.2004.09124; Butterworth MB, 2007, J BIOL CHEM, V282, P37885, DOI 10.1074/jbc.M707989200; Butterworth MB, 2009, AM J PHYSIOL-RENAL, V296, pF10, DOI 10.1152/ajprenal.90248.2008; Caldwell RA, 2005, AM J PHYSIOL-LUNG C, V288, pL813, DOI 10.1152/ajplung.00435.2004; Caldwell RA, 2004, AM J PHYSIOL-CELL PH, V286, pC190, DOI 10.1152/ajpcell.00342.2003; CANESSA CM, 1994, NATURE, V367, P463, DOI 10.1038/367463a0; Eaton Douglas C, 2004, Proc Am Thorac Soc, V1, P10, DOI 10.1513/pats.2306008; Ergonul Z, 2006, AM J PHYSIOL-RENAL, V291, pF683, DOI 10.1152/ajprenal.00422.2005; Escoubet B, 1997, AM J PHYSIOL-CELL PH, V272, pC1482, DOI 10.1152/ajpcell.1997.272.5.C1482; Farman N, 1997, AM J PHYSIOL-CELL PH, V272, pC131, DOI 10.1152/ajpcell.1997.272.1.C131; Firsov D, 1998, EMBO J, V17, P344, DOI 10.1093/emboj/17.2.344; Folkesson HG, 2008, AM J PHYSIOL-LUNG C, V294, pL399, DOI 10.1152/ajplung.00523.2007; Frindt G, 2008, J GEN PHYSIOL, V131, P617, DOI 10.1085/jgp.200809989; Garty H, 1997, PHYSIOL REV, V77, P359, DOI 10.1152/physrev.1997.77.2.359; HAGER H, 2000, AM J PHYSIOL, V280, pF1093; Harris M, 2008, J BIOL CHEM, V283, P7455, DOI 10.1074/jbc.M707399200; HEMAR A, 1995, J CELL BIOL, V129, P55, DOI 10.1083/jcb.129.1.55; Hughey RP, 2004, J BIOL CHEM, V279, P18111, DOI 10.1074/jbc.C400080200; Hughey RP, 2003, J BIOL CHEM, V278, P37073, DOI 10.1074/jbc.M307003200; Husted RF, 2007, AM J PHYSIOL-RENAL, V293, pF813, DOI 10.1152/ajprenal.00225.2007; Itani OA, 2003, AM J PHYSIOL-RENAL, V284, pF778, DOI 10.1152/ajprenal.00088.2002; Jasti J, 2007, NATURE, V449, P316, DOI 10.1038/nature06163; Ji HL, 2006, J BIOL CHEM, V281, P8233, DOI 10.1074/jbc.M512293200; Kabra R, 2008, J BIOL CHEM, V283, P6033, DOI 10.1074/jbc.M708555200; Kashlan OB, 2007, J BIOL CHEM, V282, P28149, DOI 10.1074/jbc.M703409200; Knight KK, 2006, P NATL ACAD SCI USA, V103, P2805, DOI 10.1073/pnas.0511184103; Loffing J, 2001, AM J PHYSIOL-RENAL, V280, pF675, DOI 10.1152/ajprenal.2001.280.4.F675; Loffing J, 2000, AM J PHYSIOL-RENAL, V279, pF252, DOI 10.1152/ajprenal.2000.279.2.F252; Lu C, 2007, TRAFFIC, V8, P1246, DOI 10.1111/j.1600-0854.2007.00602.x; Madala VK, 2008, AM J PHYSIOL-RENAL, V294, pF1222, DOI 10.1152/ajprenal.00604.2007; Mall M, 2004, NAT MED, V10, P487, DOI 10.1038/nm1028; Masilamani S, 1999, J CLIN INVEST, V104, pR19, DOI 10.1172/JCI7840; Matalon S, 2002, J APPL PHYSIOL, V93, P1852, DOI 10.1152/japplphysiol.01241.2001; Mohan S, 2004, J BIOL CHEM, V279, P32071, DOI 10.1074/jbc.M405091200; O'Brodovich H, 2008, AM J PHYSIOL-LUNG C, V294, pL401, DOI 10.1152/ajplung.00431.2007; ONO S, 1995, IMMUNITY, V2, P639, DOI 10.1016/1074-7613(95)90008-X; Otulakowski G, 2006, AM J RESP CELL MOL, V34, P204, DOI 10.1165/rcmb.2005-0273OC; Otulakowski G, 2004, AM J RESP CELL MOL, V30, P862, DOI 10.1165/rcmb.2003-0381OC; Planes C, 2002, J BIOL CHEM, V277, P47318, DOI 10.1074/jbc.M209158200; Randrianarison N, 2008, AM J PHYSIOL-LUNG C, V294, pL409, DOI 10.1152/ajplung.00307.2007; Rossier BC, 2003, J CLIN INVEST, V111, P947, DOI 10.1172/JCI200318232; Rotin D, 2001, AM J PHYSIOL-RENAL, V281, pF391, DOI 10.1152/ajprenal.2001.281.3.F391; Tiwari S, 2008, PHARMACOL RES, V57, P383, DOI 10.1016/j.phrs.2008.03.013; Valentijn JA, 1998, J BIOL CHEM, V273, P30344, DOI 10.1074/jbc.273.46.30344; Vallet V, 1997, NATURE, V389, P607, DOI 10.1038/39329; Verrey F, 2008, KIDNEY INT, V73, P691, DOI 10.1038/sj.ki.5002737; Wang H, 2006, J BIOL CHEM, V281, P14129, DOI 10.1074/jbc.M512511200; Weisz OA, 2003, AM J PHYSIOL-RENAL, V285, pF833, DOI 10.1152/ajprenal.00088.2003; Weisz OA, 2000, J BIOL CHEM, V275, P39886, DOI 10.1074/jbc.M003822200; Yoshimura SH, 2008, J CELL SCI, V121, P2159, DOI 10.1242/jcs.022905; Zeissig S, 2008, GASTROENTEROLOGY, V134, P1436, DOI 10.1053/j.gastro.2008.02.030	53	17	17	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 19	2008	283	51					35305	35309		10.1074/jbc.R800044200	http://dx.doi.org/10.1074/jbc.R800044200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	383QH	18713729	Green Published, hybrid			2022-12-27	WOS:000261687900001
J	Wu, WH; Lei, P; Liu, Q; Hu, J; Gunn, AP; Chen, MS; Rui, YF; Su, XY; Xie, ZP; Zhao, YF; Bush, AI; Li, YM				Wu, Wei-hui; Lei, Peng; Liu, Qian; Hu, Jia; Gunn, Adam P.; Chen, Mei-sha; Rui, Yan-fang; Su, Xiao-yang; Xie, Zuo-ping; Zhao, Yu-Fen; Bush, Ashley I.; Li, Yan-mei			Sequestration of Copper from beta-Amyloid Promotes Selective Lysis by Cyclen-Hybrid Cleavage Agents	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALZHEIMER A-BETA; TRANSGENIC MICE; HIPPOCAMPAL-NEURONS; HYDROGEN-PEROXIDE; DISEASE; PEPTIDE; BINDING; OLIGOMERS; CU(II); ZINC	Decelerated degradation of beta-amyloid (A beta) and its interaction with synaptic copper may be pathogenic in Alzheimer disease. Recently, Co(III)-cyclen tagged to an aromatic recognition motif was shown to degrade A beta in vitro. Here, we report that apocyclen attached to selective A beta recognition motifs (KLVFF or curcumin) can capture copper bound to A beta and use the Cu(II) in place of Co(III) to become proteolytically active. The resultant complexes interfere with A beta aggregation, degrade A beta into fragments, preventing H2O2 formation and toxicity in neuronal cell culture. Because A beta binds Cu in amyloid plaques, apocyclen-tagged targeting molecules may be a promising approach to the selective degradation of A beta in Alzheimer disease. The principle of copper capture generalize to other amyloidoses where copper is implicated.	[Li, Yan-mei] Tsinghua Univ, Key Lab Bioorgan Phosphorus Chem & Chem Biol, Beijing 100084, Peoples R China; [Gunn, Adam P.; Bush, Ashley I.] Univ Melbourne, Dept Pathol, Parkville, Vic 3052, Australia; [Wu, Wei-hui; Lei, Peng; Liu, Qian; Hu, Jia; Chen, Mei-sha; Rui, Yan-fang; Su, Xiao-yang; Zhao, Yu-Fen; Li, Yan-mei] Tsinghua Univ, Dept Chem, Beijing 100084, Peoples R China; [Rui, Yan-fang; Xie, Zuo-ping] Tsinghua Univ, Dept Biol Sci & Biotechnol, Beijing 100084, Peoples R China; [Bush, Ashley I.] Univ Melbourne, Mental Hlth Res Inst Victoria, Oxidat Biol Lab, Parkville, Vic 3052, Australia	Tsinghua University; University of Melbourne; Tsinghua University; Tsinghua University; University of Melbourne	Bush, AI (corresponding author), Univ Melbourne, Mental Hlth Res Inst Victoria, Oxidat Biol Lab, 155 Oak St, Parkville, Vic 3052, Australia.	abush@mhri.edu.au; liym@mail.tsinghua.edu.cn	Lei, Peng/F-6326-2010; Rui, Yanfang/A-1372-2012; Zhao, Yufen/G-3445-2010; Bush, Ashley/Y-2457-2019; Bush, Ashley I/A-1186-2007; Su, Xiaoyang/B-3398-2008; Su, Xiaoyang/Q-4884-2018; Gunn, Adam P/D-5437-2012	Lei, Peng/0000-0001-5652-1962; Bush, Ashley/0000-0001-8259-9069; Bush, Ashley I/0000-0001-8259-9069; Gunn, Adam P/0000-0002-8181-4975; Su, Xiaoyang/0000-0001-8081-1396	National Natural Science Foundation of China [20825206, 20672067]; Australian Research Council Federation; National Health and Medical Research Council	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Australian Research Council Federation(Australian Research Council); National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by National Natural Science Foundation of China Grants 20825206 and 20672067 and by an Australian Research Council Federation fellowship and the National Health and Medical Research Council (to A. I. B.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Adlard PA, 2008, NEURON, V59, P43, DOI 10.1016/j.neuron.2008.06.018; Atwood CS, 1998, J BIOL CHEM, V273, P12817, DOI 10.1074/jbc.273.21.12817; Barnham KJ, 2004, FASEB J, V18, P1427, DOI 10.1096/fj.04-1890fje; Blennow K, 2006, LANCET, V368, P387, DOI 10.1016/S0140-6736(06)69113-7; BUSH AI, 1994, J BIOL CHEM, V269, P12152; Bush AI, 2003, P NATL ACAD SCI USA, V100, P11193, DOI 10.1073/pnas.2135061100; Cherny RA, 2001, NEURON, V30, P665, DOI 10.1016/S0896-6273(01)00317-8; Cherny RA, 1999, J BIOL CHEM, V274, P23223, DOI 10.1074/jbc.274.33.23223; Citron M, 2004, NAT REV NEUROSCI, V5, P677, DOI 10.1038/nrn1495; Dong J, 2003, BIOCHEMISTRY-US, V42, P2768, DOI 10.1021/bi0272151; Eakin CM, 2006, NAT STRUCT MOL BIOL, V13, P202, DOI 10.1038/nsmb1068; Garzon-Rodriguez W, 1999, BIOORG MED CHEM LETT, V9, P2243, DOI 10.1016/S0960-894X(99)00357-1; Graef IA, 1999, NATURE, V401, P703, DOI 10.1038/44378; Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Hoshi M, 2003, P NATL ACAD SCI USA, V100, P6370, DOI 10.1073/pnas.1237107100; Huang XD, 1999, BIOCHEMISTRY-US, V38, P7609, DOI 10.1021/bi990438f; Huang XD, 1999, J BIOL CHEM, V274, P37111, DOI 10.1074/jbc.274.52.37111; IZATT RM, 1991, CHEM REV, V91, P1721, DOI 10.1021/cr00008a003; Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469; Lannfelt L, 2008, LANCET NEUROL, V7, P779, DOI 10.1016/S1474-4422(08)70167-4; Lazarov O, 2002, J NEUROSCI, V22, P9785; Lee JY, 2004, NEUROBIOL AGING, V25, P1315, DOI 10.1016/j.neurobiolaging.2004.01.005; Leissring MA, 2003, NEURON, V40, P1087, DOI 10.1016/S0896-6273(03)00787-6; Lesne S, 2006, NATURE, V440, P352, DOI 10.1038/nature04533; Liu ST, 1999, BIOCHEMISTRY-US, V38, P9373, DOI 10.1021/bi990205o; Lovell MA, 1998, J NEUROL SCI, V158, P47, DOI 10.1016/S0022-510X(98)00092-6; Ma QF, 2006, BIOPOLYMERS, V83, P20, DOI 10.1002/bip.20523; Marr RA, 2003, J NEUROSCI, V23, P1992; Miller LM, 2006, J STRUCT BIOL, V155, P30, DOI 10.1016/j.jsb.2005.09.004; Mueller-Steiner S, 2006, NEURON, V51, P703, DOI 10.1016/j.neuron.2006.07.027; Murray IVJ, 2007, J BIOL CHEM, V282, P9335, DOI 10.1074/jbc.M608589200; Nunomura A, 1999, J NEUROSCI, V19, P1959; Opazo C, 2002, J BIOL CHEM, V277, P40302, DOI 10.1074/jbc.M206428200; Pratico D, 2000, ANN NEUROL, V48, P809, DOI 10.1002/1531-8249(200011)48:5<809::AID-ANA19>3.0.CO;2-9; Ritchie CW, 2003, ARCH NEUROL-CHICAGO, V60, P1685, DOI 10.1001/archneur.60.12.1685; Roberson ED, 2006, SCIENCE, V314, P781, DOI 10.1126/science.1132813; Schlief ML, 2005, J NEUROSCI, V25, P239, DOI 10.1523/JNEUROSCI.3699-04.2005; SMITH CD, 1991, P NATL ACAD SCI USA, V88, P10540, DOI 10.1073/pnas.88.23.10540; Smith DP, 2006, J BIOL CHEM, V281, P15145, DOI 10.1074/jbc.M600417200; Suh J, 2003, ACCOUNTS CHEM RES, V36, P562, DOI 10.1021/ar020037j; Suh J, 2007, ANGEW CHEM INT EDIT, V46, P7064, DOI 10.1002/anie.200702399; Syme CD, 2004, J BIOL CHEM, V279, P18169, DOI 10.1074/jbc.M313572200; Tanzi RE, 2005, CELL, V120, P545, DOI 10.1016/j.cell.2005.02.008; Tjernberg LO, 1996, J BIOL CHEM, V271, P8545, DOI 10.1074/jbc.271.15.8545; Wilkinson-White LE, 2007, BIOCHEMISTRY-US, V46, P9123, DOI 10.1021/bi700607z; Yang FS, 2005, J BIOL CHEM, V280, P5892, DOI 10.1074/jbc.M404751200; Zhang J, 2006, FASEB J, V20, P1212, DOI 10.1096/fj.05-5214fje	48	102	106	0	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 14	2008	283	46					31657	31664		10.1074/jbc.M804722200	http://dx.doi.org/10.1074/jbc.M804722200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	370KJ	18728006	hybrid			2022-12-27	WOS:000260760800047
J	Zhang, YL; Ju, JS; Peng, H; Gao, F; Zhou, C; Zeng, Y; Xue, YF; Li, Y; Henrissat, B; Gao, GF; Ma, YH				Zhang, Yueling; Ju, Jiansong; Peng, Hao; Gao, Feng; Zhou, Cheng; Zeng, Yan; Xue, Yanfen; Li, Yin; Henrissat, Bernard; Gao, George F.; Ma, Yanhe			Biochemical and Structural Characterization of the Intracellular Mannanase AaManA of Alicyclobacillus acidocaldarius Reveals a Novel Glycoside Hydrolase Family Belonging to Clan GH-A	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PRELIMINARY-X-RAY; MUSSEL MYTILUS-EDULIS; BETA-MANNANASE; 3-DIMENSIONAL STRUCTURE; CRYSTAL-STRUCTURE; GENE CLONING; BACILLUS SP; SEQUENCE; ENZYMES; CRYSTALLIZATION	An intracellular mannanase was identified from the thermoacidophile Alicyclobacillus acidocaldarius Tc-12-31. This enzyme is particularly interesting, because it shows no significant sequence similarity to any known glycoside hydrolase. Gene cloning, biochemical characterization, and structural studies of this novel mannanase are reported in this paper. The gene consists of 963 bp and encodes a 320-amino acid protein, AaManA. Based on its substrate specificity and product profile, AaManA is classified as an endo-beta-1,4-mannanase that is capable of transglycosylation. Kinetic analysis studies revealed that the enzyme required at least five subsites for efficient hydrolysis. The crystal structure at 1.9 A resolution showed that AaManA adopted a (beta/alpha)8-barrel fold. Two catalytic residues were identified: Glu(151) at theCterminus of beta-stand beta 4 and Glu(231) at the C terminus of beta 7. Based on the structure of the enzyme and evidence of its transglycosylation activity, AaManA is placed in clan GH-A. Superpositioning of its structure with that of other clan GH-A enzymes revealed that six of the eight GH-A key residues were functionally conserved in AaManA, with the exceptions being residues Thr(95) and Cys(150). We propose a model of substrate binding in AaManAin which Glu(282) interacts with the axial OH-C(2) in -2 subsites. Based on sequence comparisons, the enzyme was assigned to a new glycoside hydrolase family (GH113) that belongs to clan GH-A.	[Zhang, Yueling; Ju, Jiansong; Peng, Hao; Gao, Feng; Zhou, Cheng; Zeng, Yan; Xue, Yanfen; Li, Yin; Gao, George F.; Ma, Yanhe] Chinese Acad Sci, Inst Microbiol, State Key Lab Microbial Resources, Beijing 100101, Peoples R China; [Zhang, Yueling; Zhou, Cheng] Chinese Acad Sci, Grad Sch, Beijing 100049, Peoples R China; [Henrissat, Bernard] CNRS, UMR6098, F-13288 Marseille, France; [Henrissat, Bernard] Univ Aix Marseille 1, F-13288 Marseille, France; [Henrissat, Bernard] Univ Aix Marseille 2, F-13288 Marseille, France	Chinese Academy of Sciences; Institute of Microbiology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite	Ma, YH (corresponding author), Chinese Acad Sci, Inst Microbiol, State Key Lab Microbial Resources, A3 Datun Rd,Chaoyang Dist, Beijing 100101, Peoples R China.	mayanhe@im.ac.cn	Jiansong, Ju/R-2177-2019; Henrissat, Bernard/J-2475-2012; Zhou, Cheng/Q-4416-2018; MA, YAN/HHN-2912-2022; Li, Yin/C-6644-2009; Gao, George Fu/ABD-5229-2021	Henrissat, Bernard/0000-0002-3434-8588; Zhou, Cheng/0000-0001-9720-9318; Li, Yin/0000-0003-0995-3070; Zhang, Yueling/0000-0002-5619-8410	Chinese Academy of Sciences Knowledge Innovation [KSCX2-SW-33]; National Natural Science Foundation of China [30621005]; Ministry of Sciences and Technology of China [2003CB716001, 2007CB707801]	Chinese Academy of Sciences Knowledge Innovation(Chinese Academy of Sciences); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Sciences and Technology of China(Ministry of Science and Technology, China)	This study was supported by Chinese Academy of Sciences Knowledge Innovation Program Grant KSCX2-SW-33, National Natural Science Foundation of China Grant 30621005, and Ministry of Sciences and Technology of China ( 973 programs) Grants 2003CB716001 and 2007CB707801. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Ademark P, 1998, J BIOTECHNOL, V63, P199, DOI 10.1016/S0168-1656(98)00086-8; AKINO T, 1987, APPL MICROBIOL BIOT, V26, P323; Akita M, 2004, ACTA CRYSTALLOGR D, V60, P1490, DOI 10.1107/S0907444904014313; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Banik M, 2001, J EXP BOT, V52, P105, DOI 10.1093/jexbot/52.354.105; BETTIOL JP, 2002, Patent No. 6376445; Bourgault R, 2005, PROTEIN SCI, V14, P1233, DOI 10.1110/ps.041260905; Charnock SJ, 1997, J BIOL CHEM, V272, P2942, DOI 10.1074/jbc.272.5.2942; Clarke JH, 2000, APPL MICROBIOL BIOT, V53, P661, DOI 10.1007/s002530000344; Cote N, 2006, BIOCHEM J, V394, P675, DOI 10.1042/BJ20051436; DAVIES G, 1995, STRUCTURE, V3, P853, DOI 10.1016/S0969-2126(01)00220-9; Davies GJ, 1997, BIOCHEM J, V321, P557, DOI 10.1042/bj3210557; Dekker R F, 1976, Adv Carbohydr Chem Biochem, V32, P277; DeLano W, 2002, PYMOL 0 99; Demirjian DC, 2001, CURR OPIN CHEM BIOL, V5, P144, DOI 10.1016/S1367-5931(00)00183-6; Dhawan S, 2007, CRIT REV BIOTECHNOL, V27, P197, DOI 10.1080/07388550701775919; Durand P, 1997, GLYCOBIOLOGY, V7, P277, DOI 10.1093/glycob/7.2.277; Eckert K, 2002, APPL MICROBIOL BIOT, V60, P428, DOI 10.1007/s00253-002-1131-4; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Ethier N, 1998, APPL ENVIRON MICROB, V64, P4428; Evrard GX, 2007, ACTA CRYSTALLOGR D, V63, P108, DOI 10.1107/S0907444906023389; Finn RD, 2006, NUCLEIC ACIDS RES, V34, pD247, DOI 10.1093/nar/gkj149; Fischer M, 2001, CARBOHYD RES, V330, P93, DOI 10.1016/S0008-6215(00)00272-X; Ginalski K, 2003, BIOINFORMATICS, V19, P1015, DOI 10.1093/bioinformatics/btg124; Gouet P, 2003, NUCLEIC ACIDS RES, V31, P3320, DOI 10.1093/nar/gkg556; HENRISSAT B, 1991, BIOCHEM J, V280, P309, DOI 10.1042/bj2800309; HENRISSAT B, 1995, P NATL ACAD SCI USA, V92, P7090, DOI 10.1073/pnas.92.15.7090; Hilge M, 1998, STRUCTURE, V6, P1433, DOI 10.1016/S0969-2126(98)00142-7; Hogg D, 2003, BIOCHEM J, V371, P1027, DOI 10.1042/BJ20021860; Hogg D, 2001, J BIOL CHEM, V276, P31186, DOI 10.1074/jbc.M010290200; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Larsson AM, 2006, J MOL BIOL, V357, P1500, DOI 10.1016/j.jmb.2006.01.044; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Le Nours K, 2005, BIOCHEMISTRY-US, V44, P12700, DOI 10.1021/bi050779v; Lo Leggio L, 2002, FEBS LETT, V523, P103, DOI 10.1016/S0014-5793(02)02954-X; Ma YH, 2004, EXTREMOPHILES, V8, P447, DOI 10.1007/s00792-004-0405-4; Marchler-Bauer A, 2005, NUCLEIC ACIDS RES, V33, pD192, DOI 10.1093/nar/gki069; Matzke J, 2000, FEMS MICROBIOL LETT, V183, P55, DOI 10.1016/S0378-1097(99)00630-8; MCCARTER JD, 1994, CURR OPIN STRUC BIOL, V4, P885, DOI 10.1016/0959-440X(94)90271-2; Niehaus F, 1999, APPL MICROBIOL BIOT, V51, P711, DOI 10.1007/s002530051456; Nielsen H, 1997, PROTEIN ENG, V10, P1, DOI 10.1093/protein/10.1.1; Politz O, 2000, APPL MICROBIOL BIOT, V53, P715, DOI 10.1007/s002530000351; Ryttersgaard C, 2002, BIOCHEMISTRY-US, V41, P15135, DOI 10.1021/bi026238c; Sabini E, 2000, ACTA CRYSTALLOGR D, V56, P3, DOI 10.1107/S0907444999013943; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; SCHWERMANN B, 1994, EUR J BIOCHEM, V226, P981, DOI 10.1111/j.1432-1033.1994.00981.x; Scott M, 1998, ACTA CRYSTALLOGR D, V54, P129, DOI 10.1107/S0907444997009062; Srivastava M, 2005, CHEM BIODIVERS, V2, P295, DOI 10.1002/cbdv.200590013; TEATHER RM, 1982, APPL ENVIRON MICROB, V43, P777, DOI 10.1128/AEM.43.4.777-780.1982; Terwilliger TC, 2003, ACTA CRYSTALLOGR D, V59, P38, DOI 10.1107/S0907444902018036; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Timell T. E., 1967, Wood Science and Technology, V1, P45, DOI 10.1007/BF00592255; Vagin AA, 2004, ACTA CRYSTALLOGR D, V60, P2184, DOI 10.1107/S0907444904023510; Violot S, 2005, J MOL BIOL, V348, P1211, DOI 10.1016/j.jmb.2005.03.026; Wu G, 2005, POULTRY SCI, V84, P894, DOI 10.1093/ps/84.6.894; Xu BZ, 2002, EUR J BIOCHEM, V269, P1753, DOI 10.1046/j.1432-1327.2002.02824.x; Zhang YL, 2008, ACTA CRYSTALLOGR F, V64, P209, DOI 10.1107/S1744309108002832	59	63	77	2	36	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 14	2008	283	46					31551	31558		10.1074/jbc.M803409200	http://dx.doi.org/10.1074/jbc.M803409200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	370KJ	18755688	hybrid			2022-12-27	WOS:000260760800034
J	Ha, UH; Lim, JH; Kim, HJ; Wu, WH; Jin, SG; Xu, HD; Li, JD				Ha, Un-Hwan; Lim, Jae Hyang; Kim, Hyun-Joong; Wu, Weihui; Jin, Shouguang; Xu, Haidong; Li, Jian-Dong			MKP1 Regulates the Induction of MUC5AC Mucin by Streptococcus pneumoniae Pneumolysin by Inhibiting the PAK4-JNK Signaling Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; AIRWAY EPITHELIAL-CELLS; INNATE IMMUNE-RESPONSES; P38 MAPK; NEGATIVE MUTANT; GENE-REGULATION; UP-REGULATION; IKK-BETA; ALPHA; TRANSCRIPTION	Mucosal epithelial cells in the respiratory tract act as the first line of host innate defense against inhaled microbes by producing a range of molecules for clearance. In particular, epithelial mucins facilitate the mucociliary clearance by physically trapping the inhaled microbes. Up-regulation of mucin production thus represents an important host innate defense response against invading microbes. Excess mucin production, however, overwhelms the mucociliary clearance, resulting in defective mucosal defenses. Thus, tight regulation of mucin production is critical for maintaining an appropriate balance between beneficial and detrimental outcomes. Among various mechanisms, negative regulation plays an important role in tightly regulating mucin production. Here we show that the PAK4-JNK signaling pathway acted as a negative regulator for Streptococcus pneumoniae pneumolysin-induced MUC5AC mucin transcription. Moreover pneumolysin also selectively induced expression of MKP1 via a TLR4-dependent MyD88-TRAF6-ERK signaling pathway, which inhibited the PAK4-JNK signaling pathway, thereby leading to up-regulation of MUC5AC mucin production to maintain effective mucosal protection against S. pneumoniae infection. These studies provide novel insights into the molecular mechanisms underlying the tight regulation of mucin overproduction in the pathogenesis of airway infectious diseases and may lead to development of new therapeutic strategies.	[Ha, Un-Hwan; Lim, Jae Hyang; Kim, Hyun-Joong; Xu, Haidong; Li, Jian-Dong] Univ Rochester, Med Ctr, Dept Microbiol & Immunol, Rochester, NY 14642 USA; [Wu, Weihui; Jin, Shouguang] Univ Florida, Coll Med, Dept Mol Genet & Microbiol, Gainesville, FL 32610 USA	University of Rochester; State University System of Florida; University of Florida	Li, JD (corresponding author), Univ Rochester, Med Ctr, Dept Microbiol & Immunol, Box 672,601 Elmwood Ave, Rochester, NY 14642 USA.	Jian-Dong_Li@urmc.rochester.edu	Ha, Un-Hwan/ABH-8017-2020; Jin, Shouguang/N-5548-2016	Li, Jian-Dong/0000-0002-5593-050X; Ha, Un-Hwan/0000-0001-9182-7000; Lim, Jae Hyang/0000-0003-0972-9271	National Institutes of Health [DC004562, DC005843, DC008703]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC004562, R01DC005843, F32DC008703] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported, in whole or in part, by National Institutes of Health Grants DC004562 and DC005843 (to J.-D. L.) and Training Grant DC008703 (to U.-H. H.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Abo A, 1998, EMBO J, V17, P6527, DOI 10.1093/emboj/17.22.6527; Ahn DH, 2005, CELL PHYSIOL BIOCHEM, V15, P29, DOI 10.1159/000083636; Bagrodia S, 1999, TRENDS CELL BIOL, V9, P350, DOI 10.1016/S0962-8924(99)01618-9; BENTON KA, 1995, INFECT IMMUN, V63, P448, DOI 10.1128/IAI.63.2.448-455.1995; BERRY AM, 1989, INFECT IMMUN, V57, P2037, DOI 10.1128/IAI.57.7.2037-2042.1989; Borchers MT, 1999, AM J PHYSIOL-LUNG C, V276, pL549, DOI 10.1152/ajplung.1999.276.4.L549; BRILES DE, 1992, INFECT IMMUN, V60, P111, DOI 10.1128/IAI.60.1.111-116.1992; Burgel PR, 2001, J IMMUNOL, V167, P5948, DOI 10.4049/jimmunol.167.10.5948; Chen R, 2004, BIOCHEM BIOPH RES CO, V324, P1087, DOI 10.1016/j.bbrc.2004.09.157; Chi HB, 2006, P NATL ACAD SCI USA, V103, P2274, DOI 10.1073/pnas.0510965103; Chun YM, 2002, ANN OTO RHINOL LARYN, V111, P507, DOI 10.1177/000348940211100606; Cockeran R, 2001, J INFECT DIS, V183, P604, DOI 10.1086/318536; Farooq A, 2004, CELL SIGNAL, V16, P769, DOI 10.1016/j.cellsig.2003.12.008; Franklin CC, 1997, J BIOL CHEM, V272, P16917, DOI 10.1074/jbc.272.27.16917; Garrington TP, 1999, CURR OPIN CELL BIOL, V11, P211, DOI 10.1016/S0955-0674(99)80028-3; Gensch E, 2004, J BIOL CHEM, V279, P39085, DOI 10.1074/jbc.M406866200; Gilbert RJC, 1999, CELL, V97, P647, DOI 10.1016/S0092-8674(00)80775-8; Gnesutta N, 2001, J BIOL CHEM, V276, P14414, DOI 10.1074/jbc.M011046200; Ha U, 2007, J IMMUNOL, V178, P1736, DOI 10.4049/jimmunol.178.3.1736; Hewson CA, 2004, J MOL BIOL, V344, P683, DOI 10.1016/j.jmb.2004.09.059; Huang YX, 2007, BIOCHEM BIOPH RES CO, V359, P691, DOI 10.1016/j.bbrc.2007.05.170; Imasato A, 2002, J BIOL CHEM, V277, P47444, DOI 10.1074/jbc.M208140200; Jono H, 2003, J BIOL CHEM, V278, P27811, DOI 10.1074/jbc.M301773200; Kato S, 2006, INT J ONCOL, V29, P33; Klugman KP, 2001, CURR OPIN INFECT DIS, V14, P173, DOI 10.1097/00001432-200104000-00011; Knowles MR, 2002, J CLIN INVEST, V109, P571, DOI 10.1172/JCI200215217; Kopp E, 2003, CURR OPIN IMMUNOL, V15, P396, DOI 10.1016/S0952-7915(03)00080-3; Li DZ, 1998, J BIOL CHEM, V273, P6812, DOI 10.1074/jbc.273.12.6812; Li QT, 2000, GENE DEV, V14, P1729; Li XF, 2005, J BIOL CHEM, V280, P41192, DOI 10.1074/jbc.M506884200; MAJIMA Y, 1988, ANN OTO RHINOL LARYN, V97, P272, DOI 10.1177/000348948809700311; Malley R, 2003, P NATL ACAD SCI USA, V100, P1966, DOI 10.1073/pnas.0435928100; Masuda K, 2001, J BIOL CHEM, V276, P39002, DOI 10.1074/jbc.M104600200; MITCHELL TJ, 1991, MOL MICROBIOL, V5, P1883, DOI 10.1111/j.1365-2958.1991.tb00812.x; Mitchell TJ, 1997, MICROB DRUG RESIST, V3, P19, DOI 10.1089/mdr.1997.3.19; Muda M, 1996, J BIOL CHEM, V271, P27205, DOI 10.1074/jbc.271.44.27205; Perez A, 2003, J BIOL CHEM, V278, P36942, DOI 10.1074/jbc.M300264200; Rose MC, 2006, PHYSIOL REV, V86, P245, DOI 10.1152/physrev.00010.2005; Rose MC, 2001, AM J RESP CELL MOL, V25, P533, DOI 10.1165/ajrcmb.25.5.f218; Sakai A, 2004, BMC MOL BIOL, V5, DOI 10.1186/1471-2199-5-2; Salojin KV, 2006, J IMMUNOL, V176, P1899, DOI 10.4049/jimmunol.176.3.1899; Schurmann A, 2000, MOL CELL BIOL, V20, P453, DOI 10.1128/MCB.20.2.453-461.2000; Song KS, 2003, J BIOL CHEM, V278, P23243, DOI 10.1074/jbc.M300096200; Srivastava A, 2005, INFECT IMMUN, V73, P6479, DOI 10.1128/IAI.73.10.6479-6487.2005; Takeyama K, 1999, P NATL ACAD SCI USA, V96, P3081, DOI 10.1073/pnas.96.6.3081; Takeyama K, 2001, AM J PHYSIOL-LUNG C, V280, pL165, DOI 10.1152/ajplung.2001.280.1.L165; Tanoue T, 1999, J BIOL CHEM, V274, P19949, DOI 10.1074/jbc.274.28.19949; XIA ZG, 1995, SCIENCE, V270, P1326, DOI 10.1126/science.270.5240.1326	48	35	37	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 7	2008	283	45					30624	30631		10.1074/jbc.M802519200	http://dx.doi.org/10.1074/jbc.M802519200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	367ID	18782768	Green Published, hybrid			2022-12-27	WOS:000260544800019
J	Huang, YC; Su, LH; Lee, GA; Chiu, PW; Cho, CC; Wu, JY; Sun, CH				Huang, Yu-Chang; Su, Li-Hsin; Lee, Gilbert A.; Chiu, Pei-Wei; Cho, Chao-Cheng; Wu, Jeng-You; Sun, Chin-Hung			Regulation of Cyst Wall Protein Promoters by Myb2 in Giardia lamblia	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							C-MYB; TRANSCRIPTIONAL ACTIVATION; GENE FAMILY; PRIMITIVE EUKARYOTE; MIM-1 GENE; V-MYB; EXPRESSION; PROTOZOAN; RNA; DNA	Myb family transcription factors are important in regulating cell proliferation, differentiation, and cell cycle progression. Giardia lamblia differentiates into infectious cysts to survive outside of the host. During encystation, genes encoding cyst wall proteins (CWPs) are coordinately induced. We have identified an encystation-induced Myb2 protein, which binds to the promoter regions of the cwp genes and myb2 itself in vitro. To elucidate the role of Myb2 in G. lamblia, we tested the hypothesis that Myb2 can activate encystation-induced genes. We found that overexpression of Myb2 resulted in an increase of expression of CWP1 at both protein and mRNA levels. Interestingly, the Myb2-overexpressing trophozoites had increased capability to differentiate into cysts. In cotransfection assays, Myb2 was able to transactivate the cwp promoters and its own promoter in vivo, suggesting that its gene can be positively autoregulated. Moreover, deletion of the N- or C-terminal domain resulted in a decrease of transactivation and autoregulation function of Myb2. We also found that the promoter of a newly identified encystation-induced gene, the giardial myeloid leukemia factor-like gene, has the Myb2 binding sites and that its mRNA levels were increased by Myb2 overexpression. Chromatin immuno-precipitation assays confirmed that Myb2 was bound to the promoters with its binding sites. Transfection of the myb2 antisense construct reduced the levels of the cwp1 transcripts and cyst formation. Our results suggest that Myb2 is a potent transactivator of the cwp genes and other endogenous genes and plays an important role in G. lamblia differentiation into cysts.	[Huang, Yu-Chang; Su, Li-Hsin; Lee, Gilbert A.; Chiu, Pei-Wei; Cho, Chao-Cheng; Wu, Jeng-You; Sun, Chin-Hung] Natl Taiwan Univ, Dept Parasitol, Coll Med, Taipei 100, Taiwan	National Taiwan University	Sun, CH (corresponding author), Natl Taiwan Univ, Dept Parasitol, Coll Med, Taipei 100, Taiwan.	chinhsun@ntu.edu.tw	Shin, Jerry/AAO-2515-2021; Lee, GA/AAI-4481-2020	SUN, CHIN-HUNG/0000-0002-8604-8085; Wu, Jeng-You/0000-0002-2403-1843; Lee, Gilbert/0000-0003-1262-4702	National Science Council [NSC 94-2320-B-002-093, NSC 96-2320-B-002-040-MY3]; National Health Research Institutes in Taiwan [NHRI-EX96-9510NC, NHRI-EX97-9510NC]; Dept. of Medical Research; NTUH	National Science Council(Ministry of Science and Technology, Taiwan); National Health Research Institutes in Taiwan(National Health Research Institutes - Taiwan); Dept. of Medical Research; NTUH	This work was supported by grants from the National Science Council (NSC 94-2320-B-002-093 and NSC 96-2320-B-002-040-MY3) and the National Health Research Institutes (NHRI-EX96-9510NC and NHRI-EX97-9510NC) in Taiwan and was also supported in part by the Dept. of Medical Research in NTUH.	Adam RD, 2001, CLIN MICROBIOL REV, V14, P447, DOI 10.1128/CMR.14.3.447-475.2001; Allen RD, 1999, GENE DEV, V13, P1073, DOI 10.1101/gad.13.9.1073; ALTSCHUL SF, 1997, NUCLEIC ACIDS RES, V25, P3402; Bender TP, 2004, NAT IMMUNOL, V5, P721, DOI 10.1038/ni1085; Best AA, 2004, GENOME RES, V14, P1537, DOI 10.1101/gr.2256604; BURK O, 1993, EMBO J, V12, P2027, DOI 10.1002/j.1460-2075.1993.tb05852.x; Chen YH, 2008, INT J PARASITOL, V38, P1305, DOI 10.1016/j.ijpara.2008.02.006; DUDEK H, 1992, P NATL ACAD SCI USA, V89, P1291, DOI 10.1073/pnas.89.4.1291; Eichinger D, 2001, CURR OPIN MICROBIOL, V4, P421, DOI 10.1016/S1369-5274(00)00229-0; Elmendorf HG, 2001, MOL BIOCHEM PARASIT, V113, P157, DOI 10.1016/S0166-6851(01)00211-0; EVANS JL, 1990, MOL CELL BIOL, V10, P5747, DOI 10.1128/MCB.10.11.5747; Gillin FD, 1996, ANNU REV MICROBIOL, V50, P679, DOI 10.1146/annurev.micro.50.1.679; HASHIMOTO T, 1995, MOL BIOL EVOL, V12, P782; HERNANDEZMUNAIN C, 1994, MOL CELL BIOL, V14, P473, DOI 10.1128/MCB.14.1.473; HOLBERTON DV, 1995, NUCLEIC ACIDS RES, V23, P2945, DOI 10.1093/nar/23.15.2945; HSIANG YHH, 1995, J IMMUNOL, V154, P5195; Jin HL, 1999, PLANT MOL BIOL, V41, P577, DOI 10.1023/A:1006319732410; Katzen AL, 1998, GENE DEV, V12, P831, DOI 10.1101/gad.12.6.831; KEISTER DB, 1983, T ROY SOC TROP MED H, V77, P487, DOI 10.1016/0035-9203(83)90120-7; Knodler LA, 1999, MOL MICROBIOL, V34, P327, DOI 10.1046/j.1365-2958.1999.01602.x; Kolodziejska KM, 2008, CIRC RES, V102, P554, DOI 10.1161/CIRCRESAHA.105.162628; Lidonnici MR, 2008, BLOOD, V111, P4771, DOI 10.1182/blood-2007-08-105072; Lu CA, 2002, PLANT CELL, V14, P1963, DOI 10.1105/tpc.001735; LUJAN HD, 1995, J BIOL CHEM, V270, P29307, DOI 10.1074/jbc.270.49.29307; Marshall MM, 1997, CLIN MICROBIOL REV, V10, P67, DOI 10.1128/CMR.10.1.67; Mercy IS, 2003, J EXP BOT, V54, P1117, DOI 10.1093/jxb/erg118; Morrison HG, 2007, SCIENCE, V317, P1921, DOI 10.1126/science.1143837; MOWATT MR, 1995, MOL MICROBIOL, V15, P955, DOI 10.1111/j.1365-2958.1995.tb02364.x; Nair M, 2007, NUCLEIC ACIDS RES, V35, P1687, DOI 10.1093/nar/gkl1141; NESS SA, 1993, GENE DEV, V7, P749, DOI 10.1101/gad.7.5.749; NESS SA, 1989, CELL, V59, P1115, DOI 10.1016/0092-8674(89)90767-8; NICOLAIDES NC, 1991, MOL CELL BIOL, V11, P6166, DOI 10.1128/MCB.11.12.6166; Oh IH, 1999, ONCOGENE, V18, P3017, DOI 10.1038/sj.onc.1202839; Park JS, 2008, PLANT CELL REP, V27, P985, DOI 10.1007/s00299-008-0521-1; Raffaele S, 2008, PLANT CELL, V20, P752, DOI 10.1105/tpc.107.054858; Ramsay RG, 2005, GROWTH FACTORS, V23, P253, DOI 10.1080/08977190500233730; Sala A, 2005, EUR J CANCER, V41, P2479, DOI 10.1016/j.ejca.2005.08.004; Seshadri V, 2003, J BIOL CHEM, V278, P27804, DOI 10.1074/jbc.M303316200; Singer SM, 1998, MOL BIOCHEM PARASIT, V92, P59, DOI 10.1016/S0166-6851(97)00225-9; SOGIN ML, 1989, SCIENCE, V243, P75, DOI 10.1126/science.2911720; Stracke R, 2001, CURR OPIN PLANT BIOL, V4, P447, DOI 10.1016/S1369-5266(00)00199-0; Su LH, 2007, MOL BIOCHEM PARASIT, V156, P124, DOI 10.1016/j.molbiopara.2007.07.015; Sun CH, 2003, J BIOL CHEM, V278, P21701, DOI 10.1074/jbc.M302023200; Sun CH, 2006, MOL BIOCHEM PARASIT, V146, P45, DOI 10.1016/j.molbiopara.2005.10.017; Sun CH, 1999, J BIOL CHEM, V274, P19699, DOI 10.1074/jbc.274.28.19699; Sun CH, 2002, MOL MICROBIOL, V46, P971, DOI 10.1046/j.1365-2958.2002.03233.x; Sun CH, 1998, MOL BIOCHEM PARASIT, V92, P123, DOI 10.1016/S0166-6851(97)00239-9; Van Keulen H, 1998, J EUKARYOT MICROBIOL, V45, P637, DOI 10.1111/j.1550-7408.1998.tb04560.x; Wang CH, 2007, J BIOL CHEM, V282, P8905, DOI 10.1074/jbc.M611170200; Weston K, 1998, CURR OPIN GENET DEV, V8, P76, DOI 10.1016/S0959-437X(98)80065-8; WIESER J, 1995, GENE DEV, V9, P491, DOI 10.1101/gad.9.4.491; WOLFE MS, 1992, CLIN MICROBIOL REV, V5, P93, DOI 10.1128/CMR.5.1.93-100.1992; Yee J, 2000, J BIOL CHEM, V275, P11432, DOI 10.1074/jbc.275.15.11432	53	42	44	2	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 7	2008	283	45					31021	31029		10.1074/jbc.M805023200	http://dx.doi.org/10.1074/jbc.M805023200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	367ID	18768462	hybrid, Green Published			2022-12-27	WOS:000260544800057
J	Ko, CY; Hsu, HC; Shen, MR; Chang, WC; Wang, JM				Ko, Chiung-Yuan; Hsu, Hey-Chi; Shen, Meng-Ru; Chang, Wen-Chang; Wang, Ju-Ming			Epigenetic Silencing of CCAAT/Enhancer-binding Protein delta Activity by YY1/Polycomb Group/DNA Methyltransferase Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA CYTOSINE-5 METHYLTRANSFERASES; ACUTE MYELOID-LEUKEMIA; EMBRYONIC STEM-CELLS; C/EBP-DELTA; ADIPOCYTE DIFFERENTIATION; BREAST-CANCER; IN-VIVO; HEPATOCELLULAR-CARCINOMA; PROMOTER ACTIVATION; MOLECULAR TARGET	Human CCAAT/enhancer-binding protein delta (CEBPD) has been reported as a tumor suppressor because it both induces growth arrest involved in differentiation and plays a crucial role as a regulator of pro-apoptotic gene expression. In this study, CEBPD gene expression is down-regulated, and " loss of function" alterations in CEBPD gene expression are observed in cervical cancer and hepatocellular carcinoma. Suppressor of zeste 12 (SUZ12), a component of the polycomb repressive complex 2 (PRC2), silences CEBPD promoter activity, enhancing the methylation of exogenous CEBPD promoter through the proximal CpG islands. Moreover, this molecular approach is consistent with the opposite mRNA expression pattern between SUZ12 and CEBPD in cervical cancer and hepatocellular carcinoma patients. We further demonstrated that Yin-Yang-1 (YY1) physically interacts with SUZ12 and can act as a mediator to recruit the polycomb group proteins and DNA methyltransferases to participate in the CEBPD gene silencing process. Taking these results into consideration, we not only demonstrate the advantage of SUZ12-silenced CEBPD expression in tumor formation but also clarify an in vivo evidence for YY1-mediated silencing paths of SUZ12 and DNA methyltransferases on the CEBPD promoter.	[Shen, Meng-Ru; Chang, Wen-Chang] Natl Cheng Kung Univ, Coll Med, Dept Pharmacol, Tainan 70101, Taiwan; [Ko, Chiung-Yuan; Chang, Wen-Chang] Natl Cheng Kung Univ, Inst Basic Med Sci, Tainan 70101, Taiwan; [Chang, Wen-Chang; Wang, Ju-Ming] Natl Cheng Kung Univ, Inst Biosignal Transduct, Tainan 70101, Taiwan; [Chang, Wen-Chang; Wang, Ju-Ming] Natl Cheng Kung Univ, Inst Bioinformat, Coll Biosci & Biotechnol, Tainan 70101, Taiwan; [Chang, Wen-Chang; Wang, Ju-Ming] Natl Cheng Kung Univ, Ctr Gene Regulat & Signal Transduct Res, Tainan 70101, Taiwan; [Hsu, Hey-Chi] Natl Taiwan Univ, Coll Med, Dept Pathol, Taipei 10002, Taiwan	National Cheng Kung University; National Cheng Kung University; National Cheng Kung University; National Cheng Kung University; National Cheng Kung University; National Taiwan University	Chang, WC (corresponding author), Natl Cheng Kung Univ, Coll Med, Dept Pharmacol, 1 Univ Rd, Tainan 70101, Taiwan.	wcchang@mail.ncku.edu.tw; wwwjm4721@yahoo.com.tw	wang, ju-ming/A-1875-2011		Taiwan National Science Council [96-2320-B-006-044-MY2]	Taiwan National Science Council(Ministry of Science and Technology, Taiwan)	This work was supported by and the funding to pay the Open Access publication charges for this article were provided by Grant 96-2320-B-006-044-MY2 from the Taiwan National Science Council. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked " advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Agrawal S, 2007, BLOOD, V109, P3895, DOI 10.1182/blood-2006-08-040147; Arai T, 2006, BREAST CANCER RES TR, V100, P169, DOI 10.1007/s10549-006-9241-9; Atchison L, 2003, EMBO J, V22, P1347, DOI 10.1093/emboj/cdg124; Banks RE, 2006, CANCER RES, V66, P2000, DOI 10.1158/0008-5472.CAN-05-3074; Bell DR, 2004, ONCOGENE, V23, P7290, DOI 10.1038/sj.onc.1207949; Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; Bracken AP, 2003, EMBO J, V22, P5323, DOI 10.1093/emboj/cdg542; Brenner S, 2003, J BIOL CHEM, V278, P5597, DOI 10.1074/jbc.M207448200; Brucher BLDM, 2006, INT J CANCER, V119, P1298, DOI 10.1002/ijc.21990; Cao R, 2004, MOL CELL, V15, P57, DOI 10.1016/j.molcel.2004.06.020; Cao R, 2002, SCIENCE, V298, P1039, DOI 10.1126/science.1076997; Cardinaux JR, 2000, GLIA, V29, P91, DOI 10.1002/(SICI)1098-1136(20000101)29:1<91::AID-GLIA9>3.0.CO;2-I; Croonquist PA, 2005, ONCOGENE, V24, P6269, DOI 10.1038/sj.onc.1208771; Darlington GJ, 1998, J BIOL CHEM, V273, P30057, DOI 10.1074/jbc.273.46.30057; Gery S, 2005, ONCOGENE, V24, P1589, DOI 10.1038/sj.onc.1208393; Gigliotti AP, 2003, EXP BIOL MED, V228, P278, DOI 10.1177/153537020322800306; Grimm SL, 2003, J MAMMARY GLAND BIOL, V8, P191, DOI 10.1023/A:1025900908026; Gutierrez S, 2002, J BIOL CHEM, V277, P1316, DOI 10.1074/jbc.M106611200; Huang AM, 2004, ONCOGENE, V23, P1549, DOI 10.1038/sj.onc.1207285; Ikezoe T, 2005, CANCER RES, V65, P4762, DOI 10.1158/0008-5472.CAN-03-3619; Jeng YM, 2004, CLIN CANCER RES, V10, P2065, DOI 10.1158/1078-0432.CCR-1057-03; Kim GD, 2002, EMBO J, V21, P4183, DOI 10.1093/emboj/cdf401; Kim J, 2008, HUM MOL GENET, V17, P391, DOI 10.1093/hmg/ddm316; KINOSHITA S, 1992, P NATL ACAD SCI USA, V89, P1473, DOI 10.1073/pnas.89.4.1473; Kirmizis A, 2004, GENE DEV, V18, P1592, DOI 10.1101/gad.1200204; Kirmizis A, 2003, MOL CANCER THER, V2, P113; Lee TI, 2006, CELL, V125, P301, DOI 10.1016/j.cell.2006.02.043; Lei H, 1996, DEVELOPMENT, V122, P3195; LEWIS EB, 1978, NATURE, V276, P565, DOI 10.1038/276565a0; LI E, 1992, CELL, V69, P915, DOI 10.1016/0092-8674(92)90611-F; Liu YW, 2003, J IMMUNOL, V171, P821, DOI 10.4049/jimmunol.171.2.821; Lund AH, 2004, CURR OPIN CELL BIOL, V16, P239, DOI 10.1016/j.ceb.2004.03.010; Lund AH, 2004, GENE DEV, V18, P2315, DOI 10.1101/gad.1232504; Mancini DN, 1998, ONCOGENE, V16, P1161, DOI 10.1038/sj.onc.1201630; O'Rourke JP, 1999, J BIOL CHEM, V274, P16582, DOI 10.1074/jbc.274.23.16582; Okano M, 1998, NAT GENET, V19, P219, DOI 10.1038/890; Okano M, 1999, CELL, V99, P247, DOI 10.1016/S0092-8674(00)81656-6; Orlando V, 2003, CELL, V112, P599, DOI 10.1016/S0092-8674(03)00157-0; Peng SY, 2004, INT J CANCER, V112, P44, DOI 10.1002/ijc.20279; Ramji DP, 2002, BIOCHEM J, V365, P561, DOI 10.1042/bj20020508; Ringrose L, 2004, ANNU REV GENET, V38, P413, DOI 10.1146/annurev.genet.38.072902.091907; RUESGA MA, 2006, CANC LETT, V250, P140; Sanford DC, 2005, PROSTATE, V63, P143, DOI 10.1002/pros.20159; Scardocci A, 2006, BRIT J CANCER, V95, P1108, DOI 10.1038/sj.bjc.6603392; Sell S, 2004, CRIT REV ONCOL HEMAT, V51, P1, DOI 10.1016/j.critrevonc.2004.04.007; Sivko GS, 2004, J CELL BIOCHEM, V93, P830, DOI 10.1002/jcb.20223; Sparmann A, 2006, NAT REV CANCER, V6, P846, DOI 10.1038/nrc1991; Tada T, 2006, JNCI-J NATL CANCER I, V98, P396, DOI 10.1093/jnci/djj093; Takeji M, 2004, J AM SOC NEPHROL, V15, P2383, DOI 10.1097/01.ASN.0000136426.01160.2F; Tanaka T, 1997, EMBO J, V16, P7432, DOI 10.1093/emboj/16.24.7432; Tang D, 2006, BREAST CANCER RES TR, V95, P161, DOI 10.1007/s10549-005-9061-3; Tengku-Muhammad TS, 2000, CYTOKINE, V12, P1430, DOI 10.1006/cyto.2000.0711; Thangaraju M, 2005, DEVELOPMENT, V132, P4675, DOI 10.1242/dev.02050; Vire E, 2006, NATURE, V439, P871, DOI 10.1038/nature04431; Wang JM, 2006, NUCLEIC ACIDS RES, V34, P217, DOI 10.1093/nar/gkj422; Wang JM, 2005, MOL BIOL CELL, V16, P3365, DOI 10.1091/mbc.E05-02-0105; Weinmann AS, 2001, MOL CELL BIOL, V21, P6820, DOI 10.1128/MCB.21.20.6820-6832.2001; Wilkinson FH, 2006, P NATL ACAD SCI USA, V103, P19296, DOI 10.1073/pnas.0603564103; YEH WC, 1995, GENE DEV, V9, P168, DOI 10.1101/gad.9.2.168; Zhu SY, 2002, P NATL ACAD SCI USA, V99, P207, DOI 10.1073/pnas.012437299	60	68	73	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 7	2008	283	45					30919	30932		10.1074/jbc.M804029200	http://dx.doi.org/10.1074/jbc.M804029200			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	367ID	18753137	Green Published, hybrid			2022-12-27	WOS:000260544800047
J	Stockl, M; Plazzo, AP; Korte, T; Herrmann, A				Stoeckl, Martin; Plazzo, Anna Pia; Korte, Thomas; Herrmann, Andreas			Detection of Lipid Domains in Model and Cell Membranes by Fluorescence Lifetime Imaging Microscopy of Fluorescent Lipid Analogues	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GPI-ANCHORED PROTEINS; SPIN-LABELED PHOSPHOLIPIDS; TIME-RESOLVED FLUORESCENCE; RESONANCE ENERGY-TRANSFER; LATERAL PHASE SEPARATION; PLASMA-MEMBRANE; ACYL-CHAIN; RAFTS; MIXTURES; MICRODOMAINS	The presence of lipid domains in cellular membranes and their characteristic features are still an issue of dividing discussion. Several recent studies implicate lipid domains in plasma membranes of mammalian cells as short lived and in the submicron range. Measuring the fluorescence lifetime of appropriate lipid analogues is a proper approach to detect domains with such properties. Here, the sensitivity of the fluorescence lifetime of 1-palmitoyl-2-[6-[(7-nitro-2-1,3-benzoxadiazol-4-yl) amino]-hexanoyl]- sn-glycero-3-phospholipid (C6-NBD-phospholipid) analogues has been employed to characterize lipid domains in giant unilamellar vesicles (GUVs) and the plasma membrane of mammalian cells by fluorescence lifetime imaging (FLIM). Fluorescence decay of C6-NBD-phosphatidylcholine is characterized by a short and long lifetime. For GUVs forming microscopically visible lipid domains the longer lifetime in the liquid disordered (ld) and the liquid ordered (lo) phase was clearly distinct, being similar to 7 ns and 11 ns, respectively. Lifetimes were not sensitive to variation of cholesterol concentration of domain-forming GUVs indicating that the lipid composition and physical properties of those lipid domains are well defined entities. Even the existence of submicroscopic domains can be detected by FLIM as demonstrated for GUVs of palmitoyloleoyl phosphatidylcholine/ N-palmitoyl-D-sphingomyelin/cholesterol mixtures. A broad distribution of the long lifetime was found for C6-NBD-phosphatidylcholine inserted in the plasma membrane of HepG2 and HeLa cells centered around 11 ns. FLIM studies on lipid domains forming giant vesicles derived from the plasma membrane of HeLa cells may suggest that a variety of submicroscopic lipid domains exists in the plasma membrane of intact cells.	[Stoeckl, Martin; Plazzo, Anna Pia; Korte, Thomas; Herrmann, Andreas] Humboldt Univ, Math Nat Wissenschaftliche Fak 1, Inst Biol Biophys, D-10115 Berlin, Germany	Humboldt University of Berlin	Herrmann, A (corresponding author), Humboldt Univ, Math Nat Wissenschaftliche Fak 1, Inst Biol Biophys, Invalidenstr 43, D-10115 Berlin, Germany.	andreas.herrmann@rz.hu-berlin.de	Stöckl, Martin T/I-6554-2016; Stöckl, Martin/AAM-6743-2020	Stöckl, Martin T/0000-0001-7986-9291; Stöckl, Martin/0000-0001-7986-9291	Deutsche Forschungsgemeinschaft [FG 475, SFB 740]; European Union [MRTN-CT-2004-005330]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); European Union(European Commission)	This work was supported by the Deutsche Forschungsgemeinschaft ( Grants FG 475 and SFB 740) and the European Union (Grant MRTN-CT-2004-005330) ( to A. H.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked " advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Alder-Baerens N, 2005, J BIOL CHEM, V280, P26321, DOI 10.1074/jbc.M413993200; Almeida PFF, 2005, BBA-BIOMEMBRANES, V1720, P1, DOI 10.1016/j.bbamem.2005.12.004; ANGELOVA MI, 1986, FARADAY DISCUSS, V81, P303, DOI 10.1039/dc9868100303; Baumgart T, 2007, BBA-BIOMEMBRANES, V1768, P2182, DOI 10.1016/j.bbamem.2007.05.012; Baumgart T, 2007, P NATL ACAD SCI USA, V104, P3165, DOI 10.1073/pnas.0611357104; BROWN DA, 1992, CELL, V68, P533, DOI 10.1016/0092-8674(92)90189-J; Bunge A, 2008, BIOPHYS J, V94, P2680, DOI 10.1529/biophysj.107.112904; CHAHINE JMEH, 1993, P NATL ACAD SCI USA, V90, P447, DOI 10.1073/pnas.90.2.447; CHATTOPADHYAY A, 1987, BIOCHEMISTRY-US, V26, P39, DOI 10.1021/bi00375a006; CHATTOPADHYAY A, 1993, BIOCHEMISTRY-US, V32, P3804, DOI 10.1021/bi00065a037; Collins MD, 2008, P NATL ACAD SCI USA, V105, P124, DOI 10.1073/pnas.0702970105; de Almeida RFM, 2005, J MOL BIOL, V346, P1109, DOI 10.1016/j.jmb.2004.12.026; de Almeida RFM, 2003, BIOPHYS J, V85, P2406, DOI 10.1016/S0006-3495(03)74664-5; de Almeida RFM, 2007, BIOPHYS J, V93, P539, DOI 10.1529/biophysj.106.098822; Devaux PF, 2002, CHEM PHYS LIPIDS, V116, P115, DOI 10.1016/S0009-3084(02)00023-3; Dietrich C, 2001, BIOPHYS J, V80, P1417, DOI 10.1016/S0006-3495(01)76114-0; Friedrichson T, 1998, NATURE, V394, P802, DOI 10.1038/29570; Hancock JF, 2006, NAT REV MOL CELL BIO, V7, P456, DOI 10.1038/nrm1925; Heerklotz H, 2002, BIOPHYS J, V83, P2693, DOI 10.1016/S0006-3495(02)75278-8; Huster D, 2001, BIOPHYS J, V80, P822, DOI 10.1016/S0006-3495(01)76061-4; Jacobson K, 2007, NAT CELL BIOL, V9, P7, DOI 10.1038/ncb0107-7; KARNOVSKY MJ, 1982, J CELL BIOL, V94, P1, DOI 10.1083/jcb.94.1.1; Kawasaki K, 2001, BIOPHYS J, V80, P738, DOI 10.1016/S0006-3495(01)76053-5; Korlach J, 1999, P NATL ACAD SCI USA, V96, P8461, DOI 10.1073/pnas.96.15.8461; Kusumi A, 2004, TRAFFIC, V5, P213, DOI 10.1111/j.1600-0854.2004.0178.x; Lagerholm BC, 2005, ANNU REV PHYS CHEM, V56, P309, DOI 10.1146/annurev.physchem.56.092503.141211; Landry YD, 2006, J BIOL CHEM, V281, P36091, DOI 10.1074/jbc.M602247200; LEE AG, 1977, BIOCHIM BIOPHYS ACTA, V472, P285, DOI 10.1016/0304-4157(77)90001-6; MABREY S, 1976, P NATL ACAD SCI USA, V73, P3862, DOI 10.1073/pnas.73.11.3862; Margineanu A, 2007, BIOPHYS J, V93, P2877, DOI 10.1529/biophysj.106.100743; MORROT G, 1986, P NATL ACAD SCI USA, V83, P6863, DOI 10.1073/pnas.83.18.6863; Mukherjee S, 2004, CHEM PHYS LIPIDS, V127, P91, DOI 10.1016/j.chemphyslip.2003.09.004; Mukherjee S, 2004, ANNU REV CELL DEV BI, V20, P839, DOI 10.1146/annurev.cellbio.20.010403.095451; Muller P, 1996, HEPATOLOGY, V24, P1497; Munro S, 2003, CELL, V115, P377, DOI 10.1016/S0092-8674(03)00882-1; Owen DM, 2006, BIOPHYS J, V90, pL80, DOI 10.1529/biophysj.106.084673; PETIT VA, 1974, SCIENCE, V184, P1183, DOI 10.1126/science.184.4142.1183; Pralle A, 2000, J CELL BIOL, V148, P997, DOI 10.1083/jcb.148.5.997; Prior IA, 2003, J CELL BIOL, V160, P165, DOI 10.1083/jcb.200209091; Raghuraman H, 2007, BBA-BIOMEMBRANES, V1768, P1258, DOI 10.1016/j.bbamem.2007.02.001; RECKTENWALD DJ, 1981, BIOCHEMISTRY-US, V20, P4505, DOI 10.1021/bi00518a042; Sharma P, 2004, CELL, V116, P577, DOI 10.1016/S0092-8674(04)00167-9; Shaw AS, 2006, NAT IMMUNOL, V7, P1139, DOI 10.1038/ni1405; Shaw JE, 2006, BIOPHYS J, V90, P2170, DOI 10.1529/biophysj.105.073510; SHIMSHICK EJ, 1973, BIOCHEMISTRY-US, V12, P2351, DOI 10.1021/bi00736a026; Silvius JR, 2006, MOL MEMBR BIOL, V23, P5, DOI 10.1080/09687860500473002; Silvius JR, 2003, BIOPHYS J, V85, P1034, DOI 10.1016/S0006-3495(03)74542-1; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; Tannert A, 2003, J BIOL CHEM, V278, P40631, DOI 10.1074/jbc.M302131200; TILLACK TW, 1983, BIOCHIM BIOPHYS ACTA, V733, P15, DOI 10.1016/0005-2736(83)90086-X; VAN MEER G, 1987, J CELL BIOL, V105, P1623, DOI 10.1083/jcb.105.4.1623; Varma R, 1998, NATURE, V394, P798, DOI 10.1038/29563; Veatch SL, 2003, BIOPHYS J, V84, P725, DOI 10.1016/S0006-3495(03)74891-7; Veatch SL, 2003, BIOPHYS J, V85, P3074, DOI 10.1016/S0006-3495(03)74726-2; Veatch SL, 2005, BBA-MOL CELL RES, V1746, P172, DOI 10.1016/j.bbamcr.2005.06.010; Wustner D, 2001, TRAFFIC, V2, P277, DOI 10.1034/j.1600-0854.2001.9o135.x; Yethiraj A, 2007, BIOPHYS J, V93, P3113, DOI 10.1529/biophysj.106.101931; Zidovetzki R, 2007, BBA-BIOMEMBRANES, V1768, P1311, DOI 10.1016/j.bbamem.2007.03.026	58	61	61	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 7	2008	283	45					30828	30837		10.1074/jbc.M801418200	http://dx.doi.org/10.1074/jbc.M801418200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	367ID	18708353	Green Published, hybrid			2022-12-27	WOS:000260544800038
J	Gijon, MA; Riekhof, WR; Zarini, S; Murphy, RC; Voelker, DR				Gijon, Miguel A.; Riekhof, Wayne R.; Zarini, Simona; Murphy, Robert C.; Voelker, Dennis R.			Lysophospholipid Acyltransferases and Arachidonate Recycling in Human Neutrophils	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LYSOPHOSPHATIDYLCHOLINE ACYLTRANSFERASE; SACCHAROMYCES-CEREVISIAE; ACYL-COA; IDENTIFICATION; METABOLISM; YEAST; BIOSYNTHESIS; REACYLATION; DISCOVERY; ACYLATION	The cycle of deacylation and reacylation of phospholipids plays a critical role in regulating availability of arachidonic acid for eicosanoid production. The major yeast lysophospholipid acyltransferase, Ale1p, is related to mammalian membrane-bound O-acyltransferase (MBOAT) proteins. We expressed four human MBOATs in yeast strains lacking Ale1p and studied their acyl-CoA and lysophospholipid specificities using novel mass spectrometry-based enzyme assays. MBOAT1 is a lysophosphatidylserine (lyso-PS) acyltransferase with preference for oleoyl-CoA. MBOAT2 also prefers oleoyl-CoA, using lysophosphatidic acid and lysophosphatidylethanolamine as acyl acceptors. MBOAT5 prefers lysophosphatidylcholine and lyso-PS to incorporate linoleoyl and arachidonoyl chains. MBOAT7 is a lysophosphatidylinositol acyltransferase with remarkable specificity for arachidonoyl-CoA. MBOAT5 and MBOAT7 are particularly susceptible to inhibition by thimerosal. Human neutrophils express mRNA for these four enzymes, and neutrophil microsomes incorporate arachidonoyl chains into phosphatidylinositol, phosphatidylcholine, PS, and phosphatidylethanolamine in a thimerosal-sensitive manner. These results strongly implicate MBOAT5 and MBOAT7 in arachidonate recycling, thus regulating free arachidonic acid levels and leukotriene synthesis in neutrophils.	[Gijon, Miguel A.; Zarini, Simona; Murphy, Robert C.; Voelker, Dennis R.] Univ Colorado, Dept Pharmacol, Aurora, CO 80045 USA; [Riekhof, Wayne R.] Natl Jewish Hlth, Cell Biol Program, Dept Med, Denver, CO 80206 USA	University of Colorado System; University of Colorado Anschutz Medical Campus; National Jewish Health	Murphy, RC (corresponding author), Univ Colorado, Dept Pharmacol, 12801 E 17th Ave, Aurora, CO 80045 USA.			Zarini, Simona/0000-0002-7460-3299	National Institutes of Health [GM076798, HL025785, 5R37GM032453, GM081461]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL025785, R01HL025785] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM076798, R37GM032453, R01GM081461, R01GM032453] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM076798 (to W. R. R.), HL025785 (to R. C. M.), 5R37GM032453 (to D. R. V.), and GM081461 (to D. R. V.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Abr?moff M.D., 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Benghezal M, 2007, J BIOL CHEM, V282, P30845, DOI 10.1074/jbc.M702719200; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Bosson R, 2006, MOL BIOL CELL, V17, P2636, DOI 10.1091/mbc.E06-02-0104; Cao JS, 2008, J BIOL CHEM, V283, P19049, DOI 10.1074/jbc.M800364200; Chen QL, 2007, FEBS LETT, V581, P5511, DOI 10.1016/j.febslet.2007.10.061; Chen XN, 2006, P NATL ACAD SCI USA, V103, P11724, DOI 10.1073/pnas.0604946103; CHILTON FH, 1986, J BIOL CHEM, V261, P7771; Ghosh M, 2006, PROG LIPID RES, V45, P487, DOI 10.1016/j.plipres.2006.05.003; Gietz RD, 2002, METHOD ENZYMOL, V350, P87; Hishikawa D, 2008, P NATL ACAD SCI USA, V105, P2830, DOI 10.1073/pnas.0712245105; Hodges E, 2005, MOL CELL PROTEOMICS, V4, P1319, DOI 10.1074/mcp.M500117-MCP200; Jain S, 2007, J BIOL CHEM, V282, P30562, DOI 10.1074/jbc.M706326200; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; LANDS WEM, 1960, J BIOL CHEM, V235, P2233; Lee HC, 2008, MOL BIOL CELL, V19, P1174, DOI 10.1091/mbc.E07-09-0893; Murphy RC, 2007, BIOCHEM J, V405, P379, DOI 10.1042/BJ20070289; Nakanishi H, 2006, J BIOL CHEM, V281, P20140, DOI 10.1074/jbc.M600225200; Oelkers P, 2002, J BIOL CHEM, V277, P8877, DOI 10.1074/jbc.M111646200; Oelkers P, 1998, J BIOL CHEM, V273, P26765, DOI 10.1074/jbc.273.41.26765; REINHOLD SL, 1989, J BIOL CHEM, V264, P21652; Riekhof WR, 2007, J BIOL CHEM, V282, P36853, DOI 10.1074/jbc.M706718200; Riekhof WR, 2007, J BIOL CHEM, V282, P28344, DOI 10.1074/jbc.M705256200; Riekhof WR, 2006, J BIOL CHEM, V281, P36588, DOI 10.1074/jbc.M608851200; Shindou H, 2007, J BIOL CHEM, V282, P6532, DOI 10.1074/jbc.M609641200; Sonnhammer E L, 1998, Proc Int Conf Intell Syst Mol Biol, V6, P175; Soupene E, 2008, P NATL ACAD SCI USA, V105, P88, DOI 10.1073/pnas.0709737104; Stahl U, 2008, FEBS LETT, V582, P305, DOI 10.1016/j.febslet.2007.12.020; SUMPER M, 1973, FEBS LETT, V30, P29, DOI 10.1016/0014-5793(73)80612-X; Tamaki H, 2007, J BIOL CHEM, V282, P34288, DOI 10.1074/jbc.M704509200; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901; Yang YZ, 2004, J BIOL CHEM, V279, P55866, DOI 10.1074/jbc.M406710200; Zarini S, 2006, J BIOL CHEM, V281, P10134, DOI 10.1074/jbc.M510783200; Zhao Y, 2008, J BIOL CHEM, V283, P8258, DOI 10.1074/jbc.M710422200	34	135	143	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 31	2008	283	44					30235	30245		10.1074/jbc.M806194200	http://dx.doi.org/10.1074/jbc.M806194200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	364WS	18772128	Green Published, hybrid			2022-12-27	WOS:000260366900068
J	Hermand, P; Pincet, F; Carvalho, S; Ansanay, H; Trinquet, E; Daoudi, M; Combadiere, C; Deterre, P				Hermand, Patricia; Pincet, Frederic; Carvalho, Stephanie; Ansanay, Herve; Trinquet, Eric; Daoudi, Mehdi; Combadiere, Christophe; Deterre, Philippe			Functional Adhesiveness of the CX3CL1 Chemokine Requires Its Aggregation ROLE OF THE TRANSMEMBRANE DOMAIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RESONANCE ENERGY-TRANSFER; FRACTALKINE RECEPTOR CX(3)CR1; TIME-RESOLVED FLUORESCENCE; CXC-CHEMOKINE; LIVING CELLS; GLYCOPROTEIN LIGAND-1; ANTITUMOR RESPONSES; INSULIN-RECEPTOR; FIRM ADHESION; TRANSFER BRET	In its native form, the chemokine CX3CL1 is a firmly adhesive molecule promoting leukocyte adhesion and migration and hence involved, along with its unique receptor CX3CR1, in various inflammatory processes. Here we investigated the role of molecular aggregation in the CX3CL1 adhesiveness. Assays of bioluminescence resonance energy transfer (BRET) and homogeneous time-resolved fluorescence (HTRF) in transfected cell lines and in primary cells showed specific signals indicative of CX3CL1 clustering. Truncation experiments showed that the transmembrane domain played a central role in this aggregation. A chimera with mutations of the 12 central transmembrane domain residues had significantly reduced BRET signals and characteristics of a non-clustering molecule. This mutant was weakly adhesive according to flow and dual pipette adhesion assays and was less glycosylated than CX3CL1, although, as we demonstrated, loss of glycosylation did not affect the CX3CL1 adhesive potency. We postulate that cell surfaces express CX3CL1 as a constitutive oligomer and that this oligomerization is essential for its adhesive potency. Inhibition of CX3CL1 self-assembly could limit the recruitment of CX3CR1-positive cells and may be a new pathway for anti-inflammatory therapies.	[Deterre, Philippe] Univ Paris 06, Fac Med Pitie Salpetriere, Lab Immunol Cellulaire, INSERM,U543, F-75013 Paris, France; [Hermand, Patricia; Carvalho, Stephanie; Daoudi, Mehdi; Combadiere, Christophe; Deterre, Philippe] Univ Paris 06, Lab Immunol Cellulaire, INSERM UMR S 543, F-75013 Paris, France; [Pincet, Frederic] Ecole Normale Super, Lab Phys Stat, UMR CNRS 8550, F-75231 Paris, France; [Ansanay, Herve; Trinquet, Eric] Cisbio Int, HTRF Res, F-30204 Bagnols Sur Ceze, France; [Combadiere, Christophe] AP HP, Lab Immunol Cellulaire & Tissulaire, F-75013 Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); Sorbonne Universite; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP)	Deterre, P (corresponding author), Univ Paris 06, Fac Med Pitie Salpetriere, Lab Immunol Cellulaire, INSERM,U543, 91 Blvd Hop, F-75013 Paris, France.	deterre@ccr.jussieu.fr	Deterre, Philippe/O-8984-2017; Combadiere, Christophe/I-5639-2013	Deterre, Philippe/0000-0001-9303-0791; Combadiere, Christophe/0000-0002-1755-4531; HERMAND, Patricia/0000-0003-0628-9733; PINCET, FREDERIC/0000-0002-4243-2157	Association de Recherche contre le Cancer; Institut National de la Sante et de la Recherche Medicale; European FP6 "INNOCHEM" [LSHB-CT-2005-518167]	Association de Recherche contre le Cancer(Fondation ARC pour la Recherche sur le Cancer); Institut National de la Sante et de la Recherche Medicale(Institut National de la Sante et de la Recherche Medicale (Inserm)); European FP6 "INNOCHEM"	This work was supported by grants from the Association de Recherche contre le Cancer and the Institut National de la Sante et de la Recherche Medicale (Programme National De Recherche Sur Les Maladies Cardiovasculaires) and by European FP6 "INNOCHEM" Contract LSHB-CT-2005-518167 (to C. C.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Abel S, 2004, J IMMUNOL, V172, P6362, DOI 10.4049/jimmunol.172.10.6362; Angers S, 2000, P NATL ACAD SCI USA, V97, P3684, DOI 10.1073/pnas.060590697; Ayoub MA, 2004, MOL PHARMACOL, V66, P312, DOI 10.1124/mol.104.000398; Bazan JF, 1997, NATURE, V385, P640, DOI 10.1038/385640a0; Bazin H, 2002, J Biotechnol, V82, P233, DOI 10.1016/S1389-0352(01)00040-X; Boute N, 2003, EMBO REP, V4, P313, DOI 10.1038/sj.embor.embor767; Bouvier M, 2001, NAT REV NEUROSCI, V2, P274, DOI 10.1038/35067575; Buensuceso C, 2003, J BIOL CHEM, V278, P15217, DOI 10.1074/jbc.M213234200; Cardona AE, 2006, NAT NEUROSCI, V9, P917, DOI 10.1038/nn1715; Charo IF, 2006, NEW ENGL J MED, V354, P610, DOI 10.1056/NEJMra052723; Combadiere B, 2007, M S-MED SCI, V23, P173, DOI 10.1051/medsci/2007232173; Combadiere C, 2007, J CLIN INVEST, V117, P2920, DOI 10.1172/JCI31692; Daoudi M, 2004, J BIOL CHEM, V279, P19649, DOI 10.1074/jbc.M313457200; Durkan AM, 2007, J AM SOC NEPHROL, V18, P74, DOI 10.1681/ASN.2006080862; Epperson TR, 2000, J BIOL CHEM, V275, P7839, DOI 10.1074/jbc.275.11.7839; Feng LL, 1999, KIDNEY INT, V56, P612, DOI 10.1046/j.1523-1755.1999.00604.x; Fong AM, 1998, J EXP MED, V188, P1413, DOI 10.1084/jem.188.8.1413; Fong AM, 2000, J BIOL CHEM, V275, P3781, DOI 10.1074/jbc.275.6.3781; Gales C, 2006, NAT STRUCT MOL BIOL, V13, P778, DOI 10.1038/nsmb1134; Garton KJ, 2001, J BIOL CHEM, V276, P37993; Gough PJ, 2004, J IMMUNOL, V172, P3678, DOI 10.4049/jimmunol.172.6.3678; Gurezka R, 1999, J BIOL CHEM, V274, P9265, DOI 10.1074/jbc.274.14.9265; Haskell CA, 1999, J BIOL CHEM, V274, P10053, DOI 10.1074/jbc.274.15.10053; Haskell CA, 2000, J BIOL CHEM, V275, P34183, DOI 10.1074/jbc.M005731200; Hermand P, 2000, J BIOL CHEM, V275, P26002, DOI 10.1074/jbc.M002823200; Hoover DM, 2000, J BIOL CHEM, V275, P23187, DOI 10.1074/jbc.M002584200; Hundhausen C, 2003, BLOOD, V102, P1186, DOI 10.1182/blood-2002-12-3775; Imai T, 1997, CELL, V91, P521, DOI 10.1016/S0092-8674(00)80438-9; Imaizumi T, 2000, TOHOKU J EXP MED, V192, P127, DOI 10.1620/tjem.192.127; James JR, 2006, NAT METHODS, V3, P1001, DOI 10.1038/nmeth978; Jia Y, 2006, ANAL BIOCHEM, V356, P273, DOI 10.1016/j.ab.2006.05.006; Kenworthy AK, 1998, J CELL BIOL, V142, P69, DOI 10.1083/jcb.142.1.69; KUAN SF, 1989, J BIOL CHEM, V264, P19271; Lavergne E, 2003, CANCER RES, V63, P7468; LeFevre KR, 2003, P NATL ACAD SCI USA, V100, P2345, DOI 10.1073/pnas.0537925100; LEMMON MA, 1994, NAT STRUCT BIOL, V1, P157, DOI 10.1038/nsb0394-157; Li RH, 2003, SCIENCE, V300, P795, DOI 10.1126/science.1079441; Liu GY, 2005, J BIOL CHEM, V280, P19858, DOI 10.1074/jbc.M413073200; Ludwig A, 2002, J IMMUNOL, V168, P604, DOI 10.4049/jimmunol.168.2.604; Luo BH, 2007, ANNU REV IMMUNOL, V25, P619, DOI 10.1146/annurev.immunol.25.022106.141618; Luster AD, 2005, NAT IMMUNOL, V6, P1182, DOI 10.1038/ni1275; Marullo S, 2007, TRENDS PHARMACOL SCI, V28, P362, DOI 10.1016/j.tips.2007.06.007; Mathis G, 1999, J BIOMOL SCREEN, V4, P309, DOI 10.1177/108705719900400605; Matloubian M, 2000, NAT IMMUNOL, V1, P298, DOI 10.1038/79738; Maurel D, 2004, ANAL BIOCHEM, V329, P253, DOI 10.1016/j.ab.2004.02.013; McDermott DH, 2003, J CLIN INVEST, V111, P1241, DOI 10.1172/JCI200316790; Mercier JF, 2002, J BIOL CHEM, V277, P44925, DOI 10.1074/jbc.M205767200; Meyer BH, 2006, P NATL ACAD SCI USA, V103, P2138, DOI 10.1073/pnas.0507686103; Mizoue LS, 1999, BIOCHEMISTRY-US, V38, P1402, DOI 10.1021/bi9820614; Moatti D, 2001, BLOOD, V97, P1925, DOI 10.1182/blood.V97.7.1925; Nouaille S, 2006, BIOCHEM PHARMACOL, V72, P1355, DOI 10.1016/j.bcp.2006.07.018; Prince SM, 2003, J MOL BIOL, V326, P307, DOI 10.1016/S0022-2836(02)01361-X; Proudfoot AEI, 2003, P NATL ACAD SCI USA, V100, P1885, DOI 10.1073/pnas.0334864100; Schulte A, 2007, BIOCHEM BIOPH RES CO, V358, P233, DOI 10.1016/j.bbrc.2007.04.100; Shimaoka T, 2004, J LEUKOCYTE BIOL, V75, P267, DOI 10.1189/jlb.1003465; Snapp KR, 1998, J CELL BIOL, V142, P263, DOI 10.1083/jcb.142.1.263; Stewart M, 1996, J CELL BIOCHEM, V61, P554, DOI 10.1002/(SICI)1097-4644(19960616)61:4<554::AID-JCB8>3.0.CO;2-N; STRYER L, 1967, P NATL ACAD SCI USA, V58, P719, DOI 10.1073/pnas.58.2.719; Tateyama M, 2004, NAT STRUCT MOL BIOL, V11, P637, DOI 10.1038/nsmb770; Trinquet E, 2001, ANAL BIOCHEM, V296, P232, DOI 10.1006/abio.2001.5298; Trinquet E, 2006, ANAL BIOCHEM, V358, P126, DOI 10.1016/j.ab.2006.08.002; VEATCH W, 1977, J MOL BIOL, V113, P89, DOI 10.1016/0022-2836(77)90042-0; Wehrle-Haller B, 2003, J PATHOL, V200, P481, DOI 10.1002/path.1399; Xu Y, 1999, P NATL ACAD SCI USA, V96, P151, DOI 10.1073/pnas.96.1.151; Yu YRA, 2007, INT J CANCER, V121, P316, DOI 10.1002/ijc.22660; Zhou JY, 2003, J PHARMACOL EXP THER, V305, P460, DOI 10.1124/jpet.102.048637	66	30	32	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 31	2008	283	44					30225	30234		10.1074/jbc.M802638200	http://dx.doi.org/10.1074/jbc.M802638200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	364WS	18725411	Green Submitted, hybrid, Green Published			2022-12-27	WOS:000260366900067
J	Necela, BM; Su, WD; Thompson, EA				Necela, Brian M.; Su, Weidong; Thompson, E. Aubrey			Peroxisome Proliferator-activated Receptor gamma Down-regulates Follistatin in Intestinal Epithelial Cells through SP1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INFLAMMATORY-BOWEL-DISEASE; ACTIVIN-BINDING PROTEIN; PPAR-GAMMA; GENE-EXPRESSION; COLON-CANCER; LIGANDS SUPPRESS; TRANSCRIPTION ACTIVATION; HUMAN PROSTATE; GROWTH; DIFFERENTIATION	Activation of peroxisome proliferator-activated receptor gamma (PPAR gamma) down-regulates the expression of follistatin mRNA in intestinal epithelial cells in vivo. The mechanism of PPAR gamma-mediated down-regulation of follistatin was investigated using non-transformed, rat intestinal epithelial cells (RIE-1). RIE cells expressed activin A, the activin receptors ActRI and ActRII, and the follistatin-315 mRNA. RIE-1 cells responded to endogenous activin A, and this response was antagonized by follistatin, as evidenced by changes in cell growth and regulation of an activin-responsive reporter. Using RIE-1 cells, we show that activation of PPAR gamma by rosiglitazone reduced follistatin mRNA levels in a dose- and concentration-dependent manner. Down-regulation of follistatin by rosiglitazone required the DNA binding domain of PPAR gamma and was dependent upon dimerization with the retinoid X receptor. Inhibition of follistatin expression by rosiglitazone was not associated with decreased follistatin mRNA stability, suggesting that regulation may be at the promoter level. Analysis of the follistatin promoter revealed consensus binding sites for AP-1, AP-2, and Sp1. Targeting the AP-1 pathway with SP600125, an inhibitor of JNK, and TAM67, a dominant negative c-Jun, had no effect on PPAR gamma-mediated down-regulation of follistatin. However, the follistatin promoter was dramatically regulated by Sp1, and this regulation was inhibited by PPAR gamma expression. Knockdown of Sp1 expression relieved repression of follistatin levels by rosiglitazone. Moreover, PPAR gamma was found to interact with Sp1 and repress its transcriptional activation function. Collectively, our data indicate that repression of Sp1 transcriptional activity by PPAR gamma is the underlying mechanism responsible for PPAR gamma-mediated regulation of follistatin expression.	[Necela, Brian M.; Su, Weidong; Thompson, E. Aubrey] Mayo Clin, Ctr Comprehens Canc, Dept Canc Biol, Jacksonville, FL 32224 USA	Mayo Clinic	Necela, BM (corresponding author), Mayo Clin, Ctr Comprehens Canc, Dept Canc Biol, Griffin Canc Res Bld,Rm 241,4500 San Pablo Rd, Jacksonville, FL 32224 USA.	necela.brian@mayo.edu			Crohn's and Colitis Foundation; Mayo Foundation	Crohn's and Colitis Foundation; Mayo Foundation	This work was supported by the Crohn's and Colitis Foundation and the Mayo Foundation. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Adachi M, 2006, GUT, V55, P1104, DOI 10.1136/gut.2005.081745; Bartholin L, 2002, ONCOGENE, V21, P2227, DOI 10.1038/sj.onc.1205294; Bartholin L, 2001, ONCOGENE, V20, P5409, DOI 10.1038/sj.onc.1204720; Bilezikjian LM, 2001, ENDOCRINOLOGY, V142, P1065, DOI 10.1210/en.142.3.1065; BLAY J, 1984, CELL BIOL INT REP, V8, P551, DOI 10.1016/0309-1651(84)90054-7; Brasier AR, 1998, J BIOL CHEM, V273, P3551, DOI 10.1074/jbc.273.6.3551; Brockman JA, 1998, GASTROENTEROLOGY, V115, P1049, DOI 10.1016/S0016-5085(98)70072-1; Bush CR, 2007, J BIOL CHEM, V282, P23387, DOI 10.1074/jbc.M702708200; Chang TH, 2000, CANCER RES, V60, P1129; Chawla A, 2001, NAT MED, V7, P48, DOI 10.1038/83336; Chen L, 2006, J BIOL CHEM, V281, P24575, DOI 10.1074/jbc.M604147200; Chen L, 2006, MOL CELL ENDOCRINOL, V251, P17, DOI 10.1016/j.mce.2006.02.006; Chen YG, 2006, EXP BIOL MED, V231, P534; Chung SS, 2006, BIOCHEM BIOPH RES CO, V348, P253, DOI 10.1016/j.bbrc.2006.07.048; Coyle AT, 2006, BIOCHEM PHARMACOL, V71, P1308, DOI 10.1016/j.bcp.2006.01.011; Crosby MB, 2005, J PHARMACOL EXP THER, V312, P69, DOI 10.1124/jpet.104.074005; DEPAOLO LV, 1991, P SOC EXP BIOL MED, V198, P500; Desreumaux P, 2001, J EXP MED, V193, P827, DOI 10.1084/jem.193.7.827; Dignass AU, 2002, SCAND J GASTROENTERO, V37, P936, DOI 10.1080/003655202760230900; Dohi T, 2005, GASTROENTEROLOGY, V128, P411, DOI 10.1053/j.gastro.2004.11.063; Drori S, 2005, GENE DEV, V19, P362, DOI 10.1101/gad.1240705; Ebert S, 2006, J NEUROL SCI, V250, P50, DOI 10.1016/j.jns.2006.06.026; Escher P, 2001, ENDOCRINOLOGY, V142, P4195, DOI 10.1210/en.142.10.4195; EVANS RM, 1988, SCIENCE, V240, P889, DOI 10.1126/science.3283939; Fajas L, 1997, J BIOL CHEM, V272, P18779, DOI 10.1074/jbc.272.30.18779; Grusch M, 2006, J HEPATOL, V45, P673, DOI 10.1016/j.jhep.2006.06.014; Gupta RA, 2003, J BIOL CHEM, V278, P7431, DOI 10.1074/jbc.M208076200; Han SW, 2005, AM J PHYSIOL-LUNG C, V289, pL419, DOI 10.1152/ajplung.00002.2005; Hardy CL, 2006, CLIN EXP ALLERGY, V36, P941, DOI 10.1111/j.1365-2222.2006.02523.x; Harkonen P, 2003, J CLIN ENDOCR METAB, V88, P705, DOI 10.1210/jc.2002-020236; Harrison CA, 2005, TRENDS ENDOCRIN MET, V16, P73, DOI 10.1016/j.tem.2005.01.003; Hazra S, 2004, J BIOL CHEM, V279, P11392, DOI 10.1074/jbc.M310284200; HU ED, 1995, P NATL ACAD SCI USA, V92, P9856, DOI 10.1073/pnas.92.21.9856; Hubner G, 1997, LAB INVEST, V77, P311; Jones KL, 2004, MOL CELL ENDOCRINOL, V225, P119, DOI 10.1016/j.mce.2004.07.010; Jones KL, 2007, P NATL ACAD SCI USA, V104, P16239, DOI 10.1073/pnas.0705971104; Jones MR, 2007, MOL HUM REPROD, V13, P237, DOI 10.1093/molehr/gal120; Jung BH, 2007, GASTROENTEROLOGY, V132, P633, DOI 10.1053/j.gastro.2006.11.018; Katayama K, 2003, GASTROENTEROLOGY, V124, P1315, DOI 10.1016/S0016-5085(03)00262-2; Kato M, 2004, J CANCER RES CLIN, V130, P73, DOI 10.1007/s00432-003-0510-2; Kitamura S, 1999, JPN J CANCER RES, V90, P75, DOI 10.1111/j.1349-7006.1999.tb00668.x; KLIEWER SA, 1992, NATURE, V358, P771, DOI 10.1038/358771a0; LEHMANN JM, 1995, J BIOL CHEM, V270, P12953, DOI 10.1074/jbc.270.22.12953; Lewis JD, 2008, GASTROENTEROLOGY, V134, P688, DOI 10.1053/j.gastro.2007.12.012; Lewis JD, 2001, AM J GASTROENTEROL, V96, P3323; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Luisi S, 2001, EUR J ENDOCRINOL, V145, P225, DOI 10.1530/eje.0.1450225; Lytle C, 2005, INFLAMM BOWEL DIS, V11, P231, DOI 10.1097/01.MIB.0000160805.46235.eb; Maeshima A, 2008, ENDOCR J, V55, P1, DOI 10.1507/endocrj.KR-113; Marin HE, 2006, CANCER RES, V66, P4394, DOI 10.1158/0008-5472.CAN-05-4277; McPherson SJ, 1999, ENDOCRINOLOGY, V140, P5303, DOI 10.1210/en.140.11.5303; Meissner M, 2004, CIRC RES, V94, P324, DOI 10.1161/01.RES.0000113781.08139.81; MIYANAGA K, 1993, MOL CELL ENDOCRINOL, V92, P99, DOI 10.1016/0303-7207(93)90080-4; Moore KJ, 2001, CURR OPIN LIPIDOL, V12, P519, DOI 10.1097/00041433-200110000-00007; Mukherjee R, 1997, J BIOL CHEM, V272, P8071, DOI 10.1074/jbc.272.12.8071; Osawa E, 2003, GASTROENTEROLOGY, V124, P361, DOI 10.1053/gast.2003.50067; Pangas SA, 2000, TRENDS ENDOCRIN MET, V11, P309, DOI 10.1016/S1043-2760(00)00294-0; Paoni NF, 2003, PHYSIOL GENOMICS, V15, P228, DOI 10.1152/physiolgenomics.00078.2003; Phillips DJ, 2000, BIOESSAYS, V22, P689, DOI 10.1002/1521-1878(200008)22:8<689::AID-BIES2>3.0.CO;2-5; Phillips DJ, 1998, FRONT NEUROENDOCRIN, V19, P287, DOI 10.1006/frne.1998.0169; Phillips DJ, 2004, GROWTH FACTORS, V22, P13, DOI 10.1080/08977190410001688687; Risbridger GP, 2001, ENDOCR REV, V22, P836, DOI 10.1210/er.22.6.836; Rossmanith W, 2002, MOL CARCINOGEN, V35, P1, DOI 10.1002/mc.10068; SADOWSKI I, 1989, NUCLEIC ACIDS RES, V17, P7539, DOI 10.1093/nar/17.18.7539; Sarraf P, 1998, NAT MED, V4, P1046, DOI 10.1038/2030; Saubermann LJ, 2002, INFLAMM BOWEL DIS, V8, P330, DOI 10.1097/00054725-200209000-00004; Schaefer KL, 2005, INFLAMM BOWEL DIS, V11, P244, DOI 10.1097/01.MIB.0000160770.94199.9b; Shah YM, 2007, AM J PHYSIOL-GASTR L, V292, pG657, DOI 10.1152/ajpgi.00381.2006; Shen ZJ, 2005, INT J GYNECOL OBSTET, V88, P336, DOI 10.1016/j.ijgo.2004.12.024; Sonoda J, 2008, FEBS LETT, V582, P2, DOI 10.1016/j.febslet.2007.11.016; Sonoyama K, 2000, AM J PHYSIOL-GASTR L, V278, pG89, DOI 10.1152/ajpgi.2000.278.1.G89; Stove C, 2004, ONCOGENE, V23, P5330, DOI 10.1038/sj.onc.1207699; Su CG, 1999, J CLIN INVEST, V104, P383, DOI 10.1172/JCI7145; Su WD, 2007, PHYSIOL GENOMICS, V30, P342, DOI 10.1152/physiolgenomics.00042.2007; Subbaramaiah K, 2001, J BIOL CHEM, V276, P12440, DOI 10.1074/jbc.M007237200; Sugawara A, 2002, J BIOL CHEM, V277, P9676, DOI 10.1074/jbc.M104560200; Sugawara A, 2001, ENDOCRINOLOGY, V142, P3125, DOI 10.1210/en.142.7.3125; Tanaka T, 2001, CANCER RES, V61, P2424; Thomas TZ, 1997, J CLIN ENDOCR METAB, V82, P3851, DOI 10.1210/jc.82.11.3851; TONTONOZ P, 1994, CELL, V79, P1147, DOI 10.1016/0092-8674(94)90006-X; Tsuchida K, 2008, ENDOCR J, V55, P11, DOI 10.1507/endocrj.KR-110; Vale W, 2004, ANN NY ACAD SCI, V1038, P142, DOI 10.1196/annals.1315.023; Wang QF, 1999, J UROLOGY, V161, P1378, DOI 10.1016/S0022-5347(01)61687-2; Welt C, 2002, EXP BIOL MED, V227, P724, DOI 10.1177/153537020222700905; Werner S, 2006, CYTOKINE GROWTH F R, V17, P157, DOI 10.1016/j.cytogfr.2006.01.001; Willert Jennifer, 2002, BMC Dev Biol, V2, P8, DOI 10.1186/1471-213X-2-8; Yoshizumi T, 2004, INT J ONCOL, V25, P631; ZHU YJ, 1995, P NATL ACAD SCI USA, V92, P7921, DOI 10.1073/pnas.92.17.7921	88	21	21	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 31	2008	283	44					29784	29794		10.1074/jbc.M804481200	http://dx.doi.org/10.1074/jbc.M804481200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	364WS	18768463	hybrid, Green Published			2022-12-27	WOS:000260366900022
J	Ravindran, S; Narayanan, K; Eapen, AS; Hao, JJ; Ramachandran, A; Blond, S; George, A				Ravindran, Sriram; Narayanan, Karthikeyan; Eapen, Asha Sarah; Hao, Jianjun; Ramachandran, Amsaveni; Blond, Sylvie; George, Anne			Endoplasmic Reticulum Chaperone Protein GRP-78 Mediates Endocytosis of Dentin Matrix Protein 1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IN-VITRO; CAVEOLAR ENDOCYTOSIS; GENE-TRANSCRIPTION; COXSACKIEVIRUS A9; CANCER CELLS; IDENTIFICATION; EXPRESSION; SURFACE; MEMBRANE; BINDING	Dentin matrix protein 1 (DMP1), a phosphorylated protein present in the mineral phase of both vertebrates and invertebrates, is a key regulatory protein during biogenic formation of mineral deposits. Previously we showed that DMP1 is localized in the nuclear compartment of preosteoblasts and preodontoblasts. In the nucleus DMP1 might play an important role in the regulation of genes that control osteoblast or odontoblast differentiation. Here, we show that cellular uptake of DMP1 occurs through endocytosis. Interestingly, this process is initiated by DMP1 binding to the glucose-regulated protein-78 (GRP-78) localized on the plasma membrane of preodontoblast cells. Binding of DMP1 to GRP-78 receptor was determined to be specific and saturable with a binding dissociation constant K-D = 85 nM. We further depict a road map for the endocytosed DMP1 and demonstrate that the internalization is mediated primarily by caveolae and that the vesicles containing DMP1 are routed to the nucleus along microtubules. Immunohistochemical analysis and binding studies performed with biotin-labeled DMP1 confirm spatial co-localization of DMP1 and GRP-78 in the preodontoblasts of a developing mouse molar. Co-localization of DMP1 with GRP-78 was also observed in T4-4 preodontoblast cells, dental pulp stem cells, and primary preodontoblasts. By small interfering RNA techniques, we demonstrate that the receptor for DMP1 is GRP-78. Therefore, binding of DMP1 with GRP-78 receptor might be an important mechanism by which DMP1 is internalized and transported to the nucleus during bone and tooth development.	[Ravindran, Sriram; Narayanan, Karthikeyan; Eapen, Asha Sarah; Hao, Jianjun; Ramachandran, Amsaveni; George, Anne] Univ Illinois, Dept Oral Biol, Chicago, IL 60612 USA; [Blond, Sylvie] Univ Illinois, Dept Pharmaceut Biotechnol, Chicago, IL 60612 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	George, A (corresponding author), Univ Illinois, Dept Oral Biol, Chicago, IL 60612 USA.	anneg@uic.edu	Narayanan, Karthikeyan/D-1957-2010	Narayanan, Karthikeyan/0000-0001-5136-2296; GEORGE, ANNE/0000-0002-9008-7642	National Institutes of Health [DE 11657, DE 16533]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE011657] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R56DE011657, R01DE016533] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported, in whole or in part, by National Institutes of Health Grants DE 11657 and DE 16533. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Altmeyer A, 1996, INT J CANCER, V69, P340, DOI 10.1002/(SICI)1097-0215(19960822)69:4<340::AID-IJC18>3.0.CO;2-9; ANDERSON RGW, 1992, SCIENCE, V255, P410, DOI 10.1126/science.1310359; BARON DA, 1985, AM J PHYSIOL-RENAL, V249, P464; Batouli S, 2003, J DENT RES, V82, P976, DOI 10.1177/154405910308201208; Broquet AH, 2003, J BIOL CHEM, V278, P21601, DOI 10.1074/jbc.M302326200; Delpino A, 2002, BIOSCIENCE REP, V22, P407, DOI 10.1023/A:1020966008615; GEORGE A, 1994, J HISTOCHEM CYTOCHEM, V42, P1527, DOI 10.1177/42.12.7983353; GEORGE A, 1993, J BIOL CHEM, V268, P12624; Gronthos S, 2000, P NATL ACAD SCI USA, V97, P13625, DOI 10.1073/pnas.240309797; Hao JJ, 2002, J BIOL CHEM, V277, P19976, DOI 10.1074/jbc.M112223200; He G, 2003, NAT MATER, V2, P552, DOI 10.1038/nmat945; He G, 2004, J BIOL CHEM, V279, P11649, DOI 10.1074/jbc.M309296200; Huang BZ, 2008, CALCIFIED TISSUE INT, V82, P401, DOI 10.1007/s00223-008-9140-7; Inal J, 2005, EXP CELL RES, V310, P54, DOI 10.1016/j.yexcr.2005.07.003; Jain A, 2002, J BIOL CHEM, V277, P13700, DOI 10.1074/jbc.M110757200; Jindadamrongwech S, 2004, ARCH VIROL, V149, P915, DOI 10.1007/s00705-003-0263-x; Karadag A, 2005, CANCER RES, V65, P11545, DOI 10.1158/0008-5472.CAN-05-2861; Katzmann DJ, 2001, CELL, V106, P145, DOI 10.1016/S0092-8674(01)00434-2; Luo TC, 2001, J VIROL, V75, P2488, DOI 10.1128/JVI.75.5.2488-2492.2001; Macdonald JL, 2005, J LIPID RES, V46, P1061, DOI 10.1194/jlr.D400041-JLR200; MacDougall M, 1998, J BONE MINER RES, V13, P422, DOI 10.1359/jbmr.1998.13.3.422; McMichael BK, 2006, BONE, V39, P694, DOI 10.1016/j.bone.2006.04.031; Misra UK, 2005, J BIOL CHEM, V280, P26278, DOI 10.1074/jbc.M414467200; Narayanan K, 2003, J BIOL CHEM, V278, P17500, DOI 10.1074/jbc.M212700200; Narayanan K, 2001, P NATL ACAD SCI USA, V98, P4516, DOI 10.1073/pnas.081075198; Narayanan K, 2006, J BIOL CHEM, V281, P19064, DOI 10.1074/jbc.M600714200; Nichols BJ, 2002, NAT CELL BIOL, V4, P374, DOI 10.1038/ncb787; Pelkmans L, 2001, NAT CELL BIOL, V3, P473, DOI 10.1038/35074539; Prevostel C, 2000, J CELL SCI, V113, P2575; Qin C, 2007, J DENT RES, V86, P1134, DOI 10.1177/154405910708601202; Qin CL, 2003, J BIOL CHEM, V278, P34700, DOI 10.1074/jbc.M305315200; Roy S, 1999, NAT CELL BIOL, V1, P98, DOI 10.1038/10067; Schousboe I, 2004, EUR J BIOCHEM, V271, P2998, DOI 10.1111/j.1432-1033.2004.04229.x; Sharma DK, 2004, MOL BIOL CELL, V15, P3114, DOI 10.1091/mbc.E04-03-0189; Smart EJ, 1999, MOL CELL BIOL, V19, P7289; Soldati T, 2006, NAT REV MOL CELL BIO, V7, P897, DOI 10.1038/nrm2060; Srinivasan R, 1999, CONNECT TISSUE RES, V40, P251, DOI 10.3109/03008209909000703; Steiglitz BM, 2004, J BIOL CHEM, V279, P980, DOI 10.1074/jbc.M310179200; Tagawa A, 2005, J CELL BIOL, V170, P769, DOI 10.1083/jcb.200506103; Triantafilou K, 2003, VIROLOGY, V317, P128, DOI 10.1016/j.virol.2003.08.036; Triantafilou K, 2002, J VIROL, V76, P633, DOI 10.1128/JVI.76.2.633-643.2002; Wiest DL, 1997, P NATL ACAD SCI USA, V94, P1884, DOI 10.1073/pnas.94.5.1884; Wu J, 2006, CELL DEATH DIFFER, V13, P374, DOI 10.1038/sj.cdd.4401840; Xiao GQ, 1999, MOL BRAIN RES, V72, P121, DOI 10.1016/S0169-328X(99)00188-6; Ye L, 2004, J BIOL CHEM, V279, P19141, DOI 10.1074/jbc.M400490200	45	41	42	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 31	2008	283	44					29658	29670		10.1074/jbc.M800786200	http://dx.doi.org/10.1074/jbc.M800786200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	364WS	18757373	Green Published, hybrid			2022-12-27	WOS:000260366900009
J	Cao, C; Lu, S; Kivlin, R; Wallin, B; Card, E; Bagdasarian, A; Tamakloe, T; Chu, WM; Guan, KL; Wan, YS				Cao, Cong; Lu, Shan; Kivlin, Rebecca; Wallin, Brittany; Card, Elizabeth; Bagdasarian, Andrew; Tamakloe, Tyrone; Chu, Wen-ming; Guan, Kun-liang; Wan, Yinsheng			AMP-activated Protein Kinase Contributes to UV- and H2O2-induced Apoptosis in Human Skin Keratinocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROSTATE-CANCER CELLS; IN-VIVO; ULTRAVIOLET-RADIATION; SURVIVAL PATHWAY; P38 MAPK; PHOSPHORYLATION; GROWTH; IRRADIATION; EXPRESSION; INHIBITOR	AMP-activated protein kinase or AMPK is an evolutionarily conserved sensor of cellular energy status, activated by a variety of cellular stresses that deplete ATP. However, the possible involvement of AMPK in UV- and H2O2-induced oxidative stresses that lead to skin aging or skin cancer has not been fully studied. We demonstrated for the first time that UV and H2O2 induce AMPK activation (Thr(172) phosphorylation) in cultured human skin keratinocytes. UV and H2O2 also phosphorylate LKB1, an upstream signal of AMPK, in an epidermal growth factor receptor-dependent manner. Using compound C, a specific inhibitor of AMPK and AMPK-specific small interfering RNA knockdown as well as AMPK activator, we found that AMPK serves as a positive regulator for p38 and p53 (Ser(15)) phosphorylation induced by UV radiation and H2O2 treatment. We also observed that AMPK serves as a negative feedback signal against UV- induced mTOR (mammalian target of rapamycin) activation in a TSC2-dependent manner. Inhibiting mTOR and positively regulating p53 and p38 might contribute to the pro-apoptotic effect of AMPK on UV- or H2O2-treated cells. Furthermore, activation of AMPK also phosphorylates acetylCoA carboxylase or ACC, the pivotal enzyme of fatty acid synthesis, and PFK2, the key protein of glycolysis in UV- radiated cells. Collectively, we conclude that AMPK contributes to UV- and H2O2-induced apoptosis via multiple mechanisms in human skin keratinocytes and AMPK plays important roles in UV- induced signal transduction ultimately leading to skin photoaging and even skin cancer.	[Cao, Cong; Lu, Shan; Kivlin, Rebecca; Wallin, Brittany; Card, Elizabeth; Bagdasarian, Andrew; Tamakloe, Tyrone; Wan, Yinsheng] Providence Coll, Dept Biol, Providence, RI 02918 USA; [Cao, Cong; Chu, Wen-ming] Brown Univ, Dept Mol Microbiol & Immunol, Providence, RI 02903 USA; [Guan, Kun-liang] Univ Calif San Diego, Dept Pharmacol, San Diego, CA 90293 USA	Providence College; Brown University; University of California System; University of California San Diego	Wan, YS (corresponding author), Providence Coll, Dept Biol, 549 River Ave, Providence, RI 02918 USA.	yswan@providence.edu	Guan, Kun-Liang/ADK-7088-2022		National Institutes of Health [P20 RR016457]; Rhode Island Foundation; Slater Center for Environmental Biotechnology; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016457] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Rhode Island Foundation; Slater Center for Environmental Biotechnology; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported, in whole or in part, by National Institutes of Health Grant P20 RR016457 from the INBRE Program of the National Center for Research Resources. This work was also supported by grants for biomedical research from the Rhode Island Foundation and the Slater Center for Environmental Biotechnology. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Arad M, 2007, CIRC RES, V100, P474, DOI 10.1161/01.RES.0000258446.23525.37; Baas AF, 2003, EMBO J, V22, P3062, DOI 10.1093/emboj/cdg292; Bai XC, 2007, SCIENCE, V318, P977, DOI 10.1126/science.1147379; BODE AM, 2003, SCI STKE, pRE2; Cai Y, 2007, FREE RADICAL BIO MED, V42, P64, DOI 10.1016/j.freeradbiomed.2006.09.018; CAO C, 2008, J CELL MOL IN PRESS; Cao C, 2008, CELL SIGNAL, V20, P1830, DOI 10.1016/j.cellsig.2008.06.010; Cao C, 2008, CANCER LETT, V266, P249, DOI 10.1016/j.canlet.2008.02.062; Cao C, 2008, J CELL PHYSIOL, V215, P506, DOI 10.1002/jcp.21336; Cao C, 2007, J CELL PHYSIOL, V212, P252, DOI 10.1002/jcp.21026; Cao C, 2006, BIOCHEM J, V400, P225, DOI 10.1042/BJ20060816; Carling D, 2004, TRENDS BIOCHEM SCI, V29, P18, DOI 10.1016/j.tibs.2003.11.005; Chen WQ, 2008, INT J MOL MED, V21, P645; Du JH, 2005, BIOCHEM BIOPH RES CO, V337, P1139, DOI 10.1016/j.bbrc.2005.09.174; Fisher GJ, 1998, J CLIN INVEST, V101, P1432, DOI 10.1172/JCI2153; Fisher GJ, 2002, ARCH DERMATOL, V138, P1462, DOI 10.1001/archderm.138.11.1462; Imamura K, 2001, BIOCHEM BIOPH RES CO, V287, P562, DOI 10.1006/bbrc.2001.5627; Inoki K, 2003, CELL, V115, P577, DOI 10.1016/S0092-8674(03)00929-2; Inoki K, 2002, NAT CELL BIOL, V4, P648, DOI 10.1038/ncb839; Inoki K, 2006, CELL, V126, P955, DOI 10.1016/j.cell.2006.06.055; Jaswal JS, 2007, AM J PHYSIOL-HEART C, V292, pH1978, DOI 10.1152/ajpheart.01121.2006; Jones RG, 2005, MOL CELL, V18, P283, DOI 10.1016/j.molcel.2005.03.027; Jung SN, 2008, CARCINOGENESIS, V29, P713, DOI 10.1093/carcin/bgn032; Kahn BB, 2005, CELL METAB, V1, P15, DOI 10.1016/j.cmet.2004.12.003; Kim WH, 2007, CELL SIGNAL, V19, P791, DOI 10.1016/j.cellsig.2006.10.004; Kobet E, 2000, P NATL ACAD SCI USA, V97, P12547, DOI 10.1073/pnas.97.23.12547; Li J, 2005, CIRC RES, V97, P872, DOI 10.1161/01.RES.0000187458.77026.10; Li JL, 2007, J BIOMED SCI, V14, P303, DOI 10.1007/s11373-007-9148-4; Li YH, 2006, INT J MOL MED, V18, P713; Lizcano JM, 2004, EMBO J, V23, P833, DOI 10.1038/sj.emboj.7600110; Marsin AS, 2000, CURR BIOL, V10, P1247, DOI 10.1016/S0960-9822(00)00742-9; Okoshi R, 2008, J BIOL CHEM, V283, P3979, DOI 10.1074/jbc.M705232200; Park Y, 2002, J IMMUNOL, V168, P5, DOI 10.4049/jimmunol.168.1.5; Rattan R, 2005, J BIOL CHEM, V280, P39582, DOI 10.1074/jbc.M507443200; Ruderman NB, 2006, DIABETES, V55, pS48, DOI 10.2337/db06-S007; Shaw RJ, 2004, P NATL ACAD SCI USA, V101, P3329, DOI 10.1073/pnas.0308061100; Siliciano JD, 1997, GENE DEV, V11, P3471, DOI 10.1101/gad.11.24.3471; Thomson DM, 2008, J APPL PHYSIOL, V104, P625, DOI 10.1152/japplphysiol.00915.2007; Towler MC, 2007, CIRC RES, V100, P328, DOI 10.1161/01.RES.0000256090.42690.05; Wan YS, 2001, INT J ONCOL, V18, P461; Wang SL, 2003, ONCOGENE, V22, P8628, DOI 10.1038/sj.onc.1207232; Xiang XQ, 2004, BIOCHEM BIOPH RES CO, V321, P161, DOI 10.1016/j.bbrc.2004.06.133; Xu YR, 2006, AM J PATHOL, V169, P823, DOI 10.2353/ajpath.2006.050449; Yamauchi M, 2008, MOL ENDOCRINOL, V22, P893, DOI 10.1210/me.2007-0249; Yoon H, 2008, BIOCHEM BIOPH RES CO, V371, P495, DOI 10.1016/j.bbrc.2008.04.102; Yoon MJ, 2006, DIABETES, V55, P2562, DOI 10.2337/db05-1322; ZHANG J, 2008, MOL CARCINO IN PRESS; Zhang QS, 2001, INT J ONCOL, V19, P1057	48	101	102	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 24	2008	283	43					28897	28908		10.1074/jbc.M804144200	http://dx.doi.org/10.1074/jbc.M804144200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	362EB	18715874	hybrid, Green Published			2022-12-27	WOS:000260179900015
J	Liu, YD; Chen, XY; Enk, JZ; Plant, M; Dillon, TM; Flynn, GC				Liu, Y. Diana; Chen, Xiaoyu; Enk, Jian Zhang-van; Plant, Matt; Dillon, Thomas M.; Flynn, Gregory C.			Human IgG2 Antibody Disulfide Rearrangement in Vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ISOMERASE; PLASMA	Proteins destined to circulate in the blood are first folded and assembled in the endoplasmic reticulum of secretory cells. For antibodies, like many other serum proteins, the folding and assembly steps involve the formation of disulfide bonds. Such bonds have been thought to be static features of proteins, stabilizing domains, and linking polypeptide chains, although some cases of extracellular disulfide bond cleavage have been noted. Recently, the human IgG2 antibody subclass was found to possess multiple structures differing in specific disulfide linkages. These structures are naturally occurring and can, in some cases, affect the activity of the antibody. Here we show that these IgG2 disulfide linkages interconvert while circulating in humans. Secretory cells initially produce primarily one form (IgG2-A), which is rapidly converted to a second form (IgG2-A/B) while circulating in the blood, followed by a slower conversion to a third form (IgG2-B). This work demonstrates that the disulfide structure of the IgG2 antibody is dynamic in vivo, on a time scale similar to that of the protein's lifetime. Thus, changes to the IgG2 disulfide structure provide a marker of the protein's age and may alter its activity over its lifetime.	[Liu, Y. Diana; Chen, Xiaoyu; Flynn, Gregory C.] Amgen Inc, Dept Analyt & Formulat Sci, Thousand Oaks, CA 91320 USA; [Enk, Jian Zhang-van] Amgen Inc, Dept Informat Syst, Thousand Oaks, CA 91320 USA; [Plant, Matt] Amgen Inc, Dept Inflammat, Thousand Oaks, CA 91320 USA; [Dillon, Thomas M.] Amgen Inc, Dept Formulat & Analyt Resources, Thousand Oaks, CA 91320 USA	Amgen; Amgen; Amgen; Amgen	Flynn, GC (corresponding author), Amgen Inc, Dept Analyt & Formulat Sci, 1 Amgen Ctr Dr,Mail Stop 30E-1-C, Thousand Oaks, CA 91320 USA.	gflynn@amgen.com	Liu, Y Diana/AAU-4624-2021					Alarazi P.N., 1988, ANNU REV IMMUNOL, V6, P550; ANDERSSON A, 1993, CLIN CHEM, V39, P1590; Chen XY, 2007, ANAL BIOCHEM, V370, P147, DOI 10.1016/j.ab.2007.08.012; Chow AW, 2006, METH MOL B, V339, P145, DOI 10.1385/1-59745-076-6:145; Di Giuseppe D, 2003, J LAB CLIN MED, V142, P21, DOI 10.1016/S0022-2143(03)00057-X; Dillon TM, 2008, J BIOL CHEM, V283, P16206, DOI 10.1074/jbc.M709988200; Dillon TM, 2006, J CHROMATOGR A, V1120, P112, DOI 10.1016/j.chroma.2006.01.016; Ellgaard L, 2005, EMBO REP, V6, P28, DOI 10.1038/sj.embor.7400311; Ellgaard L, 2003, NAT REV MOL CELL BIO, V4, P181, DOI 10.1038/nrm1052; FRANGIONE B, 1968, J MOL BIOL, V33, P983; Gruber CW, 2006, TRENDS BIOCHEM SCI, V31, P455, DOI 10.1016/j.tibs.2006.06.001; Hogg PJ, 2003, TRENDS BIOCHEM SCI, V28, P210, DOI 10.1016/S0968-0004(03)00057-4; Kolfschoten MV, 2007, SCIENCE, V317, P1554, DOI 10.1126/science.1144603; KORNFELD R, 1985, ANNU REV BIOCHEM, V54, P631, DOI 10.1146/annurev.biochem.54.1.631; KOSOWER EM, 1995, METHOD ENZYMOL, V251, P133, DOI 10.1016/0076-6879(95)51117-2; NEWTON GL, 1995, METHOD ENZYMOL, V251, P148, DOI 10.1016/0076-6879(95)51118-0; THORNTON JM, 1981, J MOL BIOL, V151, P261, DOI 10.1016/0022-2836(81)90515-5; Tu BP, 2004, J CELL BIOL, V164, P341, DOI 10.1083/jcb.200311055; Wypych J, 2008, J BIOL CHEM, V283, P16194, DOI 10.1074/jbc.M709987200	19	95	99	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 24	2008	283	43					29266	29272		10.1074/jbc.M804787200	http://dx.doi.org/10.1074/jbc.M804787200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	362EB	18713741	Green Published, hybrid			2022-12-27	WOS:000260179900053
J	Mersfelder, EL; Parthun, MR				Mersfelder, Erica L.; Parthun, Mark R.			Involvement of Hat1p (Kat1p) Catalytic Activity and Subcellular Localization in Telomeric Silencing	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ASSEMBLY FACTOR-I; HISTONE ACETYLTRANSFERASE-B; GCN5 TRANSCRIPTIONAL COACTIVATOR; SACCHAROMYCES-CEREVISIAE; CRYSTAL-STRUCTURE; COENZYME-A; ASPARAGINE RESIDUE; ACETYLATION SITES; MAIZE EMBRYOS; HIR PROTEINS	Previous studies have shown that loss of the type B histone acetyltransferase Hat1p leads to defects in telomeric silencing in Saccharomyces cerevisiae. We used this phenotype to explore a number of functional characteristics of this enzyme. To determine whether the enzymatic activity of Hat1p is necessary for its role in telomeric silencing, a structurally conserved glutamic acid residue (Glu-255) that has been proposed to be the enzymes catalytic base was mutated. Surprisingly neither this residue nor any other acidic residues near the enzymes active site were essential for enzymatic activity. This suggests that Hat1p differs from most histone acetyltransferases in that it does not use an acidic amino acid as a catalytic base. The effects of these Hat1p mutants on enzymatic activity correlated with their effects on telomeric silencing indicating that the ability of Hat1p to acetylate substrates is important for its in vivo function. Despite its presumed role in the acetylation of newly synthesized histones in the cytoplasm, Hat1p was found to be a predominantly nuclear protein. This subcellular localization of Hat1p is important for its in vivo function because a construct that prevents its accumulation in the nucleus caused defects in telomeric silencing similar to those seen with a deletion mutant. Therefore, the presence of catalytically active Hat1p in the cytoplasm is not sufficient to support normal telomeric silencing. Hence both enzymatic activity and nuclear localization are necessary characteristics of Hat1p function in telomeric silencing.	[Mersfelder, Erica L.; Parthun, Mark R.] Ohio State Univ, Dept Mol & Cellular Biochem, Columbus, OH 43210 USA	University System of Ohio; Ohio State University	Parthun, MR (corresponding author), Ohio State Univ, Dept Mol & Cellular Biochem, Columbus, OH 43210 USA.				National Institutes of Health [GM062970]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062970] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM062970. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Adams Alison, 1997, P99; Ahmad A, 2001, NUCLEIC ACIDS RES, V29, P629, DOI 10.1093/nar/29.3.629; Ai X, 2004, MOL CELL, V14, P195, DOI 10.1016/S1097-2765(04)00184-4; Barman HK, 2006, BIOCHEM BIOPH RES CO, V345, P1547, DOI 10.1016/j.bbrc.2006.05.079; Benson LJ, 2007, J BIOL CHEM, V282, P836, DOI 10.1074/jbc.M607464200; Berndsen CE, 2007, BIOCHEMISTRY-US, V46, P623, DOI 10.1021/bi602513x; BOEKE JD, 1987, METHOD ENZYMOL, V154, P164; Brownell JE, 1996, CURR OPIN GENET DEV, V6, P176, DOI 10.1016/S0959-437X(96)80048-7; Chang L, 1997, BIOCHEMISTRY-US, V36, P469, DOI 10.1021/bi962069i; CHICOINE LG, 1986, J BIOL CHEM, V261, P1071; Clements A, 1999, EMBO J, V18, P3521, DOI 10.1093/emboj/18.13.3521; Dutnall RN, 1998, CELL, V94, P427, DOI 10.1016/S0092-8674(00)81584-6; Eberharter A, 1996, FEBS LETT, V386, P75, DOI 10.1016/0014-5793(96)00401-2; Enomoto S, 1997, GENE DEV, V11, P358, DOI 10.1101/gad.11.3.358; Enomoto S, 1998, GENE DEV, V12, P219, DOI 10.1101/gad.12.2.219; FENG HP, 1993, BIOCHEMISTRY-US, V32, P7824, DOI 10.1021/bi00081a030; GOTTSCHLING DE, 1990, CELL, V63, P751, DOI 10.1016/0092-8674(90)90141-Z; Han JH, 2007, SCIENCE, V315, P653, DOI 10.1126/science.1133234; Hodawadekar SC, 2007, ONCOGENE, V26, P5528, DOI 10.1038/sj.onc.1210619; Ichiyama S, 2004, BBA-PROTEINS PROTEOM, V1698, P27, DOI 10.1016/j.bbapap.2003.10.002; Ichiyama S, 2000, J BIOL CHEM, V275, P40804, DOI 10.1074/jbc.M008065200; Imhof A, 1999, BIOCHEMISTRY-US, V38, P13085, DOI 10.1021/bi9912490; Kaufman PD, 1998, MOL CELL BIOL, V18, P4793, DOI 10.1128/MCB.18.8.4793; Kaufman PD, 1997, GENE DEV, V11, P345, DOI 10.1101/gad.11.3.345; Kelly TJ, 2000, MOL CELL BIOL, V20, P7051, DOI 10.1128/MCB.20.19.7051-7058.2000; KLEFF S, 1995, J BIOL CHEM, V270, P24674, DOI 10.1074/jbc.270.42.24674; Krawitz DC, 2002, MOL CELL BIOL, V22, P614, DOI 10.1128/MCB.22.2.614-625.2002; Langer MR, 2001, J BIOL CHEM, V276, P31321, DOI 10.1074/jbc.M103839200; Lee KK, 2007, NAT REV MOL CELL BIO, V8, P284, DOI 10.1038/nrm2145; LIN C, 2008, STRUCTURE L IN PRESS; Lin YX, 1999, NATURE, V400, P86, DOI 10.1038/21922; Liu X, 2008, NATURE, V451, P846, DOI 10.1038/nature06546; Lusser A, 1999, NUCLEIC ACIDS RES, V27, P4427, DOI 10.1093/nar/27.22.4427; Lusser A, 1997, EUR J CELL BIOL, V74, P102; Mosammaparast N, 2002, J BIOL CHEM, V277, P862, DOI 10.1074/jbc.M106845200; Neuwald AF, 1997, TRENDS BIOCHEM SCI, V22, P154, DOI 10.1016/S0968-0004(97)01034-7; Parthun MR, 2007, ONCOGENE, V26, P5319, DOI 10.1038/sj.onc.1210602; Parthun MR, 1996, CELL, V87, P85, DOI 10.1016/S0092-8674(00)81325-2; Poux AN, 2003, BIOCHEMISTRY-US, V42, P14366, DOI 10.1021/bi035632n; Poux AN, 2002, P NATL ACAD SCI USA, V99, P14065, DOI 10.1073/pnas.222373899; Poveda A, 2004, J BIOL CHEM, V279, P16033, DOI 10.1074/jbc.M314228200; Poveda A, 2008, FEBS J, V275, P2122, DOI 10.1111/j.1742-4658.2008.06367.x; PRIES F, 1995, FEBS LETT, V358, P171, DOI 10.1016/0014-5793(94)01420-6; Qin S, 2002, MOL CELL BIOL, V22, P8353, DOI 10.1128/MCB.22.23.8353-8365.2002; Rojas JR, 1999, NATURE, V401, P93, DOI 10.1038/43487; SCHULTZ MC, 1991, P NATL ACAD SCI USA, V88, P1004, DOI 10.1073/pnas.88.3.1004; Sharp JA, 2001, CURR BIOL, V11, P463, DOI 10.1016/S0960-9822(01)00140-3; SOBEL RE, 1995, P NATL ACAD SCI USA, V92, P1237, DOI 10.1073/pnas.92.4.1237; Stade K, 1997, CELL, V90, P1041, DOI 10.1016/S0092-8674(00)80370-0; STAVROPOULOS P, 2008, P NATL ACAD SCI US; STEPHENSON RC, 1989, J BIOL CHEM, V264, P6164; Suter B, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-38; Tang Y, 2008, NAT STRUCT MOL BIOL, V15, P738, DOI 10.1038/nsmb.1448; Tanner KG, 1999, J BIOL CHEM, V274, P18157, DOI 10.1074/jbc.274.26.18157; Trievel RC, 1999, P NATL ACAD SCI USA, V96, P8931, DOI 10.1073/pnas.96.16.8931; Verreault A, 1998, CURR BIOL, V8, P96, DOI 10.1016/S0960-9822(98)70040-5; Wang L, 1998, GENE DEV, V12, P640, DOI 10.1101/gad.12.5.640; Yan Y, 2000, MOL CELL, V6, P1195, DOI 10.1016/S1097-2765(00)00116-7; Yan Y, 2002, NAT STRUCT BIOL, V9, P862, DOI 10.1038/nsb849	59	8	8	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 24	2008	283	43					29060	29068		10.1074/jbc.M802564200	http://dx.doi.org/10.1074/jbc.M802564200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	362EB	18753131	Green Published, hybrid			2022-12-27	WOS:000260179900033
J	Smeets, PJH; Teunissen, BEJ; Planavila, A; den Bosch, HVV; Willemsen, PHM; van der Vusse, GJ; van Bilsen, M				Smeets, Pascal J. H.; Teunissen, Birgit E. J.; Planavila, Anna; de Vogel-van den Bosch, Heleen; Willemsen, Peter H. M.; van der Vusse, Ger J.; van Bilsen, Marc			Inflammatory Pathways Are Activated during Cardiomyocyte Hypertrophy and Attenuated by Peroxisome Proliferator-activated Receptors PPAR alpha and PPAR delta	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; TUMOR-NECROSIS-FACTOR; CARDIAC-SPECIFIC OVEREXPRESSION; VENTRICULAR HYPERTROPHY; C-JUN; GAMMA; MICE; EXPRESSION; GROWTH; ROSIGLITAZONE	Accumulating evidence indicates an important role for inflammation in cardiac hypertrophy and failure. Peroxisome proliferator-activated receptors (PPARs) have been reported to attenuate inflammatory signaling pathways and, as such, may interfere with cardiac remodeling. Accordingly, the objectives of the present study were to explore the relationship between cardiomyocyte hypertrophy and inflammation and to investigate whether PPAR alpha and PPAR delta are able to inhibit NF-kappa B activation and, consequently, the hypertrophic growth response of neonatal rat cardiomyocytes (NCM). mRNA levels of markers of both hypertrophy and inflammation were increased following treatment with the pro-hypertrophic factor phenylephrine (PE) or the chemokine TNF-alpha. Induction of inflammatory genes was found to be fast (within 2 h after stimulation) and transient, while induction of hypertrophic marker genes was more gradual (peaking at 24-48 h). Inflammatory and hypertrophic pathways appeared to converge on NF-kappa B as both PE and TNF-alpha increased NF-kappa B binding activity as measured by electrophoretic mobility shift assay. Following transient transfection, the p65-induced transcriptional activation of a NF-kappa B reporter construct was significantly blunted after co-transfection of PPAR alpha or PPAR delta in the presence of their respective ligands. Finally, adenoviral overexpression of PPAR alpha and PPAR delta markedly attenuated cell enlargement and the expression of hypertrophic marker genes in PE-stimulated NCM. The collective findings reveal a close relationship between hypertrophic and inflammatory signaling pathways in the cardiomyocyte. It was shown that both PPAR alpha and PPAR delta are able to mitigate cardiomyocyte hypertrophy in vitro by inhibiting NF-kappa B activation.	[Smeets, Pascal J. H.; Teunissen, Birgit E. J.; Planavila, Anna; de Vogel-van den Bosch, Heleen; Willemsen, Peter H. M.; van der Vusse, Ger J.; van Bilsen, Marc] Maastricht Univ, Dept Physiol, Cardiovasc Res Inst Maastricht, NL-6200 MD Maastricht, Netherlands	Maastricht University	van Bilsen, M (corresponding author), Maastricht Univ, Dept Physiol, Cardiovasc Res Inst Maastricht, POB 616, NL-6200 MD Maastricht, Netherlands.	Marc.vanbilsen@fys.unimaas.nl	van Bilsen, Marc/E-8342-2016	de Vogel-van den Bosch, Heleen/0000-0002-7454-1403; Anna, Planavila Porta/0000-0001-5474-4724	Netherlands Organization for Scientific Research [NWO 912-04-017]; EU [LSHM-CT-2005-018833]; Spanish Ministry of Education [EX2005-1376]	Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); EU(European Commission); Spanish Ministry of Education(Spanish Government)	This work was supported by a grant from the Netherlands Organization for Scientific Research (NWO 912-04-017, to M. v. B.) and EU FP6 Grant LSHM-CT-2005-018833/EUGeneHeart. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.; Supported by a postdoctoral fellowship from the Spanish Ministry of Education (EX2005-1376). Current address: Departament de Bioquimica i Biologia Molecular, Facultat de Biologia, Universitat de Barcelona, Avda Diagonal 645, 08028-Barcelona, Spain.	Blanquart C, 2003, J STEROID BIOCHEM, V85, P267, DOI 10.1016/S0960-0760(03)00214-0; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chinetti G, 2000, INFLAMM RES, V49, P497, DOI 10.1007/s000110050622; Clerk A, 1999, J MOL CELL CARDIOL, V31, P2087, DOI 10.1006/jmcc.1999.1040; Cuzzocrea S, 2004, EUR J PHARMACOL, V483, P79, DOI 10.1016/j.ejphar.2003.10.056; Delerive P, 1999, J BIOL CHEM, V274, P32048, DOI 10.1074/jbc.274.45.32048; Delerive P, 2000, J BIOL CHEM, V275, P36703, DOI 10.1074/jbc.M004045200; deVries JE, 1997, J LIPID RES, V38, P1384; Ding GL, 2006, J MOL CELL CARDIOL, V40, P821, DOI 10.1016/j.yjmcc.2006.03.422; Gilde AJ, 2003, CIRC RES, V92, P518, DOI 10.1161/01.RES.0000060700.55247.7C; Gupta S, 2005, AM J PHYSIOL-HEART C, V289, pH20, DOI 10.1152/ajpheart.00082.2005; Ha TZ, 2005, FREE RADICAL BIO MED, V39, P1570, DOI 10.1016/j.freeradbiomed.2005.08.002; Hall G, 2006, J MOL CELL CARDIOL, V41, P580, DOI 10.1016/j.yjmcc.2006.07.006; Higuchi Y, 2006, AM J PHYSIOL-HEART C, V290, pH590, DOI 10.1152/ajpheart.00379.2005; Irukayama-Tomobe Y, 2004, CIRCULATION, V109, P904, DOI 10.1161/01.CIR.0000112596.06954.00; Jucker BM, 2007, J CARDIOVASC PHARM, V50, P25, DOI 10.1097/FJC.0b013e31804b4163; Kawano S, 2005, CARDIOVASC RES, V67, P689, DOI 10.1016/j.cardiores.2005.04.030; Kubota T, 1997, CIRC RES, V81, P627, DOI 10.1161/01.RES.81.4.627; Lee CH, 2003, SCIENCE, V302, P453, DOI 10.1126/science.1087344; Lee KS, 2005, FASEB J, V19, P1033, DOI 10.1096/fj.04-3309fje; LEVINE B, 1990, NEW ENGL J MED, V323, P236, DOI 10.1056/NEJM199007263230405; Li YH, 2004, AM J PHYSIOL-HEART C, V287, pH1712, DOI 10.1152/ajpheart.00124.2004; Liang FQ, 2003, ENDOCRINOLOGY, V144, P4187, DOI 10.1210/en.2002-0217; Liu HR, 2004, CARDIOVASC RES, V62, P135, DOI 10.1016/j.cardiores.2003.12.027; Nishikawa K, 2006, AM J PHYSIOL-HEART C, V291, pH176, DOI 10.1152/ajpheart.00269.2005; Ogata T, 2004, J AM COLL CARDIOL, V43, P1481, DOI 10.1016/j.jacc.2003.11.043; Peng TQ, 2004, FASEB J, V18, P293, DOI 10.1096/fj.04-2289fje; Planavila A, 2005, J BIOL CHEM, V280, P17464, DOI 10.1074/jbc.M414220200; Planavila A, 2005, CARDIOVASC RES, V65, P832, DOI 10.1016/j.cardiores.2004.11.011; Purcell NH, 2001, P NATL ACAD SCI USA, V98, P6668, DOI 10.1073/pnas.111155798; SHUBEITA HE, 1992, P NATL ACAD SCI USA, V89, P1305, DOI 10.1073/pnas.89.4.1305; Smeets PJH, 2007, ACTA PHYSIOL, V191, P171, DOI 10.1111/j.1748-1716.2007.01752.x; Smeets PJH, 2008, CARDIOVASC RES, V78, P79, DOI 10.1093/cvr/cvn001; Takano H, 2000, CIRC RES, V87, P596, DOI 10.1161/01.RES.87.7.596; Teunissen BEJ, 2007, CARDIOVASC RES, V75, P519, DOI 10.1016/j.cardiores.2007.04.026; THAIK CM, 1995, J CLIN INVEST, V96, P1093, DOI 10.1172/JCI118095; van Bilsen M, 2002, MOL CELL BIOCHEM, V239, P131, DOI 10.1023/A:1020553428294; Wayman Nicole S, 2002, Med Sci Monit, V8, pBR243; Wayman NS, 2002, FASEB J, V16, P1027, DOI 10.1096/fj.01-0793com; Yeh CH, 2006, SHOCK, V26, P262, DOI 10.1097/01.shk.0000225863.56714.96; Yndestad A, 2006, HEART FAIL REV, V11, P83, DOI 10.1007/s10741-006-9196-2; Yokoyama T, 1997, CIRCULATION, V95, P1247	42	93	108	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 24	2008	283	43					29109	29118		10.1074/jbc.M802143200	http://dx.doi.org/10.1074/jbc.M802143200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	362EB	18701451	hybrid, Green Published			2022-12-27	WOS:000260179900038
J	Wood, JL; Liang, YL; Li, KY; Chen, JJ				Wood, Jamie L.; Liang, Yulong; Li, Kaiyi; Chen, Junjie			Microcephalin/MCPH1 Associates with the Condensin II Complex to Function in Homologous Recombination Repair	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STRAND BREAK REPAIR; DNA-DAMAGE RESPONSE; CHROMOSOME CONDENSATION; GENOMIC STABILITY; PROTEIN; MUTATIONS; MCPH1; SIZE; LOCALIZATION; PATHWAY	Microcephalin/ MCPH1 is one of the causative genes responsible for the autosomal recessive disorder primary microcephaly. Patients with this disease present with mental retardation and dramatic reduction in head size, and cells derived from these patients contain abnormally condensed chromosomes. MCPH1 contains an N-terminal BRCT and tandem C-terminal BRCT domains. More recently, MCPH1 has been implicated in the cellular response to DNA damage; however, the exact mechanism remains unclear. Here, we report the identification Condensin II as a major MCPH1-interacting protein. MCPH1 and Condensin II interact in vivo, mediated by the CAPG2 subunit of Condensin II binding to a middle domain (residues 376-485) of MCPH1. Interestingly, while Condensin II is not required for the IR-induced G2/M checkpoint, Condensin II-depleted cells have a defect in HR repair, which is also present in MCPH1 -/- MEFs. Moreover, the Condensin II binding region of MCPH1 is also required for HR function. Collectively, we have identified a novel function of MCPH1 to modulate HR repair through Condensin II, and thereby maintain genome integrity.Microcephalin/MCPH1 is one of the causative genes responsible for the autosomal recessive disorder primary microcephaly. Patients with this disease present with mental retardation and dramatic reduction in head size, and cells derived from these patients contain abnormally condensed chromosomes. MCPH1 contains an N-terminal BRCT and tandem C- terminal BRCT domains. More recently, MCPH1 has been implicated in the cellular response to DNAdamage; however, the exact mechanism remains unclear. Here, we report the identification Condensin II as a major MCPH1-interacting protein. MCPH1 and Condensin II interact in vivo, mediated by the CAPG2 subunit of Condensin II binding to a middle domain ( residues 376 - 485) of MCPH1. Interestingly, while Condensin II is not required for the IR-induced G2/M checkpoint, Condensin II- depleted cells have a defect in HR repair, which is also present in MCPH1(-/-) MEFs. Moreover, the Condensin II binding region of MCPH1 is also required for HR function. Collectively, we have identified a novel function of MCPH1 to modulate HR repair through Condensin II, and thereby maintain genome integrity.	[Liang, Yulong; Li, Kaiyi] Baylor Coll Med, Dept Surg, Houston, TX 77030 USA; [Wood, Jamie L.; Chen, Junjie] Yale Univ, Sch Med, Dept Therapeut Biol, New Haven, CT 06473 USA; [Wood, Jamie L.] Mayo Clin, Coll Med, Dept Mol Pharmacol & Expt Therapeut, Rochester, MN 55901 USA	Baylor College of Medicine; Yale University; Mayo Clinic	Li, KY (corresponding author), Baylor Coll Med, Dept Surg, Houston, TX 77030 USA.	kli@bcm.tmc.edu; Junjie.chen@yale.edu	Liang, Yulong/A-2171-2013	Liang, Yulong/0000-0001-8219-9575	National Institutes of Health [CA92312, CA100100, R01CA109574-01A]; BCTR [R0504162T]; NATIONAL CANCER INSTITUTE [R01CA092312, R01CA109574, R01CA100109] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); BCTR; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants CA92312 and CA100109 (to J. C.) and R01CA109574-01A1 ( to K. L.). This work was also supported by The Susan G. Komen Breast Cancer Foundation Grant BCTR0504162T ( to K. L.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Alderton GK, 2006, NAT CELL BIOL, V8, P725, DOI 10.1038/ncb1431; Bond J, 2005, NAT GENET, V37, P353, DOI 10.1038/ng1539; Bond J, 2002, NAT GENET, V32, P316, DOI 10.1038/ng995; Brunk K, 2007, J CELL SCI, V120, P3578, DOI 10.1242/jcs.014290; Cui YB, 2008, NAT STRUCT MOL BIOL, V15, P411, DOI 10.1038/nsmb.1410; Griffith E, 2008, NAT GENET, V40, P232, DOI 10.1038/ng.2007.80; Heale JT, 2006, MOL CELL, V21, P837, DOI 10.1016/j.molcel.2006.01.036; Hirano T, 2006, NAT REV MOL CELL BIO, V7, P311, DOI 10.1038/nrm1909; Hirano T, 2005, CURR BIOL, V15, pR265, DOI 10.1016/j.cub.2005.03.037; Hirano T, 1997, CELL, V89, P511, DOI 10.1016/S0092-8674(00)80233-0; Jackson AP, 2002, AM J HUM GENET, V71, P136, DOI 10.1086/341283; Jeffers LJ, 2008, ONCOGENE, V27, P139, DOI 10.1038/sj.onc.1210595; Lin SY, 2005, P NATL ACAD SCI USA, V102, P15105, DOI 10.1073/pnas.0507722102; Lou ZK, 2006, MOL CELL, V21, P187, DOI 10.1016/j.molcel.2005.11.025; Manke IA, 2003, SCIENCE, V302, P636, DOI 10.1126/science.1088877; O'Driscoll M, 2006, NAT REV GENET, V7, P45, DOI 10.1038/nrg1746; Onn I, 2007, EMBO J, V26, P1024, DOI 10.1038/sj.emboj.7601562; Ono T, 2004, MOL BIOL CELL, V15, P3296, DOI 10.1091/mbc.E04-03-0242; Pierce AJ, 1999, GENE DEV, V13, P2633, DOI 10.1101/gad.13.20.2633; Potts PR, 2006, EMBO J, V25, P3377, DOI 10.1038/sj.emboj.7601218; Rai R, 2006, CANCER CELL, V10, P145, DOI 10.1016/j.ccr.2006.07.002; Rauch A, 2008, SCIENCE, V319, P816, DOI 10.1126/science.1151174; Rickmyre JL, 2007, J CELL SCI, V120, P3565, DOI 10.1242/jcs.016626; Strick TR, 2004, CURR BIOL, V14, P874, DOI 10.1016/j.cub.2004.04.038; Strom L, 2007, CURR OPIN CELL BIOL, V19, P344, DOI 10.1016/j.ceb.2007.04.003; Takemoto A, 2004, J BIOL CHEM, V279, P4551, DOI 10.1074/jbc.M310925200; Trimborn M, 2006, CELL CYCLE, V5, P322, DOI 10.4161/cc.5.3.2412; Trimborn M, 2004, AM J HUM GENET, V75, P261, DOI 10.1086/422855; Trimborn Marc, 2005, Hum Mutat, V26, P496, DOI 10.1002/humu.9382; Wood JL, 2007, J BIOL CHEM, V282, P35416, DOI 10.1074/jbc.M705245200; Woods CG, 2005, AM J HUM GENET, V76, P717, DOI 10.1086/429930; Woods CG, 2004, CURR OPIN NEUROBIOL, V14, P112, DOI 10.1016/j.conb.2004.01.003; Xu XZ, 2004, J BIOL CHEM, V279, P34091, DOI 10.1074/jbc.C400139200; Yu XC, 2003, SCIENCE, V302, P639, DOI 10.1126/science.1088753	34	74	74	2	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 24	2008	283	43					29586	29592		10.1074/jbc.M804080200	http://dx.doi.org/10.1074/jbc.M804080200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	362EB	18718915	Green Published, hybrid			2022-12-27	WOS:000260179900084
J	Doebber, M; Bordignon, E; Klare, JP; Holterhues, J; Martell, S; Mennes, N; Li, L; Engelhard, M; Steinhoff, HJ				Doebber, Meike; Bordignon, Enrica; Klare, Johann P.; Holterhues, Julia; Martell, Swetlana; Mennes, Nadine; Li, Lin; Engelhard, Martin; Steinhoff, Heinz-Juergen			Salt-driven equilibrium between two conformations in the HAMP domain from Natronomonas pharaonis - The language of signal transfer?	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SPIN-LABELED PROTEINS; SENSORY-RHODOPSIN; SIDE-CHAINS; STRUCTURAL DETERMINANTS; HISTIDINE KINASE; NITROXIDE MOTION; COMPLEX; BACTERIORHODOPSIN; PHOTOTRANSDUCER; PHOBORHODOPSIN	HAMP domains (conserved in histidine kinases, adenylyl cyclases, methyl-accepting chemotaxis proteins, and phosphatases) perform their putative function as signal transducing units in diversified environments in a variety of protein families. Here the conformational changes induced by environmental agents, namely salt and temperature, on the structure and function of a HAMP domain of the phototransducer from Natronomonas pharaonis (NpHtrII) in complex with sensory rhodopsin II (NpSRII) were investigated by site-directed spin labeling electron paramagnetic resonance. A series of spin labeled mutants were engineered in NpHtrII(157), a truncated analog containing only the first HAMP domain following the transmembrane helix 2. This truncated transducer is shown to be a valid model system for a signal transduction domain anchored to the transmembrane light sensor NpSRII. The HAMP domain is found to be engaged in a "two-state" equilibrium between a highly dynamic (dHAMP) and a more compact (cHAMP) conformation. The structural properties of the cHAMP as proven by mobility, accessibility, and intra-transducer-dimer distance data are in agreement with the four helical bundle NMR model of the HAMP domain from Archaeoglobus fulgidus.	[Doebber, Meike; Bordignon, Enrica; Klare, Johann P.; Holterhues, Julia; Steinhoff, Heinz-Juergen] Max Planck Inst Mol Physiol, D-44227 Dortmund, Germany; [Martell, Swetlana; Mennes, Nadine; Li, Lin; Engelhard, Martin] Univ Osnabruck, Fachbereich Phys, D-49076 Osnabruck, Germany	Max Planck Society; University Osnabruck	Engelhard, M (corresponding author), Max Planck Inst Mol Physiol, Otto Hahn Str 11, D-44227 Dortmund, Germany.	martin.engelhard@mpi-dortmund.mpg.de; hsteinho@uos.de	Steinhoff, Heinz-Juergen/H-3791-2014; Klare, Johann P./C-1428-2009	Steinhoff, Heinz-Juergen/0000-0002-5888-0157; Klare, Johann P./0000-0002-5761-5968; Bordignon, Enrica/0000-0003-2450-5161	Deutsche Forschungsgemeinschaft Grants [SFB 431/P18, EN87/14-2]; Max Planck Society	Deutsche Forschungsgemeinschaft Grants(German Research Foundation (DFG)); Max Planck Society(Max Planck SocietyFoundation CELLEX)	This work was supported by Deutsche Forschungsgemeinschaft Grants SFB 431/P18 (to J. P. K. and H. J. S.) and EN87/14-2 (to M. E.) and the Max Planck Society (to M. E.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked " advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Alexander N, 2008, STRUCTURE, V16, P181, DOI 10.1016/j.str.2007.11.015; Altenbach C, 2005, BIOPHYS J, V89, P2103, DOI 10.1529/biophysj.105.059063; ALTENBACH C, 1994, P NATL ACAD SCI USA, V91, P1667, DOI 10.1073/pnas.91.5.1667; ALTENBACH C, 1990, SCIENCE, V248, P1088, DOI 10.1126/science.2160734; [Anonymous], 1976, SPIN LABELING THEORY, DOI DOI 10.1016/B978-0-12-092350-2.50008-4; Appleman JA, 2003, J BACTERIOL, V185, P4872, DOI 10.1128/JB.185.16.4872-4882.2003; Aravind L, 1999, FEMS MICROBIOL LETT, V176, P111, DOI 10.1016/S0378-1097(99)00197-4; Baldwin RL, 1996, BIOPHYS J, V71, P2056, DOI 10.1016/S0006-3495(96)79404-3; BAYLEY ST, 1978, CRC CR REV MICROBIOL, V6, P151, DOI 10.3109/10408417809090622; Bordignon E, 2005, J BIOL CHEM, V280, P38767, DOI 10.1074/jbc.M509391200; Borrok MJ, 2008, ACS CHEM BIOL, V3, P101, DOI 10.1021/cb700211s; Brutlach H, 2006, APPL MAGN RESON, V30, P359, DOI 10.1007/BF03166206; Falb M, 2005, GENOME RES, V15, P1336, DOI 10.1101/gr.3952905; Falke JJ, 2001, TRENDS BIOCHEM SCI, V26, P257, DOI 10.1016/S0968-0004(00)01770-9; Gordeliy VI, 2002, NATURE, V419, P484, DOI 10.1038/nature01109; Guo ZF, 2008, PROTEIN SCI, V17, P228, DOI 10.1110/ps.073174008; Guo ZF, 2007, PROTEIN SCI, V16, P1069, DOI 10.1110/ps.062739107; Hazelbauer GL, 2008, TRENDS BIOCHEM SCI, V33, P9, DOI 10.1016/j.tibs.2007.09.014; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Hofmeister F, 1888, ARCH EXP PATHOL PHAR, V25, P1, DOI [10.1007/BF01918191, DOI 10.1007/BF01918191]; Hohenfeld IP, 1999, FEBS LETT, V442, P198, DOI 10.1016/S0014-5793(98)01659-7; Hulko M, 2006, CELL, V126, P929, DOI 10.1016/j.cell.2006.06.058; Isas JM, 2002, BIOCHEMISTRY-US, V41, P1464, DOI 10.1021/bi011856z; Jeschke G, 2006, APPL MAGN RESON, V30, P473, DOI 10.1007/BF03166213; John E., 2007, CRC HDB CHEM PHYS; Jung KH, 2003, MOL MICROBIOL, V47, P1513, DOI 10.1046/j.1365-2958.2003.03395.x; Kamada K, 2006, BIOCHEMISTRY-US, V45, P4859, DOI 10.1021/bi060047i; KATES M, 1982, METHOD ENZYMOL, V88, P98; KIM SH, 1994, PROTEIN SCI, V3, P159; Kishii R, 2007, J BIOL CHEM, V282, P26401, DOI 10.1074/jbc.M701342200; Klare JP, 2004, FEBS LETT, V564, P219, DOI 10.1016/S0014-5793(04)00193-0; Klare JP, 2004, PHOTOCH PHOTOBIO SCI, V3, P543, DOI 10.1039/b402656j; LANYI JK, 1974, BACTERIOL REV, V38, P272, DOI 10.1128/MMBR.38.3.272-290.1974; MANSON MD, 1992, ADV MICROB PHYSIOL, V33, P277, DOI 10.1016/S0065-2911(08)60219-2; Mchaourab HS, 1996, BIOCHEMISTRY-US, V35, P7692, DOI 10.1021/bi960482k; Mennes N, 2007, FEBS LETT, V581, P1487, DOI 10.1016/j.febslet.2007.03.005; Moukhametzianov R, 2006, NATURE, V440, P115, DOI 10.1038/nature04520; Nara T, 1996, J BIOL CHEM, V271, P17932, DOI 10.1074/jbc.271.30.17932; Pannier M, 2000, J MAGN RESON, V142, P331, DOI 10.1006/jmre.1999.1944; Pfeiffer M, 1999, J MOL BIOL, V287, P163, DOI 10.1006/jmbi.1998.2593; Plato M, 2002, MOL PHYS, V100, P3711, DOI 10.1080/00268970210166246; Robinson JL, 2005, J BACTERIOL, V187, P923, DOI 10.1128/JB.187.3.923-929.2005; Rodriguez-Valera Francisco, 1993, P1; Salman H, 2007, NAT CELL BIOL, V9, P1098, DOI 10.1038/ncb1632; Shimono K, 1997, FEBS LETT, V420, P54, DOI 10.1016/S0014-5793(97)01487-7; SOLIMAN GSH, 1982, ZBL BAKT MIK HYG I C, V3, P318, DOI 10.1016/S0721-9571(82)80045-8; Steinhoff HJ, 1997, BIOPHYS J, V73, P3287, DOI 10.1016/S0006-3495(97)78353-X; STEINHOFF HJ, 1989, Z NATURFORSCH C, V44, P280; Swain KE, 2007, BIOCHEMISTRY-US, V46, P13684, DOI 10.1021/bi701832b; Trivedi VD, 2003, BIOCHEMISTRY-US, V42, P13887, DOI 10.1021/bi034399q; Vaknin A, 2007, J MOL BIOL, V366, P1416, DOI 10.1016/j.jmb.2006.12.024; Watts KJ, 2008, J BACTERIOL, V190, P2118, DOI 10.1128/JB.01858-07; Wegener AA, 2001, EMBO J, V20, P5312, DOI 10.1093/emboj/20.19.5312	53	34	34	0	5	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 17	2008	283	42					28691	28701		10.1074/jbc.M801931200	http://dx.doi.org/10.1074/jbc.M801931200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	359EN	18697747	hybrid, Green Published			2022-12-27	WOS:000259969300071
J	Feng, S; Okenka, GM; Bai, CX; Streets, AJ; Newby, LJ; DeChant, BT; Tsiokas, L; Obara, T; Ong, ACM				Feng, Shuang; Okenka, Genevieve M.; Bai, Chang-Xi; Streets, Andrew J.; Newby, Linda J.; DeChant, Brett T.; Tsiokas, Leonidas; Obara, Tomoko; Ong, Albert C. M.			Identification and functional characterization of an N-terminal oligomerization domain for polycystin-2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KIDNEY-DISEASE; CHANNEL; PKD2; COMPLEX; TRPC1; GENE; LOCALIZATION; ZEBRAFISH; CURRENTS; PROTEIN	Autosomal dominant polycystic kidney disease ( ADPKD), the most common inherited cause of kidney failure, is caused by mutations in either PKD1 (85%) or PKD2 (15%). The PKD2 protein, polycystin-2 (PC2 or TRPP2), is a member of the transient receptor potential (TRP) superfamily and functions as a non-selective calcium channel. PC2 has been found to form oligomers in native tissues suggesting that it may form functional homo- or heterotetramers with other subunits, similar to other TRP channels. Our experiments unexpectedly revealed that PC2 mutant proteins lacking the known C-terminal dimerization domain were still able to form oligomers and co-immunoprecipitate full-length PC2, implying the possible existence of a proximal dimerization domain. Using yeast two-hybrid and biochemical assays, we have mapped an alternative dimerization domain to the N terminus of PC2 (NT2-1-223, L224X). Functional characterization of this domain demonstrated that it was sufficient to induce cyst formation in zebrafish embryos and inhibit PC2 surface currents in mIMCD3 cells probably by a dominant-negative mechanism. In summary, we propose a model for PC2 assembly as a functional tetramer which depends on both C- and N-terminal dimerization domains. These results have significant implications for our understanding of PC2 function and disease pathogenesis in ADPKD and provide a new strategy for studying PC2 function.	[Ong, Albert C. M.] Univ Sheffield, Kidney Genet Grp, Henry Wellcome Labs Med Res,Sheffield Kidney Inst, Sch Med & Biomed Sci,Acad Unit Nephrol, Sheffield S10 2RX, S Yorkshire, England; [Okenka, Genevieve M.; DeChant, Brett T.; Obara, Tomoko] Case Western Reserve Univ, Metrohlth Med Ctr, Dept Med, Cleveland, OH 44109 USA; [Obara, Tomoko] Case Western Reserve Univ, Dept Genet, Cleveland, OH 44109 USA; [Bai, Chang-Xi; Tsiokas, Leonidas] Univ Oklahoma, Hlth Sci Ctr, Dept Cell Biol, Oklahoma City, OK 73104 USA	University of Sheffield; Case Western Reserve University; MetroHealth System; Case Western Reserve University; University of Oklahoma System; University of Oklahoma Health Sciences Center	Ong, ACM (corresponding author), Univ Sheffield, Kidney Genet Grp, Henry Wellcome Labs Med Res,Sheffield Kidney Inst, Sch Med & Biomed Sci,Acad Unit Nephrol, Beech Hill Rd, Sheffield S10 2RX, S Yorkshire, England.	a.ong@sheffield.ac.uk	Ong, Albert/AAN-9430-2021	Ong, Albert/0000-0002-7211-5400; Tsiokas, Leonidas/0000-0002-3659-1813	National Institutes of Health [R21-DK069604, RO1-DK078209, R01-DK59599]; PKD Foundation [69a2r, 119a2r]; John S. Gammill Endowed Chair in Polycystic Kidney Disease, Research Councils UK [RA108836]; Wellcome Trust [GR071201]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK059599, R01DK078209, R21DK069604] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); PKD Foundation; John S. Gammill Endowed Chair in Polycystic Kidney Disease, Research Councils UK(UK Research & Innovation (UKRI)); Wellcome Trust(Wellcome TrustEuropean Commission); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants R21-DK069604, RO1-DK078209 (to T. O.), and R01-DK59599 (to L. T.). This work was also funded by grants from the PKD Foundation (69a2r and 119a2r), John S. Gammill Endowed Chair in Polycystic Kidney Disease, Research Councils UK (RA108836) (to A. J. S.), and the Wellcome Trust (GR071201) (to A. C. M. O.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Bai CX, 2008, EMBO J, V27, P1345, DOI 10.1038/emboj.2008.70; Bai CX, 2008, EMBO REP, V9, P472, DOI 10.1038/embor.2008.29; Cai ZQ, 1999, J BIOL CHEM, V274, P28557, DOI 10.1074/jbc.274.40.28557; Calvet JP, 2001, SEMIN NEPHROL, V21, P107, DOI 10.1053/snep.2001.20929; Chen XZ, 2001, BIOCHEM BIOPH RES CO, V282, P1251, DOI 10.1006/bbrc.2001.4720; Delmas P, 2004, FASEB J, V18, P740, DOI 10.1096/fj.03-0319fje; Gallagher AR, 2006, J AM SOC NEPHROL, V17, P2719, DOI 10.1681/ASN.2005090979; Gietz RD, 2002, METHOD ENZYMOL, V350, P87; Hanaoka K, 2000, NATURE, V408, P990, DOI 10.1038/35050128; Inoue T, 2005, NAT METHODS, V2, P415, DOI 10.1038/NMETH763; Koulen P, 2002, NAT CELL BIOL, V4, P191, DOI 10.1038/ncb754; Ma R, 2005, MOL CELL BIOL, V25, P8285, DOI 10.1128/MCB.25.18.8285-8298.2005; Ma R, 2003, J BIOL CHEM, V278, P52763, DOI 10.1074/jbc.M309610200; McGrath J, 2003, CELL, V114, P61, DOI 10.1016/S0092-8674(03)00511-7; Mochizuki T, 1996, SCIENCE, V272, P1339, DOI 10.1126/science.272.5266.1339; Montell C, 2002, MOL CELL, V9, P229, DOI 10.1016/S1097-2765(02)00448-3; Nauli SM, 2003, NAT GENET, V33, P129, DOI 10.1038/ng1076; Newby LJ, 2002, J BIOL CHEM, V277, P20763, DOI 10.1074/jbc.M107788200; Obara T, 2006, J AM SOC NEPHROL, V17, P2706, DOI 10.1681/ASN.2006040412; Ong ACM, 1999, AM J PATHOL, V154, P1721, DOI 10.1016/S0002-9440(10)65428-4; Ong ACM, 2005, KIDNEY INT, V67, P1234, DOI 10.1111/j.1523-1755.2005.00201.x; Semple JI, 2005, BIOTECHNIQUES, V38, P927, DOI 10.2144/05386RR03; Streets AJ, 2006, HUM MOL GENET, V15, P1465, DOI 10.1093/hmg/ddl070; Streets AJ, 2003, J AM SOC NEPHROL, V14, P1804, DOI 10.1097/01.ASN.0000076075.49819.9B; Suh BC, 2006, SCIENCE, V314, P1454, DOI 10.1126/science.1131163; Sun ZX, 2004, DEVELOPMENT, V131, P4085, DOI 10.1242/dev.01240; Tsiokas L, 1999, P NATL ACAD SCI USA, V96, P3934, DOI 10.1073/pnas.96.7.3934; Tsiokas L, 1997, P NATL ACAD SCI USA, V94, P6965, DOI 10.1073/pnas.94.13.6965; Westerfield M., 1995, ZEBRAFISH BOOK GUIDE; Wilson PD, 2004, NEW ENGL J MED, V350, P151, DOI 10.1056/NEJMra022161	30	48	48	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 17	2008	283	42					28471	28479		10.1074/jbc.M803834200	http://dx.doi.org/10.1074/jbc.M803834200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	359EN	18701462	hybrid, Green Published			2022-12-27	WOS:000259969300049
J	Jiang, L; Li, ZQ; Rui, LY				Jiang, Lin; Li, Zhiqin; Rui, Liangyou			Leptin stimulates both JAK2-dependent and JAK2-independent signaling pathways	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENERGY-BALANCE; BODY-WEIGHT; DB/DB MICE; GLUCOSE-HOMEOSTASIS; RECEPTOR EXPRESSION; CAUSES OBESITY; ACTIVATION; PROTEIN; KINASE; JAK2	Leptin controls body weight by activating the long form of the leptin receptor (LEPRb). Janus kinase 2 (JAK2) is associated with LEPRb and autophosphorylates in response to leptin. JAK2 also phosphorylates LEPRb, STAT3, and multiple other downstream molecules. Surprisingly, here we show that JAK2 is not required for leptin stimulation of STAT3 phosphorylation. Leptin time- and dose-dependently stimulated tyrosine phosphorylation of STAT3 in both human and mouse JAK2-null cells. Leptin also increased the viability of JAK2-null cells. Overexpression of c-Src or Fyn, two Src family members, promoted STAT3 phosphorylation, whereas inhibition of the endogenous Src family members by either pharmacological inhibitors or dominant negative Src(K298M) decreased the ability of leptin to stimulate the phosphorylation of STAT3 and ERK1/2. Leptin also stimulated tyrosine phosphorylation of kinase-inactive JAK2(K882E) in JAK2-null cells. Overexpression of JAK2(K882E) enhanced the ability of leptin to stimulate STAT3 phosphorylation in JAK2-null cells. Tyr(1138) in LEPRb was required for leptin-stimulated phosphorylation of STAT3 but not JAK2(K882E). These data suggest that leptin stimulates non-JAK2 tyrosine kinase(s), including the Src family members, which phosphorylate JAK2, STAT3, and other molecules downstream of LEPRb. JAK2 mediates leptin signaling by both phosphorylating its substrates and forming a signaling complex as a scaffolding/adaptor protein. The non-JAK2 kinase(s) and JAK2 may act coordinately and synergistically to mediate leptin response.	[Jiang, Lin; Li, Zhiqin; Rui, Liangyou] Univ Michigan, Sch Med, Dept Mol & Integrat Physiol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Rui, LY (corresponding author), Univ Michigan, Sch Med, Dept Mol & Integrat Physiol, Ann Arbor, MI 48109 USA.	ruily@umich.edu	Jiang, Lin/E-7468-2012		National Institutes of Health [RO1 DK 065122, RO1 DK073601, 5P60 DK20572, 5P30 CA46592, P30AG013283, DK34933]; NATIONAL CANCER INSTITUTE [P30CA046592] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK034933, R01DK073601, P60DK020572, R01DK065122] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG013283] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1 DK 065122, RO1 DK073601, 5P60 DK20572, 5P30 CA46592, P30AG013283, and DK34933. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Anderwald C, 2002, MOL ENDOCRINOL, V16, P1612, DOI 10.1210/me.16.7.1612; Banks AS, 2000, J BIOL CHEM, V275, P14563, DOI 10.1074/jbc.275.19.14563; Bates SH, 2003, NATURE, V421, P856, DOI 10.1038/nature01388; Bettowski J, 2006, PEPTIDES, V27, P3234, DOI 10.1016/j.peptides.2006.08.010; Bjorbaek C, 1999, J BIOL CHEM, V274, P30059, DOI 10.1074/jbc.274.42.30059; Bjorbaek C, 2004, RECENT PROG HORM RES, V59, P305, DOI 10.1210/rp.59.1.305; Bjorbaek C, 1997, J BIOL CHEM, V272, P32686, DOI 10.1074/jbc.272.51.32686; Bjorbaek C, 2000, J BIOL CHEM, V275, P40649, DOI 10.1074/jbc.M007577200; Bjornholm M, 2007, J CLIN INVEST, V117, P1354, DOI 10.1172/JCI30688; Burfoot MS, 1997, J BIOL CHEM, V272, P24183, DOI 10.1074/jbc.272.39.24183; Chen H, 1996, CELL, V84, P491, DOI 10.1016/S0092-8674(00)81294-5; Chua SC, 1996, SCIENCE, V271, P994, DOI 10.1126/science.271.5251.994; Clement K, 1998, NATURE, V392, P398, DOI 10.1038/32911; Cohen P, 2005, J BIOL CHEM, V280, P10034, DOI 10.1074/jbc.M413684200; Cohen P, 2001, J CLIN INVEST, V108, P1113, DOI 10.1172/JCI200113914; Cui YX, 2004, MOL CELL BIOL, V24, P258, DOI 10.1128/MCB.24.1.258-269.2004; de Luca C, 2005, J CLIN INVEST, V115, P3484, DOI 10.1172/JCI24059; Duan CJ, 2004, J BIOL CHEM, V279, P43684, DOI 10.1074/jbc.M408495200; Feng J, 1997, MOL CELL BIOL, V17, P2497, DOI 10.1128/MCB.17.5.2497; Flier JS, 2004, CELL, V116, P337, DOI 10.1016/S0092-8674(03)01081-X; Friedman JM, 2003, SCIENCE, V299, P856, DOI 10.1126/science.1079856; Friedman JM, 1998, NATURE, V395, P763, DOI 10.1038/27376; Gao Q, 2004, P NATL ACAD SCI USA, V101, P4661, DOI 10.1073/pnas.0303992101; Herrington J, 2000, ONCOGENE, V19, P2585, DOI 10.1038/sj.onc.1203526; Kohlhuber F, 1997, MOL CELL BIOL, V17, P695, DOI 10.1128/MCB.17.2.695; Kurzer JH, 2004, MOL CELL BIOL, V24, P4557, DOI 10.1128/MCB.24.10.4557-4570.2004; Lee GH, 1996, NATURE, V379, P632, DOI 10.1038/379632a0; Li C, 1999, P NATL ACAD SCI USA, V96, P9677, DOI 10.1073/pnas.96.17.9677; Li ZQ, 2007, MOL ENDOCRINOL, V21, P2270, DOI 10.1210/me.2007-0111; Lord GM, 1998, NATURE, V394, P897, DOI 10.1038/29795; Minokoshi Y, 2002, NATURE, V415, P339, DOI 10.1038/415339a; Montecucco F, 2006, ANN NY ACAD SCI, V1069, P463, DOI 10.1196/annals.1351.045; Morioka T, 2007, J CLIN INVEST, V117, P2860, DOI 10.1172/JCI30910; Parganas E, 1998, CELL, V93, P385, DOI 10.1016/S0092-8674(00)81167-8; Park BH, 2006, J BIOL CHEM, V281, P40283, DOI 10.1074/jbc.M607545200; Ren DC, 2005, CELL METAB, V2, P95, DOI 10.1016/j.cmet.2005.07.004; Ren DC, 2007, J CLIN INVEST, V117, P397, DOI 10.1172/JCI29417; Roskoski R, 2004, BIOCHEM BIOPH RES CO, V324, P1155, DOI 10.1016/j.bbrc.2004.09.171; Schwartz MW, 2005, SCIENCE, V307, P375, DOI 10.1126/science.1104344; Tartaglia LA, 1995, CELL, V83, P1263, DOI 10.1016/0092-8674(95)90151-5; Ungureanu D, 2002, MOL CELL BIOL, V22, P3316, DOI 10.1128/MCB.22.10.3316-3326.2002; Vaisse C, 1996, NAT GENET, V14, P95, DOI 10.1038/ng0996-95; YU CL, 1995, SCIENCE, V269, P81, DOI 10.1126/science.7541555; Zhang EE, 2004, P NATL ACAD SCI USA, V101, P16064, DOI 10.1073/pnas.0405041101; ZHANG YY, 1994, NATURE, V372, P425, DOI 10.1038/372425a0	45	69	69	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 17	2008	283	42					28066	28073		10.1074/jbc.M805545200	http://dx.doi.org/10.1074/jbc.M805545200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	359EN	18718905	Green Published, hybrid			2022-12-27	WOS:000259969300008
J	Dzbek, J; Korzeniewski, B				Dzbek, Jaroslaw; Korzeniewski, Bernard			Control Over the Contribution of the Mitochondrial Membrane Potential (Delta psi) and Proton Gradient (Delta pH) to the Protonmotive Force (Delta p) IN SILICO STUDIES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							METABOLIC-CONTROL ANALYSIS; OXIDATIVE-PHOSPHORYLATION; INNER MEMBRANE; ENERGY-METABOLISM; MODEL; CONDUCTANCE; RESPIRATION; TRANSPORT; MUSCLE; HEPATOCYTES	The protonmotive force across the inner mitochondrial membrane (Delta p) has two components: membrane potential (Delta Psi) and the gradient of proton concentration (Delta pH). The computer model of oxidative phosphorylation developed previously by Korzeniewski et al. (Korzeniewski, B., Noma, A., and Matsuoka, S. (2005) Biophys. Chem. 116, 145-157) was modified by including the K+ uniport, K+/H+ exchange across the inner mitochondrial membrane, and membrane capacitance to replace the fixed Delta Psi/Delta pH ratio used previously with a variable one determined mechanistically. The extended model gave good agreement with experimental results. Computer simulations showed that the contribution of Delta Psi and Delta pH to Delta p is determined by the ratio of the rate constants of the K+ uniport and K+/H+ exchange and not by the absolute values of these constants. The value of Delta p is mostly controlled by ATP usage. The metabolic control over the Delta Psi/Delta pH ratio is exerted mostly by K+ uniport and K+/H+ exchange in the presence of these processes, and by the ATP usage, ATP/ADP carrier, and phosphate carrier in the absence of them. The K+ circulation across the inner mitochondrial membrane is controlled mainly by K+ uniport and K+/H+ exchange, whereas H+ circulation by ATP usage. It is demonstrated that the secondary K+ ion transport is not necessary for maintaining the physiological Delta Psi/Delta pH ratio.	[Dzbek, Jaroslaw; Korzeniewski, Bernard] Jagiellonian Univ, Fac Biochem Biophys & Biotechnol, PL-30387 Krakow, Poland	Jagiellonian University	Korzeniewski, B (corresponding author), Jagiellonian Univ, Fac Biochem Biophys & Biotechnol, Ul Gronostajowa 7, PL-30387 Krakow, Poland.	benio@mol.uj.edu.pl						Beard DA, 2005, PLOS COMPUT BIOL, V1, P252, DOI 10.1371/journal.pcbi.0010036; Bernardi P, 1999, PHYSIOL REV, V79, P1127, DOI 10.1152/physrev.1999.79.4.1127; Bose S, 2003, J BIOL CHEM, V278, P39155, DOI 10.1074/jbc.M306409200; BROWN G, 1994, BIOCHEM J, V197, P115; CORKEY BE, 1986, J BIOL CHEM, V261, P2567; Cortassa S, 2003, BIOPHYS J, V84, P2734, DOI 10.1016/S0006-3495(03)75079-6; CZYZ A, 1995, BIOCHEM BIOPH RES CO, V210, P98, DOI 10.1006/bbrc.1995.1632; Dufour S, 1996, BIOCHEM J, V314, P743, DOI 10.1042/bj3140743; DUSZYNSKI J, 1984, BIOCHIM BIOPHYS ACTA, V767, P540, DOI 10.1016/0005-2728(84)90053-7; FELL DA, 1992, BIOCHEM J, V286, P313, DOI 10.1042/bj2860313; Garlid KD, 2003, BBA-BIOENERGETICS, V1606, P23, DOI 10.1016/S0005-2728(03)00108-7; GROEN AK, 1982, J BIOL CHEM, V257, P2754; HAFNER RP, 1990, EUR J BIOCHEM, V188, P313, DOI 10.1111/j.1432-1033.1990.tb15405.x; HEINRICH R, 1974, EUR J BIOCHEM, V42, P89, DOI 10.1111/j.1432-1033.1974.tb03318.x; Jeneson JAL, 2000, AM J PHYSIOL-CELL PH, V279, pC813, DOI 10.1152/ajpcell.2000.279.3.C813; KACSER H, 1973, RATE CONTROL BIOL PR, P65; KORZENIEWSKI B, 1991, BIOCHIM BIOPHYS ACTA, V1060, P210, DOI 10.1016/S0005-2728(09)91009-X; Korzeniewski B, 1998, BIOCHEM J, V330, P1189, DOI 10.1042/bj3301189; Korzeniewski B, 2001, BIOPHYS CHEM, V92, P17, DOI 10.1016/S0301-4622(01)00184-3; Korzeniewski B, 1996, BIOCHEM J, V319, P143, DOI 10.1042/bj3190143; KRISHNAMOORTHY G, 1984, BIOCHEMISTRY-US, V23, P1640, DOI 10.1021/bi00303a009; KUNZ W, 1988, FEBS LETT, V233, P17, DOI 10.1016/0014-5793(88)81347-4; Lambert AJ, 2004, BIOCHEM J, V382, P511, DOI 10.1042/BJ20040485; MITCHELL P, 1961, NATURE, V191, P144, DOI 10.1038/191144a0; Nicholls D., 2002, BIOENERGETICS, V3; NICHOLLS DG, 1974, EUR J BIOCHEM, V50, P305, DOI 10.1111/j.1432-1033.1974.tb03899.x; Nicholls DG, 2005, BBA-BIOENERGETICS, V1710, P63, DOI 10.1016/j.bbabio.2005.09.002; NOBES CD, 1990, J BIOL CHEM, V265, P12903; OUHABI R, 1991, BIOCHIM BIOPHYS ACTA, V1060, P293, DOI 10.1016/S0005-2728(05)80319-6; RAIS B, 1993, MODERN TRENDS IN BIOTHERMOKINETICS, P269; REICH JG, 1983, BIOMED BIOCHIM ACTA, V42, P37; RIGOULET M, 1990, BIOCHIM BIOPHYS ACTA, V1018, P91, DOI 10.1016/0005-2728(90)90114-J; Schuster S, 1998, BIOELECTROCH BIOENER, V45, P181, DOI 10.1016/S0302-4598(98)00092-0; SCHUSTER S, 1993, MODERN TRENDS IN BIOTHERMOKINETICS, P39; SEJERSTED OM, 2000, PHYSIOL REV, V80, P1422; Wallace D C, 1987, Birth Defects Orig Artic Ser, V23, P137; WISNIEWSKI E, 1995, EUR J BIOCHEM, V230, P549	37	48	50	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 28	2008	283	48					33232	33239		10.1074/jbc.M802404200	http://dx.doi.org/10.1074/jbc.M802404200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	376KY	18694940	Green Published, hybrid			2022-12-27	WOS:000261183700026
J	Cyr, N; Madrid, KP; Strasser, R; Aurousseau, M; Finn, R; Ausio, J; Jardim, A				Cyr, Normand; Madrid, Kleber P.; Strasser, Rona; Aurousseau, Mark; Finn, Ron; Ausio, Juan; Jardim, Armando			Leishmania donovani Peroxin 14 Undergoes a Marked Conformational Change following Association with Peroxin 5	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRYPANOSOMA-BRUCEI; TARGETING SIGNAL; MEMBRANE-PROTEIN; IMPORT MACHINERY; IMMUNOCYTOCHEMICAL CHARACTERIZATION; HANSENULA-POLYMORPHA; RNA INTERFERENCE; MATRIX PROTEINS; DOCKING PROTEIN; YEAST PEX14P	The import of PTS1 proteins into the glycosome or peroxisome requires binding of a PTS1-laden PEX5 receptor to the membrane-associated protein PEX14 to facilitate translocation of PTS1 proteins into the lumen of these organelles. Quaternary structure analysis of protozoan parasite Leishmania donovani PEX14 (LdPEX14) revealed that this protein forms a homomeric complex with a size > 670 kDa. Moreover, deletion mapping indicated that disruption of LdPEX14 oligomerization correlated with the elimination of the hydrophobic region and coiled-coil motif present in LdPEX14. Analysis of the LdPEX5-LdPEX14 interaction by isothermal titration calorimetry revealed a molar binding stoichiometry of 1: 4 (LdPEX5: LdPEX14) and an in-solution dissociation constant (K-d) of similar to 74 nM. Calorimetry, circular dichroism, intrinsic fluorescence, and analytical ultracentrifugation experiments showed that binding of LdPEX5 resulted in a dramatic conformational change in the LdPEX14 oligomeric complex that involved the reorganization of the hydrophobic segment in LdPEX14. Finally, limited tryptic proteolysis assays established that in the presence of LdPEX5, LdPEX14 became more susceptible to proteolytic degradation consistent with this protein interaction triggering a significant conformational change in the recombinant and native LdPEX14 structures. These structural changes provide essential clues to how LdPEX14 functions in the translocation of folded proteins across the glycosomal membrane.	[Cyr, Normand; Madrid, Kleber P.; Strasser, Rona; Aurousseau, Mark; Jardim, Armando] McGill Univ, Inst Parasitol, Ste Anne De Bellevue, PQ H9X 3V9, Canada; [Finn, Ron; Ausio, Juan] Univ Victoria, Dept Biochem & Microbiol, Victoria, BC V8W 3P6, Canada	McGill University; University of Victoria	Jardim, A (corresponding author), McGill Univ, Inst Parasitol, Macdonald Campus,21 111 Lakeshore Rd, Ste Anne De Bellevue, PQ H9X 3V9, Canada.	armando.jardim@mcgill.ca	Cyr, Normand/G-1614-2011	Cyr, Normand/0000-0002-9024-525X	Canadian Institute of Health Research; Fonds Quebecois de la Recherche sur la Nature et les Technologies	Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); Fonds Quebecois de la Recherche sur la Nature et les Technologies(FQRNT)	This work was supported in part by operating grants from the Canadian Institute of Health Research and Regroupement Strategique from the Fonds Quebecois de la Recherche sur la Nature et les Technologies. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.; Supported by a doctoral research scholarship from Fonds Quebecois de la Recherche sur la Nature et les Technologies.; Recipient of a Canadian Institute of Health Research New Investigator Salary Support award.	Agne B, 2003, MOL CELL, V11, P635, DOI 10.1016/S1097-2765(03)00062-5; Albertini M, 1997, CELL, V89, P83, DOI 10.1016/S0092-8674(00)80185-3; Allen T, 1995, MOL BIOCHEM PARASIT, V74, P99, DOI 10.1016/0166-6851(95)02475-1; Azevedo JE, 2006, BBA-MOL CELL RES, V1763, P1574, DOI 10.1016/j.bbamcr.2006.09.002; Bakker BM, 2000, P NATL ACAD SCI USA, V97, P2087, DOI 10.1073/pnas.030539197; BLATTNER J, 1992, J CELL BIOL, V119, P1129, DOI 10.1083/jcb.119.5.1129; Brocard C, 1997, EMBO J, V16, P5491, DOI 10.1093/emboj/16.18.5491; Choe J, 2003, BIOCHEMISTRY-US, V42, P10915, DOI 10.1021/bi034248n; CONNELLY PR, 1994, P NATL ACAD SCI USA, V91, P1964, DOI 10.1073/pnas.91.5.1964; Dacks JB, 2001, CELL, V107, P419, DOI 10.1016/S0092-8674(01)00584-0; Dawson JP, 2002, J MOL BIOL, V316, P799, DOI 10.1006/jmbi.2001.5353; Douzery EJP, 2004, P NATL ACAD SCI USA, V101, P15386, DOI 10.1073/pnas.0403984101; EFTINK MR, 1981, ANAL BIOCHEM, V114, P199, DOI 10.1016/0003-2697(81)90474-7; Erdmann R, 2005, NAT REV MOL CELL BIO, V6, P738, DOI 10.1038/nrm1710; FAIRLAMB AH, 1989, PARASITOLOGY, V99, pS93, DOI 10.1017/S003118200008344X; Fransen M, 1998, P NATL ACAD SCI USA, V95, P8087, DOI 10.1073/pnas.95.14.8087; Fransen M, 2002, MOL CELL PROTEOMICS, V1, P243, DOI 10.1074/mcp.M100025-MCP200; Furuya T, 2002, P NATL ACAD SCI USA, V99, P14177, DOI 10.1073/pnas.222454899; Galland N, 2007, BBA-MOL CELL RES, V1773, P521, DOI 10.1016/j.bbamcr.2007.01.006; Girzalsky W, 1999, J CELL BIOL, V144, P1151, DOI 10.1083/jcb.144.6.1151; GOULD SJ, 1989, J CELL BIOL, V108, P1657, DOI 10.1083/jcb.108.5.1657; Gouveia AMM, 2000, J BIOL CHEM, V275, P32444, DOI 10.1074/jbc.M004366200; Greenfield Norma J, 2004, Methods Mol Biol, V261, P55; Guerra-Giraidez C, 2002, J CELL SCI, V115, P2651; Itoh R, 2006, J BIOL CHEM, V281, P10196, DOI 10.1074/jbc.M600158200; Jardim A, 2000, J BIOL CHEM, V275, P13637, DOI 10.1074/jbc.275.18.13637; Jardim A, 1999, J BIOL CHEM, V274, P34403, DOI 10.1074/jbc.274.48.34403; Jardim A, 2002, MOL BIOCHEM PARASIT, V124, P51, DOI 10.1016/S0166-6851(02)00164-0; Johnson MA, 2001, YEAST, V18, P621, DOI 10.1002/yea.711; Kessler PS, 2005, J BIOL CHEM, V280, P9030, DOI 10.1074/jbc.M412033200; Kleiger G, 2002, BIOCHEMISTRY-US, V41, P5990, DOI 10.1021/bi0200763; Komori M, 1999, FEBS LETT, V457, P397, DOI 10.1016/S0014-5793(99)01087-X; Komori M, 1997, EMBO J, V16, P44, DOI 10.1093/emboj/16.1.44; Lametschwandtner G, 1998, J BIOL CHEM, V273, P33635, DOI 10.1074/jbc.273.50.33635; Leavitt S, 2001, CURR OPIN STRUC BIOL, V11, P560, DOI 10.1016/S0959-440X(00)00248-7; Madrid KP, 2005, BIOCHEM J, V391, P105, DOI 10.1042/BJ20050328; Madrid KP, 2004, MOL CELL BIOL, V24, P7331, DOI 10.1128/MCB.24.17.7331-7344.2004; Michels PAM, 2005, MOL MEMBR BIOL, V22, P133, DOI 10.1080/09687860400024186; Moyersoen J, 2003, EUR J BIOCHEM, V270, P2059, DOI 10.1046/j.1432-1033.2003.03582.x; Niederhoff K, 2005, J BIOL CHEM, V280, P35571, DOI 10.1074/jbc.M502460200; Oliveira MEM, 2002, BBA-BIOMEMBRANES, V1567, P13, DOI 10.1016/S0005-2736(02)00635-1; OPPERDOES FR, 1993, BIOCHIMIE, V75, P231, DOI 10.1016/0300-9084(93)90081-3; OPPERDOES FR, 1977, FEBS LETT, V80, P360, DOI 10.1016/0014-5793(77)80476-6; PACE CN, 1995, PROTEIN SCI, V4, P2411, DOI 10.1002/pro.5560041120; Parsons M, 2001, MOL BIOCHEM PARASIT, V115, P19, DOI 10.1016/S0166-6851(01)00261-4; Pilar AVC, 2008, MOL BIOCHEM PARASIT, V158, P72, DOI 10.1016/j.molbiopara.2007.11.013; PURDUE PE, 1994, J BIOL CHEM, V269, P30065; Purdue PE, 2001, ANNU REV CELL DEV BI, V17, P701, DOI 10.1146/annurev.cellbio.17.1.701; Rayapuram N, 2006, BBA-MOL CELL RES, V1763, P1613, DOI 10.1016/j.bbamcr.2006.08.035; Reguenga C, 2001, J BIOL CHEM, V276, P29935, DOI 10.1074/jbc.M104114200; Robinson KA, 2003, MOL BIOCHEM PARASIT, V128, P217, DOI 10.1016/S0166-6851(03)00079-3; Salomons FA, 2000, J BIOL CHEM, V275, P12603, DOI 10.1074/jbc.275.17.12603; Schliebs W, 1999, J BIOL CHEM, V274, P5666, DOI 10.1074/jbc.274.9.5666; Shimizu N, 1999, J BIOL CHEM, V274, P12593, DOI 10.1074/jbc.274.18.12593; Shimozawa N, 2004, HUM MUTAT, V23, P552, DOI 10.1002/humu.20032; Shinohara Y, 1997, GLYCOBIOLOGY, V7, P1201, DOI 10.1093/glycob/7.8.1201; SOMMER JM, 1994, ANNU REV MICROBIOL, V48, P105, DOI 10.1146/annurev.mi.48.100194.000541; STURTEVANT JM, 1977, P NATL ACAD SCI USA, V74, P2236, DOI 10.1073/pnas.74.6.2236; Subramani S, 2000, ANNU REV BIOCHEM, V69, P399, DOI 10.1146/annurev.biochem.69.1.399; SWINKELS BW, 1991, EMBO J, V10, P3255, DOI 10.1002/j.1460-2075.1991.tb04889.x; VANHOLDE KE, 1978, BIOPOLYMERS, V17, P1387, DOI 10.1002/bip.1978.360170602; Velazquez-Campoy A, 2000, BIOCHEMISTRY-US, V39, P2201, DOI 10.1021/bi992399d; Will GK, 1999, MOL CELL BIOL, V19, P2265; Zarella-Boitz JM, 2004, MOL BIOCHEM PARASIT, V134, P43, DOI 10.1016/j.molbiopara.2003.08.016	64	22	22	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 14	2008	283	46					31488	31499		10.1074/jbc.M803529200	http://dx.doi.org/10.1074/jbc.M803529200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	370KJ	18718908	hybrid			2022-12-27	WOS:000260760800028
J	Kruh, NA; Borgaro, JG; Ruzsicska, BP; Xu, H; Tonge, PJ				Kruh, Nicole A.; Borgaro, Janine G.; Ruzsicska, Bela P.; Xu, Hua; Tonge, Peter J.			A Novel Interaction Linking the FAS-II and Phthiocerol Dimycocerosate (PDIM) Biosynthetic Pathways	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACYL CARRIER PROTEIN; MYCOBACTERIUM-TUBERCULOSIS; ENOYL REDUCTASE; MYCOLIC ACIDS; GENE-CLUSTER; SYSTEM; INHA; RESISTANCE; PURIFICATION; ADAPTATION	The fatty acid biosynthesis (FAS-II) pathway in Mycobacterium tuberculosis generates long chain fatty acids that serve as the precursors to mycolic acids, essential components of the mycobacterial cell wall. Enzymes in the FAS-II pathway are thought to form one or more noncovalent multi-enzyme complexes within the cell, and a bacterial two-hybrid screen was used to search for missing components of the pathway and to furnish additional data on interactions involving these enzymes in vivo. Using the FAS-II beta-ketoacyl synthase, KasA, as bait, an extensive bacterial two-hybrid screen of a M. tuberculosis genome fragment library unexpectedly revealed a novel interaction between KasA and PpsB as well as PpsD, two polyketide modules involved in the biosynthesis of the virulence lipid phthiocerol dimycocerosate (PDIM). Sequence analysis revealed that KasA interacts with PpsB and PpsD in the region of the acyl carrier domain of each protein, raising the possibility that lipids could be transferred between the FAS-II and PDIM biosynthetic pathways. Subsequent studies utilizing purified proteins and radiolabeled lipids revealed that fatty acids loaded onto PpsB were transferred to KasA and also incorporated into long chain fatty acids synthesized using a Mycobacterium smegmatis lysate. These data suggest that in addition to producing PDIMs, the growing phthiocerol product can also be shuttled into the FAS-II pathway via KasA as an entry point for further elongation. Interactions between these biosynthetic pathways may exist as a simple means to increase mycobacterial lipid diversity, enhancing functionality and the overall complexity of the cell wall.	[Kruh, Nicole A.; Tonge, Peter J.] SUNY Stony Brook, Grad Program Mol Genet & Microbiol, Dept Chem, Stony Brook, NY 11794 USA; [Kruh, Nicole A.; Borgaro, Janine G.; Ruzsicska, Bela P.; Xu, Hua; Tonge, Peter J.] SUNY Stony Brook, Inst Chem Biol & Drug Discovery, Dept Chem, Stony Brook, NY 11794 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Tonge, PJ (corresponding author), SUNY Stony Brook, Grad Program Mol Genet & Microbiol, Dept Chem, Stony Brook, NY 11794 USA.	peter.tonge@sunysb.edu	Kruh-Garcia, Nicole/D-5853-2017; Tonge, Peter J/A-7443-2009	Kruh-Garcia, Nicole/0000-0002-9896-8380; Tonge, Peter J/0000-0003-1606-3471	CSU-Tuberculosis Research Materials and Vaccine Testing; National Institutes of Health [N01-A1-75320, AI44639, T32 AI007539]; U. S. Department of Education Graduate Assistance in Areas of National Need (GAANN); National Research Service Award Predoctoral Fellowship; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI044639, N01AI075320, T32AI007539, R21AI044639] Funding Source: NIH RePORTER	CSU-Tuberculosis Research Materials and Vaccine Testing; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); U. S. Department of Education Graduate Assistance in Areas of National Need (GAANN)(US Department of Education); National Research Service Award Predoctoral Fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	M. tuberculosis genomic DNA was obtained through the CSU-Tuberculosis Research Materials and Vaccine Testing, National Institutes of Health, NIAID Contract N01-A1-75320.; This work was supported, in whole or in part, by National Institutes of Health Grant AI44639 (to P. J. T.).; Supported by a U. S. Department of Education Graduate Assistance in Areas of National Need (GAANN) grant and by Ruth L. Kirschstein National Research Service Award Predoctoral Fellowship T32 AI007539 from the National Institutes of Health.	Ansari MZ, 2004, NUCLEIC ACIDS RES, V32, pW405, DOI 10.1093/nar/gkh359; ASSELINEAU J, 1950, NATURE, V166, P782, DOI 10.1038/166782a0; Azad AK, 1997, J BIOL CHEM, V272, P16741, DOI 10.1074/jbc.272.27.16741; BANERJEE A, 1994, SCIENCE, V263, P227, DOI 10.1126/science.8284673; Barry CE, 1996, TRENDS MICROBIOL, V4, P275, DOI 10.1016/0966-842X(96)10031-7; Barry CE, 1998, PROG LIPID RES, V37, P143, DOI 10.1016/S0163-7827(98)00008-3; BRENNAN PJ, 1995, ANNU REV BIOCHEM, V64, P29, DOI 10.1146/annurev.bi.64.070195.000333; Camacho LR, 1999, MOL MICROBIOL, V34, P257, DOI 10.1046/j.1365-2958.1999.01593.x; Changsen C, 2003, ANTIMICROB AGENTS CH, V47, P3682, DOI 10.1128/AAC.47.12.3682-3687.2003; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Cox JS, 1999, NATURE, V402, P79, DOI 10.1038/47042; DAFFE M, 1988, J GEN MICROBIOL, V134, P2049; Dove SL, 1997, NATURE, V386, P627, DOI 10.1038/386627a0; Jain M, 2007, P NATL ACAD SCI USA, V104, P5133, DOI 10.1073/pnas.0610634104; Jain M, 2005, PLOS PATHOG, V1, P12, DOI 10.1371/journal.ppat.0010002; Kolattukudy PE, 1997, MOL MICROBIOL, V24, P263, DOI 10.1046/j.1365-2958.1997.3361705.x; Kruh NA, 2007, PROTEIN SCI, V16, P1617, DOI 10.1110/ps.062749007; La Clair JJ, 2004, CHEM BIOL, V11, P195, DOI 10.1016/j.chembiol.2004.02.010; Lambalot RH, 1996, CHEM BIOL, V3, P923, DOI 10.1016/S1074-5521(96)90181-7; Marrakchi H, 2000, MICROBIOL-UK, V146, P289, DOI 10.1099/00221287-146-2-289; ODRIOZOLA JM, 1977, BIOCHIM BIOPHYS ACTA, V488, P207, DOI 10.1016/0005-2760(77)90178-3; PARISH T, 2001, MYCOBACTERIUM TUBERC, P47; Quadri LEN, 1998, BIOCHEMISTRY-US, V37, P1585, DOI 10.1021/bi9719861; Rao A, 2004, MOL GENET GENOMICS, V272, P571, DOI 10.1007/s00438-004-1088-3; Rawat R, 2003, P NATL ACAD SCI USA, V100, P13881, DOI 10.1073/pnas.2235848100; Schaeffer ML, 2001, J BIOL CHEM, V276, P47029, DOI 10.1074/jbc.M108903200; Schaeffer ML, 2001, BBA-MOL CELL BIOL L, V1532, P67, DOI 10.1016/S1388-1981(01)00116-0; Schnappinger D, 2003, J EXP MED, V198, P693, DOI 10.1084/jem.20030846; Singh A, 2005, J BACTERIOL, V187, P4173, DOI 10.1128/JB.187.12.4173-4186.2005; Slayden RA, 2000, MOL MICROBIOL, V38, P514, DOI 10.1046/j.1365-2958.2000.02145.x; Slayden RA, 2002, TUBERCULOSIS, V82, P149, DOI 10.1054/tube.2002.0333; Talaat AM, 2004, P NATL ACAD SCI USA, V101, P4602, DOI 10.1073/pnas.0306023101; Trivedi OA, 2005, MOL CELL, V17, P631, DOI 10.1016/j.molcel.2005.02.009; Veyron-Churlet R, 2005, J MOL BIOL, V353, P847, DOI 10.1016/j.jmb.2005.09.016; Veyron-Churlet R, 2004, MOL MICROBIOL, V54, P1161, DOI 10.1111/j.1365-2958.2004.04334.x; Walsh CT, 1997, CURR OPIN CHEM BIOL, V1, P309, DOI 10.1016/S1367-5931(97)80067-1; World Health Organization, 1993, TREATM TUB GUID NAT	37	13	13	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 14	2008	283	46					31719	31725		10.1074/jbc.M802169200	http://dx.doi.org/10.1074/jbc.M802169200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	370KJ	18703500	Green Published, hybrid			2022-12-27	WOS:000260760800054
J	Samanta, U; Bahnson, BJ				Samanta, Uttamkumar; Bahnson, Brian J.			Crystal Structure of Human Plasma Platelet-activating Factor Acetylhydrolase STRUCTURAL IMPLICATION TO LIPOPROTEIN BINDING AND CATALYSIS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHOLIPASE A(2); MOLECULAR-BASIS; ATHEROSCLEROSIS; SUBSTRATE; MEMBRANE; RISK; LYSOPHOSPHATIDYLCHOLINE; IDENTIFICATION; ASSOCIATION; DARAPLADIB	Human plasma platelet-activating factor ( PAF) acetylhydrolase functions by reducing PAF levels as a general anti-inflammatory scavenger and is linked to anaphylactic shock, asthma, and allergic reactions. The enzyme has also been implicated in hydrolytic activities of other pro-inflammatory agents, such as sn-2 oxidatively fragmented phospholipids. This plasma enzyme is tightly bound to low and high density lipoprotein particles and is also referred to as lipoprotein-associated phospholipase A(2). The crystal structure of this enzyme has been solved from x- ray diffraction data collected to a resolution of 1.5 A. It has a classic lipase alpha/beta-hydrolase fold, and it contains a catalytic triad of Ser(273), His(351), and Asp(296). Two clusters of hydrophobic residues define the probable interface-binding region, and a prediction is given of how the enzyme is bound to lipoproteins. Additionally, an acidic patch of 10 carboxylate residues and a neighboring basic patch of three residues are suggested to play a role in high density lipoprotein/low density lipoprotein partitioning. A crystal structure is also presented of PAF acetylhydrolase reacted with the organophosphate compound paraoxon via its active site Ser273. The resulting diethyl phosphoryl complex was used to model the tetrahedral intermediate of the substrate PAF to the active site. The model of interface binding begins to explain the known specificity of lipoprotein-bound substrates and how the active site can be both close to the hydrophobic-hydrophobic interface and at the same time be accessible to the aqueous phase.	[Samanta, Uttamkumar; Bahnson, Brian J.] Univ Delaware, Dept Chem & Biochem, Newark, DE 19716 USA	University of Delaware	Bahnson, BJ (corresponding author), Univ Delaware, Dept Chem & Biochem, Newark, DE 19716 USA.	bahnson@udel.edu			National Institutes of Health [2P20RR015588, 1R01HL084366-A1]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR015588] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL084366] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P30EB009998] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This work was supported, in whole or in part, by National Institutes of Health Grants 2P20RR015588 and 1R01HL084366-A1. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Abuzeid AM, 2003, ATHEROSCLEROSIS, V168, P283, DOI 10.1016/S0021-9150(03)00086-8; Aiyar N, 2007, MOL CELL BIOCHEM, V295, P113, DOI 10.1007/s11010-006-9280-x; Arai H, 2002, PROSTAG OTH LIPID M, V68-9, P83, DOI 10.1016/S0090-6980(02)00023-0; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Blackie JA, 2003, BIOORG MED CHEM LETT, V13, P1067, DOI 10.1016/S0960-894X(03)00058-1; Davis B, 2008, J BIOL CHEM, V283, P6428, DOI 10.1074/jbc.M709970200; DeLano WL, 2002, PYMOL USERS MANUAL; Derewenda ZS, 2002, COLLOID SURFACE B, V26, P31, DOI 10.1016/S0927-7765(01)00314-9; Derewenda ZS, 1998, CELL MOL LIFE SCI, V54, P446, DOI 10.1007/s000180050172; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; EPSTEIN TM, 2005, THESIS U DELAWARE NE; Gardner AA, 2008, J BIOL CHEM, V283, P17099, DOI 10.1074/jbc.M802394200; Gelb MH, 2000, BBA-MOL CELL BIOL L, V1488, P20, DOI 10.1016/S1388-1981(00)00106-2; Ho YS, 1997, NATURE, V385, P89, DOI 10.1038/385089a0; Holm L, 1996, SCIENCE, V273, P595, DOI 10.1126/science.273.5275.595; Karasawa K, 2006, BBA-MOL CELL BIOL L, V1761, P1359, DOI 10.1016/j.bbalip.2006.06.017; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Kruse S, 2000, AM J HUM GENET, V66, P1522, DOI 10.1086/302901; Lomize AL, 2007, BMC STRUCT BIOL, V7, DOI 10.1186/1472-6807-7-44; Lomize AL, 2006, PROTEIN SCI, V15, P1318, DOI 10.1110/ps.062126106; Lomize MA, 2006, BIOINFORMATICS, V22, P623, DOI 10.1093/bioinformatics/btk023; Macphee CH, 2006, CURR OPIN PHARMACOL, V6, P154, DOI 10.1016/j.coph.2005.11.008; Macphee CH, 2005, CURR OPIN LIPIDOL, V16, P442, DOI 10.1097/01.mol.0000174155.61307.5f; Macphee CH, 2005, EUR HEART J, V26, P107, DOI 10.1093/eurheartj/ehi042; MacRitchie AN, 2007, FASEB J, V21, P1164, DOI 10.1096/fj.06-6743com; Mannheim D, 2008, STROKE, V39, P1448, DOI 10.1161/STROKEAHA.107.503193; Min JH, 1999, BIOCHEMISTRY-US, V38, P12935, DOI 10.1021/bi991149u; Min JH, 2001, BIOCHEMISTRY-US, V40, P4539, DOI 10.1021/bi002600g; Mohler ER, 2008, J AM COLL CARDIOL, V51, P1632, DOI 10.1016/j.jacc.2007.11.079; Ninio E, 2004, HUM MOL GENET, V13, P1341, DOI 10.1093/hmg/ddh145; OLLIS DL, 1992, PROTEIN ENG, V5, P197, DOI 10.1093/protein/5.3.197; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Packard CJ, 2000, NEW ENGL J MED, V343, P1148, DOI 10.1056/NEJM200010193431603; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; PRESCOTT SM, 1990, J BIOL CHEM, V265, P17381; Prescott SM, 2000, ANNU REV BIOCHEM, V69, P419, DOI 10.1146/annurev.biochem.69.1.419; Samanta U, 2002, PROTEIN ENG, V15, P659, DOI 10.1093/protein/15.8.659; SAMANTA U, 2008, PROTEIN PEP IN PRESS; Schaloske RH, 2006, BBA-MOL CELL BIOL L, V1761, P1246, DOI 10.1016/j.bbalip.2006.07.011; Sharikov Y, 2008, NAT METHODS, V5, P119, DOI 10.1038/nmeth0208-119; Sheldrick GM, 1997, METHOD ENZYMOL, V277, P319, DOI 10.1016/S0076-6879(97)77018-6; Stafforini DM, 1999, J CLIN INVEST, V103, P989, DOI 10.1172/JCI5574; Stafforini DM, 1999, J BIOL CHEM, V274, P7018, DOI 10.1074/jbc.274.11.7018; STREMLER KE, 1991, J BIOL CHEM, V266, P11095; Tarricone C, 2004, NEURON, V44, P809, DOI 10.1016/S0896-6273(04)00751-2; Terwilliger TC, 2003, METHOD ENZYMOL, V374, P22, DOI 10.1016/S0076-6879(03)74002-6; Tjoelker LW, 2000, BBA-MOL CELL BIOL L, V1488, P102, DOI 10.1016/S1388-1981(00)00114-1; TJOELKER LW, 1995, NATURE, V374, P549, DOI 10.1038/374549a0; TJOELKER LW, 1995, J BIOL CHEM, V270, P25481, DOI 10.1074/jbc.270.43.25481; Wei YY, 1998, STRUCTURE, V6, P511, DOI 10.1016/S0969-2126(98)00052-5; Wilensky RL, 2007, CIRCULATION, V116, P33	51	65	72	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 14	2008	283	46					31617	31624		10.1074/jbc.M804750200	http://dx.doi.org/10.1074/jbc.M804750200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	370KJ	18784071	Green Published, hybrid			2022-12-27	WOS:000260760800042
J	Campbell, GR; Spector, SA				Campbell, Grant R.; Spector, Stephen A.			CCL2 Increases X4-tropic HIV-1 Entry into Resting CD4(+) T Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MONOCYTE CHEMOATTRACTANT PROTEIN-1; CORECEPTOR USAGE; DISEASE PROGRESSION; SURFACE EXPRESSION; TYPE-1; CXCR4; CHEMOKINE; INFECTION; RECEPTOR; CHEMOTAXIS	During human immunodeficiency virus type 1 (HIV-1) infection, there is a strong positive correlation between CCL2 levels and HIV viral load. To determine whether CCL2 alters HIV-1 infection of resting CD4(+) T cells, we infected purified resting CD4(+) T cells after incubation with CCL2. We show that CCL2 up-regulates CXCR4 on resting CD4(+) T cells in a CCR2-dependent mechanism, and that this augmentation of CXCR4 expression by CCL2 increases the ability of these cells to be chemoattracted to CXCR4 using gp 120 and renders them more permissive to X4-tropic HIV-1 infection. Thus, CCL2 has the capacity to render a large population of lymphocytes more susceptible to HIV-1 late in the course of infection.	[Campbell, Grant R.; Spector, Stephen A.] Univ Calif San Diego, Dept Pediat, Div Infect Dis, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Spector, SA (corresponding author), Univ Calif San Diego, Dept Pediat, Div Infect Dis, 9500 Gilman Dr, La Jolla, CA 92093 USA.	saspector@ucsd.edu	Campbell, Grant/C-9018-2011	Campbell, Grant/0000-0003-3927-1994	National Institutes of Health [AI068632]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI068632, UM1AI068632] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant AI068632 (NIAID). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked " advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Abebe A, 1999, AIDS, V13, P1305, DOI 10.1097/00002030-199907300-00006; Agosto LM, 2007, VIROLOGY, V368, P60, DOI 10.1016/j.virol.2007.06.001; Ansari AW, 2006, INT IMMUNOL, V18, P1443, DOI 10.1093/intimm/dxl078; Babcock GJ, 2001, J BIOL CHEM, V276, P38433, DOI 10.1074/jbc.M106229200; Balabanian K, 2004, J IMMUNOL, V173, P7150, DOI 10.4049/jimmunol.173.12.7150; BARRESINOUSSI F, 1983, SCIENCE, V220, P868, DOI 10.1126/science.6189183; Batra M, 2000, AIDS RES HUM RETROV, V16, P973, DOI 10.1089/08892220050058399; Berger EA, 1997, AIDS, V11, pS3; Bjorndal A, 1997, J VIROL, V71, P7478; Campbell GR, 2007, J VIROL, V81, P5919, DOI 10.1128/JVI.01938-06; CARR MW, 1994, P NATL ACAD SCI USA, V91, P3652, DOI 10.1073/pnas.91.9.3652; Cole SW, 1999, J IMMUNOL, V162, P1392; Ding Y, 2008, EXP CELL RES, V314, P590, DOI 10.1016/j.yexcr.2007.10.032; Eckstein DA, 2001, IMMUNITY, V15, P671, DOI 10.1016/S1074-7613(01)00217-5; Fantuzzi L, 2001, J IMMUNOL, V166, P5381, DOI 10.4049/jimmunol.166.9.5381; Futahashi Y, 2007, CANCER SCI, V98, P373, DOI 10.1111/j.1349-7006.2007.00388.x; Glushakova S, 1997, AIDS RES HUM RETROV, V13, P461, DOI 10.1089/aid.1997.13.461; Gonzalez E, 2002, P NATL ACAD SCI USA, V99, P13795, DOI 10.1073/pnas.202357499; Gu L, 2000, NATURE, V404, P407, DOI 10.1038/35006097; Han YF, 2007, NAT REV MICROBIOL, V5, P95, DOI 10.1038/nrmicro1580; JAPOUR AJ, 1993, ANTIMICROB AGENTS CH, V37, P1095, DOI 10.1128/AAC.37.5.1095; Johnston ER, 2003, J VIROL, V77, P7682, DOI 10.1128/JVI.77.13.7682-7688.2003; Jourdan P, 1998, J IMMUNOL, V160, P4153; Kinter A, 1998, P NATL ACAD SCI USA, V95, P11880, DOI 10.1073/pnas.95.20.11880; Kinter AL, 2003, J IMMUNOL, V170, P2449, DOI 10.4049/jimmunol.170.5.2449; Koot M, 1996, J INFECT DIS, V173, P349, DOI 10.1093/infdis/173.2.349; Kumar A, 2006, IMMUNITY, V25, P213, DOI 10.1016/j.immuni.2006.06.015; Lee B, 1998, J VIROL, V72, P7450, DOI 10.1128/JVI.72.9.7450-7458.1998; Lole KS, 1999, J VIROL, V73, P152, DOI 10.1128/JVI.73.1.152-160.1999; MAGHAZACHI AA, 1994, J IMMUNOL, V153, P4969; MATSUSHIMA K, 1989, J EXP MED, V169, P1485, DOI 10.1084/jem.169.4.1485; Mengozzi M, 1999, BLOOD, V93, P1851, DOI 10.1182/blood.V93.6.1851.406k12_1851_1857; Park IW, 2001, BLOOD, V97, P352, DOI 10.1182/blood.V97.2.352; Patrussi L, 2007, BLOOD, V110, P1730, DOI 10.1182/blood-2007-01-068411; Peacock JW, 1999, J IMMUNOL, V162, P215; PELCHENMATTHEWS A, 1989, EMBO J, V8, P3641, DOI 10.1002/j.1460-2075.1989.tb08538.x; Philpott SM, 2003, CURR HIV RES, V1, P217, DOI 10.2174/1570162033485357; Ping LH, 1999, J VIROL, V73, P6271, DOI 10.1128/JVI.73.8.6271-6281.1999; Riol-Blanco L, 2005, J IMMUNOL, V174, P4070, DOI 10.4049/jimmunol.174.7.4070; Rovin BH, 1999, BIOCHEM BIOPH RES CO, V259, P344, DOI 10.1006/bbrc.1999.0796; Smith MW, 1997, SCIENCE, V277, P959, DOI 10.1126/science.277.5328.959; Sotsios Y, 2000, IMMUNOL REV, V177, P217, DOI 10.1034/j.1600-065X.2000.17712.x; Stanners J, 1995, J BIOL CHEM, V270, P30635, DOI 10.1074/jbc.270.51.30635; WAINHOBSON S, 1991, SCIENCE, V252, P961, DOI 10.1126/science.2035026; Wu LJ, 1996, NATURE, V384, P179, DOI 10.1038/384179a0	45	36	37	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 7	2008	283	45					30745	30753		10.1074/jbc.M804112200	http://dx.doi.org/10.1074/jbc.M804112200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	367ID	18784079	hybrid, Green Published			2022-12-27	WOS:000260544800029
J	Chow, JPH; Fujikawa, A; Shimizu, H; Suzuki, R; Noda, M				Chow, Jeremy Pak Hong; Fujikawa, Akihiro; Shimizu, Hidetada; Suzuki, Ryoko; Noda, Masaharu			Metalloproteinase- and gamma-Secretase-mediated Cleavage of Protein-tyrosine Phosphatase Receptor Type Z	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHONDROITIN SULFATE PROTEOGLYCAN; SUBSTRATE-TRAPPING SYSTEM; ALPHA-CONVERTING-ENZYME; LONG-TERM POTENTIATION; ZETA RPTP-BETA; MICE DEFICIENT; RAT-BRAIN; IDENTIFICATION; EXPRESSION; INTERACTS	Protein-tyrosine phosphatase receptor type Z (Ptprz) is preferentially expressed in the brain as a major chondroitin sulfate proteoglycan. Three splicing variants, two receptor isoforms and one secretory isoform, are known. Here, we show that the extracellular region of the receptor isoforms of Ptprz are cleaved by metalloproteinases, and subsequently the membrane-tethered fragment is cleaved by presenilin/gamma-secretase, releasing its intracellular region into the cytoplasm; of note, the intracellular fragment of Ptprz shows nuclear localization. Administration of GM6001, an inhibitor of metalloproteinases, to mice demonstrated the metalloproteinase-mediated cleavage of Ptprz under physiological conditions. Furthermore, we identified the cleavage sites in the extracellular juxtamembrane region of Ptprz by tumor necrosis factor-alpha converting enzyme and matrix metalloproteinase 9. This is the first evidence of the metalloproteinase-mediated processing of a receptor-like protein-tyrosine phosphatase in the central nervous system.	[Chow, Jeremy Pak Hong; Fujikawa, Akihiro; Shimizu, Hidetada; Suzuki, Ryoko; Noda, Masaharu] Natl Inst Basic Biol, Div Mol Neurobiol, Okazaki, Aichi 4448787, Japan; [Chow, Jeremy Pak Hong; Noda, Masaharu] Grad Univ Adv Studies, Sch Life Sci, Okazaki, Aichi 4448787, Japan	National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB); Graduate University for Advanced Studies - Japan	Noda, M (corresponding author), Natl Inst Basic Biol, Div Mol Neurobiol, 5-1 Higashiyama,Myodaijicho, Okazaki, Aichi 4448787, Japan.	madon@nibb.ac.jp	Noda, Masaharu/D-7146-2016; Fujikawa, Akihiro/K-9805-2015	Noda, Masaharu/0000-0002-3796-524X; Fujikawa, Akihiro/0000-0002-3950-0550	Ministry of Education, Science, Sports, and Culture of Japan	Ministry of Education, Science, Sports, and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by grants from the Ministry of Education, Science, Sports, and Culture of Japan. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked " advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Anders L, 2006, MOL CELL BIOL, V26, P3917, DOI 10.1128/MCB.26.10.3917-3934.2006; Arribas J, 2002, CHEM REV, V102, P4627, DOI 10.1021/cr010202t; Blobel CP, 2005, NAT REV MOL CELL BIO, V6, P32, DOI 10.1038/nrm1548; Borroto A, 2003, J BIOL CHEM, V278, P25933, DOI 10.1074/jbc.M301673200; Canoll PD, 1996, J NEUROSCI RES, V44, P199, DOI 10.1002/(SICI)1097-4547(19960501)44:3<199::AID-JNR1>3.0.CO;2-B; Chow JPH, 2008, NEUROSCI LETT, V442, P208, DOI 10.1016/j.neulet.2008.07.028; Fujikawa A, 2003, NAT GENET, V33, P375, DOI 10.1038/ng1112; Fujikawa A, 2007, J BIOCHEM, V142, P343, DOI 10.1093/jb/mvm140; Fukada M, 2005, METHODS, V35, P54, DOI 10.1016/j.ymeth.2004.07.008; Fukada M, 2006, FEBS LETT, V580, P4051, DOI 10.1016/j.febslet.2006.06.041; Garwood J, 2003, J BIOL CHEM, V278, P24164, DOI 10.1074/jbc.M211721200; GLOWINSKI J, 1966, J NEUROCHEM, V13, P655, DOI 10.1111/j.1471-4159.1966.tb09873.x; Gupta-Rossi N, 2001, J BIOL CHEM, V276, P34371, DOI 10.1074/jbc.M101343200; Harroch S, 2000, MOL CELL BIOL, V20, P7706, DOI 10.1128/MCB.20.20.7706-7715.2000; Jin GX, 2002, ANAL BIOCHEM, V302, P269, DOI 10.1006/abio.2001.5549; Kasuga K, 2007, BIOCHEM BIOPH RES CO, V360, P90, DOI 10.1016/j.bbrc.2007.06.022; Kawachi H, 1999, MOL BRAIN RES, V72, P47, DOI 10.1016/S0169-328X(99)00204-1; Kawachi H, 2001, P NATL ACAD SCI USA, V98, P6593, DOI 10.1073/pnas.041608698; KRUEGER NX, 1992, P NATL ACAD SCI USA, V89, P7417, DOI 10.1073/pnas.89.16.7417; LEVY JB, 1993, J BIOL CHEM, V268, P10573; MAEDA N, 1995, NEUROSCIENCE, V67, P23, DOI 10.1016/0306-4522(94)00069-H; MAEDA N, 1994, FEBS LETT, V354, P67, DOI 10.1016/0014-5793(94)01093-5; MAUREL P, 1994, P NATL ACAD SCI USA, V91, P2512, DOI 10.1073/pnas.91.7.2512; Nagy V, 2006, J NEUROSCI, V26, P1923, DOI 10.1523/JNEUROSCI.4359-05.2006; Niisato K, 2005, J NEUROSCI, V25, P1081, DOI 10.1523/JNEUROSCI.2565.04.2005; Nishiwaki T, 1998, J BIOCHEM-TOKYO, V123, P458; Onyango P, 1998, GENOMICS, V50, P187, DOI 10.1006/geno.1997.5186; Peiretti F, 2003, J CELL SCI, V116, P1949, DOI 10.1242/jcs.00415; Reymann KG, 2007, NEUROPHARMACOLOGY, V52, P24, DOI 10.1016/j.neuropharm.2006.07.026; Sakurai T, 1996, J NEUROSCI RES, V43, P694, DOI 10.1002/(SICI)1097-4547(19960315)43:6<694::AID-JNR6>3.3.CO;2-9; Selkoe D, 2003, ANNU REV NEUROSCI, V26, P565, DOI 10.1146/annurev.neuro.26.041002.131334; Shintani T, 1998, NEUROSCI LETT, V247, P135, DOI 10.1016/S0304-3940(98)00295-X; Suzuki R, 2000, MECH DEVELOP, V98, P37, DOI 10.1016/S0925-4773(00)00450-0; Tamura H, 2006, NEUROSCI LETT, V399, P33, DOI 10.1016/j.neulet.2006.01.045; Tonks NK, 2006, NAT REV MOL CELL BIO, V7, P833, DOI 10.1038/nrm2039	35	61	61	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 7	2008	283	45					30879	30889		10.1074/jbc.M802976200	http://dx.doi.org/10.1074/jbc.M802976200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	367ID	18713734	Green Published, hybrid			2022-12-27	WOS:000260544800043
J	Hoffmann, C; Ziegler, N; Reiner, S; Krasel, C; Lohse, MJ				Hoffmann, Carsten; Ziegler, Nicole; Reiner, Susanne; Krasel, Cornelius; Lohse, Martin J.			Agonist-selective, Receptor-specific Interaction of Human P-2Y Receptors with beta-Arrestin-1 and-2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							P2Y(2) NUCLEOTIDE RECEPTOR; PROTEIN-COUPLED RECEPTORS; DIFFERENTIAL REGULATION; BETA-ARRESTINS; DESENSITIZATION; INTERNALIZATION; ACTIVATION; PHOSPHORYLATION; ENDOCYTOSIS; MECHANISMS	Interaction of G-protein-coupled receptors with beta-arrestins is an important step in receptor desensitization and in triggering "alternative" signals. By means of confocal microscopy and fluorescence resonance energy transfer, we have investigated the internalization of the human P2Y receptors 1, 2, 4, 6, 11, and 12 and their interaction with beta-arrestin-1 and -2. Co-transfection of each individual P2Y receptor with beta-arrestin-1-GFP or beta-arrestin-2-YFP into HEK-293 cells and stimulation with the corresponding agonists resulted in a receptor-specific interaction pattern. The P2Y(1) receptor stimulated with ADP strongly translocated beta-arrestin-2-YFP, whereas only a slight translocation was observed for beta-arrestin-1-GFP. The P2Y(4) receptor exhibited equally strong translocation for beta-arrestin-1-GFP and beta-arrestin-2YFP when stimulated with UTP. The P2Y(6), P2Y(11), and P2Y(12) receptor internalized only when GRK2 was additionally cotransfected, but beta-arrestin translocation was only visible for the P2Y(6) and P2Y(11) receptor. The P2Y(2) receptor showed a beta-arrestin translocation pattern that was dependent on the agonist used for stimulation. UTP translocated beta-arrestin-1-GFP and beta-arrestin-2-YFP equally well, whereas ATP translocated beta-arrestin-1-GFP to a much lower extent than beta-arrestin2- YFP. The same agonist-dependent pattern was seen in fluorescence resonance energy transfer experiments between the fluorescently labeled P2Y(2) receptor and beta-arrestins. Thus, the P2Y(2) receptor would be classified as a class A receptor when stimulated with ATP or as a class B receptor when stimulated with UTP. The ligand-specific recruitment of beta-arrestins by ATP and UTP stimulation of P2Y(2) receptors was further found to result in differential stimulation of ERK phosphorylation. This suggests that the two different agonists induce distinct active states of this receptor that show differential interactions with beta-arrestins.	[Hoffmann, Carsten; Ziegler, Nicole; Reiner, Susanne; Krasel, Cornelius; Lohse, Martin J.] Inst Pharmacol & Toxicol, D-97078 Wurzburg, Germany		Hoffmann, C (corresponding author), Inst Pharmacol & Toxicol, Versbacher Str 9, D-97078 Wurzburg, Germany.	c.Hoffmann@toxi.uni-wuerzburg.de	Lohse, Martin J/A-7160-2012; Krasel, Cornelius/AAH-7074-2019	Lohse, Martin J/0000-0002-0599-3510; Krasel, Cornelius/0000-0001-8309-8696	Deutsche Forschungsgemeinschaft [SFB487]; Fonds der Chemischen Industrie; Ernst-Jung Award	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Fonds der Chemischen Industrie(Fonds der Chemischen IndustrieEuropean Commission); Ernst-Jung Award	This work was supported by the Deutsche Forschungsgemeinschaft Grant " Sonderforschungsbereich" SFB487 " Regulatory Membrane Proteins," by the Fonds der Chemischen Industrie, and by the Ernst-Jung Award for Medicine. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked " advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Abbracchio MP, 2006, PHARMACOL REV, V58, P281, DOI 10.1124/pr.58.3.3; Baurand A, 2005, MOL PHARMACOL, V67, P721, DOI 10.1124/mol.104.004846; Brinson AE, 2001, J BIOL CHEM, V276, P11939, DOI 10.1074/jbc.M009909200; Burnstock G, 2006, PHARMACOL REV, V58, P58, DOI 10.1124/pr.58.1.5; Burnstock G, 2004, INT REV CYTOL, V240, P31, DOI 10.1016/S0074-7696(04)40002-3; Camaioni E, 1998, J MED CHEM, V41, P183, DOI 10.1021/jm970433l; del Rey A, 2006, J BIOL CHEM, V281, P35147, DOI 10.1074/jbc.M607713200; Drake MT, 2008, J BIOL CHEM, V283, P5669, DOI 10.1074/jbc.M708118200; Ecke D, 2008, BIOCHEM J, V409, P107, DOI 10.1042/BJ20070671; Ferguson SSG, 2001, PHARMACOL REV, V53, P1; Fischer W, 2005, N-S ARCH PHARMACOL, V371, P466, DOI 10.1007/s00210-005-1070-6; Flores RV, 2005, MOL CELL BIOCHEM, V280, P35, DOI 10.1007/s11010-005-8050-5; Galandrin S, 2007, TRENDS PHARMACOL SCI, V28, P423, DOI 10.1016/j.tips.2007.06.005; Garrad RC, 1998, J BIOL CHEM, V273, P29437, DOI 10.1074/jbc.273.45.29437; GILMAN AG, 1987, ANNU REV BIOCHEM, V56, P615, DOI 10.1146/annurev.bi.56.070187.003151; Hardy AR, 2005, BLOOD, V105, P3552, DOI 10.1182/blood-2004-07-2893; Herold CL, 2004, J BIOL CHEM, V279, P11456, DOI 10.1074/jbc.M301734200; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Hoffmann C, 2008, BRIT J PHARMACOL, V153, pS358, DOI 10.1038/sj.bjp.0707615; Hoffmann C, 1999, J BIOL CHEM, V274, P14639, DOI 10.1074/jbc.274.21.14639; Hoffmann C, 2004, BIOCHEM PHARMACOL, V68, P2075, DOI 10.1016/j.bcp.2004.07.014; Kenakin T, 2007, MOL PHARMACOL, V72, P1393, DOI 10.1124/mol.107.040352; Kennedy C, 2000, MOL PHARMACOL, V57, P926; Kobilka BK, 2007, TRENDS PHARMACOL SCI, V28, P397, DOI 10.1016/j.tips.2007.06.003; Kohout TA, 2003, MOL PHARMACOL, V63, P9, DOI 10.1124/mol.63.1.9; Krasel C, 2005, J BIOL CHEM, V280, P9528, DOI 10.1074/jbc.M413078200; Leftowitz RJ, 2005, SCIENCE, V308, P512, DOI 10.1126/science.1109237; LOHSE MJ, 1990, SCIENCE, V248, P1547, DOI 10.1126/science.2163110; Mayor S, 2007, NAT REV MOL CELL BIO, V8, P603, DOI 10.1038/nrm2216; Mundell SJ, 2006, TRAFFIC, V7, P1420, DOI 10.1111/j.1600-0854.2006.00469.x; Mundell SJ, 2006, MOL PHARMACOL, V70, P1132, DOI 10.1124/mol.106.023549; Nicholas RA, 1996, MOL PHARMACOL, V50, P224; Nikolaev VO, 2006, J BIOL CHEM, V281, P24506, DOI 10.1074/jbc.M603266200; Oakley RH, 2000, J BIOL CHEM, V275, P17201, DOI 10.1074/jbc.M910348199; Otero M, 2000, MOL CELL BIOCHEM, V205, P115, DOI 10.1023/A:1007018001735; Rizzo MA, 2004, NAT BIOTECHNOL, V22, P445, DOI 10.1038/nbt945; Robaye B, 1997, EUR J PHARMACOL, V329, P231, DOI 10.1016/S0014-2999(97)89184-4; Savi P, 2006, P NATL ACAD SCI USA, V103, P11069, DOI 10.1073/pnas.0510446103; Schonbrunn A, 2008, MOL CELL ENDOCRINOL, V286, P35, DOI 10.1016/j.mce.2007.09.009; Shenoy SK, 2003, BIOCHEM J, V375, P503, DOI 10.1042/BJ20031076; Sromek SM, 1998, MOL PHARMACOL, V54, P485, DOI 10.1124/mol.54.3.485; Tulapurkar ME, 2006, J NEUROCHEM, V96, P624, DOI 10.1111/j.1471-4159.2005.03594.x; Tulapurkar ME, 2004, BRIT J PHARMACOL, V142, P869, DOI 10.1038/sj.bjp.0705859; von Kugelgen I, 2006, PHARMACOL THERAPEUT, V110, P415, DOI 10.1016/j.pharmthera.2005.08.014; Wei HJ, 2003, P NATL ACAD SCI USA, V100, P10782, DOI 10.1073/pnas.1834556100; Zhang J, 1997, J BIOL CHEM, V272, P27005, DOI 10.1074/jbc.272.43.27005	46	72	74	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 7	2008	283	45					30933	30941		10.1074/jbc.M801472200	http://dx.doi.org/10.1074/jbc.M801472200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	367ID	18703513	Green Published, hybrid			2022-12-27	WOS:000260544800048
J	Lee, HJ; Park, SJ; Choi, SH; Lee, KH				Lee, Hyun-Jung; Park, Soon-Jung; Choi, Sang Ho; Lee, Kyu-Ho			Vibrio vulnificus rpoS Expression Is Repressed by Direct Binding of cAMP-cAMP Receptor Protein Complex to Its Two Promoter Regions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MONOCLONAL-ANTIBODY USEFUL; SIGMA-FACTOR SIGMA(S); ESCHERICHIA-COLI; RNA-POLYMERASE; TRANSCRIPTIONAL INDUCTION; PATHOGENIC BACTERIUM; SIGNAL-TRANSDUCTION; GENE; PSEUDOMONAS; REGULATOR	Vibrio vulnificus, a septicemia-causing pathogenic bacterium, acquires resistance against various stresses and expresses virulence factors via an rpoS gene product. In this study, we investigated the transcriptional characteristics of this global regulator. Two distinct transcriptional initiation sites for the rpoS gene, the proximal promoter (Pp) and the distal promoter (P-d), were defined by primer extension experiments. Various rpoS::luxAB transcriptional fusions indicated that Pd is a major promoter of rpoS expression. Western blot analysis showed that RpoS levels were inversely correlated with intracellular levels of 3', 5'-cyclic AMP (cAMP). The expressions of both Pd and Pp were increased in cya and crp mutants. The exogenous addition of cAMP to the cya mutant resulted in repressed expression of rpoS. In addition, rpoS expression was significantly lowered in the cpdA mutant, in which the level of cAMP was elevated because of the absence of 3', 5'-cAMP phosphodiesterase. In vitro transcription assays using the V. vulnificus RNA polymerase showed that the transcripts from both promoters were reduced by addition of the cAMP-cAMP receptor protein (CRP). The cAMP-CRP was shown to bind to two rpoS promoters by electrophoretic mobility shift assays. The alteration of the putative CRP-binding site on each rpoS promoter, via site-directed mutagenesis, abolished the binding of cAMP-CRP as well as regulation by cAMP-CRP. Therefore, this study shows a relationship between the level of intracellular cAMP and the degree of rpoS expression and further demonstrates, for the first time, the direct binding of the cAMP-CRP complex to rpoS upstream regions, which results in repression of rpoS gene expression.	[Lee, Hyun-Jung; Lee, Kyu-Ho] Hankuk Univ Foreign Studies, Dept Environm Sci, Yongin 449791, Kyunggi Do, South Korea; [Park, Soon-Jung] Yonsei Univ, Coll Med, Dept Environm Med Biol, Brain Korea Project 21, Seoul 120752, South Korea; [Park, Soon-Jung] Yonsei Univ, Coll Med, Inst Trop Med, Brain Korea Project 21, Seoul 120752, South Korea; [Choi, Sang Ho] Seoul Natl Univ, Natl Res Lab Mol Microbiol & Toxicol, Seoul 151921, South Korea; [Choi, Sang Ho] Seoul Natl Univ, Dept Agr Biotechnol, Seoul 151921, South Korea	Hankuk University Foreign Studies; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Seoul National University (SNU); Seoul National University (SNU)	Lee, KH (corresponding author), Hankuk Univ Foreign Studies, Dept Environm Sci, Yongin 449791, Kyunggi Do, South Korea.	khlee@hufs.ac.kr		Park, Soon-Jung/0000-0002-0423-1944	KOSEF [R01-2007-000-10159-0]; Ministry of Marine Affairs and Fisheries; Republic of Korea	KOSEF(Korea Science and Engineering Foundation); Ministry of Marine Affairs and Fisheries; Republic of Korea	This work was supported by Grant R01-2007-000-10159-0 (to K.-H. L.) from KOSEF and a grant from the Extreme Molecular Genomics Research Program of the Ministry of Marine Affairs and Fisheries ( to K.-H. L.), Republic of Korea. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	ARNQVIST A, 1994, MOL MICROBIOL, V13, P1021, DOI 10.1111/j.1365-2958.1994.tb00493.x; Bergendahl V, 2003, PROTEIN EXPRES PURIF, V31, P155, DOI 10.1016/S1046-5928(03)00145-1; BOTSFORD JL, 1981, MICROBIOL REV, V45, P620, DOI 10.1128/MMBR.45.4.620-642.1981; Burtnick MN, 2007, MOL MICROBIOL, V65, P277, DOI 10.1111/j.1365-2958.2007.05813.x; Busby S, 1999, J MOL BIOL, V293, P199, DOI 10.1006/jmbi.1999.3161; GENTRY DR, 1993, J BACTERIOL, V175, P7982, DOI 10.1128/JB.175.24.7982-7989.1993; Gonzalez-Gil G, 1998, EMBO J, V17, P2877, DOI 10.1093/emboj/17.10.2877; Gottesman S, 2004, ANNU REV MICROBIOL, V58, P303, DOI 10.1146/annurev.micro.58.030603.123841; Hengge-Aronis R, 2002, MICROBIOL MOL BIOL R, V66, P373, DOI 10.1128/MMBR.66.3.373-395.2002; Hengge-Aronis R, 2000, BACTERIAL STRESS RESPONSES, P161; Hirsch M, 2005, J BACTERIOL, V187, P1568, DOI 10.1128/JB.187.5.1568-1580.2005; Hulsmann A, 2003, APPL ENVIRON MICROB, V69, P6114, DOI 10.1128/AEM.69.10.6114-6120.2003; Jeong HS, 2003, J BIOL CHEM, V278, P45072, DOI 10.1074/jbc.M308184200; Jeong HS, 2001, J BIOL CHEM, V276, P13875, DOI 10.1074/jbc.M010567200; Kim YR, 2003, BIOCHEM BIOPH RES CO, V304, P405, DOI 10.1016/S0006-291X(03)00613-2; Kojic M, 2002, J BACTERIOL, V184, P2324, DOI 10.1128/JB.184.8.2324-2330.2002; LANGE R, 1995, J BACTERIOL, V177, P4676, DOI 10.1128/jb.177.16.4676-4680.1995; Latifi A, 1996, MOL MICROBIOL, V21, P1137, DOI 10.1046/j.1365-2958.1996.00063.x; Lee HJ, 2003, J BACTERIOL, V185, P5891, DOI 10.1128/JB.185.19.5891-5896.2003; Lee HJ, 2007, J BACTERIOL, V189, P2629, DOI 10.1128/JB.01791-06; Litwin CM, 2001, MICROB PATHOGENESIS, V31, P295, DOI 10.1006/mpat.2001.0472; Ma Z, 2003, J BACTERIOL, V185, P6852, DOI 10.1128/JB.185.23.6852-6859.2003; Majdalani N, 1998, P NATL ACAD SCI USA, V95, P12462, DOI 10.1073/pnas.95.21.12462; MCCANN MP, 1993, J BACTERIOL, V175, P2143, DOI 10.1128/JB.175.7.2143-2149.1993; Mika F, 2005, GENE DEV, V19, P2770, DOI 10.1101/gad.353705; MILLER VL, 1988, J BACTERIOL, V170, P2575, DOI 10.1128/JB.170.6.2575-2583.1988; Milton DL, 2006, INT J MED MICROBIOL, V296, P61, DOI 10.1016/j.ijmm.2006.01.044; Milton DL, 1996, J BACTERIOL, V178, P1310, DOI 10.1128/jb.178.5.1310-1319.1996; Mukhopadhyay S, 2000, MOL MICROBIOL, V37, P371, DOI 10.1046/j.1365-2958.2000.01999.x; NAGASAWA S, 1992, MOL MICROBIOL, V6, P799, DOI 10.1111/j.1365-2958.1992.tb01530.x; NEWLANDS JT, 1993, J BACTERIOL, V175, P661, DOI 10.1128/JB.175.3.661-668.1993; Park KJ, 2004, J MICROBIOL BIOTECHN, V14, P1063; Park KJ, 2004, J BACTERIOL, V186, P3304, DOI 10.1128/JB.186.11.3304-3312.2004; Roh JB, 2006, J BIOL CHEM, V281, P34775, DOI 10.1074/jbc.M607844200; Sambrook J., 2001, MOL CLONING LAB MANU; Schweder T, 1996, J BACTERIOL, V178, P470, DOI 10.1128/jb.178.2.470-476.1996; Strom MS, 2000, MICROBES INFECT, V2, P177, DOI 10.1016/S1286-4579(00)00270-7; Studemann A, 2003, EMBO J, V22, P4111, DOI 10.1093/emboj/cdg411; THOMPSON NE, 1992, BIOCHEMISTRY-US, V31, P7003, DOI 10.1021/bi00145a019; Ueguchi C, 2001, J BACTERIOL, V183, P520, DOI 10.1128/JB.183.2.520-527.2001; Venturi V, 2003, MOL MICROBIOL, V49, P1, DOI 10.1046/j.1365-2958.2003.03547.x	41	16	16	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 7	2008	283	45					30438	30450		10.1074/jbc.M802219200	http://dx.doi.org/10.1074/jbc.M802219200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	367ID	18713737	Green Published, hybrid			2022-12-27	WOS:000260544800002
J	Mizuno, N; Kosaka, M				Mizuno, Nobuhiko; Kosaka, Mitsuko			Novel Variants of Oct-3/4 Gene Expressed in Mouse Somatic Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EMBRYONIC STEM-CELLS; TRANSCRIPTION FACTOR; SELF-RENEWAL; POU DOMAIN; OCT4 EXPRESSION; DNA-BINDING; ES CELLS; DIFFERENTIATION; TRANSACTIVATION; ENHANCER	It has been suggested that Oct-3/4 may regulate self-renewal in somatic stem cells, as it does in embryonic stem cells. However, recent reports raise the possibility that detection of human Oct-3/4 expression by RT-PCR is prone to artifacts generated by pseudogene transcripts and argue against a role for Oct-3/4 in somatic cells. In this study, we clarified Oct-3/4 expression in mouse somatic tissues using designed PCR primers, which can exclude amplification of its pseudogenes. We found that novel alternative transcripts are indeed expressed in somatic tissues, rather than the normal length transcripts in germline and ES cells. The alternative transcripts indicate the expression of two kinds of truncated proteins. Furthermore, we determined novel promoter regions that are sufficient for the expression of Oct-3/4 transcript variants in somatic cells. These findings provide new insights into the postnatal role of Oct-3/4 in somatic tissues.	[Mizuno, Nobuhiko; Kosaka, Mitsuko] RIKEN, Res Unit Cell Plast, Ctr Dev Biol, Chuo Ku, Kobe, Hyogo 6500047, Japan; [Kosaka, Mitsuko] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Okayama 7008558, Japan	RIKEN; Okayama University	Kosaka, M (corresponding author), RIKEN, Res Unit Cell Plast, Ctr Dev Biol, Chuo Ku, Kobe, Hyogo 6500047, Japan.	m-kosaka@md.okayama-u.ac.jp	KOSAKA, Mitsuko/B-1603-2011	KOSAKA, Mitsuko/0000-0001-6146-5184	Ministry of Education, Culture, Sports, Science and Technology of Japan [19592048]	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by Grants-in-Aid to the Leading Project and 19592048 (to M.K.) from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	Ambrosetti DC, 2000, J BIOL CHEM, V275, P23387, DOI 10.1074/jbc.M000932200; Asami M, 2007, DEV BIOL, V304, P433, DOI 10.1016/j.ydbio.2006.12.047; Botquin V, 1998, GENE DEV, V12, P2073, DOI 10.1101/gad.12.13.2073; Brehm A, 1997, MOL CELL BIOL, V17, P154, DOI 10.1128/MCB.17.1.154; Cantz T, 2008, STEM CELLS, V26, P692, DOI 10.1634/stemcells.2007-0657; Deb-Rinker P, 2005, J BIOL CHEM, V280, P6257, DOI 10.1074/jbc.C400479200; Engelhardt M, 2004, EXP EYE RES, V78, P1025, DOI 10.1016/j.exer.2003.12.002; Feldman N, 2006, NAT CELL BIOL, V8, P188, DOI 10.1038/ncb1353; Gidekel S, 2003, CANCER CELL, V4, P361, DOI 10.1016/S1535-6108(03)00270-8; Hattori N, 2004, J BIOL CHEM, V279, P17063, DOI 10.1074/jbc.M309002200; Hochedlinger K, 2005, CELL, V121, P465, DOI 10.1016/j.cell.2005.02.018; Kehler J, 2004, EMBO REP, V5, P1078, DOI 10.1038/sj.embor.7400279; KOZAK M, 1983, CELL, V34, P971, DOI 10.1016/0092-8674(83)90554-8; Lee J, 2006, J BIOL CHEM, V281, P33554, DOI 10.1074/jbc.M603937200; Lengner CJ, 2007, CELL STEM CELL, V1, P403, DOI 10.1016/j.stem.2007.07.020; Liedtke S, 2007, CELL STEM CELL, V1, P364, DOI 10.1016/j.stem.2007.09.003; Lin H, 2007, BIOCHEM BIOPH RES CO, V355, P111, DOI 10.1016/j.bbrc.2007.01.106; Minucci S, 1996, EMBO J, V15, P888, DOI 10.1002/j.1460-2075.1996.tb00423.x; Nichols J, 1998, CELL, V95, P379, DOI 10.1016/S0092-8674(00)81769-9; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; Niwa H, 2002, MOL CELL BIOL, V22, P1526, DOI 10.1128/MCB.22.5.1526-1536.2002; OKAMOTO K, 1990, CELL, V60, P461, DOI 10.1016/0092-8674(90)90597-8; OKAZAWA H, 1991, EMBO J, V10, P2997, DOI 10.1002/j.1460-2075.1991.tb07850.x; Okumura-Nakanishi S, 2005, J BIOL CHEM, V280, P5307, DOI 10.1074/jbc.m410015200; Pain D, 2005, J BIOL CHEM, V280, P6265, DOI 10.1074/jbc.C400587200; Palma I, 2008, CANCER LETT, V263, P204, DOI 10.1016/j.canlet.2008.01.019; Pan GJ, 2004, J BIOL CHEM, V279, P37013, DOI 10.1074/jbc.M405117200; SCHOLER HR, 1989, EMBO J, V8, P2543, DOI 10.1002/j.1460-2075.1989.tb08392.x; SCHOLER HR, 1990, NATURE, V344, P435, DOI 10.1038/344435a0; Suo GL, 2005, BIOCHEM BIOPH RES CO, V337, P1047, DOI 10.1016/j.bbrc.2005.09.157; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; TAKEDA J, 1992, NUCLEIC ACIDS RES, V20, P4613, DOI 10.1093/nar/20.17.4613; Wei F, 2007, J BIOL CHEM, V282, P21551, DOI 10.1074/jbc.M611041200; Yasuhara N, 2007, NAT CELL BIOL, V9, P72, DOI 10.1038/ncb1521; Yeom YI, 1996, DEVELOPMENT, V122, P881	35	28	30	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 7	2008	283	45					30997	31004		10.1074/jbc.M802992200	http://dx.doi.org/10.1074/jbc.M802992200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	367ID	18765667	hybrid, Green Published			2022-12-27	WOS:000260544800054
J	Navarro, FJ; Martin, Y; Siverio, JM				Navarro, Francisco J.; Martin, Yuse; Siverio, Jose M.			Phosphorylation of the Yeast Nitrate Transporter Ynt1 Is Essential for Delivery to the Plasma Membrane during Nitrogen Limitation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMINO-ACID PERMEASE; SACCHAROMYCES-CEREVISIAE; HANSENULA-POLYMORPHA; TRYPTOPHAN PERMEASE; POSTTRANSLATIONAL REGULATION; INTRACELLULAR TRAFFICKING; EUKARYOTIC NITRATE; URACIL PERMEASE; PEP4 GENE; ASSIMILATION	Ynt1 is the sole high affinity nitrate transporter of the yeast Hansenula polymorpha. It is highly regulated by the nitrogen source, by being down-regulated in response to glutamine by repression of the YNT1 gene and Ynt1 ubiquitinylation, endocytosis, and vacuolar degradation. On the contrary, we show that nitrogen limitation stabilizes Ynt1 levels at the plasma membrane, requiring phosphorylation of the transporter. We determined that Ser-246 in the central intracellular loop plays a key role in the phosphorylation of Ynt1 and that the nitrogen permease reactivator 1 kinase (Npr1) is necessary for Ynt1 phosphorylation. Abolition of phosphorylation led Ynt1 to the vacuole by a pep12-dependent end4-independent pathway, which is also dependent on ubiquitinylation, whereas Ynt1 protein lacking ubiquitinylation sites does not follow this pathway. We found that, under nitrogen limitation, Ynt1 phosphorylation is essential for rapid induction of nitrate assimilation genes. Our results suggest that, under nitrogen limitation, phosphorylation prevents Ynt1 delivery from the secretion route to the vacuole, which, aided by reduced ubiquitinylation, accumulates Ynt1 at the plasma membrane. This mechanism could be part of the response that allows nitrate-assimilatory organisms to cope with nitrogen depletion.	[Navarro, Francisco J.; Martin, Yuse; Siverio, Jose M.] Univ La Laguna, Nitrogen Metab Grp, Dept Bioquim & Biol Mol, Inst Enfermedades Trop & Salud Publ Canarias, E-38206 Tenerife, Canarias, Spain	Universidad de la Laguna	Siverio, JM (corresponding author), Univ La Laguna, Nitrogen Metab Grp, Dept Bioquim & Biol Mol, Inst Enfermedades Trop & Salud Publ Canarias, Astrofis Fco Sanchez S-N, E-38206 Tenerife, Canarias, Spain.	jsiverio@ull.es		NAVARRO, FRANCISCO J./0000-0002-9332-0737	Ministerio de Educacion y Ciencia (MEC, Spain) [BFU2007-60172/BMC]	Ministerio de Educacion y Ciencia (MEC, Spain)(Spanish Government)	This work was supported in part by the Ministerio de Educacion y Ciencia (MEC, Spain) (Grant BFU2007-60172/BMC to J.M.S.).	Abeliovich H, 2001, MICROBIOL MOL BIOL R, V65, P463, DOI 10.1128/MMBR.65.3.463-479.2001; AMMERER G, 1986, MOL CELL BIOL, V6, P2490, DOI 10.1128/MCB.6.7.2490; Becherer KA, 1996, MOL BIOL CELL, V7, P579, DOI 10.1091/mbc.7.4.579; Beck T, 1999, J CELL BIOL, V146, P1227, DOI 10.1083/jcb.146.6.1227; Blondel MO, 2004, MOL BIOL CELL, V15, P883, DOI 10.1091/mbc.E03-04-0202; Brito N, 1999, APPL MICROBIOL BIOT, V53, P23, DOI 10.1007/s002530051609; Chen EJ, 2003, J CELL BIOL, V161, P333, DOI 10.1083/jcb.200210141; Chen EJ, 2002, P NATL ACAD SCI USA, V99, P14837, DOI 10.1073/pnas.232591899; CRAWFORD NM, 1993, ANNU REV GENET, V27, P115, DOI 10.1146/annurev.ge.27.120193.000555; CRAWFORD NM, 1995, PLANT CELL, V7, P859, DOI 10.1105/tpc.7.7.859; Crespo JL, 2002, MICROBIOL MOL BIOL R, V66, P579, DOI 10.1128/MMBR.66.4.579-591.2002; De Craene JO, 2001, J BIOL CHEM, V276, P43939, DOI 10.1074/jbc.M102944200; FABER KN, 1994, CURR GENET, V25, P305, DOI 10.1007/BF00351482; Fernandez E, 2007, J EXP BOT, V58, P2279, DOI 10.1093/jxb/erm106; Galvan A, 2001, CELL MOL LIFE SCI, V58, P225, DOI 10.1007/PL00000850; Gerrard SR, 2000, TRAFFIC, V1, P259, DOI 10.1034/j.1600-0854.2000.010308.x; Helliwell SB, 2001, J CELL BIOL, V153, P649, DOI 10.1083/jcb.153.4.649; Hicke L, 1998, J CELL BIOL, V141, P349, DOI 10.1083/jcb.141.2.349; Ingrell CR, 2007, BIOINFORMATICS, V23, P895, DOI 10.1093/bioinformatics/btm020; Liu KH, 2003, EMBO J, V22, P1005, DOI 10.1093/emboj/cdg118; Llamas A, 2002, PLANT J, V30, P261, DOI 10.1046/j.1365-313X.2002.01281.x; Machin F, 2004, YEAST, V21, P265, DOI 10.1002/yea.1075; Magasanik B, 2002, GENE, V290, P1, DOI 10.1016/S0378-1119(02)00558-9; Marchal C, 1998, MOL CELL BIOL, V18, P314, DOI 10.1128/MCB.18.1.314; MARZLUF GA, 1993, ANNU REV MICROBIOL, V47, P31, DOI 10.1146/annurev.micro.47.1.31; Miller AJ, 2007, J EXP BOT, V58, P2297, DOI 10.1093/jxb/erm066; Montanini B, 2006, BIOCHEM J, V394, P125, DOI 10.1042/BJ20051199; Navarro FJ, 2006, J BIOL CHEM, V281, P13268, DOI 10.1074/jbc.M601253200; Navarro FJ, 2003, FEMS YEAST RES, V4, P149, DOI 10.1016/S1567-1356(03)00163-6; Perez MD, 1997, BIOCHEM J, V321, P397, DOI 10.1042/bj3210397; RATHS S, 1993, J CELL BIOL, V120, P55, DOI 10.1083/jcb.120.1.55; Roberg KJ, 1997, J CELL BIOL, V137, P1469, DOI 10.1083/jcb.137.7.1469; Schmidt A, 1998, EMBO J, V17, P6924, DOI 10.1093/emboj/17.23.6924; Siverio JM, 2002, FEMS MICROBIOL REV, V26, P277, DOI 10.1016/S0168-6445(02)00100-6; Soetens O, 2001, J BIOL CHEM, V276, P43949, DOI 10.1074/jbc.M102945200; Umebayashi K, 2003, J CELL BIOL, V161, P1117, DOI 10.1083/jcb.200303088; Wang Y, 2007, NEW PHYTOL, V175, P699, DOI 10.1111/j.1469-8137.2007.02135.x; Wirth J, 2007, J BIOL CHEM, V282, P23541, DOI 10.1074/jbc.M700901200; WOOLFORD CA, 1986, MOL CELL BIOL, V6, P2500, DOI 10.1128/MCB.6.7.2500	39	23	24	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 7	2008	283	45					31208	31217		10.1074/jbc.M802170200	http://dx.doi.org/10.1074/jbc.M802170200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	367ID	18713738	Green Published, hybrid			2022-12-27	WOS:000260544800074
J	Beran, RKF; Pyle, AM				Beran, Rudolf K. F.; Pyle, Anna Marie			Hepatitis C Viral NS3-4A Protease Activity Is Enhanced by the NS3 Helicase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SERINE-PROTEASE; CRYSTAL-STRUCTURE; ADAPTER PROTEIN; VIRUS; RNA; DOMAIN; NS4A; IDENTIFICATION; TRANSLOCATION; INHIBITORS	Non-structural protein 3 (NS3) is a multifunctional enzyme possessing serine protease, NTPase, and RNA unwinding activities that are required for hepatitis C viral (HCV) replication. HCV non-structural protein 4A (NS4A) binds to the N-terminal NS3 protease domain to stimulate NS3 serine protease activity. In addition, the NS3 protease domain enhances the RNA binding, ATPase, and RNA unwinding activities of the C-terminal NS3 helicase domain (NS3hel). To determine whether NS3hel enhances the NS3 serine protease activity, we purified truncated and full-length NS3-4A complexes and examined their serine protease activities under a variety of salt and pH conditions. Our results indicate that the helicase domain enhances serine protease activity, just as the protease domain enhances helicase activity. Thus, the two enzymatic domains of NS3-4A are highly interdependent. This is the first time that such a complete interdependence has been demonstrated for a multifunctional, single chain enzyme. NS3-4A domain interdependence has important implications for function during the viral lifecycle as well as for the design of inhibitor screens that target the NS3-4A protease.	[Beran, Rudolf K. F.; Pyle, Anna Marie] Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA; [Pyle, Anna Marie] Yale Univ, Howard Hughes Med Inst, New Haven, CT 06520 USA	Yale University; Howard Hughes Medical Institute; Yale University	Pyle, AM (corresponding author), Yale Univ, Dept Mol Biophys & Biochem, 266 Whitney Ave,Bass Bldg,Rm 334, New Haven, CT 06520 USA.	anna.pyle@yale.edu			National Institutes of Health [GM60620]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM060620, F32GM071120] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM60620. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	BARTENSCHLAGER R, 1995, J VIROL, V69, P7519, DOI 10.1128/JVI.69.12.7519-7528.1995; Beran RKF, 2007, J BIOL CHEM, V282, P34913, DOI 10.1074/jbc.M707165200; Beran RKF, 2006, J MOL BIOL, V358, P974, DOI 10.1016/j.jmb.2006.02.078; Binder M, 2007, J VIROL, V81, P5270, DOI 10.1128/JVI.00032-07; Copeland R. A., 2005, EVALUATION ENZYME IN; Dahl G, 2007, ANTIVIR THER, V12, P733; de la Cruz J, 1999, TRENDS BIOCHEM SCI, V24, P192, DOI 10.1016/S0968-0004(99)01376-6; Dimasi N, 1997, J VIROL, V71, P7461, DOI 10.1128/JVI.71.10.7461-7469.1997; FAILLA C, 1994, J VIROL, V68, P3753, DOI 10.1128/JVI.68.6.3753-3760.1994; Frick DN, 2004, J BIOL CHEM, V279, P1269, DOI 10.1074/jbc.M310630200; Gallinari P, 1999, BIOCHEMISTRY-US, V38, P5620, DOI 10.1021/bi982892+; Ikeda M, 2002, J VIROL, V76, P2997, DOI 10.1128/JVI.76.6.2997-3006.2002; Jankowsky E, 2007, CURR OPIN STRUC BIOL, V17, P316, DOI 10.1016/j.sbi.2007.05.007; Kawai T, 2005, NAT IMMUNOL, V6, P981, DOI 10.1038/ni1243; Kim JL, 1996, CELL, V87, P343, DOI 10.1016/S0092-8674(00)81351-3; Kim YI, 2000, MOL CELL, V5, P639, DOI 10.1016/S1097-2765(00)80243-9; Lam AMI, 2006, J VIROL, V80, P404, DOI 10.1128/JVI.80.1.404-411.2006; Lam AMI, 2004, NUCLEIC ACIDS RES, V32, P4060, DOI 10.1093/nar/gkh743; Lamarre D, 2003, NATURE, V426, P186, DOI 10.1038/nature02099; Li SJ, 1999, NATURE, V398, P246, DOI 10.1038/18457; Lin C, 2004, J BIOL CHEM, V279, P17508, DOI 10.1074/jbc.M313020200; Lohmann V, 1999, SCIENCE, V285, P110, DOI 10.1126/science.285.5424.110; Mao SS, 2008, ANAL BIOCHEM, V373, P1, DOI 10.1016/j.ab.2007.10.041; Meylan E, 2005, NATURE, V437, P1167, DOI 10.1038/nature04193; Ortega J, 2000, MOL CELL, V6, P1515, DOI 10.1016/S1097-2765(00)00148-9; Pang PS, 2002, EMBO J, V21, P1168, DOI 10.1093/emboj/21.5.1168; Sali DL, 1998, BIOCHEMISTRY-US, V37, P3392, DOI 10.1021/bi972010r; Seth RB, 2005, CELL, V122, P669, DOI 10.1016/j.cell.2005.08.012; Shimizu Y, 1996, J VIROL, V70, P127, DOI 10.1128/JVI.70.1.127-132.1996; Singh SK, 2000, P NATL ACAD SCI USA, V97, P8898, DOI 10.1073/pnas.97.16.8898; Steinkuhler C, 1996, J BIOL CHEM, V271, P6367, DOI 10.1074/jbc.271.11.6367; SUZICH JA, 1993, J VIROL, V67, P6152, DOI 10.1128/JVI.67.10.6152-6158.1993; Taliani M, 1996, ANAL BIOCHEM, V240, P60, DOI 10.1006/abio.1996.0331; Thibeault D, 2004, J VIROL, V78, P7352, DOI 10.1128/JVI.78.14.7352-7359.2004; Wang WY, 2004, J VIROL, V78, P700, DOI 10.1128/JVI.78.2.700-709.2004; Xu LG, 2005, MOL CELL, V19, P727, DOI 10.1016/j.molcel.2005.08.014; Yao NH, 1999, STRUCTURE, V7, P1353, DOI 10.1016/S0969-2126(00)80025-8; Yi MK, 2007, J VIROL, V81, P629, DOI 10.1128/JVI.01890-06; Zhang C, 2005, J VIROL, V79, P8687, DOI 10.1128/JVI.79.14.8687-8697.2005	39	82	84	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 31	2008	283	44					29929	29937		10.1074/jbc.M804065200	http://dx.doi.org/10.1074/jbc.M804065200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	364WS	18723512	hybrid, Green Published			2022-12-27	WOS:000260366900038
J	Pagliaccetti, NE; Eduardo, R; Kleinstein, SH; Mu, XJ; Bandi, P; Robek, MD				Pagliaccetti, Nicole E.; Eduardo, Roger; Kleinstein, Steven H.; Mu, Xinmeng Jasmine; Bandi, Prasanthi; Robek, Michael D.			Interleukin-29 Functions Cooperatively with Interferon to Induce Antiviral Gene Expression and Inhibit Hepatitis C Virus Replication	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IFN-LAMBDA; SIGNAL-TRANSDUCTION; RESPONSE ELEMENT; RNA REPLICATION; GAMMA; ALPHA; INFECTION; CELLS; TRANSCRIPTION; SYSTEM	The interferon (IFN)-related cytokine interleukin (IL)-29 (also known as IFN-lambda 1) inhibits virus replication by inducing a cellular antiviral response similar to that activated by IFN-alpha/beta. However, because it binds to a unique receptor, this cytokine may function cooperatively with IFN-alpha/beta or IFN-gamma during natural infections to inhibit virus replication, and might also be useful therapeutically in combination with other cytokines to treat chronic viral infections such as hepatitis C (HCV). We therefore investigated the ability of IL-29 and IFN-alpha or IFN-gamma to cooperatively inhibit virus replication and induce antiviral gene expression. Compared with the individual cytokines alone, the combination of IL-29 with IFN-alpha or IFN-gamma was more effective at blocking vesicular stomatitis virus and HCV replication, and this cooperative antiviral activity correlated with the magnitude of induced antiviral gene expression. Although the combined effects of IL-29 and IFN-alpha were primarily additive, the IL-29/IFN-gamma combination synergistically induced multiple genes and had the greatest antiviral activity. Two different mechanisms contributed to the enhanced gene expression induced by the cytokine combinations: increased activation of ISRE promoter elements and simultaneous activation of both ISRE and GAS elements within the same promoter. These findings provide new insight into the coregulation of a critical innate immune response by functionally distinct cytokine families.	[Pagliaccetti, Nicole E.; Eduardo, Roger; Kleinstein, Steven H.; Mu, Xinmeng Jasmine; Bandi, Prasanthi; Robek, Michael D.] Yale Univ, Sch Med, Dept Pathol, New Haven, CT 06510 USA; [Kleinstein, Steven H.] Yale Univ, Sch Med, Interdept Program Computat Biol & Bioinformat, New Haven, CT 06510 USA	Yale University; Yale University	Robek, MD (corresponding author), POB 208023,310 Cedar St,LH315A, New Haven, CT 06520 USA.	michael.robek@yale.edu	Mu, Xinmeng/P-2562-2016	Mu, Xinmeng/0000-0002-8079-0828	National Institutes of Health Training [AI055403]; Anna Fuller Fund; United States Public Health Service [K22 AI064757]; Northeast Biodefense Center [U54-AI057158-Lipkin]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI055403, U54AI057158, K22AI064757] Funding Source: NIH RePORTER	National Institutes of Health Training(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Anna Fuller Fund; United States Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); Northeast Biodefense Center; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Supported by National Institutes of Health Training Grant AI055403 and a fellowship from the Anna Fuller Fund.; Supported by United States Public Health Service Grant K22 AI064757 and a career development award from the Northeast Biodefense Center (U54-AI057158-Lipkin). To whom correspondence should be addressed: P.O. Box 208023, 310 Cedar St., LH315A, New Haven, CT 06520-8023. Tel.: 203785- 6174; Fax: 203-785-6127; E-mail: michael.robek@yale.edu.	Ank N, 2006, J VIROL, V80, P4501, DOI 10.1128/JVI.80.9.4501-4509.2006; Ank N, 2008, J IMMUNOL, V180, P2474, DOI 10.4049/jimmunol.180.4.2474; Barash Y., 2001, Algorithms in Bioinformatics. First International Workshop, WABI 2001. Proceedings (Lecture Notes in Computer Science Vol.2149), P278; Blight KJ, 2000, SCIENCE, V290, P1972, DOI 10.1126/science.290.5498.1972; BLUYSSEN HAR, 1995, P NATL ACAD SCI USA, V92, P5645, DOI 10.1073/pnas.92.12.5645; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Brand S, 2005, BIOCHEM BIOPH RES CO, V331, P543, DOI 10.1016/j.bbrc.2005.04.004; Coccia EM, 2004, EUR J IMMUNOL, V34, P796, DOI 10.1002/eji.200324610; DECKER T, 1991, MOL CELL BIOL, V11, P5147, DOI 10.1128/MCB.11.10.5147; Donnelly RP, 2004, J LEUKOCYTE BIOL, V76, P314, DOI 10.1189/jlb.0204117; DONOFRIO C, 1992, INT J IMMUNOPHARMACO, V14, P1069, DOI 10.1016/0192-0561(92)90152-B; Doyle SE, 2006, HEPATOLOGY, V44, P896, DOI 10.1002/hep.21312; Dumoutier L, 2004, J BIOL CHEM, V279, P32269, DOI 10.1074/jbc.M404789200; Fuchizaki U, 2003, J MED VIROL, V69, P188, DOI 10.1002/jmv.10286; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Itsui Y, 2006, J VIRAL HEPATITIS, V13, P690, DOI 10.1111/j.1365-2893.2006.00732.x; Jiang D, 2008, J VIROL, V82, P1665, DOI 10.1128/JVI.02113-07; Kapadia SB, 2005, P NATL ACAD SCI USA, V102, P2561, DOI 10.1073/pnas.0409834102; Kennedy RE, 2006, BIOINFORMATICS, V22, P1272, DOI 10.1093/bioinformatics/btl108; Kennedy RE, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-154; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; KHAN KD, 1993, P NATL ACAD SCI USA, V90, P6806, DOI 10.1073/pnas.90.14.6806; Kotenko SV, 2003, NAT IMMUNOL, V4, P69, DOI 10.1038/ni875; Kroger A, 2002, J INTERF CYTOK RES, V22, P5, DOI 10.1089/107999002753452610; Larkin J, 2003, J INTERF CYTOK RES, V23, P247, DOI 10.1089/107999003321829962; Lasfar A, 2006, CANCER RES, V66, P4468, DOI 10.1158/0008-5472.CAN-05-3653; LEVY DE, 1988, GENE DEV, V2, P383, DOI 10.1101/gad.2.4.383; Marcello T, 2006, GASTROENTEROLOGY, V131, P1887, DOI 10.1053/j.gastro.2006.09.052; Meager A, 2005, CYTOKINE, V31, P109, DOI 10.1016/j.cyto.2005.04.003; OHMORI Y, 1993, J BIOL CHEM, V268, P6677; Okuse C, 2005, ANTIVIR RES, V65, P23, DOI 10.1016/j.antiviral.2004.09.002; Pierce AT, 2005, J GEN VIROL, V86, P2421, DOI 10.1099/vir.0.80979-0; Poynard T, 2003, LANCET, V362, P2095, DOI 10.1016/S0140-6736(03)15109-4; PRICHARD MN, 1990, ANTIVIR RES, V14, P181, DOI 10.1016/0166-3542(90)90001-N; Ramsburg E, 2005, J VIROL, V79, P15043, DOI 10.1128/JVI.79.24.15043-15053.2005; Randall G, 2006, GASTROENTEROLOGY, V131, P1584, DOI 10.1053/j.gastro.2006.08.043; REID LE, 1989, P NATL ACAD SCI USA, V86, P840, DOI 10.1073/pnas.86.3.840; Robek MD, 2005, J VIROL, V79, P3851, DOI 10.1128/JVI.79.6.3851-3854.2005; RUBINSTEIN S, 1981, J VIROL, V37, P755, DOI 10.1128/JVI.37.2.755-758.1981; Sainz B, 2002, J VIROL, V76, P11541, DOI 10.1128/JVI.76.22.11541-11550.2002; Sainz B, 2005, VIROL J, V2, DOI 10.1186/1743-422X-2-14; Sheppard P, 2003, NAT IMMUNOL, V4, P63, DOI 10.1038/ni873; Shuai K, 2003, NAT REV IMMUNOL, V3, P900, DOI 10.1038/nri1226; Sommereyns C, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000017; Stark GR, 1998, ANNU REV BIOCHEM, V67, P227, DOI 10.1146/annurev.biochem.67.1.227; Stoltz M, 2007, J VIROL, V81, P8685, DOI 10.1128/JVI.00415-07; Taniguchi T, 2001, ANNU REV IMMUNOL, V19, P623, DOI 10.1146/annurev.immunol.19.1.623; van den Pol AN, 2007, J VIROL, V81, P332, DOI 10.1128/JVI.01592-06; Verna Elizabeth C, 2006, Clin Liver Dis, V10, P919; Wesoly J, 2007, ACTA BIOCHIM POL, V54, P27, DOI 10.18388/abp.2007_3266; *WHO, 2000, WEEKLY EPIDEMIOLOGIC, V74, P421; Zhu HZ, 2005, VIROL J, V2, DOI 10.1186/1743-422X-2-80; Zhu HZ, 2004, BIOCHEM BIOPH RES CO, V324, P518, DOI 10.1016/j.bbrc.2004.09.081; Zhu HZ, 2003, HEPATOLOGY, V37, P1180, DOI 10.1053/jhep.2003.50184	54	79	88	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 31	2008	283	44					30079	30089		10.1074/jbc.M804296200	http://dx.doi.org/10.1074/jbc.M804296200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	364WS	18757365	hybrid, Green Published			2022-12-27	WOS:000260366900053
J	Schneider, S; Sandalova, T; Schneider, G; Sprenger, GA; Samland, AK				Schneider, Sarah; Sandalova, Tatyana; Schneider, Gunter; Sprenger, Georg A.; Samland, Anne K.			Replacement of a Phenylalanine by a Tyrosine in the Active Site Confers Fructose-6-phosphate Aldolase Activity to the Transaldolase of Escherichia coli and Human Origin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SCHIFF-BASE INTERMEDIATE; CLASS-I ALDOLASE; SATURATION MUTAGENESIS; CRYSTAL-STRUCTURE; SUBSTRATE-SPECIFICITY; EXPRESSION; DEFICIENCY; CLONING; INACTIVATION; EFFICIENT	Based on a structure-assisted sequence alignment we designed 11 focused libraries at residues in the active site of transaldolase B from Escherichia coli and screened them for their ability to synthesize fructose 6-phosphate from dihydroxyacetone and glyceraldehyde 3-phosphate using a newly developed color assay. We found one positive variant exhibiting a replacement of Phe(178) to Tyr. This mutant variant is able not only to transfer a dihydroxyacetone moiety from a ketose donor, fructose 6-phosphate, onto an aldehyde acceptor, erythrose 4-phosphate (14 units/mg), but to use it as a substrate directly in an aldolase reaction (7 units/mg). With a single amino acid replacement the fructose-6-phosphate aldolase activity was increased considerably (> 70-fold compared with wild-type). Structural studies of the wild-type and mutant protein suggest that this is due to a different H-bond pattern in the active site leading to a destabilization of the Schiff base intermediate. Furthermore, we show that a homologous replacement has a similar effect in the human transaldolase Taldo1 (aldolase activity, 14 units/mg). We also demonstrate that both enzymes TalB and Taldo1 are recognized by the same polyclonal antibody.	[Schneider, Sarah; Sprenger, Georg A.; Samland, Anne K.] Univ Stuttgart, Inst Microbiol, D-70550 Stuttgart, Germany; [Sandalova, Tatyana; Schneider, Gunter] Karolinska Inst, Dept Med Biochem & Biophys, Div Mol Struct Biol, S-17177 Stockholm, Sweden	University of Stuttgart; Karolinska Institutet	Samland, AK (corresponding author), Allmandring 31, D-70550 Stuttgart, Germany.	anne.samland@imb.uni-stuttgart.de	Sprenger, Georg A./E-2384-2011	Sprenger, Georg A./0000-0002-7879-8978; Schneider, Gunter/0000-0003-0622-5713; Sandalova, Tatyana/0000-0002-7694-6420	Deutsche Forschungsgemeinschaft [SPP1170/Sp503/4-2]; Swedish Research Council	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Swedish Research Council(Swedish Research CouncilEuropean Commission)	This work was supported by Deutsche Forschungsgemeinschaft Grant SPP1170/Sp503/4-2 (to G. Sprenger) and a grant from the Swedish Research Council (to G. Schneider). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Amiss TJ, 2007, PROTEIN SCI, V16, P2350, DOI 10.1110/ps.073119507; Ang EL, 2007, FEBS J, V274, P928, DOI 10.1111/j.1742-4658.2007.05638.x; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BANKI K, 1994, J BIOL CHEM, V269, P2847; Banki K, 1996, FEBS LETT, V378, P161, DOI 10.1016/0014-5793(95)01446-2; BANKI K, 1994, J EXP MED, V180, P1649, DOI 10.1084/jem.180.5.1649; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Briggs GE, 1925, BIOCHEM J, V19, P338, DOI 10.1042/bj0190338; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Esposito M, 1999, J IMMUNOL, V163, P4027; Fujii K, 2005, APPL ENVIRON MICROB, V71, P5823, DOI 10.1128/AEM.71.10.5823-5827.2005; FURSTE JP, 1986, GENE, V48, P119, DOI 10.1016/0378-1119(86)90358-6; Gefflaut T, 1995, PROG BIOPHYS MOL BIO, V63, P301, DOI 10.1016/0079-6107(95)00008-9; GEORGESCU R, 2003, DIRECTED EVOLUTION L; Grossman CE, 2004, BIOCHEM J, V382, P725, DOI 10.1042/BJ20040413; Hayashi K, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100049; INOUE T, 2006, THESIS U STUTTGART S; Jager SAW, 2008, J BIOTECHNOL, V133, P18, DOI 10.1016/j.jbiotec.2007.08.039; Jia J, 1996, STRUCTURE, V4, P715, DOI 10.1016/S0969-2126(96)00077-9; Jia J, 1997, PROTEIN SCI, V6, P119; Kohler U, 1996, PLANT MOL BIOL, V30, P213, DOI 10.1007/BF00017817; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Novy R., 2001, INNOVATIONS, V12, P1; Parikh MR, 2005, J MOL BIOL, V352, P621, DOI 10.1016/j.jmb.2005.07.020; PARKS TD, 1995, VIROLOGY, V210, P194, DOI 10.1006/viro.1995.1331; Perl A, 2006, P NATL ACAD SCI USA, V103, P14813, DOI 10.1073/pnas.0602678103; Remm M, 2001, J MOL BIOL, V314, P1041, DOI 10.1006/jmbi.2000.5197; ROSENBERG AH, 1987, GENE, V56, P125, DOI 10.1016/0378-1119(87)90165-X; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; Schmidt S, 1999, MULT SCLER J, V5, P147, DOI 10.1177/135245859900500303; Schneider G, 2002, METHOD ENZYMOL, V354, P197; Schorken U, 1998, FEBS LETT, V441, P247, DOI 10.1016/S0014-5793(98)01521-X; Schorken U, 2001, EUR J BIOCHEM, V268, P2408, DOI 10.1046/j.1432-1327.2001.02128.x; Schurmann M, 2002, J MOL CATAL B-ENZYM, V19, P247, DOI 10.1016/S1381-1177(02)00174-1; Schurmann M, 2001, J BIOL CHEM, V276, P11055, DOI 10.1074/jbc.M008061200; SPRENGER GA, 1995, J BACTERIOL, V177, P5930, DOI 10.1128/jb.177.20.5930-5936.1995; Thorell S, 2000, FEBS LETT, V475, P205, DOI 10.1016/S0014-5793(00)01658-6; Thorell S, 2002, J MOL BIOL, V319, P161, DOI 10.1016/S0022-2836(02)00258-9; TSOLAS O, 1972, ENZYMES; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Valayannopoulos V, 2006, J PEDIATR-US, V149, P713, DOI 10.1016/j.jpeds.2006.08.016; Verhoeven NM, 2005, J INHERIT METAB DIS, V28, P169, DOI 10.1007/s10545-005-5261-6; Verhoeven NM, 2001, AM J HUM GENET, V68, P1086, DOI 10.1086/320108; Williams GJ, 2005, PROTEIN ENG DES SEL, V18, P239, DOI 10.1093/protein/gzi027	46	42	44	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 31	2008	283	44					30064	30072		10.1074/jbc.M803184200	http://dx.doi.org/10.1074/jbc.M803184200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	364WS	18687684	hybrid, Green Published			2022-12-27	WOS:000260366900051
J	Chen, GI; Tisayakorn, S; Jorgensen, C; D'Ambrosio, LM; Goudreault, M; Gingras, AC				Chen, Ginny I.; Tisayakorn, Sally; Jorgensen, Claus; D'Ambrosio, Lisa M.; Goudreault, Marilyn; Gingras, Anne-Claude			PP4R4/KIAA1622 Forms a Novel Stable Cytosolic Complex with Phosphoprotein Phosphatase 4	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN PHOSPHATASE; CATALYTIC SUBUNIT; PPP2R1B GENE; 2A; PURIFICATION; PP2A; IDENTIFICATION; REARRANGEMENTS; ORGANIZATION; H4(D10S170)	Protein serine/threonine phosphatase 4 (PP4c) is an essential polypeptide involved in critical cellular processes such as microtubule growth and organization, DNA damage checkpoint recovery, apoptosis, and tumor necrosis factor alpha signaling. Like other phosphatases of the PP2A family, PP4c interacts with regulatory proteins, which specify substrate targeting and intracellular localization. The identification of these regulatory proteins is, therefore, key to fully understanding the function of this enzyme class. Here, using a sensitive affinity purification/mass spectrometry approach, we identify a novel, stable cytosolic PP4c interacting partner, KIAA1622, which we have renamed PP4R4. PP4R4 displays weak sequence homology with the A (scaffolding) subunit of the PP2A holoenzyme and specifically associates with PP4c (and not with the related PP2Ac or PP6c phosphatases). The PP4c.PP4R4 interaction is disrupted by mutations analogous to those abrogating the association of PP2Ac with PP2A A subunit. However, unlike the PP2A A subunit, which plays a scaffolding role, PP4R4 does not bridge PP4c with previously characterized PP4 regulatory subunits. PP4c.PP4R4 complexes exhibit phosphatase activity toward a fluorogenic substrate and gamma H2AX, but this activity is lower than that associated with the PP4c.PP4R2.PP4R3 complex, which itself is less active than the free PP4c catalytic subunit. Our data demonstrate that PP4R4 forms a novel cytosolic complex with PP4c, independent from the complexes containing PP4R1, PP4R2.PP4R3, and alpha 4, and that the regulatory subunits of PP4c have evolved different modes of interaction with the catalytic subunit.	[Chen, Ginny I.; Tisayakorn, Sally; Jorgensen, Claus; D'Ambrosio, Lisa M.; Goudreault, Marilyn; Gingras, Anne-Claude] Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M4M 2Y8, Canada; [Chen, Ginny I.; Tisayakorn, Sally; D'Ambrosio, Lisa M.; Gingras, Anne-Claude] Univ Toronto, Dept Mol Genet, Toronto, ON M5S 1A8, Canada	University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto	Gingras, AC (corresponding author), Mt Sinai Hosp, Samuel Lunenfeld Res Inst, 600 Univ Ave,Rm 992, Toronto, ON M4M 2Y8, Canada.	gingras@mshri.on.ca	Gingras, Anne-Claude/E-9982-2010; Gingras, Anne-Claude/ABA-8341-2020	Gingras, Anne-Claude/0000-0002-6090-4437; Gingras, Anne-Claude/0000-0002-6090-4437; Jorgensen, Claus/0000-0002-7841-943X	Terry Fox Foundation; National Cancer Institute of Canada	Terry Fox Foundation; National Cancer Institute of Canada(Canadian Cancer Society (CCS))	This work was supported in part by a grant from the Terry Fox Foundation and the National Cancer Institute of Canada (to A. C. G.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked " advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Andrade MA, 2000, J MOL BIOL, V298, P521, DOI 10.1006/jmbi.2000.3684; ANDRADE MA, 1995, NAT GENET, V11, P115, DOI 10.1038/ng1095-115; BREWIS ND, 1992, BIOCHIM BIOPHYS ACTA, V1171, P231, DOI 10.1016/0167-4781(92)90129-N; BREWIS ND, 1993, EMBO J, V12, P987, DOI 10.1002/j.1460-2075.1993.tb05739.x; Carnegie GK, 2003, J CELL SCI, V116, P1905, DOI 10.1242/jcs.00409; Celetti A, 2004, ONCOGENE, V23, P109, DOI 10.1038/sj.onc.1206981; Chen GI, 2007, METHODS, V42, P298, DOI 10.1016/j.ymeth.2007.02.018; Chen J, 1998, BIOCHEM BIOPH RES CO, V247, P827, DOI 10.1006/bbrc.1998.8792; Cho US, 2007, NATURE, V445, P53, DOI 10.1038/nature05351; Chowdhury D, 2008, MOL CELL, V31, P33, DOI 10.1016/j.molcel.2008.05.016; Cohen PTW, 2005, FEBS LETT, V579, P3278, DOI 10.1016/j.febslet.2005.04.070; Drechsler M, 2007, ANN HEMATOL, V86, P353, DOI 10.1007/s00277-006-0247-5; Ewing RM, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100134; Forester CM, 2007, P NATL ACAD SCI USA, V104, P19867, DOI 10.1073/pnas.0709879104; Gingras AC, 2005, MOL CELL PROTEOMICS, V4, P1725, DOI 10.1074/mcp.M500231-MCP200; Gingras AC, 2007, NAT REV MOL CELL BIO, V8, P645, DOI 10.1038/nrm2208; GRIECO M, 1994, ONCOGENE, V9, P2531; Hastie CJ, 2006, FEBS J, V273, P3322, DOI 10.1111/j.1742-4658.2006.05336.x; Hastie CJ, 1998, FEBS LETT, V431, P357, DOI 10.1016/S0014-5793(98)00775-3; Hastie CJ, 2000, BIOCHEM J, V347, P845, DOI 10.1042/0264-6021:3470845; Helps NR, 1998, J CELL SCI, V111, P1331; Hombauer H, 2007, PLOS BIOL, V5, P1355, DOI 10.1371/journal.pbio.0050155; Huang RY, 2005, CANCER RES, V65, P5890, DOI 10.1158/0008-5472.CAN-04-4093; Inui S, 1998, BLOOD, V92, P539, DOI 10.1182/blood.V92.2.539.414k23_539_546; Janssens V, 2005, CURR OPIN GENET DEV, V15, P34, DOI 10.1016/j.gde.2004.12.004; Janssens V, 2001, BIOCHEM J, V353, P417, DOI 10.1042/0264-6021:3530417; Keogh MC, 2006, NATURE, V439, P497, DOI 10.1038/nature04384; Kikuno R, 2004, NUCLEIC ACIDS RES, V32, pD502, DOI 10.1093/nar/gkh035; Kloeker S, 1999, J BIOL CHEM, V274, P5339, DOI 10.1074/jbc.274.9.5339; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; Margolis SS, 2006, CELL, V127, P759, DOI 10.1016/j.cell.2006.10.035; Merolla F, 2007, ONCOGENE, V26, P6167, DOI 10.1038/sj.onc.1210446; Mumby M, 2007, CELL, V130, P21, DOI 10.1016/j.cell.2007.06.034; Nagase T, 2000, DNA RES, V7, P273; NAKADA S, 2008, EMBO REP IN PRESS; Puxeddu E, 2005, MUTAT RES-FUND MOL M, V570, P17, DOI 10.1016/j.mrfmmm.2004.09.010; Ruediger R, 2001, ONCOGENE, V20, P1892, DOI 10.1038/sj.onc.1204279; Shi YS, 2006, MOL CELL, V23, P819, DOI 10.1016/j.molcel.2006.07.022; Shui JW, 2007, MOL CELL BIOL, V27, P79, DOI 10.1128/MCB.00799-06; Takagi Y, 2000, GUT, V47, P268, DOI 10.1136/gut.47.2.268; Thierry-Mieg D, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-s1-s12; Toyo-oka K, 2008, J CELL BIOL, V180, P1133, DOI 10.1083/jcb.200705148; USUI H, 1988, J BIOL CHEM, V263, P3752; Wada T, 2001, J AM SOC NEPHROL, V12, P2601, DOI 10.1681/ASN.V12122601; Wang SS, 1998, SCIENCE, V282, P284, DOI 10.1126/science.282.5387.284; Whalen SG, 1996, J BIOL CHEM, V271, P11831, DOI 10.1074/jbc.271.20.11831; Wheeler DL, 2003, NUCLEIC ACIDS RES, V31, P28, DOI 10.1093/nar/gkg033; Xu YH, 2006, CELL, V127, P1239, DOI 10.1016/j.cell.2006.11.033; Zhang XH, 2005, GENE DEV, V19, P827, DOI 10.1101/gad.1286005; Zhou GS, 2002, J BIOL CHEM, V277, P6391, DOI 10.1074/jbc.M107014200; Zhou ZL, 1998, EMBO J, V17, P2095, DOI 10.1093/emboj/17.7.2095	51	62	66	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 24	2008	283	43					29273	29284		10.1074/jbc.M803443200	http://dx.doi.org/10.1074/jbc.M803443200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	362EB	18715871	Green Published, hybrid			2022-12-27	WOS:000260179900054
J	Asiedu, M; Wu, D; Matsumura, F; Wei, QZ				Asiedu, Michael; Wu, Di; Matsumura, Fumio; Wei, Qize			Phosphorylation of MyoGEF on Thr-574 by Plk1 promotes MyoGEF localization to the central spindle	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLO-LIKE KINASE-1; CULTURED EPITHELIAL-CELLS; SMALL-MOLECULE INHIBITOR; BOX DOMAIN; CONTRACTILE RING; CYTOKINESIS; RHOA; ECT2; ACTIVATION; POLO-LIKE-KINASE-1	We reported previously that a guanine nucleotide exchange factor, MyoGEF, localizes to the central spindle, activates RhoA, and is required for cytokinesis. In this study, we have found that Plk1 (polo-like kinase 1) can phosphorylate MyoGEF, thereby recruiting MyoGEF to the central spindle as well as enhancing MyoGEF activity toward RhoA. The in vitro kinase assay shows that Plk1 can phosphorylate MyoGEF on threonine 574. Immunoprecipitation/immunoblot analysis demonstrates that mutation of threonine 574 to alanine dramatically decreases threonine phosphorylation of MyoGEF in transfected HeLa cells, suggesting that threonine 574 is phosphorylated in vivo. Consistent with these observations, immunofluorescence shows that Plk1 and MyoGEF colocalize at the spindle pole and central spindle during mitosis and cytokinesis. Importantly, RNA interference-mediated depletion of Plk1 interferes with the localization of MyoGEF at the spindle pole and central spindle. Moreover, mutation of threonine 574 to alanine in MyoGEF or depletion of Plk1 by RNA interference leads to a decrease in MyoGEF activity toward RhoA in HeLa cells. Therefore, our results suggest that Plk1 can regulate MyoGEF activity and localization, contributing to the regulation of cytokinesis.	[Asiedu, Michael; Wu, Di; Wei, Qize] Kansas State Univ, Dept Biochem, Manhattan, KS 66506 USA; [Matsumura, Fumio] Rutgers State Univ, Dept Mol Biol & Biochem, Piscataway, NJ 08855 USA	Kansas State University; Rutgers State University New Brunswick	Wei, QZ (corresponding author), Kansas State Univ, Dept Biochem, 141 Chalmers Hall, Manhattan, KS 66506 USA.	weiq@ksu.edu		Matsumura, Fumio/0000-0002-8204-153X	National Institutes of Health [k22 HL071542, P20 RR17708, P20 RR15563]; Johnson Center for Basic Cancer Research; Kansas Agricultural Experiment Station [08-296-J]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR017708, P20RR015563] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K22HL071542] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Johnson Center for Basic Cancer Research; Kansas Agricultural Experiment Station; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants k22 HL071542 (to Q. W.) and P20 RR17708 and P20 RR15563. This work was also supported by a fund from the Terry C. Johnson Center for Basic Cancer Research (to Q. W.). This is contribution 08-296-J from the Kansas Agricultural Experiment Station (Manhattan, KS). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Barr FA, 2004, NAT REV MOL CELL BIO, V5, P429, DOI 10.1038/nrm1401; Birkenfeld J, 2007, DEV CELL, V12, P699, DOI 10.1016/j.devcel.2007.03.014; Burkard ME, 2007, P NATL ACAD SCI USA, V104, P4383, DOI 10.1073/pnas.0701140104; Cao LG, 1996, MOL BIOL CELL, V7, P225, DOI 10.1091/mbc.7.2.225; Chalamalasetty RB, 2006, J CELL SCI, V119, P3008, DOI 10.1242/jcs.03032; Cheng KY, 2003, EMBO J, V22, P5757, DOI 10.1093/emboj/cdg558; Chikumi H, 2004, ONCOGENE, V23, P233, DOI 10.1038/sj.onc.1207012; Dai BN, 2007, CELL PROLIFERAT, V40, P550, DOI 10.1111/j.1365-2184.2007.00447.x; Wu D, 2006, CELL CYCLE, V5, P1234, DOI 10.4161/cc.5.11.2815; Elia AEH, 2003, CELL, V115, P83, DOI 10.1016/S0092-8674(03)00725-6; Elia AEH, 2003, SCIENCE, V299, P1228, DOI 10.1126/science.1079079; Fabbro M, 2005, DEV CELL, V9, P477, DOI 10.1016/j.devcel.2005.09.003; Kamijo K, 2006, MOL BIOL CELL, V17, P43, DOI 10.1091/mbc.e05-06-0569; Kim JE, 2005, J BIOL CHEM, V280, P5733, DOI 10.1074/jbc.M409298200; Lane HA, 1996, J CELL BIOL, V135, P1701, DOI 10.1083/jcb.135.6.1701; Lansing TJ, 2007, MOL CANCER THER, V6, P450, DOI 10.1158/1535-7163.MCT-06-0543; Lenart P, 2007, CURR BIOL, V17, P304, DOI 10.1016/j.cub.2006.12.046; Lindon C, 2004, J CELL BIOL, V164, P233, DOI 10.1083/jcb.200309035; Liu XQ, 2002, P NATL ACAD SCI USA, V99, P8672, DOI 10.1073/pnas.132269599; Lowery DM, 2004, CELL CYCLE, V3, P128; Lowery DM, 2007, EMBO J, V26, P2262, DOI 10.1038/sj.emboj.7601683; McInnes C, 2006, NAT CHEM BIOL, V2, P608, DOI 10.1038/nchembio825; Neef R, 2003, J CELL BIOL, V162, P863, DOI 10.1083/jcb.200306009; Neef R, 2007, NAT CELL BIOL, V9, P436, DOI 10.1038/ncb1557; Niiya F, 2006, ONCOGENE, V25, P827, DOI 10.1038/sj.onc.1209124; Nishimura Y, 2006, J CELL SCI, V119, P104, DOI 10.1242/jcs.02737; Petronczki M, 2007, DEV CELL, V12, P713, DOI 10.1016/j.devcel.2007.03.013; Reynolds N, 2003, J CELL SCI, V116, P1377, DOI 10.1242/jcs.00314; Schmidt A, 2002, GENE DEV, V16, P1587, DOI 10.1101/gad.1003302; Seong YS, 2002, J BIOL CHEM, V277, P32282, DOI 10.1074/jbc.M202602200; Song S, 2000, MOL CELL BIOL, V20, P286, DOI 10.1128/MCB.20.1.286-298.2000; Sumara I, 2004, CURR BIOL, V14, P1712, DOI 10.1016/j.cub.2004.09.049; van Vugt MATM, 2004, J BIOL CHEM, V279, P36841, DOI 10.1074/jbc.M313681200; Wei QZ, 2005, J BIOL CHEM, V280, P37790, DOI 10.1074/jbc.M502974200; Wheatley SP, 1996, J CELL BIOL, V135, P981, DOI 10.1083/jcb.135.4.981; Wolf A, 2006, NAT CELL BIOL, V8, P1432, DOI 10.1038/ncb1504; Yamashiro S, 2008, DEV CELL, V14, P787, DOI 10.1016/j.devcel.2008.02.013; Yuce O, 2005, J CELL BIOL, V170, P571, DOI 10.1083/jcb.200501097; Zhao WM, 2005, P NATL ACAD SCI USA, V102, P13158, DOI 10.1073/pnas.0504145102; Zhou T, 2003, DEV CELL, V5, P127, DOI 10.1016/S1534-5807(03)00186-2; Zhu KJ, 2001, MOL CELL BIOL, V21, P425, DOI 10.1128/MCB.21.2.425-437.2001	41	17	17	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 17	2008	283	42					28392	28400		10.1074/jbc.M801801200	http://dx.doi.org/10.1074/jbc.M801801200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	359EN	18694934	hybrid, Green Published			2022-12-27	WOS:000259969300041
J	Shrivastava, IH; Jiang, J; Amara, SG; Bahar, I				Shrivastava, Indira H.; Jiang, Jie; Amara, Susan G.; Bahar, Ivet			Time-resolved mechanism of extracellular gate opening and substrate binding in a glutamate transporter	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMINO-ACID TRANSPORTERS; STEERED MOLECULAR-DYNAMICS; NORMAL-MODE ANALYSIS; REENTRANT LOOP; INDIVIDUAL SUBUNITS; POTASSIUM CHANNEL; ALLOSTERIC MODEL; UNBOUND STATE; EAAC1; TRANSLOCATION	Glutamate transporters, also referred to as excitatory amino acid transporters (EAATs), are membrane proteins that regulate glutamatergic signal transmission by clearing excess glutamate after its release at synapses. A structure-based understanding of their molecular mechanisms of function has been elusive until the recent determination of the x-ray structure of an archaeal transporter, Glt(Ph). Glt(Ph) exists as a trimer, with each subunit containing a core region that mediates substrate translocation. In the present study a series of molecular dynamics simulations have been conducted and analyzed in light of new experimental data on substrate binding properties of EAATs. The simulations provide for the first time a full atomic description of the time-resolved events that drive the recognition and binding of substrate. The core region of each subunit exhibits an intrinsic tendency to open the helical hairpin HP2 loop, the extracellular gate, within tens of nanoseconds exposing conserved polar residues that serve as attractors for substrate binding. The NMDGT motif on the partially unwound part of the transmembrane helix TM7 and the residues Asp-390 and Asp-394 on TM8 are also distinguished by their important role in substrate binding and close interaction with mediating water molecules and/or sodium ions. The simulations reveal a Na+ binding site comprised in part of Leu-303 on TM7 and Asp-405 on TM8 and support a role for sodium ions in stabilizing substrate-bound conformers. The functional importance of Leu-303 or its counterpart Leu-391 inhuman EAAT1(hEAAT1) is confirmed by site-directed mutagenesis and Na+ dependence assays conducted with hEAAT1 mutants L391C and L391A.	[Shrivastava, Indira H.; Bahar, Ivet] Univ Pittsburgh, Dept Computat Biol, Pittsburgh, PA 15213 USA; [Jiang, Jie; Amara, Susan G.] Univ Pittsburgh, Dept Neurobiol, Sch Med, Pittsburgh, PA 15213 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Bahar, I (corresponding author), Biomed Sci Tower 3,Rm 3073,3501 5th Ave, Pittsburgh, PA 15213 USA.	bahar@pitt.edu	Bahar, Ivet/AAH-2921-2020	Amara, Susan/0000-0001-8914-1106	National Institutes of Health [R33 GM068400, MH080726]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R33GM068400] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH080726] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported, in whole or in part, by National Institutes of Health Grants R33 GM068400 (to I. B.) and MH080726 (to S. G. A.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	AMADEI A, 1993, PROTEINS, V17, P412, DOI 10.1002/prot.340170408; Amara SG, 2002, NEUROCHEM INT, V41, P313, DOI 10.1016/S0197-0186(02)00018-9; Bahar I, 2005, CURR OPIN STRUC BIOL, V15, P586, DOI 10.1016/j.sbi.2005.08.007; Bahar I, 2007, CURR OPIN STRUC BIOL, V17, P633, DOI 10.1016/j.sbi.2007.09.011; Bendahan A, 2000, J BIOL CHEM, V275, P37436, DOI 10.1074/jbc.M006536200; BERENDSEN HJC, 1995, COMPUT PHYS COMMUN, V91, P43, DOI 10.1016/0010-4655(95)00042-E; Beuming T, 2006, MOL PHARMACOL, V70, P1630, DOI 10.1124/mol.106.026120; Boudker O, 2007, NATURE, V445, P387, DOI 10.1038/nature05455; Brocke L, 2002, J BIOL CHEM, V277, P3985, DOI 10.1074/jbc.M107735200; Capener CE, 2000, BIOPHYS J, V78, P2929, DOI 10.1016/S0006-3495(00)76833-0; Danbolt NC, 2001, PROG NEUROBIOL, V65, P1, DOI 10.1016/S0301-0082(00)00067-8; FAIRMAN WA, 1995, NATURE, V375, P599, DOI 10.1038/375599a0; Gendreau S, 2004, J BIOL CHEM, V279, P39505, DOI 10.1074/jbc.M408038200; Grewer C, 2000, P NATL ACAD SCI USA, V97, P9706, DOI 10.1073/pnas.160170397; Grewer C, 2005, BIOCHEMISTRY-US, V44, P11913, DOI 10.1021/bi050987n; Grunewald M, 2000, J BIOL CHEM, V275, P9684, DOI 10.1074/jbc.275.13.9684; Gullingsrud J, 2003, BIOPHYS J, V85, P2087, DOI 10.1016/S0006-3495(03)74637-2; Henzler-Wildman K, 2007, NATURE, V450, P964, DOI 10.1038/nature06522; JARDETZK.O, 1966, NATURE, V211, P969, DOI 10.1038/211969a0; Jensen MO, 2002, P NATL ACAD SCI USA, V99, P6731, DOI 10.1073/pnas.102649299; Kavanaugh MP, 1997, J BIOL CHEM, V272, P1703, DOI 10.1074/jbc.272.3.1703; Koch HP, 2007, J BIOL CHEM, V282, P24547, DOI 10.1074/jbc.M704087200; Koch HP, 2007, J NEUROSCI, V27, P2943, DOI 10.1523/JNEUROSCI.0118-07.2007; Koch HP, 2005, J NEUROSCI, V25, P1730, DOI 10.1523/JNEUROSCI.4138-04.2005; Leary GP, 2007, J NEUROSCI, V27, P2938, DOI 10.1523/JNEUROSCI.4851-06.2007; Leighton BH, 2006, J BIOL CHEM, V281, P29788, DOI 10.1074/jbc.M604991200; Ma JP, 2005, STRUCTURE, V13, P373, DOI 10.1016/j.str.2005.02.002; Otis TS, 2000, J NEUROSCI, V20, P2749; Otis TS, 1998, J NEUROSCI, V18, P7099; Rosental N, 2006, J BIOL CHEM, V281, P27905, DOI 10.1074/jbc.M600331200; Schwieters CD, 2003, J MAGN RESON, V160, P65, DOI 10.1016/S1090-7807(02)00014-9; Seal RP, 2000, NEURON, V25, P695, DOI 10.1016/S0896-6273(00)81071-5; Seal RP, 1998, NEURON, V21, P1487, DOI 10.1016/S0896-6273(00)80666-2; Shrivastava IH, 2000, BIOPHYS J, V78, P557, DOI 10.1016/S0006-3495(00)76616-1; Shrivastava IH, 2006, BIOPHYS J, V90, P3929, DOI 10.1529/biophysj.105.080093; Slotboom DJ, 1999, P NATL ACAD SCI USA, V96, P14282, DOI 10.1073/pnas.96.25.14282; Taly A, 2006, P NATL ACAD SCI USA, V103, P16965, DOI 10.1073/pnas.0607477103; Tao Z, 2006, J BIOL CHEM, V281, P10263, DOI 10.1074/jbc.M510739200; Tao Z, 2007, J GEN PHYSIOL, V129, P331, DOI 10.1085/jgp.200609678; Teichman S, 2007, J GEN PHYSIOL, V129, P527, DOI 10.1085/jgp.200609707; Tieleman DP, 1996, J CHEM PHYS, V105, P4871, DOI 10.1063/1.472323; Tobi D, 2005, P NATL ACAD SCI USA, V102, P18908, DOI 10.1073/pnas.0507603102; Torres GE, 2007, CURR OPIN NEUROBIOL, V17, P304, DOI 10.1016/j.conb.2007.05.002; WADICHE JI, 1995, NEURON, V15, P721, DOI 10.1016/0896-6273(95)90159-0; Watzke N, 2001, J GEN PHYSIOL, V117, P547, DOI 10.1085/jgp.117.6.547; Wriggers W, 1999, PROTEINS, V35, P262, DOI 10.1002/(SICI)1097-0134(19990501)35:2<262::AID-PROT11>3.0.CO;2-N; Yamashita A, 2005, NATURE, V437, P215, DOI 10.1038/nature03978; Yang LW, 2005, STRUCTURE, V13, P893, DOI 10.1016/j.str.2005.03.015; Yernool D, 2004, NATURE, V431, P811, DOI 10.1038/nature03018; Zerangue N, 1996, NATURE, V383, P634, DOI 10.1038/383634a0; Zhang YM, 1999, P NATL ACAD SCI USA, V96, P1710, DOI 10.1073/pnas.96.4.1710; Zhang YM, 1998, P NATL ACAD SCI USA, V95, P751, DOI 10.1073/pnas.95.2.751	52	80	80	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 17	2008	283	42					28680	28690		10.1074/jbc.M800889200	http://dx.doi.org/10.1074/jbc.M800889200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	359EN	18678877	Green Published, hybrid			2022-12-27	WOS:000259969300070
J	Terrak, M; Sauvage, E; Derouaux, A; Dehareng, D; Bouhss, A; Breukink, E; Jeanjean, S; Nguyen-Disteche, M				Terrak, Mohammed; Sauvage, Eric; Derouaux, Adeline; Dehareng, Dominique; Bouhss, Ahmed; Breukink, Eefjan; Jeanjean, Sylvie; Nguyen-Disteche, Martine			Importance of the conserved residues in the peptidoglycan glycosyltransferase module of the class a penicillin-binding protein 1b of Escherichia coli	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KINETIC CHARACTERIZATION; CELL-DIVISION; PBP1B; MORPHOGENESIS; POLYMERASE; FAMILY	The peptidoglycan glycosyltransferase (GT) module of class A penicillin-binding proteins (PBPs) and monofunctional GTs catalyze glycan chain elongation of the bacterial cell wall. These enzymes belong to the GT51 family, are characterized by five conserved motifs, and have some fold similarity with the phage lambda lysozyme. In this work, we have systematically modified all the conserved amino acid residues of the GT module of Escherichia coli class A PBP1b by site-directed mutagenesis and determined their importance for the in vivo and in vitro activity and the thermostability of the protein. To get an insight into the GT active site of this paradigm enzyme, a model of PBP1b GT domain was constructed based on the available crystal structures (PDB codes 2OLV and 2OLU). The data show that in addition to the essential glutamate residues Glu(233) of motif 1 and Glu(290) of motif 3, the residues Phe(237) and His(240) of motif 1 and Gly(264), Thr(267), Gln(271), and Lys(274) of motif 2, all located in the catalytic cavity of the GT domain, are essential for the in vitro enzymatic activity of the PBP1b and for its in vivo functioning. Thus, the first three conserved motifs contain most of the residues that are required for the GT activity of the PBP1b. The residues Asp(234), Phe(237), His(240), Thr(267), and Gln(271) are proposed to maintain the structure of the active site and the positioning of the catalytic Glu(233).	[Terrak, Mohammed; Sauvage, Eric; Derouaux, Adeline; Dehareng, Dominique; Jeanjean, Sylvie; Nguyen-Disteche, Martine] Univ Liege, Inst Chim, Ctr Ingn Prot, B-4000 Sart Tilman Par Liege, Belgium; [Bouhss, Ahmed] Univ Paris 11, CNRS, Lab Enveloppes Bacteriennes & Antibiot, Inst Biochim & Biophys Mol & Cellulaire,UMR 8619, F-91405 Orsay, France; [Breukink, Eefjan] Univ Utrecht, Dept Biochem Membranes, Bijvoet Ctr Biomol Res, Inst Biomembranes, NL-3584 CH Utrecht, Netherlands	University of Liege; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Utrecht University		mterrak@ulg.ac.be	Breukink, Eefjan/I-3039-2016	Breukink, Eefjan/0000-0002-7311-0660				Barrett D, 2005, J BACTERIOL, V187, P2215, DOI 10.1128/JB.187.6.2215-2217.2005; Barrett D, 2007, J BIOL CHEM, V282, P31964, DOI 10.1074/jbc.M705440200; Barrett DS, 2004, BIOCHEMISTRY-US, V43, P12375, DOI 10.1021/bi049142m; Bertsche U, 2005, J BIOL CHEM, V280, P38096, DOI 10.1074/jbc.M508646200; Bertsche U, 2006, MOL MICROBIOL, V61, P675, DOI 10.1111/j.1365-2958.2006.05280.x; Coutinho PM, 2003, J MOL BIOL, V328, P307, DOI 10.1016/S0022-2836(03)00307-3; den Blaauwen T, 2008, FEMS MICROBIOL REV, V32, P321, DOI 10.1111/j.1574-6976.2007.00090.x; Goehring NW, 2005, CURR BIOL, V15, pR514, DOI 10.1016/j.cub.2005.06.038; Goffin C, 1998, MICROBIOL MOL BIOL R, V62, P1079, DOI 10.1128/MMBR.62.4.1079-1093.1998; HARA H, 1984, FEBS LETT, V168, P155, DOI 10.1016/0014-5793(84)80226-4; Holtje JV, 1998, MICROBIOL MOL BIOL R, V62, P181; LAKAYE B, 1994, BIOCHEM J, V300, P141, DOI 10.1042/bj3000141; Lovering AL, 2007, SCIENCE, V315, P1402, DOI 10.1126/science.1136611; Marrec-Fairley M, 2000, MOL MICROBIOL, V37, P1019, DOI 10.1046/j.1365-2958.2000.02054.x; Muller P, 2007, J BIOL CHEM, V282, P36394, DOI 10.1074/jbc.M706390200; NANNINGA N, 1991, MOL MICROBIOL, V5, P791, DOI 10.1111/j.1365-2958.1991.tb00751.x; Perlstein DL, 2007, J AM CHEM SOC, V129, P12674, DOI 10.1021/ja075965y; Schwartz B, 2002, BIOCHEMISTRY-US, V41, P12552, DOI 10.1021/bi026205x; Spratt BG, 1996, MOL MICROBIOL, V19, P639, DOI 10.1046/j.1365-2958.1996.442924.x; SUZUKI H, 1978, P NATL ACAD SCI USA, V75, P664, DOI 10.1073/pnas.75.2.664; SUZUKI H, 1980, FEBS LETT, V110, P245, DOI 10.1016/0014-5793(80)80083-4; TAMAKI S, 1977, P NATL ACAD SCI USA, V74, P5472, DOI 10.1073/pnas.74.12.5472; Terrak M, 1999, MOL MICROBIOL, V34, P350, DOI 10.1046/j.1365-2958.1999.01612.x; Terrak M, 2006, J BACTERIOL, V188, P2528, DOI 10.1128/JB.188.7.2528-2532.2006; van Heijenoort J, 2001, GLYCOBIOLOGY, V11, p25R; VANHEIJENOORT Y, 1992, J BACTERIOL, V174, P3549, DOI 10.1128/JB.174.11.3549-3557.1992; Vollmer W, 1999, J BIOL CHEM, V274, P6726, DOI 10.1074/jbc.274.10.6726; Vollmer W, 2001, CURR OPIN MICROBIOL, V4, P625, DOI 10.1016/S1369-5274(01)00261-2; Vollmer W, 2008, FEMS MICROBIOL REV, V32, P149, DOI 10.1111/j.1574-6976.2007.00094.x; Yuan YQ, 2007, P NATL ACAD SCI USA, V104, P5348, DOI 10.1073/pnas.0701160104; Zawadzka-Skomial J, 2006, J BACTERIOL, V188, P1875, DOI 10.1128/JB.188.5.1875-1881.2006	32	24	25	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 17	2008	283	42					28464	28470		10.1074/jbc.M803223200	http://dx.doi.org/10.1074/jbc.M803223200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	359EN	18701463	Green Published, hybrid			2022-12-27	WOS:000259969300048
J	Galloux, M; Vitrac, H; Montagner, C; Raffestin, S; Popoff, MR; Chenal, A; Forge, V; Gillet, D				Galloux, Marie; Vitrac, Heidi; Montagner, Caroline; Raffestin, Stephanie; Popoff, Michel R.; Chenal, Alexandre; Forge, Vincent; Gillet, Daniel			Membrane interaction of botulinum neurotoxin A translocation (T) domain - The belt region is a regulatory loop for membrane interaction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DIPHTHERIA-TOXIN; PROTEIN-RECEPTOR; PORE FORMATION; BINDING; LIGHT; IDENTIFICATION; TETANUS; FUSION; PHASE; STEPS	The translocation of the catalytic domain through the membrane of the endosome to the cell cytoplasm is a key step of intoxication by botulinum neurotoxin (BoNT). This step is mediated by the translocation (T) domain upon endosome acidification, although the mechanism of interaction of the T domain with the membrane is still poorly understood. Using physicochemical approaches and spectroscopic methods, we studied the interaction of the BoNT/A T domain with the membrane as a function of pH. We found that the interaction with membranes does not involve major secondary or tertiary structural changes, as reported for other toxins like diphtheria toxin. The T domain becomes insoluble around its pI value and then penetrates into the membrane. At that stage, the T domain becomes able to permeabilize lipid vesicles. This occurs for pH values lower than 5.5, in agreement with the pH encountered by the toxin within endosomes. Electrostatic interactions are also important for the process. The role of the so-called belt region was investigated with four variant proteins presenting different lengths of the N-extremity of the T domain. We observed that this part of the T domain, which contains numerous negatively charged residues, limits the protein-membrane interaction. Indeed, interaction with the membrane of the protein deleted of this extremity takes place for higher pH values than for the entire T domain. Overall, the data suggest that acidification eliminates repulsive electrostatic interactions between the T domain and the membrane, allowing its penetration into the membrane without triggering detectable structural changes.	[Forge, Vincent] CEA, iRTSV, LCBM, UMR CNRS UJF 5249, F-38054 Grenoble, France; [Galloux, Marie; Raffestin, Stephanie; Gillet, Daniel] CEA, Inst Biol & Technol Saclay, SIMOPRO, F-91191 Gif Sur Yvette, France; [Popoff, Michel R.] Inst Pasteur, Unite Bacteries Anaerobies & Toxines, Paris, France; [Chenal, Alexandre] Dept Biol Struct & Chim, URA CNRS 2185, Unite Biochim Interact Mol, F-75724 Paris 15, France	UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); CEA; UDICE-French Research Universities; Universite Paris Saclay; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Forge, V (corresponding author), CEA, iRTSV, LCBM, UMR CNRS UJF 5249, F-38054 Grenoble, France.	vincent.forge@cea.fr; daniel.gillet@cea.fr	Chenal, Alexandre/C-2240-2009; Gillet, Daniel/C-5592-2008; Vitrac, Heidi/R-7117-2018	Chenal, Alexandre/0000-0002-4959-1003; Gillet, Daniel/0000-0003-0477-3599; Vitrac, Heidi/0000-0002-8858-4914				Arnon SS, 2001, JAMA-J AM MED ASSOC, V285, P1059, DOI 10.1001/jama.285.8.1059; BINZ T, 1990, J BIOL CHEM, V265, P9153; BLASI J, 1993, NATURE, V365, P160, DOI 10.1038/365160a0; Brunger AT, 2007, PLOS PATHOG, V3, P1191, DOI 10.1371/journal.ppat.0030113; Cai SW, 2001, BIOCHEMISTRY-US, V40, P15327, DOI 10.1021/bi011350g; Chai Q, 2006, NATURE, V444, P1096, DOI 10.1038/nature05411; Chenal A, 2002, J BIOL CHEM, V277, P43425, DOI 10.1074/jbc.M204148200; Chenal A, 2002, PROTEIN ENG, V15, P383, DOI 10.1093/protein/15.5.383; Chenal A, 2002, J TOXICOL-TOXIN REV, V21, P321, DOI 10.1081/TXR-120014408; Couesnon A, 2006, MICROBIOL-SGM, V152, P759, DOI 10.1099/mic.0.28561-0; Faudry E, 2006, BIOCHEMISTRY-US, V45, P8117, DOI 10.1021/bi060452+; Fischer A, 2007, J BIOL CHEM, V282, P29604, DOI 10.1074/jbc.M703619200; Fischer A, 2007, P NATL ACAD SCI USA, V104, P10447, DOI 10.1073/pnas.0700046104; Jin RS, 2006, NATURE, V444, P1092, DOI 10.1038/nature05387; Koriazova LK, 2003, NAT STRUCT BIOL, V10, P13, DOI 10.1038/nsb879; Lacy DB, 1998, NAT STRUCT BIOL, V5, P898, DOI 10.1038/2338; Li L, 2000, BIOCHEMISTRY-US, V39, P2399, DOI 10.1021/bi992321x; Melnyk RA, 2006, P NATL ACAD SCI USA, V103, P9802, DOI 10.1073/pnas.0604000103; MILNE JC, 1994, J BIOL CHEM, V269, P20607; Montagner C, 2007, BIOCHEMISTRY-US, V46, P1878, DOI 10.1021/bi602381z; Montecucco C, 2005, CURR OPIN PHARMACOL, V5, P274, DOI 10.1016/j.coph.2004.12.006; Montecucco C, 1995, Q REV BIOPHYS, V28, P423, DOI 10.1017/S0033583500003292; Niemann Heiner, 1994, Trends in Cell Biology, V4, P179, DOI 10.1016/0962-8924(94)90203-8; Nizard P, 1998, FEBS LETT, V433, P83, DOI 10.1016/S0014-5793(98)00890-4; Oh KJ, 1999, P NATL ACAD SCI USA, V96, P8467, DOI 10.1073/pnas.96.15.8467; Parikh S, 2007, PROTEIN J, V26, P19, DOI 10.1007/s10930-006-9040-5; Parker MW, 2005, PROG BIOPHYS MOL BIO, V88, P91, DOI 10.1016/j.pbiomolbio.2004.01.009; Perier A, 2007, J BIOL CHEM, V282, P24239, DOI 10.1074/jbc.M703392200; RIGAUD JL, 1983, BIOCHEM BIOPH RES CO, V111, P373, DOI 10.1016/0006-291X(83)90316-9; Rummel A, 2004, J BIOL CHEM, V279, P30865, DOI 10.1074/jbc.M403945200; Rummel A, 2007, P NATL ACAD SCI USA, V104, P359, DOI 10.1073/pnas.0609713104; Schiavo G, 2000, PHYSIOL REV, V80, P717, DOI 10.1152/physrev.2000.80.2.717; Simpson LL, 2004, ANNU REV PHARMACOL, V44, P167, DOI 10.1146/annurev.pharmtox.44.101802.121554; Swaminathan S, 2000, NAT STRUCT BIOL, V7, P693, DOI 10.1038/78005; Turton K, 2002, TRENDS BIOCHEM SCI, V27, P552, DOI 10.1016/S0968-0004(02)02177-1; Young JAT, 2007, ANNU REV BIOCHEM, V76, P243, DOI 10.1146/annurev.biochem.75.103004.142728	36	48	48	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 10	2008	283	41					27668	27676		10.1074/jbc.M802557200	http://dx.doi.org/10.1074/jbc.M802557200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	355OW	18693250	hybrid			2022-12-27	WOS:000259719200038
J	Mylonis, I; Chachami, G; Paraskeva, E; Simos, G				Mylonis, Ilias; Chachami, Georgia; Paraskeva, Efrosyni; Simos, George			Atypical CRM1-dependent nuclear export signal mediates regulation of hypoxia-inducible factor-1 alpha by MAPK	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HYPOXIA-INDUCIBLE FACTOR-1-ALPHA; TRANSCRIPTIONAL ACTIVITY; HIF HYDROXYLASES; HIF-1-ALPHA; OXYGEN; PHOSPHORYLATION; LOCALIZATION; RECEPTOR; ACCUMULATION; DEGRADATION	Hypoxia-inducible factor 1 (HIF-1) is the key transcriptional activator of hypoxia-inducible genes and an important anti-cancer target. Its regulated subunit, HIF-1 alpha, is controlled by oxygen levels and major signaling pathways. We reported previously that phosphorylation of Ser(641/643) by p42/44 MAPK is essential for HIF-1 alpha nuclear accumulation and activity. We now show that a fragment of HIF-1 alpha (amino acids 616-658), termed MAPK target domain, contains a nuclear export signal (NES), which has atypical hydrophobic residue spacing. Localization, reporter gene, and co-immunoprecipitation assays demonstrate that the identified NES interacts with CRM1 in a phosphorylation-sensitive manner. Furthermore, disruption of the NES (I637A/L638A/I639A) restores nuclear localization and activity of nonphosphorylated HIF-1 alpha and renders it largely resistant to inhibition of MAPK, an effect reproduced by a phosphomimetic mutation (S641E). As these data predict, overexpression of wildtype or mutant (S641A/S643A) MAPK target domain in HeLa cells modulates the activity and subcellular distribution of endogenous HIF-1 alpha. Wesuggest that control of HIF-1 alpha nuclear transport represents an important MAPK-dependent regulatory mechanism.	[Mylonis, Ilias; Chachami, Georgia; Simos, George] Univ Thessaly, Dept Med, Biochem Lab, Mezourlo 41110, Larissa, Greece; [Mylonis, Ilias; Chachami, Georgia; Paraskeva, Efrosyni; Simos, George] Inst Biomed Res & Technol BIOMED, Mezourlo 41110, Larissa, Greece	University of Thessaly	Simos, G (corresponding author), Univ Thessaly, Dept Med, Biochem Lab, POB 1400, Mezourlo 41110, Larissa, Greece.	simos@med.uth.gr	Paraskeva, Efrosyni/E-6449-2015; Simos, George/AAH-2596-2021	Paraskeva, Efrosyni/0000-0002-1312-0322; Simos, George/0000-0001-5453-3185; Mylonis, Ilias/0000-0002-0893-6618; Chachami, Georgia/0000-0002-4771-4196	European Social Fund and National Resources; EPEAEK II-PYTHAGORAS; Greek Ministry of National Education and Religious Affairs	European Social Fund and National Resources(European Social Fund (ESF)); EPEAEK II-PYTHAGORAS; Greek Ministry of National Education and Religious Affairs	This work was supported in part by a grant co-funded by the European Social Fund and National Resources, EPEAEK II-PYTHAGORAS, from the Greek Ministry of National Education and Religious Affairs (to G. S.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Bardos JI, 2005, BBA-REV CANCER, V1755, P107, DOI 10.1016/j.bbcan.2005.05.001; Bardos JI, 2004, BIOESSAYS, V26, P262, DOI 10.1002/bies.20002; Bernardi R, 2006, NATURE, V442, P779, DOI 10.1038/nature05029; Berra E, 2001, EMBO REP, V2, P615, DOI 10.1093/embo-reports/kve130; Bilton RL, 2003, EUR J BIOCHEM, V270, P791, DOI 10.1046/j.1432-1033.2003.03446.x; Chachami G, 2005, BIOCHEM BIOPH RES CO, V331, P464, DOI 10.1016/j.bbrc.2005.03.193; Chandel NS, 2007, FREE RADICAL BIO MED, V42, P165, DOI 10.1016/j.freeradbiomed.2006.10.048; DeBerardinis RJ, 2008, CELL METAB, V7, P11, DOI 10.1016/j.cmet.2007.10.002; Dery MAC, 2005, INT J BIOCHEM CELL B, V37, P535, DOI 10.1016/j.biocel.2004.08.012; Groulx I, 2002, MOL CELL BIOL, V22, P5319, DOI 10.1128/MCB.22.15.5319-5336.2002; Hutten S, 2007, TRENDS CELL BIOL, V17, P193, DOI 10.1016/j.tcb.2007.02.003; Ikuta T, 2004, J BIOL CHEM, V279, P19209, DOI 10.1074/jbc.M310492200; Kallio PJ, 1998, EMBO J, V17, P6573, DOI 10.1093/emboj/17.22.6573; Kietzmann T, 2005, SEMIN CELL DEV BIOL, V16, P474, DOI 10.1016/j.semcdb.2005.03.010; Kubis HP, 2005, BBA-MOL CELL RES, V1745, P187, DOI 10.1016/j.bbamcr.2005.05.007; Kutay U, 2005, TRENDS CELL BIOL, V15, P121, DOI 10.1016/j.tcb.2005.01.005; Lancaster DE, 2004, BIOCHEM SOC T, V32, P943, DOI 10.1042/BST0320943; Lee H, 2002, MOL CELL BIOL, V22, P5835, DOI 10.1128/MCB.22.16.5835-5845.2002; Lyberopoulou A, 2007, CELL PHYSIOL BIOCHEM, V20, P995, DOI 10.1159/000110460; Mylonis I, 2006, J BIOL CHEM, V281, P33095, DOI 10.1074/jbc.M605058200; Pan Y, 2007, MOL CELL BIOL, V27, P912, DOI 10.1128/MCB.01223-06; Pemberton LF, 2005, TRAFFIC, V6, P187, DOI 10.1111/j.1600-0854.2005.00270.x; Richard DE, 1999, J BIOL CHEM, V274, P32631, DOI 10.1074/jbc.274.46.32631; Sang NL, 2003, J BIOL CHEM, V278, P14013, DOI 10.1074/jbc.M209702200; Sasaki T, 2006, MOL CELL, V24, P63, DOI 10.1016/j.molcel.2006.08.005; Schofield CJ, 2004, NAT REV MOL CELL BIO, V5, P343, DOI 10.1038/nrm1366; Schofield CJ, 2005, BIOCHEM BIOPH RES CO, V338, P617, DOI 10.1016/j.bbrc.2005.08.111; Semenza GL, 2003, NAT REV CANCER, V3, P721, DOI 10.1038/nrc1187; SEMENZA GL, 2007, SCI STKE, pCM8, DOI DOI 10.1126/STKE.4072007CM8; Triantafyllou A, 2008, FREE RADICAL BIO MED, V44, P657, DOI 10.1016/j.freeradbiomed.2007.10.050; Zhang YP, 2001, SCIENCE, V292, P1910, DOI 10.1126/science.1058637	31	73	77	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 10	2008	283	41					27620	27627		10.1074/jbc.M803081200	http://dx.doi.org/10.1074/jbc.M803081200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	355OW	18687685	hybrid			2022-12-27	WOS:000259719200033
J	Fukuda, T; Kohda, M; Kanomata, K; Nojima, J; Nakamura, A; Kamizono, J; Noguchi, Y; Iwakiri, K; Kondo, T; Kurose, J; Endo, K; Awakura, T; Fukushi, J; Nakashima, Y; Chiyonobu, T; Kawara, A; Nishida, Y; Wada, I; Akita, M; Komori, T; Nakayama, K; Nanba, A; Maruki, Y; Yoda, T; Tomoda, H; Yu, PB; Shore, EM; Kaplan, FS; Miyazono, K; Matsuoka, M; Ikebuchi, K; Ohtake, A; Oda, H; Jimi, E; Owan, I; Okazaki, Y; Katagiri, T				Fukuda, Toru; Kohda, Masakazu; Kanomata, Kazuhiro; Nojima, Junya; Nakamura, Atsushi; Kamizono, Jyunji; Noguchi, Yasuo; Iwakiri, Kiyofumi; Kondo, Takeo; Kurose, Junichi; Endo, Ken-ichi; Awakura, Takeshi; Fukushi, Junichi; Nakashima, Yasuharu; Chiyonobu, Tomohiro; Kawara, Akira; Nishida, Yoshihiro; Wada, Ikuo; Akita, Masumi; Komori, Tetsuo; Nakayama, Konosuke; Nanba, Akira; Maruki, Yuichi; Yoda, Tetsuya; Tomoda, Hiroshi; Yu, Paul B.; Shore, Eileen M.; Kaplan, Frederick S.; Miyazono, Kohei; Matsuoka, Masaru; Ikebuchi, Kenji; Ohtake, Akira; Oda, Hiromi; Jimi, Eijiro; Owan, Ichiro; Okazaki, Yasushi; Katagiri, Takenobu			Constitutively Activated ALK2 and Increased SMAD1/5 Cooperatively Induce Bone Morphogenetic Protein Signaling in Fibrodysplasia Ossificans Progressiva	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							I RECEPTORS; HETEROTOPIC OSSIFICATION; NATURAL-HISTORY; MESSENGER-RNA; ACTIVIN-A; IDENTIFICATION; DIFFERENTIATION; PATHWAY; DYSREGULATION; INJECTION	Fibrodysplasia ossificans progressiva (FOP) is a rare autosomal dominant disorder characterized by congenital malformation of the great toes and by progressive heterotopic bone formation in muscle tissue. Recently, a mutation involving a single amino acid substitution in a bone morphogenetic protein (BMP) type I receptor, ALK2, was identified in patients with FOP. We report here that the identical mutation, R206H, was observed in 19 Japanese patients with sporadic FOP. This mutant receptor, ALK2(R206H), activates BMP signaling without ligand binding. Moreover, expression of Smad1 and Smad5 was up-regulated in response to muscular injury. ALK2(R206H) with Smad1 or Smad5 induced osteoblastic differentiation that could be inhibited by Smad7 or dorsomorphin. Taken together, these findings suggest that the heterotopic bone formation in FOP may be induced by a constitutively activated BMP receptor signaling through Smad1 or Smad5. Gene transfer of Smad7 or inhibition of type I receptors with dorsomorphin may represent strategies for blocking the activity induced by ALK2(R206H) in FOP.	[Fukuda, Toru; Kanomata, Kazuhiro; Nojima, Junya; Nakamura, Atsushi; Katagiri, Takenobu] Saitama Med Univ, Res Ctr Genom Med, Div Pathophysiol, Hidaka, Saitama 3501241, Japan; [Kohda, Masakazu; Okazaki, Yasushi] Saitama Med Univ, Res Ctr Genom Med, Div Translat Res, Hidaka, Saitama 3501241, Japan; [Fukuda, Toru; Akita, Masumi; Komori, Tetsuo; Nakayama, Konosuke; Nanba, Akira; Maruki, Yuichi; Yoda, Tetsuya; Tomoda, Hiroshi; Miyazono, Kohei; Ikebuchi, Kenji; Ohtake, Akira; Oda, Hiromi; Jimi, Eijiro; Owan, Ichiro; Okazaki, Yasushi; Katagiri, Takenobu] Saitama Med Univ, Project Clin & Basic Res FOP, Hidaka, Saitama 3501241, Japan; [Kamizono, Jyunji] Kitakyusyu City Yahata Hosp, Dept Pediat Emergency, Yahatahigashi Ku, Kitakyushu, Fukuoka 8058534, Japan; [Noguchi, Yasuo] Saga Prefectural Hosp Koseikan, Dept Orthoped Surg, Saga 8408571, Japan; [Iwakiri, Kiyofumi] Nagayoshi Orthoped Clin, Miyazaki 8800951, Japan; [Kondo, Takeo] Tohoku Univ, Grad Sch Med, Dept Phys Med & Rehabil, Aoba Ku, Sendai, Miyagi 9808474, Japan; [Kurose, Junichi] Senjyudo Hosp, Dept Orthoped Surg, Gifu 5008862, Japan; [Endo, Ken-ichi] Endo Clin, Kodaira, Tokyo 1870035, Japan; [Awakura, Takeshi] Awakura Clin, Wajima, Ishiwawa 9280246, Japan; [Fukushi, Junichi; Nakashima, Yasuharu] Kyushu Univ, Fac Med, Dept Orthoped Surg, Higashi Ku, Fukuoka 8128582, Japan; [Chiyonobu, Tomohiro] Akashi Municipal Hosp, Dept Pediat, Akashi, Hyogo 6738501, Japan; [Kawara, Akira] Kawara Clin, Higashinada Ku, Kobe, Hyogo 6580051, Japan; [Nishida, Yoshihiro] Nagoya Univ, Grad Sch, Dept Orthopaed Surg, Showa Ku, Nagoya, Aichi 4668550, Japan; [Nishida, Yoshihiro] Sch Med, Showa Ku, Nagoya, Aichi 4668550, Japan; [Wada, Ikuo] Nagoya City Univ Hosp, Dept Rehabil, Mizuho Ku, Nagoya, Aichi 4678602, Japan; [Nojima, Junya; Yoda, Tetsuya] Saitama Med Univ, Dept Oral & Maxillofacial Surg, Moroyama, Saitama 3500495, Japan; [Nanba, Akira] Saitama Med Univ, Dept Obstet & Gynecol, Moroyama, Saitama 3500495, Japan; [Nakayama, Konosuke] Saitama Med Univ, Dept Endocrinol & Diabet, Moroyama, Saitama 3500495, Japan; [Komori, Tetsuo] Saitama Med Univ, Dept Neurol, Moroyama, Saitama 3500495, Japan; [Oda, Hiromi] Saitama Med Univ, Dept Orthoped Surg, Moroyama, Saitama 3500495, Japan; [Ohtake, Akira] Saitama Med Univ, Dept Pediat, Moroyama, Saitama 3500495, Japan; [Matsuoka, Masaru; Ikebuchi, Kenji] Saitama Med Univ, Dept Lab Med, Moroyama, Saitama 3500495, Japan; [Akita, Masumi] Saitama Med Univ, Biomed Res Ctr, Div Morphol Sci, Moroyama, Saitama 3500495, Japan; [Maruki, Yuichi] Saitama Neuropsychiat Inst, Dept Neurol, Chuo Ku, Saitama 3388577, Japan; [Miyazono, Kohei] Univ Tokyo, Grad Sch Med, Dept Mol Pathol, Bunkyo Ku, Tokyo 1130033, Japan; [Tomoda, Hiroshi] Kitasato Univ, Sch Pharmaceut Sci, Minato Ku, Tokyo 1080023, Japan; [Yu, Paul B.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Div Cardiol,Dept Med, Boston, MA 02129 USA; [Yu, Paul B.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Cardiovasc Res Ctr,Dept Med, Boston, MA 02129 USA; [Shore, Eileen M.; Kaplan, Frederick S.] Univ Penn, Sch Med, Dept Orthoped Surg, Ctr Res Fibrodysplasia Ossificans Progress & Rela, Philadelphia, PA 19104 USA; [Jimi, Eijiro] Kyushu Dent Coll, Dept Biosci, Div Mol Signaling & Biochem, Kokurakita Ku, Kitakyushu, Fukuoka 8038580, Japan; [Owan, Ichiro] Univ Ryukyus, Fac Med, Dept Orthoped Surg, Nishihara, Okinawa 9030215, Japan; [Nakashima, Yasuharu] Minist Hlth Labour & Welf, Res Comm Fibrodysplasia Ossificans Progress, Bunkyo Ku, Tokyo 1138655, Japan	Saitama Medical University; Saitama Medical University; Saitama Medical University; Tohoku University; Kyushu University; Nagoya University; Nagoya City University; Saitama Medical University; Saitama Medical University; Saitama Medical University; Saitama Medical University; Saitama Medical University; Saitama Medical University; Saitama Medical University; Saitama Medical University; University of Tokyo; Kitasato University; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; University of Pennsylvania; Kyushu Dental University; University of the Ryukyus	Katagiri, T (corresponding author), Saitama Med Univ, Res Ctr Genom Med, Div Pathophysiol, 1397-1 Yamane, Hidaka, Saitama 3501241, Japan.	katagiri@saitama-med.ac.jp	Shore, Eileen/D-2593-2009; Nishida, Yoshihiro/I-7354-2014; Yu, Paul B./J-7540-2019	Yu, Paul B./0000-0003-2145-4944; Okazaki, Yasushi/0000-0003-3241-5502; Ohtake, Akira/0000-0003-1147-3113; Kaplan, Frederick/0000-0003-1277-5420; Chiyonobu, Tomohiro/0000-0001-6678-060X	NHLBI NIH HHS [K08 HL079943, K08 HL079943-04] Funding Source: Medline; NIAMS NIH HHS [R01-AR41916] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL079943] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR041916] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Afrakhte M, 1998, BIOCHEM BIOPH RES CO, V249, P505, DOI 10.1006/bbrc.1998.9170; Akiyama S, 1997, EXP CELL RES, V235, P362, DOI 10.1006/excr.1997.3680; Aoki H, 2001, J CELL SCI, V114, P1483; ATTISANO L, 1993, CELL, V75, P671, DOI 10.1016/0092-8674(93)90488-C; COHEN RB, 1993, J BONE JOINT SURG AM, V75A, P215, DOI 10.2106/00004623-199302000-00008; CONNOR JM, 1982, J BONE JOINT SURG BR, V64, P76, DOI 10.1302/0301-620X.64B1.7068725; David L, 2008, CIRC RES, V102, P914, DOI 10.1161/CIRCRESAHA.107.165530; Davies MR, 2005, J AM SOC NEPHROL, V16, P917, DOI 10.1681/ASN.2004100835; Fiori JL, 2006, J BONE MINER RES, V21, P902, DOI 10.1359/JBMR.060215; Gannon FH, 1997, HUM PATHOL, V28, P339, DOI 10.1016/S0046-8177(97)90133-7; Glaser DL, 2003, J BONE JOINT SURG AM, V85A, P2332, DOI 10.2106/00004623-200312000-00010; Goto K, 2007, J BIOL CHEM, V282, P20603, DOI 10.1074/jbc.M702100200; Ikenoue T, 1999, J CELL BIOCHEM, V75, P206, DOI 10.1002/(SICI)1097-4644(19991101)75:2<206::AID-JCB3>3.3.CO;2-K; Imamura T, 1997, NATURE, V389, P622, DOI 10.1038/39355; Kaplan FS, 2008, J BONE MINER METAB, V26, P521, DOI 10.1007/s00774-008-0879-8; Kaplan FS, 2007, J BONE JOINT SURG AM, V89A, P347, DOI 10.2106/JBJS.F.00472; Kaplan FS, 2006, ANN NY ACAD SCI, V1068, P54, DOI 10.1196/annals.1346.008; KAPLAN FS, 1990, CALCIFIED TISSUE INT, V47, P117, DOI 10.1007/BF02555995; KAPLAN FS, 1993, J BONE JOINT SURG AM, V75A, P220, DOI 10.2106/00004623-199302000-00009; KAPLAN FS, 1993, J BONE JOINT SURG AM, V75A, P1214, DOI 10.2106/00004623-199308000-00011; KATAGIRI T, 1994, J CELL BIOL, V127, P1755, DOI 10.1083/jcb.127.6.1755; Katagiri T, 2002, GENES CELLS, V7, P949, DOI 10.1046/j.1365-2443.2002.00573.x; Katagiri T, 1997, EXP CELL RES, V230, P342, DOI 10.1006/excr.1996.3432; Katagiri Takenobu, 2008, P121; Kodaira K, 2006, BIOCHEM BIOPH RES CO, V345, P1224, DOI 10.1016/j.bbrc.2006.05.045; LANCHONEY TF, 1995, J PEDIATR-US, V126, P762, DOI 10.1016/S0022-3476(95)70408-6; Link BA, 1997, EXP CELL RES, V233, P350, DOI 10.1006/excr.1997.3575; Luchetti W, 1996, ORAL SURG ORAL MED O, V81, P21, DOI 10.1016/S1079-2104(96)80141-7; Miyazono K, 2005, CYTOKINE GROWTH F R, V16, P251, DOI 10.1016/j.cytogfr.2005.01.009; Nakajima M, 2007, J HUM GENET, V52, P473, DOI 10.1007/s10038-007-0128-3; Nakao A, 1997, NATURE, V389, P631, DOI 10.1038/39369; Perry RLS, 2001, MOL CELL, V8, P291, DOI 10.1016/S1097-2765(01)00302-1; Shafritz AB, 1996, NEW ENGL J MED, V335, P555, DOI 10.1056/NEJM199608223350804; Shore EM, 2006, NAT GENET, V38, P525, DOI 10.1038/ng1783; Souchelnytskyi S, 1996, EMBO J, V15, P6231, DOI 10.1002/j.1460-2075.1996.tb01013.x; Takase M, 1998, BIOCHEM BIOPH RES CO, V244, P26, DOI 10.1006/bbrc.1998.8200; TENDIJKE P, 1993, ONCOGENE, V8, P2879; URIST MR, 1965, SCIENCE, V150, P893, DOI 10.1126/science.150.3698.893; WIESER R, 1995, EMBO J, V14, P2199, DOI 10.1002/j.1460-2075.1995.tb07214.x; WOZNEY JM, 1988, SCIENCE, V242, P1528, DOI 10.1126/science.3201241; YAMASHITA H, 1995, J CELL BIOL, V130, P217, DOI 10.1083/jcb.130.1.217; Yui PB, 2008, NAT CHEM BIOL, V4, P33, DOI 10.1038/nchembio.2007.54	42	153	162	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 13	2009	284	11					7149	7156		10.1074/jbc.M801681200	http://dx.doi.org/10.1074/jbc.M801681200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	415FF	18684712	hybrid, Green Published			2022-12-27	WOS:000263919000062
J	Gozgit, JM; Bebernitz, G; Patil, P; Ye, MW; Parmentier, J; Wu, JQ; Su, N; Wang, T; Ioannidis, S; Davies, A; Huszar, D; Zinda, M				Gozgit, Joseph M.; Bebernitz, Geraldine; Patil, Pankaj; Ye, Minwei; Parmentier, Julie; Wu, Jiaquan; Su, Nancy; Wang, Tao; Ioannidis, Stephanos; Davies, Audrey; Huszar, Dennis; Zinda, Michael			Effects of the JAK2 Inhibitor, AZ960, on Pim/BAD/BCL-xL Survival Signaling in the Human JAK2 V617F Cell Line SET-2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SERINE/THREONINE KINASE-ACTIVITY; CONSTITUTIVELY ACTIVATED FLT3; BAD-MEDIATED APOPTOSIS; MYELOPROLIFERATIVE DISORDERS; PHOSPHORYLATES BAD; BCL-X; MOLECULAR TARGETS; PIM-1; DEATH; MEGAKARYOCYTES	The Janus-associated kinase 2 (JAK2) V617F mutation is believed to play a critical role in the pathogenesis of polycythemia vera, essential thrombocythemia, and idiopathic myelofibrosis. We have characterized a novel small molecule JAK2 inhibitor, AZ960, and used it as a tool to investigate the consequences of JAK2 V617F inhibition in the SET-2 cell line. AZ960 inhibits JAK2 kinase with a K-i of 0.00045 mu M in vitro and treatment of TEL-JAK2 driven Ba/F3 cells with AZ960 blocked STAT5 phosphorylation and potently inhibited cell proliferation (GI(50) = 0.025 mu M). AZ960 demonstrated selectivity for TEL-JAK2-driven STAT5 phosphorylation and cell proliferation when compared with cell lines driven by similar fusions of the other JAK kinase family members. In the SET-2 human megakaryoblastic cell line, heterozygous for the JAK2 V617F allele, inhibition of JAK2 resulted in decreased STAT3/5 phosphorylation and inhibition of cell proliferation (GI(50) = 0.033 mu M) predominately through the induction of mitochondrial-mediated apoptosis. We provide evidence that JAK2 inhibition induces apoptosis by direct and indirect regulation of the antiapoptotic protein BCL-xL. Inhibition of JAK2 blocked BCL-XL mRNA expression resulting in a reduction of BCL-xL protein levels. Additionally, inhibition of JAK2 resulted in decreased PIM1 and PIM2 mRNA expression. Decreased PIM1 mRNA corresponded with a decrease in Pim1 protein levels and inhibition of BAD phosphorylation at Ser(112). Finally, small interfering RNA-mediated suppression of BCL-xL resulted in apoptotic cell death similar to the phenotype observed following JAK2 inhibition. These results suggest a model in which JAK2 promotes cell survival by signaling through the Pim/BAD/BCL-xL pathway.	[Gozgit, Joseph M.; Bebernitz, Geraldine; Patil, Pankaj; Ye, Minwei; Parmentier, Julie; Wu, Jiaquan; Su, Nancy; Wang, Tao; Ioannidis, Stephanos; Davies, Audrey; Huszar, Dennis; Zinda, Michael] AstraZeneca R&D Boston, Canc Biosci, Waltham, MA 02451 USA	AstraZeneca	Zinda, M (corresponding author), 35 Gatehouse Dr, Waltham, MA 02451 USA.	michael.zinda@astrazeneca.com						Adam M, 2006, CANCER RES, V66, P3828, DOI 10.1158/0008-5472.CAN-05-2309; Aho TLT, 2004, FEBS LETT, V571, P43, DOI 10.1016/j.febslet.2004.06.050; Amaravadi R, 2005, J CLIN INVEST, V115, P2618, DOI 10.1172/JCI26273; Bachmann M, 2005, INT J BIOCHEM CELL B, V37, P726, DOI 10.1016/j.biocel.2004.11.005; Baker SJ, 2007, ONCOGENE, V26, P6724, DOI 10.1038/sj.onc.1210757; Buettner R, 2002, CLIN CANCER RES, V8, P945; Campbell PJ, 2006, NEW ENGL J MED, V355, P2452, DOI 10.1056/NEJMra063728; Castedo M, 1996, J IMMUNOL, V157, P512; Ciurea SO, 2007, BLOOD, V110, P986, DOI 10.1182/blood-2006-12-064626; Delhommeau F, 2006, CELL MOL LIFE SCI, V63, P2939, DOI 10.1007/s00018-006-6272-7; Ferrajoli A, 2006, CURR CANCER DRUG TAR, V6, P671, DOI 10.2174/156800906779010227; Garcon L, 2006, BLOOD, V108, P1551, DOI 10.1182/blood-2005-10-009514; Green DR, 2005, J CLIN INVEST, V115, P2610, DOI 10.1172/JCI26321; Hexner EO, 2008, BLOOD, V111, P5663, DOI 10.1182/blood-2007-04-083402; Hexner EO, 2007, CURR OPIN HEMATOL, V14, P450, DOI 10.1097/MOH.0b013e3282861d1b; Kim KT, 2005, BLOOD, V105, P1759, DOI 10.1182/blood-2004-05-2006; Kim KT, 2006, BRIT J HAEMATOL, V134, P500, DOI 10.1111/j.1365-2141.2006.06225.x; Kim R, 2005, BIOCHEM BIOPH RES CO, V333, P336, DOI 10.1016/j.bbrc.2005.04.161; Kisseleva T, 2002, GENE, V285, P1, DOI 10.1016/S0378-1119(02)00398-0; Lacronique V, 2000, BLOOD, V95, P2076, DOI 10.1182/blood.V95.6.2076; Li YY, 2006, CANCER RES, V66, P6741, DOI 10.1158/0008-5472.CAN-05-4272; Macdonald A, 2006, BMC CELL BIOL, V7, DOI 10.1186/1471-2121-7-1; Pardanani A, 2007, LEUKEMIA, V21, P1658, DOI 10.1038/sj.leu.2404750; Pogacic V, 2007, CANCER RES, V67, P6916, DOI 10.1158/0008-5472.CAN-07-0320; Popivanova BK, 2007, CANCER SCI, V98, P321, DOI 10.1111/j.1349-7006.2007.00390.x; Puthalakath H, 2002, CELL DEATH DIFFER, V9, P505, DOI 10.1038/sj.cdd.4400998; Quentmeier H, 2006, LEUKEMIA, V20, P471, DOI 10.1038/sj.leu.2404081; Rane SG, 2000, ONCOGENE, V19, P5662, DOI 10.1038/sj.onc.1203925; Sanz C, 2001, EXP HEMATOL, V29, P728, DOI 10.1016/S0301-472X(01)00635-X; Schwernmers S, 2007, EXP HEMATOL, V35, P1695, DOI 10.1016/j.exphem.2007.07.004; Silva M, 1998, NEW ENGL J MED, V338, P564, DOI 10.1056/NEJM199802263380902; Socolovsky M, 1999, CELL, V98, P181, DOI 10.1016/S0092-8674(00)81013-2; Tenedini E, 2004, BLOOD, V104, P3126, DOI 10.1182/blood-2003-07-2597; Teofili L, 2007, BLOOD, V110, P354, DOI 10.1182/blood-2007-01-069237; Uozumi K, 2000, LEUKEMIA, V14, P142, DOI 10.1038/sj.leu.2401608; Vainchenker William, 2005, Hematology Am Soc Hematol Educ Program, P195; Walters DK, 2006, LEUKEMIA RES, V30, P1097, DOI 10.1016/j.leukres.2006.01.001; Walz C, 2006, J BIOL CHEM, V281, P18177, DOI 10.1074/jbc.M600064200; Wang Z, 2001, J Vet Sci, V2, P167; White E, 2003, GENE DEV, V17, P1813, DOI 10.1101/gad.1123103; Yan B, 2003, J BIOL CHEM, V278, P45358, DOI 10.1074/jbc.M307933200; YANG E, 1995, CELL, V80, P285, DOI 10.1016/0092-8674(95)90411-5; Yu H, 2004, NAT REV CANCER, V4, P97, DOI 10.1038/nrc1275	43	78	89	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 21	2008	283	47					32334	32343		10.1074/jbc.M803813200	http://dx.doi.org/10.1074/jbc.M803813200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	372HW	18775810	hybrid			2022-12-27	WOS:000260893700020
J	Samways, DSK; Khakh, BS; Egan, TM				Samways, Damien S. K.; Khakh, Baljit S.; Egan, Terrance M.			Tunable Calcium Current through TRPV1 Receptor Channels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ROOT GANGLION NEURONS; CAPSAICIN RECEPTOR; VANILLOID RECEPTOR; CA2+ PERMEABILITY; CATION CHANNELS; SELECTIVITY; RESIDUE; DETERMINANTS; PERMEATION; ACTIVATION	TRPV1 receptors are polymodal cation channels that open in response to diverse stimuli including noxious heat, capsaicin, and protons. Because Ca2+ is vital for TRPV1 signaling, we sought to precisely measure its contribution to TRPV1 responses and discovered that the Ca2+ current was tuned by the mode of activation. Using patch clamp photometry, we found that the fraction of the total current carried by Ca2+ (called the Pf%) was significantly smaller for TRPV1 currents evoked by protons than for those evoked by capsaicin. Using site-directed mutagenesis, we discovered that the smaller Pf% was due to protonation of three acidic amino acids (Asp(646), Glu(648), and Glu(651)) that are located in the mouth of the pore. Thus, in keeping with recent reports of time-dependent changes in the ionic permeability of some ligand gated ion channels, we now show for the first time that the physiologically important Ca2+ current of the TRPV1 receptor is also dynamic and depends on the mode of activation. This current is significantly smaller when the receptor is activated by a change in pH, owing to atomic scale interactions of H+ and Ca2+ with the fixed negative charge of side chains in the pore.	[Samways, Damien S. K.; Egan, Terrance M.] St Louis Univ, Sch Med, Dept Pharmacol & Physiol Sci, St Louis, MO 63104 USA; [Samways, Damien S. K.; Egan, Terrance M.] St Louis Univ, Sch Med, Ctr Excellence Neurosci, St Louis, MO 63104 USA; [Khakh, Baljit S.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Physiol, Los Angeles, CA 90095 USA; [Khakh, Baljit S.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurobiol, Los Angeles, CA 90095 USA	Saint Louis University; Saint Louis University; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Samways, DSK (corresponding author), St Louis Univ, Sch Med, Dept Pharmacol & Physiol Sci, 1402 S Grand Blvd, St Louis, MO 63104 USA.	samwaysds@slu.edu		Egan, Terrance/0000-0002-7249-3161	National Institutes of Health	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported, in whole or in part, by National Institutes of Health grants (to T. M. E. and B. S. K.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Ahern GP, 2006, J BIOL CHEM, V281, P8991, DOI 10.1074/jbc.M513429200; Ahern GP, 2005, J NEUROSCI, V25, P5109, DOI 10.1523/JNEUROSCI.0237-05.2005; BORDO D, 1991, J MOL BIOL, V217, P721, DOI 10.1016/0022-2836(91)90528-E; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; Cheng W, 2007, J GEN PHYSIOL, V129, P191, DOI 10.1085/jgp.200709731; Chung MK, 2008, NAT NEUROSCI, V11, P555, DOI 10.1038/nn.2102; Dorostkar M. M., 2008, V184, P479; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; Egan TM, 2004, J NEUROSCI, V24, P3413, DOI 10.1523/JNEUROSCI.5429-03.2004; Frings S, 2000, METHOD ENZYMOL, V315, P797; Garcia-Martinez C, 2000, J BIOL CHEM, V275, P32552, DOI 10.1074/jbc.M002391200; HILLE B, 2004, IONIC CHANNELS EXCIT, P445; Jatzke C, 2003, J PHYSIOL-LONDON, V549, P439, DOI 10.1113/jphysiol.2002.034413; Jatzke C, 2002, J PHYSIOL-LONDON, V538, P25, DOI 10.1113/jphysiol.2001.012897; Khakh BS, 1999, NAT NEUROSCI, V2, P322, DOI 10.1038/7233; Mohapatra DP, 2003, MOL CELL NEUROSCI, V23, P314, DOI 10.1016/S1044-7431(03)00054-X; Nagy I, 1999, J NEUROSCI, V19, P10647, DOI 10.1523/JNEUROSCI.19-24-10647.1999; NEHER E, 1995, NEUROPHARMACOLOGY, V34, P1423, DOI 10.1016/0028-3908(95)00144-U; Nilius B, 2007, BBA-MOL BASIS DIS, V1772, P805, DOI 10.1016/j.bbadis.2007.02.002; Nilius B, 2007, PHYSIOL REV, V87, P165, DOI 10.1152/physrev.00021.2006; Oh U, 1996, J NEUROSCI, V16, P1659; Owsianik G, 2006, ANNU REV PHYSIOL, V68, P685, DOI 10.1146/annurev.physiol.68.040204.101406; Paus R, 2006, J CLIN INVEST, V116, P1174, DOI 10.1172/JCI28553; Premkumar LS, 2002, J PHYSIOL-LONDON, V545, P107, DOI 10.1113/jphysiol.2002.016352; Samways DSK, 2007, J GEN PHYSIOL, V129, P245, DOI 10.1085/jgp.200609677; SCHNEGGENBURGER R, 1993, NEURON, V11, P133, DOI 10.1016/0896-6273(93)90277-X; Skeberdis VA, 2006, NAT NEUROSCI, V9, P501, DOI 10.1038/nn1664; Sobczyk A, 2007, NEURON, V53, P17, DOI 10.1016/j.neuron.2006.11.016; Venkatachalam K, 2007, ANNU REV BIOCHEM, V76, P387, DOI 10.1146/annurev.biochem.75.103004.142819; VERNINO S, 1994, J NEUROSCI, V14, P5514; Virginio C, 1999, NAT NEUROSCI, V2, P315, DOI 10.1038/7225; Voets T, 2002, J BIOL CHEM, V277, P33704, DOI 10.1074/jbc.M204828200; Welch JM, 2000, P NATL ACAD SCI USA, V97, P13889, DOI 10.1073/pnas.230146497; Wu ZZ, 2005, J BIOL CHEM, V280, P18142, DOI 10.1074/jbc.M501229200; Zeilhofer HU, 1997, J PHYSIOL-LONDON, V503, P67, DOI 10.1111/j.1469-7793.1997.067bi.x	35	28	29	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 14	2008	283	46					31274	31278		10.1074/jbc.C800131200	http://dx.doi.org/10.1074/jbc.C800131200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	370KJ	18775990	Green Published, hybrid			2022-12-27	WOS:000260760800002
J	Balloy, V; Sallenave, JM; Wu, YZ; Touqui, L; Latge, JP; Si-Tahar, M; Chignard, M				Balloy, Viviane; Sallenave, Jean-Michel; Wu, Yongzheng; Touqui, Lhousseine; Latge, Jean-Paul; Si-Tahar, Mustapha; Chignard, Michel			Aspergillus fumigatus-induced Interleukin-8 Synthesis by Respiratory Epithelial Cells Is Controlled by the Phosphatidylinositol 3-Kinase, p38 MAPK, and ERK1/2 Pathways and Not by the Toll-like Receptor-MyD88 Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; INVASIVE PULMONARY ASPERGILLOSIS; BETA-GLUCAN RECEPTOR; INFLUENZA-A-VIRUS; INNATE IMMUNITY; HOST-DEFENSE; SIGNAL-TRANSDUCTION; GENE-TRANSCRIPTION; CYSTIC-FIBROSIS; LUNG	Previous studies have established that phagocytes are key cells of the pulmonary innate immune defense against A. fumigatus, an opportunistic fungus responsible of invasive pulmonary aspergillosis. Macrophages detect A. fumigatus via Toll-like receptors 2 and 4 (TLR2 and -4) and respond by the MyD88-NF-kappa B-dependent synthesis of inflammatory mediators. In the present study, we demonstrate that respiratory epithelial cells also sense A. fumigatus and participate in the host defense. Thus, the interaction of respiratory epithelial cells with germinating but not resting conidia of A. fumigatus results in interleukin (IL)- 8 synthesis that is controlled by phosphatidylinositol 3-kinase, p38 MAPK, and ERK1/2. Using MyD88-dominant negative transfected cells, we also show that IL-8 production is not dependent on the TLR-MyD88 pathway, although the MyD88 pathway is activated by A. fumigatus and leads to NF-kappa B activation. Thus, our results provide evidence for the existence of two independent signaling pathways activated in respiratory epithelial cells by A. fumigatus, one that is MyD88-dependent and another that is My88-independent and involved in IL-8 synthesis.	[Chignard, Michel] Inst Pasteur, INSERM, U874, F-75015 Paris, France; [Balloy, Viviane; Sallenave, Jean-Michel; Wu, Yongzheng; Touqui, Lhousseine; Si-Tahar, Mustapha; Chignard, Michel] Inst Pasteur, Unite Def Innee & Inflammat, F-75015 Paris, France; [Latge, Jean-Paul] Inst Pasteur, Unite Aspergillus, F-75015 Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Chignard, M (corresponding author), Inst Pasteur, INSERM, U874, 25 Rue Dr Roux, F-75015 Paris, France.	chignard@pasteur.fr	Latge, Jean Paul/C-9846-2014; Balloy, Viviane/B-8551-2014; Chignard, Michel/B-4351-2008; Si-Tahar, Mustapha/W-8034-2019; SI-TAHAR, Mustapha/L-4149-2014; SALLENAVE, Jean-Michel/J-3746-2017	Balloy, Viviane/0000-0001-9093-9676; Chignard, Michel/0000-0003-3810-6575; Si-Tahar, Mustapha/0000-0002-5792-7742; SI-TAHAR, Mustapha/0000-0002-5792-7742; SALLENAVE, Jean-Michel/0000-0002-8595-6970	Vaincre la Mucoviscidose	Vaincre la Mucoviscidose	This work was supported by the nonprofit association Vaincre la Mucoviscidose. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Alexopoulou L, 2005, CELL MOL LIFE SCI, V62, P1349, DOI 10.1007/s00018-005-5039-x; Balloy V, 2005, INFECT IMMUN, V73, P5420, DOI 10.1128/IAI.73.9.5420-5425.2005; Bals R, 2004, EUR RESPIR J, V23, P327, DOI 10.1183/09031936.03.00098803; Basu S, 2004, AM J PHYSIOL-LUNG C, V286, pL887, DOI 10.1152/ajplung.00323.2003; Bellocchio S, 2004, J IMMUNOL, V173, P7406, DOI 10.4049/jimmunol.173.12.7406; Bellocchio S, 2004, J IMMUNOL, V172, P3059, DOI 10.4049/jimmunol.172.5.3059; Berkova N, 2006, INT IMMUNOL, V18, P139, DOI 10.1093/intimm/dxh356; Blease K, 2001, INFLAMM RES, V50, P552, DOI 10.1007/PL00000233; Borger P, 1999, J INFECT DIS, V180, P1267, DOI 10.1086/315027; Braedel S, 2004, BRIT J HAEMATOL, V125, P392, DOI 10.1111/j.1365-2141.2004.04922.x; Bretz C, 2008, INFECT IMMUN, V76, P952, DOI 10.1128/IAI.00927-07; Chignard M, 2007, CLIN IMMUNOL, V124, P238, DOI 10.1016/j.clim.2007.05.004; Deane JA, 2004, ANNU REV IMMUNOL, V22, P563, DOI 10.1146/annurev.immunol.22.012703.104721; DENNIS LJ, 1991, CURR OPIN UROL, V1, P16; Franke TF, 1997, CELL, V88, P435, DOI 10.1016/S0092-8674(00)81883-8; Greene CM, 2005, ARCH IMMUNOL THER EX, V53, P418; Greene CM, 2005, J IMMUNOL, V174, P1638, DOI 10.4049/jimmunol.174.3.1638; Guillot L, 2005, J BIOL CHEM, V280, P5571, DOI 10.1074/jbc.M410592200; Guillot L, 2004, J BIOL CHEM, V279, P2712, DOI 10.1074/jbc.M305790200; Harant H, 1996, J BIOL CHEM, V271, P26954, DOI 10.1074/jbc.271.43.26954; Hoffmann E, 2002, J LEUKOCYTE BIOL, V72, P847; Hohl TM, 2005, PLOS PATHOG, V1, P232, DOI 10.1371/journal.ppat.0010030; Holtmann H, 1999, MOL CELL BIOL, V19, P6742; Le Goffic R, 2007, J IMMUNOL, V178, P3368, DOI 10.4049/jimmunol.178.6.3368; Li J, 2002, AM J PHYSIOL-LUNG C, V283, pL690, DOI 10.1152/ajplung.00060.2002; Mambula SS, 2002, J BIOL CHEM, V277, P39320, DOI 10.1074/jbc.M201683200; Marr KA, 2002, CLIN INFECT DIS, V34, P909, DOI 10.1086/339202; Mehrad B, 2002, AM J RESP CRIT CARE, V166, P1263, DOI 10.1164/rccm.200204-367OC; Mehrad B, 1999, J IMMUNOL, V163, P6086; Meier A, 2003, CELL MICROBIOL, V5, P561, DOI 10.1046/j.1462-5822.2003.00301.x; Message SD, 2004, J LEUKOCYTE BIOL, V75, P5, DOI 10.1189/jlb.0703315; Muir A, 2004, AM J RESP CELL MOL, V30, P777, DOI 10.1165/rcmb.2003-0329OC; Mukaida N, 2000, INT J HEMATOL, V72, P391; MUKAIDA N, 1990, J BIOL CHEM, V265, P21128; MUKAIDA N, 1994, J LEUKOCYTE BIOL, V56, P554, DOI 10.1002/jlb.56.5.554; Natoli G, 2005, NAT IMMUNOL, V6, P439, DOI 10.1038/ni1196; Netea MG, 2004, J LEUKOCYTE BIOL, V75, P749, DOI 10.1189/jlb.1103543; Netea MG, 2003, J INFECT DIS, V188, P320, DOI 10.1086/376456; Pahl HL, 1999, ONCOGENE, V18, P6853, DOI 10.1038/sj.onc.1203239; Paris S, 1997, INFECT IMMUN, V65, P1510, DOI 10.1128/IAI.65.4.1510-1514.1997; Pease James E, 2002, Am J Respir Med, V1, P19; Roilides E, 1998, RES IMMUNOL, V149, P454, DOI 10.1016/S0923-2494(98)80769-4; Saccani S, 2002, NAT IMMUNOL, V3, P69, DOI 10.1038/ni748; SCHAFFNER A, 1982, J CLIN INVEST, V69, P617, DOI 10.1172/JCI110489; Serrano-Gomez D, 2004, J IMMUNOL, V173, P5635, DOI 10.4049/jimmunol.173.9.5635; Sha Q, 2004, AM J RESP CELL MOL, V31, P358, DOI 10.1165/rcmb.2003-0388OC; Sirard JC, 2006, EUR J IMMUNOL, V36, P260, DOI 10.1002/eji.200535777; Slevogt H, 2006, AM J PHYSIOL-LUNG C, V290, pL818, DOI 10.1152/ajplung.00428.2005; Steele C, 2005, PLOS PATHOG, V1, P323, DOI 10.1371/journal.ppat.0010042; Taylor PR, 2002, J IMMUNOL, V169, P3876, DOI 10.4049/jimmunol.169.7.3876; Tomee JFC, 1997, J INFECT DIS, V176, P300, DOI 10.1086/517272; Vanden Berghe W, 2006, BIOCHEM PHARMACOL, V72, P1114, DOI 10.1016/j.bcp.2006.07.012; Walsh TJ, 2005, MED MYCOL, V43, pS165, DOI 10.1080/13693780500064672; Wang JE, 2001, INFECT IMMUN, V69, P2402, DOI 10.1128/IAI.69.4.2402-2406.2001; Wasylnka JA, 2003, J CELL SCI, V116, P1579, DOI 10.1242/jcs.00329; Wasylnka JA, 2002, INFECT IMMUN, V70, P3156, DOI 10.1128/IAI.70.6.3156-3163.2002; Whitmarsh AJ, 2007, BBA-MOL CELL RES, V1773, P1285, DOI 10.1016/j.bbamcr.2006.11.011; Winzen R, 1999, EMBO J, V18, P4969, DOI 10.1093/emboj/18.18.4969; Wright Jeffrey G, 2003, Am J Respir Med, V2, P211; Yang SH, 2003, GENE, V320, P3, DOI 10.1016/S0378-1119(03)00816-3; Zaas AK, 2005, TRENDS CARDIOVAS MED, V15, P195, DOI 10.1016/j.tcm.2005.07.001; Zhang ZH, 2005, J INFECTION, V51, P375, DOI 10.1016/j.jinf.2004.12.012	63	75	79	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 7	2008	283	45					30513	30521		10.1074/jbc.M803149200	http://dx.doi.org/10.1074/jbc.M803149200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	367ID	18703508	Green Submitted, Green Published, hybrid			2022-12-27	WOS:000260544800009
J	Cheung, J; Hendrickson, WA				Cheung, Jonah; Hendrickson, Wayne A.			Crystal Structures of C-4-Dicarboxylate Ligand Complexes with Sensor Domains of Histidine Kinases DcuS and DctB	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; SIGNAL-DETECTION; GENE-EXPRESSION; BINDING DOMAIN; SYSTEM; MOLSCRIPT; PROTEINS; PROGRAM; VERSION; SUITE	Two-component signaling systems allow bacteria to adapt to changing environments. Typically, a chemical or other stimulus is detected by the periplasmic sensor domain of a transmembrane histidine kinase sensor, which in turn relays a signal through a phosphotransfer cascade to the cognate cytoplasmic response regulator. Such systems lead ultimately to changes in gene expression or cell motility. Mechanisms of ligand binding and signal transduction through the cell membrane in histidine kinases are not fully understood. In an effort to further understand such processes, we have solved the crystal structures of the periplasmic sensor domains of Escherichia coli DcuS and of Vibrio cholerae DctB in complex with the respective cognate ligands, malate and succinate. Both proteins are involved in the regulation of the transport and metabolism of C-4-dicarboxylates, but they are not highly related by sequence similarity. Our work reveals that despite disparate sizes, both structures contain a similar characteristic alpha/beta PDC (PhoQ-DcuS-CitA) sensor-domain fold and display similar modes of ligand binding, suggesting similar mechanisms of function.	[Cheung, Jonah; Hendrickson, Wayne A.] Columbia Univ, Dept Biochem & Mol Biophys, New York, NY 10032 USA; [Hendrickson, Wayne A.] Columbia Univ, Howard Hughes Med Inst, New York, NY 10032 USA	Columbia University; Columbia University; Howard Hughes Medical Institute	Hendrickson, WA (corresponding author), Columbia Univ, Dept Biochem & Mol Biophys, New York, NY 10032 USA.	wayne@convex.hhmi.columbia.edu			National Institutes of Health [GM34102]; New York Structural Biology Center; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR012848] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM034102, R01GM034102] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); New York Structural Biology Center; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM34102, and it made use of Beamline X4A of the National Synchrotron Light Source at Brookhaven National Laboratory ( Department of Energy facility), which is supported by the New York Structural Biology Center. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Abrahams JP, 1996, ACTA CRYSTALLOGR D, V52, P30, DOI 10.1107/S0907444995008754; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Boeckmann B, 2003, NUCLEIC ACIDS RES, V31, P365, DOI 10.1093/nar/gkg095; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; CEDERGRENZEPPEZAUER ES, 1994, J MOL BIOL, V240, P459, DOI 10.1006/jmbi.1994.1461; Cheung J, 2008, J BIOL CHEM, V283, P13762, DOI 10.1074/jbc.M710592200; Cho US, 2006, J MOL BIOL, V356, P1193, DOI 10.1016/j.jmb.2005.12.032; Cohn E. J., 1943, PROTEINS AMINO ACIDS, P370; Cowtan K., 1994, JOINT CCP4 ESF EACBM, V31, P34; delaFortelle E, 1997, METHOD ENZYMOL, V276, P472, DOI 10.1016/S0076-6879(97)76073-7; Esnouf RM, 1997, J MOL GRAPH MODEL, V15, P132, DOI 10.1016/S1093-3263(97)00021-1; Giblin L, 1996, FEMS MICROBIOL LETT, V139, P19, DOI 10.1111/j.1574-6968.1996.tb08174.x; GIBLIN L, 1995, FEMS MICROBIOL LETT, V126, P25, DOI 10.1016/0378-1097(94)00520-2; Golby P, 1999, J BACTERIOL, V181, P1238, DOI 10.1128/JB.181.4.1238-1248.1999; GRASBERGER B, 1986, P NATL ACAD SCI USA, V83, P6258, DOI 10.1073/pnas.83.17.6258; HOLM L, 1993, J MOL BIOL, V233, P123, DOI 10.1006/jmbi.1993.1489; Janausch IG, 2002, J BIOL CHEM, V277, P39809, DOI 10.1074/jbc.M204482200; Janausch IG, 2002, BBA-BIOENERGETICS, V1553, P39, DOI 10.1016/S0005-2728(01)00233-X; JOHNSON ML, 1981, BIOPHYS J, V36, P575, DOI 10.1016/S0006-3495(81)84753-4; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Knight SD, 2000, ACTA CRYSTALLOGR D, V56, P42, DOI 10.1107/S0907444999012913; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; LAWRENCE MC, 1993, J MOL BIOL, V234, P946, DOI 10.1006/jmbi.1993.1648; METZGER H, 1992, J IMMUNOL, V149, P1477; MINTON AP, 1981, BIOPHYS CHEM, V14, P317, DOI 10.1016/0301-4622(81)85033-8; Neiditch MB, 2006, CELL, V126, P1095, DOI 10.1016/j.cell.2006.07.032; Neiditch MB, 2005, MOL CELL, V18, P507, DOI 10.1016/j.molcel.2005.04.020; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pappalardo L, 2003, J BIOL CHEM, V278, P39185, DOI 10.1074/jbc.C300344200; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; Reid CJ, 1998, J BACTERIOL, V180, P2660, DOI 10.1128/JB.180.10.2660-2669.1998; Reinelt S, 2003, J BIOL CHEM, V278, P39189, DOI 10.1074/jbc.M305864200; Robinson VL, 2000, NAT STRUCT BIOL, V7, P626, DOI 10.1038/77915; Sevvana M, 2008, J MOL BIOL, V377, P512, DOI 10.1016/j.jmb.2008.01.024; Stock AM, 2000, ANNU REV BIOCHEM, V69, P183, DOI 10.1146/annurev.biochem.69.1.183; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Waldburger CD, 1996, J BIOL CHEM, V271, P26630, DOI 10.1074/jbc.271.43.26630; West AH, 2001, TRENDS BIOCHEM SCI, V26, P369, DOI 10.1016/S0968-0004(01)01852-7; Wolanin PM, 2002, GENOME BIOL, V3; Yeh JI, 1996, J MOL BIOL, V262, P186, DOI 10.1006/jmbi.1996.0507; Zientz E, 1998, J BACTERIOL, V180, P5421, DOI 10.1128/JB.180.20.5421-5425.1998	42	82	84	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 31	2008	283	44					30256	30265		10.1074/jbc.M805253200	http://dx.doi.org/10.1074/jbc.M805253200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	364WS	18701447	Green Published, hybrid			2022-12-27	WOS:000260366900070
J	Gavard, J; Gutkind, JS				Gavard, Julie; Gutkind, J. Silvio			Protein Kinase C-related Kinase and ROCK Are Required for Thrombin-induced Endothelial Cell Permeability Downstream from G alpha(12/13) and G alpha(11/q)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HETEROTRIMERIC G-PROTEINS; LEUKEMIA-ASSOCIATED RHO; TYROSINE PHOSPHORYLATION; DEPENDENT ENDOCYTOSIS; MYOSIN PHOSPHATASE; P115 RHOGEF; CA2+ ENTRY; ACTIVATION; RECEPTOR; DOMAIN	Increase in vascular permeability occurs under many physiological conditions such as wound repair, inflammation, and thrombotic reactions and is central in diverse human pathologies, including tumor-induced angiogenesis, ocular diseases, and septic shock. Thrombin is a pro-coagulant serine protease, which causes the local loss of endothelial barrier integrity thereby enabling the rapid extravasation of plasma proteins and the local formation of fibrin-containing clots. Available information suggests that thrombin induces endothelial permeability by promoting actomyosin contractility through the Rho/ROCK signaling pathway. Here we took advantage of pharmacological inhibitors, knockdown approaches, and the emerging knowledge on how permeability factors affect endothelial junctions to investigate in detail the mechanism underlying thrombin-induced endothelial permeability. We show that thrombin signals through PAR-1 and its coupled G proteins G alpha(12/13) and G alpha(11/q) to induce RhoA activation and intracellular calcium elevation, and that these events are interrelated. In turn, this leads to the stimulation of ROCK, which causes actin stress-fiber formation. However, this alone is not sufficient to account for thrombin-induced permeability. Instead, we found that protein kinase C-related kinase, a Rho-dependent serine/threonine kinase, is activated in endothelial cells upon thrombin stimulation and that its expression is required for endothelial permeability and the remodeling of cell-extracellular matrix and cell-cell adhesions. Our results demonstrate that the signal initiated by thrombin bifurcates at the level of RhoA to promote changes in the cytoskeletal architecture through ROCK, and the remodeling of focal adhesion components through protein kinase C-related kinase. Ultimately, both pathways converge to cause cell-cell junction disruption and provoke vascular leakage.	[Gavard, Julie; Gutkind, J. Silvio] NIDCR, Oral & Pharyngeal Canc Branch, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR)	Gavard, J (corresponding author), Univ Paris 05, CNRS, INSERM,U567, Inst Cochin,UMR8104, 22 Rue Mechain, F-75014 Paris, France.	julie.gavard@inserm.fr	Gutkind, J. Silvio/A-1053-2009; Gavard, Julie/I-5487-2012; Gutkind, J. Silvio/J-1201-2016; Gavard, Julie/I-5487-2012	Gavard, Julie/0000-0002-7985-9007; Gutkind, J. Silvio/0000-0002-5150-4482; Gavard, Julie/0000-0003-3107-2026	National Institutes of Health; CNRS; INSERM; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [ZIADE000551] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [Z01DE000551] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CNRS(Centre National de la Recherche Scientifique (CNRS)); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported, in whole or in part, by National Institutes of Health grant (Intramural Research Program of NIDCR). This work was also supported by CNRS and INSERM. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Amano M, 1996, SCIENCE, V271, P648, DOI 10.1126/science.271.5249.648; Amerongen GPV, 2000, CIRC RES, V87, P335, DOI 10.1161/01.RES.87.4.335; Amerongen GPV, 1998, CIRC RES, V83, P1115, DOI 10.1161/01.RES.83.11.1115; Basile JR, 2007, J BIOL CHEM, V282, P34888, DOI 10.1074/jbc.M705467200; Birukova AA, 2004, FASEB J, V18, P1879, DOI 10.1096/fj.04-2328com; Booden MA, 2002, MOL CELL BIOL, V22, P4053, DOI 10.1128/MCB.22.12.4053-4061.2002; Coughlin SR, 2005, J THROMB HAEMOST, V3, P1800, DOI 10.1111/j.1538-7836.2005.01377.x; Davies SP, 2000, BIOCHEM J, V351, P95, DOI 10.1042/0264-6021:3510095; Dejana E, 2004, NAT REV MOL CELL BIO, V5, P261, DOI 10.1038/nrm1357; Dong LQ, 2000, P NATL ACAD SCI USA, V97, P5089, DOI 10.1073/pnas.090491897; EDGELL CJ, 1983, P NATL ACAD SCI-BIOL, V80, P3734, DOI 10.1073/pnas.80.12.3734; Eliceiri BP, 1999, MOL CELL, V4, P915, DOI 10.1016/S1097-2765(00)80221-X; Esser S, 1998, J CELL SCI, V111, P1853; Essler M, 1998, J BIOL CHEM, V273, P21867, DOI 10.1074/jbc.273.34.21867; Flynn P, 2000, J BIOL CHEM, V275, P11064, DOI 10.1074/jbc.275.15.11064; Fukuhara S, 2000, FEBS LETT, V485, P183, DOI 10.1016/S0014-5793(00)02224-9; Fukuhara S, 1999, J BIOL CHEM, V274, P5868, DOI 10.1074/jbc.274.9.5868; Gavard J, 2008, DEV CELL, V14, P25, DOI 10.1016/j.devcel.2007.10.019; Gavard J, 2006, NAT CELL BIOL, V8, P1223, DOI 10.1038/ncb1486; Goeckeler ZM, 2005, J BIOL CHEM, V280, P33083, DOI 10.1074/jbc.M503173200; Gorovoy M, 2005, J BIOL CHEM, V280, P26533, DOI 10.1074/jbc.M502921200; Hart MJ, 1998, SCIENCE, V280, P2112, DOI 10.1126/science.280.5372.2112; Kim YM, 2002, J BIOL CHEM, V277, P16340, DOI 10.1074/jbc.M200678200; Kimura K, 1996, SCIENCE, V273, P245, DOI 10.1126/science.273.5272.245; Klarenbach SW, 2003, CIRC RES, V92, P272, DOI 10.1161/01.RES.0000057386.15390.A3; KOLODNEY MS, 1992, J CELL BIOL, V117, P73, DOI 10.1083/jcb.117.1.73; Komarova Yulia A, 2007, Sci STKE, V2007, pre8; Kozasa T, 1998, SCIENCE, V280, P2109, DOI 10.1126/science.280.5372.2109; Li XC, 2004, BLOOD, V104, P1716, DOI 10.1182/blood-2003-11-3744; Maekawa M, 1999, SCIENCE, V285, P895, DOI 10.1126/science.285.5429.895; Maesaki R, 1999, MOL CELL, V4, P793, DOI 10.1016/S1097-2765(00)80389-5; Marinissen MJ, 2003, J BIOL CHEM, V278, P46814, DOI 10.1074/jbc.M305709200; Marinissen MJ, 2004, MOL CELL, V14, P29, DOI 10.1016/S1097-2765(04)00153-4; Mehta D, 2003, J BIOL CHEM, V278, P33492, DOI 10.1074/jbc.M302401200; Mehta D, 2001, J BIOL CHEM, V276, P22614, DOI 10.1074/jbc.M101927200; Mehta D, 2006, PHYSIOL REV, V86, P279, DOI 10.1152/physrev.00012.2005; Moy AB, 2002, AM J PHYSIOL-HEART C, V282, pH21, DOI 10.1152/ajpheart.2002.282.1.H21; Mukai H, 2003, J BIOCHEM, V133, P17, DOI 10.1093/jb/mvg019; Mukai H, 1997, J BIOL CHEM, V272, P4740, DOI 10.1074/jbc.272.8.4740; PALMER RH, 1994, FEBS LETT, V356, P5, DOI 10.1016/0014-5793(94)01202-4; Potter MD, 2005, J BIOL CHEM, V280, P31906, DOI 10.1074/jbc.M505568200; Red-Horse K, 2007, DEV CELL, V12, P181, DOI 10.1016/j.devcel.2007.01.013; Rojas RJ, 2007, J BIOL CHEM, V282, P29201, DOI 10.1074/jbc.M703458200; Singh I, 2007, J BIOL CHEM, V282, P7833, DOI 10.1074/jbc.M608288200; Stockton RA, 2004, J BIOL CHEM, V279, P46621, DOI 10.1074/jbc.M408877200; Takeya R, 2008, EMBO J, V27, P618, DOI 10.1038/emboj.2008.7; Tan WF, 2008, FASEB J, V22, P1829, DOI 10.1096/fj.07-096438; UEDA S, 1990, CIRC RES, V66, P957, DOI 10.1161/01.RES.66.4.957; UI M, 1990, ADV SEC MESS PHOSPH, V24, P63; Vogt S, 2003, J BIOL CHEM, V278, P28743, DOI 10.1074/jbc.M304570200; Vouret-Craviari V, 2003, J THROMB HAEMOST, V1, P1103, DOI 10.1046/j.1538-7836.2003.00238.x; Watanabe G, 1996, SCIENCE, V271, P645, DOI 10.1126/science.271.5249.645; Weis S, 2004, J CLIN INVEST, V113, P885, DOI 10.1172/JCI200420702; Weis SM, 2005, NATURE, V437, P497, DOI 10.1038/nature03987; Williams SL, 2007, GENE DEV, V21, P2731, DOI 10.1101/gad.1592007; Wirth A, 2008, NAT MED, V14, P64, DOI 10.1038/nm1666; Wojciak-Stothard B, 2001, J CELL SCI, V114, P1343; Xiao KY, 2005, MOL BIOL CELL, V16, P5141, DOI 10.1091/mbc.E05-05-0440; Xiao KY, 2003, J CELL BIOL, V163, P535, DOI 10.1083/jcb.200306001	59	69	72	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 31	2008	283	44					29888	29896		10.1074/jbc.M803880200	http://dx.doi.org/10.1074/jbc.M803880200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	364WS	18713748	Green Submitted, Green Published, Green Accepted, hybrid			2022-12-27	WOS:000260366900033
J	Samayawardhena, LA; Pallen, CJ				Samayawardhena, Lionel A.; Pallen, Catherine J.			Protein-tyrosine Phosphatase alpha Regulates Stem Cell Factor-dependent c-Kit Activation and Migration of Mast Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SRC-FAMILY KINASES; PTP-ALPHA; RPTP-ALPHA; HEMATOPOIETIC-CELLS; SIGNALING PATHWAYS; PI 3-KINASE; FYN KINASE; LYN KINASE; RECEPTOR; PHOSPHORYLATION	The role of protein-tyrosine phosphatase alpha (PTP alpha) in mast cell function was investigated in tissues and cells from PTP alpha-deficient mice. Bone marrow-derived mast cells (BMMCs) lacking PTP alpha exhibit defective stem cell factor (SCF)-dependent polarization and migration. Investigation of the molecular basis for this reveals that SCF/c-Kit-stimulated activation of the Fyn tyrosine kinase is impaired in PTP alpha(-/-) BMMCs, with a consequent inhibition of site-specific c-Kit phosphorylation at tyrosines 567/569 and 719. Although c-Kit-mediated activation of phosphatidylinositol 3-kinase and Akt is unaffected, profound defects occur in the activation of downstream signaling proteins, including mitogen-activated protein kinases and Rho GTPases. Phosphorylation and interaction of Fyn effectors Gab2 and Shp2, which are linked to Rac/JNK activation in mast cells, are impaired in PTP alpha(-/-) BMMCs. Thus, PTP alpha is required for SCF-induced c-Kit and Fyn activation, and in this way regulates a Fyn-based c-Kit signaling axis (Fyn/Gab2/Shp2/Vav/ PAK/Rac/JNK) that mediates mast cell migration. These defective signaling events may underlie the altered tissue-resident mast cell populations found in PTP alpha(-/-) mice.	[Samayawardhena, Lionel A.; Pallen, Catherine J.] Univ British Columbia, Dept Pediat, Vancouver, BC V5Z 4H4, Canada; [Pallen, Catherine J.] Univ British Columbia, Dept Pathol & Lab Med, Vancouver, BC V5Z 4H4, Canada; [Samayawardhena, Lionel A.; Pallen, Catherine J.] Univ British Columbia, Child & Family Res Inst, Vancouver, BC V5Z 4H4, Canada	University of British Columbia; University of British Columbia; Child & Family Research Institute; University of British Columbia	Pallen, CJ (corresponding author), 3102-950 W 28th Ave, Vancouver, BC V5Z 4H4, Canada.	cpallen@interchange.ubc.ca		Pallen, Catherine/0000-0002-3576-5295	Canadian Institutes of Health Research [MOP-49410]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported in part by Canadian Institutes of Health Research Grant MOP-49410. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Agosti V, 2004, J EXP MED, V199, P867, DOI 10.1084/jem.20031983; ALAI M, 1992, J BIOL CHEM, V267, P18021; Apice G, 2006, REV RECENT CLIN TRIA, V1, P35, DOI 10.2174/157488706775246175; Bodrikov V, 2005, J CELL BIOL, V168, P127, DOI 10.1083/jcb.200405073; Brown JM, 2008, CLIN EXP ALLERGY, V38, P4, DOI 10.1111/j.1365-2222.2007.02886.x; DENHERTOG J, 1993, EMBO J, V12, P3789, DOI 10.1002/j.1460-2075.1993.tb06057.x; Fukao T, 2002, NAT IMMUNOL, V3, P295, DOI 10.1038/ni768; Galli SJ, 2005, ANNU REV IMMUNOL, V23, P749, DOI 10.1146/annurev.immunol.21.120601.141025; Hernandez-Hansen V, 2004, J LEUKOCYTE BIOL, V75, P143, DOI 10.1189/jlb.0503224; Hong L, 2004, MOL CELL BIOL, V24, P1401, DOI 10.1128/MCB.24.3.1401-1410.2004; Kimura Y, 2004, P NATL ACAD SCI USA, V101, P6015, DOI 10.1073/pnas.0305363101; KITAMURA Y, 1989, ANNU REV IMMUNOL, V7, P59, DOI 10.1146/annurev.iy.07.040189.000423; Kostic A, 2007, J CELL SCI, V120, P3895, DOI 10.1242/jcs.009852; Kovanen PT, 2007, IMMUNOL REV, V217, P105, DOI 10.1111/j.1600-065X.2007.00515.x; Le HT, 2006, J NEUROCHEM, V98, P1798, DOI 10.1111/j.1471-4159.2006.04075.x; Lei G, 2002, EMBO J, V21, P2977, DOI 10.1093/emboj/cdf292; Lennartsson J, 2005, STEM CELLS, V23, P16, DOI 10.1634/stemcells.2004-0117; Linnekin D, 1997, J BIOL CHEM, V272, P27450, DOI 10.1074/jbc.272.43.27450; Maksumova L, 2005, J IMMUNOL, V175, P7947, DOI 10.4049/jimmunol.175.12.7947; Maksumova L, 2007, J BIOL CHEM, V282, P20925, DOI 10.1074/jbc.M703157200; Nishida K, 2002, BLOOD, V99, P1866, DOI 10.1182/blood.V99.5.1866; O'Laughlin-Bunner B, 2001, BLOOD, V98, P343, DOI 10.1182/blood.V98.2.343; Odom S, 2004, J EXP MED, V199, P1491, DOI 10.1084/jem.20040382; Okayama Y, 2006, IMMUNOL RES, V34, P97, DOI 10.1385/IR:34:2:97; Orfao A, 2007, BRIT J HAEMATOL, V138, P12, DOI 10.1111/j.1365-2141.2007.06619.x; Pallen CJ, 2003, CURR TOP MED CHEM, V3, P821, DOI 10.2174/1568026033452320; Petrone A, 2003, EMBO J, V22, P4121, DOI 10.1093/emboj/cdg399; Ponniah S, 1999, CURR BIOL, V9, P535, DOI 10.1016/S0960-9822(99)80238-3; Price DJ, 1997, J BIOL CHEM, V272, P5915, DOI 10.1074/jbc.272.9.5915; Price DJ, 1999, BIOCHEM BIOPH RES CO, V259, P611, DOI 10.1006/bbrc.1999.0840; Renneville A, 2008, LEUKEMIA, V22, P915, DOI 10.1038/leu.2008.19; Ronnstrand L, 2004, CELL MOL LIFE SCI, V61, P2535, DOI 10.1007/s00018-004-4189-6; Roskoski R, 2005, BIOCHEM BIOPH RES CO, V337, P1, DOI 10.1016/j.bbrc.2005.08.055; Samayawardhena LA, 2007, BLOOD, V109, P3679, DOI 10.1182/blood-2006-11-057315; Samayawardhena LA, 2006, CELL SIGNAL, V18, P1447, DOI 10.1016/j.cellsig.2005.11.005; Sayed BA, 2008, ANNU REV IMMUNOL, V26, P705, DOI 10.1146/annurev.immunol.26.021607.090320; SERVE H, 1994, J BIOL CHEM, V269, P6026; Shivakrupa R, 2005, CELL SIGNAL, V17, P103, DOI 10.1016/j.cellsig.2004.06.004; Skelton MR, 2003, BRAIN RES, V984, P1, DOI 10.1016/S0006-8993(03)02839-7; Su J, 1999, CURR BIOL, V9, P505, DOI 10.1016/S0960-9822(99)80234-6; Tan BL, 2003, BLOOD, V101, P4725, DOI 10.1182/blood-2002-08-2521; Timokhina I, 1998, EMBO J, V17, P6250, DOI 10.1093/emboj/17.21.6250; Tiran Z, 2006, MOL BIOL CELL, V17, P4330, DOI 10.1091/mbc.E06-02-0151; Tsai W, 1999, EMBO J, V18, P109, DOI 10.1093/emboj/18.1.109; Ueda S, 2002, BLOOD, V99, P3342, DOI 10.1182/blood.V99.9.3342; von Wichert G, 2003, J CELL BIOL, V161, P143, DOI 10.1083/jcb.200211061; Yang LT, 2002, J BIOL CHEM, V277, P17406, DOI 10.1074/jbc.M111902200; Ye H, 2008, EMBO J, V27, P188, DOI 10.1038/sj.emboj.7601939; Yu M, 2006, J BIOL CHEM, V281, P28615, DOI 10.1074/jbc.M603742200; Zeng L, 2003, J CELL BIOL, V160, P137, DOI 10.1083/jcb.200206049; Zeng L, 1999, J CELL BIOL, V147, P707, DOI 10.1083/jcb.147.4.707; Zheng XM, 2001, EMBO J, V20, P6037, DOI 10.1093/emboj/20.21.6037; ZHENG XM, 1992, NATURE, V359, P336, DOI 10.1038/359336a0	53	16	18	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 24	2008	283	43					29175	29185		10.1074/jbc.M804077200	http://dx.doi.org/10.1074/jbc.M804077200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	362EB	18725415	hybrid, Green Published			2022-12-27	WOS:000260179900045
J	Corriden, R; Chen, Y; Inoue, Y; Beldi, G; Robson, SC; Insel, PA; Junger, WG				Corriden, Ross; Chen, Yu; Inoue, Yoshiaki; Beldi, Guido; Robson, Simon C.; Insel, Paul A.; Junger, Wolfgang G.			Ecto-nucleoside triphosphate diphosphohydrolase 1 (E-NTPDase1/CD39) regulates neutrophil chemotaxis by hydrolyzing released ATP to adenosine	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOTIDE; ACTIVATION; EXPRESSION; CD39	Polymorphonuclear neutrophils release ATP in response to stimulation by chemoattractants, such as the peptide N-formyl-methionyl-leucyl-phenylalanine. Released ATP and the hydrolytic product adenosine regulate chemotaxis of neutrophils by sequentially activating purinergic nucleotide and adenosine receptors, respectively. Here we show that that ecto-nucleoside triphosphate diphosphohydrolase 1 (E-NTPDase1, CD39) is a critical enzyme for hydrolysis of released ATP by neutrophils and for cell migration in response to multiple agonists (N-formyl-methionyl-leucyl-phenylalanine, interleukin-8, and C5a). Upon stimulation of human neutrophils or differentiated HL-60 cells in a chemotactic gradient, E-NTPDase1 tightly associates with the leading edge of polarized cells during chemotaxis. Inhibition of E-NTPDase1 reduces the migration speed of neutrophils but not their ability to detect the orientation of the gradient field. Studies of neutrophils from E-NTPDase1 knockout mice reveal similar impairments of chemotaxis in vitro and in vivo. Thus, E-NTPDase1 plays an important role in regulating neutrophil chemotaxis by facilitating the hydrolysis of extracellular ATP.	[Chen, Yu; Inoue, Yoshiaki; Junger, Wolfgang G.] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Dept Surg, Boston, MA 02215 USA; [Beldi, Guido; Robson, Simon C.] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Dept Med, Boston, MA 02215 USA; [Corriden, Ross; Chen, Yu; Inoue, Yoshiaki; Junger, Wolfgang G.] Univ Calif San Diego, Dept Surg, La Jolla, CA 92093 USA; [Corriden, Ross; Insel, Paul A.] Univ Calif San Diego, Dept Med & Pharmacol, La Jolla, CA 92093 USA; [Corriden, Ross; Insel, Paul A.; Junger, Wolfgang G.] Univ Calif San Diego, Biomed Sci Grad Program, La Jolla, CA 92093 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego	Junger, WG (corresponding author), Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Dept Surg, 330 Brookline Ave, Boston, MA 02215 USA.	wjunger@bidmc.harvard.edu	Junger, Wolfgang G/I-1932-2013; Robson, Simon C./AAA-8537-2021	Junger, Wolfgang G/0000-0003-3350-8452; Beldi, Guido/0000-0002-9914-3807	National Institutes of Health [R01 GM51477, GM60475, HL076540, GM66232]; NIDDK Training Grant [DK 07202]; Congressionally Directed Medical Research Programs Grant [PR043034]; Novo Nordisk Fellowship; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL076540, R01HL063972] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007202] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM066232, R01GM060475, T32GM007752, R01GM051477] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIDDK Training Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Congressionally Directed Medical Research Programs Grant; Novo Nordisk Fellowship(Novo Nordisk); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 GM51477, GM60475 (to W. G. J.), HL076540 (to S. R. C.), and GM66232 (to P. A. I.) and NIDDK Training Grant DK 07202 (R. C.). This work was also supported by Congressionally Directed Medical Research Programs Grant PR043034 ( to W. G. J.) and a Novo Nordisk Fellowship ( to Y. C.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Bodin P, 2001, NEUROCHEM RES, V26, P959, DOI 10.1023/A:1012388618693; Burnstock G, 2006, BRIT J PHARMACOL, V147, pS172, DOI 10.1038/sj.bjp.0706429; Chen Y, 2004, J LEUKOCYTE BIOL, V76, P245, DOI 10.1189/jlb.0204066; Chen Y, 2006, SCIENCE, V314, P1792, DOI 10.1126/science.1132559; CRACK BE, 1995, BRIT J PHARMACOL, V114, P475, DOI 10.1111/j.1476-5381.1995.tb13251.x; Eltzschig HK, 2006, CIRC RES, V99, P1100, DOI 10.1161/01.RES.0000250174.31269.70; Enjyoji K, 1999, NAT MED, V5, P1010, DOI 10.1038/12447; Fredholm BB, 1997, GEN PHARMACOL-VASC S, V28, P345, DOI 10.1016/S0306-3623(96)00169-3; Goding JW, 2003, BBA-MOL BASIS DIS, V1638, P1, DOI 10.1016/S0925-4439(03)00058-9; Grenz A, 2007, FASEB J, V21, P2863, DOI 10.1096/fj.06-7947com; Heine P, 1999, EUR J BIOCHEM, V262, P102, DOI 10.1046/j.1432-1327.1999.00347.x; HOHENWALLNER W, 1973, CLIN CHIM ACTA, V45, P169, DOI 10.1016/0009-8981(73)90406-3; Hunsucker SA, 2005, PHARMACOL THERAPEUT, V107, P1, DOI 10.1016/j.pharmthera.2005.01.003; Junger WG, 1998, J CLIN INVEST, V101, P2768, DOI 10.1172/JCI1354; Kaczmarek E, 1996, J BIOL CHEM, V271, P33116, DOI 10.1074/jbc.271.51.33116; Kegel B, 1997, NEUROPHARMACOLOGY, V36, P1189, DOI 10.1016/S0028-3908(97)00115-9; Kirley TL, 1997, J BIOL CHEM, V272, P1076, DOI 10.1074/jbc.272.2.1076; Lazarowski ER, 2000, J BIOL CHEM, V275, P31061, DOI 10.1074/jbc.M003255200; Muller CE, 2006, BIOORG MED CHEM LETT, V16, P5943, DOI 10.1016/j.bmcl.2006.09.003; North RA, 2006, PFLUG ARCH EUR J PHY, V452, P479, DOI 10.1007/s00424-006-0060-y; OKUN DB, 1978, AM J HEMATOL, V4, P293, DOI 10.1002/ajh.2830040312; Robson Simon C, 2006, Purinergic Signal, V2, P409, DOI 10.1007/s11302-006-9003-5; Roman RM, 1999, AM J PHYSIOL-GASTR L, V277, pG1222, DOI 10.1152/ajpgi.1999.277.6.G1222; Schwiebert EM, 2003, BBA-BIOMEMBRANES, V1615, P7, DOI 10.1016/S0005-2736(03)00210-4; Sevigny J, 2002, BLOOD, V99, P2801, DOI 10.1182/blood.V99.8.2801; Vlajkovic SM, 1998, HEARING RES, V117, P71, DOI 10.1016/S0378-5955(98)00004-5; Wang TF, 1998, J BIOL CHEM, V273, P11392, DOI 10.1074/jbc.273.18.11392; Yegutkin G, 2000, BRIT J PHARMACOL, V129, P921, DOI 10.1038/sj.bjp.0703136; ZIMMERMANN H, 2000, HDB EXPT PHARM, P209; Zimmermann Herbert, 2006, Novartis Found Symp, V276, P113	30	94	96	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 17	2008	283	42					28480	28486		10.1074/jbc.M800039200	http://dx.doi.org/10.1074/jbc.M800039200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	359EN	18713747	Green Published, hybrid			2022-12-27	WOS:000259969300050
J	Ido, H; Ito, S; Taniguchi, Y; Hayashi, M; Sato-Nishiuchi, R; Sanzen, N; Hayashi, Y; Futaki, S; Sekiguchi, K				Ido, Hiroyuki; Ito, Shunsuke; Taniguchi, Yukimasa; Hayashi, Maria; Sato-Nishiuchi, Ryoko; Sanzen, Noriko; Hayashi, Yoshitaka; Futaki, Sugiko; Sekiguchi, Kiyotoshi			Laminin isoforms containing the gamma 3 chain are unable to bind to integrins due to the absence of the glutamic acid residue conserved in the C-terminal regions of the gamma 1 and gamma 2 chains	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALPHA-DYSTROGLYCAN-BINDING; CELL-ADHESION; GLOBULAR DOMAIN; LG MODULES; BASEMENT-MEMBRANES; SULFATIDE BINDING; SPLICE VARIANTS; EXPRESSION; RECOMBINANT; MIGRATION	Laminins are the major cell adhesive proteins in basement membranes, and consist of three subunits termed alpha, beta, and gamma. Recently, we found that the Glu residue at the third position from the C termini of the gamma 1 and gamma 2 chains is critically involved in integrin binding by laminins. However, the gamma 3 chain lacks this Glu residue, suggesting that laminin isoforms containing the gamma 3 chain may be unable to bind to integrins. To address this possibility, we expressed the E8 fragment of laminin-213 and found that it was incapable of binding to integrins. Similarly, the E8 fragment of laminin-113 was expressed and also found to be inactive in binding to integrins, confirming the distinction between the integrin binding activities of gamma 3 chain-containing isoforms and those containing the gamma 1 or gamma 2 chain. To further address the importance of the Glu residue, we swapped the C-terminal four amino acids of the gamma 3 chain with the C-terminal nine amino acids of the gamma 1 chain, which contain the Glu residue. The resulting chimeric E8 fragment of laminin-213 became fully active in integrin binding, whereas replacement with the nine amino acids of the gamma 1 chain after substitution of Gln for the conserved Glu residue failed to restore the integrin binding activity. These results provide both loss-of-function and gain-of-function evidence that laminin isoforms containing the gamma 3 chain are unable to bind to integrins due to the absence of the conserved Glu residue, which should play a critical role in integrin binding by laminins.	[Ido, Hiroyuki; Ito, Shunsuke; Taniguchi, Yukimasa; Hayashi, Maria; Sato-Nishiuchi, Ryoko; Sanzen, Noriko; Futaki, Sugiko; Sekiguchi, Kiyotoshi] Osaka Univ, Inst Prot Res, Lab Extracellular Matrix Biochem, Suita, Osaka 5650871, Japan; [Hayashi, Yoshitaka] Nagoya Univ, Environm Med Res Inst, Dept Genet, Nagoya, Aichi 4648601, Japan	Osaka University; Nagoya University	Sekiguchi, K (corresponding author), Osaka Univ, Inst Prot Res, Lab Extracellular Matrix Biochem, 3-2 Yamadaoka, Suita, Osaka 5650871, Japan.	sekiguch@protein.osaka-u.ac.jp	Hayashi, Yoshitaka/I-6168-2014	Hayashi, Yoshitaka/0000-0002-7557-4303; Sanzen, Noriko/0000-0001-6518-403X	New Energy and Industrial Technology Development Organization [17082005, 18370044]	New Energy and Industrial Technology Development Organization(New Energy and Industrial Technology Development Organization (NEDO))	This study was supported in part by Grants-in-Aid for Scientific Research (17082005 and 18370044 to K. S.) and Research Contract 06001294-0 with the New Energy and Industrial Technology Development Organization of Japan. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Airenne T, 1996, GENOMICS, V32, P54, DOI 10.1006/geno.1996.0076; Airenne T, 2000, CELL TISSUE RES, V300, P129, DOI 10.1007/s004410050054; Andac Z, 1999, J MOL BIOL, V287, P253, DOI 10.1006/jmbi.1999.2606; Arnaout MA, 2002, CURR OPIN CELL BIOL, V14, P641, DOI 10.1016/S0955-0674(02)00371-X; Aumailley M, 2005, MATRIX BIOL, V24, P326, DOI 10.1016/j.matbio.2005.05.006; Belkin AM, 2000, MICROSC RES TECHNIQ, V51, P280, DOI 10.1002/1097-0029(20001101)51:3<280::AID-JEMT7>3.0.CO;2-O; CHANG HC, 1994, P NATL ACAD SCI USA, V91, P11408, DOI 10.1073/pnas.91.24.11408; Colognato H, 2000, DEV DYNAM, V218, P213, DOI 10.1002/(SICI)1097-0177(200006)218:2<213::AID-DVDY1>3.0.CO;2-R; Cserhalmi-Friedman PB, 2001, BIOCHEM BIOPH RES CO, V280, P39, DOI 10.1006/bbrc.2000.4086; Denes V, 2007, VISUAL NEUROSCI, V24, P549, DOI 10.1017/S0952523807070514; DEUTZMANN R, 1990, EUR J BIOCHEM, V191, P513, DOI 10.1111/j.1432-1033.1990.tb19151.x; Egles C, 2007, MOL CELL NEUROSCI, V34, P288, DOI 10.1016/j.mcn.2006.11.004; Emsley J, 2000, CELL, V101, P47, DOI 10.1016/S0092-8674(00)80622-4; Fujiwara H, 2004, EXP CELL RES, V292, P67, DOI 10.1016/j.yexcr.2003.08.010; Fujiwara H, 2001, J BIOL CHEM, V276, P17550, DOI 10.1074/jbc.M010155200; Fukushima Y, 1998, INT J CANCER, V76, P63, DOI 10.1002/(SICI)1097-0215(19980330)76:1<63::AID-IJC11>3.0.CO;2-H; Gersdorff N, 2005, J BIOL CHEM, V280, P22146, DOI 10.1074/jbc.M501875200; Gu JG, 2002, J BIOL CHEM, V277, P19922, DOI 10.1074/jbc.M200383200; Gu JG, 2001, J BIOL CHEM, V276, P27090, DOI 10.1074/jbc.M102284200; Hager M, 2005, AM J PATHOL, V167, P823, DOI 10.1016/S0002-9440(10)62054-8; Hayashi Y, 2002, BIOCHEM BIOPH RES CO, V299, P498, DOI 10.1016/S0006-291X(02)02642-6; Henry MD, 1999, CURR OPIN CELL BIOL, V11, P602, DOI 10.1016/S0955-0674(99)00024-1; Hirosaki T, 2000, J BIOL CHEM, V275, P22495, DOI 10.1074/jbc.M001326200; HUMPHRIES MJ, 1990, J CELL SCI, V97, P585; HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S; Ido H, 2006, MATRIX BIOL, V25, P112, DOI 10.1016/j.matbio.2005.10.003; Ido H, 2004, J BIOL CHEM, V279, P10946, DOI 10.1074/jbc.M313626200; Ido H, 2007, J BIOL CHEM, V282, P11144, DOI 10.1074/jbc.M609402200; Iivanainen A, 1999, J BIOL CHEM, V274, P14107, DOI 10.1074/jbc.274.20.14107; KALLUNKI P, 1992, J CELL BIOL, V119, P679, DOI 10.1083/jcb.119.3.679; Knight CG, 2000, J BIOL CHEM, V275, P35, DOI 10.1074/jbc.275.1.35; Koch M, 1999, J CELL BIOL, V145, P605, DOI 10.1083/jcb.145.3.605; Kunneken K, 2004, J BIOL CHEM, V279, P5184, DOI 10.1074/jbc.M310424200; Li SH, 2005, J CELL BIOL, V169, P179, DOI 10.1083/jcb.200501098; Li SH, 2003, DEV CELL, V4, P613, DOI 10.1016/S1534-5807(03)00128-X; Libby RT, 2000, J NEUROSCI, V20, P6517, DOI 10.1523/JNEUROSCI.20-17-06517.2000; Meng XM, 2003, J INVEST DERMATOL, V121, P720, DOI 10.1046/j.1523-1747.2003.12515.x; Miner JH, 2008, MICROSC RES TECHNIQ, V71, P349, DOI 10.1002/jemt.20563; Navdaev Alexei, 2008, Exp Cell Res, V314, P489, DOI 10.1016/j.yexcr.2007.10.027; Nishiuchi R, 2006, MATRIX BIOL, V25, P189, DOI 10.1016/j.matbio.2005.12.001; Okamoto O, 2003, J BIOL CHEM, V278, P44168, DOI 10.1074/jbc.M300726200; PIERSCHBACHER MD, 1984, NATURE, V309, P30, DOI 10.1038/309030a0; Smirnov SP, 2002, J BIOL CHEM, V277, P18928, DOI 10.1074/jbc.M201880200; Smyth N, 1999, J CELL BIOL, V144, P151, DOI 10.1083/jcb.144.1.151; Sterk LMT, 2002, J CELL SCI, V115, P1161; SUNG U, 1993, J CELL BIOL, V123, P1255, DOI 10.1083/jcb.123.5.1255; Takagi J, 2001, NAT STRUCT BIOL, V8, P412, DOI 10.1038/87569; Talts JF, 2000, J BIOL CHEM, V275, P35192, DOI 10.1074/jbc.M003261200; Talts JF, 1999, EMBO J, V18, P863, DOI 10.1093/emboj/18.4.863; Timpl R, 2000, MATRIX BIOL, V19, P309, DOI 10.1016/S0945-053X(00)00072-X; von der Mark H, 2002, J BIOL CHEM, V277, P6012, DOI 10.1074/jbc.M102188200; Yan HHN, 2006, J BIOL CHEM, V281, P17286, DOI 10.1074/jbc.M513218200; Yu H, 2003, BIOCHEM J, V371, P289, DOI 10.1042/BJ20021500	53	39	40	2	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 17	2008	283	42					28149	28157		10.1074/jbc.M803553200	http://dx.doi.org/10.1074/jbc.M803553200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	359EN	18697739	hybrid, Green Published			2022-12-27	WOS:000259969300017
J	Burgess, BR; Dobson, RCJ; Bailey, MF; Atkinson, SC; Griffin, MDW; Jameson, GB; Parker, MW; Gerrard, JA; Perugini, MA				Burgess, Benjamin R.; Dobson, Renwick C. J.; Bailey, Michael F.; Atkinson, Sarah C.; Griffin, Michael D. W.; Jameson, Geoffrey B.; Parker, Michael W.; Gerrard, Juliet A.; Perugini, Matthew A.			Structure and evolution of a novel dimeric enzyme from a clinically important bacterial pathogen	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COLI DIHYDRODIPICOLINATE SYNTHASE; RESISTANT STAPHYLOCOCCUS-AUREUS; ESCHERICHIA-COLI; CRYSTAL-STRUCTURE; INHIBITION; DIFFRACTION; RESOLUTION	Dihydrodipicolinate synthase (DHDPS) catalyzes the first committed step of the lysine biosynthetic pathway. The tetrameric structure of DHDPS is thought to be essential for enzymatic activity, as isolated dimeric mutants of Escherichia coli DHDPS possess less than 2.5% that of the activity of the wildtype tetramer. It has recently been proposed that the dimeric form lacks activity due to increased dynamics. Tetramerization, by buttressing two dimers together, reduces dynamics in the dimeric unit and explains why all active bacterial DHDPS enzymes to date have been shown to be homo-tetrameric. However, in this study we demonstrate for the first time that DHDPS from methicillin-resistant Staphylococcus aureus (MRSA) exists in a monomer-dimer equilibrium in solution. Fluorescence-detected analytical ultracentrifugation was employed to show that the dimerization dissociation constant of MRSA-DHDPS is 33 nM in the absence of substrates and 29 nM in the presence of (S)-aspartate semialdehyde (ASA), but is 20-fold tighter in the presence of the substrate pyruvate (1.6 nM). The MRSA-DHDPS dimer exhibits a ping-pong kinetic mechanism (k(cat) = 70 +/- 2 s(-1), K-m(Pyruvate) = 0.11 +/- 0.01 mM, and K-m(ASA) = 0.22 +/- 0.02 mM) and shows ASA substrate inhibition with a K-si(ASA) of 2.7 +/- 0.9 mM. We also demonstrate that unlike the E. coli tetramer, the MRSA-DHDPS dimer is insensitive to lysine inhibition. The near atomic resolution (1.45 angstrom) crystal structure confirms the dimeric quaternary structure and reveals that the dimerization interface of the MRSA enzyme is more extensive in buried surface area and noncovalent contacts than the equivalent interface in tetrameric DHDPS enzymes from other bacterial species. These data provide a detailed mechanistic insight into DHDPS catalysis and the evolution of quaternary structure of this important bacterial enzyme.	[Burgess, Benjamin R.; Dobson, Renwick C. J.; Bailey, Michael F.; Atkinson, Sarah C.; Griffin, Michael D. W.; Parker, Michael W.; Perugini, Matthew A.] Univ Melbourne, Bio Mol Sci & Biotechnol Inst 21, Melbourne, Vic 3010, Australia; [Burgess, Benjamin R.; Dobson, Renwick C. J.; Bailey, Michael F.; Atkinson, Sarah C.; Griffin, Michael D. W.; Parker, Michael W.; Perugini, Matthew A.] Univ Melbourne, Dept Biochem & Mol Biol, Melbourne, Vic 3010, Australia; [Jameson, Geoffrey B.] Massey Univ, Inst Fundamental Sci, Struct Biol Ctr, Palmerston North 4442, New Zealand; [Parker, Michael W.] St Vincents Inst Med Res, Fitzroy, Vic 3065, Australia; [Gerrard, Juliet A.] Univ Canterbury, Sch Biol Sci, Christchurch 8140, New Zealand	University of Melbourne; University of Melbourne; Massey University; St. Vincent's Institute of Medical Research; University of Canterbury	Perugini, MA (corresponding author), Univ Melbourne, Bio Mol Sci & Biotechnol Inst 21, Melbourne, Vic 3010, Australia.	perugini@unimelb.edu.au	Dobson, Renwick/A-9188-2011; Dobson, Renwick/AAZ-7020-2021; Parker, Michael W/F-9069-2013	Dobson, Renwick/0000-0002-5506-4939; Parker, Michael W/0000-0002-3101-1138; Perugini, Matthew/0000-0001-8052-5584; Griffin, Michael/0000-0001-9845-7735; Jameson, Geoffrey/0000-0003-4839-0784; Atkinson, Sarah/0000-0002-3518-9785	Defense Threat Reduction Agency [W911NF-07-1-0105]; Australian Research Council [DP0770888, LX0776388]	Defense Threat Reduction Agency(United States Department of DefenseDefense Threat Reduction Agency); Australian Research Council(Australian Research Council)	This work was supported by Defense Threat Reduction Agency Contract W911NF-07-1-0105 and Australian Research Council Grants DP0770888 and LX0776388 for providing funding, an Australian postdoctoral fellowship (to M. A. P.) and a Federation fellowship (to M. W. P.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Blickling S, 1997, BIOCHEMISTRY-US, V36, P24, DOI 10.1021/bi962272d; Blickling S, 1997, J MOL BIOL, V274, P608, DOI 10.1006/jmbi.1997.1393; Burgess BR, 2008, ACTA CRYSTALLOGR F, V64, P659, DOI 10.1107/S1744309108016746; CASEWELL MW, 1986, J ANTIMICROB CHEMOTH, V18, P1; Chaix C, 1999, JAMA-J AM MED ASSOC, V282, P1745, DOI 10.1001/jama.282.18.1745; Coulter CV, 1999, PESTIC SCI, V55, P887, DOI 10.1002/(SICI)1096-9063(199909)55:9&lt;887::AID-PS36&gt;3.0.CO;2-B; DEJONGE BLM, 1992, J BIOL CHEM, V267, P11248; Demeler B, 2004, ANAL BIOCHEM, V335, P279, DOI 10.1016/j.ab.2004.08.039; Demeler B, 2005, ANALYTICAL ULTRACENTRIFUGATION: TECHNIQUES AND METHODS, P210; Diederichs K, 1997, NAT STRUCT BIOL, V4, P269, DOI 10.1038/nsb0497-269; Dobson RCJ, 2005, ACTA CRYSTALLOGR D, V61, P1116, DOI 10.1107/S0907444905016318; Dobson RCJ, 2004, BIOCHIMIE, V86, P311, DOI 10.1016/j.biochi.2004.03.008; Dobson RCJ, 2004, J MOL BIOL, V338, P329, DOI 10.1016/j.jmb.2004.02.060; Dobson RCJ, 2004, BIOCHEM J, V377, P757, DOI 10.1042/bj20031389; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Furuya EY, 2006, NAT REV MICROBIOL, V4, P36, DOI 10.1038/nrmicro1325; Griffin MDW, 2008, J MOL BIOL, V380, P691, DOI 10.1016/j.jmb.2008.05.038; Hutton CA, 2007, MOL BIOSYST, V3, P458, DOI 10.1039/b705624a; Kefala G, 2008, BIOCHEM J, V411, P351, DOI 10.1042/BJ20071360; Kobayashi K, 2003, P NATL ACAD SCI USA, V100, P4678, DOI 10.1073/pnas.0730515100; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; LAMZIN VS, 1993, ACTA CRYSTALLOGR D, V49, P129, DOI 10.1107/S0907444992008886; LASKOWSKI RA, 1993, J MOL BIOL, V231, P1049, DOI 10.1006/jmbi.1993.1351; Leslie A. G. W., 1992, JOINT CCP4 ESF EAMCB; Levy ED, 2008, NATURE, V453, P1262, DOI 10.1038/nature06942; McCoy AJ, 2007, ACTA CRYSTALLOGR D, V63, P32, DOI 10.1107/S0907444906045975; MIRWALDT C, 1995, J MOL BIOL, V246, P227, DOI 10.1006/jmbi.1994.0078; Pearce FG, 2006, BIOCHEM J, V400, P359, DOI 10.1042/BJ20060771; Perugini MA, 2005, EUR BIOPHYS J BIOPHY, V34, P469, DOI 10.1007/s00249-005-0491-y; Roberts SJ, 2003, BIOORG MED CHEM LETT, V13, P265, DOI 10.1016/S0960-894X(02)00923-X; Rubin RJ, 1999, EMERG INFECT DIS, V5, P9, DOI 10.3201/eid0501.990102; Sambrook J., 2001, MOL CLONING LAB MANU; SCHLEIFER KH, 1972, BACTERIOL REV, V36, P407, DOI 10.1128/MMBR.36.4.407-477.1972; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; SNOWDEN MA, 1990, EUR J BIOCHEM, V191, P373, DOI 10.1111/j.1432-1033.1990.tb19132.x; Sreerama N, 2000, ANAL BIOCHEM, V287, P252, DOI 10.1006/abio.2000.4880; Sreerama N, 1999, PROTEIN SCI, V8, P370; *UK HLTH PROT AG, 2004, STAPH AUR BACT LAB R; Vistica J, 2004, ANAL BIOCHEM, V326, P234, DOI 10.1016/j.ab.2003.12.014; Winn MD, 2001, ACTA CRYSTALLOGR D, V57, P122, DOI 10.1107/S0907444900014736	40	77	78	1	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 10	2008	283	41					27598	27603		10.1074/jbc.M804231200	http://dx.doi.org/10.1074/jbc.M804231200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	355OW	18684709	hybrid			2022-12-27	WOS:000259719200030
J	Levy, D; Reuven, N; Shaul, Y				Levy, Dan; Reuven, Nina; Shaul, Yosef			A regulatory circuit controlling itch-mediated p73 degradation by Runx	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							E3 UBIQUITIN LIGASE; KINASE C-ABL; DNA-DAMAGE; TYROSINE KINASE; PROTEIN LIGASE; TRANSCRIPTIONAL COACTIVATOR; APOPTOTIC RESPONSE; STABILIZES P73; FEEDBACK LOOP; P53	The members of the tumor suppressor p53 family are under tight regulation by distinct ubiquitin-protein isopeptide (E3) ligases. The level of p73 is regulated by the E3 ligase Itch. Itch levels are sharply reduced in response to DNA damage with concomitant p73 accumulation and activation. The mechanism of controlling Itch level is not known. We show that the Itch promoter is a target of the transcription activator Runx. Yes-associated protein (Yap1) is a shared transcription co-activator of Runx and p73. Under normal conditions, the Runx-Yap1 complex binds the Itch promoter and supports its transcription and p73 degradation. In response to DNA damage, Yap1 is phosphorylated by c-Abl at the position Tyr-357. The modified Yap1 does not co-activate Runx in supporting Itch transcription. The subsequent reduction in the Itch level gives rise to p73 accumulation. These results demonstrate how Yap1 supports degradation of p73 via Runx and how it plays an opposite role in response to DNA damage.	[Levy, Dan; Reuven, Nina; Shaul, Yosef] Weizmann Inst Sci, Dept Mol Genet, IL-76100 Rehovot, Israel	Weizmann Institute of Science	Shaul, Y (corresponding author), Weizmann Inst Sci, Dept Mol Genet, IL-76100 Rehovot, Israel.	Yosef.Shaul@weizmann.ac.il	Levy, Dan/AAF-1871-2021; Levy, Dan/A-3226-2013; Reuven, Nina/AAM-8711-2020	Levy, Dan/0000-0003-0719-0305; Reuven, Nina/0000-0003-1569-3818	Samuel Waxman Cancer Research Foundation; Federal German Ministry for Education and Research; The Israel Science Foundation [1040/03-18.2]	Samuel Waxman Cancer Research Foundation; Federal German Ministry for Education and Research(Federal Ministry of Education & Research (BMBF)); The Israel Science Foundation(Israel Science Foundation)	This work was supported by grants from the Samuel Waxman Cancer Research Foundation, from the Minerva Foundation with funding from the Federal German Ministry for Education and Research, and from The Israel Science Foundation (Grant 1040/03-18.2). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Agami R, 1999, NATURE, V399, P809; Ainbinder E, 2002, MOL CELL BIOL, V22, P6354, DOI 10.1128/MCB.22.18.6354-6362.2002; Balint E, 1999, ONCOGENE, V18, P3923, DOI 10.1038/sj.onc.1202781; BARAK Y, 1993, EMBO J, V12, P461, DOI 10.1002/j.1460-2075.1993.tb05678.x; Bunz F, 1998, SCIENCE, V282, P1497, DOI 10.1126/science.282.5393.1497; Camargo FD, 2007, CURR BIOL, V17, P2054, DOI 10.1016/j.cub.2007.10.039; Chang LF, 2006, CELL, V124, P601, DOI 10.1016/j.cell.2006.01.021; Danovi SA, 2008, CELL DEATH DIFFER, V15, P217, DOI 10.1038/sj.cdd.4402226; Dornan D, 2004, NATURE, V429, P86, DOI 10.1038/nature02514; Gallagher E, 2006, P NATL ACAD SCI USA, V103, P1717, DOI 10.1073/pnas.0510664103; Gao BX, 2006, J BIOL CHEM, V281, P29711, DOI 10.1074/jbc.M604596200; Gao M, 2004, SCIENCE, V306, P271, DOI 10.1126/science.1099414; Gong JG, 1999, NATURE, V399, P806; Haupt Y, 1997, NATURE, V387, P296, DOI 10.1038/387296a0; Irwin MS, 2001, CELL GROWTH DIFFER, V12, P337; JUVEN T, 1993, ONCOGENE, V8, P3411; Kubbutat MHG, 1997, NATURE, V387, P299, DOI 10.1038/387299a0; Lahav G, 2004, NAT GENET, V36, P147, DOI 10.1038/ng1293; Leng RP, 2003, CELL, V112, P779, DOI 10.1016/S0092-8674(03)00193-4; Levy D, 2007, CELL DEATH DIFFER, V14, P743, DOI 10.1038/sj.cdd.4402063; Levy D, 2008, MOL CELL, V29, P350, DOI 10.1016/j.molcel.2007.12.022; Lubelsky Y, 2005, MOL CELL BIOL, V25, P10665, DOI 10.1128/MCB.25.23.10665-10673.2005; MEYERS S, 1993, MOL CELL BIOL, V13, P6336, DOI 10.1128/MCB.13.10.6336; MOMAND J, 1992, CELL, V69, P1237, DOI 10.1016/0092-8674(92)90644-R; Nelson JD, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gnj004; Oberst A, 2007, P NATL ACAD SCI USA, V104, P11280, DOI 10.1073/pnas.0701773104; Overholtzer M, 2006, P NATL ACAD SCI USA, V103, P12405, DOI 10.1073/pnas.0605579103; Perry WL, 1998, NAT GENET, V18, P143, DOI 10.1038/ng0298-143; Qiu L, 2000, J BIOL CHEM, V275, P35734, DOI 10.1074/jbc.M007300200; Rossi M, 2005, EMBO J, V24, P836, DOI 10.1038/sj.emboj.7600444; Rossi M, 2006, P NATL ACAD SCI USA, V103, P12753, DOI 10.1073/pnas.0603449103; Sanchez-Prieto R, 2002, ONCOGENE, V21, P974, DOI 10.1038/sj.onc.1205134; Schindler T, 2000, SCIENCE, V289, P1938, DOI 10.1126/science.289.5486.1938; Shaul Y, 2005, CELL RES, V15, P33, DOI 10.1038/sj.cr.7290261; Strano S, 2005, MOL CELL, V18, P447, DOI 10.1016/j.molcel.2005.04.008; Thut CJ, 1997, GENE DEV, V11, P1974, DOI 10.1101/gad.11.15.1974; Tsai KKC, 2003, CANCER RES, V63, P3418; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; WU XW, 1993, GENE DEV, V7, P1126, DOI 10.1101/gad.7.7a.1126; Yagi R, 1999, EMBO J, V18, P2551, DOI 10.1093/emboj/18.9.2551; Yang A, 2006, MOL CELL, V24, P593, DOI 10.1016/j.molcel.2006.10.018; Yuan ZM, 1999, NATURE, V399, P814, DOI 10.1038/21704; Zender L, 2006, CELL, V125, P1253, DOI 10.1016/j.cell.2006.05.030	43	41	41	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 10	2008	283	41					27462	27468		10.1074/jbc.M803941200	http://dx.doi.org/10.1074/jbc.M803941200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	355OW	18701449	hybrid			2022-12-27	WOS:000259719200016
J	Papic, N; Hunn, JP; Pawlowski, N; Zerrahn, J; Howard, JC				Papic, Natasa; Hunn, Julia P.; Pawlowski, Nikolaus; Zerrahn, Jens; Howard, Jonathan C.			Inactive and Active States of the Interferon-inducible Resistance GTPase, Irga6, in Vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IFN-GAMMA; TOXOPLASMA-GONDII; HOST-RESISTANCE; MICE DEFICIENT; INFECTION; LRG-47; MOUSE; PROTEINS; IRGB10; IIGP1	Irga6, a myristoylated, interferon-inducible member of the immunity-related GTPase family, contributes to disease resistance against Toxoplasma gondii in mice. Accumulation of Irga6 on the T. gondii parasitophorous vacuole membrane is associated with vesiculation and ultimately disruption of the vacuolar membrane in a process that requires an intact GTP-binding domain. The role of the GTP-binding domain of Irga6 in pathogen resistance is, however, unclear. We provide evidence that Irga6 in interferon-induced, uninfected cells is predominantly in a GDP-bound state that is maintained by other interferon-induced proteins. However, Irga6 that accumulates on the parasitophorous vacuole membrane after Toxoplasma infection is in the GTP-bound form. We demonstrate that a monoclonal antibody, 10D7, specifically detects GTP-bound Irga6, and we show that the formation of the 10D7 epitope follows from a GTP-dependent conformational transition of the N terminus of Irga6, anticipating an important role of the myristoyl group on Irga6 function in vivo.	[Papic, Natasa; Hunn, Julia P.; Pawlowski, Nikolaus; Howard, Jonathan C.] Univ Cologne, Inst Genet, Dept Cell Genet, D-50674 Cologne, Germany; [Zerrahn, Jens] Max Planck Inst Infect Biol, Dept Immunol, D-10117 Berlin, Germany	University of Cologne; Max Planck Society	Howard, JC (corresponding author), Univ Cologne, Inst Genet, Dept Cell Genet, Zulpicher Str 47, D-50674 Cologne, Germany.	j.howard@uni-koeln.de		Howard, Jonathan/0000-0003-2756-5143	Deutsche Forschungsgemeinschaft [SPP1110, SFB635, SFB670]; University of Cologne	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); University of Cologne	This study was supported by Deutsche Forschungsgemeinschaft Grants SPP1110, SFB635, and SFB670 and by the University of Cologne. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	Antonny B, 1997, BIOCHEMISTRY-US, V36, P4675, DOI 10.1021/bi962252b; BEKPEN C, 2005, GENOME BIOL, V92, pR1; Bernstein-Hanley I, 2006, P NATL ACAD SCI USA, V103, P14092, DOI 10.1073/pnas.0603338103; Boehm U, 1998, J IMMUNOL, V161, P6715; Butcher BA, 2005, INFECT IMMUN, V73, P3278, DOI 10.1128/IAI.73.6.3278-3286.2005; Cardoso RMF, 2005, IMMUNITY, V22, P163, DOI 10.1016/j.immuni.2004.12.011; Coers J, 2008, J IMMUNOL, V180, P6237, DOI 10.4049/jimmunol.180.9.6237; Collazo CM, 2001, J EXP MED, V194, P181, DOI 10.1084/jem.194.2.181; FAZEKAS SDS, 1963, BIOCHIM BIOPHYS ACTA, V71, P377; Feng CG, 2004, J IMMUNOL, V172, P1163, DOI 10.4049/jimmunol.172.2.1163; Ghosh A, 2004, MOL CELL, V15, P727, DOI 10.1016/j.molcel.2004.07.017; GILLINGHAM AK, 2007, ANN REV CELL DEV BIO; Goldberg J, 1998, CELL, V95, P237, DOI 10.1016/S0092-8674(00)81754-7; GORINI G, 1969, J IMMUNOL, V103, P1132; Halonen SK, 2001, INFECT IMMUN, V69, P5573, DOI 10.1128/IAI.69.9.5573-5576.2001; HARLOW E, 1988, ANTIBODIES LAB MANUA, P516; HINSHAW JE, 1995, NATURE, V374, P190, DOI 10.1038/374190a0; Hunn JP, 2008, EMBO J, V27, P2495, DOI 10.1038/emboj.2008.176; KLEINECKE J, 1979, FEBS LETT, V107, P1255; Ling YM, 2006, J EXP MED, V203, P2063, DOI 10.1084/jem.20061318; Lu SM, 2002, J BIOL CHEM, V277, P23515, DOI 10.1074/jbc.M201981200; MacMicking JD, 2003, SCIENCE, V302, P654, DOI 10.1126/science.1088063; Martens S, 2004, J IMMUNOL, V173, P2594, DOI 10.4049/jimmunol.173.4.2594; Martens S, 2005, PLOS PATHOG, V1, P187, DOI 10.1371/journal.ppat.0010024; Miyairi I, 2007, J IMMUNOL, V179, P1814, DOI 10.4049/jimmunol.179.3.1814; Nelson DE, 2005, P NATL ACAD SCI USA, V102, P10658, DOI 10.1073/pnas.0504198102; Santiago HC, 2005, J IMMUNOL, V175, P8165, DOI 10.4049/jimmunol.175.12.8165; TAINER JA, 1985, ANNU REV IMMUNOL, V3, P501, DOI 10.1146/annurev.iy.03.040185.002441; Taylor GA, 1997, J BIOL CHEM, V272, P10639; Taylor GA, 2000, P NATL ACAD SCI USA, V97, P751, DOI 10.1073/pnas.97.2.751; THORNTON JM, 1986, EMBO J, V5, P409, DOI 10.1002/j.1460-2075.1986.tb04226.x; TUMA PL, 1995, J BIOL CHEM, V270, P26707, DOI 10.1074/jbc.270.44.26707; Uthaiah RC, 2003, J BIOL CHEM, V278, P29336, DOI 10.1074/jbc.M211973200	33	43	44	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 14	2008	283	46					32143	32151		10.1074/jbc.M804846200	http://dx.doi.org/10.1074/jbc.M804846200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	370KJ	18784077	hybrid, Green Published			2022-12-27	WOS:000260760800095
J	Paredes-Gamero, EJ; Leon, CMMP; Borojevic, R; Oshiro, MEM; Ferreira, AT				Paredes-Gamero, Edgar J.; Leon, Carlos M. M. P.; Borojevic, Radovan; Oshiro, Maria E. M.; Ferreira, Alice T.			Changes in Intracellular Ca2+ Levels Induced by Cytokines and P2 Agonists Differentially Modulate Proliferation or Commitment with Macrophage Differentiation in Murine Hematopoietic Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-C; BONE-MARROW; SIGNALING PATHWAYS; GAP-JUNCTIONS; STEM-CELLS; IN-VITRO; RECEPTOR; CONNEXIN-43; PROGENITORS; ACTIVATION	The role of intracellular Ca2+ (Ca-i(2+)) on hematopoiesis was investigated in long term bone marrow cultures using cytokines and agonists of P2 receptors. Cytokines interleukin 3 and granulocyte/macrophage colony stimulator factor promoted a modest increase in Ca-i(2+) concentration ([Ca2+](i)) with activation of phospholipase C gamma, MEK1/2, and Ca2+/calmodulin kinase II. Involvement of protein kinase C was restricted to stimulation with interleukin 3. In addition, these cytokines promoted proliferation (20 times) and an increase in the Gr-1(-)Mac-1(+) population with participation of gap junctions (GJ). Nevertheless ATP, ADP, and UTP promoted a large increase in [Ca2+](i), moderate proliferation (6 times), a reduction in the primitive Gr-1(-)Mac-1(-)c-Kit(+) population, and differentiation into macrophages without participation of GJ. It is likely that Ca-i(2+) participates as a regulator of hematopoietic signaling: moderate increases in [Ca2+](i) would be related to cytokine-dependent proliferation with participation of GJ, whereas high increases in [Ca2+](i) would be related to macrophage differentiation without maintenance of the primitive population.	[Paredes-Gamero, Edgar J.; Leon, Carlos M. M. P.; Oshiro, Maria E. M.; Ferreira, Alice T.] Univ Fed Sao Paulo, Dept Biophys, BR-04023062 Sao Paulo, Brazil; [Borojevic, Radovan] Univ Fed Rio de Janeiro, Dept Histol & Embryol, BR-21941970 Rio De Janeiro, Brazil	Universidade Federal de Sao Paulo (UNIFESP); Universidade Federal do Rio de Janeiro	Paredes-Gamero, EJ (corresponding author), Univ Fed Sao Paulo, Dept Biophys, Rua Botucatu 862, BR-04023062 Sao Paulo, Brazil.	jean@biofis.epm.br	Borojevic, Radovan/V-8500-2019; Paredes-Gamero, Edgar J/C-4791-2012	Borojevic, Radovan/0000-0002-2393-7280; Paredes-Gamero, Edgar J/0000-0003-3686-8402	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This work was supported by "Fundacao de Amparo a Pesquisa do Estado de Sao Paulo."	Adrian K, 2000, BBA-GENE STRUCT EXPR, V1492, P127, DOI 10.1016/S0167-4781(00)00094-4; BERRIDGE MJ, 1984, NATURE, V312, P315, DOI 10.1038/312315a0; Bodin P, 2001, NEUROCHEM RES, V26, P959, DOI 10.1023/A:1012388618693; Bradley HL, 2002, BLOOD, V100, P3983, DOI 10.1182/blood-2002-05-1602; Cancelas JA, 2000, BLOOD, V96, P498; CARROLL MP, 1994, J BIOL CHEM, V269, P1249; Clifford EE, 1998, BLOOD, V91, P3172, DOI 10.1182/blood.V91.9.3172.3172_3172_3181; Collison K, 1998, J IMMUNOL, V161, P3737; Czerniecki BJ, 1997, J IMMUNOL, V159, P3823; DEXTER TM, 1977, J CELL PHYSIOL, V91, P335, DOI 10.1002/jcp.1040910303; Di Virgilio F, 2001, BLOOD, V97, P587, DOI 10.1182/blood.V97.3.587; Duncan AW, 2005, NAT IMMUNOL, V6, P314, DOI 10.1038/ni1164; Durig J, 2000, BRIT J HAEMATOL, V111, P416, DOI 10.1046/j.1365-2141.2000.02385.x; Dutt P, 1998, J IMMUNOL, V161, P3652; Engels FHC, 1999, P NATL ACAD SCI USA, V96, P10332, DOI 10.1073/pnas.96.18.10332; Frimberger AE, 2001, BRIT J HAEMATOL, V112, P644, DOI 10.1046/j.1365-2141.2001.02542.x; Hoebertz A, 2003, TRENDS PHARMACOL SCI, V24, P290, DOI 10.1016/S0165-6147(03)00123-8; Katayama Y, 2006, CELL, V124, P407, DOI 10.1016/j.cell.2005.10.041; Kitsos CM, 2005, J BIOL CHEM, V280, P33101, DOI 10.1074/jbc.M505208200; Koski GK, 1999, J IMMUNOL, V163, P82; Krenacs T, 1998, AM J PATHOL, V152, P993; Lemaire I, 2006, J IMMUNOL, V177, P7257, DOI 10.4049/jimmunol.177.10.7257; Lemoli RM, 2004, BLOOD, V104, P1662, DOI 10.1182/blood-2004-03-0834; Montecino-Rodriguez E, 2000, BLOOD, V96, P917, DOI 10.1182/blood.V96.3.917.015k45_917_924; NELSON MT, 1995, SCIENCE, V270, P633, DOI 10.1126/science.270.5236.633; Paraguassu-Braga FH, 2003, CELL DEATH DIFFER, V10, P1101, DOI 10.1038/sj.cdd.4401279; Paredes-Gamero EJ, 2007, EXP GERONTOL, V42, P320, DOI 10.1016/j.exger.2006.11.011; Paredes-Gamero EJ, 2006, EUR J PHARMACOL, V534, P30, DOI 10.1016/j.ejphar.2006.01.010; QUESENBERRY PJ, 1994, BLOOD CELLS, V20, P97; Reya T, 2003, NATURE, V423, P409, DOI 10.1038/nature01593; ROSENDAAL M, 1994, J CELL SCI, V107, P29; Rossi F, 1996, EMBO J, V15, P1894, DOI 10.1002/j.1460-2075.1996.tb00540.x; Rossi L, 2007, BLOOD, V109, P533, DOI 10.1182/blood-2006-01-035634; Rothermel Annette L., 2004, BMC Immunology, V5, P1; Thrower EC, 2001, TRENDS PHARMACOL SCI, V22, P580, DOI 10.1016/S0165-6147(00)01809-5; Thuringer D, 2004, ANN NY ACAD SCI, V1030, P14, DOI 10.1196/annals.1329.003; Tonon R, 2002, BIORHEOLOGY, V39, P153; WAHL MI, 1988, SCIENCE, V241, P968, DOI 10.1126/science.2457254; Wandzioch E, 2004, BLOOD, V104, P51, DOI 10.1182/blood-2003-07-2554; WHETTON AD, 1988, BIOCHEM J, V256, P585, DOI 10.1042/bj2560585	40	26	26	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 14	2008	283	46					31909	31919		10.1074/jbc.M801990200	http://dx.doi.org/10.1074/jbc.M801990200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	370KJ	18775989	hybrid			2022-12-27	WOS:000260760800073
J	Burke, JE; Hsu, YH; Deems, RA; Li, S; Woods, VL; Dennis, EA				Burke, John E.; Hsu, Yuan-Hao; Deems, Raymond A.; Li, Sheng; Woods, Virgil L., Jr.; Dennis, Edward A.			A Phospholipid Substrate Molecule Residing in the Membrane Surface Mediates Opening of the Lid Region in Group IVA Cytosolic Phospholipase A(2)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EXCHANGE MASS-SPECTROMETRY; LIPID-BINDING DOMAIN; C2 DOMAIN; CRYSTAL-STRUCTURE; CATALYTIC DOMAIN; INTERFACIAL BINDING; HYDROGEN-EXCHANGE; PROTEIN; ACTIVATION; LIPASE	The Group IVA (GIVA) phospholipase A(2) associates with natural membranes in response to an increase in intracellular Ca2+ along with increases in certain lipid mediators. This enzyme associates with the membrane surface as well as binding a single phospholipid molecule in the active site for catalysis. Employing deuterium exchange mass spectrometry, we have identified the regions of the protein binding the lipid surface and conformational changes upon a single phospholipid binding in the absence of a lipid surface. Experiments were carried out using natural palmitoyl arachidonyl phosphatidylcholine vesicles with the intact GIVA enzyme as well as the isolated C2 and catalytic domains. Lipid binding produced changes in deuterium exchange in eight different regions of the protein. The regions with decreased exchange included Ca2+ binding loop one, which has been proposed to penetrate the membrane surface, and a charged patch of residues, which may be important in interacting with the polar head groups of phospholipids. The regions with an increase in exchange are all located either in the hydrophobic core underneath the lid region or near the lid and hinge regions from 403 to 457. Using the GIVA phospholipase A2 irreversible inhibitor methyl-arachidonyl fluorophosphonate, we were able to isolate structural changes caused only by pseudo-substrate binding. This produced results that were very similar to natural lipid binding in the presence of a lipid interface with the exception of the C2 domain and region 466-470. This implies that most of the changes seen in the catalytic domain are due to a substrate-mediated, not interface-mediated, lid opening, which exposes the active site to water. Finally experiments carried out with inhibitor plus phospholipid vesicles showed decreases at the C2 domain as well as charged residues on the putative membrane binding surface of the catalytic domain revealing the binding sites of the enzyme to the lipid surface.	[Li, Sheng; Woods, Virgil L., Jr.] Univ Calif, Dept Med & Biomed Sci, Grad Program, La Jolla, CA 92093 USA; [Burke, John E.; Hsu, Yuan-Hao; Deems, Raymond A.; Dennis, Edward A.] Univ Calif, Dept Chem & Biochem, La Jolla, CA 92093 USA; [Burke, John E.; Hsu, Yuan-Hao; Deems, Raymond A.; Dennis, Edward A.] Univ Calif, Dept Pharmacol, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego	Woods, VL (corresponding author), Univ Calif, Dept Med & Biomed Sci, Grad Program, La Jolla, CA 92093 USA.	vwoods@ucsd.edu; edennis@ucsd.edu	Dennis, Edward A./M-5554-2019; Burke, John/H-3922-2019; hsu, yuan-hao/B-5744-2009; Burke, John/A-5659-2013	Dennis, Edward A./0000-0003-3738-3140; Burke, John/0000-0001-7904-9859; Burke, John/0000-0003-1668-2109	National Institutes of Health [GM20501, CA099835, CA118595, GM037684, AI0220221, AI022160]; University of California Industry.-University Cooperative Research Program [UC10591]; NATIONAL CANCER INSTITUTE [R33CA099835, R21CA118595, R21CA099835] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI022160] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM037684] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of California Industry.-University Cooperative Research Program(University of California System); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM20501 (to E. A. D.) and CA099835, CA118595, GM037684, AI0220221, and AI022160 (to V. L. W.). This work was also supported by Discovery Grant UC10591 from the University of California Industry.-University Cooperative Research Program (to V. L. W.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Ball A, 1999, P NATL ACAD SCI USA, V96, P6637, DOI 10.1073/pnas.96.12.6637; Bittova L, 1999, J BIOL CHEM, V274, P9665, DOI 10.1074/jbc.274.14.9665; Bonventre JV, 1997, NATURE, V390, P622, DOI 10.1038/37635; Brudler R, 2006, J MOL BIOL, V363, P148, DOI 10.1016/j.jmb.2006.07.078; Burke JE, 2008, BIOCHEMISTRY-US, V47, P6451, DOI 10.1021/bi8000962; Cho W, 2001, J BIOL CHEM, V276, P32407, DOI 10.1074/jbc.R100007200; CLARK JD, 1991, CELL, V65, P1043, DOI 10.1016/0092-8674(91)90556-E; Das S, 2003, J BIOL CHEM, V278, P41431, DOI 10.1074/jbc.M304897200; Das S, 2002, J BIOL CHEM, V277, P23838, DOI 10.1074/jbc.M202322200; Dessen A, 1999, CELL, V97, P349, DOI 10.1016/S0092-8674(00)80744-8; Evans JH, 2004, J BIOL CHEM, V279, P6005, DOI 10.1074/jbc.M311246200; Funk CD, 2001, SCIENCE, V294, P1871, DOI 10.1126/science.294.5548.1871; Hamuro Y, 2004, J MOL BIOL, V340, P1185, DOI 10.1016/j.jmb.2004.05.042; Hixon MS, 1998, BIOCHEMISTRY-US, V37, P8516, DOI 10.1021/bi980416d; Hoofnagle AN, 2001, P NATL ACAD SCI USA, V98, P956, DOI 10.1073/pnas.98.3.956; Hsu YH, 2008, J BIOL CHEM, V283, P9820, DOI 10.1074/jbc.M708143200; Huang Z., 1994, MEDIAT INFLAMM, V3, P307; KRAMER RM, 1991, J BIOL CHEM, V266, P5268; LESLIE CC, 1991, J BIOL CHEM, V266, P11366; Lucas KK, 2005, PROSTAG OTH LIPID M, V77, P235, DOI 10.1016/j.prostaglandins.2005.02.004; Malkova S, 2005, BIOPHYS J, V89, P1861, DOI 10.1529/biophysj.105.061515; Malmberg NJ, 2003, BIOCHEMISTRY-US, V42, P13227, DOI 10.1021/bi035119+; Mandell JG, 1998, P NATL ACAD SCI USA, V95, P14705, DOI 10.1073/pnas.95.25.14705; Mosior M, 1998, J BIOL CHEM, V273, P2184, DOI 10.1074/jbc.273.4.2184; Nagase T, 2000, NAT IMMUNOL, V1, P42, DOI 10.1038/76897; Nalefski EA, 1998, J BIOL CHEM, V273, P1365, DOI 10.1074/jbc.273.3.1365; NALEFSKI EA, 1994, J BIOL CHEM, V269, P18239; Perisic O, 1999, J BIOL CHEM, V274, P14979, DOI 10.1074/jbc.274.21.14979; Perisic O, 1998, J BIOL CHEM, V273, P1596, DOI 10.1074/jbc.273.3.1596; REYNOLDS LJ, 1993, BIOCHIM BIOPHYS ACTA, V1167, P272, DOI 10.1016/0005-2760(93)90229-3; Roussel A, 2002, J BIOL CHEM, V277, P2266, DOI 10.1074/jbc.M109484200; Schaloske RH, 2006, BBA-MOL CELL BIOL L, V1761, P1246, DOI 10.1016/j.bbalip.2006.07.011; SCHRAG JD, 1991, NATURE, V351, P761, DOI 10.1038/351761a0; Schrag JD, 1997, STRUCTURE, V5, P187, DOI 10.1016/S0969-2126(97)00178-0; Six DA, 2000, BBA-MOL CELL BIOL L, V1488, P1, DOI 10.1016/S1388-1981(00)00105-0; Six DA, 2003, J BIOL CHEM, V278, P23842, DOI 10.1074/jbc.M301386200; Stahelin RV, 2007, J BIOL CHEM, V282, P20467, DOI 10.1074/jbc.M701396200; Stahelin RV, 2003, J BIOL CHEM, V278, P12452, DOI 10.1074/jbc.M212864200; Subramanian P, 2007, J LIPID RES, V48, P2701, DOI 10.1194/jlr.M700356-JLR200; Uozumi N, 1997, NATURE, V390, P618, DOI 10.1038/37622; Wales TE, 2006, MASS SPECTROM REV, V25, P158, DOI 10.1002/mas.20064	41	43	43	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 7	2008	283	45					31227	31236		10.1074/jbc.M804492200	http://dx.doi.org/10.1074/jbc.M804492200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	367ID	18753135	Green Published, hybrid			2022-12-27	WOS:000260544800076
J	Zhang, YH; Shu, LM; Chen, XB				Zhang, Yanhong; Shu, Limin; Chen, Xinbin			Syntaxin 6, a Regulator of the Protein Trafficking Machinery and a Target of the p53 Family, Is Required for Cell Adhesion and Survival	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN CANCER-CELLS; FUNCTIONAL DOMAINS; APOPTOSIS; KINASE; ACTIVATION; GENE; EXPRESSION; PATHWAY; P21; P63	The p53 family consists of p53, p63, and p73. It has been well characterized that all of the p53 family proteins are transcription factors and capable of regulating cell cycle and apoptosis. To determine whether the p53 family exerts tumor suppression by other mechanisms, we set to identify novel p53 family target genes. Here, we found that the gene encoding STX6 (syntaxin 6), a vesicle transporter protein, is directly regulated by each of the p53 family proteins. In addition, STX6 can be induced by DNA damage and Mdm2 inhibitor Nutlin-3 in a p53-dependent manner. To examine how STX6 mediates the activity of the p53 family, STX6 is inducibly overexpressed or knocked down in various cell lines. We found that overexpression of STX6 alone has limited effect on cell proliferation. In contrast, we found that knockdown of STX6 inhibits cell proliferation and survival. We also found that knockdown of STX6 leads to cell cycle arrest and apoptosis. Interestingly, we found that p53 is necessary for STX6 knockdown-induced cell cycle arrest and apoptosis. Furthermore, we found that STX6 is necessary for proper expression of focal adhesion kinase and integrin alpha 5 adhesion receptor. Consistent with this observation, STX6 knockdown inhibits cell adhesion. Together, we postulate that STX6 is an effector and a modulator of the p53 family in the regulation of cell adhesion and survival.	[Chen, Xinbin] Univ Calif Davis, Ctr Comparat Oncol, VM Surg & Radiol Sci, Davis, CA 95616 USA	University of California System; University of California Davis	Chen, XB (corresponding author), Univ Calif Davis, Ctr Comparat Oncol, VM Surg & Radiol Sci, 2128 Tupper Hall, Davis, CA 95616 USA.	xbchen@ucdavis.edu			National Institutes of Health [CA121137, CA081237, CA076069]; NATIONAL CANCER INSTITUTE [R29CA076069, R01CA121137, R01CA076069, R01CA081237] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants CA121137, CA081237, and CA076069. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Antonescu CN, 2008, TRAFFIC, V9, P1173, DOI 10.1111/j.1600-0854.2008.00755.x; Bao WJ, 2004, J CELL BIOL, V167, P745, DOI 10.1083/jcb.200404018; Bock JB, 1996, J BIOL CHEM, V271, P17961, DOI 10.1074/jbc.271.30.17961; Bock JB, 2001, NATURE, V409, P839, DOI 10.1038/35057024; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Bunz F, 1999, J CLIN INVEST, V104, P263, DOI 10.1172/JCI6863; Carroll DK, 2006, NAT CELL BIOL, V8, P551, DOI 10.1038/ncb1420; CHEN XB, 1995, CANCER RES, V55, P4257; Choudhury A, 2006, NAT CELL BIOL, V8, P317, DOI 10.1038/ncb1380; Cohen LA, 2005, CURR CANCER DRUG TAR, V5, P629, DOI 10.2174/156800905774932798; Cox BD, 2006, J CELL BIOCHEM, V99, P36, DOI 10.1002/jcb.20956; Dohn Michael, 2003, Methods Mol Biol, V223, P221; Frisch SM, 1997, CURR OPIN CELL BIOL, V9, P701, DOI 10.1016/S0955-0674(97)80124-X; Golubovskaya VM, 2005, J BIOL CHEM, V280, P25008, DOI 10.1074/jbc.M414172200; Harms K, 2004, CELL MOL LIFE SCI, V61, P822, DOI 10.1007/s00018-003-3304-4; Harms KL, 2005, MOL CELL BIOL, V25, P2014, DOI 10.1128/MCB.25.5.2014-2030.2005; Hungerford JE, 1996, J CELL BIOL, V135, P1383, DOI 10.1083/jcb.135.5.1383; Ilic D, 1998, J CELL BIOL, V143, P547; JOHANSEN FE, 1994, MOL CELL BIOL, V14, P5920, DOI 10.1128/MCB.14.9.5920; Kabayama H, 2008, NEUROSCI LETT, V436, P340, DOI 10.1016/j.neulet.2008.03.061; Kim B, 2002, J BIOL CHEM, V277, P27393, DOI 10.1074/jbc.M201963200; Kuliawat R, 2004, MOL BIOL CELL, V15, P1690, DOI 10.1091/mbc.E03-08-0554; Lim ST, 2008, MOL CELL, V29, P9, DOI 10.1016/j.molcel.2007.11.031; Liu G, 2006, MOL CELL BIOL, V26, P1398, DOI 10.1128/MCB.26.4.1398-1413.2006; Liu G, 2003, J BIOL CHEM, V278, P17557, DOI 10.1074/jbc.M210696200; Martinez-Arca S, 2003, P NATL ACAD SCI USA, V100, P9011, DOI 10.1073/pnas.1431910100; Menendez JA, 2005, ONCOGENE, V24, P761, DOI 10.1038/sj.onc.1208238; Nozell S, 2003, ONCOGENE, V22, P4333, DOI 10.1038/sj.onc.1206470; Perera HKI, 2003, MOL BIOL CELL, V14, P2946, DOI 10.1091/mbc.E02-11-0722; Qian YJ, 2008, J BIOL CHEM, V283, P2896, DOI 10.1074/jbc.M708624200; van de Wetering M, 2003, EMBO REP, V4, P609, DOI 10.1038/sj.embor.embor865; Vassilev LT, 2004, SCIENCE, V303, P844, DOI 10.1126/science.1092472; Wade N, 2001, J BIOL CHEM, V276, P19820, DOI 10.1074/jbc.M010838200; WALDMAN T, 1995, CANCER RES, V55, P5187; Watson RT, 2008, J CELL SCI, V121, P1243, DOI 10.1242/jcs.017517; Wendler F, 2001, MOL BIOL CELL, V12, P1699, DOI 10.1091/mbc.12.6.1699; Wendler F, 2001, TRAFFIC, V2, P606, DOI 10.1034/j.1600-0854.2001.20903.x; Wierzbicka-Patynowski I, 2003, J CELL SCI, V116, P3269, DOI 10.1242/jcs.00670; Xu LH, 1996, CELL GROWTH DIFFER, V7, P413; Yan WS, 2007, CANCER RES, V67, P9117, DOI 10.1158/0008-5472.CAN-07-0996; Yan WS, 2006, J BIOL CHEM, V281, P7856, DOI 10.1074/jbc.M512655200; Yang A, 2006, MOL CELL, V24, P593, DOI 10.1016/j.molcel.2006.10.018; Zhu JH, 2000, J BIOL CHEM, V275, P39927, DOI 10.1074/jbc.M005676200	43	24	24	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 7	2008	283	45					30689	30698		10.1074/jbc.M801711200	http://dx.doi.org/10.1074/jbc.M801711200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	367ID	18779328	hybrid, Green Published			2022-12-27	WOS:000260544800025
J	Kamath, P; Krishnaswamy, S				Kamath, Parvathi; Krishnaswamy, Sriram			Fate of Membrane-bound Reactants and Products during the Activation of Human Prothrombin by Prothrombinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FACTOR-VA; BOVINE PROTHROMBIN; BLOOD-COAGULATION; FACTOR-X; MACROMOLECULAR SUBSTRATE; ENZYME COMPLEXES; ALPHA-THROMBIN; BINDING-SITE; ACTIVE-SITE; FRAGMENT 2	Membrane binding by prothrombin, mediated by its N-terminal fragment 1 (F1) domain, plays an essential role in its proteolytic activation by prothrombinase. Thrombin is produced in two cleavage reactions. One at Arg(320) yields the proteinase meizothrombin that retains membrane binding properties. The second, at Arg(271), yields thrombin and severs covalent linkage with the N-terminal fragment 1.2 (F12) region. Covalent linkage with the membrane binding domain is also lost when prethrombin 2 (P2) and F12 are produced following initial cleavage at Arg(271). We show that at the physiological concentration of prothrombin, thrombin formation results in rapid release of the proteinase into solution. Product release from the surface can be explained by the weak interaction between the proteinase and F12 domains. In contrast, the zymogen intermediate P2, formed following cleavage at Arg(271), accumulates on the surface because of a similar to 20-fold higher affinity for F12. By kinetic studies, we show that this enhanced binding adequately explains the ability of unexpectedly low concentrations of F12 to greatly enhance the conversion of P2 to thrombin. Thus, the utilization of all three possible substrate species by prothrombinase is regulated by their ability to bind membranes regardless of whether covalent linkage to the F12 region is maintained. The product, thrombin, interacts with sufficiently poor affinity with F12 so that it is rapidly released from its site of production to participate in its numerous hemostatic functions.	[Kamath, Parvathi; Krishnaswamy, Sriram] Childrens Hosp Philadelphia, Joseph Stokes Res Inst, Philadelphia, PA 19104 USA; [Krishnaswamy, Sriram] Univ Penn, Dept Pediat, Philadelphia, PA 19104 USA	University of Pennsylvania; Childrens Hospital of Philadelphia; University of Pennsylvania	Krishnaswamy, S (corresponding author), Childrens Hosp Philadelphia, Joseph Stokes Res Inst, 310 Abramson,3615 Civ Ctr Blvd, Philadelphia, PA 19104 USA.	skrishna@mail.med.upenn.edu	Krishnaswamy, Sriram/Z-4380-2019		National Institutes of Health (NHLBI) [HL-74124, HL-47465]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL047465, P01HL074124] Funding Source: NIH RePORTER	National Institutes of Health (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health (NHLBI) Grants HL-74124 and HL-47465 ( to S. K.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Anderson PJ, 2003, J BIOL CHEM, V278, P44482, DOI 10.1074/jbc.M306917200; Anderson PJ, 2003, J BIOL CHEM, V278, P44489, DOI 10.1074/jbc.M306916200; ARMSTRONG SA, 1990, J BIOL CHEM, V265, P6210; ARNI RK, 1993, BIOCHEMISTRY-US, V32, P4727, DOI 10.1021/bi00069a006; Bevington P. R., 1992, DATA REDUCTION ERROR, P141; Blostein MD, 2000, J BIOL CHEM, V275, P38120, DOI 10.1074/jbc.M007174200; BOCK PE, 1992, J BIOL CHEM, V267, P14974; BODE W, 1989, EMBO J, V8, P3467, DOI 10.1002/j.1460-2075.1989.tb08511.x; Brufatto N, 2003, J BIOL CHEM, V278, P6755, DOI 10.1074/jbc.M206413200; Brummel KE, 2002, BLOOD, V100, P148, DOI 10.1182/blood.V100.1.148; Buddai SK, 2002, J BIOL CHEM, V277, P26689, DOI 10.1074/jbc.M202507200; Bukys MA, 2008, THROMB HAEMOSTASIS, V99, P511, DOI 10.1160/TH07-08-0532; Camire RM, 2000, BIOCHEMISTRY-US, V39, P14322, DOI 10.1021/bi001074q; Chen Q, 1997, BIOCHEMISTRY-US, V36, P4701, DOI 10.1021/bi961441r; Dasgupta SK, 2007, J THROMB THROMBOLYS, V24, P157, DOI 10.1007/s11239-007-0018-8; DISCIPIO RG, 1977, BIOCHEMISTRY-US, V16, P5253, DOI 10.1021/bi00643a015; DOWNING MR, 1975, J BIOL CHEM, V250, P8897; DOYLE MF, 1993, METHOD ENZYMOL, V222, P299; DOYLE MF, 1990, J BIOL CHEM, V265, P10693; ESMON CT, 1974, J BIOL CHEM, V249, P606; Fredenburgh JC, 1997, J BIOL CHEM, V272, P25493, DOI 10.1074/jbc.272.41.25493; GITEL SN, 1973, P NATL ACAD SCI USA, V70, P1344, DOI 10.1073/pnas.70.5.1344; HELDEBRANT CM, 1973, J BIOL CHEM, V248, P7149; JACKSON CM, 1980, ANNU REV BIOCHEM, V49, P765, DOI 10.1146/annurev.bi.49.070180.004001; JENNY NS, 2006, HEMOSTASIS THROMBOSI, P193; Krishnaswamy S, 2005, J THROMB HAEMOST, V3, P54, DOI 10.1111/j.1538-7836.2004.01021.x; KRISHNASWAMY S, 1990, J BIOL CHEM, V265, P3708; Krishnaswamy S, 1997, BIOCHEMISTRY-US, V36, P3319, DOI 10.1021/bi9623993; Krishnaswamy S, 1997, BIOCHEMISTRY-US, V36, P12080, DOI 10.1021/bi970979+; KRISHNASWAMY S, 1987, J BIOL CHEM, V262, P3291; Kuzmic P, 1996, ANAL BIOCHEM, V237, P260, DOI 10.1006/abio.1996.0238; LIM TK, 1977, BIOCHEMISTRY-US, V16, P4177, DOI 10.1021/bi00638a007; Lundblad R L, 1976, Methods Enzymol, V45, P156; MALHOTRA OP, 1985, J BIOL CHEM, V260, P279; MANN KG, 1981, METHOD ENZYMOL, V80, P286; MANN KG, 1988, ANNU REV BIOCHEM, V57, P915, DOI 10.1146/annurev.bi.57.070188.004411; MANN KG, 1990, BLOOD, V76, P1; MYRMEL KH, 1976, BIOCHEMISTRY-US, V15, P1767, DOI 10.1021/bi00653a027; NESHEIM ME, 1988, J BIOL CHEM, V263, P1037; NESHEIM ME, 1981, METHOD ENZYMOL, V80, P249; Orcutt SJ, 2004, J BIOL CHEM, V279, P54927, DOI 10.1074/jbc.M410866200; Orcutt SJ, 2002, J BIOL CHEM, V277, P46191, DOI 10.1074/jbc.M208677200; PRICE PA, 1983, METHOD ENZYMOL, V91, P13; Segel I.H., 1975, ENZYME KINETICS BEHA, Vsecond, P100; STUBBS MT, 1995, TRENDS BIOCHEM SCI, V20, P23, DOI 10.1016/S0968-0004(00)88945-8; Toso R, 2004, J BIOL CHEM, V279, P21643, DOI 10.1074/jbc.M402107200; WALKER FJ, 1979, J BIOL CHEM, V254, P5618; WALKER RK, 1994, J BIOL CHEM, V269, P27441; WEI GJ, 1982, BIOCHEMISTRY-US, V21, P1949, DOI 10.1021/bi00537a039; Yegneswaran S, 2003, J BIOL CHEM, V278, P33312, DOI 10.1074/jbc.M305906200	50	21	21	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 31	2008	283	44					30164	30173		10.1074/jbc.M806158200	http://dx.doi.org/10.1074/jbc.M806158200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	364WS	18765660	Green Published, hybrid			2022-12-27	WOS:000260366900061
J	Thoden, JB; Ryan, LA; Reece, RJ; Holden, HM				Thoden, James B.; Ryan, Louise A.; Reece, Richard J.; Holden, Hazel M.			The Interaction between an Acidic Transcriptional Activator and Its Inhibitor THE MOLECULAR BASIS OF Gal4p RECOGNITION BY Gal80p	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; TRANSACTIVATION DOMAIN; REGULATORY PROTEIN; TUMOR-SUPPRESSOR; GENETIC SWITCH; YEAST; COMPLEX; GALACTOKINASE; MODEL; PARADIGM	The GAL genes, which encode the enzymes required for normal galactose metabolism in yeast, are transcriptionally regulated by three proteins: Gal4p, an activator; Gal80p, an inhibitor; and Gal3p, a galactose sensor. These proteins control the switch between inert and active gene expression. The transcriptional activation function of Gal4p is rendered inactive in the presence of Gal80p. Here we present the three-dimensional structure of a complex between the acidic activation domain of Gal4p and Gal80p. The transactivation domain initiates with an extended region of polypeptide chain followed by two turns of an amphipathic alpha-helix. It fits into and across a deep cleft within the Gal80p dimer with the protein-protein interface defined primarily by hydrophobic interactions. A disordered loop in the apo-Gal80p structure (Asp-309 to Ser-316) becomes well-defined upon binding of the transactivation domain. This investigation provides a new molecular scaffold for understanding previous biochemical and genetic studies.	[Thoden, James B.; Holden, Hazel M.] Univ Wisconsin, Dept Biochem, Madison, WI 53706 USA; [Ryan, Louise A.; Reece, Richard J.] Univ Manchester, Fac Life Sci, Manchester M13 9PT, Lancs, England	University of Wisconsin System; University of Wisconsin Madison; University of Manchester	Reece, RJ (corresponding author), Univ Wisconsin, Dept Biochem, Madison, WI 53706 USA.	Richard.Reece@manchester.ac.uk; Hazel_Holden@biochem.wisc.edu			National Institutes of Health [DK47814]; Wellcome Trust and BBSRC; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK047814, R56DK047814] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wellcome Trust and BBSRC(Wellcome Trust); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK47814 (to H. M. H.). This work was also supported by the Wellcome Trust and BBSRC (to R. J. R.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Ansari AZ, 1998, P NATL ACAD SCI USA, V95, P13543, DOI 10.1073/pnas.95.23.13543; Cowtan K, 1998, ACTA CRYSTALLOGR D, V54, P487, DOI 10.1107/S0907444997011980; DeLano W.L, PYMOL MOL GRAPHICS S; Di Lello P, 2006, MOL CELL, V22, P731, DOI 10.1016/j.molcel.2006.05.007; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; GINIGER E, 1985, CELL, V40, P767, DOI 10.1016/0092-8674(85)90336-8; Hidalgo P, 2001, GENE DEV, V15, P1007, DOI 10.1101/gad.873901; JOHNSTON M, 1987, MICROBIOL REV, V51, P458, DOI 10.1128/MMBR.51.4.458-476.1987; Kingston RL, 1996, STRUCTURE, V4, P1413, DOI 10.1016/S0969-2126(96)00149-9; Kumar PR, 2008, SCIENCE, V319, P1090, DOI 10.1126/science.1151903; Kussie PH, 1996, SCIENCE, V274, P948, DOI 10.1126/science.274.5289.948; Liu X, 2007, GENE DEV, V21, P2711, DOI 10.1101/gad.1590607; LOHR D, 1995, FASEB J, V9, P777, DOI 10.1096/fasebj.9.9.7601342; LUE NF, 1987, MOL CELL BIOL, V7, P3446, DOI 10.1128/MCB.7.10.3446; MA J, 1987, CELL, V50, P137, DOI 10.1016/0092-8674(87)90670-2; Mapp AK, 2000, P NATL ACAD SCI USA, V97, P3930, DOI 10.1073/pnas.97.8.3930; MARMORSTEIN R, 1992, NATURE, V356, P408, DOI 10.1038/356408a0; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Melcher K, 2005, GENETICS, V171, P469, DOI 10.1534/genetics.105.045237; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pilauri V, 2005, GENETICS, V169, P1903, DOI 10.1534/genetics.104.036723; Piskacek S, 2007, GENOMICS, V89, P756, DOI 10.1016/j.ygeno.2007.02.003; Platt A, 1998, EMBO J, V17, P4086, DOI 10.1093/emboj/17.14.4086; PTASHNE M, 2002, GENES SIGNALS; Radhakrishnan I, 1997, CELL, V91, P741, DOI 10.1016/S0092-8674(00)80463-8; Rubio-Texeira M, 2005, FEMS YEAST RES, V5, P1115, DOI 10.1016/j.femsyr.2005.05.003; Sellick CA, 2005, TRENDS BIOCHEM SCI, V30, P405, DOI 10.1016/j.tibs.2005.05.007; Thoden JB, 2007, J BIOL CHEM, V282, P1534, DOI 10.1074/jbc.C600285200; Thoden JB, 2005, J BIOL CHEM, V280, P36905, DOI 10.1074/jbc.M508446200; Traven A, 2006, EMBO REP, V7, P496, DOI 10.1038/sj.embor.7400679; TRONRUD DE, 1987, ACTA CRYSTALLOGR A, V43, P489, DOI 10.1107/S0108767387099124; Uesugi M, 1997, SCIENCE, V277, P1310, DOI 10.1126/science.277.5330.1310; YARGER JG, 1984, MOL CELL BIOCHEM, V61, P173; Zenke FT, 1996, SCIENCE, V272, P1662, DOI 10.1126/science.272.5268.1662	34	29	29	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 31	2008	283	44					30266	30272		10.1074/jbc.M805200200	http://dx.doi.org/10.1074/jbc.M805200200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	364WS	18701455	Green Published, hybrid			2022-12-27	WOS:000260366900071
J	Drevland, RM; Jia, YH; Palmer, DRJ; Graham, DE				Drevland, Randy M.; Jia, Yunhua; Palmer, David R. J.; Graham, David E.			Methanogen Homoaconitase Catalyzes Both Hydrolyase Reactions in Coenzyme B Biosynthesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALPHA-AMINOADIPATE PATHWAY; LYSINE BIOSYNTHESIS; ACID; ENZYME; INTERMEDIATE; PHOSPHATE; SULFUR; IRON; DEHYDROGENASE; ISOCITRATE	Homoaconitase enzymes catalyze hydrolyase reactions in the alpha-aminoadipate pathway for lysine biosynthesis or the 2-oxosuberate pathway for methanogenic coenzyme B biosynthesis. Despite the homology of this iron-sulfur protein to aconitase, previously studied homoaconitases catalyze only the hydration of cis-homoaconitate to form homoisocitrate rather than the complete isomerization of homocitrate to homoisocitrate. The MJ1003 and MJ1271 proteins from the methanogen Methanocaldococcus jannaschii formed the first homoaconitase shown to catalyze both the dehydration of (R)-homocitrate to form cis-homoaconitate, and its hydration is shown to produce homoisocitrate. This heterotetrameric enzyme also used the analogous longer chain substrates cis-(homo)(2)aconitate, cis-(homo)(3)aconitate, and cis-(homo)(4)aconitate, all with similar specificities. A combination of the homoaconitase with the M. jannaschii homoisocitrate dehydrogenase catalyzed all of the isomerization and oxidative decarboxylation reactions required to form 2-oxoadipate, 2-oxopimelate, and 2-oxosuberate, completing three iterations of the 2-oxoacid elongation pathway. Methanogenic archaeal homoaconitases and fungal homoaconitases evolved in parallel in the aconitase superfamily. The archaeal homoaconitases share a common ancestor with isopropylmalate isomerases, and both enzymes catalyzed the hydration of the minimal substrate maleate to form D-malate. The variation in substrate specificity among these enzymes correlated with the amino acid sequences of a flexible loop in the small subunits.	[Drevland, Randy M.; Graham, David E.] Univ Texas Austin, Dept Chem & Biochem, Austin, TX 78712 USA; [Graham, David E.] Univ Texas Austin, Inst Cellular & Mol Biol, Austin, TX 78712 USA; [Jia, Yunhua; Palmer, David R. J.] Univ Saskatchewan, Dept Chem, Saskatoon, SK S7N 5C9, Canada	University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; University of Saskatchewan	Graham, DE (corresponding author), 1 Univ Stn,A5300, Austin, TX 78712 USA.	degraham@mail.utexas.edu	Palmer, David R J/F-1934-2010; Graham, David E/F-8578-2010	Palmer, David R J/0000-0001-9300-7460; Graham, David E/0000-0001-8968-7344	National Science Foundation [MCB-0817903]; Petroleum Research Foundation [44382-G4]; Welch Foundation [F-1576]; Direct For Biological Sciences [1005657] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Petroleum Research Foundation; Welch Foundation(The Welch Foundation); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported in part by National Science Foundation Grant MCB-0817903, Petroleum Research Foundation Grant 44382-G4, and Welch Foundation Grant F-1576. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	BEINERT H, 1983, ANAL BIOCHEM, V131, P373, DOI 10.1016/0003-2697(83)90186-0; Beinert H, 1996, CHEM REV, V96, P2335, DOI 10.1021/cr950040z; BENTLEY R, 1970, MOL ASYMMETRY BIOL, P90; BHATTACHARJEE JK, 1992, EVOLUTION METABOLIC, P47; BULT CJ, 1996, SCIENCE, V273, P1017; Clive DLJ, 1999, J ORG CHEM, V64, P1447, DOI 10.1021/jo9822941; Curatti L, 2007, P NATL ACAD SCI USA, V104, P17626, DOI 10.1073/pnas.0703050104; Drevland RM, 2007, J BACTERIOL, V189, P4391, DOI 10.1128/JB.00166-07; Ermler U, 1997, SCIENCE, V278, P1457, DOI 10.1126/science.278.5342.1457; Graham DE, 2002, NAT PROD REP, V19, P133, DOI 10.1039/b103714p; Grimek TL, 2004, J BACTERIOL, V186, P454, DOI 10.1128/JB.186.2.454-462.2004; HENSON CP, 1967, J BIOL CHEM, V242, P3833; Horng YC, 2001, BIOCHEMISTRY-US, V40, P12875, DOI 10.1021/bi011196y; Howell DM, 1998, BIOCHEMISTRY-US, V37, P10108, DOI 10.1021/bi980662p; Howell DM, 2000, J BACTERIOL, V182, P5013, DOI 10.1128/JB.182.17.5013-5016.2000; JENSEN RA, 1976, ANNU REV MICROBIOL, V30, P409, DOI 10.1146/annurev.mi.30.100176.002205; Jia YH, 2006, BIOCHEM J, V396, P479, DOI 10.1042/BJ20051711; KOLLMANNKOCH A, 1984, H-S Z PHYSIOL CHEM, V365, P847, DOI 10.1515/bchm2.1984.365.2.847; LAUBLE H, 1992, BIOCHEMISTRY-US, V31, P2735, DOI 10.1021/bi00125a014; Li FL, 2007, J BACTERIOL, V189, P4299, DOI 10.1128/JB.00198-07; Ma GX, 2000, TETRAHEDRON LETT, V41, P9209, DOI 10.1016/S0040-4039(00)01707-X; MASSOUDI HH, 1983, SYNTHESIS-STUTTGART, P1010; Nelson R. B., 1973, ORG PREP PROCED INT, V5, P55; NOLL KM, 1986, P NATL ACAD SCI USA, V83, P4238, DOI 10.1073/pnas.83.12.4238; STRASSMAN M, 1966, J BIOL CHEM, V241, P5401; THOMAS U, 1966, BIOCHEMISTRY-US, V5, P2513, DOI 10.1021/bi00872a004; Weidner G, 1997, MOL GEN GENET, V255, P237, DOI 10.1007/s004380050494; WHITE RH, 1989, BIOCHEMISTRY-US, V28, P860, DOI 10.1021/bi00428a068; Wu SP, 2002, BIOCHEMISTRY-US, V41, P8876, DOI 10.1021/bi0256781; Xu HY, 2006, CELL BIOCHEM BIOPHYS, V46, P43, DOI 10.1385/CBB:46:1:43; Yamamoto T, 2007, BIOORGAN MED CHEM, V15, P1346, DOI 10.1016/j.bmc.2006.11.008	31	23	47	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 24	2008	283	43					28888	28896		10.1074/jbc.M802159200	http://dx.doi.org/10.1074/jbc.M802159200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	362EB	18765671	Green Published, hybrid			2022-12-27	WOS:000260179900014
J	Gong, KZ; Li, ZJ; Xu, M; Du, JH; Lv, ZZ; Zhang, YY				Gong, Kaizheng; Li, Zijian; Xu, Ming; Du, Jianhai; Lv, Zhizhen; Zhang, Youyi			A Novel Protein Kinase A-independent, beta-Arrestin-1-dependent Signaling Pathway for p38 Mitogen-activated Protein Kinase Activation by beta(2)-Adrenergic Receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-ARRESTIN RECRUITMENT; NF-KAPPA-B; NADPH OXIDASE; COUPLED RECEPTORS; MAPK ACTIVATION; ANGIOTENSIN-II; PHOSPHORYLATION; P38-ALPHA; APOPTOSIS; RAC1	A growing body of evidence has demonstrated that p38 mitogen-activated protein kinase (MAPK) has a crucial role in various physiological and pathological processes mediated by beta(2)-adrenergic receptors (beta(2)-ARs). However, the detailed mechanism of beta(2)-ARs-induced p38 MAPK activation has not yet been fully defined. The present study demonstrates a novel kinetic model of p38 MAPK activation induced by beta(2)-ARs in human embryonic kidney 293A cells. The beta(2)-AR agonist isoproterenol induced a time-dependent biphasic phosphorylation of p38 MAPK: the early phase peaked at 10 min, and was followed by a delayed phase that appeared at 90 min and was sustained for 6 h. Interestingly, inhibition of the cAMP/protein kinase A (PKA) pathway failed to affect the early phosphorylation but abolished the delayed activation. By contrast, silencing of beta-arrestin-1 expression by small interfering RNA inhibited the early phase activation of p38 MAPK. Furthermore, the NADPH oxidase complex is a downstream target of beta-arrestin-1, as evidenced by the fact that isoproterenol-induced Rac1 activation was also suppressed by beta-arrestin-1 knockdown. In addition, early phase activation of p38 MAPK was prevented by inactivation of Rac1 and NADPH oxidase by pharmacological inhibitors, overexpression of a dominant negative mutant of Rac1, and p47(phox) knockdown by RNA interference. Of note, we demonstrated that only early activation of p38 MAPK is involved in isoproterenol-induced F-actin rearrangement. Collectively, these data suggest that the classic cAMP/PKA pathway is responsible for the delayed activation, whereas a beta-arrestin-1/Rac1/NADPH oxidase-dependent signaling is a heretofore unrecognized mechanism for beta(2)-AR-mediated early activation of p38 MAPK.	Peking Univ, Inst Vasc Med, Hosp 3, Beijing 100191, Peoples R China; Minist Educ, Key Lab Mol Cardiovasc Sci, Beijing 100191, Peoples R China	Peking University	Zhang, YY (corresponding author), Huayuan Bei Rd 49, Beijing 100191, Peoples R China.	zhangyy@bjmu.edu.cn	Du, Jianhai/J-6197-2014	Du, Jianhai/0000-0002-5612-4091	People's Republic of China [G2006CB503806]; Natural Science Foundation of China [30672466, 30570716]	People's Republic of China; Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Key Basic Research Program of the People's Republic of China Grant G2006CB503806 and Natural Science Foundation of China Grants 30672466 and 30570716. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Ahn SK, 2004, J BIOL CHEM, V279, P35518, DOI 10.1074/jbc.M405878200; Ashwell JD, 2006, NAT REV IMMUNOL, V6, P532, DOI 10.1038/nri1865; Babior BM, 1999, BLOOD, V93, P1464, DOI 10.1182/blood.V93.5.1464.405a32_1464_1476; BAGRODIA S, 1995, J BIOL CHEM, V270, P27995; Barnes WG, 2005, J BIOL CHEM, V280, P8041, DOI 10.1074/jbc.M412924200; Bedard K, 2007, PHYSIOL REV, V87, P245, DOI 10.1152/physrev.00044.2005; Bhattacharya M, 2002, NAT CELL BIOL, V4, P547, DOI 10.1038/ncb821; Bruchas MR, 2006, J BIOL CHEM, V281, P18081, DOI 10.1074/jbc.M513640200; Cave AC, 2006, ANTIOXID REDOX SIGN, V8, P691, DOI 10.1089/ars.2006.8.691; Cheng G, 2006, J BIOL CHEM, V281, P17718, DOI 10.1074/jbc.M512751200; Chi David S., 2004, BMC Immunology, V5; Delghandi MP, 2005, CELL SIGNAL, V17, P1343, DOI 10.1016/j.cellsig.2005.02.003; Droge W, 2002, PHYSIOL REV, V82, P47, DOI 10.1152/physrev.00018.2001; ELLIS JA, 1988, BIOCHEM J, V251, P887, DOI 10.1042/bj2510887; Gao Y, 2004, P NATL ACAD SCI USA, V101, P7618, DOI 10.1073/pnas.0307512101; Ge BX, 2002, SCIENCE, V295, P1291, DOI 10.1126/science.1067289; Gerlo S, 2006, CELL MOL LIFE SCI, V63, P92, DOI 10.1007/s00018-005-5433-4; Hall RA, 1999, J CELL BIOL, V145, P927, DOI 10.1083/jcb.145.5.927; Hucho TB, 2005, J NEUROSCI, V25, P6119, DOI 10.1523/JNEUROSCI.0285-05.2005; Huot J, 1998, J CELL BIOL, V143, P1361, DOI 10.1083/jcb.143.5.1361; Keiper M, 2004, J BIOL CHEM, V279, P46497, DOI 10.1074/jbc.M403604200; Kim JK, 2006, J BIOL CHEM, V281, P6760, DOI 10.1074/jbc.M511024200; Lefkowitz RJ, 2006, MOL CELL, V24, P643, DOI 10.1016/j.molcel.2006.11.007; Ma L, 2007, J CELL SCI, V120, P213, DOI 10.1242/jcs.03338; Magne S, 2001, J BIOL CHEM, V276, P39539, DOI 10.1074/jbc.M100954200; Malki S, 2005, EMBO J, V24, P1798, DOI 10.1038/sj.emboj.7600660; McLaughlin NJD, 2006, J IMMUNOL, V176, P7039, DOI 10.4049/jimmunol.176.11.7039; Miller WE, 2003, J BIOL CHEM, V278, P21663, DOI 10.1074/jbc.M303219200; Moniri NH, 2007, BIOCHEM PHARMACOL, V74, P64, DOI 10.1016/j.bcp.2007.03.016; Nishihara H, 2004, J BIOL CHEM, V279, P26176, DOI 10.1074/jbc.M313346200; Noma T, 2007, J CLIN INVEST, V117, P2445, DOI 10.1172/JCI31901; Okada T, 2005, AM J PHYSIOL-HEART C, V289, pH2310, DOI 10.1152/ajpheart.00462.2005; Peter PS, 2007, J CLIN INVEST, V117, P1335, DOI 10.1172/JCI29576; Pichon S, 2004, J CELL SCI, V117, P2569, DOI 10.1242/jcs.01110; Pomerance M, 2000, J BIOL CHEM, V275, P40539, DOI 10.1074/jbc.M002097200; Reiter E, 2006, TRENDS ENDOCRIN MET, V17, P159, DOI 10.1016/j.tem.2006.03.008; Sano M, 2001, CIRC RES, V89, P661, DOI 10.1161/hh2001.098873; Semenova MM, 2007, NAT NEUROSCI, V10, P436, DOI 10.1038/nn1869; Shenoy SK, 2006, J BIOL CHEM, V281, P1261, DOI 10.1074/jbc.M506576200; Shiromizu T, 2006, GENES CELLS, V11, P477, DOI 10.1111/j.1365-2443.2006.00955.x; Siow YL, 2006, BIOCHEM J, V398, P73, DOI 10.1042/BJ20051810; Ster J, 2007, P NATL ACAD SCI USA, V104, P2519, DOI 10.1073/pnas.0611031104; Tan KS, 2007, CELL SIGNAL, V19, P251, DOI 10.1016/j.cellsig.2006.06.007; Tohgo A, 2003, J BIOL CHEM, V278, P6258, DOI 10.1074/jbc.M212231200; Ushio-Fukai M, 2006, SCI STKE, V2006, pre8, DOI DOI 10.1126/STKE.3492006RE8; Vaughan DJ, 2006, J BIOL CHEM, V281, P7684, DOI 10.1074/jbc.M500328200; Verma A, 2002, J BIOL CHEM, V277, P44988, DOI 10.1074/jbc.M207176200; Violin JD, 2006, J BIOL CHEM, V281, P20577, DOI 10.1074/jbc.M513605200; Vogt A, 2007, CELL SIGNAL, V19, P1229, DOI 10.1016/j.cellsig.2007.01.003; Wang YB, 2007, CIRCULATION, V116, P1413, DOI 10.1161/CIRCULATIONAHA.106.679589; Wisler JW, 2007, P NATL ACAD SCI USA, V104, P16657, DOI 10.1073/pnas.0707936104; Ximenes VF, 2007, ARCH BIOCHEM BIOPHYS, V457, P134, DOI 10.1016/j.abb.2006.11.010; Yamauchi JJ, 1997, J BIOL CHEM, V272, P27771, DOI 10.1074/jbc.272.44.27771; Yin F, 2006, J MOL CELL CARDIOL, V40, P384, DOI 10.1016/j.yjmcc.2005.12.005; Yin F, 2003, J BIOL CHEM, V278, P21070, DOI 10.1074/jbc.M211028200; Zhao M, 2004, J BIOL CHEM, V279, P49259, DOI 10.1074/jbc.M405118200; Zheng M, 2005, PHARMACOL THERAPEUT, V108, P257, DOI 10.1016/j.pharmthera.2005.04.006; Zheng M, 2000, J BIOL CHEM, V275, P40635, DOI 10.1074/jbc.M006325200	58	55	58	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 24	2008	283	43					29028	29036		10.1074/jbc.M801313200	http://dx.doi.org/10.1074/jbc.M801313200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	362EB	18678875	Green Published, hybrid			2022-12-27	WOS:000260179900029
J	Rogojina, AT; Nitiss, JL				Rogojina, Anna T.; Nitiss, John L.			Isolation and Characterization of mAMSA-hypersensitive Mutants CYTOTOXICITY OF Top2 COVALENT COMPLEXES CONTAINING DNA SINGLE STRAND BREAKS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							YEAST TOPOISOMERASE-II; ENZYME-DNA; ANTITUMOR DRUGS; CLEAVAGE; RESISTANCE; MUTATION; ETOPOSIDE; AMSACRINE; SENSITIVITY; REPAIR	Topoisomerase II (Top2) is the primary target for active anticancer agents. We developed an efficient approach for identifying hypersensitive Top2 mutants and isolated a panel of mutants in yeast Top2 conferring hypersensitivity to the intercalator N-[4-(9-acridinylamino)-3- methoxyphenyl]methanesulphonanilide (mAMSA). Some mutants conferred hypersensitivity to etoposide as well as mAMSA, whereas other mutants exhibited hypersensitivity only to mAMSA. Two mutants in Top2, changing Pro(473) to Leu and Gly(737) to Val, conferred extraordinary hypersensitivity to mAMSA and were chosen for further characterization. The mutant proteins were purified, and their biochemical activities were assessed. Both mutants encode enzymes that are hypersensitive to inhibition by mAMSA and other intercalating agents and exhibited elevated levels of mAMSA-induced Top2: DNA covalent complexes. While Gly(737)-> Val Top2p generated elevated levels of Top2-mediated double strand breaks in vitro, the Pro(473)-> Leu mutant protein showed only a modest increase in Top2-mediated double strand breaks but much higher levels of Top2-mediated single strand breaks. In addition, the Pro(473) -> Leu mutant protein also generated high levels of mAMSA-stabilized covalent complexes in the absence of ATP. We tested the role of single strand cleavage in cell killing with alleles of Top2 that could generate single strand breaks, but not double strand breaks. Expression in yeast of a Pro(473) -> Leu mutant that could only generate single strand breaks conferred hypersensitivity to mAMSA. These results indicate that generation of single strand breaks by Top2-targeting agents can be an drugs.	[Rogojina, Anna T.; Nitiss, John L.] St Jude Childrens Res Hosp, Dept Mol Pharmacol, Memphis, TN 38105 USA	St Jude Children's Research Hospital	Nitiss, JL (corresponding author), St Jude Childrens Res Hosp, Dept Mol Pharmacol, 262 Danny Thomas Pl, Memphis, TN 38105 USA.	john.nitiss@stjude.org	Nitiss, John/E-9974-2010	Nitiss, John/0000-0002-1013-4972	NCI [CA21765, CA52814, CA82313]; American Lebanese Syrian Associated Charities; NATIONAL CANCER INSTITUTE [R01CA082313, R01CA052814, P30CA021765] Funding Source: NIH RePORTER	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); American Lebanese Syrian Associated Charities(American Lebanese Syrian Associated Charities (ALSAC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants CA21765, CA52814, and CA82313 from NCI. This work was also supported by American Lebanese Syrian Associated Charities. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Anderson VE, 2001, CURR PHARM DESIGN, V7, P337, DOI 10.2174/1381612013398013; BUGG BY, 1991, P NATL ACAD SCI USA, V88, P7654, DOI 10.1073/pnas.88.17.7654; Burden DA, 1996, J BIOL CHEM, V271, P29238, DOI 10.1074/jbc.271.46.29238; Burden DA, 2000, METH MOL B, V95, P283; Dong JW, 2000, J BIOL CHEM, V275, P7980, DOI 10.1074/jbc.275.11.7980; Dong KC, 2007, NATURE, V450, P1201, DOI 10.1038/nature06396; ELSEA SH, 1995, J BIOL CHEM, V270, P1913, DOI 10.1074/jbc.270.4.1913; FREUDENREICH CH, 1993, EMBO J, V12, P2085, DOI 10.1002/j.1460-2075.1993.tb05857.x; FREUDENREICH CH, 1994, P NATL ACAD SCI USA, V91, P11007, DOI 10.1073/pnas.91.23.11007; GIETZ D, 1992, NUCLEIC ACIDS RES, V20, P1425, DOI 10.1093/nar/20.6.1425; HSIUNG YC, 1995, J BIOL CHEM, V270, P20359, DOI 10.1074/jbc.270.35.20359; JANNATIPOUR M, 1993, J BIOL CHEM, V268, P18586; Kingma PS, 1998, BBA-GENE STRUCT EXPR, V1400, P223, DOI 10.1016/S0167-4781(98)00138-9; Li TK, 2001, ANNU REV PHARMACOL, V41, P53, DOI 10.1146/annurev.pharmtox.41.1.53; Lindsley JE, 2000, METH MOL B, V95, P57; Liu QY, 1998, J BIOL CHEM, V273, P20252, DOI 10.1074/jbc.273.32.20252; Liu QY, 1999, P NATL ACAD SCI USA, V96, P881, DOI 10.1073/pnas.96.3.881; Malik M, 2004, EUKARYOT CELL, V3, P82, DOI 10.1128/EC.3.1.82-90.2004; Malik M, 2006, MOL CANCER THER, V5, P1405, DOI 10.1158/1535-7163.MCT-05-0263; Mao Y, 1999, BIOCHEMISTRY-US, V38, P10793, DOI 10.1021/bi9909804; NITISS J, 1988, P NATL ACAD SCI USA, V85, P7501, DOI 10.1073/pnas.85.20.7501; NITISS JL, 1994, CANCER CHEMOTH PHARM, V34, pS6, DOI 10.1007/BF00684857; Nitiss JL, 1998, CONT CANC RES, P517; NITISS JL, 1993, CANCER RES, V53, P89; Nitiss JL, 1998, BBA-GENE STRUCT EXPR, V1400, P63, DOI 10.1016/S0167-4781(98)00128-6; Nitiss JL, 1996, EUR J CANCER, V32A, P958, DOI 10.1016/0959-8049(96)00056-1; NITISS JL, 1992, CANCER RES, V52, P4467; Nitiss John L, 2002, Curr Opin Investig Drugs, V3, P1512; Nitiss KC, 2006, P NATL ACAD SCI USA, V103, P8953, DOI 10.1073/pnas.0603455103; OSHEROFF N, 1987, BIOCHEMISTRY-US, V26, P4303, DOI 10.1021/bi00388a018; POMMIER Y, 1985, BIOCHEMISTRY-US, V24, P6406, DOI 10.1021/bi00344a014; ROBINSON MJ, 1993, BIOCHEMISTRY-US, V32, P3638, DOI 10.1021/bi00065a016; ROBINSON MJ, 1990, BIOCHEMISTRY-US, V29, P2511, DOI 10.1021/bi00462a012; Sabourin M, 1998, J BIOL CHEM, V273, P29086, DOI 10.1074/jbc.273.44.29086; Strumberg D, 1999, J BIOL CHEM, V274, P7292, DOI 10.1074/jbc.274.11.7292; Strumberg D, 1999, J BIOL CHEM, V274, P28246, DOI 10.1074/jbc.274.40.28246; Vaughn J, 2005, J BIOL CHEM, V280, P11920, DOI 10.1074/jbc.M411841200; Walker JV, 2004, J BIOL CHEM, V279, P25947, DOI 10.1074/jbc.M312314200; Walker JV, 2002, CANCER INVEST, V20, P570, DOI 10.1081/CNV-120002156; Wang JC, 1998, Q REV BIOPHYS, V31, P107, DOI 10.1017/S0033583598003424; Wang JC, 2002, NAT REV MOL CELL BIO, V3, P430, DOI 10.1038/nrm831; WASSERMAN RA, 1994, CANCER RES, V54, P1795; WASSERMAN RA, 1994, J BIOL CHEM, V269, P20943; WORLAND ST, 1989, J BIOL CHEM, V264, P4412; ZECHIEDRICH EL, 1989, BIOCHEMISTRY-US, V28, P6229, DOI 10.1021/bi00441a014; ZWELLING LA, 1989, J BIOL CHEM, V264, P16411	46	13	13	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 24	2008	283	43					29239	29250		10.1074/jbc.M804058200	http://dx.doi.org/10.1074/jbc.M804058200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	362EB	18723844	Green Published, hybrid			2022-12-27	WOS:000260179900051
J	Scott, MJ; Billiar, TR				Scott, Melanie J.; Billiar, Timothy R.			beta 2-Integrin-induced p38 MAPK Activation Is a Key Mediator in the CD14/TLR4/MD2-dependent Uptake of Lipopolysaccharide by Hepatocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TOLL-LIKE RECEPTOR-4; MACROPHAGE CELL-LINE; KAPPA-B ACTIVATION; SIGNAL-TRANSDUCTION; LIPID RAFTS; GENE-EXPRESSION; BACTERIAL LIPOPOLYSACCHARIDE; SOLUBLE CD14; MD-2; LPS	The liver is the main organ that clears circulating lipopolysaccharide (LPS), and hepatocytes are a major cell type involved in LPS uptake. Little is known about the mechanisms for LPS internalization in hepatocytes and what signaling pathways are involved. Weshow here that LPS uptake is initiated after formation of a multi-receptor complex within lipid rafts. We find that essential components for LPS uptake are CD14, TLR4, MD2, and the beta 2-integrin CD11b/CD18. Activation of p38 MAPK is also essential for the initiation of LPS uptake, and interestingly, we show that this activation is not through TLR4 signaling by MyD88 but through activation of TIRAP via CD11b/CD18. However, TLR4/MD2 remain essential components at the cell surface as part of the LPS receptor complex. We therefore suggest novel roles for TLR4/MD2, CD11b/CD18, TIRAP, and p38 MAPK in LPS uptake by hepatocytes.	[Scott, Melanie J.; Billiar, Timothy R.] Univ Pittsburgh, Sch Med, Dept Surg, Pittsburgh, PA 15213 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Billiar, TR (corresponding author), Univ Pittsburgh, Sch Med, Dept Surg, NW607MUH,3459 5th Ave, Pittsburgh, PA 15213 USA.	billiartr@upmc.edu			National Institutes of Health [R01-GM-50441]; National Foundation for Infectious Diseases and the Infectious Disease Society of America; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM050441] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Foundation for Infectious Diseases and the Infectious Disease Society of America; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01-GM-50441. This work was also supported by an Astellas Young Investigator Award 2007 from the National Foundation for Infectious Diseases and the Infectious Disease Society of America (to M. S.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Akashi S, 2003, J EXP MED, V198, P1035, DOI 10.1084/jem.20031076; Bikhazi AB, 2001, COMP BIOCHEM PHYS C, V129, P339, DOI 10.1016/S1532-0456(01)00207-1; Blander JM, 2004, SCIENCE, V304, P1014, DOI 10.1126/science.1096158; Cavalli V, 2001, MOL CELL, V7, P421, DOI 10.1016/S1097-2765(01)00189-7; Coats SR, 2005, J IMMUNOL, V175, P4490, DOI 10.4049/jimmunol.175.7.4490; DASILVA CJ, 2002, J BIOL CHEM, V277, P1845, DOI [DOI 10.1074/JBC.M109910200, 10.1074/jbc.M109910200]; Dong C, 2002, ANNU REV IMMUNOL, V20, P55, DOI 10.1146/annurev.immunol.20.091301.131133; FEARNS C, 1995, J EXP MED, V181, P857, DOI 10.1084/jem.181.3.857; Fitzgerald KA, 2006, CELL, V125, P834, DOI 10.1016/j.cell.2006.05.014; Fitzgerald KA, 2004, MICROBES INFECT, V6, P1361, DOI 10.1016/j.micinf.2004.08.015; Flaherty SF, 1997, J SURG RES, V73, P85, DOI 10.1006/jsre.1997.5195; Flo TH, 2000, INFECT IMMUN, V68, P6770, DOI 10.1128/IAI.68.12.6770-6776.2000; FREUDENBERG MA, 1982, BRIT J EXP PATHOL, V63, P56; FREUDENBERG N, 1992, VIRCHOWS ARCH B, V61, P343, DOI 10.1007/BF02890437; Fujimoto T, 2004, J BIOL CHEM, V279, P47431, DOI 10.1074/jbc.M408724200; FUKUDA I, 1989, BRIT J EXP PATHOL, V70, P267; Gangloff M, 2004, TRENDS BIOCHEM SCI, V29, P294, DOI 10.1016/j.tibs.2004.04.008; Gangloff SC, 2005, J IMMUNOL, V175, P3940, DOI 10.4049/jimmunol.175.6.3940; GE YM, 1994, J INFECT DIS, V169, P95, DOI 10.1093/infdis/169.1.95; Ge YM, 1997, J INFECT DIS, V176, P1313, DOI 10.1086/514127; Hopf U, 1984, Am J Emerg Med, V2, P13, DOI 10.1016/0735-6757(84)90105-0; Horng T, 2001, NAT IMMUNOL, V2, P835, DOI 10.1038/ni0901-835; Hyakushima N, 2004, J IMMUNOL, V173, P6949, DOI 10.4049/jimmunol.173.11.6949; INGALLS RR, 1995, J EXP MED, V181, P1473, DOI 10.1084/jem.181.4.1473; Ingalls RR, 1997, J IMMUNOL, V159, P433; Kagan JC, 2006, CELL, V125, P943, DOI 10.1016/j.cell.2006.03.047; Kennedy MN, 2004, J BIOL CHEM, V279, P34698, DOI 10.1074/jbc.M405444200; KITCHENS RL, 1992, J EXP MED, V176, P485, DOI 10.1084/jem.176.2.485; Kmiec Z, 2001, ADV ANAT EMBRYOL CEL, V161, P1; Kraatz J, 1999, SHOCK, V11, P58, DOI 10.1097/00024382-199901000-00009; Liu SB, 2002, INFECT IMMUN, V70, P3433, DOI 10.1128/IAI.70.7.3433-3442.2002; Liu SB, 1998, INFECT IMMUN, V66, P5089, DOI 10.1128/IAI.66.11.5089-5098.1998; Mansell A, 2004, J BIOL CHEM, V279, P37227, DOI 10.1074/jbc.C400289200; MATHISON JC, 1979, J IMMUNOL, V123, P2133; Matsuzawa A, 2005, NAT IMMUNOL, V6, P587, DOI 10.1038/ni1200; MIMURA Y, 1995, GASTROENTEROLOGY, V109, P1969, DOI 10.1016/0016-5085(95)90765-3; Moreno C, 2004, MICROBES INFECT, V6, P990, DOI 10.1016/j.micinf.2004.05.010; Olsson S, 2006, MOL IMMUNOL, V43, P607, DOI 10.1016/j.molimm.2005.04.011; Palsson-McDermott EM, 2004, IMMUNOLOGY, V113, P153, DOI 10.1111/j.1365-2567.2004.01976.x; Parton RG, 2003, TRAFFIC, V4, P724, DOI 10.1034/j.1600-0854.2003.00128.x; Perera PY, 2001, J IMMUNOL, V166, P574, DOI 10.4049/jimmunol.166.1.574; Poltorak A, 1998, BLOOD CELL MOL DIS, V24, P340, DOI 10.1006/bcmd.1998.0201; PRAANINGVANDALEN DP, 1981, GASTROENTEROLOGY, V81, P1036; Schmitz G, 2002, CURR OPIN LIPIDOL, V13, P513, DOI 10.1097/00041433-200210000-00007; Seglen P O, 1976, Methods Cell Biol, V13, P29, DOI 10.1016/S0091-679X(08)61797-5; Shao BM, 2007, J BIOL CHEM, V282, P13726, DOI 10.1074/jbc.M609462200; Tapping RI, 1998, PROG CLIN BIOL RES, V397, P73; TREON SP, 1993, P SOC EXP BIOL MED, V202, P153; Triantafilou M, 2002, TRENDS IMMUNOL, V23, P301, DOI 10.1016/S1471-4906(02)02233-0; Triantafilou M, 2002, J CELL SCI, V115, P2603; Twining SS, 2001, J BIOL CHEM, V276, P23135, DOI 10.1074/jbc.M010748200; Viriyakosol S, 2001, J BIOL CHEM, V276, P38044; Visintin A, 2003, J BIOL CHEM, V278, P48313, DOI 10.1074/jbc.M306802200; Vodovotz Y, 2001, J ENDOTOXIN RES, V7, P365, DOI 10.1179/096805101101532936; WILSON RW, 1993, J IMMUNOL, V151, P1571; Wong KF, 2007, FASEB J, V21, P3231, DOI 10.1096/fj.06-7579com; Zaru R, 2007, NAT IMMUNOL, V8, P1227, DOI 10.1038/ni1517	57	83	89	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 24	2008	283	43					29433	29446		10.1074/jbc.M803905200	http://dx.doi.org/10.1074/jbc.M803905200			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	362EB	18701460	hybrid, Green Published			2022-12-27	WOS:000260179900070
J	Gupta, N; Ragsdale, SW				Gupta, Nirupama; Ragsdale, Stephen W.			Dual roles of an essential cysteine residue in activity of a redox-regulated bacterial transcriptional activator	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN SECONDARY STRUCTURE; DNA-BINDING DOMAIN; DEHALORESPIRATION; DEHALOGENATION; EXPRESSION; REDUCTION; VECTORS; CLUSTER; CPRK1	CprK from Desulfitobacterium dehalogenans is the first characterized transcriptional regulator of anaerobic dehalorespiration and is controlled at two levels: redox and effector binding. In the reduced state and in the presence of chlorinated aromatic compounds, CprK positively regulates expression of the cpr gene cluster. One of the products of the cpr gene cluster is CprA, which catalyzes the reductive dehalogenation of chlorinated aromatic compounds. Redox regulation of CprK occurs through a thiol/ disulfide redox switch, which includes two classes of cysteine residues. Under oxidizing conditions, Cys(11) and Cys(200) form an intermolecular disulfide bond, whereas Cys(105) and Cys(111) form an intramolecular disulfide. Here, we report that Cys(11) is involved in redox inactivation in vivo. Upon replacement of Cys(11) with serine, alanine, or aspartate, CprK loses its DNA binding activity. C11A is unstable; however, circular dichroism studies demonstrate that the stability and overall secondary structures of CprK and the C11S and C11D variants are similar. Furthermore, effector binding remains intact in the C11S and C11D variants. However, fluorescence spectroscopic results reveal that the tertiary structures of the C11S and C11D variants differ from that of the wild type protein. Thus, Cys(11) plays a dual role as a redox switch and in maintaining the correct tertiary structure that promotes DNA binding.	[Gupta, Nirupama; Ragsdale, Stephen W.] Univ Michigan, Sch Med, Dept Biol Chem, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Ragsdale, SW (corresponding author), Univ Michigan, Sch Med, Dept Biol Chem, 5301 MSRB 3,1150 W Med Ctr Dr, Ann Arbor, MI 48109 USA.	sragsdal@umich.edu	gupta, nirupama/H-2297-2012		National Institutes of Health [1P20RR17675]; National Science Foundation [GM 39451]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR017675] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported, in whole or in part, by National Institutes of Health Grant 1P20RR17675. This work was also supported by National Science Foundation Grant GM 39451 (to S. W. R.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Aravind L, 2005, FEMS MICROBIOL REV, V29, P231, DOI 10.1016/j.fmrre.2004.12.008; Gabor K, 2006, J BACTERIOL, V188, P2604, DOI 10.1128/JB.188.7.2604-2613.2006; Georgiou G, 2002, CELL, V111, P607, DOI 10.1016/S0092-8674(02)01165-0; GIESE NA, 1987, SCIENCE, V236, P1315, DOI 10.1126/science.3035718; Grossel MJ, 1996, J VIROL, V70, P7264, DOI 10.1128/JVI.70.10.7264-7269.1996; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995; HEGDE RS, 1992, NATURE, V359, P505, DOI 10.1038/359505a0; Joyce MG, 2006, J BIOL CHEM, V281, P28318, DOI 10.1074/jbc.M602654200; Korner H, 2003, FEMS MICROBIOL REV, V27, P559, DOI 10.1016/S0168-6445(03)00066-4; Krasotkina J, 2001, J BIOL CHEM, V276, P40991, DOI 10.1074/jbc.M106217200; KUBISTA M, 1994, ANALYST, V119, P417, DOI 10.1039/an9941900417; KUO MS, 1986, CARBOHYD RES, V156, P173, DOI 10.1016/S0008-6215(00)90109-5; Lambert C, 2007, J BIOL CHEM, V282, P19666, DOI 10.1074/jbc.M611527200; Lucana DOD, 2003, MOL GENET GENOMICS, V268, P618, DOI 10.1007/s00438-002-0776-0; Mazon H, 2007, J BIOL CHEM, V282, P11281, DOI 10.1074/jbc.M611177200; MCBRIDE AA, 1992, P NATL ACAD SCI USA, V89, P7531, DOI 10.1073/pnas.89.16.7531; MILLIS KK, 1993, J ORG CHEM, V58, P4144, DOI 10.1021/jo00067a060; Nath MD, 2001, ARCH BIOCHEM BIOPHYS, V392, P287, DOI 10.1006/abbi.2001.2449; Nishi T, 2002, J BIOL CHEM, V277, P44548, DOI 10.1074/jbc.M202970200; Ostergaard H, 2001, EMBO J, V20, P5853, DOI 10.1093/emboj/20.21.5853; PAJARES MA, 1991, BIOCHEM J, V274, P225, DOI 10.1042/bj2740225; Pop SM, 2004, J BIOL CHEM, V279, P49910, DOI 10.1074/jbc.M409435200; Pop SM, 2006, J BIOL CHEM, V281, P26382, DOI 10.1074/jbc.M602158200; PROVENCHER SW, 1981, BIOCHEMISTRY-US, V20, P33, DOI 10.1021/bi00504a006; Rotrekl V, 1999, EUR J BIOCHEM, V266, P1056, DOI 10.1046/j.1432-1327.1999.00948.x; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; Savitsky PA, 2002, J BIOL CHEM, V277, P20535, DOI 10.1074/jbc.M201589200; Schafer FQ, 2001, FREE RADICAL BIO MED, V30, P1191, DOI 10.1016/S0891-5849(01)00480-4; SIMONS RW, 1987, GENE, V53, P85, DOI 10.1016/0378-1119(87)90095-3; Smidt H, 2004, ANNU REV MICROBIOL, V58, P43, DOI 10.1146/annurev.micro.58.030603.123600; Smidt H, 2000, J BACTERIOL, V182, P5683, DOI 10.1128/JB.182.20.5683-5691.2000; SPIRO S, 1990, FEMS MICROBIOL LETT, V75, P399, DOI 10.1016/0378-1097(90)90690-R; Sreerama N, 2000, ANAL BIOCHEM, V287, P252, DOI 10.1006/abio.2000.4880; Staples CR, 1998, BIOCHEMISTRY-US, V37, P4612, DOI 10.1021/bi9729763; TAYLOR MF, 1990, BIOCHEMISTRY-US, V29, P6911, DOI 10.1021/bi00481a022; UTKIN I, 1994, INT J SYST BACTERIOL, V44, P612, DOI 10.1099/00207713-44-4-612; Villemur R, 2006, FEMS MICROBIOL REV, V30, P706, DOI 10.1111/j.1574-6976.2006.00029.x; Vitvitsky V, 2003, REDOX REP, V8, P57, DOI 10.1179/135100003125001260; WATERMAN MR, 1974, BIOCHIM BIOPHYS ACTA, V371, P159, DOI 10.1016/0005-2795(74)90165-2; Wiegel J, 2000, FEMS MICROBIOL ECOL, V32, P1, DOI 10.1111/j.1574-6941.2000.tb00693.x; Wiegel J, 1999, APPL ENVIRON MICROB, V65, P2217; Yang YK, 2007, AM J PHYSIOL-REG I, V293, pR1120, DOI 10.1152/ajpregu.00240.2007; Yi L, 2007, J BIOL CHEM, V282, P21056, DOI 10.1074/jbc.M700664200; Zhong LW, 2000, P NATL ACAD SCI USA, V97, P5854, DOI 10.1073/pnas.100114897	44	13	13	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 17	2008	283	42					28721	28728		10.1074/jbc.M800630200	http://dx.doi.org/10.1074/jbc.M800630200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	359EN	18687692	Green Published, hybrid			2022-12-27	WOS:000259969300074
J	Mustafa, G; Migita, CT; Ishikawa, Y; Kobayashi, K; Tagawa, S; Yamada, M				Mustafa, Golam; Migita, Catharina T.; Ishikawa, Yoshinori; Kobayashi, Kazuo; Tagawa, Seiichi; Yamada, Mamoru			Menaquinone as well as ubiquinone as a bound quinone crucial for catalytic activity and intramolecular electron transfer in Escherichia coli membrane-bound glucose dehydrogenase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMINO-ACID-RESIDUES; PYRROLOQUINOLINE QUINONE; PULSE-RADIOLYSIS; METHANOL DEHYDROGENASE; NITRITE REDUCTASE; RESPIRATORY-CHAIN; SITE; PQQ; TRANSPORT; BINDING	Escherichia coli membrane-bound glucose dehydrogenase (mGDH), which is one of quinoproteins containing pyrroloquinoline quinone (PQQ) as a coenzyme, is a good model for elucidating the function of bound quinone inside primary dehydrogenases in respiratory chains. Enzymatic analysis of purified mGDH from cells defective in synthesis of ubiquinone (UQ) and/or menaquinone (MQ) revealed that Q-free mGDH has very low levels of activity of glucose dehydrogenase and UQ(2) reductase compared with those of UQ-bearing mGDH, and both activities were significantly increased by reconstitution with UQ(1). On the other hand, MQ-bearing mGDH retains both catalytic abilities at the same levels as those of UQ-bearing mGDH. A radiolytically generated hydrated electron reacted with the bound MQ to form a semiquinone anion radical with an absorption maximum at 400 nm. Subsequently, decay of the absorbance at 400 nm was accompanied by an increase in the absorbance at 380 nm with a first order rate constant of 5.7 x 10(3) s(-1). This indicated that an intramolecular electron transfer from the bound MQ to the PQQ occurred. EPR analysis revealed that characteristics of the semiquinone radical of bound MQ are similar to those of the semiquinone radical of bound UQ and indicated an electron flow from PQQ to MQ as in the case of UQ. Taken together, the results suggest that MQ is incorporated into the same pocket as that for UQ to perform a function almost equivalent to that of UQ and that bound quinone is involved at least partially in the catalytic reaction and primarily in the intramolecular electron transfer of mGDH.	[Mustafa, Golam; Migita, Catharina T.; Yamada, Mamoru] Yamaguchi Univ, Fac Agr, Dept Biol Chem, Yamaguchi 7538515, Japan; [Ishikawa, Yoshinori; Yamada, Mamoru] Yamaguchi Univ, Grad Sch Med, Ube, Yamaguchi 7558505, Japan; [Kobayashi, Kazuo; Tagawa, Seiichi] Osaka Univ, Inst Sci & Ind Res, Osaka 5670047, Japan	Yamaguchi University; Yamaguchi University; Osaka University	Yamada, M (corresponding author), Yamaguchi Univ, Fac Agr, Dept Biol Chem, 1677-1 Yoshida, Yamaguchi 7538515, Japan.	m-yamada@yamaguchi-u.ac.jp	Kobayashi, Kazuo/H-9279-2012	Kobayashi, Kazuo/0000-0002-5586-9112; Yamada, Mamoru/0000-0003-4354-7324	Ministry of Education, Science and Culture of Japan	Ministry of Education, Science and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by a grant-in-aid for basic research from the Ministry of Education, Science and Culture of Japan (to M. Y.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	AMEYAMA M, 1985, AGR BIOL CHEM TOKYO, V49, P1227, DOI 10.1080/00021369.1985.10866884; AMEYAMA M, 1981, FEBS LETT, V130, P179, DOI 10.1016/0014-5793(81)81114-3; ANTHONY C, 1994, BIOCHEM J, V304, P665, DOI 10.1042/bj3040665; Azarkina N, 2002, J BACTERIOL, V184, P5339, DOI 10.1128/JB.184.19.5339-5347.2002; Bader MW, 2000, J BIOL CHEM, V275, P26082, DOI 10.1074/jbc.M003850200; Bekker M, 2007, MICROBIOL-SGM, V153, P1974, DOI 10.1099/mic.0.2007/006098-0; COLLINS MD, 1981, MICROBIOL REV, V45, P316, DOI 10.1128/MMBR.45.2.316-354.1981; Cozier GE, 1999, BIOCHEM J, V340, P639, DOI 10.1042/0264-6021:3400639; Cozier GE, 1995, BIOCHEM J, V312, P679, DOI 10.1042/bj3120679; DUINE JA, 1979, FEBS LETT, V108, P443, DOI 10.1016/0014-5793(79)80584-0; DULLEY JR, 1975, ANAL BIOCHEM, V64, P136, DOI 10.1016/0003-2697(75)90415-7; Elias MD, 2000, J BIOL CHEM, V275, P7321, DOI 10.1074/jbc.275.10.7321; Elias MD, 2004, J BIOL CHEM, V279, P3078, DOI 10.1074/jbc.M310163200; Elias MD, 2001, J BIOL CHEM, V276, P48356, DOI 10.1074/jbc.M107355200; GORDON S, 1964, J AM CHEM SOC, V86, P5343, DOI 10.1021/ja01077a067; HOMMES RWJ, 1984, FEMS MICROBIOL LETT, V24, P329, DOI 10.1016/0378-1097(84)90274-X; Inaba K, 2005, J BIOL CHEM, V280, P33035, DOI 10.1074/jbc.M506189200; INGLEDEW WJ, 1984, MICROBIOL REV, V48, P222, DOI 10.1128/MMBR.48.3.222-271.1984; Kobayashi K, 2005, BIOCHEMISTRY-US, V44, P13567, DOI 10.1021/bi051347n; Kobayashi K, 1997, BIOCHEMISTRY-US, V36, P13611, DOI 10.1021/bi971045o; Kobayashi K, 2003, J AM CHEM SOC, V125, P10213, DOI 10.1021/ja036211w; Kobayashi K, 2001, J BIOL CHEM, V276, P39864, DOI 10.1074/jbc.M102537200; Maklashina E, 2006, J BIOL CHEM, V281, P26655, DOI 10.1074/jbc.M602938200; MATSUSHITA K, 1987, J BACTERIOL, V169, P205, DOI 10.1128/jb.169.1.205-209.1987; Matsushita K, 1997, MICROBIOL-UK, V143, P3149, DOI 10.1099/00221287-143-10-3149; Meganathan R, 2001, VITAM HORM, V61, P173; Miyoshi H, 1999, BBA-BIOENERGETICS, V1412, P29, DOI 10.1016/S0005-2728(99)00009-2; Mustafa G, 2008, J BIOL CHEM, V283, P22215, DOI 10.1074/jbc.M800911200; PATEL KB, 1973, J CHEM SOC FARAD T 1, V69, P814, DOI 10.1039/f19736900814; Soballe B, 2000, MICROBIOL-SGM, V146, P787, DOI 10.1099/00221287-146-4-787; Sode K, 1997, BIOTECHNOL LETT, V19, P1073, DOI 10.1023/A:1018428224215; Suvarna K, 1998, J BACTERIOL, V180, P2782, DOI 10.1128/JB.180.10.2782-2787.1998; SUZUKI S, 1994, J AM CHEM SOC, V116, P11145, DOI 10.1021/ja00103a035; Takahashi YH, 2004, J BIOL CHEM, V279, P47057, DOI 10.1074/jbc.M407153200; VANSCHIE BJ, 1985, J BACTERIOL, V163, P493, DOI 10.1128/JB.163.2.493-499.1985; WALLACE BJ, 1977, BIOCHIM BIOPHYS ACTA, V461, P84, DOI 10.1016/0005-2728(77)90071-8; Yamada M, 1998, J BIOL CHEM, V273, P22021, DOI 10.1074/jbc.273.34.22021; YAMADA M, 1993, J BIOL CHEM, V268, P12812; Yamada M, 2003, BBA-PROTEINS PROTEOM, V1647, P185, DOI 10.1016/S1570-9639(03)00100-6; YAMADA M, 1993, J BACTERIOL, V175, P568, DOI 10.1128/JB.175.2.568-571.1993; Yamashita T, 2007, J BIOL CHEM, V282, P6012, DOI 10.1074/jbc.M610646200	41	15	16	1	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 17	2008	283	42					28169	28175		10.1074/jbc.M804938200	http://dx.doi.org/10.1074/jbc.M804938200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	359EN	18708350	Green Published, hybrid			2022-12-27	WOS:000259969300019
J	Das, B; Gupta, S; Vasanji, A; Xu, Z; Misra, S; Sen, S				Das, Biswajit; Gupta, Sudhiranjan; Vasanji, Amit; Xu, Zhen; Misra, Saurav; Sen, Subha			Nuclear co-translocation of myotrophin and p65 stimulates myocyte growth - Regulation by myotrophin hairpin loops	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; ANKYRIN REPEAT PROTEIN; CARDIAC-HYPERTROPHY; HEART-FAILURE; MYOCARDIAL HYPERTROPHY; CAPPING PROTEIN; ANGIOTENSIN-II; ACTIVATION; GENE; EXPRESSION	Myotrophin, a 12-kDa ankyrin repeat protein, stimulates protein synthesis and cardiomyocyte growth to initiate cardiac hypertrophy by activating the NF-kappa B signaling cascade. We found that, after internalization into myocytes, myotrophin co-translocates into the nucleus with p65 to stimulate myocyte growth. We used structure-based mutations on the hairpin loops of myotrophin to determine the effect of the loops on myotrophin and p65 localization, induction of protein synthesis, and cardiac hypertrophy. Loop mutants, most prominently glutamic acid 33 -> alanine (E33A), stimulated protein synthesis much less than wild type. Myotrophin-E33A internalized into myocytes but did not translocate into the nucleus and failed to promote nuclear translocation of p65. In addition, two cardiac hypertrophy marker genes, atrial natriuretic factor and beta-myosin heavy chain, were not up-regulated in E33A-treated cells. Myotrophin-induced myocyte growth and initiation of hypertrophy thus require nuclear co-translocation of myotrophin and p65, in a manner that depends crucially on the myotrophin hairpin loops.	[Das, Biswajit; Gupta, Sudhiranjan; Xu, Zhen; Misra, Saurav; Sen, Subha] Cleveland Clin, Dept Mol Cardiol, LRI, Cleveland, OH 44195 USA; [Vasanji, Amit] Cleveland Clin, Image Proc & Anal Ctr, Lerner Res Inst, Dept Biomed Engn, Cleveland, OH 44195 USA	Cleveland Clinic Foundation; Cleveland Clinic Foundation	Sen, S (corresponding author), Cleveland Clin, Dept Mol Cardiol, LRI, NB-50,9500 Euclid Ave, Cleveland, OH 44195 USA.	sens@ccf.org		Misra, Saurav/0000-0002-1385-8554	National Institutes of Health [HL R01 47794]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL047794] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM080271] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant HL R01 47794 (to S. S.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	Anderson KM, 1999, J MOL CELL CARDIOL, V31, P705, DOI 10.1006/jmcc.1998.0903; Bhattacharya N, 2006, J BIOL CHEM, V281, P31021, DOI 10.1074/jbc.M606278200; Brigelus-Flohe R, 1995, BIOFACTORS, V5, P169; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Goddard T. D., 2006, SPARKY; Gupta S, 2005, AM J PHYSIOL-HEART C, V289, pH20, DOI 10.1152/ajpheart.00082.2005; Gupta S, 2002, J CELL BIOL, V159, P1019, DOI 10.1083/jcb.200207149; Gupta S, 2008, J MOL BIOL, V375, P637, DOI 10.1016/j.jmb.2007.10.006; Hallhuber M, 2006, CIRC RES, V99, P626, DOI 10.1161/01.RES.0000243208.59795.d8; IWABUCHI K, 1994, P NATL ACAD SCI USA, V91, P6098, DOI 10.1073/pnas.91.13.6098; Jones W Keith, 2003, Cardiovasc Toxicol, V3, P229, DOI 10.1385/CT:3:3:229; Kalra D, 2000, CIRCULATION, V102, P1302, DOI 10.1161/01.CIR.102.11.1302; Khan SQ, 2007, CLIN SCI, V112, P251, DOI 10.1042/CS20060191; Knuefermann P, 2002, J BIOL CHEM, V277, P23888, DOI 10.1074/jbc.M202937200; Kobayashi S, 2005, GENES CELLS, V10, P253, DOI 10.1111/j.1365-2443.2005.00835.x; Lowe AR, 2007, J MOL BIOL, V365, P1245, DOI 10.1016/j.jmb.2006.10.060; Maeda T, 2002, GENE, V297, P1, DOI 10.1016/S0378-1119(02)00924-1; Michaely P, 1992, Trends Cell Biol, V2, P127, DOI 10.1016/0962-8924(92)90084-Z; Mosavi LK, 2002, J MOL BIOL, V320, P165, DOI 10.1016/S0022-2836(02)00441-2; MUKHERJEE DP, 1993, HYPERTENSION, V21, P142, DOI 10.1161/01.HYP.21.2.142; O'Brien RJ, 2003, J AM COLL CARDIOL, V42, P719, DOI 10.1016/S0735-1097(03)00755-1; Purcell NH, 2003, CIRCULATION, V108, P638, DOI 10.1161/01.CIR.0000085362.40608.DD; Purcell NH, 2001, P NATL ACAD SCI USA, V98, P6668, DOI 10.1073/pnas.111155798; Qin J, 2006, ACTA PHARMACOL SIN, V27, P1159, DOI 10.1111/j.1745-7254.2006.00370.x; Ritchie NE, 1998, CIRCULATION, V98, P1707, DOI 10.1161/01.CIR.98.17.1707; Rouet-Benzineb P, 2000, J MOL CELL CARDIOL, V32, P1767, DOI 10.1006/jmcc.2000.1211; Sarkar S, 2004, J BIOL CHEM, V279, P20422, DOI 10.1074/jbc.M308488200; SEN S, 1990, J BIOL CHEM, V265, P16635; Sil P, 1998, CIRC RES, V82, P1173, DOI 10.1161/01.RES.82.11.1173; Sil P, 2004, MOL CELL BIOCHEM, V262, P79, DOI 10.1023/B:MCBI.0000038219.46896.a4; SIL P, 1993, CIRC RES, V73, P98, DOI 10.1161/01.RES.73.1.98; Sivasubramanian N, 1996, J BIOL CHEM, V271, P2812, DOI 10.1074/jbc.271.5.2812; TAOKA M, 1994, J BIOL CHEM, V269, P9946; Taoka M, 2003, J BIOL CHEM, V278, P5864, DOI 10.1074/jbc.M211509200; THOMPSON CC, 1991, SCIENCE, V253, P762, DOI 10.1126/science.1876833; Udalova IA, 2000, MOL CELL BIOL, V20, P9113, DOI 10.1128/MCB.20.24.9113-9119.2000; Valen G, 2001, J AM COLL CARDIOL, V38, P307, DOI 10.1016/S0735-1097(01)01377-8; Wong SCY, 1998, CIRCULATION, V98, P100, DOI 10.1161/01.CIR.98.2.100; Yamakuni T, 2002, BIOCHEM BIOPH RES CO, V298, P793, DOI 10.1016/S0006-291X(02)02529-9; Yang YW, 1998, STRUCTURE, V6, P619, DOI 10.1016/S0969-2126(98)00063-X; Yang YW, 1997, PROTEIN SCI, V6, P1347, DOI 10.1002/pro.5560060625	41	6	7	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 10	2008	283	41					27947	27956		10.1074/jbc.M801210200	http://dx.doi.org/10.1074/jbc.M801210200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	355OW	18693253	hybrid, Green Published			2022-12-27	WOS:000259719200065
J	Witola, WH; El Bissati, K; Pessi, G; Xie, C; Roepe, PD; Ben Mamoun, C				Witola, William Harold; El Bissati, Kamal; Pessi, Gabriella; Xie, Changan; Roepe, Paul D.; Ben Mamoun, Choukri			Disruption of the Plasmodium falciparum PfPMT gene results in a complete loss of phosphatidylcholine biosynthesis via the serine-decarboxylase-phosphoethanolamine-methyltransferase pathway and severe growth and survival defects	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							N-METHYLTRANSFERASE; PHOSPHOCHOLINE BIOSYNTHESIS; PARASITES; METHYLATION; CLONING; YEAST	Biochemical studies in the human malaria parasite, Plasmodium falciparum, indicated that in addition to the pathway for synthesis of phosphatidylcholine from choline (CDP-choline pathway), the parasite synthesizes this major membrane phospholipid via an alternative pathway named the serine-decarboxylasephosphoethanolamine-methyltransferase (SDPM) pathway using host serine and ethanolamine as precursors. However, the role the transmethylation of phosphatidylethanolamine plays in the biosynthesis of phosphatidylcholine and the importance of the SDPM pathway in the parasite's growth and survival remain unknown. Here, we provide genetic evidence that knock-out of the PfPMT gene encoding the phosphoethanolamine methyltransferase enzyme completely abrogates the biosynthesis of phosphatidylcholine via the SDPM pathway. Lipid analysis in knock-out parasites revealed that unlike in mammalian and yeast cells, methylation of phosphatidylethanolamine to phosphatidylcholine does not occur in P. falciparum, thus making the SDPM and CDP-choline pathways the only routes for phosphatidylcholine biosynthesis in this organism. Interestingly, loss of PfPMT resulted in significant defects in parasite growth, multiplication, and viability, suggesting that this gene plays an important role in the pathogenesis of intraerythrocytic Plasmodium parasites.	[Witola, William Harold; El Bissati, Kamal; Pessi, Gabriella; Ben Mamoun, Choukri] Univ Connecticut, Ctr Hlth, Dept Genet & Dev Biol, Farmington, CT 06030 USA; [Xie, Changan; Roepe, Paul D.] Georgetown Univ, Dept Chem, Washington, DC 20057 USA; [Xie, Changan; Roepe, Paul D.] Georgetown Univ, Dept Biochem Cellular & Mol Biol, Washington, DC 20057 USA	University of Connecticut; Georgetown University; Georgetown University	Ben Mamoun, C (corresponding author), Univ Connecticut, Ctr Hlth, Dept Genet & Dev Biol, Farmington, CT 06030 USA.	choukri@up.uchc.edu	Witola, WIlliam Harold/AAD-6647-2020; Pessi, Gabriella/AGW-2342-2022	EL BISSATI, KAMAL/0000-0001-9341-4162; Pessi, Gabriella/0000-0002-8138-5541	National Institutes of Health [AI51507, AI51962]; Department of Defense [PR033005]; Burroughs Wellcome Fund [1006267]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI051507] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); Burroughs Wellcome Fund(Burroughs Wellcome Fund); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants AI51507 and AI51962. This research was also supported by Department of Defense Grant PR033005 as well as by Burroughs Wellcome Fund Award 1006267 (to C. B. M.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Ben Mamoun C, 1999, P NATL ACAD SCI USA, V96, P8716, DOI 10.1073/pnas.96.15.8716; Bolognese CP, 2000, PLANT PHYSIOL, V124, P1800, DOI 10.1104/pp.124.4.1800; Brendza KM, 2007, BIOCHEM J, V404, P439, DOI 10.1042/BJ20061815; BRENDZA KM, 2007, BIOCH J; Charron JBF, 2002, PLANT PHYSIOL, V129, P363, DOI 10.1104/pp.001776; Crabb BS, 1997, MOL BIOCHEM PARASIT, V90, P131, DOI 10.1016/S0166-6851(97)00143-6; El Bissati K, 2006, P NATL ACAD SCI USA, V103, P9286, DOI 10.1073/pnas.0602590103; Fidock DA, 1998, MOL PHARMACOL, V54, P1140, DOI 10.1124/mol.54.6.1140; FOLCH J, 1957, J BIOL CHEM, V226, P497; Francis SE, 1997, J BIOL CHEM, V272, P14961, DOI 10.1074/jbc.272.23.14961; Gligorijevic B, 2008, MOL BIOCHEM PARASIT, V159, P7, DOI 10.1016/j.molbiopara.2007.12.014; Gligorijevic B, 2006, BIOCHEMISTRY-US, V45, P12400, DOI 10.1021/bi061033f; HOLZ GG, 1977, B WORLD HEALTH ORGAN, V55, P237; Kirk K, 2001, PHYSIOL REV, V81, P495, DOI 10.1152/physrev.2001.81.2.495; KODAKI T, 1987, J BIOL CHEM, V262, P15428; Krishna S, 1997, BMJ-BRIT MED J, V315, P730, DOI 10.1136/bmj.315.7110.730; Mamoun CB, 2001, MOL MICROBIOL, V39, P26, DOI 10.1046/j.1365-2958.2001.02222.x; Mitamura T, 2000, PARASITOL INT, V49, P219, DOI 10.1016/S1383-5769(00)00048-9; MUDD SH, 1986, PLANT PHYSIOL, V82, P126, DOI 10.1104/pp.82.1.126; Nuccio ML, 2000, J BIOL CHEM, V275, P14095, DOI 10.1074/jbc.275.19.14095; Palavalli LH, 2006, BIOCHEMISTRY-US, V45, P6056, DOI 10.1021/bi060199d; Pessi G, 2005, J BIOL CHEM, V280, P12461, DOI 10.1074/jbc.M414626200; Pessi G, 2004, P NATL ACAD SCI USA, V101, P6206, DOI 10.1073/pnas.0307742101; Pessi G, 2006, FUTURE LIPIDOL, V1, P173, DOI 10.2217/17460875.1.2.173; SUMMERS EF, 1988, GENETICS, V120, P909; TRAGER W, 1976, SCIENCE, V193, P673, DOI 10.1126/science.781840; Vial HJ, 2005, MOLECULAR APPROACHES TO MALARIA, P327; WHO Expert Committee on Malaria, 2000, WHO TECH REP SER, V892, P1; Witola WH, 2006, J BIOL CHEM, V281, P21305, DOI 10.1074/jbc.M603260200; Witola WH, 2007, EUKARYOT CELL, V6, P1618, DOI 10.1128/EC.00229-07; ZEISEL SH, 1980, NEUROLOGY, V30, P1226, DOI 10.1212/WNL.30.11.1226; Zeisel SH, 2000, J AM COLL NUTR, V19, p528S, DOI 10.1080/07315724.2000.10718976	32	59	60	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 10	2008	283	41					27636	27643		10.1074/jbc.M804360200	http://dx.doi.org/10.1074/jbc.M804360200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	355OW	18694927	Green Published, hybrid			2022-12-27	WOS:000259719200035
J	Zhang, HS; Kruk, JA; Reese, JC				Zhang, Hesheng; Kruk, Jennifer A.; Reese, Joseph C.			Dissection of coactivator requirement at RNR3 reveals unexpected contributions from TFIID and SAGA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TATA-BINDING PROTEIN; GENERAL TRANSCRIPTION MACHINERY; UPSTREAM ACTIVATING SEQUENCES; TBP-ASSOCIATED FACTORS; RNA-POLYMERASE-II; IN-VIVO; SACCHAROMYCES-CEREVISIAE; CORE PROMOTER; YEAST; RECRUITMENT	The gene encoding ribonucleotide reductase 3 (RNR3)is strongly induced in response to DNA damage. Its expression is strictly dependent upon the TAF(II) subunits of TFIID, which are required for the recruitment of SWI/SNF and nucleosome remodeling. However, full activation of RNR3 also requires GCN5, the catalytic subunit of the SAGA histone acetyltransferase complex. Thus, RNR3 is dependent upon both TFIID and SAGA, two complexes that deliver TATA-binding protein (TBP) to promoters. Furthermore, unlike the majority of TFIID-dominated genes, RNR3 contains a consensus TATA-box, a feature of SAGA-regulated core promoters. Although a large fraction of the genome can be characterized as either TFIID-or SAGA-dominant, it is expected that many genes utilize both. The mechanism of activation and the relative contributions of SAGA and TFIID at genes regulated by both complexes have not been examined. Here we delineated the role of SAGA in the regulation of RNR3 and contrast it to that of TFIID. We find that SAGA components fulfill distinct functions in the regulation of RNR3. The core promoter of RNR3 is SAGA-dependent, and we provide evidence that SAGA, not TAF(II)s within TFIID, are largely responsible for TBP recruitment. This taken together with our previous work provides evidence that SAGA recruits TBP, whereas TFIID mediates chromatin remodeling. Thus, we described an unexpected shift in the division of labor between these two complexes and provide the first characterization of a gene that requires both SAGA and TFIID.	[Zhang, Hesheng; Kruk, Jennifer A.; Reese, Joseph C.] Penn State Univ, Dept Biochem & Mol Biol, Ctr Gene Regulat, University Pk, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Reese, JC (corresponding author), Penn State Univ, Dept Biochem & Mol Biol, Ctr Gene Regulat, 203 Althouse Lab, University Pk, PA 16802 USA.	Jcr8@psu.edu			National Institutes of Health [GM58672]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM058672] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM58672 (to J. C. R.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Baker SP, 2007, ONCOGENE, V26, P5329, DOI 10.1038/sj.onc.1210603; Barbaric S, 2003, MOL CELL BIOL, V23, P3468, DOI 10.1128/MCB.23.10.3468-3476.2003; Basehoar AD, 2004, CELL, V116, P699, DOI 10.1016/S0092-8674(04)00205-3; Belotserkovskaya R, 2000, MOL CELL BIOL, V20, P634, DOI 10.1128/MCB.20.2.634-647.2000; Bhaumik SR, 2001, GENE DEV, V15, P1935, DOI 10.1101/gad.911401; Brachmann CB, 1998, YEAST, V14, P115; Bryant GO, 2003, MOL CELL, V11, P1301, DOI 10.1016/S1097-2765(03)00144-8; Carey M, 2006, MOL CELL, V24, P481, DOI 10.1016/j.molcel.2006.09.012; Carrozza MJ, 2003, TRENDS GENET, V19, P321, DOI 10.1016/S0168-9525(03)00115-X; Cosma MP, 2002, MOL CELL, V10, P227, DOI 10.1016/S1097-2765(02)00604-4; Dudley AM, 1999, GENE DEV, V13, P2940, DOI 10.1101/gad.13.22.2940; Durso RJ, 2001, MOL CELL BIOL, V21, P7331, DOI 10.1128/MCB.21.21.7331-7344.2001; ELLEDGE SJ, 1992, TRENDS BIOCHEM SCI, V17, P119, DOI 10.1016/0968-0004(92)90249-9; Govind CK, 2005, MOL CELL BIOL, V25, P5626, DOI 10.1128/MCB.25.13.5626-5638.2005; Green MR, 2000, TRENDS BIOCHEM SCI, V25, P59, DOI 10.1016/S0968-0004(99)01527-3; He QY, 2008, J BIOL CHEM, V283, P5276, DOI 10.1074/jbc.M708266200; Huang MX, 1998, CELL, V94, P595, DOI 10.1016/S0092-8674(00)81601-3; Huisinga KL, 2004, MOL CELL, V13, P573, DOI 10.1016/S1097-2765(04)00087-5; Ioshikhes IP, 2006, NAT GENET, V38, P1210, DOI 10.1038/ng1878; Kristjuhan A, 2002, MOL CELL, V10, P925, DOI 10.1016/S1097-2765(02)00647-0; Kuras L, 2000, SCIENCE, V288, P1244, DOI 10.1126/science.288.5469.1244; Larschan E, 2001, GENE DEV, V15, P1946, DOI 10.1101/gad.911501; Lee TI, 2000, NATURE, V405, P701, DOI 10.1038/35015104; Lemon B, 2000, GENE DEV, V14, P2551, DOI 10.1101/gad.831000; Li B, 2001, J BIOL CHEM, V276, P33788, DOI 10.1074/jbc.M104220200; Li B, 2000, EMBO J, V19, P4091, DOI 10.1093/emboj/19.15.4091; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; Li XY, 2000, SCIENCE, V288, P1242, DOI 10.1126/science.288.5469.1242; Li XY, 2002, CURR BIOL, V12, P1240, DOI 10.1016/S0960-9822(02)00932-6; Martinez-Campa C, 2004, MOL CELL, V15, P69, DOI 10.1016/j.molcel.2004.05.022; Mencia M, 2002, MOL CELL, V9, P823, DOI 10.1016/S1097-2765(02)00490-2; Moqtaderi Z, 1996, NATURE, V383, P188, DOI 10.1038/383188a0; Pugh BF, 2000, GENE, V255, P1, DOI 10.1016/S0378-1119(00)00288-2; Qiu HF, 2005, MOL CELL BIOL, V25, P3461, DOI 10.1128/MCB.25.9.3461-3474.2005; Qiu HF, 2004, MOL CELL BIOL, V24, P4104, DOI 10.1128/MCB.24.10.4104-4117.2004; Reese JC, 2000, J BIOL CHEM, V275, P17391, DOI 10.1074/jbc.M001635200; Reese JC, 2003, METHOD ENZYMOL, V370, P415; Sermwittayawong D, 2006, EMBO J, V25, P3791, DOI 10.1038/sj.emboj.7601265; Sharma VM, 2007, MOL CELL BIOL, V27, P3199, DOI 10.1128/MCB.02311-06; Sharma VM, 2003, GENE DEV, V17, P502, DOI 10.1101/gad.1039503; Shen WC, 1997, CELL, V90, P615, DOI 10.1016/S0092-8674(00)80523-1; Swanson MJ, 2003, MOL CELL BIOL, V23, P2800, DOI 10.1128/MCB.23.8.2800-2820.2003; Tabtiang RK, 1998, MOL CELL BIOL, V18, P4707, DOI 10.1128/MCB.18.8.4707; Thomas MC, 2006, CRIT REV BIOCHEM MOL, V41, P105, DOI 10.1080/10409230600648736; Timmers HTM, 2005, TRENDS BIOCHEM SCI, V30, P7, DOI 10.1016/j.tibs.2004.11.007; Tomar RS, 2008, EMBO J, V27, P1575, DOI 10.1038/emboj.2008.93; Tsukihashi Y, 2001, J BIOL CHEM, V276, P25715, DOI 10.1074/jbc.M102416200; Warfield L, 2004, GENE DEV, V18, P1022, DOI 10.1101/gad.1192204; Whitehouse I, 2007, NATURE, V450, P1031, DOI 10.1038/nature06391; Yu YX, 2003, MOL CELL BIOL, V23, P1910, DOI 10.1128/MCB.23.6.1910-1921.2003; Zhang HS, 2007, P NATL ACAD SCI USA, V104, P8833, DOI 10.1073/pnas.0701666104; Zhang Z, 2005, MOL CELL BIOL, V25, P7399, DOI 10.1128/MCB.25.17.7399-7411.2005; Zhang Z, 2004, J BIOL CHEM, V279, P39240, DOI 10.1074/jbc.M407159200; Zhang Z, 2004, EMBO J, V23, P2246, DOI 10.1038/sj.emboj.7600227; Zhang Zhengjian, 2006, Methods Mol Biol, V313, P245	55	17	18	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 10	2008	283	41					27360	27368		10.1074/jbc.M803831200	http://dx.doi.org/10.1074/jbc.M803831200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	355OW	18682387	Green Published, hybrid			2022-12-27	WOS:000259719200004
J	Khidr, L; Wu, GK; Davila, A; Procaccio, V; Wallace, D; Lee, WH				Khidr, Lily; Wu, Guikai; Davila, Antonio; Procaccio, Vincent; Wallace, Douglas; Lee, Wen-Hwa			Role of SUV3 helicase in maintaining mitochondrial Homeostasis in human cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COLI RNA DEGRADOSOME; ESCHERICHIA-COLI; MESSENGER-RNA; POLYNUCLEOTIDE PHOSPHORYLASE; SACCHAROMYCES-CEREVISIAE; TRANSCRIPTION-FACTOR; RNA/DNA HELICASE; INNER MEMBRANE; DNA NUCLEOIDS; BOX PROTEIN	In yeast mitochondria, RNA degradation takes place through the coordinated activities of ySuv3 helicase and yDss1 exoribonuclease (mtEXO), whereas in bacteria, RNA is degraded via RNaseE, Rh1B, PNPase, and enolase. Yeast lacking the Suv3 component of the mtEXO form petits and undergo a toxic accumulation of omega intron RNAs. Mammalian mitochondria resemble their prokaryotic origins by harboring a polyadenylation-dependent RNA degradation mechanism, but whether SUV3 participates in regulating RNA turnover in mammalian mitochondria is unclear. We found that lack of hSUV3 in mammalian cells subsequently yielded an accumulation of shortened polyadenylated mtRNA species and impaired mitochondrial protein synthesis. This suggests that SUV3 may serve in part as a component of an RNA degradosome, resembling its yeast ancestor. Reduction in the expression levels of oxidative phosphorylation components correlated with an increase in reactive oxygen species generation, whereas membrane potential and ATP production were decreased. These cumulative defects led to pleiotropic effects in mitochondria such as decreased mtDNA copy number and a shift in mitochondrial morphology from tubular to granular, which eventually manifests in cellular senescence or cell death. Thus, our results suggest that SUV3 is essential for maintaining proper mitochondrial function, likely through a conserved role in mitochondrial RNA regulation.	[Khidr, Lily; Wu, Guikai; Davila, Antonio; Procaccio, Vincent; Wallace, Douglas; Lee, Wen-Hwa] Univ Calif Irvine, Dept Biol Chem, Sch Med, Irvine, CA 92697 USA; [Davila, Antonio; Procaccio, Vincent; Wallace, Douglas] Univ Calif Irvine, Ctr Mol & Mitochondrial Med & Genet, Sch Med, Irvine, CA 92697 USA	University of California System; University of California Irvine; University of California System; University of California Irvine	Lee, WH (corresponding author), Univ Calif Irvine, Dept Biol Chem, Sch Med, 124 Sprague Hall, Irvine, CA 92697 USA.	whlee@uci.edu	Lee, Wen-Hwa/C-2519-2014	procaccio, Vincent/0000-0002-1537-4684	National Institutes of Health [R01-AG027877, AG24373, AG13154, NS41850, DK73691, NS21328]; Donald Bren Endowment; NATIONAL CANCER INSTITUTE [T32CA009054] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK073691] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS041850, R01NS021328] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG024373, R01AG027877, R01AG013154] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Donald Bren Endowment; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants R01-AG027877 (to W.-H.L.) and AG24373, AG13154, NS41850, DK73691, and NS21328 (to D.W.). It was also supported by the Donald Bren Endowment (to W.-H.L. and D.W.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; Attardi G, 1979, Methods Enzymol, V56, P66; BABITZKE P, 1991, P NATL ACAD SCI USA, V88, P1, DOI 10.1073/pnas.88.1.1; Bessarab DA, 1998, P NATL ACAD SCI USA, V95, P3157, DOI 10.1073/pnas.95.6.3157; Bogenhagen DF, 2003, MOL CELL PROTEOMICS, V2, P1205, DOI 10.1074/mcp.M300035-MCP200; BOGENHAGEN DF, 2007, J BIOL CHEM; Briani F, 2007, BIOCHIMIE, V89, P145, DOI 10.1016/j.biochi.2006.09.020; Callaghan AJ, 2005, NATURE, V437, P1187, DOI 10.1038/nature04084; Carpousis AJ, 2002, BIOCHEM SOC T, V30, P150, DOI 10.1042/bst0300150; Carpousis AJ, 2001, METHOD ENZYMOL, V342, P333, DOI 10.1016/S0076-6879(01)42556-0; Chan HM, 2005, GENE DEV, V19, P196, DOI 10.1101/gad.1280205; Chandran V, 2006, J MOL BIOL, V358, P8, DOI 10.1016/j.jmb.2006.02.012; Chen HW, 2006, MOL CELL BIOL, V26, P8475, DOI 10.1128/MCB.01002-06; CHRZANOWSKALIGHTOWLERS ZMA, 1994, J BIOL CHEM, V269, P27322; Coburn GA, 1999, GENE DEV, V13, P2594, DOI 10.1101/gad.13.19.2594; Coskun PE, 2004, P NATL ACAD SCI USA, V101, P10726, DOI 10.1073/pnas.0403649101; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; DMOCHOWSKA A, 1995, CURR GENET, V28, P108, DOI 10.1007/BF00315775; Dziembowski A, 2003, J BIOL CHEM, V278, P1603, DOI 10.1074/jbc.M208287200; Dziembowski A, 1998, MOL GEN GENET, V260, P108, DOI 10.1007/s004380050876; EHRETSMANN CP, 1992, FASEB J, V6, P3186, DOI 10.1096/fasebj.6.13.1397840; Eubel H, 2004, PLANT PHYSIOL, V134, P1450, DOI 10.1104/pp.103.038018; Eubel H, 2004, PLANT PHYSIOL BIOCH, V42, P937, DOI 10.1016/j.plaphy.2004.09.010; FORABOSCO A, 1972, B SOC ITAL BIOL SPER, V48, P33; Funayama R, 2006, J CELL BIOL, V175, P869, DOI 10.1083/jcb.200604005; Gebauer D, 1996, INT J DEV BIOL, V40, P239; Genova Maria Luisa, 2003, Ital J Biochem, V52, P58; GOLIK P, 1995, CURR GENET, V28, P217, DOI 10.1007/BF00309780; Houseley J, 2006, NAT REV MOL CELL BIO, V7, P529, DOI 10.1038/nrm1964; Itahana Koji, 2007, Methods Mol Biol, V371, P21; Kang D, 2007, MITOCHONDRION, V7, P39, DOI 10.1016/j.mito.2006.11.017; KING MP, 1989, SCIENCE, V246, P500, DOI 10.1126/science.2814477; KUKAT A, 2008, NUCL ACIDS IN PRESS; Larsson NG, 1998, NAT GENET, V18, P231, DOI 10.1038/ng0398-231; Li CH, 2005, J BIOL CHEM, V280, P26193, DOI 10.1074/jbc.M501371200; Margossian SP, 1996, TRENDS BIOCHEM SCI, V21, P392, DOI 10.1016/S0968-0004(96)90129-2; Margossian SP, 1996, CELL, V84, P199, DOI 10.1016/S0092-8674(00)80975-7; McKenzie M, 2007, ANAL BIOCHEM, V364, P128, DOI 10.1016/j.ab.2007.02.022; Miczak A, 1996, P NATL ACAD SCI USA, V93, P3865, DOI 10.1073/pnas.93.9.3865; Minczuk M, 2005, BBA-GENE STRUCT EXPR, V1729, P81, DOI 10.1016/j.bbaexp.2005.04.005; Minczuk M, 2002, NUCLEIC ACIDS RES, V30, P5074, DOI 10.1093/nar/gkf647; Miranda S, 1999, BIOCHEM BIOPH RES CO, V258, P44, DOI 10.1006/bbrc.1999.0580; MORAIS R, 1988, IN VITRO CELL DEV B, V24, P649, DOI 10.1007/BF02623602; Morita T, 2004, MOL MICROBIOL, V54, P1063, DOI 10.1111/j.1365-2958.2004.04329.x; Okamoto K, 2005, ANNU REV GENET, V39, P503, DOI 10.1146/annurev.genet.38.072902.093019; PARISI MA, 1993, MOL CELL BIOL, V13, P1951, DOI 10.1128/MCB.13.3.1951; Pereira M, 2007, MECH AGEING DEV, V128, P609, DOI 10.1016/j.mad.2007.09.001; Piechota J, 2006, ACTA BIOCHIM POL, V53, P157; Regonesi ME, 2004, NUCLEIC ACIDS RES, V32, P1006, DOI 10.1093/nar/gkh268; Rodriguez-Santiago B, 2001, EUR J HUM GENET, V9, P279, DOI 10.1038/sj.ejhg.5200629; RUSTIN P, 1994, CLIN CHIM ACTA, V228, P35, DOI 10.1016/0009-8981(94)90055-8; Sarkar D, 2006, PHARMACOL THERAPEUT, V112, P243, DOI 10.1016/j.pharmthera.2006.04.003; Shadel GS, 2004, TRENDS GENET, V20, P513, DOI 10.1016/j.tig.2004.08.005; Shu ZY, 2004, BIOCHEMISTRY-US, V43, P4781, DOI 10.1021/bi0356449; Slomovic S, 2005, MOL CELL BIOL, V25, P6427, DOI 10.1128/MCB.25.15.6427-6435.2005; Spiegelman Bruce M, 2007, Novartis Found Symp, V287, P60; Stroh A, 2004, J BIOL CHEM, V279, P5000, DOI 10.1074/jbc.M309505200; Stuart RA, 2002, BBA-MOL CELL RES, V1592, P79, DOI 10.1016/S0167-4889(02)00266-5; Szczesny RJ, 2007, BIOL CELL, V99, P323, DOI 10.1042/BC20060108; Trounce I A, 1996, Methods Enzymol, V264, P484, DOI 10.1016/S0076-6879(96)64044-0; Wallace DC, 2005, COLD SH Q B, V70, P363, DOI 10.1101/sqb.2005.70.035; Wang YS, 2006, J BIOL CHEM, V281, P25791, DOI 10.1074/jbc.M604501200; Wu GK, 2003, CANCER RES, V63, P2589; Yehudai-Resheff S, 2000, NUCLEIC ACIDS RES, V28, P1139, DOI 10.1093/nar/28.5.1139; Zhang RG, 2005, DEV CELL, V8, P19, DOI 10.1016/j.devcel.2004.10.019	65	48	50	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 3	2008	283	40					27064	27073		10.1074/jbc.M802991200	http://dx.doi.org/10.1074/jbc.M802991200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	353RT	18678873	Green Published, hybrid			2022-12-27	WOS:000259586600027
J	Perez-Jimenez, R; Wiita, AP; Rodriguez-Larrea, D; Kosuri, P; Gavira, JA; Sanchez-Ruiz, JM; Fernandez, JM				Perez-Jimenez, Raul; Wiita, Arun P.; Rodriguez-Larrea, David; Kosuri, Pallav; Gavira, Jose A.; Sanchez-Ruiz, Jose M.; Fernandez, Julio M.			Force-clamp spectroscopy detects residue co-evolution in enzyme catalysis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI THIOREDOXIN; PROTEIN DISULFIDE-ISOMERASE; SINGLE-PROTEIN; ACTIVE-SITE; ELECTROSTATIC INTERACTIONS; CORRELATED MUTATIONS; EVOLUTION; NETWORK; ACTIVATION; MOLECULE	Understanding how the catalytic mechanisms of enzymes are optimized through evolution remains a major challenge in molecular biology. The concept of co-evolution implicates that compensatory mutations occur to preserve the structure and function of proteins. We have combined statistical analysis of protein sequences with the sensitivity of single molecule force-clamp spectroscopy to probe how catalysis is affected by structurally distant correlated mutations in Escherichia coli thioredoxin. Our findings show that evolutionary anti-correlated mutations have an inhibitory effect on enzyme catalysis, whereas positively correlated mutations rescue the catalytic activity. We interpret these results in terms of an evolutionary tuning of both the enzyme-substrate binding process and the chemistry of the active site. Our results constitute a direct observation of distant residue co-evolution in enzyme catalysis.	[Perez-Jimenez, Raul; Wiita, Arun P.; Kosuri, Pallav; Fernandez, Julio M.] Columbia Univ, Dept Biol Sci, New York, NY 10027 USA; [Wiita, Arun P.] Columbia Univ, Grad Program Neurobiol & Behav, New York, NY 10027 USA; [Rodriguez-Larrea, David; Sanchez-Ruiz, Jose M.] Univ Granada, Dept Quim Fis, Fac Ciencias, E-18071 Granada, Spain; [Kosuri, Pallav] Columbia Univ, Dept Biochem & Mol Biophys, New York, NY 10027 USA; [Gavira, Jose A.] Univ Granada, CSIC, Inst Andaluz Ciencias Tierra, Lab Estudios Cristalograf, Granada 18100, Spain	Columbia University; Columbia University; University of Granada; Columbia University; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto Andaluz de Ciencias de la Tierra (IACT); University of Granada	Fernandez, JM (corresponding author), Columbia Univ, Dept Biol Sci, 1011A Fairchild Ctr,1212 Amsterdam Ave,MC 2449, New York, NY 10027 USA.	jfernandez@columbia.edu	Kosuri, Pallav/J-8279-2012; Rodriguez-Larrea, David/ABH-3171-2020; Sanchez-Ruiz, Jose/H-2849-2015; Gavira, Jose A./C-2491-2009; Perez-Jimenez, Raul/C-3085-2017	Kosuri, Pallav/0000-0002-7025-3543; Rodriguez-Larrea, David/0000-0002-5580-7413; Sanchez-Ruiz, Jose/0000-0002-9056-3928; Gavira, Jose A./0000-0002-7386-6484; Perez-Jimenez, Raul/0000-0001-7094-6799	National Institutes of Health [HL66030, HL61228]; Spanish Ministry of Education and Science, FEDER Funds [BIO2006- 07332]; Junta de Andalucia [CVI-771]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL066030, R01HL061228] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Spanish Ministry of Education and Science, FEDER Funds(Spanish Government); Junta de Andalucia(Junta de Andalucia); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL66030 and HL61228 (to J.M.F.). This work was also supported by Grant BIO2006- 07332 from the Spanish Ministry of Education and Science, FEDER Funds, and Grant CVI-771 from Junta de Andalucia (to J.M.S.-R.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	ALTSCHUH D, 1987, J MOL BIOL, V193, P693, DOI 10.1016/0022-2836(87)90352-4; Bershtein S, 2006, NATURE, V444, P929, DOI 10.1038/nature05385; Carl P, 2001, P NATL ACAD SCI USA, V98, P1565, DOI 10.1073/pnas.031409698; Carrion-Vazquez M, 1999, P NATL ACAD SCI USA, V96, P3694, DOI 10.1073/pnas.96.7.3694; Chi CN, 2008, P NATL ACAD SCI USA, V105, P4679, DOI 10.1073/pnas.0711732105; Chivers PT, 1997, BIOCHEMISTRY-US, V36, P14985, DOI 10.1021/bi970071j; Chivers PT, 1997, BIOCHEMISTRY-US, V36, P15810, DOI 10.1021/bi971504l; Choi SS, 2005, NAT GENET, V37, P1367, DOI 10.1038/ng1685; Dillet V, 1998, BIOCHEMISTRY-US, V37, P10298, DOI 10.1021/bi980333x; Estabrook RA, 2005, P NATL ACAD SCI USA, V102, P994, DOI 10.1073/pnas.0409128102; Fares MA, 2006, GENETICS, V173, P9, DOI 10.1534/genetics.105.053249; Fernandes PA, 2004, CHEM-EUR J, V10, P257, DOI 10.1002/chem.200305343; Fernandez JM, 2004, SCIENCE, V303, P1674, DOI 10.1126/science.1092497; Fleishman SJ, 2004, J MOL BIOL, V340, P307, DOI 10.1016/j.jmb.2004.04.064; Garcia-Manyes S, 2007, BIOPHYS J, V93, P2436, DOI 10.1529/biophysj.107.104422; Glasner ME, 2006, J MOL BIOL, V360, P228, DOI 10.1016/j.jmb.2006.04.055; Grandbois M, 1999, SCIENCE, V283, P1727, DOI 10.1126/science.283.5408.1727; GRAUSCHOPF U, 1995, CELL, V83, P947, DOI 10.1016/0092-8674(95)90210-4; Gruber CW, 2006, TRENDS BIOCHEM SCI, V31, P455, DOI 10.1016/j.tibs.2006.06.001; Hammes-Schiffer S, 2006, ANNU REV BIOCHEM, V75, P519, DOI 10.1146/annurev.biochem.75.103004.142800; Himawan JS, 1996, J BIOL CHEM, V271, P19999, DOI 10.1074/jbc.271.33.19999; HOLMGREN A, 1985, ANNU REV BIOCHEM, V54, P237, DOI 10.1146/annurev.bi.54.070185.001321; Inaba K, 2002, EMBO J, V21, P2646, DOI 10.1093/emboj/21.11.2646; Johnson CP, 2007, SCIENCE, V317, P663, DOI 10.1126/science.1139857; Jurgens C, 2000, P NATL ACAD SCI USA, V97, P9925, DOI 10.1073/pnas.160255397; KIMURA M, 1991, P NATL ACAD SCI USA, V88, P5969, DOI 10.1073/pnas.88.14.5969; Kortemme T, 1996, BIOCHEMISTRY-US, V35, P14503, DOI 10.1021/bi9617724; KRAUSE G, 1991, J BIOL CHEM, V266, P9494; Kraut DA, 2003, ANNU REV BIOCHEM, V72, P517, DOI 10.1146/annurev.biochem.72.121801.161617; Lee BC, 2008, PROTEINS, V72, P863, DOI 10.1002/prot.21972; LeMaster DM, 1997, J BIOL CHEM, V272, P29998, DOI 10.1074/jbc.272.48.29998; Lockless SW, 1999, SCIENCE, V286, P295, DOI 10.1126/science.286.5438.295; LUNDSTROM J, 1990, J BIOL CHEM, V265, P9114; Masip L, 2008, J BIOL CHEM, V283, P840, DOI 10.1074/jbc.M705147200; Mateu MG, 1999, P NATL ACAD SCI USA, V96, P3595, DOI 10.1073/pnas.96.7.3595; Mossner E, 1998, PROTEIN SCI, V7, P1233; NEHER E, 1994, P NATL ACAD SCI USA, V91, P98, DOI 10.1073/pnas.91.1.98; NELDER JA, 1965, COMPUT J, V7, P308, DOI 10.1093/comjnl/7.4.308; Norrgard MA, 2006, P NATL ACAD SCI USA, V103, P4876, DOI 10.1073/pnas.0600849103; Oberhauser AF, 1998, NATURE, V393, P181, DOI 10.1038/30270; Ozkan E, 2005, P NATL ACAD SCI USA, V102, P18890, DOI 10.1073/pnas.0509418102; PATTHY L, 1999, PROTEIN EVOLUTION, P80; Pazos F, 1997, J MOL BIOL, V271, P511, DOI 10.1006/jmbi.1997.1198; Perez-Jimenez R, 2004, BIOPHYS J, V86, P2414, DOI 10.1016/S0006-3495(04)74298-8; Perez-Jimenez R, 2006, BIOPHYS CHEM, V119, P240, DOI 10.1016/j.bpc.2005.09.010; Pritchard L, 2000, J THEOR BIOL, V202, P77, DOI 10.1006/jtbi.1999.1043; Russ WP, 2005, NATURE, V437, P579, DOI 10.1038/nature03990; Shulman AI, 2004, CELL, V116, P417, DOI 10.1016/S0092-8674(04)00119-9; SLABY I, 1975, J BIOL CHEM, V250, P1340; SMITH TF, 1981, J MOL BIOL, V147, P195, DOI 10.1016/0022-2836(81)90087-5; Suel GM, 2003, NAT STRUCT BIOL, V10, P59, DOI 10.1038/nsb881; Szoszkiewicz R, 2008, LANGMUIR, V24, P1356, DOI 10.1021/la702368b; Wiita AP, 2007, NATURE, V450, P124, DOI 10.1038/nature06231; Wiita AP, 2006, P NATL ACAD SCI USA, V103, P7222, DOI 10.1073/pnas.0511035103; WILSON KP, 1992, J BIOL CHEM, V267, P10842; Zhang JZ, 2002, P NATL ACAD SCI USA, V99, P5486, DOI 10.1073/pnas.072626199	56	13	14	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 3	2008	283	40					27121	27129		10.1074/jbc.M803746200	http://dx.doi.org/10.1074/jbc.M803746200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	353RT	18687682	hybrid, Green Published			2022-12-27	WOS:000259586600033
J	Xu, J; Li, Y; Wang, Y; Liu, HX; Lei, L; Yang, HL; Liu, GQ; Ren, DT				Xu, Juan; Li, Yuan; Wang, Ying; Liu, Hongxia; Lei, Lei; Yang, Hailian; Liu, Guoqin; Ren, Dongtao			Activation of MAPK kinase 9 induces ethylene and camalexin biosynthesis and enhances sensitivity to salt stress in Arabidopsis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE; MAP KINASE; DISEASE RESISTANCE; SALICYLIC-ACID; 1-AMINOCYCLOPROPANE-1-CARBOXYLIC ACID; THALIANA; DEFENSE; CASCADE; GENE; PATHWAY	Mitogen-activated protein kinase (MAPK) cascades play important roles in regulating plant growth, development, and responses to various environmental stimuli. We demonstrate that MKK9, an MKK, is an upstream activator of the MPKs MPK3 and MPK6 both in vitro and in planta. Expression of active MKK9 protein in transgenic plants induces the synthesis of ethylene and camalexin through the activation of the endogenous MPK3 and MPK6 kinases. As a consequence, transcription of multiple genes responsible for ethylene biosynthesis, ethylene responses, and camalexin biosynthesis is coordinately up-regulated. The activation of MKK9 inhibits hypocotyl elongation in the etiolated seedlings. MKK9-mediated effects on hypocotyl elongation were blocked by the ethylene biosynthesis inhibitor, aminoethoxyvinylglycine, and ethylene receptor antagonist, Ag+. Expression of active MKK9 protein enhances the sensitivity of transgenic seedlings to salt stress, whereas loss of MKK9 activity reduces salt sensitivity indicating a role for MKK9 in the salt stress response. The results reported here reveal that the MKK9-MPK3/MPK6 cascade participates in the regulation of the biosynthesis of ethylene and camalexin and may be an important axis in the stress responses of Arabidopsis.	[Xu, Juan; Li, Yuan; Wang, Ying; Liu, Hongxia; Lei, Lei; Yang, Hailian; Liu, Guoqin; Ren, Dongtao] China Agr Univ, Coll Biol Sci, State Key Lab Plant Physiol & Biochem, Beijing 100094, Peoples R China	China Agricultural University	Ren, DT (corresponding author), 2 W Yuanmingyuan Rd, Beijing 100094, Peoples R China.	ren@cau.edu.cn			National Natural Science Foundation of China [30421002, 30770203, 30771124]; New Century Excellence Talents in University [04-0131]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); New Century Excellence Talents in University(Program for New Century Excellent Talents in University (NCET))	This work was supported by National Natural Science Foundation of China Grants 30421002 and 30770203, New Century Excellence Talents in University Grant 04-0131 (to D.R.), and National Natural Science Foundation of China Grant 30771124 (to H.Y.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	ADAMS DO, 1979, P NATL ACAD SCI USA, V76, P170, DOI 10.1073/pnas.76.1.170; Alonso JM, 1999, SCIENCE, V284, P2148, DOI 10.1126/science.284.5423.2148; Alzwiy IA, 2007, PLANT SCI, V173, P302, DOI 10.1016/j.plantsci.2007.06.007; Aoyama T, 1997, PLANT J, V11, P605, DOI 10.1046/j.1365-313X.1997.11030605.x; Asai T, 2002, NATURE, V415, P977, DOI 10.1038/415977a; Bohman S, 2004, PLANT J, V37, P9, DOI 10.1046/j.1365-313X.2003.01927.x; Calderini O, 2001, J BIOL CHEM, V276, P18139, DOI 10.1074/jbc.M010621200; Cardinale F, 2002, PLANT CELL, V14, P703, DOI 10.1105/tpc.010256; Chae HS, 2005, TRENDS PLANT SCI, V10, P291, DOI 10.1016/j.tplants.2005.04.006; Chae HS, 2003, PLANT CELL, V15, P545, DOI 10.1105/tpc.006882; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Dai Y, 2006, PLANT CELL, V18, P308, DOI 10.1105/tpc.105.037846; DELAAT AMM, 1983, PHYSIOL PLANT PATHOL, V22, P261; Doczi R, 2007, PLANT CELL, V19, P3266, DOI 10.1105/tpc.106.050039; Dong XN, 1998, CURR OPIN PLANT BIOL, V1, P316, DOI 10.1016/1369-5266(88)80053-0; Ferrari S, 2003, PLANT J, V35, P193, DOI 10.1046/j.1365-313X.2003.01794.x; Glawischnig E, 2004, P NATL ACAD SCI USA, V101, P8245, DOI 10.1073/pnas.0305876101; Glazebrook J, 2005, ANNU REV PHYTOPATHOL, V43, P205, DOI 10.1146/annurev.phyto.43.040204.135923; Hammerschmidt R, 1999, ANNU REV PHYTOPATHOL, V37, P285, DOI 10.1146/annurev.phyto.37.1.285; Ichimura K, 2002, TRENDS PLANT SCI, V7, P301, DOI 10.1016/S1360-1385(02)02302-6; Jirage D, 1999, P NATL ACAD SCI USA, V96, P13583, DOI 10.1073/pnas.96.23.13583; KENDE H, 1993, ANNU REV PLANT PHYS, V44, P283, DOI 10.1146/annurev.pp.44.060193.001435; Kiegerl S, 2000, PLANT CELL, V12, P2247, DOI 10.1105/tpc.12.11.2247; Kim CY, 2003, PLANT CELL, V15, P2707, DOI 10.1105/tpc.011411; Kliebenstein DJ, 2005, PLANT J, V44, P25, DOI 10.1111/j.1365-313X.2005.02508.x; Kus JV, 2002, PLANT CELL, V14, P479, DOI 10.1105/tpc.010481; Liu HX, 2008, CELL RES, V18, P422, DOI 10.1038/cr.2008.29; Liu YD, 2004, PLANT CELL, V16, P3386, DOI 10.1105/tpc.104.026609; MANSOUR SJ, 1994, SCIENCE, V265, P966, DOI 10.1126/science.8052857; Meszaros T, 2006, PLANT J, V48, P485, DOI 10.1111/j.1365-313X.2006.02888.x; Nafisi M, 2007, PLANT CELL, V19, P2039, DOI 10.1105/tpc.107.051383; Nakagami H, 2005, TRENDS PLANT SCI, V10, P339, DOI 10.1016/j.tplants.2005.05.009; Ouaked F, 2003, EMBO J, V22, P1282, DOI 10.1093/emboj/cdg131; Parisy V, 2007, PLANT J, V49, P159, DOI 10.1111/j.1365-313X.2006.02938.x; Pedley KF, 2005, CURR OPIN PLANT BIOL, V8, P541, DOI 10.1016/j.pbi.2005.07.006; Ren DT, 2008, P NATL ACAD SCI USA, V105, P5638, DOI 10.1073/pnas.0711301105; Ren DT, 2002, J BIOL CHEM, V277, P559, DOI 10.1074/jbc.M109495200; Rogers EE, 1996, MOL PLANT MICROBE IN, V9, P748, DOI 10.1094/MPMI-9-0748; Schuhegger R, 2006, PLANT PHYSIOL, V141, P1248, DOI 10.1104/pp.106.082024; SPANU P, 1994, PLANT PHYSIOL, V106, P529, DOI 10.1104/pp.106.2.529; Takahashi F, 2007, PLANT CELL, V19, P805, DOI 10.1105/tpc.106.046581; Teige M, 2004, MOL CELL, V15, P141, DOI 10.1016/j.molcel.2004.06.023; Tena G, 2001, CURR OPIN PLANT BIOL, V4, P392, DOI 10.1016/S1369-5266(00)00191-6; Thomma BPHJ, 1999, PLANT J, V19, P163, DOI 10.1046/j.1365-313X.1999.00513.x; TSUJI J, 1993, PHYSIOL MOL PLANT P, V43, P221, DOI 10.1006/pmpp.1993.1052; TSUJI J, 1992, PLANT PHYSIOL, V98, P1304, DOI 10.1104/pp.98.4.1304; van Loon LC, 2006, TRENDS PLANT SCI, V11, P184, DOI 10.1016/j.tplants.2006.02.005; Wang HC, 2007, PLANT CELL, V19, P63, DOI 10.1105/tpc.106.048298; Wang KLC, 2002, PLANT CELL, V14, pS131, DOI 10.1105/tpc.001768; Widmann C, 1999, PHYSIOL REV, V79, P143, DOI 10.1152/physrev.1999.79.1.143; WurglerMurphy SM, 1997, MOL CELL BIOL, V17, P1289, DOI 10.1128/MCB.17.3.1289; Xiong LM, 2002, PLANT CELL, V14, pS165, DOI 10.1105/tpc.000596; Yoo SD, 2008, NATURE, V451, P789, DOI 10.1038/nature06543; Zhang SQ, 2001, TRENDS PLANT SCI, V6, P520, DOI 10.1016/S1360-1385(01)02103-3; Zhang SQ, 1998, P NATL ACAD SCI USA, V95, P7433, DOI 10.1073/pnas.95.13.7433; Zhang X, 2007, PLANT J, V52, P1066, DOI 10.1111/j.1365-313X.2007.03294.x; Zhou N, 1999, PLANT CELL, V11, P2419, DOI 10.1105/tpc.11.12.2419	57	233	258	6	57	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 3	2008	283	40					26996	27006		10.1074/jbc.M801392200	http://dx.doi.org/10.1074/jbc.M801392200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	353RT	18693252	hybrid			2022-12-27	WOS:000259586600020
J	Andrews, AJ; Downing, G; Brown, K; Park, YJ; Luger, K				Andrews, Andrew J.; Downing, Gregory; Brown, Kitty; Park, Young-Jun; Luger, Karolin			A Thermodynamic Model for Nap1-Histone Interactions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOSOME ASSEMBLY PROTEIN-1; HISTONE CHAPERONE NAP1; 4-WAY JUNCTION DNA; RECOMBINANT HISTONES; IONIC-STRENGTH; CORE HISTONES; BINDING; RECONSTITUTION; TRANSCRIPTION; ASSOCIATION	The yeast nucleosome assembly protein 1 (yNap1) plays a role in chromatin maintenance by facilitating histone exchange as well as nucleosome assembly and disassembly. It has been suggested that yNap1 carries out these functions by regulating the concentration of free histones. Therefore, a quantitative understanding of yNap1-histone interactions also provides information on the thermodynamics of chromatin. We have developed quantitative methods to study the affinity of yNap1 for histones. We show that yNap1 binds H2A/H2B and H3/H4 histone complexes with low nM affinity, and that each yNap1 dimer binds two histone fold dimers. The yNap1 tails contribute synergistically to histone binding while the histone tails have a slightly repressive effect on binding. The (H3/H4)(2) tetramer binds DNA with higher affinity than it binds yNap1.	[Luger, Karolin] Colorado State Univ, Howard Hughes Med Inst, Ft Collins, CO 80523 USA; Colorado State Univ, Dept Biochem & Mol Biol, Ft Collins, CO 80523 USA	Colorado State University; Howard Hughes Medical Institute; Colorado State University	Luger, K (corresponding author), Colorado State Univ, Howard Hughes Med Inst, Ft Collins, CO 80523 USA.	Karolin.Luger@colostate.edu	Park, Young-Jun/AAF-6249-2021	Park, Young-Jun/0000-0003-2901-6949; SCHNIZER-LUGER, KAROLINE/0000-0001-5136-5331	National Institutes of Health [GM067777]; Howard Hughes Medical Institute; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067777] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM067777 and by the Howard Hughes Medical Institute. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Banks DD, 2004, PROTEIN SCI, V13, P1304, DOI 10.1110/ps.03535504; De Koning L, 2007, NAT STRUCT MOL BIOL, V14, P997, DOI 10.1038/nsmb1318; Dyer PN, 2004, METHOD ENZYMOL, V375, P23; Eitoku M, 2008, CELL MOL LIFE SCI, V65, P414, DOI 10.1007/s00018-007-7305-6; Galichet A, 2006, PLANT PHYSIOL, V142, P1412, DOI 10.1104/pp.106.088344; Karantza V, 1996, BIOCHEMISTRY-US, V35, P2037, DOI 10.1021/bi9518858; KARANTZA V, 1995, BIOCHEMISTRY-US, V34, P5988, DOI 10.1021/bi00017a028; Kepert JF, 2005, J BIOL CHEM, V280, P34063, DOI 10.1074/jbc.M507322200; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Luger K, 1999, METH MOL B, V119, P1; LUGER K, 2002, NAT GENET, V16, P16; Luger K., 2000, ENCY LIFE SCI; Mazurkiewicz J, 2006, J BIOL CHEM, V281, P16462, DOI 10.1074/jbc.M511619200; McBryant SJ, 2004, BIOCHEMISTRY-US, V43, P10592, DOI 10.1021/bi035881b; McBryant SJ, 2003, J BIOL CHEM, V278, P44574, DOI 10.1074/jbc.M305636200; Nakagawa T, 2001, J BIOL CHEM, V276, P27384, DOI 10.1074/jbc.M101331200; Park YJ, 2006, P NATL ACAD SCI USA, V103, P1248, DOI 10.1073/pnas.0508002103; Park YJ, 2005, J BIOL CHEM, V280, P1817, DOI 10.1074/jbc.M411347200; Park YJ, 2004, J BIOL CHEM, V279, P24274, DOI 10.1074/jbc.M313152200; Park YJ, 2008, J MOL BIOL, V375, P1076, DOI 10.1016/j.jmb.2007.11.031; Park YJ, 2006, BIOCHEM CELL BIOL, V84, P549, DOI 10.1139/O06-088; Sharma N, 2008, P NATL ACAD SCI USA, V105, P7959, DOI 10.1073/pnas.0800534105; Starich MR, 1996, J MOL BIOL, V255, P187, DOI 10.1006/jmbi.1996.0016; Toth KF, 2005, J BIOL CHEM, V280, P15690, DOI 10.1074/jbc.M413329200; VARGAWEISZ P, 1994, P NATL ACAD SCI USA, V91, P3525, DOI 10.1073/pnas.91.9.3525; VARGAWEISZ P, 1994, BIOCHEM BIOPH RES CO, V203, P1904, DOI 10.1006/bbrc.1994.2410; Zlatanova J, 2007, FASEB J, V21, P1294, DOI 10.1096/fj.06-7199rev	27	70	70	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 21	2008	283	47					32412	32418		10.1074/jbc.M805918200	http://dx.doi.org/10.1074/jbc.M805918200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	372HW	18728017	hybrid, Green Published			2022-12-27	WOS:000260893700029
J	Sharma, AK; Zhou, GP; Kupferman, J; Surks, HK; Christensen, EN; Chou, JJ; Mendelsohn, ME; Rigby, AC				Sharma, Alok K.; Zhou, Guo-Ping; Kupferman, Joseph; Surks, Howard K.; Christensen, Eva N.; Chou, James J.; Mendelsohn, Michael E.; Rigby, Alan C.			Probing the Interaction between the Coiled Coil Leucine Zipper of cGMP-dependent Protein Kinase I alpha and the C Terminus of the Myosin Binding Subunit of the Myosin Light Chain Phosphatase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMOOTH-MUSCLE RELAXATION; NMR-SPECTROSCOPY; CIRCULAR-DICHROISM; TARGETING SUBUNIT; BLOOD-PRESSURE; PKGI-ALPHA; DOMAIN; RESIDUES; COMPLEX; IDENTIFICATION	Nitric oxide and nitrovasodilators induce vascular smooth muscle cell relaxation in part by cGMP-dependent protein kinase I (PKG-I alpha)-mediated activation of myosin phosphatase (MLCP). Mechanistically it has been proposed that protein-protein interactions between the N-terminal leucine zipper (LZ) domain of PKG-I alpha((PKG-I alpha(1-59)) and the LZ and/or coiled coil (CC) domain of the myosin binding subunit (MBS) of MLCP are localized in the C terminus of MBS. Although recent studies have supported these interactions, the critical amino acids responsible for these interactions have not been identified. Here we present structural and biophysical data identifying that the LZ domain of PKG-I alpha(1-59) interacts with a well defined 42-residue CC motif (MBSCT42) within the C terminus of MBS. Using glutathione S-transferase pulldown experiments, chemical cross-linking, size exclusion chromatography, circular dichroism, and isothermal titration calorimetry we identified a weak dimer-dimer interaction between PKG-I alpha(1-59) and this C-terminal CC domain of MBS. The K-d of this non-covalent complex is 178.0 +/- 1.5 mu M. Furthermore our H-1-N-15 heteronuclear single quantum correlation NMR data illustrate that this interaction is mediated by several PKG-I alpha residues that are on the a, d, e, and g hydrophobic and electrostatic interface of the C-terminal heptad layers 2, 4, and 5 of PKG-I alpha. Taken together these data support a role for the LZ domain of PKG-I alpha and the CC domain of MBS in this requisite contractile complex.	[Sharma, Alok K.; Zhou, Guo-Ping; Kupferman, Joseph; Rigby, Alan C.] Harvard Univ, Beth Israel Deaconess Med Ctr, Div Mol & Vasc Med, Vasc Biol Res Ctr,Dept Med,Sch Med, Boston, MA 02215 USA; [Surks, Howard K.; Christensen, Eva N.; Mendelsohn, Michael E.] Tufts Med Ctr, Mol Cardiol Res Inst, Boston, MA 02111 USA; [Chou, James J.] Harvard Univ, Sch Med, Boston, MA 02115 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Tufts Medical Center; Harvard University; Harvard Medical School	Rigby, AC (corresponding author), Harvard Univ, Beth Israel Deaconess Med Ctr, Div Mol & Vasc Med, Vasc Biol Res Ctr,Dept Med,Sch Med, 330 Brookline Ave, Boston, MA 02215 USA.	arigby@bidmc.harvard.edu	Chou, James/AAD-6230-2022; Chou, James J/N-9840-2013	Chou, James/0000-0002-4442-0344; Chou, James J/0000-0002-4442-0344; Sharma, Alok/0000-0002-7668-3501	National Institutes of Health [1PO1HL077378, 1RO1HL74069]; Atorvastatin Research Award; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL074069, P01HL077378] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Atorvastatin Research Award; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants 1PO1HL077378 ( to M. E. M.) and 1PO1HL077378 and 1RO1HL74069 ( to H. K. S.). This work was also supported by an Atorvastatin Research Award ( to A. C. R.).	Amezcua CA, 2002, STRUCTURE, V10, P1349, DOI 10.1016/S0969-2126(02)00857-2; ANDRADE MA, 1993, PROTEIN ENG, V6, P383, DOI 10.1093/protein/6.4.383; ATKINSON RA, 1991, BIOCHEMISTRY-US, V30, P9387, DOI 10.1021/bi00103a001; BERGER B, 1995, P NATL ACAD SCI USA, V92, P8259, DOI 10.1073/pnas.92.18.8259; Burgoyne JR, 2007, SCIENCE, V317, P1393, DOI 10.1126/science.1144318; Collins BM, 2003, NAT STRUCT BIOL, V10, P607, DOI 10.1038/nsb955; COOPER TM, 1990, BIOPOLYMERS, V30, P657, DOI 10.1002/bip.360300703; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Deng YQ, 2007, PROTEIN SCI, V16, P323, DOI 10.1110/ps.062590807; Falls LA, 2001, J BIOL CHEM, V276, P23895, DOI 10.1074/jbc.M008332200; Foss TR, 2005, J MOL BIOL, V347, P841, DOI 10.1016/j.jmb.2005.01.050; Freedman SJ, 2003, J BIOL CHEM, V278, P13462, DOI 10.1074/jbc.M210483200; Gardner KH, 1998, ANNU REV BIOPH BIOM, V27, P357, DOI 10.1146/annurev.biophys.27.1.357; Given AM, 2007, AM J PHYSIOL-CELL PH, V292, pC432, DOI 10.1152/ajpcell.00175.2006; Goto NK, 2000, CURR OPIN STRUC BIOL, V10, P585, DOI 10.1016/S0959-440X(00)00135-4; Grant MA, 2004, J BIOL CHEM, V279, P32464, DOI 10.1074/jbc.M313826200; Green NS, 2005, P NATL ACAD SCI USA, V102, P14545, DOI 10.1073/pnas.0501609102; Gruen M, 1999, FEBS LETT, V453, P254, DOI 10.1016/S0014-5793(99)00727-9; Hamilton KS, 2000, J BIOMOL NMR, V18, P319, DOI 10.1023/A:1026773008237; HARBURY PB, 1993, SCIENCE, V262, P1401, DOI 10.1126/science.8248779; Hartshorne DJ, 1999, MOL CELL BIOCHEM, V190, P79, DOI 10.1023/A:1006917032557; Huang QQ, 2004, J BIOL CHEM, V279, P597, DOI 10.1074/jbc.M308496200; Ishigaki T, 2007, J BIOCHEM, V141, P855, DOI 10.1093/jb/mvm093; JUNIUS FK, 1995, BIOCHEMISTRY-US, V34, P6164, DOI 10.1021/bi00018a020; Kang RS, 2003, CELL, V113, P621, DOI 10.1016/S0092-8674(03)00362-3; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; KRAULIS PJ, 1994, BIOCHEMISTRY-US, V33, P3515, DOI 10.1021/bi00178a008; Lamb HK, 2007, PROTEIN SCI, V16, P2391, DOI 10.1110/ps.072900907; Langsetmo K, 2001, J BIOL CHEM, V276, P34318, DOI 10.1074/jbc.M103255200; Lee E, 2007, J MOL BIOL, V373, P1198, DOI 10.1016/j.jmb.2007.08.049; LUPAS A, 1991, SCIENCE, V252, P1162, DOI 10.1126/science.252.5009.1162; Malia TJ, 2007, BIOCHEMISTRY-US, V46, P514, DOI 10.1021/bi061577h; Mason JM, 2004, CHEMBIOCHEM, V5, P170, DOI 10.1002/cbic.200300781; Matsuo H, 1999, J AM CHEM SOC, V121, P9903, DOI 10.1021/ja991881g; Mendelsohn ME, 2005, J CLIN INVEST, V115, P840, DOI 10.1172/JCI200524806; Mendelsohn ME, 2005, NAT MED, V11, P115, DOI 10.1038/nm0205-115; MERELO JJ, 1994, NEUROCOMPUTING, V6, P443, DOI 10.1016/0925-2312(94)90021-3; Michael SK, 2008, P NATL ACAD SCI USA, V105, P6702, DOI 10.1073/pnas.0802128105; MONERA OD, 1994, BIOCHEMISTRY-US, V33, P3862, DOI 10.1021/bi00179a010; Noble CG, 2005, NAT STRUCT MOL BIOL, V12, P144, DOI 10.1038/nsmb887; OSHEA EK, 1993, CURR BIOL, V3, P658, DOI 10.1016/0960-9822(93)90063-T; OSHEA EK, 1992, CELL, V68, P699, DOI 10.1016/0092-8674(92)90145-3; Schlossmann J, 2000, NATURE, V404, P197, DOI 10.1038/35004606; Schnell JR, 2005, PROTEIN SCI, V14, P2421, DOI 10.1110/ps.051528905; Shekhtman A, 2001, J MOL BIOL, V314, P129, DOI 10.1006/jmbi.2001.5126; SOMLYO AP, 1994, NATURE, V372, P231, DOI 10.1038/372231a0; Soupene E, 2008, J LIPID RES, V49, P1103, DOI 10.1194/jlr.M800007-JLR200; Steinmetz MO, 2007, P NATL ACAD SCI USA, V104, P7062, DOI 10.1073/pnas.0700321104; Surks HK, 2003, CELL SIGNAL, V15, P937, DOI 10.1016/S0898-6568(03)00057-3; Surks HK, 1999, SCIENCE, V286, P1583, DOI 10.1126/science.286.5444.1583; Surks HK, 2007, CIRC RES, V101, P1078, DOI 10.1161/CIRCRESAHA.107.165779; Tang M, 2003, NAT MED, V9, P1506, DOI 10.1038/nm958; Vaynberg J, 2006, TRENDS BIOTECHNOL, V24, P22, DOI 10.1016/j.tibtech.2005.09.006; Zhang T, 2003, BIOPHYS J, V85, P3279, DOI 10.1016/S0006-3495(03)74746-8; ZHOU NE, 1992, J BIOL CHEM, V267, P2664; [No title captured]	56	79	81	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 21	2008	283	47					32860	32869		10.1074/jbc.M804916200	http://dx.doi.org/10.1074/jbc.M804916200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	372HW	18782776	hybrid, Green Published			2022-12-27	WOS:000260893700075
J	Masuhiro, Y; Kayama, K; Fukushima, A; Baba, K; Soutsu, M; Kamiya, Y; Gotoh, M; Yamaguchi, N; Hanazawa, S				Masuhiro, Yoshikazu; Kayama, Kenichi; Fukushima, Akie; Baba, Koji; Soutsu, Makio; Kamiya, Yoshiaki; Gotoh, Michio; Yamaguchi, Noboru; Hanazawa, Shigemasa			SOCS-3 Inhibits E2F/DP-1 Transcriptional Activity and Cell Cycle Progression via Interaction with DP-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							METHYLATION STATUS; BOX MOTIF; E2F; GENE; SUPPRESSOR; FAMILY; GROWTH; HYPERMETHYLATION; DIFFERENTIATION; COMPLEX	Recent studies using SOCS family knock-out mice have suggested that SOCS proteins have multiple biological functions in addition to their role as negative regulators of JAK-STAT signaling. To explore these other functions of this family of proteins, we used yeast two-hybrid screening to find proteins interacting with human SOCS-3. We identified the transcriptional factor DP-1 as a SOCS-3-interacting protein involved in regulation of the cell cycle. Immunoprecipitation-Western blot assay showed that this interaction between these endogenous proteins occurred in cells both in vitro and in vivo. SOCS-3 interacted with the C-terminal region of DP-1, and amino acids 156 172 of SOCS-3 were required for this interaction. Confocal microscopy revealed that SOCS-3 and DP-1 were primarily colocalized in the cytoplasm. SOCS-3 inhibited E2F/DP-1 transcriptional activity under the cyclin-E promoter and actually inhibited cell cycle progression and cell growth under E2F/DP-1 control. In contrast, DP-1 almost completely eliminated the inhibitory action of SOCS-3 on LIF-stimulated STAT-3 transcriptional activity in JAK-STAT signaling. Interestingly, the alternative regulatory action of SOCS-3 and DP-1 was dramatically eliminated by each siRNA. Taken together, these findings demonstrate that SOCS-3 acts as a negative regulator of the cell cycle progression under E2F/DP-1 control by interfering with heterodimer formation between DP-1 and E2F and also that DP-1 plays an important role in controlling JAK-STAT signaling.	[Hanazawa, Shigemasa] Nihon Univ, Coll Bioresource Sci, Dept Appl Biol Sci, Lab Mol & Cellular Physiol, Fujisawa, Kanagawa 2528510, Japan; [Masuhiro, Yoshikazu; Hanazawa, Shigemasa] Nihon Univ, Adv Res Inst Sci & Humanities, Chiyoda Ku, Tokyo 1020073, Japan; [Yamaguchi, Noboru] Kyushu Univ, Fac Dent Sci, Dept Prevent Dent, Higashi Ku, Fukuoka 8128582, Japan; [Fukushima, Akie] Kyushu Univ, Fac Dent Sci, Dept Oral Infect Dis & Immunol, Higashi Ku, Fukuoka 8128582, Japan	Nihon University; Nihon University; Kyushu University; Kyushu University	Hanazawa, S (corresponding author), Nihon Univ, Coll Bioresource Sci, Dept Appl Biol Sci, Lab Mol & Cellular Physiol, 1866 Kameino, Fujisawa, Kanagawa 2528510, Japan.	hanazawa@brs.nihon-u.ac.jp			Ministry of Education, Science, Sports, and Culture of Japan; OSAKA Cancer Research Foundation; Nihon University	Ministry of Education, Science, Sports, and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); OSAKA Cancer Research Foundation; Nihon University	This work was supported by a grant-in-aid for scientific research from the Ministry of Education, Science, Sports, and Culture of Japan and by the OSAKA Cancer Research Foundation. Additional support came from a Nihon University Individual Research Grant. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Aaronson DS, 2002, SCIENCE, V296, P1653, DOI 10.1126/science.1071545; Allen KE, 1997, J CELL SCI, V110, P2819; Bracken AP, 2004, TRENDS BIOCHEM SCI, V29, P409, DOI 10.1016/j.tibs.2004.06.006; Chan MWY, 2004, BIOTECHNOL LETT, V26, P1289, DOI 10.1023/B:BILE.0000044922.43572.2d; Datta A, 2005, MOL CELL BIOL, V25, P8024, DOI 10.1128/MCB.25.18.8024-8036.2005; Datta A, 2002, MOL CELL BIOL, V22, P8398, DOI 10.1128/MCB.22.24.8398-8408.2002; DEGREGORI J, 1995, MOL CELL BIOL, V15, P4215; Endo TA, 1997, NATURE, V387, P921, DOI 10.1038/43213; Galm O, 2003, BLOOD, V101, P2784, DOI 10.1182/blood-2002-06-1735; GIRLING R, 1993, NATURE, V365, P468, DOI 10.1038/365468d0; HAMEL PA, 1992, MOL CELL BIOL, V12, P3431, DOI 10.1128/MCB.12.8.3431; Hatirnaz M, 2007, AM J HEMATOL, V82, P729, DOI 10.1002/ajh.20886; He B, 2003, P NATL ACAD SCI USA, V100, P14133, DOI 10.1073/pnas.2232790100; HELIN K, 1993, GENE DEV, V7, P1850, DOI 10.1101/gad.7.10.1850; HIEBERT SW, 1992, GENE DEV, V6, P177, DOI 10.1101/gad.6.2.177; Inaba M, 2005, BIOCHEM BIOPH RES CO, V328, P953, DOI 10.1016/j.bbrc.2005.01.046; Inoue Hiromasa, 2004, Expert Reviews in Molecular Medicine, V6, P1, DOI 10.1017/S1462399404008348; Ishida H, 2005, J BIOL CHEM, V280, P24642, DOI 10.1074/jbc.M500189200; Kamura T, 1998, GENE DEV, V12, P3872, DOI 10.1101/gad.12.24.3872; Kile BT, 2002, TRENDS BIOCHEM SCI, V27, P235, DOI 10.1016/S0968-0004(02)02085-6; Kohn MJ, 2003, DEVELOPMENT, V130, P1295, DOI 10.1242/dev.00355; Magae J, 1996, J CELL SCI, V109, P1717; Magae J, 1999, ONCOGENE, V18, P593, DOI 10.1038/sj.onc.1202345; Milton A, 2006, ONCOGENE, V25, P3212, DOI 10.1038/sj.onc.1209343; Miyoshi H, 2004, J GASTROENTEROL, V39, P563, DOI 10.1007/s00535-003-1343-0; Naka T, 1997, NATURE, V387, P924, DOI 10.1038/43219; Niwa Y, 2005, ONCOGENE, V24, P6406, DOI 10.1038/sj.onc.1208788; O'Shea JJ, 2002, CELL, V109, pS121, DOI 10.1016/S0092-8674(02)00701-8; Okochi O, 2003, CLIN CANCER RES, V9, P5295; Orr SJ, 2007, BLOOD, V109, P1061, DOI 10.1182/blood-2006-05-023556; Oshimo Y, 2004, INT J CANCER, V112, P1003, DOI 10.1002/ijc.20521; Ozaki A, 2005, J IMMUNOL, V175, P5489, DOI 10.4049/jimmunol.175.8.5489; Qiao H, 2007, J BIOL CHEM, V282, P454, DOI 10.1074/jbc.M606169200; Seki Y, 2003, NAT MED, V9, P1047, DOI 10.1038/nm896; Sorensen TS, 1996, MOL CELL BIOL, V16, P5888; Spangenburg EE, 2005, J BIOL CHEM, V280, P10749, DOI 10.1074/jbc.M410604200; Starr R, 1997, NATURE, V387, P917, DOI 10.1038/43206; Stevens C, 2003, ARCH BIOCHEM BIOPHYS, V412, P157, DOI 10.1016/S0003-9861(03)00054-7; Sutherland KD, 2004, ONCOGENE, V23, P7726, DOI 10.1038/sj.onc.1207787; Tokita T, 2007, INT J ONCOL, V30, P689; Turnley AM, 2002, NAT NEUROSCI, V5, P1155, DOI 10.1038/nn954; Verona R, 1997, MOL CELL BIOL, V17, P7268, DOI 10.1128/MCB.17.12.7268; Weber A, 2005, ONCOGENE, V24, P6699, DOI 10.1038/sj.onc.1208818; WU CL, 1995, MOL CELL BIOL, V15, P2536; Yamada M, 2002, CYTOKINE, V17, P91, DOI 10.1006/cyto.2001.0992; ZAMANIAN M, 1992, EMBO J, V11, P2603, DOI 10.1002/j.1460-2075.1992.tb05325.x; Zhang JG, 1999, P NATL ACAD SCI USA, V96, P2071, DOI 10.1073/pnas.96.5.2071	47	18	18	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 14	2008	283	46					31575	31583		10.1074/jbc.M800328200	http://dx.doi.org/10.1074/jbc.M800328200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	370KJ	18687693	hybrid, Green Published			2022-12-27	WOS:000260760800037
J	Samson, WK; Zhang, JV; Avsian-Kretchmer, O; Cui, K; Yosten, GLC; Klein, C; Lyu, RM; Wang, YX; Chen, XQ; Yang, J; Price, CJ; Hoyda, TD; Ferguson, AV; Yuan, XB; Chang, JK; Hsueh, AJW				Samson, Willis K.; Zhang, Jian V.; Avsian-Kretchmer, Orna; Cui, Kai; Yosten, Gina L. C.; Klein, Cindy; Lyu, Rong-Ming; Wang, Yong Xiong; Chen, Xiang Qun; Yang, Jun; Price, Christopher J.; Hoyda, Ted D.; Ferguson, Alastair V.; Yuan, Xiao-bin; Chang, Jaw Kang; Hsueh, Aaron J. W.			Neuronostatin Encoded by the Somatostatin Gene Regulates Neuronal, Cardiovascular, and Metabolic Functions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CENTRAL-NERVOUS-SYSTEM; GROWTH-HORMONE; FOOD-INTAKE; C-FOS; MOLECULAR-BIOLOGY; BLOOD-PRESSURE; SECRETION; RECEPTORS; PEPTIDE; BRAIN	Somatostatin is important in the regulation of diverse neuroendocrine functions. Based on bioinformatic analyses of evolutionarily conserved sequences, we predicted another peptide hormone in pro-somatostatin and named it neuronostatin. Immuno-affinity purification allowed the sequencing of an amidated neuronostatin peptide of 13 residues from porcine tissues. In vivo treatment with neuronostatin induced c-Fos expression in gastrointestinal tissues, anterior pituitary, cerebellum, and hippocampus. In vitro treatment with neuronostatin promoted the migration of cerebellar granule cells and elicited direct depolarizing actions on paraventricular neurons in hypothalamic slices. In a gastric tumor cell line, neuronostatin induced c-Fos expression, stimulated SRE reporter activity, and promoted cell proliferation. Furthermore, intracerebroventricular treatment with neuronostatin increased blood pressure but suppressed food intake and water drinking. Our findings demonstrate diverse neuronal, neuroendocrine, and cardiovascular actions of a somatostatin gene-encoded hormone and provide the basis to investigate the physiological roles of this endogenously produced brain/gut peptide.	[Samson, Willis K.; Yosten, Gina L. C.] St Louis Univ, Sch Med, Dept Pharmacol & Physiol Sci, St Louis, MO 63104 USA; [Zhang, Jian V.; Avsian-Kretchmer, Orna; Klein, Cindy; Hsueh, Aaron J. W.] Stanford Univ, Sch Med, Dept Obstet & Gynecol, Div Reprod Biol, Stanford, CA 94305 USA; [Cui, Kai; Yuan, Xiao-bin] Chinese Acad Sci, Inst Neurosci, Shanghai 200031, Peoples R China; [Cui, Kai; Yuan, Xiao-bin] Chinese Acad Sci, Shanghai Inst Biol Sci, Key Lab Neurobiol, Shanghai 200031, Peoples R China; [Lyu, Rong-Ming; Wang, Yong Xiong; Chen, Xiang Qun; Yang, Jun; Chang, Jaw Kang] Phoenix Pharmaceut Inc, Burlingame, CA 94010 USA; [Price, Christopher J.; Hoyda, Ted D.; Ferguson, Alastair V.] Queens Univ, Dept Physiol, Kingston, ON K7L 3N6, Canada	Saint Louis University; Stanford University; Chinese Academy of Sciences; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Queens University - Canada	Samson, WK (corresponding author), St Louis Univ, Sch Med, Dept Pharmacol & Physiol Sci, St Louis, MO 63104 USA.	samsonwk@slu.edu; aaron.hsueh@stanford.edu	ZHANG, Jian/B-5157-2009; Yosten, Gina/R-3885-2019	Yuan, Xiaobing/0000-0002-1632-8460	National Institutes of Health [HL68652, HL66023]; Johnson & Johnson Pharmaceutical Research & Development, L.L.C; Shanghai Institutes of Biological Sciences; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL068652, R01HL066023] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Johnson & Johnson Pharmaceutical Research & Development, L.L.C(Johnson & JohnsonJohnson & Johnson USA); Shanghai Institutes of Biological Sciences; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL68652 (to W. K. S.) and HL66023 (to W. K. S. and A. V. F.). This work was also supported by Johnson & Johnson Pharmaceutical Research & Development, L.L.C (to A. J. H.), and a grant from the Shanghai Institutes of Biological Sciences (to X. B. Y.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	Avsian-Kretchmer O, 2004, MOL ENDOCRINOL, V18, P1, DOI 10.1210/me.2003-0227; Batterham RL, 2002, NATURE, V418, P650, DOI 10.1038/nature00887; BELL GI, 1993, TRENDS NEUROSCI, V16, P34, DOI 10.1016/0166-2236(93)90050-V; BENOIT R, 1987, SCIENCE, V238, P1126, DOI 10.1126/science.2891188; BERSANI M, 1989, J BIOL CHEM, V264, P10633; BRAZEAU P, 1973, SCIENCE, V179, P77, DOI 10.1126/science.179.4068.77; BROWN MR, 1988, NEUROENDOCRINOLOGY, V47, P556, DOI 10.1159/000124975; Caston-Balderrama AL, 1998, J HISTOCHEM CYTOCHEM, V46, P547, DOI 10.1177/002215549804600416; Coward P, 1999, ANAL BIOCHEM, V270, P242, DOI 10.1006/abio.1999.4061; deLecea L, 1996, NATURE, V381, P242, DOI 10.1038/381242a0; FEIFEL D, 1990, BRAIN RES, V535, P189, DOI 10.1016/0006-8993(90)91600-L; Hajdu I, 2003, BRAIN RES, V994, P115, DOI 10.1016/j.brainres.2003.09.029; Hajdu I, 2000, AM J PHYSIOL-REG I, V279, pR271, DOI 10.1152/ajpregu.2000.279.1.R271; HALAZONETIS TD, 1988, CELL, V55, P917, DOI 10.1016/0092-8674(88)90147-X; HOFFMAN GE, 1993, FRONT NEUROENDOCRIN, V14, P173, DOI 10.1006/frne.1993.1006; Kojima M, 1999, NATURE, V402, P656, DOI 10.1038/45230; LAMBERTS SWJ, 1988, ENDOCR REV, V9, P417, DOI 10.1210/edrv-9-4-417; LAMBERTS SWJ, 1991, ENDOCR REV, V12, P450, DOI 10.1210/edrv-12-4-450; LARSSON LI, 1979, SCIENCE, V205, P1393, DOI 10.1126/science.382360; LOHOF AM, 1992, J NEUROSCI, V12, P1253; LOTTER EC, 1981, J COMP PHYSIOL PSYCH, V95, P278, DOI 10.1037/h0077777; Low MJ, 2004, BEST PRACT RES CL EN, V18, P607, DOI 10.1016/j.beem.2004.08.005; Morton GJ, 2006, NATURE, V443, P289, DOI 10.1038/nature05026; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Patel YC, 1999, FRONT NEUROENDOCRIN, V20, P157, DOI 10.1006/frne.1999.0183; REICHLIN S, 1983, NEW ENGL J MED, V309, P1495, DOI 10.1056/NEJM198312153092406; REISINE T, 1995, ENDOCR REV, V16, P427, DOI 10.1210/er.16.4.427; RETTIG R, 1989, AM J PHYSIOL, V257, pR588, DOI 10.1152/ajpregu.1989.257.3.R588; Samson WK, 2007, AM J PHYSIOL-REG I, V292, pR637, DOI 10.1152/ajpregu.00395.2006; Samson WK, 1999, BRAIN RES, V831, P248, DOI 10.1016/S0006-8993(99)01457-2; SAMSON WK, 1980, PEPTIDES, V1, P325, DOI 10.1016/0196-9781(80)90010-8; SCHMIDT WE, 1985, FEBS LETT, V192, P141, DOI 10.1016/0014-5793(85)80060-0; SHAW PE, 1989, CELL, V56, P563, DOI 10.1016/0092-8674(89)90579-5; Shimada M, 2003, BIOCHEM BIOPH RES CO, V302, P520, DOI 10.1016/S0006-291X(03)00178-5; Sunter D, 2003, NEUROSCI LETT, V353, P1, DOI 10.1016/S0304-3940(03)00351-3; Taylor MM, 2006, ENDOCRINOLOGY, V147, P859, DOI 10.1210/en.2005-0949; Taylor MM, 2005, AM J PHYSIOL-REG I, V288, pR919, DOI 10.1152/ajpregu.00744.2004; VALE W, 1972, CR ACAD SCI D NAT, V275, P2913; Xiang Y, 2002, NAT NEUROSCI, V5, P843, DOI 10.1038/nn899; Yacubova E, 2002, NATURE, V415, P77, DOI 10.1038/415077a; YAMADA Y, 1992, P NATL ACAD SCI USA, V89, P251, DOI 10.1073/pnas.89.1.251; Yuill EA, 2007, EUR J NEUROSCI, V25, P425, DOI 10.1111/j.1460-9568.2006.05293.x	42	84	87	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 14	2008	283	46					31949	31959		10.1074/jbc.M804784200	http://dx.doi.org/10.1074/jbc.M804784200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	370KJ	18753129	Green Published, hybrid			2022-12-27	WOS:000260760800077
J	Cabib, E; Farkas, V; Kosik, O; Blanco, N; Arroyo, J; McPhie, P				Cabib, Enrico; Farkas, Vladimir; Kosik, Ondrej; Blanco, Noelia; Arroyo, Javier; McPhie, Peter			Assembly of the Yeast Cell Wall Crh1p AND Crh2p ACT AS TRANSGLYCOSYLASES IN VIVO AND IN VITRO	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; CHITIN; PROTEINS; POROSITY; BETA-1,6-GLUCAN; ENDOCHITINASE; BIOSYNTHESIS; LOCALIZATION; PURIFICATION; ARCHITECTURE	The cross-linking of polysaccharides to assemble new cell wall in fungi requires mechanisms by which a preexisting linkage is broken for each new one made, to allow for the absence of free energy sources outside the plasma membrane. Previous work showed that Crh1p and Crh2p, putative transglycosylases, are required for the linkage of chitin to beta(1-3) glucose branches of beta(1-6) glucan in the cell wall of budding yeast. To explore the linking reaction in vivo and in vitro, we used fluorescent sulfor-hodamine-linked laminari-oligosaccharides as artificial chitin acceptors. In vivo, fluorescence was detected in bud scars and at a lower level in the cell contour, both being dependent on the CRH genes. The linking reaction was also shown in digitonin-permeabilized cells, with UDP-N-acetylglucosamine as the substrate for nascent chitin production. Both the nucleotide and the Crh proteins were required here. A gas1 mutant that overexpresses Crh1p showed very high fluorescence both in intact and permeabilized cells. In the latter, fluorescence was still incorporated in patches in the absence of UDP-GlcNAc. Isolated cell walls of this strain, when incubated with sulforhodamine-oligosaccharide, also showed Crhp-dependent fluorescence in patches, which were identified as bud scars. In all three systems, binding of the fluorescent material to chitin was verified by chitinase digestion. Moreover, the cell wall reaction was inhibited by chitooligosaccharides. These results demonstrate that the Crh proteins act by transferring chitin chains to beta(1-6) glucan, with a newly observed high activity in the bud scar. The importance of transglycosylation for cell wall assembly is thus firmly established.	[Cabib, Enrico; McPhie, Peter] NIDDK, Lab Biochem & Genet, NIH, Dept Hlth & Human Serv, Bethesda, MD 20892 USA; [Farkas, Vladimir; Kosik, Ondrej] Slovak Acad Sci, Ctr Excellence GLYCOBIOS, Inst Chem, Bratislava 84538, Slovakia; [Blanco, Noelia; Arroyo, Javier] Univ Complutense Madrid, Fac Farm, Dept Microbiol 2, E-28040 Madrid, Spain	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); Slovak Academy of Sciences; Complutense University of Madrid	Cabib, E (corresponding author), NIDDK, Lab Biochem & Genet, NIH, Dept Hlth & Human Serv, Bldg 8,Rm 403, Bethesda, MD 20892 USA.	enricoc@bdg10.niddk.nih.gov	Arroyo, Javier/E-9308-2016; Kosik, Ondrej/AAR-1206-2021	Arroyo, Javier/0000-0002-1971-1721; Kosik, Ondrej/0000-0003-3117-0224; Farkas, Vladimir/0000-0002-8219-4288	National Institutes of Health; European Commission [MRTN-CT-2004-512265]; Scientific Grant Agency VEGA, Slovakia [2/3158/25]; MEC (Spanish Government) [BIO2007-67821]; Comunidad de Madrid [S-SAL-0246/2006]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [Z01DK024945, ZIADK024964, ZIADK024945, Z01DK024964] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); European Commission(European CommissionEuropean Commission Joint Research Centre); Scientific Grant Agency VEGA, Slovakia(Vedecka grantova agentura MSVVaS SR a SAV (VEGA)); MEC (Spanish Government)(Spanish Government); Comunidad de Madrid(Comunidad de Madrid); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by a National Institutes of Health grant (Intramural Research Program, NIDDK). This work was also supported by Grant MRTN-CT-2004-512265 from the 6FP of the European Commission, by Grant 2/3158/25 from the Scientific Grant Agency VEGA, Slovakia, and by Projects BIO2007-67821 from the MEC (Spanish Government) and S-SAL-0246/2006 from Comunidad de Madrid. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Baladron V, 2002, EUKARYOT CELL, V1, P774, DOI 10.1128/EC.1.5.774-786.2002; BORASTON AB, 2004, BIOCHEM J, V382, P921; CABIB E, 1983, P NATL ACAD SCI-BIOL, V80, P3318, DOI 10.1073/pnas.80.11.3318; Cabib E, 2005, J BIOL CHEM, V280, P9170, DOI 10.1074/jbc.M414005200; Cabib E, 2001, J BIOL CHEM, V276, P19679, DOI 10.1074/jbc.R000031200; CABIB E, 1988, MICROBIOL SCI, V5, P370; Cabib E, 2007, MOL MICROBIOL, V63, P921, DOI 10.1111/j.1365-2958.2006.05565.x; CHOI WJ, 1994, ANAL BIOCHEM, V219, P368, DOI 10.1006/abio.1994.1278; CORREA JU, 1982, J BIOL CHEM, V257, P1392; Coutinho PM, 1999, ROY SOC CH, P3; Crotti LB, 2001, ANAL BIOCHEM, V292, P8, DOI 10.1006/abio.2001.5051; DEITS T, 1984, J BIOL CHEM, V259, P3525; DENOBEL JG, 1990, YEAST, V6, P483, DOI 10.1002/yea.320060605; FERNANDEZ MP, 1982, J BACTERIOL, V152, P1255; Gomez-Esquer F, 2004, MICROBIOL-SGM, V150, P3269, DOI 10.1099/mic.0.27314-0; Kapteyn JC, 1996, GLYCOBIOLOGY, V6, P337, DOI 10.1093/glycob/6.3.337; KOLLAR R, 1995, J BIOL CHEM, V270, P1170, DOI 10.1074/jbc.270.3.1170; Kollar R, 1997, J BIOL CHEM, V272, P17762, DOI 10.1074/jbc.272.28.17762; Kosik O, 2008, ANAL BIOCHEM, V375, P232, DOI 10.1016/j.ab.2007.11.025; Lagorce A, 2003, J BIOL CHEM, V278, P20345, DOI 10.1074/jbc.M211604200; Lesage G, 2006, MICROBIOL MOL BIOL R, V70, P317, DOI 10.1128/MMBR.00038-05; Magnelli P, 2002, ANAL BIOCHEM, V301, P136, DOI 10.1006/abio.2001.5473; MOHAND FA, 2006, CARBOHYD RES, V46, P478; MOLANO J, 1979, J BIOL CHEM, V254, P4901; Montijn RC, 1999, J BACTERIOL, V181, P7414, DOI 10.1128/JB.181.24.7414-7420.1999; Mouyna I, 2000, J BIOL CHEM, V275, P14882, DOI 10.1074/jbc.275.20.14882; PARK JT, 1949, J BIOL CHEM, V181, P149; Popolo L, 1999, BBA-GEN SUBJECTS, V1426, P385, DOI 10.1016/S0304-4165(98)00138-X; ROBERTS RL, 1982, ANAL BIOCHEM, V127, P402, DOI 10.1016/0003-2697(82)90194-4; Rodriguez-Pena JM, 2000, MOL CELL BIOL, V20, P3245, DOI 10.1128/MCB.20.9.3245-3255.2000; Scheffers DJ, 2005, MICROBIOL MOL BIOL R, V69, P585, DOI 10.1128/MMBR.69.4.585-607.2005; SCHERRER R, 1974, J BACTERIOL, V118, P534, DOI 10.1128/JB.118.2.534-540.1974; SHAW JA, 1991, J CELL BIOL, V114, P111, DOI 10.1083/jcb.114.1.111; SHEMATEK EM, 1980, J BIOL CHEM, V255, P888; SIKORSKI RS, 1989, GENETICS, V122, P19; Voth WP, 2005, EUKARYOT CELL, V4, P1018, DOI 10.1128/EC.4.6.1018-1028.2005; Wach A, 1996, YEAST, V12, P259, DOI 10.1002/(SICI)1097-0061(19960315)12:3<259::AID-YEA901>3.0.CO;2-C; Wiederhold NP, 2003, EXPERT OPIN INV DRUG, V12, P1313, DOI 10.1517/13543784.12.8.1313; Yin QY, 2007, FEMS YEAST RES, V7, P887, DOI 10.1111/j.1567-1364.2007.00272.x; ZLOTNIK H, 1984, J BACTERIOL, V159, P1018, DOI 10.1128/JB.159.3.1018-1026.1984	40	73	73	1	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 31	2008	283	44					29859	29872		10.1074/jbc.M804274200	http://dx.doi.org/10.1074/jbc.M804274200			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	364WS	18694928	hybrid, Green Published			2022-12-27	WOS:000260366900030
J	Tsoporis, JN; Izhar, S; Parker, TG				Tsoporis, James N.; Izhar, Shehla; Parker, Thomas G.			Expression of S100A6 in Cardiac Myocytes Limits Apoptosis Induced by Tumor Necrosis Factor-alpha	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; CALCIUM-BINDING PROTEINS; CALCYCLIN S100A6; GROWTH-FACTOR; NEURITE OUTGROWTH; CELL-SURVIVAL; P53 PROTEIN; GENE; PROMOTER; RECEPTOR	S100A6 is induced in myocardium post-infarction in vivo and in response to growth factors and inflammatory cytokines in vitro. Forced expression of S100A6 in cardiomyocytes inhibits regulation of cardiac specific gene expression in response to trophic stimulation. To define regulation and function of S100A6, we characterized the human S100A6 promoter and mapped upstream regulatory elements in rat neonatal cardiac myocytes, fibroblasts, and vascular smooth muscle cells and defined a functional role for S100A6 in tumor necrosis factor-alpha-induced myocyte apoptosis. The functional S100A6 promoter was localized to region -167/+134 containing 167 upstream base pairs. The S100A6 promoter is regulated by positive (-361/+167 and -588/+361) and negative (-1371/+1194) elements. Tumor necrosis factor-alpha-induced the maximal S100A6 promoter and transcription factor NF-kappa B (p65 subunit). Electrophoretic mobility shift showed that tumor necrosis factor-alpha-induced p65 binding to a potential NF-kappa B-binding site at -460/-451. Chromatin immunoprecipitation analysis revealed p65 is recruited to the S100A6 promoter upon tumor necrosis factor-alpha stimulation. The NF-kappa B inhibitor caffeic acid phenethyl ester and mutation of the NF-kappa B-binding site inhibited S100A6 promoter activation by tumor necrosis factor-alpha. Tumor necrosis factor-alpha-induced cardiac myocyte apoptosis. Specific inhibition of S100A6 using a small interfering RNA directed against S100A6 potentiated tumor necrosis factor-alpha-induced myocyte apoptosis, whereas overexpression of S100A6 by gene transfer prevented tumor necrosis factor-alpha-induced myocyte apoptosis by interfering with p53 phosphorylation. These results demonstrate that S100A6 is induced by tumor necrosis factor-alpha via an NF-kappa B-dependent mechanism, serving a role in homeostasis to limit tumor necrosis factor-alpha-induced apoptosis by regulating p53 phosphorylation.	[Tsoporis, James N.; Izhar, Shehla; Parker, Thomas G.] Univ Toronto, St Michaels Hosp, Li Ka Shing Knowledge Inst,Dept Med, Keenan Res Ctr,Div Cardiol, Toronto, ON M5B 1W8, Canada	University of Toronto; Li Ka Shing Knowledge Institute; University Toronto Affiliates; Saint Michaels Hospital Toronto	Parker, TG (corresponding author), Univ Toronto, St Michaels Hosp, Li Ka Shing Knowledge Inst,Dept Med, Keenan Res Ctr,Div Cardiol, Rm 6-044,Queen Wing,30 Bond St, Toronto, ON M5B 1W8, Canada.	parkertg@smh.toronto.on.ca			Canadian Institutes of Health Research; Heart and Stroke Foundation of Canada	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Heart and Stroke Foundation of Canada(Heart & Stroke Foundation of Canada)	This work was supported by the Canadian Institutes of Health Research and the Heart and Stroke Foundation of Canada. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	BAEUERLE PA, 1991, BIOCHIM BIOPHYS ACTA, V1072, P63, DOI 10.1016/0304-419X(91)90007-8; Bergmann MW, 2001, J MOL CELL CARDIOL, V33, P1223, DOI 10.1006/jmcc.2001.1385; Breen EC, 2003, J CELL BIOCHEM, V88, P848, DOI 10.1002/jcb.10398; CALABRETTA B, 1986, P NATL ACAD SCI USA, V83, P1495, DOI 10.1073/pnas.83.5.1495; CANMAN CE, 1995, GENE DEV, V9, P600, DOI 10.1101/gad.9.5.600; Choufani G, 1999, LARYNGOSCOPE, V109, P1825, DOI 10.1097/00005537-199911000-00019; Courtois-Coutry N, 2002, J BIOL CHEM, V277, P25728, DOI 10.1074/jbc.M112435200; DEWET JR, 1987, MOL CELL BIOL, V7, P725, DOI 10.1128/MCB.7.2.725; ENGELKAMP D, 1992, BIOCHEMISTRY-US, V31, P10258, DOI 10.1021/bi00157a012; FEENER EP, 1995, J CLIN INVEST, V95, P1353, DOI 10.1172/JCI117786; GHEZZO F, 1988, J BIOL CHEM, V263, P4758; GONG YW, 1992, CELL GROWTH DIFFER, V3, P847; Grigorian M, 2001, J BIOL CHEM, V276, P22699, DOI 10.1074/jbc.M010231200; HIRSCHHORN RR, 1984, P NATL ACAD SCI-BIOL, V81, P6004, DOI 10.1073/pnas.81.19.6004; Hsieh PCH, 2006, J CLIN INVEST, V116, P237, DOI 10.1172/JCI25878; Huttunen HJ, 1999, J BIOL CHEM, V274, P19919, DOI 10.1074/jbc.274.28.19919; Huttunen HJ, 2000, J BIOL CHEM, V275, P40096, DOI 10.1074/jbc.M006993200; HYLAND JK, 1984, P NATL ACAD SCI-BIOL, V81, P400, DOI 10.1073/pnas.81.2.400; Johnson CM, 2007, J BIOL CHEM, V282, P31197, DOI 10.1074/jbc.M705151200; JOHNSON P, 1993, MOL CELL BIOL, V13, P1456, DOI 10.1128/MCB.13.3.1456; Joo JH, 2003, BIOCHEM BIOPH RES CO, V307, P274, DOI 10.1016/S0006-291X(03)01199-9; Joo JH, 2008, J CELL BIOCHEM, V103, P1183, DOI 10.1002/jcb.21496; Kanoh M, 1999, CIRCULATION, V99, P2757, DOI 10.1161/01.CIR.99.21.2757; KARIYA K, 1991, J BIOL CHEM, V266, P10023; KLIGMAN D, 1988, TRENDS BIOCHEM SCI, V13, P437, DOI 10.1016/0968-0004(88)90218-6; Krown KA, 1996, J CLIN INVEST, V98, P2854, DOI 10.1172/JCI119114; Kubota T, 2001, J MOL CELL CARDIOL, V33, P1331, DOI 10.1006/jmcc.2001.1393; Kurrelmeyer KM, 2000, P NATL ACAD SCI USA, V97, P5456, DOI 10.1073/pnas.070036297; KUZNICKI J, 1992, EXP CELL RES, V200, P425, DOI 10.1016/0014-4827(92)90191-A; KUZNICKI J, 1989, FEBS LETT, V254, P141, DOI 10.1016/0014-5793(89)81026-9; Leclerc E, 2007, J BIOL CHEM, V282, P31317, DOI 10.1074/jbc.M703951200; Lesniak W, 2000, ACTA NEUROBIOL EXP, V60, P569; Lesniak W, 2006, J CELL BIOCHEM, V97, P1017, DOI 10.1002/jcb.20699; Lesniak W, 2005, BBA-MOL CELL RES, V1744, P29, DOI 10.1016/j.bbamcr.2004.11.003; Lesniak W, 2000, BBA-GENE STRUCT EXPR, V1517, P73, DOI 10.1016/S0167-4781(00)00259-1; Lin J, 2001, J BIOL CHEM, V276, P35037, DOI 10.1074/jbc.M104379200; LONG CS, 1991, CELL REGUL, V2, P1081, DOI 10.1091/mbc.2.12.1081; Mueller A, 2005, J BIOL CHEM, V280, P29186, DOI 10.1074/jbc.M505000200; Purcell NH, 2003, CIRCULATION, V108, P638, DOI 10.1161/01.CIR.0000085362.40608.DD; Satoh M, 1999, CIRCULATION, V99, P3260, DOI 10.1161/01.CIR.99.25.3260; Schafer BW, 1996, TRENDS BIOCHEM SCI, V21, P134, DOI 10.1016/S0968-0004(96)80167-8; Song W, 2000, CARDIOVASC RES, V45, P595, DOI 10.1016/S0008-6363(99)00395-8; Stewart AFR, 1998, CIRC RES, V83, P43, DOI 10.1161/01.RES.83.1.43; Sun M, 2007, CIRCULATION, V115, P1398, DOI 10.1161/CIRCULATIONAHA.106.643585; TIMMONS PM, 1993, J CELL SCI, V104, P187; Tsoporis JN, 2005, EXP CELL RES, V303, P471, DOI 10.1016/j.yexcr.2004.10.018; Tsoporis JN, 2003, AM J PHYSIOL-HEART C, V284, pH193, DOI 10.1152/ajpheart.00161.2002; VANGRONINGEN JJM, 1995, BIOCHEM BIOPH RES CO, V213, P1122, DOI 10.1006/bbrc.1995.2243; ZIMMER DB, 1995, BRAIN RES BULL, V37, P417, DOI 10.1016/0361-9230(95)00040-2	49	33	33	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 31	2008	283	44					30174	30183		10.1074/jbc.M805318200	http://dx.doi.org/10.1074/jbc.M805318200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	364WS	18753141	hybrid, Green Published			2022-12-27	WOS:000260366900062
J	Averna, M; Stifanese, R; De Tullio, R; Passalacqua, M; Salamino, F; Pontremoli, S; Melloni, E				Averna, Monica; Stifanese, Roberto; De Tullio, Roberta; Passalacqua, Mario; Salamino, Franca; Pontremoli, Sandro; Melloni, Edon			Functional Role of HSP90 Complexes with Endothelial Nitric-oxide Synthase (eNOS) and Calpain on Nitric Oxide Generation in Endothelial Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEAT-SHOCK-PROTEIN; SIGNAL-TRANSDUCTION; ATP-BINDING; RAT; TRAFFICKING; DYSFUNCTION; CALMODULIN; ACTIVATION; EXPRESSION; CAVEOLINS	Although several reports have indicated that eNOS is a highly sensitive calpain substrate, the occurrence of a concomitant Ca2(+)-dependent activation of the synthase and of the protease has never been analyzed in specific direct experiments. In this study, we have explored in vivo how eNOS can undergo Ca2(+)-dependent translocation and activation, protected against degradation by activated calpain. Here we demonstrate that following a brief exposure to Ca2(+)-loading, the cytosolic eNOS-HSP90 complex recruits calpain in a form in which the chaperone and the synthase are almost completely resistant to digestion by the protease. Furthermore, in the presence of the HSP90 inhibitor geldanamycin, a significant decrease in NO production and an extensive degradation of eNOS protein occurs, indicating that dissociation from membranes and association with the chaperone is correlated to the protection of the synthase. Experiments with isolated membrane preparations confirm the primary role of HSP90 in dissociation of eNOS from caveolae. Prolonged exposure of cells to Ca2+-loading resulted in an extensive degradation of both eNOS and HSP90, accompanied by a large suppression of NO production. We propose that the protective effect exerted by HSP90 on eNOS degradation mediated by calpain represents a novel and critical mechanism that assures the reversibility of the intracellular trafficking and activation of the synthase.	[Melloni, Edon] Univ Genoa, DIMES, Biochem Sect, I-16132 Genoa, Italy; Univ Genoa, CEBR, I-16132 Genoa, Italy	University of Genoa; University of Genoa	Melloni, E (corresponding author), Univ Genoa, DIMES, Biochem Sect, Viale Benedetto XV, I-16132 Genoa, Italy.	melloni@unige.it	Passalacqua, Mario/W-1973-2019; AVERNA, MONICA/R-5719-2019	Passalacqua, Mario/0000-0003-2779-6259; AVERNA, MONICA/0000-0002-9463-7533; DE TULLIO, ROBERTA/0000-0001-6925-3207	University of Genoa	University of Genoa	This work was supported in part by grants from MIUR, FIRB, and PRIN projects, and from the University of Genoa. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Alderton WK, 2001, BIOCHEM J, V357, P593, DOI 10.1042/0264-6021:3570593; Averna M, 2008, FEBS J, V275, P2501, DOI 10.1111/j.1742-4658.2008.06394.x; Averna M, 2007, FEBS J, V274, P6116, DOI 10.1111/j.1742-4658.2007.06133.x; Averna M, 2007, J BIOL CHEM, V282, P2656, DOI 10.1074/jbc.M606919200; Bae Y, 2007, J CONTROL RELEASE, V122, P16, DOI 10.1016/j.jconrel.2007.06.005; Bloch W, 2001, NITRIC OXIDE-BIOL CH, V5, P317, DOI 10.1006/niox.2000.0339; Blunt BC, 2007, AM J PHYSIOL-HEART C, V293, pH1518, DOI 10.1152/ajpheart.00269.2006; Chaubourt E, 2002, J PHYSIOLOGY-PARIS, V96, P43, DOI 10.1016/S0928-4257(01)00079-1; De Tullio R, 1999, BIOCHEM J, V343, P467; Fan GC, 2005, CIRCULATION, V111, P1792, DOI 10.1161/01.CIR.0000160851.41872.C6; Feron O, 1998, J BIOL CHEM, V273, P3125, DOI 10.1074/jbc.273.6.3125; Feron O, 2006, CARDIOVASC RES, V69, P788, DOI 10.1016/j.cardiores.2005.12.014; Fleming I, 1999, CARDIOVASC RES, V43, P532, DOI 10.1016/S0008-6363(99)00094-2; Fulton D, 2002, J BIOL CHEM, V277, P4277, DOI 10.1074/jbc.M106302200; Goetz RM, 1999, P NATL ACAD SCI USA, V96, P2788, DOI 10.1073/pnas.96.6.2788; Goligorsky MS, 2002, AM J PHYSIOL-RENAL, V283, pF1, DOI 10.1152/ajprenal.00377.2001; Goll DE, 2003, PHYSIOL REV, V83, P731, DOI 10.1152/physrev.00029.2002; Govers R, 2001, AM J PHYSIOL-RENAL, V280, pF193, DOI 10.1152/ajprenal.2001.280.2.F193; Gratton JP, 2004, CIRC RES, V94, P1408, DOI 10.1161/01.RES.0000129178.56294.17; Gratton JP, 2000, J BIOL CHEM, V275, P22268, DOI 10.1074/jbc.M001644200; Grenert JP, 1997, J BIOL CHEM, V272, P23843, DOI 10.1074/jbc.272.38.23843; Husain K, 2007, CELL MOL BIOL, V53, P70, DOI 10.1170/T777; Jiang JH, 2003, J BIOL CHEM, V278, P49332, DOI 10.1074/jbc.M304738200; Ju H, 1997, J BIOL CHEM, V272, P18522, DOI 10.1074/jbc.272.30.18522; Kojima H, 1998, ANAL CHEM, V70, P2446, DOI 10.1021/ac9801723; Kone BC, 2003, AM J PHYSIOL-RENAL, V285, pF178, DOI 10.1152/ajprenal.00048.2003; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Landmesser U, 2007, CURR OPIN CARDIOL, V22, P316, DOI 10.1097/HCO.0b013e3281ca710d; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Lu XY, 2008, CARDIOVASC RES, V79, P500, DOI 10.1093/cvr/cvn091; McLaughlin SH, 2006, J MOL BIOL, V356, P746, DOI 10.1016/j.jmb.2005.11.085; Michel JB, 1997, J BIOL CHEM, V272, P25907, DOI 10.1074/jbc.272.41.25907; Michel JB, 1997, J BIOL CHEM, V272, P15583, DOI 10.1074/jbc.272.25.15583; Michel T, 1999, BRAZ J MED BIOL RES, V32, P1361, DOI 10.1590/S0100-879X1999001100006; Mitchell Brett M., 2007, V139, P105; Nakatsubo N, 1998, FEBS LETT, V427, P263, DOI 10.1016/S0014-5793(98)00440-2; Obermann WMJ, 1998, J CELL BIOL, V143, P901, DOI 10.1083/jcb.143.4.901; Oess S, 2006, BIOCHEM J, V396, P401, DOI 10.1042/BJ20060321; Onuoha SC, 2007, J MOL BIOL, V372, P287, DOI 10.1016/j.jmb.2007.06.065; Ortiz PA, 2003, ACTA PHYSIOL SCAND, V179, P107, DOI 10.1046/j.1365-201X.2003.01207.x; Osawa Y, 2003, J PHARMACOL EXP THER, V304, P493, DOI 10.1124/jpet.102.035055; PALEJWALA S, 1992, P NATL ACAD SCI USA, V89, P4202, DOI 10.1073/pnas.89.9.4202; PANZA JA, 1995, CIRCULATION, V91, P1732, DOI 10.1161/01.CIR.91.6.1732; Peng XY, 2005, J BIOL CHEM, V280, P13148, DOI 10.1074/jbc.M410838200; PONTREMOLI S, 1988, J BIOL CHEM, V263, P1915; Pott C, 2006, AM J PHYSIOL-CELL PH, V290, pC1437, DOI 10.1152/ajpcell.00005.2005; Scheibel T, 1997, J BIOL CHEM, V272, P18608, DOI 10.1074/jbc.272.30.18608; Schwock J, 2008, CANCER CHEMOTH PHARM, V61, P669, DOI 10.1007/s00280-007-0522-8; Shao HS, 2006, MOL CELL BIOL, V26, P5481, DOI 10.1128/MCB.02243-05; Smart EJ, 1999, MOL CELL BIOL, V19, P7289; Smith AR, 2006, ARCH BIOCHEM BIOPHYS, V454, P100, DOI 10.1016/j.abb.2006.02.017; Sorimachi H, 1997, BIOCHEM J, V328, P721, DOI 10.1042/bj3280721; Stalker TJ, 2005, DIABETES, V54, P1132, DOI 10.2337/diabetes.54.4.1132; Stalker TJ, 2003, FASEB J, V17, P1511, DOI 10.1096/fj.02-1213fje; Stifanese R, 2006, ARCH BIOCHEM BIOPHYS, V456, P48, DOI 10.1016/j.abb.2006.09.022; Su YC, 2000, AM J PHYSIOL-LUNG C, V278, pL1204, DOI 10.1152/ajplung.2000.278.6.L1204; Sud N, 2007, AM J PHYSIOL-LUNG C, V293, pL1444, DOI 10.1152/ajplung.00175.2007; Takahashi S, 2003, J BIOL CHEM, V278, P9339, DOI 10.1074/jbc.M212651200; Wu WC, 2007, EXP EYE RES, V85, P721, DOI 10.1016/j.exer.2007.08.005; Wunderlich C, 2008, PULM PHARMACOL THER, V21, P507, DOI 10.1016/j.pupt.2007.11.005; Xu Y, 2002, J BIOL CHEM, V277, P21474, DOI 10.1074/jbc.M111689200; Yetik-Anacak G, 2006, AM J PHYSIOL-HEART C, V291, pH260, DOI 10.1152/ajpheart.01027.2005	62	38	38	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 24	2008	283	43					29069	29076		10.1074/jbc.M803638200	http://dx.doi.org/10.1074/jbc.M803638200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	362EB	18682401	Green Published, hybrid			2022-12-27	WOS:000260179900034
J	Lim, JC; Choi, HI; Park, YS; Nam, HW; Woo, HA; Kwon, KS; Kim, YS; Rhee, SG; Kim, K; Chae, HZ				Lim, Jung Chae; Choi, Hoon-In; Park, Yu Sun; Nam, Hyung Wook; Woo, Hyun Ae; Kwon, Ki-Sun; Kim, Yu Sam; Rhee, Sue Goo; Kim, Kanghwa; Chae, Ho Zoon			Irreversible Oxidation of the Active-site Cysteine of Peroxiredoxin to Cysteine Sulfonic Acid for Enhanced Molecular Chaperone Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEAT-SHOCK PROTEINS; SULFINIC ACID; IN-VIVO; STRESS; STATE; OVEROXIDATION; INACTIVATION; PEROXIDASE; MECHANISMS; REDUCTION	The thiol (-SH) of the active cysteine residue in peroxiredoxin (Prx) is known to be reversibly hyperoxidized to cysteine sulfinic acid (-SO2H), which can be reduced back to thiol by sulfiredoxin/sestrin. However, hyperoxidized Prx of an irreversible nature has not been reported yet. Using an antibody developed against the sulfonylated (-SO3H) yeast Prx (Tsa1p) active-site peptide (AFTFVCPTEI), we observed an increase in the immunoblot intensity in proportion to the H2O2 concentrations administered to the yeast cells. We identified two species of hyperoxidized Tsa1p: one can be reduced back (reversible) with sulfiredoxin, and the other cannot (irreversible). Irreversibly hyperoxidized Tsa1p was identified as containing the active-site cysteine sulfonic acid (Tsa1p-SO3H) by mass spectrometry. Tsa1p-SO3H was not an autoxidation product of Tsa1p-SO2H and was maintained in yeast cells even after two doubling cycles. Tsa1p-SO3H self-assembled into a ring-shaped multimeric form was shown by electron microscopy. Although the Tsa1p-SO3H multimer lost its peroxidase activity, it gained similar to 4-fold higher chaperone activity compared with Tsa1p-SH. In this study, we identify an irreversibly hyperoxidized Prx, Tsa1p-SO3H, with enhanced molecular chaperone activity and suggest that Tsa1p-SO3H is a marker of cumulative oxidative stress in cells.	[Lim, Jung Chae; Choi, Hoon-In; Park, Yu Sun; Chae, Ho Zoon] Chonnam Natl Univ, Dept Biol Sci, Kwangju 500757, South Korea; [Kim, Kanghwa] Chonnam Natl Univ, Dept Food & Nutr, Kwangju 500757, South Korea; [Chae, Ho Zoon] Chonnam Natl Univ, Sch Biol Sci & Technol, Kwangju 500757, South Korea; [Nam, Hyung Wook; Kim, Yu Sam] Yonsei Univ, Coll Sci, Dept Biochem, Prot Network Res Ctr, Seoul 120749, South Korea; [Woo, Hyun Ae; Rhee, Sue Goo] Ewha Womans Univ, Div Life & Pharmaceut Sci, Seoul 120750, South Korea; [Kwon, Ki-Sun] Korea Res Inst Biosci & Biotechnol, Om & Integrat Res Ctr, Korea Lab Cell Signaling, Taejon 305333, South Korea	Chonnam National University; Chonnam National University; Chonnam National University; Yonsei University; Ewha Womans University; Korea Research Institute of Bioscience & Biotechnology (KRIBB)	Chae, HZ (corresponding author), Chonnam Natl Univ, Dept Biol Sci, Kwangju 500757, South Korea.	hzchae@jnu.ac.kr	Woo, Hyun Ae/AAT-9586-2021		Korea Research Foundation [KRF-20070940]; Korea Science and Engineering Foundation [RO1-2004000-10242-0]; Korean Ministry of Science and Technology [M10642040003, M10648000164]	Korea Research Foundation(National Research Foundation of Korea); Korea Science and Engineering Foundation(Korea Science and Engineering Foundation); Korean Ministry of Science and Technology(Ministry of Science & Technology (MOST), Republic of Korea)	This work was supported by Korea Research Foundation Grant KRF-20070940 and Korea Science and Engineering Foundation Grant RO1-2004000-10242-0 (to H.Z.C.) and Korean Ministry of Science and Technology Grants M10642040003 and M10648000164 (to K.-S.K.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement"	Barford D, 2004, CURR OPIN STRUC BIOL, V14, P679, DOI 10.1016/j.sbi.2004.09.012; Belle A, 2006, P NATL ACAD SCI USA, V103, P13004, DOI 10.1073/pnas.0605420103; Biteau B, 2003, NATURE, V425, P980, DOI 10.1038/nature02075; Budanov AV, 2004, SCIENCE, V304, P596, DOI 10.1126/science.1095569; CHAE HZ, 1994, J BIOL CHEM, V269, P27670; Chang TS, 2004, J BIOL CHEM, V279, P50994, DOI 10.1074/jbc.M409482200; Cross JV, 2006, ANTIOXID REDOX SIGN, V8, P1819, DOI 10.1089/ars.2006.8.1819; Friguet B, 2006, FEBS LETT, V580, P2910, DOI 10.1016/j.febslet.2006.03.028; Fu XY, 2001, J BIOL CHEM, V276, P41279, DOI 10.1074/jbc.M106958200; Fujiwara N, 2007, J BIOL CHEM, V282, P35933, DOI 10.1074/jbc.M702941200; Haslbeck M, 2005, NAT STRUCT MOL BIOL, V12, P842, DOI 10.1038/nsmb993; HAYWARD MA, 1987, METHOD ENZYMOL, V143, P279; Hofmann B, 2002, BIOL CHEM, V383, P347, DOI 10.1515/BC.2002.040; JABOB C, 2006, BIOL CHEM, V387, P1385; Jacob C, 2003, ANGEW CHEM INT EDIT, V42, P4742, DOI 10.1002/anie.200300573; Jacob C, 2004, ORG BIOMOL CHEM, V2, P1953, DOI 10.1039/b406180b; Jang HH, 2004, CELL, V117, P625, DOI 10.1016/j.cell.2004.05.002; KICE JL, 1980, ADV PHYS ORG CHEM, V17, P65; Kiley PJ, 2004, PLOS BIOL, V2, P1714, DOI 10.1371/journal.pbio.0020400; KIM KW, 1988, J BIOL CHEM, V263, P4704; Kinumi T, 2004, BIOCHEM BIOPH RES CO, V317, P722, DOI 10.1016/j.bbrc.2004.03.110; Mallis RJ, 2002, BIOL CHEM, V383, P649, DOI 10.1515/BC.2002.067; Mitsumoto A, 2001, FREE RADICAL BIO MED, V30, P625, DOI 10.1016/S0891-5849(00)00503-7; Moon JC, 2005, J BIOL CHEM, V280, P28775, DOI 10.1074/jbc.M505362200; Nakamoto H, 2007, CELL MOL LIFE SCI, V64, P294, DOI 10.1007/s00018-006-6321-2; Phalen TJ, 2006, J CELL BIOL, V175, P779, DOI 10.1083/jcb.200606005; POOLE LB, 1989, J BIOL CHEM, V264, P12330; Poole LB, 2005, ARCH BIOCHEM BIOPHYS, V433, P240, DOI 10.1016/j.abb.2004.09.006; Poole LB, 2004, ANNU REV PHARMACOL, V44, P325, DOI 10.1146/annurev.pharmtox.44.101802.121735; Rabilloud T, 2002, J BIOL CHEM, V277, P19396, DOI 10.1074/jbc.M106585200; Rhee SG, 2007, KIDNEY INT, V72, pS3, DOI 10.1038/sj.ki.5002380; Rhee SG, 2005, FREE RADICAL BIO MED, V38, P1543, DOI 10.1016/j.freeradbiomed.2005.02.026; Rhee SG, 2006, SCIENCE, V312, P1882, DOI 10.1126/science.1130481; Salmeen A, 2003, NATURE, V423, P769, DOI 10.1038/nature01680; Seth D, 2006, BIOCHEMISTRY-US, V45, P8476, DOI 10.1021/bi060157p; Stadtman ER, 2006, FREE RADICAL RES, V40, P1250, DOI 10.1080/10715760600918142; Sun Y, 2005, CELL MOL LIFE SCI, V62, P2460, DOI 10.1007/s00018-005-5190-4; van Montfort RLM, 2003, NATURE, V423, P773, DOI 10.1038/nature01681; Vivancos AP, 2005, P NATL ACAD SCI USA, V102, P8875, DOI 10.1073/pnas.0503251102; Wagner E, 2002, BIOCHEM J, V366, P777, DOI 10.1042/BJ20020525; Woo HA, 2003, J BIOL CHEM, V278, P47361, DOI 10.1074/jbc.C300428200; Woo HA, 2003, SCIENCE, V300, P653, DOI 10.1126/science.1080273; Wood ZA, 2003, TRENDS BIOCHEM SCI, V28, P32, DOI 10.1016/S0968-0004(02)00003-8; Yang KS, 2002, J BIOL CHEM, V277, P38029, DOI 10.1074/jbc.M206626200	44	141	149	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 24	2008	283	43					28873	28880		10.1074/jbc.M804087200	http://dx.doi.org/10.1074/jbc.M804087200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	362EB	18725414	Green Published, hybrid			2022-12-27	WOS:000260179900012
J	Doan, N; Gettins, PGW				Doan, Ninh; Gettins, Peter G. W.			alpha-macroglobulins are present in some Gram-negative bacteria - Characterization of the alpha(2)-macroglobulin from Escherichia coli	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN SECONDARY STRUCTURE; COMPLEMENT COMPONENT C3; RAY CRYSTAL-STRUCTURE; HUMAN ALPHA-2-MACROGLOBULIN; CONFORMATIONAL-CHANGES; SULFHYDRYL-GROUPS; BAIT REGION; BINDING; MEMBER; FORMS	alpha-Macroglobulins (alpha Ms) are large glycoproteins that have been identified in a wide range of vertebrate and invertebrate species and are mostly thiol ester containing proteinase inhibitors. A recent analysis of bacterial genomes (Budd, A., Blandin, S., Levashina, E. A., and Gibson, T. J. (2004) Genome Biol. 5, R38) identified many alpha-macroglobulin-like sequences that appear to have been acquired by Gram-negative bacteria from their metazoan hosts. We report the first expression and characterization of such a bacterial alpha-macroglobulin, that from Escherichia coli. This is also the first alpha-macroglobulin to be characterized that is predicted to be membrane-anchored. We found that the 183-kDa protein contains an intact thiol ester, is monomeric, and is localized to the periplasmic space. Reaction with proteinase results in limited cleavage within a bait region, rapid activation of the thiol ester, cross-linking to the attacking proteinase or other available nucleophiles, and partial protection of the proteinase against macromolecular substrates. Given these properties and the co-occurrence of the alpha M gene with one for a repair transglycosylase, this suggests a possible role for bacterial alpha Ms in cell defense following host attack. Such a role would make bacterial alpha Ms appropriate novel targets for antibiotic drugs.	[Doan, Ninh; Gettins, Peter G. W.] Univ Illinois, Dept Biochem & Mol Genet, Chicago, IL 60607 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Gettins, PGW (corresponding author), 900 S Ashland,M-C 669, Chicago, IL 60607 USA.	pgettins@uic.edu			National Institutes of Health [R01 GM54414]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR022361, S10RR015958] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM054414] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 GM54414. The MicroCal VP differential scanning calorimeter and the Beckman XL-1 analytical ultracentrifuge were purchased through National Institutes of Health Grants S10 RR15958 and S10 RR22361, respectively. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Ajees AA, 2006, NATURE, V444, P221, DOI 10.1038/nature05258; Alekshun MN, 2006, BIOCHEM PHARMACOL, V71, P893, DOI 10.1016/j.bcp.2005.12.040; Arandjelovic S, 2005, ARCH BIOCHEM BIOPHYS, V438, P29, DOI 10.1016/j.abb.2005.03.019; Armstrong PB, 1996, J INSECT PHYSIOL, V42, P53, DOI 10.1016/0022-1910(95)00082-8; Balbo A, 2005, P NATL ACAD SCI USA, V102, P81, DOI 10.1073/pnas.0408399102; BARRETT AJ, 1979, BIOCHEM J, V181, P401, DOI 10.1042/bj1810401; BARRETT AJ, 1973, BIOCHEM J, V133, P709, DOI 10.1042/bj1330709; BJORK I, 1984, BIOCHEM J, V217, P303; BJORK I, 1982, BIOCHEM J, V207, P347; BORK P, 1993, J MOL BIOL, V231, P539, DOI 10.1006/jmbi.1993.1305; Bowen ME, 1998, J BIOL CHEM, V273, P1825, DOI 10.1074/jbc.273.3.1825; Brokx SJ, 2004, J BACTERIOL, V186, P3254, DOI 10.1128/JB.186.10.3254-3258.2004; Budd A, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-6-r38; CHU CT, 1994, LAB INVEST, V71, P792; CUNNINGHAM LW, 1990, BIOCHEMISTRY-US, V29, P1638, DOI 10.1021/bi00458a040; DANGOTT LJ, 1982, BIOCHEM BIOPH RES CO, V107, P1243, DOI 10.1016/S0006-291X(82)80131-9; Doan N, 2007, BIOCHEM J, V407, P23, DOI 10.1042/BJ20070764; ELLMAN GL, 1959, ARCH BIOCHEM BIOPHYS, V82, P70, DOI 10.1016/0003-9861(59)90090-6; Godehardt AW, 2004, BIOCHEM J, V381, P877, DOI 10.1042/BJ20030919; HARPEL PC, 1979, J BIOL CHEM, V254, P8669; Herz J, 2001, J CLIN INVEST, V108, P779, DOI 10.1172/JCI200113992; Janssen BJC, 2006, NATURE, V444, P213, DOI 10.1038/nature05172; Janssen BJC, 2005, NATURE, V437, P505, DOI 10.1038/nature04005; JENSEN PEH, 1986, J BIOL CHEM, V261, P5863; LARSSON LJ, 1987, BIOCHEM J, V243, P47, DOI 10.1042/bj2430047; LARSSON LJ, 1984, BIOCHEMISTRY-US, V23, P2802, DOI 10.1021/bi00307a041; Li ZF, 2004, GENOMICS, V83, P1083, DOI 10.1016/j.ygeno.2003.12.005; Lin M, 2002, BLOOD, V99, P1683, DOI 10.1182/blood.V99.5.1683; Nagar B, 1998, SCIENCE, V280, P1277, DOI 10.1126/science.280.5367.1277; Onara DF, 2008, DEV COMP IMMUNOL, V32, P339, DOI 10.1016/j.dci.2007.06.007; PRIVALOV PL, 1982, ADV PROTEIN CHEM, V35, P1, DOI 10.1016/S0065-3233(08)60468-4; PUGSLEY AP, 1993, MICROBIOL REV, V57, P50, DOI 10.1128/MMBR.57.1.50-108.1993; Rasmussen M, 1999, J BIOL CHEM, V274, P15336, DOI 10.1074/jbc.274.22.15336; ROST B, 1993, J MOL BIOL, V232, P584, DOI 10.1006/jmbi.1993.1413; Rost B, 1996, ANNU REV BIOPH BIOM, V25, P113, DOI 10.1146/annurev.bb.25.060196.000553; ROST B, 1994, COMPUT APPL BIOSCI, V10, P53; SAND O, 1985, J BIOL CHEM, V260, P5723; SANKARAN K, 1995, METHOD ENZYMOL, V250, P683; Schiffer G, 1999, J BIOL CHEM, V274, P32031, DOI 10.1074/jbc.274.45.32031; Seydel A, 1999, MOL MICROBIOL, V34, P810, DOI 10.1046/j.1365-2958.1999.01647.x; SOTTRUPJENSEN J, 1989, J BIOL CHEM, V264, P11539; SOTTRUPJENSEN L, 1980, FEBS LETT, V121, P275, DOI 10.1016/0014-5793(80)80361-9; SOTTRUPJENSEN L, 1984, J BIOL CHEM, V259, P8318; SOTTRUPJENSEN L, 1985, P NATL ACAD SCI USA, V82, P9, DOI 10.1073/pnas.82.1.9; SOTTRUPJENSEN L, 1981, FEBS LETT, V127, P167, DOI 10.1016/0014-5793(81)80197-4; STRICKLAND DK, 1984, BIOCHEMISTRY-US, V23, P3115, DOI 10.1021/bi00309a002; Toppel AW, 2003, J INFECT DIS, V187, P1694, DOI 10.1086/375029; van den Elsen JMH, 2002, J MOL BIOL, V322, P1103, DOI 10.1016/S0022-2836(02)00854-9; YAMAGUCHI K, 1988, CELL, V53, P423, DOI 10.1016/0092-8674(88)90162-6	49	19	20	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 17	2008	283	42					28747	28756		10.1074/jbc.M803127200	http://dx.doi.org/10.1074/jbc.M803127200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	359EN	18697741	Green Published, hybrid			2022-12-27	WOS:000259969300077
J	Delelis, O; Carayon, K; Guiot, E; Leh, H; Tauc, P; Brochon, JC; Mouscadet, JF; Deprez, E				Delelis, Olivier; Carayon, Kevin; Guiot, Elvire; Leh, Herve; Tauc, Patrick; Brochon, Jean-Claude; Mouscadet, Jean-Francois; Deprez, Eric			Insight into the integrase-DNA recognition mechanism - A specific DNA-binding mode revealed by an enzymatically labeled integrase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; RESOLVED FLUORESCENCE ANISOTROPY; CARBOXYL-TERMINAL DOMAINS; MAXIMUM-ENTROPY METHOD; HIV-1 INTEGRASE; VIRAL-DNA; IN-VITRO; NUCLEOCAPSID PROTEIN; CATALYTIC CORE; REPLICATION	Integration catalyzed by integrase (IN) is a key process in the retrovirus life cycle. Many biochemical or structural human immunodeficiency virus, type 1 (HIV-1) IN studies have been severely impeded by its propensity to aggregate. We characterized a retroviral IN (primate foamy virus (PFV-1)) that displays a solubility profile different from that of HIV-1 IN. Using various techniques, including fluorescence correlation spectroscopy, time-resolved fluorescence anisotropy, and size exclusion chromatography, we identified a monomer-dimer equilibrium for the protein alone, with a half-transition concentration of 20-30 mu M. We performed specific enzymatic labeling of PFV-1 IN and measured the fluorescence resonance energy transfer between carboxytetramethylrhodamine-labeled IN and fluorescein-labeled DNA substrates. FRET and fluorescence anisotropy highlight the preferential binding of PFV-1 IN to the 3'-end processing site. Sequence-specific DNA binding was not observed with HIV-1 IN, suggesting that the intrinsic ability of retroviral INs to bind preferentially to the processing site is highly underestimated in the presence of aggregates. IN is in a dimeric state for 3'-processing on short DNA substrates, whereas IN polymerization, mediated by nonspecific contacts at internal DNA positions, occurs on longer DNAs. Additionally, aggregation, mediated by nonspecific IN-IN interactions, occurs preferentially with short DNAs at high IN/DNA ratios. The presence of either higher order complex is detrimental for specific activity. Ionic strength favors catalytically competent over higher order complexes by selectively disrupting nonspecific IN-IN interactions. This counteracting effect was not observed with polymerization. The synergic effect on the selection of specific/competent complexes, obtained by using short DNA substrates under high salt conditions, may have important implications for further structural studies in IN.DNA complexes.	[Delelis, Olivier; Carayon, Kevin; Guiot, Elvire; Leh, Herve; Tauc, Patrick; Brochon, Jean-Claude; Mouscadet, Jean-Francois; Deprez, Eric] Ecole Normale Super, CNRS, Lab Biol & Pharmacol Appl, Inst Alembert, F-94235 Cachan, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay	Deprez, E (corresponding author), Ecole Normale Super, CNRS, Lab Biol & Pharmacol Appl, Inst Alembert, 61 Ave President Wilson, F-94235 Cachan, France.	deprez@lbpa.ens-cachan.fr			TrioH European Project [FP6 503480]; Agence Nationale de la Recherche [06-PCVI-0015]; CNRS; Institut d'Alembert	TrioH European Project; Agence Nationale de la Recherche(French National Research Agency (ANR)); CNRS(Centre National de la Recherche Scientifique (CNRS)); Institut d'Alembert	This work was supported by TrioH European Project Grant FP6 503480, Agence Nationale de la Recherche Grant 06-PCVI-0015, and grants from CNRS and Institut d'Alembert. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Agapkina J, 2006, J BIOL CHEM, V281, P11530, DOI 10.1074/jbc.M512271200; Baranova S, 2007, NUCLEIC ACIDS RES, V35, P975, DOI 10.1093/nar/gkl1111; Bosserman MA, 2007, BIOCHEMISTRY-US, V46, P11231, DOI 10.1021/bi700197a; BROCHON JC, 1994, METHOD ENZYMOL, V240, P262; Carteau S, 1997, J VIROL, V71, P6225, DOI 10.1128/JVI.71.8.6225-6229.1997; Chen JCH, 2000, P NATL ACAD SCI USA, V97, P8233, DOI 10.1073/pnas.150220297; Cherepanov P, 2005, P NATL ACAD SCI USA, V102, P17308, DOI 10.1073/pnas.0506924102; Cherepanov P, 2007, NUCLEIC ACIDS RES, V35, P113, DOI 10.1093/nar/gkl885; Delelis O, 2005, RETROVIROLOGY, V2, DOI 10.1186/1742-4690-2-31; Delelis O, 2004, CURR OPIN MICROBIOL, V7, P400, DOI 10.1016/j.mib.2004.06.009; Deprez E, 2000, BIOCHEMISTRY-US, V39, P9275, DOI 10.1021/bi000397j; Deprez E, 2004, MOL PHARMACOL, V65, P85, DOI 10.1124/mol.65.1.85; Deprez E, 2001, P NATL ACAD SCI USA, V98, P10090, DOI 10.1073/pnas.181024498; Dicker IB, 2007, J BIOL CHEM, V282, P31186, DOI 10.1074/jbc.M704935200; ENGELMAN A, 1994, J VIROL, V68, P5911, DOI 10.1128/JVI.68.9.5911-5917.1994; Enssle J, 1999, J GEN VIROL, V80, P1445, DOI 10.1099/0022-1317-80-6-1445; Esposito D, 1998, EMBO J, V17, P5832, DOI 10.1093/emboj/17.19.5832; Faure A, 2005, NUCLEIC ACIDS RES, V33, P977, DOI 10.1093/nar/gki241; Goldgur Y, 1998, P NATL ACAD SCI USA, V95, P9150, DOI 10.1073/pnas.95.16.9150; Guiot E, 2006, J BIOL CHEM, V281, P22707, DOI 10.1074/jbc.M602198200; Harding SE, 1999, BIOPHYS J, V76, P2432, DOI 10.1016/S0006-3495(99)77398-4; Jenkins TM, 1996, J BIOL CHEM, V271, P7712, DOI 10.1074/jbc.271.13.7712; Jenkins TM, 1997, EMBO J, V16, P6849, DOI 10.1093/emboj/16.22.6849; Johnson AA, 2006, J BIOL CHEM, V281, P461, DOI 10.1074/jbc.M511348200; Laboulais C, 2001, BIOPHYS J, V81, P473, DOI 10.1016/S0006-3495(01)75715-3; LAKOWICS J, 2006, PRINCIPLES FLUORESCE; LAPADATTAPOLSKY M, 1993, NUCLEIC ACIDS RES, V21, P831, DOI 10.1093/nar/21.4.831; Lee HS, 2005, MOL CELLS, V19, P246; Leh H, 2000, BIOCHEMISTRY-US, V39, P9285, DOI 10.1021/bi000398b; Li M, 2006, EMBO J, V25, P1295, DOI 10.1038/sj.emboj.7601005; LINDEN J, 1982, J CYCLIC NUCL PROT, V8, P163; Marchand C, 2003, MOL PHARMACOL, V64, P600, DOI 10.1124/mol.64.3.600; Moebes A, 1997, J VIROL, V71, P7305, DOI 10.1128/JVI.71.10.7305-7311.1997; Oh YT, 1999, BIOCHEM MOL BIOL INT, V47, P621; PAHL A, 1995, J BIOL CHEM, V270, P2957, DOI 10.1074/jbc.270.7.2957; Ren G, 2007, J MOL BIOL, V366, P286, DOI 10.1016/j.jmb.2006.11.029; Sinha S, 2005, J VIROL, V79, P8208, DOI 10.1128/JVI.79.13.8208-8216.2005; Smolov M, 2006, FEBS J, V273, P1137, DOI 10.1111/j.1742-4658.2006.05139.x; Taki M, 2004, PROTEIN ENG DES SEL, V17, P119, DOI 10.1093/protein/gzh015; Wang JY, 2001, EMBO J, V20, P7333, DOI 10.1093/emboj/20.24.7333; Yu SF, 1996, SCIENCE, V271, P1579, DOI 10.1126/science.271.5255.1579; Yu SF, 1999, J VIROL, V73, P1565, DOI 10.1128/JVI.73.2.1565-1572.1999; Zhao Z, 2008, J BIOL CHEM, V283, P5632, DOI 10.1074/jbc.M705241200; Zhou HX, 1995, BIOPHYS J, V69, P2298, DOI 10.1016/S0006-3495(95)80100-1	45	41	42	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 10	2008	283	41					27838	27849		10.1074/jbc.M803257200	http://dx.doi.org/10.1074/jbc.M803257200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	355OW	18697740	hybrid			2022-12-27	WOS:000259719200055
J	Li, XK; Barkho, BZ; Luo, YP; Smrt, RD; Santistevan, NJ; Liu, CM; Kuwabara, T; Gage, FH; Zhao, XY				Li, Xuekun; Barkho, Basam Z.; Luo, Yuping; Smrt, Richard D.; Santistevan, Nicholas J.; Liu, Changmei; Kuwabara, Tomoko; Gage, Fred H.; Zhao, Xinyu			Epigenetic regulation of the stem cell mitogen Fgf-2 by Mbd1 in adult neural stem/progenitor cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FIBROBLAST-GROWTH-FACTOR; METHYL-CPG BINDING-PROTEIN-1; DNA METHYLATION; TRANSCRIPTIONAL REPRESSION; SUBVENTRICULAR ZONE; CEREBRAL-CORTEX; PROLIFERATION; BRAIN; DIFFERENTIATION; NEUROGENESIS	Whether and how mechanisms intrinsic to stem cells modulate their proliferation and differentiation are two central questions in stem cell biology. Although exogenous basic fibroblast growth factor 2 (FGF-2/Fgf-2) is commonly used to expand adult neural stem/progenitor cells (NSPCs) in vitro, we do not yet understand the functional significance or the molecular regulation of Fgf-2 expressed endogenously by adult NSPCs. We previously demonstrated that methylated CpG binding protein 1 (MBD1/Mbd1) is a transcriptional repressor of Fgf-2 and is enriched in adult brains. Mbd1 deficiency in mice selectively affected adult neurogenesis and the differentiation of NSPCs. Here we show that an Mbd1 and DNA methylation-mediated epigenetic mechanism regulated the expression of stem cell mitogen Fgf-2 in adult NSPCs. Mbd1 bound to the Fgf-2 promoter and regulates its expression in adult NSPCs. In the absence of functional Mbd1, the Fgf-2 promoter was hypomethylated, and treatment with a DNA methylation inhibitor resulted in increased Fgf-2 expression in adult NSPCs. We further demonstrated that both acute knockdown of Mbd1 or overexpression of Fgf-2 in adult NSPCs inhibited their neuronal differentiation, which could be responsible for the neurogenic deficits observed in Mbd1-deficient mice. These data indicate that intrinsic epigenetic mechanisms play critical roles in the regulation of adult NSPC functions.	[Li, Xuekun; Barkho, Basam Z.; Luo, Yuping; Smrt, Richard D.; Santistevan, Nicholas J.; Liu, Changmei; Zhao, Xinyu] Univ New Mexico, Sch Med, Dept Neurosci, Albuquerque, NM 87131 USA; [Kuwabara, Tomoko; Gage, Fred H.] Salk Inst Biol Studies, Genet Lab, La Jolla, CA 92037 USA	University of New Mexico; Salk Institute	Zhao, XY (corresponding author), Univ New Mexico, Sch Med, Dept Neurosci, Albuquerque, NM 87131 USA.	xzhao@salud.unm.edu	Santistevan, Nicholas/L-3233-2015; Liu, Changmei/H-9600-2012	Santistevan, Nicholas/0000-0002-4657-6860; 	National Institutes of Health [MH080434, MH078972]; Oxnard Foundation; International Rett Syndrome Foundation; University of New Mexico School of Medicine; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T34GM008751] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH080434, R01MH078972] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Oxnard Foundation; International Rett Syndrome Foundation; University of New Mexico School of Medicine; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported, in whole or in part, by National Institutes of Health Grants MH080434 and MH078972. This work was also supported in part by the Oxnard Foundation, International Rett Syndrome Foundation, and University of New Mexico School of Medicine. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Allan AM, 2008, HUM MOL GENET, V17, P2047, DOI 10.1093/hmg/ddn102; Barkho BZ, 2006, STEM CELLS DEV, V15, P407, DOI 10.1089/scd.2006.15.407; Biesiada E, 1996, J BIOL CHEM, V271, P18576, DOI 10.1074/jbc.271.31.18576; Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; Care A, 1996, MOL CELL BIOL, V16, P4842; Cheng LC, 2005, NEURON, V46, P363, DOI 10.1016/j.neuron.2005.04.027; Decker L, 2002, J NEUROSCI RES, V69, P763, DOI 10.1002/jnr.10411; Dennis K, 2001, GENE DEV, V15, P2940, DOI 10.1101/gad.929101; Gage FH, 2002, J NEUROSCI, V22, P612, DOI 10.1523/JNEUROSCI.22-03-00612.2002; Grayson DR, 2006, PHARMACOL THERAPEUT, V111, P272, DOI 10.1016/j.pharmthera.2005.01.007; Herman JG, 1996, P NATL ACAD SCI USA, V93, P9821, DOI 10.1073/pnas.93.18.9821; Ichimura T, 2005, J BIOL CHEM, V280, P13928, DOI 10.1074/jbc.M413654200; Israsena N, 2004, DEV BIOL, V268, P220, DOI 10.1016/j.ydbio.2003.12.024; Klose RJ, 2006, TRENDS BIOCHEM SCI, V31, P89, DOI 10.1016/j.tibs.2005.12.008; Kobayakawa S, 2007, GENES CELLS, V12, P447, DOI 10.1111/j.1365-2443.2007.01063.x; Lillien L, 2000, DEVELOPMENT, V127, P4993; Ma DK, 2005, CURR OPIN NEUROBIOL, V15, P514, DOI 10.1016/j.conb.2005.08.003; Nagarajan RP, 2006, EPIGENETICS-US, V1, P172, DOI 10.4161/epi.1.4.3514; Palmer TD, 1999, J NEUROSCI, V19, P8487; PALMER TD, 1995, MOL CELL NEUROSCI, V6, P474, DOI 10.1006/mcne.1995.1035; Raballo R, 2000, J NEUROSCI, V20, P5012; Sakamoto Y, 2007, J BIOL CHEM, V282, P16391, DOI 10.1074/jbc.M700011200; Shames DS, 2007, CURR MOL MED, V7, P85, DOI 10.2174/156652407779940413; Shi YH, 2004, NATURE, V427, P78, DOI 10.1038/nature02211; Sorensen V, 2006, BIOESSAYS, V28, P504, DOI 10.1002/bies.20405; Spivakov M, 2007, NAT REV GENET, V8, P263, DOI 10.1038/nrg2046; Stachowiak EK, 1997, ONCOGENE, V14, P2201, DOI 10.1038/sj.onc.1201057; Stachowiak MK, 2003, J CELL BIOCHEM, V90, P662, DOI 10.1002/jcb.10606; Takizawa T, 2001, DEV CELL, V1, P749, DOI 10.1016/S1534-5807(01)00101-0; Tureyen K, 2005, NEUROSURGERY, V57, P1254, DOI 10.1227/01.NEU.0000186040.96929.8A; Ueba T, 1999, J BIOL CHEM, V274, P10382, DOI 10.1074/jbc.274.15.10382; Vaccarino FM, 1999, NAT NEUROSCI, V2, P246, DOI 10.1038/6350; Zhao XY, 2003, P NATL ACAD SCI USA, V100, P6777, DOI 10.1073/pnas.1131928100; Zheng W, 2004, DEV NEUROSCI-BASEL, V26, P181, DOI 10.1159/000082136	34	80	82	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 10	2008	283	41					27644	27652		10.1074/jbc.M804899200	http://dx.doi.org/10.1074/jbc.M804899200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	355OW	18689796	Green Published, hybrid			2022-12-27	WOS:000259719200036
J	Park, PH; Huang, HL; McMullen, MR; Mandal, P; Sun, L; Nagy, LE				Park, Pil-Hoon; Huang, Honglian; McMullen, Megan R.; Mandal, Palash; Sun, Lei; Nagy, Laura E.			Suppression of lipopolysaccharide-stimulated tumor necrosis factor-alpha production by adiponectin is mediated by transcriptional and post-transcriptional mechanisms	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESSENGER-RNA STABILITY; ACTIVATED PROTEIN-KINASE; NF-KAPPA-B; AU-RICH ELEMENTS; HUMAN MONOCYTIC CELLS; TNF-ALPHA; CHRONIC ETHANOL; EGR-1 EXPRESSION; ANTIINFLAMMATORY CYTOKINES; INFLAMMATORY RESPONSES	Adiponectin is an adipokine with potent anti-inflammatory properties. Treatment of macrophages with adiponectin results in a suppression of lipopolysaccharide (LPS)-stimulated cytokine production. Here we investigated the transcriptional and post-transcriptional mechanisms by which adiponectin suppresses LPS-stimulated tumor necrosis factor (TNF)-alpha production. Treatment of RAW 264.7 macrophages with LPS increased TNF-alpha promoter-driven luciferase activity (TNF-alpha promoter/Luc activity) by 20-fold over basal. After culture with 1 mu g/ml globular adiponectin (gAcrp) for 18 h, TNF-alpha promoter/Luc activity was increased even in the absence of LPS; further challenge with LPS only increased TNF-alpha promoter/Luc activity by 1.4-fold. Treatment with gAcrp decreased LPS-stimulated ERK1/2 phosphorylation and I kappa B degradation and suppressed the ability of LPS to increase the DNA binding activity of Egr-1 and p65. gAcrp also suppressed LPS-mediated stabilization of TNF-alpha mRNA. In controls cells, the half-life of TNF-alpha mRNA was increased from similar to 30 min at base line to similar to 80 min in response to LPS. After treatment with gAcrp for 18 h, LPS failed to increase TNF-alpha mRNA stability. This gAcrp-mediated loss of stimulus-induced stabilization of TNF-alpha mRNA required the presence of the TNF-alpha 3 '-untranslated region and was associated with an increase in expression and RNA binding activity of tristetraprolin, an mRNA-binding protein that destabilizes TNF-alpha mRNA. In summary, these data characterize the complex transcriptional and post-transcriptional effects of gAcrp on LPS-stimulated TNF-alpha expression in macrophages. gAcrp treatment profoundly suppressed the ability of LPS to increase TNF-alpha transcription and reduced the stimulus-induced stabilization of TNF-alpha mRNA in response to LPS.	[Park, Pil-Hoon; Huang, Honglian; McMullen, Megan R.; Mandal, Palash; Sun, Lei; Nagy, Laura E.] Cleveland Clin, Dept Pathobiol, Cleveland, OH 44195 USA; [Nagy, Laura E.] Cleveland Clin, Dept Gastroenterol, Cleveland, OH 44195 USA	Cleveland Clinic Foundation; Cleveland Clinic Foundation	Nagy, LE (corresponding author), Cleveland Clin Fdn, LRI NE40,9500 Euclid Ave, Cleveland, OH 44195 USA.	laura.nagy@case.edu	MANDAL, PALASH/I-5238-2019; huang, Honglian/E-8679-2010; Huang, H/E-9490-2010	MANDAL, PALASH/0000-0001-6612-3773; 	National Institutes of Health [AA011975, AA013868]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA013868, R56AA011975, R01AA011975] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported, in whole or in part, by National Institutes of Health Grants AA011975 and AA013868 (to L.E.N.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Berg AH, 2002, TRENDS ENDOCRIN MET, V13, P84, DOI 10.1016/S1043-2760(01)00524-0; BEUTLER B, 1995, J INVEST MED, V43, P227; Biswas R, 2003, J IMMUNOL, V170, P6202, DOI 10.4049/jimmunol.170.12.6202; Bohuslav J, 1998, J CLIN INVEST, V102, P1645, DOI 10.1172/JCI3877; Bonizzi G, 2004, TRENDS IMMUNOL, V25, P280, DOI 10.1016/j.it.2004.03.008; Brennan CM, 2001, CELL MOL LIFE SCI, V58, P266, DOI 10.1007/PL00000854; Brinkman BMN, 1999, J BIOL CHEM, V274, P30882, DOI 10.1074/jbc.274.43.30882; Brook M, 2006, MOL CELL BIOL, V26, P2408, DOI 10.1128/MCB.26.6.2408-2418.2006; Brook M, 2000, FEBS LETT, V483, P57, DOI 10.1016/S0014-5793(00)02084-6; Carballo E, 1998, SCIENCE, V281, P1001, DOI 10.1126/science.281.5379.1001; Carballo E, 2001, J BIOL CHEM, V276, P42580, DOI 10.1074/jbc.M104953200; Chinetti G, 2004, BIOCHEM BIOPH RES CO, V314, P151, DOI 10.1016/j.bbrc.2003.12.058; Datta S, 2008, J IMMUNOL, V180, P2545, DOI 10.4049/jimmunol.180.4.2545; Dean JLE, 2001, MOL CELL BIOL, V21, P721, DOI 10.1128/MCB.21.3.721-730.2001; Deleault KM, 2008, MOL IMMUNOL, V45, P13, DOI 10.1016/j.molimm.2007.05.017; Dumitru CD, 2000, CELL, V103, P1071, DOI 10.1016/S0092-8674(00)00210-5; Garnon J, 2005, J BIOL CHEM, V280, P5750, DOI 10.1074/jbc.M401988200; Ghosh S, 1998, ANNU REV IMMUNOL, V16, P225, DOI 10.1146/annurev.immunol.16.1.225; Guha M, 2001, BLOOD, V98, P1429, DOI 10.1182/blood.V98.5.1429; Hamilton TA, 2002, IMMUNOL RES, V25, P229, DOI 10.1385/IR:25:3:229; Han JH, 2005, NAT IMMUNOL, V6, P1198, DOI 10.1038/ni1274; Hel Z, 1996, MOL CELL BIOL, V16, P5579; Hitti E, 2006, MOL CELL BIOL, V26, P2399, DOI 10.1128/MCB.26.6.2399-2407.2006; Jacob CO, 1996, J IMMUNOL, V156, P3043; JACOB CO, 1992, IMMUNOL TODAY, V13, P122, DOI 10.1016/0167-5699(92)90107-I; Kishore R, 2001, J BIOL CHEM, V276, P41930, DOI 10.1074/jbc.M107181200; Kontoyiannis D, 1999, IMMUNITY, V10, P387, DOI 10.1016/S1074-7613(00)80038-2; Kontoyiannis D, 2001, EMBO J, V20, P3760, DOI 10.1093/emboj/20.14.3760; LAGNADO CA, 1994, MOL CELL BIOL, V14, P7984, DOI 10.1128/MCB.14.12.7984; Lai WS, 2000, J BIOL CHEM, V275, P17827, DOI 10.1074/jbc.M001696200; Mahtani KR, 2001, MOL CELL BIOL, V21, P6461, DOI 10.1128/MCB.21.9.6461-6469.2001; Marchant A, 1996, J INFLAMM, V46, P114; McMullen MR, 2003, J BIOL CHEM, V278, P38333, DOI 10.1074/jbc.M304566200; Neininger A, 2002, J BIOL CHEM, V277, P3065, DOI 10.1074/jbc.C100685200; Niranjanakumari S, 2002, METHODS, V26, P182, DOI 10.1016/S1046-2023(02)00021-X; Okamoto Y, 2002, CIRCULATION, V106, P2767, DOI 10.1161/01.CIR.0000042707.50032.19; Park PH, 2008, J LEUKOCYTE BIOL, V83, P1258, DOI 10.1189/jlb.0907631; Park PH, 2007, J BIOL CHEM, V282, P21695, DOI 10.1074/jbc.M701419200; Rajasingh J, 2006, FASEB J, V20, P2112, DOI 10.1096/fj.06-6084fje; Sauer I, 2006, BLOOD, V107, P4790, DOI 10.1182/blood-2005-07-3058; SCHERER PE, 1995, J BIOL CHEM, V270, P26746, DOI 10.1074/jbc.270.45.26746; Shi L, 2002, AM J PHYSIOL-CELL PH, V282, pC1205, DOI 10.1152/ajpcell.00511.2001; Shi L, 2002, J BIOL CHEM, V277, P14777, DOI 10.1074/jbc.M108967200; Steer JH, 2000, J BIOL CHEM, V275, P18432, DOI 10.1074/jbc.M906304199; Taylor GA, 1996, MOL ENDOCRINOL, V10, P140, DOI 10.1210/me.10.2.140; Thakur V, 2006, AM J PHYSIOL-GASTR L, V290, pG998, DOI 10.1152/ajpgi.00553.2005; Tsai EY, 2000, MOL CELL BIOL, V20, P6084, DOI 10.1128/MCB.20.16.6084-6094.2000; Tsatsanis C, 2005, BIOCHEM BIOPH RES CO, V335, P1254, DOI 10.1016/j.bbrc.2005.07.197; Vasudevan S, 2007, CELL, V128, P1105, DOI 10.1016/j.cell.2007.01.038; Wang FZ, 2005, MED HYPOTHESES, V65, P1082, DOI 10.1016/j.mehy.2005.05.047; Wang Y, 2004, PROTEOMICS, V4, P3933, DOI 10.1002/pmic.200400826; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Wolf AM, 2004, BIOCHEM BIOPH RES CO, V323, P630, DOI 10.1016/j.bbrc.2004.08.145; Wulster-Radcliffe MC, 2004, BIOCHEM BIOPH RES CO, V316, P924, DOI 10.1016/j.bbrc.2004.02.130; Xu AM, 2003, J CLIN INVEST, V112, P91, DOI 10.1172/JCI200317797; Yamaguchi N, 2005, FEBS LETT, V579, P6821, DOI 10.1016/j.febslet.2005.11.019; Yamauchi T, 2003, NATURE, V423, P762, DOI 10.1038/nature01705; Yao J, 1997, J BIOL CHEM, V272, P17795, DOI 10.1074/jbc.272.28.17795; Yokota T, 2000, BLOOD, V96, P1723, DOI 10.1182/blood.V96.5.1723; Zhu W, 2001, AM J PHYSIOL-LUNG C, V281, pL499, DOI 10.1152/ajplung.2001.281.2.L499	60	58	59	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 3	2008	283	40					26850	26858		10.1074/jbc.M802787200	http://dx.doi.org/10.1074/jbc.M802787200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	353RT	18678874	hybrid, Green Published			2022-12-27	WOS:000259586600004
J	Shi, CS; Kehrl, JH				Shi, Chong-Shan; Kehrl, John H.			MyD88 and Trif Target Beclin 1 to Trigger Autophagy in Macrophages	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TOLL-LIKE RECEPTORS; ADAPTIVE IMMUNITY; SIGNALING PATHWAYS; DENDRITIC CELLS; INNATE IMMUNITY; CUTTING EDGE; DOMAIN; PROTEINS; FAMILY; TOLL-LIKE-RECEPTOR-4	The Toll-like receptors (TLR) play an instructive role in innate and adaptive immunity by recognizing specific molecular patterns from pathogens. Autophagy removes intracellular pathogens and participates in antigen presentation. Here, we demonstrate that not only TLR4, but also other TLR family members induce autophagy in macrophages, which is inhibited by MyD88, Trif, or Beclin 1 shRNA expression. MyD88 and Trif co-immunoprecipitate with Beclin 1, a key factor in autophagosome formation. TLR signaling enhances the interaction of MyD88 and Trif with Beclin 1, and reduces the binding of Beclin 1 to Bcl-2. These findings indicate TLR signaling via its adaptor proteins reduces the binding of Beclin 1 to Bcl-2 by recruiting Beclin 1 into the TLR-signaling complex leading to autophagy.	[Shi, Chong-Shan; Kehrl, John H.] NIAID, B Cell Mol Immunol Sect, Immunoregulat Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Shi, CS (corresponding author), Bldg 10,Rm 11B08,10 Ctr Dr,MSC 1876, Bethesda, MD 20892 USA.	cshi@niaid.nih.gov; kehrl@niaid.nih.gov	Kehrl, John/AAE-6292-2019	Kehrl, John/0000-0002-6526-159X	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000739, Z01AI000739] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Akira S, 2001, NAT IMMUNOL, V2, P675, DOI 10.1038/90609; Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Andrade RM, 2006, J CLIN INVEST, V116, P2366, DOI 10.1172/JCI28796; Blander JM, 2006, NATURE, V440, P808, DOI 10.1038/nature04596; Carty M, 2006, NAT IMMUNOL, V7, P1074, DOI 10.1038/ni1382; Cirl C, 2008, NAT MED, V14, P399, DOI 10.1038/nm1734; Delgado MA, 2008, EMBO J, V27, P1110, DOI 10.1038/emboj.2008.31; Deretic V, 2005, TRENDS IMMUNOL, V26, P523, DOI 10.1016/j.it.2005.08.003; Feng CG, 2003, J IMMUNOL, V171, P4758, DOI 10.4049/jimmunol.171.9.4758; Gazzinelli RT, 2006, NAT REV IMMUNOL, V6, P895, DOI 10.1038/nri1978; Gutierrez MG, 2004, CELL, V119, P753, DOI 10.1016/j.cell.2004.11.038; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kawai T, 2006, CELL DEATH DIFFER, V13, P816, DOI 10.1038/sj.cdd.4401850; Kihara A, 2001, EMBO REP, V2, P330, DOI 10.1093/embo-reports/kve061; Klionsky DJ, 2008, AUTOPHAGY, V4, P151, DOI 10.4161/auto.5338; Levine B, 2007, NAT REV IMMUNOL, V7, P767, DOI 10.1038/nri2161; Maiuri MC, 2007, EMBO J, V26, P2527, DOI 10.1038/sj.emboj.7601689; Medzhitov R, 1998, MOL CELL, V2, P253, DOI 10.1016/S1097-2765(00)80136-7; O'Neill LAJ, 2007, NAT REV IMMUNOL, V7, P353, DOI 10.1038/nri2079; Pattingre S, 2005, CELL, V122, P927, DOI 10.1016/j.cell.2005.07.002; Qi HY, 2005, J BIOL CHEM, V280, P38969, DOI 10.1074/jbc.M509352200; Scanga CA, 2002, J IMMUNOL, V168, P5997, DOI 10.4049/jimmunol.168.12.5997; Schmid D, 2007, IMMUNITY, V27, P11, DOI 10.1016/j.immuni.2007.07.004; Schmid D, 2007, IMMUNITY, V26, P79, DOI 10.1016/j.immuni.2006.10.018; Shintani T, 2004, SCIENCE, V306, P990, DOI 10.1126/science.1099993; Trinchieri G, 2007, NAT REV IMMUNOL, V7, P179, DOI 10.1038/nri2038; Xie ZP, 2007, NAT CELL BIOL, V9, P1102, DOI 10.1038/ncb1007-1102; Xu Y, 2007, IMMUNITY, V27, P135, DOI 10.1016/j.immuni.2007.05.022; Yamamoto M, 2002, J IMMUNOL, V169, P6668, DOI 10.4049/jimmunol.169.12.6668	30	292	307	2	30	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 28	2008	283	48					33175	33182		10.1074/jbc.M804478200	http://dx.doi.org/10.1074/jbc.M804478200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	376KY	18772134	Green Published, hybrid			2022-12-27	WOS:000261183700020
J	Yegneswaran, S; Hackeng, TM; Dawson, PE; Griffin, JH				Yegneswaran, Subramanian; Hackeng, Tilman M.; Dawson, Philip E.; Griffin, John H.			The Thrombin-sensitive Region of Protein S Mediates Phospholipid-dependent Interaction with Factor Xa	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INDEPENDENT ANTICOAGULANT ACTIVITY; FACTOR V-A; ACTIVE-SITE; MEMBRANE-SURFACE; TISSUE FACTOR; PROTHROMBINASE COMPLEX; STRUCTURAL-CHANGES; CHEMICAL-SYNTHESIS; PATHWAY INHIBITOR; ENERGY-TRANSFER	To test the hypothesis that factor Xa (fXa) interacts with protein S, fXa was labeled active-site specifically with a dansyl (D) dye via a Glu-Gly-Arg (EGR) tether to yield DEGR-fXa(i). When protein S was added to phosphatidylcholine/phosphatidylserine (PC/PS, 4:1) vesicle-bound DEGR-fXa(i), the anisotropy of the dansyl moiety was altered from 0.219 +/- 0.002 to 0.245 +/- 0.003. This change in dansyl anisotropy was not observed when DEGR-Xa(i) was titrated with protein S in the absence of PC/PS vesicles, or in the presence of 100% PC vesicles, or when PC/PS vesicle-bound DEGR-fXa(i) was titrated with thrombin-cleaved protein S. The protein S-dependent dansyl fluorescence change was specific for fXa because it was not observed for two homologous and similarly labeled DEGR-fIXa(i) and DEGR-fVIIa(i). Furthermore, protein S specifically and saturably altered the fluorescence anisotropy of PC/PS-bound active site-labeled LWB-FPR-fXa(i) (K-d = 33 nM) and was photocross-linked to PC/PS-bound LWB-FPR-fXa(i) analog, independently confirming the above results. Chemically synthesized microprotein S, comprising residues 1-116 of protein S and including the gamma-carboxyglutamic-rich domain, the thrombin-sensitive region (TSR), and the first epidermal growth factor-like domain (EGF1) of protein S, altered the anisotropy of PC/PS-bound DEGR-fXa(i) from 0.219 to 0.242, similar to the effect of the protein S titration (K-d = 303 nM), suggesting that microprotein S binds to DEGR-fXa(i). To identify individual protein S domain(s) that binds DEGR-fXa(i), the EGF1 and TSR domains were chemically synthesized and studied. The TSR altered the anisotropy of DEGR-fXa(i) by similar to 16%(K-d = 3.9 mu M), but the EGF1 domain had no effect on the signal. In controls, the TSR domain did not alter the anisotropy of DEGR-fIXa(i) and DEGR-fVIIa(i), respectively. These data demonstrate that membrane-bound fXa binding to protein S involves the TSR of protein S.	[Yegneswaran, Subramanian; Griffin, John H.] Scripps Res Inst, Dept Mol & Expt Med, La Jolla, CA 92037 USA; [Dawson, Philip E.] Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA; [Dawson, Philip E.] Scripps Res Inst, Dept Chem, La Jolla, CA 92037 USA; [Hackeng, Tilman M.] Univ Maastricht, Cardiovasc Res Inst Maastricht, NL-6200 MD Maastricht, Netherlands	Scripps Research Institute; Scripps Research Institute; Scripps Research Institute; Maastricht University	Griffin, JH (corresponding author), Scripps Res Inst, Dept Mol & Expt Med, 10666 N Torrey Pines Rd, La Jolla, CA 92037 USA.	jgriffin@scripps.edu		Griffin, John/0000-0002-4302-2547; Hackeng, Tilman/0000-0003-0142-0843	National Institutes of Health [R01 HL21544]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL021544] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 HL21544 (to J.H.G.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Dahlback B, 2007, THROMB HAEMOSTASIS, V98, P90, DOI 10.1160/TH07-04-0269; DELL VA, 1990, BIOCHEMISTRY-US, V29, P1757, DOI 10.1021/bi00459a014; Hackeng TM, 2000, BIOCHEM J, V349, P757, DOI 10.1042/bj3490757; Hackeng TM, 2006, P NATL ACAD SCI USA, V103, P3106, DOI 10.1073/pnas.0504240103; HACKENG TM, 1994, J BIOL CHEM, V269, P21051; Hackeng TM, 1998, BIOPOLYMERS, V46, P53, DOI 10.1002/(SICI)1097-0282(199808)46:2<53::AID-BIP1>3.0.CO;2-W; Hackeng TM, 2000, P NATL ACAD SCI USA, V97, P14074, DOI 10.1073/pnas.260239797; Hayashi T, 1995, BBA-MOL BASIS DIS, V1272, P159, DOI 10.1016/0925-4439(95)00081-X; Heeb MJ, 2006, J THROMB HAEMOST, V4, P2215, DOI 10.1111/j.1538-7836.2006.02117.x; Heeb MJ, 2006, J THROMB HAEMOST, V4, P385, DOI 10.1111/j.1538-7836.2006.01743.x; HEEB MJ, 1994, P NATL ACAD SCI USA, V91, P2728, DOI 10.1073/pnas.91.7.2728; HOLBROOK JJ, 1973, BIOCHEM J, V131, P739, DOI 10.1042/bj1310739; HUSTEN EJ, 1987, J BIOL CHEM, V262, P12953; Koppaka V, 1997, BIOPHYS J, V73, P2638, DOI 10.1016/S0006-3495(97)78293-6; Koppaka V, 1996, BIOPHYS J, V70, P2930, DOI 10.1016/S0006-3495(96)79863-6; Long GL, 1998, J BIOL CHEM, V273, P11521, DOI 10.1074/jbc.273.19.11521; Majumder R, 2003, BIOPHYS J, V84, P1238, DOI 10.1016/S0006-3495(03)74939-X; Mann KG, 2005, BLOOD, V106, P1884, DOI 10.1182/blood-2004-12-4706; McCallum CD, 1996, J BIOL CHEM, V271, P28168, DOI 10.1074/jbc.271.45.28168; MUTUCUMARANA VP, 1992, J BIOL CHEM, V267, P17012; Ndonwi M, 2008, J THROMB HAEMOST, V6, P1044, DOI 10.1111/j.1538-7836.2008.02980.x; Pauls JED, 2000, BIOCHEMISTRY-US, V39, P5468, DOI 10.1021/bi992747b; SCHNOLZER M, 1992, INT J PEPT PROT RES, V40, P180; Sere KM, 2001, BIOCHEMISTRY-US, V40, P8852; Stenberg Y, 1999, J MOL BIOL, V293, P653, DOI 10.1006/jmbi.1999.3139; STINSON RA, 1973, BIOCHEM J, V131, P719, DOI 10.1042/bj1310719; van Wijnen M, 1998, THROMB HAEMOSTASIS, V80, P930; van't Veer C, 1999, THROMB HAEMOSTASIS, V82, P80; vanWijnen M, 1996, THROMB HAEMOSTASIS, V76, P397; YE J, 1991, J BIOL CHEM, V266, P23016; Yegneswaran S, 1997, J BIOL CHEM, V272, P25013, DOI 10.1074/jbc.272.40.25013; Yegneswaran S, 2002, CHEM BIOL, V9, P485, DOI 10.1016/S1074-5521(02)00132-1	32	14	14	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 28	2008	283	48					33046	33052		10.1074/jbc.M806527200	http://dx.doi.org/10.1074/jbc.M806527200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	376KY	18784085	hybrid, Green Published			2022-12-27	WOS:000261183700004
J	Baraibar, MA; Barbeito, AG; Muhoberac, BB; Vidal, R				Baraibar, Martin A.; Barbeito, Ana G.; Muhoberac, Barry B.; Vidal, Ruben			Iron-mediated Aggregation and a Localized Structural Change Characterize Ferritin from a Mutant Light Chain Polypeptide That Causes Neurodegeneration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN SECONDARY STRUCTURE; RECOMBINANT HUMAN H; HEREDITARY FERRITINOPATHY; CONFORMATIONAL-CHANGE; THERMAL-STABILITY; MUTATION; NEUROFERRITINOPATHY; EXPRESSION; DICHROWEB; TERMINUS	Nucleotide insertions in the ferritin light chain (FTL) polypeptide gene cause hereditary ferritinopathy, a neurodegenerative disease characterized by abnormal accumulation of ferritin and iron in the central nervous system. Here we describe for the first time the protein structure and iron storage function of the FTL mutant p. Phe167SerfsX26 (MT-FTL), which has a C terminus altered in sequence and extended in length. MT-FTL polypeptides assembled spontaneously into soluble, spherical 24-mers that were ultrastructurally indistinguishable from those of the wild type. Far-UV CD showed a decrease in alpha-helical content, and 8-anilino-1- naphthalenesulfonate fluorescence revealed the appearance of hydrophobic binding sites. Near-UV CD and proteolysis studies suggested little or no structural alteration outside of the C-terminal region. In contrast to wild type, MT-FTL homopolymers precipitated at much lower iron loading, had a diminished capacity to incorporate iron, and were less thermostable. However, precipitation was significantly reversed by addition of iron chelators both in vitro and in vivo. Our results reveal substantial protein conformational changes localized at the 4-fold pore of MT-FTL homopolymers and imply that the C terminus of the MT-FTL polypeptide plays an important role in ferritin solubility, stability, and iron management. We propose that the protrusion of some portion of the C terminus above the spherical shell allows it to cross-link with other mutant polypeptides through iron bridging, leading to enhanced mutant precipitation by iron. Our data suggest that hereditary ferritinopathy pathogenesis is likely to result from a combination of reduction in iron storage function and enhanced toxicity associated with iron-induced ferritin aggregates.	[Baraibar, Martin A.; Barbeito, Ana G.; Vidal, Ruben] Indiana Univ Sch Med, Dept Pathol & Lab Med, Indianapolis, IN 46202 USA; [Muhoberac, Barry B.] Indiana Univ Purdue Univ, Dept Chem & Chem Biol, Indianapolis, IN 46202 USA	Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University-Purdue University Indianapolis	Vidal, R (corresponding author), Indiana Univ Sch Med, Dept Pathol & Lab Med, 635 Barnhill Dr,MSB A136, Indianapolis, IN 46202 USA.	rvidal@iupui.edu			National Institutes of Health [NS050227]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS050227] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant NS050227 (to R. V.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Beard JL, 2003, ANNU REV NUTR, V23, P41, DOI 10.1146/annurev.nutr.23.020102.075739; Bou-Abdallah F, 2002, BIOCHEMISTRY-US, V41, P11184, DOI 10.1021/bi020215g; Cassina P, 2002, J NEUROSCI RES, V67, P21, DOI 10.1002/jnr.10107; Chou P Y, 1978, Adv Enzymol Relat Areas Mol Biol, V47, P45; Cozzi A, 2006, NEUROBIOL DIS, V23, P644, DOI 10.1016/j.nbd.2006.05.004; Cuff JA, 2000, PROTEINS, V40, P502, DOI 10.1002/1097-0134(20000815)40:3<502::AID-PROT170>3.0.CO;2-Q; Curtis ARJ, 2001, NAT GENET, V28, P350, DOI 10.1038/ng571; FISH WW, 1988, METHOD ENZYMOL, V158, P357, DOI 10.1016/0076-6879(88)58067-9; Fontana A, 1997, J MOL BIOL, V266, P223, DOI 10.1006/jmbi.1996.0787; FONTANA A, 1986, BIOCHEMISTRY-US, V25, P1847, DOI 10.1021/bi00356a001; Granier T, 2001, ACTA CRYSTALLOGR D, V57, P1491, DOI 10.1107/S0907444901008897; Harrison PM, 1996, BBA-BIOENERGETICS, V1275, P161, DOI 10.1016/0005-2728(96)00022-9; Hempstead PD, 1997, J MOL BIOL, V268, P424, DOI 10.1006/jmbi.1997.0970; Ingrassia R, 2006, J BIOCHEM, V139, P881, DOI 10.1093/jb/mvj101; JAPPELLI R, 1992, J MOL BIOL, V227, P532, DOI 10.1016/0022-2836(92)90905-Y; Jappelli R, 1998, BIOCHEM BIOPH RES CO, V250, P342, DOI 10.1006/bbrc.1998.9317; Johnson WC, 1999, PROTEINS, V35, P307, DOI 10.1002/(SICI)1097-0134(19990515)35:3<307::AID-PROT4>3.0.CO;2-3; Kim SW, 2001, BIOCHEM BIOPH RES CO, V289, P125, DOI 10.1006/bbrc.2001.5931; LEVI S, 1989, BIOCHEMISTRY-US, V28, P5179, DOI 10.1021/bi00438a040; LEVI S, 1994, J MOL BIOL, V238, P649, DOI 10.1006/jmbi.1994.1325; LEVI S, 1988, J BIOL CHEM, V263, P18086; LEVI S, 1989, BIOCHEM J, V264, P381, DOI 10.1042/bj2640381; Liu XF, 2005, ACCOUNTS CHEM RES, V38, P167, DOI 10.1021/ar0302336; Lobley A, 2002, BIOINFORMATICS, V18, P211, DOI 10.1093/bioinformatics/18.1.211; LUZZAGO A, 1989, EMBO J, V8, P569, DOI 10.1002/j.1460-2075.1989.tb03411.x; Maciel P, 2005, NEUROLOGY, V65, P603, DOI 10.1212/01.wnl.0000178224.81169.c2; Mancuso M, 2005, J NEUROPATH EXP NEUR, V64, P280, DOI 10.1093/jnen/64.4.280; Martsev SP, 1998, PROTEIN ENG, V11, P377, DOI 10.1093/protein/11.5.377; Ohta E, 2008, NEUROLOGY, V70, P1493, DOI 10.1212/01.wnl.0000310428.74624.95; PROVENCHER SW, 1981, BIOCHEMISTRY-US, V20, P33, DOI 10.1021/bi00504a006; Saneto RP., 1987, NEUROCHEMISTRY PRACT, P27; SANTAMBROGIO P, 1992, J BIOL CHEM, V267, P14077; SANTAMBROGIO P, 1993, J BIOL CHEM, V268, P12744; Santambrogio P, 2000, PROTEIN EXPRES PURIF, V19, P212, DOI 10.1006/prep.2000.1212; SCATCHARD G, 1949, ANN NY ACAD SCI, V51, P660, DOI 10.1111/j.1749-6632.1949.tb27297.x; Sreerama N, 1999, PROTEIN SCI, V8, P370; SREERAMA N, 1993, ANAL BIOCHEM, V209, P32, DOI 10.1006/abio.1993.1079; Stefanini S, 1996, ARCH BIOCHEM BIOPHYS, V325, P58, DOI 10.1006/abbi.1996.0007; Theil EC, 2003, J NUTR, V133, p1549S, DOI 10.1093/jn/133.5.1549S; Theil EC, 2006, J BIOL INORG CHEM, V11, P803, DOI 10.1007/s00775-006-0125-6; Vidal R, 2004, J NEUROPATH EXP NEUR, V63, P363, DOI 10.1093/jnen/63.4.363; Vidal R, 2004, J NEUROPATH EXP NEUR, V63, P787, DOI 10.1093/jnen/63.8.787; Vidal R, 2008, J NEUROSCI, V28, P60, DOI 10.1523/JNEUROSCI.3962-07.2008; Wang ZM, 2006, ACTA CRYSTALLOGR D, V62, P800, DOI 10.1107/S0907444906018294; Whitmore L, 2004, NUCLEIC ACIDS RES, V32, pW668, DOI 10.1093/nar/gkh371; WOLZ RL, 1990, ANAL BIOCHEM, V191, P314; YANG DW, 1994, BBA-PROTEIN STRUCT M, V1206, P173, DOI 10.1016/0167-4838(94)90205-4	47	39	40	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 14	2008	283	46					31679	31689		10.1074/jbc.M805532200	http://dx.doi.org/10.1074/jbc.M805532200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	370KJ	18755684	Green Published, hybrid			2022-12-27	WOS:000260760800050
J	Cunha, SR; Mohler, PJ				Cunha, Shane R.; Mohler, Peter J.			Obscurin Targets Ankyrin-B and Protein Phosphatase 2A to the Cardiac M-line	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN ERYTHROCYTE ANKYRIN; AXON INITIAL SEGMENTS; C-TERMINAL DOMAIN; SARCOPLASMIC-RETICULUM; NEONATAL CARDIOMYOCYTES; SKELETAL-MUSCLE; INOSITOL 1,4,5-TRISPHOSPHATE; SPECTRIN CYTOSKELETON; ISOFORM SPECIFICITY; RYANODINE RECEPTOR	Ankyrin-B targets ion channels and transporters in excitable cells. Dysfunction in ankyrin-B-based pathways results in defects in cardiac physiology. Despite a wealth of knowledge regarding the role of ankyrin-B for cardiac function, little is known regarding the mechanisms underlying ankyrin-B regulation. Moreover, the pathways underlying ankyrin-B targeting in heart are unclear. We report that alternative splicing regulates ankyrin-B localization and function in cardiomyocytes. Specifically, we identify a novel exon (exon 43') in the ankyrin-B regulatory domain that mediates interaction with the Rho-GEF obscurin. Ankyrin-B transcripts harboring exon 43' represent the primary cardiac isoform in human and mouse. We demonstrate that ankyrin-B and obscurin are co-localized at the M-line of myocytes and co-immunoprecipitate from heart. We define the structural requirements for ankyrin-B/obscurin interaction to two motifs in the ankyrin-B regulatory domain and demonstrate that both are critical for obscurin/ankyrin-B interaction. In addition, we demonstrate that interaction with obscurin is required for ankyrin-B M-line targeting. Specifically, both obscurin-binding motifs are required for the M-line targeting of a GFP-ankyrin-B regulatory domain. Moreover, this construct acts as a dominant-negative by competing with endogenous ankyrin-B for obscurin-binding at the M-line, thus providing a powerful new tool to evaluate the function of obscurin/ankyrin-B interactions. With this new tool, we demonstrate that the obscurin/ankyrin-B interaction is critical for recruitment of PP2A to the cardiac M-line. Together, these data provide the first evidence for the molecular basis of ankyrin-B and PP2A targeting and function at the cardiac M-line. Finally, we report that ankyrin-B R1788W is localized adjacent to the ankyrin-B obscurin-binding motif and increases binding activity for obscurin. In summary, our new findings demonstrate that ANK2 is subject to alternative splicing that gives rise to unique polypeptides with diverse roles in cardiac function.	[Cunha, Shane R.; Mohler, Peter J.] Univ Iowa, Carver Coll Med, Dept Internal Med, Iowa City, IA 52242 USA; [Mohler, Peter J.] Univ Iowa, Carver Coll Med, Dept Mol Physiol & Biophys, Iowa City, IA 52242 USA	University of Iowa; University of Iowa	Cunha, SR (corresponding author), 285 Newton Rd,CBRB 2283, Iowa City, IA 52242 USA.	shane-cunha@uiowa.edu			National Institutes of Health [HL084583, HL083422]; Pew Scholars Trust; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL083422, R01HL084583] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pew Scholars Trust; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL084583 and HL083422 (to P. J. M.). This work was also supported by Pew Scholars Trust (to P. J. M.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	Abdi KM, 2006, J BIOL CHEM, V281, P5741, DOI 10.1074/jbc.M506697200; Armani A, 2006, EXP CELL RES, V312, P3546, DOI 10.1016/j.yexcr.2006.07.027; Bagnato P, 2003, J CELL BIOL, V160, P245, DOI 10.1083/jcb.200208109; Beck KA, 1997, J CELL SCI, V110, P1239; Benian GM, 1996, J CELL BIOL, V132, P835, DOI 10.1083/jcb.132.5.835; Bhasin N, 2007, AM J PHYSIOL-HEART C, V293, pH109, DOI 10.1152/ajpheart.00059.2007; Birkenmeier CS, 1998, GENOMICS, V50, P79, DOI 10.1006/geno.1998.5305; BIRKENMEIER CS, 1993, J BIOL CHEM, V268, P9533; Borisov AB, 2006, HISTOCHEM CELL BIOL, V125, P227, DOI 10.1007/s00418-005-0069-x; Borisov AB, 2004, J HISTOCHEM CYTOCHEM, V52, P1117, DOI 10.1369/jhc.3A6183.2004; Borzok MA, 2007, J BIOL CHEM, V282, P32384, DOI 10.1074/jbc.M704089200; Bowman AL, 2007, FEBS LETT, V581, P1549, DOI 10.1016/j.febslet.2007.03.011; Brewis N, 2000, AM J PHYSIOL-HEART C, V279, pH1307, DOI 10.1152/ajpheart.2000.279.3.H1307; Cartegni L, 2002, NAT REV GENET, V3, P285, DOI 10.1038/nrg775; Cunha SR, 2007, J BIOL CHEM, V282, P4875, DOI 10.1074/jbc.M607096200; Das A, 2006, J CELL BIOL, V175, P325, DOI 10.1083/jcb.200602095; Davare MA, 2000, J BIOL CHEM, V275, P39710, DOI 10.1074/jbc.M005462200; Davare MA, 2001, SCIENCE, V293, P98, DOI 10.1126/science.293.5527.98; DAVIS JQ, 1994, J BIOL CHEM, V269, P27163; DAVIS LH, 1992, J BIOL CHEM, V267, P18966; Devarajan P, 1996, J CELL BIOL, V133, P819, DOI 10.1083/jcb.133.4.819; DRENCKHAHN D, 1987, EUR J CELL BIOL, V43, P479; Dubreuil RR, 2006, J MEMBRANE BIOL, V211, P151, DOI 10.1007/s00232-006-0863-y; Dzhashiashvili Y, 2007, J CELL BIOL, V177, P857, DOI 10.1083/jcb.200612012; Fukuzawa A, 2005, J MUSCLE RES CELL M, V26, P427, DOI 10.1007/s10974-005-9025-6; Gagelin C, 2002, J BIOL CHEM, V277, P12978, DOI 10.1074/jbc.M111299200; Gallagher PG, 1998, J BIOL CHEM, V273, P1339, DOI 10.1074/jbc.273.3.1339; Gergs U, 2004, J BIOL CHEM, V279, P40827, DOI 10.1074/jbc.M405770200; Gotthardt M, 2003, J BIOL CHEM, V278, P6059, DOI 10.1074/jbc.M211723200; Hall DD, 2006, BIOCHEMISTRY-US, V45, P3448, DOI 10.1021/bi051593z; HALL TG, 1987, J BIOL CHEM, V262, P10537; Hopitzan AA, 2006, MOL BIOL EVOL, V23, P46, DOI 10.1093/molbev/msj004; Hopitzan AA, 2005, EXP CELL RES, V309, P86, DOI 10.1016/j.yexcr.2005.04.013; Kizhatil K, 2007, J BIOL CHEM, V282, P2029, DOI 10.1074/jbc.M608921200; Kontrogianni-Konstantopoulos A, 2004, AM J PHYSIOL-CELL PH, V287, pC209, DOI 10.1152/ajpcell.00497.2003; Kontrogianni-Konstantopoulos A, 2003, MOL BIOL CELL, V14, P1138, DOI 10.1091/mbc.E02-07-0411; Kontrogianni-Konstantopoulos A, 2003, J BIOL CHEM, V278, P3985, DOI 10.1074/jbc.M209012200; Kontrogianni-Konstantopoulos A, 2006, FASEB J, V20, P2102, DOI 10.1096/fj.06-5761com; Koticha D, 2006, DEV BIOL, V293, P1, DOI 10.1016/j.ydbio.2005.05.028; Lacas-Gervais S, 2004, J CELL BIOL, V166, P983, DOI 10.1083/jcb.200408007; LAMBERT S, 1990, P NATL ACAD SCI USA, V87, P1730, DOI 10.1073/pnas.87.5.1730; LAMBERT S, 1993, J NEUROSCI, V13, P3725; Lange S, 2005, SCIENCE, V308, P1599, DOI 10.1126/science.1110463; Lowe JS, 2008, J CELL BIOL, V180, P173, DOI 10.1083/jcb.200710107; Lustig M, 2001, CURR BIOL, V11, P1864, DOI 10.1016/S0960-9822(01)00586-3; LUX SE, 1990, NATURE, V344, P36, DOI 10.1038/344036a0; Marx SO, 2000, CELL, V101, P365, DOI 10.1016/S0092-8674(00)80847-8; Marx SO, 2002, SCIENCE, V295, P496, DOI 10.1126/science.1066843; Mayans O, 1998, NATURE, V395, P863, DOI 10.1038/27603; Mohler PJ, 2007, CIRCULATION, V115, P432, DOI 10.1161/CIRCULATIONAHA.106.656512; Mohler PJ, 2005, PLOS BIOL, V3, P2158, DOI 10.1371/journal.pbio.0030423; Mohler PJ, 2004, P NATL ACAD SCI USA, V101, P17533, DOI 10.1073/pnas.0403711101; Mohler PJ, 2004, J BIOL CHEM, V279, P40185, DOI 10.1074/jbc.M406018200; Mohler PJ, 2004, P NATL ACAD SCI USA, V101, P9137, DOI 10.1073/pnas.0402546101; Mohler PJ, 2004, J BIOL CHEM, V279, P25798, DOI 10.1074/jbc.M401296200; Mohler PJ, 2004, J BIOL CHEM, V279, P12980, DOI 10.1074/jbc.M313979200; Mohler PJ, 2003, NATURE, V421, P634, DOI 10.1038/nature01335; Mohler PJ, 2002, J BIOL CHEM, V277, P10599, DOI 10.1074/jbc.M110958200; MUMBY MC, 1993, PHYSIOL REV, V73, P673, DOI 10.1152/physrev.1993.73.4.673; Musa H, 2006, J CELL SCI, V119, P4322, DOI 10.1242/jcs.03198; Neumann J, 1997, J MOL CELL CARDIOL, V29, P265, DOI 10.1006/jmcc.1996.0271; Ogawa Y, 2006, J NEUROSCI, V26, P5230, DOI 10.1523/JNEUROSCI.0425-06.2006; Peng J, 2007, CIRCULATION, V115, P743, DOI 10.1161/CIRCULATIONAHA.106.645499; PETERS LL, 1991, J CELL BIOL, V114, P1233, DOI 10.1083/jcb.114.6.1233; Raeker MO, 2006, DEV DYNAM, V235, P2018, DOI 10.1002/dvdy.20812; Scotland P, 1998, J CELL BIOL, V143, P1305, DOI 10.1083/jcb.143.5.1305; Sherman J, 2005, HEART RHYTHM, V2, P1218, DOI 10.1016/j.hrthm.2005.07.026; Vandenbroucke I I, 2001, Nucleic Acids Res, V29, pE68, DOI 10.1093/nar/29.13.e68; Weinert S, 2006, J CELL BIOL, V173, P559, DOI 10.1083/jcb.200601014; Yang Y, 2004, J NEUROSCI, V24, P7230, DOI 10.1523/JNEUROSCI.2125-04.2004; Young P, 2001, J CELL BIOL, V154, P123, DOI 10.1083/jcb.200102110; Zhang X, 1998, J CELL BIOL, V142, P1571, DOI 10.1083/jcb.142.6.1571; Zhou DX, 1997, J CELL BIOL, V136, P621, DOI 10.1083/jcb.136.3.621	73	63	63	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 14	2008	283	46					31968	31980		10.1074/jbc.M806050200	http://dx.doi.org/10.1074/jbc.M806050200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	370KJ	18782775	Green Published, hybrid			2022-12-27	WOS:000260760800079
J	Park, JI; Semyonov, J; Yi, W; Chang, CL; Hsu, SYT				Park, Jae-Il; Semyonov, Jenia; Yi, Wei; Chang, Chia Lin; Hsu, Sheau Yu Teddy			Regulation of Receptor Signaling by Relaxin A Chain Motifs DERIVATION OF PAN-SPECIFIC AND LGR7-SPECIFIC HUMAN RELAXIN ANALOGS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECOMBINANT HUMAN RELAXIN; INSULIN-LIKE PEPTIDE; A-CHAIN; FAMILY PEPTIDES; BINDING SITE; FACTOR RLF; IDENTIFICATION; MEMBER; GENE; TESTIS	Relaxin peptides are important hormones for the regulation of reproductive tissue remodeling and the renal cardiovascular system during pregnancy. Recent studies demonstrated that two of the seven human relaxin family peptides, relaxin H2 (RLN2) and INSL3, signal exclusively through leucine-rich repeat-containing G protein-coupled receptors, LGR7 and LGR8. Although it was well characterized that an RXXXRXXI motif at the RLN2 B chain confers receptor activation activity, it is not clear what roles RLN2 A chain plays in receptor interaction. Analyses of relaxin family genes on syntenic regions of model tetrapods showed that the A chain of RLN2 orthologs exhibited a greater sequence divergence as compared with the receptor-binding domain-containing B chain, foreshadowing a potential role in receptor interactions; hence, defining receptor selectivity in this fast evolving peptide hormone. To test our hypothesis that select residues in the human RLN2 A chain play key roles in receptor interaction, we studied mutant peptides with residue substitution(s) in the A chain. Here, we showed that alanine substitution at the A16 and A17 positions enhances LGR8-activation activity of RLN2, whereas mutation at the A22-23 region (RLN2(A22-23)) ablates LGR8, but not LGR7, activation activity. In addition, we demonstrated that the functional characteristics of the RLN2(A22-23) mutant are mainly attributed to modifications at the Phe(A23) position. Taken together, our studies indicated that Thr(A16), Lys(A17), and Phe(A23) constitute part of the receptor-binding interface of human RLN2, and that modification of these residues has led to the generation of novel human RLN2 analogs that would allow selective activation of human LGR7, but not LGR8, in vivo.	[Park, Jae-Il; Semyonov, Jenia; Yi, Wei; Hsu, Sheau Yu Teddy] Stanford Univ, Sch Med, Dept Obstet & Gynecol, Reprod Biol & Stem Cell Res Program, Stanford, CA 94305 USA; [Chang, Chia Lin] Chang Gung Univ, Sch Med, Chang Gung Mem Hosp, Dept Obstet & Gynecol, Tao Yuan, Taiwan	Stanford University; Chang Gung Memorial Hospital; Chang Gung University	Hsu, SYT (corresponding author), 300 Pasteur Dr,Rm A344D, Stanford, CA 94305 USA.	teddyhsu@stanford.edu			National Institutes of Health [R21 HD47606]; March of Dimes; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [U54HD031398, R21HD047606] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK070652] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); March of Dimes(March of Dimes); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant R21 HD47606 (to S. Y. H.). This work was also supported by a March of Dimes research grant (to S. Y. H.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	Adham IM, 2000, MOL CELL ENDOCRINOL, V160, P11, DOI 10.1016/S0303-7207(99)00188-4; Adham IM, 2002, MOL ENDOCRINOL, V16, P244, DOI 10.1210/me.16.2.244; Bathgate RAD, 2002, J BIOL CHEM, V277, P1148, DOI 10.1074/jbc.M107882200; Bathgate RAD, 2006, BIOCHEMISTRY-US, V45, P1043, DOI 10.1021/bi052233e; Bogatcheva NV, 2003, MOL ENDOCRINOL, V17, P2639, DOI 10.1210/me.2003-0096; BULLESBACH EE, 1992, J BIOL CHEM, V267, P22957; BULLESBACH EE, 1991, J BIOL CHEM, V266, P10754; BULLESBACH EE, 1987, J BIOL CHEM, V262, P12496; Bullesbach EE, 2005, J BIOL CHEM, V280, P14051, DOI 10.1074/jbc.M500030200; Bullesbach EE, 1999, J BIOL CHEM, V274, P22354, DOI 10.1074/jbc.274.32.22354; BULLESBACH EE, 1986, BIOCHEMISTRY-US, V25, P5998; Bullesbach EE, 1999, BIOCHEMISTRY-US, V38, P3073, DOI 10.1021/bi982687u; BULLESBACH EE, 1994, J BIOL CHEM, V269, P13124; Bullesbach EE, 2006, J BIOL CHEM, V281, P26136, DOI 10.1074/jbc.M601414200; CHASSIN D, 1995, GENOMICS, V29, P465, DOI 10.1006/geno.1995.9980; CHEN SA, 1993, PHARMACEUT RES, V10, P834, DOI 10.1023/A:1018901009062; Conklin D, 1999, GENOMICS, V60, P50, DOI 10.1006/geno.1999.5899; Dawson NF, 1999, J PEPT RES, V53, P542, DOI 10.1034/j.1399-3011.1999.00060.x; Dschietzig T, 2006, PHARMACOL THERAPEUT, V112, P38, DOI 10.1016/j.pharmthera.2006.03.004; EIGENBROT C, 1991, J MOL BIOL, V221, P15, DOI 10.1016/0022-2836(91)90796-9; Feng S, 2005, ANN NY ACAD SCI, V1041, P82, DOI 10.1196/annals.1282.012; Fu P, 2004, J PEPT RES, V63, P91, DOI 10.1111/j.1399-3011.2003.00118.x; Furst Daniel E., 1998, Current Opinion in Rheumatology, V10, P123, DOI 10.1097/00002281-199803000-00007; Ganesh S, 2007, CANCER RES, V67, P4399, DOI 10.1158/0008-5472.CAN-06-4260; Halls ML, 2005, J PHARMACOL EXP THER, V313, P677, DOI 10.1124/jpet.104.080655; Hossain MA, 2008, J BIOL CHEM, V283, P17287, DOI 10.1074/jbc.M801911200; Hsu SY, 1999, MOL ENDOCRINOL, V13, P2163, DOI 10.1210/me.13.12.2163; Hsu SY, 2002, SCIENCE, V295, P671, DOI 10.1126/science.1065654; Hua QX, 2006, J BIOL CHEM, V281, P24889, DOI 10.1074/jbc.M602617200; Ivell R, 2002, BIOL REPROD, V67, P699, DOI 10.1095/biolreprod.102.005199; Kamat AA, 2004, ENDOCRINOLOGY, V145, P4712, DOI 10.1210/en.2004-0515; Kawamura K, 2004, P NATL ACAD SCI USA, V101, P7323, DOI 10.1073/pnas.0307061101; Kim JH, 2006, JNCI-J NATL CANCER I, V98, P1482, DOI 10.1093/jnci/djj397; Koskimies P, 2003, MOL CELL ENDOCRINOL, V206, P159, DOI 10.1016/S0303-7207(02)00425-2; Krajnc-Franken MAM, 2004, MOL CELL BIOL, V24, P687, DOI 10.1128/MCB.24.2.687-696.2004; Kumagai J, 2002, J BIOL CHEM, V277, P31283, DOI 10.1074/jbc.C200398200; Lee HC, 2000, NATURE, V408, P483, DOI 10.1038/35044106; Liu CL, 2003, J BIOL CHEM, V278, P50765, DOI 10.1074/jbc.M308996200; Liu CL, 2003, J BIOL CHEM, V278, P50754, DOI 10.1074/jbc.M308995200; Liu M, 2003, J BIOL CHEM, V278, P14798, DOI 10.1074/jbc.M212070200; Lok S, 2000, BIOL REPROD, V62, P1593, DOI 10.1095/biolreprod62.6.1593; MARRIOTT D, 1992, MOL ENDOCRINOL, V6, P1441, DOI 10.1210/me.6.9.1441; Martz E, 2002, TRENDS BIOCHEM SCI, V27, P107, DOI 10.1016/S0968-0004(01)02008-4; Nef S, 2000, GENE DEV, V14, P3075, DOI 10.1101/gad.843800; Park JI, 2008, GENOME RES, V18, P974, DOI 10.1101/gr.7119108; Park JI, 2005, REV ENDOCR METAB DIS, V6, P291, DOI 10.1007/s11154-005-6187-x; Rosengren KJ, 2006, J BIOL CHEM, V281, P28287, DOI 10.1074/jbc.M603829200; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; Seibold JR, 2000, ANN INTERN MED, V132, P871, DOI 10.7326/0003-4819-132-11-200006060-00004; Sherwood O D, 1993, Oxf Rev Reprod Biol, V15, P143; Sherwood OD, 2004, ENDOCR REV, V25, P205, DOI 10.1210/er.2003-0013; Spanel-Borowski K, 2001, MOL REPROD DEV, V58, P281, DOI 10.1002/1098-2795(200103)58:3&lt;281::AID-MRD6&gt;3.0.CO;2-0; STEWART D, 2006, SOC STUD REPR 39 ANN; Sudo S, 2003, J BIOL CHEM, V278, P7855, DOI 10.1074/jbc.M212457200; Tan YY, 1999, BRIT J PHARMACOL, V127, P91, DOI 10.1038/sj.bjp.0702517; Weiss G, 2001, FRONT HORM RES, V27, P105; Wilkinson TN, 2005, BMC EVOL BIOL, V5, DOI 10.1186/1471-2148-5-14; Zarreh-Hoshyari-Khah R, 2001, REGUL PEPTIDES, V97, P139, DOI 10.1016/S0167-0115(00)00205-6; Zhao L, 2000, BIOL REPROD, V63, P697, DOI 10.1095/biolreprod63.3.697; Zhao L, 1999, ENDOCRINOLOGY, V140, P445, DOI 10.1210/en.140.1.445	60	31	33	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 14	2008	283	46					32099	32109		10.1074/jbc.M806817200	http://dx.doi.org/10.1074/jbc.M806817200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	370KJ	18772127	Green Published, hybrid			2022-12-27	WOS:000260760800091
J	Azam, S; Jouvet, N; Jilani, A; Vongsamphanh, R; Yang, XM; Yang, S; Ramotar, D				Azam, Sonish; Jouvet, Nathalie; Jilani, Arshad; Vongsamphanh, Ratsavarinh; Yang, Xiaoming; Yang, Stephen; Ramotar, Dindial			Human Glyceraldehyde-3-phosphate Dehydrogenase Plays a Direct Role in Reactivating Oxidized Forms of the DNA Repair Enzyme APE1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEAR TRANSLOCATION; OXIDATIVE STRESS; APURINIC/APYRIMIDINIC ENDONUCLEASE; REDOX REGULATION; BINDING ACTIVITY; CELL-DEATH; PROTEIN; GAPDH; IDENTIFICATION; APOPTOSIS	Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) has diverse biological functions including its nuclear translocation in response to oxidative stress. We show that GAPDH physically associates with APE1, an essential enzyme involved in the repair of abasic sites in damaged DNA, as well as in the redox regulation of several transcription factors. This interaction allows GAPDH to convert the oxidized species of APE1 to the reduced form, thereby reactivating its endonuclease activity to cleave abasic sites. The GAPDH variants C152G and C156G retain the ability to interact with but are unable to reactivate APE1, implicating these cysteines in catalyzing the reduction of APE1. Interestingly, GAPDH-small interfering RNA knockdown sensitized the cells to methyl methane sulfonate and bleomycin, which generate lesions that are repaired by APE1, but showed normal sensitivity to 254-nm UV. Moreover, the GAPDH knockdown cells exhibited an increased level of spontaneous abasic sites in the genomic DNA as a result of diminished APE1 endonuclease activity. Thus, the nuclear translocation of GAPDH during oxidative stress constitutes a protective mechanism to safeguard the genome by preventing structural inactivation of APE1.	[Azam, Sonish; Jouvet, Nathalie; Jilani, Arshad; Vongsamphanh, Ratsavarinh; Yang, Xiaoming; Yang, Stephen; Ramotar, Dindial] Univ Montreal, Maisonneuve Rosemont Hosp, Res Ctr, Montreal, PQ H1T 2M4, Canada	Universite de Montreal	Ramotar, D (corresponding author), 5415 Assompt, Montreal, PQ H1T 2M4, Canada.	dramotar.hmr@ssss.gouv.qc.ca	Yang, Stephen/M-8177-2019	Yang, Stephen/0000-0003-3859-5110	Natural Sciences and Engineering Research Council of Canada [202432-01]; Canadian Institute of Health Research [MOP-13152]; Maisonneuve-Rosemont Hospital	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); Maisonneuve-Rosemont Hospital	This work was supported partially by Natural Sciences and Engineering Research Council of Canada Grant 202432-01 and Canadian Institute of Health Research Grant MOP-13152 (to D. R.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.; Supported by a fellowship from Maisonneuve-Rosemont Hospital.	Azam S, 2007, APOPTOSIS, V12, P1243, DOI 10.1007/s10495-006-0050-8; Branzei D, 2008, NAT REV MOL CELL BIO, V9, P297, DOI 10.1038/nrm2351; BRODIE AE, 1990, ARCH BIOCHEM BIOPHYS, V276, P212, DOI 10.1016/0003-9861(90)90028-W; Brown VM, 2004, J BIOL CHEM, V279, P5984, DOI 10.1074/jbc.M307071200; Cumming RC, 2005, FASEB J, V19, P2060, DOI 10.1096/fj.05-4195fje; Cumming RC, 2004, J BIOL CHEM, V279, P21749, DOI 10.1074/jbc.M312267200; Dastoor Z, 2001, J CELL SCI, V114, P1643; DEMPLE B, 1991, P NATL ACAD SCI USA, V88, P11450, DOI 10.1073/pnas.88.24.11450; Erzberger JP, 1999, J MOL BIOL, V290, P447, DOI 10.1006/jmbi.1999.2888; Fung H, 2005, MOL CELL, V17, P463, DOI 10.1016/j.molcel.2004.12.029; GEORGIADIS MM, 2008, MUTAT RES IN PRESS; Gros L, 2004, NUCLEIC ACIDS RES, V32, P73, DOI 10.1093/nar/gkh165; Hara MR, 2005, NAT CELL BIOL, V7, P665, DOI 10.1038/ncb1268; Hess DT, 2005, NAT REV MOL CELL BIO, V6, P150, DOI 10.1038/nrm1569; Hirota K, 1997, P NATL ACAD SCI USA, V94, P3633, DOI 10.1073/pnas.94.8.3633; Jayaraman L, 1997, GENE DEV, V11, P558, DOI 10.1101/gad.11.5.558; Jenkins JL, 2006, ACTA CRYSTALLOGR D, V62, P290, DOI 10.1107/S0907444905042289; Jilani A, 2003, BIOCHEMISTRY-US, V42, P6436, DOI 10.1021/bi034163m; Kelley MR, 2001, ANTIOXID REDOX SIGN, V3, P671, DOI 10.1089/15230860152543014; Krynetski EY, 2001, MOL PHARMACOL, V59, P367, DOI 10.1124/mol.59.2.367; Mathonnet R, 2003, P NATL ACAD SCI USA, V100, P7219, DOI 10.1073/pnas.123216100; MEYERSIEGLER K, 1991, P NATL ACAD SCI USA, V88, P8460, DOI 10.1073/pnas.88.19.8460; Nakajima H, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M704199200; Patterson RL, 2005, P NATL ACAD SCI USA, V102, P1357, DOI 10.1073/pnas.0409657102; Saunders PA, 1999, J NEUROCHEM, V72, P925, DOI 10.1046/j.1471-4159.1999.0720925.x; SCHULZE H, 1993, J NEUROCHEM, V60, P1915, DOI 10.1111/j.1471-4159.1993.tb13420.x; Sen N, 2008, NAT CELL BIOL, V10, P866, DOI 10.1038/ncb1747; Shatilla A, 2002, BIOCHEM J, V365, P547, DOI 10.1042/BJ20020375; SINGH R, 1993, SCIENCE, V259, P365, DOI 10.1126/science.8420004; Sirover MA, 1999, BBA-PROTEIN STRUCT M, V1432, P159, DOI 10.1016/S0167-4838(99)00119-3; Strauss PR, 1997, J BIOL CHEM, V272, P1302, DOI 10.1074/jbc.272.2.1302; Tarze A, 2007, ONCOGENE, V26, P2606, DOI 10.1038/sj.onc.1210074; Tatton WG, 2000, ADV RES NEURODEGENER, V8, P77; WALKER LJ, 1993, MOL CELL BIOL, V13, P5370, DOI 10.1128/MCB.13.9.5370; WALKER LJ, 1994, NUCLEIC ACIDS RES, V22, P4884, DOI 10.1093/nar/22.23.4884; XANTHOUDAKIS S, 1992, EMBO J, V11, P3323, DOI 10.1002/j.1460-2075.1992.tb05411.x; XANTHOUDAKIS S, 1992, EMBO J, V11, P653, DOI 10.1002/j.1460-2075.1992.tb05097.x; Xing CG, 2004, P NATL ACAD SCI USA, V101, P5862, DOI 10.1073/pnas.0307476101; Zheng L, 2003, CELL, V114, P255, DOI 10.1016/S0092-8674(03)00552-X	39	104	110	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 7	2008	283	45					30632	30641		10.1074/jbc.M801401200	http://dx.doi.org/10.1074/jbc.M801401200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	367ID	18776186	hybrid, Green Published			2022-12-27	WOS:000260544800020
J	Dugan, AS; Maginnis, MS; Jordan, JA; Gasparovic, ML; Manley, K; Page, R; Williams, G; Porter, E; O'Hara, BA; Atwood, WJ				Dugan, Aisling S.; Maginnis, Melissa S.; Jordan, Joslynn A.; Gasparovic, Megan L.; Manley, Kate; Page, Rebecca; Williams, Geoffrey; Porter, Edith; O'Hara, Bethany A.; Atwood, Walter J.			Human alpha-Defensins Inhibit BK Virus Infection by Aggregating Virions and Blocking Binding to Host Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RENAL-TRANSPLANT RECIPIENTS; HUMAN NEUTROPHIL PEPTIDES; HERPES-SIMPLEX-VIRUS; JC-VIRUS; THETA-DEFENSINS; IN-VITRO; POLYOMAVIRUS-NEPHROPATHY; IMMUNOSUPPRESSIVE DRUGS; INTERSTITIAL NEPHRITIS; NEISSERIA-GONORRHOEAE	BK virus (BKV) is a polyomavirus that establishes a lifelong persistence in most humans and is a major impediment to success of kidney grafts. The function of the innate immune system in BKV infection and pathology has not been investigated. Here we examine the role of antimicrobial defensins in BKV infection of Vero cells. Our data show that alpha-defensin human neutrophil protein 1 (HNP1) and human alpha-defensin 5 (HD5) inhibit BKV infection by targeting an early event in the viral lifecycle. HD5 treatment of BKV reduced viral attachment to cells, whereas cellular treatment with HD5 did not. Colocalization studies indicated that HD5 interacts directly with BKV. Ultrastructural analysis revealed HD5-induced aggregation of virions. HD5 also inhibited infection of cells by other related polyomaviruses. This is the first study to demonstrate polyomavirus sensitivity to defensins. We also show a novel mechanism whereby HD5 binds to BKV leading to aggregation of virion particles preventing normal virus binding to the cell surface and uptake into cells.	[Dugan, Aisling S.; Maginnis, Melissa S.; Manley, Kate; Page, Rebecca; Williams, Geoffrey; O'Hara, Bethany A.; Atwood, Walter J.] Brown Univ, Dept Biochem Mol Biol & Cell Biol, Providence, RI 02912 USA; [Jordan, Joslynn A.] Brown Univ, Grad Program Pathobiol, Providence, RI 02912 USA; [Gasparovic, Megan L.] Brown Univ, Grad Program Mol & Cell Biol & Biochem, Providence, RI 02912 USA; [Porter, Edith] Calif State Univ Los Angeles, Dept Biol Sci, Los Angeles, CA 90032 USA	Brown University; Brown University; Brown University; California State University System; California State University Los Angeles	Atwood, WJ (corresponding author), Box G-E434,70 Ship St, Providence, RI 02903 USA.	Walter_Atwood@Brown.edu	Stanifer, Megan/ABB-4254-2020	Stanifer, Megan/0000-0002-5606-1297	National Institutes of Health [R01 CA71878]; NCI [R01 NS43097]; NATIONAL CANCER INSTITUTE [R01CA071878] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS043097] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 CA71878 from the NCI and R01 NS43097 from the NINDS (to W.J.A.).	Aceti A, 2006, J VIRAL HEPATITIS, V13, P821, DOI 10.1111/j.1365-2893.2006.00762.x; Agerberth B, 2000, BLOOD, V96, P3086, DOI 10.1182/blood.V96.9.3086.h8003086_3086_3093; Aldred PMR, 2005, HUM MOL GENET, V14, P2045, DOI 10.1093/hmg/ddi209; ARTHUR RR, 1988, J INFECT DIS, V158, P563, DOI 10.1093/infdis/158.3.563; Bdeir K, 1999, BLOOD, V94, P2007; Binet I, 1999, TRANSPLANTATION, V67, P918, DOI 10.1097/00007890-199903270-00022; Biragyn A, 2002, SCIENCE, V298, P1025, DOI 10.1126/science.1075565; Bofill-Mas S, 2000, APPL ENVIRON MICROB, V66, P238, DOI 10.1128/AEM.66.1.238-245.2000; Buck CB, 2006, P NATL ACAD SCI USA, V103, P1516, DOI 10.1073/pnas.0508033103; Chang TL, 2005, J CLIN INVEST, V115, P765, DOI 10.1172/JCI200521948; Chen BJ, 2002, VIROLOGY, V300, P282, DOI 10.1006/viro.2002.1522; Chen YP, 2006, J VIROL, V80, P3495, DOI 10.1128/JVI.80.7.3495-3505.2006; COLEMAN DV, 1980, J INFECT DIS, V142, P1, DOI 10.1093/infdis/142.1.1; Cunliffe RN, 2004, J LEUKOCYTE BIOL, V75, P49, DOI 10.1189/jlb.0503249; DAHER KA, 1986, J VIROL, V60, P1068, DOI 10.1128/JVI.60.3.1068-1074.1986; Dhaliwal W, 2003, MOL IMMUNOL, V40, P469, DOI 10.1016/S0161-5890(03)00156-1; Drachenberg CB, 2007, TRANSPLANTATION, V84, P323, DOI 10.1097/01.tp.0000269706.59977.a5; Dugan AS, 2008, J VIROL, V82, P2560, DOI 10.1128/JVI.02123-07; Dugan AS, 2005, J VIROL, V79, P14442, DOI 10.1128/JVI.79.22.14442-14445.2005; Duits LA, 2003, FEMS IMMUNOL MED MIC, V38, P59, DOI 10.1016/S0928-8244(03)00106-8; Eash S, 2004, J VIROL, V78, P11583, DOI 10.1128/JVI.78.21.11583-11590.2004; EISENHAUER PB, 1989, INFECT IMMUN, V57, P2021, DOI 10.1128/IAI.57.7.2021-2027.1989; Falco A, 2007, ANTIVIR RES, V76, P111, DOI 10.1016/j.antiviral.2007.06.006; Frye M, 2000, EUR J CLIN INVEST, V30, P695; Furci L, 2007, BLOOD, V109, P2928, DOI 10.1182/blood-2006-05-024489; Gallo SA, 2006, J BIOL CHEM, V281, P18787, DOI 10.1074/jbc.M602422200; Giesemann T, 2008, GASTROENTEROLOGY, V134, P2049, DOI 10.1053/j.gastro.2008.03.008; Gropp R, 1999, HUM GENE THER, V10, P957, DOI 10.1089/10430349950018355; Hazrati E, 2006, J IMMUNOL, V177, P8658, DOI 10.4049/jimmunol.177.12.8658; Hein M, 2002, AM J OBSTET GYNECOL, V187, P137, DOI 10.1067/mob.2002.123034; HERITAGE J, 1981, J MED VIROL, V8, P143, DOI 10.1002/jmv.1890080208; Hirsch HH, 2002, NEW ENGL J MED, V347, P488, DOI 10.1056/NEJMoa020439; Howell MD, 2007, J ALLERGY CLIN IMMUN, V119, P1022, DOI 10.1016/j.jaci.2007.01.044; Ihi T, 1997, CLIN INFECT DIS, V25, P1134, DOI 10.1086/516075; JIN L, 1995, CLIN DIAGN VIROL, V3, P285, DOI 10.1016/S0928-0197(94)00044-1; Klotman ME, 2008, J IMMUNOL, V180, P6176, DOI 10.4049/jimmunol.180.9.6176; Klotman ME, 2006, NAT REV IMMUNOL, V6, P447, DOI 10.1038/nri1860; Knowles WA, 2003, J MED VIROL, V71, P115, DOI 10.1002/jmv.10450; Koo SP, 1997, INFECT IMMUN, V65, P4795, DOI 10.1128/IAI.65.11.4795-4800.1997; Kota S, 2008, J BIOL CHEM, V283, P22417, DOI 10.1074/jbc.M710415200; Lehrer RI, 1997, CLIN INFECT DIS, V25, P1141, DOI 10.1086/516082; Leikina E, 2005, NAT IMMUNOL, V6, P995, DOI 10.1038/ni1248; Lillard JW, 1999, P NATL ACAD SCI USA, V96, P651, DOI 10.1073/pnas.96.2.651; Lin PL, 2001, PEDIATR TRANSPLANT, V5, P398, DOI 10.1034/j.1399-3046.2001.00037.x; MAJOR EO, 1985, P NATL ACAD SCI USA, V82, P1257, DOI 10.1073/pnas.82.4.1257; Manley K, 2008, VIROLOGY, V372, P48, DOI 10.1016/j.virol.2007.10.029; Manley K, 2006, J VIROL, V80, P12079, DOI 10.1128/JVI.01456-06; Mengel M, 2003, NEPHROL DIAL TRANSPL, V18, P1190, DOI 10.1093/ndt/gfg072; NAKASHIMA H, 1993, AIDS, V7, P1129, DOI 10.1097/00002030-199308000-00019; Niyonsaba Francois, 2003, Current Drug Targets - Inflammation and Allergy, V2, P224, DOI 10.2174/1568010033484115; PANYUTICH AV, 1993, J LAB CLIN MED, V122, P202; Porter E, 2005, INFECT IMMUN, V73, P4823, DOI 10.1128/IAI.73.8.4823-4833.2005; Porter EM, 1997, INFECT IMMUN, V65, P2396, DOI 10.1128/IAI.65.6.2396-2401.1997; Quinones-Mateu ME, 2003, AIDS, V17, pF39, DOI [10.1097/00002030-200311070-00001, 10.1097/01.aids.0000096878.73209.4f]; Ramos E, 2002, J AM SOC NEPHROL, V13, DOI 10.1097/01.ASN.0000023435.07320.81; Randhawa PS, 1999, TRANSPLANTATION, V67, P103, DOI 10.1097/00007890-199901150-00018; RAPTIS L, 2001, SV40 PROTOCOLS; ROSEN S, 1983, NEW ENGL J MED, V308, P1192, DOI 10.1056/NEJM198305193082004; SHAH KV, 1975, J NATL CANCER I, V54, P945; SHIOMI K, 1993, BIOCHEM BIOPH RES CO, V195, P1336, DOI 10.1006/bbrc.1993.2190; Smith JG, 2008, CELL HOST MICROBE, V3, P11, DOI 10.1016/j.chom.2007.12.001; Sundbom M, 2007, J CLIN PATHOL, V60, P1029, DOI 10.1136/jcp.2006.041871; Sundsfjord A, 1999, J INFECT DIS, V180, P1, DOI 10.1086/314830; SUNDSFJORD A, 1994, J CLIN MICROBIOL, V32, P1390, DOI 10.1128/JCM.32.5.1390-1394.1994; Svenson J, 2007, J MED CHEM, V50, P3334, DOI 10.1021/jm0703542; Svinarich DM, 1997, AM J OBSTET GYNECOL, V176, P470, DOI 10.1016/S0002-9378(97)70517-9; Tran D, 2002, J BIOL CHEM, V277, P3079, DOI 10.1074/jbc.M109117200; Vanchiere JA, 2005, J INFECT DIS, V192, P658, DOI 10.1086/432076; Vanchiere JA, 2005, J MED VIROL, V75, P447, DOI 10.1002/jmv.20287; Wang W, 2004, J IMMUNOL, V173, P515, DOI 10.4049/jimmunol.173.1.515; Wehkamp J, 2005, P NATL ACAD SCI USA, V102, P18129, DOI 10.1073/pnas.0505256102; WIMLEY WC, 1994, PROTEIN SCI, V3, P1362, DOI 10.1002/pro.5560030902; Wu ZB, 2005, FEBS LETT, V579, P162, DOI 10.1016/j.febslet.2004.11.062; Yang D, 1999, SCIENCE, V286, P525, DOI 10.1126/science.286.5439.525; Yang D, 2004, ANNU REV IMMUNOL, V22, P181, DOI 10.1146/annurev.immunol.22.012703.104603; Yasin B, 2000, EUR J CLIN MICROBIOL, V19, P187, DOI 10.1007/s100960050457	76	60	71	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 7	2008	283	45					31125	31132		10.1074/jbc.M805902200	http://dx.doi.org/10.1074/jbc.M805902200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	367ID	18782756	Green Published, hybrid			2022-12-27	WOS:000260544800067
J	Garcia-Pino, A; Christensen-Dalsgaard, M; Wyns, L; Yarmolinsky, M; Magnuson, RD; Gerdes, K; Loris, R				Garcia-Pino, Abel; Christensen-Dalsgaard, Mikkel; Wyns, Lode; Yarmolinsky, Michael; Magnuson, Roy David; Gerdes, Kenn; Loris, Remy			Doc of Prophage P1 Is Inhibited by Its Antitoxin Partner Phd through Fold Complementation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLASMID ADDICTION SYSTEM; PROGRAMMED CELL-DEATH; ESCHERICHIA-COLI; CRYSTAL-STRUCTURE; STRUCTURAL BASIS; MESSENGER-RNAS; CYCLIC-AMP; TOXIN; PROTEIN; ANTIDOTE	Prokaryotic toxin-antitoxin modules are involved in major physiological events set in motion under stress conditions. The toxin Doc (death on curing) from the phd/doc module on phage P1 hosts the C-terminal domain of its antitoxin partner Phd (prevents host death) through fold complementation. This Phd domain is intrinsically disordered in solution and folds into an alpha-helix upon binding to Doc. The details of the interactions reveal the molecular basis for the inhibitory action of the antitoxin. The complex resembles the Fic (filamentation induced by cAMP) proteins and suggests a possible evolutionary origin for the phd/doc operon. Doc induces growth arrest of Escherichia coli cells in a reversible manner, by targeting the protein synthesis machinery. Moreover, Doc activates the endogenous E. coli RelE mRNA interferase but does not require this or any other known chromosomal toxin-antitoxin locus for its action in vivo.	[Garcia-Pino, Abel; Wyns, Lode; Loris, Remy] Vrije Univ Brussel, Lab Ultrastruct, B-1050 Brussels, Belgium; [Garcia-Pino, Abel; Wyns, Lode; Loris, Remy] Vlaams Interuniv Inst Biotechnol VIB, Dept Mol & Cellular Interact, B-1050 Brussels, Belgium; [Christensen-Dalsgaard, Mikkel; Gerdes, Kenn] Univ Newcastle, Sch Med, Inst Cell & Mol Biosci, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England; [Christensen-Dalsgaard, Mikkel] Univ So Denmark, Dept Biochem & Mol Biol, DK-5230 Odense M, Denmark; [Yarmolinsky, Michael] NCI, Biochem & Mol Biol Lab, NIH, Bethesda, MD 20892 USA; [Magnuson, Roy David] Univ Alabama, Dept Biol Sci, Huntsville, AL 35899 USA	Vrije Universiteit Brussel; Flanders Institute for Biotechnology (VIB); Newcastle University - UK; University of Southern Denmark; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Alabama System; University of Alabama Huntsville	Loris, R (corresponding author), Vrije Univ Brussel, Lab Ultrastruct, Pl Laan 2, B-1050 Brussels, Belgium.	reloris@vub.ac.be	Loris, Remy/GPG-0894-2022; Gerdes, Kenn/AAS-5548-2021; Gerdes, Kenn/M-2420-2014	Gerdes, Kenn/0000-0002-7462-4612; Gerdes, Kenn/0000-0002-7462-4612; Loris, Remy/0000-0002-8862-3338; Garcia-Pino, Abel/0000-0002-0634-0300	National Institutes of Health [2 R15 GM67668-03]; National Institutes of Health Intramural Research Training Award; VIB; Fonds voor Wetenschappelijk Onderzoek Vlaanderen; Centre for mRNP Biogenesis and Metabolism of the Danish National Research Foundation; Onderzoeksraad of the Vrije Universiteit Brussel; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R15GM067668] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health Intramural Research Training Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); VIB; Fonds voor Wetenschappelijk Onderzoek Vlaanderen(FWO); Centre for mRNP Biogenesis and Metabolism of the Danish National Research Foundation(Danmarks Grundforskningsfond); Onderzoeksraad of the Vrije Universiteit Brussel; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant 2 R15 GM67668-03 from the NIGMS (to R. D. M.) and a National Institutes of Health Intramural Research Training Award grant. This work was also supported by grants from the VIB, the Fonds voor Wetenschappelijk Onderzoek Vlaanderen, the Centre for mRNP Biogenesis and Metabolism of the Danish National Research Foundation, and the Onderzoeksraad of the Vrije Universiteit Brussel. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked " advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Anantharaman V, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-12-r81; Buts L, 2005, TRENDS BIOCHEM SCI, V30, P672, DOI 10.1016/j.tibs.2005.10.004; Christensen SK, 2003, MOL MICROBIOL, V48, P1389, DOI 10.1046/j.1365-2958.2003.03512.x; DAM M, 1994, J MOL BIOL, V236, P1289, DOI 10.1016/0022-2836(94)90058-2; Gazit E, 1999, J BIOL CHEM, V274, P2652, DOI 10.1074/jbc.274.5.2652; Gazit E, 1999, J BIOL CHEM, V274, P16813, DOI 10.1074/jbc.274.24.16813; Gerdes K, 2005, NAT REV MICROBIOL, V3, P371, DOI 10.1038/nrmicro1147; GERDES K, 1986, P NATL ACAD SCI USA, V83, P3116, DOI 10.1073/pnas.83.10.3116; Hazan R, 2001, J BACTERIOL, V183, P2046, DOI 10.1128/JB.183.6.2046-2050.2001; Kamada K, 2005, MOL CELL, V19, P497, DOI 10.1016/j.molcel.2005.07.004; KAWAMUKAI M, 1989, J BACTERIOL, V171, P4525, DOI 10.1128/JB.171.8.4525-4529.1989; LEHNHERR H, 1993, J MOL BIOL, V233, P414, DOI 10.1006/jmbi.1993.1521; Liu M, 2008, P NATL ACAD SCI USA, V105, P5885, DOI 10.1073/pnas.0711949105; LIVINGSTONE CD, 1993, COMPUT APPL BIOSCI, V9, P745; Loris R, 2003, J BIOL CHEM, V278, P28252, DOI 10.1074/jbc.M302336200; Madl T, 2006, J MOL BIOL, V364, P170, DOI 10.1016/j.jmb.2006.08.082; Magnuson P, 1996, J BIOL CHEM, V271, P18705, DOI 10.1074/jbc.271.31.18705; Magnuson R, 1998, J BACTERIOL, V180, P6342; Marti-Renom MA, 2004, PROTEIN SCI, V13, P1071, DOI 10.1110/ps.03379804; McKinley JE, 2005, J BACTERIOL, V187, P765, DOI 10.1128/JB.187.2.765-770.2005; Morris RJ, 2003, METHOD ENZYMOL, V374, P229, DOI 10.1016/S0076-6879(03)74011-7; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Oberer M, 2007, PROTEIN SCI, V16, P1676, DOI 10.1110/ps.062680707; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pandey DP, 2005, NUCLEIC ACIDS RES, V33, P966, DOI 10.1093/nar/gki201; Panjikar S, 2005, ACTA CRYSTALLOGR D, V61, P449, DOI 10.1107/S0907444905001307; Pedersen K, 2002, MOL MICROBIOL, V45, P501, DOI 10.1046/j.1365-2958.2002.03027.x; Remaut H, 2006, TRENDS BIOCHEM SCI, V31, P436, DOI 10.1016/j.tibs.2006.06.007; Sauer FG, 1999, SCIENCE, V285, P1058, DOI 10.1126/science.285.5430.1058; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; Shah D, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-53; Smith JA, 2004, J BACTERIOL, V186, P2692, DOI 10.1128/JB.186.9.2692-2698.2004; STUDIER FW, 1986, J MOL BIOL, V189, P113, DOI 10.1016/0022-2836(86)90385-2; Szekeres S, 2007, MOL MICROBIOL, V63, P1588, DOI 10.1111/j.1365-2958.2007.05613.x; Takagi H, 2005, NAT STRUCT MOL BIOL, V12, P327, DOI 10.1038/nsmb911; UTSUMI R, 1982, J BACTERIOL, V151, P807, DOI 10.1128/JB.151.2.807-812.1982; Watson JD, 2002, J MOL BIOL, V315, P171, DOI 10.1006/jmbi.2001.5227; Yan YW, 1998, PROTEIN SCI, V7, P837; YARMOLINSKY MB, 1995, SCIENCE, V267, P836, DOI 10.1126/science.7846528; Zhang YL, 2003, MOL CELL, V12, P913, DOI 10.1016/S1097-2765(03)00402-7	40	88	93	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 7	2008	283	45					30821	30827		10.1074/jbc.M805654200	http://dx.doi.org/10.1074/jbc.M805654200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	367ID	18757857	Green Published, hybrid			2022-12-27	WOS:000260544800037
J	Mayanagi, T; Morita, T; Hayashi, K; Fukumoto, K; Sobue, K				Mayanagi, Taira; Morita, Tsuyoshi; Hayashi, Ken'ichiro; Fukumoto, Kentaro; Sobue, Kenji			Glucocorticoid Receptor-mediated Expression of Caldesmon Regulates Cell Migration via the Reorganization of the Actin Cytoskeleton	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CALMODULIN-BINDING PROTEIN; PITUITARY-ADRENAL AXIS; SMOOTH-MUSCLE; STRESS FIBERS; TRANSCRIPTIONAL REGULATION; PROSTATE-CANCER; GENE-EXPRESSION; RHO-KINASE; TROPOMYOSIN; ACTIVATION	Glucocorticoids (GCs) play important roles in numerous cellular processes, including growth, development, homeostasis, inhibition of inflammation, and immunosuppression. Here we found that GC-treated human lung carcinoma A549 cells exhibited the enhanced formation of the thick stress fibers and focal adhesions, resulting in suppression of cell migration. In a screen for GC-responsive genes encoding actin-interacting proteins, we identified caldesmon (CaD), which is specifically up-regulated in response to GCs. CaD is a regulatory protein involved in actomyosin-based contraction and the stability of actin filaments. We further demonstrated that the up-regulation of CaD expression was controlled by glucocorticoid receptor (GR). An activated form of GR directly bound to the two glucocorticoid-response element-like sequences in the human CALD1 promoter and transactivated the CALD1 gene, thereby up-regulating the CaD protein. Forced expression of CaD, without GC treatment, also enhanced the formation of thick stress fibers and focal adhesions and suppressed cell migration. Conversely, depletion of CaD abrogated the GC-induced phenotypes. The results of this study suggest that the GR-dependent up-regulation of CaD plays a pivotal role in regulating cell migration via the reorganization of the actin cytoskeleton.	[Sobue, Kenji] Osaka Univ, Grad Sch Med, Dept Neurosci D13, Res Ctr Child Mental Dev, Suita, Osaka 5650871, Japan; [Morita, Tsuyoshi; Hayashi, Ken'ichiro; Fukumoto, Kentaro; Sobue, Kenji] Osaka Univ, Grad Sch Med, Dept Neurosci, Suita, Osaka 5650871, Japan	Osaka University; Osaka University	Sobue, K (corresponding author), Osaka Univ, Grad Sch Med, Dept Neurosci D13, Res Ctr Child Mental Dev, Yamadaoka 2-2, Suita, Osaka 5650871, Japan.	sobue@nbiochem.med.osaka-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [15GS0312]; Japan Society [20240038]	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by Grant-in-aid for Scientific Research 15GS0312 from the Ministry of Education, Culture, Sports, Science and Technology of Japan (to K.S.) and Grant-in-aid for Scientific Research 20240038 from the Japan Society for the Promotion of Science (to K.S.).	Abe M, 2007, J CELL BIOCHEM, V102, P1290, DOI 10.1002/jcb.21359; Adcock IM, 2003, J ENDOCRINOL, V178, P347, DOI 10.1677/joe.0.1780347; Amerongen GPV, 2003, ARTERIOSCL THROM VAS, V23, P211, DOI 10.1161/01.ATV.0000054198.68894.88; Bamberger CM, 1996, ENDOCR REV, V17, P245, DOI 10.1210/er.17.3.245; Barnes PJ, 1998, CLIN SCI, V94, P557, DOI 10.1042/cs0940557; BODIN P, 1991, AM J PHYSIOL, V260, pC151, DOI 10.1152/ajpcell.1991.260.1.C151; BRETSCHER A, 1985, J CELL BIOL, V100, P1656, DOI 10.1083/jcb.100.5.1656; CASTELLINO F, 1992, P NATL ACAD SCI USA, V89, P3775, DOI 10.1073/pnas.89.9.3775; CASTELLINO F, 1995, J CELL BIOL, V131, P1223, DOI 10.1083/jcb.131.5.1223; Chhabra ES, 2007, NAT CELL BIOL, V9, P1110, DOI 10.1038/ncb1007-1110; Coiffier B, 2002, NEW ENGL J MED, V346, P235, DOI 10.1056/NEJMoa011795; COLE TJ, 1995, GENE DEV, V9, P1608, DOI 10.1101/gad.9.13.1608; Condeelis J, 2003, NAT REV CANCER, V3, P921, DOI 10.1038/nrc1231; De Kloet ER, 1998, ENDOCR REV, V19, P269, DOI 10.1210/er.19.3.269; Eppinga RD, 2006, CELL MOTIL CYTOSKEL, V63, P543, DOI 10.1002/cm.20144; Fakih M, 2002, UROLOGY, V60, P553, DOI 10.1016/S0090-4295(02)01741-7; FAY FS, 1973, P NATL ACAD SCI USA, V70, P641, DOI 10.1073/pnas.70.3.641; Fukata Y, 2001, TRENDS PHARMACOL SCI, V22, P32, DOI 10.1016/S0165-6147(00)01596-0; HAYASHI K, 1992, P NATL ACAD SCI USA, V89, P12122, DOI 10.1073/pnas.89.24.12122; Hotulainen P, 2006, J CELL BIOL, V173, P383, DOI 10.1083/jcb.200511093; ISHIKAWA R, 1989, J BIOL CHEM, V264, P7490; Itani OA, 2002, AM J PHYSIOL-ENDOC M, V283, pE971, DOI 10.1152/ajpendo.00021.2002; KREIS TE, 1980, CELL, V22, P555, DOI 10.1016/0092-8674(80)90365-7; Li Y, 2004, J CELL SCI, V117, P3593, DOI 10.1242/jcs.01216; LYNCH WP, 1987, J BIOL CHEM, V262, P7429; Meijsing SH, 2007, MOL CELL BIOL, V27, P2442, DOI 10.1128/MCB.01570-06; Mirzapoiazova T, 2005, J CELL PHYSIOL, V203, P520, DOI 10.1002/jcp.20244; Morita T, 2007, J CELL BIOL, V179, P1027, DOI 10.1083/jcb.200708174; Morita T, 2007, EXP CELL RES, V313, P3432, DOI 10.1016/j.yexcr.2007.07.008; Morita T, 2007, J BIOL CHEM, V282, P8454, DOI 10.1074/jbc.M609983200; MUNCK A, 1984, ENDOCR REV, V5, P25, DOI 10.1210/edrv-5-1-25; MUNCK A, 1976, J STEROID BIOCHEM, V7, P1117, DOI 10.1016/0022-4731(76)90042-X; NGAI PK, 1984, J BIOL CHEM, V259, P3656; Nishida W, 2002, J BIOL CHEM, V277, P7308, DOI 10.1074/jbc.M111824200; NOBES CD, 1995, CELL, V81, P53, DOI 10.1016/0092-8674(95)90370-4; OWADA MK, 1984, P NATL ACAD SCI-BIOL, V81, P3133, DOI 10.1073/pnas.81.10.3133; Pantaloni D, 2001, SCIENCE, V292, P1502, DOI 10.1126/science.1059975; Pellegrin S, 2007, J CELL SCI, V120, P3491, DOI 10.1242/jcs.018473; Planey SL, 2000, BIOCHEM BIOPH RES CO, V279, P307, DOI 10.1006/bbrc.2000.3922; REINER GCA, 1984, CANCER RES, V44, P2302; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Riento K, 2003, NAT REV MOL CELL BIO, V4, P446, DOI 10.1038/nrm1128; Schoneveld OJLM, 2004, BBA-GENE STRUCT EXPR, V1680, P114, DOI 10.1016/j.bbaexp.2004.09.004; SOBUE K, 1991, J BIOL CHEM, V266, P12115; SOBUE K, 1982, BIOMED RES-TOKYO, V3, P188, DOI 10.2220/biomedres.3.188; SOBUE K, 1981, P NATL ACAD SCI-BIOL, V78, P5652, DOI 10.1073/pnas.78.9.5652; TANAKA J, 1993, J CELL SCI, V104, P595; Tronche F, 2004, GENE DEV, V18, P492, DOI 10.1101/gad.284704; Turnbull AV, 1999, PHYSIOL REV, V79, P1, DOI 10.1152/physrev.1999.79.1.1; UEKI N, 1987, P NATL ACAD SCI USA, V84, P9049, DOI 10.1073/pnas.84.24.9049; VAN AL, 1997, GENE DEV, V11, P2295; Vicente-Manzanares M, 2002, J IMMUNOL, V168, P400, DOI 10.4049/jimmunol.168.1.400; Wang DZ, 2001, CELL, V105, P851, DOI 10.1016/S0092-8674(01)00404-4; Wang WG, 2005, TRENDS CELL BIOL, V15, P138, DOI 10.1016/j.tcb.2005.01.003; WARREN KS, 1994, J CELL BIOL, V125, P359, DOI 10.1083/jcb.125.2.359; WICK G, 1993, ENDOCR REV, V14, P539, DOI 10.1210/edrv-14-5-539; YANO H, 1995, J BIOL CHEM, V270, P23661, DOI 10.1074/jbc.270.40.23661; Yemelyanov A, 2007, ONCOGENE, V26, P1885, DOI 10.1038/sj.onc.1209991; YONEZAWA N, 1988, BIOCHEM J, V251, P121, DOI 10.1042/bj2510121; Yoshio T, 2007, FEBS LETT, V581, P3777, DOI 10.1016/j.febslet.2007.06.073; Zheng R, 2006, ONCOGENE, V25, P5942, DOI 10.1038/sj.onc.1209586; Zhou JG, 2005, STEROIDS, V70, P407, DOI 10.1016/j.steroids.2005.02.006; Zimerman B, 2004, CELL MOTIL CYTOSKEL, V58, P143, DOI 10.1002/cm.20005	63	43	45	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 7	2008	283	45					31183	31196		10.1074/jbc.M801606200	http://dx.doi.org/10.1074/jbc.M801606200			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	367ID	18772142	hybrid, Green Published			2022-12-27	WOS:000260544800072
J	Tomasinsig, L; Pizzirani, C; Skerlavaj, B; Pellegatti, P; Gulinelli, S; Tossi, A; Di Virgilio, F; Zanetti, M				Tomasinsig, Linda; Pizzirani, Cinzia; Skerlavaj, Barbara; Pellegatti, Patrizia; Gulinelli, Sara; Tossi, Alessandro; Di Virgilio, Francesco; Zanetti, Margherita			The Human Cathelicidin LL-37 Modulates the Activities of the P2X(7) Receptor in a Structure-dependent Manner	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANTIMICROBIAL PEPTIDE LL-37; IN-VITRO; KERATINOCYTE MIGRATION; NUCLEOTIDE RECEPTOR; EXTRACELLULAR ATP; MICROGLIAL CELLS; EPITHELIAL-CELLS; PORE FORMATION; GROWTH-FACTOR; ACTIVATION	Extracellular ATP, released at sites of inflammation or tissue damage, activates the P2X(7) receptor, which in turn triggers a range of responses also including cell proliferation. In this study the ability of the human cathelicidin LL-37 to stimulate fibroblast growth was inhibited by commonly used P2X(7) blockers. We investigated the structural requirements of the growth-promoting activity of LL-37 and found that it did not depend on helix sense (the all-D analog was active) but did require a strong helix-forming propensity in aqueous solution (a scrambled analog and primate LL-37 orthologs devoid of this property were inactive). The involvement of P2X(7) was analyzed using P2X(7)-expressing HEK293 cells. LL-37 induced proliferation of these cells, triggered Ca2+ influx, promoted ethidium bromide uptake, and synergized with benzoyl ATP to enhance the pore and channel functions of P2X(7). The activity of LL-37 had an absolute requirement for P2X(7) expression as it was blocked by the P2X(7) inhibitor KN-62, was absent in cells lacking P2X(7), and was restored by P2X(7) transfection. Of particular interest, LL-37 led to pore-forming activity in cells expressing a truncated P2X(7) receptor unable to generate the non-selective pore typical of the full-length receptor. Our results indicate that P2X(7) is involved in the proliferative cell response to LL-37 and that the structural/aggregational properties of LL-37 determine its capacity to modulate the activation state of P2X(7).	[Tomasinsig, Linda; Skerlavaj, Barbara; Zanetti, Margherita] Univ Udine, Dept Biomed Sci & Technol, I-33100 Udine, Italy; [Pizzirani, Cinzia; Pellegatti, Patrizia; Gulinelli, Sara; Di Virgilio, Francesco] Univ Ferrara, Dept Expt & Diagnost Med, Sect Gen Pathol, I-44100 Ferrara, Italy; [Pizzirani, Cinzia; Pellegatti, Patrizia; Gulinelli, Sara; Di Virgilio, Francesco] Univ Ferrara, Interdisciplinary Ctr Study Inflammat, I-44100 Ferrara, Italy; [Tossi, Alessandro] Univ Trieste, Dept Biochem Biophys & Macromol Chem, I-34127 Trieste, Italy; [Zanetti, Margherita] Natl Lab Interuniv Consortium Biotechnol, I-34012 Trieste, Italy	University of Udine; University of Ferrara; University of Ferrara; University of Trieste	Zanetti, M (corresponding author), Univ Udine, Dept Biomed Sci & Technol, Ple Kolbe 4, I-33100 Udine, Italy.	mzanetti@mail.dstb.uniud.it	Di Virgilio, Francesco/J-3754-2018; DI VIRGILIO, Francesco/O-4634-2019; Tossi, Alessandro/U-2474-2017; Pellegatti, Patrizia/A-1891-2011; Tossi, Alessandro/ABC-9061-2020	Di Virgilio, Francesco/0000-0003-3566-1362; DI VIRGILIO, Francesco/0000-0003-3566-1362; Tossi, Alessandro/0000-0001-9087-5764; SKERLAVAJ, Barbara/0000-0003-0437-802X	Italian Ministry of Education, University and Research [2005068150_001, 2005051341_004]; Regione Friuli-Venezia Giulia [23 L. R. 26/2005]; Italian Association for Cancer Research; Telethon of Italy [GGP06070]; Italian Space Agency (Agenzia Spaziale Italiana-Osteoporosi e Atrofia Muscolare); Commission of European Communities [HEALTH-F2-2007-202231]; University of Ferrara	Italian Ministry of Education, University and Research(Ministry of Education, Universities and Research (MIUR)); Regione Friuli-Venezia Giulia(Regione Friuli Venezia Giulia); Italian Association for Cancer Research(Fondazione AIRC per la ricerca sul cancro); Telethon of Italy(Fondazione Telethon); Italian Space Agency (Agenzia Spaziale Italiana-Osteoporosi e Atrofia Muscolare)(Agenzia Spaziale Italiana (ASI)); Commission of European Communities(European Commission); University of Ferrara	This work was supported by the Italian Ministry of Education, University and Research (Progetti di Ricerca di Interesse Nazionale 2005 Grants 2005068150_001 and 2005051341_004), Regione Friuli-Venezia Giulia (Grant art. 23 L. R. 26/2005), the Italian Association for Cancer Research, Telethon of Italy (Grant GGP06070), the Italian Space Agency (Agenzia Spaziale Italiana-Osteoporosi e Atrofia Muscolare), the Commission of European Communities (7th Framework Program HEALTH-F2-2007-202231), and institutional funds from the University of Ferrara. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Adinolfi E, 2005, MOL BIOL CELL, V16, P3260, DOI 10.1091/mbc.E04-11-1025; Agerberth B, 2000, BLOOD, V96, P3086, DOI 10.1182/blood.V96.9.3086.h8003086_3086_3093; Alloisio S, 2006, MOL PHARMACOL, V69, P1975, DOI 10.1124/mol.105.020164; Baricordi OR, 1999, J BIOL CHEM, V274, P33206, DOI 10.1074/jbc.274.47.33206; Bianco F, 2006, J NEUROCHEM, V99, P745, DOI 10.1111/j.1471-4159.2006.04101.x; Braff MH, 2005, J IMMUNOL, V174, P4271, DOI 10.4049/jimmunol.174.7.4271; CHEN YH, 1974, BIOCHEMISTRY-US, V13, P3350, DOI 10.1021/bi00713a027; Cirioni O, 2006, ANTIMICROB AGENTS CH, V50, P1672, DOI 10.1128/AAC.50.5.1672-1679.2006; Darville T, 2007, J IMMUNOL, V179, P3707, DOI 10.4049/jimmunol.179.6.3707; Denlinger LC, 2001, J IMMUNOL, V167, P1871, DOI 10.4049/jimmunol.167.4.1871; Di Nardo A, 2007, J IMMUNOL, V178, P1829, DOI 10.4049/jimmunol.178.3.1829; DIVIRGILIO F, 1990, CELL CALCIUM, V11, P57, DOI 10.1016/0143-4160(90)90059-4; DiVirgilio F, 1996, CIBA F SYMP, V198, P290; DIVIRGILIO F, 1987, J BIOL CHEM, V262, P9189; Dorschner RA, 2001, J INVEST DERMATOL, V117, P91, DOI 10.1046/j.1523-1747.2001.01340.x; Elssner A, 2004, J IMMUNOL, V172, P4987, DOI 10.4049/jimmunol.172.8.4987; Ferrari D, 2004, J IMMUNOL, V173, P4652, DOI 10.4049/jimmunol.173.7.4652; Ferrari D, 1997, NEUROPHARMACOLOGY, V36, P1295, DOI 10.1016/S0028-3908(97)00137-8; Frohm M, 1997, J BIOL CHEM, V272, P15258, DOI 10.1074/jbc.272.24.15258; Gerasimovskaya EV, 2002, J BIOL CHEM, V277, P44638, DOI 10.1074/jbc.M203012200; Gerber D, 2005, FASEB J, V19, P1190, DOI 10.1096/fj.04-3498fje; Giacometti A, 2003, J ANTIMICROB CHEMOTH, V51, P843, DOI 10.1093/jac/dkg149; Hancock REW, 2006, NAT BIOTECHNOL, V24, P1551, DOI 10.1038/nbt1267; Heilborn JD, 2005, INT J CANCER, V114, P713, DOI 10.1002/ijc.20795; Heilborn JD, 2003, J INVEST DERMATOL, V120, P379, DOI 10.1046/j.1523-1747.2003.12069.x; Henzler-Wildman KA, 2004, BIOCHEMISTRY-US, V43, P8459, DOI 10.1021/bi036284s; Hibell AD, 2001, J PHARMACOL EXP THER, V296, P947; Humphreys BD, 1998, MOL PHARMACOL, V54, P22, DOI 10.1124/mol.54.1.22; Jiang LH, 2000, MOL PHARMACOL, V58, P82, DOI 10.1124/mol.58.1.82; Johansson J, 1998, J BIOL CHEM, V273, P3718, DOI 10.1074/jbc.273.6.3718; Koczulla R, 2003, J CLIN INVEST, V111, P1665, DOI 10.1172/JCI200317545; Lister Martin F, 2007, J Inflamm (Lond), V4, P5, DOI 10.1186/1476-9255-4-5; Michel AD, 2007, BRIT J PHARMACOL, V152, P523, DOI 10.1038/sj.bjp.0707417; MURGIA M, 1993, J BIOL CHEM, V268, P8199; Nagaoka I, 2006, J IMMUNOL, V176, P3044, DOI 10.4049/jimmunol.176.5.3044; Nilsson MF, 1999, INFECT IMMUN, V67, P2561, DOI 10.1128/IAI.67.5.2561-2566.1999; Niyonsaba F, 2002, IMMUNOLOGY, V106, P20, DOI 10.1046/j.1365-2567.2002.01398.x; Niyonsaba F, 2007, J INVEST DERMATOL, V127, P594, DOI 10.1038/sj.jid.5700599; North RA, 2002, PHYSIOL REV, V82, P1013, DOI 10.1152/physrev.00015.2002; Oppenheim JJ, 2005, CURR OPIN IMMUNOL, V17, P359, DOI 10.1016/j.coi.2005.06.002; Pelegrin P, 2006, EMBO J, V25, P5071, DOI 10.1038/sj.emboj.7601378; Sal-Man N, 2004, J MOL BIOL, V344, P855, DOI 10.1016/j.jmb.2004.09.066; Skerlavaj B, 1996, J BIOL CHEM, V271, P28375, DOI 10.1074/jbc.271.45.28375; Solini A, 1999, J CELL SCI, V112, P297; Sorensen O, 1997, BLOOD, V90, P2796; STEINBERG TH, 1987, J BIOL CHEM, V262, P8884; Surprenant A, 1996, SCIENCE, V272, P735, DOI 10.1126/science.272.5262.735; Takenouchi T, 2007, J NEUROCHEM, V102, P1518, DOI 10.1111/j.1471-4159.2007.04570.x; Tokumaru S, 2005, J IMMUNOL, V175, P4662, DOI 10.4049/jimmunol.175.7.4662; Tomasinsig L, 2006, J BIOL CHEM, V281, P383, DOI 10.1074/jbc.M510354200; Tomasinsig L, 2005, CURR PROTEIN PEPT SC, V6, P23, DOI 10.2174/1389203053027520; Tossi A, 2000, BIOPOLYMERS, V55, P4; Yang D, 2000, J EXP MED, V192, P1069, DOI 10.1084/jem.192.7.1069; Zanetti M, 2004, J LEUKOCYTE BIOL, V75, P39, DOI 10.1189/jlb.0403147; Zasloff M, 2002, NATURE, V415, P389, DOI 10.1038/415389a; Zelezetsky I, 2005, BIOCHEM J, V390, P177, DOI 10.1042/BJ20042138; Zelezetsky I, 2006, J BIOL CHEM, V281, P19861, DOI 10.1074/jbc.M511108200	57	120	122	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 7	2008	283	45					30471	30481		10.1074/jbc.M802185200	http://dx.doi.org/10.1074/jbc.M802185200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	367ID	18765670	Green Published, hybrid			2022-12-27	WOS:000260544800005
J	Ungaro, P; Teperino, R; Mirra, P; Cassese, A; Fiory, F; Perruolo, G; Miele, C; Laakso, M; Formisano, P; Beguinot, F				Ungaro, Paola; Teperino, Raffaele; Mirra, Paola; Cassese, Angela; Fiory, Francesca; Perruolo, Giuseppe; Miele, Claudia; Laakso, Markku; Formisano, Pietro; Beguinot, Francesco			Molecular Cloning and Characterization of the Human PED/PEA-15 Gene Promoter Reveal Antagonistic Regulation by Hepatocyte Nuclear Factor 4 alpha and Chicken Ovalbumin Upstream Promoter Transcription Factor II	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							THYROID-HORMONE RECEPTOR; PROTEIN-KINASE-C; INSULIN-SECRETION; GLUCOSE-TRANSPORT; PEA15 GENE; COUP-TF; EXPRESSION; PEA-15; ACTIVATION; PHOSPHOPROTEIN	Overexpression of the ped/pea-15 gene in mice impairs glucose tolerance and leads to diabetes in conjunction with high fat diet treatment. PED/PEA-15 is also overexpressed in type 2 diabetics as well as in euglycemic offspring from these subjects. The cause(s) of this abnormality remains unclear. In the present work we have cloned and localized the promoter region of the human PED/PEA-15 gene within the first 230 bp of the 5'-flanking region. A cis-acting regulatory element located between -320 and -335 bps upstream the PED/PEA-15 gene transcriptional start site (+1) is recognized by both the hepatocyte nuclear factor 4 alpha (HNF-4 alpha) and the chicken ovalbumin upstream promoter transcription factor II (COUP-TFII), two members of the steroid/thyroid superfamily of transcription factors, both of which are involved in the control of lipid and glucose homeostasis. HNF-4 alpha represses PED/PEA-15 expression in HeLa cells, whereas COUP-TFII activates its expression. In hepatocytes, the activation of PED/PEA-15 gene transcription is paralleled by the establishment of a partially dedifferentiated phenotype accompanied by a reduction in mRNA levels encoded by genes normally expressed during liver development. Cotransfection of HeLa cells with a reporter construct containing the PED/PEA-15 response element and various combinations of HNF-4 alpha and COUP-TFII expression vectors indicated that COUP-TFII antagonizes the repression of the PED/PEA-15 gene by HNF-4 alpha. Thus, at least in part, transcription of the PED/PEA-15 gene in vivo is dependent upon the intracellular balance of these positive and negative regulatory factors. Abnormalities in HNF-4 alpha and COUP-TFII balance might have important consequences on glucose tolerance in humans.	[Ungaro, Paola; Teperino, Raffaele; Mirra, Paola; Cassese, Angela; Fiory, Francesca; Perruolo, Giuseppe; Miele, Claudia; Formisano, Pietro; Beguinot, Francesco] CNR, Ist Endocrinol & Oncol Sperimentale Gaetano Salva, I-80131 Naples, Italy; [Ungaro, Paola; Teperino, Raffaele; Mirra, Paola; Cassese, Angela; Fiory, Francesca; Perruolo, Giuseppe; Miele, Claudia; Formisano, Pietro; Beguinot, Francesco] Univ Naples Federico II, Dipartimento Biol Patol Cellulare & Mol, I-80131 Naples, Italy; [Laakso, Markku] Univ Kuopio, Dept Med, SF-70210 Kuopio, Finland; [Laakso, Markku] Kuopio Univ Hosp, SF-70210 Kuopio, Finland	Consiglio Nazionale delle Ricerche (CNR); Istituto per Endocrinologia e Oncologia "Gaetano Salvatore" (IEOS-CNR); University of Naples Federico II; University of Eastern Finland; Kuopio University Hospital; University of Eastern Finland	Beguinot, F (corresponding author), CNR, Ist Endocrinol & Oncol Sperimentale Gaetano Salva, Via S Pansini 5, I-80131 Naples, Italy.	beguino@unina.it	Formisano, Pietro/J-4237-2018; giuseppe, perruolo/AAW-3869-2021	Perruolo, Giuseppe/0000-0003-0479-8729; Formisano, Pietro/0000-0001-7020-6870; Teperino, Raffaele/0000-0001-8815-1409	European Community [FP6 EUGENE2, LSHM-CT-2004-512013, FP7 PREPROBEDIA, 201681]; European Foundation for the Study of Diabetes (EFSD)/Lilly; Associazione Italiana per la Ricerca sul Cancro; Ministero dell'Universita e della Ricerca Scientifica	European Community(European Commission); European Foundation for the Study of Diabetes (EFSD)/Lilly(Eli Lilly); Associazione Italiana per la Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro); Ministero dell'Universita e della Ricerca Scientifica(Ministry of Education, Universities and Research (MIUR))	This work was supported, in part, by European Community FP6 EUGENE2 Contract LSHM-CT-2004-512013, FP7 PREPROBEDIA Grant 201681, and by grants from the European Foundation for the Study of Diabetes (EFSD)/Lilly, the Associazione Italiana per la Ricerca sul Cancro), and the Ministero dell'Universita e della Ricerca Scientifica.	ARAUJO H, 1993, J BIOL CHEM, V268, P5911; Barbier O, 2005, MOL PHARMACOL, V67, P241, DOI 10.1124/mol.104.003863; Black MH, 2008, DIABETES, V57, P1048, DOI 10.2337/db07-0848; BONADONNA RC, 1991, DIABETES METAB, V17, P112; BURRIS TP, 1995, P NATL ACAD SCI USA, V92, P9525, DOI 10.1073/pnas.92.21.9525; Cairns W, 1996, J BIOL CHEM, V271, P25269, DOI 10.1074/jbc.271.41.25269; CAVAILLES V, 1995, EMBO J, V14, P3741, DOI 10.1002/j.1460-2075.1995.tb00044.x; CHEN JD, 1995, NATURE, V377, P454, DOI 10.1038/377454a0; Condorelli G, 2001, DIABETES, V50, P1244, DOI 10.2337/diabetes.50.6.1244; Condorelli G, 1998, EMBO J, V17, P3858, DOI 10.1093/emboj/17.14.3858; Condorelli G, 1999, ONCOGENE, V18, P4409, DOI 10.1038/sj.onc.1202831; Condorelli G, 2002, J BIOL CHEM, V277, P11013, DOI 10.1074/jbc.M110934200; DANZIGER N, 1995, J NEUROCHEM, V64, P1016; Eeckhoute J, 2001, MOL ENDOCRINOL, V15, P1200, DOI 10.1210/me.15.7.1200; Estelles A, 1996, J BIOL CHEM, V271, P14800, DOI 10.1074/jbc.271.25.14800; Estelles A, 1999, DEV BIOL, V216, P16, DOI 10.1006/dbio.1999.9510; Formisano P, 2005, ONCOGENE, V24, P7012, DOI 10.1038/sj.onc.1208871; Formstecher E, 2001, DEV CELL, V1, P239, DOI 10.1016/S1534-5807(01)00035-1; Fraser JD, 1998, NUCLEIC ACIDS RES, V26, P2702, DOI 10.1093/nar/26.11.2702; GALSON DL, 1995, MOL CELL BIOL, V15, P2135; GLASS CK, 1988, CELL, V54, P313, DOI 10.1016/0092-8674(88)90194-8; Glass CK, 2000, GENE DEV, V14, P121; Hao CH, 2001, CANCER RES, V61, P1162; Hatzis P, 2001, MOL CELL BIOL, V21, P7320, DOI 10.1128/MCB.21.21.7320-7330.2001; Hayhurst GP, 2001, MOL CELL BIOL, V21, P1393, DOI 10.1128/MCB.21.4.1393-1403.2001; HORLEIN AJ, 1995, NATURE, V377, P397, DOI 10.1038/377397a0; HWUNG YP, 1988, MOL CELL BIOL, V8, P2070, DOI 10.1128/MCB.8.5.2070; Johansson S, 2007, DIABETES, V56, P3112, DOI 10.2337/db07-0513; KIMURA A, 1993, J BIOL CHEM, V268, P11125; KTISTAKI E, 1994, NUCLEIC ACIDS RES, V22, P4689, DOI 10.1093/nar/22.22.4689; KUROKAWA R, 1995, NATURE, V377, P451, DOI 10.1038/377451a0; LADIAS JAA, 1992, J BIOL CHEM, V267, P15849; Lausen J, 2000, NUCLEIC ACIDS RES, V28, P430, DOI 10.1093/nar/28.2.430; LEDOUARIN B, 1995, EMBO J, V14, P2020, DOI 10.1002/j.1460-2075.1995.tb07194.x; LEE JW, 1995, NATURE, V374, P91, DOI 10.1038/374091a0; Li JX, 2000, GENE DEV, V14, P464; Lou DQ, 1999, J BIOL CHEM, V274, P28385, DOI 10.1074/jbc.274.40.28385; Menjivar M, 2008, CLIN GENET, V73, P185, DOI 10.1111/j.1399-0004.2007.00928.x; Mercado Maria M, 2002, Curr Diab Rep, V2, P83, DOI 10.1007/s11892-002-0063-9; Miele C, 2007, DIABETES, V56, P622, DOI 10.2337/db06-1260; MIETUSSNYDER M, 1992, MOL CELL BIOL, V12, P1708, DOI 10.1128/MCB.12.4.1708; ONATE SA, 1995, SCIENCE, V270, P1354; Owen KR, 2007, CURR OPIN GENET DEV, V17, P239, DOI 10.1016/j.gde.2007.04.003; PARK J, 2002, KEIO J MED, V52, P174; Parviz F, 2003, NAT GENET, V34, P292, DOI 10.1038/ng1175; Pereira FA, 2000, CELL MOL LIFE SCI, V57, P1388, DOI 10.1007/PL00000624; Perfetti A, 2007, J BIOL CHEM, V282, P8648, DOI 10.1074/jbc.M608359200; QIU YH, 1994, P NATL ACAD SCI USA, V91, P4451, DOI 10.1073/pnas.91.10.4451; QIU YH, 1994, TRENDS ENDOCRIN MET, V5, P234, DOI 10.1016/1043-2760(94)P3081-H; Shih DQ, 2000, DIABETES, V49, P832, DOI 10.2337/diabetes.49.5.832; Shin DJ, 2003, J BIOL CHEM, V278, P50047, DOI 10.1074/jbc.M309736200; Song KH, 2006, J BIOL CHEM, V281, P10081, DOI 10.1074/jbc.M513420200; Trencia A, 2003, MOL CELL BIOL, V23, P4511, DOI 10.1128/MCB.23.13.4511-4521.2003; Valentino R, 2006, DIABETOLOGIA, V49, P3058, DOI 10.1007/s00125-006-0455-5; Vigliotta G, 2004, MOL CELL BIOL, V24, P5005, DOI 10.1128/MCB.24.11.5005-5015.2004; WIGLER M, 1979, P NATL ACAD SCI USA, V76, P1373, DOI 10.1073/pnas.76.3.1373; Wolford JK, 2000, GENE, V241, P143, DOI 10.1016/S0378-1119(99)00455-2; WOLFRUM C, 2003, DIABETES, V52, P2989; XANTHOPOULOS KG, 1991, P NATL ACAD SCI USA, V88, P3807, DOI 10.1073/pnas.88.9.3807; Xiao C, 2002, J BIOL CHEM, V277, P25020, DOI 10.1074/jbc.M202946200; Zhang Y, 2000, J BIOL CHEM, V275, P35224, DOI 10.1074/jbc.M003329200	61	24	24	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 7	2008	283	45					30970	30979		10.1074/jbc.M803895200	http://dx.doi.org/10.1074/jbc.M803895200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	367ID	18765665	Green Published, hybrid			2022-12-27	WOS:000260544800052
J	Aoki, K; Porterfield, M; Lee, SS; Dong, B; Nguyen, K; McGlamry, KH; Tiemeyer, M				Aoki, Kazuhiro; Porterfield, Mindy; Lee, Samuel S.; Dong, Brian; Nguyen, Khoi; McGlamry, Katherine H.; Tiemeyer, Michael			The Diversity of O-Linked Glycans Expressed during Drosophila melanogaster Development Reflects Stage- and Tissue-specific Requirements for Cell Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLYPEPTIDE N-ACETYLGALACTOSAMINYLTRANSFERASE; CHROMATOGRAPHY-MASS-SPECTROMETRY; HEPARAN-SULFATE PROTEOGLYCANS; MUCIN-TYPE GLYCOPROTEIN; NOTCH-LIGAND BINDING; FUNCTIONAL-CHARACTERIZATION; UDP-GALNAC; PROTEIN O-FUCOSYL-TRANSFERASE-1; PERMETHYLATED OLIGOSACCHARIDES; GLYCOSYLTRANSFERASE FRINGE	Appropriate glycoprotein O-glycosylation is essential for normal development and tissue function in multicellular organisms. To comprehensively assess the developmental and functional impact of altered O-glycosylation, we have extensively analyzed the non-glycosaminoglycan, O-linked glycans expressed in Drosophila embryos. Through multidimensional mass spectrometric analysis of glycans released from glycoproteins by beta-elimination, we detected novel as well as previously reported O-glycans that exhibit developmentally modulated expression. The core 1 mucin-type disaccharide (Gal beta 1-3GalNAc) is the predominant glycan in the total profile. HexNAcitol, hexitol, xylosylated hexitol, and branching extension of core 1 with HexNAc (to generate core 2 glycans) were also evident following release and reduction. After Gal beta 1 3GalNAc, the next most prevalent glycans were a mixture of novel, isobaric, linear, and branched forms of a glucuronyl core 1 disaccharide. Other less prevalent structures were also extended with HexA, including an O-fucose glycan. Although the expected disaccharide product of the Fringe glycosyltransferase, (GlcNAc beta 1-3) fucitol, was not detectable in whole embryos, mass spectrometry fragmentation and exoglycosidase sensitivity defined a novel glucuronyl trisaccharide as GlcNAc beta 1-3(GlcA beta 1-4) fucitol. Consistent with the spatial distribution of the Fringe function, the GlcA-extended form of the Fringe product was enriched in the dorsal portion of the wing imaginal disc. Furthermore, loss of Fringe activity reduced the prevalence of the O-Fuc trisaccharide. Therefore, O-Fuc glycans necessary for the modulation of important signaling events in Drosophila are, as in vertebrates, substrates for extension beyond the addition of a single HexNAc.	[Tiemeyer, Michael] Univ Georgia, Complex Carbohydrate Res Ctr, Athens, GA 30602 USA; Univ Georgia, Dept Biochem & Mol Biol, Athens, GA 30602 USA	University System of Georgia; University of Georgia; University System of Georgia; University of Georgia	Tiemeyer, M (corresponding author), Univ Georgia, Complex Carbohydrate Res Ctr, 315 Riverbend Rd, Athens, GA 30602 USA.	mtiemeyer@ccrc.uga.edu	Aoki, Kazuhiro/H-8283-2014	Aoki, Kazuhiro/0000-0003-0029-4291	1-R01-GM072839 [NIGMS]; 1-U01-CA128454 [NCI]; Toyobo Biotechnology Foundation; NATIONAL CANCER INSTITUTE [U01CA128454] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM072839] Funding Source: NIH RePORTER	1-R01-GM072839; 1-U01-CA128454; Toyobo Biotechnology Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants 1-R01-GM072839 from NIGMS and 1-U01-CA128454 from NCI (both to M. T.). This work was also supported by a Toyobo Biotechnology Foundation long-term research grant (to K. A.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Acar M, 2008, CELL, V132, P247, DOI 10.1016/j.cell.2007.12.016; ACHESON A, 1991, J CELL BIOL, V114, P143, DOI 10.1083/jcb.114.1.143; ANUMULA KR, 1992, ANAL BIOCHEM, V203, P101, DOI 10.1016/0003-2697(92)90048-C; Aoki K, 2004, J BIOL CHEM, V279, P32028, DOI 10.1074/jbc.M312918200; Aoki K, 2007, J BIOL CHEM, V282, P9127, DOI 10.1074/jbc.M606711200; Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; Ashline DJ, 2007, ANAL CHEM, V79, P3830, DOI 10.1021/ac062383a; Barresi R, 2006, J CELL SCI, V119, P199, DOI 10.1242/jcs.02814; Bellaiche Y, 1998, NATURE, V394, P85, DOI 10.1038/27932; Bishop JR, 2007, NATURE, V446, P1030, DOI 10.1038/nature05817; Breloy I, 2008, FEBS LETT, V582, P1593, DOI 10.1016/j.febslet.2008.04.003; CALLAERTS P, 1995, ROUX ARCH DEV BIOL, V204, P229, DOI 10.1007/BF00208490; Chen JH, 2001, P NATL ACAD SCI USA, V98, P13716, DOI 10.1073/pnas.241398098; CMELIK SHW, 1969, COMP BIOCHEM PHYSIOL, V31, P65, DOI 10.1016/0010-406X(69)92169-0; Correia T, 2003, P NATL ACAD SCI USA, V100, P6404, DOI 10.1073/pnas.1131007100; DAMICO P, 1995, TISSUE CELL, V27, P23, DOI 10.1016/S0040-8166(95)80005-0; DOMON B, 1988, GLYCOCONJUGATE J, V5, P397, DOI 10.1007/BF01049915; Ervasti JM, 1997, J BIOL CHEM, V272, P22315, DOI 10.1074/jbc.272.35.22315; ERVASTI JM, 1991, CELL, V66, P1121, DOI 10.1016/0092-8674(91)90035-W; Esko JD, 2002, ANNU REV BIOCHEM, V71, P435, DOI 10.1146/annurev.biochem.71.110601.135458; FREDIEU JR, 1994, ACTA ANAT, V149, P89; Grammont M, 2001, DEVELOPMENT, V128, P2243; GRAVER RC, 1965, J AM OIL CHEM SOC, V42, P294; Greis KD, 1996, ANAL BIOCHEM, V234, P38, DOI 10.1006/abio.1996.0047; Guerardel Y, 2001, BIOCHEM J, V357, P167, DOI 10.1042/0264-6021:3570167; Haines N, 2003, NAT REV MOL CELL BIO, V4, P786, DOI 10.1038/nrm1228; Haines N, 2007, MOL BIOL CELL, V18, P4721, DOI 10.1091/mbc.E07-01-0047; Haltiwanger RS, 2002, BBA-GEN SUBJECTS, V1573, P328, DOI 10.1016/S0304-4165(02)00400-2; Haltiwanger RS, 2004, ANNU REV BIOCHEM, V73, P491, DOI 10.1146/annurev.biochem.73.011303.074043; HANISCH FG, 1993, EUR J BIOCHEM, V217, P645, DOI 10.1111/j.1432-1033.1993.tb18288.x; HANSSON GC, 1989, BIOCHEMISTRY-US, V28, P6672, DOI 10.1021/bi00442a021; HARDY MR, 1988, ANAL BIOCHEM, V170, P54, DOI 10.1016/0003-2697(88)90089-9; Huang HH, 2001, GLYCOBIOLOGY, V11, P395, DOI 10.1093/glycob/11.5.395; Huang YP, 2002, RAPID COMMUN MASS SP, V16, P1199, DOI 10.1002/rcm.701; Ichimiya T, 2004, J BIOL CHEM, V279, P42638, DOI 10.1074/jbc.M404900200; IRVINE KD, 1994, CELL, V79, P595, DOI 10.1016/0092-8674(94)90545-2; Ishimizu T, 2007, J BIOCHEM, V141, P593, DOI 10.1093/jb/mvm064; Iwaki DD, 2002, MECH DEVELOP, V114, P71, DOI 10.1016/S0925-4773(02)00061-8; Ju TZ, 2002, P NATL ACAD SCI USA, V99, P16613, DOI 10.1073/pnas.262438199; KARLSSON H, 1989, ANAL BIOCHEM, V182, P438, DOI 10.1016/0003-2697(89)90620-9; KELLY WG, 1989, CELL, V57, P243, DOI 10.1016/0092-8674(89)90962-8; Kim BT, 2003, J BIOL CHEM, V278, P9116, DOI 10.1074/jbc.M209344200; Kirschner KN, 2008, J COMPUT CHEM, V29, P622, DOI 10.1002/jcc.20820; Koles K, 2004, J BIOL CHEM, V279, P4346, DOI 10.1074/jbc.M309912200; Kramerov AA, 1997, INSECT BIOCHEM MOLEC, V27, P513, DOI 10.1016/S0965-1748(97)00026-X; Kramerov AA, 1996, FEBS LETT, V378, P213, DOI 10.1016/0014-5793(95)01444-6; Kreppel LK, 1997, J BIOL CHEM, V272, P9308; Lai EC, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-7-r42; Lin XH, 2004, DEVELOPMENT, V131, P6009, DOI 10.1242/dev.01522; Lopez M, 1999, BBA-GEN SUBJECTS, V1427, P49, DOI 10.1016/S0304-4165(98)00176-7; Lyalin D, 2006, GENETICS, V172, P343, DOI 10.1534/genetics.105.049650; Maes E, 2005, CARBOHYD RES, V340, P1852, DOI 10.1016/j.carres.2005.05.008; Martin PT, 2003, GLYCOBIOLOGY, V13, p67R, DOI 10.1093/glycob/cwg077; MartinBlanco E, 1996, P NATL ACAD SCI USA, V93, P6048, DOI 10.1073/pnas.93.12.6048; Michele DE, 2003, J BIOL CHEM, V278, P15457, DOI 10.1074/jbc.R200031200; Moloney DJ, 2000, J BIOL CHEM, V275, P9604, DOI 10.1074/jbc.275.13.9604; Moloney DJ, 2000, NATURE, V406, P369, DOI 10.1038/35019000; Moore SA, 2002, NATURE, V418, P422, DOI 10.1038/nature00838; Mourad R, 2001, EUR J BIOCHEM, V268, P1990, DOI 10.1046/j.1432-1327.2001.02071.x; Muller R, 2005, FEBS J, V272, P4295, DOI 10.1111/j.1742-4658.2005.04838.x; North SJ, 2006, GLYCOCONJUGATE J, V23, P345, DOI 10.1007/s10719-006-6693-4; Okajima T, 2003, J BIOL CHEM, V278, P42340, DOI 10.1074/jbc.M308687200; Okajima T, 2002, CELL, V111, P893, DOI 10.1016/S0092-8674(02)01114-5; Okajima T, 2008, BMC BIOL, V6, DOI 10.1186/1741-7007-6-1; Overgaard J, 2008, J INSECT PHYSIOL, V54, P619, DOI 10.1016/j.jinsphys.2007.12.011; Panin VM, 2002, J BIOL CHEM, V277, P29945, DOI 10.1074/jbc.M204445200; Prien JM, 2008, GLYCOBIOLOGY, V18, P353, DOI 10.1093/glycob/cwn010; Rosen SD, 2004, ANNU REV IMMUNOL, V22, P129, DOI 10.1146/annurev.immunol.21.090501.080131; SAITO M, 1979, J BIOL CHEM, V254, P7845; SCHACHTER H, 1986, BIOCHEM CELL BIOL, V64, P163, DOI 10.1139/o86-026; Schwientek T, 2007, PROTEOMICS, V7, P3264, DOI 10.1002/pmic.200600793; Seppo A, 2000, EUR J BIOCHEM, V267, P3549, DOI 10.1046/j.1432-1327.2000.01383.x; Shao L, 2002, GLYCOBIOLOGY, V12, P763, DOI 10.1093/glycob/cwf085; Snapp KR, 2001, BLOOD, V97, P3806, DOI 10.1182/blood.V97.12.3806; Stanley P, 2007, CURR OPIN STRUC BIOL, V17, P530, DOI 10.1016/j.sbi.2007.09.007; SUGITA M, 1989, J BIOL CHEM, V264, P15028; TAKAHASHI N, 1995, ANAL BIOCHEM, V226, P139, DOI 10.1006/abio.1995.1201; Ten Hagen KG, 2002, J BIOL CHEM, V277, P22616, DOI 10.1074/jbc.M201807200; Ten Hagen KG, 2003, J BIOL CHEM, V278, P35039, DOI 10.1074/jbc.M303836200; TENHAGEN KG, 2003, GLYCOBIOLOGY, V13, P1; Theopold U, 2001, INSECT BIOCHEM MOLEC, V31, P189, DOI 10.1016/S0965-1748(00)00117-X; Thomas GB, 2007, DEVELOPMENT, V134, P591, DOI 10.1242/dev.02754; THOMSEN DR, 1990, J CELL BIOCHEM, V43, P67, DOI 10.1002/jcb.240430107; Tian E, 2007, GLYCOBIOLOGY, V17, P820, DOI 10.1093/glycob/cwm056; Tian E, 2007, J BIOL CHEM, V282, P606, DOI 10.1074/jbc.M606268200; Tian E, 2006, GLYCOBIOLOGY, V16, P83, DOI 10.1093/glycob/cwj051; UttenweilerJoseph S, 1997, ANAL BIOCHEM, V247, P366, DOI 10.1006/abio.1997.2083; Van den Steen P, 1998, CRIT REV BIOCHEM MOL, V33, P151; Walters JW, 2006, DEV BIOL, V297, P323, DOI 10.1016/j.ydbio.2006.04.454; Weitzhandler M, 1996, ANAL BIOCHEM, V241, P128, DOI 10.1006/abio.1996.0386; White SJ, 2001, J IMMUNOL, V167, P628, DOI 10.4049/jimmunol.167.2.628; WIEGANDT H, 1992, BIOCHIM BIOPHYS ACTA, V1123, P117, DOI 10.1016/0005-2760(92)90101-Z; Wilson IBH, 2002, J BIOL CHEM, V277, P21207, DOI 10.1074/jbc.M201634200; WOODS RJ, 1995, J PHYS CHEM-US, V99, P3832, DOI 10.1021/j100011a061; Xu AG, 2007, J BIOL CHEM, V282, P35153, DOI 10.1074/jbc.M707040200; Zhao DB, 2000, J CELL SCI, V113, P3781	96	100	101	4	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 31	2008	283	44					30385	30400		10.1074/jbc.M804925200	http://dx.doi.org/10.1074/jbc.M804925200			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	364WS	18725413	Green Published, hybrid			2022-12-27	WOS:000260366900082
J	Pincetic, A; Medina, G; Carter, C; Leis, J				Pincetic, Andrew; Medina, Gisselle; Carter, Carol; Leis, Jonathan			Avian Sarcoma Virus and Human Immunodeficiency Virus, Type 1 Use Different Subsets of ESCRT Proteins to Facilitate the Budding Process	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MULTIVESICULAR ENDOSOMES; PARTICLE RELEASE; ASSEMBLY DOMAIN; SORTING PATHWAY; GAG PROTEIN; HIV-1 GAG; UBIQUITIN; TSG101; COMPLEX; TRAFFICKING	Members of the Nedd4 family of E3 ubiquitin ligases bind the L domain in avian sarcoma virus (ASV) Gag and facilitate viral particle release. Translational fusion of ASV Gag with an L domain deletion (Delta p2b) to proteins that comprise ESCRT-I, -II, and -III (the endocytic sorting complexes required for transport) rescued both Gag ubiquitination and particle release from cells. The ESCRT-I factors Vps37C or Tsg101 were more effective in rescue of Gag/Delta p2b budding than the ESCRT-II factor Eap20 or the ESCRT-III component CHMP6. Thus ESCRT components can substitute for Nedd4 family members in ASV Gag release. Unlike wild type, ASV Gag/Delta p2b-ESCRT chimeras failed to co-immunoprecipitate with co-expressed hemagglutinin-tagged Nedd4, indicating that Nedd4 was not stably associated with these Gag fusions. Release of the Gag-ESCRT-I or -II fusions was inhibited by a dominant negative mutant of Vps4 ATPase similar to wild type ASV Gag. In contrast to ASV Gag, HIV-1 Gag containing an L domain inactivating mutation (P7L) was efficiently rescued by fusion to a component of ESCRT-III (Chmp6) but not ESCRT-II (Eap20). Depletion of the endogenous pool of Eap20 (ESCRT-II) had little effect on HIV-1 Gag release but blocked ASV Gag release. In contrast, depletion of the endogenous pool of Vps37C (ESCRT-I) had little effect on ASV but blocked HIV-1 Gag release. Furthermore, an N-terminal fragment of Chmp6 inhibited both HIV-1 and ASV Gag release in a dominant negative manner. Taken together, these results indicate that ASV and HIV-1 Gag utilize different combinations of ESCRT proteins to facilitate the budding process, although they share some common elements.	[Pincetic, Andrew; Leis, Jonathan] Northwestern Univ, Feinberg Sch Med, Dept Microbiol & Immunol, Chicago, IL 60611 USA; [Medina, Gisselle; Carter, Carol] SUNY Stony Brook, Dept Mol Genet & Microbiol, Stony Brook, NY 11794 USA	Northwestern University; Feinberg School of Medicine; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Leis, J (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Microbiol & Immunol, 303 E Chicago Ave, Chicago, IL 60611 USA.	j-leis@northwestern.edu	Medina, Gisselle N/AAO-3560-2021; Medina, Gisselle N/ACU-5726-2022		National Institutes of Health Predoctoral Training [5T32 CA-09176]; United States Public Health Service [AI054143, AI68463]; Training Program in Viral Replication [T32 AI060523]; W. Burghardt Turner Pre- doctoral Fellowship; Stony Brook University [35583]; NATIONAL CANCER INSTITUTE [T32CA009176] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI068463, R56AI054143, R01AI068463, T32AI060523] Funding Source: NIH RePORTER	National Institutes of Health Predoctoral Training(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); Training Program in Viral Replication; W. Burghardt Turner Pre- doctoral Fellowship; Stony Brook University; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Predoctoral Training Grant 5T32 CA-09176. This work was also supported by United States Public Health Service Grants AI054143 (to J. L.) and AI68463 (to C. C.). 1 Supported in part by the Training Program in Viral Replication T32 AI060523. 2 Supported in part by a W. Burghardt Turner Pre- doctoral Fellowship and by Grant 35583 from the National Science Foundation-Human Resource Development-funded SUNY AGEP Program at Stony Brook University.	Agromayor M, 2006, J BIOL CHEM, V281, P23083, DOI 10.1074/jbc.M513803200; Babst M, 2005, TRAFFIC, V6, P2, DOI 10.1111/j.1600-0854.2004.00246.x; Booth AM, 2006, J CELL BIOL, V172, P923, DOI 10.1083/jcb.200508014; Bowers K, 2006, J BIOL CHEM, V281, P5094, DOI 10.1074/jbc.M508632200; Chung HY, 2008, J VIROL, V82, P4884, DOI 10.1128/JVI.02667-07; Eastman SW, 2005, J BIOL CHEM, V280, P628, DOI 10.1074/jbc.M410384200; Garrus JE, 2001, CELL, V107, P55, DOI 10.1016/S0092-8674(01)00506-2; Goff A, 2003, J VIROL, V77, P9173, DOI 10.1128/JVI.77.17.9173-9182.2003; GOTTLINGER HG, 1991, P NATL ACAD SCI USA, V88, P3195, DOI 10.1073/pnas.88.8.3195; Gottwein E, 2006, J VIROL, V80, P6267, DOI 10.1128/JVI.02177-05; Gruenberg J, 2004, NAT REV MOL CELL BIO, V5, P317, DOI 10.1038/nrm1360; Hurley JH, 2006, ANNU REV BIOPH BIOM, V35, P277, DOI 10.1146/annurev.biophys.35.040405.102126; Kikonyogo A, 2001, P NATL ACAD SCI USA, V98, P11199, DOI 10.1073/pnas.201268998; Kyuuma M, 2006, CELL STRUCT FUNCT, V31, P159, DOI 10.1247/csf.06023; Langelier C, 2006, J VIROL, V80, P9465, DOI 10.1128/JVI.01049-06; Martin-Serrano J, 2005, J CELL BIOL, V168, P89, DOI 10.1083/jcb.200408155; Martin-Serrano J, 2004, J VIROL, V78, P5554, DOI 10.1128/JVI.78.11.5554-5563.2004; Martin-Serrano J, 2003, J VIROL, V77, P4794, DOI 10.1128/JVI.77.8.4794-4804.2003; McCullough J, 2006, CURR BIOL, V16, P160, DOI 10.1016/j.cub.2005.11.073; McDonald B, 2008, MOL BIOL CELL, V19, P754, DOI 10.1091/mbc.E07-09-0957; Medina G, 2005, TRAFFIC, V6, P880, DOI 10.1111/j.1600-0854.2005.00323.x; Medina G, 2008, VIROLOGY, V377, P30, DOI 10.1016/j.virol.2008.04.024; Ott DE, 1998, J VIROL, V72, P2962, DOI 10.1128/JVI.72.4.2962-2968.1998; Ott DE, 2000, VIROLOGY, V278, P111, DOI 10.1006/viro.2000.0648; PARENT LJ, 1995, J VIROL, V69, P5455, DOI 10.1128/JVI.69.9.5455-5460.1995; Patnaik A, 2000, P NATL ACAD SCI USA, V97, P13069, DOI 10.1073/pnas.97.24.13069; Perlman M, 2006, TRAFFIC, V7, P731, DOI 10.1111/j.1398-9219.2006.00428.x; Pornillos O, 2003, J CELL BIOL, V162, P425, DOI 10.1083/jcb.200302138; PUTTERMAN D, 1990, VIROLOGY, V176, P633, DOI 10.1016/0042-6822(90)90035-P; Raiborg C, 2003, CURR OPIN CELL BIOL, V15, P446, DOI 10.1016/S0955-0674(03)00080-2; Russell MRG, 2006, CURR OPIN CELL BIOL, V18, P422, DOI 10.1016/j.ceb.2006.06.002; Schubert U, 2000, P NATL ACAD SCI USA, V97, P13057, DOI 10.1073/pnas.97.24.13057; Shehu-Xhilaga M, 2004, J VIROL, V78, P724, DOI 10.1128/JVI.78.2.724-732.2004; Shim S, 2007, TRAFFIC, V8, P1068, DOI 10.1111/j.1600-0854.2007.00584.x; Spidel JL, 2004, J VIROL, V78, P10606, DOI 10.1128/JVI.78.19.10606-10616.2004; Strack B, 2003, CELL, V114, P689, DOI 10.1016/S0092-8674(03)00653-6; Stuchell MD, 2004, J BIOL CHEM, V279, P36059, DOI 10.1074/jbc.M405226200; Umebayashi K, 2003, CELL STRUCT FUNCT, V28, P443, DOI 10.1247/csf.28.443; Usami Y, 2008, J VIROL, V82, P4898, DOI 10.1128/JVI.02675-07; Vana ML, 2004, J VIROL, V78, P13943, DOI 10.1128/JVI.78.24.13943-13953.2004; VerPlank L, 2001, P NATL ACAD SCI USA, V98, P7724, DOI 10.1073/pnas.131059198; von Schwedler UK, 2003, CELL, V114, P701, DOI 10.1016/S0092-8674(03)00714-1; WILLS JW, 1994, J VIROL, V68, P6605, DOI 10.1128/JVI.68.10.6605-6618.1994; Xiang Y, 1996, J VIROL, V70, P5695, DOI 10.1128/JVI.70.8.5695-5700.1996	44	40	41	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 31	2008	283	44					29822	29830		10.1074/jbc.M804157200	http://dx.doi.org/10.1074/jbc.M804157200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	364WS	18723511	hybrid, Green Published			2022-12-27	WOS:000260366900026
J	Surucu, B; Bozulic, L; Hynx, D; Parcellier, A; Hemmings, BA				Surucu, Banu; Bozulic, Lana; Hynx, Debby; Parcellier, Arnaud; Hemmings, Brian A.			In Vivo Analysis of Protein Kinase B (PKB)/Akt Regulation in DNA-PKcs-null Mice Reveals a Role for PKB/Akt in DNA Damage Response and Tumorigenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FOXO TRANSCRIPTION FACTORS; GLUCOSE-HOMEOSTASIS; INSULIN-RESISTANCE; CATALYTIC SUBUNIT; CANCER CELLS; ACTIVATION; AKT; GROWTH; PATHWAY; MTOR	Full activation of protein kinase B (PKB/Akt) requires phosphorylation on Thr-308 and Ser-473. It is well established that Thr-308 is phosphorylated by 3-phosphoinositide-dependent kinase-1 (PDK1). Ser-473 phosphorylation is mediated by both mammalian target of rapamycin-rictor complex (mTORC2) and DNA-dependent protein kinase (DNA-PK) depending on type of stimulus. However, the physiological role of DNA-PK in the regulation of PKB phosphorylation remains to be established. To address this, we analyzed basal, insulin-induced, and DNA damage-induced PKB Ser-473 phosphorylation in DNA-PK catalytic subunit-null DNA-PKcs(-/-) mice. Our results revealed that DNA-PK is required for DNA damage-induced phosphorylation but dispensable for insulin-and growth factor-induced PKB Ser-473 phosphorylation. Moreover, DNA-PKcs(-/-) mice showed a tissue- specific increase in basal PKB phosphorylation. In particular, persistent PKB hyperactivity in the thymus apparently contributed to spontaneous lymphomagenesis in DNAPKcs(-/-) mice. Significantly, these tumors could be prevented by deletion of PKB alpha. These findings reveal stimulus-specific regulation of PKB activation by specific upstream kinases and provide genetic evidence of PKB deregulation in DNA-PKcs(-/-) mice.	[Surucu, Banu; Bozulic, Lana; Hynx, Debby; Parcellier, Arnaud; Hemmings, Brian A.] Friedrich Miescher Inst Biomed Res, CH-4058 Basel, Switzerland	Friedrich Miescher Institute for Biomedical Research	Hemmings, BA (corresponding author), Friedrich Miescher Inst Biomed Res, Maulbeerstr 66, CH-4058 Basel, Switzerland.	brian.hemmings@fmi.ch			Oncosuisse [OCS-01667-02-2005]; Novartis Research Foundation	Oncosuisse; Novartis Research Foundation	This work was supported in part by Oncosuisse Grant OCS-01667-02-2005. Friedrich Miescher Institute is part of the Novartis Research Foundation. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Anderson CM, 2008, GENE DEV, V22, P854, DOI 10.1101/gad.1646208; Andjelkovic M, 1997, J BIOL CHEM, V272, P31515, DOI 10.1074/jbc.272.50.31515; Aster JC, 2008, ANNU REV PATHOL-MECH, V3, P587, DOI 10.1146/annurev.pathmechdis.3.121806.154300; Barata JT, 2001, BLOOD, V98, P1524, DOI 10.1182/blood.V98.5.1524; Belyanskaya LL, 2005, INT J CANCER, V117, P755, DOI 10.1002/ijc.21242; Boehme KA, 2008, P NATL ACAD SCI USA, V105, P7785, DOI 10.1073/pnas.0703423105; Bouchard C, 2007, GENE DEV, V21, P2775, DOI 10.1101/gad.453107; Bozulic L, 2008, MOL CELL, V30, P203, DOI 10.1016/j.molcel.2008.02.024; Brazil DP, 2001, TRENDS BIOCHEM SCI, V26, P657, DOI 10.1016/S0968-0004(01)01958-2; Burma S, 2004, DNA REPAIR, V3, P909, DOI 10.1016/j.dnarep.2004.03.021; Chan SM, 2007, BLOOD, V110, P278, DOI 10.1182/blood-2006-08-039883; Chang M, 2008, SCIENCE, V320, P60, DOI 10.1126/science.1155132; Chen WS, 2001, GENE DEV, V15, P2203, DOI 10.1101/gad.913901; Cho H, 2001, J BIOL CHEM, V276, P38349, DOI 10.1074/jbc.C100462200; Cho H, 2001, SCIENCE, V292, P1728, DOI 10.1126/science.292.5522.1728; Dragoi AM, 2005, EMBO J, V24, P779, DOI 10.1038/sj.emboj.7600539; Dummler B, 2006, MOL CELL BIOL, V26, P8042, DOI 10.1128/MCB.00722-06; Easton RM, 2005, MOL CELL BIOL, V25, P1869, DOI 10.1128/MCB.25.5.1869-1878.2005; Espejel S, 2004, EMBO REP, V5, P503, DOI 10.1038/sj.embor.7400127; Fayard E, 2005, J CELL SCI, V118, P5675, DOI 10.1242/jcs.02724; Fayard E, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000992; Feng JH, 2004, J BIOL CHEM, V279, P41189, DOI 10.1074/jbc.M406731200; Feng JH, 2004, J BIOL CHEM, V279, P35510, DOI 10.1074/jbc.M404936200; Gao YJ, 1998, IMMUNITY, V9, P367, DOI 10.1016/S1074-7613(00)80619-6; Garofalo RS, 2003, J CLIN INVEST, V112, P197, DOI 10.1172/JCI200316885; Greer EL, 2005, ONCOGENE, V24, P7410, DOI 10.1038/sj.onc.1209086; Guertin DA, 2006, DEV CELL, V11, P859, DOI 10.1016/j.devcel.2006.10.007; Hambardzumyan D, 2008, GENE DEV, V22, P436, DOI 10.1101/gad.1627008; Harrington LS, 2004, J CELL BIOL, V166, P213, DOI 10.1083/jcb.200403069; Huang JX, 2008, MOL CELL BIOL, V28, P4104, DOI 10.1128/MCB.00289-08; Jones RG, 2000, J EXP MED, V191, P1721, DOI 10.1084/jem.191.10.1721; Juntilla MA, 2008, IMMUNOL LETT, V116, P104, DOI 10.1016/j.imlet.2007.12.008; Juntilla MM, 2007, P NATL ACAD SCI USA, V104, P12105, DOI 10.1073/pnas.0705285104; Kanoh J, 2007, GENES CELLS, V12, P1301, DOI 10.1111/j.1365-2443.2007.01142.x; Kim MS, 2006, PHOTOCHEM PHOTOBIOL, V82, P645, DOI 10.1562/2005-09-29-RA-702; Kurimasa A, 1999, P NATL ACAD SCI USA, V96, P1403, DOI 10.1073/pnas.96.4.1403; Li XQ, 2005, BREAST CANCER RES, V7, pR589, DOI 10.1186/bcr1259; LUPERTZ R, 2008, CARCINOGENESIS  0806, DOI DOI 10.1093/CARCIN/BGN184; Malstrom S, 2001, P NATL ACAD SCI USA, V98, P14967, DOI 10.1073/pnas.231467698; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Mao CC, 2007, J IMMUNOL, V178, P5443, DOI 10.4049/jimmunol.178.9.5443; Masri J, 2007, CANCER RES, V67, P11712, DOI 10.1158/0008-5472.CAN-07-2223; Mitsiades CS, 2004, CURR CANCER DRUG TAR, V4, P235, DOI 10.2174/1568009043333032; Nutley BP, 2005, BRIT J CANCER, V93, P1011, DOI 10.1038/sj.bjc.6602823; Paik JH, 2007, CELL, V128, P309, DOI 10.1016/j.cell.2006.12.029; Pallard C, 1999, IMMUNITY, V10, P525, DOI 10.1016/S1074-7613(00)80052-7; Palomero T, 2007, NAT MED, V13, P1203, DOI 10.1038/nm1636; Parcellier A, 2008, CELL SIGNAL, V20, P21, DOI 10.1016/j.cellsig.2007.07.010; Rathmell JC, 2003, EUR J IMMUNOL, V33, P2223, DOI 10.1002/eji.200324048; Sarbassov DD, 2006, MOL CELL, V22, P159, DOI 10.1016/j.molcel.2006.03.029; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Sarbassov DD, 2004, CURR BIOL, V14, P1296, DOI 10.1016/j.cub.2004.06.054; Scheid MP, 2002, MOL CELL BIOL, V22, P6247, DOI 10.1128/MCB.22.17.6247-6260.2002; Shah OJ, 2004, CURR BIOL, V14, P1650, DOI 10.1016/j.cub.2004.08.026; Shiota C, 2006, DEV CELL, V11, P583, DOI 10.1016/j.devcel.2006.08.013; Smith GCM, 1999, GENE DEV, V13, P916, DOI 10.1101/gad.13.8.916; Taccioli GE, 1998, IMMUNITY, V9, P355, DOI 10.1016/S1074-7613(00)80618-4; Takai H, 2007, CELL, V131, P1248, DOI 10.1016/j.cell.2007.10.052; Tamburini J, 2008, BLOOD, V111, P379, DOI 10.1182/blood-2007-03-080796; Taniyama Y, 2002, J MOL CELL CARDIOL, V34, P1241, DOI 10.1006/jmcc.2002.2068; Tothova Z, 2007, CELL, V128, P325, DOI 10.1016/j.cell.2007.01.003; Tschopp O, 2005, DEVELOPMENT, V132, P2943, DOI 10.1242/dev.01864; Tsuji H, 2004, CANCER RES, V64, P8882, DOI 10.1158/0008-5472.CAN-03-1163; Tsuji H, 2003, CARCINOGENESIS, V24, P1257, DOI 10.1093/carcin/bgg071; Um SH, 2004, NATURE, V431, P200, DOI 10.1038/nature02866; van der Horst A, 2007, NAT REV MOL CELL BIO, V8, P440, DOI 10.1038/nrm2190; van Slegtenhorst M, 1998, HUM MOL GENET, V7, P1053, DOI 10.1093/hmg/7.6.1053; Vella A, 1997, J EXP MED, V186, P325, DOI 10.1084/jem.186.2.325; Viniegra JG, 2005, J BIOL CHEM, V280, P4029, DOI 10.1074/jbc.M410344200; Whiteman EL, 2002, TRENDS ENDOCRIN MET, V13, P444, DOI 10.1016/S1043-2760(02)00662-8; Winograd-Katz SE, 2006, ONCOGENE, V25, P7381, DOI 10.1038/sj.onc.1209737; Yang Q, 2006, GENE DEV, V20, P2820, DOI 10.1101/gad.1461206; Yang X, 2008, BRIT J CANCER, V98, P803, DOI 10.1038/sj.bjc.6604223; Yang ZZ, 2003, J BIOL CHEM, V278, P32124, DOI 10.1074/jbc.M302847200; Yang ZZ, 2004, BIOCHEM SOC T, V32, P350, DOI 10.1042/BST0320350; Yu HG, 2008, INT J CANCER, V122, P433, DOI 10.1002/ijc.23049; Zeng ZH, 2007, BLOOD, V109, P3509, DOI 10.1182/blood-2006-06-030833; Zhao Y, 2006, CANCER RES, V66, P5354, DOI 10.1158/0008-5472.CAN-05-4275	78	62	64	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 31	2008	283	44					30025	30033		10.1074/jbc.M803053200	http://dx.doi.org/10.1074/jbc.M803053200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	364WS	18757368	Green Published, hybrid			2022-12-27	WOS:000260366900047
J	Chudakova, DA; Zeidan, YH; Wheeler, BW; Yu, J; Novgorodov, SA; Kindy, MS; Hannun, YA; Gudz, TI				Chudakova, Daria A.; Zeidan, Youssef H.; Wheeler, Brian W.; Yu, Jin; Novgorodov, Sergei A.; Kindy, Mark S.; Hannun, Yusuf A.; Gudz, Tatyana I.			Integrin-associated Lyn Kinase Promotes Cell Survival by Suppressing Acid Sphingomyelinase Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SRC FAMILY KINASES; OLIGODENDROCYTE PROGENITOR MIGRATION; CYTOPLASMIC DOMAIN; CEREBRAL-ISCHEMIA; TYROSINE KINASES; SALVAGE PATHWAY; FACTOR RECEPTOR; BRAIN-INJURY; C-DELTA; CERAMIDE	Integrins govern cellular adhesion and transmit signals leading to activation of intracellular signaling pathways aimed to prevent apoptosis. Herein we report that attachment of oligodendrocytes (OLs) to fibronectin via alpha(v)beta(3) integrin receptors rendered the cells more resistant to apoptosis than the cells attached to laminin via alpha(6)beta(1) integrins. Investigation of molecular mechanisms involved in alpha(v)beta(3) integrin-mediated cell survival revealed that ligation of the integrin with fibronectin results in higher expression of activated Lyn kinase. Both in OLs and in the mouse brain, Lyn selectively associates with alpha(v)beta(3) integrin, not with alpha(v)beta(5) integrin, leading to suppression of acid sphingomyelinase activity and preventing ceramide-mediated apoptosis. In OLs, knockdown of Lyn with small interfering RNA resulted in OL apoptosis with concomitant accumulation of C-16-ceramide due to activation of acid sphingomyelinase (ASMase) and sphingomyelin hydrolysis. Knocking down ASMase partially protected OLs from apoptosis. In the brain, ischemia/reperfusion (IR) triggered rearrangements in the alpha(v)beta(3) integrin-Lyn kinase complex leading to disruption of Lyn kinase-mediated suppression of ASMase activity. Thus, co-immunoprecipitation studies revealed an increased association of alpha(v)beta(3) integrin-Lyn kinase complex with ionotropic glutamate receptor subunits, GluR2 and GluR4, after cerebral IR. Sphingolipid analysis of the brain demonstrated significant accumulation of ceramide and sphingomyelin hydrolysis. The data suggest a novel mechanism for regulation of ASMase activity during cell adhesion in which Lyn acts as a key upstream kinase that may play a critical role in cerebral IR injury.	[Chudakova, Daria A.; Wheeler, Brian W.; Yu, Jin; Kindy, Mark S.; Gudz, Tatyana I.] Med Univ S Carolina, Dept Neurosci, Charleston, SC 29425 USA; [Kindy, Mark S.; Gudz, Tatyana I.] Ralph H Johnson Vet Affairs Med Ctr, Charleston, SC 29401 USA; [Novgorodov, Sergei A.] Med Univ S Carolina, Dept Med, Charleston, SC 29425 USA; [Zeidan, Youssef H.; Novgorodov, Sergei A.; Hannun, Yusuf A.] Med Univ S Carolina, Dept Biochem & Mol Biol, Charleston, SC 29425 USA	Medical University of South Carolina; US Department of Veterans Affairs; Veterans Health Administration (VHA); Ralph H Johnson VA Medical Center; Medical University of South Carolina; Medical University of South Carolina	Gudz, TI (corresponding author), Med Univ S Carolina, Dept Neurosci, 114 Doughty St, Charleston, SC 29425 USA.	gudz@musc.edu	Chudakova, Daria/ABB-3032-2020; Zeidan, Youssef H./H-7578-2019	Zeidan, Youssef H./0000-0002-1951-8585	National Institutes of Health/NCCR COBRE in Lipidomics and Pathobiology [P20 RR 17677-04]; National Institutes of Health [P01-CA97132, AG16583]; National Science Foundation EPSCOR [EPS0132573]; Veterans Affairs Merit Awards; NATIONAL CANCER INSTITUTE [P01CA097132] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR017677] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG016583] Funding Source: NIH RePORTER	National Institutes of Health/NCCR COBRE in Lipidomics and Pathobiology(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation EPSCOR(National Science Foundation (NSF)); Veterans Affairs Merit Awards(US Department of Veterans Affairs); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health/NCCR COBRE in Lipidomics and Pathobiology Grant P20 RR 17677-04 (to T. I. G.) and National Institutes of Health Grant P01-CA97132 (to Y.A.H.). This work was also supported by National Science Foundation EPSCOR Grant EPS0132573 (to M. S. K.), and Veterans Affairs Merit Awards (to T. I. G. and M. S. K.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.; Supported by National Institutes of Health Grant AG16583.	Arias-Salgado EG, 2003, P NATL ACAD SCI USA, V100, P13298, DOI 10.1073/pnas.2336149100; Baron W, 2005, GLIA, V49, P467, DOI 10.1002/glia.20132; Bates RC, 2001, CANCER RES, V61, P5275; Becker KP, 2005, J BIOL CHEM, V280, P2606, DOI 10.1074/jbc.M409066200; Bielawski J, 2006, METHODS, V39, P82, DOI 10.1016/j.ymeth.2006.05.004; Blake RA, 2000, MOL CELL BIOL, V20, P9018, DOI 10.1128/MCB.20.23.9018-9027.2000; Blaschuk KL, 2000, DEVELOPMENT, V127, P1961; Boggon TJ, 2004, ONCOGENE, V23, P7918, DOI 10.1038/sj.onc.1208081; BROOKS PC, 1994, CELL, V79, P1157, DOI 10.1016/0092-8674(94)90007-8; Colognato H, 2002, NAT CELL BIOL, V4, P833, DOI 10.1038/ncb865; Colombaioni L, 2004, BRAIN RES REV, V46, P328, DOI 10.1016/j.brainresrev.2004.07.014; Cui QL, 2006, NEUROCHEM INT, V48, P383, DOI 10.1016/j.neuint.2005.11.014; Eliceiri BP, 2001, CIRC RES, V89, P1104, DOI 10.1161/hh2401.101084; Erdreich-Epstein A, 2005, BLOOD, V105, P4353, DOI 10.1182/blood-2004-08-3098; Ferlinz K, 1999, CHEM PHYS LIPIDS, V102, P35, DOI 10.1016/S0009-3084(99)00073-0; Frisch SM, 1997, CURR OPIN CELL BIOL, V9, P701, DOI 10.1016/S0955-0674(97)80124-X; Gary DS, 1998, J CEREBR BLOOD F MET, V18, P1283, DOI 10.1097/00004647-199812000-00001; Giancotti FG, 2003, ANNU REV CELL DEV BI, V19, P173, DOI 10.1146/annurev.cellbio.19.031103.133334; Gilmore AP, 2005, CELL DEATH DIFFER, V12, P1473, DOI 10.1038/sj.cdd.4401723; Ginsberg MH, 2005, CURR OPIN CELL BIOL, V17, P509, DOI 10.1016/j.ceb.2005.08.010; Grazide S, 2002, FASEB J, V16, P1685, DOI 10.1096/fj.01-0794fje; Green DR, 2000, CELL, V102, P1, DOI 10.1016/S0092-8674(00)00003-9; Grishin AV, 2001, P NATL ACAD SCI USA, V98, P10172, DOI 10.1073/pnas.191130798; Gudz TI, 2006, J NEUROSCI, V26, P2458, DOI 10.1523/JNEUROSCI.4054-05.2006; Gudz TI, 2002, J NEUROSCI, V22, P7398; GURRATH M, 1992, EUR J BIOCHEM, V210, P911, DOI 10.1111/j.1432-1033.1992.tb17495.x; Hannun YA, 2008, NAT REV MOL CELL BIO, V9, P139, DOI 10.1038/nrm2329; Herr I, 1999, BRAIN RES, V826, P210, DOI 10.1016/S0006-8993(99)01288-3; Itoh T, 2002, J NEUROCHEM, V81, P390, DOI 10.1046/j.1471-4159.2002.00866.x; Joseloff E, 2002, J BIOL CHEM, V277, P12318, DOI 10.1074/jbc.M111618200; Kabuyama Y, 2002, EUR J BIOCHEM, V269, P664, DOI 10.1046/j.0014-2956.2001.02698.x; Katagiri K, 1996, J BIOL CHEM, V271, P11557, DOI 10.1074/jbc.271.19.11557; Kitatani K, 2008, CELL SIGNAL, V20, P1010, DOI 10.1016/j.cellsig.2007.12.006; Kolesnick RN, 1998, ANNU REV PHYSIOL, V60, P643, DOI 10.1146/annurev.physiol.60.1.643; Kubota M, 1996, NEUROL RES, V18, P337; Liang XQ, 2004, J NEUROSCI, V24, P7140, DOI 10.1523/JNEUROSCI.5319-03.2004; Liu HN, 2002, J NEUROCHEM, V82, P398, DOI 10.1046/j.1471-4159.2002.00981.x; Liu SC, 2000, J CELL SCI, V113, P3563; Marchesini N, 2004, BIOCHEM CELL BIOL, V82, P27, DOI 10.1139/o03-091; MILNER R, 1994, DEVELOPMENT, V120, P3497; Muller PY, 2002, BIOTECHNIQUES, V32, P1372; Nakane M, 2000, NEUROSCI LETT, V296, P89, DOI 10.1016/S0304-3940(00)01655-4; Nicholls DG, 1999, ANN NY ACAD SCI, V893, P1, DOI 10.1111/j.1749-6632.1999.tb07813.x; Novgorodov AS, 2007, FASEB J, V21, P1503, DOI 10.1096/fj.06-7420com; Pace A, 2006, BBA-MOL CELL RES, V1763, P356, DOI 10.1016/j.bbamcr.2006.03.004; Pewzner-Jung Y, 2006, J BIOL CHEM, V281, P25001, DOI 10.1074/jbc.R600010200; Plow EF, 2000, J BIOL CHEM, V275, P21785, DOI 10.1074/jbc.R000003200; Qin SF, 1998, FEBS LETT, V427, P139, DOI 10.1016/S0014-5793(98)00383-4; Rao RV, 2004, CELL DEATH DIFFER, V11, P372, DOI 10.1038/sj.cdd.4401378; Ron D, 1999, FASEB J, V13, P1658, DOI 10.1096/fasebj.13.13.1658; Sakai T, 2001, NAT MED, V7, P324, DOI 10.1038/85471; Sanchez-Gomez MV, 2003, J NEUROSCI, V23, P9519; Stupack DG, 2001, J CELL BIOL, V155, P459, DOI 10.1083/jcb.200106070; Stupack DG, 2002, J CELL SCI, V115, P3729, DOI 10.1242/jcs.00071; Testai FD, 2004, J NEUROSCI RES, V75, P66, DOI 10.1002/jnr.10816; Thomas SM, 1997, ANNU REV CELL DEV BI, V13, P513, DOI 10.1146/annurev.cellbio.13.1.513; Umemori H, 1999, J NEUROSCI, V19, P1393; Yu J, 2007, J BIOL CHEM, V282, P25940, DOI 10.1074/jbc.M701812200; Yu ZF, 2000, J MOL NEUROSCI, V15, P85, DOI 10.1385/JMN:15:2:85; Zeidan YH, 2007, J BIOL CHEM, V282, P11549, DOI 10.1074/jbc.M609424200; Zeidan YH, 2006, J BIOL CHEM, V281, P24695, DOI 10.1074/jbc.M604713200; Zheng TS, 1999, CELL DEATH DIFFER, V6, P1043, DOI 10.1038/sj.cdd.4400593; Zheng W, 2006, BBA-BIOMEMBRANES, V1758, P1864, DOI 10.1016/j.bbamem.2006.08.009	63	36	38	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 24	2008	283	43					28806	28816		10.1074/jbc.M803301200	http://dx.doi.org/10.1074/jbc.M803301200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	362EB	18682390	Green Published, hybrid			2022-12-27	WOS:000260179900005
J	Matsunaga, I; Naka, T; Talekar, RS; McConnell, MJ; Katoh, K; Nakao, H; Otsuka, A; Behar, SM; Yano, I; Moody, DB; Sugita, M				Matsunaga, Isamu; Naka, Takashi; Talekar, Rahul S.; McConnell, Matthew J.; Katoh, Kumiko; Nakao, Hitomi; Otsuka, Atsushi; Behar, Samuel M.; Yano, Ikuya; Moody, D. Branch; Sugita, Masahiko			Mycolyltransferase-mediated Glycolipid Exchange in Mycobacteria	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							T-CELLS; LIPID ANTIGENS; TUBERCULOSIS; RECOGNITION; BIOSYNTHESIS; CARBOHYDRATE; INFECTION; RESPONSES; AVIUM; GENE	Trehalose dimycolate (TDM), also known as cord factor, is a major surface glycolipid of the cell wall of mycobacteria. Because of its potent biological functions in models of infection, adjuvancy, and immunotherapy, it is important to determine how its biosynthesis is regulated. Here we show that glucose, a host-derived product that is not readily available in the environment, causes Mycobacterium avium to down-regulate TDM expression while up-regulating production of another major glycolipid with immunological roles in T cell activation, glucose monomycolate (GMM). In vitro, the mechanism of reciprocal regulation of TDM and GMM involves competitive substrate selection by antigen 85A. The switch from TDM to GMM biosynthesis occurs near the physiological concentration of glucose present in mammalian hosts. We further demonstrate that GMM is produced in vivo by mycobacteria growing in mouse lung. These results establish an enzymatic pathway for GMM production. More generally, these observations provide a specific enzymatic mechanism for dynamic alterations of cell wall glycolipid remodeling in response to the transition from noncellular to cellular growth environments, including factors that are monitored by the host immune system.	[Matsunaga, Isamu; Katoh, Kumiko; Nakao, Hitomi; Otsuka, Atsushi; Sugita, Masahiko] Kyoto Univ, Inst Virus Res, Lab Cell Regulat, Kyoto 6068507, Japan; [Matsunaga, Isamu; Katoh, Kumiko; Nakao, Hitomi; Sugita, Masahiko] Kyoto Univ, Grad Sch Biostudies, Lab Cell Regulat & Mol Network, Kyoto 6068507, Japan; [Naka, Takashi; Yano, Ikuya] Japan BCG Lab, Tokyo 2040022, Japan; [Talekar, Rahul S.; McConnell, Matthew J.; Behar, Samuel M.; Moody, D. Branch] Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Rheumatol Allergy & Immunol, Boston, MA 02115 USA	Kyoto University; Kyoto University; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Sugita, M (corresponding author), 53 Kawahara Cho,Sakyo Ku, Kyoto 6068507, Japan.	msugita@virus.kyoto-u.ac.jp	Behar, Samuel M/C-3541-2009	Sugita, Masahiko/0000-0001-5511-1304; Behar, Samuel/0000-0002-3374-6699; Matsunaga, Isamu/0000-0001-9541-350X	National Institutes of Health (NIAID) [R01 07155]; Ministry of Education, Culture, Sports, Science and Technology; Ministry of Health, Labour, and Welfare Research on Emerging and Re-emerging Infectious Diseases; Burroughs Wellcome Fund	National Institutes of Health (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labour, and Welfare Research on Emerging and Re-emerging Infectious Diseases(Ministry of Health, Labour and Welfare, Japan); Burroughs Wellcome Fund(Burroughs Wellcome Fund)	This work was supported, in whole or in part, by National Institutes of Health Grant R01 07155 (NIAID) (to D. B. M.). This work was also supported by grants-in-aid from scientific research on priority areas from the Ministry of Education, Culture, Sports, Science and Technology (to M. S.), grants-in-aid for scientific research B (to M. S.) and C (to I. M.) from the Japan Society for the Promotion of Science, grants from the Ministry of Health, Labour, and Welfare Research on Emerging and Re-emerging Infectious Diseases (to M. S.), and by the Burroughs Wellcome Fund (to D. B. M.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Anderson DH, 2001, J MOL BIOL, V307, P671, DOI 10.1006/jmbi.2001.4461; Barry CE, 1998, PROG LIPID RES, V37, P143, DOI 10.1016/S0163-7827(98)00008-3; Belisle JT, 1997, SCIENCE, V276, P1420, DOI 10.1126/science.276.5317.1420; BRENNAN P, 1967, J BIOL CHEM, V242, P3046; Cheng TY, 2006, EMBO J, V25, P2989, DOI 10.1038/SJ.EMBOJ.7601185; Enomoto Y, 2005, BIOCHEM BIOPH RES CO, V337, P452, DOI 10.1016/j.bbrc.2005.09.070; Grant EP, 1999, J EXP MED, V189, P195, DOI 10.1084/jem.189.1.195; Hou JY, 2002, INFECT IMMUN, V70, P3714, DOI 10.1128/IAI.70.7.3714-3726.2002; Kremer L, 2002, LETT APPL MICROBIOL, V34, P233, DOI 10.1046/j.1472-765x.2002.01091.x; Mariani F, 2000, GENE, V253, P281, DOI 10.1016/S0378-1119(00)00249-3; Matsunaga I, 1996, J BIOCHEM-TOKYO, V120, P663; Matsunaga I, 2004, J EXP MED, V200, P1559, DOI 10.1084/jem.20041429; MATSUNAGA I, 1990, FEMS MICROBIOL LETT, V67, P49, DOI 10.1111/j.1574-6968.1990.tb13834.x; MATSUNAGA I, 2007, CURR IMMUNOL REV, V3, P145; Moody DB, 2000, J EXP MED, V192, P965, DOI 10.1084/jem.192.7.965; Moody DB, 1997, SCIENCE, V278, P283, DOI 10.1126/science.278.5336.283; NATSUHARA Y, 1990, CANCER IMMUNOL IMMUN, V31, P99, DOI 10.1007/BF01742373; OHARA N, 1993, INFECT IMMUN, V61, P1173, DOI 10.1128/IAI.61.4.1173-1179.1993; Primm TP, 2004, CLIN MICROBIOL REV, V17, P98, DOI 10.1128/CMR.17.1.98-106.2004; Ryll R, 2001, MICROBIOL IMMUNOL, V45, P801, DOI 10.1111/j.1348-0421.2001.tb01319.x; SATHYAMOORTHY N, 1987, J BIOL CHEM, V262, P13417; Sugita M, 1997, J IMMUNOL, V159, P2358; Ulrichs T, 2003, INFECT IMMUN, V71, P3076, DOI 10.1128/IAI.71.6.3076-3087.2003	23	41	43	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 24	2008	283	43					28835	28841		10.1074/jbc.M805776200	http://dx.doi.org/10.1074/jbc.M805776200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	362EB	18703502	hybrid, Green Published			2022-12-27	WOS:000260179900008
J	O'Donoghue, AJ; Mahon, CS; Goetz, DH; O'Malley, JM; Gallagher, DM; Zhou, M; Murray, PG; Craik, CS; Tuohy, MG				O'Donoghue, Anthony J.; Mahon, Cathal S.; Goetz, David H.; O'Malley, James M.; Gallagher, Denise M.; Zhou, Min; Murray, Patrick G.; Craik, Charles S.; Tuohy, Maria G.			Inhibition of a Secreted Glutamic Peptidase Prevents Growth of the Fungus Talaromyces emersonii	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ASPERGILLUS-NIGER; ASPERGILLOGLUTAMIC PEPTIDASE; SCYTALIDIUM-LIGNICOLUM; SCYTALIDOGLUTAMIC PEPTIDASE; CRYPHONECTRIA-PARASITICA; PENICILLIUM-MARNEFFEI; SUBSTRATE-SPECIFICITY; CATALYTIC MECHANISM; CARBOXYL PROTEINASE; ANTIFUNGAL PROTEINS	secretes a variety of hydrolytic enzymes that are of interest for processing of biomass into fuel. Many carbohydrases have been isolated and characterized from this fungus, but no studies had been performed on peptidases. In this study, two acid-acting endopeptidases were isolated and characterized from the culture filtrate of T. emersonii. One of these enzymes was identified as a member of the recently classified glutamic peptidase family and was subsequently named T. emersonii glutamic peptidase 1 (TGP1). The second enzyme was identified as an aspartyl peptidase (PEP1). TGP1 was cloned and sequenced and shown to exhibit 64 and 47% protein identity to peptidases from Aspergillus niger and Scytalidium ligno-colum, respectively. Substrate profiling of 16 peptides determined that TGP1 has broad specificity with a preference for large residues in the P1 site, particularly Met, Gln, Phe, Lys, Glu, and small amino acids at P1' such as Ala, Gly, Ser, or Thr. This enzyme efficiently cleaves an internally quenched fluorescent substrate containing the zymogen activation sequence (k(cat)/K-m = 2 x 10(5) M-1 s(-1)). Maximum hydrolysis occurs at pH 3.4 and 50 degrees C. The reaction is strongly inhibited by a transition state peptide analog, TA1 (K-i = 1.5 nM), as well as a portion of the propeptide sequence, PT1 (K-i = 32 nM). Ex vivo studies show that hyphal extension of T. emersonii in complex media is unaffected by the aspartyl peptidase inhibitor pepstatin but is inhibited by TA1 and PT1. This study provides insight into the functional role of the glutamic peptidase TGP1 for growth of T. emersonii.	[O'Donoghue, Anthony J.; Goetz, David H.; O'Malley, James M.; Zhou, Min; Craik, Charles S.] Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94158 USA; [O'Donoghue, Anthony J.; Mahon, Cathal S.; O'Malley, James M.; Gallagher, Denise M.; Murray, Patrick G.; Tuohy, Maria G.] Natl Univ Ireland, Dept Biochem, Galway, Ireland	University of California System; University of California San Francisco; Ollscoil na Gaillimhe-University of Galway	Craik, CS (corresponding author), Univ Calif San Francisco, Dept Pharmaceut Chem, Mail Code 2280,600th 16th St, San Francisco, CA 94158 USA.	craik@cgl.ucsf.edu		Murray, Patrick/0000-0001-6349-7761	National Institutes of Health [GM082250]; Irish Research Council for Science, Engineering, and Technology; Enterprise Ireland; County Cork Vocational Education Committee; National University of Ireland Galway; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM082250] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Irish Research Council for Science, Engineering, and Technology(Irish Research Council for Science, Engineering and Technology); Enterprise Ireland; County Cork Vocational Education Committee; National University of Ireland Galway; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM082250 (to C. S. C.). This work was also supported in part by Enterprise Ireland Research Innovation and Higher Education Authority pre-PRTLI, PRTLI awards (to M. G. T.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.; Recipient of post-graduate funding awards from Irish Research Council for Science, Engineering, and Technology, Enterprise Ireland, County Cork Vocational Education Committee, and National University of Ireland Galway and an education abroad program fellowship from National University of Ireland Galway.	Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Brown RS, 1997, INT J MASS SPECTROM, V169, P1, DOI 10.1016/S0168-1176(97)00217-6; BUROKERKILGORE M, 1993, ANAL BIOCHEM, V208, P387, DOI 10.1006/abio.1993.1066; Cooper J. B., 2004, HDB PROTEOLYTIC ENZY, P104; COPELAND RA, 1995, BIOORG MED CHEM LETT, V5, P1947, DOI 10.1016/0960-894X(95)00330-V; Dash C, 2001, ANTIMICROB AGENTS CH, V45, P2008, DOI 10.1128/AAC.45.7.2008-2017.2001; Fianchi L, 2004, MYCOSES, V47, P163, DOI 10.1111/j.1439-0507.2004.00960.x; Fujinaga M, 2004, P NATL ACAD SCI USA, V101, P3364, DOI 10.1073/pnas.0400246101; Grassick A, 2004, EUR J BIOCHEM, V271, P4495, DOI 10.1111/j.1432-1033.2004.04409.x; Heneghan MN, 2007, ENZYME MICROB TECH, V41, P677, DOI 10.1016/j.enzmictec.2007.05.014; HOFMANN T, 2004, HDB PROTEOLYTIC ENZY, P99; Huang XP, 2000, J BIOL CHEM, V275, P26607, DOI 10.1074/jbc.M910243199; ICHISHIMA E, 2004, HDB PROTEOLYTIC ENZY, P92; IIO K, 1976, BIOCHIM BIOPHYS ACTA, V429, P912, DOI 10.1016/0005-2744(76)90336-3; Jara P, 1996, MOL GEN GENET, V250, P97, DOI 10.1007/BF02191829; JARAI G, 1994, GENE, V145, P171, DOI 10.1016/0378-1119(94)90002-7; Kataoka Y, 2005, FEBS LETT, V579, P2991, DOI 10.1016/j.febslet.2005.04.050; Koiwa H, 1997, PLANT CELL PHYSIOL, V38, P783, DOI 10.1093/oxfordjournals.pcp.a029236; Kubota K, 2005, J BIOL CHEM, V280, P999, DOI 10.1074/jbc.M410852200; Lee BR, 2003, BIOCHEM J, V371, P541, DOI 10.1042/BJ20021691; LORITO M, 1994, MOL PLANT MICROBE IN, V7, P525, DOI 10.1094/MPMI-7-0525; Magnuson J.K., 2004, ADV FUNGAL BIOTECHNO, P307, DOI DOI 10.1007/978-1-4419-8859-1_12; Marzluf GA, 1997, MICROBIOL MOL BIOL R, V61, P17, DOI 10.1128/.61.1.17-32.1997; Moon JL, 2006, BIOL CHEM, V387, P985, DOI 10.1515/BC.2006.122; Murray PG, 2003, BIOCHEM BIOPH RES CO, V301, P280, DOI 10.1016/S0006-291X(02)03025-5; Murray PG, 2001, ENZYME MICROB TECH, V29, P90, DOI 10.1016/S0141-0229(01)00354-4; Nishii W, 2003, BIOCHEM BIOPH RES CO, V301, P1023, DOI 10.1016/S0006-291X(03)00083-4; ODA K, 1976, AGR BIOL CHEM TOKYO, V40, P1221, DOI 10.1080/00021369.1976.10862184; ODA K, 1987, BIOCHIM BIOPHYS ACTA, V923, P463, DOI 10.1016/0304-4165(87)90055-9; ODA K, 2004, HDB PROTEOLYTIC ENZY, P219; Oda N, 1998, BIOSCI BIOTECH BIOCH, V62, P1637, DOI 10.1271/bbb.62.1637; Pillai B, 2007, J MOL BIOL, V365, P343, DOI 10.1016/j.jmb.2006.09.058; Poussereau N, 2001, MICROBIOL-UK, V147, P717, DOI 10.1099/00221287-147-3-717; RAEDER U, 1985, LETT APPL MICROBIOL, V1, P17, DOI 10.1111/j.1472-765X.1985.tb01479.x; Rawlings ND, 2006, NUCLEIC ACIDS RES, V34, pD270, DOI 10.1093/nar/gkj089; RAZANAMPARANY V, 1992, CURR GENET, V21, P455, DOI 10.1007/BF00351655; ROBERTS WK, 1986, BIOCHIM BIOPHYS ACTA, V880, P161, DOI 10.1016/0304-4165(86)90076-0; Sasaki H, 2005, P JPN ACAD B-PHYS, V81, P441, DOI 10.2183/pjab.81.441; Sims AH, 2004, FEMS MICROBIOL LETT, V239, P95, DOI 10.1016/j.femsle.2004.08.023; Sleat DE, 1999, AM J HUM GENET, V64, P1511, DOI 10.1086/302427; TAKAHASHI K, 2004, HDB PROTEOLYTIC ENZY, P221; TUOHY MG, 1993, BIOCHEM J, V290, P515, DOI 10.1042/bj2900515; Tuohy MG, 2002, BBA-PROTEIN STRUCT M, V1596, P366, DOI 10.1016/S0167-4838(01)00308-9; Ustianowski AP, 2008, CURR OPIN INFECT DIS, V21, P31, DOI 10.1097/QCO.0b013e3282f406ae; VandenHombergh JPTW, 1997, EUR J BIOCHEM, V247, P605; Vernekar JV, 1999, BIOCHEM BIOPH RES CO, V262, P702, DOI 10.1006/bbrc.1999.1269; Wiles AM, 2006, MICROBIOL-SGM, V152, P3133, DOI 10.1099/mic.0.29055-0; Wlodawer A, 2003, ACTA BIOCHIM POL, V50, P81; Yabuki Y, 2004, FEBS LETT, V569, P161, DOI 10.1016/j.febslet.2004.05.041; Yang XY, 2006, PEPTIDES, V27, P1726, DOI 10.1016/j.peptides.2006.01.020	50	19	25	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 24	2008	283	43					29186	29195		10.1074/jbc.M802366200	http://dx.doi.org/10.1074/jbc.M802366200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	362EB	18687686	hybrid, Green Published			2022-12-27	WOS:000260179900046
J	Ronnebaum, SM; Jensen, MV; Hohmeier, HE; Burgess, SC; Zhou, YP; Qian, S; MacNeil, D; Howard, A; Thornberry, N; Ilkayeva, O; Lu, DH; Sherry, AD; Newgard, CB				Ronnebaum, Sarah M.; Jensen, Mette V.; Hohmeier, Hans E.; Burgess, Shawn C.; Zhou, Yun-Ping; Qian, Su; MacNeil, Douglas; Howard, Andrew; Thornberry, Nancy; Ilkayeva, Olga; Lu, Danhong; Sherry, A. Dean; Newgard, Christopher B.			Silencing of Cytosolic or Mitochondrial Isoforms of Malic Enzyme Has No Effect on Glucose-stimulated Insulin Secretion from Rodent Islets	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NMR ISOTOPOMER ANALYSIS; PANCREATIC BETA-CELLS; FATTY-ACID SYNTHASE; ATP-CITRATE LYASE; REGULATED ANAPLEROSIS; PYRUVATE-CARBOXYLASE; NULL MUTATION; MOUSE; SUPPRESSION; METABOLISM	We have previously demonstrated a role for pyruvate cycling in glucose-stimulated insulin secretion (GSIS). Some of the possible pyruvate cycling pathways are completed by conversion of malate to pyruvate by malic enzyme. Using INS-1-derived 832/13 cells, it has recently been shown by other laboratories that NADP-dependent cytosolic malic enzyme (MEc), but not NAD-dependent mitochondrial malic enzyme (MEm), regulates GSIS. In the current study, we show that small interfering RNA-mediated suppression of either MEm or MEc results in decreased GSIS in both 832/13 cells and a new and more glucose- and incretin-responsive INS-1-derived cell line, 832/3. The effect of MEm to suppress GSIS in these cell lines was linked to a substantial decrease in cell growth, whereas MEc suppression resulted in decreased NADPH, shown previously to be correlated with GSIS. However, adenovirus-mediated delivery of small interfering RNAs specific to MEc and MEm to isolated rat islets, while leading to effective suppression of the targets transcripts, had no effect on GSIS. Furthermore, islets isolated from MEc-null MOD1(-/-) mice exhibit normal glucose- and potassium-stimulated insulin secretion. These results indicate that pyruvate-malate cycling does not control GSIS in primary rodent islets.	[Newgard, Christopher B.] Duke Univ, Med Ctr, Sarah W Stedman Nutr & Metab Ctr, Duke Independence Pk Facil, Durham, NC 27704 USA; [Ronnebaum, Sarah M.; Jensen, Mette V.; Hohmeier, Hans E.; Ilkayeva, Olga; Lu, Danhong; Newgard, Christopher B.] Duke Univ, Med Ctr, Dept Pharmacol, Durham, NC 27704 USA; [Ronnebaum, Sarah M.; Jensen, Mette V.; Hohmeier, Hans E.; Ilkayeva, Olga; Lu, Danhong; Newgard, Christopher B.] Duke Univ, Med Ctr, Dept Canc Biol, Durham, NC 27704 USA; [Hohmeier, Hans E.; Newgard, Christopher B.] Duke Univ, Med Ctr, Dept Med, Durham, NC 27704 USA; [Burgess, Shawn C.; Sherry, A. Dean] Univ Texas SW Med Ctr Dallas, Adv Imaging Res Ctr, Dallas, TX 75235 USA; [Burgess, Shawn C.; Sherry, A. Dean] Univ Texas SW Med Ctr Dallas, Dept Radiol, Dallas, TX 75235 USA; [Zhou, Yun-Ping; Qian, Su; MacNeil, Douglas; Howard, Andrew; Thornberry, Nancy] Merck Res Labs, Rahway, NJ 07065 USA	Duke University; Duke University; Duke University; Duke University; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Merck & Company	Newgard, CB (corresponding author), Duke Univ, Med Ctr, Sarah W Stedman Nutr & Metab Ctr, Duke Independence Pk Facil, 4321 Med Pk Dr,Ste 200, Durham, NC 27704 USA.	newga002@mc.duke.edu	Sherry, Dean/P-2348-2018	Sherry, Dean/0000-0001-7150-8301; Ronnebaum, Sarah/0000-0003-4787-754X; MacNeil, Doug/0000-0001-7089-0668	National Institutes of Health [DK42583, DK 58398]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK058398] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK42583 (to C. B. N.) and DK 58398 (to C. B. N. and A. D. S.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact. 1 These authors contributed equally to this work.	Antinozzi PA, 1998, J BIOL CHEM, V273, P16146, DOI 10.1074/jbc.273.26.16146; ASFARI M, 1992, ENDOCRINOLOGY, V130, P167, DOI 10.1210/en.130.1.167; Bain JR, 2004, DIABETES, V53, P2190, DOI 10.2337/diabetes.53.9.2190; Boucher A, 2004, J BIOL CHEM, V279, P27263, DOI 10.1074/jbc.M401167200; BROWN ML, 1988, J BIOL CHEM, V263, P4494; Chakravarthy MV, 2007, J CLIN INVEST, V117, P2539, DOI 10.1172/JCI31183; Cline GW, 2004, J BIOL CHEM, V279, P44370, DOI 10.1074/jbc.M311842200; COBB RR, 1990, MUTAT RES, V234, P1, DOI 10.1016/0165-1161(90)90024-I; Corkey BE, 2000, J NUTR, V130, p299S, DOI 10.1093/jn/130.2.299S; Farfari S, 2000, DIABETES, V49, P718, DOI 10.2337/diabetes.49.5.718; Fransson U, 2006, DIABETOLOGIA, V49, P1578, DOI 10.1007/s00125-006-0263-y; Guay C, 2007, J BIOL CHEM, V282, P35657, DOI 10.1074/jbc.M707294200; Gunawardana SC, 2004, AM J PHYSIOL-ENDOC M, V287, pE828, DOI 10.1152/ajpendo.00381.2003; Henquin JC, 2003, EUR J CLIN INVEST, V33, P742, DOI 10.1046/j.1365-2362.2003.01207.x; Herrero L, 2005, DIABETES, V54, P462, DOI 10.2337/diabetes.54.2.462; Hohmeier HE, 2004, MOL CELL ENDOCRINOL, V228, P121, DOI 10.1016/j.mce.2004.04.017; Hohmeier HE, 2000, DIABETES, V49, P424, DOI 10.2337/diabetes.49.3.424; Ivarsson R, 2005, DIABETES, V54, P2132, DOI 10.2337/diabetes.54.7.2132; Jensen MV, 2006, J BIOL CHEM, V281, P22342, DOI 10.1074/jbc.M604350200; JENSEN MV, 2008, AM J PHYSL IN PRESS; Joseph JW, 2007, J BIOL CHEM, V282, P31592, DOI 10.1074/jbc.M706080200; Joseph JW, 2006, J BIOL CHEM, V281, P35624, DOI 10.1074/jbc.M602606200; Khan A, 1996, J BIOL CHEM, V271, P2539, DOI 10.1074/jbc.271.5.2539; Komatsu M, 1999, DIABETES, V48, P1543, DOI 10.2337/diabetes.48.8.1543; LEE CY, 1980, MOL CELL BIOCHEM, V30, P143; LEE CY, 1980, BIOCHEMISTRY-US, V19, P5098, DOI 10.1021/bi00563a025; Li CH, 2008, J BIOL CHEM, V283, P17238, DOI 10.1074/jbc.M709235200; Lu DH, 2002, P NATL ACAD SCI USA, V99, P2708, DOI 10.1073/pnas.052005699; MacDonald MJ, 2007, J BIOL CHEM, V282, P30596, DOI 10.1074/jbc.M702732200; MACDONALD MJ, 1993, ARCH BIOCHEM BIOPHYS, V305, P205, DOI 10.1006/abbi.1993.1413; MacDonald MJ, 2002, AM J PHYSIOL-ENDOC M, V283, pE302, DOI 10.1152/ajpendo.00041.2002; MacDonald MJ, 2001, MOL CELL BIOCHEM, V220, P117, DOI 10.1023/A:1010821821921; MILBURN JL, 1995, J BIOL CHEM, V270, P1295, DOI 10.1074/jbc.270.3.1295; Mulder H, 2001, J BIOL CHEM, V276, P6479, DOI 10.1074/jbc.M010364200; Muoio DM, 2008, NAT REV MOL CELL BIO, V9, P193, DOI 10.1038/nrm2327; Pongratz RL, 2007, J BIOL CHEM, V282, P200, DOI 10.1074/jbc.M602954200; Roduit R, 2004, DIABETES, V53, P1007, DOI 10.2337/diabetes.53.4.1007; Ronnebaum SM, 2008, J BIOL CHEM, V283, P14248, DOI 10.1074/jbc.M800119200; Ronnebaum SM, 2006, J BIOL CHEM, V281, P30593, DOI 10.1074/jbc.M511908200; Schuit F, 1997, J BIOL CHEM, V272, P18572, DOI 10.1074/jbc.272.30.18572	40	59	59	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 24	2008	283	43					28909	28917		10.1074/jbc.M804665200	http://dx.doi.org/10.1074/jbc.M804665200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	362EB	18755687	hybrid, Green Published			2022-12-27	WOS:000260179900016
J	Zhou, LY; Qi, XP; Potashkin, JA; Abdul-Karim, FW; Gorodeski, GI				Zhou, Lingyin; Qi, Xiaoping; Potashkin, Judith A.; Abdul-Karim, Fadi W.; Gorodeski, George I.			MicroRNAs miR-186 and miR-150 down-regulate expression of the pro-apoptotic purinergic P2X(7) receptor by activation of instability sites at the 3 '-untranslated region of the gene that decrease steady-state levels of the transcript	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EXTRACELLULAR ATP; CANCER-CELLS; DETERMINANTS; INHIBITION; RELEASE; NEURONS; PROFILE; MIRNAS; GROWTH	The P2X(7) receptor regulates cell growth through mediation of apoptosis. P2X(7) levels are lower in cancer epithelial cells than in normal cells, and previous studies showed that expression of P2X(7) was regulated post-transcriptionally. The objective of the study was to understand regulation of P2X(7) mRNA stability. Overexpression of a reporter containing the full-length human P2X(7) 3'-untranslated region (3'-UTR) or reporters containing parts of the 3'-UTR-P2X(7) were associated with increased abundance of the construct in normal cells and decreased abundance in cancer epithelial cells. Sequences within the 3'-UTR-P2X(7), which are putative target sites for the microRNAs, miR-186 (middle segment) and miR-150 (distal segment), decreased the abundance of the P2X(7) transcript. Overexpression in cancer cells of mutated miR-186 and miR-150 target sites was associated with lower levels of the reporter genes. In normal cells overexpression of the mutated miR-186 target site was associated with marked increased concentration, but overexpression of the miR-150 target site reporters, wild-type and mutant, did not change over time. Levels of miR-186 and miR-150 were higher in cancer than in normal cells, and treatment with miR-186 and miR-150 inhibitors increased P2X(7) mRNA. In human embryonic kidney-293 cells heterologously expressing the full-length 3'-UTR-P2X(7) luciferase reporter, miR-186 and miR-150 inhibitors increased luciferase activity, whereas miR-186 and miR-150 mimics decreased luciferase activity after actinomycin D treatment. These data suggest that increased expression of miR-186 and miR-150 in cancer epithelial cells decreases P2X(7) mRNA by activation of miR-186 and miR-150 instability target sites located at the 3'-UTR-P2X(7).	[Zhou, Lingyin; Qi, Xiaoping; Gorodeski, George I.] Case Western Reserve Univ, Dept Reprod Biol, Cleveland, OH 44106 USA; [Abdul-Karim, Fadi W.] Case Western Reserve Univ, Dept Pathol, Cleveland, OH 44106 USA; [Gorodeski, George I.] Case Western Reserve Univ, Dept Oncol, Cleveland, OH 44106 USA; [Gorodeski, George I.] Case Western Reserve Univ, Dept Physiol & Biophys, Cleveland, OH 44106 USA; [Potashkin, Judith A.] Rosalind Franklin Univ Med & Sci, Chicago Med Sch, Dept Cellular & Mol Pharmacol, N Chicago, IL 60064 USA	Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; Chicago Medical School; Rosalind Franklin University Medical & Science	Gorodeski, GI (corresponding author), Case Western Reserve Univ Hosp, Med Ctr, Dept Obstet & Gynecol, Univ Hosp MacDonald Womens Ctr, 11100 Euclid Ave, Cleveland, OH 44106 USA.	gig@cwru.edu			National Institutes of Health [AG15955]; CytoCore Inc.; NATIONAL INSTITUTE ON AGING [R01AG015955, R55AG015955] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CytoCore Inc.; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grant AG15955. This work was also supported by an unrestricted grant by CytoCore Inc. (to G. I. G.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Bagga S, 2005, CELL, V122, P553, DOI 10.1016/j.cell.2005.07.031; Bobanovic LK, 2002, J NEUROSCI, V22, P4814, DOI 10.1523/JNEUROSCI.22-12-04814.2002; Brennecke J, 2005, PLOS BIOL, V3, P404, DOI 10.1371/journal.pbio.0030085; Bruchova H, 2007, EXP HEMATOL, V35, P1657, DOI 10.1016/j.exphem.2007.08.021; Buell G, 1996, EUR J NEUROSCI, V8, P2221, DOI 10.1111/j.1460-9568.1996.tb00745.x; Buell GN, 1998, RECEPTOR CHANNEL, V5, P347; Calin GA, 2004, P NATL ACAD SCI USA, V101, P2999, DOI 10.1073/pnas.0307323101; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Calin GA, 2006, CANCER RES, V66, P7390, DOI 10.1158/0008-5472.CAN-06-0800; Cheng AM, 2005, NUCLEIC ACIDS RES, V33, P1290, DOI 10.1093/nar/gki200; DUBYAK GR, 1993, AM J PHYSIOL, V265, pC577, DOI 10.1152/ajpcell.1993.265.3.C577; Farh KKH, 2005, SCIENCE, V310, P1817, DOI 10.1126/science.1121158; Feng YH, 2005, AM J PHYSIOL-CELL PH, V288, pC1342, DOI 10.1152/ajpcell.00315.2004; Feng YH, 2006, J BIOL CHEM, V281, P17228, DOI 10.1074/jbc.M602999200; Fulci V, 2007, BLOOD, V109, P4944, DOI 10.1182/blood-2006-12-062398; Gasser S, 2006, SEMIN CANCER BIOL, V16, P344, DOI 10.1016/j.semcancer.2006.07.004; GORODESKI GI, 1994, DIFFERENTIATION, V56, P107, DOI 10.1046/j.1432-0436.1994.56120107.x; Grahames CBA, 1999, BRIT J PHARMACOL, V127, P1915, DOI 10.1038/sj.bjp.0702732; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Gu BJ, 2000, AM J PHYSIOL-CELL PH, V279, pC1189, DOI 10.1152/ajpcell.2000.279.4.C1189; Guerra AN, 2003, J ENDOTOXIN RES, V9, P256, DOI 10.1179/096805103225001468; Guglielmelli P, 2007, EXP HEMATOL, V35, P1708, DOI 10.1016/j.exphein.2007.08.020; Guhaniyogi J, 2001, GENE, V265, P11, DOI 10.1016/S0378-1119(01)00350-X; Henriksen KL, 2003, CELL PHYSIOL BIOCHEM, V13, P93, DOI 10.1159/000070253; Khakh BS, 2001, PHARMACOL REV, V53, P107; Kujoth GC, 2006, CANCER RES, V66, P7386, DOI 10.1158/0008-5472.CAN-05-4670; Lai EC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-9-115; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li GH, 2000, J BIOL CHEM, V275, P29107, DOI 10.1074/jbc.M910277199; LI X, 2006, CANCER EPIDEM BIOMAR, V15, P1, DOI DOI 10.1158/1055-9965.EPI-05-0923; Li X, 2007, GYNECOL ONCOL, V106, P233, DOI 10.1016/j.ygyno.2007.03.032; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Loomis WH, 2003, J BIOL CHEM, V278, P4590, DOI 10.1074/jbc.M207868200; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Lui WO, 2007, CANCER RES, V67, P6031, DOI 10.1158/0008-5472.CAN-06-0561; Martinez I, 2008, ONCOGENE, V27, P2575, DOI 10.1038/sj.onc.1210919; Mitchell P, 2001, CURR OPIN CELL BIOL, V13, P320, DOI 10.1016/S0955-0674(00)00214-3; Nielsen CB, 2007, RNA, V13, P1894, DOI 10.1261/rna.768207; Olsen PH, 1999, DEV BIOL, V216, P671, DOI 10.1006/dbio.1999.9523; Ovcharenko D, 2007, CANCER RES, V67, P10782, DOI 10.1158/0008-5472.CAN-07-1484; Ralevic V, 1998, PHARMACOL REV, V50, P413; Rodriguez-Nieto S, 2006, CURR PHARM DESIGN, V12, P4411, DOI 10.2174/138161206779010495; Soto F, 1997, J MEMBRANE BIOL, V160, P91, DOI 10.1007/s002329900298; Sperlagh B, 1998, NEUROCHEM INT, V33, P209, DOI 10.1016/S0197-0186(98)00025-4; Surprenant A, 1996, SCIENCE, V272, P735, DOI 10.1126/science.272.5262.735; Virginio C, 1999, J PHYSIOL-LONDON, V519, P335, DOI 10.1111/j.1469-7793.1999.0335m.x; Wang LQ, 2005, ENDOCRINOLOGY, V146, P164, DOI 10.1210/en.2004-1026; Wang QF, 2004, ENDOCRINOLOGY, V145, P5568, DOI 10.1210/en.2004-0807; Wang QF, 2004, AM J PHYSIOL-CELL PH, V287, pC1349, DOI 10.1152/ajpcell.00256.2004; Wang Y, 2007, FRONT BIOSCI-LANDMRK, V12, P2316, DOI 10.2741/2234; Wu HQ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001020; Xiao CC, 2007, CELL, V131, P146, DOI 10.1016/j.cell.2007.07.021; Xie XH, 2005, NATURE, V434, P338, DOI 10.1038/nature03441; Zhou BY, 2007, P NATL ACAD SCI USA, V104, P7080, DOI 10.1073/pnas.0702409104	55	112	123	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 17	2008	283	42					28274	28286		10.1074/jbc.M802663200	http://dx.doi.org/10.1074/jbc.M802663200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	359EN	18682393	Green Published, hybrid			2022-12-27	WOS:000259969300029
J	Lamanna, WC; Frese, MA; Balleininger, M; Dierks, T				Lamanna, William C.; Frese, Marc-Andre; Balleininger, Martina; Dierks, Thomas			Sulf loss influences N-, 2-O-, and 6-O-sulfation of multiple heparan sulfate proteoglycans and modulates fibroblast growth factor signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-SURFACE; IN-VIVO; DOMAIN-STRUCTURE; SPECIFICITY; EXPRESSION; BINDING; PROTEIN; QSULF1; 6-O-ENDOSULFATASES; GLYCOSAMINOGLYCANS	Sulf1 and Sulf2 are two heparan sulfate 6-O-endosulfatases that regulate the activity of multiple growth factors, such as fibroblast growth factor and Wnt, and are essential for mammalian development and survival. In this study, the mammalian Sulfs were functionally characterized using overexpressing cell lines, in vitro enzyme assays, and in vivo Sulf knock-out cell models. Analysis of subcellular Sulf localization revealed significant differences in enzyme secretion and detergent solubility between the human isoforms and their previously characterized quail orthologs. Further, the activity of the Sulfs toward their native heparan sulfate substrates was determined in vitro, demonstrating restricted specificity for S-domain-associated 6S disaccharides and an inability to modify transition zone-associated UA-GlcNAc( 6S). Analysis of heparan sulfate composition from different cell surface, shed, glycosylphosphatidylinositol- anchored and extracellular matrix proteoglycan fractions of Sulf knock-out cell lines established differential effects of Sulf1 and/or Sulf2 loss on nonsubstrate N-, 2-O-, and 6-O-sulfate groups. These findings indicate a dynamic influence of Sulf deficiency on the HS biosynthetic machinery. Real time PCR analysis substantiated differential expression of the Hs2st and Hs6st heparan sulfate sulfotransferase enzymes in the Sulf knock-out cell lines. Functionally, the changes in heparan sulfate sulfation resulting from Sulf loss were shown to elicit significant effects on fibroblast growth factor signaling. Taken together, this study implicates that the Sulfs are involved in a potential cellular feed-back mechanism, in which they edit the sulfation of multiple heparan sulfate proteoglycans, thereby regulating cellular signaling and modulating the expression of heparan sulfate biosynthetic enzymes.	[Lamanna, William C.; Frese, Marc-Andre; Dierks, Thomas] Univ Bielefeld, Fak Chem Biochem 1, D-33615 Bielefeld, Germany; [Balleininger, Martina] Univ Gottingen, Biochem Abt 2, Zentrum Biochem & Mol Zellbiol, D-37073 Gottingen, Germany	University of Bielefeld; University of Gottingen	Dierks, T (corresponding author), Univ Bielefeld, Fak Chem Biochem 1, Univ Str 25, D-33615 Bielefeld, Germany.	thomas.dierks@uni-bielefeld.de	Dierks, Thomas/A-3596-2012	Dierks, Thomas/0000-0001-6426-1339	Deutsche Forschungsgemeinschaft; Fonds der Chemischen Industrie; Shire Human Genetic Therapies Inc. (Cambridge, MA)	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Fonds der Chemischen Industrie(Fonds der Chemischen IndustrieEuropean Commission); Shire Human Genetic Therapies Inc. (Cambridge, MA)	This work was supported by the Deutsche Forschungsgemeinschaft, the Fonds der Chemischen Industrie, and Shire Human Genetic Therapies Inc. (Cambridge, MA). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Ai XB, 2006, J BIOL CHEM, V281, P4969, DOI 10.1074/jbc.M511902200; Ai XB, 2003, J CELL BIOL, V162, P341, DOI 10.1083/jcb.200212083; Ai XB, 2007, DEVELOPMENT, V134, P3327, DOI 10.1242/dev.007674; ARTELT P, 1988, GENE, V68, P213, DOI 10.1016/0378-1119(88)90023-6; Bernfield M, 1999, ANNU REV BIOCHEM, V68, P729, DOI 10.1146/annurev.biochem.68.1.729; Bulow HE, 2006, ANNU REV CELL DEV BI, V22, P375, DOI 10.1146/annurev.cellbio.22.010605.093433; Dai YM, 2005, J BIOL CHEM, V280, P40066, DOI 10.1074/jbc.M508136200; DAVID G, 1992, J CELL BIOL, V119, P961, DOI 10.1083/jcb.119.4.961; De Cat B, 2003, J CELL BIOL, V163, P625, DOI 10.1083/jcb.200302152; Dhoot GK, 2001, SCIENCE, V293, P1663, DOI 10.1126/science.293.5535.1663; Dierks T, 1997, P NATL ACAD SCI USA, V94, P11963, DOI 10.1073/pnas.94.22.11963; Edgren G, 1997, GLYCOBIOLOGY, V7, P103, DOI 10.1093/glycob/7.1.103; Esko JD, 2002, ANNU REV BIOCHEM, V71, P435, DOI 10.1146/annurev.biochem.71.110601.135458; Frese MA, 2008, J BIOL CHEM, V283, P11388, DOI 10.1074/jbc.M709917200; Gallagher JT, 2006, BIOCHEM SOC T, V34, P438, DOI 10.1042/BST0340438; GITAYGOREN H, 1992, J BIOL CHEM, V267, P6093; Grobe K, 2002, J BIOL CHEM, V277, P30699, DOI 10.1074/jbc.M111904200; GUIMOND S, 1993, J BIOL CHEM, V268, P23906; HEREMANS A, 1988, J BIOL CHEM, V263, P4731; Holst CR, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000575; Kamimura K, 2006, J CELL BIOL, V174, P773, DOI 10.1083/jcb.200603129; Kikuno R, 1999, DNA Res, V6, P197, DOI 10.1093/dnares/6.3.197; Kreuger J, 2006, J CELL BIOL, V174, P323, DOI 10.1083/jcb.200604035; Lamanna WC, 2007, J BIOTECHNOL, V129, P290, DOI 10.1016/j.jbiotec.2007.01.022; Lamanna WC, 2006, BIOCHEM J, V400, P63, DOI 10.1042/BJ20060848; Ledin J, 2004, J BIOL CHEM, V279, P42732, DOI 10.1074/jbc.M405382200; Lum DH, 2007, MOL CELL BIOL, V27, P678, DOI 10.1128/MCB.01279-06; Maccarana M, 1996, J BIOL CHEM, V271, P17804, DOI 10.1074/jbc.271.30.17804; Merry CLR, 2001, J BIOL CHEM, V276, P35429, DOI 10.1074/jbc.M100379200; Morimoto-Tomita M, 2005, NEOPLASIA, V7, P1001, DOI 10.1593/neo.05496; Morimoto-Tomita M, 2002, J BIOL CHEM, V277, P49175, DOI 10.1074/jbc.M205131200; Murphy KJ, 2004, J BIOL CHEM, V279, P27239, DOI 10.1074/jbc.M401774200; Nagase T, 1999, DNA Res, V6, P337, DOI 10.1093/dnares/6.5.337; Narita K, 2006, CANCER RES, V66, P6025, DOI 10.1158/0008-5472.CAN-05-3582; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; RAPRAEGER AC, 1991, SCIENCE, V252, P1705, DOI 10.1126/science.1646484; Ratzka A, 2008, DEV DYNAM, V237, P339, DOI 10.1002/dvdy.21423; Reichsman F, 1996, J CELL BIOL, V135, P819, DOI 10.1083/jcb.135.3.819; Saad OM, 2005, GLYCOBIOLOGY, V15, P818, DOI 10.1093/glycob/cwi064; Saoncella S, 1999, P NATL ACAD SCI USA, V96, P2805, DOI 10.1073/pnas.96.6.2805; SCHUERMANN M, 1990, NUCLEIC ACIDS RES, V18, P4945, DOI 10.1093/nar/18.16.4945; Sugaya N, 2008, J BIOL CHEM, V283, P10366, DOI 10.1074/jbc.M705948200; Tumova S, 2000, J BIOL CHEM, V275, P9410, DOI 10.1074/jbc.275.13.9410; Uchimura Kenji, 2006, BMC Biochem, V7, P2, DOI 10.1186/1471-2091-7-2; Viviano BL, 2004, J BIOL CHEM, V279, P5604, DOI 10.1074/jbc.M310691200; Wang SW, 2004, P NATL ACAD SCI USA, V101, P4833, DOI 10.1073/pnas.0401028101; YAYON A, 1991, CELL, V64, P841, DOI 10.1016/0092-8674(91)90512-W; Yue XP, 2008, J BIOL CHEM, V283, P20397, DOI 10.1074/jbc.M802850200; Zimmermann P, 2005, DEV CELL, V9, P377, DOI 10.1016/j.devcel.2005.07.011	49	113	114	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 10	2008	283	41					27724	27735		10.1074/jbc.M802130200	http://dx.doi.org/10.1074/jbc.M802130200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	355OW	18687675	hybrid			2022-12-27	WOS:000259719200044
J	Lan, F; Cacicedo, JM; Ruderman, N; Ido, Y				Lan, Fan; Cacicedo, Jose M.; Ruderman, Neil; Ido, Yasuo			SIRT1 modulation of the acetylation status, cytosolic localization, and activity of LKB1 - Possible role in AMP-activated protein kinase activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELLS; PHOSPHORYLATION; DEACETYLASE; METABOLISM	SIRT1, a histone/protein deacetylase, and AMP-activated protein kinase (AMPK) are key enzymes responsible for longevity and energy homeostasis. We examined whether a mechanistic connection exists between these molecules that involves the major AMPK kinase LKB1. Initial studies demonstrated that LKB1 is acetylated in cultured (HEK293T) cells, mouse white adipose tissue, and rat liver. In the 293T cells, SIRT1 overexpression diminished lysine acetylation of LKB1 and concurrently increased its activity, cytoplasmic/nuclear ratio, and association with the LKB1 activator STRAD. In contrast, short hairpin RNA for SIRT1, where studied, had opposite effects on these parameters. Mass spectrometric analysis established that acetylation of LKB1 occurs on multiple, but specific, lysine residues; however, only mutation of lysine 48 to arginine, which mimics deacetylation, reproduced all of the effects of activated SIRT1. SIRT1 also affected downstream targets of LKB1. Thus its overexpression increased AMPK and acetyl-CoA carboxylase phosphorylation, and conversely, RNA interference-mediated SIRT1 knockdown reduced AMPK phosphorylation and that of another LKB1 target MARK1. Consistent with the results in cultured cells, total LKB1 lysine acetylation was decreased by 60% in the liver of 48-h starved rats compared with starved-refed rats, and this was associated with modest but significant increases in both LKB1 and AMPK activities. These results suggest that LKB1 deacetylation is regulated by SIRT1 and that this in turn influences its intracellular localization, association with STRAD, kinase activity, and ability to activate AMPK.	[Lan, Fan; Cacicedo, Jose M.; Ruderman, Neil; Ido, Yasuo] Boston Univ, Sch Med, Diabet & Metab Res Unit, Dept Med,Sect Endocrinol, Boston, MA 02118 USA; [Cacicedo, Jose M.] Boston Univ, Sch Med, Dept Pathol & Lab Med, Boston, MA 02118 USA	Boston University; Boston University	Ido, Y (corresponding author), 650 Albany St,Rm 820, Boston, MA 02118 USA.	yido@bu.edu		/0000-0001-8417-9754; Ido, Yasuo/0000-0002-3036-9971; Ruderman, Neil/0000-0002-6589-6587	National Institutes of Health [P01 HL08758, DK19514]; Kilo Diabetes Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK019514] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Kilo Diabetes Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants P01 HL08758 and DK19514 (to N. R.). This work was also supported by grants from the Kilo Diabetes Foundation (to Y. I.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Adachi T, 2004, J BIOL CHEM, V279, P29857, DOI 10.1074/jbc.M313320200; Alessi DR, 2006, ANNU REV BIOCHEM, V75, P137, DOI 10.1146/annurev.biochem.75.103004.142702; Assifi MM, 2005, AM J PHYSIOL-ENDOC M, V289, pE794, DOI 10.1152/ajpendo.00144.2005; Bordone L, 2006, PLOS BIOL, V4, P210, DOI 10.1371/journal.pbio.0040031; Boudeau J, 2003, EMBO J, V22, P5102, DOI 10.1093/emboj/cdg490; Dasgupta B, 2007, P NATL ACAD SCI USA, V104, P7217, DOI 10.1073/pnas.0610068104; Dorfman J, 2008, MOL BIOL CELL, V19, P1614, DOI 10.1091/mbc.E07-05-0454; Hardie DG, 2006, J PHYSIOL-LONDON, V574, P7, DOI 10.1113/jphysiol.2006.108944; Hou XY, 2008, J BIOL CHEM, V283, P20015, DOI 10.1074/jbc.M802187200; Jing EX, 2007, CELL METAB, V6, P105, DOI 10.1016/j.cmet.2007.07.003; Lee IH, 2008, P NATL ACAD SCI USA, V105, P3374, DOI 10.1073/pnas.0712145105; MEGEE PC, 1990, SCIENCE, V247, P841, DOI 10.1126/science.2106160; Rodgers JT, 2005, NATURE, V434, P113, DOI 10.1038/nature03354; Ruderman N, 2004, NAT REV DRUG DISCOV, V3, P340, DOI 10.1038/nrd1344; Sanders MJ, 2007, BIOCHEM J, V403, P139, DOI 10.1042/BJ20061520; Sapkota GP, 2001, J BIOL CHEM, V276, P19469, DOI 10.1074/jbc.M009953200; SCHNEIDER C, 1982, J BIOL CHEM, V257, P766; Shelly M, 2007, CELL, V129, P565, DOI 10.1016/j.cell.2007.04.012; Sinclair DA, 2006, SCI AM, V294, P48, DOI 10.1038/scientificamerican0306-48; Suzuki K, 2007, BIOCHEM BIOPH RES CO, V359, P665, DOI 10.1016/j.bbrc.2007.05.164; Xie Z, 2008, CIRCULATION, V117, P952, DOI 10.1161/CIRCULATIONAHA.107.744490	21	584	617	2	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 10	2008	283	41					27628	27635		10.1074/jbc.M805711200	http://dx.doi.org/10.1074/jbc.M805711200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	355OW	18687677	Green Published, hybrid			2022-12-27	WOS:000259719200034
J	Basso, E; Petronilli, V; Forte, MA; Bernardi, P				Basso, Emy; Petronilli, Valeria; Forte, Michael A.; Bernardi, Paolo			Phosphate is essential for inhibition of the mitochondrial permeability transition pore by cyclosporin A and by cyclophilin D ablation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INORGANIC-PHOSPHATE; INNER MEMBRANE; UBIQUINONE ANALOGS; HEART-MITOCHONDRIA; CALCIUM-UPTAKE; LIVER; MATRIX; RESPIRATION; DYSFUNCTION; MODULATION	Energized mouse liver mitochondria displayed the same calcium retention capacity (a sensitive measure of the propensity of the permeability transition pore (PTP) to open) irrespective of whether phosphate, arsenate, or vanadate was the permeating anion. Unexpectedly, however, phosphate was specifically required for PTP desensitization by cyclosporin A (CsA) or by genetic inactivation of cyclophilin D (CyP-D). Indeed, when phosphate was replaced by arsenate, vanadate, or bicarbonate, the inhibitory effects of CsA and of CyP-D ablation on the PTP disappeared. After loading with the same amount of Ca2+ in the presence of arsenate or vanadate but in the absence of phosphate, the sensitivity of the PTP to a variety of inducers was identical in mitochondria from wild-type mice, CyP-D-null mice, and wild-type mice treated with CsA. These findings call for a reassessment of conclusions on the role of the PTP in cell death that are based on the effects of CsA or of CyP-D ablation.	[Basso, Emy; Petronilli, Valeria; Bernardi, Paolo] Univ Padua, Dept Biomed Sci, I-35121 Padua, Italy; [Basso, Emy; Petronilli, Valeria; Bernardi, Paolo] Univ Padua, Consiglio Nazl Ric Inst Neurosci, I-35121 Padua, Italy; [Forte, Michael A.] Oregon Hlth & Sci Univ, Vollum Inst, Portland, OR 97239 USA	University of Padua; University of Padua; Oregon Health & Science University	Bernardi, P (corresponding author), Univ Padua, Dept Biomed Sci, Viale Giuseppe Colombo 3, I-35121 Padua, Italy.	bernardi@bio.unipd.it	Bernardi, Paolo/C-3656-2008; Petronilli, Valeria/C-3558-2015; Basso, Emy/F-7687-2015	Bernardi, Paolo/0000-0001-9187-3736; Petronilli, Valeria/0000-0003-4026-6404; Basso, Emy/0000-0003-2962-7213	United States Public Health Service [GM69883]; Ministero per l'Universita e la Ricerca, Italy; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM069883] Funding Source: NIH RePORTER	United States Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); Ministero per l'Universita e la Ricerca, Italy; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM69883 from the United States Public Health Service (to M. A. F. and P. B.). This work was also supported by the Ministero per l'Universita e la Ricerca, Italy (to P. B.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Abramov AY, 2007, P NATL ACAD SCI USA, V104, P18091, DOI 10.1073/pnas.0708959104; Angelin A, 2007, P NATL ACAD SCI USA, V104, P991, DOI 10.1073/pnas.0610270104; AZZONE GF, 1977, FEBS LETT, V78, P21, DOI 10.1016/0014-5793(77)80264-0; Baines CP, 2005, NATURE, V434, P658, DOI 10.1038/nature03434; Basso E, 2005, J BIOL CHEM, V280, P18558, DOI 10.1074/jbc.C500089200; Bernardi P, 2006, FEBS J, V273, P2077, DOI 10.1111/j.1742-4658.2006.05213.x; BERNARDI P, 1992, J BIOL CHEM, V267, P2934; BERNARDI P, 1982, FEBS LETT, V139, P9, DOI 10.1016/0014-5793(82)80475-4; Bose S, 2003, J BIOL CHEM, V278, P39155, DOI 10.1074/jbc.M306409200; BROEKEMEIER KM, 1989, J BIOL CHEM, V264, P7826; CARAFOLI E, 1964, J BIOL CHEM, V239, P3055; Cesura AM, 2003, J BIOL CHEM, V278, P49812, DOI 10.1074/jbc.M304748200; Chalmers S, 2003, J BIOL CHEM, V278, P19062, DOI 10.1074/jbc.M212661200; CONNERN CP, 1994, BIOCHEM J, V302, P321, DOI 10.1042/bj3020321; CROMPTON M, 1988, BIOCHEM J, V255, P357; DELUCA HF, 1961, P NATL ACAD SCI USA, V47, P1744, DOI 10.1073/pnas.47.11.1744; EMAUS RK, 1986, BIOCHIM BIOPHYS ACTA, V850, P436, DOI 10.1016/0005-2728(86)90112-X; Fontaine E, 1998, J BIOL CHEM, V273, P25734, DOI 10.1074/jbc.273.40.25734; Forte M, 2007, P NATL ACAD SCI USA, V104, P7558, DOI 10.1073/pnas.0702228104; FOURNIER N, 1987, J BIOENERG BIOMEMBR, V19, P297, DOI 10.1007/BF00762419; HALESTRAP AP, 1990, BIOCHEM J, V268, P153, DOI 10.1042/bj2680153; HARRIS EJ, 1977, FEBS LETT, V79, P284, DOI 10.1016/0014-5793(77)80804-1; HAWORTH RA, 1979, ARCH BIOCHEM BIOPHYS, V195, P460, DOI 10.1016/0003-9861(79)90372-2; HUNTER DR, 1976, J BIOL CHEM, V251, P5069; Irwin WA, 2003, NAT GENET, V35, P367, DOI 10.1038/ng1270; KATZ LA, 1988, AM J PHYSIOL, V255, pH189, DOI 10.1152/ajpheart.1988.255.1.H189; Kroemer G, 2007, PHYSIOL REV, V87, P99, DOI 10.1152/physrev.00013.2006; LEHNINGER AL, 1963, BIOCHEM BIOPH RES CO, V10, P444, DOI 10.1016/0006-291X(63)90377-2; Leung AWC, 2008, J BIOL CHEM, V283, P26312, DOI 10.1074/jbc.M805235200; Merlini L, 2008, P NATL ACAD SCI USA, V105, P5225, DOI 10.1073/pnas.0800962105; Millay DP, 2008, NAT MED, V14, P442, DOI 10.1038/nm1736; MITCHELL P, 1979, SCIENCE, V206, P1148, DOI 10.1126/science.388618; Nakagawa T, 2005, NATURE, V434, P652, DOI 10.1038/nature03317; NICHOLLS DG, 1978, BIOCHEM J, V176, P463, DOI 10.1042/bj1760463; NICOLLI A, 1993, BIOCHEMISTRY-US, V32, P4461, DOI 10.1021/bi00067a039; Nicolli A, 1996, J BIOL CHEM, V271, P2185, DOI 10.1074/jbc.271.4.2185; Pavlov E, 2005, BIOPHYS J, V88, P2614, DOI 10.1529/biophysj.104.057281; Piot C, 2008, NEW ENGL J MED, V359, P473, DOI 10.1056/NEJMoa071142; SCARPA A, 1970, EUR J BIOCHEM, V12, P328, DOI 10.1111/j.1432-1033.1970.tb00854.x; Schinzel AC, 2005, P NATL ACAD SCI USA, V102, P12005, DOI 10.1073/pnas.0505294102; SELWYN MJ, 1970, FEBS LETT, V10, P1, DOI 10.1016/0014-5793(70)80402-1; VASINGTON FD, 1962, J BIOL CHEM, V237, P2670; Walter L, 2002, FREE RADICAL RES, V36, P405, DOI 10.1080/10715760290021252; Walter L, 2000, J BIOL CHEM, V275, P29521, DOI 10.1074/jbc.M004128200; WINGROVE DE, 1984, J BIOL CHEM, V259, P9390	45	133	138	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 26	2008	283	39					26307	26311		10.1074/jbc.C800132200	http://dx.doi.org/10.1074/jbc.C800132200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	350GV	18684715	Green Published, hybrid			2022-12-27	WOS:000259341600003
J	Courchet, J; Buchet-Poyau, K; Potemski, A; Bres, A; Jariel-Encontre, I; Billaud, M				Courchet, Julien; Buchet-Poyau, Karine; Potemski, Auriane; Bres, Aurelie; Jariel-Encontre, Isabelle; Billaud, Marc			Interaction with 14-3-3 Adaptors Regulates the Sorting of hMex-3B RNA-binding Protein to Distinct Classes of RNA Granules	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MICRORNA-DEPENDENT LOCALIZATION; PROCESSING BODIES; STRUCTURAL BASIS; STRESS GRANULES; MESSENGER-RNAS; P-BODIES; PHOSPHORYLATION; DECAY; INHIBITION; MEX-3	Stress granules (SG) and processing bodies (PBs) are cytoplasmic ribonucleoprotein particles whose assembly is induced by different stimuli. SG are the site of storage of untranslated transcripts formed in response to environmental stress, whereas PBs are involved in mRNA turnover. We recently characterized a novel family of four human proteins related to the Caenorhabditis elegans Mex-3, a RNA binding protein involved in the establishment of the anterior-posterior embryonic asymmetry and in the maintenance of germline pluripotency. We now report that the adaptorproteins 14-3-3 bind to hMex-3B but not to the three other hMex-3 family members. Serine 462, when phosphorylated, is the major 14-3-3 docking site on hMex-3B, and manipulation of this interaction reveals that 14-3-3 both stabilizes hMex-3B and modulates its ability to bind RNA. Furthermore, the complex formed between hMex-3B and Argonaute proteins is excluded from PBs when the interaction with 14-3-3 is disrupted, whereas the recruitment to SG is not affected. Thus, 14-3-3 exerts combined effects on hMex-3B and acts as a major regulator of the sorting between distinct classes of RNA granules.	[Courchet, Julien; Buchet-Poyau, Karine; Potemski, Auriane; Bres, Aurelie; Billaud, Marc] CNRS, Lab Genet Mol Signalisat & Canc, UMR5201, F-69008 Lyon, France; Univ Lyon, F-69008 Lyon, France; Univ Lyon 1, F-69008 Lyon, France; [Jariel-Encontre, Isabelle] CNRS, Inst Genet Mol Montpellier, F-34293 Montpellier, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier	Billaud, M (corresponding author), CNRS, Lab Genet Mol Signalisat & Canc, UMR5201, F-69008 Lyon, France.	billaud@univ-lyon1.fr	COURCHET, JULIEN/E-9645-2016; Billaud, Marc N/M-6954-2013	COURCHET, JULIEN/0000-0002-1199-9329; 				Anderson P, 2006, J CELL BIOL, V172, P803, DOI 10.1083/jcb.200512082; Benjamin D, 2006, MOL CELL BIOL, V26, P9497, DOI 10.1128/MCB.01099-06; Benton R, 2003, CELL, V115, P691, DOI 10.1016/S0092-8674(03)00938-3; Benton R, 2002, DEV CELL, V3, P659, DOI 10.1016/S1534-5807(02)00320-9; Bhattacharyya SN, 2006, CELL, V125, P1111, DOI 10.1016/j.cell.2006.04.031; Bowerman B, 1997, DEVELOPMENT, V124, P3815; Buchet-Poyau K, 2007, NUCLEIC ACIDS RES, V35, P1289, DOI 10.1093/nar/gkm016; Chen HK, 2003, CELL, V113, P457, DOI 10.1016/S0092-8674(03)00349-0; Ciosk R, 2006, SCIENCE, V311, P851, DOI 10.1126/science.1122491; Ciosk R, 2004, DEVELOPMENT, V131, P4831, DOI 10.1242/dev.01352; Cougot N, 2004, J CELL BIOL, V165, P31, DOI 10.1083/jcb.200309008; Donnini M, 2004, J BIOL CHEM, V279, P20154, DOI 10.1074/jbc.M314071200; Draper BW, 1996, CELL, V87, P205, DOI 10.1016/S0092-8674(00)81339-2; Durand S, 2007, J CELL BIOL, V178, P1145, DOI 10.1083/jcb.200611086; Eulalio A, 2007, NAT REV MOL CELL BIO, V8, P9, DOI 10.1038/nrm2080; GALLO CM, 2008, DEV BIOL IN PRESS; Ganguly S, 2005, P NATL ACAD SCI USA, V102, P1222, DOI 10.1073/pnas.0406871102; Gherzi R, 2007, PLOS BIOL, V5, P82, DOI 10.1371/journal.pbio.0050005; Gilks N, 2004, MOL BIOL CELL, V15, P5383, DOI 10.1091/mbc.E04-08-0715; He C, 2006, EMBO J, V25, P3823, DOI 10.1038/sj.emboj.7601264; Hermeking H, 2003, NAT REV CANCER, V3, P931, DOI 10.1038/nrc1230; Hitti E, 2006, MOL CELL BIOL, V26, P2399, DOI 10.1128/MCB.26.6.2399-2407.2006; Hoffmeister M, 2008, J BIOL CHEM, V283, P2297, DOI 10.1074/jbc.M706825200; Hu CD, 2003, NAT BIOTECHNOL, V21, P539, DOI 10.1038/nbt816; Huang NN, 2002, DEVELOPMENT, V129, P747; Hunter CP, 1996, CELL, V87, P217, DOI 10.1016/S0092-8674(00)81340-9; Ingelfinger D, 2002, RNA, V8, P1489, DOI 10.1017/S1355838202021726; Jing Q, 2005, CELL, V120, P623, DOI 10.1016/j.cell.2004.12.038; Jud MC, 2008, DEV BIOL, V318, P38, DOI 10.1016/j.ydbio.2008.02.059; Kedersha N, 2005, J CELL BIOL, V169, P871, DOI 10.1083/jcb.200502088; Kedersha N, 2007, METHOD ENZYMOL, V431, P61, DOI 10.1016/S0076-6879(07)31005-7; Kedersha NL, 1999, J CELL BIOL, V147, P1431, DOI 10.1083/jcb.147.7.1431; Kim HH, 2008, GENE DEV, V22, P1804, DOI 10.1101/gad.1645808; Leung AKL, 2006, P NATL ACAD SCI USA, V103, P18125, DOI 10.1073/pnas.0608845103; Liu JD, 2005, NAT CELL BIOL, V7, P719, DOI 10.1038/ncb1274; Mackintosh C, 2004, BIOCHEM J, V381, P329, DOI 10.1042/BJ20031332; Margolis SS, 2003, EMBO J, V22, P5734, DOI 10.1093/emboj/cdg545; Masters SC, 1999, BIOCHEMISTRY-US, V38, P5216, DOI 10.1021/bi982492m; Masters SC, 2001, J BIOL CHEM, V276, P45193, DOI 10.1074/jbc.M105971200; Morton DG, 2002, DEV BIOL, V241, P47, DOI 10.1006/dbio.2001.0489; Muslin AJ, 1996, CELL, V84, P889, DOI 10.1016/S0092-8674(00)81067-3; Noble SL, 2008, J CELL BIOL, V182, P559, DOI 10.1083/jcb.200802128; Nonhoff U, 2007, MOL BIOL CELL, V18, P1385, DOI 10.1091/mbc.E06-12-1120; Nony P, 2003, ONCOGENE, V22, P9165, DOI 10.1038/sj.onc.1207179; Pillai RS, 2005, SCIENCE, V309, P1573, DOI 10.1126/science.1115079; Puig O, 2001, METHODS, V24, P218, DOI 10.1006/meth.2001.1183; Rigaut G, 1999, NAT BIOTECHNOL, V17, P1030, DOI 10.1038/13732; Sato M, 2002, CURR BIOL, V12, P141, DOI 10.1016/S0960-9822(01)00654-6; Schmidlin M, 2004, EMBO J, V23, P4760, DOI 10.1038/sj.emboj.7600477; Sheth U, 2003, SCIENCE, V300, P805, DOI 10.1126/science.1082320; Stoecklin G, 2004, EMBO J, V23, P1313, DOI 10.1038/sj.emboj.7600163; Teixeira D, 2005, RNA, V11, P371, DOI 10.1261/rna.7258505; Tourriere H, 2003, J CELL BIOL, V160, P823, DOI 10.1083/jcb.200212128; Tzivion G, 2002, J BIOL CHEM, V277, P3061, DOI 10.1074/jbc.R100059200; Van der Hoeven PCJ, 2000, BIOCHEM J, V345, P297, DOI 10.1042/0264-6021:3450297; van Dijk E, 2002, EMBO J, V21, P6915, DOI 10.1093/emboj/cdf678; Vander Haar E, 2007, NAT CELL BIOL, V9, P316, DOI 10.1038/ncb1547; Wilczynska A, 2005, J CELL SCI, V118, P981, DOI 10.1242/jcs.01692; Wilker EW, 2005, J BIOL CHEM, V280, P18891, DOI 10.1074/jbc.M500982200; Yaffe MB, 2002, FEBS LETT, V513, P53, DOI 10.1016/S0014-5793(01)03288-4; Yaffe MB, 1997, CELL, V91, P961, DOI 10.1016/S0092-8674(00)80487-0	61	28	29	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 14	2008	283	46					32131	32142		10.1074/jbc.M802927200	http://dx.doi.org/10.1074/jbc.M802927200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	370KJ	18779327	Green Published, hybrid			2022-12-27	WOS:000260760800094
J	Andersen, DS; Tapon, N				Andersen, Ditte S.; Tapon, Nicolas			Drosophila MFAP1 Is Required for Pre-mRNA Processing and G(2)/M Progression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMALL NUCLEAR RIBONUCLEOPROTEIN; CELL-CYCLE PROGRESSION; BOX SPLICING FACTOR; SCHIZOSACCHAROMYCES-POMBE; SACCHAROMYCES-CEREVISIAE; PRP19P-ASSOCIATED COMPLEX; SPLICEOSOME ACTIVATION; GENETIC-CONTROL; DIVISION CYCLE; PROTEIN-COMPOSITION	The mammalian spliceosome has mainly been studied using proteomics. The isolation and comparison of different splicing intermediates has revealed the dynamic association of more than 200 splicing factors with the spliceosome, relatively few of which have been studied in detail. Here, we report the characterization of the Drosophila homologue of microfibril-associated protein 1 (dMFAP1), a previously uncharacterized protein found in some human spliceosomal fractions (Jurica, M. S., and Moore, M. J. (2003) Mol. Cell 12, 5-14). We show that dMFAP1 binds directly to the Drosophila homologue of Prp38p (dPrp38), a tri-small nuclear ribonucleoprotein component (Xie, J., Beickman, K., Otte, E., and Rymond, B. C. (1998) EMBO J. 17, 2938 2946), and is required for pre-mRNA processing. dMFAP1, like dPrp38, is essential for viability, and our in vivo data show that cells with reduced levels of dMFAP1 or dPrp38 proliferate more slowly than normal cells and undergo apoptosis. Consistent with this, double-stranded RNA-mediated depletion of dPrp38 or dMFAP1 causes cells to arrest in G(2)/M, and this is paralleled by a reduction in mRNA levels of the mitotic phosphatase string/cdc25. Interestingly double-stranded RNA-mediated depletion of a wide range of core splicing factors elicits a similar phenotype, suggesting that the observed G(2)/M arrest might be a general consequence of interfering with spliceosome function.	[Andersen, Ditte S.; Tapon, Nicolas] London Res Inst, Apoptosis & Proliferat Control Lab, London WC2A 3PX, England		Tapon, N (corresponding author), POB 123,44 Lincolns Inn Fields, London WC2A 3PX, England.	nicolas.tapon@cancer.org.uk		Andersen, Ditte/0000-0003-1209-6102; Tapon, Nicolas/0000-0001-5267-6510	Cancer Research UK Funding Source: Medline	Cancer Research UK(Cancer Research UK)		Bernstein HS, 1998, J BIOL CHEM, V273, P4666, DOI 10.1074/jbc.273.8.4666; Bessonov S, 2008, NATURE, V452, P846, DOI 10.1038/nature06842; BLANTON S, 1992, MOL CELL BIOL, V12, P3939, DOI 10.1128/MCB.12.9.3939; Boger-Nadjar E, 1998, MOL GEN GENET, V260, P232, DOI 10.1007/s004380050891; Bousquet-Antonelli C, 2000, CELL, V102, P765, DOI 10.1016/S0092-8674(00)00065-9; BRAND AH, 1994, METHOD CELL BIOL, V44, P635, DOI 10.1016/S0091-679X(08)60936-X; BRAND AH, 1993, DEVELOPMENT, V118, P401; Brow DA, 2002, ANNU REV GENET, V36, P333, DOI 10.1146/annurev.genet.36.043002.091635; Burns CG, 2002, MOL CELL BIOL, V22, P801, DOI 10.1128/MCB.22.3.801-815.2002; Chan SP, 2005, J BIOL CHEM, V280, P31190, DOI 10.1074/jbc.M505060200; Chan SP, 2003, SCIENCE, V302, P279, DOI 10.1126/science.1086602; Chawla G, 2003, NUCLEIC ACIDS RES, V31, P2333, DOI 10.1093/nar/gkg333; Chen CH, 2001, J BIOL CHEM, V276, P488, DOI 10.1074/jbc.M006958200; Chen JYF, 2001, MOL CELL, V7, P227, DOI 10.1016/S1097-2765(01)00170-8; Chen YIG, 2006, J MOL BIOL, V361, P412, DOI 10.1016/j.jmb.2006.06.052; Cho SY, 2007, J BIOL CHEM, V282, P2456, DOI 10.1074/jbc.M608042200; Dahan O, 2004, NUCLEIC ACIDS RES, V32, P2529, DOI 10.1093/nar/gkh574; Deckert J, 2006, MOL CELL BIOL, V26, P5528, DOI 10.1128/MCB.00582-06; Diaz B, 2005, EXP CELL RES, V306, P317, DOI 10.1016/j.yexcr.2005.03.017; EDGAR BA, 1989, CELL, V57, P177, DOI 10.1016/0092-8674(89)90183-9; Habara Y, 2001, RNA, V7, P671, DOI 10.1017/S1355838201001200; Hartmuth K, 2002, P NATL ACAD SCI USA, V99, P16719, DOI 10.1073/pnas.262483899; HARTWELL LH, 1973, GENETICS, V74, P267; HORRIGAN SK, 1992, J BIOL CHEM, V267, P10087; Hwang LH, 1997, MOL BIOL CELL, V8, P1877, DOI 10.1091/mbc.8.10.1877; James SA, 2002, RNA, V8, P1068, DOI 10.1017/S1355838202022033; JOHNSTON LH, 1982, MOL GEN GENET, V186, P439, DOI 10.1007/BF00729466; Jurica MS, 2003, MOL CELL, V12, P5, DOI 10.1016/S1097-2765(03)00270-3; Jurica MS, 2002, RNA, V8, P426, DOI 10.1017/S1355838202021088; Kittler R, 2004, NATURE, V432, P1036, DOI 10.1038/nature03159; Li XL, 2005, GENE DEV, V19, P2705, DOI 10.1101/gad.1359305; Lundgren K, 1996, MOL BIOL CELL, V7, P1083, DOI 10.1091/mbc.7.7.1083; MADHANI HD, 1994, ANNU REV GENET, V28, P1; Makarov EM, 2002, SCIENCE, V298, P2205, DOI 10.1126/science.1077783; Makarova OV, 2004, EMBO J, V23, P2381, DOI 10.1038/sj.emboj.7600241; Merendino L, 1999, NATURE, V402, P838, DOI 10.1038/45602; Neubauer G, 2005, METHOD ENZYMOL, V405, P236, DOI 10.1016/S0076-6879(05)05010-X; Neubauer G, 1998, NAT GENET, V20, P46, DOI 10.1038/1700; NURSE P, 1976, MOL GEN GENET, V146, P167, DOI 10.1007/BF00268085; Ohi R, 1998, MOL CELL BIOL, V18, P4097, DOI 10.1128/MCB.18.7.4097; OHI R, 1994, EMBO J, V13, P471, DOI 10.1002/j.1460-2075.1994.tb06282.x; Pacheco TR, 2006, MOL BIOL CELL, V17, P4187, DOI 10.1091/mbc.E06-01-0036; Park JW, 2004, P NATL ACAD SCI USA, V101, P15974, DOI 10.1073/pnas.0407004101; Perriman R, 2000, GENE DEV, V14, P97; Pignoni F, 1997, P NATL ACAD SCI USA, V94, P9220, DOI 10.1073/pnas.94.17.9220; Potashkin J, 1998, CURR GENET, V34, P153, DOI 10.1007/s002940050381; Raghunathan PL, 1998, CURR BIOL, V8, P847, DOI 10.1016/S0960-9822(07)00345-4; ROSBASH M, 1991, TRENDS BIOCHEM SCI, V16, P187, DOI 10.1016/0968-0004(91)90073-5; RUBIN GM, 1982, SCIENCE, V218, P348, DOI 10.1126/science.6289436; RUBY SW, 1988, SCIENCE, V242, P1028, DOI 10.1126/science.2973660; Schneider S, 2004, J BIOL CHEM, V279, P8617, DOI 10.1074/jbc.M312715200; Schneider S, 2002, J BIOL CHEM, V277, P15452, DOI 10.1074/jbc.M112473200; SHEA JE, 1994, NUCLEIC ACIDS RES, V22, P5555, DOI 10.1093/nar/22.25.5555; Singh R, 2000, RNA, V6, P901, DOI 10.1017/S1355838200000376; Staley JP, 1998, CELL, V92, P315, DOI 10.1016/S0092-8674(00)80925-3; Stevens SW, 1999, P NATL ACAD SCI USA, V96, P7226, DOI 10.1073/pnas.96.13.7226; TAKAHASHI K, 1994, MOL BIOL CELL, V5, P1145, DOI 10.1091/mbc.5.10.1145; Tsai WY, 1999, J BIOL CHEM, V274, P9455, DOI 10.1074/jbc.274.14.9455; UMEN JG, 1995, RNA, V1, P584; Urlaub H, 2002, METHODS, V26, P170, DOI 10.1016/S1046-2023(02)00020-8; Urushiyama S, 1997, GENETICS, V147, P101; VAISMAN N, 1995, MOL GEN GENET, V247, P123, DOI 10.1007/BF00705642; Wang Y, 1998, RNA, V4, P1216, DOI 10.1017/S1355838298980992; Wu SP, 1999, NATURE, V402, P832, DOI 10.1038/45590; Xie J, 1998, EMBO J, V17, P2938, DOI 10.1093/emboj/17.10.2938; XU T, 1993, DEVELOPMENT, V117, P1223; Zhu J, 2001, MOL CELL, V8, P1351, DOI 10.1016/S1097-2765(01)00409-9; Zorio DAR, 1999, NATURE, V402, P835, DOI 10.1038/45597	68	30	32	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 7	2008	283	45					31256	31267		10.1074/jbc.M803512200	http://dx.doi.org/10.1074/jbc.M803512200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	367ID	18765666	Green Published, hybrid			2022-12-27	WOS:000260544800079
J	Klein, EA; Campbell, LE; Kothapalli, D; Fournier, AK; Assoian, RK				Klein, Eric A.; Campbell, Latoya E.; Kothapalli, Devashish; Fournier, Alaina K.; Assoian, Richard K.			Joint Requirement for Rac and ERK Activities Underlies the Mid-G1 Phase Induction of Cyclin D1 and S Phase Entry in Both Epithelial and Mesenchymal Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; SMOOTH-MUSCLE-CELLS; G(1) PHASE; G1 PHASE; CASCADE ACTIVATION; SIGNALING PATHWAY; GENE-EXPRESSION; D-1 EXPRESSION; PROGRESSION; INTEGRINS	Cyclin D1 gene induction is a key event in G1 phase progression. Our previous studies indicated that signaling to cyclin D1 is cell type-dependent because the timing of cyclin D1 gene expression in MCF10A mammary epithelial cells and mesenchymal cells such as fibroblasts and vascular smooth muscle cells is very different, with epithelial cells first expressing cyclin D1 in early rather than mid-G1 phase. In this report, we induced a mesenchymal phenotype in MCF10A cells by long-term exposure to TGF-beta and used the control and transitioned cells to examine cell type specificity of the signaling pathways that regulate cyclin D1 gene expression. We show that early-G1 phase cyclin D1 gene expression in MCF10A cells is under the control of Rac, whereas mid-G1 phase cyclin D1 induction requires parallel signaling from Rac and ERK, both in the control and transitioned cells. This combined requirement for Rac and ERK signaling is associated with an increased requirement for intracellular tension, Rb phosphorylation, and S phase entry. A similar co-regulation of cyclin D1 mRNA by Rac and ERK is seen in primary mesenchymal cells. Overall, our results reveal two mechanistically distinct phases of Rac-dependent cyclin D1 expression and emphasize that the acquisition of Rac/ERK codependence is required for the mid-G1 phase induction of cyclin D1 associated with S phase entry.	[Klein, Eric A.; Campbell, Latoya E.; Kothapalli, Devashish; Fournier, Alaina K.; Assoian, Richard K.] Univ Penn, Sch Med, Dept Pharmacol, Philadelphia, PA 19104 USA	University of Pennsylvania	Assoian, RK (corresponding author), Univ Penn, Sch Med, Dept Pharmacol, 3620 Hamilton Walk, Philadelphia, PA 19104 USA.	assoian@mail.med.upenn.edu		Klein, Eric/0000-0003-3941-6233	National Institutes of Health [CA72639, GM069064, HL083367]; NATIONAL CANCER INSTITUTE [R01CA072639] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL083367] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM069064] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants CA72639, GM069064, and HL083367. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked " advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Aplin AE, 1998, PHARMACOL REV, V50, P197; Assoian RK, 2001, CURR OPIN GENET DEV, V11, P48, DOI 10.1016/S0959-437X(00)00155-6; Balmanno K, 1999, ONCOGENE, V18, P3085, DOI 10.1038/sj.onc.1202647; Blagosklonny MV, 2002, CELL CYCLE, V1, P103, DOI 10.4161/cc.1.2.108; Bohmer RM, 1996, MOL BIOL CELL, V7, P101; Braga V, 2000, EXP CELL RES, V261, P83, DOI 10.1006/excr.2000.5050; Cook SJ, 1999, MOL CELL BIOL, V19, P330; Del Pozo MA, 2002, NAT CELL BIOL, V4, P232, DOI 10.1038/ncb759; Fournier AK, 2008, J CELL SCI, V121, P226, DOI 10.1242/jcs.017012; Frost JA, 1997, EMBO J, V16, P6426, DOI 10.1093/emboj/16.21.6426; Hirsch E, 2002, J CELL BIOL, V157, P481, DOI 10.1083/jcb.200111065; Joyce D, 1999, J BIOL CHEM, V274, P25245, DOI 10.1074/jbc.274.36.25245; Klein EA, 2007, METHOD ENZYMOL, V426, P155, DOI 10.1016/S0076-6879(07)26008-2; Klein EA, 2007, CELL CYCLE, V6, P1115, DOI 10.4161/cc.6.9.4147; Kothapalli D, 2007, J CELL BIOL, V176, P535, DOI 10.1083/jcb.200611058; Maeda M, 2005, J CELL SCI, V118, P873, DOI 10.1242/jcs.01634; Neve RM, 2002, ONCOGENE, V21, P4567, DOI 10.1038/sj.onc.1205555; Page K, 1999, AM J RESP CELL MOL, V20, P1294, DOI 10.1165/ajrcmb.20.6.3597; Page K, 1999, J BIOL CHEM, V274, P22065, DOI 10.1074/jbc.274.31.22065; Peinado H, 2003, J BIOL CHEM, V278, P21113, DOI 10.1074/jbc.M211304200; Ramakrishnan M, 1998, AM J RESP CELL MOL, V18, P736, DOI 10.1165/ajrcmb.18.6.3152; Roovers K, 1999, MOL BIOL CELL, V10, P3197, DOI 10.1091/mbc.10.10.3197; Roovers K, 2000, BIOESSAYS, V22, P818, DOI 10.1002/1521-1878(200009)22:9<818::AID-BIES7>3.3.CO;2-Y; Talarmin H, 1999, MOL CELL BIOL, V19, P6003; Villanueva J, 2007, MOL BIOL CELL, V18, P1457, DOI 10.1091/mbc.E06-10-0908; Watanabe G, 1996, J BIOL CHEM, V271, P22570, DOI 10.1074/jbc.271.37.22570; Weber JD, 1997, BIOCHEM J, V326, P61, DOI 10.1042/bj3260061; Welsh CF, 2001, NAT CELL BIOL, V3, P950, DOI 10.1038/ncb1101-950; Westwick JK, 1997, MOL CELL BIOL, V17, P1324, DOI 10.1128/MCB.17.3.1324; Yang C, 2008, BIOCHEM J, V410, P167, DOI 10.1042/BJ20070781; Zavadil J, 2005, ONCOGENE, V24, P5764, DOI 10.1038/sj.onc.1208927	31	22	22	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 7	2008	283	45					30911	30918		10.1074/jbc.M804537200	http://dx.doi.org/10.1074/jbc.M804537200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	367ID	18715870	Green Published, hybrid			2022-12-27	WOS:000260544800046
J	Kumari, A; Minko, IG; Harbut, MB; Finkel, SE; Goodman, MF; Lloyd, RS				Kumari, Anuradha; Minko, Irina G.; Harbut, Michael B.; Finkel, Steven E.; Goodman, Myron F.; Lloyd, R. Stephen			Replication bypass of interstrand cross-link intermediates by Escherichia coli DNA polymerase IV	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAMMALIAN-CELLS; POL-KAPPA; REPAIR; ACROLEIN; ADDUCT; FIDELITY; EXCISION; RECOMBINATION; PURIFICATION; MUTATIONS	Repair of interstrand DNA cross-links (ICLs) in Escherichia coli can occur through a combination of nucleotide excision repair (NER) and homologous recombination. However, an alternative mechanism has been proposed in which repair is initiated by NER followed by translesion DNA synthesis (TLS) and completed through another round of NER. Using site-specifically modified oligodeoxynucleotides that serve as a model for potential repair intermediates following incision by E. coli NER proteins, the ability of E. coli DNA polymerases (pol) II and IV to catalyze TLS past N-2-N-2-guanine ICLs was determined. No biochemical evidence was found suggesting that pol II could bypass these lesions. In contrast, pol IV could catalyze TLS when the nucleotides that are 5' to the cross-link were removed. The efficiency of TLS was further increased when the nucleotides 3' to the cross-linked site were also removed. The correct nucleotide, C, was preferentially incorporated opposite the lesion. When E. coli cells were transformed with a vector carrying a site-specific N-2- N-2- guanine ICL, the transformation efficiency of a pol II-deficient strain was indistinguishable from that of the wild type. However, the ability to replicate the modified vector DNA was nearly abolished in a pol IV-deficient strain. These data strongly suggest that pol IV is responsible for TLS past N-2-N-2- guanine ICLs.	[Kumari, Anuradha; Minko, Irina G.; Harbut, Michael B.; Lloyd, R. Stephen] Oregon Hlth & Sci Univ, Ctr Res Occupat & Environm Toxicol, Portland, OR 97239 USA; [Kumari, Anuradha; Minko, Irina G.; Harbut, Michael B.; Lloyd, R. Stephen] Oregon Hlth & Sci Univ, Dept Mol & Med Genet, Portland, OR 97239 USA; [Finkel, Steven E.; Goodman, Myron F.] Univ So Calif, Mol & Computat Biol Program, Dept Biol Sci, Los Angeles, CA 90089 USA; [Goodman, Myron F.] Univ So Calif, Dept Chem, Los Angeles, CA 90089 USA	Oregon Health & Science University; Oregon Health & Science University; University of Southern California; University of Southern California	Lloyd, RS (corresponding author), Oregon Hlth & Sci Univ, Ctr Res Occupat & Environm Toxicol, 3181 SW Sam Jackson Pk Rd, Portland, OR 97239 USA.	lloydst@ohsu.edu		Lloyd, R. Stephen/0000-0001-7273-372X	National Institutes of Health [ES05355, R37 GM21244, ES012259]; Center Grant [ES000267]; National Science Foundation Career Award [MCB-0237975]; NATIONAL CANCER INSTITUTE [P01CA160032] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES012259, P30ES000267, P01ES005355] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Center Grant; National Science Foundation Career Award(National Science Foundation (NSF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grant ES05355 (to R. S. L.) and Center Grant ES000267 and National Institutes of Health Grants R37 GM21244 and ES012259 (to M. F. G.). This work was also supported by National Science Foundation Career Award MCB-0237975 (to S. E. F.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact. at ISI, Thomson Scientific on October 6, 2008 www. jbc. org Downloaded from	Berardini M, 1999, J BACTERIOL, V181, P2878, DOI 10.1128/JB.181.9.2878-2882.1999; Berardini M, 1997, BIOCHEMISTRY-US, V36, P3506, DOI 10.1021/bi962778w; Cai H, 1995, METHOD ENZYMOL, V262, P13; COLE RS, 1973, P NATL ACAD SCI USA, V70, P1064, DOI 10.1073/pnas.70.4.1064; Creighton S, 1995, METHOD ENZYMOL, V262, P232; CREIGHTON S, 1995, J BIOL CHEM, V270, P4759, DOI 10.1074/jbc.270.9.4759; Gerlach VL, 2001, J BIOL CHEM, V276, P92, DOI 10.1074/jbc.M004413200; Kanuri M, 2005, DNA REPAIR, V4, P1374, DOI 10.1016/j.dnarep.2005.08.011; Kanuri M, 2002, J BIOL CHEM, V277, P18257, DOI 10.1074/jbc.M112419200; Kim HYH, 2002, J AM CHEM SOC, V124, P9324, DOI 10.1021/ja020333r; Kobayashi S, 2002, J BIOL CHEM, V277, P34198, DOI 10.1074/jbc.M204826200; Kozekov ID, 2003, J AM CHEM SOC, V125, P50, DOI 10.1021/ja020778f; Lee CH, 2006, J MOL GRAPH MODEL, V25, P87, DOI 10.1016/j.jmgm.2005.10.009; Minko IG, 2003, J BIOL CHEM, V278, P784, DOI 10.1074/jbc.M207774200; Minko IG, 2008, J BIOL CHEM, V283, P17075, DOI 10.1074/jbc.M801238200; MORIYA M, 1988, P NATL ACAD SCI USA, V85, P1586, DOI 10.1073/pnas.85.5.1586; Noll DM, 2006, CHEM REV, V106, P277, DOI 10.1021/cr040478b; VANHOUTEN B, 1986, P NATL ACAD SCI USA, V83, P8077; VANHOUTEN B, 1990, MICROBIOL REV, V54, P18, DOI 10.1128/MMBR.54.1.18-51.1990; Yeiser B, 2002, P NATL ACAD SCI USA, V99, P8737, DOI 10.1073/pnas.092269199; ZAMBRANO MM, 1993, SCIENCE, V259, P1757, DOI 10.1126/science.7681219	21	39	40	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 10	2008	283	41					27433	27437		10.1074/jbc.M801237200	http://dx.doi.org/10.1074/jbc.M801237200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	355OW	18697749	Green Published, hybrid			2022-12-27	WOS:000259719200012
J	Palle, K; Pattarello, L; van der Merwe, M; Losasso, C; Benedetti, P; Bjornsti, MA				Palle, Komaraiah; Pattarello, Luca; van der Merwe, Marie; Losasso, Carmen; Benedetti, Piero; Bjornsti, Mary-Ann			Disulfide cross-links reveal conserved features of DNA topoisomerase I architecture and a role for the n terminus in clamp closure	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CAMPTOTHECIN RESISTANCE; CATALYTIC-ACTIVITY; FUNCTIONAL LINKER; CELL LETHALITY; SLIDING CLAMP; MECHANISM; DOMAIN; RELAXATION; SENSITIVITY; YEAST	In eukaryotes, DNA topoisomerase I (Top1) catalyzes the relaxation of supercoiled DNA by a conserved mechanism of transient DNA strand breakage, rotation, and religation. The unusual architecture of the monomeric human enzyme comprises a conserved protein clamp, which is tightly wrapped about duplex DNA, and an extended coiled-coil linker domain that appropriately positions the C-terminal active site tyrosine domain against the Top1 core to form the catalytic pocket. A structurally undefined N-terminal domain, dispensable for enzyme activity, mediates protein-protein interactions. Previously, reversible disulfide bonds were designed to assess whether locking the Top1 clamp around duplex DNA would restrict DNA strand rotation within the covalent Top1-DNA intermediate. The active site proximal disulfide bond in full-length Top1-clamp(534) restricted DNA rotation ( Woo, M. H., Losasso, C., Guo, H., Pattarello, L., Benedetti, P., and Bjornsti, M. A. (2003) Proc. Natl. Acad. Sci. U. S. A. 100, 13767-13772), whereas the more distal disulfide bond of the N-terminally truncated Topo70-clamp(499) did not (Carey, J. F., Schultz, S. J., Sisson, L., Fazzio, T. G., and Champoux, J. J. ( 2003) Proc. Natl. Acad. Sci. U. S. A. 100, 5640-5645). To assess the contribution of the N-terminal domain to the dynamics of Top1 clamping of DNA, the same disulfide bonds were engineered into full-length Top1 and truncated Topo70, and the activities of these proteins were assessed in vitro and in yeast. Here we report that the N terminus impacts the opening and closing of the Top1 protein clamp. We also show that the architecture of yeast and human Top1 is conserved in so far as cysteine substitutions of the corresponding residues suffice to lock the Top1-clamp. However, the composition of the divergent N-terminal/linker domains impacts Top1-clamp activity and stability in vivo.	[Pattarello, Luca; Losasso, Carmen; Benedetti, Piero; Bjornsti, Mary-Ann] Univ Padua, Dept Biol, I-35131 Padua, Italy; [Palle, Komaraiah; van der Merwe, Marie; Bjornsti, Mary-Ann] St Jude Childrens Hosp, Dept Mol Pharmacol, Memphis, TN 38015 USA	University of Padua; St Jude Children's Research Hospital	Benedetti, P (corresponding author), Univ Padua, Dept Biol, Via Bassi 58-B, I-35131 Padua, Italy.	pietro.benedetti@unipd.it; ann.bjornsti@stjude.org	Losasso, Carmen/AAC-9734-2022; losasso, carmen/C-2928-2013; Losasso, Carmen/AAC-9790-2022	Losasso, Carmen/0000-0002-8234-1292; losasso, carmen/0000-0002-8234-1292; Losasso, Carmen/0000-0002-8234-1292	National Institutes of Health [CA58755, CA111542]; National Institutes of Health; NCI; Cancer Center Core [CA21765]; Ministero dell'Istruzione, dell'Universita e della Ricerca, Cofinanziamento; NATIONAL CANCER INSTITUTE [R01CA058755, P30CA021765, R01CA111542] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Cancer Center Core; Ministero dell'Istruzione, dell'Universita e della Ricerca, Cofinanziamento; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants CA58755 and CA111542 (to M.-A. B.) and National Institutes of Health, NCI, Cancer Center Core Grant CA21765. This work was also supported by the American Lebanese Syrian Associated Charities and grants from Ministero dell'Istruzione, dell'Universita e della Ricerca, Cofinanziamento 2005-2007 and Ministero della Salute (to P. B.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	ALSNER J, 1992, J BIOL CHEM, V267, P12408; BJORNSTI MA, 1987, P NATL ACAD SCI USA, V84, P8971, DOI 10.1073/pnas.84.24.8971; Bjornsti MA, 2002, CANCER CELL, V2, P267, DOI 10.1016/S1535-6108(02)00160-5; Carey JF, 2003, P NATL ACAD SCI USA, V100, P5640, DOI 10.1073/pnas.1031537100; Champoux JJ, 2001, ANNU REV BIOCHEM, V70, P369, DOI 10.1146/annurev.biochem.70.1.369; Cheng CH, 1998, CELL, V92, P841, DOI 10.1016/S0092-8674(00)81411-7; Chrencik JE, 2004, J MOL BIOL, V339, P773, DOI 10.1016/j.jmb.2004.03.007; Colley WC, 2004, J BIOL CHEM, V279, P54069, DOI 10.1074/jbc.M409764200; Corbett KD, 2004, ANNU REV BIOPH BIOM, V33, P95, DOI 10.1146/annurev.biophys.33.110502.140357; Desai SD, 1997, J BIOL CHEM, V272, P24159, DOI 10.1074/jbc.272.39.24159; Dionne I, 2008, MOL MICROBIOL, V68, P216, DOI 10.1111/j.1365-2958.2008.06150.x; Fiorani P, 2004, J BIOL CHEM, V279, P21271, DOI 10.1074/jbc.M312338200; Fiorani P, 2003, J BIOL CHEM, V278, P43268, DOI 10.1074/jbc.M303899200; Frohlich RF, 2004, J MOL BIOL, V336, P93, DOI 10.1016/j.jmb.2003.12.007; Frohlich RF, 2008, BIOCHEMISTRY-US, V47, P7127, DOI 10.1021/bi800031k; Frohlich RF, 2007, NUCLEIC ACIDS RES, V35, P6170, DOI 10.1093/nar/gkm669; Geiss-Friedlander R, 2007, NAT REV MOL CELL BIO, V8, P947, DOI 10.1038/nrm2293; Georgescu RE, 2008, CELL, V132, P43, DOI 10.1016/j.cell.2007.11.045; Haluska P, 1998, ADV ENZYME REGUL, V38, P253, DOI 10.1016/S0065-2571(97)00008-3; Jacquiau HR, 2005, J BIOL CHEM, V280, P23566, DOI 10.1074/jbc.M500947200; Jansen JG, 2007, MOL CELL, V28, P522, DOI 10.1016/j.molcel.2007.11.005; Kaiser C., 1994, METHODS YEAST GENETI; KAUH EA, 1995, P NATL ACAD SCI USA, V92, P6299, DOI 10.1073/pnas.92.14.6299; Koster DA, 2005, NATURE, V434, P671, DOI 10.1038/nature03395; Koster DA, 2007, NATURE, V448, P213, DOI 10.1038/nature05938; Leppard JB, 2005, CHROMOSOMA, V114, P75, DOI 10.1007/s00412-005-0345-5; Lin CP, 2008, J BIOL CHEM, V283, P21074, DOI 10.1074/jbc.M803493200; Lisby M, 2001, J BIOL CHEM, V276, P20220, DOI 10.1074/jbc.M010991200; Liu LF, 2000, ANN NY ACAD SCI, V922, P1; Losasso C, 2007, J BIOL CHEM, V282, P9855, DOI 10.1074/jbc.M608200200; Megonigal MD, 1997, J BIOL CHEM, V272, P12801, DOI 10.1074/jbc.272.19.12801; Mo YY, 2000, J BIOL CHEM, V275, P41107, DOI 10.1074/jbc.M003135200; Pommier Y, 2006, NAT REV CANCER, V6, P789, DOI 10.1038/nrc1977; Redinbo MR, 1998, SCIENCE, V279, P1504, DOI 10.1126/science.279.5356.1504; Redinbo MR, 2000, BIOCHEMISTRY-US, V39, P6832, DOI 10.1021/bi992690t; Roca J, 1996, P NATL ACAD SCI USA, V93, P4057, DOI 10.1073/pnas.93.9.4057; Staker BL, 2002, P NATL ACAD SCI USA, V99, P15387, DOI 10.1073/pnas.242259599; Stewart L, 1999, J BIOL CHEM, V274, P32950, DOI 10.1074/jbc.274.46.32950; Stewart L, 1997, J MOL BIOL, V269, P355, DOI 10.1006/jmbi.1997.1056; Stewart L, 1998, SCIENCE, V279, P1534, DOI 10.1126/science.279.5356.1534; Stewart L, 1996, J BIOL CHEM, V271, P7602, DOI 10.1074/jbc.271.13.7602; van der Merwe M, 2008, J BIOL CHEM, V283, P3305, DOI 10.1074/jbc.M705781200; van Waardenburg RCAM, 2006, MOL CELL BIOL, V26, P4958, DOI 10.1128/MCB.00160-06; Wang JC, 2002, NAT REV MOL CELL BIO, V3, P430, DOI 10.1038/nrm831; Woo MH, 2003, P NATL ACAD SCI USA, V100, P13767, DOI 10.1073/pnas.2235886100; Woo MH, 2002, J BIOL CHEM, V277, P3813, DOI 10.1074/jbc.M110484200	46	7	7	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 10	2008	283	41					27767	27775		10.1074/jbc.M804826200	http://dx.doi.org/10.1074/jbc.M804826200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	355OW	18693244	Green Published, hybrid			2022-12-27	WOS:000259719200048
J	Zhang, AS; Enns, CA				Zhang, An-Sheng; Enns, Caroline A.			Iron Homeostasis: Recently Identified Proteins Provide Insight into Novel Control Mechanisms	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							HEREDITARY HEMOCHROMATOSIS PROTEIN; TRANSFERRIN RECEPTOR 2; SOLUBLE HEMOJUVELIN; RESPONSIVE ELEMENT; MOLECULAR-BASIS; MOUSE MODEL; EXPRESSION; HFE; HEPCIDIN; GENE	Iron is an essential nutrient required for a variety of biochemical processes. It is a vital component of the heme in hemoglobin, myoglobin, and cytochromes and is also an essential cofactor for non-heme enzymes such as ribonucleotide reductase, the limiting enzyme for DNA synthesis. When in excess, iron is toxic because it generates superoxide anions and hydroxyl radicals that react readily with biological molecules, including proteins, lipids, and DNA. As a result, humans possess elegant control mechanisms to maintain iron homeostasis by coordinately regulating iron absorption, iron recycling, and mobilization of stored iron. Disruption of these processes causes either iron-deficient anemia or iron overload disorders. In this minireview, we focus on the roles of recently identified proteins in the regulation of iron homeostasis.	[Zhang, An-Sheng; Enns, Caroline A.] Oregon Hlth & Sci Univ, Dept Cell & Dev Biol, Portland, OR 97239 USA	Oregon Health & Science University	Enns, CA (corresponding author), Oregon Hlth & Sci Univ, Dept Cell & Dev Biol, Portland, OR 97239 USA.	ennsca@ohsu.edu			National Institutes of Health Grants [DK054488, DK072166, DK080765]; Amgen; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK080765, R01DK072166] Funding Source: NIH RePORTER	National Institutes of Health Grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Amgen(Amgen); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK054488 and DK072166 ( to C. A. E.) and DK080765 ( to A.- S. Z.). The work was also supported by Amgen ( to A.- S. Z.). This is the first article of three in the Thematic Minireview Series on Metals in Biology. This minireview will be reprinted in the 2009 Minireview Compendium, which will be available in January, 2010.	Allen KJ, 2008, NEW ENGL J MED, V358, P221, DOI 10.1056/NEJMoa073286; Babitt JL, 2006, NAT GENET, V38, P531, DOI 10.1038/ng1777; Babitt JL, 2007, J CLIN INVEST, V117, P1933, DOI 10.1172/JCI31342; BALI PK, 1991, BIOCHEMISTRY-US, V30, P324, DOI 10.1021/bi00216a003; BEAUMONT C, 1995, NAT GENET, V11, P444, DOI 10.1038/ng1295-444; BERNSTEIN SE, 1987, J LAB CLIN MED, V110, P690; Camaschella C, 2000, NAT GENET, V25, P14, DOI 10.1038/75534; Canonne-Hergaux F, 2001, BLOOD, V98, P3823, DOI 10.1182/blood.V98.13.3823; Cazzola M, 1999, BRIT J HAEMATOL, V106, P752, DOI 10.1046/j.1365-2141.1999.01600.x; Chen JX, 2007, J BIOL CHEM, V282, P36862, DOI 10.1074/jbc.M706720200; COOK JD, 1990, BRIT J HAEMATOL, V75, P603, DOI 10.1111/j.1365-2141.1990.tb07806.x; Cox JS, 1996, CELL, V87, P391, DOI 10.1016/S0092-8674(00)81360-4; De Domenico I, 2008, NAT REV MOL CELL BIO, V9, P72, DOI 10.1038/nrm2295; Feder JN, 1996, NAT GENET, V13, P399, DOI 10.1038/ng0896-399; Feder JN, 1997, J BIOL CHEM, V272, P14025, DOI 10.1074/jbc.272.22.14025; Feelders RA, 1999, CLIN CHEM LAB MED, V37, P1, DOI 10.1515/CCLM.1999.001; Fleming RE, 2000, P NATL ACAD SCI USA, V97, P2214, DOI 10.1073/pnas.040548097; FLOWERS CA, 1986, AM J HEMATOL, V23, P141, DOI 10.1002/ajh.2830230209; Galy B, 2008, CELL METAB, V7, P79, DOI 10.1016/j.cmet.2007.10.006; GIRELLI D, 1995, BLOOD, V86, P4050, DOI 10.1182/blood.V86.11.4050.bloodjournal86114050; Goswami T, 2006, J BIOL CHEM, V281, P28494, DOI 10.1074/jbc.C600197200; HARRIS ZL, 1995, P NATL ACAD SCI USA, V92, P2539, DOI 10.1073/pnas.92.7.2539; Huang FW, 2005, J CLIN INVEST, V115, P2187, DOI 10.1172/JCI25049; Johnson MB, 2007, MOL BIOL CELL, V18, P743, DOI 10.1091/mbc.E06-09-0798; Johnson MB, 2004, BLOOD, V104, P4287, DOI 10.1182/blood-2004-06-2477; Kawabata H, 2005, BLOOD, V105, P376, DOI 10.1182/blood-2004-04-1416; Kawabata H, 1999, J BIOL CHEM, V274, P20826, DOI 10.1074/jbc.274.30.20826; Keel SB, 2008, SCIENCE, V319, P825, DOI 10.1126/science.1151133; Kushner J P, 2001, Hematology Am Soc Hematol Educ Program, P47; Latunde-Dada GO, 2006, FEBS LETT, V580, P6865, DOI 10.1016/j.febslet.2006.11.048; Lin L, 2008, BLOOD CELL MOL DIS, V40, P122, DOI 10.1016/j.bcmd.2007.06.023; Nemeth E, 2004, SCIENCE, V306, P2090, DOI 10.1126/science.1104742; Nicolas G, 2002, P NATL ACAD SCI USA, V99, P4596, DOI 10.1073/pnas.072632499; Nicolas G, 2001, P NATL ACAD SCI USA, V98, P8780, DOI 10.1073/pnas.151179498; Niederkofler V, 2005, J CLIN INVEST, V115, P2180, DOI 10.1172/JCI25683; Ohgami RS, 2005, NAT GENET, V37, P1264, DOI 10.1038/ng1658; Papanikolaou G, 2004, NAT GENET, V36, P77, DOI 10.1038/ng1274; Peyssonnaux C, 2007, J CLIN INVEST, V117, P1926, DOI 10.1172/JCI31370; Qiu AD, 2006, CELL, V127, P917, DOI 10.1016/j.cell.2006.09.041; R'zik S, 2001, HAEMATOLOGICA, V86, P244; RAJA KB, 1986, BRIT J HAEMATOL, V64, P587, DOI 10.1111/j.1365-2141.1986.tb02214.x; Raja KB, 1999, BLOOD, V94, P3185, DOI 10.1182/blood.V94.9.3185.421a20_3185_3192; Robb A, 2004, BLOOD, V104, P4294, DOI 10.1182/blood-2004-06-2481; Santos M, 1996, J EXP MED, V184, P1975, DOI 10.1084/jem.184.5.1975; Sarkar J, 2003, J BIOL CHEM, V278, P44018, DOI 10.1074/jbc.M304926200; Schmidt PJ, 2008, CELL METAB, V7, P205, DOI 10.1016/j.cmet.2007.11.016; Shayeghi M, 2005, CELL, V122, P789, DOI 10.1016/j.cell.2005.06.025; Silvestri L, 2008, BLOOD, V111, P924, DOI 10.1182/blood-2007-07-100677; SIPE DM, 1991, J BIOL CHEM, V266, P8002; SMITH A, 1990, EUR J CELL BIOL, V53, P234; Spasic MV, 2008, CELL METAB, V7, P173, DOI 10.1016/j.cmet.2007.11.014; Spasic MV, 2007, BLOOD, V109, P4511, DOI 10.1182/blood-2006-07-036186; Tanno T, 2007, NAT MED, V13, P1096, DOI 10.1038/nm1629; TAYLOR P, 1988, J NUTR, V118, P1110, DOI 10.1093/jn/118.9.1110; Wallace DF, 2007, GASTROENTEROLOGY, V132, P301, DOI 10.1053/j.gastro.2006.11.028; Wang RH, 2005, CELL METAB, V2, P399, DOI 10.1016/j.cmet.2005.10.010; Weinstein DA, 2002, BLOOD, V100, P3776, DOI 10.1182/blood-2002-04-1260; West AP, 2000, J BIOL CHEM, V275, P38135, DOI 10.1074/jbc.C000664200; Wrighting DM, 2008, CURR TOP DEV BIOL, V82, P141, DOI 10.1016/S0070-2153(07)00006-3; Yang F, 2008, BIOCHEMISTRY-US, V47, P4237, DOI 10.1021/bi800036h; Zhang AS, 2007, J BIOL CHEM, V282, P12547, DOI 10.1074/jbc.M608788200; Zhang AS, 2004, BLOOD, V103, P1509, DOI 10.1182/blood-2003-07-2378; Zhang AS, 2005, J BIOL CHEM, V280, P33885, DOI 10.1074/jbc.M506207200; Zhou XY, 1998, P NATL ACAD SCI USA, V95, P2492, DOI 10.1073/pnas.95.5.2492	64	108	110	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 9	2009	284	2					711	715		10.1074/jbc.R800017200	http://dx.doi.org/10.1074/jbc.R800017200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	389VP	18757363	Green Published, hybrid			2022-12-27	WOS:000262122900002
J	McLean, P; Kunjara, S; Greenbaum, AL; Gumaa, K; Lopez-Prados, J; Martin-Lomas, M; Rademacher, TW				McLean, Patricia; Kunjara, Sirilaksana; Greenbaum, A. Leslie; Gumaa, Khalid; Lopez-Prados, Javier; Martin-Lomas, Manuel; Rademacher, Thomas W.			Reciprocal Control of Pyruvate Dehydrogenase Kinase and Phosphatase by Inositol Phosphoglycans DYNAMIC STATE SET BY "PUSH-PULL" SYSTEM	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							D-CHIRO-INOSITOL; INSULIN MEDIATORS; PHOSPHOLIPASE-C; RAT-LIVER; MANGANESE; COMPLEX; ZINC; PHOSPHODIESTERASE; METABOLISM; MECHANISMS	Reversible phosphorylation of proteins regulates numerous aspects of cell function, and abnormal phosphorylation is causal in many diseases. Pyruvate dehydrogenase complex (PDC) is central to the regulation of glucose homeostasis. PDC exists in a dynamic equilibrium between de-phospho-(active) and phosphorylated (inactive) forms controlled by pyruvate dehydrogenase phosphatases (PDP1,2) and pyruvate dehydrogenase kinases (PDK1-4). In contrast to the reciprocal regulation of the phospho/de-phospho cycle of PDC and at the level of expression of the isoforms of PDK and PDP regulated by hormones and diet, there is scant evidence for regulatory factors acting in vivo as reciprocal "on-off" switches. Here we show that the putative insulin mediator inositol phosphoglycan P-type (IPG-P) has a sigmoidal inhibitory action on PDK in addition to its known linear stimulation of PDP. Thus, at critical levels of IPG-P, this sigmoidal/linear model markedly enhances the switchover from the inactive to the active form of PDC, a "push-pull" system that, combined with the developmental and hormonal control of IPG-P, indicates their powerful regulatory function. The release of IPGs from cell membranes by insulin is significant in relation to diabetes. The chelation of IPGs with Mn2+ and Zn2+ suggests a role as "catalytic chelators" coordinating the traffic of metal ions in cells. Synthetic inositol hexosamine analogues are shown here to have a similar linear/sigmoidal reciprocal action on PDC exerting push-pull effects, suggesting their potential for treatment of metabolic disorders, including diabetes.	[McLean, Patricia; Kunjara, Sirilaksana; Greenbaum, A. Leslie; Rademacher, Thomas W.] UCL, Div Infect & Immun, Sch Med, London W1T 4JF, England; [McLean, Patricia; Kunjara, Sirilaksana; Greenbaum, A. Leslie; Gumaa, Khalid; Rademacher, Thomas W.] Sylus Pharmaceut, Oxford OX13 6BH, England; [Lopez-Prados, Javier; Martin-Lomas, Manuel] CSIC, Inst Invest Quim, Seville 41092, Spain; [Gumaa, Khalid] Arabian Gulf Univ, Coll Med & Med Sci, Manama, Bahrain	University of London; University College London; UCL Medical School; Consejo Superior de Investigaciones Cientificas (CSIC); University of Sevilla; CSIC-USE - Instituto de Investigaciones Quimicas (IIQ); Arabian Gulf University	Rademacher, TW (corresponding author), UCL, Div Infect & Immun, Sch Med, Windeyer Bldg,46 Cleveland St, London W1T 4JF, England.	t.rademacher@ucl.ac.uk			Medical Research Council; Basil Samuel Charitable Trust	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Basil Samuel Charitable Trust	This work was supported in part by grants from the Medical Research Council and the Basil Samuel Charitable Trust. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Adachi Y, 2006, BIOCHEM BIOPH RES CO, V351, P165, DOI 10.1016/j.bbrc.2006.10.014; ASPLIN I, 1993, P NATL ACAD SCI USA, V90, P5924, DOI 10.1073/pnas.90.13.5924; Bajotto G, 2004, LIFE SCI, V75, P2117, DOI 10.1016/j.lfs.2004.04.016; BAQUER NZ, 1975, BIOCHEM BIOPH RES CO, V62, P634, DOI 10.1016/0006-291X(75)90446-5; Basuki W, 2007, J INORG BIOCHEM, V101, P692, DOI 10.1016/j.jinorgbio.2006.12.015; Bonilla JB, 2002, EUR J ORG CHEM, V2002, P889, DOI 10.1002/1099-0690(200203)2002:5<889::AID-EJOC889>3.0.CO;2-3; Bonnet S, 2007, CANCER CELL, V11, P37, DOI 10.1016/j.ccr.2006.10.020; Bowker-Kinley MM, 1998, BIOCHEM J, V329, P191, DOI 10.1042/bj3290191; BRAUTIGAN DL, 1994, RECENT PROG HORM RES, V49, P197; Caro HN, 1997, BIOCHEM MOL MED, V61, P214, DOI 10.1006/bmme.1997.2607; Chen YI, 2003, BIOCHEM J, V374, P633, DOI 10.1042/BJ20030268; Cid MB, 2002, EUR J ORG CHEM, V2002, P881; Cohen P, 2004, NAT REV DRUG DISCOV, V3, P479, DOI 10.1038/nrd1415; Cohen P, 2001, EUR J BIOCHEM, V268, P5001, DOI 10.1046/j.0014-2956.2001.02473.x; Cohen P, 2002, NAT CELL BIOL, V4, pE127, DOI 10.1038/ncb0502-e127; COTTAZ S, 1995, J CHEM SOC PERK T 1, P1673, DOI 10.1039/p19950001673; COULSTON L, 1980, DIABETES, V29, P665, DOI 10.2337/diabetes.29.8.665; Culotta VC, 2005, EUKARYOT CELL, V4, P1159, DOI 10.1128/EC.4.7.1159-1165.2005; Denton RM, 1996, ADV ENZYME REGUL, V36, P183, DOI 10.1016/0065-2571(95)00020-8; Fonteles MC, 2000, HORM METAB RES, V32, P129, DOI 10.1055/s-2007-978606; GAULTON GN, 1991, DIABETES, V40, P1297, DOI 10.2337/diabetes.40.10.1297; Haase H, 2005, J TRACE ELEM MED BIO, V19, P37, DOI 10.1016/j.jtemb.2005.02.004; Harris RA, 2002, ADV ENZYME REGUL, V42, P249, DOI 10.1016/S0065-2571(01)00061-9; Holness MJ, 2003, BIOCHEM SOC T, V31, P1143; Huang BL, 2003, DIABETES, V52, P1371, DOI 10.2337/diabetes.52.6.1371; Huang BL, 1998, J BIOL CHEM, V273, P17680, DOI 10.1074/jbc.273.28.17680; Jones DR, 1999, MOL MED, V5, P505, DOI 10.1007/BF03401978; Karpova T, 2003, BBA-PROTEINS PROTEOM, V1652, P126, DOI 10.1016/j.bbapap.2003.08.010; Kato M, 2007, STRUCTURE, V15, P992, DOI 10.1016/j.str.2007.07.001; KOLABOVA J, 2001, AM J PHYSIOL, V862, P69; Kunjara S, 1999, MOL GENET METAB, V68, P488, DOI 10.1006/mgme.1999.2936; KUNJARA S, 1995, BIOPOLYMERS BIOPRODU, P301; Larner J, 2003, J MED CHEM, V46, P3283, DOI 10.1021/jm030071j; Larner J, 2001, IUBMB LIFE, V51, P139, DOI 10.1080/152165401753544205; Lemire J, 2008, J APPL TOXICOL, V28, P175, DOI 10.1002/jat.1263; LILLEY K, 1992, ARCH BIOCHEM BIOPHYS, V296, P170, DOI 10.1016/0003-9861(92)90559-F; Lopez-Prados J, 2005, ORG BIOMOL CHEM, V3, P764, DOI 10.1039/b418041k; Luk E, 2003, J BIOL INORG CHEM, V8, P803, DOI 10.1007/s00775-003-0482-3; Marangos P J, 1999, Expert Opin Investig Drugs, V8, P373, DOI 10.1517/13543784.8.4.373; Martin-Lomas M, 2000, TETRAHEDRON-ASYMMETR, V11, P37, DOI 10.1016/S0957-4166(99)00588-1; Mayers RM, 2003, BIOCHEM SOC T, V31, P1165; MERIDA I, 1988, FEBS LETT, V236, P251, DOI 10.1016/0014-5793(88)80325-9; Mueller G, 2008, MOL PHARMACOL, V73, P1513, DOI 10.1124/mol.107.043935; Muller G, 1997, ENDOCRINOLOGY, V138, P3459, DOI 10.1210/en.138.8.3459; Muller G, 2000, BIOCHEMISTRY-US, V39, P1475, DOI 10.1021/bi9920432; NESTLER JE, 1991, ENDOCRINOLOGY, V129, P2951, DOI 10.1210/endo-129-6-2951; NEWMAN JD, 1985, ENDOCRINOLOGY, V116, P1912, DOI 10.1210/endo-116-5-1912; PLOURDE R, 1992, J ORG CHEM, V57, P2606, DOI 10.1021/jo00035a015; Poyner RR, 2001, BIOCHEMISTRY-US, V40, P8009, DOI 10.1021/bi0103922; RADEMACHER TW, 1994, BRAZ J MED BIOL RES, V27, P327; RENNIE PIC, 1981, HORM METAB RES, V13, P145, DOI 10.1055/s-2007-1019202; Roche TE, 2007, CELL MOL LIFE SCI, V64, P830, DOI 10.1007/s00018-007-6380-z; Roche TE, 2001, PROG NUCLEIC ACID RE, V70, P33, DOI 10.1016/S0079-6603(01)70013-X; RODBELL M, 1964, J BIOL CHEM, V239, P375; Romero G, 1993, Adv Pharmacol, V24, P21, DOI 10.1016/S1054-3589(08)60932-1; Ryan M, 1996, J MED CHEM, V39, P4366, DOI 10.1021/jm960434y; SALTIEL AR, 1987, ENDOCRINOLOGY, V120, P967, DOI 10.1210/endo-120-3-967; SANCHEZARIAS JA, 1992, ENDOCRINOLOGY, V131, P1727, DOI 10.1210/en.131.4.1727; SCORPIO RM, 1970, BIOCHEM J, V118, P391, DOI 10.1042/bj1180391; Shashkin PN, 1997, DIABETOLOGIA, V40, P557, DOI 10.1007/s001250050715; Sleight S, 2002, BIOCHEM BIOPH RES CO, V295, P561, DOI 10.1016/S0006-291X(02)00701-5; Smolenski RT, 2001, EUR J CARDIO-THORAC, V19, P865, DOI 10.1016/S1010-7940(01)00659-5; SUBASINGHE S, 1985, BIOCHEM MED METAB B, V34, P83, DOI 10.1016/0006-2944(85)90064-X; Sugden M. C., 2002, Current Drug Targets - Immune Endocrine and Metabolic Disorders, V2, P151, DOI 10.2174/1568008023340785; Sugden MC, 2001, BIOCHEM SOC T, V29, P272, DOI 10.1042/0300-5127:0290272; SUZUKI S, 1987, J BIOL CHEM, V262, P3199; THAMPY KG, 1985, J BIOL CHEM, V260, P6318; VarelaNieto I, 1996, COMP BIOCHEM PHYS B, V115, P223, DOI 10.1016/0305-0491(96)00087-9; Wu PF, 2000, ARCH BIOCHEM BIOPHYS, V381, P1, DOI 10.1006/abbi.2000.1946; Ye B, 2001, P NATL ACAD SCI USA, V98, P2317, DOI 10.1073/pnas.041619198; YU KT, 1987, J BIOL CHEM, V262, P16677	71	21	21	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 28	2008	283	48					33428	33436		10.1074/jbc.M801781200	http://dx.doi.org/10.1074/jbc.M801781200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	376KY	18768479	Green Published, hybrid			2022-12-27	WOS:000261183700047
J	Hausmann, S; Zheng, S; Costanzo, M; Brost, RL; Garcin, D; Boone, C; Shuman, S; Schwer, B				Hausmann, Stephane; Zheng, Sushuang; Costanzo, Michael; Brost, Renee L.; Garcin, Dominique; Boone, Charles; Shuman, Stewart; Schwer, Beate			Genetic and Biochemical Analysis of Yeast and Human Cap Trimethylguanosine Synthase FUNCTIONAL OVERLAP OF 2,2,7-TRIMETHYLGUANOSINE CAPS, SMALL NUCLEAR RIBONUCLEOPROTEIN COMPONENTS, PRE-mRNA SPLICING FACTORS, AND RNA DECAY PATHWAYS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							U2 SNRNP PROTEIN; SACCHAROMYCES-CEREVISIAE; U1 SNRNP; MUTATIONAL ANALYSIS; ANALYSIS REVEALS; GIARDIA-LAMBLIA; BINDING PROTEIN; RIBOSOMAL-RNA; COMPLEX; METHYLTRANSFERASE	Trimethylguanosine synthase (Tgs1) is the enzyme that converts standard m(7)G caps to the 2,2,7-trimethylguanosine (TMG) caps characteristic of spliceosomal small nuclear RNAs. Fungi and mammalian somatic cells are able to grow in the absence of Tgs1 and TMG caps, suggesting that an essential function of the TMG cap might be obscured by functional redundancy. A systematic screen in budding yeast identified nonessential genes that, when deleted, caused synthetic growth defects with tgs1 Delta. The Tgs1 interaction network embraced proteins implicated in small nuclear ribonucleoprotein function and spliceosome assembly, including Mud2, Nam8, Brr1, Lea1, Ist3, Isy1, Cwc21, and Bud13. Complementation of the synthetic lethality of mud2 Delta tgs1 Delta and nam8 Delta tgs1 Delta strains by wild-type TGS1, but not by catalytically defective mutants, indicated that the TMG cap is essential for mitotic growth when redundant splicing factors are missing. Our genetic analysis also highlighted synthetic interactions of Tgs1 with proteins implicated in RNA end processing and decay (Pat1, Lsm1, and Trf4) and regulation of polymerase II transcription (Rpn4, Spt3, Srb2, Soh1, Swr1, and Htz1). We find that the C-terminal domain of human Tgs1 can function in lieu of the yeast protein in vivo. We present a biochemical characterization of the human Tgs1 guanine-N-2 methyltransferase reaction and identify individual amino acids required for methyltransferase activity in vitro and in vivo.	[Hausmann, Stephane; Garcin, Dominique] Univ Geneva, Dept Microbiol & Mol Med, CH-1211 Geneva, Switzerland; [Zheng, Sushuang; Shuman, Stewart] Sloan Kettering Inst, Program Mol Biol, New York, NY 10065 USA; [Costanzo, Michael; Brost, Renee L.; Boone, Charles] Univ Toronto, Banting & Best Dept Med Res, Toronto, ON M5S 3E1, Canada; [Schwer, Beate] Weill Cornell Med Coll, Dept Microbiol & Immunol, New York, NY 10065 USA	University of Geneva; Memorial Sloan Kettering Cancer Center; University of Toronto; Cornell University	Hausmann, S (corresponding author), Univ Geneva, Dept Microbiol & Mol Med, CH-1211 Geneva, Switzerland.	Stephane.Hausmann@medecine.unige.ch; s-shuman@ski.mkscc.org; bschwer@med.cornell.edu		Schwer, Beate/0000-0002-3824-9819	National Institutes of Health [GM52470]; Genome Canada [2004-OGI-3-01]; Ontario Genomics Institute; Canadian Institutes of Health [GSP-41567]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM052470] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Genome Canada(Genome Canada); Ontario Genomics Institute; Canadian Institutes of Health(Canadian Institutes of Health Research (CIHR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM52470 (to S. S. and B. S.). This work was also supported by Research Agreement 2004-OGI-3-01 from Genome Canada, the Ontario Genomics Institute, and Research Agreement GSP-41567 from Canadian Institutes of Health (to C. B.).	ABOVICH N, 1994, GENE DEV, V8, P843, DOI 10.1101/gad.8.7.843; Allmang C, 1999, EMBO J, V18, P5399, DOI 10.1093/emboj/18.19.5399; Boone C, 2007, NAT REV GENET, V8, P437, DOI 10.1038/nrg2085; Bouveret E, 2000, EMBO J, V19, P1661, DOI 10.1093/emboj/19.7.1661; BUSCH H, 1982, ANNU REV BIOCHEM, V51, P617, DOI 10.1146/annurev.bi.51.070182.003153; Caspary F, 1998, EMBO J, V17, P6348, DOI 10.1093/emboj/17.21.6348; Chen CH, 2002, NUCLEIC ACIDS RES, V30, P1029, DOI 10.1093/nar/30.4.1029; Chen CH, 2001, J BIOL CHEM, V276, P488, DOI 10.1074/jbc.M006958200; Colau G, 2004, MOL CELL BIOL, V24, P7976, DOI 10.1128/MCB.24.18.7976-7986.2004; Del Gato-Konczak F, 2000, MOL CELL BIOL, V20, P6287, DOI 10.1128/MCB.20.17.6287-6299.2000; Demirci H, 2008, J BIOL CHEM, V283, P26548, DOI 10.1074/jbc.M804005200; Dix I, 1999, RNA, V5, P360, DOI 10.1017/S1355838299981396; Dohmen RJ, 2007, BBA-MOL CELL RES, V1773, P1599, DOI 10.1016/j.bbamcr.2007.05.015; Dziembowski A, 2004, EMBO J, V23, P4847, DOI 10.1038/sj.emboj.7600482; Enyenihi AH, 2003, GENETICS, V163, P47; Fabrega C, 2004, MOL CELL, V13, P77, DOI 10.1016/S1097-2765(03)00522-7; Forch P, 2000, MOL CELL, V6, P1089, DOI 10.1016/S1097-2765(00)00107-6; FRESCO LD, 1994, P NATL ACAD SCI USA, V91, P6624, DOI 10.1073/pnas.91.14.6624; FromontRacine M, 1997, NAT GENET, V16, P277, DOI 10.1038/ng0797-277; Girard C, 2008, J BIOL CHEM, V283, P2060, DOI 10.1074/jbc.M704209200; Goldstein AL, 1999, YEAST, V15, P1541, DOI 10.1002/(SICI)1097-0061(199910)15:14<1541::AID-YEA476>3.3.CO;2-B; Gottschalk A, 1998, RNA, V4, P374; Gottschalk A, 2001, MOL CELL BIOL, V21, P3037, DOI 10.1128/MCB.21.9.3037-3046.2001; Guglielmi B, 2004, NUCLEIC ACIDS RES, V32, P5379, DOI 10.1093/nar/gkh878; Guillemette B, 2006, BIOCHEM CELL BIOL, V84, P528, DOI 10.1139/O06-077; Harbison CT, 2004, NATURE, V431, P99, DOI 10.1038/nature02800; Hausmann S, 2005, J BIOL CHEM, V280, P32101, DOI 10.1074/jbc.M506438200; Hausmann S, 2005, J BIOL CHEM, V280, P4021, DOI 10.1074/jbc.C400554200; Hausmann S, 2007, NUCLEIC ACIDS RES, V35, P1411, DOI 10.1093/nar/gkl1150; Kadaba S, 2004, GENE DEV, V18, P1227, DOI 10.1101/gad.1183804; Kobor MS, 2004, PLOS BIOL, V2, P587, DOI 10.1371/journal.pbio.0020131; Komonyi O, 2005, J BIOL CHEM, V280, P12397, DOI 10.1074/jbc.M409251200; Krogan NJ, 2003, MOL CELL, V12, P1565, DOI 10.1016/S1097-2765(03)00497-0; LaCava J, 2005, CELL, V121, P713, DOI 10.1016/j.cell.2005.04.029; Lemm I, 2006, MOL BIOL CELL, V17, P3221, DOI 10.1091/mbc.E06-03-0247; LIAO XLC, 1993, GENE DEV, V7, P419, DOI 10.1101/gad.7.3.419; Linder T, 2004, J BIOL CHEM, V279, P49455, DOI 10.1074/jbc.M409046200; LIOU RF, 1990, MOL CELL BIOL, V10, P1764, DOI 10.1128/MCB.10.4.1764; Mao XD, 1996, MOL CELL BIOL, V16, P475; Misra P, 2002, J BIOL CHEM, V277, P20011, DOI 10.1074/jbc.M201739200; Mitchell P, 2003, MOL CELL BIOL, V23, P6982, DOI 10.1128/MCB.23.19.6982-6992.2003; Mizuguchi G, 2004, SCIENCE, V303, P343, DOI 10.1126/science.1090701; Mouaikel J, 2003, NUCLEIC ACIDS RES, V31, P4899, DOI 10.1093/nar/gkg656; Mouaikel J, 2002, MOL CELL, V9, P891, DOI 10.1016/S1097-2765(02)00484-7; Murphy MW, 2004, GENETICS, V166, P53, DOI 10.1534/genetics.166.1.53; Neubauer G, 1997, P NATL ACAD SCI USA, V94, P385, DOI 10.1073/pnas.94.2.385; Noble SM, 1996, EMBO J, V15, P4368, DOI 10.1002/j.1460-2075.1996.tb00810.x; Ohi MD, 2002, MOL CELL BIOL, V22, P2011, DOI 10.1128/MCB.22.7.2011-2024.2002; Pilkington GR, 2008, MOL CELL BIOL, V28, P1298, DOI 10.1128/MCB.00936-07; Ping Yueh-Hsin, 2004, Retrovirology, V1, P46, DOI 10.1186/1742-4690-1-46; Puig O, 1999, GENE DEV, V13, P569, DOI 10.1101/gad.13.5.569; Rutz B, 1999, RNA, V5, P819, DOI 10.1017/S1355838299982286; Scherrer FW, 2006, RNA, V12, P1361, DOI 10.1261/rna.2276806; SCHIESTL RH, 1989, CURR GENET, V16, P339, DOI 10.1007/BF00340712; Schwer B, 1998, NUCLEIC ACIDS RES, V26, P2050, DOI 10.1093/nar/26.9.2050; SCHWER B, 1994, P NATL ACAD SCI USA, V91, P4328, DOI 10.1073/pnas.91.10.4328; Seto AG, 1999, NATURE, V401, P177, DOI 10.1038/43694; Shuman S, 2001, COLD SPRING HARB SYM, V66, P301, DOI 10.1101/sqb.2001.66.301; Spingola M, 2000, MOL CELL, V6, P329, DOI 10.1016/S1097-2765(00)00033-2; Spingola M, 2004, NUCLEIC ACIDS RES, V32, P1242, DOI 10.1093/nar/gkh281; Srinivasan P, 2003, J BIOL CHEM, V278, P14168, DOI 10.1074/jbc.M212102200; Stevens SW, 2002, MOL CELL, V9, P31, DOI 10.1016/S1097-2765(02)00436-7; Takagi T, 2003, J BIOL CHEM, V278, P14174, DOI 10.1074/jbc.M212101200; Teixeira D, 2007, MOL BIOL CELL, V18, P2274, DOI 10.1091/mbc.E07-03-0199; Tharun S, 2000, NATURE, V404, P515, DOI 10.1038/35006676; THOMPSON CM, 1993, CELL, V73, P1361, DOI 10.1016/0092-8674(93)90362-T; Tong AHY, 2004, SCIENCE, V303, P808, DOI 10.1126/science.1091317; Tong AHY, 2001, SCIENCE, V294, P2364, DOI 10.1126/science.1065810; Tong Amy Hin Yan, 2006, Methods Mol Biol, V313, P171; Van Hoof A, 2000, MOL CELL BIOL, V20, P441, DOI 10.1128/MCB.20.2.441-452.2000; Vanacova S, 2005, PLOS BIOL, V3, P986, DOI 10.1371/journal.pbio.0030189; Verheggen C, 2002, EMBO J, V21, P2736, DOI 10.1093/emboj/21.11.2736; Villa T, 2005, GENE DEV, V19, P1894, DOI 10.1101/gad.1336305; Wu PYJ, 2004, MOL CELL, V15, P199, DOI 10.1016/j.molcel.2004.06.005; Wyers F, 2005, CELL, V121, P725, DOI 10.1016/j.cell.2005.04.030; Zhu YJ, 2001, P NATL ACAD SCI USA, V98, P10380, DOI 10.1073/pnas.181347498	76	55	58	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 14	2008	283	46					31706	31718		10.1074/jbc.M806127200	http://dx.doi.org/10.1074/jbc.M806127200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	370KJ	18775984	Green Published, hybrid			2022-12-27	WOS:000260760800053
J	Rost, M; Doering, T; Prange, R				Rost, Martina; Doering, Tatjana; Prange, Reinhild			gamma 2-Adaptin, a Ubiquitin-interacting Adaptor, Is a Substrate to Coupled Ubiquitination by the Ubiquitin Ligase Nedd4 and Functions in the Endosomal Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANS-GOLGI NETWORK; B-VIRUS MATURATION; BINDING DOMAINS; GAMMA-ADAPTIN; C2 DOMAIN; RECEPTOR ENDOCYTOSIS; ESCRT-III; PROTEINS; MOTIF; MONOUBIQUITINATION	gamma 2-Adaptin is a putative member of the clathrin adaptor protein family with unknown physiological function. We previously reported that gamma 2-adaptin acts as a ubiquitin receptor by virtue of its ubiquitin-interacting motif. Here we demonstrate that this motif mediates a specific physical interaction with the ubiquitin ligase Nedd4 and promotes ubiquitination of gamma 2-adaptin. By mapping regions of Nedd4 involved in binding to gamma 2-adaptin, we identified its C2 domain to be essential, whereas the WW and HECT domains are dispensable. Consistent with this, we uncovered that the C2 domain of Nedd4 is ubiquitinated itself and as such is recruited by the ubiquitin-interacting motif of gamma 2-adaptin for subsequent ubiquitin conjugation. Unlike known coupled ubiquitination reactions, this novel type of interaction leads to mono- and multi/polyubiquitinated gamma 2-adaptin. In addition, we show that gamma 2-adaptin functions in the endosomal/multivesicular body (MVB) pathway. Depletion of gamma 2-adaptin impairs the degradation of internalized epidermal growth factor and results in defective MVB morphology characterized by significantly enlarged vesicles. These defects cannot be rescued by gamma 1-adaptin, a closely related homolog of gamma 2-adaptin, which is unable to bind ubiquitin. Together, these results indicate that gamma 2-adaptin may operate within the MVB sorting system in a manner different from that of classic adaptins.	[Rost, Martina; Doering, Tatjana; Prange, Reinhild] Johannes Gutenberg Univ Mainz, Dept Med Microbiol & Hyg, D-55101 Mainz, Germany	Johannes Gutenberg University of Mainz	Prange, R (corresponding author), Johannes Gutenberg Univ Mainz, Dept Med Microbiol & Hyg, D-55101 Mainz, Germany.	prange@uni-mainz.de		Prange, Reinhild/0000-0001-8312-4970	Deutsche Forschungsgemeinschaft [SFB 490-D1, PR 305/1-3]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft Grants SFB 490-D1 and PR 305/1-3 (to R. P.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	Babst M, 2002, DEV CELL, V3, P271, DOI 10.1016/S1534-5807(02)00220-4; Boehm M, 2001, MOL BIOL CELL, V12, P2907, DOI 10.1091/mbc.12.10.2907; Bouamr F, 2003, J VIROL, V77, P11882, DOI 10.1128/JVI.77.22.11882-11895.2003; Chen BJ, 2008, VIROLOGY, V372, P221, DOI 10.1016/j.virol.2007.11.008; Chen C, 2007, CANCER METAST REV, V26, P587, DOI 10.1007/s10555-007-9091-x; Dolnik O, 2008, CELL MOL LIFE SCI, V65, P756, DOI 10.1007/s00018-007-7406-2; Dunn R, 2004, J CELL BIOL, V165, P135, DOI 10.1083/jcb.200309026; Fallon L, 2006, NAT CELL BIOL, V8, P834, DOI 10.1038/ncb1441; Fujita H, 2003, J CELL SCI, V116, P401, DOI 10.1242/jcs.00213; Haglund K, 2003, TRENDS BIOCHEM SCI, V28, P598, DOI 10.1016/j.tibs.2003.09.005; Hartmann-Stuhler C, 2001, J VIROL, V75, P5343, DOI 10.1128/JVI.75.11.5343-5351.2001; Hicke L, 2005, NAT REV MOL CELL BIO, V6, P610, DOI 10.1038/nrm1701; Hicke L, 2001, CELL, V106, P527, DOI 10.1016/S0092-8674(01)00485-8; Hirst J, 2000, J CELL BIOL, V149, P67, DOI 10.1083/jcb.149.1.67; Hoeller D, 2006, NAT CELL BIOL, V8, P163, DOI 10.1038/ncb1354; Hofmann K, 2001, TRENDS BIOCHEM SCI, V26, P347, DOI 10.1016/S0968-0004(01)01835-7; Hurley JH, 2008, CURR OPIN CELL BIOL, V20, P4, DOI 10.1016/j.ceb.2007.12.002; Hurley JH, 2006, BIOCHEM J, V399, P361, DOI 10.1042/BJ20061138; Ingham RJ, 2004, ONCOGENE, V23, P1972, DOI 10.1038/sj.onc.1207436; Katz M, 2002, TRAFFIC, V3, P740, DOI 10.1034/j.1600-0854.2002.31006.x; Kobayashi T, 1998, NATURE, V392, P193, DOI 10.1038/32440; Lambert C, 2007, J VIROL, V81, P9050, DOI 10.1128/JVI.00479-07; Lewin DA, 1998, FEBS LETT, V435, P263, DOI 10.1016/S0014-5793(98)01083-7; Marchese A, 2003, DEV CELL, V5, P709, DOI 10.1016/S1534-5807(03)00321-6; Martin-Serrano J, 2005, J CELL BIOL, V168, P89, DOI 10.1083/jcb.200408155; Martin-Serrano J, 2007, TRAFFIC, V8, P1297, DOI 10.1111/j.1600-0854.2007.00609.x; Miller SLH, 2004, J BIOL CHEM, V279, P33528, DOI 10.1074/jbc.M313097200; Mizuno E, 2003, MOL BIOL CELL, V14, P3675, DOI 10.1091/mbc.E02-12-0823; Pak Y, 2006, J CELL BIOL, V175, P631, DOI 10.1083/jcb.200603001; Plant PJ, 2000, J CELL BIOL, V149, P1473, DOI 10.1083/jcb.149.7.1473; Polo S, 2002, NATURE, V416, P451, DOI 10.1038/416451a; Puertollano R, 2004, NAT CELL BIOL, V6, P244, DOI 10.1038/ncb1106; Robinson MS, 2004, TRENDS CELL BIOL, V14, P167, DOI 10.1016/j.tcb.2004.02.002; Rost M, 2006, J BIOL CHEM, V281, P29297, DOI 10.1074/jbc.M603517200; Saksena S, 2007, TRENDS BIOCHEM SCI, V32, P561, DOI 10.1016/j.tibs.2007.09.010; Scheffner M, 2007, BMC BIOCHEM, V8, DOI 10.1186/1471-2091-8-S1-S6; Schmid SL, 1997, ANNU REV BIOCHEM, V66, P511, DOI 10.1146/annurev.biochem.66.1.511; Scott PM, 2004, NAT CELL BIOL, V6, P252, DOI 10.1038/ncb1107; Shiba Y, 2004, J BIOL CHEM, V279, P7105, DOI 10.1074/jbc.M311702200; Shih SC, 2002, NAT CELL BIOL, V4, P389, DOI 10.1038/ncb790; Takatsu H, 1998, J BIOL CHEM, V273, P24693, DOI 10.1074/jbc.273.38.24693; TREIER M, 1994, CELL, V78, P787, DOI 10.1016/S0092-8674(94)90502-9; von Zastrow M, 2007, CURR OPIN CELL BIOL, V19, P436, DOI 10.1016/j.ceb.2007.04.021; Watanabe T, 2007, P NATL ACAD SCI USA, V104, P10205, DOI 10.1073/pnas.0704000104; Wiesner S, 2007, CELL, V130, P651, DOI 10.1016/j.cell.2007.06.050; Williams RL, 2007, NAT REV MOL CELL BIO, V8, P355, DOI 10.1038/nrm2162; Woelk T, 2006, NAT CELL BIOL, V8, P1246, DOI 10.1038/ncb1484; Yogosawa S, 2006, BIOCHEM BIOPH RES CO, V350, P82, DOI 10.1016/j.bbrc.2006.09.013; Zizioli D, 1999, J BIOL CHEM, V274, P5385, DOI 10.1074/jbc.274.9.5385	49	21	22	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 14	2008	283	46					32119	32130		10.1074/jbc.M802632200	http://dx.doi.org/10.1074/jbc.M802632200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	370KJ	18772139	hybrid			2022-12-27	WOS:000260760800093
J	Baden, EM; Randles, EG; Aboagye, AK; Thompson, JR; Ramirez-Alvarado, M				Baden, Elizabeth M.; Randles, Edward G.; Aboagye, Awo K.; Thompson, James R.; Ramirez-Alvarado, Marina			Structural Insights into the Role of Mutations in Amyloidogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VARIABLE REGION; LIGHT-CHAINS; MODEL; ASSOCIATION; REPLACEMENT; AMYLOIDOSIS; STABILITY; FEATURES; TOOLS	Mechanisms of amyloidogenesis are not well understood, including potential structural contributions of mutations in the process. Our previous research indicated that the dimer interface of amyloidogenic immunoglobulin light chain protein AL-09 is twisted 90 degrees relative to the protein from its germline sequence, kappa IO18/O8. Here we report a systematic restoration of AL-09 to its germline sequence by mutating the non-conservative somatic mutations located in the light chain dimer interface. Among these mutants, we find a correlation between increased thermodynamic stability and an increase in the lag time for fibril formation. The restorative mutant AL-09 H87Y completes the trifecta and restores the dimer interface observed in kappa I O18/O8, emphasizing the potential importance of the structural integrity of these proteins to protect against amyloidogenicity. We also find that adding amyloidogenic mutations into the germline protein illustrates mutational cooperativity in promoting amyloidogenesis.	[Baden, Elizabeth M.; Randles, Edward G.; Aboagye, Awo K.; Ramirez-Alvarado, Marina] Mayo Clin, Coll Med, Dept Biochem & Mol Biol, Rochester, MN 55905 USA; [Thompson, James R.] Mayo Clin, Coll Med, Dept Physiol & Biomed Engn, Rochester, MN 55905 USA	Mayo Clinic; Mayo Clinic	Ramirez-Alvarado, M (corresponding author), Mayo Clin, Coll Med, Dept Biochem & Mol Biol, 200 1st St SW, Rochester, MN 55905 USA.	ramirezalvarado.marina@mayo.edu		Ramirez-Alvarado, Marina/0000-0003-2325-6773	National Institutes of Health [GM071514]; Biotechnology and Medical Genomics [SPAP-50-013-P-FY06];  [University of Minnesota Supercomputing Institute]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM071514] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Biotechnology and Medical Genomics; ; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM071514 ( to M. R.- A.). This work was also supported by Minnesota Partnership for Biotechnology and Medical Genomics Grant SPAP-50-013-P-FY06 ( to J. R. T.) and the Basic Sciences Computing Laboratory of the University of Minnesota Supercomputing Institute ( to J. R. T.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked " advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Baden EM, 2008, J BIOL CHEM, V283, P15853, DOI 10.1074/jbc.M705347200; Comenzo RL, 1999, BRIT J HAEMATOL, V106, P744, DOI 10.1046/j.1365-2141.1999.01591.x; Davis DP, 2000, IMMUNITY, V13, P433, DOI 10.1016/S1074-7613(00)00043-1; Yauner LD, 2008, PROTEINS, V72, P684, DOI 10.1002/prot.21934; DUL JL, 1990, P NATL ACAD SCI USA, V87, P8135, DOI 10.1073/pnas.87.20.8135; DUL JL, 1992, J IMMUNOL, V149, P1927; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; HURLE MR, 1994, P NATL ACAD SCI USA, V91, P5446, DOI 10.1073/pnas.91.12.5446; Kim YS, 2000, J BIOL CHEM, V275, P1570, DOI 10.1074/jbc.275.3.1570; KYLE RA, 1995, SEMIN HEMATOL, V32, P45; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; McLaughlin RW, 2006, PROTEIN SCI, V15, P1710, DOI 10.1110/ps.051997606; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pace C. N., 1997, PROTEIN STRUCTURE PR, V2, P299; Palaninathan SK, 2008, J MOL BIOL, V382, P1157, DOI 10.1016/j.jmb.2008.07.029; Pflugrath JW, 1999, ACTA CRYSTALLOGR D, V55, P1718, DOI 10.1107/S090744499900935X; Read RJ, 2001, ACTA CRYSTALLOGR D, V57, P1373, DOI 10.1107/S0907444901012471; Richardson JS, 2003, METHOD ENZYMOL, V374, P385, DOI 10.1016/S0076-6879(03)74018-X; SCHORMANN N, 1995, P NATL ACAD SCI USA, V92, P9490, DOI 10.1073/pnas.92.21.9490; STEVENS FJ, 1980, P NATL ACAD SCI-BIOL, V77, P1144, DOI 10.1073/pnas.77.2.1144; STEVENS PW, 1995, PROTEIN SCI, V4, P421; Storoni LC, 2004, ACTA CRYSTALLOGR D, V60, P432, DOI 10.1107/S0907444903028956; Vaguine AA, 1999, ACTA CRYSTALLOGR D, V55, P191, DOI 10.1107/S0907444998006684; Wall J, 1999, BIOCHEMISTRY-US, V38, P14101, DOI 10.1021/bi991131j; Wall JS, 2004, J MOL RECOGNIT, V17, P323, DOI 10.1002/jmr.681; Wetzel R, 1997, ADV PROTEIN CHEM, V50, P183, DOI 10.1016/S0065-3233(08)60322-8; Winn MD, 2001, ACTA CRYSTALLOGR D, V57, P122, DOI 10.1107/S0907444900014736	28	52	52	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 7	2008	283	45					30950	30956		10.1074/jbc.M804822200	http://dx.doi.org/10.1074/jbc.M804822200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	367ID	18768467	Green Published, hybrid			2022-12-27	WOS:000260544800049
J	Ling, J; Liao, HL; Clark, R; Wong, MSM; Lo, DD				Ling, Jun; Liao, Hailing; Clark, Robin; Wong, Mandy Sze Man; Lo, David D.			Structural Constraints for the Binding of Short Peptides to Claudin-4 Revealed by Surface Plasmon Resonance	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CLOSTRIDIUM-PERFRINGENS ENTEROTOXIN; C-TERMINAL FRAGMENT; TIGHT JUNCTION BARRIER; PEYERS PATCH; EXPRESSION; RECEPTOR; PROTEIN; CANCER; MODULATOR; DOMAIN	Claudin family transmembrane proteins play an important role in tight junction structure and function in epithelial cells. Among the 24 isoforms identified in mice and humans, claudin-4 and -3 serve as the receptor for Clostridium perfringens enterotoxin (Cpe). The second extracellular loop (Ecl2) of claudin-4 is responsible for the binding to the C-terminal 30 amino acids of Cpe (Cpe30). To define the structural constraints for the claudin-4/Cpe30 interaction, a surface plasmon resonance (SPR) method was developed. GST fusions with claudin-4 revealed that Ecl2 with the downstream transmembrane domain of claudin-4 reconstituted the basic structural requirement for optimal binding activity to Cpe30, with affinity in the nanomolar range. Two 12-mer peptides selected by phage display against claudin-4-transfected CHO cells and a 12-mer Cpe mutant peptide also showed significant affinity for claudin-4 with this SPR assay, suggesting that a short peptide can establish stable contact with Ecl2 with nanomolar affinity. Alignment of these short peptides unveiled a common Ecl2 binding motif: <XX(Y/W)(X)(3 or 4)Y(Y/X)(L/I)XX>. Whereas the short peptides bound native claudin-4 on transfected CHO cells in pull-down assays, only the larger Cpe30 peptide affected trans-epithelial electrical resistance (TER) in peptide-treated Caco-2BBe monolayers. Importantly, Cpe30 retained its binding to claudin-4 when fused to the C terminus of influenza hemagglutinin, demonstrating that its binding activity can be maintained in a different biochemical context. These studies may help in the design of assays for membrane receptor interactions with soluble ligands, and in applying new targeting ligands to delivering attached "cargo" proteins.	[Ling, Jun; Liao, Hailing; Clark, Robin; Wong, Mandy Sze Man; Lo, David D.] Univ Calif Riverside, Div Biomed Sci, Riverside, CA 92521 USA; [Lo, David D.] La Jolla Inst Allergy & Immunol, Div Dev Immunol, La Jolla, CA 92037 USA	University of California System; University of California Riverside; La Jolla Institute for Immunology	Lo, DD (corresponding author), Univ Calif Riverside, Div Biomed Sci, 900 Univ Ave, Riverside, CA 92521 USA.	david.lo@ucr.edu			National Institutes of Health; Bill and Melinda Gates Foundation	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation)	This work was supported, in whole or in part, by the National Institutes of Health. This work was also supported by a Grand Challenges in Global Health grant from the Bill and Melinda Gates Foundation. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Brayden DJ, 2005, DRUG DISCOV TODAY, V10, P1145, DOI 10.1016/S1359-6446(05)03536-1; Cherezov V, 2007, SCIENCE, V318, P1258, DOI 10.1126/science.1150577; Ebihara C, 2007, BIOCHEM PHARMACOL, V73, P824, DOI 10.1016/j.bcp.2006.11.013; Fujita K, 2000, FEBS LETT, V476, P258, DOI 10.1016/S0014-5793(00)01744-0; Katahira J, 1997, J CELL BIOL, V136, P1239, DOI 10.1083/jcb.136.6.1239; KokaiKun JF, 1997, CLIN INFECT DIS, V25, pS165, DOI 10.1086/516246; Kondoh M, 2005, MOL PHARMACOL, V67, P749, DOI 10.1124/mol.104.008375; Koval M, 2006, CELL COMMUN ADHES, V13, P127, DOI 10.1080/15419060600726209; Kuo WL, 2006, ONCOL REP, V16, P729; Lo D, 2004, INT IMMUNOL, V16, P91, DOI 10.1093/intimm/dxh011; Masuyama A, 2005, J PHARMACOL EXP THER, V314, P789, DOI 10.1124/jpet.105.085399; MEDLEY JG, 2007, INFECT IMMUN, V75, P2381; Morin PJ, 2005, CANCER RES, V65, P9603, DOI 10.1158/0008-5472.CAN-05-2782; Oliveira SS, 2007, CELL MOL LIFE SCI, V64, P17, DOI 10.1007/s00018-006-6314-1; Rahner C, 2001, GASTROENTEROLOGY, V120, P411, DOI 10.1053/gast.2001.21736; Rosenbaum DM, 2007, SCIENCE, V318, P1266, DOI 10.1126/science.1150609; Rost B, 2004, NUCLEIC ACIDS RES, V32, pW321, DOI 10.1093/nar/gkh377; Sonoda N, 1999, J CELL BIOL, V147, P195, DOI 10.1083/jcb.147.1.195; Takahashi A, 2005, J CONTROL RELEASE, V108, P56, DOI 10.1016/j.jconrel.2005.07.008; Takahashi A, 2008, BIOCHEM PHARMACOL, V75, P1639, DOI 10.1016/j.bcp.2007.12.016; Tanaka M, 2005, J BIOL CHEM, V280, P42375, DOI 10.1074/jbc.M503786200; Van Itallie CM, 2008, J BIOL CHEM, V283, P268, DOI 10.1074/jbc.M708066200; Van Itallie CM, 2004, J MEMBRANE BIOL, V199, P29, DOI 10.1007/s00232-004-0673-z	23	52	58	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 7	2008	283	45					30585	30595		10.1074/jbc.M803548200	http://dx.doi.org/10.1074/jbc.M803548200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	367ID	18782762	Green Published, hybrid			2022-12-27	WOS:000260544800017
J	Ho, TC; Chen, SL; Yang, YC; Chen, CY; Feng, FP; Hsieh, JW; Cheng, HC; Tsao, YP				Ho, Tsung-Chuan; Chen, Show-Li; Yang, Yuh-Cheng; Chen, Chia-Yi; Feng, Fang-Ping; Hsieh, Jui-Wen; Cheng, Huey-Chuan; Tsao, Yeou-Ping			15-Deoxy-Delta(12,14)-prostaglandin J(2) Induces Vascular Endothelial Cell Apoptosis through the Sequential Activation of MAPKS and p53	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECEPTOR-GAMMA LIGANDS; FACTOR-KAPPA-B; CYCLOPENTENONE PROSTAGLANDINS; OXIDATIVE STRESS; PPAR-GAMMA; ENDOGENOUS ELECTROPHILE; SIGNALING PATHWAY; UP-REGULATION; LUNG-CANCER; PHOSPHORYLATION	15-Deoxy-Delta(12,14)-prostaglandin J(2) (15d-PGJ(2)) is a potent anti-angiogenic factor and induces endothelial cell apoptosis, although the mechanism remains unclear. In this study, 15d-PGJ(2) was found to increase p53 levels of the human umbilical vein endothelial cells by stabilizing p53. Both 15d-PGJ(2)-induced apoptosis and the induction of p21(Waf1) and Bax can be abolished by p53 small interfering RNA but not by peroxisome proliferator-activated receptor gamma inhibitors. Moreover, 15d-PGJ(2) activated JNK and p38 MAPK while inducing p53 phosphorylation at sites responsible for p53 activity. JNK inhibitor (SP600125) or p38 MAPK inhibitor (SB203580) pretreatment attenuated 15d-PGJ(2)-mediated apoptosis and suppressed the p21Waf1 and Bax expressions without affecting p53 protein accumulation. Pretreatment with SP600125 partially prevented the phosphorylation of p53 at serines 33 and 392 induced by 15d-PGJ(2). 15d-PGJ(2) was also found to induce reactive oxygen species generation and partially blocked nuclear factor-kappa B activity. Pretreatment with antioxidant N-acetylcysteine prevented the p53 accumulation, the phosphorylations of JNK and p38 MAPK, the inhibition of NF-kappa B activity, as well as the apoptosis induced by 15d-PGJ(2). Using a mouse model of corneal neovascularization, it was demonstrated in vivo that 15d-PGJ(2) induced reactive oxygen species generation, activated JNK and p38 MAPK, induced p53 accumulation/phosphorylation, and induced vascular endothelial cell apoptosis, which could be abolished by N-acetylcysteine, SP600125, SB203580, or a virus-derived amphipathic peptides-based p53 small interfering RNA. This is the first study that 15d-PGJ(2) induces vascular endothelial cell apoptosis through the signaling of JNK and p38 MAPK-mediated p53 activation both in vitro and in vivo, further establishing the potential of 15d-PGJ(2) as an anti-angiogenesis agent.	[Ho, Tsung-Chuan; Yang, Yuh-Cheng; Chen, Chia-Yi; Feng, Fang-Ping; Tsao, Yeou-Ping] Natl Taiwan Univ, Sch Med, Dept Med Res, Taipei 251, Taiwan; [Hsieh, Jui-Wen; Cheng, Huey-Chuan; Tsao, Yeou-Ping] Natl Taiwan Univ, Sch Med, Mackay Mem Hosp, Dept Ophthalmol, Taipei 251, Taiwan; [Chen, Show-Li] Natl Taiwan Univ, Sch Med, Dept Microbiol, Taipei 251, Taiwan; [Yang, Yuh-Cheng; Hsieh, Jui-Wen] Taipei Med Univ, Nursing & Management Coll, Taipei 251, Taiwan; [Yang, Yuh-Cheng] Taipei Med Univ, Sch Med, Taipei 251, Taiwan; [Tsao, Yeou-Ping] Natl Def Med Ctr, Dept Microbiol & Immunol, Taipei 251, Taiwan	National Taiwan University; Mackay Memorial Hospital; National Taiwan University; National Taiwan University; Mackay Junior College of Medicine, Nursing & Management; Taipei Medical University; Taipei Medical University; National Defense Medical Center	Tsao, YP (corresponding author), Natl Taiwan Univ, Sch Med, Dept Med Res, Taipei 251, Taiwan.	yptsao@yahoo.com			National Science Council, Taiwan [NSC 95-2314-B-195-009-MY3, NSC 96-3112-B-195-001]; Mackay Memorial Hospital [MMH-E-96006]	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan); Mackay Memorial Hospital	This work was supported by Grants NSC 95-2314-B-195-009-MY3 and NSC 96-3112-B-195-001 from the National Science Council, Taiwan, and Grant MMH-E-96006 from Mackay Memorial Hospital. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Bean LJH, 2001, ONCOGENE, V20, P1076, DOI 10.1038/sj.onc.1204204; Bishop-Bailey D, 1999, J BIOL CHEM, V274, P17042, DOI 10.1074/jbc.274.24.17042; Bubici C, 2006, ONCOGENE, V25, P6731, DOI 10.1038/sj.onc.1209936; Bulavin DV, 1999, EMBO J, V18, P6845, DOI 10.1093/emboj/18.23.6845; Buschmann T, 2001, MOL CELL BIOL, V21, P2743, DOI 10.1128/MCB.21.8.2743-2754.2001; Cernuda-Morollon E, 2001, J BIOL CHEM, V276, P35530, DOI 10.1074/jbc.M104518200; Chang LF, 2001, NATURE, V410, P37, DOI 10.1038/35065000; Chehab NH, 1999, P NATL ACAD SCI USA, V96, P13777, DOI 10.1073/pnas.96.24.13777; Chen NG, 2001, BIOCHEM BIOPH RES CO, V282, P717, DOI 10.1006/bbrc.2001.4628; Dong YG, 2004, ACTA PHARMACOL SIN, V25, P47; Duan SZ, 2008, CIRC RES, V102, P283, DOI 10.1161/CIRCRESAHA.107.164384; Erl W, 2004, EUR J IMMUNOL, V34, P241, DOI 10.1002/eji.200324053; Figarella K, 2006, CELL DEATH DIFFER, V13, P1802, DOI 10.1038/sj.cdd.4401862; FORMAN BM, 1995, CELL, V83, P803, DOI 10.1016/0092-8674(95)90193-0; FUKUSHIMA M, 1992, PROSTAG LEUKOTR ESS, V47, P1, DOI 10.1016/0952-3278(92)90178-L; Fulzele SV, 2007, ANTI-CANCER DRUG, V18, P65, DOI 10.1097/CAD.0b013e3280101006; Giaginis C, 2007, EXPERT OPIN INV DRUG, V16, P1561, DOI 10.1517/13543784.16.10.1561; Harmand PO, 2003, INT J ONCOL, V23, P105; Hashimoto K, 2004, PANCREAS, V28, P153, DOI 10.1097/00006676-200403000-00006; Ho TC, 2007, CARDIOVASC RES, V76, P213, DOI 10.1016/j.cardiores.2007.06.032; Holownia A, 2003, NEOPLASMA, V50, P266; Kim HS, 1996, PROSTAGLANDINS, V51, P413, DOI 10.1016/0090-6980(96)00047-0; KLIEWER SA, 1995, CELL, V83, P813, DOI 10.1016/0092-8674(95)90194-9; Kondo M, 2002, P NATL ACAD SCI USA, V99, P7367, DOI 10.1073/pnas.112212599; Landar A, 2006, AM J PHYSIOL-HEART C, V290, pH1777, DOI 10.1152/ajpheart.01087.2005; Li LY, 2001, J BIOL CHEM, V276, P38152; Murakami M, 2000, BBA-MOL CELL BIOL L, V1488, P159, DOI 10.1016/S1388-1981(00)00118-9; Pasquier E, 2004, MOL CANCER THER, V3, P1301; Ray DM, 2006, J IMMUNOL, V177, P5068, DOI 10.4049/jimmunol.177.8.5068; Rizzo G, 2006, CURR OPIN PHARMACOL, V6, P421, DOI 10.1016/j.coph.2006.03.012; Sanchez-Prieto R, 2000, CANCER RES, V60, P2464; Shan ZZ, 2004, J BIOL CHEM, V279, P37939, DOI 10.1074/jbc.M402424200; Shibata T, 2003, BIOCHEMISTRY-US, V42, P13960, DOI 10.1021/bi035215a; Shishodia S, 2002, J BIOCHEM MOL BIOL, V35, P28; Straus DS, 2000, P NATL ACAD SCI USA, V97, P4844, DOI 10.1073/pnas.97.9.4844; Teodoro JG, 2006, SCIENCE, V313, P968, DOI 10.1126/science.1126391; Tsao YP, 2006, LIFE SCI, V79, P545, DOI 10.1016/j.lfs.2006.01.041; Uchida K, 2008, CHEM RES TOXICOL, V21, P138, DOI 10.1021/tx700177j; Vosseler CA, 2003, BIOCHEM BIOPH RES CO, V307, P322, DOI 10.1016/S0006-291X(03)01204-X; Wu GS, 2004, CANCER BIOL THER, V3, P156, DOI 10.4161/cbt.3.2.614; XIA ZG, 1995, SCIENCE, V270, P1326, DOI 10.1126/science.270.5240.1326; Xin XH, 1999, J BIOL CHEM, V274, P9116, DOI 10.1074/jbc.274.13.9116; Zacchi P, 2002, NATURE, V419, P853, DOI 10.1038/nature01120; Zernecke A, 2003, FASEB J, V17, P1099, DOI 10.1096/fj.02-0485fje; Zhang J, 2006, SPECTROSC SPECT ANAL, V26, P37	45	32	32	1	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 31	2008	283	44					30273	30288		10.1074/jbc.M804196200	http://dx.doi.org/10.1074/jbc.M804196200			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	364WS	18718914	Green Published, hybrid			2022-12-27	WOS:000260366900072
J	Nguyen, T; Ogbi, M; Johnson, JA				Nguyen, Tiffany; Ogbi, Mourad; Johnson, John A.			Delta Protein Kinase C Interacts with the d Subunit of the F1F0 ATPase in Neonatal Cardiac Myocytes Exposed to Hypoxia or Phorbol Ester IMPLICATIONS FOR F1F0 ATPase REGULATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BOVINE HEART-MITOCHONDRIA; CYTOCHROME-C; INHIBITOR PROTEIN; OXIDASE ACTIVITY; EPSILON INTERACTS; COMPLEX-I; RAT-HEART; CARDIOLIPIN; SYNTHASE; REPERFUSION	Mitochondrial protein kinase C isozymes have been reported to mediate both cardiac ischemic preconditioning and ischemia/reperfusion injury. In addition, cardiac preconditioning improves the recovery of ATP levels after ischemia/reperfusion injury. We have, therefore, evaluated protein kinase C modulation of the F1F0 ATPase in neonatal cardiac myocytes. Exposure of cells to 3 or 100 nM 4 beta-phorbol 12-myristate-13-acetate induced co-immunoprecipitation of delta protein kinase C (but not alpha,epsilon,or zeta protein kinase C) with the d subunit of the F1F0 ATPase. This co-immunoprecipitation correlated with 40 +/- 3% and 72 +/- 9% inhibitions of oligomycin-sensitive F1F0 ATPase activity, respectively. We observed prominent expression of delta protein kinase C in cardiac myocyte mitochondria, which was enhanced following a 4-h hypoxia exposure. In contrast, hypoxia decreased mitochondrial zeta PKC levels by 85 +/- 1%. Following 4 h of hypoxia, F1F0 ATPase activity was inhibited by 75 +/- 9% and delta protein kinase C co-immunoprecipitated with the d subunit of F1F0 ATPase. In vitro incubation of protein kinase C with F1F0 ATPase enhanced F1F0 activity in the absence of protein kinase C activators and inhibited it in the presence of activators. Recombinant delta protein kinase C also inhibited F1F0 ATPase activity. Protein kinase C overlay assays revealed delta protein kinase C binding to the d subunit of F1F0 ATPase, which was modulated by diacylglycerol, phosphatidylserine, and cardiolipin. Our results suggest a novel regulation of the F1F0 ATPase by the delta protein kinase C isozyme.	[Nguyen, Tiffany; Ogbi, Mourad; Johnson, John A.] Med Coll Georgia, Sch Med, Dept Pharmacol & Toxicol, Augusta, GA 30912 USA; [Nguyen, Tiffany; Ogbi, Mourad; Johnson, John A.] Med Coll Georgia, Inst Mol Med & Genet, Program Regenerat Med, Augusta, GA 30912 USA	University System of Georgia; Augusta University; University System of Georgia; Augusta University	Johnson, JA (corresponding author), 1459 Laney Walker Blvd, Augusta, GA 30912 USA.	jjohnson@mail.mcg.edu	Nguyen, Tiffany/HGD-2431-2022		National Institutes of Health [R01HL76805]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL076805] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01HL76805 (to J. A. J.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Arrell DK, 2006, CIRC RES, V99, P706, DOI 10.1161/01.RES.0000243995.74395.f8; Baines CP, 2003, CIRC RES, V92, P873, DOI 10.1161/01.RES.0000069215.36389.8D; Buchanan SK, 1996, BIOCHEM J, V318, P343, DOI 10.1042/bj3180343; Carbajo RJ, 2005, J MOL BIOL, V351, P824, DOI 10.1016/j.jmb.2005.06.012; Chen Q, 2006, FREE RADICAL BIO MED, V40, P976, DOI 10.1016/j.freeradbiomed.2005.10.043; Chicco AJ, 2007, AM J PHYSIOL-CELL PH, V292, pC33, DOI 10.1152/ajpcell.00243.2006; Churchill EN, 2005, CIRC RES, V97, P78, DOI 10.1161/01.RES.0000173896.32522.6e; CONRICODE KM, 1992, J BIOL CHEM, V267, P7199; Di Pancrazio F, 2004, BBA-BIOENERGETICS, V1659, P52, DOI 10.1016/j.bbabio.2004.07.009; EBLE KS, 1990, J BIOL CHEM, V265, P19434; Edmondson RD, 2002, MOL CELL PROTEOMICS, V1, P421, DOI 10.1074/mcp.M100036-MCP200; Gaballo A, 2002, CURR PROTEIN PEPT SC, V3, P451, DOI 10.2174/1389203023380558; Goerke A, 2002, J BIOL CHEM, V277, P32054, DOI 10.1074/jbc.M203734200; Gray MO, 1997, J BIOL CHEM, V272, P30945, DOI 10.1074/jbc.272.49.30945; Green DW, 2000, BBA-BIOENERGETICS, V1458, P343, DOI 10.1016/S0005-2728(00)00085-2; Groth G, 1996, BIOCHEM J, V318, P351, DOI 10.1042/bj3180351; Guo DH, 2007, AM J PHYSIOL-HEART C, V293, pH2219, DOI 10.1152/ajpheart.01306.2006; HARRIS DA, 1991, BIOCHEM J, V280, P561, DOI 10.1042/bj2800561; Inagaki K, 2003, CIRCULATION, V108, P2304, DOI 10.1161/01.CIR.0000101682.24138.36; Inagaki K, 2003, CIRCULATION, V108, P869, DOI 10.1161/01.CIR.0000081943.93653.73; JENNINGS RB, 1991, J MOL CELL CARDIOL, V23, P1383, DOI 10.1016/0022-2828(91)90185-O; Johnson JA, 1996, CIRC RES, V79, P1086, DOI 10.1161/01.RES.79.6.1086; JOHNSON JA, 1995, CIRC RES, V76, P654, DOI 10.1161/01.RES.76.4.654; Korzick DH, 2007, AM J PHYSIOL-HEART C, V293, pH2056, DOI 10.1152/ajpheart.00403.2007; KUNZE D, 1984, CLIN CHIM ACTA, V140, P215, DOI 10.1016/0009-8981(84)90202-X; Lesnefsky EJ, 2004, AM J PHYSIOL-HEART C, V287, pH258, DOI 10.1152/ajpheart.00348.2003; Lesnefsky EJ, 2001, J MOL CELL CARDIOL, V33, P1065, DOI 10.1006/jmcc.2001.1378; Liang BT, 1997, AM J PHYSIOL-HEART C, V273, pH847, DOI 10.1152/ajpheart.1997.273.2.H847; Malhotra A, 2005, AM J PHYSIOL-HEART C, V289, pH1343, DOI 10.1152/ajpheart.01200.2004; MANAT R, 2006, AM J PHYSIOL-HEART C, V291, pH854; Mayr M, 2004, AM J PHYSIOL-HEART C, V287, pH946, DOI 10.1152/ajpheart.00878.2003; Mayr M, 2004, AM J PHYSIOL-HEART C, V287, pH937, DOI 10.1152/ajpheart.00877.2003; McDonald T, 2006, MOL CELL PROTEOMICS, V5, P2392, DOI 10.1074/mcp.T500036-MCP200; McMillin JB, 2002, BBA-MOL CELL BIOL L, V1585, P97, DOI 10.1016/S1388-1981(02)00329-3; MOCHLYROSEN D, 1987, J BIOL CHEM, V262, P2291; Moghaddas S, 2002, J GERONTOL A-BIOL, V57, pB22, DOI 10.1093/gerona/57.1.B22; NGUYEN T, 2007, CURR ENZ INHIB, V3, P143; Nishikawa K, 1998, J BIOL CHEM, V273, P23126, DOI 10.1074/jbc.273.36.23126; Ogbi M, 2006, BIOCHEM J, V393, P191, DOI 10.1042/BJ20050757; Ogbi M, 2004, BIOCHEM J, V382, P923, DOI 10.1042/BJ20040468; Paradies G, 2004, CIRC RES, V94, P53, DOI 10.1161/01.RES.0000109416.56608.64; QUEST AFG, 1994, PROTEIN KINASE C, P64; RON D, 1995, J BIOL CHEM, V270, P1; Schechtman Deborah, 2003, Methods Mol Biol, V233, P345; Solaini G, 2005, BIOCHEM J, V390, P377, DOI 10.1042/BJ20042006; Sparagna GC, 2005, J LIPID RES, V46, P1196, DOI 10.1194/jlr.M500031-JLR200; Vance JE, 2003, PROG NUCLEIC ACID RE, V75, P69, DOI 10.1016/S0079-6603(03)75003-X; VUORINEN K, 1995, CIRCULATION, V91, P2810, DOI 10.1161/01.CIR.91.11.2810; Walker JE, 2006, BBA-BIOENERGETICS, V1757, P286, DOI 10.1016/j.bbabio.2006.01.001; Wang YG, 1999, CIRC RES, V85, P731, DOI 10.1161/01.RES.85.8.731; Williams SD, 2002, BIOCHEM J, V362, P23, DOI 10.1042/bj3620023; Wood CD, 2007, FEBS LETT, V581, P3494, DOI 10.1016/j.febslet.2007.06.060; Ylitalo K, 2001, BBA-BIOENERGETICS, V1504, P329, DOI 10.1016/S0005-2728(00)00261-9; Zanotti F, 2004, J BIOENERG BIOMEMBR, V36, P447, DOI 10.1023/B:JOBB.0000047327.68173.9b; Zhang M, 2002, J BIOL CHEM, V277, P43553, DOI 10.1074/jbc.C200551200	55	26	28	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 31	2008	283	44					29831	29840		10.1074/jbc.M801642200	http://dx.doi.org/10.1074/jbc.M801642200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	364WS	18725417	Green Published, hybrid			2022-12-27	WOS:000260366900027
J	Tan, WQ; Wang, K; Lv, DY; Li, PF				Tan, Wei-Qi; Wang, Kun; Lv, Dao-Yuan; Li, Pei-Feng			Foxo3a Inhibits Cardiomyocyte Hypertrophy through Transactivating Catalase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; PROTEIN-KINASE CK2; CARDIAC-HYPERTROPHY; TRANSCRIPTION FACTORS; OXIDATIVE MODIFICATION; IN-VIVO; OXYGEN; STRESS; AKT; APOPTOSIS	The forkhead transcription factor Foxo3a is able to inhibit cardiomyocyte hypertrophy. However, its underlying molecular mechanism remains to be fully understood. Our present study demonstrates that Foxo3a can regulate cardiomyocyte hypertrophy through transactivating catalase. Insulin was able to induce cardiomyocyte hypertrophy with an elevated level of reactive oxygen species (ROS). The antioxidant agents, including catalase and N-acetyl- L-cysteine, could inhibit cardiomyocyte hypertrophy induced by insulin, suggesting that ROS is necessary for insulin to induce hypertrophy. Strikingly, we observed that the levels of catalase were decreased in response to insulin treatment. The transcriptional activity of Foxo3a depends on its phosphorylation status with the nonphosphorylated but not phosphorylated form to be functional. Insulin treatment led to an increase in the phosphorylated levels of Foxo3a. To understand the relationship between Foxo3a and catalase in the hypertrophic pathway, we characterized that catalase was a transcriptional target of Foxo3a. Foxo3a bound to the promoter region of catalase and stimulated its activity. The inhibitory effect of Foxo3a on cardiomyocyte hypertrophy depended on its transcriptional regulation of catalase. Finally, we identified that myocardin was a downstream mediator of ROS in conveying the hypertrophic signal of insulin or insulin-like growth factor-1. Foxo3a could negatively regulate myocardin expression levels through up-regulating catalase and the consequent reduction of ROS levels. Taken together, our results reveal that Foxo3a can inhibit hypertrophy by transcriptionally targeting catalase.	[Tan, Wei-Qi; Wang, Kun; Lv, Dao-Yuan; Li, Pei-Feng] Chinese Acad Sci, Div Cardiovasc Res, Natl Key Lab Biomembrane & Membrane Biotechnol, Inst Zool, Beijing 100101, Peoples R China; [Li, Pei-Feng] Univ Illinois, Coll Med, Chicago, IL 60612 USA	Chinese Academy of Sciences; Institute of Zoology, CAS; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Li, PF (corresponding author), Chinese Acad Sci, Div Cardiovasc Res, Natl Key Lab Biomembrane & Membrane Biotechnol, Inst Zool, Beijing 100101, Peoples R China.	peifli@ioz.ac.cn	Li, Peifeng/AHE-6906-2022; Li, Peifeng/ABD-5663-2021	Li, Peifeng/0000-0002-0969-9407; 	National Natural Science Foundation of China [30730045]; National Basic Research Program of China [2007CB512000]; American Heart Association	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China); American Heart Association(American Heart Association)	This work was supported by the National Natural Science Foundation of China (Grant 30730045), the National Basic Research Program of China (973 Program, Grant 2007CB512000), and the American Heart Association. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Accili D, 2004, CELL, V117, P421, DOI 10.1016/S0092-8674(04)00452-0; Ago T, 2007, ANTIOXID REDOX SIGN, V9, P679, DOI 10.1089/ars.2007.1529; Aikawa R, 2001, BIOCHEM BIOPH RES CO, V289, P901, DOI 10.1006/bbrc.2001.6068; Alcendor RR, 2007, CIRC RES, V100, P1512, DOI 10.1161/01.RES.0000267723.65696.4a; Anderson MJ, 1998, GENOMICS, V47, P187, DOI 10.1006/geno.1997.5122; Badorff C, 2005, CIRC RES, V97, P645, DOI 10.1161/01.RES.0000184684.88750.FE; Biswas S, 2007, AM J PHYSIOL-HEART C, V292, pH758, DOI 10.1152/ajpheart.00718.2006; Brasier AR, 2000, MOL CELL BIOCHEM, V212, P155, DOI 10.1023/A:1007133710837; Condorelli G, 2002, P NATL ACAD SCI USA, V99, P12333, DOI 10.1073/pnas.172376399; De Windt LJ, 2000, CIRC RES, V86, P255, DOI 10.1161/01.RES.86.3.255; Furuyama T, 2000, BIOCHEM J, V349, P629, DOI 10.1042/0264-6021:3490629; Giordano FJ, 2005, J CLIN INVEST, V115, P500, DOI 10.1172/JCI200524408; Greer EL, 2005, ONCOGENE, V24, P7410, DOI 10.1038/sj.onc.1209086; Hardt SE, 2002, CIRC RES, V90, P1055, DOI 10.1161/01.RES.0000018952.70505.F1; Higuchi Y, 2002, J MOL CELL CARDIOL, V34, P233, DOI 10.1006/jmcc.2001.1505; Hirotani S, 2002, CIRCULATION, V105, P509, DOI 10.1161/hc0402.102863; Huang J, 2008, J BIOL CHEM, V283, P19748, DOI 10.1074/jbc.M802605200; Kass DA, 2004, CIRC RES, V94, P1533, DOI 10.1161/01.RES.0000129254.25507.d6; Kassiri Z, 2002, CIRC RES, V90, P578, DOI 10.1161/01.RES.0000012223.86441.A1; Kuster GM, 2006, ANTIOXID REDOX SIGN, V8, P2153, DOI 10.1089/ars.2006.8.2153; Kuster GM, 2005, CIRCULATION, V111, P1192, DOI 10.1161/01.CIR.0000157148.59308.F5; Li HH, 2007, J CLIN INVEST, V117, P3211, DOI 10.1172/JCI31757; Li PF, 1999, EMBO J, V18, P6027, DOI 10.1093/emboj/18.21.6027; Li PF, 2002, MOL CELL, V10, P247, DOI 10.1016/S1097-2765(02)00600-7; Li YZ, 2008, MOL CELL BIOL, V28, P564, DOI 10.1128/MCB.00738-07; Matsui T, 2002, J BIOL CHEM, V277, P22896, DOI 10.1074/jbc.M200347200; McMullen JR, 2004, J BIOL CHEM, V279, P4782, DOI 10.1074/jbc.M310405200; Murtaza I, 2008, J BIOL CHEM, V283, P5996, DOI 10.1074/jbc.M706466200; Nadal-Ginard B, 2003, CIRC RES, V92, P139, DOI 10.1161/01.RES.0000053618.86362.DF; Nakamura K, 1998, CIRCULATION, V98, P794, DOI 10.1161/01.CIR.98.8.794; Ni YG, 2006, CIRCULATION, V114, P1159, DOI 10.1161/CIRCULATIONAHA.106.637124; Nishida M, 2000, NATURE, V408, P492, DOI 10.1038/35044120; PAOLISSO G, 1995, EUR J CLIN INVEST, V25, P529, DOI 10.1111/j.1365-2362.1995.tb01740.x; Pimentel DR, 2001, CIRC RES, V89, P453, DOI 10.1161/hh1701.096615; Ruwhof C, 2000, CARDIOVASC RES, V47, P23, DOI 10.1016/S0008-6363(00)00076-6; Samuelsson AM, 2006, AM J PHYSIOL-HEART C, V291, pH787, DOI 10.1152/ajpheart.00974.2005; Sandri M, 2004, CELL, V117, P399, DOI 10.1016/S0092-8674(04)00400-3; Satoh M, 2006, P NATL ACAD SCI USA, V103, P7432, DOI 10.1073/pnas.0510444103; Sen CK, 2005, AM J PHYSIOL-HEART C, V289, pH17, DOI 10.1152/ajpheart.00250.2005; Shang YF, 2000, CELL, V103, P843, DOI 10.1016/S0092-8674(00)00188-4; Shiojima I, 2006, GENE DEV, V20, P3347, DOI 10.1101/gad.1492806; Skurk C, 2005, J BIOL CHEM, V280, P20814, DOI 10.1074/jbc.M500528200; Sugden PH, 2003, CIRC RES, V93, P1179, DOI 10.1161/01.RES.0000106132.04301.F5; Tanaki K, 2001, J AM COLL CARDIOL, V37, P676, DOI 10.1016/S0735-1097(00)01123-2; Taniyama Yoshiaki, 2005, J Mol Cell Cardiol, V38, P375, DOI 10.1016/j.yjmcc.2004.12.002; Vega RB, 2003, P NATL ACAD SCI USA, V100, P669, DOI 10.1073/pnas.0237225100; von Harsdorf R, 1999, CIRCULATION, V99, P2934, DOI 10.1161/01.CIR.99.22.2934; Wilkins BJ, 2004, BIOCHEM BIOPH RES CO, V322, P1178, DOI 10.1016/j.bbrc.2004.07.121; Wollert KC, 2000, CIRCULATION, V101, P1172, DOI 10.1161/01.CIR.101.10.1172; Xing WB, 2006, CIRC RES, V98, P1089, DOI 10.1161/01.RES.0000218781.23144.3e; Xu FP, 2004, CIRCULATION, V110, P1269, DOI 10.1161/01.CIR.0000140766.52771.6D	51	141	146	0	30	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 31	2008	283	44					29730	29739		10.1074/jbc.M805514200	http://dx.doi.org/10.1074/jbc.M805514200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	364WS	18772130	Green Published, hybrid			2022-12-27	WOS:000260366900017
J	Exposito, JY; Larroux, C; Cluzel, C; Valcourt, U; Lethias, C; Degnan, BM				Exposito, Jean-Yves; Larroux, Claire; Cluzel, Caroline; Valcourt, Ulrich; Lethias, Claire; Degnan, Bernard M.			Demosponge and sea anemone fibrillar collagen diversity reveals the early emergence of A/C clades and the maintenance of the modular structure of type V/XI collagens from sponge to human	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							V COLLAGEN; SEQUENCE ALIGNMENT; GENE; VERTEBRATE; EVOLUTION; ORIGIN; EXPRESSION; INSIGHTS; GENOME; IDENTIFICATION	Collagens are often considered a metazoan hallmark, with the fibril-forming fibrillar collagens present from sponges to human. From evolutionary studies, three fibrillar collagen clades (named A, B, and C) have been defined and shown to be present in mammals, whereas the emergence of the A and B clades predates the protostome/deuterostome split. Moreover, several C clade fibrillar collagen chains are present in some invertebrate deuterostome genomes but not in protostomes whose genomes have been sequenced. The newly sequenced genomes of the choanoflagellate Monosiga brevicollis, the demosponge Amphimedon queenslandica, and the cnidarians Hydra magnipapillata (Hydra) and Nematostella vectensis (sea anemone) allow us to have a better understanding of the origin and evolution of fibrillar collagens. Analysis of these genomes suggests that an ancestral fibrillar collagen gene arose at the dawn of the Metazoa, before the divergence of sponge and eumetazoan lineages. The duplication events leading to the formation of the three fibrillar collagen clades (A, B, and C) occurred before the eumetazoan radiation. Interestingly, only the B clade fibrillar collagens preserved their characteristic modular structure from sponge to human. This observation is compatible with the suggested primordial function of type V/XI fibrillar collagens in the initiation of the formation of the collagen fibrils.	[Exposito, Jean-Yves; Cluzel, Caroline; Valcourt, Ulrich; Lethias, Claire] IBCP, CNRS, UMR 5086, F-69367 Lyon, France; [Exposito, Jean-Yves; Cluzel, Caroline; Valcourt, Ulrich; Lethias, Claire] Univ Lyon 1, IFR 128, F-69365 Lyon, France; [Exposito, Jean-Yves; Cluzel, Caroline; Valcourt, Ulrich; Lethias, Claire] Univ Lyon, Lyon, France; [Larroux, Claire; Degnan, Bernard M.] Univ Queensland, Sch Integrat Biol, Brisbane, Qld 4072, Australia	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; University of Queensland	Exposito, JY (corresponding author), IBCP, CNRS, UMR 5086, 7 Passage Vercors, F-69367 Lyon, France.	jy.exposito@ibcp.fr	VALCOURT, Ulrich/ABB-3943-2021; Larroux, Claire/U-7981-2017	VALCOURT, Ulrich/0000-0002-1727-4409; Larroux, Claire/0000-0002-3503-4150; Degnan, Bernard/0000-0001-7573-8518; Cluzel, Caroline/0000-0001-8946-3439; Exposito, Jean-Yves/0000-0002-4926-4942				Aouacheria A, 2004, J BIOL CHEM, V279, P47711, DOI 10.1074/jbc.M408950200; Aouacheria A, 2006, MOL BIOL EVOL, V23, P2288, DOI 10.1093/molbev/msl100; Birk DE, 2001, MICRON, V32, P223, DOI 10.1016/S0968-4328(00)00043-3; Boot-Handford RP, 2003, J BIOL CHEM, V278, P31067, DOI 10.1074/jbc.M212889200; Borchiellini C, 2004, MOL PHYLOGENET EVOL, V32, P823, DOI 10.1016/j.ympev.2004.02.021; Borchiellini C, 2001, J EVOLUTION BIOL, V14, P171, DOI 10.1046/j.1420-9101.2001.00244.x; Bos KJ, 2001, J MOL BIOL, V306, P1011, DOI 10.1006/jmbi.2000.4429; Boute N, 1996, BIOL CELL, V88, P37, DOI 10.1016/S0248-4900(97)86829-3; Burge C, 1997, J MOL BIOL, V268, P78, DOI 10.1006/jmbi.1997.0951; Cluzel C, 2004, J BIOL CHEM, V279, P9811, DOI 10.1074/jbc.M311803200; Deutzmann R, 2000, DEVELOPMENT, V127, P4669; Exposito JY, 2000, MATRIX BIOL, V19, P275, DOI 10.1016/S0945-053X(00)00067-6; EXPOSITO JY, 1990, P NATL ACAD SCI USA, V87, P6669, DOI 10.1073/pnas.87.17.6669; EXPOSITO JY, 1993, J MOL EVOL, V37, P254, DOI 10.1007/BF00175502; EXPOSITO JY, 1992, J BIOL CHEM, V267, P15559; Exposito JY, 2002, ANAT RECORD, V268, P302, DOI 10.1002/ar.10162; Felsenstein J, 1996, METHOD ENZYMOL, V266, P418; Galtier N, 1996, COMPUT APPL BIOSCI, V12, P543; Guindon S, 2005, NUCLEIC ACIDS RES, V33, pW557, DOI 10.1093/nar/gki352; Hjorten R, 2007, BONE, V41, P535, DOI 10.1016/j.bone.2007.06.024; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; King N, 2008, NATURE, V451, P783, DOI 10.1038/nature06617; Koch M, 2003, J BIOL CHEM, V278, P43236, DOI 10.1074/jbc.M302112200; Kortschak RD, 2003, CURR BIOL, V13, P2190, DOI 10.1016/j.cub.2003.11.030; Larroux C, 2006, EVOL DEV, V8, P150, DOI 10.1111/j.1525-142X.2006.00086.x; Larroux C, 2008, MOL BIOL EVOL, V25, P980, DOI 10.1093/molbev/msn047; Larroux C, 2007, CURR BIOL, V17, P706, DOI 10.1016/j.cub.2007.03.008; Leys SP, 2002, INVERTEBR BIOL, V121, P171; Leys SP, 2001, BIOL BULL-US, V201, P323, DOI 10.2307/1543611; Mizuno K, 2001, MICRON, V32, P317, DOI 10.1016/S0968-4328(00)00036-6; Myllyharju J, 2004, TRENDS GENET, V20, P33, DOI 10.1016/j.tig.2003.11.004; Nichols SA, 2006, P NATL ACAD SCI USA, V103, P12451, DOI 10.1073/pnas.0604065103; OLSEN BR, 1982, NEW TRENDS BASEMENT, P225; Pace JM, 2003, MATRIX BIOL, V22, P3, DOI 10.1016/S0945-053X(03)00007-6; Page RDM, 1996, COMPUT APPL BIOSCI, V12, P357; Peterson KJ, 2005, P NATL ACAD SCI USA, V102, P9547, DOI 10.1073/pnas.0503660102; Plumb DA, 2007, J BIOL CHEM, V282, P12791, DOI 10.1074/jbc.C700021200; Putnam NH, 2007, SCIENCE, V317, P86, DOI 10.1126/science.1139158; Rasmussen M, 2003, J BIOL CHEM, V278, P32313, DOI 10.1074/jbc.M304709200; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Roulet M, 2007, CELL TISSUE RES, V327, P323, DOI 10.1007/s00441-006-0294-1; Rychel AL, 2006, MOL BIOL EVOL, V23, P541, DOI 10.1093/molbev/msj055; Schroder HC, 2006, J BIOL CHEM, V281, P12001, DOI 10.1074/jbc.M512677200; Schultz J, 1998, P NATL ACAD SCI USA, V95, P5857, DOI 10.1073/pnas.95.11.5857; Sicot FX, 1997, EUR J BIOCHEM, V246, P50, DOI 10.1111/j.1432-1033.1997.00050.x; Simionato E, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-33; Soderhall C, 2007, PLOS BIOL, V5, P1952, DOI 10.1371/journal.pbio.0050242; Thompson JD, 2003, BIOINFORMATICS, V19, P1155, DOI 10.1093/bioinformatics/btg133; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Veit G, 2006, J BIOL CHEM, V281, P3494, DOI 10.1074/jbc.M509333200; Wada H, 2006, EVOL DEV, V8, P370, DOI 10.1111/j.1525-142X.2006.00109.x; Wang C, 2006, P NATL ACAD SCI USA, V103, P6647, DOI 10.1073/pnas.0601951103; Wenstrup RJ, 2004, J BIOL CHEM, V279, P53331, DOI 10.1074/jbc.M409622200; Zhang XM, 2007, J BIOL CHEM, V282, P6792, DOI 10.1074/jbc.M607528200	54	52	52	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 17	2008	283	42					28226	28235		10.1074/jbc.M804573200	http://dx.doi.org/10.1074/jbc.M804573200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	359EN	18697744	Green Published, hybrid			2022-12-27	WOS:000259969300024
J	Gouveia, RM; Gomes, CM; Sousa, M; Alves, PM; Costa, J				Gouveia, Ricardo M.; Gomes, Claudio M.; Sousa, Marcos; Alves, Paula M.; Costa, Julia			Kinetic analysis of L1 homophilic interaction - Role of the first four immunoglobulin domains and implications on binding mechanism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-ADHESION MOLECULE; NEURITE OUTGROWTH; CRYSTAL-STRUCTURE; SITE; MUTATIONS; EXPRESSION; HORSESHOE; PROMOTION; INTEGRIN; SUGGESTS	L1 is a cell adhesion molecule of the immunoglobulin (Ig) superfamily, critical for central nervous system development, and involved in several neuronal biological events. It is a type I membrane glycoprotein. The L1 ectodomain, composed of six Ig-like and five fibronectin (Fn) type-III domains, is involved in homophilic binding. Here, co-immunoprecipitation studies between recombinant truncated forms of human L1 expressed and purified from insect Spodoptera frugiperda Sf9 cells, and endogenous full-length L1 from human NT2N neurons, showed that the L1 ectodomain (L1/ECD) and L1/Ig1-4 interacted homophilically in trans, contrary to mutants L1/Ig1-3 and L1/Ig2-Fn5. All mutants were correctly folded as evaluated by combination of far-UV CD and fluorescence spectroscopy. Surface plasmon resonance analysis showed comparable dissociation constants of 116 +/- 2 and 130 +/- 6 nM for L1/ECD-L1/ECD and L1/ECD-L1/Ig1-4, respectively, whereas deletion mutants for Ig1 or Ig4 did not interact. Accordingly, in vivo, Sf9 cells stably expressing L1 were found to adhere only to L1/ECD-and L1/Ig1-4-coated surfaces. Furthermore, only these mutants bound to HEK293 cells overexpressing L1 at the cell surface. Enhancement of neurite outgrowth, which is the consequence of signaling events caused by L1 homophilic binding, was comparable between L1/ECD and L1/Ig1-4. Altogether, these results showed that domains Ig1 to Ig4 are necessary and sufficient for L1 homophilic binding in trans, and that the rest of the molecule does not contribute to the affinity under the conditions of the current study. Furthermore, they are compatible with a cooperative interaction between modules Ig1-Ig4 in a horseshoe conformation.	[Gouveia, Ricardo M.; Gomes, Claudio M.; Alves, Paula M.; Costa, Julia] Inst Tecnol Quim & Biol, P-2780157 Oeiras, Portugal; [Sousa, Marcos; Alves, Paula M.; Costa, Julia] Inst Biol Expt & Tecnol, P-2781901 Oeiras, Portugal		Costa, J (corresponding author), Inst Tecnol Quim & Biol, Ave Republ,Apartado 127, P-2780157 Oeiras, Portugal.	jcosta@itqb.unl.pt	Alves, Paula M/C-1070-2008; Costa, Júlia C/B-7131-2008; Gomes, Cláudio M./A-8152-2008	Alves, Paula M/0000-0003-1445-3556; Costa, Júlia C/0000-0001-7782-6319; Gomes, Cláudio M./0000-0003-4662-6933; Gouveia, Ricardo/0000-0002-2968-1298	CellPROM [500039-2]; European Commission [LSHG-CT-2004-503228]; Fundacao para a Ciencia e a Tecnologia, Portugal [SFRH/BD/24013/2005]	CellPROM(European Commission); European Commission(European CommissionEuropean Commission Joint Research Centre); Fundacao para a Ciencia e a Tecnologia, Portugal(Portuguese Foundation for Science and Technology)	This work was supported in part by CellPROM number 500039-2 and Signalling & Traffic number LSHG-CT-2004-503228 from the European Commission. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact. Supported by Ph. D. fellowship SFRH/BD/24013/2005 from Fundacao para a Ciencia e a Tecnologia, Portugal.	Altmann F, 1999, GLYCOCONJUGATE J, V16, P109, DOI 10.1023/A:1026488408951; Arevalo E, 2008, P NATL ACAD SCI USA, V105, P371, DOI 10.1073/pnas.0707815105; Bateman A, 1996, EMBO J, V15, P6050, DOI 10.1002/j.1460-2075.1996.tb00993.x; Blaess S, 1998, J NEUROCHEM, V71, P2615, DOI 10.1046/j.1471-4159.1998.71062615.x; Brito C, 2007, J NEUROSCI RES, V85, P1260, DOI 10.1002/jnr.21230; BurdenGulley SM, 1997, CELL TISSUE RES, V290, P415, DOI 10.1007/s004410050948; De Angelis E, 2002, HUM MOL GENET, V11, P1, DOI 10.1093/hmg/11.1.1; De Angelis E, 2001, J BIOL CHEM, V276, P32738, DOI 10.1074/jbc.M105156200; De Angelis E, 1999, EMBO J, V18, P4744, DOI 10.1093/emboj/18.17.4744; Escrevente C, 2008, BBA-GEN SUBJECTS, V1780, P905, DOI 10.1016/j.bbagen.2008.03.004; Freigang J, 2000, CELL, V101, P425, DOI 10.1016/S0092-8674(00)80852-1; Gouveia RM, 2007, PROTEIN EXPRES PURIF, V52, P182, DOI 10.1016/j.pep.2006.10.008; Hall H, 2000, J NEUROCHEM, V75, P336, DOI 10.1046/j.1471-4159.2000.0750336.x; Hara K, 2008, PROG NEUROBIOL, V85, P318, DOI 10.1016/j.pneurobio.2008.04.005; Haspel J, 2003, FRONT BIOSCI-LANDMRK, V8, pS1210, DOI 10.2741/1108; Haspel J, 2000, J NEUROBIOL, V42, P287, DOI 10.1002/(SICI)1097-4695(20000215)42:3<287::AID-NEU1>3.3.CO;2-O; Helenius A, 2004, ANNU REV BIOCHEM, V73, P1019, DOI 10.1146/annurev.biochem.73.011303.073752; Itoh K, 2004, J CELL BIOL, V165, P145, DOI 10.1083/jcb.200312107; Jacob J, 2002, J NEUROBIOL, V51, P177, DOI 10.1002/neu.10052; Kenwrick S, 2000, HUM MOL GENET, V9, P879, DOI 10.1093/hmg/9.6.879; Kiselyov VV, 1997, J BIOL CHEM, V272, P10125; Lakowicz JR, 1999, PRINCIPLES FLUORESCE; Loers G, 2005, J NEUROCHEM, V92, P1463, DOI 10.1111/j.1471-4159.2004.02983.x; Mechtersheimer S, 2001, J CELL BIOL, V155, P661, DOI 10.1083/jcb.200101099; Meijering E, 2004, CYTOM PART A, V58A, P167, DOI 10.1002/cyto.a.20022; Mendiratta SS, 2006, J BIOL CHEM, V281, P36052, DOI 10.1074/jbc.M608073200; Mortl M, 2007, PROTEIN SCI, V16, P2174, DOI 10.1110/ps.072802707; Oleszewski M, 2000, J BIOL CHEM, V275, P34478, DOI 10.1074/jbc.M004147200; Retzler C, 1996, J BIOL CHEM, V271, P27304, DOI 10.1074/jbc.271.44.27304; Schurmann G, 2001, MOL BIOL CELL, V12, P1765, DOI 10.1091/mbc.12.6.1765; Silletti S, 2000, J CELL BIOL, V149, P1485, DOI 10.1083/jcb.149.7.1485; Stipp CS, 2000, J CELL SCI, V113, P1871; Su XD, 1998, SCIENCE, V281, P991, DOI 10.1126/science.281.5379.991; Yip PM, 2001, J NEUROCHEM, V76, P1552, DOI 10.1046/j.1471-4159.2001.00152.x; Yip PM, 1998, MOL BIOL CELL, V9, P277, DOI 10.1091/mbc.9.2.277; Zhao XN, 1998, J NEUROCHEM, V71, P960; ZHAO XO, 1995, J BIOL CHEM, V270, P29413, DOI 10.1074/jbc.270.49.29413	37	34	34	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 17	2008	283	42					28038	28047		10.1074/jbc.M804991200	http://dx.doi.org/10.1074/jbc.M804991200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	359EN	18701456	Green Published, hybrid			2022-12-27	WOS:000259969300005
J	Hartmann, M; Skryabin, BV; Muller, T; Gazinski, A; Schroter, J; Gassner, B; Nikolaev, VO; Bunemann, M; Kuhn, M				Hartmann, Michael; Skryabin, Boris V.; Mueller, Thomas; Gazinski, Alexandra; Schroeter, Juliane; Gassner, Birgit; Nikolaev, Viacheslav O.; Buenemann, Moritz; Kuhn, Michaela			Alternative splicing of the guanylyl cyclase-A receptor modulates atrial natriuretic peptide signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESSENTIAL-HYPERTENSION; DOWN-REGULATION; BINDING DOMAIN; HEART-FAILURE; SPLIT GENES; NPR-B; PROTEIN; MICE; IDENTIFICATION; POLYMORPHISMS	Atrial (ANP) and B-type natriuretic peptides (BNP) modulate blood pressure and volume through the stimulation of cyclic GMP production by their guanylyl cyclase-A (GC-A) receptor. A novel isoform of GC-A has been identified that is the result of differential splicing of exon 4. The deletion of a 51-bp sequence is predicted to delete 17 amino acids (Lys(314)-Gln(330)) in the membrane-distal part of the extracellular domain. Reverse transcription-PCR analyses demonstrated low messenger RNA expression levels of spliced GC-A in all tissues. Homology modeling suggested that the alterations in the protein structure could interfere with ANP binding or signaling. Indeed, functional studies in transfected HEK 293 cells demonstrated that binding of ANP and ANP-induced cyclic GMP formation by GC-A Delta(Lys314-Gln330) were totally abolished. Furthermore, cotransfection studies showed that this GC-A variant forms heterodimers with the wild type receptor and inhibits ligand-inducible cGMP generation. Finally, treatment of mice with angiotensin II (300 ng/kg/min during 7 days) resulted in enhanced pulmonary mRNA expression of spliced GC-A, which was concomitant to diminished GC-A/cGMP responses to ANP. We conclude that alternative splicing can regulate endogenous ANP/GC-A signaling. Angiotensin II-induced alternative splicing of GC-A may represent a novel mechanism for reducing the sensitivity to ANP.	[Hartmann, Michael; Gazinski, Alexandra; Schroeter, Juliane; Gassner, Birgit; Kuhn, Michaela] Univ Wurzburg, Inst Physiol, D-97070 Wurzburg, Germany; [Skryabin, Boris V.] Univ Hosp Munster, Inst Expt Pathol, D-48149 Munster, Germany; [Mueller, Thomas] Univ Wurzburg, Dept Mol Plant Physiol & Biophys, Julius von Sachs Inst, Bioctr, D-97070 Wurzburg, Germany; [Nikolaev, Viacheslav O.; Buenemann, Moritz] Univ Wurzburg, Inst Pharmacol & Toxicol, D-97070 Wurzburg, Germany	University of Wurzburg; University of Munster; University of Wurzburg; University of Wurzburg	Kuhn, M (corresponding author), Univ Wurzburg, Inst Physiol, Rontgenring 9, D-97070 Wurzburg, Germany.	michaela.kuhn@mail.uni-wuerzburg.de	Nikolaev, Vyacheslav/AAT-7746-2020; Skryabin, Boris/AAL-3100-2020	Skryabin, Boris/0000-0002-4392-185X; Mueller, Thomas/0000-0003-1862-7357	Deutsche Forschungsgemeinschaft Sonderforschungsbereich 487; Sonderforschungsbereich 688	Deutsche Forschungsgemeinschaft Sonderforschungsbereich 487(German Research Foundation (DFG)); Sonderforschungsbereich 688(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft Sonderforschungsbereich 487 (to T. M., M. B., and M. K.) and Sonderforschungsbereich 688 (to M. K.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	Arise KK, 2006, BIOCHEM BIOPH RES CO, V349, P131, DOI 10.1016/j.bbrc.2006.08.003; Bartels CF, 2004, AM J HUM GENET, V75, P27, DOI 10.1086/422013; BEHRENDS S, 1995, J BIOL CHEM, V270, P21109, DOI 10.1074/jbc.270.36.21109; Beige J, 1997, AM J HYPERTENS, V10, P1316; BREATHNACH R, 1981, ANNU REV BIOCHEM, V50, P349, DOI 10.1146/annurev.bi.50.070181.002025; BREITBART RE, 1987, ANNU REV BIOCHEM, V56, P467, DOI 10.1146/annurev.bi.56.070187.002343; Bryan PM, 2006, BIOCHEMISTRY-US, V45, P1295, DOI 10.1021/bi051253d; Bryan PM, 2002, J BIOL CHEM, V277, P16041, DOI 10.1074/jbc.M110626200; Bulut D, 2003, EUR J CLIN INVEST, V33, P567, DOI 10.1046/j.1365-2362.2003.01188.x; BURNETT JC, 1986, SCIENCE, V231, P1145, DOI 10.1126/science.2935937; Fan DH, 2005, MOL PHARMACOL, V67, P174, DOI 10.1124/mol.104.002436; Francoeur F., 1995, Clinical and Experimental Pharmacology and Physiology, V22, pS172, DOI 10.1111/j.1440-1681.1995.tb02869.x; Gupta G, 1997, J CLIN INVEST, V100, P1488, DOI 10.1172/JCI119670; HIROOKA Y, 1990, CIRCULATION, V82, P147, DOI 10.1161/01.CIR.82.1.147; Holtwick R, 2003, J CLIN INVEST, V111, P1399, DOI 10.1172/JCI200317061; JOHN SWM, 1995, SCIENCE, V267, P679, DOI 10.1126/science.7839143; Kilic A, 2005, CIRCULATION, V112, P2307, DOI 10.1161/CIRCULATIONAHA.105.542209; Kuhn M, 2003, CIRC RES, V93, P700, DOI 10.1161/01.RES.0000094745.28948.4D; LOPEZ MJ, 1995, NATURE, V378, P65, DOI 10.1038/378065a0; McNicoll N, 1996, BIOCHEMISTRY-US, V35, P12950, DOI 10.1021/bi960818q; Mei ZZ, 2006, AM J PHYSIOL-CELL PH, V291, pC1022, DOI 10.1152/ajpcell.00606.2005; Nikolaev VO, 2006, NAT METHODS, V3, P23, DOI 10.1038/nmeth816; Ogawa H, 2004, J BIOL CHEM, V279, P28625, DOI 10.1074/jbc.M313222200; Potter LR, 2001, J BIOL CHEM, V276, P6057, DOI 10.1074/jbc.R000033200; Potthast R, 2001, ENDOCRINOLOGY, V142, P3087, DOI 10.1210/en.142.7.3087; Rubattu S, 2006, J AM COLL CARDIOL, V48, P499, DOI 10.1016/j.jacc.2005.12.081; RUTLEDGE DR, 1995, J HYPERTENS, V13, P953, DOI 10.1097/00004872-199509000-00003; Sala C, 2001, J CLIN ENDOCR METAB, V86, P1957, DOI 10.1210/jc.86.5.1957; Schreier B, 2008, ENDOCRINOLOGY, V149, P4193, DOI 10.1210/en.2008-0212; Sharina IG, 2008, J BIOL CHEM, V283, P15104, DOI 10.1074/jbc.M710269200; SHARP PA, 1994, CELL, V77, P805, DOI 10.1016/0092-8674(94)90130-9; TALLERICOMELNYK T, 1995, BIOCHEM BIOPH RES CO, V209, P930, DOI 10.1006/bbrc.1995.1587; Tamura N, 2003, J BIOL CHEM, V278, P48880, DOI 10.1074/jbc.M308680200; van den Akker F, 2000, NATURE, V406, P101, DOI 10.1038/35017602; van den Akker F, 2001, J MOL BIOL, V311, P923, DOI 10.1006/jmbi.2001.4922; WILSON EM, 1995, BIOCHEMISTRY-US, V34, P4696, DOI 10.1021/bi00014a025; Yang RB, 1997, J BIOL CHEM, V272, P13738, DOI 10.1074/jbc.272.21.13738	37	9	10	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 17	2008	283	42					28313	28320		10.1074/jbc.M805521200	http://dx.doi.org/10.1074/jbc.M805521200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	359EN	18713751	Green Published, hybrid			2022-12-27	WOS:000259969300033
J	Hasan, NM; Longacre, MJ; Stoker, SW; Boonsaen, T; Jitrapakdee, S; Kendrick, MA; Wallace, JC; MacDonald, MJ				Hasan, Noaman M.; Longacre, Melissa J.; Stoker, Scott W.; Boonsaen, Thirajit; Jitrapakdee, Sarawut; Kendrick, Mindy A.; Wallace, John C.; MacDonald, Michael J.			Impaired anaplerosis and insulin secretion in insulinoma cells caused by small interfering RNA-mediated suppression of pyruvate carboxylase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLYCEROL PHOSPHATE DEHYDROGENASE; GLUCOSE-REGULATED ANAPLEROSIS; NMR ISOTOPOMER ANALYSIS; PANCREATIC BETA-CELL; ATP-CITRATE LYASE; MALIC ENZYME; PHOSPHOENOLPYRUVATE CARBOXYKINASE; MITOCHONDRIAL METABOLISM; METHYL SUCCINATE; INS-1 CELLS	Anaplerosis, the synthesis of citric acid cycle intermediates, by pancreatic beta cell mitochondria has been proposed to be as important for insulin secretion as mitochondrial energy production. However, studies designed to lower the rate of anaplerosis in the beta cell have been inconclusive. To test the hypothesis that anaplerosis is important for insulin secretion, we lowered the activity of pyruvate carboxylase ( PC), the major enzyme of anaplerosis in the beta cell. Stable transfection of short hairpin RNA was used to generate a number of INS-1 832/13-derived cell lines with various levels of PC enzyme activity that retained normal levels of control enzymes, insulin content, and glucose oxidation. Glucose-induced insulin release was decreased in proportion to the decrease in PC activity. Insulin release in response to pyruvate alone, 2-aminobicyclo[ 2,2,1] heptane-2-carboxylic acid (BCH) plus glutamine, or methyl succinate plus beta-hydroxybutyrate was also decreased in the PC knockdown cells. Consistent with a block at PC, the most PC-deficient cells showed a metabolic crossover point at PC with increased basal and/or glucose-stimulated pyruvate plus lactate and decreased malate and citrate. In addition, in BCH plus glutamine-stimulated PC knockdown cells, pyruvate plus lactate was increased, whereas citrate was severely decreased, and malate and aspartate were slightly decreased. The incorporation of C-14 into lipid from [U-14C] glucose was decreased in the PC knockdown cells. The results confirm the central importance of PC and anaplerosis to generate metabolites from glucose that support insulin secretion and even suggest PC insulin secretion stimulated by noncarbohydrate insulin secretagogues.	[Hasan, Noaman M.; Longacre, Melissa J.; Stoker, Scott W.; Kendrick, Mindy A.; MacDonald, Michael J.] Univ Wisconsin, Sch Med & Publ Hlth, Childrens Diabet Ctr, Madison, WI 53706 USA; [Boonsaen, Thirajit; Jitrapakdee, Sarawut] Mahidol Univ, Fac Sci, Dept Biochem, Bangkok 10400, Thailand; [Wallace, John C.] Univ Adelaide, Sch Mol & Biomed Sci, Adelaide, SA 5005, Australia	University of Wisconsin System; University of Wisconsin Madison; Mahidol University; University of Adelaide	MacDonald, MJ (corresponding author), 3459 Med Sci Ctr,1300 Univ Ave, Madison, WI 53706 USA.	mjmacdon@wisc.edu	, John/AAP-5150-2020	MacDonald, Michael/0000-0002-0201-9245	National Institutes of Health [DK28348]; Oscar C. Rennebohm Foundation; Faculty of Science, Mahidol University); Thailand Research Fund [4680002]; Australian Research Council [DP0346807]; medical scholar program (Mahidol University, Thailand); Department of Education, Science, and Training, Australia; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R55DK028348, R01DK028348] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Oscar C. Rennebohm Foundation; Faculty of Science, Mahidol University); Thailand Research Fund(Thailand Research Fund (TRF)); Australian Research Council(Australian Research Council); medical scholar program (Mahidol University, Thailand); Department of Education, Science, and Training, Australia; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK28348. This work was also supported by a grant from the Oscar C. Rennebohm Foundation (to M. J. M.); a Career Development Grant (Faculty of Science, Mahidol University) and Thailand Research Fund RSA Grant 4680002 ( to S. J.); and Australian Research Council Grant DP0346807 (to J. C. W.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact. Supported by an M. D./Ph. D. medical scholar program (Mahidol University, Thailand) and the Endeavour Asia-Australia postgraduate research fellowship from the Department of Education, Science, and Training, Australia.	Antinozzi PA, 2006, P NATL ACAD SCI USA, V103, P3698, DOI 10.1073/pnas.0510521103; Antinozzi PA, 2002, J BIOL CHEM, V277, P11746, DOI 10.1074/jbc.M108462200; ASFARI M, 1992, ENDOCRINOLOGY, V130, P167, DOI 10.1210/en.130.1.167; BERGMEYER HU, 1985, METHOD ENZYMAT AN, V7, P261; Brunengraber H, 2006, J INHERIT METAB DIS, V29, P327, DOI 10.1007/s10545-006-0320-1; Castanotto D, 2007, NUCLEIC ACIDS RES, V35, P5154, DOI 10.1093/nar/gkm543; Cline GW, 2004, J BIOL CHEM, V279, P44370, DOI 10.1074/jbc.M311842200; Comte B, 2002, AM J PHYSIOL-HEART C, V283, pH1505, DOI 10.1152/ajpheart.00287.2002; Farfari S, 2000, DIABETES, V49, P718, DOI 10.2337/diabetes.49.5.718; Flamez D, 2002, DIABETES, V51, P2018, DOI 10.2337/diabetes.51.7.2018; Guay C, 2007, J BIOL CHEM, V282, P35657, DOI 10.1074/jbc.M707294200; GYLFE E, 1976, ACTA DIABETOL LAT, V13, P20, DOI 10.1007/BF02591577; HEDESKOV CJ, 1984, BIOCHIM BIOPHYS ACTA, V791, P37, DOI 10.1016/0167-4838(84)90278-4; Hohmeier HE, 2000, DIABETES, V49, P424, DOI 10.2337/diabetes.49.3.424; Jensen MV, 2006, J BIOL CHEM, V281, P22342, DOI 10.1074/jbc.M604350200; Jitrapakdee S, 2006, CELL MOL LIFE SCI, V63, P843, DOI 10.1007/s00018-005-5410-y; Jitrapakdee S, 1998, J BIOL CHEM, V273, P34422, DOI 10.1074/jbc.273.51.34422; Jitrapakdee S, 2008, BIOCHEM J, V413, P369, DOI 10.1042/BJ20080709; Khan A, 1996, J BIOL CHEM, V271, P2539, DOI 10.1074/jbc.271.5.2539; Li CH, 2008, J BIOL CHEM, V283, P17238, DOI 10.1074/jbc.M709235200; LOUIS NA, 1992, J BIOL CHEM, V267, P2287; Lu DH, 2002, P NATL ACAD SCI USA, V99, P2708, DOI 10.1073/pnas.052005699; MacDonald MJ, 2008, MOL CELL BIOCHEM, V313, P195, DOI 10.1007/s11010-008-9757-x; MacDonald MJ, 2008, BBA-GEN SUBJECTS, V1780, P966, DOI 10.1016/j.bbagen.2008.03.017; MacDonald MJ, 2008, ARCH BIOCHEM BIOPHYS, V470, P153, DOI 10.1016/j.abb.2007.11.017; MacDonald MJ, 2008, AM J PHYSIOL-CELL PH, V294, pC442, DOI 10.1152/ajpcell.00368.2007; MacDonald MJ, 2007, J BIOL CHEM, V282, P30596, DOI 10.1074/jbc.M702732200; MacDonald MJ, 2007, J BIOL CHEM, V282, P6043, DOI 10.1074/jbc.M606652200; MACDONALD MJ, 1993, ARCH BIOCHEM BIOPHYS, V300, P201, DOI 10.1006/abbi.1993.1028; MacDonald MJ, 2006, ARCH BIOCHEM BIOPHYS, V447, P118, DOI 10.1016/j.abb.2006.01.019; MacDonald MJ, 2005, AM J PHYSIOL-ENDOC M, V288, pE1, DOI 10.1152/ajpendo.00218.2004; MACDONALD MJ, 1993, METABOLISM, V42, P1229, DOI 10.1016/0026-0495(93)90118-8; MACDONALD MJ, 1992, HORM METAB RES, V24, P158, DOI 10.1055/s-2007-1003284; MACDONALD MJ, 1993, ARCH BIOCHEM BIOPHYS, V305, P205, DOI 10.1006/abbi.1993.1413; MacDonald MJ, 2004, MOL CELL BIOCHEM, V258, P201, DOI 10.1023/B:MCBI.0000012856.31929.91; MACDONALD MJ, 1985, DIABETES, V34, P246, DOI 10.2337/diabetes.34.3.246; MacDonald MJ, 2003, BBA-GEN SUBJECTS, V1619, P77, DOI 10.1016/S0304-4165(02)00443-9; MacDonald MJ, 1996, DIABETES, V45, P1626, DOI 10.2337/diabetes.45.11.1626; MACDONALD MJ, 1981, ENDOCRINOLOGY, V108, P1899, DOI 10.1210/endo-108-5-1899; MacDonald MJ, 2002, AM J PHYSIOL-ENDOC M, V283, pE302, DOI 10.1152/ajpendo.00041.2002; MACDONALD MJ, 1982, ARCH BIOCHEM BIOPHYS, V213, P643, DOI 10.1016/0003-9861(82)90594-X; MacDonald MJ, 2001, MOL CELL BIOCHEM, V220, P117, DOI 10.1023/A:1010821821921; MACDONALD MJ, 1995, J BIOL CHEM, V270, P20051; MacDonald MJ, 1996, DIABETES, V45, P886, DOI 10.2337/diabetes.45.7.886; MACDONALD MJ, 1991, J BIOL CHEM, V266, P22392; Pongratz RL, 2007, J BIOL CHEM, V282, P200, DOI 10.1074/jbc.M602954200; Queval G, 2007, ANAL BIOCHEM, V363, P58, DOI 10.1016/j.ab.2007.01.005; Ronnebaum SM, 2006, J BIOL CHEM, V281, P30593, DOI 10.1074/jbc.M511908200; Samid D, 2000, CLIN CANCER RES, V6, P933; Schuit F, 1997, J BIOL CHEM, V272, P18572, DOI 10.1074/jbc.272.30.18572; SENER A, 1981, P NATL ACAD SCI-BIOL, V78, P5460, DOI 10.1073/pnas.78.9.5460; Shack S, 1996, CLIN CANCER RES, V2, P865; Simpson NE, 2006, DIABETOLOGIA, V49, P1338, DOI 10.1007/s00125-006-0216-5; Sunyakumthorn P, 2005, BIOCHEM BIOPH RES CO, V329, P188, DOI 10.1016/j.bbrc.2005.01.108; Vickers TA, 2007, NUCLEIC ACIDS RES, V35, P6598, DOI 10.1093/nar/gkm663; Yang LL, 2008, J BIOL CHEM, V283, P21988, DOI 10.1074/jbc.M803455200	56	64	64	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 17	2008	283	42					28048	28059		10.1074/jbc.M804170200	http://dx.doi.org/10.1074/jbc.M804170200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	359EN	18697738	Green Published, hybrid			2022-12-27	WOS:000259969300006
J	Joshi, P; Carrington, EA; Wang, L; Ketel, CS; Miller, EL; Jones, RS; Simon, JA				Joshi, Preeti; Carrington, Elizabeth A.; Wang, Liangjun; Ketel, Carrie S.; Miller, Ellen L.; Jones, Richard S.; Simon, Jeffrey A.			Dominant alleles identify SET domain residues required for histone methyltransferase of polycomb repressive complex 2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EMBRYONIC STEM-CELLS; PROTEIN LYSINE METHYLTRANSFERASES; DROSOPHILA-MELANOGASTER; GROUP GENE; CHROMATIN-STRUCTURE; TARGET GENES; IN-VIVO; DEVELOPMENTAL REGULATORS; CAENORHABDITIS-ELEGANS; PRODUCT SPECIFICITY	Polycomb gene silencing requires histone methyltransferase activity of Polycomb repressive complex 2 (PRC2), which methylates lysine 27 of histone H3. Information on how PRC2 works is limited by lack of structural data on the catalytic subunit, Enhancer of zeste (E(Z)), and the paucity of E(z) mutant alleles that alter its SET domain. Here we analyze missense alleles of Drosophila E(z), selected for molecular study because of their dominant genetic effects. Four missense alleles identify key E(Z) SET domain residues, and a fifth is located in the adjacent CXC domain. Analysis of mutant PRC2 complexes in vitro, and H3-K27 methylation in vivo, shows that each SET domain mutation disrupts PRC2 histone methyltransferase. Based on known SET domain structures, the mutations likely affect either the lysine-substrate binding pocket, the binding site for the adenosylmethionine methyl donor, or a critical tyrosine predicted to interact with the substrate lysine epsilon-amino group. In contrast, the CXC mutant retains catalytic activity, Lys-27 specificity, and trimethylation capacity. Deletion analysis also reveals a functional requirement for a conserved E(Z) domain N-terminal to CXC and SET. These results identify critical SET domain residues needed for PRC2 enzyme function, and they also emphasize functional inputs from outside the SET domain.	[Carrington, Elizabeth A.] So Methodist Univ, Dept Biol Sci, Dallas, TX 75275 USA; [Joshi, Preeti; Wang, Liangjun; Ketel, Carrie S.; Miller, Ellen L.; Simon, Jeffrey A.] Univ Minnesota, Dept Genet Cell Biol & Dev, Minneapolis, MN 55455 USA	Southern Methodist University; University of Minnesota System; University of Minnesota Twin Cities	Jones, RS (corresponding author), So Methodist Univ, Dept Biol Sci, Dallas, TX 75275 USA.	rjones@mail.smu.edu; simon004@umn.edu			National Institutes of Health	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported, in whole or in part, by National Institutes of Health grants (to J. S. and R. J.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Bajusz I, 2001, GENETICS, V159, P1135; Ben-Porath I, 2008, NAT GENET, V40, P499, DOI 10.1038/ng.127; Bender LB, 2004, CURR BIOL, V14, P1639, DOI 10.1016/j.cub.2004.08.062; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Birve A, 2001, DEVELOPMENT, V128, P3371; Bornemann D, 1996, DEVELOPMENT, V122, P1621; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Bracken AP, 2006, GENE DEV, V20, P1123, DOI 10.1101/gad.381706; Brown JL, 1998, MOL CELL, V1, P1057, DOI 10.1016/S1097-2765(00)80106-9; Cao R, 2004, MOL CELL, V15, P57, DOI 10.1016/j.molcel.2004.06.020; Cao R, 2002, SCIENCE, V298, P1039, DOI 10.1126/science.1076997; Cao R, 2008, MOL CELL BIOL, V28, P1862, DOI 10.1128/MCB.01589-07; Carrington EA, 1996, DEVELOPMENT, V122, P4073; Chanvivattana Y, 2004, DEVELOPMENT, V131, P5263, DOI 10.1242/dev.01400; Chen S, 2008, MOL GENET GENOMICS, V279, P159, DOI 10.1007/s00438-007-0304-3; Cheng XD, 2007, MUTAT RES-FUND MOL M, V618, P102, DOI 10.1016/j.mrfmmm.2006.05.041; Collins RE, 2005, J BIOL CHEM, V280, P5563, DOI 10.1074/jbc.M410483200; Couture JF, 2006, CURR OPIN STRUC BIOL, V16, P753, DOI 10.1016/j.sbi.2006.10.002; Couture JF, 2005, GENE DEV, V19, P1455, DOI 10.1101/gad.1318405; Czermin B, 2002, CELL, V111, P185, DOI 10.1016/S0092-8674(02)00975-3; Dillon SC, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-8-227; Fanti L, 2008, CHROMOSOMA, V117, P25, DOI 10.1007/s00412-007-0123-7; Francis NJ, 2001, MOL CELL, V8, P545, DOI 10.1016/S1097-2765(01)00316-1; GATTI M, 1989, GENE DEV, V3, P438, DOI 10.1101/gad.3.4.438; Han ZF, 2007, STRUCTURE, V15, P1306, DOI 10.1016/j.str.2007.08.007; Heard E, 2005, CURR OPIN GENET DEV, V15, P482, DOI 10.1016/j.gde.2005.08.009; Holdeman R, 1998, DEVELOPMENT, V125, P2457; HULSKAMP M, 1991, BIOESSAYS, V13, P261, DOI 10.1002/bies.950130602; Jones CA, 1998, MOL CELL BIOL, V18, P2825, DOI 10.1128/MCB.18.5.2825; JONES RS, 1990, GENETICS, V126, P185; Kahn TG, 2006, J BIOL CHEM, V281, P29064, DOI 10.1074/jbc.M605430200; KALISCH WE, 1974, HEREDITAS, V78, P97; Ketel CS, 2005, MOL CELL BIOL, V25, P6857, DOI 10.1128/MCB.25.16.6857-6868.2005; Klymenko T, 2006, GENE DEV, V20, P1110, DOI 10.1101/gad.377406; Kuzmichev A, 2002, GENE DEV, V16, P2893, DOI 10.1101/gad.1035902; Laible G, 1997, EMBO J, V16, P3219, DOI 10.1093/emboj/16.11.3219; Lee TI, 2006, CELL, V125, P301, DOI 10.1016/j.cell.2006.02.043; Levenstein ME, 2002, J BIOL CHEM, V277, P8749, DOI 10.1074/jbc.M111212200; LEWIS EB, 1978, NATURE, V276, P565, DOI 10.1038/276565a0; Manzur KL, 2003, NAT STRUCT BIOL, V10, P187, DOI 10.1038/nsb898; Montgomery ND, 2005, CURR BIOL, V15, P942, DOI 10.1016/j.cub.2005.04.051; Muller J, 2002, CELL, V111, P197, DOI 10.1016/S0092-8674(02)00976-5; Negre N, 2006, PLOS BIOL, V4, P917, DOI 10.1371/journal.pbio.0040170; Nekrasov M, 2005, EMBO REP, V6, P348, DOI 10.1038/sj.embor.7400376; Nekrasov M, 2007, EMBO J, V26, P4078, DOI 10.1038/sj.emboj.7601837; O'Connell S, 2001, J BIOL CHEM, V276, P43065, DOI 10.1074/jbc.M104294200; O'Dor E, 2006, DEV BIOL, V290, P312, DOI 10.1016/j.ydbio.2005.11.015; Ohm JE, 2007, NAT GENET, V39, P237, DOI 10.1038/ng1972; Papp B, 2006, GENE DEV, V20, P2041, DOI 10.1101/gad.388706; Pasini D, 2004, EMBO J, V23, P4061, DOI 10.1038/sj.emboj.7600402; Pasini D, 2007, MOL CELL BIOL, V27, P3769, DOI 10.1128/MCB.01432-06; PELEGRI F, 1994, GENETICS, V136, P1341; Peters AHFM, 2003, MOL CELL, V12, P1577, DOI 10.1016/S1097-2765(03)00477-5; PHILLIPS MD, 1990, GENETICS, V125, P91; Pien S, 2007, BBA-GENE STRUCT EXPR, V1769, P375, DOI 10.1016/j.bbaexp.2007.01.010; Qian C, 2006, CELL MOL LIFE SCI, V63, P2755, DOI 10.1007/s00018-006-6274-5; Qian CM, 2006, J MOL BIOL, V359, P86, DOI 10.1016/j.jmb.2006.03.006; Rea S, 2000, NATURE, V406, P593, DOI 10.1038/35020506; Sarma K, 2008, MOL CELL BIOL, V28, P2718, DOI 10.1128/MCB.02017-07; Savla U, 2008, DEVELOPMENT, V135, P813, DOI 10.1242/dev.016006; Schlesinger Y, 2007, NAT GENET, V39, P232, DOI 10.1038/ng1950; Schubert D, 2006, EMBO J, V25, P4638, DOI 10.1038/sj.emboj.7601311; Schwartz YB, 2007, NAT REV GENET, V8, P9, DOI 10.1038/nrg1981; Schwartz YB, 2006, NAT GENET, V38, P700, DOI 10.1038/ng1817; Shao ZH, 1999, CELL, V98, P37, DOI 10.1016/S0092-8674(00)80604-2; SIMON J, 1992, DEVELOPMENT, V114, P493; Sparmann A, 2006, NAT REV CANCER, V6, P846, DOI 10.1038/nrc1991; Spillane C, 2000, CURR BIOL, V10, P1535, DOI 10.1016/S0960-9822(00)00839-3; Squazzo SL, 2006, GENOME RES, V16, P890, DOI 10.1101/gr.5306606; STRUHL G, 1985, EMBO J, V4, P3259, DOI 10.1002/j.1460-2075.1985.tb04075.x; Tie F, 1998, DEVELOPMENT, V125, P3483; Tolhuis B, 2006, NAT GENET, V38, P694, DOI 10.1038/ng1792; WANG C, 1991, CELL, V66, P637, DOI 10.1016/0092-8674(91)90110-K; Wang L, 2004, MOL CELL, V14, P637, DOI 10.1016/j.molcel.2004.05.009; WHARTON RP, 1991, CELL, V67, P955, DOI 10.1016/0092-8674(91)90368-9; Widschwendter M, 2007, NAT GENET, V39, P157, DOI 10.1038/ng1941; Wilson JR, 2002, CELL, V111, P105, DOI 10.1016/S0092-8674(02)00964-9; WU CT, 1989, MOL GEN GENET, V218, P559, DOI 10.1007/BF00332424; Xiao B, 2003, NATURE, V421, P652, DOI 10.1038/nature01378; Xiao B, 2005, GENE DEV, V19, P1444, DOI 10.1101/gad.1315905; Xiao B, 2003, CURR OPIN STRUC BIOL, V13, P699, DOI 10.1016/j.sbi.2003.10.003; Xu L, 2001, P NATL ACAD SCI USA, V98, P5061, DOI 10.1073/pnas.081016198; Yu J, 2007, CANCER RES, V67, P10657, DOI 10.1158/0008-5472.CAN-07-2498; Zhang X, 2002, CELL, V111, P117, DOI 10.1016/S0092-8674(02)00999-6; Zhang X, 2003, MOL CELL, V12, P177, DOI 10.1016/S1097-2765(03)00224-7	85	44	44	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 10	2008	283	41					27757	27766		10.1074/jbc.M804442200	http://dx.doi.org/10.1074/jbc.M804442200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	355OW	18693240	Green Published, hybrid			2022-12-27	WOS:000259719200047
J	Turski, ML; Thiele, DJ				Turski, Michelle L.; Thiele, Dennis J.			New Roles for Copper Metabolism in Cell Proliferation, Signaling, and Disease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							HUMAN LYSYL OXIDASE; TRANSPORTER CTR1; MODULATES DIFFERENTIATION; SACCHAROMYCES-CEREVISIAE; SELF-RENEWAL; CISPLATIN; MECHANISMS; CANCER; SUPEROXIDE-DISMUTASE-1; PURIFICATION		[Turski, Michelle L.; Thiele, Dennis J.] Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Durham, NC 27710 USA	Duke University	Thiele, DJ (corresponding author), Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Durham, NC 27710 USA.	dennis.thiele@duke.edu			National Institutes of Health [ES010356]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P42ES010356] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grant ES010356. This is the second article of three in the Thematic Minireview Series on Metals in Biology. This minireview will be reprinted in the 2009 Minireview Compendium, which will be available in January, 2010.	Aller SG, 2006, P NATL ACAD SCI USA, V103, P3627, DOI 10.1073/pnas.0509929103; ANDREWS PA, 1990, CANCER CELL-MON REV, V2, P35; Bertini I., 2007, BIOL INORGANIC CHEM; Cobine PA, 2006, BBA-MOL CELL RES, V1763, P759, DOI 10.1016/j.bbamcr.2006.03.002; Culotta VC, 2006, BBA-MOL CELL RES, V1763, P747, DOI 10.1016/j.bbamcr.2006.05.003; DAMERON CT, 1991, P NATL ACAD SCI USA, V88, P6127, DOI 10.1073/pnas.88.14.6127; DANCIS A, 1994, J BIOL CHEM, V269, P25660; FINNEY L, 2008, CLIN EXP PH IN PRESS; Fong SFT, 2007, GENE CHROMOSOME CANC, V46, P644, DOI 10.1002/gcc.20444; Franz KJ, 2008, NAT CHEM BIOL, V4, P85, DOI 10.1038/nchembio0208-85; Geschickter C.F., 1930, J CHEM EDUC, DOI [10.1021/ed007p179, DOI 10.1021/ED007P179]; Guo Y, 2004, J BIOL CHEM, V279, P46393, DOI 10.1074/jbc.M407777200; Haremaki T, 2007, P NATL ACAD SCI USA, V104, P12029, DOI 10.1073/pnas.0701413104; Holzer AK, 2006, CANCER RES, V66, P10944, DOI 10.1158/0008-5472.CAN-06-1710; Hwang PM, 2001, NAT MED, V7, P1111, DOI 10.1038/nm1001-1111; Ishida S, 2002, P NATL ACAD SCI USA, V99, P14298, DOI 10.1073/pnas.162491399; Juarez JC, 2008, P NATL ACAD SCI USA, V105, P7147, DOI 10.1073/pnas.0709451105; Juarez JC, 2006, CLIN CANCER RES, V12, P4974, DOI 10.1158/1078-0432.CCR-06-0171; Jung ST, 2003, PROTEIN EXPRES PURIF, V31, P240, DOI 10.1016/S1046-5928(03)00217-1; Kim BE, 2008, NAT CHEM BIOL, V4, P176, DOI 10.1038/nchembio.72; Kim MS, 2003, J BIOL CHEM, V278, P52071, DOI 10.1074/jbc.M308856200; Kuo YM, 2001, P NATL ACAD SCI USA, V98, P6836, DOI 10.1073/pnas.111057298; Leary SC, 2004, HUM MOL GENET, V13, P1839, DOI 10.1093/hmg/ddh197; Lee J, 2002, J BIOL CHEM, V277, P4380, DOI 10.1074/jbc.M104728200; Lee J, 2002, J BIOL CHEM, V277, P40253, DOI 10.1074/jbc.M208002200; Lee LW, 2001, P NATL ACAD SCI USA, V98, P6842, DOI 10.1073/pnas.111058698; Lin XJ, 2002, MOL PHARMACOL, V62, P1154, DOI 10.1124/mol.62.5.1154; Lippard S. J., 1994, PRINCIPLES BIOINORGA; Lucero HA, 2006, CELL MOL LIFE SCI, V63, P2304, DOI 10.1007/s00018-006-6149-9; Lutsenko S, 2007, PHYSIOL REV, V87, P1011, DOI 10.1152/physrev.00004.2006; Matoba S, 2006, SCIENCE, V312, P1650, DOI 10.1126/science.1126863; Mendelsohn BA, 2006, CELL METAB, V4, P155, DOI 10.1016/j.cmet.2006.05.001; Molnar J, 2003, BBA-PROTEINS PROTEOM, V1647, P220, DOI 10.1016/S1570-9639(03)00053-0; Payne SL, 2007, J CELL BIOCHEM, V101, P1338, DOI 10.1002/jcb.21371; Peinado H, 2005, CELL CYCLE, V4, P1749, DOI 10.4161/cc.4.12.2224; Peinado H, 2005, EMBO J, V24, P3446, DOI 10.1038/sj.emboj.7600781; Peled T, 2002, BRIT J HAEMATOL, V116, P655, DOI 10.1046/j.0007-1048.2001.03316.x; Peled T, 2005, EXP HEMATOL, V33, P1092, DOI 10.1016/j.exphem.2005.06.015; Pouyssegur J, 2006, NATURE, V441, P437, DOI 10.1038/nature04871; Prohaska JR, 2004, J NUTR, V134, P1003, DOI 10.1093/jn/134.5.1003; Puig S, 2002, CURR OPIN CHEM BIOL, V6, P171, DOI 10.1016/S1367-5931(02)00298-3; Puig S, 2002, J BIOL CHEM, V277, P26021, DOI 10.1074/jbc.M202547200; Rawls JF, 2001, DEV BIOL, V240, P301, DOI 10.1006/dbio.2001.0418; Reaume AG, 1996, NAT GENET, V13, P43, DOI 10.1038/ng0596-43; Rhee SG, 2006, SCIENCE, V312, P1882, DOI 10.1126/science.1130481; Ridge PG, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001378; Rutherford JC, 2004, EUKARYOT CELL, V3, P1, DOI 10.1128/EC.3.1.1-13.2004; Sinani D, 2007, J BIOL CHEM, V282, P26775, DOI 10.1074/jbc.M703973200	48	277	292	0	37	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 9	2009	284	2					717	721		10.1074/jbc.R800055200	http://dx.doi.org/10.1074/jbc.R800055200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	389VP	18757361	hybrid, Green Published			2022-12-27	WOS:000262122900003
J	Abouzahr-Rifai, S; Hasmim, M; Boukerche, H; Hamelin, J; Janji, B; Jalil, A; Kieda, C; Mami-Chouaib, F; Bertoglio, J; Chouaib, S				Abouzahr-Rifai, Soraya; Hasmim, Meriem; Boukerche, Habib; Hamelin, Jocelyne; Janji, Bassam; Jalil, Abdelali; Kieda, Claudine; Mami-Chouaib, Fathia; Bertoglio, Jacques; Chouaib, Salem			Resistance of Tumor Cells to Cytolytic T Lymphocytes Involves Rho-GTPases and Focal Adhesion Kinase Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BREAST-CANCER CELLS; STRESS FIBERS; FACTOR-I; ACTIN; EXPRESSION; PROTEINS; BINDING; IMMUNOSURVEILLANCE; IDENTIFICATION; LOCALIZATION	Tumor cells evade adaptive immunity by a variety of mechanisms, including selection of variants that are resistant to specific cytotoxic T lymphocyte (CTL) pressure. Recently, we have reported that the reorganization of the actin cytoskeleton can be used by tumor cells as a strategy to promote their resistance to CTL-mediated lysis. In this study, we further examined the functional features of a CTL-resistant tumor variant and investigated the relationship between cytoskeleton alteration, the acquisition of tumor resistance to CTL-induced cell death, Rho-GTPases, and focal adhesion kinase (FAK) pathways. Our data indicate that although the resistant cells do not display an increased migratory potential, an alteration of adhesion to the extracellular matrix was observed. When Rho-GTPases were activated in cells by the bacterial CNF1 (cytotoxic necrotizing factor 1), striking changes in the cell morphology, including actin cytoskeleton, focal adhesions, and membrane extensions, were observed. More importantly, such activation also resulted in a significant attenuation of resistance to CTL-induced cell death. Furthermore, we demonstrate that FAK signaling pathways were constitutively defective in the resistant cells. Silencing of FAK in the sensitive target cells resulted in the inhibition of immune synapse formation with specific CTLs and their subsequent lysis. Expression of the FAK mutant (Y397F) resulted in an inhibition of IGR-Heu cell adhesion and of their susceptibility to specific lysis. These results suggest that FAK activation plays a role in the control of tumor cell susceptibility to CTL-mediated lysis.	[Abouzahr-Rifai, Soraya; Hasmim, Meriem; Jalil, Abdelali; Mami-Chouaib, Fathia; Chouaib, Salem] Inst Gustave Roussy, INSERM, U753, F-94800 Villejuif, France; [Boukerche, Habib] Univ Lyon 1, INSERM, Lab Hemobiol, EA 4174, F-69372 Lyon, France; [Hamelin, Jocelyne; Bertoglio, Jacques] INSERM, U749, F-92296 Chatenay Malabry, France; [Kieda, Claudine] Ctr Biophys Mol, F-45071 Orleans, France; [Janji, Bassam] Publ Res Ctr Hlth, Lab Expt Hematocancerol, L-1526 Luxembourg, Luxembourg	Institut National de la Sante et de la Recherche Medicale (Inserm); UNICANCER; Gustave Roussy; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Institut National de la Sante et de la Recherche Medicale (Inserm)	Chouaib, S (corresponding author), Inst Gustave Roussy, INSERM, U753, 39 Rue Camille Desmoulins, F-94805 Villejuif, France.	chouaib@igr.fr	Chouaib, Salem/F-7939-2016; Mami-Chouaib, Fathia/E-5267-2016; HAMELIN, Jocelyne JH/R-4590-2018; Kieda, Claudine/U-1361-2019	HAMELIN, Jocelyne JH/0000-0003-4222-0792; JANJI, Bassam/0000-0002-9763-0943; JALIL, Abdelali/0000-0003-2710-8735; Hasmim, Meriem/0000-0002-7920-2443	INSERM; Association pour la Recherche Contre le Cancer [4744, 3501, 3922]; Canceropole Ile-de-France; Institut National du Cancer	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Association pour la Recherche Contre le Cancer(Fondation ARC pour la Recherche sur le Cancer); Canceropole Ile-de-France(Region Ile-de-France); Institut National du Cancer(Institut National du Cancer (INCA) France)	This work was supported by grants from INSERM, Association pour la Recherche Contre le Cancer Grants 4744, 3501, and 3922, by the Canceropole Ile-de-France, and by the Institut National du Cancer. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact. 1 Both authors contributed equally to this work.	Abouzahr S, 2006, P NATL ACAD SCI USA, V103, P1428, DOI 10.1073/pnas.0510454103; Asselin-Paturel C, 2001, CANCER-AM CANCER SOC, V91, P113, DOI 10.1002/1097-0142(20010101)91:1<113::AID-CNCR15>3.0.CO;2-7; Bershadsky AD, 2003, ANNU REV CELL DEV BI, V19, P677, DOI 10.1146/annurev.cellbio.19.111301.153011; Brakebusch C, 2003, EMBO J, V22, P2324, DOI 10.1093/emboj/cdg245; Chang FM, 2007, MOL BIOL CELL, V18, P253, DOI 10.1091/mbc.E06-03-0207; Chouaib S, 1997, IMMUNOL TODAY, V18, P493, DOI 10.1016/S0167-5699(97)01115-8; ChrzanowskaWodnicka M, 1996, J CELL BIOL, V133, P1403, DOI 10.1083/jcb.133.6.1403; Dunn GP, 2002, NAT IMMUNOL, V3, P991, DOI 10.1038/ni1102-991; Echchakir H, 1999, INT J CANCER, V81, P205, DOI 10.1002/(SICI)1097-0215(19990412)81:2<205::AID-IJC7>3.0.CO;2-M; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Flatau G, 1997, NATURE, V387, P729, DOI 10.1038/42743; Gabriel B, 2006, CLIN CANCER RES, V12, P2476, DOI 10.1158/1078-0432.CCR-05-1867; Golubovskaya VM, 2008, MOL CARCINOGEN, V47, P222, DOI 10.1002/mc.20380; Haddad E, 2001, BLOOD, V97, P33, DOI 10.1182/blood.V97.1.33; Hall A, 2005, BIOCHEM SOC T, V33, P891, DOI 10.1042/BST0330891; Holinstat M, 2006, J BIOL CHEM, V281, P2296, DOI 10.1074/jbc.M511248200; Jaffe AB, 2005, ANNU REV CELL DEV BI, V21, P247, DOI 10.1146/annurev.cellbio.21.020604.150721; Janke J, 2000, J EXP MED, V191, P1675, DOI 10.1084/jem.191.10.1675; Klein RM, 2008, MOL BIOL CELL, V19, P498, DOI 10.1091/mbc.E07-09-0895; KRAMER RH, 1989, J BIOL CHEM, V264, P4684; Lacerda HM, 1997, J BIOL CHEM, V272, P9587; LANG P, 1993, BIOCHEM BIOPH RES CO, V196, P1522, DOI 10.1006/bbrc.1993.2424; Lerm M, 1999, INFECT IMMUN, V67, P496, DOI 10.1128/IAI.67.2.496-503.1999; Liu TJ, 2007, MOL CANCER THER, V6, P1357, DOI 10.1158/1535-7163.MCT-06-0476; Madan R, 2006, HUM PATHOL, V37, P9, DOI 10.1016/j.humpath.2005.09.024; McLean GW, 2005, NAT REV CANCER, V5, P505, DOI 10.1038/nrc1647; Meslin F, 2007, CANCER RES, V67, P10910, DOI 10.1158/0008-5472.CAN-07-0512; Mitra SK, 2005, NAT REV MOL CELL BIO, V6, P56, DOI 10.1038/nrm1549; Moreau V, 2003, MOL CELL BIOL, V23, P6809, DOI 10.1128/MCB.23.19.6809-6822.2003; Nobes CD, 1998, J CELL BIOL, V141, P187, DOI 10.1083/jcb.141.1.187; Ohta R, 2006, ONCOLOGY-BASEL, V71, P417, DOI 10.1159/000107109; Oktay MH, 2003, HUM PATHOL, V34, P240, DOI 10.1053/hupa.2003.40; RIDLEY AJ, 1992, CELL, V70, P389, DOI 10.1016/0092-8674(92)90163-7; SCHALLER MD, 1995, J CELL BIOL, V130, P1181, DOI 10.1083/jcb.130.5.1181; SCHALLER MD, 1994, CURR OPIN CELL BIOL, V6, P705, DOI 10.1016/0955-0674(94)90097-3; SCHALLER MD, 1994, MOL CELL BIOL, V14, P1680, DOI 10.1128/MCB.14.3.1680; Schlaepfer DD, 1999, PROG BIOPHYS MOL BIO, V71, P435, DOI 10.1016/S0079-6107(98)00052-2; Schmidt G, 1997, NATURE, V387, P725, DOI 10.1038/42735; Serrels B, 2007, NAT CELL BIOL, V9, P1046, DOI 10.1038/ncb1626; Smyth MJ, 2001, NAT IMMUNOL, V2, P293, DOI 10.1038/86297; Subauste MC, 2000, J BIOL CHEM, V275, P9725, DOI 10.1074/jbc.275.13.9725; Tachibana K, 1997, J BIOL CHEM, V272, P29083, DOI 10.1074/jbc.272.46.29083; Verrills NM, 2006, J NATL CANCER I, V98, P1363, DOI 10.1093/jnci/djj372; Wozniak MA, 2004, BBA-MOL CELL RES, V1692, P103, DOI 10.1016/j.bbamcr.2004.04.007; Wu XY, 2004, J BIOL CHEM, V279, P9565, DOI 10.1074/jbc.M310739200; Yano H, 2004, J CELL BIOL, V166, P283, DOI 10.1083/jcb.200312013; Yasuda M, 2001, CANCER RES, V61, P2022	47	15	15	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 14	2008	283	46					31665	31672		10.1074/jbc.M800078200	http://dx.doi.org/10.1074/jbc.M800078200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	370KJ	18779334	hybrid			2022-12-27	WOS:000260760800048
J	Gigout, A; Jolicoeur, M; Nelea, M; Raynal, N; Farndale, R; Buschmann, MD				Gigout, Anne; Jolicoeur, Mario; Nelea, Monica; Raynal, Nicolas; Farndale, Richard; Buschmann, Michael D.			Chondrocyte Aggregation in Suspension Culture Is GFOGER-GPP- and beta 1 Integrin-dependent	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EXTRACELLULAR-MATRIX PROTEINS; DISCOIDIN DOMAIN RECEPTOR; COLLAGEN-BINDING; ARTICULAR CHONDROCYTES; II COLLAGEN; ULTRASTRUCTURAL ANALYSIS; INTERSTITIAL COLLAGENS; CELL ATTACHMENT; ANNEXIN-V; CARTILAGE	Isolated chondrocytes form aggregates in suspension culture that maintain chondrocyte phenotype in a physiological pericellular environment. The molecular mechanisms involved in chondrocyte aggregation have not been previously identified. Using this novel suspension culture system, we performed mRNA and protein expression analysis along with immunohistochemistry for potential cell adhesion molecules and extracellular matrix integrin ligands. Inhibition of aggregation assays were performed using specific blocking agents. We found that: (i) direct cell-cell interactions were not involved in chondrocyte aggregation, (ii) chondrocytes in aggregates were surrounded by a matrix rich in collagen II and cartilage oligomeric protein (COMP), (iii) aggregation depends on a beta 1-integrin, which binds a triple helical GFOGER sequence found in collagens, (iv) integrin alpha 10-subunit is the most highly expressed alpha-subunit among those tested, including alpha 5, in aggregating chondrocytes. Taken together, this body of evidence suggests that the main molecular interaction involved in aggregation of phenotypically stable chondrocytes is the alpha 10 beta 1-collagen II interaction.	[Gigout, Anne; Jolicoeur, Mario; Nelea, Monica; Buschmann, Michael D.] Ecole Polytech, Dept Chem Engn, Montreal, PQ H3C 3A7, Canada; [Gigout, Anne; Jolicoeur, Mario; Nelea, Monica; Buschmann, Michael D.] Ecole Polytech, Inst Biomed Engn, Montreal, PQ H3C 3A7, Canada; [Raynal, Nicolas; Farndale, Richard] Univ Cambridge, Dept Biochem, Cambridge CB2 1QW, England	Universite de Montreal; Polytechnique Montreal; Universite de Montreal; Polytechnique Montreal; University of Cambridge	Buschmann, MD (corresponding author), Ecole Polytech, Dept Chem Engn, PO 6079 Stn Ctr Ville, Montreal, PQ H3C 3A7, Canada.	michael.buschmann@polymtl.ca	Gigout, Anne/AAN-9566-2020	Gigout, Anne/0000-0003-1399-7957; Buschmann, Michael/0000-0002-2242-6198	Canadian Institutes of Health Research (CIHR); Canada Research Chairs program; Natural Sciences and Engineering Research Council of Canada (NSERC); MRC [G0400701] Funding Source: UKRI; Medical Research Council [G0400701] Funding Source: researchfish	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Canada Research Chairs program(Canada Research Chairs); Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported in part by the Canadian Institutes of Health Research (CIHR), the Canada Research Chairs program, and the Natural Sciences and Engineering Research Council of Canada (NSERC). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Adams J, 2004, INT J BIOCHEM CELL B, V36, P960, DOI 10.1016/j.biocel.2004.02.009; Attur MG, 2000, J IMMUNOL, V164, P2684, DOI 10.4049/jimmunol.164.5.2684; Camper L, 1998, J BIOL CHEM, V273, P20383, DOI 10.1074/jbc.273.32.20383; Camper L, 2001, CELL TISSUE RES, V306, P107, DOI 10.1007/s004410100385; Camper L, 1997, J CELL BIOL, V138, P1159, DOI 10.1083/jcb.138.5.1159; Cao L, 1999, MATRIX BIOL, V18, P343, DOI 10.1016/S0945-053X(99)00027-X; Chen FH, 2005, J BIOL CHEM, V280, P32655, DOI 10.1074/jbc.M504778200; Di Cesare PE, 2002, MATRIX BIOL, V21, P461, DOI 10.1016/S0945-053X(02)00015-X; Durr J, 1996, EXP CELL RES, V222, P225, DOI 10.1006/excr.1996.0028; DURR J, 1993, EXP CELL RES, V207, P235, DOI 10.1006/excr.1993.1189; ENOMOTO M, 1993, EXP CELL RES, V205, P276, DOI 10.1006/excr.1993.1087; Furukawa KS, 2003, CELL TRANSPLANT, V12, P475, DOI 10.3727/000000003108747037; Gehris AL, 1997, DEV BIOL, V190, P191, DOI 10.1006/dbio.1997.8693; Gigout A, 2005, OSTEOARTHR CARTILAGE, V13, P1012, DOI 10.1016/j.joca.2005.06.003; Halasz K, 2007, J BIOL CHEM, V282, P31166, DOI 10.1074/jbc.M705735200; HEDLUND H, 1993, APMIS, V101, P133, DOI 10.1111/j.1699-0463.1993.tb00092.x; Hughes L C, 2005, Eur Cell Mater, V9, P68; HYNES RO, 1987, CELL, V48, P549, DOI 10.1016/0092-8674(87)90233-9; Ichikawa O, 2007, EMBO J, V26, P4168, DOI 10.1038/sj.emboj.7601833; KIRSCH T, 1992, FEBS LETT, V310, P143, DOI 10.1016/0014-5793(92)81316-E; Knight CG, 2000, J BIOL CHEM, V275, P35, DOI 10.1074/jbc.275.1.35; Knudson W, 2002, CELL MOL LIFE SCI, V59, P36, DOI 10.1007/s00018-002-8403-0; Konitsiotis AD, 2008, J BIOL CHEM, V283, P6861, DOI 10.1074/jbc.M709290200; Kreidberg JA, 2000, CURR OPIN CELL BIOL, V12, P548, DOI 10.1016/S0955-0674(00)00130-7; KROG L, 1992, APMIS, V100, P53; LANGE TS, 1994, EXP CELL RES, V214, P381, DOI 10.1006/excr.1994.1271; Lee V, 2000, J CELL BIOCHEM, V79, P322, DOI 10.1002/1097-4644(20001101)79:2<322::AID-JCB150>3.0.CO;2-U; Leitinger B, 2004, J MOL BIOL, V344, P993, DOI 10.1016/j.jmb.2004.09.089; Liu WH, 2002, BIOCHEM BIOPH RES CO, V294, P347, DOI 10.1016/S0006-291X(02)00478-3; LOESER RF, 1995, EXP CELL RES, V217, P248, DOI 10.1006/excr.1995.1084; LOESER RF, 1993, ARTHRITIS RHEUM, V36, P1103, DOI 10.1002/art.1780360811; Loeser RF, 2000, BIORHEOLOGY, V37, P109; Lucic D, 2003, CONNECT TISSUE RES, V44, P225, DOI 10.1080/03008200390248632; Mann HH, 2007, MATRIX BIOL, V26, P167, DOI 10.1016/j.matbio.2006.10.010; Mansson B, 2001, J BIOL CHEM, V276, P32883, DOI 10.1074/jbc.M101680200; Neame PJ, 1999, CELL MOL LIFE SCI, V55, P1327, DOI 10.1007/s000180050373; Noonan KJ, 1998, J ORTHOPAED RES, V16, P500, DOI 10.1002/jor.1100160416; OBERLENDER SA, 1994, CELL ADHES COMMUN, V2, P521, DOI 10.3109/15419069409014216; Ohno S, 1999, BBA-MOL CELL RES, V1451, P196, DOI 10.1016/S0167-4889(99)00093-2; Onley DJ, 2000, J BIOL CHEM, V275, P24560, DOI 10.1074/jbc.M004111200; PFAFF M, 1993, EXP CELL RES, V206, P167, DOI 10.1006/excr.1993.1134; POOLE CA, 1987, J ORTHOP RES, V5, P509, DOI 10.1002/jor.1100050406; Poole CA, 1997, J ANAT, V191, P1, DOI 10.1046/j.1469-7580.1997.19110001.x; Reid DL, 2000, J ORTHOPAED RES, V18, P364, DOI 10.1002/jor.1100180307; Ruoslahti E, 1996, ANNU REV CELL DEV BI, V12, P697, DOI 10.1146/annurev.cellbio.12.1.697; Salicioni AM, 2004, J BIOL CHEM, V279, P10005, DOI 10.1074/jbc.M306625200; Seiffert D, 1996, J HISTOCHEM CYTOCHEM, V44, P275, DOI 10.1177/44.3.8648088; Siljander PRM, 2004, J BIOL CHEM, V279, P47763, DOI 10.1074/jbc.M404685200; Tavella S, 1997, J CELL SCI, V110, P2261; TAVELLA S, 1994, EXP CELL RES, V215, P354, DOI 10.1006/excr.1994.1352; Tiger CF, 2001, DEV BIOL, V237, P116, DOI 10.1006/dbio.2001.0363; TUCKWELL DS, 1994, J CELL SCI, V107, P993; Wagener R, 2005, FEBS LETT, V579, P3323, DOI 10.1016/j.febslet.2005.03.018; White DJ, 2004, INT J BIOCHEM CELL B, V36, P1405, DOI 10.1016/j.biocel.2003.08.016; Wiberg C, 2003, J BIOL CHEM, V278, P37698, DOI 10.1074/jbc.M304638200; WIDELITZ RB, 1993, J CELL PHYSIOL, V156, P399, DOI 10.1002/jcp.1041560224; Woods A, 2007, J CELL PHYSIOL, V213, P1, DOI 10.1002/jcp.21110; WOODS VL, 1994, ARTHRITIS RHEUM, V37, P537, DOI 10.1002/art.1780370414; Zaucke F, 2001, BIOCHEM J, V358, P17, DOI 10.1042/0264-6021:3580017; Zhang WM, 2003, J BIOL CHEM, V278, P7270, DOI 10.1074/jbc.M210313200; Zhang ZJ, 2004, J ANAT, V205, P229, DOI 10.1111/j.0021-8782.2004.00327.x	61	40	43	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 14	2008	283	46					31522	31530		10.1074/jbc.M804234200	http://dx.doi.org/10.1074/jbc.M804234200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	370KJ	18723503	hybrid			2022-12-27	WOS:000260760800031
J	Tripathi, M; Nandana, S; Yamashita, H; Ganesan, R; Kirchhofer, D; Quaranta, V				Tripathi, Manisha; Nandana, Srinivas; Yamashita, Hironobu; Ganesan, Rajkumar; Kirchhofer, Daniel; Quaranta, Vito			Laminin-332 Is a Substrate for Hepsin, a Protease Associated with Prostate Cancer Progression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEPATOCYTE GROWTH-FACTOR; TUMOR-SUPPRESSOR GENES; EXTRACELLULAR-MATRIX; CELL-MIGRATION; SERINE-PROTEASE; BETA-3 CHAIN; VII COLLAGEN; CARCINOMA-CELLS; NC1 DOMAIN; EXPRESSION	Hepsin, a cell surface protease, is widely reported to be over-expressed in more than 90% of human prostate tumors. Hepsin expression correlates with tumor progression, making it a significant marker and target for prostate cancer. Recently, it was reported that in a prostate cancer mouse model, hepsin up-regulation in tumor tissue promotes progression and metastasis. The underlying mechanisms, however, remain largely uncharacterized. Hepsin transgenic mice displayed reduced laminin-332 (Ln-332) expression in prostate tumors. This is an intriguing cue, since proteolytic processing of extracellular matrix macromolecules, such as Ln-332, is believed to be involved in cancer progression, and Ln-332 expression is lost during human prostate cancer progression. In this study, we provide the first direct evidence that hepsin cleaves Ln-332. Cleavage is specific, since it is both inhibited in a dose-dependent manner by a hepsin inhibitor (Kunitz domain-1) and does not occur when catalytically inactive hepsin is used. By Western blotting and mass spectrometry, we determined that hepsin cleaves the beta 3 chain of Ln-332. N-terminal sequencing identified the cleavage site at beta 3 Arg(245), in a sequence context (SQLR(245) down arrow LQGSCFC) conserved among species and in remarkable agreement with reported consensus target sequences for hepsin activity. In vitro cell migration assays showed that hepsin-cleaved Ln-332 enhanced motility of DU145 prostate cancer cells, which was inhibited by Kunitz domain-1. Further, hepsin-overexpressing LNCaP prostate cancer cells also exhibited increased migration on Ln-332. Direct cleavage of Ln-332 may be one mechanism by which hepsin promotes prostate tumor progression and metastasis, possibly by up-regulating prostate cancer cell motility.	[Tripathi, Manisha; Nandana, Srinivas; Yamashita, Hironobu; Quaranta, Vito] Vanderbilt Univ, Sch Med, Dept Canc Biol, Nashville, TN 37232 USA; [Ganesan, Rajkumar; Kirchhofer, Daniel] Genentech Inc, Dept Prot Engn, San Francisco, CA 94080 USA	Vanderbilt University; Roche Holding; Genentech	Quaranta, V (corresponding author), Vanderbilt Univ, Sch Med, Dept Canc Biol, 771 Preston Res Bldg,2220 Pierce Ave, Nashville, TN 37232 USA.	vito.quaranta@vanderbilt.edu	Quaranta, Vito/G-6512-2016; Ganesan, Rajkumar/B-1093-2008	Quaranta, Vito/0000-0001-7491-8672; Ganesan, Rajkumar/0000-0002-3431-9664; Yamashita, Hironobu/0000-0003-2587-7100	National Institutes of Health [CA47858-17A2, GM067221-03]; NATIONAL CANCER INSTITUTE [R01CA047858] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067221] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants CA47858-17A2 and GM067221-03 (to V. Q.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Amano S, 2000, J BIOL CHEM, V275, P22728, DOI 10.1074/jbc.M002345200; Aumailley M, 2005, MATRIX BIOL, V24, P326, DOI 10.1016/j.matbio.2005.05.006; Bair EL, 2005, NEOPLASIA, V7, P380, DOI 10.1593/neo.04619; BIRKEDALHANSEN H, 1995, CURR OPIN CELL BIOL, V7, P728, DOI 10.1016/0955-0674(95)80116-2; Brittingham R, 2006, BIOCHEM BIOPH RES CO, V343, P692, DOI 10.1016/j.bbrc.2006.03.034; Calaluce R, 2006, PROSTATE, V66, P1381, DOI 10.1002/pros.20393; Chen M, 1999, J INVEST DERMATOL, V112, P177, DOI 10.1046/j.1523-1747.1999.00491.x; Chen ZX, 2003, J UROLOGY, V169, P1316, DOI 10.1097/01.ju.0000050648.40164.0d; Davis TL, 2001, PROSTATE, V46, P240; Dhanasekaran SM, 2001, NATURE, V412, P822, DOI 10.1038/35090585; Ernst T, 2002, AM J PATHOL, V160, P2169, DOI 10.1016/S0002-9440(10)61165-0; Falk-Marzillier J, 1998, BIOCHEM BIOPH RES CO, V251, P49, DOI 10.1006/bbrc.1998.9400; Giannelli G, 1997, SCIENCE, V277, P225, DOI 10.1126/science.277.5323.225; Gupta GP, 2006, CELL, V127, P679, DOI 10.1016/j.cell.2006.11.001; Halvorsen OJ, 2005, INT J ONCOL, V26, P329; Hao JS, 2001, AM J PATHOL, V158, P1129, DOI 10.1016/S0002-9440(10)64060-6; Herter S, 2005, BIOCHEM J, V390, P125, DOI 10.1042/BJ20041955; Hintermann E, 2004, MATRIX BIOL, V23, P75, DOI 10.1016/j.matbio.2004.03.001; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; Jenkins RB, 1997, CANCER RES, V57, P524; Jones JCR, 1998, BIOESSAYS, V20, P488, DOI 10.1002/(SICI)1521-1878(199806)20:6<488::AID-BIES7>3.0.CO;2-I; KAZAMA Y, 1995, J BIOL CHEM, V270, P66, DOI 10.1074/jbc.270.1.66; Kirchhofer D, 2005, FEBS LETT, V579, P1945, DOI 10.1016/j.febslet.2005.01.085; Klezovitch O, 2004, CANCER CELL, V6, P185, DOI 10.1016/j.ccr.2004.07.008; Koshikawa N, 2003, FASEB J, V17, P364, DOI 10.1096/fj.03-0584fje; Lai YL, 2004, BIOINFORMATICS, V20, P3146, DOI 10.1093/bioinformatics/bth379; Landers KA, 2005, INT J CANCER, V114, P950, DOI 10.1002/ijc.20760; LI W, 2007, AM ASS CAN RES ANN M; Litjens SHM, 2006, TRENDS CELL BIOL, V16, P376, DOI 10.1016/j.tcb.2006.05.004; Luo J, 2001, CANCER RES, V61, P4683; MacGrogan D, 1997, SEMIN CANCER BIOL, V8, P11, DOI 10.1006/scbi.1997.0048; Magee JA, 2001, CANCER RES, V61, P5692; Meneguzzi G, 1992, Exp Dermatol, V1, P221, DOI 10.1111/j.1600-0625.1992.tb00080.x; Moran P, 2006, J BIOL CHEM, V281, P30439, DOI 10.1074/jbc.M605440200; Morrissey C, 2008, CLIN EXP METASTAS, V25, P377, DOI 10.1007/s10585-007-9116-4; Mundy GR, 2002, NAT REV CANCER, V2, P584, DOI 10.1038/nrc867; Mydel P, 2008, J BIOL CHEM, V283, P9513, DOI 10.1074/jbc.M706239200; Nagle RB, 2004, J CELL BIOCHEM, V91, P36, DOI 10.1002/jcb.10692; NAGLE RB, 1995, AM J PATHOL, V146, P1498; Nakashima Y, 2005, J BIOCHEM, V138, P539, DOI 10.1093/jb/mvi153; Narla G, 2001, SCIENCE, V294, P2563, DOI 10.1126/science.1066326; Noel A, 1997, INVAS METAST, V17, P221; Ortiz-Urda S, 2005, SCIENCE, V307, P1773, DOI 10.1126/science.1106209; Pirila E, 2003, BIOCHEM BIOPH RES CO, V303, P1012, DOI 10.1016/S0006-291X(03)00452-2; Plopper G, 1996, J CELL SCI, V109, P1965; Quaranta V, 2003, TUMORI J, V89, P343, DOI 10.1177/030089160308900401; Remy L, 2006, CANCER RES, V66, P11228, DOI 10.1158/0008-5472.CAN-06-1187; ROUSSELLE P, 1991, J CELL BIOL, V114, P567, DOI 10.1083/jcb.114.3.567; Ryan MC, 1996, MATRIX BIOL, V15, P369, DOI 10.1016/S0945-053X(96)90157-2; Schenk S, 2003, TRENDS CELL BIOL, V13, P366, DOI 10.1016/S0962-8924(03)00129-6; Shia S, 2005, J MOL BIOL, V346, P1335, DOI 10.1016/j.jmb.2004.12.048; Singh D, 2002, CANCER CELL, V1, P203, DOI 10.1016/S1535-6108(02)00030-2; Somoza JR, 2003, STRUCTURE, V11, P1123, DOI 10.1016/S0969-2126(03)00148-5; Stephan C, 2004, J UROLOGY, V171, P187, DOI 10.1097/01.ju.0000101622.74236.94; Turner DP, 2008, EXPERT REV ANTICANC, V8, P33, DOI 10.1586/14737140.8.1.33; Udayakumar TS, 2003, CANCER RES, V63, P2292; Vasioukhin V, 2004, CELL CYCLE, V3, P1394, DOI 10.4161/cc.3.11.1273; Veitch DP, 2003, J BIOL CHEM, V278, P15661, DOI 10.1074/jbc.M210588200; Wang B, 2006, J BIOL CHEM, V281, P6020, DOI 10.1074/jbc.M509134200; Wang SI, 1998, CLIN CANCER RES, V4, P811; Waterman EA, 2007, CANCER RES, V67, P4264, DOI 10.1158/0008-5472.CAN-06-4141; Woodward JKL, 2007, BONE, V41, P912, DOI 10.1016/j.bone.2007.07.024; Wu QY, 2007, FRONT BIOSCI-LANDMRK, V12, P5052, DOI 10.2741/2447; Xuan JA, 2006, CANCER RES, V66, P3611, DOI 10.1158/0008-5472.CAN-05-2983; Yurchenco PD, 2004, CURR OPIN CELL BIOL, V16, P572, DOI 10.1016/j.ceb.2004.07.013; Zapatka M, 2007, ONCOGENE, V26, P1417, DOI 10.1038/sj.onc.1209918	66	72	91	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 7	2008	283	45					30576	30584		10.1074/jbc.M802312200	http://dx.doi.org/10.1074/jbc.M802312200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	367ID	18784072	Green Published, hybrid			2022-12-27	WOS:000260544800016
J	Yabu, T; Imamura, S; Yamashita, M; Okazaki, T				Yabu, Takeshi; Imamura, Shintaro; Yamashita, Michiaki; Okazaki, Toshiro			Identification of Mg2+-dependent Neutral Sphingomyelinase 1 as a Mediator of Heat Stress-induced Ceramide Generation and Apoptosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTESTINAL ALKALINE SPHINGOMYELINASE; TUMOR-NECROSIS-FACTOR; SUBCELLULAR-LOCALIZATION; ACID SPHINGOMYELINASE; CELL-DIFFERENTIATION; SIGNAL-TRANSDUCTION; FUNCTIONAL-ANALYSIS; BACILLUS-CEREUS; HL-60 CELLS; RAT-LIVER	Neutral sphingomyelinases (SMases) are involved in the induction of ceramide-mediated proapoptotic signaling under heat stress conditions. Although ceramide is an important mediator of apoptosis, the neutral SMase that is activated under heat stress has not been identified. In this study, we cloned an Mg2+-dependent neutral SMase from a zebrafish embryonic cell cDNA library using an Escherichia coli expression-cloning vector. Screening of the clones using an SMase activity assay with C-6-7-nitro-2-1,3-benzoxadiazol-4-yl-sphingomyelin as the substrate resulted in the isolation of one neutral SMase cDNA clone. This cDNA encoded a polypeptide of 420 amino acids (putative molecular weight: 46,900) containing two predicted transmembrane domains in its C-terminal region. The cloned neutral SMase 1 acted as a mediator of stress-induced apoptosis. Bacterially expressed recombinant neutral SMase 1 hydrolyzed [choline-methyl-C-14] sphingomyelin optimally at pH 7.5 in the presence of an Mg2+ ion. In zebrafish embryonic cells, the endogenous SMase enzyme was localized in the microsomal fraction. In FLAG-tagged SMase-overexpressing cells, neutral SMase 1 colocalized with a Golgi marker in a cytochemical analysis. Inactivation of the enzyme by an antisense phosphorothioate oligonucleotide repressed the induction of ceramide generation, caspase-3 activation, and apoptotic cell death by heat stress. Thus, neutral SMase 1 participates in an inducible ceramide-mediating, proapoptotic signaling pathway that operates in heat-induced apoptosis in zebrafish embryonic cells.	[Yabu, Takeshi; Imamura, Shintaro; Yamashita, Michiaki] Natl Res Inst Fisheries Sci, Kanagawa 2368648, Japan; [Okazaki, Toshiro] Tottori Univ, Dept Hematol, Clin Lab Med, Sch Med, Tottori 6838504, Japan	Japan Fisheries Research & Education Agency (FRA); Tottori University	Yabu, T (corresponding author), Natl Res Inst Fisheries Sci, 2-12-4 Fukuura, Kanagawa 2368648, Japan.	tyabu@fra.affrc.go.jp			Japan Science and Technology Corporation; Japan Society for the Promotion of Science; Ministry of Agriculture, Forestry, and Fisheries of Japan	Japan Science and Technology Corporation(Japan Science & Technology Agency (JST)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Agriculture, Forestry, and Fisheries of Japan(Ministry of Agriculture Forestry & Fisheries - Japan)	This work was supported by grants from the Japan Science and Technology Corporation, the Japan Society for the Promotion of Science, and the Ministry of Agriculture, Forestry, and Fisheries of Japan. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Andrieu N, 1996, EUR J BIOCHEM, V236, P738, DOI 10.1111/j.1432-1033.1996.00738.x; Andrieu-Abadie N, 2002, BBA-MOL CELL BIOL L, V1585, P126, DOI 10.1016/S1388-1981(02)00332-3; Bevers EM, 1998, LUPUS, V7, pS126, DOI 10.1177/096120339800700228; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Chang Y, 1995, P NATL ACAD SCI USA, V92, P12275, DOI 10.1073/pnas.92.26.12275; Duan RD, 2003, J BIOL CHEM, V278, P38528, DOI 10.1074/jbc.M305437200; Duan RD, 2003, J LIPID RES, V44, P1241, DOI 10.1194/jlr.M300037-JLR200; DUAN RD, 1995, BBA-LIPID LIPID MET, V1259, P49, DOI 10.1016/0005-2760(95)00137-2; FERLINZ K, 1994, BIOCHEM J, V301, P855, DOI 10.1042/bj3010855; Fujii S, 1998, J BIOCHEM-TOKYO, V124, P1178, DOI 10.1093/oxfordjournals.jbchem.a022236; Fujii S, 1999, J BIOCHEM-TOKYO, V126, P90, DOI 10.1093/oxfordjournals.jbchem.a022441; Gamen S, 1996, FEBS LETT, V390, P233, DOI 10.1016/0014-5793(96)00666-7; GATT S, 1976, BIOCHEM BIOPH RES CO, V68, P235, DOI 10.1016/0006-291X(76)90034-6; Hannun YA, 1996, SCIENCE, V274, P1855, DOI 10.1126/science.274.5294.1855; Hannun YA, 2000, TRENDS CELL BIOL, V10, P73, DOI 10.1016/S0962-8924(99)01694-3; HELLER M, 1966, BIOCHEM J, V98, P763, DOI 10.1042/bj0980763; Hofmann K, 2000, P NATL ACAD SCI USA, V97, P5895, DOI 10.1073/pnas.97.11.5895; HOSTETLER KY, 1979, J LIPID RES, V20, P456; Imamura S, 2003, FEBS LETT, V549, P14, DOI 10.1016/S0014-5793(03)00723-3; Jenkins GM, 2002, J BIOL CHEM, V277, P42572, DOI 10.1074/jbc.M207346200; Kondo T, 2000, J BIOL CHEM, V275, P7668, DOI 10.1074/jbc.275.11.7668; Kondo T, 2000, J BIOL CHEM, V275, P8872, DOI 10.1074/jbc.275.12.8872; Kronke M, 1999, CHEM PHYS LIPIDS, V102, P157, DOI 10.1016/S0009-3084(99)00084-5; Krut O, 2006, J BIOL CHEM, V281, P13784, DOI 10.1074/jbc.M511306200; Lee JT, 2004, J CELL BIOL, V164, P123, DOI 10.1083/jcb.200307017; Letunic I, 2006, NUCLEIC ACIDS RES, V34, pD257, DOI 10.1093/nar/gkj079; LINARDIC CM, 1994, J BIOL CHEM, V269, P23530; Liu B, 1997, SEMIN CELL DEV BIOL, V8, P311, DOI 10.1006/scdb.1997.0153; Marchesini N, 2004, BIOCHEM CELL BIOL, V82, P27, DOI 10.1139/o03-091; Martin SF, 2007, ARCH BIOCHEM BIOPHYS, V459, P295, DOI 10.1016/j.abb.2006.11.007; Matsuo Y, 1996, PROTEIN SCI, V5, P2459, DOI 10.1002/pro.5560051208; NILSSON A, 1969, BIOCHIM BIOPHYS ACTA, V176, P339, DOI 10.1016/0005-2760(69)90192-1; Nyberg L, 1996, BBA-LIPID LIPID MET, V1300, P42, DOI 10.1016/0005-2760(95)00245-6; OBEID LM, 1993, SCIENCE, V259, P1769, DOI 10.1126/science.8456305; OBEID LM, 2003, SCI AGING KNOWLEDGE, P27; OKAZAKI T, 1989, J BIOL CHEM, V264, P19076; OKAZAKI T, 1994, J BIOL CHEM, V269, P4070; Oorni K, 1998, J BIOL CHEM, V273, P29127, DOI 10.1074/jbc.273.44.29127; Pena LA, 1997, BIOCHEM PHARMACOL, V53, P615, DOI 10.1016/S0006-2952(96)00834-9; RAO BG, 1976, J LIPID RES, V17, P506; Sawada N, 2000, CELL DEATH DIFFER, V7, P761, DOI 10.1038/sj.cdd.4400711; Sawai H, 1999, J BIOL CHEM, V274, P38131, DOI 10.1074/jbc.274.53.38131; SAWAI H, 1995, J BIOL CHEM, V270, P27326, DOI 10.1074/jbc.270.45.27326; Sawai H, 1999, CHEM PHYS LIPIDS, V102, P141, DOI 10.1016/S0009-3084(99)00082-1; Schissel SL, 1996, J BIOL CHEM, V271, P18431, DOI 10.1074/jbc.271.31.18431; SPENCE MW, 1989, J BIOL CHEM, V264, P5358; Stoffel W, 1999, CHEM PHYS LIPIDS, V102, P107, DOI 10.1016/S0009-3084(99)00079-1; Tepper AD, 1999, J CLIN INVEST, V103, P971, DOI 10.1172/JCI5457; Tepper AD, 1997, J BIOL CHEM, V272, P24308, DOI 10.1074/jbc.272.39.24308; Tepper AD, 2001, BIOCHEM BIOPH RES CO, V280, P634, DOI 10.1006/bbrc.2000.4166; Tomiuk S, 2000, J BIOL CHEM, V275, P5710, DOI 10.1074/jbc.275.8.5710; Tomiuk S, 1998, P NATL ACAD SCI USA, V95, P3638, DOI 10.1073/pnas.95.7.3638; Tonnetti L, 1999, J EXP MED, V189, P1581, DOI 10.1084/jem.189.10.1581; Veiga MP, 1999, BIOPHYS J, V76, P342, DOI 10.1016/S0006-3495(99)77201-2; Verheij M, 1996, NATURE, V380, P75, DOI 10.1038/380075a0; Yabu T, 2005, BLOOD, V106, P125, DOI 10.1182/blood-2004-09-3679; Yabu T, 2003, FISHERIES SCI, V69, P1218, DOI 10.1111/j.0919-9268.2003.00748.x; Yabu T, 2001, BIOCHEM J, V360, P39, DOI 10.1042/0264-6021:3600039; Yabu T, 2001, FISHERIES SCI, V67, P333, DOI 10.1046/j.1444-2906.2001.00233.x; Yoshimura Y, 2004, J BIOL CHEM, V279, P44012, DOI 10.1074/jbc.M405598200; Zumbansen M, 2002, MOL CELL BIOL, V22, P3633, DOI 10.1128/MCB.22.11.3633-3638.2002; Zwaal RFA, 1997, BLOOD, V89, P1121, DOI 10.1182/blood.V89.4.1121	62	40	40	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 31	2008	283	44					29971	29982		10.1074/jbc.M805402200	http://dx.doi.org/10.1074/jbc.M805402200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	364WS	18678863	Green Published, hybrid			2022-12-27	WOS:000260366900042
J	O'Brien, TC; Mackey, ZB; Fetter, RD; Choe, Y; O'Donoghue, AJ; Zhou, M; Craik, CS; Caffrey, CR; McKerrow, JH				O'Brien, Theresa C.; Mackey, Zachary B.; Fetter, Richard D.; Choe, Youngchool; O'Donoghue, Anthony J.; Zhou, Min; Craik, Charles S.; Caffrey, Conor R.; McKerrow, James H.			A Parasite Cysteine Protease Is Key to Host Protein Degradation and Iron Acquisition	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LYSOSOMAL MEMBRANE GLYCOPROTEIN; TRYPANOSOMA-BRUCEI; TRANSFERRIN RECEPTOR; AFRICAN TRYPANOSOMES; SUBCELLULAR-LOCALIZATION; SUBSTRATE-SPECIFICITY; LEISHMANIA-MEXICANA; CATHEPSIN-B; GRANZYME-B; TRAFFICKING	Cysteine proteases of the Clan CA (papain) family are the predominant protease group in primitive invertebrates. Cysteine protease inhibitors arrest infection by the protozoan parasite, Trypanosoma brucei. RNA interference studies implicated a cathepsin B-like protease, tbcatB, as a key inhibitor target. Utilizing parasites in which one of the two alleles of tbcatb has been deleted, the key role of this protease in degradation of endocytosed host proteins is delineated. TbcatB deficiency results in a decreased growth rate and dysmorphism of the flagellar pocket and the subjacent endocytic compartment. Western blot and microscopic analysis indicate that deficiency in tbcatB results in accumulation of both host and parasite proteins, including the lysosomal marker p67. A critical function for parasitism is the degradation of host transferrin, which is necessary for iron acquisition. Substrate specificity analysis of recombinant tbcatB revealed the optimal peptide cleavage sequences for the enzyme and these were confirmed experimentally using FRET-based substrates. Degradation of transferrin was validated by SDS-PAGE and the specific cleavage sites identified by N-terminal sequencing. Because even a modest deficiency in tbcatB is lethal for the parasite, tbcatB is a logical target for the development of new anti-trypanosomal chemotherapy.	[O'Brien, Theresa C.; Mackey, Zachary B.; Caffrey, Conor R.; McKerrow, James H.] Univ Calif San Francisco, Dept Pathol, Calif Inst Quantitat Biomed Res QB3, San Francisco, CA 94158 USA; [O'Brien, Theresa C.; Mackey, Zachary B.; Caffrey, Conor R.; McKerrow, James H.] Univ Calif San Francisco, Sandler Ctr Basic Res Parasit Dis, Calif Inst Quantitat Biomed Res QB3, San Francisco, CA 94158 USA; [Fetter, Richard D.; Choe, Youngchool; O'Donoghue, Anthony J.; Zhou, Min; Craik, Charles S.] Univ Calif San Francisco, Calif Inst Quantitat Biomed Res QB3, Dept Biochem & Biophys, San Francisco, CA 94158 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	McKerrow, JH (corresponding author), Univ Calif San Francisco, Dept Pathol, Calif Inst Quantitat Biomed Res QB3, 1700,4th St,Box 2550, San Francisco, CA 94158 USA.	jmck@cgl.ucsf.edu		Mackey, Zachary/0000-0002-4533-0973	National Institutes of Health [AI35707]; National Science Foundation Graduate Research Fellowship; Sandler Family Supporting Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI035707] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation Graduate Research Fellowship(National Science Foundation (NSF)); Sandler Family Supporting Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant AI35707 from the NIAID Tropical Disease Research Unit. This work was also supported by a National Science Foundation Graduate Research Fellowship (to T. C. O.) and the Sandler Family Supporting Foundation. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Alexander DL, 2002, J CELL SCI, V115, P3253; Allen CL, 2003, EMBO J, V22, P4991, DOI 10.1093/emboj/cdg481; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bogyo M, 2000, CHEM BIOL, V7, P27, DOI 10.1016/S1074-5521(00)00061-2; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRICKMAN MJ, 1994, J CELL SCI, V107, P3191; Brooks DR, 2000, J CELL SCI, V113, P4035; BUTTLE DJ, 1992, ARCH BIOCHEM BIOPHYS, V299, P377, DOI 10.1016/0003-9861(92)90290-D; Caffrey C. R., 2000, Current Drug Targets, V1, P155, DOI 10.2174/1389450003349290; Caffrey CR, 2001, MOL BIOCHEM PARASIT, V118, P61, DOI 10.1016/S0166-6851(01)00368-1; Choe Y, 2006, J BIOL CHEM, V281, P12824, DOI 10.1074/jbc.M513331200; Doyle PS, 2007, ANTIMICROB AGENTS CH, V51, P3932, DOI 10.1128/AAC.00436-07; Engel JC, 1998, J EXP MED, V188, P725, DOI 10.1084/jem.188.4.725; Garcia-Salcedo JA, 2004, EMBO J, V23, P780, DOI 10.1038/sj.emboj.7600094; Gerrits H, 2002, MOL BIOCHEM PARASIT, V119, P237, DOI 10.1016/S0166-6851(01)00417-0; GRAB DJ, 1993, EUR J CELL BIOL, V62, P114; Hall B, 2004, MOL BIOCHEM PARASIT, V138, P67, DOI 10.1016/j.molbiopara.2004.07.007; Hall BS, 2005, EUKARYOT CELL, V4, P971, DOI 10.1128/EC.4.5.971-980.2005; Harris JL, 1998, J BIOL CHEM, V273, P27364, DOI 10.1074/jbc.273.42.27364; Kabiri M, 2000, EUR J BIOCHEM, V267, P3309, DOI 10.1046/j.1432-1327.2000.01361.x; Kelley RJ, 1995, MOL BIOCHEM PARASIT, V74, P167, DOI 10.1016/0166-6851(95)02493-X; Kelley RJ, 1999, MOL BIOCHEM PARASIT, V98, P17, DOI 10.1016/S0166-6851(98)00155-8; Loeb CRK, 2006, J BIOL CHEM, V281, P28326, DOI 10.1074/jbc.M604544200; Luscher A, 2007, CURR PHARM DESIGN, V13, P555, DOI 10.2174/138161207780162809; Mackey ZB, 2004, J BIOL CHEM, V279, P48426, DOI 10.1074/jbc.M402470200; Mathieu MA, 2002, MOL BIOCHEM PARASIT, V121, P99, DOI 10.1016/S0166-6851(02)00026-9; Mottram JC, 1997, J BIOL CHEM, V272, P14285, DOI 10.1074/jbc.272.22.14285; Mussmann R, 2004, J BIOL CHEM, V279, P40690, DOI 10.1074/jbc.M404697200; Mussmann R, 2003, MOL MICROBIOL, V47, P23, DOI 10.1046/j.1365-2958.2003.03245.x; Nkemngu NJ, 2003, INT J ANTIMICROB AG, V22, P155, DOI 10.1016/S0924-8579(03)00096-7; Obenauer JC, 2003, NUCLEIC ACIDS RES, V31, P3635, DOI 10.1093/nar/gkg584; Pal A, 2003, BIOCHEM J, V374, P443, DOI 10.1042/BJ20030469; Rawlings ND, 2004, NUCLEIC ACIDS RES, V32, pD160, DOI 10.1093/nar/gkp971; Renslo AR, 2006, NAT CHEM BIOL, V2, P701, DOI 10.1038/nchembio837; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Scory S, 1999, EXP PARASITOL, V91, P327, DOI 10.1006/expr.1998.4381; SCORY S, 2007, KINETOPLASTID BIOL D, V6, P1; Steverding Dietmar, 2000, Parasitology International, V48, P191, DOI 10.1016/S1383-5769(99)00018-5; Triggs VP, 2003, EUKARYOT CELL, V2, P76, DOI 10.1128/EC.2.1.76-83.2003; van den Hoff M J, 1995, Methods Mol Biol, V48, P185; van Luenen HGAM, 2005, MOL MICROBIOL, V58, P151, DOI 10.1111/j.1365-2958.2005.04831.x	41	60	60	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 24	2008	283	43					28934	28943		10.1074/jbc.M805824200	http://dx.doi.org/10.1074/jbc.M805824200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	362EB	18701454	Green Published, hybrid			2022-12-27	WOS:000260179900019
J	Pakhomova, S; Bartlett, SG; Augustus, A; Kuzuyama, T; Newcomer, ME				Pakhomova, Svetlana; Bartlett, Sue G.; Augustus, Alexandria; Kuzuyama, Tomohisa; Newcomer, Marcia E.			Crystal structure of fosfomycin resistance kinase FomA from Streptomyces wedmorensis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; UMP KINASE; PSEUDOMONAS-AERUGINOSA; ARGININE-BIOSYNTHESIS; SECONDARY-STRUCTURE; ENZYME FAMILY; PROTEIN; PHOSPHONOMYCIN; IDENTIFICATION; STATE	The fosfomycin resistance protein FomA inactivates fosfomycin by phosphorylation of the phosphonate group of the antibiotic in the presence of ATP and Mg(II). We report the crystal structure of FomA from the fosfomycin biosynthetic gene cluster of Streptomyces wedmorensis in complex with diphosphate and in ternary complex with the nonhydrolyzable ATP analog adenosine 5'-(beta,gamma-imido)-triphosphate (AMPPNP), Mg(II), and fosfomycin, at 1.53 and 2.2 angstrom resolution, respectively. The polypeptide exhibits an open alpha beta alpha sandwich fold characteristic for the amino acid kinase family of enzymes. The diphosphate complex shows significant disorder in loops surrounding the active site. As a result, the nucleotide-binding site is wide open. Binding of the substrates is followed by the partial closure of the active site and ordering of the alpha 2-helix. Structural comparison with N-acetyl-L-glutamate kinase shows several similarities in the site of phosphoryl transfer: 1) preservation of architecture of the catalytical amino acids of N-acetyl-L-glutamate kinase(Lys(9), Lys(216), and Asp(150) in FomA); 2) good super-position of the phosphate acceptor groups of the substrates, and 3) good super-position of the diphosphate molecule with the beta-and gamma-phosphates of AMPPNP, suggesting that the reaction could proceed by an associative in-line mechanism. However, differences in conformations of the triphosphate moiety of AMPPNP molecules, the long distance (5.1 angstrom) between the phosphate acceptor and donor groups in FomA, and involvement of Lys(18) instead of Lys(9) in binding with the gamma-phosphate may indicate a different reaction mechanism. The present work identifies the active site residues of FomA responsible for substrate binding and specificity and proposes their roles in catalysis.	[Pakhomova, Svetlana; Bartlett, Sue G.; Augustus, Alexandria; Newcomer, Marcia E.] Louisiana State Univ, Dept Biol Sci, Baton Rouge, LA 70803 USA; [Kuzuyama, Tomohisa] Univ Tokyo, Biotechnol Res Ctr, Lab Cell Biotechnol, Bunkyo Ku, Tokyo 1138657, Japan	Louisiana State University System; Louisiana State University; University of Tokyo	Pakhomova, S (corresponding author), Louisiana State Univ, Dept Biol Sci, 202 Life Sci Bldg, Baton Rouge, LA 70803 USA.	sveta@lsu.edu		Kuzuyama, Tomohisa/0000-0002-7221-5858	National Institutes of Health [R03AI074770]; Louisiana Governor's Biotechnology Initiative; National Science Foundation [DBI-9871464]; National Institute for General Medical Sciences; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R03AI074770] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Louisiana Governor's Biotechnology Initiative; National Science Foundation(National Science Foundation (NSF)); National Institute for General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant R03AI074770. This work was also supported in part by the Louisiana Governor's Biotechnology Initiative. The Gulf Coast Protein Crystallography Beamline was supported by National Science Foundation Grant DBI-9871464 with co-funding from the National Institute for General Medical Sciences. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked" advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bernat BA, 1997, BIOCHEMISTRY-US, V36, P3050, DOI 10.1021/bi963172a; Briozzo P, 2005, J BIOL CHEM, V280, P25533, DOI 10.1074/jbc.M501849200; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cao M, 2001, J BACTERIOL, V183, P2380, DOI 10.1128/JB.183.7.2380-2383.2001; Cassone M, 2004, MICROB DRUG RESIST, V10, P43, DOI 10.1089/107662904323047790; CHRISTENSEN BG, 1969, SCIENCE, V166, P123, DOI 10.1126/science.166.3901.123; Cleland WW, 2006, CHEM REV, V106, P3252, DOI 10.1021/cr050287o; DeLano W.L, PYMOL MOL GRAPHICS S; Egeblad-Welin L, 2007, FEBS J, V274, P6403, DOI 10.1111/j.1742-4658.2007.06157.x; ETIENNE J, 1989, FEMS MICROBIOL LETT, V61, P133, DOI 10.1016/0378-1097(89)90184-5; Faehnle CR, 2006, ACTA CRYSTALLOGR F, V62, P962, DOI 10.1107/S1744309106038279; Galatti L, 2006, J ANTIMICROB CHEMOTH, V57, P551, DOI 10.1093/jac/dkl008; GARCIALOBO JM, 1982, J BACTERIOL, V151, P477; Gil-Ortiz F, 2003, J MOL BIOL, V331, P231, DOI 10.1016/S0022-2836(03)00716-2; Gobernado M, 2003, Rev Esp Quimioter, V16, P15; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; HENDLIN D, 1969, SCIENCE, V166, P122, DOI 10.1126/science.166.3901.122; HOWLIN B, 1993, J APPL CRYSTALLOGR, V26, P622, DOI 10.1107/S0021889893002729; Jensen KS, 2007, BIOCHEMISTRY-US, V46, P2745, DOI 10.1021/bi0618159; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; KADNER RJ, 1973, J BACTERIOL, V113, P895, DOI 10.1128/JB.113.2.895-900.1973; KAHAN FM, 1974, ANN NY ACAD SCI, V235, P364, DOI 10.1111/j.1749-6632.1974.tb43277.x; Kobayashi S, 2000, ANTIMICROB AGENTS CH, V44, P647, DOI 10.1128/AAC.44.3.647-650.2000; Kotaka M, 2006, J BIOL CHEM, V281, P31544, DOI 10.1074/jbc.M605886200; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Lobel B, 2003, INT J ANTIMICROB AG, V22, pS85, DOI 10.1016/S0924-8579(03)00237-1; Marco-Marin C, 2005, J MOL BIOL, V352, P438, DOI 10.1016/j.jmb.2005.07.045; Marco-Marin C, 2007, J MOL BIOL, V367, P1431, DOI 10.1016/j.jmb.2007.01.073; Marina A, 1999, PROTEIN SCI, V8, P934; MARQUARDT JL, 1994, BIOCHEMISTRY-US, V33, P10646, DOI 10.1021/bi00201a011; Mas-Droux C, 2006, PLANT CELL, V18, P1681, DOI 10.1105/tpc.105.040451; MILLER R, 1994, J APPL CRYSTALLOGR, V27, P613, DOI 10.1107/S0021889894000191; Nakazawa Hiroaki, 2003, Journal of Infection and Chemotherapy, V9, P304, DOI 10.1007/s10156-003-0266-2; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Painter J, 2006, J APPL CRYSTALLOGR, V39, P109, DOI 10.1107/S0021889805038987; Ramon-Maiques S, 2006, J MOL BIOL, V356, P695, DOI 10.1016/j.jmb.2005.11.079; Ramon-Maiques S, 2002, STRUCTURE, V10, P329, DOI 10.1016/S0969-2126(02)00721-9; Shimizu M, 2000, ANTIMICROB AGENTS CH, V44, P2007, DOI 10.1128/AAC.44.7.2007-2008.2000; SHOJI J, 1986, J ANTIBIOT, V39, P1011, DOI 10.7164/antibiotics.39.1011; Stein GE, 1998, ANN PHARMACOTHER, V32, P215, DOI 10.1345/aph.17227; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; SUAREZ JE, 1991, ANTIMICROB AGENTS CH, V35, P791, DOI 10.1128/AAC.35.5.791; TSURUOKA T, 1975, J ANTIBIOT, V28, P906, DOI 10.7164/antibiotics.28.906; VENKATESWARAN PS, 1972, J BACTERIOL, V110, P935, DOI 10.1128/JB.110.3.935-944.1972; Woodyer RD, 2006, CHEM BIOL, V13, P1171, DOI 10.1016/j.chembiol.2006.09.007	48	20	22	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 17	2008	283	42					28518	28526		10.1074/jbc.M803709200	http://dx.doi.org/10.1074/jbc.M803709200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	359EN	18701452	Green Published, hybrid			2022-12-27	WOS:000259969300055
J	Shim, JH; Choi, HS; Pugliese, A; Lee, SY; Chae, JI; Choi, BY; Bode, AM; Dong, Z				Shim, Jung-Hyun; Choi, Hong Seok; Pugliese, Angelo; Lee, Sung-Young; Chae, Jung-Il; Choi, Bu Young; Bode, Ann M.; Dong, Zigang			(-)-Epigallocatechin gallate regulates CD3-mediated T cell receptor signaling in leukemia through the inhibition of ZAP-70 kinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHRONIC LYMPHOCYTIC-LEUKEMIA; PROTEIN-TYROSINE KINASE; GREEN TEA; MASS-SPECTROMETRY; ZETA-CHAIN; IN-VITRO; ACTIVATION; PHOSPHORYLATION; EXPRESSION; APOPTOSIS	The zeta chain-associated 70-kDa protein (ZAP-70) of tyrosine kinase plays a critical role in T cell receptor-mediated signal transduction and the immune response. A high level of ZAP-70 expression is observed in leukemia, which suggests ZAP-70 as a logical target for immunomodulatory therapies. (-)-Epigallocatechin gallate (EGCG) is one of the major green tea catechins that is suggested to have a role as a preventive agent in cancer, obesity, diabetes, and cardiovascular disease. Here we identified ZAP-70 as an important and novel molecular target of EGCG in leukemia cells. ZAP-70 and EGCG displayed high binding affinity (K-d = 0.6207 mu mol/liter), and additional results revealed that EGCG effectively suppressed ZAP-70, linker for the activation of T cells, phospholipase C gamma 1, extracellular signaling-regulated kinase, and MAPK kinase activities in CD3-activated T cell leukemia. Furthermore, the activation of activator protein-1 and interleukin-2 induced by CD3 was dose-dependently inhibited by EGCG treatment. Notably, EGCG dose-dependently induced caspase-mediated apoptosis in P116.cl39 ZAP-70-expressing leukemia cells, whereas P116 ZAP-70-deficient cells were resistant to EGCG treatment. Molecular docking studies, supported by site-directed mutagenesis experiments, showed that EGCG could form a series of intermolecular hydrogen bonds and hydrophobic interactions within the ATP binding domain, which may contribute to the stability of the ZAP-70-EGCG complex. Overall, these results strongly indicated that ZAP-70 activity was inhibited specifically by EGCG, which contributed to suppressing the CD3-mediated T cell-induced pathways in leukemia cells.	[Shim, Jung-Hyun; Choi, Hong Seok; Pugliese, Angelo; Lee, Sung-Young; Choi, Bu Young; Bode, Ann M.; Dong, Zigang] Univ Minnesota, Hormel Inst, Austin, MN 55912 USA; [Chae, Jung-Il] Korea Res Inst Biosci & Biotechnol, Ctr Regenerat Med, Taejon 305806, South Korea	University of Minnesota System; Korea Research Institute of Bioscience & Biotechnology (KRIBB)	Dong, Z (corresponding author), Univ Minnesota, Hormel Inst, 801 16th Ave NE, Austin, MN 55912 USA.	zgdong@hi.umn.edu	pugliese, angelo/C-1729-2008	Shim, Jung-Hyun/0000-0002-4062-4016	National Institutes of Health [CA81064, CA77646, CA111536, CA120388]; The Hormel Foundation; NATIONAL CANCER INSTITUTE [R01CA111536, R01CA120388, R01CA077646, R37CA081064, R01CA081064] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); The Hormel Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants CA81064, CA77646, CA111536, and CA120388. This work was also supported by The Hormel Foundation. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Acuto O, 2000, ANNU REV IMMUNOL, V18, P165, DOI 10.1146/annurev.immunol.18.1.165; Alberola-Ila J, 2003, IMMUNOL REV, V191, P79, DOI 10.1034/j.1600-065X.2003.00012.x; Asano Y, 1996, LIFE SCI, V60, P135, DOI 10.1016/S0024-3205(96)00603-0; Bene MC, 2006, CYTOM PART B-CLIN CY, V70B, P204, DOI 10.1002/cyto.b.20124; Blume-Jensen P, 2001, NATURE, V411, P355, DOI 10.1038/35077225; Brdicka T, 2005, MOL CELL BIOL, V25, P4924, DOI 10.1128/MCB.25.12.4924-4933.2005; Bremer E, 2006, BLOOD, V107, P2863, DOI 10.1182/blood-2005-07-2929; Brill LM, 2004, ANAL CHEM, V76, P2763, DOI 10.1021/ac035352d; Budihardjo I, 1999, ANNU REV CELL DEV BI, V15, P269, DOI 10.1146/annurev.cellbio.15.1.269; Buggins AGS, 1998, BRIT J HAEMATOL, V100, P784; Cantrell D, 1996, ANNU REV IMMUNOL, V14, P259, DOI 10.1146/annurev.immunol.14.1.259; Cantrell DA, 2002, IMMUNOLOGY, V105, P369, DOI 10.1046/j.1365-2567.2002.01391.x; CHAN AC, 1995, EMBO J, V14, P2499, DOI 10.1002/j.1460-2075.1995.tb07247.x; CHAN AC, 1991, P NATL ACAD SCI USA, V88, P9166, DOI 10.1073/pnas.88.20.9166; CHAN AC, 1992, CELL, V71, P649, DOI 10.1016/0092-8674(92)90598-7; Crespo M, 2003, NEW ENGL J MED, V348, P1764, DOI 10.1056/NEJMoa023143; Deindl S, 2007, CELL, V129, P735, DOI 10.1016/j.cell.2007.03.039; Di Bartolo V, 1999, J BIOL CHEM, V274, P6285, DOI 10.1074/jbc.274.10.6285; Dumont FJ, 1998, J IMMUNOL, V160, P2579; Earnshaw WC, 1999, NATURE, V397, P387, DOI 10.1038/17015; Ermakova S, 2005, J BIOL CHEM, V280, P16882, DOI 10.1074/jbc.M414185200; Fabbro D, 2002, PHARMACOL THERAPEUT, V93, P79, DOI 10.1016/S0163-7258(02)00179-1; Freund-Michel V, 2008, PHARMACOL THERAPEUT, V117, P52, DOI 10.1016/j.pharmthera.2007.07.003; Friesner RA, 2004, J MED CHEM, V47, P1739, DOI 10.1021/jm0306430; Gibbs G, 2007, INT J LAB HEMATOL, V29, P225, DOI 10.1111/j.1751-553X.2006.00869.x; Hamblin TJ, 2007, BEST PRACT RES CL HA, V20, P455, DOI 10.1016/j.beha.2007.02.001; Houtman JCD, 2005, J IMMUNOL, V175, P2449, DOI 10.4049/jimmunol.175.4.2449; Iwashima M, 2003, IMMUNOL REV, V191, P196, DOI 10.1034/j.1600-065X.2003.00024.x; IWASHIMA M, 1994, SCIENCE, V263, P1136, DOI 10.1126/science.7509083; Jin L, 2004, J BIOL CHEM, V279, P42818, DOI 10.1074/jbc.M407096200; Junttila MR, 2008, FASEB J, V22, P954, DOI 10.1096/fj.06-7859rev; Kersh EN, 1998, SCIENCE, V281, P572, DOI 10.1126/science.281.5376.572; Khan IH, 2006, MOL CELL PROTEOMICS, V5, P758, DOI 10.1074/mcp.T500032-MCP200; Li HC, 2000, JPN J CANCER RES, V91, P34, DOI 10.1111/j.1349-7006.2000.tb00857.x; Lin J, 2001, J CELL SCI, V114, P243; Martelli MP, 2000, BLOOD, V96, P2181; McGovern SL, 2003, J MED CHEM, V46, P2895, DOI 10.1021/jm0300330; Nakagawa H, 2004, CARCINOGENESIS, V25, P1567, DOI 10.1093/carcin/bgh168; Nakazato T, 2005, HAEMATOLOGICA, V90, P317; NEUMEISTER EN, 1995, MOL CELL BIOL, V15, P3171; RODRIGUES CA, 1994, CURR OPIN GENET DEV, V4, P15, DOI 10.1016/0959-437X(94)90086-8; Shim JH, 2005, PROTEOMICS, V5, P2112, DOI 10.1002/pmic.200401106; SUZUSHIMA H, 1991, CANCER RES, V51, P6084; van Leeuwen JEM, 1999, CURR OPIN IMMUNOL, V11, P242, DOI 10.1016/S0952-7915(99)80040-5; VANDONGEN JJM, 1987, J IMMUNOL, V138, P1260; WANGE RL, 1993, J BIOL CHEM, V268, P19797; WATTS JD, 1994, J BIOL CHEM, V269, P29520; Wiestner A, 2003, BLOOD, V101, P4944, DOI 10.1182/blood-2002-10-3306; Williams BL, 1999, EMBO J, V18, P1832, DOI 10.1093/emboj/18.7.1832; Williams BL, 1998, MOL CELL BIOL, V18, P1388, DOI 10.1128/MCB.18.3.1388; Yang CS, 2002, ANNU REV PHARMACOL, V42, P25, DOI 10.1146/annurev.pharmtox.42.082101.154309; YANG CS, 1993, J NATL CANCER I, V85, P1038, DOI 10.1093/jnci/85.13.1038; Yang DJ, 2006, J CHROMATOGR A, V1119, P277, DOI 10.1016/j.chroma.2005.12.031; Zanotti R, 2007, LEUKEMIA, V21, P102, DOI 10.1038/sj.leu.2404458; Zaveri NT, 2006, LIFE SCI, V78, P2073, DOI 10.1016/j.lfs.2005.12.006	55	81	83	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 17	2008	283	42					28370	28379		10.1074/jbc.M802200200	http://dx.doi.org/10.1074/jbc.M802200200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	359EN	18687687	Green Published, hybrid			2022-12-27	WOS:000259969300039
J	Chen, CL; Chen, JF; Rawale, S; Varadharaj, S; Kaumaya, PPT; Zweier, JL; Chen, YR				Chen, Chwen-Lih; Chen, Jingfeng; Rawale, Sharad; Varadharaj, Saradhadevi; Kaumaya, Pravin P. T.; Zweier, Jay L.; Chen, Yeong-Renn			Protein tyrosine nitration of the flavin subunit is associated with oxidative modification of mitochondrial Complex II in the post-ischemic myocardium	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ELECTRON-PARAMAGNETIC-RESONANCE; CYTOCHROME-C-REDUCTASE; OXYGEN-FREE RADICALS; NITRIC-OXIDE; SUCCINATE-UBIQUINONE; ENDOTHELIAL DYSFUNCTION; QUINONE OXIDOREDUCTASES; SUPEROXIDE GENERATION; NADH DEHYDROGENASE; HEART	Increased O-2(-) and NO production is a key mechanism of mitochondrial dysfunction in myocardial ischemia/reperfusion injury. A crucial segment of the mitochondrial electron transport chain is succinate ubiquinone reductase (SQR or Complex II). In SQR, oxidative impairment and deglutathionylation of the 70-kDa flavin protein occurs in the post-ischemic heart (Chen, Y. R., Chen, C. L., Pfeiffer, D. R., and Zweier, J. L. (2007) J. Biol. Chem. 282, 32640 -32654). To gain insights into the oxidative modification of the 70-kDa protein in the post-ischemic myocardium, we used the identified S-glutathionylated peptide ((77)AAFGLSEAGFNTA (C) under bar VTK93) of the 70-kDa protein as a chimeric epitope incorporating a "promiscuous" T cell epitope to generate a high titer polyclonal antibody, AbGSC90. Purified AbGSC90 showed a high binding affinity to isolated SQR. Antibodies of AbGSC90 moderately inhibited the electron transfer and superoxide generation activities of SQR. To test for protein nitration, rats were subjected to 30 min of coronary ligation followed by 24 h of reperfusion. Tissue homogenates were immunoprecipitated with AbGSC90 and probed with antibodies against 3-nitrotyrosine. Enhancement of protein tyrosine nitration was detected in the post-ischemic myocardium. Isolated SQR was subjected to in vitro protein nitration with peroxynitrite, leading to site-specific nitration at the 70-kDa polypeptide and impairment of SQR electron transfer activity. Protein nitration of SQR further impaired its protein-protein interaction with Complex III. Liquid chromatography/tandem mass spectrometry analysis indicated that Tyr-56 and Tyr-142 were involved in protein tyrosine nitration. When the isolated SQR was subjected to in vitro S-glutathionylation, oxidative modification and impairment mediated by peroxynitrite were significantly decreased, thus confirming the protective effect of S-glutathionylation from the oxidative damage of nitration.	[Chen, Chwen-Lih; Chen, Jingfeng; Varadharaj, Saradhadevi; Zweier, Jay L.; Chen, Yeong-Renn] Ohio State Univ, Davis Heart & Lung Res Inst, Div Cardiovasc Med, Dept Internal Med, Columbus, OH 43210 USA; [Zweier, Jay L.; Chen, Yeong-Renn] Ohio State Univ, Dept Mol & Cellular Biochem, Coll Med, Columbus, OH 43210 USA; [Rawale, Sharad; Kaumaya, Pravin P. T.] Ohio State Univ, Dept Obstet & Gynecol, Coll Med, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Chen, YR (corresponding author), Ohio State Univ, Davis Heart & Lung Res Inst 607, 473 W 12th Ave, Columbus, OH 43210 USA.	yeong-renn.chen@osumc.edu	Kaumaya, Pravin T. P/E-3354-2011		National Institutes of Health [HL83237, HL63744, HL38324]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL083237, R01HL038324, R01HL063744, R29HL038324] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL83237 (to Y.-R. C.) and HL63744 and HL38324 (to J. L. Z.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	AMBROSIO G, 1993, J BIOL CHEM, V268, P18532; Aulak KS, 2004, AM J PHYSIOL-HEART C, V286, pH30, DOI 10.1152/ajpheart.00743.2003; Becker LB, 2004, CARDIOVASC RES, V61, P461, DOI 10.1016/j.cardiores.2003.10.025; CADENAS E, 1977, ARCH BIOCHEM BIOPHYS, V180, P248, DOI 10.1016/0003-9861(77)90035-2; Chen YR, 2007, J BIOL CHEM, V282, P32640, DOI 10.1074/jbc.M702294200; Chen YR, 2006, J BIOL CHEM, V281, P13159, DOI 10.1074/jbc.M513627200; Chen YR, 2005, J BIOL CHEM, V280, P37339, DOI 10.1074/jbc.M503936200; Dakappagari NK, 2005, J BIOL CHEM, V280, P54, DOI 10.1074/jbc.M411020200; DULING DR, 1994, J MAGN RESON SER B, V104, P105, DOI 10.1006/jmrb.1994.1062; FERRARI R, 1995, AM J CARDIOL, V76, pB17; FERRARI R, 1994, ADV EXP MED BIOL, V366, P99; FERRARI R, 1991, AM J CLIN NUTR, V53, pS215, DOI 10.1093/ajcn/53.1.215S; FERRARI R, 1998, AM J CARDIOL, V82, P2; FREJAVILLE C, 1995, J MED CHEM, V38, P258, DOI 10.1021/jm00002a007; Galkin A, 2005, J BIOL CHEM, V280, P30129, DOI 10.1074/jbc.M504709200; Grune T, 1997, FASEB J, V11, P526, DOI 10.1096/fasebj.11.7.9212076; Guo Y, 1998, AM J PHYSIOL, V275, P1375; GWAK SH, 1986, BIOCHEMISTRY-US, V25, P7675, DOI 10.1021/bi00371a059; Hagerhall C, 1997, BBA-BIOENERGETICS, V1320, P107, DOI 10.1016/S0005-2728(97)00019-4; Han ZS, 2007, AM J PHYSIOL-CELL PH, V292, pC1103, DOI 10.1152/ajpcell.00389.2006; Hansen JM, 2006, ANNU REV PHARMACOL, V46, P215, DOI 10.1146/annurev.pharmtox.46.120604.141122; Hatefi Y, 1978, Methods Enzymol, V53, P11; Kissner R, 1997, CHEM RES TOXICOL, V10, P1285, DOI 10.1021/tx970160x; KOBSCONRAD S, 1993, J BIOL CHEM, V268, P25285; Koeck T, 2005, BIOCHEM SOC T, V33, P1399, DOI 10.1042/BST0331399; Koeck T, 2004, J BIOL CHEM, V279, P27257, DOI 10.1074/jbc.M401586200; Kozlov AV, 1999, FEBS LETT, V454, P127, DOI 10.1016/S0014-5793(99)00788-7; Kudin AP, 2004, J BIOL CHEM, V279, P4127, DOI 10.1074/jbc.M310341200; LEE GY, 1995, J BIOL CHEM, V270, P6193, DOI 10.1074/jbc.270.11.6193; LEFER AM, 1991, FASEB J, V5, P2029, DOI 10.1096/fasebj.5.7.2010056; Lemos RS, 2002, BBA-BIOENERGETICS, V1553, P158, DOI 10.1016/S0005-2728(01)00239-0; Liu PT, 1997, AM J PHYSIOL-HEART C, V272, pH2327, DOI 10.1152/ajpheart.1997.272.5.H2327; Sun F, 2005, CELL, V121, P1043, DOI 10.1016/j.cell.2005.05.025; Sundaram R, 2004, J BIOL CHEM, V279, P24141, DOI 10.1074/jbc.M313210200; TSAO PS, 1990, AM J PHYSIOL, V259, pH1660, DOI 10.1152/ajpheart.1990.259.6.H1660; TURRENS JF, 1980, BIOCHEM J, V191, P421, DOI 10.1042/bj1910421; TURRENS JF, 1985, ARCH BIOCHEM BIOPHYS, V237, P408, DOI 10.1016/0003-9861(85)90293-0; VERCESI A, 1978, J BIOL CHEM, V253, P6379; Wang PH, 1996, J BIOL CHEM, V271, P29223, DOI 10.1074/jbc.271.46.29223; Watts JA, 2003, ACAD EMERG MED, V10, P985, DOI 10.1197/S1069-6563(03)00319-1; YU L, 1982, J BIOL CHEM, V257, P2016; Zhao X, 2005, CIRCULATION, V111, P2966, DOI 10.1161/CIRCULATIONAHA.104.527226; Zhao X, 2007, AM J PHYSIOL-HEART C, V292, pH1541, DOI 10.1152/ajpheart.00264.2006; Zhu XH, 2007, AM J PHYSIOL-HEART C, V293, pH1442, DOI 10.1152/ajpheart.00256.2007; ZWEIER JL, 1995, NAT MED, V1, P804, DOI 10.1038/nm0895-804; Zweier JL, 1999, BBA-BIOENERGETICS, V1411, P250, DOI 10.1016/S0005-2728(99)00018-3; ZWEIER JL, 1995, J BIOL CHEM, V270, P304, DOI 10.1074/jbc.270.1.304; ZWEIER JL, 1989, J BIOL CHEM, V264, P18890	48	54	54	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 10	2008	283	41					27991	28003		10.1074/jbc.M802691200	http://dx.doi.org/10.1074/jbc.M802691200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	355OW	18682392	Green Published, hybrid			2022-12-27	WOS:000259719200069
J	Li, Y; Wang, Z; Kong, D; Li, R; Sarkar, SH				Li, Yiwei; Wang, Zhiwei; Kong, Dejuan; Li, Ran; Sarkar, Sanila H.			Regulation of Akt/FOXO3a/GSK-3 beta/AR signaling network by isoflavone in prostate cancer cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLYCOGEN-SYNTHASE KINASE-3-BETA; FACTOR-KAPPA-B; ANDROGEN RECEPTOR; BETA-CATENIN; SOY ISOFLAVONES; AKT; APOPTOSIS; INHIBITION; GENISTEIN; PATHWAY	We have previously shown that genistein could inhibit Akt activation and down-regulate AR (androgen receptor) and PSA (prostate-specific antigen) expression in prostate cancer (PCa) cells. However, pure genistein showed increased lymph node metastasis in an animal model, but such an adverse effect was not seen with isoflavone, suggesting that further mechanistic studies are needed for elucidating the role of isoflavone in PCa. It is known that FOXO3a and GSK-3 beta, targets of Akt, regulate cell proliferation and apoptosis. Moreover, FOXO3a, GSK-3 beta, and Src are AR regulators and regulate transactivation of AR, mediating the development and progression of PCa. Therefore, we investigated the molecular effects of isoflavone on the Akt/FOXO3a/GSK-3 beta/AR signaling network in hormone-sensitive LNCaP and hormone- insensitive C4-2B PCa cells. We found that isoflavone inhibited the phosphorylation of Akt and FOXO3a, regulated the phosphorylation of Src, and increased the expression of GSK-3 beta, leading to the down-regulation of AR and its target gene PSA. We also found that isoflavone inhibited AR nuclear translocation and promoted FOXO3a translocation to the nucleus. By electrophoretic mobility shift assay and chromatin immunoprecipitation assay, we found that isoflavone inhibited FOXO3a binding to the promoter of AR and increased FOXO3a binding to the p27(KIP1) promoter, resulting in the alteration of AR and p27KIP1 expression, the inhibition of cell proliferation, and the induction of apoptosis in both androgen-sensitive and -insensitive PCa cells. These results suggest that isoflavone-induced inhibition of cell proliferation and induction of apoptosis are partly mediated through the regulation of the Akt/FOXO3a/GSK-3 beta/AR signaling network. In conclusion, our data suggest that isoflavone could be useful for the prevention and/or treatment of PCa.	[Li, Yiwei; Wang, Zhiwei; Kong, Dejuan; Li, Ran; Sarkar, Sanila H.] Wayne State Univ, Sch Med, Barbara Ann Karmanos Canc Inst, Dept Pathol,Hudson Webber Canc Res Ctr, Detroit, MI 48201 USA	Barbara Ann Karmanos Cancer Institute; Wayne State University	Sarkar, SH (corresponding author), Wayne State Univ, Sch Med, Barbara Ann Karmanos Canc Inst, Dept Pathol,Hudson Webber Canc Res Ctr 740, Detroit, MI 48201 USA.	fsarkar@med.wayne.edu			National Institutes of Health; NCI [5R01CA083695, 5R01CA101870]; Puschelberg Foundation; NATIONAL CANCER INSTITUTE [R01CA101870, R01CA083695] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Puschelberg Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health, NCI, Grants 5R01CA083695 and 5R01CA101870 (to F. H. S.). This work was also supported by the Puschelberg Foundation. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Asim M, 2008, ONCOGENE, V27, P3596, DOI 10.1038/sj.onc.1211016; Balk SP, 2002, UROLOGY, V60, P132, DOI 10.1016/S0090-4295(02)01593-5; BARNES S, 1995, J NUTR, V125, pS777, DOI 10.1093/jn/125.3_Suppl.777S; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Burgering BMT, 2002, TRENDS BIOCHEM SCI, V27, P352, DOI 10.1016/S0968-0004(02)02113-8; Busby MG, 2002, AM J CLIN NUTR, V75, P126, DOI 10.1093/ajcn/75.1.126; Chen L, 2004, NEW ASTRON, V10, P39, DOI 10.1016/j.newast.2004.04.008; Cheng JQ, 2005, ONCOGENE, V24, P7482, DOI 10.1038/sj.onc.1209088; Chong ZZ, 2006, CURR NEUROVASC RES, V3, P107, DOI 10.2174/156720206776875830; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Davis JN, 2002, MOL CARCINOGEN, V34, P91, DOI 10.1002/mc.10053; Edwards J, 2005, BJU INT, V95, P1320, DOI 10.1111/j.1464-410X.2005.05526.x; El Touny LH, 2007, CARCINOGENESIS, V28, P1710, DOI 10.1093/carcin/bgm103; Franke TF, 2003, ONCOGENE, V22, P8983, DOI 10.1038/sj.onc.1207115; Furuyama T, 2000, BIOCHEM J, V349, P629, DOI 10.1042/0264-6021:3490629; Guo ZY, 2006, CANCER CELL, V10, P309, DOI 10.1016/j.ccr.2006.08.021; Heinlein CA, 2004, ENDOCR REV, V25, P276, DOI 10.1210/er.2002-0032; Hillman GG, 2004, MOL CANCER THER, V3, P1271; Hu YY, 2005, MOL BIOL CELL, V16, P3705, DOI 10.1091/mbc.E05-04-0301; Huang Haojie, 2006, Future Oncol, V2, P83, DOI 10.2217/14796694.2.1.83; Kazi A, 2003, BIOCHEM PHARMACOL, V66, P965, DOI 10.1016/S0006-2952(03)00414-3; Kikuchi A, 1999, CELL SIGNAL, V11, P777, DOI 10.1016/S0898-6568(99)00054-6; Lawlor MA, 2000, MOL CELL BIOL, V20, P8983, DOI 10.1128/MCB.20.23.8983-8995.2000; Lemon B, 2000, GENE DEV, V14, P2551, DOI 10.1101/gad.831000; Li BY, 2007, CARCINOGENESIS, V28, P572, DOI 10.1093/carcin/bgl193; Li PF, 2003, MOL CELL BIOL, V23, P104, DOI 10.1128/MCB.23.1.104-118.2003; Li YW, 2007, J BIOL CHEM, V282, P21542, DOI 10.1074/jbc.M701978200; Li YW, 2005, CANCER RES, V65, P6934, DOI 10.1158/0008-5472.CAN-04-4604; Li YW, 1999, ONCOGENE, V18, P3166, DOI 10.1038/sj.onc.1202650; Li YW, 2002, CLIN CANCER RES, V8, P2369; Lin HK, 2003, J BIOL CHEM, V278, P50902, DOI 10.1074/jbc.M300676200; Lin HK, 2001, P NATL ACAD SCI USA, V98, P7200, DOI 10.1073/pnas.121173298; Liu S, 2008, ONCOGENE, V27, P499, DOI 10.1038/sj.onc.1210671; Lynch RL, 2005, MOL CANCER RES, V3, P163, DOI 10.1158/1541-7786.MCR-04-0163; Mulholland DJ, 2006, ONCOGENE, V25, P329, DOI 10.1038/sj.onc.1209020; Prueitt RL, 2007, INT J CANCER, V120, P796, DOI 10.1002/ijc.22336; Raffoul JJ, 2007, INT J CANCER, V120, P2491, DOI 10.1002/ijc.22548; Rannikko A, 2006, PROSTATE, V66, P82, DOI 10.1002/pros.20315; Rosas M, 2006, J LEUKOCYTE BIOL, V80, P186, DOI 10.1189/jlb.1105636; Salas TR, 2004, J BIOL CHEM, V279, P19191, DOI 10.1074/jbc.M309560200; Salas TR, 2003, J BIOL CHEM, V278, P41338, DOI 10.1074/jbc.M302972200; Segrelles C, 2006, ONCOGENE, V25, P1174, DOI 10.1038/sj.onc.1209155; TRAN H, 2003, SCI STKE, pRE5, DOI DOI 10.1126/STKE.2003.172.RE5; Truica CI, 2000, CANCER RES, V60, P4709; Wen Y, 2000, CANCER RES, V60, P6841; Yang L, 2005, J BIOL CHEM, V280, P33558, DOI 10.1074/jbc.M504461200	46	90	94	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 10	2008	283	41					27707	27716		10.1074/jbc.M802759200	http://dx.doi.org/10.1074/jbc.M802759200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	355OW	18687691	hybrid, Green Published			2022-12-27	WOS:000259719200042
J	Pajonk, S; Kwon, C; Clemens, N; Panstruga, R; Schulze-Lefert, P				Pajonk, Simone; Kwon, Chian; Clemens, Natascha; Panstruga, Ralph; Schulze-Lefert, Paul			Activity determinants and functional specialization of Arabidopsis PEN1 syntaxin in innate immunity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SYNAPTOSOME-ASSOCIATED PROTEIN; 25 KDA SNAP-25; SNARE COMPLEX; NEUROTRANSMITTER RELEASE; PENETRATION RESISTANCE; SYNAPTIC-TRANSMISSION; NONHOST RESISTANCE; POWDERY MILDEW; C-TERMINUS; RESPONSES	In eukaryotes, proteins of the soluble N-ethylmaleimide-sensitive factor attachment protein receptor (SNARE) family are believed to have a general role for the fusion of intracellular transport vesicles with acceptor membranes. Arabidopsis thaliana PEN1 syntaxin resides in the plasma membrane and was previously shown to act together with its partner SNAREs, the adaptor protein SNAP33, and endomembrane-anchored VAMP721/722 in the execution of secretory immune responses against powdery mildew fungi. We conducted a structure-function analysis of PEN1 and show that N-terminal phospho-mimicking and non-phosphorylatable variants neither affected binary nor ternary SNARE complex formation with cognate partners in vitro. However, expression of these syntaxin variants at native protein levels in a pen1 mutant background suggests that phosphorylation is required for full resistance activity in planta. All tested site-directed substitutions of SNARE domain or "linker region" residues reduced PEN1 defense activity. Two of the variants failed to form ternary complexes with the partner SNAREs in vitro, possibly explaining their diminished in planta activity. However, impaired pathogen defense in plants expressing a linker region variant is likely because of PEN1 destabilization. Although Arabidopsis PEN1 and SYP122 syntaxins share overlapping functions in plant growth and development, PEN1 activity in disease resistance is apparently the result of a complete functional specialization. Our findings are consistent with the hypothesis that PEN1 acts in plant defense through the formation of ternary SNARE complexes and point to the existence of unknown regulatory factors. Our data indirectly support structural inferences that the four-helical coiled coil bundle in ternary SNARE complexes is formed in a sequential order from the N- to C-terminal direction.	[Pajonk, Simone; Kwon, Chian; Clemens, Natascha; Panstruga, Ralph; Schulze-Lefert, Paul] Max Planck Inst Plant Breeding Res, Dept Plant Microbe Interact, D-50829 Cologne, Germany	Max Planck Society	Schulze-Lefert, P (corresponding author), Max Planck Inst Plant Breeding Res, Dept Plant Microbe Interact, D-50829 Cologne, Germany.	schlef@mpiz-koeln.mpg.de	Bruening, Stefan/B-8505-2011; Schulze-Lefert, Paul/B-6707-2011; Panstruga, Ralph/F-3340-2011	Panstruga, Ralph/0000-0002-3756-8957	Max Planck Society; Deutsche Forschungsgemeinschaft [SPP1212, SFB670]	Max Planck Society(Max Planck Society); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by funds from the Max Planck Society and Deutsche Forschungsgemeinschaft Grants SPP1212 (to C.K. and P.S.-L.) and SFB670 (to R.P. and P.S.-L.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	An SJ, 2004, SCIENCE, V306, P1042, DOI 10.1126/science.1102559; Assaad FF, 2004, MOL BIOL CELL, V15, P5118, DOI 10.1091/mbc.E04-02-0140; Assaad FF, 2001, J CELL BIOL, V152, P531, DOI 10.1083/jcb.152.3.531; Benschop JJ, 2007, MOL CELL PROTEOMICS, V6, P1198, DOI 10.1074/mcp.M600429-MCP200; Bhat RA, 2005, P NATL ACAD SCI USA, V102, P3135, DOI 10.1073/pnas.0500012102; Birchler JA, 2001, DEV BIOL, V234, P275, DOI 10.1006/dbio.2001.0262; Bock JB, 2001, NATURE, V409, P839, DOI 10.1038/35057024; Buschges R, 1997, CELL, V88, P695, DOI 10.1016/S0092-8674(00)81912-1; Collins NC, 2003, NATURE, V425, P973, DOI 10.1038/nature02076; Criado M, 1999, P NATL ACAD SCI USA, V96, P7256, DOI 10.1073/pnas.96.13.7256; Douchkov D, 2005, MOL PLANT MICROBE IN, V18, P755, DOI 10.1094/MPMI-18-0755; Dubois T, 2002, EUR J BIOCHEM, V269, P909, DOI 10.1046/j.0014-2956.2001.02725.x; Dulubova I, 1999, EMBO J, V18, P4372, DOI 10.1093/emboj/18.16.4372; Elliott C, 2005, BIOCHEM J, V385, P243, DOI 10.1042/BJ20040993; Fergestad T, 2001, J NEUROSCI, V21, P9142, DOI 10.1523/JNEUROSCI.21-23-09142.2001; Fiebig KM, 1999, NAT STRUCT BIOL, V6, P117; Foletti DL, 2000, J NEUROSCI, V20, P4535, DOI 10.1523/JNEUROSCI.20-12-04535.2000; Freialdenhoven A, 1996, PLANT CELL, V8, P5, DOI 10.1105/tpc.8.1.5; Gallwitz D, 2003, TRENDS BIOCHEM SCI, V28, P113, DOI 10.1016/S0968-0004(03)00028-8; Hanson PI, 1997, CURR OPIN NEUROBIOL, V7, P310, DOI 10.1016/S0959-4388(97)80057-8; Heese A, 2005, PLANT PHYSIOL, V138, P2406, DOI 10.1104/pp.105.063032; Heese M, 2001, J CELL BIOL, V155, P239, DOI 10.1083/jcb.200107126; Humphry M, 2006, MOL PLANT PATHOL, V7, P605, DOI 10.1111/j.1364-3703.2006.00362.X; Kalde M, 2007, P NATL ACAD SCI USA, V104, P11850, DOI 10.1073/pnas.0701083104; Kloepper TH, 2007, MOL BIOL CELL, V18, P3463, DOI 10.1091/mbc.E07-03-0193; Kobayashi Y, 1997, PLANT J, V11, P525, DOI 10.1046/j.1365-313X.1997.11030525.x; Koh S, 2005, PLANT J, V44, P516, DOI 10.1111/j.1365-313X.2005.02545.x; Kwon C, 2008, PLANT PHYSIOL, V147, P1575, DOI 10.1104/pp.108.121566; Kwon C, 2008, NATURE, V451, P835, DOI 10.1038/nature06545; Lipka V, 2005, CURR OPIN PLANT BIOL, V8, P625, DOI 10.1016/j.pbi.2005.09.006; Lipka V, 2007, ANNU REV CELL DEV BI, V23, P147, DOI 10.1146/annurev.cellbio.23.090506.123529; Nonet ML, 1998, J NEUROSCI, V18, P70; Nuhse TS, 2003, J BIOL CHEM, V278, P45248, DOI 10.1074/jbc.M307443200; Rao SS, 2001, EMBO J, V20, P6761, DOI 10.1093/emboj/20.23.6761; Richmond JE, 2001, NATURE, V412, P338, DOI 10.1038/35085583; Richmond JE, 1999, NAT NEUROSCI, V2, P791, DOI 10.1038/12160; Risinger C, 1999, J NEUROCHEM, V72, P614, DOI 10.1046/j.1471-4159.1999.0720614.x; Rizo J, 2006, TRENDS CELL BIOL, V16, P549; Rossi G, 1997, J BIOL CHEM, V272, P16610, DOI 10.1074/jbc.272.26.16610; Saifee O, 1998, MOL BIOL CELL, V9, P1235, DOI 10.1091/mbc.9.6.1235; Sanderfoot A, 2007, PLANT PHYSIOL, V144, P6, DOI 10.1104/pp.106.092973; Shen QH, 2007, EMBO J, V26, P4293, DOI 10.1038/sj.emboj.7601854; Sorensen JB, 2006, EMBO J, V25, P955, DOI 10.1038/sj.emboj.7601003; Sutton RB, 1998, NATURE, V395, P347, DOI 10.1038/26412; Wu MN, 1999, NEURON, V23, P593, DOI 10.1016/S0896-6273(00)80811-9; Wu MN, 1998, EMBO J, V17, P127, DOI 10.1093/emboj/17.1.127; Zhang ZG, 2007, PLANT J, V49, P302, DOI 10.1111/j.1365-313X.2006.02961.x	47	54	58	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 3	2008	283	40					26974	26984		10.1074/jbc.M805236200	http://dx.doi.org/10.1074/jbc.M805236200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	353RT	18678865	hybrid, Green Published			2022-12-27	WOS:000259586600018
J	Jackson, M; Brennan, PJ				Jackson, Mary; Brennan, Patrick J.			Polymethylated Polysaccharides from Mycobacterium Species Revisited	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							PALMITOYL-COENZYME-A; METHYLMANNOSE POLYSACCHARIDE; REVISED STRUCTURE; BIOSYNTHESIS; LIPOPOLYSACCHARIDE; SMEGMATIS; IDENTIFICATION; TUBERCULOSIS; POLYMETHYLPOLYSACCHARIDES; 6-O-METHYL-D-GLUCOSE	Mycobacteria produce two sets of unusual polymethylated polysaccharides, the 3-O-methylmannose polysaccharides and the 6-O-methylglucose lipopolysaccharides. Both polysaccharides localize to the cytoplasm, where they have been postulated to regulate fatty acid metabolism due to their ability to form stable 1: 1 complexes with fatty acyl chains. Physiological evidence for this assumption is lacking, however. Recent advances in our knowledge of the processes underlying sugar transfer in mycobacteria, together with the availability of genome sequences and tools for the genetic manipulation of these microorganisms, have opened the way to the elucidation of the biosynthetic pathways and biological functions of these unique carbohydrates.	[Jackson, Mary; Brennan, Patrick J.] Colorado State Univ, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA	Colorado State University	Brennan, PJ (corresponding author), Colorado State Univ, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA.	Patrick.Brennan@colostate.edu	Jackson, Mary/D-5345-2017	Jackson, Mary/0000-0002-9212-0258	National Institutes of Health [AI064798]; European Commission [LSHP-CT-2005-018923]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI064798] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); European Commission(European CommissionEuropean Commission Joint Research Centre); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant AI064798 from NIAID. This work was also supported by European Commission Contract LSHP-CT-2005-018923 (NM4TB).	Berg S, 2007, GLYCOBIOLOGY, V17, p35R, DOI 10.1093/glycob/cwm010; Bloch K, 1977, Adv Enzymol Relat Areas Mol Biol, V45, P1; Empadinhas N, 2008, FEMS MICROBIOL LETT, V280, P195, DOI 10.1111/j.1574-6968.2007.01064.x; FERGUSON JA, 1970, J BIOL CHEM, V245, P4213; Fernandes C, 2007, J BACTERIOL, V189, P4014, DOI 10.1128/JB.00075-07; FORSBERG LS, 1982, J BIOL CHEM, V257, P3555; Fulton Z, 2008, J BIOL CHEM, V283, P27881, DOI 10.1074/jbc.M801853200; Fulton Z, 2008, ACTA CRYSTALLOGR F, V64, P428, DOI 10.1107/S1744309108011196; GRAY GR, 1971, J BIOL CHEM, V246, P6835; GRELLERT E, 1972, J BIOL CHEM, V247, P3236; HARRIS LS, 1977, J BIOL CHEM, V252, P2470; HINDSGAUL O, 1984, BIOCHEMISTRY-US, V23, P577, DOI 10.1021/bi00298a028; HUNTER SW, 1986, J BIOL CHEM, V261, P2345; KAMISANGO K, 1987, J BIOL CHEM, V262, P4580; KELLER JM, 1968, J BIOL CHEM, V243, P2905; LEE YC, 1966, J BIOL CHEM, V241, P1899; LEE YC, 1964, J BIOL CHEM, V239; LORNITZO FA, 1968, BIOCHIM BIOPHYS ACTA, V158, P329, DOI 10.1016/0304-4165(68)90286-9; MACHIDA Y, 1973, P NATL ACAD SCI USA, V70, P1146, DOI 10.1073/pnas.70.4.1146; MAGGIO JE, 1980, P NATL ACAD SCI-BIOL, V77, P2582, DOI 10.1073/pnas.77.5.2582; MAITRA SK, 1977, J BIOL CHEM, V252, P2459; MALONEY DH, 1980, J BACTERIOL, V141, P1217, DOI 10.1128/JB.141.3.1217-1221.1980; Murakami T, 2006, J BACTERIOL, V188, P5915, DOI 10.1128/JB.00390-06; POMMIER MT, 1986, J GEN MICROBIOL, V132, P2433; Sambou T, 2008, MOL MICROBIOL, V70, P762, DOI 10.1111/j.1365-2958.2008.06445.x; Stadthagen G, 2007, J BIOL CHEM, V282, P27270, DOI 10.1074/jbc.M702676200; Tuffal G, 1998, GLYCOBIOLOGY, V8, P675, DOI 10.1093/glycob/8.7.675; TUFFAL G, 1995, EUR J BIOCHEM, V233, P377, DOI 10.1111/j.1432-1033.1995.377_1.x; Tuffal G, 1998, ANAL CHEM, V70, P1853, DOI 10.1021/ac971101r; TUNG KK, 1973, J BIOL CHEM, V248, P7126; Tzvetkov M, 2003, MICROBIOL-SGM, V149, P1659, DOI 10.1099/mic.0.26205-0; WEISMAN LS, 1984, J BIOL CHEM, V259, P3457; WEISMAN LS, 1984, J BIOL CHEM, V259, P3464; YABUSAKI KK, 1978, P NATL ACAD SCI USA, V75, P691, DOI 10.1073/pnas.75.2.691; YABUSAKI KK, 1979, J BIOL CHEM, V254, P2314; YAMADA H, 1979, J BIOL CHEM, V254, P1972	36	44	44	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 23	2009	284	4					1949	1953		10.1074/jbc.R800047200	http://dx.doi.org/10.1074/jbc.R800047200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	395TE	18786916	Green Published, hybrid			2022-12-27	WOS:000262545600001
J	Brzeska, H; Hwang, KJ; Korn, ED				Brzeska, Hanna; Hwang, Kae-Jung; Korn, Edward D.			Acanthamoeba Myosin IC Colocalizes with Phosphatidylinositol 4,5-Bisphosphate at the Plasma Membrane Due to the High Concentration of Negative Charge	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIN-BINDING-SITES; PHOSPHOINOSITIDE-BINDING; HEAVY-CHAIN; INTRACELLULAR-LOCALIZATION; PHOSPHORYLATION SITE; CAPPING PROTEIN; LIGHT-CHAIN; SH3 DOMAIN; IN-VIVO; SPECIFICITY	The tail of Acanthamoeba myosin IC (AMIC) has a basic region (BR), which contains a putative pleckstrin homology (PH) domain, followed by two Gly/Pro/Ala (GPA)-rich regions separated by a Src homology 3 (SH3) domain. Cryoelectron microscopy had shown that the tail is folded back on itself at the junction of BR and GPA1, and nuclear magnetic resonance spectroscopy indicated that the SH3 domain may interact with the putative PH domain. The BR binds to acidic phospholipids, and the GPA region binds to F-actin. We now show that the folded tail does not affect the affinity of AMIC for acidic phospholipids. AMIC binds phosphatidylinositol 4,5-bisphosphate (PIP2) with high affinity (similar to 1 mu M), but binding is not stereospecific. When normalized to net negative charge, AMIC binds with equal affinity to phosphatidylserine (PS) and PIP2. This and other data show that the putative PH domain of AMIC is not a typical PIP2-specific PH domain. We have identified a 13-residue sequence of basic-hydrophobic-basic amino acids within the putative PH domain that may be a major determinant of binding of AMIC to acidic phospholipids. Despite the lack of stereospecificity, AMIC binds 10 times more strongly to vesicles containing 5% PIP2 plus 25% PS than to vesicles containing only 25% PS, suggesting that AMIC may be targeted to PIP2-enriched regions of the plasma membrane. In agreement with this, AMIC colocalizes with PIP2 at dynamic, protrusive regions of the plasma membrane. We discuss the possibility that AMIC binding to PIP2 may initiate the formation of a multiprotein complex at the plasma membrane.	[Brzeska, Hanna; Hwang, Kae-Jung; Korn, Edward D.] NHLBI, Cell Biol Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Brzeska, H (corresponding author), NHLBI, Cell Biol Lab, NIH, 9000 Rockville Pike,Bldg 50,Rm 2515, Bethesda, MD 20892 USA.	brzeskah@mail.nih.gov	Korn, Edward D/F-9929-2012	Korn, Edward/0000-0003-3867-6295	National Institutes of Health; NHLBI, Division of Intramural Research; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL000506, Z01HL000506] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NHLBI, Division of Intramural Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was authored, in whole or in part, by National Institutes of Health staff. This work was supported, in whole or in part, by the National Institutes of Health, NHLBI, Division of Intramural Research. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	BAINES IC, 1990, J CELL BIOL, V111, P1895, DOI 10.1083/jcb.111.5.1895; BAINES IC, 1992, J CELL BIOL, V119, P1193, DOI 10.1083/jcb.119.5.1193; Berg JS, 2001, MOL BIOL CELL, V12, P780, DOI 10.1091/mbc.12.4.780; BRZESKA H, 1989, J BIOL CHEM, V264, P19340; Brzeska H, 2004, CELL MOTIL CYTOSKEL, V58, P186, DOI 10.1002/cm.20009; BRZESKA H, 1988, J BIOL CHEM, V263, P427; Bubb MR, 1998, CELL MOTIL CYTOSKEL, V39, P134, DOI 10.1002/(SICI)1097-0169(1998)39:2<134::AID-CM4>3.0.CO;2-6; COOPER JA, 1984, J CELL BIOL, V99, P217, DOI 10.1083/jcb.99.1.217; Cronin TC, 2004, EMBO J, V23, P3711, DOI 10.1038/sj.emboj.7600388; Cullen PJ, 2001, CURR BIOL, V11, pR882, DOI 10.1016/S0960-9822(01)00523-1; DiNitto JP, 2006, BBA-MOL CELL BIOL L, V1761, P850, DOI 10.1016/j.bbalip.2006.04.008; DINITTO JP, 2003, SCI STKE, pRE16, DOI DOI 10.1126/STKE.2132003RE16; DOBERSTEIN SK, 1992, J CELL BIOL, V117, P1241, DOI 10.1083/jcb.117.6.1241; DOBERSTEIN SK, 1993, NATURE, V365, P841, DOI 10.1038/365841a0; Gambhir A, 2004, BIOPHYS J, V86, P2188, DOI 10.1016/S0006-3495(04)74278-2; Heo WD, 2006, SCIENCE, V314, P1458, DOI 10.1126/science.1134389; Hokanson DE, 2006, MOL BIOL CELL, V17, P4856, DOI 10.1091/mbc.e06-05-0449; Hokanson DE, 2006, P NATL ACAD SCI USA, V103, P3118, DOI 10.1073/pnas.0505685103; Hwang KJ, 2007, P NATL ACAD SCI USA, V104, P784, DOI 10.1073/pnas.0610231104; Ishikawa T, 2004, P NATL ACAD SCI USA, V101, P12189, DOI 10.1073/pnas.0404835101; Jung G, 2001, J CELL BIOL, V153, P1479, DOI 10.1083/jcb.153.7.1479; JUNG G, 1987, P NATL ACAD SCI USA, V84, P6720, DOI 10.1073/pnas.84.19.6720; JUNG G, 1993, J BIOL CHEM, V268, P14981; Kavran JM, 1998, J BIOL CHEM, V273, P30497, DOI 10.1074/jbc.273.46.30497; Kong HH, 2002, J CELL SCI, V115, P4993, DOI 10.1242/jcs.00159; Lemmon MA, 2003, TRAFFIC, V4, P201, DOI 10.1034/j.1600-0854.2004.00071.x; Lemmon MA, 2002, FEBS LETT, V513, P71, DOI 10.1016/S0014-5793(01)03243-4; Liu X, 2000, J BIOL CHEM, V275, P24886, DOI 10.1074/jbc.M004287200; Lomize AL, 2007, BMC STRUCT BIOL, V7, DOI 10.1186/1472-6807-7-44; LYNCH TJ, 1986, J BIOL CHEM, V261, P7156; LYNCH TJ, 1991, METHOD ENZYMOL, V196, P12; LYNCH TJ, 1989, J BIOL CHEM, V264, P19333; Maffucci T, 2001, FEBS LETT, V506, P173, DOI 10.1016/S0014-5793(01)02909-X; McLaughlin S, 2005, NATURE, V438, P605, DOI 10.1038/nature04398; McLaughlin S, 2002, ANNU REV BIOPH BIOM, V31, P151, DOI 10.1146/annurev.biophys.31.082901.134259; Morita YS, 1996, EUR J CELL BIOL, V71, P371; Niggli V, 2001, TRENDS BIOCHEM SCI, V26, P604, DOI 10.1016/S0968-0004(01)01927-2; Nikolovska-Coleska Z, 2004, ANAL BIOCHEM, V332, P261, DOI 10.1016/j.ab.2004.05.055; Novak KD, 1998, MOL BIOL CELL, V9, P75, DOI 10.1091/mbc.9.1.75; Ostap EM, 2003, CELL MOTIL CYTOSKEL, V54, P29, DOI 10.1002/cm.10081; POLLARD TD, 1991, ANNU REV PHYSIOL, V53, P653, DOI 10.1146/annurev.ph.53.030191.003253; Rameh LE, 1997, J BIOL CHEM, V272, P22059, DOI 10.1074/jbc.272.35.22059; Scott DL, 2006, THEOR BIOL MED MODEL, V3, DOI 10.1186/1742-4682-3-17; Sellers JR, 2000, BBA-MOL CELL RES, V1496, P3, DOI 10.1016/S0167-4889(00)00005-7; Senda S, 2001, J BIOL CHEM, V276, P2898, DOI 10.1074/jbc.M008059200; Wang GP, 2006, J MED CHEM, V49, P6139, DOI 10.1021/jm060460o; WANG ZY, 1995, J BIOL CHEM, V270, P27969, DOI 10.1074/jbc.270.46.27969; Wang ZY, 1998, P NATL ACAD SCI USA, V95, P15200, DOI 10.1073/pnas.95.26.15200; Wang ZY, 1997, J MUSCLE RES CELL M, V18, P395, DOI 10.1023/A:1018686428955; XU P, 1995, J BIOL CHEM, V270, P25316, DOI 10.1074/jbc.270.43.25316; Yu JW, 2004, MOL CELL, V13, P677, DOI 10.1016/S1097-2765(04)00083-8	51	23	23	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 14	2008	283	46					32014	32023		10.1074/jbc.M804828200	http://dx.doi.org/10.1074/jbc.M804828200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	370KJ	18772133	hybrid, Green Published			2022-12-27	WOS:000260760800083
J	Du, JX; Bialkowska, AB; McConnell, BB; Yang, VW				Du, James X.; Bialkowska, Agnieszka B.; McConnell, Beth B.; Yang, Vincent W.			SUMOylation Regulates Nuclear Localization of Kruppel-like Factor 5	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANTI-FUNGAL ANTIBIOTICS; PLURIPOTENT STEM-CELLS; NUCLEOCYTOPLASMIC TRANSPORT; CELLULAR-TRANSFORMATION; SUMO-1 MODIFICATION; PROTEIN INHIBITOR; EXPORT SIGNALS; LEPTOMYCIN-B; P53 ACTIVITY; TRANSCRIPTION	SUMOylation is a form of post-translational modification shown to control nuclear transport. Kruppel-like factor 5 (KLF5) is an important mediator of cell proliferation and is primarily localized to the nucleus. Here we show that mouse KLF5 is SUMOylated at lysine residues 151 and 202. Mutation of these two lysines or two conserved nearby glutamates results in the loss of SUMOylation and increased cytoplasmic distribution of KLF5, suggesting that SUMOylation enhances nuclear localization of KLF5. Lysine 151 is adjacent to a nuclear export signal (NES) that resembles a consensus NES. The NES in KLF5 directs a fused green fluorescence protein to the cytoplasm, binds the nuclear export receptor CRM1, and is inhibited by leptomycin and site-directed mutagenesis. SUMOylation facilitates nuclear localization of KLF5 by inhibiting this NES activity, and enhances the ability of KLF5 to stimulate anchorage-independent growth of HCT116 colon cancer cells. A survey of proteins whose nuclear localization is regulated by SUMOylation reveals that SUMOylation sites are frequently located in close proximity to NESs. A relatively common mechanism for SUMOylation to regulate nucleocytoplasmic transport may lie in the interplay between neighboring NES and SUMOylation motifs.	[Du, James X.; Bialkowska, Agnieszka B.; McConnell, Beth B.; Yang, Vincent W.] Emory Univ, Sch Med, Div Digest Dis, Dept Med, Atlanta, GA 30322 USA; [Yang, Vincent W.] Emory Univ, Sch Med, Winship Canc Ctr, Atlanta, GA 30322 USA	Emory University; Emory University	Yang, VW (corresponding author), 615 Michael St, Atlanta, GA 30322 USA.	vyang@emory.edu			National Institutes of Health [DK52230, DK64399, DK77381, CA84197]; NATIONAL CANCER INSTITUTE [R01CA084197] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F32DK077381, R01DK052230, R24DK064399] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK52230, DK64399, DK77381, and CA84197. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	Arco PGD, 2005, MOL CELL BIOL, V25, P2688, DOI 10.1128/MCB.25.7.2688-2697.2005; Bialkowska A, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-113; Buschbeck M, 2005, J BIOL CHEM, V280, P2659, DOI 10.1074/jbc.M412599200; Carter S, 2007, NAT CELL BIOL, V9, P428, DOI 10.1038/ncb1562; Chen A, 2006, J CELL BIOCHEM, V98, P895, DOI 10.1002/jcb.20703; Chen CH, 2006, INT J CANCER, V118, P1346, DOI 10.1002/ijc.21533; Comerford KM, 2003, P NATL ACAD SCI USA, V100, P986, DOI 10.1073/pnas.0337412100; Conkright MD, 1999, NUCLEIC ACIDS RES, V27, P1263, DOI 10.1093/nar/27.5.1263; COX AD, 1994, METHOD ENZYMOL, V238, P277; Dang DT, 2002, NUCLEIC ACIDS RES, V30, P2736, DOI 10.1093/nar/gkf400; Du JX, 2007, J BIOL CHEM, V282, P4782, DOI 10.1074/jbc.M603413200; Endter C, 2001, P NATL ACAD SCI USA, V98, P11312, DOI 10.1073/pnas.191361798; Fogal V, 2000, EMBO J, V19, P6185, DOI 10.1093/emboj/19.22.6185; Gama-Carvalho M, 2001, FEBS LETT, V498, P157, DOI 10.1016/S0014-5793(01)02487-5; Ghaleb AM, 2005, CELL RES, V15, P92, DOI 10.1038/sj.cr.7290271; Gregoire S, 2006, J BIOL CHEM, V281, P4423, DOI 10.1074/jbc.M509471200; Guillemin I, 2005, PROTEOMICS, V5, P35, DOI 10.1002/pmic.200400892; Haft CR, 1998, MOL CELL BIOL, V18, P7278, DOI 10.1128/MCB.18.12.7278; HAMAMOTO T, 1983, J ANTIBIOT, V36, P639, DOI 10.7164/antibiotics.36.639; HAMAMOTO T, 1983, J ANTIBIOT, V36, P646, DOI 10.7164/antibiotics.36.646; Hay RT, 2005, MOL CELL, V18, P1, DOI 10.1016/j.molcel.2005.03.012; Henderson BR, 2000, EXP CELL RES, V256, P213, DOI 10.1006/excr.2000.4825; Hietakangas V, 2003, MOL CELL BIOL, V23, P2953, DOI 10.1128/MCB.23.8.2953-2968.2003; Hsu YHR, 2006, J BIOL CHEM, V281, P33008, DOI 10.1074/jbc.M604380200; Huang TT, 2003, CELL, V115, P565, DOI 10.1016/S0092-8674(03)00895-X; Jiang JM, 2008, NAT CELL BIOL, V10, P353, DOI 10.1038/ncb1698; Johnson ES, 2004, ANNU REV BIOCHEM, V73, P355, DOI 10.1146/annurev.biochem.73.011303.074118; Kaffman A, 1999, ANNU REV CELL DEV BI, V15, P291, DOI 10.1146/annurev.cellbio.15.1.291; Kindsmuller K, 2007, P NATL ACAD SCI USA, V104, P6684, DOI 10.1073/pnas.0702158104; Kutay U, 2005, TRENDS CELL BIOL, V15, P121, DOI 10.1016/j.tcb.2005.01.005; Lin X, 2003, MOL CELL, V11, P1389, DOI 10.1016/S1097-2765(03)00175-8; McConnell BB, 2007, BIOESSAYS, V29, P549, DOI 10.1002/bies.20581; Miyauchi Y, 2002, J BIOL CHEM, V277, P50131, DOI 10.1074/jbc.M208319200; Muller S, 2000, J BIOL CHEM, V275, P13321, DOI 10.1074/jbc.275.18.13321; Nagai R, 2005, J THROMB HAEMOST, V3, P1569, DOI 10.1111/j.1538-7836.2005.01366.x; Nandan MO, 2008, GASTROENTEROLOGY, V134, P120, DOI 10.1053/j.gastro.2007.10.023; Nandan MO, 2005, FEBS LETT, V579, P4757, DOI 10.1016/j.febslet.2005.07.053; Nandan MO, 2004, ONCOGENE, V23, P3404, DOI 10.1038/sj.onc.1207397; OGAWA H, 1995, P NATL ACAD SCI USA, V92, P11899, DOI 10.1073/pnas.92.25.11899; Oishi Y, 2008, NAT MED, V14, P656, DOI 10.1038/nm1756; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Perdomo J, 2005, MOL CELL BIOL, V25, P1549, DOI 10.1128/MCB.25.4.1549-1559.2005; Pichler A, 2002, TRAFFIC, V3, P381, DOI 10.1034/j.1600-0854.2002.30601.x; PINOLROMA S, 1992, NATURE, V355, P730, DOI 10.1038/355730a0; Rosas-Acosta G, 2008, VIROLOGY, V373, P149, DOI 10.1016/j.virol.2007.12.017; Roth J, 1998, EMBO J, V17, P554, DOI 10.1093/emboj/17.2.554; Salinas S, 2004, J CELL BIOL, V165, P767, DOI 10.1083/jcb.200310136; Shi HP, 1999, NUCLEIC ACIDS RES, V27, P4807, DOI 10.1093/nar/27.24.4807; Shields JM, 1997, J BIOL CHEM, V272, P18504, DOI 10.1074/jbc.272.29.18504; Shindo T, 2002, NAT MED, V8, P856, DOI 10.1038/nm738; Singh BB, 1999, J BIOL CHEM, V274, P37370, DOI 10.1074/jbc.274.52.37370; Sobko A, 2002, DEV CELL, V2, P745, DOI 10.1016/S1534-5807(02)00186-7; Sun RG, 2001, J BIOL CHEM, V276, P6897, DOI 10.1074/jbc.C000870200; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tao WK, 1999, P NATL ACAD SCI USA, V96, P6937, DOI 10.1073/pnas.96.12.6937; Terry LJ, 2007, SCIENCE, V318, P1412, DOI 10.1126/science.1142204; Terui Y, 2004, J BIOL CHEM, V279, P28257, DOI 10.1074/jbc.M403153200; Turpin P, 1999, FEBS LETT, V452, P82, DOI 10.1016/S0014-5793(99)00533-5; Vollert CS, 2004, MOL CELL PROTEOMICS, V3, P1053, DOI 10.1074/mcp.M400081-MCP200; Wilson VG, 2001, EXP CELL RES, V271, P57, DOI 10.1006/excr.2001.5366; Wood LD, 2003, P NATL ACAD SCI USA, V100, P3257, DOI 10.1073/pnas.0637114100; Xu Y, 2001, NAT CELL BIOL, V3, P658, DOI 10.1038/35083051; Yang YZ, 2005, CANCER BIOL THER, V4, P1216, DOI 10.4161/cbt.4.11.2090; Yaseen NR, 1999, P NATL ACAD SCI USA, V96, P5516, DOI 10.1073/pnas.96.10.5516; Yashiroda Y, 2003, CURR MED CHEM, V10, P741, DOI 10.2174/0929867033457791; Zhu J, 2005, CANCER CELL, V7, P143, DOI 10.1016/j.ccr.2005.01.005	67	69	70	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 14	2008	283	46					31991	32002		10.1074/jbc.M803612200	http://dx.doi.org/10.1074/jbc.M803612200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	370KJ	18782761	hybrid, Green Published			2022-12-27	WOS:000260760800081
J	Bai, S; Zha, JK; Zhao, HB; Ross, FP; Teitelbaum, SL				Bai, Shuting; Zha, Jikun; Zhao, Haibo; Ross, F. Patrick; Teitelbaum, Steven L.			Tumor Necrosis Factor Receptor-associated Factor 6 Is an Intranuclear Transcriptional Coactivator in Osteoclasts	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIM PROTEIN FHL2; DEFECTIVE INTERLEUKIN-1; UBIQUITIN LIGASE; BETA-CATENIN; TRAF6; ACTIVATION; DIFFERENTIATION; IDENTIFICATION; OSTEOPETROSIS; REQUIRES	Tumor necrosis factor receptor-associated factor 6 (TRAF6) associates with the cytoplasmic domain of receptor activator of NF-kappa B (RANK) and is an essential component of the signaling complex mediating osteoclastogenesis. However, the osteoclastic activity of TRAF6 is blunted by its association with four and half LIM domain 2 (FHL2), which functions as an adaptor protein in the cytoplasm and transcriptional regulator in the nucleus. We find that TRAF6 also localizes in the nuclei of osteoclasts but not their bone marrow macrophage precursors and that osteoclast intranuclear abundance is specifically increased by RANK ligand (RANKL). TRAF6 nuclear localization requires FHL2 and is diminished in fhl2(-/-) osteoclasts. Suggesting transcriptional activity, TRAF6 interacts with the transcription factor RUNX1 in the osteoclast nucleus. FHL2 also associates with RUNX1 but does so only in the presence of TRAF6. Importantly, TRAF6 recognizes FHL2 and RUNX1 in osteoclast nuclei, and the three molecules form a DNA-binding complex that recognizes and transactivates the RUNX1 response element in the fhl2 promoter. Finally, TRAF6 and its proximal activator, RANKL, polyubiquitinate FHL2, prompting its proteasomal degradation. These observations suggest a feedback mechanism whereby TRAF6 negatively regulates osteoclast formation by intracytoplasmic sequestration of FHL2 to blunt RANK activation and as a component of a transcription complex promoting FHL2 expression.	[Bai, Shuting; Zha, Jikun; Zhao, Haibo; Ross, F. Patrick; Teitelbaum, Steven L.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA	Washington University (WUSTL)	Teitelbaum, SL (corresponding author), Washington Univ, Sch Med, Dept Pathol, Campus Box 8118,660 S Euclid Ave, St Louis, MO 63110 USA.	teitelbs@wustl.edu	Zhao, Haibo/ABG-9729-2021	ZHAO, HAIBO/0000-0003-0836-7555; Teitelbaum, Steven/0000-0002-4054-6679	National Institutes Health [AR032788, AR046523, AR046852, AR054190]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR046852, R37AR046523, R01AR032788, R21AR054190, R01AR046523] Funding Source: NIH RePORTER	National Institutes Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes Health Grants AR032788 and AR046523 ( to S. L. T.) and AR046852 and AR054190 ( to F. P. R.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked " advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Armstrong AP, 2002, J BIOL CHEM, V277, P44347, DOI 10.1074/jbc.M202009200; Asagiri M, 2007, BONE, V40, P251, DOI 10.1016/j.bone.2006.09.023; Bai ST, 2005, J CLIN INVEST, V115, P2742, DOI 10.1172/JCI24921; Burgess TL, 1999, J CELL BIOL, V145, P527, DOI 10.1083/jcb.145.3.527; Chen YH, 2006, BLOOD, V108, P566, DOI 10.1182/blood-2005-12-4777; Deng L, 2000, CELL, V103, P351, DOI 10.1016/S0092-8674(00)00126-4; Feng YF, 2007, J BIOL CHEM, V282, P39, DOI 10.1074/jbc.M607399200; Geetha T, 2005, EMBO J, V24, P3859, DOI 10.1038/sj.emboj.7600845; Geetha T, 2005, MOL CELL, V20, P301, DOI 10.1016/j.molcel.2005.09.014; Gohda J, 2005, EMBO J, V24, P790, DOI 10.1038/sj.emboj.7600564; Johannessen M, 2006, CELL MOL LIFE SCI, V63, P268, DOI 10.1007/s00018-005-5438-z; Kahl P, 2006, CANCER RES, V66, P11341, DOI 10.1158/0008-5472.CAN-06-1570; Labalette C, 2004, MOL CELL BIOL, V24, P10689, DOI 10.1128/MCB.24.24.10689-10702.2004; Lacey DL, 1998, CELL, V93, P165, DOI 10.1016/S0092-8674(00)81569-X; Lam J, 2000, J CLIN INVEST, V106, P1481, DOI 10.1172/JCI11176; Lamothe B, 2007, J BIOL CHEM, V282, P4102, DOI 10.1074/jbc.M609503200; Lee JW, 2004, BLOOD, V103, P2308, DOI 10.1182/blood-2003-06-1992; Lomaga MA, 1999, GENE DEV, V13, P1015, DOI 10.1101/gad.13.8.1015; Mikhail FM, 2006, J CELL PHYSIOL, V207, P582, DOI 10.1002/jcp.20538; Nair SS, 2007, MOL ENDOCRINOL, V21, P613, DOI 10.1210/me.2006-0269; Naito A, 1999, GENES CELLS, V4, P353, DOI 10.1046/j.1365-2443.1999.00265.x; Okada H, 1998, ONCOGENE, V17, P2287, DOI 10.1038/sj.onc.1202151; Rong ZL, 2007, CELL SIGNAL, V19, P1514, DOI 10.1016/j.cellsig.2007.01.025; Sun LJ, 2004, MOL CELL, V14, P289, DOI 10.1016/S1097-2765(04)00236-9; Wang MWH, 2004, J CLIN INVEST, V114, P206, DOI 10.1172/JCI200415797; Wei S, 2005, J CLIN INVEST, V115, P282, DOI 10.1172/JCI200523394; Wei Y, 2003, J BIOL CHEM, V278, P5188, DOI 10.1074/jbc.M207216200; Wertz IE, 2004, NATURE, V430, P694, DOI 10.1038/nature02794; Wu H, 2003, BIOESSAYS, V25, P1096, DOI 10.1002/bies.10352; ZHANG DE, 1994, MOL CELL BIOL, V14, P8085, DOI 10.1128/MCB.14.12.8085	30	34	35	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 7	2008	283	45					30861	30867		10.1074/jbc.M802525200	http://dx.doi.org/10.1074/jbc.M802525200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	367ID	18768464	Green Published, hybrid			2022-12-27	WOS:000260544800041
J	Cho, T; Jung, Y; Koschinsky, ML				Cho, Taewoo; Jung, Yoojin; Koschinsky, Marlys L.			Apolipoprotein(a), through Its Strong Lysine-binding Site in KIV10, Mediates Increased Endothelial Cell Contraction and Permeability via a Rho/Rho Kinase/MYPT1-dependent Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIGHT-CHAIN PHOSPHATASE; RHO-KINASE; CARDIOVASCULAR-DISEASE; LIPOPROTEIN(A) LEVELS; MYOSIN PHOSPHATASE; ISOMETRIC TENSION; RECOMBINANT FORM; IN-VIVO; PLASMINOGEN; EXPRESSION	Substantial evidence indicates that endothelial dysfunction plays a critical role in atherogenesis. We previously demonstrated that apolipoprotein(a) (apo(a); the distinguishing protein component of the atherothrombotic risk factor lipoprotein(a)) elicits rearrangement of the actin cytoskeleton in human umbilical vein endothelial cells, characterized by increased myosin light chain (MLC) phosphorylation via a Rho/Rho kinase-dependent signaling pathway. Apo(a) contains kringle (K)IV and KV domains similar to those in plasminogen: apo(a) contains 10 types of plasminogen KIV-like sequences, followed by sequences homologous to the plasminogen KV and protease domains. Several of the apo(a) kringles contain lysine-binding sites (LBS) that have been proposed to contribute to the pathogenicity of Lp(a). Here we demonstrate that apo(a)-induced endothelial barrier dysfunction is mediated via a Rho/Rho kinase-dependent signaling pathway that results in increased MYPT1 phosphorylation and hence decreased MLC phosphatase activity, thus leading to an increase in MLC phosphorylation, stress fiber formation, cell contraction, and permeability. In addition, studies using recombinant apo(a) variants indicated that these effects of apo(a) are dependent on sequences within the C-terminal half of the apo(a) molecule, specifically, the strong LBS in KIV10. In parallel experiments, the apo(a)-induced effects were completely abolished by treatment of the cells with the lysine analogue epsilon-aminocaproic acid and the Rho kinase inhibitor Y27632. Taken together, our findings indicate that the strong LBS in apo(a) KIV10 mediates all of our observed effects of apo(a) on human umbilical vein endothelial cell barrier dysfunction. Studies are ongoing to further dissect the molecular basis of these findings.	[Cho, Taewoo; Jung, Yoojin; Koschinsky, Marlys L.] Queens Univ, Dept Biochem, Kingston, ON K7L 3N6, Canada	Queens University - Canada	Koschinsky, ML (corresponding author), Queens Univ, Dept Biochem, Kingston, ON K7L 3N6, Canada.	mk11@queensu.ca		Koschinsky, Marlys/0000-0002-2643-2288	Heart and Stroke Foundation of Ontario [T-5916]	Heart and Stroke Foundation of Ontario(Heart & Stroke Foundation of Ontario)	This work was supported by the Heart and Stroke Foundation of Ontario (Grant T-5916 to M. L. K.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Allen S, 1998, FASEB J, V12, P1765, DOI 10.1096/fasebj.12.15.1765; Amerongen GPV, 1998, CIRC RES, V83, P1115, DOI 10.1161/01.RES.83.11.1115; Angelin B, 1997, CURR OPIN LIPIDOL, V8, P337, DOI 10.1097/00041433-199712000-00003; Anuurad E, 2006, CLIN LAB MED, V26, P751, DOI 10.1016/j.cll.2006.07.002; Babbin BA, 2007, AM J PATHOL, V170, P951, DOI 10.2353/ajpath.2007.060647; Becker L, 2004, BIOCHEMISTRY-US, V43, P9978, DOI 10.1021/bi049536d; Becker L, 2001, J BIOL CHEM, V276, P36155, DOI 10.1074/jbc.M104789200; Belczewski AR, 2005, BIOCHEMISTRY-US, V44, P555, DOI 10.1021/bi048156p; Bodmer JE, 1997, MICROVASC RES, V53, P261, DOI 10.1006/mvre.1997.2011; Boonmark NW, 1997, J CLIN INVEST, V100, P558, DOI 10.1172/JCI119565; del Pozo MA, 2004, SCIENCE, V303, P839, DOI 10.1126/science.1092571; Essler M, 1999, J BIOL CHEM, V274, P30361, DOI 10.1074/jbc.274.43.30361; Essler M, 1998, J BIOL CHEM, V273, P21867, DOI 10.1074/jbc.273.34.21867; GABEL BR, 1995, BIOCHEMISTRY-US, V34, P15777, DOI 10.1021/bi00048a023; GARCIA JGN, 1995, J CELL PHYSIOL, V163, P510, DOI 10.1002/jcp.1041630311; GOECKELER ZM, 1995, J CELL BIOL, V130, P613, DOI 10.1083/jcb.130.3.613; Guan JL, 2004, SCIENCE, V303, P773, DOI 10.1126/science.1094376; Gunduz D, 2003, CARDIOVASC RES, V59, P470, DOI 10.1016/S0008-6363(03)00427-9; Hancock MA, 2003, J BIOL CHEM, V278, P23260, DOI 10.1074/jbc.M302780200; Haque NS, 2000, CIRCULATION, V102, P786, DOI 10.1161/01.CIR.102.7.786; Hughes SD, 1997, J CLIN INVEST, V100, P1493, DOI 10.1172/JCI119671; Kawano Y, 1999, J CELL BIOL, V147, P1023, DOI 10.1083/jcb.147.5.1023; Kimura K, 1996, SCIENCE, V273, P245, DOI 10.1126/science.273.5272.245; Koschinsky Marlys L., 2006, Cardiovascular & Hematological Disorders - Drug Targets, V6, P267; KOSCHINSKY ML, 1991, BIOCHEMISTRY-US, V30, P5044, DOI 10.1021/bi00234a029; KOSCHINSKY ML, 1993, J BIOL CHEM, V268, P19819; Kwon MJ, 2005, FRONT BIOSCI-LANDMRK, V10, P300, DOI 10.2741/1529; LACKNER C, 1993, HUM MOL GENET, V2, P933, DOI 10.1093/hmg/2.7.933; LUM H, 1992, AM J PHYSIOL, V263, pL219, DOI 10.1152/ajplung.1992.263.2.L219; Marcovina SM, 2003, CLIN CHEM, V49, P1785, DOI 10.1373/clinchem.2003.023689; MCLEAN JW, 1987, NATURE, V330, P132, DOI 10.1038/330132a0; Michel CC, 1999, PHYSIOL REV, V79, P703, DOI 10.1152/physrev.1999.79.3.703; Palazzo AF, 2004, SCIENCE, V303, P836, DOI 10.1126/science.1091325; Pellegrino M, 2004, J BIOL CHEM, V279, P6526, DOI 10.1074/jbc.M309705200; REDLITZ A, 1995, BAILLIERE CLIN HAEM, V8, P313, DOI 10.1016/S0950-3536(05)80270-7; Sangrar W, 2000, BIOCHEM CELL BIOL, V78, P519, DOI 10.1139/bcb-78-4-519; Sangrar W, 1997, BIOCHEMISTRY-US, V36, P10353, DOI 10.1021/bi962433d; Schachinger V, 1997, J AM COLL CARDIOL, V30, P927, DOI 10.1016/S0735-1097(97)00237-4; SCHNITTLER HJ, 1990, J PHYSIOL-LONDON, V431, P379, DOI 10.1113/jphysiol.1990.sp018335; Somlyo AP, 2000, J PHYSIOL-LONDON, V522, P177, DOI 10.1111/j.1469-7793.2000.t01-2-00177.x; SORENSEN KE, 1994, J CLIN INVEST, V93, P50, DOI 10.1172/JCI116983; Takami S, 1998, CIRCULATION, V97, P721, DOI 10.1161/01.CIR.97.8.721; TSURUMI Y, 1995, J AM COLL CARDIOL, V26, P1242, DOI 10.1016/0735-1097(95)00321-5; VANDERHOEK YY, 1993, HUM MOL GENET, V2, P361, DOI 10.1093/hmg/2.4.361; Wojciak-Stothard B, 1998, J CELL PHYSIOL, V176, P150, DOI 10.1002/(SICI)1097-4652(199807)176:1<150::AID-JCP17>3.0.CO;2-B; Zhao S, 2000, THROMB RES, V100, P501, DOI 10.1016/S0049-3848(00)00363-7	46	34	36	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 7	2008	283	45					30503	30512		10.1074/jbc.M802648200	http://dx.doi.org/10.1074/jbc.M802648200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	367ID	18776185	hybrid, Green Published			2022-12-27	WOS:000260544800008
J	Notari, S; Strammiello, R; Capellari, S; Giese, A; Cescatti, M; Grassi, J; Ghetti, B; Langeveld, JPM; Zou, WQ; Gambetti, P; Kretzschmar, HA; Parchi, P				Notari, Silvio; Strammiello, Rosaria; Capellari, Sabina; Giese, Armin; Cescatti, Maura; Grassi, Jacques; Ghetti, Bernardino; Langeveld, Jan P. M.; Zou, Wen-Quan; Gambetti, Pierluigi; Kretzschmar, Hans A.; Parchi, Piero			Characterization of Truncated Forms of Abnormal Prion Protein in Creutzfeldt-Jakob Disease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STRAUSSLER-SCHEINKER-DISEASE; PHENOTYPIC VARIABILITY; MOLECULAR-BASIS; SCRAPIE; PRP; IDENTIFICATION; CLASSIFICATION; GENOTYPE; STRAINS; AGENT	In prion disease, the abnormal conformer of the cellular prion protein, PrPSc, deposits in fibrillar protein aggregates in brain and other organs. Limited exposure of PrPSc to proteolytic digestion in vitro generates a core fragment of 19-21 kDa, named PrP27-30, which is also found in vivo. Recent evidence indicates that abnormal truncated fragments other than PrP27-30 may form in prion disease either in vivo or in vitro. We characterized a novel protease-resistant PrP fragment migrating 2-3 kDa faster than PrP27-30 in Creutzfeldt-Jakob disease (CJD) brains. The fragment has a size of about 18.5 kDa when associated with PrP27-30 type 1 (21 kDa) and of 17 kDa when associated with type 2 (19 kDa). Molecular mass and epitope mapping showed that the two fragments share the primary N-terminal sequence with PrP27-30 types 1 and 2, respectively, but lack a few amino acids at the very end of C terminus together with the glycosylphosphatidylinositol anchor. The amounts of the 18.5- or 17-kDa fragments and the previously described 13-kDa PrPSc C-terminal fragment relatively to the PrP27-30 signal significantly differed among CJD subtypes. Furthermore, protease digestion of PrPSc or PrP27-30 in partially denaturing conditions generated an additional truncated fragment of about 16 kDa only in typical sporadic CJD (i.e. MM1). These results show that the physicochemical heterogeneity of PrPSc in CJD extends to abnormal truncated forms of the protein. The findings support the notion of distinct structural "conformers" of PrPSc and indicate that the characterization of truncated PrPSc forms may further improve molecular typing in CJD.	[Notari, Silvio; Strammiello, Rosaria; Capellari, Sabina; Cescatti, Maura; Parchi, Piero] Univ Bologna, Dipartimento Sci Neurol, I-40123 Bologna, Italy; [Giese, Armin; Kretzschmar, Hans A.] Univ Munich, Inst Neuropathol, D-80539 Munich, Germany; [Grassi, Jacques] CEA Saclay, Serv Pharmacol & Immunol, F-91191 Gif Sur Yvette, France; [Ghetti, Bernardino] Indiana Univ, Inst Pathol, Indianapolis, IN 46202 USA; [Langeveld, Jan P. M.] Wageningen Univ, Cent Vet Inst, NL-8200 AB Lelystad, Netherlands; [Zou, Wen-Quan; Gambetti, Pierluigi] Case Western Reserve Univ, Inst Pathol, Cleveland, OH 44106 USA	University of Bologna; University of Munich; CEA; UDICE-French Research Universities; Universite Paris Saclay; Indiana University System; Indiana University-Purdue University Indianapolis; Wageningen University & Research; Case Western Reserve University	Parchi, P (corresponding author), Univ Bologna, Dipartimento Sci Neurol, Via Foscolo 7, I-40123 Bologna, Italy.	piero.parchi@unibo.it	capellari, sabina/F-5545-2012; Giese, Armin/F-3271-2010; Parchi, Piero/L-9833-2015; Zou, Wenquan/GWQ-3489-2022; Zou, Wenquan/ABF-2875-2020	capellari, sabina/0000-0003-1631-1439; Giese, Armin/0000-0002-8238-4102; Parchi, Piero/0000-0002-9444-9524; 	European Commission [FOOD-CT-2004-506579]; Italian Ministry of University, Research and Technology [FIRB-2003-RBNE03FMCJ_006]	European Commission(European CommissionEuropean Commission Joint Research Centre); Italian Ministry of University, Research and Technology(Ministry of Education, Universities and Research (MIUR))	This study was supported by grants from the European Commission (Grant FOOD-CT-2004-506579) and the Italian Ministry of University, Research and Technology (Grant FIRB-2003-RBNE03FMCJ_006). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Baron T, 2007, VACCINE, V25, P5625, DOI 10.1016/j.vaccine.2006.10.058; Barron RM, 2001, EMBO J, V20, P5070, DOI 10.1093/emboj/20.18.5070; BESSEN RA, 1994, J VIROL, V68, P7859, DOI 10.1128/JVI.68.12.7859-7868.1994; BOLTON DC, 1987, ARCH BIOCHEM BIOPHYS, V258, P579, DOI 10.1016/0003-9861(87)90380-8; BOLTON DC, 1982, SCIENCE, V218, P1309, DOI 10.1126/science.6815801; BORCHELT DR, 1993, GLYCOBIOLOGY, V3, P319, DOI 10.1093/glycob/3.4.319; Bruce ME, 1997, NATURE, V389, P498, DOI 10.1038/39057; BRUCE ME, 1991, J GEN VIROL, V72, P595, DOI 10.1099/0022-1317-72-3-595; Buschmann A, 1998, BIOCHEM BIOPH RES CO, V253, P693, DOI 10.1006/bbrc.1998.9838; Capellari S, 2000, AM J PATHOL, V157, P613, DOI 10.1016/S0002-9440(10)64572-5; CAUGHEY B, 1991, J BIOL CHEM, V266, P18217; Caughey B, 1998, J BIOL CHEM, V273, P32230, DOI 10.1074/jbc.273.48.32230; CAUGHEY BW, 1991, BIOCHEMISTRY-US, V30, P7672, DOI 10.1021/bi00245a003; CHEN SG, 1995, J BIOL CHEM, V270, P19173, DOI 10.1074/jbc.270.32.19173; Chesebro B, 2005, SCIENCE, V308, P1435, DOI 10.1126/science.1110837; Feraudet C, 2005, J BIOL CHEM, V280, P11247, DOI 10.1074/jbc.M407006200; Gambetti P, 2003, BRIT MED BULL, V66, P213, DOI 10.1093/bmb/66.1.213; GOLDMANN W, 1994, J GEN VIROL, V75, P989, DOI 10.1099/0022-1317-75-5-989; Jacobs JG, 2007, J CLIN MICROBIOL, V45, P1821, DOI 10.1128/JCM.00160-07; KASCSAK RJ, 1986, J VIROL, V59, P676, DOI 10.1128/JVI.59.3.676-683.1986; KASCSAK RJ, 1987, J VIROL, V61, P3688, DOI 10.1128/JVI.61.12.3688-3693.1987; Kobayashi A, 2007, J BIOL CHEM, V282, P30022, DOI 10.1074/jbc.M704597200; Kocisko DA, 1996, BIOCHEMISTRY-US, V35, P13434, DOI 10.1021/bi9610562; KOCISKO DA, 1994, NATURE, V370, P471, DOI 10.1038/370471a0; Korth C, 2003, P NATL ACAD SCI USA, V100, P4784, DOI 10.1073/pnas.2627989100; Kretzschmar H, 2007, PRIONS IN HUMANS AND ANIMALS, P287; Langeveld Jan P M, 2006, BMC Vet Res, V2, P19, DOI 10.1186/1746-6148-2-19; Lawson VA, 2001, J BIOL CHEM, V276, P35265, DOI 10.1074/jbc.M103799200; Nonno R, 2006, PLOS PATHOG, V2, P112, DOI 10.1371/journal.ppat.0020012; Notari S, 2004, J BIOL CHEM, V279, P16797, DOI 10.1074/jbc.M313220200; Notari S, 2007, LAB INVEST, V87, P1103, DOI 10.1038/labinvest.3700676; PALMER MS, 1991, NATURE, V352, P340, DOI 10.1038/352340a0; PAN KM, 1993, P NATL ACAD SCI USA, V90, P10962, DOI 10.1073/pnas.90.23.10962; Pan T, 2005, J NEUROCHEM, V92, P132, DOI 10.1111/j.1471-4159.2004.02859.x; Parchi P, 2000, P NATL ACAD SCI USA, V97, P10168, DOI 10.1073/pnas.97.18.10168; Parchi P, 2005, PRIONS: FOOD AND DRUG SAFETY, P77, DOI 10.1007/4-431-29402-3_6; Parchi P, 1998, P NATL ACAD SCI USA, V95, P8322, DOI 10.1073/pnas.95.14.8322; Parchi P, 1999, ANN NEUROL, V46, P224, DOI 10.1002/1531-8249(199908)46:2<224::AID-ANA12>3.0.CO;2-W; Parchi P, 1999, ALZHEIMER'S DISEASE AND RELATED DISORDERS, P561; Parchi P, 1996, ANN NEUROL, V39, P767, DOI 10.1002/ana.410390613; Parchi P, 1997, NATURE, V386, P232, DOI 10.1038/386232a0; Parkin ET, 2004, J BIOL CHEM, V279, P11170, DOI 10.1074/jbc.M312105200; Piccardo P, 1998, J NEUROPATH EXP NEUR, V57, P979, DOI 10.1097/00005072-199810000-00010; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Safar J, 1998, NAT MED, V4, P1157, DOI 10.1038/2654; Satoh K, 2003, J GEN VIROL, V84, P2885, DOI 10.1099/vir.0.19236-0; Somerville RA, 1997, NATURE, V386, P564, DOI 10.1038/386564a0; STAHL N, 1990, BIOCHEMISTRY-US, V29, P8879, DOI 10.1021/bi00490a001; TAGLIAVINI F, 1991, EMBO J, V10, P513, DOI 10.1002/j.1460-2075.1991.tb07977.x; Telling GC, 1996, SCIENCE, V274, P2079, DOI 10.1126/science.274.5295.2079; Yuan J, 2006, J BIOL CHEM, V281, P34848, DOI 10.1074/jbc.M602238200; Zanusso G, 2004, J BIOL CHEM, V279, P38936, DOI 10.1074/jbc.M405468200; Zou WQ, 2003, J BIOL CHEM, V278, P40429, DOI 10.1074/jbc.M308550200; ZOU WQ, 2002, NEUROGENETICS METHOD, P305	54	63	63	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 7	2008	283	45					30557	30565		10.1074/jbc.M801877200	http://dx.doi.org/10.1074/jbc.M801877200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	367ID	18753138	Green Published, hybrid			2022-12-27	WOS:000260544800014
J	Rabiet, MJ; Huet, E; Boulay, F				Rabiet, Marie-Josephe; Huet, Emilie; Boulay, Francois			Complement Component 5a Receptor Oligomerization and Homologous Receptor Down-regulation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTOR; C5A ANAPHYLATOXIN RECEPTOR; BETA-ARRESTIN; HL-60 CELLS; MEDIATED INTERNALIZATION; CONFORMATIONAL-CHANGES; PHOSPHORYLATION SITES; SIGNAL-TRANSDUCTION; PAIRED ACTIVATION; CRYSTAL-STRUCTURE	Most G-protein-coupled receptors (GPCRs) form di(oligo)-meric structures that constitute signaling and trafficking units and might be essential for receptor functions. Cell responses to complement C5a receptor (C5aR) are tightly controlled by receptor desensitization and internalization. To examine the implication of dimerization in C5aR regulation, we generated an NH2-terminally modified C5aR mutant, unable to bind C5a, and a phosphorylation-deficient mutant. Neither an intact NH2 terminus nor the presence of COOH-terminal phosphorylation sites appeared to be required for the formation of C5aR dimers. Upon C5a stimulation, mutant receptors did not internalize when individually expressed. C5a stimulation of cells that co-expressed wild type C5aR together with either unliganded or phosphorylation-deficient mutant resulted in co-internalization of mutant receptors with C5aR. Unliganded GPCRs can be cross-phosphorylated within a heterologous receptor dimer or by second messenger-activated kinases. C5a stimulation of P-32-labeled cells that co-expressed the unliganded mutant with either C5aR or the phosphorylation-deficient mutant did not induce phosphorylation of the unliganded mutant. We can thus postulate that, in the case of C5aR, the stimulation and phosphorylation of one monomer is enough to lead to dimer internalization. The existence and functional implication of di(oligo) mer formation may be important for an accurate C5aR down-regulation in pathological conditions.	[Rabiet, Marie-Josephe] Commissariat Energie Atom Grenoble, Lab Biochim & Biophys Syst Integres, Inst Rech Technol & Sci Vivant, UMR 5092, F-38054 Grenoble 9, France; CNRS, UMR 5092, F-38054 Grenoble, France; Univ Grenoble 1, F-38000 Grenoble, France	CEA; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA)	Rabiet, MJ (corresponding author), Commissariat Energie Atom Grenoble, Lab Biochim & Biophys Syst Integres, Inst Rech Technol & Sci Vivant, UMR 5092, 17 Rue Martyrs, F-38054 Grenoble 9, France.	marie-josephe.rabiet@cea.fr			Commissariat a l'Energie Atomique; CNRS; University Joseph Fourier	Commissariat a l'Energie Atomique(French Atomic Energy Commission); CNRS(Centre National de la Recherche Scientifique (CNRS)); University Joseph Fourier	This work was supported by grants from the Commissariat a l'Energie Atomique, CNRS, and the University Joseph Fourier.	Angers S, 2002, ANNU REV PHARMACOL, V42, P409, DOI 10.1146/annurev.pharmtox.42.091701.082314; Bai M, 2004, CELL SIGNAL, V16, P175, DOI 10.1016/S0898-6568(03)00128-1; Balasubramanian S, 2004, J BIOL CHEM, V279, P18840, DOI 10.1074/jbc.M313470200; Baneres JL, 2003, J MOL BIOL, V329, P815, DOI 10.1016/S0022-2836(03)00439-X; Braun L, 2003, J BIOL CHEM, V278, P4277, DOI 10.1074/jbc.M210120200; Christophe T, 2000, J BIOL CHEM, V275, P1656, DOI 10.1074/jbc.275.3.1656; Czermak BJ, 1999, NAT MED, V5, P788, DOI 10.1038/10512; Damian M, 2008, J BIOL CHEM, V283, P21084, DOI 10.1074/jbc.M710419200; Damian M, 2006, EMBO J, V25, P5693, DOI 10.1038/sj.emboj.7601449; DEMARTINO JA, 1994, J BIOL CHEM, V269, P14446; Ernst OP, 2007, P NATL ACAD SCI USA, V104, P10859, DOI 10.1073/pnas.0701967104; Floyd DH, 2003, J BIOL CHEM, V278, P35354, DOI 10.1074/jbc.M305607200; Fotiadis D, 2006, CURR OPIN STRUC BIOL, V16, P252, DOI 10.1016/j.sbi.2006.03.013; Fotiadis D, 2003, NATURE, V421, P127, DOI 10.1038/421127a; GIANNINI E, 1995, J BIOL CHEM, V270, P19166, DOI 10.1074/jbc.270.32.19166; GIERSCHIK P, 1989, J BIOL CHEM, V264, P21470; Goudet C, 2005, J BIOL CHEM, V280, P24380, DOI 10.1074/jbc.M502642200; Guo W, 2003, J BIOL CHEM, V278, P4385, DOI 10.1074/jbc.C200679200; Han M, 2001, STRUCTURE, V9, P869, DOI 10.1016/S0969-2126(01)00644-X; Hansen JL, 2004, J BIOL CHEM, V279, P24108, DOI 10.1074/jbc.M400092200; Hanson SM, 2007, P NATL ACAD SCI USA, V104, P3125, DOI 10.1073/pnas.0610886104; Hlavackova V, 2005, EMBO J, V24, P499, DOI 10.1038/sj.emboj.7600557; Huttenrach F, 2005, J BIOL CHEM, V280, P37503, DOI 10.1074/jbc.M500535200; Jones KA, 1998, NATURE, V396, P674, DOI 10.1038/25348; Jordan BA, 2001, P NATL ACAD SCI USA, V98, P343, DOI 10.1073/pnas.011384898; Kaupmann K, 1998, NATURE, V396, P683, DOI 10.1038/25360; Klco JM, 2003, J BIOL CHEM, V278, P35345, DOI 10.1074/jbc.M305606200; Klein U, 2001, J BIOL CHEM, V276, P17442, DOI 10.1074/jbc.M009214200; Kobilka BK, 2002, J PEPT RES, V60, P317, DOI 10.1034/j.1399-3011.2002.21062.x; LAEMMLI UK, 1973, NATURE, V227, P680, DOI DOI 10.1038/227680A0; Liang Y, 2003, J BIOL CHEM, V278, P21655, DOI 10.1074/jbc.M302536200; MERY L, 1994, J BIOL CHEM, V269, P3457; Milligan G, 2004, MOL PHARMACOL, V66, P1, DOI 10.1124/mol.104.000497.; Milligan G, 2005, FEBS J, V272, P2914, DOI 10.1111/j.1742-4658.2005.04731.x; Naik N, 1997, J CELL SCI, V110, P2381; Novi F, 2005, J BIOL CHEM, V280, P19768, DOI 10.1074/jbc.M411281200; Novi F, 2004, J BIOL CHEM, V279, P7476, DOI 10.1074/jbc.M306818200; Overton MC, 2000, CURR BIOL, V10, P341, DOI 10.1016/S0960-9822(00)00386-9; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; Park PSH, 2004, BIOCHEMISTRY-US, V43, P15643, DOI 10.1021/bi047907k; Perez DM, 2005, PHARMACOL REV, V57, P147, DOI 10.1124/pr.57.2.2; Pin JP, 2005, FEBS J, V272, P2947, DOI 10.1111/j.1742-4658.2005.04728.x; PITCHER JA, 1992, SCIENCE, V257, P1264, DOI 10.1126/science.1325672; Pitcher JA, 1998, ANNU REV BIOCHEM, V67, P653, DOI 10.1146/annurev.biochem.67.1.653; Rabiet MJ, 2007, BIOCHIMIE, V89, P1089, DOI 10.1016/j.biochi.2007.02.015; Sartania N, 2007, CELL SIGNAL, V19, P1928, DOI 10.1016/j.cellsig.2007.05.002; Shi GW, 2005, J BIOL CHEM, V280, P41184, DOI 10.1074/jbc.M506935200; TARDIF M, 1993, J IMMUNOL, V150, P3534; White JH, 1998, NATURE, V396, P679, DOI 10.1038/25354; Whorton MR, 2008, J BIOL CHEM, V283, P4387, DOI 10.1074/jbc.M703346200; Whorton MR, 2007, P NATL ACAD SCI USA, V104, P7682, DOI 10.1073/pnas.0611448104	51	14	14	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 7	2008	283	45					31038	31046		10.1074/jbc.M805260200	http://dx.doi.org/10.1074/jbc.M805260200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	367ID	18772131	Green Published, hybrid			2022-12-27	WOS:000260544800059
J	Cheng, D; Iqbal, J; Devenny, J; Chu, CH; Chen, LP; Dong, J; Seethala, R; Keim, WJ; Azzara, AV; Lawrence, RM; Pelleymounter, MA; Hussain, MM				Cheng, Dong; Iqbal, Jahangir; Devenny, James; Chu, Ching-Hsuen; Chen, Luping; Dong, Jessica; Seethala, Ramakrishna; Keim, William J.; Azzara, Anthony V.; Lawrence, R. Michael; Pelleymounter, Mary Ann; Hussain, M. Mahmood			Acylation of Acylglycerols by Acyl Coenzyme A:Diacylglycerol Acyltransferase 1 (DGAT1) FUNCTIONAL IMPORTANCE OF DGAT1 IN THE INTESTINAL FAT ABSORPTION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COA-DIACYLGLYCEROL ACYLTRANSFERASE; TRIGLYCERIDE TRANSFER PROTEIN; DIFFERENTIATED CACO-2 CELLS; MONOACYLGLYCEROL ACYLTRANSFERASE; TRIACYLGLYCEROL SYNTHESIS; VITAMIN-E; SECRETION; IDENTIFICATION; CHYLOMICRONS; MECHANISMS	Acyl coenzyme A: diacylglycerol acyltransferase 1 (DGAT1) is one of the four intestinal membrane bound acyltransferases implicated in dietary fat absorption. Recently, it was found that, in addition to acylating diacylglycerol (DAG), DGAT1 also possesses robust enzymatic activity for acylating monoacylglycerol (MAG) (Yen, C. L., Monetti, M., Burri, B. J., and Farese, R. V., Jr. (2005) J. Lipid Res. 46, 1502-1511). In the current paper, we have conducted a detailed characterization of this reaction in test tube, intact cell culture, and animal models. Enzymatically, we found that triacylglycerol (TAG) synthesis from MAG by DGAT1 does not behave according to classic Michaelis-Menten kinetics. At low concentrations of 2-MAG (< 50 mu M), the major acylation product by DGAT1 was TAG; however, increased concentrations of 2-MAG (50-200 mu M) resulted in decreased TAG formation. This unique product/substrate relationship is similar to MGAT3 but distinct from DGAT2 and MGAT2. We have also found that XP620 is an inhibitor that selectively inhibits the acylation of MAG by DGAT1(IC50 of human DGAT1: 16.6 +/- 4.0 nM (MAG as substrate) and 1499 +/- 318 nM (DAG as substrate); IC50 values of human DGAT2, MGAT2, and MGAT3 are > 30,000 nM). Using this pharmacological tool, we have shown that similar to 76 and similar to 89% of the in vitro TAG synthesis initiated from MAG is mediated by DGAT1 in Caco-2 cell and rat intestinal mucosal membranes, respectively. When applied to intact cultured cells, XP620 substantially decreased but did not abolish apoB secretion in differentiated Caco-2 cells. It also decreased TAG and DAG syntheses in primary enterocytes. Last, when delivered orally to rats, XP620 decreased absorption of orally administered lipids by similar to 50%. Based on these data, we conclude that the acylation of acylglycerols by DGAT1 is important for dietary fat absorption in the intestine.	[Cheng, Dong; Lawrence, R. Michael] Bristol Myers Squibb Co, Res & Dev, Dept Discovery Chem, Princeton, NJ 08543 USA; [Cheng, Dong; Chu, Ching-Hsuen; Chen, Luping; Keim, William J.; Azzara, Anthony V.; Pelleymounter, Mary Ann] Bristol Myers Squibb Co, Dept Metab Dis, Princeton, NJ 08543 USA; [Iqbal, Jahangir; Hussain, M. Mahmood] SUNY Downstate Med Ctr, Dept Anat & Cell Biol, Brooklyn, NY 11203 USA; [Iqbal, Jahangir; Hussain, M. Mahmood] SUNY Downstate Med Ctr, Dept Pediat, Brooklyn, NY 11203 USA	Bristol-Myers Squibb; Bristol-Myers Squibb; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center	Cheng, D (corresponding author), Bristol Myers Squibb Co, Res & Dev, Dept Discovery Chem, POB 5400, Princeton, NJ 08543 USA.	dong.cheng@bms.com	Iqbal, Jahangir/B-3903-2014	Iqbal, Jahangir/0000-0002-9021-2271				Anwar K, 2007, J LIPID RES, V48, P2028, DOI 10.1194/jlr.M700207-JLR200; Anwar K, 2006, J LIPID RES, V47, P1261, DOI 10.1194/jlr.M500523-JLR200; Athar H, 2004, J LIPID RES, V45, P764, DOI 10.1194/jlr.D300026-JLR200; Bakillah A, 1997, LIPIDS, V32, P1113, DOI 10.1007/s11745-997-0143-8; Bligh EG, 1959, J BIO CHEM PHYSL, V35, P911, DOI DOI 10.1139/059-099.PUBMED:13671378; Buhman KK, 2002, J BIOL CHEM, V277, P25474, DOI 10.1074/jbc.M202013200; Cao JS, 2007, J LIPID RES, V48, P583, DOI 10.1194/jlr.M600331-JLR200; Cao JS, 2004, J BIOL CHEM, V279, P18878, DOI 10.1074/jbc.M313272200; Cao JS, 2003, J BIOL CHEM, V278, P25657, DOI 10.1074/jbc.M302835200; Cases S, 1998, P NATL ACAD SCI USA, V95, P13018, DOI 10.1073/pnas.95.22.13018; Cases S, 2001, J BIOL CHEM, V276, P38870, DOI 10.1074/jbc.M106219200; Chang TY, 1997, ANNU REV BIOCHEM, V66, P613, DOI 10.1146/annurev.biochem.66.1.613; Cheng D, 2001, BIOCHEM J, V359, P707, DOI 10.1042/0264-6021:3590707; Cheng D, 2003, J BIOL CHEM, V278, P13611, DOI 10.1074/jbc.C300042200; COLEMAN RA, 1986, J BIOL CHEM, V261, P224; Fatma S, 2006, J LIPID RES, V47, P2422, DOI 10.1194/jlr.M600211-JLR200; Guo ZY, 2005, J BIOL CHEM, V280, P37814, DOI 10.1074/jbc.M508384200; Hussain MM, 2000, ATHEROSCLEROSIS, V148, P1; Hussain MM, 1996, BBA-LIPID LIPID MET, V1300, P151, DOI 10.1016/0005-2760(96)00041-0; HUSSAIN MM, 1995, ARTERIOSCL THROM VAS, V15, P485, DOI 10.1161/01.ATV.15.4.485; Hussain MM, 2001, FRONT BIOSCI, V6, pD320, DOI 10.2741/Hussain; Iqbal J, 2005, J LIPID RES, V46, P1491, DOI 10.1194/jlr.M500023-JLR200; Iqbal J, 2003, J BIOL CHEM, V278, P31610, DOI 10.1074/jbc.M301177200; JAMDAR SC, 1992, ARCH BIOCHEM BIOPHYS, V296, P419, DOI 10.1016/0003-9861(92)90592-K; Jamil H, 1996, P NATL ACAD SCI USA, V93, P11991, DOI 10.1073/pnas.93.21.11991; Lockwood JF, 2003, AM J PHYSIOL-ENDOC M, V285, pE927, DOI 10.1152/ajpendo.00179.2003; Luchoomun J, 1999, J BIOL CHEM, V274, P19565, DOI 10.1074/jbc.274.28.19565; MORAN TH, 1988, AM J PHYSIOL, V254, pR628, DOI 10.1152/ajpregu.1988.254.4.R628; Nayak N, 2001, J LIPID RES, V42, P272; Orland MD, 2005, BBA-MOL CELL BIOL L, V1737, P76, DOI 10.1016/j.bbalip.2005.09.003; Smith SJ, 2000, NAT GENET, V25, P87, DOI 10.1038/75651; Stone SJ, 2006, J BIOL CHEM, V281, P40273, DOI 10.1074/jbc.M607986200; TROTTER PJ, 1993, J BIOL CHEM, V268, P10017; Yen CLE, 2003, J BIOL CHEM, V278, P18532, DOI 10.1074/jbc.M301633200; Yen CLE, 2005, J LIPID RES, V46, P1502, DOI 10.1194/jlr.M500036-JLR200; Yen CLE, 2002, P NATL ACAD SCI USA, V99, P8512, DOI 10.1073/pnas.132274899	36	62	65	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 31	2008	283	44					29802	29811		10.1074/jbc.M800494200	http://dx.doi.org/10.1074/jbc.M800494200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	364WS	18768481	Green Published, hybrid			2022-12-27	WOS:000260366900024
J	Houchens, CR; Lu, WY; Chuang, RY; Frattini, MG; Fuller, A; Simancek, P; Kelly, TJ				Houchens, Christopher R.; Lu, Wenyan; Chuang, Ray-Yuan; Frattini, Mark G.; Fuller, Alex; Simancek, Pam; Kelly, Thomas J.			Multiple Mechanisms Contribute to Schizosaccharomyces pombe Origin Recognition Complex-DNA Interactions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DIHYDROFOLATE-REDUCTASE ORIGIN; ESCHERICHIA-COLI CHROMOSOME; GENOME-WIDE DISTRIBUTION; REPLICATION ORIGINS; FISSION YEAST; SACCHAROMYCES-CEREVISIAE; ADENINE/THYMINE STRETCHES; FUNCTIONAL ELEMENTS; EUKARYOTIC CELLS; INITIATION SITES	Eukaryotic DNA replication requires the assembly of multiprotein pre-replication complexes (pre-RCs) at chromosomal origins of DNA replication. Here we describe the interactions of highly purified Schizosaccharomyces pombe pre-RC components, SpORC, SpCdc18, and SpCdt1, with each other and with ars1 origin DNA. We show that SpORC binds DNA in at least two steps. The first step likely involves electrostatic interactions between the AT-hook motifs of SpOrc4 and AT tracts in ars1 DNA and results in the formation of a salt-sensitive complex. In the second step, the salt-sensitive complex is slowly converted to a salt-stable complex that involves additional interactions between SpORC and DNA. Binding of SpORC to ars1 DNA is facilitated by negative supercoiling and is accompanied by changes in DNA topology, suggesting that SpORC-DNA complexes contain underwound or negatively writhed DNA. Purified human origin recognition complex (ORC) induces similar topological changes in origin DNA, indicating that this property of ORC is conserved in eukaryotic evolution and plays an important role in ORC function. We also show that SpCdc18 and SpCdt1 form a binary complex that has greater affinity for DNA than either protein alone. In addition, both proteins contribute significantly to the stability of the initial SpORC-DNA complex and enhance the SpORC-dependent topology changes in origin DNA. Thus, the formation of stable protein-DNA complexes at S. pombe origins of replication involves binary interactions among all three proteins, as well as interactions of both SpORC and SpCdt1-SpCdc18 with origin DNA. These findings demonstrate that SpORC is not the sole determinant of origin recognition.	[Houchens, Christopher R.; Lu, Wenyan; Fuller, Alex; Simancek, Pam; Kelly, Thomas J.] Mem Sloan Kettering Canc Ctr, Program Mol Biol, New York, NY 10021 USA; [Frattini, Mark G.] Mem Sloan Kettering Canc Ctr, Dept Med, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center	Houchens, CR (corresponding author), 609 Rockefeller Res Labs,430 E 67th St, New York, NY 10021 USA.	chouchens@sainc.com			National Institutes of Health [GM 50806]; NIGMS; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM050806] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or part, by National Institutes of Health Grant GM 50806 from the NIGMS (to T. K.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Aggarwal BD, 2004, NATURE, V430, P372, DOI 10.1038/nature02694; Arias EE, 2004, FRONT BIOSCI-LANDMRK, V9, P3029, DOI 10.2741/1457; Bell SP, 2002, ANNU REV BIOCHEM, V71, P333, DOI 10.1146/annurev.biochem.71.110601.135425; BELL SP, 1992, NATURE, V357, P128, DOI 10.1038/357128a0; Biamonti G, 2003, CHROMOSOME RES, V11, P403, DOI 10.1023/A:1024910307162; Biswas SB, 2005, CELL CYCLE, V4, P494; BRAMHILL D, 1988, CELL, V54, P915, DOI 10.1016/0092-8674(88)90102-X; BRAMHILL D, 1988, CELL, V52, P743, DOI 10.1016/0092-8674(88)90412-6; Breier AM, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-4-r22; Bustin M, 1996, PROG NUCLEIC ACID RE, V54, P35, DOI 10.1016/S0079-6603(08)60360-8; Chesnokov I, 1999, GENE DEV, V13, P1289, DOI 10.1101/gad.13.10.1289; Chuang RY, 1999, P NATL ACAD SCI USA, V96, P2656, DOI 10.1073/pnas.96.6.2656; Chuang RY, 2002, J BIOL CHEM, V277, P16920, DOI 10.1074/jbc.M107710200; Clarey MG, 2006, NAT STRUCT MOL BIOL, V13, P684, DOI 10.1038/nsmb1121; Clyne RK, 1995, EMBO J, V14, P6348, DOI 10.1002/j.1460-2075.1995.tb00326.x; Clyne RK, 1997, METHODS, V13, P221, DOI 10.1006/meth.1997.0522; Cui TJ, 2005, J MOL BIOL, V352, P629, DOI 10.1016/j.jmb.2005.07.048; Dai JL, 2005, P NATL ACAD SCI USA, V102, P337, DOI 10.1073/pnas.0408811102; DIJKWEL PA, 1994, NUCLEIC ACIDS RES, V22, P4989, DOI 10.1093/nar/22.23.4989; Dijkwel PA, 2000, EXP CELL RES, V256, P150, DOI 10.1006/excr.2000.4809; Dijkwel PA, 2002, MOL CELL BIOL, V22, P3053, DOI 10.1128/MCB.22.9.3053-3065.2002; Dubey DD, 1996, CURR BIOL, V6, P467, DOI 10.1016/S0960-9822(02)00514-6; FANGMAN WL, 1983, CELL, V32, P831, DOI 10.1016/0092-8674(83)90069-7; Feng WY, 2007, METHODS, V41, P151, DOI 10.1016/j.ymeth.2006.07.023; Gaczynska M, 2004, P NATL ACAD SCI USA, V101, P17952, DOI 10.1073/pnas.0408369102; Gerbi SA, 2002, CURR OPIN GENET DEV, V12, P243, DOI 10.1016/S0959-437X(02)00292-7; Harvey KJ, 2003, J BIOL CHEM, V278, P48524, DOI 10.1074/jbc.M307661200; Hayashi M, 2007, EMBO J, V26, P1327, DOI 10.1038/sj.emboj.7601585; Heichinger C, 2006, EMBO J, V25, P5171, DOI 10.1038/sj.emboj.7601390; HUANG RY, 1993, EMBO J, V12, P4521, DOI 10.1002/j.1460-2075.1993.tb06141.x; Huth JR, 1997, NAT STRUCT BIOL, V4, P657, DOI 10.1038/nsb0897-657; Iizuka M, 2006, MOL CELL BIOL, V26, P1098, DOI 10.1128/MCB.26.3.1098-1108.2006; JACOB F, 1963, COLD SPRING HARB SYM, V28, P329, DOI 10.1101/SQB.1963.028.01.048; KEARSEY S, 1983, EMBO J, V2, P1571, DOI 10.1002/j.1460-2075.1983.tb01626.x; Kelly TJ, 2000, ANNU REV BIOCHEM, V69, P829, DOI 10.1146/annurev.biochem.69.1.829; Kong DC, 2001, MOL CELL BIOL, V21, P8095, DOI 10.1128/MCB.21.23.8095-8103.2001; Lee C, 2004, NATURE, V430, P913, DOI 10.1038/nature02813; Lee JK, 2001, P NATL ACAD SCI USA, V98, P13589, DOI 10.1073/pnas.251530398; Maher JF, 1996, P NATL ACAD SCI USA, V93, P6716, DOI 10.1073/pnas.93.13.6716; MARAHRENS Y, 1992, SCIENCE, V255, P817, DOI 10.1126/science.1536007; MECHALI M, 1984, CELL, V38, P55, DOI 10.1016/0092-8674(84)90526-9; Melendy T, 2001, FRONT BIOSCI-LANDMRK, V6, pD1048, DOI 10.2741/Melendy; Mesner LD, 2003, MOL CELL BIOL, V23, P804, DOI 10.1128/MCB.23.3.804-814.2003; Messer W, 2002, FEMS MICROBIOL REV, V26, P355, DOI 10.1016/S0168-6445(02)00127-4; Moon KY, 1999, P NATL ACAD SCI USA, V96, P12367, DOI 10.1073/pnas.96.22.12367; Nishitani H, 2002, GENES CELLS, V7, P523, DOI 10.1046/j.1365-2443.2002.00544.x; Norio P, 2005, MOL CELL, V20, P575, DOI 10.1016/j.molcel.2005.10.029; Okuno Y, 1999, MOL CELL BIOL, V19, P6699; RAO H, 1994, MOL CELL BIOL, V14, P7643, DOI 10.1128/MCB.14.11.7643; Reeves R, 2001, BBA-GENE STRUCT EXPR, V1519, P13, DOI 10.1016/S0167-4781(01)00215-9; Remus D, 2004, EMBO J, V23, P897, DOI 10.1038/sj.emboj.7600077; Rowles A, 1999, J CELL SCI, V112, P2011; Segurado M, 2003, EMBO REP, V4, P1048, DOI 10.1038/sj.embor.7400008; SEKIMIZU K, 1988, J BIOL CHEM, V263, P7124; Speck C, 2005, NAT STRUCT MOL BIOL, V12, P965, DOI 10.1038/nsmb1002; Speck C, 2007, J BIOL CHEM, V282, P11705, DOI 10.1074/jbc.M700399200; Takahashi T, 2001, GENES CELLS, V6, P837, DOI 10.1046/j.1365-2443.2001.00468.x; Teer Jamie K., 2006, V42, P31, DOI 10.1007/b137221; THEIS JF, 1994, MOL CELL BIOL, V14, P7652, DOI 10.1128/MCB.14.11.7652; Vashee S, 2003, GENE DEV, V17, P1894, DOI 10.1101/gad.1084203; Wyrick JJ, 2001, SCIENCE, V294, P2357, DOI 10.1126/science.1066101	61	26	26	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 31	2008	283	44					30216	30224		10.1074/jbc.M802649200	http://dx.doi.org/10.1074/jbc.M802649200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	364WS	18723846	Green Published, hybrid			2022-12-27	WOS:000260366900066
J	Huang, XW; Li, X; Guo, B				Huang, Xiangwei; Li, Xia; Guo, Bin			KLF6 Induces Apoptosis in Prostate Cancer Cells through Up-regulation of ATF3	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATING TRANSCRIPTION FACTOR-3; TUMOR-SUPPRESSOR GENE; KRUPPEL-LIKE FACTOR-6; HEPATOCELLULAR-CARCINOMA; RESPONSE GENE; ALLELIC LOSS; C-MYC; EXPRESSION; PROLIFERATION; HOMEOSTASIS	KLF6 (Kruppel-like factor 6) is a zinc finger transcription factor and a tumor suppressor that is frequently mutated in prostate cancer. KLF6 suppresses tumor growth and induces apoptosis in cancer cells through mechanisms still not defined. Here we show that KLF6 induces apoptosis in prostate cancer cells by ATF3 (activating transcription factor 3) expression. KLF6 binds directly to and activates the ATF3 promoter. ATF3 induced apoptosis when ectopically expressed in cells, whereas knockdown of ATF3 by small interference RNA blocked KLF6-induced apoptosis. KLF6 mutants derived from clinical prostate cancers failed to activate the ATF3 promoter and were unable to induce apoptosis. Furthermore, stress conditions (exposure to staurosporine and hypoxia induced by sodium azide) caused significant increase in ATF3 expression and induced apoptosis, whereas knockdown of KLF6 by small interference RNA blocked the increase of ATF3 as well as the induction of apoptosis in these conditions. Thus, ATF3 is a key mediator of KLF6-induced apoptosis in prostate cancer cells.	[Huang, Xiangwei; Li, Xia; Guo, Bin] N Dakota State Univ, Dept Pharmaceut Sci, Coll Pharm, Fargo, ND 58105 USA	North Dakota State University Fargo	Guo, B (corresponding author), N Dakota State Univ, Dept Pharmaceut Sci, Coll Pharm, Fargo, ND 58105 USA.	Bin.Guo@ndsu.edu	Guo, Bin/AAA-2445-2019; Huang, Xiangwei/H-4884-2014	Guo, Bin/0000-0003-3296-9177; 	National Institutes of Health [5R21CA111765, 2P20RR015566]; NATIONAL CANCER INSTITUTE [R21CA111765] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR015566] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported, in whole or in part, by National Institutes of Health Grants 5R21CA111765 (from NCI) and 2P20RR015566 (from the NCRR). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Allen-Jennings AE, 2001, J BIOL CHEM, V276, P29507, DOI 10.1074/jbc.M100986200; Bandyopadhyay S, 2006, CANCER RES, V66, P11983, DOI 10.1158/0008-5472.CAN-06-0943; Benzeno S, 2004, CANCER RES, V64, P3885, DOI 10.1158/0008-5472.CAN-03-2818; Boyle Robert George, 2006, Anti-Cancer Agents in Medicinal Chemistry, V6, P281; Chen BPC, 1996, MOL CELL BIOL, V16, P1157, DOI 10.1128/mcb.16.3.1157; Chen CS, 2003, AM J PATHOL, V162, P1349, DOI 10.1016/S0002-9440(10)63930-2; Chiambaretta F, 2006, INVEST OPHTH VIS SCI, V47, P582, DOI 10.1167/iovs.05-0551; Glinsky GV, 2004, J CLIN INVEST, V113, P913, DOI 10.1172/JCI200420032; Hai T, 1999, GENE EXPRESSION, V7, P321; Hai T, 2001, GENE, V273, P1, DOI 10.1016/S0378-1119(01)00551-0; Hartman MG, 2004, MOL CELL BIOL, V24, P5721, DOI 10.1128/MCB.24.13.5721-5732.2004; Ito G, 2004, CANCER RES, V64, P3838, DOI 10.1158/0008-5472.CAN-04-0185; Ittmann M, 1996, CANCER RES, V56, P2143; Jamerson MH, 2000, ONCOGENE, V19, P1065, DOI 10.1038/sj.onc.1203268; Kremer-Tal S, 2004, HEPATOLOGY, V40, P1047, DOI 10.1002/hep.20460; Li D, 2005, CANCER RES, V65, P9216, DOI 10.1158/0008-5472.CAN-05-1040; Liang GS, 1996, J BIOL CHEM, V271, P1695, DOI 10.1074/jbc.271.3.1695; Lu D, 2006, J BIOL CHEM, V281, P10473, DOI 10.1074/jbc.M509278200; Mashima T, 2001, J CELL PHYSIOL, V188, P352, DOI 10.1002/jcp.1130; MIYASHITA T, 1995, CELL, V80, P293; Narla G, 2007, ONCOGENE, V26, P4428, DOI 10.1038/sj.onc.1210223; Narla G, 2005, CANCER RES, V65, P5761, DOI 10.1158/0008-5472.CAN-05-0217; Narla G, 2005, CANCER RES, V65, P1213, DOI 10.1158/0008-5472.CAN-04-4249; Narla G, 2001, SCIENCE, V294, P2563, DOI 10.1126/science.1066326; Pelzer AE, 2006, J UROLOGY, V175, P1517, DOI 10.1016/S0022-5347(05)00651-8; Syed V, 2005, ONCOGENE, V24, P1774, DOI 10.1038/sj.onc.1207991; Tamura K, 2005, EMBO J, V24, P2590, DOI 10.1038/sj.emboj.7600742; Trybus TM, 1996, CANCER RES, V56, P2263; Vaupel P, 2004, ONCOLOGIST, V9, P4, DOI 10.1634/theoncologist.9-90005-4; Yin X, 2008, ONCOGENE, V27, P2118, DOI 10.1038/sj.onc.1210861; Yu J, 2001, MOL CELL, V7, P673, DOI 10.1016/S1097-2765(01)00213-1	31	98	108	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 31	2008	283	44					29795	29801		10.1074/jbc.M802515200	http://dx.doi.org/10.1074/jbc.M802515200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	364WS	18755691	hybrid, Green Published			2022-12-27	WOS:000260366900023
J	Melchers, J; Diechtierow, M; Feher, K; Sinning, I; Tews, I; Krauth-Siegel, RL; Muhle-Goll, C				Melchers, Johannes; Diechtierow, Michael; Feher, Krisztina; Sinning, Irmgard; Tews, Ivo; Krauth-Siegel, R. Luise; Muhle-Goll, Claudia			Structural Basis for a Distinct Catalytic Mechanism in Trypanosoma brucei Tryparedoxin Peroxidase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLUTATHIONE-PEROXIDASE; CRYSTAL-STRUCTURE; SEQUENCE IDENTITY; AMINO-ACIDS; PROTEIN; TRYPANOTHIONE; SPECIFICITY; METABOLISM; ASSIGNMENT; DYNAMICS	Trypanosoma brucei, the causative agent of African sleeping sickness, encodes three cysteine homologues (Px I-III) of classical selenocysteine-containing glutathione peroxidases. The enzymes obtain their reducing equivalents from the unique trypanothione (bis(glutathionyl) spermidine)/tryparedoxin system. During catalysis, these tryparedoxin peroxidases cycle between an oxidized form with an intramolecular disulfide bond between Cys(47) and Cys(95) and the reduced peroxidase with both residues in the thiol state. Here we report on the three-dimensional structures of oxidized T. brucei Px III at 1.4 angstrom resolution obtained by x-ray crystallography and of both the oxidized and the reduced protein determined by NMR spectroscopy. Px III is a monomeric protein unlike the homologous poplar thioredoxin peroxidase (TxP). The structures of oxidized and reduced Px III are essentially identical in contrast to what was recently found for TxP. In Px III, Cys(47), Gln(82), and Trp(137) do not form the catalytic triad observed in the selenoenzymes, and related proteins and the latter two residues are unaffected by the redox state of the protein. The mutational analysis of three conserved lysine residues in the vicinity of the catalytic cysteines revealed that exchange of Lys(107) against glutamate abrogates the reduction of hydrogen peroxide, whereas Lys(97) and Lys(99) play a crucial role in the interaction with tryparedoxin.	[Melchers, Johannes; Feher, Krisztina; Muhle-Goll, Claudia] Karlsruhe Inst Technol, Inst Biol Grenzflachen IBG 2, D-76021 Karlsruhe, Germany; [Melchers, Johannes; Diechtierow, Michael; Sinning, Irmgard; Tews, Ivo; Krauth-Siegel, R. Luise] Heidelberg Univ, Zentrum Biochem, D-69120 Heidelberg, Germany; [Feher, Krisztina; Muhle-Goll, Claudia] Max Planck Inst Med Res, D-69120 Heidelberg, Germany	Helmholtz Association; Karlsruhe Institute of Technology; Ruprecht Karls University Heidelberg; Max Planck Society	Muhle-Goll, C (corresponding author), Karlsruhe Inst Technol, Inst Biol Grenzflachen IBG 2, POB 3640, D-76021 Karlsruhe, Germany.	claudia.muhle@kit.edu	Tews, Ivo/A-2750-2010; Muhle-Goll, Claudia/AAM-6070-2021	Tews, Ivo/0000-0002-4704-1139; 	Deutsche Forschungsgemeinschaft [SFB 544]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft SFB 544, project B3 (to L.K.-S.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Alexander PA, 2007, P NATL ACAD SCI USA, V104, P11963, DOI 10.1073/pnas.0700922104; Alphey MS, 2003, J BIOL CHEM, V278, P25919, DOI 10.1074/jbc.M301526200; Aumann KD, 1997, BIOMED ENVIRON SCI, V10, P136; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Brigelius-Flohe R, 2003, BIOFACTORS, V17, P93, DOI 10.1002/biof.5520170110; Brigelius-Flohe R, 2006, BIOL CHEM, V387, P1329, DOI 10.1515/BC.2006.166; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Burley SK, 2002, CURR OPIN STRUC BIOL, V12, P383, DOI 10.1016/S0959-440X(02)00330-5; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; De Vries SJ, 2007, PROTEINS, V69, P726, DOI 10.1002/prot.21723; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Delano W.L., 2002, DELANO SCI; Delaunay A, 2002, CELL, V111, P471, DOI 10.1016/S0092-8674(02)01048-6; Dominguez C, 2003, J AM CHEM SOC, V125, P1731, DOI 10.1021/ja026939x; Eisenmesser EZ, 2002, SCIENCE, V295, P1520, DOI 10.1126/science.1066176; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; EPP O, 1983, EUR J BIOCHEM, V133, P51, DOI 10.1111/j.1432-1033.1983.tb07429.x; Evrard C, 2004, J MOL BIOL, V337, P1079, DOI 10.1016/j.jmb.2004.02.017; FAIRLAMB AH, 1992, ANNU REV MICROBIOL, V46, P695, DOI 10.1146/annurev.micro.46.1.695; Foloppe N, 2007, J MOL BIOL, V372, P798, DOI 10.1016/j.jmb.2007.05.101; Herbette S, 2007, FEBS J, V274, P2163, DOI 10.1111/j.1742-4658.2007.05774.x; Hillebrand H, 2003, J BIOL CHEM, V278, P6809, DOI 10.1074/jbc.M210392200; Hirotsu S, 1999, P NATL ACAD SCI USA, V96, P12333, DOI 10.1073/pnas.96.22.12333; Hofmann B, 2001, BIOL CHEM, V382, P459, DOI 10.1515/BC.2001.056; HUBBARD SJ, 1991, J MOL BIOL, V220, P507, DOI 10.1016/0022-2836(91)90027-4; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; Jung BG, 2002, J BIOL CHEM, V277, P12572, DOI 10.1074/jbc.M110791200; Karplus P. Andrew, 2007, V44, P41; Koh CS, 2007, J MOL BIOL, V370, P512, DOI 10.1016/j.jmb.2007.04.031; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Krauth-Siegel Luise R., 2007, V44, P231; Krauth-Siegel RL, 2005, ANGEW CHEM INT EDIT, V44, P690, DOI 10.1002/anie.200300639; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Linge JP, 2001, METHOD ENZYMOL, V339, P71, DOI 10.1016/S0076-6879(01)39310-2; Ludemann H, 1998, FEBS LETT, V431, P381, DOI 10.1016/S0014-5793(98)00793-5; MAIORINO M, 1995, BIOL CHEM H-S, V376, P651, DOI 10.1515/bchm3.1995.376.11.651; Maiorino M, 2007, J MOL BIOL, V365, P1033, DOI 10.1016/j.jmb.2006.10.033; Melchers J, 2008, BIOMOL NMR ASSIGM, V2, P65, DOI 10.1007/s12104-008-9086-8; Melchers J, 2007, J BIOL CHEM, V282, P8678, DOI 10.1074/jbc.M608140200; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Navrot N, 2006, PLANT PHYSIOL, V142, P1364, DOI 10.1104/pp.106.089458; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; Platt A, 2000, P NATL ACAD SCI USA, V97, P3154, DOI 10.1073/pnas.97.7.3154; Prabhakar R, 2005, BIOCHEMISTRY-US, V44, P11864, DOI 10.1021/bi050815q; Ren B, 1997, J MOL BIOL, V268, P869, DOI 10.1006/jmbi.1997.1005; Scheerer P, 2007, BIOCHEMISTRY-US, V46, P9041, DOI 10.1021/bi700840d; Schlecker T, 2005, J BIOL CHEM, V280, P14385, DOI 10.1074/jbc.M413338200; Schlecker T, 2007, BIOCHEM J, V405, P445, DOI 10.1042/BJ20070259; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; SULLIVAN FX, 1991, MOL BIOCHEM PARASIT, V44, P145, DOI 10.1016/0166-6851(91)90231-T; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Utomo A, 2004, J BIOL CHEM, V279, P43522, DOI 10.1074/jbc.M407141200; WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127; Wilkinson SR, 2003, J BIOL CHEM, V278, P31640, DOI 10.1074/jbc.M303035200; Wood ZA, 2003, TRENDS BIOCHEM SCI, V28, P32, DOI 10.1016/S0968-0004(02)00003-8; YANG YF, 1991, J BIOL CHEM, V266, P12759	57	26	26	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 31	2008	283	44					30401	30411		10.1074/jbc.M803563200	http://dx.doi.org/10.1074/jbc.M803563200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	364WS	18684708	hybrid, Green Published, Green Accepted			2022-12-27	WOS:000260366900083
J	Ruusala, A; Pawson, T; Heldin, CH; Aspenstrom, P				Ruusala, Aino; Pawson, Tony; Heldin, Carl-Henrik; Aspenstrom, Pontus			Nck Adapters Are Involved in the Formation of Dorsal Ruffles, Cell Migration, and Rho Signaling Downstream of the Platelet-derived Growth Factor beta Receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FACTOR-INDUCED CHEMOTAXIS; ACTIN POLYMERIZATION; SURFACE-RECEPTORS; PDGF RECEPTOR; BINDING-SITE; PROTEIN; KINASE; TRANSDUCTION; CYTOSKELETON; FIBROBLASTS	The SH3 and SH2 domain-containing adapter proteins Nck1 and Nck2 are known to function downstream of activated tyrosine kinase receptors, such as the platelet-derived growth factor (PDGF) receptors. The SH2 domain of Nck1 binds to phosphorylated tyrosine residue 751 in PDGF beta receptor and has been suggested to have a role in the PDGF-induced mobilization of the actin filament system. Because Tyr-751 is a site for additional receptor interactors, it has been difficult to discriminate the signaling from Nck from signaling via other molecules. For this reason we have used mouse embryonic fibroblasts derived from mice in which the genes for Nck1 and Nck2 have been inactivated by gene targeting (knock-out (KO) cells). The mutant cells had a reduced ability to form edge ruffles in response to PDGF, and the presence of Nck was obligatory for the formation of dorsal ruffles. In addition, the KO cells had a reduced chemotactic and migratory potential. Importantly, KO cells had reduced cell attachment properties and a reduced ability to form focal adhesions in response to serum stimulation. Moreover, signaling involving the Rho GTPases was defective in KO cells. In summary, our observations suggest that the Nck adapters are needed for signaling to Rho GTPases and actin dynamics downstream of the PDGF beta receptor.	[Ruusala, Aino; Heldin, Carl-Henrik; Aspenstrom, Pontus] Uppsala Univ, Biomed Ctr, Ludwig Inst Canc Res, SE-75124 Uppsala, Sweden; [Pawson, Tony] Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada; [Aspenstrom, Pontus] Karolinska Inst, Dept Microbiol Tumour & Cell Biol, SE-17177 Stockholm, Sweden	Ludwig Institute for Cancer Research; Uppsala University; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; Karolinska Institutet	Aspenstrom, P (corresponding author), Uppsala Univ, Biomed Ctr, Ludwig Inst Canc Res, SE-75124 Uppsala, Sweden.	pontus.aspenstrom@ki.se	Pawson, Tony J/E-4578-2013		Swedish Cancer Society; Swedish Research Council	Swedish Cancer Society(Swedish Cancer Society); Swedish Research Council(Swedish Research CouncilEuropean Commission)	This work was supported in part by grants from the Swedish Cancer Society and the Swedish Research Council.	Aspenstrom P, 2004, BIOCHEM J, V377, P327, DOI 10.1042/BJ20031041; Bladt F, 2003, MOL CELL BIOL, V23, P4586, DOI 10.1128/MCB.23.13.4586-4597.2003; Braverman LE, 1999, J BIOL CHEM, V274, P5542, DOI 10.1074/jbc.274.9.5542; Buday L, 2002, CELL SIGNAL, V14, P723, DOI 10.1016/S0898-6568(02)00027-X; Chen M, 2000, MOL CELL BIOL, V20, P7867, DOI 10.1128/MCB.20.21.7867-7880.2000; CHOU MM, 1992, MOL CELL BIOL, V12, P5834, DOI 10.1128/MCB.12.12.5834; Demoulin JB, 2003, BIOCHEM J, V376, P505, DOI 10.1042/BJ20030385; DENHARTIGH JC, 1992, J CELL BIOL, V119, P349, DOI 10.1083/jcb.119.2.349; Eden S, 2002, NATURE, V418, P790, DOI 10.1038/nature00859; Edlund S, 2002, MOL BIOL CELL, V13, P902, DOI 10.1091/mbc.01-08-0398; Frischknecht F, 1999, NATURE, V401, P926, DOI 10.1038/44860; Garrity PA, 1996, CELL, V85, P639, DOI 10.1016/S0092-8674(00)81231-3; Higaki M, 1996, J BIOL CHEM, V271, P29342, DOI 10.1074/jbc.271.46.29342; Jaffe AB, 2005, ANNU REV CELL DEV BI, V21, P247, DOI 10.1146/annurev.cellbio.21.020604.150721; KASHISHIAN A, 1992, EMBO J, V11, P1373, DOI 10.1002/j.1460-2075.1992.tb05182.x; KAZLAUSKAS A, 1993, P NATL ACAD SCI USA, V90, P6939, DOI 10.1073/pnas.90.15.6939; KAZLAUSKAS A, 1992, MOL CELL BIOL, V12, P2534, DOI 10.1128/MCB.12.6.2534; KAZLAUSKAS A, 1989, CELL, V58, P1121, DOI 10.1016/0092-8674(89)90510-2; Legg JA, 2007, MOL BIOL CELL, V18, P678, DOI 10.1091/mbc.E06-06-0569; LEHMANN JM, 1990, NUCLEIC ACIDS RES, V18, P1048, DOI 10.1093/nar/18.4.1048; LI W, 1992, MOL CELL BIOL, V12, P5824, DOI 10.1128/MCB.12.12.5824; Li W, 2001, ONCOGENE, V20, P6403, DOI 10.1038/sj.onc.1204782; NISHIMURA R, 1993, MOL CELL BIOL, V13, P6889, DOI 10.1128/MCB.13.11.6889; NOBES CD, 1995, J CELL SCI, V108, P225; Orth JD, 2006, CANCER RES, V66, P11094, DOI 10.1158/0008-5472.CAN-06-3397; Rao Y, 2005, INT J BIOL SCI, V1, P80; Rijken PJ, 1998, EXP CELL RES, V243, P254, DOI 10.1006/excr.1998.4142; Rivera GM, 2006, P NATL ACAD SCI USA, V103, P9536, DOI 10.1073/pnas.0603786103; Rivera GM, 2004, CURR BIOL, V14, P11, DOI 10.1016/j.cub.2003.12.033; Rohatgi R, 2001, J BIOL CHEM, V276, P26448, DOI 10.1074/jbc.M103856200; Ronnstrand L, 2001, INT J CANCER, V91, P757, DOI 10.1002/1097-0215(200002)9999:9999<::AID-IJC1136>3.0.CO;2-J; Ronnstrand L, 1999, ONCOGENE, V18, P3696, DOI 10.1038/sj.onc.1202705; RONNSTRAND L, 1992, EMBO J, V11, P3911, DOI 10.1002/j.1460-2075.1992.tb05484.x; Suetsugu S, 2003, DEV CELL, V5, P595, DOI 10.1016/S1534-5807(03)00297-1; Tallquist M, 2004, CYTOKINE GROWTH F R, V15, P205, DOI 10.1016/j.cytogfr.2004.03.003; Wennerberg K, 1996, J CELL BIOL, V132, P227, DOI 10.1083/jcb.132.1.227; WENNSTROM S, 1994, CURR BIOL, V4, P385, DOI 10.1016/S0960-9822(00)00087-7; WENNSTROM S, 1994, ONCOGENE, V9, P651; Wu CY, 1999, J CELL SCI, V112, P4485	39	30	30	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 31	2008	283	44					30034	30044		10.1074/jbc.M800913200	http://dx.doi.org/10.1074/jbc.M800913200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	364WS	18765673	Green Published, hybrid			2022-12-27	WOS:000260366900048
J	Amano, K; Ichida, F; Sugita, A; Hata, K; Wada, M; Takigawa, Y; Nakanishi, M; Kogo, M; Nishimura, R; Yoneda, T				Amano, Katsuhiko; Ichida, Fumitaka; Sugita, Atsushi; Hata, Kenji; Wada, Masahiro; Takigawa, Yoko; Nakanishi, Masako; Kogo, Mikihiko; Nishimura, Riko; Yoneda, Toshiyuki			Msx2 Stimulates Chondrocyte Maturation by Controlling Ihh Expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOCHONDRAL BONE-DEVELOPMENT; INDIAN-HEDGEHOG; CHONDROGENIC DIFFERENTIATION; OSTEOGENIC DIFFERENTIATION; MESENCHYMAL CELLS; IN-VITRO; PROTEIN; GROWTH; ROLES; BINDING	Several studies indicated that a homeobox gene, Msx2, is implicated in regulation of skeletal development by controlling enchondral ossification as well as membranous ossification. However, the molecular basis by which Msx2 conducts chondrogenesis is currently unclear. In this study, we examined the role of Msx2 in chondrocyte differentiation using mouse primary chondrocytes and embryonic metatarsal explants. Treatment with BMP2 up-regulated the expression of Msx2 mRNA along with chondrocyte differentiation in murine primary chondrocytes. Overexpression of wild-type Msx2 stimulated calcification of primary chondrocytes in the presence of BMP2. We also found that constitutively active Msx2(caMsx2) enhanced BMP2 dependent calcification more efficiently than wild- type Msx2. Consistently, caMsx2 overexpression up-regulated the expression of alkaline phosphatase and collagen type X induced by BMP2. Furthermore, organ culture experiments using mouse embryonic metatarsals indicated that caMsx2 clearly stimulated the maturation of chondrocytes into the prehypertrophic and hypertrophic stages in the presence of BMP2. In contrast, knockdown of Msx2 inhibited maturation of primary chondrocytes. The stimulatory effect of Msx2 on chondrocyte maturation was enhanced by overexpression of Smad1 and Smad4 but inhibited by Smad6, an inhibitory Smad for BMP2 signaling. These data suggest that Msx2 requires BMP2/Smad signaling for its chondrogenic action. In addition, caMsx2 overexpression induced Ihh (Indian hedgehog) expression in mouse primary chondrocytes. Importantly, treatment with cyclopamine, a specific inhibitor for hedgehogs, blocked Msx2-induced chondrogenesis. Collectively, our results indicated that Msx2 promotes the maturation of chondrocytes, at least in part, through up-regulating Ihh expression.	[Amano, Katsuhiko; Ichida, Fumitaka; Sugita, Atsushi; Hata, Kenji; Wada, Masahiro; Takigawa, Yoko; Nakanishi, Masako; Nishimura, Riko; Yoneda, Toshiyuki] Osaka Univ, Grad Sch Dent, Dept Mol & Cellular Biol, Suita, Osaka 5650871, Japan; [Amano, Katsuhiko; Kogo, Mikihiko] Osaka Univ, Grad Sch Dent, Dept Oral & Maxillofacial Surg, Suita, Osaka 5650871, Japan; [Sugita, Atsushi] Osaka Univ, Sch Med, Dept Orthoped Surg, Suita, Osaka 5650871, Japan	Osaka University; Osaka University; Osaka University	Nishimura, R (corresponding author), Osaka Univ, Grad Sch Dent, Dept Mol & Cellular Biol, 1-8 Yamadaoka, Suita, Osaka 5650871, Japan.	rikonisi@dent.osaka-u.ac.jp	Kogo, Mikihiko/ABD-7080-2020	Kogo, Mikihiko/0000-0002-4556-2491; Nishimura, Riko/0000-0001-7279-8363	Ministry of Education, Science, Sports, Japan; Naito Foundation	Ministry of Education, Science, Sports, Japan; Naito Foundation(Naito Memorial Foundation)	This work was supported by the Ministry of Education, Science, Sports, Japan, a culture grant-in-aid for scientific research, the Naito Foundation, and the Novartis Foundation. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Akiyama H, 2004, GENE DEV, V18, P1072, DOI 10.1101/gad.1171104; Carlberg AL, 2001, DIFFERENTIATION, V67, P128, DOI 10.1046/j.1432-0436.2001.670405.x; Cheng SL, 2003, J BIOL CHEM, V278, P45969, DOI 10.1074/jbc.M306972200; Chuang PT, 1999, NATURE, V397, P617, DOI 10.1038/17611; Enomoto-Iwamoto M, 2000, J BONE MINER RES, V15, P1659, DOI 10.1359/jbmr.2000.15.9.1659; Gao B, 2001, NAT GENET, V28, P386, DOI 10.1038/ng577; Gartland A, 2005, BONE, V37, P530, DOI 10.1016/j.bone.2005.04.034; Haaijman A, 1997, J BONE MINER RES, V12, P1815, DOI 10.1359/jbmr.1997.12.11.1815; Hata K, 2003, MOL BIOL CELL, V14, P545, DOI 10.1091/mbc.E02-06-0356; Hellemans J, 2003, AM J HUM GENET, V72, P1040, DOI 10.1086/374318; Ichida F, 2004, J BIOL CHEM, V279, P34015, DOI 10.1074/jbc.M403621200; Imamura T, 1997, NATURE, V389, P622, DOI 10.1038/39355; Kobayashi T, 2005, J CLIN INVEST, V115, P1734, DOI 10.1172/JCI24397; Kobayashi T, 2005, ENDOCRINOLOGY, V146, P1012, DOI 10.1210/en.2004-1343; Lai LP, 2005, J CELL BIOCHEM, V96, P1163, DOI 10.1002/jcb.20635; Lanske B, 1996, SCIENCE, V273, P663, DOI 10.1126/science.273.5275.663; LIU YH, 1995, P NATL ACAD SCI USA, V92, P6137, DOI 10.1073/pnas.92.13.6137; Ma L, 1996, HUM MOL GENET, V5, P1915, DOI 10.1093/hmg/5.12.1915; Nifuji A, 2004, ENDOCRINOLOGY, V145, P3434, DOI 10.1210/en.2003-0685; Nishimura R, 2002, BONE, V31, P303, DOI 10.1016/S8756-3282(02)00826-8; Provot S, 2005, BIOCHEM BIOPH RES CO, V328, P658, DOI 10.1016/j.bbrc.2004.11.068; Ryoo HM, 2006, GENE, V366, P51, DOI 10.1016/j.gene.2005.10.011; Satokata I, 2000, NAT GENET, V24, P391, DOI 10.1038/74231; Seki K, 2004, J BIOL CHEM, V279, P18544, DOI 10.1074/jbc.M311592200; Semba I, 2000, DEV DYNAM, V217, P401, DOI 10.1002/(SICI)1097-0177(200004)217:4<401::AID-DVDY7>3.0.CO;2-D; Shea CM, 2003, J CELL BIOCHEM, V90, P1112, DOI 10.1002/jcb.10734; Shimoyama A, 2007, MOL BIOL CELL, V18, P2411, DOI 10.1091/mbc.E06-08-0743; Shum L, 2002, ARTHRITIS RES, V4, P94, DOI 10.1186/ar396; St-Jacques B, 1999, GENE DEV, V13, P2072, DOI 10.1101/gad.13.16.2072; Takahashi K, 2001, DEV DYNAM, V222, P252, DOI 10.1002/dvdy.1185; Vortkamp A, 1996, SCIENCE, V273, P613, DOI 10.1126/science.273.5275.613; Wilkie AOM, 2000, NAT GENET, V24, P387, DOI 10.1038/74224; Yasoda A, 1998, J BIOL CHEM, V273, P11695, DOI 10.1074/jbc.273.19.11695; Yoshida CA, 2004, GENE DEV, V18, P952, DOI 10.1101/gad.1174704	34	29	29	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 24	2008	283	43					29513	29521		10.1074/jbc.M803681200	http://dx.doi.org/10.1074/jbc.M803681200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	362EB	18682398	Green Published, hybrid			2022-12-27	WOS:000260179900077
J	Benesch, JLP; Ayoub, M; Robinson, CV; Aquilina, JA				Benesch, Justin L. P.; Ayoub, Marina; Robinson, Carol V.; Aquilina, J. Andrew			Small heat shock protein activity is regulated by variable oligomeric substructure	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALPHA-B-CRYSTALLIN; MASS-SPECTROMETRY REVEALS; DESMIN-RELATED MYOPATHY; A-CRYSTALLIN; CHAPERONE ACTIVITY; MUTATION; PHOSPHORYLATION; DEAMIDATION	The alpha-crystallins are members of the small heat shock protein family of molecular chaperones that have evolved to minimize intracellular protein aggregation; however, they are also implicated in a number of protein deposition diseases. In this study, we employed novel mass spectrometry techniques to investigate the changes in quaternary structure associated with this switch from chaperone to adjuvant of aggregation. We replicated the oligomeric rearrangements observed for post-translationally modified alpha-crystallins, without altering the protein sequence, by refolding the alpha-crystallins in vitro. This refolding resulted in a loss of dimeric substructure concomitant with an augmentation of substrate affinity. We show that packaging of small heat shock proteins into dimeric units is used to control the level of chaperone function by regulating the exposure of hydrophobic surfaces. We propose that a bias toward monomeric substructure is responsible for the aberrant chaperone behavior associated with the alpha-crystallins in protein deposition diseases.	[Benesch, Justin L. P.; Robinson, Carol V.] Univ Cambridge, Dept Chem, Cambridge CB2 1EW, England; [Ayoub, Marina; Aquilina, J. Andrew] Univ Wollongong, Sch Biol Sci, Wollongong, NSW 2522, Australia	University of Cambridge; University of Wollongong		aquilina@uow.edu.au	Aquilina, J. Andrew/A-5366-2013; Aquilina, John Andrew/AGF-4013-2022	Benesch, Justin/0000-0002-1507-3742; robinson, carol/0000-0001-7829-5505	Engineering and Physical Sciences Research Council; Biotechnology and Biological Sciences Research Council	Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	Supported by the Engineering and Physical Sciences Research Council and the Biotechnology and Biological Sciences Research Council.	Aquilina JA, 2005, J BIOL CHEM, V280, P14485, DOI 10.1074/jbc.M500135200; Aquilina JA, 2004, J BIOL CHEM, V279, P28675, DOI 10.1074/jbc.M403348200; Aquilina JA, 2003, P NATL ACAD SCI USA, V100, P10611, DOI 10.1073/pnas.1932958100; Aquilina JA, 2001, BIOCHEM BIOPH RES CO, V285, P1107, DOI 10.1006/bbrc.2001.5288; Benesch JLP, 2006, CHEM BIOL, V13, P597, DOI 10.1016/j.chembiol.2006.04.006; Bova MP, 1999, P NATL ACAD SCI USA, V96, P6137, DOI 10.1073/pnas.96.11.6137; Brady JP, 1997, P NATL ACAD SCI USA, V94, P884, DOI 10.1073/pnas.94.3.884; Claxton DP, 2008, J MOL BIOL, V375, P1026, DOI 10.1016/j.jmb.2007.11.014; Ecroyd H, 2007, BIOCHEM J, V401, P129, DOI 10.1042/BJ20060981; Gupta R, 2004, J BIOL CHEM, V279, P44258, DOI 10.1074/jbc.M405648200; Gupta R, 2004, INVEST OPHTH VIS SCI, V45, P206, DOI 10.1167/iovs.03-0720; Haslbeck M, 2005, NAT STRUCT MOL BIOL, V12, P842, DOI 10.1038/nsmb993; Horwitz J, 2003, EXP EYE RES, V76, P145, DOI 10.1016/S0014-4835(02)00278-6; Horwitz J, 1998, METHOD ENZYMOL, V290, P365, DOI 10.1016/S0076-6879(98)90032-5; Kappe G, 2003, CELL STRESS CHAPERON, V8, P53, DOI 10.1379/1466-1268(2003)8<53:THGECS>2.0.CO;2; Narberhaus F, 2002, MICROBIOL MOL BIOL R, V66, P64, DOI 10.1128/MMBR.66.1.64-93.2002; Rajasekaran NS, 2007, CELL, V130, P427, DOI 10.1016/j.cell.2007.06.044; Robinson CV, 2007, NATURE, V450, P973, DOI 10.1038/nature06523; Saha S, 2007, PROTEIN J, V26, P315, DOI 10.1007/s10930-007-9074-3; Sun Y, 2005, FEBS J, V272, P2613, DOI 10.1111/j.1742-4658.2005.04708.x; Van Montfort R, 2002, ADV PROTEIN CHEM, V59, P105; Vicart P, 1998, NAT GENET, V20, P92, DOI 10.1038/1765	22	83	85	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 17	2008	283	42					28513	28517		10.1074/jbc.M804729200	http://dx.doi.org/10.1074/jbc.M804729200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	359EN	18713743	Green Published, hybrid, Green Submitted			2022-12-27	WOS:000259969300054
J	Biliran, H; Jan, YW; Chen, RW; Pasquale, EB; Ruoslahti, E				Biliran, Hector; Jan, Yiwen; Chen, Renwei; Pasquale, Elena B.; Ruoslahti, Erkki			Protein kinase D is a positive regulator of Bit1 apoptotic function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHORYLATION SITES; SIGNALING PATHWAYS; WIDE PREDICTION; ACTIVATION; ANOIKIS; IDENTIFICATION; INTEGRINS; SURVIVAL; ADHESION	Bit1 (Bcl-2 inhibitor of transcription) is a mitochondrial protein that induces caspase-independent apoptosis upon its release into the cytoplasm. Bit1 is primarily associated with anoikis (cell death induced by detachment from the extracellular matrix), because the apoptotic function of Bit1 is inhibited by integrin-mediated cell attachment but not by many other antiapoptotic treatments. Here, we show that protein kinase D (PKD) regulates Bit1 apoptotic function. Overexpression of constitutively active PKD or PKD activation by treatment with phorbol 12-myristate 13-acetate results in phosphorylation of two serine residues (Ser(5) and Ser(87)) in a form of Bit1 that is confined to the cytoplasm and concomitantly increases the apoptotic activity of cytoplasmic Bit1. Conversely, suppressing PKD activity with pharmacological inhibitors or small interfering RNA approaches attenuates apoptosis induced by cytoplasmic Bit1. Furthermore, PKD regulates induction of cell death by wild-type Bit1 following loss of cell attachment to the extracellular matrix. Activation of PKD enhances Bit1 function in anoikis, whereas inhibiting PKD function with pharmacological inhibitors or small interfering RNA compromises the ability of Bit1 to induce anoikis. The induction of Bit1-mediated apoptosis by PKD is in part attributable to the release of Bit1 from mitochondria to the cytoplasm as a consequence of phosphorylation of Ser5 in the mitochondrial localization sequence of Bit1. Consistent with the regulatory role of PKD in the anoikis function of Bit1, we found that cell attachment to fibronectin inhibits PKD activity. These studies identify the PKD serine/threonine kinase as one of the signaling molecules through which integrin-mediated cell attachment controls Bit1 activity and anoikis.	[Ruoslahti, Erkki] Univ Calif Santa Barbara, MCDB, Burnham Inst Med Res, Santa Barbara, CA 93106 USA; [Jan, Yiwen; Pasquale, Elena B.; Ruoslahti, Erkki] Burnham Inst Med Res, La Jolla, CA 92037 USA	Sanford Burnham Prebys Medical Discovery Institute; University of California System; University of California Santa Barbara; Sanford Burnham Prebys Medical Discovery Institute	Ruoslahti, E (corresponding author), Univ Calif Santa Barbara, MCDB, Burnham Inst Med Res, 3119 Biol 2 Bldg, Santa Barbara, CA 93106 USA.	ruoslahti@burnham.org	Chen, Renwei/I-7557-2013		National Institutes of Health; NCI [CA102583, CA098162]; NATIONAL CANCER INSTITUTE [R01CA098162, P01CA102583] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health, NCI, Grants CA102583 and CA098162. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Bouchentouf M, 2007, AM J TRANSPLANT, V7, P1491, DOI 10.1111/j.1600-6143.2007.01830.x; Claros MG, 1996, EUR J BIOCHEM, V241, P779, DOI 10.1111/j.1432-1033.1996.00779.x; de Pereda JM, 2004, J BIOL CHEM, V279, P8111, DOI 10.1074/jbc.M311449200; England K, 2001, J BIOL CHEM, V276, P10437, DOI 10.1074/jbc.M009421200; Frisch SM, 1996, J CELL BIOL, V134, P793, DOI 10.1083/jcb.134.3.793; Frisch SM, 1997, CURR OPIN CELL BIOL, V9, P701, DOI 10.1016/S0955-0674(97)80124-X; Iglesias T, 1998, J BIOL CHEM, V273, P27662, DOI 10.1074/jbc.273.42.27662; Ivaska J, 2003, BIOCHEM SOC T, V31, P90, DOI 10.1042/bst0310090; Jamora C, 1999, CELL, V98, P59, DOI 10.1016/S0092-8674(00)80606-6; Jan YW, 2004, CELL, V116, P751, DOI 10.1016/S0092-8674(04)00204-1; Kairouz-Wahbe R, 2008, P NATL ACAD SCI USA, V105, P1528, DOI 10.1073/pnas.0711357105; Khwaja A, 1997, EMBO J, V16, P2783, DOI 10.1093/emboj/16.10.2783; Lemonnier J, 2004, J BIOL CHEM, V279, P259, DOI 10.1074/jbc.M308665200; Obenauer JC, 2003, NUCLEIC ACIDS RES, V31, P3635, DOI 10.1093/nar/gkg584; Okuda H, 1999, ONCOGENE, V18, P5604, DOI 10.1038/sj.onc.1202946; ROSENGURT E, 1984, P NATL ACAD SCI USA, V81, P5748; Schwartz MA, 2001, TRENDS CELL BIOL, V11, P466, DOI 10.1016/S0962-8924(01)02152-3; Storz P, 2004, MOL CELL BIOL, V24, P2614, DOI 10.1128/MCB.24.7.2614-2626.2004; Vega RB, 2004, MOL CELL BIOL, V24, P8374, DOI 10.1128/MCB.24.19.8374-8385.2004; Vertommen D, 2000, J BIOL CHEM, V275, P19567, DOI 10.1074/jbc.M001357200; Yaffe MB, 2001, NAT BIOTECHNOL, V19, P348, DOI 10.1038/86737	21	28	30	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 17	2008	283	42					28029	28037		10.1074/jbc.M803139200	http://dx.doi.org/10.1074/jbc.M803139200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	359EN	18703509	Green Published, hybrid			2022-12-27	WOS:000259969300004
J	Lewarchik, CM; Peters, KW; Qi, JJ; Frizzell, RA				Lewarchik, Christopher M.; Peters, Kathryn W.; Qi, Juanjuan; Frizzell, Raymond A.			Regulation of CFTR trafficking by its R domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSMEMBRANE CONDUCTANCE REGULATOR; CYSTIC-FIBROSIS GENE; CHLORIDE CHANNEL; PLASMA-MEMBRANE; XENOPUS-OOCYTES; EPITHELIAL-CELLS; SODIUM-CHANNEL; CL-CHANNELS; G-PROTEINS; HALF-LIFE	Phosphorylation of the R domain is required for cystic fibrosis transmembrane conductance regulator (CFTR) channel gating, and cAMP/protein kinase A (PKA) simulation can also elicit insertion of CFTR into the plasma membrane from intracellular compartments (Bertrand, C. A., and Frizzell, R. A. (2003) Am. J. Physiol. 285, C1-C18). We evaluated the structural basis of regulated CFTR trafficking by determining agonist-evoked increases in plasma membrane capacitance ( Cm) of Xenopus oocytes expressing CFTR deletion mutants. Expression of CFTR as a split construct that omitted the R domain (Delta amino acids 635-834) produced a channel with elevated basal current (I-m) and no Delta I-m or trafficking response (Delta C-m) upon cAMP/PKA stimulation, indicating that the structure(s) required for regulated CFTR trafficking are contained within the R domain. Additional deletions showed that removal of amino acids 817 838, a 22-amino acid conserved helical region having a net charge of -9, termed NEG2 (Xie, J., Adams, L. M., Zhao, J., Gerken, T. A., Davis, P. B., and Ma, J. ( 2002) J. Biol. Chem. 277, 23019-23027), produced a channel with regulated gating that lacked the agonist-induced increase in CFTR trafficking. Injection of NEG2 peptides into oocytes expressing split Delta NEG2 CFTR prior to stimulation restored the agonist-evoked Delta C-m, consistent with the concept that this sequence mediates the regulated trafficking event. In support of this idea, Delta NEG2 CFTR escaped from the inhibition of wild type CFTR trafficking produced by overexpression of syntaxin 1A. These observations suggest that the NEG2 region at the C terminus of the R domain allows stabilization of CFTR in a regulated intracellular compartment from which it traffics to the plasma membrane in response to cAMP/PKA stimulation.	[Lewarchik, Christopher M.; Peters, Kathryn W.; Qi, Juanjuan; Frizzell, Raymond A.] Univ Pittsburgh, Sch Med, Dept Cell Biol & Physiol, Pittsburgh, PA 15261 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Frizzell, RA (corresponding author), Univ Pittsburgh, Sch Med, Dept Cell Biol & Physiol, S368 BST,3500 Terrace St, Pittsburgh, PA 15261 USA.	frizzell@pitt.edu			National Institutes of Health [DK68196, DK72506]; Cystic Fibrosis Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK072506, R01DK068196] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cystic Fibrosis Foundation(Italian Cystic Fibrosis Research Foundation); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK68196 and DK72506. This work was also supported by the Cystic Fibrosis Foundation. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Ameen NA, 2003, AM J PHYSIOL-CELL PH, V284, pC429, DOI 10.1152/ajpcell.00261.2002; ANDERSON MP, 1991, CELL, V67, P775, DOI 10.1016/0092-8674(91)90072-7; Baker JMR, 2007, NAT STRUCT MOL BIOL, V14, P738, DOI 10.1038/nsmb1278; Baldursson O, 2001, J BIOL CHEM, V276, P1904, DOI 10.1074/jbc.M006934200; Bertrand CA, 2003, AM J PHYSIOL-CELL PH, V285, pC1, DOI 10.1152/ajpcell.00554.2002; BRADBURY NA, 1992, SCIENCE, V256, P530, DOI 10.1126/science.1373908; Butterworth MB, 2005, J GEN PHYSIOL, V125, P81, DOI 10.1085/jgp.2004.09124; Chambers LA, 2007, RESP PHYSIOL NEUROBI, V159, P256, DOI 10.1016/j.resp.2007.06.005; CHANG XB, 1993, J BIOL CHEM, V268, P11304; Chappe V, 2005, EMBO J, V24, P2730, DOI 10.1038/sj.emboj.7600747; CHENG SH, 1991, CELL, V66, P1027, DOI 10.1016/0092-8674(91)90446-6; Condliffe SB, 2004, J BIOL CHEM, V279, P10085, DOI 10.1074/jbc.M313592200; Condliffe SB, 2003, J BIOL CHEM, V278, P12796, DOI 10.1074/jbc.M210772200; Csanady L, 2000, J GEN PHYSIOL, V116, P477, DOI 10.1085/jgp.116.3.477; CUNNINGHAM SA, 1992, AM J PHYSIOL, V262, pC783, DOI 10.1152/ajpcell.1992.262.3.C783; Devidas S, 1998, J BIOL CHEM, V273, P29373, DOI 10.1074/jbc.273.45.29373; Dubel SJ, 2004, J BIOL CHEM, V279, P29263, DOI 10.1074/jbc.M313450200; Firsov D, 1999, J BIOL CHEM, V274, P2743, DOI 10.1074/jbc.274.5.2743; Gadsby David C., 1999, Physiological Reviews, V79, pS77; Gentzsch M, 2004, MOL BIOL CELL, V15, P2684, DOI 10.1091/mbc.E04-03-0176; GOLDIN AL, 1991, METHOD CELL BIOL, V36, P487; Heda GD, 2001, AM J PHYSIOL-CELL PH, V280, pC166, DOI 10.1152/ajpcell.2001.280.1.C166; HIGGINS CF, 1992, ANNU REV CELL BIOL, V8, P67, DOI 10.1146/annurev.cb.08.110192.000435; Jones HM, 2004, J BIOL CHEM, V279, P15531, DOI 10.1074/jbc.M400069200; Lang JC, 1997, EMBO J, V16, P5837, DOI 10.1093/emboj/16.19.5837; Lehrich RW, 1998, J CLIN INVEST, V101, P737, DOI 10.1172/JCI803; Liu XH, 2001, J GEN PHYSIOL, V118, P433, DOI 10.1085/jgp.118.4.433; Lukacs GL, 1997, BIOCHEM J, V328, P353; LUKACS GL, 1993, J BIOL CHEM, V268, P21592; Luo JX, 1998, AM J PHYSIOL-CELL PH, V274, pC1397, DOI 10.1152/ajpcell.1998.274.5.C1397; Ma D, 2002, NEURON, V33, P715, DOI 10.1016/S0896-6273(02)00614-1; Ma JJ, 2000, NEWS PHYSIOL SCI, V15, P154; Ma JJ, 1997, J BIOL CHEM, V272, P28133, DOI 10.1074/jbc.272.44.28133; Naren AP, 1999, SCIENCE, V286, P544, DOI 10.1126/science.286.5439.544; Naren AP, 1998, P NATL ACAD SCI USA, V95, P10972, DOI 10.1073/pnas.95.18.10972; Naren AP, 1997, NATURE, V390, P302, DOI 10.1038/36882; Ostedgaard LS, 2000, P NATL ACAD SCI USA, V97, P5657, DOI 10.1073/pnas.100588797; Peters KW, 1999, AM J PHYSIOL-CELL PH, V277, pC174, DOI 10.1152/ajpcell.1999.277.1.C174; Pilewski Joseph M., 1999, Physiological Reviews, V79, pS215; Prince LS, 1999, J BIOL CHEM, V274, P3602, DOI 10.1074/jbc.274.6.3602; PRINCE LS, 1994, P NATL ACAD SCI USA, V91, P5192, DOI 10.1073/pnas.91.11.5192; RICH DP, 1991, SCIENCE, V253, P205, DOI 10.1126/science.1712985; RICH DP, 1993, RECEPTOR CHANNEL, V1, P221; RIORDAN JR, 1989, SCIENCE, V245, P1066; SARGEANT RJ, 1993, BIOCHEM J, V290, P913, DOI 10.1042/bj2900913; Schillers H, 2001, J MEMBRANE BIOL, V180, P205, DOI 10.1007/s002320010071; Schultz BD, 1999, J MEMBRANE BIOL, V170, P51, DOI 10.1007/s002329900537; SCHWIEBERT EM, 1994, AM J PHYSIOL, V267, pC272, DOI 10.1152/ajpcell.1994.267.1.C272; Sharma M, 2001, J BIOL CHEM, V276, P8942, DOI 10.1074/jbc.M009172200; Shimkets RA, 1997, J BIOL CHEM, V272, P25537, DOI 10.1074/jbc.272.41.25537; Silvis MR, 2003, J BIOL CHEM, V278, P11554, DOI 10.1074/jbc.M212843200; Smith PC, 2002, MOL CELL, V10, P139, DOI 10.1016/S1097-2765(02)00576-2; Swiatecka-Urban A, 2005, J BIOL CHEM, V280, P36762, DOI 10.1074/jbc.M508944200; TABCHARANI JA, 1991, NATURE, V352, P628, DOI 10.1038/352628a0; Takahashi A, 1996, AM J PHYSIOL-CELL PH, V271, pC1887, DOI 10.1152/ajpcell.1996.271.6.C1887; UEZONO Y, 1993, RECEPTOR CHANNEL, V1, P233; Vergani P, 2005, NATURE, V433, P876, DOI 10.1038/nature03313; Weber WM, 1999, PFLUG ARCH EUR J PHY, V438, P561, DOI 10.1007/s004240051076; Winter MC, 1997, NATURE, V389, P294, DOI 10.1038/38514; Xie JX, 2002, J BIOL CHEM, V277, P23019, DOI 10.1074/jbc.M201661200	60	16	17	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 17	2008	283	42					28401	28412		10.1074/jbc.M800516200	http://dx.doi.org/10.1074/jbc.M800516200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	359EN	18694937	Green Published, hybrid			2022-12-27	WOS:000259969300042
J	Liu, DL; Fritz, DT; Rogers, MB; Shatkin, AJ				Liu, Donglin; Fritz, David T.; Rogers, Melissa B.; Shatkin, Aaron J.			Species-specific cis-regulatory elements in the 3 '-untranslated region direct alternative polyadenylation of bone morphogenetic protein 2 mRNA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENE-EXPRESSION; CANDIDATE GENES; BMP2; TRANSCRIPTION; MECHANISM; MOUSE; CELLS; POLYMORPHISM; REPRESSION; GROWTH	BMP2 (bone morphogenetic protein 2) is a multifunctional member of the transforming growth factor-beta family of growth factors. Disruption of BMP2 signaling results in developmental defects, cancers, and other diseases. BMP2 mRNAs are alternatively polyadenylated, resulting in mRNAs with distinct 3'-untranslated regions. The longer mRNA contains additional putative binding sites for post-transcriptional regulatory factors, including micro-RNAs. We combined functional assays with computational analyses of emerging genome data to define site- and species-specific polyadenylation determinants. In all mouse and human cell lines tested, shorter mRNAs resulting from using the first polyadenylation signal (PA1) were more abundant than mRNAs from the second signal (PA2). However, the PA1/PA2 usage ratios were 2-3-fold higher in human than in mouse cells. Expression of human BMP2 constructs in mouse cells and mouse constructs in human cells showed that cis-regulatory elements direct species-specific 3' processing of BMP2 transcripts. A 72-nucleotide region downstream of PA2 in the mouse sequence contains two novel cis-acting elements previously hypothesized to regulate polyadenylation in a bioinformatics analysis. Mutations that humanized the mouse-specific elements lowered the affinity for cleavage stimulation factor CstF64 and significantly weakened the PA2 signal relative to the PA1 signal. Thus, we have experimentally defined for the first time cis-regulatory elements that control a species-specific difference in the 3'-end processing of BMP2 and potentially of other genes.	[Liu, Donglin; Shatkin, Aaron J.] Rutgers State Univ, Ctr Adv Biotechnol & Med, Piscataway, NJ 08854 USA; [Fritz, David T.; Rogers, Melissa B.] Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Biochem & Mol Biol, Newark, NJ 07101 USA	Rutgers State University New Brunswick; Rutgers State University New Brunswick; Rutgers State University Medical Center	Shatkin, AJ (corresponding author), Rutgers State Univ, Ctr Adv Biotechnol & Med, 679 Hoes Ln, Piscataway, NJ 08854 USA.	shatkin@cabm.rutgers.edu			New Jersey Commission on Cancer Research [05-2413-CCR-EO]; Foundation of UMDNJ; Center for Advanced Biotechnology and Medicine	New Jersey Commission on Cancer Research; Foundation of UMDNJ; Center for Advanced Biotechnology and Medicine	This work was supported by New Jersey Commission on Cancer Research Postdoctoral Fellowship 05-2413-CCR-EO (to D. L.), by a grant from the Foundation of UMDNJ (to M. B. R.), and by the Center for Advanced Biotechnology and Medicine. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	Abrams KL, 2004, J BIOL CHEM, V279, P15916, DOI 10.1074/jbc.M313531200; Canadillas JMP, 2003, EMBO J, V22, P2821, DOI 10.1093/emboj/cdg259; Chen D, 2004, FRONT BIOSCI-LANDMRK, V9, P349, DOI 10.2741/1090; Chen D, 2004, GROWTH FACTORS, V22, P233, DOI 10.1080/08977190412331279890; Cheng YM, 2006, BIOINFORMATICS, V22, P2320, DOI 10.1093/bioinformatics/btl394; Colgan DF, 1997, GENE DEV, V11, P2755, DOI 10.1101/gad.11.21.2755; Conne B, 2000, NAT MED, V6, P637, DOI 10.1038/76211; Edmonds M, 2002, PROG NUCLEIC ACID RE, V71, P285, DOI 10.1016/S0079-6603(02)71046-5; EdwaldsGilbert G, 1997, NUCLEIC ACIDS RES, V25, P2547, DOI 10.1093/nar/25.13.2547; Farh KKH, 2005, SCIENCE, V310, P1817, DOI 10.1126/science.1121158; FENG JQ, 1994, BBA-GENE STRUCT EXPR, V1218, P221, DOI 10.1016/0167-4781(94)90017-5; Fritz DT, 2006, MOL ENDOCRINOL, V20, P1574, DOI 10.1210/me.2005-0469; Fritz DT, 2004, J BIOL CHEM, V279, P48950, DOI 10.1074/jbc.M409620200; Fukui N, 2006, J BIOL CHEM, V281, P27229, DOI 10.1074/jbc.M603385200; Gilmartin GM, 2005, GENE DEV, V19, P2517, DOI 10.1101/gad.1378105; Grzybowska EA, 2001, BIOCHEM BIOPH RES CO, V288, P291, DOI 10.1006/bbrc.2001.5738; Hallahan AR, 2003, NAT MED, V9, P1033, DOI 10.1038/nm904; Hardwick JCH, 2004, GASTROENTEROLOGY, V126, P111, DOI 10.1053/j.gastro.2003.10.067; Heller LC, 1999, J BIOL CHEM, V274, P1394, DOI 10.1074/jbc.274.3.1394; Hillier LW, 2004, NATURE, V432, P695, DOI 10.1038/nature03154; Hogan BLM, 1996, GENE DEV, V10, P1580, DOI 10.1101/gad.10.13.1580; Horvath LG, 2004, PROSTATE, V59, P234, DOI 10.1002/pros.10361; Hu J, 2005, RNA, V11, P1485, DOI 10.1261/rna.2107305; Keene JD, 2002, MOL CELL, V9, P1161, DOI 10.1016/S1097-2765(02)00559-2; Langenfeld EM, 2003, CARCINOGENESIS, V24, P1445, DOI 10.1093/carcin/bgg100; McGregor AP, 2007, NATURE, V448, P587, DOI 10.1038/nature05988; Natalizio BJ, 2002, J BIOL CHEM, V277, P42733, DOI 10.1074/jbc.M208070200; Pennisi E, 2004, SCIENCE, V306, P632, DOI 10.1126/science.306.5696.632; Pillai RS, 2007, TRENDS CELL BIOL, V17, P118, DOI 10.1016/j.tcb.2006.12.007; Proudfoot N, 1996, CELL, V87, P779, DOI 10.1016/S0092-8674(00)81982-0; Proudfoot N, 2000, TRENDS BIOCHEM SCI, V25, P290, DOI 10.1016/S0968-0004(00)01591-7; REDDY BM, 2001, INT J HUM GENET, V1, P1; Reinholz MM, 2002, BREAST CANCER RES TR, V74, P255, DOI 10.1023/A:1016339120506; Riley EH, 1996, CLIN ORTHOP RELAT R, P39, DOI 10.1097/00003086-199603000-00006; SAMPATH TK, 1993, P NATL ACAD SCI USA, V90, P6004, DOI 10.1073/pnas.90.13.6004; Shimasaki S, 2004, ENDOCR REV, V25, P72, DOI 10.1210/er.2003-0007; Tian B, 2005, NUCLEIC ACIDS RES, V33, P201, DOI 10.1093/nar/gki158; URIST MR, 1965, SCIENCE, V150, P893, DOI 10.1126/science.150.3698.893; Valdes AM, 2006, ARTHRITIS RHEUM-US, V54, P533, DOI 10.1002/art.21621; Wahle E, 1997, PROG NUCLEIC ACID RE, V57, P41, DOI 10.1016/S0079-6603(08)60277-9; Wahle E, 1999, FEMS MICROBIOL REV, V23, P277, DOI 10.1016/S0168-6445(99)00008-X; Weiner AM, 2005, MOL CELL, V20, P168, DOI 10.1016/j.molcel.2005.10.009; Wittrant Y, 2006, INT J ONCOL, V28, P261; WOZNEY JM, 1988, SCIENCE, V242, P1528, DOI 10.1126/science.3201241; Xiong DH, 2006, J BONE MINER RES, V21, P1678, DOI 10.1359/JBMR.060808; Xu JW, 2007, GENE, V392, P221, DOI 10.1016/j.gene.2006.12.032; Yan J, 2005, GENOME RES, V15, P369, DOI 10.1101/gr.3109605; Yoshio TD, 1997, MOL CELL BIOL, V17, P3907, DOI 10.1128/MCB.17.7.3907; Zhang HB, 1996, DEVELOPMENT, V122, P2977; Zhao J, 1999, MICROBIOL MOL BIOL R, V63, P405, DOI 10.1128/MMBR.63.2.405-445.1999	50	12	13	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 17	2008	283	42					28010	28019		10.1074/jbc.M804895200	http://dx.doi.org/10.1074/jbc.M804895200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	359EN	18703506	Green Published, hybrid			2022-12-27	WOS:000259969300002
J	Pedro-Segura, E; Vergara, SV; Rodriguez-Navarro, S; Parker, R; Thiele, DJ; Puig, S				Pedro-Segura, Elisa; Vergara, Sandra V.; Rodriguez-Navarro, Susana; Parker, Roy; Thiele, Dennis J.; Puig, Sergi			The Cth2 ARE-binding protein recruits the Dhh1 helicase to promote the decay of succinate dehydrogenase SDH4 mRNA in response to iron deficiency	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ZINC-FINGER PROTEINS; AU-RICH ELEMENTS; SACCHAROMYCES-CEREVISIAE; PROCESSING BODIES; P-BODIES; GENE-EXPRESSION; YEAST; HOMEOSTASIS; TRISTETRAPROLIN; DEGRADATION	Iron is an essential nutrient that participates as a redox cofactor in a broad range of cellular processes. In response to iron deficiency, the budding yeast Saccharomyces cerevisiae induces the expression of the Cth1 and Cth2 mRNA-binding proteins to promote a genome-wide remodeling of cellular metabolism that contributes to the optimal utilization of iron. Cth1 and Cth2 proteins bind to specific AU-rich elements within the 3'-untranslated region of many mRNAs encoding proteins involved in iron-dependent pathways, thereby promoting their degradation. Here, we show that the DEAD box Dhh1 helicase plays a crucial role in the mechanism of Cth2-mediated mRNA turnover. Yeast two-hybrid experiments indicate that Cth2 protein interacts in vivo with the carboxyl-terminal domain of Dhh1. We demonstrate that the degradation of succinate dehydrogenase SDH4 mRNA, a known target of Cth2 on iron-deficient conditions, depends on Dhh1. In addition, we localize the Cth2 protein to cytoplasmic processing bodies in strains defective in the 5' to 3' mRNA decay pathway. Finally, the degradation of trapped SDH4 mRNA intermediates by Cth2 supports the 5' to 3' directionality of mRNA turnover. Taken together, these results suggest that Cth2 protein recruits the Dhh1 helicase to ARE-containing mRNAs to promote mRNA decay.	[Pedro-Segura, Elisa; Puig, Sergi] Univ Valencia, Dept Bioquim & Biol Mol, E-46100 Valencia, Spain; [Vergara, Sandra V.; Thiele, Dennis J.] Duke Univ, Dept Pharmacol & Canc Biol, Med Ctr, Durham, NC 27710 USA; [Rodriguez-Navarro, Susana] Ctr Invest Principe Felipe, E-46013 Valencia, Spain; [Parker, Roy] Univ Arizona, Dept Mol & Cellular Biol, Tucson, AZ 85721 USA; [Parker, Roy] Univ Arizona, Howard Hughes Med Inst, Tucson, AZ 85721 USA	University of Valencia; Duke University; Prince Felipe Research Center; University of Arizona; Howard Hughes Medical Institute; University of Arizona	Pedro-Segura, E (corresponding author), Univ Valencia, Dept Bioquim & Biol Mol, E-46100 Valencia, Spain.	sergi.puig@uv.es	Rodríguez-Navarro, Susana/B-5182-2014; Puig, Sergi/E-4788-2010	Rodríguez-Navarro, Susana/0000-0001-7472-3111; Puig, Sergi/0000-0002-1856-490X	National Institutes of Health [GM041840, FDK081304A]; Spanish Ministerio de Educacion y Ciencia [BIO2005-07120]; Generalitat Valenciana Grant [GV05-081]; European Community; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM041840] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Spanish Ministerio de Educacion y Ciencia(Spanish Government); Generalitat Valenciana Grant(Center for Forestry Research & Experimentation (CIEF)); European Community(European Commission); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM041840 (to D. J. T.) and National Institutes of Health Predoctoral Fellowship FDK081304A (to S. V. V.). This work was also supported by Spanish Ministerio de Educacion y Ciencia Grant BIO2005-07120, Generalitat Valenciana Grant GV05-081, and FEDER funds from the European Community (to S. P.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	BAYNES RD, 1990, ANNU REV NUTR, V10, P133, DOI [10.1146/annurev.nutr.10.1.133, 10.1146/annurev.nu.10.070190.001025]; Blackshear PJ, 2002, BIOCHEM SOC T, V30, P945, DOI 10.1042/BST0300945; Chen CY, 2001, CELL, V107, P451, DOI 10.1016/S0092-8674(01)00578-5; Cheng ZH, 2005, RNA, V11, P1258, DOI 10.1261/rna.2920905; Ciais D, 2008, NUCLEIC ACIDS RES, V36, P3075, DOI 10.1093/nar/gkn160; Coller J, 2005, CELL, V122, P875, DOI 10.1016/j.cell.2005.07.012; Coller JM, 2001, RNA, V7, P1717, DOI 10.1017/S135583820101994X; Courel M, 2005, MOL CELL BIOL, V25, P6760, DOI 10.1128/MCB.25.15.6760-6771.2005; Decker CJ, 2007, J CELL BIOL, V179, P437, DOI 10.1083/jcb.200704147; Eulalio A, 2007, NAT REV MOL CELL BIO, V8, P9, DOI 10.1038/nrm2080; Fenger-Gron M, 2005, MOL CELL, V20, P905, DOI 10.1016/j.molcel.2005.10.031; Foury F, 2001, J BIOL CHEM, V276, P7762, DOI 10.1074/jbc.M005804200; Franks TM, 2007, GENE DEV, V21, P719, DOI 10.1101/gad.1494707; Garneau NL, 2007, NAT REV MOL CELL BIO, V8, P113, DOI 10.1038/nrm2104; Goldstrohm AC, 2007, J BIOL CHEM, V282, P109, DOI 10.1074/jbc.M609413200; Goldstrohm AC, 2006, NAT STRUCT MOL BIOL, V13, P533, DOI 10.1038/nsmb1100; Hau HH, 2007, J CELL BIOCHEM, V100, P1477, DOI 10.1002/jcb.21130; He WH, 1999, METHODS, V17, P3, DOI 10.1006/meth.1998.0701; Hentze MW, 2004, CELL, V117, P285, DOI 10.1016/S0092-8674(04)00343-5; Jang LT, 2006, J BIOL CHEM, V281, P29379, DOI 10.1074/jbc.M601573200; Kaplan J, 2006, BBA-MOL CELL RES, V1763, P646, DOI 10.1016/j.bbamcr.2006.03.008; Kedersha N, 2005, J CELL BIOL, V169, P871, DOI 10.1083/jcb.200502088; Lai WS, 1999, MOL CELL BIOL, V19, P4311; Lykke-Andersen J, 2005, GENE DEV, V19, P351, DOI 10.1101/gad.1282305; Masse E, 2005, TRENDS BIOCHEM SCI, V30, P462, DOI 10.1016/j.tibs.2005.06.005; Parker R, 2004, NAT STRUCT MOL BIOL, V11, P121, DOI 10.1038/nsmb724; Parker R, 2007, MOL CELL, V25, P635, DOI 10.1016/j.molcel.2007.02.011; Pilkington GR, 2008, MOL CELL BIOL, V28, P1298, DOI 10.1128/MCB.00936-07; Puig S, 2005, CELL, V120, P99, DOI 10.1016/j.cell.2004.11.032; Puig S, 2008, CELL METAB, V7, P555, DOI 10.1016/j.cmet.2008.04.010; Puig S, 2007, PLANT CELL ENVIRON, V30, P271, DOI 10.1111/j.1365-3040.2007.01642.x; Rouault TA, 2006, NAT CHEM BIOL, V2, P406, DOI 10.1038/nchembio807; Rutherford JC, 2003, J BIOL CHEM, V278, P27636, DOI 10.1074/jbc.M300076200; Shakoury-Elizeh M, 2004, MOL BIOL CELL, V15, P1233, DOI 10.1091/mbc.E03-09-0642; Sheth U, 2003, SCIENCE, V300, P805, DOI 10.1126/science.1082320; Stoecklin G, 2006, EMBO REP, V7, P72, DOI 10.1038/sj.embor.7400572; Teixeira D, 2005, RNA, V11, P371, DOI 10.1261/rna.7258505; Teixeira D, 2007, MOL BIOL CELL, V18, P2274, DOI 10.1091/mbc.E07-03-0199; Thompson MJ, 1996, GENE, V174, P225, DOI 10.1016/0378-1119(96)00084-4	39	58	60	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 17	2008	283	42					28527	28535		10.1074/jbc.M804910200	http://dx.doi.org/10.1074/jbc.M804910200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	359EN	18715869	Green Published, hybrid			2022-12-27	WOS:000259969300056
J	van Hellemond, EW; Mazon, H; Heck, AJ; van den Heuvel, RHH; Heuts, DPHM; Janssen, DB; Fraaije, MW				van Hellemond, Erik W.; Mazon, Hortense; Heck, Albert J.; van den Heuvel, Robert H. H.; Heuts, Dominic P. H. M.; Janssen, Dick B.; Fraaije, Marco W.			ADP competes with FAD binding in putrescine oxidase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FLAVIN ADENINE-DINUCLEOTIDE; MONOAMINE-OXIDASE; MICROCOCCUS-RUBENS; DRUG TARGET; FLAVINYLATION; POLYAMINES; RECONSTITUTION; FLAVOPROTEINS; DISCOVERY; ENZYME	Putrescine oxidase from Rhodococcus erythropolis NCIMB 11540 (PuORh) is a soluble homodimeric flavoprotein of 100 kDa, which catalyzes the oxidative deamination of putrescine and some other aliphatic amines. The initial characterization of PuORh uncovered an intriguing feature: the enzyme appeared to contain only one noncovalently bound FAD cofactor per dimer. Here we show that this low FAD/protein ratio is the result of tight binding of ADP, thereby competing with FAD binding. MS analysis revealed that the enzyme is isolated as a mixture of dimers containing two molecules of FAD, two molecules ADP, or one FAD and one ADP molecule. In addition, based on a structural model of PuORh that was built using the crystal structure of human monoamine oxidase B (MAO-B), we constructed an active mutant enzyme, PuORh A394C, that contains covalently bound FAD. These findings show that the covalent FAD-protein linkage can be formed autocatalytically and hint to a new-found rationale for covalent flavinylation: covalent flavinylation may have evolved to prevent binding of ADP or related cellular compounds, which would prohibit formation of flavinylated and functional enzyme.	[van Hellemond, Erik W.; Heuts, Dominic P. H. M.; Janssen, Dick B.; Fraaije, Marco W.] Univ Groningen, Biochem Lab, Groningen Biomol Sci & Biotechnol Inst, NL-9747 AG Groningen, Netherlands; [Mazon, Hortense; Heck, Albert J.; van den Heuvel, Robert H. H.] Univ Utrecht, Biomol Mass Spectrometry & Proteom Grp, Bijvoet Ctr Biomol Res, NL-3584 CA Utrecht, Netherlands; [Mazon, Hortense; Heck, Albert J.; van den Heuvel, Robert H. H.] Univ Utrecht, Utrecht Inst Pharmaceut Sci, NL-3584 CA Utrecht, Netherlands	University of Groningen; Utrecht University; Utrecht University	Fraaije, MW (corresponding author), Univ Groningen, Biochem Lab, Groningen Biomol Sci & Biotechnol Inst, Nijenborgh 4, NL-9747 AG Groningen, Netherlands.	m.w.fraaije@rug.nl	Fraaije, Marco/E-8421-2014; Heck, Albert/D-7098-2011	Heck, Albert/0000-0002-2405-4404; Fraaije, Marco/0000-0001-6346-5014	Netherlands Organisation for Scientific Research (NWO)	Netherlands Organisation for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO))	This research was supported by the Integrated Biosynthesis Organic Synthesis (IBOS) program of the Netherlands Organisation for Scientific Research (NWO). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Binda C, 2002, NAT STRUCT BIOL, V9, P22, DOI 10.1038/nsb732; Binda C, 2004, FEBS LETT, V564, P225, DOI 10.1016/S0014-5793(04)00209-1; Bruckner RC, 2007, BIOCHEMISTRY-US, V46, P819, DOI 10.1021/bi062087s; Casero RA, 2007, NAT REV DRUG DISCOV, V6, P373, DOI 10.1038/nrd2243; DESA RJ, 1972, J BIOL CHEM, V247, P5527; Edmondson DE, 2004, NEUROTOXICOLOGY, V25, P63, DOI 10.1016/S0161-813X(03)00114-1; Edmondson DE, 2001, ANTIOXID REDOX SIGN, V3, P789, DOI 10.1089/15230860152664984; Fraaije MW, 1999, J BIOL CHEM, V274, P35514, DOI 10.1074/jbc.274.50.35514; Hassan-Abdallah A, 2006, BIOCHEMISTRY-US, V45, P9454, DOI 10.1021/bi0607352; Heck AJR, 2004, MASS SPECTROM REV, V23, P368, DOI 10.1002/mas.10081; Hefti MH, 2003, EUR J BIOCHEM, V270, P4227, DOI 10.1046/j.1432-1033.2003.03802.x; Inaba Y, 2004, BIOSENS BIOELECTRON, V20, P833, DOI 10.1016/j.bios.2004.03.022; ISHIZUKA H, 1993, J GEN MICROBIOL, V139, P425, DOI 10.1099/00221287-139-3-425; ISOBE K, 1987, CLIN BIOCHEM, V20, P157, DOI 10.1016/S0009-9120(87)80113-3; Jin JF, 2007, FEBS J, V274, P2311, DOI 10.1111/j.1742-4658.2007.05767.x; Kay CWM, 2007, J AM CHEM SOC, V129, P16091, DOI 10.1021/ja076090q; Medina MA, 2003, CRIT REV BIOCHEM MOL, V38, P23, DOI 10.1080/713609209; Mewies M, 1998, PROTEIN SCI, V7, P7, DOI 10.1002/pro.5560070102; Nandigama RK, 2000, J BIOL CHEM, V275, P20527, DOI 10.1074/jbc.M002132200; Rochette JF, 2005, ANAL BIOCHEM, V336, P305, DOI 10.1016/j.ab.2004.10.027; SCHILLING B, 1995, MOL GEN GENET, V247, P430, DOI 10.1007/BF00293144; Shih JC, 1999, ANNU REV NEUROSCI, V22, P197, DOI 10.1146/annurev.neuro.22.1.197; TABOR CW, 1984, ANNU REV BIOCHEM, V53, P749, DOI 10.1146/annurev.bi.53.070184.003533; van Hellemond EW, 2008, APPL MICROBIOL BIOT, V78, P455, DOI 10.1007/s00253-007-1310-4; VANBERKEL WJH, 1988, EUR J BIOCHEM, V178, P197; WU HF, 1993, MOL PHARMACOL, V43, P888; YAMADA H, 1965, AGR BIOL CHEM TOKYO, V29, P1148, DOI 10.1080/00021369.1965.10858523; YAMADA H, 1965, AGR BIOL CHEM TOKYO, V29, P260, DOI 10.1080/00021369.1965.10858382; Yamada H., 1971, METHODS ENZYMOL B, V17, P726; ZHOU BP, 1995, J BIOL CHEM, V270, P23653, DOI 10.1074/jbc.270.40.23653; Zhou BP, 1998, J BIOL CHEM, V273, P14862, DOI 10.1074/jbc.273.24.14862	31	7	7	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 17	2008	283	42					28259	28264		10.1074/jbc.M803255200	http://dx.doi.org/10.1074/jbc.M803255200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	359EN	18678871	hybrid, Green Published			2022-12-27	WOS:000259969300027
J	Murai, J; Ikegami, D; Okamoto, M; Yoshikawa, H; Tsumaki, N				Murai, Junko; Ikegami, Daisuke; Okamoto, Mina; Yoshikawa, Hideki; Tsumaki, Noriyuki			Insulation of the ubiquitous Rxrb promoter from the cartilage-specific adjacent gene, Col11a2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHONDROCYTE-SPECIFIC ENHANCER; COLLAGEN GENE; CTCF; EXPRESSION; BINDING; ELEMENTS; GENOME; DOMAIN; ALPHA; LINE	The retinoid X receptor beta gene (Rxrb) is located just upstream of the alpha 2(XI) collagen chain gene (Col11a2) in a head-to-tail manner. However, the domain structures of these genes are unknown. Col11a2 is specifically expressed in cartilage. In the present study, we found Rxrb expression in various tissues with low expression in the cartilage. Col11a2 1st intron enhancer directed cartilage specific expression when linked to the heterologous promoter in transgenic mice. These results suggest the presence of enhancer-blocking elements that insulate Rxrb promoter from the Col11a2 enhancer. So far, most of insulators examined in vertebrates contain a binding site for CTCF. We found two possible CTCF-binding sites: one (11P) in the intergenic region between Rxrb and Col11a2 by electrophoretic mobility shift assays, and the other in the 4th intron of RXRB by data base search. To examine the function of these elements, we prepared bacterial artificial chromosome (BAC) transgene constructs containing a 142-kb genomicDNAinsert with RXRB and COL11A2 sequences in the middle. Mutation of 11P significantly decreased the RXRB promoter activity in muscular cells and significantly increased expression levels of RXRB in chondrosarcoma cells. In transgenic mouse assays, the wild-type BAC transgene partly recapitulated endogenous Rxrb expression patterns. A 507-bp deletion mutation including 11P enhanced the cartilage-specific activity of the RXRB promoter in BACtransgenic mice. Chromatin immunoprecipitation analysis showed that CTCF was associated with RX4, but not with 11P. Our results showed that the intergenic sequence including 11P insulates Rxrb promoter from Col11a2 enhancer, possibly associating with unknown factors that recognize a motif similar to CTCF.	[Murai, Junko; Ikegami, Daisuke; Okamoto, Mina; Tsumaki, Noriyuki] Osaka Univ, Dept Bone & Cartilage Biol, Grad Sch Med, Suita, Osaka 5650871, Japan; [Murai, Junko; Ikegami, Daisuke; Okamoto, Mina; Yoshikawa, Hideki] Osaka Univ, Dept Orthopaed Surg, Grad Sch Med, Suita, Osaka 5650871, Japan	Osaka University; Osaka University	Tsumaki, N (corresponding author), Osaka Univ, Dept Bone & Cartilage Biol, Grad Sch Med, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.	ntsumaki@dbcb.med.osaka-u.ac.jp	Murai, Junko/AAU-9516-2021	Tsumaki, Noriyuki/0000-0002-0520-3654	Ministry of Education, Culture, Sports, Science and Technology of Japan [19659378]; Health and Labor Sciences Research Grants of Japan	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Health and Labor Sciences Research Grants of Japan	This work was supported in part by Scientific Research Grants 18390415 and 19659378 from the Ministry of Education, Culture, Sports, Science and Technology of Japan and Health and Labor Sciences Research Grants of Japan. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Awad TA, 1999, J BIOL CHEM, V274, P27092, DOI 10.1074/jbc.274.38.27092; Bao L, 2008, NUCLEIC ACIDS RES, V36, pD83, DOI 10.1093/nar/gkm875; Bridgewater LC, 1998, J BIOL CHEM, V273, P14998, DOI 10.1074/jbc.273.24.14998; Butler JEF, 2001, GENE DEV, V15, P2515, DOI 10.1101/gad.924301; Charron G, 1995, J BIOL CHEM, V270, P30604, DOI 10.1074/jbc.270.51.30604; Davies SR, 2004, GENOMICS, V83, P667, DOI 10.1016/j.ygeno.2003.09.013; DAWES KE, 1993, EUR J CELL BIOL, V61, P126; DPELTON RW, 1990, DEVELOPMENT, V110, P609; Felsenfeld G, 2004, COLD SPRING HARB SYM, V69, P245, DOI 10.1101/sqb.2004.69.245; Gaszner M, 2006, NAT REV GENET, V7, P703, DOI 10.1038/nrg1925; Germain P, 2006, PHARMACOL REV, V58, P685, DOI 10.1124/pr.58.4.2; Kastner P, 1996, GENE DEV, V10, P80, DOI 10.1101/gad.10.1.80; Kim TH, 2007, CELL, V128, P1231, DOI 10.1016/j.cell.2006.12.048; Krezel W, 1998, SCIENCE, V279, P863, DOI 10.1126/science.279.5352.863; Kuo MH, 1998, GENE DEV, V12, P627, DOI 10.1101/gad.12.5.627; LEVI A, 1985, SCIENCE, V229, P393, DOI 10.1126/science.3839317; LI Y, 1995, CELL, V80, P423, DOI 10.1016/0092-8674(95)90492-1; Loukinov DI, 2002, P NATL ACAD SCI USA, V99, P6806, DOI 10.1073/pnas.092123699; Magdinier F, 2004, J BIOL CHEM, V279, P25381, DOI 10.1074/jbc.M403121200; MANGELSDORF DJ, 1992, GENE DEV, V6, P329, DOI 10.1101/gad.6.3.329; MENDLER M, 1989, J CELL BIOL, V108, P191, DOI 10.1083/jcb.108.1.191; MORRIS NP, 1987, J BIOL CHEM, V262, P11345; MUKHOPADHYAY K, 1995, J BIOL CHEM, V270, P27711, DOI 10.1074/jbc.270.46.27711; Nagy A., 2003, MANIPULATING MOUSE E; Okazaki K, 2006, J CELL BIOCHEM, V97, P857, DOI 10.1002/jcb.20648; Parelho V, 2008, CELL, V132, P422, DOI 10.1016/j.cell.2008.01.011; PITOT H. C., 1964, NAT CANCER INST MONOGR, V13, P229; Repa JJ, 2000, SCIENCE, V289, P1524, DOI 10.1126/science.289.5484.1524; Smale ST, 2001, GENE DEV, V15, P2503, DOI 10.1101/gad.937701; Sugimoto M, 1998, CELL TISSUE RES, V292, P325, DOI 10.1007/s004410051063; Tsumaki N, 1996, J CELL BIOL, V134, P1573, DOI 10.1083/jcb.134.6.1573; Tsumaki N, 1998, J BIOL CHEM, V273, P22861, DOI 10.1074/jbc.273.36.22861; TSUMAKI N, 1995, J BIOL CHEM, V270, P2372, DOI 10.1074/jbc.270.5.2372; VAUGHAN L, 1988, J CELL BIOL, V106, P991, DOI 10.1083/jcb.106.3.991; VIKKULA M, 1995, CELL, V80, P431, DOI 10.1016/0092-8674(95)90493-X; Wallace JA, 2007, CURR OPIN GENET DEV, V17, P400, DOI 10.1016/j.gde.2007.08.005; Wendt KS, 2008, NATURE, V451, P796, DOI 10.1038/nature06634; West AG, 2002, GENE DEV, V16, P271, DOI 10.1101/gad.954702; Xie XH, 2007, P NATL ACAD SCI USA, V104, P7145, DOI 10.1073/pnas.0701811104; YAFFE D, 1968, P NATL ACAD SCI USA, V61, P477, DOI 10.1073/pnas.61.2.477	40	4	5	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 10	2008	283	41					27677	27687		10.1074/jbc.M803657200	http://dx.doi.org/10.1074/jbc.M803657200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	355OW	18682388	hybrid			2022-12-27	WOS:000259719200039
J	Konrad, S; Ali, SR; Wiege, K; Syed, SN; Engling, L; Piekorz, RP; Hirsch, E; Nurnberg, B; Schmidt, RE; Gessner, JE				Konrad, Stephanie; Ali, Syed R.; Wiege, Kristina; Syed, Shahzad N.; Engling, Linda; Piekorz, Roland P.; Hirsch, Emilio; Nuernberg, Bernd; Schmidt, Reinhold E.; Gessner, J. Engelbert			Phosphoinositide 3-Kinases gamma and delta, Linkers of Coordinate C5a Receptor-Fc gamma Receptor Activation and Immune Complex-induced Inflammation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							B-CELL DEVELOPMENT; T-CELL; AIRWAY INFLAMMATION; ARTHUS REACTION; LUNG-DISEASE; P110-DELTA; PI3K-GAMMA; MICE; AUTOIMMUNITY; GENERATION	Fc gamma receptors (Fc gamma R) and the C5a receptor (C5aR) are key effectors of the acute inflammatory response to IgG immune complexes (IC). Their coordinated activation is critical in IC-induced diseases, although the significance of combined signaling by these two different receptor classes in tissue injury is unclear. Here we used the mouse model of the passive reverse lung Arthus reaction to define their requirements for distinct phosphoinositide 3-kinase (PI3K) activities in vivo. We show that genetic deletion of class IB PI3K gamma abrogates C5aR signaling that is crucial for Fc gamma R-mediated activation of lung macrophages. Thus, in PI3K gamma(-/-) mice, IgG IC-induced Fc gamma R regulation, cytokine release, and neutrophil recruitment were blunted. Notably, however, C5a production occurred normally in PI3K gamma(-/-) mice but was impaired in PI3K gamma(-/-) mice. Consequently, class IA PI3K delta deficiency caused resistance to acute IC lung injury. These results demonstrate that PI3K gamma and PI3K delta coordinate the inflammatory effects of C5aR and Fc gamma R and define PI3K delta as a novel and essential element of Fc gamma R signaling in the generation of C5a in IC disease.	[Konrad, Stephanie; Ali, Syed R.; Wiege, Kristina; Syed, Shahzad N.; Engling, Linda; Schmidt, Reinhold E.; Gessner, J. Engelbert] Hannover Med Sch, Clin Immunol & Rheumatol, Mol Immunol Res Unit, D-30625 Hannover, Germany; [Gessner, J. Engelbert] Hannover Med Sch, Collaborat Res Program Deutsch Forschungsgemeinsc, D-30625 Hannover, Germany; [Piekorz, Roland P.; Nuernberg, Bernd] Univ Dusseldorf, Dept Biochem & Mol Biol 2, D-40225 Dusseldorf, Germany; [Hirsch, Emilio] Univ Turin, Dept Genet Biol & Biochem, I-10124 Turin, Italy	Hannover Medical School; Hannover Medical School; Heinrich Heine University Dusseldorf; University of Turin	Gessner, JE (corresponding author), Hannover Med Sch, Clin Immunol & Rheumatol, Mol Immunol Res Unit, Carl Neuberg Str 1, D-30625 Hannover, Germany.	gessner.johannes@mh-hannover.de	Hirsch, Emilio/F-4848-2013; ali, syed/J-6124-2014; Ali, Syed/M-7418-2013	Hirsch, Emilio/0000-0002-9073-6024; Syed, Shahzad Nawaz/0000-0002-6660-6561; Nurnberg, Bernd/0000-0002-5995-6555	Deutsche Forschungsgemeinschaft [SFB 587, FOR 729]; Fonds der Chemischen Industrie; Freundesgesellschaft der Medizinische Hochschule Hannover	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Fonds der Chemischen Industrie(Fonds der Chemischen IndustrieEuropean Commission); Freundesgesellschaft der Medizinische Hochschule Hannover	This work was supported in part by Deutsche Forschungsgemeinschaft Grants SFB 587 (to J. E. G.) and FOR 729 (to B. N.) and the Fonds der Chemischen Industrie. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.; Recipient of a fellowship of the international M.D./Ph.D. program provided by the Freundesgesellschaft der Medizinische Hochschule Hannover. Present address: Dept. of Pharmacology, University of California, San Diego, La Jolla, CA 92093-0636.	Al-Alwan MM, 2007, J IMMUNOL, V178, P2328, DOI 10.4049/jimmunol.178.4.2328; Ali K, 2004, NATURE, V431, P1007, DOI 10.1038/nature02991; Barberis L, 2008, THROMB HAEMOSTASIS, V99, P279, DOI 10.1160/TH07-10-0632; Canetti C, 2007, J IMMUNOL, V179, P8350, DOI 10.4049/jimmunol.179.12.8350; Chouchakova N, 2001, J IMMUNOL, V166, P5193, DOI 10.4049/jimmunol.166.8.5193; Clayton E, 2002, J EXP MED, V196, P753, DOI 10.1084/jem.20020805; Del Prete A, 2004, EMBO J, V23, P3505, DOI 10.1038/sj.emboj.7600361; Fitch JCK, 1999, CIRCULATION, V100, P2499, DOI 10.1161/01.CIR.100.25.2499; Fruman DA, 1998, ANNU REV BIOCHEM, V67, P481, DOI 10.1146/annurev.biochem.67.1.481; Fruman DA, 2002, SEMIN IMMUNOL, V14, P7, DOI 10.1006/smim.2001.0337; Fruman DA, 1999, SCIENCE, V283, P393, DOI 10.1126/science.283.5400.393; Hirsch E, 2000, SCIENCE, V287, P1049, DOI 10.1126/science.287.5455.1049; Hopken UE, 1997, J EXP MED, V186, P749, DOI 10.1084/jem.186.5.749; Huber-Lang M, 2006, NAT MED, V12, P682, DOI 10.1038/nm1419; Ji H, 2002, IMMUNITY, V16, P157, DOI 10.1016/S1074-7613(02)00275-3; Ji H, 2007, BLOOD, V110, P2940, DOI 10.1182/blood-2007-04-086751; Jou ST, 2002, MOL CELL BIOL, V22, P8580, DOI 10.1128/MCB.22.24.8580-8591.2002; Katso R, 2001, ANNU REV CELL DEV BI, V17, P615, DOI 10.1146/annurev.cellbio.17.1.615; Kim N, 2007, BLOOD, V110, P3202, DOI 10.1182/blood-2007-02-075366; Kinet JP, 1999, ANNU REV IMMUNOL, V17, P931, DOI 10.1146/annurev.immunol.17.1.931; Konrad S, 2007, J BIOL CHEM, V282, P37906, DOI 10.1074/jbc.M707937200; Koyasu S, 2003, NAT IMMUNOL, V4, P313, DOI 10.1038/ni0403-313; Kumar V, 2006, J CLIN INVEST, V116, P512, DOI 10.1172/JCI25536; Laffargue M, 2002, IMMUNITY, V16, P441, DOI 10.1016/S1074-7613(02)00282-0; Li Z, 2000, SCIENCE, V287, P1046, DOI 10.1126/science.287.5455.1046; Lian LR, 2005, BLOOD, V106, P110, DOI 10.1182/blood-2004-05-2005; Marone R, 2008, BBA-PROTEINS PROTEOM, V1784, P159, DOI 10.1016/j.bbapap.2007.10.003; Medina-Tato DA, 2007, IMMUNOLOGY, V121, P448, DOI 10.1111/j.1365-2567.2007.02663.x; Monk PN, 2007, BRIT J PHARMACOL, V152, P429, DOI 10.1038/sj.bjp.0707332; Nashed BF, 2007, EUR J IMMUNOL, V37, P416, DOI 10.1002/eji.200636401; Nimmerjahn F, 2006, IMMUNITY, V24, P19, DOI 10.1016/j.immuni.2005.11.010; Okkenhaug K, 2003, BIOCHEM SOC T, V31, P270, DOI 10.1042/bst0310270; Okkenhaug K, 2002, SCIENCE, V297, P1031; PIEKORZ RP, 2004, PHOSPHOLIPID KINASES; Puri KD, 2004, BLOOD, V103, P3448, DOI 10.1182/blood-2003-05-1667; Radeke HH, 2002, J BIOL CHEM, V277, P27535, DOI 10.1074/jbc.M200419200; Randis TM, 2008, EUR J IMMUNOL, V38, P1215, DOI 10.1002/eji.200838266; Ravetch JV, 2001, ANNU REV IMMUNOL, V19, P275, DOI 10.1146/annurev.immunol.19.1.275; Rommel C, 2007, NAT REV IMMUNOL, V7, P191, DOI 10.1038/nri2036; Sasaki T, 2000, SCIENCE, V287, P1040, DOI 10.1126/science.287.5455.1040; Schiller C, 2000, EUR J IMMUNOL, V30, P481; Schmidt RE, 2005, IMMUNOL LETT, V100, P56, DOI 10.1016/j.imlet.2005.06.022; Shushakova N, 2002, J CLIN INVEST, V110, P1823, DOI 10.1172/JCI200216577; Skokowa J, 2005, J IMMUNOL, V174, P3041, DOI 10.4049/jimmunol.174.5.3041; STEVENS JH, 1986, J CLIN INVEST, V77, P1812, DOI 10.1172/JCI112506; Suzuki H, 1999, SCIENCE, V283, P390, DOI 10.1126/science.283.5400.390; Takai T, 2002, NAT REV IMMUNOL, V2, P580, DOI 10.1038/nri856; Thomas MJ, 2005, EUR J IMMUNOL, V35, P1283, DOI 10.1002/eji.200425634; Vakeva AP, 1998, CIRCULATION, V97, P2259, DOI 10.1161/01.CIR.97.22.2259; Volanakis J. E., 1998, HUMAN COMPLEMENT SYS; Wymann MP, 1998, BBA-MOL CELL BIOL L, V1436, P127, DOI 10.1016/S0005-2760(98)00139-8	51	37	45	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 28	2008	283	48					33296	33303		10.1074/jbc.M804617200	http://dx.doi.org/10.1074/jbc.M804617200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	376KY	18786920	hybrid, Green Published			2022-12-27	WOS:000261183700033
J	Gupta, D; Jetton, TL; Mortensen, RM; Duan, SZ; Peshavaria, M; Leahy, JL				Gupta, Dhananjay; Jetton, Thomas L.; Mortensen, Richard M.; Duan, Sheng Zhong; Peshavaria, Mina; Leahy, Jack L.			In Vivo and in Vitro Studies of a Functional Peroxisome Proliferator-activated Receptor gamma Response Element in the Mouse pdx-1 Promoter	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-CELL FUNCTION; STIMULATED INSULIN-SECRETION; RETINOID-X-RECEPTOR; PPAR-GAMMA; GLUCOSE-HOMEOSTASIS; PANCREATIC DEVELOPMENT; NUCLEAR RECEPTORS; HISPANIC WOMEN; ISLET CELLS; INS-1 CELLS	We reported that peroxisome proliferator-activated receptor gamma(PPAR gamma) transcriptionally regulates the beta-cell differentiation factor pancreatic duodenal homeobox (PDX)-1 based on in vitro RNA interference studies. We have now studied mice depleted of PPAR gamma within the pancreas (PANC PPAR gamma(-/-)) created by a Cre/loxP recombinase system, with Cre driven by the pdx-1 promoter. Male PANC PPAR gamma(-/-) mice were hyperglycemic at 8 weeks of age (8.1 +/- 0.2 mM versus 6.4 +/- 0.3 mM, p = 0.009) with islet cytoarchitecture and pancreatic mass of islet beta-cells that were indistinguishable from the controls. Islet PDX-1 mRNA (p = 0.001) and protein levels (p = 0.003) were lowered 60 and 40%, respectively, in tandem with impaired glucose-induced insulin secretion and loss of thiazolidinedione-induced increase in PDX-1 expression. We next identified a putative PPAR-response element (PPRE) in the mouse pdx-1 promoter with substantial homology to the corresponding region of the human PDX-1 promoter. Electrophoretic mobility supershift assays with nuclear extracts from beta-cell lines and mouse islets, also in vitro translated PPAR gamma and retinoid X receptor, and chromatin immunoprecipitation analysis demonstrated specific binding of PPAR gamma and retinoid X receptor to the human and mouse pdx-1 Chi PPREs. Transient transfection assays of beta-cells with reporter constructs of mutated PPREs showed dramatically reduced pdx-1 promoter activity. In summary, we have presented in vivo and in vitro evidence showing PPAR gamma regulation of pdx-1 transcription in beta-cells, plus our results support an important regulatory role for PPAR gamma in beta-cell physiology and thiazolidinedione pharmacology of type 2 diabetes.	[Leahy, Jack L.] Univ Vermont, Coll Med, Dept Med, Div Endocrinol Diabet & Metab, Burlington, VT 05405 USA; [Mortensen, Richard M.; Duan, Sheng Zhong] Univ Michigan, Dept Mol & Integrat Physiol, Ann Arbor, MI 48109 USA	University of Vermont; University of Michigan System; University of Michigan	Leahy, JL (corresponding author), Univ Vermont, Coll Med, Dept Med, Div Endocrinol Diabet & Metab, Given Bldg C331, Burlington, VT 05405 USA.	jleahy@uvm.edu		duan, sheng zhong/0000-0001-5399-7252	National Institutes of Health [DK56818, DK66635, DK59851]; American Diabetes Association; Juvenile Diabetes Research Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK056818, R01DK066635, R01DK056818] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association(American Diabetes Association); Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK56818 and DK66635 (to J.L.L.) and DK59851 (to T.L.J.). This work was also supported by American Diabetes Association (to T.L.J. and M. P.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.; Supported by a mentor-based fellowship award (to J.L.L.) from the American Diabetes Association.; Recipient of a career development award from the Juvenile Diabetes Research Foundation.	Ahlgren U, 1998, GENE DEV, V12, P1763, DOI 10.1101/gad.12.12.1763; Braissant O, 1996, ENDOCRINOLOGY, V137, P354, DOI 10.1210/en.137.1.354; Brissova M, 2005, AM J PHYSIOL-ENDOC M, V288, pE707, DOI 10.1152/ajpendo.00252.2004; Brissova M, 2002, J BIOL CHEM, V277, P11225, DOI 10.1074/jbc.M111272200; Buchanan TA, 2002, DIABETES, V51, P2796, DOI 10.2337/diabetes.51.9.2796; Diabetes Prevention Progam, 2005, DIABETES, V54, P1150; Dubois M, 2000, DIABETOLOGIA, V43, P1165, DOI 10.1007/s001250051508; Feige JN, 2006, PROG LIPID RES, V45, P120, DOI 10.1016/j.plipres.2005.12.002; Francis GA, 2003, ANNU REV PHYSIOL, V65, P261, DOI 10.1146/annurev.physiol.65.092101.142528; Gannon M, 2000, GENESIS, V26, P143, DOI 10.1002/(SICI)1526-968X(200002)26:2<143::AID-GENE13>3.0.CO;2-L; GEARING KL, 1993, P NATL ACAD SCI USA, V90, P1440, DOI 10.1073/pnas.90.4.1440; Gerrish K, 2000, J BIOL CHEM, V275, P3485, DOI 10.1074/jbc.275.5.3485; Gerstein HC, 2006, LANCET, V368, P1096, DOI 10.1016/S0140-6736(06)69420-8; Gu GQ, 2002, DEVELOPMENT, V129, P2447; Holland AM, 2002, P NATL ACAD SCI USA, V99, P12236, DOI 10.1073/pnas.192255099; Hsu MH, 1998, J BIOL CHEM, V273, P27988, DOI 10.1074/jbc.273.43.27988; Ijpenberg A, 1997, J BIOL CHEM, V272, P20108, DOI 10.1074/jbc.272.32.20108; Ivashchenko CY, 2007, AM J PHYSIOL-GASTR L, V293, pG319, DOI 10.1152/ajpgi.00056.2007; Jetton TL, 2005, DIABETES, V54, P2294, DOI 10.2337/diabetes.54.8.2294; Jetton TL, 2001, DIABETOLOGIA, V44, P2056, DOI 10.1007/s001250100011; Johnson JD, 2003, J CLIN INVEST, V111, P1147, DOI 10.1172/JCI200316537; Kahn SE, 2006, NEW ENGL J MED, V355, P2427, DOI 10.1056/NEJMoa066224; KLIEWER SA, 1992, NATURE, V358, P771, DOI 10.1038/358771a0; Kulkarni RN, 2004, J CLIN INVEST, V114, P828, DOI 10.1172/JCI200421845; Lee JY, 2006, J BIOL CHEM, V281, P2649, DOI 10.1074/jbc.M512373200; Lee JY, 2005, BIOCHEM BIOPH RES CO, V334, P764, DOI 10.1016/j.bbrc.2005.06.162; Lehrke M, 2005, CELL, V123, P993, DOI 10.1016/j.cell.2005.11.026; Lemay DG, 2006, J LIPID RES, V47, P1583, DOI 10.1194/jlr.M500504-JLR200; Lin CY, 2005, J CLIN ENDOCR METAB, V90, P6678, DOI 10.1210/jc.2005-0079; Lin YQ, 2001, DIABETOLOGIA, V44, P1026, DOI 10.1007/s001250100597; Liu YQ, 2000, AM J PHYSIOL-ENDOC M, V279, pE68, DOI 10.1152/ajpendo.2000.279.1.E68; Moibi JA, 2007, DIABETES, V56, P88, DOI 10.2337/db06-0948; Niswender KD, 2007, J CLIN INVEST, V117, P2753, DOI 10.1172/JCI33528; Ohtani K, 1998, ENDOCRINOLOGY, V139, P172, DOI 10.1210/en.139.1.172; Picard F, 2002, ANNU REV NUTR, V22, P167, DOI 10.1146/annurev.nutr.22.010402.102808; Rosen ED, 2003, MOL CELL BIOL, V23, P7222, DOI 10.1128/MCB.23.20.7222-7229.2003; Rosen ED, 2001, J BIOL CHEM, V276, P37731, DOI 10.1074/jbc.R100034200; Schisler JC, 2005, P NATL ACAD SCI USA, V102, P7297, DOI 10.1073/pnas.0502168102; Servitja JM, 2004, DIABETOLOGIA, V47, P597, DOI 10.1007/s00125-004-1368-9; Temple KA, 2005, J BIOL CHEM, V280, P3529, DOI 10.1074/jbc.M411422200; TUGWOOD JD, 1992, EMBO J, V11, P433, DOI 10.1002/j.1460-2075.1992.tb05072.x; Wang H, 2005, DIABETOLOGIA, V48, P720, DOI 10.1007/s00125-005-1692-8; Xiang AH, 2006, DIABETES, V55, P517, DOI 10.2337/diabetes.55.02.06.db05-1066; Yki-Jarvinen H, 2004, NEW ENGL J MED, V351, P1106, DOI 10.1056/NEJMra041001	44	51	53	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 21	2008	283	47					32462	32470		10.1074/jbc.M801813200	http://dx.doi.org/10.1074/jbc.M801813200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	372HW	18718916	Green Published, hybrid			2022-12-27	WOS:000260893700034
J	Berchner-Pfannschmidt, U; Tug, S; Trinidad, B; Oehme, F; Yamac, H; Wotzlaw, C; Flamme, I; Fandrey, J				Berchner-Pfannschmidt, Utta; Tug, Suzan; Trinidad, Buena; Oehme, Felix; Yamac, Hatice; Wotzlaw, Christoph; Flamme, Ingo; Fandrey, Joachim			Nuclear Oxygen Sensing: Induction of Endogenous Prolyl-hydroxylase 2 Activity by Hypoxia and Nitric Oxide	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INDUCIBLE FACTOR 1-ALPHA; HIF-ALPHA; FACTOR-I; DEGRADATION; HIF-1-ALPHA; PROTEIN; FACTOR-1-ALPHA; EXPRESSION; DOMAIN; PHD2	The abundance of the transcription factor hypoxia-inducible factor is regulated through hydroxylation of its alpha-subunits by a family of prolyl-hydroxylases (PHD1-3). Enzymatic activity of these PHDs is O-2-dependent, which enables PHDs to act as cellular O-2 sensor enzymes. Herein we studied endogenous PHD activity that was induced in cells grown under hypoxia or in the presence of nitric oxide. Under such conditions nuclear extracts contained much higher PHD activity than the respective cytoplasmic extracts. Although PHD1-3 were abundant in both compartments, knockdown experiments for each isoenzyme revealed that nuclear PHD activity was only due to PHD2. Maximal PHD2 activity was found between 120 and 210 mu M O-2. PHD2 activity was strongly decreased below 100 mu M O-2 with a half-maximum activity at 53 +/- 13 mu M O-2 for the cytosolic and 54 +/- 10 mu M O-2 for nuclear PHD2 matching the physiological O-2 concentration within most cells. Our data suggest a role for PHD2 as a decisive oxygen sensor of the hypoxia-inducible factor degradation pathway within the cell nucleus.	[Berchner-Pfannschmidt, Utta; Tug, Suzan; Trinidad, Buena; Yamac, Hatice; Wotzlaw, Christoph; Fandrey, Joachim] Univ Duisburg Essen, Inst Physiol, D-45122 Essen, Germany; [Oehme, Felix; Flamme, Ingo] Bayer HealthCare, Inst Cardiovasc Res, D-42096 Wuppertal, Germany	University of Duisburg Essen; Bayer AG; Bayer Healthcare Pharmaceuticals	Fandrey, J (corresponding author), Univ Duisburg Essen, Inst Physiol, Hufelandstr 55, D-45122 Essen, Germany.	joachim.fandrey@uni-due.de	Fandrey, Joachim/AAA-3524-2021	Fandrey, Joachim/0000-0001-9585-0531	Deutsche Forschungsgemeinschaft [FA225/19-3]; European Commission [LSHM-CT-2005-018725]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); European Commission(European CommissionEuropean Commission Joint Research Centre)	This work was supported by Deutsche Forschungsgemeinschaft Grant FA225/19-3 and by the European Commission under 6th Framework Programme Contract LSHM-CT-2005-018725, PULMOTENSION.	ACKER H, 2003, OXYGEN SENSING RESPO, P507; Appelhoff RJ, 2004, J BIOL CHEM, V279, P38458, DOI 10.1074/jbc.M406026200; Berchner-Pfannschmidt U, 2004, BIOL CHEM, V385, P231, DOI 10.1515/BC.2004.017; Berchner-Pfannschmidt U, 2007, J BIOL CHEM, V282, P1788, DOI 10.1074/jbc.M607065200; Berra E, 2003, EMBO J, V22, P4082, DOI 10.1093/emboj/cdg392; Berra E, 2001, EMBO REP, V2, P615, DOI 10.1093/embo-reports/kve130; Bruick RK, 2001, SCIENCE, V294, P1337, DOI 10.1126/science.1066373; Chan DA, 2005, MOL CELL BIOL, V25, P6415, DOI 10.1128/MCB.25.15.6415-6426.2005; Cummins EP, 2006, P NATL ACAD SCI USA, V103, P18154, DOI 10.1073/pnas.0602235103; D'Angelo G, 2003, J BIOL CHEM, V278, P38183, DOI 10.1074/jbc.M302244200; Ehrismann D, 2007, BIOCHEM J, V401, P227, DOI 10.1042/BJ20061151; Epstein ACR, 2001, CELL, V107, P43, DOI 10.1016/S0092-8674(01)00507-4; Giaccia AJ, 2004, GENE DEV, V18, P2183, DOI 10.1101/gad.1243304; Ginouves A, 2008, P NATL ACAD SCI USA, V105, P4745, DOI 10.1073/pnas.0705680105; Groulx I, 2002, MOL CELL BIOL, V22, P5319, DOI 10.1128/MCB.22.15.5319-5336.2002; Hirsila M, 2003, J BIOL CHEM, V278, P30772, DOI 10.1074/jbc.M304982200; Huang JH, 2002, J BIOL CHEM, V277, P39792, DOI 10.1074/jbc.M206955200; Huang LE, 1998, P NATL ACAD SCI USA, V95, P7987, DOI 10.1073/pnas.95.14.7987; Ivan M, 2001, SCIENCE, V292, P464, DOI 10.1126/science.1059817; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; Jokilehto T, 2006, CLIN CANCER RES, V12, P1080, DOI 10.1158/1078-0432.CCR-05-2022; Koivunen P, 2006, J BIOL CHEM, V281, P28712, DOI 10.1074/jbc.M604628200; Lando D, 2002, GENE DEV, V16, P1466, DOI 10.1101/gad.991402; Liu Q, 2004, P NATL ACAD SCI USA, V101, P4302, DOI 10.1073/pnas.0400265101; Mahon PC, 2001, GENE DEV, V15, P2675, DOI 10.1101/gad.924501; Marxsen JH, 2004, BIOCHEM J, V381, P761, DOI 10.1042/BJ20040620; Maxwell PH, 1999, NATURE, V399, P271, DOI 10.1038/20459; METZEN E, 1995, RESP PHYSIOL, V100, P101, DOI 10.1016/0034-5687(94)00125-J; Metzen E, 2005, BIOCHEM J, V387, P711, DOI 10.1042/BJ20041736; Metzen E, 2003, J CELL SCI, V116, P1319, DOI 10.1242/jcs.00318; Nakayama K, 2007, BIOCHEM J, V401, P217, DOI 10.1042/BJ20061135; Oehme F, 2004, ANAL BIOCHEM, V330, P74, DOI 10.1016/j.ab.2004.03.066; Pereira T, 2006, CELL CYCLE, V5, P2720, DOI 10.4161/cc.5.23.3536; Pescador N, 2005, BIOCHEM J, V390, P189, DOI 10.1042/BJ20042121; Salceda S, 1997, J BIOL CHEM, V272, P22642, DOI 10.1074/jbc.272.36.22642; Semenza GL, 1998, CURR OPIN GENET DEV, V8, P588, DOI 10.1016/S0959-437X(98)80016-6; Soilleux EJ, 2005, HISTOPATHOLOGY, V47, P602, DOI 10.1111/j.1365-2559.2005.02280.x; Sonnenschein K, 2004, J BIOL CHEM, V279, P45433, DOI 10.1074/jbc.M405987200; Stiehl DP, 2006, J BIOL CHEM, V281, P23482, DOI 10.1074/jbc.M601719200; Tan S, 2001, PROTEIN EXPRES PURIF, V21, P224, DOI 10.1006/prep.2000.1363; Tuckerman JR, 2004, FEBS LETT, V576, P145, DOI 10.1016/j.febslet.2004.09.005; VAUPEL P, 1991, CANCER RES, V51, P3316; WANG GL, 1995, P NATL ACAD SCI USA, V92, P5510, DOI 10.1073/pnas.92.12.5510; Wenger Roland H, 2005, Sci STKE, V2005, pre12, DOI 10.1126/stke.3062005re12; Zheng XW, 2006, MOL CELL BIOL, V26, P4628, DOI 10.1128/MCB.02236-05	45	56	57	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 14	2008	283	46					31745	31753		10.1074/jbc.M804390200	http://dx.doi.org/10.1074/jbc.M804390200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	370KJ	18776187	hybrid			2022-12-27	WOS:000260760800057
J	Estrada, R; Zeng, Q; Lu, HW; Sarojini, H; Lee, JF; Mathis, SP; Sanchez, T; Wang, E; Kontos, CD; Lin, CY; Hla, T; Haribabu, B; Lee, MJ				Estrada, Rosendo; Zeng, Qun; Lu, Hongwei; Sarojini, Harshini; Lee, Jen-Fu; Mathis, Steven P.; Sanchez, Teresa; Wang, Eugenia; Kontos, Christopher D.; Lin, Chen-Yong; Hla, Timothy; Haribabu, Bodduluri; Lee, Menq-Jer			Up-regulating Sphingosine 1-Phosphate Receptor-2 Signaling Impairs Chemotactic, Wound-healing, and Morphogenetic Responses in Senescent Endothelial Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELLULAR SENESCENCE; INHIBITS MIGRATION; OXIDATIVE STRESS; PROTEIN; CERAMIDE; SPHINGOSINE-1-PHOSPHATE; EDG-1; AGE; ATHEROSCLEROSIS; ACTIVATION	Vascular endothelial cells (ECs) have a finite lifespan when cultured in vitro and eventually enter an irreversible growth arrest state called "cellular senescence." It has been shown that sphingo-lipids may be involved in senescence; however, the molecular links involved are poorly understood. In this study, we investigated the signaling and functions of sphingosine 1-phosphate (S1P), a serum-borne bioactive sphingolipid, in ECs of different in vitro ages. We observed that S1P-regulated responses are significantly inhibited and the S1P(1-3) receptor subtypes are markedly increased in senescent ECs. Increased expression of S1P(1) and S1P(2) was also observed in the lesion regions of atherosclerotic endothelium, where senescent ECs have been identified in vivo. S1P-induced Akt and ERK1/2 activation were comparable between ECs of different in vitro ages; however, PTEN (phosphatase and tensin homolog deleted on chromosome 10) activity was significantly elevated and Rac activation was inhibited in senescent ECs. Rac activation and senescent-associated impairments were restored in senescent ECs by the expression of dominant-negative PTEN and by knocking down S1P(2) receptors. Furthermore, the senescent-associated impairments were induced in young ECs by the expression of S1P(2) to a level similar to that of in vitro senescence. These results indicate that the impairment of function in senescent ECs in culture is mediated by an increase in S1P signaling through S1P(2)-mediated activation of the lipid phosphatase PTEN.	[Estrada, Rosendo; Zeng, Qun; Lu, Hongwei; Sarojini, Harshini; Lee, Jen-Fu; Wang, Eugenia; Lee, Menq-Jer] Univ Louisville, Hlth Sci Ctr, Gheens Ctr Aging, Louisville, KY 40202 USA; [Mathis, Steven P.; Haribabu, Bodduluri; Lee, Menq-Jer] Univ Louisville, Hlth Sci Ctr, Dept Microbiol & Immunol, Louisville, KY 40202 USA; [Sanchez, Teresa; Hla, Timothy] Univ Connecticut, Ctr Hlth, Ctr Vasc Biol, Farmington, CT 06030 USA; [Kontos, Christopher D.] Duke Univ, Med Ctr, Div Cardiol, Dept Med, Durham, NC 27710 USA; [Kontos, Christopher D.] Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Durham, NC 27710 USA; [Lin, Chen-Yong] Univ Maryland, Sch Med, Dept Biochem & Mol Biol, Greenebaum Canc Ctr, Baltimore, MD 21201 USA	University of Louisville; University of Louisville; University of Connecticut; Duke University; Duke University; University System of Maryland; University of Maryland Baltimore	Lee, MJ (corresponding author), Univ Louisville, Hlth Sci Ctr, Gheens Ctr Aging, 580 S Preston St, Louisville, KY 40202 USA.	menqjer.lee@louisville.edu	Hla, Timothy/G-5873-2012; LEE, JEN-FU/GRO-3670-2022; Bodduluri, Haribabu/A-2584-2010; Sarojini, Harshini/AAD-4870-2019	Hla, Timothy/0000-0001-8355-4065; Bodduluri, Haribabu/0000-0002-8261-3294; Sarojini, Harshini/0000-0002-3103-9712; Kontos, Christopher/0000-0002-8056-3115; Mathis, Steven/0000-0001-7704-1220	National Institutes of Health [R01HL071071]; American Heart Association [0755245B]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL071071] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01HL071071 (to M. L). This work was also supported by American Heart Association Grant-in-Aid 0755245B (to M. L.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be herebymarked" advertisement" in accordance with 18U.S.C. Section 1734 solely to indicate this fact.	Albrecht EWJA, 2003, J PATHOL, V199, P8, DOI 10.1002/path.1250; An SZ, 1998, J CELL BIOCHEM, P147; Ancellin N, 1999, J BIOL CHEM, V274, P18997, DOI 10.1074/jbc.274.27.18997; Campisi J, 2001, TRENDS CELL BIOL, V11, pS27, DOI 10.1016/S0962-8924(01)02151-1; Campisi J, 2001, EXP GERONTOL, V36, P1619, DOI 10.1016/S0531-5565(01)00160-7; Chun J, 2002, PHARMACOL REV, V54, P265, DOI 10.1124/pr.54.2.265; Ciacci-Zanella JR, 1998, FOOD CHEM TOXICOL, V36, P791, DOI 10.1016/S0278-6915(98)00034-9; Crivello NA, 2005, NEUROCHEM INT, V47, P573, DOI 10.1016/j.neuint.2005.06.011; Deshpande SS, 2003, ARTERIOSCL THROM VAS, V23, pE1, DOI 10.1161/01.ATV.0000047869.13737.53; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Erusalimsky J D, 2006, Handb Exp Pharmacol, P213; Erusalimsky JD, 2005, EXP GERONTOL, V40, P634, DOI 10.1016/j.exger.2005.04.010; Freedman DA, 2005, EXP CELL RES, V307, P118, DOI 10.1016/j.yexcr.2005.03.025; Goparaju SK, 2005, MOL CELL BIOL, V25, P4237, DOI 10.1128/MCB.25.10.4237-4249.2005; Hampel B, 2006, EXP GERONTOL, V41, P474, DOI 10.1016/j.exger.2006.03.001; Hannun YA, 2008, NAT REV MOL CELL BIO, V9, P139, DOI 10.1038/nrm2329; Hla T, 1999, BIOCHEM PHARMACOL, V58, P201; Huang JH, 2002, J BIOL CHEM, V277, P10760, DOI 10.1074/jbc.M110219200; Huang L, 2005, INVEST OPHTH VIS SCI, V46, P1682, DOI 10.1167/iovs.04-1155; Igarashi Y, 1998, ACTA BIOCHIM POL, V45, P299, DOI 10.18388/abp.1998_4226; Im DS, 2000, J BIOL CHEM, V275, P14281, DOI 10.1074/jbc.275.19.14281; Jala Venkatakrishna R., 2006, V332, P159; JAYADEV S, 1995, J BIOL CHEM, V270, P2047, DOI 10.1074/jbc.270.5.2047; Keese CR, 2004, P NATL ACAD SCI USA, V101, P1554, DOI 10.1073/pnas.0307588100; Lee JF, 2006, J BIOL CHEM, V281, P29190, DOI 10.1074/jbc.M604310200; Lee MJ, 1998, SCIENCE, V279, P1552, DOI 10.1126/science.279.5356.1552; Lee MJ, 1999, CELL, V99, P301, DOI 10.1016/S0092-8674(00)81661-X; Lee MJ, 2001, MOL CELL, V8, P693, DOI 10.1016/S1097-2765(01)00324-0; Lepley D, 2005, CANCER RES, V65, P3788, DOI 10.1158/0008-5472.CAN-04-2311; MAIER JAM, 1990, SCIENCE, V249, P1570, DOI 10.1126/science.2218499; Minamino T, 2004, J MOL CELL CARDIOL, V36, P175, DOI 10.1016/j.yjmcc.2003.11.010; Minamino T, 2002, CIRCULATION, V105, P1541, DOI 10.1161/01.CIR.0000013836.85741.17; Moolenaar WH, 1999, EXP CELL RES, V253, P230, DOI 10.1006/excr.1999.4702; Mouton RE, 2000, MECH AGEING DEV, V113, P169, DOI 10.1016/S0047-6374(99)00105-0; Ogretmen B, 2001, J BIOL CHEM, V276, P24901, DOI 10.1074/jbc.M100314200; PASSANITI A, 1992, LAB INVEST, V67, P519; Rao RP, 2007, P NATL ACAD SCI USA, V104, P11364, DOI 10.1073/pnas.0705049104; Rivard A, 1999, CIRCULATION, V99, P111, DOI 10.1161/01.CIR.99.1.111; Ryu Y, 2002, CIRC RES, V90, P325, DOI 10.1161/hh0302.104455; Sanchez T, 2005, P NATL ACAD SCI USA, V102, P4312, DOI 10.1073/pnas.0409784102; SATO I, 1993, BIOCHEM BIOPH RES CO, V195, P1070, DOI 10.1006/bbrc.1993.2153; Spiegel S, 1999, J LEUKOCYTE BIOL, V65, P341, DOI 10.1002/jlb.65.3.341; Subbarao K, 2004, ARTERIOSCL THROM VAS, V24, P369, DOI 10.1161/01.ATV.0000110503.16605.15; Sugimoto N, 2003, MOL CELL BIOL, V23, P1534, DOI 10.1128/MCB.23.5.1534-1545.2003; Tamama K, 2005, ATHEROSCLEROSIS, V178, P19, DOI 10.1016/j.atherosclerosis.2004.07.032; Venable ME, 2006, MECH AGEING DEV, V127, P473, DOI 10.1016/j.mad.2006.01.003; Venable ME, 1995, J BIOL CHEM, V270, P30701, DOI 10.1074/jbc.270.51.30701; Wang L, 2008, HISTOCHEM CELL BIOL, V129, P579, DOI 10.1007/s00418-008-0389-8; Windh RT, 1999, J BIOL CHEM, V274, P27351, DOI 10.1074/jbc.274.39.27351; Yokoo E, 2004, J BIOCHEM, V135, P673, DOI 10.1093/jb/mvh081; Zondag GCM, 1998, BIOCHEM J, V330, P605, DOI 10.1042/bj3300605	51	38	41	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 31	2008	283	44					30363	30375		10.1074/jbc.M804392200	http://dx.doi.org/10.1074/jbc.M804392200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	364WS	18765664	Green Published, hybrid			2022-12-27	WOS:000260366900080
J	Miller, TE; Ghoshal, K; Ramaswamy, B; Roy, S; Datta, J; Shapiro, CL; Jacob, S; Majumder, S				Miller, Tyler E.; Ghoshal, Kalpana; Ramaswamy, Bhuvaneswari; Roy, Satavisha; Datta, Jharna; Shapiro, Charles L.; Jacob, Samson; Majumder, Sarmila			MicroRNA-221/222 Confers Tamoxifen Resistance in Breast Cancer by Targeting p27Kip1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENE-EXPRESSION; P27(KIP1); MECHANISMS; MICRORNAS; DEREGULATION; CARCINOMAS; MIR-222; CELLS	We explored the role of microRNAs (miRNAs) in acquiring resistance to tamoxifen, a drug successfully used to treat women with estrogen receptor-positive breast cancer. miRNA microarray analysis of MCF-7 cell lines that are either sensitive (parental) or resistant (4-hydroxytamoxifen-resistant (OHTR)) to tamoxifen showed significant (> 1.8-fold) up-regulation of eight miRNAs and marked down-regulation (> 50%) of seven miRNAs in OHTR cells compared with parental MCF-7cells. Increased expression of three of the most promising up-regulated (miR-221, miR-222, and miR181) and down-regulated (miR-21, miR-342, and miR-489) miRNAs was validated by real-time reverse transcription-PCR. The expression of miR-221 and miR-222 was also significantly (2-fold) elevated in HER2/neu-positive primary human breast cancer tissues that are known to be resistant to endocrine therapy compared with HER2/neu-negative tissue samples. Ectopic expression of miR-221/222 rendered the parental MCF-7 cells resistant to tamoxifen. The protein level of the cell cycle inhibitor p27(Kip1), a known target of miR-221/222, was reduced by 50% in OHTR cells and by 28-50% in miR-221/222-overexpressing MCF-7 cells. Furthermore, overexpression of p27(Kip1) in the resistant OHTR cells caused enhanced cell death when exposed to tamoxifen. This is the first study demonstrating a relationship between miR-221/222 expression and HER2/neu overexpression in primary breast tumors that are generally resistant to tamoxifen therapy. This finding also provides the rationale for the application of altered expression of specific miRNAs as a predictive tamoxifen-resistant breast cancer marker.	[Miller, Tyler E.; Ghoshal, Kalpana; Roy, Satavisha; Datta, Jharna; Jacob, Samson; Majumder, Sarmila] Ohio State Univ, Coll Med, Dept Mol & Cellular Biochem, Columbus, OH 43210 USA; [Ramaswamy, Bhuvaneswari; Shapiro, Charles L.; Jacob, Samson] Ohio State Univ, Coll Med, Dept Internal Med, Columbus, OH 43210 USA; [Ghoshal, Kalpana; Ramaswamy, Bhuvaneswari; Shapiro, Charles L.; Jacob, Samson; Majumder, Sarmila] Ohio State Univ, Ctr Comprehens Canc, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University	Majumder, S (corresponding author), Ohio State Univ, Coll Med, Dept Mol & Cellular Biochem, 690D Tzagournis Med Res Facil,420 W 12th Ave, Columbus, OH 43210 USA.	Sarmila.majumder@osumc.edu	Ramaswamy, Bhuvaneswari/E-3919-2011	Miller, Tyler E/0000-0002-1269-1895	National Institutes of Health [CA101956, CA122523, CA086978]; NATIONAL CANCER INSTITUTE [R21CA122523, P01CA101956, R01CA086978] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants CA101956, CA122523, and CA086978. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Abe O, 2005, LANCET, V365, P1687, DOI 10.1016/s0140-6736(05)66544-0; Blain SW, 2002, NAT MED, V8, P1076, DOI 10.1038/nm1002-1076; Carlomagno C, 1996, J CLIN ONCOL, V14, P2702, DOI 10.1200/JCO.1996.14.10.2702; Ciafre SA, 2005, BIOCHEM BIOPH RES CO, V334, P1351, DOI 10.1016/j.bbrc.2005.07.030; Croce CM, 2008, NEW ENGL J MED, V358, P502, DOI 10.1056/NEJMra072367; Datta J, 2007, CANCER RES, V67, P2736, DOI 10.1158/0008-5472.CAN-06-4433; Fan MY, 2006, CANCER RES, V66, P11954, DOI 10.1158/0008-5472.CAN-06-1666; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Iorio MV, 2005, CANCER RES, V65, P7065, DOI 10.1158/0008-5472.CAN-05-1783; Kisanga ER, 2004, CLIN CANCER RES, V10, P2336, DOI 10.1158/1078-0432.CCR-03-0538; le Sage C, 2007, EMBO J, V26, P3699, DOI 10.1038/sj.emboj.7601790; Lee EJ, 2007, INT J CANCER, V120, P1046, DOI 10.1002/ijc.22394; Lewis JS, 2005, MUTAT RES-FUND MOL M, V591, P247, DOI 10.1016/j.mrfmmm.2005.02.028; Liang JY, 2007, NAT CELL BIOL, V9, P218, DOI 10.1038/ncb1537; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Masuda A, 2001, AM J PATHOL, V158, P87, DOI 10.1016/S0002-9440(10)63947-8; Medina R, 2008, CANCER RES, V68, P2773, DOI 10.1158/0008-5472.CAN-07-6754; Meng FY, 2006, GASTROENTEROLOGY, V130, P2113, DOI 10.1053/j.gastro.2006.02.057; Obrero M, 2002, J BIOL CHEM, V277, P45695, DOI 10.1074/jbc.M208092200; Pallante P, 2006, ENDOCR-RELAT CANCER, V13, P497, DOI 10.1677/erc.1.01209; Shou J, 2004, JNCI-J NATL CANCER I, V96, P926, DOI 10.1093/jnci/djh166; Visone R, 2007, ENDOCR-RELAT CANCER, V14, P791, DOI 10.1677/ERC-07-0129; Yang H, 2008, CANCER RES, V68, P425, DOI 10.1158/0008-5472.CAN-07-2488; Zhu L, 2004, CLIN CANCER RES, V10, P4639, DOI 10.1158/1078-0432.CCR-04-0057	24	613	652	0	57	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 31	2008	283	44					29897	29903		10.1074/jbc.M804612200	http://dx.doi.org/10.1074/jbc.M804612200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	364WS	18708351	Green Published, hybrid			2022-12-27	WOS:000260366900034
J	Revert, F; Ventura, I; Martinez-Martinez, P; Granero-Molto, F; Revert-Ros, F; Macias, J; Saus, J				Revert, Fernando; Ventura, Ignacio; Martinez-Martinez, Pilar; Granero-Molto, Froilan; Revert-Ros, Francisco; Macias, Jesus; Saus, Juan			Goodpasture Antigen-binding Protein Is a Soluble Exportable Protein That Interacts with Type IV Collagen IDENTIFICATION OF NOVEL MEMBRANE-BOUND ISOFORMS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CERAMIDE TRANSPORT PROTEIN; ENDOPLASMIC-RETICULUM; SPLICED VARIANT; KINASE; PHOSPHORYLATION; TRAFFICKING; DOMAIN; START; TRANSLATION; METABOLISM	Goodpasture-antigen binding protein (GPBP) is a nonconventional Ser/Thr kinase for basement membrane type IV collagen. Various studies have questioned these findings and proposed that GPBP serves as transporter of ceramide between the endoplasmic reticulum and the Golgi apparatus. Here we show that cells expressed at least two GPBP isoforms resulting from canonical(77-kDa) and noncanonical (91-kDa) mRNA translation initiation. The 77-kDa polypeptide interacted with type IV collagen and localized as a soluble form in the extracellular compartment. The 91-kDa polypeptide and its derived 120-kDa polypeptide associated with cellular membranes and regulated the extracellular levels of the 77-kDa polypeptide. A short motif containing two phenylalanines in an acidic tract and the 26-residue Ser-rich region were required for efficient 77-kDa polypeptide secretion. Removal of the 26-residue Ser-rich region by alternative exon splicing rendered the protein cytosolic and sensitive to the reduction of sphingomyelin cellular levels. These and previous data implicate GPBPs in a multi-compartmental program for protein secretion (i.e. type IV collagen) that includes: 1) phosphorylation and regulation of protein molecular/supramolecular organization and 2) interorganelle ceramide trafficking and regulation of protein cargo transport to the plasma membrane.	[Revert, Fernando; Ventura, Ignacio; Martinez-Martinez, Pilar; Granero-Molto, Froilan; Revert-Ros, Francisco; Macias, Jesus; Saus, Juan] Ctr Invest Principe Felipe, Valencia 46012, Spain; [Saus, Juan] Univ Valencia, Dept Bioquim & Biol Mol, Valencia 46010, Spain	Prince Felipe Research Center; University of Valencia	Saus, J (corresponding author), Ctr Invest Principe Felipe, Avda Autopista Saler 16, Valencia 46012, Spain.	jsaus@cipf.es	REVERT, FERNANDO/ABF-8171-2021; Granero-Moltó, Froilán/H-6975-2017; Ventura, Ignacio/HCI-8162-2022; Revert-Ros, Francisco/AAB-7055-2019	REVERT, FERNANDO/0000-0002-7304-5846; Granero-Moltó, Froilán/0000-0003-4817-5232; Ventura, Ignacio/0000-0001-6426-2999; Martinez Martinez, Pilar/0000-0002-5990-3373; Revert-Ros, Francisco/0000-0002-6162-3370; Saus, Juan/0000-0003-2082-1597	Ministerio de Educacion y Ciencia [SAF97/0065, SAF2000/0047, SAF2001/0453, SAF2003-09772-C03-01, SAF2006-12520-C02-01]; Fundacion "La Caixa," [98/102-00]; Generalitat Valenciana (Spain) [GV04B-285, BM-001/2002]	Ministerio de Educacion y Ciencia(Spanish Government); Fundacion "La Caixa,"(La Caixa Foundation); Generalitat Valenciana (Spain)(Center for Forestry Research & Experimentation (CIEF))	This work was supported by Grants SAF97/0065, SAF2000/0047, SAF2001/0453, SAF2003-09772-C03-01, and SAF2006-12520-C02-01 from Ministerio de Educacion y Ciencia, Grant 98/102-00 from Fundacion "La Caixa," and Grants GV04B-285 and BM-001/2002 from Generalitat Valenciana (Spain) (to J. S.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Alpy F, 2005, J CELL SCI, V118, P2791, DOI 10.1242/jcs.02485; Bendtsen JD, 2004, PROTEIN ENG DES SEL, V17, P349, DOI 10.1093/protein/gzh037; Calvete JJ, 2006, PROTEOMICS, V6, pS237, DOI 10.1002/pmic.200500495; Dowler S, 2000, BIOCHEM J, V351, P19, DOI 10.1042/0264-6021:3510019; Fugmann T, 2007, J CELL BIOL, V178, P15, DOI 10.1083/jcb.200612017; Granero F, 2005, FEBS J, V272, P5291, DOI 10.1111/j.1742-4658.2005.04925.x; Granero-Molto F, 2008, J BIOL CHEM, V283, P20495, DOI 10.1074/jbc.M801806200; Hanada K, 2003, NATURE, V426, P803, DOI 10.1038/nature02188; Hudson BG, 2003, NEW ENGL J MED, V348, P2543, DOI 10.1056/NEJMra022296; Kanekura K, 2006, J BIOL CHEM, V281, P30223, DOI 10.1074/jbc.M605049200; Kawano M, 2006, J BIOL CHEM, V281, P30279, DOI 10.1074/jbc.M605032200; Kumagai K, 2007, J BIOL CHEM, V282, P17758, DOI 10.1074/jbc.M702291200; Lamour NF, 2007, J LIPID RES, V48, P1293, DOI 10.1194/jlr.M700083-JLR200; Lemmon MA, 2000, BIOCHEM J, V350, P1, DOI 10.1042/0264-6021:3500001; Loewen CJR, 2003, EMBO J, V22, P2025, DOI 10.1093/emboj/cdg201; Netzer KO, 1999, J BIOL CHEM, V274, P11267, DOI 10.1074/jbc.274.16.11267; Ni M, 2007, FEBS LETT, V581, P3641, DOI 10.1016/j.febslet.2007.04.045; PEABODY DS, 1989, J BIOL CHEM, V264, P5031; Perry RJ, 2006, MOL BIOL CELL, V17, P2604, DOI 10.1091/mbc.E06-01-0060; Raya A, 1999, J BIOL CHEM, V274, P12642, DOI 10.1074/jbc.274.18.12642; Raya A, 2000, J BIOL CHEM, V275, P40392, DOI 10.1074/jbc.M002769200; REVERT F, 1995, J BIOL CHEM, V270, P13254, DOI 10.1074/jbc.270.22.13254; Revert F, 2007, AM J PATHOL, V171, P1419, DOI 10.2353/ajpath.2007.070205; Rual JF, 2005, NATURE, V437, P1173, DOI 10.1038/nature04209; Soccio RE, 2003, J BIOL CHEM, V278, P22183, DOI 10.1074/jbc.R300003200; Swanton C, 2007, CANCER CELL, V11, P498, DOI 10.1016/j.ccr.2007.04.011; Touriol C, 2003, BIOL CELL, V95, P169, DOI 10.1016/S0248-4900(03)00033-9; Wyles JP, 2002, J BIOL CHEM, V277, P29908, DOI 10.1074/jbc.M201191200; Yang Y, 2005, MOL CELLS, V20, P173; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0	30	24	28	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 31	2008	283	44					30246	30255		10.1074/jbc.M805026200	http://dx.doi.org/10.1074/jbc.M805026200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	364WS	18772132	Green Published, hybrid			2022-12-27	WOS:000260366900069
J	Fan, W; Luo, JY				Fan, Wei; Luo, Jianyuan			RecQ4 Facilitates UV Light-induced DNA Damage Repair through Interaction with Nucleotide Excision Repair Factor Xeroderma Pigmentosum Group A (XPA)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ROTHMUND-THOMSON-SYNDROME; WERNER-SYNDROME; GENE-PRODUCT; PROTEIN; REPLICATION; INVOLVEMENT; PATHWAY; IRRADIATION; EUKARYOTES; INITIATION	Mutations in the RECQL4 helicase gene have been linked to Rothmund-Thomson syndrome, which is characterized by genome instability, cancer susceptibility, and premature aging. To better define the cellular function of the RecQ4 protein, we investigated the subcellular localization of RecQ4 upon treatment of cells with different DNA-damaging agents including-UV irradiation, 4-nitroquinoline 1-oxide, camptothecin, etoposide, hydroxyurea, and H2O2. We found that RecQ4 formed discrete nuclear foci specifically in response to UV irradiation and 4-nitroquinoline 1-oxide. We demonstrated that functional RecQ4 was required for the efficient removal of UV lesions and could rescue UV sensitivity of RecQ4-deficient Rothmund-Thomson syndrome cells. Furthermore, UV treatment also resulted in the colocalization of the nuclear foci formed with RecQ4 and xeroderma pigmentosum group A in human cells. Consistently, RecQ4 could directly interact with xeroderma pigmentosum group A, and this interaction was stimulated by UV irradiation. By fractionating whole cell extracts into cytoplasmic, soluble nuclear, and chromatin-bound fractions, we observed that RecQ4 protein bound more tightly to chromatin upon UV irradiation. Taken together, our findings suggest a role of RecQ4 in the repair of UV-induced DNA damages in human cells.	[Luo, Jianyuan] Univ Massachusetts, Sch Med, Dept Canc Biol, Worcester, MA 01605 USA; Univ Massachusetts, Sch Med, Ctr Canc, Worcester, MA 01605 USA	University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester	Luo, JY (corresponding author), Univ Massachusetts, Sch Med, Dept Canc Biol, 422 LRB,364 Plantat St, Worcester, MA 01605 USA.	Jianyuan.luo@umassmed.edu	Luo, Jianyuan/ABI-7585-2020	Luo, Jianyuan/0000-0001-6057-2914	National Institutes of Health [R01AG026534]; Worcester Foundation Annual Research Award; NATIONAL INSTITUTE ON AGING [R01AG026534] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Worcester Foundation Annual Research Award; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grant R01AG026534 (to J. L.) through the NIA. This work was also supported in part by grants from Worcester Foundation Annual Research Award. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Ababou M, 2002, ONCOGENE, V21, P2079, DOI 10.1038/sj.onc.1205246; Bachrati CZ, 2003, BIOCHEM J, V374, P577, DOI 10.1042/BJ20030491; BERG E, 1987, J AM ACAD DERMATOL, V17, P332, DOI 10.1016/S0190-9622(87)70207-2; Costa RMA, 2003, BIOCHIMIE, V85, P1083, DOI 10.1016/j.biochi.2003.10.017; de Laat WL, 1999, GENE DEV, V13, P768, DOI 10.1101/gad.13.7.768; Harrigan JA, 2006, NUCLEIC ACIDS RES, V34, P745, DOI 10.1093/nar/gkj475; HE ZG, 1995, NATURE, V374, P566, DOI 10.1038/374566a0; Hickson ID, 2003, NAT REV CANCER, V3, P169, DOI 10.1038/nrc1012; Kitao S, 1999, GENOMICS, V61, P268, DOI 10.1006/geno.1999.5959; Kitao S, 1998, GENOMICS, V54, P443, DOI 10.1006/geno.1998.5595; Kumata Y, 2007, BBA-MOL CELL RES, V1773, P556, DOI 10.1016/j.bbamcr.2007.01.005; Li G, 1998, BRIT J DERMATOL, V139, P3; Lindor NM, 2000, AM J MED GENET, V90, P223, DOI 10.1002/(SICI)1096-8628(20000131)90:3<223::AID-AJMG7>3.0.CO;2-Z; Macris MA, 2006, DNA REPAIR, V5, P172, DOI 10.1016/j.dnarep.2005.09.005; Matsuno K, 2006, MOL CELL BIOL, V26, P4843, DOI 10.1128/MCB.02267-05; Park SJ, 2006, DNA CELL BIOL, V25, P696, DOI 10.1089/dna.2006.25.696; Petkovic M, 2005, J CELL SCI, V118, P4261, DOI 10.1242/jcs.02556; Riedl T, 2003, EMBO J, V22, P5293, DOI 10.1093/emboj/cdg489; Sancar A, 2004, ANNU REV BIOCHEM, V73, P39, DOI 10.1146/annurev.biochem.73.011303.073723; Sangrithi MN, 2005, CELL, V121, P887, DOI 10.1016/j.cell.2005.05.015; Vasseur F, 1999, ACTA DERM-VENEREOL, V79, P150; VENNOS EM, 1995, DERMATOL CLIN, V13, P143, DOI 10.1016/S0733-8635(18)30117-7; VENNOS EM, 1992, J AM ACAD DERMATOL, V27, P750, DOI 10.1016/0190-9622(92)70249-F; Werner SR, 2006, BIOCHEM BIOPH RES CO, V345, P403, DOI 10.1016/j.bbrc.2006.04.093; Woo LL, 2006, EXP CELL RES, V312, P3443, DOI 10.1016/j.yexcr.2006.07.023; Wood RD, 1996, ANNU REV BIOCHEM, V65, P135, DOI 10.1146/annurev.bi.65.070196.001031; Wu X, 2007, ONCOGENE, V26, P757, DOI 10.1038/sj.onc.1209828; Wu XM, 2006, CANCER RES, V66, P2997, DOI 10.1158/0008-5472.CAN-05-3403; Wu XM, 2005, ONCOGENE, V24, P4728, DOI 10.1038/sj.onc.1208674; Yin JH, 2004, HUM MOL GENET, V13, P2421, DOI 10.1093/hmg/ddh269	30	56	58	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	OCT 24	2008	283	43					29037	29044		10.1074/jbc.M801928200	http://dx.doi.org/10.1074/jbc.M801928200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	362EB	18693251	Green Published, hybrid			2022-12-27	WOS:000260179900030
J	Lokeshwar, VB; Gomez, P; Kramer, M; Knapp, J; McCornack, MA; Lopez, LE; Fregien, N; Dhir, N; Scherer, S; Klumpp, DJ; Manoharan, M; Soloway, MS; Lokeshwar, BL				Lokeshwar, Vinata B.; Gomez, Pablo; Kramer, Mario; Knapp, Judith; McCornack, Melissa A.; Lopez, Luis E.; Fregien, Nevis; Dhir, Neetika; Scherer, Steve; Klumpp, David J.; Manoharan, Murugesan; Soloway, Mark S.; Lokeshwar, Bal L.			Epigenetic Regulation of HYAL-1 Hyaluronidase Expression IDENTIFICATION OF HYAL-1 PROMOTER	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							WEAK TATA BOX; BLADDER-CANCER; TUMOR-MARKERS; PROSTATE-CANCER; HEPARANASE EXPRESSION; DNA METHYLATION; ACID; GROWTH; HYPOMETHYLATION; TRANSCRIPTION	HYAL-1 (hyaluronoglucosaminidase-1) belongs to the hyaluronidase family of enzymes that degrade hyaluronic acid. HYAL-1 is a marker for cancer diagnosis and a molecular determinant of tumor growth, invasion, and angiogenesis. The regulation of HYAL-1 expression is unknown. Real time reverse transcription-PCR using 11 bladder and prostate cancer cells and 69 bladder tissues showed that HYAL-1 mRNA levels are elevated 10-30-fold in cells/tissues that express high hyaluronidase activity. Although multiple transcription start sites (TSS) for HYAL-1 mRNA were detected in various tissues, the major TSS in many tissues, including bladder and prostate, was at nucleotide 27274 in the cosmid clone LUCA13 (AC002455). By analyzing the 1532 base sequence 5' to this TSS, using cloning and luciferase reporter assays, we identified a TACAAA sequence at position -31 and the minimal promoter region between nucleotides -93 and -38. Mutational analysis identified that nucleotides -73 to -50 (which include overlapping binding consensus sites for SP1, Egr-1, and AP-2), bases C-71 and C-59, and an NF kappa B-binding site (at position -15) are necessary for promoter activity. The chromatin immunoprecipitation assay identified that Egr-1, AP-2, and NF kappa B bind to the promoter in HYAL-1-expressing cells, whereas SP1 binds to the promoter in non-HYAL-1-expressing cells. 5-Aza-2'-deoxycytidine treatment, bisulfite DNA sequencing, and methylation-specific PCR revealed that HYAL-1 expression is regulated by methylation at C-71 and C-59; both Cs are part of the SP1/Egr-1-binding sites. Thus, HYAL-1 expression is epigenetically regulated by the binding of different transcription factors to the methylated and unmethylated HYAL-1 promoter.	[Lokeshwar, Vinata B.; Gomez, Pablo; Kramer, Mario; Knapp, Judith; Lopez, Luis E.; Dhir, Neetika; Manoharan, Murugesan; Soloway, Mark S.; Lokeshwar, Bal L.] Univ Miami, Miller Sch Med, Dept Urol, Miami, FL 33101 USA; [Lokeshwar, Vinata B.; Fregien, Nevis] Univ Miami, Miller Sch Med, Dept Cell Biol & Anat, Miami, FL 33101 USA; [Lokeshwar, Vinata B.; Lokeshwar, Bal L.] Univ Miami, Miller Sch Med, Sylvester Comprehens Canc Ctr, Miami, FL 33101 USA; [McCornack, Melissa A.] Promega Corp, Madison, WI 53711 USA; [Scherer, Steve] Baylor Coll Med, Dept Mol & Human Genet, Human Genome Sequencing Ctr, Houston, TX 77030 USA; [Klumpp, David J.] Northwestern Univ, Feinberg Sch Med, Dept Urol, Chicago, IL 60611 USA	University of Miami; University of Miami; University of Miami; Promega Corporation; Baylor College of Medicine; Northwestern University; Feinberg School of Medicine	Kramer, M (corresponding author), Univ Miami, Miller Sch Med, Dept Urol M 800, POB 016960, Miami, FL 33101 USA.	vlokeshw@med.miami.edu	Kramer, Mario/GZH-1137-2022; Lokeshwar, Bal/O-3196-2019	Lokeshwar, Bal/0000-0002-1763-4718	National Institutes of Health [R01 072821-09, R01 CA 123063-01]; Florida Department of Health Bankhead Coley Cancer Research Program; NATIONAL CANCER INSTITUTE [R01CA123063] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Florida Department of Health Bankhead Coley Cancer Research Program; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 072821-09 and R01 CA 123063-01 (NCI) (to V. B. L.). This work was also supported by Florida Department of Health Bankhead Coley Cancer Research Program Grant. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Aboughalia AH, 2006, ARCH MED RES, V37, P109, DOI 10.1016/j.arcmed.2005.04.019; Chow G, 2005, J BIOL CHEM, V280, P26904, DOI 10.1074/jbc.M413845200; Csoka AB, 2001, MATRIX BIOL, V20, P499, DOI 10.1016/S0945-053X(01)00172-X; Csoka TB, 1997, FEBS LETT, V417, P307, DOI 10.1016/S0014-5793(97)01309-4; Das PM, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-28; Das PM, 2004, J CLIN ONCOL, V22, P4632, DOI 10.1200/JCO.2004.07.151; Droller MJ, 2002, UROL CLIN N AM, V29, P229, DOI 10.1016/S0094-0143(02)00008-3; Ehrlich M, 2002, ONCOGENE, V21, P5400, DOI 10.1038/sj.onc.1205651; Eissa S, 2005, CANCER-AM CANCER SOC, V103, P1356, DOI 10.1002/cncr.20902; Ekici S, 2004, INT J CANCER, V112, P121, DOI 10.1002/ijc.20368; Franzmann EJ, 2003, INT J CANCER, V106, P438, DOI 10.1002/ijc.11252; Frost GI, 1997, BIOCHEM BIOPH RES CO, V236, P10, DOI 10.1006/bbrc.1997.6773; Frost GI, 2000, ONCOGENE, V19, P870, DOI 10.1038/sj.onc.1203317; Golshani R, 2007, INT J CANCER, V120, P1712, DOI 10.1002/ijc.22222; Hascall VC, 2004, BBA-GEN SUBJECTS, V1673, P3, DOI 10.1016/j.bbagen.2004.02.013; Hautmann SH, 2001, J UROLOGY, V165, P2068, DOI 10.1016/S0022-5347(05)66296-9; Klug J, 1996, MOL CELL BIOL, V16, P6398; Li LC, 2002, BIOINFORMATICS, V18, P1427, DOI 10.1093/bioinformatics/18.11.1427; Li LL, 2007, BIOCHEM J, V404, P327, DOI 10.1042/BJ20061757; Lokeshwar VB, 2000, J UROLOGY, V163, P348, DOI 10.1016/S0022-5347(05)68050-0; Lokeshwar VB, 2002, CANCER-AM CANCER SOC, V95, P61, DOI 10.1002/cncr.10652; Lokeshwar VB, 2005, CANCER RES, V65, P7782, DOI 10.1158/0008-5472.CAN-05-1022; Lokeshwar VB, 2005, CANCER RES, V65, P2243, DOI 10.1158/0008-5472.CAN-04-2805; Lokeshwar VB, 2002, J BIOL CHEM, V277, P33654, DOI 10.1074/jbc.M203821200; Lokeshwar VB, 2001, J BIOL CHEM, V276, P11922, DOI 10.1074/jbc.M008432200; Lokeshwar VB, 1999, CANCER RES, V59, P4464; Lokeshwar VB, 2006, CANCER RES, V66, P11219, DOI 10.1158/0008-5472.CAN-06-1121; Meyer T, 1997, J BIOL CHEM, V272, P30709, DOI 10.1074/jbc.272.49.30709; Naomoto Y, 2005, ONCOL REP, V14, P3; Ogishima T, 2005, CLIN CANCER RES, V11, P1028; Ogishima T, 2005, ONCOGENE, V24, P6765, DOI 10.1038/sj.onc.1208811; Ohno S, 2002, J PERIODONTOL, V73, P1331, DOI 10.1902/jop.2002.73.11.1331; Pham HT, 1997, CANCER RES, V57, P1622; Poola I, 2008, CLIN CANCER RES, V14, P1274, DOI 10.1158/1078-0432.CCR-07-4053; Posey JT, 2003, CANCER RES, V63, P2638; Sasaki M, 2003, BIOCHEM BIOPH RES CO, V309, P305, DOI 10.1016/j.bbrc.2003.08.005; Schroeder GL, 2004, J UROLOGY, V172, P1123, DOI 10.1097/01.ju.0000134347.14643.ab; Schulz WA, 2006, J CELL MOL MED, V10, P100, DOI 10.1111/j.1582-4934.2006.tb00293.x; Seifert HH, 2007, EXP MOL PATHOL, V82, P292, DOI 10.1016/j.yexmp.2006.08.002; Selbi W, 2004, J AM SOC NEPHROL, V15, P1199, DOI 10.1097/01.ASN.0000125619.27422.8E; Shteper PJ, 2003, ONCOGENE, V22, P7737, DOI 10.1038/sj.onc.1207056; Shukeir N, 2006, CANCER RES, V66, P9202, DOI 10.1158/0008-5472.CAN-06-1954; Simpson MA, 2008, FRONT BIOSCI-LANDMRK, V13, P5664; Simpson MA, 2006, AM J PATHOL, V169, P247, DOI 10.2353/ajpath.2006.060032; Slevin M, 2007, MATRIX BIOL, V26, P58, DOI 10.1016/j.matbio.2006.08.261; Stern R, 2006, CHEM REV, V106, P818, DOI 10.1021/cr050247k; Stern R, 2005, PATHOL BIOL, V53, P372, DOI 10.1016/j.patbio.2004.12.021; Stern R, 2006, EUR J CELL BIOL, V85, P699, DOI 10.1016/j.ejcb.2006.05.009; Tammi MI, 2002, J BIOL CHEM, V277, P4581, DOI 10.1074/jbc.R100037200; Toole BP, 2005, CELLS TISSUES ORGANS, V179, P66, DOI 10.1159/000084510; Toole BP, 2004, NAT REV CANCER, V4, P528, DOI 10.1038/nrc1391; Vlodavsky I, 2006, PATHOPHYSIOL HAEMO T, V35, P116, DOI 10.1159/000093553; Xue Y, 2006, NUCLEIC ACIDS RES, V34, pW254, DOI 10.1093/nar/gkl207	53	35	36	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 24	2008	283	43					29215	29227		10.1074/jbc.M801101200	http://dx.doi.org/10.1074/jbc.M801101200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	362EB	18718911	hybrid, Green Published			2022-12-27	WOS:000260179900049
J	Markkanen, PMH; Petaja-Repo, UE				Markkanen, Piia M. H.; Petaja-Repo, Ulla E.			N-Glycan-mediated Quality Control in the Endoplasmic Reticulum Is Required for the Expression of Correctly Folded delta-Opioid Receptors at the Cell Surface	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTORS; ASPARAGINE-LINKED OLIGOSACCHARIDES; LUTEINIZING-HORMONE RECEPTOR; SITE-DIRECTED MUTAGENESIS; DISULFIDE BOND FORMATION; PLASMA-MEMBRANE; GLYCOSYLATION SITES; PHARMACOLOGICAL CHAPERONES; RHODOPSIN MATURATION; WILD-TYPE	A great majority of G protein-coupled receptors are modified by N-glycosylation, but the functional significance of this modification for receptor folding and intracellular transport has remained elusive. Here we studied these phenomena by mutating the two N-terminal N-glycosylation sites (Asn(18) and Asn(33)) of the human delta-opioid receptor, and expressing the mutants from the same chromosomal integration site in stably transfected inducible HEK293 cells. Both N-glycosylation sites were used, and their abolishment decreased the steady-state level of receptors at the cell surface. However, pulse-chase labeling, cell surface biotinylation, and immunofluorescence microscopy revealed that this was not because of intracellular accumulation. Instead, the non-N-glycosylated receptors were exported from the endoplasmic reticulum with enhanced kinetics. The results also revealed differences in the significance of the individual N-glycans, as the one attached to Asn33 was found to be more important for endoplasmic reticulum retention of the receptor. The non-N-glycosylated receptors did not show gross functional impairment, but flow cytometry revealed that a fraction of them was incapable of ligand binding at the cell surface. In addition, the receptors that were devoid of N-glycans showed accelerated turnover and internalization and were targeted for lysosomal degradation. The results accentuate the importance of protein conformation-based screening before export from the endoplasmic reticulum, and demonstrate how the system is compromised when N-glycosylation is disrupted. We conclude that N-glycosylation of the delta-opioid receptor is needed to maintain the expression of fully functional and stable receptor molecules at the cell surface.	[Markkanen, Piia M. H.; Petaja-Repo, Ulla E.] Univ Oulu, Inst Biomed, Dept Anat & Cell Biol, FI-90014 Oulu, Finland	University of Oulu	Petaja-Repo, UE (corresponding author), Univ Oulu, Inst Biomed, Dept Anat & Cell Biol, POB 5000, FI-90014 Oulu, Finland.	Ulla.Petaja-Repo@oulu.fi	Markkanen, Piia/ABD-8843-2020; Petäjä-Repo, Ulla/AAV-6115-2021	Markkanen, Piia/0000-0002-7200-6490	Academy of Finland [206230]	Academy of Finland(Academy of Finland)	This work was supported by the Biocenter Oulu and Grant 206230 from the Academy of Finland. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	ALLEN S, 1995, J BIOL CHEM, V270, P4797, DOI 10.1074/jbc.270.9.4797; Apaja PM, 2006, MOL BIOL CELL, V17, P2243, DOI 10.1091/mbc.E05-09-0875; Benya RV, 2000, MOL PHARMACOL, V58, P1490, DOI 10.1124/mol.58.6.1490; Boer U, 2000, BIOCHEM J, V350, P839, DOI 10.1042/0264-6021:3500839; Branza-Nichita N, 2000, J BIOL CHEM, V275, P8169, DOI 10.1074/jbc.275.11.8169; Couvineau A, 1996, BIOCHEMISTRY-US, V35, P1745, DOI 10.1021/bi952022h; Deprez P, 2005, MOL CELL, V19, P183, DOI 10.1016/j.molcel.2005.05.029; Deslauriers B, 1999, BIOCHEM J, V339, P397, DOI 10.1042/0264-6021:3390397; Ellgaard L, 2003, NAT REV MOL CELL BIO, V4, P181, DOI 10.1038/nrm1052; Elliott S, 2004, J BIOL CHEM, V279, P16854, DOI 10.1074/jbc.M311095200; Fan J, 2005, MOL ENDOCRINOL, V19, P2579, DOI 10.1210/me.2004-0301; Frang H, 2003, ASSAY DRUG DEV TECHN, V1, P275, DOI 10.1089/15406580360545080; Free RB, 2007, J BIOL CHEM, V282, P21285, DOI 10.1074/jbc.M701555200; FUKUSHIMA Y, 1995, BIOCHEM J, V310, P553, DOI 10.1042/bj3100553; Gether U, 1997, J BIOL CHEM, V272, P2587, DOI 10.1074/jbc.272.5.2587; GUAN XM, 1992, J BIOL CHEM, V267, P21995; Hebert DN, 1997, J CELL BIOL, V139, P613, DOI 10.1083/jcb.139.3.613; Helenius A, 2004, ANNU REV BIOCHEM, V73, P1019, DOI 10.1146/annurev.biochem.73.011303.073752; Imperiali B, 1999, CURR OPIN CHEM BIOL, V3, P643, DOI 10.1016/S1367-5931(99)00021-6; Karpa KD, 1999, MOL PHARMACOL, V56, P1071, DOI 10.1124/mol.56.5.1071; KAUSHAL S, 1994, P NATL ACAD SCI USA, V91, P4024, DOI 10.1073/pnas.91.9.4024; KNAPP RJ, 1995, FASEB J, V9, P516, DOI 10.1096/fasebj.9.7.7737460; Lanctot PM, 1999, BIOCHEMISTRY-US, V38, P8621, DOI 10.1021/bi9830516; LANDOLTMARTICORENA C, 1994, BIOCHEM J, V302, P253, DOI 10.1042/bj3020253; Leskela TT, 2007, J BIOL CHEM, V282, P23171, DOI 10.1074/jbc.M610896200; Li JG, 2007, BIOCHEMISTRY-US, V46, P10960, DOI 10.1021/bi700443j; Liu Y, 2006, J BIOL CHEM, V281, P31457, DOI 10.1074/jbc.M606643200; Lu M, 2003, TRAFFIC, V4, P416, DOI 10.1034/j.1600-0854.2003.00097.x; MCDOWELL W, 1988, BIOCHIMIE, V70, P1535, DOI 10.1016/0300-9084(88)90290-8; McGinnes LW, 1997, J VIROL, V71, P3083, DOI 10.1128/JVI.71.4.3083-3089.1997; Mellquist JL, 1998, BIOCHEMISTRY-US, V37, P6833, DOI 10.1021/bi972217k; Mentesana PE, 2001, BIOCHEMISTRY-US, V40, P9685, DOI 10.1021/bi0108507; Michineau S, 2004, BIOL CHEM, V385, P49, DOI 10.1515/BC.2004.007; Mizrachi D, 2004, MOL ENDOCRINOL, V18, P1768, DOI 10.1210/me.2003-0406; Morello JP, 2001, BIOCHEMISTRY-US, V40, P6766, DOI 10.1021/bi002699r; NILSSON I, 1993, J BIOL CHEM, V268, P5798; Petaja-Repo UE, 2002, EMBO J, V21, P1628, DOI 10.1093/emboj/21.7.1628; Petaja-Repo UE, 2000, J BIOL CHEM, V275, P13727, DOI 10.1074/jbc.275.18.13727; Petaja-Repo UE, 2001, J BIOL CHEM, V276, P4416, DOI 10.1074/jbc.M007151200; Petaja-Repo UE, 2006, J BIOL CHEM, V281, P15780, DOI 10.1074/jbc.M602267200; Petrescu AJ, 2004, GLYCOBIOLOGY, V14, P103, DOI 10.1093/glycob/cwh008; Pietila EM, 2005, J BIOL CHEM, V280, P26622, DOI 10.1074/jbc.M413815200; Ray K, 1998, J BIOL CHEM, V273, P34558, DOI 10.1074/jbc.273.51.34558; Robert J, 2005, J BIOL CHEM, V280, P42198, DOI 10.1074/jbc.M510180200; Rosenbaum EE, 2006, NEURON, V49, P229, DOI 10.1016/j.neuron.2005.12.011; Ruddock LW, 2006, J CELL SCI, V119, P4373, DOI 10.1242/jcs.03225; SEGLEN PO, 1979, EUR J BIOCHEM, V95, P215, DOI 10.1111/j.1432-1033.1979.tb12956.x; Sharma M, 2004, J CELL BIOL, V164, P923, DOI 10.1083/jcb.200312018; Siffroi-Fernandez S, 2002, EUR J BIOCHEM, V269, P4930, DOI 10.1046/j.1432-1033.2002.03192.x; Trombetta ES, 2003, ANNU REV CELL DEV BI, V19, P649, DOI 10.1146/annurev.cellbio.19.110701.153949; Tuusa JT, 2007, J MOL BIOL, V371, P622, DOI 10.1016/j.jmb.2007.02.108; VANKOPPEN CJ, 1990, J BIOL CHEM, V265, P20887; Waldhoer M, 2004, ANNU REV BIOCHEM, V73, P953, DOI 10.1146/annurev.biochem.73.011303.073940; Webel R, 2000, J BIOL CHEM, V275, P24752, DOI 10.1074/jbc.M002668200; Wujek P, 2004, J BIOL CHEM, V279, P12827, DOI 10.1074/jbc.M313173200	55	48	48	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 24	2008	283	43					29086	29098		10.1074/jbc.M801880200	http://dx.doi.org/10.1074/jbc.M801880200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	362EB	18703511	hybrid, Green Published			2022-12-27	WOS:000260179900036
J	Ulrich, M; Petre, A; Youhnovski, N; Promm, F; Schirle, M; Schumm, M; Pero, RS; Doyle, A; Checkel, J; Kita, H; Thiyagarajan, N; Acharya, KR; Schmid-Grendelmeier, P; Simon, HU; Schwarz, H; Tsutsui, M; Shimokawa, H; Bellon, G; Lee, JJ; Przybylski, M; Doring, G				Ulrich, Martina; Petre, Alina; Youhnovski, Nikolay; Proemm, Franziska; Schirle, Markus; Schumm, Michael; Pero, Ralph S.; Doyle, Alfred; Checkel, James; Kita, Hirohito; Thiyagarajan, Nethaji; Acharya, K. Ravi; Schmid-Grendelmeier, Peter; Simon, Hans-Uwe; Schwarz, Heinz; Tsutsui, Masato; Shimokawa, Hiroaki; Bellon, Gabriel; Lee, James J.; Przybylski, Michael; Doering, Gerd			Post-translational tyrosine nitration of eosinophil granule toxins mediated by eosinophil peroxidase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAJOR BASIC-PROTEIN; NITRIC-OXIDE SYNTHASE; RIBONUCLEOLYTIC ACTIVE-SITE; TRYPANOSOMA-CRUZI; ANGSTROM RESOLUTION; CRYSTAL-STRUCTURE; CATIONIC PROTEIN; IN-VITRO; IDENTIFICATION; CLONING	Nitration of tyrosine residues has been observed during various acute and chronic inflammatory diseases. However, the mechanism of tyrosine nitration and the nature of the proteins that become tyrosine nitrated during inflammation remain unclear. Here we show that eosinophils but not other cell types including neutrophils contain nitrotyrosine-positive proteins in specific granules. Furthermore, we demonstrate that the human eosinophil toxins, eosinophil peroxidase (EPO), major basic protein, eosinophil-derived neurotoxin (EDN) and eosinophil cationic protein (ECP), and the respective murine toxins, are post-translationally modified by nitration at tyrosine residues during cell maturation. High resolution affinity-mass spectrometry identified specific single nitration sites at Tyr(349) in EPO and Tyr(33) in both ECP and EDN. ECP and EDN crystal structures revealed and EPO structure modeling suggested that the nitrated tyrosine residues in the toxins are surface exposed. Studies in EPO-/-, gp91(phox-/-), and NOS-/- mice revealed that tyrosine nitration of these toxins is mediated by EPO in the presence of hydrogen peroxide and minute amounts of NOx. Tyrosine nitration of eosinophil granule toxins occurs during maturation of eosinophils, independent of inflammation. These results provide evidence that post-translational tyrosine nitration is unique to eosinophils.	[Ulrich, Martina; Proemm, Franziska; Doering, Gerd] Univ Klinikum Tubingen, Inst Med Microbiol & Hyg, D-72074 Tubingen, Germany; [Petre, Alina; Youhnovski, Nikolay; Przybylski, Michael] Univ Konstanz, Dept Chem, Analyt Chem Lab, D-78457 Constance, Germany; [Schirle, Markus] Novartis Inst BioMed Res Inc, Cambridge, MA 02139 USA; [Schumm, Michael] Univ Klinikum Tubingen, Childrens Clin, D-72076 Tubingen, Germany; [Pero, Ralph S.; Doyle, Alfred; Lee, James J.] Mayo Clin, Scottsdale, AZ 85259 USA; [Checkel, James; Kita, Hirohito] Mayo Clin, Rochester, MN 55905 USA; [Thiyagarajan, Nethaji; Acharya, K. Ravi] Univ Bath, Dept Biol & Biochem, Bath BA2 7AY, Avon, England; [Schmid-Grendelmeier, Peter] Univ Zurich Hosp, Dept Dermatol, Allergy Unit, CH-8004 Zurich, Switzerland; [Simon, Hans-Uwe] Univ Bern, Inst Pharmakol, CH-3010 Bern, Switzerland; [Schwarz, Heinz] Max Planck Inst Dev Biol, D-72076 Tubingen, Germany; [Tsutsui, Masato] Univ Occupat & Environm Hlth, Sch Med, Dept Pharmacol, Kitakyushu, Fukuoka 8078555, Japan; [Shimokawa, Hiroaki] Tohoku Univ, Dept Cardiovasc Med, Sendai, Miyagi 9808974, Japan; [Bellon, Gabriel] Univ Lyon, Hosp Civils Lyon, F-69600 Lyon, France	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; University of Konstanz; Novartis; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; TUBINGEN UNIVERSITY CHILDRENS HOSPITAL; Mayo Clinic; Mayo Clinic Phoenix; Mayo Clinic; University of Bath; University of Zurich; University Zurich Hospital; University of Bern; Max Planck Society; University of Occupational & Environmental Health - Japan; Tohoku University; CHU Lyon	Doring, G (corresponding author), Wilhelmstr 31, D-72074 Tubingen, Germany.	gerd.doering@med.uni-tuebingen.de	Simon, Hans-Uwe/AAU-7410-2020; Petre, Brindusa-Alina/C-2793-2011	Simon, Hans-Uwe/0000-0002-9404-7736; Acharya, K. Ravi/0000-0002-3009-4058; Shimokawa, Hiroaki/0000-0001-7534-4826	Deutsche Forschungs-gemeinschaft, Bonn, Germany; European Union	Deutsche Forschungs-gemeinschaft, Bonn, Germany(German Research Foundation (DFG)); European Union(European Commission)	This work was supported in part by grants from the Deutsche Forschungs-gemeinschaft, Bonn, Germany, and the European Union (to M. P.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	ABUGHAZALEH RI, 1992, J LEUKOCYTE BIOL, V52, P611, DOI 10.1002/jlb.52.6.611; Aulak KS, 2001, P NATL ACAD SCI USA, V98, P12056, DOI 10.1073/pnas.221269198; Beckman JS, 1996, AM J PHYSIOL-CELL PH, V271, pC1424; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; BUTTERWORTH AE, 1984, ADV PARASIT, V23, P143, DOI 10.1016/S0065-308X(08)60287-0; Cormier SA, 2001, MAMM GENOME, V12, P352, DOI 10.1007/s003350020007; delPozo V, 1997, J IMMUNOL, V158, P859; Denzler KL, 2001, J IMMUNOL, V167, P1672, DOI 10.4049/jimmunol.167.3.1672; Duguet A, 2001, AM J RESP CRIT CARE, V164, P1119, DOI 10.1164/ajrccm.164.7.2010085; Eiserich JP, 1998, NATURE, V391, P393, DOI 10.1038/34923; Fiedler TJ, 2000, J BIOL CHEM, V275, P11964, DOI 10.1074/jbc.275.16.11964; Furtmuller PG, 2006, ARCH BIOCHEM BIOPHYS, V445, P199, DOI 10.1016/j.abb.2005.09.017; Ghosh S, 2006, J IMMUNOL, V176, P5587, DOI 10.4049/jimmunol.176.9.5587; Giembycz MA, 1999, PHARMACOL REV, V51, P213; GLEICH GJ, 1993, ANNU REV MED, V44, P85, DOI 10.1146/annurev.me.44.020193.000505; GOLDSTEIN W, 1986, AM REV RESPIR DIS, V134, P49; HANSEL TT, 1991, J IMMUNOL METHODS, V145, P105, DOI 10.1016/0022-1759(91)90315-7; Horton MA, 1996, J LEUKOCYTE BIOL, V60, P285, DOI 10.1002/jlb.60.2.285; Ischiropoulos H, 1998, ARCH BIOCHEM BIOPHYS, V356, P1, DOI 10.1006/abbi.1998.0755; Jiang Q, 1997, J BIOL CHEM, V272, P32767, DOI 10.1074/jbc.272.52.32767; KOBZIK L, 1997, AM J RESP CRIT CARE, V155, pA60; KOIZUMI C, 1971, J FOOD SCI, V36, P1105; Kurashima K, 1996, LAB INVEST, V75, P689; LARSON KA, 1995, J IMMUNOL, V155, P3002; LEE B, 1971, J MOL BIOL, V55, P379, DOI 10.1016/0022-2836(71)90324-X; Lee NA, 1997, J IMMUNOL, V158, P1332; Leonidas DD, 2001, J BIOL CHEM, V276, P15009, DOI 10.1074/jbc.M010585200; Macht M, 2004, ANAL BIOANAL CHEM, V378, P1102, DOI 10.1007/s00216-003-2159-8; Macias MP, 2000, J LEUKOCYTE BIOL, V67, P567, DOI 10.1002/jlb.67.4.567; MacPherson JC, 2001, J IMMUNOL, V166, P5763, DOI 10.4049/jimmunol.166.9.5763; McGaughey GB, 1998, J BIOL CHEM, V273, P15458, DOI 10.1074/jbc.273.25.15458; METCALF JA, 1986, LABORATORY MANUAL NE, P1; Mohan CG, 2002, BIOCHEMISTRY-US, V41, P12100, DOI 10.1021/bi0264521; MOLINA HA, 1988, AM J TROP MED HYG, V38, P327, DOI 10.4269/ajtmh.1988.38.327; MOLINA HA, 1989, IMMUNOLOGY, V66, P289; Morishita T, 2005, P NATL ACAD SCI USA, V102, P10616, DOI 10.1073/pnas.0502236102; MOTOJIMA S, 1989, AM REV RESPIR DIS, V139, P801, DOI 10.1164/ajrccm/139.3.801; NICHOLLS P, 1964, BIOCHEM J, V90, P331, DOI 10.1042/bj0900331; NOGUEIRA NM, 1982, J IMMUNOL, V128, P1705; Ohmori J, 1996, INT ARCH ALLERGY IMM, V111, P30, DOI 10.1159/000237341; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; Pero RS, 2007, P NATL ACAD SCI USA, V104, P4371, DOI 10.1073/pnas.0700185104; Pfeiffer S, 2001, FASEB J, V15, P2355, DOI 10.1096/fj.01-0295com; POLLOCK JD, 1995, NAT GENET, V9, P202, DOI 10.1038/ng0295-202; Popken-Harris P, 1998, BLOOD, V92, P623, DOI 10.1182/blood.V92.2.623.414k32_623_631; RAPPOPORY Z, 1984, CRC HDB TABLES ORGAN, P20; ROSENBERG HF, 1995, J BIOL CHEM, V270, P30234; Saleh D, 1997, AM J RESP CRIT CARE, V155, P1763, DOI 10.1164/ajrccm.155.5.9154889; Sampson JB, 1998, ARCH BIOCHEM BIOPHYS, V356, P207, DOI 10.1006/abbi.1998.0772; Schwarz Heinz, 2007, Methods Mol Biol, V369, P229; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; TEN RM, 1989, J EXP MED, V169, P1757, DOI 10.1084/jem.169.5.1757; vanderVliet A, 1997, J BIOL CHEM, V272, P7617, DOI 10.1074/jbc.272.12.7617; VILLALTA F, 1987, J PROTOZOOL, V34, P285, DOI 10.1111/j.1550-7408.1987.tb03176.x; Wang JG, 2006, ARCH BIOCHEM BIOPHYS, V445, P256, DOI 10.1016/j.abb.2005.10.008; WASMOEN TL, 1988, J BIOL CHEM, V263, P12559; Wu WJ, 1999, J BIOL CHEM, V274, P25933, DOI 10.1074/jbc.274.36.25933; Yamakura F, 1998, J BIOL CHEM, V273, P14085, DOI 10.1074/jbc.273.23.14085; YOUNG JD, 1986, NATURE, V321, P613, DOI 10.1038/321613a0; Zanardo RCO, 1997, P NATL ACAD SCI USA, V94, P14111, DOI 10.1073/pnas.94.25.14111	60	39	47	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 17	2008	283	42					28629	28640		10.1074/jbc.M801196200	http://dx.doi.org/10.1074/jbc.M801196200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	359EN	18694936	Green Published, Green Submitted, hybrid			2022-12-27	WOS:000259969300065
J	Eisenberg, S; Giehl, K; Henis, YI; Ehrlich, M				Eisenberg, Sharon; Giehl, Klaudia; Henis, Yoav I.; Ehrlich, Marcelo			Differential interference of chlorpromazine with the membrane interactions of oncogenic K-Ras and its effects on cell growth	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLASMA-MEMBRANE; RECEPTOR ACTIVATION; PROTEINS; SURFACE; CANCER; DRUGS; PALMITOYLATION; INHIBITORS; PATHWAY; GOLGI	Membrane anchorage of Ras proteins is important for their signaling and oncogenic potential. K-Ras4B (K-Ras), the Ras isoform most often mutated in human cancers, is the only Ras isoform where a polybasic motif contributes essential electrostatic interactions with the negatively charged cytoplasmic leaflet. Here we studied the effects of the cationic amphiphilic drug chlorpromazine (CPZ) on the membrane association of oncogenic K-Ras(G12V), cell proliferation, and apoptosis. Combining live cell microscopy, FRAP beam size analysis, and cell fractionation studies, we show that CPZ reduces the association of GFP-K-Ras(G12V) with the plasma membrane and increases its exchange between plasma membrane and cytoplasmic pools. These effects appear to depend on electrostatic interactions because the membrane association of another related protein that has a membrane-interacting polybasic cluster (Rac1(G12V)) was also affected, whereas that of H-Ras was not. The weakened association with the plasma membrane led to a higher fraction of GFP-K-Ras(G12V) in the cytoplasm and in internal membranes, accompanied by either cell cycle arrest (PANC-1 cells) or apoptosis (Rat-1 fibroblasts), the latter being in correlation with the targeting of K-Ras(G12V) to mitochondria. In accord with these results, CPZ compromised the transformed phenotype of PANC-1 cells, as indicated by inhibition of cell migration and growth in soft agar.	[Ehrlich, Marcelo] Tel Aviv Univ, George S Wise Fac Life Sci, Dept Cell Res & Immunol, IL-69978 Tel Aviv, Israel; [Eisenberg, Sharon; Henis, Yoav I.] Tel Aviv Univ, George S Wise Fac Life Sci, Dept Neurobiol, IL-69978 Tel Aviv, Israel; [Giehl, Klaudia] Univ Ulm, Med Ctr, Inst Pharmacol & Toxicol, D-98070 Ulm, Germany; [Giehl, Klaudia] Univ Ulm, Med Ctr, Dept Internal Med 1, D-98070 Ulm, Germany	Tel Aviv University; Tel Aviv University; Ulm University; Ulm University	Ehrlich, M (corresponding author), Tel Aviv Univ, George S Wise Fac Life Sci, Dept Cell Res & Immunol, IL-69978 Tel Aviv, Israel.	henis@post.tau.ac; marceloe@tauex.tau.ac.il		Henis, Yoav/0000-0002-1408-3877; Ehrlich, Marcelo/0000-0002-2352-1808	Jacqueline Seroussi Memorial Foundation for Cancer Research	Jacqueline Seroussi Memorial Foundation for Cancer Research	This work was supported in part by an award from the Jacqueline Seroussi Memorial Foundation for Cancer Research (to Y. I. H.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	AGARD DA, 1989, METHOD CELL BIOL, V30, P353; BARBACID M, 1987, ANNU REV BIOCHEM, V56, P779, DOI 10.1146/annurev.bi.56.070187.004023; Basso AD, 2006, J LIPID RES, V47, P15, DOI 10.1194/jlr.R500012-JLR200; Bendetz-Nezer S, 2007, J BIOL CHEM, V282, P25114, DOI 10.1074/jbc.M703120200; Bivona TG, 2006, MOL CELL, V21, P481, DOI 10.1016/j.molcel.2006.01.012; BOS JL, 1989, CANCER RES, V49, P4682; Chen JY, 2003, BBA-BIOMEMBRANES, V1616, P95, DOI 10.1016/S0005-2736(03)00229-3; Chen LM, 2005, WORLD J GASTROENTERO, V11, P831, DOI 10.3748/wjg.v11.i6.831; Chiu VK, 2002, NAT CELL BIOL, V4, P343, DOI 10.1038/ncb783; Dreissigacker U, 2006, CELL SIGNAL, V18, P1156, DOI 10.1016/j.cellsig.2005.09.004; Eisenberg S, 2006, MOL CELL BIOL, V26, P7190, DOI 10.1128/MCB.01059-06; Fivaz M, 2005, J CELL BIOL, V170, P429, DOI 10.1083/jcb.200409157; Fleming JB, 2005, MOL CANCER RES, V3, P413, DOI 10.1158/1541-7786.MCR-04-0206; FORD JM, 1989, MOL PHARMACOL, V35, P105; Friday BB, 2005, BBA-REV CANCER, V1756, P127, DOI 10.1016/j.bbcan.2005.08.001; FUJITA K, 1958, NATURE, V181, P54, DOI 10.1038/181054a0; Golebiewska U, 2006, BIOPHYS J, V91, P588, DOI 10.1529/biophysj.106.081562; Gomez GA, 2007, FEBS J, V274, P2210, DOI 10.1111/j.1742-4658.2007.05758.x; Haklai R, 1998, BIOCHEMISTRY-US, V37, P1306, DOI 10.1021/bi972032d; Hancock JF, 2005, BIOCHEM J, V389, P1, DOI 10.1042/BJ20050231; HANCOCK JF, 1990, CELL, V63, P133, DOI 10.1016/0092-8674(90)90294-O; HANCOCK JF, 1991, EMBO J, V10, P4033, DOI 10.1002/j.1460-2075.1991.tb04979.x; Hancock JF, 2003, NAT REV MOL CELL BIO, V4, P373, DOI 10.1038/nrm1105; Henis YI, 2006, METHODS, V40, P183, DOI 10.1016/j.ymeth.2006.02.003; Heo WD, 2006, SCIENCE, V314, P1458, DOI 10.1126/science.1134389; Illenberger D, 2003, J BIOL CHEM, V278, P8645, DOI 10.1074/jbc.M211971200; Kfir S, 2005, MOL CELL BIOL, V25, P8239, DOI 10.1128/MCB.25.18.8239-8250.2005; Kloog Y, 2004, SEMIN CANCER BIOL, V14, P253, DOI 10.1016/j.semcancer.2004.04.004; Knauf JA, 2006, J BIOL CHEM, V281, P3800, DOI 10.1074/jbc.M511690200; Koera K, 1997, ONCOGENE, V15, P1151, DOI 10.1038/sj.onc.1201284; Laude AJ, 2008, J CELL SCI, V121, P421, DOI 10.1242/jcs.020107; Liu X, 2004, ONCOGENE, V23, P763, DOI 10.1038/sj.onc.1207188; Lopez-Munoz Francisco, 2005, Ann Clin Psychiatry, V17, P113, DOI 10.1080/10401230591002002; McLaughlin S, 2002, ANNU REV BIOPH BIOM, V31, P151, DOI 10.1146/annurev.biophys.31.082901.134259; Motohashi Noboru, 2000, Current Drug Targets, V1, P237, DOI 10.2174/1389450003349191; Murakoshi H, 2004, P NATL ACAD SCI USA, V101, P7317, DOI 10.1073/pnas.0401354101; Niv H, 1999, J BIOL CHEM, V274, P1606, DOI 10.1074/jbc.274.3.1606; Niv H, 2002, J CELL BIOL, V157, P865, DOI 10.1083/jcb.200202009; Nordenberg J, 1999, BIOCHEM PHARMACOL, V58, P1229, DOI 10.1016/S0006-2952(99)00156-2; OLIVER MH, 1989, J CELL SCI, V92, P513; POLLIACK A, 1972, CANCER RES, V32, P1912; Prior IA, 2003, J CELL BIOL, V160, P165, DOI 10.1083/jcb.200209091; Quatela SE, 2006, CURR OPIN CELL BIOL, V18, P162, DOI 10.1016/j.ceb.2006.02.004; Rocks O, 2006, CURR OPIN CELL BIOL, V18, P351, DOI 10.1016/j.ceb.2006.06.007; SCHRIER SL, 1992, BLOOD, V79, P782; Sengupta P, 2007, J BIOL CHEM, V282, P8474, DOI 10.1074/jbc.M607211200; SOFER A, 1995, J BIOL CHEM, V270, P12117, DOI 10.1074/jbc.270.20.12117; Voice JK, 1999, J BIOL CHEM, V274, P17164, DOI 10.1074/jbc.274.24.17164; Walsh AB, 2001, J BIOL CHEM, V276, P15609, DOI 10.1074/jbc.M010573200; Welman A, 2000, ONCOGENE, V19, P4582, DOI 10.1038/sj.onc.1203818; Yeung T, 2006, SCIENCE, V313, P347, DOI 10.1126/science.1129551; Zhang FL, 1996, ANNU REV BIOCHEM, V65, P241, DOI 10.1146/annurev.bi.65.070196.001325	52	25	25	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 3	2008	283	40					27279	27288		10.1074/jbc.M804589200	http://dx.doi.org/10.1074/jbc.M804589200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	353RT	18693247	hybrid			2022-12-27	WOS:000259586600047
J	Breslow, R				Breslow, Ronald			Biomimetic Chemistry: Biology as an Inspiration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							THIAMINE ACTION; MODEL SYSTEMS; MECHANISM; RIBONUCLEASE; CATALYSIS; TURNOVERS; STEROIDS; MIMICS; DNA		Columbia Univ, Dept Chem, New York, NY 10027 USA	Columbia University	Breslow, R (corresponding author), Columbia Univ, Dept Chem, New York, NY 10027 USA.				the Ronald Breslow Award	the Ronald Breslow Award	The American Chemical Society has established an annual prize, the Ronald Breslow Award in Biomimetic Chemistry.	BALL P, 2001, STORIES INVISIBLE GU; Biscoe MR, 2003, J AM CHEM SOC, V125, P12718, DOI 10.1021/ja0379924; BRESLOW R, 1958, J AM CHEM SOC, V80, P3719, DOI 10.1021/ja01547a064; BRESLOW R, 1959, J AM CHEM SOC, V81, P3080, DOI 10.1021/ja01521a042; BRESLOW R, 1957, J AM CHEM SOC, V79, P1762, DOI 10.1021/ja01564a064; Breslow R, 2005, ARTIFICIAL ENZYMES, P1, DOI 10.1002/3527606645; BRESLOW R, 1993, J AM CHEM SOC, V115, P10988, DOI 10.1021/ja00076a066; Breslow R, 2002, J AM CHEM SOC, V124, P3622, DOI 10.1021/ja012293h; BRESLOW R, 1990, P NATL ACAD SCI USA, V87, P167, DOI 10.1073/pnas.87.1.167; BRESLOW R, 1972, CHEM SOC REV, V1, P553, DOI 10.1039/cs9720100553; BRESLOW R, 1991, TETRAHEDRON, V47, P2365, DOI 10.1016/S0040-4020(01)81774-9; Breslow R, 1998, CHEM BIOL, V5, pR27, DOI 10.1016/S1074-5521(98)90138-7; Breslow R, 1996, PURE APPL CHEM, V68, P2037, DOI 10.1351/pac199668112037; BRESLOW R, 1994, PURE APPL CHEM, V66, P1573, DOI 10.1351/pac199466081573; BRESLOW R, 1974, J AM CHEM SOC, V96, P6791, DOI 10.1021/ja00828a058; BRESLOW R, 1973, J AM CHEM SOC, V95, P3251, DOI 10.1021/ja00791a031; Breslow R, 1997, P NATL ACAD SCI USA, V94, P11156, DOI 10.1073/pnas.94.21.11156; Breslow R, 1996, J AM CHEM SOC, V118, P6588, DOI 10.1021/ja9526933; BRESLOW R, 1995, ACCOUNTS CHEM RES, V28, P146, DOI 10.1021/ar00051a008; BRESLOW R, 1957, CHEM IND-LONDON, P893; Breslow R, 2005, ARTIFICIAL ENZYMES, P1, DOI 10.1002/3527606645.ch1; Klotz IM, 2005, ARTIFICIAL ENZYMES, P63, DOI 10.1002/3527606645.ch3; Levine M, 2008, ORG LETT, V10, P2433, DOI 10.1021/ol8007099; Liu L, 2004, J AM CHEM SOC, V126, P8136, DOI 10.1021/ja048671a; Liu L, 2002, J AM CHEM SOC, V124, P12660, DOI 10.1021/ja028151k; Liu L, 2005, ARTIFICIAL ENZYMES, P37, DOI 10.1002/3527606645.ch2; Marks PA, 2007, NAT BIOTECHNOL, V25, P84, DOI 10.1038/nbt1272; Sheppard TL, 1996, J AM CHEM SOC, V118, P9810, DOI 10.1021/ja962184g	28	66	71	1	53	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 16	2009	284	3					1337	1342		10.1074/jbc.X800011200	http://dx.doi.org/10.1074/jbc.X800011200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	392VK	18784073	hybrid			2022-12-27	WOS:000262330100001
J	Kamdar, K; Maemoto, A; Qu, XQ; Young, SK; Ouellette, AJ				Kamdar, Karishma; Maemoto, Atsuo; Qu, Xiaoqing; Young, Steven K.; Ouellette, Andre J.			In Vitro Activation of the Rhesus Macaque Myeloid alpha-Defensin Precursor proRMAD-4 by Neutrophil Serine Proteinases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOUSE CRYPTDIN-4; MATRIX METALLOPROTEINASE-7; DISULFIDE ARRAY; INNATE IMMUNITY; SMALL-INTESTINE; SALT BRIDGE; GRANULES; CELLS; DETERMINANTS; LEUKOCYTES	alpha-Defensins are mammalian antimicrobial peptides expressed mainly by cells of myeloid lineage or small intestinal Paneth cells. The peptides are converted from inactive 8.5-kDa precursors to membrane-disruptive forms by post-translational proteolytic events. Because rhesus myeloid pro-alpha-defensin-4 (proRMAD-4((20-94))) lacks bactericidal peptide activity in vitro, we tested whether neutrophil azurophil granule serine proteinases, human neutrophil elastase (NE), cathepsin G (CG), and proteinase-3 (P3) have in vitro convertase activity. Only NE cleaved proRMAD-4((20-94)) at the native RMAD-4Nterminus to produce fully processed, bactericidal RMAD-4((62-94)). The final CG cleavage product was RMAD-4((55-94)), and P3 produced both RMAD-4((55-94)) and RMAD-4((57-94)). Nevertheless, NE, CG, and P3 digests of proRMAD4 and purified RMAD-4((62-94)), RMAD-4((55-94)), and RMAD-4((57-94)) peptides had equivalent in vitro bactericidal activities. Bactericidal peptide activity assays of proRMAD-4((20-94)) variants containing complete charge-neutralizing D/E to N/Q or D/E to A substitutions showed that (DE/NQ)-proRMAD-4((20-94)) and (DE/A)-proRMAD-4((20-94)) were as active as mature RMAD-4((62-94)). Therefore, proregion Asp and Glu side chains inhibit the RMAD-4 component of full-length proRMAD-4((20-94)), perhaps by a combination of charge-neutralizing and hydrogen-bonding interactions. Although native RMAD-4((62-94)) resists NE, CG, and P3 proteolysis completely, RMAD-4((62-94)) variants with disulfide pairing disruptions or lacking disulfide bonds were degraded extensively, evidence that the disulfide array protects the alpha-defensin moiety from degradation by the myeloid converting enzymes. These in vitro analyses support the conclusion that rhesus macaque myeloid pro-alpha-defensins are converted to active forms by serine proteinases that co-localize in azurophil granules.	[Kamdar, Karishma; Maemoto, Atsuo; Qu, Xiaoqing; Young, Steven K.; Ouellette, Andre J.] Univ Calif Irvine, Coll Hlth Sci, Sch Med, Dept Pathol & Lab Med, Irvine, CA 92697 USA; [Ouellette, Andre J.] Univ Calif Irvine, Coll Hlth Sci, Sch Med, Dept Microbiol & Mol Genet, Irvine, CA 92697 USA	University of California System; University of California Irvine; University of California System; University of California Irvine	Ouellette, AJ (corresponding author), Univ Calif Irvine, Coll Hlth Sci, Sch Med, Dept Pathol & Lab Med, Med Sci D440, Irvine, CA 92697 USA.	aouellet@uci.edu		Young, Steven/0000-0002-1586-5651	National Institutes of Health [AI059346, DK044632]; Human Frontiers Science Program; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI059346] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R55DK044632, R01DK044632] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Human Frontiers Science Program(Human Frontier Science Program); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants AI059346 and DK044632 and the Human Frontiers Science Program. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Aarbiou J, 2002, J LEUKOCYTE BIOL, V72, P167; Arnljots K, 1998, LEUKEMIA, V12, P1789, DOI 10.1038/sj.leu.2401202; Ayabe T, 2002, J BIOL CHEM, V277, P5219, DOI 10.1074/jbc.M109410200; BAINTON DF, 1971, J EXP MED, V134, P907, DOI 10.1084/jem.134.4.907; Borregaard N, 2007, TRENDS IMMUNOL, V28, P340, DOI 10.1016/j.it.2007.06.002; Cowland JB, 1999, J LEUKOCYTE BIOL, V66, P989, DOI 10.1002/jlb.66.6.989; GANZ T, 1985, J CLIN INVEST, V76, P1427, DOI 10.1172/JCI112120; GANZ T, 1993, BLOOD, V82, P641; Ganz T, 2003, NAT REV IMMUNOL, V3, P710, DOI 10.1038/nri1180; Ghosh D, 2002, NAT IMMUNOL, V3, P583, DOI 10.1038/ni797; LEHRER RI, 1988, J IMMUNOL METHODS, V108, P153, DOI 10.1016/0022-1759(88)90414-0; LEHRER RI, 1991, CELL, V64, P229, DOI 10.1016/0092-8674(91)90632-9; Maemoto A, 2004, J BIOL CHEM, V279, P44188, DOI 10.1074/jbc.M406154200; Ouellette AJ, 2006, CURR TOP MICROBIOL, V306, P1; Rosengren KJ, 2006, J BIOL CHEM, V281, P28068, DOI 10.1074/jbc.M604992200; Satchell DP, 2003, PEPTIDES, V24, P1795, DOI 10.1016/j.peptides.2003.08.020; Satchell DP, 2003, J BIOL CHEM, V278, P13838, DOI 10.1074/jbc.M212115200; Selsted M E, 1993, Genet Eng (N Y), V15, P131; Selsted ME, 2005, NAT IMMUNOL, V6, P551, DOI 10.1038/ni1206; SELSTED ME, 1989, J BIOL CHEM, V264, P4003; Shirafuji Y, 2003, J BIOL CHEM, V278, P7910, DOI 10.1074/jbc.M210600200; Tanabe H, 2004, J VIROL, V78, P11622, DOI 10.1128/JVI.78.21.11622-11631.2004; Tanabe H, 2004, J BIOL CHEM, V279, P11976, DOI 10.1074/jbc.M310251200; Tanabe H, 2004, INFECT IMMUN, V72, P1470, DOI 10.1128/IAI.72.3.1470-1478.2004; Tang YQ, 1999, INFECT IMMUN, V67, P6139, DOI 10.1128/IAI.67.11.6139-6144.1999; Valore EV, 1996, J CLIN INVEST, V97, P1624, DOI 10.1172/JCI118588; VALORE EV, 1992, BLOOD, V79, P1538; Weeks CS, 2006, J BIOL CHEM, V281, P28932, DOI 10.1074/jbc.M602041200; WHITE SH, 1995, CURR OPIN STRUC BIOL, V5, P521, DOI 10.1016/0959-440X(95)80038-7; Wilson CL, 1999, SCIENCE, V286, P113, DOI 10.1126/science.286.5437.113; Woessner JF, 2004, HDB PROTEOLYTIC ENZY; Wu ZB, 2003, P NATL ACAD SCI USA, V100, P8880, DOI 10.1073/pnas.1533186100; Wu ZB, 2005, J BIOL CHEM, V280, P43039, DOI 10.1074/jbc.M510562200	33	17	17	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 21	2008	283	47					32361	32368		10.1074/jbc.M805296200	http://dx.doi.org/10.1074/jbc.M805296200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	372HW	18775986	hybrid, Green Published			2022-12-27	WOS:000260893700023
J	Akiduki, S; Ikemoto, MJ				Akiduki, Saori; Ikemoto, Mitsushi J.			Modulation of the Neural Glutamate Transporter EAAC1 by the Addicsin-interacting Protein ARL6IP1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EXPRESSION PROFILE; FUNCTIONAL-CHARACTERIZATION; MOUSE-BRAIN; C6 GLIOMA; KINASE-C; LOCALIZATION; GENE; ADDICSIN/GTRAP3-18; NEURODEGENERATION; IDENTIFICATION	Addicsin (Arl6ip5) is a murine homologue of rat glutamate transporter-associated protein 3-18 (GTRAP3-18), a putative negative modulator of Na+-dependent neural glutamate transporter-excitatory amino acid carrier 1 (EAAC1). Here we report that ADP-ribosylation factor-like 6 interacting protein 1 (Arl6ip1) is a novel addicsin-associated partner that indirectly promotes EAAC1-mediated glutamate transport activity in a protein kinase C activity-dependent manner. Like addicsin, Arl6ip1 is expressed in numerous tissues and proved likely to be co-localized with addicsin in certain neurons in the matured brain. Arl6ip1 was not translocated from the subcellular compartments under any of the test conditions and had no association with any molecules on the plasma membrane. Immunoprecipitation assay demonstrated that Arl6ip1 bound directly to addicsin and that the hydrophobic region located at amino acids 103-117 of addicsin was crucial to the formation of the Arl6ip1-addicsin heterodimer and addicsin homodimer. Glutamate transport assay revealed that increasing the expression of Arl6ip1 in C6BU-1 cells markedly enhanced Na+-dependent EAAC1-mediated glutamate transport activity in the presence of 100 nM phorbol 12-myristate 13-acetate. Under these conditions, kinetic analyses demonstrated that EAAC1 altered glutamate transport activity by increasing its glutamate affinity but not its maximal velocity. Meanwhile, increasing expression of addicsin Y110A/L112A mutant lacking binding ability for Arl6ip1 showed no enhancement of EAAC1-mediated glutamate transport activity, regardless of phorbol 12-myristate 13-acetate activation, suggesting that association between addicsin and Arl6ip1 causes altered EAAC1-mediated glutamate transport activity. Our findings suggest that Arl6ip1 is a novel addicsin-associated partner that promotes EAAC1-mediated glutamate transport activity by decreasing the number of addicsin molecules available for interaction with EAAC1.	[Akiduki, Saori; Ikemoto, Mitsushi J.] Natl Inst Adv Ind Sci & Technol, Age Dimens Res Ctr, Tsukuba, Ibaraki 3058566, Japan; [Ikemoto, Mitsushi J.] Toho Univ, Grad Sch Sci, Chiba 2748510, Japan	National Institute of Advanced Industrial Science & Technology (AIST); Toho University	Ikemoto, MJ (corresponding author), Natl Inst Adv Ind Sci & Technol, Age Dimens Res Ctr, Tsukuba Cent 6,1-1-1 Higashi, Tsukuba, Ibaraki 3058566, Japan.	m.ikemoto@aist.go.jp	IKEMOTO, Mitsushi J/L-8861-2018	IKEMOTO, Mitsushi J/0000-0001-5799-0672	National Institute of Advanced Industrial Science and Technology, Japan	National Institute of Advanced Industrial Science and Technology, Japan	This work was supported by the National Institute of Advanced Industrial Science and Technology, Japan (to M. J. I.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Akiduki S, 2007, NEUROSCI LETT, V426, P149, DOI 10.1016/j.neulet.2007.08.056; Aoyama K, 2006, NAT NEUROSCI, V9, P119, DOI 10.1038/nn1609; Arriza JL, 1997, P NATL ACAD SCI USA, V94, P4155, DOI 10.1073/pnas.94.8.4155; Butchbach MER, 2002, GENE, V292, P81, DOI 10.1016/S0378-1119(02)00669-8; Chen R, 2007, FREE RADICAL BIO MED, V42, P1704, DOI 10.1016/j.freeradbiomed.2007.02.018; Danbolt NC, 2001, PROG NEUROBIOL, V65, P1, DOI 10.1016/S0301-0082(00)00067-8; Davis KE, 1998, J NEUROSCI, V18, P2475; Dowd LA, 1996, J NEUROCHEM, V67, P508, DOI 10.1046/j.1471-4159.1996.67020508.x; Fo CS, 2006, GENE, V371, P154, DOI 10.1016/j.gene.2005.12.009; Furuta A, 1997, NEUROSCIENCE, V81, P1031, DOI 10.1016/S0306-4522(97)00252-2; Gonzalez MI, 2004, MOL INTERV, V4, P48, DOI 10.1124/mi.4.1.48; Gonzalez MI, 2002, MOL PHARMACOL, V62, P901, DOI 10.1124/mol.62.4.901; Huerta B, 2006, SYNAPSE, V59, P394, DOI 10.1002/syn.20250; Ikemoto MJ, 2002, NEUROREPORT, V13, P2079, DOI 10.1097/00001756-200211150-00018; Ingley E, 1999, FEBS LETT, V459, P69, DOI 10.1016/S0014-5793(99)01188-6; Inoue K, 2005, NEUROSCI LETT, V386, P184, DOI 10.1016/j.neulet.2005.06.013; Kanai Y, 1995, NEUROREPORT, V6, P2357, DOI 10.1097/00001756-199511270-00020; KANAI Y, 1992, NATURE, V360, P467, DOI 10.1038/360467a0; Kiryu-Seo S, 2006, EMBO J, V25, P3411, DOI 10.1038/sj.emboj.7601225; Levenson J, 2002, NAT NEUROSCI, V5, P155, DOI 10.1038/nn791; Lin CLG, 2001, NATURE, V410, P84, DOI 10.1038/35065084; Palos TP, 1996, MOL BRAIN RES, V37, P297, DOI 10.1016/0169-328X(95)00331-L; Peghini P, 1997, EMBO J, V16, P3822, DOI 10.1093/emboj/16.13.3822; Pettersson M, 2000, GENOMICS, V68, P351, DOI 10.1006/geno.2000.6278; Pow DV, 2000, NEUROSCI LETT, V280, P21, DOI 10.1016/S0304-3940(99)00988-X; ROTHSTEIN JD, 1994, NEURON, V13, P713, DOI 10.1016/0896-6273(94)90038-8; Rothstein JD, 1996, NEURON, V16, P675, DOI 10.1016/S0896-6273(00)80086-0; ROTHSTEIN JD, 1993, P NATL ACAD SCI USA, V90, P6591, DOI 10.1073/pnas.90.14.6591; Sepkuty JP, 2002, J NEUROSCI, V22, P6372; Takai Y, 2001, PHYSIOL REV, V81, P153, DOI 10.1152/physrev.2001.81.1.153; Tomoda K, 2002, J BIOL CHEM, V277, P2302, DOI 10.1074/jbc.M104431200; TONG G, 1994, NEURON, V13, P1195, DOI 10.1016/0896-6273(94)90057-4; Zerangue N, 1996, NATURE, V383, P634, DOI 10.1038/383634a0	33	25	28	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 14	2008	283	46					31323	31332		10.1074/jbc.M801570200	http://dx.doi.org/10.1074/jbc.M801570200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	370KJ	18684713	hybrid			2022-12-27	WOS:000260760800009
J	Tateishi, K; He, J; Taranova, O; Liang, GY; D'Alessio, AC; Zhang, Y				Tateishi, Keisuke; He, Jin; Taranova, Olena; Liang, Gaoyang; D'Alessio, Ana C.; Zhang, Yi			Generation of Insulin-secreting Islet-like Clusters from Human Skin Fibroblasts	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLURIPOTENT STEM-CELLS; DIFFERENTIATION; ADULT; TISSUE	Increasing evidence suggests that islet cell transplantation for patients with type I diabetes holds great promise for achieving insulin independence. However, the extreme shortage of matched organ donors and the necessity for chronic immunosuppression has made it impossible for this treatment to be used for the general diabetic population. Recent success in generating insulin-secreting islet-like cells from human embryonic stem (ES) cells, in combination with the success in deriving human ES cell-like induced pluripotent stem (iPS) cells from human fibroblasts by defined factors, have raised the possibility that patient-specific insulin-secreting islet-like cells might be derived from somatic cells through cell fate reprogramming using defined factors. Here we confirm that human ES-like iPS cells can be derived from human skin cells by retroviral expression of OCT4, SOX2, c-MYC, and KLF4. Importantly, using a serum-free protocol, we successfully generated insulin-producing islet-like clusters (ILCs) from the iPS cells under feeder-free conditions. We demonstrate that, like human ES cells, skin fibroblast-derived iPS cells have the potential to be differentiated into islet-like clusters through definitive and pancreatic endoderm. The iPS-derived ILCs not only contain C-peptidepositive and glucagon-positive cells but also release C-peptide upon glucose stimulation. Thus, our study provides evidence that insulin-secreting ILCs can be generated from skin fibroblasts, raising the possibility that patient-specific iPS cells could potentially provide a treatment for diabetes in the future.	[Tateishi, Keisuke; He, Jin; Taranova, Olena; Liang, Gaoyang; D'Alessio, Ana C.; Zhang, Yi] Univ N Carolina, Lineberger Comprehens Canc Ctr, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA; [Tateishi, Keisuke; He, Jin; Taranova, Olena; Liang, Gaoyang; D'Alessio, Ana C.; Zhang, Yi] Univ N Carolina, Lineberger Comprehens Canc Ctr, Howard Hughes Med Inst, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; Howard Hughes Medical Institute; University of North Carolina; University of North Carolina Chapel Hill	Zhang, Y (corresponding author), Univ N Carolina, Lineberger Comprehens Canc Ctr, Howard Hughes Med Inst, Chapel Hill, NC 27599 USA.	yi_zhang@med.unc.edu	Liang, Gaoyang/L-2087-2013; liang, gaoyang/A-8059-2010	Liang, Gaoyang/0000-0002-2157-974X; Zhang, Yi/0000-0002-2789-0811	Leukemia and Lymphoma Society	Leukemia and Lymphoma Society(Leukemia and Lymphoma Society)	A fellow of the Leukemia and Lymphoma Society.	Campbell PM, 2007, AM J TRANSPLANT, V7, P2311, DOI 10.1111/j.1600-6143.2007.01923.x; CLARK SJ, 1994, NUCLEIC ACIDS RES, V22, P2990, DOI 10.1093/nar/22.15.2990; Eftat S, 2008, ADV DRUG DELIVER REV, V60, P114, DOI 10.1016/j.addr.2007.08.033; Federici M, 2001, DIABETES, V50, P1290, DOI 10.2337/diabetes.50.6.1290; Gangemi A, 2008, AM J TRANSPLANT, V8, P1250, DOI 10.1111/j.1600-6143.2008.02234.x; Jiang JJ, 2007, STEM CELLS, V25, P1940, DOI 10.1634/stemcells.2006-0761; Kitamura T, 2003, EXP HEMATOL, V31, P1007, DOI 10.1016/j.exphem.2003.07.005; Kroon E, 2008, NAT BIOTECHNOL, V26, P443, DOI 10.1038/nbt1393; Lakey JRT, 2006, METH MOL B, V333, P47; Lowry WE, 2008, P NATL ACAD SCI USA, V105, P2883, DOI 10.1073/pnas.0711983105; Maherali N, 2007, CELL STEM CELL, V1, P55, DOI 10.1016/j.stem.2007.05.014; Mali P, 2008, STEM CELLS, V26, P1998, DOI 10.1634/stemcells.2008-0346; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Osafune K, 2008, NAT BIOTECHNOL, V26, P313, DOI 10.1038/nbt1383; Park IH, 2008, NATURE, V451, P141, DOI [10.1038/nature06534, 10.1038/natureO6534]; Sapir T, 2005, P NATL ACAD SCI USA, V102, P7964, DOI 10.1073/pnas.0405277102; Shapiro AMJ, 2006, NEW ENGL J MED, V355, P1318, DOI 10.1056/NEJMoa061267; Simonsson S, 2004, NAT CELL BIOL, V6, P984, DOI 10.1038/ncb1176; Suzuki A, 2003, P NATL ACAD SCI USA, V100, P5034, DOI 10.1073/pnas.0936260100; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Wernig M, 2007, NATURE, V448, P318, DOI 10.1038/nature05944; Wu H, 2007, P NATL ACAD SCI USA, V104, P13821, DOI 10.1073/pnas.0706199104; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zalzman M, 2005, DIABETES, V54, P2568, DOI 10.2337/diabetes.54.9.2568	25	274	318	2	29	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 14	2008	283	46					31601	31607		10.1074/jbc.M806597200	http://dx.doi.org/10.1074/jbc.M806597200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	370KJ	18782754	hybrid, Green Published			2022-12-27	WOS:000260760800040
J	Villareal, VA; Pilpa, RM; Robson, SA; Fadeev, EA; Clubb, RT				Villareal, Valerie A.; Pilpa, Rosemarie M.; Robson, Scott A.; Fadeev, Evgeny A.; Clubb, Robert T.			The IsdC Protein from Staphylococcus aureus Uses a Flexible Binding Pocket to Capture Heme	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAGNETIC-RESONANCE RELAXATION; NMR STRUCTURE DETERMINATION; MODEL-FREE APPROACH; SURFACE PROTEIN; SORTASE-B; HEMOGLOBIN RECEPTOR; TRANSPORTER DOMAIN; BACKBONE DYNAMICS; DEGRADING ENZYMES; CRYSTAL-STRUCTURE	Staphylococcus aureus scavenges heme-iron from host hemoproteins using iron-regulated surface determinant (Isd) proteins. IsdC is the central conduit through which heme is passed across the cell wall and binds this molecule using a NEAr Transporter (NEAT) domain. NMR spectroscopy was used to determine the structure of IsdC in complex with a heme analog, zinc-substituted protoporphyrin IX (ZnPPIX). The backbone coordinates of the ensemble of conformers representing the structure exhibit a root mean square deviation to the mean structure of 0.53 +/- 0.11 angstrom. IsdC partially buries protoporphyrin within a large hydrophobic pocket that is located at the end of its beta-barrel structure. The central metal ion of the analog adopts a pentacoordinate geometry in which a highly conserved tyrosine residue serves as a proximal ligand. Consistent with the structure and its role in heme transfer across the cell wall, we show that IsdC weakly binds heme (KD = 0.34 +/- 0.12 mu M) and that ZnPPIX rapidly dissociates from the protein at a rate of 126 +/- 30 s(-1). NMR studies of the apo-form of IsdC reveal that a 310 helix within the binding pocket undergoes a flexible to rigid transition as heme is captured. This structural plasticity may increase the efficiency of heme transfer across the cell wall by facilitating protein-protein interactions between apoIsdC and upstream hemoproteins.	Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90095 USA; [Clubb, Robert T.] Univ Calif Los Angeles, Dept Chem & Biochem, UCLA DOE Inst Genom & Proteom, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; United States Department of Energy (DOE); University of California System; University of California Los Angeles	Clubb, RT (corresponding author), Univ Calif Los Angeles, Dept Chem & Biochem, UCLA DOE Inst Genom & Proteom, Los Angeles, CA 90095 USA.	rclubb@mbi.ucla.edu		Robson, Scott/0000-0002-0529-0399	National Institutes of Health [R01-AI5221701]; United States Department of Energy [DE-FC-03-87ER60615]; National Institutes of Health NIGMS [F31GM075564]; UCLA; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI052217] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F31GM075564] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States Department of Energy(United States Department of Energy (DOE)); National Institutes of Health NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); UCLA; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01-AI5221701 (to R. T. C.). This work was also supported by United States Department of Energy Grant DE-FC-03-87ER60615 (to R. T. C.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.; Supported by National Institutes of Health NIGMS Grant F31GM075564.; Supported by a UCLA Dissertation Year Fellowship. Present address: The Salk Institute for Biological Studies, La Jolla, CA 92037.	Andrade MA, 2002, GENOME BIOL, V3; Andrews SC, 2003, FEMS MICROBIOL REV, V27, P215, DOI 10.1016/S0168-6445(03)00055-X; Aranda R, 2007, J MOL BIOL, V374, P374, DOI 10.1016/j.jmb.2007.08.058; ARCHER SJ, 1991, J MAGN RESON, V95, P636, DOI 10.1016/0022-2364(91)90182-S; BAX A, 1993, ACCOUNTS CHEM RES, V26, P131, DOI 10.1021/ar00028a001; BAX A, 1990, J MAGN RESON, V88, P425, DOI 10.1016/0022-2364(90)90202-K; BAX A, 2001, DIPOLAR COUPLINGS MA; Bertini I, 2005, CHEMBIOCHEM, V6, P1536, DOI 10.1002/cbic.200500124; Bierne H, 2004, J BACTERIOL, V186, P1972, DOI 10.1128/JB.186.7.1972-1982.2004; Bruschweiler R, 2003, CURR OPIN STRUC BIOL, V13, P175, DOI 10.1016/S0959-440X(03)00036-8; BRUSCHWEILER R, 1995, SCIENCE, V268, P886, DOI 10.1126/science.7754375; Carlomagno T, 1996, J BIOMOL NMR, V8, P161, DOI 10.1007/BF00211162; Casey AL, 2007, INT J ANTIMICROB AG, V29, pS23, DOI 10.1016/S0924-8579(07)72175-1; Cavanagh J., 1996, PROTEIN NMR SPECTROS; Chang WN, 2001, INFECTION, V29, P245, DOI 10.1007/s15010-001-1092-z; Clarke SR, 2004, MOL MICROBIOL, V51, P1509, DOI 10.1111/j.1365-2958.2003.03938.x; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; DeLano W., 2006, PYMOL MOL GRAPHICS S; Dinges MM, 2000, CLIN MICROBIOL REV, V13, P16, DOI 10.1128/CMR.13.1.16-34.2000; Drazek ES, 2000, MOL MICROBIOL, V36, P68, DOI 10.1046/j.1365-2958.2000.01818.x; Dryla A, 2003, MOL MICROBIOL, V49, P37, DOI 10.1046/j.1365-2958.2003.03542.x; Dyson HJ, 2005, NAT REV MOL CELL BIO, V6, P197, DOI 10.1038/nrm1589; FARROW NA, 1994, BIOCHEMISTRY-US, V33, P5984, DOI 10.1021/bi00185a040; GARRETT DS, 1991, J MAGN RESON, V95, P214, DOI 10.1016/0022-2364(91)90341-P; Goddard T. D., 2001, SPARKY NMR ANAL SOFT; Grigg JC, 2007, MOL MICROBIOL, V63, P139, DOI 10.1111/j.1365-2958.2006.05502.x; GRZESIEK S, 1993, J MAGN RESON SER B, V101, P114, DOI 10.1006/jmrb.1993.1019; Herrmann T, 2002, J MOL BIOL, V319, P209, DOI 10.1016/S0022-2836(02)00241-3; Herrmann T, 2002, J BIOMOL NMR, V24, P171, DOI 10.1023/A:1021614115432; Ilangovan U, 1999, BIOCHEMISTRY-US, V38, P8367, DOI 10.1021/bi990530b; Ishima R, 2000, NAT STRUCT BIOL, V7, P740, DOI 10.1038/78963; Iwahara J, 2001, J BIOMOL NMR, V19, P231, DOI 10.1023/A:1011296112710; KAY LE, 1992, J AM CHEM SOC, V114, P10663, DOI 10.1021/ja00052a088; Keller R., 2004, COMPUTER AIDED RESON, V1; Kneller JM, 2002, J AM CHEM SOC, V124, P1852, DOI 10.1021/ja017461k; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; KORDEL J, 1992, BIOCHEMISTRY-US, V31, P4856; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Lee LK, 1997, J BIOMOL NMR, V9, P287, DOI 10.1023/A:1018631009583; Lei BF, 2003, INFECT IMMUN, V71, P5962, DOI 10.1128/IAI.71.10.5962-5969.2003; Lian L. Y., 1993, NMR MACROMOLECULES P, P153; LIPARI G, 1982, J AM CHEM SOC, V104, P4559, DOI 10.1021/ja00381a010; LIPARI G, 1982, J AM CHEM SOC, V104, P4546, DOI 10.1021/ja00381a009; Liu MY, 2008, J BIOL CHEM, V283, P6668, DOI 10.1074/jbc.M708372200; Liu MY, 2005, INFECT IMMUN, V73, P5086, DOI 10.1128/IAI.73.8.5086-5092.2005; Lundblad JR, 1996, MOL ENDOCRINOL, V10, P607, DOI 10.1210/me.10.6.607; Mack J, 2004, BIOCHEM BIOPH RES CO, V320, P781, DOI 10.1016/j.bbrc.2004.06.025; MANDEL AM, 1995, J MOL BIOL, V246, P144, DOI 10.1006/jmbi.1994.0073; Mandel AM, 1996, BIOCHEMISTRY-US, V35, P16009, DOI 10.1021/bi962089k; Maresso AW, 2006, BIOMETALS, V19, P193, DOI 10.1007/s10534-005-4863-7; Maresso AW, 2006, J BACTERIOL, V188, P8145, DOI 10.1128/JB.01011-06; Marraffini LA, 2005, J BIOL CHEM, V280, P16263, DOI 10.1074/jbc.M500071200; Mazmanian SK, 2003, SCIENCE, V299, P906, DOI 10.1126/science.1081147; Naik MT, 2006, J BIOL CHEM, V281, P1817, DOI 10.1074/jbc.M506123200; Nygaard TK, 2006, J BIOL CHEM, V281, P20761, DOI 10.1074/jbc.M601832200; Pilpa RM, 2005, J BIOMOL NMR, V33, P137, DOI 10.1007/s10858-005-2898-2; Pilpa RM, 2006, J MOL BIOL, V360, P435, DOI 10.1016/j.jmb.2006.05.019; Reniere ML, 2007, BIOMETALS, V20, P333, DOI 10.1007/s10534-006-9032-0; Schwieters CD, 2003, J MAGN RESON, V160, P65, DOI 10.1016/S1090-7807(02)00014-9; Sharp KH, 2007, J BIOL CHEM, V282, P10625, DOI 10.1074/jbc.M700234200; Skaar EP, 2004, MICROBES INFECT, V6, P390, DOI 10.1016/j.micinf.2003.12.008; Skaar EP, 2004, SCIENCE, V305, P1626, DOI 10.1126/science.1099930; Skaar EP, 2004, J BIOL CHEM, V279, P436, DOI 10.1074/jbc.M307952200; SKELTON NJ, 1993, J MAGN RESON SER B, V102, P253, DOI 10.1006/jmrb.1993.1095; Stojiljkovic I, 1999, MOL MICROBIOL, V31, P429, DOI 10.1046/j.1365-2958.1999.01175.x; TJANDRA N, 1995, EUR J BIOCHEM, V230, P1014, DOI 10.1111/j.1432-1033.1995.tb20650.x; Torres VJ, 2006, J BACTERIOL, V188, P8421, DOI 10.1128/JB.01335-06; Vermeiren CL, 2006, BIOCHEMISTRY-US, V45, P12867, DOI 10.1021/bi0607711; Wandersman C, 2004, ANNU REV MICROBIOL, V58, P611, DOI 10.1146/annurev.micro.58.030603.123811; Wilks A, 2007, NAT PROD REP, V24, P511, DOI 10.1039/b604193k; Wu RY, 2005, J BIOL CHEM, V280, P2840, DOI 10.1074/jbc.M409526200; YAMAZAKI T, 1993, J AM CHEM SOC, V115, P11054, DOI 10.1021/ja00076a099; ZHU H, 2008, J BIOL CHEM	74	66	71	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 14	2008	283	46					31591	31600		10.1074/jbc.M801126200	http://dx.doi.org/10.1074/jbc.M801126200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	370KJ	18715872	hybrid, Green Published			2022-12-27	WOS:000260760800039
J	Yang, YJ; Chen, W; Carrigan, SO; Chen, WM; Roth, K; Akiyama, T; Inoue, JI; Marshall, JS; Berman, JN; Lin, TJ				Yang, Yong Jun; Chen, Wei; Carrigan, Svetlana O.; Chen, Wei-Min; Roth, Kristy; Akiyama, Taishin; Inoue, Jun-ichiro; Marshall, Jean S.; Berman, Jason N.; Lin, Tong-Jun			TRAF6 Specifically Contributes to Fc epsilon RI-mediated Cytokine Production but Not Mast Cell Degranulation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NECROSIS-FACTOR RECEPTOR; SIGNAL-TRANSDUCTION; DEFECTIVE INTERLEUKIN-1; TRAF6-DEFICIENT MICE; IKK ACTIVATION; KAPPA-B; TNF; PATHWAYS; KINASES; DOMAIN	TRAF6 (tumor necrosis factor-associated factor 6) is an essential adaptor downstream from the tumor necrosis factor (TNF) receptor and Toll-like receptor superfamily members. This molecule is critical for dendritic cell maturation and T cell homeostasis. Here we show that TRAF6 is important in high affinity IgE receptor, Fc epsilon RI-mediated mast cell activation. In contrast to dendritic cells and T cells, TRAF6-deficient mast cells matured normally and showed normal IgE-dependent degranulation. Importantly, TRAF6-deficient mast cells showed impaired production of cytokine interleukin-6, CCL-9, interleukin-13, and TNF following Fc epsilon RI aggregation. Chromatin immunoprecipitation assay showed decreased NF-kappa B p65 binding to CCL-9 and TNF promoters in TRAF6-deficient mast cells. Antigen and IgE-induced I kappa B phosphorylation and NF-kappa B p65 translocation to the nucleus were diminished in TRAF6-deficient mast cells. NF-kappa B luciferase activity in response to antigen and IgE stimulation was severely impaired in TRAF6-deficient mast cells. In addition, antigen and IgE-induced phosphorylation of mitogen-activated protein kinase p38 and JNK, but not ERK1/2, was significantly reduced in TRAF6-deficient mast cells. These results identified TRAF6 as an important signal transducer in Fc epsilon RI-mediated signaling in mast cells. Our findings implicate TRAF6 as a new adaptor/regulator molecule for allergen-mediated inflammation in allergy.	[Yang, Yong Jun; Chen, Wei; Carrigan, Svetlana O.; Roth, Kristy; Marshall, Jean S.; Berman, Jason N.; Lin, Tong-Jun] Dalhousie Univ, Dept Microbiol & Immunol, Halifax, NS B3K 6R8, Canada; [Yang, Yong Jun; Chen, Wei; Carrigan, Svetlana O.; Roth, Kristy; Marshall, Jean S.; Berman, Jason N.; Lin, Tong-Jun] Dalhousie Univ, Dept Pediat, Halifax, NS B3K 6R8, Canada; [Chen, Wei-Min] Fujian Prov Hosp, Dept Hematol, Fuzhou 350001, Peoples R China; [Akiyama, Taishin; Inoue, Jun-ichiro] Univ Tokyo, Inst Med Sci, Div Cellular & Mol Biol, Tokyo 1088639, Japan	Dalhousie University; Dalhousie University; Fujian Provincial Hospital; University of Tokyo	Lin, TJ (corresponding author), IWK Hlth Ctr, Dept Pediat, 5850 Univ Ave, Halifax, NS B3K 6R8, Canada.	tong-jun.lin@dal.ca			Canadian Institutes of Health Research; Nova Scotia Health Research Foundation; Izaak Walton Killam Health Center	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Nova Scotia Health Research Foundation; Izaak Walton Killam Health Center	This work was supported in part by grants from the Canadian Institutes of Health Research, Nova Scotia Health Research Foundation, and Izaak Walton Killam Health Center (to T. J. L.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	Ahonen CL, 2002, NAT IMMUNOL, V3, P451, DOI 10.1038/ni792; Baud V, 1999, GENE DEV, V13, P1297, DOI 10.1101/gad.13.10.1297; Bradley JR, 2001, ONCOGENE, V20, P6482, DOI 10.1038/sj.onc.1204788; Cao ZD, 1996, NATURE, V383, P443, DOI 10.1038/383443a0; Eliopoulos AG, 2003, EMBO J, V22, P3855, DOI 10.1093/emboj/cdg386; Galli SJ, 2005, ANNU REV IMMUNOL, V23, P749, DOI 10.1146/annurev.immunol.21.120601.141025; Gilfillan AM, 2006, NAT REV IMMUNOL, V6, P218, DOI 10.1038/nri1782; Gohda J, 2004, J IMMUNOL, V173, P2913, DOI 10.4049/jimmunol.173.5.2913; Hayden MS, 2004, GENE DEV, V18, P2195, DOI 10.1101/gad.1228704; Ishizuka T, 1997, P NATL ACAD SCI USA, V94, P6358, DOI 10.1073/pnas.94.12.6358; Kawakami Y, 1998, J IMMUNOL, V161, P1795; Kinet JP, 1999, ANNU REV IMMUNOL, V17, P931, DOI 10.1146/annurev.immunol.17.1.931; King CG, 2006, NAT MED, V12, P1088, DOI 10.1038/nm1449; Klemm S, 2006, J EXP MED, V203, P337, DOI 10.1084/jem.20051982; Kobayashi T, 2003, IMMUNITY, V19, P353, DOI 10.1016/S1074-7613(03)00230-9; Kobayashi T, 2004, MICROBES INFECT, V6, P1333, DOI 10.1016/j.micinf.2004.09.001; Li B, 2006, BLOOD, V107, P2814, DOI 10.1182/blood-2005-09-3610; Lomaga MA, 1999, GENE DEV, V13, P1015, DOI 10.1101/gad.13.8.1015; Maezawa Y, 2006, J IMMUNOL, V176, P1013, DOI 10.4049/jimmunol.176.2.1013; Naito A, 2002, P NATL ACAD SCI USA, V99, P8766, DOI 10.1073/pnas.132636999; Naito A, 1999, GENES CELLS, V4, P353, DOI 10.1046/j.1365-2443.1999.00265.x; RAVETCH JV, 1994, CELL, V78, P553, DOI 10.1016/0092-8674(94)90521-5; Rivera J, 2006, J ALLERGY CLIN IMMUN, V117, P1214, DOI 10.1016/j.jaci.2006.04.015; ROTHE M, 1994, CELL, V78, P681, DOI 10.1016/0092-8674(94)90532-0; RUDOLPH AK, 1981, EUR J IMMUNOL, V11, P527, DOI 10.1002/eji.1830110617; Saitoh S, 2000, IMMUNITY, V12, P525, DOI 10.1016/S1074-7613(00)80204-6; Schwandner R, 2000, J EXP MED, V191, P1233, DOI 10.1084/jem.191.7.1233; Sun LJ, 2004, MOL CELL, V14, P289, DOI 10.1016/S1097-2765(04)00236-9; Takaesu G, 2000, MOL CELL, V5, P649, DOI 10.1016/S1097-2765(00)80244-0; Takeda K, 2004, SEMIN IMMUNOL, V16, P3, DOI 10.1016/j.smim.2003.10.003; Wajant H, 2001, CELL SIGNAL, V13, P389, DOI 10.1016/S0898-6568(01)00160-7; Wang C, 2001, NATURE, V412, P346, DOI 10.1038/35085597; Wu H, 2003, BIOESSAYS, V25, P1096, DOI 10.1002/bies.10352; Xu LG, 2004, J BIOL CHEM, V279, P17278, DOI 10.1074/jbc.C400063200; Ye H, 2002, NATURE, V418, P443, DOI 10.1038/nature00888	35	19	21	1	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 14	2008	283	46					32110	32118		10.1074/jbc.M802610200	http://dx.doi.org/10.1074/jbc.M802610200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	370KJ	18772140	hybrid			2022-12-27	WOS:000260760800092
J	Delille, HK; Schrader, M				Delille, Hannah K.; Schrader, Michael			Targeting of hFis1 to Peroxisomes Is Mediated by Pex19p	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MITOCHONDRIAL OUTER-MEMBRANE; TAIL-ANCHORED PROTEINS; DYNAMIN-LIKE PROTEIN-1; ASCORBATE PEROXIDASE; FISSION; FIS1; IMPORT; DIVISION; SIGNALS; PROLIFERATION	The processes of peroxisome formation and proliferation are still a matter of debate. We have previously shown that peroxisomes share some components of their division machinery with mitochondria. hFis1, a tail-anchored membrane protein, regulates the membrane fission of both organelles by DLP1/Drp1 recruitment, but nothing is known about the mechanisms of the dual targeting of hFis1. Here we demonstrate for the first time that peroxisomal targeting of hFis1 depends on Pex19p, a peroxisomal membrane protein import factor. hFis1/Pex19p binding was demonstrated by expression and co-immunoprecipitation studies. Using mutated versions of hFis1 an essential binding region for Pex19p was located within the last 26 C-terminal amino acids of hFis1, which are required for proper targeting to both mitochondria and peroxisomes. The basic amino acids in the very C terminus are not essential for Pex19p binding and peroxisomal targeting, but are instead required for mitochondrial targeting. Silencing of Pex19p by small interference RNA reduced the targeting of hFis1 to peroxisomes, but not to mitochondria. In contrast, overexpression of Pex19p alone was not sufficient to shift the targeting of hFis1 to peroxisomes. Our findings indicate that targeting of hFis1 to peroxisomes and mitochondria are independent events and support a direct, Pex19p-dependent targeting of peroxisomal tail-anchored proteins.	[Delille, Hannah K.; Schrader, Michael] Univ Aveiro, Ctr Cell Biol, P-3810193 Aveiro, Portugal; [Delille, Hannah K.; Schrader, Michael] Univ Aveiro, Dept Biol, P-3810193 Aveiro, Portugal; [Delille, Hannah K.] Univ Marburg, Dept Cell Biol & Cell Pathol, D-35037 Marburg, Germany	Universidade de Aveiro; Universidade de Aveiro; Philipps University Marburg	Schrader, M (corresponding author), Univ Aveiro, Ctr Cell Biol, Campus Univ Santiago, P-3810193 Aveiro, Portugal.	mschrader@ua.pt			German Research Foundation [SCHR 518/6-1,2]; Portuguese Foundation for Science and Technology [PTDC/BIA-BCM/71932/2006]; University of Aveiro	German Research Foundation(German Research Foundation (DFG)); Portuguese Foundation for Science and Technology(Portuguese Foundation for Science and Technology); University of Aveiro(European Commission)	This work was supported by the German Research Foundation (Grant SCHR 518/6-1,2), the Portuguese Foundation for Science and Technology (Grant PTDC/BIA-BCM/71932/2006), and the University of Aveiro.	Abe I, 1998, FEBS LETT, V431, P468, DOI 10.1016/S0014-5793(98)00815-1; Boll A, 2005, J HISTOCHEM CYTOCHEM, V53, P1037, DOI 10.1369/jhc.5B6681.2005; Borgese N, 2003, J CELL BIOL, V161, P1013, DOI 10.1083/jcb.200303069; Borgese N, 2007, CURR OPIN CELL BIOL, V19, P368, DOI 10.1016/j.ceb.2007.04.019; Detmer SA, 2007, NAT REV MOL CELL BIO, V8, P870, DOI 10.1038/nrm2275; Dohm JA, 2004, PROTEINS, V54, P153, DOI 10.1002/prot.10524; Elgersma Y, 1997, EMBO J, V16, P7326, DOI 10.1093/emboj/16.24.7326; Fang Y, 2004, J CELL BIOL, V164, P863, DOI 10.1083/jcb.200311131; Fischer D, 1999, PHARMACEUT RES, V16, P1273, DOI 10.1023/A:1014861900478; Fransen M, 2001, MOL CELL BIOL, V21, P4413, DOI 10.1128/MCB.21.13.4413-4424.2001; Fujiki Y, 2006, BBA-MOL CELL RES, V1763, P1639, DOI 10.1016/j.bbamcr.2006.08.030; GANDREBABBE S, 2008, MOL BIOL CELL; Halbach A, 2005, J BIOL CHEM, V280, P21176, DOI 10.1074/jbc.M501750200; Halbach A, 2006, J CELL SCI, V119, P2508, DOI 10.1242/jcs.02979; Heiland I, 2005, FEBS J, V272, P2362, DOI 10.1111/j.1742-4658.2005.04690.x; Herzig S, 2008, CURR MOL MED, V8, P131, DOI 10.2174/156652408783769625; James DI, 2003, J BIOL CHEM, V278, P36373, DOI 10.1074/jbc.M303758200; Jones JM, 2004, J CELL BIOL, V164, P57, DOI 10.1083/jcb.200304111; Kemper C, 2008, J CELL SCI, V121, P1990, DOI 10.1242/jcs.024034; Kobayashi S, 2007, EXP CELL RES, V313, P1675, DOI 10.1016/j.yexcr.2007.02.028; Koch A, 2005, MOL BIOL CELL, V16, P5077, DOI 10.1091/mbc.E05-02-0159; Koch A, 2004, J CELL SCI, V117, P3995, DOI 10.1242/jcs.01268; Koch A, 2003, J BIOL CHEM, V278, P8597, DOI 10.1074/jbc.M211761200; Kuravi K, 2006, J CELL SCI, V119, P3994, DOI 10.1242/jcs.03166; Li XL, 2003, J BIOL CHEM, V278, P17012, DOI 10.1074/jbc.M212031200; Li XL, 2002, J CELL BIOL, V156, P643, DOI 10.1083/jcb.200112028; Matsuzono Y, 2006, J CELL SCI, V119, P3539, DOI 10.1242/jcs.03100; Mozdy AD, 2000, J CELL BIOL, V151, P367, DOI 10.1083/jcb.151.2.367; Mullen RT, 1999, PLANT CELL, V11, P2167, DOI 10.1105/tpc.11.11.2167; Mullen RT, 2000, J BIOL CHEM, V275, P16337, DOI 10.1074/jbc.M001266200; Muntau AC, 2003, EUR J CELL BIOL, V82, P333, DOI 10.1078/0171-9335-00325; Neupert W, 2007, ANNU REV BIOCHEM, V76, P723, DOI 10.1146/annurev.biochem.76.052705.163409; Neuspiel M, 2008, CURR BIOL, V18, P102, DOI 10.1016/j.cub.2007.12.038; Nito K, 2001, PLANT CELL PHYSIOL, V42, P20, DOI 10.1093/pcp/pce003; Rapaport D, 2003, EMBO REP, V4, P948, DOI 10.1038/sj.embor.embor937; Rottensteiner H, 2004, MOL BIOL CELL, V15, P3406, DOI 10.1091/mbc.E04-03-0188; Sacksteder KA, 2000, J CELL BIOL, V148, P931, DOI 10.1083/jcb.148.5.931; Schliebs W, 2004, CURR BIOL, V14, pR397, DOI 10.1016/j.cub.2004.05.017; Schluter A, 2007, NUCLEIC ACIDS RES, V35, pD815, DOI 10.1093/nar/gkl935; Schrader M, 2000, J CELL SCI, V113, P3663; Schrader M, 1996, EUR J CELL BIOL, V69, P24; Schrader M, 1998, J BIOL CHEM, V273, P29607, DOI 10.1074/jbc.273.45.29607; Schrader M, 2007, BIOESSAYS, V29, P1105, DOI 10.1002/bies.20659; Schrader M, 2006, BBA-MOL CELL RES, V1763, P531, DOI 10.1016/j.bbamcr.2006.01.004; Setoguchi K, 2006, EMBO J, V25, P5635, DOI 10.1038/sj.emboj.7601438; Smirnova E, 2001, MOL BIOL CELL, V12, P2245, DOI 10.1091/mbc.12.8.2245; Snyder WB, 2000, J CELL BIOL, V149, P1171, DOI 10.1083/jcb.149.6.1171; Stojanovski D, 2004, J CELL SCI, V117, P1201, DOI 10.1242/jcs.01058; Suzuki M, 2005, J BIOL CHEM, V280, P21444, DOI 10.1074/jbc.M414092200; Suzuki M, 2003, J MOL BIOL, V334, P445, DOI 10.1016/j.jmb.2003.09.064; Van Ael E, 2006, BBA-MOL CELL RES, V1763, P1629, DOI 10.1016/j.bbamcr.2006.08.020; Waterham HR, 2007, NEW ENGL J MED, V356, P1736, DOI 10.1056/NEJMoa064436; Wattenberg B, 2001, TRAFFIC, V2, P66, DOI 10.1034/j.1600-0854.2001.20108.x; Yoon Y, 2003, MOL CELL BIOL, V23, P5409, DOI 10.1128/MCB.23.15.5409-5420.2003; Yu TZ, 2005, J CELL SCI, V118, P4141, DOI 10.1242/jcs.02537	55	59	59	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 7	2008	283	45					31107	31115		10.1074/jbc.M803332200	http://dx.doi.org/10.1074/jbc.M803332200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	367ID	18782765	Green Published, hybrid			2022-12-27	WOS:000260544800065
J	Kanei-Ishii, C; Nomura, T; Takagi, T; Watanabe, N; Nakayama, KI; Ishii, S				Kanei-Ishii, Chie; Nomura, Teruaki; Takagi, Tsuyoshi; Watanabe, Nobumoto; Nakayama, Keiichi I.; Ishii, Shunsuke			Fbxw7 Acts as an E3 Ubiquitin Ligase That Targets c-Myb for Nemo-like Kinase (NLK)-induced Degradation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYCLIN-E; TUMOR-SUPPRESSOR; V-MYB; MULTISITE PHOSPHORYLATION; DEPENDENT UBIQUITINATION; PROTEIN-DEGRADATION; COACTIVATOR CBP; B-MYB; GENE; LEUKEMIA	The c-myb proto-oncogene product (c-Myb) is degraded in response to Wnt-1 signaling via a pathway involving TAK1 (transforming growth factor-beta-activated kinase 1), HIPK2 (homeodomain-interacting protein kinase 2), and NLK (Nemo-like kinase). NLK directly binds to c-Myb, which results in the phosphorylation of c-Myb at multiple sites, and induces its ubiquitination and proteasome-dependent degradation. Here, we report that Fbxw7, the F-box protein of an SCF complex, targets c-Myb for degradation in a Wnt-1- and NLK-dependent manner. Fbxw7 alpha directly binds to c-Myb via its C-terminal WD40 domain and induces the ubiquitination of c-Myb in the presence of NLK in vivo and in vitro. The c-Myb phosphorylation site mutant failed to interact with Fbxw7 alpha, suggesting that the c-Myb/Fbxw7 alpha interaction is enhanced by NLK phosphorylation of c-Myb. Treatment of M1 cells with Fbxw7 small interfering RNA (siRNA) rescued the Wnt-induced c-Myb degradation and also the Wnt-induced inhibition of cell proliferation. NLK bound to Cul1, a component of the SCF complex, while HIPK2 interacted with both Fbxw7 alpha and Cul1, suggesting that both kinases enhance the c-Myb/SCF interaction. In contrast to c-Myb, the v-myb gene product (v-Myb) encoded by the avian myeloblastosis virus was resistant to NLK/Fbxw7 alpha-induced degradation. Thus, Fbxw7 is an E3 ubiquitin ligase of c-Myb, and the increased c-Myb levels may contribute, at least partly, to transformation induced by mutation of Fbxw7.	[Kanei-Ishii, Chie; Nomura, Teruaki; Takagi, Tsuyoshi; Ishii, Shunsuke] RIKEN, Tsukuba Inst, Mol Genet Lab, Tsukuba, Ibaraki 3050074, Japan; [Watanabe, Nobumoto] RIKEN, Discovery Res Inst, Antibiot Lab, Wako, Saitama 3510198, Japan; [Nakayama, Keiichi I.] Kyushu Univ, Med Inst Bioregulat, Dept Mol & Cellular Biol, Higashi Ku, Fukuoka 8128582, Japan	RIKEN; RIKEN; Kyushu University	Ishii, S (corresponding author), RIKEN, Tsukuba Inst, Mol Genet Lab, 3-1-1 Koyadai, Tsukuba, Ibaraki 3050074, Japan.	sishii@rtc.riken.jp	Ishii, Shunsuke/A-5271-2016; Watanabe, Nobumoto/N-6959-2015	Ishii, Shunsuke/0000-0002-6530-2478; Watanabe, Nobumoto/0000-0002-2130-1334	Ministry of Education, Culture, Sports, Science and Technology of Japan	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by grants-in-aid for scientific research from the Ministry of Education, Culture, Sports, Science and Technology of Japan. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Bender TP, 2004, NAT IMMUNOL, V5, P721, DOI 10.1038/ni1085; Charrasse S, 2000, ONCOGENE, V19, P2986, DOI 10.1038/sj.onc.1203618; Clurman BE, 1996, GENE DEV, V10, P1979, DOI 10.1101/gad.10.16.1979; Dai P, 1996, GENE DEV, V10, P528, DOI 10.1101/gad.10.5.528; Frampton J, 1996, GENE DEV, V10, P2720, DOI 10.1101/gad.10.21.2720; Hao B, 2007, MOL CELL, V26, P131, DOI 10.1016/j.molcel.2007.02.022; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hubbard EJA, 1997, GENE DEV, V11, P3182, DOI 10.1101/gad.11.23.3182; Kanei-Ishii C, 2004, J BIOL CHEM, V279, P44582, DOI 10.1074/jbc.M407831200; Kanei-Ishii C, 2004, GENE DEV, V18, P816, DOI 10.1101/gad.1170604; KANEIISHII C, 1992, P NATL ACAD SCI USA, V89, P3088, DOI 10.1073/pnas.89.7.3088; KLEMPNAUER KH, 1982, CELL, V31, P453, DOI 10.1016/0092-8674(82)90138-6; Koepp DM, 2001, SCIENCE, V294, P173, DOI 10.1126/science.1065203; KowenzLeutz E, 1997, CELL, V91, P185, DOI 10.1016/S0092-8674(00)80401-8; Kurahashi T, 2005, MOL BIOL CELL, V16, P4705, DOI 10.1091/mbc.E05-05-0470; Ladendorff NE, 2001, ONCOGENE, V20, P125, DOI 10.1038/sj.onc.1204048; Lahortiga I, 2007, NAT GENET, V39, P593, DOI 10.1038/ng2025; Mao JH, 2004, NATURE, V432, P775, DOI 10.1038/nature03155; Moberg KH, 2001, NATURE, V413, P311, DOI 10.1038/35095068; Morita Y, 2005, MOL BIOL CELL, V16, P5433, DOI 10.1091/mbc.E05-08-0731; MUCENSKI ML, 1991, CELL, V65, P677, DOI 10.1016/0092-8674(91)90099-K; NAKAGOSHI H, 1992, ONCOGENE, V7, P1233; Nakayama KI, 2005, SEMIN CELL DEV BIOL, V16, P323, DOI 10.1016/j.semcdb.2005.02.010; Nash P, 2001, NATURE, V414, P514, DOI 10.1038/35107009; Nateri AS, 2004, SCIENCE, V303, P1374, DOI 10.1126/science.1092880; Nomura T, 2004, J BIOL CHEM, V279, P16715, DOI 10.1074/jbc.M313069200; Oelgeschlager M, 1996, EMBO J, V15, P2771, DOI 10.1002/j.1460-2075.1996.tb00637.x; OGATA K, 1994, CELL, V79, P639, DOI 10.1016/0092-8674(94)90549-5; Orlicky S, 2003, CELL, V112, P243, DOI 10.1016/S0092-8674(03)00034-5; Petroski MD, 2005, METHOD ENZYMOL, V398, P143, DOI 10.1016/S0076-6879(05)98013-0; Petroski MD, 2003, MOL CELL, V11, P1435, DOI 10.1016/S1097-2765(03)00221-1; Rajagopalan H, 2004, NATURE, V428, P77, DOI 10.1038/nature02313; SAKURA H, 1989, P NATL ACAD SCI USA, V86, P5758, DOI 10.1073/pnas.86.15.5758; Sano Y, 2001, J BIOL CHEM, V276, P3674, DOI 10.1074/jbc.M006896200; Spruck CH, 2002, CANCER RES, V62, P4535; Staal FJT, 2005, NAT REV IMMUNOL, V5, P21, DOI 10.1038/nri1529; Strohmaier H, 2001, NATURE, V413, P316, DOI 10.1038/35095076; Taylor D, 1996, GENE DEV, V10, P2732, DOI 10.1101/gad.10.21.2732; Thompson BJ, 2007, J EXP MED, V204, P1825, DOI 10.1084/jem.20070872; van Drogen F, 2006, MOL CELL, V23, P37, DOI 10.1016/j.molcel.2006.05.020; Watanabe N, 2004, P NATL ACAD SCI USA, V101, P4419, DOI 10.1073/pnas.0307700101; Welcker M, 2004, CURR BIOL, V14, P1852, DOI 10.1016/j.cub.2004.09.083; Welcker M, 2004, P NATL ACAD SCI USA, V101, P9085, DOI 10.1073/pnas.0402770101; Welcker M, 2003, MOL CELL, V12, P381, DOI 10.1016/S1097-2765(03)00287-9; Won KA, 1996, EMBO J, V15, P4182, DOI 10.1002/j.1460-2075.1996.tb00793.x; Yada M, 2004, EMBO J, V23, P2116, DOI 10.1038/sj.emboj.7600217; Ye X, 2004, J BIOL CHEM, V279, P50110, DOI 10.1074/jbc.M409226200	47	50	53	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 7	2008	283	45					30540	30548		10.1074/jbc.M804340200	http://dx.doi.org/10.1074/jbc.M804340200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	367ID	18765672	hybrid, Green Published			2022-12-27	WOS:000260544800012
J	Klein-Hessling, S; Bopp, T; Jha, MK; Schmidt, A; Miyatake, S; Schmitt, E; Serfling, E				Klein-Hessling, Stefan; Bopp, Tobias; Jha, Mithilesh K.; Schmidt, Arthur; Miyatake, Shoichiro; Schmitt, Edgar; Serfling, Edgar			Cyclic AMP-induced Chromatin Changes Support the NFATc-mediated Recruitment of GATA-3 to the Interleukin 5 Promoter	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTOR GATA-3; PROTEIN-KINASE-A; LOCUS-CONTROL REGION; RANGE INTRACHROMOSOMAL INTERACTIONS; CYTOKINE GENE-EXPRESSION; CIS-REGULATORY ELEMENTS; T-CELL DIFFERENTIATION; NUCLEAR FACTOR; IL-5 GENE; TH2 CELLS	Elevated intracellular cyclic AMP levels, which suppress the proliferation of naive T cells and type 1 T helper (Th1) cells are a property of T helper 2 (Th2) cells and regulatory T cells. While cyclic AMP signals interfere with the IL-2 promoter induction, they support the induction of Th2-type genes, in particular of il-5 gene. We show here that cyclic AMP signals support the generation of three inducible DNase I hypersensitive chromatin sites over the il-5 locus, including its promoter region. In addition, cyclic AMP signals enhance histone H3 acetylation at the IL-5 promoter and the concerted binding of GATA-3 and NFATc to the promoter. This is facilitated by direct protein-protein interactions involving the C-terminal Zn2+-finger of GATA-3 and the C-terminal region of the NFATc1 DNA binding domain. Because inhibition of NFATc binding to the IL-5 promoter in vivo also affects the binding of GATA-3, one may conclude that upon induction of Th2 effector cells NFATc recruits GATA-3 to Th2-type genes. These data demonstrate the functional importance of cyclic AMP signals for the interplay between GATA-3 and NFATc factors in the transcriptional control of lymphokine expression in Th2 effector cells.	[Klein-Hessling, Stefan; Jha, Mithilesh K.; Schmidt, Arthur; Serfling, Edgar] Univ Wurzburg, Inst Pathol, Dept Mol Pathol, D-97080 Wurzburg, Germany; [Bopp, Tobias; Schmitt, Edgar] Johannes Gutenberg Univ Mainz, Inst Immunol, D-55131 Mainz, Germany; [Miyatake, Shoichiro] Tokyo Metropolitan Inst Med Sci, Dept Immunol, Tokyo 1138613, Japan	University of Wurzburg; Johannes Gutenberg University of Mainz; Tokyo Metropolitan Institute of Medical Science	Klein-Hessling, S (corresponding author), Josef Schneider Str 2, D-97080 Wurzburg, Germany.	stefan.klein-hessling@mail.uni-wuerzburg.de; serfling.e@mail.uni-wuerzburg.de	Bopp, Tobias/A-4328-2018; Serfling, Edgar/X-7212-2019	Bopp, Tobias/0000-0002-3232-8065; 	Deutsche Forschungsgemeinschaft; Wilhelm-Sander-Stiftung; Mildred-Scheel-Stiftung/Deutsche Krebshilfe	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Wilhelm-Sander-Stiftung; Mildred-Scheel-Stiftung/Deutsche Krebshilfe(Deutsche Krebshilfe)	This work was supported by the Deutsche Forschungsgemeinschaft, the Wilhelm-Sander-Stiftung, and the Mildred-Scheel-Stiftung/Deutsche Krebshilfe. The costs of publication of this article were defrayed in part by the payment of page charges.	Agarwal S, 2000, IMMUNITY, V12, P643, DOI 10.1016/S1074-7613(00)80215-0; Amsen D, 2007, IMMUNITY, V27, P89, DOI 10.1016/j.immuni.2007.05.021; Ansel KM, 2003, NAT IMMUNOL, V4, P616, DOI 10.1038/ni0703-616; Avni O, 2002, NAT IMMUNOL, V3, P643, DOI 10.1038/ni808; Avni O, 2000, CURR OPIN IMMUNOL, V12, P654, DOI 10.1016/S0952-7915(00)00158-8; Baratelli F, 2005, J IMMUNOL, V175, P1483, DOI 10.4049/jimmunol.175.3.1483; BETZ M, 1991, J IMMUNOL, V146, P108; Blumenthal SG, 1999, J BIOL CHEM, V274, P12910, DOI 10.1074/jbc.274.18.12910; BOHJANEN PR, 1990, P NATL ACAD SCI USA, V87, P5283, DOI 10.1073/pnas.87.14.5283; Bopp T, 2007, J EXP MED, V204, P1303, DOI 10.1084/jem.20062129; Chen CH, 2000, J IMMUNOL, V165, P5597, DOI 10.4049/jimmunol.165.10.5597; Chen L, 1998, NATURE, V392, P42, DOI 10.1038/32100; Chow CW, 2000, MOL CELL BIOL, V20, P702, DOI 10.1128/MCB.20.2.702-712.2000; Chuvpilo S, 2002, IMMUNITY, V16, P881, DOI 10.1016/S1074-7613(02)00329-1; Cockerill P N, 2000, Methods Mol Biol, V130, P29; De Boer ML, 1999, INT J BIOCHEM CELL B, V31, P1221, DOI 10.1016/S1357-2725(99)00069-2; Fang TC, 2007, IMMUNITY, V27, P100, DOI 10.1016/j.immuni.2007.04.018; Fields PE, 2004, IMMUNITY, V21, P865, DOI 10.1016/j.immuni.2004.10.015; Frazer KA, 2004, NUCLEIC ACIDS RES, V32, pW273, DOI 10.1093/nar/gkh458; Hernandez-Hoyos G, 2003, IMMUNITY, V19, P83, DOI 10.1016/S1074-7613(03)00176-6; Hogan PG, 2003, GENE DEV, V17, P2205, DOI 10.1101/gad.1102703; KAMMER GM, 1988, IMMUNOL TODAY, V9, P222, DOI 10.1016/0167-5699(88)91220-0; Kel A, 1999, J MOL BIOL, V288, P353, DOI 10.1006/jmbi.1999.2684; Klein-Hessling S, 2003, J IMMUNOL, V170, P2956, DOI 10.4049/jimmunol.170.6.2956; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Lee GR, 2005, NAT IMMUNOL, V6, P42, DOI 10.1038/ni1148; Lee GR, 2003, IMMUNITY, V19, P145, DOI 10.1016/S1074-7613(03)00179-1; LEE HJ, 1995, J BIOL CHEM, V270, P17541, DOI 10.1074/jbc.270.29.17196; Lee HJ, 2000, J EXP MED, V192, P105, DOI 10.1084/jem.192.1.105; Lee HJ, 1998, J IMMUNOL, V160, P2343; Macian F, 2001, ONCOGENE, V20, P2476, DOI 10.1038/sj.onc.1204386; Maneechotesuwan K, 2007, J IMMUNOL, V178, P2491, DOI 10.4049/jimmunol.178.4.2491; Molkentin JD, 1998, CELL, V93, P215, DOI 10.1016/S0092-8674(00)81573-1; Nirula A, 2006, J EXP MED, V203, P1733, DOI 10.1084/jem.20051715; Ouyang WJ, 2000, IMMUNITY, V12, P27, DOI 10.1016/S1074-7613(00)80156-9; Pai SY, 2003, IMMUNITY, V19, P863, DOI 10.1016/S1074-7613(03)00328-5; Serfling E, 2000, BBA-MOL CELL RES, V1498, P1, DOI 10.1016/S0167-4889(00)00082-3; Serfling E, 2006, TRENDS IMMUNOL, V27, P461, DOI 10.1016/j.it.2006.08.005; Sheridan CM, 2002, J BIOL CHEM, V277, P48664, DOI 10.1074/jbc.M207029200; SIEGEL MD, 1995, J BIOL CHEM, V270, P24548, DOI 10.1074/jbc.270.41.24548; Soutoglou E, 2002, SCIENCE, V295, P1901, DOI 10.1126/science.1068356; Spilianakis CG, 2004, NAT IMMUNOL, V5, P1017, DOI 10.1038/ni1115; Stroud JC, 2003, J MOL BIOL, V334, P1009, DOI 10.1016/j.jmb.2003.09.065; Thomas MA, 1999, EUR J BIOCHEM, V265, P300, DOI 10.1046/j.1432-1327.1999.00732.x; Ting CN, 1996, NATURE, V384, P474, DOI 10.1038/384474a0; Tokoyoda K, 2004, INT IMMUNOL, V16, P643, DOI 10.1093/intimm/dxh072; Urwin DL, 2004, EUR J IMMUNOL, V34, P3633, DOI 10.1002/eji.200425279; Wang J, 2006, INT IMMUNOL, V18, P313, DOI 10.1093/intimm/dxh370; Wu CC, 2003, MOL CELL BIOL, V23, P6442, DOI 10.1128/MCB.23.18.6442-6454.2003; Zhang DH, 1998, J IMMUNOL, V161, P3817; Zhang DH, 1997, J BIOL CHEM, V272, P21597, DOI 10.1074/jbc.272.34.21597; Zheng WP, 1997, CELL, V89, P587, DOI 10.1016/S0092-8674(00)80240-8	52	16	18	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 7	2008	283	45					31030	31037		10.1074/jbc.M805929200	http://dx.doi.org/10.1074/jbc.M805929200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	367ID	18772129	hybrid, Green Published			2022-12-27	WOS:000260544800058
J	Daskalogianni, C; Apcher, S; Candeias, MM; Naski, N; Calvo, F; Fahraeus, R				Daskalogianni, Chrysoula; Apcher, Sebastien; Candeias, Marco M.; Naski, Nadia; Calvo, Fabien; Fahraeus, Robin			Gly-Ala Repeats Induce Position-and Substrate-specific Regulation of 26 S Proteasome-dependent Partial Processing	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPSTEIN-BARR-VIRUS; NF-KAPPA-B; GLYCINE-ALANINE REPEAT; NUCLEAR ANTIGEN 1; TRANSCRIPTION FACTORS; PROTEIN-DEGRADATION; MEDIATED DEGRADATION; UBIQUITIN LIGASE; P53 STABILITY; RICH REGION	Partial degradation or regulated ubiquitin proteasome-dependent processing by the 26 S proteasome has been demonstrated, but the underlying molecular mechanisms and the prevalence of this phenomenon remain obscure. Here we show that the Gly-Ala repeat (GAr) sequence of EBNA1 affects processing of substrates via the ubiquitin-dependent degradation pathway in a substrate- and position-specific fashion. GAr-mediated increase in stability of proteins targeted for degradation via the 26 S proteasome was associated with a fraction of the substrates being partially processed and the release of the free GAr. The GAr did not cause a problem for the proteolytic activity of the proteasome, and its fusion to the N terminus of p53 resulted in an increase in the rate of degradation of the entire chimera. Interestingly the GAr had little effect on the stability of EBNA1 protein itself, and targeting EBNA1 for 26 S proteasome-dependent degradation led to its complete degradation. Taken together, our data suggest a model in which the GAr prevents degradation or promotes endoproteolytic processing of substrates targeted for the 26 S proteasome by interfering with the initiation step of substrate unfolding. These results will help to further understand the underlying mechanisms for partial proteasome-dependent degradation.	[Daskalogianni, Chrysoula; Apcher, Sebastien; Candeias, Marco M.; Naski, Nadia; Calvo, Fabien; Fahraeus, Robin] Univ Paris 07, Hop St Louis, Inst Genet Mol, INSERM,U716, F-75010 Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Fahraeus, R (corresponding author), Univ Paris 07, Hop St Louis, Inst Genet Mol, INSERM,U716, 27 Rue Juliette Dodu, F-75010 Paris, France.	robinfahraeus@yahoo.co.uk	Apcher, Sebastien/P-2590-2018; Apcher, Sebastien/B-6356-2015; fahraeus, robin/K-8726-2014	, robin/0000-0003-0402-8492; Candeias, Marco/0000-0002-5731-0179; calvo, fabien/0000-0002-0298-7633; daskalogianni, chrysoula/0000-0001-8177-3141	La Ligue Nationale Contre le Cancer; Agence National de Recherche; INSERM Ile de France; Fundacao para a Ciencia e a Tecnologia of Portugal [SFRH/BD/16697/2004]	La Ligue Nationale Contre le Cancer(Ligue nationale contre le cancer); Agence National de Recherche(French National Research Agency (ANR)); INSERM Ile de France(Institut National de la Sante et de la Recherche Medicale (Inserm)); Fundacao para a Ciencia e a Tecnologia of Portugal(Portuguese Foundation for Science and Technology)	This work was supported in part by La Ligue Nationale Contre le Cancer and the Agence National de Recherche. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.; Supported by INSERM Ile de France.; Supported by Grant SFRH/BD/16697/2004 from the Fundacao para a Ciencia e a Tecnologia of Portugal.	Chai YH, 2004, J BIOL CHEM, V279, P3605, DOI 10.1074/jbc.M310939200; Cummings CJ, 1998, NAT GENET, V19, P148, DOI 10.1038/502; Dantuma NP, 2000, P NATL ACAD SCI USA, V97, P8381, DOI 10.1073/pnas.140217397; Dantuma NP, 2002, CURR TOP MICROBIOL, V269, P23; Dantuma NP, 2002, FEBS LETT, V529, P22, DOI 10.1016/S0014-5793(02)03252-0; Elsasser S, 2005, NAT CELL BIOL, V7, P742, DOI 10.1038/ncb0805-742; FAN CM, 1991, NATURE, V354, P395, DOI 10.1038/354395a0; Glickman MH, 2002, PHYSIOL REV, V82, P373, DOI 10.1152/physrev.00027.2001; Haupt Y, 1997, NATURE, V387, P296, DOI 10.1038/387296a0; Heessen S, 2003, FEBS LETT, V555, P397, DOI 10.1016/S0014-5793(03)01296-1; Heessen S, 2002, P NATL ACAD SCI USA, V99, P1532, DOI 10.1073/pnas.022306499; Holmberg CI, 2004, EMBO J, V23, P4307, DOI 10.1038/sj.emboj.7600426; Honda R, 1997, FEBS LETT, V420, P25, DOI 10.1016/S0014-5793(97)01480-4; Hoppe T, 2000, CELL, V102, P577, DOI 10.1016/S0092-8674(00)00080-5; Hoppe T, 2001, CURR OPIN CELL BIOL, V13, P344, DOI 10.1016/S0955-0674(00)00218-0; Hoyt MA, 2006, EMBO J, V25, P1720, DOI 10.1038/sj.emboj.7601058; Kubbutat MHG, 1997, NATURE, V387, P299, DOI 10.1038/387299a0; Leonchiks A, 1998, FEBS LETT, V440, P365, DOI 10.1016/S0014-5793(98)01488-4; Leonchiks A, 2002, FEBS LETT, V522, P93, DOI 10.1016/S0014-5793(02)02897-1; Levitskaya J, 1997, P NATL ACAD SCI USA, V94, P12616, DOI 10.1073/pnas.94.23.12616; LEVITSKAYA J, 1995, NATURE, V375, P685, DOI 10.1038/375685a0; Lin L, 1996, MOL CELL BIOL, V16, P2248; Liu CW, 2003, SCIENCE, V299, P408, DOI 10.1126/science.1079293; MILNER J, 1991, CELL, V65, P765, DOI 10.1016/0092-8674(91)90384-B; MILNER J, 1994, SEMIN CANCER BIOL, V5, P211; Moorthy AK, 2006, EMBO J, V25, P1945, DOI 10.1038/sj.emboj.7601081; Orian A, 1999, MOL CELL BIOL, V19, P3664; PALOMBELLA VJ, 1994, CELL, V78, P773, DOI 10.1016/S0092-8674(94)90482-0; Pan Y, 2007, J BIOL CHEM, V282, P10846, DOI 10.1074/jbc.M608599200; Piechocki MP, 2001, CELL IMMUNOL, V212, P138, DOI 10.1006/cimm.2001.1853; Piwko W, 2006, NAT STRUCT MOL BIOL, V13, P691, DOI 10.1038/nsmb1122; Powis SH, 1998, NAT MED, V4, P887, DOI 10.1038/nm0898-887; Prakash S, 2004, TRENDS BIOCHEM SCI, V29, P593, DOI 10.1016/j.tibs.2004.09.011; Prakash S, 2004, NAT STRUCT MOL BIOL, V11, P830, DOI 10.1038/nsmb814; Rape M, 2004, BBA-MOL CELL RES, V1695, P209, DOI 10.1016/j.bbamcr.2004.09.022; Rape M, 2002, NAT CELL BIOL, V4, pE113, DOI 10.1038/ncb0502-e113; RODRIGUEZ MS, 1995, MOL CELL BIOL, V15, P2413; Rodriguez MS, 2000, MOL CELL BIOL, V20, P8458, DOI 10.1128/MCB.20.22.8458-8467.2000; Sharipo A, 1998, NAT MED, V4, P939, DOI 10.1038/nm0898-939; Sorokin AV, 2005, EMBO J, V24, P3602, DOI 10.1038/sj.emboj.7600830; Suzuki H, 1999, BIOCHEM BIOPH RES CO, V256, P121, DOI 10.1006/bbrc.1999.0296; Tellam J, 2004, J EXP MED, V199, P1421, DOI 10.1084/jem.20040191; Tellam J, 2001, J BIOL CHEM, V276, P33353, DOI 10.1074/jbc.M104535200; Tian L, 2005, NAT STRUCT MOL BIOL, V12, P1045, DOI 10.1038/nsmb1018; Venkatraman P, 2004, MOL CELL, V14, P95, DOI 10.1016/S1097-2765(04)00151-0; Waelter S, 2001, MOL BIOL CELL, V12, P1393, DOI 10.1091/mbc.12.5.1393; WHITESIDE ST, 1995, MOL CELL BIOL, V15, P5339; Yin Y, 2003, SCIENCE, V301, P1371, DOI 10.1126/science.1088902; Yin YL, 2002, NAT CELL BIOL, V4, P462, DOI 10.1038/ncb801; Zhang MS, 2004, J BIOL CHEM, V279, P8635, DOI 10.1074/jbc.M310449200; Zoghbi HY, 2000, ANNU REV NEUROSCI, V23, P217, DOI 10.1146/annurev.neuro.23.1.217	51	38	38	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 31	2008	283	44					30090	30100		10.1074/jbc.M803290200	http://dx.doi.org/10.1074/jbc.M803290200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	364WS	18757367	hybrid, Green Published			2022-12-27	WOS:000260366900054
J	Huang, JY; Huang, AJ; Zhang, Q; Lin, YC; Yu, HG				Huang, Jianying; Huang, Aijie; Zhang, Qi; Lin, Yen-Chang; Yu, Han-Gang			Novel Mechanism for Suppression of Hyperpolarization-activated Cyclic Nucleotide-gated Pacemaker Channels by Receptor-like Tyrosine Phosphatase-alpha	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VENTRICULAR MYOCYTES; SINUS BRADYCARDIA; KINASE; SRC; INHIBITION; MUTATION; CELLS; I(F); GLYCOSYLATION; TRAFFICKING	We have previously reported an important role of increased tyrosine phosphorylation activity by Src in the modulation of hyperpolarization-activated cyclic nucleotide-gated (HCN) channels. Here we provide evidence showing a novel mechanism of decreased tyrosine phosphorylation on HCN channel properties. We found that the receptor-like protein-tyrosine phosphatase-alpha (RPTP alpha) significantly inhibited or eliminated HCN2 channel expression in HEK293 cells. Biochemical evidence showed that the surface expression of HCN2 was remarkably reduced by RPTP alpha, which was in parallel to the decreased tyrosine phosphorylation of the channel protein. Confocal imaging confirmed that the membrane surface distribution of the HCN2 channel was inhibited by RPTP alpha. Moreover, we detected the presence of RPTP alpha proteins in cardiac ventricles with expression levels changed during development. Inhibition of tyrosine phosphatase activity by phenylarsine oxide or sodium orthovanadate shifted ventricular hyperpolarization-activated current (I-f, generated by HCN channels) activation from nonphysiological voltages into physiological voltages associated with accelerated activation kinetics. In conclusion, we showed a critical role RPTP alpha plays in HCN channel function via tyrosine dephosphorylation. These findings are also important to neurons where HCN and RPTP alpha are richly expressed.	[Huang, Jianying; Huang, Aijie; Zhang, Qi; Lin, Yen-Chang; Yu, Han-Gang] W Virginia Univ, Sch Med, Dept Physiol & Pharmacol, Ctr Interdisciplinary Res Cardiovasc Sci, Morgantown, WV 26506 USA	West Virginia University	Yu, HG (corresponding author), W Virginia Univ, Sch Med, Dept Physiol & Pharmacol, Ctr Interdisciplinary Res Cardiovasc Sci, Morgantown, WV 26506 USA.	hyu@hsc.wvu.edu			National Institutes of Health [HL075023]; Office of Research and Graduate Programs/HSC at West Virginia University; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL075023] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Office of Research and Graduate Programs/HSC at West Virginia University; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant HL075023 (NHLBI). This work was also supported by the Office of Research and Graduate Programs/HSC at West Virginia University (to H. G. Y.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Ahuja P, 2007, EXP CELL RES, V313, P1270, DOI 10.1016/j.yexcr.2007.01.009; Arinsburg SS, 2006, J CARDIOVASC PHARM, V47, P578, DOI 10.1097/01.fjc.0000211740.47960.8b; BARTUTI A, 2008, ANN NY ACAD SCI, V1123, P213; Cerbai E, 1996, CIRCULATION, V94, P1674, DOI 10.1161/01.CIR.94.7.1674; Chen J, 2000, J BIOL CHEM, V275, P36465, DOI 10.1074/jbc.M007034200; DAUM G, 1994, J BIOL CHEM, V269, P10524; DAUM G, 1991, J BIOL CHEM, V266, P12211; GARCIAMORALES P, 1990, P NATL ACAD SCI USA, V87, P9255, DOI 10.1073/pnas.87.23.9255; Gil-Henn H, 2001, J BIOL CHEM, V276, P31772, DOI 10.1074/jbc.M103395200; Hoppe UC, 1998, CARDIOVASC RES, V38, P788, DOI 10.1016/S0008-6363(98)00047-9; KAPLAN R, 1990, P NATL ACAD SCI USA, V87, P7000, DOI 10.1073/pnas.87.18.7000; Li CH, 2008, AM J PHYSIOL-CELL PH, V294, pC355, DOI 10.1152/ajpcell.00236.2007; Milanesi R, 2006, NEW ENGL J MED, V354, P151, DOI 10.1056/NEJMoa052475; Much B, 2003, J BIOL CHEM, V278, P43781, DOI 10.1074/jbc.M306958200; Nof E, 2007, CIRCULATION, V116, P463, DOI 10.1161/CIRCULATIONAHA.107.706887; Ponniah S, 1999, CURR BIOL, V9, P535, DOI 10.1016/S0960-9822(99)80238-3; Robinson RB, 1997, PFLUG ARCH EUR J PHY, V433, P533, DOI 10.1007/s004240050309; Robinson RB, 2003, ANNU REV PHYSIOL, V65, P453, DOI 10.1146/annurev.physiol.65.092101.142734; Santoro B, 2003, TRENDS NEUROSCI, V26, P550, DOI 10.1016/j.tins.2003.08.003; Schulze-Bahr E, 2003, J CLIN INVEST, V111, P1537, DOI 10.1172/JCI200316387; SEARGEANT LE, 1979, BIOCHEM J, V181, P247, DOI 10.1042/bj1810247; Shi WM, 1999, CIRC RES, V85, pE1; Stoker AW, 2005, J ENDOCRINOL, V185, P19, DOI 10.1677/joe.1.06069; Su J, 1999, CURR BIOL, V9, P505, DOI 10.1016/S0960-9822(99)80234-6; Ueda K, 2004, J BIOL CHEM, V279, P27194, DOI 10.1074/jbc.M311953200; Wu JY, 2000, BBA-BIOMEMBRANES, V1463, P15, DOI 10.1016/S0005-2736(99)00233-3; Yu HG, 2004, PFLUG ARCH EUR J PHY, V447, P392, DOI 10.1007/s00424-003-1204-y; YU HG, 1995, J PHYSIOL-LONDON, V485, P469, DOI 10.1113/jphysiol.1995.sp020743; YU HG, 1993, PFLUG ARCH EUR J PHY, V422, P614, DOI 10.1007/BF00374010; YU HG, 1993, CIRC RES, V72, P232, DOI 10.1161/01.RES.72.1.232; Yu X, 2007, AM J PHYSIOL-CELL PH, V292, pC1147, DOI 10.1152/ajpcell.00598.2005; Zong XG, 2005, J BIOL CHEM, V280, P34224, DOI 10.1074/jbc.M506544200	32	25	26	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 31	2008	283	44					29912	29919		10.1074/jbc.M804205200	http://dx.doi.org/10.1074/jbc.M804205200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	364WS	18768480	Green Published, hybrid			2022-12-27	WOS:000260366900036
J	Maruta, T; Yonemitsu, M; Yabuta, Y; Tamoi, M; Ishikawa, T; Shigeoka, S				Maruta, Takanori; Yonemitsu, Miki; Yabuta, Yukinori; Tamoi, Masahiro; Ishikawa, Takahiro; Shigeoka, Shigeru			Arabidopsis Phosphomannose Isomerase 1, but Not Phosphomannose Isomerase 2, Is Essential for Ascorbic Acid Biosynthesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							L-GALACTOSE PHOSPHORYLASE; DE-NOVO BIOSYNTHESIS; VITAMIN-C; CANDIDA-ALBICANS; GENE-EXPRESSION; CELL-WALL; PROTEIN GLYCOSYLATION; SUSPENSION-CULTURE; SUGAR STARVATION; HIGHER-PLANTS	We studied molecular and functional properties of Arabidopsis phosphomannose isomerase isoenzymes (PMI1 and PMI2) that catalyze reversible isomerization between D-fructose 6-phosphate and D-mannose 6-phosphate (Man-6P). The apparent K-m and V-max values for Man-6P of purified recombinant PMI1 were 41.3 +/- 4.2 mu M and 1.89 mu mol/min/mg protein, respectively, whereas those of purified recombinant PMI2 were 372 +/- 13 mu M and 22.5 mu mol/min/mg protein, respectively. Both PMI1 and PMI2 were inhibited by incubation with EDTA, Zn2+, Cd2+, and L-ascorbic acid (AsA). Arabidopsis PMI1 protein was constitutively expressed in both vegetative and reproductive organs under normal growth conditions, whereas the PMI2 protein was not expressed in any organs under light. The induction of PMI1 expression and an increase in the AsA level were observed in leaves under continuous light, whereas the induction of PMI2 expression and a decrease in the AsA level were observed under long term darkness. PMI1 showed a diurnal expression pattern in parallel with the total PMI activity and the total AsA content in leaves. Moreover, a reduction of PMI1 expression through RNA interference resulted in a substantial decrease in the total AsA content of leaves of knock down PMI1 plants, whereas the complete inhibition of PMI2 expression did not affect the total AsA levels in leaves of knock-out PMI2 plants. Consequently, this study improves our understanding of the molecular and functional properties of Arabidopsis PMI isoenzymes and provides genetic evidence of the involvement of PMI1, but not PMI2, in the biosynthesis of AsA in Arabidopsis plants.	[Maruta, Takanori; Yonemitsu, Miki; Tamoi, Masahiro; Shigeoka, Shigeru] Kinki Univ, Fac Agr, Dept Adv Biosci, Nara 6318505, Japan; [Yabuta, Yukinori] Tottori Univ, Fac Agr, Sch Agr Biol & Environm Sci, Tottori 6808550, Japan; [Ishikawa, Takahiro] Shimane Univ, Fac Life & Environm Sci, Matsue, Shimane 6908504, Japan	Kindai University (Kinki University); Tottori University; Shimane University	Shigeoka, S (corresponding author), Kinki Univ, Fac Agr, Dept Adv Biosci, 3327-204 Nakamachi, Nara 6318505, Japan.	shigeoka@nara.kindai.ac.jp	Yabuta, Yukinori/T-3615-2019; Ishikawa, Takahiro/AAX-5792-2021; Tamoi, Masahiro/AAJ-1054-2021	Yabuta, Yukinori/0000-0002-6982-8522; Maruta, Takanori/0000-0003-4144-7821	Nara Institute of Science and Technology; Ministry of Education, Culture, Sports, Science and Technology, Japan [19208031]; Ministry of Education, Culture, Sports, Science and Technology	Nara Institute of Science and Technology; Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by Scientific Research for Plant Graduate Students from the Nara Institute of Science and Technology (to T. M.), Grant-in-aid for Scientific Research 19208031 from the Ministry of Education, Culture, Sports, Science and Technology, Japan, and the "Academic Frontier" Project for Private Universities matching fund subsidy from Ministry of Education, Culture, Sports, Science and Technology 2004-2008 (to S. S.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Bartoli CG, 2006, J EXP BOT, V57, P1621, DOI 10.1093/jxb/erl005; Bechtold N, 1998, METH MOL B, V82, P259; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brouquisse R, 2007, PLANTA, V225, P693, DOI 10.1007/s00425-006-0378-x; Cleasby A, 1996, NAT STRUCT BIOL, V3, P470, DOI 10.1038/nsb0596-470; Conklin PL, 2006, J BIOL CHEM, V281, P15662, DOI 10.1074/jbc.M601409200; Conklin PL, 1996, P NATL ACAD SCI USA, V93, P9970, DOI 10.1073/pnas.93.18.9970; Conklin PL, 1997, PLANT PHYSIOL, V115, P1277, DOI 10.1104/pp.115.3.1277; Conklin PL, 1999, P NATL ACAD SCI USA, V96, P4198, DOI 10.1073/pnas.96.7.4198; Conklin PL, 2000, GENETICS, V154, P847; Contento AL, 2004, PLANT PHYSIOL, V135, P2330, DOI 10.1104/pp.104.044362; COULIN F, 1993, BIOCHEMISTRY-US, V32, P14139, DOI 10.1021/bi00214a010; DALESSANDRO G, 1986, PLANTA, V169, P564, DOI 10.1007/BF00392108; Davey MW, 1999, PLANT PHYSIOL, V121, P535, DOI 10.1104/pp.121.2.535; Dowdle J, 2007, PLANT J, V52, P673, DOI 10.1111/j.1365-313X.2007.03266.x; Foyer CH, 1996, J PLANT PHYSIOL, V148, P391, DOI 10.1016/S0176-1617(96)80271-9; Fujiki Y, 2000, PLANT PHYSIOL, V124, P1139, DOI 10.1104/pp.124.3.1139; Fujiki Y, 2001, PHYSIOL PLANTARUM, V111, P345, DOI 10.1034/j.1399-3054.2001.1110312.x; GRACY RW, 1968, J BIOL CHEM, V243, P4109; GRACY RW, 1968, J BIOL CHEM, V243, P5410; HEROLD A, 1977, NEW PHYTOL, V79, P1, DOI 10.1111/j.1469-8137.1977.tb02178.x; Hoeberichts FA, 2008, J BIOL CHEM, V283, P5708, DOI 10.1074/jbc.M704991200; Ishikawa T, 2006, PHYSIOL PLANTARUM, V126, P343, DOI 10.1111/j.1399-3054.2006.00640.x; Ishikawa T, 2008, BIOSCI BIOTECH BIOCH, V72, P1143, DOI 10.1271/bbb.80062; Jain AK, 2000, MOL BREEDING, V6, P73, DOI 10.1023/A:1009680818138; Laing WA, 2004, P NATL ACAD SCI USA, V101, P16976, DOI 10.1073/pnas.0407453101; Laing WA, 2007, P NATL ACAD SCI USA, V104, P9534, DOI 10.1073/pnas.0701625104; Lee EJ, 2007, PLANT CELL PHYSIOL, V48, P405, DOI 10.1093/pcp/pcm009; Lerouge P, 1998, PLANT MOL BIOL, V38, P31, DOI 10.1023/A:1006012005654; Linster CL, 2007, J BIOL CHEM, V282, P18879, DOI 10.1074/jbc.M702094200; Lorence A, 2004, PLANT PHYSIOL, V134, P1200, DOI 10.1104/pp.103.033936; Lukowitz W, 2001, P NATL ACAD SCI USA, V98, P2262, DOI 10.1073/pnas.051625798; Mieda T, 2004, PLANT CELL PHYSIOL, V45, P1271, DOI 10.1093/pcp/pch152; MILES JS, 1984, GENE, V32, P41, DOI 10.1016/0378-1119(84)90030-1; Nishizawa A, 2006, PLANT J, V48, P535, DOI 10.1111/j.1365-313X.2006.02889.x; Pagnussat GC, 2005, DEVELOPMENT, V132, P603, DOI 10.1242/dev.01595; Pallanca JE, 2000, J EXP BOT, V51, P669, DOI 10.1093/jexbot/51.345.669; Proudfoot AEI, 1996, BIOCHEM J, V318, P437, DOI 10.1042/bj3180437; PROUDFOOT AEI, 1994, EUR J BIOCHEM, V219, P415, DOI 10.1111/j.1432-1033.1994.tb19954.x; PROUDFOOT AEI, 1994, J PROTEIN CHEM, V13, P619, DOI 10.1007/BF01890460; Qian WQ, 2007, PLANT J, V49, P399, DOI 10.1111/j.1365-313X.2006.02967.x; REINBOTHE S, 1994, PLANT CELL, V6, P1197, DOI 10.1105/tpc.6.9.1197; Roux C, 2007, J COMPUT CHEM, V28, P938, DOI 10.1002/jcc.20586; Schmid M, 2005, NAT GENET, V37, P501, DOI 10.1038/ng1543; Seifert GJ, 2004, CURR OPIN PLANT BIOL, V7, P277, DOI 10.1016/j.pbi.2004.03.004; Sharples SC, 2007, PLANT J, V52, P252, DOI 10.1111/j.1365-313X.2007.03225.x; Smirnoff N, 2001, ANNU REV PLANT PHYS, V52, P437, DOI 10.1146/annurev.arplant.52.1.437; Smirnoff N, 2000, CRIT REV BIOCHEM MOL, V35, P291, DOI 10.1080/10409230008984166; SMITH DJ, 1994, MOL CELL BIOL, V14, P6030, DOI 10.1128/MCB.14.9.6030; Spiro RG, 2002, GLYCOBIOLOGY, V12, p43R, DOI 10.1093/glycob/12.4.43R; Turner JG, 2002, PLANT CELL, V14, pS153, DOI 10.1105/tpc.000679; WELLS TNC, 1993, BIOCHEMISTRY-US, V32, P1294, DOI 10.1021/bi00056a014; Wheeler GL, 1998, NATURE, V393, P365, DOI 10.1038/30728; Wolucka BA, 2005, J EXP BOT, V56, P2527, DOI 10.1093/jxb/eri246; Wolucka BA, 2003, J BIOL CHEM, V278, P47483, DOI 10.1074/jbc.M309135200; YABUTA Y, 2008, BIOSCI BIOT IN PRESS; Yabuta Y, 2007, J EXP BOT, V58, P2661, DOI 10.1093/jxb/erm124; Yoshimura K, 2004, PLANT J, V37, P21, DOI 10.1046/j.1365-313X.2003.01930.x; Zhang W, 2008, PLANT PHYSIOL, V146, P431, DOI 10.1104/pp.107.109934	59	71	81	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 24	2008	283	43					28842	28851		10.1074/jbc.M805538200	http://dx.doi.org/10.1074/jbc.M805538200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	362EB	18755683	hybrid, Green Published			2022-12-27	WOS:000260179900009
J	Sokolova, O; Bozko, PM; Naumann, M				Sokolova, Olga; Bozko, Przemyslaw M.; Naumann, Michael			Helicobacter pylori Suppresses Glycogen Synthase Kinase 3 beta to Promote beta-Catenin Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GASTRIC EPITHELIAL-CELLS; MOTOGENIC RESPONSE; SIGNALING PATHWAY; WNT PATHWAY; E-CADHERIN; CYCLIN D1; CANCER; EXPRESSION; PROTEIN; CAGA	The human pathogen Helicobacter pylori influences cell adhesion, proliferation, and apoptosis and is involved in gastric adenocarcinoma formation. In our study we analyzed the impact of H. pylori infection on the regulation of beta-catenin, which plays a central role in both cell adhesion and tumorigenesis. Infection of Madin-Darby canine kidney cells with H. pylori led to suppression of Ser/Thr phosphorylation and ubiquitin-dependent degradation of beta-catenin and to up-regulation of lymphoid enhancer-binding factor/T cell factor (LEF/TCF)dependent transcription. The impaired Ser/Thr phosphorylation of beta-catenin was accompanied by an increase of glycogen synthase kinase 3 beta phosphorylation. Inhibition of Akt kinase, an up-stream regulator of glycogen synthase kinase 3 beta by a specific inhibitor Akti-1/2 or depletion of Akt with siRNA restored Ser/Thr phosphorylation of beta-catenin. We conclude that glycogen synthase kinase 3 beta activity exerts an important role in beta-catenin regulation and LEF/TCF transactivation in H. pylori-infected Madin-Darby canine kidney cells.	[Sokolova, Olga; Bozko, Przemyslaw M.; Naumann, Michael] Otto von Guericke Univ, Inst Expt Internal Med, D-39120 Magdeburg, Germany	Otto von Guericke University	Naumann, M (corresponding author), Otto von Guericke Univ, Inst Expt Internal Med, D-39120 Magdeburg, Germany.	Naumann@med.ovgu.de	Sokolova, Olga/G-2123-2013; Naumann, Michael/B-5285-2011	Sokolova, Olga/0000-0003-1070-504X; Naumann, Michael/0000-0002-8060-2313	Bundesministerium fur Bildung und Forschung [01ZZ0407]	Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF))	This work was supported in part by the Bundesministerium fur Bildung und Forschung Grant 01ZZ0407. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Aberle H, 1997, EMBO J, V16, P3797, DOI 10.1093/emboj/16.13.3797; Barker N, 2000, ADV CANCER RES, V77, P1; Barnett SF, 2005, BIOCHEM J, V385, P399, DOI 10.1042/BJ20041140; Bebb JR, 2006, J CLIN PATHOL, V59, P1261, DOI 10.1136/jcp.2006.036772; Behrens J, 2000, ANN NY ACAD SCI, V910, P21; Bijur GN, 2001, J BIOL CHEM, V276, P37436, DOI 10.1074/jbc.M105725200; Brabletz T, 2005, CELLS TISSUES ORGANS, V179, P56, DOI 10.1159/000084509; Chen XY, 2005, HUM PATHOL, V36, P1294, DOI 10.1016/j.humpath.2005.09.003; Chesire DR, 2003, ENDOCR-RELAT CANCER, V10, P537, DOI 10.1677/erc.0.0100537; Churin Y, 2003, J CELL BIOL, V161, P249, DOI 10.1083/jcb.200208039; Cowin P, 2005, CURR OPIN CELL BIOL, V17, P499, DOI 10.1016/j.ceb.2005.08.014; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; Diehl JA, 2002, CANCER BIOL THER, V1, P226, DOI 10.4161/cbt.72; Doble BW, 2003, J CELL SCI, V116, P1175, DOI 10.1242/jcs.00384; Foryst-Ludwig A, 2004, BIOCHEM BIOPH RES CO, V316, P1065, DOI 10.1016/j.bbrc.2004.02.158; Franco AT, 2008, CANCER RES, V68, P379, DOI 10.1158/0008-5472.CAN-07-0824; Franco AT, 2005, P NATL ACAD SCI USA, V102, P10646, DOI 10.1073/pnas.0504927102; Gottardi CJ, 2004, J CELL BIOL, V167, P339, DOI 10.1083/jcb.200402153; Hart M, 1999, CURR BIOL, V9, P207, DOI 10.1016/S0960-9822(99)80091-8; Hendriksen J, 2008, J CELL SCI, V121, P1793, DOI 10.1242/jcs.025536; Huber AH, 2001, CELL, V105, P391, DOI 10.1016/S0092-8674(01)00330-0; Ikenoue T, 2002, JPN J CANCER RES, V93, P1213, DOI 10.1111/j.1349-7006.2002.tb01226.x; Karim RZ, 2004, PATHOLOGY, V36, P120, DOI 10.1080/00313020410001671957; Kirikoshi H, 2001, INT J ONCOL, V19, P533; Kurashima Y, 2008, INT J CANCER, V122, P823, DOI 10.1002/ijc.23190; Latres E, 1999, ONCOGENE, V18, P849, DOI 10.1038/sj.onc.1202653; Lilien J, 2002, DEV DYNAM, V224, P18, DOI 10.1002/dvdy.10087; Liu CM, 2002, CELL, V108, P837, DOI 10.1016/S0092-8674(02)00685-2; Lynch HT, 2005, J SURG ONCOL, V90, P114, DOI 10.1002/jso.20214; Murata-Kamiya N, 2007, ONCOGENE, V26, P4617, DOI 10.1038/sj.onc.1210251; Nabais S, 2003, INT J SURG PATHOL, V11, P1, DOI 10.1177/106689690301100102; Naumann M, 2005, INT J MED MICROBIOL, V295, P335, DOI 10.1016/j.ijmm.2005.06.007; Naumann M, 2004, TRENDS MICROBIOL, V12, P29, DOI 10.1016/j.tim.2003.11.005; Nelson WJ, 2004, SCIENCE, V303, P1483, DOI 10.1126/science.1094291; Orford K, 1997, J BIOL CHEM, V272, P24735, DOI 10.1074/jbc.272.40.24735; Pap M, 2002, MOL CELL BIOL, V22, P578, DOI 10.1128/MCB.22.2.578-586.2002; Peifer M, 2000, SCIENCE, V287, P1606, DOI 10.1126/science.287.5458.1606; Penta R, 2005, J EXP CLIN CANC RES, V24, P337; Polat A, 2002, NEOPLASMA, V49, P95; Romiti A, 2005, WORLD J GASTROENTERO, V11, P4400; Rubinfeld B, 1996, SCIENCE, V272, P1023, DOI 10.1126/science.272.5264.1023; Sadot E, 2002, J CELL SCI, V115, P2771; SCHMITT W, 1994, MOL MICROBIOL, V12, P307, DOI 10.1111/j.1365-2958.1994.tb01019.x; Sepulveda AR, 2002, ALIMENT PHARM THERAP, V16, P145, DOI 10.1046/j.1365-2036.16.s2.4.x; Shtutman M, 1999, P NATL ACAD SCI USA, V96, P5522, DOI 10.1073/pnas.96.10.5522; Shun CT, 2001, ONCOLOGY-BASEL, V60, P339, DOI 10.1159/000058530; Sokolova O, 2004, CELL MICROBIOL, V6, P1153, DOI 10.1111/j.1462-5822.2004.00422.x; Staal FJT, 2002, EMBO REP, V3, P63, DOI 10.1093/embo-reports/kvf002; Stambolic V, 1996, CURR BIOL, V6, P1664, DOI 10.1016/S0960-9822(02)70790-2; Stoicov C, 2004, GENE, V341, P1, DOI 10.1016/j.gene.2004.07.023; Suzuki M, 2005, J EXP MED, V202, P1235, DOI 10.1084/jem.20051027; Taya S, 1999, GENES CELLS, V4, P757, DOI 10.1046/j.1365-2443.1999.00297.x; Tsutsumi R, 2006, MOL CELL BIOL, V26, P261, DOI 10.1128/MCB.26.1.261-276.2006; van Amsterdam K, 2006, FEMS MICROBIOL REV, V30, P131, DOI 10.1111/j.1574-6976.2005.00006.x; Wallasch C, 2002, BIOCHEM BIOPH RES CO, V295, P695, DOI 10.1016/S0006-291X(02)00740-4; Wessler S, 2002, FASEB J, V16, P417, DOI 10.1096/fj.01-0766fje; Weydig C, 2007, EXP CELL RES, V313, P3459, DOI 10.1016/j.yexcr.2007.07.015; Yamaoka Y, 2006, GUT, V55, P775, DOI 10.1136/gut.2005.083014; Yang Y, 2003, J CLIN PATHOL-MOL PA, V56, P19, DOI 10.1136/mp.56.1.19; Yokozaki H, 2000, PATHOL INT, V50, P767, DOI 10.1046/j.1440-1827.2000.01117.x	60	52	53	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 24	2008	283	43					29367	29374		10.1074/jbc.M801818200	http://dx.doi.org/10.1074/jbc.M801818200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	362EB	18772141	hybrid, Green Published			2022-12-27	WOS:000260179900063
J	Szabo, R; Hobson, JP; List, K; Molinolo, A; Lin, CY; Bugge, TH				Szabo, Roman; Hobson, John P.; List, Karin; Molinolo, Alfredo; Lin, Chen-Yong; Bugge, Thomas H.			Potent Inhibition and Global Co-localization Implicate the Transmembrane Kunitz-type Serine Protease Inhibitor Hepatocyte Growth Factor Activator Inhibitor-2 in the Regulation of Epithelial Matriptase Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPIDERMAL BARRIER FUNCTION; FUNCTIONAL-CHARACTERIZATION; PLACENTAL BIKUNIN; EXPRESSION; DOMAIN; IDENTIFICATION; CLONING; MOUSE; HAI-1; GENE	Hepatocyte growth factor activator inhibitors (HAI)-1 and -2 are recently identified and closely related Kunitz-type transmembrane serine protease inhibitors. Whereas HAI-1 is well established as an inhibitor of the serine proteases matriptase and hepatocyte growth factor activator, the physiological targets of HAI-2 are unknown. Here we show that HAI-2 displays potent inhibitory activity toward matriptase, forms SDS-stable complexes with the serine protease, and blocks matriptase-dependent activation of its candidate physiological substrates pro-prostasin and cell surface-bound pro-urokinase plasminogen activator. To further explore the potential functional relationship between HAI-2 and matriptase, we generated a transgenic mouse strain with a promoterless beta-galactosidase marker gene inserted into the endogenous locus encoding HAI-2 protein and performed a global high resolution mapping of the expression of HAI-2, matriptase, and HAI-1 proteins in all adult tissues. This analysis showed striking co-localization of HAI-2 with matriptase and HAI-1 in epithelial cells of all major organ systems, thus strongly supporting a role of HAI-2 as a physiological regulator of matriptase activity, possibly acting in a redundant or partially redundant manner with HAI-1. Unlike HAI-1 and matriptase, however, HAI-2 expression was also detected in non-epithelial cells of brain and lymph nodes, suggesting that HAI-2 may also be involved in inhibition of serine proteases other than matriptase.	[Szabo, Roman; Hobson, John P.; List, Karin; Molinolo, Alfredo; Bugge, Thomas H.] NIDCR, Oral & Pharyngeal Canc Branch, NIH, Bethesda, MD 20892 USA; [Lin, Chen-Yong] Univ Maryland, Sch Med, Dept Biochem & Mol Biol, Greenebaum Canc Ctr, Baltimore, MD 21201 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR); University System of Maryland; University of Maryland Baltimore	Bugge, TH (corresponding author), NIDCR, Oral & Pharyngeal Canc Branch, NIH, 30 Convent Dr,Rm 211, Bethesda, MD 20892 USA.	thomas.bugge@nih.gov			National Institutes of Health Intramural Program; Department of Defense [DAMD-17-02-1-0693]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [ZIADE000699] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [Z01DE000699] Funding Source: NIH RePORTER	National Institutes of Health Intramural Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported, in whole or in part, by the National Institutes of Health Intramural Program. This work was also supported by a Grant DAMD-17-02-1-0693 from the Department of Defense (to T. H. B.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Carney TJ, 2007, DEVELOPMENT, V134, P3461, DOI 10.1242/dev.004556; Delaria KA, 1997, J BIOL CHEM, V272, P12209, DOI 10.1074/jbc.272.18.12209; Denda K, 2002, J BIOL CHEM, V277, P14053, DOI 10.1074/jbc.M112263200; Fan B, 2005, J BIOL CHEM, V280, P34513, DOI 10.1074/jbc.M502119200; Fan B, 2007, DEV BIOL, V303, P222, DOI 10.1016/j.ydbio.2006.11.005; Friedrich R, 2002, J BIOL CHEM, V277, P2160, DOI 10.1074/jbc.M109830200; Herter S, 2005, BIOCHEM J, V390, P125, DOI 10.1042/BJ20041955; Itoh H, 2000, AM J PHYSIOL-GASTR L, V278, pG635, DOI 10.1152/ajpgi.2000.278.4.G635; Itoh H, 1999, BIOCHEM BIOPH RES CO, V255, P740, DOI 10.1006/bbrc.1999.0268; Kataoka H, 2000, CANCER LETT, V148, P127, DOI 10.1016/S0304-3835(99)00322-5; Kawaguchi T, 1997, J BIOL CHEM, V272, P27558, DOI 10.1074/jbc.272.44.27558; Kilpatrick LM, 2006, BLOOD, V108, P2616, DOI 10.1182/blood-2006-02-001073; Kirchhofer D, 2005, FEBS LETT, V579, P1945, DOI 10.1016/j.febslet.2005.01.085; Kirchhofer D, 2003, J BIOL CHEM, V278, P36341, DOI 10.1074/jbc.M304643200; Leyvraz C, 2005, J CELL BIOL, V170, P487, DOI 10.1083/jcb.200501038; Lin CY, 1999, J BIOL CHEM, V274, P18237, DOI 10.1074/jbc.274.26.18237; List K, 2006, AM J PATHOL, V168, P1513, DOI 10.2353/ajpath.2006.051071; List K, 2002, ONCOGENE, V21, P3765, DOI 10.1038/sj.onc.1205502; List K, 2007, J CELL PHYSIOL, V213, P237, DOI 10.1002/jcp.21115; Marlor CW, 1997, J BIOL CHEM, V272, P12202, DOI 10.1074/jbc.272.18.12202; Mathias JR, 2007, J CELL SCI, V120, P3372, DOI 10.1242/jcs.009159; Mitchell KJ, 2001, NAT GENET, V28, P241, DOI 10.1038/90074; Muller-Pillasch F, 1998, BBA-GENE STRUCT EXPR, V1395, P88, DOI 10.1016/S0167-4781(97)00129-2; Netzel-Arnett S, 2006, J BIOL CHEM, V281, P32941, DOI 10.1074/jbc.C600208200; Parr C, 2004, CLIN CANCER RES, V10, P202, DOI 10.1158/1078-0432.CCR-0553-3; Puente XS, 2003, NAT REV GENET, V4, P544, DOI 10.1038/nrg1111; Qin L, 1998, FEBS LETT, V436, P111, DOI 10.1016/S0014-5793(98)01105-3; Rau JC, 2007, J THROMB HAEMOST, V5, P102, DOI 10.1111/j.1538-7836.2007.02516.x; RAWLINGS ND, 1994, METHOD ENZYMOL, V244, P19; Shimomura T, 1997, J BIOL CHEM, V272, P6370, DOI 10.1074/jbc.272.10.6370; Szabo R, 2007, ONCOGENE, V26, P1546, DOI 10.1038/sj.onc.1209966; Tanaka H, 2005, MOL CELL BIOL, V25, P5687, DOI 10.1128/MCB.25.13.5687-5698.2005; Voss AK, 1998, DEV DYNAM, V212, P171, DOI 10.1002/(SICI)1097-0177(199806)212:2<171::AID-AJA3>3.0.CO;2-E; WURST W, 2000, GENE TARGETING PRACT, P207; Yamauchi M, 2004, J UROLOGY, V171, P890, DOI 10.1097/01.ju.0000092861.21122.d2; Yamauchi M, 2002, BIOL CHEM, V383, P1953, DOI 10.1515/BC.2002.220	36	85	85	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 24	2008	283	43					29495	29504		10.1074/jbc.M801970200	http://dx.doi.org/10.1074/jbc.M801970200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	362EB	18713750	hybrid, Green Published			2022-12-27	WOS:000260179900075
J	Tsao, PN; Chen, F; Izvolsky, KI; Walker, J; Kukuruzinska, MA; Lu, JN; Cardoso, WV				Tsao, Po-Nien; Chen, Felicia; Izvolsky, Konstantin I.; Walker, Janice; Kukuruzinska, Maria A.; Lu, Jining; Cardoso, Wellington V.			gamma-Secretase Activation of Notch Signaling Regulates the Balance of Proximal and Distal Fates in Progenitor Cells of the Developing Lung	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPITHELIAL-MESENCHYMAL INTERACTIONS; DEVELOPING MOUSE LUNG; EMBRYONIC LETHALITY; MICE LACKING; IN-VIVO; TRANSGENIC MICE; DIFFERENTIATION; MORPHOGENESIS; EXPRESSION; PROLIFERATION	Little is known about the mechanisms by which the lung epithelial progenitors are initially patterned and how proximaldistal boundaries are established and maintained when the lung primordium forms and starts to branch. Here we identified a number of Notch pathway components in respiratory progenitors of the early lung, and we investigated the role of Notch in lung pattern formation. By preventing gamma-secretase cleavage of Notch receptors, we have disrupted global Notch signaling in the foregut and in the lung during the initial stages of murine lung morphogenesis. We demonstrate that Notch signaling is not necessary for lung bud initiation; however, Notch is required to maintain a balance of proximal-distal cell fates at these early stages. Disruption of Notch signaling dramatically expands the population of distal progenitors, altering morphogenetic boundaries and preventing formation of proximal structures. Our data suggest a novel mechanism in which Notch and fibroblast growth factor signaling interact to control the proximaldistal pattern of forming airways in the mammalian lung.	[Tsao, Po-Nien; Chen, Felicia; Izvolsky, Konstantin I.; Lu, Jining; Cardoso, Wellington V.] Boston Univ, Sch Med, Ctr Pulm, Dept Med, Boston, MA 02118 USA; [Kukuruzinska, Maria A.] Boston Univ, Sch Dent Med, Dept Cell & Mol Biol, Boston, MA 02118 USA; [Tsao, Po-Nien] Natl Taiwan Univ, Coll Med, Dept Pediat, Taipei, Taiwan; [Walker, Janice] Thomas Jefferson Univ, Dept Pathol Anat & Cell Biol, Philadelphia, PA 19107 USA	Boston University; Boston University; National Taiwan University; Jefferson University	Cardoso, WV (corresponding author), Boston Univ, Sch Med, Ctr Pulm, Dept Med, 715 Albany St,R-304, Boston, MA 02118 USA.	wcardoso@bu.edu	Tsao, Po-Nien/E-5671-2012	Kukukruzinska, Maria/0000-0001-5314-1454; Chen, Felicia/0000-0001-6092-1774; Cardoso, Wellington/0000-0002-2550-3697; TSAO, PO-NIEN/0000-0002-6114-1769; Lu, Jining/0000-0001-9263-9212	National Institutes of Health [PO1 HL47049]; NIH/EE [014798]; National Health Research Institutes-Taiwan Physician Scientist Award [PS9402]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL047049] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH/EE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Health Research Institutes-Taiwan Physician Scientist Award(National Health Research Institutes - Taiwan); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health, NHLBI, Grant PO1 HL47049 (to W. V. C.) and NIH/EE Grant 014798 (to J.W. and M. A. K.). This work was also supported by National Health Research Institutes-Taiwan Physician Scientist Award PS9402 (to P. N. T.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; Benedito R, 2005, GENE EXPR PATTERNS, V5, P750, DOI 10.1016/j.modgep.2005.04.004; Bolos V, 2007, ENDOCR REV, V28, P339, DOI 10.1210/er.2006-0046; Brooker R, 2006, DEVELOPMENT, V133, P1277, DOI 10.1242/dev.02284; Cardoso WV, 2006, DEVELOPMENT, V133, P1611, DOI 10.1242/dev.02310; Chandu D, 2006, J NEUROCHEM, V96, P228, DOI 10.1111/j.1471-4159.2005.03547.x; Chen F, 2007, DEVELOPMENT, V134, P2969, DOI 10.1242/dev.006221; Cheng HT, 2003, DEVELOPMENT, V130, P5031, DOI 10.1242/dev.00697; Collins BJ, 2004, SEMIN CANCER BIOL, V14, P357, DOI 10.1016/j.semcancer.2004.04.015; Dang TP, 2000, J NATL CANCER I, V92, P1355, DOI 10.1093/jnci/92.16.1355; Dang TP, 2003, ONCOGENE, V22, P1988, DOI 10.1038/sj.onc.1206230; deAngelis MH, 1997, NATURE, V386, P717, DOI 10.1038/386717a0; deCelis JF, 1997, DEVELOPMENT, V124, P3241; Desai TJ, 2004, DEV BIOL, V273, P402, DOI 10.1016/j.ydbio.2004.04.039; Doerfler P, 2001, P NATL ACAD SCI USA, V98, P9312, DOI 10.1073/pnas.161102498; Gale NW, 2004, P NATL ACAD SCI USA, V101, P15949, DOI 10.1073/pnas.0407290101; GASSMANN M, 1995, NATURE, V378, P390, DOI 10.1038/378390a0; Ge RR, 2006, CLIN CANCER RES, V12, P4315, DOI 10.1158/1078-0432.CCR-06-0162; Geling A, 2002, EMBO REP, V3, P688, DOI 10.1093/embo-reports/kvf124; Ghabrial AS, 2006, NATURE, V441, P746, DOI 10.1038/nature04829; Hamada Y, 1999, DEVELOPMENT, V126, P3415; Harris KS, 2006, P NATL ACAD SCI USA, V103, P2208, DOI 10.1073/pnas.0510839103; Hart A, 2003, DEV DYNAM, V228, P185, DOI 10.1002/dvdy.10368; Heber S, 2000, J NEUROSCI, V20, P7951; Hellstrom M, 2007, NATURE, V445, P776, DOI 10.1038/nature05571; Herzog EL, 2006, STEM CELLS, V24, P1986, DOI 10.1634/stemcells.2005-0579; Ikeya T, 1999, DEVELOPMENT, V126, P4455; Ilagan Maria Xenia G, 2007, Cell, V128, P1246; Inagaki M, 2005, DEVELOPMENT, V132, P1525, DOI 10.1242/dev.01697; Ishii Y, 1998, DEV DYNAM, V213, P464, DOI 10.1002/(SICI)1097-0177(199812)213:4<464::AID-AJA11>3.0.CO;2-Z; Ito T, 2000, DEVELOPMENT, V127, P3913; Kong YP, 2004, AM J PHYSIOL-LUNG C, V286, pL1075, DOI 10.1152/ajplung.00438.2002; Konishi J, 2007, CANCER RES, V67, P8051, DOI 10.1158/0008-5472.CAN-07-1022; KUBBUTAT MHG, 1994, J CLIN PATHOL, V47, P524, DOI 10.1136/jcp.47.6.524; LARUE L, 1994, P NATL ACAD SCI USA, V91, P8263, DOI 10.1073/pnas.91.17.8263; Lewis J, 1998, SEMIN CELL DEV BIOL, V9, P583, DOI 10.1006/scdb.1998.0266; Lin MH, 2003, DEV BIOL, V263, P343, DOI 10.1016/j.ydbio.2003.07.007; Llimargas M, 1999, DEVELOPMENT, V126, P2355; Lu J, 2004, DEV BIOL, V273, P418, DOI 10.1016/j.ydbio.2004.05.035; Lu JN, 2005, J BIOL CHEM, V280, P4834, DOI 10.1074/jbc.M410714200; Maeda Y, 2007, PHYSIOL REV, V87, P219, DOI 10.1152/physrev.00028.2006; Marambaud P, 2002, EMBO J, V21, P1948, DOI 10.1093/emboj/21.8.1948; Marschang P, 2004, MOL CELL BIOL, V24, P3782, DOI 10.1128/MCB.24.9.3782-3793.2004; Medina M, 2003, CELL SIGNAL, V15, P829, DOI 10.1016/S0898-6568(03)00041-X; Micchelli CA, 2002, FASEB J, V16, P79, DOI 10.1096/fj.02-0394fje; Minoo P, 1999, DEV BIOL, V209, P60, DOI 10.1006/dbio.1999.9234; Miralles F, 2006, INT J DEV BIOL, V50, P17, DOI 10.1387/ijdb.052080fm; Mitsiadis TA, 1997, DEVELOPMENT, V124, P1473; Murtaugh LC, 2003, P NATL ACAD SCI USA, V100, P14920, DOI 10.1073/pnas.2436557100; Nakagawa M, 2001, J CELL SCI, V114, P1829; OKA C, 1995, DEVELOPMENT, V121, P3291; Park KS, 2007, J CLIN INVEST, V117, P978, DOI 10.1172/JCI29176; Park WY, 1998, DEV BIOL, V201, P125, DOI 10.1006/dbio.1998.8994; Petit A, 2003, J NEUROSCI RES, V74, P370, DOI 10.1002/jnr.10747; Post LC, 2000, MECH DEVELOP, V98, P95, DOI 10.1016/S0925-4773(00)00432-9; Que J, 2007, DEVELOPMENT, V134, P2521, DOI 10.1242/dev.003855; Radtke F, 2005, EMBO REP, V6, P1120, DOI 10.1038/sj.embor.7400585; Savill NJ, 2003, DEV BIOL, V258, P141, DOI 10.1016/S0012-1606(03)00107-6; Schmits R, 1997, BLOOD, V90, P2217, DOI 10.1182/blood.V90.6.2217.2217_2217_2233; Shan L, 2007, AM J PHYSIOL-LUNG C, V292, pL500, DOI 10.1152/ajplung.00052.2006; Shi SL, 2003, P NATL ACAD SCI USA, V100, P5234, DOI 10.1073/pnas.0831126100; SWIATEK PJ, 1994, GENE DEV, V8, P707, DOI 10.1101/gad.8.6.707; Taichman DB, 2002, DEV DYNAM, V225, P166, DOI 10.1002/dvdy.10146; van Eyll JM, 2004, J CELL SCI, V117, P2077, DOI 10.1242/jcs.01067; van Tuyl M, 2005, AM J PHYSIOL-LUNG C, V288, pL672, DOI 10.1152/ajplung.00247.2004; VESTWEBER D, 1985, EMBO J, V4, P3393, DOI 10.1002/j.1460-2075.1985.tb04095.x; Wang XD, 2006, DEV BIOL, V290, P66, DOI 10.1016/j.ydbio.2005.11.009; Weinmaster G, 2006, DEVELOPMENT, V133, P3277, DOI 10.1242/dev.02515; Xue YZ, 1999, HUM MOL GENET, V8, P723, DOI 10.1093/hmg/8.5.723	69	79	81	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 24	2008	283	43					29532	29544		10.1074/jbc.M801565200	http://dx.doi.org/10.1074/jbc.M801565200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	362EB	18694942	hybrid, Green Published			2022-12-27	WOS:000260179900079
J	Loo, TW; Bartlett, MC; Clarke, DM				Loo, Tip W.; Bartlett, M. Claire; Clarke, David M.			Processing mutations disrupt interactions between the nucleotide binding and transmembrane domains of P-glycoprotein and the cystic fibrosis transmembrane conductance regulator (CFTR)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DRUG-BINDING; MULTIDRUG TRANSPORTER; PROMOTE MATURATION; ABC TRANSPORTER; ATP HYDROLYSIS; CROSS-LINKING; MUTANTS; MECHANISM; SEGMENTS; GENE	P-glycoprotein (P-gp, ABCB1) is an ATP-dependent drug pump. Each of its two homologous halves contains a transmembrane domain (TMD) that has six transmembrane (TM) segments and a nucleotide-binding domain (NBD). Determining how the two halves interact may provide insight into the folding of P-gp as the drug-binding pocket and nucleotide-binding sites are predicted to be at the interface between the two halves. Here, we present evidence for NBD1-TMD2 and NBD2-TMD1 interactions. We also show that TMD-NBD interactions in immature and mature P-gp can be affected by the presence of a processing mutation. We found that the NBD-TMD mutants L443C(NBD1)/S909C(TMD2) and A266C(TMD1)/F1086C(NBD2) could be cross-linked at 0 degrees C with oxidant (copper phenanthroline). Cross-linking was inhibited by vanadate-trapping of nucleotide. The presence of a processing mutation (G268V/L443C(NBD1)/S909C(TMD2); L1260A/A266C(TMD1)/F1086C(NBD2)) resulted in the synthesis of the immature (150 kDa) protein as the major product and the mutants could not be cross-linked with copper phenanthroline. Expression of the processing mutants in the presence of a pharmacological chaperone (cyclosporin A), however, resulted in the expression of mature (170 kDa) protein at the cell surface that could be crosslinked. Similarly, CFTR mutants A274C(TMD1)/L1260C(NBD2) and V510C(NBD1)/A1067C(TMD2) could be cross-linked at 0 degrees C with copper phenanthroline. Introduction of Delta F508 mutation in these mutants, however, resulted in the synthesis of immature CFTR that could not be cross-linked. These results suggest that establishment of NBD interactions with the opposite TMD is a key step in folding of ABC transporters.	[Clarke, David M.] Univ Toronto, Dept Med, Toronto, ON M5S 1A8, Canada; Univ Toronto, Dept Biochem, Toronto, ON M5S 1A8, Canada	University of Toronto; University of Toronto	Clarke, DM (corresponding author), Univ Toronto, Dept Med, 1 Kings Coll Circle,Rm 7342,Med Sci Bldg, Toronto, ON M5S 1A8, Canada.	david.clarke@utoronto.ca	Clarke, David M./A-1112-2008	Clarke, David M./0000-0003-4335-7184; Loo, Tip W/0000-0003-2108-0188	Cystic Fibrosis Foundation [CLARKE08GO]; Canadian Institutes for Health Research [62832, 25043]; National Cancer Institute of Canada; Canadian Cancer Society [19074]	Cystic Fibrosis Foundation(Italian Cystic Fibrosis Research Foundation); Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); National Cancer Institute of Canada(Canadian Cancer Society (CCS)); Canadian Cancer Society(Canadian Cancer Society (CCS))	This work was supported by grants from the Cystic Fibrosis Foundation (Grant CLARKE08GO), Canadian Institutes for Health Research (Grants 62832 and 25043), and the National Cancer Institute of Canada through the Canadian Cancer Society (Grant 19074). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Ambudkar SV, 1997, J BIOL CHEM, V272, P21160, DOI 10.1074/jbc.272.34.21160; Ambudkar SV, 1999, ANNU REV PHARMACOL, V39, P361, DOI 10.1146/annurev.pharmtox.39.1.361; Bobadilla JL, 2002, HUM MUTAT, V19, P575, DOI 10.1002/humu.10041; CHEN CJ, 1986, CELL, V47, P381, DOI 10.1016/0092-8674(86)90595-7; Dawson RJP, 2006, NATURE, V443, P180, DOI 10.1038/nature05155; HE L, 2008, J BIOL CHEM IN PRESS; Kleizen B, 2005, MOL CELL, V20, P277, DOI 10.1016/j.molcel.2005.09.007; KOBASHI K, 1968, BIOCHIM BIOPHYS ACTA, V158, P239, DOI 10.1016/0304-4165(68)90136-0; Lee CGL, 1998, BIOCHEMISTRY-US, V37, P3594, DOI 10.1021/bi972709x; Lewis HA, 2005, J BIOL CHEM, V280, P1346, DOI 10.1074/jbc.M410968200; Locher KP, 2002, SCIENCE, V296, P1091, DOI 10.1126/science.1071142; Loo TW, 2008, BIOCHEM J, V413, P29, DOI 10.1042/BJ20071690; Loo TW, 2008, ARCH BIOCHEM BIOPHYS, V476, P51, DOI 10.1016/j.abb.2008.02.025; Loo TW, 2007, J BIOL CHEM, V282, P32043, DOI 10.1074/jbc.M706175200; Loo TW, 1997, J BIOL CHEM, V272, P709, DOI 10.1074/jbc.272.2.709; Loo TW, 2003, J BIOL CHEM, V278, P39706, DOI 10.1074/jbc.M308559200; Loo TW, 2005, J MEMBRANE BIOL, V206, P173, DOI 10.1007/s00232-005-0792-1; Loo TW, 2003, J BIOL CHEM, V278, P13603, DOI 10.1074/jbc.C300073200; Loo TW, 2005, J BIOL CHEM, V280, P2522, DOI 10.1074/jbc.M411483200; Loo TW, 2004, J BIOL CHEM, V279, P38395, DOI 10.1074/jbc.M405623200; Loo TW, 2004, J BIOL CHEM, V279, P7692, DOI 10.1074/jbc.M311825200; Loo TW, 1999, FASEB J, V13, P1724, DOI 10.1096/fasebj.13.13.1724; Loo TW, 1999, J BIOL CHEM, V274, P35388, DOI 10.1074/jbc.274.50.35388; Loo TW, 1999, J BIOL CHEM, V274, P24759, DOI 10.1074/jbc.274.35.24759; Loo TW, 1996, J BIOL CHEM, V271, P27482, DOI 10.1074/jbc.271.44.27482; LOO TW, 1995, J BIOL CHEM, V270, P843, DOI 10.1074/jbc.270.2.843; Loo TW, 2002, J BIOL CHEM, V277, P27585, DOI 10.1074/jbc.C200330200; LOO TW, 1994, J BIOL CHEM, V269, P7243; Loo TW, 2002, J BIOL CHEM, V277, P41303, DOI 10.1074/jbc.C200484200; Loo TW, 1998, J BIOL CHEM, V273, P14671, DOI 10.1074/jbc.273.24.14671; Loo TW, 2002, P NATL ACAD SCI USA, V99, P3511, DOI 10.1073/pnas.022049799; LOO TW, 1994, BIOCHEMISTRY-US, V33, P14049, DOI 10.1021/bi00251a013; LOO TW, 1995, J BIOL CHEM, V270, P21449, DOI 10.1074/jbc.270.37.21449; LOO TW, 1994, J BIOL CHEM, V269, P7750; LOO TW, 1995, J BIOL CHEM, V270, P21839, DOI 10.1074/jbc.270.37.21839; Loo TW, 1998, METHOD ENZYMOL, V292, P480; Lugo MR, 2005, BIOCHEMISTRY-US, V44, P14020, DOI 10.1021/bi0511179; PAGANT S, 2008, J BIOL CHEM IN PRESS; Pedemonte N, 2005, J CLIN INVEST, V115, P2564, DOI 10.1172/JCI24898; RIORDAN JR, 1989, SCIENCE, V245, P1066; SCHINKEL AH, 1994, CELL, V77, P491, DOI 10.1016/0092-8674(94)90212-7; Senior AE, 1997, SEMIN CANCER BIOL, V8, P143, DOI 10.1006/scbi.1997.0065; Serohijos AWR, 2008, P NATL ACAD SCI USA, V105, P3256, DOI 10.1073/pnas.0800254105; THIEBAUT F, 1987, P NATL ACAD SCI USA, V84, P7735, DOI 10.1073/pnas.84.21.7735; URBATSCH IL, 1995, J BIOL CHEM, V270, P19383, DOI 10.1074/jbc.270.33.19383; Wang Y, 2007, J BIOL CHEM, V282, P33247, DOI 10.1074/jbc.C700175200; Wang Y, 2007, BIOCHEM J, V406, P257, DOI 10.1042/BJ20070478; Zolnerciks JK, 2007, FASEB J, V21, P3937, DOI 10.1096/fj.07-8610com	48	65	65	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 17	2008	283	42					28190	28197		10.1074/jbc.M805834200	http://dx.doi.org/10.1074/jbc.M805834200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	359EN	18708637	hybrid, Green Published			2022-12-27	WOS:000259969300021
J	Papi, A; Contoli, M; Gasparini, P; Bristot, L; Edwards, MR; Chicca, M; Leis, M; Ciaccia, A; Caramori, G; Johnston, SL; Pinamonti, S				Papi, Alberto; Contoli, Marco; Gasparini, Pierluigi; Bristot, Laura; Edwards, Michael R.; Chicca, Milvia; Leis, Marilena; Ciaccia, Adalberto; Caramori, Gaetano; Johnston, Sebastian L.; Pinamonti, Silvano			Role of xanthine oxidase activation and reduced glutathione depletion in rhinovirus induction of inflammation in respiratory epithelial cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; NF-KAPPA-B; INTERCELLULAR-ADHESION MOLECULE-1; OXIDATIVE STRESS; COMMON COLD; AIRWAY INFLAMMATION; GENE-EXPRESSION; ASTHMA; EXACERBATIONS; RECEPTOR	Rhinoviruses are the major cause of the common cold and acute exacerbations of asthma and chronic obstructive pulmonary disease. We previously reported rapid rhinovirus induction of intracellular superoxide anion, resulting in NF-kappa B activation and pro-inflammatory molecule production. The mechanisms of rhinovirus superoxide induction are poorly understood. Here we found that the proteolytic activation of the xanthine dehy-drogenase/xanthine oxidase (XD/XO) system was required because pretreatment with serine protease inhibitors abolished rhinovirus-induced superoxide generation in primary bronchial and A549 respiratory epithelial cells. These findings were confirmed by Western blotting analysis and by silencing experiments. Rhinovirus infection induced intracellular depletion of reduced glutathione (GSH) that was abolished by pretreatment with either XO inhibitor oxypurinol or serine protease inhibitors. Increasing intracellular GSH with exogenous H2S or GSH prevented both rhinovirus-mediated intracellular GSH depletion and rhinovirus-induced superoxide production. We propose that rhinovirus infection proteolytically activates XO initiating a pro-inflammatory vicious circle driven by virus-induced depletion of intracellular reducing power. Inhibition of these pathways has therapeutic potential.	[Papi, Alberto; Contoli, Marco; Bristot, Laura; Ciaccia, Adalberto; Caramori, Gaetano] Univ Ferrara, Res Ctr Asthma & COPD, I-44100 Ferrara, Italy; [Gasparini, Pierluigi; Chicca, Milvia; Leis, Marilena; Pinamonti, Silvano] Univ Ferrara, Dept Biol, I-44100 Ferrara, Italy; [Edwards, Michael R.; Johnston, Sebastian L.] Univ London Imperial Coll Sci Technol & Med, Dept Resp Med, Natl Heart & Lung Inst, Wright Fleming Inst Infect & Immun, London W2 1PG, England; [Edwards, Michael R.; Johnston, Sebastian L.] Univ London Imperial Coll Sci Technol & Med, MRC, London W2 1PG, England; [Edwards, Michael R.; Johnston, Sebastian L.] Univ London Imperial Coll Sci Technol & Med, Asthma UK Ctr Allerg Mech Asthma, London W2 1PG, England	University of Ferrara; University of Ferrara; Imperial College London; Imperial College London; Imperial College London; University of London; King's College London	Pinamonti, S (corresponding author), Via Savonarola 9, I-44100 Ferrara, Italy.	ppa@unife.it	Gasparini, Pierluigi/ABA-2811-2021; Papi, alberto/AAC-1888-2019; Contoli, Marco/K-3947-2018; Johnston, Sebastian Lennox/I-2423-2012; Caramori, Gaetano/AAS-8611-2020	Gasparini, Pierluigi/0000-0001-8311-8845; Contoli, Marco/0000-0002-2731-5809; Johnston, Sebastian Lennox/0000-0003-3009-9200; Caramori, Gaetano/0000-0002-9807-327X; Edwards, Michael Robert/0000-0001-6837-0532; PAPI, ALBERTO/0000-0002-6924-4500	Medical Research Council [G0400503B] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)		Amineva SP, 2004, J GEN VIROL, V85, P2969, DOI 10.1099/vir.0.80164-0; BARTL K, 1979, CLIN CHEM, V25, P619; Bhattacharya S, 2001, BMC Struct Biol, V1, P4, DOI 10.1186/1472-6807-1-4; Bustin SA, 2000, J MOL ENDOCRINOL, V25, P169, DOI 10.1677/jme.0.0250169; Cahill CM, 2008, J BIOL CHEM, V283, P25900, DOI 10.1074/jbc.M707692200; CALHOUN WJ, 1994, J CLIN INVEST, V94, P2200, DOI 10.1172/JCI117581; Caramori G, 2004, THORAX, V59, P170, DOI 10.1136/thorax.2002.002477; Casola A, 2001, J BIOL CHEM, V276, P19715, DOI 10.1074/jbc.M101526200; Ciriolo MR, 1997, J BIOL CHEM, V272, P2700, DOI 10.1074/jbc.272.5.2700; Contoli M, 2006, NAT MED, V12, P1023, DOI 10.1038/nm1462; Corne JM, 2002, LANCET, V359, P831, DOI 10.1016/S0140-6736(02)07953-9; Edwards MR, 2007, J BIOL CHEM, V282, P15366, DOI 10.1074/jbc.M701325200; Edwards MR, 2007, MOL IMMUNOL, V44, P1587, DOI 10.1016/j.molimm.2006.08.014; Enroth C, 2000, P NATL ACAD SCI USA, V97, P10723, DOI 10.1073/pnas.97.20.10723; FRAENKEL DJ, 1995, AM J RESP CRIT CARE, V151, P879; GREVE JM, 1989, CELL, V56, P839, DOI 10.1016/0092-8674(89)90688-0; Grissell TV, 2005, AM J RESP CRIT CARE, V172, P433, DOI 10.1164/rccm.200412-1621OC; Halliwell B., 1999, FREE RADICAL BIOL ME; Harrison R, 2002, FREE RADICAL BIO MED, V33, P774, DOI 10.1016/S0891-5849(02)00956-5; HASSOUN PM, 1995, AM J PHYSIOL-LUNG C, V268, pL809, DOI 10.1152/ajplung.1995.268.5.L809; Heikkinen T, 2003, LANCET, V361, P51, DOI 10.1016/S0140-6736(03)12162-9; HILLE R, 1995, FASEB J, V9, P995, DOI 10.1096/fasebj.9.11.7649415; Janssen-Heininger YMW, 2000, FREE RADICAL BIO MED, V28, P1317, DOI 10.1016/S0891-5849(00)00218-5; JEFFERSON TO, 2007, COCHRANE DB SYST REV, V18, P2743; Jobsis RQ, 2001, MEDIAT INFLAMM, V10, P351; JOHNSTON SL, 1995, BRIT MED J, V310, P1225, DOI 10.1136/bmj.310.6989.1225; Johnston SL., 1997, DIAGNOSTIC PROCEDURE, P553; Kageyama T, 2002, CELL MOL LIFE SCI, V59, P288, DOI 10.1007/s00018-002-8423-9; Kaul P, 2000, J INFECT DIS, V181, P1885, DOI 10.1086/315504; Lee MM, 2004, MOL CELL BIOCHEM, V259, P15, DOI 10.1023/B:MCBI.0000021340.79014.a3; Li NX, 1999, FASEB J, V13, P1137, DOI 10.1096/fasebj.13.10.1137; Mallia P, 2007, CURR PHARM DESIGN, V13, P73, DOI 10.2174/138161207779313777; MCCORD JM, 1973, PHOTOCHEM PHOTOBIOL, V17, P115, DOI 10.1111/j.1751-1097.1973.tb06340.x; Morre DJ, 2002, ANTIOXID REDOX SIGN, V4, P207, DOI 10.1089/152308602753625960; Papadopoulos NG, 2000, J INFECT DIS, V181, P1875, DOI 10.1086/315513; Papi A, 2002, FASEB J, V16, P1934, DOI 10.1096/fj.02-0118fje; Papi A, 1999, J BIOL CHEM, V274, P9707, DOI 10.1074/jbc.274.14.9707; Papi A, 2006, AM J RESP CRIT CARE, V173, P1114, DOI 10.1164/rccm.200506-859OC; PETERHANS E, 1997, J NUTR, V127, P962; Pinamonti S, 1996, FREE RADICAL BIO MED, V21, P147, DOI 10.1016/0891-5849(96)00030-5; PRIEST DG, 1972, ANAL BIOCHEM, V50, P195, DOI 10.1016/0003-2697(72)90499-X; Psarras S, 2005, CURR PHARM DESIGN, V11, P2053, DOI 10.2174/1381612054065774; Seemungal T, 2001, AM J RESP CRIT CARE, V164, P1618, DOI 10.1164/ajrccm.164.9.2105011; SPECTOR T, 1988, BIOCHEM PHARMACOL, V37, P349, DOI 10.1016/0006-2952(88)90739-3; STANWAY G, 1994, ENCY VIROLOGY, V3, P1253; Stracher A, 1999, ANN NY ACAD SCI, V884, P52, DOI 10.1111/j.1749-6632.1999.tb08635.x; STYLIANOU E, 1992, J BIOL CHEM, V267, P15836; TAMAI M, 1986, J PHARMACOBIO-DYNAM, V9, P672, DOI 10.1248/bpb1978.9.672; UNCAPHER CR, 1991, VIROLOGY, V180, P814, DOI 10.1016/0042-6822(91)90098-V; Varani K, 2006, AM J RESP CRIT CARE, V173, P398, DOI 10.1164/rccm.200506-869OC; Wark PAB, 2005, J EXP MED, V201, P937, DOI 10.1084/jem.20041901; Wegner Julie, 2003, J Extra Corpor Technol, V35, P326; Yeh CT, 2004, BIOCHEM BIOPH RES CO, V323, P32, DOI 10.1016/j.bbrc.2004.08.079; Zsengeller ZK, 2001, AM J PHYSIOL-LUNG C, V280, pL503, DOI 10.1152/ajplung.2001.280.3.L503	54	40	41	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 17	2008	283	42					28595	28606		10.1074/jbc.M805766200	http://dx.doi.org/10.1074/jbc.M805766200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	359EN	18678861	Green Published, hybrid			2022-12-27	WOS:000259969300062
J	Popowski, M; Ferguson, HA; Sion, AM; Koller, E; Knudsen, E; Van den Berg, CL				Popowski, Melissa; Ferguson, Heather A.; Sion, Amy M.; Koller, Erich; Knudsen, Erik; Van den Berg, Carla L.			Stress and IGF-I differentially control cell fate through mammalian target of rapamycin (mTOR) and retinoblastoma protein (pRB)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							THERAPEUTIC RESPONSE; INDUCED APOPTOSIS; INHIBITION; PHOSPHORYLATION; TRANSLATION; ACTIVATION; CANCER; DEPHOSPHORYLATION; KINASE; P53	Significant discoveries have recently contributed to our knowledge of intracellular growth factor and nutrient signaling via mTOR (mammalian target of rapamycin). This signaling pathway is essential in cellular metabolism and cell survival by enhancing protein translation through phosphorylation of 4EBP-1 and p70S6K. Growth factors like insulin-like growth factor-I induce mTOR to prevent cell death during cellular stress. Agents targeting mTOR are of major interest as anticancer agents. We show here, using human breast cancer cells, that certain types of stress activate mTOR leading to 4E-BP1 and p70S6K phosphorylation. UV treatment increased phosphorylation of the translation inhibitor eIF2 alpha, suggesting a potential mechanism for UV activation of Akt and mTOR. c-Myc, a survival protein regulated by cap-dependent protein translation, increased with IGF-I treatment, but this response was not inhibited by rapamycin. Additionally, UV treatment potently increased c-Myc degradation, which was reduced by co-treatment with the proteasomal inhibitor, MG-132. Together, these data suggest that protein translation does not strongly mediate cell survival in these models. In contrast, the phosphorylation status of retinoblastoma protein (pRB) was mediated by mTOR through its inhibitory effects on phosphatase activity. This effect was most notable during DNA damage and rapamycin treatment. Hypophosphorylated pRB was susceptible to inactivation by caspase-mediated cleavage, resulting in cell death. Reduction of pRB expression inhibited IGF-I survival effects. Our data support an important role of phosphatases and pRB in IGF-I/mTOR-mediated cell survival. These studies provide new directions in optimizing anticancer efficacy of m TOR inhibitors when used in combination with DNA-damaging agents.	[Popowski, Melissa; Van den Berg, Carla L.] Univ Texas Austin, Coll Pharm, Austin, TX 78712 USA; [Ferguson, Heather A.; Sion, Amy M.; Van den Berg, Carla L.] Univ Colorado, Sch Pharm, Hlth Sci Ctr, Denver, CO 80262 USA; [Koller, Erich] Isis Pharmaceut Inc, Carlsbad, CA 92008 USA; [Knudsen, Erik] Univ Cincinnati, Dept Cell Biol, Vontz Ctr Mol Studies, Coll Med, Cincinnati, OH 45267 USA	University of Texas System; University of Texas Austin; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; Isis Pharmaceuticals Inc; University System of Ohio; University of Cincinnati	Van den Berg, CL (corresponding author), Univ Texas Austin, Coll Pharm, 1 Univ Ave,A1915, Austin, TX 78712 USA.	cvandenberg@mail.utexas.edu			National Institutes of Health [CA 89288]; United States Army Medical Research [DAMD17-99-9142]; NATIONAL CANCER INSTITUTE [R01CA089288] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States Army Medical Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA 89288 and the United States Army Medical Research Grant DAMD17-99-9142 (to C.L.V.D.B.). The content of this information does not necessarily reflect the position or the policy of the Government, and no official endorsement should be inferred. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Averous J, 2006, ONCOGENE, V25, P6423, DOI 10.1038/sj.onc.1209887; Avni D, 2003, MOL CELL, V12, P735, DOI 10.1016/S1097-2765(03)00355-1; Beuvink I, 2005, CELL, V120, P747, DOI 10.1016/j.cell.2004.12.040; Bosco EE, 2007, J CLIN INVEST, V117, P218, DOI 10.1172/JCI28803; Britton S, 2008, CELL CYCLE, V7, P63, DOI 10.4161/cc.7.1.5111; Chakraborty S, 2007, GENOMICS, V90, P344, DOI 10.1016/j.ygeno.2007.05.002; Cicchillitti L, 2003, J BIOL CHEM, V278, P19509, DOI 10.1074/jbc.M300511200; Fattman CL, 2001, ONCOGENE, V20, P2918, DOI 10.1038/sj.onc.1204414; Feng ZH, 2005, P NATL ACAD SCI USA, V102, P8204, DOI 10.1073/pnas.0502857102; Ferguson HA, 2003, J BIOL CHEM, V278, P45793, DOI 10.1074/jbc.M307979200; Giles FJ, 2005, CURR MOL MED, V5, P653, DOI 10.2174/156652405774641034; Gingras AC, 2001, GENE DEV, V15, P807, DOI 10.1101/gad.887201; Guertin DA, 2007, CANCER CELL, V12, P9, DOI 10.1016/j.ccr.2007.05.008; Huang SL, 2004, J BIOL CHEM, V279, P36490, DOI 10.1074/jbc.M401208200; Inoki K, 2002, NAT CELL BIOL, V4, P648, DOI 10.1038/ncb839; Kazemi S, 2007, MOL BIOL CELL, V18, P3635, DOI 10.1091/mbc.E07-01-0053; Kong M, 2004, SCIENCE, V306, P695, DOI 10.1126/science.1100537; Krucher NA, 2006, EXP CELL RES, V312, P2757, DOI 10.1016/j.yexcr.2006.05.002; Lee CH, 2007, EMBO J, V26, P4812, DOI 10.1038/sj.emboj.7601900; Levine AJ, 2006, GENE DEV, V20, P267, DOI 10.1101/gad.1363206; McMahon LP, 2002, MOL CELL BIOL, V22, P7428, DOI 10.1128/MCB.22.21.7428-7438.2002; Mingo-Sion AM, 2005, BREAST CANCER RES TR, V91, P259, DOI 10.1007/s10549-005-0669-0; Peterson RT, 1999, P NATL ACAD SCI USA, V96, P4438, DOI 10.1073/pnas.96.8.4438; Polunovsky VA, 1996, MOL CELL BIOL, V16, P6573; Saelens X, 2001, J BIOL CHEM, V276, P41620, DOI 10.1074/jbc.M103674200; Schaim SS, 2003, CURR BIOL, V13, P797, DOI 10.1016/S0960-9822(03)00329-4; Schmelzle T, 2000, CELL, V103, P253, DOI 10.1016/S0092-8674(00)00117-3; Sharma A, 2007, CANCER RES, V67, P6192, DOI 10.1158/0008-5472.CAN-06-4424; Tan A, 2000, ONCOGENE, V19, P1437, DOI 10.1038/sj.onc.1203446; Tee AR, 2000, ONCOGENE, V19, P3021, DOI 10.1038/sj.onc.1203622; THIMMAIAH KN, 2003, CANCER RES, P364; Vignot S, 2005, ANN ONCOL, V16, P525, DOI 10.1093/annonc/mdi113; Yan Y, 1999, J BIOL CHEM, V274, P31917, DOI 10.1074/jbc.274.45.31917; Yokogami K, 2000, CURR BIOL, V10, P47, DOI 10.1016/S0960-9822(99)00268-7; Zagorski WA, 2007, CANCER RES, V67, P8264, DOI 10.1158/0008-5472.CAN-06-4753; Zhou JB, 2007, P NATL ACAD SCI USA, V104, P16158, DOI 10.1073/pnas.0702596104	36	17	18	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 17	2008	283	42					28265	28273		10.1074/jbc.M805724200	http://dx.doi.org/10.1074/jbc.M805724200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	359EN	18697743	Green Published, hybrid			2022-12-27	WOS:000259969300028
J	Ponnusamy, S; Alderson, NL; Hama, H; Bielawski, J; Jiang, JC; Bhandari, R; Snyder, SH; Jazwinski, SM; Ogretmen, B				Ponnusamy, Suriyan; Alderson, Nathan L.; Hama, Hiroko; Bielawski, Jacek; Jiang, James C.; Bhandari, Rashna; Snyder, Solomon H.; Jazwinski, S. Michal; Ogretmen, Besim			Regulation of telomere length by fatty acid elongase 3 in yeast - Involvement of inositol phosphate metabolism and Ku70/80 function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; CHROMOSOME TERMINI; CERAMIDE SYNTHESIS; DNA-REPAIR; ELONGATION; KU; GENE; PYROPHOSPHATES; SPHINGOLIPIDS; PROTEINS	In this study, we investigated the roles of very long-chain fatty acid (VLCFA) synthesis by fatty acid elongase 3 (ELO3) in the regulation of telomere length and life span in the yeast Saccharomyces cerevisiae. Loss of VLCFA synthesis via deletion of ELO3 reduced telomere length, and reconstitution of the expression of wild type ELO3, and not by its mutant with decreased catalytic activity, rescued telomere attrition. Further experiments revealed that alterations of phytoceramide seem to be dispensable for telomere shortening in response to loss of ELO3. Interestingly, telomere shortening in elo3 Delta cells was almost completely prevented by deletion of IPK2 or KCS1, which are involved in the generation of inositol phosphates (IP4, IP5, and inositol pyrophosphates). Deletion of IPK1, which generates IP6, however, did not affect regulation of telomere length. Further data also suggested that elo3 Delta cells exhibit accelerated chronologic aging, and reduced replicative life span compared with wild type cells, and deletion of KCS1 helped recover these biological defects. Importantly, to determine downstream mechanisms, epistasis experiments were performed, and data indicated that ELO3 and YKU70/80 share a common pathway for the regulation of telomere length. More specifically, chromatin immunoprecipitation assays revealed that the telomere binding and protective function of YKu80p in vivo was reduced in elo3 Delta cells, whereas its non-homologues end-joining function was not altered. Deletion of KCS1 in elo3 Delta cells recovered the telomere binding and protective function of Ku, consistent with the role of KCS1 mutation in the rescue of telomere length attrition. Thus, these findings provide initial evidence of a possible link between Elo3-dependent VLCFA synthesis, and IP metabolism by KCS1 and IPK2 in the regulation of telomeres, which play important physiological roles in the control of senescence and aging, via a mechanism involving alterations of the telomere-binding/protection function of Ku.	[Ponnusamy, Suriyan; Bielawski, Jacek; Ogretmen, Besim] Med Univ S Carolina, Hollings Canc Ctr, Charleston, SC 29425 USA; [Ponnusamy, Suriyan; Alderson, Nathan L.; Hama, Hiroko; Bielawski, Jacek; Ogretmen, Besim] Med Univ S Carolina, Dept Biochem & Mol Biol, Charleston, SC 29425 USA; [Jiang, James C.; Jazwinski, S. Michal] Tulane Univ, Dept Med, Sch Med, New Orleans, LA 70118 USA; [Bhandari, Rashna; Snyder, Solomon H.] Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA	Medical University of South Carolina; Medical University of South Carolina; Tulane University; Johns Hopkins University	Ogretmen, B (corresponding author), Med Univ S Carolina, Hollings Canc Ctr, 86 Jonathan Lucas St,Rm HO512A, Charleston, SC 29425 USA.	ogretmen@musc.edu		Bhandari, Rashna/0000-0003-3101-0204	National Institutes of Health [CA88932, DE016572, AG006168]; NATIONAL CANCER INSTITUTE [R01CA088932] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE016572] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R37AG006168, R01AG006168] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants CA88932 and DE016572 (to B. O.) and AG006168 (to S. M.J.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Alderson NL, 2004, J BIOL CHEM, V279, P48562, DOI 10.1074/jbc.M406649200; Askree SH, 2004, P NATL ACAD SCI USA, V101, P8658, DOI 10.1073/pnas.0401263101; BAUDIN A, 1993, NUCLEIC ACIDS RES, V21, P3329, DOI 10.1093/nar/21.14.3329; Baumann P, 2000, MOL BIOL CELL, V11, P3265, DOI 10.1091/mbc.11.10.3265; Bertuch AA, 2003, MOL CELL BIOL, V23, P8202, DOI 10.1128/MCB.23.22.8202-8215.2003; Bertuch AA, 2006, CURR OPIN CELL BIOL, V18, P247, DOI 10.1016/j.ceb.2006.04.005; Bielawski J, 2006, METHODS, V39, P82, DOI 10.1016/j.ymeth.2006.05.004; Blackburn EH, 2006, NAT MED, V12, P1133, DOI 10.1038/nm1006-1133; Daley JM, 2005, ANNU REV GENET, V39, P431, DOI 10.1146/annurev.genet.39.073003.113340; David D, 1998, J CELL BIOL, V143, P1167, DOI 10.1083/jcb.143.5.1167; Dickson RC, 2002, BBA-MOL CELL BIOL L, V1583, P13, DOI 10.1016/S1388-1981(02)00210-X; Dickson RC, 2006, PROG LIPID RES, V45, P447, DOI 10.1016/j.plipres.2006.03.004; Dittrich F, 1998, EUR J BIOCHEM, V252, P477, DOI 10.1046/j.1432-1327.1998.2520477.x; Eisenkolb M, 2002, MOL BIOL CELL, V13, P4414, DOI 10.1091/mbc.E02-02-0116; Fabrizio Paola, 2007, Methods Mol Biol, V371, P89; Fisher TS, 2005, DNA REPAIR, V4, P1215, DOI 10.1016/j.dnarep.2005.04.021; Gaigg B, 2006, J BIOL CHEM, V281, P34135, DOI 10.1074/jbc.M603791200; Guillas I, 2001, EMBO J, V20, P2655, DOI 10.1093/emboj/20.11.2655; Hanakahi LA, 2002, EMBO J, V21, P2038, DOI 10.1093/emboj/21.8.2038; Jazwinski SM, 2002, INT J BIOCHEM CELL B, V34, P1491, DOI 10.1016/S1357-2725(02)00044-4; Ju YJ, 2006, EXP MOL MED, V38, P686, DOI 10.1038/emm.2006.81; Kim S, 1999, MOL BIOL CELL, V10, P3125, DOI 10.1091/mbc.10.10.3125; Kitagaki H, 2007, BBA-BIOMEMBRANES, V1768, P2849, DOI 10.1016/j.bbamem.2007.07.019; Kobayashi SD, 2003, EUKARYOT CELL, V2, P284, DOI 10.1128/EC.2.2.284-294.2003; Kohlwein SD, 2001, MOL CELL BIOL, V21, P109, DOI 10.1128/MCB.21.1.109-125.2001; Lee YS, 2007, SCIENCE, V316, P109, DOI 10.1126/science.1139080; Levine TP, 2000, MOL BIOL CELL, V11, P2267, DOI 10.1091/mbc.11.7.2267; Li WM, 2007, INT J BIOL SCI, V3, P120; Ma YM, 2002, J BIOL CHEM, V277, P10756, DOI 10.1074/jbc.C200030200; Obeid L.M., 2003, SCI AGING KNOWLEDGE, V2003, pPE27; Oh CS, 1997, J BIOL CHEM, V272, P17376, DOI 10.1074/jbc.272.28.17376; Reggiori F, 1998, J BIOL CHEM, V273, P30550, DOI 10.1074/jbc.273.46.30550; Ribes-Zamora A, 2007, NAT STRUCT MOL BIOL, V14, P301, DOI 10.1038/nsmb1214; Saiardi A, 2005, P NATL ACAD SCI USA, V102, P1911, DOI 10.1073/pnas.0409322102; Saiardi A, 2002, P NATL ACAD SCI USA, V99, P14206, DOI 10.1073/pnas.212527899; Sawai H, 2000, J BIOL CHEM, V275, P39793, DOI 10.1074/jbc.M007721200; Seeds AM, 2007, BIOCHEM SOC SYMP, V74, P183, DOI 10.1042/BSS2007c16; Shen XT, 2003, SCIENCE, V299, P112, DOI 10.1126/science.1078068; Smogorzewska A, 2004, ANNU REV BIOCHEM, V73, P177, DOI 10.1146/annurev.biochem.73.071403.160049; Sundararaj KP, 2004, J BIOL CHEM, V279, P6152, DOI 10.1074/jbc.M310549200; Takata H, 2005, MOL CELL, V17, P573, DOI 10.1016/j.molcel.2005.01.014; Toke DA, 1996, J BIOL CHEM, V271, P18413, DOI 10.1074/jbc.271.31.18413; Vallee B, 2005, EMBO J, V24, P730, DOI 10.1038/sj.emboj.7600562; Vasireddy V, 2007, HUM MOL GENET, V16, P471, DOI 10.1093/hmg/ddl480; Wooten-Blanks LG, 2007, FASEB J, V21, P3386, DOI 10.1096/fj.07-8621com; York JD, 2006, BBA-MOL CELL BIOL L, V1761, P552, DOI 10.1016/j.bbalip.2006.04.014; York SJ, 2005, J BIOL CHEM, V280, P4264, DOI 10.1074/jbc.M412070200; Zakian VA, 1996, ANNU REV GENET, V30, P141, DOI 10.1146/annurev.genet.30.1.141	48	22	23	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 10	2008	283	41					27514	27524		10.1074/jbc.M802980200	http://dx.doi.org/10.1074/jbc.M802980200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	355OW	18694931	Green Published, hybrid			2022-12-27	WOS:000259719200022
J	Yamano, K; Kuroyanagi-Hasegawa, M; Esaki, M; Yokota, M; Endo, T				Yamano, Koji; Kuroyanagi-Hasegawa, Mika; Esaki, Masatoshi; Yokota, Mihoko; Endo, Toshiya			Step-size analyses of the mitochondrial Hsp70 import motor reveal the Brownian ratchet in operation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN IMPORT; PRECURSOR PROTEINS; TRANSLOCATION; PATHWAYS; CHAPERONES; TRANSPORT	Newly synthesized mitochondrial precursor proteins have to become unfolded by the mitochondrial Hsp70 ( mtHsp70) import motor to cross the mitochondrial membranes. To assess the mechanism of unfolding of precursor proteins by mtHsp70, we designed a system to measure step sizes of the mtHsp70 import motor, which are distances at which the motor system moves along polypeptide chains during a single turnover of ATP. We made a series of fusion proteins consisting of a mitochondrial presequence containing the first mtHsp70 binding site, a spacer sequence containing an Hsp70 avoidance segment followed by the second mtHsp70 binding site, and different folded mature domains. Analyses of the dependence of the import rates of those fusion proteins on the lengths of Hsp70 avoidance segments allowed us to estimate the step sizes, which differ for different mature domains and different lengths of the spacers. These results suggest that the mtHsp70 import motor functions at least as a molecular Brownian ratchet to unfold mitochondrial precursor proteins.	[Yamano, Koji; Kuroyanagi-Hasegawa, Mika; Esaki, Masatoshi; Yokota, Mihoko; Endo, Toshiya] Nagoya Univ, Grad Sch Sci, Dept Chem, Chikusa Ku, Nagoya, Aichi 4648602, Japan; [Endo, Toshiya] Nagoya Univ, Japan Sci & Technol Corp JST, CREST, Chikusa Ku, Nagoya, Aichi 4648602, Japan	Nagoya University; Japan Science & Technology Agency (JST); Nagoya University	Endo, T (corresponding author), Nagoya Univ, Grad Sch Sci, Dept Chem, Chikusa Ku, Nagoya, Aichi 4648602, Japan.	endo@biochem.chem.nagoya-u.ac.jp	Esaki, Masatoshi/ABS-6645-2022; Esaki, Masatoshi/L-6591-2017		Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT); JST	Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); JST(Japan Science & Technology Agency (JST))	This work was supported by grants-in aid for scientific research from the Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT) and a grant from the JST. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Astumian RD, 1997, SCIENCE, V276, P917, DOI 10.1126/science.276.5314.917; Bolender N, 2008, EMBO REP, V9, P42, DOI 10.1038/sj.embor.7401126; Bukau B, 1998, CELL, V92, P351, DOI 10.1016/S0092-8674(00)80928-9; Chang YW, 2008, J BIOL CHEM, V283, P15502, DOI 10.1074/jbc.M708992200; CREIGHTON TE, 1993, PROTEINS STRUCTURES, P183; De los Rios P, 2006, P NATL ACAD SCI USA, V103, P6166, DOI 10.1073/pnas.0510496103; Gaume B, 1998, EMBO J, V17, P6497, DOI 10.1093/emboj/17.22.6497; GLICK BS, 1995, CELL, V80, P11, DOI 10.1016/0092-8674(95)90444-1; Goloubinoff P, 2007, TRENDS BIOCHEM SCI, V32, P372, DOI 10.1016/j.tibs.2007.06.008; GRAGEROV A, 1994, J MOL BIOL, V235, P848, DOI 10.1006/jmbi.1994.1043; Howard J, 2006, CURR BIOL, V16, pR517, DOI 10.1016/j.cub.2006.06.045; Huang SH, 1999, NAT STRUCT BIOL, V6, P1132; Jiang JW, 2005, MOL CELL, V20, P513, DOI 10.1016/j.molcel.2005.09.028; Kanamori T, 1997, P NATL ACAD SCI USA, V94, P485, DOI 10.1073/pnas.94.2.485; Liu QL, 2003, SCIENCE, V300, P139, DOI 10.1126/science.1083379; Matlack KES, 1999, CELL, V97, P553, DOI 10.1016/S0092-8674(00)80767-9; Matouschek A, 1997, EMBO J, V16, P6727, DOI 10.1093/emboj/16.22.6727; Moro F, 1999, EMBO J, V18, P3667, DOI 10.1093/emboj/18.13.3667; Neupert W, 2002, NAT REV MOL CELL BIO, V3, P555, DOI 10.1038/nrm878; Neupert W, 2007, ANNU REV BIOCHEM, V76, P723, DOI 10.1146/annurev.biochem.76.052705.163409; Okamoto K, 2002, EMBO J, V21, P3659, DOI 10.1093/emboj/cdf358; RASSOW J, 1990, FEBS LETT, V275, P190, DOI 10.1016/0014-5793(90)81469-5; Rock RS, 2001, P NATL ACAD SCI USA, V98, P13655, DOI 10.1073/pnas.191512398; Sato T, 2005, P NATL ACAD SCI USA, V102, P17999, DOI 10.1073/pnas.0504495102; Schatz G, 1996, SCIENCE, V271, P1519, DOI 10.1126/science.271.5255.1519; SCHWARZ E, 1993, EMBO J, V12, P2295, DOI 10.1002/j.1460-2075.1993.tb05883.x; UNGERMANN C, 1994, SCIENCE, V266, P1250, DOI 10.1126/science.7973708; Voisine C, 1999, CELL, V97, P565, DOI 10.1016/S0092-8674(00)80768-0; Yamamoto H, 2002, CELL, V111, P519, DOI 10.1016/S0092-8674(02)01053-X	29	30	30	2	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 3	2008	283	40					27325	27332		10.1074/jbc.M805249200	http://dx.doi.org/10.1074/jbc.M805249200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	353RT	18678864	hybrid			2022-12-27	WOS:000259586600051
J	Shindou, H; Shimizu, T				Shindou, Hideo; Shimizu, Takao			Acyl-CoA: Lysophospholipid Acyltransferases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							PLATELET-ACTIVATING-FACTOR; LYSOPHOSPHATIDIC ACID ACYLTRANSFERASE; CYTOSOLIC PHOSPHOLIPASE A(2); GLYCEROL-3-PHOSPHATE ACYLTRANSFERASE; SACCHAROMYCES-CEREVISIAE; FUNCTIONAL-CHARACTERIZATION; TRIACYLGLYCEROL SYNTHESIS; MOLECULAR-IDENTIFICATION; SUBSTRATE-SPECIFICITY; O-ACYLTRANSFERASES	Cell membranes contain several classes of glycerophospholipids, which have numerous structural and functional roles in the cells. Polyunsaturated fatty acids, including arachidonic acid and eicosapentaenoic acid, are located at the sn-2 (but not sn-1)-position of glycerophospholipids in an asymmetrical manner. Using acyl-CoAs as donors, glycerophospholipids are formed by a de novo pathway (Kennedy pathway) and modified by a remodeling pathway (Lands' cycle) to generate membrane asymmetry and diversity. Both pathways were reported in the 1950s. Whereas enzymes involved in the Kennedy pathway have been well characterized, including enzymes in the 1-acylglycerol-3-phosphate O-acyltransferase family, little is known about enzymes involved in the Lands' cycle. Recently, several laboratories, including ours, isolated enzymes working in the remodeling pathway. These enzymes were discovered not only in the 1-acylglycerol-3-phosphate O-acyltransferase family but also in the membrane-bound O-acyltransferase family. In this review, we summarize recent studies on cloning and characterization of lysophospholipid acyltransferases that contribute to membrane asymmetry and diversity.	[Shindou, Hideo; Shimizu, Takao] Univ Tokyo, Dept Biochem & Mol Biol, Fac Med, Bunkyo Ku, Tokyo 1130033, Japan	University of Tokyo	Shimizu, T (corresponding author), Univ Tokyo, Dept Biochem & Mol Biol, Fac Med, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	tshimizu@m.u-tokyo.ac.jp	Shimizu, Takao/AAV-7052-2021		Ministry of Education, Culture, Sports, Science, and Technology of Japan; Japan Society for Promotion of Sciences; Center for NanoBio Integration at The University of Tokyo; Ministry of Health, Labour, and Welfare of Japan; Mitsubishi Pharma Research Foundation; Ono Medical Research Foundation	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for Promotion of Sciences(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Center for NanoBio Integration at The University of Tokyo; Ministry of Health, Labour, and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Mitsubishi Pharma Research Foundation; Ono Medical Research Foundation	This work was supported in part by grants-in-aid from the Ministry of Education, Culture, Sports, Science, and Technology of Japan and the Global COE Program (The University of Tokyo) from the Japan Society for Promotion of Sciences (to T. S.), by the Center for NanoBio Integration at The University of Tokyo (to T. S. and H. S.), and by Health and Labour Sciences research grants (Research on Allergic Disease and Immunology) supported by the Ministry of Health, Labour, and Welfare of Japan, the Mitsubishi Pharma Research Foundation, and the Ono Medical Research Foundation (to H. S.). This minireview will be reprinted in the 2009 Minireview Compendium, which will be available in January, 2010.	Agarwal AK, 2002, NAT GENET, V31, P21, DOI 10.1038/ng880; Agarwal AK, 2006, ARCH BIOCHEM BIOPHYS, V449, P64, DOI 10.1016/j.abb.2006.03.014; Benghezal M, 2007, J BIOL CHEM, V282, P30845, DOI 10.1074/jbc.M702719200; Bosson R, 2006, MOL BIOL CELL, V17, P2636, DOI 10.1091/mbc.E06-02-0104; Cao JS, 2008, J BIOL CHEM, V283, P19049, DOI 10.1074/jbc.M800364200; Cao JS, 2006, P NATL ACAD SCI USA, V103, P19695, DOI 10.1073/pnas.0609140103; Cao JS, 2004, J BIOL CHEM, V279, P31727, DOI 10.1074/jbc.M402930200; Chen MH, 2004, GENE DEV, V18, P641, DOI 10.1101/gad.1185804; Chen QL, 2007, FEBS LETT, V581, P5511, DOI 10.1016/j.febslet.2007.10.061; Chen XN, 2006, P NATL ACAD SCI USA, V103, P11724, DOI 10.1073/pnas.0604946103; Chen YQ, 2008, J BIOL CHEM, V283, P10048, DOI 10.1074/jbc.M708151200; Coleman RA, 2004, PROG LIPID RES, V43, P134, DOI 10.1016/S0163-7827(03)00051-1; Eberhardt C, 1997, J BIOL CHEM, V272, P20299, DOI 10.1074/jbc.272.32.20299; Harada N, 2007, MOL CELL BIOCHEM, V297, P41, DOI 10.1007/s11010-006-9321-5; Harayama T, 2008, J BIOL CHEM, V283, P11097, DOI 10.1074/jbc.M708909200; Hishikawa D, 2008, P NATL ACAD SCI USA, V105, P2830, DOI 10.1073/pnas.0712245105; Hofmann K, 2000, TRENDS BIOCHEM SCI, V25, P111, DOI 10.1016/S0968-0004(99)01539-X; Hollenback D, 2006, J LIPID RES, V47, P593, DOI 10.1194/jlr.M500435-JLR200; Ibba M, 2000, ANNU REV BIOCHEM, V69, P617, DOI 10.1146/annurev.biochem.69.1.617; Ishii S, 2000, PROG LIPID RES, V39, P41, DOI 10.1016/S0163-7827(99)00016-8; Jain S, 2007, J BIOL CHEM, V282, P30562, DOI 10.1074/jbc.M706326200; KENNEDY EP, 1956, J BIOL CHEM, V222, P193; KORNBERG A, 1953, J BIOL CHEM, V204, P329; Kume K, 1997, BIOCHEM BIOPH RES CO, V237, P663, DOI 10.1006/bbrc.1997.7214; LANDS WEM, 1958, J BIOL CHEM, V231, P883; Lands WEM, 2000, BBA-MOL CELL BIOL L, V1483, P1, DOI 10.1016/S1388-1981(99)00177-8; Lee HC, 2008, MOL BIOL CELL, V19, P1174, DOI 10.1091/mbc.E07-09-0893; Lewin TM, 1999, BIOCHEMISTRY-US, V38, P5764, DOI 10.1021/bi982805d; Lu B, 2005, BIOCHEM J, V385, P469, DOI 10.1042/BJ20041348; Murray NR, 1998, J BIOL CHEM, V273, P11514, DOI 10.1074/jbc.273.19.11514; Nagle CA, 2008, J LIPID RES, V49, P823, DOI 10.1194/jlr.M700592-JLR200; Nakanishi H, 2006, J BIOL CHEM, V281, P20140, DOI 10.1074/jbc.M600225200; Riekhof WR, 2007, J BIOL CHEM, V282, P28344, DOI 10.1074/jbc.M705256200; Schlame M, 2000, PROG LIPID RES, V39, P257, DOI 10.1016/S0163-7827(00)00005-9; Schlame M, 2003, J AM COLL CARDIOL, V42, P1994, DOI 10.1016/j.jacc.2003.06.015; Shikano S, 2003, P NATL ACAD SCI USA, V100, P5783, DOI 10.1073/pnas.1031748100; SHIMIZU T, 2009, ANN REV PHA IN PRESS; Shimizu T, 2006, IUBMB LIFE, V58, P328, DOI 10.1080/15216540600702289; Shindou H, 2005, J IMMUNOL, V175, P1177, DOI 10.4049/jimmunol.175.2.1177; Shindou H, 2000, BIOCHEM BIOPH RES CO, V271, P812, DOI 10.1006/bbrc.2000.2723; Shindou H, 2007, J BIOL CHEM, V282, P6532, DOI 10.1074/jbc.M609641200; Smith WL, 2001, J CLIN INVEST, V107, P1491, DOI 10.1172/JCI13271; Soupene E, 2008, P NATL ACAD SCI USA, V105, P88, DOI 10.1073/pnas.0709737104; Stamps AC, 1997, BIOCHEM J, V326, P455, DOI 10.1042/bj3260455; Stevens TP, 2007, CHEST, V131, P1577, DOI 10.1378/chest.06-2371; Takada R, 2006, DEV CELL, V11, P791, DOI 10.1016/j.devcel.2006.10.003; Tamaki H, 2007, J BIOL CHEM, V282, P34288, DOI 10.1074/jbc.M704509200; van Meer G, 2008, NAT REV MOL CELL BIO, V9, P112, DOI 10.1038/nrm2330; vandenBosch H, 1997, BBA-LIPID LIPID MET, V1348, P1; WAKU K, 1972, J BIOCHEM-TOKYO, V72, P495, DOI 10.1093/oxfordjournals.jbchem.a129928; Wang S, 2007, ARCH BIOCHEM BIOPHYS, V465, P347, DOI 10.1016/j.abb.2007.06.033; West J, 1997, DNA CELL BIOL, V16, P691, DOI 10.1089/dna.1997.16.691; Yamashita A, 1997, J BIOCHEM-TOKYO, V122, P1; Yamashita A, 2007, BBA-MOL CELL BIOL L, V1771, P1202, DOI 10.1016/j.bbalip.2007.07.002; Yang J, 2008, CELL, V132, P387, DOI 10.1016/j.cell.2008.01.017; YET SF, 1993, BIOCHEMISTRY-US, V32, P9486, DOI 10.1021/bi00087a029; Zhao Y, 2008, J BIOL CHEM, V283, P8258, DOI 10.1074/jbc.M710422200	57	303	314	4	38	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 2	2009	284	1					1	5		10.1074/jbc.R800046200	http://dx.doi.org/10.1074/jbc.R800046200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	387TP	18718904	hybrid			2022-12-27	WOS:000261974800001
J	Okazaki, H; Igarashi, M; Nishi, M; Sekiya, M; Tajima, M; Takase, S; Takanashi, M; Ohta, K; Tamura, Y; Okazaki, S; Yahagi, N; Ohashi, K; Amemiya-Kudo, M; Nakagawa, Y; Nagai, R; Kadowaki, T; Osuga, J; Ishibashi, S				Okazaki, Hiroaki; Igarashi, Masaki; Nishi, Makiko; Sekiya, Motohiro; Tajima, Makiko; Takase, Satoru; Takanashi, Mikio; Ohta, Keisuke; Tamura, Yoshiaki; Okazaki, Sachiko; Yahagi, Naoya; Ohashi, Ken; Amemiya-Kudo, Michiyo; Nakagawa, Yoshimi; Nagai, Ryozo; Kadowaki, Takashi; Osuga, Jun-ichi; Ishibashi, Shun			Identification of Neutral Cholesterol Ester Hydrolase, a Key Enzyme Removing Cholesterol from Macrophages	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HORMONE-SENSITIVE LIPASE; FOAM CELLS; MESSENGER-RNA; EXPRESSION; HYDROLYSIS; LIPOLYSIS; ATHEROSCLEROSIS; METABOLISM; DISTINCT; ABSENCE	Unstable lipid-rich plaques in atherosclerosis are characterized by the accumulation of macrophage foam cells loaded with cholesterol ester (CE). Although hormone-sensitive lipase and cholesteryl ester hydrolase (CEH) have been proposed to mediate the hydrolysis of CE in macrophages, circumstantial evidence suggests the presence of other enzymes with neutral cholesterol ester hydrolase (nCEH) activity. Here we show that the murine orthologue of KIAA1363, designated as neutral cholesterol ester hydrolase (NCEH), is a microsomal nCEH with high expression in murine and human macrophages. The effect of various concentrations of NaCl on its nCEH activity resembles that on endogenous nCEH activity of macrophages. RNA silencing of NCEH decreases nCEH activity at least by 50%; conversely, its overexpression inhibits the CE formation in macrophages. Immunohistochemistry reveals that NCEH is expressed in macrophage foam cells in atherosclerotic lesions. These data indicate that NCEH is responsible for a major part of nCEH activity in macrophages and may be a potential therapeutic target for the prevention of atherosclerosis.	[Ishibashi, Shun] Jichi Med Univ, Div Endocrinol & Metab, Dept Med, Sch Med, Shimotsuke, Tochigi 3290498, Japan; [Okazaki, Hiroaki; Igarashi, Masaki; Nishi, Makiko; Sekiya, Motohiro; Tajima, Makiko; Takase, Satoru; Takanashi, Mikio; Ohta, Keisuke; Tamura, Yoshiaki; Okazaki, Sachiko; Yahagi, Naoya; Ohashi, Ken; Amemiya-Kudo, Michiyo; Kadowaki, Takashi; Osuga, Jun-ichi; Ishibashi, Shun] Univ Tokyo, Grad Sch Med, Dept Metab Dis, Bunkyo Ku, Tokyo 1138655, Japan; [Nagai, Ryozo] Univ Tokyo, Grad Sch Med, Dept Cardiovasc Dis, Bunkyo Ku, Tokyo 1138655, Japan; [Amemiya-Kudo, Michiyo] Okinaka Mem Inst Med Res, Tokyo 1050001, Japan; [Amemiya-Kudo, Michiyo] Toranomon Gen Hosp, Tokyo 1050001, Japan; [Nakagawa, Yoshimi] Univ Tsukuba, Inst Clin Med, Tsukuba, Ibaraki 3058575, Japan	Jichi Medical University; University of Tokyo; University of Tokyo; Toranomon Hospital; University of Tsukuba	Ishibashi, S (corresponding author), Jichi Med Univ, Div Endocrinol & Metab, Dept Med, Sch Med, 3311-1 Yakushiji, Shimotsuke, Tochigi 3290498, Japan.	ishibash@jichi.ac.jp	Yahagi, Naoya/D-2360-2014	Yahagi, Naoya/0000-0002-1823-1865	Ministry of Education, Science, and Culture; National Institute of Biomedical Innovation; Takeda Science Foundation	Ministry of Education, Science, and Culture(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); National Institute of Biomedical Innovation(National Institute of Biomedical Innovation); Takeda Science Foundation(Takeda Science Foundation (TSF))	This work was supported by a grant-in-aid for scientific research from the Ministry of Education, Science, and Culture and the Program for Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation and Takeda Science Foundation. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	BROWN MS, 1980, J BIOL CHEM, V255, P9344; Chang TY, 2006, ANNU REV CELL DEV BI, V22, P129, DOI 10.1146/annurev.cellbio.22.010305.104656; Contreras JA, 2002, BIOCHEM BIOPH RES CO, V292, P900, DOI 10.1006/bbrc.2002.6757; CONTRERAS JA, 1994, ARTERIOSCLER THROMB, V14, P443, DOI 10.1161/01.ATV.14.3.443; Escary JL, 1998, ARTERIOSCL THROM VAS, V18, P991, DOI 10.1161/01.ATV.18.6.991; Faber BCG, 2001, CIRC RES, V89, P547, DOI 10.1161/hh1801.096340; Fuster V, 2005, J AM COLL CARDIOL, V46, P937, DOI 10.1016/j.jacc.2005.03.074; Ghosh S, 2000, PHYSIOL GENOMICS, V2, P1, DOI 10.1152/physiolgenomics.2000.2.1.1; GOODMAN DS, 1965, PHYSIOL REV, V45, P747, DOI 10.1152/physrev.1965.45.4.747; Greaves DR, 2005, J LIPID RES, V46, P11, DOI 10.1194/jlr.R400011-JLR200; HAJJAR DP, 1983, J BIOL CHEM, V258, P192; Harte RA, 2000, ATHEROSCLEROSIS, V149, P343, DOI 10.1016/S0021-9150(99)00345-7; HEIDER JG, 1978, J LIPID RES, V19, P514; Holm C, 2000, ANNU REV NUTR, V20, P365, DOI 10.1146/annurev.nutr.20.1.365; HOLM C, 1988, SCIENCE, V241, P1503, DOI 10.1126/science.3420405; Jepson CA, 1996, BIOCHEM J, V318, P173, DOI 10.1042/bj3180173; Kanehisa M, 2002, NUCLEIC ACIDS RES, V30, P42, DOI 10.1093/nar/30.1.42; KHOO JC, 1993, J LIPID RES, V34, P1969; KHOO JC, 1981, J BIOL CHEM, V256, P2659; Kraemer FB, 2002, J LIPID RES, V43, P1585, DOI 10.1194/jlr.R200009-JLR200; Lehner R, 1999, BIOCHEM J, V343, P1, DOI 10.1042/0264-6021:3430001; Nomura DK, 2005, P NATL ACAD SCI USA, V102, P6195, DOI 10.1073/pnas.0501915102; Okazaki H, 2002, DIABETES, V51, P3368, DOI 10.2337/diabetes.51.12.3368; Okazaki H, 2002, J BIOL CHEM, V277, P31893, DOI 10.1074/jbc.M204016200; Okazaki H, 2006, DIABETES, V55, P2091, DOI 10.2337/db05-0585; OLLIS DL, 1992, PROTEIN ENG, V5, P197, DOI 10.1093/protein/5.3.197; Oram JF, 2006, CIRC RES, V99, P1031, DOI 10.1161/01.RES.0000250171.54048.5c; Osterlund T, 2001, EUR J BIOCHEM, V268, P1899, DOI 10.1046/j.1432-1327.2001.02097.x; Osuga J, 2000, P NATL ACAD SCI USA, V97, P787, DOI 10.1073/pnas.97.2.787; Reue K, 1997, ARTERIOSCL THROM VAS, V17, P3428, DOI 10.1161/01.ATV.17.12.3428; ROST B, 1993, J MOL BIOL, V232, P584, DOI 10.1006/jmbi.1993.1413; SMALL CA, 1989, FEBS LETT, V247, P205, DOI 10.1016/0014-5793(89)81335-3; Yagyu H, 2000, J BIOL CHEM, V275, P21324, DOI 10.1074/jbc.M002541200; Zhao B, 2007, J CLIN INVEST, V117, P2983, DOI 10.1172/JCI30485	34	77	86	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 28	2008	283	48					33357	33364		10.1074/jbc.M802686200	http://dx.doi.org/10.1074/jbc.M802686200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	376KY	18782767	hybrid, Green Published			2022-12-27	WOS:000261183700040
J	Bandyopadhyay, BC; Ong, HL; Lockwich, TP; Liu, XB; Paria, BC; Singh, BB; Ambudkar, IS				Bandyopadhyay, Bidhan C.; Ong, Hwei L.; Lockwich, Timothy P.; Liu, Xibao; Paria, Biman C.; Singh, Brij B.; Ambudkar, Indu S.			TRPC3 Controls Agonist-stimulated Intracellular Ca2+ Release by Mediating the Interaction between Inositol 1,4,5-Trisphosphate Receptor and RACK1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-C; PLASMA-MEMBRANE; INOSITOL-1,4,5-TRISPHOSPHATE RECEPTOR; CHANNELS; BINDING; ACTIVATION; COMPLEX; SRC; MODULATION; EXPRESSION	Activation of TRPC3 channels is concurrent with inositol 1,4,5-trisphosphate (IP3) receptor (IP3R)-mediated intracellular Ca2+ release and associated with phosphatidylinositol 4,5-bisphosphate hydrolysis and recruitment to the plasma membrane. Here we report that interaction of TRPC3 with receptor for activated C-kinase-1 (RACK1) not only determines plasma membrane localization of the channel but also the interaction of IP3R with RACK1 and IP3-dependent intracellular Ca2+ release. We show that TRPC3 interacts with RACK1 via N-terminal residues Glu-232, Asp-233, Glu-240, and Glu-244. Carbachol (CCh) stimulation of HEK293 cells expressing wild type TRPC3 induced recruitment of a ternary TRPC3-RACK1-IP3R complex and increased surface expression of TRPC3 and Ca2+ entry. Mutation of the putative RACK1 binding sequence in TRPC3 disrupted plasma membrane localization of the channel. CCh-stimulated recruitment of TRPC3-RACK1-IP3R complex as well as increased surface expression of TRPC3 and receptor-operated Ca2+ entry were also attenuated. Importantly, CCh-induced intracellular Ca2+ release was significantly reduced as was RACK1-IP3R association without any change in thapsigargin-stimulated Ca2+ release and entry. Knockdown of endogenous TRPC3 also decreased RACK1-IP3R association and decreased CCh-stimulated Ca2+ entry. Furthermore, an oscillatory pattern of CCh-stimulated intracellular Ca2+ release was seen in these cells compared with the more sustained pattern seen in control cells. Similar oscillatory pattern of Ca2+ release was seen after CCh stimulation of cells expressing the TRPC3 mutant. Together these data demonstrate a novel role for TRPC3 in regulation of IP3R function. We suggest TRPC3 controls agonist-stimulated intracellular Ca2+ release by mediating interaction between IP3R and RACK1.	[Bandyopadhyay, Bidhan C.; Ong, Hwei L.; Lockwich, Timothy P.; Paria, Biman C.; Ambudkar, Indu S.] NIDCR, Secretory Physiol Sect, Mol Physiol & Therapeut Branch, NIH, Bethesda, MD 20892 USA; [Singh, Brij B.] Univ N Dakota, Dept Biochem & Mol Biol, Sch Med & Hlth Sci, Grand Forks, ND 58203 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR); University of North Dakota Grand Forks	Ambudkar, IS (corresponding author), NIDCR, Secretory Physiol Sect, Mol Physiol & Therapeut Branch, NIH, Bldg 10,Rm 1N-113, Bethesda, MD 20892 USA.	indu.ambudkar@nih.gov	Bandyopadhyay, Bidhan/AAC-6828-2022	Bandyopadhyay, Bidhan/0000-0003-2364-8945; Ong, Hwei Ling/0000-0002-7551-6883; Singh, Brij/0000-0003-0535-5997	National Institutes of Health [R01 DE 017102]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR017699] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE017102, ZIADE000438] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported in part by National Institutes of Health Grant R01 DE 017102 ( to B. B. S.).	Ambudkar IS, 2007, PFLUG ARCH EUR J PHY, V455, P187, DOI 10.1007/s00424-007-0252-0; Bandyopadhyay BC, 2005, J BIOL CHEM, V280, P12908, DOI 10.1074/jbc.M410013200; BERRIDGE MJ, 1995, BIOCHEM J, V312, P1, DOI 10.1042/bj3120001; Bosanac I, 2005, MOL CELL, V17, P193, DOI 10.1016/j.molcel.2004.11.047; Boulay G, 1999, P NATL ACAD SCI USA, V96, P14955, DOI 10.1073/pnas.96.26.14955; Chang BY, 2001, J BIOL CHEM, V276, P20346, DOI 10.1074/jbc.M101375200; Doan AT, 2007, EXP CELL RES, V313, P2667, DOI 10.1016/j.yexcr.2007.05.013; Goel M, 2007, AM J PHYSIOL-RENAL, V293, pF1476, DOI 10.1152/ajprenal.00186.2007; Kheifets V, 2007, PHARMACOL RES, V55, P467, DOI 10.1016/j.phrs.2007.04.014; Kiely PA, 2006, MOL CELL BIOL, V26, P4041, DOI 10.1128/MCB.01868-05; Kim JH, 2006, J BIOL CHEM, V281, P26144, DOI 10.1074/jbc.M603636200; Kim JY, 2005, J BIOL CHEM, V280, P32035, DOI 10.1074/jbc.M500429200; Kiselyov K., 2007, V179, P559; Lee EH, 2006, J BIOL CHEM, V281, P10042, DOI 10.1074/jbc.M600981200; Li Y, 2005, J BIOL CHEM, V280, P41298, DOI 10.1074/jbc.M510082200; Liu X, 2004, J MEMBRANE BIOL, V200, P93, DOI 10.1007/s00232-004-0698-3; Lockwich T, 2001, J BIOL CHEM, V276, P42401, DOI 10.1074/jbc.M106956200; Mikoshiba K, 2007, J NEUROCHEM, V102, P1426, DOI 10.1111/j.1471-4159.2007.04825.x; Miller LD, 2004, ONCOGENE, V23, P5682, DOI 10.1038/sj.onc.1207735; MOCHLYROSEN D, 1995, BIOCHEM SOC T, V23, P596, DOI 10.1042/bst0230596; Montell Craig, 2005, Sci STKE, V2005, pre3, DOI 10.1126/stke.2722005re3; Ong HL, 2007, J BIOL CHEM, V282, P9105, DOI 10.1074/jbc.M608942200; Patterson RL, 2004, P NATL ACAD SCI USA, V101, P2328, DOI 10.1073/pnas.0308567100; REDONDO PC, 2007, BIOCHIM BIOPHYS ACTA, V1783, P1163; Rodriguez MM, 1999, BIOCHEMISTRY-US, V38, P13787, DOI 10.1021/bi991055k; RON D, 1994, J BIOL CHEM, V269, P21395; Singh BB, 2004, MOL CELL, V15, P635, DOI 10.1016/j.molcel.2004.07.010; Smyth JT, 2006, J BIOL CHEM, V281, P11712, DOI 10.1074/jbc.M510541200; Soboloff J., 2007, V179, P575; Trebak M, 2003, CELL CALCIUM, V33, P451, DOI 10.1016/S0143-4160(03)00056-3; Trebak M, 2003, J BIOL CHEM, V278, P16244, DOI 10.1074/jbc.M300544200; Trebak M, 2002, J BIOL CHEM, V277, P21617, DOI 10.1074/jbc.M202549200; van Rossum DB, 2005, NATURE, V434, P99, DOI 10.1038/nature03340; Vanlingen S, 2001, BIOCHEM PHARMACOL, V61, P803, DOI 10.1016/S0006-2952(01)00540-8; Vazquez G, 2001, P NATL ACAD SCI USA, V98, P11777, DOI 10.1073/pnas.201238198; Venkatachalam K, 2003, J BIOL CHEM, V278, P29031, DOI 10.1074/jbc.M302751200; Venkatachalam K, 2001, J BIOL CHEM, V276, P33980, DOI 10.1074/jbc.C100321200; Venkatachalam K, 2007, ANNU REV BIOCHEM, V76, P387, DOI 10.1146/annurev.biochem.75.103004.142819; Wedel BJ, 2003, J BIOL CHEM, V278, P25758, DOI 10.1074/jbc.M303890200; Yarwood SJ, 1999, J BIOL CHEM, V274, P14909, DOI 10.1074/jbc.274.21.14909; Zhang ZM, 2001, P NATL ACAD SCI USA, V98, P3168, DOI 10.1073/pnas.051632698	41	41	42	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 21	2008	283	47					32821	32830		10.1074/jbc.M805382200	http://dx.doi.org/10.1074/jbc.M805382200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	372HW	18755685	Green Published, hybrid			2022-12-27	WOS:000260893700071
J	Hirota, S; Kawahara, T; Beltramini, M; Di Muro, P; Magliozzo, RS; Peisach, J; Powers, LS; Tanaka, N; Nagao, S; Bubacco, L				Hirota, Shun; Kawahara, Takumi; Beltramini, Mariano; Di Muro, Paolo; Magliozzo, Richard S.; Peisach, Jack; Powers, Linda S.; Tanaka, Naoki; Nagao, Satoshi; Bubacco, Luigi			Molecular Basis of the Bohr Effect in Arthropod Hemocyanin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PANULIRUS-INTERRUPTUS HEMOCYANIN; LIMULUS-POLYPHEMUS HEMOCYANIN; ABSORPTION-EDGE SPECTROSCOPY; OXYGEN-BINDING; CRYSTAL-STRUCTURE; ELECTRONIC-STRUCTURE; QUATERNARY STRUCTURE; SUBUNIT COMPOSITION; CARBON-MONOXIDE; ACTIVE-SITE	Flash photolysis and K-edge x-ray absorption spectroscopy (XAS) were used to investigate the functional and structural effects of pH on the oxygen affinity of three homologous arthropod hemocyanins (Hcs). Flash photolysis measurements showed that the well-characterized pH dependence of oxygen affinity (Bohr effect) is attributable to changes in the oxygen binding rate constant, k(on), rather than changes in k(off). In parallel, coordination geometry of copper in Hc was evaluated as a function of pH by XAS. It was found that the geometry of copper in the oxygenated protein is unchanged at all pH values investigated, while significant changes were observed for the deoxygenated protein as a function of pH. The interpretation of these changes was based on previously described correlations between spectral lineshape and coordination geometry obtained for model compounds of known structure (Blackburn, N. J., Strange, R. W., Reedijk, J., Volbeda, A., Farooq, A., Karlin, K. D., and Zubieta, J. (1989) Inorg. Chem., 28, 1349-1357). A pH-dependent change in the geometry of cuprous copper in the active site of deoxyHc, from pseudotetrahedral toward trigonal was assigned from the observed intensity dependence of the 1s --> 4p(z) transition in x-ray absorption near edge structure (XANES) spectra. The structural alteration correlated well with increase in oxygen affinity at alkaline pH determined in flash photolysis experiments. These results suggest that the oxygen binding rate in deoxyHc depends on the coordination geometry of Cu(I) and suggest a structural origin for the Bohr effect in arthropod Hcs.	[Hirota, Shun; Tanaka, Naoki; Nagao, Satoshi] Nara Inst Sci & Technol, Grad Sch Mat Sci, Nara 6300192, Japan; [Hirota, Shun; Kawahara, Takumi] Kyoto Pharmaceut Univ, Dept Phys Chem, Kyoto 6078414, Japan; [Hirota, Shun; Kawahara, Takumi] Kyoto Pharmaceut Univ, 21st Century COE Program, Kyoto 6078414, Japan; [Beltramini, Mariano; Di Muro, Paolo; Bubacco, Luigi] Univ Padua, Dept Biol, I-35121 Padua, Italy; [Magliozzo, Richard S.] CUNY Brooklyn Coll, Dept Chem, Brooklyn, NY 11210 USA; [Peisach, Jack] Albert Einstein Coll Med, Dept Physiol & Biophys, Bronx, NY 10461 USA; [Powers, Linda S.] Univ Arizona, Natl Ctr Design Mol Funct, Tucson, AZ 85721 USA	Nara Institute of Science & Technology; Kyoto Pharmaceutical University; Kyoto Pharmaceutical University; University of Padua; City University of New York (CUNY) System; Brooklyn College (CUNY); Yeshiva University; Albert Einstein College of Medicine; University of Arizona	Hirota, S (corresponding author), Nara Inst Sci & Technol, Grad Sch Mat Sci, Nara 6300192, Japan.	hirota@ms.naist.jp; luigi.bubacco@unipd.it	Bubacco, Luigi/B-5602-2012; Di Muro, Paolo/F-5811-2013; Hirota, Shun/AAD-2651-2021	Bubacco, Luigi/0000-0001-7927-9208; Hirota, Shun/0000-0003-3227-8376; Nagao, Satoshi/0000-0003-1674-7697	National Institutes of Health [060014]; MEXT [18031038, 20051016]; JSPS; JST; Progetto di Ateneo; UniPd FIRB; MUR(PRIN);  [GM040168]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI060014, R56AI060014] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P30EB009998] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM040168, R37GM040168] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); JST(Japan Science & Technology Agency (JST)); Progetto di Ateneo; UniPd FIRB; MUR(PRIN)(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN)); ; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants 060014 from the NIAID (to R. S. M.) and GM040168 (to J. P.). This work was also supported by Grants-in-Aid for Scientific Research from MEXT (Priority Areas, Nos. 18031038 and 20051016, to S. H.), JSPS (Category C, No. 19550169, and the 21st COE Program (to S. H.)), JST (to S. H.), and by the Progetto di Ateneo, UniPd FIRB and MUR(PRIN) (to L. B. and M. B.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	ANDREW CR, 1993, BIOCHIM BIOPHYS ACTA, V1162, P105, DOI 10.1016/0167-4838(93)90135-E; Beltramini M, 2005, FEBS J, V272, P2060, DOI 10.1111/j.1742-4658.2005.04634.x; BLACKBURN NJ, 1989, INORG CHEM, V28, P1349, DOI 10.1021/ic00306a027; BLUMBERG WE, 1976, IRON COPPER PROTEINS, P389; BRENOWITZ M, 1984, ARCH BIOCHEM BIOPHYS, V230, P238, DOI 10.1016/0003-9861(84)90105-X; BRENOWITZ M, 1981, ARCH BIOCHEM BIOPHYS, V210, P748, DOI 10.1016/0003-9861(81)90242-3; BROUWER M, 1978, BIOCHEMISTRY-US, V17, P2148, DOI 10.1021/bi00604a019; BROWN JM, 1980, J AM CHEM SOC, V102, P4210, DOI 10.1021/ja00532a037; BRUNORI M, 1981, J MOL BIOL, V153, P1111, DOI 10.1016/0022-2836(81)90470-8; CRAMER SP, 1976, J AM CHEM SOC, V98, P1287, DOI 10.1021/ja00421a053; Cuff ME, 1998, J MOL BIOL, V278, P855, DOI 10.1006/jmbi.1998.1647; Dainese E, 1998, EUR J BIOCHEM, V256, P350, DOI 10.1046/j.1432-1327.1998.2560350.x; FEITERS MC, 1990, COMMENTS INORG CHEM, V11, P131; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; HAZES B, 1993, PROTEIN SCI, V2, P597; HEIRWEGH K, 1961, BIOCHIM BIOPHYS ACTA, V48, P517, DOI 10.1016/0006-3002(61)90049-X; Hirota S, 2005, J AM CHEM SOC, V127, P17966, DOI 10.1021/ja0541128; JOLLEY RL, 1974, J BIOL CHEM, V249, P335; Karlin KD, 1997, J MOL CATAL A-CHEM, V117, P215, DOI 10.1016/S1381-1169(96)00250-6; KAU LS, 1987, J AM CHEM SOC, V109, P6433, DOI 10.1021/ja00255a032; Klabunde T, 1998, NAT STRUCT BIOL, V5, P1084, DOI 10.1038/4193; KRAUS DW, 1990, J BIOL CHEM, V265, P16043; KUIPER HA, 1980, BIOCHIM BIOPHYS ACTA, V626, P412, DOI 10.1016/0005-2795(80)90136-1; KUIPER HA, 1975, J MOL BIOL, V99, P619, DOI 10.1016/S0022-2836(75)80176-8; MAGLIOZZO RS, 1995, BIOCHEMISTRY-US, V34, P1513, DOI 10.1021/bi00005a007; MAGNUS KA, 1991, PROTEINS, V9, P240, DOI 10.1002/prot.340090403; MAGNUS KA, 1994, PROTEINS, V19, P302, DOI 10.1002/prot.340190405; Markl J., 1992, Advances in Comparative and Environmental Physiology, V13, P325; Martin AG, 2007, J MOL BIOL, V366, P1332, DOI 10.1016/j.jmb.2006.11.075; Matoba Y, 2006, J BIOL CHEM, V281, P8981, DOI 10.1074/jbc.M509785200; Menze MA, 2000, BIOCHEMISTRY-US, V39, P10806, DOI 10.1021/bi000008l; Metz M, 2001, J AM CHEM SOC, V123, P4938, DOI 10.1021/ja004166b; Molon A, 2000, EUR J BIOCHEM, V267, P7046, DOI 10.1046/j.1432-1327.2000.01803.x; Sabatucci A, 2002, J BIOL INORG CHEM, V7, P120, DOI 10.1007/s007750100272; SMITH TA, 1985, J AM CHEM SOC, V107, P5945, DOI 10.1021/ja00307a020; SOLOMON EI, 1993, SCIENCE, V259, P1575, DOI 10.1126/science.8384374; STERNER R, 1994, P NATL ACAD SCI USA, V91, P4835, DOI 10.1073/pnas.91.11.4835; VANHOLDE KE, 1967, BIOCHEMISTRY-US, V6, P93, DOI 10.1021/bi00853a016; VOLBEDA A, 1989, J MOL BIOL, V209, P249, DOI 10.1016/0022-2836(89)90276-3; VOLBEDA A, 1989, EUR J BIOCHEM, V181, P669, DOI 10.1111/j.1432-1033.1989.tb14775.x	40	12	12	1	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 14	2008	283	46					31941	31948		10.1074/jbc.M803433200	http://dx.doi.org/10.1074/jbc.M803433200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	370KJ	18725416	hybrid, Green Published			2022-12-27	WOS:000260760800076
J	Li, P; Chaurasia, SS; Gao, Y; Carr, AL; Iuvone, PM; Li, L				Li, Ping; Chaurasia, Shyam S.; Gao, Yan; Carr, Aprell L.; Iuvone, P. Michael; Li, Lei			CLOCK Is Required for Maintaining the Circadian Rhythms of Opsin mRNA Expression in Photoreceptor Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RHODOPSIN PROMOTER EXPRESSION; N-ACETYLTRANSFERASE; MELATONIN; GENETICS; NPAS2; ROLES	In zebrafish, the expression of long-wavelength cone (LC) opsin mRNA fluctuated rhythmically between the day and night. In a 24-h period, expression was high in the afternoon and low in the early morning. This pattern of fluctuation persisted in zebrafish that were kept in constant darkness, suggesting an involvement of circadian clocks. Functional expression of Clock, a circadian clock gene that contributes to the central circadian pacemaker, was found to play an important role in maintaining the circadian rhythms of LC opsin mRNA expression. In zebrafish embryos, in which the translation of Clock was inhibited by anti-Clock morpholinos, the circadian rhythms of LC opsin mRNA expression diminished. CLOCK may regulate the circadian rhythms of LC opsin mRNA expression via cyclic adenosine monophosphate (cAMP)-dependent signaling pathways. In control retinas, the concentration of cAMP was high in the early morning and low in the remainder of the day and night. Inhibition of Clock translation abolished the fluctuation in the concentration of cAMP, thereby diminishing the circadian rhythms of opsin mRNA expression. Transient increase of cAMP concentrations in the early morning (i. e. by treating the embryos with 8-bromo-cAMP) restored the circadian rhythms of LC opsin mRNA expression in morpholino-treated embryos. Together, the data suggest that Clock plays important roles in regulating the circadian rhythms in photoreceptor cells.	[Li, Ping; Gao, Yan; Carr, Aprell L.; Li, Lei] Univ Notre Dame, Dept Biol Sci, Notre Dame, IN 46556 USA; [Chaurasia, Shyam S.; Iuvone, P. Michael] Emory Univ, Dept Pharmacol, Atlanta, GA 30322 USA; [Li, Lei] Nankai Univ, Sch Med, Dept Physiol, Tianjin 300071, Peoples R China	University of Notre Dame; Emory University; Nankai University	Li, L (corresponding author), Univ Notre Dame, Dept Biol Sci, Notre Dame, IN 46556 USA.	Li.78@nd.edu	Chaurasia, Shyam/AAB-4709-2019; Li, Lei/F-5722-2015	Chaurasia, Shyam/0000-0001-8725-676X; Li, Lei/0000-0001-9703-2102	National Institutes of Health [R01 EY013147, EY004864, EY 014764]; Core Grant for Vision Research [P30 EY03630]; NATIONAL EYE INSTITUTE [P30EY006360, R01EY013147, R01EY004864, R01EY014764] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Core Grant for Vision Research; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 EY013147 (to L. L.), EY004864 and EY 014764 (to P. M. I.), and Core Grant for Vision Research P30 EY03630. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Alfinito PD, 2001, J NEUROCHEM, V76, P881, DOI 10.1046/j.1471-4159.2001.00109.x; BESHARSE JC, 1977, SCIENCE, V196, P536, DOI 10.1126/science.300504; CAHILL GM, 1993, NEURON, V10, P573, DOI 10.1016/0896-6273(93)90160-S; Chaurasia SS, 2006, J NEUROCHEM, V99, P1142, DOI 10.1111/j.1471-4159.2006.04154.x; Corey DR, 2001, GENOME BIOL, V2; DeBruyne JP, 2007, NAT NEUROSCI, V10, P543, DOI 10.1038/nn1884; Fukuhara C, 2004, J NEUROSCI, V24, P1803, DOI 10.1523/JNEUROSCI.4988-03.2004; Green CB, 2004, J BIOL RHYTHM, V19, P91, DOI 10.1177/0748730404263002; Green CB, 2003, J NEUROENDOCRINOL, V15, P350, DOI 10.1046/j.1365-2826.2003.00999.x; Hayasaka N, 2002, J NEUROSCI, V22, P1600, DOI 10.1523/JNEUROSCI.22-05-01600.2002; Iuvone PM, 2005, PROG RETIN EYE RES, V24, P433, DOI 10.1016/j.preteyeres.2005.01.003; Ivanova TN, 2003, BRAIN RES, V991, P96, DOI 10.1016/j.brainres.2003.08.003; KORENBROT JI, 1989, NATURE, V337, P454, DOI 10.1038/337454a0; Li P, 2005, J EXP BIOL, V208, P497, DOI 10.1242/jeb.01424; PIERCE ME, 1993, NEURON, V10, P579, DOI 10.1016/0896-6273(93)90161-J; Reick M, 2001, SCIENCE, V293, P506, DOI 10.1126/science.1060699; Reppert SM, 2002, NATURE, V418, P935, DOI 10.1038/nature00965; Ribelayga C, 2003, J COMP NEUROL, V467, P243, DOI 10.1002/cne.10927; ROBINSON J, 1993, P NATL ACAD SCI USA, V90, P6009, DOI 10.1073/pnas.90.13.6009; Ruan GX, 2006, P NATL ACAD SCI USA, V103, P9703, DOI 10.1073/pnas.0601940103; TAKAHASHI JS, 1995, ANNU REV NEUROSCI, V18, P531, DOI 10.1146/annurev.neuro.18.1.531; WESTERFIELD M, 1995, ZEBRAFISH BOOK; Young MW, 2001, NAT REV GENET, V2, P702, DOI 10.1038/35088576; Yu CJ, 2007, J EXP BIOL, V210, P676, DOI 10.1242/jeb.02694; Yu CJ, 2007, J NEUROSCI RES, V85, P488, DOI 10.1002/jnr.21157; Zhang DQ, 2007, J NEUROSCI, V27, P692, DOI 10.1523/JNEUROSCI.4478-06.2007	26	22	25	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 14	2008	283	46					31673	31678		10.1074/jbc.M803875200	http://dx.doi.org/10.1074/jbc.M803875200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	370KJ	18687681	Green Published, hybrid			2022-12-27	WOS:000260760800049
J	Mace, PD; Linke, K; Feltham, R; Schumacher, FR; Smith, CA; Vaux, DL; Silke, J; Day, CL				Mace, Peter D.; Linke, Katrin; Feltham, Rebecca; Schumacher, Frances-Rose; Smith, Clyde A.; Vaux, David L.; Silke, John; Day, Catherine L.			Structures of the cIAP2 RING Domain Reveal Conformational Changes Associated with Ubiquitin-conjugating Enzyme (E2) Recruitment	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KAPPA-B ACTIVATION; PROTEIN LIGASE; APOPTOSIS; INHIBITOR; IAPS; COMPLEX; UBIQUITYLATION; BINDING; SMAC	Inhibitor of apoptosis (IAP) proteins are key negative regulators of cell death that are highly expressed in many cancers. Cell death caused by antagonists that bind to IAP proteins is associated with their ubiquitylation and degradation. The RING domain at the C terminus of IAP proteins is pivotal. Here we report the crystal structures of the cIAP2 RING domain homodimer alone, and bound to the ubiquitin-conjugating (E2) enzyme UbcH5b. These structures show that small changes in the RING domain accompany E2 binding. By mutating residues at the E2-binding surface, we show that autoubiquitylation is required for regulation of IAP abundance. Dimer formation is also critical, and mutation of a single C-terminal residue abrogated dimer formation and E3 ligase activity was diminished. We further demonstrate that disruption of E2 binding, or dimerization, stabilizes IAP proteins against IAP antagonists in vivo.	[Mace, Peter D.; Linke, Katrin; Schumacher, Frances-Rose; Day, Catherine L.] Univ Otago, Dept Biochem, Dunedin 9054, New Zealand; [Feltham, Rebecca; Vaux, David L.; Silke, John] La Trobe Univ, Dept Biochem, Bundoora, Vic 3086, Australia; [Smith, Clyde A.] Stanford Synchrotron Radiat Lab, Menlo Pk, CA 94025 USA	University of Otago; La Trobe University; Stanford University; United States Department of Energy (DOE); SLAC National Accelerator Laboratory	Day, CL (corresponding author), Univ Otago, Dept Biochem, Dunedin 9054, New Zealand.	catherine.day@stonebow.otago.ac.nz	Vaux, David L/C-7249-2013; Silke, John/B-7622-2008	Vaux, David L/0000-0003-2703-1651; Silke, John/0000-0002-7611-5774; Day, Catherine/0000-0003-1571-4367; Feltham, Rebecca/0000-0001-8376-6869; Mace, Peter/0000-0003-2175-9537	Marsden Fund (New Zealand); National Health and Medical Research Council (Australia); Leukemia and Lymphoma Society; University of Otago	Marsden Fund (New Zealand)(Royal Society of New ZealandMarsden Fund (NZ)); National Health and Medical Research Council (Australia)(National Health and Medical Research Council (NHMRC) of Australia); Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); University of Otago	This work was supported by the Marsden Fund (New Zealand), the National Health and Medical Research Council (Australia), and the Leukemia and Lymphoma Society. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.; A recipient of a Health Sciences Career Development Award (University of Otago).	BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Borden KLB, 1996, CURR OPIN STRUC BIOL, V6, P395, DOI 10.1016/S0959-440X(96)80060-1; Brzovic PS, 2001, NAT STRUCT BIOL, V8, P833, DOI 10.1038/nsb1001-833; Buchwald G, 2006, EMBO J, V25, P2465, DOI 10.1038/sj.emboj.7601144; Christensen DE, 2007, NAT STRUCT MOL BIOL, V14, P941, DOI 10.1038/nsmb1295; Danial NN, 2004, CELL, V116, P205, DOI 10.1016/S0092-8674(04)00046-7; Dominguez C, 2004, STRUCTURE, V12, P633, DOI 10.1016/j.str.2004.03.004; Du CY, 2000, CELL, V102, P33, DOI 10.1016/S0092-8674(00)00008-8; Hu SM, 2003, J BIOL CHEM, V278, P10055, DOI 10.1074/jbc.M207197200; Huang HK, 2000, J BIOL CHEM, V275, P26661; Hunter AM, 2007, APOPTOSIS, V12, P1543, DOI 10.1007/s10495-007-0087-3; Linke K, 2008, CELL DEATH DIFFER, V15, P841, DOI 10.1038/sj.cdd.4402309; Ozkan E, 2005, P NATL ACAD SCI USA, V102, P18890, DOI 10.1073/pnas.0509418102; Petersen SL, 2007, CANCER CELL, V12, P445, DOI 10.1016/j.ccr.2007.08.029; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; Salvesen GS, 2002, NAT REV MOL CELL BIO, V3, P401, DOI 10.1038/nrm830; Samuel T, 2006, J BIOL CHEM, V281, P1080, DOI 10.1074/jbc.M509381200; Silke J, 2005, P NATL ACAD SCI USA, V102, P16182, DOI 10.1073/pnas.0502828102; Silke J, 2002, J CELL BIOL, V157, P115, DOI 10.1083/jcb.200108085; Storoni LC, 2004, ACTA CRYSTALLOGR D, V60, P432, DOI 10.1107/S0907444903028956; Uldrijan S, 2007, EMBO J, V26, P102, DOI 10.1038/sj.emboj.7601469; Vander Kooi CW, 2006, BIOCHEMISTRY-US, V45, P121, DOI 10.1021/bi051787e; Varfolomeev E, 2007, CELL, V131, P669, DOI 10.1016/j.cell.2007.10.030; Varfolomeev E, 2006, J BIOL CHEM, V281, P29022, DOI 10.1074/jbc.M605116200; Vaux DL, 2005, NAT REV MOL CELL BIO, V6, P287, DOI 10.1038/nrm1621; Verhagen AM, 2000, CELL, V102, P43, DOI 10.1016/S0092-8674(00)00009-X; Vince JE, 2007, CELL, V131, P682, DOI 10.1016/j.cell.2007.10.037; Wiesner S, 2007, CELL, V130, P651, DOI 10.1016/j.cell.2007.06.050; Yang Y, 2000, SCIENCE, V288, P874, DOI 10.1126/science.288.5467.874; Zhang MH, 2005, MOL CELL, V20, P525, DOI 10.1016/j.molcel.2005.09.023; Zheng N, 2000, CELL, V102, P533, DOI 10.1016/S0092-8674(00)00057-X	31	130	130	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 14	2008	283	46					31633	31640		10.1074/jbc.M804753200	http://dx.doi.org/10.1074/jbc.M804753200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	370KJ	18784070	hybrid			2022-12-27	WOS:000260760800044
J	Shmelzer, Z; Karter, M; Eisenstein, M; Leto, TL; Hadad, N; Ben-Menahem, D; Gitler, D; Banani, S; Wolach, B; Rotem, M; Levy, R				Shmelzer, Zeev; Karter, Maria; Eisenstein, Miriam; Leto, Thomas L.; Hadad, Nurit; Ben-Menahem, David; Gitler, Daniel; Banani, Shirly; Wolach, Baruch; Rotem, Meir; Levy, Rachel			Cytosolic Phospholipase A(2)alpha Is Targeted to the p47(phox)-PX Domain of the Assembled NADPH Oxidase via a Novel Binding Site in Its C2 Domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHORYLATION-INDUCED ACTIVATION; PROTEIN-PROTEIN DOCKING; SRC HOMOLOGY-3 DOMAINS; ESSENTIAL REQUIREMENT; RESPIRATORY BURST; HUMAN NEUTROPHILS; INTRAMOLECULAR INTERACTION; DIRECTED MUTAGENESIS; CRYSTAL-STRUCTURE; CATALYTIC DOMAIN	We have previously demonstrated a physical interaction between cytosolic phospholipase A2 alpha (cPLA(2)) and the assembled NADPH oxidase on plasma membranes following neutrophil stimulation. The aim of the present study was to define the exact binding sites between these two enzymes. Here we show, based on blot overlay experiments, Forster resonance energy transfer analysis and studies in neutrophils from patients with chronic granulomatous disease deficient in p67(phox) or p47(phox), that cPLA2 specifically binds to p47(phox) and that p47(phox) is sufficient to anchor cPLA2 to the assembled oxidase on the plasma membranes upon stimulation. Blot overlay and affinity binding experiments using subfragments of cPLA2 and p47(phox) demonstrated that the cPLA(2)-C2 domain and the p47(phox)-PX domain interact to form a complex that is resistant to high salt. Computational docking was used to identify hydrophobic peptides within these two domains that inhibited the association between the two enzymes and NADPH oxidase activity in electro-permeabilized neutrophils. These results were used in new docking computations that produced an interaction model. Based on this model, cPLA(2)-C2 domain mutations were designed to explore its interaction p47(phox) in neutrophillysates. The triple mutant F35A/M38A/L39A of the cPLA(2)-C2 domain caused a slight inhibition of the affinity binding to p47(phox), whereas the single mutant I67A was highly effective. The double mutant M59A/H115A of the p47(phox)-PX domain caused a significant inhibition of the affinity binding to cPLA(2). Thus, Ile(67) of the cPLA(2)-C2 domain is identified as a critical, centrally positioned residue in a hydrophobic interaction in the p47(phox)-PX domain.	[Shmelzer, Zeev; Karter, Maria; Hadad, Nurit; Banani, Shirly; Levy, Rachel] Soroka Univ, Med Ctr, Fac Hlth Sci, Infect Dis Lab,Dept Clin Biochem, IL-84105 Beer Sheva, Israel; [Ben-Menahem, David] Soroka Univ, Med Ctr, Fac Hlth Sci, Dept Pharmacol, IL-84105 Beer Sheva, Israel; [Gitler, Daniel] Soroka Univ, Med Ctr, Fac Hlth Sci, Dept Physiol, IL-84105 Beer Sheva, Israel; Ben Gurion Univ Negev, IL-84105 Beer Sheva, Israel; [Eisenstein, Miriam] Weizmann Inst Sci, Dept Chem Res Support, IL-76100 Rehovot, Israel; [Wolach, Baruch] Meir Hosp, Dept Pediat, Lab Leukocyte Funct, IL-44281 Kefar Sava, Israel; [Rotem, Meir] Ha Emek Hosp, Dept Pediat, IL-18110 Afula, Israel; [Leto, Thomas L.] NIAID, Host Def Lab, NIH, Bethesda, MD 20892 USA	Ben Gurion University; Soroka Medical Center; Ben Gurion University; Soroka Medical Center; Ben Gurion University; Soroka Medical Center; Ben Gurion University; Weizmann Institute of Science; Tel Aviv University; Sackler Faculty of Medicine; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Levy, R (corresponding author), Soroka Univ, Med Ctr, Fac Hlth Sci, Infect Dis Lab,Dept Clin Biochem, IL-84105 Beer Sheva, Israel.	ral@bgu.ac.il	Gitler, Daniel/F-1304-2012	Gitler, Daniel/0000-0001-9544-3610; Ben-Menahem, David/0000-0002-8985-0591	Israel Sciences Foundation; Israel Academy of Sciences and Humanities [438/03]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000614, Z01AI000614] Funding Source: NIH RePORTER	Israel Sciences Foundation(Israel Science Foundation); Israel Academy of Sciences and Humanities; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the Israel Sciences Foundation founded by the Israel Academy of Sciences and Humanities (Grant 438/03).	Ago T, 1999, J BIOL CHEM, V274, P33644, DOI 10.1074/jbc.274.47.33644; Bae YS, 2000, J IMMUNOL, V164, P4089, DOI 10.4049/jimmunol.164.8.4089; Ben-Zeev E, 2003, PROTEINS, V52, P24, DOI 10.1002/prot.10391; Berchanski A, 2004, PROTEINS, V56, P130, DOI 10.1002/prot.20145; CLARK JD, 1990, P NATL ACAD SCI USA, V87, P7708, DOI 10.1073/pnas.87.19.7708; CLARK RA, 1990, J CLIN INVEST, V85, P714, DOI 10.1172/JCI114496; Dana R, 1998, J BIOL CHEM, V273, P441, DOI 10.1074/jbc.273.1.441; Das S, 2002, J BIOL CHEM, V277, P23838, DOI 10.1074/jbc.M202322200; DEMENDEZ I, 1994, J BIOL CHEM, V269, P16326; deMendez I, 1997, MOL CELL BIOL, V17, P2177, DOI 10.1128/MCB.17.4.2177; Dessen A, 1999, CELL, V97, P349, DOI 10.1016/S0092-8674(00)80744-8; Dusi S, 1996, BIOCHEM J, V314, P409, DOI 10.1042/bj3140409; Essen LO, 1997, BIOCHEMISTRY-US, V36, P2753, DOI 10.1021/bi962466t; Ghosh M, 2006, PROG LIPID RES, V45, P487, DOI 10.1016/j.plipres.2006.05.003; Girotti M, 2004, J BIOL CHEM, V279, P19113, DOI 10.1074/jbc.M313867200; GLOVER S, 1995, J BIOL CHEM, V270, P15359, DOI 10.1074/jbc.270.25.15359; GRINSTEIN S, 1988, J BIOL CHEM, V263, P1779; Groemping Y, 2005, BIOCHEM J, V386, P401, DOI 10.1042/BJ20041835; Groemping Y, 2003, CELL, V113, P343, DOI 10.1016/S0092-8674(03)00314-3; Hazan I, 1997, BIOCHEM J, V326, P867, DOI 10.1042/bj3260867; Hazan-Halevy I, 2000, J BIOL CHEM, V275, P12416, DOI 10.1074/jbc.275.17.12416; Heifetz A, 2002, PROTEIN SCI, V11, P571, DOI 10.1110/ps.26002; HEYWORTH PG, 1991, J CLIN INVEST, V87, P352, DOI 10.1172/JCI114993; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Jares-Erijman EA, 2006, CURR OPIN CHEM BIOL, V10, P409, DOI 10.1016/j.cbpa.2006.08.021; Kanai F, 2001, NAT CELL BIOL, V3, P675, DOI 10.1038/35083070; Karathanassis D, 2002, EMBO J, V21, P5057, DOI 10.1093/emboj/cdf519; KATCHALSKIKATZIR E, 1992, P NATL ACAD SCI USA, V89, P2195, DOI 10.1073/pnas.89.6.2195; Kenworthy AK, 2001, METHODS, V24, P289, DOI 10.1006/meth.2001.1189; LETO TL, 1991, J BIOL CHEM, V266, P19812; LETO TL, 1994, P NATL ACAD SCI USA, V91, P10650, DOI 10.1073/pnas.91.22.10650; Leto TL., 1999, INFLAMMATION BASIC P, P769; LEVY R, 1990, J IMMUNOL, V145, P2595; Li Q, 1997, J BIOL CHEM, V272, P2404, DOI 10.1074/jbc.272.4.2404; Lowenthal A, 1999, J BIOL CHEM, V274, P21603, DOI 10.1074/jbc.274.31.21603; NALEFSKI EA, 1994, J BIOL CHEM, V269, P18239; O'Dowd YM, 2004, BIOCHEM PHARMACOL, V67, P183, DOI 10.1016/j.bcp.2003.08.026; Perisic O, 1998, J BIOL CHEM, V273, P1596, DOI 10.1074/jbc.273.3.1596; Pessach I, 2001, J BIOL CHEM, V276, P33495, DOI 10.1074/jbc.M011417200; Roos D, 1996, BLOOD, V87, P1663; ROTROSEN D, 1990, J BIOL CHEM, V265, P8745; Rubin BB, 2005, J BIOL CHEM, V280, P7519, DOI 10.1074/jbc.M407438200; Sato TK, 2001, SCIENCE, V294, P1881, DOI 10.1126/science.1065763; Scaife RM, 2003, J CELL SCI, V116, P463, DOI 10.1242/jcs.00244; Shmelzer Z, 2003, J CELL BIOL, V162, P683, DOI 10.1083/jcb.200211056; Ueyama T, 2008, J IMMUNOL, V181, P629, DOI 10.4049/jimmunol.181.1.629; Ueyama T, 2007, MOL BIOL CELL, V18, P441, DOI 10.1091/mbc.E06-08-0731; Yuzawa S, 2004, J BIOL CHEM, V279, P29752, DOI 10.1074/jbc.M401457200; Zhen L, 1998, J BIOL CHEM, V273, P6575, DOI 10.1074/jbc.273.11.6575	49	24	25	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 14	2008	283	46					31898	31908		10.1074/jbc.M804674200	http://dx.doi.org/10.1074/jbc.M804674200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	370KJ	18765662	hybrid			2022-12-27	WOS:000260760800072
J	Zhang, XJ; Cahill, KB; Elfenbein, A; Arshavsky, VY; Cote, RH				Zhang, Xiu-Jun; Cahill, Karyn B.; Elfenbein, Arye; Arshavsky, Vadim Y.; Cote, Rick H.			Direct Allosteric Regulation between the GAF Domain and Catalytic Domain of Photoreceptor Phosphodiesterase PDE6	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ROD CGMP PHOSPHODIESTERASE; CYCLIC-GMP PHOSPHODIESTERASE; INHIBITORY GAMMA-SUBUNIT; STATIONARY NIGHT BLINDNESS; BINDING-SITES; NONCATALYTIC CGMP; NUCLEOTIDE PHOSPHODIESTERASE; STRUCTURAL BASIS; HIGH-AFFINITY; BETA-SUBUNIT	Photoreceptor cGMP phosphodiesterase (PDE6) is the central enzyme in the visual transduction cascade. The PDE6 catalytic subunit contains a catalytic domain and regulatory GAF domains. Unlike most GAF domain-containing cyclic nucleotide phosphodiesterases, little is known about direct allosteric communication of PDE6. In this study, we demonstrate for the first time direct, inter-domain allosteric communication between the GAF and catalytic domains in PDE6. The binding affinity of PDE6 for pharmacological inhibitors or for the C-terminal region of the inhibitory gamma subunit (P gamma), known to directly inhibit PDE6 catalysis, was increased similar to 2-fold by ligands binding to the GAF domain. Binding of the N-terminal half of P gamma to the GAF domains suffices to induce this allosteric effect. Allosteric communication between GAF and catalytic domains is reciprocal, in that drug binding to the catalytic domain slowed cGMP dissociation from the GAF domain. Although cGMP hydrolysis was not affected by binding of P gamma-60, P gamma lacking its last seven amino acids decreased the Michaelis constant of PDE6 by 2.5- fold. P gamma 1-60 binding to the GAF domain increased vardenafil but not cGMP affinity, indicating that substrate- and inhibitor-binding sites do not totally overlap. In addition, prolonged incubation of PDE6 with vardenafil or sildenafil (but not 3-isobutyl-1-methylxanthine and zaprinast) induced a distinct conformational change in the catalytic domain without affecting the binding properties of the GAF domains. We conclude that although P gamma-mediated regulation plays the dominant role in visual excitation, the direct, inter-domain allosteric regulation described in this study may play a feedback role in light adaptational processes during phototransduction.	[Zhang, Xiu-Jun; Cahill, Karyn B.; Cote, Rick H.] Univ New Hampshire, Dept Biochem & Mol Biol, Durham, NH 03824 USA; [Elfenbein, Arye; Arshavsky, Vadim Y.] Duke Univ, Med Ctr, Dept Ophthalmol, Durham, NC 27710 USA; [Elfenbein, Arye; Arshavsky, Vadim Y.] Duke Univ, Med Ctr, Dept Pharmacol, Durham, NC 27710 USA	University System Of New Hampshire; University of New Hampshire; Duke University; Duke University	Cote, RH (corresponding author), Univ New Hampshire, Dept Biochem & Mol Biol, Durham, NH 03824 USA.	rick.cote@unh.edu	Cote, Rick H/G-3363-2013	Cote, Rick H/0000-0002-1573-6526	National Institutes of Health [EY-05798]; NATIONAL EYE INSTITUTE [R01EY005798] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported, in whole or in part, by National Institutes of Health Grant EY-05798. This is Scientific Contribution Number 2361 from the New Hampshire Agricultural Experiment Station. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Aravind L, 1997, TRENDS BIOCHEM SCI, V22, P458, DOI 10.1016/S0968-0004(97)01148-1; ARSHAVSKY VY, 1992, J BIOL CHEM, V267, P24501; Arshavsky VY, 2002, ANNU REV PHYSIOL, V64, P153, DOI 10.1146/annurev.physiol.64.082701.102229; Artemyev NO, 1996, P NATL ACAD SCI USA, V93, P5407, DOI 10.1073/pnas.93.11.5407; ARTEMYEV NO, 1992, BIOCHEM J, V283, P273, DOI 10.1042/bj2830273; Artemyev NO, 1998, METHODS, V14, P93, DOI 10.1006/meth.1997.0568; Blount MA, 2004, MOL PHARMACOL, V66, P144, DOI 10.1124/mol.66.1.144; Blount MA, 2007, J PHARMACOL EXP THER, V323, P730, DOI 10.1124/jpet.107.126540; CAHILL KB, 2007, INVESTIG OPHTHALMOL, V48; Calvert PD, 1998, J GEN PHYSIOL, V111, P39, DOI 10.1085/jgp.111.1.39; Card GL, 2004, STRUCTURE, V12, P2233, DOI 10.1016/j.str.2004.10.004; Corbin JD, 2000, EUR J BIOCHEM, V267, P2760, DOI 10.1046/j.1432-1327.2000.01297.x; Corbin JD, 2003, MOL PHARMACOL, V63, P1364, DOI 10.1124/mol.63.6.1364; Cote R.H., 2006, CYCLIC NUCLEOTIDE PH, DOI DOI 10.1201/9781420020847.CH8; Cote RH, 2004, INT J IMPOT RES, V16, pS28, DOI 10.1038/sj.ijir.3901212; COTE RH, 1994, P NATL ACAD SCI USA, V91, P4845, DOI 10.1073/pnas.91.11.4845; Cote RH, 2000, METHOD ENZYMOL, V315, P646; Cote Rick H., 2005, V307, P141; D'Amours MR, 1999, BIOCHEM J, V340, P863, DOI 10.1042/0264-6021:3400863; Fain G, 2003, SENSORY TRANSDUCTION; FRANCIS SH, 1980, J BIOL CHEM, V255, P620; Francis SH, 2002, J BIOL CHEM, V277, P47581, DOI 10.1074/jbc.M206088200; GAL A, 1994, NAT GENET, V7, P64, DOI 10.1038/ng0594-64; Granovsky AE, 2000, J BIOL CHEM, V275, P41258, DOI 10.1074/jbc.M008094200; Gross-Langenhoff M, 2006, J BIOL CHEM, V281, P2841, DOI 10.1074/jbc.M511468200; Guo LW, 2006, J BIOL CHEM, V281, P15412, DOI 10.1074/jbc.M600595200; Guo LW, 2005, J BIOL CHEM, V280, P12585, DOI 10.1074/jbc.M410380200; He F, 2000, J BIOL CHEM, V275, P20572, DOI 10.1074/jbc.M000440200; Hebert MC, 1998, J BIOL CHEM, V273, P5557, DOI 10.1074/jbc.273.10.5557; Huai Q, 2004, J BIOL CHEM, V279, P13095, DOI 10.1074/jbc.M311556200; Huang DM, 2004, J BIOL CHEM, V279, P48143, DOI 10.1074/jbc.M404338200; Jungbauer A, 2001, J CLIN LIGAND ASSAY, V24, P270; Lamb TD, 2006, INVEST OPHTH VIS SCI, V47, P5138, DOI 10.1167/iovs.06-0849; LIPKIN VM, 1988, FEBS LETT, V234, P287, DOI 10.1016/0014-5793(88)80100-5; MARTINS TJ, 1982, J BIOL CHEM, V257, P1973; Mou HM, 1999, J BIOL CHEM, V274, P18813, DOI 10.1074/jbc.274.26.18813; Mou HM, 2001, J BIOL CHEM, V276, P27527, DOI 10.1074/jbc.M103316200; Mullershausen F, 2003, J CELL BIOL, V160, P719, DOI 10.1083/jcb.200211041; Muradov H, 2006, VISION RES, V46, P860, DOI 10.1016/j.visres.2005.09.015; Muradov H, 2004, VISION RES, V44, P2437, DOI 10.1016/j.visres.2004.05.013; Muradov KG, 2003, BIOCHEMISTRY-US, V42, P3305, DOI 10.1021/bi027095x; Pentia Dana C., 2005, V307, P125; Rybalkin SD, 2003, EMBO J, V22, P469, DOI 10.1093/emboj/cdg051; Rybalkin SD, 2002, J BIOL CHEM, V277, P3310, DOI 10.1074/jbc.M106562200; SKIBA NP, 1995, J BIOL CHEM, V270, P13210, DOI 10.1074/jbc.270.22.13210; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; Song J, 2008, P NATL ACAD SCI USA, V105, P1505, DOI 10.1073/pnas.0709558105; TAKEMOTO DJ, 1992, BIOCHEM J, V281, P637, DOI 10.1042/bj2810637; THOMAS MK, 1990, J BIOL CHEM, V265, P14964; Tsang SH, 2007, HUM MUTAT, V28, P243, DOI 10.1002/humu.20425; Turko IV, 1999, J BIOL CHEM, V274, P29038, DOI 10.1074/jbc.274.41.29038; Turko IV, 1999, MOL PHARMACOL, V56, P124, DOI 10.1124/mol.56.1.124; Wang H, 2008, MOL PHARMACOL, V73, P104, DOI 10.1124/mol.107.040212; Wang HC, 2006, J BIOL CHEM, V281, P21469, DOI 10.1074/jbc.M512527200; Wyman J, 1990, BINDING LINKAGE FUNC; YAMAMOTO T, 1983, J BIOL CHEM, V258, P2526; YAMAZAKI A, 1982, P NATL ACAD SCI-BIOL, V79, P3702, DOI 10.1073/pnas.79.12.3702; YAMAZAKI A, 1980, J BIOL CHEM, V255, P1619; Zhang KYJ, 2004, MOL CELL, V15, P279, DOI 10.1016/j.molcel.2004.07.005; Zhang XJ, 2005, FRONT BIOSCI-LANDMRK, V10, P1191, DOI 10.2741/1612; Zhang XJ, 2005, INVEST OPHTH VIS SCI, V46, P3060, DOI 10.1167/iovs.05-0257; Zoraghi R, 2004, MOL PHARMACOL, V65, P267, DOI 10.1124/mol.65.2.267	62	15	15	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 31	2008	283	44					29699	29705		10.1074/jbc.M803948200	http://dx.doi.org/10.1074/jbc.M803948200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	364WS	18779324	hybrid, Green Published			2022-12-27	WOS:000260366900013
J	Choi, WI; Jeon, BN; Park, H; Yoo, JY; Kim, YS; Koh, DI; Kim, MH; Kim, YR; Lee, CE; Kim, KS; Osborne, TF; Hur, MW				Choi, Won-Il; Jeon, Bu-Nam; Park, Hyejin; Yoo, Jung-Yoon; Kim, Yeon-Sook; Koh, Dong-In; Kim, Myung-Hwa; Kim, Yu-Ri; Lee, Choong-Eun; Kim, Kyung-Sup; Osborne, Timothy F.; Hur, Man-Wook			Proto-oncogene FBI-1 (Pokemon) and SREBP-1 Synergistically Activate Transcription of Fatty-acid Synthase Gene (FASN)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STEROL REGULATORY ELEMENT; LIPOPROTEIN RECEPTOR GENE; BINDING PROTEIN; POZ DOMAIN; INSULIN REGULATION; PROMOTER; CANCER; SP1; CHOLESTEROL; HOMEOSTASIS	FBI-1 (Pokemon/ZBTB7A) is a proto-oncogenic transcription factor of the BTB/POZ (bric-a-brac, tramtrack, and broad complex and pox virus zinc finger) domain family. Recent evidence suggested that FBI-1 might be involved in adipogenic gene expression. Coincidentally, expression of FBI-1 and fatty-acid synthase (FASN) genes are often increased in cancer and immortalized cells. Both FBI-1 and FASN are important in cancer cell proliferation. SREBP-1 is a major regulator of many adipogenic genes, and FBI-1 and SREBP-1 (sterol-responsive element (SRE)-binding protein 1) interact with each other directly via their DNA binding domains. FBI-1 enhanced the transcriptional activation of SREBP-1 on responsive promoters, pGL2-6x(SRE)-Luc and FASN gene. FBI-1 and SREBP-1 synergistically activate transcription of the FASN gene by acting on the proximal GC-box and SRE/E-box. FBI-1, Sp1, and SREBP-1 can bind to all three SRE, GC-box, and SRE/E-box. Binding competition among the three transcription factors on the GC-box and SRE/E-box appears important in the transcription regulation. FBI-1 is apparently changing the binding pattern of Sp1 and SREBP-1 on the two elements in the presence of induced SREBP-1 and drives more Sp1 binding to the proximal promoter with less of an effect on SREBP-1 binding. The changes induced by FBI-1 appear critical in the synergistic transcription activation. The molecular mechanism revealed provides insight into how proto-oncogene FBI-1 may attack the cellular regulatory mechanism of FASN gene expression to provide more phospholipid membrane components needed for rapid cancer cell proliferation.	[Choi, Won-Il; Jeon, Bu-Nam; Park, Hyejin; Yoo, Jung-Yoon; Kim, Yeon-Sook; Koh, Dong-In; Kim, Myung-Hwa; Kim, Yu-Ri; Kim, Kyung-Sup; Hur, Man-Wook] Yonsei Univ, Sch Med, Dept Biochem & Mol Biol, Inst Genet Sci,Brain Korea Project Med Sci 21, Seoul 120752, South Korea; [Lee, Choong-Eun] Sungkyunkwan Univ, Dept Biol Sci, Suwon 440746, South Korea; [Osborne, Timothy F.] Univ Calif Irvine, Sch Biol Sci, Dept Mol Biol & Biochem, Irvine, CA 92697 USA	Yonsei University; Sungkyunkwan University (SKKU); University of California System; University of California Irvine	Hur, MW (corresponding author), Yonsei Univ, Sch Med, Dept Biochem & Mol Biol, Inst Genet Sci,Brain Korea Project Med Sci 21, 134 ShinChon Dong, Seoul 120752, South Korea.	mwhur2@yuhs.ac		CHOI, WONIL/0000-0002-4837-0436; Hur, Man-Wook/0000-0002-3416-1334; Kim, Yeon-Sook/0000-0003-1142-5488; Kim, Kyung-sup/0000-0001-8483-8537; Yoo, Jung-Yoon/0000-0001-9366-3863	Korea Research Foundation [E00046]; Korea Ministry of Education; Korea Science and Engineering Foundation [R0A-2003-000-10318-0 from]; Korea Ministry of Science and Technology	Korea Research Foundation(National Research Foundation of Korea); Korea Ministry of Education(Ministry of Education (MOE), Republic of Korea); Korea Science and Engineering Foundation(Korea Science and Engineering Foundation); Korea Ministry of Science and Technology(Ministry of Science & Technology (MOST), Republic of Korea)	This work was supported by a Korea Research Foundation Grant E00046 (2005), Korea Ministry of Education, and National Research Laboratory Grant R0A-2003-000-10318-0 from Korea Science and Engineering Foundation, Korea Ministry of Science and Technology. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Athanikar JN, 1997, MOL CELL BIOL, V17, P5193, DOI 10.1128/MCB.17.9.5193; BARDWELL VJ, 1994, GENE DEV, V8, P1664, DOI 10.1101/gad.8.14.1664; BENNETT MK, 1995, J BIOL CHEM, V270, P25578, DOI 10.1074/jbc.270.43.25578; Chirala SS, 2004, LIPIDS, V39, P1045, DOI 10.1007/s11745-004-1329-9; Costello LC, 2005, MOL CELL BIOCHEM, V280, P1, DOI 10.1007/s11010-005-8841-8; Davies JM, 1999, ONCOGENE, V18, P365, DOI 10.1038/sj.onc.1202332; Griffin MJ, 2004, IUBMB LIFE, V56, P595, DOI 10.1080/15216540400022474; Horton JD, 2002, J CLIN INVEST, V109, P1125, DOI 10.1172/JCI200215593; Inoue N, 2005, MOL CELL BIOL, V25, P8938, DOI 10.1128/MCB.25.20.8938-8947.2005; Kelly KF, 2006, TRENDS CELL BIOL, V16, P578, DOI 10.1016/j.tcb.2006.09.003; Kim JB, 1998, J CLIN INVEST, V101, P1, DOI 10.1172/JCI1411; Kuhajda FP, 2006, CANCER RES, V66, P5977, DOI 10.1158/0008-5472.CAN-05-4673; Kuhajda FP, 2000, NUTRITION, V16, P202, DOI 10.1016/S0899-9007(99)00266-X; Kukita A, 1999, BLOOD, V94, P1987, DOI 10.1182/blood.V94.6.1987.418k26_1987_1997; Latasa MJ, 2000, P NATL ACAD SCI USA, V97, P10619, DOI 10.1073/pnas.180306597; Laudes M, 2004, J BIOL CHEM, V279, P11711, DOI 10.1074/jbc.M310240200; Lee DK, 2005, J BIOL CHEM, V280, P27783, DOI 10.1074/jbc.M504909200; Lee DK, 2002, J BIOL CHEM, V277, P26761, DOI 10.1074/jbc.M202078200; Maeda T, 2005, NATURE, V433, P278, DOI 10.1038/nature03203; Maeda T, 2007, SCIENCE, V316, P860, DOI 10.1126/science.1140881; Magana MM, 1996, J BIOL CHEM, V271, P32689, DOI 10.1074/jbc.271.51.32689; MEDES G, 1953, CANCER RES, V13, P27; Menendez JA, 2007, NAT REV CANCER, V7, P763, DOI 10.1038/nrc2222; Morrison DJ, 1999, NUCLEIC ACIDS RES, V27, P1251, DOI 10.1093/nar/27.5.1251; Oliner JD, 1996, GENE DEV, V10, P2903, DOI 10.1101/gad.10.22.2903; Osborne TF, 2000, J BIOL CHEM, V275, P32379, DOI 10.1074/jbc.R000017200; Pendergrast PS, 2002, MOL BIOL CELL, V13, P915, DOI 10.1091/mbc.01-08-0383; Pessler F, 1997, MOL CELL BIOL, V17, P3786, DOI 10.1128/MCB.17.7.3786; Pessler F, 2003, J BIOL CHEM, V278, P29327, DOI 10.1074/jbc.M302980200; SANCHEZ HB, 1995, J BIOL CHEM, V270, P1161, DOI 10.1074/jbc.270.3.1161; Shimomura I, 1997, J CLIN INVEST, V99, P838, DOI 10.1172/JCI119247; SMITH JR, 1990, J BIOL CHEM, V265, P2306; Swinnen JV, 2003, BIOCHEM BIOPH RES CO, V302, P898, DOI 10.1016/S0006-291X(03)00265-1; TONTONOZ P, 1993, MOL CELL BIOL, V13, P4753, DOI 10.1128/MCB.13.8.4753; Wolf Siegmund S., 1998, Biochemical Society Transactions, V26, pS95; Yang FJ, 2006, NATURE, V442, P700, DOI 10.1038/nature04942; YIEH L, 1995, P NATL ACAD SCI USA, V92, P6102, DOI 10.1073/pnas.92.13.6102; YOKOYAMA C, 1993, CELL, V75, P187, DOI 10.1016/S0092-8674(05)80095-9	38	60	70	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 24	2008	283	43					29341	29354		10.1074/jbc.M802477200	http://dx.doi.org/10.1074/jbc.M802477200			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	362EB	18682402	Green Published, hybrid			2022-12-27	WOS:000260179900061
J	Hu, JJ; Dong, LX; Outten, CE				Hu, Jingjing; Dong, Lixue; Outten, Caryn E.			The Redox Environment in the Mitochondrial Intermembrane Space Is Maintained Separately from the Cytosol and Matrix	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DISULFIDE BOND FORMATION; FLUORESCENT PROTEIN INDICATORS; CYTOCHROME-C PEROXIDASE; SACCHAROMYCES-CEREVISIAE; GLUTATHIONE-REDUCTASE; YEAST MITOCHONDRIA; ESCHERICHIA-COLI; OXIDATIVE STRESS; INTRACELLULAR PH; IMPORT PATHWAY	Redox control in the mitochondrion is essential for the proper functioning of this organelle. Disruption of mitochondrial redox processes contributes to a host of human disorders, including cancer, neurodegenerative diseases, and aging. To better characterize redox control pathways in this organelle, we have targeted a green fluorescent protein-based redox sensor to the intermembrane space (IMS) and matrix of yeast mitochondria. This approach allows us to separately monitor the redox state of the matrix and the IMS, providing a more detailed picture of redox processes in these two compartments. To verify that the sensors respond to localized glutathione (GSH) redox changes, we have genetically manipulated the subcellular redox state using oxidized GSH (GSSG) reductase localization mutants. These studies indicate that redox control in the cytosol and matrix are maintained separately by cytosolic and mitochondrial isoforms of GSSG reductase. Our studies also demonstrate that the mitochondrial IMS is considerably more oxidizing than the cytosol and mitochondrial matrix and is not directly influenced by endogenous GSSGreductase activity. These redox measurements are used to predict the oxidation state of thiol-containing proteins that are imported into the IMS.	[Hu, Jingjing; Dong, Lixue; Outten, Caryn E.] Univ S Carolina, Dept Chem & Biochem, Columbia, SC 29208 USA	University of South Carolina; University of South Carolina System; University of South Carolina Columbia	Outten, CE (corresponding author), Univ S Carolina, Dept Chem & Biochem, 631 Sumter St, Columbia, SC 29205 USA.	caryn.outten@chem.sc.edu	Outten, Caryn E./I-9433-2019; Hu, Jingjing/E-2713-2012	Outten, Caryn E./0000-0003-0335-6531; 	National Institutes of Health [ES 13780]; University of South Carolina Center; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [K22ES013780] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of South Carolina Center; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grant ES 13780 (to C. E. O.). This work was also supported by the University of South Carolina Center for Colon Cancer Research. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Allen S, 2005, J MOL BIOL, V353, P937, DOI 10.1016/j.jmb.2005.08.049; Aon MA, 2007, J BIOL CHEM, V282, P21889, DOI 10.1074/jbc.M702841200; Banci L, 2008, J BIOL CHEM, V283, P7912, DOI 10.1074/jbc.M708016200; BEASLEY EM, 1993, EMBO J, V12, P2303, DOI 10.1002/j.1460-2075.1993.tb05884.x; BENZ R, 1994, BBA-REV BIOMEMBRANES, V1197, P167, DOI 10.1016/0304-4157(94)90004-3; Bjornberg O, 2006, ANTIOXID REDOX SIGN, V8, P354, DOI 10.1089/ars.2006.8.354; Breeuwer P, 2000, J MICROBIOL METH, V39, P253, DOI 10.1016/S0167-7012(99)00124-4; Carmel-Harel O, 2000, ANNU REV MICROBIOL, V54, P439, DOI 10.1146/annurev.micro.54.1.439; CORTESE JD, 1992, BIOCHIM BIOPHYS ACTA, V1100, P189; CUBITT AB, 1995, TRENDS BIOCHEM SCI, V20, P448, DOI 10.1016/S0968-0004(00)89099-4; Dabir DV, 2007, EMBO J, V26, P4801, DOI 10.1038/sj.emboj.7601909; DAUM G, 1982, J BIOL CHEM, V257, P3028; Diekert K, 2001, METHOD CELL BIOL, V65, P37, DOI 10.1016/S0091-679X(01)65003-9; Dooley CT, 2004, J BIOL CHEM, V279, P22284, DOI 10.1074/jbc.M312847200; Gabriel K, 2007, J MOL BIOL, V365, P612, DOI 10.1016/j.jmb.2006.10.038; GIETZ RD, 1991, YEAST, V7, P253, DOI 10.1002/yea.320070307; Goldsteins G, 2008, J BIOL CHEM, V283, P8446, DOI 10.1074/jbc.M706111200; Hancock JT, 2003, ANN NY ACAD SCI, V1010, P446, DOI 10.1196/annals.1299.081; Hanson GT, 2004, J BIOL CHEM, V279, P13044, DOI 10.1074/jbc.M312846200; Hell K, 2008, BBA-MOL CELL RES, V1783, P601, DOI 10.1016/j.bbamcr.2007.12.005; Herrmann JM, 2005, TRENDS BIOCHEM SCI, V30, P205, DOI 10.1016/j.tibs.2005.02.005; Herrmann JM, 2007, J CELL BIOL, V176, P559, DOI 10.1083/jcb.200611060; Holmgren A, 2005, BIOCHEM SOC T, V33, P1375, DOI 10.1042/BST0331375; Hurd TR, 2005, ANTIOXID REDOX SIGN, V7, P999, DOI 10.1089/ars.2005.7.999; HWANG C, 1992, SCIENCE, V257, P1496, DOI 10.1126/science.1523409; IMAI T, 1995, J BIOTECHNOL, V38, P165, DOI 10.1016/0168-1656(94)00130-5; Jones DP, 2006, CHEM-BIOL INTERACT, V163, P38, DOI 10.1016/j.cbi.2006.07.008; Khalimonchuk O, 2007, BIOCHIM BIOPHYS ACTA, V1783, P618; Koehler CM, 2006, ANTIOXID REDOX SIGN, V8, P813, DOI 10.1089/ars.2006.8.813; Le Moan N, 2006, J BIOL CHEM, V281, P10420, DOI 10.1074/jbc.M513346200; Lu H, 2005, J MOL BIOL, V353, P897, DOI 10.1016/j.jmb.2005.09.002; MARTENSSON J, 1990, P NATL ACAD SCI USA, V87, P7185, DOI 10.1073/pnas.87.18.7185; Matsuyama S, 2000, NAT CELL BIOL, V2, P318, DOI 10.1038/35014006; Melvin BK, 1996, BIOTECHNOL PROGR, V12, P257, DOI 10.1021/bp9500775; Mesecke N, 2005, CELL, V121, P1059, DOI 10.1016/j.cell.2005.04.011; Monteiro G, 2004, ARCH BIOCHEM BIOPHYS, V425, P14, DOI 10.1016/j.abb.2004.03.005; Morgan B, 2008, BIOCHEM J, V411, P115, DOI 10.1042/BJ20071476; Muller JM, 2008, MOL BIOL CELL, V19, P226, DOI 10.1091/mbc.E07-08-0814; Muller EGD, 1996, MOL BIOL CELL, V7, P1805, DOI 10.1091/mbc.7.11.1805; Nakamoto H, 2004, BBA-MOL CELL RES, V1694, P111, DOI 10.1016/j.bbamcr.2004.02.012; Ostergaard H, 2004, J CELL BIOL, V166, P337, DOI 10.1083/jcb.200402120; Ostergaard H, 2001, EMBO J, V20, P5853, DOI 10.1093/emboj/20.21.5853; Outten CE, 2004, J BIOL CHEM, V279, P7785, DOI 10.1074/jbc.M312421200; Outten CE, 2003, EMBO J, V22, P2015, DOI 10.1093/emboj/cdg211; Pai HV, 2007, ANTIOXID REDOX SIGN, V9, P2027, DOI 10.1089/ars.2007.1642; Porcelli AM, 2005, BIOCHEM BIOPH RES CO, V326, P799, DOI 10.1016/j.bbrc.2004.11.105; Porras P, 2006, J BIOL CHEM, V281, P16551, DOI 10.1074/jbc.M600790200; Rebrin I, 2005, FREE RADICAL BIO MED, V39, P549, DOI 10.1016/j.freeradbiomed.2005.04.008; Schafer FQ, 2001, FREE RADICAL BIO MED, V30, P1191, DOI 10.1016/S0891-5849(01)00480-4; Sesaki H, 1999, J CELL BIOL, V147, P699, DOI 10.1083/jcb.147.4.699; Shen DX, 2005, J BIOL CHEM, V280, P25305, DOI 10.1074/jbc.M500095200; SIKORSKI RS, 1989, GENETICS, V122, P19; STEVENS BJ, 1977, BIOL CELLULAIRE, V28, P37; Stojanovski D, 2008, BBA-MOL CELL RES, V1783, P610, DOI 10.1016/j.bbamcr.2007.10.004; Sturtz LA, 2001, J BIOL CHEM, V276, P38084; Ueda S, 2002, ANTIOXID REDOX SIGN, V4, P405, DOI 10.1089/15230860260196209; VONHEIJNE G, 1986, EMBO J, V5, P1335, DOI 10.1002/j.1460-2075.1986.tb04364.x; Voronova A, 2007, BIOCHEM J, V408, P139, DOI 10.1042/BJ20070804	58	195	197	0	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 24	2008	283	43					29126	29134		10.1074/jbc.M803028200	http://dx.doi.org/10.1074/jbc.M803028200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	362EB	18708636	Green Published, hybrid			2022-12-27	WOS:000260179900040
J	Balan, V; Miller, GS; Kaplun, L; Balan, K; Chong, ZZ; Li, FQ; Kaplun, A; VanBerkum, MFA; Arking, R; Freeman, DC; Maiese, K; Tzivion, G				Balan, Vitaly; Miller, Gregory S.; Kaplun, Ludmila; Balan, Karina; Chong, Zhao-Zhong; Li, Faqi; Kaplun, Alexander; VanBerkum, Mark F. A.; Arking, Robert; Freeman, D. Carl; Maiese, Kenneth; Tzivion, Guri			Life span extension and neuronal cell protection by Drosophila nicotinamidase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CALORIE RESTRICTION; NAD BIOSYNTHESIS; SACCHAROMYCES-CEREVISIAE; SIR2 FAMILY; SIRTUINS; PATHWAY; FOXO; METABOLISM; ACTIVATION; REGULATOR	The life span of model organisms can be modulated by environmental conditions that influence cellular metabolism, oxidation, or DNA integrity. The yeast nicotinamidase gene pnc1 was identified as a key transcriptional target and mediator of calorie restriction and stress-induced life span extension. PNC1 is thought to exert its effect on yeast life span by modulating cellular nicotinamide and NAD levels, resulting in increased activity of Sir2 family class III histone deacetylases. In Caenorhabditis elegans, knockdown of a pnc1 homolog was shown recently to shorten the worm life span, whereas its overexpression increased survival under conditions of oxidative stress. The function and regulation of nicotinamidases in higher organisms has not been determined. Here, we report the identification and biochemical characterization of the Drosophila nicotinamidase, D-NAAM, and demonstrate that its overexpression significantly increases median and maximal fly life span. The life span extension was reversed in Sir2 mutant flies, suggesting Sir2 dependence. Testing for physiological effectors of D-NAAM in Drosophila S2 cells, we identified oxidative stress as a primary regulator, both at the transcription level and protein activity. In contrast to the yeast model, stress factors such as high osmolarity and heat shock, calorie restriction, or inhibitors of TOR and phosphatidylinositol 3-kinase pathways do not appear to regulate D-NAAM in S2 cells. Interestingly, the expression of D-NAAM in human neuronal cells conferred protection from oxidative stress-induced cell death in a sirtuin-dependent manner. Together, our findings establish a life span extending the ability of nicotinamidase in flies and offer a role for nicotina-mide-modulating genes in oxidative stress regulated pathways influencing longevity and neuronal cell survival.	[Balan, Vitaly; Kaplun, Ludmila; Balan, Karina; Kaplun, Alexander; Tzivion, Guri] Wayne State Univ, Karmanos Canc Inst, Detroit, MI 48201 USA; [Balan, Vitaly; Kaplun, Ludmila; Balan, Karina; Kaplun, Alexander; Tzivion, Guri] Wayne State Univ, Dept Pathol, Detroit, MI 48201 USA; [Miller, Gregory S.; VanBerkum, Mark F. A.; Arking, Robert; Freeman, D. Carl] Wayne State Univ, Dept Biol Sci, Detroit, MI 48201 USA; [Chong, Zhao-Zhong; Li, Faqi; Maiese, Kenneth] Wayne State Univ, Dept Neurol Anat & Cell Biol, Detroit, MI 48201 USA	Barbara Ann Karmanos Cancer Institute; Wayne State University; Wayne State University; Wayne State University; Wayne State University	Tzivion, G (corresponding author), Wayne State Univ, Karmanos Canc Inst, 4100 John R,HWCRC-716, Detroit, MI 48201 USA.	tziviong@karmanos.org	Kaplun, Alexander/AAH-5033-2020; Tzivion, Guri/D-8954-2011		National Institutes of Health [R01-GM067134, NS053946]; American Diabetes Association; American Heart Association Bugher Foundation Award; Wayne State University; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067134] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS053946] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association(American Diabetes Association); American Heart Association Bugher Foundation Award(American Heart Association); Wayne State University; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01-GM067134 (to G. T.) and NS053946 (to K. M.). This work was also supported by the American Diabetes Association, the American Heart Association Bugher Foundation Award, and Wayne State University institutional support (to M. V. B.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Anderson RM, 2003, SCIENCE, V302, P2124, DOI 10.1126/science.1088697; Anderson RM, 2003, NATURE, V423, P181, DOI 10.1038/nature01578; Anekonda TS, 2006, J NEUROCHEM, V96, P305, DOI 10.1111/j.1471-4159.2005.03492.x; Araki T, 2004, SCIENCE, V305, P1010, DOI 10.1126/science.1098014; Arden KC, 2004, MOL CELL, V14, P416, DOI 10.1016/S1097-2765(04)00213-8; Barthel A, 2005, TRENDS ENDOCRIN MET, V16, P183, DOI 10.1016/j.tem.2005.03.010; Baur JA, 2006, NATURE, V444, P337, DOI 10.1038/nature05354; Belenky P, 2007, TRENDS BIOCHEM SCI, V32, P12, DOI 10.1016/j.tibs.2006.11.006; Berger F, 2004, TRENDS BIOCHEM SCI, V29, P111, DOI 10.1016/j.tibs.2004.01.007; Bitterman KJ, 2002, J BIOL CHEM, V277, P45099, DOI 10.1074/jbc.M205670200; Blander G, 2004, ANNU REV BIOCHEM, V73, P417, DOI 10.1146/annurev.biochem.73.011303.073651; Bogan KL, 2008, ANNU REV NUTR, V28, P115, DOI 10.1146/annurev.nutr.28.061807.155443; Bordone L, 2005, NAT REV MOL CELL BIO, V6, P298, DOI 10.1038/nrm1616; BRAND AH, 1993, DEVELOPMENT, V118, P401; Brunet A, 2004, SCIENCE, V303, P2011, DOI 10.1126/science.1094637; Busso N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002267; CHAYKIN S, 1969, ANAL BIOCHEM, V31, P375, DOI 10.1016/0003-2697(69)90278-4; Chonga ZZ, 2004, EXP CELL RES, V296, P196, DOI 10.1016/j.yexcr.2004.01.021; Csiszar Anna, 2005, Current Vascular Pharmacology, V3, P285, DOI 10.2174/1570161054368616; Daitoku H, 2004, P NATL ACAD SCI USA, V101, P10042, DOI 10.1073/pnas.0400593101; Denu JM, 2005, TRENDS BIOCHEM SCI, V30, P479, DOI 10.1016/j.tibs.2005.07.004; Denu JM, 2005, CURR OPIN CHEM BIOL, V9, P431, DOI 10.1016/j.cbpa.2005.08.010; Denu JM, 2007, CELL, V129, P453, DOI 10.1016/j.cell.2007.04.023; Du XL, 2001, BIOCHEMISTRY-US, V40, P14166, DOI 10.1021/bi0115479; Gallo CA, 2004, MOL CELL BIOL, V24, P1301, DOI 10.1128/MCB.24.3.1301-1312.2004; Giannakou ME, 2004, TRENDS CELL BIOL, V14, P408, DOI 10.1016/j.tcb.2004.07.006; Guarente L, 2007, COLD SPRING HARB SYM, V72, P483, DOI 10.1101/sqb.2007.72.024; Guarente L, 2005, MECH AGEING DEV, V126, P923, DOI 10.1016/j.mad.2005.03.013; Guarente L, 2000, NATURE, V408, P255, DOI 10.1038/35041700; Haigis MC, 2006, GENE DEV, V20, P2913, DOI 10.1101/gad.1467506; Hallows WC, 2006, P NATL ACAD SCI USA, V103, P10230, DOI 10.1073/pnas.0604392103; Hunt L, 2007, PLANT J, V51, P341, DOI 10.1111/j.1365-313X.2007.03151.x; Kaeberlein M, 1999, GENE DEV, V13, P2570, DOI 10.1101/gad.13.19.2570; Kaeberlein M, 2006, NATURE, V444, P280, DOI 10.1038/nature05308; Kang JQ, 2003, MOL PHARMACOL, V64, P557, DOI 10.1124/mol.64.3.557; Lagouge M, 2006, CELL, V127, P1109, DOI 10.1016/j.cell.2006.11.013; Longo VD, 2006, CELL, V126, P257, DOI 10.1016/j.cell.2006.07.002; LUCKINBILL LS, 1984, EVOLUTION, V38, P996, DOI 10.1111/j.1558-5646.1984.tb00369.x; Medvedik O, 2007, PLOS BIOL, V5, P2330, DOI 10.1371/journal.pbio.0050261; Michishita E, 2005, MOL BIOL CELL, V16, P4623, DOI 10.1091/mbc.E05-01-0033; Newman BL, 2002, GENETICS, V162, P1675; Nisoli E, 2005, SCIENCE, V310, P314, DOI 10.1126/science.1117728; Parker JA, 2005, NAT GENET, V37, P349, DOI 10.1038/ng1534; Partridge L, 2005, CELL, V120, P461, DOI 10.1016/j.cell.2005.01.026; Porcu M, 2005, TRENDS PHARMACOL SCI, V26, P94, DOI 10.1016/j.tips.2004.12.009; Revollo JR, 2007, CELL METAB, V6, P363, DOI 10.1016/j.cmet.2007.09.003; Revollo JR, 2004, J BIOL CHEM, V279, P50754, DOI 10.1074/jbc.M408388200; Rogina B, 2004, P NATL ACAD SCI USA, V101, P15998, DOI 10.1073/pnas.0404184101; Rongvaux A, 2003, BIOESSAYS, V25, P683, DOI 10.1002/bies.10297; Sandmeier JJ, 2002, GENETICS, V160, P877; Sauve AA, 2008, J PHARMACOL EXP THER, V324, P883, DOI 10.1124/jpet.107.120758; Sinclair DA, 2005, MECH AGEING DEV, V126, P987, DOI 10.1016/j.mad.2005.03.019; Starai VJ, 2002, SCIENCE, V298, P2390, DOI 10.1126/science.1077650; Tatar M, 2003, SCIENCE, V299, P1346, DOI 10.1126/science.1081447; Tissenbaum HA, 2001, NATURE, V410, P227, DOI 10.1038/35065638; Tsuchiya M, 2006, AGING CELL, V5, P505, DOI 10.1111/j.1474-9726.2006.00240.x; van der Horst A, 2007, MECH AGEING DEV, V128, P346, DOI 10.1016/j.mad.2007.01.004; van der Veer E, 2007, J BIOL CHEM, V282, P10841, DOI 10.1074/jbc.C700018200; Wang F, 2007, AGING CELL, V6, P505, DOI 10.1111/j.1474-9726.2007.00304.x; Wang GD, 2007, PLANT J, V49, P1020, DOI 10.1111/j.1365-313X.2006.03013.x; Wang J, 2005, J CELL BIOL, V170, P349, DOI 10.1083/jcb.200504028; Wang YM, 2006, MECH AGEING DEV, V127, P48, DOI 10.1016/j.mad.2005.09.005; Yang HY, 2007, CELL, V130, P1095, DOI 10.1016/j.cell.2007.07.035; Yang HY, 2006, EXP GERONTOL, V41, P718, DOI 10.1016/j.exger.2006.06.003	64	125	130	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 10	2008	283	41					27810	27819		10.1074/jbc.M804681200	http://dx.doi.org/10.1074/jbc.M804681200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	355OW	18678867	Green Published, hybrid			2022-12-27	WOS:000259719200052
J	Xia, R; Mei, ZZ; Mao, HJ; Yang, W; Dong, L; Bradley, H; Beech, DJ; Jiang, LH				Xia, Rong; Mei, Zhu-Zhong; Mao, Hong-Ju; Yang, Wei; Dong, Li; Bradley, Helen; Beech, David J.; Jiang, Lin-Hua			Identification of pore residues engaged in determining divalent cationic permeation in transient receptor potential melastatin subtype channel	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLECULAR DETERMINANTS; EPITHELIAL CA2+; TRPM2 CHANNEL; ADP-RIBOSE; SELECTIVITY; MG2+; ACID; SUSCEPTIBILITY; INFLUX; TRPC5	The molecular basis for divalent cationic permeability in transient receptor potential melastatin subtype ( TRPM) channels is not fully understood. Here we studied the roles of all eight acidic residues, glutamate or aspartate, and also the glutamine residue between pore helix and selectivity filter in the pore of TRPM2 channel. Mutants with alanine substitution in each of the acidic residues, except Glu-960 and Asp-987, formed functional channels. These channels exhibited similar Ca2+ and Mg2+ permeability to wild type channel, with the exception of the E1022A mutant, which displayed increased Mg2+ permeability. More conservative E960Q, E960D, and D987N mutations also led to loss of function. The D987E mutant was functional and showed greater Ca2+ permeability along with concentration-dependent inhibition of Na+ carrying currents by Ca2+. Incorporation of negative charge in place of Gln-981 between the pore helix and selectivity filter by changing it to glutamate, which is present in the more Ca2+ -permeable TRPM channels, substantially increased Ca2+ permeability. Expression of concatemers linking wild type and E960D mutant subunits resulted in functional channels that exhibited reduced Ca2+ permeability. These data taken together suggest that Glu-960, Gln-981, Asp-987, and Glu-1022 residues are engaged in determining divalent cationic permeation properties of the TRPM2 channel.	[Xia, Rong; Mei, Zhu-Zhong; Mao, Hong-Ju; Yang, Wei; Dong, Li; Bradley, Helen; Beech, David J.; Jiang, Lin-Hua] Univ Leeds, Fac Biol Sci, Inst Membrane & Syst Biol, Leeds LS2 9JT, W Yorkshire, England	University of Leeds	Jiang, LH (corresponding author), Univ Leeds, Fac Biol Sci, Inst Membrane & Syst Biol, Leeds LS2 9JT, W Yorkshire, England.	h.jiang@leeds.ac.uk	Jiang, Lin-Hua/D-2030-2010; Jiang, Lin-Hua/AAU-1078-2020	Jiang, Lin-Hua/0000-0001-6398-0411; Jiang, Lin-Hua/0000-0001-6398-0411; Beech, David/0000-0002-7683-9422	Wellcome Trust	Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by the Wellcome Trust (to L.-H. Jiang). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Bo XN, 2003, MOL PHARMACOL, V63, P1407, DOI 10.1124/mol.63.6.1407; Clapham DE, 2003, NATURE, V426, P517, DOI 10.1038/nature02196; Fleig A, 2004, TRENDS PHARMACOL SCI, V25, P633, DOI 10.1016/j.tips.2004.10.004; Fonfria E, 2005, J NEUROCHEM, V95, P715, DOI 10.1111/j.1471-4159.2005.03396.x; Garcia-Martinez C, 2000, J BIOL CHEM, V275, P32552, DOI 10.1074/jbc.M002391200; Hara Y, 2002, MOL CELL, V9, P163, DOI 10.1016/S1097-2765(01)00438-5; Hecquet CM, 2008, CIRC RES, V102, P347, DOI 10.1161/CIRCRESAHA.107.160176; Hill K, 2004, NEUROPHARMACOLOGY, V47, P450, DOI 10.1016/j.neuropharm.2004.04.014; Hille B., 2001, IONIC CHANNELS EXCIT, P539; Hoenderop JGJ, 2005, J AM SOC NEPHROL, V16, P15, DOI 10.1681/ASN.2004070523; Inoue R, 2006, CIRC RES, V99, P119, DOI 10.1161/01.RES.0000233356.10630.8a; Jordt SE, 2000, P NATL ACAD SCI USA, V97, P8134, DOI 10.1073/pnas.100129497; Jung S, 2003, J BIOL CHEM, V278, P3562, DOI 10.1074/jbc.M211484200; Kraft R, 2006, BRIT J PHARMACOL, V148, P264, DOI 10.1038/sj.bjp.0706739; Li MJ, 2007, J BIOL CHEM, V282, P25817, DOI 10.1074/jbc.M608972200; Liu D, 2005, J BIOL CHEM, V280, P20691, DOI 10.1074/jbc.M414072200; McHugh D, 2003, J BIOL CHEM, V278, P11002, DOI 10.1074/jbc.M210810200; Mei ZZ, 2006, J BIOL CHEM, V281, P38748, DOI 10.1074/jbc.M607591200; Mei ZZ, 2006, AM J PHYSIOL-CELL PH, V291, pC1022, DOI 10.1152/ajpcell.00606.2005; Monteilh-Zoller MK, 2003, J GEN PHYSIOL, V121, P49, DOI 10.1085/jgp.20028740; Nilius B, 2005, J BIOL CHEM, V280, P22899, DOI 10.1074/jbc.M501686200; Nilius B, 2001, J BIOL CHEM, V276, P1020, DOI 10.1074/jbc.M006184200; Nilius B, 2007, PHYSIOL REV, V87, P165, DOI 10.1152/physrev.00021.2006; Oberwinkler J, 2005, J BIOL CHEM, V280, P22540, DOI 10.1074/jbc.M503092200; Owsianik G, 2006, ANNU REV PHYSIOL, V68, P685, DOI 10.1146/annurev.physiol.68.040204.101406; Perraud AL, 2003, CELL CALCIUM, V33, P519, DOI 10.1016/S0143-4160(03)00057-5; Perraud AL, 2001, NATURE, V411, P595, DOI 10.1038/35079100; Sano Y, 2001, SCIENCE, V293, P1327, DOI 10.1126/science.1062473; Sather WA, 2003, ANNU REV PHYSIOL, V65, P133, DOI 10.1146/annurev.physiol.65.092101.142345; Schmitz C, 2003, CELL, V114, P191, DOI 10.1016/S0092-8674(03)00556-7; Schnitzler MMY, 2008, FASEB J, V22, P1540, DOI 10.1096/fj.07-9694com; Semtner M, 2007, J BIOL CHEM, V282, P33868, DOI 10.1074/jbc.M702577200; Starkus J, 2007, J GEN PHYSIOL, V130, P427, DOI 10.1085/jgp.200709836; Togashi K, 2006, EMBO J, V25, P1804, DOI 10.1038/sj.emboj.7601083; Topala CN, 2007, CELL CALCIUM, V41, P513, DOI 10.1016/j.ceca.2006.10.003; Venkatachalam K, 2007, ANNU REV BIOCHEM, V76, P387, DOI 10.1146/annurev.biochem.75.103004.142819; Voets T, 2004, J BIOL CHEM, V279, P19, DOI 10.1074/jbc.M311201200; Voets T, 2002, J BIOL CHEM, V277, P33704, DOI 10.1074/jbc.M204828200; Zhang W, 2003, J BIOL CHEM, V278, P16222, DOI 10.1074/jbc.M300298200	39	49	51	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 10	2008	283	41					27426	27432		10.1074/jbc.M801049200	http://dx.doi.org/10.1074/jbc.M801049200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	355OW	18687688	Green Published, hybrid			2022-12-27	WOS:000259719200011
J	Ouellet, YH; Daigle, R; Lague, P; Dantsker, D; Milani, M; Bolognesi, M; Friedman, JM; Guertin, M				Ouellet, Yannick H.; Daigle, Richard; Laguee, Patrick; Dantsker, David; Milani, Mario; Bolognesi, Martino; Friedman, Joel M.; Guertin, Michel			Ligand binding to truncated hemoglobin N from Mycobacterium tuberculosis is strongly modulated by the interplay between the distal heme pocket residues and internal water	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOCHROME-C-OXIDASE; NITRIC-OXIDE; MOLECULAR-DYNAMICS; CRYSTAL-STRUCTURES; ESCHERICHIA-COLI; MYOGLOBIN; REACTIVITY; OXYGEN; O-2; DETOXIFICATION	The survival of Mycobacterium tuberculosis requires detoxification of host center dot NO. Oxygenated Mycobacterium tuberculosis truncated hemoglobin N catalyzes the rapid oxidation of nitric oxide to innocuous nitrate with a second-order rate constant (k'NOD approximate to 745 x 10(6) M(-1 center dot)s(-1)), which is similar to 15-fold faster than the reaction of horse heart myoglobin. We ask what aspects of structure and/or dynamics give rise to this enhanced reactivity. A first step is to expose what controls ligand/substrate binding to the heme. We present evidence that the main barrier to ligand binding to deoxy-truncated hemoglobin N (deoxy-trHbN) is the displacement of a distal cavity water molecule, which is mainly stabilized by residue Tyr(B10) but not coordinated to the heme iron. As observed in the Tyr( B10)/Gln(E11) apolar mutants, once this kinetic barrier is lowered, CO and O-2 binding is very rapid with rates approaching 1 - 2 x 10(9) M(-1 center dot)s(-1). These large values almost certainly represent the upper limit for ligand binding to a heme protein and also indicate that the iron atom in trHbN is highly reactive. Kinetic measurements on the photoproduct of the center dot NO derivative of met-trHbN, where both the center dot NO and water can be directly followed, revealed that water rebinding is quite fast (similar to 1.49 x 10(8) s(-1)) and is responsible for the low geminate yield in trHbN. Molecular dynamics simulations, performed with trHbN and its distal mutants, indicated that in the absence of a distal water molecule, ligand access to the heme iron is not hindered. They also showed that a water molecule is stabilized next to the heme iron through hydrogen-bonding with Tyr(B10) and Gln(E11).	[Ouellet, Yannick H.; Daigle, Richard; Laguee, Patrick; Guertin, Michel] Univ Laval, Dept Biochem & Microbiol, Quebec City, PQ G1K 7P4, Canada; [Dantsker, David; Friedman, Joel M.] Albert Einstein Coll Med, Dept Physiol & Biophys, Bronx, NY 10461 USA; [Milani, Mario; Bolognesi, Martino] Univ Milan, Milano Res Unit, CNR, INFM, I-20131 Milan, Italy; [Milani, Mario; Bolognesi, Martino] Univ Milan, Dept Biomol Sci & Biotechnol, I-20131 Milan, Italy	Laval University; Yeshiva University; Albert Einstein College of Medicine; Consiglio Nazionale delle Ricerche (CNR); Istituto Nazionale per la Fisica della Materia (INFM-CNR); University of Milan; University of Milan	Guertin, M (corresponding author), Univ Laval, Dept Biochem & Microbiol, Pavillon Charles Eugene Marchand,Rm 3145, Quebec City, PQ G1K 7P4, Canada.	Michel.Guertin@rsvs.ulaval.ca	Bolognesi, Martino/B-7924-2017; Milani, Mario/B-6446-2015	Bolognesi, Martino/0000-0002-9253-5170; Milani, Mario/0000-0001-6098-3991; Lague, Patrick/0000-0002-5236-4979	National Institutes of Health [1-R01-AI052258]; National Sciences and Engineering Research Council [46306- 01]; Fonds Que be cois de la Recherche sur la Nature et les Technologies [104897]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI052258] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); Fonds Que be cois de la Recherche sur la Nature et les Technologies(FQRNT); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant 1-R01-AI052258 (to J. M. F.). This work was also supported by National Sciences and Engineering Research Council Grant 46306- 01 (2005- 2010) and Fonds Que be cois de la Recherche sur la Nature et les Technologies Grant 104897 (M. G.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	BLOUGH NV, 1985, INORG CHEM, V24, P3502, DOI 10.1021/ic00216a003; BOLOGNESI M, 1982, J MOL BIOL, V158, P305, DOI 10.1016/0022-2836(82)90435-1; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; BROWN GC, 1994, FEBS LETT, V356, P295, DOI 10.1016/0014-5793(94)01290-3; Brunori M, 1999, CELL MOL LIFE SCI, V56, P549, DOI 10.1007/s000180050452; Brunori M, 2001, TRENDS BIOCHEM SCI, V26, P21, DOI 10.1016/S0968-0004(00)01698-4; Cao WX, 2001, BIOCHEMISTRY-US, V40, P5728, DOI 10.1021/bi010067e; Christian JF, 1997, BIOCHEMISTRY-US, V36, P11198, DOI 10.1021/bi9710075; CLEETER MWJ, 1994, FEBS LETT, V345, P50, DOI 10.1016/0014-5793(94)00424-2; Couture M, 1999, P NATL ACAD SCI USA, V96, P11223, DOI 10.1073/pnas.96.20.11223; Dantsker D, 2005, J BIOL CHEM, V280, P38740, DOI 10.1074/jbc.M506333200; Dantsker D, 2004, J BIOL CHEM, V279, P38844, DOI 10.1074/jbc.M401513200; Dantsker D, 2005, BBA-PROTEINS PROTEOM, V1749, P234, DOI 10.1016/j.bbapap.2005.04.002; Draghi F, 2002, J BIOL CHEM, V277, P7509, DOI 10.1074/jbc.M109206200; Eich RF, 1996, BIOCHEMISTRY-US, V35, P6976, DOI 10.1021/bi960442g; Feller SE, 1996, J PHYS CHEM-US, V100, P17011, DOI 10.1021/jp9614658; Gardner PR, 1997, J BIOL CHEM, V272, P25071, DOI 10.1074/jbc.272.40.25071; Gardner PR, 1998, J BIOL CHEM, V273, P26528, DOI 10.1074/jbc.273.41.26528; Goldbeck RA, 2006, P NATL ACAD SCI USA, V103, P1254, DOI 10.1073/pnas.0507840103; HUIE RE, 1993, FREE RADICAL RES COM, V18, P195, DOI 10.3109/10715769309145868; Kissner R, 1997, CHEM RES TOXICOL, V10, P1285, DOI 10.1021/tx970160x; KLEYWEGT GJ, 1994, ACTA CRYSTALLOGR D, V50, P178, DOI 10.1107/S0907444993011333; Mackerell AD, 2004, J COMPUT CHEM, V25, P1400, DOI 10.1002/jcc.20065; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Marti MA, 2008, J AM CHEM SOC, V130, P1688, DOI 10.1021/ja076853+; Milani M, 2001, EMBO J, V20, P3902, DOI 10.1093/emboj/20.15.3902; Olson JS, 1997, J BIOL INORG CHEM, V2, P544, DOI 10.1007/s007750050169; Olson JS, 1996, J BIOL CHEM, V271, P17593, DOI 10.1074/jbc.271.30.17593; Ouellet Y, 2006, BIOCHEMISTRY-US, V45, P8770, DOI 10.1021/bi060112o; Ouellett H, 2002, P NATL ACAD SCI USA, V99, P5902, DOI 10.1073/pnas.092017799; Pfeiffer S, 1997, J BIOL CHEM, V272, P3465, DOI 10.1074/jbc.272.6.3465; Price DJ, 2004, J CHEM PHYS, V121, P10096, DOI 10.1063/1.1808117; QUILLIN ML, 1995, J MOL BIOL, V245, P416, DOI 10.1006/jmbi.1994.0034; QUILLIN ML, 1993, J MOL BIOL, V234, P140, DOI 10.1006/jmbi.1993.1569; ROHLFS RJ, 1990, J BIOL CHEM, V265, P3168; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Samuni U, 2006, BIOCHEMISTRY-US, V45, P2820, DOI 10.1021/bi050010i; Samuni U, 2004, J AM CHEM SOC, V126, P2682, DOI 10.1021/ja038093i; Samuni U, 2002, J BIOL CHEM, V277, P25783, DOI 10.1074/jbc.M200301200; Samuni U, 2007, GENE, V398, P234, DOI 10.1016/j.gene.2007.04.032; Samuni U, 2007, J AM CHEM SOC, V129, P12756, DOI 10.1021/ja072342b; Scott EE, 2001, J BIOL CHEM, V276, P5177, DOI 10.1074/jbc.M008282200; SPRINGER BA, 1994, CHEM REV, V94, P699, DOI 10.1021/cr00027a007; Stevanin TM, 2000, J BIOL CHEM, V275, P35868, DOI 10.1074/jbc.M002471200; Vojtechovsky J, 1999, BIOPHYS J, V77, P2153, DOI 10.1016/S0006-3495(99)77056-6	45	27	28	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 3	2008	283	40					27270	27278		10.1074/jbc.M804215200	http://dx.doi.org/10.1074/jbc.M804215200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	353RT	18676995	Green Published, hybrid			2022-12-27	WOS:000259586600046
J	Keating, SE; Bowie, AG				Keating, Sinead E.; Bowie, Andrew G.			Role of Non-degradative Ubiquitination in Interleukin-1 and Toll-like Receptor Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							NF-KAPPA-B; INTERFERON-ALPHA INDUCTION; POLYUBIQUITIN CHAINS; CONJUGATING ENZYME; LYS(63)-LINKED POLYUBIQUITINATION; LYS63-LINKED POLYUBIQUITINATION; PELLINO PROTEINS; IMMUNE-RESPONSE; INNATE IMMUNITY; KINASE COMPLEX		[Keating, Sinead E.; Bowie, Andrew G.] Univ Dublin Trinity Coll, Sch Biochem & Immunol, Dublin 2, Ireland	Trinity College Dublin	Bowie, AG (corresponding author), Univ Dublin Trinity Coll, Sch Biochem & Immunol, Dublin 2, Ireland.	agbowie@tcd.ie		Bowie, Andrew/0000-0001-5316-4373	Science Foundation Ireland; Enterprise Ireland; Irish Health Research Board	Science Foundation Ireland(Science Foundation IrelandEuropean Commission); Enterprise Ireland; Irish Health Research Board	This work was supported by Science Foundation Ireland, Enterprise Ireland, and the Irish Health Research Board. This is the first of three articles in the Thematic Minireview Series on Regulation of Signaling by Non-degradative Ubiquitination.	Abbott DW, 2007, MOL CELL BIOL, V27, P6012, DOI 10.1128/MCB.00270-07; Abbott DW, 2004, CURR BIOL, V14, P2217, DOI 10.1016/j.cub.2004.12.032; Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Butler MP, 2007, J BIOL CHEM, V282, P29729, DOI 10.1074/jbc.M704558200; Chau TL, 2008, TRENDS BIOCHEM SCI, V33, P171, DOI 10.1016/j.tibs.2008.01.002; Chen ZJJ, 2005, NAT CELL BIOL, V7, P758, DOI 10.1038/ncb0805-758; Conze DB, 2008, MOL CELL BIOL, V28, P3538, DOI 10.1128/MCB.02098-07; Cusson-Hermance N, 2005, J BIOL CHEM, V280, P36560, DOI 10.1074/jbc.M506831200; Deng L, 2000, CELL, V103, P351, DOI 10.1016/S0092-8674(00)00126-4; Fukushima T, 2007, P NATL ACAD SCI USA, V104, P6371, DOI 10.1073/pnas.0700548104; Gatot JS, 2007, J BIOL CHEM, V282, P31131, DOI 10.1074/jbc.M701690200; Haas T, 2008, IMMUNITY, V28, P315, DOI 10.1016/j.immuni.2008.01.013; Hacker H, 2006, NATURE, V439, P204, DOI 10.1038/nature04369; Huang YS, 2004, J BIOL CHEM, V279, P51697, DOI 10.1074/jbc.M410369200; Jiang ZF, 2003, J BIOL CHEM, V278, P16713, DOI 10.1074/jbc.M300562200; Kanayama A, 2004, MOL CELL, V15, P535, DOI 10.1016/j.molcel.2004.08.008; Kawagoe T, 2008, NAT IMMUNOL, V9, P684, DOI 10.1038/ni.1606; Kawai T, 2004, NAT IMMUNOL, V5, P1061, DOI 10.1038/ni1118; Kayagaki N, 2007, SCIENCE, V318, P1628, DOI 10.1126/science.1145918; Keating SE, 2007, J BIOL CHEM, V282, P33435, DOI 10.1074/jbc.M705266200; Meylan E, 2004, NAT IMMUNOL, V5, P503, DOI 10.1038/ni1061; Meylan E, 2006, MOL CELL, V22, P561, DOI 10.1016/j.molcel.2006.05.012; Muzio M, 1997, SCIENCE, V278, P1612, DOI 10.1126/science.278.5343.1612; Ninomiya-Tsuji J, 1999, NATURE, V398, P252, DOI 10.1038/18465; O'Neill LAJ, 2007, NAT REV IMMUNOL, V7, P353, DOI 10.1038/nri2079; Oganesyan G, 2006, NATURE, V439, P208, DOI 10.1038/nature04374; Ordureau A, 2008, BIOCHEM J, V409, P43, DOI 10.1042/BJ20071365; Pickart CM, 2004, CURR OPIN CHEM BIOL, V8, P610, DOI 10.1016/j.cbpa.2004.09.009; Schauvliege R, 2006, FEBS LETT, V580, P4697, DOI 10.1016/j.febslet.2006.07.046; Sebban-Benin H, 2007, HUM MOL GENET, V16, P2805, DOI 10.1093/hmg/ddm237; Song YJ, 2006, P NATL ACAD SCI USA, V103, P2689, DOI 10.1073/pnas.0511096103; Sun LJ, 2004, MOL CELL, V14, P289, DOI 10.1016/S1097-2765(04)00236-9; Sun SC, 2008, NAT REV IMMUNOL, V8, P501, DOI 10.1038/nri2337; Sweet CR, 2007, CELL MICROBIOL, V9, P2700, DOI 10.1111/j.1462-5822.2007.00990.x; Tang ED, 2003, J BIOL CHEM, V278, P37297, DOI 10.1074/jbc.M303389200; Thompson AJ, 2007, IMMUNOL CELL BIOL, V85, P435, DOI 10.1038/sj.icb.7100100; Uematsu S, 2005, J EXP MED, V201, P915, DOI 10.1084/jem.20042372; Unterholzner L, 2008, BIOCHEM PHARMACOL, V75, P589, DOI 10.1016/j.bcp.2007.07.043; Wang C, 2001, NATURE, V412, P346, DOI 10.1038/35085597; Windheim M, 2008, MOL CELL BIOL, V28, P1783, DOI 10.1128/MCB.02380-06; Wu CJ, 2006, NAT CELL BIOL, V8, P398, DOI 10.1038/ncb1384; Xiao H, 2008, J BIOL CHEM, V283, P14654, DOI 10.1074/jbc.M706931200; Yamamoto M, 2006, NAT IMMUNOL, V7, P962, DOI 10.1038/ni1367; Yamin TT, 1997, J BIOL CHEM, V272, P21540, DOI 10.1074/jbc.272.34.21540; Zhou HL, 2004, NATURE, V427, P167, DOI 10.1038/nature02273; Zhou R, 2005, J BIOL CHEM, V280, P34048, DOI 10.1074/jbc.M506655200	46	13	13	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 27	2009	284	13					8211	8215		10.1074/jbc.R800038200	http://dx.doi.org/10.1074/jbc.R800038200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	421ZW	18684710	Green Published, Green Submitted, hybrid			2022-12-27	WOS:000264397800002
J	Fromigue, O; Hamidouche, Z; Marie, PJ				Fromigue, Olivia; Hamidouche, Zahia; Marie, Pierre J.			Blockade of the RhoA-JNK-c-Jun-MMP2 Cascade by Atorvastatin Reduces Osteosarcoma Cell Invasion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HMG-COA REDUCTASE; BREAST-CANCER CELLS; MATRIX METALLOPROTEINASES; C-JUN; MMP-9 SECRETION; IV COLLAGENASE; MESSENGER-RNA; ACTIVATION; EXPRESSION; APOPTOSIS	Osteosarcoma is characterized by a high malignant and metastatic potential, which points to the need for new therapeutic strategies to prevent cell metastasis. In this study, we show that statin-induced HMG-CoA reductase inhibition reduces cell migration and invasion in human and murine osteosarcoma cells, independently of the genotype. The statin-induced reduction of cell migration and invasion was independent of induction of apoptosis and was geranylgeranylpyrophosphate-dependent. The statin reduced matrix metalloproteinase (MMP) 2, 9, and 14 and TIMP2 expression or activity in invading cells. Forced expression of MMP2 and MMP14 overcame the inhibitory effect of the statin on cell invasion, suggesting a role for these MMPs in invasive potential. We also investigated the mechanisms involved in the reduced MMP2 activity and cell invasion. Inhibition of JNK, but not ERK1/2 signaling, reduced MMP2 activity. Pharmacological or constitutive activation of JNK overcame the reduced MMP2 activity and cell invasion induced by the statin. The statin decreased JNK phosphorylation and c-Jun nuclear translocation, suggesting that HMG-CoA reductase inhibition targets the JNK-c-Jun signaling pathway. We showed that mevalonate or geranylgeranylpyrophosphate treatment prevented the statin-induced reduction in JNK phosphorylation, MMP2 activity, and cell invasion. Forced expression of a constitutively active form of RhoA increased JNK phosphorylation and overcame the inhibitory effect of atorvastatin on MMP2 activity and cell invasion. The data establish a link between RhoA, JNK, c-Jun, and MMP2 activity that is functionally involved in the reduction in osteosarcoma cell invasion by the statin. This suggests a novel strategy targeting RhoA-JNK-c-Jun signaling to reduce osteosarcoma cell tumorigenesis.	[Fromigue, Olivia] Hop Lariboisiere, INSERM, Lab Osteoblast Biol & Pathol, U606, F-75475 Paris 10, France; Univ Paris 07, Hop Lariboisiere, F-75475 Paris 10, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Lariboisiere-Fernand-Widal - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Lariboisiere-Fernand-Widal - APHP; UDICE-French Research Universities; Universite Paris Cite	Fromigue, O (corresponding author), Hop Lariboisiere, INSERM, Lab Osteoblast Biol & Pathol, U606, 2 Rue Ambroise Pare, F-75475 Paris 10, France.	olivia.fromigue@inserm.fr	Fromigue, Olivia/B-8225-2013	Fromigue, Olivia/0000-0002-3050-6155	INSERM; Association pour la Recherche Contre le Cancer [4315]; Association Rhumatisme et Travail (Paris, France)	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Association pour la Recherche Contre le Cancer(Fondation ARC pour la Recherche sur le Cancer); Association Rhumatisme et Travail (Paris, France)	This work was supported in part by INSERM, Association pour la Recherche Contre le Cancer Contract 4315, and the Association Rhumatisme et Travail (Paris, France). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Aznar S, 2001, CANCER LETT, V165, P1, DOI 10.1016/S0304-3835(01)00412-8; Behrens A, 2001, P NATL ACAD SCI USA, V98, P1769, DOI 10.1073/pnas.98.4.1769; Bian JH, 1997, MOL CELL BIOL, V17, P6330, DOI 10.1128/MCB.17.11.6330; Bjornland K, 2005, J SURG RES, V127, P151, DOI 10.1016/j.jss.2004.12.016; Bruland OS, 2005, CLIN CANCER RES, V11, P4666, DOI 10.1158/1078-0432.CCR-05-0165; Cheung LWT, 2006, CANCER RES, V66, P10902, DOI 10.1158/0008-5472.CAN-06-2217; Coussens LM, 2002, SCIENCE, V295, P2387, DOI 10.1126/science.1067100; David JP, 2005, J CLIN INVEST, V115, P664, DOI 10.1172/JCI200522877; Denoyelle C, 2003, CELL SIGNAL, V15, P327, DOI 10.1016/S0898-6568(02)00124-9; Denoyelle C, 2001, CARCINOGENESIS, V22, P1139, DOI 10.1093/carcin/22.8.1139; Deryugina EI, 2006, CANCER METAST REV, V25, P9, DOI 10.1007/s10555-006-7886-9; Duncan RE, 2004, J BIOL CHEM, V279, P33079, DOI 10.1074/jbc.M400732200; Eferl R, 2003, NAT REV CANCER, V3, P859, DOI 10.1038/nrc1209; Egeblad M, 2002, NAT REV CANCER, V2, P161, DOI 10.1038/nrc745; Franchi A, 1998, VIRCHOWS ARCH, V432, P515, DOI 10.1007/s004280050199; Fritz G, 1999, INT J CANCER, V81, P682, DOI 10.1002/(SICI)1097-0215(19990531)81:5<682::AID-IJC2>3.0.CO;2-B; Fromigue O, 2006, CELL DEATH DIFFER, V13, P1845, DOI 10.1038/sj.cdd.4401873; Fromigue O, 2001, J BONE MINER RES, V16, P1600, DOI 10.1359/jbmr.2001.16.9.1600; Graaf MR, 2004, CANCER TREAT REV, V30, P609, DOI 10.1016/j.ctrv.2004.06.010; Himelstein Bruce P., 1998, Current Opinion in Oncology, V10, P326, DOI 10.1097/00001622-199807000-00009; Hsieh YS, 2007, CARCINOGENESIS, V28, P977, DOI 10.1093/carcin/bgl221; Hu B, 2006, CANCER RES, V66, P775, DOI 10.1158/0008-5472.CAN-05-1149; Ispanovic E, 2006, AM J PHYSIOL-CELL PH, V291, pC579, DOI 10.1152/ajpcell.00300.2005; Khanna C, 2000, CLIN EXP METASTAS, V18, P261, DOI 10.1023/A:1006767007547; Kusama T, 2006, INT J ONCOL, V29, P217; Li YC, 2006, AM J PATHOL, V168, P1107, DOI 10.2353/ajpath.2006.050959; Maquoi E, 2000, J BIOL CHEM, V275, P11368, DOI 10.1074/jbc.275.15.11368; Matsumoto Y, 2001, JPN J CANCER RES, V92, P429, DOI 10.1111/j.1349-7006.2001.tb01113.x; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Orosco A, 2007, CANCER RES, V67, P3708, DOI 10.1158/0008-5472.CAN-06-4164; Papachristou DJ, 2003, BONE, V32, P364, DOI 10.1016/S8756-3282(03)00026-7; Porter KE, 2004, CARDIOVASC RES, V64, P507, DOI 10.1016/j.cardiores.2004.07.020; Pratap J, 2005, MOL CELL BIOL, V25, P8581, DOI 10.1128/MCB.25.19.8581-8591.2005; Reuben PM, 2006, FRONT BIOSCI-LANDMRK, V11, P1199, DOI 10.2741/1873; Rochet N, 1999, INT J CANCER, V82, P282, DOI 10.1002/(SICI)1097-0215(19990719)82:2<282::AID-IJC20>3.0.CO;2-R; RODAN SB, 1987, CANCER RES, V47, P4961; Sabapathy K, 2004, MOL CELL, V15, P713, DOI 10.1016/j.molcel.2004.08.028; Sawada K, 2002, CANCER RES, V62, P6015; Stenner-Liewen Frank, 2003, Cancer Research, V63, P263; Sternlicht MD, 2001, ANNU REV CELL DEV BI, V17, P463, DOI 10.1146/annurev.cellbio.17.1.463; STRONGIN AY, 1995, J BIOL CHEM, V270, P5331, DOI 10.1074/jbc.270.10.5331; Thunyakitpisal PD, 2004, J PHARMACOL SCI, V94, P403, DOI 10.1254/jphs.94.403; Turner NA, 2005, FASEB J, V19, P804, DOI 10.1096/fj.04-2852fje; Turner NA, 2007, J MOL CELL CARDIOL, V43, P168, DOI 10.1016/j.yjmcc.2007.05.006; Uchibori M, 2006, INT J ONCOL, V28, P33; Van Noorden CJF, 1998, ACTA HISTOCHEM, V100, P337, DOI 10.1016/S0065-1281(98)80030-5; Wagner EF, 2005, IMMUNOL REV, V208, P126, DOI 10.1111/j.0105-2896.2005.00332.x; Wang IK, 2000, ONCOLOGY-BASEL, V59, P245, DOI 10.1159/000012168; Waxman DJ, 2003, CANCER RES, V63, P8563; Wong WWL, 2002, LEUKEMIA, V16, P508, DOI 10.1038/sj.leu.2402476; Woodhouse EC, 1997, CANCER-AM CANCER SOC, V80, P1529, DOI 10.1002/(SICI)1097-0142(19971015)80:8+<1529::AID-CNCR2>3.0.CO;2-F	51	111	123	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 7	2008	283	45					30549	30556		10.1074/jbc.M801436200	http://dx.doi.org/10.1074/jbc.M801436200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	367ID	18757369	Green Published, hybrid			2022-12-27	WOS:000260544800013
J	Shi, XR; Burkart, A; Nicoloro, SM; Czech, MP; Straubhaar, J; Corvera, S				Shi, Xiarong; Burkart, Alison; Nicoloro, Sarah M.; Czech, Michael P.; Straubhaar, Juerg; Corvera, Silvia			Paradoxical Effect of Mitochondrial Respiratory Chain Impairment on Insulin Signaling and Glucose Transport in Adipose Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							METABOLIC SYNDROME; STIMULATED PHOSPHORYLATION; OXIDATIVE-PHOSPHORYLATION; TRANSCRIPTION-FACTOR; DIABETES-MELLITUS; MAMMALIAN-CELLS; SKELETAL-MUSCLE; GENE-EXPRESSION; ROS PRODUCTION; TISSUE	Adipocyte function is crucial for the control of whole body energy homeostasis. Pathway analysis of differentiating 3T3-L1 adipocytes reveals that major metabolic pathways induced during differentiation involve mitochondrial function. However, it is not clear why differentiated white adipocytes require enhanced respiratory chain activity relative to pre-adipocytes. To address this question, we used small interference RNA to interfere with the induction of the transcription factor Tfam, which is highly induced between days 2 and 4 of differentiation and is crucial for replication of mitochondrial DNA. Interference with Tfam resulted in cells with decreased respiratory chain capacity, reflected by decreased basal oxygen consumption, and decreased mitochondrial ATP synthesis, but no difference in many other adipocyte functions or expression levels of adipose-specific genes. However, insulin-stimulated GLUT4 translocation to the cell surface and subsequent glucose transport are impaired in Tfam knockdown cells. Paradoxically, insulin-stimulated Akt phosphorylation is significantly enhanced in these cells. These studies reveal independent links between mitochondrial function, insulin signaling, and glucose transport, in which impaired respiratory chain activity enhances insulin signaling to Akt phosphorylation, but impairs GLUT4 translocation. These results indicate that mitochondrial respiratory chain dysfunction in adipocytes can cause impaired insulin responsiveness of GLUT4 translocation by a mechanism downstream of the Akt protein kinase.	[Shi, Xiarong; Burkart, Alison; Nicoloro, Sarah M.; Czech, Michael P.; Straubhaar, Juerg; Corvera, Silvia] Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA 01605 USA	University of Massachusetts System; University of Massachusetts Worcester	Corvera, S (corresponding author), Univ Massachusetts, Sch Med, Program Mol Med, 373 Plantat St, Worcester, MA 01605 USA.	silvia.corvera@umassmed.edu		Nicoloro, Sarah/0000-0002-8638-4556	National Institutes of Health [DK60837]; University of Massachusetts Diabetes and Endocrinology Research Center [DK32520]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK032520, R01DK060837] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Massachusetts Diabetes and Endocrinology Research Center; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK60837. Informatics core services were supported by University of Massachusetts Diabetes and Endocrinology Research Center Grant DK32520. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Asin-Cayuela J, 2007, TRENDS BIOCHEM SCI, V32, P111, DOI 10.1016/j.tibs.2007.01.003; Axelrod D, 2001, TRAFFIC, V2, P764, DOI 10.1034/j.1600-0854.2001.21104.x; BASHAN N, 1993, AM J PHYSIOL, V264, pC430, DOI 10.1152/ajpcell.1993.264.2.C430; Beale EG, 2003, TRENDS BIOCHEM SCI, V28, P402, DOI 10.1016/S0968-0004(03)00163-4; Boden G, 2005, DIABETES, V54, P880, DOI 10.2337/diabetes.54.3.880; Bogacka I, 2005, J CLIN ENDOCR METAB, V90, P6650, DOI 10.1210/jc.2005-1024; Bogacka I, 2005, DIABETES, V54, P1392, DOI 10.2337/diabetes.54.5.1392; Brunelle JK, 2005, CELL METAB, V1, P409, DOI 10.1016/j.cmet.2005.05.002; Chavez JA, 2006, BIOCHEM BIOPH RES CO, V342, P1218, DOI 10.1016/j.bbrc.2006.02.091; Choo HJ, 2006, DIABETOLOGIA, V49, P784, DOI 10.1007/s00125-006-0170-2; Dahlman I, 2006, DIABETES, V55, P1792, DOI 10.2337/db05-1421; Falkenberg M, 2007, ANNU REV BIOCHEM, V76, P679, DOI 10.1146/annurev.biochem.76.060305.152028; Flachs P, 2005, DIABETOLOGIA, V48, P2365, DOI 10.1007/s00125-005-1944-7; Gridley S, 2005, CELL SIGNAL, V17, P59, DOI 10.1016/j.cellsig.2004.05.013; Guzy RD, 2005, CELL METAB, V1, P401, DOI 10.1016/j.cmet.2005.05.001; Hresko RC, 1998, J BIOL CHEM, V273, P20658, DOI 10.1074/jbc.273.32.20658; Huang SH, 2007, MOL CELL BIOL, V27, P3456, DOI 10.1128/MCB.01719-06; Imoto K, 2006, DIABETES, V55, P1197, DOI 10.2337/db05-1187; Kaaman M, 2007, DIABETOLOGIA, V50, P2526, DOI 10.1007/s00125-007-0818-6; Kane S, 2002, J BIOL CHEM, V277, P22115, DOI 10.1074/jbc.C200198200; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; Kang D, 2007, MITOCHONDRION, V7, P39, DOI 10.1016/j.mito.2006.11.017; Karlsson HKR, 2005, DIABETES, V54, P1692, DOI 10.2337/diabetes.54.6.1692; Katic M, 2007, AGING CELL, V6, P827, DOI 10.1111/j.1474-9726.2007.00346.x; Kim JY, 2007, J CLIN INVEST, V117, P2621, DOI 10.1172/JCI31021; Koh EH, 2007, DIABETES, V56, P2973, DOI 10.2337/db07-0510; Kwon J, 2004, P NATL ACAD SCI USA, V101, P16419, DOI 10.1073/pnas.0407396101; Laplante M, 2006, DIABETES, V55, P2771, DOI 10.2337/db06-0551; Larsson NG, 1998, NAT GENET, V18, P231, DOI 10.1038/ng0398-231; Linford NJ, 2007, AGING CELL, V6, P673, DOI 10.1111/j.1474-9726.2007.00319.x; Mansfield KD, 2005, CELL METAB, V1, P393, DOI 10.1016/j.cmet.2005.05.003; Martindale JL, 2002, J CELL PHYSIOL, V192, P1, DOI 10.1002/jcp.10119; Nishikawa T, 2007, ANTIOXID REDOX SIGN, V9, P343, DOI 10.1089/ars.2006.1458; Picard F, 2005, INT J OBESITY, V29, pS36, DOI 10.1038/sj.ijo.0802912; Pospisilik JA, 2007, CELL, V131, P476, DOI 10.1016/j.cell.2007.08.047; Rajala MW, 2003, ENDOCRINOLOGY, V144, P3765, DOI 10.1210/en.2003-0580; Rasouli N, 2007, DIABETES OBES METAB, V9, P1, DOI 10.1111/j.1463-1326.2006.00590.x; Ravussin E, 2002, ANN NY ACAD SCI, V967, P363; Reshef L, 2003, J BIOL CHEM, V278, P30413, DOI 10.1074/jbc.R300017200; Sano H, 2003, J BIOL CHEM, V278, P14599, DOI 10.1074/jbc.C300063200; Scarpulla RC, 2006, J CELL BIOCHEM, V97, P673, DOI 10.1002/jcb.20743; SORBRIS R, 1982, METABOLISM, V31, P973, DOI 10.1016/0026-0495(82)90137-8; Trujillo ME, 2005, J INTERN MED, V257, P167, DOI 10.1111/j.1365-2796.2004.01426.x; Unger RH, 2003, ENDOCRINOLOGY, V144, P5159, DOI 10.1210/en.2003-0870; Wilson-Fritch L, 2004, J CLIN INVEST, V114, P1281, DOI 10.1172/JCI200421752; Wilson-Fritch L, 2003, MOL CELL BIOL, V23, P1085, DOI 10.1128/MCB.23.3.1085-1094.2003; Wredenberg A, 2006, BIOCHEM BIOPH RES CO, V350, P202, DOI 10.1016/j.bbrc.2006.09.029; Zeigerer A, 2004, MOL BIOL CELL, V15, P4406, DOI 10.1091/mbc.e04-04-0333	48	50	53	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 7	2008	283	45					30658	30667		10.1074/jbc.M800510200	http://dx.doi.org/10.1074/jbc.M800510200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	367ID	18779333	Green Published, hybrid			2022-12-27	WOS:000260544800023
J	Singh, JK; Makde, RD; Kumar, V; Panda, D				Singh, Jay Kumar; Makde, Ravindra D.; Kumar, Vinay; Panda, Dulal			SepF Increases the Assembly and Bundling of FtsZ Polymers and Stabilizes FtsZ Protofilaments by Binding along Its Length	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-DIVISION PROTEIN; BACILLUS-SUBTILIS; ESCHERICHIA-COLI; INTERACTING PROTEIN; BACTERIAL DIVISION; GTP HYDROLYSIS; Z-RING; MEMBRANE; ZIPA; POLYMERIZATION	SepF (Septum Forming) protein has been recently identified through genetic studies, and it has been suggested to be involved in the division of Bacillus subtilis cells. We have purified functional B. subtilis SepF from the inclusion bodies overexpressed in Escherichia coli. Far-UV circular dichroism and fluorescence spectroscopic analysis involving the extrinsic fluorescent probe 1-anilinonaphthalene-8-sulfonic acid suggested that the purified SepF had characteristics of folded proteins. SepF was found to promote the assembly and bundling of FtsZ protofilaments using three complimentary techniques, namely 90 light scattering, sedimentation, and transmission electron microscopy. SepF also decreased the critical concentration of FtsZ assembly, prevented the dilution-induced disassembly of FtsZ protofilaments, and suppressed the GTPase activity of FtsZ. Further, thick bundles of FtsZ protofilaments were observed using fluorescein isothiocyanate-labeled SepF (FITC-SepF). Interestingly, FITC-SepF was found to be uniformly distributed along the length of the FtsZ protofilaments, suggesting that SepF copolymerizes with FtsZ. SepF formed a stable complex with FtsZ, as evident from the gel filtration analysis. Using a C-terminal tail truncated FtsZ (FtsZ Delta 16) and a C-terminal synthetic peptide of B. subtilis FtsZ (366-382); we provided evidence indicating that SepF binds primarily to the C-terminal tail of FtsZ. The present work in concert with the available in vivo data support a model in which SepF plays an important role in regulating the assembly dynamics of the divisome complex; therefore, it may have an important role in bacterial cell division.	[Singh, Jay Kumar; Panda, Dulal] Indian Inst Technol, Sch Biosci & Bioengn, Bombay 400076, Maharashtra, India; [Makde, Ravindra D.; Kumar, Vinay] Bhabha Atom Res Ctr, High Pressure Phys Div, Bombay 400085, Maharashtra, India	Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Bombay; Bhabha Atomic Research Center (BARC)	Panda, D (corresponding author), Indian Inst Technol, Sch Biosci & Bioengn, Bombay 400076, Maharashtra, India.	panda@iitb.ac.in	Singh, Jaikaran/O-5363-2015	Singh, Jaikaran/0000-0002-9273-6765; Makde, Ravindra D./0000-0001-7020-0065	Dept. of Science and Technology, Government of India; Council of Scientific and Industrial Research	Dept. of Science and Technology, Government of India(Department of Science & Technology (India)); Council of Scientific and Industrial Research(Council of Scientific & Industrial Research (CSIR) - India)	This work is supported by a grant from the Dept. of Science and Technology, Government of India (to D.P.) and a Council of Scientific and Industrial Research doctoral fellowship (to J.K.S.).	Arakawa T, 2007, BIOPHYS CHEM, V127, P1, DOI 10.1016/j.bpc.2006.12.007; Beuria TK, 2003, J BIOL CHEM, V278, P3735, DOI 10.1074/jbc.M205760200; BOHM G, 1992, PROTEIN ENG, V5, P191, DOI 10.1093/protein/5.3.191; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Edwards DH, 1997, MOL MICROBIOL, V24, P905, DOI 10.1046/j.1365-2958.1997.3811764.x; Fadda D, 2003, J BACTERIOL, V185, P6209, DOI 10.1128/JB.185.20.6209-6214.2003; Feucht A, 2001, MOL MICROBIOL, V40, P115, DOI 10.1046/j.1365-2958.2001.02356.x; Geissler B, 2003, P NATL ACAD SCI USA, V100, P4197, DOI 10.1073/pnas.0635003100; GELADOPOULOS TP, 1991, ANAL BIOCHEM, V192, P112, DOI 10.1016/0003-2697(91)90194-X; Gueiros FJ, 2002, GENE DEV, V16, P2544, DOI 10.1101/gad.1014102; Hale CA, 1997, CELL, V88, P175, DOI 10.1016/S0092-8674(00)81838-3; Hamoen LW, 2006, MOL MICROBIOL, V59, P989, DOI 10.1111/j.1365-2958.2005.04987.x; Huecas S, 2007, J BIOL CHEM, V282, P37515, DOI 10.1074/jbc.M706399200; Ishikawa S, 2006, MOL MICROBIOL, V60, P1364, DOI 10.1111/j.1365-2958.2006.05184.x; Jensen SO, 2005, J BACTERIOL, V187, P6536, DOI 10.1128/JB.187.18.6536-6544.2005; Jones LJF, 2001, CELL, V104, P913, DOI 10.1016/S0092-8674(01)00287-2; LEE SY, 1993, MOL MICROBIOL, V7, P601, DOI 10.1111/j.1365-2958.1993.tb01151.x; Levin PA, 1999, P NATL ACAD SCI USA, V96, P9642, DOI 10.1073/pnas.96.17.9642; Low HH, 2004, J MOL BIOL, V341, P839, DOI 10.1016/j.jmb.2004.05.031; Lu CL, 1998, CELL MOTIL CYTOSKEL, V40, P71, DOI 10.1002/(SICI)1097-0169(1998)40:1<71::AID-CM7>3.3.CO;2-Z; Ma XL, 1999, J BACTERIOL, V181, P7531, DOI 10.1128/JB.181.24.7531-7544.1999; Margolin W, 2003, CURR BIOL, V13, pR16, DOI 10.1016/S0960-9822(02)01381-7; Michie KA, 2006, ANNU REV BIOCHEM, V75, P467, DOI 10.1146/annurev.biochem.75.103004.142452; Osawa M, 2008, SCIENCE, V320, P792, DOI 10.1126/science.1154520; Pichoff S, 2005, MOL MICROBIOL, V55, P1722, DOI 10.1111/j.1365-2958.2005.04522.x; Pichoff S, 2002, EMBO J, V21, P685, DOI 10.1093/emboj/21.4.685; Raskin DM, 1999, P NATL ACAD SCI USA, V96, P4971, DOI 10.1073/pnas.96.9.4971; Romberg L, 2003, ANNU REV MICROBIOL, V57, P125, DOI 10.1146/annurev.micro.57.012903.074300; Rothfield L, 2005, NAT REV MICROBIOL, V3, P959, DOI 10.1038/nrmicro1290; Santra MK, 2004, J BIOL CHEM, V279, P25959, DOI 10.1074/jbc.M312473200; Santra MK, 2003, J BIOL CHEM, V278, P21336, DOI 10.1074/jbc.M301303200; Sapay N, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-255; Scheffers DJ, 2002, MOL MICROBIOL, V43, P1517, DOI 10.1046/j.1365-2958.2002.02828.x; Singh JK, 2007, BIOCHEMISTRY-US, V46, P11013, DOI 10.1021/bi700710j; Wang XD, 1997, J BACTERIOL, V179, P5551, DOI 10.1128/jb.179.17.5551-5559.1997; Weart RB, 2005, MOL MICROBIOL, V57, P238, DOI 10.1111/j.1365-2958.2005.04673.x; WOLDRINGH CL, 1990, RES MICROBIOL, V141, P39, DOI 10.1016/0923-2508(90)90096-9; Yu XC, 1997, EMBO J, V16, P5455, DOI 10.1093/emboj/16.17.5455	39	69	69	2	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 7	2008	283	45					31116	31124		10.1074/jbc.M805910200	http://dx.doi.org/10.1074/jbc.M805910200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	367ID	18782755	Green Published, hybrid			2022-12-27	WOS:000260544800066
J	Tavraz, NN; Friedrich, T; Durr, KL; Koenderink, JB; Bamberg, E; Freilinger, T; Dichgans, M				Tavraz, Neslihan N.; Friedrich, Thomas; Duerr, Katharina L.; Koenderink, Jan B.; Bamberg, Ernst; Freilinger, Tobias; Dichgans, Martin			Diverse Functional Consequences of Mutations in the Na+/K+-ATPase alpha(2)-Subunit Causing Familial Hemiplegic Migraine Type 2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CENTRAL-NERVOUS-SYSTEM; ATP1A2 MUTATION; NA,K-ATPASE ALPHA; CRYSTAL-STRUCTURE; MESSENGER-RNAS; CALCIUM-PUMP; SUBUNIT; GENE; MECHANISMS; CHANNEL	Mutations in ATP1A2, the gene coding for the Na+/K+-ATPase alpha(2)-subunit, are associated with both familial hemiplegic migraine and sporadic cases of hemiplegic migraine. In this study, we examined the functional properties of 11 ATP1A2 mutations associated with familial or sporadic hemiplegic migraine, including missense mutations (T263M, T376M, R383H, A606T, R763H, M829R, R834Q, R937P, and X1021R), a deletion mutant (del(K935-S940) ins(I)), and a frameshift mutation (S966fs). According to the Na+/K+-ATPase crystal structure, a subset of the mutated residues (Ala(606), Arg(763), Met(829), and Arg(834)) is involved in important interdomain H-bond networks, and the C terminus of the enzyme, which is elongated by the X1021R mutation, has been implicated in voltage dependence and formation of a third Na+-binding site. Upon heterologous expression in Xenopus oocytes, the analysis of electrogenic transport properties, Rb+ uptake, and protein expression revealed pronounced and markedly diverse functional alterations in all ATP1A2 mutants. Abnormalities included a complete loss of function (T376M), impaired plasma membrane expression (del(K935-S940) ins(I) and S966fs), and altered apparent affinities for extracellular cations or reduced enzyme turnover (R383H, A606T, R763H, R834Q, and X1021R). In addition, changes in the voltage dependence of pump currents and the increased rate constants of the voltage jump-induced redistribution between E1P and E2P states were observed. Thus, mutations that disrupt distinct interdomain H-bond patterns can cause abnormal conformational flexibility and exert long range consequences on apparent cation affinities or voltage dependence. Of interest, the X1021R mutation severely impaired voltage dependence and kinetics of Na+-translocating partial reactions, corroborating the critical role of the C terminus of Na+/K+-ATPase in these processes.	[Tavraz, Neslihan N.; Friedrich, Thomas; Duerr, Katharina L.] Tech Univ Berlin, Inst Chem, D-10623 Berlin, Germany; [Koenderink, Jan B.] Radboud Univ Nijmegen, Med Ctr, Dept Pharmacol & Toxicol, Nijmegen Ctr Mol Life Sci, NL-6500 HB Nijmegen, Netherlands; [Bamberg, Ernst] Max Planck Inst Biophys, Dept Biophys Chem, D-60438 Frankfurt, Germany; [Freilinger, Tobias; Dichgans, Martin] Univ Munich, Klinikum Grosshadern, Neurol Klin, D-81377 Munich, Germany	Technical University of Berlin; Radboud University Nijmegen; Max Planck Society; University of Munich	Friedrich, T (corresponding author), Tech Univ Berlin, Inst Chem, Sekr PC-14,Str 17 Juni 135, D-10623 Berlin, Germany.	friedrich@chem.tu-berlin.de	Dichgans, Martin/HCH-3247-2022; Friedrich, Thomas/AAA-3418-2022; Koenderink, Jan/N-3578-2014; Duerr, Katharina/A-6975-2015	Dichgans, Martin/0000-0002-0654-387X; Duerr, Katharina/0000-0002-3245-4088	Max-Planck-Gesellschaft; Deutsche Forschungsgemeinschaft [DI 722/8-2, KFG K1 027, KFG K1 028, SFB 740 TPC4]	Max-Planck-Gesellschaft(Max Planck Society); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the Max-Planck-Gesellschaft and Deutsche Forschungsgemeinschaft Grants (DI 722/8-2, KFG K1 027, KFG K1 028, and SFB 740 TPC4, Cluster of Excellence "Unifying Concepts in Catalysis").	ALBERS RW, 1967, ANNU REV BIOCHEM, V36, P727, DOI 10.1146/annurev.bi.36.070167.003455; Axelsen KB, 1998, J MOL EVOL, V46, P84, DOI 10.1007/PL00006286; De Fusco M, 2003, NAT GENET, V33, P192, DOI 10.1038/ng1081; DEWEER P, 1994, SODIUM PUMP, P472; Dichgans M, 2005, LANCET, V366, P371, DOI 10.1016/S0140-6736(05)66786-4; Ducros A, 2001, NEW ENGL J MED, V345, P17, DOI 10.1056/NEJM200107053450103; Golovina VA, 2003, AM J PHYSIOL-CELL PH, V284, pC475, DOI 10.1152/ajpcell.00383.2002; Hadjikhani N, 2001, P NATL ACAD SCI USA, V98, P4687, DOI 10.1073/pnas.071582498; Jorgensen PL, 2003, ANNU REV PHYSIOL, V65, P817, DOI 10.1146/annurev.physiol.65.092101.142558; Jorgensen PL, 2001, J BIOENERG BIOMEMBR, V33, P367, DOI 10.1023/A:1010611322024; Jurkat-Rott K, 2004, NEUROLOGY, V62, P1857, DOI 10.1212/01.WNL.0000127310.11526.FD; Kamsteeg EJ, 2001, BIOCHEM BIOPH RES CO, V282, P683, DOI 10.1006/bbrc.2001.4629; Kaplan JH, 2002, ANNU REV BIOCHEM, V71, P511, DOI 10.1146/annurev.biochem.71.102201.141218; Kaunisto MA, 2004, NEUROGENETICS, V5, P141, DOI 10.1007/s10048-004-0178-z; Koenderink JB, 2005, BBA-BIOMEMBRANES, V1669, P61, DOI 10.1016/j.bbamem.2005.01.003; Koenderink JB, 2003, J BIOL CHEM, V278, P51213, DOI 10.1074/jbc.M306384200; MCGRAIL KM, 1991, J NEUROSCI, V11, P381, DOI 10.1523/jneurosci.11-02-00381.1991; Morth JP, 2007, NATURE, V450, P1043, DOI 10.1038/nature06419; Moseley AE, 2003, J BIOL CHEM, V278, P5317, DOI 10.1074/jbc.M211315200; Moskowitz MA, 2004, ANN NEUROL, V55, P276, DOI 10.1002/ana.20035; NAKAO M, 1986, NATURE, V323, P628, DOI 10.1038/323628a0; Ogawa H, 2002, P NATL ACAD SCI USA, V99, P15977, DOI 10.1073/pnas.202622299; Ophoff RA, 1996, CELL, V87, P543, DOI 10.1016/S0092-8674(00)81373-2; ORLOWSKI J, 1988, J BIOL CHEM, V263, P10436; Peng L, 1997, J NEUROSCI, V17, P3488; Pierelli F, 2006, CEPHALALGIA, V26, P324, DOI 10.1111/j.1468-2982.2006.01002.x; Pietrobon D, 2003, NAT REV NEUROSCI, V4, P386, DOI 10.1038/nrn1102; POST RL, 1972, J BIOL CHEM, V247, P6530; PRICE EM, 1988, BIOCHEMISTRY-US, V27, P8400, DOI 10.1021/bi00422a016; RAKOWSKI RF, 1991, J MEMBRANE BIOL, V121, P177, DOI 10.1007/BF01870531; Riant F, 2005, HUM MUTAT, V26, DOI 10.1002/humu.9361; Segall L, 2005, P NATL ACAD SCI USA, V102, P11106, DOI 10.1073/pnas.0504323102; Segall L, 2004, J BIOL CHEM, V279, P43692, DOI 10.1074/jbc.M407471200; Somjen GG, 2001, PHYSIOL REV, V81, P1065, DOI 10.1152/physrev.2001.81.3.1065; Spadaro M, 2004, NEUROGENETICS, V5, P177, DOI 10.1007/s10048-004-0183-2; Swoboda KJ, 2004, ANN NEUROL, V55, P884, DOI 10.1002/ana.20134; Thomsen LL, 2007, BRAIN, V130, P346, DOI 10.1093/brain/awl334; Todt U, 2005, HUM MUTAT, V26, P315, DOI 10.1002/humu.20229; Tonelli A, 2007, CLIN GENET, V72, P517, DOI 10.1111/j.1399-0004.2007.00892.x; Toyoshima C, 2000, NATURE, V405, P647, DOI 10.1038/35015017; Toyoshima C, 2002, NATURE, V418, P605, DOI 10.1038/nature00944; Vanmolkot Kaate R J, 2007, Hum Mutat, V28, P522, DOI 10.1002/humu.9486; Vanmolkot KR, 2006, EUR J HUM GENET, V14, P555, DOI 10.1038/sj.ejhg.5201607; Vanmolkot KRJ, 2006, ANN NEUROL, V59, P310, DOI 10.1002/ana.20760; Vanmolkot KRJ, 2003, LANCET NEUROL, V2, P721, DOI 10.1016/S1474-4422(03)00591-X; Vanmolkot KRJ, 2003, ANN NEUROL, V54, P360, DOI 10.1002/ana.10674; WATTS AG, 1991, P NATL ACAD SCI USA, V88, P7425, DOI 10.1073/pnas.88.16.7425	47	62	63	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 7	2008	283	45					31097	31106		10.1074/jbc.M802771200	http://dx.doi.org/10.1074/jbc.M802771200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	367ID	18728015	Green Published, hybrid			2022-12-27	WOS:000260544800064
J	Du, JQ; Wu, J; Zhang, HJ; Zhang, YH; Qiu, BY; Wu, F; Chen, YH; Li, JY; Nan, FJ; Ding, JP; Li, J				Du, Jun-Qing; Wu, Jian; Zhang, Hua-Jie; Zhang, Ya-Hui; Qiu, Bei-Ying; Wu, Fang; Chen, Yi-Hua; Li, Jing-Ya; Nan, Fa-Jun; Ding, Jian-Ping; Li, Jia			Isoquinoline-1,3,4-trione Derivatives Inactivate Caspase-3 by Generation of Reactive Oxygen Species	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SELECTIVE NONPEPTIDE INHIBITORS; HYDROGEN-PEROXIDE; INDUCED APOPTOSIS; LIPOIC ACID; POTENT; CELLS; SPECIFICITY; DISCOVERY; OXIDATION; FEATURES	Caspase-3 is an attractive therapeutic target for treatment of diseases involving disregulated apoptosis. We report here the mechanism of caspase-3 inactivation by isoquinoline-1,3,4-trione derivatives. Kinetic analysis indicates the compounds can irreversibly inactivate caspase-3 in a 1,4-dithiothreitol (DTT)- and oxygen-dependent manner, implying that a redox cycle might take place in the inactivation process. Reactive oxygen species detection experiments using a chemical indicator, together with electron spin resonance measurement, suggest that ROS can be generated by reaction of isoquinoline-1,3,4-trione derivatives with DTT. Oxygen-free radical scavenger catalase and superoxide dismutase eliciting the inactivation of caspase-3 by the inhibitors confirm that ROS mediates the inactivation process. Crystal structures of caspase-3 in complexes with isoquinoline-1,3,4-trione derivatives show that the catalytic cysteine is oxidized to sulfonic acid (-SO3H) and isoquinoline-1,3,4-trione derivatives are bound at the dimer interface of caspase-3. Further mutagenesis study shows that the binding of the inhibitors with caspase-3 appears to be nonspecific. Isoquinoline-1,3,4-trione derivative-catalyzed caspase-3 inactivation could also be observed when DTT is substituted with dihydrolipoic acid, which exists widely in cells and might play an important role in the in vivo inactivation process in which the inhibitors inactivate caspase-3 in cells and then prevent the cells from apoptosis. These results provide valuable information for further development of small molecular inhibitors against caspase-3 or other oxidation-sensitive proteins.	[Du, Jun-Qing; Zhang, Hua-Jie; Zhang, Ya-Hui; Qiu, Bei-Ying; Wu, Fang; Chen, Yi-Hua; Li, Jing-Ya; Nan, Fa-Jun; Li, Jia] Chinese Acad Sci, Shanghai Inst Biol Sci, Shanghai Inst Mat Med, Chinese Natl Ctr Drug Screening, 189 Guo Shou Jing Rd,Zhangjiang Hi Tech Pk, Shanghai 201203, Peoples R China; [Wu, Jian; Ding, Jian-Ping] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, State Key Lab Mol Biol, Shanghai 200031, Peoples R China; [Wu, Jian; Ding, Jian-Ping] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, Res Ctr Struct Biol, Shanghai 200031, Peoples R China	Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	Nan, FJ (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Shanghai Inst Mat Med, Chinese Natl Ctr Drug Screening, 189 Guo Shou Jing Rd,Zhangjiang Hi Tech Pk, Shanghai 201203, Peoples R China.	fjnan@mail.shcnc.ac.cn; jpding@sibs.ac.cn; jli@mail.shcnc.ac.cn	Li, Jia/F-9116-2011; li, jia/GVT-7587-2022; Chen, Yihua/A-4323-2013; Chen, Yihua/O-2743-2019; Du, Junqing/B-7803-2016	Chen, Yihua/0000-0003-1733-7980; Chen, Yihua/0000-0003-1733-7980; Du, Junqing/0000-0001-7449-1170	Ministry of Science and Technology of China [2006AA02Z112, 2006AA02A313]; National Natural Science Foundation of China [90713046, 20730028]	Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The work was supported by Ministry of Science and Technology of China Grants 2006AA02Z112 and 2006AA02A313 and National Natural Science Foundation of China Grants 90713046 and 20730028. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Afzal M, 2003, BIOCHEM BIOPH RES CO, V304, P619, DOI 10.1016/S0006-291X(03)00641-7; Agniswamy J, 2007, FEBS J, V274, P4752, DOI 10.1111/j.1742-4658.2007.05994.x; Becker JW, 2004, J MED CHEM, V47, P2466, DOI 10.1021/jm0305523; Borutaite V, 2001, FEBS LETT, V500, P114, DOI 10.1016/S0014-5793(01)02593-5; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Byun CH, 2005, J BONE MINER RES, V20, P1125, DOI 10.1359/JBMR.050302; Chen YH, 2006, J MED CHEM, V49, P1613, DOI 10.1021/jm050896o; Chu WH, 2005, J MED CHEM, V48, P7637, DOI 10.1021/jm0506625; Cohen GM, 1997, BIOCHEM J, V326, P1, DOI 10.1042/bj3260001; Copeland R. A., 2005, EVALUATION ENZYME IN; Fuentes-Prior P, 2004, BIOCHEM J, V384, P201, DOI 10.1042/BJ20041142; Guertin KR, 2003, BIOORG MED CHEM LETT, V13, P2895, DOI 10.1016/S0960-894X(03)00623-1; Guo ZM, 2001, BIOORGAN MED CHEM, V9, P99, DOI 10.1016/S0968-0896(00)00222-4; Hampton MB, 1997, FEBS LETT, V414, P552, DOI 10.1016/S0014-5793(97)01068-5; Hardy JA, 2004, P NATL ACAD SCI USA, V101, P12461, DOI 10.1073/pnas.0404781101; Hengartner MO, 2000, NATURE, V407, P770, DOI 10.1038/35037710; HENSON CP, 1964, BIOCHEMISTRY-US, V3, P338, DOI 10.1021/bi00891a007; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kravchenko DV, 2005, J MED CHEM, V48, P3680, DOI 10.1021/jm048987t; Lal M, 1997, J AM CHEM SOC, V119, P5735, DOI 10.1021/ja970744l; Lee D, 2001, J MED CHEM, V44, P2015, DOI 10.1021/jm0100537; Lee D, 2000, J BIOL CHEM, V275, P16007, DOI 10.1074/jbc.275.21.16007; Lee Y, 1999, J BIOL CHEM, V274, P19792, DOI 10.1074/jbc.274.28.19792; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; Meier P, 2000, NATURE, V407, P796, DOI 10.1038/35037734; Metzstein MM, 1998, TRENDS GENET, V14, P410, DOI 10.1016/S0168-9525(98)01573-X; Mottley C, 2001, J BIOL CHEM, V276, P42677, DOI 10.1074/jbc.M104889200; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nicholson DW, 2000, NATURE, V407, P810, DOI 10.1038/35037747; Nobel CSI, 1997, CHEM RES TOXICOL, V10, P1319, DOI 10.1021/tx970131m; Okun I, 2006, J BIOMOL SCREEN, V11, P694, DOI 10.1177/1087057106289231; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Packer L, 2001, NUTRITION, V17, P888, DOI 10.1016/S0899-9007(01)00658-X; Porter AG, 1999, CELL DEATH DIFFER, V6, P99, DOI 10.1038/sj.cdd.4400476; Reed JC, 2002, NAT REV DRUG DISCOV, V1, P111, DOI 10.1038/nrd726; REED LJ, 1974, ACCOUNTS CHEM RES, V7, P40, DOI 10.1021/ar50074a002; Salvesen GS, 1997, CELL, V91, P443, DOI 10.1016/S0092-8674(00)80430-4; Samali A, 1999, BIOCHEM BIOPH RES CO, V255, P6, DOI 10.1006/bbrc.1998.0139; Scott CW, 2003, J PHARMACOL EXP THER, V304, P433, DOI 10.1124/jpet.102.039651; Smith GK, 2002, ARCH BIOCHEM BIOPHYS, V399, P195, DOI 10.1006/abbi.2002.2757; Stefan C, 1997, CHEM RES TOXICOL, V10, P636, DOI 10.1021/tx970006a; STELLER H, 1995, SCIENCE, V267, P1445, DOI 10.1126/science.7878463; THOMPSON CB, 1995, SCIENCE, V267, P1456, DOI 10.1126/science.7878464; Thornberry NA, 1998, SCIENCE, V281, P1312, DOI 10.1126/science.281.5381.1312; TRAYNER ID, 1995, J IMMUNOL METHODS, V186, P275, DOI 10.1016/0022-1759(95)00152-Z; VAUX DL, 1994, CELL, V76, P777, DOI 10.1016/0092-8674(94)90350-6; Wang QP, 2004, BIOCHEMISTRY-US, V43, P4294, DOI 10.1021/bi035986e; WUNDERLICH M, 1993, PROTEIN SCI, V2, P717, DOI 10.1002/pro.5560020503; Zhang YH, 2006, FEBS J, V273, P4842, DOI 10.1111/j.1742-4658.2006.05483.x	49	50	55	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 31	2008	283	44					30205	30215		10.1074/jbc.M803347200	http://dx.doi.org/10.1074/jbc.M803347200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	364WS	18768468	Green Published, hybrid			2022-12-27	WOS:000260366900065
J	Leissring, MA				Leissring, Malcolm A.			The A beta Cs of A beta-cleaving Proteases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							ANGIOTENSIN-CONVERTING ENZYME; INSULIN-DEGRADING ENZYME; ALZHEIMERS-DISEASE; PROTEOLYTIC DEGRADATION; PLAQUE-FORMATION; NEPRILYSIN NEP; CATHEPSIN-B; IN-VIVO; PROTEIN; PEPTIDE	The amyloid beta-protein (A beta), which accumulates abnormally in Alzheimer disease (AD), is degraded by a diverse set of proteolytic enzymes. A beta-cleaving proteases, largely ignored until only recently, are now known to play a pivotal role in the regulation of cerebral A beta levels and amyloid plaque formation in animal models, and accumulating evidence suggests that defective A beta proteolysis may be operative in many AD cases. This review summarizes the growing body of evidence supporting the involvement of specific A beta-cleaving proteases in the etiology and potential treatment of AD. Recognition of the importance of A beta degradation to the overall economy of A beta has revised our thinking about the mechanistic basis of AD pathogenesis and identified a novel class of enzymes that may serve as both therapeutic targets and therapeutic agents.	Mayo Clin, Dept Neurosci, Jacksonville, FL 32224 USA	Mayo Clinic	Leissring, MA (corresponding author), Mayo Clin, Dept Neurosci, Jacksonville, FL 32224 USA.	leissring@mayo.edu	LEISSRING, MALCOLM/AAW-5361-2021	LEISSRING, MALCOLM/0000-0001-7185-4255				Bateman RJ, 2007, NEUROLOGY, V68, P666, DOI 10.1212/01.wnl.0000256043.50901.e3; Chen X, 2006, IUBMB LIFE, V58, P686, DOI 10.1080/15216540601047767; Eckman EA, 2001, J BIOL CHEM, V276, P24540, DOI 10.1074/jbc.M007579200; Eckman EA, 2005, BIOCHEM SOC T, V33, P1101, DOI 10.1042/BST0331101; Eckman EA, 2006, J BIOL CHEM, V281, P30471, DOI 10.1074/jbc.M605827200; Falkevall A, 2006, J BIOL CHEM, V281, P29096, DOI 10.1074/jbc.M602532200; Farris W, 2003, P NATL ACAD SCI USA, V100, P4162, DOI 10.1073/pnas.0230450100; Farris W, 2007, AM J PATHOL, V171, P241, DOI 10.2353/ajpath.2007.070105; Frautschy SA, 1998, J NEUROSCI, V18, P8311; Hemming ML, 2007, PLOS MED, V4, P1405, DOI 10.1371/journal.pmed.0040262; Hemming ML, 2007, NEUROBIOL DIS, V26, P273, DOI 10.1016/j.nbd.2007.01.004; Hersh LB, 2006, CELL MOL LIFE SCI, V63, P2432, DOI 10.1007/s00018-006-6238-9; Hu JG, 2001, J BIOL CHEM, V276, P47863, DOI 10.1074/jbc.M104068200; Iwata N, 2000, NAT MED, V6, P143, DOI 10.1038/72237; Iwata N, 2001, SCIENCE, V292, P1550, DOI 10.1126/science.1059946; Jacobsen JS, 2008, P NATL ACAD SCI USA, V105, P8754, DOI 10.1073/pnas.0710823105; Jiang Q, 2008, NEURON, V58, P681, DOI 10.1016/j.neuron.2008.04.010; Kanemitsu H, 2003, NEUROSCI LETT, V350, P113, DOI 10.1016/S0304-3940(03)00898-X; Leissring MA, 2003, NEURON, V40, P1087, DOI 10.1016/S0896-6273(03)00787-6; Leissring MA, 2004, BIOCHEM J, V383, P439, DOI 10.1042/BJ20041081; Leissring MA, 2007, ADV GENETICS MOL CEL, P157; Leissring Malcolm A., 2006, Current Alzheimer Research, V3, P431, DOI 10.2174/156720506779025206; Marr RA, 2004, J MOL NEUROSCI, V22, P5, DOI 10.1385/JMN:22:1-2:5; Melchor JP, 2003, J NEUROSCI, V23, P8867; Miners JS, 2008, BRAIN PATHOL, V18, P240, DOI 10.1111/j.1750-3639.2008.00132.x; Mort JS, 1997, INT J BIOCHEM CELL B, V29, P715, DOI 10.1016/S1357-2725(96)00152-5; Mueller-Steiner S, 2006, NEURON, V51, P703, DOI 10.1016/j.neuron.2006.07.027; Myohanen H, 2004, CELL MOL LIFE SCI, V61, P2840, DOI 10.1007/s00018-004-4230-9; Neant-Fery M, 2008, P NATL ACAD SCI USA, V105, P9582, DOI 10.1073/pnas.0801261105; Portelius E, 2006, NEUROSCI LETT, V409, P215, DOI 10.1016/j.neulet.2006.09.044; Qiu WQ, 1997, J BIOL CHEM, V272, P6641, DOI 10.1074/jbc.272.10.6641; Roques BP, 1998, PATHOL BIOL, V46, P191; Selkoe DJ, 2003, ANNU REV PHARMACOL, V43, P545, DOI 10.1146/annurev.pharmtox.43.100901.140248; Selkoe DJ, 2001, NEURON, V32, P177, DOI 10.1016/S0896-6273(01)00475-5; Selkoe DJ, 1997, SCIENCE, V275, P630, DOI 10.1126/science.275.5300.630; Serretti A, 2007, J ALZHEIMERS DIS, V12, P73; Tucker HM, 2000, J NEUROCHEM, V75, P2172, DOI 10.1046/j.1471-4159.2000.0752172.x; Tucker HM, 2004, NEUROSCI LETT, V368, P285, DOI 10.1016/j.neulet.2004.07.011; Tucker HM, 2000, J NEUROSCI, V20, P3937; Turner AJ, 2007, INT REV NEUROBIOL, V82, P113, DOI 10.1016/S0074-7742(07)82006-X; Turner AJ, 2006, CELL MOL BIOL, V52, P40, DOI 10.1170/T725; Turner AJ, 2001, BIOESSAYS, V23, P261, DOI 10.1002/1521-1878(200103)23:3<261::AID-BIES1036>3.0.CO;2-K; Van Nostrand WE, 1999, BIOCHEMISTRY-US, V38, P11570, DOI 10.1021/bi990610f; Vartak DG, 2007, J DRUG TARGET, V15, P1, DOI 10.1080/10611860600968967; Vekrellis K, 2000, J NEUROSCI, V20, P1657; Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a; Wang DS, 2006, J BIOMED BIOTECHNOL, DOI 10.1155/JBB/2006/58406; White AR, 2006, J BIOL CHEM, V281, P17670, DOI 10.1074/jbc.M602487200; Yin KJ, 2006, J NEUROSCI, V26, P10939, DOI 10.1523/JNEUROSCI.2085-06.2006	49	71	75	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 31	2008	283	44					29645	29649		10.1074/jbc.R800022200	http://dx.doi.org/10.1074/jbc.R800022200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	364WS	18723506	hybrid, Green Published			2022-12-27	WOS:000260366900007
J	Mio, K; Ogura, T; Mio, M; Shimizu, H; Hwang, TC; Sato, C; Sohma, Y				Mio, Kazuhiro; Ogura, Toshihiko; Mio, Muneyo; Shimizu, Hiroyasu; Hwang, Tzyh-Chang; Sato, Chikara; Sohma, Yoshiro			Three-dimensional Reconstruction of Human Cystic Fibrosis Transmembrane Conductance Regulator Chloride Channel Revealed an Ellipsoidal Structure with Orifices beneath the Putative Transmembrane Domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AUTOMATIC PARTICLE PICKUP; BLUE NATIVE ELECTROPHORESIS; MEMBRANE-PROTEIN COMPLEXES; NUCLEOTIDE-BINDING; PLASMA-MEMBRANE; FUNCTIONAL UNIT; NEURAL-NETWORK; CFTR; PORE; PURIFICATION	The cystic fibrosis transmembrane conductance regulator ( CFTR) chloride channel is a membrane-integral protein that belongs to an ATP-binding cassette superfamily. Mutations in the CFTR gene cause cystic fibrosis in which salt, water, and protein transports are defective in various tissues. Here we expressed wild-type human CFTR as a FLAG-fused protein in HEK293 cells heterologously and purified it in three steps: anti-FLAG and wheat germ agglutinin affinity chromatographies and size exclusion chromatography. The stoichiometry of the protein was analyzed using various biochemical approaches, including chemical cross-linking, blue-native PAGE, size exclusion chromatography, and electron microscopy ( EM) observation of antibody-decorated CFTR. All these data support a dimeric assembly of CFTR. Using 5,039 automatically selected particles from negatively stained EM images, the three-dimensional structure of CFTR was reconstructed at 2-nm resolution assuming a 2-fold symmetry. CFTR, presumably in a closed state, was shown to be an ellipsoidal particle with dimensions of 120 x 106 x 162 angstrom. It comprises a small dome-shaped extracellular and membrane-spanning domain and a large cytoplasmic domain with orifices beneath the putative transmembrane domain. EM observation of CFTR.anti-regulatory domain antibody complex confirmed that two regulatory domains are located around the bottom end of the larger oval cytoplasmic domain.	[Mio, Kazuhiro; Ogura, Toshihiko; Mio, Muneyo; Sato, Chikara] Natl Inst Adv Ind Sci & Technol, Neurosci Res Inst, Tsukuba, Ibaraki 3058568, Japan; [Ogura, Toshihiko] Japan Sci & Technol Agcy, PRESTO, Saitama 3320012, Japan; [Shimizu, Hiroyasu; Hwang, Tzyh-Chang; Sohma, Yoshiro] Univ Missouri, John M Dalton Cardiovasc Res Ctr, Columbia, MO 65211 USA; [Shimizu, Hiroyasu] Osaka Med Coll, Dept Hyg & Publ Hlth, Osaka 5698686, Japan; [Sohma, Yoshiro] Osaka Med Coll, Dept Physiol, Osaka 5698686, Japan; [Sohma, Yoshiro] Keio Univ, Sch Med, Dept Pharmacol, Shinjyuku Ku, Tokyo 1608582, Japan	National Institute of Advanced Industrial Science & Technology (AIST); Japan Science & Technology Agency (JST); University of Missouri System; University of Missouri Columbia; Osaka Medical College; Osaka Medical College; Keio University	Sato, C (corresponding author), Natl Inst Adv Ind Sci & Technol, Neurosci Res Inst, Umezono 1-1-4, Tsukuba, Ibaraki 3058568, Japan.	ti-sato@aist.go.jp	Sohma, Yoshiro/K-9058-2013; Mio, Kazuhiro/L-7488-2018; Sato, Chikara/M-7183-2016; Ogura, Toshihiko/M-4089-2018	Mio, Kazuhiro/0000-0002-1655-8231; Sato, Chikara/0000-0001-5543-4496; 	National Institutes of Health [R01 DK55835-09, R01 HL53445-11]; Japan New Energy and Industrial Technology Development Organization (NEDO); Japan Science and Technology Agency; Japan Society for the Promotion of Science (JSPS) [19590215]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL053445] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK055835] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Japan New Energy and Industrial Technology Development Organization (NEDO)(New Energy and Industrial Technology Development Organization (NEDO)); Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 DK55835-09 and R01 HL53445-11 (to T.-C. H.). This work was also supported by a grant-in-aid for scientific research on priority areas, structure of biological macromolecular assemblies ( to K. M. and C. S.); by a grant from the Japan New Energy and Industrial Technology Development Organization (NEDO) (to C. S.); by a grant from PRESTO of the Japan Science and Technology Agency (to T. O.); and by Japan Society for the Promotion of Science (JSPS) Grant 19590215 (to Y. S.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Awayn NH, 2005, BIOCHEM SOC T, V33, P996, DOI 10.1042/BST0330996; Baker JMR, 2007, NAT STRUCT MOL BIOL, V14, P738, DOI 10.1038/nsmb1278; BEAR CE, 1992, CELL, V68, P809, DOI 10.1016/0092-8674(92)90155-6; Bhattacharya S K, 1995, J Indian Med Assoc, V93, P237; Bompadre SG, 2005, J GEN PHYSIOL, V125, P361, DOI 10.1085/jgp.200409227; Bompadre SG, 2005, J GEN PHYSIOL, V125, P377, DOI 10.1085/jgp.200409228; Bompadre SG, 2007, J GEN PHYSIOL, V129, P285, DOI 10.1085/jgp.200609667; Chen JH, 2002, J MEMBRANE BIOL, V188, P55, DOI 10.1007/s00232-001-0174-2; Chen TY, 2008, PHYSIOL REV, V88, P351, DOI 10.1152/physrev.00058.2006; CHENG SH, 1990, CELL, V63, P827, DOI 10.1016/0092-8674(90)90148-8; Davidson AL, 2004, ANNU REV BIOCHEM, V73, P241, DOI 10.1146/annurev.biochem.73.011303.073626; DENNING GM, 1992, J CLIN INVEST, V89, P339, DOI 10.1172/JCI115582; Eskandari S, 1998, P NATL ACAD SCI USA, V95, P11235, DOI 10.1073/pnas.95.19.11235; Frank J, 2006, 3 DIMENSIONAL ELECT; GABRIEL SE, 1994, SCIENCE, V266, P107, DOI 10.1126/science.7524148; Gadsby David C., 1999, Physiological Reviews, V79, pS77; GRAHAM FL, 1973, VIROLOGY, V52, P456, DOI 10.1016/0042-6822(73)90341-3; HARAUZ G, 1986, OPTIK, V73, P146; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAURENT TC, 1964, J CHROMATOGR, V14, P317, DOI 10.1016/S0021-9673(00)86637-6; Lewis HA, 2005, J BIOL CHEM, V280, P1346, DOI 10.1074/jbc.M410968200; Lewis HA, 2004, EMBO J, V23, P282, DOI 10.1038/sj.emboj.7600040; Long SB, 2005, SCIENCE, V309, P897, DOI 10.1126/science.1116269; Mendoza JL, 2007, J BIOENERG BIOMEMBR, V39, P499, DOI 10.1007/s10863-007-9117-7; Mio K, 2005, BIOCHEM BIOPH RES CO, V333, P768, DOI 10.1016/j.bbrc.2005.05.181; O'Riordan CR, 2000, GLYCOBIOLOGY, V10, P1225, DOI 10.1093/glycob/10.11.1225; Ogura T, 2003, J STRUCT BIOL, V143, P185, DOI 10.1016/j.jsb.2003.08.005; Ogura T, 2004, J STRUCT BIOL, V145, P63, DOI 10.1016/S1047-8477(03)00139-4; Ogura T, 2004, J STRUCT BIOL, V146, P344, DOI 10.1016/j.jsb.2004.01.007; Ogura T, 2001, J STRUCT BIOL, V136, P227, DOI 10.1006/jsbi.2002.4442; Ogura T, 2006, J STRUCT BIOL, V156, P371, DOI 10.1016/j.jsb.2006.05.016; PENCZEK P, 1992, ULTRAMICROSCOPY, V40, P33, DOI 10.1016/0304-3991(92)90233-A; PENCZEK PA, 1994, ULTRAMICROSCOPY, V53, P251, DOI 10.1016/0304-3991(94)90038-8; Raghuram V, 2001, P NATL ACAD SCI USA, V98, P1300, DOI 10.1073/pnas.031538898; Ramjeesingh M, 2003, BIOCHEM J, V374, P793, DOI 10.1042/BJ20030683; Ramjeesingh M, 2001, BIOCHEMISTRY-US, V40, P10700, DOI 10.1021/bi0108195; RIORDAN JR, 1989, SCIENCE, V245, P1066; RIORDAN JR, 2005, ANNU REV PHYSIOL, V68, P809; Rosenberg MF, 2004, J BIOL CHEM, V279, P39051, DOI 10.1074/jbc.M407434200; Sato C, 2001, NATURE, V409, P1047, DOI 10.1038/35059098; SCHAGGER H, 1994, ANAL BIOCHEM, V217, P220, DOI 10.1006/abio.1994.1112; SCHAGGER H, 1991, ANAL BIOCHEM, V199, P223, DOI 10.1016/0003-2697(91)90094-A; Schillers H, 2004, CELL PHYSIOL BIOCHEM, V14, P1, DOI 10.1159/000076921; Sears CL, 1996, MICROBIOL REV, V60, P167, DOI 10.1128/MMBR.60.1.167-215.1996; STECK T L, 1973, Journal of Supramolecular Structure, V1, P220, DOI 10.1002/jss.400010307; Tsui LC, 1997, HOSP PRACT, V32, P115, DOI 10.1080/21548331.1997.11443512; van Heel M, 2000, Q REV BIOPHYS, V33, P307, DOI 10.1017/S0033583500003644; vanHeel M, 1996, J STRUCT BIOL, V116, P17, DOI 10.1006/jsbi.1996.0004; Vergani P, 2005, NATURE, V433, P876, DOI 10.1038/nature03313; Wang XD, 2006, CELL, V127, P803, DOI 10.1016/j.cell.2006.09.043; WELSH MJ, 1993, CELL, V73, P1251, DOI 10.1016/0092-8674(93)90353-R; Yazawa M, 2007, NATURE, V448, P78, DOI 10.1038/nature05928; Zerhusen B, 1999, J BIOL CHEM, V274, P7627, DOI 10.1074/jbc.274.12.7627; Zhang ZR, 2005, J BIOL CHEM, V280, P458, DOI 10.1074/jbc.M409626200; Zhou Z, 2005, J PHYSIOL-LONDON, V569, P447, DOI 10.1113/jphysiol.2005.095083; Zhou Z, 2006, J GEN PHYSIOL, V128, P413, DOI 10.1085/jgp.200609622	56	35	37	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 31	2008	283	44					30300	30310		10.1074/jbc.M803185200	http://dx.doi.org/10.1074/jbc.M803185200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	364WS	18723516	Green Published, hybrid			2022-12-27	WOS:000260366900074
J	Marobbio, CMT; Giannuzzi, G; Paradies, E; Pierri, CL; Palmieri, F				Marobbio, Carlo M. T.; Giannuzzi, Giulia; Paradies, Eleonora; Pierri, Ciro L.; Palmieri, Ferdinando			alpha-isopropylmalate, a leucine biosynthesis intermediate in yeast, is transported by the mitochondrial oxalacetate carrier	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMINO-ACID-RESIDUES; SACCHAROMYCES-CEREVISIAE; FUNCTIONAL RECONSTITUTION; SUBCELLULAR-LOCALIZATION; OXOGLUTARATE CARRIER; BACTERIAL EXPRESSION; BOVINE MITOCHONDRIA; PHOSPHATE CARRIER; GENE-EXPRESSION; STRUCTURAL ROLE	In Saccharomyces cerevisiae, alpha-isopropylmalate (alpha-IPM), which is produced in mitochondria, must be exported to the cytosol where it is required for leucine biosynthesis. Recombinant and reconstituted mitochondrial oxalacetate carrier (Oac1p) efficiently transported alpha-IPM in addition to its known substrates oxalacetate, sulfate, and malonate and in contrast to other di- and tricarboxylate transporters as well as the previously proposed alpha-IPM transporter. Transport was saturable with a half-saturation constant of 75 +/- 4 mu M for alpha-IPM and 0.31 +/- 0.04 mM for alpha-IPM and was inhibited by the substrates of Oac1p. Though not transported, alpha-ketoisocaproate, the immediate precursor of leucine in the biosynthetic pathway, inhibited Oac1p activity competitively. In contrast, leucine, alpha-ketoisovalerate, valine, and isoleucine neither inhibited nor were transported by Oac1p. Consistent with the function of Oac1p as an alpha-IPM transporter, cells lacking the gene for this carrier required leucine for optimal growth on fermentable carbon sources. Single deletions of other mitochondrial carrier genes or of LEU4, which is the only other enzyme that can provide the cytosol with alpha-IPM (in addition to Oac1p) exhibited no growth defect, whereas the double mutant Delta OAC1 Delta LEU4 did not grow at all on fermentable substrates in the absence of leucine. The lack of growth of Delta OAC1 Delta LEU4 cells was partially restored by adding the leucine biosynthetic cytosolic intermediates alpha-ketoisocaproate and alpha-IPM to these cells as well as by complementing them with one of the two unknown human mitochondrial carriers SLC25A34 and SLC25A35. Oac1p is important for leucine biosynthesis on fermentable carbon sources catalyzing the export of alpha-IPM, probably in exchange for oxalacetate.	[Marobbio, Carlo M. T.; Giannuzzi, Giulia; Paradies, Eleonora; Pierri, Ciro L.; Palmieri, Ferdinando] Univ Bari, Dept Pharmacobiol, Biochem & Mol Biol Lab, I-70125 Bari, Italy; [Palmieri, Ferdinando] CNR, Inst Biomembranes & Bioenerget, I-70125 Bari, Italy	Universita degli Studi di Bari Aldo Moro; Consiglio Nazionale delle Ricerche (CNR)	Palmieri, F (corresponding author), Via Orabona 4, I-70125 Bari, Italy.	fpalm@farmbiol.uniba.it	MAROBBIO, Carlo/G-5775-2015; Pierri, Ciro Leonardo L/G-4753-2013; Paradies, Eleonora/K-4606-2014	MAROBBIO, Carlo/0000-0002-2516-0321; Pierri, Ciro Leonardo L/0000-0003-1816-548X; Paradies, Eleonora/0000-0002-1668-7148	Ministero dell'Universita e della Ricerca (MUR); Center of Excellence in Genomics (CEGBA); European Commission [LSHM-CT-2004503116]; University local funds	Ministero dell'Universita e della Ricerca (MUR)(Ministry of Education, Universities and Research (MIUR)); Center of Excellence in Genomics (CEGBA); European Commission(European CommissionEuropean Commission Joint Research Centre); University local funds	This work was supported by grants from Ministero dell'Universita e della Ricerca (MUR), the Center of Excellence in Genomics (CEGBA) and Apulia Region, a contract from the European Commission (LSHM-CT-2004503116), and University local funds. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Boer VM, 2005, FEMS YEAST RES, V5, P885, DOI 10.1016/j.femsyr.2005.04.003; Brachmann CB, 1998, YEAST, V14, P115; Cappello AR, 2007, J MOL BIOL, V369, P400, DOI 10.1016/j.jmb.2007.03.048; Cappello AR, 2006, J MOL BIOL, V363, P51, DOI 10.1016/j.jmb.2006.08.041; Casalone E, 2000, YEAST, V16, P539, DOI 10.1002/(SICI)1097-0061(200004)16:6<539::AID-YEA547>3.0.CO;2-K; Catoni E, 2003, FEBS LETT, V534, P87, DOI 10.1016/S0014-5793(02)03782-1; DeRisi JL, 1997, SCIENCE, V278, P680, DOI 10.1126/science.278.5338.680; Fiermonte G, 1998, J BIOL CHEM, V273, P22782, DOI 10.1074/jbc.273.35.22782; FIERMONTE G, 1993, BIOCHEM J, V294, P293, DOI 10.1042/bj2940293; Gasch AP, 2000, MOL BIOL CELL, V11, P4241, DOI 10.1091/mbc.11.12.4241; Giangregorio N, 2007, BBA-BIOENERGETICS, V1767, P1331, DOI 10.1016/j.bbabio.2007.08.010; Goldstein AL, 1999, YEAST, V15, P1541, DOI 10.1002/(SICI)1097-0061(199910)15:14<1541::AID-YEA476>3.3.CO;2-B; Haitina T, 2006, GENOMICS, V88, P779, DOI 10.1016/j.ygeno.2006.06.016; Hoyos ME, 2003, PLANT J, V33, P1027, DOI 10.1046/j.1365-313X.2003.01685.x; Jansen G, 2005, GENE, V344, P43, DOI 10.1016/j.gene.2004.10.016; KAPLAN RS, 1993, J BIOL CHEM, V268, P13682; KAPLAN RS, 1995, J BIOL CHEM, V270, P4108, DOI 10.1074/jbc.270.8.4108; Klingenberg M, 2005, BIOCHEMISTRY-US, V44, P8563, DOI 10.1021/bi050543r; Kohlhaw GB, 2003, MICROBIOL MOL BIOL R, V67, P1, DOI 10.1128/MMBR.67.1.1-15.2003; Kovaleva Galina Yu., 2006, Journal of Bioinformatics and Computational Biology, V4, P981, DOI 10.1142/S0219720006002284; Kumar A, 2002, GENE DEV, V16, P707, DOI 10.1101/gad.970902; Marobbio CMT, 2003, EMBO J, V22, P5975, DOI 10.1093/emboj/cdg574; Meisinger C, 2000, ANAL BIOCHEM, V287, P339, DOI 10.1006/abio.2000.4868; Miotto G, 2007, FUNGAL GENET BIOL, V44, P740, DOI 10.1016/j.fgb.2006.12.004; Palmieri F, 2004, PFLUG ARCH EUR J PHY, V447, P689, DOI 10.1007/s00424-003-1099-7; Palmieri F, 1995, METHOD ENZYMOL, V260, P349, DOI 10.1016/0076-6879(95)60150-3; Palmieri F, 2006, BBA-BIOENERGETICS, V1757, P1249, DOI 10.1016/j.bbabio.2006.05.023; Palmieri L, 1999, J BIOL CHEM, V274, P22184, DOI 10.1074/jbc.274.32.22184; Palmieri L, 1997, FEBS LETT, V417, P114, DOI 10.1016/S0014-5793(97)01269-6; Palmieri L, 1996, FEBS LETT, V399, P299, DOI 10.1016/S0014-5793(96)01350-6; Palmieri L, 2001, EMBO J, V20, P5060, DOI 10.1093/emboj/20.18.5060; Pebay-Peyroula E, 2003, NATURE, V426, P39, DOI 10.1038/nature02056; Robinson AJ, 2006, P NATL ACAD SCI USA, V103, P2617, DOI 10.1073/pnas.0509994103; RYAN ED, 1973, J BACTERIOL, V116, P222, DOI 10.1128/JB.116.1.222-225.1973; Schroers A, 1997, J BIOL CHEM, V272, P10558; SHERMAN F, 1991, METHOD ENZYMOL, V194, P3; SIKORSKI RS, 1989, GENETICS, V122, P19	37	56	67	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 17	2008	283	42					28445	28453		10.1074/jbc.M804637200	http://dx.doi.org/10.1074/jbc.M804637200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	359EN	18682385	Green Published, hybrid			2022-12-27	WOS:000259969300046
J	Wegener, KM; Welsh, EA; Thornton, LE; Keren, N; Jacobs, JM; Hixson, KK; Monroe, ME; Camp, DG; Smith, RD; Pakrasi, HB				Wegener, Kimberly M.; Welsh, Eric A.; Thornton, Leeann E.; Keren, Nir; Jacobs, Jon M.; Hixson, Kim K.; Monroe, Matthew E.; Camp, David G., II; Smith, Richard D.; Pakrasi, Himadri B.			High sensitivity proteomics assisted discovery of a novel operon involved in the assembly of photosystem II, a membrane protein complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FTICR MASS-SPECTROMETRY; PSBQ PROTEIN; FUNCTIONAL-CHARACTERIZATION; OXYGEN EVOLUTION; SIGNAL PEPTIDES; CHLOROPHYLL-A; SYNECHOCYSTIS; ARCHITECTURE; LIPOPROTEIN; PREDICTION	Photosystem II (PSII) is a large membrane protein complex that performs the water oxidation reactions of photosynthesis in cyanobacteria, algae, and plants. The unusual redox reactions in PSII often lead to damage, degradation, and reassembly of this molecular machine. To identify novel assembly factors, high sensitivity proteomic analysis of PSII purified from the cyanobacterium Synechocystis sp. PCC6803 was performed. This analysis identified six PSII-associated proteins that are encoded by an operon containing nine genes, slr0144 to slr0152. This operon encodes proteins that are not essential components of the PSII holocomplex but accumulate to high levels in pre-complexes lacking any of the lumenal proteins PsbP, PsbQ, or PsbV. The operon contains genes with putative binding domains for chlorophylls and bilins, suggesting these proteins may function as a reservoir for cofactors needed during the PSII lifecycle. Genetic deletion of this operon shows that removal of these protein products does not alter photoautotrophic growth or PSII fluorescence properties. However, the deletion does result in decreased PSII-mediated oxygen evolution and an altered distribution of the S states of the catalytic manganese cluster. These data demonstrate that the proteins encoded by the genes in this operon are necessary for optimal function of PSII and function as accessory proteins during assembly of the PSII complex. Thus, we have named the products of the slr0144-slr0152 operon Pap (Photosystem II assembly proteins).	[Wegener, Kimberly M.; Welsh, Eric A.; Thornton, Leeann E.; Keren, Nir; Pakrasi, Himadri B.] Washington Univ, Dept Biol, St Louis, MO 63130 USA; [Jacobs, Jon M.; Hixson, Kim K.; Monroe, Matthew E.; Camp, David G., II; Smith, Richard D.] Pacific NW Natl Lab, Environm Mol Sci Biol Sci Div & Lab, Richland, WA 99352 USA	Washington University (WUSTL); United States Department of Energy (DOE); Pacific Northwest National Laboratory	Pakrasi, HB (corresponding author), Washington Univ, Dept Biol, CB 1137, St Louis, MO 63130 USA.	Pakrasi@wustl.edu	Monroe, Matthew/L-1157-2019; Hixson, Kim/AAW-2332-2020; Keren, Nir/GON-9181-2022; Hixson, Kim/AAJ-7714-2020; Smith, Richard D/J-3664-2012	Hixson, Kim/0000-0003-3915-7040; Hixson, Kim/0000-0003-3716-0326; Smith, Richard D/0000-0002-2381-2349; Keren, Nir/0000-0002-7356-8831	National Science Foundation [MCB0745611]; W. R. Wiley Environmental Molecular Sciences Laboratory,; United States Department of Energy Office of Biological and Environmental Research program, located at Pacific Northwest National Laboratory; Direct For Biological Sciences [0745611] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); W. R. Wiley Environmental Molecular Sciences Laboratory,; United States Department of Energy Office of Biological and Environmental Research program, located at Pacific Northwest National Laboratory; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by National Science Foundation Grant MCB0745611 (to H. B. P.) and by funds from a Membrane Biology EMSL Scientific Grand Challenge project at the W. R. Wiley Environmental Molecular Sciences Laboratory, a national scientific user facility sponsored by the United States Department of Energy Office of Biological and Environmental Research program, located at Pacific Northwest National Laboratory. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Abr?moff M.D., 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; ALLEN MM, 1968, J PHYCOL, V4, P1, DOI 10.1111/j.1529-8817.1968.tb04667.x; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Anantharaman V, 2001, J MOL BIOL, V307, P1271, DOI 10.1006/jmbi.2001.4508; Andersson B, 2001, ADV PHOTOSYNTH, V11, P377; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Bogdanov B, 2005, MASS SPECTROM REV, V24, P168, DOI 10.1002/mas.20015; Bricker TM, 1998, BBA-BIOENERGETICS, V1409, P50, DOI 10.1016/S0005-2728(98)00148-0; ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2; Ferreira KN, 2004, SCIENCE, V303, P1831, DOI 10.1126/science.1093087; Harkewicz R, 2002, J AM SOC MASS SPECTR, V13, P144, DOI 10.1016/S1044-0305(01)00343-9; Ifuku K, 2005, PLANT PHYSIOL, V139, P1175, DOI 10.1104/pp.105.068643; Inoue-Kashino N, 2005, BIOCHEMISTRY-US, V44, P12214, DOI 10.1021/bi047539k; Juncker AS, 2003, PROTEIN SCI, V12, P1652, DOI 10.1110/ps.0303703; Kashino Y, 2002, BIOCHEMISTRY-US, V41, P8004, DOI 10.1021/bi026012+; Kashino Y, 2007, BBA-BIOENERGETICS, V1767, P1269, DOI 10.1016/j.bbabio.2007.08.008; Kashino Y, 2007, J CHROMATOGR B, V849, P282, DOI 10.1016/j.jchromb.2006.10.067; Kashino Y, 2006, J BIOL CHEM, V281, P20834, DOI 10.1074/jbc.M603188200; Keren N, 2005, PLANT CELL, V17, P2768, DOI 10.1105/tpc.105.035048; Keren N, 2005, J BIOL CHEM, V280, P6548, DOI 10.1074/jbc.M410218200; Loll B, 2005, NATURE, V438, P1040, DOI 10.1038/nature04224; Mamedov F, 2007, BIOCHEMISTRY-US, V46, P5542, DOI 10.1021/bi7000399; MANNAN RM, 1993, PLANT PHYSIOL, V103, P971, DOI 10.1104/pp.103.3.971; MEUNIER PC, 1993, PHOTOSYNTH RES, V36, P111, DOI 10.1007/BF00016276; Muller B, 1999, PLANT CELL, V11, P2365, DOI 10.1105/tpc.11.12.2365; Nakamura Y, 1998, NUCLEIC ACIDS RES, V26, P63, DOI 10.1093/nar/26.1.63; Nowaczyk MM, 2006, PLANT CELL, V18, P3121, DOI 10.1105/tpc.106.042671; Ogawa T, 2002, J BIOL CHEM, V277, P28981, DOI 10.1074/jbc.M204175200; Page JS, 2004, CURR OPIN BIOTECH, V15, P3, DOI 10.1016/j.copbio.2004.01.002; PORRA RJ, 1989, BIOCHIM BIOPHYS ACTA, V975, P384, DOI 10.1016/S0005-2728(89)80347-0; Rokka A, 2005, BIOCHEM J, V388, P159, DOI 10.1042/BJ20042098; Roose JL, 2004, J BIOL CHEM, V279, P45417, DOI 10.1074/jbc.M408458200; Roose JL, 2007, P NATL ACAD SCI USA, V104, P2548, DOI 10.1073/pnas.0609337104; Seidler A, 1996, BBA-BIOENERGETICS, V1277, P35, DOI 10.1016/S0005-2728(96)00102-8; Shen JR, 1998, BIOCHEMISTRY-US, V37, P1551, DOI 10.1021/bi971676i; Singh AK, 2004, PHYSIOL PLANTARUM, V120, P27, DOI 10.1111/j.0031-9317.2004.0232.x; Thornton LE, 2004, PLANT CELL, V16, P2164, DOI 10.1105/tpc.104.023515; THORNTON LE, 2005, LIGHT DRIVEN WATER P; Vavilin D, 2007, BBA-BIOENERGETICS, V1767, P920, DOI 10.1016/j.bbabio.2007.03.010; Zhang LX, 2002, FEBS LETT, V512, P13, DOI 10.1016/S0014-5793(02)02218-4	41	35	35	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 10	2008	283	41					27829	27837		10.1074/jbc.M803918200	http://dx.doi.org/10.1074/jbc.M803918200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	355OW	18693241	hybrid			2022-12-27	WOS:000259719200054
J	dos Santos, CO; Dore, LC; Valentine, E; Shelat, SG; Hardison, RC; Ghosh, M; Wang, W; Eisenstein, RS; Costa, FF; Weiss, MJ				dos Santos, Camila O.; Dore, Louis C.; Valentine, Eric; Shelat, Suresh G.; Hardison, Ross C.; Ghosh, Manik; Wang, Wei; Eisenstein, Richard S.; Costa, Fernando F.; Weiss, Mitchell J.			An iron responsive element-like stem-loop regulates alpha-hemoglobin-stabilizing protein mRNA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LOCUS-CONTROL REGION; BINDING-PROTEIN; BETA-THALASSEMIA; HIGH-AFFINITY; HAIRPIN LOOP; ERYTHROID-DIFFERENTIATION; TRANSLATIONAL REGULATION; 5'-UNTRANSLATED REGION; 3'-UNTRANSLATED REGION; DEPENDENT REGULATION	Hemoglobin production during erythropoiesis is mechanistically coupled to the acquisition and metabolism of iron. We discovered that iron regulates the expression of alpha-hemoglobin-stabilizing protein (AHSP), a molecular chaperone that binds and stabilizes free alpha-globin during hemoglobin synthesis. In primates, the 3 '-untranslated region (UTR) of AHSP mRNA contains a nucleotide sequence resembling iron responsive elements (IREs), stem-loop structures that regulate gene expression post-transcriptionally by binding iron regulatory proteins (IRPs). The AHSP IRE-like stem-loop deviates from classical consensus sequences and binds IRPs poorly in electrophoretic mobility shift assays. However, in cytoplasmic extracts, AHSP mRNA co-immunoprecipitates with IRPs in a fashion that is dependent on the stem-loop structure and inhibited by iron. Moreover, this interaction enhances AHSP mRNA stability in erythroid and heterologous cells. Our findings demonstrate that IRPs can regulate mRNA expression through non-canonical IREs and extend the repertoire of known iron-regulated genes. In addition, we illustrate a new mechanism through which hemoglobin may be modulated according to iron status.	[dos Santos, Camila O.; Dore, Louis C.; Valentine, Eric; Weiss, Mitchell J.] Childrens Hosp Philadelphia, Div Hematol, Philadelphia, PA 19104 USA; [Shelat, Suresh G.] Childrens Hosp Philadelphia, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; [Hardison, Ross C.] Penn State Univ, Dept Biochem & Mol Biol, Ctr Comparat Genom & Bioinformat, University Pk, PA 16802 USA; [Ghosh, Manik] NICHD, NIH, Cell Biol & Metab Branch, Bethesda, MD 20892 USA; [Wang, Wei] Wake Forest Univ Hlth Sci, Dept Biochem, Winston Salem, NC 27157 USA; [Eisenstein, Richard S.] Univ Wisconsin, Dept Nutr Sci, Madison, WI 53706 USA; [Costa, Fernando F.] Univ Estadual Campinas, Ctr Hemotherapy & Hematol, Sao Paulo, Brazil	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); Wake Forest University; Wake Forest University School of Medicine; University of Wisconsin System; University of Wisconsin Madison; Universidade Estadual de Campinas	Weiss, MJ (corresponding author), Childrens Hosp Philadelphia, Div Hematol, 3615 Civ Ctr Blvd, Philadelphia, PA 19104 USA.	weissmi@email.chop.edu	Weiss, Mitchell J/W-9814-2018; Costa, Fernando F/D-1566-2012; Weiss, Mitchell J/A-1245-2013; Hardison, Ross C/G-1142-2010; Dore, Louis/A-5689-2009	Weiss, Mitchell J/0000-0003-2460-3036; Costa, Fernando F/0000-0002-4632-572X; Hardison, Ross C/0000-0003-4084-7516; Dore, Louis/0000-0002-7837-5887	National Institutes of Health [R01 DK61692, R01 HL087427, R01 DK65806, R01 DK66600]; American Heart Association Postdoctoral Fellowship Award [4247620608]; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [02/13801-7]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL087427] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK061692, R01DK065806, R01DK066600] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association Postdoctoral Fellowship Award(American Heart Association); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 DK61692 and R01 HL087427 (to M.J.W.), R01 DK65806 (to R. C. H.), and R01 DK66600 (to R. S. E.). This work was also supported by an American Heart Association Postdoctoral Fellowship Award (Grant 4247620608) (to C.O.S.), by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) (Grant 02/13801-7) (to F. F. C.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Allerson CR, 1999, J BIOL CHEM, V274, P26439, DOI 10.1074/jbc.274.37.26439; BARTON HA, 1990, J BIOL CHEM, V265, P7000; BENBASSA.I, 1974, BLOOD, V44, P551, DOI 10.1182/blood.V44.4.551.551; Beutler Ernest, 2003, Hematology Am Soc Hematol Educ Program, P40; BINDER R, 1994, EMBO J, V13, P1969, DOI 10.1002/j.1460-2075.1994.tb06466.x; Brown NM, 1998, P NATL ACAD SCI USA, V95, P15235, DOI 10.1073/pnas.95.26.15235; Butt J, 1996, P NATL ACAD SCI USA, V93, P4345, DOI 10.1073/pnas.93.9.4345; CASEY JL, 1988, SCIENCE, V240, P924, DOI 10.1126/science.2452485; CAUGHMAN SW, 1988, J BIOL CHEM, V263, P19048; Chen JJ, 2007, BLOOD, V109, P2693, DOI 10.1182/blood-2006-08-041830; Cmejla R, 2006, BIOCHEM BIOPH RES CO, V341, P158, DOI 10.1016/j.bbrc.2005.12.155; DANDEKAR T, 1991, EMBO J, V10, P1903, DOI 10.1002/j.1460-2075.1991.tb07716.x; Erlitzki R, 2002, J BIOL CHEM, V277, P42579, DOI 10.1074/jbc.M207918200; Feng L, 2005, NATURE, V435, P697, DOI 10.1038/nature03609; Feng L, 2004, CELL, V119, P629, DOI 10.1016/j.cell.2004.11.025; Feng YQ, 2005, MOL CELL BIOL, V25, P3864, DOI 10.1128/MCB.25.10.3864-3874.2005; Friedlich AL, 2007, MOL PSYCHIATR, V12, P222, DOI 10.1038/sj.mp.4001937; Gallagher PG, 2005, J BIOL CHEM, V280, P39016, DOI 10.1074/jbc.M506062200; Gell D, 2002, J BIOL CHEM, V277, P40602, DOI 10.1074/jbc.M206084200; Goessling LS, 1998, J BIOL CHEM, V273, P12555, DOI 10.1074/jbc.273.20.12555; Gunshin H, 2001, FEBS LETT, V509, P309, DOI 10.1016/S0014-5793(01)03189-1; GUO B, 1994, J BIOL CHEM, V269, P24252; HAILE DJ, 1989, MOL CELL BIOL, V9, P5055, DOI 10.1128/MCB.9.11.5055; HAILE DJ, 1992, P NATL ACAD SCI USA, V89, P11735, DOI 10.1073/pnas.89.24.11735; HENDERSON BR, 1994, J BIOL CHEM, V269, P17481; Hodge D, 2006, BLOOD, V107, P3359, DOI 10.1182/blood-2005-07-2888; Huang TS, 1999, INSECT BIOCHEM MOLEC, V29, P1, DOI 10.1016/S0965-1748(98)00097-6; Igarashi K, 2006, ANTIOXID REDOX SIGN, V8, P107, DOI 10.1089/ars.2006.8.107; Ishikawa H, 2005, MOL CELL, V19, P171, DOI 10.1016/j.molcel.2005.05.027; Iwai K, 1998, P NATL ACAD SCI USA, V95, P4924, DOI 10.1073/pnas.95.9.4924; IWAI K, 1995, EMBO J, V14, P5350, DOI 10.1002/j.1460-2075.1995.tb00219.x; Jeong JS, 2004, J BIOL CHEM, V279, P45450, DOI 10.1074/jbc.M407562200; Ke YH, 2000, BIOCHEMISTRY-US, V39, P6235, DOI 10.1021/bi9924765; Keys JR, 2007, BRIT J HAEMATOL, V136, P150, DOI 10.1111/j.1365-2141.2006.06381.x; Kihm AJ, 2002, NATURE, V417, P758, DOI 10.1038/nature00803; KOELLER DM, 1989, P NATL ACAD SCI USA, V86, P3574, DOI 10.1073/pnas.86.10.3574; Kong J, 2003, MOL CELL BIOL, V23, P1125, DOI 10.1128/MCB.23.4.1125-1134.2003; Kong Y, 2004, J CLIN INVEST, V114, P1457, DOI 10.1172/JCI200421982; Lai MI, 2006, BRIT J HAEMATOL, V133, P675, DOI 10.1111/j.1365-2141.2006.06075.x; Meehan HA, 2001, J BIOL CHEM, V276, P14791, DOI 10.1074/jbc.M010295200; Meyron-Holtz EG, 2004, EMBO J, V23, P386, DOI 10.1038/sj.emboj.7600041; Miller W, 2007, GENOME RES, V17, P1797, DOI 10.1101/gr.6761107; Muckenthaler MU, 2008, ANNU REV NUTR, V28, P197, DOI 10.1146/annurev.nutr.28.061807.155521; MULLNER EW, 1988, CELL, V53, P815, DOI 10.1016/0092-8674(88)90098-0; Pavesi G, 2004, NUCLEIC ACIDS RES, V32, P3258, DOI 10.1093/nar/gkh650; Piccinelli P, 2007, RNA, V13, P952, DOI 10.1261/rna.464807; Pilon AM, 2006, MOL CELL BIOL, V26, P4368, DOI 10.1128/MCB.02216-05; Rodgers ND, 2002, RNA, V8, P1526, DOI 10.1017/S1355838202029035; Rogers JT, 2002, J BIOL CHEM, V277, P45518, DOI 10.1074/jbc.M207435200; ROUAULT T, 1985, J BIOL CHEM, V260, P4862; Rouault TA, 2006, NAT CHEM BIOL, V2, P406, DOI 10.1038/nchembio807; Sanchez M, 2007, NAT PROTOC, V2, P2033, DOI 10.1038/nprot.2007.293; Sanchez M, 2007, NAT STRUCT MOL BIOL, V14, P420, DOI 10.1038/nsmb1222; Sanchez M, 2006, J BIOL CHEM, V281, P22865, DOI 10.1074/jbc.M603876200; Schlegl J, 1997, RNA, V3, P1159; Schranzhofer M, 2006, BLOOD, V107, P4159, DOI 10.1182/blood-2005-05-1809; SEISER C, 1995, J BIOL CHEM, V270, P29400, DOI 10.1074/jbc.270.49.29400; SIERZPUTOWSKAGRACZ H, 1995, NUCLEIC ACIDS RES, V23, P146, DOI 10.1093/nar/23.1.146; Solano-Gonzalez E, 2007, FEBS LETT, V581, P2919, DOI 10.1016/j.febslet.2007.05.056; Tahara T, 2004, BIOCHEM BIOPH RES CO, V324, P77, DOI 10.1016/j.bbrc.2004.09.022; Tahara T, 2004, J BIOL CHEM, V279, P5480, DOI 10.1074/jbc.M302733200; Waggoner SA, 2003, MOL CELL BIOL, V23, P7055, DOI 10.1128/MCB.23.19.7055-7067.2003; Walden WE, 2006, SCIENCE, V314, P1903, DOI 10.1126/science.1133116; Wallander ML, 2006, BBA-MOL CELL RES, V1763, P668, DOI 10.1016/j.bbamcr.2006.05.004; Wang W, 2007, J BIOL CHEM, V282, P24650, DOI 10.1074/jbc.M703167200; Weiss MJ, 2005, ANN NY ACAD SCI, V1054, P103, DOI 10.1196/annals.1345.013; YIP YK, 1972, J BIOL CHEM, V247, P7237; Yu X, 2007, J CLIN INVEST, V117, P1856, DOI 10.1172/JCI31664; ZUKER M, 1981, NUCLEIC ACIDS RES, V9, P133, DOI 10.1093/nar/9.1.133	69	40	40	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 3	2008	283	40					26956	26964		10.1074/jbc.M802421200	http://dx.doi.org/10.1074/jbc.M802421200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	353RT	18676996	Green Published, hybrid			2022-12-27	WOS:000259586600016
J	Bruzzone, S; Bodrato, N; Usai, C; Guida, L; Moreschi, I; Nano, R; Antonioli, B; Fruscione, F; Magnone, M; Scarfi, S; De Flora, A; Zocchi, E				Bruzzone, Santina; Bodrato, Nicoletta; Usai, Cesare; Guida, Lucrezia; Moreschi, Iliana; Nano, Rita; Antonioli, Barbara; Fruscione, Floriana; Magnone, Mirko; Scarfi, Sonia; De Flora, Antonio; Zocchi, Elena			Abscisic Acid Is an Endogenous Stimulator of Insulin Release from Human Pancreatic Islets with Cyclic ADP Ribose as Second Messenger	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TEMPERATURE-SIGNALING CASCADE; BETA-CELLS; HUMAN GRANULOCYTES; CADP-RIBOSE; IN-VITRO; INFLAMMATION; RESISTANCE; SECRETION; HYPERGLYCEMIA; OBESITY	Abscisic acid (ABA) is a plant stress hormone recently identified as an endogenous pro-inflammatory cytokine in human granulocytes. Because paracrine signaling between pancreatic beta cells and inflammatory cells is increasingly recognized as a pathogenetic mechanism in the metabolic syndrome and type II diabetes, we investigated the effect of ABA on insulin secretion. Nanomolar ABA increases glucose-stimulated insulin secretion from RIN-m and INS-1 cells and from murine and human pancreatic islets. The signaling cascade triggered by ABA in insulin-releasing cells sequentially involves a pertussis toxin-sensitive G protein, cAMP overproduction, protein kinase A-mediated activation of the ADP-ribosyl cyclase CD38, and cyclic ADP-ribose overproduction. ABA is rapidly produced and released from human islets, RIN-m, and INS-1 cells stimulated with high glucose concentrations. In conclusion, ABA is an endogenous stimulator of insulin secretion in human and murine pancreatic beta cells. Autocrine release of ABA by glucose-stimulated pancreatic beta cells, and the paracrine production of the hormone by activated granulocytes and monocytes suggest that ABA may be involved in the physiology of insulin release as well as in its dysregulation under conditions of inflammation.	[Bruzzone, Santina; Bodrato, Nicoletta; Guida, Lucrezia; Moreschi, Iliana; Fruscione, Floriana; Magnone, Mirko; Scarfi, Sonia; De Flora, Antonio; Zocchi, Elena] Univ Genoa, Biochem Sect, Dept Expt Med, I-16132 Genoa, Italy; [Bruzzone, Santina; Bodrato, Nicoletta; Guida, Lucrezia; Moreschi, Iliana; Fruscione, Floriana; Magnone, Mirko; Scarfi, Sonia; De Flora, Antonio; Zocchi, Elena] Univ Genoa, Ctr Excellence Biomed Res, I-16132 Genoa, Italy; [Bruzzone, Santina; Guida, Lucrezia; Fruscione, Floriana; Magnone, Mirko; Scarfi, Sonia; Zocchi, Elena] Adv Biotechnol Ctr, I-16132 Genoa, Italy; [Usai, Cesare] CNR, Inst Biophys, I-16149 Genoa, Italy; [Nano, Rita; Antonioli, Barbara] Ist Sci San Raffaele, Islet Proc Facil, I-20132 Milan, Italy	University of Genoa; University of Genoa; Consiglio Nazionale delle Ricerche (CNR); Istituto di Biofisica (IBF-CNR); Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele	Zocchi, E (corresponding author), Univ Genoa, Biochem Sect, Dept Expt Med, Viale Benedetto XV 1, I-16132 Genoa, Italy.	ezocchi@unige.it	Bruzzone, Santina/A-4264-2015; Scarfi, Sonia/AAJ-2387-2020; fruscione, floriana/AAA-8747-2020; Nano, Rita/AAC-1934-2019	Bruzzone, Santina/0000-0003-2034-3716; Scarfi, Sonia/0000-0002-7079-6919; Nano, Rita/0000-0003-4520-8481; Usai, Cesare/0000-0001-8863-7759; fruscione, floriana/0000-0002-4054-645X	Associazione Italiana per la Ricerca sul Cancro; Italian Ministry of Education, University and Scientific Research [MIUR-PRIN 2005, MIUR FIRB RBAUO19A3C, MIUR FIRB RBNE01ERXR, MIUR FIRB RBLA039LSF, MIUR FIRB RBIP06LSS2]; University of Genova and Fondazione Cassa di Risparmio di Genova e Imperia	Associazione Italiana per la Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro); Italian Ministry of Education, University and Scientific Research(Ministry of Education, Universities and Research (MIUR)); University of Genova and Fondazione Cassa di Risparmio di Genova e Imperia	This work was supported in part by grants from Regione Liguria, from the Associazione Italiana per la Ricerca sul Cancro, from the Italian Ministry of Education, University and Scientific Research Grants MIUR-PRIN 2005, MIUR FIRB RBAUO19A3C, MIUR FIRB RBNE01ERXR, MIUR FIRB RBLA039LSF, and MIUR FIRB RBIP06LSS2, and the University of Genova and Fondazione Cassa di Risparmio di Genova e Imperia. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Bacova Z, 2005, CELL PHYSIOL BIOCHEM, V16, P59, DOI 10.1159/000087732; Boittin FX, 2003, J BIOL CHEM, V278, P9602, DOI 10.1074/jbc.M204891200; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bruzzone S, 2006, BIOCHEM J, V393, P697, DOI 10.1042/BJ20051302; Bruzzone S, 2007, P NATL ACAD SCI USA, V104, P5759, DOI 10.1073/pnas.0609379104; CHARLES MA, 1973, SCIENCE, V179, P569, DOI 10.1126/science.179.4073.569; Dandona P, 2004, TRENDS IMMUNOL, V25, P4, DOI 10.1016/j.it.2003.10.013; Dandona P, 2007, CURR OPIN CLIN NUTR, V10, P511, DOI 10.1097/MCO.0b013e3281e38774; de Luca C, 2008, FEBS LETT, V582, P97, DOI 10.1016/j.febslet.2007.11.057; DeFlora A, 1996, BIOCHEM J, V320, P665, DOI 10.1042/bj3200665; Federici M, 2001, DIABETES, V50, P1290, DOI 10.2337/diabetes.50.6.1290; Feng DD, 2006, ENDOCRINOLOGY, V147, P674, DOI 10.1210/en.2005-0225; Furman B, 2006, CURR OPIN INVEST DR, V7, P898; Gearhart MM, 2006, AACN ADV CRIT CARE, V17, P50, DOI 10.1097/00044067-200601000-00007; Graeff R, 2002, BIOCHEM J, V361, P379, DOI 10.1042/bj3610379; Grill E, 1998, CURR OPIN PLANT BIOL, V1, P412, DOI 10.1016/S1369-5266(98)80265-3; Guri AJ, 2007, CLIN NUTR, V26, P107, DOI 10.1016/j.clnu.2006.07.008; Guse AH, 2005, FEBS J, V272, P4590, DOI 10.1111/j.1742-4658.2005.04863.x; Islam MS, 2002, DIABETES, V51, P1299, DOI 10.2337/diabetes.51.5.1299; LEE HC, 1989, J BIOL CHEM, V264, P1608; Lee HC, 2005, J BIOL CHEM, V280, P33693, DOI 10.1074/jbc.R500012200; LEE HC, 2002, CYCLIC ADP RIBOSE NA, P1; Liu DM, 2006, DIABETES, V55, P1043, DOI 10.2337/diabetes.55.04.06.db05-1089; Marik PE, 2004, INTENS CARE MED, V30, P748, DOI 10.1007/s00134-004-2167-y; Masgrau R, 2003, CURR BIOL, V13, P247, DOI 10.1016/S0960-9822(03)00041-1; McCowen KC, 2001, CRIT CARE CLIN, V17, P107, DOI 10.1016/S0749-0704(05)70154-8; Melzi R, 2007, TRANSPLANTATION, V83, P167, DOI 10.1097/01.tp.0000250659.24286.43; Miguel JC, 2003, BIOCHEM PHARMACOL, V65, P283, DOI 10.1016/S0006-2952(02)01482-X; Morita K, 1997, J BIOL CHEM, V272, P21002, DOI 10.1074/jbc.272.34.21002; Muoio DM, 2008, NAT REV MOL CELL BIO, V9, P193, DOI 10.1038/nrm2327; Puce S, 2004, J BIOL CHEM, V279, P39783, DOI 10.1074/jbc.M405348200; SCHUBART UK, 1977, J BIOL CHEM, V252, P92; SHARP GWG, 1979, DIABETOLOGIA, V16, P287, DOI 10.1007/BF01223617; Shoelson SE, 2007, GASTROENTEROLOGY, V132, P2169, DOI 10.1053/j.gastro.2007.03.059; Takasawa S, 1998, J BIOL CHEM, V273, P2497, DOI 10.1074/jbc.273.5.2497; TAKASAWA S, 1993, SCIENCE, V259, P370, DOI 10.1126/science.8420005; Verderio C, 2001, J NEUROCHEM, V78, P646, DOI 10.1046/j.1471-4159.2001.00455.x; Wu Y, 1997, SCIENCE, V278, P2126, DOI 10.1126/science.278.5346.2126; Xie GH, 2005, BIOCHEM BIOPH RES CO, V330, P1290, DOI 10.1016/j.bbrc.2005.03.114; Zocchi E, 2003, J CELL SCI, V116, P629, DOI 10.1242/jcs.00277; Zocchi E, 2001, P NATL ACAD SCI USA, V98, P14859, DOI 10.1073/pnas.261448698; ZOCCHI E, 2006, FLURIDONE ANTIN 1006	42	107	114	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 21	2008	283	47					32188	32197		10.1074/jbc.M802603200	http://dx.doi.org/10.1074/jbc.M802603200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	372HW	18784081	hybrid, Green Published			2022-12-27	WOS:000260893700005
J	Ouchi, N; Oshima, Y; Ohashi, K; Higuchi, A; Ikegami, C; Izumiya, Y; Walsh, K				Ouchi, Noriyuki; Oshima, Yuichi; Ohashi, Koji; Higuchi, Akiko; Ikegami, Chiaki; Izumiya, Yasuhiro; Walsh, Kenneth			Follistatin-like 1, a Secreted Muscle Protein, Promotes Endothelial Cell Function and Revascularization in Ischemic Tissue through a Nitric-oxide Synthase-dependent Mechanism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADIPONECTIN STIMULATES ANGIOGENESIS; RAT PLANTARIS MUSCLE; SKELETAL-MUSCLE; GROWTH-FACTOR; CARDIAC-HYPERTROPHY; FIBER TYPES; KINASE AKT; EXPRESSION; GENE; TSC-36	Myogenic Akt signaling coordinates blood vessel recruitment with normal tissue growth. Here, we investigated the role of Follistatin-like 1 (Fstl1) in the regulation of endothelial cell function and blood vessel growth in muscle. Transgenic Akt1 overexpression in skeletal muscle led to myofiber growth that was coupled to an increase in muscle capillary density. Myogenic Akt signaling or ischemic hind limb surgery led to the induction of Fstl1 in muscle and increased circulating levels of Fstl1. Intramuscular administration of an adenoviral vector expressing Fstl1 (Ad-Fstl1) accelerated flow recovery and increased capillary density in the ischemic hind limbs of wild-type mice, and this was associated with an increase in endothelial nitric oxide synthase (eNOS) phosphorylation at residue Ser-1179. In cultured endothelial cells, Ad-Fstl1 stimulated migration and differentiation into network structures and inhibited apoptosis under conditions of serum deprivation. These cell responses were associated with the activating phosphorylation of Akt and eNOS. Conversely, transduction with dominant-negative Akt or LY294002 blocked Fstl1-stimulated eNOS phosphorylation and inhibited Fstl1-stimulated cellular responses. Treatment with the eNOS inhibitor N-G-nitro-L-arginine methyl ester also reduced endothelial cell migration and differentiation induced by Ad-Fstl1. The stimulatory effect of Ad-Fstl1 on ischemic limb reperfusion was abolished in mice lacking eNOS. These data indicate that Fstl1 is a secreted muscle protein or myokine that can function to promote endothelial cell function and stimulates revascularization in response to ischemic insult through its ability to activate Akt-eNOS signaling.	[Ouchi, Noriyuki; Oshima, Yuichi; Ohashi, Koji; Higuchi, Akiko; Ikegami, Chiaki; Izumiya, Yasuhiro; Walsh, Kenneth] Boston Univ, Sch Med, Mol Cardiol Whitaker Cardiovasc Inst, Boston, MA 02118 USA	Boston University	Ouchi, N (corresponding author), Boston Univ, Sch Med, Mol Cardiol Whitaker Cardiovasc Inst, 715 Albany St,W611, Boston, MA 02118 USA.	nouchi@bu.edu	OHASHI, Koji/I-7307-2014; OUCHI, Noriyuki/I-7306-2014	Walsh, Kenneth/0000-0001-7580-2276	National Institutes of Health [HL77774, HL86785, AG15052, HL81587]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported, in whole or in part, by National Institutes of Health Grants HL77774, HL86785, AG15052, and HL81587 (to K.W.).	Balemans W, 2002, DEV BIOL, V250, P231, DOI 10.1006/dbio.2002.0779; Bodine SC, 2001, NAT CELL BIOL, V3, P1014, DOI 10.1038/ncb1101-1014; Breit S, 2000, CANCER RES, V60, P4596; Carmeliet P, 2005, NATURE, V438, P932, DOI 10.1038/nature04478; Couffinhal T, 1999, CIRCULATION, V99, P3188, DOI 10.1161/01.CIR.99.24.3188; DEGENS H, 1993, INT J BIOCHEM, V25, P1141, DOI 10.1016/0020-711X(93)90592-3; DEGENS H, 1992, J ANAT, V180, P455; Dimmeler S, 1999, NATURE, V399, P601, DOI 10.1038/21224; Forstermann U, 2006, CIRCULATION, V113, P1708, DOI 10.1161/CIRCULATIONAHA.105.602532; Fujio Y, 1999, J BIOL CHEM, V274, P16349, DOI 10.1074/jbc.274.23.16349; Fulton D, 1999, NATURE, V399, P597, DOI 10.1038/21218; INGJER F, 1979, EUR J APPL PHYSIOL, V40, P197, DOI 10.1007/BF00426942; Izumiya Y, 2006, HYPERTENSION, V47, P887, DOI 10.1161/01.HYP.0000215207.54689.31; Izumiya Y, 2008, CELL METAB, V7, P159, DOI 10.1016/j.cmet.2007.11.003; Johnston IMP, 2000, ONCOGENE, V19, P5348, DOI 10.1038/sj.onc.1203927; Kano Y, 1997, EUR J APPL PHYSIOL, V75, P97, DOI 10.1007/s004210050132; Kawashima S, 2004, ARTERIOSCL THROM VAS, V24, P998, DOI 10.1161/01.ATV.0000125114.88079.96; Kim HS, 2002, J BIOL CHEM, V277, P41888, DOI 10.1074/jbc.M206657200; Kobayashi H, 2004, CIRC RES, V94, pE27, DOI 10.1161/01.RES.0000119921.86460.37; Kozian DH, 1997, LAB INVEST, V76, P267; Kureishi Y, 2000, NAT MED, V6, P1004, DOI 10.1038/79510; Lai KMV, 2004, MOL CELL BIOL, V24, P9295, DOI 10.1128/MCB.24.21.9295-9304.2004; Lee RJ, 2000, CIRCULATION, V102, P898; Mashimo J, 1997, CANCER LETT, V113, P213, DOI 10.1016/S0304-3835(97)04700-9; Murohara T, 1998, J CLIN INVEST, V101, P2567, DOI 10.1172/JCI1560; Oshima Y, 2008, CIRCULATION, V117, P3099, DOI 10.1161/CIRCULATIONAHA.108.767673; Ouchi N, 2005, CIRC RES, V96, P838, DOI 10.1161/01.RES.0000163633.10240.3b; Ouchi N, 2004, J BIOL CHEM, V279, P1304, DOI 10.1074/jbc.M310389200; Pedersen BK, 2007, J APPL PHYSIOL, V103, P1093, DOI 10.1152/japplphysiol.00080.2007; Rivard A, 1999, AM J PATHOL, V154, P355, DOI 10.1016/S0002-9440(10)65282-0; SHIBANUMA M, 1993, EUR J BIOCHEM, V217, P13, DOI 10.1111/j.1432-1033.1993.tb18212.x; Shibata R, 2004, J BIOL CHEM, V279, P28670, DOI 10.1074/jbc.M402558200; Shibata R, 2005, NAT MED, V11, P1096, DOI 10.1038/nm1295; Shiojima I, 2005, J CLIN INVEST, V115, P2108, DOI 10.1172/JCI24682; Shiojima I, 2002, CIRC RES, V90, P1243, DOI 10.1161/01.RES.0000022200.71892.9F; Shiojima I, 2006, GENE DEV, V20, P3347, DOI 10.1101/gad.1492806; Sumitomo K, 2000, CANCER LETT, V155, P37, DOI 10.1016/S0304-3835(00)00407-9; Takahashi A, 2002, MOL CELL BIOL, V22, P4803, DOI 10.1128/MCB.22.13.4803-4814.2002; Vale P R, 2001, J Interv Cardiol, V14, P511, DOI 10.1111/j.1540-8183.2001.tb00367.x	39	216	228	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 21	2008	283	47					32802	32811		10.1074/jbc.M803440200	http://dx.doi.org/10.1074/jbc.M803440200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	372HW	18718903	Green Published, hybrid			2022-12-27	WOS:000260893700069
J	Stamler, R; Keutmann, HT; Sidis, Y; Kattamuri, C; Schneyer, A; Thompson, TB				Stamler, Robin; Keutmann, Henry T.; Sidis, Yisrael; Kattamuri, Chandramohan; Schneyer, Alan; Thompson, Thomas B.			The Structure of FSTL3.Activin A Complex DIFFERENTIAL BINDING OF N-TERMINAL DOMAINS INFLUENCES FOLLISTATIN-TYPE ANTAGONIST SPECIFICITY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BONE-MORPHOGENETIC PROTEIN; TGF-BETA SUPERFAMILY; ACTIVIN-BINDING; RECEPTOR-BINDING; FAMILY; GENE; CELL; MECHANISMS; MYOSTATIN; RECOGNITION	Transforming growth factor beta family ligands are neutralized by a number of structurally divergent antagonists. Follistatin-type antagonists, which include splice variants of follistatin (FS288 and FS315) and follistatin-like 3 (FSTL3), have high affinity for activin A but differ in their affinity for other ligands, particularly bone morphogenetic proteins. To understand the structural basis for ligand specificity within FS-type antagonists, we determined the x-ray structure of activin A in complex with FSTL3 to a resolution of 2.5 angstrom. Similar to the previously resolved FS.activin A structures, the ligand is encircled by two antagonist molecules blocking all ligand receptor-binding sites. Recently, the significance of the FS N-terminal domain interaction at the ligand type I receptor site has been questioned; however, our data show that for FSTL3, the N-terminal domain forms a more intimate contact with activin A, implying that this interaction is stronger than that for FS. Furthermore, binding studies revealed that replacing the FSTL3 N-terminal domain with the corresponding FS domain considerably lowers activin A affinity. Therefore, both structural and biochemical evidence support a significant interaction of the N-terminal domain of FSTL3 with activin A. In addition, structural comparisons with bone morphogenetic proteins suggest that the interface where the N-terminal domain binds may be the key site for determining FS-type antagonist specificity.	[Stamler, Robin; Kattamuri, Chandramohan; Thompson, Thomas B.] Univ Cincinnati, Dept Mol Genet Biochem & Microbiol, Cincinnati, OH 45267 USA; [Keutmann, Henry T.] Massachusetts Gen Hosp, Endocrine Unit, Boston, MA 02114 USA; [Sidis, Yisrael] Massachusetts Gen Hosp, Reprod Endocrine Unit, Boston, MA 02114 USA; [Schneyer, Alan] Baystate Med Ctr, Pioneer Valley Life Sci Inst, Springfield, MA 01107 USA	University System of Ohio; University of Cincinnati; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Baystate Medical Center	Thompson, TB (corresponding author), Univ Cincinnati, Dept Mol Genet Biochem & Microbiol, Med Sci Bldg,231 Albert Sabin Way, Cincinnati, OH 45267 USA.	tom.thompson@ucmail.uc.edu		Thompson, Thomas/0000-0002-7041-5047	National Institutes of Health [GM084186, DK053828]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK053828] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084186] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM084186 ( to T. B. T.) and DK053828 ( to H. T. K.).	Allendorph GP, 2006, P NATL ACAD SCI USA, V103, P7643, DOI 10.1073/pnas.0602558103; Amthor H, 2002, DEV BIOL, V243, P115, DOI 10.1006/dbio.2001.0555; Arai KY, 2006, PROTEIN EXPRES PURIF, V49, P78, DOI 10.1016/j.pep.2006.04.003; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Costantini S, 2008, BIOINFORMATION, V2, P271, DOI 10.6026/97320630002271; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Glister C, 2004, REPRODUCTION, V127, P239, DOI 10.1530/rep.1.00090; Greenwald J, 2004, MOL CELL, V15, P485, DOI 10.1016/j.molcel.2004.07.011; Greenwald J, 2003, MOL CELL, V11, P605, DOI 10.1016/S1097-2765(03)00094-7; Groppe J, 2002, NATURE, V420, P636, DOI 10.1038/nature01245; Groppe J, 2008, MOL CELL, V29, P157, DOI 10.1016/j.molcel.2007.11.039; Harrington AE, 2006, EMBO J, V25, P1035, DOI 10.1038/sj.emboj.7601000; Harrison CA, 2006, ENDOCRINOLOGY, V147, P2744, DOI 10.1210/en.2006-0131; Hayette S, 1998, ONCOGENE, V16, P2949, DOI 10.1038/sj.onc.1201807; Hill JJ, 2002, J BIOL CHEM, V277, P40735, DOI 10.1074/jbc.M206379200; Holm L, 2000, BIOINFORMATICS, V16, P566, DOI 10.1093/bioinformatics/16.6.566; Iemura S, 1998, P NATL ACAD SCI USA, V95, P9337, DOI 10.1073/pnas.95.16.9337; INOUYE S, 1991, ENDOCRINOLOGY, V129, P815, DOI 10.1210/endo-129-2-815; Keller S, 2004, NAT STRUCT MOL BIOL, V11, P481, DOI 10.1038/nsmb756; Keutmann HT, 2004, MOL ENDOCRINOL, V18, P228, DOI 10.1210/me.2003-0112; Kirsch T, 2000, NAT STRUCT BIOL, V7, P492; Korupolu RV, 2008, J BIOL CHEM, V283, P3782, DOI 10.1074/jbc.M704530200; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Lerch TF, 2007, J BIOL CHEM, V282, P15930, DOI 10.1074/jbc.M700737200; Lin SY, 2003, REPRODUCTION, V126, P133, DOI 10.1530/rep.0.1260133; MATZUK MM, 1995, NATURE, V374, P360, DOI 10.1038/374360a0; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; MICHEL U, 1993, MOL CELL ENDOCRINOL, V91, P1, DOI 10.1016/0303-7207(93)90248-I; Mukherjee A, 2007, P NATL ACAD SCI USA, V104, P1348, DOI 10.1073/pnas.0607966104; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; NAKAMURA T, 1990, SCIENCE, V247, P836, DOI 10.1126/science.2106159; Nickel J, 2005, J MOL BIOL, V349, P933, DOI 10.1016/j.jmb.2005.04.015; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Painter J, 2006, ACTA CRYSTALLOGR D, V62, P439, DOI 10.1107/S0907444906005270; Painter J, 2006, J APPL CRYSTALLOGR, V39, P109, DOI 10.1107/S0021889805038987; Schneyer A, 2001, MOL CELL ENDOCRINOL, V180, P33, DOI 10.1016/S0303-7207(01)00501-9; Schneyer AL, 2004, J CLIN ENDOCR METAB, V89, P5067, DOI 10.1210/jc.2004-0162; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Shimmi O, 2005, CELL, V120, P873, DOI 10.1016/j.cell.2005.02.009; Sidis Y, 2001, J BIOL CHEM, V276, P17718, DOI 10.1074/jbc.M100736200; Sidis Y, 2006, ENDOCRINOLOGY, V147, P3586, DOI 10.1210/en.2006-0089; SUGINO K, 1993, J BIOL CHEM, V268, P15579; Thompson TB, 2005, DEV CELL, V9, P535, DOI 10.1016/j.devcel.2005.09.008; Thompson TB, 2003, EMBO J, V22, P1555, DOI 10.1093/emboj/cdg156; Tsuchida K, 2004, MOL CELL ENDOCRINOL, V225, P1, DOI 10.1016/j.mce.2004.02.006; Tsuchida K, 2000, J BIOL CHEM, V275, P40788, DOI 10.1074/jbc.M006114200; Weber D, 2007, BMC STRUCT BIOL, V7, DOI 10.1186/1472-6807-7-6; Welt C, 2002, EXP BIOL MED, V227, P724, DOI 10.1177/153537020222700905; Winn MD, 2001, ACTA CRYSTALLOGR D, V57, P122, DOI 10.1107/S0907444900014736; Zhang JL, 2007, J BIOL CHEM, V282, P20002, DOI 10.1074/jbc.M700456200	50	52	58	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 21	2008	283	47					32831	32838		10.1074/jbc.M801266200	http://dx.doi.org/10.1074/jbc.M801266200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	372HW	18768470	Green Published, hybrid			2022-12-27	WOS:000260893700072
J	Ge, M; Xia, XY; Pan, XM				Ge, Meng; Xia, Xia-Yu; Pan, Xian-Ming			Salt Bridges in the Hyperthermophilic Protein Ssh10b Are Resilient to Temperature Increases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SURFACE ELECTROSTATIC INTERACTIONS; DNA-BINDING PROTEIN; GLUTAMATE-DEHYDROGENASE; PYROCOCCUS-FURIOSUS; CRYSTAL-STRUCTURE; SIDE-CHAIN; KEY ROLE; STABILITY; THERMOSTABILITY; MUTANT	A double mutant cycle (DMC) approach was employed to estimate the effect of temperature on the contribution of two highly conserved salt bridges to protein stability in the hyperthermophilic protein Ssh10b. The coupling free energy were 2.4 +/- 0.4 kJ/mol at 298 K and 2.2 +/- 0.4 kJ/mol at 353 K for Glu-54/Arg-57, and 6.0 +/- 0.2 kJ/mol at 298 K and 5.9 +/- 0.6 kJ/mol at 353 K for Glu-36/Lys-68. The stability free energy of Ssh10b decrease greatly with increasing temperature, while the direct contribution of these two salt bridges to protein stability remain almost constant, providing evidence supporting the theoretical prediction that salt bridges are extremely resilient to temperature increases and thus are specially suited to improving protein stability at high temperatures. The reason for the difference in coupling free energy between salt bridges Glu-54/Arg-57 and Glu-36/Lys-68 is discussed. Comparing our results with published DMC data for the contribution of salt bridges to stability in other proteins, we found that the energy contribution of a salt bridge formed by two charged residues far apart in the primary sequence is higher than that of those formed between two very close ones. Implications of this finding are useful for engineering proteins with enhanced thermostability.	[Ge, Meng; Xia, Xia-Yu; Pan, Xian-Ming] Tsinghua Univ, Dept Biol Sci & Biotechnol, Minist Educ, Key Lab Bioinformat, Beijing 100084, Peoples R China	Tsinghua University	Pan, XM (corresponding author), Tsinghua Univ, Dept Biol Sci & Biotechnol, Minist Educ, Key Lab Bioinformat, Beijing 100084, Peoples R China.	pan-xm@mail.tsinghua.edu.cn			Natural Science Foundation of China [30230100, 30670420]; Program for Changjiang Scholars and Innovative Research Team in University	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for Changjiang Scholars and Innovative Research Team in University(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT))	This work was supported in part by grants from the Natural Science Foundation of China (No. 30230100 and No. 30670420) and the Program for Changjiang Scholars and Innovative Research Team in University.	ADAMS MWW, 1993, ANNU REV MICROBIOL, V47, P627, DOI 10.1146/annurev.micro.47.1.627; AGASHE VR, 1995, BIOCHEMISTRY-US, V34, P3286, DOI 10.1021/bi00010a019; BARLOW DJ, 1983, J MOL BIOL, V168, P867, DOI 10.1016/S0022-2836(83)80079-5; Barril X, 1998, PROTEINS, V32, P67, DOI 10.1002/(SICI)1097-0134(19980701)32:1<67::AID-PROT8>3.0.CO;2-B; Blasie CA, 1997, BIOCHEMISTRY-US, V36, P6218, DOI 10.1021/bi962805i; Bosshard HR, 2004, J MOL RECOGNIT, V17, P1, DOI 10.1002/jmr.657; BRITTON KL, 1995, EUR J BIOCHEM, V229, P688, DOI 10.1111/j.1432-1033.1995.tb20515.x; CHEN BL, 1989, BIOCHEMISTRY-US, V28, P685, DOI 10.1021/bi00428a041; Cui Q, 2003, J BIOL CHEM, V278, P51015, DOI 10.1074/jbc.M308510200; DAOPIN S, 1991, BIOCHEMISTRY-US, V30, P7142, DOI 10.1021/bi00243a015; Elcock AH, 1998, J MOL BIOL, V284, P489, DOI 10.1006/jmbi.1998.2159; Freire E, 1995, METHOD ENZYMOL, V259, P144; HENDSCH ZS, 1994, PROTEIN SCI, V3, P211; Hennig M, 1995, STRUCTURE, V3, P1295, DOI 10.1016/S0969-2126(01)00267-2; Hong H, 2006, NAT CHEM BIOL, V2, P627, DOI 10.1038/nchembio827; HOROVITZ A, 1990, J MOL BIOL, V216, P1031, DOI 10.1016/S0022-2836(99)80018-7; Ibarra-Molero B, 2004, J MOL BIOL, V336, P989, DOI 10.1016/j.jmb.2003.12.069; Jaenicke R, 1996, ADV PROTEIN CHEM, V48, P181; Kamal JKA, 2002, J BIOL CHEM, V277, P40717, DOI 10.1074/jbc.M208129200; Kawamura S, 1997, J BIOCHEM-TOKYO, V121, P448; KORNDORFER I, 1995, J MOL BIOL, V246, P511, DOI 10.1006/jmbi.1994.0103; Krylov D, 1998, J MOL BIOL, V279, P959, DOI 10.1006/jmbi.1998.1762; Ladenstein R, 1998, Adv Biochem Eng Biotechnol, V61, P37; Lassila KS, 2002, PROTEIN SCI, V11, P688, DOI 10.1110/ps.23502; Lebbink JHG, 2002, BIOCHEMISTRY-US, V41, P15524, DOI 10.1021/bi020461s; Lounnas V, 1997, BIOCHEMISTRY-US, V36, P5402, DOI 10.1021/bi9622940; Luisi DL, 2003, BIOCHEMISTRY-US, V42, P7050, DOI 10.1021/bi027202n; Makhatadze GI, 2003, J MOL BIOL, V327, P1135, DOI 10.1016/S0022-2836(03)00233-X; Mao Yong-Jin, 2007, BMC Biochemistry, V8, P28, DOI 10.1186/1471-2091-8-28; MARQUSEE S, 1994, PROTEIN SCI, V3, P2217, DOI 10.1002/pro.5560031207; Marti DN, 2003, J MOL BIOL, V330, P621, DOI 10.1016/S0022-2836(03)00623-5; Merkel JS, 1999, STRUCT FOLD DES, V7, P1333, DOI 10.1016/S0969-2126(00)80023-4; NICHOLSON H, 1991, BIOCHEMISTRY-US, V30, P9816, DOI 10.1021/bi00105a002; NOJIMA H, 1977, J MOL BIOL, V116, P429, DOI 10.1016/0022-2836(77)90078-X; NOJIMA H, 1978, BIOCH THERMOPHILY, P305; RUSSELL RJM, 1994, STRUCTURE, V2, P1157, DOI 10.1016/S0969-2126(94)00118-9; SALI D, 1991, J MOL BIOL, V220, P779, DOI 10.1016/0022-2836(91)90117-O; SANTORO MM, 1988, BIOCHEMISTRY-US, V27, P8063, DOI 10.1021/bi00421a014; SCHELLMAN JA, 1987, ANNU REV BIOPHYS BIO, V16, P115, DOI 10.1146/annurev.bb.16.060187.000555; SCHUMANN J, 1993, PROTEIN SCI, V2, P1612, DOI 10.1002/pro.5560021007; SERRANO L, 1990, BIOCHEMISTRY-US, V29, P9343, DOI 10.1021/bi00492a006; SPASSOV VZ, 1995, PROTEIN SCI, V4, P1516, DOI 10.1002/pro.5560040809; Strop P, 2000, BIOCHEMISTRY-US, V39, P1251, DOI 10.1021/bi992257j; Szilagyi A, 2000, STRUCTURE, V8, P493, DOI 10.1016/S0969-2126(00)00133-7; Thomas AS, 2004, J AM CHEM SOC, V126, P2208, DOI 10.1021/ja039159c; Tissot AC, 1996, BIOCHEMISTRY-US, V35, P6786, DOI 10.1021/bi952930e; Vaughan CK, 2002, ACTA CRYSTALLOGR D, V58, P591, DOI 10.1107/S0907444902001567; Vetriani C, 1998, P NATL ACAD SCI USA, V95, P12300, DOI 10.1073/pnas.95.21.12300; Vieille C, 2001, MICROBIOL MOL BIOL R, V65, P1, DOI 10.1128/MMBR.65.1.1-43.2001; Vieille C, 1996, TRENDS BIOTECHNOL, V14, P183, DOI 10.1016/0167-7799(96)10026-3; WALDBURGER CD, 1995, NAT STRUCT BIOL, V2, P122, DOI 10.1038/nsb0295-122; Wardleworth BN, 2002, EMBO J, V21, P4654, DOI 10.1093/emboj/cdf465; WOESE CR, 1990, P NATL ACAD SCI USA, V87, P4576, DOI 10.1073/pnas.87.12.4576; Xu S, 2004, BIOCHEM J, V382, P433, DOI 10.1042/BJ20040191; Xue H, 2000, J BACTERIOL, V182, P3929, DOI 10.1128/JB.182.14.3929-3933.2000; YIP KSP, 1995, STRUCTURE, V3, P1147, DOI 10.1016/S0969-2126(01)00251-9	56	35	36	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 14	2008	283	46					31690	31696		10.1074/jbc.M805750200	http://dx.doi.org/10.1074/jbc.M805750200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	370KJ	18779322	hybrid			2022-12-27	WOS:000260760800051
J	Baugher, PJ; Richmond, A				Baugher, Paige J.; Richmond, Ann			The Carboxyl-terminal PDZ Ligand Motif of Chemokine Receptor CXCR2 Modulates Post-endocytic Sorting and Cellular Chemotaxis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED-RECEPTORS; AGONIST-PROMOTED UBIQUITINATION; ETHYLMALEIMIDE-SENSITIVE FACTOR; CLATHRIN-MEDIATED ENDOCYTOSIS; INTERLEUKIN-8 RECEPTOR; MULTIVESICULAR BODY; BETA-ARRESTIN; MEMBRANE-TRAFFICKING; SIGNAL-TRANSDUCTION; DOMAIN PROTEINS	Adaptor protein interaction with specific peptide motifs found within the intracellular, carboxyl terminus of chemokine receptor CXCR2 has been shown to modulate intracellular trafficking and receptor function. Efficient ligand-induced internalization of this receptor is dependent on the binding of adaptor protein 2 to the specific LLKIL motif found within the carboxyl terminus (1). In this study we show that the carboxyl-terminal type 1 PDZ ligand motif (-STTL) of CXCR2 plays an essential role in both proper intracellular receptor trafficking and efficient cellular chemotaxis. First, we show that CXCR2 is sorted to and degraded in the lysosome upon long-term ligand stimulation. We also show that receptor degradation is not dependent upon receptor ubiquitination, but is instead modulated by the carboxyl-terminal type I PDZ ligand of CXCR2. Deletion of this ligand results in increased degradation, earlier co-localization with the lysosome, and enhanced sorting to the Rab7-positive late endosome. We also show that deletion of this ligand effects neither receptor internalization nor receptor recycling. Furthermore, we demonstrate that deletion of the PDZ ligand motif results in impaired chemotactic response. The data presented here demonstrate that the type I PDZ ligand of CXCR2 acts to both delay lysosomal sorting and facilitate proper chemotactic response.	[Richmond, Ann] Vet Affairs Med Ctr, Dept Vet Affairs, Nashville, TN 37212 USA; [Baugher, Paige J.] Vanderbilt Univ, Sch Med, Dept Canc Biol, Nashville, TN 37232 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Tennessee Valley Healthcare System; Vanderbilt University	Richmond, A (corresponding author), 771 PRB,23rd Ave S & Pierce, Nashville, TN 37232 USA.	ann.richmond@vanderbilt.edu	Richmond, Ann/A-3048-2014	RICHMOND, ANN/0000-0002-9580-900X	National Institutes of Health NCI [CA34590]; Multidisciplinaryasic Research Training in Cance [T32CA09592]; Vanderbilt-Ingram Cancer Center [CA68485]; Department of Veterans Affairs; NATIONAL CANCER INSTITUTE [R23CA034590, R01CA034590, T32CA009592, P30CA068485] Funding Source: NIH RePORTER	National Institutes of Health NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Multidisciplinaryasic Research Training in Cance; Vanderbilt-Ingram Cancer Center; Department of Veterans Affairs(US Department of Veterans Affairs); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health NCI Grant CA34590 ( to A. R.). This work was also supported by Multidisciplinaryasic Research Training in Cancer Grant T32CA09592 ( to P. B.), Vanderbilt-Ingram Cancer Center Support Grant CA68485, and a Senior Career Scientist Award from the Department of Veterans Affairs ( to A. R.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked " advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Ahuja SK, 1996, J BIOL CHEM, V271, P20545, DOI 10.1074/jbc.271.34.20545; Babst M, 2002, DEV CELL, V3, P283, DOI 10.1016/S1534-5807(02)00219-8; Babst M, 2005, TRAFFIC, V6, P2, DOI 10.1111/j.1600-0854.2004.00246.x; Babst M, 2002, DEV CELL, V3, P271, DOI 10.1016/S1534-5807(02)00220-4; Babst M, 2000, TRAFFIC, V1, P248, DOI 10.1034/j.1600-0854.2000.010307.x; Babst M, 1997, EMBO J, V16, P1820, DOI 10.1093/emboj/16.8.1820; Barbero P, 2002, J CELL BIOL, V156, P511, DOI 10.1083/jcb.200109030; Barlic J, 1999, J BIOL CHEM, V274, P16287, DOI 10.1074/jbc.274.23.16287; BENBARUCH A, 1995, J BIOL CHEM, V270, P9121, DOI 10.1074/jbc.270.16.9121; Bhandari D, 2007, J BIOL CHEM, V282, P36971, DOI 10.1074/jbc.M705085200; Brone B, 2005, AM J PHYSIOL-CELL PH, V288, pC20, DOI 10.1152/ajpcell.00368.2004; Cao TT, 1999, NATURE, V401, P286, DOI 10.1038/45816; Coblitz B, 2006, FEBS LETT, V580, P1531, DOI 10.1016/j.febslet.2006.02.014; Delhaye M, 2007, MOL PHARMACOL, V72, P1497, DOI 10.1124/mol.107.038422; Fan GH, 2004, MOL BIOL CELL, V15, P2456, DOI 10.1091/mbc.E03-09-0706; Fan GH, 2001, BIOCHEMISTRY-US, V40, P791, DOI 10.1021/bi001661b; Fan GH, 2003, BLOOD, V101, P2115, DOI 10.1182/blood-2002-07-1965; GABILONDO AM, 1994, PSYCHOPHARMACOLOGY, V115, P135, DOI 10.1007/BF02244763; Gage RM, 2005, J BIOL CHEM, V280, P3305, DOI 10.1074/jbc.M406934200; Gage RM, 2001, J BIOL CHEM, V276, P44712, DOI 10.1074/jbc.M107417200; Ghosh P, 2003, NAT REV MOL CELL BIO, V4, P202, DOI 10.1038/nrm1050; Girnita L, 2005, J BIOL CHEM, V280, P24412, DOI 10.1074/jbc.M501129200; Grovdal LM, 2004, EXP CELL RES, V300, P388, DOI 10.1016/j.yexcr.2004.07.003; Gruenberg J, 2001, NAT REV MOL CELL BIO, V2, P721, DOI 10.1038/35096054; Hanyaloglu AC, 2008, ANNU REV PHARMACOL, V48, P537, DOI 10.1146/annurev.pharmtox.48.113006.094830; Heydorn A, 2004, J BIOL CHEM, V279, P54291, DOI 10.1074/jbc.M406169200; Hicke L, 1996, CELL, V84, P277, DOI 10.1016/S0092-8674(00)80982-4; Hislop JN, 2004, J BIOL CHEM, V279, P22522, DOI 10.1074/jbc.M311062200; Hoefen RJ, 2006, J CELL SCI, V119, P1469, DOI 10.1242/jcs.02925; Hryciw DH, 2006, J BIOL CHEM, V281, P16068, DOI 10.1074/jbc.M512559200; Hurley JH, 2006, ANNU REV BIOPH BIOM, V35, P277, DOI 10.1146/annurev.biophys.35.040405.102126; Ishii M, 2003, LIFE SCI, V74, P163, DOI 10.1016/j.lfs.2003.09.004; James MF, 2004, J CELL SCI, V117, P2951, DOI 10.1242/jcs.01156; Jelen F, 2003, ACTA BIOCHIM POL, V50, P985; Katzmann DJ, 2001, CELL, V106, P145, DOI 10.1016/S0092-8674(01)00434-2; Kim EJ, 2004, NAT REV NEUROSCI, V5, P771, DOI 10.1038/nrn1517; Lakadamyali M, 2006, CELL, V124, P997, DOI 10.1016/j.cell.2005.12.038; Lapierre LA, 2007, AM J PHYSIOL-GASTR L, V292, pG1249, DOI 10.1152/ajpgi.00505.2006; LEE J, 1992, J BIOL CHEM, V267, P16283; Lin DT, 2007, J NEUROSCI, V27, P13903, DOI 10.1523/JNEUROSCI.1750-07.2007; LOETSCHER P, 1994, FEBS LETT, V341, P187, DOI 10.1016/0014-5793(94)80454-0; Marchese A, 2001, J BIOL CHEM, V276, P45509, DOI 10.1074/jbc.C100527200; Marchese A, 2008, ANNU REV PHARMACOL, V48, P601, DOI 10.1146/annurev.pharmtox.48.113006.094646; Martin NP, 2003, J BIOL CHEM, V278, P45954, DOI 10.1074/jbc.M308285200; Moore CAC, 2007, ANNU REV PHYSIOL, V69, P451, DOI 10.1146/annurev.physiol.69.022405.154712; MUELLER SG, 1994, J BIOL CHEM, V269, P1973; Mueller SG, 1997, J BIOL CHEM, V272, P8207, DOI 10.1074/jbc.272.13.8207; Mukhopadhyay D, 2007, SCIENCE, V315, P201, DOI 10.1126/science.1127085; Neel NF, 2005, CYTOKINE GROWTH F R, V16, P637, DOI 10.1016/j.cytogfr.2005.05.008; Neel NF, 2007, J CELL SCI, V120, P1559, DOI 10.1242/jcs.03437; Neptune ER, 1997, P NATL ACAD SCI USA, V94, P14489, DOI 10.1073/pnas.94.26.14489; Nickerson DP, 2007, EMBO REP, V8, P644, DOI 10.1038/sj.embor.7401004; Nourry Claire, 2003, Sci STKE, V2003, pRE7; Orsini MJ, 1999, J BIOL CHEM, V274, P31076, DOI 10.1074/jbc.274.43.31076; Orsini MJ, 2000, J BIOL CHEM, V275, P25876; Paasche JD, 2005, MOL PHARMACOL, V67, P1581, DOI 10.1124/mol.104.007013; Paing MM, 2006, MOL CELL BIOL, V26, P3231, DOI 10.1128/MCB.26.8.3231-3242.2006; Raman D, 2007, CANCER LETT, V256, P137, DOI 10.1016/j.canlet.2007.05.013; Richardson RM, 2003, J IMMUNOL, V170, P2904, DOI 10.4049/jimmunol.170.6.2904; Rincon E, 2007, MOL CELL PROTEOMICS, V6, P1073, DOI 10.1074/mcp.M700047-MCP200; Shenoy SK, 2001, SCIENCE, V294, P1307, DOI 10.1126/science.1063866; Shenoy SK, 2007, CIRC RES, V100, P1142, DOI 10.1161/01.RES.0000261939.88744.5a; Shih SC, 2002, NAT CELL BIOL, V4, P389, DOI 10.1038/ncb790; Snow BE, 1998, J BIOL CHEM, V273, P17749, DOI 10.1074/jbc.273.28.17749; Snow BE, 1999, P NATL ACAD SCI USA, V96, P6489, DOI 10.1073/pnas.96.11.6489; Strieter RM, 2006, EUR J CANCER, V42, P768, DOI 10.1016/j.ejca.2006.01.006; Trejo JA, 2005, MOL PHARMACOL, V67, P1388, DOI 10.1124/mol.105.011288; Tsao PI, 2001, PHARMACOL THERAPEUT, V89, P139, DOI 10.1016/S0163-7258(00)00107-8; Tulipano G, 2004, J BIOL CHEM, V279, P21374, DOI 10.1074/jbc.M313522200; Urbe S, 2005, ESSAYS BIOCHEM, V41, P81, DOI 10.1042/EB0410081; Wang B, 2007, J BIOL CHEM, V282, P36214, DOI 10.1074/jbc.M707263200; Wente W, 2005, J BIOL CHEM, V280, P32419, DOI 10.1074/jbc.M507198200; Wheeler D, 2007, J BIOL CHEM, V282, P25076, DOI 10.1074/jbc.M701544200; Williams RL, 2007, NAT REV MOL CELL BIO, V8, P355, DOI 10.1038/nrm2162; Winter V, 2006, TRENDS PLANT SCI, V11, P115, DOI 10.1016/j.tplants.2006.01.008; Wolfe BL, 2007, TRAFFIC, V8, P462, DOI 10.1111/j.1600-0854.2007.00551.x; Yang W, 1999, J BIOL CHEM, V274, P11328, DOI 10.1074/jbc.274.16.11328; Zimmermann P, 2005, DEV CELL, V9, P377, DOI 10.1016/j.devcel.2005.07.011	78	41	41	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 7	2008	283	45					30868	30878		10.1074/jbc.M804054200	http://dx.doi.org/10.1074/jbc.M804054200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	367ID	18755694	hybrid, Green Published			2022-12-27	WOS:000260544800042
J	Liu, LP; Wise, DR; Diehl, JA; Simon, MC				Liu, Liping; Wise, David R.; Diehl, J. Alan; Simon, M. Celeste			Hypoxic Reactive Oxygen Species Regulate the Integrated Stress Response and Cell Survival	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UNFOLDED PROTEIN RESPONSE; MESSENGER-RNA TRANSLATION; ENDOPLASMIC-RETICULUM STRESS; OXIDATIVE STRESS; KINASE PERK; IN-VIVO; PHOSPHORYLATION; ACTIVATION; GROWTH; HOMEOSTASIS	Under hypoxic conditions, cells suppress energy-intensive mRNA translation by modulating the mammalian target of rapamycin (mTOR) and pancreatic eIF2 alpha kinase ( PERK) pathways. Much is known about hypoxic inhibition of mTOR activity; however, the cellular processes activating PERK remain unclear. Since hypoxia is known to increase intracellular reactive oxygen species (ROS), we hypothesized that hypoxic ROS regulate mTOR and PERK to control mRNA translation and cell survival. Our data indicate that although exogenous ROS inhibit mTOR, eIF2 alpha, and eEF2, mTOR and eEF2 were largely refractory to ROS generated under moderate hypoxia (0.5% O-2). In direct contrast, the PERK/eIF2 alpha/ATF4 integrated stress response (ISR) was activated by hypoxic ROS and contributed to global protein synthesis inhibition and adaptive ATF4-mediated gene expression. The ISR as well as exogenous growth factors were critical for cell viability during extended hypoxia, since ISR inhibition decreased the viability of cells deprived of O2 and growth factors. Collectively, our data support an important role for ROS in hypoxic cell survival. Under conditions of moderate hypoxia, ROS induce the ISR, thereby promoting energy and redox homeostasis and enhancing cellular survival.	[Liu, Liping; Simon, M. Celeste] Univ Penn, Sch Med, Howard Hughes Med Inst, Philadelphia, PA 19104 USA; [Liu, Liping; Wise, David R.; Diehl, J. Alan; Simon, M. Celeste] Univ Penn, Sch Med, Abramson Family Canc Res Inst, Philadelphia, PA 19104 USA	Howard Hughes Medical Institute; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine	Simon, MC (corresponding author), 421 Curie Blvd, Philadelphia, PA 19104 USA.	celeste2@mail.med.upenn.edu	liu, li/HGC-0900-2022; Simon, Celeste/AAG-3941-2021	Wise, David/0000-0003-3419-4723	National Institutes of Health [PO1 CA 104838]; Abramson Family Cancer Research Institute; NATIONAL CANCER INSTITUTE [P01CA104838] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Abramson Family Cancer Research Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant PO1 CA 104838. This work was also supported by the Abramson Family Cancer Research Institute.	Arsham AM, 2003, J BIOL CHEM, V278, P29655, DOI 10.1074/jbc.M212770200; Bernardi R, 2006, NATURE, V442, P779, DOI 10.1038/nature05029; Bi MX, 2005, EMBO J, V24, P3470, DOI 10.1038/sj.emboj.7600777; Blais JD, 2006, MOL CELL BIOL, V26, P9517, DOI 10.1128/MCB.01145-06; Blais JD, 2004, MOL CELL BIOL, V24, P7469, DOI 10.1128/MCB.24.17.7469-7482.2004; Brahimi-Horn MC, 2007, CURR OPIN CELL BIOL, V19, P223, DOI 10.1016/j.ceb.2007.02.003; Brugarolas J, 2004, GENE DEV, V18, P2893, DOI 10.1101/gad.1256804; Brunelle JK, 2005, CELL METAB, V1, P409, DOI 10.1016/j.cmet.2005.05.002; Cai SL, 2006, J CELL BIOL, V173, P279, DOI 10.1083/jcb.200507119; Chandel NS, 1998, P NATL ACAD SCI USA, V95, P11715, DOI 10.1073/pnas.95.20.11715; Connolly E, 2006, MOL CELL BIOL, V26, P3955, DOI 10.1128/MCB.26.10.3955-3965.2006; Csordas G, 2006, J CELL BIOL, V174, P915, DOI 10.1083/jcb.200604016; Cullinan SB, 2004, J BIOL CHEM, V279, P20108, DOI 10.1074/jbc.M314219200; DeYoung MP, 2008, GENE DEV, V22, P239, DOI 10.1101/gad.1617608; Duranteau J, 1998, J BIOL CHEM, V273, P11619, DOI 10.1074/jbc.273.19.11619; Edinger AL, 2002, MOL BIOL CELL, V13, P2276, DOI 10.1091/mbc.01-12-0584; Finkel T, 2001, IUBMB LIFE, V52, P3, DOI 10.1080/15216540252774694; Gao P, 2007, CANCER CELL, V12, P230, DOI 10.1016/j.ccr.2007.08.004; Genestra M, 2007, CELL SIGNAL, V19, P1807, DOI 10.1016/j.cellsig.2007.04.009; Gess B, 2003, EUR J BIOCHEM, V270, P2228, DOI 10.1046/j.1432-1033.2003.03590.x; Giaccia A, 2003, NAT REV DRUG DISCOV, V2, P803, DOI 10.1038/nrd1199; Gorlach A, 2006, ANTIOXID REDOX SIGN, V8, P1391, DOI 10.1089/ars.2006.8.1391; Guzy RD, 2005, CELL METAB, V1, P401, DOI 10.1016/j.cmet.2005.05.001; Hamanaka RB, 2005, MOL BIOL CELL, V16, P5493, DOI 10.1091/mbc.E05-03-0268; Harding HP, 2003, MOL CELL, V11, P619, DOI 10.1016/S1097-2765(03)00105-9; HEACOCK CS, 1986, INT J RADIAT ONCOL, V12, P1287, DOI 10.1016/0360-3016(86)90155-0; Hu CJ, 2003, MOL CELL BIOL, V23, P9361, DOI 10.1128/MCB.23.24.9361-9374.2003; Kaelin WG, 2002, GENE DEV, V16, P1441, DOI 10.1101/gad.1003602; Kim JW, 2006, CANCER RES, V66, P8927, DOI 10.1158/0008-5472.CAN-06-1501; Kim JW, 2006, CELL METAB, V3, P177, DOI 10.1016/j.cmet.2006.02.002; Kim YJ, 2007, CANCER RES, V67, P546, DOI 10.1158/0008-5472.CAN-06-2401; Koritzinsky M, 2006, EMBO J, V25, P1114, DOI 10.1038/sj.emboj.7600998; Koritzinsky M, 2007, RADIOTHER ONCOL, V83, P353, DOI 10.1016/j.radonc.2007.04.031; Koumenis C, 2002, MOL CELL BIOL, V22, P7405, DOI 10.1128/MCB.22.21.7405-7416.2002; Koumenis C, 2006, MOL CANCER RES, V4, P423, DOI 10.1158/1541-7786.MCR-06-0150; Liu LP, 2006, MOL CELL, V21, P521, DOI 10.1016/j.molcel.2006.01.010; Lu LR, 2001, MOL CELL BIOL, V21, P7971, DOI 10.1128/MCB.21.23.7971-7980.2001; Lu PD, 2004, EMBO J, V23, P169, DOI 10.1038/sj.emboj.7600030; Lum JJ, 2007, GENE DEV, V21, P1037, DOI 10.1101/gad.1529107; Magagnin MG, 2006, DRUG RESIST UPDATE, V9, P185, DOI 10.1016/j.drup.2006.07.002; Malhotra JD, 2007, ANTIOXID REDOX SIGN, V9, P2277, DOI 10.1089/ars.2007.1782; Mansfield KD, 2005, CELL METAB, V1, P393, DOI 10.1016/j.cmet.2005.05.003; Marciniak SJ, 2006, J CELL BIOL, V172, P201, DOI 10.1083/jcb.200508099; Marciniak SJ, 2004, GENE DEV, V18, P3066, DOI 10.1101/gad.1250704; Novoa I, 2001, J CELL BIOL, V153, P1011, DOI 10.1083/jcb.153.5.1011; Papandreou I, 2006, CELL METAB, V3, P187, DOI 10.1016/j.cmet.2006.01.012; Papandreou I, 2005, CANCER RES, V65, P3171, DOI 10.1158/0008-5472.CAN-04-3395; Patel J, 2002, EUR J BIOCHEM, V269, P3076, DOI 10.1046/j.1432-1033.2002.02992.x; Perkins G, 1997, J STRUCT BIOL, V119, P260, DOI 10.1006/jsbi.1997.3885; Reiling JH, 2004, GENE DEV, V18, P2879, DOI 10.1101/gad.322704; Rhee SG, 1999, EXP MOL MED, V31, P53, DOI 10.1038/emm.1999.9; Scheuner D, 2001, MOL CELL, V7, P1165, DOI 10.1016/S1097-2765(01)00265-9; Semenza GL, 2001, TRENDS MOL MED, V7, P345, DOI 10.1016/S1471-4914(01)02090-1; Simon MC, 2008, NAT REV MOL CELL BIO, V9, P285, DOI 10.1038/nrm2354; Vander Heiden MG, 2001, MOL CELL BIOL, V21, P5899, DOI 10.1128/MCB.21.17.5899-5912.2001; Wouters BG, 2005, SEMIN CELL DEV BIOL, V16, P487, DOI 10.1016/j.semcdb.2005.03.009; Xue X, 2005, J BIOL CHEM, V280, P33917, DOI 10.1074/jbc.M505818200	57	147	151	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 7	2008	283	45					31153	31162		10.1074/jbc.M805056200	http://dx.doi.org/10.1074/jbc.M805056200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	367ID	18768473	Green Published, hybrid			2022-12-27	WOS:000260544800069
J	Maillet, M; Purcell, NH; Sargent, MA; York, AJ; Bueno, OF; Molkentin, JD				Maillet, Marjorie; Purcell, Nicole H.; Sargent, Michelle A.; York, Allen J.; Bueno, Orlando F.; Molkentin, Jeffery D.			DUSP6 (MKP3) Null Mice Show Enhanced ERK1/2 Phosphorylation at Baseline and Increased Myocyte Proliferation in the Heart Affecting Disease Susceptibility	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; MUSCLE CELL-PROLIFERATION; SIGNAL-REGULATED KINASE-2; PHOSPHATASE 2A; CARDIAC-HYPERTROPHY; GENETIC INHIBITION; P38 MAPK; ERK2; OVEREXPRESSION; SPECIFICITY	The strength and duration of mitogen-activated protein kinase signaling is regulated through phosphorylation and dephosphorylation by dedicated dual-specificity kinases and phosphatases, respectively. Here we investigated the physiological role that extracellular signal-regulated kinases 1/2 (ERK1/2) dephosphorylation plays in vivo through targeted disruption of the gene encoding dual-specificity phosphatase 6 (Dusp6) in the mouse. Dusp6(-/-) mice, which were viable, fertile, and otherwise overtly normal, showed an increase in basal ERK1/2 phosphorylation in the heart, spleen, kidney, brain, and fibroblasts, but no change in ERK5, p38, or c-Jun N-terminal kinases activation. However, loss of Dusp6 did not increase or prolong ERK1/2 activation after stimulation, suggesting that its function is more dedicated to basal ERK1/2 signaling tone. In-depth analysis of the physiological effect associated with increased baseline ERK1/2 signaling was performed in cultured mouse embryonic fibroblasts (MEFs) and the heart. Interestingly, mice lacking Dusp6 had larger hearts at every age examined, which was associated with greater rates of myocyte proliferation during embryonic development and in the early postnatal period, resulting in cardiac hypercellularity. This increase in myocyte content in the heart was protective against decompensation and hypertrophic cardiomyopathy following long term pressure overload and myocardial infarction injury in adult mice. Dusp6(-/-) MEFs also showed reduced apoptosis rates compared with wild-type MEFs. These results demonstrate that ERK1/2 signaling is physiologically restrained by DUSP6 in coordinating cellular development and survival characteristics, directly impacting disease-responsiveness in adulthood.	[Molkentin, Jeffery D.] Univ Cincinnati, Dept Pediat, Cincinnati Childrens Hosp, Med Ctr,Div Mol Cardiovasc Biol, Cincinnati, OH 45229 USA	Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati	Molkentin, JD (corresponding author), Univ Cincinnati, Dept Pediat, Cincinnati Childrens Hosp, Med Ctr,Div Mol Cardiovasc Biol, 240 Albert Sabin Way,MLC7020, Cincinnati, OH 45229 USA.	Jeff.Molkentin@cchmc.org		Molkentin, Jeffery/0000-0002-3558-6529	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL081104, P01HL069779, R01HL060562, P50HL077101, R01HL062927] Funding Source: NIH RePORTER; NHLBI NIH HHS [P50 HL077101, R01 HL081104, R01 HL062927, R01 HL060562, R01 HL081104-04, P01 HL069779-06A10003, P50 HL077101-050004, R01 HL060562-11, R01 HL062927-10A1, P01 HL069779] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Adams DG, 2005, J BIOL CHEM, V280, P42644, DOI 10.1074/jbc.M502464200; Alvarado-Kristensson M, 2005, J BIOL CHEM, V280, P6238, DOI 10.1074/jbc.M409718200; Bueno OF, 2002, CIRC RES, V91, P776, DOI 10.1161/01.RES.0000038488.38975.1A; Bueno OF, 2000, EMBO J, V19, P6341, DOI 10.1093/emboj/19.23.6341; Camps M, 2000, FASEB J, V14, P6, DOI 10.1096/fasebj.14.1.6; CLAYCOMB WC, 1983, ADV EXP MED BIOL, V161, P249; Colomer JM, 2004, ENDOCRINOLOGY, V145, P1356, DOI 10.1210/en.2003-1119; Fischer AM, 2005, IMMUNITY, V23, P431, DOI 10.1016/j.immuni.2005.08.013; Fjeld CC, 2000, J BIOL CHEM, V275, P6749, DOI 10.1074/jbc.275.10.6749; Fremin C, 2007, HEPATOLOGY, V45, P1035, DOI 10.1002/hep.21551; Garrington TP, 1999, CURR OPIN CELL BIOL, V11, P211, DOI 10.1016/S0955-0674(99)80028-3; Hatano N, 2003, GENES CELLS, V8, P847, DOI 10.1046/j.1365-2443.2003.00680.x; HO KKL, 1993, J AM COLL CARDIOL, V22, pA6, DOI 10.1016/0735-1097(93)90455-A; Kaiser RA, 2005, J BIOL CHEM, V280, P32602, DOI 10.1074/jbc.M500684200; Kajstura J, 2001, DIABETES, V50, P1414, DOI 10.2337/diabetes.50.6.1414; Letourneux C, 2006, EMBO J, V25, P727, DOI 10.1038/sj.emboj.7600980; LEVY D, 1990, NEW ENGL J MED, V322, P1561, DOI 10.1056/NEJM199005313222203; Li CY, 2007, DEVELOPMENT, V134, P167, DOI 10.1242/dev.02701; Limana F, 2002, P NATL ACAD SCI USA, V99, P6257, DOI 10.1073/pnas.092672899; Liu QH, 2004, AM J PHYSIOL-HEART C, V286, pH2204, DOI 10.1152/ajpheart.01050.2003; Liu SJ, 2006, P NATL ACAD SCI USA, V103, P5326, DOI 10.1073/pnas.0510506103; Meloche S, 2007, ONCOGENE, V26, P3227, DOI 10.1038/sj.onc.1210414; Muda M, 1996, J BIOL CHEM, V271, P4319; Nakayama H, 2007, J CLIN INVEST, V117, P2431, DOI 10.1172/JCI31060; Oh H, 2001, P NATL ACAD SCI USA, V98, P10308, DOI 10.1073/pnas.191169098; Oka T, 2006, CIRC RES, V98, P837, DOI 10.1161/01.RES.0000215985.18538.c4; Ory S, 2003, CURR BIOL, V13, P1356, DOI 10.1016/S0960-9822(03)00535-9; Owens DM, 2007, ONCOGENE, V26, P3203, DOI 10.1038/sj.onc.1210412; Pages G, 1999, SCIENCE, V286, P1374, DOI 10.1126/science.286.5443.1374; Parsons SA, 2006, AM J PATHOL, V168, P1975, DOI 10.2353/ajpath.2006.051316; Purcell NH, 2007, P NATL ACAD SCI USA, V104, P14074, DOI 10.1073/pnas.0610906104; Reiss K, 1996, P NATL ACAD SCI USA, V93, P8630, DOI 10.1073/pnas.93.16.8630; Roberts PJ, 2007, ONCOGENE, V26, P3291, DOI 10.1038/sj.onc.1210422; Saba-El-Leil MK, 2003, EMBO REP, V4, P964, DOI 10.1038/sj.embor.embor939; Shaul YD, 2007, BBA-MOL CELL RES, V1773, P1213, DOI 10.1016/j.bbamcr.2006.10.005; Sundaresan P, 2002, FEBS LETT, V528, P139, DOI 10.1016/S0014-5793(02)03277-5; Taigen T, 2000, P NATL ACAD SCI USA, V97, P1196, DOI 10.1073/pnas.97.3.1196; Theodosiou A, 2002, GENOME BIOL, V3; Weisleder N, 2004, P NATL ACAD SCI USA, V101, P769, DOI 10.1073/pnas.0303202101; Wilkins BJ, 2004, CIRC RES, V94, P110, DOI 10.1161/01.RES.0000109415.17511.18; Wilkins BJ, 2002, MOL CELL BIOL, V22, P7603, DOI 10.1128/MCB.22.21.7603-7613.2002; Yao Y, 2003, P NATL ACAD SCI USA, V100, P12759, DOI 10.1073/pnas.2134254100; Zhang JL, 2003, J BIOL CHEM, V278, P29901, DOI 10.1074/jbc.M303909200; Zhao Y, 2001, J BIOL CHEM, V276, P32382, DOI 10.1074/jbc.M103369200; Zhou B, 2001, J BIOL CHEM, V276, P6506, DOI 10.1074/jbc.M009753200; Zhou B, 1999, J BIOL CHEM, V274, P35526, DOI 10.1074/jbc.274.50.35526; Zhou B, 2002, J BIOL CHEM, V277, P31818, DOI 10.1074/jbc.M203969200; Zhou B, 2006, J BIOL CHEM, V281, P38834, DOI 10.1074/jbc.M608916200; Zindy F, 1998, GENE DEV, V12, P2424, DOI 10.1101/gad.12.15.2424	49	124	128	4	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 7	2008	283	45					31246	31255		10.1074/jbc.M806085200	http://dx.doi.org/10.1074/jbc.M806085200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	367ID	18753132	Green Published, hybrid			2022-12-27	WOS:000260544800078
J	Mukai, H; Hokari, Y; Seki, T; Takao, T; Kubota, M; Matsuo, Y; Tsukagoshi, H; Kato, M; Kimura, H; Shimonishi, Y; Kiso, Y; Nishi, Y; Wakamatsu, K; Munekata, E				Mukai, Hidehito; Hokari, Yoshinori; Seki, Tetsuo; Takao, Toshifumi; Kubota, Makoto; Matsuo, Yuko; Tsukagoshi, Hiroyuki; Kato, Masahiko; Kimura, Hirokazu; Shimonishi, Yasutsugu; Kiso, Yoshiaki; Nishi, Yoshisuke; Wakamatsu, Kaori; Munekata, Eisuke			Discovery of Mitocryptide-1, a Neutrophil-activating Cryptide from Healthy Porcine Heart	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							G-PROTEIN; LEUKEMIA-CELLS; HL-60 CELLS; RECEPTOR; PEPTIDES; BINDING; IDENTIFICATION; INVOLVEMENT; MASTOPARAN; INJURY	Although neutrophils are known to migrate in response to various chemokines and complement factors, the substances involved in the early stages of their transmigration and activation have been poorly characterized to date. Here we report the discovery of a peptide isolated from healthy porcine hearts that activated neutrophils. Its primary structure is H-Leu-Ser-Phe-Leu-Ile-Pro-Ala-Gly-Trp-Val-Leu-Ser-His-Leu-Asp-His-Tyr-Lys-Arg-Ser-Ser-Ala-Ala-OH, and it was indicated to originate from mitochondrial cytochrome c oxidase subunit VIII. This peptide caused chemotaxis at concentrations lower than that inducing beta-hexosaminidase release. Such responses were observed in neutrophilic/granulocytic differentiated HL-60 cells but not in undifferentiated cells, and G(i2)-type G proteins were suggested to be involved in the peptide signaling. Moreover the peptide activated human neutrophils to induce beta-hexosaminidase secretion. A number of other amphipathic neutrophil-activating peptides presumably originating from mitochondrial proteins were also found. The present results suggest that neutrophils monitor such amphipathic peptides including the identified peptide as an initiation signal for inflammation at injury sites.	[Mukai, Hidehito; Kiso, Yoshiaki] Kyoto Pharmaceut Univ, 21st Century COE Program, Kyoto 6078412, Japan; [Mukai, Hidehito; Hokari, Yoshinori; Seki, Tetsuo; Munekata, Eisuke] Univ Tsukuba, Inst Appl Biochem, Tsukuba, Ibaraki 3058572, Japan; [Mukai, Hidehito; Matsuo, Yuko] Mitsubishi Kagaku Inst Life Sci, Lab Peptide Biosignal Engn, Tokyo 1948511, Japan; [Mukai, Hidehito; Nishi, Yoshisuke] JT Inc, Lab Life Sci & Biomol Engn, Kanagawa 2278512, Japan; [Takao, Toshifumi; Shimonishi, Yasutsugu] Osaka Univ, Inst Prot Res, Osaka 5650871, Japan; [Kubota, Makoto; Wakamatsu, Kaori] Gunma Univ, Fac Engn, Dept Biol & Chem Engn, Gunma 3768515, Japan; [Tsukagoshi, Hiroyuki; Kato, Masahiko] Gunma Prefectural Inst Publ Hlth & Environm Sci, Gunma 3710052, Japan; [Kimura, Hirokazu] Natl Inst Infect Dis, Infect Dis Surveillance Ctr, Tokyo 2080011, Japan	Kyoto Pharmaceutical University; University of Tsukuba; Mitsubishi Kagaku Institute of Life Sciences (MITILS); Osaka University; Gunma University; National Institute of Infectious Diseases (NIID)	Mukai, H (corresponding author), Kyoto Pharmaceut Univ, 21st Century COE Program, 1 Shichono Cho, Kyoto 6078412, Japan.	hmukai-endo@umin.ac.jp	Wakamatsu, Kaori/AAQ-9690-2020	Wakamatsu, Kaori/0000-0003-1412-5691	Special Research Project on the Circulation Biosystem; University of Tsukuba; Naito Foundation; Mitsubishi Chemical Corp.; JT Inc.; Ministry of Education, Culture, Sports, Science and Technology of Japan [06680605]	Special Research Project on the Circulation Biosystem; University of Tsukuba; Naito Foundation(Naito Memorial Foundation); Mitsubishi Chemical Corp.; JT Inc.; Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This study was supported by a research grant from the Special Research Project on the Circulation Biosystem, the University of Tsukuba, the Naito Foundation, Mitsubishi Chemical Corp., JT Inc., and Grant-in-aid for Scientific Research 06680605 from the Ministry of Education, Culture, Sports, Science and Technology of Japan. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	BLANK JL, 1991, J BIOL CHEM, V266, P18206; CARP H, 1982, J EXP MED, V155, P264, DOI 10.1084/jem.155.1.264; CHAPLINSKI TJ, 1982, J CLIN INVEST, V70, P953, DOI 10.1172/JCI110707; COLLINS SJ, 1977, NATURE, V270, P347, DOI 10.1038/270347a0; DOUGHERTY RW, 1984, BIOCHEM J, V222, P307, DOI 10.1042/bj2220307; Fukuhara S, 1996, J NEUROCHEM, V67, P1282; GILMAN AG, 1987, ANNU REV BIOCHEM, V56, P615, DOI 10.1146/annurev.bi.56.070187.003151; HIGASHIJIMA T, 1988, J BIOL CHEM, V263, P6491; HIGASHIJIMA T, 1990, J BIOL CHEM, V265, P14176; KAJIRO Y, 1991, ANNU REV BIOCHEM, V60, P349; KANGAWA K, 1983, BIOCHEM BIOPH RES CO, V114, P533, DOI 10.1016/0006-291X(83)90813-6; KANGAWA K, 1984, NATURE, V312, P152, DOI 10.1038/312152a0; Kato M, 2002, J IMMUNOL, V169, P5252, DOI 10.4049/jimmunol.169.9.5252; Klinker JF, 1996, GEN PHARMACOL, V27, P33, DOI 10.1016/0306-3623(95)00107-7; Kojima M, 1999, NATURE, V402, P656, DOI 10.1038/45230; KORTHUIS RJ, 1988, AM J PHYSIOL, V254, pH823, DOI 10.1152/ajpheart.1988.254.5.H823; KRAUTWURST D, 1992, BIOCHEM J, V288, P1025, DOI 10.1042/bj2881025; LAGUNOFF D, 1987, IN VITRO METHODS STU, P13; Ley K, 1996, CARDIOVASC RES, V32, P733, DOI 10.1016/0008-6363(96)00066-1; McColl SR, 1999, J IMMUNOL, V163, P2829; MOUSLI M, 1990, TRENDS PHARMACOL SCI, V11, P358, DOI 10.1016/0165-6147(90)90179-C; MUKAI H, 1989, AM J PHYSIOL, V257, pE235, DOI 10.1152/ajpendo.1989.257.2.E235; MUKAI H, 1987, AM J PHYSIOL, V252, pE765, DOI 10.1152/ajpendo.1987.252.6.E765; MUKAI H, 1992, J BIOL CHEM, V267, P16237; MURPHY PM, 1991, J BIOL CHEM, V266, P12560; Nakajima T, 2000, METH TOOLS BIOSCI ME, P116; Nice Edouard C, 2007, Expert Rev Proteomics, V4, P705, DOI 10.1586/14789450.4.6.705; OINUMA M, 1987, J BIOL CHEM, V262, P8347; Pimenta DC, 2007, PEPTIDES, V28, P2403, DOI 10.1016/j.peptides.2007.10.005; REIM DF, 1997, CURRENT PROTOCOLS PR; ROMSON JL, 1983, CIRCULATION, V67, P1016, DOI 10.1161/01.CIR.67.5.1016; SHAWAR SM, 1995, BIOCHEM BIOPH RES CO, V211, P812, DOI 10.1006/bbrc.1995.1884; SPRINGER TA, 1994, CELL, V76, P301, DOI 10.1016/0092-8674(94)90337-9; TAKAO T, 1993, ANAL CHEM, V65, P2394, DOI 10.1021/ac00065a037; Tanaka T, 1998, J BIOL CHEM, V273, P3247, DOI 10.1074/jbc.273.6.3247; Ueki N, 2007, BIOPOLYMERS, V88, P190, DOI 10.1002/bip.20687; Vinten-Johansen J, 2004, CARDIOVASC RES, V61, P481, DOI 10.1016/j.cardiores.2003.10.011; VITALE N, 1993, J BIOL CHEM, V268, P14715; Xu JS, 2005, P NATL ACAD SCI USA, V102, P6884, DOI 10.1073/pnas.0502106102; ZOGORSKI J, 1997, J IMMUNOL, V159, P1059	40	29	30	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 7	2008	283	45					30596	30605		10.1074/jbc.M803913200	http://dx.doi.org/10.1074/jbc.M803913200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	367ID	18768476	Green Published, hybrid			2022-12-27	WOS:000260544800018
J	Pai, VP; Horseman, ND				Pai, Vaibhav P.; Horseman, Nelson D.			Biphasic Regulation of Mammary Epithelial Resistance by Serotonin through Activation of Multiple Pathways	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TIGHT JUNCTION PERMEABILITY; MILK SECRETION; FEEDBACK INHIBITOR; GLAND DEVELOPMENT; 5-HT7 RECEPTOR; PROTEIN; KINASE; CAMP; PHOSPHORYLATION; INVOLUTION	Mammary gland homeostasis and the lactation-to-involution switch are regulated by serotonin (5-hydroxytryptamine (5-HT)). Mammary epithelial tight junctions are physiological targets of 5-HT, and their disruption marks an early stage of mammary gland involution. In these studies, we have identified signal transduction mechanism employed by 5-HT during regulation of mammary gland transepithelial resistance. Transepithelial electrical resistance and tight junction protein architecture were studied in cultures of MCF10A human mammary epithelial cells. Serotonin had biphasic effects on mammary epithelial resistance. At lower concentrations and earlier time points, 5-HT potentiated epithelial transmembrane resistance, whereas at higher concentrations and later time points, 5-HT decreased transepithelial electrical resistance and disrupted tight junctions. Both the early and delayed actions of 5-HT were mediated by the 5-HT7 receptor through activation of G(s)/cAMP. 5-HT induced the activities of both protein kinase A and p38 mitogen-activated protein kinase. Inhibition of p38 mitogen-activated protein kinase abrogated 5-HT-induced disruption of mammary epithelial tight junctions (the delayed effect). In contrast, inhibition of protein kinase A prevented the increased epithelial resistance in response to 5-HT (the transient effect). These studies imply an integrated set of mechanisms whereby transient, modest activation of 5-HT7 promotes tight junction integrity, and sustained 5-HT7 activation drives involution by disrupting tight junctions.	[Pai, Vaibhav P.; Horseman, Nelson D.] Univ Cincinnati, Dept Mol & Cellular Physiol, Cincinnati, OH 45267 USA	University System of Ohio; University of Cincinnati	Horseman, ND (corresponding author), Univ Cincinnati, Dept Mol & Cellular Physiol, 231 Albert Sabin way,MSB, Cincinnati, OH 45267 USA.	nelson.horseman@uc.edu			National Institutes of HEalth [DK52134]; Department of the Army [BC052576]; National Research Initiative Competitive [2007-35206-17898]; States Department of Agriculture Cooperative State Research, Education, and Extension Service; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK052134] Funding Source: NIH RePORTER	National Institutes of HEalth(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of the Army; National Research Initiative Competitive(United States Department of Agriculture (USDA)); States Department of Agriculture Cooperative State Research, Education, and Extension Service; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of HEalth Grant DK52134. This work was also supported by Department of the Army Grant BC052576 ( to N. D. H.). This project was also supported by National Research Initiative Competitive Grant 2007-35206-17898 from the States Department of Agriculture Cooperative State Research, Education, and Extension Service. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked " advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Andreeva AY, 2001, J BIOL CHEM, V276, P38480, DOI 10.1074/jbc.M104923200; BARD JA, 1993, J BIOL CHEM, V268, P23422; BERGA SE, 1984, AM J PHYSIOL, V247, pC20, DOI 10.1152/ajpcell.1984.247.1.C20; Berle P, 1972, Zentralbl Gynakol, V94, P1081; D'Souza T, 2005, J BIOL CHEM, V280, P26233, DOI 10.1074/jbc.M502003200; DAVIS JW, 1969, ENDOCRINOLOGY, V85, P155, DOI 10.1210/endo-85-1-155; Debnath J, 2003, METHODS, V30, P256, DOI 10.1016/S1046-2023(03)00032-X; Debnath J, 2002, CELL, V111, P29, DOI 10.1016/S0092-8674(02)01001-2; Dhanasekaran N, 1996, CELL SIGNAL, V8, P235, DOI 10.1016/0898-6568(96)00048-4; FAURE M, 1994, J BIOL CHEM, V269, P7851; FLINT DJ, 1994, ENDOCRINOLOGY, V135, P1119, DOI 10.1210/en.135.3.1119; Gonzalez-Mariscal L, 2008, BBA-BIOMEMBRANES, V1778, P729, DOI 10.1016/j.bbamem.2007.08.018; Grimm SL, 2002, MOL ENDOCRINOL, V16, P2675, DOI 10.1210/me.2002-0239; GROSVENOR CE, 1959, P SOC EXP BIOL MED, V101, P699, DOI 10.3181/00379727-101-25066; Guillemot L, 2008, BBA-BIOMEMBRANES, V1778, P601, DOI 10.1016/j.bbamem.2007.09.032; Guthrie CR, 2005, J PHARMACOL EXP THER, V313, P1003, DOI 10.1124/jpet.104.081919; Hendry KAK, 1998, J MOL ENDOCRINOL, V21, P169, DOI 10.1677/jme.0.0210169; Hernandez LL, 2008, J DAIRY SCI, V91, P1834, DOI 10.3168/jds.2007-0766; Hernandez S, 2007, EXP CELL RES, V313, P1533, DOI 10.1016/j.yexcr.2007.01.026; Knight CH, 1998, REV REPROD, V3, P104, DOI 10.1530/ror.0.0030104; Krobert KA, 2002, BRIT J PHARMACOL, V135, P1563, DOI 10.1038/sj.bjp.0704588; Kvachnina E, 2005, J NEUROSCI, V25, P7821, DOI 10.1523/JNEUROSCI.1790-05.2005; Lin SL, 2003, J NEUROCHEM, V87, P1076, DOI 10.1046/j.1471-4159.2003.02076.x; Lui WY, 2005, J CELL PHYSIOL, V203, P564, DOI 10.1002/jcp.20254; Lund LR, 1996, DEVELOPMENT, V122, P181; Mahe C, 2004, BRIT J PHARMACOL, V143, P404, DOI 10.1038/sj.bjp.0705936; Martin TA, 2004, EUR J CANCER, V40, P2717, DOI 10.1016/j.ejca.2004.08.008; Matsuda M, 2004, DEV CELL, V6, P193, DOI 10.1016/S1534-5807(04)00022-X; McManaman JL, 2003, ADV DRUG DELIVER REV, V55, P629, DOI 10.1016/S0169-409X(03)00033-4; MORGAN G, 1982, J DAIRY RES, V49, P1, DOI 10.1017/S002202990002207X; Nguyen DA, 2001, J ENDOCRINOL, V170, P347, DOI 10.1677/joe.0.1700347; Nguyen DAD, 1998, J MAMMARY GLAND BIOL, V3, P233, DOI 10.1023/A:1018707309361; PEAKER M, 1980, J PHYSIOL-LONDON, V301, P415, DOI 10.1113/jphysiol.1980.sp013214; Raymond JR, 2001, PHARMACOL THERAPEUT, V92, P179, DOI 10.1016/S0163-7258(01)00169-3; RENNISON ME, 1993, J CELL SCI, V106, P641; RUAT M, 1993, P NATL ACAD SCI USA, V90, P8547, DOI 10.1073/pnas.90.18.8547; Sakakibara A, 1997, J CELL BIOL, V137, P1393, DOI 10.1083/jcb.137.6.1393; Schneeberger EE, 2004, AM J PHYSIOL-CELL PH, V286, pC1213, DOI 10.1152/ajpcell.00558.2003; Seo M, 2002, J BIOL CHEM, V277, P24197, DOI 10.1074/jbc.M201717200; Seo MR, 2004, J BIOL CHEM, V279, P17366, DOI 10.1074/jbc.M312442200; Shimizu M, 1998, BRAIN RES, V784, P57, DOI 10.1016/S0006-8993(97)01185-2; Shin K, 2006, ANNU REV CELL DEV BI, V22, P207, DOI 10.1146/annurev.cellbio.22.010305.104219; SINGER KL, 1994, J BIOL CHEM, V269, P16108; SOULE HD, 1990, CANCER RES, V50, P6075; Stein T, 2007, J MAMMARY GLAND BIOL, V12, P25, DOI 10.1007/s10911-007-9035-7; STELWAGEN K, 1995, AM J PHYSIOL-REG I, V269, pR848, DOI 10.1152/ajpregu.1995.269.4.R848; Stelwagen K, 1997, AM J PHYSIOL-REG I, V273, pR379, DOI 10.1152/ajpregu.1997.273.1.R379; Stelwagen K, 1999, MOL CELL ENDOCRINOL, V156, P55, DOI 10.1016/S0303-7207(99)00145-8; STELWAGEN K, 1994, J DAIRY SCI, V77, P426, DOI 10.3168/jds.S0022-0302(94)76969-1; STUCKI JC, 1960, ACTA ENDOCRINOL-COP, V33, P73; Stull MA, 2007, P NATL ACAD SCI USA, V104, P16708, DOI 10.1073/pnas.0708136104; Watson CJ, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1401; WILDE CJ, 1987, BIOCHEM J, V242, P285, DOI 10.1042/bj2420285; Zahraoui A, 2000, J CELL BIOL, V151, pF31, DOI 10.1083/jcb.151.5.F31	54	74	77	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 7	2008	283	45					30901	30910		10.1074/jbc.M802476200	http://dx.doi.org/10.1074/jbc.M802476200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	367ID	18782769	Green Published, hybrid			2022-12-27	WOS:000260544800045
J	Plesca, D; Mazumder, S; Gama, V; Matsuyama, S; Almasan, A				Plesca, Dragos; Mazumder, Suparna; Gama, Vivian; Matsuyama, Shigemi; Almasan, Alexandru			A C-terminal Fragment of Cyclin E, Generated by Caspase-mediated Cleavage, Is Degraded in the Absence of a Recognizable Phosphodegron	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SCFFBW7 UBIQUITIN LIGASE; CELL-CYCLE; MULTISITE PHOSPHORYLATION; HEMATOPOIETIC-CELLS; DNA-REPLICATION; APOPTOSIS; CANCER; DEGRADATION; PROTEIN; PROTEASOME	We have previously shown that caspase-mediated cleavage of Cyclin E generates p18-Cyclin E in hematopoietic tumor cells. Its expression can induce apoptosis or sensitize to apoptotic stimuli in many cell types. However, p18-cyclin E has a much shorter halflife than Cyclin E, being more effectively ubiquitinated and degraded by the 26 S proteasome. A two-step process has emerged that regulates accelerated degradation of Cyclin E, with a caspase-mediated cleavage followed by enhanced proteasome- mediated degradation. We show that recognition of p18-Cyclin E by the Skp1-Cul1-Fbw7 (SCF) complex and its interaction with the Fbw7 protein isoforms can take place independently of phosphorylation of p18-Cyclin E at a C-terminal phosphodegron. In addition to the SCFFbw7 pathway, Ku70 binding that facilitates Hdm2 recruitment may also be implicated in p18-Cyclin E ubiquitination. Blocking p18-Cyclin E degradation with proteasome inhibitors increases levels of p18-Cyclin E and enhances its association with Ku70, thus leading to Bax release, its activation, and apoptosis. Moreover, cells expressing p18-Cyclin E are more sensitive to treatment with proteasome inhibitors, such as Bortezomib. By preventing its proteasomal degradation, p18-Cyclin E, but not Cyclin E, may become an effective therapeutic target for Bortezomib and apoptotic effectors in hematopoietic malignancies.	[Plesca, Dragos; Mazumder, Suparna; Almasan, Alexandru] Cleveland Clin, Dept Canc Biol, Lerner Res Inst, Cleveland, OH 44195 USA; [Almasan, Alexandru] Cleveland Clin, Dept Radiat Oncol, Cleveland, OH 44195 USA; [Plesca, Dragos] Kent State Univ, Sch Biomed Sci, Kent, OH 44240 USA; [Gama, Vivian; Matsuyama, Shigemi] Case Western Reserve Univ, Dept Med, Div Hematol Oncol, Cleveland, OH 44106 USA; [Gama, Vivian; Matsuyama, Shigemi] Case Western Reserve Univ, Dept Pharmacol, Cleveland, OH 44106 USA; [Matsuyama, Shigemi] Case Comprehens Canc Ctr, Div Gen Med Sci Oncol, Cleveland, OH 44106 USA	Cleveland Clinic Foundation; Cleveland Clinic Foundation; University System of Ohio; Kent State University; Kent State University Kent; Kent State University Salem; Case Western Reserve University; Case Western Reserve University; Case Western Reserve University	Almasan, A (corresponding author), 9500 Euclid Ave,NB4, Cleveland, OH 44195 USA.	almasaa@ccf.org	Almasan, Alex/C-2715-2008	Almasan, Alex/0000-0002-8916-6650; Gama, Vivian/0000-0002-1201-1394	National Institutes of Health [CA-81504]; NATIONAL CANCER INSTITUTE [R01CA081504] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA-81504. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked " advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Adams J, 2004, NAT REV CANCER, V4, P349, DOI 10.1038/nrc1361; Chauhan D, 2005, MOL CANCER THER, V4, P686, DOI 10.1158/1535-7163.MCT-04-0338; Clurman BE, 1996, GENE DEV, V10, P1979, DOI 10.1101/gad.10.16.1979; Elledge SJ, 1996, SCIENCE, V274, P1664, DOI 10.1126/science.274.5293.1664; Geisen C, 2002, J BIOL CHEM, V277, P39909, DOI 10.1074/jbc.M205919200; Gong BD, 1999, CELL GROWTH DIFFER, V10, P491; Green DR, 2002, CANCER CELL, V1, P19, DOI 10.1016/S1535-6108(02)00024-7; Grim JE, 2008, J CELL BIOL, V181, P913, DOI 10.1083/jcb.200802076; Hao B, 2007, MOL CELL, V26, P131, DOI 10.1016/j.molcel.2007.02.022; Haupt Y, 1997, NATURE, V387, P296, DOI 10.1038/387296a0; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; JACKSON PK, 1995, J CELL BIOL, V130, P755, DOI 10.1083/jcb.130.4.755; Jin JP, 2003, GENE DEV, V17, P3062, DOI 10.1101/gad.1157503; Kanemori Y, 2005, P NATL ACAD SCI USA, V102, P6279, DOI 10.1073/pnas.0501873102; Koepp DM, 2001, SCIENCE, V294, P173, DOI 10.1126/science.1065203; Kubbutat MHG, 1997, NATURE, V387, P299, DOI 10.1038/387299a0; Mazumder S, 2002, MOL CELL BIOL, V22, P2398, DOI 10.1128/MCB.22.7.2398-2409.2002; Mazumder S, 2000, ONCOGENE, V19, P2828, DOI 10.1038/sj.onc.1203623; Mazumder S, 2007, CELL CYCLE, V6, P1437; Mazumder S, 2007, MOL CELL BIOL, V27, P3511, DOI 10.1128/MCB.01448-06; McEvoy JD, 2007, MOL CELL BIOL, V27, P3651, DOI 10.1128/MCB.00720-06; Minella AC, 2008, GENE DEV, V22, P1677, DOI 10.1101/gad.1650208; Moberg KH, 2001, NATURE, V413, P311, DOI 10.1038/35095068; Murray AW, 2004, CELL, V116, P221, DOI 10.1016/S0092-8674(03)01080-8; Nakayama KI, 2006, NAT REV CANCER, V6, P369, DOI 10.1038/nrc1881; Nash P, 2001, NATURE, V414, P514, DOI 10.1038/35107009; Nawrocki ST, 2005, CANCER RES, V65, P11510, DOI 10.1158/0008-5472.CAN-05-2394; OHTSUBO M, 1995, MOL CELL BIOL, V15, P2612; Orlowski RZ, 2008, CLIN CANCER RES, V14, P1649, DOI 10.1158/1078-0432.CCR-07-2218; Reed SI, 2003, NAT REV MOL CELL BIO, V4, P855, DOI 10.1038/nrm1246; RESNITZKY D, 1995, MOL CELL BIOL, V15, P3463; Singer JD, 1999, GENE DEV, V13, P2375, DOI 10.1101/gad.13.18.2375; Sobol RW, 2008, MOL CELL, V29, P413, DOI 10.1016/j.molcel.2008.02.004; Spruck CH, 2002, CANCER RES, V62, P4535; Strohmaier H, 2001, NATURE, V413, P316, DOI 10.1038/35095076; Taylor RC, 2008, NAT REV MOL CELL BIO, V9, P231, DOI 10.1038/nrm2312; van Drogen F, 2006, MOL CELL, V23, P37, DOI 10.1016/j.molcel.2006.05.020; Welcker M, 2003, MOL CELL, V12, P381, DOI 10.1016/S1097-2765(03)00287-9; Welcker M, 2008, NAT REV CANCER, V8, P83, DOI 10.1038/nrc2290; Won KA, 1996, EMBO J, V15, P4182, DOI 10.1002/j.1460-2075.1996.tb00793.x; Ye X, 2004, J BIOL CHEM, V279, P50110, DOI 10.1074/jbc.M409226200; Zhang W, 2006, MOL CANCER RES, V4, P935, DOI 10.1158/1541-7786.MCR-06-0253	42	13	13	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 7	2008	283	45					30796	30803		10.1074/jbc.M804642200	http://dx.doi.org/10.1074/jbc.M804642200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	367ID	18784078	hybrid, Green Published			2022-12-27	WOS:000260544800034
J	Reeder, BJ; Grey, M; Silaghi-Dumitrescu, RL; Svistunenko, DA; Bulow, L; Cooper, CE; Wilson, MT				Reeder, Brandon J.; Grey, Marie; Silaghi-Dumitrescu, Radu-Lucian; Svistunenko, Dimitri A.; Bulow, Leif; Cooper, Chris E.; Wilson, Michael T.			Tyrosine Residues as Redox Cofactors in Human Hemoglobin IMPLICATIONS FOR ENGINEERING NONTOXIC BLOOD SUBSTITUTES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OXIDATIVE STRESS; FERRYL MYOGLOBIN; HEME; RHABDOMYOLYSIS; MECHANISM; PEROXIDE; RADICALS; PROTECT; STATES; ACID	Respiratory proteins such as myoglobin and hemoglobin can, under oxidative conditions, form ferryl heme iron and protein-based free radicals. Ferryl myoglobin can safely be returned to the ferric oxidation state by electron donation from exogenous reductants via a mechanism that involves two distinct pathways. In addition to direct transfer between the electron donor and ferryl heme edge, there is a second pathway that involves "through-protein" electron transfer via a tyrosine residue (tyrosine 103, sperm whale myoglobin). Here we show that the heterogeneous subunits of human hemoglobin, the alpha and beta chains, display significantly different kinetics for ferryl reduction by exogenous reductants. By using selected hemoglobin mutants, we show that the alpha chain possesses two electron transfer pathways, similar to myoglobin. Furthermore, tyrosine 42 is shown to be a critical component of the high affinity, through-protein electron transfer pathway. We also show that the beta chain of hemoglobin, lacking the homologous tyrosine, does not possess this through-protein electron transfer pathways.However, such a pathway can be engineered into the protein by mutation of a specific phenylalanine residue to a tyrosine. High affinity through-protein electron transfer pathways, whether native or engineered, enhance the kinetics of ferryl removal by reductants, particularly at low reductant concentrations. Ferryl iron has been suggested to be a major cause of the oxidative toxicity of hemoglobin-based blood substitutes. Engineering hemoglobin with enhanced rates of ferryl removal, as we show here, is therefore likely to result in molecules better suited for in vivo oxygen delivery.	[Reeder, Brandon J.; Svistunenko, Dimitri A.; Cooper, Chris E.; Wilson, Michael T.] Univ Essex, Dept Biol Sci, Colchester CO4 3SQ, Essex, England; [Grey, Marie; Bulow, Leif] Lund Univ, Dept Pure & Appl Biochem, SE-22100 Lund, Sweden; [Silaghi-Dumitrescu, Radu-Lucian] Univ Babes Bolyai, RO-400084 Cluj Napoca, Romania	University of Essex; Lund University; Babes Bolyai University from Cluj	Reeder, BJ (corresponding author), Univ Essex, Dept Biol Sci, Wivenhoe Pk, Colchester CO4 3SQ, Essex, England.	reedb@essex.ac.uk	Cooper, Chris/AAK-9729-2020; Silaghi-Dumitrescu, Radu/A-2883-2008; Reeder, Brandon/AAI-1450-2020	Cooper, Chris/0000-0003-0381-3990; Silaghi-Dumitrescu, Radu/0000-0003-3038-7747; Reeder, Brandon/0000-0001-7474-2611; Svistunenko, Dimitri/0000-0001-8060-2738	European Union Framework VI; Biotechnology and Biological Sciences Research Council	European Union Framework VI(European Commission); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by European Union Framework VI and Biotechnology and Biological Sciences Research Council. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	Alayash AI, 2007, EXPERT OPIN BIOL TH, V7, P665, DOI 10.1517/14712598.7.5.665; Antonini E., 1971, FRONT BIOL, P13; ARDUINI A, 1990, FREE RADICAL BIO MED, V9, P511, DOI 10.1016/0891-5849(90)90130-B; BULL C, 1975, P NATL ACAD SCI USA, V72, P3382, DOI 10.1073/pnas.72.9.3382; BURKERT LB, 1976, BLOOD, V48, P645; COOPER CE, 1994, FREE RADICAL RES, V20, P219, DOI 10.3109/10715769409147518; D'Agnillo F, 2002, FREE RADICAL BIO MED, V33, P1153, DOI 10.1016/S0891-5849(02)01007-9; GIULIVI C, 1993, FEBS LETT, V332, P287, DOI 10.1016/0014-5793(93)80651-A; Holt S, 1999, LANCET, V353, P1241, DOI 10.1016/S0140-6736(98)05768-7; IMAI K, 1991, J MOL BIOL, V218, P769, DOI 10.1016/0022-2836(91)90265-8; Kavanaugh JS, 2005, BIOCHEMISTRY-US, V44, P3806, DOI 10.1021/bi0484670; Lardinois OM, 2004, BIOCHEMISTRY-US, V43, P4601, DOI 10.1021/bi036241b; MAILLETT DH, 2006, DESIGNING RECOMBINAN; Moore KP, 1998, J BIOL CHEM, V273, P31731, DOI 10.1074/jbc.273.48.31731; Natanson C, 2008, JAMA-J AM MED ASSOC, V299, P2304, DOI 10.1001/jama.299.19.jrv80007; OSAWA Y, 1991, P NATL ACAD SCI USA, V88, P7081, DOI 10.1073/pnas.88.16.7081; Panetta G, 2008, BBA-PROTEINS PROTEOM, V1784, P1462, DOI 10.1016/j.bbapap.2008.01.003; Reeder BJ, 2005, CURR MED CHEM, V12, P2741, DOI 10.2174/092986705774463021; Reeder BJ, 2005, CHEM RES TOXICOL, V18, P1004, DOI 10.1021/tx049660y; Reeder BJ, 2002, BIOCHEM SOC T, V30, P745, DOI 10.1042/bst0300745; Reeder BJ, 2002, BIOCHEMISTRY-US, V41, P367, DOI 10.1021/bi011335b; Reeder BJ, 2008, FREE RADICAL BIO MED, V44, P264, DOI 10.1016/j.freeradbiomed.2007.08.006; Reeder BJ, 2008, FREE RADICAL BIO MED, V44, P274, DOI 10.1016/j.freeradbiomed.2007.06.030; Sambrook J, 2001, MOL CLONING LAB MAN; Svistunenko DA, 2002, BIOPHYS J, V83, P2845, DOI 10.1016/S0006-3495(02)75293-4; Svistunenko DA, 1997, J BIOL CHEM, V272, P7114, DOI 10.1074/jbc.272.11.7114; Vollaard NBJ, 2005, FREE RADICAL BIO MED, V39, P1216, DOI 10.1016/j.freeradbiomed.2005.06.012; Vuletich JL, 2000, BIOCHEM BIOPH RES CO, V269, P647, DOI 10.1006/bbrc.2000.2349; WALTERS FP, 1983, FEBS LETT, V163, P292, DOI 10.1016/0014-5793(83)80838-2; WEIL JA, 1994, ELECT PARAMAGNETIC R, P510; Winslow RM, 2006, VOX SANG, V91, P102, DOI 10.1111/j.1423-0410.2006.00789.x	31	105	111	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 7	2008	283	45					30780	30787		10.1074/jbc.M804709200	http://dx.doi.org/10.1074/jbc.M804709200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	367ID	18728007	hybrid, Green Published			2022-12-27	WOS:000260544800083
J	Santelia, D; Henrichs, S; Vincenzetti, V; Sauer, M; Bigler, L; Klein, M; Bailly, A; Lee, Y; Friml, J; Geisler, M; Martinoia, E				Santelia, Diana; Henrichs, Sina; Vincenzetti, Vincent; Sauer, Michael; Bigler, Laurent; Klein, Markus; Bailly, Aurelien; Lee, Youngsook; Friml, Jiri; Geisler, Markus; Martinoia, Enrico			Flavonoids Redirect PIN-mediated Polar Auxin Fluxes during Root Gravitropic Responses	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ARABIDOPSIS-THALIANA; P-GLYCOPROTEINS; ABC TRANSPORTERS; EFFLUX; REGULATORS; LOCALIZATION; PROTEINS; PLANTS; ACCUMULATION; GLYCOSIDES	The rate, polarity, and symmetry of the flow of the plant hormone auxin are determined by the polar cellular localization of PIN-FORMED (PIN) auxin efflux carriers. Flavonoids, a class of secondary plant metabolites, have been suspected to modulate auxin transport and tropic responses. Nevertheless, the identity of specific flavonoid compounds involved and their molecular function and targets in vivo are essentially unknown. Here we show that the root elongation zone of agravitropic pin2/eir1/wav6/agr1 has an altered pattern and amount of flavonol glycosides. Application of nanomolar concentrations of flavonols to pin2 roots is sufficient to partially restore root gravitropism. By employing a quantitative cell biological approach, we demonstrate that flavonoids partially restore the formation of lateral auxin gradients in the absence of PIN2. Chemical complementation by flavonoids correlates with an asymmetric distribution of the PIN1 protein. pin2 complementation probably does not result from inhibition of auxin efflux, as supply of the auxin transport inhibitor N-1-naphthylphthalamic acid failed to restore pin2 gravitropism. We propose that flavonoids promote asymmetric PIN shifts during gravity stimulation, thus redirecting basipetal auxin streams necessary for root bending.	[Santelia, Diana; Henrichs, Sina; Vincenzetti, Vincent; Klein, Markus; Bailly, Aurelien; Geisler, Markus; Martinoia, Enrico] Univ Zurich, Inst Plant Biol, Lab Mol Plant Physiol, CH-8008 Zurich, Switzerland; [Sauer, Michael; Friml, Jiri] Univ Gottingen, Dept Plant Cell Biol, D-30073 Gottingen, Germany; [Bigler, Laurent] Univ Zurich, Inst Organ Chem, CH-8057 Zurich, Switzerland; [Lee, Youngsook; Martinoia, Enrico] Pohang Univ Sci & Technol, Postech UZH Global Res Lab, Pohang 790784, South Korea	University of Zurich; University of Gottingen; University of Zurich; Pohang University of Science & Technology (POSTECH)	Geisler, M (corresponding author), Univ Zurich, Inst Plant Biol, Lab Mol Plant Physiol, Zollikerstr 107, CH-8008 Zurich, Switzerland.	markus.geisler@botinst.uzh.ch; enrico.martinoia@botinst.uzh.ch	Martinoia, Enrico/AAH-8712-2021; Lee, Youngsook/E-6578-2016; Friml, Jiri/D-9511-2012; Geisler, Markus M/B-3921-2012; Bigler, Laurent/AAP-3799-2020; Santelia, Diana/AAQ-3967-2020; Sauer, Michael/F-6519-2014; Sauer, Michael/G-3424-2011	Lee, Youngsook/0000-0002-5808-9613; Friml, Jiri/0000-0002-8302-7596; Geisler, Markus M/0000-0002-6641-5810; Bigler, Laurent/0000-0003-3548-3594; Sauer, Michael/0000-0002-4014-9825; 	Swiss National Foundation [3100AO-111912]; Novartis foundation; Ministry of Science and Technology of South Korea	Swiss National Foundation(Swiss National Science Foundation (SNSF)); Novartis foundation(Novartis); Ministry of Science and Technology of South Korea(Ministry of Science & Technology (MOST), Republic of Korea)	This work was supported by the Swiss National Foundation Grant 3100AO-111912 (to M.G.) and a grant to E.M. (within the NCCR Plant Survival), a grant from the Novartis foundation (to M.G.) and by a grant from the Ministry of Science and Technology of South Korea (to Y.L. and E.M.).	Abas L, 2006, NAT CELL BIOL, V8, P249, DOI 10.1038/ncb1369; Bailly A, 2008, J BIOL CHEM, V283, P21817, DOI 10.1074/jbc.M709655200; Blakeslee JJ, 2007, PLANT CELL, V19, P131, DOI 10.1105/tpc.106.040782; Blilou I, 2005, NATURE, V433, P39, DOI 10.1038/nature03184; Bouchard R, 2006, J BIOL CHEM, V281, P30603, DOI 10.1074/jbc.M604604200; Brown DE, 2001, PLANT PHYSIOL, V126, P524, DOI 10.1104/pp.126.2.524; Buer CS, 2007, PLANT PHYSIOL, V145, P478, DOI 10.1104/pp.107.101824; Buer CS, 2006, PLANT PHYSIOL, V140, P1384, DOI 10.1104/pp.105.075671; Buer CS, 2004, PLANT CELL, V16, P1191, DOI 10.1105/tpc.020313; Casimiro I, 2001, PLANT CELL, V13, P843, DOI 10.1105/tpc.13.4.843; Chen RJ, 1998, P NATL ACAD SCI USA, V95, P15112, DOI 10.1073/pnas.95.25.15112; Conseil G, 1998, P NATL ACAD SCI USA, V95, P9831, DOI 10.1073/pnas.95.17.9831; Friml J, 2004, SCIENCE, V306, P862, DOI 10.1126/science.1100618; Friml J, 2003, PLANT J, V34, P115, DOI 10.1046/j.1365-313X.2003.01705.x; Geisler M, 2006, FEBS LETT, V580, P1094, DOI 10.1016/j.febslet.2005.11.054; Geisler M, 2005, PLANT J, V44, P179, DOI 10.1111/j.1365-313X.2005.02519.x; JACOBS M, 1988, SCIENCE, V241, P346, DOI 10.1126/science.241.4863.346; Kerhoas L, 2006, J AGR FOOD CHEM, V54, P6603, DOI 10.1021/jf061043n; Kerr ID, 2007, BIOCHEM J, V401, P613, DOI 10.1042/BJ20061411; Lewis DR, 2007, PLANT CELL, V19, P1838, DOI 10.1105/tpc.107.051599; Lomax Terri L., 1995, P509; Luschnig C, 1998, GENE DEV, V12, P2175, DOI 10.1101/gad.12.14.2175; Luschnig C, 2002, TRENDS PLANT SCI, V7, P329, DOI 10.1016/S1360-1385(02)02292-6; Marchant A, 1999, EMBO J, V18, P2066, DOI 10.1093/emboj/18.8.2066; Michniewicz M, 2007, CELL, V130, P1044, DOI 10.1016/j.cell.2007.07.033; Moore I, 2002, CURR BIOL, V12, pR452, DOI 10.1016/S0960-9822(02)00943-0; Morris DA, 2000, PLANT GROWTH REGUL, V32, P161, DOI 10.1023/A:1010701527848; Morris ME, 2006, LIFE SCI, V78, P2116, DOI 10.1016/j.lfs.2005.12.003; Muday GK, 2001, J PLANT GROWTH REGUL, V20, P226, DOI 10.1007/s003440010027; Muller A, 1998, EMBO J, V17, P6903, DOI 10.1093/emboj/17.23.6903; Murphy A, 2000, PLANTA, V211, P315, DOI 10.1007/s004250000300; Noh B, 2001, PLANT CELL, V13, P2441, DOI 10.1105/tpc.13.11.2441; Ottenschlager I, 2003, P NATL ACAD SCI USA, V100, P2987, DOI 10.1073/pnas.0437936100; Paciorek T, 2005, NATURE, V435, P1251, DOI 10.1038/nature03633; Peer W.A., 2006, SCI FLAVONOIDS, P239, DOI [10.1007/978-0-387-28822-2_9, DOI 10.1007/978-0-387-28822-2_9]; Peer WA, 2004, PLANT CELL, V16, P1898, DOI 10.1105/tpc.021501; Peer WA, 2001, PLANT PHYSIOL, V126, P536, DOI 10.1104/pp.126.2.536; Peer WA, 2007, TRENDS PLANT SCI, V12, P556, DOI 10.1016/j.tplants.2007.10.003; Rashotte AM, 2000, PLANT PHYSIOL, V122, P481, DOI 10.1104/pp.122.2.481; Rashotte AM, 2001, PLANT CELL, V13, P1683, DOI 10.1105/tpc.13.7.1683; Routaboul JM, 2006, PLANTA, V224, P96, DOI 10.1007/s00425-005-0197-5; Santner AA, 2006, PLANT J, V45, P752, DOI 10.1111/j.1365-313X.2005.02641.x; Stobiecki M, 1999, PHYTOCHEM ANALYSIS, V10, P198, DOI 10.1002/(SICI)1099-1565(199907/08)10:4&lt;198::AID-PCA454&gt;3.0.CO;2-C; Swarup R, 2001, GENE DEV, V15, P2648, DOI 10.1101/gad.210501; Taylor LP, 2005, CURR OPIN PLANT BIOL, V8, P317, DOI 10.1016/j.pbi.2005.03.005; Terasaka K, 2005, PLANT CELL, V17, P2922, DOI 10.1105/tpc.105.035816; Tohge T, 2005, PLANT J, V42, P218, DOI 10.1111/j.1365-313X.2005.02371.x; Utsuno K, 1998, PLANT CELL PHYSIOL, V39, P1111, DOI 10.1093/oxfordjournals.pcp.a029310; Vieten A, 2005, DEVELOPMENT, V132, P4521, DOI 10.1242/dev.02027; Vieten A, 2007, TRENDS PLANT SCI, V12, P160, DOI 10.1016/j.tplants.2007.03.006; Wisniewska J, 2006, SCIENCE, V312, P883, DOI 10.1126/science.1121356; Wu G, 2007, PLANT CELL, V19, P1826, DOI 10.1105/tpc.106.048777	52	137	143	1	57	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 7	2008	283	45					31218	31226		10.1074/jbc.M710122200	http://dx.doi.org/10.1074/jbc.M710122200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	367ID	18718912	hybrid, Green Published, Green Accepted			2022-12-27	WOS:000260544800075
J	Galdiero, S; Falanga, A; Vitiello, M; Raiola, L; Fattorusso, R; Browne, H; Pedone, C; Isernia, C; Galdiero, M				Galdiero, Stefania; Falanga, Annarita; Vitiello, Mariateresa; Raiola, Luca; Fattorusso, Roberto; Browne, Helena; Pedone, Carlo; Isernia, Carla; Galdiero, Massimiliano			Analysis of a Membrane Interacting Region of Herpes Simplex Virus Type 1 Glycoprotein H	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FUSION PEPTIDE; ALPHA-HELIX; CELL-FUSION; TRANSMEMBRANE ORIENTATION; PHOSPHOLIPID-MEMBRANES; FUSOGENIC DOMAINS; CRYSTAL-STRUCTURE; CYTOPLASMIC TAIL; HEPARAN-SULFATE; HEPTAD-REPEAT	Glycoprotein H (gH) of herpes simplex virus type I (HSV-1) is involved in the complex mechanism of membrane fusion of the viral envelope with the host cell. Membrane interacting regions and potential fusion peptides have been identified in HSV-1 gH as well as glycoprotein B (gB). Because of the complex fusion mechanism of HSV-1, which requires four viral glycoproteins, and because there are only structural data for gB and glycoprotein D, many questions regarding the mechanism by which HSV-1 fuses its envelope with the host cell membrane remain unresolved. Previous studies have shown that peptides derived from certain regions of gH have the potential to interact with membranes, and based on these findings we have generated a set of peptides containing mutations in one of these domains, gH-(626-644), to investigate further the functional role of this region. Using a combination of biochemical, spectroscopic, and nuclear magnetic resonance techniques, we showed that the alpha-helical nature of this stretch of amino acids in gH is important for membrane interaction and that the aromatic residues, tryptophan and tyrosine, are critical for induction of fusion.	[Galdiero, Stefania; Pedone, Carlo; Galdiero, Massimiliano] Univ Naples Federico II, Ctr Interuniv Ric Peptidi Bioattivi, I-80134 Naples, Italy; [Galdiero, Stefania; Falanga, Annarita; Pedone, Carlo] Univ Naples Federico II, Dept Biol Sci, Div Biostruct, I-80134 Naples, Italy; [Vitiello, Mariateresa; Galdiero, Massimiliano] Univ Naples Federico II, Dept Expt Med 2, I-80138 Naples, Italy; [Galdiero, Stefania] CNR, Ist Biostrutture & Bioimmagini, I-80134 Naples, Italy; [Browne, Helena] Univ Cambridge, Dept Pathol, Div Virol, Cambridge CB2 1QPZ, England; [Raiola, Luca; Fattorusso, Roberto; Isernia, Carla] Univ Naples Federico II, Dept Environm Sci 2, I-81100 Caserta, Italy	University of Naples Federico II; University of Naples Federico II; University of Naples Federico II; Consiglio Nazionale delle Ricerche (CNR); Istituto di Biostrutture e Bioimmagini (IBB-CNR); University of Cambridge; University of Naples Federico II	Galdiero, M (corresponding author), Univ Naples Federico II, Ctr Interuniv Ric Peptidi Bioattivi, Via Mezzocannone 16, I-80134 Naples, Italy.	massimiliano.galdiero@unina2.it	Galdiero, Stefania/M-3225-2019; Isernia, Carla/ABD-8156-2021; galdiero, stefania/B-1357-2010	Galdiero, Stefania/0000-0002-7849-7024; Falanga, Anna/0000-0001-6906-9020; Galdiero, Massimiliano/0000-0002-1576-6290; Isernia, Carla/0000-0002-1504-2479; FALANGA, Annarita/0000-0001-6538-8585; Fattorusso, Roberto/0000-0002-3539-5343				Atanasiu D, 2007, P NATL ACAD SCI USA, V104, P18718, DOI 10.1073/pnas.0707452104; BARTELS C, 1995, J BIOMOL NMR, V6, P1, DOI 10.1007/BF00417486; BESCHIASCHVILI G, 1990, BIOCHEMISTRY-US, V29, P52, DOI 10.1021/bi00453a007; Buzon V, 2005, BIOCHEMISTRY-US, V44, P13354, DOI 10.1021/bi050382r; Cairns TM, 2005, VIROLOGY, V332, P550, DOI 10.1016/j.virol.2004.12.006; Cairns TM, 2003, J VIROL, V77, P6731, DOI 10.1128/JVI.77.12.6731-6742.2003; Carfi A, 2001, MOL CELL, V8, P169, DOI 10.1016/S1097-2765(01)00298-2; Cavanagh J., 1996, PROTEIN NMR SPECTROS; DEKROON AIP, 1990, BIOCHEMISTRY-US, V29, P8229, DOI 10.1021/bi00488a006; Delahunty MD, 1996, VIROLOGY, V218, P94, DOI 10.1006/viro.1996.0169; EFTINK MR, 1976, J PHYS CHEM-US, V80, P486, DOI 10.1021/j100546a014; FORRESTER A, 1992, J VIROL, V66, P341, DOI 10.1128/JVI.66.1.341-348.1992; Freitas MS, 2007, J BIOL CHEM, V282, P27306, DOI 10.1074/jbc.M611864200; Fusco D, 2005, P NATL ACAD SCI USA, V102, P9323, DOI 10.1073/pnas.0503907102; GAGE PJ, 1993, J VIROL, V67, P2191, DOI 10.1128/JVI.67.4.2191-2201.1993; Galdiero M, 1997, J VIROL, V71, P2163, DOI 10.1128/JVI.71.3.2163-2170.1997; Galdiero S, 2005, J BIOL CHEM, V280, P28632, DOI 10.1074/jbc.M505196200; Galdiero S, 2004, PROTEIN SCI, V13, P1503, DOI 10.1110/ps.03561104; Galdiero S, 2006, J GEN VIROL, V87, P1085, DOI 10.1099/vir.0.81794-0; Galdiero S, 2008, PEPTIDES, V29, P1461, DOI 10.1016/j.peptides.2008.04.022; Galdiero S, 2008, CHEMBIOCHEM, V9, P758, DOI 10.1002/cbic.200700457; Galdiero S, 2007, CHEMBIOCHEM, V8, P885, DOI 10.1002/cbic.200700044; Galdiero S, 2007, CURR PROTEIN PEPT SC, V8, P63, DOI 10.2174/138920307779941541; GAZIT E, 1995, BIOCHEMISTRY-US, V34, P11479, DOI 10.1021/bi00036a021; Geraghty RJ, 1998, SCIENCE, V280, P1618, DOI 10.1126/science.280.5369.1618; Gianni T, 2005, J VIROL, V79, P7042, DOI 10.1128/JVI.79.11.7042-7049.2005; Gianni T, 2005, J VIROL, V79, P2931, DOI 10.1128/JVI.79.5.2931-2940.2005; Hammond K, 2002, BIOCHEMISTRY-US, V41, P3243, DOI 10.1021/bi011163i; Han X, 2001, NAT STRUCT BIOL, V8, P715, DOI 10.1038/90434; Harman A, 2002, J VIROL, V76, P10708, DOI 10.1128/JVI.76.21.10708-10716.2002; Heldwein EE, 2006, SCIENCE, V313, P217, DOI 10.1126/science.1126548; Herrmann T, 2002, J MOL BIOL, V319, P209, DOI 10.1016/S0022-2836(02)00241-3; HUTCHINSON L, 1992, J VIROL, V66, P2240, DOI 10.1128/JVI.66.4.2240-2250.1992; HWANG TL, 1995, J MAGN RESON SER A, V112, P275, DOI 10.1006/jmra.1995.1047; Kielian M, 2006, NAT REV MICROBIOL, V4, P67, DOI 10.1038/nrmicro1326; KILLIAN JA, 1994, FEBS LETT, V348, P161, DOI 10.1016/0014-5793(94)00594-X; Kliger Y, 1997, J BIOL CHEM, V272, P13496, DOI 10.1074/jbc.272.21.13496; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Krummenacher C, 2005, EMBO J, V24, P4144, DOI 10.1038/sj.emboj.7600875; Lai AL, 2007, J BIOL CHEM, V282, P23946, DOI 10.1074/jbc.M704008200; Li YL, 2005, J VIROL, V79, P12065, DOI 10.1128/JVI.79.18.12065-12076.2005; Lopper M, 2004, J VIROL, V78, P8333, DOI 10.1128/jvi.78.15.8333-8341.2004; MAO D, 1984, BIOCHEMISTRY-US, V23, P2667, DOI 10.1021/bi00307a020; Montgomery RI, 1996, CELL, V87, P427, DOI 10.1016/S0092-8674(00)81363-X; POUNY Y, 1992, BIOCHEMISTRY-US, V31, P12416, DOI 10.1021/bi00164a017; POUNY Y, 1992, BIOCHEMISTRY-US, V31, P9482, DOI 10.1021/bi00154a022; Qiao H, 1999, MOL BIOL CELL, V10, P2759, DOI 10.1091/mbc.10.8.2759; RAJARATHNAM K, 1989, BIOCHEMISTRY-US, V28, P3168, DOI 10.1021/bi00434a009; RAPAPORT D, 1991, J BIOL CHEM, V266, P23769; RAPAPORT D, 1992, J BIOL CHEM, V267, P6502; Ren JH, 1997, BIOCHEMISTRY-US, V36, P10213, DOI 10.1021/bi9709295; Ren JH, 1999, BIOCHEMISTRY-US, V38, P5905, DOI 10.1021/bi982942a; Rey FA, 2006, EMBO REP, V7, P1000, DOI 10.1038/sj.embor.7400807; RICHARDSON CD, 1980, VIROLOGY, V105, P205, DOI 10.1016/0042-6822(80)90168-3; Roche S, 2006, SCIENCE, V313, P187, DOI 10.1126/science.1127683; ROOP C, 1993, J VIROL, V67, P2285, DOI 10.1128/JVI.67.4.2285-2297.1993; Satoh T, 2008, CELL, V132, P935, DOI 10.1016/j.cell.2008.01.043; SCHWARZ G, 1986, BIOCHIM BIOPHYS ACTA, V861, P141, DOI 10.1016/0005-2736(86)90412-8; Shukla D, 1999, CELL, V99, P13, DOI 10.1016/S0092-8674(00)80058-6; Shukla D, 2001, J CLIN INVEST, V108, P503, DOI 10.1172/JCI13799; Silburn KA, 1998, AIDS RES HUM RETROV, V14, P385, DOI 10.1089/aid.1998.14.385; Spear PG, 2006, VIROLOGY, V344, P17, DOI 10.1016/j.virol.2005.09.016; STANKOWSKI S, 1990, BIOCHIM BIOPHYS ACTA, V1025, P164, DOI 10.1016/0005-2736(90)90094-5; STRUCK DK, 1981, BIOCHEMISTRY-US, V20, P4093, DOI 10.1021/bi00517a023; Subramanian RP, 2007, P NATL ACAD SCI USA, V104, P2903, DOI 10.1073/pnas.0608374104; THIAUDIERE E, 1991, EUR J BIOCHEM, V195, P203, DOI 10.1111/j.1432-1033.1991.tb15696.x; Turner A, 1998, J VIROL, V72, P873, DOI 10.1128/JVI.72.1.873-875.1998; Warner MS, 1998, VIROLOGY, V246, P179, DOI 10.1006/viro.1998.9218; Weissenhorn W, 2007, FEBS LETT, V581, P2150, DOI 10.1016/j.febslet.2007.01.093; WILSON DW, 1994, J VIROL, V68, P6985, DOI 10.1128/JVI.68.11.6985-6993.1994; Wimley WC, 1996, NAT STRUCT BIOL, V3, P842, DOI 10.1038/nsb1096-842; WISHART DS, 1992, BIOCHEMISTRY-US, V31, P1647, DOI 10.1021/bi00121a010; Yau WM, 1998, BIOCHEMISTRY-US, V37, P14713, DOI 10.1021/bi980809c	73	54	54	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 31	2008	283	44					29993	30009		10.1074/jbc.M803092200	http://dx.doi.org/10.1074/jbc.M803092200			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	364WS	18678872	hybrid, Green Published			2022-12-27	WOS:000260366900044
J	Hozoji, M; Munehira, Y; Ikeda, Y; Makishima, M; Matsuo, M; Kioka, N; Ueda, K				Hozoji, Masako; Munehira, Youichi; Ikeda, Yuika; Makishima, Makoto; Matsuo, Michinori; Kioka, Noriyuki; Ueda, Kazumitsu			Direct Interaction of Nuclear Liver X Receptor-beta with ABCA1 Modulates Cholesterol Efflux	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CASSETTE TRANSPORTER A1; TANGIER-DISEASE; CELLULAR CHOLESTEROL; ATP; ALPHA; GENE; DEGRADATION; MUTATIONS; STABILIZATION; MACROPHAGES	Cholesterol is an essential component of eukaryotic cells; at the same time, however, hyperaccumulation of cholesterol is harmful. Therefore, the ABCA1 gene, the product of which mediates secretion of cholesterol, is highly regulated at both the transcriptional and post-transcriptional levels. The transcription of ABCA1 is regulated by intracellular oxysterol concentration via the nuclear liver X receptor (LXR)/retinoid X receptor (RXR); once synthesized, ABCA1 protein turns over rapidly with a half-life of 1-2 h. Here, we show that the LXR beta/RXR complex binds directly to ABCA1 on the plasma membrane of macrophages and modulates cholesterol secretion. When cholesterol does not accumulate, ABCA1-LXR beta/RXR localizes on the plasma membrane, but is inert. When cholesterol accumulates, oxysterols bind to LXR beta, and the LXR beta/RXR complex dissociates from ABCA1, restoring ABCA1 activity and allowing apoA-I-dependent cholesterol secretion. LXR beta can exert an immediate post-translational response, as well as a rather slow transcriptional response, to changes in cellular cholesterol accumulation. Thus, we provide the first demonstration that protein-protein interaction suppresses ABCA1 function. Furthermore, we show that LXR beta is involved in both the transcriptional and post-transcriptional regulation of the ABCA1 transporter.	[Ueda, Kazumitsu] Kyoto Univ, Inst Integrated Cell Mat Sci, Kyoto 6068502, Japan; [Hozoji, Masako; Munehira, Youichi; Ikeda, Yuika; Matsuo, Michinori; Kioka, Noriyuki; Ueda, Kazumitsu] Kyoto Univ, Grad Sch Agr, Div Appl Life Sci, Lab Cellular Biochem, Kyoto 6068502, Japan; [Makishima, Makoto] Nihon Univ, Sch Med, Dept Biochem, Tokyo 1738610, Japan	Kyoto University; Kyoto University; Nihon University	Ueda, K (corresponding author), Kyoto Univ, Inst Integrated Cell Mat Sci, Kitashirakawa Oiwake Cho, Kyoto 6068502, Japan.	uedak@kais.kyoto-u.ac.jp		Kioka, Noriyuki/0000-0002-2708-537X; Ueda, Kazumitsu/0000-0003-2980-6078	Ministry of Education, Culture, Sports, Science, and Technology of Japan; Program for Promotion of Fundamental Studies in Health Sciences; National Institute of Biomedical Innovation; World Premier International Research Center Initiative; Grants-in-Aid for Scientific Research [20228001] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Program for Promotion of Fundamental Studies in Health Sciences; National Institute of Biomedical Innovation(National Institute of Biomedical Innovation); World Premier International Research Center Initiative(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a grant-in-aid for scientific research (S) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan, by the Program for Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation, and by the World Premier International Research Center Initiative, Ministry of Education, Culture, Sports, Science, and Technology of Japan.	Abe-Dohmae S, 2000, BIOCHEMISTRY-US, V39, P11092, DOI 10.1021/bi0008175; Arakawa R, 2004, J BIOL CHEM, V279, P6217, DOI 10.1074/jbc.C300553200; Arakawa R, 2002, J BIOL CHEM, V277, P22426, DOI 10.1074/jbc.M202996200; Bodzioch M, 1999, NAT GENET, V22, P347, DOI 10.1038/11914; Brooks-Wilson A, 1999, NAT GENET, V22, P336, DOI 10.1038/11905; Costet P, 2000, J BIOL CHEM, V275, P28240; Kaneko E, 2003, J BIOL CHEM, V278, P36091, DOI 10.1074/jbc.M304153200; Laffitte BA, 2001, MOL CELL BIOL, V21, P7558, DOI 10.1128/MCB.21.22.7558-7568.2001; Makishima M, 2002, SCIENCE, V296, P1313, DOI 10.1126/science.1070477; Metivier R, 2002, MOL CELL, V10, P1019, DOI 10.1016/S1097-2765(02)00746-3; Munehira Y, 2004, J BIOL CHEM, V279, P15091, DOI 10.1074/jbc.M313436200; Okuhira K, 2005, J BIOL CHEM, V280, P39653, DOI 10.1074/jbc.M510187200; Oram JF, 2006, CIRC RES, V99, P1031, DOI 10.1161/01.RES.0000250171.54048.5c; Repa JJ, 2000, SCIENCE, V289, P1524, DOI 10.1126/science.289.5484.1524; Rust S, 1999, NAT GENET, V22, P352, DOI 10.1038/11921; Singaraja RR, 2003, ARTERIOSCL THROM VAS, V23, P1322, DOI 10.1161/01.ATV.0000078520.89539.77; Tanaka AR, 2003, J BIOL CHEM, V278, P8815, DOI 10.1074/jbc.M206885200; Venkateswaran A, 2000, P NATL ACAD SCI USA, V97, P12097, DOI 10.1073/pnas.200367697; Wang N, 2003, J CLIN INVEST, V111, P99, DOI 10.1172/JCI200316808; Wang YT, 2002, J BIOL CHEM, V277, P5692, DOI 10.1074/jbc.M109977200; Whitney KD, 2001, J BIOL CHEM, V276, P43509, DOI 10.1074/jbc.M106155200; Yokoyama S, 2000, BBA-MOL CELL BIOL L, V1529, P231, DOI 10.1016/S1388-1981(00)00152-9	22	56	60	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 31	2008	283	44					30057	30063		10.1074/jbc.M804599200	http://dx.doi.org/10.1074/jbc.M804599200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	364WS	18782758	Green Published, hybrid			2022-12-27	WOS:000260366900050
J	Rousseau, F; Chevalier, S; Guillet, C; Ravon, E; Diveu, C; Froger, J; Barbier, F; Grimaud, L; Gascan, H				Rousseau, Francois; Chevalier, Sylvie; Guillet, Catherine; Ravon, Elisa; Diveu, Caroline; Froger, Josy; Barbier, Fabien; Grimaud, Linda; Gascan, Hugues			Ciliary Neurotrophic Factor, Cardiotrophin-like Cytokine, and Neuropoietin Share a Conserved Binding Site on the Ciliary Neurotrophic Factor Receptor alpha Chain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LEUKEMIA INHIBITORY FACTOR; IL-6 SIGNAL TRANSDUCER; CRYSTAL-STRUCTURE; INTERLEUKIN-6 RECEPTOR; MOLECULAR-CLONING; PROTEIN; GP130; CNTF; EXPRESSION; FORM	Ciliary neurotrophic factor, cardiotrophin-like cytokine, and neuropoietin are members of the four-helix bundle cytokine family. These proteins signal through a common tripartite receptor composed of leukemia inhibitory factor receptor, gp130, and ciliary neurotrophic factor receptor alpha. Binding to ciliary neurotrophic factor receptor alpha occurs through an interaction site located at the C terminus of the cytokine AB loop and alpha D helix, known as site 1. In the present study, we have generated a model of neuropoietin and identified a conserved binding site for the three cytokines interacting with ciliary neurotrophic factor receptor alpha. To identify the counterpart of this site on ciliary neurotrophic factor receptor alpha, its cytokine binding domain was modeled, and the physicochemical properties of its surface were analyzed. This analysis revealed an area displaying properties complementary to the site 1 of ciliary neurotrophic factor, cardiotrophin-like cytokine, and neuropoietin. Based on our computational predictions, residues were selected for their potential involvement in the ciliary neurotrophic factor receptor alpha binding epitope, and site-directed mutagenesis was carried out. Biochemical, cell proliferation, and cell signaling analyses showed that Phe(172) and Glu(286) of ciliary neurotrophic factor receptor alpha are key interaction residues. Our results demonstrated that ciliary neurotrophic factor, cardiotrophin-like cytokine, and neuropoietin share a conserved binding site on ciliary neurotrophic factor receptor alpha.	[Rousseau, Francois; Chevalier, Sylvie; Guillet, Catherine; Ravon, Elisa; Diveu, Caroline; Froger, Josy; Barbier, Fabien; Grimaud, Linda; Gascan, Hugues] INSERM, UMR 564, F-49033 Angers 01, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite d'Angers	Gascan, H (corresponding author), INSERM, UMR 564, Batiment Monteclair,4 Rue Larrey, F-49033 Angers 01, France.	hugues.gascan@univ-angers.fr			Association Francaise contre les Myopathies [9884]; Ciblage Moleculaire et Application Therapeutique (CIMATH)	Association Francaise contre les Myopathies(Association Francaise contre les Myopathies); Ciblage Moleculaire et Application Therapeutique (CIMATH)	This work was supported by Association Francaise contre les Myopathies Grant 9884 and by the Ciblage Moleculaire et Application Therapeutique (CIMATH) program of the region Pays de la Loire. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; BAZAN JF, 1991, NEURON, V7, P197, DOI 10.1016/0896-6273(91)90258-2; BAZAN JF, 1990, P NATL ACAD SCI USA, V87, P6934, DOI 10.1073/pnas.87.18.6934; Boulanger MJ, 2004, ADV PROTEIN CHEM, V68, P107; Boulanger MJ, 2003, MOL CELL, V12, P577, DOI 10.1016/S1097-2765(03)00365-4; Boulanger MJ, 2003, SCIENCE, V300, P2101, DOI 10.1126/science.1083901; Bravo J, 1998, EMBO J, V17, P1665, DOI 10.1093/emboj/17.6.1665; Bravo J, 2000, EMBO J, V19, P2399, DOI 10.1093/emboj/19.11.2399; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; Canutescu AA, 2003, PROTEIN SCI, V12, P2001, DOI 10.1110/ps.03154503; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; Chevalier S, 1996, J BIOL CHEM, V271, P14764, DOI 10.1074/jbc.271.25.14764; Chow DC, 2001, SCIENCE, V291, P2150, DOI 10.1126/science.1058308; Cognet I, 2005, J IMMUNOL METHODS, V301, P53, DOI 10.1016/j.jim.2005.03.012; Collison LW, 2007, NATURE, V450, P566, DOI 10.1038/nature06306; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; CURTIS R, 1993, NATURE, V365, P253, DOI 10.1038/365253a0; DAVIS S, 1993, SCIENCE, V260, P1805, DOI 10.1126/science.8390097; DAVIS S, 1993, SCIENCE, V259, P1736, DOI 10.1126/science.7681218; DAVIS S, 1991, SCIENCE, V253, P59, DOI 10.1126/science.1648265; Deleage G, 1997, BIOCHIMIE, V79, P681, DOI 10.1016/S0300-9084(97)83524-9; Derouet D, 2004, P NATL ACAD SCI USA, V101, P4827, DOI 10.1073/pnas.0306178101; Devergne O, 1997, P NATL ACAD SCI USA, V94, P12041, DOI 10.1073/pnas.94.22.12041; DEVOS AM, 1992, SCIENCE, V255, P306, DOI 10.1126/science.1549776; Duff E, 2003, NUTR REV, V61, P423, DOI 10.1301/nr.2003.dec.423-426; EISENBERG D, 1984, P NATL ACAD SCI-BIOL, V81, P140, DOI 10.1073/pnas.81.1.140; Elson GCA, 2000, NAT NEUROSCI, V3, P867, DOI 10.1038/78765; GEARING DP, 1991, EMBO J, V10, P2839, DOI 10.1002/j.1460-2075.1991.tb07833.x; Guillet C, 1999, J NEUROSCI, V19, P1257; Heinrich PC, 1998, BIOCHEM J, V334, P297, DOI 10.1042/bj3340297; HELGREN ME, 1994, CELL, V76, P493, DOI 10.1016/0092-8674(94)90113-9; HIBI M, 1990, CELL, V63, P1149, DOI 10.1016/0092-8674(90)90411-7; Kalai M, 1997, BLOOD, V89, P1319, DOI 10.1182/blood.V89.4.1319; Kokoeva MV, 2005, SCIENCE, V310, P679, DOI 10.1126/science.1115360; LIN LFH, 1989, SCIENCE, V246, P1023, DOI 10.1126/science.2587985; Linker RA, 2002, NAT MED, V8, P620, DOI 10.1038/nm0602-620; LUTTICKEN C, 1994, SCIENCE, V263, P89, DOI 10.1126/science.8272872; Ma BY, 2003, P NATL ACAD SCI USA, V100, P5772, DOI 10.1073/pnas.1030237100; MCDONALD NQ, 1995, EMBO J, V14, P2689, DOI 10.1002/j.1460-2075.1995.tb07269.x; MITSUMOTO H, 1994, SCIENCE, V265, P1107, DOI 10.1126/science.8066451; Mustard D, 2005, PROTEINS, V60, P269, DOI 10.1002/prot.20569; OPPENHEIM RW, 1991, SCIENCE, V251, P1616, DOI 10.1126/science.2011743; Oppmann B, 2000, IMMUNITY, V13, P715, DOI 10.1016/S1074-7613(00)00070-4; PANAYOTATOS N, 1995, J BIOL CHEM, V270, P14007, DOI 10.1074/jbc.270.23.14007; Perret D, 2004, J BIOL CHEM, V279, P43961, DOI 10.1074/jbc.M407686200; Peters M, 1998, BLOOD, V92, P3495, DOI 10.1182/blood.V92.10.3495.422k47_3495_3504; Pflanz S, 2002, IMMUNITY, V16, P779, DOI 10.1016/S1074-7613(02)00324-2; Plun-Favreau H, 2003, J BIOL CHEM, V278, P27169, DOI 10.1074/jbc.M303168200; Plun-Favreau H, 2001, EMBO J, V20, P1692, DOI 10.1093/emboj/20.7.1692; ROBINSON RC, 1994, CELL, V77, P1101, DOI 10.1016/0092-8674(94)90449-9; Robledo O, 1996, J NEUROCHEM, V66, P1391; Rousseau F, 2006, P NATL ACAD SCI USA, V103, P10068, DOI 10.1073/pnas.0509598103; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Senaldi G, 1999, P NATL ACAD SCI USA, V96, P11458, DOI 10.1073/pnas.96.20.11458; SENDTNER M, 1992, NATURE, V358, P502, DOI 10.1038/358502a0; STAHL N, 1994, SCIENCE, V263, P92, DOI 10.1126/science.8272873; STAHL N, 1995, SCIENCE, V267, P1349, DOI 10.1126/science.7871433; STOCKLI KA, 1989, NATURE, V342, P920, DOI 10.1038/342920a0; Taga T, 1997, ANNU REV IMMUNOL, V15, P797, DOI 10.1146/annurev.immunol.15.1.797; Yoon C, 2000, EMBO J, V19, P3530, DOI 10.1093/emboj/19.14.3530	60	14	15	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 31	2008	283	44					30341	30350		10.1074/jbc.M803239200	http://dx.doi.org/10.1074/jbc.M803239200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	364WS	18728012	Green Published, hybrid			2022-12-27	WOS:000260366900078
J	Seifert, JP; Zhou, YX; Hicks, SN; Sondek, J; Harden, TK				Seifert, Jason P.; Zhou, Yixing; Hicks, Stephanie N.; Sondek, John; Harden, T. Kendall			Dual Activation of Phospholipase C-epsilon by Rho and Ras GTPases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-GAMMA-SUBUNITS; PLECKSTRIN HOMOLOGY DOMAIN; PROTEIN-KINASE; RECEPTOR; STIMULATION; EFFECTOR; CALCIUM; ISOZYME; G-ALPHA(12); PHOSPHATES	Phospholipase C-epsilon (PLC-epsilon) is a highly elaborated PLC required for a diverse set of signaling pathways. Here we use a combination of cellular assays and studies with purified proteins to show that activated RhoA and Ras isoforms directly engage distinct regions of PLC-epsilon to stimulate its phospholipase activity. Purified PLC-epsilon was activated in a guanine nucleotide- and concentration-dependent fashion by purified lipidated K-Ras reconstituted in PtdIns(4,5) P2-containing phospholipid vesicles. Whereas mutation of two critical lysine residues within the second Ras-association domain of PLC-epsilon prevented K-Ras-dependent activation of the purified enzyme, guanine nucleotide-dependent activation by RhoA was retained. Deletion of a loop unique to PLC-epsilon eliminated its activation by RhoA but not H-Ras. In contrast, removal of the autoinhibitory X/Y-linker region of the catalytic core of PLC-epsilon markedly activates the enzyme (Hicks, S. N., Jezyk, M. R., Gershburg, S., Seifert, J. P., Harden, T. K., and Sondek, J. ( 2008) Mol. Cell, 31, 383-394), but PLC-epsilon lacking this regulatory region retained activation by both Rho and Ras GTPases. Additive activation of PLC-epsilon by RhoA and K- or H-Ras was observed in intact cell studies, and this additivity was recapitulated in experiments in which activation of purified PLC-epsilon was quantified with PtdIns( 4,5) P2-containing phospholipid vesicles reconstituted with purified, isoprenylated GTPases. A maximally effective concentration of activated RhoA also increased the sensitivity of purified PLC-epsilon to activation by K- Ras. These results indicate that PLC-epsilon can be directly and concomitantly activated by both RhoA and individual Ras GTPases resulting in diverse upstream control of signaling cascades downstream of PLC-epsilon.	[Seifert, Jason P.; Zhou, Yixing; Hicks, Stephanie N.; Sondek, John; Harden, T. Kendall] Univ N Carolina, Sch Med, Dept Pharmacol, Chapel Hill, NC 27599 USA; [Sondek, John; Harden, T. Kendall] Univ N Carolina, Sch Med, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [Sondek, John] Univ N Carolina, Sch Med, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Harden, TK (corresponding author), Univ N Carolina, Sch Med, Dept Pharmacol, CB 7365, Chapel Hill, NC 27599 USA.	tkh@med.unc.edu		Sondek, John/0000-0002-1127-8310	National Institutes of Health [GM57391, GM65533]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057391, P01GM065533] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM57391 and GM65533. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Baek KJ, 2001, J BIOL CHEM, V276, P5591, DOI 10.1074/jbc.M008252200; Bai YF, 2004, CANCER RES, V64, P8808, DOI 10.1158/0008-5472.CAN-04-3143; BERRIDGE MJ, 1989, NATURE, V341, P197, DOI 10.1038/341197a0; BLANK JL, 1992, J BIOL CHEM, V267, P23069; BOYER JL, 1992, J BIOL CHEM, V267, P25451; BROWN HA, 1991, MOL PHARMACOL, V40, P648; Bunney TD, 2006, MOL CELL, V21, P495, DOI 10.1016/j.molcel.2006.01.008; Bunney TD, 2006, TRENDS CELL BIOL, V16, P640, DOI 10.1016/j.tcb.2006.10.007; CAMPS M, 1992, NATURE, V360, P684, DOI 10.1038/360684a0; CANTLEY LC, 1986, ANN NY ACAD SCI, V488, P481; Citro S, 2007, P NATL ACAD SCI USA, V104, P15543, DOI 10.1073/pnas.0702943104; Hicks SN, 2008, MOL CELL, V31, P383, DOI 10.1016/j.molcel.2008.06.018; Hinkes B, 2006, NAT GENET, V38, P1397, DOI 10.1038/ng1918; Illenberger D, 2003, J BIOL CHEM, V278, P3006, DOI 10.1074/jbc.M208282200; Illenberger D, 1998, EMBO J, V17, P6241, DOI 10.1093/emboj/17.21.6241; Jezyk MR, 2006, NAT STRUCT MOL BIOL, V13, P1135, DOI 10.1038/nsmb1175; Kapust RB, 2001, PROTEIN ENG, V14, P993, DOI 10.1093/protein/14.12.993; Kelley GG, 2004, BIOCHEM J, V378, P129, DOI 10.1042/BJ20031370; Kelley GG, 2001, EMBO J, V20, P743, DOI 10.1093/emboj/20.4.743; Kim YH, 1999, J BIOL CHEM, V274, P26127, DOI 10.1074/jbc.274.37.26127; KISHIMOTO A, 1980, J BIOL CHEM, V255, P2273; Kozasa T, 1998, SCIENCE, V280, P2109, DOI 10.1126/science.280.5372.2109; Lemmon MA, 2003, TRAFFIC, V4, P201, DOI 10.1034/j.1600-0854.2004.00071.x; Lopez I, 2001, J BIOL CHEM, V276, P2758, DOI 10.1074/jbc.M008119200; Lutz S, 2005, J BIOL CHEM, V280, P11134, DOI 10.1074/jbc.M411322200; Lutz S, 2007, SCIENCE, V318, P1923, DOI 10.1126/science.1147554; MEISENHELDER J, 1989, CELL, V57, P1109, DOI 10.1016/0092-8674(89)90048-2; Mitin N, 2005, CURR BIOL, V15, pR563, DOI 10.1016/j.cub.2005.07.010; Niggli V, 2005, ANNU REV CELL DEV BI, V21, P57, DOI 10.1146/annurev.cellbio.21.021704.102317; Oestreich EA, 2007, J BIOL CHEM, V282, P5488, DOI 10.1074/jbc.M608495200; Piechulek T, 2005, J BIOL CHEM, V280, P38923, DOI 10.1074/jbc.M509396200; RHEE SG, 1992, J BIOL CHEM, V267, P12393; Rojas RJ, 2007, J BIOL CHEM, V282, P29201, DOI 10.1074/jbc.M703458200; Rossman KL, 2005, NAT REV MOL CELL BIO, V6, P167, DOI 10.1038/nrm1587; Saunders CM, 2002, DEVELOPMENT, V129, P3533; Seifert JP, 2006, METHOD ENZYMOL, V406, P260, DOI 10.1016/S0076-6879(06)06019-8; Seifert JP, 2004, J BIOL CHEM, V279, P47992, DOI 10.1074/jbc.M407111200; Shibatohge M, 1998, J BIOL CHEM, V273, P6218, DOI 10.1074/jbc.273.11.6218; SMRCKA AV, 1991, SCIENCE, V251, P804, DOI 10.1126/science.1846707; Snyder JT, 2003, J BIOL CHEM, V278, P21099, DOI 10.1074/jbc.M301418200; Song C, 2001, J BIOL CHEM, V276, P2752, DOI 10.1074/jbc.M008324200; STREB H, 1983, NATURE, V306, P67, DOI 10.1038/306067a0; Suire S, 2002, CURR BIOL, V12, P1068, DOI 10.1016/S0960-9822(02)00933-8; Tadano M, 2005, MOL CELL BIOL, V25, P2191, DOI 10.1128/MCB.25.6.2191-2199.2005; TAYLOR SJ, 1991, NATURE, V350, P516, DOI 10.1038/350516a0; WAHL MI, 1989, P NATL ACAD SCI USA, V86, P1568, DOI 10.1073/pnas.86.5.1568; WAKELAM MJO, 1986, NATURE, V323, P173, DOI 10.1038/323173a0; WALDO GL, 1991, J BIOL CHEM, V266, P14217; Wang H, 2005, CIRC RES, V97, P1305, DOI 10.1161/01.RES.0000196578.15385.bb; Wing MR, 2003, J BIOL CHEM, V278, P41253, DOI 10.1074/jbc.M306904200; Wing MR, 2001, J BIOL CHEM, V276, P48257, DOI 10.1074/jbc.C100574200; Yoda A, 2004, DEV BIOL, V268, P245, DOI 10.1016/j.ydbio.2003.12.028; Zhou YX, 2008, BIOCHEMISTRY-US, V47, P4410, DOI 10.1021/bi800044n; Zhou YX, 2005, BIOCHEM J, V391, P667, DOI 10.1042/BJ20050839	54	30	32	3	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 31	2008	283	44					29690	29698		10.1074/jbc.M805038200	http://dx.doi.org/10.1074/jbc.M805038200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	364WS	18765661	hybrid, Green Published			2022-12-27	WOS:000260366900012
J	Xiao, D; Powolny, AA; Singh, SV				Xiao, Dong; Powolny, Anna A.; Singh, Shivendra V.			Benzyl Isothiocyanate Targets Mitochondrial Respiratory Chain to Trigger Reactive Oxygen Species-dependent Apoptosis in Human Breast Cancer Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASES; PROSTATE-CANCER; PHENETHYL ISOTHIOCYANATE; CYCLE ARREST; BAX ACTIVATION; HUMAN PLASMA; DEATH; INHIBITION; INDUCTION; RISK	Benzyl isothiocyanate (BITC), a dietary cancer chemopreventive agent, causes apoptosis in MDA-MB-231 and MCF-7 human breast cancer cells, but the mechanism of cell death is not fully understood. We now demonstrate that the BITC-induced apoptosis in human breast cancer cells is initiated by reactive oxygen species (ROS) due to inhibition of complex III of the mitochondrial respiratory chain. The BITC-induced ROS production and apoptosis were significantly inhibited by overexpression of catalase and Cu,Zn-superoxide dismutase and pharmacological inhibition of the mitochondrial respiratory chain. The mitochondrial DNA-deficient Rho-0 variant of MDA-MB-231 cells was nearly completely resistant to BITC-mediated ROS generation and apoptosis. The Rho-0 MDA-MB-231 cells also resisted BITC-mediated mitochondrial translocation (activation) of Bax. Biochemical assays revealed inhibition of complex III activity in BITC-treated MDA-MB-231 cells as early as at 1 h of treatment. The BITC treatment caused activation of c-Jun N-terminal kinase (JNK) and p38 mitogen-activated protein kinase (MAPK), which function upstream of Bax activation in apoptotic response to various stimuli. Pharmacological inhibition of both JNK and p38 MAPK conferred partial yet significant protection against BITC-induced apoptosis. Activation of JNK and p38 MAPK resulting from BITC exposure was abolished by overexpression of catalase. The BITC-mediated conformational change of Bax was markedly suppressed by ectopic expression of catalytically inactive mutant of JNK kinase 2 (JNKK2(AA)). Interestingly, a normal human mammary epithelial cell line was resistant to BITC-mediated ROS generation, JNK/p38 MAPK activation, and apoptosis. In conclusion, the present study indicates that the BITC-induced apoptosis in human breast cancer cells is initiated by mitochondria-derived ROS.	Univ Pittsburgh, Sch Med, Dept Pharmacol & Chem Biol, Pittsburgh, PA 15213 USA; Univ Pittsburgh, Sch Med, Inst Canc, Pittsburgh, PA 15213 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Singh, SV (corresponding author), 2-32A Hillman Canc Ctr Res Pavil,5117 Ctr Ave, Pittsburgh, PA 15213 USA.	singhs@upmc.edu			National Institutes of Health; NCI [CA129347, CA101753]; NATIONAL CANCER INSTITUTE [R01CA101753, R01CA129347] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health, NCI, Grants CA129347 and CA101753. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Ambrosone CB, 2004, J NUTR, V134, P1134, DOI 10.1093/jn/134.5.1134; ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; Antosiewicz J, 2006, CANCER RES, V66, P5379, DOI 10.1158/0008-5472.CAN-06-0356; Biswas G, 2003, J CELL BIOL, V161, P507, DOI 10.1083/jcb.200211104; Biswas G, 2005, GENE, V354, P132, DOI 10.1016/j.gene.2005.03.028; Braithwaite RS, 2003, J GEN INTERN MED, V18, P937, DOI 10.1046/j.1525-1497.2003.20724.x; Buccellato LJ, 2004, J BIOL CHEM, V279, P6753, DOI 10.1074/jbc.M310145200; Buchet K, 1998, J BIOL CHEM, V273, P22983, DOI 10.1074/jbc.273.36.22983; Cai JY, 1998, J BIOL CHEM, V273, P11401, DOI 10.1074/jbc.273.19.11401; Cauley JA, 1999, ANN INTERN MED, V130, P270, DOI 10.7326/0003-4819-130-4_Part_1-199902160-00004; Chandel NS, 2000, J BIOL CHEM, V275, P25130, DOI 10.1074/jbc.M001914200; Chandel NS, 1999, FEBS LETT, V454, P173, DOI 10.1016/S0014-5793(99)00783-8; Chen CY, 1998, SCIENCE, V280, P1945, DOI 10.1126/science.280.5371.1945; Chen YQ, 2007, J CELL SCI, V120, P4155, DOI 10.1242/jcs.011163; Choi S, 2005, CANCER RES, V65, P2035, DOI 10.1158/0008-5472.CAN-04-3616; Choi S, 2007, CARCINOGENESIS, V28, P151, DOI 10.1093/carcin/bgl144; Cohen JH, 2000, JNCI-J NATL CANCER I, V92, P61, DOI 10.1093/jnci/92.1.61; Conaway CC, 2002, CURR DRUG METAB, V3, P233, DOI 10.2174/1389200023337496; COSSARIZZA A, 1993, BIOCHEM BIOPH RES CO, V197, P40, DOI 10.1006/bbrc.1993.2438; Cuzick J, 2002, LANCET, V360, P817; Fisher B, 1998, J NATL CANCER I, V90, P1371, DOI 10.1093/jnci/90.18.1371; Fowke JH, 2003, CANCER RES, V63, P3980; Gilkerson RW, 2000, FEBS LETT, V474, P1, DOI 10.1016/S0014-5793(00)01527-1; Gottlieb E, 2000, MOL CELL BIOL, V20, P5680, DOI 10.1128/MCB.20.15.5680-5689.2000; Hankinson SE, 1998, JNCI-J NATL CANCER I, V90, P1292, DOI 10.1093/jnci/90.17.1292; Hecht SS, 2000, DRUG METAB REV, V32, P395, DOI 10.1081/DMR-100102342; HULKA BS, 1995, LANCET, V346, P883, DOI 10.1016/S0140-6736(95)92713-1; Jakubikova J, 2005, INT J ONCOL, V27, P1449; Jemal A, 2006, CA-CANCER J CLIN, V56, P106, DOI 10.3322/canjclin.56.2.106; Ji Y, 2003, ANAL BIOCHEM, V323, P39, DOI 10.1016/j.ab.2003.08.011; Jiang JF, 2008, BIOCHEM BIOPH RES CO, V368, P145, DOI 10.1016/j.bbrc.2008.01.055; Kawakami M, 2005, BIOSCI BIOTECH BIOCH, V69, P2439, DOI 10.1271/bbb.69.2439; KELSEY JL, 1993, EPIDEMIOL REV, V15, P36, DOI 10.1093/oxfordjournals.epirev.a036115; Kim BJ, 2006, J BIOL CHEM, V281, P21256, DOI 10.1074/jbc.M510644200; Kim WH, 2004, MOL PHARMACOL, V66, P1383, DOI 10.1124/mol.104.001347; King M P, 1996, Methods Enzymol, V264, P313, DOI 10.1016/S0076-6879(96)64030-0; KING MP, 1989, SCIENCE, V246, P500, DOI 10.1126/science.2814477; KOLM RH, 1995, BIOCHEM J, V311, P453, DOI 10.1042/bj3110453; Kolonel LN, 2000, CANCER EPIDEM BIOMAR, V9, P795; Liebes L, 2001, ANAL BIOCHEM, V291, P279, DOI 10.1006/abio.2001.5030; LIN JM, 1993, CANCER LETT, V74, P151, DOI 10.1016/0304-3835(93)90237-4; Longpre JM, 2008, FREE RADICAL RES, V42, P533, DOI 10.1080/10715760802126692; Lui VWY, 2003, CARCINOGENESIS, V24, P1705, DOI 10.1093/carcin/bgg127; MacKenzie EL, 2008, FREE RADICAL BIO MED, V44, P1762, DOI 10.1016/j.freeradbiomed.2008.01.031; Martino S, 2004, J NATL CANCER I, V96, P1751, DOI 10.1093/jnci/djh319; Mi LX, 2007, CANCER RES, V67, P6409, DOI 10.1158/0008-5472.CAN-07-0340; Miyoshi N, 2004, CANCER RES, V64, P2134, DOI 10.1158/0008-5472.CAN-03-2296; Nakamura Y, 2000, CANCER RES, V60, P219; Nakamura Y, 2002, J BIOL CHEM, V277, P8492, DOI 10.1074/jbc.M109760200; Narayanan PK, 1997, CANCER RES, V57, P3963; Raha S, 2001, AM J MED GENET, V106, P62, DOI 10.1002/ajmg.1398; Ricci JE, 2003, CELL DEATH DIFFER, V10, P488, DOI 10.1038/sj.cdd.4401225; ROTHE G, 1990, J LEUKOCYTE BIOL, V47, P440, DOI 10.1002/jlb.47.5.440; Saitoh M, 1998, EMBO J, V17, P2596, DOI 10.1093/emboj/17.9.2596; Song JJ, 2002, J BIOL CHEM, V277, P46566, DOI 10.1074/jbc.M206826200; Srivastava SK, 2004, CARCINOGENESIS, V25, P1701, DOI 10.1093/carcin/bgh179; SUGIE S, 1993, JPN J CANCER RES, V84, P865, DOI 10.1111/j.1349-7006.1993.tb02059.x; Talalay P, 2001, J NUTR, V131, p3027S, DOI 10.1093/jn/131.11.3027S; Trachootham D, 2006, CANCER CELL, V10, P241, DOI 10.1016/j.ccr.2006.08.009; Verloop J, 2000, J NATL CANCER I, V92, P128, DOI 10.1093/jnci/92.2.128; WATTENBERG LW, 1977, J NATL CANCER I, V58, P395, DOI 10.1093/jnci/58.2.395; Wu XJ, 2007, CANCER BIOL THER, V6, P646, DOI 10.4161/cbt.6.5.4092; Wu ZG, 1997, MOL CELL BIOL, V17, P7407, DOI 10.1128/MCB.17.12.7407; Xiao D, 2003, CARCINOGENESIS, V24, P891, DOI 10.1093/carcin/bgg023; Xiao D, 2006, MOL CANCER THER, V5, P2931, DOI 10.1158/1535-7163.MCT-06-0396; Xiao D, 2006, CARCINOGENESIS, V27, P2223, DOI 10.1093/carcin/bgl087; Yamaguchi H, 2004, J BIOL CHEM, V279, P39431, DOI 10.1074/jbc.M401530200; Yang YM, 2002, CANCER RES, V62, P2; Zhang YS, 2003, MOL CANCER THER, V2, P1045	69	130	131	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 31	2008	283	44					30151	30163		10.1074/jbc.M802529200	http://dx.doi.org/10.1074/jbc.M802529200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	364WS	18768478	hybrid, Green Published			2022-12-27	WOS:000260366900060
J	Armand, AS; Bourajjaj, M; Martinez-Martinez, S; el Azzouzi, H; Martins, PAD; Hatzis, P; Seidler, T; Redondo, JM; De Windt, LJ				Armand, Anne-Sophie; Bourajjaj, Meriem; Martinez-Martinez, Sara; el Azzouzi, Hamid; da Costa Martins, Paula A.; Hatzis, Pantelis; Seidler, Tim; Miguel Redondo, Juan; De Windt, Leon J.			Cooperative Synergy between NFAT and MyoD Regulates Myogenin Expression and Myogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SKELETAL-MUSCLE; TRANSCRIPTION FACTOR; DEFICIENT MICE; HEART-FAILURE; CALCINEURIN; GENE; MOUSE; MEF2; SELECTION; POLARITY	Calcineurin/NFAT signaling is involved in multiple aspects of skeletal muscle development and disease. The myogenic basic helix-loop-helix transcription factors, MyoD, myogenin, Myf5, and MRF4 specify the myogenic lineage. Here we show that calcineurin/NFAT (nuclear factor of activated T cells) signaling is required for primary myogenesis by transcriptional cooperation with the basic helix-loop-helix transcription factor MyoD. Calcineurin/NFAT signaling is involved in myogenin expression in differentiating myoblasts, where the myogenic regulatory factor MyoD synergistically cooperates with NFATc2/c3 at the myogenin promoter. Using gel shift and chromatin immunoprecipitation assays, we identified two conserved NFAT binding sites in the myogenin promoter that were occupied by NFATc3 upon skeletal muscle differentiation. The transcriptional integration between NFATc3 and MyoD is crucial for primary myogenesis in vivo, as myogenin expression is weak in myod:nfatc3 double null embryos, whereas myogenin expression is unaffected in embryos with null mutations for either factor alone. Thus, the combined findings provide a novel transcriptional paradigm for the first steps of myogenesis, where a calcineurin/NFATc3 pathway regulates myogenin induction in cooperation with MyoD during myogenesis.	[Bourajjaj, Meriem; da Costa Martins, Paula A.; De Windt, Leon J.] Univ Med Ctr Utrecht, Dept Med Physiol, Div Heart & Lungs, NL-3584 CM Utrecht, Netherlands; [Armand, Anne-Sophie; Bourajjaj, Meriem; el Azzouzi, Hamid; da Costa Martins, Paula A.; Hatzis, Pantelis; De Windt, Leon J.] Royal Netherlands Acad Sci, Hubrecht Inst, NL-3584 CT Utrecht, Netherlands; [Armand, Anne-Sophie; Bourajjaj, Meriem; el Azzouzi, Hamid; da Costa Martins, Paula A.; Hatzis, Pantelis; De Windt, Leon J.] Royal Netherlands Acad Sci, Interuniv Cardiol Inst Netherlands, NL-3584 CT Utrecht, Netherlands; [Martinez-Martinez, Sara; Miguel Redondo, Juan] Ctr Nacl Invest Cardiovasc, Dept Vasc Biol & Inflammat, Madrid 28029, Spain; [Seidler, Tim] Univ Gottingen, Dept Cardiol, D-37075 Gottingen, Germany	Utrecht University; Utrecht University Medical Center; Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW); Interuniversity Cardiology Institute of the Netherlands; Utrecht University; Centro Nacional de Investigaciones Cardiovasculares (CNIC); University of Gottingen	De Windt, LJ (corresponding author), Univ Med Ctr Utrecht, Dept Med Physiol, Div Heart & Lungs, Yalelaan 50, NL-3584 CM Utrecht, Netherlands.	L.J.deWindt@umcutrecht.nl	Redondo, Juan Miguel/H-6351-2015; Seidler, Tim/B-3929-2014; de Windt, Leon/AAO-6395-2020; Seidler, Tim/ABH-8333-2020	Redondo, Juan Miguel/0000-0001-5779-9122; de Windt, Leon/0000-0002-7793-2856; Seidler, Tim/0000-0002-6158-5087; el Azzouzi, Hamid/0000-0003-1242-9691; Armand, Anne-Sophie/0000-0002-0291-6421	Netherlands Organization for Health Research and Development [912-04-054, 912-04-017]; VIDI Award [917-863-72]; Netherlands Heart Foundation Program [NHS2007B167]; European Union [LSHM-CT-2005-018833]; EUGeneHeart	Netherlands Organization for Health Research and Development(Netherlands Organization for Health Research and Development); VIDI Award; Netherlands Heart Foundation Program(Netherlands Heart Foundation); European Union(European Commission); EUGeneHeart	This work was supported by Netherlands Organization for Health Research and Development Grants 912-04-054 and 912-04-017 and VIDI Award 917-863-72, Netherlands Heart Foundation Program Grant NHS2007B167, and European Union Contract LSHM-CT-2005-018833/EUGeneHeart (to L. J. D. W.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Aramburu J, 1999, SCIENCE, V285, P2129, DOI 10.1126/science.285.5436.2129; Bourajjaj M, 2008, J BIOL CHEM, V283, P22295, DOI 10.1074/jbc.M801296200; Buckingham M, 1996, BIOCHEM SOC T, V24, P506, DOI 10.1042/bst0240506; de la Pompa JL, 1998, NATURE, V392, P182, DOI 10.1038/32419; de la Serna IL, 2005, MOL CELL BIOL, V25, P3997, DOI 10.1128/MCB.25.10.3997-4009.2005; Delling U, 2000, MOL CELL BIOL, V20, P6600, DOI 10.1128/MCB.20.17.6600-6611.2000; EDMONDSON DG, 1992, MOL CELL BIOL, V12, P3665, DOI 10.1128/MCB.12.9.3665; Gajewski K, 2003, P NATL ACAD SCI USA, V100, P1040, DOI 10.1073/pnas.0337662100; Graef IA, 2003, CELL, V113, P657, DOI 10.1016/S0092-8674(03)00390-8; Graef IA, 2001, CELL, V105, P863, DOI 10.1016/S0092-8674(01)00396-8; HASTY P, 1993, NATURE, V364, P501, DOI 10.1038/364501a0; He TC, 1998, P NATL ACAD SCI USA, V95, P2509, DOI 10.1073/pnas.95.5.2509; Hodge MR, 1996, IMMUNITY, V4, P397, DOI 10.1016/S1074-7613(00)80253-8; Horsley V, 2003, CELL, V113, P483, DOI 10.1016/S0092-8674(03)00319-2; Johnson J, 2001, DEV BIOL, V229, P176, DOI 10.1006/dbio.2000.9969; Kassar-Duchossoy L, 2004, NATURE, V431, P466, DOI 10.1038/nature02876; Kegley KM, 2001, DEV BIOL, V232, P115, DOI 10.1006/dbio.2001.0179; Massari ME, 2000, MOL CELL BIOL, V20, P429, DOI 10.1128/MCB.20.2.429-440.2000; McCullagh KJA, 2004, P NATL ACAD SCI USA, V101, P10590, DOI 10.1073/pnas.0308035101; Molkentin JD, 1996, CURR OPIN GENET DEV, V6, P445, DOI 10.1016/S0959-437X(96)80066-9; NABESHIMA Y, 1993, NATURE, V364, P532, DOI 10.1038/364532a0; Oukka M, 1998, IMMUNITY, V9, P295, DOI 10.1016/S1074-7613(00)80612-3; Parsons SA, 2003, MOL CELL BIOL, V23, P4331, DOI 10.1128/MCB.23.12.4331-4343.2003; Rao A, 1997, ANNU REV IMMUNOL, V15, P707, DOI 10.1146/annurev.immunol.15.1.707; Rodriguez A, 2005, J BIOL CHEM, V280, P9980, DOI 10.1074/jbc.C400401200; Roelen BAJ, 2002, MECH DEVELOP, V119, P81, DOI 10.1016/S0925-4773(02)00329-5; RUDNICKI MA, 1993, CELL, V75, P1351, DOI 10.1016/0092-8674(93)90621-V; Sakuma K, 2003, ACTA NEUROPATHOL, V105, P271, DOI 10.1007/s00401-002-0647-0; SASSOON D, 1989, NATURE, V341, P303, DOI 10.1038/341303a0; Schnorrer F, 2004, DEV CELL, V7, P9, DOI 10.1016/j.devcel.2004.06.010; van Oort RJ, 2006, CIRCULATION, V114, P298, DOI 10.1161/CIRCULATIONAHA.105.608968; VENUTI JM, 1995, J CELL BIOL, V128, P563, DOI 10.1083/jcb.128.4.563; WRIGHT WE, 1989, CELL, V56, P607, DOI 10.1016/0092-8674(89)90583-7; Wu H, 2001, EMBO J, V20, P6414, DOI 10.1093/emboj/20.22.6414; Youn HD, 2000, EMBO J, V19, P4323, DOI 10.1093/emboj/19.16.4323	35	61	62	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 24	2008	283	43					29004	29010		10.1074/jbc.M801297200	http://dx.doi.org/10.1074/jbc.M801297200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	362EB	18676376	Green Published, hybrid			2022-12-27	WOS:000260179900026
J	Hu, QC; Nelson, WJ; Spiliotis, ET				Hu, Qicong; Nelson, W. James; Spiliotis, Elias T.			Forchlorfenuron Alters Mammalian Septin Assembly, Organization, and Dynamics	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BINDING PROTEIN; BREAST-CANCER; MICROTUBULE-BINDING; FILAMENT FORMATION; CELL-LINES; EXPRESSION; YEAST; GENE; CYTOKINESIS; SCAFFOLD	Septins are filamentous GTPases that associate with cell membranes and the cytoskeleton and play essential roles in cell division and cellular morphogenesis. Septins are implicated in many human diseases including cancer and neuropathies. Small molecules that reversibly perturb septin organization and function would be valuable tools for dissecting septin functions and could be used for therapeutic treatment of septin-related diseases. Forchlorfenuron (FCF) is a plant cytokinin previously shown to disrupt septin localization in budding yeast. However, it is unknown whether FCF directly targets septins and whether it affects septin organization and functions in mammalian cells. Here, we show that FCF alters septin assembly in vitro without affecting either actin or tubulin polymerization. In live mammalian cells, FCF dampens septin dynamics and induces the assembly of abnormally large septin structures. FCF has a low level of cytotoxicity, and these effects are reversed upon FCF washout. Significantly, FCF treatment induces mitotic and cell migration defects that phenocopy the effects of septin depletion by small interfering RNA. We conclude that FCF is a promising tool to study mammalian septin organization and functions.	[Hu, Qicong; Nelson, W. James; Spiliotis, Elias T.] Stanford Univ, Dept Biol, Stanford, CA 94305 USA; [Nelson, W. James] Stanford Univ, Dept Cellular & Mol Physiol, Stanford, CA 94305 USA	Stanford University; Stanford University	Spiliotis, ET (corresponding author), Drexel Univ, Dept Biosci & Biotechnol, Philadelphia, PA 19104 USA.	ets33@drexel.edu			National Institutes of Health [GM35527]; Cell and Molecular Biology Training; Department of Defense Breast Cancer Research Program Predoctoral Fellowship [BC083077]; Stanford Digestive Disease Center; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM035527, R01GM035527] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cell and Molecular Biology Training; Department of Defense Breast Cancer Research Program Predoctoral Fellowship(United States Department of Defense); Stanford Digestive Disease Center; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM35527 (to W. J. N.). This work was also supported by a Cell and Molecular Biology Training Grant and by grants from the Department of Defense Breast Cancer Research Program Predoctoral Fellowship BC083077 (to Q. H.) and the Stanford Digestive Disease Center (N. G.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Arnir S, 2007, CANCER BIOL THER, V6, P1926, DOI 10.4161/cbt.6.12.4971; Barral Y, 2008, CURR OPIN CELL BIOL, V20, P12, DOI 10.1016/j.ceb.2007.12.001; Beites CL, 1999, NAT NEUROSCI, V2, P434, DOI 10.1038/8100; Bulinski JC, 2001, J CELL SCI, V114, P3885; Burrows JF, 2003, J PATHOL, V201, P581, DOI 10.1002/path.1484; Capurso G, 2005, NEUROENDOCRINOLOGY, V81, P311, DOI 10.1159/000088449; Chacko AD, 2005, J PATHOL, V206, P458, DOI 10.1002/path.1794; Craven RA, 2006, PROTEOMICS, V6, P2853, DOI 10.1002/pmic.200500549; Faty M, 2002, CURR GENET, V41, P123, DOI 10.1007/s00294-002-0304-0; Gladfelter AS, 2001, CURR OPIN MICROBIOL, V4, P681, DOI 10.1016/S1369-5274(01)00269-7; Gonzalez ME, 2007, CANCER RES, V67, P8554, DOI 10.1158/0008-5472.CAN-07-1474; Hall PA, 2004, J PATHOL, V204, P489, DOI 10.1002/path.1654; HARTWELL LH, 1971, EXP CELL RES, V69, P265, DOI 10.1016/0014-4827(71)90223-0; Hsu SC, 1998, NEURON, V20, P1111, DOI 10.1016/S0896-6273(00)80493-6; Ihara M, 2003, J BIOL CHEM, V278, P24095, DOI 10.1074/jbc.M301352200; Ihara M, 2007, NEURON, V53, P519, DOI 10.1016/j.neuron.2007.01.019; Iwase M, 2004, GENES GENET SYST, V79, P199, DOI 10.1266/ggs.79.199; Joo E, 2007, DEV CELL, V13, P677, DOI 10.1016/j.devcel.2007.09.001; Kim CS, 2007, J VIROL, V81, P3852, DOI 10.1128/JVI.01311-06; Kinoshita A, 1998, AM J PATHOL, V153, P1551, DOI 10.1016/S0002-9440(10)65743-4; Kinoshita M, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-11-236; Kinoshita M, 2002, DEV CELL, V3, P791, DOI 10.1016/S1534-5807(02)00366-0; Kinoshita M, 1997, GENE DEV, V11, P1535, DOI 10.1101/gad.11.12.1535; Kremer BE, 2005, MOL BIOL CELL, V16, P4648, DOI 10.1091/mbc.E05-03-0267; Kremer BE, 2007, CELL, V130, P837, DOI 10.1016/j.cell.2007.06.053; Larisch S, 2004, CELL CYCLE, V3, P1021; Lindsey R, 2006, CURR OPIN MICROBIOL, V9, P559, DOI 10.1016/j.mib.2006.10.009; Longtine MS, 2003, TRENDS CELL BIOL, V13, P403, DOI 10.1016/S0962-8924(03)00151-X; Longtine MS, 1996, CURR OPIN CELL BIOL, V8, P106, DOI 10.1016/S0955-0674(96)80054-8; Mendoza M, 2002, CURR BIOL, V12, P1858, DOI 10.1016/S0960-9822(02)01258-7; Montagna C, 2003, CANCER RES, V63, P2179; Nagata K, 2003, J BIOL CHEM, V278, P18538, DOI 10.1074/jbc.M205246200; Nagata KI, 2005, ONCOGENE, V24, P65, DOI 10.1038/sj.onc.1208101; Pizarro-Cerda J, 2002, CELL MICROBIOL, V4, P101, DOI 10.1046/j.1462-5822.2002.00169.x; Russell SEH, 2005, BRIT J CANCER, V93, P499, DOI 10.1038/sj.bjc.6602753; Sheffield PJ, 2003, J BIOL CHEM, V278, P3483, DOI 10.1074/jbc.M209701200; Sirajuddin M, 2007, NATURE, V449, P311, DOI 10.1038/nature06052; Spiliotis ET, 2008, J CELL BIOL, V180, P295, DOI 10.1083/jcb.200710039; Spiliotis ET, 2006, J CELL SCI, V119, P4, DOI 10.1242/jcs.02746; Spiliotis ET, 2005, SCIENCE, V307, P1781, DOI 10.1126/science.1106823; Sprague BL, 2005, TRENDS CELL BIOL, V15, P84, DOI 10.1016/j.tcb.2004.12.001; Surka MC, 2002, MOL BIOL CELL, V13, P3532, DOI 10.1091/mbc.E02-01-0042; Turner DP, 2007, CANCER RES, V67, P1618, DOI 10.1158/0008-5472.CAN-06-2913; Versele M, 2005, TRENDS CELL BIOL, V15, P414, DOI 10.1016/j.tcb.2005.06.007; Weirich CS, 2008, NAT REV MOL CELL BIO, V9, P478, DOI 10.1038/nrm2407; Yamada S, 2005, CELL, V123, P889, DOI 10.1016/j.cell.2005.09.020; ZHU M, 2008, J BIOL CHEM	47	79	84	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 24	2008	283	43					29563	29571		10.1074/jbc.M804962200	http://dx.doi.org/10.1074/jbc.M804962200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	362EB	18713753	Green Published, hybrid			2022-12-27	WOS:000260179900082
J	Mareeva, T; Martinez-Hackert, E; Sykulev, Y				Mareeva, Tatiana; Martinez-Hackert, Erik; Sykulev, Yuri			How a T Cell Receptor-like Antibody Recognizes Major Histocompatibility Complex-bound Peptide	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TCR-MHC INTERACTION; CRYSTAL-STRUCTURE; STRUCTURAL BASIS; ANTIGEN; BINDING; SELF; CD8; CD8-ALPHA-ALPHA; MECHANISM; MOLECULE	We determined the crystal structures of the T cell receptor (TCR)-like antibody 25-D1.16 Fab fragment bound to a complex of SIINFEKL peptide from ovalbumin and the H-2K(b) molecule. Remarkably, this antibody directly "reads" the structure of the major histocompatibility complex (MHC)-bound peptide, employing the canonical diagonal binding mode utilized by most TCRs. This is in marked contrast with another TCR-like antibody, Hyb3, bound to melanoma peptide MAGE-A1 in association with HLA-A1 MHC class I. Hyb3 assumes a non-canonical orientation over its cognate peptide-MHC and appears to recognize a conformational epitope in which the MHC contribution is dominant. We conclude that TCR-like antibodies can recognize MHC-bound peptide via two different mechanisms: one is similar to that exploited by the preponderance of TCRs and the other requires a non-canonical antibody orientation over the peptide-MHC complex.	[Sykulev, Yuri] Thomas Jefferson Univ, Dept Microbiol & Immunol, Kimmel Canc Ctr, Philadelphia, PA 19107 USA; [Martinez-Hackert, Erik] Columbia Univ, Dept Biochem & Mol Biophys, New York, NY 10032 USA	Jefferson University; Columbia University	Sykulev, Y (corresponding author), Thomas Jefferson Univ, Dept Microbiol & Immunol, Kimmel Canc Ctr, BLSB 650, Philadelphia, PA 19107 USA.	ysykulev@mail.jci.tju.edu		Martinez-Hackert, Erik/0000-0002-6182-7023	National Institutes of Health Research [AI058755]; New York Structural Biology Center; NATIONAL CANCER INSTITUTE [P30CA056036] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI058755] Funding Source: NIH RePORTER	National Institutes of Health Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); New York Structural Biology Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Research Grant AI058755 (to Y. S.). Beamline X4A at the National Synchrotron Light Source, a Department of Energy facility, was supported by the New York Structural Biology Center. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Alam SM, 1999, IMMUNITY, V10, P227, DOI 10.1016/S1074-7613(00)80023-0; Anikeeva N, 2003, BIOCHEMISTRY-US, V42, P4709, DOI 10.1021/bi026864+; Anikeeva N, 2006, P NATL ACAD SCI USA, V103, P16846, DOI 10.1073/pnas.0607771103; Boniface JJ, 1999, P NATL ACAD SCI USA, V96, P11446, DOI 10.1073/pnas.96.20.11446; Borg NA, 2007, NATURE, V448, P44, DOI 10.1038/nature05907; Buslepp J, 2003, J IMMUNOL, V170, P373, DOI 10.4049/jimmunol.170.1.373; Cho BK, 2001, P NATL ACAD SCI USA, V98, P1723, DOI 10.1073/pnas.98.4.1723; Colf LA, 2007, CELL, V129, P135, DOI 10.1016/j.cell.2007.01.048; Eisen H. N., 1997, ANTIGEN BINDING MOL, P1; Feng D, 2007, NAT IMMUNOL, V8, P975, DOI 10.1038/ni1502; Gakamsky DM, 1996, BIOCHEMISTRY-US, V35, P14841, DOI 10.1021/bi961707u; Gakamsky DM, 1999, BIOCHEMISTRY-US, V38, P12165, DOI 10.1021/bi9905821; Gao GF, 2000, J BIOL CHEM, V275, P15232, DOI 10.1074/jbc.275.20.15232; Garcia KC, 1998, SCIENCE, V279, P1166, DOI 10.1126/science.279.5354.1166; Garcia KC, 2005, CELL, V122, P333, DOI 10.1016/j.cell.2005.07.015; Garcia KC, 1996, NATURE, V384, P577, DOI 10.1038/384577a0; Hahn M, 2005, NAT IMMUNOL, V6, P490, DOI 10.1038/ni1187; Housset D, 2003, TRENDS IMMUNOL, V24, P429, DOI 10.1016/S1471-4906(03)00180-7; HUBER R, 1974, J MOL BIOL, V89, P73, DOI 10.1016/0022-2836(74)90163-6; Hulsmeyer M, 2005, J BIOL CHEM, V280, P2972, DOI 10.1074/jbc.M411323200; Huseby ES, 2005, CELL, V122, P247, DOI 10.1016/j.cell.2005.05.013; JAMESON SC, 1993, J EXP MED, V177, P1541, DOI 10.1084/jem.177.6.1541; Kern PS, 1998, IMMUNITY, V9, P519, DOI 10.1016/S1074-7613(00)80635-4; Li H, 1997, P NATL ACAD SCI USA, V94, P3584, DOI 10.1073/pnas.94.8.3584; LUESCHER IF, 1995, NATURE, V373, P353, DOI 10.1038/373353a0; Mareeva T, 2004, J BIOL CHEM, V279, P44243, DOI 10.1074/jbc.M407021200; Markvicheva EA, 2000, APPL BIOCHEM BIOTECH, V88, P145, DOI 10.1385/ABAB:88:1-3:145; MARQUART M, 1983, ACTA CRYSTALLOGR B, V39, P480, DOI 10.1107/S010876818300275X; Marrack P, 2008, ANNU REV IMMUNOL, V26, P171, DOI 10.1146/annurev.immunol.26.021607.090421; Mazza C, 2007, EMBO J, V26, P1972, DOI 10.1038/sj.emboj.7601605; Porgador A, 1997, IMMUNITY, V6, P715, DOI 10.1016/S1074-7613(00)80447-1; Reay PA, 2000, J IMMUNOL, V164, P5626, DOI 10.4049/jimmunol.164.11.5626; Reiser JB, 2002, IMMUNITY, V16, P345, DOI 10.1016/S1074-7613(02)00288-1; Rudolph MG, 2006, ANNU REV IMMUNOL, V24, P419, DOI 10.1146/annurev.immunol.23.021704.115658; Tynan FE, 2005, NAT IMMUNOL, V6, P1114, DOI 10.1038/ni1257; Willcox BE, 1999, IMMUNITY, V10, P357, DOI 10.1016/S1074-7613(00)80035-7; Yachi PP, 2007, J EXP MED, V204, P2747, DOI 10.1084/jem.20062610	37	33	37	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 24	2008	283	43					29053	29059		10.1074/jbc.M804996200	http://dx.doi.org/10.1074/jbc.M804996200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	362EB	18703505	Green Published, hybrid			2022-12-27	WOS:000260179900032
J	Xu, J; Liu, Y; Zhang, GY				Xu, Jie; Liu, Yong; Zhang, Guang-Yi			Neuroprotection of GluR5-containing Kainate Receptor Activation against Ischemic Brain Injury through Decreasing Tyrosine Phosphorylation of N-Methyl-D-aspartate Receptors Mediated by Src Kinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CEREBRAL-ISCHEMIA; SYNAPTIC-TRANSMISSION; GLUR6-DEFICIENT MICE; RAT HIPPOCAMPUS; NMDA RECEPTORS; SUBUNITS; GLUR5; INTERNEURONS; INHIBITION; INCREASES	Previous studies indicate that cerebral ischemia breaks the dynamic balance between excitatory and inhibitory inputs. The neural excitotoxicity induced by ionotropic glutamate receptors gain the upper hand during ischemia-reperfusion. In this paper, we investigate whether GluR5 (glutamate receptor 5)-containing kainate receptor activation could lead to a neuroprotective effect against ischemic brain injury and the related mechanism. The results showed that (RS)-2-amino-3-(3-hydroxy-5-tert-butylisoxazol-4-yl) propanoic acid (ATPA), a selective GluR5 agonist, could suppress Src tyrosine phosphorylation and interactions among N-methyl-D-aspartate (NMDA) receptor subunit 2A (NR2A), postsynaptic density protein 95 (PSD-95), and Src and then decrease NMDA receptor activation through attenuating tyrosine phosphorylation of NR2A and NR2B. More importantly, ATPA had a neuroprotective effect against ischemia reperfusion induced neuronal cell death in vivo. However, four separate drugs were found to abolish the effects of ATPA. These were selective GluR5 antagonist NS3763; GluR5 antisense oligodeoxynucleotides; CdCl2, a broad spectrum blocker of voltage-gated calcium channels; and bicuculline, an antagonist of gamma-aminobutyric acid A (GABA(A)) receptor. GABA(A) receptor agonist muscimol could attenuate Src activation and interactions among NR2A, PSD-95 and Src, resulting the suppression of NMDA receptor tyrosine phosphorylation. Moreover, patch clamp recording proved that the activated GABAA receptor could inhibit NMDA receptor-mediated whole-cell currents. Taken together, the results suggest that during ischemia-reperfusion, activated GluR5 may facilitate Ca2+-dependent GABA release from interneurons. The released GABA can activate postsynaptic GABAA receptors, which then attenuates NMDA Src. The final result of this process is that the pyramidal neurons are rescued from hyperexcitability.	[Xu, Jie; Liu, Yong; Zhang, Guang-Yi] Xuzhou Med Coll, Res Ctr Biochem & Mol Biol, Jiangsu Key Lab Brain Dis Bioinformat, Xuzhou 221002, Peoples R China	Xuzhou Medical University	Zhang, GY (corresponding author), Xuzhou Med Coll, Res Ctr Biochem & Mol Biol, Jiangsu Key Lab Brain Dis Bioinformat, 84 W Huai Hai Rd, Xuzhou 221002, Peoples R China.	gyzhang@xzmc.edu.cn	, lyong74/AEV-2086-2022	LIU, Yong/0000-0003-4079-2156	National Natural Science Foundation of China [90608015]; Natural Science foundation of Jiangsu Province, China [BK2007546]; President Special Grant of Xuzhou Medical College [07KJZ08]; Natural Science Foundation of the Jiangsu Higher Education Institutions of China [06KJB180116, 07KJA18030]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science foundation of Jiangsu Province, China(Natural Science Foundation of Jiangsu Province); President Special Grant of Xuzhou Medical College; Natural Science Foundation of the Jiangsu Higher Education Institutions of China(National Natural Science Foundation of China (NSFC))	This work was supported by Great Research Project of the National Natural Science Foundation of China Grant 90608015, Natural Science foundation of Jiangsu Province, China, Grant BK2007546, and the President Special Grant of Xuzhou Medical College 07KJZ08 and Natural Science Foundation of the Jiangsu Higher Education Institutions of China Grants 06KJB180116 and 07KJA18030. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Ali DW, 2001, CURR OPIN NEUROBIOL, V11, P336, DOI 10.1016/S0959-4388(00)00216-6; Andersson O, 2001, GENOMICS, V78, P178, DOI 10.1006/geno.2001.6666; BAHN S, 1994, J NEUROSCI, V14, P5525; Bormann J, 2000, TRENDS PHARMACOL SCI, V21, P16, DOI 10.1016/S0165-6147(99)01413-3; Braga MFM, 2003, J NEUROSCI, V23, P442, DOI 10.1523/JNEUROSCI.23-02-00442.2003; Bureau I, 1999, J NEUROSCI, V19, P653; Chatterton JE, 2002, NATURE, V415, P793, DOI 10.1038/nature715; Chittajallu R, 1999, TRENDS PHARMACOL SCI, V20, P26, DOI 10.1016/S0165-6147(98)01286-3; Christensen JK, 2004, J NEUROSCI, V24, P8986, DOI 10.1523/JNEUROSCI.2156-04.2004; Clarke VRJ, 1997, NATURE, V389, P599, DOI 10.1038/39315; COOPER JA, 1988, P NATL ACAD SCI USA, V85, P4232, DOI 10.1073/pnas.85.12.4232; Cossart R, 1998, NAT NEUROSCI, V1, P470, DOI 10.1038/2185; Fisahn A, 2004, J NEUROSCI, V24, P9658, DOI 10.1523/JNEUROSCI.2973-04.2004; Freund TF, 1996, HIPPOCAMPUS, V6, P347, DOI 10.1002/(SICI)1098-1063(1996)6:4<347::AID-HIPO1>3.0.CO;2-I; HOLLMANN M, 1994, ANNU REV NEUROSCI, V17, P31, DOI 10.1146/annurev.ne.17.030194.000335; Hou XY, 2003, NEUROSCI LETT, V343, P125, DOI 10.1016/S0304-3940(03)00365-3; Jiang L, 2001, NEURON, V30, P503, DOI 10.1016/S0896-6273(01)00298-7; Jiang Q, 2000, BRAIN RES, V857, P71, DOI 10.1016/S0006-8993(99)02364-1; Khalilov I, 2002, J NEUROPHYSIOL, V88, P523, DOI 10.1152/jn.2002.88.1.523; Laube B, 1998, J NEUROSCI, V18, P2954; Lee JM, 2000, J CLIN INVEST, V106, P723, DOI 10.1172/JCI11003; Lee JM, 1999, NATURE, V399, pA7, DOI 10.1038/399a007; Liu Y, 2001, BRAIN RES, V909, P51, DOI 10.1016/S0006-8993(01)02619-1; LOWRY OH, 1951, J BIOL CHEM, V193, P265; LYDEN PD, 1992, STROKE, V23, P1463, DOI 10.1161/01.STR.23.10.1463; LYDEN PD, 1994, STROKE, V25, P189, DOI 10.1161/01.STR.25.1.189; Mulle C, 1998, NATURE, V392, P601, DOI 10.1038/33408; Nakazawa T, 2001, J BIOL CHEM, V276, P693, DOI 10.1074/jbc.M008085200; O'Neill MJ, 2000, NEUROPHARMACOLOGY, V39, P1575, DOI 10.1016/S0028-3908(99)00250-6; OJA SS, 1990, NEUROCHEM RES, V15, P797, DOI 10.1007/BF00968557; Pei DS, 2006, BRAIN, V129, P465, DOI 10.1093/brain/awh700; Pei L, 2000, ACTA PHARMACOL SIN, V21, P695; PULSINELLI WA, 1979, STROKE, V10, P267, DOI 10.1161/01.STR.10.3.267; RodriguezMoreno A, 1997, NEURON, V19, P893, DOI 10.1016/S0896-6273(00)80970-8; Schwartz-Bloom RD, 2001, J NEUROCHEM, V77, P353, DOI 10.1046/j.1471-4159.2001.00274.x; SEEBURG PH, 1993, TRENDS NEUROSCI, V16, P359, DOI 10.1016/0166-2236(93)90093-2; SHUAIB A, 1993, EXP NEUROL, V123, P284, DOI 10.1006/exnr.1993.1160; Takagi N, 1999, J CEREBR BLOOD F MET, V19, P880, DOI 10.1097/00004647-199908000-00007; Takagi N, 1997, J NEUROCHEM, V69, P1060; WANG YT, 1994, NATURE, V369, P233, DOI 10.1038/369233a0; Wang YT, 1996, P NATL ACAD SCI USA, V93, P1721, DOI 10.1073/pnas.93.4.1721; Yu XM, 1997, SCIENCE, V275, P674, DOI 10.1126/science.275.5300.674	42	36	40	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 24	2008	283	43					29355	29366		10.1074/jbc.M800393200	http://dx.doi.org/10.1074/jbc.M800393200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	362EB	18678878	Green Published, hybrid			2022-12-27	WOS:000260179900062
J	Galm, U; Wang, LY; Wendt-Pienkowski, E; Yang, RY; Liu, W; Tao, MF; Coughlin, JM; Shen, B				Galm, Ute; Wang, Liyan; Wendt-Pienkowski, Evelyn; Yang, Runying; Liu, Wen; Tao, Meifeng; Coughlin, Jane M.; Shen, Ben			In vivo manipulation of the bleomycin biosynthetic gene cluster in Streptomyces verticillus ATCC15003 revealing new insights into its biosynthetic pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANTITUMOR DRUG BLEOMYCIN; DNA STRAND SCISSION; HETEROLOGOUS EXPRESSION; ESCHERICHIA-COLI; HYBRID PEPTIDE; CONJUGAL TRANSFER; GROUP ANTIBIOTICS; PRODUCER; CLONING; TALLYSOMYCIN	Bleomycin (BLM), an important clinically used antitumor compound, and its analogs are challenging to prepare by chemical synthesis. Genetic engineering of the biosynthetic pathway in the producer strain would provide an efficient and convenient method of generating new derivatives of this complex molecule in vivo. However, the BLM producing Streptomyces verticillus ATCC15003 has been refractory to all means of introducing plasmid DNA into its cells for nearly two decades. Several years after cloning and identification of the bleomycin biosynthetic gene cluster, this study demonstrates, for the first time, genetic accessibility of this pharmaceutically relevant producer strain by intergeneric Escherichia coli-Streptomyces conjugation. Gene replacement and in-frame deletion mutants were created by lambda RED-mediated PCR targeting mutagenesis, and the secondary metabolite profile of the resultant mutants confirmed the identity of the BLM biosynthetic gene cluster and established its boundaries. Ultimately, the in-frame blmD deletion mutant strain S. verticillus SB5 resulted in the production of a bleomycin intermediate. The structure of this compound, decarbamoyl-BLM, was elucidated, and its DNA cleavage activity was compared with the parent compounds.	[Shen, Ben] Univ Wisconsin, Div Pharmaceut Sci, Sch Pharm, Madison, WI 53705 USA; [Shen, Ben] Univ Wisconsin, Natl Cooperat Drug Discovery Grp, Madison, WI 53705 USA; [Shen, Ben] Univ Wisconsin, Dept Chem, Madison, WI 53705 USA; [Yang, Runying; Shen, Ben] Univ Calif Davis, Dept Chem, Davis, CA 95616 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of California System; University of California Davis	Shen, B (corresponding author), Univ Wisconsin, Div Pharmaceut Sci, Sch Pharm, 777 Highland Ave, Madison, WI 53705 USA.	bshen@pharmacy.wisc.edu			National Institutes of Health [CA94426]; NATIONAL CANCER INSTITUTE [R01CA094426] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA94426. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	BIERMAN M, 1992, GENE, V116, P43, DOI 10.1016/0378-1119(92)90627-2; BOGER DL, 1995, J AM CHEM SOC, V117, P7344, DOI 10.1021/ja00133a008; Burke J, 2001, P NATL ACAD SCI USA, V98, P6289, DOI 10.1073/pnas.101589398; Calafat AM, 1997, J AM CHEM SOC, V119, P3656, DOI 10.1021/ja963392b; CALCUTT MJ, 1994, GENE, V151, P17, DOI 10.1016/0378-1119(94)90627-0; Chen JY, 2005, NAT REV CANCER, V5, P102, DOI 10.1038/nrc1547; Du LC, 2000, CHEM BIOL, V7, P623, DOI 10.1016/S1074-5521(00)00011-9; Du LC, 2003, BIOCHEMISTRY-US, V42, P9731, DOI 10.1021/bi034817r; Du LC, 1999, CHEM BIOL, V6, P507, DOI 10.1016/S1074-5521(99)80083-0; Du LC, 2000, FEMS MICROBIOL LETT, V189, P171, DOI 10.1016/S0378-1097(00)00274-3; EHRENFELD GM, 1987, BIOCHEMISTRY-US, V26, P931, DOI 10.1021/bi00377a038; Eustaquio AS, 2005, APPL ENVIRON MICROB, V71, P2452, DOI 10.1128/AEM.71.5.2452-2459.2005; Flett F, 1997, FEMS MICROBIOL LETT, V155, P223, DOI 10.1111/j.1574-6968.1997.tb13882.x; Galm U, 2005, CHEM REV, V105, P739, DOI 10.1021/cr030117g; Galm U, 2006, EXPERT OPIN DRUG DIS, V1, P409, DOI 10.1517/17460441.1.5.409; Goodwin KD, 2008, P NATL ACAD SCI USA, V105, P5052, DOI 10.1073/pnas.0708143105; Gregory MA, 2003, J BACTERIOL, V185, P5320, DOI 10.1128/JB.185.17.5320-5323.2003; Gust B, 2003, P NATL ACAD SCI USA, V100, P1541, DOI 10.1073/pnas.0337542100; Hecht SM, 2000, J NAT PROD, V63, P158, DOI 10.1021/np990549f; Katano K, 1998, J AM CHEM SOC, V120, P11285, DOI 10.1021/ja9819458; Kieser T., 2000, PRACTICAL STREPTOMYC, V4362; Meyers CLF, 2004, ANGEW CHEM INT EDIT, V43, P67, DOI 10.1002/anie.200352626; Mutka SC, 2006, BIOCHEMISTRY-US, V45, P1321, DOI 10.1021/bi052075r; NAGANAWA H, 1977, J ANTIBIOT, V30, P388, DOI 10.7164/antibiotics.30.388; Paget MSB, 1999, J BACTERIOL, V181, P204, DOI 10.1128/JB.181.1.204-211.1999; Sambrook J., 2001, MOL CLONING LAB MANU; Sanchez C, 2001, CHEM BIOL, V8, P725, DOI 10.1016/S1074-5521(01)00047-3; Sekurova ON, 2004, J BACTERIOL, V186, P1345, DOI 10.1128/JB.186.5.1345-1354.2004; Shen B, 2001, J IND MICROBIOL BIOT, V27, P378, DOI 10.1038/sj.jim.7000194; Shen B, 2002, J NAT PROD, V65, P422, DOI 10.1021/np010550q; Shen B, 1999, BIOORG CHEM, V27, P155, DOI 10.1006/bioo.1998.1131; Slick B. I., 1985, BLEOMYCIN CHEMOTHERA; SUGIYAMA H, 1985, J NAT PROD, V48, P869, DOI 10.1021/np50042a001; SUGIYAMA H, 1986, J AM CHEM SOC, V108, P3852, DOI 10.1021/ja00273a063; Sun YH, 2002, MICROBIOL-SGM, V148, P361, DOI 10.1099/00221287-148-2-361; TAKITA T, 1978, J ANTIBIOT, V31, P801, DOI 10.7164/antibiotics.31.801; Tao MF, 2007, MOL BIOSYST, V3, P60, DOI 10.1039/b615284h; UMEZAWA H, 1966, J ANTIBIOT, V19, P200; Wang LY, 2007, J NAT PROD, V70, P402, DOI 10.1021/np060592k; Wenzel SC, 2005, CHEM BIOL, V12, P349, DOI 10.1016/j.chembiol.2004.12.012; Wenzel SC, 2005, CURR OPIN BIOTECH, V16, P594, DOI 10.1016/j.copbio.2005.10.001; YAMAMOTO H, 1986, J ANTIBIOT, V39, P1304, DOI 10.7164/antibiotics.39.1304	42	31	32	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 17	2008	283	42					28236	28245		10.1074/jbc.M804971200	http://dx.doi.org/10.1074/jbc.M804971200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	359EN	18697737	Green Published, hybrid			2022-12-27	WOS:000259969300025
J	Syson, K; Tomlinson, C; Chapados, BR; Sayers, JR; Tainer, JA; Williams, NH; Grasby, JA				Syson, Karl; Tomlinson, Christopher; Chapados, Brian R.; Sayers, Jon R.; Tainer, John A.; Williams, Nicholas H.; Grasby, Jane A.			Three metal ions participate in the reaction catalyzed by T5 flap endonuclease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-POLYMERASE-I; T4 RNASE-H; CRYSTAL-STRUCTURE; SUBSTRATE-SPECIFICITY; STRUCTURAL BASIS; BINDING-SITES; RESTRICTION ENDONUCLEASES; BACILLUS-CEREUS; PHOSPHOLIPASE-C; ACTIVE-SITE	Protein nucleases and RNA enzymes depend on divalent metal ions to catalyze the rapid hydrolysis of phosphate diester linkages of nucleic acids during DNA replication, DNA repair, RNA processing, and RNA degradation. These enzymes are widely proposed to catalyze phosphate diester hydrolysis using a "two-metal-ion mechanism." Yet, analyses of flap endonuclease (FEN) family members, which occur in all domains of life and act in DNA replication and repair, exemplify controversies regarding the classical two-metal-ion mechanism for phosphate diester hydrolysis. Whereas substrate-free structures of FENs identify two active site metal ions, their typical separation of >4 A appears incompatible with this mechanism. To clarify the roles played by FEN metal ions, we report here a detailed evaluation of the magnesium ion response of T5FEN. Kinetic investigations reveal that overall the T5FEN-catalyzed reaction requires at least three magnesium ions, implying that an additional metal ion is bound. The presence of at least two ions bound with differing affinity is required to catalyze phosphate diester hydrolysis. Analysis of the inhibition of reactions by calcium ions is consistent with a requirement for two viable cofactors (Mg2+ or Mn2+). The apparent substrate association constant is maximized by binding two magnesium ions. This may reflect a metal-dependent unpairing of duplex substrate required to position the scissile phosphate in contact with metal ion(s). The combined results suggest that T5FEN primarily uses a two-metal-ion mechanism for chemical catalysis, but that its overall metallobiochemistry is more complex and requires three ions.	[Syson, Karl; Tomlinson, Christopher; Williams, Nicholas H.; Grasby, Jane A.] Univ Sheffield, Dept Chem, Krebs Inst, Ctr Chem Biol, Sheffield S3 7HF, S Yorkshire, England; [Sayers, Jon R.] Univ Sheffield, Sch Med & Biomed Sci, Henry Wellcome Labs Med Res, Sheffield S10 2RX, S Yorkshire, England; [Chapados, Brian R.; Tainer, John A.] Scripps Res Inst, Dept Mol Biol, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA	University of Sheffield; University of Sheffield; Scripps Research Institute	Grasby, JA (corresponding author), Univ Sheffield, Dept Chem, Krebs Inst, Ctr Chem Biol, Sheffield S3 7HF, S Yorkshire, England.	j.a.grasby@sheffield.ac.uk	Sayers, Jon R/I-8974-2012; Sayers, Jon R/AAP-6179-2020; Tainer, John/GWQ-4878-2022; Classen, Scott/AAY-8176-2020	Sayers, Jon R/0000-0002-5082-1443; Sayers, Jon R/0000-0002-5082-1443; Tainer, John/0000-0003-1659-2429; Williams, Nicholas/0000-0002-4457-4220	National Institutes of Health [CA081967]; SBDR [P01 CA92584]; BBSRC [B20079, F0147321]; BBSRC [BB/F014732/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [B20079, BB/F014732/1] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [R01CA081967, P01CA092584] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); SBDR; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA081967 (to J. A. T.) and SBDR Program Grant P01 CA92584 (to J. A. T.). This work was also supported by BBSRC Grants B20079 and F0147321 (to J. A. G. and N. H. W.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Amyes TL, 2005, J AM CHEM SOC, V127, P15708, DOI 10.1021/ja055493s; BEESE LS, 1991, EMBO J, V10, P25, DOI 10.1002/j.1460-2075.1991.tb07917.x; Bhagwat M, 1997, J BIOL CHEM, V272, P28531, DOI 10.1074/jbc.272.45.28531; Ceska TA, 1996, NATURE, V382, P90, DOI 10.1038/382090a0; Chapados BR, 2004, CELL, V116, P39, DOI 10.1016/S0092-8674(03)01036-5; Dervan JJ, 2002, P NATL ACAD SCI USA, V99, P8542, DOI 10.1073/pnas.082241699; Devos JM, 2007, J BIOL CHEM, V282, P31713, DOI 10.1074/jbc.M703209200; Feng M, 2004, NAT STRUCT MOL BIOL, V11, P450, DOI 10.1038/nsmb754; Gangisetty O, 2005, J BIOL CHEM, V280, P12876, DOI 10.1074/jbc.M414025200; Garcin ED, 2008, NAT STRUCT MOL BIOL, V15, P515, DOI 10.1038/nsmb.1414; GUTFREUND F, 1995, KINETICS LIFE SCI; HAN H, 1991, BIOCHEMISTRY-US, V30, P11104, DOI 10.1021/bi00110a012; HANSEN S, 1993, J MOL BIOL, V234, P179, DOI 10.1006/jmbi.1993.1572; Hitomi K, 2007, DNA REPAIR, V6, P410, DOI 10.1016/j.dnarep.2006.10.004; Horton NC, 2004, BIOCHEMISTRY-US, V43, P6841, DOI 10.1021/bi0499056; Hosfield DJ, 1999, CELL, V98, P397, DOI 10.1016/S0092-8674(00)81968-6; Hosfield DJ, 1998, CELL, V95, P135, DOI 10.1016/S0092-8674(00)81789-4; HOUGH E, 1989, NATURE, V338, P357, DOI 10.1038/338357a0; Hwang KY, 1998, NAT STRUCT BIOL, V5, P707, DOI 10.1038/1406; KIM EE, 1991, J MOL BIOL, V218, P449, DOI 10.1016/0022-2836(91)90724-K; KIM Y, 1995, NATURE, V376, P612, DOI 10.1038/376612a0; Matsui E, 2002, J BIOL CHEM, V277, P37840, DOI 10.1074/jbc.M205235200; McConnell TS, 1997, BIOCHEMISTRY-US, V36, P8293, DOI 10.1021/bi9700678; Mueser TC, 1996, CELL, V85, P1101, DOI 10.1016/S0092-8674(00)81310-0; Nowotny M, 2005, CELL, V121, P1005, DOI 10.1016/j.cell.2005.04.024; Patel D, 2002, J MOL BIOL, V320, P1025, DOI 10.1016/S0022-2836(02)00547-8; Pickering TJ, 1999, J BIOL CHEM, V274, P17711, DOI 10.1074/jbc.274.25.17711; Pingoud A, 2005, CELL MOL LIFE SCI, V62, P685, DOI 10.1007/s00018-004-4513-1; Sakurai S, 2005, EMBO J, V24, P683, DOI 10.1038/sj.emboj.7600519; SAYERS JR, 1990, J BIOL CHEM, V265, P18311; Schroeder GK, 2006, P NATL ACAD SCI USA, V103, P4052, DOI 10.1073/pnas.0510879103; Shan SO, 1999, P NATL ACAD SCI USA, V96, P12299, DOI 10.1073/pnas.96.22.12299; Shen BH, 1997, NUCLEIC ACIDS RES, V25, P3332, DOI 10.1093/nar/25.16.3332; Sigel RKO, 2007, CHEM REV, V107, P97, DOI 10.1021/cr0502605; Tock MR, 2003, EMBO J, V22, P995, DOI 10.1093/emboj/cdg098; VIPOND IB, 1995, BIOCHEMISTRY-US, V34, P697, DOI 10.1021/bi00002a037; VOLBEDA A, 1991, EMBO J, V10, P1607, DOI 10.1002/j.1460-2075.1991.tb07683.x; Williams R, 2007, J MOL BIOL, V371, P34, DOI 10.1016/j.jmb.2007.04.063; Yang W, 2006, MOL CELL, V22, P5, DOI 10.1016/j.molcel.2006.03.013; YANG W, 1990, SCIENCE, V249, P1398, DOI 10.1126/science.2169648; Zheng L, 2002, BIOCHEMISTRY-US, V41, P10323, DOI 10.1021/bi025841s	41	38	38	0	29	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 17	2008	283	42					28741	28746		10.1074/jbc.M801264200	http://dx.doi.org/10.1074/jbc.M801264200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	359EN	18697748	hybrid, Green Published			2022-12-27	WOS:000259969300076
J	Wang, Y; Boudreaux, DM; Estrada, DF; Egan, CW; Jeor, SC; De Guzman, RN				Wang, Yu; Boudreaux, Daniel M.; Estrada, D. Fernando; Egan, Chet W.; St Jeor, Stephen C.; De Guzman, Roberto N.			NMR structure of the N-terminal coiled coil domain of the Andes hantavirus nucleocapsid protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VIRUS CORE PARTICLES; PULMONARY SYNDROME; TULA HANTAVIRUS; UNITED-STATES; OUTBREAK; DISEASE; OLIGOMERIZATION; SPECTROSCOPY; RECOGNITION; ASSOCIATION	The hantaviruses are emerging infectious viruses that in humans can cause a cardiopulmonary syndrome or a hemorrhagic fever with renal syndrome. The nucleocapsid (N) is the most abundant viral protein, and during viral assembly, the N protein forms trimers and packages the viral RNA genome. Here, we report the NMR structure of the N-terminal domain (residues 1-74, called N1-74) of the Andes hantavirus N protein. N1-74 forms two long helices (alpha(1) and alpha(2)) that intertwine into a coiled coil domain. The conserved hydrophobic residues at the helix alpha(1)-alpha(2) interface stabilize the coiled coil; however, there are many conserved surface residues whose function is not known. Site-directed mutagenesis, CD spectroscopy, and immunocytochemistry reveal that a point mutation in the conserved basic surface formed by Arg(22) or Lys(26) lead to antibody recognition based on the subcellular localization of the N protein. Thus, Arg(22) and Lys(26) are likely involved in a conformational change or molecular recognition when the N protein is trafficked from the cytoplasm to the Golgi, the site of viral assembly and maturation.	[Wang, Yu; Estrada, D. Fernando; Egan, Chet W.; De Guzman, Roberto N.] Univ Kansas, Dept Mol Biosci, Lawrence, KS 66045 USA; [Boudreaux, Daniel M.; St Jeor, Stephen C.] Univ Nevada, Dept Microbiol & Immunol, Reno, NV 89557 USA	University of Kansas; Nevada System of Higher Education (NSHE); University of Nevada Reno	De Guzman, RN (corresponding author), Univ Kansas, Dept Mol Biosci, 1200 Sunnyside Ave, Lawrence, KS 66045 USA.	rdguzman@ku.edu	wang, yu/A-3473-2011; Pacific-Southwest, RCE/B-6155-2009		National Institutes of Health [AI057160, AI65359]; American Heart Association [0755724Z]; National Science Foundation Program [EF 0326999]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI065359] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); National Science Foundation Program(National Science Foundation (NSF)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants AI057160 and AI65359. This work was also supported by American Heart Association Grant 0755724Z ( to R. N. D.); National Science Foundation Program Grant EF 0326999 ( to S.C.S.J.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Alfadhli A, 2002, J BIOL CHEM, V277, P27103, DOI 10.1074/jbc.M203395200; Alfadhli A, 2001, J VIROL, V75, P2019, DOI 10.1128/JVI.75.4.2019-2023.2001; Alminaite A, 2006, J VIROL, V80, P9073, DOI 10.1128/JVI.00515-06; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Boudko SP, 2007, J MOL BIOL, V366, P1538, DOI 10.1016/j.jmb.2006.12.046; CASE DA, 2002, AMBER7; Choy N, 2003, J MOL BIOL, V334, P527, DOI 10.1016/j.jmb.2003.09.059; Dames SA, 2002, P NATL ACAD SCI USA, V99, P5271, DOI 10.1073/pnas.082121399; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Deyde VM, 2005, VIROLOGY, V331, P307, DOI 10.1016/j.virol.2004.11.003; FESIK SW, 1988, J MAGN RESON, V78, P588, DOI 10.1016/0022-2364(88)90144-8; Geldmacher A, 2005, VACCINE, V23, P3973, DOI 10.1016/j.vaccine.2005.02.025; Geldmacher A, 2004, VIROLOGY, V323, P108, DOI 10.1016/j.virol.2004.02.022; Gott P, 1997, VIRUS GENES, V14, P31, DOI 10.1023/A:1007983306341; GOTT P, 1993, VIROLOGY, V194, P332, DOI 10.1006/viro.1993.1263; GRZESIEK S, 1992, BIOCHEMISTRY-US, V31, P8180, DOI 10.1021/bi00150a009; GRZESIEK S, 1993, J AM CHEM SOC, V115, P12593, DOI 10.1021/ja00079a052; GRZESIEK S, 1993, J BIOMOL NMR, V3, P185; Guntert Peter, 2004, Methods Mol Biol, V278, P353; HJELLE B, 1994, J VIROL, V68, P592, DOI 10.1128/JVI.68.2.592-596.1994; Johnson Bruce A, 2004, Methods Mol Biol, V278, P313; Kaukinen P, 2005, ARCH VIROL, V150, P1693, DOI 10.1007/s00705-005-0555-4; Kaukinen P, 2004, J VIROL, V78, P13669, DOI 10.1128/JVI.78.24.13669-13677.2004; Kaukinen P, 2003, J VIROL, V77, P10910, DOI 10.1128/JVI.77.20.10910-10916.2003; Kaukinen P, 2003, VIRUS RES, V92, P37, DOI 10.1016/S0168-1702(02)00312-X; Khaiboullina SF, 2005, CURR MOL MED, V5, P773, DOI 10.2174/156652405774962317; Khaiboullina SF, 2005, J MED VIROL, V75, P267, DOI 10.1002/jmv.20266; Kiss RS, 1999, BIOCHEMISTRY-US, V38, P4327, DOI 10.1021/bi982597p; Koster F., 1993, Morbidity and Mortality Weekly Report, V42, P421; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Lee BH, 2003, VIRUS RES, V98, P83, DOI 10.1016/j.virusres.2003.09.001; Li XD, 2002, J GEN VIROL, V83, P759, DOI 10.1099/0022-1317-83-4-759; Lundkvist A, 2002, VIRAL IMMUNOL, V15, P177, DOI 10.1089/088282402317340323; Maeda A, 2003, VIROLOGY, V305, P288, DOI 10.1006/viro.2002.1767; Maes P, 2006, INTERVIROLOGY, V49, P253, DOI 10.1159/000093454; MARION D, 1989, BIOCHEMISTRY-US, V28, P6150, DOI 10.1021/bi00441a004; Mertz GJ, 2006, CURR OPIN INFECT DIS, V19, P437, DOI 10.1097/01.qco.0000244048.38758.1f; Mir MA, 2006, J VIROL, V80, P11283, DOI 10.1128/JVI.00820-06; Mir MA, 2005, J VIROL, V79, P1824, DOI 10.1128/JVI.79.3.1824-1835.2005; Mir MA, 2004, J VIROL, V78, P8281, DOI 10.1128/jvi.78.15.8281-8288.2004; MUHANDIRAM DR, 1994, J MAGN RESON SER B, V103, P203, DOI 10.1006/jmrb.1994.1032; NICHOL ST, 1993, SCIENCE, V262, P914, DOI 10.1126/science.8235615; NOLTE KB, 1995, HUM PATHOL, V26, P110, DOI 10.1016/0046-8177(95)90123-X; Padula PJ, 1998, VIROLOGY, V241, P323, DOI 10.1006/viro.1997.8976; PENSIERO MN, 1992, J VIROL, V66, P5929, DOI 10.1128/JVI.66.10.5929-5936.1992; Ramanathan HN, 2007, J VIROL, V81, P8634, DOI 10.1128/JVI.00418-07; Ravkov EV, 1998, J VIROL, V72, P2865, DOI 10.1128/JVI.72.4.2865-2870.1998; Schmaljohn C, 1997, EMERG INFECT DIS, V3, P95, DOI 10.3201/eid0302.970202; Severson W, 1999, J BIOL CHEM, V274, P33732, DOI 10.1074/jbc.274.47.33732; Spiropoulou CF, 2001, CURR TOP MICROBIOL, V256, P33; TOLMAN JR, 1992, J MAGN RESON, V98, P462, DOI 10.1016/0022-2364(92)90149-2; Wishart DS, 1998, BIOCHEM CELL BIOL, V76, P153, DOI 10.1139/bcb-76-2-3-153; WITTEKIND M, 1993, J MAGN RESON SER B, V101, P201, DOI 10.1006/jmrb.1993.1033; Yoshimatsu K, 2003, J VIROL, V77, P943, DOI 10.1128/JVI.77.2.943-952.2003; ZAKI SR, 1995, AM J PATHOL, V146, P552; ZHOU NE, 1992, BIOPOLYMERS, V32, P419, DOI 10.1002/bip.360320419	56	19	21	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 17	2008	283	42					28297	28304		10.1074/jbc.M804869200	http://dx.doi.org/10.1074/jbc.M804869200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	359EN	18687679	Green Published, hybrid			2022-12-27	WOS:000259969300031
J	Krauss, M; Jia, JY; Roux, A; Beck, R; Wieland, FT; De Camilli, P; Haucke, V				Krauss, Michael; Jia, Jun-Yong; Roux, Aurelien; Beck, Rainer; Wieland, Felix T.; De Camilli, Pietro; Haucke, Volker			Arf1-GTP-induced tubule formation suggests a function of Arf family proteins in curvature acquisition at sites of vesicle budding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADP-RIBOSYLATION FACTOR-1; MEMBRANE CURVATURE; PLASMA-MEMBRANE; TRANSPORT; GOLGI; DYNAMIN; BAR; AMPHIPHYSIN; MECHANISMS; MULTIPLE	ADP-ribosylation factor (Arf) and related small GTPases play crucial roles in membrane traffic within the exo- and endocytic pathways. Arf proteins in their GTP-bound state are associated with curved membrane buds and tubules, frequently together with effector coat proteins to which they bind. Here we report that Arf1 is found on membrane tubules originating from the Golgi complex where it colocalizes with COPI and GGA1 vesicle coat proteins. Arf1 also induces tubulation of liposomes in vitro. Mutations within the amino-terminal amphipathic helix (NTH) of Arf1 affect the number of Arf1-positive tubules in vivo and its property to tubulate liposomes. Moreover, hydrophilic substitutions within the hydrophobic part of its NTH impair Arf1-catalyzed budding of COPI vesicles in vitro. Our data indicate that GTP-controlled local induction of high curvature membranes is an important property of Arf1 that might be shared by a subgroup of Arf/Arl family GTPases.	[Krauss, Michael; Jia, Jun-Yong; Haucke, Volker] Free Univ Berlin, Dept Membrane Biochem, Inst Chem & Biochem, D-14195 Berlin, Germany; [Roux, Aurelien; De Camilli, Pietro] Yale Univ, Sch Med, Dept Cell Biol, New Haven, CT 06510 USA; [Roux, Aurelien] Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT 06510 USA; [Beck, Rainer; Wieland, Felix T.] Univ Heidelberg, Zentrum Biochem, D-69120 Heidelberg, Germany	Free University of Berlin; Yale University; Howard Hughes Medical Institute; Yale University; Ruprecht Karls University Heidelberg	Haucke, V (corresponding author), Free Univ Berlin, Dept Membrane Biochem, Inst Chem & Biochem, Takustr 6, D-14195 Berlin, Germany.	v.haucke@biochemie.fu-berlin.de	Roux, Aurelien R/G-9541-2013; Roux, Aurelien/AAU-1262-2021	Roux, Aurelien R/0000-0002-6088-0711; Haucke, Volker/0000-0003-3119-6993; Krauss, Michael/0000-0003-1010-9723; Beck, Rainer/0000-0001-9304-2733	German Research Funding Agency DFG [HA2686/4-1, SFB 740/TP C6, SFB 638/TP A10]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS036251] Funding Source: NIH RePORTER	German Research Funding Agency DFG(German Research Foundation (DFG)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported in part by German Research Funding Agency DFG Grants HA2686/4-1, SFB 740/TP C6 (to V. H.), and SFB 638/TP A10 (to F. T. W.) and European Molecular Biology Organization (EMBO) YIP Programme (to V. H.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Antonny B, 1997, BIOCHEMISTRY-US, V36, P4675, DOI 10.1021/bi962252b; Bos JL, 2007, CELL, V129, P865, DOI 10.1016/j.cell.2007.05.018; Burd CG, 2004, TRENDS CELL BIOL, V14, P687, DOI 10.1016/j.tcb.2004.10.004; Cai HQ, 2007, DEV CELL, V12, P671, DOI 10.1016/j.devcel.2007.04.005; Caplan S, 2002, EMBO J, V21, P2557, DOI 10.1093/emboj/21.11.2557; D'Souza-Schorey C, 2006, NAT REV MOL CELL BIO, V7, P347, DOI 10.1038/nrm1910; Farsad K, 2003, CURR OPIN CELL BIOL, V15, P372, DOI 10.1016/S0955-0674(03)00073-5; Farsad K, 2001, J CELL BIOL, V155, P193, DOI 10.1083/jcb.200107075; Ford MGJ, 2002, NATURE, V419, P361, DOI 10.1038/nature01020; Gallop JL, 2006, EMBO J, V25, P2898, DOI 10.1038/sj.emboj.7601174; Gillingham AK, 2007, ANNU REV CELL DEV BI, V23, P579, DOI 10.1146/annurev.cellbio.23.090506.123209; Godi A, 1999, NAT CELL BIOL, V1, P280, DOI 10.1038/12993; Itoh T, 2005, DEV CELL, V9, P791, DOI 10.1016/j.devcel.2005.11.005; Kahn RA, 2006, J CELL BIOL, V172, P645, DOI 10.1083/jcb.200512057; Lee MCS, 2005, CELL, V122, P605, DOI 10.1016/j.cell.2005.07.025; Lee MCS, 2004, ANNU REV CELL DEV BI, V20, P87, DOI 10.1146/annurev.cellbio.20.010403.105307; LIPPINCOTTSCHWARTZ J, 1990, CELL, V60, P821, DOI 10.1016/0092-8674(90)90096-W; Losonczi JA, 1998, BIOCHEMISTRY-US, V37, P706, DOI 10.1021/bi9717791; McMahon HT, 2005, NATURE, V438, P590, DOI 10.1038/nature04396; Peter BJ, 2004, SCIENCE, V303, P495, DOI 10.1126/science.1092586; Polishchuk RS, 2006, TRAFFIC, V7, P1092, DOI 10.1111/j.1600-0854.2006.00453.x; Randazzo PA, 1997, J BIOL CHEM, V272, P7688; Robinson MS, 2004, TRENDS CELL BIOL, V14, P167, DOI 10.1016/j.tcb.2004.02.002; Rothman JE, 2002, NAT MED, V8, P1059, DOI 10.1038/nm770; Roux A, 2006, NATURE, V441, P528, DOI 10.1038/nature04718; Sciaky N, 1997, J CELL BIOL, V139, P1137, DOI 10.1083/jcb.139.5.1137; Sun Z, 2007, TRAFFIC, V8, P582, DOI 10.1111/j.1600-0854.2007.00554.x; Takei K, 1999, NAT CELL BIOL, V1, P33, DOI 10.1038/9004; Yahara N, 2001, MOL BIOL CELL, V12, P221, DOI 10.1091/mbc.12.1.221	29	80	80	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 10	2008	283	41					27717	27723		10.1074/jbc.M804528200	http://dx.doi.org/10.1074/jbc.M804528200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	355OW	18693248	hybrid, Green Published			2022-12-27	WOS:000259719200043
J	Sun, JM; Pedersen, M; Ronnstrand, L				Sun, Jianmin; Pedersen, Malin; Ronnstrand, Lars			Gab2 is involved in differential phosphoinositide 3-kinase signaling by two splice forms of c-kit	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECEPTOR TYROSINE KINASE; PI 3-KINASE; ADAPTER PROTEINS; CELL-SURVIVAL; ISOFORMS; TRANSDUCTION; ACTIVATION; EXPRESSION; ROLES; PHOSPHORYLATION	The stem cell factor receptor/c-Kit plays an important physiological role in hematopoiesis, melanogenesis, and gametogenesis. It has also been implicated in numerous human malignancies. Signal transduction pathways shown to be of importance for c-Kit-mediated transformation include the phosphoinositide 3-kinase (PI3K)/Akt pathway. We have previously shown that two alternative splice forms of c-Kit, denoted GNNK(-) and GNNK(+), mediate distinctively different signals. In this study, we found that in the hematopoietic cell line Ba/F3, GNNK(-) c-Kit mediates a substantially stronger activation of PI3K/Akt than GNNK(-) c-Kit. This difference in signaling was shown to be dependent on the association of the scaffolding protein Gab2 with c-Kit, and Src-mediated phosphorylation of Gab2 was shown to be to be independent of the direct association of PI3K with c-Kit. Furthermore, proliferation and survival of Ba/F3 cells expressing a mutant of c-Kit that fails to bind to PI3K directly were slightly decreased compared with wild-type c-Kit-expressing cells. Using small interfering RNA technology, we further verified a role of Gab2 in inducing activation of PI3K/ Akt downstream of c-Kit. To summarize, we show that PI3K activation by c-Kit is both splice form-dependent and cell type-specific. Furthermore, activation of PI3K by c-Kit is dependent both on the direct PI3K-binding site in c-Kit and on the phosphorylation of Gab2. The fact that c-Kit has been found mutated in numerous human malignancies, including acute myeloid leukemia, and that Gab2 is often overexpressed in acute myeloid leukemia suggests a potential role of Gab2-mediated PI3K activation in transformation.	[Ronnstrand, Lars] Lund Univ, Malmo Univ Hosp, Dept Lab Med, Wallenberg Lab, SE-20502 Malmo, Sweden	Lund University; Skane University Hospital	Ronnstrand, L (corresponding author), Lund Univ, Malmo Univ Hosp, Dept Lab Med, Wallenberg Lab, SE-20502 Malmo, Sweden.	Lars.Ronnstrand@med.lu.se	Sun, Jianmin/AAX-5094-2021; Ronnstrand, Lars/A-2429-2011	Sun, Jianmin/0000-0003-2327-4285; Ronnstrand, Lars/0000-0003-1275-5809	Swedish Cancer Society; Swedish Research Council; Gunnar Nilsson Cancer Foundation; Alfred Osterlund Foundation; Malmo University Hospital Foundation; Malmo University Hospital Cancer Foundation; Royal Physiographical Society	Swedish Cancer Society(Swedish Cancer Society); Swedish Research Council(Swedish Research CouncilEuropean Commission); Gunnar Nilsson Cancer Foundation; Alfred Osterlund Foundation; Malmo University Hospital Foundation; Malmo University Hospital Cancer Foundation; Royal Physiographical Society(Royal Society of London)	This work was supported by grants from the Swedish Cancer Society, the Swedish Research Council, the Gunnar Nilsson Cancer Foundation, the Alfred Osterlund Foundation, the Malmo University Hospital Foundation, the Malmo University Hospital Cancer Foundation, and the Royal Physiographical Society. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Ali K, 2004, NATURE, V431, P1007, DOI 10.1038/nature02991; Antonescu CR, 2007, INT J CANCER, V121, P257, DOI 10.1002/ijc.22681; Blume-Jensen P, 2000, NAT GENET, V24, P157, DOI 10.1038/72814; Blume-Jensen P, 1998, CURR BIOL, V8, P779, DOI 10.1016/S0960-9822(98)70302-1; BLUMEJENSEN P, 1993, EMBO J, V12, P4199, DOI 10.1002/j.1460-2075.1993.tb06104.x; Caruana G, 1998, ONCOGENE, V16, P179, DOI 10.1038/sj.onc.1201494; Chian RJ, 2001, BLOOD, V98, P1365, DOI 10.1182/blood.V98.5.1365; CROSIER PS, 1993, BLOOD, V82, P1151; Gu HH, 2003, TRENDS CELL BIOL, V13, P122, DOI 10.1016/S0962-8924(03)00002-3; Hooshmand-Rad R, 2000, J CELL SCI, V113, P207; Karlsson R, 2003, J LEUKOCYTE BIOL, V74, P923, DOI 10.1189/jlb.0403142; Kissel H, 2000, EMBO J, V19, P1312, DOI 10.1093/emboj/19.6.1312; Moller C, 2005, BLOOD, V106, P1330, DOI 10.1182/blood-2004-12-4792; Nguyen MHH, 2001, J BIOL CHEM, V276, P32704, DOI 10.1074/jbc.M103100200; Nishida K, 2003, CANCER SCI, V94, P1029, DOI 10.1111/j.1349-7006.2003.tb01396.x; Nishida K, 2002, BLOOD, V99, P1866, DOI 10.1182/blood.V99.5.1866; Nishida K, 1999, BLOOD, V93, P1809, DOI 10.1182/blood.V93.6.1809.406k35_1809_1816; PIAO XH, 1994, BLOOD, V83, P476; REITH AD, 1991, EMBO J, V10, P2451, DOI 10.1002/j.1460-2075.1991.tb07784.x; Ronnstrand L, 2004, CELL MOL LIFE SCI, V61, P2535, DOI 10.1007/s00018-004-4189-6; SERVE H, 1995, EMBO J, V14, P473, DOI 10.1002/j.1460-2075.1995.tb07023.x; SERVE H, 1994, J BIOL CHEM, V269, P6026; Sun J, 2007, EXP CELL RES, V313, P3935, DOI 10.1016/j.yexcr.2007.08.021; Thommes K, 1999, BIOCHEM J, V341, P211, DOI 10.1042/0264-6021:3410211; Voytyuk O, 2003, J BIOL CHEM, V278, P9159, DOI 10.1074/jbc.M211726200; Young SM, 2007, CELL SIGNAL, V19, P2572, DOI 10.1016/j.cellsig.2007.08.004; Yu M, 2006, J BIOL CHEM, V281, P28615, DOI 10.1074/jbc.M603742200; Yuzawa S, 2007, CELL, V130, P323, DOI 10.1016/j.cell.2007.05.055; ZHOU SY, 1993, CELL, V72, P767, DOI 10.1016/0092-8674(93)90404-E	29	42	43	1	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 10	2008	283	41					27444	27451		10.1074/jbc.M709703200	http://dx.doi.org/10.1074/jbc.M709703200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	355OW	18697750	Green Submitted, hybrid			2022-12-27	WOS:000259719200014
J	Ofosu, FA; Dewar, L; Craven, SJ; Song, YQ; Cedrone, A; Freedman, J; Fenton, JW				Ofosu, Frederick A.; Dewar, Lori; Craven, Sharon J.; Song, Yingqi; Cedrone, Aisha; Freedman, John; Fenton, John W., II			Coordinate activation of human platelet protease-activated receptor-1 and-4 in response to subnanomolar alpha-thrombin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ASPIRIN RESISTANCE; ANTIPLATELET THERAPY; DIABETIC-PATIENTS; CLEAVED PEPTIDE; GLUCOSE-LEVELS; N-TERMINUS; IN-VIVO; HEMOSTASIS; BINDING; CLONING	We previously demonstrated that human platelets activated with SFLLRN release PAR-1 activation peptide, PAR-1-(1-41), even in the presence of hirudin. This observation suggests that during their activation, platelets generate a protease that activates PAR-1. In this study, PAR-1 and -4 activation peptides were detected 10 s after <= 1.0 nM alpha-thrombin, 10 mu M SFLLRN, or 100 mu M AYPGKF were added to platelets. When SFLLRN or AYGPKF were added to platelets, generation of PAR-1 and -4 activation peptides was complete at 10 s. Generation of both PAR-1 and -4 activation peptides in response to 1 nM alpha-thrombin was significantly inhibited by affinity-purified anti-PAR-1(35-62) IgY, anti-PAR-4-(34-54) IgY, and by the specific PAR-1 antagonist BMS 200261, but not by the PAR-4 antagonist YD3. Effective inhibition of platelet aggregation in response to 1.0 nM alpha-thrombin occurred only in the presence of both anti-PAR span antibodies. We conclude that platelet activation initiated with <= 1.0 nM alpha-thrombin proceeds via simultaneous PAR-1 and -4 activation. Inhibiting the activation of either PAR inhibits activation of the other. Both PAR-1 and -4 activation must be inhibited to prevent platelet activation subsequent to thrombin binding to platelets. The more efficient generation of PAR activation peptides by platelets activated with SFLLRN or AYGPKF, compared with alpha-thrombin, indicates that a platelet-derived serine protease that is inactivated by soybean trypsin inhibitor propagates PAR-1 and -4 activation.	[Ofosu, Frederick A.; Dewar, Lori; Craven, Sharon J.] Canadian Blood Serv, Hamilton, ON, Canada; [Ofosu, Frederick A.; Song, Yingqi; Cedrone, Aisha] McMaster Univ, Dept Pathol & Mol Med, Hamilton, ON L8N 3Z5, Canada; [Freedman, John] Univ Toronto, St Michaels Hosp, Dept Med, Toronto, ON M5B 1W8, Canada; [Fenton, John W., II] Albany Coll Pharm, Pharmaceut Res Inst, Rensselaer, NY 12144 USA	Canadian Blood Services; McMaster University; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; Albany College of Pharmacy & Health Sciences	Ofosu, FA (corresponding author), 1200 Main St W,HSC 3N26, Hamilton, ON L8N 3Z5, Canada.	ofosuf@mcmaster.ca			Heart and Stroke Foundation of Ontario; Canadian Blood Services, Research and Development	Heart and Stroke Foundation of Ontario(Heart & Stroke Foundation of Ontario); Canadian Blood Services, Research and Development	This work was supported by a grant-in-aid from the Heart and Stroke Foundation of Ontario and operational support funds from the Canadian Blood Services, Research and Development. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Ahn HS, 1997, MOL PHARMACOL, V51, P350, DOI 10.1124/mol.51.2.350; Andrade-Gordon P, 1999, P NATL ACAD SCI USA, V96, P12257, DOI 10.1073/pnas.96.22.12257; Bah A, 2007, P NATL ACAD SCI USA, V104, P11603, DOI 10.1073/pnas.0704409104; Bernatowicz MS, 1996, J MED CHEM, V39, P4879, DOI 10.1021/jm960455s; Brass LF, 2003, CHEST, V124, p18S, DOI 10.1378/chest.124.3_suppl.18S; BRASS LF, 1992, J BIOL CHEM, V267, P13795; CHUNG I, 2008, ANN MED, V11, P1; Cohen HW, 2008, J DIABETES COMPLICAT, V22, P224, DOI 10.1016/j.jdiacomp.2007.05.002; Coughlin SR, 2005, J THROMB HAEMOST, V3, P1800, DOI 10.1111/j.1538-7836.2005.01377.x; Covic L, 2000, BIOCHEMISTRY-US, V39, P5458, DOI 10.1021/bi9927078; Day JRS, 2004, CIRCULATION, V110, P2597, DOI 10.1161/01.CIR.0000138027.80056.31; FENTON JW, 1977, J BIOL CHEM, V252, P3587; Furman MI, 2000, THROMB HAEMOSTASIS, V84, P897, DOI 10.1055/s-0037-1614134; Furman MI, 1998, P NATL ACAD SCI USA, V95, P3082, DOI 10.1073/pnas.95.6.3082; Gasparyan AY, 2008, J AM COLL CARDIOL, V51, P1829, DOI 10.1016/j.jacc.2007.11.080; GouinThibault I, 1996, BRIT J HAEMATOL, V95, P738, DOI 10.1046/j.1365-2141.1996.d01-1963.x; Guthikonda S, 2008, THROMB HAEMOSTASIS, V100, P83, DOI 10.1160/TH07-10-0590; Hamilton JR, 2004, J THROMB HAEMOST, V2, P1429, DOI 10.1111/j.1538-7836.2004.00783.x; HUNG DT, 1992, J BIOL CHEM, V267, P20831; Kahn ML, 1999, J CLIN INVEST, V103, P879, DOI 10.1172/JCI6042; Kahn ML, 1998, NATURE, V394, P690, DOI 10.1038/29325; Leger AJ, 2006, CIRCULATION, V113, P1244, DOI 10.1161/CIRCULATIONAHA.105.587758; Liu LB, 1997, J BIOL CHEM, V272, P1997, DOI 10.1074/jbc.272.3.1997; LIU LB, 1994, BRIT J HAEMATOL, V88, P592, DOI 10.1111/j.1365-2141.1994.tb05078.x; LONGENECKER GL, 1985, PLATELETS PHYSL PHAR; Ludwig S, 2005, DIABETES RES CLIN PR, V70, P110, DOI 10.1016/j.diabres.2005.03.025; MUSTARD JF, 1972, BRIT J HAEMATOL, V22, P193, DOI 10.1111/j.1365-2141.1972.tb08800.x; Nakanishi-Matsui M, 2000, NATURE, V404, P609, DOI 10.1038/35007085; Ofosu FA, 1996, BRIT J HAEMATOL, V94, P407, DOI 10.1046/j.1365-2141.1996.d01-1793.x; Ofosu FA, 1998, BIOCHEM J, V336, P283, DOI 10.1042/bj3360283; Poullis M, 2000, J THORAC CARDIOV SUR, V120, P370, DOI 10.1067/mtc.2000.108531; Ramachandran R, 1997, THROMB HAEMOSTASIS, V78, P1119; RASMUSSEN UB, 1991, FEBS LETT, V288, P123, DOI 10.1016/0014-5793(91)81017-3; Sambrano GR, 2001, NATURE, V413, P74, DOI 10.1038/35092573; Shantsila E, 2008, THROMB HAEMOSTASIS, V100, P7, DOI 10.1160/TH08-06-0342; Sudic D, 2006, BRIT J HAEMATOL, V133, P315, DOI 10.1111/j.1365-2141.2006.06012.x; THOMAS AP, 1991, CELLULAR CALCIUM PRA, P33; Undas A, 2008, DIABETES CARE, V31, P1590, DOI 10.2337/dc08-0282; VASSALLO RR, 1992, J BIOL CHEM, V267, P6081; VU TKH, 1991, CELL, V64, P1057, DOI 10.1016/0092-8674(91)90261-V; Weiss EJ, 2002, BLOOD, V100, P3240, DOI 10.1182/blood-2002-05-1470; Wu CC, 2002, THROMB HAEMOSTASIS, V87, P1026, DOI 10.1055/s-0037-1613128; Xu WF, 1998, P NATL ACAD SCI USA, V95, P6642, DOI 10.1073/pnas.95.12.6642	43	18	18	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 3	2008	283	40					26886	26893		10.1074/jbc.M802237200	http://dx.doi.org/10.1074/jbc.M802237200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	353RT	18682394	hybrid			2022-12-27	WOS:000259586600008
J	Lee, NY; Ray, B; How, T; Blobe, GC				Lee, Nam Y.; Ray, Bridgette; How, Tam; Blobe, Gerard C.			Endoglin Promotes Transforming Growth Factor beta-mediated Smad 1/5/8 Signaling and Inhibits Endothelial Cell Migration through Its Association with GIPC	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEREDITARY HEMORRHAGIC TELANGIECTASIA; RECEPTOR COMPLEX; ANGIOGENESIS; KINASE; ALK1; PROLIFERATION; ACTIVATION; FAMILY; DOMAIN; TRANSDUCTION	Transforming growth factor beta (TGF-beta) signals through two distinct pathways to regulate endothelial cell proliferation, migration, and angiogenesis, the ALK-1/Smad 1/5/8 and ALK-5/Smad2/3 pathways. Endoglin is a co-receptor predominantly expressed in endothelial cells that participates in TGF beta-mediated signaling with ALK-1 and ALK-5 and regulates critical aspects of cellular and biological responses. The embryonic lethal phenotype of knock-out mice because of defects in angiogenesis and disease-causing mutations resulting in human vascular diseases both support essential roles for endoglin, ALK-1, and ALK-5 in the vasculature. However, the mechanism by which endoglin mediates TGF-beta signaling through ALK-1 and ALK-5 has remained elusive. Here we describe a novel interaction between endoglin and GIPC, a scaffolding protein known to regulate cell surface receptor expression and trafficking. Co-immunoprecipitation and immunofluorescence confocal studies both demonstrate a specific interaction between endoglin and GIPC in endothelial cells, mediated by a class I PDZ binding motif in the cytoplasmic domain of endoglin. Subcellular distribution studies demonstrate that endoglin recruits GIPC to the plasma membrane and co-localizes with GIPC in a TGF beta-independent manner, with GIPC-promoting cell surface retention of endoglin. Endoglin specifically enhanced TGF-beta 1-induced phosphorylation of Smad 1/5/8, increased a Smad 1/5/8 responsive promoter, and inhibited endothelial cell migration in a manner dependent on the ability of endoglin to interact with GIPC. These studies define a novel mechanism for the regulation of endoglin signaling and function in endothelial cells and demonstrate a new role for GIPC in TGF-beta signaling.	[Blobe, Gerard C.] Duke Univ, Med Ctr, Dept Med, Durham, NC 27708 USA; Duke Univ, Med Ctr, Dept Pharmacol, Durham, NC 27708 USA; Duke Univ, Med Ctr, Dept Canc Biol, Durham, NC 27708 USA	Duke University; Duke University; Duke University	Blobe, GC (corresponding author), Duke Univ, Med Ctr, Dept Med, 354 LSRC,Box 91004, Durham, NC 27708 USA.	blobe001@mc.duke.edu	Blobe, Gerard/AAJ-5945-2020; Lee, Nam/H-3073-2016	Blobe, Gerard/0000-0002-4274-8901; 	National Institutes of Health [R01-CA105255]; NCI; NATIONAL CANCER INSTITUTE [R01CA105255] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01-CA105255 from the NCI (to G. C. B.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Barbara NP, 1999, J BIOL CHEM, V274, P584, DOI 10.1074/jbc.274.2.584; Blanco FJ, 2005, J CELL PHYSIOL, V204, P574, DOI 10.1002/jcp.20311; Blobe GC, 2000, NEW ENGL J MED, V342, P1350, DOI 10.1056/NEJM200005043421807; Blobe GC, 2001, J BIOL CHEM, V276, P39608, DOI 10.1074/jbc.M106831200; Bourdeau A, 1999, J CLIN INVEST, V104, P1343, DOI 10.1172/JCI8088; CHEIFETZ S, 1988, J BIOL CHEM, V263, P16984; CHEIFETZ S, 1992, J BIOL CHEM, V267, P19027; Conley BA, 2004, J BIOL CHEM, V279, P27440, DOI 10.1074/jbc.M312561200; David L, 2007, J CELL PHYSIOL, V213, P484, DOI 10.1002/jcp.21126; David L, 2007, BLOOD, V109, P1953, DOI 10.1182/blood-2006-07-034124; Fonsatti E, 2003, ONCOGENE, V22, P6557, DOI 10.1038/sj.onc.1206813; Goumans MJ, 2002, EMBO J, V21, P1743, DOI 10.1093/emboj/21.7.1743; Goumans MJ, 2003, MOL CELL, V12, P817, DOI 10.1016/S1097-2765(03)00386-1; Guerrero-Esteo M, 2002, J BIOL CHEM, V277, P29197, DOI 10.1074/jbc.M111991200; Katoh M, 2002, INT J MOL MED, V9, P585; Koleva RI, 2006, J BIOL CHEM, V281, P25110, DOI 10.1074/jbc.M601288200; Lastres P, 1996, J CELL BIOL, V133, P1109, DOI 10.1083/jcb.133.5.1109; Lebrin F, 2004, EMBO J, V23, P4018, DOI 10.1038/sj.emboj.7600386; Lee NY, 2007, J BIOL CHEM, V282, P21507, DOI 10.1074/jbc.M700176200; Letamendia A, 1998, J BIOL CHEM, V273, P33011, DOI 10.1074/jbc.273.49.33011; Li DY, 1999, SCIENCE, V284, P1534, DOI 10.1126/science.284.5419.1534; Massague J, 1998, ANNU REV BIOCHEM, V67, P753, DOI 10.1146/annurev.biochem.67.1.753; Massague Joan, 1994, Trends in Cell Biology, V4, P172, DOI 10.1016/0962-8924(94)90202-X; Nakao A, 1997, EMBO J, V16, P5353, DOI 10.1093/emboj/16.17.5353; Oh SP, 2000, P NATL ACAD SCI USA, V97, P2626, DOI 10.1073/pnas.97.6.2626; Park SO, 2008, BLOOD, V111, P633, DOI 10.1182/blood-2007-08-107359; Pece-Barbara N, 2005, J BIOL CHEM, V280, P27800, DOI 10.1074/jbc.M503471200; Sanz-Rodriguez F, 2004, J BIOL CHEM, V279, P32858, DOI 10.1074/jbc.M400843200; Scharpfenecker M, 2007, J CELL SCI, V120, P964, DOI 10.1242/jcs.002949; Ten Dijke PT, 2002, J CELL PHYSIOL, V191, P1, DOI 10.1002/jcp.10066; WRANA JL, 1994, NATURE, V370, P341, DOI 10.1038/370341a0; Yang X, 1999, DEVELOPMENT, V126, P1571	32	86	87	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 21	2008	283	47					32527	32533		10.1074/jbc.M803059200	http://dx.doi.org/10.1074/jbc.M803059200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	372HW	18775991	hybrid, Green Published			2022-12-27	WOS:000260893700041
J	Romero, A; Cakir, I; Vaslet, CA; Stuart, RC; Lansari, O; Lucero, HA; Nillni, EA				Romero, Amparo; Cakir, Isin; Vaslet, Charles A.; Stuart, Ronald C.; Lansari, Omar; Lucero, Hector A.; Nillni, Eduardo A.			Role of a Pro-sequence in the Secretory Pathway of Prothyrotropin-releasing Hormone	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROHORMONE CONVERTASES; PROPROTEIN CONVERTASES; ENDOPLASMIC-RETICULUM; PROLINE RESIDUES; QUALITY-CONTROL; PROTEIN; PEPTIDES; PROINSULIN; PC1; BIOSYNTHESIS	The biogenesis of rat thyrotropin releasing hormone (TRH) involves the processing of its precursor (proTRH) into five biologically active TRH peptides and several non-TRH peptides where two of them had been attributed potential biological functions. This process implicates 1) proper folding of proTRH in the endoplasmic reticulum after its biosynthesis and exit to the Golgi apparatus and beyond, 2) initial processing of proTRH in the trans Golgi network and, 3) sorting of proTRH-derived peptides to the regulated secretory pathway. Previous studies have focused on elucidating the processing and sorting determinants of proTRH. However, the role of protein folding in the sorting of proTRH remains unexplored. Here we have investigated the role in the secretion of proTRH of a sequence comprising 22 amino acid residues, located at the N-terminal region of proTRH, residues 31-52. Complete deletion of these 22 amino acids dramatically compromised the biosynthesis of proTRH, manifested as a severe reduction in the steady state level of proTRH in the endoplasmic reticulum. This effect was largely reproduced by the deletion of only three amino acid residues, (40)PGL(42), within the proTRH(31-52) sequence. The decreased steady state level of the mutant Delta PGL was due to enhanced endoplasmic reticulum-associated protein degradation. However, the remnant of Delta PGL that escaped degradation was properly processed and sorted to secretory granules. Thus, these results suggest that the N-terminal domain within the prohormone sequence does not act as "sorting signal" in late secretion; instead, it seems to play a key role determining the proper folding pathway of the precursor and, thus, its stability.	[Romero, Amparo; Cakir, Isin; Stuart, Ronald C.; Lansari, Omar; Nillni, Eduardo A.] Brown Univ, Warren Alpert Med Sch, Div Endocrinol, Rhode Isl Hosp,Dept Med, Providence, RI 02903 USA; [Vaslet, Charles A.] Brown Univ, Dept Pathol & Lab Med, Providence, RI 02903 USA; [Nillni, Eduardo A.] Brown Univ, Dept Mol & Cellular Biol, Providence, RI 02903 USA; [Nillni, Eduardo A.] Brown Univ, Dept Biochem, Providence, RI 02903 USA; [Lucero, Hector A.] Boston Univ, Sch Med, Dept Biochem, Boston, MA 02118 USA	Brown University; Lifespan Health Rhode Island; Rhode Island Hospital; Brown University; Brown University; Brown University; Boston University	Nillni, EA (corresponding author), Brown Univ, Warren Alpert Med Sch, Div Endocrinol, Rhode Isl Hosp,Dept Med, 55 Claverick St,Rm 320, Providence, RI 02903 USA.	Eduardo_Nillni@Brown.edu		cakir, isin/0000-0003-4293-7267; Romero-Pico, Amparo/0000-0001-5104-6998	National Institutes of Health [R01 DK58148 (NIDDK), R01 NS045231 (NINDS)]; National Institutes of Health Public Health Services [HL13262-31]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL013262] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK058148] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS045231] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health Public Health Services(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 DK58148 (NIDDK) and R01 NS045231 (NINDS) (to E. A. N.) and National Institutes of Health Public Health Services Grant HL13262-31. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Bundgaard JR, 2004, J BIOL CHEM, V279, P5488, DOI 10.1074/jbc.M310547200; delaCruz IP, 1996, J BIOL CHEM, V271, P22736, DOI 10.1074/jbc.271.37.22736; EIPPER BA, 1992, ANNU REV NEUROSCI, V15, P57, DOI 10.1146/annurev.ne.15.030192.000421; Ellgaard L, 2003, NAT REV MOL CELL BIO, V4, P181, DOI 10.1038/nrm1052; Fisher KE, 2007, BIOCHEMISTRY-US, V46, P640, DOI 10.1021/bi061600z; FRICKER LD, 1988, ANNU REV PHYSIOL, V50, P309, DOI 10.1146/annurev.ph.50.030188.001521; Fricker LD, 2007, ENDOCRINOLOGY, V148, P4185, DOI 10.1210/en.2007-0123; FRIEDMAN TC, 1995, ENDOCRINOLOGY, V136, P4462, DOI 10.1210/en.136.10.4462; FULLERTO.WW, 1970, P NATL ACAD SCI USA, V66, P1213, DOI 10.1073/pnas.66.4.1213; Hagihara Y, 2002, P NATL ACAD SCI USA, V99, P6619, DOI 10.1073/pnas.102172099; Kincaid MM, 2007, MOL BIOL CELL, V18, P455, DOI 10.1091/mbc.E06-08-0696; Kjeldsen T, 2002, J BIOL CHEM, V277, P18245, DOI 10.1074/jbc.C200137200; Kowalski JM, 1998, J BIOL CHEM, V273, P19453, DOI 10.1074/jbc.273.31.19453; Kuliawat R, 2000, MOL BIOL CELL, V11, P1959, DOI 10.1091/mbc.11.6.1959; LEVITT M, 1981, J MOL BIOL, V145, P251, DOI 10.1016/0022-2836(81)90342-9; MATTHEWS BW, 1987, P NATL ACAD SCI USA, V84, P6663, DOI 10.1073/pnas.84.19.6663; Meerovitch K, 1998, J BIOL CHEM, V273, P21025, DOI 10.1074/jbc.273.33.21025; Mulcahy LR, 2006, REGUL PEPTIDES, V133, P123, DOI 10.1016/j.regpep.2005.09.027; Mulcahy LR, 2005, J BIOL CHEM, V280, P39818, DOI 10.1074/jbc.M507193200; Nakagawa K, 2006, BIOCHEMISTRY-US, V45, P15468, DOI 10.1021/bi061420p; NILLNI EA, 1993, ENDOCRINOLOGY, V132, P1260, DOI 10.1210/en.132.3.1260; NILLNI EA, 1993, ENDOCRINOLOGY, V132, P1271, DOI 10.1210/en.132.3.1271; Nillni EA, 1999, ENDOCR REV, V20, P599, DOI 10.1210/er.20.5.599; NILLNI EA, 1995, J NEUROCHEM, V65, P2462; Nillni EA, 1996, ENDOCRINOLOGY, V137, P5651, DOI 10.1210/en.137.12.5651; Nillni EA, 2002, J BIOL CHEM, V277, P48587, DOI 10.1074/jbc.M206702200; Osvath S, 2003, BIOPHYS J, V85, P1215, DOI 10.1016/S0006-3495(03)74557-3; Prigge ST, 1997, SCIENCE, V278, P1300, DOI 10.1126/science.278.5341.1300; Scamuffa N, 2006, FASEB J, V20, P1954, DOI 10.1096/fj.05-5491rev; Schaner P, 1997, J BIOL CHEM, V272, P19958, DOI 10.1074/jbc.272.32.19958; Seidah NG, 1999, BRAIN RES, V848, P45, DOI 10.1016/S0006-8993(99)01909-5; SEVARINO KA, 1989, J BIOL CHEM, V264, P21529; SNELL CR, 1975, J BIOL CHEM, V250, P6291; Steiner DF, 1998, CURR OPIN CHEM BIOL, V2, P31, DOI 10.1016/S1367-5931(98)80033-1; Trombetta ES, 2003, ANNU REV CELL DEV BI, V19, P649, DOI 10.1146/annurev.cellbio.19.110701.153949; Truckses DM, 1996, PROTEIN SCI, V5, P1907, DOI 10.1002/pro.5560050917; Varlamov O, 1999, J BIOL CHEM, V274, P14040, DOI 10.1074/jbc.274.20.14040; Wigley WC, 2002, NAT STRUCT BIOL, V9, P381, DOI 10.1038/nsb784; YUTANI K, 1991, PROTEINS, V9, P90, DOI 10.1002/prot.340090203; ZHOU A, 1993, J BIOL CHEM, V268, P1763	40	5	5	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 14	2008	283	46					31438	31448		10.1074/jbc.M803413200	http://dx.doi.org/10.1074/jbc.M803413200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	370KJ	18779326	hybrid, Green Published			2022-12-27	WOS:000260760800023
J	Bitto, E; Bingman, CA; Bittova, L; Kondrashov, DA; Bannen, RM; Fox, BG; Markley, JL; Phillips, GN				Bitto, Eduard; Bingman, Craig A.; Bittova, Lenka; Kondrashov, Dmitry A.; Bannen, Ryan M.; Fox, Brian G.; Markley, John L.; Phillips, George N., Jr.			Structure of Human J-type Co-chaperone HscB Reveals a Tetracysteine Metal-binding Domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CLUSTER ASSEMBLY PROTEIN; IRON-SULFUR CLUSTERS; ZINC-FINGER DOMAIN; CRYSTAL-STRUCTURE; GENE-CLUSTER; ISCU; SCAFFOLD; 2FE-2S; BIOGENESIS; IDENTIFICATION	Iron-sulfur proteins play indispensable roles in a broad range of biochemical processes. The biogenesis of iron-sulfur proteins is a complex process that has become a subject of extensive research. The final step of iron-sulfur protein assembly involves transfer of an iron-sulfur cluster from a cluster-donor to a cluster-acceptor protein. This process is facilitated by a specialized chaperone system, which consists of a molecular chaperone from the Hsc70 family and a co-chaperone of the J-domain family. The 3.0 angstrom crystal structure of a human mitochondrial J-type co-chaperone HscB revealed an L-shaped protein that resembles Escherichia coli HscB. The important difference between the two homologs is the presence of an auxiliary metal-binding domain at the N terminus of human HscB that coordinates a metal via the tetracysteine consensus motif CWXCX(9-13)FCXXCXXXQ. The domain is found in HscB homologs from animals and plants as well as in magnetotactic bacteria. The metal-binding site of the domain is structurally similar to that of rubredoxin and several zinc finger proteins containing rubredoxin-like knuckles. The normal mode analysis of HscB revealed that this L-shaped protein preferentially undergoes a scissors-like motion that correlates well with the conformational changes of human HscB observed in the crystals.	[Bannen, Ryan M.; Fox, Brian G.; Markley, John L.; Phillips, George N., Jr.] Univ Wisconsin, Dept Biochem, Madison, WI 53706 USA; [Bitto, Eduard; Bingman, Craig A.; Bittova, Lenka; Fox, Brian G.; Markley, John L.; Phillips, George N., Jr.] Univ Wisconsin, Ctr Eukaryot Struct Genom, Madison, WI 53706 USA; [Kondrashov, Dmitry A.] Univ Chicago, Biol Sci Coll Div, Chicago, IL 60637 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Chicago	Phillips, GN (corresponding author), Univ Wisconsin, Dept Biochem, Madison, WI 53706 USA.	phillips@biochem.wisc.edu	Bittova, Lenka/K-4375-2015	Bittova, Lenka/0000-0002-3556-5234; Bannen, Ryan/0000-0002-6001-3060	National Institutes of Health [P50 GM64598, U54 GM074901]; Department of Energy, Basic Energy Sciences, Office of Science [W-31-109-ENG-38]; National Cancer Institute [Y1-CO-1020]; National Institute of General Medical Science [Y1-GM-1104]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM064598, U54GM074901, R01GM058667] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Energy, Basic Energy Sciences, Office of Science(United States Department of Energy (DOE)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of General Medical Science(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants P50 GM64598 and U54 GM074901 ( to J. L. M.). This work was also supported by the Department of Energy, Basic Energy Sciences, Office of Science, under Contract W-31-109-ENG-38, by National Cancer Institute Grant Y1-CO-1020, and by National Institute of General Medical Science Grant Y1-GM-1104. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Agar JN, 2000, BIOCHEMISTRY-US, V39, P7856, DOI 10.1021/bi000931n; Andrew AJ, 2006, J BIOL CHEM, V281, P14580, DOI 10.1074/jbc.M600842200; Ayala-Castro C, 2008, MICROBIOL MOL BIOL R, V72, P110, DOI 10.1128/MMBR.00034-07; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bazylinski DA, 2004, NAT REV MICROBIOL, V2, P217, DOI 10.1038/nrmicro842; Bilder PW, 2004, BIOCHEMISTRY-US, V43, P133, DOI 10.1021/bi035440s; Blommel PG, 2007, BIOTECHNOL PROGR, V23, P585, DOI 10.1021/bp070011x; BROOKS B, 1983, P NATL ACAD SCI-BIOL, V80, P6571, DOI 10.1073/pnas.80.21.6571; Chandramouli K, 2006, BIOCHEMISTRY-US, V45, P11087, DOI 10.1021/bi061237w; CORPET F, 1988, NUCLEIC ACIDS RES, V16, P10881, DOI 10.1093/nar/16.22.10881; Cramer Patrick, 2001, Science (Washington D C), V292, P1863, DOI 10.1126/science.1059493; Cupp-Vickery JR, 2004, J MOL BIOL, V342, P1265, DOI 10.1016/j.jmb.2004.07.025; Cupp-Vickery JR, 2004, J MOL BIOL, V338, P127, DOI 10.1016/j.jmb.2004.02.027; Cupp-Vickery JR, 2003, J MOL BIOL, V330, P1049, DOI 10.1016/S0022-2836(03)00690-9; Cupp-Vickery JR, 2000, J MOL BIOL, V304, P835, DOI 10.1006/jmbi.2000.4252; Dauter Z, 1996, P NATL ACAD SCI USA, V93, P8836, DOI 10.1073/pnas.93.17.8836; delaFortelle E, 1997, METHOD ENZYMOL, V276, P472, DOI 10.1016/S0076-6879(97)76073-7; Delano W.L, 2002, PYMOL USERS MANUAL; Ding H, 2004, J BIOL CHEM, V279, P37499, DOI 10.1074/jbc.M404533200; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fuzery AK, 2008, BIOCHEMISTRY-US, V47, P9394, DOI 10.1021/bi800502r; GO N, 1983, P NATL ACAD SCI-BIOL, V80, P3696, DOI 10.1073/pnas.80.12.3696; Grosse-Kunstleve RW, 2003, ACTA CRYSTALLOGR D, V59, P1966, DOI 10.1107/S0907444903018043; Hagelueken G, 2007, P NATL ACAD SCI USA, V104, P12276, DOI 10.1073/pnas.0702919104; Hoff KG, 2002, J BIOL CHEM, V277, P27353, DOI 10.1074/jbc.M202814200; Hoff KG, 2000, P NATL ACAD SCI USA, V97, P7790, DOI 10.1073/pnas.130201997; JACOBSON MR, 1989, MOL GEN GENET, V219, P49, DOI 10.1007/BF00261156; Jaroszewski L, 2005, NUCLEIC ACIDS RES, V33, pW284, DOI 10.1093/nar/gki418; Jeon Won Bae, 2005, Journal of Structural and Functional Genomics, V6, P143, DOI 10.1007/s10969-005-1908-7; Johnson DC, 2005, ANNU REV BIOCHEM, V74, P247, DOI 10.1146/annurev.biochem.74.082803.133518; Komeili A, 2006, SCIENCE, V311, P242, DOI 10.1126/science.1123231; Komelli A, 2007, ANNU REV BIOCHEM, V76, P351, DOI 10.1146/annurev.biochem.74.082803.133444; Kondrashov DA, 2007, STRUCTURE, V15, P169, DOI 10.1016/j.str.2006.12.006; Lill R, 2005, TRENDS BIOCHEM SCI, V30, P133, DOI 10.1016/j.tibs.2005.01.006; Liu JY, 2005, PROTEINS, V59, P875, DOI 10.1002/prot.20421; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; MADEJ T, 1995, PROTEINS, V23, P356, DOI 10.1002/prot.340230309; Mancias JD, 2007, MOL CELL, V26, P403, DOI 10.1016/j.molcel.2007.03.017; Marquet A, 2007, NAT PROD REP, V24, P1027, DOI 10.1039/b703109m; Meyer J, 2008, J BIOL INORG CHEM, V13, P157, DOI 10.1007/s00775-007-0318-7; Morimoto K, 2006, J MOL BIOL, V360, P117, DOI 10.1016/j.jmb.2006.04.067; Muhlenhoff U, 2003, EMBO J, V22, P4815, DOI 10.1093/emboj/cdg446; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Outten FW, 2004, MOL MICROBIOL, V52, P861, DOI 10.1111/j.1365-2958.2004.04025.x; Patzer SI, 1999, J BACTERIOL, V181, P3307, DOI 10.1128/JB.181.10.3307-3309.1999; Pearl FMG, 2003, NUCLEIC ACIDS RES, V31, P452, DOI 10.1093/nar/gkg062; Ramelot TA, 2004, J MOL BIOL, V344, P567, DOI 10.1016/j.jmb.2004.08.038; Rawlings DE, 1999, MICROBIOL-UK, V145, P5, DOI 10.1099/13500872-145-1-5; Rice LM, 2000, ACTA CRYSTALLOGR D, V56, P1413, DOI 10.1107/S0907444900010039; Rojas-Chapana JA, 2004, FEMS MICROBIOL ECOL, V47, P19, DOI 10.1016/S0168-6496(03)00221-6; Rouault TA, 2005, NAT REV MOL CELL BIO, V6, P345, DOI 10.1038/nrm1620; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Silberg JJ, 2004, J BIOL CHEM, V279, P53924, DOI 10.1074/jbc.M410117200; Sreenath HK, 2005, PROTEIN EXPRES PURIF, V40, P256, DOI 10.1016/j.pep.2004.12.022; Sun GF, 2003, J HUM GENET, V48, P415, DOI 10.1007/s10038-003-0048-9; Takahashi Y, 1999, J BIOCHEM, V126, P917, DOI 10.1093/oxfordjournals.jbchem.a022535; Tama F, 2006, ANNU REV BIOPH BIOM, V35, P115, DOI 10.1146/annurev.biophys.35.040405.102010; Thao Sandy, 2004, Journal of Structural and Functional Genomics, V5, P267, DOI 10.1007/s10969-004-7148-4; Tirion MM, 1996, PHYS REV LETT, V77, P1905, DOI 10.1103/PhysRevLett.77.1905; Tokumoto U, 2004, J BIOCHEM, V136, P199, DOI 10.1093/jb/mvh104; Tsai J, 1996, J BIOL CHEM, V271, P9347, DOI 10.1074/jbc.271.16.9347; Unciuleac MC, 2007, BIOCHEMISTRY-US, V46, P6812, DOI 10.1021/bi6026665; Urbina HD, 2001, J BIOL CHEM, V276, P44521, DOI 10.1074/jbc.M106907200; Vickery LE, 2007, CRIT REV BIOCHEM MOL, V42, P95, DOI 10.1080/10409230701322298; Wang B, 2003, J BIOL CHEM, V278, P20225, DOI 10.1074/jbc.M300459200; Wang X, 2007, BIOCHEMISTRY-US, V46, P752, DOI 10.1021/bi061870h; Wu Q, 2006, APPL ENVIRON MICROB, V72, P3608, DOI 10.1128/AEM.72.5.3608-3614.2006; Ye YZ, 2003, BIOINFORMATICS, V19, pII246, DOI 10.1093/bioinformatics/btg1086; Yu GW, 2006, PROTEIN SCI, V15, P384, DOI 10.1110/ps.051927306; Zheng LM, 1998, J BIOL CHEM, V273, P13264, DOI 10.1074/jbc.273.21.13264; Zolnai Zsolt, 2003, Journal of Structural and Functional Genomics, V4, P11, DOI 10.1023/A:1024684404761	72	33	35	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 31	2008	283	44					30184	30192		10.1074/jbc.M804746200	http://dx.doi.org/10.1074/jbc.M804746200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	364WS	18713742	Green Published, hybrid			2022-12-27	WOS:000260366900063
J	Gourdine, JP; Cioci, G; Miguet, L; Unverzagt, C; Silva, DV; Varrot, A; Gautier, C; Smith-Ravin, EJ; Imberty, A				Gourdine, Jean-Philippe; Cioci, Gianluca; Miguet, Laurence; Unverzagt, Carlo; Silva, Daniel Varon; Varrot, Annabelle; Gautier, Catherine; Smith-Ravin, Emilie Juliette; Imberty, Anne			High Affinity Interaction between a Bivalve C-type Lectin and a Biantennary Complex-type N-Glycan Revealed by Crystallography and Microcalorimetry	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CARBOHYDRATE-RECOGNITION DOMAIN; DC-SIGN; 3-DIMENSIONAL STRUCTURES; CRYSTAL-STRUCTURE; E-SELECTIN; DATA-BANK; BINDING; OLIGOSACCHARIDES; DISACCHARIDES; REFINEMENT	Codakine is an abundant 14-kDa mannose-binding C-type lectin isolated from the gills of the sea bivalve Codakia orbicularis. Binding studies using inhibition of hemagglutination indicated specificity for mannose and fucose monosaccharides. Further experiments using a glycan array demonstrated, however, a very fine specificity for N-linked biantennary complex-type glycans. An unusually high affinity was measured by titration microcalorimetry performed with a biantennary Asn-linked nonasaccharide. The crystal structure of the native lectin at 1.3 angstrom resolution revealed a new type of disulfide-bridged homodimer. Each monomer displays three intramolecular disulfide bridges and contains only one calcium ion located in the canonical binding site that is occupied by a glycerol molecule. The structure of the complex between Asn-linked nonasaccharide and codakine has been solved at 1.7 angstrom resolution. All residues could be located in the electron density map, except for the capping beta 1 - 4-linked galactosides. The alpha 1 - 6-linked mannose binds to calcium by coordinating the O3 and O4 hydroxyl groups. The GlcNAc moiety of the alpha 1,6 arm engages in several hydrogen bonds with the protein, whereas the GlcNAc on the other antenna is stacked against Trp(108), forming an extended binding site. This is the first structural report for a bivalve lectin.	[Miguet, Laurence; Varrot, Annabelle; Gautier, Catherine; Imberty, Anne] Univ Grenoble 1, CERMAV CNRS, F-38041 Grenoble 09, France; [Gourdine, Jean-Philippe; Smith-Ravin, Emilie Juliette] Univ Antilles Guyane, Dept Biol, F-97159 Guadeloupe, France; [Cioci, Gianluca] European Synchrotron Radiat Facil, Expt Div, F-38043 Grenoble, France; [Unverzagt, Carlo; Silva, Daniel Varon] Univ Bayreuth, D-95440 Bayreuth, Germany; [Miguet, Laurence; Varrot, Annabelle; Gautier, Catherine; Imberty, Anne] Inst Chim Mol Grenoble, F-38041 Grenoble, France; [Miguet, Laurence; Varrot, Annabelle; Gautier, Catherine; Imberty, Anne] Univ Grenoble 1, CNRS, CERMAV, F-38041 Grenoble, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Universite des Antilles; European Synchrotron Radiation Facility (ESRF); University of Bayreuth; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA)	Imberty, A (corresponding author), Univ Grenoble 1, CERMAV CNRS, BP53, F-38041 Grenoble 09, France.	imberty@cermav.cnrs.fr	Gourdine, Jean-Philippe/P-4323-2018; Gourdine, Jean-Philippe F/E-3739-2012; Silva, Daniel Varon/D-5819-2014; Imberty, Anne/P-6451-2018	Gourdine, Jean-Philippe/0000-0001-9969-8610; Gourdine, Jean-Philippe F/0000-0001-9969-8610; Silva, Daniel Varon/0000-0003-2804-1923; Varrot, Annabelle/0000-0001-6667-8162; Imberty, Anne/0000-0001-6825-9527	CNRS; French Ministry of Research; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM062116] Funding Source: NIH RePORTER	CNRS(Centre National de la Recherche Scientifique (CNRS)); French Ministry of Research(Ministry of Research, FranceEuropean Commission); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by CNRS and the French Ministry of Research. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; BERG CJ, 1984, AQUACULTURE, V39, P165, DOI 10.1016/0044-8486(84)90264-3; Blixt O, 2004, P NATL ACAD SCI USA, V101, P17033, DOI 10.1073/pnas.0407902101; BrUnger A. T., 1992, X PLOR VERSION 3 1 S; Bulgakov AA, 2004, FISH SHELLFISH IMMUN, V16, P487, DOI 10.1016/j.fsi.2003.08.006; Bulgheresi S, 2006, APPL ENVIRON MICROB, V72, P2950, DOI 10.1128/AEM.72.4.2950-2956.2006; Chatwell L, 2008, MOL IMMUNOL, V45, P1981, DOI 10.1016/j.molimm.2007.10.030; Dam TK, 2002, CHEM REV, V102, P387, DOI 10.1021/cr000401x; DAY AJ, 1994, BIOCHEM SOC T, V22, P83, DOI 10.1042/bst0220083; Drickamer K, 1999, CURR OPIN STRUC BIOL, V9, P585, DOI 10.1016/S0959-440X(99)00009-3; DRICKAMER K, 1993, CURR OPIN STRUC BIOL, V3, P393, DOI 10.1016/S0959-440X(05)80112-5; Drickamer K, 1996, BIOCHEM SOC T, V24, P146, DOI 10.1042/bst0240146; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Feinberg H, 2001, SCIENCE, V294, P2163, DOI 10.1126/science.1066371; Feinberg H, 2007, J BIOL CHEM, V282, P17250, DOI 10.1074/jbc.M701624200; Feinberg H, 2007, J BIOL CHEM, V282, P4202, DOI 10.1074/jbc.M609689200; Foadi J, 2000, ACTA CRYSTALLOGR D, V56, P1137, DOI 10.1107/S090744490000932X; Gerbaud V, 2000, J BIOL CHEM, V275, P1057, DOI 10.1074/jbc.275.2.1057; Gourdine JP, 2007, FISH SHELLFISH IMMUN, V23, P831, DOI 10.1016/j.fsi.2007.03.009; Gourdine JP, 2007, FISH SHELLFISH IMMUN, V22, P498, DOI 10.1016/j.fsi.2006.06.013; Gourdine JP, 2002, PREP BIOCHEM BIOTECH, V32, P341, DOI 10.1081/PB-120015458; GRAVES BJ, 1994, NATURE, V367, P532, DOI 10.1038/367532a0; Gronwald W, 1998, BIOCHEMISTRY-US, V37, P4712, DOI 10.1021/bi972788c; Gutternigg M, 2007, GLYCOCONJUGATE J, V24, P475, DOI 10.1007/s10719-007-9040-5; IMBERTY A, 1991, GLYCOCONJUGATE J, V8, P456, DOI 10.1007/BF00769847; IMBERTY A, 1990, GLYCOCONJUGATE J, V7, P27, DOI 10.1007/BF01050401; Iwanaga S, 2005, J BIOCHEM MOL BIOL, V38, P128; JACOB GS, 1995, BIOCHEMISTRY-US, V34, P1210, DOI 10.1021/bi00004a014; Jimbo M, 2005, BIOCHEM BIOPH RES CO, V330, P157, DOI 10.1016/j.bbrc.2005.02.137; Kajihara Y, 2004, CHEM-EUR J, V10, P971, DOI 10.1002/chem.200305115; Kastrup JS, 1998, ACTA CRYSTALLOGR D, V54, P757, DOI 10.1107/S0907444997016806; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Leslie A. G. W., 1992, JOINT CCP4 ESF EAMCB; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Minamikawa M, 2004, FISH SHELLFISH IMMUN, V17, P463, DOI 10.1016/j.fsi.2004.05.001; Moy GW, 2008, P NATL ACAD SCI USA, V105, P1993, DOI 10.1073/pnas.0711862105; MULLER WEG, 1985, ACTA HISTOCHEM, P37; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; Poget SF, 1999, J MOL BIOL, V290, P867, DOI 10.1006/jmbi.1999.2910; Quesenberry MS, 1997, BIOCHEMISTRY-US, V36, P2724, DOI 10.1021/bi9622635; Seko A, 1997, BBA-GEN SUBJECTS, V1335, P23, DOI 10.1016/S0304-4165(96)00118-3; Sugawara H, 2004, J BIOL CHEM, V279, P45219, DOI 10.1074/jbc.M408840200; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Vasta GR, 2004, CURR OPIN STRUC BIOL, V14, P617, DOI 10.1016/j.sbi.2004.09.008; VASTA GR, 1994, ANN NY ACAD SCI, V712, P55, DOI 10.1111/j.1749-6632.1994.tb33562.x; VASTA GR, 1992, GLYCOCONJUGATES COMP, P593; VRIEND G, 1990, J MOL GRAPHICS, V8, P52, DOI 10.1016/0263-7855(90)80070-V; Wang H, 2007, MOL IMMUNOL, V44, P722, DOI 10.1016/j.molimm.2006.04.015; Wang H, 2008, BIOCHEMISTRY-US, V47, P710, DOI 10.1021/bi7020553; WEIS WI, 1991, SCIENCE, V254, P1608, DOI 10.1126/science.1721241; WISEMAN T, 1989, ANAL BIOCHEM, V179, P131, DOI 10.1016/0003-2697(89)90213-3; Yamaura K, 2008, COMP BIOCHEM PHYS B, V149, P168, DOI 10.1016/j.cbpb.2007.09.004	56	32	33	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 31	2008	283	44					30112	30120		10.1074/jbc.M804353200	http://dx.doi.org/10.1074/jbc.M804353200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	364WS	18687680	Green Published, hybrid			2022-12-27	WOS:000260366900056
J	Bose, JK; Wang, IF; Hung, L; Tarn, WY; Shen, CKJ				Bose, Jayarama Krishnan; Wang, I. -Fan; Hung, Li; Tarn, Woan-Yuh; Shen, C. -K. James			TDP-43 Overexpression Enhances Exon 7 Inclusion during the Survival of Motor Neuron Pre-mRNA Splicing	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SPINAL MUSCULAR-ATROPHY; AMYOTROPHIC-LATERAL-SCLEROSIS; FRONTOTEMPORAL LOBAR DEGENERATION; NUCLEAR FACTOR TDP-43; CFTR EXON-9; FUNCTIONAL IMPLICATIONS; SINGLE NUCLEOTIDE; SMN GENE; HNRNP-G; HTRA2-BETA-1	TDP-43 is a highly conserved, 43-kDa RNA-binding protein implicated to play a role in transcription repression, nuclear organization, and alternative splicing. More recently, this factor has been identified as the major disease protein of several neurodegenerative diseases, including frontotemporal lobar degeneration with ubiquitin-positive inclusions and amyotrophic lateral sclerosis. For the splicing activity, the factor has been shown to be mainly an exon-skipping promoter. In this study using the survival of motor neuron (SMN) minigenes as the reporters in transfection assay, we show for the first time that TDP-43 could also act as an exon-inclusion factor. Furthermore, both RNA-recognition motif domains are required for its ability to enhance the SMN2 exon 7 inclusion. Combined protein-immunoprecipitation and RNA-immunoprecipitation experiments also suggested that this exon inclusion activity might be mediated by multimeric complex(es) consisting of this protein interacting with other splicing factors, including Htra2-beta 1. Our data further evidence TDP-43 as a multifunctional RNA-binding protein for a diverse set of cellular activities.	[Bose, Jayarama Krishnan; Shen, C. -K. James] Natl Taiwan Univ, Inst Mol Med, Taipei 106, Taiwan; [Tarn, Woan-Yuh] Acad Sinica, Inst Biomed Sci, Taipei 11529, Taiwan; [Bose, Jayarama Krishnan; Wang, I. -Fan; Hung, Li; Shen, C. -K. James] Acad Sinica, Inst Mol Biol, Taipei 11529, Taiwan	National Taiwan University; Academia Sinica - Taiwan; Academia Sinica - Taiwan	Shen, CKJ (corresponding author), Natl Taiwan Univ, Inst Mol Med, Taipei 106, Taiwan.	ckshen@imb.sinica.edu.tw	shen, Che-Kun James/L-1343-2015; Tarn, Woan-Yuh/N-8464-2018	Wang, I-Fan/0000-0002-6856-0691	Academia Sinica and National Science Council, Taipei, Taiwan	Academia Sinica and National Science Council, Taipei, Taiwan	This work was supported by the Academia Sinica and National Science Council, Taipei, Taiwan. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Arai T, 2006, BIOCHEM BIOPH RES CO, V351, P602, DOI 10.1016/j.bbrc.2006.10.093; Ayala YM, 2006, FEBS LETT, V580, P1339, DOI 10.1016/j.febslet.2006.01.052; Buratti E, 2005, J BIOL CHEM, V280, P37572, DOI 10.1074/jbc.M505557200; Buratti E, 2001, J BIOL CHEM, V276, P36337, DOI 10.1074/jbc.M104236200; Buratti E, 2001, EMBO J, V20, P1774, DOI 10.1093/emboj/20.7.1774; Cartegni L, 2002, NAT GENET, V30, P377, DOI 10.1038/ng854; Dickson DW, 2007, ACTA NEUROPATHOL, V114, P71, DOI 10.1007/s00401-007-0234-5; DREYFUSS G, 1993, ANNU REV BIOCHEM, V62, P289, DOI 10.1146/annurev.bi.62.070193.001445; Hofmann Y, 2000, P NATL ACAD SCI USA, V97, P9618, DOI 10.1073/pnas.160181697; Hofmann Y, 2002, HUM MOL GENET, V11, P2037, DOI 10.1093/hmg/11.17.2037; IGNATIUS SH, 1995, J VIROL, V69, P3584, DOI 10.1128/JVI.69.6.3584-3596.1995; Ince PG, 1998, NEUROPATH APPL NEURO, V24, P104, DOI 10.1046/j.1365-2990.1998.00108.x; Jin W, 2004, CANCER RES, V64, P8901, DOI 10.1158/0008-5472.CAN-04-0716; Kashima T, 2003, NAT GENET, V34, P460, DOI 10.1038/ng1207; Kashima T, 2007, HUM MOL GENET, V16, P3149, DOI 10.1093/hmg/ddm276; KRAINER AR, 1990, CELL, V62, P35, DOI 10.1016/0092-8674(90)90237-9; Lorson CL, 1999, P NATL ACAD SCI USA, V96, P6307, DOI 10.1073/pnas.96.11.6307; Lorson CL, 1998, NAT GENET, V19, P63, DOI 10.1038/ng0598-63; Lorson CL, 2000, HUM MOL GENET, V9, P259, DOI 10.1093/hmg/9.2.259; Maris C, 2005, FEBS J, V272, P2118, DOI 10.1111/j.1742-4658.2005.04653.x; Mercado PA, 2005, NUCLEIC ACIDS RES, V33, P6000, DOI 10.1093/nar/gki897; Monani UR, 1999, HUM MOL GENET, V8, P1177, DOI 10.1093/hmg/8.7.1177; Nasim MT, 2003, HUM MOL GENET, V12, P1337, DOI 10.1093/hmg/ddg136; Neumann M, 2006, SCIENCE, V314, P130, DOI 10.1126/science.1134108; Shaw C E, 2001, Curr Neurol Neurosci Rep, V1, P69, DOI 10.1007/s11910-001-0078-7; Singh NN, 2004, CRIT REV EUKAR GENE, V14, P271, DOI 10.1615/CritRevEukaryotGeneExpr.v14.i4.30; Singh NN, 2004, BIOCHEM BIOPH RES CO, V315, P381, DOI 10.1016/j.bbrc.2004.01.067; Wang HY, 2004, GENOMICS, V83, P130, DOI 10.1016/S0888-7543(03)00214-3; Wang IF, 2008, J NEUROCHEM, V105, P797, DOI 10.1111/j.1471-4159.2007.05190.x; Wang IF, 2002, P NATL ACAD SCI USA, V99, P13583, DOI 10.1073/pnas.212483099; WANG IF, 2008, TRENDS MOL IN PRESS; Wang YZ, 2005, J BIOL CHEM, V280, P14230, DOI 10.1074/jbc.M413846200; WYATT JR, 1991, BIOTECHNIQUES, V11, P764; Young PJ, 2002, HUM MOL GENET, V11, P577, DOI 10.1093/hmg/11.5.577	34	148	155	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 24	2008	283	43					28852	28859		10.1074/jbc.M805376200	http://dx.doi.org/10.1074/jbc.M805376200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	362EB	18703504	Green Published, hybrid			2022-12-27	WOS:000260179900010
J	Edelblum, KL; Goettel, JA; Koyama, T; McElroy, SJ; Yan, F; Polk, DB				Edelblum, Karen L.; Goettel, Jeremy A.; Koyama, Tatsuki; McElroy, Steven J.; Yan, Fang; Polk, D. Brent			TNFR1 Promotes Tumor Necrosis Factor-mediated Mouse Colon Epithelial Cell Survival through RAF Activation of NF-kappa B	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INFLAMMATORY-BOWEL-DISEASE; CHRONIC INTESTINAL INFLAMMATION; MONOCLONAL-ANTIBODY CA2; FACTOR-ALPHA; PROTEIN-KINASE; NEUTRAL SPHINGOMYELINASE; TRANSCRIPTIONAL ACTIVATION; FACTOR RECEPTORS; CROHNS-DISEASE; C-RAF-1 GENE	Tumor necrosis factor (TNF) is a therapeutic target in the treatment of inflammatory bowel disease; however, the exact role of TNF signaling in the colon epithelium remains unclear. We demonstrate that TNF activation of TNF receptor (R) 1 stimulates both pro- and anti-apoptotic signaling pathways in the colon epithelium; however, TNFR1 protects against colon epithelial cell apoptosis following TNF exposure. To investigate anti-apoptotic signaling pathways downstream of TNFR1, we generated an intestinal epithelium-specific Raf knock-out mouse and identified Raf kinase as a key regulator of colon epithelial cell survival in response to TNF. Surprisingly, Raf promotes NF-kappa Bp65 phosphorylation, independent of MEK signaling, to support cell survival. Taken together, these data demonstrate a novel pathway in which Raf promotes colon epithelial cell survival through NF-kappa B downstream of TNFR1 activation. Thus, further understanding of colon epithelial cell-specific TNFR signaling may result in the identification of new targets for inflammatory bowel disease treatment and define novel mediators of colitis-associated cancer.	[Edelblum, Karen L.; Goettel, Jeremy A.; Polk, D. Brent] Vanderbilt Univ, Sch Med, Dept Cell & Dev Biol, Nashville, TN 37232 USA; [Koyama, Tatsuki] Vanderbilt Univ, Sch Med, Dept Biostat, Nashville, TN 37232 USA; [McElroy, Steven J.] Vanderbilt Univ, Sch Med, Dept Pediat, Div Neonatol, Nashville, TN 37232 USA; [Yan, Fang] Vanderbilt Univ, Sch Med, Dept Pediat, Div Gastroenterol Hepatol & Nutr, Nashville, TN 37232 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University	Polk, DB (corresponding author), 2215 Garland Ave,1025 MRB 4, Nashville, TN 37232 USA.	d-brent.polk@vanderbilt.edu	McElroy, Steven/AAC-7204-2019; McElroy, Steven/AGR-6835-2022	McElroy, Steven/0000-0002-4321-723X; McElroy, Steven/0000-0002-4321-723X	National Institutes of Health [DK56008, DK66176, CA68485, DK20593, DK58404, HD15052, DK59637, EY08126]; Frank Revetta and the Vanderbilt Ingram Cancer Center; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD015052] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P30CA068485] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [P30EY008126] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK066176, P30DK020593, U24DK059637, U2CDK059637, P60DK020593, P30DK058404] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008554] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Frank Revetta and the Vanderbilt Ingram Cancer Center; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants DK56008 and DK66176 (to D. B. P.), T32GM008554 (CBMS training grant) (to K. L. E.), and DK58404 (through Vanderbilt University Digestive Disease Research Center). This work was also supported by Frank Revetta and the Vanderbilt Ingram Cancer Center (for ARIOL image analysis). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.; We thank Manuela Baccarini (Vienna Biocenter) for the Rafflx mice, Sylvie Robine (Curie Institute) for the villin-Cre mice, Mark Frey and Philip Dube for thoughtful discussions and manuscript suggestions. Differential interference contrast imaging was performed using the Vanderbilt University School of Medicine Cell Imaging Shared Resource (supported by National Institutes of Health Grants CA68485, DK20593, DK58404, HD15052, DK59637, and EY08126).	Abu-Amer Y, 2000, J BIOL CHEM, V275, P27307; Adam D, 1996, J BIOL CHEM, V271, P14617, DOI 10.1074/jbc.271.24.14617; AdamKlages S, 1996, CELL, V86, P937, DOI 10.1016/S0092-8674(00)80169-5; Anrather J, 2005, J BIOL CHEM, V280, P244, DOI 10.1074/jbc.M409344200; Ashkenazi A, 1998, SCIENCE, V281, P1305, DOI 10.1126/science.281.5381.1305; Baccarini M, 2005, FEBS LETT, V579, P3271, DOI 10.1016/j.febslet.2005.03.024; BELKA C, 1995, EMBO J, V14, P1156, DOI 10.1002/j.1460-2075.1995.tb07099.x; Biragyn A, 2008, J LEUKOCYTE BIOL, V83, P998, DOI 10.1189/jlb.1007700; BREESE EJ, 1994, GASTROENTEROLOGY, V106, P1455, DOI 10.1016/0016-5085(94)90398-0; BUSCHER D, 1995, MOL CELL BIOL, V15, P466; Chan FKM, 2000, IMMUNITY, V13, P419, DOI 10.1016/S1074-7613(00)00041-8; Corredor J, 2003, AM J PHYSIOL-CELL PH, V284, pC953, DOI 10.1152/ajpcell.00309.2002; DAS DVM, 1984, BIOCHIM BIOPHYS ACTA, V777, P339; Declercq W, 1998, J IMMUNOL, V161, P390; Depuydt B, 2005, J CELL SCI, V118, P497, DOI 10.1242/jcs.01640; Edelblum KL, 2008, GASTROENTEROLOGY, V135, P539, DOI 10.1053/j.gastro.2008.04.025; FARNSWORTH CL, 1991, MOL CELL BIOL, V11, P4822, DOI 10.1128/MCB.11.10.4822; Ferrero E, 2001, AM J PHYSIOL-CELL PH, V281, pC1173, DOI 10.1152/ajpcell.2001.281.4.C1173; Foo SY, 1999, TRENDS GENET, V15, P229; FUJITA T, 1992, GENE DEV, V6, P775, DOI 10.1101/gad.6.5.775; Fukata M, 2006, GASTROENTEROLOGY, V131, P862, DOI 10.1053/j.gastro.2006.06.017; Grell M, 1999, EMBO J, V18, P3034, DOI 10.1093/emboj/18.11.3034; Greten FR, 2004, CELL, V118, P285, DOI 10.1016/j.cell.2004.07.013; Gringhuis SI, 2007, IMMUNITY, V26, P605, DOI 10.1016/j.immuni.2007.03.012; Gupta S., 2001, Current Molecular Medicine (Hilversum), V1, P317, DOI 10.2174/1566524013363780; Hoffmann A, 2006, ONCOGENE, V25, P6706, DOI 10.1038/sj.onc.1209933; Jesenberger V, 2001, J EXP MED, V193, P353, DOI 10.1084/jem.193.3.353; Jin SH, 2005, J BIOL CHEM, V280, P24698, DOI 10.1074/jbc.M413374200; Kaiser GC, 1997, GASTROENTEROLOGY, V112, P1231, DOI 10.1016/S0016-5085(97)70135-5; Kaiser GC, 1999, EXP CELL RES, V249, P349, DOI 10.1006/excr.1999.4488; Kontoyiannis D, 1999, IMMUNITY, V10, P387, DOI 10.1016/S1074-7613(00)80038-2; Kubota T, 2001, J MOL CELL CARDIOL, V33, P1331, DOI 10.1006/jmcc.2001.1393; Locksley RM, 2001, CELL, V104, P487, DOI 10.1016/S0092-8674(01)00237-9; Mikula M, 2001, EMBO J, V20, P1952, DOI 10.1093/emboj/20.8.1952; Misra S, 2008, J BIOL CHEM, V283, P14335, DOI 10.1074/jbc.M703811200; Mizoguchi E, 2002, GASTROENTEROLOGY, V122, P134, DOI 10.1053/gast.2002.30347; MORRISON DK, 1993, J BIOL CHEM, V268, P17309; Morrison DK, 1997, CURR OPIN CELL BIOL, V9, P174, DOI 10.1016/S0955-0674(97)80060-9; Naito Y, 2003, J GASTROEN HEPATOL, V18, P560, DOI 10.1046/j.1440-1746.2003.03034.x; Nenci A, 2007, NATURE, V446, P557, DOI 10.1038/nature05698; NICHOLLS S, 1993, J CLIN PATHOL, V46, P757, DOI 10.1136/jcp.46.8.757; Okazaki T, 2003, BIOCHEM BIOPH RES CO, V300, P807, DOI 10.1016/S0006-291X(02)02932-7; Pahl HL, 1999, ONCOGENE, V18, P6853, DOI 10.1038/sj.onc.1203239; Pearson G, 2000, J BIOL CHEM, V275, P37303, DOI 10.1074/jbc.C000570200; Piazzolla D, 2005, J CELL BIOL, V171, P1013, DOI 10.1083/jcb.200504137; Pinto D, 1999, J BIOL CHEM, V274, P6476, DOI 10.1074/jbc.274.10.6476; Popivanova BK, 2008, J CLIN INVEST, V118, P560, DOI [10.1172/JC132453, 10.1172/JCI32453]; PRZEMIOSLO RT, 1994, GUT, V35, P1398, DOI 10.1136/gut.35.10.1398; Reuter BK, 1999, AM J PHYSIOL-GASTR L, V277, pG847, DOI 10.1152/ajpgi.1999.277.4.G847; Roberts PJ, 2007, ONCOGENE, V26, P3291, DOI 10.1038/sj.onc.1210422; Schmidt M, 2000, J BIOL CHEM, V275, P41011, DOI 10.1074/jbc.M003716200; Stuber E, 1999, GUT, V45, P229, DOI 10.1136/gut.45.2.229; Takeuchi M, 1996, J BIOL CHEM, V271, P19935, DOI 10.1074/jbc.271.33.19935; Tamatani M, 1999, J BIOL CHEM, V274, P8531, DOI 10.1074/jbc.274.13.8531; Targan SR, 1997, NEW ENGL J MED, V337, P1029, DOI 10.1056/NEJM199710093371502; TARTAGLIA LA, 1993, J BIOL CHEM, V268, P18542; TEAM RDC, 2007, LANGUAGE ENV STAT CO; Theiss AL, 2005, J BIOL CHEM, V280, P36099, DOI 10.1074/jbc.M505291200; Vanden Berghe T, 2003, J BIOL CHEM, V278, P5622, DOI 10.1074/jbc.M208925200; VANDENABEELE P, 1995, TRENDS CELL BIOL, V5, P392, DOI 10.1016/S0962-8924(00)89088-1; VANDULLEMEN HM, 1995, GASTROENTEROLOGY, V109, P129, DOI 10.1016/0016-5085(95)90277-5; Vermeulen L, 2003, EMBO J, V22, P1313, DOI 10.1093/emboj/cdg139; Wang J, 2005, IMMUNOL REV, V204, P144, DOI 10.1111/j.0105-2896.2005.00218.x; WHITEHEAD RH, 1993, P NATL ACAD SCI USA, V90, P587, DOI 10.1073/pnas.90.2.587; Winkler DG, 1998, J BIOL CHEM, V273, P21578, DOI 10.1074/jbc.273.34.21578; Xing HM, 1997, CURR BIOL, V7, P294, DOI 10.1016/S0960-9822(06)00152-7; Xing HR, 2000, J BIOL CHEM, V275, P17276, DOI 10.1074/jbc.C900989199; Xing HR, 2001, J BIOL CHEM, V276, P9733, DOI 10.1074/jbc.M008096200; Yamaguchi O, 2004, J CLIN INVEST, V114, P937, DOI 10.1172/JCI200420317; Yamamoto K, 1995, J BIOL CHEM, V270, P31315, DOI 10.1074/jbc.270.52.31315; Yan F, 2004, J CLIN INVEST, V114, P1272, DOI 10.1172/JCI200421022; Yan F, 2001, CANCER RES, V61, P8668; Yan F, 2001, CANCER RES, V61, P963; YAO B, 1995, NATURE, V378, P307, DOI 10.1038/378307a0; Zhang YH, 1997, CELL, V89, P63, DOI 10.1016/S0092-8674(00)80183-X; Zhong HH, 1998, MOL CELL, V1, P661, DOI 10.1016/S1097-2765(00)80066-0; Zhong HH, 2002, MOL CELL, V9, P625, DOI 10.1016/S1097-2765(02)00477-X	77	30	30	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 24	2008	283	43					29485	29494		10.1074/jbc.M801269200	http://dx.doi.org/10.1074/jbc.M801269200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	362EB	18713739	Green Published, hybrid			2022-12-27	WOS:000260179900074
J	Du, ZH; Fenn, S; Tjhen, R; James, TL				Du, Zhihua; Fenn, Sebastian; Tjhen, Richard; James, Thomas L.			Structure of a construct of a human poly(C)-binding protein containing the first and second KH domains reveals insights into its regulatory mechanisms	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESSENGER-RNA STABILITY; POLY(RC) BINDING-PROTEIN; HUMAN TELOMERIC DNA; C-RICH STRAND; 3' UNTRANSLATED REGION; ERYTHROID-DIFFERENTIATION; CRYSTAL-STRUCTURE; MOLECULAR-BASIS; POLIOVIRUS RNA; HNRNP-K	Poly(C)-binding proteins (PCBPs) are important regulatory proteins that contain three KH (hnRNP K homology) domains. Binding poly(C) D/RNA sequences via KH domains is essential for multiple PCBP functions. To reveal the basis for PCBP-D/RNA interactions and function, we determined the structure of a construct containing the first two domains (KH1-KH2) of human PCBP2 by NMR. KH1 and KH2 form an intramolecular pseudodimer. The large hydrophobic dimerization surface of each KH domain is on the side opposite the D/RNA binding interface. Chemical shift mapping indicates both domains bind poly(C) DNA motifs without disrupting the KH1-KH2 interaction. Spectral comparison of KH1-KH2, KH3, and full-length PCBP2 constructs suggests that the KH1-KH2 pseudodimer forms, but KH3 does not interact with other parts of the protein. From NMR studies and modeling, we propose possible modes of cooperative binding tandem poly(C) motifs by the KH domains. D/RNA binding may induce pseudodimer dissociation or stabilize dissociated KH1 and KH2, making protein interaction surfaces available to PCBP-binding partners. This conformational change may represent a regulatory mechanism linking D/RNA binding to PCBP functions.	[Du, Zhihua; Fenn, Sebastian; Tjhen, Richard; James, Thomas L.] Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	James, TL (corresponding author), Univ Calif San Francisco, Dept Pharmaceut Chem, 600 16th St,Genentech Hall, San Francisco, CA 94143 USA.	james@picasso.ucsf.edu			National Institutes of Health [AI46967]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI046967] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant AI46967 (to T. L. J.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Baber JL, 1999, J MOL BIOL, V289, P949, DOI 10.1006/jmbi.1999.2818; Backe PH, 2005, STRUCTURE, V13, P1055, DOI 10.1016/j.str.2005.04.008; Blyn LB, 1997, J VIROL, V71, P6243, DOI 10.1128/JVI.71.8.6243-6246.1997; Blyn LB, 1996, P NATL ACAD SCI USA, V93, P11115, DOI 10.1073/pnas.93.20.11115; Braddock DT, 2002, NATURE, V415, P1051, DOI 10.1038/4151051a; Braddock DT, 2002, EMBO J, V21, P3476, DOI 10.1093/emboj/cdf352; Chkheidze AN, 1999, MOL CELL BIOL, V19, P4572; Chmiel NH, 2006, RNA, V12, P283, DOI 10.1261/rna.2175706; CHOTHIA C, 1975, NATURE, V256, P705, DOI 10.1038/256705a0; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; Czyzyk-Krzeska MF, 1999, BLOOD, V93, P2111, DOI 10.1182/blood.V93.6.2111.406k24_2111_2120; Dejgaard K, 1996, EUR J BIOCHEM, V241, P425, DOI 10.1111/j.1432-1033.1996.00425.x; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Du ZH, 2005, J BIOL CHEM, V280, P38823, DOI 10.1074/jbc.M508183200; Du ZH, 2004, J BIOL CHEM, V279, P48126, DOI 10.1074/jbc.M405371200; Du Z, 2007, RNA, V13, P1043, DOI 10.1261/rna.410107; Emerald BS, 2007, J BIOL CHEM, V282, P680, DOI 10.1074/jbc.M600224200; Fenn S, 2007, NUCLEIC ACIDS RES, V35, P2651, DOI 10.1093/nar/gkm139; Gamarnik AV, 1998, GENE DEV, V12, P2293, DOI 10.1101/gad.12.15.2293; Gamarnik AV, 2000, J VIROL, V74, P2219, DOI 10.1128/JVI.74.5.2219-2226.2000; Gamarnik AV, 1997, RNA, V3, P882; Garcia-Mayoral MF, 2007, STRUCTURE, V15, P485, DOI 10.1016/j.str.2007.03.006; GODDARD TD, 1998, SPARKY 3 0; JONES S, 1995, PROG BIOPHYS MOL BIO, V63, P31, DOI 10.1016/0079-6107(94)00008-W; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Lewis HA, 2000, CELL, V100, P323, DOI 10.1016/S0092-8674(00)80668-6; Lewis HA, 1999, STRUCTURE, V7, P191, DOI 10.1016/S0969-2126(99)80025-2; Lindquist JN, 2000, NUCLEIC ACIDS RES, V28, P4306, DOI 10.1093/nar/28.21.4306; Liu ZH, 2001, SCIENCE, V294, P1098, DOI 10.1126/science.1064719; Maguire ML, 2005, J MOL BIOL, V348, P265, DOI 10.1016/j.jmb.2005.02.058; Makeyev AV, 2002, RNA, V8, P265, DOI 10.1017/S1355838202024627; Malik AK, 2006, BRAIN RES, V1112, P33, DOI 10.1016/j.brainres.2006.07.019; Mulder FAA, 1999, J MOL BIOL, V292, P111, DOI 10.1006/jmbi.1999.3034; Musco G, 1996, CELL, V85, P237, DOI 10.1016/S0092-8674(00)81100-9; Ostareck DH, 2001, CELL, V104, P281, DOI 10.1016/S0092-8674(01)00212-4; Ostareck DH, 1997, CELL, V89, P597, DOI 10.1016/S0092-8674(00)80241-X; OSTARECKLEDERER A, 1994, EMBO J, V13, P1476, DOI 10.1002/j.1460-2075.1994.tb06402.x; Parsley TB, 1997, RNA, V3, P1124; Paulding WR, 1999, J BIOL CHEM, V274, P2532, DOI 10.1074/jbc.274.4.2532; Persson PB, 2003, AM J PHYSIOL-REG I, V285, pR491, DOI 10.1152/ajpregu.00101.2003; Schwieters CD, 2003, J MAGN RESON, V160, P65, DOI 10.1016/S1090-7807(02)00014-9; Sidiqi M, 2005, NUCLEIC ACIDS RES, V33, P1213, DOI 10.1093/nar/gki265; Stefanovic B, 1997, MOL CELL BIOL, V17, P5201, DOI 10.1128/MCB.17.9.5201; Thompsett AR, 2005, J BIOL CHEM, V280, P42750, DOI 10.1074/jbc.M506521200; Tomonaga T, 1996, P NATL ACAD SCI USA, V93, P5830, DOI 10.1073/pnas.93.12.5830; Valverde R, 2007, STRUCTURE, V15, P1090, DOI 10.1016/j.str.2007.06.022; Waggoner SA, 2003, EXP BIOL MED, V228, P387, DOI 10.1177/153537020322800409; Wang ZR, 1999, MOL CELL BIOL, V19, P4552; WEISS IM, 1995, MOL CELL BIOL, V15, P2457; Xiao XL, 2001, J BIOL CHEM, V276, P41510, DOI 10.1074/jbc.M106824200; Yu J, 2001, MOL CELL BIOL, V21, P5879, DOI 10.1128/MCB.21.17.5879-5888.2001	51	44	48	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 17	2008	283	42					28757	28766		10.1074/jbc.M803046200	http://dx.doi.org/10.1074/jbc.M803046200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	359EN	18701464	Green Published, hybrid			2022-12-27	WOS:000259969300078
J	Lee, BC; Le, DT; Gladyshev, VN				Lee, Byung Cheon; Le, Dung Tien; Gladyshev, Vadim N.			Mammals reduce methionine-S-sulfoxide with MsrA and are unable to reduce methionine-R-sulfoxide, and this function can be restored with a yeast reductase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; AMINO-ACIDS; LIFE-SPAN; METABOLISM; PROTEIN; TRANSCRIPTION; CYSTEINE; REVEALS; CELLS; ATF3	Methionine is an essential amino acid in mammals at the junction of methylation, protein synthesis, and sulfur pathways. However, this amino acid is highly susceptible to oxidation, resulting in a mixture of methionine-S-sulfoxide and methionine-R-sulfoxide. Whether methionine is quantitatively regenerated from these compounds is unknown. Here we report that SK-Hep1 hepatocytes grew on methionine-S-sulfoxide and consumed this compound by import and methionine-S-sulfoxide reductase (MsrA)-dependent reduction, but methionine-R-sulfoxide reductases were not involved in this process, and methionine-R-sulfoxide could not be used by the cells. However, SKHep1 cells expressing a yeast free methionine-R-sulfoxide reductase proliferated in the presence of either sulfoxide, reduced them, and showed increased resistance to oxidative stress. Only methionine-R-sulfoxide was detected in the plasma of wild type mice, but both sulfoxides were in the plasma of MsrA knock-out mice. These results show that mammals can support methionine metabolism by reduction of methionine-S-sulfoxide, that this process is dependent on MsrA, that mammals are inherently deficient in the reduction of methionine-R-sulfoxide, and that expression of yeast free methionine-R-sulfoxide reductase can fully compensate for this deficiency.	[Gladyshev, Vadim N.] Univ Nebraska, Beadle Ctr N151, Dept Biochem, Lincoln, NE 68588 USA; Univ Nebraska, Redox Biol Ctr, Lincoln, NE 68588 USA	University of Nebraska System; University of Nebraska Lincoln; University of Nebraska System; University of Nebraska Lincoln	Gladyshev, VN (corresponding author), Univ Nebraska, Beadle Ctr N151, Dept Biochem, Lincoln, NE 68588 USA.	vgladyshev1@unl.edu	Le, Dung Tien/A-7276-2008; Gladyshev, Vadim N/A-9894-2013; Gladyshev, Vadim N/J-6187-2013	Le, Dung Tien/0000-0002-5117-3476; Gladyshev, Vadim/0000-0002-0372-7016; Lee, Byung Cheon/0000-0003-1467-1940	National Institutes of Health [AG021518]; NATIONAL INSTITUTE ON AGING [R01AG021518] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grant AG021518 (to V. N. G.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Baker DH, 2005, P NATL ACAD SCI USA, V102, P17897, DOI 10.1073/pnas.0509317102; Boschi-Muller S, 2005, BBA-PROTEINS PROTEOM, V1703, P231, DOI 10.1016/j.bbapap.2004.09.016; Brosnan JT, 2006, J NUTR, V136, p1636S, DOI 10.1093/jn/136.6.1636S; Elmore CL, 2007, ANTIOXID REDOX SIGN, V9, P1911, DOI 10.1089/ars.2007.1795; Etienne F, 2003, BIOCHEM BIOPH RES CO, V300, P378, DOI 10.1016/S0006-291X(02)02870-X; Ezraty B, 2005, J BACTERIOL, V187, P231, DOI 10.1128/JB.187.1.231-237.2005; Fukushima E, 2007, J BACTERIOL, V189, P7134, DOI 10.1128/JB.00751-06; HAENOLD R, 2007, FREE RADICAL RES, V28, P1; Kim HY, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-11; Kim HY, 2004, MOL BIOL CELL, V15, P1055, DOI 10.1091/mbc.E03-08-0629; Kim HY, 2005, BIOCHEMISTRY-US, V44, P8059, DOI 10.1021/bi0501131; Koc A, 2004, P NATL ACAD SCI USA, V101, P7999, DOI 10.1073/pnas.0307929101; LAVINE TF, 1947, J BIOL CHEM, V169, P477; Lin ZD, 2007, P NATL ACAD SCI USA, V104, P9597, DOI 10.1073/pnas.0703774104; Moskovitz J, 2001, P NATL ACAD SCI USA, V98, P12920, DOI 10.1073/pnas.231472998; Oien DB, 2007, BIOCHEM BIOPH RES CO, V352, P556, DOI 10.1016/j.bbrc.2006.11.063; Okamoto A, 2006, MOL CELL BIOL, V26, P1087, DOI 10.1128/MCB.26.3.1087-1097.2006; Pan YX, 2003, J BIOL CHEM, V278, P38402, DOI 10.1074/jbc.M304574200; Prudova A, 2006, P NATL ACAD SCI USA, V103, P6489, DOI 10.1073/pnas.0509531103; Ruan H, 2002, P NATL ACAD SCI USA, V99, P2748, DOI 10.1073/pnas.032671199; Sharov VS, 1999, FEBS LETT, V455, P247, DOI 10.1016/S0014-5793(99)00888-1; Stadtman ER, 2002, MOL CELL BIOCHEM, V234, P3, DOI 10.1023/A:1015916831583; Stipanuk MH, 2004, ANNU REV NUTR, V24, P539, DOI 10.1146/annurev.nutr.24.012003.132418; Tamura K, 2005, EMBO J, V24, P2590, DOI 10.1038/sj.emboj.7600742; Vougier S, 2003, BIOCHEM J, V373, P531, DOI 10.1042/BJ20030443; Wassef R, 2007, J NEUROSCI, V27, P12808, DOI 10.1523/JNEUROSCI.0322-07.2007; Weissbach H, 2005, BBA-PROTEINS PROTEOM, V1703, P203, DOI 10.1016/j.bbapap.2004.10.004	27	43	46	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 17	2008	283	42					28361	28369		10.1074/jbc.M805059200	http://dx.doi.org/10.1074/jbc.M805059200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	359EN	18697736	Green Published, hybrid			2022-12-27	WOS:000259969300038
J	Li, YJ; Wei, YS; Fu, XH; Hao, DL; Xue, Z; Gong, H; Zhang, ZQ; Liu, DP; Liang, CC				Li, Ya-Jun; Wei, Yu-Sheng; Fu, Xiang-Hui; Hao, De-Long; Xue, Zheng; Gong, Huan; Zhang, Zhu-Qin; Liu, De-Pei; Liang, Chih-Chuan			The apolipoprotein CIII enhancer regulates both extensive histone modification and Intergenic transcription of human apolipoprotien AI/CIII/AIV genes but not apolipoprotein AV	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LOCUS-CONTROL REGION; BETA-GLOBIN LOCUS; RESPONSE ELEMENT; ACETYLTRANSFERASE ACTIVITY; TARGETED RECRUITMENT; TRANSGENIC MICE; ACTIVE GENES; IN-VIVO; C-III; CHROMATIN	The apolipoprotein (apo) AI/CIII/AIV/AV cluster genes are expressed at different levels in the liver and intestine. The apoCIII enhancer, a common regulatory element, regulates the tissue-specific expression of apoAI, apoCIII, and apoAIV but not apoAV. To study this regulation at the chromatin level, the histone modifications and intergenic transcription in the human apoAI/CIII/AIV/AV cluster were investigated in HepG2 and Caco-2 cells and in the livers of transgenic mice carrying the human gene cluster constructs with or without the apoCIII enhancer. We found that both the promoters and the intergenic regions of the apoAI/CIII/AIV genes were hyperacetylated and formed an open subdomain that did not include the apoAV gene. Hepatic and intestinal intergenic transcripts were identified to transcribe bidirectionally with strand preferences along the cluster. The deletion of the apoCIII enhancer influenced both histone modification and intergenic transcription in the apoAI/CIII/AIV gene region. These results demonstrate that the apoCIII enhancer contributes to the maintenance of an active chromatin subdomain of the apoAI/CIII/AIV genes, but not apoAV.	[Liu, De-Pei] Chinese Acad Med Sci, Natl Lab Med Mol Biol, Inst Basic Med Sci, Beijing 100005, Peoples R China; Peking Union Med Coll, Beijing 100005, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Basic Medical Sciences - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Liu, DP (corresponding author), Chinese Acad Med Sci, Natl Lab Med Mol Biol, Inst Basic Med Sci, Beijing 100005, Peoples R China.	liudp@pumc.edu.cn	fu, xianghui/B-9165-2014	Fu, Xianghui/0000-0001-9808-3892; Liu, De-Pei/0000-0002-2636-4297	National Natural Science Foundation of China [30500297, 30721063]; National Basic Research Program of China [2005CB522402, 2006CB503801]; National High-tech Research and Development Program of China [2006AA02A406]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China); National High-tech Research and Development Program of China(National High Technology Research and Development Program of China)	This work was supported by the National Natural Science Foundation of China Grants 30500297 and 30721063, National Basic Research Program of China Grants 2005CB522402 and 2006CB503801, and National High-tech Research and Development Program of China Grant 2006AA02A406. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Adachi S, 2005, NUCLEIC ACIDS RES, V33, P3200, DOI 10.1093/nar/gki637; Bernstein BE, 2005, CELL, V120, P169, DOI 10.1016/j.cell.2005.01.001; Bottardi S, 2003, BLOOD, V102, P3989, DOI 10.1182/blood-2003-05-1540; Bulger M, 2003, MOL CELL BIOL, V23, P5234, DOI 10.1128/MCB.23.15.5234-5244.2003; Cajiao I, 2004, EMBO J, V23, P3854, DOI 10.1038/sj.emboj.7600365; Carter D, 2002, NAT GENET, V32, P623, DOI 10.1038/ng1051; Elefant F, 2000, J BIOL CHEM, V275, P13827, DOI 10.1074/jbc.275.18.13827; Forsberg EC, 2000, P NATL ACAD SCI USA, V97, P14494, DOI 10.1073/pnas.97.26.14494; Fu XH, 2005, EXP CELL RES, V309, P174, DOI 10.1016/j.yexcr.2005.05.015; Gao J, 2005, J BIOL CHEM, V280, P12559, DOI 10.1074/jbc.M409883200; Genoux A, 2005, ARTERIOSCL THROM VAS, V25, P1186, DOI 10.1161/01.ATV.0000163841.85333.83; Gerber M, 2003, J BIOL CHEM, V278, P26303, DOI 10.1074/jbc.R300014200; Gribnau J, 2000, MOL CELL, V5, P377, DOI 10.1016/S1097-2765(00)80432-3; HADDAD IA, 1986, J BIOL CHEM, V261, P3268; Ho YG, 2006, MOL CELL, V23, P365, DOI 10.1016/j.molcel.2006.05.041; Jakel H, 2006, ANN MED, V38, P2, DOI 10.1080/07853890500407488; Kan HY, 2000, J BIOL CHEM, V275, P30423, DOI 10.1074/jbc.M005641200; Kardassis D, 2002, BIOCHEMISTRY-US, V41, P1217, DOI 10.1021/bi015618f; Kim A, 2003, MOL CELL BIOL, V23, P8099, DOI 10.1128/MCB.23.22.8099-8109.2003; Kim A, 2007, MOL CELL BIOL, V27, P2980, DOI 10.1128/MCB.02337-06; Krumm A, 1998, P NATL ACAD SCI USA, V95, P13501, DOI 10.1073/pnas.95.23.13501; Kurahashi H, 2004, J BIOL CHEM, V279, P35377, DOI 10.1074/jbc.M400354200; Kurahashi H, 2001, HUM MOL GENET, V10, P2605, DOI 10.1093/hmg/10.23.2605; Li QL, 2006, TRENDS GENET, V22, P197, DOI 10.1016/j.tig.2006.02.004; Li YJ, 2004, INT J BIOCHEM CELL B, V36, P1411, DOI 10.1016/j.biocel.2003.11.003; Mito Y, 2007, SCIENCE, V315, P1408, DOI 10.1126/science.1134004; Ng HH, 2003, MOL CELL, V11, P709, DOI 10.1016/S1097-2765(03)00092-3; Pennacchio LA, 2001, SCIENCE, V294, P169, DOI 10.1126/science.1064852; Prieur X, 2005, MOL ENDOCRINOL, V19, P3107, DOI 10.1210/me.2005-0048; Prieur X, 2003, J BIOL CHEM, V278, P25468, DOI 10.1074/jbc.M301302200; Rong JX, 2000, ANN MED, V32, P642, DOI 10.3109/07853890009002035; Santos-Rosa H, 2002, NATURE, V419, P407, DOI 10.1038/nature01080; Schneider R, 2004, NAT CELL BIOL, V6, P73, DOI 10.1038/ncb1076; Schubeler D, 2004, GENE DEV, V18, P1263, DOI 10.1101/gad.1198204; Sims RJ, 2006, GENE DEV, V20, P2779, DOI 10.1101/gad.1468206; Soutoglou E, 2001, EMBO J, V20, P1984, DOI 10.1093/emboj/20.8.1984; Suzuki T, 2000, GENES CELLS, V5, P29, DOI 10.1046/j.1365-2443.2000.00302.x; Tolhuis B, 2002, MOL CELL, V10, P1453, DOI 10.1016/S1097-2765(02)00781-5; van Dijk KW, 2004, CURR OPIN LIPIDOL, V15, P239, DOI [10.1097/01.mol.00001300096.77252.1f, 10.1097/00041433-200406000-00002]; ZANNIS VI, 1985, BIOCHEMISTRY-US, V24, P4450, DOI 10.1021/bi00337a028; Zannis VI, 2001, CURR OPIN LIPIDOL, V12, P181, DOI 10.1097/00041433-200104000-00012; Zhu XG, 2007, NUCLEIC ACIDS RES, V35, P5532, DOI 10.1093/nar/gkm595	42	6	6	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 17	2008	283	42					28436	28444		10.1074/jbc.M710289200	http://dx.doi.org/10.1074/jbc.M710289200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	359EN	18678879	Green Published, hybrid			2022-12-27	WOS:000259969300045
J	Nissen, MS; Youn, BY; Knowles, BD; Ballinger, JW; Jun, SY; Belchik, SM; Xun, LY; Kang, CH				Nissen, Mark S.; Youn, Buhyun; Knowles, Benjamin D.; Ballinger, Jordan W.; Jun, Se-Young; Belchik, Sara M.; Xun, Luying; Kang, ChulHee			Crystal structures of NADH: FMN oxidoreductase (EmoB) at different stages of catalysis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							4-HYDROXYPHENYLACETATE 3-MONOOXYGENASE; ESCHERICHIA-COLI; BACTERIUM BNC1; EDTA; REDUCTASE; DEGRADATION; MECHANISM; MONOOXYGENASE; SYSTEM; ENZYME	EDTA has become a major organic pollutant in the environment because of its extreme usage and resistance to biodegradation. Recently, two critical enzymes, EDTA monooxygenase (EmoA) and NADH:FMN oxidoreductase (EmoB), belonging to the newly established two-component flavin-diffusible monooxygenase family, were identified in the EDTA degradation pathway in Mesorhizobium sp. BNC1. EmoA is an FMNH2-dependent enzyme that requires EmoB to provide FMNH2 for the conversion of EDTA to ethylenediaminediacetate. To understand the molecular basis of this FMN-mediated reaction, the crystal structures of the apo-form, FMN.FMN complex, and FMN . NADH complex of EmoB were determined at 2.5 angstrom resolution. The structure of EmoB is a homotetramer consisting of four alpha/beta-single-domain monomers of five parallel beta-strands flanked by five alpha-helices, which is quite different from those of other known two-component flavin-diffusible monooxygenase family members, such as PheA2 and HpaC, in terms of both tertiary and quaternary structures. For the first time, the crystal structures of both the FMN.FMN and FMN.NADH complexes of an NADH: FMN oxidoreductase were determined. Two stacked isoalloxazine rings and nicotinamide/isoalloxazine rings were at a proper distance for hydride transfer. The structures indicated a ping-pong reaction mechanism, which was confirmed by activity assays. Thus, the structural data offer detailed mechanistic information for hydride transfer between NADH to an enzyme-bound FMN and between the bound FMNH2 and a diffusible FMN.	[Nissen, Mark S.; Youn, Buhyun; Knowles, Benjamin D.; Ballinger, Jordan W.; Jun, Se-Young; Belchik, Sara M.; Xun, Luying; Kang, ChulHee] Washington State Univ, Sch Mol Biosci, Pullman, WA 99164 USA	Washington State University	Kang, CH (corresponding author), Washington State Univ, Sch Mol Biosci, Pullman, WA 99164 USA.	chkang@wsu.edu		Kang, ChulHee/0000-0002-0693-7860	United States Department of Agriculture Cooperative State Research, Education, and Extension Service [2006-35318-17452]; Office of Biological and Environmental Research of the Department of Energy [DE-FG02-05ER63974]; American Heart Association [0850084Z]	United States Department of Agriculture Cooperative State Research, Education, and Extension Service(United States Department of Agriculture (USDA)National Institute of Food and Agriculture); Office of Biological and Environmental Research of the Department of Energy(United States Department of Energy (DOE)); American Heart Association(American Heart Association)	The work was supported in part by National Research Initiative Grant 2006-35318-17452 from the United States Department of Agriculture Cooperative State Research, Education, and Extension Service, Grant DE-FG02-05ER63974 from the Environmental Remediation Sciences Division Program of the Office of Biological and Environmental Research of the Department of Energy, and American Heart Association Grant 0850084Z. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Agarwal R, 2006, ACTA CRYSTALLOGR D, V62, P383, DOI [10.1107/S0907444906001600, 10.1107/S0904777906001600]; ALTSCHUL SF, 1997, NUCLEIC ACIDS RES, V25, P3402; BARBER LB, 1995, ORGANIC CONTAMINATIO, P115; Bohuslavek J, 2001, APPL ENVIRON MICROB, V67, P688, DOI 10.1128/AEM.67.2.688-695.2001; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Bucheli-Witschel M, 2001, FEMS MICROBIOL REV, V25, P69, DOI 10.1111/j.1574-6976.2001.tb00572.x; Chen HZ, 2005, MICROBIOL-SGM, V151, P1433, DOI 10.1099/mic.0.27805-0; CLEVELAND JM, 1981, SCIENCE, V212, P1506, DOI 10.1126/science.212.4502.1506; Dirilgen N, 1998, CHEMOSPHERE, V37, P771, DOI 10.1016/S0045-6535(98)00080-0; Roldan M, 2008, FEMS MICROBIOL REV, V32, P474, DOI 10.1111/j.1574-6976.2008.00107.x; Fang HY, 2003, APPL BIOCHEM BIOTECH, V111, P81, DOI 10.1385/ABAB:111:2:81; Filisetti L, 2003, J BIOL CHEM, V278, P296, DOI 10.1074/jbc.M209689200; Gao BL, 2005, BIOCHEM BIOPH RES CO, V331, P1137, DOI 10.1016/j.bbrc.2005.04.033; Gisi MR, 2003, J BACTERIOL, V185, P2786, DOI 10.1128/JB.185.9.2786-2792.2003; Gray KA, 1996, NAT BIOTECHNOL, V14, P1705, DOI 10.1038/nbt1296-1705; HASTINGS JW, 1975, J BIOL CHEM, V250, P7288; HENDRICKSON WA, 1991, SCIENCE, V254, P51, DOI 10.1126/science.1925561; HOLM L, 1993, J MOL BIOL, V233, P123, DOI 10.1006/jmbi.1993.1489; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kahnert A, 2000, J BACTERIOL, V182, P2869, DOI 10.1128/JB.182.10.2869-2878.2000; Kim SH, 2008, PROTEINS, V70, P718, DOI 10.1002/prot.21534; LAUFF JJ, 1990, APPL ENVIRON MICROB, V56, P3346, DOI 10.1128/AEM.56.11.3346-3353.1990; LESK AM, 1989, PROTEINS, V5, P139, DOI 10.1002/prot.340050208; Liger D, 2004, J BIOL CHEM, V279, P34890, DOI 10.1074/jbc.M405404200; Liu Y, 2001, APPL ENVIRON MICROB, V67, P696, DOI 10.1128/AEM.67.2.696-701.2001; Lopez-Llano J, 2004, J BIOL CHEM, V279, P47184, DOI 10.1074/jbc.M405791200; Louie TM, 2003, BIOCHEMISTRY-US, V42, P7509, DOI 10.1021/bi034092r; MEANS JL, 1978, SCIENCE, V200, P1477, DOI 10.1126/science.200.4349.1477; Natalello A, 2007, BIOCHEMISTRY-US, V46, P543, DOI 10.1021/bi061769c; Nortemann B, 1999, APPL MICROBIOL BIOT, V51, P751, DOI 10.1007/s002530051458; Okai M, 2006, BIOCHEMISTRY-US, V45, P5103, DOI 10.1021/bi052313i; Otto K, 2004, J BACTERIOL, V186, P5292, DOI 10.1128/JB.186.16.5292-5302.2004; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Sillanpaa M, 1996, CHEMOSPHERE, V32, P1485, DOI 10.1016/0045-6535(96)00057-4; Terwilliger TC, 2001, ACTA CRYSTALLOGR D, V57, P1755, DOI 10.1107/S0907444901013737; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; THIBAUT D, 1995, J BACTERIOL, V177, P5199, DOI 10.1128/jb.177.18.5199-5205.1995; TOSTE AP, 1995, J RADIOAN NUCL CH AR, V194, P25, DOI 10.1007/BF02037609; van den Heuvel RHH, 2004, J BIOL CHEM, V279, P12860, DOI 10.1074/jbc.M313765200; Weilenmann HU, 2004, BIODEGRADATION, V15, P289, DOI 10.1023/B:BIOD.0000042184.35056.ab; Witschel M, 1997, J BACTERIOL, V179, P6937, DOI 10.1128/jb.179.22.6937-6943.1997; Xun LY, 2000, APPL ENVIRON MICROB, V66, P481, DOI 10.1128/AEM.66.2.481-486.2000; Youn BY, 2005, J BIOL CHEM, V280, P12917, DOI 10.1074/jbc.M413266200	43	38	39	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 17	2008	283	42					28710	28720		10.1074/jbc.M804535200	http://dx.doi.org/10.1074/jbc.M804535200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	359EN	18701448	hybrid, Green Published			2022-12-27	WOS:000259969300073
J	Evaul, K; Hammes, SR				Evaul, Kristen; Hammes, Stephen R.			Cross-talk between g protein-coupled and epidermal growth factor receptors regulates gonadotropin-mediated steroidogenesis in Leydig cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LUTEINIZING-HORMONE; BETA(2)-ADRENERGIC RECEPTOR; KINASE CASCADES; EGF RECEPTOR; TUMOR-CELLS; CYCLIC-AMP; ACTIVATION; STAR; PHOSPHORYLATION; MECHANISMS	Gonadal steroid production is stimulated by gonadotropin binding to G protein-coupled receptors (GPCRs). Although GPCR-mediated increases in intracellular cAMP are known regulators of steroidogenesis, the roles of other signaling pathways in mediating steroid production are not well characterized. Recent studies suggest that luteinizing hormone (LH) receptor activation leads to trans-activation of epidermal growth factor (EGF) receptors in the testes and ovary. This pathway is critical for LH-induced steroid production in ovarian follicles, probably through matrix metalloproteinase (MMP)-mediated release of EGF receptor (EGFR) binding ectodomains. Here we examined LH and EGF receptor crosstalk in testicular steroidogenesis using mouse MLTC-1 Leydig cells. We demonstrated that, similar to the ovary, trans-activation of the EGF receptor was critical for gonadotropin-induced steroid production in Leydig cells. LH-induced increases in cAMP and cAMP-dependent protein kinase (PKA) activity mediated trans-activation of the EGF receptor and subsequent mitogen-activated protein kinase (MAPK) activation, ultimately leading to StAR phosphorylation and mitochondrial translocation. Steroidogenesis in Leydig cells was unaffected by MMP inhibitors, suggesting that cAMP and PKA trans-activated EGF receptors in an intracellular fashion. Interestingly, although cAMP was always needed for steroidogenesis, the EGFR/MAPK pathway was activated and necessary only for early (30-60 min), but not late (120 min or more), LH-induced steroidogenesis in vitro. In contrast, 36-h EGF receptor inhibition in vivo significantly reduced serum testosterone levels in male mice, demonstrating the physiologic importance of this cross-talk. These results suggest that GPCR-EGF receptor cross-talk is a conserved regulator of gonadotropin-induced steroidogenesis in the gonads, although the mechanisms of EGF receptor trans-activation may vary.	[Hammes, Stephen R.] Univ Texas SW Med Ctr Dallas, Dept Internal Med, Dallas, TX 75390 USA; Univ Texas SW Med Ctr Dallas, Dept Pharmacol, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Hammes, SR (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Internal Med, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	stephen.hammes@utsouthwestern.edu			National Institutes of Health [DK59913]; Welch Foundation Grant [1-1506]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK059913] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Welch Foundation Grant(The Welch Foundation); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK59913. This work was also supported by Welch Foundation Grant 1-1506. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Arakane F, 1997, J BIOL CHEM, V272, P32656, DOI 10.1074/jbc.272.51.32656; Ashkenazi H, 2005, ENDOCRINOLOGY, V146, P77, DOI 10.1210/en.2004-0588; Barbier AJ, 1999, J BIOL CHEM, V274, P14067, DOI 10.1074/jbc.274.20.14067; CHASE DJ, 1992, J REPROD FERTIL, V95, P657, DOI 10.1530/jrf.0.0950657; Daaka Y, 1997, NATURE, V390, P88, DOI 10.1038/36362; Drube S, 2006, CELL SIGNAL, V18, P1633, DOI 10.1016/j.cellsig.2006.01.003; DUFAU ML, 1977, P NATL ACAD SCI USA, V74, P3419, DOI 10.1073/pnas.74.8.3419; Hamra FK, 2002, P NATL ACAD SCI USA, V99, P14931, DOI 10.1073/pnas.222561399; Jamnongjit M, 2005, P NATL ACAD SCI USA, V102, P16257, DOI 10.1073/pnas.0508521102; Jamnongjit M, 2006, CELL CYCLE, V5, P1178, DOI 10.4161/cc.5.11.2803; Keenan DM, 2004, AM J PHYSIOL-REG I, V286, pR381, DOI 10.1152/ajpregu.00376.2003; Kim J, 2002, J BIOL CHEM, V277, P32116, DOI 10.1074/jbc.M204895200; Kok SW, 2004, AM J PHYSIOL-ENDOC M, V287, pE630, DOI 10.1152/ajpendo.00060.2004; Lutz LB, 2000, J BIOL CHEM, V275, P41512, DOI 10.1074/jbc.M006757200; Manna PR, 2006, MOL ENDOCRINOL, V20, P362, DOI 10.1210/me.2004-0526; Manna PR, 2002, BIOL REPROD, V67, P1393, DOI 10.1095/biolreprod.102.007179; Manna PR, 2006, J MOL ENDOCRINOL, V37, P81, DOI 10.1677/jme.1.02065; Maudsley S, 2000, J BIOL CHEM, V275, P9572, DOI 10.1074/jbc.275.13.9572; Miller WL, 2007, BBA-MOL CELL BIOL L, V1771, P663, DOI 10.1016/j.bbalip.2007.02.012; Panigone S, 2008, MOL ENDOCRINOL, V22, P924, DOI 10.1210/me.2007-0246; Pierce KL, 2001, ONCOGENE, V20, P1532, DOI 10.1038/sj.onc.1204184; Piiper A, 2003, BIOCHEM BIOPH RES CO, V301, P848, DOI 10.1016/S0006-291X(03)00055-X; PODESTA EJ, 1978, BIOCHEMISTRY-US, V17, P1566, DOI 10.1021/bi00601a033; SCAGLIA HE, 1991, J ANDROL, V12, P273; Shah BH, 2005, MOL ENDOCRINOL, V19, P2535, DOI 10.1210/me.2005-0082; Shiraishi K, 2008, EXP CELL RES, V314, P25, DOI 10.1016/j.yexcr.2007.06.025; Shiraishi K, 2006, ENDOCRINOLOGY, V147, P3419, DOI 10.1210/en.2005-1478; Stocco DM, 1996, BIOCHEM PHARMACOL, V51, P197, DOI 10.1016/0006-2952(95)02093-4; Stocco DM, 1997, BIOL REPROD, V56, P328, DOI 10.1095/biolreprod56.2.328; STOCCO DM, 1990, CELL SIGNAL, V2, P161, DOI 10.1016/0898-6568(90)90019-7; TALBOT JA, 1990, ACTA ENDOCRINOL-COP, V122, P643, DOI 10.1530/acta.0.1220643; Zwick E, 1999, TRENDS PHARMACOL SCI, V20, P408, DOI 10.1016/S0165-6147(99)01373-5	32	75	79	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 10	2008	283	41					27525	27533		10.1074/jbc.M803867200	http://dx.doi.org/10.1074/jbc.M803867200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	355OW	18701461	hybrid, Green Published			2022-12-27	WOS:000259719200023
J	Liang, XB; Butterworth, MB; Peters, KW; Walker, WH; Frizzell, RA				Liang, Xiubin; Butterworth, Michael B.; Peters, Kathryn W.; Walker, William H.; Frizzell, Raymond A.			An obligatory heterodimer of 14-3-3 beta and 14-3-3 epsilon is required for aldosterone regulation of the epithelial sodium channel	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-SURFACE EXPRESSION; COLLECTING DUCT CELLS; NA+ CHANNEL; CRYSTAL-STRUCTURE; UBIQUITIN LIGASE; STRUCTURAL BASIS; BLOOD-PRESSURE; RAT-KIDNEY; PROTEINS; ENAC	Increased distal nephron sodium absorption in response to aldosterone involves Nedd4-2 phosphorylation, which blocks its ability to ubiquitylate ENaC and increases apical membrane channel density by reducing its endocytosis. Our prior work (Liang, X., Peters, K. W., Butterworth, M. B., and Frizzell, R. A. ( 2006) J. Biol. Chem. 281, 16323-16332) showed that aldosterone selectively increased 14-3-3 protein isoform expression and that the association of 14-3-3 with phospho-Nedd4-2 was required for sodium transport stimulation. The knockdown of 14-3-3 beta alone nearly eliminated the response to aldosterone, despite the expression of other 14-3-3 isoforms in cortical collecting duct (CCD) cells. To further examine this marked effect of 14-3-3 knockdown, we evaluated the hypothesis that phospho-Nedd4-2 binding prefers a heterodimer composed of two different 14-3-3 isoforms. We tested this concept in polarized CCD cells using RNA interference and assays of sodium transport and of the interaction of Nedd4-2 with 14-3-3 epsilon, a second aldosterone-induced isoform. As observed previously for 14-3-3 knockdown, small interfering RNA-induced reduction of 14-3-3 markedly attenuated aldosterone-stimulated ENaC expression and sodium transport and increased the interaction of Nedd4-2 with ENaC toward prealdosterone levels. After aldosterone induction, 14-3-3 and 14-3-3 were quantitatively co-immunoprecipitated from CCD cell lysates, and the association of both isoforms with Nedd4-2 increased. Finally, the knockdown of either 14-3-3 or 14-3-3 reduced the association of Nedd4-2 with the other isoform. We conclude that the two aldosterone- induced 14-3-3 isoforms, beta and epsilon, interact with phospho-Nedd4-2 as an obligatory heterodimer, blocking its interaction with ENaC and thereby increasing apical ENaC density and sodium transport.	[Liang, Xiubin; Butterworth, Michael B.; Peters, Kathryn W.; Walker, William H.; Frizzell, Raymond A.] Univ Pittsburgh, Dept Cell Biol & Physiol, Sch Med, Pittsburgh, PA 15261 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Frizzell, RA (corresponding author), Univ Pittsburgh, Dept Cell Biol & Physiol, Sch Med, S362 BST,3500 Terrace St, Pittsburgh, PA 15261 USA.	frizzell@pitt.edu			National Institutes of Health [DK54814, DK72506]; Cystic Fibrosis Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK054814, K99DK078917, P30DK072506] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cystic Fibrosis Foundation(Italian Cystic Fibrosis Research Foundation); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK54814 and DK72506. This work was also supported by the Cystic Fibrosis Foundation. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Aitken A, 2002, BIOCHEM SOC T, V30, P351, DOI 10.1042/bst0300351; Benzinger A, 2005, CELL RES, V15, P219, DOI 10.1038/sj.cr.7290290; Bhalla V, 2005, MOL ENDOCRINOL, V19, P3073, DOI 10.1210/me.2005-0193; Bonny O, 2002, J AM SOC NEPHROL, V13, P2399, DOI 10.1097/01.ASN.0000028641.59030.B2; BRIDGES D, 2005, SCI STKE, pRE10, DOI DOI 10.1126/STKE.2962005RE10; Butterworth MB, 2005, J GEN PHYSIOL, V125, P81, DOI 10.1085/jgp.2004.09124; BUTTERWORTH MB, 2008, AM J PHYSL IN PRESS; Butterworth MB, 2007, J BIOL CHEM, V282, P37885, DOI 10.1074/jbc.M707989200; CANESSA CM, 1994, NATURE, V367, P463, DOI 10.1038/367463a0; CANESSA CM, 1993, NATURE, V361, P467, DOI 10.1038/361467a0; Chaudhri M, 2003, BIOCHEM BIOPH RES CO, V300, P679, DOI 10.1016/S0006-291X(02)02902-9; Coblitz B, 2005, J BIOL CHEM, V280, P36263, DOI 10.1074/jbc.M507559200; Debonneville C, 2001, EMBO J, V20, P7052, DOI 10.1093/emboj/20.24.7052; Ergonul Z, 2006, AM J PHYSIOL-RENAL, V291, pF683, DOI 10.1152/ajprenal.00422.2005; Fakitsas P, 2007, J AM SOC NEPHROL, V18, P1084, DOI 10.1681/ASN.2006080902; Gardino AK, 2006, SEMIN CANCER BIOL, V16, P173, DOI 10.1016/j.semcancer.2006.03.007; Garty H, 1997, PHYSIOL REV, V77, P359, DOI 10.1152/physrev.1997.77.2.359; Hou JH, 2002, J AM SOC NEPHROL, V13, P1190, DOI 10.1097/01.ASN.0000013702.73570.3B; Ichimura T, 2005, J BIOL CHEM, V280, P13187, DOI 10.1074/jbc.M412884200; Kamynina E, 2001, FASEB J, V15, P204, DOI 10.1096/fj.00-0191com; Liang XB, 2006, J BIOL CHEM, V281, P16323, DOI 10.1074/jbc.M601360200; Lifton Richard P, 2004, Harvey Lect, V100, P71; Lifton RP, 2001, CELL, V104, P545, DOI 10.1016/S0092-8674(01)00241-0; LIU D, 1995, NATURE, V376, P191, DOI 10.1038/376191a0; Loffing J, 2001, AM J PHYSIOL-RENAL, V280, pF675, DOI 10.1152/ajprenal.2001.280.4.F675; Masilamani S, 1999, J CLIN INVEST, V104, pR19, DOI 10.1172/JCI7840; Muslin AJ, 1996, CELL, V84, P889, DOI 10.1016/S0092-8674(00)81067-3; Naray-Fejes-Toth A, 2004, MOL CELL ENDOCRINOL, V217, P197, DOI 10.1016/j.mce.2003.10.043; Pfau A, 2007, MOL CELL ENDOCRINOL, V264, P35, DOI 10.1016/j.mce.2006.10.002; Rimessi A, 2005, J BIOL CHEM, V280, P37195, DOI 10.1074/jbc.M504921200; Sagnella GA, 2006, CURR PHARM DESIGN, V12, P2221, DOI 10.2174/138161206777585157; Snyder PM, 2004, J BIOL CHEM, V279, P5042, DOI 10.1074/jbc.M312477200; Staub O, 1996, EMBO J, V15, P2371, DOI 10.1002/j.1460-2075.1996.tb00593.x; Staub O, 2005, J AM SOC NEPHROL, V16, P3167, DOI 10.1681/ASN.2005050454; Stockand JD, 2002, AM J PHYSIOL-RENAL, V282, pF559, DOI 10.1152/ajprenal.00320.2001; Stokes JB, 1999, KIDNEY INT, V56, P2318, DOI 10.1046/j.1523-1755.1999.00803.x; Vinciguerra M, 2003, MOL BIOL CELL, V14, P2677, DOI 10.1091/mbc.E02-11-0720; Wang J, 2001, AM J PHYSIOL-RENAL, V280, pF303, DOI 10.1152/ajprenal.2001.280.2.F303; Wilker E, 2004, J MOL CELL CARDIOL, V37, P633, DOI 10.1016/j.yjmcc.2004.04.015; Wilker EW, 2005, J BIOL CHEM, V280, P18891, DOI 10.1074/jbc.M500982200; Xiao Bing, 1995, Nature (London), V376, P188, DOI 10.1038/376188a0; Yaffe MB, 2002, FEBS LETT, V513, P53, DOI 10.1016/S0014-5793(01)03288-4; Yaffe MB, 1997, CELL, V91, P961, DOI 10.1016/S0092-8674(00)80487-0; Zhou RF, 2007, J BIOL CHEM, V282, P20207, DOI 10.1074/jbc.M611329200	44	52	52	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 10	2008	283	41					27418	27425		10.1074/jbc.M803687200	http://dx.doi.org/10.1074/jbc.M803687200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	355OW	18687683	Green Published, hybrid			2022-12-27	WOS:000259719200010
J	Guengerich, FP				Guengerich, F. Peter			Thematic Series: Metals in Biology	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Editorial Material								Metals are important in biochemistry, and the concentrations of many are highly regulated. This prologue introduces the thematic series "Metals in Biology," which includes minireviews on three metals: iron, copper, and selenium. Deficiencies and excesses of all three of these metals cause problems in human health. The three minireviews deal with regulation of iron homeostasis, the roles of copper metabolism in cell regulation and disease, and the functions of selenoproteins.	[Guengerich, F. Peter] Vanderbilt Univ, Sch Med, Dept Biochem, Nashville, TN 37232 USA; [Guengerich, F. Peter] Vanderbilt Univ, Sch Med, Ctr Mol Toxicol, Nashville, TN 37232 USA	Vanderbilt University; Vanderbilt University	Guengerich, FP (corresponding author), Vanderbilt Univ, Sch Med, Dept Biochem, 221 Kirkland Hall, Nashville, TN 37232 USA.	f.guengerich@vanderbilt.edu							0	20	20	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 9	2009	284	2					709	709		10.1074/jbc.R800060200	http://dx.doi.org/10.1074/jbc.R800060200			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	389VP	18757360	hybrid			2022-12-27	WOS:000262122900001
J	Wacker, JL; Feller, DB; Tang, XB; DeFino, MC; Namkung, Y; Lyssand, JS; Mhyre, AJ; Tan, X; Jensen, JB; Hague, C				Wacker, Jennifer L.; Feller, David B.; Tang, Xiao-Bo; DeFino, Mia C.; Namkung, Yuree; Lyssand, John S.; Mhyre, Andrew J.; Tan, Xu; Jensen, Jill B.; Hague, Chris			Disease-causing Mutation in GPR54 Reveals the Importance of the Second Intracellular Loop for Class A G-protein-coupled Receptor Function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HYPOGONADOTROPIC HYPOGONADISM; CRYSTAL-STRUCTURE; STRUCTURAL BASIS; AMINO-ACID; ACTIVATION; TRAFFICKING; RHODOPSIN; G-PROTEIN-COUPLED-RECEPTOR-54; TRANSDUCIN; MEMBRANE	The G-protein-coupled receptor (GPCR) GPR54 is essential for the development and maintenance of reproductive function in mammals. A point mutation (L148S) in the second intracellular loop (IL2) of GPR54 causes idiopathic hypogonadotropic hypogonadism, a disorder characterized by delayed puberty and infertility. Here, we characterize the molecular mechanism by which the L148S mutation causes disease and address the role of IL2 in Class A GPCR function. Biochemical, immunocytochemical, and pharmacological analysis demonstrates that the mutation does not affect the expression, ligand binding properties, or protein interaction network of GPR54. In contrast, diverse GPR54 functional responses are markedly inhibited by the L148S mutation. Importantly, the leucine residue at this position is highly conserved among class A GPCRs. Indeed, mutating the corresponding leucine of the alpha(1A)-AR recapitulates the effects observed with L148S GPR54, suggesting the critical importance of this hydrophobic IL2 residue for Class A GPCR functional coupling. Interestingly, co-immunoprecipitation studies indicate that L148S does not hinder the association of G alpha subunits with GPR54. However, fluorescence resonance energy transfer analysis strongly suggests that L148S impairs the ligand-induced catalytic activation of G alpha. Combining our data with a predictive Class A GPCR/G alpha model suggests that IL2 domains contain a conserved hydrophobic motif that, upon agonist stimulation, might stabilize the switch II region of G alpha. Such an interaction could promote opening of switch II of G alpha to facilitate GDP-GTP exchange and coupling to downstream signaling responses. Importantly, mutations that disrupt this key hydrophobic interface can manifest as human disease.	[Wacker, Jennifer L.; Feller, David B.; Tang, Xiao-Bo; DeFino, Mia C.; Namkung, Yuree; Lyssand, John S.; Tan, Xu; Hague, Chris] Univ Washington, Dept Pharmacol, Seattle, WA 98195 USA; [Jensen, Jill B.] Univ Washington, Dept Physiol & Biophys, Seattle, WA 98195 USA; [Mhyre, Andrew J.] Fred Hutchinson Canc Res Ctr, Clin Div, Seattle, WA 98109 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Fred Hutchinson Cancer Center	Hague, C (corresponding author), 1959 NE Pacific St,Box 357280, Seattle, WA 98195 USA.	chague@u.washington.edu	Tan, Xu/E-7170-2011	Tan, Xu/0000-0003-4861-4573; Jensen, Jill/0000-0002-3527-0911	National Institutes of Health [T32 HD07453]; NIGMS National Research Service Award [T32 GM07270, T32 GM07750, T32 GM07108, RO1 NS08174, U54HD12629]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [T32HD007453, U54HD012629] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007750, T32GM007270, T32GM007108] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS008174] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIGMS National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant T32 HD07453 (to J.L.W.); NIGMS National Research Service Award T32 GM07270 (to J.S.L.); T32 GM07750 (to M.C.D.); and T32 GM07108, RO1 NS08174 (BH), and U54HD12629 (to J.B.J.).	ARORA KK, 1995, J BIOL CHEM, V270, P22820, DOI 10.1074/jbc.270.39.22820; BELCHETZ PE, 1978, SCIENCE, V202, P631, DOI 10.1126/science.100883; Bhagavath B, 2007, SEMIN REPROD MED, V25, P272, DOI 10.1055/s-2007-980221; BLIN N, 1995, J BIOL CHEM, V270, P17741, DOI 10.1074/jbc.270.30.17741; Burstein ES, 1998, J BIOL CHEM, V273, P24322, DOI 10.1074/jbc.273.38.24322; Cai K, 2001, P NATL ACAD SCI USA, V98, P4877, DOI 10.1073/pnas.051632898; Chen HX, 2005, ANAL BIOCHEM, V338, P136, DOI 10.1016/j.ab.2004.11.015; Cherezov V, 2007, SCIENCE, V318, P1258, DOI 10.1126/science.1150577; Conn PM, 2007, PHARMACOL REV, V59, P225, DOI 10.1124/pr.59.3.2; Conn PM, 2006, J ENDOCRINOL, V190, P13, DOI 10.1677/joe.1.06771; Costa EMF, 2001, J CLIN ENDOCR METAB, V86, P2680, DOI 10.1210/jc.86.6.2680; Daulat AM, 2007, MOL CELL PROTEOMICS, V6, P835, DOI 10.1074/mcp.M600298-MCP200; de Roux N, 2003, P NATL ACAD SCI USA, V100, P10972, DOI 10.1073/pnas.1834399100; Dhillo WS, 2005, J CLIN ENDOCR METAB, V90, P6609, DOI 10.1210/jc.2005-1468; DOHLMAN HG, 1987, BIOCHEMISTRY-US, V26, P2657, DOI 10.1021/bi00384a001; Funes S, 2003, BIOCHEM BIOPH RES CO, V312, P1357, DOI 10.1016/j.bbrc.2003.11.066; Gaborik Z, 2003, ENDOCRINOLOGY, V144, P2220, DOI 10.1210/en.2002-0135; Geiser AH, 2006, PROTEIN SCI, V15, P1679, DOI 10.1110/ps.062192306; Gottsch ML, 2004, ENDOCRINOLOGY, V145, P4073, DOI 10.1210/en.2004-0431; Gray JJ, 2003, J MOL BIOL, V331, P281, DOI 10.1016/S0022-2836(03)00670-3; Hall RA, 2002, CIRC RES, V91, P672, DOI 10.1161/01.RES.0000037000.74258.03; Iiri T, 1998, NATURE, V394, P35, DOI 10.1038/27831; Iovane A, 2004, EUR J ENDOCRINOL, V151, pU83, DOI 10.1530/eje.0.151U083; Irwig MS, 2004, NEUROENDOCRINOLOGY, V80, P264, DOI 10.1159/000083140; Johnston CA, 2007, MOL PHARMACOL, V72, P219, DOI 10.1124/mol.107.034348; Johnston CA, 2007, P NATL ACAD SCI USA, V104, P2001, DOI 10.1073/pnas.0608599104; Kang HT, 2005, BIOCHEM BIOPH RES CO, V329, P684, DOI 10.1016/j.bbrc.2005.02.040; Lyssand JS, 2008, J BIOL CHEM, V283, P18792, DOI 10.1074/jbc.M801860200; Marion S, 2006, J BIOL CHEM, V281, P2932, DOI 10.1074/jbc.M508074200; MORO O, 1993, J BIOL CHEM, V268, P22273; Nanoff C, 2006, MOL PHARMACOL, V69, P397, DOI 10.1124/mol.105.016725; Navarro VM, 2005, ENDOCRINOLOGY, V146, P156, DOI 10.1210/en.2004-0836; Oldham WM, 2008, NAT REV MOL CELL BIO, V9, P60, DOI 10.1038/nrm2299; Oldham WM, 2006, Q REV BIOPHYS, V39, P117, DOI 10.1017/S0033583506004306; Rovati GE, 2007, MOL PHARMACOL, V71, P959, DOI 10.1124/mol.106.029470; SCHLIEFENBAUM J, 2008, BIOPH SOC M LONG BEA; Seminara SB, 2003, NEW ENGL J MED, V349, P1614, DOI 10.1056/NEJMoa035322; Seminara SB, 2006, NAT CLIN PRACT ENDOC, V2, P328, DOI 10.1038/ncpendmet0139; Semple RK, 2005, J CLIN ENDOCR METAB, V90, P1849, DOI 10.1210/jc.2004-1418; Tan CM, 2004, ANNU REV PHARMACOL, V44, P559, DOI 10.1146/annurev.pharmtox.44.101802.121558; Tao YX, 2006, PHARMACOL THERAPEUT, V111, P949, DOI 10.1016/j.pharmthera.2006.02.008; Tena-Sempere M, 2003, REPROD MED MOL CELLU, P225; Tesmer JJG, 1997, SCIENCE, V278, P1907, DOI 10.1126/science.278.5345.1907; Tesmer JJG, 1997, CELL, V89, P251, DOI 10.1016/S0092-8674(00)80204-4; Tesmer VM, 2005, SCIENCE, V310, P1686, DOI 10.1126/science.1118890; Zhang Y, 2006, PLOS COMPUT BIOL, V2, P88, DOI 10.1371/journal.pcbi.0020013; Zhou HP, 1999, BIOCHEM BIOPH RES CO, V264, P171, DOI 10.1006/bbrc.1999.1508	47	57	59	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 7	2008	283	45					31068	31078		10.1074/jbc.M805251200	http://dx.doi.org/10.1074/jbc.M805251200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	367ID	18772143	Green Published, hybrid			2022-12-27	WOS:000260544800061
J	Page, MJ; Di Cera, E				Page, Michael J.; Di Cera, Enrico			Evolution of Peptidase Diversity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROCESSING PEPTIDASE; PROTEASE; FAMILY; CLASSIFICATION; SUPERFAMILY; CASPASES; CLEAVAGE; COHESIN; REVEAL; SYSTEM	A wide variety of peptidases associate with vital biological pathways, but the origin and evolution of their tremendous diversity are poorly defined. Application of the MEROPS classification to a comprehensive set of genomes yields a simple pattern of peptidase distribution and provides insight into the organization of proteolysis in all forms of life. Unexpectedly, a near ubiquitous core set of peptidases is shown to contain more types than those unique to higher multicellular organisms. From this core group, an array of eukaryote-specific peptidases evolved to yield well known intracellular and extracellular processes. The paucity of peptidase families unique to higher metazoa suggests gains in proteolytic network complexity required a limited number of biochemical inventions. These findings provide a framework for deeper investigation into the evolutionary forces that shaped each peptidase family and a roadmap to develop a time-line for their expansion as an interconnected system.	[Page, Michael J.; Di Cera, Enrico] Washington Univ, Sch Med, Dept Biochem & Mol Biophys, St Louis, MO 63110 USA	Washington University (WUSTL)	Di Cera, E (corresponding author), Washington Univ, Sch Med, Dept Biochem & Mol Biophys, St Louis, MO 63110 USA.	enrico@wustl.edu			National Institutes of Health [HL49413, HL58141, HL73813]; American Heart Association; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R29HL049413, R01HL049413, R01HL058141, R01HL073813] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL49413, HL58141, and HL73813 (to E. D. C.). This work was also supported by a postdoctoral fellowship from the American Heart Association (to M. J. P.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Aravind L, 1999, J MOL BIOL, V287, P1023, DOI 10.1006/jmbi.1999.2653; Barrett AJ, 2007, BIOL CHEM, V388, P1151, DOI 10.1515/BC.2007.151; BECKER AB, 1992, P NATL ACAD SCI USA, V89, P3835, DOI 10.1073/pnas.89.9.3835; Beutler B, 2004, MOL IMMUNOL, V40, P845, DOI 10.1016/j.molimm.2003.10.005; Black RA, 1997, NATURE, V385, P729, DOI 10.1038/385729a0; Boldt HB, 2001, BIOCHEM J, V358, P359, DOI 10.1042/0264-6021:3580359; BRANNIGAN JA, 1995, NATURE, V378, P416, DOI 10.1038/378416a0; Cavalier-Smith T, 2002, INT J SYST EVOL MICR, V52, P297, DOI 10.1099/00207713-52-2-297; Cohen GM, 1997, BIOCHEM J, V326, P1, DOI 10.1042/bj3260001; Coux O, 1996, ANNU REV BIOCHEM, V65, P801, DOI 10.1146/annurev.bi.65.070196.004101; Devos D, 2001, TRENDS GENET, V17, P429, DOI 10.1016/S0168-9525(01)02348-4; Di Cera E, 2008, MOL ASPECTS MED, V29, P203, DOI 10.1016/j.mam.2008.01.001; Doolittle RF, 2005, CURR OPIN STRUC BIOL, V15, P248, DOI 10.1016/j.sbi.2005.04.001; Doolittle WF, 1999, SCIENCE, V284, P2124, DOI 10.1126/science.284.5423.2124; Eddy SR, 1998, BIOINFORMATICS, V14, P755, DOI 10.1093/bioinformatics/14.9.755; Eddy SR, 1996, CURR OPIN STRUC BIOL, V6, P361, DOI 10.1016/S0959-440X(96)80056-X; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Evans JS, 2007, J NEUROCHEM, V103, P849, DOI 10.1111/j.1471-4159.2007.04815.x; Evans PC, 2003, J BIOL CHEM, V278, P23180, DOI 10.1074/jbc.M301863200; Feng DF, 1997, P NATL ACAD SCI USA, V94, P13028, DOI 10.1073/pnas.94.24.13028; Glas R, 1998, NATURE, V392, P618, DOI 10.1038/33443; Goll DE, 2003, PHYSIOL REV, V83, P731, DOI 10.1152/physrev.00029.2002; Hochstrasser M, 2000, NAT CELL BIOL, V2, pE153, DOI 10.1038/35019643; Holmquist M, 2000, CURR PROTEIN PEPT SC, V1, P209, DOI 10.2174/1389203003381405; Johnson KA, 2006, EMBO J, V25, P1977, DOI 10.1038/sj.emboj.7601080; Karata K, 1999, J BIOL CHEM, V274, P26225, DOI 10.1074/jbc.274.37.26225; Karplus K, 1998, BIOINFORMATICS, V14, P846, DOI 10.1093/bioinformatics/14.10.846; KOHL NE, 1988, P NATL ACAD SCI USA, V85, P4686, DOI 10.1073/pnas.85.13.4686; Kovalenko A, 2003, NATURE, V424, P801, DOI 10.1038/nature01802; Krem MM, 2001, EMBO J, V20, P3036, DOI 10.1093/emboj/20.12.3036; Leiting B, 2003, BIOCHEM J, V371, P525, DOI 10.1042/BJ20021643; Liu Z, 2006, PLANT CELL, V18, P1213, DOI 10.1105/tpc.105.036913; Lopez-Otin C, 2002, NAT REV MOL CELL BIO, V3, P509, DOI 10.1038/nrm858; Lopez-Otin C, 2008, J BIOL CHEM, V283, P30433, DOI 10.1074/jbc.R800035200; Mott JD, 2004, CURR OPIN CELL BIOL, V16, P558, DOI 10.1016/j.ceb.2004.07.010; Nicholson DW, 1997, TRENDS BIOCHEM SCI, V22, P299, DOI 10.1016/S0968-0004(97)01085-2; Ochman H, 2001, SCIENCE, V292, P1096, DOI 10.1126/science.1058543; Osman C, 2007, MOL BIOL CELL, V18, P627, DOI 10.1091/mbc.E06-09-0839; Page MJ, 2008, CELL MOL LIFE SCI, V65, P1220, DOI 10.1007/s00018-008-7565-9; Puente XS, 2005, GENOMICS, V86, P638, DOI 10.1016/j.ygeno.2005.07.009; Puente XS, 2005, BIOCHEM SOC T, V33, P331, DOI 10.1042/BST0330331; Puente XS, 2003, NAT REV GENET, V4, P544, DOI 10.1038/nrg1111; Rawlings ND, 2008, NUCLEIC ACIDS RES, V36, pD320, DOI 10.1093/nar/gkm954; Rea D, 2006, CELL BIOCHEM BIOPHYS, V44, P349, DOI 10.1385/CBB:44:3:349; Reznik SE, 2001, CELL MOL LIFE SCI, V58, P1790, DOI 10.1007/PL00000819; Shen YQ, 2006, NATURE, V443, P870, DOI 10.1038/nature05143; Stajich JE, 2002, GENOME RES, V12, P1611, DOI 10.1101/gr.361602; STOCKER W, 1995, PROTEIN SCI, V4, P823; Suzuki H, 2002, J BIOL CHEM, V277, P43536, DOI 10.1074/jbc.M207680200; Taylor AB, 2001, STRUCTURE, V9, P615, DOI 10.1016/S0969-2126(01)00621-9; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Uhlmann F, 1999, NATURE, V400, P37, DOI 10.1038/21831; Urban S, 2001, CELL, V107, P173, DOI 10.1016/S0092-8674(01)00525-6; Varshavsky A, 1996, P NATL ACAD SCI USA, V93, P12142, DOI 10.1073/pnas.93.22.12142; WOESE CR, 1990, P NATL ACAD SCI USA, V87, P4576, DOI 10.1073/pnas.87.12.4576; Wu WF, 1999, J BACTERIOL, V181, P3681, DOI 10.1128/JB.181.12.3681-3687.1999; Yang S, 2005, P NATL ACAD SCI USA, V102, P373, DOI 10.1073/pnas.0408810102; Yao R, 1996, P NATL ACAD SCI USA, V93, P10134, DOI 10.1073/pnas.93.19.10134	58	70	72	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 31	2008	283	44					30010	30014		10.1074/jbc.M804650200	http://dx.doi.org/10.1074/jbc.M804650200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	364WS	18768474	Green Published, hybrid			2022-12-27	WOS:000260366900045
J	Rusconi, L; Salvatoni, L; Giudici, L; Bertani, I; Kilstrup-Nielsen, C; Broccoli, V; Landsberger, N				Rusconi, Laura; Salvatoni, Lisa; Giudici, Laura; Bertani, Ilaria; Kilstrup-Nielsen, Charlotte; Broccoli, Vania; Landsberger, Nicoletta			CDKL5 Expression Is Modulated during Neuronal Development and Its Subcellular Distribution Is Tightly Regulated by the C-terminal Tail	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EARLY-ONSET SEIZURES; RETT-SYNDROME; INFANTILE SPASMS; BDNF TRANSCRIPTION; MECP2; MUTATIONS; GENE; DNA; PHOSPHORYLATION; INCLUSION	Mutations in the human X-linked cyclin-dependent kinase-like 5 (CDKL5) gene have been identified in patients with Rett syndrome (RTT), West syndrome, and X-linked infantile spasms, sharing the common feature of mental retardation and early seizures. CDKL5 is a rather uncharacterized kinase, but its involvement in RTT seems to be explained by the fact that it works upstream of MeCP2, the main cause of Rett syndrome. To understand the role of this kinase for nervous system functions and to address if molecular mechanisms are involved in regulating its distribution and activity, we studied the ontogeny of CDKL5 expression in developing mouse brains by immunostaining and Western blotting. The expression profile of CDKL5 was compared with that of MeCP2. The two proteins share a general expression profile in the adult mouse brain, but CDKL5 levels appear to be highly modulated at the regional level. Its expression is strongly induced in early postnatal stages, and in the adult brain CDKL5 is present in mature neurons, but not in astroglia. Interestingly, the presence of CDKL5 in the cell nucleus varies at the regional level of the adult brain and is developmentally regulated. CDKL5 shuttles between the cytoplasm and the nucleus and the C-terminal tail is involved in localizing the protein to the cytoplasm in a mechanism depending on active nuclear export. Accordingly, Rett derivatives containing disease-causing truncations of the C terminus are constitutively nuclear, suggesting that they might act as gain of function mutations in this cellular compartment.	[Rusconi, Laura; Giudici, Laura; Bertani, Ilaria; Kilstrup-Nielsen, Charlotte; Landsberger, Nicoletta] Univ Insubria, Dept Struct & Funct Biol, I-21052 Busto Arsizio, VA, Italy; [Salvatoni, Lisa; Broccoli, Vania] Ist Sci San Raffaele, Stem Cell Res Inst, I-20132 Milan, Italy	University of Insubria; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele	Landsberger, N (corresponding author), Univ Insubria, Dept Struct & Funct Biol, Via Alberto da Giussano 12, I-21052 Busto Arsizio, VA, Italy.	landsben@uninsubria.it	Kilstrup-Nielsen, Charlotte/A-6348-2014; Broccoli, Vania/K-3464-2016	Broccoli, Vania/0000-0003-4050-0926; Kilstrup-Nielsen, Charlotte/0000-0003-4977-4077; Landsberger, Nicoletta/0000-0003-0820-3155; Bertani, Ilaria/0000-0003-3175-8677	Rett Syndrome Research Foundation; Telethon; Ministero dell'Istruzione dell'Universita e della Ricerca; Fondazione Cariplo; E-rare EuroRETT network	Rett Syndrome Research Foundation; Telethon(Fondazione Telethon); Ministero dell'Istruzione dell'Universita e della Ricerca(Ministry of Education, Universities and Research (MIUR)); Fondazione Cariplo(Fondazione Cariplo); E-rare EuroRETT network	This work was supported by the Rett Syndrome Research Foundation (to C. K.-N. and V. B.), Telethon (to N. L.), Ministero dell'Istruzione dell'Universita e della Ricerca (to N. L.), Fondazione Cariplo (to C. K.-N. and N. L.), and the E-rare EuroRETT network (to V. B., C. K.-N., and N. L.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Amir RE, 1999, NAT GENET, V23, P185, DOI 10.1038/13810; Archer HL, 2006, J MED GENET, V43, P729, DOI 10.1136/jmg.2006.041467; Armstrong DD, 2002, MENT RETARD DEV D R, V8, P72, DOI 10.1002/mrdd.10027; Bahi-Buisson N, 2008, EPILEPSIA, V49, P1027, DOI 10.1111/j.1528-1167.2007.01520.x; Bertani I, 2006, J BIOL CHEM, V281, P32048, DOI 10.1074/jbc.M606325200; Chahrour M, 2008, SCIENCE, V320, P1224, DOI 10.1126/science.1153252; Chahrour M, 2007, NEURON, V56, P422, DOI 10.1016/j.neuron.2007.10.001; Cheadle JP, 2000, HUM MOL GENET, V9, P1119, DOI 10.1093/hmg/9.7.1119; Chen WG, 2003, SCIENCE, V302, P885, DOI 10.1126/science.1086446; Evans JC, 2005, EUR J HUM GENET, V13, P1113, DOI 10.1038/sj.ejhg.5201451; Fornerod M, 1997, CELL, V90, P1051, DOI 10.1016/S0092-8674(00)80371-2; Fuks F, 2003, J BIOL CHEM, V278, P4035, DOI 10.1074/jbc.M210256200; HAGBERG B, 1983, ANN NEUROL, V14, P471, DOI 10.1002/ana.410140412; HAGBERG B, 1985, BRAIN DEV-JPN, V7, P372, DOI 10.1016/S0387-7604(85)80048-6; HAGBERG BA, 1994, PEDIATR NEUROL, V11, P5, DOI 10.1016/0887-8994(94)90082-5; HANEFELD F, 1985, BRAIN DEV-JPN, V7, P320, DOI 10.1016/S0387-7604(85)80037-1; Ishibashi T, 2008, FEBS LETT, V582, P1157, DOI 10.1016/j.febslet.2008.03.005; Jones PL, 1998, NAT GENET, V19, P187, DOI 10.1038/561; Jung BP, 2003, J NEUROBIOL, V55, P86, DOI 10.1002/neu.10201; Kalscheuer VM, 2003, AM J HUM GENET, V72, P1401, DOI 10.1086/375538; Kaufmann WE, 2005, BRAIN DEV-JPN, V27, pS77, DOI 10.1016/j.braindev.2004.10.008; Kishi N, 2004, MOL CELL NEUROSCI, V27, P306, DOI 10.1016/j.mcn.2004.07.006; la Cour T, 2004, PROTEIN ENG DES SEL, V17, P527, DOI 10.1093/protein/gzh062; Lin C, 2005, HUM MOL GENET, V14, P3775, DOI 10.1093/hmg/ddi391; Mari F, 2005, HUM MOL GENET, V14, P1935, DOI 10.1093/hmg/ddi198; Martinowich K, 2003, SCIENCE, V302, P890, DOI 10.1126/science.1090842; Montini E, 1998, GENOMICS, V51, P427, DOI 10.1006/geno.1998.5391; Mullaney BC, 2004, NEUROSCIENCE, V123, P939, DOI 10.1016/j.neuroscience.2003.11.025; Nan XS, 1998, NATURE, V393, P386, DOI 10.1038/30764; Rosas-Vargas H, 2008, J MED GENET, V45, P172, DOI 10.1136/jmg.2007.053504; Scala E, 2005, J MED GENET, V42, P103, DOI 10.1136/jmg.2004.026237; Schmid RS, 2008, NEUROREPORT, V19, P393, DOI 10.1097/WNR.0b013e3282f5661c; Shahbazian MD, 2002, HUM MOL GENET, V11, P115, DOI 10.1093/hmg/11.2.115; Tao J, 2004, AM J HUM GENET, V75, P1149, DOI 10.1086/426460; Van Esch H, 2007, AM J MED GENET A, V143A, P364, DOI 10.1002/ajmg.a.31572; Wan MM, 1999, AM J HUM GENET, V65, P1520, DOI 10.1086/302690; Weaving LS, 2004, AM J HUM GENET, V75, P1079, DOI 10.1086/426462; Yasui DH, 2007, P NATL ACAD SCI USA, V104, P19416, DOI 10.1073/pnas.0707442104; Young JI, 2005, P NATL ACAD SCI USA, V102, P17551, DOI 10.1073/pnas.0507856102; Zhou ZL, 2006, NEURON, V52, P255, DOI 10.1016/j.neuron.2006.09.037	40	119	125	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 31	2008	283	44					30101	30111		10.1074/jbc.M804613200	http://dx.doi.org/10.1074/jbc.M804613200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	364WS	18701457	Green Published, hybrid			2022-12-27	WOS:000260366900055
J	Uhrig, RG; She, YM; Leach, CA; Plaxton, WC				Uhrig, R. Glen; She, Yi-Min; Leach, Craig A.; Plaxton, William C.			Regulatory Monoubiquitination of Phosphoenolpyruvate Carboxylase in Germinating Castor Oil Seeds	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POSTTRANSLATIONAL REGULATION; UBIQUITINATED PROTEINS; BACTERIAL-TYPE; IN-VIVO; ENDOSPERM; IDENTIFICATION; PURIFICATION; COMPLEX; ENZYME; PLANT	Phosphoenolpyruvate carboxylase ( PEPC) is a tightly regulated enzyme situated at the core of plant C-metabolism. Although its anaplerotic role and control by allosteric effectors, reversible phosphorylation, and oligomerization have been well documented in the endosperm of developing castor oil seeds (COS), relatively little is known about PEPC in germinating COS. The initial phase of COS germination was accompanied by elevated PEPC activity and accumulation of comparable amounts of pre-existing 107-kDa and inducible 110-kDa immunoreactive PEPC polypeptides (p107 and p110, respectively). A 440-kDa PEPC heterotetramer composed of an equivalent ratio of non-phosphorylated p110 and p107 subunits was purified from germinated COS. N-terminal microsequencing, mass spectrometry, and immunoblotting revealed that both subunits arose from the same gene (RcPpc3) that encodes the p107 subunit of a phosphorylated 410-kDa PEP Chomotetramer in developing COS but that p110 is a monoubiquitinated form of p107. Tandem mass spectrometry sequencing of a diglycinated tryptic peptide identified Lys-628 as p110's monoubiquitination site. This residue is conserved in vascular plant PEPCs and is proximal to a PEP-binding/catalytic domain. Incubation with a human deubiquitinating enzyme (USP-2 core) converted the p110: p107 PEPC heterotetramer into a p107 homotetramer while significantly reducing the enzyme's Km(PEP) and sensitivity to allosteric activators (hexose-Ps, glycerol-3-P) and inhibitors (malate, aspartate). Monoubiquitination is a non-destructive and reversible post-translational modification involved in the control of diverse processes such as transcription, endocytosis, and signal transduction. The current study demonstrates that tissue-specific monoubiquitination of a metabolic enzyme can also occur and that this modification influences its kinetic and regulatory properties.	[Uhrig, R. Glen; Plaxton, William C.] Queens Univ, Dept Biol, Kingston, ON K7L 3N6, Canada; [She, Yi-Min] Queens Univ, Dept Chem, Kingston, ON K7L 3N6, Canada; [Plaxton, William C.] Queens Univ, Dept Biochem, Kingston, ON K7L 3N6, Canada; [Leach, Craig A.] Progenra Inc, Malvern, PA 19355 USA	Queens University - Canada; Queens University - Canada; Queens University - Canada	Plaxton, WC (corresponding author), Queens Univ, Dept Biol, Biosci Complex, Kingston, ON K7L 3N6, Canada.	plaxton@queensu.ca	Gruissem, Wilhelm/H-1752-2013; Plaxton, William C/O-3353-2013	Plaxton, William C/0000-0002-8447-7249; She, Yi-Min/0000-0002-0571-4630; Uhrig, R Glen/0000-0003-2773-4381	Natural Sciences and Engineering Research Council of Canada; Queen's Research Chairs program	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Queen's Research Chairs program	This work was supported by grants from the Natural Sciences and Engineering Research Council of Canada and the Queen's Research Chairs program (to W.C.P.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	Agetsuma M, 2005, PLANT CELL PHYSIOL, V46, P389, DOI 10.1093/pcp/pci043; Baret P, 1999, CR ACAD SCI III-VIE, V322, P29, DOI 10.1016/S0764-4469(99)80014-6; Blonde JD, 2003, J BIOL CHEM, V278, P11867, DOI 10.1074/jbc.M211269200; BOTHA FC, 1992, PLANT GROWTH REGUL, V11, P211, DOI 10.1007/BF00024560; BROOKS SPJ, 1992, BIOTECHNIQUES, V13, P906; Chollet R, 1996, ANNU REV PLANT PHYS, V47, P273, DOI 10.1146/annurev.arplant.47.1.273; Crowley V, 2005, PLANT CELL PHYSIOL, V46, P1855, DOI 10.1093/pcp/pci203; Downes B, 2005, BIOCHEM SOC T, V33, P393, DOI 10.1042/BST0330393; Gennidakis S, 2007, PLANT J, V52, P839, DOI 10.1111/j.1365-313X.2007.03274.x; Glevarec G, 2004, PLANTA, V219, P286, DOI 10.1007/s00425-004-1214-9; Gonzalez MC, 1998, PLANT PHYSIOL, V116, P1249, DOI 10.1104/pp.116.4.1249; Gousseva N, 2003, GENE EXPRESSION, V11, P163, DOI 10.3727/000000003108749053; Graham JWA, 2007, PLANT CELL, V19, P3723, DOI 10.1105/tpc.107.053371; Izui K, 2004, ANNU REV PLANT BIOL, V55, P69, DOI 10.1146/annurev.arplant.55.031903.141619; KOBR MJ, 1971, PLANT PHYSIOL, V47, P48, DOI 10.1104/pp.47.1.48; LAW RD, 1995, BIOCHEM J, V307, P807, DOI 10.1042/bj3070807; Lin HJ, 2001, J BIOL CHEM, V276, P20357, DOI 10.1074/jbc.M008761200; Manzano C, 2008, PLANT MOL BIOL, V68, P145, DOI 10.1007/s11103-008-9358-9; Maor R, 2007, MOL CELL PROTEOMICS, V6, P601, DOI 10.1074/mcp.M600408-MCP200; Martin M, 2007, PHYSIOL PLANTARUM, V130, P484, DOI 10.1111/j.1399-3054.2007.00917.x; MOORHEAD GBG, 1994, ARCH BIOCHEM BIOPHYS, V312, P326, DOI 10.1006/abbi.1994.1316; Mukhopadhyay D, 2007, SCIENCE, V315, P201, DOI 10.1126/science.1127085; Murmu J, 2007, PLANTA, V226, P1299, DOI 10.1007/s00425-007-0551-x; Nhiri M, 2000, PLANT SCI, V151, P29, DOI 10.1016/S0168-9452(99)00191-0; Osuna L, 1996, PLANT PHYSIOL, V111, P551, DOI 10.1104/pp.111.2.551; Osuna L, 1999, PLANT PHYSIOL, V119, P511, DOI 10.1104/pp.119.2.511; Plaxton WC, 2006, CRIT REV PLANT SCI, V25, P159, DOI 10.1080/07352680600563876; SALON C, 1988, J BIOL CHEM, V263, P12278; SANGWAN RS, 1992, PLANT PHYSIOL, V99, P445, DOI 10.1104/pp.99.2.445; Schnell JD, 2003, J BIOL CHEM, V278, P35857, DOI 10.1074/jbc.R300018200; SCHULZ M, 1993, BOT ACTA, V106, P143, DOI 10.1111/j.1438-8677.1993.tb00350.x; Smalle J, 2004, ANNU REV PLANT BIOL, V55, P555, DOI 10.1146/annurev.arplant.55.031903.141801; Tripodi KE, 2005, PLANT PHYSIOL, V139, P969, DOI 10.1104/pp.105.066647; Uhrig RG, 2008, PLANT PHYSIOL, V146, P1346, DOI 10.1104/pp.107.110361; Usuba T, 2001, INT J CANCER, V94, P662, DOI 10.1002/ijc.1524; Wang DX, 2006, ANAL CHEM, V78, P3681, DOI 10.1021/ac051904b; Wang DX, 2005, ANAL CHEM, V77, P1458, DOI 10.1021/ac048834d	37	56	57	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 31	2008	283	44					29650	29657		10.1074/jbc.M806102200	http://dx.doi.org/10.1074/jbc.M806102200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	364WS	18728004	Green Published, hybrid			2022-12-27	WOS:000260366900008
J	Anunciado-Koza, R; Ukropec, J; Koza, RA; Kozak, LP				Anunciado-Koza, Rea; Ukropec, Jozef; Koza, Robert A.; Kozak, Leslie P.			Inactivation of UCP1 and the glycerol phosphate cycle synergistically increases energy expenditure to resist diet-induced obesity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MITOCHONDRIAL UNCOUPLING-PROTEIN; BROWN ADIPOSE-TISSUE; COLD-INDUCED THERMOGENESIS; TRANSGENIC MICE LACKING; NONSHIVERING THERMOGENESIS; WHITE FAT; GLYCEROL-3-PHOSPHATE DEHYDROGENASE; BLOOD-FLOW; EXPRESSION; GENE	Our current paradigm for obesity assumes that reduced thermogenic capacity increases susceptibility to obesity, whereas enhanced thermogenic capacity protects against obesity. Here we report that elimination of two major thermogenic pathways encoded by the mitochondrial uncoupling protein (Ucp1) and mitochondrial glycerol-3-phosphate dehydrogenase (Gdm) result in mice with increased resistance to diet-induced obesity when housed at 28 C, provided prior adaptation occurred at 20 C. Obesity resistant Gdm(-/-) .Ucp1(-/-) mice maintained at 28 C have increased energy expenditure, in part through conversion of white to brown adipocytes in inguinal fat. Increased oxygen consumption in inguinal fat cell suspensions and the up-regulation of genes of mitochondrial function and fat metabolism indicated increased thermogenic activity, despite the absence of UCP1, whereas liver and skeletal muscle showed no changes in gene expression. Additionally, comparisons of energy expenditure in UCP1-deficient and wild type mice fed an obesogenic diet indicates that UCP1-based brown fat-based thermogenesis plays no role in so-called diet-induced thermogenesis. Accordingly, a new paradigm for obesity emerges in which the inactivation of major thermogenic pathways force the induction of alternative pathways that increase metabolic inefficiency.	[Anunciado-Koza, Rea; Ukropec, Jozef; Koza, Robert A.; Kozak, Leslie P.] Pennington Biomed Res Ctr, Baton Rouge, LA 70808 USA	Louisiana State University System; Louisiana State University; Pennington Biomedical Research Center	Kozak, LP (corresponding author), Pennington Biomed Res Ctr, 6400 Perkins Rd, Baton Rouge, LA 70808 USA.	kozaklp@pbrc.edu	Ukropec, Jozef/AAI-5590-2020; Ukropec, Jozef/D-5960-2018	Ukropec, Jozef/0000-0001-8401-6621	National Institutes of Health [R01-HD08431]; Clinical Nutrition Research Unit (CNRU); COBRE Center [P-30DK072476, P20-RR021945]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD008431] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR021945] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK072476] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Clinical Nutrition Research Unit (CNRU); COBRE Center; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant R01-HD08431. This work was also supported by Clinical Nutrition Research Unit (CNRU) and COBRE Center Grants P-30DK072476 and P20-RR021945, respectively. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	BLOCK BA, 1994, ANNU REV PHYSIOL, V56, P535; BLUNDELL JE, 2004, HDB OBESITY ETIOLOGY, P427; BRAND MD, 1994, BBA-BIOENERGETICS, V1187, P132, DOI 10.1016/0005-2728(94)90099-X; Brand MD, 2005, CELL METAB, V2, P85, DOI 10.1016/j.cmet.2005.06.002; Brown LJ, 2002, J BIOL CHEM, V277, P32892, DOI 10.1074/jbc.M202408200; Cao WH, 2004, MOL CELL BIOL, V24, P3057, DOI 10.1128/MCB.24.7.3057-3067.2004; Cederberg A, 2001, CELL, V106, P563, DOI 10.1016/S0092-8674(01)00474-3; CHAMPIGNY O, 1991, P NATL ACAD SCI USA, V88, P10774, DOI 10.1073/pnas.88.23.10774; Collins S, 1997, ENDOCRINOLOGY, V138, P405, DOI 10.1210/en.138.1.405; Coulter AA, 2003, PHYSIOL GENOMICS, V14, P139, DOI 10.1152/physiolgenomics.00057.2003; Couplan E, 2002, J BIOL CHEM, V277, P43079, DOI 10.1074/jbc.M206726200; Cummings DE, 1996, NATURE, V382, P622, DOI 10.1038/382622a0; de Meis L, 2006, J BIOL CHEM, V281, P16384, DOI 10.1074/jbc.M600678200; Dossantos RA, 2003, ENDOCRINOLOGY, V144, P5469, DOI 10.1210/en.2003-0687; Dulloo AG, 2004, INT J OBESITY, V28, pS29, DOI 10.1038/sj.ijo.0802861; DUMONTEIL E, 1993, AM J PHYSIOL, V265, pC507, DOI 10.1152/ajpcell.1993.265.2.C507; Enerback S, 1997, NATURE, V387, P90, DOI 10.1038/387090a0; Fiermonte G, 2004, J BIOL CHEM, V279, P30722, DOI 10.1074/jbc.M400445200; FOSTER DO, 1979, CAN J PHYSIOL PHARM, V57, P257, DOI 10.1139/y79-039; FOSTER DO, 1978, CAN J PHYSIOL PHARM, V56, P110, DOI 10.1139/y78-015; Gambert S, 2007, CURR OPIN CLIN NUTR, V10, P664, DOI 10.1097/MCO.0b013e3282f0b69d; Golozoubova V, 2001, FASEB J, V15, P2048, DOI 10.1096/fj.00-0536fje; Guerra C, 1998, J CLIN INVEST, V102, P412, DOI 10.1172/JCI3155; Hansen JB, 2004, P NATL ACAD SCI USA, V101, P4112, DOI 10.1073/pnas.0301964101; HILL J, 2004, HDB OBESITY, P631; HIMMSHAGEN J, 1994, AM J PHYSIOL, V266, pR1371, DOI 10.1152/ajpregu.1994.266.4.R1371; Hirsch J, 1997, NATURE, V387, P27, DOI 10.1038/387027a0; Kopecky J, 1995, J CLIN INVEST, V96, P2914, DOI 10.1172/JCI118363; Koza RA, 1996, ARCH BIOCHEM BIOPHYS, V336, P97, DOI 10.1006/abbi.1996.0536; Kozak LP, 2000, ANNU REV NUTR, V20, P339, DOI 10.1146/annurev.nutr.20.1.339; KOZAK UC, 1994, MOL CELL BIOL, V14, P59, DOI 10.1128/MCB.14.1.59; Krauss S, 2005, NAT REV MOL CELL BIO, V6, P248, DOI 10.1038/nrm1592; LABARCA C, 1980, ANAL BIOCHEM, V102, P344, DOI 10.1016/0003-2697(80)90165-7; LARDY H, 1990, ANNU REV BIOCHEM, V59, P689, DOI 10.1146/annurev.biochem.59.1.689; Levin BE, 2007, AM J PHYSIOL-REG I, V293, pR988, DOI 10.1152/ajpregu.00434.2007; Liang HY, 2006, ADV PHYSIOL EDUC, V30, P145, DOI 10.1152/advan.00052.2006; Liu XT, 2003, J CLIN INVEST, V111, P399, DOI 10.1172/JCI200315737; Lowell BB, 2000, NATURE, V404, P652, DOI 10.1038/35007527; MACLENNAN DH, 1992, SCIENCE, V256, P789, DOI 10.1126/science.1589759; Marrif H, 2005, ENDOCRINOLOGY, V146, P2872, DOI 10.1210/en.2004-1544; NICHOLLS DG, 1984, PHYSIOL REV, V64, P1, DOI 10.1152/physrev.1984.64.1.1; RATNER PL, 1981, J BIOL CHEM, V256, P3576; RICQUIER D, 1976, BIOCHEM BIOPH RES CO, V73, P577, DOI 10.1016/0006-291X(76)90849-4; Robidoux J, 2005, MOL CELL BIOL, V25, P5466, DOI 10.1128/MCB.25.13.5466-5479.2005; ROTHWELL NJ, 1979, NATURE, V281, P31, DOI 10.1038/281031a0; Satrustegui J, 2007, PHYSIOL REV, V87, P29, DOI 10.1152/physrev.00005.2006; SCHUTZ Y, 2004, HDB OBESITY ETIOLOGY, P615; Schwartz MW, 2003, DIABETES, V52, P232, DOI 10.2337/diabetes.52.2.232; Soloveva V, 1997, MOL ENDOCRINOL, V11, P27, DOI 10.1210/me.11.1.27; Stefl B, 1998, AM J PHYSIOL-ENDOC M, V274, pE527, DOI 10.1152/ajpendo.1998.274.3.E527; SURWIT RS, 1988, DIABETES, V37, P1163, DOI 10.2337/diabetes.37.9.1163; Ukropec J, 2006, ENDOCRINOLOGY, V147, P2468, DOI 10.1210/en.2005-1216; Ukropec J, 2006, J BIOL CHEM, V281, P31894, DOI 10.1074/jbc.M606114200; Xue BZ, 2007, J LIPID RES, V48, P41, DOI 10.1194/jlr.M600287-JLR200; Xue BZ, 2005, MOL CELL BIOL, V25, P8311, DOI 10.1128/MCB.25.18.8311-8322.2005	55	77	77	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 10	2008	283	41					27688	27697		10.1074/jbc.M804268200	http://dx.doi.org/10.1074/jbc.M804268200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	355OW	18678870	Green Published, hybrid			2022-12-27	WOS:000259719200040
J	Oswald, C; Smits, SHJ; Hoing, M; Sohn-Bosser, L; Dupont, L; Le Rudulier, D; Schmitt, L; Bremer, E				Oswald, Christine; Smits, Sander H. J.; Hoeing, Marina; Sohn-Boesser, Linda; Dupont, Laurence; Le Rudulier, Daniel; Schmitt, Lutz; Bremer, Erhard			Crystal Structures of the Choline/Acetylcholine Substrate-binding Protein ChoX from Sinorhizobium meliloti in the Liganded and Unliganded-Closed States	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NICOTINIC ACETYLCHOLINE-RECEPTORS; SOLUTES GLYCINE BETAINE; CATION-PI INTERACTIONS; COMPATIBLE SOLUTES; BACILLUS-SUBTILIS; ESCHERICHIA-COLI; ABC TRANSPORTER; MATHEMATICAL TREATMENT; MALTOSE TRANSPORT; DIFFRACTION DATA	The ATP-binding cassette transporter ChoVWX is one of several choline import systems operating in Sinorhizobium meliloti. Here fluorescence-based ligand binding assays were used to quantitate substrate binding by the periplasmic ligand-binding protein ChoX. These data confirmed that ChoX recognizes choline and acetylcholine with high and medium affinity, respectively. We also report the crystal structures of ChoX in complex with either choline or acetylcholine. These structural investigations revealed an architecture of the ChoX binding pocket and mode of substrate binding similar to that reported previously for several compatible solute-binding proteins. Additionally the ChoX-acetylcholine complex permitted a detailed structural comparison with the carbamylcholine-binding site of the acetylcholine-binding protein from the mollusc Lymnaea stagnalis. In addition to the two liganded structures of ChoX, we were also able to solve the crystal structure of ChoX in a closed, substrate-free conformation that revealed an architecture of the ligand-binding site that is superimposable to the closed, ligand-bound form of ChoX. This structure is only the second of its kind and raises the important question of how ATP-binding cassette transporters are capable of distinguishing liganded and unliganded-closed states of the binding protein.	[Oswald, Christine; Smits, Sander H. J.; Schmitt, Lutz] Univ Dusseldorf, Inst Biochem, D-40225 Dusseldorf, Germany; [Hoeing, Marina; Sohn-Boesser, Linda; Bremer, Erhard] Univ Marburg, Microbiol Lab, Dept Biol, D-35032 Marburg, Germany; [Dupont, Laurence; Le Rudulier, Daniel] Univ Nice Sophia Antipolis, Unite Interact Plantes Microorganismes & Sante Ve, UMR6192, CNRS,INRA,Ctr INRA Agrobiotech, Sophia Antipolis, France	Heinrich Heine University Dusseldorf; Philipps University Marburg; Centre National de la Recherche Scientifique (CNRS); INRAE; UDICE-French Research Universities; Universite Cote d'Azur	Schmitt, L (corresponding author), Univ Dusseldorf, Inst Biochem, Univ Str 1, D-40225 Dusseldorf, Germany.	lutz.schmitt@uni-duesseldorf.de			University of Duesseldorf; Deutsche Forschungsgemeinschaft [SFB 395]; Fonds der chemischen Industrie; Planck Institute for terrestrial Microbiology (Marburg, Germany)	University of Duesseldorf; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Fonds der chemischen Industrie(Fonds der Chemischen IndustrieEuropean Commission); Planck Institute for terrestrial Microbiology (Marburg, Germany)	This work was supported in part by grants from the University of Duesseldorf ( to L. S.) and the Deutsche Forschungsgemeinschaft through SFB 395, the Fonds der chemischen Industrie, and the Max Planck Institute for terrestrial Microbiology ( Marburg, Germany) ( to E. B.).	Abele R, 2000, J BIOL CHEM, V275, P21355, DOI 10.1074/jbc.M909883199; ALTSCHUL SF, 1997, NUCLEIC ACIDS RES, V25, P3402; Ames GFL, 1996, J BIOL CHEM, V271, P14264, DOI 10.1074/jbc.271.24.14264; BERNARD T, 1986, ARCH MICROBIOL, V143, P359, DOI 10.1007/BF00412803; Biemans-Oldehinkel E, 2006, FEBS LETT, V580, P1023, DOI 10.1016/j.febslet.2005.11.079; Bjorkman AJ, 1998, J MOL BIOL, V279, P651, DOI 10.1006/jmbi.1998.1785; BOHL E, 1995, J THEOR BIOL, V172, P83, DOI 10.1006/jtbi.1995.0006; Celie PHN, 2004, NEURON, V41, P907, DOI 10.1016/S0896-6273(04)00115-1; DAVIDSON AL, 1992, P NATL ACAD SCI USA, V89, P2360, DOI 10.1073/pnas.89.6.2360; Davidson AL, 2008, MICROBIOL MOL BIOL R, V72, P317, DOI 10.1128/MMBR.00031-07; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; de Rudder KEE, 1999, J BIOL CHEM, V274, P20011, DOI 10.1074/jbc.274.28.20011; Dougherty DA, 1996, SCIENCE, V271, P163, DOI 10.1126/science.271.5246.163; Dupont L, 2004, J BACTERIOL, V186, P5988, DOI 10.1128/JB.186.18.5988-5996.2004; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FLOCCO MM, 1994, J BIOL CHEM, V269, P8931; Hanekop N, 2007, J MOL BIOL, V374, P1237, DOI 10.1016/j.jmb.2007.09.071; Hollenstein K, 2007, NATURE, V446, P213, DOI 10.1038/nature05626; Horn C, 2006, J MOL BIOL, V357, P592, DOI 10.1016/j.jmb.2005.12.085; Horn C, 2005, FEBS LETT, V579, P5765, DOI 10.1016/j.febslet.2005.09.063; Hvorup RN, 2007, SCIENCE, V317, P1387, DOI 10.1126/science.1145950; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Kempf B, 1997, J BACTERIOL, V179, P6213, DOI 10.1128/jb.179.20.6213-6220.1997; KORTSTEE GJ, 1970, ARCH MIKROBIOL, V71, P235, DOI 10.1007/BF00410157; KUO MS, 1986, CARBOHYD RES, V156, P173, DOI 10.1016/S0008-6215(00)90109-5; LAMZIN VS, 1993, ACTA CRYSTALLOGR D, V49, P129, DOI 10.1107/S0907444992008886; Li AJ, 1998, PROTEINS, V32, P111, DOI 10.1002/(SICI)1097-0134(19980701)32:1<111::AID-PROT12>3.0.CO;2-H; LONG SR, 1989, CELL, V56, P203, DOI 10.1016/0092-8674(89)90893-3; Lopez-Lara IM, 2003, MOL PLANT MICROBE IN, V16, P567, DOI 10.1094/MPMI.2003.16.7.567; Ma JC, 1997, CHEM REV, V97, P1303, DOI 10.1021/cr9603744; Magnusson U, 2002, J BIOL CHEM, V277, P14077, DOI 10.1074/jbc.M200514200; MAO B, 1982, J BIOL CHEM, V257, P1131; MERINO G, 1995, J THEOR BIOL, V177, P171, DOI 10.1006/jtbi.1995.0236; Millet O, 2003, P NATL ACAD SCI USA, V100, P12700, DOI 10.1073/pnas.2134311100; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Oldham ML, 2007, NATURE, V450, P515, DOI 10.1038/nature06264; Osteras M, 1998, P NATL ACAD SCI USA, V95, P11394, DOI 10.1073/pnas.95.19.11394; Oswald C, 2008, INT J MOL SCI, V9, P1131, DOI 10.3390/ijms9071131; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Padilla JE, 2003, ACTA CRYSTALLOGR D, V59, P1124, DOI 10.1107/S0907444903007947; POCARD JA, 1989, J BACTERIOL, V171, P531, DOI 10.1128/jb.171.1.531-537.1989; QILKINSON J, 2003, ABC PROTEINS BACTERI, P178; Quiocho FA, 1996, MOL MICROBIOL, V20, P17, DOI 10.1111/j.1365-2958.1996.tb02484.x; RAMACHANDRAN GN, 1963, J MOL BIOL, V7, P95, DOI 10.1016/S0022-2836(63)80023-6; SACK JS, 1989, J MOL BIOL, V206, P171, DOI 10.1016/0022-2836(89)90531-7; Schiefner A, 2004, J BIOL CHEM, V279, P48270, DOI 10.1074/jbc.M403540200; Schiefner A, 2004, J BIOL CHEM, V279, P5588, DOI 10.1074/jbc.M309771200; Sheldrick GM, 1997, METHOD ENZYMOL, V277, P319, DOI 10.1016/S0076-6879(97)77018-6; Smit AB, 2006, J MOL NEUROSCI, V30, P9, DOI 10.1385/JMN:30:1:9; Smits SHJ, 2008, J BACTERIOL, V190, P5663, DOI 10.1128/JB.00346-08; Tang C, 2007, NATURE, V449, P1078, DOI 10.1038/nature06232; Telmer PG, 2003, J BIOL CHEM, V278, P34555, DOI 10.1074/jbc.M301004200; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Vagin A, 2000, ACTA CRYSTALLOGR D, V56, P1622, DOI 10.1107/S0907444900013780	55	79	80	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 21	2008	283	47					32848	32859		10.1074/jbc.M806021200	http://dx.doi.org/10.1074/jbc.M806021200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	372HW	18779321	Green Published, hybrid			2022-12-27	WOS:000260893700074
J	Rodland, KD; Bollinger, N; Ippolito, D; Opresko, LK; Coffey, RJ; Zangar, R; Wiley, HS				Rodland, Karin D.; Bollinger, Nikki; Ippolito, Danielle; Opresko, Lee K.; Coffey, Robert J.; Zangar, Richard; Wiley, H. Steven			Multiple Mechanisms Are Responsible for Transactivation of the Epidermal Growth Factor Receptor in Mammary Epithelial Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NECROSIS-FACTOR-ALPHA; MATRIX-METALLOPROTEINASE INHIBITOR; EGFR SIGNAL TRANSACTIVATION; PROTEIN-COUPLED RECEPTORS; CANCER-CELLS; CARCINOMA CELLS; ACTIVATION; LIGANDS; PROLIFERATION; MIGRATION	The number of distinct signaling pathways that can transactivate the epidermal growth factor receptor (EGFR) in a single cell type is unclear. Using a single strain of human mammary epithelial cells, we found that a wide variety of agonists, such as lysophosphatidic acid (LPA), uridine triphosphate, growth hormone, vascular endothelial growth factor, insulin-like growth factor-1 (IGF-1), and tumor necrosis factor-alpha, require EGFR activity to induce ERK phosphorylation. In contrast, hepatocyte growth factor can stimulate ERK phosphorylation independent of the EGFR. EGFR transactivation also correlated with an increase in cell proliferation and could be inhibited with metalloprotease inhibitors. However, there were significant differences with respect to transactivation kinetics and sensitivity to different inhibitors. In particular, IGF-1 displayed relatively slow transactivation kinetics and was resistant to inhibition by the selective ADAM-17 inhibitor WAY-022 compared with LPA-induced transactivation. Studies using anti-ligand antibodies showed that IGF-1 transactivation required amphiregulin production, whereas LPA was dependent on multiple ligands. Direct measurement of ligand shedding confirmed that LPA treatment stimulated shedding of multiple EGFR ligands, but paradoxically, IGF-1 had little effect on the shedding rate of any ligand, including amphiregulin. Instead, IGF-1 appeared to work by enhancing EGFR activation of Ras in response to constitutively produced amphiregulin. This enhancement of EGFR signaling was independent of both receptor phosphorylation and PI-3-kinase activity, suggestive of a novel mechanism. Our studies demonstrate that within a single cell type, the EGFR autocrine system can couple multiple signaling pathways to ERK activation and that this modulation of EGFR autocrine signaling can be accomplished at multiple regulatory steps.	[Coffey, Robert J.] Vanderbilt Univ, Med Ctr, Nashville, TN 37232 USA; [Wiley, H. Steven] Pacific NW Natl Lab, Environm Mol Sci Lab, Richland, WA 99354 USA; [Rodland, Karin D.; Bollinger, Nikki; Ippolito, Danielle; Opresko, Lee K.; Zangar, Richard] Pacific NW Natl Lab, Div Biol Sci, Richland, WA 99354 USA; [Rodland, Karin D.; Bollinger, Nikki; Ippolito, Danielle; Opresko, Lee K.; Zangar, Richard; Wiley, H. Steven] Pacific NW Natl Lab, Syst Biol Program, Richland, WA 99354 USA	Vanderbilt University; United States Department of Energy (DOE); Pacific Northwest National Laboratory; United States Department of Energy (DOE); Pacific Northwest National Laboratory; United States Department of Energy (DOE); Pacific Northwest National Laboratory	Rodland, KD (corresponding author), Pacific NW Natl Lab, P7-56,POB 999, Richland, WA 99352 USA.	karin.rodland@pnl.gov	Rodland, Karin/R-6186-2019	Wiley, Steven/0000-0003-0232-6867	National Institutes of Health, NCI, [CA 46413]; Biomolecular Systems Initiative Laboratory Directed Research; Pacific Northwest National Laboratory; Department of Energy [DE-AC05-76RL01830]; Gastrointestinal Special Program of Research Excellence [P50 95103]; NATIONAL CANCER INSTITUTE [P50CA095103, R01CA046413] Funding Source: NIH RePORTER	National Institutes of Health, NCI,(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Biomolecular Systems Initiative Laboratory Directed Research; Pacific Northwest National Laboratory(United States Department of Energy (DOE)); Department of Energy(United States Department of Energy (DOE)); Gastrointestinal Special Program of Research Excellence; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health, NCI, Grant CA 46413 (to R. J. C.). This work was also supported by the Biomolecular Systems Initiative Laboratory Directed Research and Development Program at the Pacific Northwest National Laboratory, a multiprogram national laboratory operated by Battelle for the United States Department of Energy under Contract DE-AC05-76RL01830 and by Gastrointestinal Special Program of Research Excellence Grant P50 95103 (to R. J. C.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Al-Obeidi FA, 2000, ONCOGENE, V19, P5690, DOI 10.1038/sj.onc.1203926; BAND V, 1989, P NATL ACAD SCI USA, V86, P1249, DOI 10.1073/pnas.86.4.1249; BERCHERER JD, 2003, CURR TOP DEV BIOL, V54, P2031; Brown PD, 1998, BREAST CANCER RES TR, V52, P125, DOI 10.1023/A:1006119319695; Chen WNU, 2004, J BIOL CHEM, V279, P18488, DOI 10.1074/jbc.M310874200; Daub H, 1997, EMBO J, V16, P7032, DOI 10.1093/emboj/16.23.7032; deRooij J, 1997, ONCOGENE, V14, P623, DOI 10.1038/sj.onc.1201005; DeWitt A, 2002, DEV BIOL, V250, P305, DOI 10.1006/dbio.2002.0807; Diaz-Rodriguez E, 2002, MOL BIOL CELL, V13, P2031, DOI 10.1091/mbc.01-11-0561; Dong JY, 2005, MOL BIOL CELL, V16, P2984, DOI 10.1091/mbc.E04-11-0994; Dong JY, 2000, J BIOL CHEM, V275, P557, DOI 10.1074/jbc.275.1.557; Dong JY, 1999, P NATL ACAD SCI USA, V96, P6235, DOI 10.1073/pnas.96.11.6235; Dreesen O, 2007, STEM CELL REV, V3, P7, DOI 10.1007/s12015-007-0004-8; El-Shewy HM, 2004, MOL ENDOCRINOL, V18, P2727, DOI 10.1210/me.2004-0174; Fan HZ, 1999, EMBO J, V18, P6962, DOI 10.1093/emboj/18.24.6962; Fischer OM, 2003, BIOCHEM SOC T, V31, P1203; Gschwind A, 2001, ONCOGENE, V20, P1594, DOI 10.1038/sj.onc.1204192; Gschwind A, 2003, EMBO J, V22, P2411, DOI 10.1093/emboj/cdg231; Hart S, 2005, BIOL CHEM, V386, P845, DOI 10.1515/BC.2005.099; Hendriks BS, 2005, J BIOL CHEM, V280, P6157, DOI 10.1074/jbc.M410491200; Jacobs JM, 2004, J PROTEOME RES, V3, P68, DOI 10.1021/pr034062a; Klapper LN, 1999, P NATL ACAD SCI USA, V96, P4995, DOI 10.1073/pnas.96.9.4995; Kue PF, 2002, INT J CANCER, V102, P572, DOI 10.1002/ijc.10734; Lauffenburger DA, 1998, P NATL ACAD SCI USA, V95, P15368, DOI 10.1073/pnas.95.26.15368; Lee DC, 2003, ANN NY ACAD SCI, V995, P22, DOI 10.1111/j.1749-6632.2003.tb03207.x; Liu T, 2005, PROTEOMICS, V5, P1263, DOI 10.1002/pmic.200401055; McKay MM, 2007, ONCOGENE, V26, P3113, DOI 10.1038/sj.onc.1210394; Merchant NB, 2005, SURGERY, V138, P415, DOI 10.1016/j.surg.2005.06.030; MITAMURA T, 1995, J BIOL CHEM, V270, P1015, DOI 10.1074/jbc.270.3.1015; Monine MI, 2005, BIOPHYS J, V88, P2384, DOI 10.1529/biophysj.104.051425; Montero JC, 2002, BIOCHEM J, V363, P211, DOI 10.1042/0264-6021:3630211; Ohtsu H, 2006, ARTERIOSCL THROM VAS, V26, pE133, DOI 10.1161/01.ATV.0000236203.90331.d0; Pierce KL, 2001, J BIOL CHEM, V276, P23155, DOI 10.1074/jbc.M101303200; Prenzel N, 1999, NATURE, V402, P884, DOI 10.1038/47260; Roudabush FL, 2000, J BIOL CHEM, V275, P22583, DOI 10.1074/jbc.M002915200; Sampaio C, 2008, MOL CELL BIOL, V28, P587, DOI 10.1128/MCB.01318-07; Santiskulvong C, 2003, EXP CELL RES, V290, P437, DOI 10.1016/S0014-4827(03)00355-0; Schafer B, 2004, ONCOGENE, V23, P991, DOI 10.1038/sj.onc.1207278; Shah BH, 2003, J BIOL CHEM, V278, P19118, DOI 10.1074/jbc.M212932200; Shankaran H, 2006, BIOPHYS J, V90, P3993, DOI 10.1529/biophysj.105.080580; Solorzano CC, 1997, SHOCK, V7, P427, DOI 10.1097/00024382-199706000-00007; Stampfer M R, 1988, Cancer Treat Res, V40, P1; STAMPFER MR, 1993, CANCER SURV, V18, P7; Stortelers C, 2003, J BIOL CHEM, V278, P12055, DOI 10.1074/jbc.M211948200; Tomlins SA, 2005, EXP CELL RES, V308, P439, DOI 10.1016/j.yexcr.2005.04.032; Vacca F, 2000, CANCER RES, V60, P5310; Wiley HS, 2003, TRENDS CELL BIOL, V13, P43; Wolf-Yadlin A, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100094; Wu WD, 2002, J BIOL CHEM, V277, P24252, DOI 10.1074/jbc.M200437200; Xi SC, 2003, J BIOL CHEM, V278, P31574, DOI 10.1074/jbc.M303499200; Yan YB, 2002, J CELL BIOL, V158, P221, DOI 10.1083/jcb.200112026; Zhang Q, 2004, CANCER RES, V64, P6166, DOI 10.1158/0008-5472.CAN-04-0504; Zhang Y, 2005, MOL CELL PROTEOMICS, V4, P1240, DOI 10.1074/mcp.M500089-MCP200; Zwick E, 1999, TRENDS PHARMACOL SCI, V20, P408, DOI 10.1016/S0165-6147(99)01373-5	54	47	47	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 14	2008	283	46					31477	31487		10.1074/jbc.M800456200	http://dx.doi.org/10.1074/jbc.M800456200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	370KJ	18782770	hybrid, Green Published			2022-12-27	WOS:000260760800027
J	Shi, W; Ma, ZF; Willers, H; Akhtar, K; Scott, SP; Zhang, JQ; Powell, S; Zhang, JR				Shi, Wei; Ma, Zhefu; Willers, Henning; Akhtar, Kamal; Scott, Shaun P.; Zhang, Jiuqin; Powell, Simon; Zhang, Junran			Disassembly of MDC1 Foci Is Controlled by Ubiquitin-Proteasome-dependent Degradation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-DAMAGE RESPONSE; DOUBLE-STRAND BREAKS; REPAIR PROTEINS; HOMOLOGOUS RECOMBINATION; CONJUGATED UBIQUITIN; SIGNALING PATHWAYS; MAMMALIAN-CELLS; HISTONE H2AX; REPLICATION; CHECKPOINT	The orderly recruitment, retention, and disassembly of DNA damage response proteins at sites of damaged DNA is a conserved process throughout eukaryotic evolution. The recruitment and retention of DNA repair factors in foci is mediated by a complex network of protein-protein interactions; however, the mechanisms of focus disassembly remain to be defined. Mediator of DNA damage checkpoint protein 1 (MDC1) is an early and key component of the genome surveillance network activated by DNA double-strand breaks (DSBs). Here, we investigated the disassembly of MDC1 foci. First, we show that ubiquitylation directs the MDC1 protein for proteasome-dependent degradation. Ubiquitylated MDC1 associates with chromatin before and after exposure of cells to ionizing radiation (IR). In addition, increased MDC1 ubiquitylation in the chromatin fraction is observed in response to IR, which is correlated with a reduction in total MDC1 protein levels. We demonstrate that blocking MDC1 degradation by proteasome inhibitors leads to a persistence of MDC1 foci. Consistent with this observation, chromatin immunoprecipitation experiments reveal increased MDC1 protein at site-specific DSBs. Interestingly, we show that the persistence of MDC1 foci is associated with an abrogated recruitment of the downstream factor BRCA1 in a manner that is RNF8 independent. Collectively, the evidence presented here supports a novel mechanism for the disassembly of MDC1 foci via ubiquitin-proteasome dependent degradation, which appears to be a key step for the efficient assembly of BRCA1 foci.	[Shi, Wei; Akhtar, Kamal; Scott, Shaun P.; Zhang, Jiuqin; Zhang, Junran] Washington Univ, Sch Med, Dept Radiat Oncol, St Louis, MO 63108 USA; [Ma, Zhefu] Nanchang Univ, Affiliated Hosp 1, Dept Surg, Breast Ctr, Nanchang 330006, Peoples R China; [Willers, Henning] Massachusetts Gen Hosp, Dept Radiat Oncol, Boston, MA 02114 USA; [Powell, Simon] Mem Sloan Kettering Canc Ctr, Dept Radiat Oncol, New York, NY 10065 USA	Washington University (WUSTL); Nanchang University; Harvard University; Massachusetts General Hospital; Memorial Sloan Kettering Cancer Center	Zhang, JR (corresponding author), Washington Univ, Sch Med, Dept Radiat Oncol, 4511 Forest Pk Blvd, St Louis, MO 63108 USA.	jzhang@radonc.wustl.edu	Shi, Wei/AAX-6450-2021	Shi, Wei/0000-0002-0378-8361	Department of Radiation Oncology, Washington University School of Medicine; Dr. Joseph Roti Roti and Stephanie Pagano Fund for Mesothelioma Research [IRG-58-010-51]; American Cancer Society	Department of Radiation Oncology, Washington University School of Medicine; Dr. Joseph Roti Roti and Stephanie Pagano Fund for Mesothelioma Research; American Cancer Society(American Cancer Society)	This work was supported by a seed grant and startup fund from the Department of Radiation Oncology, Washington University School of Medicine, by the Dr. Joseph Roti Roti and Stephanie Pagano Fund for Mesothelioma Research, and by Grant IRG-58-010-51 from the American Cancer Society (to J. Z.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Adori C, 2006, J HISTOCHEM CYTOCHEM, V54, P263, DOI 10.1369/jhc.5B6752.2005; Anton LC, 1999, J CELL BIOL, V146, P113, DOI 10.1083/jcb.146.1.113; Bekker-Jensen S, 2006, J CELL BIOL, V173, P195, DOI 10.1083/jcb.200510130; Bekker-Jensen S, 2005, J CELL BIOL, V170, P201, DOI 10.1083/jcb.200503043; Bin W, 2007, P NATL ACAD SCI USA, V104, P20759, DOI 10.1073/pnas.0710061104; Blickwedehl J, 2007, RADIAT RES, V167, P663, DOI 10.1667/RR0690.1; Callebaut I, 1997, FEBS LETT, V400, P25, DOI 10.1016/S0014-5793(96)01312-9; Chang M, 2002, P NATL ACAD SCI USA, V99, P16934, DOI 10.1073/pnas.262669299; Dimitrova DS, 2000, EXP CELL RES, V254, P321, DOI 10.1006/excr.1999.4770; Essers J, 2002, EMBO J, V21, P2030, DOI 10.1093/emboj/21.8.2030; Everett RD, 2000, J VIROL, V74, P9994, DOI 10.1128/JVI.74.21.9994-10005.2000; Ferguson DO, 2001, ONCOGENE, V20, P5572, DOI 10.1038/sj.onc.1204767; FUJIMURO M, 1994, FEBS LETT, V349, P173, DOI 10.1016/0014-5793(94)00647-4; Gasior SL, 2001, P NATL ACAD SCI USA, V98, P8411, DOI 10.1073/pnas.121046198; Golding SE, 2007, CANCER RES, V67, P1046, DOI 10.1158/0008-5472.CAN-06-2371; Haglund K, 2005, EMBO J, V24, P3353, DOI 10.1038/sj.emboj.7600808; Huang TT, 2006, NAT REV MOL CELL BIO, V7, P323, DOI 10.1038/nrm1908; Huen MSY, 2007, CELL, V131, P901, DOI 10.1016/j.cell.2007.09.041; HUGLE B, 1983, EUR J CELL BIOL, V32, P157; Jackson SP, 2001, BIOCHEM SOC T, V29, P655, DOI 10.1042/BST0290655; Jacquemont C, 2007, CANCER RES, V67, P7395, DOI 10.1158/0008-5472.CAN-07-1015; Kirschner M, 1999, TRENDS CELL BIOL, V9, pM42, DOI 10.1016/S0962-8924(99)01666-9; Kolas NK, 2007, SCIENCE, V318, P1637, DOI 10.1126/science.1150034; Krogan NJ, 2004, MOL CELL, V16, P1027, DOI 10.1016/j.molcel.2004.11.033; Lafarga M, 2002, MOL BIOL CELL, V13, P2771, DOI 10.1091/mbc.E02-03-0122; Lee DH, 1998, TRENDS CELL BIOL, V8, P397, DOI 10.1016/S0962-8924(98)01346-4; Lisby M, 2004, CELL, V118, P699, DOI 10.1016/j.cell.2004.08.015; Lisby M, 2005, BIOCHIMIE, V87, P579, DOI 10.1016/j.biochi.2004.10.023; Lopes M, 2001, NATURE, V412, P557, DOI 10.1038/35087613; Lou ZK, 2006, MOL CELL, V21, P187, DOI 10.1016/j.molcel.2005.11.025; Lou ZK, 2003, NATURE, V421, P957, DOI 10.1038/nature01447; Lou ZK, 2003, J BIOL CHEM, V278, P13599, DOI 10.1074/jbc.C300060200; Lukas C, 2004, EMBO J, V23, P2674, DOI 10.1038/sj.emboj.7600269; Lukas J, 2004, DNA REPAIR, V3, P997, DOI 10.1016/j.dnarep.2004.03.006; MacNeill SA, 2005, CURR BIOL, V15, pR21, DOI 10.1016/j.cub.2004.12.014; Mailand N, 2007, CELL, V131, P887, DOI 10.1016/j.cell.2007.09.040; Mendez J, 2000, MOL CELL BIOL, V20, P8602, DOI 10.1128/MCB.20.22.8602-8612.2000; Mimnaugh EG, 1997, BIOCHEMISTRY-US, V36, P14418, DOI 10.1021/bi970998j; Morris JR, 2004, HUM MOL GENET, V13, P807, DOI 10.1093/hmg/ddh095; Mukhopadhyay A, 2008, NAT PROTOC, V3, P698, DOI 10.1038/nprot.2008.38; Murakawa Y, 2007, CANCER RES, V67, P8536, DOI 10.1158/0008-5472.CAN-07-1166; NISSEN S, 1994, POULTRY SCI, V73, P137, DOI 10.3382/ps.0730137; Ozaki T, 2000, DNA CELL BIOL, V19, P475, DOI 10.1089/10445490050128403; Paull TT, 2000, CURR BIOL, V10, P886, DOI 10.1016/S0960-9822(00)00610-2; Peng AM, 2003, J BIOL CHEM, V278, P8873, DOI 10.1074/jbc.C300001200; Pickart CM, 2004, CURR OPIN CHEM BIOL, V8, P610, DOI 10.1016/j.cbpa.2004.09.009; Pierce AJ, 1999, GENE DEV, V13, P2633, DOI 10.1101/gad.13.20.2633; Reits EAJ, 1997, EMBO J, V16, P6087, DOI 10.1093/emboj/16.20.6087; Rodrigue A, 2006, EMBO J, V25, P222, DOI 10.1038/sj.emboj.7600914; Shang YL, 2003, J BIOL CHEM, V278, P6323, DOI 10.1074/jbc.M210749200; Shiloh Y, 2003, NAT REV CANCER, V3, P155, DOI 10.1038/nrc1011; Sobhian B, 2007, SCIENCE, V316, P1198, DOI 10.1126/science.1139516; SPENCE J, 1995, MOL CELL BIOL, V15, P1265; Stucki M, 2005, CELL, V123, P1213, DOI 10.1016/j.cell.2005.09.038; Tercero JA, 2001, NATURE, V412, P553, DOI 10.1038/35087607; Vassin VM, 2004, MOL CELL BIOL, V24, P1930, DOI 10.1128/MCB.24.5.1930-1943.2004; Vilenchik MM, 2003, P NATL ACAD SCI USA, V100, P12871, DOI 10.1073/pnas.2135498100; von Mikecz A, 2006, J CELL SCI, V119, P1977, DOI 10.1242/jcs.03008; WARD CL, 1995, CELL, V83, P121, DOI 10.1016/0092-8674(95)90240-6; Weissman AM, 2001, NAT REV MOL CELL BIO, V2, P169, DOI 10.1038/35056563; Xu XZ, 2003, J BIOL CHEM, V278, P8795, DOI 10.1074/jbc.M211392200; Zhang D, 2006, CELL, V126, P529, DOI 10.1016/j.cell.2006.06.039; Zhang JR, 2005, NAT STRUCT MOL BIOL, V12, P902, DOI 10.1038/nsmb991	63	53	54	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 14	2008	283	46					31608	31616		10.1074/jbc.M801082200	http://dx.doi.org/10.1074/jbc.M801082200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	370KJ	18757370	hybrid			2022-12-27	WOS:000260760800041
J	Kawamura, S; Hervold, K; Ramirez-Weber, FA; Kornberg, TB				Kawamura, Shiho; Hervold, Kieran; Ramirez-Weber, Felipe-Andres; Kornberg, Thomas B.			Two Patched Protein Subtypes and a Conserved Domain of Group I Proteins That Regulates Turnover	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEDGEHOG SIGNAL-TRANSDUCTION; MULTIPLE SEQUENCE ALIGNMENT; STEROL-SENSING DOMAIN; SONIC HEDGEHOG; SUBCELLULAR-LOCALIZATION; VESICULAR TRAFFICKING; HUMAN HOMOLOG; GENE; DROSOPHILA; MUTATIONS	Patched (Ptc) is a 12-cross membrane protein that binds the secreted Hedgehog protein. Its regulation of the Hedgehog signaling pathway is critical to normal development and to a number of human diseases. This report analyzes features of sequence similarity and divergence in the Ptc protein family and identifies two subtypes distinguished by novel conserved domains. We used these results to propose a rational basis for classification. We show that one of the conserved sequence regions in the C-terminal domain of Ptch1 is responsible, at least in part, for rapid turnover. This sequence is absent in the stable Ptch2 protein.	[Kawamura, Shiho; Kornberg, Thomas B.] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94158 USA; [Kawamura, Shiho; Hervold, Kieran; Ramirez-Weber, Felipe-Andres] San Francisco State Univ, Dept Biol, San Francisco, CA 94132 USA	University of California System; University of California San Francisco; California State University System; San Francisco State University	Kornberg, TB (corresponding author), Univ Calif San Francisco, Dept Biochem & Biophys, 1550 4th St, San Francisco, CA 94158 USA.	tkornberg@ucsf.edu			National Institutes of Health [GM077407]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM077407] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM077407 (to T.B.K.).	Bijlsma MF, 2006, PLOS BIOL, V4, P1397, DOI 10.1371/journal.pbio.0040232; Briscoe J, 2001, MOL CELL, V7, P1279, DOI 10.1016/S1097-2765(01)00271-4; Burge C, 1997, J MOL BIOL, V268, P78, DOI 10.1006/jmbi.1997.0951; CAPDEVILA J, 1994, DEVELOPMENT, V120, P987; Carpenter D, 1998, P NATL ACAD SCI USA, V95, P13630, DOI 10.1073/pnas.95.23.13630; Carstea ED, 1997, SCIENCE, V277, P228, DOI 10.1126/science.277.5323.228; Clamp M, 2004, BIOINFORMATICS, V20, P426, DOI 10.1093/bioinformatics/btg430; Corcoran RB, 2006, P NATL ACAD SCI USA, V103, P8408, DOI 10.1073/pnas.0602852103; Denef N, 2000, CELL, V102, P521, DOI 10.1016/S0092-8674(00)00056-8; Dwyer JR, 2007, J BIOL CHEM, V282, P8959, DOI 10.1074/jbc.M611741200; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Fuse N, 1999, P NATL ACAD SCI USA, V96, P10992, DOI 10.1073/pnas.96.20.10992; Hahn H, 1996, CELL, V85, P841, DOI 10.1016/S0092-8674(00)81268-4; Hua XX, 1996, CELL, V87, P415, DOI 10.1016/S0092-8674(00)81362-8; Incardona JP, 2002, CURR BIOL, V12, P983, DOI 10.1016/S0960-9822(02)00895-3; INGHAM PW, 1991, NATURE, V353, P184, DOI 10.1038/353184a0; Johnson RL, 1996, SCIENCE, V272, P1668, DOI 10.1126/science.272.5268.1668; Kent WJ, 2003, P NATL ACAD SCI USA, V100, P11484, DOI 10.1073/pnas.1932072100; Lee Y, 2006, CANCER RES, V66, P6964, DOI 10.1158/0008-5472.CAN-06-0505; Lindstrom E, 2006, HUM MUTAT, V27, P215, DOI 10.1002/humu.20296; Lu XW, 2006, GENE DEV, V20, P2539, DOI 10.1101/gad.1461306; Marigo V, 1996, NATURE, V384, P176, DOI 10.1038/384176a0; Martin V, 2001, CURR BIOL, V11, P601, DOI 10.1016/S0960-9822(01)00178-6; Murakami S, 2002, NATURE, V419, P587, DOI 10.1038/nature01050; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Osborne TF, 1998, CURR OPIN LIPIDOL, V9, P137, DOI 10.1097/00041433-199804000-00010; Parra G, 2000, GENOME RES, V10, P511, DOI 10.1101/gr.10.4.511; Stanke M, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-62; Stone DM, 1996, NATURE, V384, P129, DOI 10.1038/384129a0; Strutt H, 2001, CURR BIOL, V11, P608, DOI 10.1016/S0960-9822(01)00179-8; Taipale J, 2002, NATURE, V418, P892, DOI 10.1038/nature00989; Tseng Tsai-Tien, 1999, Journal of Molecular Microbiology and Biotechnology, V1, P107; Zhu AJ, 2003, GENE DEV, V17, P1240, DOI 10.1101/gad.1080803	33	15	16	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 7	2008	283	45					30964	30969		10.1074/jbc.M806242200	http://dx.doi.org/10.1074/jbc.M806242200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	367ID	18768465	Green Published, hybrid			2022-12-27	WOS:000260544800051
J	Lin, JJ; Xu, P; LaVallee, P; Hoidal, JR				Lin, Junji; Xu, Ping; LaVallee, Patricia; Hoidal, John R.			Identification of Proteins Binding to E-Box/Ku86 Sites and Function of the Tumor Suppressor SAFB1 in Transcriptional Regulation of the Human Xanthine Oxidoreductase Gene	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RENAL EPITHELIAL-CELLS; BREAST-CANCER; URIC-ACID; OXIDASE ACTIVITY; MAMMARY-GLAND; NITRIC-OXIDE; DNA-BINDING; RAT-LIVER; DEHYDROGENASE GENE; MOLECULAR-CLONING	The xanthine oxidoreductase gene (XOR) encodes an important source of reactive oxygen species and uric acid, and its expression is associated with various human diseases including several forms of cancer. We previously reported that basal human XOR (hXOR) expression is restricted or repressed by E-box and TATA-like elements and a cluster of transcriptional proteins, including AREB6-like proteins and DNA-dependent protein kinase (DNA-PK). We now demonstrate that the cluster contains the tumor suppressors SAFB1, BRG1, and SAF-A. We further demonstrate that SAFB1 silencing increases hXOR expression and that SAFB1 directly binds to the E-box. Multiple studies in vitro and in vivo including pull-down, immunoprecipitation and chromatin immunoprecipitation analyses indicate that SAFB1, Ku86, and BRG1 associate with each other. The results suggest that the SAFB1 complex binds to the hXOR promoter in a chromatin environment and plays a critical role in restricting hXOR expression via its direct interaction with the E-box, DNA-PK, and tumor suppressors. Moreover, we demonstrate that the cytokine, oncostatinM(OSM), induces the phosphorylation of SAFB1 and that the OSM-induced hXOR mRNA expression is significantly inhibited by silencing the DNA-PK catalytic subunit or SAFB1 expression. The present studies for the first time demonstrate that hXOR is a tumor suppressor-targeted gene and that the phosphorylation of SAFB1 is regulated by OSM, providing a molecular basis for understanding the role of SAFB1-regulated hXOR transcription in cytokine stimulation and tumorigenesis.	[Lin, Junji; Xu, Ping] Fudan Univ, State Key Lab Neurosci, Lab Genom Physiol, Shanghai 200032, Peoples R China; [Xu, Ping; LaVallee, Patricia; Hoidal, John R.] Univ Utah, Dept Internal Med, Div Resp Crit Care & Occupat Med, Hlth Sci Ctr, Salt Lake City, UT 84132 USA; [Xu, Ping; LaVallee, Patricia; Hoidal, John R.] Vet Affairs Med Ctr, Salt Lake City, UT 84132 USA	Fudan University; Utah System of Higher Education; University of Utah; US Department of Veterans Affairs; Veterans Health Administration (VHA)	Xu, P (corresponding author), Fudan Univ, State Key Lab Neurosci, Lab Genom Physiol, Shanghai 200032, Peoples R China.	matibuck@yahoo.com; john.hoidal@hsc.utah.edu			National Institutes of Health [5RO1HL40665]; Veterans Administration Research Service; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL040665] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veterans Administration Research Service(US Department of Veterans Affairs); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant 5RO1HL40665. This work was also supported by the Veterans Administration Research Service. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	ABADEH S, 1992, BIOCHIM BIOPHYS ACTA, V1117, P25, DOI 10.1016/0304-4165(92)90157-P; AKAIKE T, 1990, J CLIN INVEST, V85, P739, DOI 10.1172/JCI114499; AMAYA Y, 1990, J BIOL CHEM, V265, P14170; Ambrosone CB, 2000, ANTIOXID REDOX SIGN, V2, P903, DOI 10.1089/ars.2000.2.4-903; AMES BN, 1981, P NATL ACAD SCI-BIOL, V78, P6858, DOI 10.1073/pnas.78.11.6858; ANDREWS NC, 1991, NUCLEIC ACIDS RES, V19, P2499, DOI 10.1093/nar/19.9.2499; ATHAR M, 1989, J CLIN INVEST, V83, P1137, DOI 10.1172/JCI113993; BECKER BF, 1989, PFLUG ARCH EUR J PHY, V415, P127, DOI 10.1007/BF00370582; Berry CE, 2004, J PHYSIOL-LONDON, V555, P589, DOI 10.1113/jphysiol.2003.055913; Bonifacino J.S., 2001, CURR PROTOC MOL BIOL, V10; Castro GD, 2001, TOXICOLOGY, V160, P11, DOI 10.1016/S0300-483X(00)00433-9; Chae YH, 1999, CHEM RES TOXICOL, V12, P180, DOI 10.1021/tx9802318; Cheung KJ, 2007, CELL METAB, V5, P115, DOI 10.1016/j.cmet.2007.01.005; COWELL IG, 1994, TRENDS BIOCHEM SCI, V19, P38, DOI 10.1016/0968-0004(94)90172-4; DAVIES KJA, 1986, BIOCHEM J, V235, P747, DOI 10.1042/bj2350747; Decker T, 2000, ONCOGENE, V19, P2628, DOI 10.1038/sj.onc.1203481; DIAMOND JR, 1986, KIDNEY INT, V29, P478, DOI 10.1038/ki.1986.24; Dizdaroglu M, 2002, FREE RADICAL BIO MED, V32, P1102, DOI 10.1016/S0891-5849(02)00826-2; Donovan J, 2000, BREAST CANCER RES, V2, P116, DOI 10.1186/bcr43; DUPONT GP, 1992, J CLIN INVEST, V89, P197, DOI 10.1172/JCI115563; Elend M, 1999, CURR BIOL, V9, pR936, DOI 10.1016/S0960-9822(00)80109-8; FALCIANI F, 1992, BIOCHEM J, V285, P1001, DOI 10.1042/bj2851001; FINNIE N, 1993, BIOCHEM SOC T, V21, P930, DOI 10.1042/bst0210930; Fu YP, 2003, CANCER RES, V63, P2440; Gasco M, 2002, BREAST CANCER RES, V4, P70, DOI 10.1186/bcr426; GIFFIN W, 1994, J BIOL CHEM, V269, P1449; Giffin W, 1999, MOL CELL BIOL, V19, P4065; GRANGER DN, 1988, AM J PHYSIOL, V255, pH1269, DOI 10.1152/ajpheart.1988.255.6.H1269; HannaRose W, 1996, TRENDS GENET, V12, P229, DOI 10.1016/0168-9525(96)10022-6; Harrison R, 1997, BIOCHEM SOC T, V25, P786, DOI 10.1042/bst0250786; Harrison R, 2002, FREE RADICAL BIO MED, V33, P774, DOI 10.1016/S0891-5849(02)00956-5; HASSOUN PM, 1994, AM J PHYSIOL, V266, pL163, DOI 10.1152/ajplung.1994.266.2.L163; Hendricks KB, 2004, MOL CELL BIOL, V24, P362, DOI 10.1128/MCB.24.1.362-376.2004; HOWELL RR, 1960, J BIOL CHEM, V235, P3544; Hu DE, 2004, CANCER RES, V64, P5059, DOI 10.1158/0008-5472.CAN-04-1586; IKEDA K, 1995, EUR J BIOCHEM, V233, P73, DOI 10.1111/j.1432-1033.1995.073_1.x; Kang Duck-Hee, 2002, AACN Clin Issues, V13, P540, DOI 10.1097/00044067-200211000-00007; KAWAMURA T, 1991, KIDNEY INT, V40, P291, DOI 10.1038/ki.1991.213; Kaynar H, 2005, CANCER LETT, V227, P133, DOI 10.1016/j.canlet.2004.12.005; Khan SA, 2004, P NATL ACAD SCI USA, V101, P15944, DOI 10.1073/pnas.0404136101; Klaunig JE, 2004, ANNU REV PHARMACOL, V44, P239, DOI 10.1146/annurev.pharmtox.44.101802.121851; KNAUS UG, 1991, SCIENCE, V254, P1512, DOI 10.1126/science.1660188; Kopnin BP, 2000, BIOCHEMISTRY-MOSCOW+, V65, P2; LINAS SL, 1990, AM J PHYSIOL, V258, pF711, DOI 10.1152/ajprenal.1990.258.3.F711; MASSEY V, 1969, J BIOL CHEM, V244, P1682; Miyamoto Y, 1996, P SOC EXP BIOL MED, V211, P366; MUXFELDT M, 1987, BASIC RES CARDIOL, V82, P486, DOI 10.1007/BF01907096; Oesterreich S, 2001, BRIT J CANCER, V84, P493, DOI 10.1054/bjoc.2000.1606; Ohtsubo T, 2004, CIRC RES, V95, P1118, DOI 10.1161/01.RES.0000149571.96304.36; PALLER MS, 1991, KIDNEY INT, V40, P1041, DOI 10.1038/ki.1991.312; PEDEN DB, 1990, P NATL ACAD SCI USA, V87, P7638, DOI 10.1073/pnas.87.19.7638; PFEFFER KD, 1994, J IMMUNOL, V153, P1789; Pharoah PDP, 1999, BRIT J CANCER, V80, P1968, DOI 10.1038/sj.bjc.6690628; Reisman DN, 2003, CANCER RES, V63, P560; Renz A, 1996, NUCLEIC ACIDS RES, V24, P843, DOI 10.1093/nar/24.5.843; Ritter CL, 2002, CHEM RES TOXICOL, V15, P536, DOI 10.1021/tx010172p; Ritter CL, 2000, CHEM RES TOXICOL, V13, P793, DOI 10.1021/tx0000567; RODELL TC, 1987, J APPL PHYSIOL, V63, P2159, DOI 10.1152/jappl.1987.63.5.2159; ROMIG H, 1992, EMBO J, V11, P3431, DOI 10.1002/j.1460-2075.1992.tb05422.x; Rosen EM, 2003, J CELL PHYSIOL, V196, P19, DOI 10.1002/jcp.10257; Ross JS, 2003, EXPERT REV MOL DIAGN, V3, P573, DOI 10.1586/14737159.3.5.573; SANDERS KA, 1999, CHEST S1, V116, P56; Sanders SA, 1997, EUR J BIOCHEM, V245, P541, DOI 10.1111/j.1432-1033.1997.00541.x; Schild-Poulter C, 2001, J BIOL CHEM, V276, P16848, DOI 10.1074/jbc.M100768200; Sears RC, 2002, J BIOL CHEM, V277, P11617, DOI 10.1074/jbc.R100063200; Sen CK, 1996, FASEB J, V10, P709, DOI 10.1096/fasebj.10.7.8635688; Shi Y, 2003, NATURE, V425, P516, DOI 10.1038/nature01991; Slot O, 1994, Ugeskr Laeger, V156, P2396; Smith GCM, 1999, GENE DEV, V13, P916, DOI 10.1101/gad.13.8.916; SULCINER DJ, 1996, BIOCHEM J, V318, P379; Tsao SM, 2007, NUTR CANCER, V59, P8, DOI 10.1080/01635580701365043; Vorbach C, 2002, GENE DEV, V16, P3223, DOI 10.1101/gad.1032702; WAJNER M, 1989, BIOCHIM BIOPHYS ACTA, V991, P79, DOI 10.1016/0304-4165(89)90031-7; WAUD WR, 1976, ARCH BIOCHEM BIOPHYS, V172, P365, DOI 10.1016/0003-9861(76)90088-6; Wright RM, 1999, FREE RADICAL BIO MED, V26, P348, DOI 10.1016/S0891-5849(98)00204-4; Xu P, 2000, J BIOL CHEM, V275, P5918, DOI 10.1074/jbc.275.8.5918; XU P, 1994, GENOMICS, V23, P289, DOI 10.1006/geno.1994.1498; Xu P, 1996, GENOMICS, V34, P173, DOI 10.1006/geno.1996.0262; Xu P, 2004, J BIOL CHEM, V279, P16057, DOI 10.1074/jbc.M305856200; XU P, 1994, BIOCHEM BIOPH RES CO, V199, P998, DOI 10.1006/bbrc.1994.1328	80	21	23	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 31	2008	283	44					29681	29689		10.1074/jbc.M802076200	http://dx.doi.org/10.1074/jbc.M802076200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	364WS	18772145	Green Published, hybrid			2022-12-27	WOS:000260366900011
J	Martinez, HD; Jasavala, RJ; Hinkson, I; Fitzgerald, LD; Trimmer, JS; Kung, HJ; Wright, ME				Martinez, Harryl D.; Jasavala, Rohini J.; Hinkson, Izumi; Fitzgerald, Latricia D.; Trimmer, James S.; Kung, Hsing-Jien; Wright, Michael E.			RNA Editing of Androgen Receptor Gene Transcripts in Prostate Cancer Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIGAND-BINDING DOMAIN; MOLECULAR CHARACTERIZATION; LNCAP CELLS; LINE LNCAP; CARCINOMA; MUTATIONS; PROLIFERATION; CWR22; PC-3; DNA	Reactivation of the androgen receptor (AR) signaling pathway represents a critical step in the growth and survival of androgen-independent (AI) prostate cancer (CaP). In this study we show the DU145 and PC3 AI human CaP cell lines respond to androgens and require AR expression for optimal proliferation in vitro. Interestingly, AR gene transcripts in DU145 and PC3 cells harbored a large number of single base pair nucleotide transitions that resulted in missense mutations in selected AR codons. The most notable lesion detected in AR gene transcripts included the oncogenic codon 877T -> Again-of-function mutation. Surprisingly, AR gene transcript nucleotide transitions were not genome-encoded substitutions, but instead the mutations co-localized to putative A-to-I, U-to-C, C-to-U, and G-to-A RNA editing sites, suggesting the lesions were mediated through RNA editing mechanisms. Higher levels of mRNA encoding the A-to-I RNA editing enzymes ADAR1 and ADARB1 were observed in DU145 and PC3 cells relative to the androgen-responsive LNCaP and 22Rv1 human CaP cell lines, which correlated with higher levels of AR gene transcript A-to-I editing detected in DU145 and PC3 cells. Our results suggest that AR gene transcripts are targeted by different RNA editing enzymes in DU145 and PC3 cells. Thus RNA editing of AR gene transcripts may contribute to the etiology of hormone-refractory phenotypes in advanced stage AI CaP.	[Martinez, Harryl D.; Jasavala, Rohini J.; Hinkson, Izumi; Wright, Michael E.] Univ Calif Davis, Genome Ctr, Dept Pharmacol, Davis, CA 95616 USA; [Fitzgerald, Latricia D.; Kung, Hsing-Jien] Calif State Univ Sacramento, Sch Med, Univ Calif Davis Canc Ctr, Dept Biochem & Mol Med, Sacramento, CA 95817 USA; [Trimmer, James S.] Univ Calif Davis, Coll Biol Sci, Dept Neurobiol Physiol & Behav, Davis, CA 95616 USA; [Trimmer, James S.] Univ Calif Davis, Sch Med, Dept Physiol & Membrane Biol, Davis, CA 95616 USA	University of California System; University of California Davis; California State University System; California State University Sacramento; University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis	Wright, ME (corresponding author), Univ Calif Davis, Genome Ctr, Dept Pharmacol, SOM,451 E Hlth Sci Dr,GBSF 4511,1 Shields Ave, Davis, CA 95616 USA.	mewright@ucdavis.edu	Kung, Hsing-Jien/C-7651-2013	Wright, Michael/0000-0002-4243-2931				Alimirah F, 2006, FEBS LETT, V580, P2294, DOI 10.1016/j.febslet.2006.03.041; Athanasiadis A, 2004, PLOS BIOL, V2, P2144, DOI 10.1371/journal.pbio.0020391; Bass BL, 2002, ANNU REV BIOCHEM, V71, P817, DOI 10.1146/annurev.biochem.71.110601.135501; BERNS EMJJ, 1986, PROSTATE, V9, P247, DOI 10.1002/pros.2990090305; Bourara K, 2000, SCIENCE, V289, P1564, DOI 10.1126/science.289.5484.1564; Buchanan G, 2001, CLIN CANCER RES, V7, P1273; Chlenski A, 2001, PROSTATE, V47, P66; Clegg N, 2003, PROSTATE, V55, P55, DOI 10.1002/pros.10217; CULIG Z, 1993, PROSTATE, V22, P11, DOI 10.1002/pros.2990220103; Duff J, 2005, MOL ENDOCRINOL, V19, P2943, DOI 10.1210/me.2005-0231; ECHAN LA, 1996, CURRENT PROTOCOLS PR; Gottlieb B, 1998, NUCLEIC ACIDS RES, V26, P234, DOI 10.1093/nar/26.1.234; HIGUCHI M, 1993, CELL, V75, P1361, DOI 10.1016/0092-8674(93)90622-W; Hiort O, 1998, J PEDIATR-US, V132, P939, DOI 10.1016/S0022-3476(98)70387-7; Jasavala R, 2007, MOL CELL PROTEOMICS, V6, P252, DOI 10.1074/mcp.M600169-MCP200; KAIGHN ME, 1979, INVEST UROL, V17, P16; Kawahara Y, 2007, SCIENCE, V315, P1137, DOI 10.1126/science.1138050; KINGSTON RE, 1987, CURRENT PROTOCOLS MO; Kohany O, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-474; Lacroix M, 2008, INT J CANCER, V122, P1, DOI 10.1002/ijc.23233; LANGELER EG, 1993, PROSTATE, V23, P213, DOI 10.1002/pros.2990230304; Litvinov IV, 2006, P NATL ACAD SCI USA, V103, P15085, DOI 10.1073/pnas.0603057103; Litvinov IV, 2006, PROSTATE, V66, P1329, DOI 10.1002/pros.20483; Marcelli M, 2000, CANCER RES, V60, P944; Miyamoto H, 2004, PROSTATE, V61, P332, DOI 10.1002/pros.20115; Nishikura K, 2006, NAT REV MOL CELL BIO, V7, P919, DOI 10.1038/nrm2061; Richter E, 2007, PROSTATE CANCER P D, V10, P114, DOI 10.1038/sj.pcan.4500936; Sathya G, 2003, CANCER RES, V63, P8029; Shah RB, 2004, CANCER RES, V64, P9209, DOI 10.1158/0008-5472.CAN-04-2442; Sobel RE, 2005, J UROLOGY, V173, P342, DOI 10.1097/01.ju.0000141580.30910.57; STONE KR, 1978, INT J CANCER, V21, P274, DOI 10.1002/ijc.2910210305; Sun C, 2006, ONCOGENE, V25, P3905, DOI 10.1038/sj.onc.1209424; Tan J, 1997, MOL ENDOCRINOL, V11, P450, DOI 10.1210/me.11.4.450; Tepper CG, 2002, CANCER RES, V62, P6606; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; TILLEY WD, 1990, CANCER RES, V50, P5382; van Bokhoven A, 2003, PROSTATE, V57, P205, DOI 10.1002/pros.10290; VELDSCHOLTE J, 1990, BIOCHEM BIOPH RES CO, V173, P534, DOI 10.1016/S0006-291X(05)80067-1; Wright ME, 2003, MOL ENDOCRINOL, V17, P1726, DOI 10.1210/me.2003-0031; Yang WD, 2005, J BIOL CHEM, V280, P3946, DOI 10.1074/jbc.M407876200; YUAN SX, 1993, CANCER RES, V53, P1304; Yuan X, 2006, AM J PATHOL, V169, P682, DOI 10.2353/ajpath.2006.051047; Zegarra-Moro OL, 2002, CANCER RES, V62, P1008; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	44	36	39	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 31	2008	283	44					29938	29949		10.1074/jbc.M800534200	http://dx.doi.org/10.1074/jbc.M800534200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	364WS	18708348	Green Published, hybrid			2022-12-27	WOS:000260366900039
J	Walliser, C; Retlich, M; Harris, R; Everett, KL; Josephs, MB; Vatter, P; Esposito, D; Driscoll, PC; Katan, M; Gierschik, P; Bunney, TD				Walliser, Claudia; Retlich, Michael; Harris, Richard; Everett, Katy L.; Josephs, Michelle B.; Vatter, Petra; Esposito, Diego; Driscoll, Paul C.; Katan, Matilda; Gierschik, Peter; Bunney, Tom D.			Rac Regulates Its Effector Phospholipase C gamma(2) through Interaction with a Split Pleckstrin Homology Domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ISOZYME-SPECIFIC STIMULATION; BETA-GAMMA DIMERS; B-CELL; C-EPSILON; RHO GTPASES; CHEMICAL-SHIFT; PROTEIN; ACTIVATION; C-BETA(2); RECEPTOR	Several isoforms of phospholipase C (PLC) are regulated through interactions with Ras superfamily GTPases, including Rac proteins. Interestingly, of two closely related PLC gamma isoforms, only PLC gamma(2) has previously been shown to be activated by Rac. Here, we explore the molecular basis of this interaction as well as the structural properties of PLC gamma(2) required for activation. Based on reconstitution experiments with isolated PLC gamma variants and Rac2, we show that an unusual pleckstrin homology (PH) domain, designated as the split PH domain (spPH), is both necessary and sufficient to effect activation of PLC gamma(2) by Rac2. We also demonstrate that Rac2 directly binds to PLC gamma(2) as well as to the isolated spPH of this isoform. Furthermore, through the use of NMR spectroscopy and mutational analysis, we determine the structure of spPH, define the structural features of spPH required for Rac interaction, and identify critical amino acid residues at the interaction interface. We further discuss parallels and differences between PLC gamma(1) and PLC gamma(2) and the implications of our findings for their respective signaling roles.	[Everett, Katy L.; Josephs, Michelle B.; Katan, Matilda; Bunney, Tom D.] Inst Canc Res, Chester Beatty Labs, Canc Res UK Ctr Cell & Mol Biol, London SW3 6JB, England; [Walliser, Claudia; Retlich, Michael; Vatter, Petra; Gierschik, Peter] Univ Ulm, Med Ctr, Inst Pharmacol & Toxicol, D-89070 Ulm, Germany; [Harris, Richard; Driscoll, Paul C.] UCL, Div Biosci, Inst Struct & Mol Biol, London WC1E 6BT, England; [Esposito, Diego; Driscoll, Paul C.] Natl Inst Med Res, MRC, Div Mol Struct, London NW7 1AA, England	Cancer Research UK; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; Ulm University; University of London; Birkbeck University London; University College London; MRC National Institute for Medical Research	Bunney, TD (corresponding author), Inst Canc Res, Chester Beatty Labs, Canc Res UK Ctr Cell & Mol Biol, Fulham Rd, London SW3 6JB, England.	tom.bunney@icr.ac.uk	Driscoll, Paul C/B-8007-2010	Driscoll, Paul C/0000-0002-4124-6950; Harris, Richard/0000-0001-7459-1745; Bunney, Tom/0000-0002-0281-8813	MRC [MC_U117533887] Funding Source: UKRI; Medical Research Council [MC_U117533887, MC_U117574559] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		BOUCHER W, 1996, THESIS U CAMBRIDGE C; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Bunney TD, 2006, MOL CELL, V21, P495, DOI 10.1016/j.molcel.2006.01.008; Bunney TD, 2006, TRENDS CELL BIOL, V16, P640, DOI 10.1016/j.tcb.2006.10.007; CAMPS M, 1990, BIOCHEM J, V271, P743, DOI 10.1042/bj2710743; Carpenter G, 1999, EXP CELL RES, V253, P15, DOI 10.1006/excr.1999.4671; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; DeBell K, 2007, MOL CELL BIOL, V27, P854, DOI 10.1128/MCB.01400-06; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; DIETRICH A, 1992, FEBS LETT, V313, P220, DOI 10.1016/0014-5793(92)81195-R; Dvorsky R, 2004, EMBO REP, V5, P1130, DOI 10.1038/sj.embor.7400293; Frankel P, 2005, EMBO J, V24, P54, DOI 10.1038/sj.emboj.7600497; Geiser M, 2001, BIOTECHNIQUES, V31, P88, DOI 10.2144/01311st05; Harden TK, 2006, ANNU REV PHARMACOL, V46, P355, DOI 10.1146/annurev.pharmtox.46.120604.141223; Horstman DA, 1996, P NATL ACAD SCI USA, V93, P7518, DOI 10.1073/pnas.93.15.7518; Horstman DA, 1999, ARCH BIOCHEM BIOPHYS, V361, P149, DOI 10.1006/abbi.1998.0978; HORTON RM, 1990, BIOTECHNIQUES, V8, P528; Illenberger D, 2000, METHOD ENZYMOL, V325, P167; Illenberger D, 2003, J BIOL CHEM, V278, P8645, DOI 10.1074/jbc.M211971200; Illenberger D, 2003, J BIOL CHEM, V278, P3006, DOI 10.1074/jbc.M208282200; Illenberger D, 1997, EUR J BIOCHEM, V246, P71, DOI 10.1111/j.1432-1033.1997.t01-1-00071.x; Illenberger D, 1998, EMBO J, V17, P6241, DOI 10.1093/emboj/17.21.6241; Inabe K, 2002, FEBS LETT, V514, P260, DOI 10.1016/S0014-5793(02)02375-X; Inabe K, 2002, J EXP MED, V195, P189, DOI 10.1084/jem.20011571; Ishiai M, 1999, IMMUNITY, V10, P117, DOI 10.1016/S1074-7613(00)80012-6; Jezyk MR, 2006, NAT STRUCT MOL BIOL, V13, P1135, DOI 10.1038/nsmb1175; Ji QS, 1997, P NATL ACAD SCI USA, V94, P2999, DOI 10.1073/pnas.94.7.2999; Katan Matilda, 2005, Biochem J, V391, pe7; Kelley GG, 2001, EMBO J, V20, P743, DOI 10.1093/emboj/20.4.743; Kim YJ, 2004, MOL CELL BIOL, V24, P9986, DOI 10.1128/MCB.24.22.9986-9999.2004; KRAULIS PJ, 1989, J MAGN RESON, V84, P627, DOI 10.1016/0022-2364(89)90130-3; Kurosaki T, 2002, NAT REV IMMUNOL, V2, P354, DOI 10.1038/nri801; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lemmon MA, 2000, BIOCHEM J, V350, P1, DOI 10.1042/0264-6021:3500001; Linge JP, 1999, J BIOMOL NMR, V13, P51, DOI 10.1023/A:1008365802830; Matsuda M, 2001, J CELL BIOL, V153, P599, DOI 10.1083/jcb.153.3.599; McAlister MSB, 1996, BIOCHEMISTRY-US, V35, P5982, DOI 10.1021/bi952756u; Mott HR, 1999, NATURE, V399, P384, DOI 10.1038/20732; OFFERMANNS S, 1995, J BIOL CHEM, V270, P15175, DOI 10.1074/jbc.270.25.15175; Piechulek T, 2005, J BIOL CHEM, V280, P38923, DOI 10.1074/jbc.M509396200; Plevin MJ, 2004, J MOL BIOL, V341, P171, DOI 10.1016/j.jmb.2004.05.057; Rebecchi MJ, 2000, PHYSIOL REV, V80, P1291, DOI 10.1152/physrev.2000.80.4.1291; Regunathan J, 2006, J IMMUNOL, V177, P5365, DOI 10.4049/jimmunol.177.8.5365; Rhee SG, 1997, J BIOL CHEM, V272, P15045, DOI 10.1074/jbc.272.24.15045; Rodriguez R, 2001, J BIOL CHEM, V276, P47982, DOI 10.1074/jbc.M107577200; Sekiya F, 2004, J BIOL CHEM, V279, P32181, DOI 10.1074/jbc.M405116200; Sidhu RS, 2005, J BIOL CHEM, V280, P21933, DOI 10.1074/jbc.M412966200; Singh SM, 2003, PROTEIN SCI, V12, P1934, DOI 10.1110/ps.0358803; Snyder JT, 2003, J BIOL CHEM, V278, P21099, DOI 10.1074/jbc.M301418200; Song C, 2001, J BIOL CHEM, V276, P2752, DOI 10.1074/jbc.M008324200; Sorli SC, 2005, ONCOGENE, V24, P90, DOI 10.1038/sj.onc.1208168; Teo HL, 2006, CELL, V125, P99, DOI 10.1016/j.cell.2006.01.047; Thompson Gladstone, 1997, Biochemical Society Transactions, V25, p509S; Upshaw JL, 2005, J IMMUNOL, V175, P213, DOI 10.4049/jimmunol.175.1.213; Walmsley MJ, 2003, SCIENCE, V302, P459, DOI 10.1126/science.1089709; Wang DM, 2000, IMMUNITY, V13, P25, DOI 10.1016/S1074-7613(00)00005-4; Wen WY, 2006, J BIOL CHEM, V281, P12060, DOI 10.1074/jbc.M600336200; Wilde JI, 2001, CELL SIGNAL, V13, P691, DOI 10.1016/S0898-6568(01)00191-7; Wing MR, 2003, J BIOL CHEM, V278, P41253, DOI 10.1074/jbc.M306904200; Wing MR, 2001, J BIOL CHEM, V276, P48257, DOI 10.1074/jbc.C100574200; WISHART DS, 1995, J BIOMOL NMR, V6, P135, DOI 10.1007/BF00211777; Wohlgemuth S, 2005, J MOL BIOL, V348, P741, DOI 10.1016/j.jmb.2005.02.048; Yan J, 2005, EMBO J, V24, P3985, DOI 10.1038/sj.emboj.7600858; Zhou C, 1999, J BIOL CHEM, V274, P2786, DOI 10.1074/jbc.274.5.2786	64	45	46	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 31	2008	283	44					30351	30362		10.1074/jbc.M803316200	http://dx.doi.org/10.1074/jbc.M803316200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	364WS	18728011	hybrid, Green Published			2022-12-27	WOS:000260366900079
J	Case, N; Ma, MY; Sen, B; Xie, ZH; Gross, TS; Rubin, J				Case, Natasha; Ma, Meiyun; Sen, Buer; Xie, Zhihui; Gross, Ted S.; Rubin, Janet			beta-Catenin Levels Influence Rapid Mechanical Responses in Osteoblasts	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-B; DOWN-REGULATION; IN-VITRO; WNT; BONE; PHOSPHORYLATION; ACTIVATION; EXPRESSION; CAVEOLIN-1; CYCLOOXYGENASE-2	Mechanical loading of bone initiates an anabolic, anticatabolic pattern of response, yet the molecular events involved in mechanical signal transduction are not well understood. Wnt/beta-catenin signaling has been recognized in promoting bone anabolism, and application of strain has been shown to induce beta-catenin activation. In this work, we have used a preosteoblastic cell line to study the effects of dynamic mechanical strain on beta-catenin signaling. We found that mechanical strain caused a rapid, transient accumulation of active beta-catenin in the cytoplasm and its translocation to the nucleus. This was followed by up-regulation of the Wnt/beta-catenin target genes Wisp1 and Cox2, with peak responses at 4 and 1 h of strain, respectively. The increase of beta-catenin was temporally related to the activation of Akt and subsequent inactivation of GSK3 beta, and caveolin-1 was not required for these molecular events. Application of Dkk-1, which disrupts canonical Wnt/LRP5 signaling, did not block strain-induced nuclear translocation of beta-catenin or up-regulation of Wisp1 and Cox2 expression. Conditions that increased basal beta-catenin levels, such as lithium chloride treatment or repression of caveolin-1 expression, were shown to enhance the effects of strain. In summary, mechanical strain activates Akt and inactivates GSK3 beta to allow beta-catenin translocation, and Wnt signaling through LRP5 is not required for these strain-mediated responses. Thus, beta-catenin serves as both a modulator and effector of mechanical signals in bone cells.	[Case, Natasha; Ma, Meiyun; Sen, Buer; Xie, Zhihui; Rubin, Janet] Univ N Carolina, Dept Med, Chapel Hill, NC 27599 USA; [Gross, Ted S.] Univ Washington, Dept Orthopaed & Sports Med, Seattle, WA 98104 USA	University of North Carolina; University of North Carolina Chapel Hill; University of Washington; University of Washington Seattle	Case, N (corresponding author), Univ N Carolina, Dept Med, 5030 Burnett Womack,CB 7170, Chapel Hill, NC 27599 USA.	ncase@med.unc.edu			National Institutes of Health [AR42360, AR52014]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR042360, R56AR042360, R01AR056655, R01AR052014] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health Grants AR42360 and AR52014. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Araki Y, 2003, CANCER RES, V63, P728; Armstrong VJ, 2007, J BIOL CHEM, V282, P20715, DOI 10.1074/jbc.M703224200; Bilic J, 2007, SCIENCE, V316, P1619, DOI 10.1126/science.1137065; Castellone MD, 2005, SCIENCE, V310, P1504, DOI 10.1126/science.1116221; Cohen P, 2001, NAT REV MOL CELL BIO, V2, P769, DOI 10.1038/35096075; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; Fan M, 2006, J CELL PHYSIOL, V207, P454, DOI 10.1002/jcp.20581; Galbiati F, 1998, EMBO J, V17, P6633, DOI 10.1093/emboj/17.22.6633; Gaur T, 2005, J BIOL CHEM, V280, P33132, DOI 10.1074/jbc.M500608200; Haq S, 2003, P NATL ACAD SCI USA, V100, P4610, DOI 10.1073/pnas.0835895100; Hasaneen NA, 2007, AM J PHYSIOL-LUNG C, V293, pL1059, DOI 10.1152/ajplung.00480.2006; Hedgepeth CM, 1997, DEV BIOL, V185, P82, DOI 10.1006/dbio.1997.8552; Holmen SL, 2005, J BIOL CHEM, V280, P21162, DOI 10.1074/jbc.M501900200; Kim SJ, 2002, BIOCHEM BIOPH RES CO, V296, P221, DOI 10.1016/S0006-291X(02)00824-0; Kippenberger S, 2005, J BIOL CHEM, V280, P3060, DOI 10.1074/jbc.M409590200; Krishnan V, 2006, J CLIN INVEST, V116, P1202, DOI 10.1172/JCI28551; Lee HK, 2006, NUCLEIC ACIDS RES, V34, P5705, DOI 10.1093/nar/gkl698; Norvell SM, 2004, CALCIFIED TISSUE INT, V75, P396, DOI 10.1007/s00223-004-0213-y; Pavalko FM, 2003, J CELL PHYSIOL, V194, P194, DOI 10.1002/jcp.10221; Ragab AA, 2002, AM J PHYSIOL-CELL PH, V283, pC679, DOI 10.1152/ajpcell.00421.2001; Rice KM, 2007, EXP PHYSIOL, V92, P963, DOI 10.1113/expphysiol.2007.037275; Robinson JA, 2006, J BIOL CHEM, V281, P31720, DOI 10.1074/jbc.M602308200; Rodda SJ, 2006, DEVELOPMENT, V133, P3231, DOI 10.1242/dev.02480; RUBIN CT, 1984, J BONE JOINT SURG AM, V66A, P397, DOI 10.2106/00004623-198466030-00012; Rubin J, 1999, J ORTHOPAED RES, V17, P639, DOI 10.1002/jor.1100170504; Rubin J, 2003, J BIOL CHEM, V278, P34018, DOI 10.1074/jbc.M302822200; Rubin J, 2007, J BONE MINER RES, V22, P1408, DOI 10.1359/jbmr.070601; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Sawakami K, 2006, J BIOL CHEM, V281, P23698, DOI 10.1074/jbc.M601000200; Sedding DG, 2005, CIRC RES, V96, P635, DOI 10.1161/01.RES.0000160610.61306.0f; Torres VA, 2007, MOL CELL BIOL, V27, P7703, DOI 10.1128/MCB.01991-06; Troussard AA, 2003, J BIOL CHEM, V278, P22374, DOI 10.1074/jbc.M303083200; van Noort M, 2002, J BIOL CHEM, V277, P17901, DOI 10.1074/jbc.M111635200; Yamamoto H, 2006, DEV CELL, V11, P213, DOI 10.1016/j.devcel.2006.07.003; Yun K, 2007, BIOCHEM BIOPH RES CO, V364, P270, DOI 10.1016/j.bbrc.2007.09.129; Zhang BF, 2007, CELL SIGNAL, V19, P1690, DOI 10.1016/j.cellsig.2007.03.005	36	118	126	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 24	2008	283	43					29196	29205		10.1074/jbc.M801907200	http://dx.doi.org/10.1074/jbc.M801907200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	362EB	18723514	hybrid, Green Published			2022-12-27	WOS:000260179900047
J	Garud, DR; Tran, VM; Victor, XV; Koketsu, M; Kuberan, B				Garud, Dinesh R.; Tran, Vy M.; Victor, Xylophone V.; Koketsu, Mamoru; Kuberan, Balagurunathan			Inhibition of Heparan Sulfate and Chondroitin Sulfate Proteoglycan Biosynthesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN LINKAGE REGION; BETA-D-XYLOSIDES; BREFELDIN-A; RAT CHONDROSARCOMA; MOLECULAR-CLONING; XT-II; CELLS; GLYCOSAMINOGLYCAN; EXPRESSION; CARTILAGE	Proteoglycans (PGs) are composed of a protein moiety and a complex glycosaminoglycan ( GAG) polysaccharide moiety. GAG chains are responsible for various biological activities. GAG chains are covalently attached to serine residues of the core protein. The first step in PG biosynthesis is xylosylation of certain serine residues of the core protein. A specific linker tetrasaccharide is then assembled and serves as an acceptor for elongation of GAG chains. If the production of endogenous GAG chains is selectively inhibited, one could determine the role of these endogenous molecules in physiological and developmental functions in a spatiotemporal manner. Biosynthesis of PGs is often blocked with the aid of nonspecific agents such as chlorate, a bleaching agent, and brefeldin A, a fungal metabolite, to elucidate the biological roles of GAG chains. Unfortunately, these agents are highly lethal to model organisms. Xylosides are known to prime GAG chains. Therefore, we hypothesized that modified xylose analogs may able to inhibit the biosynthesis of PGs. To test this, we synthesized a library of novel 4-deoxy-4-fluoroxylosides with various aglycones using click chemistry and examined each for its ability to inhibit heparan sulfate and chondroitin sulfate using Chinese hamster ovary cells as a model cellular system.	[Victor, Xylophone V.; Kuberan, Balagurunathan] Univ Utah, Dept Med Chem, Salt Lake City, UT 84112 USA; [Garud, Dinesh R.] Gifu Univ, Fac Engn, Dept Chem, Gifu 5011193, Japan; [Koketsu, Mamoru] Gifu Univ, Life Sci Res Ctr, Div Instrumental Anal, Gifu 5011193, Japan; [Tran, Vy M.; Kuberan, Balagurunathan] Univ Utah, Dept Bioengn, Salt Lake City, UT 84112 USA	Utah System of Higher Education; University of Utah; Gifu University; Gifu University; Utah System of Higher Education; University of Utah	Kuberan, B (corresponding author), Univ Utah, Dept Med Chem, Skaggs Hall,Rm 307,30 South 2000 East, Salt Lake City, UT 84112 USA.	KUBY@pharm.utah.edu	Tran, Vy/GWC-8836-2022; Garud, Dinesh Ramesh/X-2586-2018	Garud, Dinesh Ramesh/0000-0002-8735-7920; Balagurunathan, Kuberan/0000-0001-9203-8118	National Institutes of Health [GM075168]; Human Frontiers Science Program; Ministry of Education, Culture, Sports, Science, and Technology of Japan; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM075168] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Human Frontiers Science Program(Human Frontier Science Program); Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, by National Institutes of Health Grant GM075168 (to B. K.). This work was also supported by the Human Frontiers Science Program (to B. K.) and by a grant-in-aid for science research from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (to M. K.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Almeida R, 1999, J BIOL CHEM, V274, P26165, DOI 10.1074/jbc.274.37.26165; Bai XM, 2001, J BIOL CHEM, V276, P48189, DOI 10.1074/jbc.M107339200; BAILEY DS, 1981, BIOCHEM J, V195, P139, DOI 10.1042/bj1950139; BATEY JF, 1975, CARBOHYD RES, V43, P43; Berkin A, 2005, GLYCOCONJUGATE J, V22, P443, DOI 10.1007/s10719-005-5060-1; Bernfield M, 1999, ANNU REV BIOCHEM, V68, P729, DOI 10.1146/annurev.biochem.68.1.729; CALABRO A, 1994, J BIOL CHEM, V269, P22764; Cuellar K, 2007, J BIOL CHEM, V282, P5195, DOI 10.1074/jbc.M611048200; Dax K, 2000, CARBOHYD RES, V327, P47, DOI 10.1016/S0008-6215(00)00022-7; Esko JD, 2002, ANNU REV BIOCHEM, V71, P435, DOI 10.1146/annurev.biochem.71.110601.135458; FRITZ TA, 1994, J BIOL CHEM, V269, P300; Gotting C, 2000, J MOL BIOL, V304, P517, DOI 10.1006/jmbi.2000.4261; GREVE H, 1988, J BIOL CHEM, V263, P12886; Gulberti S, 2005, J BIOL CHEM, V280, P1417, DOI 10.1074/jbc.M411552200; HUMPHRIES DE, 1988, BIOCHEM BIOPH RES CO, V154, P365, DOI 10.1016/0006-291X(88)90694-8; Kitagawa H, 1998, J BIOL CHEM, V273, P6615, DOI 10.1074/jbc.273.12.6615; Kuberan B, 2008, CHEMBIOCHEM, V9, P198, DOI 10.1002/cbic.200700494; LINDAHL U, 1966, J BIOL CHEM, V241, P2113; Lindahl U, 2007, THROMB HAEMOSTASIS, V98, P109, DOI 10.1160/Th07-04-0310; Moses J, 1997, EUR J BIOCHEM, V248, P521, DOI 10.1111/j.1432-1033.1997.00521.x; MUIR H, 1958, BIOCHEM J, V69, P195, DOI 10.1042/bj0690195; O'Brien J, 2000, EUR J BIOCHEM, V267, P5421, DOI 10.1046/j.1432-1327.2000.01606.x; OEGEMA TR, 1984, J BIOL CHEM, V259, P1720; OKAYAMA M, 1973, J BIOCHEM-TOKYO, V74, P1069; Prydz K, 2000, J CELL SCI, V113, P193; ROBINSON HC, 1975, BIOCHEM J, V148, P25, DOI 10.1042/bj1480025; Safaiyan F, 1999, J BIOL CHEM, V274, P36267, DOI 10.1074/jbc.274.51.36267; Salmivirta M, 1996, FASEB J, V10, P1270, DOI 10.1096/fasebj.10.11.8836040; SAMPATH D, 1992, J BIOL CHEM, V267, P4440; Sasisekharan R, 2000, CURR OPIN CHEM BIOL, V4, P626, DOI 10.1016/S1367-5931(00)00145-9; Schon S, 2006, J BIOL CHEM, V281, P14224, DOI 10.1074/jbc.M510690200; Schwartz NB, 2004, GLYCOCONJUGATE J, V21, P329, DOI 10.1023/B:GLYC.0000046278.34016.36; SHERWOOD AL, 1992, J BIOL CHEM, V267, P25328; SUGUMARAN G, 1992, J BIOL CHEM, V267, P8802; Turnbull JE, 2007, NAT CHEM BIOL, V3, P74, DOI 10.1038/nchembio0207-74; UHLINHANSEN L, 1993, J BIOL CHEM, V268, P17370; Wicki J, 2007, BIOCHEMISTRY-US, V46, P6996, DOI 10.1021/bi700359e; Yamada S, 2002, J BIOL CHEM, V277, P31877, DOI 10.1074/jbc.M205078200; Zhang LJ, 2001, J BIOL CHEM, V276, P42311, DOI 10.1074/jbc.M101441200	39	32	33	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 24	2008	283	43					28881	28887		10.1074/jbc.M805939200	http://dx.doi.org/10.1074/jbc.M805939200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	362EB	18708345	Green Published, hybrid			2022-12-27	WOS:000260179900013
J	Kawamata, H; Magrane, J; Kunst, C; King, MP; Manfredi, G				Kawamata, Hibiki; Magrane, Jordi; Kunst, Catherine; King, Michael P.; Manfredi, Giovanni			Lysyl-tRNA synthetase is a target for mutant SOD1 toxicity in mitochondria	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; SUPEROXIDE-DISMUTASE; PROTEIN INTERACTIONS; TRANSGENIC MICE; G93A-SOD1 MICE; DEGENERATION; DYSFUNCTION; CELLS; ALS; DISEASE	Amyotrophic lateral sclerosis (ALS) is a devastating neurodegenerative disease affecting the motor neurons. The majority of familial forms of ALS are caused by mutations in the Cu,Zn-superoxide dismutase (SOD1). In mutant SOD1 spinal cord motor neurons, mitochondria develop abnormal morphology, bioenergetic defects, and degeneration. However, the mechanisms of mitochondrial toxicity are still unclear. One possibility is that mutant SOD1 establishes aberrant interactions with nuclear-encoded mitochondrial proteins, which can interfere with their normal trafficking from the cytosol to mitochondria. Lysyl-tRNA synthetase (KARS), an enzyme required for protein translation that was shown to interact with mutant SOD1 in yeast, is a good candidate as a target for interaction with mutant SOD1 at the mitochondrion in mammals because of its dual cytosolic and mitochondrial localization. Here, we show that in mammalian cells mutant SOD1 interacts preferentially with the mitochondrial form of KARS (mitoKARS). KARS-SOD1 interactions occur also in the mitochondria of the nervous system in transgenic mice. In the presence of mutant SOD1, mitoKARS displays a high propensity to misfold and aggregate prior to its import into mitochondria, becoming a target for proteasome degradation. Impaired mitoKARS import correlates with decreased mitochondrial protein synthesis. Ultimately, the abnormal interactions between mutant SOD1 and mitoKARS result in mitochondrial morphological abnormalities and cell toxicity. mitoKARS is the first described member of a group of mitochondrial proteins whose interaction with mutant SOD1 contributes to mitochondrial dysfunction in ALS.	[Kawamata, Hibiki; Magrane, Jordi; Manfredi, Giovanni] Cornell Univ, Weill Med Coll, Dept Neurol & Neurosci, New York, NY 10065 USA; [Kunst, Catherine] Univ Denver, Eleanor Roosevelt Inst, Denver, CO 80206 USA; [King, Michael P.] Thomas Jefferson Univ, Dept Mol Pharmacol & Biochem, Philadelphia, PA 19107 USA	Cornell University; University of Denver; Jefferson University	Manfredi, G (corresponding author), Cornell Univ, Weill Med Coll, Dept Neurol & Neurosci, 525 E 68th St,A-505, New York, NY 10065 USA.	gim2004@med.cornell.edu	Magrané, Jordi/AAJ-2967-2020	Magrané, Jordi/0000-0002-6785-2166	National Institutes of Health [P01-NS011766, R01-NS051419, F31 NS054554]; Robert Packard ALS Research Center; New York Community Trust; Muscular Dystrophy Association; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS011766, R01NS051419, F31NS054554] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Robert Packard ALS Research Center; New York Community Trust; Muscular Dystrophy Association(Muscular Dystrophy Association); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants P01-NS011766, R01-NS051419, and F31 NS054554. This work was also supported by the Robert Packard ALS Research Center, The New York Community Trust, and the Muscular Dystrophy Association.	Antonellis A, 2003, AM J HUM GENET, V72, P1293, DOI 10.1086/375039; Brandina I, 2007, FEBS LETT, V581, P4248, DOI 10.1016/j.febslet.2007.08.013; Cen S, 2002, J VIROL, V76, P13111, DOI 10.1128/JVI.76.24.13111-13115.2002; Chomyn A, 1996, Methods Enzymol, V264, P197, DOI 10.1016/S0076-6879(96)64020-8; D'Aurelio M, 2006, HUM MOL GENET, V15, P2157, DOI 10.1093/hmg/ddl141; DALCANTO MC, 1995, BRAIN RES, V676, P25, DOI 10.1016/0006-8993(95)00063-V; Damiano M, 2006, J NEUROCHEM, V96, P1349, DOI 10.1111/j.1471-4159.2006.03619.x; Deng HX, 2006, P NATL ACAD SCI USA, V103, P7142, DOI 10.1073/pnas.0602046103; Fisk HA, 1999, J CELL BIOL, V145, P1199, DOI 10.1083/jcb.145.6.1199; Gould TW, 2006, J NEUROSCI, V26, P8774, DOI 10.1523/JNEUROSCI.2315-06.2006; GURNEY ME, 1994, SCIENCE, V264, P1772, DOI 10.1126/science.8209258; Hervias I, 2006, MUSCLE NERVE, V33, P598, DOI 10.1002/mus.20489; Higgins CMJ, 2002, J NEUROSCI, V22, DOI 10.1523/JNEUROSCI.22-06-j0001.2002; Jaarsma D, 2001, ACTA NEUROPATHOL, V102, P293; Jung CW, 2002, J NEUROSCI METH, V114, P165, DOI 10.1016/S0165-0270(01)00524-6; Kabashi E, 2006, BBA-MOL BASIS DIS, V1762, P1038, DOI 10.1016/j.bbadis.2006.06.006; Kirkinezos IG, 2005, J NEUROSCI, V25, P164, DOI 10.1523/JNEUROSCI.3829-04.2005; Kong JM, 1998, J NEUROSCI, V18, P3241; Kunst CB, 1997, NAT GENET, V15, P91, DOI 10.1038/ng0197-91; Lee JW, 2006, NATURE, V443, P50, DOI 10.1038/nature05096; Liu J, 2004, NEURON, V43, P5, DOI 10.1016/j.neuron.2004.06.016; Mattiazzi M, 2002, J BIOL CHEM, V277, P29626, DOI 10.1074/jbc.M203065200; Menzies FM, 2002, BRAIN, V125, P1522, DOI 10.1093/brain/awf167; MIRANDE M, 1985, EUR J BIOCHEM, V147, P281, DOI 10.1111/j.1432-1033.1985.tb08748.x; Okado-Matsumoto A, 2001, J BIOL CHEM, V276, P38388, DOI 10.1074/jbc.M105395200; Okado-Matsumoto A, 2002, P NATL ACAD SCI USA, V99, P9010, DOI 10.1073/pnas.132260399; Pallotti F, 2001, METHOD CELL BIOL, V65, P1, DOI 10.1016/S0091-679X(01)65002-7; Park SG, 2008, P NATL ACAD SCI USA, V105, P11043, DOI 10.1073/pnas.0802862105; Park SG, 2005, TRENDS BIOCHEM SCI, V30, P569, DOI 10.1016/j.tibs.2005.08.004; Pasinelli P, 2004, NEURON, V43, P19, DOI 10.1016/j.neuron.2004.06.021; Pearce DA, 1997, J BIOL CHEM, V272, P31829, DOI 10.1074/jbc.272.50.31829; Raimondi A, 2006, EUR J NEUROSCI, V24, P387, DOI 10.1111/j.1460-9568.2006.04922.x; Rinaldi T, 2004, BIOCHEM J, V381, P275, DOI 10.1042/BJ20040008; RIZZUTO R, 1995, CURR BIOL, V5, P635, DOI 10.1016/S0960-9822(95)00128-X; Robinson JC, 2000, J MOL BIOL, V304, P983, DOI 10.1006/jmbi.2000.4242; Son M, 2007, P NATL ACAD SCI USA, V104, P6072, DOI 10.1073/pnas.0610923104; Tolkunova E, 2000, J BIOL CHEM, V275, P35063, DOI 10.1074/jbc.M006265200; Vijayvergiya C, 2005, J NEUROSCI, V25, P2463, DOI 10.1523/JNEUROSCI.4385-04.2005; Wang J, 2002, NEUROBIOL DIS, V9, P139, DOI 10.1006/nbdi.2001.0471; WONG PC, 1995, NEURON, V14, P1105, DOI 10.1016/0896-6273(95)90259-7; Yannay-Cohen N, 2006, MOL CELLS, V22, P127; Young JC, 2004, NAT REV MOL CELL BIO, V5, P781, DOI 10.1038/nrm1492	42	36	39	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 17	2008	283	42					28321	28328		10.1074/jbc.M805599200	http://dx.doi.org/10.1074/jbc.M805599200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	359EN	18715867	Green Published, hybrid			2022-12-27	WOS:000259969300034
J	Rakotomalala, L; Studach, L; Wang, WH; Gregori, G; Hullinger, RL; Andrisani, O				Rakotomalala, Lova; Studach, Leo; Wang, Wen-Horng; Gregori, Gerald; Hullinger, Ronald L.; Andrisani, Ourania			Hepatitis B virus X protein increases the Cdt1-to-geminin ratio inducing DNA re-replication and polyploidy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LICENSING FACTOR CDT1; GENOMIC INSTABILITY; HEPATOCELLULAR-CARCINOMA; CELL-CYCLE; GENE-EXPRESSION; COMET ASSAY; C-KIT; GEMININ; LIVER; KINASE	Hepatitis B virus X protein (pX) is implicated in hepatocellular carcinoma pathogenesis by an unknown mechanism. Employing the tetracycline-regulated pX-expressing 4pX-1 cell line, derived from the murine AML12 hepatocyte cell line, we demonstrate that pX induces partial polyploidy (> 4N DNA). Depletion of p53 in 4pX-1 cells increases by 5-fold the polyploid cells in response to pX expression, indicating that p53 antagonizes pX-induced polyploidy. Dual-parameter flow cytometric analyses show pX-dependent bromodeoxyuridine (BrdUrd) incorporation in 4pX-1 cells containing 4N and > 4N DNA, suggesting pX induces DNA re-replication. Interestingly, pX increases expression of endogenous replication initiation factors Cdc6 and Cdtl while suppressing geminin expression, a negative regulator of re-replication. In comparison to a geminin knockdown 4pX-1 cell line used as DNA re-replication control, the Cdt1/geminin ratio is greater in 4pX-1 cells expressing pX, indicating that pX promotes DNA re-replication. In support of this conclusion, pX-expressing 4pX-1 cells, similar to the geminin knockdown 4pX-1 cells, continue to incorporate BrdUrd in the G(2) phase and exhibit nuclear Cdc6 and MCM5 co-localization and the absence of geminin. In addition, pX expression activates the ATR kinase, the sensor of DNA re-replication, which in turn phosphorylates RAD17 and H2AX. Interestingly, phospho-H2AX-positive and BrdUrd-positive cells progress through mitosis, demonstrating a link between pX-induced DNA re-replication and polyploidy. Our studies highlight a novel function of pX that likely contributes to hepatocellular carcinoma pathogenesis.	[Rakotomalala, Lova; Studach, Leo; Wang, Wen-Horng; Gregori, Gerald; Hullinger, Ronald L.; Andrisani, Ourania] Purdue Univ, Dept Basic Med Sci, W Lafayette, IN 47907 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus	Andrisani, O (corresponding author), Purdue Univ, Dept Basic Med Sci, 625 Harrison St, W Lafayette, IN 47907 USA.	andrisao@purdue.edu	Grégori, Gérald J/D-8657-2013	Grégori, Gérald J/0000-0003-1645-9468; Andrisani, Ourania/0000-0002-6230-0303	National Institutes of Health [044533]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported, in whole or in part, by National Institutes of Health Grant 044533 (to O. A.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked " advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Abraham RT, 2001, GENE DEV, V15, P2177, DOI 10.1101/gad.914401; Andrisani OM, 1999, INT J ONCOL, V15, P373; Ballabeni A, 2004, EMBO J, V23, P3122, DOI 10.1038/sj.emboj.7600314; Bao SD, 2001, NATURE, V411, P969, DOI 10.1038/35082110; Bao SL, 2004, ONCOGENE, V23, P5586, DOI 10.1038/sj.onc.1207753; Bartkova J, 2005, NATURE, V434, P864, DOI 10.1038/nature03482; BEASLEY RP, 1981, LANCET, V2, P1129; Bell SP, 2002, ANNU REV BIOCHEM, V71, P333, DOI 10.1146/annurev.biochem.71.110601.135425; Blow JJ, 2005, NAT REV MOL CELL BIO, V6, P476, DOI 10.1038/nrm1663; Bouchard MJ, 2004, J VIROL, V78, P12725, DOI 10.1128/JVI.78.23.12725-12734.2004; Budzowska M, 2004, EMBO J, V23, P3548, DOI 10.1038/sj.emboj.7600353; Butel JS, 2000, CARCINOGENESIS, V21, P405, DOI 10.1093/carcin/21.3.405; Chen X, 2002, MOL BIOL CELL, V13, P1929, DOI 10.1091/mbc.02-02-0023; Cho RJ, 2001, NAT GENET, V27, P48, DOI 10.1038/83751; Cougot D, 2005, J CLIN VIROL, V34, pS75, DOI 10.1016/S1386-6532(05)80014-9; Crosby HA, 2001, GASTROENTEROLOGY, V120, P534, DOI 10.1053/gast.2001.21175; Dan YY, 2006, P NATL ACAD SCI USA, V103, P9912, DOI 10.1073/pnas.0603824103; Dandri M, 1996, J VIROL, V70, P5246, DOI 10.1128/JVI.70.8.5246-5254.1996; Diffley JFX, 2004, CURR BIOL, V14, pR778, DOI 10.1016/j.cub.2004.09.019; Duensing S, 2000, P NATL ACAD SCI USA, V97, P10002, DOI 10.1073/pnas.170093297; Fei PW, 2003, ONCOGENE, V22, P5774, DOI 10.1038/sj.onc.1206677; Frenzilli G, 2006, ANN NY ACAD SCI, V1074, P478, DOI 10.1196/annals.1369.048; Fujita M, 1998, J BIOL CHEM, V273, P17095, DOI 10.1074/jbc.273.27.17095; Gorgoulis VG, 2005, NATURE, V434, P907, DOI 10.1038/nature03485; Hodgson B, 2002, CURR BIOL, V12, P678, DOI 10.1016/S0960-9822(02)00778-9; Itzhaki JE, 1997, NAT GENET, V15, P258, DOI 10.1038/ng0397-258; Jin DY, 1998, CELL, V93, P81, DOI 10.1016/S0092-8674(00)81148-4; Karahashi H, 2000, BBA-MOL BASIS DIS, V1502, P207, DOI 10.1016/S0925-4439(00)00045-4; Kawai H, 2000, HEPATOLOGY, V31, P1246, DOI 10.1053/jhep.2000.7298; Kurata S, 2000, J BIOL CHEM, V275, P23413, DOI 10.1074/jbc.C000308200; Lee C, 2004, NATURE, V430, P913, DOI 10.1038/nature02813; Lee ES, 2005, AM J CLIN PATHOL, V124, P31, DOI 10.1309/LETTWN3LUF516HR0; Lee S, 2002, J BIOL CHEM, V277, P8730, DOI 10.1074/jbc.M108025200; Madden CR, 2001, J VIROL, V75, P3851, DOI 10.1128/JVI.75.8.3851-3858.2001; Marchio A, 1997, GENE CHROMOSOME CANC, V18, P59, DOI 10.1002/(SICI)1098-2264(199701)18:1<59::AID-GCC7>3.0.CO;2-0; McGarry TJ, 1998, CELL, V93, P1043, DOI 10.1016/S0092-8674(00)81209-X; Melixetian M, 2004, J CELL BIOL, V165, P473, DOI 10.1083/jcb.200403106; Mendez J, 2000, MOL CELL BIOL, V20, P8602, DOI 10.1128/MCB.20.22.8602-8612.2000; Mihaylov IS, 2002, MOL CELL BIOL, V22, P1868, DOI 10.1128/MCB.22.6.1868-1880.2002; Nemoto S, 1998, J BIOL CHEM, V273, P16415, DOI 10.1074/jbc.273.26.16415; Nishitani H, 2006, EMBO J, V25, P1126, DOI 10.1038/sj.emboj.7601002; Nishitani H, 2004, FRONT BIOSCI-LANDMRK, V9, P2115; Nishitani H, 2004, J BIOL CHEM, V279, P30807, DOI 10.1074/jbc.M312644200; Ohmori S, 2004, INT J MOL MED, V14, P179; Olive Peggy L, 2002, Methods Mol Biol, V203, P179; Prasanth SG, 2004, PHILOS T R SOC B, V359, P7, DOI 10.1098/rstb.2003.1360; Pusapati RV, 2006, P NATL ACAD SCI USA, V103, P1446, DOI 10.1073/pnas.0507367103; Saxena S, 2005, MUTAT RES-FUND MOL M, V569, P111, DOI 10.1016/j.mrfmmm.2004.05.026; Su Q, 1998, HEPATOLOGY, V27, P1109, DOI 10.1002/hep.510270428; Sugimoto N, 2004, J BIOL CHEM, V279, P19691, DOI 10.1074/jbc.M313175200; Tada S, 2001, NAT CELL BIOL, V3, P107, DOI 10.1038/35055000; Tarn C, 1999, J BIOL CHEM, V274, P2327, DOI 10.1074/jbc.274.4.2327; Tarn C, 2002, J VIROL, V76, P9763, DOI 10.1128/JVI.76.19.9763-9772.2002; Tarn C, 2001, J BIOL CHEM, V276, P34671, DOI 10.1074/jbc.M104105200; Thorgeirsson SS, 2002, NAT GENET, V31, P339, DOI 10.1038/ng0802-339; Thorgeirsson SS, 1996, FASEB J, V10, P1249, DOI 10.1096/fasebj.10.11.8836038; Vaziri C, 2003, MOL CELL, V11, P997, DOI 10.1016/S1097-2765(03)00099-6; Wang WH, 2008, J BIOL CHEM, V283, P25455, DOI 10.1074/jbc.M801934200; Wang WH, 2004, MOL CELL BIOL, V24, P10352, DOI 10.1128/MCB.24.23.10352-10365.2004; Wang X, 2003, GENE DEV, V17, P965, DOI 10.1101/gad.1065103; Ward IM, 2001, J BIOL CHEM, V276, P47759, DOI 10.1074/jbc.C100569200; Weiss RS, 2000, GENE DEV, V14, P1886; Wilkens L, 2004, P NATL ACAD SCI USA, V101, P1309, DOI 10.1073/pnas.0305817101; Wohlschlegel JA, 2000, SCIENCE, V290, P2309, DOI 10.1126/science.290.5500.2309; Zhang SH, 2004, J CANCER RES CLIN, V130, P757, DOI 10.1007/s00432-004-0613-4; Zhu WG, 2004, MOL CELL BIOL, V24, P7140, DOI 10.1128/MCB.24.16.7140-7150.2004; Zou L, 2002, GENE DEV, V16, P198, DOI 10.1101/gad.950302; ZOULIM F, 1994, J VIROL, V68, P2026, DOI 10.1128/JVI.68.3.2026-2030.1994	68	46	47	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 17	2008	283	42					28729	28740		10.1074/jbc.M802751200	http://dx.doi.org/10.1074/jbc.M802751200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	359EN	18693245	Green Published, hybrid			2022-12-27	WOS:000259969300075
J	Shinnakasu, R; Yamashita, M; Kuwahara, M; Hosokawa, H; Hasegawa, A; Motohashi, S; Nakayama, T				Shinnakasu, Ryo; Yamashita, Masakatsu; Kuwahara, Makoto; Hosokawa, Hiroyuki; Hasegawa, Akihiro; Motohashi, Shinichiro; Nakayama, Toshinori			Gfi1-mediated stabilization of GATA3 protein is required for Th2 cell differentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTOR GATA-3; ZINC-FINGER PROTEIN; HEMATOPOIETIC STEM-CELLS; CIS-REGULATORY ELEMENTS; T-CELLS; GENE LOCUS; HISTONE HYPERACETYLATION; PROTEASOMAL DEGRADATION; TH2-SPECIFIC EXPRESSION; INTERLEUKIN-5 GENE	The differentiation of naive CD4 T cells into Th2 cells requires the T cell receptor-mediated activation of the ERK MAPK cascade. Little is known, however, in regard to how the ERK MAPK cascade regulates Th2 cell differentiation. We herein identified Gfi1 (growth factor independent-1) as a downstream target of the ERK MAPK cascade for Th2 cell differentiation. In the absence of Gfi1, interleukin-5 production and the change of histone modification at the interleukin-5 gene locus were severely impaired. Furthermore, the interferon gamma gene showed a striking activation in the Gfi1(-/-) Th2 cells. An enhanced ubiquitin/proteasome-dependent degradation of GATA3 protein was observed in Gfi1(-/-) Th2 cells, and the overexpression of GATA3 eliminated the defect of Th2 cell function in Gfi1-deficient Th2 cells. These data suggest that the T cell receptor-mediated induction of Gfi1 controls Th2 cell differentiation through the regulation of GATA3 protein stability.	[Shinnakasu, Ryo; Yamashita, Masakatsu; Kuwahara, Makoto; Hosokawa, Hiroyuki; Hasegawa, Akihiro; Motohashi, Shinichiro; Nakayama, Toshinori] Chiba Univ, Dept Immunol, Grad Sch Med, Chuo Ku, Chiba 2608670, Japan	Chiba University	Yamashita, M (corresponding author), Chiba Univ, Dept Immunol, Grad Sch Med, Chuo Ku, 1-8-1 Inohana, Chiba 2608670, Japan.	yamamasa@faculty.chiba-u.jp	Nakayama, Toshinori/E-1067-2017	Nakayama, Toshinori/0000-0002-1434-2007; Hosokawa, Hiroyuki/0000-0002-9592-2889	Ministry of Education, Culture, Sports, Science and Technology [20060003, 17390139, 20590485, 19659121, 19890041]; Ministry of Health, Labor and Welfar, the Kanae Foundation, the Uehara Memorial Foundation, the Astellas Foundation, and the Sagawa Foundation	Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labor and Welfar, the Kanae Foundation, the Uehara Memorial Foundation, the Astellas Foundation, and the Sagawa Foundation	This work was supported by Ministry of Education, Culture, Sports, Science and Technology Grants-in-Aid for Scientific Research on Priority Areas 20060003, Scientific Research (B) 17390139, Scientific Research (C) 20590485, Exploratory Research 19659121, and Young Scientists (Start-up) 19890041; by Special Coordination Funds for Promoting Science and Technology; and by the Ministry of Health, Labor and Welfar, the Kanae Foundation, the Uehara Memorial Foundation, the Astellas Foundation, and the Sagawa Foundation. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Abbas AK, 1996, NATURE, V383, P787, DOI 10.1038/383787a0; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Bettelli E, 2007, NAT IMMUNOL, V8, P345, DOI 10.1038/ni0407-345; Constant SL, 1997, ANNU REV IMMUNOL, V15, P297, DOI 10.1146/annurev.immunol.15.1.297; Dong C, 1998, SCIENCE, V282, P2092, DOI 10.1126/science.282.5396.2092; GILKS CB, 1993, MOL CELL BIOL, V13, P1759, DOI 10.1128/MCB.13.3.1759; Grimes HL, 1996, MOL CELL BIOL, V16, P6263; Hock H, 2004, NATURE, V431, P1002, DOI 10.1038/nature02994; Hock H, 2003, IMMUNITY, V18, P109, DOI 10.1016/S1074-7613(02)00501-0; Inami M, 2004, J BIOL CHEM, V279, P23123, DOI 10.1074/jbc.M401248200; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Kaminuma O, 2004, FEBS LETT, V570, P63, DOI 10.1016/j.febslet.2004.06.026; Karsunky H, 2002, ONCOGENE, V21, P1571, DOI 10.1038/sj/onc/1205216; Kimura M, 2001, IMMUNITY, V15, P275, DOI 10.1016/S1074-7613(01)00182-0; Kimura MY, 2005, J EXP MED, V201, P397, DOI 10.1084/jem.20040733; Lee HJ, 1998, J IMMUNOL, V160, P2343; Mangan PR, 2006, NATURE, V441, P231, DOI 10.1038/nature04754; Marteijn JAF, 2007, BLOOD, V110, P3128, DOI 10.1182/blood-2006-11-058602; Marteijn JAF, 2007, BLOOD, V109, P100, DOI 10.1182/blood-2006-02-003590; Murphy KM, 2000, ANNU REV IMMUNOL, V18, P451, DOI 10.1146/annurev.immunol.18.1.451; Nelms K, 1999, ANNU REV IMMUNOL, V17, P701, DOI 10.1146/annurev.immunol.17.1.701; O'Garra A, 1998, IMMUNITY, V8, P275, DOI 10.1016/S1074-7613(00)80533-6; Omori M, 2003, IMMUNITY, V19, P281, DOI 10.1016/S1074-7613(03)00210-3; Ouyang W, 1998, IMMUNITY, V9, P745, DOI 10.1016/S1074-7613(00)80671-8; REINER SL, 1995, ANNU REV IMMUNOL, V13, P151, DOI 10.1146/annurev.iy.13.040195.001055; Rodel B, 2000, EMBO J, V19, P5845, DOI 10.1093/emboj/19.21.5845; Saleque S, 2007, MOL CELL, V27, P562, DOI 10.1016/j.molcel.2007.06.039; Schwenger GTF, 2001, J BIOL CHEM, V276, P48502, DOI 10.1074/jbc.M107836200; SEDER RA, 1994, ANNU REV IMMUNOL, V12, P635, DOI 10.1146/annurev.iy.12.040194.003223; Shevach EM, 2006, IMMUNITY, V25, P195, DOI 10.1016/j.immuni.2006.08.003; Shibata Y, 2002, J IMMUNOL, V169, P2134, DOI 10.4049/jimmunol.169.4.2134; Shinnakasu R, 2006, J IMMUNOL, V177, P5801, DOI 10.4049/jimmunol.177.9.5801; Stockinger B, 2007, CURR OPIN IMMUNOL, V19, P281, DOI 10.1016/j.coi.2007.04.005; Szabo SJ, 2002, SCIENCE, V295, P338, DOI 10.1126/science.1065543; Usui T, 2003, IMMUNITY, V18, P415, DOI 10.1016/S1074-7613(03)00057-8; Veldhoen M, 2006, IMMUNITY, V24, P179, DOI 10.1016/j.immuni.2006.01.001; Wan YSY, 2006, IMMUNOL REV, V212, P114, DOI 10.1111/j.0105-2896.2006.00407.x; Yamashita M, 2005, J BIOL CHEM, V280, P29409, DOI 10.1074/jbc.M502333200; Yamashita M, 1998, INT IMMUNOL, V10, P577, DOI 10.1093/intimm/10.5.577; Yamashita M, 1999, P NATL ACAD SCI USA, V96, P1024, DOI 10.1073/pnas.96.3.1024; Yamashita M, 2002, J BIOL CHEM, V277, P42399, DOI 10.1074/jbc.M205876200; Yamashita M, 2000, J EXP MED, V191, P1869, DOI 10.1084/jem.191.11.1869; Yamashita M, 2006, IMMUNITY, V24, P611, DOI 10.1016/j.immuni.2006.03.017; Yang DD, 1998, IMMUNITY, V9, P575, DOI 10.1016/S1074-7613(00)80640-8; Zeng H, 2004, EMBO J, V23, P4116, DOI 10.1038/sj.emboj.7600419; Zhang DH, 1998, J IMMUNOL, V161, P3817; Zhang DH, 1997, J BIOL CHEM, V272, P21597, DOI 10.1074/jbc.272.34.21597; Zheng WP, 1997, CELL, V89, P587, DOI 10.1016/S0092-8674(00)80240-8; Zhu JF, 2002, IMMUNITY, V16, P733, DOI 10.1016/S1074-7613(02)00317-5; Zhu JF, 2006, P NATL ACAD SCI USA, V103, P18214, DOI 10.1073/pnas.0608981103; ZweidlerMcKay PA, 1996, MOL CELL BIOL, V16, P4024	51	43	47	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 17	2008	283	42					28216	28225		10.1074/jbc.M804174200	http://dx.doi.org/10.1074/jbc.M804174200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	359EN	18701459	Green Published, hybrid			2022-12-27	WOS:000259969300023
J	Yokoyama, U; Minamisawa, S; Quan, H; Akaike, T; Suzuki, S; Jin, M; Jiao, Q; Watanabe, M; Otsu, K; Iwasaki, S; Nishimaki, S; Sato, M; Ishikawa, Y				Yokoyama, Utako; Minamisawa, Susumu; Quan, Hong; Akaike, Toru; Suzuki, Sayaka; Jin, Meihua; Jiao, Qibin; Watanabe, Mayumi; Otsu, Koji; Iwasaki, Shiho; Nishimaki, Shigeru; Sato, Motohiko; Ishikawa, Yoshihiro			Prostaglandin E-2-activated Epac promotes neointimal formation of the rat ductus arteriosus by a process distinct from that of cAMP-dependent protein kinase A	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MUSCLE-CELL-MIGRATION; CYCLIC-AMP; ENDOTHELIAL-CELLS; UP-REGULATION; ACTIVATION; EXPRESSION; RECEPTOR; MECHANISMS	We have demonstrated that chronic stimulation of the prostaglandin E-2-cAMP-dependent protein kinase A (PKA) signal pathway plays a critical role in intimal cushion formation in perinatal ductus arteriosus (DA) through promoting synthesis of hyaluronan. We hypothesized that Epac, a newly identified effector of cAMP, may play a role in intimal cushion formation (ICF) in the DA distinct from that of PKA. In the present study, we found that the levels of Epac1 and Epac2 mRNAs were significantly up-regulated in the rat DA during the perinatal period. A specific EP4 agonist, ONO-AE1 -329, increased Rap1 activity in the presence of a PKA inhibitor, PKI-(14-22)-amide, in DA smooth muscle cells. 8-pCPT-2-O-Me-cAMP (O-Me-cAMP), a cAMP analog selective to Epac activator, promoted migration of DA smooth muscle cells (SMC) in a dose-dependent manner. Adenovirus-mediated Epac1 or Epac2 gene transfer further enhanced O-Me-cAMP-induced cell migration, although the effect of Epac1 overexpression on cell migration was stronger than that of Epac2. In addition, transfection of small interfering RNAs for Epac1, but not Epac2, significantly inhibited serum-mediated migration of DA SMCs. In the presence of O-Me-cAMP, actin stress fibers were well organized with enhanced focal adhesion, and cell shape was widely expanded. Adenovirus-mediated Epac1, but not Epac2 gene transfer, induced prominent ICF in the rat DA explants when compared with those with green fluorescent protein gene transfer. The thickness of intimal cushion became significantly greater (1.98-fold) in Epac1-overexpressed DA. O-Me-cAMP did not change hyaluronan production, although it decreased proliferation of DA SMCs. The present study demonstrated that Epac, especially Epac1, plays an important role in promoting SMC migration and thereby ICF in the rat DA.	[Minamisawa, Susumu] Waseda Univ, Grad Sch Adv Sci & Engn, Dept Life Sci & Med Biosci, Shinjuku Ku, Tokyo 1628480, Japan; [Yokoyama, Utako; Minamisawa, Susumu; Quan, Hong; Akaike, Toru; Suzuki, Sayaka; Jin, Meihua; Jiao, Qibin; Watanabe, Mayumi; Otsu, Koji; Sato, Motohiko; Ishikawa, Yoshihiro] Yokohama City Univ, Grad Sch Med, Cardiovasc Res Inst, Kanagawa 2360027, Japan; [Iwasaki, Shiho; Nishimaki, Shigeru] Yokohama City Univ, Grad Sch Med, Dept Pediat, Kanagawa 2360027, Japan; [Minamisawa, Susumu] Waseda Univ, Inst Biomed Engn, Consolidated Res Inst Adv Sci & Med Care, Tokyo 1628480, Japan; [Ishikawa, Yoshihiro] Univ Med & Dent New Jersey, New Jersey Med Sch, Cardiovasc Res Inst, Dept Cell Biol & Mol Med, Newark, NJ 07101 USA; [Ishikawa, Yoshihiro] Univ Med & Dent New Jersey, New Jersey Med Sch, Cardiovasc Res Inst, Dept Med Cardiol, Newark, NJ 07101 USA	Waseda University; Yokohama City University; Yokohama City University; Waseda University; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center	Minamisawa, S (corresponding author), Waseda Univ, Grad Sch Adv Sci & Engn, Dept Life Sci & Med Biosci, Shinjuku Ku, 2-2 Wakamatsu Cho, Tokyo 1628480, Japan.	sminamis@waseda.jp	Yokoyama, Utako/AAD-1404-2022	Yokoyama, Utako/0000-0003-1803-0155; Minamisawa, Susumu/0000-0003-4728-2116	National Institutes of Health Grant [RO1 GM067773]; Yokohama Foundation for Advanced Medical Science; Ministry of Education, Science, Sports and Culture of Japan; Mother and Child Health Foundation; Miyata Cardiology Research Promotion Founds; Takeda Science Foundation; Foundation for Growth Science; JapanCardiovascular Research Foundation; Mitsubishi Pharma Research Foundation; Special Coordination Funds for Promoting Science and Technology, MEXT; Waseda University Grant; Yokohama Academic Foundation; Uehara memorial foundation; Kitsuen Research Foundation; Japan Space Forum; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067773] Funding Source: NIH RePORTER	National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Yokohama Foundation for Advanced Medical Science; Ministry of Education, Science, Sports and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Mother and Child Health Foundation(Mother and Child Health Foundation); Miyata Cardiology Research Promotion Founds; Takeda Science Foundation(Takeda Science Foundation (TSF)); Foundation for Growth Science; JapanCardiovascular Research Foundation; Mitsubishi Pharma Research Foundation; Special Coordination Funds for Promoting Science and Technology, MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Waseda University Grant; Yokohama Academic Foundation; Uehara memorial foundation(Uehara Memorial Foundation); Kitsuen Research Foundation; Japan Space Forum; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in part, by National Institutes of Health Grant RO1 GM067773 (to Y. I.). This work was also supported by grants from the Yokohama Foundation for Advanced Medical Science (to S. M., U. Y., T. A., and Y. I.), the Ministry of Education, Science, Sports and Culture of Japan (to S. M., Y. I., and S. I.), the Mother and Child Health Foundation (to S. M.), the Miyata Cardiology Research Promotion Founds (to S. M.), the Takeda Science Foundation (to S. M.), the Foundation for Growth Science (to S. M.), the JapanCardiovascular Research Foundation (to S. M.), the Mitsubishi Pharma Research Foundation (to S. M.), the Special Coordination Funds for Promoting Science and Technology, MEXT(to S. M.), the Waseda University Grant for Special Research Projects (to S. M.), the Yokohama Academic Foundation(to H. Q. and S. I.), the Uehara memorial foundation (to U. Y.) the Kitsuen Research Foundation (to Y. I.), and the Japan Space Forum (to Y. I.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked " advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Bos JL, 2003, NAT REV MOL CELL BIO, V4, P733, DOI 10.1038/nrm1197; Gerthoffer WT, 2007, CIRC RES, V100, P607, DOI 10.1161/01.RES.0000258492.96097.47; Hu YL, 2007, BIOCHEM BIOPH RES CO, V357, P871, DOI 10.1016/j.bbrc.2007.04.028; Indolfi C, 1997, NAT MED, V3, P775, DOI 10.1038/nm0797-775; Kang GX, 2003, J BIOL CHEM, V278, P8279, DOI 10.1074/jbc.M211682200; Mei FC, 2002, J BIOL CHEM, V277, P11497, DOI 10.1074/jbc.M110856200; Newby AC, 2000, J PATHOL, V190, P300, DOI 10.1002/(SICI)1096-9896(200002)190:3<300::AID-PATH596>3.0.CO;2-I; Rabinovitch M, 1996, SEMIN PERINATOL, V20, P531, DOI 10.1016/S0146-0005(96)80067-X; Rangarajan S, 2003, J CELL BIOL, V160, P487, DOI 10.1083/jcb.200209105; Seta K, 2002, J BIOL CHEM, V277, P9268, DOI 10.1074/jbc.M109221200; Smith GCS, 1998, PHARMACOL REV, V50, P35; Sun JX, 2002, CIRC RES, V90, P1020, DOI 10.1161/01.RES.0000017727.35930.33; Ulucan C, 2007, AM J PHYSIOL-HEART C, V293, pH1662, DOI 10.1152/ajpheart.00159.2007; Waleh N, 2004, CIRCULATION, V110, P2326, DOI 10.1161/01.CIR.0000145159.16637.5D; Yokoyama U, 2006, AM J PHYSIOL-HEART C, V290, pH1660, DOI 10.1152/ajpheart.00100.2004; Yokoyama U, 2008, P NATL ACAD SCI USA, V105, P6386, DOI 10.1073/pnas.0801490105; Yokoyama U, 2006, J CLIN INVEST, V116, P3026, DOI 10.1172/JCI28639; Zhang F, 2003, BLOOD, V102, P2115, DOI 10.1182/blood-2003-01-0049	18	53	56	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 17	2008	283	42					28702	28709		10.1074/jbc.M804223200	http://dx.doi.org/10.1074/jbc.M804223200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	359EN	18697745	hybrid, Green Published			2022-12-27	WOS:000259969300072
J	Capendeguy, O; Iwaszkiewicz, J; Michielin, O; Horisberger, JD				Capendeguy, Oihana; Iwaszkiewicz, Justyna; Michielin, Olivier; Horisberger, Jean-Daniel			The fourth extracellular loop of the alpha subunit of Na, K-ATPase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-SUBUNIT; CALCIUM-PUMP; BINDING-SITE; SARCOPLASMIC-RETICULUM; XENOPUS OOCYTES; AMINO-ACIDS; SODIUM-PUMP; FUNCTIONAL EXPRESSION; GASTRIC H,K-ATPASE; CRYSTAL-STRUCTURE	Na, K-ATPase is the main active transport system that maintains the large gradients of Na+ and K+ across the plasma membrane of animal cells. The crystal structure of a K+-occluding conformation of this protein has been recently published, but the movements of its different domains allowing for the cation pumping mechanism are not yet known. The structure of many more conformations is known for the related calcium ATPase SERCA, but the reliability of homology modeling is poor for several domains with low sequence identity, in particular the extracellular loops. To better define the structure of the large fourth extracellular loop between the seventh and eighth transmembrane segments of the alpha subunit, we have studied the formation of a disulfide bond between pairs of cysteine residues introduced by site-directed mutagenesis in the second and the fourth extracellular loop. We found a specific pair of cysteine positions (Y308C and D884C) for which extracellular treatment with an oxidizing agent inhibited the Na, K pump function, which could be rapidly restored by a reducing agent. The formation of the disulfide bond occurred preferentially under the E2-P conformation of Na, K-ATPase, in the absence of extracellular cations. Using recently published crystal structure and a distance constraint reproducing the existence of disulfide bond, we performed an extensive conformational space search using simulated annealing and showed that the Tyr(308) and Asp(884) residues can be in close proximity, and simultaneously, the SYGQ motif of the fourth extracellular loop, known to interact with the extracellular domain of the beta subunit, can be exposed to the exterior of the protein and can easily interact with the beta subunit.	[Capendeguy, Oihana; Horisberger, Jean-Daniel] Univ Lausanne, Dept Pharmacol & Toxicol, CH-1005 Lausanne, Switzerland; [Iwaszkiewicz, Justyna; Michielin, Olivier] Univ Lausanne, Swiss Inst Bioinformat, CH-1005 Lausanne, Switzerland; [Michielin, Olivier] Univ Lausanne, Ludwig Inst Canc Res, Lausanne Branch, CH-1005 Lausanne, Switzerland; [Michielin, Olivier] Univ Lausanne, Ctr Pluridisciplinaire Oncol, CH-1005 Lausanne, Switzerland	University of Lausanne; Swiss Institute of Bioinformatics; University of Lausanne; Ludwig Institute for Cancer Research; University of Lausanne; University of Lausanne	Horisberger, JD (corresponding author), Univ Lausanne, Dept Pharmacol & Toxicol, Rue Bugnon 27, CH-1005 Lausanne, Switzerland.	Jean-Daniel.Horisberger@unil.ch	Horisberger, Jean-Daniel/A-2538-2009; Michielin, Olivier/ABE-7924-2020		Swiss National Fund [31-65441.01]	Swiss National Fund(Swiss National Science Foundation (SNSF))	This work was supported by Swiss National Fund Grant 31-65441.01 (to J.-D. H.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	Artigas P, 2006, P NATL ACAD SCI USA, V103, P12613, DOI 10.1073/pnas.0602720103; Axelsen KB, 1998, J MOL EVOL, V46, P84, DOI 10.1007/PL00006286; Beguin P, 2000, MOL BIOL CELL, V11, P1657, DOI 10.1091/mbc.11.5.1657; Capendeguy O, 2006, J GEN PHYSIOL, V127, P341, DOI 10.1085/jgp.200509418; Capendeguy O, 2005, J PHYSIOL-LONDON, V565, P207, DOI 10.1113/jphysiol.2004.080218; Colonna TE, 1997, J BIOL CHEM, V272, P12366, DOI 10.1074/jbc.272.19.12366; Crambert G, 2004, MOL PHARMACOL, V65, P335, DOI 10.1124/mol.65.2.335; Feig M, 2004, J MOL GRAPH MODEL, V22, P377, DOI 10.1016/j.jmgm.2003.12.005; Geering K, 2001, J BIOENERG BIOMEMBR, V33, P425, DOI 10.1023/A:1010623724749; GEERING K, 1989, AM J PHYSIOL, V257, pC851, DOI 10.1152/ajpcell.1989.257.5.C851; Horisberger JD, 2004, PHYSIOLOGY, V19, P377, DOI 10.1152/physiol.00013.2004; Horisberger JD, 2004, J BIOL CHEM, V279, P29542, DOI 10.1074/jbc.M400585200; Horisberger JD, 2002, J PHYSIOL-LONDON, V539, P669, DOI 10.1113/jphysiol.2001.013201; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; JAISSER F, 1992, J BIOL CHEM, V267, P16895; JAUNIN P, 1992, J BIOL CHEM, V267, P577; Jorgensen PL, 2003, ANNU REV PHYSIOL, V65, P817, DOI 10.1146/annurev.physiol.65.092101.142558; JORGENSEN PL, 1988, J MEMBRANE BIOL, V103, P95, DOI 10.1007/BF01870942; Keenan SM, 2005, J MOL GRAPH MODEL, V23, P465, DOI 10.1016/j.jmgm.2005.02.001; KIRLEY TL, 1989, J BIOL CHEM, V264, P7185; LEMAS MV, 1994, J BIOL CHEM, V269, P8255; Li CM, 2005, P NATL ACAD SCI USA, V102, P12706, DOI 10.1073/pnas.0505980102; Melo F, 1998, J MOL BIOL, V277, P1141, DOI 10.1006/jmbi.1998.1665; Morth JP, 2007, NATURE, V450, P1043, DOI 10.1038/nature06419; Ogawa H, 2002, P NATL ACAD SCI USA, V99, P15977, DOI 10.1073/pnas.202622299; Paula S, 2005, BIOCHEMISTRY-US, V44, P498, DOI 10.1021/bi048680w; Qiu LY, 2006, J BIOL CHEM, V281, P13533, DOI 10.1074/jbc.M600551200; Qiu LY, 2005, J BIOL CHEM, V280, P32349, DOI 10.1074/jbc.M505168200; Rakowski RF, 2003, NEWS PHYSIOL SCI, V18, P164, DOI 10.1152/nips.01441.2003; Sanchez R, 2000, METH MOL B, V143, P97; SCHULTHEIS PJ, 1993, BIOCHEMISTRY-US, V32, P544, DOI 10.1021/bi00053a020; Sorensen TLM, 2004, SCIENCE, V304, P1672, DOI 10.1126/science.1099366; Sweadner KJ, 2001, BIOCHEM J, V356, P685, DOI 10.1042/0264-6021:3560685; Toyoshima C, 2004, ANNU REV BIOCHEM, V73, P269, DOI 10.1146/annurev.biochem.73.011303.073700; Toyoshima C, 2004, NATURE, V432, P361, DOI 10.1038/nature02981; Toyoshima C, 2000, NATURE, V405, P647, DOI 10.1038/35015017; Toyoshima C, 2002, NATURE, V418, P605, DOI 10.1038/nature00944	37	6	7	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 10	2008	283	41					27850	27858		10.1074/jbc.M802194200	http://dx.doi.org/10.1074/jbc.M802194200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	355OW	18693246	hybrid			2022-12-27	WOS:000259719200056
J	Hilvo, M; Baranauskiene, L; Salzano, AM; Scaloni, A; Matulis, D; Innocenti, A; Scozzafava, A; Monti, SM; Di Fiore, A; De Simone, G; Lindfors, M; Janis, J; Valjakka, J; Pastorekova, S; Pastorek, J; Kulomaa, MS; Nordlund, HR; Supuran, CT; Parkkila, S				Hilvo, Mika; Baranauskiene, Lina; Salzano, Anna Maria; Scaloni, Andrea; Matulis, Daumantas; Innocenti, Alessio; Scozzafava, Andrea; Monti, Simona Maria; Di Fiore, Anna; De Simone, Giuseppina; Lindfors, Mikaela; Janis, Janne; Valjakka, Jarkko; Pastorekova, Silvia; Pastorek, Jaromir; Kulomaa, Markku S.; Nordlund, Henri R.; Supuran, Claudiu T.; Parkkila, Seppo			Biochemical characterization of CA IX, one of the most active carbonic anhydrase isozymes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESSENGER-RNA EXPRESSION; BREAST-CANCER; CDNA CLONING; KERATAN SULFATE; CELL-LINES; DOMAIN; MUCIN; LOCALIZATION; INHIBITION; INDUCTION	Carbonic anhydrase IX (CA IX) is an exceptional member of the CA protein family; in addition to its classical role in pH regulation, it has also been proposed to participate in cell proliferation, cell adhesion, and tumorigenic processes. To characterize the biochemical properties of this membrane protein, two soluble recombinant forms were produced using the baculovirus-insect cell expression system. The recombinant proteins consisted of either the CA IX catalytic domain only (CA form) or the extracellular domain, which included both the proteoglycan and catalytic domains (PG + CA form). The produced proteins lacked the small transmembrane and intracytoplasmic regions of CA IX. Stopped-flow spectrophotometry experiments on both proteins demonstrated that in the excess of certain metal ions the PG + CA form exhibited the highest catalytic activity ever measured for any CA isozyme. Investigations on the oligomerization and stability of the enzymes revealed that both recombinant proteins form dimers that are stabilized by intermolecular disulfide bond(s). Mass spectrometry experiments showed that CA IX contains an intramolecular disulfide bridge (Cys(119)-Cys(299)) and a unique N-linked glycosylation site (Asn(309)) that bears high mannosetype glycan structures. Parallel experiments on a recombinant protein obtained by a mammalian cell expression system demonstrated the occurrence of an additional O-linked glycosylation site (Thr(78)) and characterized the nature of the oligosaccharide structures. This study provides novel information on the biochemical properties of CA IX and may help characterize the various cellular and pathophysiological processes in which this unique enzyme is involved.	[Hilvo, Mika; Lindfors, Mikaela; Valjakka, Jarkko; Kulomaa, Markku S.; Nordlund, Henri R.; Parkkila, Seppo] Univ Tampere, Inst Med Technol, FI-33014 Tampere, Finland; [Parkkila, Seppo] Univ Tampere, Sch Med, FI-33014 Tampere, Finland; [Parkkila, Seppo] Tampere Univ Hosp, FI-33014 Tampere, Finland; [Baranauskiene, Lina; Matulis, Daumantas] Inst Biotechnol, Lab Biothermodynam & Drug Design, LT-02241 Vilnius, Lithuania; [Salzano, Anna Maria; Scaloni, Andrea] CNR, ISPAAM, Proteom & Mass Spectrometry Lab, I-80147 Naples, Italy; [Innocenti, Alessio; Scozzafava, Andrea; Supuran, Claudiu T.] Univ Florence, Bioinorgan Chem Lab, I-50019 Florence, Italy; [Monti, Simona Maria; Di Fiore, Anna; De Simone, Giuseppina] CNR, Inst Biostruct & Bioimages, I-80134 Naples, Italy; [Janis, Janne] Univ Joensuu, Dept Chem, FI-80101 Joensuu, Finland; [Pastorekova, Silvia; Pastorek, Jaromir] Slovak Acad Sci, Ctr Mol Med, Inst Virol, Bratislava 84505, Slovakia	Tampere University; Tampere University; Tampere University; Tampere University Hospital; Vilnius University; Consiglio Nazionale delle Ricerche (CNR); Istituto Per Il Sistema Produzione Animale In Ambiente Mediterraneo (ISPAAM-CNR); University of Florence; Consiglio Nazionale delle Ricerche (CNR); Istituto di Biostrutture e Bioimmagini (IBB-CNR); University of Eastern Finland; Slovak Academy of Sciences	Hilvo, M (corresponding author), Univ Tampere, Inst Med Technol, Biokatu 6, FI-33014 Tampere, Finland.	Mika.Hilvo@uta.fi	Baranauskiene, Lina/P-5088-2016; Kulomaa, Markku S/C-9063-2014; Matulis, Daumantas/F-9367-2010; Hilvo, Mika/AAC-7468-2020; Pastorekova, Silvia/C-6685-2018; Di Fiore, Anna/AAX-5655-2020; Monti, Simona M/J-5214-2012; Pastorek, Jaromir/AAR-2647-2020; Jänis, Janne/B-7326-2014; Supuran, Claudiu T/A-5151-2008; Di Fiore, Anna/AAW-3780-2020; De Simone, Giuseppina/AAJ-4964-2021; Salzano, Anna Maria/C-7139-2012; MONTI, SIMONA MARIA/GQQ-0129-2022	Baranauskiene, Lina/0000-0002-9924-9177; Matulis, Daumantas/0000-0002-6178-6276; Di Fiore, Anna/0000-0003-2924-5194; Salzano, Anna Maria/0000-0001-7192-8760; Parkkila, Seppo/0000-0001-7323-8536; Hilvo, Mika/0000-0003-0663-5843; Supuran, Claudiu/0000-0003-4262-0323; Scozzafava, Andrea/0000-0001-5020-3322; De Simone, Giuseppina/0000-0001-9783-5431; MONTI, SIMONA MARIA/0000-0001-9647-7089; Scaloni, Andrea/0000-0001-9362-8515	Finnish Cultural Foundation; European Union projects Euroxy and DeZnIT; Lithuanian State Science and Studies Foundation; Italian National Research Council [RSTL 862, MERIT]	Finnish Cultural Foundation(Finnish Cultural FoundationFinnish IT center for science); European Union projects Euroxy and DeZnIT(European Commission); Lithuanian State Science and Studies Foundation(Research Council of Lithuania (LMTLT)); Italian National Research Council(Consiglio Nazionale delle Ricerche (CNR))	This work was supported in part by grants from the Finnish Cultural Foundation, European Union projects Euroxy and DeZnIT, the Lithuanian State Science and Studies Foundation, and the Italian National Research Council (RSTL 862 and MERIT). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	Bernardini G, 2004, PROTEOMICS, V4, P2893, DOI 10.1002/pmic.200400946; Brockhausen I, 2003, BIOCHEM SOC T, V31, P318, DOI 10.1042/BST0310318; BROCKHAUSEN I, 1995, EUR J BIOCHEM, V233, P607, DOI 10.1111/j.1432-1033.1995.607_2.x; Brockhausen I, 2006, EMBO REP, V7, P599, DOI 10.1038/sj.embor.7400705; Chandrasekaran EV, 2006, CARBOHYD RES, V341, P983, DOI 10.1016/j.carres.2006.02.017; Delcommenne M, 2002, GLYCOBIOLOGY, V12, P613, DOI 10.1093/glycob/cwf080; FOGHANDERSEN N, 1995, CLIN CHEM, V41, P1522; Folta-Stogniew E, 1999, J Biomol Tech, V10, P51; Fujikawa-Adachi K, 1999, J BIOL CHEM, V274, P21228, DOI 10.1074/jbc.274.30.21228; Fujikawa-Adachi K, 1999, GENOMICS, V61, P74, DOI 10.1006/geno.1999.5938; Funderburgh JL, 2000, GLYCOBIOLOGY, V10, P951, DOI 10.1093/glycob/10.10.951; Gasbarri A, 2003, MELANOMA RES, V13, P325, DOI 10.1097/00008390-200308000-00001; Grillo C, 2007, J BIOL CHEM, V282, P10299, DOI 10.1074/jbc.M700966200; Gross N, 2001, MED PEDIATR ONCOL, V36, P139; Hakomori S, 2002, P NATL ACAD SCI USA, V99, P10231, DOI 10.1073/pnas.172380699; Hilvo M, 2004, J HISTOCHEM CYTOCHEM, V52, P1313, DOI 10.1369/jhc.3A6225.2004; Hilvo M, 2008, CURR PHARM DESIGN, V14, P672, DOI 10.2174/138161208783877811; Hilvo M, 2005, BIOCHEM J, V392, P83, DOI 10.1042/BJ20051102; Holland JW, 2004, PROTEOMICS, V4, P743, DOI 10.1002/pmic.200300613; Honke K, 2002, MED RES REV, V22, P637, DOI 10.1002/med.10020; KHALIFAH RG, 1971, J BIOL CHEM, V246, P2561; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lehtonen J, 2004, J BIOL CHEM, V279, P2719, DOI 10.1074/jbc.M308984200; Lloyd KO, 1996, J BIOL CHEM, V271, P33325, DOI 10.1074/jbc.271.52.33325; Maiti A, 1998, SCIENCE, V282, P941, DOI 10.1126/science.282.5390.941; MAJUMDER K, 1992, GENE, V116, P115; MONTGOMERY JC, 1991, GENOMICS, V11, P835, DOI 10.1016/0888-7543(91)90006-Z; MURAKAMI H, 1987, J BIOL CHEM, V262, P1382; Nishimori I, 2007, BIOORG MED CHEM LETT, V17, P1037, DOI 10.1016/j.bmcl.2006.11.028; Opavsky R, 1996, GENOMICS, V33, P480, DOI 10.1006/geno.1996.0223; ORTOVAGUT M, 2002, GASTROENTEROLOGY, V123, P1889; Ozensoy O, 2005, BIOORG MED CHEM LETT, V15, P4862, DOI 10.1016/j.bmcl.2005.08.048; PASTOREK J, 1994, ONCOGENE, V9, P2877; Pastorekova S, 2004, CRC ENZYM INHIB SER, P255; PASTOREKOVA S, 1992, VIROLOGY, V187, P620, DOI 10.1016/0042-6822(92)90464-Z; Pastorekova S, 1997, GASTROENTEROLOGY, V112, P398, DOI 10.1053/gast.1997.v112.pm9024293; Pastorekova S, 2004, CANC THER, V2, P245; Rafajova M, 2004, INT J ONCOL, V24, P995; Salzano AM, 2007, PROTEOMICS, V7, P1420, DOI 10.1002/pmic.200601030; Sewell R, 2006, J BIOL CHEM, V281, P3586, DOI 10.1074/jbc.M511826200; SLY WS, 1995, ANNU REV BIOCHEM, V64, P375, DOI 10.1146/annurev.bi.64.070195.002111; Supuran CT, 2004, CRC ENZYM INHIB SER, P1, DOI 10.1201/9780203475300.ch1; Takahashi K, 1996, J BIOL CHEM, V271, P9490, DOI 10.1074/jbc.271.16.9490; Tureci O, 1998, P NATL ACAD SCI USA, V95, P7608, DOI 10.1073/pnas.95.13.7608; Whittington DA, 2004, J BIOL CHEM, V279, P7223, DOI 10.1074/jbc.M310809200; Wingo T, 2001, BIOCHEM BIOPH RES CO, V288, P666, DOI 10.1006/bbrc.2001.5824; Zat'ovicova M, 2003, J IMMUNOL METHODS, V282, P117, DOI 10.1016/j.jim.2003.08.011; ZAVADA J, 1993, INT J CANCER, V54, P268, DOI 10.1002/ijc.2910540218; ZHU XL, 1990, J BIOL CHEM, V265, P8795	49	216	225	0	54	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 10	2008	283	41					27799	27809		10.1074/jbc.M800938200	http://dx.doi.org/10.1074/jbc.M800938200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	355OW	18703501	hybrid			2022-12-27	WOS:000259719200051
J	Rossi, ML; Pike, JE; Wang, W; Burgers, PMJ; Campbell, JL; Bambara, RA				Rossi, Marie L.; Pike, Jason E.; Wang, Wensheng; Burgers, Peter M. J.; Campbell, Judith L.; Bambara, Robert A.			Pif1 helicase directs eukaryotic Okazaki fragments toward the two-nuclease cleavage pathway for primer removal	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-POLYMERASE-DELTA; CALF RTH-1 NUCLEASE; ESSENTIAL IN-VIVO; ENDONUCLEASE ACTIVITY; FLAP ENDONUCLEASE-1; REPLICATION FORK; LIGATABLE NICK; STRANDED DNA; HUMAN FEN1; YEAST	Eukaryotic Okazaki fragment maturation requires complete removal of the initiating RNA primer before ligation occurs. Polymerase delta (Pol delta) extends the upstream Okazaki fragment and displaces the 5'-end of the downstream primer into a single nucleotide flap, which is removed by FEN1 nuclease cleavage. This process is repeated until all RNA is removed. However, a small fraction of flaps escapes cleavage and grows long enough to be coated with RPA and requires the consecutive action of the Dna2 and FEN1 nucleases for processing. Here we tested whether RPA inhibits FEN1 cleavage of long flaps as proposed. Surprisingly, we determined that RPA binding to long flaps made dynamically by polymerase delta only slightly inhibited FEN1 cleavage, apparently obviating the need for Dna2. Therefore, we asked whether other relevant proteins promote long flap cleavage via the Dna2 pathway. The Pif1 helicase, implicated in Okazaki maturation from genetic studies, improved flap displacement and increased RPA inhibition of long flap cleavage by FEN1. These results suggest that Pif1 accelerates long flap growth, allowingRPA to bind before FEN1 can act, thereby inhibiting FEN1 cleavage. Therefore, Pif1 directs long flaps toward the two-nuclease pathway, requiring Dna2 cleavage for primer removal.	[Rossi, Marie L.; Pike, Jason E.; Wang, Wensheng; Bambara, Robert A.] Univ Rochester, Sch Med & Dent, Dept Biochem & Biophys, Rochester, NY 14642 USA; [Burgers, Peter M. J.] Washington Univ, Sch Med, Dept Biochem & Mol Biophys, St Louis, MO 63110 USA; [Campbell, Judith L.] CALTECH, Braun Labs, Pasadena, CA 91125 USA	University of Rochester; Washington University (WUSTL); California Institute of Technology	Bambara, RA (corresponding author), 601 Elmwood Ave,Box 712, Rochester, NY 14642 USA.	robert_bambara@urmc.rochester.edu	Burgers, Peter M/AAW-6621-2021		National Institutes of Health [GM024441]; NIH [GM087666, GM32431, T32-GM068411]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM068411, R01GM032431, R01GM024441] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health (NIH) Grant GM024441 (to R. A. B.) with additional support from NIH Grants GM087666 (to J.L.C.) and GM32431 (to P. M. J.B.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Ayyagari R, 2003, J BIOL CHEM, V278, P1618, DOI 10.1074/jbc.M209801200; Bae SH, 1998, J BIOL CHEM, V273, P26880, DOI 10.1074/jbc.273.41.26880; Bae SH, 2001, NATURE, V412, P456, DOI 10.1038/35086609; Bae SH, 2000, J BIOL CHEM, V275, P38022, DOI 10.1074/jbc.M006513200; Bambara RA, 1997, J BIOL CHEM, V272, P4647, DOI 10.1074/jbc.272.8.4647; Bessler JB, 2001, TRENDS CELL BIOL, V11, P60, DOI 10.1016/S0962-8924(00)01877-8; Boule JB, 2005, NATURE, V438, P57, DOI 10.1038/nature04091; Boule JB, 2006, NUCLEIC ACIDS RES, V34, P4147, DOI 10.1093/nar/gkl561; Budd ME, 2006, MOL CELL BIOL, V26, P2490, DOI 10.1128/MCB.26.7.2490-2500.2006; Budd ME, 2000, J BIOL CHEM, V275, P16518, DOI 10.1074/jbc.M909511199; Budd ME, 1997, MOL CELL BIOL, V17, P2136, DOI 10.1128/MCB.17.4.2136; Budd ME, 2000, MUTAT RES-DNA REPAIR, V459, P173, DOI 10.1016/S0921-8777(99)00072-5; Burgers PMJ, 1998, J BIOL CHEM, V273, P19756, DOI 10.1074/jbc.273.31.19756; Friedrich-Heineken E, 2003, J MOL BIOL, V328, P73, DOI 10.1016/S0022-2836(03)00270-5; Garg P, 2004, GENE DEV, V18, P2764, DOI 10.1101/gad.1252304; Gerik KJ, 1997, J BIOL CHEM, V272, P1256, DOI 10.1074/jbc.272.2.1256; HARRINGTON JJ, 1994, EMBO J, V13, P1235, DOI 10.1002/j.1460-2075.1994.tb06373.x; Huang L, 1996, BIOCHEMISTRY-US, V35, P9266, DOI 10.1021/bi9603074; Hubscher U, 2002, ANNU REV BIOCHEM, V71, P133, DOI 10.1146/annurev.biochem.71.090501.150041; Jin YH, 2003, J BIOL CHEM, V278, P1626, DOI 10.1074/jbc.M209803200; Jin YH, 2001, P NATL ACAD SCI USA, V98, P5122, DOI 10.1073/pnas.091095198; Johansson E, 2004, J BIOL CHEM, V279, P22204, DOI 10.1074/jbc.M402652200; Kao HI, 2004, J BIOL CHEM, V279, P50840, DOI 10.1074/jbc.M409231200; Kao HI, 2004, J BIOL CHEM, V279, P15014, DOI 10.1074/jbc.M313216200; Kao HI, 2003, CRIT REV BIOCHEM MOL, V38, P433, DOI 10.1080/10409230390259382; Kao KI, 2002, J BIOL CHEM, V277, P14379, DOI 10.1074/jbc.M110662200; Kornberg A., 1992, DNA REPLICATION, VSecond, P113; Lee KH, 2000, NUCLEIC ACIDS RES, V28, P2873, DOI 10.1093/nar/28.15.2873; Liu Y, 2004, ANNU REV BIOCHEM, V73, P589, DOI 10.1146/annurev.biochem.73.012803.092453; Murante RS, 1996, J BIOL CHEM, V271, P25888, DOI 10.1074/jbc.271.42.25888; Murante RS, 1995, J BIOL CHEM, V270, P30377, DOI 10.1074/jbc.270.51.30377; Rossi ML, 2006, J BIOL CHEM, V281, P26051, DOI 10.1074/jbc.M604805200; Rossi ML, 2006, CHEM REV, V106, P453, DOI 10.1021/cr040497l; Ryu GH, 2004, NUCLEIC ACIDS RES, V32, P4205, DOI 10.1093/nar/gkh720; Storici F, 2002, EMBO J, V21, P5930, DOI 10.1093/emboj/cdf587; Waga S, 1998, ANNU REV BIOCHEM, V67, P721, DOI 10.1146/annurev.biochem.67.1.721; Wold MS, 1997, ANNU REV BIOCHEM, V66, P61, DOI 10.1146/annurev.biochem.66.1.61; Zhang DH, 2006, NUCLEIC ACIDS RES, V34, P1393, DOI 10.1093/nar/gkl029; Zhou JQ, 2002, MOL BIOL CELL, V13, P2180, DOI 10.1091/mbc.02-02-0021	39	83	84	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 10	2008	283	41					27483	27493		10.1074/jbc.M804550200	http://dx.doi.org/10.1074/jbc.M804550200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	355OW	18689797	Green Published, hybrid, Green Accepted			2022-12-27	WOS:000259719200019
J	Fasken, MB; Stewart, M; Corbett, AH				Fasken, Milo B.; Stewart, Murray; Corbett, Anita H.			Functional significance of the interaction between the mRNA-binding protein, Nab2, and the nuclear pore-associated protein, Mlp1, in mRNA export	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FG-REPEAT NUCLEOPORINS; HNRNP-LIKE PROTEINS; SACCHAROMYCES-CEREVISIAE; POLY(A)(+) RNA; COMPLEX-FORMATION; YEAST; MEX67P; DOMAIN; LOCALIZATION; TAP	Nuclear export of mRNA requires several key mRNA-binding proteins that recognize and remodel the mRNA and target it for export via interactions with the nuclear pore complex. In Saccharomyces cerevisiae, the shuttling heterogeneous nuclear ribonucleoprotein, Nab2, which is essential for mRNA export, specifically recognizes poly( A) RNA and binds to the nuclear pore-associated protein, myosin- like protein 1 (Mlp1), which functions in mRNA export and quality control. Specifically, the N-terminal domain of Nab2 (Nab2-N; residues 1-97) interacts directly with the C-terminal globular domain of Mlp1 (CT-Mlp1: residues 1490-1875). Recent structural and binding studies focused on Nab2-N have shown that Nab2-N contains a hydrophobic patch centered on Phe(73) that is critical for interaction with Mlp1. Engineered amino acid changes within this patch disrupt the Nab2/Mlp1 interaction in vitro. Given the importance of Nab2 and Mlp1 to mRNA export, we have examined the Nab2/Mlp1 interaction in greater detail and analyzed the functional consequences of disrupting the interaction in vivo. We find that the Nab2-binding domain of Mlp1 (Mlp1-NBD) maps to a 183-residue region (residues 1586-1768) within CT-Mlp1, binds directly to Nab2 with micromolar affinity, and confers nuclear accumulation of poly( A) RNA. Furthermore, we show that cells expressing a Nab2 F73D mutant that cannot interact with Mlp1 exhibit nuclear accumulation of poly(A) RNA and that this nab2 F73D mutant genetically interacts with alleles of two essential mRNA export genes, MEX67 and YRA1. These data provide in vivo evidence for a model of mRNA export in which Nab2 is important for targeting mRNAs to the nuclear pore for export.	[Fasken, Milo B.; Corbett, Anita H.] Emory Univ, Sch Med, Dept Biochem, Atlanta, GA 30322 USA; [Stewart, Murray] MRC, Mol Biol Lab, Cambridge CB2 2QH, England	Emory University; MRC Laboratory Molecular Biology	Corbett, AH (corresponding author), 1510 Clifton Rd, Atlanta, GA 30322 USA.	acorbe2@emory.edu	Corbett, Anita/AAH-6106-2021; Fasken, Milo/K-2177-2019	Corbett, Anita/0000-0002-0461-6895; Fasken, Milo/0000-0003-4317-7909	National Institutes of Health; Wellcome Trust Programme; Medical Research Council [MC_U105178939] Funding Source: researchfish; MRC [MC_U105178939] Funding Source: UKRI; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM058728] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wellcome Trust Programme(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by a National Institutes of Health grant (to A. H. C.). This work was also supported by a Wellcome Trust Programme Grant (to M. S.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Adams A, 1997, METHODS YEAST GENETI; Aitchison JD, 1996, SCIENCE, V274, P624, DOI 10.1126/science.274.5287.624; Alcazar-Roman AR, 2006, NAT CELL BIOL, V8, P711, DOI 10.1038/ncb1427; ANDERSON JT, 1993, MOL CELL BIOL, V13, P2730, DOI 10.1128/MCB.13.5.2730; Bangs P, 1998, J CELL BIOL, V143, P1801, DOI 10.1083/jcb.143.7.1801; Bayliss R, 1999, J MOL BIOL, V293, P579, DOI 10.1006/jmbi.1999.3166; Bayliss R, 2002, J BIOL CHEM, V277, P50597, DOI 10.1074/jbc.M209037200; Bennett-Lovsey RM, 2008, PROTEINS, V70, P611, DOI 10.1002/prot.21688; BOEKE JD, 1987, METHOD ENZYMOL, V154, P164; Braun IC, 2001, J BIOL CHEM, V276, P20536, DOI 10.1074/jbc.M100400200; BYRD DA, 1994, J CELL BIOL, V127, P1515, DOI 10.1083/jcb.127.6.1515; Cordes VC, 1997, J CELL BIOL, V136, P515, DOI 10.1083/jcb.136.3.515; Fasken MB, 2005, NAT STRUCT MOL BIOL, V12, P482, DOI 10.1038/nsmb945; Feuerbach F, 2002, NAT CELL BIOL, V4, P214, DOI 10.1038/ncb756; Fribourg S, 2001, MOL CELL, V8, P645, DOI 10.1016/S1097-2765(01)00348-3; Galy V, 2004, CELL, V116, P63, DOI 10.1016/S0092-8674(03)01026-2; Gatfield D, 2002, J CELL BIOL, V159, P579, DOI 10.1083/jcb.200207128; Gilbert W, 2004, MOL CELL, V13, P201, DOI 10.1016/S1097-2765(04)00030-9; Grant RP, 2008, J MOL BIOL, V376, P1048, DOI 10.1016/j.jmb.2007.11.087; Green DM, 2003, P NATL ACAD SCI USA, V100, P1010, DOI 10.1073/pnas.0336594100; Green DM, 2002, J BIOL CHEM, V277, P7752, DOI 10.1074/jbc.M110053200; Gruter P, 1998, MOL CELL, V1, P649, DOI 10.1016/S1097-2765(00)80065-9; Guzik BW, 2001, MOL CELL BIOL, V21, P2545, DOI 10.1128/MCB.21.7.2545-2554.2001; Hase ME, 2003, MOL BIOL CELL, V14, P1923, DOI 10.1091/mbc.E02-09-0620; Hector RE, 2002, EMBO J, V21, P1800, DOI 10.1093/emboj/21.7.1800; Henry M, 1996, GENETICS, V142, P103; Herold A, 2001, RNA, V7, P1768; Hieronymus H, 2003, NAT GENET, V33, P155, DOI 10.1038/ng1080; Hodel MR, 2001, J BIOL CHEM, V276, P1317, DOI 10.1074/jbc.M008522200; Hodge CA, 1999, EMBO J, V18, P5778, DOI 10.1093/emboj/18.20.5778; Katahira J, 2002, J BIOL CHEM, V277, P9242, DOI 10.1074/jbc.M110007200; Kelly SM, 2007, P NATL ACAD SCI USA, V104, P12306, DOI 10.1073/pnas.0701244104; Kohler A, 2007, NAT REV MOL CELL BIO, V8, P761, DOI 10.1038/nrm2255; KOLLING R, 1993, MOL GEN GENET, V237, P359; Kosova B, 2000, J BIOL CHEM, V275, P343, DOI 10.1074/jbc.275.1.343; Lange A, 2008, J BIOL CHEM, V283, P12926, DOI 10.1074/jbc.M800898200; Lee DCY, 1999, J BIOL CHEM, V274, P29031, DOI 10.1074/jbc.274.41.29031; Lei EP, 2001, GENE DEV, V15, P1771, DOI 10.1101/gad.892401; Longman D, 2003, RNA, V9, P881, DOI 10.1261/rna.5420503; Lund MK, 2005, MOL CELL, V20, P645, DOI 10.1016/j.molcel.2005.10.005; Marfatia KA, 2003, J BIOL CHEM, V278, P6731, DOI 10.1074/jbc.M207571200; Proudfoot NJ, 2002, CELL, V108, P501, DOI 10.1016/S0092-8674(02)00617-7; Rodrigues JP, 2001, P NATL ACAD SCI USA, V98, P1030, DOI 10.1073/pnas.98.3.1030; RUSSELL I, 1995, EUR J CELL BIOL, V66, P293; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; Santos-Rosa H, 1998, MOL CELL BIOL, V18, P6826, DOI 10.1128/MCB.18.11.6826; SCHLENSTEDT G, 1995, P NATL ACAD SCI USA, V92, P225, DOI 10.1073/pnas.92.1.225; Segref A, 1997, EMBO J, V16, P3256, DOI 10.1093/emboj/16.11.3256; SINGLETON DR, 1995, J CELL SCI, V108, P265; Snay-Hodge CA, 1998, EMBO J, V17, P2663, DOI 10.1093/emboj/17.9.2663; Sommer P, 2005, CURR OPIN CELL BIOL, V17, P294, DOI 10.1016/j.ceb.2005.04.007; Strahm Y, 1999, EMBO J, V18, P5761, DOI 10.1093/emboj/18.20.5761; Strambio-de-Castillia C, 1999, J CELL BIOL, V144, P839, DOI 10.1083/jcb.144.5.839; Strasser K, 2000, J CELL BIOL, V150, P695, DOI 10.1083/jcb.150.4.695; Strasser K, 2000, EMBO J, V19, P410, DOI 10.1093/emboj/19.3.410; Stutz F, 2003, TRENDS CELL BIOL, V13, P319, DOI 10.1016/S0962-8924(03)00106-5; Stutz F, 2000, RNA, V6, P638, DOI 10.1017/S1355838200000078; Suntharalingam M, 2004, J BIOL CHEM, V279, P35384, DOI 10.1074/jbc.M402044200; Suntharalingam M, 2003, DEV CELL, V4, P775, DOI 10.1016/S1534-5807(03)00162-X; Szymczyna BR, 2003, GENE DEV, V17, P461, DOI 10.1101/gad.1060403; Tan W, 2000, RNA, V6, P1762, DOI 10.1017/S1355838200000832; Terry LJ, 2007, J CELL BIOL, V178, P1121, DOI 10.1083/jcb.200704174; Tran EJ, 2007, MOL CELL, V28, P850, DOI 10.1016/j.molcel.2007.09.019; Tseng SSL, 1998, EMBO J, V17, P2651, DOI 10.1093/emboj/17.9.2651; Vinciguerra P, 2004, CURR OPIN CELL BIOL, V16, P285, DOI 10.1016/j.ceb.2004.03.013; Vinciguerra P, 2005, EMBO J, V24, P813, DOI 10.1038/sj.emboj.7600527; Weirich CS, 2006, NAT CELL BIOL, V8, P668, DOI 10.1038/ncb1424; Wiegand HL, 2002, MOL CELL BIOL, V22, P245, DOI 10.1128/MCB.22.1.245-256.2002; WILSON SM, 1994, J CELL BIOL, V127, P1173, DOI 10.1083/jcb.127.5.1173; Wong DH, 1997, MOL CELL BIOL, V17, P3755, DOI 10.1128/MCB.17.7.3755; Zenklusen D, 2002, MOL CELL BIOL, V22, P8241, DOI 10.1128/MCB.22.23.8241-8253.2002; Zenklusen D, 2001, MOL CELL BIOL, V21, P4219, DOI 10.1128/MCB.21.13.4219-4232.2001; Zhou ZL, 2000, NATURE, V407, P401, DOI 10.1038/35030160	73	55	57	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 3	2008	283	40					27130	27143		10.1074/jbc.M803649200	http://dx.doi.org/10.1074/jbc.M803649200			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	353RT	18682389	Green Published, hybrid			2022-12-27	WOS:000259586600034
J	Hao, F; Tan, MQ; Xu, XM; Cui, MZ				Hao, Feng; Tan, Mingqi; Xu, Xuemin; Cui, Mei-Zhen			Histamine induces Egr-1 expression in human aortic endothelial cells via the H1 receptor-mediated protein kinase C delta-dependent ERK activation pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMOOTH-MUSCLE-CELLS; TISSUE FACTOR EXPRESSION; EARLY GROWTH RESPONSE-1; NITRIC-OXIDE SYNTHASE; NF-KAPPA-B; GENE-EXPRESSION; CORONARY-ARTERY; ATHEROSCLEROSIS; MONOCYTES/MACROPHAGES; CYCLOOXYGENASE-2	Histamine, a potent inflammatory mediator, has multiple effects on the pathogenesis of atherosclerosis. This study investigates the effect of histamine on the expression of early growth response factor 1 (Egr-1), a master transcription factor that regulates the expression of an array of atherogenic genes in atherosclerotic lesions. Histamine markedly and rapidly induces Egr-1 mRNA and protein expression in primary human aortic endothelial cells (HAECs). Histamine-induced Egr-1 expression is dependent on the activation of the H1 receptor. Histamine also rapidly and transiently activates protein kinase C-delta (PKC delta), extracellular signal-regulated kinase (ERK) 1/2, p38 kinase, and c-Jun N-terminal kinase (JNK) prior to Egr-1 induction. Using specific pharmacological inhibitors and small interfering RNA technology, we determined that PKC delta and ERK, but not p38 and JNK, mediate histamine-induced Egr-1 expression. Our data provide the first evidence that histamine regulates expression of Egr-1 in mammalian cells and demonstrate a novel role of PKC delta in up-regulation of Egr-1 expression. The present study reveals the following regulatory mechanism: histamine up-regulates Egr-1 expression in primary HAECs via the H1 receptor and the PKC delta-dependent ERK activation pathway. Our data also imply that CREB, a downstream component of the ERK pathway, regulates Egr-1 expression in HAECs. Importantly, these results suggest a central role of Egr-1 in histamine-induced gene expression and in histamine-induced vascular disease.	[Hao, Feng; Tan, Mingqi; Xu, Xuemin; Cui, Mei-Zhen] Univ Tennessee, Coll Vet Med, Dept Pathobiol, Knoxville, TN 37996 USA	University of Tennessee System; University of Tennessee Knoxville; UT Institute of Agriculture	Cui, MZ (corresponding author), 2407 River Dr, Knoxville, TN 37996 USA.	cuim@utk.edu		Cui, Mei-Zhen/0000-0003-4745-6999; xu, xuemin/0000-0002-7426-272X	National Institutes of Health [HL074341, AG026640]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL074341] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG026640] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants HL074341 (to M.-Z.C.) and AG026640 (to X. X.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	ASAKO H, 1994, J CLIN INVEST, V93, P1508, DOI 10.1172/JCI117129; Blaschke F, 2004, REV ENDOCR METAB DIS, V5, P249, DOI 10.1023/B:REMD.0000032413.88756.ee; Brodie C, 2003, APOPTOSIS, V8, P19, DOI 10.1023/A:1021640817208; Choi EY, 2007, J CELL BIOCHEM, V102, P1442, DOI 10.1002/jcb.21367; Cui MZ, 2006, ARTERIOSCL THROM VAS, V26, P1029, DOI 10.1161/01.ATV.0000214980.90567.b5; Cui MZ, 2003, ARTERIOSCL THROM VAS, V23, P224, DOI 10.1161/01.ATV.0000054660.61191.7D; DELNESTE Y, 1994, CLIN EXP IMMUNOL, V98, P344; Fang YI, 2005, LIFE SCI, V77, P241, DOI 10.1016/j.lfs.2004.05.041; GSCHWENDT M, 1994, BIOCHEM BIOPH RES CO, V199, P93, DOI 10.1006/bbrc.1994.1199; Gschwendt M, 1996, FEBS LETT, V392, P77, DOI 10.1016/0014-5793(96)00785-5; Haller H, 1996, ARTERIOSCL THROM VAS, V16, P678, DOI 10.1161/01.ATV.16.5.678; Higuchi S, 2001, FEBS LETT, V505, P217, DOI 10.1016/S0014-5793(01)02823-X; JEANNIN P, 1994, BLOOD, V84, P2229; Khachigian LM, 2006, CIRC RES, V98, P186, DOI 10.1161/01.RES.0000200177.53882.c3; Kimura S, 2004, PATHOL INT, V54, P465, DOI 10.1111/j.1440-1827.2004.01653.x; KRIZBAI I, 1995, J NEUROCHEM, V65, P459; Li HG, 2003, CIRCULATION, V107, P2348, DOI 10.1161/01.CIR.0000066697.19571.AF; Li Y, 2001, MICROVASC RES, V61, P253, DOI 10.1006/mvre.2001.2304; Linton MF, 2004, CURR OPIN PHARMACOL, V4, P116, DOI 10.1016/j.coph.2003.12.003; Lo LW, 2001, J CELL PHYSIOL, V188, P304, DOI 10.1002/jcp.1124; MARTINYBARON G, 1993, J BIOL CHEM, V268, P9194; Miyazawa N, 1998, EUR J PHARMACOL, V362, P53, DOI 10.1016/S0014-2999(98)00716-X; Packard RRS, 2008, CLIN CHEM, V54, P24, DOI 10.1373/clinchem.2007.097360; Prince JM, 2007, SHOCK, V27, P157, DOI 10.1097/01.shk.0000245025.01365.8e; SAKAMOTO KM, 1994, MOL CELL BIOL, V14, P5975, DOI 10.1128/MCB.14.9.5975; Sasaguri Y, 2005, CIRC RES, V96, P974, DOI 10.1161/01.RES.0000166325.00383.ed; SATOH T, 1994, ATHEROSCLEROSIS, V110, P53, DOI 10.1016/0021-9150(94)90067-1; Sayasith K, 2006, J MOL ENDOCRINOL, V37, P239, DOI 10.1677/jme.1.02078; Steffel J, 2005, CIRCULATION, V112, P341, DOI 10.1161/CIRCULATIONAHA.105.553735; TAKAGISHI T, 1995, AM J PATHOL, V146, P981; Tan X, 2007, J IMMUNOL, V179, P7899, DOI 10.4049/jimmunol.179.11.7899; Tanimoto A, 2007, ARTERIOSCL THROM VAS, V27, P1556, DOI 10.1161/ATVBAHA.106.139089; Tanimoto A, 2006, TRENDS CARDIOVAS MED, V16, P280, DOI 10.1016/j.tcm.2006.06.001; TOULLEC D, 1991, J BIOL CHEM, V266, P15771; Wheaton K, 2004, MOL CELL BIOL, V24, P7298, DOI 10.1128/MCB.24.16.7298-7311.2004; Yan SF, 1999, J BIOL CHEM, V274, P15030, DOI 10.1074/jbc.274.21.15030	36	26	28	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 3	2008	283	40					26928	26936		10.1074/jbc.M803071200	http://dx.doi.org/10.1074/jbc.M803071200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	353RT	18682391	Green Published, hybrid			2022-12-27	WOS:000259586600013
J	Arredondo, S; Segatori, L; Gilbert, HF; Georgiou, G				Arredondo, Silvia; Segatori, Laura; Gilbert, Hiram F.; Georgiou, George			De Novo Design and Evolution of Artificial Disulfide Isomerase Enzymes Analogous to the Bacterial DsbC	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; ACTIVE-SITE; RIBONUCLEASE-A; BOND FORMATION; ALKALINE-PHOSPHATASE; CRYSTAL-STRUCTURE; CXXC MOTIF; IN-VIVO; PROTEIN; THIOREDOXIN	The Escherichia coli disulfide isomerase, DsbC is a V-shaped homodimer with each monomer comprising a dimerization region that forms part of a putative peptide-binding pocket and a thioredoxin catalytic domain. Disulfide isomerases from prokaryotes and eukaryotes exhibit little sequence homology but display very similar structural organization with two thioredoxin domains facing each other on top of the dimerization/peptide- binding region. To aid the understanding of the mechanistic significance of thioredoxin domain dimerization and of the peptide-binding cleft of DsbC, we constructed a series of protein chimeras comprising unrelated protein dimerization domains fused to thioredoxin superfamily enzymes. Chimeras consisting of the dimerization domain and the alpha-helical linker of the bacterial proline cis/trans isomerase FkpA and the periplasmic oxidase DsbA gave rise to enzymes that catalyzed the folding of multidisulfide substrate proteins in vivo with comparable efficiency to E. coli DsbC. In addition, expression of FkpA-DsbAs conferred modest resistance to CuCl2, a phenotype that depends on disulfide bond isomerization. Selection for resistance to elevated CuCl2 concentrations led to the isolation of FkpA-DsbA mutants containing a single amino acid substitution that changed the active site of the DsbAdo main from CP (H) under barC into CP (Y) under barC, increasing the similarity to the DsbC active site ( CG (Y) under barC). Unlike DsbC, which is resistant to oxidation by DsbB-DsbA and does not normally catalyze disulfide bond formation under physiological conditions, the FkpA-DsbA chimeras functioned both as oxidases and isomerases. The engineering of these efficient artificial isomerases delineates the key features of catalysis of disulfide bond isomerization and enhances our understanding of its evolution.	[Gilbert, Hiram F.] Baylor Coll Med, Dept Biochem, Houston, TX 77030 USA; [Georgiou, George] Univ Texas Austin, Inst Cell & Mol Biol, Austin, TX 78712 USA; [Arredondo, Silvia; Segatori, Laura; Georgiou, George] Univ Texas Austin, Dept Chem Engn, Austin, TX 78712 USA; [Georgiou, George] Univ Texas Austin, Dept Biomed Engn, Austin, TX 78712 USA; [Georgiou, George] Univ Texas Austin, Dept Mol Genet & Microbiol, Austin, TX 78712 USA	Baylor College of Medicine; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin	Georgiou, G (corresponding author), 1 Univ Stn Stop C0400, Austin, TX 78712 USA.	gg@che.utexas.edu			National Institutes of Health [GM 55090]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM055090] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM 55090. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Bader MW, 2001, EMBO J, V20, P1555, DOI 10.1093/emboj/20.7.1555; Berkmen M, 2005, J BIOL CHEM, V280, P11387, DOI 10.1074/jbc.M411774200; Bessette PH, 1999, P NATL ACAD SCI USA, V96, P13703, DOI 10.1073/pnas.96.24.13703; Bessette PH, 1999, J BIOL CHEM, V274, P7784, DOI 10.1074/jbc.274.12.7784; BRICKMAN E, 1975, J MOL BIOL, V96, P307, DOI 10.1016/0022-2836(75)90350-2; Buchner J, 1998, METHOD ENZYMOL, V290, P323, DOI 10.1016/S0076-6879(98)90029-5; Chivers PT, 1997, BIOCHEMISTRY-US, V36, P4061, DOI 10.1021/bi9628580; Chivers PT, 1996, EMBO J, V15, P2659, DOI 10.1002/j.1460-2075.1996.tb00626.x; Collet JF, 2002, MOL MICROBIOL, V44, P1, DOI 10.1046/j.1365-2958.2002.02851.x; Debarbieux L, 1998, P NATL ACAD SCI USA, V95, P10751, DOI 10.1073/pnas.95.18.10751; Foloppe N, 2004, STRUCTURE, V12, P289, DOI 10.1016/j.str.2004.01.009; FROMANT M, 1995, ANAL BIOCHEM, V224, P347, DOI 10.1006/abio.1995.1050; GRAUSCHOPF U, 1995, CELL, V83, P947, DOI 10.1016/0092-8674(95)90210-4; Grauschopf U, 2003, EMBO J, V22, P3503, DOI 10.1093/emboj/cdg356; Gruber CW, 2006, TRENDS BIOCHEM SCI, V31, P455, DOI 10.1016/j.tibs.2006.06.001; GUILHOT C, 1995, P NATL ACAD SCI USA, V92, P9895, DOI 10.1073/pnas.92.21.9895; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995; HAWKINS HC, 1991, BIOCHEM J, V275, P349, DOI 10.1042/bj2750349; Hiniker A, 2005, J BIOL CHEM, V280, P33785, DOI 10.1074/jbc.M505742200; HOLMGREN A, 1979, J BIOL CHEM, V254, P9627; Huber-Wunderlich M, 1998, FOLD DES, V3, P161, DOI 10.1016/S1359-0278(98)00024-8; Jonda S, 1999, EMBO J, V18, P3271, DOI 10.1093/emboj/18.12.3271; Kadokura H, 2003, ANNU REV BIOCHEM, V72, P111, DOI 10.1146/annurev.biochem.72.121801.161459; KAMITANI S, 1992, EMBO J, V11, P57, DOI 10.1002/j.1460-2075.1992.tb05027.x; KISHIGAMI S, 1995, J BIOL CHEM, V270, P17072, DOI 10.1074/jbc.270.29.17072; KRAUSE G, 1991, J BIOL CHEM, V266, P9494; Kulp MS, 2006, J BIOL CHEM, V281, P876, DOI 10.1074/jbc.M511764200; LUNDSTROM J, 1992, J BIOL CHEM, V267, P9047; LUNDSTROMLJUNG J, 1995, J BIOL CHEM, V270, P7822, DOI 10.1074/jbc.270.14.7822; LYLES MM, 1991, BIOCHEMISTRY-US, V30, P613, DOI 10.1021/bi00217a004; MARTIN JL, 1995, STRUCTURE, V3, P245, DOI 10.1016/S0969-2126(01)00154-X; McCarthy AA, 2000, NAT STRUCT BIOL, V7, P196; Messens J, 2006, INT J BIOCHEM CELL B, V38, P1050, DOI 10.1016/j.biocel.2005.12.011; PACK P, 1992, BIOCHEMISTRY-US, V31, P1579, DOI 10.1021/bi00121a001; Qiu J, 1998, APPL ENVIRON MICROB, V64, P4891; Ruoppolo M, 2003, PROTEIN SCI, V12, P939, DOI 10.1110/ps.0242803; Saul FA, 2004, J MOL BIOL, V335, P595, DOI 10.1016/j.jmb.2003.10.056; Segatori L, 2006, J BIOL CHEM, V281, P4911, DOI 10.1074/jbc.M505453200; Segatori L, 2004, P NATL ACAD SCI USA, V101, P10018, DOI 10.1073/pnas.0403003101; Sun XX, 2000, J BIOL CHEM, V275, P22743, DOI 10.1074/jbc.M002406200; Tian G, 2006, CELL, V124, P61, DOI 10.1016/j.cell.2005.10.044; Yeh SM, 2007, ACTA CRYSTALLOGR D, V63, P465, DOI 10.1107/S0907444907003320; Zhao Z, 2003, J BIOL CHEM, V278, P43292, DOI 10.1074/jbc.M306945200	43	14	14	3	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 14	2008	283	46					31469	31476		10.1074/jbc.M803346200	http://dx.doi.org/10.1074/jbc.M803346200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	370KJ	18782764	Green Published, hybrid			2022-12-27	WOS:000260760800026
J	Madan, D; Lin, Z; Rye, HS				Madan, Damian; Lin, Zong; Rye, Hays S.			Triggering Protein Folding within the GroEL-GroES Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OLIGOMERIC CHAPERONIN GROEL; CRYSTAL-STRUCTURE; ATPASE CYCLE; CRYOELECTRON MICROSCOPY; ALLOSTERIC SITE; CENTRAL CAVITY; SUBSTRATE; BINDING; POLYPEPTIDE; MECHANISM	The folding of many proteins depends on the assistance of chaperonins like GroEL and GroES and involves the enclosure of substrate proteins inside an internal cavity that is formed when GroES binds to GroEL in the presence of ATP. Precisely how assembly of the GroEL-GroES complex leads to substrate protein encapsulation and folding remains poorly understood. Here we use a chemically modified mutant of GroEL (EL43Py) to uncouple substrate protein encapsulation from release and folding. Although EL43Py correctly initiates a substrate protein encapsulation reaction, this mutant stalls in an intermediate allosteric state of the GroEL ring, which is essential for both GroES binding and the forced unfolding of the substrate protein. This intermediate conformation of the GroEL ring possesses simultaneously high affinity for both GroES and non-native substrate protein, thus preventing escape of the substrate protein while GroES binding and substrate protein compaction takes place. Strikingly, assembly of the folding-active GroEL-GroES complex appears to involve a strategic delay in ATP hydrolysis that is coupled to disassembly of the old, ADP-bound GroEL-GroES complex on the opposite ring.	[Madan, Damian; Lin, Zong; Rye, Hays S.] Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA	Princeton University	Rye, HS (corresponding author), Shultz Lab, Rm 216, Princeton, NJ 08544 USA.	hrye@princeton.edu		Rye, Hays/0000-0002-9420-3137	National Institutes of Health [GM065421]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065421] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM065421. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	BADCOE IG, 1991, BIOCHEMISTRY-US, V30, P9195, DOI 10.1021/bi00102a010; BRAIG K, 1994, NATURE, V371, P578, DOI 10.1038/371578a0; BUCHNER J, 1991, BIOCHEMISTRY-US, V30, P1586, DOI 10.1021/bi00220a020; BURSTON SG, 1995, J MOL BIOL, V249, P138, DOI 10.1006/jmbi.1995.0285; Chen LL, 1999, CELL, V99, P757, DOI 10.1016/S0092-8674(00)81673-6; CHEN S, 1994, NATURE, V371, P261, DOI 10.1038/371261a0; Cliff MJ, 2006, J BIOL CHEM, V281, P21266, DOI 10.1074/jbc.M601605200; Elad N, 2007, MOL CELL, V26, P415, DOI 10.1016/j.molcel.2007.04.004; Erlanson DA, 2000, P NATL ACAD SCI USA, V97, P9367, DOI 10.1073/pnas.97.17.9367; Farr GW, 2007, P NATL ACAD SCI USA, V104, P5342, DOI 10.1073/pnas.0700820104; FENTON WA, 1994, NATURE, V371, P614, DOI 10.1038/371614a0; Fenton WA, 2003, Q REV BIOPHYS, V36, P229, DOI 10.1017/S0033583503003883; GOLOUBINOFF P, 1989, NATURE, V342, P884, DOI 10.1038/342884a0; Hardy JA, 2004, P NATL ACAD SCI USA, V101, P12461, DOI 10.1073/pnas.0404781101; Jeong YJ, 2004, P NATL ACAD SCI USA, V101, P7264, DOI 10.1073/pnas.0400372101; Kad NM, 1998, J MOL BIOL, V278, P267, DOI 10.1006/jmbi.1998.1704; KREUZER KN, 1983, METHOD ENZYMOL, V100, P144; Levin MK, 2003, J BIOL CHEM, V278, P23311, DOI 10.1074/jbc.M301283200; Lin Z, 2004, MOL CELL, V16, P23, DOI 10.1016/j.molcel.2004.09.003; Lin Z, 2008, NAT STRUCT MOL BIOL, V15, P303, DOI 10.1038/nsmb.1394; Lin Z, 2006, CRIT REV BIOCHEM MOL, V41, P211, DOI 10.1080/10409230600760382; Machida K, 2008, J BIOL CHEM, V283, P6886, DOI 10.1074/jbc.M708002200; MARTIN J, 1991, NATURE, V352, P36, DOI 10.1038/352036a0; Mayhew M, 1996, NATURE, V379, P420, DOI 10.1038/379420a0; Murai N, 1996, J BIOL CHEM, V271, P28229, DOI 10.1074/jbc.271.45.28229; Poso D, 2004, J MOL BIOL, V338, P969, DOI 10.1016/j.jmb.2004.03.010; Ranson NA, 2006, NAT STRUCT MOL BIOL, V13, P147, DOI 10.1038/nsmb1046; Ranson NA, 2001, CELL, V107, P869, DOI 10.1016/S0092-8674(01)00617-1; Roseman AM, 1996, CELL, V87, P241, DOI 10.1016/S0092-8674(00)81342-2; Rye HS, 1999, CELL, V97, P325, DOI 10.1016/S0092-8674(00)80742-4; Rye HS, 1997, NATURE, V388, P792, DOI 10.1038/42047; Rye HS, 2001, METHODS, V24, P278, DOI 10.1006/meth.2001.1188; Scheer JM, 2006, P NATL ACAD SCI USA, V103, P7595, DOI 10.1073/pnas.0602571103; Sparrer H, 1997, J BIOL CHEM, V272, P14080, DOI 10.1074/jbc.272.22.14080; Tang YC, 2006, CELL, V125, P903, DOI 10.1016/j.cell.2006.04.027; Thiyagarajan P, 1996, STRUCTURE, V4, P79, DOI 10.1016/S0969-2126(96)00011-1; TODD MJ, 1994, SCIENCE, V265, P659, DOI 10.1126/science.7913555; Ueno T, 2004, MOL CELL, V14, P423, DOI 10.1016/S1097-2765(04)00261-8; VIITANEN PV, 1991, BIOCHEMISTRY-US, V30, P9716, DOI 10.1021/bi00104a021; WEISSMAN JS, 1994, CELL, V78, P693, DOI 10.1016/0092-8674(94)90533-9; Weissman JS, 1996, CELL, V84, P481, DOI 10.1016/S0092-8674(00)81293-3; WEISSMAN JS, 1995, CELL, V83, P577, DOI 10.1016/0092-8674(95)90098-5; Xu ZH, 1997, NATURE, V388, P741, DOI 10.1038/41944; YIFRACH O, 1994, J MOL BIOL, V243, P397, DOI 10.1006/jmbi.1994.1667; YIFRACH O, 1995, BIOCHEMISTRY-US, V34, P5303, DOI 10.1021/bi00016a001; Young JC, 2004, NAT REV MOL CELL BIO, V5, P781, DOI 10.1038/nrm1492	46	28	29	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 14	2008	283	46					32003	32013		10.1074/jbc.M802898200	http://dx.doi.org/10.1074/jbc.M802898200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	370KJ	18782766	Green Published, hybrid			2022-12-27	WOS:000260760800082
J	Zang, MW; Gong, J; Luo, LQ; Zhou, J; Xiang, XQ; Huang, W; Huang, QR; Luo, XX; Olbrot, M; Peng, YH; Chen, CY; Luo, ZJ				Zang, Mengwei; Gong, Jun; Luo, Lingqi; Zhou, Jing; Xiang, Xiaoqin; Huang, Wei; Huang, Qiren; Luo, Xixi; Olbrot, Martin; Peng, Yihong; Chen, Changyan; Luo, Zhijun			Characterization of Ser(338) Phosphorylation for Raf-1 Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CROSS-CASCADE ACTIVATION; PROTEIN-KINASE; B-RAF; PHOSPHATIDYLINOSITOL 3-KINASE; REGULATED KINASE; BRAF MUTATIONS; SIGNALING PATHWAYS; SERINE; PAK; IDENTIFICATION	Raf kinases are essential for regulating cell proliferation, survival, and tumorigenesis. However, the mechanisms by which Raf is activated are still incompletely understood. Phosphorylation plays a critical role in Raf activation in response to mitogens. The present study characterizes phosphorylation of Ser(338), a crucial event for Raf-1 activation. Here we report that mutation of Lys(375) to Met diminishes phosphorylation of Ser(338) on both wild type Raf-1 in cells treated with epidermal growth factor (EGF) or 12-O-tetradecanoylphorbol-13-acetate (TPA) and a constitutively active mutant in which Tyr(340)/Tyr(341) are replaced by 2 aspartic acids, a conserved substitution present in natural B-Raf. The loss of Ser(338) phosphorylation in these Raf mutants is not engendered by a mutation-induced conformational change, inasmuch as mutation of another site (Ser(471) to Ala) in the activation segment also abolishes Ser(338) phosphorylation, whereas both the kinase-dead mutants of Raf-1 are phosphorylated well by active Pak1. Furthermore, our data demonstrate that EGF-stimulated phosphorylation of Ser(338) is inhibited by Sorafenib, a Raf kinase inhibitor, but not by the MEK inhibitor U0126. Interestingly, a kinase-dead mutation and Sorafenib also markedly reduce phosphorylation of Ser(445) on B-Raf, a site equivalent to Raf-1 Ser(338). Finally, our data reveal that Ser(338) is phosphorylated on inactive Raf-1 by an active mutant of Raf-1 when they are dimerized in cells and that artificial dimerization of Raf-1 causes Ser(338) phosphorylation, accompanied by activation of ERK1/2. Altogether, our data suggest that Ser(338) on Raf-1 is autophosphorylated in response to mitogens.	[Gong, Jun; Luo, Lingqi; Zhou, Jing; Luo, Zhijun] Boston Univ, Sch Med, Dept Biochem, Boston, MA 02118 USA; [Zang, Mengwei; Xiang, Xiaoqin; Luo, Xixi; Olbrot, Martin; Luo, Zhijun] Boston Univ, Sch Med, Dept Med, Boston, MA 02118 USA; [Huang, Wei; Huang, Qiren; Luo, Zhijun] Boston Univ, Sch Med, Genome Sci Inst, Boston, MA 02118 USA; [Peng, Yihong] Peking Univ, Hlth Sci Ctr, Dept Microbiol, Beijing 100083, Peoples R China; [Chen, Changyan] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Dept Radiol & Oncol, Boston, MA 02215 USA	Boston University; Boston University; Boston University; Peking University; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Luo, ZJ (corresponding author), 715 Albany St,Evans 645, Boston, MA 02118 USA.	zluo@bu.edu	Luo, Zhijun/AAE-9302-2019	Luo, Zhijun/0000-0001-8105-5289; Zang, Mengwei/0000-0002-2502-2586; Luo, Zhijun/0000-0003-3509-4046	National Institutes of Health [GM057959, CA118918]; NATIONAL CANCER INSTITUTE [R01CA118918] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057959] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM057959 and CA118918 (to Z. L.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Abraham D, 2000, J BIOL CHEM, V275, P22300, DOI 10.1074/jbc.M003259200; Bagrodia S, 1999, TRENDS CELL BIOL, V9, P350, DOI 10.1016/S0962-8924(99)01618-9; BARBACID M, 1987, ANNU REV BIOCHEM, V56, P779, DOI 10.1146/annurev.bi.56.070187.004023; Barnard D, 1998, ONCOGENE, V17, P1539, DOI 10.1038/sj.onc.1202061; Beeser A, 2005, J BIOL CHEM, V280, P36609, DOI 10.1074/jbc.M502306200; Brose MS, 2002, CANCER RES, V62, P6997; CARROLL MP, 1994, J BIOL CHEM, V269, P1249; Chaudhary A, 2000, CURR BIOL, V10, P551, DOI 10.1016/S0960-9822(00)00475-9; Chiloeches A, 2001, MOL CELL BIOL, V21, P2423, DOI 10.1128/MCB.21.7.2423-2434.2001; Chong H, 2001, EMBO J, V20, P3716, DOI 10.1093/emboj/20.14.3716; Chong HR, 2003, J BIOL CHEM, V278, P36269, DOI 10.1074/jbc.M212803200; Cohen Yossi, 2003, Hematol J, V4, P151, DOI 10.1038/sj.thj.6200208; Coles LC, 2002, ONCOGENE, V21, P2236, DOI 10.1038/sj.onc.1205302; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Dhillon AS, 2007, ONCOGENE, V26, P3279, DOI 10.1038/sj.onc.1210421; Dhillon AS, 2007, CELL CYCLE, V6, P3, DOI 10.4161/cc.6.1.3593; Dhillon AS, 2002, EMBO J, V21, P64, DOI 10.1093/emboj/21.1.64; Diaz B, 1997, MOL CELL BIOL, V17, P4509, DOI 10.1128/MCB.17.8.4509; Downward J, 2003, NAT REV CANCER, V3, P11, DOI 10.1038/nrc969; Eblen ST, 2002, MOL CELL BIOL, V22, P6023, DOI 10.1128/MCB.22.17.6023-6033.2002; FABIAN JR, 1993, MOL CELL BIOL, V13, P7170, DOI 10.1128/MCB.13.11.7170; Farrar MA, 1996, NATURE, V383, P178, DOI 10.1038/383178a0; Frost JA, 1997, EMBO J, V16, P6426, DOI 10.1093/emboj/16.21.6426; Garnett MJ, 2005, MOL CELL, V20, P963, DOI 10.1016/j.molcel.2005.10.022; Hagemann C, 1999, EXP CELL RES, V253, P34, DOI 10.1006/excr.1999.4689; Huser M, 2001, EMBO J, V20, P1940, DOI 10.1093/emboj/20.8.1940; Inouye K, 2000, J BIOL CHEM, V275, P3737, DOI 10.1074/jbc.275.6.3737; Kimura ET, 2003, CANCER RES, V63, P1454; King AJ, 2001, FEBS LETT, V497, P6, DOI 10.1016/S0014-5793(01)02425-5; King AJ, 1998, NATURE, V396, P180, DOI 10.1038/24184; KOLCH W, 1993, NATURE, V364, P249, DOI 10.1038/364249a0; Kubicek M, 2002, J BIOL CHEM, V277, P7913, DOI 10.1074/jbc.M108733200; Lang J, 2003, HUM MUTAT, V21, P327, DOI 10.1002/humu.10188; Leicht DT, 2007, BBA-MOL CELL RES, V1773, P1196, DOI 10.1016/j.bbamcr.2007.05.001; Li WQ, 2001, J BIOL CHEM, V276, P34728, DOI 10.1074/jbc.M103496200; Luo ZJ, 1996, NATURE, V383, P181, DOI 10.1038/383181a0; MARAIS R, 1995, EMBO J, V14, P3136, DOI 10.1002/j.1460-2075.1995.tb07316.x; Mason CS, 1999, EMBO J, V18, P2137, DOI 10.1093/emboj/18.8.2137; Michaloglou C, 2008, ONCOGENE, V27, P877, DOI 10.1038/sj.onc.1210704; MICHAUD NR, 1995, MOL CELL BIOL, V15, P3390; Mikula M, 2001, EMBO J, V20, P1952, DOI 10.1093/emboj/20.8.1952; MORRISON DK, 1993, J BIOL CHEM, V268, P17309; Muslin AJ, 1996, CELL, V84, P889, DOI 10.1016/S0092-8674(00)81067-3; Park ER, 2007, CELL SIGNAL, V19, P1488, DOI 10.1016/j.cellsig.2007.01.018; Park S, 2006, FEBS LETT, V580, P6405, DOI 10.1016/j.febslet.2006.10.054; Pollock PM, 2003, NAT GENET, V33, P19, DOI 10.1038/ng1054; Pollock PM, 2002, CANCER CELL, V2, P5, DOI 10.1016/S1535-6108(02)00089-2; Pritchard CA, 1996, CURR BIOL, V6, P614, DOI 10.1016/S0960-9822(02)00548-1; Qin HJ, 2005, J BIOL CHEM, V280, P7603, DOI 10.1074/jbc.M412141200; Rajagopalan H, 2002, NATURE, V418, P934, DOI 10.1038/418934a; Rommel C, 1996, ONCOGENE, V12, P609; Roy S, 1998, MOL CELL BIOL, V18, P3947, DOI 10.1128/MCB.18.7.3947; Schonwasser DC, 1998, MOL CELL BIOL, V18, P790, DOI 10.1128/MCB.18.2.790; Singer G, 2003, J NATL CANCER I, V95, P484, DOI 10.1093/jnci/95.6.484; Slack-Davis JK, 2003, J CELL BIOL, V162, P281, DOI 10.1083/jcb.200212141; STORM SM, 1990, ONCOGENE, V5, P345; Sun HY, 2000, CURR BIOL, V10, P281, DOI 10.1016/S0960-9822(00)00359-6; Tannapfel A, 2003, GUT, V52, P706, DOI 10.1136/gut.52.5.706; Thorson JA, 1998, MOL CELL BIOL, V18, P5229, DOI 10.1128/MCB.18.9.5229; Tran NH, 2005, J BIOL CHEM, V280, P16244, DOI 10.1074/jbc.M501185200; Tran NH, 2003, J BIOL CHEM, V278, P11221, DOI 10.1074/jbc.M210318200; Tzivion G, 1998, NATURE, V394, P88, DOI 10.1038/27938; Weber CK, 2001, CANCER RES, V61, P3595; Wojnowski L, 1997, NAT GENET, V16, P293, DOI 10.1038/ng0797-293; Wojnowski L, 1998, MECH DEVELOP, V76, P141, DOI 10.1016/S0925-4773(98)00111-7; Yuen ST, 2002, CANCER RES, V62, P6451; Zang MW, 2001, J BIOL CHEM, V276, P25157, DOI 10.1074/jbc.M100152200; Zhang BH, 2000, EMBO J, V19, P5429, DOI 10.1093/emboj/19.20.5429; Zhu J, 2005, MOL BIOL CELL, V16, P4733, DOI 10.1091/mbc.E05-02-0090	70	47	48	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 14	2008	283	46					31429	31437		10.1074/jbc.M802855200	http://dx.doi.org/10.1074/jbc.M802855200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	370KJ	18775988	hybrid, Green Published			2022-12-27	WOS:000260760800022
J	Burton, RL; Hanes, JW; Grant, GA				Burton, Rodney L.; Hanes, Jeremiah W.; Grant, Gregory A.			A Stopped Flow Transient Kinetic Analysis of Substrate Binding and Catalysis in Escherichia coli D-3-Phosphoglycerate Dehydrogenase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							END PRODUCT INHIBITION; PHOSPHOGLYCERATE DEHYDROGENASE; SERINE BIOSYNTHESIS; EFFECTOR-BINDING; MECHANISM; PURIFICATION; SITE	Pre-steady state, stopped flow analysis of Escherichia coli D-3-phosphoglycerate dehydrogenase was performed by following the fluorescence of protein tryptophan and the fluorescence resonance energy transfer from protein tryptophan to bound NADH. The results indicate that binding of substrates is ordered, with coenzyme, NADH, binding first. Furthermore, the analysis indicated that there are two sets of sites on the tetrameric enzyme that can be differentiated by their kinetic behavior. NADH binding was consistent with an initial binding event followed by a slow conformational change for each site. The slow conformational change is responsible for the apparent tight binding of NADH to the apoenzyme but is too slow to participate in the catalytic cycle when the enzyme is rapidly turning over. Subsequent binding of the substrate, alpha-ketoglutarate, was characterized by a rapid equilibrium binding event followed by a conformational change for each site. Catalysis in the direction of NAD(+) reduction showed a distinct burst of activity followed by a slow rate of turnover, indicating that the rate-limiting step is after hydride transfer. Catalysis in the direction of NADH oxidation did not display burst kinetics, indicating that the rate-limiting step is at or before the hydride transfer step. The burst data indicated that the rate of NAD(+) reduction (3.8 s(-1)) is similar to the k(cat) of the enzyme (2-3 s(-1)) in that direction. However, analysis of the reaction with deuterated NADH failed to show an effect on the velocity of the reaction with aV(H)/V-D = 1.07 +/- 0.06. None of the other rates determined by stopped flow analysis could account for the k(cat) of the enzyme in either direction (forward k(cat) = 0.01 s(-1), reverse k(cat) = 2-3 s(-1)), suggesting that the rate-limiting step in both directions is a conformational change in the enzyme that is not detected optically.	[Burton, Rodney L.; Grant, Gregory A.] Washington Univ, Sch Med, Dept Dev Biol, St Louis, MO 63110 USA; [Grant, Gregory A.] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA; [Hanes, Jeremiah W.] Cornell Univ, Dept Chem & Chem Biol, Ithaca, NY 14853 USA	Washington University (WUSTL); Washington University (WUSTL); Cornell University	Grant, GA (corresponding author), Washington Univ, Sch Med, Dept Dev Biol, Box 8103,660 S Euclid Ave, St Louis, MO 63110 USA.	ggrant@wustl.edu			National Institutes of Health [GM 56676]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056676] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM 56676 (to G. A. G.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	AlRabiee R, 1996, J BIOL CHEM, V271, P13013, DOI 10.1074/jbc.271.22.13013; Aravind L, 1999, J MOL BIOL, V287, P1023, DOI 10.1006/jmbi.1999.2653; Bell JK, 2004, BIOCHEMISTRY-US, V43, P3450, DOI 10.1021/bi035462e; DUBROW R, 1977, J BIOL CHEM, V252, P1527; DUBROW R, 1977, J BIOL CHEM, V252, P1539; Grant GA, 2004, J BIOL CHEM, V279, P13452, DOI 10.1074/jbc.M313593200; Grant GA, 2002, J BIOL CHEM, V277, P39548, DOI 10.1074/jbc.M208019200; Grant GA, 2006, J BIOL CHEM, V281, P33825, DOI 10.1074/jbc.R600024200; Johnson K. A., 1992, ENZYMES, P1; Johnson Kenneth A., 2003, P1; MERRILL DK, 1981, ARCH BIOCHEM BIOPHYS, V212, P717, DOI 10.1016/0003-9861(81)90416-1; Pizer L. I, 1971, METHOD ENZYMOL, V17, P325, DOI [10.1016/0076-6879(71)17056-5, DOI 10.1016/0076-6879(71)17056-5]; SCHULLER DJ, 1995, NAT STRUCT BIOL, V2, P69, DOI 10.1038/nsb0195-69; SCHULLER DJ, 1989, J BIOL CHEM, V264, P2645; SUGIMOTO E, 1968, J BIOL CHEM, V243, P2090; SUGIMOTO E, 1968, J BIOL CHEM, V243, P2081; VIOLA RE, 1979, ANAL BIOCHEM, V96, P334, DOI 10.1016/0003-2697(79)90590-6; WALSH DA, 1966, J BIOL CHEM, V241, P4068; Zhao GS, 1996, J BACTERIOL, V178, P232, DOI 10.1128/jb.178.1.232-239.1996	19	14	14	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 31	2008	283	44					29706	29714		10.1074/jbc.M805180200	http://dx.doi.org/10.1074/jbc.M805180200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	364WS	18776184	Green Published, hybrid			2022-12-27	WOS:000260366900014
J	Ang, XL; Seeburg, DP; Sheng, M; Harper, JW				Ang, Xiaolu L.; Seeburg, Daniel P.; Sheng, Morgan; Harper, J. Wade			Regulation of Postsynaptic RapGAP SPAR by Polo-like Kinase 2 and the SCF beta-TRCP Ubiquitin Ligase in Hippocampal Neurons	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANAPHASE PROMOTING COMPLEX; VENTRAL NERVE CORD; GLUTAMATE RECEPTORS; PROTEIN-DEGRADATION; E3 LIGASE; DESTRUCTION; PHOSPHORYLATION; CLASPIN; CATENIN; PROGRESSION	The ubiquitin-proteasome pathway (UPP) regulates synaptic function, but little is known about specific UPP targets and mechanisms in mammalian synapses. We report here that the SCF beta-TRCP complex, a multisubunit E3 ubiquitin ligase, targets the postsynaptic spine-associated Rap GTPase activating protein (SPAR) for degradation in neurons. SPAR degradation by SCF(beta-TRCP)depended on the activity-inducible protein kinase Polo-like kinase 2 (Plk2). In the presence of Plk2, SPAR physically associated with the SCF beta-TRCP complex through a canonical phosphodegron. In hippocampal neurons, disruption of the SCF beta-TRCP complex by overexpression of dominant interfering beta-TRCP or Cul1 constructs prevented Plk2-dependent degradation of SPAR. Our results identify a specific E3 ubiquitin ligase that mediates degradation of a key postsynaptic regulator of synaptic morphology and function.	[Ang, Xiaolu L.; Harper, J. Wade] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; [Seeburg, Daniel P.; Sheng, Morgan] MIT, Howard Hughes Med Inst, Neurosci Res Ctr, RIKEN,Picower Inst Learning & Memory, Cambridge, MA 02139 USA	Harvard University; Harvard Medical School; Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Northwell Health; RIKEN	Harper, JW (corresponding author), Harvard Univ, Sch Med, Dept Pathol, 77 Ave Louis Pasteur,NRB 940, Boston, MA 02115 USA.	wade_harper@hms.harvard.edu	Cambronne, Xiaolu Ang/GRY-7149-2022	Cambronne, Xiaolu Ang/0000-0002-3547-448X; Sheng, Morgan/0000-0002-8703-5366; Harper, Jeffrey/0000-0002-6944-7236	National Institutes of Health [AG11085, GM54137]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM054137] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F31NS054507] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG011085] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants AG11085 and GM54137 (to J. W. H.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Bashir T, 2004, NATURE, V428, P190, DOI 10.1038/nature02330; Bingol B, 2005, CURR OPIN NEUROBIOL, V15, P536, DOI 10.1016/j.conb.2005.08.016; Bingol B, 2006, NATURE, V441, P1144, DOI 10.1038/nature04769; Bonhoeffer T, 2002, NEURON, V35, P1019, DOI 10.1016/S0896-6273(02)00906-6; Busino L, 2003, NATURE, V426, P87, DOI 10.1038/nature02082; Cardozo T, 2004, NAT REV MOL CELL BIO, V5, P739, DOI 10.1038/nrm1471; Carlisle HJ, 2005, TRENDS NEUROSCI, V28, P182, DOI 10.1016/j.tins.2005.01.008; Ciechanover A, 2003, NEURON, V40, P427, DOI 10.1016/S0896-6273(03)00606-8; Cline H, 2003, CURR BIOL, V13, pR514, DOI 10.1016/S0960-9822(03)00443-3; Collins CA, 2006, NEURON, V51, P57, DOI 10.1016/j.neuron.2006.05.026; Cullinan SB, 2004, MOL CELL BIOL, V24, P8477, DOI 10.1128/MCB.24.19.8477-8486.2004; Dreier L, 2005, NEURON, V46, P51, DOI 10.1016/j.neuron.2004.12.058; Ehlers MD, 2003, NAT NEUROSCI, V6, P231, DOI 10.1038/nn1013; Fong A, 2002, J BIOL CHEM, V277, P22111, DOI 10.1074/jbc.C200151200; Guardavaccaro D, 2003, DEV CELL, V4, P799, DOI 10.1016/S1534-5807(03)00154-0; Guardavaccaro D, 2008, NATURE, V452, P365, DOI 10.1038/nature06641; Hansen DV, 2006, P NATL ACAD SCI USA, V103, P608, DOI 10.1073/pnas.0509549102; Hansen DV, 2004, MOL BIOL CELL, V15, P5623, DOI 10.1091/mbc.E04-07-0598; Jin JP, 2003, GENE DEV, V17, P3062, DOI 10.1101/gad.1157503; Jin JP, 2005, METHOD ENZYMOL, V399, P287, DOI 10.1016/S0076-6879(05)99020-4; Juo P, 2004, CURR BIOL, V14, P2057, DOI 10.1016/j.cub.2004.11.010; Jurd R, 2008, J BIOL CHEM, V283, P301, DOI 10.1074/jbc.M705580200; Kasai H, 2003, TRENDS NEUROSCI, V26, P360, DOI 10.1016/S0166-2236(03)00162-0; Kato A, 2005, P NATL ACAD SCI USA, V102, P5600, DOI 10.1073/pnas.0501769102; Kauselmann G, 1999, EMBO J, V18, P5528, DOI 10.1093/emboj/18.20.5528; Liao EH, 2004, NATURE, V430, P345, DOI 10.1038/nature02647; Liu CM, 2002, CELL, V108, P837, DOI 10.1016/S0092-8674(02)00685-2; Liu JJ, 2005, CURR BIOL, V15, P1458, DOI 10.1016/j.cub.2005.07.030; Mailand N, 2006, MOL CELL, V23, P307, DOI 10.1016/j.molcel.2006.06.016; Mamely I, 2006, CURR BIOL, V16, P1950, DOI 10.1016/j.cub.2006.08.026; Margottin-Goguet F, 2003, DEV CELL, V4, P813, DOI 10.1016/S1534-5807(03)00153-9; Moshe Y, 2004, P NATL ACAD SCI USA, V101, P7937, DOI 10.1073/pnas.0402442101; Myat A, 2002, NEURON, V35, P447, DOI 10.1016/S0896-6273(02)00795-X; Nakata K, 2005, CELL, V120, P407, DOI 10.1016/j.cell.2004.12.017; Newton SS, 2003, J NEUROSCI, V23, P10841; Pak DTS, 2001, NEURON, V31, P289, DOI 10.1016/S0896-6273(01)00355-5; Pak DTS, 2003, SCIENCE, V302, P1368, DOI 10.1126/science.1082475; Patrick GN, 2006, CURR OPIN NEUROBIOL, V16, P90, DOI 10.1016/j.conb.2006.01.007; Peschiaroli A, 2006, MOL CELL, V23, P319, DOI 10.1016/j.molcel.2006.06.013; Petroski MD, 2005, NAT REV MOL CELL BIO, V6, P9, DOI 10.1038/nrm1547; Petrucelli L, 2004, ANN MED, V36, P315, DOI 10.1080/07853890410031948; Piva R, 2002, MOL CELL BIOL, V22, P8375, DOI 10.1128/MCB.22.23.8375-8387.2002; Rauh NR, 2005, NATURE, V437, P1048, DOI 10.1038/nature04093; Seeburg DP, 2008, NEURON, V58, P571, DOI 10.1016/j.neuron.2008.03.021; Shirogane T, 2005, J BIOL CHEM, V280, P26863, DOI 10.1074/jbc.M502862200; Stegmuller J, 2006, NEURON, V50, P389, DOI 10.1016/j.neuron.2006.03.034; Tada T, 2006, CURR OPIN NEUROBIOL, V16, P95, DOI 10.1016/j.conb.2005.12.001; Tsai IC, 2007, DEV CELL, V12, P335, DOI 10.1016/j.devcel.2007.02.009; Turrigiano G, 2007, CURR OPIN NEUROBIOL, V17, P318, DOI 10.1016/j.conb.2007.04.004; van Roessel P, 2004, CELL, V119, P707, DOI 10.1016/j.cell.2004.11.028; Watanabe N, 2004, P NATL ACAD SCI USA, V101, P4419, DOI 10.1073/pnas.0307700101; Welcker M, 2004, P NATL ACAD SCI USA, V101, P9085, DOI 10.1073/pnas.0402770101; Westbrook TF, 2008, NATURE, V452, P370, DOI 10.1038/nature06780; Winston JT, 1999, GENE DEV, V13, P270, DOI 10.1101/gad.13.3.270; Wu G, 2003, MOL CELL, V11, P1445, DOI 10.1016/S1097-2765(03)00234-X; Yi JJ, 2005, NEURON, V47, P629, DOI 10.1016/j.neuron.2005.07.008	56	47	49	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 24	2008	283	43					29424	29432		10.1074/jbc.M802475200	http://dx.doi.org/10.1074/jbc.M802475200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	362EB	18723513	hybrid, Green Published			2022-12-27	WOS:000260179900069
J	Lebreton, S; Paladino, S; Zurzolo, C				Lebreton, Stephanie; Paladino, Simona; Zurzolo, Chiara			Selective Roles for Cholesterol and Actin in Compartmentalization of Different Proteins in the Golgi and Plasma Membrane of Polarized Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GPI-ANCHORED PROTEINS; INFLUENZA-VIRUS HEMAGGLUTININ; RESONANCE ENERGY-TRANSFER; THYROID EPITHELIAL-CELLS; MDCK CELLS; APICAL MEMBRANE; LIPID RAFTS; SURFACE; DYNAMICS; CYCLODEXTRINS	To determine the roles of cholesterol and the actin cytoskeleton in apical and basolateral protein organization and sorting, we have performed comprehensive confocal fluorescence recovery after photobleaching analyses of apical and basolateral and raft- and non-raft-associated proteins, both at the plasma membrane and in the Golgi apparatus of polarized MDCK cells. We show that at both the apical and basolateral plasma membrane domains, raft- associated proteins diffuse faster than non-raft-associated proteins and that, different from the latter, they become restricted upon depletion of cholesterol. Furthermore, only transmembrane apical proteins are restricted by the actin network. This indicates that cholesterol-dependent domains exist both at the apical and basolateral membranes of polarized cells and that the actin cytoskeleton has a predominant role in the organization of transmembrane proteins independent of their association with rafts at the apical membrane. In the Golgi apparatus apical proteins appear to be segregated from the basolateral ones in a compartment that is sensitive both to cholesterol depletion and actin rearrangements. Furthermore, consistent with the role of actin rearrangements in apical protein sorting, we found that apical proteins exhibit a differential sensitivity to actin depolymerization in the Golgi of polarized and nonpolarized cells.	[Lebreton, Stephanie; Zurzolo, Chiara] Inst Pasteur, Unite Traf Membranaire & Pathogenese, F-75015 Paris, France; [Paladino, Simona; Zurzolo, Chiara] Univ Naples Federico 2, Dipartimento Biol & Patol Cellulare & Mol, I-80131 Naples, Italy	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; University of Naples Federico II	Zurzolo, C (corresponding author), Inst Pasteur, Unite Traf Membranaire & Pathogenese, 25 Rue Dr Roux, F-75015 Paris, France.	zurzolo@pasteur.fr	Zurzolo, Chiara/AAH-5225-2019; Paladino, Simona/J-5383-2018; Paladino, Simona/ABH-7826-2020	Paladino, Simona/0000-0001-5332-6774; ZURZOLO, Chiara/0000-0001-6048-6602; Lebreton, Stephanie/0000-0002-9879-0404	Agence Nationale de la Recherche [05-BLAN 296-01]; Ministero dell' Universita e della Ricerca Scientifica e Tecnologica	Agence Nationale de la Recherche(French National Research Agency (ANR)); Ministero dell' Universita e della Ricerca Scientifica e Tecnologica(Ministry of Education, Universities and Research (MIUR))	This work was supported by Agence Nationale de la Recherche Grant 05-BLAN 296-01 and Ministero dell' Universita e della Ricerca Scientifica e Tecnologica Grant PRIN 2006. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Benting JH, 1999, J CELL BIOL, V146, P313, DOI 10.1083/jcb.146.2.313; BROWN DA, 1989, SCIENCE, V245, P1499, DOI 10.1126/science.2571189; Brugger B, 2004, J BIOL CHEM, V279, P7530, DOI 10.1074/jbc.M310207200; Cherukuri A, 2001, IMMUNITY, V14, P657, DOI 10.1016/S1074-7613(01)00156-X; Christian AE, 1997, J LIPID RES, V38, P2264; Delacour D, 2006, CELL MOL LIFE SCI, V63, P2491, DOI 10.1007/s00018-006-6210-8; Delacour D, 2006, CURR BIOL, V16, P408, DOI 10.1016/j.cub.2005.12.046; Delacour D, 2007, TRAFFIC, V8, P379, DOI 10.1111/j.1600-0854.2007.00539.x; Hancock JF, 2006, NAT REV MOL CELL BIO, V7, P456, DOI 10.1038/nrm1925; Jacob R, 2003, CURR BIOL, V13, P607, DOI 10.1016/S0960-9822(03)00188-X; Jacob R, 2001, CURR BIOL, V11, P1444, DOI 10.1016/S0960-9822(01)00446-8; Keller P, 1998, J CELL BIOL, V140, P1357, DOI 10.1083/jcb.140.6.1357; Kenworthy AK, 2004, J CELL BIOL, V165, P735, DOI 10.1083/jcb.200312170; Kenworthy AK, 1998, J CELL BIOL, V142, P69, DOI 10.1083/jcb.142.1.69; Kenworthy AK, 1999, METH MOL B, V116, P37; Kreitzer G, 2003, NAT CELL BIOL, V5, P126, DOI 10.1038/ncb917; Kusumi A, 2004, TRAFFIC, V5, P213, DOI 10.1111/j.1600-0854.2004.0178.x; Lazaro-Dieguez F, 2007, FEBS LETT, V581, P3875, DOI 10.1016/j.febslet.2007.07.015; Lenne PF, 2006, EMBO J, V25, P3245, DOI 10.1038/sj.emboj.7601214; Leser GP, 2005, VIROLOGY, V342, P215, DOI 10.1016/j.virol.2005.09.049; Lipardi C, 1999, BIOCHIMIE, V81, P347, DOI 10.1016/S0300-9084(99)80080-7; Lipardi C, 2000, MOL BIOL CELL, V11, P531, DOI 10.1091/mbc.11.2.531; Lippincott-Schwartz J, 2001, NAT REV MOL CELL BIO, V2, P444, DOI 10.1038/35073068; LISANTI MP, 1989, J CELL BIOL, V109, P2145, DOI 10.1083/jcb.109.5.2145; LISANTI MP, 1988, P NATL ACAD SCI USA, V85, P9557, DOI 10.1073/pnas.85.24.9557; Liu GP, 1997, J CELL BIOL, V139, P1719, DOI 10.1083/jcb.139.7.1719; Manes S, 2000, EMBO REP, V1, P190, DOI 10.1093/embo-reports/kvd025; Marguet D, 2006, EMBO J, V25, P3446, DOI 10.1038/sj.emboj.7601204; Meder D, 2006, P NATL ACAD SCI USA, V103, P329, DOI 10.1073/pnas.0509885103; Mirchev R, 2001, BLOOD CELL MOL DIS, V27, P143, DOI 10.1006/bcmd.2000.0367; Morone N, 2006, J CELL BIOL, V174, P851, DOI 10.1083/jcb.200606007; Morton WM, 2000, NAT CELL BIOL, V2, P376, DOI 10.1038/35014075; Murase K, 2004, BIOPHYS J, V86, P4075, DOI 10.1529/biophysj.103.035717; Nguyen DH, 2004, MOL INTERV, V4, P318, DOI 10.1124/mi4.6.3; Paladino S, 2006, J CELL BIOL, V172, P1023, DOI 10.1083/jcb.200507116; Paladino S, 2004, J CELL BIOL, V167, P699, DOI 10.1083/jcb.200407094; Pike LJ, 2006, J LIPID RES, V47, P1597, DOI 10.1194/jlr.E600002-JLR200; Polishchuk R, 2004, NAT CELL BIOL, V6, P297, DOI 10.1038/ncb1109; Remaley AT, 1998, J LIPID RES, V39, P1231; Scheiffele P, 1997, EMBO J, V16, P5501, DOI 10.1093/emboj/16.18.5501; Shvartsman DE, 2006, TRAFFIC, V7, P917, DOI 10.1111/j.1600-0854.2006.00437.x; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; SOUMPASIS DM, 1983, BIOPHYS J, V41, P95, DOI 10.1016/S0006-3495(83)84410-5; Sprague BL, 2005, TRENDS CELL BIOL, V15, P84, DOI 10.1016/j.tcb.2004.12.001; Suzuki KGN, 2007, J CELL BIOL, V177, P731, DOI 10.1083/jcb.200609175; Suzuki KGN, 2007, J CELL BIOL, V177, P717, DOI 10.1083/jcb.200609174; Tivodar S, 2006, FEBS LETT, V580, P5705, DOI 10.1016/j.febslet.2006.09.022; van Meer G, 2005, EMBO J, V24, P3159, DOI 10.1038/sj.emboj.7600798; Zidovetzki R, 2007, BBA-BIOMEMBRANES, V1768, P1311, DOI 10.1016/j.bbamem.2007.03.026; ZURZOLO C, 1993, J CELL BIOL, V121, P1031, DOI 10.1083/jcb.121.5.1031	50	32	32	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 24	2008	283	43					29545	29553		10.1074/jbc.M803819200	http://dx.doi.org/10.1074/jbc.M803819200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	362EB	18701450	Green Published, hybrid			2022-12-27	WOS:000260179900080
J	Nishitani, H; Shiomi, Y; Iida, H; Michishita, M; Takami, T; Tsurimoto, T				Nishitani, Hideo; Shiomi, Yasushi; Iida, Hiroka; Michishita, Masato; Takami, Toshihiro; Tsurimoto, Toshiki			CDK Inhibitor p21 Is Degraded by a Proliferating Cell Nuclear Antigen-coupled Cul4-DDB1(Cdt2) Pathway during S Phase and after UV Irradiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SCFSKP2 UBIQUITIN LIGASE; LICENSING FACTOR CDT1; REG-GAMMA-PROTEASOME; DNA-DAMAGE; MEDIATED DEGRADATION; ESCHERICHIA-COLI; SLIDING CLAMP; CYCLE CONTROL; REPLICATION; PROTEOLYSIS	Previous reports showed that chromatin-associated PCNA couples DNA replication with Cul4-DDB1(Cdt2)-dependent proteolysis of the licensing factor Cdt1. The CDK inhibitor p21, another PCNA-binding protein, is also degraded both in S phase and after UV irradiation. Here we show that p21 is degraded by the same ubiquitin-proteasome pathway as Cdt1 in HeLa cells. When PCNA or components of Cul4-DDB1(Cdt2) were silenced or when the PCNA binding site on p21 was mutated, degradation of p21 was prevented both in S phase and after UV irradiation. p21 was co-immunoprecipitated with Cul4A and DDB1 proteins when expressed in cells. The purified Cul4A-DDB1(Cdt2) complex ubiquitinated p21 in vitro. Consistently, p21 protein levels are low during S phase and increase around G(2) phase. Mutational analysis suggested that in addition to the PCNA binding domain, its flanking regions are also important for recognition by Cul4-DDB1(Cdt2). Our findings provide a new aspect of proteolytic control of p21 during the cell cycle.	[Nishitani, Hideo; Shiomi, Yasushi; Michishita, Masato; Takami, Toshihiro] Univ Hyogo, Grad Sch Life Sci, Kamigori, Hyogo 6781297, Japan; [Nishitani, Hideo; Iida, Hiroka] Kyushu Univ, Grad Sch Med Sci, Higashi Ku, Fukuoka 8128581, Japan; [Tsurimoto, Toshiki] Kyushu Univ, Dept Biol, Higashi Ku, Fukuoka 8128581, Japan	University of Hyogo; Kyushu University; Kyushu University	Nishitani, H (corresponding author), Univ Hyogo, Grad Sch Life Sci, Kamigori, Hyogo 6781297, Japan.	hideon@sci.u-hyogo.ac.jp		Tsurimoto, Toshiki/0000-0001-7597-2216; Nishitani, Hideo/0000-0001-5907-9380	Ministry of Education, Culture, Sport, Science, and Technology of Japan	Ministry of Education, Culture, Sport, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by Grants-in-aid for Scientific Research (C) and Scientific Research on Priority Areas from the Ministry of Education, Culture, Sport, Science, and Technology of Japan. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Arias EE, 2006, NAT CELL BIOL, V8, P84, DOI 10.1038/ncb1346; Arias EE, 2007, GENE DEV, V21, P497, DOI 10.1101/gad.1508907; Bendjennat M, 2003, CELL, V114, P599, DOI 10.1016/j.cell.2003.08.001; Bloom J, 2003, CELL, V115, P71, DOI 10.1016/S0092-8674(03)00755-4; Blow JJ, 2005, NAT REV MOL CELL BIO, V6, P476, DOI 10.1038/nrm1663; Bondar T, 2006, MOL CELL BIOL, V26, P2531, DOI 10.1128/MCB.26.7.2531-2539.2006; Bornstein G, 2003, J BIOL CHEM, V278, P25752, DOI 10.1074/jbc.M301774200; Cardozo T, 2004, NAT REV MOL CELL BIO, V5, P739, DOI 10.1038/nrm1471; Carrano AC, 1999, NAT CELL BIOL, V1, P193, DOI 10.1038/12013; Chen XY, 2007, MOL CELL, V26, P843, DOI 10.1016/j.molcel.2007.05.022; Chuang LC, 2005, J BIOL CHEM, V280, P35299, DOI 10.1074/jbc.M506429200; HARTWELL LH, 1994, SCIENCE, V266, P1821, DOI 10.1126/science.7997877; Higa LA, 2006, CELL CYCLE, V5, P1675, DOI 10.4161/cc.5.15.3149; Hu J, 2006, J BIOL CHEM, V281, P3753, DOI 10.1074/jbc.C500464200; Jin JP, 2006, MOL CELL, V23, P709, DOI 10.1016/j.molcel.2006.08.010; Katayama T, 1998, CELL, V94, P61, DOI 10.1016/S0092-8674(00)81222-2; Lee H, 2006, J BIOL CHEM, V281, P26876, DOI 10.1074/jbc.M605366200; Lee JY, 2007, MOL CELL BIOL, V27, P3187, DOI 10.1128/MCB.01461-06; Li XH, 2003, J BIOL CHEM, V278, P30854, DOI 10.1074/jbc.C300251200; Li XT, 2007, MOL CELL, V26, P831, DOI 10.1016/j.molcel.2007.05.028; Maga G, 2003, J CELL SCI, V116, P3051, DOI 10.1242/jcs.00653; Melixetian M, 2004, J CELL BIOL, V165, P473, DOI 10.1083/jcb.200403106; NAKANISHI M, 1995, P NATL ACAD SCI USA, V92, P4352, DOI 10.1073/pnas.92.10.4352; Nakayama KI, 2006, NAT REV CANCER, V6, P369, DOI 10.1038/nrc1881; Nishitani H, 2002, GENES CELLS, V7, P523, DOI 10.1046/j.1365-2443.2002.00544.x; Nishitani H, 2006, EMBO J, V25, P1126, DOI 10.1038/sj.emboj.7601002; Nishitani H, 2004, J BIOL CHEM, V279, P30807, DOI 10.1074/jbc.M312644200; Nishitani H, 2001, J BIOL CHEM, V276, P44905, DOI 10.1074/jbc.M105406200; NURSE P, 1994, CELL, V79, P547, DOI 10.1016/0092-8674(94)90539-8; Ralph E, 2006, EMBO REP, V7, P1134, DOI 10.1038/sj.embor.7400827; Senga T, 2006, J BIOL CHEM, V281, P6246, DOI 10.1074/jbc.M512705200; Sheaff RJ, 2000, MOL CELL, V5, P403, DOI 10.1016/S1097-2765(00)80435-9; Sherr CJ, 1999, GENE DEV, V13, P1501, DOI 10.1101/gad.13.12.1501; Shiomi Y, 2004, GENES CELLS, V9, P279, DOI 10.1111/j.1356-9597.2004.00724.x; Su'etsugu M, 2004, GENES CELLS, V9, P509, DOI 10.1111/j.1356-9597.2004.00741.x; Sugimoto N, 2004, J BIOL CHEM, V279, P19691, DOI 10.1074/jbc.M313175200; Takeda DY, 2005, J BIOL CHEM, V280, P23416, DOI 10.1074/jbc.M501208200; Touitou R, 2001, EMBO J, V20, P2367, DOI 10.1093/emboj/20.10.2367; Vaziri C, 2003, MOL CELL, V11, P997, DOI 10.1016/S1097-2765(03)00099-6; Vodermaier HC, 2004, CURR BIOL, V14, pR787, DOI 10.1016/j.cub.2004.09.020; Wang W, 2005, BIOCHEMISTRY-US, V44, P14553, DOI 10.1021/bi051071j; Zhong WW, 2003, NATURE, V423, P885, DOI 10.1038/nature01747; Zhu WG, 2004, MOL CELL BIOL, V24, P7140, DOI 10.1128/MCB.24.16.7140-7150.2004	43	187	195	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 24	2008	283	43					29045	29052		10.1074/jbc.M806045200	http://dx.doi.org/10.1074/jbc.M806045200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	362EB	18703516	hybrid, Green Published			2022-12-27	WOS:000260179900031
J	Pletnev, S; Shcherbo, D; Chudakov, DM; Pletneva, N; Merzlyak, EM; Wlodawer, A; Dauter, Z; Pletnev, V				Pletnev, Sergei; Shcherbo, Dmitry; Chudakov, Dmitry M.; Pletneva, Nadezhda; Merzlyak, Ekaterina M.; Wlodawer, Alexander; Dauter, Zbigniew; Pletnev, Vladimir			A Crystallographic Study of Bright Far-Red Fluorescent Protein mKate Reveals pH-induced cis-trans Isomerization of the Chromophore	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; IN-VIVO; STRUCTURAL BASIS; WHOLE-BODY; GREEN; CHROMOPROTEIN; MATURATION; MECHANISM; EXTENSION; PROGRAM	The far-red fluorescent protein mKate (lambda(ex), 588 nm; lambda(em), 635 nm; chromophore-forming triad Met(63)-Tyr(64)-Gly(65)), originating from wild-type red fluorescent progenitor eqFP578 (sea anemone Entacmaea quadricolor), is monomeric and characterized by the pronounced pH dependence of fluorescence, relatively high brightness, and high photostability. The protein has been crystallized at a pH ranging from 2 to 9 in three space groups, and four structures have been determined by x-ray crystallography at the resolution of 1.75-2.6 angstrom. The pH-dependent fluorescence of mKate has been shown to be due to reversible cis-trans isomerization of the chromophore phenolic ring. In the non-fluorescent state at pH 2.0, the chromophore of mKate is in the trans-isomeric form. The weakly fluorescent state of the protein at pH 4.2 is characterized by a mixture of trans and cis isomers. The chromophore in a highly fluorescent state at pH 7.0/9.0 adopts the cis form. Three key residues, Ser(143), Leu(174), and Arg(197) residing in the vicinity of the chromophore, have been identified as being primarily responsible for the far-red shift in the spectra. A group of residues consisting of Val(93), Arg(122), Glu(155), Arg(157), Asp(159), His(169), Ile(171), Asn(173), Val(192), Tyr(194), and Val(216), are most likely responsible for the observed monomeric state of the protein in solution.	[Pletnev, Sergei] SAIC Frederick Inc, Basic Res Program, Argonne, IL 60439 USA; [Pletnev, Sergei; Dauter, Zbigniew] NCI, Macromol Crystallog Lab, NIH, Argonne, IL 60439 USA; [Shcherbo, Dmitry; Chudakov, Dmitry M.; Pletneva, Nadezhda; Pletnev, Vladimir] Russian Acad Sci, Shemyakin Ovchinnikov Inst Bioorgan Chem, Moscow 117997, Russia; [Merzlyak, Ekaterina M.] Evrogen JSC, Moscow 117997, Russia; [Wlodawer, Alexander] NCI, Macromol Crystallog Lab, NIH, Frederick, MD 21702 USA	Science Applications International Corporation (SAIC); SAIC-Frederick; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Russian Academy of Sciences; Pushchino Scientific Center for Biological Research (PSCBI) of the Russian Academy of Sciences; Institute of Bioorganic Chemistry of the Russian Academy of Sciences; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Pletnev, S (corresponding author), SAIC Frederick Inc, Basic Res Program, Argonne, IL 60439 USA.	svp@ncifcrf.gov	Pletneva, Nadya/F-7839-2014; Shcherbo, Dmitry S/B-3549-2019; Chudakov, Dmitriy M/G-7741-2014; Merzlyak, Ekaterina/AAN-8272-2020; Pletnev, Vladimir/Q-6151-2016	Chudakov, Dmitriy M/0000-0003-0430-790X; Pletneva, Nadya/0000-0001-9681-4022; Merzlyak, Ekaterina/0000-0001-5695-0396	National Institutes of Health Intramural Research Program of the Center for Cancer Research; NCI [NO1-CO-12400]; Russian Foundation for Basic Research [07-04-00054, 07-04-12189]; Russian Federal Agency for Science and Innovations [02.513.12.3013]; NATIONAL CANCER INSTITUTE [ZIABC010348, ZIABC010378] Funding Source: NIH RePORTER	National Institutes of Health Intramural Research Program of the Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); Russian Federal Agency for Science and Innovations(Federal Agency for Science & Innovations (FASI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by the National Institutes of Health Intramural Research Program of the Center for Cancer Research, NCI, and with Federal funds from NCI Contract No. NO1-CO-12400. This work was also supported by the Russian Foundation for Basic Research (Grants 07-04-00054 and 07-04-12189), Russian Federal Agency for Science and Innovations (Grant 02.513.12.3013). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Andresen M, 2005, P NATL ACAD SCI USA, V102, P13070, DOI 10.1073/pnas.0502772102; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Barondeau DP, 2003, P NATL ACAD SCI USA, V100, P12111, DOI 10.1073/pnas.2133463100; Chudakov DM, 2005, TRENDS BIOTECHNOL, V23, P605, DOI 10.1016/j.tibtech.2005.10.005; Chudakov DM, 2003, J BIOL CHEM, V278, P7215, DOI 10.1074/jbc.M211988200; DeLano W.L, PYMOL MOL GRAPHICS S; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; EVANS SV, 1993, J MOL GRAPHICS, V11, P134, DOI 10.1016/0263-7855(93)87009-T; Evdokimov AG, 2006, EMBO REP, V7, P1006, DOI 10.1038/sj.embor.7400787; Gurskaya NG, 2001, FEBS LETT, V507, P16, DOI 10.1016/S0014-5793(01)02930-1; Haugwitz M, 2003, GENET ENG NEWS, V23, P36; He X, 2003, FEBS LETT, V549, P35, DOI 10.1016/S0014-5793(03)00761-0; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Hoffman RM, 2005, J BIOMED OPT, V10, DOI 10.1117/1.1992485; Hoffman RM, 2005, CURR TOP DEV BIOL, V70, P121, DOI 10.1016/S0070-2153(05)70006-5; Hoffman RM, 2005, NAT REV CANCER, V5, P796, DOI 10.1038/nrc1717; Konig K, 2000, J MICROSC-OXFORD, V200, P83, DOI 10.1046/j.1365-2818.2000.00738.x; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; MCDONALD IK, 1994, J MOL BIOL, V238, P777, DOI 10.1006/jmbi.1994.1334; Merzlyak EM, 2007, NAT METHODS, V4, P555, DOI 10.1038/NMETH1062; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pakhomov AA, 2006, BIOCHEMISTRY-US, V45, P7256, DOI 10.1021/bi060207q; Passamaneck YJ, 2006, MICROSC RES TECHNIQ, V69, P160, DOI 10.1002/jemt.20284; Perrakis A, 1997, ACTA CRYSTALLOGR D, V53, P448, DOI 10.1107/S0907444997005696; Petersen J, 2003, J BIOL CHEM, V278, P44626, DOI 10.1074/jbc.M307896200; Pletneva N, 2007, ACTA CRYSTALLOGR D, V63, P1082, DOI 10.1107/S0907444907042461; Prescott M, 2003, STRUCTURE, V11, P275, DOI 10.1016/S0969-2126(03)00028-5; Quillin ML, 2005, BIOCHEMISTRY-US, V44, P5774, DOI 10.1021/bi047644u; Remington SJ, 2006, CURR OPIN STRUC BIOL, V16, P714, DOI 10.1016/j.sbi.2006.10.001; Seitz G, 2006, J PEDIATR SURG, V41, P1369, DOI 10.1016/j.jpedsurg.2006.04.039; Shcherbo D, 2007, NAT METHODS, V4, P741, DOI 10.1038/NMETH1083; Shkrob MA, 2005, BIOCHEM J, V392, P649, DOI 10.1042/BJ20051314; Stewart CN, 2006, TRENDS BIOTECHNOL, V24, P155, DOI 10.1016/j.tibtech.2006.02.002; Tallini YN, 2006, P NATL ACAD SCI USA, V103, P4753, DOI 10.1073/pnas.0509378103; Tsien RY, 1998, ANNU REV BIOCHEM, V67, P509, DOI 10.1146/annurev.biochem.67.1.509; Tubbs JL, 2005, BIOCHEMISTRY-US, V44, P9833, DOI 10.1021/bi0472907; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Verkhusha VV, 2004, NAT BIOTECHNOL, V22, P289, DOI 10.1038/nbt943; Wacker SA, 2007, DEV DYNAM, V236, P473, DOI 10.1002/dvdy.20955; Wall MA, 2000, NAT STRUCT BIOL, V7, P1133; WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127; Wang L, 2004, P NATL ACAD SCI USA, V101, P16745, DOI 10.1073/pnas.0407752101; Wilmann PG, 2005, J MOL BIOL, V349, P223, DOI 10.1016/j.jmb.2005.03.020; Yarbrough D, 2001, P NATL ACAD SCI USA, V98, P462, DOI 10.1073/pnas.98.2.462; ZUBOVA NN, 2005, USP BIOL KHIM, V45, P1; 1998, GREEN FLUORESCENT PR, P120	48	85	88	0	27	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 24	2008	283	43					28980	28987		10.1074/jbc.M800599200	http://dx.doi.org/10.1074/jbc.M800599200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	362EB	18682399	Green Published, hybrid			2022-12-27	WOS:000260179900023
J	Yamasaki, K; Wang, GL; Daiho, T; Danko, S; Suzuki, H				Yamasaki, Kazuo; Wang, Guoli; Daiho, Takashi; Danko, Stefania; Suzuki, Hiroshi			Roles of Tyr(122)-hydrophobic Cluster and K+ Binding in Ca2+-releasing Process of ADP-insensitive Phosphoenzyme of Sarcoplasmic Reticulum Ca2(+)-ATPase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							1ST TRANSMEMBRANE HELIX; CALCIUM-PUMP; ADENOSINE-TRIPHOSPHATASE; SKELETAL-MUSCLE; A-DOMAIN; PHOSPHORYLATED INTERMEDIATE; TRANSPORT ACTIVITY; KINETIC-PROPERTIES; REACTION-MECHANISM; CRYSTAL-STRUCTURES	Tyr(122)-hydrophobic cluster (Y122-HC) is an interaction network formed by the top part of the second transmembrane helix and the cytoplasmic actuator and phosphorylation domains of sarcoplasmic reticulum Ca2+-ATPase. We have previously found that Y122-HC plays critical roles in the processing of ADP-insensitive phosphoenzyme (E2P) after its formation by the isomerization from ADP-sensitive phosphoenzyme (E1PCa(2)) (Wang, G., Yamasaki, K., Daiho, T., and Suzuki, H. (2005) J. Biol. Chem. 280, 26508-26516). Here, we further explored kinetic properties of the alanine-substitution mutants of Y122-HC to examine roles of Y122-HC for Ca2+ release process in E2P. In the steady state, the amount of E2P decreased so that of E1PCa(2) increased with increasing lumenal Ca2+ concentration in the mutants with K-0.5 110-320 mu M at pH 7.3. These lumenal Ca2+ affinities in E2P agreed with those estimated from the forward and lumenal Ca2+-induced reverse kinetics of the E1PCa(2)-E2P isomerization. K-0.5 of the wild type in the kinetics was estimated to be 1.5 mM. Thus, E2P of the mutants possesses significantly higher affinities for lumenal Ca2+ than that of the wild type. The kinetics further indicated that the rates of lumenal Ca2+ access and binding to the transport sites of E2P were substantially slowed by the mutations. Therefore, the proper formation of Y122-HC and resulting compactly organized structure are critical for both decreasing Ca2+ affinity and opening the lumenal gate, thus for Ca2+ release from E2PCa(2). Interestingly, when K+ was omitted from the medium of the wild type, the properties of the wild type became similar to those of Y122-HC mutants. K+ binding likely functions via producing the compactly organized structure, in this sense, similarly to Y122-HC.	[Yamasaki, Kazuo; Wang, Guoli; Daiho, Takashi; Danko, Stefania; Suzuki, Hiroshi] Asahikawa Med Coll, Dept Biochem, Asahikawa, Hokkaido 0788510, Japan	Asahikawa Medical College	Yamasaki, K (corresponding author), Asahikawa Med Coll, Dept Biochem, Asahikawa, Hokkaido 0788510, Japan.	kyamasak@asahikawa-med.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by a grant-in-aid for scientific research (C) (to K. Y.) and (B) (to H. S.) from the Ministry of Education, Culture, Sports, Science and Technology of Japan. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Champeil P, 1997, BIOCHEMISTRY-US, V36, P12383, DOI 10.1021/bi9709699; CLARKE DM, 1989, J BIOL CHEM, V264, P11246; COAN C, 1979, J BIOL CHEM, V254, P2968; Daiho T, 2003, J BIOL CHEM, V278, P39197, DOI 10.1074/jbc.M305200200; Daiho T, 1999, FEBS LETT, V444, P54, DOI 10.1016/S0014-5793(99)00027-7; Daiho T, 2007, J BIOL CHEM, V282, P34429, DOI 10.1074/jbc.M707665200; Danko S, 2004, J BIOL CHEM, V279, P14991, DOI 10.1074/jbc.M313363200; Danko S, 2001, FEBS LETT, V505, P129, DOI 10.1016/S0014-5793(01)02801-0; Danko S, 2001, FEBS LETT, V489, P277, DOI 10.1016/S0014-5793(01)02111-1; DEMEIS L, 1980, BIOCHEMISTRY-US, V19, P4252, DOI 10.1021/bi00559a017; DEMEIS L, 1982, J BIOL CHEM, V257, P1289; EBASHI S, 1962, J CELL BIOL, V14, P389, DOI 10.1083/jcb.14.3.389; Fersht A, 1999, STRUCTURE MECH PROTE, P132; HASSELBACH W, 1961, BIOCHEM Z, V333, P518; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; INESI G, 1990, PHYSIOL REV, V70, P749, DOI 10.1152/physrev.1990.70.3.749; KANAZAWA T, 1970, J BIOCHEM-TOKYO, V67, P693, DOI 10.1093/oxfordjournals.jbchem.a129297; Kato S, 2003, J BIOL CHEM, V278, P9624, DOI 10.1074/jbc.M208861200; KAUFMAN RJ, 1989, MOL CELL BIOL, V9, P946, DOI 10.1128/MCB.9.3.946; LEE AG, 1995, BIOCHEM J, V305, P225, DOI 10.1042/bj3050225; Lenoir G, 2004, J BIOL CHEM, V279, P9156, DOI 10.1074/jbc.M311411200; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MacLennan DH, 1997, J BIOL CHEM, V272, P28815, DOI 10.1074/jbc.272.46.28815; MARUYAMA K, 1988, P NATL ACAD SCI USA, V85, P3314, DOI 10.1073/pnas.85.10.3314; McIntosh D.B., 1998, ADV MOL CEL A&B, V23A, P33; Moller JV, 2002, J BIOL CHEM, V277, P38647, DOI 10.1074/jbc.M204603200; Moller JV, 1996, BBA-REV BIOMEMBRANES, V1286, P1, DOI 10.1016/0304-4157(95)00017-8; Olesen C, 2004, SCIENCE, V306, P2251, DOI 10.1126/science.1106289; Olesen C, 2007, NATURE, V450, P1036, DOI 10.1038/nature06418; PRAGER R, 1979, EUR J BIOCHEM, V97, P239, DOI 10.1111/j.1432-1033.1979.tb13108.x; Sato K, 2004, J BIOL CHEM, V279, P35595, DOI 10.1074/jbc.M404887200; SHIGEKAWA M, 1983, J BIOL CHEM, V258, P8698; SHIGEKAWA M, 1976, J BIOL CHEM, V251, P6947; SHIGEKAWA M, 1978, J BIOL CHEM, V253, P1451; Sorensen TLM, 2004, SCIENCE, V304, P1672, DOI 10.1126/science.1099366; Sorensen TLM, 2004, J BIOL CHEM, V279, P46355, DOI 10.1074/jbc.C400414200; Takahashi M, 2007, P NATL ACAD SCI USA, V104, P5800, DOI 10.1073/pnas.0700979104; Toyoshima C, 2004, NATURE, V430, P529, DOI 10.1038/nature02680; Toyoshima C, 2004, ANNU REV BIOCHEM, V73, P269, DOI 10.1146/annurev.biochem.73.011303.073700; Toyoshima C, 2004, NATURE, V432, P361, DOI 10.1038/nature02981; Toyoshima C, 2000, NATURE, V405, P647, DOI 10.1038/35015017; Toyoshima C, 2002, NATURE, V418, P605, DOI 10.1038/nature00944; Toyoshima C, 2008, ARCH BIOCHEM BIOPHYS, V476, P3, DOI 10.1016/j.abb.2008.04.017; Toyoshima C, 2007, P NATL ACAD SCI USA, V104, P19831, DOI 10.1073/pnas.0709978104; WAKABAYASHI S, 1987, J BIOL CHEM, V262, P11524; Wang GL, 2005, J BIOL CHEM, V280, P26508, DOI 10.1074/jbc.M503789200; WEBER K, 1969, J BIOL CHEM, V244, P4406; Yamasaki K, 2004, J BIOL CHEM, V279, P2202, DOI 10.1074/jbc.M309398200	48	22	23	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 24	2008	283	43					29144	29155		10.1074/jbc.M804596200	http://dx.doi.org/10.1074/jbc.M804596200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	362EB	18728008	hybrid, Green Published, Green Submitted			2022-12-27	WOS:000260179900042
J	Jin, Z; Heinnickel, M; Krebs, C; Shen, G; Golbeck, JH; Bryant, DA				Jin, Zhao; Heinnickel, Mark; Krebs, Carsten; Shen, Gaozhong; Golbeck, John H.; Bryant, Donald A.			Biogenesis of iron-sulfur clusters in photosystem I - HOLO-NfuA from the cyanobacterium synechococcus sp PCC 7002 rapidly and efficiently transfers [4Fe-4S] clusters to apo-PsaC in vitro	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MONOTHIOL GLUTAREDOXINS; SCAFFOLD PROTEIN; CORE PROTEIN; AZOTOBACTER-VINELANDII; SUFBCDS OPERON; SP PCC-7002; NIFU; MITOCHONDRIA; RECONSTITUTION; BIOSYNTHESIS	The NfuA protein has been postulated to act as a scaffolding protein in the biogenesis of photosystem (PS) I and other iron-sulfur (Fe/S) proteins in cyanobacteria and chloroplasts. To determine the properties of NfuA, recombinant NfuA from Synechococcus sp. PCC 7002 was overproduced and purified. In vitro reconstituted NfuA contained oxygen-and EDTA-labile Fe/S cluster(s), which had EPR properties consistent with [4Fe-4S] clusters. After reconstitution with Fe-57(2+), Mossbauer studies of NfuA showed a broad quadrupole doublet that confirmed the presence of [4Fe-4S](2+) clusters. Native gel electrophoresis under anoxic conditions and chemical cross-linking showed that holo-NfuA forms dimers and tetramers harboring Fe/S cluster(s). Combined with iron and sulfide analyses, the results indicated that one [4Fe-4S] cluster was bound per NfuA dimer. Fe/S cluster transfer from holo-NfuA to apo-PsaC of PS I was studied by reconstitution of PS I complexes using P700-FX core complexes, PsaD, apo-PsaC, and holo-NfuA. Electron transfer measurements by time-resolved optical spectroscopy showed that holo-NfuA rapidly and efficiently transferred [4Fe-4S] clusters to PsaC in a reaction that required contact between the two proteins. The NfuA-reconstituted PS I complexes had typical charge recombination kinetics from [FA/FB](-) to P700(+) and light-induced low-temperature EPR spectra. These results establish that cyanobacterial NfuA can act as a scaffolding protein for the insertion of [4Fe-4S] clusters into PsaC of PS I in vitro.	[Jin, Zhao; Heinnickel, Mark; Krebs, Carsten; Shen, Gaozhong; Golbeck, John H.; Bryant, Donald A.] Penn State Univ, Dept Biochem & Mol Biol, University Pk, PA 16802 USA; [Krebs, Carsten; Golbeck, John H.] Penn State Univ, Dept Chem, University Pk, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Bryant, DA (corresponding author), Penn State Univ, Dept Biochem & Mol Biol, S-235 Frear Bldg, University Pk, PA 16802 USA.	dab14@psu.edu	Jin, Zhao/C-5405-2011; Krebs, Carsten/D-4773-2009	Krebs, Carsten/0000-0002-3302-7053	U. S. Dept. of Agriculture Contract [2005-35318-15284]; National Science Foundation [MCB-0077586]; Center for the Study of Biometals in Health and Disease [417-12Hy TSF]; Pennsylvania Dept. of Health	U. S. Dept. of Agriculture Contract; National Science Foundation(National Science Foundation (NSF)); Center for the Study of Biometals in Health and Disease; Pennsylvania Dept. of Health	This work was supported by U. S. Dept. of Agriculture Contract 2005-35318-15284 (to J. H. G. and D. A. B.), National Science Foundation Grant MCB-0077586 (to D. A. B. and J. H. G.), and "Center for the Study of Biometals in Health and Disease" Grant 417-12Hy TSF (to C. K.). This work was also supported, in part, under a grant with the Pennsylvania Dept. of Health using Tobacco Settlement Funds. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Angelini S, 2008, J BIOL CHEM, V283, P14084, DOI 10.1074/jbc.M709405200; Antonkine ML, 2003, J MOL BIOL, V327, P671, DOI 10.1016/S0022-2836(03)00145-1; Balasubramanian R, 2006, J BACTERIOL, V188, P3182, DOI 10.1128/JB.188.9.3182-3191.2006; Bandyopadhyay S, 2008, J BIOL CHEM, V283, P14092, DOI 10.1074/jbc.M709161200; Bandyopadhyay S, 2008, EMBO J, V27, P1122, DOI 10.1038/emboj.2008.50; BEARDEN AJ, 1976, BIOCHIM BIOPHYS ACTA, V430, P538, DOI 10.1016/0005-2728(76)90029-3; Beinert H, 1978, Methods Enzymol, V54, P435; Chandramouli K, 2007, BIOCHEMISTRY-US, V46, P6804, DOI 10.1021/bi6026659; CRANKSHAW MW, 1996, CURRENT PROTOCOLS PR, P2218; DEAN DR, 1993, J BACTERIOL, V175, P6737, DOI 10.1128/jb.175.21.6737-6744.1993; Dos Santos PC, 2004, J BIOL CHEM, V279, P19705, DOI 10.1074/jbc.M400278200; Frazzon J, 2003, CURR OPIN CHEM BIOL, V7, P166, DOI 10.1016/S1367-5931(03)00021-8; FU WG, 1994, BIOCHEMISTRY-US, V33, P13455, DOI 10.1021/bi00249a034; Golbeck J. H., 1995, CRC HDB ORGANIC PHOT, P1407; GOLBECK JH, 1976, BIOCHEM BIOPH RES CO, V71, P452, DOI 10.1016/0006-291X(76)90808-1; GOLBECK JH, 1988, FEBS LETT, V240, P9, DOI 10.1016/0014-5793(88)80331-4; Golbeck JH, 1994, MOL BIOL CYANOBACTER, P319; GOLBECK JH, 2006, PHOTOSYSTEM, V1; GRABAREK Z, 1990, ANAL BIOCHEM, V185, P131, DOI 10.1016/0003-2697(90)90267-D; Heinnickel M, 2005, BIOCHEMISTRY-US, V44, P9950, DOI 10.1021/bi050588s; Johnson DC, 2005, ANNU REV BIOCHEM, V74, P247, DOI 10.1146/annurev.biochem.74.082803.133518; Jordan P, 2001, NATURE, V411, P909, DOI 10.1038/35082000; Keren N, 2004, PLANT PHYSIOL, V135, P1666, DOI 10.1104/pp.104.042770; KUO CF, 1988, ANAL BIOCHEM, V170, P183, DOI 10.1016/0003-2697(88)90106-6; Leon S, 2003, BIOCHEM J, V371, P823, DOI 10.1042/BJ20021946; LI N, 1991, BIOCHIM BIOPHYS ACTA, V1059, P215, DOI 10.1016/S0005-2728(05)80206-3; LI N, 1991, BIOCHEMISTRY-US, V30, P7863, DOI 10.1021/bi00245a028; Molina-Navarro MM, 2006, FEBS LETT, V580, P2273, DOI 10.1016/j.febslet.2006.03.037; Muhlenhoff U, 2000, BBA-BIOENERGETICS, V1459, P370, DOI 10.1016/S0005-2728(00)00174-2; Nishio K, 2000, J BIOL CHEM, V275, P22615, DOI 10.1074/jbc.C000279200; Picciocchi A, 2007, BIOCHEMISTRY-US, V46, P15018, DOI 10.1021/bi7013272; Schilke B, 1999, P NATL ACAD SCI USA, V96, P10206, DOI 10.1073/pnas.96.18.10206; Shen G, 2007, J BIOL CHEM, V282, P31909, DOI 10.1074/jbc.M705554200; Shen Gaozhong, 2006, V24, P529; Shen GZ, 2002, J BIOL CHEM, V277, P20355, DOI 10.1074/jbc.M201104200; Shen GZ, 2002, J BIOL CHEM, V277, P20343, DOI 10.1074/jbc.M201103200; Smith AD, 2005, BIOCHEMISTRY-US, V44, P12955, DOI 10.1021/bi051257i; Tong WH, 2003, P NATL ACAD SCI USA, V100, P9762, DOI 10.1073/pnas.1732541100; Touraine B, 2004, PLANT J, V40, P101, DOI 10.1111/j.1365-313X.2004.02189.x; Unciuleac MC, 2007, BIOCHEMISTRY-US, V46, P6812, DOI 10.1021/bi6026665; Vassiliev IR, 1997, BIOPHYS J, V72, P301, DOI 10.1016/S0006-3495(97)78669-7; Wang T, 2004, J BACTERIOL, V186, P956, DOI 10.1128/JB.186.4.956-967.2004; Wollenberg M, 2003, EUR J BIOCHEM, V270, P1662, DOI 10.1046/j.1432-1033.2003.03522.x; Wu SP, 2003, BIOCHEMISTRY-US, V42, P5784, DOI 10.1021/bi026939+; Yabe T, 2004, PLANT CELL, V16, P993, DOI 10.1105/tpc.020511; Yu JP, 2003, J BACTERIOL, V185, P3878, DOI 10.1128/JB.185.13.3878-3887.2003; Yuvaniyama P, 2000, P NATL ACAD SCI USA, V97, P599, DOI 10.1073/pnas.97.2.599	47	34	33	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 17	2008	283	42					28426	28435		10.1074/jbc.M803395200	http://dx.doi.org/10.1074/jbc.M803395200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	359EN	18694929	Green Published, hybrid			2022-12-27	WOS:000259969300044
J	Hannemann, S; Madrid, R; Stastna, J; Kitzing, T; Gasteier, J; Schonichen, A; Bouchet, J; Jimenez, A; Geyer, M; Grosse, R; Benichou, S; Fackler, OT				Hannemann, Sebastian; Madrid, Ricardo; Stastna, Jana; Kitzing, Thomas; Gasteier, Judith; Schoenichen, Andre; Bouchet, Jerome; Jimenez, Alberto; Geyer, Matthias; Grosse, Robert; Benichou, Serge; Fackler, Oliver T.			The diaphanous-related formin FHOD1 associates with ROCK1 and promotes Src-dependent plasma membrane blebbing	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-CELL INVASION; MAMMALIAN FORMIN; RHO-GTPASES; ACTIN; PROTEIN; MIGRATION; ACTIVATION; MECHANISM; PHOSPHORYLATION; IDENTIFICATION	Diaphanous-related formins (DRFs) mediate GTPase-triggered actin rearrangements to regulate central cellular processes, such as cell motility and cytokinesis. The DRF FHOD1 interacts with the Rho-GTPase Rac1 and mediates formation of actin stress fibers in its deregulated form; the physiologically relevant activities and molecular mechanisms of endogenous FHOD1, however, are still unknown. Here we report that FHOD1 physically associates via the N-terminal part of its FH2 domain with the central domain of ROCK1. Although FHOD1 does not affect the kinase activity of ROCK1, the DRF is an efficient substrate for phosphorylation by ROCK1. Co-expression of FHOD1 and ROCK1 results in the generation of nonapoptotic plasma membrane (PM) blebs, to which the DRF is efficiently recruited. Blebbing induced by FHOD1 and ROCK1 depends on F-actin integrity, the Rho-ROCK cascade, and Src activity and is reminiscent of the recently described PM blebs triggered by expression of Src homology 4 (SH4) domain PM targeting signals. Consistently, endogenous FHOD1 is required in SH4 domain expressing cells for efficient PM blebbing and rounded cell morphology in two-dimensional cultures or three-dimensional matrices, respectively. Efficient association of FHOD1 with ROCK1, as well as recruitment of the DRF to blebs, depends on Src activity, suggesting that the functional interaction between both proteins is regulated by Src. These results define a role for endogenous FHOD1 in SH4 domain-induced blebbing and suggest that its activity is regulated by ROCK1 in a Src-dependent manner.	[Hannemann, Sebastian; Stastna, Jana; Gasteier, Judith; Fackler, Oliver T.] Heidelberg Univ, Dept Virol, D-69120 Heidelberg, Germany; [Kitzing, Thomas; Grosse, Robert] Heidelberg Univ, Inst Pharmacol, D-69120 Heidelberg, Germany; [Madrid, Ricardo; Bouchet, Jerome; Benichou, Serge] Univ Paris 05, Inst Cochin, CNRS, UMR 8104, F-75014 Paris, France; [Madrid, Ricardo; Bouchet, Jerome; Benichou, Serge] INSERM, U567, F-75014 Paris, France; [Madrid, Ricardo; Jimenez, Alberto] Univ Autonoma Madrid, Ctr Biol Mol Severo Ochoa, E-28049 Madrid, Spain; [Madrid, Ricardo; Jimenez, Alberto] CSIC, E-28049 Madrid, Spain; [Schoenichen, Andre; Geyer, Matthias] Max Planck Inst Mol Physiol, Phys Biochem Abt, D-44227 Dortmund, Germany	Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM); Consejo Superior de Investigaciones Cientificas (CSIC); Max Planck Society	Fackler, OT (corresponding author), Heidelberg Univ, Dept Virol, Neuenheimer Feld 324, D-69120 Heidelberg, Germany.	oliver_fackler@med.uni-heidelberg.de	bouchet, jerome/I-7716-2019	bouchet, jerome/0000-0002-6611-4380; Fackler, Oliver Till/0000-0003-2982-4209; Geyer, Matthias/0000-0002-7718-5002; Madrid Gonzalez, Ricardo/0000-0002-1350-9864; Grosse, Robert/0000-0002-3380-5273; Benichou, Serge/0000-0003-3602-3530	Deutsche Forschungsgemeinschaft [Fa 378/6-1, Ge 976/4-1, Gr 2111/1-3, GRK1188]; French Agency for AIDS Research; Sidaction; Ministerio de Educacion y Cultura, Ramon y Cajal program	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); French Agency for AIDS Research(French National Research Agency (ANR)); Sidaction; Ministerio de Educacion y Cultura, Ramon y Cajal program(Spanish Government)	This work was supported by Deutsche Forschungsgemeinschaft Grants Fa 378/6-1 (to O.T.F.), Ge 976/4-1 (to M. G.), Gr 2111/1-3 (to R. G.), and GRK1188 (to S. H. and J. S.) and grants from the French Agency for AIDS Research (to S. B.), Sidaction (to S. B., R. M., and J. B.), and the Ministerio de Educacion y Cultura, Ramon y Cajal program (to R. M.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	Alberts AS, 2001, J BIOL CHEM, V276, P2824, DOI 10.1074/jbc.M006205200; Aspenstrom P, 2006, EXP CELL RES, V312, P2180, DOI 10.1016/j.yexcr.2006.03.013; BENICHOU S, 1994, J BIOL CHEM, V269, P30073; Blaser H, 2006, DEV CELL, V11, P613, DOI 10.1016/j.devcel.2006.09.023; Brandt DT, 2007, J CELL BIOL, V178, P193, DOI 10.1083/jcb.200612071; Charras GT, 2005, NATURE, V435, P365, DOI 10.1038/nature03550; Charras GT, 2008, BIOPHYS J, V94, P1836, DOI 10.1529/biophysj.107.113605; Charras GT, 2006, J CELL BIOL, V175, P477, DOI 10.1083/jcb.200602085; Coleman ML, 2001, NAT CELL BIOL, V3, P339, DOI 10.1038/35070009; CUNNINGHAM CC, 1995, J CELL BIOL, V129, P1589, DOI 10.1083/jcb.129.6.1589; Eisenmann KM, 2007, CURR BIOL, V17, P579, DOI 10.1016/j.cub.2007.03.024; Fackler OT, 2008, J CELL BIOL, V181, P879, DOI 10.1083/jcb.200802081; Faix J, 2006, DEV CELL, V10, P693, DOI 10.1016/j.devcel.2006.05.001; FISHKIND DJ, 1991, J CELL BIOL, V114, P967, DOI 10.1083/jcb.114.5.967; Gadea G, 2007, J CELL BIOL, V178, P23, DOI 10.1083/jcb.200701120; Gasman S, 2003, NAT CELL BIOL, V5, P195, DOI 10.1038/ncb935; Gasteier JE, 2005, EXP CELL RES, V306, P192, DOI 10.1016/j.yexcr.2005.02.006; Gasteier JE, 2003, J BIOL CHEM, V278, P38902, DOI 10.1074/jbc.M306229200; Goode BL, 2007, ANNU REV BIOCHEM, V76, P593, DOI 10.1146/annurev.biochem.75.103004.142647; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; Haller C, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001212; Harris ES, 2006, J BIOL CHEM, V281, P14383, DOI 10.1074/jbc.M510923200; Kitzing TM, 2007, GENE DEV, V21, P1478, DOI 10.1101/gad.424807; Klinghoffer RA, 1999, EMBO J, V18, P2459, DOI 10.1093/emboj/18.9.2459; Koka S, 2005, BIOCHEM BIOPH RES CO, V336, P1285, DOI 10.1016/j.bbrc.2005.08.257; Koka S, 2003, J CELL SCI, V116, P1745, DOI 10.1242/jcs.00386; Lammers M, 2005, EMBO J, V24, P4176, DOI 10.1038/sj.emboj.7600879; Liu W, 2008, P NATL ACAD SCI USA, V105, P210, DOI 10.1073/pnas.0707277105; MacKenzie A, 2001, IMMUNITY, V15, P825, DOI 10.1016/S1074-7613(01)00229-1; Madrid R, 2005, FEBS LETT, V579, P441, DOI 10.1016/j.febslet.2004.12.009; Peytavi R, 1999, J BIOL CHEM, V274, P1635, DOI 10.1074/jbc.274.3.1635; Pinner S, 2008, NAT CELL BIOL, V10, P127, DOI 10.1038/ncb1675; Rauch S, 2008, J VIROL, V82, P2918, DOI 10.1128/JVI.02185-07; Sahai E, 2003, NAT CELL BIOL, V5, P711, DOI 10.1038/ncb1019; Sahai E, 2005, CURR OPIN GENET DEV, V15, P87, DOI 10.1016/j.gde.2004.12.002; Schonichen A, 2006, J BIOL CHEM, V281, P5084, DOI 10.1074/jbc.M509226200; Schwartz MA, 1998, ONCOGENE, V17, P625, DOI 10.1038/sj.onc.1201977; Sebbagh M, 2001, NAT CELL BIOL, V3, P346, DOI 10.1038/35070019; Sheetz MP, 2006, ANNU REV BIOPH BIOM, V35, P417, DOI 10.1146/annurev.biophys.35.040405.102017; Takeya R, 2003, J CELL SCI, V116, P4567, DOI 10.1242/jcs.00769; Takeya R, 2008, EMBO J, V27, P618, DOI 10.1038/emboj.2008.7; Tominaga T, 2000, MOL CELL, V5, P13, DOI 10.1016/S1097-2765(00)80399-8; Torgerson RR, 1998, J CELL SCI, V111, P2911; Tournaviti S, 2007, J CELL SCI, V120, P3820, DOI 10.1242/jcs.011130; Wang YP, 2004, J BIOL CHEM, V279, P24420, DOI 10.1074/jbc.M313823200; Westendorf JJ, 1999, GENE, V232, P173, DOI 10.1016/S0378-1119(99)00127-4; Westendorf JJ, 2001, J BIOL CHEM, V276, P46453, DOI 10.1074/jbc.M105162200; Wolf K, 2003, J CELL BIOL, V160, P267, DOI 10.1083/jcb.200209006; Wyckoff JB, 2006, CURR BIOL, V16, P1515, DOI 10.1016/j.cub.2006.05.065	49	55	57	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 10	2008	283	41					27891	27903		10.1074/jbc.M801800200	http://dx.doi.org/10.1074/jbc.M801800200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	355OW	18694941	hybrid			2022-12-27	WOS:000259719200060
J	Zhang, JH; Xie, ZL; Dong, YZ; Wang, SX; Liu, C; Zou, MH				Zhang, Junhua; Xie, Zhonglin; Dong, Yunzhou; Wang, Shuangxi; Liu, Chao; Zou, Ming-Hui			Identification of nitric oxide as an endogenous activator of the AMP-activated protein kinase in vascular endothelial cells (Publication with Expression of Concern. See vol. 294, pg. 10027, 2019) (Withdrawn Publication. See vol. 295, pg. 670, 2020)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article; Withdrawn Publication							CYTOSOLIC CA2+ CONCENTRATION; C-ZETA; UPSTREAM KINASE; PHOSPHORYLATION; BETA; SYNTHASE; PATHWAY; GLUCOSE; PEROXYNITRITE; INSULIN	In endothelial cells, the AMP-activated protein kinase ( AMPK) is stimulated by sheer stress or growth factors that stimulate release of nitric oxide ( NO). Wehypothesized that NO might act as an endogenous activator of AMPK in endothelial cells. Exposure of human umbilical vein endothelial cells (HUVECs) to NO donors caused an increase in phosphorylation of both Thr-172 of AMPK and Ser-1177 of endothelial nitric oxide synthase, a downstream enzyme of AMPK. NO-induced activation of AMPK was not affected by inhibition of LKB1, an AMPK kinase. In contrast, inhibition of calcium calmodulin-dependent protein kinase kinase abolished the effect of NO in HUVECs. NO-induced AMPK activation in HeLa S3 cells was abolished by either 1H-(1,2,4)-oxadiazole[4,3-a] quinoxalon-1-one, a potent inhibitor for guanylyl cyclase, or 1,2-bis(2-aminophenoxy) ethane-N,N,N',N'-tetraacetic acid tetrakis ( acetoxymethyl ester) (BAPTA-AM), an intracellular Ca2+ chelator, indicating that NO-induced AMPK activation is guanylyl cyclase-mediated and calcium-dependent. Exposure of HUVECs or isolated mice aortas to either calcium ionophore A23187 or bradykinin significantly increased AMPK Thr-172 phosphorylation, which was abolished by N-nitro-L-arginine methyl ester, an inhibitor of nitric oxide synthase. Finally, A23187- or bradykinin-enhanced AMPK activation was significantly greater in aortas from wild type mice than those in the aortas of endothelial nitric oxide synthase knock-out mice. Taken together, we conclude that NO might act as an endogenous AMPK activator.	[Zhang, Junhua; Xie, Zhonglin; Dong, Yunzhou; Wang, Shuangxi; Liu, Chao; Zou, Ming-Hui] Univ Oklahoma, Hlth Sci Ctr, Dept Med, Div Endocrinol & Diabet, Oklahoma City, OK 73104 USA	University of Oklahoma System; University of Oklahoma Health Sciences Center	Zou, MH (corresponding author), Univ Oklahoma, Hlth Sci Ctr, Dept Med, Div Endocrinol & Diabet, BSEB 325,941 Stanton L Young Blvd, Oklahoma City, OK 73104 USA.	ming-hui-zou@ouhsc.edu			National Institutes of Health [HL079584, HL080499, HL074399, HL089920]; American Diabetes Association; Juvenile Diabetes Research Foundation; Oklahoma Center for the Advancement of Science and Technology; University of Oklahoma Health Sciences Center; American Heart Association; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL080499, R01HL079584, R01HL074399, R01HL089920] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association(American Diabetes Association); Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); Oklahoma Center for the Advancement of Science and Technology; University of Oklahoma Health Sciences Center; American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL079584, HL080499, HL074399, and HL089920 (to M. H.-Z.). This work was also supported by a research award from the American Diabetes Association, a research award from the Juvenile Diabetes Research Foundation, a grant from the Oklahoma Center for the Advancement of Science and Technology, and funds from the Paul H. Doris Eaton Travis Chair in Endocrinology of the University of Oklahoma Health Sciences Center (to M. H.-Z.), and this work was supported in part by a Scientist Development Grant from the American Heart Association (to Z. X.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact. at ISI, Thomson Scientific on October 6, 2008 www. jbc. org Downloaded from	An ZB, 2007, J BIOL CHEM, V282, P26793, DOI 10.1074/jbc.M703701200; Bian K, 2006, J PHARMACOL SCI, V101, P271, DOI 10.1254/jphs.CRJ06009X; Bredt DS, 2003, J CELL SCI, V116, P9, DOI 10.1242/jcs.00183; Chen ZP, 1999, FEBS LETT, V443, P285, DOI 10.1016/S0014-5793(98)01705-0; Cheung PCF, 2000, BIOCHEM J, V346, P659, DOI 10.1042/0264-6021:3460659; Dudzinski DM, 2006, ANNU REV PHARMACOL, V46, P235, DOI 10.1146/annurev.pharmtox.44.101802.121844; Elahi MM, 2007, FEBS J, V274, P906, DOI 10.1111/j.1742-4658.2007.05660.x; Fisslthaler B, 2007, CIRC RES, V100, pE12, DOI 10.1161/01.RES.0000257747.74358.1c; Fryer LGD, 2000, DIABETES, V49, P1978, DOI 10.2337/diabetes.49.12.1978; Gao F, 2002, CIRCULATION, V105, P1497, DOI 10.1161/01.CIR.0000012529.00367.0F; Hardie DG, 1997, EUR J BIOCHEM, V246, P259, DOI 10.1111/j.1432-1033.1997.00259.x; Hardie DG, 1998, ANNU REV BIOCHEM, V67, P821, DOI 10.1146/annurev.biochem.67.1.821; HAWLEY SA, 1995, J BIOL CHEM, V270, P27186, DOI 10.1074/jbc.270.45.27186; Hawley SA, 2005, CELL METAB, V2, P9, DOI 10.1016/j.cmet.2005.05.009; Hawley SA, 1996, J BIOL CHEM, V271, P27879, DOI 10.1074/jbc.271.44.27879; Hawley Simon A, 2003, J Biol, V2, P28, DOI 10.1186/1475-4924-2-28; Hurley RL, 2005, J BIOL CHEM, V280, P29060, DOI 10.1074/jbc.M503824200; Hwang TL, 2003, MOL PHARMACOL, V64, P1419, DOI 10.1124/mol.64.6.1419; Ishikawa T, 2003, J PHARMACOL SCI, V91, P41, DOI 10.1254/jphs.91.41; Jobgen WS, 2006, J NUTR BIOCHEM, V17, P571, DOI 10.1016/j.jnutbio.2005.12.001; Kaneko Y, 2003, AM J PHYSIOL-CELL PH, V284, pC1215, DOI 10.1152/ajpcell.00223.2002; Kim J, 2001, J BIOL CHEM, V276, P19102, DOI 10.1074/jbc.M011579200; Levine YC, 2007, J BIOL CHEM, V282, P20351, DOI 10.1074/jbc.M702182200; Li J, 2004, AM J PHYSIOL-ENDOC M, V287, pE834, DOI 10.1152/ajpendo.00234.2004; Mount PF, 2008, ATHEROSCLEROSIS, V200, P28, DOI 10.1016/j.atherosclerosis.2007.12.003; Munzel T, 2005, CIRC RES, V97, P618, DOI 10.1161/01.RES.0000184694.03262.6d; Nisoli E, 2003, SCIENCE, V299, P896, DOI 10.1126/science.1079368; Park SH, 2002, J APPL PHYSIOL, V92, P2475, DOI 10.1152/japplphysiol.00071.2002; Quintero M, 2006, P NATL ACAD SCI USA, V103, P5379, DOI 10.1073/pnas.0601026103; Reihill JA, 2007, BIOCHEM BIOPH RES CO, V354, P1084, DOI 10.1016/j.bbrc.2007.01.110; Shearer J, 2004, DIABETES, V53, P1429, DOI 10.2337/diabetes.53.6.1429; Song P, 2008, J BIOL CHEM, V283, P12446, DOI 10.1074/jbc.M708208200; Spector NL, 2007, P NATL ACAD SCI USA, V104, P10607, DOI 10.1073/pnas.0701286104; Stahmann N, 2006, MOL CELL BIOL, V26, P5933, DOI 10.1128/MCB.00383-06; Stasch JP, 2006, J CLIN INVEST, V116, P2552, DOI 10.1172/JCI28371; Weber M, 2001, FREE RADICAL BIO MED, V31, P1360, DOI 10.1016/S0891-5849(01)00706-7; Winder WW, 2001, J APPL PHYSIOL, V91, P1017, DOI 10.1152/jappl.2001.91.3.1017; Wohlfart P, 1999, BRIT J PHARMACOL, V128, P1316, DOI 10.1038/sj.bjp.0702921; Woods A, 2003, CURR BIOL, V13, P2004, DOI 10.1016/j.cub.2003.10.031; Woods A, 2005, CELL METAB, V2, P21, DOI 10.1016/j.cmet.2005.06.005; Xie Z, 2008, CIRCULATION, V117, P952, DOI 10.1161/CIRCULATIONAHA.107.744490; Xie ZL, 2006, J BIOL CHEM, V281, P6366, DOI 10.1074/jbc.M511178200; Yaekura K, 1996, DIABETES, V45, P295, DOI 10.2337/diabetes.45.3.295; Zhang YJ, 2006, ARTERIOSCL THROM VAS, V26, P1281, DOI 10.1161/01.ATV.0000221230.08596.98; Zou MH, 2004, J BIOL CHEM, V279, P43940, DOI 10.1074/jbc.M404421200; Zou MH, 2003, J BIOL CHEM, V278, P34003, DOI 10.1074/jbc.M300215200; Zou MH, 2002, J BIOL CHEM, V277, P32552, DOI 10.1074/jbc.M204512200	47	95	101	1	7	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 10	2008	283	41					27452	27461		10.1074/jbc.M802578200	http://dx.doi.org/10.1074/jbc.M802578200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	355OW	18693249	Green Published, hybrid			2022-12-27	WOS:000259719200015
J	Vivian, JP; Scoullar, J; Robertson, AL; Bottomley, SP; Horne, J; Chin, Y; Wielens, J; Thompson, PE; Velkov, T; Piek, S; Byres, E; Beddoe, T; Wilce, MCJ; Kahler, CM; Rossjohn, J; Scanlon, MJ				Vivian, Julian P.; Scoullar, Jessica; Robertson, Amy L.; Bottomley, Stephen P.; Horne, James; Chin, Yanni; Wielens, Jerome; Thompson, Philip E.; Velkov, Tony; Piek, Susannah; Byres, Emma; Beddoe, Travis; Wilce, Matthew C. J.; Kahler, Charlene M.; Rossjohn, Jamie; Scanlon, Martin J.			Structural and Biochemical Characterization of the Oxidoreductase NmDsbA3 from Neisseria meningitidis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DISULFIDE BOND FORMATION; STAPHYLOCOCCUS-AUREUS DSBA; ESCHERICHIA-COLI DSBA; DESTABILIZING DISULFIDE; CRYSTAL-STRUCTURE; PROTEINS; IDENTIFICATION; THIOREDOXIN; ISOMERASE	DsbA is an enzyme found in the periplasm of Gram-negative bacteria that catalyzes the formation of disulfide bonds in a diverse array of protein substrates, many of which are involved in bacterial pathogenesis. Although most bacteria possess only a single essential DsbA, Neisseria meningitidis is unusual in that it possesses three DsbAs, although the reason for this additional redundancy is unclear. Two of these N. meningitidis enzymes (NmDsbA1 and NmDsbA2) play an important role in meningococcal attachment to human epithelial cells, whereas NmDsbA3 is considered to have a narrow substrate repertoire. To begin to address the role of DsbAs in the pathogenesis of N. meningitidis, we have determined the structure of NmDsbA3 to 2.3-angstrom resolution. Although the sequence identity between NmDsbA3 and other DsbAs is low, the NmDsbA3 structure adopted a DsbA-like fold. Consistent with this finding, we demonstrated that NmDsbA3 acts as a thiol-disulfide oxidoreductase in vitro and is reoxidized by Escherichia coli DsbB (EcDsbB). However, pronounced differences in the structures between DsbA3 and EcDsbA, which are clustered around the active site of the enzyme, suggested a structural basis for the unusual substrate specificity that is observed for NmDsbA3.	[Scoullar, Jessica; Piek, Susannah; Kahler, Charlene M.] Univ Western Australia, QEII Med Ctr, Sch Biomed Biomol & Chem Sci, Crawley, WA 6009, Australia; [Vivian, Julian P.; Robertson, Amy L.; Bottomley, Stephen P.; Byres, Emma; Beddoe, Travis; Wilce, Matthew C. J.; Rossjohn, Jamie] Monash Univ, Sch Biomed Sci, ARC Ctr Excellence Struct & Funct Microbial Genom, Prot Crystallog Unit, Clayton, Vic 3800, Australia; [Horne, James; Chin, Yanni; Wielens, Jerome; Thompson, Philip E.; Velkov, Tony; Scanlon, Martin J.] Monash Univ, Monash Inst Pharmaceut Sci, Parkville, Vic 3052, Australia	University of Western Australia; Monash University; Monash University	Kahler, CM (corresponding author), Univ Western Australia, QEII Med Ctr, Sch Biomed Biomol & Chem Sci, Crawley, WA 6009, Australia.	ckahler@cyllene.uwa.edu.au; Jamie.rossjohn@med.monash.edu.au; Martin.Scanlon@pharm.monash.edu.au	Chin, Yanni/D-2139-2017; Kahler, Charlene M/H-5159-2014; Rossjohn, Jamie/F-9032-2013; Beddoe, Travis/F-3415-2014	Chin, Yanni/0000-0002-3367-6897; Kahler, Charlene M/0000-0003-4322-3055; Rossjohn, Jamie/0000-0002-2020-7522; Beddoe, Travis/0000-0003-4550-2277; Wielens, Jerome/0000-0003-3406-4136; Horne, James/0000-0002-1935-2378; velkov, tony/0000-0002-0017-7952; Vivian, Julian/0000-0002-9400-4437; Scanlon, Martin/0000-0002-9230-7506; Thompson, Philip/0000-0002-5910-7625	Australian Research Council (ARC) [LP0455508]; National Health and Medical Research Council (NHMRC) [455860]; Ada Bartholomew Medical Research Trust; Medical and Health Research Infrastructure Fund of Western Australia	Australian Research Council (ARC)(Australian Research Council); National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Ada Bartholomew Medical Research Trust; Medical and Health Research Infrastructure Fund of Western Australia	This work was supported in part by Australian Research Council (ARC) Grant LP0455508 and National Health and Medical Research Council (NHMRC) Grant 455860. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.; Supported by grants from the Ada Bartholomew Medical Research Trust and the Medical and Health Research Infrastructure Fund of Western Australia.	AKIYAMA Y, 1992, J BIOL CHEM, V267, P22440; Bader M, 1998, J BIOL CHEM, V273, P10302, DOI 10.1074/jbc.273.17.10302; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BARDWELL JCA, 1991, CELL, V67, P581, DOI 10.1016/0092-8674(91)90532-4; BOURDOULOUS S, 2006, HDB MENINGOCOCCAL DI; CHUNG CT, 1988, NUCLEIC ACIDS RES, V16, P3580, DOI 10.1093/nar/16.8.3580; DAILEY FE, 1993, P NATL ACAD SCI USA, V90, P1043, DOI 10.1073/pnas.90.3.1043; Dumoulin A, 2005, ARCH MICROBIOL, V184, P117, DOI 10.1007/s00203-005-0024-1; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Guddat LW, 1997, PROTEIN SCI, V6, P1148, DOI 10.1002/pro.5560060603; Heras B, 2008, J BIOL CHEM, V283, P4261, DOI 10.1074/jbc.M707838200; Hiniker A, 2007, P NATL ACAD SCI USA, V104, P11670, DOI 10.1073/pnas.0704692104; Hizukuri Y, 2006, J BACTERIOL, V188, P4190, DOI 10.1128/JB.01896-05; HOLMGREN A, 1979, J BIOL CHEM, V254, P9627; Horne J, 2007, J MOL BIOL, V371, P703, DOI 10.1016/j.jmb.2007.05.067; Hu SH, 1997, J MOL BIOL, V268, P137, DOI 10.1006/jmbi.1997.0940; Inaba K, 2006, CELL, V127, P789, DOI 10.1016/j.cell.2006.10.034; Kadokura H, 2004, SCIENCE, V303, P534, DOI 10.1126/science.1091724; MACNAB RM, 1986, METHOD ENZYMOL, V125, P563; Marley J, 2001, J BIOMOL NMR, V20, P71, DOI 10.1023/A:1011254402785; MARTIN JL, 1995, STRUCTURE, V3, P245, DOI 10.1016/S0969-2126(01)00154-X; MARTIN JL, 1993, NATURE, V365, P464, DOI 10.1038/365464a0; MARTIN JL, 1993, J MOL BIOL, V230, P1097, DOI 10.1006/jmbi.1993.1226; MISSIAKAS D, 1993, P NATL ACAD SCI USA, V90, P7084, DOI 10.1073/pnas.90.15.7084; MISSIAKAS D, 1994, EMBO J, V13, P2013, DOI 10.1002/j.1460-2075.1994.tb06471.x; MISSIAKAS D, 1995, EMBO J, V14, P3415, DOI 10.1002/j.1460-2075.1995.tb07347.x; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nakamoto H, 2004, BBA-MOL CELL RES, V1694, P111, DOI 10.1016/j.bbamcr.2004.02.012; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PEEK JA, 1992, P NATL ACAD SCI USA, V89, P6210, DOI 10.1073/pnas.89.13.6210; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; Sardesai AA, 2003, EMBO J, V22, P1461, DOI 10.1093/emboj/cdg152; Sinha S, 2004, MICROBIOL-SGM, V150, P2993, DOI 10.1099/mic.0.27216-0; Sinha S, 2008, MICROBIOL-SGM, V154, P217, DOI 10.1099/mic.0.2007/010496-0; Stephens DS, 2007, LANCET, V369, P2196, DOI 10.1016/S0140-6736(07)61016-2; STEPHENS DS, 1981, J INFECT DIS, V143, P525, DOI 10.1093/infdis/143.4.525; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; TAKESHITA S, 1987, GENE, V61, P63, DOI 10.1016/0378-1119(87)90365-9; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Tinsley CR, 2004, J BIOL CHEM, V279, P27078, DOI 10.1074/jbc.M313404200; Vagin AA, 2001, ACTA CRYSTALLOGR D, V57, P1451, DOI 10.1107/S0907444901012409; ZAPUN A, 1993, BIOCHEMISTRY-US, V32, P5083, DOI 10.1021/bi00070a016	42	23	23	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 21	2008	283	47					32452	32461		10.1074/jbc.M803990200	http://dx.doi.org/10.1074/jbc.M803990200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	372HW	18715864	hybrid			2022-12-27	WOS:000260893700033
J	Gakh, O; Smith, DY; Isaya, G				Gakh, Oleksandr; Smith, Douglas Y.; Isaya, Grazia			Assembly of the Iron-binding Protein Frataxin in Saccharomyces cerevisiae Responds to Dynamic Changes in Mitochondrial Iron Influx and Stress Level	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SULFUR CLUSTER BIOSYNTHESIS; HEAT-SHOCK RESPONSE; YEAST FRATAXIN; FRIEDREICH ATAXIA; PROCESSING PEPTIDASE; ESCHERICHIA-COLI; REPEAT EXPANSION; OXIDATIVE STRESS; DEFICIENT STRAIN; 2FE-2S CLUSTERS	Defects in frataxin result in Friedreich ataxia, a genetic disease characterized by early onset of neurodegeneration, cardiomyopathy, and diabetes. Frataxin is a conserved mitochondrial protein that controls iron needed for iron-sulfur cluster assembly and heme synthesis and also detoxifies excess iron. Studies in vitro have shown that either monomeric or oligomeric frataxin delivers iron to other proteins, whereas ferritin-like frataxin particles convert redox-active iron to an inert mineral. We have investigated how these different forms of frataxin are regulated in vivo. In Saccharomyces cerevisiae, only monomeric yeast frataxin (Yfh1) was detected in unstressed cells when mitochondrial iron uptake was maintained at a steady, low nanomolar level. Increments in mitochondrial iron uptake induced step-wise assembly of Yfh1 species ranging from trimer to >= 24-mer, independent of interactions between Yfh1 and its major iron-binding partners, Isu1/Nfs1 or aconitase. The rate-limiting step in Yfh1 assembly was a structural transition that preceded conversion of monomer to trimer. This step was induced, independently or synergistically, by mitochondrial iron increments, overexpression of wild type Yfh1 monomer, mutations that stabilize Yfh1 trimer, or heat stress. Faster assembly kinetics correlated with reduced oxidative damage and higher levels of aconitase activity, respiratory capacity, and cell survival. However, deregulation of Yfh1 assembly resulted in Yfh1 aggregation, aconitase sequestration, and mitochondrial DNA depletion. The data suggest that Yfh1 assembly responds to dynamic changes in mitochondrial iron uptake or stress exposure in a highly controlled fashion and that this may enable frataxin to simultaneously promote respiratory function and stress tolerance.	Mayo Clin, Coll Med, Dept Adolescent Med, Rochester, MN 55905 USA; Mayo Clin, Coll Med, Dept Biochem & Mol Biol, Rochester, MN 55905 USA; [Isaya, Grazia] Mayo Clin, Coll Med, Dept Pediat, Rochester, MN 55905 USA	Mayo Clinic; Mayo Clinic; Mayo Clinic	Isaya, G (corresponding author), Mayo Clin, Coll Med, Dept Pediat, 200 1st St SW,Stabile 7-52, Rochester, MN 55905 USA.	isaya@mayo.edu			National Institutes of Health [AG15709]; Friedreich Ataxia Research Alliance/Muscular Dystrophy Association; NATIONAL INSTITUTE ON AGING [R01AG015709] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Friedreich Ataxia Research Alliance/Muscular Dystrophy Association(Muscular Dystrophy Association); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grant AG15709. This work was also supported by the Friedreich Ataxia Research Alliance/Muscular Dystrophy Association. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Adam AC, 2006, EMBO J, V25, P174, DOI 10.1038/sj.emboj.7600905; Adamec J, 2000, AM J HUM GENET, V67, P549, DOI 10.1086/303056; Adinolfi S, 2002, HUM MOL GENET, V11, P1865, DOI 10.1093/hmg/11.16.1865; Al-Mahdawi S, 2006, GENOMICS, V88, P580, DOI 10.1016/j.ygeno.2006.06.015; Aloria K, 2004, EMBO REP, V5, P1096, DOI 10.1038/sj.embor.7400272; Anderson PR, 2008, P NATL ACAD SCI USA, V105, P611, DOI 10.1073/pnas.0709691105; Babcock M, 1997, SCIENCE, V276, P1709, DOI 10.1126/science.276.5319.1709; Bou-Abdallah F, 2004, J MOL BIOL, V341, P605, DOI 10.1016/j.jmb.2004.05.072; Branda SS, 1999, J BIOL CHEM, V274, P22763, DOI 10.1074/jbc.274.32.22763; Bulteau AL, 2004, SCIENCE, V305, P242, DOI 10.1126/science.1098991; Campanella A, 2004, HUM MOL GENET, V13, P2279, DOI 10.1093/hmg/ddh232; Campuzano V, 1996, SCIENCE, V271, P1423, DOI 10.1126/science.271.5254.1423; Cavadini P, 2002, HUM MOL GENET, V11, P217, DOI 10.1093/hmg/11.3.217; Chen OS, 2000, J BIOL CHEM, V275, P7626, DOI 10.1074/jbc.275.11.7626; Chen OS, 2004, J BIOL CHEM, V279, P29513, DOI 10.1074/jbc.M403209200; Chen OS, 2002, P NATL ACAD SCI USA, V99, P12321, DOI 10.1073/pnas.192449599; Chen XJ, 2007, P NATL ACAD SCI USA, V104, P13738, DOI 10.1073/pnas.0703078104; Cook JD, 2006, BIOCHEMISTRY-US, V45, P7767, DOI 10.1021/bi060424r; Duby G, 2002, HUM MOL GENET, V11, P2635, DOI 10.1093/hmg/11.21.2635; Emond M, 2000, NEUROLOGY, V55, P1752, DOI 10.1212/WNL.55.11.1752; Felice MR, 2005, J BIOL CHEM, V280, P22181, DOI 10.1074/jbc.M414663200; Foury F, 1999, FEBS LETT, V456, P281, DOI 10.1016/S0014-5793(99)00961-8; Foury F, 2001, J BIOL CHEM, V276, P7762, DOI 10.1074/jbc.M005804200; Foury F, 2007, EMBO REP, V8, P194, DOI 10.1038/sj.embor.7400881; Gakh O, 2006, HUM MOL GENET, V15, P467, DOI 10.1093/hmg/ddi461; Gardner PR, 2002, METHOD ENZYMOL, V349, P9, DOI 10.1016/S0076-6879(02)49317-2; Hart PE, 2005, ARCH NEUROL-CHICAGO, V62, P621, DOI 10.1001/archneur.62.4.621; He YN, 2004, BIOCHEMISTRY-US, V43, P16254, DOI 10.1021/bi0488193; Herman PK, 2002, CURR OPIN MICROBIOL, V5, P602, DOI 10.1016/S1369-5274(02)00377-6; Jeffery CJ, 1999, TRENDS BIOCHEM SCI, V24, P8, DOI 10.1016/S0968-0004(98)01335-8; KAEBERLEIN M, 2001, SCI AGING KNOWLEDGE, pE1, DOI DOI 10.1126/SAGEKE.2001.1.PE1; Karlberg T, 2006, STRUCTURE, V14, P1535, DOI 10.1016/j.str.2006.08.010; Karthikeyan G, 2003, HUM MOL GENET, V12, P3331, DOI 10.1093/hmg/ddg349; Kondapalli KC, 2008, BIOCHEMISTRY-US, V47, P6917, DOI 10.1021/bi800366d; Layer G, 2006, J BIOL CHEM, V281, P16256, DOI 10.1074/jbc.M513569200; Martelli A, 2007, HUM MOL GENET, V16, P2651, DOI 10.1093/hmg/ddm163; Molik S, 2007, METHOD CELL BIOL, V80, P261, DOI 10.1016/S0091-679X(06)80013-0; Moraitis C, 2004, YEAST, V21, P313, DOI 10.1002/yea.1078; Muhlenhoff U, 2002, HUM MOL GENET, V11, P2025, DOI 10.1093/hmg/11.17.2025; MUMBERG D, 1995, GENE, V156, P119, DOI 10.1016/0378-1119(95)00037-7; Neupert W, 2007, ANNU REV BIOCHEM, V76, P723, DOI 10.1146/annurev.biochem.76.052705.163409; Nichol H, 2003, BIOCHEMISTRY-US, V42, P5971, DOI 10.1021/bi027021l; O'Neill HA, 2005, J MOL BIOL, V345, P433, DOI 10.1016/j.jmb.2004.10.074; Park S, 2003, J BIOL CHEM, V278, P31340, DOI 10.1074/jbc.M303158200; Park S, 2002, J BIOL CHEM, V277, P38589, DOI 10.1074/jbc.M206711200; Popescu BFG, 2007, J INORG BIOCHEM, V101, P957, DOI 10.1016/j.jinorgbio.2007.03.004; Ristow M, 2000, P NATL ACAD SCI USA, V97, P12239, DOI 10.1073/pnas.220403797; Ristow M, 2003, J CLIN INVEST, V112, P527, DOI 10.1172/JCI200318107; Schagerlof U, 2008, BIOCHEMISTRY-US, V47, P4948, DOI 10.1021/bi800052m; Schoenfeld RA, 2005, HUM MOL GENET, V14, P3787, DOI 10.1093/hmg/ddi393; Schulz JB, 2000, NEUROLOGY, V55, P1719, DOI 10.1212/WNL.55.11.1719; Seznec H, 2004, HUM MOL GENET, V13, P1017, DOI 10.1093/hmg/ddh114; Shoichet SA, 2002, HUM MOL GENET, V11, P815, DOI 10.1093/hmg/11.7.815; Sugiyama K, 2000, J BIOL CHEM, V275, P15535, DOI 10.1074/jbc.275.20.15535; Taylor AB, 2001, STRUCTURE, V9, P615, DOI 10.1016/S0969-2126(01)00621-9; Tong WH, 2006, CELL METAB, V3, P199, DOI 10.1016/j.cmet.2006.02.003; Vazquez-Manrique RP, 2005, FASEB J, V19, P172, DOI 10.1096/fj.05-4212fje; Velagapudi VR, 2006, PROCESS BIOCHEM, V41, P2170, DOI 10.1016/j.procbio.2006.06.016; Wang T, 2008, J BIOL CHEM, V283, P12674, DOI 10.1074/jbc.M800399200; Wilson RB, 1997, NAT GENET, V16, P352, DOI 10.1038/ng0897-352; Wong A, 1999, HUM MOL GENET, V8, P425, DOI 10.1093/hmg/8.3.425; Yoon T, 2004, J BIOL CHEM, V279, P25943, DOI 10.1074/jbc.C400107200; Yoon T, 2003, J AM CHEM SOC, V125, P6078, DOI 10.1021/ja027967i; Zanella I, 2008, BBA-MOL BASIS DIS, V1782, P90, DOI 10.1016/j.bbadis.2007.11.006; Zhang Y, 2005, J BIOL CHEM, V280, P19794, DOI 10.1074/jbc.M500397200	65	29	29	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 14	2008	283	46					31500	31510		10.1074/jbc.M805415200	http://dx.doi.org/10.1074/jbc.M805415200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	370KJ	18784075	Green Published, hybrid			2022-12-27	WOS:000260760800029
J	Ghosh, S; Hamdan, SM; Cook, TE; Richardson, CC				Ghosh, Sharmistha; Hamdan, Samir M.; Cook, Timothy E.; Richardson, Charles C.			Interactions of Escherichia coli Thioredoxin, the Processivity Factor, with Bacteriophage T7 DNA Polymerase and Helicase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REPLICATION IN-VITRO; DEOXYRIBONUCLEIC-ACID; CONFERS PROCESSIVITY; CRYSTAL-STRUCTURE; MECHANISMS; BINDING; PROTEIN; PRIMASE	Escherichia coli thioredoxin binds to a unique flexible loop of 71 amino acid residues, designated the thioredoxin binding domain (TBD), located in the thumb subdomain of bacteriophage T7 gene 5 DNA polymerase. The initial designation of thioredoxin as a processivity factor was premature. Rather it remodels the TBD for interaction with DNA and the other replication proteins. The binding of thioredoxin exposes a number of basic residues on the TBD that lie over the duplex region of the primer-template and increases the processivity of nucleotide polymerization. Two small solvent-exposed loops (loops A and B) located within TBD electrostatically interact with the acidic C-terminal tail of T7 gene 4 helicase-primase, an interaction that is enhanced by the binding of thioredoxin. Several basic residues on the surface of thioredoxin in the polymerase-thioredoxin complex lie in close proximity to the TBD. One of these residues, lysine 36, is located proximal to loop A. The substitution of glutamate for lysine has a dramatic effect on the binding of gene 4 helicase to a DNA polymerase-thioredoxin complex lacking charges on loop B; binding is decreased 15-fold relative to that observed with wild-type thioredoxin. This defective interaction impairs the ability of T7 DNA polymerase-thioredoxin together with T7 helicase to mediate strand displacement synthesis. This is the first demonstration that thioredoxin interacts with replication proteins other than T7 DNA polymerase.	[Ghosh, Sharmistha; Hamdan, Samir M.; Cook, Timothy E.; Richardson, Charles C.] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Richardson, CC (corresponding author), Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, 200 Longwood Ave, Boston, MA 02115 USA.	ccr@hms.harvard.edu		Hamdan, Samir/0000-0001-5192-1852	National Institutes of Health [GM 54397 (USPHS)]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM054397] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM 54397 (USPHS). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	BAMBARA RA, 1978, J BIOL CHEM, V253, P413; Bedford E, 1997, P NATL ACAD SCI USA, V94, P479, DOI 10.1073/pnas.94.2.479; BEESE LS, 1993, SCIENCE, V260, P352, DOI 10.1126/science.8469987; BRYANT FR, 1983, BIOCHEMISTRY-US, V22, P3537, DOI 10.1021/bi00284a001; Cannistraro VJ, 2004, J BIOL CHEM, V279, P18288, DOI 10.1074/jbc.M400282200; Delagoutte E, 2001, BIOCHEMISTRY-US, V40, P4459, DOI 10.1021/bi001306l; Doublie S, 1998, NATURE, V391, P251, DOI 10.1038/34593; DYSON HJ, 1990, BIOCHEMISTRY-US, V29, P4129, DOI 10.1021/bi00469a016; Hamdan SM, 2007, MOL CELL, V27, P539, DOI 10.1016/j.molcel.2007.06.020; Hamdan SM, 2005, P NATL ACAD SCI USA, V102, P5096, DOI 10.1073/pnas.0501637102; Himawan JS, 1996, J BIOL CHEM, V271, P19999, DOI 10.1074/jbc.271.33.19999; HIMAWAN JS, 1992, P NATL ACAD SCI USA, V89, P9774, DOI 10.1073/pnas.89.20.9774; HUBER HE, 1986, J BIOL CHEM, V261, P5006; HUBER HE, 1987, J BIOL CHEM, V262, P16224; Johnson DE, 2003, J BIOL CHEM, V278, P23762, DOI 10.1074/jbc.M301366200; Johnson DE, 2007, P NATL ACAD SCI USA, V104, P5312, DOI 10.1073/pnas.0701062104; KATTI SK, 1990, J MOL BIOL, V212, P167, DOI 10.1016/0022-2836(90)90313-B; Kelman Z, 1998, STRUCTURE, V6, P121, DOI 10.1016/S0969-2126(98)00014-8; Kumar JK, 2001, J BIOL CHEM, V276, P46151, DOI 10.1074/jbc.M106319200; Lee J, 1998, MOL CELL, V1, P1001, DOI 10.1016/S1097-2765(00)80100-8; Lee JB, 2006, NATURE, V439, P621, DOI 10.1038/nature04317; MARK DF, 1976, P NATL ACAD SCI USA, V73, P780, DOI 10.1073/pnas.73.3.780; MODRICH P, 1975, J BIOL CHEM, V250, P5515; Notarnicola SM, 1997, J BIOL CHEM, V272, P18425, DOI 10.1074/jbc.272.29.18425; RICHARDSON CC, 1983, CELL, V33, P315, DOI 10.1016/0092-8674(83)90411-7; SARKAR G, 1990, BIOTECHNIQUES, V8, P404; TABOR S, 1987, J BIOL CHEM, V262, P16212; Yang XM, 1997, J BIOL CHEM, V272, P6599, DOI 10.1074/jbc.272.10.6599	28	30	31	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 14	2008	283	46					32077	32084		10.1074/jbc.M805062200	http://dx.doi.org/10.1074/jbc.M805062200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	370KJ	18757858	Green Published, hybrid			2022-12-27	WOS:000260760800089
J	Hast, MA; Beese, LS				Hast, Michael A.; Beese, Lorena S.			Structure of Protein Geranylgeranyltransferase-I from the Human Pathogen Candida albicans Complexed with a Lipid Substrate	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FARNESYL TRANSFERASE INHIBITORS; X-RAY CRYSTALLOGRAPHY; ANGSTROM RESOLUTION; ENZYME-INHIBITORS; CRYSTAL-STRUCTURE; FARNESYLTRANSFERASE; BINDING; STATE; PRENYLATION; EXPRESSION	Protein geranylgeranyltransferase-I (GGTase-I) catalyzes the transfer of a 20-carbon isoprenoid lipid to the sulfur of a cysteine residue located near the C terminus of numerous cellular proteins, including members of the Rho superfamily of small GTPases and other essential signal transduction proteins. In humans, GGTase-I and the homologous protein farnesyltransferase ( FTase) are targets of anticancer therapeutics because of the role small GTPases play in oncogenesis. Protein prenyltransferases are also essential for many fungal and protozoan pathogens that infect humans, and have therefore become important targets for treating infectious diseases. Candida albicans, a causative agent of systemic fungal infections in immunocompromised individuals, is one pathogen for which protein prenylation is essential for survival. Here we present the crystal structure of GGTase-I from C. albicans (CaGGTase-I) in complex with its cognate lipid substrate, geranylgeranylpyrophosphate. This structure provides a high-resolution picture of a non-mammalian protein prenyltransferase. There are significant variations between species in critical areas of the active site, including the isoprenoid-binding pocket, as well as the putative product exit groove. These differences indicate the regions where specific protein prenyltransferase inhibitors with antifungal activity can be designed.	[Hast, Michael A.; Beese, Lorena S.] Duke Univ, Med Ctr, Dept Biochem, Durham, NC 27710 USA	Duke University	Beese, LS (corresponding author), 212 Nanaline Duke Bldg,Box 3711,Res Dr, Durham, NC 27710 USA.	lsb@biochem.duke.edu	beese, lorena/G-4993-2010		National Institutes of Health; United States Dept. of Energy; Office of Science; Office of Basic Energy Sciences [W-31-109-Eng-38]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM052382, R37GM052382] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States Dept. of Energy; Office of Science(United States Department of Energy (DOE)); Office of Basic Energy Sciences(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM52382 (to L. S. B.). Use of the Advanced Photon Source was supported by the United States Dept. of Energy, Office of Science, Office of Basic Energy Sciences, under Contract No. W-31-109-Eng-38.	Basso AD, 2006, J LIPID RES, V47, P15, DOI 10.1194/jlr.R500012-JLR200; Bishop WR, 2003, CANCER BIOL THER, V2, pS96; Brunger AT, 1997, STRUCTURE, V5, P325, DOI 10.1016/S0969-2126(97)00190-1; CHEN WJ, 1993, J BIOL CHEM, V268, P9675; Delano W.L., 2002, DELANO SCI; Dolence JM, 1995, BIOCHEMISTRY-US, V34, P16687, DOI 10.1021/bi00051a017; Dolence JM, 1997, BIOCHEMISTRY-US, V36, P9246, DOI 10.1021/bi970039p; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Eswar N., 2007, CURR PROTOC PROTEIN; FURFINE ES, 1995, BIOCHEMISTRY-US, V34, P6857, DOI 10.1021/bi00020a032; Hartman HL, 2004, J BIOL CHEM, V279, P30546, DOI 10.1074/jbc.M403469200; Hightower KE, 1998, BIOCHEMISTRY-US, V37, P15555, DOI 10.1021/bi981525v; Huang CC, 2000, BIOCHEMISTRY-US, V39, P2593, DOI 10.1021/bi992356x; Kalinin A, 2001, PROTEIN EXPRES PURIF, V22, P84, DOI 10.1006/prep.2001.1423; Kelly R, 2000, J BACTERIOL, V182, P704, DOI 10.1128/JB.182.3.704-713.2000; Lane KT, 2006, J LIPID RES, V47, P681, DOI 10.1194/jlr.R600002-JLR200; Langer G, 2008, NAT PROTOC, V3, P1171, DOI 10.1038/nprot.2008.91; Long SB, 2000, STRUCTURE, V8, P209, DOI 10.1016/S0969-2126(00)00096-4; Long SB, 2002, NATURE, V419, P645, DOI 10.1038/nature00986; Long SB, 2001, P NATL ACAD SCI USA, V98, P12948, DOI 10.1073/pnas.241407898; Mathis JR, 1997, BIOCHEMISTRY-US, V36, P6367, DOI 10.1021/bi9629182; MAYER ML, 1992, J BIOL CHEM, V267, P20589; Mazur P, 1999, MICROBIOL-UK, V145, P1123, DOI 10.1099/13500872-145-5-1123; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Murthi KK, 2003, BIOORG MED CHEM LETT, V13, P1935, DOI 10.1016/S0960-894X(03)00320-2; Pappas PG, 2007, CLIN INFECT DIS, V45, P883, DOI 10.1086/520980; Park HW, 1997, SCIENCE, V275, P1800, DOI 10.1126/science.275.5307.1800; Pickett JS, 2003, J BIOL CHEM, V278, P51243, DOI 10.1074/jbc.M309226200; Pickett JS, 2003, BIOCHEMISTRY-US, V42, P9741, DOI 10.1021/bi0346852; Reid TS, 2004, J MOL BIOL, V343, P417, DOI 10.1016/j.jmb.2004.08.056; Reid TS, 2004, BIOCHEMISTRY-US, V43, P9000, DOI 10.1021/bi049280b; Saderholm MJ, 2000, BIOCHEMISTRY-US, V39, P12398, DOI 10.1021/bi0011781; SEABRA MC, 1992, J BIOL CHEM, V267, P14497; Smalera I, 2000, BBA-PROTEIN STRUCT M, V1480, P132, DOI 10.1016/S0167-4838(00)00067-4; Song JL, 2003, MICROBIOL-SGM, V149, P249, DOI 10.1099/mic.0.25887-0; STIRTAN WG, 1995, ARCH BIOCHEM BIOPHYS, V321, P182, DOI 10.1006/abbi.1995.1384; Storoni LC, 2004, ACTA CRYSTALLOGR D, V60, P432, DOI 10.1107/S0907444903028956; Sunami S, 2002, BIOORG MED CHEM LETT, V12, P629, DOI 10.1016/S0960-894X(01)00813-7; Taylor JS, 2003, EMBO J, V22, P5963, DOI 10.1093/emboj/cdg571; Terry KL, 2006, BIOCHEMISTRY-US, V45, P9746, DOI 10.1021/bi060295e; Tschantz WR, 1997, J BIOL CHEM, V272, P9989; White TC, 1998, CLIN MICROBIOL REV, V11, P382, DOI 10.1128/CMR.11.2.382; Witter DJ, 1996, BIOCHEMISTRY-US, V35, P10454, DOI 10.1021/bi960500y; Zaoutis TE, 2005, CLIN INFECT DIS, V41, P1232, DOI 10.1086/496922; Zhang FL, 1996, BIOCHEM J, V320, P925, DOI 10.1042/bj3200925	46	17	20	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 14	2008	283	46					31933	31940		10.1074/jbc.M805330200	http://dx.doi.org/10.1074/jbc.M805330200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	370KJ	18713740	Green Published, hybrid			2022-12-27	WOS:000260760800075
J	Bal, M; Zhang, J; Zaika, O; Hernandez, CC; Shapiro, MS				Bal, Manjot; Zhang, Jie; Zaika, Oleg; Hernandez, Ciria C.; Shapiro, Mark S.			Homomeric and Heteromeric Assembly of KCNQ (Kv7) K+ Channels Assayed by Total Internal Reflection Fluorescence/Fluorescence Resonance Energy Transfer and Patch Clamp Analysis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYSTEINE-MODIFYING REAGENT; NUCLEOTIDE-GATED CHANNELS; ANCHORING PROTEIN YOTIAO; HEART POTASSIUM CHANNEL; NEURONAL M-CURRENT; SUBUNIT STOICHIOMETRY; FLUORESCENCE MICROSCOPY; FUNCTIONAL EXPRESSION; TRANSMITTER RELEASE; DOMINANT DEAFNESS	M-type K+ channels, consisting of KCNQ1-5 (Kv7.1-7.5) subunits, form a variety of homomeric and heteromeric channels. Whereas all the subunits can assemble into homomeric channels, the ability of the subunits to assemble into heteromultimers is highly variable. KCNQ3 is widely thought to co-assemble with several other KCNQ subtypes, whereas KCNQ1 and KCNQ2 do not. However, the existence of other subunit assemblies is not well studied. To systematically explore the heteromeric assembly of KCNQ channels in individual living cells, we performed fluorescence resonance energy transfer (FRET) between cyan fluorescent protein- and yellow fluorescent protein- tagged KCNQ subunits expressed in Chinese hamster ovary cells under total internal reflection fluorescence microscopy in which excitation light only penetrates several hundred nanometers into the cell, thus isolating membrane events. We found significant FRET between homomeric subunits as expected from their functional expression in heterologous expression systems. Also as expected from previous work, robust FRET was observed between KCNQ2 and KCNQ3. KCNQ3 and KCNQ4 also showed substantial FRET as did KCNQ4 and KCNQ5. To determine functional assembly of KCNQ4/KCNQ5 heteromers, we performed two types of experiments. In the first, we constructed a mutant tetraethylammonium ion-sensitive KCNQ4 subunit and tested its assembly with KCNQ5 by patch clamp analysis of the tetraethylammonium ion sensitivity of the resulting current; however, those data were not conclusive. In the second, we co-expressed a KCNQ4 (G285S) pore mutant with KCNQ5 and found the former to act as a dominant negative, suggesting co-assembly of the two types of subunits. These data confirm that among the allowed assembly conformations are KCNQ3/4 and KCNQ4/5 heteromers.	[Bal, Manjot; Zhang, Jie; Zaika, Oleg; Hernandez, Ciria C.; Shapiro, Mark S.] Univ Texas Hlth Sci Ctr San Antonio, Dept Physiol, San Antonio, TX 78229 USA	University of Texas System; University of Texas Health San Antonio	Shapiro, MS (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Dept Physiol, MS 7756,7703 Floyd Curl Dr, San Antonio, TX 78229 USA.	shapirom@uthscsa.edu		Hernandez, Ciria/0000-0001-9715-1734	National Institutes of Health [R01 NS043394]; American Heart Association-Texas; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS043394] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association-Texas(American Heart Association); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 NS043394 (to M. S. S.). This work was also supported by an American Heart Association-Texas affiliate grant-in-aid (to M. S. S.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Amiri H, 2003, CELL CALCIUM, V33, P463, DOI 10.1016/S0143-4160(03)00061-7; Anantharam A, 2003, J BIOL CHEM, V278, P11739, DOI 10.1074/jbc.M212751200; Axelrod D, 2003, METHOD ENZYMOL, V361, P1; Bal M, 2008, J PHYSIOL-LONDON, V586, P2307, DOI 10.1113/jphysiol.2008.152777; Biervert C, 1998, SCIENCE, V279, P403, DOI 10.1126/science.279.5349.403; Castaldo P, 2002, J NEUROSCI, V22, DOI 10.1523/JNEUROSCI.22-02-j0003.2002; Centonze VE, 2003, METHOD ENZYMOL, V360, P542; Chen L, 2005, J BIOL CHEM, V280, P31347, DOI 10.1074/jbc.M505191200; Chen S, 2008, J PHYSIOL-LONDON, V586, P1351, DOI 10.1113/jphysiol.2007.148171; Cooper EC, 2000, P NATL ACAD SCI USA, V97, P4914, DOI 10.1073/pnas.090092797; Cooper EC, 2003, ARCH NEUROL-CHICAGO, V60, P496, DOI 10.1001/archneur.60.4.496; Cooper EC, 2001, J NEUROSCI, V21, P9529, DOI 10.1523/JNEUROSCI.21-24-09529.2001; Coppola G, 2003, NEUROLOGY, V61, P131, DOI 10.1212/01.WNL.0000069465.53698.BD; Delmas P, 2005, NAT REV NEUROSCI, V6, P850, DOI 10.1038/nrn1785; Devaux JJ, 2004, J NEUROSCI, V24, P1236, DOI 10.1523/JNEUROSCI.4512-03.2004; Etxeberria A, 2004, J NEUROSCI, V24, P9146, DOI 10.1523/JNEUROSCI.3194-04.2004; Fowler CE, 2007, J PHYSIOL-LONDON, V580, P51, DOI 10.1113/jphysiol.2006.123216; Gamper N, 2005, MOL BIOL CELL, V16, P3538, DOI 10.1091/mbc.E04-09-0849; Gamper N, 2003, J NEUROSCI, V23, P84; Gamper Nikita, 2005, Journal of Pharmacological and Toxicological Methods, V51, P177, DOI 10.1016/j.vascn.2004.08.008; Gordon GW, 1998, BIOPHYS J, V74, P2702, DOI 10.1016/S0006-3495(98)77976-7; Gu N, 2005, J PHYSIOL-LONDON, V566, P689, DOI 10.1113/jphysiol.2005.086835; Hadley JK, 2003, J NEUROSCI, V23, P5012; Hadley JK, 2000, BRIT J PHARMACOL, V129, P413, DOI 10.1038/sj.bjp.0703086; HEGINBOTHAM L, 1992, NEURON, V8, P483, DOI 10.1016/0896-6273(92)90276-J; Hoshi N, 2003, NAT NEUROSCI, V6, P564, DOI 10.1038/nn1062; Hoshi N, 2005, NAT CELL BIOL, V7, P1066, DOI 10.1038/ncb1315; Howard RJ, 2007, NEURON, V53, P663, DOI 10.1016/j.neuron.2007.02.010; Hurley KM, 2006, J NEUROSCI, V26, P10253, DOI 10.1523/JNEUROSCI.2596-06.2006; Jentsch TJ, 2000, NAT REV NEUROSCI, V1, P21, DOI 10.1038/35036198; Jespersen T, 2005, PHYSIOLOGY, V20, P408, DOI 10.1152/physiol.00031.2005; KAVANAUGH MP, 1992, NEURON, V8, P493, DOI 10.1016/0896-6273(92)90277-K; Kerschensteiner D, 2005, P NATL ACAD SCI USA, V102, P6160, DOI 10.1073/pnas.0500468102; Kharkovets T, 2000, P NATL ACAD SCI USA, V97, P4333, DOI 10.1073/pnas.97.8.4333; Kubisch C, 1999, CELL, V96, P437, DOI 10.1016/S0092-8674(00)80556-5; Kurokawa J, 2004, P NATL ACAD SCI USA, V101, P16374, DOI 10.1073/pnas.0405583101; Lawrence JJ, 2006, J NEUROSCI, V26, P12325, DOI 10.1523/JNEUROSCI.3521-06.2006; Lerche C, 2000, J BIOL CHEM, V275, P22395, DOI 10.1074/jbc.M002378200; Lerche H, 2001, AM J MED GENET, V106, P146, DOI 10.1002/ajmg.1582; Li Y, 2005, J NEUROSCI, V25, P9825, DOI 10.1523/JNEUROSCI.2597-05.2005; Li Y, 2004, J NEUROSCI, V24, P5079, DOI 10.1523/JNEUROSCI.0882-04.2004; LIMAN ER, 1992, NEURON, V9, P861, DOI 10.1016/0896-6273(92)90239-A; Loussouarn Gildas, 2006, V337, P167; MACKINNON R, 1990, SCIENCE, V250, P276, DOI 10.1126/science.2218530; Maljevic S, 2008, J PHYSIOL-LONDON, V586, P1791, DOI 10.1113/jphysiol.2008.150656; Martire M, 2004, J NEUROSCI, V24, P592, DOI 10.1523/JNEUROSCI.3143-03.2004; Marx SO, 2006, HANDB EXP PHARMACOL, V171, P221; Nakajo K, 2008, J PHYSIOL-LONDON, V586, P2827, DOI 10.1113/jphysiol.2007.148601; Nicolas MT, 2001, HEARING RES, V153, P132, DOI 10.1016/S0378-5955(00)00268-9; Passmore GM, 2003, J NEUROSCI, V23, P7227, DOI 10.1523/JNEUROSCI.23-18-07227.2003; Peretz A, 2007, J NEUROPHYSIOL, V97, P283, DOI 10.1152/jn.00634.2006; Peroz D, 2008, J PHYSIOL-LONDON, V586, P1785, DOI 10.1113/jphysiol.2007.148254; Piccinin S, 2006, J NEUROPHYSIOL, V95, P3105, DOI 10.1152/jn.01083.2005; Robbins J, 2001, PHARMACOL THERAPEUT, V90, P1, DOI 10.1016/S0163-7258(01)00116-4; Roche JP, 2002, BRIT J PHARMACOL, V137, P1173, DOI 10.1038/sj.bjp.0704989; Schroeder BC, 2000, J BIOL CHEM, V275, P24089, DOI 10.1074/jbc.M003245200; Schroeder BC, 1998, NATURE, V396, P687, DOI 10.1038/25367; Schwake M, 2006, J NEUROSCI, V26, P3757, DOI 10.1523/JNEUROSCI.5017-05.2006; Schwake M, 2000, J BIOL CHEM, V275, P13343, DOI 10.1074/jbc.275.18.13343; Schwake M, 2003, EMBO REP, V4, P76, DOI 10.1038/sj.embor.embor715; Sekar RB, 2003, J CELL BIOL, V160, P629, DOI 10.1083/jcb.200210140; Shah MM, 2002, J PHYSIOL-LONDON, V544, P29, DOI 10.1113/jphysiol.2002.028571; Shapiro MS, 2000, J NEUROSCI, V20, P1710; Shen WX, 2005, J NEUROSCI, V25, P7449, DOI 10.1523/JNEUROSCI.1381-05.2005; Staruschenko A, 2004, J BIOL CHEM, V279, P27729, DOI 10.1074/jbc.M404169200; Steyer JA, 2001, NAT REV MOL CELL BIO, V2, P268, DOI 10.1038/35067069; Strutz-Seebohm N, 2006, CELL PHYSIOL BIOCHEM, V18, P57, DOI 10.1159/000095158; Suh BC, 2007, J PHYSIOL-LONDON, V582, P911, DOI 10.1113/jphysiol.2007.132647; Vervaeke K, 2006, J PHYSIOL-LONDON, V576, P235, DOI 10.1113/jphysiol.2006.111336; Wang HS, 1998, SCIENCE, V282, P1890, DOI 10.1126/science.282.5395.1890; Wickenden AD, 2001, BRIT J PHARMACOL, V132, P381, DOI 10.1038/sj.bjp.0703861; Wladyka CL, 2008, J PHYSIOL-LONDON, V586, P795, DOI 10.1113/jphysiol.2007.145284; Wladyka CL, 2006, J PHYSIOL-LONDON, V575, P175, DOI 10.1113/jphysiol.2006.113308; Yang WP, 1998, J BIOL CHEM, V273, P19419, DOI 10.1074/jbc.273.31.19419; Yue CY, 2006, J NEUROPHYSIOL, V95, P3480, DOI 10.1152/jn.01333.2005; Yus-Najera E, 2003, NEUROSCIENCE, V120, P353, DOI 10.1016/S0306-4522(03)00321-X; ZAIKA O, 2008, BIOPHYS J IN PRESS; Zaika O, 2007, J NEUROSCI, V27, P8914, DOI 10.1523/JNEUROSCI.1739-07.2007; Zaika O, 2006, J PHYSIOL-LONDON, V575, P49, DOI 10.1113/jphysiol.2006.114074; Zheng J, 2004, NEURON, V42, P411, DOI 10.1016/S0896-6273(04)00253-3; Zheng J, 2002, NEURON, V36, P891, DOI 10.1016/S0896-6273(02)01099-1	81	56	57	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 7	2008	283	45					30668	30676		10.1074/jbc.M805216200	http://dx.doi.org/10.1074/jbc.M805216200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	367ID	18786918	Green Published, hybrid			2022-12-27	WOS:000260544800024
J	Crespo, PM; Silvestre, DC; Gil, GA; Maccioni, HJF; Daniotti, JL; Caputto, BL				Crespo, Pilar M.; Silvestre, David C.; Gil, German A.; Maccioni, Hugo J. F.; Daniotti, Jose L.; Caputto, Beatriz L.			c-Fos Activates Glucosylceramide Synthase and Glycolipid Synthesis in PC12 Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NERVE GROWTH-FACTOR; IMMEDIATE-EARLY GENES; PHOSPHOLIPID-SYNTHESIS; GLYCOSPHINGOLIPID SYNTHESIS; PHEOCHROMOCYTOMA CELLS; ENDOPLASMIC-RETICULUM; EXPRESSION; GOLGI; SYSTEM; LIGHT	It has been demonstrated that c-Fos has, in addition to its well recognized AP-1 transcription factor activity, the capacity to associate to the endoplasmic reticulum and activate key enzymes involved in the synthesis of phospholipids required for membrane biogenesis during cell growth and neurite formation. Because membrane genesis requires the coordinated supply of all its integral membrane components, the question emerges as to whether c-Fos also activates the synthesis of glycolipids, another ubiquitous membrane component. We show that c-Fos activates the metabolic labeling of glycolipids in differentiating PC12 cells. Specifically, c-Fos activates the enzyme glucosylceramide synthase (GlcCerS), the product of which, GlcCer, is the first glycosylated intermediate in the pathway of synthesis of glycolipids. By contrast, the activities of GlcCer galactosyltransferase 1 and lactosylceramide sialyltransferase 1 are essentially unaffected by c-Fos. Co-immunoprecipitation experiments in cells co-transfected with c-Fos and a V5-tagged version of GlcCerS evidenced that both proteins participate in a physical association. c-Fos expression is tightly regulated by specific environmental cues. This strict regulation assures that lipid metabolism activation will occur as a response to cell requirements thus pointing to c-Fos as an important regulator of key membrane metabolisms in membrane biogenesis-demanding processes.	[Crespo, Pilar M.; Silvestre, David C.; Gil, German A.; Maccioni, Hugo J. F.; Daniotti, Jose L.; Caputto, Beatriz L.] Univ Nacl Cordoba, Ctr Invest Quim Biol Cordoba, UNC Consejo Nacl Invest Cient & Tecn, CIQUIBIC,Dept Quim Biol,Fac Ciencias Quim, RA-5000 Cordoba, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of Cordoba	Caputto, BL (corresponding author), Univ Nacl Cordoba, Ctr Invest Quim Biol Cordoba, UNC Consejo Nacl Invest Cient & Tecn, CIQUIBIC,Dept Quim Biol,Fac Ciencias Quim, Ciudad Univ,Cordoba X5000HUA, RA-5000 Cordoba, Argentina.	bcaputto@mail.fcq.unc.edu.ar	GIL, GERMAN A./T-3018-2019	GIL, GERMAN A./0000-0001-6714-2693	Aqencia Nacional de Promocion Cientifica y Tecnologica Ministerio de Ciencia; Tecnologia e Innovacion Productiva de Argentina; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Sectretaria de Ciencia y Tecnologia-Universidad Nacional de Cordoba; McDonnell Foundation; Howard Hughes Medical Institute	Aqencia Nacional de Promocion Cientifica y Tecnologica Ministerio de Ciencia(ANPCyT); Tecnologia e Innovacion Productiva de Argentina; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Sectretaria de Ciencia y Tecnologia-Universidad Nacional de Cordoba; McDonnell Foundation; Howard Hughes Medical Institute(Howard Hughes Medical Institute)	This work was supported in part by grants from the Aqencia Nacional de Promocion Cientifica y Tecnologica Ministerio de Ciencia, Tecnologia e Innovacion Productiva de Argentina, Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET), and Sectretaria de Ciencia y Tecnologia-Universidad Nacional de Cordoba (to H.J.F.M., J.L.D., and B.L.C.), the J.S. McDonnell Foundation (to B.L.C.), and the Howard Hughes Medical Institute (to H.J.F.M.).	AKARI W, 1997, P NATL ACAD SCI USA, V94, P11946; ANGEL P, 1991, BIOCHIM BIOPHYS ACTA, V1072, P129, DOI 10.1016/0304-419X(91)90011-9; Bonifacino JS, 2004, CELL, V116, P153, DOI 10.1016/S0092-8674(03)01079-1; Borioli GA, 2005, BBA-BIOMEMBRANES, V1668, P41, DOI 10.1016/j.bbamem.2004.11.007; Borioli GA, 2004, FEBS LETT, V570, P82, DOI 10.1016/j.febslet.2004.06.033; Borioli GA, 2001, BIOCHEM BIOPH RES CO, V280, P9, DOI 10.1006/bbrc.2000.4081; Bussolino DF, 2001, FASEB J, V15, P556; Bussolino DF, 1998, MOL BRAIN RES, V58, P10, DOI 10.1016/S0169-328X(98)00065-5; Caputto BL, 2000, NEUROCHEM RES, V25, P153, DOI 10.1023/A:1007508020173; COSTE H, 1986, BIOCHIM BIOPHYS ACTA, V858, P6, DOI 10.1016/0005-2736(86)90285-3; D'Angelo G, 2007, NATURE, V449, P62, DOI 10.1038/nature06097; DANIOTTI JL, 1994, J NEUROCHEM, V62, P1131; FUTERMAN AH, 1991, BIOCHEM J, V280, P295, DOI 10.1042/bj2800295; Gil GA, 2004, MOL BIOL CELL, V15, P1881, DOI 10.1091/mbc.e03-09-0705; Giraudo CG, 2003, MOL BIOL CELL, V14, P3753, DOI 10.1091/mbc.E03-02-0101; GREENBERG ME, 1985, J BIOL CHEM, V260, P4101; GREENE LA, 1976, P NATL ACAD SCI USA, V73, P2424, DOI 10.1073/pnas.73.7.2424; Guido ME, 1996, J NEUROSCI RES, V43, P93, DOI 10.1002/jnr.490430112; Halter D, 2007, J CELL BIOL, V179, P101, DOI 10.1083/jcb.200704091; Herdegen T, 1998, BRAIN RES REV, V28, P370, DOI 10.1016/S0165-0173(98)00018-6; HUGHES P, 1995, PHARMACOL REV, V47, P133; Ichikawa S, 1998, BIOCHEM BIOPH RES CO, V253, P707, DOI 10.1006/bbrc.1998.9855; JECKEL D, 1992, J CELL BIOL, V117, P259, DOI 10.1083/jcb.117.2.259; Kohyama-Koganeya A, 2004, J BIOL CHEM, V279, P35995, DOI 10.1074/jbc.M400444200; KOUZARIDES T, 1989, NATURE, V340, P568, DOI 10.1038/340568a0; KRUIJER W, 1985, P NATL ACAD SCI USA, V82, P7330, DOI 10.1073/pnas.82.21.7330; MACCIONI HJ, 1974, BIOCHEM J, V138, P291, DOI 10.1042/bj1380291; Maccioni HJF, 2007, J NEUROCHEM, V103, P81, DOI 10.1111/j.1471-4159.2007.04717.x; MARGOLIS RK, 1983, J BIOL CHEM, V258, P4110; MARGOLIS RU, 1984, FEBS LETT, V172, P339, DOI 10.1016/0014-5793(84)81153-9; MAXZUD MK, 1995, J BIOL CHEM, V270, P20207, DOI 10.1074/jbc.270.34.20207; MITZUTANI A, 1996, BIOCHEM BIOPH RES CO, V222, P494; MORGAN JI, 1995, TRENDS NEUROSCI, V18, P66; MORGAN JI, 1987, SCIENCE, V237, P192, DOI 10.1126/science.3037702; MUTOH T, 1993, J NEUROCHEM, V60, P1540, DOI 10.1111/j.1471-4159.1993.tb03319.x; Portal MM, 2007, ONCOGENE, V26, P3551, DOI 10.1038/sj.onc.1210137; Ravni A, 2006, J NEUROCHEM, V98, P321, DOI 10.1111/J.1471-4159.2006.03884.X; SCHWARZ A, 1995, J BIOL CHEM, V270, P10990, DOI 10.1074/jbc.270.18.10990; Shaulian E, 2002, NAT CELL BIOL, V4, pE131, DOI 10.1038/ncb0502-e131; UEMURA K, 1991, J BIOCHEM-TOKYO, V110, P96, DOI 10.1093/oxfordjournals.jbchem.a123549; Uliana AS, 2006, J BIOL CHEM, V281, P32852, DOI 10.1074/jbc.M605805200; Vaudry D, 2002, SCIENCE, V296, P1648, DOI 10.1126/science.1071552; Veldman RJ, 2003, FASEB J, V17, P1144, DOI 10.1096/fj.02-1053fje; Yanagisawa M, 2006, J NEUROSCI RES, V84, P1343, DOI 10.1002/jnr.21031; Yu RK, 2004, J LIPID RES, V45, P783, DOI 10.1194/jlr.R3000020-JLR200; Zerpa GAD, 1999, J NEUROCHEM, V73, P1228, DOI 10.1046/j.1471-4159.1999.0731228.x	46	31	31	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 7	2008	283	45					31163	31171		10.1074/jbc.M709257200	http://dx.doi.org/10.1074/jbc.M709257200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	367ID	18784083	hybrid, Green Published			2022-12-27	WOS:000260544800070
J	Dabert-Gay, AS; Czarny, B; Devel, L; Beau, F; Lajeunesse, E; Bregant, S; Thai, R; Yiotakis, A; Dive, V				Dabert-Gay, Anne-Sophie; Czarny, Bertrand; Devel, Laurent; Beau, Fabrice; Lajeunesse, Evelyne; Bregant, Sarah; Thai, Robert; Yiotakis, Athanasios; Dive, Vincent			Molecular Determinants of Matrix Metalloproteinase-12 Covalent Modification by a Photoaffinity Probe INSIGHTS INTO ACTIVITY- BASED PROBE DEVELOPMENT AND CONFORMATIONAL VARIABILITY OF MATRIX METALLOPROTEINASES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MACROPHAGE ELASTASE MMP-12; STRUCTURAL BASIS; INHIBITOR; CANCER; COMPLEXES; SUBSTRATE; OPINION; DESIGN; LIGAND; ROLES	Mass spectroscopy, microsequencing, and site-directed mutagenesis studies have been performed to identify in human matrix metalloelastase (hMMP-12) residues covalently modified by a photoaffinity probe, previously shown to be able to covalently label specifically the active site of matrix metalloproteinases (MMPs). Results obtained led us to conclude that photoactivation of this probe in complex with hMMP-12 affects a single residue in human MMP-12, Lys(241), through covalent modification of its side chain epsilon NH2 group. Because x-ray and NMR studies of hMMP-12 indicate that Lys241 side chain is highly flexible, our data reveal the existence of particular Lys241 side-chain conformation in which the epsilon NH2 group points toward the photolabile group of the probe, an event explaining the high levels of cross-linking yield between hMMP-12 and the probe. Lys241 is not conserved in MMPs, thus differences in cross-linking yields observed with this probe between MMP members may be linked to the residue variability observed at position 241 in this family.	[Dabert-Gay, Anne-Sophie; Czarny, Bertrand; Devel, Laurent; Beau, Fabrice; Lajeunesse, Evelyne; Bregant, Sarah; Thai, Robert; Dive, Vincent] CEA Saclay, CEA, Serv Ingn Mol Prot, F-91191 Gif Sur Yvette, France; [Yiotakis, Athanasios] Univ Athens, Dept Organ Chem, Organ Chem Lab, GR-15771 Athens, Greece	CEA; UDICE-French Research Universities; Universite Paris Saclay; National & Kapodistrian University of Athens	Dive, V (corresponding author), CEA Saclay, CEA, Serv Ingn Mol Prot, 152, F-91191 Gif Sur Yvette, France.	vincent.dive@cea.fr	Czarny, Bertrand/F-2001-2018; CZARNY, bertrand/AAP-6603-2020	Czarny, Bertrand/0000-0002-9586-0913; CZARNY, bertrand/0000-0002-9586-0913; Thai, Robert/0000-0001-9438-4225	Commissariat a l'Energie Atomique; European Commission [FP6RDT, LSHC-CT-2003-503297]	Commissariat a l'Energie Atomique(French Atomic Energy Commission); European Commission(European CommissionEuropean Commission Joint Research Centre)	This work was supported by funds from the Commissariat a l'Energie Atomique and from the European Commission (Grant FP6RDT, Cancer Degradome project, LSHC-CT-2003-503297).	Babine RE, 1997, CHEM REV, V97, P1359, DOI 10.1021/cr960370z; Bayley H., 1984, AZIDES NITRENES REAC, P433; Bertini I, 2005, P NATL ACAD SCI USA, V102, P5334, DOI 10.1073/pnas.0407106102; Bhaskaran R, 2007, J MOL BIOL, V374, P1333, DOI 10.1016/j.jmb.2007.10.028; BIEMANN K, 1990, METHOD ENZYMOL, V193, P886, DOI 10.1016/0076-6879(90)93460-3; BODE W, 1993, FEBS LETT, V331, P134, DOI 10.1016/0014-5793(93)80312-I; Brinckerhoff CE, 2002, NAT REV MOL CELL BIO, V3, P207, DOI 10.1038/nrm763; Chan EWS, 2004, J AM CHEM SOC, V126, P14435, DOI 10.1021/ja047044i; Coussens LM, 2002, SCIENCE, V295, P2387, DOI 10.1126/science.1067100; Cravatt BF, 2008, ANNU REV BIOCHEM, V77, P383, DOI 10.1146/annurev.biochem.75.101304.124125; David A, 2007, ANGEW CHEM INT EDIT, V46, P3275, DOI 10.1002/anie.200604408; Devel L, 2006, J BIOL CHEM, V281, P11152, DOI 10.1074/jbc.M600222200; Egeblad M, 2002, NAT REV CANCER, V2, P161, DOI 10.1038/nrc745; Engel CK, 2005, CHEM BIOL, V12, P181, DOI 10.1016/j.chembiol.2004.11.014; Fingleton B, 2006, FRONT BIOSCI-LANDMRK, V11, P479, DOI 10.2741/1811; Fingleton B, 2007, CURR PHARM DESIGN, V13, P333, DOI 10.2174/138161207779313551; FLEMING SA, 1995, TETRAHEDRON, V51, P12479; Gomis-Ruth FX, 2003, MOL BIOTECHNOL, V24, P157, DOI 10.1385/MB:24:2:157; Hesek D, 2006, CHEM BIOL, V13, P379, DOI 10.1016/j.chembiol.2006.01.012; HOROVITZ A, 1987, P NATL ACAD SCI USA, V84, P6654, DOI 10.1073/pnas.84.19.6654; Johnson AR, 2007, J BIOL CHEM, V282, P27781, DOI 10.1074/jbc.M703286200; Johnson JL, 2005, P NATL ACAD SCI USA, V102, P15575, DOI 10.1073/pnas.0506201102; Kato D, 2005, NAT CHEM BIOL, V1, P33, DOI 10.1038/nchembio707; KOTZYBAHIBERT F, 1995, ANGEW CHEM INT EDIT, V34, P1296, DOI 10.1002/anie.199512961; Kramer F, 2008, BIOMARKERS, V13, P270, DOI 10.1080/13547500801903123 ; Lang R, 2001, J MOL BIOL, V312, P731, DOI 10.1006/jmbi.2001.4954; Lopez-Otin C, 2007, NAT REV CANCER, V7, P800, DOI 10.1038/nrc2228; Massova I, 1998, FASEB J, V12, P1075, DOI 10.1096/fasebj.12.12.1075; Nagase H, 1999, J BIOL CHEM, V274, P21491, DOI 10.1074/jbc.274.31.21491; Nar H, 2001, J MOL BIOL, V312, P743, DOI 10.1006/jmbi.2001.4953; Overall CM, 2006, NAT REV CANCER, V6, P227, DOI 10.1038/nrc1821; Overall CM, 2002, NAT REV CANCER, V2, P657, DOI 10.1038/nrc884; Page-McCaw A, 2007, NAT REV MOL CELL BIO, V8, P221, DOI 10.1038/nrm2125; Rizk MS, 2006, BIOCHEMISTRY-US, V45, P543, DOI 10.1021/bi0516632; Rosenblum G, 2003, J BIOL CHEM, V278, P27009, DOI 10.1074/jbc.M301139200; Rydlova M, 2008, ANTICANCER RES, V28, P1389; Saghatelian A, 2004, P NATL ACAD SCI USA, V101, P10000, DOI 10.1073/pnas.0402784101; Sieber SA, 2006, NAT CHEM BIOL, V2, P274, DOI 10.1038/nchembio781; STOCKER W, 1995, CURR OPIN STRUC BIOL, V5, P383, DOI 10.1016/0959-440X(95)80101-4; Tochowicz A, 2007, J MOL BIOL, V371, P989, DOI 10.1016/j.jmb.2007.05.068; Unsal D, 2008, AM J CLIN ONCOL-CANC, V31, P55, DOI 10.1097/COC.0b013e318068b4e2; Visse R, 2003, CIRC RES, V92, P827, DOI 10.1161/01.RES.0000070112.80711.3D; Whittaker M, 1999, CHEM REV, V99, P2735, DOI 10.1021/cr9804543	43	26	27	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 7	2008	283	45					31058	31067		10.1074/jbc.M805795200	http://dx.doi.org/10.1074/jbc.M805795200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	367ID	18775985	Green Published, hybrid			2022-12-27	WOS:000260544800060
J	Hou, T; Ray, S; Lee, C; Brasier, AR				Hou, Tieying; Ray, Sutapa; Lee, Chang; Brasier, Allan R.			The STAT3 NH2-terminal Domain Stabilizes Enhanceosome Assembly by Interacting with the p300 Bromodomain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA-POLYMERASE-II; HISTONE ACETYLTRANSFERASE; DNA-BINDING; TRANSCRIPTIONAL ACTIVATION; SIGNAL TRANSDUCER; STRUCTURAL BASIS; ACETYLATION; PROTEIN; GENE; EXPRESSION	Signal transducer and activator of transcription 3(STAT3) is a latent transcription factor mainly activated by the interleukin-6 cytokine family. Previous studies have shown that activated STAT3 recruits p300, a coactivator whose intrinsic histone acetyltransferase activity is essential for transcription. Here we investigated the function of the STAT3 NH2-terminal domain and how its interaction with p300 regulates STAT3 signal transduction. In STAT3(-/-) mouse embryonic fibroblasts, a stably expressed NH2 terminus-deficient STAT3 mutant (STAT3-Delta N) was unable to efficiently induce either STAT3-mediated reporter activity or endogenous mRNA expression. Chromatin immunoprecipitation assays were performed to determine whether the NH2-terminal domain regulates p300 recruitment or stabilizes enhanceosome assembly. Despite equivalent levels of STAT3 binding, cells expressing the STAT3-Delta N mutant were unable to recruit p300 and RNA polymerase II to the native socs3 promoter as efficiently as those expressing STAT3-full length. We previously reported that the STAT3 NH2-terminal domain is acetylated by p300 at Lys-49 and Lys-87. By introducing K49R/K87R mutations, here we found that the acetylation status of the STAT3 NH2-terminal domain regulates its interaction with p300. In addition, the STAT3 NH2-terminal binding site maps to the p300 bromodomain, a region spanning from amino acids 995 to 1255. Finally a p300 mutant lacking the bromodomain (p300-Delta B) exhibited a weaker binding to STAT3, and the enhanceosome formation on the socs3 promoter was inhibited when p300-Delta B was overexpressed. Taken together, our data suggest that the STAT3 NH2-terminal domain plays an important role in the interleukin-6 signaling pathway by interacting with the p300 bromodomain, thereby stabilizing enhanceosome assembly.	[Brasier, Allan R.] Univ Texas Galveston, Med Branch, Div Endocrinol, Dept Internal Med, Galveston, TX 77555 USA; [Hou, Tieying] Univ Texas Galveston, Med Branch, Dept Biochem & Mol Biol, Galveston, TX 77555 USA; [Brasier, Allan R.] Univ Texas Galveston, Med Branch, Sealy Ctr Mol Med, Galveston, TX 77555 USA	University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston	Brasier, AR (corresponding author), Univ Texas Galveston, Med Branch, Div Endocrinol, Dept Internal Med, MRB 8-138,301 Univ Blvd, Galveston, TX 77555 USA.	arbrasie@utmb.edu	Ray, Sutapa/D-3272-2012	Brasier, Allan/0000-0002-5012-4090; Ray, Sutapa/0000-0003-4234-2124	National Institutes of Health [P30 ES06676]; DIVISION OF HEART AND VASCULAR DISEASES [N01HV028184] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL070925] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES006676] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DIVISION OF HEART AND VASCULAR DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	We thank Dr. Stephanie Watowich from University of Texas M. D. Anderson Cancer Center and Dr. David Levy from New York University for generously providing STAT3<SUP>+/-</SUP> and STAT3<SUP>-/-</SUP> MEFs. Core laboratory support was provided by National Institutes of Health Grant P30 ES06676 (to J. Ward, University of Texas Medical Branch).	Auernhammer CJ, 1999, P NATL ACAD SCI USA, V96, P6964, DOI 10.1073/pnas.96.12.6964; Bayle JH, 1997, CHEM BIOL, V4, P885, DOI 10.1016/S1074-5521(97)90296-9; Bellido T, 1998, J BIOL CHEM, V273, P21137, DOI 10.1074/jbc.273.33.21137; Bhattacharya S, 1996, NATURE, V383, P344, DOI 10.1038/383344a0; Brownell JE, 1996, CELL, V84, P843, DOI 10.1016/S0092-8674(00)81063-6; Chan HM, 2001, J CELL SCI, V114, P2363; Chang HC, 2003, J BIOL CHEM, V278, P32471, DOI 10.1074/jbc.M302776200; Chen XM, 2003, PROTEIN SCI, V12, P361, DOI 10.1110/ps.0218903; Cho H, 1998, MOL CELL BIOL, V18, P5355, DOI 10.1128/MCB.18.9.5355; DARNELL JE, 1994, SCIENCE, V264, P1415, DOI 10.1126/science.8197455; Dhalluin C, 1999, NATURE, V399, P491, DOI 10.1038/20974; ECKNER R, 1994, GENE DEV, V8, P869, DOI 10.1101/gad.8.8.869; Ernst M, 2004, TRENDS GENET, V20, P23, DOI 10.1016/j.tig.2003.11.003; Gu W, 1997, CELL, V90, P595, DOI 10.1016/S0092-8674(00)80521-8; Hampsey M, 1999, CURR OPIN GENET DEV, V9, P132, DOI 10.1016/S0959-437X(99)80020-3; He B, 2003, BIOCHEM BIOPH RES CO, V301, P386, DOI 10.1016/S0006-291X(02)03071-1; Heinrich PC, 1998, BIOCHEM J, V334, P297, DOI 10.1042/bj3340297; Heinrich PC, 2003, BIOCHEM J, V374, P1, DOI 10.1042/BJ20030407; Herrera JE, 1999, MOL CELL BIOL, V19, P3466; Hou TY, 2008, CURR CARDIOL REV, V4, P179, DOI 10.2174/157340308785160570; Hou T, 2007, J BIOL CHEM, V282, P37091, DOI 10.1074/jbc.M706458200; Jacobson RH, 2000, SCIENCE, V288, P1422, DOI 10.1126/science.288.5470.1422; John S, 1999, MOL CELL BIOL, V19, P1910; Kammerer RA, 1997, MATRIX BIOL, V15, P555, DOI 10.1016/S0945-053X(97)90031-7; Leo C, 2000, GENE, V245, P1, DOI 10.1016/S0378-1119(00)00024-X; Levy DE, 2002, NAT REV MOL CELL BIO, V3, P651, DOI 10.1038/nrm909; LU H, 1991, P NATL ACAD SCI USA, V88, P10004, DOI 10.1073/pnas.88.22.10004; LUTTICKEN C, 1994, SCIENCE, V263, P89, DOI 10.1126/science.8272872; Manning ET, 2001, MOL CELL BIOL, V21, P3876, DOI 10.1128/MCB.21.12.3876-3887.2001; Mao X, 2005, MOL CELL, V17, P761, DOI 10.1016/j.molcel.2005.02.021; Martinez-Balbas MA, 2000, EMBO J, V19, P662, DOI 10.1093/emboj/19.4.662; Meyer T, 2004, J BIOL CHEM, V279, P18998, DOI 10.1074/jbc.M400766200; Mizzen CA, 1996, CELL, V87, P1261, DOI 10.1016/S0092-8674(00)81821-8; Mujtaba S, 2002, MOL CELL, V9, P575, DOI 10.1016/S1097-2765(02)00483-5; Munshi N, 1998, MOL CELL, V2, P457, DOI 10.1016/S1097-2765(00)80145-8; Murray PJ, 2007, J IMMUNOL, V178, P2623, DOI 10.4049/jimmunol.178.5.2623; Neish AS, 1998, NUCLEIC ACIDS RES, V26, P847, DOI 10.1093/nar/26.3.847; Nowak DE, 2005, BIOTECHNIQUES, V39, P715, DOI 10.2144/000112014; Ogryzko VV, 1996, CELL, V87, P953, DOI 10.1016/S0092-8674(00)82001-2; Owen DJ, 2000, EMBO J, V19, P6141, DOI 10.1093/emboj/19.22.6141; Paul C, 2000, EUR J BIOCHEM, V267, P5849, DOI 10.1046/j.1432-1327.2000.01395.x; Polesskaya A, 2001, MOL CELL BIOL, V21, P5312, DOI 10.1128/MCB.21.16.5312-5320.2001; Ray S, 2005, GASTROENTEROLOGY, V129, P1616, DOI 10.1053/j.gastro.2005.07.055; Ray S, 2002, MOL ENDOCRINOL, V16, P824, DOI 10.1210/me.16.4.824; Shikama N, 2000, MOL CELL BIOL, V20, P8933, DOI 10.1128/MCB.20.23.8933-8943.2000; SHUAI K, 1994, CELL, V76, P821, DOI 10.1016/0092-8674(94)90357-3; Soutoglou E, 2000, MOL CELL, V5, P745, DOI 10.1016/S1097-2765(00)80253-1; Sun W, 2006, FEBS LETT, V580, P5880, DOI 10.1016/j.febslet.2006.09.054; Vinkemeier U, 1998, SCIENCE, V279, P1048, DOI 10.1126/science.279.5353.1048; Vinkemeier U, 1996, EMBO J, V15, P5616, DOI 10.1002/j.1460-2075.1996.tb00946.x; Workman JL, 1998, ANNU REV BIOCHEM, V67, P545, DOI 10.1146/annurev.biochem.67.1.545; Xu L, 1999, CURR OPIN GENET DEV, V9, P140, DOI 10.1016/S0959-437X(99)80021-5; Xu XA, 1996, SCIENCE, V273, P794, DOI 10.1126/science.273.5276.794; Yang E, 2003, J BIOL CHEM, V278, P15794, DOI 10.1074/jbc.M213073200; Yang XJ, 1996, NATURE, V382, P319, DOI 10.1038/382319a0; Yang XZ, 1997, P NATL ACAD SCI USA, V94, P12331, DOI 10.1073/pnas.94.23.12331; Yuan ZL, 2005, SCIENCE, V307, P269, DOI 10.1126/science.1105166; Zeng L, 2002, FEBS LETT, V513, P124, DOI 10.1016/S0014-5793(01)03309-9; Zhang JJ, 1996, P NATL ACAD SCI USA, V93, P15092, DOI 10.1073/pnas.93.26.15092; Zhang L, 2006, MOL CELL BIOCHEM, V288, P179, DOI 10.1007/s11010-006-9137-3; Zhang XK, 1999, MOL CELL BIOL, V19, P7138; Zhang XK, 2001, J BIOL CHEM, V276, P33576, DOI 10.1074/jbc.M104978200	62	60	60	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 7	2008	283	45					30725	30734		10.1074/jbc.M805941200	http://dx.doi.org/10.1074/jbc.M805941200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	367ID	18782771	hybrid, Green Published			2022-12-27	WOS:000260544800028
J	Gonzalez-Guerrero, M; Eren, E; Rawat, S; Stemmler, TL; Arguello, JM				Gonzalez-Guerrero, Manuel; Eren, Elif; Rawat, Swati; Stemmler, Timothy L.; Argueello, Jose M.			Structure of the Two Transmembrane Cu+ Transport Sites of the Cu+-ATPases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RAY-ABSORPTION SPECTROSCOPY; WILSON-DISEASE PROTEIN; SODIUM-POTASSIUM PUMP; METAL-BINDING DOMAIN; P-TYPE-ATPASE; ARCHAEOGLOBUS-FULGIDUS; SARCOPLASMIC-RETICULUM; COPPER UPTAKE; MECHANISM; COPA	Cu+-ATPases drive metal efflux from the cell cytoplasm. Paramount to this function is the binding of Cu+ within the transmembrane region and its coupled translocation across the permeability barrier. Here, we describe the two transmembrane Cu+ transport sites present in Archaeoglobus fulgidus CopA. Both sites can be independently loaded with Cu+. However, their simultaneous occupation is associated with enzyme turnover. Site I is constituted by two Cys in transmembrane segment (TM) 6 and a Tyr in TM7. An Asn in TM7 and Met and Ser in TM8 form Site II. Single site x-ray spectroscopic analysis indicates a trigonal coordination in both sites. This architecture is distinct from that observed in Cu+-trafficking chaperones and classical cuproproteins. The high affinity of these sites for Cu+ (Site I K-a = 1.3 fM(-1), Site II K-a = 1.1 fM(-1)), in conjunction with reversible direct Cu+ transfer from chaperones, points to a transport mechanism where backward release of free Cu+ to the cytoplasm is largely prevented.	[Gonzalez-Guerrero, Manuel; Eren, Elif; Argueello, Jose M.] Worcester Polytech Inst, Dept Chem & Biochem, Worcester, MA 01609 USA; [Rawat, Swati; Stemmler, Timothy L.] Wayne State Univ, Sch Med, Dept Biochem & Mol Biol, Detroit, MI 48201 USA	Worcester Polytechnic Institute; Wayne State University	Arguello, JM (corresponding author), Worcester Polytech Inst, Dept Chem & Biochem, 100 Inst Rd, Worcester, MA 01609 USA.	arguello@wpi.edu	Gonzalez-Guerrero, Manuel/N-2281-2019; Gonzalez-Guerrero, Manuel/E-7338-2011; Arguello, Jose/D-1997-2012	Gonzalez-Guerrero, Manuel/0000-0001-7334-5286; Gonzalez-Guerrero, Manuel/0000-0001-7334-5286; Eren, Elif/0000-0002-7942-4943; Arguello, Jose/0000-0003-3940-6297	National Institutes of Health [DK068139]; National Science Foundation [MCB-0743901]; United States Department of Energy; Office of Science; Office of Basic Energy Sciences [DE-AC02-06CH11357]; Department of Energy; Office of Biological and Environmental Research; National Center for Research Resources; Biomedical Technology Program; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK068139] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); United States Department of Energy(United States Department of Energy (DOE)); Office of Science(United States Department of Energy (DOE)); Office of Basic Energy Sciences(United States Department of Energy (DOE)); Department of Energy(United States Department of Energy (DOE)); Office of Biological and Environmental Research(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Biomedical Technology Program; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK068139 (to T. L. S.). This work was also supported by National Science Foundation Grant MCB-0743901 (to J. M. A.). This work was also supported in part by United States Department of Energy, Office of Science, Office of Basic Energy Sciences Contract DE-AC02-06CH11357, by the Department of Energy, Office of Biological and Environmental Research, and by the National Institutes of Health, National Center for Research Resources, Biomedical Technology Program. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Aller SG, 2006, P NATL ACAD SCI USA, V103, P3627, DOI 10.1073/pnas.0509929103; Ankudinov AL, 1997, PHYS REV B, V56, pR1712, DOI 10.1103/PhysRevB.56.R1712; Arguello JM, 2003, J MEMBRANE BIOL, V195, P93, DOI 10.1007/s00232-003-2048-2; Arguello JM, 2007, BIOMETALS, V20, P233, DOI 10.1007/s10534-006-9055-6; Arnesano F, 2002, GENOME RES, V12, P255, DOI 10.1101/gr.196802; Axelsen KB, 1998, J MOL EVOL, V46, P84, DOI 10.1007/PL00006286; Bagai I, 2007, J BIOL CHEM, V282, P35695, DOI 10.1074/jbc.M703937200; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRENNER AJ, 1995, ANAL BIOCHEM, V226, P80, DOI 10.1006/abio.1995.1194; Cattoni DI, 2008, ARCH BIOCHEM BIOPHYS, V471, P198, DOI 10.1016/j.abb.2007.12.013; Chintalapati S, 2008, J MOL BIOL, V378, P581, DOI 10.1016/j.jmb.2008.01.094; Cox DW, 2002, J BIOENERG BIOMEMBR, V34, P333, DOI 10.1023/A:1021293818125; Dmitriev O, 2006, P NATL ACAD SCI USA, V103, P5302, DOI 10.1073/pnas.0507416103; Eisses JF, 2005, J BIOL CHEM, V280, P37159, DOI 10.1074/jbc.M508822200; Eren E, 2006, J BIOL CHEM, V281, P33881, DOI 10.1074/jbc.M605218200; ESMANN M, 1985, BIOCHEM BIOPH RES CO, V127, P857, DOI 10.1016/S0006-291X(85)80022-X; Frausto da Silva J, 2001, BIOL CHEM ELEMENTS, P418; FUJIMORI T, 1990, J BIOL CHEM, V265, P16262; GLYNN IM, 1982, J PHYSIOL-LONDON, V330, P17, DOI 10.1113/jphysiol.1982.sp014326; Gonzalez-Guerrero M, 2008, P NATL ACAD SCI USA, V105, P5992, DOI 10.1073/pnas.0711446105; Hatori Y, 2008, J BIOL CHEM, V283, P22541, DOI 10.1074/jbc.M802735200; KAU LS, 1987, J AM CHEM SOC, V109, P6433, DOI 10.1021/ja00255a032; Lieberman RL, 2006, INORG CHEM, V45, P8372, DOI 10.1021/ic060739v; Liu T, 2007, NAT CHEM BIOL, V3, P60, DOI 10.1038/nchembio844; Loftin IR, 2007, PROTEIN SCI, V16, P2287, DOI 10.1110/ps.073021307; Lowe J, 2004, J BIOL CHEM, V279, P25986, DOI 10.1074/jbc.M308736200; Lutsenko S, 2007, ARCH BIOCHEM BIOPHYS, V463, P134, DOI 10.1016/j.abb.2007.04.013; Lutsenko S, 2007, PHYSIOL REV, V87, P1011, DOI 10.1152/physrev.00004.2006; MacPherson IS, 2007, CELL MOL LIFE SCI, V64, P2887, DOI 10.1007/s00018-007-7310-9; Mandal AK, 2004, J BIOL CHEM, V279, P54802, DOI 10.1074/jbc.M410854200; Mandal AK, 2003, BIOCHEMISTRY-US, V42, P11040, DOI 10.1021/bi034806y; Mandal AK, 2002, J BIOL CHEM, V277, P7201, DOI 10.1074/jbc.M109964200; MISSIAEN L, 1988, BIOCHEM J, V253, P827, DOI 10.1042/bj2530827; Moreira OC, 2005, BBA-BIOENERGETICS, V1708, P411, DOI 10.1016/j.bbabio.2005.05.010; Morth JP, 2007, NATURE, V450, P1043, DOI 10.1038/nature06419; O'Halloran TV, 2000, J BIOL CHEM, V275, P25057, DOI 10.1074/jbc.R000006200; Olesen C, 2007, NATURE, V450, P1036, DOI 10.1038/nature06418; PRITZ RA, 1997, J INVEST DERMATOL, V109, P207; Pufahl RA, 1997, SCIENCE, V278, P853, DOI 10.1126/science.278.5339.853; Puig S, 2002, J BIOL CHEM, V277, P26021, DOI 10.1074/jbc.M202547200; Ralle M, 1998, J AM CHEM SOC, V120, P13525, DOI 10.1021/ja982990i; Rosenzweig AC, 2006, CURR OPIN STRUC BIOL, V16, P729, DOI 10.1016/j.sbi.2006.09.005; Sakurai T, 2007, CELL MOL LIFE SCI, V64, P2642, DOI 10.1007/s00018-007-7183-y; Sazinsky MH, 2006, BIOCHEMISTRY-US, V45, P9949, DOI 10.1021/bi0610045; Sazinsky MH, 2006, J BIOL CHEM, V281, P11161, DOI 10.1074/jbc.M510708200; Tapiero H, 2003, BIOMED PHARMACOTHER, V57, P386, DOI 10.1016/S0753-3322(03)00012-X; Toyoshima C, 2004, ANNU REV BIOCHEM, V73, P269, DOI 10.1146/annurev.biochem.73.011303.073700; Wu CC, 2008, STRUCTURE, V16, P976, DOI 10.1016/j.str.2008.02.025; Xue Y, 2008, NAT CHEM BIOL, V4, P107, DOI 10.1038/nchembio.2007.57; Yang Y, 2007, BBA-BIOMEMBRANES, V1768, P495, DOI 10.1016/j.bbamem.2006.09.013; Yatsunyk LA, 2007, J BIOL CHEM, V282, P8622, DOI 10.1074/jbc.M609533200	51	80	80	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 31	2008	283	44					29753	29759		10.1074/jbc.M803248200	http://dx.doi.org/10.1074/jbc.M803248200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	364WS	18772137	Green Published, hybrid			2022-12-27	WOS:000260366900019
J	Klein, S; Partisani, M; Franco, M; Luton, F				Klein, Stephanie; Partisani, Mariagrazia; Franco, Michel; Luton, Frederic			EFA6 Facilitates the Assembly of the Tight Junction by Coordinating an Arf6-dependent and -independent Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GTPASE-ACTIVATING PROTEINS; ADP-RIBOSYLATION FACTOR-6; ACTIN CYTOSKELETON; EXCHANGE FACTOR; CELL-ADHESION; E-CADHERIN; ARF6; MEMBRANE; RAC1; DOMAIN	We have previously reported that EFA6, exchange factor for Arf6, is implicated upon E-cadherin engagement in the process of epithelial cell polarization. We had found that EFA6 acts through stabilization of the apical actin ring onto which the tight junction is anchored. Mutagenesis experiments showed that both the catalytic domain of EFA6 and its C-terminal domain were required for full EFA6 function. Here we address the contribution of the specific substrate of EFA6, the small G protein Arf6. Unexpectedly, depletion of Arf6 by RNA interference or expression of the constitutively active fast-cycling mutant (Arf6T157N) revealed that Arf6 plays an opposing role to EFA6 by destabilizing the apical actin cytoskeleton and the associated tight junction. However, in complementation experiments, when the C-terminal domain of EFA6 is co-expressed with Arf6T157N, it reverts the effects of Arf6T157N expressed alone to faithfully mimic the phenotypes induced by EFA6. In addition, we find that the two signaling pathways downstream of EFA6, i.e. the one originating from the activated Arf6GTP and the other one from the EFA6 C-terminal domain, need to be tightly balanced to promote the proper reorganization of the actin cytoskeleton. Altogether, our results indicate that to regulate the tight junction, EFA6 activates Arf6 through its Sec7 catalytic domain as it modulates this activity through its C-terminal domain.	[Klein, Stephanie; Partisani, Mariagrazia; Franco, Michel; Luton, Frederic] Univ Nice Sophia Antipolis, Inst Pharmacol Mol & Cellulaire, CNRS, UMR 6097, F-06560 Valbonne, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Cote d'Azur	Luton, F (corresponding author), Univ Nice Sophia Antipolis, Inst Pharmacol Mol & Cellulaire, CNRS, UMR 6097, 660 Route Lucioles, F-06560 Valbonne, France.	luton@ipmc.cnrs.fr	Luton, Frederic/N-7673-2017; Franco, Michel/ABH-4993-2020; FRANCO, michel/AAA-9735-2021	Franco, Michel/0000-0003-1853-8661; 	Association pour la Recherche sur le Cancer; Canceropole PACA; Agence Nationale de la Recherche	Association pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le CancerAustralian Research Council); Canceropole PACA(Region Grand-Est); Agence Nationale de la Recherche(French National Research Agency (ANR))	This work was supported in part by a grant from the Association pour la Recherche sur le Cancer, the Canceropole PACA, and the Agence Nationale de la Recherche. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Al-Awar O, 2000, MOL CELL BIOL, V20, P5998, DOI 10.1128/MCB.20.16.5998-6007.2000; Bruewer M, 2004, AM J PHYSIOL-CELL PH, V287, pC327, DOI 10.1152/ajpcell.00087.2004; Chaffer CL, 2007, CELLS TISSUES ORGANS, V185, P7, DOI 10.1159/000101298; Cohen LA, 2007, MOL BIOL CELL, V18, P2244, DOI 10.1091/mbc.E06-11-0998; D'Souza-Schorey C, 2006, NAT REV MOL CELL BIO, V7, P347, DOI 10.1038/nrm1910; Derrien V, 2002, J CELL SCI, V115, P2867; Dunphy JL, 2006, CURR BIOL, V16, P315, DOI 10.1016/j.cub.2005.12.032; Franco M, 1999, EMBO J, V18, P1480, DOI 10.1093/emboj/18.6.1480; Frank SR, 1998, MOL BIOL CELL, V9, P3133, DOI 10.1091/mbc.9.11.3133; Gillingham AK, 2007, ANNU REV CELL DEV BI, V23, P579, DOI 10.1146/annurev.cellbio.23.090506.123209; Hartsock A, 2008, BBA-BIOMEMBRANES, V1778, P660, DOI 10.1016/j.bbamem.2007.07.012; Hiroi T, 2006, P NATL ACAD SCI USA, V103, P10672, DOI 10.1073/pnas.0604091103; Hugo H, 2007, J CELL PHYSIOL, V213, P374, DOI 10.1002/jcp.21223; Jackson TR, 2000, J CELL BIOL, V151, P627, DOI 10.1083/jcb.151.3.627; Jou TS, 1998, J CELL BIOL, V142, P101, DOI 10.1083/jcb.142.1.101; Jou TS, 1998, J CELL BIOL, V142, P85, DOI 10.1083/jcb.142.1.85; Klein S, 2006, J BIOL CHEM, V281, P12352, DOI 10.1074/jbc.M601021200; Kondo A, 2000, MOL BIOL CELL, V11, P1315, DOI 10.1091/mbc.11.4.1315; Lee JM, 2006, J CELL BIOL, V172, P973, DOI 10.1083/jcb.200601018; Luton F, 2005, METHOD ENZYMOL, V404, P332, DOI 10.1016/S0076-6879(05)04029-2; Luton F, 2004, MOL BIOL CELL, V15, P1134, DOI 10.1091/mbc.E03-10-0751; Macia E, 2004, J CELL SCI, V117, P2389, DOI 10.1242/jcs.01090; Marshansky V, 1997, ELECTROPHORESIS, V18, P538, DOI 10.1002/elps.1150180334; Naslavsky N, 2003, MOL BIOL CELL, V14, P417, DOI 10.1091/mbc.02-04-0053; Palacios F, 2002, NAT CELL BIOL, V4, P929, DOI 10.1038/ncb881; Palacios F, 2003, J BIOL CHEM, V278, P17395, DOI 10.1074/jbc.M300998200; Palacios F, 2001, EMBO J, V20, P4973, DOI 10.1093/emboj/20.17.4973; Powelka AM, 2004, TRAFFIC, V5, P20, DOI 10.1111/j.1600-0854.2004.00150.x; Randazzo PA, 2004, CELL SIGNAL, V16, P401, DOI 10.1016/j.cellsig.2003.09.012; Santy LC, 2001, J CELL BIOL, V154, P599, DOI 10.1083/jcb.200104019; Shin K, 2006, ANNU REV CELL DEV BI, V22, P207, DOI 10.1146/annurev.cellbio.22.010305.104219; Tague SE, 2004, P NATL ACAD SCI USA, V101, P9671, DOI 10.1073/pnas.0403531101; Thiery JP, 2006, NAT REV MOL CELL BIO, V7, P131, DOI 10.1038/nrm1835; Tsukita S, 2001, NAT REV MOL CELL BIO, V2, P285, DOI 10.1038/35067088; Tushir JS, 2007, EMBO J, V26, P1806, DOI 10.1038/sj.emboj.7601644; Venkateswarlu K, 1998, CURR BIOL, V8, P463, DOI 10.1016/S0960-9822(98)70181-2	36	16	16	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 31	2008	283	44					30129	30138		10.1074/jbc.M803375200	http://dx.doi.org/10.1074/jbc.M803375200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	364WS	18779331	Green Published, hybrid			2022-12-27	WOS:000260366900058
J	Leoff, C; Choudhury, B; Saile, E; Quinn, CP; Carlson, RW; Kannenberg, EL				Leoff, Christine; Choudhury, Biswa; Saile, Elke; Quinn, Conrad P.; Carlson, Russell W.; Kannenberg, Elmar L.			Structural Elucidation of the Nonclassical Secondary Cell Wall Polysaccharide from Bacillus cereus ATCC 10987 COMPARISON WITH THE POLYSACCHARIDES FROM BACILLUS ANTHRACIS AND B. CEREUS TYPE STRAIN ATCC 14579 REVEALS BOTH UNIQUE AND COMMON STRUCTURAL FEATURES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENES; IDENTIFICATION; THURINGIENSIS; SEQUENCE	Nonclassical secondary cell wall polysaccharides constitute a major cell wall structure in the Bacillus cereus group of bacteria. The structure of the secondary cell wall polysaccharide from Bacillus cereus ATCC 10987, a strain that is closely related to Bacillus anthracis, was determined. This polysaccharide was released from the cell wall with aqueous hydrogen fluoride (HF) and purified by gel filtration chromatography. The purified polysaccharide, HF-PS, was characterized by glycosyl composition and linkage analyses, mass spectrometry, and one-and two-dimensional NMR analysis. The results showed that the B. cereus ATCC 10987 HF-PS has a repeating oligosaccharide consisting of a -> 6)-alpha-GalNAc-(1 -> 4)-beta-ManNAc-(1 -> 4)-beta-GlcNAc-(1 -> trisaccharide that is substituted with beta-Gal at O3 of the alpha-GalNAc residue and nonstoichiometrically acetylated at O3 of the N-acetylmannosamine (ManNAc) residue. Comparison of this structure with that of the B. anthracis HF-PS and with structural data obtained for the HF-PS from B. cereus type strain ATCC 14579 revealed that each HF-PS had the same general structural theme consisting of three HexNAc and one Hex residues. A common structural feature in the HF-PSs from B. cereus ATCC 10987 and B. anthracis was the presence of a repeating unit consisting of a HexNAc(3) trisaccharide backbone in which two of the three HexNAc residues are GlcNAc and ManNAc and the third can be either GlcNAc or GalNAc. The implications of these results with regard to the possible functions of the HF-PSs are discussed.	[Leoff, Christine; Choudhury, Biswa; Saile, Elke; Carlson, Russell W.; Kannenberg, Elmar L.] Univ Georgia, Complex Carbohydrate Res Ctr, Athens, GA 30602 USA; [Saile, Elke; Quinn, Conrad P.] Ctr Dis Control & Prevent, Atlanta, GA 30333 USA; [Leoff, Christine; Kannenberg, Elmar L.] Univ Tubingen, Dept Microbiol, D-72076 Tubingen, Germany; [Leoff, Christine; Kannenberg, Elmar L.] Univ Tubingen, Dept Biotechnol, D-72076 Tubingen, Germany	University System of Georgia; University of Georgia; Centers for Disease Control & Prevention - USA; Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen	Carlson, RW (corresponding author), Univ Georgia, Complex Carbohydrate Res Ctr, 220 Riverbend Rd, Athens, GA 30602 USA.	rcarlson@ccrc.uga.edu			National Institutes of Health; NIAID [R21 AI059577]; Department of Energy [DE-FG02-93ER20097]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Department of Energy(United States Department of Energy (DOE))	This work was supported, in whole or in part, by National Institutes of Health, NIAID, Grant R21 AI059577 (to R. W. C.). This work was also supported in part by Department of Energy Grant DE-FG02-93ER20097 (to the CCRC). Patent pending (University of Georgia Research Foundation, Inc. and United States Centers for Disease Control and Prevention). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	AMANO K, 1977, EUR J BIOCHEM, V75, P513, DOI 10.1111/j.1432-1033.1977.tb11552.x; BROWN WC, 1973, APPL MICROBIOL, V25, P295, DOI 10.1128/AEM.25.2.295-300.1973; Choudhury B, 2006, J BIOL CHEM, V281, P27932, DOI 10.1074/jbc.M605768200; CIUCANU I, 1984, CARBOHYD RES, V131, P209, DOI 10.1016/0008-6215(84)85242-8; Claesson MJ, 2006, P NATL ACAD SCI USA, V103, P6718, DOI 10.1073/pnas.0511060103; Fedhila S, 2006, MOL MICROBIOL, V62, P339, DOI 10.1111/j.1365-2958.2006.05362.x; Fischetti VA, 2006, NAT BIOTECHNOL, V24, P1508, DOI 10.1038/nbt1206-1508; GONZALEZ JM, 1982, P NATL ACAD SCI-BIOL, V79, P6951, DOI 10.1073/pnas.79.22.6951; Helgason E, 2000, APPL ENVIRON MICROB, V66, P2627, DOI 10.1128/AEM.66.6.2627-2630.2000; Hoffmaster AR, 2006, J CLIN MICROBIOL, V44, P3352, DOI 10.1128/JCM.00561-06; Hoffmaster AR, 2004, P NATL ACAD SCI USA, V101, P8449, DOI 10.1073/pnas.0402414101; Inoue T, 2007, J BACTERIOL, V189, P950, DOI 10.1128/JB.01294-06; Kern JW, 2008, MOL MICROBIOL, V68, P504, DOI 10.1111/j.1365-2958.2008.06169.x; Kim W, 2008, J MED MICROBIOL, V57, P279, DOI 10.1099/jmm.0.47642-0; Klee SR, 2006, J BACTERIOL, V188, P5333, DOI 10.1128/JB.00303-06; KOJIMA N, 1985, EUR J BIOCHEM, V148, P479, DOI 10.1111/j.1432-1033.1985.tb08864.x; Leendertz FH, 2006, PLOS PATHOG, V2, P632, DOI 10.1371/journal.ppat.0020008; Leoff C, 2008, J BACTERIOL, V190, P112, DOI 10.1128/JB.01292-07; Low LY, 2005, J BIOL CHEM, V280, P35433, DOI 10.1074/jbc.M502723200; Mesnage S, 2000, EMBO J, V19, P4473, DOI 10.1093/emboj/19.17.4473; Mock M, 2001, ANNU REV MICROBIOL, V55, P647, DOI 10.1146/annurev.micro.55.1.647; Okinaka RT, 1999, J BACTERIOL, V181, P6509, DOI 10.1128/JB.181.20.6509-6515.1999; Rasko DA, 2005, FEMS MICROBIOL REV, V29, P303, DOI 10.1016/j.femsre.2004.12.005; Rasko DA, 2004, NUCLEIC ACIDS RES, V32, P977, DOI 10.1093/nar/gkh258; Schaffer C, 2005, MICROBIOL-SGM, V151, P643, DOI 10.1099/mic.0.27749-0; Schuch R, 2002, NATURE, V418, P884, DOI 10.1038/nature01026; YORK WS, 1986, METHOD ENZYMOL, V118, P3	27	33	36	0	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 31	2008	283	44					29812	29821		10.1074/jbc.M803234200	http://dx.doi.org/10.1074/jbc.M803234200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	364WS	18757856	hybrid, Green Published			2022-12-27	WOS:000260366900025
J	Baglole, CJ; Maggirwar, SB; Gasiewicz, TA; Thatcher, TH; Phipps, RP; Sime, PJ				Baglole, Carolyn J.; Maggirwar, Sanjay B.; Gasiewicz, Thomas A.; Thatcher, Thomas H.; Phipps, Richard P.; Sime, Patricia J.			The Aryl Hydrocarbon Receptor Attenuates Tobacco Smoke-induced Cyclooxygenase-2 and Prostaglandin Production in Lung Fibroblasts through Regulation of the NF-kappa B Family Member RelB	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NECROSIS-FACTOR-ALPHA; RNA-BINDING PROTEIN; CIGARETTE-SMOKE; MESSENGER-RNA; AH RECEPTOR; TRANSCRIPTIONAL ACTIVITY; DIFFERENTIAL INDUCTION; POTENTIAL MECHANISM; MEDIATED ACTIVATION; OXIDATIVE STRESS	Diseases such as chronic obstructive pulmonary disease and lung cancer caused by cigarette smoke affect millions of people worldwide. The aryl hydrocarbon receptor (AhR) is a ligand-activated transcription factor that influences responses to certain environmental pollutants such as tobacco smoke. However, the physiological function(s) of the AhR is unknown. Herein we propose that the physiologic role of the AhR is to limit inflammation. We show that lung fibroblasts from AhR(-/-) mice produce a heightened inflammatory response to cigarette smoke, typified by increased levels of cyclooxygenase-2 (COX-2) and prostaglandins (PGs), when compared with wild type (AhR(+/+)) fibroblasts. This response was dependent on AhR expression as transient transfection of an AhR expression plasmid into AhR(-/-) fibroblasts significantly attenuated the smoke-induced COX-2 and PG production, confirming the anti-inflammatory role of the AhR. The AhR can interact with NF-kappa B. However, the heightened inflammatory response observed in AhR(-/-) fibroblasts was not the result of NF-kappa B (p50/p65) activation. Instead it was coupled with a loss of the NF-kappa B family member RelB in AhR(-/-) fibroblasts. Taken together, these studies provide compelling evidence that AhR expression limits proinflammatory COX-2 and PG production by maintaining RelB expression. The association between RelB and AhR may represent a new therapeutic and more selective target with which to combat inflammation associated diseases.	[Thatcher, Thomas H.; Sime, Patricia J.] Univ Rochester, Sch Med & Dent, Div Pulm & Crit Care Med, Rochester, NY 14642 USA; [Baglole, Carolyn J.; Gasiewicz, Thomas A.; Phipps, Richard P.; Sime, Patricia J.] Univ Rochester, Sch Med & Dent, Dept Environm Med, Rochester, NY 14642 USA; [Maggirwar, Sanjay B.] Univ Rochester, Sch Med & Dent, Dept Microbiol & Immunol, Rochester, NY 14642 USA; [Baglole, Carolyn J.; Phipps, Richard P.; Sime, Patricia J.] Univ Rochester, Sch Med & Dent, Lung Biol & Dis Program, Rochester, NY 14642 USA	University of Rochester; University of Rochester; University of Rochester; University of Rochester	Sime, PJ (corresponding author), Univ Rochester, Sch Med & Dent, Div Pulm & Crit Care Med, 601 Elmwood Ave,Box 692, Rochester, NY 14642 USA.	Patricia_Sime@urmc.rochester.edu		Thatcher, Thomas/0000-0001-7177-3041	National Institutes of Health [ULIRR024160, T32HL66988, T32ES07026, DE011390, AI071064, ES015775, ES01247, HL075432, HL088325]; American Lung Association; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024160] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL066988, R01HL088325, R01HL075432] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI071064] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE011390] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R21ES015775, T32ES007026, P30ES001247] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Lung Association; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grants ULIRR024160, T32HL66988, T32ES07026, DE011390, AI071064, ES015775, ES01247, HL075432, and HL088325. This work was also supported by an American Lung Association research training fellowship and a Parker B. Francis fellowship (to C. J. B.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	An ZB, 2007, J BIOL CHEM, V282, P26793, DOI 10.1074/jbc.M703701200; Anto RJ, 2002, CARCINOGENESIS, V23, P1511, DOI 10.1093/carcin/23.9.1511; Baglole CJ, 2006, AM J PHYSIOL-LUNG C, V291, pL19, DOI 10.1152/ajplung.00306.2005; Baglole CJ, 2006, IMMUNOL INVEST, V35, P297, DOI 10.1080/08820130600754960; Baglole CJ, 2005, METH MOLEC MED, V117, P115; Beinke S, 2004, BIOCHEM J, V382, P393, DOI 10.1042/BJ20040544; Brown JR, 2004, CLIN CANCER RES, V10, p4266S, DOI 10.1158/1078-0432.CCR-040014; Buchanan FG, 2003, J BIOL CHEM, V278, P35451, DOI 10.1074/jbc.M302474200; Carnevali S, 2003, AM J PHYSIOL-LUNG C, V284, pL955, DOI 10.1152/ajplung.00466.2001; Carnevali S, 2006, AM J RESP CRIT CARE, V174, P393, DOI 10.1164/rccm.200512-1835OC; CARP H, 1978, AM REV RESPIR DIS, V118, P617; Chen GG, 2006, CANCER LETT, V234, P193, DOI 10.1016/j.canlet.2005.03.032; Chen LJ, 2005, TOXICOL SCI, V83, P372, DOI 10.1093/toxsci/kfi019; Chun KS, 2004, BIOCHEM PHARMACOL, V68, P1089, DOI 10.1016/j.bcp.2004.05.031; Cok SJ, 2003, J BIOL CHEM, V278, P36157, DOI 10.1074/jbc.M302547200; Dempke W, 2001, J CANCER RES CLIN, V127, P411, DOI 10.1007/s004320000225; Deng WG, 2004, BLOOD, V103, P2135, DOI 10.1182/blood-2003-09-3131; Denison MS, 1998, B ENVIRON CONTAM TOX, V61, P557, DOI 10.1007/PL00002973; Dixon DA, 2000, J BIOL CHEM, V275, P11750, DOI 10.1074/jbc.275.16.11750; Dixon DA, 2003, J EXP MED, V198, P475, DOI 10.1084/jem.20030616; Dixon DA, 2003, PROG EXP TUMOR RES, V37, P52; Dixon DA, 2001, J CLIN INVEST, V108, P1657, DOI 10.1172/JCI200112973; Doller A, 2008, MOL CELL BIOL, V28, P2608, DOI 10.1128/MCB.01530-07; Gao ZG, 2005, J BIOL CHEM, V280, P21091, DOI 10.1074/jbc.M500754200; Graf BA, 1999, EUR J IMMUNOL, V29, P3793, DOI 10.1002/(SICI)1521-4141(199911)29:11<3793::AID-IMMU3793>3.0.CO;2-3; Grossmann M, 1999, INT J BIOCHEM CELL B, V31, P1209, DOI 10.1016/S1357-2725(99)00068-0; Harris RE, 2007, INT J BIOL SCI, V3, P328; Harris SG, 2002, TRENDS IMMUNOL, V23, P144, DOI 10.1016/S1471-4906(01)02154-8; Hata AN, 2004, PHARMACOL THERAPEUT, V103, P147, DOI 10.1016/j.pharmthera.2004.06.003; Hecht SS, 2003, NAT REV CANCER, V3, P733, DOI 10.1038/nrc1190; Henry EC, 2006, ARCH BIOCHEM BIOPHYS, V450, P67, DOI 10.1016/j.abb.2006.02.008; Hestermann EV, 2003, MOL CELL BIOL, V23, P7920, DOI 10.1128/MCB.23.21.7920-7925.2003; Hida T, 1998, CANCER RES, V58, P3761; Holz O, 2004, EUR RESPIR J, V24, P575, DOI 10.1183/09031936.04.00143703; Hoshino Y, 2001, AM J PHYSIOL-LUNG C, V281, pL509, DOI 10.1152/ajplung.2001.281.2.L509; Ishii T, 2001, AM J PHYSIOL-LUNG C, V280, pL1189, DOI 10.1152/ajplung.2001.280.6.L1189; Kamiyama M, 2006, ONCOGENE, V25, P7019, DOI 10.1038/sj.onc.1209694; Kazlauskas A, 1999, J BIOL CHEM, V274, P13519, DOI 10.1074/jbc.274.19.13519; Ke S, 2001, J BIOL CHEM, V276, P39638, DOI 10.1074/jbc.M106286200; Kehry M R, 1994, Semin Immunol, V6, P287, DOI 10.1006/smim.1994.1037; Keith RL, 2006, ANTICANCER RES, V26, P2857; Kim DW, 2000, ONCOGENE, V19, P5498, DOI 10.1038/sj.onc.1203945; Kim HJ, 2004, AM J RESP CELL MOL, V31, P483, DOI 10.1165/rcmb.2002-0300OC; Kim JH, 2007, LUNG CANCER, V56, P9, DOI 10.1016/j.lungcan.2006.11.010; Knaapen AM, 2007, MUTAT RES-FUND MOL M, V621, P31, DOI 10.1016/j.mrfmmm.2006.12.010; Koumas L, 2002, AM J PHYSIOL-CELL PH, V283, pC599, DOI 10.1152/ajpcell.00065.2002; Kraemer SA, 1996, ARCH BIOCHEM BIOPHYS, V330, P319, DOI 10.1006/abbi.1996.0259; Kreutzer M, 2007, ONCOL REP, V18, P497; Lee MH, 2002, IMMUNOLOGY, V106, P496, DOI 10.1046/j.1365-2567.2002.01451.x; Lin SC, 1998, MOL CELL BIOL, V18, P5523, DOI 10.1128/MCB.18.9.5523; Machado FS, 2006, NAT MED, V12, P330, DOI 10.1038/nm1355; Marienfeld R, 2001, ONCOGENE, V20, P8142, DOI 10.1038/sj.onc.1204884; Martey CA, 2005, AM J PHYSIOL-LUNG C, V289, pL391, DOI 10.1152/ajplung.00062.2005; Martey CA, 2004, AM J PHYSIOL-LUNG C, V287, pL981, DOI 10.1152/ajplung.00239.2003; MCLEMORE TL, 1988, CANCER RES, V48, P3140; Mineva ND, 2007, J BIOL CHEM, V282, P17475, DOI 10.1074/jbc.M607313200; Mukhopadhyay D, 2003, MOL CELL, V11, P113, DOI 10.1016/S1097-2765(03)00012-1; Murmu N, 2004, P NATL ACAD SCI USA, V101, P13873, DOI 10.1073/pnas.0406066101; Neumann M, 1996, J IMMUNOL, V157, P4862; Nguyen LP, 2008, CHEM RES TOXICOL, V21, P102, DOI 10.1021/tx7001965; O'Sullivan BJ, 2002, J IMMUNOL, V168, P5491, DOI 10.4049/jimmunol.168.11.5491; Ohtake F, 2007, NATURE, V446, P562, DOI 10.1038/nature05683; PENNEY DP, 1992, ANAT RECORD, V232, P432, DOI 10.1002/ar.1092320312; Pollenz RS, 2002, CHEM-BIOL INTERACT, V141, P41, DOI 10.1016/S0009-2797(02)00065-0; Puga A, 1997, BIOCHEM PHARMACOL, V54, P1287, DOI 10.1016/S0006-2952(97)00417-6; Qualtrough D, 2007, INT J CANCER, V121, P734, DOI 10.1002/ijc.22755; Ravenel JG, 2008, AM J ROENTGENOL, V190, P755, DOI 10.2214/AJR.07.2899; Rodriguez-Sosa M, 2005, FEBS LETT, V579, P6403, DOI 10.1016/j.febslet.2005.10.023; Ryan EP, 2005, J IMMUNOL, V174, P2619, DOI 10.4049/jimmunol.174.5.2619; RYSECK RP, 1992, MOL CELL BIOL, V12, P674, DOI 10.1128/MCB.12.2.674; Schaldach CM, 1999, BIOCHEMISTRY-US, V38, P7594, DOI 10.1021/bi982861e; Sempowski GD, 1997, J PERIODONTOL, V68, P284, DOI 10.1902/jop.1997.68.3.284; Shapiro SD, 2004, AM J RESP CELL MOL, V31, P481, DOI 10.1165/rcmb.F285; Sheng HM, 1998, J BIOL CHEM, V273, P22120, DOI 10.1074/jbc.273.34.22120; Shin VY, 2005, MOL CANCER RES, V3, P607, DOI 10.1158/1541-7786.MCR-05-0106; Smith RS, 1997, AM J PATHOL, V151, P317; Smith WL, 2000, ANNU REV BIOCHEM, V69, P145, DOI 10.1146/annurev.biochem.69.1.145; Solan NJ, 2002, J BIOL CHEM, V277, P1405, DOI 10.1074/jbc.M109619200; Song JS, 2002, P NATL ACAD SCI USA, V99, P14694, DOI 10.1073/pnas.232562899; Subbaramaiah K, 2003, TRENDS PHARMACOL SCI, V24, P96, DOI 10.1016/S0165-6147(02)00043-3; Sully G, 2004, BIOCHEM J, V377, P629, DOI 10.1042/BJ20031484; Sureban SM, 2007, GASTROENTEROLOGY, V132, P1055, DOI 10.1053/j.gastro.2006.12.031; Swauger JE, 2002, REGUL TOXICOL PHARM, V35, P142, DOI 10.1006/rtph.2001.1521; Thatcher TH, 2007, AM J PATHOL, V170, P855, DOI 10.2353/ajpath.2007.060391; Tian Y, 1999, J BIOL CHEM, V274, P510, DOI 10.1074/jbc.274.1.510; Vogel CFA, 2007, MOL ENDOCRINOL, V21, P2941, DOI 10.1210/me.2007-0211; Wang DZ, 2004, P NATL ACAD SCI USA, V101, P415, DOI 10.1073/pnas.0307640100; WEIH F, 1995, CELL, V80, P331, DOI 10.1016/0092-8674(95)90416-6; Wingo PA, 1999, J NATL CANCER I, V91, P675, DOI 10.1093/jnci/91.8.675; Wolfle D, 2000, CARCINOGENESIS, V21, P15, DOI 10.1093/carcin/21.1.15; Wong HPS, 2007, TOXICOL SCI, V97, P279, DOI 10.1093/toxsci/kfm060; Wong LS, 2004, BMC CELL BIOL, V5, DOI 10.1186/1471-2121-5-13; Xaubet A, 2004, SARCOIDOSIS VASC DIF, V21, P35; Xia YY, 1999, MOL CELL BIOL, V19, P7688; Xia YY, 1997, AM J PATHOL, V151, P375; Yan ZP, 2000, J BIOL CHEM, V275, P4949, DOI 10.1074/jbc.275.7.4949; Zhang Y, 1998, J IMMUNOL, V160, P1053; Zhou JG, 2003, MOL PHARMACOL, V63, P915, DOI 10.1124/mol.63.4.915; Zou YX, 2007, AM J HUM GENET, V80, P561, DOI 10.1086/512489	99	118	120	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 24	2008	283	43					28944	28957		10.1074/jbc.M800685200	http://dx.doi.org/10.1074/jbc.M800685200			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	362EB	18697742	Green Published, hybrid			2022-12-27	WOS:000260179900020
J	Chen, YB; Wang, XH; Di, L; Fu, GP; Chen, YH; Bai, L; Liu, JZ; Feng, X; McDonald, JM; Michalek, S; He, YH; Yu, M; Fu, YX; Wen, RR; Wu, H; Wang, DM				Chen, Yabing; Wang, Xiaohong; Di, Lie; Fu, Guoping; Chen, Yuhong; Bai, Li; Liu, Jianzhong; Feng, Xu; McDonald, Jay M.; Michalek, Sue; He, Yinghong; Yu, Mei; Fu, Yang-Xin; Wen, Renren; Wu, Hui; Wang, Demin			Phospholipase C gamma 2 Mediates RANKL-stimulated Lymph Node Organogenesis and Osteoclastogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; ACTIVATED PROTEIN-KINASE; CELL ANTIGEN-RECEPTOR; SIGNAL-REGULATED KINASE; LYMPHOTOXIN-BETA-RECEPTOR; JUN NH2-TERMINAL KINASE; ALPHA-DEFICIENT MICE; ORGAN DEVELOPMENT; NUCLEAR-FACTOR; C-FOS	Phospholipase C gamma 2 (PLC gamma 2) is an important signaling effector of multiple receptors in the immune system. Here we show that PLC gamma 2-deficient mice displayed impaired lymph node organogenesis but normal splenic structure and Peyer's patches. Receptor activator of NF-kappa Bligand (RANKL) is a tumor necrosis factor family cytokine and is essential for lymph node organogenesis. Importantly, PLC gamma 2 deficiency severely impaired RANKL signaling, resulting in marked reduction of RANKL-induced activation of MAPKs, p38 and JNK, but not ERK. The lack of PLC gamma 2 markedly diminished RANKL-induced activation of NF-kappa B, AP-1, and NFATc1. Moreover, PLC gamma 2 deficiency impaired RANKL-mediated biological function, leading to failure of the PLC gamma 2- deficient bone marrow macrophage precursors to differentiate into osteoclasts after RANKL stimulation. Re-introduction of PLC gamma 2 but not PLC gamma 1 restores RANKL-mediated osteoclast differentiation of PLC gamma 2- deficient bone marrow-derived monocyte/macrophage. Taken together, PLC gamma 2 is essential for RANK signaling, and its deficiency leads to defective lymph node organogenesis and osteoclast differentiation.	[Wang, Xiaohong; Wu, Hui] Univ Alabama, Dept Pediat Dent, Birmingham, AL 35294 USA; [Chen, Yabing; Liu, Jianzhong; Feng, Xu; McDonald, Jay M.] Univ Alabama, Dept Pathol, Birmingham, AL 35294 USA; [Michalek, Sue] Univ Alabama, Dept Microbiol, Birmingham, AL 35294 USA; [McDonald, Jay M.] Vet Affairs Med Ctr, Birmingham, AL 35294 USA; [Fu, Yang-Xin] Univ Chicago, Dept Pathol, Chicago, IL 60637 USA; [Di, Lie; Fu, Guoping; Chen, Yuhong; Bai, Li; He, Yinghong; Yu, Mei; Wen, Renren; Wang, Demin] Blood Ctr SE Wisconsin Inc, Blood Res Inst, Milwaukee, WI 53226 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; US Department of Veterans Affairs; Veterans Health Administration (VHA); University of Chicago; Versiti Blood Center of Wisconsin	Wu, H (corresponding author), Univ Alabama, Dept Pediat Dent, Birmingham, AL 35294 USA.	hwu@uab.edu; demin.wang@bcw.edu	Yu, Mei/K-2206-2017; Wang, Demin/AAX-4449-2020	Wang, Demin/0000-0001-5549-3795; fu, yang-xin/0000-0001-8441-6617	National Institutes of Health [AR055339, AR046031-080003, AI52327, HL073284, AI079087]; University of Alabama at Birmingham Center; Metabolic Bone Disease; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL073284] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI079087, R01AI052327] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR046031, R03AR055339] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Alabama at Birmingham Center; Metabolic Bone Disease; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health Grants AR055339 (to Yabing Chen), AR046031-080003 (to H. W.), AI52327 (to R. W.), and HL073284 and AI079087 (to D. W.). This work was also supported by a University of Alabama at Birmingham Center for Metabolic Bone Disease pilot project award (to Yabing Chen), a Scholar Award from the Leukemia and Lymphoma Society, and a grant from Advancing a Healthier Wisconsin endowment fund (to D. W.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Abu-Amer Y, 2001, J CLIN INVEST, V107, P1375, DOI 10.1172/JCI10530; Akagi T, 2000, P NATL ACAD SCI USA, V97, P7290, DOI 10.1073/pnas.140210297; Alimzhanov MB, 1997, P NATL ACAD SCI USA, V94, P9302, DOI 10.1073/pnas.94.17.9302; Anderson DM, 1997, NATURE, V390, P175, DOI 10.1038/36593; Ansel KM, 2000, NATURE, V406, P309, DOI 10.1038/35018581; Baldwin AS, 1996, ANNU REV IMMUNOL, V14, P649, DOI 10.1146/annurev.immunol.14.1.649; BANKS TA, 1995, J IMMUNOL, V155, P1685; BOULTON TG, 1991, CELL, V65, P663, DOI 10.1016/0092-8674(91)90098-J; Bunting KD, 1998, NAT MED, V4, P58, DOI 10.1038/nm0198-058; Campbell KS, 1999, CURR OPIN IMMUNOL, V11, P256, DOI 10.1016/S0952-7915(99)80042-9; CHAO TSO, 1994, J BIOL CHEM, V269, P7337; Chen Y, 2003, J BIOL CHEM, V278, P16520, DOI 10.1074/jbc.M210572200; Chen YB, 2004, J CELL BIOCHEM, V92, P178, DOI 10.1002/jcb.20058; Colucci F, 2002, NAT IMMUNOL, V3, P807, DOI 10.1038/ni0902-807; CREWS CM, 1992, SCIENCE, V258, P478, DOI 10.1126/science.1411546; David JP, 2002, J CELL SCI, V115, P4317, DOI 10.1242/jcs.00082; Dejardin E, 2002, IMMUNITY, V17, P525, DOI 10.1016/S1074-7613(02)00423-5; DERIJARD B, 1994, CELL, V76, P1025, DOI 10.1016/0092-8674(94)90380-8; DETOGNI P, 1994, SCIENCE, V264, P703, DOI 10.1126/science.8171322; Dougall WC, 1999, GENE DEV, V13, P2412, DOI 10.1101/gad.13.18.2412; Drayton DL, 2006, NAT IMMUNOL, V7, P344, DOI 10.1038/ni1330; Feng X, 2002, ENDOCRINOLOGY, V143, P4868, DOI 10.1210/en.2002-220467; Feng X, 2001, J CLIN INVEST, V107, P1137, DOI 10.1172/JCI12040; Forster R, 1996, CELL, V87, P1037, DOI 10.1016/S0092-8674(00)81798-5; Franzoso G, 1997, GENE DEV, V11, P3482, DOI 10.1101/gad.11.24.3482; Ghosh S, 1998, ANNU REV IMMUNOL, V16, P225, DOI 10.1146/annurev.immunol.16.1.225; GRIGORIADIS AE, 1994, SCIENCE, V266, P443, DOI 10.1126/science.7939685; Hashimoto A, 2000, J IMMUNOL, V165, P1738, DOI 10.4049/jimmunol.165.4.1738; Hashimoto A, 1998, J EXP MED, V188, P1287, DOI 10.1084/jem.188.7.1287; HIBI M, 1993, GENE DEV, V7, P2135, DOI 10.1101/gad.7.11.2135; HIRASAWA N, 1995, J IMMUNOL, V154, P5391; Humphrey MB, 2004, J BONE MINER RES, V19, P224, DOI 10.1359/JBMR.0301234; Ji QS, 1997, P NATL ACAD SCI USA, V94, P2999, DOI 10.1073/pnas.94.7.2999; Jiang A, 1998, J EXP MED, V188, P1297, DOI 10.1084/jem.188.7.1297; Kaifu T, 2003, J CLIN INVEST, V111, P323, DOI 10.1172/JCI200316923; Karin M, 2000, ANNU REV IMMUNOL, V18, P621, DOI 10.1146/annurev.immunol.18.1.621; Kawakami Y, 1998, J IMMUNOL, V161, P1795; Koga T, 2004, NATURE, V428, P758, DOI 10.1038/nature02444; Kong YY, 1999, NATURE, V397, P315, DOI 10.1038/16852; Koni PA, 1997, IMMUNITY, V6, P491, DOI 10.1016/S1074-7613(00)80292-7; KYRIAKIS JM, 1994, NATURE, V369, P156, DOI 10.1038/369156a0; Lacey DL, 1998, CELL, V93, P165, DOI 10.1016/S0092-8674(00)81569-X; Lee SE, 2002, BONE, V30, P71, DOI 10.1016/S8756-3282(01)00657-3; Leibson PJ, 1997, IMMUNITY, V6, P655, DOI 10.1016/S1074-7613(00)80441-0; Li XT, 2002, ENDOCRINOLOGY, V143, P3105, DOI 10.1210/en.143.8.3105; Lin X, 2004, SEMIN IMMUNOL, V16, P429, DOI 10.1016/j.smim.2004.08.022; Lomaga MA, 1999, GENE DEV, V13, P1015, DOI 10.1101/gad.13.8.1015; Mao DL, 2006, J CLIN INVEST, V116, P2869, DOI 10.1172/JCI28775; Matsumoto M, 2004, J BIOL CHEM, V279, P45969, DOI 10.1074/jbc.M408795200; Matsumoto M, 1996, SCIENCE, V271, P1289, DOI 10.1126/science.271.5253.1289; Matsuo K, 2004, J BIOL CHEM, V279, P26475, DOI 10.1074/jbc.M313973200; Matsuo K, 2000, NAT GENET, V24, P184, DOI 10.1038/72855; Matsushima A, 2001, J EXP MED, V193, P631, DOI 10.1084/jem.193.5.631; McHugh KP, 2000, J CLIN INVEST, V105, P433, DOI 10.1172/JCI8905; MIYAWAKI S, 1994, EUR J IMMUNOL, V24, P429, DOI 10.1002/eji.1830240224; Mocsai A, 2004, P NATL ACAD SCI USA, V101, P6158, DOI 10.1073/pnas.0401602101; Muller G, 2003, CURR OPIN IMMUNOL, V15, P217, DOI 10.1016/S0952-7915(03)00014-1; Nagy TR, 2000, OBES RES, V8, P392, DOI 10.1038/oby.2000.47; NISHIBE S, 1990, SCIENCE, V250, P1253, DOI 10.1126/science.1700866; PARFITT AM, 1987, J BONE MINER RES, V2, P595, DOI 10.1002/jbmr.5650020617; Pasparakis M, 1996, J EXP MED, V184, P1397, DOI 10.1084/jem.184.4.1397; Rao A, 1997, ANNU REV IMMUNOL, V15, P707, DOI 10.1146/annurev.immunol.15.1.707; Regunathan J, 2006, J IMMUNOL, V177, P5365, DOI 10.4049/jimmunol.177.8.5365; RHEE SG, 1992, J BIOL CHEM, V267, P12393; Rhee SG, 1997, J BIOL CHEM, V272, P15045, DOI 10.1074/jbc.272.24.15045; Roa M, 1997, J IMMUNOL, V159, P2815; Rodriguez R, 2001, J BIOL CHEM, V276, P47982, DOI 10.1074/jbc.M107577200; Salvador JM, 2005, NAT IMMUNOL, V6, P390, DOI 10.1038/ni1177; Takayanagi H, 2002, DEV CELL, V3, P889, DOI 10.1016/S1534-5807(02)00369-6; Tassi I, 2005, J IMMUNOL, V175, P749, DOI 10.4049/jimmunol.175.2.749; Thome M, 2004, NAT REV IMMUNOL, V4, P348, DOI 10.1038/nri1352; Wang DM, 2000, IMMUNITY, V13, P25, DOI 10.1016/S1074-7613(00)00005-4; Watanabe D, 2001, J BIOL CHEM, V276, P38595, DOI 10.1074/jbc.M103675200; Wei S, 2001, ENDOCRINOLOGY, V142, P1290, DOI 10.1210/en.142.3.1290; WEISS A, 1991, P NATL ACAD SCI USA, V88, P5484, DOI 10.1073/pnas.88.13.5484; Wen RR, 2004, EMBO J, V23, P4007, DOI 10.1038/sj.emboj.7600405; Wen RR, 2003, J BIOL CHEM, V278, P43654, DOI 10.1074/jbc.M307318200; Wen RR, 2002, J IMMUNOL, V169, P6743, DOI 10.4049/jimmunol.169.12.6743; Wen RR, 2001, MOL CELL BIOL, V21, P678, DOI 10.1128/MCB.21.2.678-689.2001; Wong BR, 1998, J BIOL CHEM, V273, P28355, DOI 10.1074/jbc.273.43.28355; Yasuda H, 1998, P NATL ACAD SCI USA, V95, P3597, DOI 10.1073/pnas.95.7.3597; YOSHIDA H, 1990, NATURE, V345, P442, DOI 10.1038/345442a0; Zhang C, 1997, J IMMUNOL, V158, P4968	83	24	24	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 24	2008	283	43					29593	29601		10.1074/jbc.M802493200	http://dx.doi.org/10.1074/jbc.M802493200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	362EB	18728019	Green Published, hybrid			2022-12-27	WOS:000260179900085
J	Li, WL; Ju, JH; Rajski, SR; Osada, H; Shen, B				Li, Wenli; Ju, Jianhua; Rajski, Scott R.; Osada, Hiroyuki; Shen, Ben			Characterization of the tautomycin biosynthetic gene cluster from Streptomyces spiroverticillatus unveiling new insights into dialkylmaleic anhydride and polyketide biosynthesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN PHOSPHATASE-1; OKADAIC ACID; SACCHAROPOLYSPORA-ERYTHRAEA; ENZYMATIC DOMAINS; CRYSTAL-STRUCTURE; CALYCULIN-A; IN-VITRO; INHIBITOR; ORGANIZATION; SYNTHASE	Tautomycin (TTM) is a highly potent and specific protein phosphatase inhibitor isolated from Streptomyces spiroverticillatus. The biological activity of TTM makes it an important lead for drug discovery, whereas its spiroketal-containing polyketide chain and rare dialkylmaleic anhydride moiety draw attention to novel biosynthetic chemistries responsible for its production. To elucidate the biosynthetic machinery associated with these novel molecular features, the ttm biosynthetic gene cluster from S. spiroverticillatus was isolated and characterized, and its involvement in TTM biosynthesis was confirmed by gene inactivation and complementation experiments. The ttm cluster was localized to a 86-kb DNA region, consisting of 20 open reading frames that encode three modular type I polyketide synthases (TtmHIJ), one type II thioesterase (TtmT), five proteins for methoxymalonyl-S-acyl carrier protein biosynthesis (Ttm-ABCDE), eight proteins for dialkylmaleic anhydride biosynthesis and regulation (TtmKLMNOPRS), as well as two additional regulatory proteins (TtmF and TtmQ) and one tailoring enzyme (TtmG). A model for TTM biosynthesis is proposed based on functional assignments from sequence analysis, which agrees well with previous feeding experiments, and has been further supported by in vivo gene inactivation experiments. These findings set the stage to fully investigate TTM biosynthesis and to biosynthetically engineer new TTM analogs.	[Li, Wenli; Ju, Jianhua; Rajski, Scott R.; Shen, Ben] Univ Wisconsin, Sch Pharm, Div Pharmaceut Sci, Madison, WI 53705 USA; [Shen, Ben] Univ Wisconsin, Natl Cooperat Drug Discovery Grp, Madison, WI 53705 USA; [Shen, Ben] Univ Wisconsin, Dept Chem, Madison, WI 53705 USA; [Osada, Hiroyuki] RIKEN, Discovery Res Inst, Antibiot Lab, Wako, Saitama 3510198, Japan	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; RIKEN	Shen, B (corresponding author), Univ Wisconsin, Sch Pharm, Div Pharmaceut Sci, 777 Highland Ave, Madison, WI 53705 USA.	bshen@pharmacy.wisc.edu	Osada, Hiroyuki/N-4305-2014; Osada, Hiroyuki/AAY-6254-2020		National Institutes of Health [CA113297]; NATIONAL CANCER INSTITUTE [U19CA113297] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA113297. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Aparicio JF, 1996, GENE, V169, P9, DOI 10.1016/0378-1119(95)00800-4; BEVITT DJ, 1992, EUR J BIOCHEM, V204, P39, DOI 10.1111/j.1432-1033.1992.tb16603.x; BIALOJAN C, 1988, BIOCHEM J, V256, P283, DOI 10.1042/bj2560283; CHENG XC, 1990, J ANTIBIOT, V43, P809, DOI 10.7164/antibiotics.43.809; CHENG XC, 1987, J ANTIBIOT, V40, P907, DOI 10.7164/antibiotics.40.907; CHENG XC, 1990, J ANTIBIOT, V43, P890, DOI 10.7164/antibiotics.43.890; CHENG XC, 1989, J ANTIBIOT, V42, P141; Colby DA, 2003, BIOORG MED CHEM LETT, V13, P1601, DOI 10.1016/S0960-894X(03)00106-9; Dai JP, 1996, TETRAHEDRON LETT, V37, P491, DOI 10.1016/0040-4039(95)02188-4; DONADIO S, 1992, GENE, V111, P51, DOI 10.1016/0378-1119(92)90602-L; Dorrestein PC, 2006, J AM CHEM SOC, V128, P10386, DOI 10.1021/ja0639362; Frank B, 2007, CHEM BIOL, V14, P221, DOI 10.1016/j.chembiol.2006.11.013; Giddens SR, 2002, MOL MICROBIOL, V45, P769, DOI 10.1046/j.1365-2958.2002.03048.x; Goulding CW, 2007, J MOL BIOL, V365, P275, DOI 10.1016/j.jmb.2006.09.086; Gust B, 2003, P NATL ACAD SCI USA, V100, P1541, DOI 10.1073/pnas.0337542100; Han DJ, 2003, TRANSPL P, V35, P547, DOI 10.1016/S0041-1345(02)03905-2; Honkanen RE, 2002, CURR MED CHEM, V9, P2055, DOI 10.2174/0929867023368836; Horswill AR, 2001, BIOCHEMISTRY-US, V40, P4703, DOI 10.1021/bi015503b; Ikeda H, 1999, P NATL ACAD SCI USA, V96, P9509, DOI 10.1073/pnas.96.17.9509; ISHIHARA H, 1989, BIOCHEM BIOPH RES CO, V159, P871, DOI 10.1016/0006-291X(89)92189-X; Kieser T., 2000, PRACTICAL STREPTOMYC, V4362; Kim BS, 2002, J BIOL CHEM, V277, P48028, DOI 10.1074/jbc.M207770200; Kita A, 2002, STRUCTURE, V10, P715, DOI 10.1016/S0969-2126(02)00764-5; LESKIW BK, 1991, MOL MICROBIOL, V5, P2861, DOI 10.1111/j.1365-2958.1991.tb01845.x; Li WL, 2006, J BACTERIOL, V188, P4148, DOI 10.1128/JB.00172-06; LI YM, 1992, P NATL ACAD SCI USA, V89, P11867, DOI 10.1073/pnas.89.24.11867; Liu W, 2000, ANTIMICROB AGENTS CH, V44, P382, DOI 10.1128/AAC.44.2.382-392.2000; Lomovskaya N, 1998, J BACTERIOL, V180, P2379, DOI 10.1128/JB.180.9.2379-2386.1998; MACKINTOSH C, 1990, FEBS LETT, V277, P137, DOI 10.1016/0014-5793(90)80828-7; Mitsuhashi S, 2003, J BIOL CHEM, V278, P82, DOI 10.1074/jbc.M208888200; Mitsuhashi S, 2001, BIOCHEM BIOPH RES CO, V287, P328, DOI 10.1006/bbrc.2001.5596; Montero-Moran GM, 2007, BIOCHEMISTRY-US, V46, P5293, DOI 10.1021/bi700065h; NAGAE J, 1988, J ANTIBIOT, V41, P932; Oikawa H, 2002, CURR MED CHEM, V9, P2033, DOI 10.2174/0929867023368818; OIKAWA H, 1994, TETRAHEDRON LETT, V35, P4809, DOI 10.1016/S0040-4039(00)76974-7; OIKAWA M, 1995, J ORG CHEM, V60, P5048, DOI 10.1021/jo00121a026; PABO CO, 1992, ANNU REV BIOCHEM, V61, P1053, DOI 10.1146/annurev.bi.61.070192.005201; Paget MSB, 1999, J BACTERIOL, V181, P204, DOI 10.1128/JB.181.1.204-211.1999; Price AC, 2004, STRUCTURE, V12, P417, DOI 10.1016/j.str.2004.02.008; Quigley PM, 2004, PROTEIN SCI, V13, P269, DOI 10.1110/ps.03399604; RETZLAFF L, 1995, MOL MICROBIOL, V18, P151, DOI 10.1111/j.1365-2958.1995.mmi_18010151.x; Sakoff JA, 2004, CURR PHARM DESIGN, V10, P1139, DOI 10.2174/1381612043452686; Schleheck D, 2007, APPL ENVIRON MICROB, V73, P4725, DOI 10.1128/AEM.00632-07; Serre L, 2001, J MOL BIOL, V310, P617, DOI 10.1006/jmbi.2001.4784; Shen B, 1996, P NATL ACAD SCI USA, V93, P6600, DOI 10.1073/pnas.93.13.6600; Sheppeck JE, 1997, J ORG CHEM, V62, P387, DOI 10.1021/jo961633s; Shim JH, 2002, P NATL ACAD SCI USA, V99, P10617, DOI 10.1073/pnas.162522099; SITNIKOV DM, 1995, MOL MICROBIOL, V17, P801, DOI 10.1111/j.1365-2958.1995.mmi_17050801.x; Spiller B, 1999, P NATL ACAD SCI USA, V96, P12305, DOI 10.1073/pnas.96.22.12305; Staunton J, 2001, NAT PROD REP, V18, P380, DOI 10.1039/a909079g; Stenmark P, 2004, BIOCHEMISTRY-US, V43, P13996, DOI 10.1021/bi048481c; Tao MF, 2007, MOL BIOSYST, V3, P60, DOI 10.1039/b615284h; UBUKATA M, 1995, J CHEM SOC P1, V19, P2399; UBUKATA M, 1990, CHEM COMMUN, V3, P244; UBUKATA M, 1993, J CHEM SOC P1, V5, P617	55	39	46	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 17	2008	283	42					28607	28617		10.1074/jbc.M804279200	http://dx.doi.org/10.1074/jbc.M804279200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	359EN	18708355	Green Published, hybrid			2022-12-27	WOS:000259969300063
J	Morla, L; Crambert, G; Mordasini, D; Favre, G; Doucet, A; Imbert-Teboul, M				Morla, Luciana; Crambert, Gilles; Mordasini, David; Favre, Guillaume; Doucet, Alain; Imbert-Teboul, Martine			Proteinase-activated receptor 2 stimulates Na,K-ATPase and sodium reabsorption in native kidney epithelium	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							THICK ASCENDING LIMB; PROTEINASE-ACTIVATED RECEPTOR-2; CORTICAL COLLECTING DUCT; ION-TRANSPORT; PARACELLULAR PERMEABILITY; SURFACE EXPRESSION; HORMONAL-CONTROL; K+-ATPASE; KINASE-C; CELL	Proteinase-activated receptors 2 (PAR2) are expressed in kidney, but their function is mostly unknown. Since PAR2 control ion transport in several epithelia, we searched for an effect on sodium transport in the cortical thick ascending limb of Henle's loop, a nephron segment that avidly reabsorbs NaCl, and for its signaling. Activation of PAR2, by either trypsin or a specific agonist peptide, increased the maximal activity of Na, K-ATPase, its apparent affinity for sodium, the sodium permeability of the paracellular pathway, and the lumen-positive transepithelial voltage, featuring increased NaCl reabsorption. PAR2 activation induced calcium signaling and phosphorylation of ERK1,2. PAR2-induced stimulation of Na,K-ATPase V-max was fully prevented by inhibition of phospholipase C, of changes in intracellular concentration of calcium, of classical protein kinases C, and of ERK1,2 phosphorylation. PAR2-induced increase in paracellular sodium permeability was mediated by the same signaling cascade. In contrast, increase in the apparent affinity of Na,K-ATPase for sodium, although dependent on phospholipase C, was independent of calcium signaling, was insensitive to inhibitors of classical protein kinases C and of ERK1,2 phosphorylation, but was fully prevented by the nonspecific protein kinase inhibitor staurosporine, as was the increase in transepithelial voltage. In conclusion, PAR2 increases sodium reabsorption in rat thick ascending limb of Henle's loop along both the transcellular and the paracellular pathway. PAR2 effects are mediated in part by a phospholipase C/protein kinase C/ERK1,2 cascade, which increases Na,K-ATPase maximal activity and the paracellular sodium permeability, and by a different phospholipase C-dependent, staurosporine-sensitive cascade that controls the sodium affinity of Na, K-ATPase.	[Morla, Luciana; Crambert, Gilles; Mordasini, David; Favre, Guillaume; Doucet, Alain; Imbert-Teboul, Martine] Univ Paris 06, UMR 7134, F-75005 Paris, France; [Morla, Luciana; Crambert, Gilles; Mordasini, David; Favre, Guillaume; Doucet, Alain; Imbert-Teboul, Martine] CNRS, Inst Cordeliers, UMR 7134, Lab Physiol & Genom Renales, F-75006 Paris, France	UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite	Doucet, A (corresponding author), 15 Rue Ecole Med, F-75270 Paris 6, France.	alain.doucet@bhdc.jussieu.fr	Crambert, Gilles/ABF-2753-2020	Crambert, Gilles/0000-0001-7065-9124; Morla, Luciana/0000-0002-1527-4392	Amgen [2005/29-N]	Amgen(Amgen)	This work was supported by a grant from Amgen (2005/29-N). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Aristimuno PC, 1997, AM J PHYSIOL-RENAL, V272, pF624, DOI 10.1152/ajprenal.1997.272.5.F624; BARLETBAS C, 1990, J BIOL CHEM, V265, P7799; Bertog M, 1999, J PHYSIOL-LONDON, V521, P3, DOI 10.1111/j.1469-7793.1999.00003.x; Bohm SK, 1996, BIOCHEM J, V314, P1009; Cenac N, 2004, J PHYSIOL-LONDON, V558, P913, DOI 10.1113/jphysiol.2004.061721; CHAMPIGNEULLE A, 1993, AM J PHYSIOL, V265, pF35, DOI 10.1152/ajprenal.1993.265.1.F35; Cuffe JE, 2002, J PHYSIOL-LONDON, V539, P209, DOI 10.1113/jphysiol.2001.013159; Cunningham MA, 2000, J EXP MED, V191, P455, DOI 10.1084/jem.191.3.455; Danahay H, 2001, AM J PHYSIOL-CELL PH, V280, pC1455, DOI 10.1152/ajpcell.2001.280.6.C1455; Dechenes G, 2000, J AM SOC NEPHROL, V11, P604, DOI 10.1681/ASN.V114604; FERAILLE E, 1995, AM J PHYSIOL-CELL PH, V268, pC1277, DOI 10.1152/ajpcell.1995.268.5.C1277; Feraille E, 2001, PHYSIOL REV, V81, P345, DOI 10.1152/physrev.2001.81.1.345; Ferreira NCD, 1997, J PHYSIOL-LONDON, V505, P749, DOI 10.1111/j.1469-7793.1997.749ba.x; Fyfe M, 2005, CYTOKINE, V31, P358, DOI 10.1016/j.cyto.2005.06.004; Grandaliano G, 2003, J AM SOC NEPHROL, V14, P2072, DOI 10.1097/01.ASN.0000080315.37254.A1; GREGER R, 1985, PHYSIOL REV, V65, P760, DOI 10.1152/physrev.1985.65.3.760; Gui Y, 2003, AM J PHYSIOL-RENAL, V285, pF95, DOI 10.1152/ajprenal.00396.2002; Jacob C, 2005, J BIOL CHEM, V280, P31936, DOI 10.1074/jbc.M506338200; Juncos R, 2005, AM J PHYSIOL-RENAL, V288, pF982, DOI 10.1152/ajprenal.00348.2004; Kawao N, 2005, J PHARMACOL EXP THER, V315, P576, DOI 10.1124/jpet.105.089490; Kunzelmann K, 2005, FASEB J, V19, P969, DOI 10.1096/fj.04-2469fje; Kunzelmann K, 2002, CELL BIOCHEM BIOPHYS, V36, P209, DOI 10.1385/CBB:36:2-3:209; MARCHETTI J, 1984, PFLUG ARCH EUR J PHY, V401, P27, DOI 10.1007/BF00581529; Michlig S, 2004, J BIOL CHEM, V279, P51002, DOI 10.1074/jbc.M405674200; MOREL F, 1986, PHYSIOL REV, V66, P377, DOI 10.1152/physrev.1986.66.2.377; Nguyen TD, 1999, J CLIN INVEST, V103, P261, DOI 10.1172/JCI2539; Nishibori M, 2005, J PHARMACOL SCI, V97, P25, DOI 10.1254/jphs.FMJ04005X5; Ohtomo Y, 1996, DIABETOLOGIA, V39, P199, DOI 10.1007/BF00403963; Oikonomopoulou K, 2006, BIOL CHEM, V387, P817, DOI 10.1515/BC.2006.104; Ortiz PA, 2006, AM J PHYSIOL-RENAL, V290, pF608, DOI 10.1152/ajprenal.00248.2005; Ossovskaya VS, 2004, PHYSIOL REV, V84, P579, DOI 10.1152/physrev.00028.2003; Rondeau E, 2001, NEPHROL DIAL TRANSPL, V16, P1529, DOI 10.1093/ndt/16.8.1529; Silva GB, 2006, HYPERTENSION, V48, P467, DOI 10.1161/01.HYP.0000236646.83354.51; Tsimaratos M, 2003, DIABETOLOGIA, V46, P124, DOI 10.1007/s00125-002-0996-1; Vinciguerra M, 2003, MOL BIOL CELL, V14, P2677, DOI 10.1091/mbc.E02-11-0720; Wang Y, 2004, EXP EYE RES, V78, P125, DOI 10.1016/j.exer.2003.09.002; XU YC, 1995, AM J PATHOL, V146, P101	37	12	14	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 17	2008	283	42					28020	28028		10.1074/jbc.M804399200	http://dx.doi.org/10.1074/jbc.M804399200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	359EN	18678869	Green Published, hybrid			2022-12-27	WOS:000259969300003
J	Song, HW; Kong, W; Weatherspoon, N; Qin, GZ; Tyler, W; Turk, J; Curtiss, R; Shi, YX				Song, Haowei; Kong, Wei; Weatherspoon, Natasha; Qin, Guozheng; Tyler, William; Turk, John; Curtiss, Roy, III; Shi, Yixin			Modulation of the regulatory activity of bacterial two-component systems by SlyA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI K-12; SALMONELLA-TYPHIMURIUM; ANTIMICROBIAL PEPTIDES; SENSOR KINASE; PHOP; RESISTANCE; IDENTIFICATION; GENES; EXPRESSION; PHOP/PHOQ	Activation of the transcriptional regulator SlyA by the PhoP/PhoQ two-component system controls intracellular expression of numerous factors influencing Salmonella virulence. By dissecting the SlyA regulon using stable isotope labeling with amino acids in cell culture analysis, we found that SlyA enhances overall transcription of PhoP-activated loci. This amplification of cellular responses to Mg2+ occurs when SlyA binds to the phoPQ promoter thereby activating phoP autoregulation via a positive feedback mechanism. SlyA footprints a DNA region located one helical turn upstream of the PhoP box, which overlaps the H-NS-binding motif required for signal-dependent phoP repression in high Mg2+ conditions. Therefore, binding of SlyA likely antagonizes H-NS and facilitates the interaction of PhoP to its own promoter, subsequently activating the phoPQ operon. Establishment of this regulatory circuit allows SlyA to exert its effect on the PhoP/PhoQ system specifically in Salmonella, which may confer an additional transcriptional regulation. Thus, our results provide a molecular mechanism that determines SlyA-dependent activation of PhoP-regulated genes in modulating Salmonella virulence. Evidence from this study also suggests a function of SlyA as a mediator in signal transduction from the PhoP/PhoQ system to other bacterial two-component systems in Salmonella.	[Weatherspoon, Natasha; Qin, Guozheng; Tyler, William; Curtiss, Roy, III; Shi, Yixin] Arizona State Univ, Sch Life Sci, Tempe, AZ 85287 USA; [Kong, Wei; Curtiss, Roy, III; Shi, Yixin] Arizona State Univ, Biodesign Inst, Ctr Infect Dis & Vaccinol, Tempe, AZ 85287 USA; [Song, Haowei; Turk, John] Washington Univ, Sch Med, Dept Internal Med, Mass Spectrometry Resource,Div Endocrinol Diabet, St Louis, MO 63110 USA	Arizona State University; Arizona State University-Tempe; Arizona State University; Arizona State University-Tempe; Washington University (WUSTL)	Shi, YX (corresponding author), Arizona State Univ, Sch Life Sci, POB 874501, Tempe, AZ 85287 USA.	yixin.shi@asu.edu	SHI, YIXIN/M-5751-2019; Qin, Guozheng/E-6871-2011; Tyler, William/J-1818-2012	Tyler, William/0000-0002-7758-5022	Arizona State University	Arizona State University	This work was supported by start-up funds from Arizona State University (to Y. S.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Bader MW, 2005, CELL, V122, P461, DOI 10.1016/j.cell.2005.05.030; Buchmeier N, 1997, INFECT IMMUN, V65, P3725, DOI 10.1128/IAI.65.9.3725-3730.1997; CASADABAN MJ, 1976, J MOL BIOL, V104, P541, DOI 10.1016/0022-2836(76)90119-4; CHEREPANOV PP, 1995, GENE, V158, P9, DOI 10.1016/0378-1119(95)00193-A; DANESE PN, 1995, GENE DEV, V9, P387, DOI 10.1101/gad.9.4.387; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Davis R., 1980, ADV BACTERIAL GENETI; Detweiler CS, 2003, MOL MICROBIOL, V48, P385, DOI 10.1046/j.1365-2958.2003.03455.x; Eguchi Y, 2004, J BACTERIOL, V186, P3006, DOI 10.1128/JB.186.10.3006-3014.2004; Ellermeier CD, 2002, GENE, V290, P153, DOI 10.1016/S0378-1119(02)00551-6; Gunn JS, 1996, J BACTERIOL, V178, P6369, DOI 10.1128/jb.178.21.6369-6373.1996; HANAHAN D, 1983, J MOL BIOL, V166, P557, DOI 10.1016/S0022-2836(83)80284-8; HOCH JA, 1995, 2 COMPONENT SIGNAL T, P105; Kato A, 1999, J BACTERIOL, V181, P5516, DOI 10.1128/JB.181.17.5516-5520.1999; Kato A, 2003, P NATL ACAD SCI USA, V100, P4706, DOI 10.1073/pnas.0836837100; KIER LD, 1979, J BACTERIOL, V138, P155, DOI 10.1128/JB.138.1.155-161.1979; Kong W, 2008, J BIOL CHEM, V283, P16612, DOI 10.1074/jbc.M800547200; Kox LFF, 2000, EMBO J, V19, P1861, DOI 10.1093/emboj/19.8.1861; KUO MS, 1986, CARBOHYD RES, V156, P173, DOI 10.1016/S0008-6215(00)90109-5; LIBBY SJ, 1994, P NATL ACAD SCI USA, V91, P489, DOI 10.1073/pnas.91.2.489; Navarre WW, 2005, MOL MICROBIOL, V56, P492, DOI 10.1111/j.1365-2958.2005.04553.x; NEIDHARDT FC, 1996, ESCHERICHIA COLI SAL, P408; Norte VA, 2003, J BACTERIOL, V185, P3508, DOI 10.1128/JB.185.12.3508-3514.2003; Ong SE, 2002, MOL CELL PROTEOMICS, V1, P376, DOI 10.1074/mcp.M200025-MCP200; Prost LR, 2007, MOL CELL, V26, P165, DOI 10.1016/j.molcel.2007.03.008; RUSSO FD, 1991, J MOL BIOL, V222, P567, DOI 10.1016/0022-2836(91)90497-T; Shi YX, 2004, J BIOL CHEM, V279, P38618, DOI 10.1074/jbc.M406149200; Shi YX, 2004, MOL MICROBIOL, V53, P229, DOI 10.1111/j.1365-2958.2004.04107.x; Shin D, 2005, J BIOL CHEM, V280, P4089, DOI 10.1074/jbc.M412741200; SHUMAN S, 1989, P NATL ACAD SCI USA, V86, P3489, DOI 10.1073/pnas.86.10.3489; SNAVELY MD, 1991, J BIOL CHEM, V266, P815; Soncini FC, 1996, J BACTERIOL, V178, P5092, DOI 10.1128/jb.178.17.5092-5099.1996; SONCINI FC, 1995, J BACTERIOL, V177, P4364, DOI 10.1128/jb.177.15.4364-4371.1995; Song HW, 2004, J AM SOC MASS SPECTR, V15, P1780, DOI 10.1016/j.jasms.2004.08.012; Stapleton MR, 2002, J BIOL CHEM, V277, P17630, DOI 10.1074/jbc.M110178200; STEIN MA, 1994, BIOESSAYS, V16, P537, DOI 10.1002/bies.950160805; TAYLOR RK, 1981, J BACTERIOL, V147, P255, DOI 10.1128/JB.147.1.255-258.1981; Tu X, 2006, P NATL ACAD SCI USA, V103, P13503, DOI 10.1073/pnas.0606026103; Vescovi EG, 1996, CELL, V84, P165, DOI 10.1016/S0092-8674(00)81003-X; Zhou DG, 2001, MICROBES INFECT, V3, P1293, DOI 10.1016/S1286-4579(01)01489-7	40	25	26	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 17	2008	283	42					28158	28168		10.1074/jbc.M801058200	http://dx.doi.org/10.1074/jbc.M801058200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	359EN	18678876	Green Published, hybrid			2022-12-27	WOS:000259969300018
J	Diaz-Ruiz, R; Averet, N; Araiza, D; Pinson, B; Uribe-Carvajal, S; Devin, A; Rigoulet, M				Diaz-Ruiz, Rodrigo; Averet, Nicole; Araiza, Daniela; Pinson, Benoit; Uribe-Carvajal, Salvador; Devin, Anne; Rigoulet, Michel			Mitochondrial oxidative phosphorylation is regulated by fructose 1,6-bisphosphate - A possible role in Crabtree effect induction?	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEAR-MAGNETIC-RESONANCE; EHRLICH ASCITES TUMOR; SACCHAROMYCES-CEREVISIAE; HEXOKINASE-II; OUTER-MEMBRANE; WILD-TYPE; GLUCOSE; GLYCOLYSIS; GROWTH; GENE	In numerous cell types, tumoral cells, proliferating cells, bacteria, and yeast, respiration is inhibited when high concentrations of glucose are added to the culture medium. This phenomenon has been named the "Crabtree effect." We used yeast to investigate (i) the short term event(s) associated with the Crabtree effect and (ii) a putative role of hexose phosphates in the inhibition of respiration. Indeed, yeast divide into "Crabtree-positive," where the Crabtree effect occurs, and "Crabtree-negative," where it does not. In mitochondria isolated from these two categories of yeast, we found that low, physiological concentrations of glucose 6-phosphate and fructose 6-phosphate slightly (20%) stimulated the respiratory flux and that this effect was strongly antagonized by fructose 1,6-bisphosphate (F16bP). On the other hand, F16bP by itself was able to inhibit mitochondrial respiration only in mitochondria isolated from a Crabtree-positive strain. Using permeabilized spheroplasts from Crabtree-positive yeast, we have shown that the sole effect observed at physiological concentrations of hexose phosphates is an inhibition of oxidative phosphorylation by F16bP. This F16bP-mediated inhibition was also observed in isolated rat liver mitochondria, extending this process to mammalian cells. From these results and taking into account that F16bP is able to accumulate in the cell cytoplasm, we propose that F16bP regulates oxidative phosphorylation and thus participates in the establishment of the Crabtree effect.	[Diaz-Ruiz, Rodrigo; Averet, Nicole; Pinson, Benoit; Devin, Anne; Rigoulet, Michel] Univ Bordeaux 2, F-33077 Bordeaux, France; [Diaz-Ruiz, Rodrigo; Averet, Nicole; Araiza, Daniela; Pinson, Benoit; Devin, Anne; Rigoulet, Michel] CNRS, Inst Biochim & Genet Cellulaires, UMR 5095, F-33077 Bordeaux, France; [Diaz-Ruiz, Rodrigo; Uribe-Carvajal, Salvador] Univ Nacl Autonoma Mexico, Dept Bioquim, Inst Fisiol Celular, Mexico City 04510, DF, Mexico	UDICE-French Research Universities; Universite de Bordeaux; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux; Universidad Nacional Autonoma de Mexico	Rigoulet, M (corresponding author), Univ Bordeaux 2, 1 Rue Camille St Saens, F-33077 Bordeaux, France.		Diaz, Rodrigo/A-9073-2011	Diaz, Rodrigo/0000-0001-5683-8345; Pinson, Benoit/0000-0003-2936-9058; Uribe-Carvajal, Salvador/0000-0002-7028-8121	ECOS-Nord/Consejo Nacional de Ciencia y Tecnologia (CONACYT) [MOS04]	ECOS-Nord/Consejo Nacional de Ciencia y Tecnologia (CONACYT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	This work was supported in part by the France-Mexico collaboration program ECOS-Nord/Consejo Nacional de Ciencia y Tecnologia (CONACYT) MOS04. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Averet N, 1998, MOL CELL BIOCHEM, V184, P67, DOI 10.1023/A:1006830810440; Averet N, 2002, J BIOENERG BIOMEMBR, V34, P499, DOI 10.1023/A:1022526411188; BEAUVOIT B, 1993, EUR J BIOCHEM, V214, P163, DOI 10.1111/j.1432-1033.1993.tb17909.x; BLAZQUEZ MA, 1993, FEBS LETT, V329, P51, DOI 10.1016/0014-5793(93)80191-V; Boubekeur S, 1999, J BIOL CHEM, V274, P21044, DOI 10.1074/jbc.274.30.21044; CHAPMAN C, 1969, BIOCHEM J, V111, P609, DOI 10.1042/bj1110609; Chevtzoff C, 2005, BBA-BIOENERGETICS, V1706, P117, DOI 10.1016/j.bbabio.2004.10.001; Colombo S, 2004, J BIOL CHEM, V279, P46715, DOI 10.1074/jbc.M405136200; Crabtree HG, 1928, BIOCHEM J, V22, P1289, DOI 10.1042/bj0221289; DAVIES SEC, 1992, BIOCHEMISTRY-US, V31, P4729, DOI 10.1021/bi00134a028; Dejean L, 2002, BBA-BIOENERGETICS, V1554, P159, DOI 10.1016/S0005-2728(02)00240-2; DENHOLLANDER JA, 1981, BIOCHEMISTRY-US, V20, P5871, DOI 10.1021/bi00523a034; Diderich JA, 2002, FEMS YEAST RES, V2, P165, DOI 10.1111/j.1567-1364.2002.tb00081.x; Diderich JA, 2001, APPL ENVIRON MICROB, V67, P1587, DOI 10.1128/AEM.67.4.1587-1593.2001; EMAUS RK, 1986, BIOCHIM BIOPHYS ACTA, V850, P436, DOI 10.1016/0005-2728(86)90112-X; Ernandes JR, 1998, YEAST, V14, P255, DOI 10.1002/(SICI)1097-0061(199802)14:3<255::AID-YEA228>3.0.CO;2-N; EVTODIENKO YV, 1994, CELL CALCIUM, V15, P439, DOI 10.1016/0143-4160(94)90108-2; FONTAINE EM, 1995, BIOCHEM BIOPH RES CO, V213, P138, DOI 10.1006/bbrc.1995.2108; Gancedo JM, 1998, MICROBIOL MOL BIOL R, V62, P334, DOI 10.1128/MMBR.62.2.334-361.1998; GATT S, 1959, J BIOL CHEM, V234, P1015; GONZALEZ MI, 1992, YEAST, V8, P183, DOI 10.1002/yea.320080304; GREINER EF, 1994, J BIOL CHEM, V269, P31484; Guerin B, 1979, Methods Enzymol, V55, P149; HESS B, 1961, J BIOL CHEM, V236, P239; HOHMANN S, 1993, CURR GENET, V23, P281, DOI 10.1007/BF00310888; LEE AC, 1994, J BIOL CHEM, V269, P30974; Loret MO, 2007, YEAST, V24, P47, DOI 10.1002/yea.1435; Marin-Hernandez A, 2006, FEBS J, V273, P1975, DOI 10.1111/j.1742-4658.2006.05214.x; MAZAT JP, 1986, BIOCHIM BIOPHYS ACTA, V849, P7, DOI 10.1016/0005-2728(86)90090-3; Moreno-Sanchez R, 2007, FEBS J, V274, P1393, DOI 10.1111/j.1742-4658.2007.05686.x; MULLER S, 1995, J BACTERIOL, V177, P4517; MUSTEA I, 1967, CANCER-AM CANCER SOC, V20, P1499, DOI 10.1002/1097-0142(196709)20:9<1499::AID-CNCR2820200917>3.0.CO;2-Q; NAVON G, 1979, BIOCHEMISTRY-US, V18, P4487, DOI 10.1021/bi00588a006; Noubhani A, 2000, EUR J BIOCHEM, V267, P4566, DOI 10.1046/j.1432-1327.2000.01511.x; OHNISHI T, 1966, J BIOL CHEM, V241, P1797; Pastorino JG, 2002, J BIOL CHEM, V277, P7610, DOI 10.1074/jbc.M109950200; RIGOULET M, 1987, EUR J BIOCHEM, V168, P275, DOI 10.1111/j.1432-1033.1987.tb13417.x; Rodriguez-Enriquez S, 2001, EUR J BIOCHEM, V268, P2512, DOI 10.1046/j.1432-1327.2001.02140.x; Rodriguez-Enriquez S, 2000, ARCH BIOCHEM BIOPHYS, V375, P21, DOI 10.1006/abbi.1999.1582; Rolland F, 2001, FEMS YEAST RES, V1, P33, DOI 10.1111/j.1567-1364.2001.tb00011.x; SAAVEDRAMOLINA A, 1990, BIOCHEM BIOPH RES CO, V167, P148, DOI 10.1016/0006-291X(90)91743-C; SAKS V, 1995, BIOCHEM BIOPH RES CO, V208, P919, DOI 10.1006/bbrc.1995.1422; Sanchez NS, 2006, YEAST, V23, P361, DOI 10.1002/yea.1360; THEVELEIN JM, 1994, YEAST, V10, P1753, DOI 10.1002/yea.320101308; THEVELEIN JM, 1995, TRENDS BIOCHEM SCI, V20, P3, DOI 10.1016/S0968-0004(00)88938-0; Tisi R, 2002, FEBS LETT, V520, P133, DOI 10.1016/S0014-5793(02)02806-5; VANAELST L, 1991, EMBO J, V10, P2095, DOI 10.1002/j.1460-2075.1991.tb07742.x; VANDIJKEN JP, 1993, ANTON LEEUW INT J G, V63, P343, DOI 10.1007/BF00871229; VANURK H, 1990, APPL ENVIRON MICROB, V56, P281, DOI 10.1128/AEM.56.1.281-287.1990; Wojtczak L, 1999, EUR J BIOCHEM, V263, P495, DOI 10.1046/j.1432-1327.1999.00522.x; ZIZI M, 1994, J BIOL CHEM, V269, P1614	51	106	109	0	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 3	2008	283	40					26948	26955		10.1074/jbc.M800408200	http://dx.doi.org/10.1074/jbc.M800408200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	353RT	18682403	hybrid			2022-12-27	WOS:000259586600015
J	Eaton, SA; Funnell, APW; Sue, N; Nicholas, H; Pearson, RCM; Crossley, M				Eaton, Sally A.; Funnell, Alister P. W.; Sue, Nancy; Nicholas, Hannah; Pearson, Richard C. M.; Crossley, Merlin			A network of Kruppel-like factors (klfs) - Klf8 is repressed by Klf3 and activated by Klf1 in vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EMBRYONIC STEM-CELLS; BOX-BINDING-PROTEIN; EKLF-NULL MICE; TRANSCRIPTION FACTOR; PRIMITIVE ERYTHROPOIESIS; BETA-THALASSEMIA; ERYTHROID-CELLS; GLOBIN GENE; ADIPOGENESIS; INACTIVATION	Transcription factors of the Sp/Klf (Kruppel-like factor) family regulate biological processes such as hematopoiesis, adipogenesis, and stem cell maintenance. Here we show that Bklf or Klf3 ( Basic Kruppel-like factor) represses the Klf8 (Kruppel-like Factor 8) gene in vivo. Conversely, Eklf or Klf1 (Erythroid Kruppel-like factor) activates the Klf8 gene. Klf8 is driven by two promoters, both of which contain multiple CACCC sites. Klf3 can repress Klf1-mediated activation of both promoters. Chromatin immunoprecipitation experiments confirm that Klf3 occupies both Klf8 promoters in vivo. Interestingly, in Klf3 knock-out tissue Klf1 gains access, binds, and activates both Klf8 promoters. These results demonstrate direct competition between activating and repressing Klfs in vivo. Together with previous evidence that Klf1 directly activates the Klf3 gene, the results reveal an elaborate network of cross-talk within the Klf family. The recognition of cross-regulation and potential redundancy between Klf family members is critical to the interpretation of various Klf knock-out mice and the understanding of individual Klfs in particular contexts.	[Eaton, Sally A.; Funnell, Alister P. W.; Sue, Nancy; Nicholas, Hannah; Pearson, Richard C. M.; Crossley, Merlin] Univ Sydney, Sch Mol & Microbial Biosci, Sydney, NSW 2006, Australia	University of Sydney	Crossley, M (corresponding author), Univ Sydney, Sch Mol & Microbial Biosci, G08, Sydney, NSW 2006, Australia.	m.crossley@mmb.usyd.edu.au	Pearson, Richard/J-4411-2012; Crossley, Merlin/D-7888-2011	Pearson, Richard/0000-0002-7918-9111; Crossley, Merlin/0000-0003-2057-3642; Nicholas, Hannah/0000-0002-2239-9249; Eaton, Sally/0000-0003-2036-1607; Funnell, Alister/0000-0002-1062-5296	National Institutes of Health [HL073443]; Australian Research Council; National Health and Medical Research Council; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL073443] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Australian Research Council(Australian Research Council); National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant HL073443. This work was also supported by grants from the Australian Research Council and National Health and Medical Research Council ( to M. C.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Banerjee SS, 2003, J BIOL CHEM, V278, P2581, DOI 10.1074/jbc.M210859200; Basu P, 2005, BLOOD, V106, P2566, DOI 10.1182/blood-2005-02-0674; Birsoy K, 2008, CELL METAB, V7, P339, DOI 10.1016/j.cmet.2008.02.001; Bouwman P, 2002, MOL CELL ENDOCRINOL, V195, P27, DOI 10.1016/S0303-7207(02)00221-6; BRAUN T, 1992, CELL, V71, P369, DOI 10.1016/0092-8674(92)90507-9; Coghill E, 2001, BLOOD, V97, P1861, DOI 10.1182/blood.V97.6.1861; COUREY AJ, 1988, CELL, V55, P887, DOI 10.1016/0092-8674(88)90144-4; Crossley M, 1996, MOL CELL BIOL, V16, P1695; Dang DT, 2000, INT J BIOCHEM CELL B, V32, P1103, DOI 10.1016/S1357-2725(00)00059-5; Drissen R, 2005, MOL CELL BIOL, V25, P5205, DOI 10.1128/MCB.25.12.5205-5214.2005; FENG WC, 1994, J BIOL CHEM, V269, P1493; Forsberg EC, 2000, BLOOD, V96, P334, DOI 10.1182/blood.V96.1.334.013k17_334_339; Funnell APW, 2007, MOL CELL BIOL, V27, P2777, DOI 10.1128/MCB.01658-06; Ghaleb AM, 2005, CELL RES, V15, P92, DOI 10.1038/sj.cr.7290271; Hildebrand JD, 2002, MOL CELL BIOL, V22, P5296, DOI 10.1128/MCB.22.15.5296-5307.2002; Hodge D, 2006, BLOOD, V107, P3359, DOI 10.1182/blood-2005-07-2888; Hu JH, 2007, J MOL BIOL, V366, P1064, DOI 10.1016/j.jmb.2006.12.047; Jiang JM, 2008, NAT CELL BIOL, V10, P353, DOI 10.1038/ncb1698; Kaczynski J, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-2-206; Kaczynski JA, 2002, BIOCHEM J, V366, P873, DOI 10.1042/BJ20020388; Kawamura Y, 2006, MOL ENDOCRINOL, V20, P844, DOI 10.1210/me.2005-0138; Keys JR, 2007, BRIT J HAEMATOL, V136, P150, DOI 10.1111/j.1365-2141.2006.06381.x; Kim JW, 2008, CELL, V132, P1049, DOI 10.1016/j.cell.2008.02.039; LITTLEWOOD TD, 1995, NUCLEIC ACIDS RES, V23, P1686, DOI 10.1093/nar/23.10.1686; Lomberk G, 2005, BIOCHEM J, V392, P1, DOI 10.1042/BJ20051234; Matsumoto N, 2006, BLOOD, V107, P1357, DOI 10.1182/blood-2005-05-1916; MILLER IJ, 1993, MOL CELL BIOL, V13, P2776, DOI 10.1128/MCB.13.5.2776; Mori T, 2005, J BIOL CHEM, V280, P12867, DOI 10.1074/jbc.M410515200; NUEZ B, 1995, NATURE, V375, P316, DOI 10.1038/375316a0; Oishi Y, 2005, CELL METAB, V1, P27, DOI 10.1016/j.cmet.2004.11.005; Patel S, 2006, P NATL ACAD SCI USA, V103, P18668, DOI 10.1073/pnas.0608658103; Pearson R, 2008, INT J BIOCHEM CELL B, V40, P1996, DOI 10.1016/j.biocel.2007.07.018; Perdomo J, 2005, MOL CELL BIOL, V25, P1549, DOI 10.1128/MCB.25.4.1549-1559.2005; PERKINS AC, 1995, NATURE, V375, P318; Rawls A, 1998, DEVELOPMENT, V125, P2349; RUDNICKI MA, 1992, CELL, V71, P383, DOI 10.1016/0092-8674(92)90508-A; RUDNICKI MA, 1993, CELL, V75, P1351, DOI 10.1016/0092-8674(93)90621-V; Sambrook J., 2001, MOL CLONING LAB MANU, Vthird edition; Schuierer M, 2001, J BIOL CHEM, V276, P27944, DOI 10.1074/jbc.M100070200; SMITH DB, 1988, GENE, V67, P31, DOI 10.1016/0378-1119(88)90005-4; SOGAWA K, 1993, J BIOCHEM, V114, P605, DOI 10.1093/oxfordjournals.jbchem.a124224; Sue N, 2008, MOL CELL BIOL, V28, P3967, DOI 10.1128/MCB.01942-07; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Turner J, 1998, EMBO J, V17, P5129, DOI 10.1093/emboj/17.17.5129; van Vliet J, 2000, NUCLEIC ACIDS RES, V28, P1955; Wang X, 2007, ONCOGENE, V26, P456, DOI 10.1038/sj.onc.1209796; Wang XH, 2007, CANCER RES, V67, P7184, DOI 10.1158/0008-5472.CAN-06-4729; Wani MA, 1998, TRANSGENIC RES, V7, P229, DOI 10.1023/A:1008809809843; Wei HJ, 2006, J BIOL CHEM, V281, P16664, DOI 10.1074/jbc.M513135200; Zeng PY, 2006, BIOTECHNIQUES, V41, P694, DOI 10.2144/000112297; Zhang P, 2005, BLOOD CELL MOL DIS, V35, P227, DOI 10.1016/j.bcmd.2005.04.009; Zhang WQ, 1998, J BIOL CHEM, V273, P17917, DOI 10.1074/jbc.273.28.17917; Zhao JH, 2003, MOL CELL, V11, P1503, DOI 10.1016/S1097-2765(03)00179-5	53	91	107	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 3	2008	283	40					26937	26947		10.1074/jbc.M804831200	http://dx.doi.org/10.1074/jbc.M804831200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	353RT	18687676	Green Published, hybrid			2022-12-27	WOS:000259586600014
J	Tzankov, S; Wong, MJH; Shi, K; Nassif, C; Young, JC				Tzankov, Stefan; Wong, Michael J. H.; Shi, Kun; Nassif, Christina; Young, Jason C.			Functional divergence between co-chaperones of Hsc70	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HSP70 NUCLEOTIDE EXCHANGE; MITOCHONDRIAL INNER-MEMBRANE; CRYSTAL-STRUCTURE; ATPASE ACTIVITY; MOLECULAR CHAPERONES; UBIQUITIN LIGASE; REACTION CYCLE; DNAJ HOMOLOG; YEAST HSP40; PROTEIN	The ATPase cycle of the chaperone Hsc70 is regulated by co-chaperones; Hsp40/DnaJ-related proteins stimulate ATP hydrolysis by Hsc70 and can bind unfolded polypeptides themselves. Conversely, various nucleotide exchange factors (NEFs) stimulate ADP-ATP exchange by Hsc70. We analyzed the purified Hsp40-related co-chaperones DJA1 (Hdj2) and DJA2 (Hdj3) and found that they had a distinct pattern of binding to a range of polypeptides. DJA2 alone could stimulate Hsc70-mediated refolding of luciferase in the absence of NEF, whereas DJA1 was much less active. The addition of the Bag1 NEF increased refolding by Hsc70 and DJA2, as did the newly characterized NEF Hsp110, but each NEF had a different optimal concentration ratio to Hsc70. Notably, the NEF HspBP1 could not increase refolding by Hsc70 and DJA2 at any concentration, and none of the NEFs improved the refolding activity with DJA1. Instead, DJA1 was inhibitory of refolding with DJA2 and Hsc70. All combinations of DJA1 or DJA2 with the three NEFs stimulated the Hsc70 ATPase rate, although Hsp110 became less effective with increasing concentrations. A chimeric DJA2 having its Hsc70-stimulatory J domain replaced with that of DJA1 was functional for polypeptide binding and ATPase stimulation of Hsc70. However, it could not support efficient Hsc70-mediated refolding and also inhibited refolding with DJA2 and Hsc70. These results suggest a more complex model of Hsc70 mechanism than has been previously thought, with notable functional divergence between Hsc70 co- chaperones.	[Tzankov, Stefan; Wong, Michael J. H.; Shi, Kun; Nassif, Christina; Young, Jason C.] McGill Univ, Dept Biochem, Montreal, PQ H3G 1Y6, Canada	McGill University	Young, JC (corresponding author), McGill Univ, Dept Biochem, 3655 Promenade Sir William Osler, Montreal, PQ H3G 1Y6, Canada.	jason.young2@mcgill.ca			Canadian Institutes of Health Research; Canadian Foundation for Innovation	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Foundation for Innovation(Canada Foundation for Innovation)	This work was supported by a Canadian Institutes of Health Research operating grant and the Canadian Foundation for Innovation. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	Abell BM, 2007, J CELL SCI, V120, P1743, DOI 10.1242/jcs.002410; Alberti S, 2004, MOL BIOL CELL, V15, P4003, DOI 10.1091/mbc.E04-04-0293; Andreasson C, 2008, J BIOL CHEM, V283, P8877, DOI 10.1074/jbc.M710063200; Arndt V, 2005, MOL BIOL CELL, V16, P5891, DOI 10.1091/mbc.E05-07-0660; Aron R, 2005, GENETICS, V169, P1873, DOI 10.1534/genetics.104.037242; Bhangoo MK, 2007, MOL BIOL CELL, V18, P3414, DOI 10.1091/mbc.E07-01-0088; Borges JC, 2005, J BIOL CHEM, V280, P13671, DOI 10.1074/jbc.M408349200; Cajo GC, 2006, J BIOL CHEM, V281, P12436, DOI 10.1074/jbc.M511192200; Dai Q, 2005, J BIOL CHEM, V280, P38673, DOI 10.1074/jbc.M507986200; de Marcos-Lousa C, 2006, TRENDS BIOCHEM SCI, V31, P259, DOI 10.1016/j.tibs.2006.03.006; Dragovic Z, 2006, EMBO J, V25, P2519, DOI 10.1038/sj.emboj.7601138; Fan ACY, 2006, J BIOL CHEM, V281, P33313, DOI 10.1074/jbc.M605250200; Gassler CS, 2001, J BIOL CHEM, V276, P32538, DOI 10.1074/jbc.M105328200; Hafizur RM, 2004, J BIOCHEM, V135, P193, DOI 10.1093/jb/mvh023; Hohfeld J, 1997, EMBO J, V16, P6209, DOI 10.1093/emboj/16.20.6209; Jiang JW, 2007, MOL CELL, V28, P422, DOI 10.1016/j.molcel.2007.08.022; Kabani M, 2002, FEBS LETT, V531, P339, DOI 10.1016/S0014-5793(02)03570-6; Li JZ, 2003, STRUCTURE, V11, P1475, DOI 10.1016/j.str.2003.10.012; LIBEREK K, 1991, P NATL ACAD SCI USA, V88, P2874, DOI 10.1073/pnas.88.7.2874; Liu QL, 2007, CELL, V131, P106, DOI 10.1016/j.cell.2007.08.039; Luders J, 2000, J BIOL CHEM, V275, P14817, DOI 10.1074/jbc.275.20.14817; Mayer MP, 2005, CELL MOL LIFE SCI, V62, P670, DOI 10.1007/s00018-004-4464-6; Minami Y, 1996, J BIOL CHEM, V271, P19617, DOI 10.1074/jbc.271.32.19617; Oh HJ, 1997, J BIOL CHEM, V272, P31636, DOI 10.1074/jbc.272.50.31636; Palmisano A, 1998, BIOCHEM J, V333, P151, DOI 10.1042/bj3330151; Picard D, 2006, TRENDS ENDOCRIN MET, V17, P229, DOI 10.1016/j.tem.2006.06.003; Pratt WB, 2003, EXP BIOL MED, V228, P111, DOI 10.1177/153537020322800201; Qiu XB, 2006, CELL MOL LIFE SCI, V63, P2560, DOI 10.1007/s00018-006-6192-6; Raviol H, 2006, EMBO J, V25, P2510, DOI 10.1038/sj.emboj.7601139; Raynes DA, 1998, J BIOL CHEM, V273, P32883, DOI 10.1074/jbc.273.49.32883; Shaner L, 2006, BIOCHEMISTRY-US, V45, P15075, DOI 10.1021/bi061279k; Shomura Y, 2005, MOL CELL, V17, P367, DOI 10.1016/j.molcel.2004.12.023; Sondermann H, 2001, SCIENCE, V291, P1553, DOI 10.1126/science.1057268; SZABO A, 1994, P NATL ACAD SCI USA, V91, P10345, DOI 10.1073/pnas.91.22.10345; Takayama S, 2001, NAT CELL BIOL, V3, pE237, DOI 10.1038/ncb1001-e237; Tanimura S, 2007, J BIOL CHEM, V282, P35430, DOI 10.1074/jbc.M707547200; Terada K, 2000, J BIOL CHEM, V275, P24728, DOI 10.1074/jbc.M002021200; Terada K, 1997, J CELL BIOL, V139, P1089, DOI 10.1083/jcb.139.5.1089; WAWRZYNOW A, 1995, J BIOL CHEM, V270, P19307, DOI 10.1074/jbc.270.33.19307; Wu YK, 2005, J MOL BIOL, V346, P1005, DOI 10.1016/j.jmb.2004.12.040; Yamagishi N, 2004, J BIOL CHEM, V279, P41727, DOI 10.1074/jbc.M407947200; Yamagishi N, 2000, BIOCHEM BIOPH RES CO, V272, P850, DOI 10.1006/bbrc.2000.2864; Young JC, 2004, NAT REV MOL CELL BIO, V5, P781, DOI 10.1038/nrm1492; Young JC, 2003, TRENDS BIOCHEM SCI, V28, P541, DOI 10.1016/j.tibs.2003.08.009; Zara V, 2003, J MOL BIOL, V325, P399, DOI 10.1016/S0022-2836(02)01236-6	45	60	60	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 3	2008	283	40					27100	27109		10.1074/jbc.M803923200	http://dx.doi.org/10.1074/jbc.M803923200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	353RT	18684711	Green Accepted, hybrid			2022-12-27	WOS:000259586600031
J	Elgan, TH; Berndt, KD				Elgan, Tobias H.; Berndt, Kurt D.			Quantifying Escherichia coli Glutaredoxin-3 Substrate Specificity Using Ligand-induced Stability	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MIXED DISULFIDE; CONFORMATIONAL STABILITY; HUMAN THIOREDOXIN; NMR STRUCTURE; GLUTATHIONE; BINDING; MUTANT; THIOLTRANSFERASE; STABILIZATION; PROTEINS	Traditionally, quantification of protein-ligand affinity is performed using kinetic or equilibrium measurements. However, if the binding reaction proceeds via a stable covalent complex, these approaches are often limited. By exploiting the fact that the conformational stabilization of a protein is altered upon ligand binding due to specific interactions, and using an array of selectively chosen ligand analogs, one can quantify the contribution individual interactions have on specificity. We have used ligand-induced stability as a basis to dissect the interaction between glutaredoxin-3 (Grx3) and one of its native substrates, the tripeptide glutathione. Taking advantage of the fact that Grx3 can be trapped in a covalent mixed disulfide to glutathione or to selected synthetic glutathione analogs as part of the natural catalytic cycle, individual contributions to binding of specific molecular groups can be quantified by changes in ligand-induced stability. These changes in conformational stability are interpreted in terms of interaction energies (i.e. specificity) of the particular groups present on the ligand analog. Our results illustrate that although Grx3 recognizes glutathione predominantly through independent and additive ionic interactions at the N- and C-terminal of glutathione, van der Waals interactions from the unique gamma-glutamate moiety of glutathione also play an important role. This study places us closer to understanding the complex task of accommodating multiple substrate specificities in proteins of the thioredoxin superfamily and underscores the general applicability of ligand-induced stability to probe substrate specificity.	[Elgan, Tobias H.; Berndt, Kurt D.] Karolinska Inst, Dept Biosci & Nutr, S-14157 Huddinge, Sweden; [Elgan, Tobias H.; Berndt, Kurt D.] Sodertorns Hgsk, Sch Life Sci, S-14189 Huddinge, Sweden	Karolinska Institutet; Sodertorn University	Berndt, KD (corresponding author), Halsovagen 7, S-14157 Huddinge, Sweden.	kurt.berndt@ki.se	Berndt, Kurt/J-8574-2015; Elgan, Tobias H/B-8573-2017; Elgan, Tobias/AAD-5281-2019	Berndt, Kurt/0000-0002-3049-967X; Elgan, Tobias H/0000-0001-6406-4685; Elgan, Tobias/0000-0001-6406-4685	Karolinska Institutet and Sodertorns Hogskola	Karolinska Institutet and Sodertorns Hogskola	This work was supported by grants from the Karolinska Institutet and Sodertorns Hogskola.	Aslund F, 1997, J BIOL CHEM, V272, P30780, DOI 10.1074/jbc.272.49.30780; ASLUND F, 1994, P NATL ACAD SCI USA, V91, P9813, DOI 10.1073/pnas.91.21.9813; Berardi MJ, 1999, J MOL BIOL, V292, P151, DOI 10.1006/jmbi.1999.3067; BUSHWELLER JH, 1994, J MOL BIOL, V235, P1585, DOI 10.1006/jmbi.1994.1108; BUSHWELLER JH, 1992, BIOCHEMISTRY-US, V31, P9288, DOI 10.1021/bi00153a023; Chan WC, 2000, FMOC SOLID PHASE PEP; Erlanson DA, 2004, ANNU REV BIOPH BIOM, V33, P199, DOI 10.1146/annurev.biophys.33.110502.140409; Fernandes AP, 2004, ANTIOXID REDOX SIGN, V6, P63, DOI 10.1089/152308604771978354; Fountoulakis M, 1998, J CHROMATOGR A, V826, P109, DOI 10.1016/S0021-9673(98)00721-3; Gallogly MM, 2007, CURR OPIN PHARMACOL, V7, P381, DOI 10.1016/j.coph.2007.06.003; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; GRAVINA SA, 1993, BIOCHEMISTRY-US, V32, P3368, DOI 10.1021/bi00064a021; HOLMGREN A, 1979, J BIOL CHEM, V254, P3664; HOLMGREN A, 1989, J BIOL CHEM, V264, P13963; KLEANTHOUS C, 1991, J BIOL CHEM, V266, P10893; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; MARTIN JL, 1995, STRUCTURE, V3, P245, DOI 10.1016/S0969-2126(01)00154-X; Nagarajan R, 2004, BIOCHEMISTRY-US, V43, P9664, DOI 10.1021/bi049309b; Nordstrand K, 1999, J MOL BIOL, V286, P541, DOI 10.1006/jmbi.1998.2444; Nordstrand K, 2000, J MOL BIOL, V303, P423, DOI 10.1006/jmbi.2000.4145; Pace C. N., 1997, PROTEIN STRUCTURE PR, V2, P299; PACE CN, 1980, J BIOL CHEM, V255, P3862; PACE CN, 1988, J BIOL CHEM, V263, P11820; PACE CN, 1990, TRENDS BIOCHEM SCI, V15, P14, DOI 10.1016/0968-0004(90)90124-T; Peltoniemi MJ, 2006, J BIOL CHEM, V281, P33107, DOI 10.1074/jbc.M605602200; Powell KD, 2002, J AM CHEM SOC, V124, P10256, DOI 10.1021/ja026574g; Prinz WA, 1997, J BIOL CHEM, V272, P15661, DOI 10.1074/jbc.272.25.15661; QIN J, 1995, STRUCTURE, V3, P289, DOI 10.1016/S0969-2126(01)00159-9; Qin J, 1996, STRUCTURE, V4, P613, DOI 10.1016/S0969-2126(96)00065-2; Sagemark J, 2007, PROTEINS, V68, P879, DOI 10.1002/prot.21416; SANTORO MM, 1988, BIOCHEMISTRY-US, V27, P8063, DOI 10.1021/bi00421a014; VlamisGardikas A, 1997, J BIOL CHEM, V272, P11236; Wurth C, 2001, PROTEIN SCI, V10, P63, DOI 10.1110/ps.27401; Xie D, 2000, J AM CHEM SOC, V122, P11533, DOI 10.1021/ja003230m; Yang YW, 1998, BIOCHEMISTRY-US, V37, P17145, DOI 10.1021/bi9806504; Yu J, 2008, PROTEINS, V72, P1077, DOI 10.1002/prot.22096	36	12	12	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 21	2008	283	47					32839	32847		10.1074/jbc.M804019200	http://dx.doi.org/10.1074/jbc.M804019200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	372HW	18757366	hybrid			2022-12-27	WOS:000260893700073
J	Goldshmidt, H; Sheiner, L; Butikofer, P; Roditi, I; Uliel, S; Gunzel, M; Engstler, M; Michaeli, S				Goldshmidt, Hanoch; Sheiner, Lilach; Buetikofer, Peter; Roditi, Isabel; Uliel, Shai; Guenzel, Mark; Engstler, Markus; Michaeli, Shulamit			Role of Protein Translocation Pathways across the Endoplasmic Reticulum in Trypanosoma brucei	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIGNAL-RECOGNITION-PARTICLE; PROCYCLIC CULTURE FORMS; RNA-LIKE MOLECULE; MEMBRANE-PROTEINS; AFRICAN TRYPANOSOMES; SACCHAROMYCES-CEREVISIAE; ESCHERICHIA-COLI; SURFACE PROTEIN; ER MEMBRANE; FUNCTIONAL-CHARACTERIZATION	The translocation of secretory and membrane proteins across the endoplasmic reticulum (ER) membrane is mediated by co-translational (via the signal recognition particle (SRP)) and post-translational mechanisms. In this study, we investigated the relative contributions of these two pathways in trypanosomes. A homologue of SEC71, which functions in the post-translocation chaperone pathway in yeast, was identified and silenced by RNA interference. This factor is essential for parasite viability. In SEC71-silenced cells, signal peptide (SP)-containing proteins traversed the ER, but several were mislocalized, whereas polytopic membrane protein biogenesis was unaffected. Surprisingly trypanosomes can interchangeably utilize two of the pathways to translocate SP-containing proteins except for glycosylphosphatidylinositol-anchored proteins, whose level was reduced in SEC71-silenced cells but not in cells depleted for SRP68, an SRP-binding protein. Entry of SP-containing proteins to the ER was significantly blocked only in cells co-silenced for the two translocation pathways (SEC71 and SRP68). SEC63, a factor essential for both translocation pathways in yeast, was identified and silenced by RNA interference. SEC63 silencing affected entry to the ER of both SP-containing proteins and polytopic membrane proteins, suggesting that, as in yeast, this factor is essential for both translocation pathways in vivo. This study suggests that, unlike bacteria or other eukaryotes, trypanosomes are generally promiscuous in their choice of mechanism for translocating SP-containing proteins to the ER, although the SRP-independent pathway is favored for glycosylphosphatidylinositol-anchored proteins, which are the most abundant surface proteins in these parasites.	[Goldshmidt, Hanoch; Sheiner, Lilach; Uliel, Shai; Michaeli, Shulamit] Bar Ilan Univ, Mina & Everard Goodman Fac Life Sci, IL-52900 Ramat Gan, Israel; [Buetikofer, Peter] Univ Bern, Inst Biochem & Mol Med, CH-3012 Bern, Switzerland; [Roditi, Isabel] Univ Bern, Inst Cell Biol, CH-3012 Bern, Switzerland; [Guenzel, Mark; Engstler, Markus] Tech Univ Darmstadt, Dept Genet & Microbiol, Cellular Dynam Unit, D-64287 Darmstadt, Germany	Bar Ilan University; University of Bern; University of Bern; Technical University of Darmstadt	Michaeli, S (corresponding author), Bar Ilan Univ, Mina & Everard Goodman Fac Life Sci, IL-52900 Ramat Gan, Israel.	michaes@mail.biu.ac.il	Engstler, Markus/E-6054-2010; Michaeli, Shulamit/AAC-8255-2022	Roditi, Isabel/0000-0003-2812-6513	Israeli Science Foundation; European Molecular Biology Organization	Israeli Science Foundation(Israel Science Foundation); European Molecular Biology Organization(European Molecular Biology Organization (EMBO))	This work was initially supported by a grant from the Israeli Science Foundation. The collaboration between our groups was initiated through funding by a European Molecular Biology Organization short term fellowship (to L. S.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	Bangs JD, 1998, CURR OPIN MICROBIOL, V1, P448, DOI 10.1016/S1369-5274(98)80064-7; Barth S, 2005, J BIOL CHEM, V280, P34558, DOI 10.1074/jbc.M503465200; BASSFORD P, 1991, CELL, V65, P367, DOI 10.1016/0092-8674(91)90453-6; BEJA O, 1993, MOL BIOCHEM PARASIT, V57, P223, DOI 10.1016/0166-6851(93)90198-7; BRODSKY JL, 1993, J CELL BIOL, V123, P1355, DOI 10.1083/jcb.123.6.1355; BRODSKY JL, 1995, P NATL ACAD SCI USA, V92, P9643, DOI 10.1073/pnas.92.21.9643; BROWN JD, 1994, EMBO J, V13, P4390, DOI 10.1002/j.1460-2075.1994.tb06759.x; BRUN R, 1979, ACTA TROP, V36, P289; Butikofer P, 1997, BIOCHEM J, V326, P415; Butikofer P, 2002, MOL BIOCHEM PARASIT, V119, P87, DOI 10.1016/S0166-6851(01)00398-X; Corsi AK, 1996, J BIOL CHEM, V271, P30299, DOI 10.1074/jbc.271.48.30299; CROSS GAM, 1975, PARASITOLOGY, V71, P393, DOI 10.1017/S003118200004717X; DESHAIES RJ, 1991, NATURE, V349, P806, DOI 10.1038/349806a0; Engstler M, 2004, GENE DEV, V18, P2798, DOI 10.1101/gad.323404; FANG H, 1994, MOL BIOL CELL, V5, P933, DOI 10.1091/mbc.5.9.933; FELDHEIM D, 1993, MOL BIOL CELL, V4, P931, DOI 10.1091/mbc.4.9.931; FERGUSON MAJ, 1994, PARASITOLOGY, V108, pS45, DOI 10.1017/S0031182000075715; Ferguson MAJ, 1999, J CELL SCI, V112, P2799; FERGUSON MAJ, 1988, SCIENCE, V239, P753, DOI 10.1126/science.3340856; GORLICH D, 1993, CELL, V75, P615, DOI 10.1016/0092-8674(93)90483-7; HANN BC, 1991, CELL, V67, P131, DOI 10.1016/0092-8674(91)90577-L; Henriques C, 2003, MOL BIOCHEM PARASIT, V130, P101, DOI 10.1016/S0166-6851(03)00167-1; Hill JE, 2000, BIOCHEM J, V351, P281, DOI 10.1042/0264-6021:3510281; Jermy AJ, 2006, J BIOL CHEM, V281, P7899, DOI 10.1074/jbc.M511402200; Kalies KU, 1998, EUR J BIOCHEM, V254, P1, DOI 10.1046/j.1432-1327.1998.2540001.x; Kang SW, 2006, CELL, V127, P999, DOI 10.1016/j.cell.2006.10.032; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Lakkaraju AKK, 2007, EXP CELL RES, V313, P834, DOI 10.1016/j.yexcr.2006.12.003; Lee HC, 2001, P NATL ACAD SCI USA, V98, P3471, DOI 10.1073/pnas.051484198; LEE MGS, 1994, J BIOL CHEM, V269, P8408; LEE MGS, 1990, MOL CELL BIOL, V10, P4506, DOI 10.1128/MCB.10.9.4506; Liu L, 2003, J BIOL CHEM, V278, P18271, DOI 10.1074/jbc.M209215200; Liu L, 2002, J BIOL CHEM, V277, P47348, DOI 10.1074/jbc.M207736200; Lustig Y, 2005, J CELL SCI, V118, P4551, DOI 10.1242/jcs.02578; Lustig Y, 2007, EUKARYOT CELL, V6, P1865, DOI 10.1128/EC.00134-07; Lustig Y, 2007, EMBO REP, V8, P408, DOI 10.1038/sj.embor.7400930; Mandelboim M, 2003, J BIOL CHEM, V278, P51469, DOI 10.1074/jbc.M308997200; Matlack KES, 1999, CELL, V97, P553, DOI 10.1016/S0092-8674(00)80767-9; McConville MJ, 2002, MICROBIOL MOL BIOL R, V66, P122, DOI 10.1128/MMBR.66.1.122-154.2002; Mutomba MC, 1997, MOL BIOCHEM PARASIT, V90, P491, DOI 10.1016/S0166-6851(97)00197-7; Osborne AR, 2005, ANNU REV CELL DEV BI, V21, P529, DOI 10.1146/annurev.cellbio.21.012704.133214; PANZNER S, 1995, CELL, V81, P561, DOI 10.1016/0092-8674(95)90077-2; Plath K, 2000, J CELL BIOL, V151, P167, DOI 10.1083/jcb.151.1.167; Rapoport TA, 2007, NATURE, V450, P663, DOI 10.1038/nature06384; RIFKIN MR, 1995, J BIOL CHEM, V270, P16160, DOI 10.1074/jbc.270.27.16160; Roditi I, 1999, MOL BIOCHEM PARASIT, V103, P99, DOI 10.1016/S0166-6851(99)00124-3; Roditi I, 1998, MOL BIOCHEM PARASIT, V91, P117, DOI 10.1016/S0166-6851(97)00195-3; Rothmann C, 2000, COMP BIOCHEM PHYS A, V125, P75, DOI 10.1016/S1095-6433(99)00157-9; SCHLENSTEDT G, 1990, J BIOL CHEM, V265, P13960; SCHLENSTEDT G, 1987, EMBO J, V6, P699, DOI 10.1002/j.1460-2075.1987.tb04810.x; Schwartz KJ, 2005, J CELL SCI, V118, P5499, DOI 10.1242/jcs.02667; Seluanov A, 1997, J BIOL CHEM, V272, P2053; Shan SO, 2005, FEBS LETT, V579, P921, DOI 10.1016/j.febslet.2004.11.049; Treumann A, 1997, J MOL BIOL, V269, P529, DOI 10.1006/jmbi.1997.1066; Triggs VP, 2003, EUKARYOT CELL, V2, P76, DOI 10.1128/EC.2.1.76-83.2003; Tuteja R, 2007, ARCH BIOCHEM BIOPHYS, V467, P249, DOI 10.1016/j.abb.2007.08.031; Ulbrandt ND, 1997, CELL, V88, P187, DOI 10.1016/S0092-8674(00)81839-5; Vassella E, 2003, MOL BIOL CELL, V14, P1308, DOI 10.1091/mbc.E02-10-0694; Wang ZF, 2000, J BIOL CHEM, V275, P40174, DOI 10.1074/jbc.M008405200; Willer M, 2003, YEAST, V20, P133, DOI 10.1002/yea.954; Wittke S, 2000, MOL BIOL CELL, V11, P3859, DOI 10.1091/mbc.11.11.3859; Wolfe MS, 2004, SCIENCE, V305, P1119, DOI 10.1126/science.1096187; Xong HV, 1998, CELL, V95, P839, DOI 10.1016/S0092-8674(00)81706-7; Young BP, 2001, EMBO J, V20, P262, DOI 10.1093/emboj/20.1.262; Zimmermann R, 1998, BIOL CHEM, V379, P275	65	27	29	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 14	2008	283	46					32085	32098		10.1074/jbc.M801499200	http://dx.doi.org/10.1074/jbc.M801499200			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	370KJ	18768469	hybrid			2022-12-27	WOS:000260760800090
J	Mochizuki, H; Yoshida, K; Shibata, Y; Kimata, K				Mochizuki, Hideo; Yoshida, Keiichi; Shibata, Yuniko; Kimata, Koji			Tetrasulfated Disaccharide Unit in Heparan Sulfate ENZYMATIC FORMATION AND TISSUE DISTRIBUTION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HERPES-SIMPLEX-VIRUS; D-GLUCOSAMINYL 3-O-SULFOTRANSFERASE; TUMOR SUPPRESSORS; MOLECULAR-CLONING; DOMAIN-STRUCTURE; FINE-STRUCTURE; BINDING SITE; HUMAN CDNAS; PROTEOGLYCANS; SPECIFICITY	We previously reported that the heparan sulfate 3-O-sulfo-transferase (3OST)-5 produces a novel component of heparan sulfate, i.e. the tetrasulfated disaccharide (Di-tetraS) unit (Mochizuki, H., Yoshida, K., Gotoh, M., Sugioka, S., Kikuchi, N., Kwon, Y.-D., Tawada, A., Maeyama, K., Inaba, N., Hiruma, T., Kimata, K., and Narimatsu, H. (2003) J. Biol. Chem. 278, 26780 26787). In the present study, we investigated the potential of other 3OST isoforms to produce Di-tetraS with heparan sulfate and heparin as acceptor substrates. 3OST-2, 3OST-3, and 3OST-4 produce Di-tetraS units as a major product from both substrates. 3OST-5 showed the same specificity for heparin, but the production from heparan sulfate was very low. Di-tetraS production by 3OST-1 was negligible. We then investigated the presence of Di-tetraS units in heparan sulfates from various rat tissues. Di-tetraS was detected in all of the tissues analyzed. Liver and spleen contain relatively high levels of Di-tetraS, 1.6 and 0.95%, respectively. However, the content of this unit in heart, large intestine, ileum, and lung is low, less than 0.2%. We further determined the expression levels of 3OST transcripts by quantitative real time PCR. The 3OST-3 transcripts are highly expressed in spleen and liver. The 3OST-2 and -4 are specifically expressed in brain. These results indicate that the Di-tetraS unit is widely distributed throughout the body as a rare and unique component of heparan sulfate and is synthesized by tissue-specific 3OST isoforms specific for Di-tetraS production.	[Mochizuki, Hideo] Seikagaku Corp, Cent Res Labs, Tokyo 2070021, Japan; [Yoshida, Keiichi] Mizutani Fdn Glycosci, Chiyoda Ku, Tokyo 1000005, Japan; [Shibata, Yuniko] Seikagaku Biobusiness Corp, Res Labs, Tokyo 2070021, Japan; [Kimata, Koji] Aichi Med Univ, Inst Mol Sci Med, Aichi 4801195, Japan	Seikagaku Corporation; Aichi Medical University	Mochizuki, H (corresponding author), Seikagaku Corp, Cent Res Labs, 3-1253 Tateno, Tokyo 2070021, Japan.	hideo.mochizuki@seikagaku.co.jp						Barth H, 2003, J BIOL CHEM, V278, P41003, DOI 10.1074/jbc.M302267200; Bernfield M, 1999, ANNU REV BIOCHEM, V68, P729, DOI 10.1146/annurev.biochem.68.1.729; Bishop JR, 2007, NATURE, V446, P1030, DOI 10.1038/nature05817; Brickman YG, 1998, J BIOL CHEM, V273, P4350, DOI 10.1074/jbc.273.8.4350; Chen YP, 1997, NAT MED, V3, P866, DOI 10.1038/nm0897-866; Coppi A, 2007, CELL HOST MICROBE, V2, P316, DOI 10.1016/j.chom.2007.10.002; DESAI UR, 1993, ARCH BIOCHEM BIOPHYS, V306, P461, DOI 10.1006/abbi.1993.1538; Esko JD, 2002, ANNU REV BIOCHEM, V71, P435, DOI 10.1146/annurev.biochem.71.110601.135458; Esko JD, 2001, J CLIN INVEST, V108, P169, DOI 10.1172/JCI200113530; Gallagher JT, 2001, J CLIN INVEST, V108, P357, DOI 10.1172/JCI13713; Habuchi O, 2000, BBA-GEN SUBJECTS, V1474, P115, DOI 10.1016/S0304-4165(00)00016-7; HajMohammadi S, 2003, J CLIN INVEST, V111, P989, DOI 10.1172/JCI200315809; HEINEGARD D, 1987, METHOD ENZYMOL, V144, P319; Iwai T, 2002, J BIOL CHEM, V277, P12802, DOI 10.1074/jbc.M112457200; Kamimura K, 2004, J CELL BIOL, V166, P1069, DOI 10.1083/jcb.200403077; KARIYA Y, 1992, COMP BIOCHEM PHYS B, V103, P473, DOI 10.1016/0305-0491(92)90323-J; Kuberan B, 2004, J BIOL CHEM, V279, P5053, DOI 10.1074/jbc.C300492200; Kutyavin IV, 2000, NUCLEIC ACIDS RES, V28, P655, DOI 10.1093/nar/28.2.655; Lawrence R, 2004, GLYCOBIOLOGY, V14, P467, DOI 10.1093/glycob/cwh057; Lawrence R, 2007, MATRIX BIOL, V26, P442, DOI 10.1016/j.matbio.2007.03.002; Lin XH, 2004, DEVELOPMENT, V131, P6009, DOI 10.1242/dev.01522; Lindahl U, 1998, J BIOL CHEM, V273, P24979, DOI 10.1074/jbc.273.39.24979; LINDAHL U, 1980, P NATL ACAD SCI-BIOL, V77, P6551, DOI 10.1073/pnas.77.11.6551; Liu J, 1996, J BIOL CHEM, V271, P27072, DOI 10.1074/jbc.271.43.27072; Liu J, 2002, J BIOL CHEM, V277, P33456, DOI 10.1074/jbc.M202034200; Liu JA, 1999, J BIOL CHEM, V274, P38155, DOI 10.1074/jbc.274.53.38155; Liu JA, 1999, J BIOL CHEM, V274, P5185, DOI 10.1074/jbc.274.8.5185; LYON M, 1994, J BIOL CHEM, V269, P11208; MacArthur JM, 2007, J CLIN INVEST, V117, P153, DOI 10.1172/JCI29154; Maccarana M, 1996, J BIOL CHEM, V271, P17804, DOI 10.1074/jbc.271.30.17804; McCormick C, 2000, P NATL ACAD SCI USA, V97, P668, DOI 10.1073/pnas.97.2.668; Mochizuki H, 2003, J BIOL CHEM, V278, P26780, DOI 10.1074/jbc.M301861200; Murphy KJ, 2004, J BIOL CHEM, V279, P27239, DOI 10.1074/jbc.M401774200; Nakato H, 2002, BBA-GEN SUBJECTS, V1573, P312, DOI 10.1016/S0304-4165(02)00398-7; NORGARDSUMNICHT K, 1995, J BIOL CHEM, V270, P12012, DOI 10.1074/jbc.270.20.12012; Pinhal MAS, 2001, P NATL ACAD SCI USA, V98, P12984, DOI 10.1073/pnas.241175798; Schulze A, 2007, HEPATOLOGY, V46, P1759, DOI 10.1002/hep.21896; Senay C, 2000, EMBO REP, V1, P282, DOI 10.1093/embo-reports/kvd045; Shukla D, 1999, CELL, V99, P13, DOI 10.1016/S0092-8674(00)80058-6; Shworak NW, 1997, J BIOL CHEM, V272, P28008, DOI 10.1074/jbc.272.44.28008; Shworak NW, 1999, J BIOL CHEM, V274, P5170, DOI 10.1074/jbc.274.8.5170; Sugahara K, 2002, IUBMB LIFE, V54, P163, DOI 10.1080/15216540214928; Toida T, 1997, BIOCHEM J, V322, P499, DOI 10.1042/bj3220499; Toyoda H, 2000, J BIOL CHEM, V275, P2269, DOI 10.1074/jbc.275.4.2269; TURNBULL JE, 1991, BIOCHEM J, V273, P553, DOI 10.1042/bj2730553; vandenBorn J, 1995, J BIOL CHEM, V270, P31303, DOI 10.1074/jbc.270.52.31303; Warda M, 2006, GLYCOCONJUGATE J, V23, P555, DOI 10.1007/s10719-006-7668-1; Wu ZLL, 2004, J BIOL CHEM, V279, P1861, DOI 10.1074/jbc.M311398200; Xia GQ, 2002, J BIOL CHEM, V277, P37912, DOI 10.1074/jbc.M204209200; Yamada S, 1999, FEBS LETT, V459, P327, DOI 10.1016/S0014-5793(99)01286-7; YAMADA S, 1995, J BIOL CHEM, V270, P8696; YAMADA SH, 1993, J BIOL CHEM, V268, P4780; YANAGISHITA M, 1992, J BIOL CHEM, V267, P9451	53	36	36	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 7	2008	283	45					31237	31245		10.1074/jbc.M801586200	http://dx.doi.org/10.1074/jbc.M801586200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	367ID	18757372	Green Published, hybrid			2022-12-27	WOS:000260544800077
J	Chacinska, A; Guiard, B; Muller, JM; Schulze-Specking, A; Gabriel, K; Kutik, S; Pfanner, N				Chacinska, Agnieszka; Guiard, Bernard; Mueller, Judith M.; Schulze-Specking, Agnes; Gabriel, Kipros; Kutik, Stephan; Pfanner, Nikolaus			Mitochondrial Biogenesis, Switching the Sorting Pathway of the Intermembrane Space Receptor Mia40	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DISULFIDE RELAY SYSTEM; PROTEIN IMPORT; PRESEQUENCE TRANSLOCASE; TARGETING SEQUENCES; ERV1	Mitochondrial precursor proteins are directed into the intermembrane space via two different routes, the presequence pathway and the redox-dependent MIA pathway. The pathways were assumed to be independent and transport different proteins. We report that the intermembrane space receptor Mia40 can switch between both pathways. In fungi, Mia40 is synthesized as large protein with an N-terminal presequence, whereas in metazoans and plants, Mia40 consists only of the conserved C-terminal domain. Human MIA40 and the C-terminal domain of yeast Mia40 (termed Mia40(core)) rescued the viability of Mia40-deficient yeast independently of the presence of a presequence. Purified Mia40(core) was imported into mitochondria via the MIA pathway. With cells expressing both full-length Mia40 and Mia40(core), we demonstrate that yeast Mia40 contains dual targeting information, directing the large precursor onto the presequence pathway and the smaller Mia40(core) onto the MIA pathway, raising interesting implications for the evolution of mitochondrial protein sorting.	[Chacinska, Agnieszka; Mueller, Judith M.; Schulze-Specking, Agnes; Gabriel, Kipros; Kutik, Stephan; Pfanner, Nikolaus] Univ Freiburg, Inst Biochem & Molekularbiol, ZBMZ, D-79104 Freiburg, Germany; [Chacinska, Agnieszka; Kutik, Stephan; Pfanner, Nikolaus] Univ Freiburg, Ctr Biol Signalling Studies Bioss, D-79104 Freiburg, Germany; [Guiard, Bernard] CNRS, Ctr Genet Mol, F-91190 Gif Sur Yvette, France	University of Freiburg; University of Freiburg; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay	Pfanner, N (corresponding author), Univ Freiburg, Inst Biochem & Molekularbiol, ZBMZ, Stefan Meier Str 17, D-79104 Freiburg, Germany.	Nikolaus.Pfanner@biochemie.uni-freiburg.de	Pfanner, Nikolaus/AAV-7878-2021	Chacinska, Agnieszka/0000-0002-2832-2568	Deutsche Forschungsgemeinschaft (Sonderforschungsbereich 746); Excellence Initiative of the German Federal and State Governments [EXC 294]; Gottfried Wilhelm Leibniz Program; Fonds der Chemischen Industrie	Deutsche Forschungsgemeinschaft (Sonderforschungsbereich 746)(German Research Foundation (DFG)); Excellence Initiative of the German Federal and State Governments; Gottfried Wilhelm Leibniz Program; Fonds der Chemischen Industrie(Fonds der Chemischen IndustrieEuropean Commission)	This work was supported in part by Deutsche Forschungsgemeinschaft (Sonderforschungsbereich 746), the Excellence Initiative of the German Federal and State Governments (EXC 294), the Gottfried Wilhelm Leibniz Program, and the Fonds der Chemischen Industrie. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Allen S, 2005, J MOL BIOL, V353, P937, DOI 10.1016/j.jmb.2005.08.049; Chacinska A, 2005, CELL, V120, P817, DOI 10.1016/j.cell.2005.01.011; Chacinska A, 2004, EMBO J, V23, P3735, DOI 10.1038/sj.emboj.7600389; Claros MG, 1996, EUR J BIOCHEM, V241, P779, DOI 10.1111/j.1432-1033.1996.00779.x; Dolezal P, 2006, SCIENCE, V313, P314, DOI 10.1126/science.1127895; Emanuelsson O, 2000, J MOL BIOL, V300, P1005, DOI 10.1006/jmbi.2000.3903; Endo T, 2003, J CELL SCI, V116, P3259, DOI 10.1242/jcs.00667; Gabriel K, 2007, J MOL BIOL, V365, P612, DOI 10.1016/j.jmb.2006.10.038; GLICK BS, 1992, CELL, V69, P809, DOI 10.1016/0092-8674(92)90292-K; Grumbt B, 2007, J BIOL CHEM, V282, P37461, DOI 10.1074/jbc.M707439200; Hofhaus G, 2003, EUR J BIOCHEM, V270, P1528, DOI 10.1046/j.1432-1033.2003.03519.x; Hofmann S, 2005, J MOL BIOL, V353, P517, DOI 10.1016/j.jmb.2005.08.064; Jensen RE, 2001, NAT STRUCT BIOL, V8, P1008, DOI 10.1038/nsb1201-1008; Koehler CM, 2004, TRENDS BIOCHEM SCI, V29, P1, DOI 10.1016/j.tibs.2003.11.003; Mesecke N, 2005, CELL, V121, P1059, DOI 10.1016/j.cell.2005.04.011; Milenkovic D, 2007, J BIOL CHEM, V282, P22472, DOI 10.1074/jbc.M703294200; Muller JM, 2008, MOL BIOL CELL, V19, P226, DOI 10.1091/mbc.E07-08-0814; Naoe M, 2004, J BIOL CHEM, V279, P47815, DOI 10.1074/jbc.M410272200; Neupert W, 2007, ANNU REV BIOCHEM, V76, P723, DOI 10.1146/annurev.biochem.76.052705.163409; Oka T, 2005, MOL CELL, V18, P145, DOI 10.1016/j.molcel.2005.03.022; Page RDM, 1996, COMPUT APPL BIOSCI, V12, P357; Rissler M, 2005, J MOL BIOL, V353, P485, DOI 10.1016/j.jmb.2005.08.051; Sideris DP, 2007, MOL MICROBIOL, V65, P1360, DOI 10.1111/j.1365-2958.2007.05880.x; Small I, 2004, PROTEOMICS, V4, P1581, DOI 10.1002/pmic.200300776; Stojanovski D, 2008, BBA-MOL CELL RES, V1783, P610, DOI 10.1016/j.bbamcr.2007.10.004; Terziyska N, 2005, FEBS LETT, V579, P179, DOI 10.1016/j.febslet.2004.11.072; Terziyska N, 2007, FEBS LETT, V581, P1098, DOI 10.1016/j.febslet.2007.02.014; Tokatlidis K, 2005, CELL, V121, P965, DOI 10.1016/j.cell.2005.06.019; Truscott KN, 2003, CURR BIOL, V13, pR326, DOI 10.1016/S0960-9822(03)00239-2; van der Laan M, 2007, NAT CELL BIOL, V9, P1152, DOI 10.1038/ncb1635	30	54	56	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 31	2008	283	44					29723	29729		10.1074/jbc.M805356200	http://dx.doi.org/10.1074/jbc.M805356200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	364WS	18779329	Green Published, hybrid			2022-12-27	WOS:000260366900016
J	Wang, Q; Zhang, X; Zhang, L; He, F; Zhang, GW; Jamrich, M; Wensel, TG				Wang, Qiong; Zhang, Xue; Zhang, Li; He, Feng; Zhang, Guowei; Jamrich, Milan; Wensel, Theodore G.			Activation-dependent Hindrance of Photoreceptor G Protein Diffusion by Lipid Microdomains	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RESISTANT MEMBRANE RAFTS; GTPASE-ACCELERATING PROTEIN; ROD OUTER SEGMENTS; TRANSGENIC XENOPUS-LAEVIS; LATERAL DIFFUSION; DISK MEMBRANES; FUSION PROTEIN; ROTATIONAL DIFFUSION; COUPLED RECEPTORS; DOMAIN FORMATION	The dynamics of G protein-mediated signal transduction depend on the two-dimensional diffusion of membrane-bound G proteins and receptors, which has been suggested to be rate-limiting for vertebrate phototransduction, a highly amplified G protein-coupled signaling pathway. Using fluorescence recovery after photobleaching (FRAP), we measured the diffusion of the G protein transducin alpha-subunit (G alpha(t)) and the G protein-coupled receptor rhodopsin on disk membranes of living rod photoreceptors from transgenic Xenopus laevis. Treatment with either methyl-beta-cyclodextrin or filipin III to disrupt cholesterol-containing lipid microdomains dramatically accelerated diffusion of G alpha(t) in its GTP-bound state and of the rhodopsin-G alpha beta gamma(t) complex but not of rhodopsin or inactive GDP-bound G alpha beta gamma. These results imply an activity-dependent sequestration of G proteins into cholesterol-dependent lipid microdomains, which limits diffusion and exclude the majority of free rhodopsin and the free G protein heterotrimer. Our data offer a novel demonstration of lipid microdomains in the internal membranes of living sensory neurons.	[Wang, Qiong; Zhang, Xue; He, Feng; Zhang, Guowei; Wensel, Theodore G.] Baylor Coll Med, Verna & Marrs Mclean Dept Biochem & Mol Biol, Houston, TX 77030 USA; [Zhang, Li] Baylor Coll Med, Program Dev Biol, Houston, TX 77030 USA; [Jamrich, Milan] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine	Wensel, TG (corresponding author), Baylor Coll Med, Dept Biochem & Mol Biol, 1 Baylor Plaza, Houston, TX 77030 USA.	twensel@bcm.edu		Wensel, Theodore/0000-0003-3518-9352	National Institutes of Health [R01-EY07981, R01-EY12505]; Welch Foundation [Q0035]; NATIONAL EYE INSTITUTE [R01EY007981, R01EY012505] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Welch Foundation(The Welch Foundation); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported, in whole or in part, by National Institutes of Health Grants R01-EY07981 and R01-EY12505 from NEI. This work was also supported by Welch Foundation Grant Q0035. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	ADAMUS G, 1991, VISION RES, V31, P17, DOI 10.1016/0042-6989(91)90069-H; BIRRELL GB, 1976, BIOCHEMISTRY-US, V15, P2925, DOI 10.1021/bi00658a035; Boesze-Battaglia K, 2002, J BIOL CHEM, V277, P41843, DOI 10.1074/jbc.M207111200; BRANN MR, 1987, SCIENCE, V235, P585, DOI 10.1126/science.3101175; Calvert PD, 2001, NATURE, V411, P90, DOI 10.1038/35075083; Chabre M, 2005, BIOCHEMISTRY-US, V44, P9395, DOI 10.1021/bi050720o; Chabre M, 2003, NATURE, V426, P30, DOI 10.1038/426030b; Chini B, 2004, J MOL ENDOCRINOL, V32, P325, DOI 10.1677/jme.0.0320325; Cowan CW, 1998, P NATL ACAD SCI USA, V95, P5351, DOI 10.1073/pnas.95.9.5351; CRANK J, 1975, MATH DIFFFUSION; DUMKE CL, 1994, J GEN PHYSIOL, V103, P1071, DOI 10.1085/jgp.103.6.1071; Edrington TC, 2008, BIOPHYS J, V95, P2859, DOI 10.1529/biophysj.108.128868; Elias R, 2004, MOL VIS, V10, P672; Fotiadis D, 2004, FEBS LETT, V564, P281, DOI 10.1016/S0014-5793(04)00194-2; Fotiadis D, 2006, CURR OPIN STRUC BIOL, V16, P252, DOI 10.1016/j.sbi.2006.03.013; Fotiadis D, 2003, NATURE, V421, P127, DOI 10.1038/421127a; GUPTA BD, 1990, J PHYSIOL-LONDON, V430, P483, DOI 10.1113/jphysiol.1990.sp018303; HAMM HE, 1986, BIOCHEMISTRY-US, V25, P4512, DOI 10.1021/bi00364a010; Harlow E., 1988, ANTIBODIES LAB MANUA; He W, 2000, J BIOL CHEM, V275, P37093, DOI 10.1074/jbc.M006982200; Heerklotz H, 2002, BIOPHYS J, V83, P2693, DOI 10.1016/S0006-3495(02)75278-8; Hu G, 2002, P NATL ACAD SCI USA, V99, P9755, DOI 10.1073/pnas.152094799; Hughes TE, 2001, J BIOL CHEM, V276, P4227, DOI 10.1074/jbc.M007608200; Janetopoulos C, 2001, SCIENCE, V291, P2408, DOI 10.1126/science.1055835; Jin S, 2003, FEBS LETT, V542, P142, DOI 10.1016/S0014-5793(03)00368-5; Jin SN, 2003, NAT NEUROSCI, V6, P731, DOI 10.1038/nn1070; KOUTALOS Y, 1995, BIOPHYS J, V68, P373, DOI 10.1016/S0006-3495(95)80198-0; LIEBMAN PA, 1974, SCIENCE, V185, P457, DOI 10.1126/science.185.4149.457; Liu H, 2003, BIOCHEM BIOPH RES CO, V303, P19, DOI 10.1016/S0006-291X(03)00284-5; Lobanova ES, 2007, J NEUROSCI, V27, P1151, DOI 10.1523/JNEUROSCI.5010-06.2007; Malinski JA, 1996, J BIOL CHEM, V271, P12919, DOI 10.1074/jbc.271.22.12919; Mani SS, 2001, J BIOL CHEM, V276, P36557, DOI 10.1074/jbc.M101685200; Martin RE, 2005, INVEST OPHTH VIS SCI, V46, P1147, DOI 10.1167/iovs.04-1207; Mbamala EC, 2005, BIOPHYS J, V88, P1702, DOI 10.1529/biophysj.104.048132; Melia TJ, 1999, J STRUCT BIOL, V128, P119, DOI 10.1006/jsbi.1999.4151; Moritz OL, 2001, J BIOL CHEM, V276, P28242, DOI 10.1074/jbc.M101476200; Munro S, 2003, CELL, V115, P377, DOI 10.1016/S0092-8674(03)00882-1; Nair KS, 2005, NEURON, V46, P555, DOI 10.1016/j.neuron.2005.03.023; Nair KS, 2002, CURR BIOL, V12, P421, DOI 10.1016/S0960-9822(02)00691-7; Nickell S, 2007, J CELL BIOL, V177, P917, DOI 10.1083/jcb.200612010; Nieuwkoop P.D., 1967, NORMAL TABLE XENOPUS; Niu SL, 2002, J BIOL CHEM, V277, P20139, DOI 10.1074/jbc.M200594200; Perkins BD, 2002, VISUAL NEUROSCI, V19, P257, DOI 10.1017/S0952523802192030; PETERS R, 1982, P NATL ACAD SCI-BIOL, V79, P4317, DOI 10.1073/pnas.79.14.4317; POO MM, 1974, NATURE, V247, P438, DOI 10.1038/247438a0; Poveda JA, 2002, BIOCHEMISTRY-US, V41, P12253, DOI 10.1021/bi0200099; Rajala RVS, 2006, ADV EXP MED BIOL, V572, P491; RIETVELD A, 1987, EUR J BIOCHEM, V164, P137, DOI 10.1111/j.1432-1033.1987.tb11004.x; Rosenzweig DH, 2007, J NEUROSCI, V27, P5484, DOI 10.1523/JNEUROSCI.1421-07.2007; SAFFMAN PG, 1975, P NATL ACAD SCI USA, V72, P3111, DOI 10.1073/pnas.72.8.3111; Senin II, 2004, J BIOL CHEM, V279, P48647, DOI 10.1074/jbc.M402516200; Seno K, 2001, J BIOL CHEM, V276, P20813, DOI 10.1074/jbc.C100032200; Sokolov M, 2002, NEURON, V34, P95, DOI 10.1016/S0896-6273(02)00636-0; Swaminathan R, 1997, BIOPHYS J, V72, P1900, DOI 10.1016/S0006-3495(97)78835-0; Wensel Theodore G., 2005, V307, P289; WEY CL, 1981, BIOPHYS J, V33, P225, DOI 10.1016/S0006-3495(81)84883-7; WHELAN JP, 1988, J NEUROSCI RES, V20, P263, DOI 10.1002/jnr.490200216; YAMANAKA G, 1985, BIOCHEMISTRY-US, V24, P8094, DOI 10.1021/bi00348a039; Zhang ZX, 2004, J BIOL CHEM, V279, P33937, DOI 10.1074/jbc.M403404200	59	42	45	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 31	2008	283	44					30015	30024		10.1074/jbc.M803953200	http://dx.doi.org/10.1074/jbc.M803953200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	364WS	18713731	hybrid, Green Published			2022-12-27	WOS:000260366900046
J	Ilioaia, C; Johnson, MP; Horton, P; Ruban, AV				Ilioaia, Cristian; Johnson, Matthew P.; Horton, Peter; Ruban, Alexander V.			Induction of Efficient Energy Dissipation in the Isolated Light-harvesting Complex of Photosystem II in the Absence of Protein Aggregation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TIME-RESOLVED FLUORESCENCE; ABSORBED EXCITATION-ENERGY; CHLOROPHYLL-A FLUORESCENCE; PH-DEPENDENT DISSIPATION; PHOTOSYNTHETIC MEMBRANES; MECHANISM; STATE; ZEAXANTHIN; KINETICS; BINDING	Under excess illumination, the Photosystem II light-harvesting antenna of higher plants has the ability to switch into an efficient photoprotective mode, allowing safe dissipation of excitation energy into heat. In this study, we show induction of the energy dissipation state, monitored by chlorophyll fluorescence quenching, in the isolated major light-harvesting complex (LHCII) incorporated into a solid gel system. Removal of detergent caused strong fluorescence quenching, which was totally reversible. Singlet-singlet annihilation and gel electrophoresis experiments suggested that the quenched complexes were in the trimeric not aggregated state. Both the formation and recovery of this quenching state were inhibited by a cross-linker, implying involvement of conformational changes. Absorption and CD measurements performed on the samples in the quenched state revealed specific alterations in the spectral bands assigned to the red forms of chlorophyll a, neoxanthin, and lutein 1 molecules. The majority of these alterations were similar to those observed during LHCII aggregation. This suggests that not the aggregation process as such but rather an intrinsic conformational transition in the complex is responsible for establishment of quenching. 77 K fluorescence measurements showed red-shifted chlorophyll a fluorescence in the 690-705 nm region, previously observed in aggregated LHCII. The fact that all spectral changes associated with the dissipative mode observed in the gel were different from those of the partially denatured complex strongly argues against the involvement of protein denaturation in the observed quenching. The implications of these findings for proposed mechanisms of energy dissipation in the Photosystem II antenna are discussed.	[Johnson, Matthew P.; Ruban, Alexander V.] Queen Mary Univ London, Sch Biol & Chem Sci, London E1 4NS, England; [Ilioaia, Cristian; Horton, Peter] Univ Sheffield, Dept Mol Biol & Biotechnol, Sheffield S10 2TN, S Yorkshire, England	University of London; Queen Mary University London; University of Sheffield	Ruban, AV (corresponding author), Queen Mary Univ London, Sch Biol & Chem Sci, Mile End Rd,Fogg Bldg, London E1 4NS, England.	a.ruban@qmul.ac.uk	Horton, Peter/A-3958-2012	Horton, Peter/0000-0002-6095-1460; Johnson, Matthew/0000-0002-1663-0205; ILIOAIA, Cristian/0000-0001-7505-1900	Biotechnology and Biological Sciences Research Council; The Royal Society; INTRO2 Marie Curie Research Training Network	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); The Royal Society(Royal Society of London); INTRO2 Marie Curie Research Training Network(European Commission)	This work was supported by grants (to A. V. R. and P. H.) from the Biotechnology and Biological Sciences Research Council and The Royal Society and by the INTRO2 Marie Curie Research Training Network of the European Union. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Ahn TK, 2008, SCIENCE, V320, P794, DOI 10.1126/science.1154800; Amarie S, 2007, J PHYS CHEM B, V111, P3481, DOI 10.1021/jp066458q; Avenson TJ, 2008, J BIOL CHEM, V283, P3550, DOI 10.1074/jbc.M705645200; Barzda V, 2001, BIOPHYS J, V80, P2409, DOI 10.1016/S0006-3495(01)76210-8; Busch F, 2007, PLANT PHYSIOL, V143, P1242, DOI 10.1104/pp.106.092312; Crimi M, 2001, EUR J BIOCHEM, V268, P260, DOI 10.1046/j.1432-1033.2001.01874.x; Dekker JP, 2005, BBA-BIOENERGETICS, V1706, P12, DOI 10.1016/j.bbabio.2004.09.009; DENHOLLANDER WTF, 1993, BIOCHIM BIOPHYS ACTA, V725, P492; GILMORE AM, 1995, P NATL ACAD SCI USA, V92, P2273, DOI 10.1073/pnas.92.6.2273; Gilmore AM, 1998, BIOCHEMISTRY-US, V37, P13582, DOI 10.1021/bi981384x; Holt NE, 2005, SCIENCE, V307, P433, DOI 10.1126/science.1105833; Holt NE, 2004, BIOCHEMISTRY-US, V43, P8281, DOI 10.1021/bi0494020; Horton P, 2000, PHILOS T R SOC B, V355, P1361, DOI 10.1098/rstb.2000.0698; Horton P, 2005, FEBS LETT, V579, P4201, DOI 10.1016/j.febslet.2005.07.003; Horton P, 1996, ANNU REV PLANT PHYS, V47, P655, DOI 10.1146/annurev.arplant.47.1.655; IDE JP, 1987, BIOCHIM BIOPHYS ACTA, V893, P349, DOI 10.1016/0005-2728(87)90056-9; Kirchhoff H, 2003, BBA-BIOENERGETICS, V1606, P105, DOI 10.1016/S0005-2728(03)00105-1; KWA SLS, 1992, BIOCHIM BIOPHYS ACTA, V1101, P143, DOI 10.1016/0005-2728(92)90198-B; Li XP, 2004, J BIOL CHEM, V279, P22866, DOI 10.1074/jbc.M402461200; Liu ZF, 2004, NATURE, V428, P287, DOI 10.1038/nature02373; Moya I, 2001, BIOCHEMISTRY-US, V40, P12552, DOI 10.1021/bi010342x; Pascal AA, 2005, NATURE, V436, P134, DOI 10.1038/nature03795; QUICK WP, 1984, P ROY SOC LOND B BIO, V226, P237; Ruban AV, 2007, NATURE, V450, P575, DOI 10.1038/nature06262; Ruban AV, 1999, J BIOL CHEM, V274, P10458, DOI 10.1074/jbc.274.15.10458; Ruban AV, 1998, BIOCHEMISTRY-US, V37, P11586, DOI 10.1021/bi9809369; RUBAN AV, 1994, PLANT PHYSIOL, V104, P227, DOI 10.1104/pp.104.1.227; RUBAN AV, 1992, BIOCHIM BIOPHYS ACTA, V1102, P39, DOI 10.1016/0167-4838(92)90496-Z; RUBAN AV, 1992, BIOCHIM BIOPHYS ACTA, V1102, P30, DOI 10.1016/0005-2728(92)90061-6; Ruban AV, 1997, BBA-BIOENERGETICS, V1321, P61, DOI 10.1016/S0005-2728(97)00047-9; SCHREIBER U, 1986, PHOTOSYNTH RES, V9, P261, DOI 10.1007/BF00029749; Standfuss R, 2005, EMBO J, V24, P919, DOI 10.1038/sj.emboj.7600585; Tang YL, 2007, PLANT PHYSIOL, V143, P629, DOI 10.1104/pp.106.090712; Wagner B, 1996, J PHOTOCH PHOTOBIO B, V36, P339, DOI 10.1016/S1011-1344(96)07391-5	34	88	88	5	32	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 24	2008	283	43					29505	29512		10.1074/jbc.M802438200	http://dx.doi.org/10.1074/jbc.M802438200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	362EB	18728016	Green Published, hybrid			2022-12-27	WOS:000260179900076
J	Mori, T; Kitano, K; Terawaki, S; Maesaki, R; Fukami, Y; Hakoshima, T				Mori, Tomoyuki; Kitano, Ken; Terawaki, Shin-ichi; Maesaki, Ryoko; Fukami, Yayoi; Hakoshima, Toshio			Structural Basis for CD44 Recognition by ERM Proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-SURFACE GLYCOPROTEIN; HYALURONIC-ACID; CYTOPLASMIC DOMAIN; CRYSTALLOGRAPHIC CHARACTERIZATION; INTRAMEMBRANE PROTEOLYSIS; INTRACELLULAR DOMAIN; CRYSTAL-STRUCTURE; BINDING DOMAIN; FERM DOMAIN; F-ACTIN	CD44 is an important adhesion molecule that functions as the major hyaluronan receptor which mediates cell adhesion and migration in a variety of physiological and pathological processes. Although full activity of CD44 requires binding to ERM (ezrin/radixin/moesin) proteins, the CD44 cytoplasmic region, consisting of 72 amino acid residues, lacks the Motif-1 consensus sequence for ERM binding found in intercellular adhesion molecule (ICAM)-2 and other adhesion molecules of the immunoglobulin superfamily. Ultracentrifugation sedimentation studies and circular dichroism measurements revealed an extended monomeric form of the cytoplasmic peptide in solution. The crystal structure of the radixin FERM domain complexed with a CD44 cytoplasmic peptide reveals that the KKKLVIN sequence of the peptide forms a beta strand followed by a short loop structure that binds subdomain C of the FERM domain. Like Motif-1 binding, theCD44 beta strand binds the shallow groove between strand beta 5C and helix alpha 1C and augments the beta sheet beta 5C-beta 7C from subdomain C. Two hydrophobic CD44 residues, Leu and Ile, are docked into a hydrophobic pocket with the formation of hydrogen bonds between Asn of the CD44 short loop and loop beta 4C-beta 5C from subdomain C. This binding mode resembles that of NEP (neutral endopeptidase 24.11) rather than ICAM-2. Our results reveal a characteristic versatility of peptide recognition by the FERM domains from ERM proteins, suggest a possible mechanism by which the CD44 tail is released from the cytoskeleton for nuclear translocation by regulated intramembrane proteolysis, and provide a structural basis for Smad1 interactions with activated CD44 bound to ERM protein.	[Mori, Tomoyuki; Kitano, Ken; Terawaki, Shin-ichi; Maesaki, Ryoko; Fukami, Yayoi; Hakoshima, Toshio] Nara Inst Sci & Technol, Struct Biol Lab, Nara 6300192, Japan; [Hakoshima, Toshio] Japan Sci & Technol Agcy, CREST, Nara 6300192, Japan	Nara Institute of Science & Technology; Japan Science & Technology Agency (JST)	Hakoshima, T (corresponding author), Nara Inst Sci & Technol, Struct Biol Lab, 8916-5 Takayama, Nara 6300192, Japan.	hakosima@bs.naist.jp	Terawaki, Shin-ichi/V-7082-2019	Terawaki, Shin-ichi/0000-0002-2859-0589; Mori, Tomoyuki/0000-0003-2019-5370	Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan	Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by a grant-in-aid for scientific research ( A) and scientific research on priority areas from the Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan (to T. H.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bajorath J, 2000, PROTEINS, V39, P103, DOI 10.1002/(SICI)1097-0134(20000501)39:2<103::AID-PROT1>3.3.CO;2-7; Banerji S, 2007, NAT STRUCT MOL BIOL, V14, P234, DOI 10.1038/nsmb1201; Bonilha VL, 1999, J CELL BIOL, V147, P1533, DOI 10.1083/jcb.147.7.1533; Bourguignon LYW, 2000, J BIOL CHEM, V275, P1829, DOI 10.1074/jbc.275.3.1829; Bretscher A, 2002, NAT REV MOL CELL BIO, V3, P586, DOI 10.1038/nrm882; Brown KL, 2005, EXP CELL RES, V303, P400, DOI 10.1016/j.yexcr.2004.10.002; Brown MS, 2000, CELL, V100, P391, DOI 10.1016/S0092-8674(00)80675-3; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cichy J, 2003, J CELL BIOL, V161, P839, DOI 10.1083/jcb.200302098; Cywes C, 2001, NATURE, V414, P648, DOI 10.1038/414648a; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Dhalluin C, 2000, MOL CELL, V6, P921, DOI 10.1016/S1097-2765(00)00089-7; Eck MJ, 1996, CELL, V85, P695, DOI 10.1016/S0092-8674(00)81236-2; Fievet BT, 2004, J CELL BIOL, V164, P653, DOI 10.1083/jcb.200307032; Garcia-Alvarez B, 2003, MOL CELL, V11, P49, DOI 10.1016/S1097-2765(02)00823-7; GARY R, 1995, MOL BIOL CELL, V6, P1061, DOI 10.1091/mbc.6.8.1061; Hamada K, 2000, ACTA CRYSTALLOGR D, V56, P922, DOI 10.1107/S0907444900006363; Hamada K, 2000, EMBO J, V19, P4449, DOI 10.1093/emboj/19.17.4449; Hamada K, 2003, EMBO J, V22, P502, DOI 10.1093/emboj/cdg039; Hirao M, 1996, J CELL BIOL, V135, P37, DOI 10.1083/jcb.135.1.37; Ishikawa H, 2001, J MOL BIOL, V310, P973, DOI 10.1006/jmbi.2001.4818; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kawano Y, 2000, J BIOL CHEM, V275, P29628, DOI 10.1074/jbc.M002440200; Lammich S, 2002, J BIOL CHEM, V277, P44754, DOI 10.1074/jbc.M206872200; Lee JH, 2004, J CELL BIOL, V167, P327, DOI 10.1083/jcb.200403091; Legg JW, 2002, NAT CELL BIOL, V4, P399, DOI 10.1038/ncb797; Lesley J, 2000, J BIOL CHEM, V275, P26967; LESLEY J, 1992, J EXP MED, V175, P257, DOI 10.1084/jem.175.1.257; LESLEY J, 1993, ADV IMMUNOL, V54, P271, DOI 10.1016/S0065-2776(08)60537-4; Li QZ, 2007, J MOL BIOL, V365, P1446, DOI 10.1016/j.jmb.2006.10.075; Li SC, 1998, NAT STRUCT BIOL, V5, P1075, DOI 10.1038/4185; Liu DC, 1996, CELL IMMUNOL, V174, P73, DOI 10.1006/cimm.1996.0295; LOKESHWAR VB, 1991, J BIOL CHEM, V266, P17983; Martin TA, 2003, CRIT REV ONCOL HEMAT, V46, P165, DOI 10.1016/S1040-8428(02)00172-5; Matsui T, 1998, J CELL BIOL, V140, P647, DOI 10.1083/jcb.140.3.647; McClatchey AI, 2003, NAT REV CANCER, V3, P877, DOI 10.1038/nrc1213; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; Mori H, 2002, EMBO J, V21, P3949, DOI 10.1093/emboj/cdf411; Mori T, 2007, ACTA CRYSTALLOGR F, V63, P844, DOI 10.1107/S1744309107041152; Moustakas A, 2001, J CELL SCI, V114, P4359; Murakami D, 2003, ONCOGENE, V22, P1511, DOI 10.1038/sj.onc.1206298; Nagano O, 2004, CANCER SCI, V95, P930, DOI 10.1111/j.1349-7006.2004.tb03179.x; Naor D, 1997, ADV CANCER RES, V71, P241, DOI 10.1016/S0065-230X(08)60101-3; Okamoto I, 2001, J CELL BIOL, V155, P755, DOI 10.1083/jcb.200108159; Okamoto I, 1999, ONCOGENE, V18, P1435, DOI 10.1038/sj.onc.1202447; Oliferenko S, 2000, J CELL BIOL, V148, P1159, DOI 10.1083/jcb.148.6.1159; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pearson MA, 2000, CELL, V101, P259, DOI 10.1016/S0092-8674(00)80836-3; PERSCHL A, 1995, EUR J IMMUNOL, V25, P495, DOI 10.1002/eji.1830250228; Peterson RS, 2004, J CELL BIOL, V166, P1081, DOI 10.1083/jcb.200402138; Pietromonaco SF, 1998, J BIOL CHEM, V273, P7594, DOI 10.1074/jbc.273.13.7594; Ponta H, 2003, NAT REV MOL CELL BIO, V4, P33, DOI 10.1038/nrm1004; Pouponnot C, 1998, J BIOL CHEM, V273, P22865, DOI 10.1074/jbc.273.36.22865; Sainio M, 1997, J CELL SCI, V110, P2249; Sasaki A, 2001, J BIOL CHEM, V276, P17871, DOI 10.1074/jbc.M008422200; Shimizu T, 2002, J BIOL CHEM, V277, P10332, DOI 10.1074/jbc.M109979200; Takai Y, 2007, GENES CELLS, V12, P1329, DOI 10.1111/j.1365-2443.2007.01137.x; Tammi MI, 2002, J BIOL CHEM, V277, P4581, DOI 10.1074/jbc.R100037200; Terawaki S, 2006, STRUCTURE, V14, P777, DOI 10.1016/j.str.2006.01.015; Terawaki S, 2007, J BIOL CHEM, V282, P19854, DOI 10.1074/jbc.M609232200; Teriete P, 2004, MOL CELL, V13, P483, DOI 10.1016/S1097-2765(04)00080-2; THOMAS L, 1992, J CELL BIOL, V118, P971, DOI 10.1083/jcb.118.4.971; Thorne RF, 2004, J CELL SCI, V117, P373, DOI 10.1242/jcs.00954; Toole BP, 2002, J BIOL CHEM, V277, P4593, DOI 10.1074/jbc.R100039200; Tsukazaki T, 1998, CELL, V95, P779, DOI 10.1016/S0092-8674(00)81701-8; TSUKITA S, 1994, J CELL BIOL, V126, P391, DOI 10.1083/jcb.126.2.391; Tsukita S, 1999, J BIOL CHEM, V274, P34507, DOI 10.1074/jbc.274.49.34507; Wegener KL, 2007, CELL, V128, P171, DOI 10.1016/j.cell.2006.10.048; Wu G, 2000, SCIENCE, V287, P92, DOI 10.1126/science.287.5450.92; Yonemura S, 1998, J CELL BIOL, V140, P885, DOI 10.1083/jcb.140.4.885; Yonemura S, 2002, J CELL SCI, V115, P2569; Yonemura S, 1999, J CELL BIOL, V145, P1497, DOI 10.1083/jcb.145.7.1497; Zohar R, 2000, J CELL PHYSIOL, V184, P118, DOI 10.1002/(SICI)1097-4652(200007)184:1<118::AID-JCP13>3.3.CO;2-P	74	86	93	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 24	2008	283	43					29602	29612		10.1074/jbc.M803606200	http://dx.doi.org/10.1074/jbc.M803606200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	362EB	18753140	Green Published, hybrid			2022-12-27	WOS:000260179900086
J	Shi, ZH; Rudzinski, M; Meerovitch, K; Lebrun-Julien, F; Birman, E; Di Polo, A; Saragovi, HU				Shi, ZhiHua; Rudzinski, Marcelo; Meerovitch, Karen; Lebrun-Julien, Frederic; Birman, Elena; Di Polo, Adriana; Saragovi, H. Uri			alpha 2-Macroglobulin Is a Mediator of Retinal Ganglion Cell Death in Glaucoma	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECEPTOR-RELATED PROTEIN; ELEVATED INTRAOCULAR-PRESSURE; DIFFERENTIAL GENE-EXPRESSION; PROMOTED NEURITE OUTGROWTH; METHYL-D-ASPARTATE; OPTIC-NERVE HEAD; MICROARRAY ANALYSIS; AMYLOID-BETA; TNF-ALPHA; ALPHA(2)-MACROGLOBULIN	Glaucoma is defined as a chronic and progressive optic nerve neuropathy, characterized by apoptosis of retinal ganglion cells (RGC) that leads to irreversible blindness. Ocular hypertension is a major risk factor, but in glaucoma RGC death can persist after ocular hypertension is normalized. To understand the mechanism underlying chronic RGC death we identified and characterized a gene product, alpha 2-macroglobulin (alpha 2M), whose expression is up-regulated early in ocular hypertension and remains up-regulated long after ocular hypertension is normalized. In ocular hypertension retinal glia up-regulate alpha 2M, which binds to low-density lipoprotein receptor-related protein-1 receptors in RGCs, and is neurotoxic in a paracrine fashion. Neutralization of alpha 2M delayed RGC loss during ocular hypertension; whereas delivery of alpha 2M to normal eyes caused progressive apoptosis of RGC mimicking glaucoma without ocular hypertension. This work adds to our understanding of the pathology and molecular mechanisms of glaucoma, and illustrates emerging paradigms for studying chronic neurodegeneration in glaucoma and perhaps other disorders.	[Shi, ZhiHua; Birman, Elena; Saragovi, H. Uri] McGill Univ, Lady Davis Inst Jewish Gen Hosp, Montreal, PQ, Canada; [Rudzinski, Marcelo; Saragovi, H. Uri] McGill Univ, Dept Pharmacol & Therapeut, Montreal, PQ, Canada; [Meerovitch, Karen] McGill Univ, Dept Biochem, Montreal, PQ, Canada; [Saragovi, H. Uri] McGill Univ, Dept Oncol, Montreal, PQ, Canada; [Saragovi, H. Uri] McGill Univ, Ctr Canc, Montreal, PQ, Canada; [Lebrun-Julien, Frederic; Di Polo, Adriana] Univ Montreal, Dept Pathol & Cell Biol, Montreal, PQ H3T 1J4, Canada; [Lebrun-Julien, Frederic; Di Polo, Adriana] Univ Montreal, Dept Ophthalmol, Montreal, PQ H3T 1J4, Canada	Lady Davis Institute; McGill University; McGill University; McGill University; McGill University; McGill University; Universite de Montreal; Universite de Montreal	Saragovi, HU (corresponding author), 3755 Cote St Catherine,E-535, Montreal, PQ H3T 1E2, Canada.	uri.saragovi@mcgill.ca			National Institutes of Health [CA82642]; Canadian Institutes of Health Research [MT13265, MOP57690]; NATIONAL CANCER INSTITUTE [R01CA082642] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA82642. This work was also supported by Canadian Institutes of Health Research Grants MT13265 and MOP57690. Patents have been licensed to Mimetogen Pharmaceuticals Inc., and H. U. S. discloses interest in the company. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Ahmed F, 2004, INVEST OPHTH VIS SCI, V45, P1247, DOI 10.1167/iovs.03-1123; Bacskai BJ, 2000, P NATL ACAD SCI USA, V97, P11551, DOI 10.1073/pnas.200238297; Birkenmeier G, 1997, FEBS LETT, V416, P193, DOI 10.1016/S0014-5793(97)01201-5; Bruno MA, 2004, J NEUROSCI, V24, P8009, DOI 10.1523/JNEUROSCI.1508-04.2004; Bu GJ, 2006, ANN NY ACAD SCI, V1086, P35, DOI 10.1196/annals.1377.005; Chiabrando GA, 2002, J NEUROSCI RES, V70, P57, DOI 10.1002/jnr.10369; Di Polo A, 1998, P NATL ACAD SCI USA, V95, P3978, DOI 10.1073/pnas.95.7.3978; Esson DW, 2004, INVEST OPHTH VIS SCI, V45, P4450, DOI 10.1167/iovs.04-0375; Fabrizi C, 1999, EXP NEUROL, V155, P252, DOI 10.1006/exnr.1998.6978; Fabrizi C, 2001, J NEUROCHEM, V78, P406, DOI 10.1046/j.1471-4159.2001.00419.x; Farkas RH, 2001, INT OPHTHALMOL CLIN, V41, P111, DOI 10.1097/00004397-200101000-00011; Gonias SL, 2000, J BIOL CHEM, V275, P5826, DOI 10.1074/jbc.275.8.5826; Gourine AV, 2002, AM J PHYSIOL-REG I, V283, pR218, DOI 10.1152/ajpregu.00746.2001; Guo L, 2007, P NATL ACAD SCI USA, V104, P13444, DOI 10.1073/pnas.0703707104; Halpern D Lynn, 2002, Ophthalmol Clin North Am, V15, P61, DOI 10.1016/S0896-1549(01)00012-8; HART WM, 1982, OPHTHALMOLOGY, V89, P268; Hartwick ATE, 2001, OPTOMETRY VISION SCI, V78, P85, DOI 10.1097/00006324-200102000-00008; Hashimoto Y, 2000, J NEUROSCI, V20, P8401, DOI 10.1523/JNEUROSCI.20-22-08401.2000; Hayashi H, 2007, J NEUROSCI, V27, P1933, DOI 10.1523/JNEUROSCI.5471-06.2007; Hernandez MR, 2002, GLIA, V38, P45, DOI 10.1002/glia.10051; Herz J, 2003, J CLIN INVEST, V112, P1483, DOI 10.1172/JCI200320337; Huang W, 2005, P NATL ACAD SCI USA, V102, P12242, DOI 10.1073/pnas.0505138102; JAMES K, 1992, IMMUNOL LETT, V32, P49, DOI 10.1016/0165-2478(92)90198-W; Ji JZ, 2005, VISION RES, V45, P169, DOI 10.1016/j.visres.2004.08.008; KASS MA, 1989, ARCH OPHTHALMOL-CHIC, V107, P1590, DOI 10.1001/archopht.1989.01070020668025; Kerrigan LA, 1997, ARCH OPHTHALMOL-CHIC, V115, P1031, DOI 10.1001/archopht.1997.01100160201010; Kovacs DM, 2000, EXP GERONTOL, V35, P473, DOI 10.1016/S0531-5565(00)00113-3; Kwon YH, 2003, J GLAUCOMA, V12, P409, DOI 10.1097/00061198-200310000-00003; Laquis S, 1998, BRAIN RES, V784, P100, DOI 10.1016/S0006-8993(97)01189-X; Lee PG, 1999, J NEUROSCI RES, V57, P872, DOI 10.1002/(SICI)1097-4547(19990915)57:6<872::AID-JNR13>3.3.CO;2-9; Levin LA, 2001, J GLAUCOMA, V10, pS19, DOI 10.1097/00061198-200110001-00008; Lipton S A, 2001, Prog Brain Res, V131, P712; Lo WR, 2003, INVEST OPHTH VIS SCI, V44, P473, DOI 10.1167/iovs.02-0444; Maliartchouk S, 2000, MOL PHARMACOL, V57, P385; McKinnon SJ, 2003, FRONT BIOSCI-LANDMRK, V8, pS1140, DOI 10.2741/1172; Miyahara T, 2003, INVEST OPHTH VIS SCI, V44, P4347, DOI 10.1167/iovs.02-1032; MOORE CG, 1995, CURR EYE RES, V14, P711, DOI 10.3109/02713689508998499; Nakazawa T, 2006, J NEUROSCI, V26, P12633, DOI 10.1523/JNEUROSCI.2801-06.2006; OBRIEN C, 1991, AM J OPHTHALMOL, V111, P491, DOI 10.1016/S0002-9394(14)72386-4; Pang IH, 2005, INVEST OPHTH VIS SCI, V46, P1313, DOI 10.1167/iovs.04-0829; Pease ME, 2000, INVEST OPHTH VIS SCI, V41, P764; Qiu ZH, 2004, J BIOL CHEM, V279, P34948, DOI 10.1074/jbc.M401055200; Qiu ZH, 2002, J BIOL CHEM, V277, P14458, DOI 10.1074/jbc.M112066200; Qiu ZH, 2001, J NEUROPATH EXP NEUR, V60, P430, DOI 10.1093/jnen/60.5.430; Rudzinski M, 2004, J NEUROBIOL, V58, P341, DOI 10.1002/neu.10293; Rudzinski Marcelo, 2005, Current Medicinal Chemistry - Central Nervous System Agents, V5, P43; Saragovi HU, 2005, J NEUROCHEM, V95, P1472, DOI 10.1111/j.1471-4159.2005.03479.x; Shi Z, 2007, DEV NEUROBIOL, V67, P884, DOI 10.1002/dneu.20360; Siu AW, 2002, EXP EYE RES, V75, P401, DOI 10.1006/exer.2002.2029; Skornicka EL, 2002, J NEUROSCI RES, V67, P346, DOI 10.1002/jnr.10097; Soto I, 2008, J NEUROSCI, V28, P548, DOI 10.1523/JNEUROSCI.3714-07.2008; Tezel G, 2001, INVEST OPHTH VIS SCI, V42, P1787; Vorwerk CK, 2000, INVEST OPHTH VIS SCI, V41, P3615; Waldron E, 2006, NEURODEGENER DIS, V3, P233, DOI 10.1159/000095261; WEGENKA UM, 1993, MOL CELL BIOL, V13, P276, DOI 10.1128/MCB.13.1.276; WoldeMussie E, 2002, J GLAUCOMA, V11, P474, DOI 10.1097/00061198-200212000-00003; WOLF BB, 1994, BIOCHEMISTRY-US, V33, P11270, DOI 10.1021/bi00203a024; Wu SM, 1998, J IMMUNOL, V161, P4356; Zenkel M, 2005, INVEST OPHTH VIS SCI, V46, P3742, DOI 10.1167/iovs.05-0249; Zhou Y, 2005, MOL THER, V12, P402, DOI 10.1016/j.ymthe.2005.04.004	60	35	35	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 24	2008	283	43					29156	29165		10.1074/jbc.M802365200	http://dx.doi.org/10.1074/jbc.M802365200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	362EB	18701465	hybrid, Green Published			2022-12-27	WOS:000260179900043
J	Celic, A; Petri, ET; Demeler, B; Ehrlich, BE; Boggon, TJ				Celic, Andjelka; Petri, Edward T.; Demeler, Borries; Ehrlich, Barbara E.; Boggon, Titus J.			Domain mapping of the polycystin-2 C-terminal tail using de novo molecular modeling and biophysical analysis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN SECONDARY STRUCTURE; KIDNEY-DISEASE; CATION CHANNEL; PKD2; GENE; PREDICTION; INTERACTS; DICHROWEB	In polycystic kidney disease (PKD), polycystin-2 (PC2) is frequently mutated or truncated in the C-terminal cytoplasmic tail (PC2-C). The currently accepted model of PC2-C consists of an EF-hand motif overlapping with a short coiled coil; however, this model fails to explain the mechanisms by which PC2 truncations C-terminal to this region lead to PKD. Moreover, direct PC2 binding to inositol 1,4,5-trisphosphate receptor, KIF3A, and TRPC1 requires residues in PC2-C outside this region. To address these discrepancies and investigate the role of PC2-C in PC2 function, we performed de novo molecular modeling and biophysical analysis. De novo molecular modeling of PC2-C using the ROBETTA server predicts two domains as follows: an EF-hand motif (PC2-EF) connected by a linker to a previously unidentified C-terminal coiled coil (PC2-CC). This model differs substantially from the current model and correlates with limited proteolysis, matrix-assisted laser desorption/ionization mass spectroscopy, N-terminal sequencing, and improved coiled coil prediction algorithms. PC2-C is elongated and oligomerizes through PC2-CC, as measured by analytical ultracentrifugation and size exclusion chromatography, whereas PC2-EF is globular and monomeric. We show that PC2-C and PC2-EF have micromolar affinity for calcium (Ca2+) by isothermal titration calorimetry and undergo Ca2+-induced conformational changes by circular dichroism. Mutation of predicted EF-hand loop residues in PC2 to alanine abolishes Ca2+ binding. Our results suggest that PC2-CC is involved in PC2 oligomerization, and PC2-EF is a Ca2+-sensitive switch. PKD-associated PC2 mutations are located in regions that may disrupt these functions, providing structural insight into how PC2 mutations lead to disease.	[Celic, Andjelka; Petri, Edward T.; Ehrlich, Barbara E.; Boggon, Titus J.] Yale Univ, Sch Med, Dept Pharmacol, New Haven, CT 06520 USA; [Ehrlich, Barbara E.] Yale Univ, Sch Med, Dept Cellular & Mol Physiol, New Haven, CT 06520 USA; [Demeler, Borries] Univ Texas Hlth Sci Ctr San Antonio, Ctr Analyt Ultracentrifugat Macromol Assemblies, San Antonio, TX 78229 USA	Yale University; Yale University; University of Texas System; University of Texas Health San Antonio	Ehrlich, BE (corresponding author), Yale Univ, Sch Med, Dept Pharmacol, 333 Cedar St, New Haven, CT 06520 USA.	barbara.ehrlich@yale.edu; titus.boggon@yale.edu	Celic, Andjeka S/AAC-1865-2022; /AAX-8408-2021	/0000-0001-9657-9704; Celic, Andjelka/0000-0002-1058-6872; Demeler, Borries/0000-0002-2414-9518; Petri, Edward/0000-0002-3650-1523	National Institutes of Health [DK57328, CA009085, RR022200, CA054174]; PKD Foundation; Robert J. Kleberg Jr., and Helen C. Kleberg Foundation; National Science Foundation [TGMCB070038]; NATIONAL CANCER INSTITUTE [T32CA009085, P30CA054174] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [R01RR022200] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P50DK057328] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); PKD Foundation; Robert J. Kleberg Jr., and Helen C. Kleberg Foundation; National Science Foundation(National Science Foundation (NSF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK57328 ( to B. E. E.), CA009085 ( training grant to E. T. P.), RR022200 (UltraScan software development), and CA054174 ( to the Center for Analytical Ultracentrifugation of Macromolecular Assemblies facility). This work was also supported in part by a grant from the PKD Foundation, UltraScan software development was also supported by the Robert J. Kleberg Jr., and Helen C. Kleberg Foundation, and AUC calculations were supported by National Science Foundation Grant TGMCB070038 ( to B. D.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Anyatonwu GI, 2005, J BIOL CHEM, V280, P29488, DOI 10.1074/jbc.M504359200; BROOKES E, 2006, P 2006 ACM IEEE C SU; Cai YQ, 2004, J BIOL CHEM, V279, P19987, DOI 10.1074/jbc.M312031200; Chivian D, 2005, PROTEINS, V61, P157, DOI 10.1002/prot.20733; Chivian D, 2003, PROTEINS, V53, P524, DOI 10.1002/prot.10529; Clapham DE, 2003, NATURE, V426, P517, DOI 10.1038/nature02196; Cohn E. J., 1943, PROTEINS AMINO ACIDS; Delmas P, 2004, BIOL RES, V37, P681; Delorenzi M, 2002, BIOINFORMATICS, V18, P617, DOI 10.1093/bioinformatics/18.4.617; Demeler B, 1998, BIOPHYS J, V74, P444, DOI 10.1016/S0006-3495(98)77802-6; Demeler B, 1997, BIOPHYS J, V72, P397, DOI 10.1016/S0006-3495(97)78680-6; Demeler B, 2004, ANAL BIOCHEM, V335, P279, DOI 10.1016/j.ab.2004.08.039; Demeler B, 2008, COLLOID POLYM SCI, V286, P129, DOI 10.1007/s00396-007-1699-4; Demeler B, 2005, ANALYTICAL ULTRACENTRIFUGATION: TECHNIQUES AND METHODS, P210; Diemand AV, 2004, NUCLEIC ACIDS RES, V32, pW512, DOI 10.1093/nar/gkh403; Gattiker A, 2002, PROTEOMICS, V2, P1435, DOI 10.1002/1615-9861(200210)2:10<1435::AID-PROT1435>3.0.CO;2-9; Gifford JL, 2007, BIOCHEM J, V405, P199, DOI 10.1042/BJ20070255; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; Gonzalez-Perrett S, 2001, P NATL ACAD SCI USA, V98, P1182, DOI 10.1073/pnas.021456598; Hanaoka K, 2000, NATURE, V408, P990, DOI 10.1038/35050128; Kim DE, 2004, NUCLEIC ACIDS RES, V32, pW526, DOI 10.1093/nar/gkh468; Koulen P, 2002, NAT CELL BIOL, V4, P191, DOI 10.1038/ncb754; LAUE TM, 1992, MODERN ANAL ULTRACEN, P90; Li Q, 2003, J MOL BIOL, V325, P949, DOI 10.1016/S0022-2836(02)01333-5; Li Q, 2003, BIOCHEMISTRY-US, V42, P450, DOI 10.1021/bi0267792; Li Q, 2006, J BIOL CHEM, V281, P37566, DOI 10.1074/jbc.M603643200; Li XG, 2005, NAT CELL BIOL, V7, P1202, DOI 10.1038/ncb1326; Li Y, 2005, J BIOL CHEM, V280, P41298, DOI 10.1074/jbc.M510082200; Lobley A, 2002, BIOINFORMATICS, V18, P211, DOI 10.1093/bioinformatics/18.1.211; Luo Y, 2003, MOL CELL BIOL, V23, P2600, DOI 10.1128/MCB.23.7.2600-2607.2003; Lupas AN, 2005, ADV PROTEIN CHEM, V70, P37, DOI 10.1016/S0065-3233(04)70003-0; Mochizuki T, 1996, SCIENCE, V272, P1339, DOI 10.1126/science.272.5266.1339; Pei Y, 1998, KIDNEY INT, V53, P1127, DOI 10.1046/j.1523-1755.1998.00890.x; Qian F, 1997, NAT GENET, V16, P179, DOI 10.1038/ng0697-179; Reynolds DM, 1999, J AM SOC NEPHROL, V10, P2342; Somlo S, 2001, CURR BIOL, V11, pR356, DOI 10.1016/S0960-9822(01)00193-2; Somlo S, 2000, CURR OPIN NEPHROL HY, V9, P385, DOI 10.1097/00041552-200007000-00010; Sreerama N, 2000, ANAL BIOCHEM, V287, P252, DOI 10.1006/abio.2000.4880; Tsiokas L, 1999, P NATL ACAD SCI USA, V96, P3934, DOI 10.1073/pnas.96.7.3934; Tsiokas L, 1997, P NATL ACAD SCI USA, V94, P6965, DOI 10.1073/pnas.94.13.6965; Tsuruda PR, 2006, NEURON, V51, P201, DOI 10.1016/j.neuron.2006.06.023; Whitmore L, 2004, NUCLEIC ACIDS RES, V32, pW668, DOI 10.1093/nar/gkh371; WU G, 1998, CELL, V93, P7; Xu GM, 2002, GENOMICS, V79, P87, DOI 10.1006/geno.2001.6684	44	61	64	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 17	2008	283	42					28305	28312		10.1074/jbc.M802743200	http://dx.doi.org/10.1074/jbc.M802743200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	359EN	18694932	hybrid, Green Published			2022-12-27	WOS:000259969300032
J	Jan, A; Gokce, O; Luthi-Carter, R; Lashuel, HA				Jan, Asad; Gokce, Ozgun; Luthi-Carter, Ruth; Lashuel, Hilal A.			The ratio of monomeric to aggregated forms of A beta 40 and A beta 42 is an important determinant of amyloid-beta aggregation, fibrillogenesis, and toxicity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FAMILIAL ALZHEIMERS-DISEASE; PROTEIN A-BETA; IN-VITRO; FIBRIL FORMATION; TRANSGENIC MICE; SENILE PLAQUES; MOUSE MODELS; LEWY BODIES; WILD-TYPE; PEPTIDE	Aggregation and fibril formation of amyloid-beta (A beta) peptides A beta 40 and A beta 42 are central events in the pathogenesis of Alzheimer disease. Previous studies have established the ratio of A beta 40 to A beta 42 as an important factor in determining the fibrillogenesis, toxicity, and pathological distribution of A beta. To better understand the molecular basis underlying the pathologic consequences associated with alterations in the ratio of A beta 40 to A beta 42, we probed the concentration- and ratio-dependent interactions between well defined states of the two peptides at different stages of aggregation along the amyloid formation pathway. We report that monomeric A beta 40 alters the kinetic stability, solubility, and morphological properties of A beta 42 aggregates and prevents their conversion into mature fibrils. A beta 40, at approximately equimolar ratios (A beta 40/A beta 42 similar to 0.5-1), inhibits (> 50%) fibril formation by monomeric A beta 42, whereas inhibition of protofibrillar A beta 42 fibrillogenesis is achieved at lower, substoichiometric ratios (A beta 40/A beta 42 similar to 0.1). The inhibitory effect of A beta 40 on A beta 42 fibrillogenesis is reversed by the introduction of excess A beta 42 monomer. Additionally, monomeric A beta 42 and A beta 40 are constantly recycled and compete for binding to the ends of protofibrillar and fibrillar A beta aggregates. Whereas the fibrillogenesis of both monomeric species can be seeded by fibrils composed of either peptide, A beta 42 protofibrils selectively seed the fibrillogenesis of monomeric A beta 42 but not monomeric A beta 40. Finally, we also show that the amyloidogenic propensities of different individual and mixed A beta species correlates with their relative neuronal toxicities. These findings, which highlight specific points in the amyloid peptide equilibrium that are highly sensitive to the ratio of A beta 40 to A beta 42, carry important implications for the pathogenesis and current therapeutic strategies of Alzheimer disease.	[Jan, Asad; Lashuel, Hilal A.] Ecole Polytech Fed Lausanne, Brain Mind Inst, Lab Mol Neurobiol & Neuroprote, CH-1015 Lausanne, Switzerland; [Gokce, Ozgun; Luthi-Carter, Ruth] Ecole Polytech Fed Lausanne, Brain Mind Inst, Lab Funct Neurogenom, CH-1015 Lausanne, Switzerland	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne	Lashuel, HA (corresponding author), Ecole Polytech Fed Lausanne, Brain Mind Inst, Lab Mol Neurobiol & Neuroprote, CH-1015 Lausanne, Switzerland.	hilal.lashuel@epfl.ch	Lashuel, Hilal/M-3500-2017; Jan, Asad/AAZ-2920-2021; Jan, Asad/D-4389-2009	Jan, Asad/0000-0002-3636-0070; Jan, Asad/0000-0002-3636-0070; gokce, ozgun/0000-0001-6319-404X	Swiss Federal Institute of Technology [310000-110027]	Swiss Federal Institute of Technology	This work was supported by the Swiss Federal Institute of Technology Lausanne (all investigators) and Grant 310000-110027 from the Swiss National Science Foundation (to H. L. A. and A. J.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Anderton BH, 1998, PROG NEUROBIOL, V55, P595, DOI 10.1016/S0301-0082(98)00022-7; ARISPE N, 1993, P NATL ACAD SCI USA, V90, P567, DOI 10.1073/pnas.90.2.567; Bibl M, 2006, J NEURAL TRANSM, V113, P1771, DOI 10.1007/s00702-006-0537-z; Bibl M, 2006, BRAIN, V129, P1177, DOI 10.1093/brain/awl063; BLOW DM, 1994, PROTEIN SCI, V3, P1638, DOI 10.1002/pro.5560031003; Borchelt DR, 1996, NEURON, V17, P1005, DOI 10.1016/S0896-6273(00)80230-5; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; BURDICK D, 1992, J BIOL CHEM, V267, P546; BUSCIGLIO J, 1993, P NATL ACAD SCI USA, V90, P2092, DOI 10.1073/pnas.90.5.2092; Carulla N, 2005, NATURE, V436, P554, DOI 10.1038/nature03986; Caughey B, 2003, ANNU REV NEUROSCI, V26, P267, DOI 10.1146/annurev.neuro.26.010302.081142; Cheng IH, 2007, J BIOL CHEM, V282, P23818, DOI 10.1074/jbc.M701078200; Citron M, 1997, NAT MED, V3, P67, DOI 10.1038/nm0197-67; Collins SR, 2004, PLOS BIOL, V2, P1582, DOI 10.1371/journal.pbio.0020321; Cupers P, 2001, J CELL BIOL, V154, P731, DOI 10.1083/jcb.200104045; Dahlgren KN, 2002, J BIOL CHEM, V277, P32046, DOI 10.1074/jbc.M201750200; DePace AH, 2002, NAT STRUCT BIOL, V9, P389, DOI 10.1038/nsb786; Dickson DW, 1997, J NEUROPATH EXP NEUR, V56, P321, DOI 10.1097/00005072-199704000-00001; Esler WP, 2000, BIOCHEMISTRY-US, V39, P6288, DOI 10.1021/bi992933h; Frost D, 2003, EUR J BIOCHEM, V270, P654, DOI 10.1046/j.1432-1033.2003.03415.x; Glenner G G, 1984, Appl Pathol, V2, P357; GRAVINA SA, 1995, J BIOL CHEM, V270, P7013, DOI 10.1074/jbc.270.13.7013; HAASS C, 1992, NATURE, V359, P322, DOI 10.1038/359322a0; Hardy J, 1997, P NATL ACAD SCI USA, V94, P2095, DOI 10.1073/pnas.94.6.2095; HARDY JA, 1992, SCIENCE, V256, P184, DOI 10.1126/science.1566067; Harper JD, 1997, ANNU REV BIOCHEM, V66, P385, DOI 10.1146/annurev.biochem.66.1.385; Hartley DM, 1999, J NEUROSCI, V19, P8876, DOI 10.1523/JNEUROSCI.19-20-08876.1999; Hasegawa K, 1999, BIOCHEMISTRY-US, V38, P15514, DOI 10.1021/bi991161m; Herzig MC, 2004, NAT NEUROSCI, V7, P954, DOI 10.1038/nn1302; Hsia AY, 1999, P NATL ACAD SCI USA, V96, P3228, DOI 10.1073/pnas.96.6.3228; IWATSUBO T, 1994, NEURON, V13, P45, DOI 10.1016/0896-6273(94)90458-8; IWATSUBO T, 1995, ANN NEUROL, V37, P294, DOI 10.1002/ana.410370305; JARRETT JT, 1993, CELL, V73, P1055, DOI 10.1016/0092-8674(93)90635-4; JARRETT JT, 1993, BIOCHEMISTRY-US, V32, P4693, DOI 10.1021/bi00069a001; Jensen M, 1999, ANN NEUROL, V45, P504, DOI 10.1002/1531-8249(199904)45:4<504::AID-ANA12>3.0.CO;2-9; JOACHIM CL, 1988, ANN NEUROL, V24, P50, DOI 10.1002/ana.410240110; Kim J, 2007, J NEUROSCI, V27, P627, DOI 10.1523/JNEUROSCI.4849-06.2007; Klafki HW, 1996, J BIOL CHEM, V271, P28655, DOI 10.1074/jbc.271.45.28655; Kodali R, 2007, CURR OPIN STRUC BIOL, V17, P48, DOI 10.1016/j.sbi.2007.01.007; Krebs MRH, 2004, PROTEIN SCI, V13, P1933, DOI 10.1110/ps.04707004; Lambert MP, 1998, P NATL ACAD SCI USA, V95, P6448, DOI 10.1073/pnas.95.11.6448; Lashuel HA, 2002, J MOL BIOL, V322, P1089, DOI 10.1016/S0022-2836(02)00735-0; Lashuel HA, 2003, J MOL BIOL, V332, P795, DOI 10.1016/S0022-2836(03)00927-6; Lashuel HA, 2002, NATURE, V418, P291, DOI 10.1038/418291a; Lemere CA, 1996, NAT MED, V2, P1146, DOI 10.1038/nm1096-1146; Lomakin A, 1997, P NATL ACAD SCI USA, V94, P7942, DOI 10.1073/pnas.94.15.7942; LORENZO A, 1994, P NATL ACAD SCI USA, V91, P12243, DOI 10.1073/pnas.91.25.12243; McGowan E, 2005, NEURON, V47, P191, DOI 10.1016/j.neuron.2005.06.030; MILLER DL, 1993, ARCH BIOCHEM BIOPHYS, V301, P41, DOI 10.1006/abbi.1993.1112; Mucke L, 2000, J NEUROSCI, V20, P4050, DOI 10.1523/jneurosci.20-11-04050.2000; Nichols MR, 2002, BIOCHEMISTRY-US, V41, P6115, DOI 10.1021/bi015985r; O'Nuallain B, 2005, BIOCHEMISTRY-US, V44, P12709, DOI 10.1021/bi050927h; O'Nuallain B, 2004, J BIOL CHEM, V279, P17490, DOI 10.1074/jbc.M311300200; PACE CN, 1995, PROTEIN SCI, V4, P2411, DOI 10.1002/pro.5560041120; Selkoe DJ, 2001, PHYSIOL REV, V81, P741, DOI 10.1152/physrev.2001.81.2.741; SELKOE DJ, 1991, NEURON, V6, P487, DOI 10.1016/0896-6273(91)90052-2; SELKOE DJ, 1991, SCI AM, V265, P40, DOI 10.1038/scientificamerican1191-68; SEUBERT P, 1992, NATURE, V359, P325, DOI 10.1038/359325a0; SHERRINGTON R, 1995, NATURE, V375, P754, DOI 10.1038/375754a0; SHOJI M, 1992, SCIENCE, V258, P126, DOI 10.1126/science.1439760; Shoji M, 1998, J NEUROL SCI, V158, P134, DOI 10.1016/S0022-510X(98)00122-1; TAMAOKA A, 1994, BIOCHEM BIOPH RES CO, V205, P834, DOI 10.1006/bbrc.1994.2740; Walsh DM, 1997, J BIOL CHEM, V272, P22364, DOI 10.1074/jbc.272.35.22364; Walsh DM, 2005, BIOCHEM SOC T, V33, P1087, DOI 10.1042/BST0331087; Walsh DM, 1999, J BIOL CHEM, V274, P25945, DOI 10.1074/jbc.274.36.25945; Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a; Wiltfang J, 2007, J NEUROCHEM, V101, P1053, DOI 10.1111/j.1471-4159.2006.04404.x; Wogulis M, 2005, J NEUROSCI, V25, P1071, DOI 10.1523/JNEUROSCI.2381-04.2005; Yan YL, 2007, J MOL BIOL, V369, P909, DOI 10.1016/j.jmb.2007.04.014; Yankner BA, 1996, NAT MED, V2, P850, DOI 10.1038/nm0896-850; YOUNKIN SG, 1995, ANN NEUROL, V37, P287, DOI 10.1002/ana.410370303; Zala D, 2005, NEUROBIOL DIS, V20, P785, DOI 10.1016/j.nbd.2005.05.017; Zou K, 2003, J NEUROCHEM, V87, P609, DOI 10.1046/j.1471-4159.2003.02018.x	74	201	203	0	39	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 17	2008	283	42					28176	28189		10.1074/jbc.M803159200	http://dx.doi.org/10.1074/jbc.M803159200			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	359EN	18694930	Green Published, hybrid			2022-12-27	WOS:000259969300020
J	Zhuo, Y; Chammas, R; Bellis, SL				Zhuo, Ya; Chammas, Roger; Bellis, Susan L.			Sialylation of beta 1 Integrins blocks cell adhesion to galectin-3 and protects cells against galectin-3-induced apoptosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN COLON-CANCER; MYELOID FIBRONECTIN RECEPTORS; BINDING-PROTEINS; N-GLYCOSYLATION; CARCINOMA CELLS; CARCINOEMBRYONIC ANTIGEN; PROSTATE-CANCER; RAT-LIVER; EXPRESSION; DEATH	In previous studies, we determined that beta 1 integrins from human colon tumors have elevated levels of alpha 2-6 sialylation, a modification added by beta-galactosamide alpha-2,6-sialyltranferase I (ST6Gal-I). Intriguingly, the beta 1 integrin is thought to be a ligand for galectin-3 (gal-3), a tumor-associated lectin. The effects of gal-3 are complex; intracellular forms typically protect cells against apoptosis through carbohydrate-independent mechanisms, whereas secreted forms bind to cell surface oligosaccharides and induce apoptosis. In the current study, we tested whether alpha 2-6 sialylation of the beta 1 integrin modulates binding to extracellular gal-3. Herein we report that SW48 colonocytes lacking alpha 2-6 sialylation exhibit beta 1 integrin-dependent binding to gal-3-coated tissue culture plates; however, binding is attenuated upon forced expression of ST6Gal-I. Removal of alpha 2-6 sialic acids from ST6Gal-I expressors by neuraminidase treatment restores gal-3 binding. Additionally, using a blot overlay approach, we determined that gal-3 binds directly and preferentially to unsialylated, as compared with alpha 2-6-sialylated, beta 1 integrins. To understand the physiologic consequences of gal-3 binding, cells were treated with gal-3 and monitored for apoptosis. Galectin-3 was found to induce apoptosis in parental SW48 colonocytes ( unsialylated), whereas ST6Gal-I expressors were protected. Importantly, gal-3-induced apoptosis was inhibited by function blocking antibodies against the beta 1 subunit, suggesting that beta 1 integrins are critical transducers of gal-3-mediated effects on cell survival. Collectively, our results suggest that the coordinate up-regulation of gal-3 and ST6Gal-I, a feature that is characteristic of colon carcinoma, may confer tumor cells with a selective advantage by providing a mechanism for blockade of the pro-apoptotic effects of secreted gal-3.	[Zhuo, Ya; Bellis, Susan L.] Univ Alabama Birmingham, Dept Physiol & Biophys, Birmingham, AL 35294 USA; [Chammas, Roger] Univ Sao Paulo, Fac Med, BR-01246903 Sao Paulo, Brazil	University of Alabama System; University of Alabama Birmingham; Universidade de Sao Paulo	Bellis, SL (corresponding author), 982A MCLM,1918 Univ Blvd, Birmingham, AL 35294 USA.	bellis@physiology.uab.edu	Chammas, Roger/A-8004-2011	Chammas, Roger/0000-0003-0342-8726	NCI NIH HHS [R01CA84248] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA084248] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Akahani S, 1997, CANCER RES, V57, P5272; Amano M, 2003, J BIOL CHEM, V278, P7469, DOI 10.1074/jbc.M209595200; Andre S, 2007, FEBS J, V274, P3233, DOI 10.1111/j.1742-4658.2007.05851.x; Ashery U, 2006, CELL MOL NEUROBIOL, V26, P471, DOI 10.1007/s10571-006-9059-3; Bellis SL, 2004, BBA-BIOMEMBRANES, V1663, P52, DOI 10.1016/j.bbamem.2004.03.012; Bremer E, 2006, TRENDS MOL MED, V12, P382, DOI 10.1016/j.molmed.2006.06.002; BRESALIER RS, 1990, CANCER RES, V50, P1299; Bresalier RS, 1998, GASTROENTEROLOGY, V115, P287, DOI 10.1016/S0016-5085(98)70195-7; Cabrera PV, 2006, BLOOD, V108, P2399, DOI 10.1182/blood-2006-04-018556; Califice S, 2004, ONCOGENE, V23, P7527, DOI 10.1038/sj.onc.1207997; Chammas R, 1996, MOL BIOL CELL, V7, P1691, DOI 10.1091/mbc.7.11.1691; Dall'Olio Fabio, 2000, Glycoconjugate Journal, V17, P669, DOI 10.1023/A:1011077000164; DALLOLIO F, 1995, BIOCHEM BIOPH RES CO, V211, P554, DOI 10.1006/bbrc.1995.1849; Dalziel M, 2004, EUR J BIOCHEM, V271, P3623, DOI 10.1111/j.1432-1033.2004.04284.x; de Melo FHM, 2007, J HISTOCHEM CYTOCHEM, V55, P1015, DOI 10.1369/jhc.7A7174.2007; Demetriou M, 2001, NATURE, V409, P733, DOI 10.1038/35055582; Dennis J W, 1991, Semin Cancer Biol, V2, P411; Dumic J, 2006, BBA-GEN SUBJECTS, V1760, P616, DOI 10.1016/j.bbagen.2005.12.020; Elad-Sfadia G, 2004, J BIOL CHEM, V279, P34922, DOI 10.1074/jbc.M312697200; Elola MT, 2007, CELL MOL LIFE SCI, V64, P1679, DOI 10.1007/s00018-007-7044-8; Fernandez GC, 2005, GLYCOBIOLOGY, V15, P519, DOI 10.1093/glycob/cwi026; Fukumori T, 2003, CANCER RES, V63, P8302; Fukumori T, 2004, CANCER RES, V64, P3376, DOI 10.1158/0008-5472.CAN-04-0336; Gorelik E, 2001, CANCER METAST REV, V20, P245, DOI 10.1023/A:1015535427597; Hakomori S, 1996, CANCER RES, V56, P5309; HAY R, 1994, ATCC CELL LINES HYBR; Hirabayashi J, 2002, BBA-GEN SUBJECTS, V1572, P232, DOI 10.1016/S0304-4165(02)00311-2; Holikova Z, 2002, APMIS, V110, P845, DOI 10.1034/j.1600-0463.2002.1101202.x; Hughes RC, 1999, BBA-GEN SUBJECTS, V1473, P172, DOI 10.1016/S0304-4165(99)00177-4; Iurisci I, 2000, CLIN CANCER RES, V6, P1389; Kannicht C, 1999, GLYCOBIOLOGY, V9, P897, DOI 10.1093/glycob/9.9.897; Lahm H, 2003, GLYCOCONJUGATE J, V20, P227, DOI 10.1023/B:GLYC.0000025817.24297.17; Lanteri M, 2003, GLYCOBIOLOGY, V13, P909, DOI 10.1093/glycob/cwg110; LEMARER N, 1995, GLYCOBIOLOGY, V5, P219, DOI 10.1093/glycob/5.2.219; Leppanen A, 2005, J BIOL CHEM, V280, P5549, DOI 10.1074/jbc.m412019200; Lin SQ, 2002, EXP CELL RES, V276, P101, DOI 10.1006/excr.2002.5521; Liu FT, 2005, NAT REV CANCER, V5, P29, DOI 10.1038/nrc1527; Nakahara S, 2005, APOPTOSIS, V10, P267, DOI 10.1007/s10495-005-0801-y; Ochieng J, 2002, GLYCOCONJUGATE J, V19, P527, DOI 10.1023/B:GLYC.0000014082.99675.2f; OHANNESIAN DW, 1995, CANCER RES, V55, P2191; Partridge EA, 2004, SCIENCE, V306, P120, DOI 10.1126/science.1102109; ROSENBERG I, 1991, J BIOL CHEM, V266, P18731; Seales EC, 2005, J BIOL CHEM, V280, P37610, DOI 10.1074/jbc.M508476200; Seales EC, 2005, CANCER RES, V65, P4645, DOI 10.1158/0008-5472.CAN-04-3117; Seales EC, 2003, ONCOGENE, V22, P7137, DOI 10.1038/sj.onc.1206834; Semel AC, 2002, J BIOL CHEM, V277, P32830, DOI 10.1074/jbc.M202493200; Silva-Monteiro E, 2007, AM J PATHOL, V170, P546, DOI 10.2353/ajpath.2007.060389; Stillman BN, 2006, J IMMUNOL, V176, P778, DOI 10.4049/jimmunol.176.2.778; Stowell SR, 2008, J BIOL CHEM, V283, P10109, DOI 10.1074/jbc.M709545200; Suzuki O, 2006, INT J ONCOL, V28, P155; Suzuki O, 2008, ONCOL REP, V19, P743; Suzuki Y, 2008, BBA-MOL CELL RES, V1783, P924, DOI 10.1016/j.bbamcr.2008.01.025; Toscano MA, 2007, NAT IMMUNOL, V8, P825, DOI 10.1038/ni1482; Valenzuela HF, 2007, CANCER RES, V67, P6155, DOI 10.1158/0008-5472.CAN-05-4431; Yang RY, 1996, P NATL ACAD SCI USA, V93, P6737, DOI 10.1073/pnas.93.13.6737; Yu F, 2002, J BIOL CHEM, V277, P15819, DOI 10.1074/jbc.M200154200; Zhu YT, 2001, BBA-MOL BASIS DIS, V1536, P148, DOI 10.1016/S0925-4439(01)00044-8	57	118	121	0	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 8	2008	283	32					22177	22185		10.1074/jbc.M8000015200	http://dx.doi.org/10.1074/jbc.M8000015200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	332WV	18676377	Green Published, Bronze			2022-12-27	WOS:000258114700037
J	Lu, J; Holmgren, A				Lu, Jun; Holmgren, Arne			Selenoproteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							MAMMALIAN THIOREDOXIN REDUCTASE; SELENOENZYME GLUTATHIONE-PEROXIDASE; MUSCULAR-DYSTROPHY; SELENOCYSTEINE; MECHANISM; MUTATIONS; SELENIUM; EXPRESSION; SUBSTRATE; PROTEINS	Selenium is an essential micronutrient for man and animals. The role of selenium has been attributed largely to its presence in selenoproteins as the 21st amino acid, selenocysteine ( Sec, U). Sec is encoded by TGA in DNA. A unique mechanism is used to decode the UGA codon in mRNA to co-translationally incorporate Sec into the growing polypeptide because there is no free pool of Sec. In the human genome, 25 genes for selenoproteins have been identified. Selenoproteins such as glutathione peroxidases, thioredoxin reductases, and iodothyronine deiodinases are involved in redox reactions, and Sec is an active-site residue essential for catalytic activity. Selenoproteins have biological functions in oxidoreductions, redox signaling, antioxidant defense, thyroid hormone metabolism, and immune responses. They thus possess a strong correlation with human diseases such as cancer, Keshan disease, virus infections, male infertility, and abnormalities in immune responses and thyroid hormone function.	[Lu, Jun; Holmgren, Arne] Karolinska Inst, Dept Med Biochem & Biophys, Med Nobel Inst Biochem, SE-17177 Stockholm, Sweden	Karolinska Institutet	Holmgren, A (corresponding author), Karolinska Inst, Dept Med Biochem & Biophys, Med Nobel Inst Biochem, SE-17177 Stockholm, Sweden.	Arne.Holmgren@ki.se	Lu, Jun/E-9701-2017	Lu, Jun/0000-0002-1699-8835	Swedish Cancer Society [961]; Swedish Research Medicine Council [13x-3529]; K. A. Wallenberg Foundation; Karolinska Institute	Swedish Cancer Society(Swedish Cancer Society); Swedish Research Medicine Council; K. A. Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Karolinska Institute(Karolinska Institutet)	This work was supported by Swedish Cancer Society Grant 961, Swedish Research Medicine Council Grant 13x-3529, a K. A. Wallenberg Foundation grant, and the Karolinska Institute. This is the third article of three in the Thematic Minireview Series on Metals in Biology. This minireview will be reprinted in the 2009 Minireview Compendium, which will be available in January, 2010.	Aachmann FL, 2007, J BIOL CHEM, V282, P37036, DOI 10.1074/jbc.M705410200; Arner ESJ, 2006, SEMIN CANCER BIOL, V16, P420, DOI 10.1016/j.semcancer.2006.10.009; Arner ESJ, 2000, EUR J BIOCHEM, V267, P6102, DOI 10.1046/j.1432-1327.2000.01701.x; Banning A, 2005, MOL CELL BIOL, V25, P4914, DOI 10.1128/MCB.25.12.4914-4923.2005; Bianco AC, 2005, THYROID, V15, P777, DOI 10.1089/thy.2005.15.777; Biterova EI, 2005, P NATL ACAD SCI USA, V102, P15018, DOI 10.1073/pnas.0504218102; BJORNSTEDT M, 1992, J BIOL CHEM, V267, P8030; BOCK A, 1991, TRENDS BIOCHEM SCI, V16, P463, DOI 10.1016/0968-0004(91)90180-4; Brigelius-Flohe R, 1999, FREE RADICAL BIO MED, V27, P951, DOI 10.1016/S0891-5849(99)00173-2; Burk RF, 2005, ANNU REV NUTR, V25, P215, DOI 10.1146/annurev.nutr.24.012003.132120; Callebaut I, 2003, J BIOL CHEM, V278, P36887, DOI 10.1074/jbc.M305725200; Curran JE, 2005, NAT GENET, V37, P1234, DOI 10.1038/ng1655; Dikiy A, 2007, BIOCHEMISTRY-US, V46, P6871, DOI 10.1021/bi602462q; Dumitrescu AM, 2005, NAT GENET, V37, P1247, DOI 10.1038/ng1654; EPP O, 1983, EUR J BIOCHEM, V133, P51, DOI 10.1111/j.1432-1033.1983.tb07429.x; Fang JG, 2005, J BIOL CHEM, V280, P25284, DOI 10.1074/jbc.M414645200; Ferguson AD, 2006, J BIOL CHEM, V281, P3536, DOI 10.1074/jbc.M511386200; Ferreiro A, 2002, AM J HUM GENET, V71, P739, DOI 10.1086/342719; Gladyshev VN, 1996, P NATL ACAD SCI USA, V93, P6146, DOI 10.1073/pnas.93.12.6146; Gromer S, 2005, CELL MOL LIFE SCI, V62, P2414, DOI 10.1007/s00018-005-5143-y; Hadaszadeh BM, 2006, PHYSIOLOGY, V21, P307, DOI 10.1152/physiol.00021.2006; Hatfield D.L., 2002, SELENIUM ITS MOL BIO, V36, P235, DOI 10.1080/10715760290006394; Hoffmann PR, 2005, THYROID, V15, P769, DOI 10.1089/thy.2005.15.769; HOLMGREN A, 1989, J BIOL CHEM, V264, P13963; Johansson L, 2005, BBA-GEN SUBJECTS, V1726, P1, DOI 10.1016/j.bbagen.2005.05.010; Kryukov GV, 2003, SCIENCE, V300, P1439, DOI 10.1126/science.1083516; Kuiper GGJM, 2005, THYROID, V15, P787, DOI 10.1089/thy.2005.15.787; KUMAR S, 1992, EUR J BIOCHEM, V207, P435, DOI 10.1111/j.1432-1033.1992.tb17068.x; LADENSTEIN R, 1979, J MOL BIOL, V134, P199, DOI 10.1016/0022-2836(79)90032-9; Lee SR, 1999, J BIOL CHEM, V274, P4722, DOI 10.1074/jbc.274.8.4722; Lillig CH, 2007, ANTIOXID REDOX SIGN, V9, P25, DOI 10.1089/ars.2007.9.25; Lu J, 2006, CANCER RES, V66, P4410, DOI 10.1158/0008-5472.CAN-05-3310; Lu J, 2007, P NATL ACAD SCI USA, V104, P12288, DOI 10.1073/pnas.0701549104; Moghadaszadeh B, 2001, NAT GENET, V29, P17, DOI 10.1038/ng713; Novoselov SV, 2007, J BIOL CHEM, V282, P11960, DOI 10.1074/jbc.M701605200; Papp LV, 2006, MOL CELL BIOL, V26, P4895, DOI 10.1128/MCB.02284-05; Ren B, 1997, J MOL BIOL, V268, P869, DOI 10.1006/jmbi.1997.1005; Sakurai A, 2005, J CELL PHYSIOL, V203, P529, DOI 10.1002/jcp.20246; Sandalova T, 2001, P NATL ACAD SCI USA, V98, P9533, DOI 10.1073/pnas.171178698; Scheerer P, 2007, BIOCHEMISTRY-US, V46, P9041, DOI 10.1021/bi700840d; Squires JE, 2008, IUBMB LIFE, V60, P232, DOI 10.1002/iub.38; Sun QA, 1999, J BIOL CHEM, V274, P24522, DOI 10.1074/jbc.274.35.24522; Sun QA, 2001, P NATL ACAD SCI USA, V98, P3673, DOI 10.1073/pnas.051454398; Urig S, 2006, SEMIN CANCER BIOL, V16, P452, DOI 10.1016/j.semcancer.2006.09.004; Ursini F, 1999, SCIENCE, V285, P1393, DOI 10.1126/science.285.5432.1393; Papp LV, 2007, ANTIOXID REDOX SIGN, V9, P775, DOI 10.1089/ars.2007.1528; Zhon LW, 1998, J BIOL CHEM, V273, P8581, DOI 10.1074/jbc.273.15.8581; Zhong LW, 2000, P NATL ACAD SCI USA, V97, P5854, DOI 10.1073/pnas.100114897; Zhong LW, 2000, J BIOL CHEM, V275, P18121, DOI 10.1074/jbc.M000690200	49	493	508	2	106	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 9	2009	284	2					723	727		10.1074/jbc.R800045200	http://dx.doi.org/10.1074/jbc.R800045200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	389VP	18757362	hybrid			2022-12-27	WOS:000262122900004
J	Nebert, DW; Karp, CL				Nebert, Daniel W.; Karp, Christopher L.			Endogenous Functions of the Aryl Hydrocarbon Receptor (AHR): Intersection of Cytochrome P450 1 (CYP1)-metabolized Eicosanoids and AHR Biology	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							ARACHIDONIC-ACID METABOLISM; EPOXYEICOSATRIENOIC ACIDS; OMEGA-HYDROXYLATION; FATTY-ACIDS; STEREOSELECTIVE FORMATION; ARYLHYDROCARBON RECEPTOR; EICOSAPENTAENOIC ACID; SEMINAL-VESICLES; CYP4A ISOFORMS; MOUSE SKIN		[Nebert, Daniel W.] Univ Cincinnati, Med Ctr, Dept Environm Hlth, Cincinnati, OH 45267 USA; [Nebert, Daniel W.] Univ Cincinnati, Med Ctr, Ctr Environm Genet, Cincinnati, OH 45267 USA; [Karp, Christopher L.] Univ Cincinnati, Coll Med, Cincinnati Childrens Hosp Res Fdn, Div Mol Immunol, Cincinnati, OH 45229 USA	University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati; Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Research Foundation; University System of Ohio; University of Cincinnati	Nebert, DW (corresponding author), Univ Cincinnati, Med Ctr, Dept Environm Hlth, Cincinnati, OH 45267 USA.	dan.nebert@uc.edu		Karp, Christopher/0000-0002-0832-2659	National Institutes of Health [P30 ES06096]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES006096] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grant P30 ES06096. This minireview will be reprinted in the 2008 Minireview Compendium, which will be available in January, 2009.	Aitken AE, 2001, ARCH BIOCHEM BIOPHYS, V393, P329, DOI 10.1006/abbi.2001.2501; AOYAMA T, 1990, J LIPID RES, V31, P1477; Bannenberg GL, 2004, J EXP MED, V199, P515, DOI 10.1084/jem.20031325; Barouki R, 2007, FEBS LETT, V581, P3608, DOI 10.1016/j.febslet.2007.03.046; Boverhof DR, 2004, MOL PHARMACOL, V66, P1662, DOI 10.1124/mol.104.002915; Bylund J, 2000, J BIOL CHEM, V275, P21844, DOI 10.1074/jbc.M001712200; Bylund J, 2001, ARCH BIOCHEM BIOPHYS, V389, P123, DOI 10.1006/abbi.2001.2322; Chang MS, 1996, BIOCHEMISTRY-US, V35, P464, DOI 10.1021/bi952081v; Choudhary D, 2004, DRUG METAB DISPOS, V32, P840, DOI 10.1124/dmd.32.8.840; Chuang SS, 2004, J BIOL CHEM, V279, P6305, DOI 10.1074/jbc.M311830200; Cowart LA, 2002, J BIOL CHEM, V277, P35105, DOI 10.1074/jbc.M201575200; Dey A, 1998, BIOCHEM BIOPH RES CO, V251, P657, DOI 10.1006/bbrc.1998.9519; Dragin N, 2008, MOL PHARMACOL, V73, P1844, DOI 10.1124/mol.108.045658; Du LP, 2006, J PHARMACOL EXP THER, V316, P371, DOI 10.1124/jpet.105.093922; Du LP, 2005, ARCH BIOCHEM BIOPHYS, V435, P125, DOI 10.1016/j.abb.2004.11.023; Fer M, 2008, ARCH BIOCHEM BIOPHYS, V471, P116, DOI 10.1016/j.abb.2008.01.002; FERNANDEZSALGUERO P, 1995, SCIENCE, V268, P722, DOI 10.1126/science.7732381; Frericks M, 2007, TOXICOL APPL PHARM, V220, P320, DOI 10.1016/j.taap.2007.01.014; Fritsche E, 2007, P NATL ACAD SCI USA, V104, P8851, DOI 10.1073/pnas.0701764104; GIELEN JE, 1971, J BIOL CHEM, V246, P5189; Hahn ME, 2006, J EXP ZOOL PART A, V305A, P693, DOI 10.1002/jez.a.323; Hao CM, 2008, ANNU REV PHYSIOL, V70, P357, DOI 10.1146/annurev.physiol.70.113006.100614; Harmon SD, 2006, PROSTAG LEUKOTR ESS, V75, P169, DOI 10.1016/j.plefa.2006.05.005; HAWKINS DJ, 1989, ARCH BIOCHEM BIOPHYS, V268, P447, DOI 10.1016/0003-9861(89)90312-3; HOLM KA, 1989, ARCH BIOCHEM BIOPHYS, V269, P664, DOI 10.1016/0003-9861(89)90151-3; IMAOKA S, 1993, J PHARMACOL EXP THER, V267, P1012; Ito SJ, 2007, J CLIN INVEST, V117, P1940, DOI 10.1172/JCI31647; Jiang HL, 2007, PROSTAG OTH LIPID M, V82, P4, DOI 10.1016/j.prostaglandins.2006.05.013; Jiang JG, 2005, CANCER RES, V65, P4707, DOI 10.1158/0008-5472.CAN-04-4173; Kalsotra A, 2004, TOXICOL APPL PHARM, V199, P295, DOI 10.1016/j.taap.2003.12.033; Kalsotra A, 2007, ARCH BIOCHEM BIOPHYS, V461, P104, DOI 10.1016/j.abb.2007.02.027; Kawashima H, 1997, ARCH BIOCHEM BIOPHYS, V347, P148, DOI 10.1006/abbi.1997.0342; Keeney DS, 1998, J BIOL CHEM, V273, P32071, DOI 10.1074/jbc.273.48.32071; Kikuta Y, 2000, ARCH BIOCHEM BIOPHYS, V383, P225, DOI 10.1006/abbi.2000.2078; KIMURA S, 1987, Journal of Experimental Pathology (New York), V3, P61; King LM, 2002, MOL PHARMACOL, V61, P840, DOI 10.1124/mol.61.4.840; Kulas J, 2008, ARCH BIOCHEM BIOPHYS, V472, P65, DOI 10.1016/j.abb.2008.02.002; Labitzke EM, 2007, ARCH BIOCHEM BIOPHYS, V468, P70, DOI 10.1016/j.abb.2007.08.012; LAETHEM RM, 1993, J BIOL CHEM, V268, P12912; Lahvis GP, 2005, MOL PHARMACOL, V67, P714, DOI 10.1124/mol.104.008888; Le Quere V, 2004, J LIPID RES, V45, P1446, DOI 10.1194/jlr.M300463-JLR200; Machado FS, 2008, J EXP MED, V205, P1077, DOI 10.1084/jem.20072416; McMillan BJ, 2007, MOL PHARMACOL, V72, P487, DOI 10.1124/mol.107.037259; Mezentsev A, 2005, J PHARMACOL EXP THER, V315, P42, DOI 10.1124/jpet.105.088211; Michaelis UR, 2005, ARTERIOSCL THROM VAS, V25, P321, DOI 10.1161/01.ATV.0000151648.58516.eb; Miyata N, 2001, BRIT J PHARMACOL, V133, P325, DOI 10.1038/sj.bjp.0704101; Montuschi P, 2008, MINI-REV MED CHEM, V8, P647, DOI 10.2174/138955708784567395; Muller DN, 2007, BIOCHEM J, V403, P109, DOI 10.1042/BJ20061328; Nebert DW, 2006, NAT REV CANCER, V6, P947, DOI 10.1038/nrc2015; Nebert DW, 2002, LANCET, V360, P1155, DOI 10.1016/S0140-6736(02)11203-7; Nigam S, 2007, FEBS J, V274, P3503, DOI 10.1111/j.1742-4658.2007.05910.x; Node K, 1999, SCIENCE, V285, P1276, DOI 10.1126/science.285.5431.1276; Oleksiak MF, 2003, ARCH BIOCHEM BIOPHYS, V411, P223, DOI 10.1016/S0003-9861(02)00734-8; Oliw EH, 2001, BIOCHEM PHARMACOL, V62, P407, DOI 10.1016/S0006-2952(01)00683-9; Peebles KA, 2007, EXPERT REV ANTICANC, V7, P1405, DOI 10.1586/14737140.7.10.1405; Plastaras JP, 2000, J BIOL CHEM, V275, P11784, DOI 10.1074/jbc.275.16.11784; Qu W, 2001, J BIOL CHEM, V276, P25467, DOI 10.1074/jbc.M100545200; RIFKIND AB, 1995, ARCH BIOCHEM BIOPHYS, V320, P380, DOI 10.1016/0003-9861(95)90023-3; Romano M, 2007, THESCIENTIFICWORLDJO, V7, P1393, DOI 10.1100/tsw.2007.186; Salinthone Sonemany, 2008, Endocrine Metabolic & Immune Disorders-Drug Targets, V8, P132, DOI 10.2174/187153008784534303; Schwarz D, 2004, BIOCHEM PHARMACOL, V67, P1445, DOI 10.1016/j.bcp.2003.12.023; Seidel SD, 2001, J BIOCHEM MOL TOXIC, V15, P187; Serhan CN, 2007, ANNU REV IMMUNOL, V25, P101, DOI 10.1146/annurev.immunol.25.022106.141647; Seta F, 2007, PROSTAG OTH LIPID M, V84, P116, DOI 10.1016/j.prostaglandins.2007.05.001; Shi LZ, 2007, J IMMUNOL, V179, P6952, DOI 10.4049/jimmunol.179.10.6952; Stark K, 2004, BASIC CLIN PHARMACOL, V94, P177; Su AI, 2002, P NATL ACAD SCI USA, V99, P4465, DOI 10.1073/pnas.012025199; TANAKA S, 1990, BIOCHIM BIOPHYS ACTA, V1043, P177, DOI 10.1016/0005-2760(90)90293-7; Thompson CM, 2000, J PHARMACOL EXP THER, V294, P1120; Tsitsigiannis DI, 2007, TRENDS MICROBIOL, V15, P109, DOI 10.1016/j.tim.2007.01.005; Vance RE, 2004, P NATL ACAD SCI USA, V101, P2135, DOI 10.1073/pnas.0307308101; Ward NC, 2008, HYPERTENSION, V51, P1393, DOI 10.1161/HYPERTENSIONAHA.107.104463; Wu ZL, 2006, MOL PHARMACOL, V69, P2007, DOI 10.1124/mol.106.023648	73	116	119	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 26	2008	283	52					36061	36065		10.1074/jbc.R800053200	http://dx.doi.org/10.1074/jbc.R800053200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	385VA	18713746	Green Published, hybrid			2022-12-27	WOS:000261840500001
J	Sancar, A				Sancar, Aziz			Structure and Function of Photolyase and in Vivo Enzymology: 50th Anniversary	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							BLUE-LIGHT PHOTORECEPTOR; ESCHERICHIA-COLI; DNA PHOTOLYASE; CRYSTAL-STRUCTURE; ELECTRON-TRANSFER; PHOTOREACTIVATING ENZYME; 2ND CHROMOPHORE; CIRCADIAN CLOCK; ACTION SPECTRUM; ENERGY-TRANSFER	Photoreactivation is the reversal of the harmful effects of far-UV radiation (200-300 nm) on organisms, such as growth delay, mutation, cell death, and cancer, by concomitant or subsequent exposure of the organism to near-UV/blue light (300-500 nm). The two major lesions induced in DNA by UV light are cyclobutane pyrimidine dimers (Pyr <> Pyr(2) or CPD), which constitute similar to 80-90% of the photoproducts, and pyrimidine-pyrimidone (6-4) photoproducts (Pyr[6-4] Pyr), which account for the 10-20% of the UV lesions. Photoreactivation results from the repair of these lesions in situ by flavoproteins called photoreactivating enzymes (photolyase) that use a blue-light photon as a co-substrate. Photolyases that repair these two photoproducts are evolutionarily related but functionally distinct. Enzymes that repair CPDs are referred to as CPD photolyase, and enzymes that repair (6-4) photoproducts are called (6-4) photolyase. For historical reasons and as a matter of common practice, the term "photolyase" without further qualification means CPD photolyase, and it will be used as such in this review, which celebrates the 50th anniversary of the discovery of photolyase.	Univ N Carolina, Sch Med, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Sancar, A (corresponding author), Univ N Carolina, Sch Med, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA.	aziz_sancar@med.unc.edu			National Institutes of Health [GM31082]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM031082, R01GM031082] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM31082. This minireview will be reprinted in the 2008 Minireview Compendium, which will be available in January, 2009.	AHMAD M, 1993, NATURE, V366, P162, DOI 10.1038/366162a0; Bornemann S, 2002, NAT PROD REP, V19, P761, DOI 10.1039/b108916c; Brautigam CA, 2004, P NATL ACAD SCI USA, V101, P12142, DOI 10.1073/pnas.0404851101; Cashmore AR, 2003, CELL, V114, P537, DOI 10.1016/j.cell.2003.08.004; EKER AP, 1988, BIOCHEMISTRY-US, V27, P1758, DOI 10.1021/bi00405a056; Fujihashi M, 2007, J MOL BIOL, V365, P903, DOI 10.1016/j.jmb.2006.10.012; Gegear RJ, 2008, NATURE, V454, P1014, DOI 10.1038/nature07183; HARM W, 1968, MUTAT RES, V6, P371, DOI 10.1016/0027-5107(68)90054-7; Hitomi K, 2001, J BIOL CHEM, V276, P10103, DOI 10.1074/jbc.M008828200; Hoang N, 2008, PLOS BIOL, V6, P1559, DOI 10.1371/journal.pbio.0060160; Hsu DS, 1996, BIOCHEMISTRY-US, V35, P13871, DOI 10.1021/bi962209o; Huang YH, 2006, P NATL ACAD SCI USA, V103, P17701, DOI 10.1073/pnas.0608554103; HUSAIN I, 1987, J BIOL CHEM, V262, P13188; HUSAIN I, 1987, NUCLEIC ACIDS RES, V15, P1109; JOHNSON JL, 1988, P NATL ACAD SCI USA, V85, P2046, DOI 10.1073/pnas.85.7.2046; JORNS MS, 1984, BIOCHEMISTRY-US, V23, P2673, DOI 10.1021/bi00307a021; Kao YT, 2005, P NATL ACAD SCI USA, V102, P16128, DOI 10.1073/pnas.0506586102; Kavakli IH, 2004, BIOCHEMISTRY-US, V43, P15103, DOI 10.1021/bi0478796; KELNER A, 1949, P NATL ACAD SCI USA, V35, P73, DOI 10.1073/pnas.35.2.73; KIM ST, 1991, BIOCHEMISTRY-US, V30, P8623, DOI 10.1021/bi00099a019; KIM ST, 1992, BIOCHEMISTRY-US, V31, P11244, DOI 10.1021/bi00160a040; KIM ST, 1994, J BIOL CHEM, V269, P8535; Lin CT, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-5-220; Losi A, 2007, PHOTOCHEM PHOTOBIOL, V83, P1283, DOI 10.1111/j.1751-1097.2007.00196.x; MAUL MJ, 2008, ANGEW CHEM IN PRESS; Mees A, 2004, SCIENCE, V306, P1789, DOI 10.1126/science.1101598; Miyamoto Y, 1998, P NATL ACAD SCI USA, V95, P6097, DOI 10.1073/pnas.95.11.6097; Ozturk N, 2007, COLD SPRING HARB SYM, V72, P119, DOI 10.1101/sqb.2007.72.015; Ozturk N, 2008, J BIOL CHEM, V283, P3256, DOI 10.1074/jbc.M708612200; PARK HW, 1995, SCIENCE, V268, P1866, DOI 10.1126/science.7604260; Partch CL, 2005, PHOTOCHEM PHOTOBIOL, V81, P1291, DOI 10.1562/2005-07-08-IR-607; PAYNE G, 1990, BIOCHEMISTRY-US, V29, P7715, DOI 10.1021/bi00485a021; Ringe D, 2008, SCIENCE, V320, P1428, DOI 10.1126/science.1159747; RUPERT CS, 1958, J GEN PHYSIOL, V41, P451, DOI 10.1085/jgp.41.3.451; SANCAR A, 1984, J BIOL CHEM, V259, P6028; SANCAR A, 1994, BIOCHEMISTRY-US, V33, P2, DOI 10.1021/bi00167a001; Sancar A, 2004, J BIOL CHEM, V279, P34079, DOI 10.1074/jbc.R400016200; Sancar A, 2003, CHEM REV, V103, P2203, DOI 10.1021/cr0204348; SANCAR A, 1978, GENE, V4, P295, DOI 10.1016/0378-1119(78)90047-1; Saxena C, 2004, J PHYS CHEM B, V108, P18026, DOI 10.1021/jp048376c; Selby CP, 2006, P NATL ACAD SCI USA, V103, P17696, DOI 10.1073/pnas.0607993103; Song SH, 2007, J BIOL CHEM, V282, P17608, DOI 10.1074/jbc.M702874200; Stanewsky R, 1998, CELL, V95, P681, DOI 10.1016/S0092-8674(00)81638-4; Tamada T, 1997, NAT STRUCT BIOL, V4, P887, DOI 10.1038/nsb1197-887; Thresher RJ, 1998, SCIENCE, V282, P1490, DOI 10.1126/science.282.5393.1490; Todo T, 1996, SCIENCE, V272, P109, DOI 10.1126/science.272.5258.109; TODO T, 1993, NATURE, V361, P371, DOI 10.1038/361371a0; Ueda T, 2005, J BIOL CHEM, V280, P36237, DOI 10.1074/jbc.M507972200; vanVickle-Chavez SJ, 2007, J BIOL CHEM, V282, P10561, DOI 10.1074/jbc.M609314200; Widom J, 2005, P NATL ACAD SCI USA, V102, P16909, DOI 10.1073/pnas.0508686102; Yuan Q, 2007, MOL BIOL EVOL, V24, P948, DOI 10.1093/molbev/msm011; Zhao XD, 1997, J BIOL CHEM, V272, P32580, DOI 10.1074/jbc.272.51.32580	52	134	138	1	56	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 21	2008	283	47					32153	32157		10.1074/jbc.R800052200	http://dx.doi.org/10.1074/jbc.R800052200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	372HW	18682397	Green Published, hybrid			2022-12-27	WOS:000260893700001
J	Kim, MH; Kim, Y; Park, HJ; Lee, JS; Kwak, SN; Jung, WH; Lee, SG; Kim, D; Lee, YC; Oh, TK				Kim, Myung Hee; Kim, Yoonjeong; Park, Hyo-Jung; Lee, Jong Suk; Kwak, Su-Nam; Jung, Woo-Hyuk; Lee, Seung-Goo; Kim, Dooil; Lee, Young-Choon; Oh, Tae-Kwang			Structural Insight into Bioremediation of Triphenylmethane Dyes by Citrobacter sp Triphenylmethane Reductase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MALACHITE GREEN; PROTEIN; DECOLORIZATION; AZO; BIOTRANSFORMATION; PURIFICATION; PROGRAM; FUNGUS	Triphenylmethane dyes are aromatic xenobiotic compounds that are widely considered to be one of the main culprits of environmental pollution. Triphenylmethane reductase (TMR) from Citrobacter sp. strain KCTC 18061P was initially isolated and biochemically characterized as an enzyme that catalyzes the reduction of triphenylmethane dyes. Information from the primary amino acid sequence suggests that TMR is a dinucleotide-binding motif-containing enzyme; however, no other functional clues can be derived from sequence analysis. We present the crystal structure of TMR in complex with NADP(+) at 2.0-angstrom resolution. Despite limited sequence similarity, the enzyme shows remarkable structural similarity to short-chain dehydrogenase/reductase (SDR) family proteins. Functional assignments revealed that TMR has features of both classic and extended SDR family members and does not contain a conserved active site. Thus, it constitutes a novel class of SDR family proteins. On the basis of simulated molecular docking using the substrate malachite green and the TMR/NADP(+) crystal structure, together with site-directed mutagenesis, we have elucidated a potential molecular mechanism for triphenylmethane dye reduction.	[Kim, Myung Hee; Kim, Yoonjeong; Park, Hyo-Jung; Lee, Jong Suk; Kwak, Su-Nam; Jung, Woo-Hyuk; Lee, Seung-Goo; Kim, Dooil; Oh, Tae-Kwang] Korea Res Inst Biosci & Biotechnol, Syst Microbiol Res Ctr, Taejon 305806, South Korea; [Lee, Young-Choon] Dong A Univ, Coll Nat Resources & Life Sci, Pusan 604714, South Korea	Korea Research Institute of Bioscience & Biotechnology (KRIBB); Dong A University	Kim, MH (corresponding author), Korea Res Inst Biosci & Biotechnol, Syst Microbiol Res Ctr, Taejon 305806, South Korea.	mhk8n@kribb.re.kr; otk@kribb.re.kr	Lee, Seung-Goo/AAS-1613-2021; Lee, Seung-Goo/AAR-9823-2021	Lee, Seung-Goo/0000-0003-4539-9812; Park, Hyo-Jung/0000-0002-1601-7638	21C Frontier Microbial Genomics and Applications Center Program, MEST, Republic of Korea	21C Frontier Microbial Genomics and Applications Center Program, MEST, Republic of Korea(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This work was supported by funding from the 21C Frontier Microbial Genomics and Applications Center Program, MEST, Republic of Korea. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; An SY, 2002, BIOTECHNOL LETT, V24, P1037, DOI 10.1023/A:1015610018103; Azmi W, 1998, ENZYME MICROB TECH, V22, P185, DOI 10.1016/S0141-0229(97)00159-2; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Binkowski TA, 2003, NUCLEIC ACIDS RES, V31, P3352, DOI 10.1093/nar/gkg512; Cha CJ, 2001, APPL ENVIRON MICROB, V67, P4358, DOI 10.1128/AEM.67.9.4358-4360.2001; Cooper DR, 2007, ACTA CRYSTALLOGR D, V63, P636, DOI 10.1107/S0907444907010931; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Filling C, 2002, J BIOL CHEM, V277, P25677, DOI 10.1074/jbc.M202160200; Guerra-Lopez D, 2007, MICROBIOL-SGM, V153, P2724, DOI 10.1099/mic.0.2006/009241-0; Holm L, 1996, SCIENCE, V273, P595, DOI 10.1126/science.273.5275.595; Jadhav JP, 2006, YEAST, V23, P315, DOI 10.1002/yea.1356; Jang MS, 2005, APPL ENVIRON MICROB, V71, P7955, DOI 10.1128/AEM.71.12.7955-7960.2005; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; JORNVALL H, 1995, BIOCHEMISTRY-US, V34, P6003, DOI 10.1021/bi00018a001; Kallberg Y, 2002, EUR J BIOCHEM, V269, P4409, DOI 10.1046/j.1432-1033.2002.03130.x; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Liu WX, 2004, J IND MICROBIOL BIOT, V31, P127, DOI 10.1007/s10295-004-0123-z; Louie GV, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000993; Min TP, 2003, J BIOL CHEM, V278, P50714, DOI 10.1074/jbc.M308493200; Mulichak AM, 1999, P NATL ACAD SCI USA, V96, P13097, DOI 10.1073/pnas.96.23.13097; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nelson KE, 2004, NUCLEIC ACIDS RES, V32, P2386, DOI 10.1093/nar/gkh562; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Ren SZ, 2006, APPL MICROBIOL BIOT, V72, P1316, DOI 10.1007/s00253-006-0418-2; Robinson T, 2001, BIORESOURCE TECHNOL, V77, P247, DOI 10.1016/S0960-8524(00)00080-8; Schluter A, 2007, APPL ENVIRON MICROB, V73, P6345, DOI 10.1128/AEM.01177-07; Shedbalkar U, 2008, J HAZARD MATER, V157, P472, DOI 10.1016/j.jhazmat.2008.01.023; Sheffield P, 1999, PROTEIN EXPRES PURIF, V15, P34, DOI 10.1006/prep.1998.1003; Shin KS, 1998, BIOTECHNOL LETT, V20, P569; Stammers DK, 2001, EMBO J, V20, P6619, DOI 10.1093/emboj/20.23.6619; Tekere M, 2001, ENZYME MICROB TECH, V28, P420, DOI 10.1016/S0141-0229(00)00343-4; Terwilliger TC, 2001, ACTA CRYSTALLOGR D, V57, P1755, DOI 10.1107/S0907444901013737; Terwilliger TC, 1997, ACTA CRYSTALLOGR D, V53, P571, DOI 10.1107/S0907444997005398; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127; Weisburger JH, 2002, MUTAT RES-FUND MOL M, V506, P9, DOI 10.1016/S0027-5107(02)00147-1; Zheng XF, 2007, P NATL ACAD SCI USA, V104, P8809, DOI 10.1073/pnas.0700480104	39	31	32	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 14	2008	283	46					31981	31990		10.1074/jbc.M804092200	http://dx.doi.org/10.1074/jbc.M804092200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	370KJ	18782772	hybrid			2022-12-27	WOS:000260760800080
J	Harmon, S; Preston, RJS; Ainle, FN; Johnson, JA; Cunningham, MS; Smith, OP; White, B; O'Donnell, JS				Harmon, Shona; Preston, Roger J. S.; Ainle, Fionnuala Ni; Johnson, Jennifer A.; Cunningham, Moya S.; Smith, Owen P.; White, Barry; O'Donnell, James S.			Dissociation of Activated Protein C Functions by Elimination of Protein S Cofactor Enhancement	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							THROMBIN-SENSITIVE REGION; ENDOTHELIAL BARRIER PROTECTION; RANDOMIZED CONTROLLED-TRIAL; FACTOR PATHWAY INHIBITOR; HUMAN BRAIN ENDOTHELIUM; TISSUE FACTOR PATHWAY; SEVERE SEPSIS; GLA DOMAIN; ANTICOAGULANT ACTIVITY; PHOSPHOLIPID-BINDING	Activated protein C (APC) plays a critical anticoagulant role in vivo by inactivating procoagulant factor Va and factor VIIIa and thus down-regulating thrombin generation. In addition, APC bound to the endothelial cell protein C receptor can initiate protease-activated receptor-1 (PAR-1)-mediated cytoprotective signaling. Protein S constitutes a critical cofactor for the anticoagulant function of APC but is not known to be involved in regulating APC-mediated protective PAR-1 signaling. In this study we utilized a site-directed mutagenesis strategy to characterize a putative protein S binding region within the APC Gla domain. Three single amino acid substitutions within the APC Gla domain (D35T, D36A, and A39V) were found to mildly impair protein S-dependent anticoagulant activity (<2-fold) but retained entirely normal cytoprotective activity. However, a single amino acid substitution (L38D) ablated the ability of protein S to function as a cofactor for this APC variant. Consequently, in assays of protein S-dependent factor Va proteolysis using purified proteins or in the plasma milieu, APC-L38D variant exhibited minimal residual anticoagulant activity compared with wild type APC. Despite the location of Leu-38 in the Gla domain, APC-L38D interacted normally with endothelial cell protein C receptor and retained its ability to trigger PAR-1 mediated cytoprotective signaling in a manner indistinguishable from that of wild type APC. Consequently, elimination of protein S cofactor enhancement of APC anticoagulant function represents a novel and effective strategy by which to separate the anticoagulant and cytoprotective functions of APC for potential therapeutic gain.	[Harmon, Shona; Preston, Roger J. S.; Ainle, Fionnuala Ni; Johnson, Jennifer A.; Cunningham, Moya S.; O'Donnell, James S.] Trinity Coll Dublin, St James Hosp, Inst Mol Med, Haemostasis Res Grp, Dublin 8, Ireland; [Smith, Owen P.] Our Ladys Childrens Hosp Crumlin, Dept Haematol, Dublin 12, Ireland; [White, Barry; O'Donnell, James S.] St James Hosp, Natl Ctr Hereditary Coagulat Disorders, Dublin 8, Ireland	Trinity College Dublin; National Children's Research Centre (NCRC); Our Ladys Children Hospital Crumlin; Trinity College Dublin	Preston, RJS (corresponding author), Trinity Coll Dublin, St James Hosp, Inst Mol Med, Haemostasis Res Grp, Dublin 8, Ireland.	prestonr@tcd.ie	Smith, Owen/AAU-8929-2020; O'Donnell, James/A-6171-2009	Preston, Roger/0000-0003-0108-4077; Ni Ainle, Fionnuala/0000-0003-0163-792X; O'Donnell, James/0000-0003-0309-3313	Health Research Board [PD/2006/24]; Irish Heart Foundation; Children's Medical Research Foundation; Science Foundation Ireland President of Ireland Young Researcher [06/Y12/0925]	Health Research Board; Irish Heart Foundation; Children's Medical Research Foundation; Science Foundation Ireland President of Ireland Young Researcher(Science Foundation Ireland)	This work was supported by a Health Research Board Fellowship PD/2006/24 (to R. J. S. P.), an Irish Heart Foundation grant (to J. S. O. D.), a Children's Medical Research Foundation Award (to F. N. A. and O. P. S.), and Science Foundation Ireland President of Ireland Young Researcher Award 06/Y12/0925 (to J. S. O. D.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Abraham E, 2003, JAMA-J AM MED ASSOC, V290, P238, DOI 10.1001/jama.290.2.238; Bae JS, 2007, J BIOL CHEM, V282, P9251, DOI 10.1074/jbc.M610547200; Berg DT, 2003, P NATL ACAD SCI USA, V100, P4423, DOI 10.1073/pnas.0736918100; Bernard GR, 2001, NEW ENGL J MED, V344, P699, DOI 10.1056/NEJM200103083441001; Bertolini G, 2007, INTENS CARE MED, V33, P426, DOI 10.1007/s00134-007-0554-x; Cheng T, 2003, NAT MED, V9, P338, DOI 10.1038/nm826; DAHLBACK B, 1990, J BIOL CHEM, V265, P8127; Domotor E, 2003, BLOOD, V101, P4797, DOI 10.1182/blood-2002-12-3680; ESMON CT, 1989, J BIOL CHEM, V264, P4743; FAY PJ, 1991, J BIOL CHEM, V266, P20139; Feistritzer C, 2005, J THROMB HAEMOST, V3, P2798, DOI 10.1111/j.1538-7836.2005.01610.x; Feistritzer C, 2005, BLOOD, V105, P3178, DOI 10.1182/blood-2004-10-3985; Giri TK, 1999, THROMB HAEMOSTASIS, V82, P1627, DOI 10.1055/s-0037-1614890; Griffin JH, 2002, SEMIN HEMATOL, V39, P197, DOI 10.1053/shem.2002.34093; Hackeng TM, 2006, P NATL ACAD SCI USA, V103, P3106, DOI 10.1073/pnas.0504240103; Han MH, 2008, NATURE, V451, P1076, DOI 10.1038/nature06559; He XH, 1998, J BIOL CHEM, V273, P27449, DOI 10.1074/jbc.273.42.27449; HE XH, 1995, EUR J BIOCHEM, V227, P433, DOI 10.1111/j.1432-1033.1995.tb20406.x; Isermann B, 2007, NAT MED, V13, P1349, DOI 10.1038/nm1667; Joyce DE, 2001, J BIOL CHEM, V276, P11199, DOI 10.1074/jbc.C100017200; Kanji S, 2007, INTENS CARE MED, V33, P517, DOI 10.1007/s00134-007-0555-9; Kerschen EJ, 2007, J EXP MED, V204, P2439, DOI 10.1084/jem.20070404; Mille-Baker B, 2003, BLOOD, V101, P1416, DOI 10.1182/blood-2002-08-2353; Mosnier LO, 2007, J BIOL CHEM, V282, P33022, DOI 10.1074/jbc.M705824200; Mosnier LO, 2004, BLOOD, V104, P1740, DOI 10.1182/blood-2004-01-0110; NICOLAES GAF, 1995, J BIOL CHEM, V270, P21158, DOI 10.1074/jbc.270.36.21158; Preston RJS, 2005, FEBS J, V272, P97, DOI 10.1111/j.1432-1033.2004.04401.x; Preston RJS, 2006, J BIOL CHEM, V281, P28850, DOI 10.1074/jbc.M604966200; REITSMA PH, 1993, THROMB HAEMOSTASIS, V69, P77; Riewald M, 2005, J BIOL CHEM, V280, P19808, DOI 10.1074/jbc.M500747200; Riewald M, 2002, SCIENCE, V296, P1880, DOI 10.1126/science.1071699; Saller F, 2006, J THROMB HAEMOST, V4, P704, DOI 10.1111/j.1538-7836.2006.01827.x; Saller F, 2005, BLOOD, V105, P122, DOI 10.1182/blood-2004-06-2176; Scaldaferri F, 2007, J CLIN INVEST, V117, P1951, DOI 10.1172/JCI31027; SELIGSOHN U, 1984, NEW ENGL J MED, V310, P559, DOI 10.1056/NEJM198403013100904; Smirnov MD, 1998, J BIOL CHEM, V273, P9031, DOI 10.1074/jbc.273.15.9031; StearnsKurosawa DJ, 1996, P NATL ACAD SCI USA, V93, P10212, DOI 10.1073/pnas.93.19.10212; WALKER FJ, 1979, BIOCHIM BIOPHYS ACTA, V571, P333, DOI 10.1016/0005-2744(79)90103-7; WALKER FJ, 1984, SEMIN THROMB HEMOST, V10, P131, DOI 10.1055/s-2007-1004415; Warren BL, 2001, JAMA-J AM MED ASSOC, V286, P1869, DOI 10.1001/jama.286.15.1869; White B, 2000, BRIT J HAEMATOL, V110, P130, DOI 10.1046/j.1365-2141.2000.02128.x; Yegneswaran S, 1999, J BIOL CHEM, V274, P5462, DOI 10.1074/jbc.274.9.5462	42	38	41	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 7	2008	283	45					30531	30539		10.1074/jbc.M802338200	http://dx.doi.org/10.1074/jbc.M802338200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	367ID	18779332	Green Published, hybrid			2022-12-27	WOS:000260544800011
J	Chong, YE; Yang, XL; Schimmel, P				Chong, Yeeting E.; Yang, Xiang-Lei; Schimmel, Paul			Natural Homolog of tRNA Synthetase Editing Domain Rescues Conditional Lethality Caused by Mistranslation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RIBONUCLEIC-ACID SYNTHETASE; ISOLEUCYL-TRANSFER-RNA; ESCHERICHIA-COLI; PROTEIN-SYNTHESIS; CELL VIABILITY; ENZYME; VALINE; DISCRIMINATION; DEACYLATION; REJECTION	AlaXp is a widely distributed (from bacteria to humans) genome-encoded homolog of the editing domain of alanyl-tRNA synthetases. Editing repairs the confusion of serine and glycine for alanine through clearance of mischarged (with Ser or Gly) tRNA(Ala). Because genome-encoded fragments of editing domains of other synthetases are scarce, the AlaXp redundancy of the editing domain of alanyl-tRNA synthetase is thought to reflect an unusual sensitivity of cells to mistranslation at codons for Ala. Indeed, a small defect in the editing activity of alanyl-tRNA synthetase is causally linked to neurodegeneration in the mouse. Although limited earlier studies demonstrated that AlaXp deacylated mischarged tRNAAla in vitro, the significance of this activity in vivo has not been clear. Here we describe a bacterial system specifically designed to investigate activity of AlaXp in vivo. Serine toxicity, experienced by a strain harboring an editing-defective alanyl-tRNA synthetase, was rescued by an AlaXp-encoding transgene. Rescue was dependent on amino acid residues in AlaXp that are needed for its in vitro catalytic activity. Thus, the editing activity per se of AlaXp was essential for suppressing mistranslation. The results support the idea that the unique widespread distribution of AlaXp arises from the singular difficulties, for translation, poised by alanine.	Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA; Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA	Scripps Research Institute; Scripps Research Institute	Schimmel, P (corresponding author), BCC379,10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.	schimmel@scripps.edu	Chong, Yeeting/AAE-3792-2020; Yang, Xiang-Lei/AAR-7107-2020	Yang, Xiang-Lei/0000-0003-2554-084X	National Institutes of Health [GM 23562]; National Foundation for Cancer Research; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM023562] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Foundation for Cancer Research; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM 23562. This work was also supported by a fellowship from the National Foundation for Cancer Research. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Ahel I, 2003, P NATL ACAD SCI USA, V100, P15422, DOI 10.1073/pnas.2136934100; An S, 2005, J BIOL CHEM, V280, P34465, DOI 10.1074/jbc.M507550200; Bacher JM, 2005, P NATL ACAD SCI USA, V102, P1697, DOI 10.1073/pnas.0409064102; Beebe K, 2003, EMBO J, V22, P668, DOI 10.1093/emboj/cdg065; Beebe K, 2008, NATURE, V451, P90, DOI 10.1038/nature06454; Beebe K, 2007, ANAL BIOCHEM, V368, P111, DOI 10.1016/j.ab.2007.05.013; Beuning PJ, 2000, P NATL ACAD SCI USA, V97, P8916, DOI 10.1073/pnas.97.16.8916; Chen JF, 2000, BIOCHEMISTRY-US, V39, P6726, DOI 10.1021/bi000108r; Dock-Bregeon AC, 2000, CELL, V103, P877, DOI 10.1016/S0092-8674(00)00191-4; Doring V, 2001, SCIENCE, V292, P501, DOI 10.1126/science.1057718; ELDRED EW, 1972, J BIOL CHEM, V247, P2961; ENGLISCH S, 1986, NUCLEIC ACIDS RES, V14, P7529, DOI 10.1093/nar/14.19.7529; FERSHT AR, 1977, BIOCHEMISTRY-US, V16, P1025, DOI 10.1021/bi00624a034; FERSHT AR, 1976, BIOCHEMISTRY-US, V15, P3342, DOI 10.1021/bi00660a026; Fukunaga R, 2007, ACTA CRYSTALLOGR D, V63, P390, DOI 10.1107/S090744490605640X; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995; HOU YM, 1988, NATURE, V333, P140, DOI 10.1038/333140a0; JAKUBOWSKI H, 1992, MICROBIOL REV, V56, P412, DOI 10.1128/MMBR.56.3.412-429.1992; JASIN M, 1983, NATURE, V306, P441, DOI 10.1038/306441a0; JASIN M, 1984, J BACTERIOL, V159, P783, DOI 10.1128/JB.159.2.783-786.1984; Korencic D, 2004, P NATL ACAD SCI USA, V101, P10260, DOI 10.1073/pnas.0403926101; Larkin DC, 2002, NUCLEIC ACIDS RES, V30, P2103, DOI 10.1093/nar/30.10.2103; Lee JW, 2006, NATURE, V443, P50, DOI 10.1038/nature05096; Martinis S A, 1997, Nucleic Acids Symp Ser, V36, P125; Miller J. H., 1972, EXPT MOL GENETICS, P431; Nangle LA, 2002, J BIOL CHEM, V277, P45729, DOI 10.1074/jbc.M208093200; Nangle LA, 2006, CHEM BIOL, V13, P1091, DOI 10.1016/j.chembiol.2006.08.011; REGAN L, 1987, SCIENCE, V235, P1651, DOI 10.1126/science.2435005; Schimmel P, 2000, TRENDS BIOCHEM SCI, V25, P207, DOI 10.1016/S0968-0004(00)01553-X; SCHREIER AA, 1972, BIOCHEMISTRY-US, V11, P1582, DOI 10.1021/bi00759a006; Sokabe M, 2005, P NATL ACAD SCI USA, V102, P11669, DOI 10.1073/pnas.0502119102; TSUI WC, 1981, NUCLEIC ACIDS RES, V9, P4627, DOI 10.1093/nar/9.18.4627; Wong FC, 2003, J BIOL CHEM, V278, P52857, DOI 10.1074/jbc.M309627200; YARUS M, 1972, P NATL ACAD SCI USA, V69, P1915, DOI 10.1073/pnas.69.7.1915	34	45	47	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 31	2008	283	44					30073	30078		10.1074/jbc.M805943200	http://dx.doi.org/10.1074/jbc.M805943200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	364WS	18723508	Green Published, hybrid			2022-12-27	WOS:000260366900052
J	Fluhrer, R; Fukumori, A; Martin, L; Grammer, G; Haug-Kroper, M; Klier, B; Winkler, E; Kremmer, E; Condron, MM; Teplow, DB; Steiner, H; Haass, C				Fluhrer, Regina; Fukumori, Akio; Martin, Lucas; Grammer, Gudula; Haug-Kroeper, Martina; Klier, Baerbel; Winkler, Edith; Kremmer, Elisabeth; Condron, Margaret M.; Teplow, David B.; Steiner, Harald; Haass, Christian			Intramembrane Proteolysis of GXGD-type Aspartyl Proteases Is Slowed by a Familial Alzheimer Disease-like Mutation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMYLOID PRECURSOR PROTEIN; SIGNAL PEPTIDE PEPTIDASE; GAMMA-SECRETASE ACTIVITY; TRANSMEMBRANE DOMAIN; PRESENILIN HOMOLOGS; TALKING POINT; ZETA-CLEAVAGE; BETA-PEPTIDE; TNF-ALPHA; IN-VIVO	More than 150 familial Alzheimer disease (FAD)-associated missense mutations in presenilins (PS1 and PS2), the catalytic subunit of the gamma-secretase complex, cause aberrant amyloid beta-peptide (A beta) production, by increasing the relative production of the highly amyloidogenic 42-amino acid variant. The molecular mechanism behind this pathological activity is unclear, and different possibilities ranging from a gain of function to a loss of function have been discussed. gamma-Secretase, signal peptide peptidase (SPP) and SPP-like proteases (SPPLs) belong to the same family of GXGD-type intramembrane cleaving aspartyl proteases and share several functional similarities. We have introduced the FAD-associated PS1 G384A mutation, which occurs within the highly conserved GXGD motif of PS1 right next to the catalytically critical aspartate residue, into the corresponding GXGD motif of the signal peptide peptidase-like 2b (SPPL2b). Compared with wild-type SPPL2b, mutant SPPL2b slowed intramembrane proteolysis of tumor necrosis factor alpha and caused a relative increase of longer intracellular cleavage products. Because the N termini of the secreted counterparts remain unchanged, the mutation selectively affects the liberation of the intracellular processing products. In vitro experiments demonstrate that the apparent accumulation of longer intracellular cleavage products is the result of slowed sequential intramembrane cleavage. The longer cleavage products are still converted to shorter peptides, however only after prolonged incubation time. This suggests that FAD-associated PS mutation may also result in reduced intramembrane cleavage of beta-amyloid precursor protein (beta APP). Indeed, in vitro experiments demonstrate slowed intramembrane proteolysis by gamma-secretase containing PS1 with the G384A mutation. As compared with wildtype PS1, the mutation selectively slowed A beta 40 production, whereas A beta 42 generation remained unaffected. Thus, the PS1 G384A mutation causes a selective loss of function by slowing the processing pathway leading to the benign A beta 40.	[Fluhrer, Regina; Fukumori, Akio; Martin, Lucas; Grammer, Gudula; Haug-Kroeper, Martina; Klier, Baerbel; Winkler, Edith; Steiner, Harald; Haass, Christian] Univ Munich, Ctr Integrated Prot Sci Munich, D-80336 Munich, Germany; [Fluhrer, Regina; Fukumori, Akio; Martin, Lucas; Grammer, Gudula; Haug-Kroeper, Martina; Klier, Baerbel; Winkler, Edith; Steiner, Harald; Haass, Christian] Univ Munich, Adolf Butenandt Inst, Dept Biochem, Lab Neurodegenerat Dis Res, D-80336 Munich, Germany; [Kremmer, Elisabeth] Helmholtz Zentrum Munchen, Inst Mol Immunol, D-81377 Munich, Germany; [Condron, Margaret M.; Teplow, David B.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurol, Los Angeles, CA 90095 USA; [Condron, Margaret M.; Teplow, David B.] Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90095 USA; [Condron, Margaret M.; Teplow, David B.] Univ Calif Los Angeles, Brain Res Inst, Los Angeles, CA 90095 USA	University of Munich; University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Haass, C (corresponding author), Univ Munich, Ctr Integrated Prot Sci Munich, D-80336 Munich, Germany.	chaass@med.uni-muenchen.de	Fluhrer, Regina/F-2642-2011		National Institutes of Health [NS038328]; Leibniz Award of Deutsche Forschungsgemeinschaft [NS038328]; Collaborative Research Center Molecular Mechanisms of Neurodegeneration [SFB 596]; DFG [HA1737-11-1]; Center for Integrated Protein Science Munich; Hans and Ilse Breuer Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS038328] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Leibniz Award of Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Collaborative Research Center Molecular Mechanisms of Neurodegeneration; DFG(German Research Foundation (DFG)); Center for Integrated Protein Science Munich; Hans and Ilse Breuer Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant NS038328 (to D. B. T.). This work was also supported by the Leibniz Award of Deutsche Forschungsgemeinschaft (DFG, to C. H.), by the Collaborative Research Center Molecular Mechanisms of Neurodegeneration (Grant SFB 596 to C. H., H. S., and E. K.), by DFG Grant HA1737-11-1 (to C. H. and R. F.), and by the Center for Integrated Protein Science Munich and the Alzheimer Research Award of the Hans and Ilse Breuer Foundation (to H. S.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Baumeister R, 1997, Genes Funct, V1, P149; Bentahir M, 2006, J NEUROCHEM, V96, P732, DOI 10.1111/j.1471-4159.2005.03578.x; Berezovska O, 2005, J NEUROSCI, V25, P3009, DOI 10.1523/JNEUROSCI.0364-05.2005; BUSCIGLIO J, 1993, P NATL ACAD SCI USA, V90, P2092, DOI 10.1073/pnas.90.5.2092; Davis JA, 1998, NEURON, V20, P603, DOI 10.1016/S0896-6273(00)80998-8; De Strooper B, 2007, EMBO REP, V8, P141, DOI 10.1038/sj.embor.7400897; Doerfler P, 2001, P NATL ACAD SCI USA, V98, P9312, DOI 10.1073/pnas.161102498; Edbauer D, 2003, NAT CELL BIOL, V5, P486, DOI 10.1038/ncb960; Fluhrer R, 2002, J NEUROCHEM, V81, P1011, DOI 10.1046/j.1471-4159.2002.00908.x; Fluhrer R, 2007, NEURODEGENER DIS, V4, P112, DOI 10.1159/000101835; Fluhrer R, 2006, NAT CELL BIOL, V8, P894, DOI 10.1038/ncb1450; Friedmann E, 2004, J BIOL CHEM, V279, P50790, DOI 10.1074/jbc.M407898200; Friedmann E, 2006, NAT CELL BIOL, V8, P843, DOI 10.1038/ncb1440; Geling A, 2002, EMBO REP, V3, P688, DOI 10.1093/embo-reports/kvf124; Gu YJ, 2001, J BIOL CHEM, V276, P35235, DOI 10.1074/jbc.C100357200; Haass C, 2004, EMBO J, V23, P483, DOI 10.1038/sj.emboj.7600061; Haass C, 2002, TRENDS CELL BIOL, V12, P556, DOI 10.1016/S0962-8924(02)02394-2; HAASS C, 1992, NATURE, V359, P325; Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101; Kaeser SA, 2007, NAT GENET, V39, P1437, DOI 10.1038/ng.2007.23; Kim J, 2007, J NEUROSCI, V27, P627, DOI 10.1523/JNEUROSCI.4849-06.2007; Kirkin V, 2007, CELL DEATH DIFFER, V14, P1678, DOI 10.1038/sj.cdd.4402175; Kopan R, 2004, NAT REV MOL CELL BIO, V5, P499, DOI 10.1038/nrm1406; Krawitz P, 2005, J BIOL CHEM, V280, P39515, DOI 10.1074/jbc.M501645200; LaPointe CF, 2000, J BIOL CHEM, V275, P1502, DOI 10.1074/jbc.275.2.1502; Lemberg MK, 2007, MOL CELL, V28, P930, DOI 10.1016/j.molcel.2007.12.003; Levitan D, 1996, P NATL ACAD SCI USA, V93, P14940, DOI 10.1073/pnas.93.25.14940; Loureiro J, 2006, NATURE, V441, P894, DOI 10.1038/nature04830; Martin L, 2008, J BIOL CHEM, V283, P1644, DOI 10.1074/jbc.M706661200; Moehlmann T, 2002, P NATL ACAD SCI USA, V99, P8025, DOI 10.1073/pnas.112686799; Ponting CP, 2002, HUM MOL GENET, V11, P1037, DOI 10.1093/hmg/11.9.1037; Qi-Takahara Y, 2005, J NEUROSCI, V25, P436, DOI 10.1523/JNEUROSCI.1575-04.2005; Rawson RB, 1997, MOL CELL, V1, P47, DOI 10.1016/S1097-2765(00)80006-4; Sastre M, 2001, EMBO REP, V2, P835, DOI 10.1093/embo-reports/kve180; Sato T, 2003, J BIOL CHEM, V278, P24294, DOI 10.1074/jbc.M211161200; Sato T, 2006, BIOCHEMISTRY-US, V45, P8649, DOI 10.1021/bi060597g; Selkoe DJ, 2007, CELL, V131, P215, DOI 10.1016/j.cell.2007.10.012; Shen J, 2007, P NATL ACAD SCI USA, V104, P403, DOI 10.1073/pnas.0608332104; Shimojo M, 2008, J BIOL CHEM, V283, P16488, DOI 10.1074/jbc.M801279200; SHOJI M, 1992, SCIENCE, V258, P126, DOI 10.1126/science.1439760; Steiner H, 2000, NAT CELL BIOL, V2, P848, DOI 10.1038/35041097; Wang J, 2006, J NEUROCHEM, V96, P218, DOI 10.1111/j.1471-4159.2005.03548.x; Weidemann A, 2002, BIOCHEMISTRY-US, V41, P2825, DOI 10.1021/bi015794o; Weihofen A, 2000, J BIOL CHEM, V275, P30951, DOI 10.1074/jbc.M005980200; Weihofen A, 2003, TRENDS CELL BIOL, V13, P71, DOI 10.1016/S0962-8924(02)00041-7; Weihofen A, 2002, SCIENCE, V296, P2215, DOI 10.1126/science.1070925; Wiltfang J, 1997, ELECTROPHORESIS, V18, P527, DOI 10.1002/elps.1150180332; Wolfe MS, 2007, EMBO REP, V8, P136, DOI 10.1038/sj.embor.7400896; Wolfe MS, 1999, NATURE, V398, P513, DOI 10.1038/19077; Yamasaki A, 2006, J NEUROSCI, V26, P3821, DOI 10.1523/JNEUROSCI.5354-05.2006; Zhao GJ, 2005, J BIOL CHEM, V280, P37689, DOI 10.1074/jbc.M507993200; Zhao GJ, 2004, J BIOL CHEM, V279, P50647, DOI 10.1074/jbc.C400473200	52	27	27	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 31	2008	283	44					30121	30128		10.1074/jbc.M806092200	http://dx.doi.org/10.1074/jbc.M806092200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	364WS	18768471	hybrid, Green Published			2022-12-27	WOS:000260366900057
J	Das, A; Xi, L; Kukreja, RC				Das, Anindita; Xi, Lei; Kukreja, Rakesh C.			Protein Kinase G-dependent Cardioprotective Mechanism of Phosphodiesterase-5 Inhibition Involves Phosphorylation of ERK and GSK3 beta	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLYCOGEN-SYNTHASE KINASE-3-BETA; NITRIC-OXIDE SYNTHASE; RABBIT VENTRICULAR MYOCYTES; CYCLIC-GMP; MOUSE HEART; CARDIOMYOCYTE APOPTOSIS; ERECTILE DYSFUNCTION; CARDIAC-HYPERTROPHY; IN-VIVO; SILDENAFIL	Sildenafil, a potent inhibitor of phosphodiesterase-5 (PDE-5) induces powerful protection against myocardial ischemia-reperfusion injury. PDE-5 inhibition increases cGMP levels that activate cGMP-dependent protein kinase (PKG). However, the cause and effect relationship of PKG in sildenafil-induced cardioprotection and the downstream targets of PKG remain unclear. Adult ventricular myocytes were treated with sildenafil and subjected to simulated ischemia and reoxygenation. Sildenafil treatment significantly decreased cardiomyocyte necrosis and apoptosis. The PKG inhibitors, KT5823, guanosine 3', 5'-cyclic monophosphorothioate, 8-(4-chloro-phenylthio) (R-p-8-pCPT-cGMPs), or DT-2 blocked the anti-necrotic and anti-apoptotic effect of sildenafil. Selective knockdown of PKG in cardiomyocytes with adenoviral vector containing short hairpin RNA of PKG also abolished sildenafil-induced protection. Furthermore, intra-coronary infusion of sildenafil in Langendorffisolated mouse hearts prior to ischemia-reperfusion significantly reduced myocardial infarct size after 20 min ischemia and 30 min reperfusion, which was abrogated by KT5823. Sildenafil significantly increased PKG activity in intact hearts and cardiomyocytes. Sildenafil also enhanced the Bcl-2/Bax ratio, phosphorylation of Akt, ERK1/2, and glycogen synthase kinase 3 beta. All these changes ( except Akt phosphorylation) were significantly blocked by KT5823 and short hairpin RNA of PKG. These studies provide the first evidence for an essential role of PKG in sildenafil-induced cardioprotection. Moreover, our results demonstrate that sildenafil activates a PKG-dependent novel signaling cascade that involves activation of ERK and inhibition of glycogen synthase kinase 3 beta leading to cytoprotection.	[Das, Anindita; Xi, Lei; Kukreja, Rakesh C.] Virginia Commonwealth Univ, Div Cardiol, Dept Internal Med, Richmond, VA 23298 USA	Virginia Commonwealth University	Kukreja, RC (corresponding author), Virginia Commonwealth Univ, Div Cardiol, Dept Internal Med, Box 980204,1101 E Marshall St,Rm 7-046, Richmond, VA 23298 USA.	rakesh@vcu.edu	Xi, Lei/A-3078-2008; Das, Anindita/K-8003-2013	Xi, Lei/0000-0002-7569-3329; Das, Anindita/0000-0003-4422-7277	National Institutes of Health [HL51045, HL59469, HL79424, HL093685]; American Heart Association Mid-Atlantic Affiliate Beginning [0765273U]; National Scientist Development; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL051045, R01HL051045, R01HL079424, R01HL059469, R01HL093685] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association Mid-Atlantic Affiliate Beginning(American Heart Association); National Scientist Development; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL51045, HL59469, HL79424, and HL093685 ( to R. C. K.). This work was also supported by American Heart Association Mid-Atlantic Affiliate Beginning Grant-in-Aid 0765273U ( to A. D.) and National Scientist Development Grant 0530157N ( to L. X.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Ali A, 2001, CHEM REV, V101, P2527, DOI 10.1021/cr000110o; Badorff C, 2002, J CLIN INVEST, V109, P373, DOI 10.1172/JCI200213779; Bender AT, 2006, PHARMACOL REV, V58, P488, DOI 10.1124/pr.58.3.5; Bergmann MW, 2004, J MOL CELL CARDIOL, V37, P681, DOI 10.1016/j.yjmcc.2004.05.025; Boolell M, 1996, Int J Impot Res, V8, P47; Cohen P, 2001, NAT REV MOL CELL BIO, V2, P769, DOI 10.1038/35096075; Costa ADT, 2005, CIRC RES, V97, P329, DOI 10.1161/01.RES.0000178451.08719.5b; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; Dang VC, 2006, AM J PHYSIOL-HEART C, V290, pH1808, DOI 10.1152/ajpheart.00772.2005; Das A, 2005, J BIOL CHEM, V280, P12944, DOI 10.1074/jbc.M404706200; Das A, 2004, AM J PHYSIOL-HEART C, V286, pH1455, DOI 10.1152/ajpheart.01040.2003; Das A, 2006, J BIOL CHEM, V281, P38644, DOI 10.1074/jbc.M606142200; ELDARFINKELMAN H, 1995, J BIOL CHEM, V270, P987, DOI 10.1074/jbc.270.3.987; Fang XJ, 2000, P NATL ACAD SCI USA, V97, P11960, DOI 10.1073/pnas.220413597; Fisher PW, 2005, CIRCULATION, V111, P1601, DOI 10.1161/01.CIR.0000160359.49478.C2; Fujio Y, 2000, CIRCULATION, V101, P660, DOI 10.1161/01.CIR.101.6.660; Gambaryan S, 2001, HISTOCHEM CELL BIOL, V116, P535, DOI 10.1007/s00418-001-0353-3; Ghofrani HA, 2006, NAT REV DRUG DISCOV, V5, P689, DOI 10.1038/nrd2030; Hall JL, 2001, DIABETES, V50, P1171, DOI 10.2337/diabetes.50.5.1171; Han J, 2002, AM J PHYSIOL-HEART C, V283, pH1545, DOI 10.1152/ajpheart.01052.2001; Han J, 2001, J BIOL CHEM, V276, P22140, DOI 10.1074/jbc.M010103200; Hardt SE, 2002, CIRC RES, V90, P1055, DOI 10.1161/01.RES.0000018952.70505.F1; He B, 1998, MOL CELL BIOL, V18, P6624, DOI 10.1128/MCB.18.11.6624; Hetman M, 2002, J BIOL CHEM, V277, P49577, DOI 10.1074/jbc.M111227200; Hirotani S, 2007, CIRC RES, V101, P1164, DOI 10.1161/CIRCRESAHA.107.160614; Hofmann F, 2000, J CELL SCI, V113, P1671; Hofmann F, 2005, J BIOL CHEM, V280, P1, DOI 10.1074/jbc.R400035200; Juhaszova M, 2004, J CLIN INVEST, V113, P1535, DOI 10.1172/JCI200419906; Kaga S, 2006, J MOL CELL CARDIOL, V40, P138, DOI 10.1016/j.yjmcc.2005.09.009; KEILBACH A, 1992, EUR J BIOCHEM, V208, P467, DOI 10.1111/j.1432-1033.1992.tb17209.x; Komalavilas P, 1999, J BIOL CHEM, V274, P34301, DOI 10.1074/jbc.274.48.34301; Krieg T, 2005, AM J PHYSIOL-HEART C, V288, pH1976, DOI 10.1152/ajpheart.00883.2004; Kukreja RC, 2007, BRIT J PHARMACOL, V150, P538, DOI 10.1038/sj.bjp.0707132; Li MT, 2000, MOL CELL BIOL, V20, P9356, DOI 10.1128/MCB.20.24.9356-9363.2000; LINCOLN TM, 1993, FASEB J, V7, P328, DOI 10.1096/fasebj.7.2.7680013; Maas O, 2008, BRIT J PHARMACOL, V154, P25, DOI 10.1038/bjp.2008.71; Matsui T, 2001, CIRCULATION, V104, P330; Maurer U, 2006, MOL CELL, V21, P749, DOI 10.1016/j.molcel.2006.02.009; Ockaili R, 2002, AM J PHYSIOL-HEART C, V283, pH1263, DOI 10.1152/ajpheart.00324.2002; Pap M, 1998, J BIOL CHEM, V273, P19929, DOI 10.1074/jbc.273.32.19929; Pilz RB, 2003, CIRC RES, V93, P1034, DOI 10.1161/01.RES.0000103311.52853.48; Ping PP, 1999, AM J PHYSIOL-HEART C, V276, pH1468, DOI 10.1152/ajpheart.1999.276.5.H1468; Porst H, 2001, INT J IMPOT RES, V13, P192, DOI 10.1038/sj.ijir.3900713; Qin QN, 2004, AM J PHYSIOL-HEART C, V287, pH712, DOI 10.1152/ajpheart.00954.2003; Salloum F, 2003, CIRC RES, V92, P595, DOI 10.1161/01.RES.0000066853.09821.98; Salloum FN, 2008, AM J PHYSIOL-HEART C, V294, pH1398, DOI [10.1152/ajpheart.ajpheart.91438.2007, 10.1152/ajpheart.91438.2007]; Senzaki H, 2001, FASEB J, V15, P1718, DOI 10.1096/fj.00-0538com; STAMBOLIC V, 1994, BIOCHEM J, V303, P701, DOI 10.1042/bj3030701; Takimoto E, 2005, CIRC RES, V96, P100, DOI 10.1161/01.RES.0000152262.22968.72; Tong HY, 2002, CIRC RES, V90, P377, DOI 10.1161/01.RES.0000012567.95445.55; Wang XY, 2008, J MOL CELL CARDIOL, V44, P105, DOI 10.1016/j.yjmcc.2007.10.006; Xavier IJ, 2000, J BIOL CHEM, V275, P29147, DOI 10.1074/jbc.M002169200; Xi L, 1999, CIRCULATION, V99, P2157, DOI 10.1161/01.CIR.99.16.2157; Xi L, 1998, MOL CELL BIOCHEM, V186, P69, DOI 10.1023/A:1006811128561; Zhao X, 2005, J BIOL CHEM, V280, P32683, DOI 10.1074/jbc.M505486200	55	155	160	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 24	2008	283	43					29572	29585		10.1074/jbc.M801547200	http://dx.doi.org/10.1074/jbc.M801547200			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	362EB	18723505	hybrid, Green Published			2022-12-27	WOS:000260179900083
J	Giordano, RJ; Lahdenranta, J; Zhen, LJ; Chukwueke, U; Petrache, I; Langley, RR; Fidler, IJ; Pasqualini, R; Tuder, RM; Arap, W				Giordano, Ricardo J.; Lahdenranta, Johanna; Zhen, Lijie; Chukwueke, Ugonma; Petrache, Irina; Langley, Robert R.; Fidler, Isaiah J.; Pasqualini, Renata; Tuder, Rubin M.; Arap, Wadih			Targeted Induction of Lung Endothelial Cell Apoptosis Causes Emphysema-like Changes in the Mouse	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR; VEGF; VASCULATURE; ANGIOGENESIS; PATHOGENESIS; DESTRUCTION; INHIBITION; EXPRESSION; RECEPTORS; ABLATION	Pulmonary gas exchange relies on a rich capillary network, which, together with alveolar epithelial type I and II cells, form alveolar septa, the functional units in the lung. Alveolar capillary endothelial cells are critical in maintaining alveolar structure, because disruption of endothelial cell integrity underlies several lung diseases. Here we show that targeted ablation of lung capillary endothelial cells recapitulates the cellular events involved in cigarette smoke-induced emphysema, one of the most prevalent nonneoplastic lung diseases. Based on phage library screening on an immortalized lung endothelial cell line, we identified a lung endothelial cell-binding peptide, which preferentially homes to lung blood vessels. This peptide fused to a proapoptotic motif specifically induced programmed cell death of lung endothelial cells in vitro as well as targeted apoptosis of the lung microcirculation in vivo. As early as 4 days following peptide administration, mice developed air space enlargement associated with enhanced oxidative stress, influx of macrophages, and up-regulation of ceramide. Given that these are all critical elements of the corresponding human emphysema caused by cigarette smoke, these data provide evidence for a central role for the alveolar endothelial cells in the maintenance of lung structure and of endothelial cell apoptosis in the pathogenesis of emphysema-like changes. Thus, our data enable the generation of a convenient mouse model of human emphysema. Finally, combinatorial screenings on immortalized cells followed by in vivo targeting establishes an experimental framework for discovery and validation of additional ligand-directed pharmacodelivery systems.	[Giordano, Ricardo J.; Lahdenranta, Johanna; Langley, Robert R.; Fidler, Isaiah J.; Pasqualini, Renata; Arap, Wadih] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA; [Zhen, Lijie; Chukwueke, Ugonma; Petrache, Irina; Tuder, Rubin M.] Johns Hopkins Univ, Sch Med, Baltimore, MD 21205 USA; [Petrache, Irina] Indiana Univ, Indianapolis, IN 46204 USA; [Tuder, Rubin M.] Univ Colorado, Sch Med, Denver, CO 80262 USA	University of Texas System; UTMD Anderson Cancer Center; Johns Hopkins University; Indiana University System; Indiana University-Purdue University Indianapolis; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver	Pasqualini, R (corresponding author), Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA.	rpasqual@mdanderson.org; rubin.tuder@uchsc.edu; warap@mdanderson.org	Giordano, Ricardo/A-2074-2010; Petrache, Irina/AAZ-9648-2020	Giordano, Ricardo/0000-0001-8116-6771; 	National Institutes of Health [HL 066554, HL 077328, CA 122568]; Department of Defense [W91ZSQ-4348-N602, DAMD17-01-1-0644]; American Thoracic Society/Alpha One Foundation Research; American Lung Association; AngelWorks, the Gillson-Longenbaugh Foundation; V Foundation; Damon Runyon Cancer Research Foundation; NATIONAL CANCER INSTITUTE [R01CA122568] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL066554, R01HL077328] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); American Thoracic Society/Alpha One Foundation Research; American Lung Association; AngelWorks, the Gillson-Longenbaugh Foundation; V Foundation; Damon Runyon Cancer Research Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL 066554 (to R. M. T.) and HL 077328 (to I. P.) and Grant CA 122568 (to W. A. and R. P.). This work was also supported by Department of Defense IMPACT Grant W91ZSQ-4348-N602 (to W. A. and R. P.) and a Department of Defense Grant DAMD17-01-1-0644 (to R. J. G.); an American Thoracic Society/Alpha One Foundation Research Grant (to R. M. T.); a grant from the American Lung Association (to I. P.); and awards from AngelWorks, the Gillson-Longenbaugh Foundation, the V Foundation (to W. A. and R. P.). Robert Black fellow of the Damon Runyon Cancer Research Foundation (J. L.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Aird WC, 2003, CRIT CARE MED, V31, pS221, DOI 10.1097/01.CCM.0000057847.32590.C1; ALON T, 1995, NAT MED, V1, P1024, DOI 10.1038/nm1095-1024; Aoshiba K, 2003, AM J RESP CELL MOL, V28, P555, DOI 10.1165/rcmb.2002-0090OC; Arap MA, 2004, CANCER CELL, V6, P275, DOI 10.1016/j.ccr.2004.08.018; Arap MA, 2004, MOL THER, V9, P305, DOI 10.1016/j.ymthe.2003.11.016; Arap W, 1998, SCIENCE, V279, P377, DOI 10.1126/science.279.5349.377; Arap W, 2002, NAT MED, V8, P121, DOI 10.1038/nm0202-121; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Brown KRS, 2001, AM J PHYSIOL-LUNG C, V281, pL1001, DOI 10.1152/ajplung.2001.281.4.L1001; Carmeliet P, 2005, NATURE, V438, P932, DOI 10.1038/nature04478; Compernolle V, 2002, NAT MED, V8, P702, DOI 10.1038/nm721; Dobrowsky RT, 2001, METHOD CELL BIOL, V66, P135; Ellerby HM, 1999, NAT MED, V5, P1032, DOI 10.1038/12469; Giordano RJ, 2001, NAT MED, V7, P1249, DOI 10.1038/nm1101-1249; HaimovitzFriedman A, 1997, J EXP MED, V186, P1831, DOI 10.1084/jem.186.11.1831; Hajitou A, 2006, CELL, V125, P385, DOI 10.1016/j.cell.2006.02.042; Hajitou A, 2008, P NATL ACAD SCI USA, V105, P4471, DOI 10.1073/pnas.0712184105; Healy AM, 2000, DEV DYNAM, V219, P341, DOI 10.1002/1097-0177(2000)9999:9999<::AID-DVDY1061>3.0.CO;2-M; JAT PS, 1991, P NATL ACAD SCI USA, V88, P5096, DOI 10.1073/pnas.88.12.5096; Kanazawa H, 2003, EUR RESPIR J, V22, P609, DOI 10.1183/09031936.03.00030403; Kanazawa H, 2003, AM J MED, V114, P354, DOI 10.1016/S0002-9343(02)01562-0; Kasahara Y, 2000, J CLIN INVEST, V106, P1311, DOI 10.1172/JCI10259; Kasahara Y, 2001, AM J RESP CRIT CARE, V163, P737, DOI 10.1164/ajrccm.163.3.2002117; Kelly JJ, 1998, AM J PHYSIOL-LUNG C, V274, pL810, DOI 10.1152/ajplung.1998.274.5.L810; Kolesnick R, 2003, ONCOGENE, V22, P5897, DOI 10.1038/sj.onc.1206702; Kolonin MG, 2004, NAT MED, V10, P625, DOI 10.1038/nm1048; Kolonin MG, 2002, P NATL ACAD SCI USA, V99, P13055, DOI 10.1073/pnas.162468499; Koyama S, 2002, AM J RESP CRIT CARE, V166, P382, DOI 10.1164/rccm.2103112; Lahdenranta J, 2007, FASEB J, V21, P3272, DOI 10.1096/fj.07-8273com; Langley RR, 2003, CANCER RES, V63, P2971; Le Cras TD, 2002, AM J PHYSIOL-LUNG C, V283, pL555, DOI 10.1152/ajplung.00408.2001; LIEBOW AA, 1959, AM REV RESPIR DIS, V80, P67; Marchio S, 2004, CANCER CELL, V5, P151, DOI 10.1016/S1535-6108(04)00025-X; Oh Y, 2005, CHEST, V128, p596S, DOI 10.1378/chest.128.6_suppl.596S; Pasqualini R, 1997, NAT BIOTECHNOL, V15, P542, DOI 10.1038/nbt0697-542; Pasqualini R, 1996, NATURE, V380, P364, DOI 10.1038/380364a0; Petrache I, 2005, NAT MED, V11, P491, DOI 10.1038/nm1238; Petrache I, 2008, AM J PHYSIOL-LUNG C, V295, pL44, DOI 10.1152/ajplung.00448.2007; Petrache I, 2006, AM J PATHOL, V169, P1155, DOI 10.2353/ajpath.2006.060058; Rajotte D, 1998, J CLIN INVEST, V102, P430, DOI 10.1172/JCI3008; Rangasamy T, 2004, J CLIN INVEST, V114, P1248, DOI 10.1172/JCI200421146; Sato M, 2007, ONCOLOGY-NY, V21, P1346; Shapiro SD, 1995, P ASSOC AM PHYSICIAN, V107, P346; Sirianni FE, 2003, AM J RESP CRIT CARE, V168, P1532, DOI 10.1164/rccm.200303-371OC; SNIDER GL, 1985, AM REV RESPIR DIS, V132, P182; Stevens Troy, 2001, American Journal of Physiology, V281, pC1422; Storkebaum E, 2004, BIOESSAYS, V26, P943, DOI 10.1002/bies.20092; Tang KC, 2004, J APPL PHYSIOL, V97, P1559, DOI 10.1152/japplphysiol.00221.2004; Tuder RM, 2003, AM J RESP CELL MOL, V29, P88, DOI 10.1165/rcmb.2002-0228OC; Tuder RM, 2003, AM J RESP CELL MOL, V28, P551, DOI 10.1165/rcmb.F269; Tuder Rubin M, 2006, Proc Am Thorac Soc, V3, P503, DOI 10.1513/pats.200603-054MS; Vandivier RW, 2002, J CLIN INVEST, V109, P661, DOI 10.1172/JCI200213572; Yao VJ, 2005, AM J PATHOL, V166, P625, DOI 10.1016/S0002-9440(10)62283-3; Zheng T, 2005, J IMMUNOL, V174, P8106, DOI 10.4049/jimmunol.174.12.8106	54	92	93	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 24	2008	283	43					29447	29460		10.1074/jbc.M804595200	http://dx.doi.org/10.1074/jbc.M804595200			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	362EB	18718906	Green Published, hybrid			2022-12-27	WOS:000260179900071
J	Matsubara, T; Kida, K; Yamaguchi, A; Hata, K; Ichida, F; Meguro, H; Aburatani, H; Nishimura, R; Yoneda, T				Matsubara, Takuma; Kida, Kumiko; Yamaguchi, Akira; Hata, Kenji; Ichida, Fumitaka; Meguro, Hiroko; Aburatani, Hiroyuki; Nishimura, Riko; Yoneda, Toshiyuki			BMP2 Regulates Osterix through Msx2 and Runx2 during Osteoblast Differentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BONE MORPHOGENETIC PROTEIN-2; GENE-EXPRESSION; CELLS; GROWTH; C2C12; CBFA1; SMAD5; OSSIFICATION; COOPERATION; INDUCTION	Osterix/Sp7, a member of the Sp1 transcription factor family, plays an essential role in bone formation and osteoblastogenesis. Although Osterix has been shown to be induced by BMP2 in a mesenchymal cell line, the molecular basis of the regulation, expression and function of Osterix during osteoblast differentiation, is not fully understood. Thus we examined the role of BMP2 signaling in the regulation of Osterix using the mesenchymal cell lines C3H10T1/2 and C2C12. Osterix overexpression induced alkaline phosphatase activity and osteocalcin expression in C2C12 cells and stimulated calcification of murine primary osteoblasts. Considering that Runx2 overexpression induces Osterix, these results suggest that Osterix functions as downstream of Runx2. Surprisingly, BMP2 treatment induced Osterix expression and alkaline phosphatase activity in mesenchymal cells derived from Runx2-deficient mice. Furthermore, overexpression of Smad1 and Smad4 up-regulated Osterix expression, and an inhibitory Smad, Smad6, markedly suppressed BMP2-induced Osterix expression in the Runx2-deficient cells. Moreover, overexpression of a homeobox gene, Msx2, which is up-regulated by BMP2 and promotes osteoblastic differentiation, induced Osterix expression in the Runx2-deficient cells. Knockdown of Msx2 clearly inhibited induction of Osterix by BMP2 in the Runx2-deficient mesenchymal cells. Interestingly, microarray analyses using the Runx2-deficient cells revealed that the role of Osterix was distinct from that of Runx2. These findings suggest that Osterix is regulated via both Runx2-dependent and -independent mechanisms, and that Osterix controls osteoblast differentiation, at least in part, by regulating the expression of genes not controlled by Runx2.	[Matsubara, Takuma; Kida, Kumiko; Hata, Kenji; Ichida, Fumitaka; Nishimura, Riko; Yoneda, Toshiyuki] Osaka Univ, Grad Sch Dent, Dept Mol & Cellular Biochem, Osaka 5650871, Japan; [Yamaguchi, Akira] Tokyo Med & Dent Univ, Dept Oral Pathol, Bunkyo Ku, Tokyo 1138549, Japan; [Meguro, Hiroko; Aburatani, Hiroyuki] Univ Tokyo, Genome Sci Div, Adv Sci & Technol Res Ctr, Meguro Ku, Tokyo 1538904, Japan	Osaka University; Tokyo Medical & Dental University (TMDU); University of Tokyo	Nishimura, R (corresponding author), Osaka Univ, Grad Sch Dent, Dept Mol & Cellular Biochem, 1-8 Yamadaoka, Osaka 5650871, Japan.	rikonisi@dent.osaka-u.ac.jp	Yamaguchi, Akira/AAX-9286-2020; Matsubara, Takuma/B-5031-2019	Matsubara, Takuma/0000-0002-8505-0431; Nishimura, Riko/0000-0001-7279-8363	Ministry of Education, Science, and Sports of Japan [A 17209059, B15390560]; Naito Foundation; Novartis Foundation	Ministry of Education, Science, and Sports of Japan; Naito Foundation(Naito Memorial Foundation); Novartis Foundation(Novartis)	This work was supported in part by the Ministry of Education, Science, and Sports of Japan, Culture Grants-in-aid for Scientific Research A 17209059, B15390560, the Naito Foundation, and the Novartis Foundation. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Baron R, 2006, CURR TOP DEV BIOL, V76, P103, DOI 10.1016/S0070-2153(06)76004-5; Bodine PVN, 2004, MOL ENDOCRINOL, V18, P1222, DOI 10.1210/me.2003-0498; Celil AB, 2005, J BIOL CHEM, V280, P31353, DOI 10.1074/jbc.M503845200; Celil AB, 2005, J CELL BIOCHEM, V95, P518, DOI 10.1002/jcb.20429; Chen D, 1997, CALCIFIED TISSUE INT, V60, P283, DOI 10.1007/s002239900230; Cheng SL, 2003, J BIOL CHEM, V278, P45969, DOI 10.1074/jbc.M306972200; Cohen MM, 2002, AM J MED GENET, V109, P87, DOI 10.1002/ajmg.10289; Ducy P, 1997, CELL, V89, P747, DOI 10.1016/S0092-8674(00)80257-3; Hanai J, 1999, J BIOL CHEM, V274, P31577, DOI 10.1074/jbc.274.44.31577; Hata K, 2005, MOL CELL BIOL, V25, P1971, DOI 10.1128/MCB.25.5.1971-1979.2005; Hu HL, 2005, DEVELOPMENT, V132, P49, DOI 10.1242/dev.01564; Ichida F, 2004, J BIOL CHEM, V279, P34015, DOI 10.1074/jbc.M403621200; Igarashi M, 2007, MOL CELL BIOL, V27, P7947, DOI 10.1128/MCB.00813-07; Ishii M, 2000, GENOMICS, V68, P136, DOI 10.1006/geno.2000.6284; Javed A, 2001, MOL CELL BIOL, V21, P2891, DOI 10.1128/MCB.21.8.2891-2905.2001; Kaback LA, 2008, J CELL PHYSIOL, V214, P173, DOI 10.1002/jcp.21176; Kim YJ, 2004, J BIOL CHEM, V279, P50773, DOI 10.1074/jbc.M404145200; Komori T, 1997, CELL, V89, P755, DOI 10.1016/S0092-8674(00)80258-5; Lee KS, 2000, MOL CELL BIOL, V20, P8783, DOI 10.1128/MCB.20.23.8783-8792.2000; Lee MH, 2003, BIOCHEM BIOPH RES CO, V309, P689, DOI 10.1016/j.bbrc.2003.08.058; Liu TJ, 2007, J CELL PHYSIOL, V211, P728, DOI 10.1002/jcp.20988; MANIATOPOULOS C, 1988, CELL TISSUE RES, V254, P317; Milona M, 2003, BMC GENOMICS, V4, DOI 10.1186/1471-2164-4-43; Miyake S, 1996, P NATL ACAD SCI USA, V93, P1320, DOI 10.1073/pnas.93.3.1320; Nakashima K, 2002, CELL, V108, P17, DOI 10.1016/s0092-8674(01)00622-5; Nishimura R, 2002, BONE, V31, P303, DOI 10.1016/S8756-3282(02)00826-8; Nishimura R, 1998, J BIOL CHEM, V273, P1872, DOI 10.1074/jbc.273.4.1872; Otto F, 1997, CELL, V89, P765, DOI 10.1016/S0092-8674(00)80259-7; Satokata I, 2000, NAT GENET, V24, P391, DOI 10.1038/74231; Wilkie AOM, 2000, NAT GENET, V24, P387, DOI 10.1038/74224; Yin T, 2006, J CLIN INVEST, V116, P1195, DOI 10.1172/JCI28568	31	386	422	3	35	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 24	2008	283	43					29119	29125		10.1074/jbc.M801774200	http://dx.doi.org/10.1074/jbc.M801774200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	362EB	18703512	Green Published, hybrid			2022-12-27	WOS:000260179900039
J	Schieke, SM; Ma, MC; Cao, L; Mccoy, JP; Liu, CY; Hensel, NF; Barrett, AJ; Boehm, M; Finkel, T				Schieke, Stefan M.; Ma, Mingchao; Cao, Liu; Mccoy, J. Philip, Jr.; Liu, Chengyu; Hensel, Nancy F.; Barrett, A. John; Boehm, Manfred; Finkel, Toren			Mitochondrial metabolism modulates differentiation and teratoma formation capacity in mouse embryonic stem cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BONE-MARROW; HYPOXIA; OXYGEN; MESODERM; MTOR; PROLIFERATION; PRECURSORS; PATHWAY; GROWTH	Relatively little is known regarding the role of mitochondrial metabolism in stem cell biology. Here we demonstrate that mouse embryonic stem cells sorted for low and high resting mitochondrial membrane potential ( Delta Psi L-m and Delta Psi H-m) are indistinguishable morphologically and by the expression of pluripotency markers, whereas markedly differing in metabolic rates. Interestingly, Delta Psi L-m cells are highly efficient at in vitro mesodermal differentiation yet fail to efficiently form teratomas in vivo, whereas Delta Psi H-m cells behave in the opposite fashion. We further demonstrate that Delta Psi(m) reflects the degree of overall mammalian target of rapamycin ( mTOR) activation and that the (mTOR) inhibitor rapamycin reduces metabolic rate, augments differentiation, and inhibits tumor formation of the mouse embryonic stem cells with a high metabolic rate. Taken together, our results suggest a coupling between intrinsic metabolic parameters and stem cell fate that might form a basis for novel enrichment strategies and therapeutic options.	[Schieke, Stefan M.; Ma, Mingchao; Cao, Liu; Boehm, Manfred; Finkel, Toren] NHLBI, Translat Med Branch, NIH, Bethesda, MD 20892 USA; [Hensel, Nancy F.; Barrett, A. John] NHLBI, Hematol Branch, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Boehm, M (corresponding author), Bldg 10-CRC 5-3132,10 Ctr Dr Bethesda, Bethesda, MD 20892 USA.	Manfred.Boehm@nih.gov; finkelt@nih.gov	mccoy, john philip/ABD-9348-2021		NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL005012, ZIAHL002342, ZICHL005905, Z01HL005012, ZICHL005907, Z01HL005907, Z01HL005066, Z01HL002342, ZIAHL005066, Z01HL005905] Funding Source: NIH RePORTER	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Balaban RS, 2005, CELL, V120, P483, DOI 10.1016/j.cell.2005.02.001; Chow DC, 2001, BIOPHYS J, V81, P685, DOI 10.1016/S0006-3495(01)75733-5; CIPOLLESCHI MG, 1993, BLOOD, V82, P2031; Covello KL, 2006, GENE DEV, V20, P557, DOI 10.1101/gad.1399906; Cunningham JT, 2007, NATURE, V450, P736, DOI 10.1038/nature06322; Danet GH, 2003, J CLIN INVEST, V112, P126, DOI 10.1172/JCI200317669; Deb KD, 2008, J TRANSL MED, V6, DOI 10.1186/1479-5876-6-7; Genbacev O, 1997, SCIENCE, V277, P1669, DOI 10.1126/science.277.5332.1669; Gustafsson MV, 2005, DEV CELL, V9, P617, DOI 10.1016/j.devcel.2005.09.010; Ivanovic Z, 2000, TRANSFUSION, V40, P1482, DOI 10.1046/j.1537-2995.2000.40121482.x; JOHANSSON BM, 1995, MOL CELL BIOL, V15, P141, DOI 10.1128/MCB.15.1.141; Kaidi A, 2007, NAT CELL BIOL, V9, P210, DOI 10.1038/ncb1534; Keith B, 2007, CELL, V129, P465, DOI 10.1016/j.cell.2007.04.019; Kim JW, 2006, CANCER RES, V66, P8927, DOI 10.1158/0008-5472.CAN-06-1501; Morrison SJ, 2000, J NEUROSCI, V20, P7370; Murakami M, 2004, MOL CELL BIOL, V24, P6710, DOI 10.1128/mcb.24.15.6710-6718.2004; Parmar K, 2007, P NATL ACAD SCI USA, V104, P5431, DOI 10.1073/pnas.0701152104; Ramirez-Bergeron DL, 2004, DEVELOPMENT, V131, P4623, DOI 10.1242/dev.01310; Saretzki G, 2004, STEM CELLS, V22, P962, DOI 10.1634/stemcells.22-6-962; Schieke SM, 2006, J BIOL CHEM, V281, P27643, DOI 10.1074/jbc.M603536200; Studer L, 2000, J NEUROSCI, V20, P7377; Takahashi K, 2005, BIOCHEM SOC T, V33, P1522, DOI 10.1042/BST0331522; WILKINSON DG, 1990, NATURE, V343, P657, DOI 10.1038/343657a0; YAMAGUCHI TP, 1993, DEVELOPMENT, V118, P489; Ying QL, 2003, CELL, V115, P281, DOI 10.1016/S0092-8674(03)00847-X	25	147	151	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 17	2008	283	42					28506	28512		10.1074/jbc.M802763200	http://dx.doi.org/10.1074/jbc.M802763200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	359EN	18713735	hybrid, Green Published			2022-12-27	WOS:000259969300053
J	Taneva, S; Dennis, MK; Ding, Z; Smith, JL; Cornell, RB				Taneva, Svetla; Dennis, Melissa K.; Ding, Ziwei; Smith, Jillian L.; Cornell, Rosemary B.			Contribution of each membrane binding domain of the CTP : phosphocholine cytidylyltransferase-alpha dimer to its activation, membrane binding, and membrane cross-bridging	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RAT-LIVER CTP; NUCLEAR-LOCALIZATION SIGNAL; PROTEIN-KINASE-C; GLYCEROL-3-PHOSPHATE CYTIDYLYLTRANSFERASE; PLASMA-MEMBRANE; IDENTIFICATION; LIPIDS; CELLS; PHOSPHATIDYLSERINE; ELECTROSTATICS	CTP:phosphocholine cytidylyltransferase (CCT), a rate-limiting enzyme in phosphatidylcholine synthesis, is regulated by reversible membrane interactions mediated by an amphipathic helical domain ( M) that binds selectively to anionic lipids. CCT is a dimer; thus the functional unit has two M domains. To probe the functional contribution of each domain M we prepared a CCT heterodimer composed of one full-length subunit paired with a CCT subunit truncated before domain M that was also catalytically dead. We compared this heterodimer to the full-length homodimer with respect to activation by anionic vesicles, vesicle binding affinities, and promotion of vesicle aggregation. Surprisingly for all three functions the dimer with just one domain M behaved similarly to the dimer with two M domains. Full activation of the wild-type subunit was not impaired by loss of one domain M in its partner. Membrane binding affinities were the same for dimers with one versus two M domains, suggesting that the two M domains of the dimer do not engage a single bilayer simultaneously. Vesicle cross-bridging was also unhindered by loss of one domain M, suggesting that another motif couples with domain M for cross-bridging anionic membranes. Mutagenesis revealed that the positively charged nuclear localization signal sequence constitutes that second motif for membrane cross-bridging. We propose that the two M domains of the CCT dimer engage a single bilayer via an alternating binding mechanism. The tethering function involves the cooperation of domain M and the nuclear localization signal sequence, each engaging separate membranes. Membrane binding of a single M domain is sufficient to fully activate the enzymatic activity of the CCT dimer while sustaining the low affinity, reversible membrane interaction required for regulation of CCT activity.	[Taneva, Svetla; Dennis, Melissa K.; Ding, Ziwei; Smith, Jillian L.; Cornell, Rosemary B.] Simon Fraser Univ, Dept Mol Biol & Biochem, Burnaby, BC V5A 1S6, Canada; [Cornell, Rosemary B.] Simon Fraser Univ, Dept Chem, Burnaby, BC V5A 1S6, Canada	Simon Fraser University; Simon Fraser University	Cornell, RB (corresponding author), Simon Fraser Univ, Dept Mol Biol & Biochem, 8888 Univ Dr, Burnaby, BC V5A 1S6, Canada.	cornell@sfu.ca			Canadian Institutes of Health [12134]	Canadian Institutes of Health(Canadian Institutes of Health Research (CIHR))	This work was supported by Canadian Institutes of Health Research Grant 12134. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	BARTLETT GR, 1959, J BIOL CHEM, V234, P468; Bogan MJ, 2005, J BIOL CHEM, V280, P19613, DOI 10.1074/jbc.M414028200; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BUSER CA, 1994, BIOCHEMISTRY-US, V33, P13093, DOI 10.1021/bi00248a019; Celton-Morizur S, 2004, MOL CELL BIOL, V24, P10621, DOI 10.1128/MCB.24.24.10621-10635.2004; CORNELL R, 1989, J BIOL CHEM, V264, P9077; CORNELL RB, 1991, BIOCHEMISTRY-US, V30, P5881, DOI 10.1021/bi00238a011; Cornell RB, 2000, TRENDS BIOCHEM SCI, V25, P441, DOI 10.1016/S0968-0004(00)01625-X; CRAIG L, 1994, J BIOL CHEM, V269, P3311; Davies SMA, 2001, BIOCHEMISTRY-US, V40, P10522, DOI 10.1021/bi010904c; Friesen JA, 1999, J BIOL CHEM, V274, P13384, DOI 10.1074/jbc.274.19.13384; Gehrig K, 2008, MOL BIOL CELL, V19, P237, DOI 10.1091/mbc.E07-02-0179; Giorgione JR, 2006, J BIOL CHEM, V281, P1660, DOI 10.1074/jbc.M510251200; Helmink BA, 2004, BBA-MOL CELL BIOL L, V1683, P78, DOI 10.1016/j.bbalip.2004.04.008; Helmink BA, 2003, BIOCHEMISTRY-US, V42, P5043, DOI 10.1021/bi027431+; Heo WD, 2006, SCIENCE, V314, P1458, DOI 10.1126/science.1134389; Hodel MR, 2001, J BIOL CHEM, V276, P1317, DOI 10.1074/jbc.M008522200; JAMIL H, 1993, BIOCHEM J, V291, P419, DOI 10.1042/bj2910419; Johnson JE, 1997, BBA-BIOMEMBRANES, V1324, P273, DOI 10.1016/S0005-2736(96)00233-7; Johnson JE, 2000, BIOCHEMISTRY-US, V39, P11360, DOI 10.1021/bi000902c; Johnson JE, 2003, J BIOL CHEM, V278, P514, DOI 10.1074/jbc.M206072200; Johnson JE, 2007, BIOCHEM J, V406, P223, DOI 10.1042/BJ20070294; Lykidis A, 1999, J BIOL CHEM, V274, P26992, DOI 10.1074/jbc.274.38.26992; MACDONALD JIS, 1993, PROTEIN EXPRES PURIF, V4, P1, DOI 10.1006/prep.1993.1001; McLaughlin S, 2005, NATURE, V438, P605, DOI 10.1038/nature04398; Murray D, 1998, BIOCHEMISTRY-US, V37, P2145, DOI 10.1021/bi972012b; Pattridge KA, 2003, J BIOL CHEM, V278, P51863, DOI 10.1074/jbc.M306174200; POEHLING HM, 1981, ELECTROPHORESIS, V2, P141, DOI 10.1002/elps.1150020304; Rhee SG, 2001, ANNU REV BIOCHEM, V70, P281, DOI 10.1146/annurev.biochem.70.1.281; Ridsdale R, 2001, J BIOL CHEM, V276, P49148, DOI 10.1074/jbc.M103566200; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P379; Sciorra VA, 2002, J CELL BIOL, V159, P1039, DOI 10.1083/jcb.200205056; SOHAL PS, 1990, J BIOL CHEM, V265, P11746; Taneva S, 2003, BIOCHEMISTRY-US, V42, P11768, DOI 10.1021/bi035234k; Taneva SG, 2005, BIOCHEMISTRY-US, V44, P9382, DOI 10.1021/bi050679p; Tian Y, 2007, MOL CELL BIOL, V27, P975, DOI 10.1128/MCB.01512-06; Vance JE, 2005, PROG LIPID RES, V44, P207, DOI 10.1016/j.plipres.2005.05.001; Vargo MA, 2004, PROTEIN SCI, V13, P1586, DOI 10.1110/ps.04694004; WALKEY CJ, 1994, J BIOL CHEM, V269, P5742; WANG YL, 1993, J BIOL CHEM, V268, P5512; WANG YL, 1995, J BIOL CHEM, V270, P354, DOI 10.1074/jbc.270.1.354; Weber CH, 1999, STRUCTURE, V7, P1113, DOI 10.1016/S0969-2126(99)80178-6; WEINHOLD PA, 1989, BIOCHIM BIOPHYS ACTA, V1006, P299, DOI 10.1016/0005-2760(89)90017-9; Williams CL, 2003, CELL SIGNAL, V15, P1071, DOI 10.1016/S0898-6568(03)00098-6; Xie MT, 2004, J BIOL CHEM, V279, P28817, DOI 10.1074/jbc.M403311200; YANG W, 1995, J BIOL CHEM, V270, P16503, DOI 10.1074/jbc.270.28.16503	46	27	27	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 17	2008	283	42					28137	28148		10.1074/jbc.M802595200	http://dx.doi.org/10.1074/jbc.M802595200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	359EN	18694933	Green Published, hybrid			2022-12-27	WOS:000259969300016
J	Yamashita, T; Suzuki, R; Backlund, PS; Yamashita, Y; Yergey, AL; Rivera, J				Yamashita, Toshiyuki; Suzuki, Ryo; Backlund, Peter S.; Yamashita, Yumi; Yergey, Alfred L.; Rivera, Juan			Differential dephosphorylation of the FcR gamma immunoreceptor tyrosine-based activation motif tyrosines with dissimilar potential for activating Syk	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AFFINITY IGE RECEPTOR; LEUKEMIA RBL-2H3 CELLS; EPSILON-RI; MAST-CELLS; IMMUNOGLOBULIN-E; KINASE SYK; MEDIATED DEGRANULATION; PHOSPHATASES SHP-1; BETA-SUBUNIT; PHOSPHORYLATION	The cell surface-expressed gamma chain of the high affinity receptor for IgE (Fc epsilon RI) can be phosphorylated on two tyrosine residues of the immunoreceptor tyrosine-based activation motif (ITAM), leading to recruitment and activation of spleen tyrosine kinase (Syk), a kinase that is essential for mast cell signaling and allergic responses. However, it is not known whether preferential phosphorylation or dephosphorylation of the two individual FcR gamma tyrosines (the N-terminal Tyr(47) and C-terminal Tyr(58)) could regulate Syk activation. Herein we report that phosphorylation of only Tyr(58) was able to elicit Syk phosphorylation and a weak rise in intracellular calcium, suggesting that Tyr(58) phosphorylation may be distinctively important for Syk activation. In vitro and in vivo studies revealed that both Tyr(47) and Tyr(58) could be similarly phosphorylated. However, mass spectrometric analysis of the phosphorylated Fc epsilon R gamma from bone marrow-derived mast cells showed that phosphorylation at Tyr(47) was at least 2-fold greater than at Tyr(58). This suggested that, once phosphorylated, Tyr(58) is preferentially dephosphorylated. In vitro studies demonstrated more efficient dephosphorylation of Tyr(58) (by the receptor-associated phosphatases SHP-1 and SHP-2) than of Tyr(47). Analysis of Syk binding to wild type and mutant phosphorylated Fc epsilon RI revealed that mutation at Tyr(58) almost completely ablated Syk binding, whereas mutation at Tyr(47) moderately reduced Syk binding. The findings argue for a novel regulatory mechanism, where dephosphorylation of phospho-Tyr(58) is likely to promote the down-regulation of Syk activation and suppression of mast cell responses.	[Yamashita, Toshiyuki; Suzuki, Ryo; Yamashita, Yumi; Rivera, Juan] NIAMS, Lab Immune Cell Signaling, Bethesda, MD 20892 USA; [Backlund, Peter S.; Yergey, Alfred L.] NICHD, Lab Cellular & Mol Biophys, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS); National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Rivera, J (corresponding author), NIAMS, NIH, Bldg 10,Rm 13C103, Bethesda, MD 20892 USA.	juan_rivera@nih.gov			EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZICHD001421] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [Z01HD001421] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [ZIAAR041101, Z01AR041101] Funding Source: NIH RePORTER	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Adachi T, 2007, BIOCHEM BIOPH RES CO, V364, P111, DOI 10.1016/j.bbrc.2007.09.100; Arias-Palomo E, 2007, BBA-PROTEINS PROTEOM, V1774, P1493, DOI 10.1016/j.bbapap.2007.10.008; BENHAMOU M, 1993, J BIOL CHEM, V268, P23318; Berton G, 2005, TRENDS IMMUNOL, V26, P208, DOI 10.1016/j.it.2005.02.002; Bruhns P, 2005, CURR OPIN IMMUNOL, V17, P662, DOI 10.1016/j.coi.2005.09.012; Chen T, 1996, J BIOL CHEM, V271, P25308, DOI 10.1074/jbc.271.41.25308; Costello PS, 1996, ONCOGENE, V13, P2595; ElHillal O, 1997, P NATL ACAD SCI USA, V94, P1919, DOI 10.1073/pnas.94.5.1919; Furumoto Y, 2004, J BIOL CHEM, V279, P49177, DOI 10.1074/jbc.M404730200; Gonzalez-Espinosa C, 2003, J EXP MED, V197, P1453, DOI 10.1084/jem.20021806; Huang ZY, 2003, J LEUKOCYTE BIOL, V73, P823, DOI 10.1189/jlb.0902454; Huber M, 2002, IMMUNOL LETT, V82, P17, DOI 10.1016/S0165-2478(02)00012-3; Huber M, 1998, EMBO J, V17, P7311, DOI 10.1093/emboj/17.24.7311; KIHARA H, 1994, J BIOL CHEM, V269, P22427; Kimura T, 1996, J BIOL CHEM, V271, P27962, DOI 10.1074/jbc.271.44.27962; Kimura T, 1997, J IMMUNOL, V159, P4426; Kitaura J, 2003, P NATL ACAD SCI USA, V100, P12911, DOI 10.1073/pnas.1735525100; Lin SQ, 1996, CELL, V85, P985, DOI 10.1016/S0092-8674(00)81300-8; LIU FT, 1980, J IMMUNOL, V124, P2728; MENDOZA G, 1976, NATURE, V264, P548, DOI 10.1038/264548a0; Neel BG, 1997, CURR OPIN CELL BIOL, V9, P193, DOI 10.1016/S0955-0674(97)80063-4; On M, 2004, J BIOL CHEM, V279, P45782, DOI 10.1074/jbc.M404890200; PAOLINI R, 1993, EMBO J, V12, P779, DOI 10.1002/j.1460-2075.1993.tb05712.x; PAOLINI R, 1991, NATURE, V353, P855, DOI 10.1038/353855a0; PRIBLUDA VS, 1994, P NATL ACAD SCI USA, V91, P11246, DOI 10.1073/pnas.91.23.11246; Rao N, 2001, EMBO J, V20, P7085, DOI 10.1093/emboj/20.24.7085; Rivera J, 2002, CURR OPIN IMMUNOL, V14, P688, DOI 10.1016/S0952-7915(02)00396-5; RIVERA J, 1988, MOL IMMUNOL, V25, P647, DOI 10.1016/0161-5890(88)90100-9; Sada K, 2000, J IMMUNOL, V164, P338, DOI 10.4049/jimmunol.164.1.338; Sada K, 2002, BLOOD, V100, P2138, DOI 10.1182/blood-2001-12-0340; Saitoh S, 2000, IMMUNITY, V12, P525, DOI 10.1016/S1074-7613(00)80204-6; Siraganian RP, 2002, MOL IMMUNOL, V38, P1229, DOI 10.1016/S0161-5890(02)00068-8; SWIETER M, 1995, J IMMUNOL, V155, P5330; TAKAI T, 1994, CELL, V76, P519, DOI 10.1016/0092-8674(94)90115-5; Xie ZH, 2000, J IMMUNOL, V164, P1521, DOI 10.4049/jimmunol.164.3.1521; YAMASHITA T, 1994, P NATL ACAD SCI USA, V91, P11251, DOI 10.1073/pnas.91.23.11251; Zhang J, 2004, J IMMUNOL, V173, P1811, DOI 10.4049/jimmunol.173.3.1811; Zhang J, 1996, J EXP MED, V184, P71, DOI 10.1084/jem.184.1.71	38	25	27	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 17	2008	283	42					28584	28594		10.1074/jbc.M802679200	http://dx.doi.org/10.1074/jbc.M802679200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	359EN	18715866	Green Published, hybrid			2022-12-27	WOS:000259969300061
J	Zhao, ZZ; Michaely, P				Zhao, Zhenze; Michaely, Peter			The epidermal growth factor homology domain of the LDL receptor drives lipoprotein release through an allosteric mechanism involving H190, H562, and H586	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LOW-DENSITY-LIPOPROTEIN; MOUSE PERITONEAL-MACROPHAGES; CELL-SURFACE RECEPTORS; FAMILIAL HYPERCHOLESTEROLEMIA; HUMAN-FIBROBLASTS; MEDIATED ENDOCYTOSIS; APOLIPOPROTEIN-E; ADAPTER PROTEIN; CYTOPLASMIC DOMAIN; BINDING DOMAIN	The low density lipoprotein (LDL) receptor (LDLR) mediates efficient endocytosis of VLDL, VLDL remnants, and LDL. As part of the endocytic process, the LDLR releases lipoproteins in endosomes. The release process correlates with an acid-dependent conformational change in the receptor from an extended, "open" state to a compact, "closed" state. The closed state has an intramolecular contact involving H190, H562, and H586. The current model for lipoprotein release holds that protonation of these histidines drives the conformational change that is associated with release. We tested the roles of H190, H562, and H586 on LDLR conformation and on lipoprotein binding, uptake, and release using variants in which the three histidines were replaced with alanine (AAA variant) or in which the histidines were replaced with charged residues that can form ionic contacts at neutral pH (DRK variant). Contrary to expectation, both the AAA and the DRK variants exhibited normal acid-dependent transitions from open to closed conformations. Despite this similarity, both the AAA and DRK mutations modulated lipoprotein release, indicating that H190, H562, and H586 act subsequent to the conformational transition. These observations also suggest that the intramolecular contact does not drive release through a competitive mechanism. In support of this possibility, mutagenesis experiments showed that beta-VLDL binding was inhibited by mutations at D203 and E208, which are exposed in the closed conformation of the LDLR. We propose that H190, H562, and H586 are part of an allosteric mechanism that drives lipoprotein release.	[Zhao, Zhenze; Michaely, Peter] Univ Texas SW Med Ctr Dallas, Dept Cell Biol, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas	Zhao, ZZ (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Cell Biol, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	Peter.Michaely@utsouthwestern.edu	Zhao, Zhenze/AAW-5870-2020		National Institutes of Health [HL085218]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL085218] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant HL085218. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Arias-Moreno X, 2008, J BIOL CHEM, V283, P13627, DOI 10.1074/jbc.M800755200; Beglova N, 2005, TRENDS BIOCHEM SCI, V30, P309, DOI 10.1016/j.tibs.2005.03.007; Beglova N, 2004, MOL CELL, V16, P281, DOI 10.1016/j.molcel.2004.09.038; Blacklow SC, 1996, NAT STRUCT BIOL, V3, P758, DOI 10.1038/nsb0996-758; Blasiole DA, 2008, J BIOL CHEM, V283, P11374, DOI 10.1074/jbc.M710457200; BRADLEY WA, 1986, J LIPID RES, V27, P40; BROWN MS, 1974, P NATL ACAD SCI USA, V71, P788, DOI 10.1073/pnas.71.3.788; BROWN MS, 1986, SCIENCE, V232, P34, DOI 10.1126/science.3513311; BROWN MS, 1981, SCIENCE, V212, P628, DOI 10.1126/science.6261329; BROWN MS, 1981, COLD SPRING HARB SYM, V46, P713, DOI 10.1101/SQB.1982.046.01.068; CHEN WJ, 1990, J BIOL CHEM, V265, P3116; Counter CM, 1998, P NATL ACAD SCI USA, V95, P14723, DOI 10.1073/pnas.95.25.14723; DALY NL, 1995, P NATL ACAD SCI USA, V92, P6334, DOI 10.1073/pnas.92.14.6334; DAVIS CG, 1987, NATURE, V326, P760, DOI 10.1038/326760a0; DAVIS CG, 1986, CELL, V45, P15, DOI 10.1016/0092-8674(86)90533-7; ESSER V, 1988, J BIOL CHEM, V263, P13282; Fass D, 1997, NATURE, V388, P691, DOI 10.1038/41798; Fisher C, 2004, BIOCHEMISTRY-US, V43, P1037, DOI 10.1021/bi035529y; Fisher C, 2006, MOL CELL, V22, P277, DOI 10.1016/j.molcel.2006.02.021; GOLDSTEIN JL, 1983, METHOD ENZYMOL, V98, P241; GOLDSTEIN JL, 1980, J BIOL CHEM, V255, P1839; He GC, 2002, J BIOL CHEM, V277, P44044, DOI 10.1074/jbc.M208539200; HEUSER JE, 1989, J CELL BIOL, V108, P389, DOI 10.1083/jcb.108.2.389; Hobbs Helen H., 1992, Human Mutation, V1, P445, DOI 10.1002/humu.1380010602; Hopkins PN, 1999, J HUM GENET, V44, P364, DOI 10.1007/s100380050179; Jeon H, 2001, NAT STRUCT BIOL, V8, P499, DOI 10.1038/88556; Jones NL, 2000, J LIPID RES, V41, P1823; Keyel PA, 2006, MOL BIOL CELL, V17, P4300, DOI 10.1091/mbc.E06-05-0421; LEHRMAN MA, 1985, CELL, V41, P735, DOI 10.1016/S0092-8674(85)80054-4; Liu XD, 1997, P NATL ACAD SCI USA, V94, P10669, DOI 10.1073/pnas.94.20.10669; LOMBARDI P, 1993, J BIOL CHEM, V268, P26113; MAHLEY RW, 1977, J BIOL CHEM, V252, P7279; MAHLEY RW, 1977, J BIOL CHEM, V252, P3980; Maurer ME, 2006, J CELL SCI, V119, P4235, DOI 10.1242/jcs.03217; Maxfield FR, 2004, NAT REV MOL CELL BIO, V5, P121, DOI 10.1038/nrm1315; Michaely P, 2007, EMBO J, V26, P3273, DOI 10.1038/sj.emboj.7601769; Mishra SK, 2002, P NATL ACAD SCI USA, V99, P16099, DOI 10.1073/pnas.252630799; Morales CP, 1999, NAT GENET, V21, P115, DOI 10.1038/5063; North CL, 2000, BIOCHEMISTRY-US, V39, P2564, DOI 10.1021/bi992087a; PITAS RE, 1979, P NATL ACAD SCI USA, V76, P2311, DOI 10.1073/pnas.76.5.2311; Prevost M, 2004, PROTEINS, V55, P874, DOI 10.1002/prot.20080; Rudenko G, 2002, SCIENCE, V298, P2353, DOI 10.1126/science.1078124; RUSSELL DW, 1989, J BIOL CHEM, V264, P21682; SCHNEIDER WJ, 1981, J CLIN INVEST, V68, P1075, DOI 10.1172/JCI110330; Sirinian MI, 2005, J BIOL CHEM, V280, P38416, DOI 10.1074/jbc.M504343200; SUN XM, 1994, ARTERIOSCLER THROMB, V14, P85, DOI 10.1161/01.ATV.14.1.85; TABAS I, 1991, J CELL BIOL, V115, P1547, DOI 10.1083/jcb.115.6.1547; TABAS I, 1990, J CELL BIOL, V111, P929, DOI 10.1083/jcb.111.3.929; WEISGRABER KH, 1983, J BIOL CHEM, V258, P2348; WEISGRABER KH, 1978, J BIOL CHEM, V253, P9053; YAMAMOTO T, 1984, CELL, V39, P27, DOI 10.1016/0092-8674(84)90188-0; YANG CY, 1986, NATURE, V323, P738, DOI 10.1038/323738a0	53	21	21	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 26	2008	283	39					26528	26537		10.1074/jbc.M804624200	http://dx.doi.org/10.1074/jbc.M804624200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	350GV	18677035	hybrid, Green Published			2022-12-27	WOS:000259341600029
J	Wang, YY; Chang, RB; Waters, HN; Mckemy, DD; Liman, ER				Wang, Yuanyuan Y.; Chang, Rui B.; Waters, Hang N.; Mckemy, David D.; Liman, Emily R.			The Nociceptor Ion Channel TRPA1 Is Potentiated and Inactivated by Permeating Calcium Ions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VANILLOID RECEPTOR TRPV1; EPITHELIAL CA2+ CHANNEL; ROOT GANGLION NEURONS; PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE; CATION CHANNEL; MUSTARD OIL; PROTEIN-KINASE; COVALENT MODIFICATION; CAPSAICIN RECEPTOR; INFLAMMATORY PAIN	The transient receptor potential A1 (TRPA1) channel is the molecular target for environmental irritants and pungent chemicals, such as cinnamaldehyde and mustard oil. Extracellular Ca2+ is a key regulator of TRPA1 activity, both potentiating and subsequently inactivating it. In this report, we provide evidence that the effect of extracellular Ca2+ on these processes is indirect and can be entirely attributed to entry through TRPA1 and subsequent elevation of intracellular calcium. Specifically, we found that in a pore mutant of TRPA1, D918A, in which Ca2+ permeability was greatly reduced, extracellular Ca2+ produced neither potentiation nor inactivation. Both processes were restored by reducing intracellular Ca2+ buffering, which allowed intracellular Ca2+ levels to become elevated upon entry through D918A channels. Application of Ca2+ to the cytosolic face of excised patches was sufficient to produce both potentiation and inactivation of TRPA1 channels. Moreover, in whole cell recordings, elevation of intracellular Ca2+ by UV uncaging of 1-(4,5-dimethoxy-2-nitrophenyl)-EDTA-potentiated TRPA1 currents. In addition, our data show that potentiation and inactivation are independent processes. TRPA1 currents could be inactivated by Mg2+, Ba2+, and Ca2+ but potentiated only by Ba2+ and Ca2+. Saturating activation by cinnamaldehyde or mustard oil occluded potentiation but did not interfere with inactivation. Last, neither process was affected by mutation of a putative intracellular Ca2+-binding EF-hand motif. In conclusion, we have further clarified the mechanisms of potentiation and inactivation of TRPA1 using the D918A pore mutant, an important tool for investigating the contribution of Ca2+ influx through TRPA1 to nociceptive signaling.	[Wang, Yuanyuan Y.; Chang, Rui B.; Waters, Hang N.; Mckemy, David D.; Liman, Emily R.] Univ So Calif, Neurobiol Sect, Los Angeles, CA 90089 USA; Univ So Calif, Dept Biol Sci, Los Angeles, CA 90089 USA; [Wang, Yuanyuan Y.; Chang, Rui B.; Mckemy, David D.; Liman, Emily R.] Univ So Calif, Program Neurosci, Los Angeles, CA 90089 USA	University of Southern California; University of Southern California; University of Southern California	Liman, ER (corresponding author), Univ So Calif, Neurobiol Sect, 3641 Watt Way, Los Angeles, CA 90089 USA.	liman@usc.edu	Wang, Yuanyuan/H-3651-2012; Liman, Emily/AAC-7383-2021	liman, emily/0000-0003-4765-5496	National Institutes of Health, NIDCD [004564]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS054069] Funding Source: NIH RePORTER	National Institutes of Health, NIDCD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health, NIDCD, Grant 004564 ( to E. L.).	Akopian AN, 2007, J PHYSIOL-LONDON, V583, P175, DOI 10.1113/jphysiol.2007.133231; Alam A, 2007, P NATL ACAD SCI USA, V104, P15334, DOI 10.1073/pnas.0707324104; ALDRICH RW, 1983, NATURE, V306, P436, DOI 10.1038/306436a0; Andersson DA, 2008, J NEUROSCI, V28, P2485, DOI 10.1523/JNEUROSCI.5369-07.2008; Bandell M, 2004, NEURON, V41, P849, DOI 10.1016/S0896-6273(04)00150-3; Bandell M, 2007, CURR OPIN NEUROBIOL, V17, P490, DOI 10.1016/j.conb.2007.07.014; Bautista DM, 2005, P NATL ACAD SCI USA, V102, P12248, DOI 10.1073/pnas.0505356102; Bautista DM, 2006, CELL, V124, P1269, DOI 10.1016/j.cell.2006.02.023; Bessac BF, 2008, J CLIN INVEST, V118, P1899, DOI 10.1172/JCI34192; Bradley J, 2005, CURR OPIN NEUROBIOL, V15, P343, DOI 10.1016/j.conb.2005.05.014; Brand G, 2002, CHEM SENSES, V27, P593, DOI 10.1093/chemse/27.7.593; Caterina MJ, 2001, ANNU REV NEUROSCI, V24, P487, DOI 10.1146/annurev.neuro.24.1.487; Cavanaugh EJ, 2008, NEUROSCIENCE, V154, P1467, DOI 10.1016/j.neuroscience.2008.04.048; CHEN TY, 1994, NATURE, V368, P545, DOI 10.1038/368545a0; CHOLEWINSKI A, 1993, NEUROSCIENCE, V55, P1015, DOI 10.1016/0306-4522(93)90315-7; Chuang HH, 2001, NATURE, V411, P957, DOI 10.1038/35082088; Dai Y, 2007, J CLIN INVEST, V117, P1979, DOI 10.1172/JCI30951; DELANEY KR, 1990, J PHYSIOL-LONDON, V426, P473, DOI 10.1113/jphysiol.1990.sp018150; DeMaria CD, 2001, NATURE, V411, P484, DOI 10.1038/35078091; Docherty RJ, 1996, PFLUG ARCH EUR J PHY, V431, P828, DOI 10.1007/BF02332166; Doerner JF, 2007, J BIOL CHEM, V282, P13180, DOI 10.1074/jbc.M607849200; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; Garcia-Martinez C, 2000, J BIOL CHEM, V275, P32552, DOI 10.1074/jbc.M002391200; Gifford JL, 2007, BIOCHEM J, V405, P199, DOI 10.1042/BJ20070255; HEGINBOTHAM L, 1992, SCIENCE, V258, P1152, DOI 10.1126/science.1279807; Hille B., 2001, IONIC CHANNELS EXCIT, P814; Hinman A, 2006, P NATL ACAD SCI USA, V103, P19564, DOI 10.1073/pnas.0609598103; Hofmann T, 2003, CURR BIOL, V13, P1153, DOI 10.1016/S0960-9822(03)00431-7; Jordt SE, 2004, NATURE, V427, P260, DOI 10.1038/nature02282; KAPLAN JH, 1988, P NATL ACAD SCI USA, V85, P6571, DOI 10.1073/pnas.85.17.6571; Karashima Y, 2008, PFLUG ARCH EUR J PHY, V457, P77, DOI 10.1007/s00424-008-0493-6; Karashima Y, 2007, J NEUROSCI, V27, P9874, DOI 10.1523/JNEUROSCI.2221-07.2007; Kim D, 2008, AM J PHYSIOL-CELL PH, V295, pC92, DOI 10.1152/ajpcell.00023.2008; Kim D, 2007, J NEUROSCI, V27, P6500, DOI 10.1523/JNEUROSCI.0623-07.2007; Kwan KY, 2006, NEURON, V50, P277, DOI 10.1016/j.neuron.2006.03.042; Kwon Y, 2007, MOL CELL, V25, P491, DOI 10.1016/j.molcel.2007.01.021; Lambers TT, 2004, J BIOL CHEM, V279, P28855, DOI 10.1074/jbc.M313637200; Launay P, 2002, CELL, V109, P397, DOI 10.1016/S0092-8674(02)00719-5; Lee A, 1999, NATURE, V399, P155, DOI 10.1038/20194; Lee SP, 2008, BRIT J PHARMACOL, V153, P1739, DOI 10.1038/bjp.2008.85; Liang HY, 2003, NEURON, V39, P951, DOI 10.1016/S0896-6273(03)00560-9; Lishko PV, 2007, NEURON, V54, P905, DOI 10.1016/j.neuron.2007.05.027; Liu BY, 2005, J NEUROSCI, V25, P4835, DOI 10.1523/JNEUROSCI.1296-05.2005; Liu CH, 2007, J NEUROSCI, V27, P604, DOI 10.1523/JNEUROSCI.4099-06.2007; Liu D, 2003, P NATL ACAD SCI USA, V100, P15160, DOI 10.1073/pnas.2334159100; Macpherson LJ, 2007, J NEUROSCI, V27, P11412, DOI 10.1523/JNEUROSCI.3600-07.2007; Macpherson LJ, 2007, NATURE, V445, P541, DOI 10.1038/nature05544; McNamara CR, 2007, P NATL ACAD SCI USA, V104, P13525, DOI 10.1073/pnas.0705924104; Mohapatra DP, 2005, J BIOL CHEM, V280, P13424, DOI 10.1074/jbc.M410917200; Moran MM, 2004, CURR OPIN NEUROBIOL, V14, P362, DOI 10.1016/j.conb.2004.05.003; Myers BR, 2008, NEURON, V58, P362, DOI 10.1016/j.neuron.2008.04.012; Nagata K, 2005, J NEUROSCI, V25, P4052, DOI 10.1523/JNEUROSCI.0013-05.2005; NEHER E, 1993, NEURON, V10, P21, DOI 10.1016/0896-6273(93)90238-M; Neher E, 1998, NEURON, V20, P389, DOI 10.1016/S0896-6273(00)80983-6; Niemeyer BA, 2001, P NATL ACAD SCI USA, V98, P3600, DOI 10.1073/pnas.051511398; Nilius B, 2006, EMBO J, V25, P467, DOI 10.1038/sj.emboj.7600963; Nilius B, 2005, J PHYSIOL-LONDON, V567, P35, DOI 10.1113/jphysiol.2005.088377; Nilius B, 2001, J BIOL CHEM, V276, P1020, DOI 10.1074/jbc.M006184200; Okuse K, 2007, INT J BIOCHEM CELL B, V39, P490, DOI 10.1016/j.biocel.2006.11.016; Ordaz B, 2005, J BIOL CHEM, V280, P30788, DOI 10.1074/jbc.M504745200; Owsianik G, 2006, ANNU REV PHYSIOL, V68, P685, DOI 10.1146/annurev.physiol.68.040204.101406; Peterson BZ, 1999, NEURON, V22, P549, DOI 10.1016/S0896-6273(00)80709-6; Prawitt D, 2003, P NATL ACAD SCI USA, V100, P15166, DOI 10.1073/pnas.2334624100; Prescott ED, 2003, SCIENCE, V300, P1284, DOI 10.1126/science.1083646; Qin N, 1999, P NATL ACAD SCI USA, V96, P2435, DOI 10.1073/pnas.96.5.2435; Rohacs T, 2005, NAT NEUROSCI, V8, P626, DOI 10.1038/nn1451; Runnels LW, 2002, NAT CELL BIOL, V4, P329, DOI 10.1038/ncb781; Ruparel NB, 2008, PAIN, V135, P271, DOI 10.1016/j.pain.2007.06.005; Sawada Y, 2008, EUR J NEUROSCI, V27, P1131, DOI 10.1111/j.1460-9568.2008.06093.x; Shi N, 2006, NATURE, V440, P570, DOI 10.1038/nature04508; Simons CT, 2003, CHEM SENSES, V28, P459, DOI 10.1093/chemse/28.6.459; Story GM, 2003, CELL, V112, P819, DOI 10.1016/S0092-8674(03)00158-2; Suh BC, 2005, CURR OPIN NEUROBIOL, V15, P370, DOI 10.1016/j.conb.2005.05.005; Suh BC, 2006, SCIENCE, V314, P1454, DOI 10.1126/science.1131163; Susankova K, 2007, J NEUROSCI, V27, P7578, DOI 10.1523/JNEUROSCI.1956-07.2007; SWENSON RP, 1981, NATURE, V291, P427, DOI 10.1038/291427a0; Thyagarajan B, 2008, J BIOL CHEM, V283, P14980, DOI 10.1074/jbc.M704224200; Ullrich ND, 2005, CELL CALCIUM, V37, P267, DOI 10.1016/j.ceca.2004.11.001; Varnai P, 2006, J CELL BIOL, V175, P377, DOI 10.1083/jcb.200607116; Wang HB, 2006, BIOL CHEM, V387, P11, DOI 10.1515/BC.2006.003; Wang S, 2008, BRAIN, V131, P1241, DOI 10.1093/brain/awn060; Xiao R, 2008, J BIOL CHEM, V283, P6162, DOI 10.1074/jbc.M706535200; Xu HX, 2006, NAT NEUROSCI, V9, P628, DOI 10.1038/nn1692; Zagotta WN, 2006, NATURE, V440, P427, DOI 10.1038/440427a; Zhang Z, 2005, J BIOL CHEM, V280, P39185, DOI 10.1074/jbc.M506965200; Zhang Z, 2007, J NEUROSCI, V27, P5777, DOI 10.1523/JNEUROSCI.4973-06.2007; Zhu Michael X, 2004, Novartis Found Symp, V258, P44; Zuhlke RD, 1999, NATURE, V399, P159, DOI 10.1038/20200; Zurborg S, 2007, NAT NEUROSCI, V10, P277, DOI 10.1038/nn1843	89	193	202	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 21	2008	283	47					32691	32703		10.1074/jbc.M803568200	http://dx.doi.org/10.1074/jbc.M803568200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	372HW	18775987	hybrid, Green Published			2022-12-27	WOS:000260893700059
J	Yonus, H; Neumann, P; Zimmermann, S; May, JJ; Marahiel, MA; Stubbs, MT				Yonus, Huma; Neumann, Piotr; Zimmermann, Stephan; May, Juergen J.; Marahiel, Mohamed A.; Stubbs, Milton T.			Crystal Structure of DltA IMPLICATIONS FOR THE REACTION MECHANISM OF NON-RIBOSOMAL PEPTIDE SYNTHETASE ADENYLATION DOMAINS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALANYL-LIPOTEICHOIC ACID; FORMING ENZYME SUPERFAMILY; CARRIER PROTEIN; FIREFLY LUCIFERASE; BACILLUS-SUBTILIS; D-ALANINE; DIFFRACTION DATA; TEICHOIC-ACIDS; BIOSYNTHESIS; STAPHYLOCOCCUS	DltA, the D-alanine:D-alanyl carrier protein ligase responsible for the initial step of lipoteichoic acid D-alanylation in Gram-positive bacteria, belongs to the adenylation domain superfamily, which also includes acetyl-CoA synthetase and the adenylation domains of non-ribosomal synthetases. The two-step reaction catalyzed by these enzymes ( substrate adenylation followed by transfer to the reactive thiol group of CoA or the phosphopantheinyl prosthetic group of peptidyl carrier proteins) has been suggested to proceed via large scale rearrangements of structural domains within the enzyme. The structures of DltA reported here reveal the determinants for D-Ala substrate specificity and confirm that the peptidyl carrier protein-activating domains are able to adopt multiple conformational states, in this case corresponding to the thiolation reaction. Comparisons of available structures allow us to propose a mechanism whereby small perturbations of finely balanced metastable structural states would be able to direct an ordered formation of non-ribosomal synthetase products.	[Yonus, Huma; Neumann, Piotr; Zimmermann, Stephan; Stubbs, Milton T.] Univ Halle Wittenberg, Inst Biochem & Biotechnol, D-06120 Halle, Germany; [May, Juergen J.; Marahiel, Mohamed A.] Univ Marburg, Fachbereich Chem Biochem, D-35032 Marburg, Germany; [Stubbs, Milton T.] Univ Halle Wittenberg, Mitteldeutsch Zentrum Struktur & Dynam Prot, D-06120 Halle, Germany	Martin Luther University Halle Wittenberg; Philipps University Marburg; Martin Luther University Halle Wittenberg	Stubbs, MT (corresponding author), Univ Halle Wittenberg, Inst Biochem & Biotechnol, Kurt Mothes Str 3, D-06120 Halle, Germany.	stubbs@biochemtech.uni-halle.de	Stubbs, Milton/ABC-7585-2020	Stubbs, Milton/0000-0003-1278-9013	Deutsche Forschungsgemeinschaft	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the Schwerpunktprogramm SPP1152 "Evolution metabolischer Diversitat" and the Graduiertenkolleg 1026 "Conformational transitions in macromolecular interactions" of the Deutsche Forschungsgemeinschaft. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Abachin E, 2002, MOL MICROBIOL, V43, P1, DOI 10.1046/j.1365-2958.2002.02723.x; Ayabe K, 2005, FEBS LETT, V579, P4389, DOI 10.1016/j.febslet.2005.07.004; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Boyd DA, 2000, J BACTERIOL, V182, P6055, DOI 10.1128/JB.182.21.6055-6065.2000; Branchini BR, 2005, BIOCHEMISTRY-US, V44, P1385, DOI 10.1021/bi047903f; Branchini BR, 2000, BIOCHEMISTRY-US, V39, P5433, DOI 10.1021/bi9928804; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Challis GL, 2000, CHEM BIOL, V7, P211, DOI 10.1016/S1074-5521(00)00091-0; Chang KH, 1997, BIOCHEMISTRY-US, V36, P15650, DOI 10.1021/bi971262p; Clemans DL, 1999, INFECT IMMUN, V67, P2464, DOI 10.1128/IAI.67.5.2464-2474.1999; Conti E, 1997, EMBO J, V16, P4174, DOI 10.1093/emboj/16.14.4174; Conti E, 1996, STRUCTURE, V4, P287, DOI 10.1016/S0969-2126(96)00033-0; Debabov DV, 2000, J BACTERIOL, V182, P2855, DOI 10.1128/JB.182.10.2855-2864.2000; Dieckmann R, 1997, EUR J BIOCHEM, V247, P1074, DOI 10.1111/j.1432-1033.1997.01074.x; Doublie S, 1997, METHOD ENZYMOL, V276, P523, DOI 10.1016/S0076-6879(97)76075-0; Drake EJ, 2006, CHEM BIOL, V13, P409, DOI 10.1016/j.chembiol.2006.02.005; Finking R, 2004, ANNU REV MICROBIOL, V58, P453, DOI 10.1146/annurev.micro.58.030603.123615; FISCHER W, 1988, ADV MICROB PHYSIOL, V29, P233, DOI 10.1016/S0065-2911(08)60349-5; Franks NP, 1998, BIOPHYS J, V75, P2205, DOI 10.1016/S0006-3495(98)77664-7; GOCHT M, 1994, J BACTERIOL, V176, P2654, DOI 10.1128/JB.176.9.2654-2662.1994; Gotz F, 2002, MOL MICROBIOL, V43, P1367, DOI 10.1046/j.1365-2958.2002.02827.x; Gross M, 2001, INFECT IMMUN, V69, P3423, DOI 10.1128/IAI.69.5.3423-3426.2001; Gulick AM, 2004, BIOCHEMISTRY-US, V43, P8670, DOI 10.1021/bi049384m; Gulick AM, 2003, BIOCHEMISTRY-US, V42, P2866, DOI 10.1021/bi0271603; Hisanaga Y, 2004, J BIOL CHEM, V279, P31717, DOI 10.1074/jbc.M400100200; Jenni S, 2007, SCIENCE, V316, P254, DOI 10.1126/science.1138248; Jogl G, 2004, BIOCHEMISTRY-US, V43, P1425, DOI 10.1021/bi035911a; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Koglin A, 2006, SCIENCE, V312, P273, DOI 10.1126/science.1122928; Lai JR, 2006, J AM CHEM SOC, V128, P11002, DOI 10.1021/ja063238h; Leibundgut M, 2007, SCIENCE, V316, P288, DOI 10.1126/science.1138249; May JJ, 2002, P NATL ACAD SCI USA, V99, P12120, DOI 10.1073/pnas.182156699; May JJ, 2005, FEBS J, V272, P2993, DOI 10.1111/j.1742-4658.2005.04700.x; Nakatsu T, 2006, NATURE, V440, P372, DOI 10.1038/nature04542; Neuhaus FC, 2003, MICROBIOL MOL BIOL R, V67, P686, DOI 10.1128/MMBR.67.4.686-723.2003; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PAI EF, 1990, EMBO J, V9, P2351, DOI 10.1002/j.1460-2075.1990.tb07409.x; PEREGO M, 1995, J BIOL CHEM, V270, P15598, DOI 10.1074/jbc.270.26.15598; Peschel A, 1999, J BIOL CHEM, V274, P8405, DOI 10.1074/jbc.274.13.8405; Poyart C, 2001, J BACTERIOL, V183, P6324, DOI 10.1128/JB.183.21.6324-6334.2001; Reger AS, 2007, BIOCHEMISTRY-US, V46, P6536, DOI 10.1021/bi6026506; Samel SA, 2007, STRUCTURE, V15, P781, DOI 10.1016/j.str.2007.05.008; SARASTE M, 1990, TRENDS BIOCHEM SCI, V15, P430, DOI 10.1016/0968-0004(90)90281-F; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; Schwarzer D, 2001, NATURWISSENSCHAFTEN, V88, P93, DOI 10.1007/s001140100211; Schwarzer D, 2003, NAT PROD REP, V20, P275, DOI 10.1039/b111145k; Sieber SA, 2005, CHEM REV, V105, P715, DOI 10.1021/cr0301191; Stachelhaus T, 1999, CHEM BIOL, V6, P493, DOI 10.1016/S1074-5521(99)80082-9; Stevens BW, 2006, BIOCHEMISTRY-US, V45, P15495, DOI 10.1021/bi061788m; Stuible HP, 2000, FEBS LETT, V467, P117, DOI 10.1016/S0014-5793(00)01133-9; Tang GL, 2007, J BIOL CHEM, V282, P20273, DOI 10.1074/jbc.M702814200; Tanovic A, 2008, SCIENCE, V321, P659, DOI 10.1126/science.1159850; Volkman BF, 2001, BIOCHEMISTRY-US, V40, P7964, DOI 10.1021/bi010355a; Weber T, 2001, STRUCTURE, V9, pR3, DOI 10.1016/S0969-2126(00)00560-8; Wecke J, 1996, MICROB DRUG RESIST, V2, P123, DOI 10.1089/mdr.1996.2.123; Zhou Z, 2007, P NATL ACAD SCI USA, V104, P11621, DOI 10.1073/pnas.0705122104	58	100	105	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 21	2008	283	47					32484	32491		10.1074/jbc.M800557200	http://dx.doi.org/10.1074/jbc.M800557200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	372HW	18784082	hybrid			2022-12-27	WOS:000260893700036
J	Cooper, MP; Uldry, M; Kajimura, S; Arany, Z; Spiegelman, BM				Cooper, Marcus P.; Uldry, Marc; Kajimura, Shingo; Arany, Zoltan; Spiegelman, Bruce M.			Modulation of PGC-1 Coactivator Pathways in Brown Fat Differentiation through LRP130	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MITOCHONDRIAL UNCOUPLING PROTEIN; C-OXIDASE DEFICIENCY; ADIPOSE CELL LINE; MESSENGER-RNA; ADIPOCYTE DIFFERENTIATION; TRANSGENIC MICE; IN-VIVO; ADAPTIVE THERMOGENESIS; INDUCIBLE COACTIVATOR; ENERGY-METABOLISM	The PGC-1 coactivators are important regulators of oxidative metabolism. We previously demonstrated that LRP130 is a binding partner of PGC-1 alpha, required for hepatic gluconeogenesis. LRP130 is the gene mutated in Leigh syndrome French Canadian variant, a rare neurodegenerative disease. The importance of LRP130 in other, non-hepatocyte biology remains obscure. To better understand PGC-1 coactivator function in brown fat development, we explored the metabolic role of LRP130 in brown adipocyte differentiation. We show that LRP130 is preferentially enriched in brown fat compared with white, and induced in a PGC-1-dependent manner during differentiation. Despite intact PGC-1 coactivator expression, brown fat cells deficient for LRP130 exhibit attenuated expression of several genes characteristic of brown fat, including uncoupling protein 1. Oxygen consumption studies support a specific defect in proton leak due to attenuated uncoupling protein 1 expression. Notably, brown fat cell development common to both PGC-1 coactivators is governed by LRP130. Conversely, the cAMP response controlled by PGC-1 alpha is not regulated by LRP130. These data implicate LRP130 in brown fat cell development and differentiation.	[Spiegelman, Bruce M.] Harvard Univ, Sch Med, Dana Farber Canc Inst, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Harvard Medical School	Spiegelman, BM (corresponding author), Harvard Univ, Sch Med, Dana Farber Canc Inst, 1 Jimmy Fund Way, Boston, MA 02115 USA.	marcus.cooper@umassmed.edu; bruce_spiegelman@dfci.harvard.edu	Kajimura, Shingo/AAC-5090-2019	Kajimura, Shingo/0000-0003-0672-5910	National Institutes of Health [R01DK61562, K08DK071017]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R03DK081564, K08DK071017, R01DK061562] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants R01DK61562 (to B. M. S.) and K08DK071017 (to M. P. C.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	Andersson U, 2001, MOL CELL BIOL, V21, P3738, DOI 10.1128/MCB.21.11.3738-3749.2001; Barbera MJ, 2001, J BIOL CHEM, V276, P1486, DOI 10.1074/jbc.M006246200; BEARDEN JC, 1978, BIOCHIM BIOPHYS ACTA, V533, P525, DOI 10.1016/0005-2795(78)90398-7; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003; Cao WH, 2004, MOL CELL BIOL, V24, P3057, DOI 10.1128/MCB.24.7.3057-3067.2004; Cederberg A, 2001, CELL, V106, P563, DOI 10.1016/S0092-8674(01)00474-3; Cooper MP, 2006, GENE DEV, V20, P2996, DOI 10.1101/gad.1483906; DAWKINS MJR, 1964, J PHYSIOL-LONDON, V172, P216, DOI 10.1113/jphysiol.1964.sp007414; Debevec D, 2007, MOL ENDOCRINOL, V21, P1581, DOI 10.1210/me.2007-0103; Fan M, 2004, GENE DEV, V18, P278, DOI 10.1101/gad.1152204; Fasshauer M, 2001, MOL CELL BIOL, V21, P319, DOI 10.1128/MCB.21.1.319-329.2001; GREEN H, 1976, CELL, V7, P105, DOI 10.1016/0092-8674(76)90260-9; GREEN H, 1974, CELL, V3, P127, DOI 10.1016/0092-8674(74)90116-0; GREEN H, 1975, CELL, V5, P19, DOI 10.1016/0092-8674(75)90087-2; Hamann A, 1996, ENDOCRINOLOGY, V137, P21, DOI 10.1210/en.137.1.21; Hansen JB, 2006, BIOCHEM J, V398, P153, DOI 10.1042/BJ20060402; HEATON GM, 1978, EUR J BIOCHEM, V82, P515, DOI 10.1111/j.1432-1033.1978.tb12045.x; HULL D, 1965, J PHYSIOL-LONDON, V181, P468, DOI 10.1113/jphysiol.1965.sp007775; HUTTUNEN P, 1981, EUR J APPL PHYSIOL O, V46, P339, DOI 10.1007/BF00422121; Kiskinis E, 2007, EMBO J, V26, P4831, DOI 10.1038/sj.emboj.7601908; Klein J, 2002, BIOESSAYS, V24, P382, DOI 10.1002/bies.10058; Kopecky J, 1995, J CLIN INVEST, V96, P2914, DOI 10.1172/JCI118363; Kopecky J, 1996, AM J PHYSIOL-ENDOC M, V270, pE768, DOI 10.1152/ajpendo.1996.270.5.E768; Lelliott CJ, 2006, PLOS BIOL, V4, P2042, DOI 10.1371/journal.pbio.0040369; Leone TC, 2005, PLOS BIOL, V3, P672, DOI 10.1371/journal.pbio.0030101; Lin JD, 2004, CELL, V119, P121, DOI 10.1016/j.cell.2004.09.013; Lin JD, 2002, J BIOL CHEM, V277, P1645, DOI 10.1074/jbc.C100631200; LOWELL BB, 1993, NATURE, V366, P740, DOI 10.1038/366740a0; Melnyk A, 1997, AM J PHYSIOL-REG I, V272, pR1088, DOI 10.1152/ajpregu.1997.272.4.R1088; Mili S, 2003, MOL CELL BIOL, V23, P4972, DOI 10.1128/MCB.23.14.4972-4982.2003; Mootha VK, 2004, P NATL ACAD SCI USA, V101, P6570, DOI 10.1073/pnas.0401401101; Mootha VK, 2003, P NATL ACAD SCI USA, V100, P605, DOI 10.1073/pnas.242716699; MORIN C, 1993, AM J HUM GENET, V53, P488; Murray R, 2006, HARPERS ILLUSTRATED; Puigserver P, 1998, CELL, V92, P829, DOI 10.1016/S0092-8674(00)81410-5; RICQUIER D, 1982, J CLIN ENDOCR METAB, V54, P803; RICQUIER D, 1976, BIOCHEM BIOPH RES CO, V73, P577, DOI 10.1016/0006-291X(76)90849-4; RICQUIER D, 1983, J BIOL CHEM, V258, P6675; Rosen ED, 1999, MOL CELL, V4, P611, DOI 10.1016/S1097-2765(00)80211-7; Seale P, 2007, CELL METAB, V6, P38, DOI 10.1016/j.cmet.2007.06.001; SIMON HE, 1950, AM J SURG, V80, P127, DOI 10.1016/0002-9610(50)90575-7; Sonoda J, 2007, P NATL ACAD SCI USA, V104, P5223, DOI 10.1073/pnas.0611623104; SPIEGELMAN BM, 1983, J BIOL CHEM, V258, P83; St-Pierre J, 2003, J BIOL CHEM, V278, P26597, DOI 10.1074/jbc.M301850200; Tai TAC, 1996, J BIOL CHEM, V271, P29909, DOI 10.1074/jbc.271.47.29909; Tseng YH, 2004, MOL CELL BIOL, V24, P1918, DOI 10.1128/MCB.24.5.1918-1929.2004; Tsuchiya N, 2004, BIOCHEM BIOPH RES CO, V317, P736, DOI 10.1016/j.bbrc.2004.03.103; Uldry M, 2006, CELL METAB, V3, P333, DOI 10.1016/j.cmet.2006.04.002; Xu FH, 2004, BIOCHEM J, V382, P331, DOI 10.1042/BJ20040469	50	43	48	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 14	2008	283	46					31960	31967		10.1074/jbc.M805431200	http://dx.doi.org/10.1074/jbc.M805431200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	370KJ	18728005	Green Published, hybrid			2022-12-27	WOS:000260760800078
J	Pham, P; Zhang, K; Goodman, MF				Pham, Phuong; Zhang, Ke; Goodman, Myron F.			Hypermutation at A/T Sites during G center dot U Mismatch Repair in Vitro by Human B-cell Lysates	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CLASS-SWITCH RECOMBINATION; INDUCED CYTIDINE DEAMINASE; DNA-POLYMERASE-ETA; SINGLE-STRANDED-DNA; IMMUNOGLOBULIN GENE HYPERMUTATION; ANTIBODY DIVERSIFICATION ENZYME; ACTIVATION-INDUCED DEAMINASE; SOMATIC HYPERMUTATION; IG GENES; APOBEC PROTEINS	Somatic hypermutation in the variable regions of immunoglobulin genes is required to produce high affinity antibody molecules. Somatic hypermutation results by processing G.U mismatches generated when activation-induced cytidine deaminase (AID) deaminates C to U. Mutations at C/G sites are targeted mainly at deamination sites, whereas mutations at A/T sites entail error-prone DNA gap repair. We used B-cell lysates to analyze salient features of somatic hypermutation with in vitro mutational assays. Tonsil and hypermutating Ramos B-cells convert C -> U in accord with AID motif specificities, whereas HeLa cells do not. Using tonsil cell lysates to repair a G.U mismatch, A/T and G/C targeted mutations occur about equally, whereas Ramos cell lysates make fewer mutations at A/T sites (similar to 24%) compared with G/C sites (similar to 76%). In contrast, mutations in HeLa cell lysates occur almost exclusively at G/C sites (> 95%). By recapitulating two basic features of B-cell-specific somatic hypermutation, G/C mutations targeted to AID hot spot motifs and elevated A/T mutations dependent on error-prone processing of G.U mispairs, these cell free assays provide a practical method to reconstitute error-prone mismatch repair using purified B-cell proteins.	[Pham, Phuong; Goodman, Myron F.] Univ So Calif, Dept Biol Sci, Los Angeles, CA 90089 USA; [Pham, Phuong; Goodman, Myron F.] Univ So Calif, Dept Chem, Los Angeles, CA 90089 USA; [Zhang, Ke] Univ Calif Los Angeles, Sch Med, Div Clin Immunol Allergy, Dept Med, Los Angeles, CA 90095 USA	University of Southern California; University of Southern California; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Goodman, MF (corresponding author), Univ So Calif, Dept Biol Sci, RRI-201, Los Angeles, CA 90089 USA.	mgoodman@usc.edu			UGI protein; National Institutes of Health [ES013192, R37GM21422]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES013192] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM021422] Funding Source: NIH RePORTER	UGI protein; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Drs. Dale Mosbaugh and Samuel Bennett for their generous gift of UGI protein, and we also thank Dr. Matthew D. Scharff for reading and commenting on the manuscript.; This work was supported, in whole or in part, by National Institutes of Health Grants ES013192 and R37GM21422 (to M. F. G.).	Bardwell PD, 2004, NAT IMMUNOL, V5, P224, DOI 10.1038/ni1031; Basu U, 2005, NATURE, V438, P508, DOI 10.1038/nature04255; Beale RCL, 2004, J MOL BIOL, V337, P585, DOI 10.1016/j.jmb.2004.01.046; Bennett SE, 2001, J BIOL CHEM, V276, P42588, DOI 10.1074/jbc.M106212200; Bishop KN, 2004, SCIENCE, V305, P645, DOI 10.1126/science.1100658; Bishop KN, 2004, CURR BIOL, V14, P1392, DOI 10.1016/j.cub.2004.06.057; Bransteitter R, 2004, J BIOL CHEM, V279, P51612, DOI 10.1074/jbc.M408135200; Bransteitter R, 2003, P NATL ACAD SCI USA, V100, P4102, DOI 10.1073/pnas.0730835100; Chaudhuri J, 2004, NATURE, V430, P992, DOI 10.1038/nature02821; Chaudhuri J, 2003, NATURE, V422, P726, DOI 10.1038/nature01574; Chaudhuri J, 2004, NAT REV IMMUNOL, V4, P541, DOI 10.1038/nri1395; Chelico L, 2006, NAT STRUCT MOL BIOL, V13, P392, DOI 10.1038/nsmb1086; Conticello SG, 2005, MOL BIOL EVOL, V22, P367, DOI 10.1093/molbev/msi026; Creighton S, 1995, METHOD ENZYMOL, V262, P232; Delbos F, 2005, J EXP MED, V201, P1191, DOI 10.1084/jem.20050292; Delbos F, 2007, J EXP MED, V204, P17, DOI 10.1084/jem.20062131; Di Nola JM, 2007, ANNU REV BIOCHEM, V76, P1, DOI 10.1146/annurev.biochem.76.061705.090740; Dickerson SK, 2003, J EXP MED, V197, P1291, DOI 10.1084/jem.20030481; EBELING SB, 1993, EUR J IMMUNOL, V23, P1405, DOI 10.1002/eji.1830230636; Faili A, 2004, J EXP MED, V199, P265, DOI 10.1084/jem.20031831; Fortini P, 2007, DNA REPAIR, V6, P398, DOI 10.1016/j.dnarep.2006.10.008; Foster SJ, 1999, EUR J IMMUNOL, V29, P3122, DOI 10.1002/(SICI)1521-4141(199910)29:10<3122::AID-IMMU3122>3.3.CO;2-F; Fukita Y, 1998, IMMUNITY, V9, P105, DOI 10.1016/S1074-7613(00)80592-0; Goodman Myron F, 2007, Adv Immunol, V94, P127, DOI 10.1016/S0065-2776(06)94005-X; Harris RS, 2003, CELL, V113, P803, DOI 10.1016/S0092-8674(03)00423-9; Harris RS, 2001, J VIROL, V75, P10488, DOI 10.1128/JVI.75.21.10488-10492.2001; Harris RS, 2004, NAT REV IMMUNOL, V4, P868, DOI 10.1038/nri1489; Haushalter KA, 1999, CURR BIOL, V9, P174, DOI 10.1016/S0960-9822(99)80087-6; HOLMES J, 1990, P NATL ACAD SCI USA, V87, P5837, DOI 10.1073/pnas.87.15.5837; Ito S, 2004, P NATL ACAD SCI USA, V101, P1975, DOI 10.1073/pnas.0307335101; Jansen JG, 2006, J EXP MED, V203, P319, DOI 10.1084/jem.20052227; Kannouche PL, 2004, MOL CELL, V14, P491, DOI 10.1016/S1097-2765(04)00259-X; Kunkel TA, 2005, ANNU REV BIOCHEM, V74, P681, DOI 10.1146/annurev.biochem.74.082803.133243; Langerak P, 2007, J EXP MED, V204, P1989, DOI 10.1084/jem.20070902; Larson ED, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.3.e14; Li ZQ, 2007, ADV EXP MED BIOL, V596, P93; Martin A, 2003, J EXP MED, V198, P1171, DOI 10.1084/jem.20030880; Martin A, 2002, NATURE, V415, P802, DOI 10.1038/nature714; Martomo SA, 2004, J EXP MED, V200, P61, DOI 10.1084/jem.20040691; Masuda K, 2005, P NATL ACAD SCI USA, V102, P13986, DOI 10.1073/pnas.0505636102; Masuda K, 2007, J BIOL CHEM, V282, P17387, DOI 10.1074/jbc.M611849200; McBride KM, 2006, P NATL ACAD SCI USA, V103, P8798, DOI 10.1073/pnas.0603272103; McBride KM, 2004, J EXP MED, V199, P1235, DOI 10.1084/jem.20040373; Milstein C, 1998, P NATL ACAD SCI USA, V95, P8791, DOI 10.1073/pnas.95.15.8791; Modrich P, 2006, J BIOL CHEM, V281, P30305, DOI 10.1074/jbc.R600022200; Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7; Navaratnam N, 2006, INT J HEMATOL, V83, P195, DOI 10.1532/IJH97.06032; Neddermann P, 1996, J BIOL CHEM, V271, P12767, DOI 10.1074/jbc.271.22.12767; Ouchida R, 2008, DNA REPAIR, V7, P1392, DOI 10.1016/j.dnarep.2008.04.014; Pasqualucci L, 2006, P NATL ACAD SCI USA, V103, P395, DOI 10.1073/pnas.0509969103; Pavlov YI, 2002, P NATL ACAD SCI USA, V99, P9954, DOI 10.1073/pnas.152126799; Peled JU, 2008, ANNU REV IMMUNOL, V26, P481, DOI 10.1146/annurev.immunol.26.021607.090236; Perlot T, 2008, P NATL ACAD SCI USA, V105, P3843, DOI 10.1073/pnas.0712291105; Peters A, 1996, IMMUNITY, V4, P57, DOI 10.1016/S1074-7613(00)80298-8; Pham P, 2003, NATURE, V424, P103, DOI 10.1038/nature01760; Pham P, 2005, BIOCHEMISTRY-US, V44, P2703, DOI 10.1021/bi047481+; Pham P, 2008, J BIOL CHEM, V283, P17428, DOI 10.1074/jbc.M802121200; Pham P, 2007, DNA REPAIR, V6, P689, DOI 10.1016/j.dnarep.2007.01.001; Phung QH, 1998, J EXP MED, V187, P1745, DOI 10.1084/jem.187.11.1745; Rada C, 2004, MOL CELL, V16, P163, DOI 10.1016/j.molcel.2004.10.011; Rada C, 2002, P NATL ACAD SCI USA, V99, P7003, DOI 10.1073/pnas.092160999; Rada C, 1998, IMMUNITY, V9, P135, DOI 10.1016/S1074-7613(00)80595-6; RAJEWSKY K, 1987, SCIENCE, V238, P1088, DOI 10.1126/science.3317826; Razanajaona D, 1997, J IMMUNOL, V159, P3347; Revy P, 2000, CELL, V102, P565, DOI 10.1016/S0092-8674(00)00079-9; Rogozin IB, 2001, NAT IMMUNOL, V2, P530, DOI 10.1038/88732; Sanderson RJ, 2001, PROG NUCLEIC ACID RE, V68, P165; Seki M, 2005, EMBO REP, V6, P1143, DOI 10.1038/sj.embor.7400582; Shen HM, 2005, MOL CELL BIOL, V25, P10815, DOI 10.1128/MCB.25.24.10815-10821.2005; Shen HM, 2006, J IMMUNOL, V177, P5386, DOI 10.4049/jimmunol.177.8.5386; Sohail A, 2003, NUCLEIC ACIDS RES, V31, P2990, DOI 10.1093/nar/gkg464; Stavnezer J, 2008, ANNU REV IMMUNOL, V26, P261, DOI 10.1146/annurev.immunol.26.021607.090248; Suspene R, 2004, NUCLEIC ACIDS RES, V32, P2421, DOI 10.1093/nar/gkh554; THOMAS DC, 1991, J BIOL CHEM, V266, P3744; Unniraman S, 2007, SCIENCE, V317, P1227, DOI 10.1126/science.1145065; Wiesendanger M, 2000, J EXP MED, V191, P579, DOI 10.1084/jem.191.3.579; Wilson SH, 2000, COLD SPRING HARB SYM, V65, P143, DOI 10.1101/sqb.2000.65.143; Xiao Z, 2007, MOL IMMUNOL, V44, P2659, DOI 10.1016/j.molimm.2006.12.006; Yu Q, 2004, NAT STRUCT MOL BIOL, V11, P435, DOI 10.1038/nsmb758; Zan H, 2005, EMBO J, V24, P3757, DOI 10.1038/sj.emboj.7600833; Zan H, 2001, IMMUNITY, V14, P643, DOI 10.1016/S1074-7613(01)00142-X; Zeng XM, 2001, NAT IMMUNOL, V2, P537, DOI 10.1038/88740; Zhang K, 2002, J ALLERGY CLIN IMMUN, V110, P421, DOI 10.1067/mai.2002.126382; Zhu Yi, 2003, Journal of Medical and Dental Sciences, V50, P41	84	12	12	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 14	2008	283	46					31754	31762		10.1074/jbc.M805524200	http://dx.doi.org/10.1074/jbc.M805524200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	370KJ	18786917	hybrid, Green Published			2022-12-27	WOS:000260760800058
J	Torrelles, JB; Knaup, R; Kolareth, A; Slepushkina, T; Kaufman, TM; Kang, P; Hill, PJ; Brennan, PJ; Chatterjee, D; Belisle, JT; Musser, JM; Schlesinger, LS				Torrelles, Jordi B.; Knaup, Rose; Kolareth, Avina; Slepushkina, Tatiana; Kaufman, Thomas M.; Kang, Peter; Hill, Preston J.; Brennan, Patrick J.; Chatterjee, Delphi; Belisle, John T.; Musser, James M.; Schlesinger, Larry S.			Identification of Mycobacterium tuberculosis Clinical Isolates with Altered Phagocytosis by Human Macrophages Due to a Truncated Lipoarabinomannan	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MANNOSE RECEPTOR; STRUCTURAL DEFINITION; ATTENUATED STRAINS; VIRULENT-STRAIN; BOVIS BCG; BIOSYNTHESIS; NUCLEOTIDE; RESIDUES; FEATURES; BINDING	Phenotypically distinct clinical isolates of Mycobacterium tuberculosis are capable of altering the balance that exists between the pathogen and human host and ultimately the outcome of infection. This study has identified two M. tuberculosis strains (i.e. HN885 and HN1554) among a bank of clinical isolates with a striking defect in phagocytosis by primary human macrophages when compared with strain Erdman, a commonly used laboratory strain for studies of pathogenesis. Mass spectrometry in conjunction with NMR studies unequivocally confirmed that both HN885 and HN1554 contain truncated and more branched forms of mannose-capped lipoarabinomannan(ManLAM) with a marked reduction of their linear arabinan (corresponding mainly to the inner Araf-alpha(1 -> 5)-Araf unit) and mannan (with fewer 6-Manp residues and more substitutions in the linear Manp-alpha(1 -> 6)-Manp unit) domains. The truncation in the ManLAM molecules produced by strains HN885 and HN1554 led to a significant reduction in their surface availability. In addition, there was a marked reduction of higher order phosphatidyl-myo-inositol mannosides and the presence of dimycocerosates, triglycerides, and phenolic glycolipid in their cell envelope. Less exposed ManLAM and reduced higher order phosphatidyl-myo-inositol mannosides in strains HN885 and HN1554 resulted in their low association with the macrophage mannose receptor. Despite reduced phagocytosis, ingested bacilli replicated at a fast rate following serum opsonization. Our results provide evidence that the clinical spectrum of tuberculosis may be dictated not only by the host but also by the amounts and ratios of surface exposed mycobacterial adherence factors defined by strain genotype.	[Torrelles, Jordi B.; Knaup, Rose; Schlesinger, Larry S.] Ohio State Univ, Ctr Microbial Interface Biol, Dept Internal Med, Div Infect Dis, Columbus, OH 43210 USA; [Torrelles, Jordi B.; Knaup, Rose; Schlesinger, Larry S.] Ohio State Univ, Dept Mol Virol, Columbus, OH 43210 USA; [Torrelles, Jordi B.; Knaup, Rose; Schlesinger, Larry S.] Ohio State Univ, Dept Med Genet, Columbus, OH 43210 USA; [Kolareth, Avina; Slepushkina, Tatiana; Kaufman, Thomas M.; Kang, Peter] Univ Iowa, Dept Med, Iowa City, IA 52240 USA; [Kolareth, Avina; Slepushkina, Tatiana; Kaufman, Thomas M.; Kang, Peter] Univ Iowa, Dept Microbiol, Iowa City, IA 52240 USA; [Kolareth, Avina; Slepushkina, Tatiana; Kaufman, Thomas M.; Kang, Peter] Univ Iowa, Dept Pathol, Iowa City, IA 52240 USA; [Hill, Preston J.; Brennan, Patrick J.; Chatterjee, Delphi; Belisle, John T.] Colorado State Univ, Mycobacteria Res Labs, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA; [Musser, James M.] Methodist Hosp, Res Inst, Ctr Mol & Translat Human Infect Dis Res, Houston, TX 77030 USA; [Musser, James M.] Methodist Hosp, Res Inst, Dept Pathol, Houston, TX 77030 USA; [Torrelles, Jordi B.; Knaup, Rose; Schlesinger, Larry S.] Ohio State Univ, Dept Immunol, Columbus, OH 43210 USA; [Torrelles, Jordi B.; Knaup, Rose; Schlesinger, Larry S.] Ohio State Univ, Dept Microbiol, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University of Iowa; University of Iowa; University of Iowa; Colorado State University; The Methodist Hospital System; The Methodist Hospital - Houston; The Methodist Hospital System; The Methodist Hospital - Houston; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Schlesinger, LS (corresponding author), Ohio State Univ, Ctr Microbial Interface Biol, Dept Med, Div Infect Dis, 460 W 12th Ave,Biomed Res Tower,Rm 1004, Columbus, OH 43210 USA.	larry.schlesinger@osumc.edu	Belisle, John T/B-8944-2017; Torrelles, Jordi/E-4204-2011	Belisle, John T/0000-0002-2539-2798; 	National Institutes of Health [AI052458, AI33004, NO1 AI-040091]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI033004, R00AI073856, R29AI033004, R01AI052458, R21AI052458] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants AI052458 and AI33004 (to L. S. S.) and Contract NO1 AI-040091 (to J. T. B.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	[Anonymous], 2007, GLOB TUB CONTR SURV; Berg S, 2005, J BIOL CHEM, V280, P5651, DOI 10.1074/jbc.M411418200; Bhamidi S, 2008, J BIOL CHEM, V283, P12992, DOI 10.1074/jbc.M800222200; Briken V, 2004, MOL MICROBIOL, V53, P391, DOI 10.1111/j.1365-2958.2004.04183.x; CHATTERJEE D, 1992, J BIOL CHEM, V267, P6234; CHATTERJEE D, 1991, J BIOL CHEM, V266, P9652; Chatterjee D, 1998, GLYCOBIOLOGY, V8, P113, DOI 10.1093/glycob/8.2.113; CHATTERJEE D, 1992, J BIOL CHEM, V267, P6228; Cox JS, 1999, NATURE, V402, P79, DOI 10.1038/47042; Delmas C, 1997, GLYCOBIOLOGY, V7, P811, DOI 10.1093/glycob/7.6.811; Draper P, 1997, BIOCHEM J, V327, P519, DOI 10.1042/bj3270519; DUBOIS M, 1951, NATURE, V168, P167, DOI 10.1038/168167a0; Fenton MJ, 2005, TUBERCULOSIS AND THE TUBERCLE BACILLUS, P405; Kang PB, 2005, J EXP MED, V202, P987, DOI 10.1084/jem.20051239; Kaur D, 2002, MICROBIOL-SGM, V148, P3049, DOI 10.1099/00221287-148-10-3049; Khoo HH, 2001, J BIOL CHEM, V276, P3863, DOI 10.1074/jbc.M004010200; KHOO KH, 1995, GLYCOBIOLOGY, V5, P117, DOI 10.1093/glycob/5.1.117; Manca C, 1999, J IMMUNOL, V162, P6740; Manca C, 2001, P NATL ACAD SCI USA, V98, P5752, DOI 10.1073/pnas.091096998; Martinez-Pomares L, 2001, IMMUNOBIOLOGY, V204, P527, DOI 10.1078/0171-2985-00089; McCarthy TR, 2005, MOL MICROBIOL, V58, P774, DOI 10.1111/j.1365-2958.2005.04862.x; MCNEIL MR, 1994, GLYCOBIOLOGY, V4, P165, DOI 10.1093/glycob/4.2.165; Nigou J, 1999, GLYCOCONJUGATE J, V16, P257, DOI 10.1023/A:1007046609341; Olakanmi O, 2000, INFECT IMMUN, V68, P5619, DOI 10.1128/IAI.68.10.5619-5627.2000; PRINZIS S, 1993, J GEN MICROBIOL, V139, P2649, DOI 10.1099/00221287-139-11-2649; Reed MB, 2004, NATURE, V431, P84, DOI 10.1038/nature02837; Reed MB, 2007, J BACTERIOL, V189, P2583, DOI 10.1128/JB.01670-06; Rouse DA, 1996, MOL MICROBIOL, V22, P583, DOI 10.1046/j.1365-2958.1996.00133.x; Schlesinger L. S., 2008, HDB TUBERCULOSIS IMM; Schlesinger LS, 1996, J IMMUNOL, V157, P4568; SCHLESINGER LS, 1994, J IMMUNOL, V152, P4070; SCHLESINGER LS, 1993, J IMMUNOL, V150, P2920; SCHLESINGER LS, 1990, J IMMUNOL, V144, P2771; Sreevatsan S, 1997, P NATL ACAD SCI USA, V94, P9869, DOI 10.1073/pnas.94.18.9869; Sreevatsan S, 1996, J CLIN MICROBIOL, V34, P2007, DOI 10.1128/JCM.34.8.2007-2010.1996; TAKIFF HE, 1994, ANTIMICROB AGENTS CH, V38, P773, DOI 10.1128/AAC.38.4.773; Torrelles JB, 2004, J BIOL CHEM, V279, P41227, DOI 10.1074/jbc.M405180200; Torrelles JB, 2006, J IMMUNOL, V177, P1805, DOI 10.4049/jimmunol.177.3.1805; Turnbull WB, 2004, ANGEW CHEM INT EDIT, V43, P3918, DOI 10.1002/anie.200454119; Valway SE, 1998, NEW ENGL J MED, V338, P633, DOI 10.1056/NEJM199803053381001; VanderVen BC, 2005, SCIENCE, V309, P941, DOI 10.1126/science.1114347; VENISSE A, 1993, J BIOL CHEM, V268, P12401; WILEMAN TE, 1986, P NATL ACAD SCI USA, V83, P2501, DOI 10.1073/pnas.83.8.2501	43	50	55	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 14	2008	283	46					31417	31428		10.1074/jbc.M806350200	http://dx.doi.org/10.1074/jbc.M806350200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	370KJ	18784076	hybrid, Green Published			2022-12-27	WOS:000260760800021
J	Brocker, MJ; Watzlich, D; Uliczka, F; Virus, S; Saggu, M; Lendzian, F; Scheer, H; Rudiger, W; Moser, J; Jahn, D				Broecker, Markus J.; Waetzlich, Denise; Uliczka, Frank; Virus, Simone; Saggu, Miguel; Lendzian, Friedhelm; Scheer, Hugo; Ruediger, Wolfhart; Moser, Juergen; Jahn, Dieter			Substrate Recognition of Nitrogenase-like Dark Operative Protochlorophyllide Oxidoreductase from Prochlorococcus marinus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DIVINYL CHLOROPHYLL-A; VINYL REDUCTASE GENE; ABSOLUTE-CONFIGURATION; BCHN-BCHB; BIOSYNTHESIS; SULFUR; OXYGEN; IDENTIFICATION; EVOLUTION; PHOTOSYNTHESIS	Chlorophyll and bacteriochlorophyll biosynthesis requires the two-electron reduction of protochlorophyllide a ring D by a protochlorophyllide oxidoreductase to form chlorophyllide a. A light-dependent (light-dependent Pchlide oxidoreductase (LPOR)) and an unrelated dark operative enzyme (dark operative Pchlide oxidoreductase (DPOR)) are known. DPOR plays an important role in chlorophyll biosynthesis of gymnosperms, mosses, ferns, algae, and photosynthetic bacteria in the absence of light. Although DPOR shares significant amino acid sequence homologies with nitrogenase, only the initial catalytic steps resemble nitrogenase catalysis. Substrate coordination and subsequent [Fe-S] cluster-dependent catalysis were proposed to be unrelated. Here we characterized the first cyanobacterial DPOR consisting of the homodimeric protein complex ChlL(2) and a heterotetrameric protein complex (ChlNB)(2). The ChlL2 dimer contains one EPR active [4Fe-4S] cluster, whereas the (ChlNB) 2 complex exhibited EPR signals for two [ 4Fe-4S] clusters with differences in their g values and temperature-dependent relaxation behavior. These findings indicate variations in the geometry of the individual [4Fe-4S] clusters found in (ChlNB) 2. For the analysis of DPOR substrate recognition, 11 synthetic derivatives with altered substituents on the four pyrrole rings and the isocyclic ring plus eight chlorophyll biosynthetic intermediates were tested as DPOR substrates. Although DPOR tolerated minor modifications of the ring substituents on rings A-C, the catalytic target ring D was apparently found to be coordinated with high specificity. Furthermore, protochlorophyllide a, the corresponding [8-vinyl]-derivative and protochlorophyllide b were equally utilized as substrates. Distinct differences from substrate binding by LPOR were observed. Alternative biosynthetic routes for cyanobacterial chlorophyll biosynthesis with regard to the reduction of the C8-vinyl group and the interconversion of a chlorophyll a/b type C7 methyl/formyl group were deduced.	[Broecker, Markus J.; Waetzlich, Denise; Uliczka, Frank; Virus, Simone; Moser, Juergen; Jahn, Dieter] Tech Univ Carolo Wilhelmina Braunschweig, Inst Mikrobiol, D-38106 Braunschweig, Germany; [Saggu, Miguel; Lendzian, Friedhelm] Tech Univ Berlin, Inst Chem, Max Volmer Lab, D-10623 Berlin, Germany; [Scheer, Hugo; Ruediger, Wolfhart] Univ Munich, Dept Biol 1, D-80638 Munich, Germany	Braunschweig University of Technology; Technical University of Berlin; University of Munich	Moser, J (corresponding author), Tech Univ Carolo Wilhelmina Braunschweig, Inst Mikrobiol, Spielmannstr 7, D-38106 Braunschweig, Germany.	j.moser@tu-bs.de	Saggu, Miguel/B-1224-2009	Jahn, Dieter/0000-0002-4064-9205	Deutsche Forschungsgemeinschaft	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by grants from the Deutsche Forschungsgemeinschaft. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Agar JN, 2000, BIOCHEMISTRY-US, V39, P7856, DOI 10.1021/bi000931n; Apel K, 2001, ADV PHOTOSYNTH, V11, P235; BAZZAZ MB, 1981, PHOTOBIOCH PHOTOBIOP, V2, P199; BEINERT H, 1983, ANAL BIOCHEM, V131, P373, DOI 10.1016/0003-2697(83)90186-0; Belyaeva OB, 2001, BIOCHEMISTRY-MOSCOW+, V66, P173, DOI 10.1023/A:1002891531118; BOLLIVAR DW, 1994, J MOL BIOL, V237, P622, DOI 10.1006/jmbi.1994.1260; Brocker MJ, 2008, J BIOL CHEM, V283, P10559, DOI 10.1074/jbc.M708010200; BURKE DH, 1993, P NATL ACAD SCI USA, V90, P7134, DOI 10.1073/pnas.90.15.7134; CAMPBELL L, 1994, LIMNOL OCEANOGR, V39, P954, DOI 10.4319/lo.1994.39.4.0954; Chew AGM, 2007, J BIOL CHEM, V282, P2967, DOI 10.1074/jbc.M609730200; FOGO JK, 1949, ANAL CHEM, V21, P732, DOI 10.1021/ac60030a028; Fujita Y, 2000, J BIOL CHEM, V275, P23583, DOI 10.1074/jbc.M002904200; FUJITA Y, 1993, PLANT CELL PHYSIOL, V34, P305; Fujita Y, 1996, PLANT CELL PHYSIOL, V37, P411, DOI 10.1093/oxfordjournals.pcp.a028962; GOERICKE R, 1992, LIMNOL OCEANOGR, V37, P425; GRIFFITHS WT, 1980, BIOCHEM J, V186, P267, DOI 10.1042/bj1860267; Guigliarelli B, 1999, ADV INORG CHEM, V47, P421, DOI 10.1016/S0898-8838(08)60084-7; Hanzelmann P, 2004, J BIOL CHEM, V279, P34721, DOI 10.1074/jbc.M313398200; Helfrich M, 2003, BBA-BIOENERGETICS, V1605, P97, DOI 10.1016/S0005-2728(03)00081-1; Helfrich M, 1996, J AM CHEM SOC, V118, P2606, DOI 10.1021/ja953440c; HELFRICH M, 1994, EUR J BIOCHEM, V219, P267, DOI 10.1111/j.1432-1033.1994.tb19938.x; Heyes DJ, 2003, NAT STRUCT BIOL, V10, P491, DOI 10.1038/nsb929; Heyes DJ, 2002, P NATL ACAD SCI USA, V99, P11145, DOI 10.1073/pnas.182274199; HOWARD JB, 1994, ANNU REV BIOCHEM, V63, P235, DOI 10.1146/annurev.bi.63.070194.001315; Huberman A, 2002, ANAL BIOCHEM, V307, P375, DOI 10.1016/S0003-2697(02)00047-7; Igarashi RY, 2003, CRIT REV BIOCHEM MOL, V38, P351, DOI 10.1080/10409230390242380; Ito H, 2008, J BIOL CHEM, V283, P9002, DOI 10.1074/jbc.M708369200; Klement H, 1999, EUR J BIOCHEM, V265, P862, DOI 10.1046/j.1432-1327.1999.00627.x; Kolossov VL, 2003, J BIOL CHEM, V278, P49675, DOI 10.1074/jbc.C300449200; Lanzilotta WN, 1997, J BIOL CHEM, V272, P4157, DOI 10.1074/jbc.272.7.4157; LI KWK, 1995, MARINE ECOLOGY PROGR, V122, P1; Liu HB, 1997, AQUAT MICROB ECOL, V12, P39, DOI 10.3354/ame012039; Masuda T, 2004, PHOTOSYNTH RES, V81, P1, DOI 10.1023/B:PRES.0000028392.80354.7c; MCFEETERS RF, 1971, PLANT PHYSIOL, V47, P609, DOI 10.1104/pp.47.5.609; MOSS GP, 1987, PURE APPL CHEM, V59, P779, DOI 10.1351/pac198759060779; Mouesca JM, 1998, COORDIN CHEM REV, V178, P1573, DOI 10.1016/S0010-8545(98)00155-6; Nagata N, 2005, PLANT CELL, V17, P233, DOI 10.1105/tpc.104.027276; Nagata N, 2007, PLANT CELL PHYSIOL, V48, P1803, DOI 10.1093/pcp/pcm153; Nomata J, 2005, BBA-BIOENERGETICS, V1708, P229, DOI 10.1016/j.bbabio.2005.02.002; Nomata J, 2008, FEBS LETT, V582, P1346, DOI 10.1016/j.febslet.2008.03.018; Nomata J, 2006, FEBS LETT, V580, P6151, DOI 10.1016/j.febslet.2006.10.014; Oster U, 2000, PLANT J, V21, P305, DOI 10.1046/j.1365-313x.2000.00672.x; Partensky F, 1999, MICROBIOL MOL BIOL R, V63, P106, DOI 10.1128/MMBR.63.1.106-127.1999; PETERS JW, 1995, ANNU REV MICROBIOL, V49, P335, DOI 10.1146/annurev.mi.49.100195.002003; PORRA RJ, 1994, EUR J BIOCHEM, V219, P671, DOI 10.1111/j.1432-1033.1994.tb19983.x; Reinbothe C, 1999, NATURE, V397, P80, DOI 10.1038/16283; Rudiger W, 2005, BIOCHEMISTRY-US, V44, P10864, DOI 10.1021/bi0504198; RUDIGER W, 2003, PORPHYRIN HDB, V13, P71; Scheumann V, 1999, FEBS LETT, V445, P445, DOI 10.1016/S0014-5793(99)00169-6; SCHNEEGURT MA, 1992, BIOCHEMISTRY-US, V31, P11677, DOI 10.1021/bi00162a002; SCHOCH S, 1995, EUR J BIOCHEM, V229, P291, DOI 10.1111/j.1432-1033.1995.tb20468.x; Schoefs B, 2001, PHOTOSYNTH RES, V70, P257, DOI 10.1023/A:1014769707404; SHEDBALKAR VP, 1992, ANAL BIOCHEM, V207, P261, DOI 10.1016/0003-2697(92)90010-5; STESMANS A, 1989, REV SCI INSTRUM, V60, P2949, DOI 10.1063/1.1140633; Stoll S, 2006, J MAGN RESON, V178, P42, DOI 10.1016/j.jmr.2005.08.013; Suzuki JY, 1997, ANNU REV GENET, V31, P61, DOI 10.1146/annurev.genet.31.1.61; Tanaka A, 1998, P NATL ACAD SCI USA, V95, P12719, DOI 10.1073/pnas.95.21.12719; TANAKA A, 1991, PLANT CELL PHYSIOL, V32, P195, DOI 10.1093/oxfordjournals.pcp.a078064; Xiong J, 1998, P NATL ACAD SCI USA, V95, P14851, DOI 10.1073/pnas.95.25.14851; Xu H, 2002, J BIOL CHEM, V277, P42726, DOI 10.1074/jbc.M205237200; YANG ZM, 1990, J BACTERIOL, V172, P5001, DOI 10.1128/jb.172.9.5001-5010.1990	62	25	27	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 31	2008	283	44					29873	29881		10.1074/jbc.M805206200	http://dx.doi.org/10.1074/jbc.M805206200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	364WS	18693243	Green Published, hybrid			2022-12-27	WOS:000260366900031
J	Huang, X; Swanson, R; Broze, GJ; Olson, ST				Huang, Xin; Swanson, Richard; Broze, George J., Jr.; Olson, Steven T.			Kinetic Characterization of the Protein Z-dependent Protease Inhibitor Reaction with Blood Coagulation Factor Xa	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLASMINOGEN-ACTIVATOR INHIBITOR-1; TICK ANTICOAGULANT PEPTIDE; ANTITHROMBIN-III; Z DEFICIENCY; FACTOR IXA; COMPLEX; HEPARIN; SERPIN; MECHANISM; PROTHROMBINASE	Protein Z-dependent protease inhibitor (ZPI) is a recently identified member of the serpin superfamily that functions as a cofactor-dependent regulator of blood coagulation factors Xa (FXa) and XIa. Here we show that ZPI and its cofactor, protein Z (PZ), inhibit procoagulant membrane-bound factor Xa by the branched pathway acyl-intermediate trapping mechanism used by other serpins, but with significant variations of this mechanism that are unique to ZPI. Rapid kinetic analyses showed that the reaction proceeded by the initial assembly of a membrane-associated PZ-ZPI-FXa Michaelis complex (K-M 53 +/- 5 nM) followed by conversion to a stable ZPI-FXa complex (k(lim) 1.2 +/- 0.1 s(-1)). Cofactor premixing experiments together with independent kinetic analyses of ZPI-PZ and factor Xa-PZ-membrane complex formation suggested that assembly of the Michaelis complex through either ZPI-PZ-lipid or factor Xa-PZ-lipid intermediates was rate-limiting. Reaction stoichiometry analyses and native PAGE showed that for every factor Xa molecule inhibited by ZPI, two serpin molecules were cleaved. Native PAGE and immunoblotting showed that PZ dissociated from ZPI once ZPI forms a stable complex with FXa, and kinetic analyses confirmed that PZ acted catalytically to accelerate the membrane-dependent ZPI-factor Xa reaction. The ZPI-FXa complex was only transiently stable and dissociated with a rate constant that showed a bell-shaped pH dependence indicative of participation of factor Xa active-site residues. The complex was detectable by SDS-PAGE when denatured at low pH, consistent with it being a kinetically trapped covalent acyl-intermediate. Together our findings show that ZPI functions like other serpins to regulate the activity of FXa but in a manner uniquely dependent on protein Z, procoagulant membranes, and pH.	[Huang, Xin; Swanson, Richard; Olson, Steven T.] Univ Illinois, Ctr Mol Biol Oral Dis, Chicago, IL 60612 USA; [Broze, George J., Jr.] Washington Univ, Sch Med, Div Hematol, St Louis, MO 63110 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Washington University (WUSTL)	Olson, ST (corresponding author), Univ Illinois, Ctr Mol Biol Oral Dis, 801 S Paulina St,Rm 530C M-C 860, Chicago, IL 60612 USA.	stolson@uic.edu		Huang, Xin/0000-0002-4730-9318	National Institutes of Health [HL-78827, HL-060782]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL060782, R01HL078827] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL-78827 (to S. T. O.) and HL-060782 (to G. J. B.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Barker-Carlson K, 2002, J BIOL CHEM, V277, P46852, DOI 10.1074/jbc.M207740200; Bedsted T, 2003, BIOCHEMISTRY-US, V42, P8143, DOI 10.1021/bi034363y; Bjork I, 1997, ADV EXP MED BIOL, V425, P17; BROZE GJ, 1984, J CLIN INVEST, V73, P933, DOI 10.1172/JCI111317; BROZE GJ, 1990, BIOCHEMISTRY-US, V29, P7539, DOI 10.1021/bi00485a001; Broze GJ, 2001, THROMB HAEMOSTASIS, V86, P8; Brufatto N, 2001, J BIOL CHEM, V276, P17663, DOI 10.1074/jbc.M011586200; Calugaru SV, 2001, J BIOL CHEM, V276, P32446, DOI 10.1074/jbc.M104731200; Dementiev A, 2006, J BIOL CHEM, V281, P3452, DOI 10.1074/jbc.M510564200; ERSDALBADJU E, 1995, BIOCHEM J, V310, P323, DOI 10.1042/bj3100323; Gettins PGW, 2002, CHEM REV, V102, P4751, DOI 10.1021/cr010170+; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; Han JH, 1998, BIOCHEMISTRY-US, V37, P3203, DOI 10.1021/bi9722195; Han X, 1999, BIOCHEMISTRY-US, V38, P11073, DOI 10.1021/bi990641a; Han X, 2000, BLOOD, V96, P3049; Han X, 1998, P NATL ACAD SCI USA, V95, P9250, DOI 10.1073/pnas.95.16.9250; Hedstrom L, 1996, BIOCHEMISTRY-US, V35, P4515, DOI 10.1021/bi951928k; Heeb MJ, 2005, J BIOL CHEM, V280, P33819, DOI 10.1074/jbc.M506502200; HEEB MJ, 1993, J BIOL CHEM, V268, P2872; Huntington JA, 2000, NATURE, V407, P923, DOI 10.1038/35038119; Izaguirre G, 2003, J BIOL CHEM, V278, P51433, DOI 10.1074/jbc.M309266200; Izaguirre G, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M702462200; JORDAN SP, 1992, BIOCHEMISTRY-US, V31, P5374, DOI 10.1021/bi00138a019; Kvassman JO, 1998, BIOCHEMISTRY-US, V37, P15491, DOI 10.1021/bi9814787; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lu G, 2004, J BIOL CHEM, V279, P17241, DOI 10.1074/jbc.M312827200; MAO SS, 1995, BIOCHEMISTRY-US, V34, P5098, DOI 10.1021/bi00015a021; McDonald JF, 1997, BIOCHEMISTRY-US, V36, P5120, DOI 10.1021/bi9626160; OLSON ST, 1985, J BIOL CHEM, V260, P153; OLSON ST, 1993, METHOD ENZYMOL, V222, P525; Olson ST, 2001, BIOCHEMISTRY-US, V40, P11742, DOI 10.1021/bi0107290; Plotnick MI, 2002, BIOCHEMISTRY-US, V41, P334, DOI 10.1021/bi015650+; Rezaie AR, 2005, J BIOL CHEM, V280, P32722, DOI 10.1074/jbc.M505517200; Rezaie AR, 2001, BLOOD, V97, P2308, DOI 10.1182/blood.V97.8.2308; Tabatabai A, 2001, THROMB HAEMOSTASIS, V85, P655, DOI 10.1055/s-0037-1615649; Yin ZF, 2000, P NATL ACAD SCI USA, V97, P6734, DOI 10.1073/pnas.120081897; Zhang J, 2008, BLOOD, V111, P4973, DOI 10.1182/blood-2007-12-126391; Zhou AW, 2001, J BIOL CHEM, V276, P27541, DOI 10.1074/jbc.M102594200	38	36	36	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 31	2008	283	44					29770	29783		10.1074/jbc.M805214200	http://dx.doi.org/10.1074/jbc.M805214200			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	364WS	18768472	Green Published, hybrid			2022-12-27	WOS:000260366900021
J	Shi, J; Huang, GR; Kandror, KV				Shi, Jun; Huang, Guanrong; Kandror, Konstantin V.			Self-assembly of Glut4 Storage Vesicles during Differentiation of 3T3-L1 Adipocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INSULIN-RESPONSIVE AMINOPEPTIDASE; REGULATED MEMBRANE AMINOPEPTIDASE; ENDOSOMAL RECYCLING COMPARTMENT; GLUCOSE-TRANSPORTER GLUT4; RAT ADIPOSE-CELLS; GLUT4-CONTAINING VESICLES; PLASMA-MEMBRANE; MAJOR PROTEIN; SORTILIN; TRANSLOCATION	Glut4 storage vesicles (GSVs) represent translocation-competent vesicular carriers in fat and skeletal muscle cells that deliver Glut4 to the plasma membrane in response to insulin stimulation. GSVs include three major cargo proteins: Glut4, insulin-responsive aminopeptidase ( IRAP), and sortilin. Previous work has suggested that the lumenal interaction between Glut4 and sortilin and the cytoplasmic interaction between sortilin and GGA adaptors play an important role in recruitment of Glut4 into the GSVs. However, the mechanism of IRAP targeting to this compartment remains unknown. To address this question, we show that in differentiating adipocytes IRAP enters the GSVs from the "donor" membranes on day 3 of differentiation. Forced expression of sortilin in undifferentiated cells does not recruit IRAP into the vesicles. However, double expression of sortilin and Glut4 reconstitutes functional GSVs that incorporate endogenous IRAP. To explain this process, we show by a yeast two-hybrid system and chemical cross-linking that the lumenal domain of IRAP can interact with the lumenal loop of Glut4. IRAP without the lumenal domain is faithfully targeted to the donor membranes but has significantly lower insulin responsiveness than full-length IRAP. We suggest that lumenal interactions between Glut4 and IRAP play an important role in the assembly of the GSVs.	[Shi, Jun; Huang, Guanrong; Kandror, Konstantin V.] Boston Univ, Sch Med, Dept Biochem, Boston, MA 02118 USA	Boston University	Kandror, KV (corresponding author), Boston Univ, Sch Med, Dept Biochem, K124D,715 Albany St, Boston, MA 02118 USA.	kandror@biochem.bumc.bu.edu		Kandror, Konstantin/0000-0002-8601-9313	National Institutes of Health [DK52057, DK56736]; American Diabetes Association; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK052057, R01DK056736, R01DK052057] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association(American Diabetes Association); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK52057 and DK56736. This work was also supported by a Research Award from the American Diabetes Association ( to K. V. K.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Abel ED, 2004, MOL ENDOCRINOL, V18, P2491, DOI 10.1210/me.2004-0175; Ariga M, 2008, J BIOL CHEM, V283, P10208, DOI 10.1074/jbc.M710604200; Bogan JS, 2001, MOL CELL BIOL, V21, P4785, DOI 10.1128/MCB.21.14.4785-4806.2001; Bose A, 2001, MOL CELL BIOL, V21, P5262, DOI 10.1128/MCB.21.15.5262-5275.2001; CAIN CC, 1992, J BIOL CHEM, V267, P11681; Carvalho E, 2004, J BIOL CHEM, V279, P21598, DOI 10.1074/jbc.M312269200; El-Jack AK, 1999, MOL BIOL CELL, V10, P1581, DOI 10.1091/mbc.10.5.1581; Gross DN, 2004, MOL CELL BIOL, V24, P7151, DOI 10.1128/MCB.24.16.7151-7162.2004; Hosaka T, 2005, MOL BIOL CELL, V16, P2882, DOI 10.1091/mbc.E05-01-0072; Hou JCQ, 2007, CURR OPIN CELL BIOL, V19, P466, DOI 10.1016/j.ceb.2007.04.018; Hou JC, 2006, J BIOL CHEM, V281, P33457, DOI 10.1074/jbc.M601583200; Huang SH, 2007, CELL METAB, V5, P237, DOI 10.1016/j.cmet.2007.03.006; HUDSON AW, 1992, J CELL BIOL, V116, P785, DOI 10.1083/jcb.116.3.785; JAMES DE, 1988, NATURE, V333, P183, DOI 10.1038/333183a0; Jiang H, 2001, BIOCHEM BIOPH RES CO, V284, P519, DOI 10.1006/bbrc.2001.4994; Johnson AO, 2001, MOL BIOL CELL, V12, P367, DOI 10.1091/mbc.12.2.367; KANDROR KV, 1994, J BIOL CHEM, V269, P30777; KANDROR KV, 1994, P NATL ACAD SCI USA, V91, P8017, DOI 10.1073/pnas.91.17.8017; Kandror KV, 1999, J BIOL CHEM, V274, P25210, DOI 10.1074/jbc.274.36.25210; Karylowski O, 2004, MOL BIOL CELL, V15, P870, DOI 10.1091/mbc.E03-07-0517; Keller SR, 2002, J BIOL CHEM, V277, P17677, DOI 10.1074/jbc.M202037200; KELLER SR, 1995, J BIOL CHEM, V270, P23612, DOI 10.1074/jbc.270.40.23612; Kupriyanova TA, 2000, J BIOL CHEM, V275, P36263, DOI 10.1074/jbc.M002797200; Kupriyanova TA, 2002, J BIOL CHEM, V277, P9133, DOI 10.1074/jbc.M106999200; Lampson MA, 2001, MOL BIOL CELL, V12, P3489, DOI 10.1091/mbc.12.11.3489; Larance M, 2005, J BIOL CHEM, V280, P37803, DOI 10.1074/jbc.M503897200; Li J, 2007, J CELL BIOL, V178, P453, DOI 10.1083/jcb.200608033; Li LV, 2005, MOL ENDOCRINOL, V19, P2145, DOI 10.1210/me.2005-0032; Lin BZ, 1997, J BIOL CHEM, V272, P24145, DOI 10.1074/jbc.272.39.24145; Liu LB, 2007, DIABETES, V56, P1977, DOI 10.2337/db06-1100; Morris NJ, 1998, J BIOL CHEM, V273, P3582, DOI 10.1074/jbc.273.6.3582; Nielsen MS, 1999, J BIOL CHEM, V274, P8832, DOI 10.1074/jbc.274.13.8832; Nielsen MS, 2001, EMBO J, V20, P2180, DOI 10.1093/emboj/20.9.2180; Peck GR, 2006, MOL ENDOCRINOL, V20, P2576, DOI 10.1210/me.2005-0476; Ross SA, 1998, BIOCHEM J, V330, P1003; Shewan AM, 2003, MOL BIOL CELL, V14, P973, DOI 10.1091/mbc.E02-06-0315; Shi J, 2005, DEV CELL, V9, P99, DOI 10.1016/j.devcel.2005.04.004; Shi J, 2007, J BIOL CHEM, V282, P9008, DOI 10.1074/jbc.M608971200; SIMPSON IA, 1983, BIOCHIM BIOPHYS ACTA, V763, P393, DOI 10.1016/0167-4889(83)90101-5; Stephens JM, 1997, J BIOL CHEM, V272, P971, DOI 10.1074/jbc.272.2.971; Subtil A, 2000, J BIOL CHEM, V275, P4787, DOI 10.1074/jbc.275.7.4787; Waters SB, 1997, J BIOL CHEM, V272, P23323, DOI 10.1074/jbc.272.37.23323; Watson RT, 2004, EMBO J, V23, P2059, DOI 10.1038/sj.emboj.7600159; Wu ZD, 1998, J CLIN INVEST, V101, P22, DOI 10.1172/JCI1244; Xu Z, 2002, J BIOL CHEM, V277, P47972, DOI 10.1074/jbc.C200486200; Yeh TYJ, 2007, BIOCHEM J, V402, P279, DOI 10.1042/BJ20060793; Zeigerer A, 2002, MOL BIOL CELL, V13, P2421, DOI 10.1091/mbc.E02-02-0071	47	32	32	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 31	2008	283	44					30311	30321		10.1074/jbc.M805182200	http://dx.doi.org/10.1074/jbc.M805182200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	364WS	18713752	hybrid, Green Published			2022-12-27	WOS:000260366900075
J	Hou, ZJ; Kelly, EM; Robia, SL				Hou, Zhanjia; Kelly, Eileen M.; Robia, Seth L.			Phosphomimetic Mutations Increase Phospholamban Oligomerization and Alter the Structure of Its Regulatory Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CARDIAC SARCOPLASMIC-RETICULUM; RESONANCE ENERGY-TRANSFER; DEPENDENT PROTEIN-KINASE; MONOCLONAL-ANTIBODY; LIPID-BILAYERS; CALCIUM-PUMP; PHOSPHORYLATION; INHIBITION; ATPASE; CA2+	To investigate the effect of phosphorylation on the interactions of phospholamban (PLB) with itself and its regulatory target, SERCA, we measured FRET from CFP-SERCA or CFP-PLB to YFP-PLB in live AAV-293 cells. Phosphorylation of PLB was mimicked by mutations S16E (PKA site) or S16E/T17E (PKA + CaMKII sites). FRET increased with protein concentration up to a maximum (FRETmax) that was taken to represent the intrinsic FRET of the bound complex. The concentration dependence of FRET yielded dissociation constants (K-D) for the PLB-PLB and PLB-SERCA interactions. PLB-PLB FRET data suggest pseudo-phosphorylation of PLB increased oligomerization of PLB but did not alter PLB pentamer quaternary structure. PLB-SERCA FRET experiments showed an apparent decrease in binding of PLB to SERCA and an increase in the apparent PLB-SERCA binding cooperativity. It is likely that these changes are secondary effects of increased oligomerization of PLB; a change in the inherent affinity of monomeric PLB for SERCA was not detected. In addition, PLB-SERCA complex FRETmax was reduced by phosphomimetic mutations, suggesting the conformation of the regulatory complex is significantly altered by PLB phosphorylation.	[Hou, Zhanjia; Kelly, Eileen M.; Robia, Seth L.] Loyola Univ Chicago, Dept Physiol, Maywood, IL 60153 USA	Loyola University Chicago	Robia, SL (corresponding author), Loyola Univ Chicago, Dept Physiol, 2160 S 1st Ave, Maywood, IL 60153 USA.	srobia@lumc.edu			National Institutes of Health Mentored Research Scientist Development Award [EB006061]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL106189, R01HL092321] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [K01EB006061] Funding Source: NIH RePORTER	National Institutes of Health Mentored Research Scientist Development Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This work was supported, in whole or in part, by National Institutes of Health Mentored Research Scientist Development Award EB006061. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Antipenko AY, 1997, BIOCHEMISTRY-US, V36, P12903, DOI 10.1021/bi971109v; Asahi M, 2000, J BIOL CHEM, V275, P15034, DOI 10.1074/jbc.275.20.15034; Brittsan AG, 2000, J BIOL CHEM, V275, P12129, DOI 10.1074/jbc.275.16.12129; Chen Z, 2007, J BIOL CHEM, V282, P20968, DOI 10.1074/jbc.M703516200; Clayton JC, 2005, BIOCHEMISTRY-US, V44, P17016, DOI 10.1021/bi0511383; Cornea RL, 1997, BIOCHEMISTRY-US, V36, P2960, DOI 10.1021/bi961955q; Dolinsky TJ, 2004, NUCLEIC ACIDS RES, V32, pW665, DOI 10.1093/nar/gkh381; FORSTER T, 1948, ANN PHYS-BERLIN, V2, P55, DOI 10.1002/andp.19484370105; Hoshijima M, 2002, NAT MED, V8, P864, DOI 10.1038/nm739; Hutter MC, 2002, CHEMBIOCHEM, V3, P1200, DOI 10.1002/1439-7633(20021202)3:12<1200::AID-CBIC1200>3.0.CO;2-H; Karim CB, 2006, J MOL BIOL, V358, P1032, DOI 10.1016/j.jmb.2006.02.051; Karim CB, 2004, P NATL ACAD SCI USA, V101, P14437, DOI 10.1073/pnas.0402801101; Kelly EM, 2008, J BIOL CHEM, V283, P12202, DOI 10.1074/jbc.M707590200; Kimura Y, 1997, J BIOL CHEM, V272, P15061, DOI 10.1074/jbc.272.24.15061; KRANIAS EG, 1982, NATURE, V298, P182, DOI 10.1038/298182a0; Li H, 2005, PROTEINS, V61, P704, DOI 10.1002/prot.20660; Li JH, 2004, BIOCHEMISTRY-US, V43, P3870, DOI 10.1021/bi036183u; Li JH, 2003, BIOCHEMISTRY-US, V42, P10674, DOI 10.1021/bi034708c; Li M, 1999, BIOPHYS J, V76, P2587, DOI 10.1016/S0006-3495(99)77411-4; MacLennan DH, 2003, NAT REV MOL CELL BIO, V4, P566, DOI 10.1038/nrm1151; Mahaney JE, 2005, BIOCHEMISTRY-US, V44, P7713, DOI 10.1021/bi048011i; Negash S, 2000, BIOCHEM J, V351, P195, DOI 10.1042/0264-6021:3510195; Oxenoid K, 2005, P NATL ACAD SCI USA, V102, P10870, DOI 10.1073/pnas.0504920102; Oxenoid K, 2007, PROTEIN SCI, V16, P1977, DOI 10.1110/ps.072975107; Patterson GH, 2000, ANAL BIOCHEM, V284, P438, DOI 10.1006/abio.2000.4708; Robia SL, 2007, CIRC RES, V101, P1123, DOI 10.1161/CIRCRESAHA.107.159947; Robia SL, 2005, BIOCHEMISTRY-US, V44, P4302, DOI 10.1021/bi0478446; Simmerman HKB, 1998, PHYSIOL REV, V78, P921, DOI 10.1152/physrev.1998.78.4.921; Smith SO, 2001, J MOL BIOL, V313, P1139, DOI 10.1006/jmbi.2001.5101; TADA M, 1975, J BIOL CHEM, V250, P2640; TATULIAN SA, 1995, BIOCHEMISTRY-US, V34, P4448, DOI 10.1021/bi00013a038; Toyoshima C, 2003, P NATL ACAD SCI USA, V100, P467, DOI 10.1073/pnas.0237326100; Traaseth NJ, 2006, J MOL BIOL, V358, P1041, DOI 10.1016/j.jmb.2006.02.047; Traaseth NJ, 2008, BIOCHEMISTRY-US, V47, P3, DOI 10.1021/bi701668v; Traaseth NJ, 2007, P NATL ACAD SCI USA, V104, P14676, DOI 10.1073/pnas.0701016104; WEGENER AD, 1984, J BIOL CHEM, V259, P1834; WEGENER AD, 1989, J BIOL CHEM, V264, P11468; Winters DL, 2008, BIOCHEMISTRY-US, V47, P4246, DOI 10.1021/bi702089j; Zamoon J, 2003, BIOPHYS J, V85, P2589, DOI 10.1016/S0006-3495(03)74681-5	39	43	43	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 24	2008	283	43					28996	29003		10.1074/jbc.M804782200	http://dx.doi.org/10.1074/jbc.M804782200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	362EB	18708665	hybrid, Green Published			2022-12-27	WOS:000260179900025
J	Li, HY; Xu, LL; Masuda, K; Raymundo, E; Mcleod, DG; Dobi, A; Srivastava, S				Li, Hongyun; Xu, Linda L.; Masuda, Katsuaki; Raymundo, Eliza; Mcleod, David G.; Dobi, Albert; Srivastava, Shiv			A Feedback Loop between the Androgen Receptor and a NEDD4-binding Protein, PMEPA1, in Prostate Cancer Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIGASE NEDD4; TUMOR SUPPRESSION; UBIQUITIN LIGASE; HOMEOBOX GENE; WW DOMAINS; EXPRESSION; GROWTH; NKX3.1; PTEN; DIFFERENTIATION	PMEPA1 was identified originally as a highly androgen-inducible gene with prostate-abundant expression that was restricted to prostatic epithelial cells. PMEPA1 protein is a NEDD4 (ubiquitin-protein isopeptide ligase)-binding protein, which negatively regulates prostate cancer cell growth. In this study we establish that PMEPA1 is a direct transcriptional target of the androgen receptor (AR). We also demonstrate that PMEPA1 negatively regulates AR protein levels in different cell culture models. Transient expression of PMEPA1 down-regulates AR protein levels and AR transcriptional targets in prostate cancer cells. Conversely, knockdown of PMEPA1 leads to elevated levels of AR protein, AR transcriptional targets (prostate-specific antigen), and increased cell cycle S phase. We define that the PMEPA1-dependent down-regulation of AR is because of AR ubiquitination and proteasome-mediated degradation. The mutant PMEPA1 (PY1/2 motif mutation) that is impaired in NEDD4 recruitment shows attenuated AR ubiquitination and AR protein down-regulation. These data support the hypothesis that PMEPA1 negatively regulates the stability of AR protein by enhancing AR ubiquitination and proteasome-mediated degradation through NEDD4. The effect of PMEPA1 on AR ubiquitination and degradation appears to be MDM2-independent. Thus, the PMEPA1-AR degradation pathway may represent a new androgen-dependent mechanism for regulating AR levels in prostate epithelial cells. These findings underscore that the decreased PMEPA1 expression frequently noted in prostate cancers may lead to increased AR functions and strengthen the biological role of PMEPA1 in prostate cancers.	[Li, Hongyun; Xu, Linda L.; Masuda, Katsuaki; Raymundo, Eliza; Mcleod, David G.; Dobi, Albert; Srivastava, Shiv] Uniformed Serv Univ Hlth Sci, Dept Surg, Ctr Prostate Dis Res, Rockville, MD 20852 USA; [Mcleod, David G.] Walter Reed Army Med Ctr, Dept Surg, Urol Serv, Washington, DC 20307 USA; [Mcleod, David G.; Dobi, Albert; Srivastava, Shiv] Walter Reed Army Med Ctr, US Mil Canc Inst, Washington, DC 20307 USA	Uniformed Services University of the Health Sciences - USA; United States Department of Defense; United States Army; Walter Reed National Military Medical Center; United States Department of Defense; United States Army; Walter Reed National Military Medical Center	Dobi, A (corresponding author), Uniformed Serv Univ Hlth Sci, Dept Surg, Ctr Prostate Dis Res, Rockville, MD 20852 USA.	adobi@cpdr.org; ssrivastava@cpdr.org			National Institutes of Health (NCI) [1R01CA106653]; Center for Prostate Disease Research Program [HU001-04-C-1502]; NATIONAL CANCER INSTITUTE [R01CA106653] Funding Source: NIH RePORTER	National Institutes of Health (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Center for Prostate Disease Research Program; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant 1R01CA106653 (NCI) (to S. S. and A. D.). This work was also supported by the Center for Prostate Disease Research Program through the Henry M. Jackson Foundation for the Advancement of Military Medicine under Contract HU001-04-C-1502 (2004) with the Uniformed Services University. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Anan T, 1998, GENES CELLS, V3, P751, DOI 10.1046/j.1365-2443.1998.00227.x; Anindya R, 2007, MOL CELL, V28, P386, DOI 10.1016/j.molcel.2007.10.008; Bhatia-Gaur R, 1999, GENE DEV, V13, P966, DOI 10.1101/gad.13.8.966; Bieberich CJ, 1996, J BIOL CHEM, V271, P31779, DOI 10.1074/jbc.271.50.31779; Bowen C, 2000, CANCER RES, V60, P6111; Brunschwig EB, 2003, CANCER RES, V63, P1568; Chen H, 2002, CANCER RES, V62, P338; Crosetto N, 2006, MOL CANCER RES, V4, P899, DOI 10.1158/1541-7786.MCR-06-0328; Debes JD, 2004, NEW ENGL J MED, V351, P1488, DOI 10.1056/NEJMp048178; Dehm SM, 2007, MOL ENDOCRINOL, V21, P2855, DOI 10.1210/me.2007-0223; Dehm SM, 2006, J CELL BIOCHEM, V99, P333, DOI 10.1002/jcb.20794; Fang SY, 2000, J BIOL CHEM, V275, P8945, DOI 10.1074/jbc.275.12.8945; Gelmann EP, 2002, J CLIN ONCOL, V20, P3001, DOI 10.1200/JCO.2002.10.018; Gregory CW, 2001, CANCER RES, V61, P2892; Harvey KF, 1999, J BIOL CHEM, V274, P12525, DOI 10.1074/jbc.274.18.12525; Ing NH, 2005, BIOL REPROD, V72, P1290, DOI 10.1095/biolreprod.105.040014; Ingham RJ, 2004, ONCOGENE, V23, P1972, DOI 10.1038/sj.onc.1207436; Jolliffe CN, 2000, BIOCHEM J, V351, P557, DOI 10.1042/0264-6021:3510557; Kang ZG, 2002, J BIOL CHEM, V277, P48366, DOI 10.1074/jbc.M209074200; Kumar S, 1997, GENOMICS, V40, P435, DOI 10.1006/geno.1996.4582; Lange CA, 2007, ANNU REV PHYSIOL, V69, P171, DOI 10.1146/annurev.physiol.69.031905.160319; Lee DK, 2003, J CLIN ENDOCR METAB, V88, P4043, DOI 10.1210/jc.2003-030261; Lei QY, 2006, CANCER CELL, V9, P367, DOI 10.1016/j.ccr.2006.03.031; Lin HK, 2002, EMBO J, V21, P4037, DOI 10.1093/emboj/cdf406; Litvinov IV, 2006, P NATL ACAD SCI USA, V103, P15085, DOI 10.1073/pnas.0603057103; Macias MJ, 1996, NATURE, V382, P646, DOI 10.1038/382646a0; Masuda K, 2005, J MOL BIOL, V353, P763, DOI 10.1016/j.jmb.2005.09.009; Mostaghel Elahe A, 2007, Curr Urol Rep, V8, P224, DOI 10.1007/s11934-007-0010-z; Nieto M, 2007, INT J BIOCHEM CELL B, V39, P1562, DOI 10.1016/j.biocel.2007.01.005; Poukka H, 2000, J CELL SCI, V113, P2991; Richter E, 2007, PROSTATE CANCER P D, V10, P114, DOI 10.1038/sj.pcan.4500936; Richter E, 2007, EPIGENETICS-US, V2, P100, DOI 10.4161/epi.2.2.4611; Salmena L, 2007, NAT REV CANCER, V7, P409, DOI 10.1038/nrc2145; Sheflin L, 2000, BIOCHEM BIOPH RES CO, V276, P144, DOI 10.1006/bbrc.2000.3424; Shen MM, 2003, DEV DYNAM, V228, P767, DOI 10.1002/dvdy.10397; Sun C, 2006, ONCOGENE, V25, P3905, DOI 10.1038/sj.onc.1209424; Thompson IM, 2007, CAN MED ASSOC J, V176, P1853, DOI 10.1503/cmaj.060955; Trotman LC, 2007, CELL, V128, P141, DOI 10.1016/j.cell.2006.11.040; Wang XJ, 2007, CELL, V128, P129, DOI 10.1016/j.cell.2006.11.039; Wu C P, 1991, Prog Clin Biol Res, V370, P249; Wu CT, 2007, P NATL ACAD SCI USA, V104, P12679, DOI 10.1073/pnas.0704940104; Xu LL, 2000, GENOMICS, V66, P257, DOI 10.1006/geno.2000.6214; Xu LL, 2003, CANCER RES, V63, P4299; Yeh SY, 2000, P NATL ACAD SCI USA, V97, P11256, DOI 10.1073/pnas.190353897	44	55	57	2	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 24	2008	283	43					28988	28995		10.1074/jbc.M710528200	http://dx.doi.org/10.1074/jbc.M710528200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	362EB	18703514	Green Published, hybrid			2022-12-27	WOS:000260179900024
J	Marjanovic, JA; Stojanovic, A; Brovkovych, VM; Skidgel, RA; Du, XP				Marjanovic, Jasna A.; Stojanovic, Aleksandra; Brovkovych, Viktor M.; Skidgel, Randal A.; Du, Xiaoping			Signaling-mediated Functional Activation of Inducible Nitric-oxide Synthase and Its Role in Stimulating Platelet Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT PROTEIN-KINASE; DIRECT ELECTROCHEMICAL MEASUREMENT; HUMAN-BLOOD PLATELETS; IN-VITRO; NO; AGGREGATION; INHIBITION; SECRETION; APOPTOSIS; ISOFORMS	Nitric oxide (NO) is a short lived secondary messenger, synthesized by nitric-oxide synthases (NOS). It is believed that the activity of inducible NOS (iNOS) is regulated primarily at the transcription level by inducing expression of iNOS mRNA and protein, which then continuously produces NO, until its degradation. Platelets do not have the nuclear transcriptional regulatory mechanisms of the iNOS gene and are believed to generate NO in response to agonist stimulation via endothelial NOS (eNOS). However, here we show that agonist-induced NO production is only partially eNOS-dependent and is also mediated by iNOS. Platelet agonist-induced NO production is significantly reduced in iNOS-knockout platelets. Platelet NO production occurs within seconds after agonist addition and is not accompanied by changes in iNOS protein levels, indicating a signaling-mediated functional activation mechanism of iNOS. Importantly, iNOS knock-out and iNOS inhibitors reduce agonist-induced platelet secretion and aggregation and cGMP levels, indicating that iNOS activation is important in stimulating platelets via the newly identified NO-cGMP-dependent platelet secretion pathway. Furthermore, iNOS knock-out mice have prolonged bleeding time, suggesting that this novel mode of regulation of iNOS activity plays a physiologically relevant role in hemostasis.	[Marjanovic, Jasna A.; Stojanovic, Aleksandra; Brovkovych, Viktor M.; Skidgel, Randal A.; Du, Xiaoping] Univ Illinois, Coll Med, Dept Pharmacol, Chicago, IL 60612 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Du, XP (corresponding author), Univ Illinois, Coll Med, Dept Pharmacol, 835 S Wolcott Ave, Chicago, IL 60612 USA.	xdu@uic.edu			National Institutes of Health [HL062350, HL068819, HL080264, HL60678]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL060678, R01HL062350, R01HL068819, R01HL080264] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL062350, HL068819, and HL080264 (to X. D.) and HL60678 (to R. A. S.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Alderton WK, 2001, BIOCHEM J, V357, P593, DOI 10.1042/0264-6021:3570593; Brovkovych V, 1999, J PHARMACEUT BIOMED, V19, P135, DOI 10.1016/S0731-7085(98)00090-9; Browning DD, 1999, J BIOL CHEM, V274, P537, DOI 10.1074/jbc.274.1.537; Browning DD, 2000, J BIOL CHEM, V275, P2811, DOI 10.1074/jbc.275.4.2811; Brune B, 2002, KIDNEY INT, V61, P786, DOI 10.1046/j.1523-1755.2002.00221.x; Cambien B, 2003, J CLIN INVEST, V112, P1589, DOI 10.1172/JCI200319284; Cauwels A, 2006, J CLIN INVEST, V116, P2244, DOI 10.1172/JCI25426; Chen LY, 1996, J CARDIOVASC PHARM, V27, P154, DOI 10.1097/00005344-199601000-00024; Connelly L, 2001, J IMMUNOL, V166, P3873, DOI 10.4049/jimmunol.166.6.3873; DU XP, 1991, CELL, V65, P409, DOI 10.1016/0092-8674(91)90458-B; Fleming I, 2003, AM J PHYSIOL-REG I, V284, pR1, DOI 10.1152/ajpregu.00323.2002; Freedman JE, 1999, CIRC RES, V84, P1416; Garvey EP, 1997, J BIOL CHEM, V272, P4959, DOI 10.1074/jbc.272.8.4959; GRIFFITHS MJD, 1993, BRIT J PHARMACOL, V110, P963, DOI 10.1111/j.1476-5381.1993.tb13907.x; HASLAM RJ, 1974, BIOCHEM J, V138, P317, DOI 10.1042/bj1380317; Jang EK, 2002, BRIT J HAEMATOL, V117, P664, DOI 10.1046/j.1365-2141.2002.03479.x; KIEFFER N, 1987, EUR J BIOCHEM, V164, P189, DOI 10.1111/j.1432-1033.1987.tb11010.x; Kleinert H, 2004, EUR J PHARMACOL, V500, P255, DOI 10.1016/j.ejphar.2004.07.030; Lechner M, 2005, SEMIN CANCER BIOL, V15, P277, DOI 10.1016/j.semcancer.2005.04.004; Li ZY, 2004, J BIOL CHEM, V279, P42469, DOI 10.1074/jbc.M401532200; Li ZY, 2003, J BIOL CHEM, V278, P30725, DOI 10.1074/jbc.M301838200; Li ZY, 2003, BLOOD, V101, P4423, DOI 10.1182/blood-2002-10-3210; Li ZY, 2003, CELL, V112, P77, DOI 10.1016/S0092-8674(02)01254-0; LUNDBERG JON, 1995, NAT MED, V1, P370, DOI 10.1038/nm0495-370; MacMicking J, 1997, ANNU REV IMMUNOL, V15, P323, DOI 10.1146/annurev.immunol.15.1.323; MALINSKI T, 1993, BIOCHEM BIOPH RES CO, V194, P960, DOI 10.1006/bbrc.1993.1914; Marjanovic JA, 2005, J BIOL CHEM, V280, P37430, DOI 10.1074/jbc.M506518200; MELLION BT, 1981, BLOOD, V57, P946; Morrell CN, 2005, P NATL ACAD SCI USA, V102, P3782, DOI 10.1073/pnas.0408310102; Razavi HM, 2005, PHARMACOL THERAPEUT, V106, P147, DOI 10.1016/j.pharmthera.2004.11.006; Roy A, 2003, J BIOL CHEM, V278, P4397, DOI 10.1074/jbc.M207295200; Santolini J, 2001, J BIOL CHEM, V276, P48887, DOI 10.1074/jbc.M108666200; Schlossmann J, 2003, ANN MED, V35, P21, DOI 10.1080/07853890310004093; Seiser RM, 2000, J BIOL CHEM, V275, P33820, DOI 10.1074/jbc.M004462200; Stojanovic A, 2006, J BIOL CHEM, V281, P16333, DOI 10.1074/jbc.M512378200; Stuehr DJ, 2004, J BIOL CHEM, V279, P36167, DOI 10.1074/jbc.R400017200; TOJO A, 1994, J AM SOC NEPHROL, V4, P1438; ULMER AJ, 1979, J IMMUNOL METHODS, V30, P1, DOI 10.1016/0022-1759(79)90268-0; Vodovotz Y, 2004, CURR MOL MED, V4, P753, DOI 10.2174/1566524043359944; Wallerath T, 1997, THROMB HAEMOSTASIS, V77, P163; WARSHAW AL, 1967, J BIOL CHEM, V242, P2094; Weyrich AS, 1998, P NATL ACAD SCI USA, V95, P5556, DOI 10.1073/pnas.95.10.5556	42	27	30	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 24	2008	283	43					28827	28834		10.1074/jbc.M801646200	http://dx.doi.org/10.1074/jbc.M801646200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	362EB	18753139	hybrid, Green Published			2022-12-27	WOS:000260179900007
J	Milic, D; Demidkina, TV; Faleev, NG; Matkovic-Calogovic, D; Antson, AA				Milic, Dalibor; Demidkina, Tatyana V.; Faleev, Nicolai G.; Matkovic-Calogovic, Dubravka; Antson, Alfred A.			Insights into the Catalytic Mechanism of Tyrosine Phenol-lyase from X-ray Structures of Quinonoid Intermediates	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SITE-DIRECTED MUTAGENESIS; CRYSTALLINE BETA-TYROSINASE; TRYPTOPHAN INDOLE-LYASE; CITROBACTER-FREUNDII; ALANINE RACEMASE; ESCHERICHIA-INTERMEDIA; SUBSTRATE-SPECIFICITY; AMINO-ACIDS; MODEL; REFINEMENT	Amino acid transformations catalyzed by a number of pyridoxal 5'-phosphate (PLP)-dependent enzymes involve abstraction of the C alpha proton from an external aldimine formed between a substrate and the cofactor leading to the formation of a quinonoid intermediate. Despite the key role played by the quinonoid intermediates in the catalysis by PLP-dependent enzymes, limited accurate information is available about their structures. We trapped the quinonoid intermediates of Citrobacter freundii tyrosine phenol-lyase with L-alanine and L-methionine in the crystalline state and determined their structures at 1.9- and 1.95-angstrom resolution, respectively, by cryo-crystallography. The data reveal a network of protein-PLP substrate interactions that stabilize the planar geometry of the quinonoid intermediate. In both structures the protein subunits are found in two conformations, open and closed, uncovering the mechanism by which binding of the substrate and restructuring of the active site during its closure protect the quinonoid intermediate from the solvent and bring catalytically important residues into positions suitable for the abstraction of phenol during the beta-elimination of L-tyrosine. In addition, the structural data indicate a mechanism for alanine racemization involving two bases, Lys-257 and a water molecule. These two bases are connected by a hydrogen bonding system allowing internal transfer of the C alpha proton.	[Milic, Dalibor; Matkovic-Calogovic, Dubravka] Univ Zagreb, Lab Gen & Inorgan Chem, Dept Chem, Fac Sci, HR-10000 Zagreb, Croatia; [Demidkina, Tatyana V.] Russian Acad Sci, VA Engelhardt Mol Biol Inst, Moscow 119991, Russia; [Faleev, Nicolai G.] Russian Acad Sci, AN Nesmeyanov Organoelement Cpds Inst, Moscow 119991, Russia; [Antson, Alfred A.] Univ York, Dept Chem, York Struct Biol Lab, York YO10 5YW, N Yorkshire, England	University of Zagreb; Russian Academy of Sciences; Engelhardt Institute of Molecular Biology, RAS; Russian Academy of Sciences; Nesmeyanov Institute of Organoelement Compounds; University of York - UK	Milic, D (corresponding author), Univ Zagreb, Lab Gen & Inorgan Chem, Dept Chem, Fac Sci, Horvatovac 102A, HR-10000 Zagreb, Croatia.	dmilic@chem.pmf.hr	Demidkina, Tatyana/AAD-9427-2019; Milić, Dalibor/B-4882-2011; Antson, Alfred/N-2551-2016	Milić, Dalibor/0000-0001-5760-6677; Antson, Alfred/0000-0002-4533-3816	Ministry of Science, Education and Sports of the Republic of Croatia [119-1193079-1084]; Russian Foundation for Basic Research [08-04-00117, 07-04-01138]; Fogarty Foundation [R03 TW00604501-2A]; Wellcome Trust [081916]; FOGARTY INTERNATIONAL CENTER [R03TW006045] Funding Source: NIH RePORTER; Medical Research Council [G0500367] Funding Source: researchfish; MRC [G0500367] Funding Source: UKRI	Ministry of Science, Education and Sports of the Republic of Croatia(Ministry of Science, Education and Sports, Republic of Croatia); Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); Fogarty Foundation(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); Wellcome Trust(Wellcome TrustEuropean Commission); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the Ministry of Science, Education and Sports of the Republic of Croatia (Grant 119-1193079-1084 (to D. M. and D. M.-C..)), by the Russian Foundation for Basic Research(Grants 08-04-00117(to T. V. D.) and 07-04-01138 (to N.G.F.)), by the Fogarty Foundation (Grant R03 TW00604501-2A (to T. V. D.)), and by the Wellcome Trust (Fellowship 081916, to A. A. A.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	ANTSON AA, 1993, BIOCHEMISTRY-US, V32, P4195, DOI 10.1021/bi00067a006; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Barbolina MV, 2000, PROTEIN ENG, V13, P207, DOI 10.1093/protein/13.3.207; Barends TRM, 2008, CHEMBIOCHEM, V9, P1024, DOI 10.1002/cbic.200700703; CHEN HY, 1995, BIOCHEMISTRY-US, V34, P12276, DOI 10.1021/bi00038a023; CHEN HY, 1995, EUR J BIOCHEM, V229, P540, DOI 10.1111/j.1432-1033.1995.tb20496.x; CHEN HY, 1993, BIOCHEMISTRY-US, V32, P11591, DOI 10.1021/bi00094a016; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; DeLano W.L, PYMOL MOL GRAPHICS S; DEMIDKINA TV, 1989, BIOCHIMIE, V71, P565, DOI 10.1016/0300-9084(89)90188-0; Demidkina TV, 2002, BIOCHEM J, V363, P745, DOI 10.1042/0264-6021:3630745; DEMIDKINA TV, 1987, EUR J BIOCHEM, V170, P311, DOI 10.1111/j.1432-1033.1987.tb13701.x; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; ENEI H, 1972, FEBS LETT, V21, P39, DOI 10.1016/0014-5793(72)80157-1; FALEEV NG, 1988, EUR J BIOCHEM, V177, P395, DOI 10.1111/j.1432-1033.1988.tb14388.x; FALEEV NG, 1983, ENZYME MICROB TECH, V5, P219, DOI 10.1016/0141-0229(83)90099-6; Faleev NG, 2000, EUR J BIOCHEM, V267, P6897, DOI 10.1046/j.1432-1327.2000.01794.x; Faleev NG, 2004, EUR J BIOCHEM, V271, P4565, DOI 10.1111/j.1432-1033.2004.04428.x; Faleev NG, 1996, J CHEM SOC PERK T 2, P2001, DOI 10.1039/p29960002001; FALEEV NG, 2003, PROTEIN STRUCTURES K; Hasek J, 2006, Z KRISTALLOGR, P613; IVANOV VI, 1969, ADV ENZYMOL RAMB, V32, P21; KIRSCH JF, 1984, J MOL BIOL, V174, P497, DOI 10.1016/0022-2836(84)90333-4; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; KUMAGAI H, 1970, J BIOL CHEM, V245, P1773; KUMAGAI H, 1969, BIOCHEM BIOPH RES CO, V34, P266, DOI 10.1016/0006-291X(69)90826-2; KUMAGAI H, 1970, BIOCHEM BIOPH RES CO, V39, P796, DOI 10.1016/0006-291X(70)90393-1; KUMAGAI H, 1970, J BIOL CHEM, V245, P1767; Milic D, 2006, BIOCHEMISTRY-US, V45, P7544, DOI 10.1021/bi0601858; Mouratou B, 1999, J BIOL CHEM, V274, P1320, DOI 10.1074/jbc.274.3.1320; MURO T, 1978, J BIOCHEM-TOKYO, V84, P633, DOI 10.1093/oxfordjournals.jbchem.a132168; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PALCIC MM, 1987, Z NATURFORSCH C, V42, P307; Papisova A I, 2003, Dokl Biochem Biophys, V391, P225, DOI 10.1023/A:1025117626374; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; PHILLIPS RS, 1987, ARCH BIOCHEM BIOPHYS, V256, P302, DOI 10.1016/0003-9861(87)90450-4; Phillips RS, 2003, BBA-PROTEINS PROTEOM, V1647, P167, DOI 10.1016/S1570-9639(03)00089-X; Phillips RS, 2002, J BIOL CHEM, V277, P21592, DOI 10.1074/jbc.M200216200; PHILLIPS RS, 1989, ENZYME MICROB TECH, V11, P80, DOI 10.1016/0141-0229(89)90064-1; Pletnev SV, 1997, CRYSTALLOGR REP+, V42, P809; READ RJ, 1986, ACTA CRYSTALLOGR A, V42, P140, DOI 10.1107/S0108767386099622; Schnackerz KD, 2006, BBA-PROTEINS PROTEOM, V1764, P230, DOI 10.1016/j.bbapap.2005.10.009; Stamper CGF, 1998, BIOCHEMISTRY-US, V37, P10438, DOI 10.1021/bi980692s; Sun SX, 1999, BIOCHEMISTRY-US, V38, P4058, DOI 10.1021/bi982924t; Sundararaju B, 1997, BIOCHEMISTRY-US, V36, P6502, DOI 10.1021/bi962917+; Szebenyi DME, 2000, BIOCHEMISTRY-US, V39, P13313, DOI 10.1021/bi000635a; UENO T, 1970, BIOCHIM BIOPHYS ACTA, V206, P476, DOI 10.1016/0005-2744(70)90163-4; Watanabe A, 1999, J BIOCHEM-TOKYO, V126, P781, DOI 10.1093/oxfordjournals.jbchem.a022517; Winn MD, 2001, ACTA CRYSTALLOGR D, V57, P122, DOI 10.1107/S0907444900014736; YAMADA H, 1972, BIOCHEM BIOPH RES CO, V46, P370, DOI 10.1016/S0006-291X(72)80148-7; Yamada H, 1975, Adv Appl Microbiol, V19, P249, DOI 10.1016/S0065-2164(08)70431-3	53	32	33	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 24	2008	283	43					29206	29214		10.1074/jbc.M802061200	http://dx.doi.org/10.1074/jbc.M802061200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	362EB	18715865	Green Accepted, Green Published, hybrid			2022-12-27	WOS:000260179900048
J	Plate, I; Hallwyl, SCL; Shi, I; Krejci, L; Muller, C; Albertsen, L; Sung, P; Mortensen, UH				Plate, Iben; Hallwyl, Swee C. L.; Shi, Idina; Krejci, Lumir; Muller, Christian; Albertsen, Line; Sung, Patrick; Mortensen, Uffe H.			Interaction with RPA Is Necessary for Rad52 Repair Center Formation and for Its Mediator Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOUBLE-STRAND-BREAK; REPLICATION PROTEIN-A; DNA-BINDING-PROTEIN; HOMOLOGOUS RECOMBINATION; N-TERMINUS; LOCALIZATION; EXCHANGE; COMPLEX; ASSOCIATION; CHECKPOINT	Homologous recombination (HR) is a major DNA repair pathway and therefore essential for maintaining the integrity of the genome. HR is catalyzed by proteins encoded by genes of the RAD52 epistasis group, including the recombinase Rad51 and its mediator Rad52. HR proteins fused with green fluorescent protein form foci at damaged DNA reflecting the assembly of repair centers that harbor a high concentration of repair proteins. Rad52 mediates the recruitment of Rad51 and other HR proteins to DNA damage. To understand the mechanism for the assembly of Rad52-dependent DNA repair centers, we used a mutational strategy to identify a Rad52 domain essential for its recruitment to DNA repair foci. We present evidence to implicate an acidic domain in Rad52 in DNA repair focus formation. Mutations in this domain confer marked DNA damage sensitivity and recombination deficiency. Importantly, these Rad52 mutants are specifically compromised for interaction with the single-stranded DNA-binding factor RPA. Based on these findings, we propose a model where Rad52 displaces RPA from single-stranded DNA using the acidic domain as a molecular lever.	[Plate, Iben; Hallwyl, Swee C. L.; Muller, Christian; Albertsen, Line; Mortensen, Uffe H.] Tech Univ Denmark, Ctr Microbial Biotechnol, DK-2800 Lyngby, Denmark; [Shi, Idina; Krejci, Lumir; Sung, Patrick] Yale Univ, Sch Med, Dept Mol Biophys & Biochem, New Haven, CT 06530 USA	Technical University of Denmark; Yale University	Mortensen, UH (corresponding author), Bldg 223, DK-2800 Lyngby, Denmark.	um@biocentrum.dtu.dk	Mortensen, Uffe/AAQ-1150-2021; Krejci, Lumir/B-7842-2009; Classen, Scott/AAY-8176-2020	Krejci, Lumir/0000-0002-4732-1405; 	National Institutes of Health [ES07061, GM57814, P01CA92584]; Danish Research Council for Technology and Production Sciences; Hartmann Foundation; Lundbeck Foundation; Technical University of Denmark; NATIONAL CANCER INSTITUTE [P01CA092584] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES007061] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057814] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Danish Research Council for Technology and Production Sciences; Hartmann Foundation; Lundbeck Foundation(Lundbeckfonden); Technical University of Denmark; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants ES07061, GM57814, and P01CA92584 (to P. S.). This work was also supported by the Danish Research Council for Technology and Production Sciences (to U. H. M.), the Hartmann Foundation (to U. H. M.), the Lundbeck Foundation (to U. H. M.), and the Technical University of Denmark (to S. C. L. H.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Asleson EN, 1999, GENETICS, V153, P681; BENDIXEN C, 1994, NUCLEIC ACIDS RES, V22, P1778, DOI 10.1093/nar/22.9.1778; Benson FE, 1998, NATURE, V391, P401, DOI 10.1038/34937; Bochkareva E, 2005, P NATL ACAD SCI USA, V102, P15412, DOI 10.1073/pnas.0504614102; BOUNDYMILLS KL, 1993, GENETICS, V133, P39; de Mayolo AA, 2006, NUCLEIC ACIDS RES, V34, P2587, DOI 10.1093/nar/gkl280; Erdeniz N, 1997, GENOME RES, V7, P1174, DOI 10.1101/gr.7.12.1174; Essers J, 2002, EMBO J, V21, P2030, DOI 10.1093/emboj/21.8.2030; Feng Q, 2007, DNA REPAIR, V6, P27, DOI 10.1016/j.dnarep.2006.08.007; Filippo JS, 2008, ANNU REV BIOCHEM, V77, P229, DOI 10.1146/annurev.biochem.77.061306.125255; Gasior SL, 1998, GENE DEV, V12, P2208, DOI 10.1101/gad.12.14.2208; GIETZ D, 1992, NUCLEIC ACIDS RES, V20, P1425, DOI 10.1093/nar/20.6.1425; Hays SL, 1998, MOL CELL BIOL, V18, P4400, DOI 10.1128/MCB.18.7.4400; Jiang H, 1996, J BIOL CHEM, V271, P33181, DOI 10.1074/jbc.271.52.33181; Krejci L, 2002, J BIOL CHEM, V277, P40132, DOI 10.1074/jbc.M206511200; Lao JP, 2008, MOL CELL, V29, P517, DOI 10.1016/j.molcel.2007.12.014; Lettier G, 2006, PLOS GENET, V2, P1773, DOI 10.1371/journal.pgen.0020194; Lisby M, 2004, CELL, V118, P699, DOI 10.1016/j.cell.2004.08.015; Lisby M, 2005, BIOCHIMIE, V87, P579, DOI 10.1016/j.biochi.2004.10.023; Lisby M, 2003, NAT CELL BIOL, V5, P572, DOI 10.1038/ncb997; Lisby M, 2001, P NATL ACAD SCI USA, V98, P8276, DOI 10.1073/pnas.121006298; Liu YL, 1999, CURR BIOL, V9, P975, DOI 10.1016/S0960-9822(99)80427-8; MALONE RE, 1988, CURR GENET, V14, P211, DOI 10.1007/BF00376741; MILNE GT, 1993, GENE DEV, V7, P1755, DOI 10.1101/gad.7.9.1755; Miyazaki T, 2004, EMBO J, V23, P939, DOI 10.1038/sj.emboj.7600091; Mortensen UH, 2002, GENETICS, V161, P549; Mortensen UH, 1996, P NATL ACAD SCI USA, V93, P10729, DOI 10.1073/pnas.93.20.10729; New JH, 1998, NATURE, V391, P407, DOI 10.1038/34950; Paques F, 1999, MICROBIOL MOL BIOL R, V63, P349; Pellegrini L, 2004, TRENDS BIOCHEM SCI, V29, P310, DOI 10.1016/j.tibs.2004.04.009; Plate I, 2008, DNA REPAIR, V7, P57, DOI 10.1016/j.dnarep.2007.07.016; PRAKASH L, 1977, GENETICS, V86, P33; ROSE M, 1983, METHOD ENZYMOL, V101, P167; Scully R, 1997, CELL, V88, P265, DOI 10.1016/S0092-8674(00)81847-4; Seong C, 2008, J BIOL CHEM, V283, P12166, DOI 10.1074/jbc.M800763200; Sherman F., 1986, METHODS YEAST GENETI; Shinohara A, 1998, NATURE, V391, P404, DOI 10.1038/34943; Shinohara A, 1998, GENES CELLS, V3, P145, DOI 10.1046/j.1365-2443.1998.00176.x; SMITH J, 1995, MOL CELL BIOL, V15, P1632; Sugawara N, 2003, MOL CELL, V12, P209, DOI 10.1016/S1097-2765(03)00269-7; Sugiyama T, 1997, J BIOL CHEM, V272, P7940, DOI 10.1074/jbc.272.12.7940; Sugiyama T, 1998, P NATL ACAD SCI USA, V95, P6049, DOI 10.1073/pnas.95.11.6049; Sugiyama T, 2006, EMBO J, V25, P5539, DOI 10.1038/sj.emboj.7601412; Sung P, 2003, J BIOL CHEM, V278, P42729, DOI 10.1074/jbc.R300027200; Sung P, 1997, GENE DEV, V11, P1111, DOI 10.1101/gad.11.9.1111; Sung P, 1997, J BIOL CHEM, V272, P28194, DOI 10.1074/jbc.272.45.28194; Sung P, 2006, NAT REV MOL CELL BIO, V7, P739, DOI 10.1038/nrm2008; Symington LS, 2002, MICROBIOL MOL BIOL R, V66, P630, DOI 10.1128/MMBR.66.4.630-670.2002; Tan TLR, 1999, CURR BIOL, V9, P325, DOI 10.1016/S0960-9822(99)80142-0; THOMAS BJ, 1989, CELL, V56, P619, DOI 10.1016/0092-8674(89)90584-9; Thorpe PH, 2006, MOL CELL BIOL, V26, P3752, DOI 10.1128/MCB.26.10.3752-3763.2006; Trujillo KM, 2001, J BIOL CHEM, V276, P35458, DOI 10.1074/jbc.M105482200; Wolner B, 2003, MOL CELL, V12, P221, DOI 10.1016/S1097-2765(03)00242-9	53	52	53	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 24	2008	283	43					29077	29085		10.1074/jbc.M804881200	http://dx.doi.org/10.1074/jbc.M804881200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	362EB	18703507	Green Published, hybrid			2022-12-27	WOS:000260179900035
J	Selivanov, VA; Zeak, JA; Roca, J; Cascante, M; Trucco, M; Votyakova, TV				Selivanov, Vitaly A.; Zeak, Jennifer A.; Roca, Josep; Cascante, Marta; Trucco, Massimo; Votyakova, Tatyana V.			The Role of External and Matrix pH in Mitochondrial Reactive Oxygen Species Generation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTON-ELECTROCHEMICAL GRADIENT; BOVINE HEART-MITOCHONDRIA; CYTOCHROME BC(1) COMPLEX; RAT-LIVER MITOCHONDRIA; SUPEROXIDE-PRODUCTION; HYDROGEN-PEROXIDE; OXIDATIVE STRESS; PERMEABILITY TRANSITION; UNCOUPLING PROTEINS; INNER MEMBRANE	Reactive oxygen species (ROS) generation in mitochondria as a side product of electron and proton transport through the inner membrane is important for normal cell operation as well as development of pathology. Matrix and cytosol alkalization stabilizes semiquinone radical, a potential superoxide producer, and we hypothesized that proton deficiency under the excess of electron donors enhances reactive oxygen species generation. We tested this hypothesis by measuring pH dependence of reactive oxygen species released by mitochondria. The experiments were performed in the media with pH varying from 6 to 8 in the presence of complex II substrate succinate or under more physiological conditions with complex I substrates glutamate and malate. Matrix pH was manipulated by inorganic phosphate, nigericine, and low concentrations of uncoupler or valinomycin. We found that high pH strongly increased the rate of free radical generation in all of the conditions studied, even when Delta pH = 0 in the presence of nigericin. In the absence of inorganic phosphate, when the matrix was the most alkaline, pH shift in the medium above 7 induced permeability transition accompanied by the decrease of ROS production. ROS production increase induced by the alkalization of medium was observed with intact respiring mitochondria as well as in the presence of complex I inhibitor rotenone, which enhanced reactive oxygen species release. The phenomena revealed in this report are important for understanding mechanisms governing mitochondrial production of reactive oxygen species, in particular that related with uncoupling proteins.	[Votyakova, Tatyana V.] Univ Pittsburgh, Sch Med, Inst Diabet, Dept Pediat,Rangos Res Ctr, Pittsburgh, PA 15213 USA; [Selivanov, Vitaly A.; Cascante, Marta] Univ Barcelona, Dept Biochem & Mol Biol, CSIC, Associated Unit,Inst Biomed, E-08028 Barcelona, Spain; [Selivanov, Vitaly A.; Cascante, Marta] Univ Barcelona, Fac Biol, Catalan Theoret & Computat Chem Reference Network, E-08028 Barcelona, Spain; [Selivanov, Vitaly A.] Moscow MV Lomonosov State Univ, AN Belozersky Inst Physicochem Biol, Moscow 199899, Russia; [Zeak, Jennifer A.; Trucco, Massimo; Votyakova, Tatyana V.] Childrens Hosp Pittsburgh, Pittsburgh, PA 15213 USA; [Selivanov, Vitaly A.; Roca, Josep] Univ Barcelona, IDIBAPS, Hosp Clin Ciberes, E-08036 Barcelona, Catalunya, Spain	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Consejo Superior de Investigaciones Cientificas (CSIC); University of Barcelona; University of Barcelona; Lomonosov Moscow State University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; CIBER - Centro de Investigacion Biomedica en Red; CIBERES; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS	Votyakova, TV (corresponding author), Univ Pittsburgh, Sch Med, Inst Diabet, Dept Pediat,Rangos Res Ctr, 3460 5th Ave, Pittsburgh, PA 15213 USA.	tav2@pitt.edu	CASCANTE, MARTA/AAG-4355-2022; Roca, Josep/J-2583-2015; CASCANTE, MARTA/AFK-5991-2022	CASCANTE, MARTA/0000-0002-2062-4633; Roca, Josep/0000-0003-4768-8722; CASCANTE, MARTA/0000-0002-2062-4633; Selivanov, Vitaly/0000-0002-7937-9249	National Institutes of Health, NIA [AG 20899]; European Commission (FP6) BioBridge [LSHG-CT-2006-037939]; Spanish government and European Union FEDER funds ISCIII-RTICC [RD06/0020/0046]; Generalitat de Catalunya [2005SGR00204, 2006ITT-10007]; Ministerio de Ciencia y Tecnologia of the Spanish Government [SAF2008-00164, AGL2004-07579-C04-03/ALI]; NATIONAL INSTITUTE ON AGING [R01AG020899] Funding Source: NIH RePORTER	National Institutes of Health, NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); European Commission (FP6) BioBridge(European CommissionEuropean Commission Joint Research Centre); Spanish government and European Union FEDER funds ISCIII-RTICC; Generalitat de Catalunya(Generalitat de Catalunya); Ministerio de Ciencia y Tecnologia of the Spanish Government(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health, NIA, Grant AG 20899. This work was also supported by European Commission (FP6) BioBridge Grant LSHG-CT-2006-037939; Spanish government and European Union FEDER funds ISCIII-RTICC Grant RD06/0020/0046; Generalitat de Catalunya Grants 2005SGR00204 and 2006ITT-10007; and Ministerio de Ciencia y Tecnologia of the Spanish Government Grants SAF2008-00164 and AGL2004-07579-C04-03/ALI. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked " advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Anderson EJ, 2007, J BIOL CHEM, V282, P31257, DOI 10.1074/jbc.M706129200; Andrews ZB, 2005, NAT REV NEUROSCI, V6, P829, DOI 10.1038/nrn1767; Barja G, 1998, J BIOENERG BIOMEMBR, V30, P235, DOI 10.1023/A:1020592719405; Bernardi P, 1999, PHYSIOL REV, V79, P1127, DOI 10.1152/physrev.1999.79.4.1127; BERNARDI P, 1992, J BIOL CHEM, V267, P8834; Bottino R, 2004, DIABETES, V53, P2559, DOI 10.2337/diabetes.53.10.2559; BOVERIS A, 1973, BIOCHEM J, V134, P707, DOI 10.1042/bj1340707; Costa ADT, 2006, AM J PHYSIOL-HEART C, V290, pH406, DOI 10.1152/ajpheart.00794.2005; Covian R, 2006, J BIOL CHEM, V281, P30925, DOI 10.1074/jbc.M604694200; Dlaskova A, 2006, BBA-BIOENERGETICS, V1757, P467, DOI 10.1016/j.bbabio.2006.05.005; Genova ML, 2001, FEBS LETT, V505, P364, DOI 10.1016/S0014-5793(01)02850-2; Guzy RD, 2005, CELL METAB, V1, P401, DOI 10.1016/j.cmet.2005.05.001; Guzy RD, 2006, EXP PHYSIOL, V91, P807, DOI 10.1113/expphysiol.2006.033506; Gyulkhandanyan AV, 2004, J NEUROCHEM, V90, P405, DOI 10.1111/j.1471-4159.2004.02489.x; Han D, 2001, BIOCHEM J, V353, P411, DOI 10.1042/0264-6021:3530411; Hare JM, 2004, NEW ENGL J MED, V351, P2112, DOI 10.1056/NEJMe048269; Herrero A, 2000, J BIOENERG BIOMEMBR, V32, P609, DOI 10.1023/A:1005626712319; JONES JG, 1993, BIOCHEMISTRY-US, V32, P12240, DOI 10.1021/bi00096a037; Kiritoshi S, 2003, DIABETES, V52, P2570, DOI 10.2337/diabetes.52.10.2570; Koechlin C, 2004, AM J RESP CRIT CARE, V169, P1022, DOI 10.1164/rccm.200310-1465OC; Lambert AJ, 2004, BIOCHEM J, V382, P511, DOI 10.1042/BJ20040485; Lee KU, 2005, CIRC RES, V96, P1200, DOI 10.1161/01.RES.0000170075.73039.5b; Lenaz G, 2002, ANN NY ACAD SCI, V959, P199, DOI 10.1111/j.1749-6632.2002.tb02094.x; Li LX, 2001, BIOCHEM BIOPH RES CO, V282, P273, DOI 10.1006/bbrc.2001.4577; Magnitsky S, 2002, J BIOENERG BIOMEMBR, V34, P193, DOI 10.1023/A:1016083419979; Muller FL, 2003, BIOCHEMISTRY-US, V42, P6493, DOI 10.1021/bi0342160; Newsholme P, 2007, J PHYSIOL-LONDON, V583, P9, DOI 10.1113/jphysiol.2007.135871; NICHOLLS DG, 1974, EUR J BIOCHEM, V50, P305, DOI 10.1111/j.1432-1033.1974.tb03899.x; Nishikawa T, 2000, NATURE, V404, P787, DOI 10.1038/35008121; OGAWA S, 1978, P NATL ACAD SCI USA, V75, P1796, DOI 10.1073/pnas.75.4.1796; Ohnishi ST, 2005, J BIOENERG BIOMEMBR, V37, P1, DOI 10.1007/s10863-005-4117-y; OHNISHI T, 1980, J BIOL CHEM, V255, P3278; Pieczenik SR, 2007, EXP MOL PATHOL, V83, P84, DOI 10.1016/j.yexmp.2006.09.008; PISARENKO O, 1988, BIOCHIM BIOPHYS ACTA, V934, P55, DOI 10.1016/0005-2728(88)90119-3; Selivanov VA, 1998, BIOPHYS CHEM, V72, P111, DOI 10.1016/S0301-4622(98)00127-6; Sluse FE, 2006, BBA-BIOENERGETICS, V1757, P480, DOI 10.1016/j.bbabio.2006.02.004; St-Pierre J, 2002, J BIOL CHEM, V277, P44784, DOI 10.1074/jbc.M207217200; TAKESHIGE K, 1979, BIOCHEM J, V180, P129, DOI 10.1042/bj1800129; TRUMPOWER BL, 1994, ANNU REV BIOCHEM, V63, P675, DOI 10.1146/annurev.bi.63.070194.003331; TURRENS JF, 1980, BIOCHEM J, V191, P421, DOI 10.1042/bj1910421; Votyakova TV, 2004, ARCH BIOCHEM BIOPHYS, V431, P138, DOI 10.1016/j.abb.2004.07.025; Zhang L, 1998, J BIOL CHEM, V273, P33972, DOI 10.1074/jbc.273.51.33972	42	93	94	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 24	2008	283	43					29292	29300		10.1074/jbc.M801019200	http://dx.doi.org/10.1074/jbc.M801019200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	362EB	18687689	Green Published, hybrid			2022-12-27	WOS:000260179900056
J	Lu, CW; Lin, SC; Chen, KF; Lai, YY; Tsai, SJ				Lu, Chun-Wun; Lin, Shih-Chieh; Chen, Ko-Fan; Lai, Yen-Yu; Tsai, Shaw-Jenq			Induction of pyruvate dehydrogenase kinase-3 by hypoxia-inducible factor-1 promotes metabolic switch and drug resistance	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOMETRIOTIC STROMAL CELLS; ACUTE REGULATORY PROTEIN; FACTOR 1-ALPHA; GROWTH-FACTOR; UP-REGULATION; EXPRESSION; COMPLEX; CANCER; HIF-1; GENE	The switch of cellular metabolism from mitochondrial respiration to glycolysis is the hallmark of cancer cells and associated with tumor malignancy. However, the mechanism of this metabolic switch remains largely unknown. Herein, we reported that hypoxia-inducible factor-1 (HIF-1) induced pyruvate dehydrogenase kinase-3 ( PDK3) expression leading to inhibition of mitochondrial respiration. Promoter activity assay, small interference RNA knockdown assay, and chromatin immunoprecipitation assay demonstrated that hypoxia-induced PDK3 gene activity was regulated by HIF-1 at the transcriptional level. Forced expression of PDK3 in cancer cells resulted in increased lactic acid accumulation and drugs resistance, whereas knocking down PDK3 inhibited hypoxia-induced cytoplasmic glycolysis and cell survival. These data demonstrated that increased PDK3 expression due to elevated HIF-1 alpha in cancer cells may play critical roles in metabolic switch during cancer progression and chemoresistance in cancer therapy.	[Lu, Chun-Wun; Lin, Shih-Chieh; Tsai, Shaw-Jenq] Natl Cheng Kung Univ, Inst Basic Med Sci, Tainan 701, Taiwan; [Chen, Ko-Fan; Lai, Yen-Yu; Tsai, Shaw-Jenq] Natl Cheng Kung Univ, Coll Med, Dept Physiol, Tainan 701, Taiwan	National Cheng Kung University; National Cheng Kung University	Tsai, SJ (corresponding author), Natl Cheng Kung Univ, Inst Basic Med Sci, 1 Univ Rd, Tainan 701, Taiwan.	seantsai@mail.ncku.edu.tw	Lin, Shih-Chieh/AAK-1978-2020; Tsai, Shaw-Jenq/AAG-6569-2019	TSAI, SHAW-JENQ/0000-0002-3569-5813; Chen, Ko-Fan/0000-0002-7305-6254	National Research Program [NSC94-3112-B-006-010]; National Cheng Kung University, Taiwan [A-0123]	National Research Program; National Cheng Kung University, Taiwan	This work was supported by the National Research Program of Genome Medicine (Grant NSC94-3112-B-006-010) and the Landmark Project (Grant A-0123) of National Cheng Kung University, Taiwan. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Baker JC, 2000, J BIOL CHEM, V275, P15773, DOI 10.1074/jbc.M909488199; Bonnet S, 2007, CANCER CELL, V11, P37, DOI 10.1016/j.ccr.2006.10.020; Bowker-Kinley MM, 1998, BIOCHEM J, V329, P191, DOI 10.1042/bj3290191; Bridge AJ, 2003, NAT GENET, V34, P263, DOI 10.1038/ng1173; Brown JM, 1998, CANCER RES, V58, P1408; Chen KF, 2005, NUCLEIC ACIDS RES, V33, P5190, DOI 10.1093/nar/gki839; Chuang PC, 2006, MOL CELL BIOL, V26, P8281, DOI 10.1128/MCB.00941-06; Ema M, 1997, P NATL ACAD SCI USA, V94, P4273, DOI 10.1073/pnas.94.9.4273; Fantin VR, 2006, CANCER CELL, V9, P425, DOI 10.1016/j.ccr.2006.04.023; Greijer AE, 2005, J PATHOL, V206, P291, DOI 10.1002/path.1778; GUDI R, 1995, J BIOL CHEM, V270, P28989, DOI 10.1074/jbc.270.48.28989; Haase VH, 2006, AM J PHYSIOL-RENAL, V291, pF271, DOI 10.1152/ajprenal.00071.2006; Holmquist-Mengelbier L, 2006, CANCER CELL, V10, P413, DOI 10.1016/j.ccr.2006.08.026; Holness MJ, 2000, DIABETES, V49, P775, DOI 10.2337/diabetes.49.5.775; Iyer NV, 1998, GENE DEV, V12, P149, DOI 10.1101/gad.12.2.149; Ke QD, 2006, MOL PHARMACOL, V70, P1469, DOI 10.1124/mol.106.027029; Kim JW, 2006, CELL METAB, V3, P177, DOI 10.1016/j.cmet.2006.02.002; Papandreou I, 2006, CELL METAB, V3, P187, DOI 10.1016/j.cmet.2006.01.012; Patel MS, 2001, EXP MOL MED, V33, P191, DOI 10.1038/emm.2001.32; Pelicano H, 2006, J CELL BIOL, V175, P913, DOI 10.1083/jcb.200512100; Roche TE, 2007, CELL MOL LIFE SCI, V64, P830, DOI 10.1007/s00018-007-6380-z; Rosenberger C, 2002, J AM SOC NEPHROL, V13, DOI 10.1097/01.ASN.0000017223.49823.2A; Seagroves TN, 2001, MOL CELL BIOL, V21, P3436, DOI 10.1128/MCB.21.10.3436-3444.2001; Semenza GL, 2002, BIOCHEM PHARMACOL, V64, P993, DOI 10.1016/S0006-2952(02)01168-1; Sun HS, 2003, ENDOCRINOLOGY, V144, P3934, DOI 10.1210/en.2003-0289; Tian H, 1997, GENE DEV, V11, P72, DOI 10.1101/gad.11.1.72; Tian H, 1998, GENE DEV, V12, P3320, DOI 10.1101/gad.12.21.3320; Tsai SJ, 2002, ENDOCRINOLOGY, V143, P2715, DOI 10.1210/en.143.7.2715; Tsai SJ, 2001, J CLIN ENDOCR METAB, V86, P5765, DOI 10.1210/jc.86.12.5765; Tuganova A, 2002, BIOCHEM J, V366, P129, DOI 10.1042/BJ20020301; Warburg O., 1930, METABOLISM TUMORS, P254; Wiesener MS, 2002, FASEB J, V16, P271, DOI 10.1096/fj.02-0445fje; Wu MH, 2007, AM J PATHOL, V170, P590, DOI 10.2353/ajpath.2007.060477; Wu PF, 2000, ARCH BIOCHEM BIOPHYS, V381, P1, DOI 10.1006/abbi.2000.1946; Wu PF, 1999, DIABETES, V48, P1593, DOI 10.2337/diabetes.48.8.1593; Zhong H, 1999, CANCER RES, V59, P5830	36	212	224	0	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 17	2008	283	42					28106	28114		10.1074/jbc.M803508200	http://dx.doi.org/10.1074/jbc.M803508200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	359EN	18718909	hybrid, Green Published			2022-12-27	WOS:000259969300013
J	Imbeault, D; Gamar, L; Rufiange, A; Paquet, E; Nourani, A				Imbeault, David; Gamar, Lynda; Rufiange, Anne; Paquet, Eric; Nourani, Amine			The Rtt106 histone chaperone is functionally linked to transcription elongation and is involved in the regulation of spurious transcription from cryptic promoters in yeast	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA-POLYMERASE-II; SACCHAROMYCES-CEREVISIAE; INITIATION; CHROMATIN; ASF1	Rtt106 is a histone chaperone that has been suggested to play a role in heterochromatin-mediated silencing in Saccharomyces cerevisiae. It interacts physically and functionally with the chromatin assembly factor-1 (CAF-1), which is associated with replication-coupled nucleosomal deposition. In this work, we have taken several approaches to study Rtt106 in greater detail and have identified a previously unknown function of Rtt106. We found genetic interactions between rtt106 Delta and mutations in genes encoding transcription elongation factors, including Spt6, TFIIS, and members of the PAF and yeast DSIF complexes. In addition, chromatin immunoprecipitation analysis indicates that Rtt106 is associated with transcribed regions of active genes. Furthermore, our results show that Rtt106 is required for the repression of transcription from a cryptic promoter within a coding region. This observation strongly suggests that Rtt106 is involved in the regulation of chromatin structure of transcribed regions. Finally, we provide evidence that Rtt106 plays a role in regulating the levels of histone H3 transcription-coupled deposition over transcribed regions. Taken together, our results indicate a direct link for Rtt106 with transcription elongation and the chromatin dynamics associated with RNA polymerase II passage.	[Imbeault, David; Gamar, Lynda; Rufiange, Anne; Paquet, Eric; Nourani, Amine] Univ Laval, Hotel Dieu Quebec CHUQ, Ctr Rech Cancerol, Quebec City, PQ G1R 2J6, Canada	Laval University	Nourani, A (corresponding author), Univ Laval, Hotel Dieu Quebec CHUQ, Ctr Rech Cancerol, Quebec City, PQ G1R 2J6, Canada.	Amine.Nourani@crhdq.ulaval.ca		Paquet, Eric/0000-0001-9194-1655	Canadian Institutes of Health Research; Natural Sciences and Engineering Research Council of Canada	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This work was supported by grants from the Canadian Institutes of Health Research and Natural Sciences and Engineering Research Council of Canada (to A.N.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Carrozza MJ, 2005, CELL, V123, P581, DOI 10.1016/j.cell.2005.10.023; Collins SR, 2007, NATURE, V446, P806, DOI 10.1038/nature05649; Dion MF, 2007, SCIENCE, V315, P1405, DOI 10.1126/science.1134053; HUANG S, 2005, P NATL ACAD SCI US; Huang SB, 2007, EMBO J, V26, P2274, DOI 10.1038/sj.emboj.7601670; IZBAN MG, 1991, GENE DEV, V5, P683, DOI 10.1101/gad.5.4.683; Kaplan CD, 2003, SCIENCE, V301, P1096, DOI 10.1126/science.1087374; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; Mason PB, 2003, MOL CELL BIOL, V23, P8323, DOI 10.1128/MCB.23.22.8323-8333.2003; Nourani A, 2006, MOL CELL BIOL, V26, P1496, DOI 10.1128/MCB.26.4.1496-1509.2006; Prather D, 2005, MOL CELL BIOL, V25, P10122, DOI 10.1128/MCB.25.22.10122-10135.2005; Rufiange A, 2007, MOL CELL, V27, P393, DOI 10.1016/j.molcel.2007.07.011; Schermer UJ, 2005, MOL CELL, V19, P279, DOI 10.1016/j.molcel.2005.05.028; Schwabish MA, 2006, MOL CELL, V22, P415, DOI 10.1016/j.molcel.2006.03.014; Tong AHY, 2001, SCIENCE, V294, P2364, DOI 10.1126/science.1065810; Williams LR, 2007, SIGHT SOUND, V17, P93; Workman JL, 2006, GENE DEV, V20, P2009, DOI 10.1101/gad.1435706	17	50	50	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 10	2008	283	41					27350	27354		10.1074/jbc.C800147200	http://dx.doi.org/10.1074/jbc.C800147200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	355OW	18708354	hybrid			2022-12-27	WOS:000259719200002
J	Hasler, U; Leroy, V; Jeon, US; Bouley, R; Dimitrov, M; Kim, JA; Brown, D; Kwon, HM; Martin, PY; Feraille, E				Hasler, Udo; Leroy, Valeeie; Jeon, Un Sil; Bouley, Richard; Dimitrov, Mitko; Kim, Jeong Ah; Brown, Dennis; Kwon, H. Moo; Martin, Pierre-Yves; Feraille, Eric			NF-kappa B modulates aquaporin-2 transcription in renal collecting duct principal cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INDUCED NEPHROTIC SYNDROME; ENHANCER-BINDING PROTEIN; WATER CHANNEL EXPRESSION; DOWN-REGULATION; NULL MICE; ACTIVATION; MECHANISM; GENE; HYPERTONICITY; PERMEABILITY	Renal tubulo-interstitial inflammation is frequently associated with polyuria and urine concentration defects. This led us to investigate the effects of the major pro-inflammatory nuclear factor kappa B (NF-kappa B) pathway on aquaporin 2 (AQP2) expression by the collecting duct. Using immortalized collecting duct principal cells (mpkCCD(c14)), we found that, acting independently of vasopressin, activation of NF-kappa B by lipopolysaccharide (LPS) decreased AQP2 mRNA and protein levels in a time-and dose-dependent manner but did not decrease AQP2 mRNA stability. Consistently, constitutively active I kappa B kinase beta decreased AQP2 expression. The LPS-induced decrease in AQP2 mRNA levels was confirmed in rat kidney slices and was reproduced both under conditions of elevated cAMP concentration and V-2 receptor antagonism. Computer analysis of the AQP2 promoter revealed two putative kappa B elements. Mutation of either kappa B element abolished the LPS-induced decrease of luciferase activity in cells expressing AQP2 promoter-luciferase plasmid constructs. Chromatin immunoprecipitation revealed that LPS challenge decreased p65, increased p50 and p52, and had no effect on RelB and c-Rel binding to kappa B elements of the AQP2 promoter. RNA-mediated interference silencing of p65, p50, and p52 confirmed controlled AQP2 transcription by these NF-kappa B subunits. We additionally found that hypertonicity activated NF-kappa B in mpkCCD(c14) cells, an effect that may counteract the Tonicity-responsive enhancer binding protein (TonEBP)-dependent increase in AQP2 gene transcription. Taken together, these findings indicate that NF-kappa B is an important physiological regulator of AQP2 transcription.	[Hasler, Udo; Leroy, Valeeie; Dimitrov, Mitko; Martin, Pierre-Yves; Feraille, Eric] Fdn Rech Med, Serv Nephrol, CH-1211 Geneva 4, Switzerland; [Hasler, Udo; Leroy, Valeeie; Dimitrov, Mitko; Martin, Pierre-Yves; Feraille, Eric] Univ Geneva, CH-1211 Geneva 4, Switzerland; [Jeon, Un Sil; Kim, Jeong Ah; Kwon, H. Moo] Univ Maryland, Dept Med, Baltimore, MD 21201 USA; [Bouley, Richard; Brown, Dennis] Harvard Univ, Sch Med, Dept Med, Boston, MA USA; [Bouley, Richard; Brown, Dennis] Massachusetts Gen Hosp, MGH Ctr Syst Biol, Program Membrane Biol, Boston, MA USA; [Bouley, Richard; Brown, Dennis] Massachusetts Gen Hosp, Div Nephrol, Boston, MA USA	University of Geneva; University of Geneva; University System of Maryland; University of Maryland Baltimore; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital	Feraille, E (corresponding author), Fdn Rech Med, Serv Nephrol, 64 Ave Roseraie, CH-1211 Geneva 4, Switzerland.	Eric.Feraille@medecine.unige.ch	Dimitrov, Mitko/C-9822-2009; Lee-Kwon, Whaseon/D-6021-2011; Nunes-Hasler, Paula/N-4337-2015	Nunes-Hasler, Paula/0000-0002-4598-685X; Feraille, Eric/0000-0003-1656-8365	National Institutes of Health [R01-DK-42479, DK38452]; Swiss National Foundation [31-67878.02, 31-109473]; Elsie de Reuter Foundation; Ernest Boninchi Foundation; Fondation pour la Recherche Medicale	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Swiss National Foundation(Swiss National Science Foundation (SNSF)); Elsie de Reuter Foundation; Ernest Boninchi Foundation; Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale)	This work was supported, in whole or in part, by National Institutes of Health Grants R01-DK-42479 (to H. M. K.) and DK38452 (to D. B). This work was also supported in part by Swiss National Foundation Grants 31-67878.02 and 31-109473, a Carlos and Elsie de Reuter Foundation grant, a Ernest Boninchi Foundation grant (to E. F.), and a Fondation pour la Recherche Medicale grant (to U. H.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Apostol E, 1997, J AM SOC NEPHROL, V8, P15; Bouley R, 2008, SEMIN NEPHROL, V28, P266, DOI 10.1016/j.semnephrol.2008.03.010; Breton S, 1998, J AM SOC NEPHROL, V9, P155; Bustamante M, 2005, AM J PHYSIOL-RENAL, V288, pF334, DOI 10.1152/ajprenal.00180.2004; Bustamante M, 2008, J AM SOC NEPHROL, V19, P109, DOI 10.1681/ASN.2007010092; Carranza ML, 1996, AM J PHYSIOL-CELL PH, V271, pC136, DOI 10.1152/ajpcell.1996.271.1.C136; Chou CL, 1999, J CLIN INVEST, V103, P491, DOI 10.1172/JCI5704; Fernandez-Llama P, 1998, KIDNEY INT, V53, P1244, DOI 10.1046/j.1523-1755.1998.00878.x; Fernandez-Llama P, 1998, KIDNEY INT, V54, P170, DOI 10.1046/j.1523-1755.1998.00984.x; Ferraris JD, 2002, P NATL ACAD SCI USA, V99, P739, DOI 10.1073/pnas.241637298; Frokiaer J, 1997, AM J PHYSIOL-RENAL, V273, pF213, DOI 10.1152/ajprenal.1997.273.2.F213; Frokiaer J, 1999, AM J PHYSIOL-RENAL, V276, pF179; FUJITA T, 1993, GENE DEV, V7, P1354, DOI 10.1101/gad.7.7b.1354; Furuno M, 1996, AM J PHYSIOL-RENAL, V271, pF854, DOI 10.1152/ajprenal.1996.271.4.F854; Gaeggeler HP, 2005, J AM SOC NEPHROL, V16, P878, DOI 10.1681/ASN.2004121110; Gerondakis S, 1999, ONCOGENE, V18, P6888, DOI 10.1038/sj.onc.1203236; Ghosh S, 1998, ANNU REV IMMUNOL, V16, P225, DOI 10.1146/annurev.immunol.16.1.225; Ghosh S, 2002, CELL, V109, pS81, DOI 10.1016/S0092-8674(02)00703-1; Grinevich V, 2004, KIDNEY INT, V65, P54, DOI 10.1111/j.1523-1755.2004.00378.x; Han KH, 2004, AM J PHYSIOL-RENAL, V287, pF878, DOI 10.1152/ajprenal.00047.2004; Hao CM, 2000, J CLIN INVEST, V106, P973, DOI 10.1172/JCI9956; Hasler U, 2006, AM J PHYSIOL-RENAL, V290, pF177, DOI 10.1152/ajprenal.00056.2005; Hasler U, 2005, J AM SOC NEPHROL, V16, P1571, DOI 10.1681/ASN.2004110930; Hasler U, 2003, J BIOL CHEM, V278, P21639, DOI 10.1074/jbc.M212388200; Hasler U, 2002, J BIOL CHEM, V277, P10379, DOI 10.1074/jbc.M111880200; Hasler U, 2008, J BIOL CHEM, V283, P28095, DOI 10.1074/jbc.M801071200; Hasler U, 2006, J AM SOC NEPHROL, V17, P1521, DOI 10.1681/ASN.2005121317; Hayden MS, 2004, GENE DEV, V18, P2195, DOI 10.1101/gad.1228704; Hoffmann A, 2003, EMBO J, V22, P5530, DOI 10.1093/emboj/cdg534; Hozawa S, 1996, AM J PHYSIOL-CELL PH, V270, pC1695, DOI 10.1152/ajpcell.1996.270.6.C1695; Husted RF, 1998, AM J PHYSIOL-RENAL, V275, pF946, DOI 10.1152/ajprenal.1998.275.6.F946; KLAHR S, 1988, PEDIATR NEPHROL, V2, P34, DOI 10.1007/BF00870378; KOHAN DE, 1994, J LAB CLIN MED, V123, P668; Kumar A, 2001, NEPHROL DIAL TRANSPL, V16, P1062, DOI 10.1093/ndt/16.5.1062; LEROY V, J AM SOC NE IN PRESS; Leung TH, 2004, CELL, V118, P453, DOI 10.1016/j.cell.2004.08.007; Li CL, 2001, AM J PHYSIOL-RENAL, V281, pF163, DOI 10.1152/ajprenal.2001.281.1.F163; Lopez-Rodriguez C, 2001, IMMUNITY, V15, P47, DOI 10.1016/S1074-7613(01)00165-0; Mercurio F, 1997, SCIENCE, V278, P860, DOI 10.1126/science.278.5339.860; Miyakawa H, 1999, P NATL ACAD SCI USA, V96, P2538, DOI 10.1073/pnas.96.5.2538; Mordasini D, 2005, AM J PHYSIOL-RENAL, V289, pF1031, DOI 10.1152/ajprenal.00128.2005; Nejsum LN, 2005, CELL MOL LIFE SCI, V62, P1692, DOI 10.1007/s00018-005-4549-x; NIELSEN S, 1995, P NATL ACAD SCI USA, V92, P1013, DOI 10.1073/pnas.92.4.1013; Oyama T, 1998, J IMMUNOL, V160, P1224; Ping DS, 1999, J IMMUNOL, V162, P727; Ryser S, 2007, J BIOL CHEM, V282, P5075, DOI 10.1074/jbc.M607847200; Schnermann J, 1998, P NATL ACAD SCI USA, V95, P9660, DOI 10.1073/pnas.95.16.9660; Shi XZ, 2005, GASTROENTEROLOGY, V129, P1518, DOI 10.1053/j.gastro.2005.07.058; Storm R, 2003, AM J PHYSIOL-RENAL, V284, pF189, DOI 10.1152/ajprenal.00245.2002; Terris J, 1996, AM J PHYSIOL-RENAL, V271, pF414, DOI 10.1152/ajprenal.1996.271.2.F414; Woo SK, 2000, AM J PHYSIOL-RENAL, V278, pF1006; Xu DL, 1997, J CLIN INVEST, V99, P1500, DOI 10.1172/JCI119312; Yasui M, 1997, AM J PHYSIOL-RENAL, V272, pF443, DOI 10.1152/ajprenal.1997.272.4.F443; Zhang LP, 2005, CANCER RES, V65, P457	54	104	107	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 17	2008	283	42					28095	28105		10.1074/jbc.M708350200	http://dx.doi.org/10.1074/jbc.M708350200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	359EN	18664568	Green Published, hybrid			2022-12-27	WOS:000259969300012
J	Beretta, M; Gruber, K; Kollau, A; Russwurm, M; Koesling, D; Goessler, W; Keung, WM; Schmidt, K; Mayer, B				Beretta, Matteo; Gruber, Karl; Kollau, Alexander; Russwurm, Michael; Koesling, Doris; Goessler, Walter; Keung, Wing Ming; Schmidt, Kurt; Mayer, Bernd			Bioactivation of nitroglycerin by purified mitochondrial and cytosolic aldehyde dehydrogenases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SENSITIVE GUANYLYL CYCLASE; NITRIC-OXIDE; NITRATE TOLERANCE; IN-VITRO; MECHANISM; PEROXYNITRITE; OXIDATION; 1H-<1,2,4>OXADIAZOLO<4,3-A>QUINOXALIN-1-ONE; PURIFICATION; METABOLISM	Metabolism of nitroglycerin (GTN) to 1,2-glycerol dinitrate (GDN) and nitrite by mitochondrial aldehyde dehydrogenase (ALDH2) is essentially involved in GTN bioactivation resulting in cyclic GMP-mediated vascular relaxation. The link between nitrite formation and activation of soluble guanylate cyclase (sGC) is still unclear. To test the hypothesis that the ALDH2 reaction is sufficient for GTN bioactivation, we measured GTN-induced formation of cGMP by purified sGC in the presence of purified ALDH2 and used a Clark-type electrode to probe for nitric oxide ( NO) formation. In addition, we studied whether GTN bioactivation is a specific feature of ALDH2 or is also catalyzed by the cytosolic isoform ( ALDH1). Purified ALDH1 and ALDH2 metabolized GTN to 1,2- and 1,3-GDN with predominant formation of the 1,2- isomer that was inhibited by chloral hydrate ( ALDH1 and ALDH2) and daidzin ( ALDH2). GTN had no effect on sGC activity in the presence of bovine serum albumin but caused pronounced cGMP accumulation in the presence of ALDH1 or ALDH2. The effects of the ALDH isoforms were dependent on the amount of added protein and, like 1,2- GDN formation, were sensitive to ALDH inhibitors. GTN caused biphasic sGC activation with apparent EC50 values of 42 +/- 2.9 and 3.1 +/- 0.4 mu M in the presence of ALDH1 and ALDH2, respectively. Incubation of ALDH1 or ALDH2 with GTN resulted in sustained, chloral hydrate-sensitive formation of NO. These data may explain the coupling of ALDH2-catalyzed GTN metabolism to sGC activation in vascular smooth muscle.	[Beretta, Matteo; Kollau, Alexander; Schmidt, Kurt; Mayer, Bernd] Karl Franzens Univ Graz, Dept Pharmacol & Toxicol, A-8010 Graz, Austria; [Gruber, Karl; Goessler, Walter] Karl Franzens Univ Graz, Dept Chem, A-8010 Graz, Austria; [Russwurm, Michael; Koesling, Doris] Ruhr Univ Bochum, Dept Pharmacol & Toxicol, D-44780 Bochum, Germany; [Keung, Wing Ming] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA	University of Graz; University of Graz; Ruhr University Bochum; Harvard University; Harvard Medical School	Mayer, B (corresponding author), Karl Franzens Univ Graz, Dept Pharmacol & Toxicol, Univ Pl 2, A-8010 Graz, Austria.	mayer@uni-graz.at	Gruber, Karl/GPP-6706-2022; Beretta, Matteo/D-8573-2012; Mayer, Bernd/B-9391-2008; Goessler, Walter/A-1084-2016	Gruber, Karl/0000-0002-3485-9740; Goessler, Walter/0000-0002-0142-9373; Kollau, Alexander/0000-0002-3326-0517; Gorren, Antonius Cornelis Franciscus/0000-0003-3476-6162; Mayer, Bernd/0000-0002-2921-3494; Beretta, Matteo/0000-0001-5564-4282	Austrian Science Fund FWF [W 901, P 20669] Funding Source: Medline; Austrian Science Fund FWF [P 20669, W 901] Funding Source: Medline; Austrian Science Fund (FWF) [W 901] Funding Source: researchfish	Austrian Science Fund FWF(Austrian Science Fund (FWF)); Austrian Science Fund FWF(Austrian Science Fund (FWF)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))		BENNETT BM, 1994, TRENDS PHARMACOL SCI, V15, P245, DOI 10.1016/0165-6147(94)90319-0; Booth BP, 2000, BIOCHEM PHARMACOL, V59, P1603, DOI 10.1016/S0006-2952(00)00290-2; Castello PR, 2006, CELL METAB, V3, P277, DOI 10.1016/j.cmet.2006.02.011; Chen ZQ, 2006, TRENDS CARDIOVAS MED, V16, P259, DOI 10.1016/j.tcm.2006.05.001; Chen ZQ, 2005, P NATL ACAD SCI USA, V102, P12159, DOI 10.1073/pnas.0503723102; Chen ZQ, 2002, P NATL ACAD SCI USA, V99, P8306, DOI 10.1073/pnas.122225199; Difabio J, 2003, MOL PHARMACOL, V64, P1109, DOI 10.1124/mol.64.5.1109; Dikalov S, 1998, J PHARMACOL EXP THER, V286, P938; Fink B, 2000, FREE RADICAL BIO MED, V28, P121, DOI 10.1016/S0891-5849(99)00228-2; Fung HL, 2004, ANNU REV PHARMACOL, V44, P67, DOI 10.1146/annurev.pharmtox.44.101802.121646; GARTHWAITE J, 1995, MOL PHARMACOL, V48, P184; GHENBOT G, 1992, PROTEIN EXPRES PURIF, V3, P470, DOI 10.1016/1046-5928(92)90064-4; Gorren ACF, 2005, BIOCHEM J, V390, P625, DOI 10.1042/BJ20050565; Ho KK, 2005, BIOCHEMISTRY-US, V44, P8022, DOI 10.1021/bi050038u; ISHII K, 1991, AM J PHYSIOL, V261, pH598, DOI 10.1152/ajpheart.1991.261.2.H598; KEUNG WM, 1993, P NATL ACAD SCI USA, V90, P1247, DOI 10.1073/pnas.90.4.1247; Klyosov AA, 1996, BIOCHEMISTRY-US, V35, P4445, DOI 10.1021/bi9521093; Kollau A, 2005, BIOCHEM J, V385, P769, DOI 10.1042/BJ20041354; Kollau A, 2007, MOL PHARMACOL, V72, P191, DOI 10.1124/mol.107.035642; KOMURA S, 1974, ACTA PHARMACOL TOX, V35, P145; Kozlov AV, 1999, FEBS LETT, V454, P127, DOI 10.1016/S0014-5793(99)00788-7; Mackenzie IS, 2005, ARTERIOSCL THROM VAS, V25, P1891, DOI 10.1161/01.ATV.0000179599.71086.89; MAYER B, 1995, J BIOL CHEM, V270, P655, DOI 10.1074/jbc.270.2.655; Miranda KM, 2003, P NATL ACAD SCI USA, V100, P9196, DOI 10.1073/pnas.1430507100; MUKERJEE N, 1994, J BIOL CHEM, V269, P21664; Munzel T, 2005, CIRC RES, V97, P618, DOI 10.1161/01.RES.0000184694.03262.6d; Munzel T, 2000, CIRC RES, V86, pE7, DOI 10.1161/01.RES.86.1.e7; Pfeiffer S, 2001, J BIOL CHEM, V276, P34051, DOI 10.1074/jbc.M100585200; Rocha JBT, 2005, BIOL PHARM BULL, V28, P1485, DOI 10.1248/bpb.28.1485; Russwurm M, 2005, METHOD ENZYMOL, V396, P492, DOI 10.1016/S0076-6879(05)96041-2; SCHMIDT K, 1994, BIOCHEM J, V301, P645, DOI 10.1042/bj3010645; Schrammel A, 2003, FREE RADICAL BIO MED, V34, P1078, DOI 10.1016/S0891-5849(03)00038-8; Schrammel A, 1996, MOL PHARMACOL, V50, P1; Schultz G., 1984, METHOD ENZYMAT AN, P379; Sydow K, 2004, J CLIN INVEST, V113, P482, DOI 10.1172/JCI200419267; Thatcher GRJ, 2004, FREE RADICAL BIO MED, V37, P1122, DOI 10.1016/j.freeradbiomed.2004.06.013; TOWELL J, 1985, ALCOHOL CLIN EXP RES, V9, P438, DOI 10.1111/j.1530-0277.1985.tb05579.x; Wenzel P, 2007, J BIOL CHEM, V282, P792, DOI 10.1074/jbc.M606477200; Zhang J, 2004, CIRCULATION, V110, P750, DOI 10.1161/01.CIR.0000138105.17864.6B; ZHENG CF, 1993, ALCOHOL CLIN EXP RES, V17, P828, DOI 10.1111/j.1530-0277.1993.tb00849.x	40	86	87	2	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 27	2008	283	26					17873	17880		10.1074/jbc.M801182200	http://dx.doi.org/10.1074/jbc.M801182200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	316KU	18786921	Green Published, hybrid			2022-12-27	WOS:000256949200015
J	Kao, CY; Kim, C; Huang, F; Wu, R				Kao, Cheng-Yuan; Kim, Christy; Huang, Fei; Wu, Reen			Requirements for two proximal NF-kappa B binding sites and I kappa B-zeta in IL-17A-induced human beta-defensin 2 expression by conducting airway epithelium	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEDIATED TRANSCRIPTIONAL REGULATION; KLEBSIELLA-PNEUMONIAE INFECTION; COLONY-STIMULATING FACTOR; NEUTROPHIL RECRUITMENT; GENE-EXPRESSION; UP-REGULATION; T-CELL; INTERLEUKIN-17 FAMILY; ADAPTIVE IMMUNITY; BETA-DEFENSINS	Among a panel of 21 cytokines (IL-1 alpha, -1 beta, -2-13, and -15-18; interferon-gamma granulocyte-macrophage colony-stimulating factor; and tumor necrosis factor a), we have recently observed that IL-17A is the most potent inducer for human P-defensin 2 (hBD-2) in conducting airway epithelial cells (Kao, C. Y., Chen, Y., Thai, P., Wachi, S., Huang, F., Kim, C., Harper, R. W., and Wu, R. (2004) J. Immunol. 173,3482-3491). The molecular basis of this regulation is not known. In this study, we demonstrated a coordinated degradation of inhibitory kappa B (I kappa B)-alpha followed by a nuclear translocation of p50 and p65 NF-kappa B subunits and their binding to NF-kappa B sites of hBD-2 promoter region. With site-directed mutagenesis, we demonstrated the requirement of two proximal NF-kappa B binding sites (p kappa B1, -205 to -186; p kappa B2, -596 to -572) but not the distal site (d kappa B, -2193 to -2182) in supporting IL-17A-induced hBD-2 promoter activity. These results are consistent with the data of the chromatin immunoprecipitation assay, which showed enhanced p50 binding to these p kappa B sites but not the d kappa B site in cells after IL-17A treatment. We also found that the NF-kappa B binding cofactor, I kappa B-zeta, was up-regulated by IL-17A, and the knockdown of I kappa B-zeta significantly diminished the IL-17A-induced hBD-2 expression. This is the first demonstration of the involvement of two proximal NF-kappa B sites and I kappa B-zeta in the regulation of hBD-2 by IL-17A, two important genes responsible for host defense.	[Wu, Reen] Univ Calif Davis, Ctr Comparat Resp Biol & Med, Genome & Biomed Sci Facil, Davis, CA 95616 USA	University of California System; University of California Davis	Wu, R (corresponding author), Univ Calif Davis, Ctr Comparat Resp Biol & Med, Genome & Biomed Sci Facil, Suite 6523,451 Hlth Sci Dr, Davis, CA 95616 USA.	rwu@ucdavis.edu	Macheroux, Peter/AAB-5157-2019; KAO, CHENG-YUAN/A-7531-2010	Macheroux, Peter/0000-0002-0242-454X; KAO, CHENG-YUAN/0000-0003-0946-9270	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL077902, R01HL077315, R01HL035635, R37HL035635] Funding Source: NIH RePORTER; Austrian Science Fund FWF [W 901] Funding Source: Medline; NHLBI NIH HHS [HL 077902, HL 35635, HL 077315] Funding Source: Medline; NIEHS NIH HHS [ES 00628] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Austrian Science Fund FWF(Austrian Science Fund (FWF)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Becker MN, 2000, J BIOL CHEM, V275, P29731, DOI 10.1074/jbc.M000184200; Bonizzi G, 2004, TRENDS IMMUNOL, V25, P280, DOI 10.1016/j.it.2004.03.008; Chen Y, 2003, J BIOL CHEM, V278, P17036, DOI 10.1074/jbc.M210429200; Cowland JB, 2006, J IMMUNOL, V176, P5559, DOI 10.4049/jimmunol.176.9.5559; Duits LA, 2003, FEMS IMMUNOL MED MIC, V38, P59, DOI 10.1016/S0928-8244(03)00106-8; Ferretti S, 2003, J IMMUNOL, V170, P2106, DOI 10.4049/jimmunol.170.4.2106; Fossiez F, 1996, J EXP MED, V183, P2593, DOI 10.1084/jem.183.6.2593; Ghosh S, 1998, ANNU REV IMMUNOL, V16, P225, DOI 10.1146/annurev.immunol.16.1.225; Happel KI, 2003, J IMMUNOL, V170, P4432, DOI 10.4049/jimmunol.170.9.4432; Harder J, 2000, AM J RESP CELL MOL, V22, P714, DOI 10.1165/ajrcmb.22.6.4023; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; Hayot F, 2006, J THEOR BIOL, V240, P583, DOI 10.1016/j.jtbi.2005.10.018; Hoffmann A, 2002, SCIENCE, V298, P1241, DOI 10.1126/science.1071914; Hoshino H, 1999, AM J RESP CRIT CARE, V159, P1423, DOI 10.1164/ajrccm.159.5.9806008; Huang F, 2007, J IMMUNOL, V179, P6504, DOI 10.4049/jimmunol.179.10.6504; Jang BC, 2004, BIOCHEM BIOPH RES CO, V320, P1026, DOI 10.1016/j.bbrc.2004.06.049; Jones CE, 2002, AM J RESP CELL MOL, V26, P748, DOI 10.1165/ajrcmb.26.6.4757; Jovanovic DV, 1998, J IMMUNOL, V160, P3513; Kao CY, 2005, J IMMUNOL, V175, P6676, DOI 10.4049/jimmunol.175.10.6676; Kao CY, 2004, J IMMUNOL, V173, P3482, DOI 10.4049/jimmunol.173.5.3482; Kawaguchi M, 2001, J ALLERGY CLIN IMMUN, V108, P804, DOI 10.1067/mai.2001.119027; Knowles MR, 2002, J CLIN INVEST, V109, P571, DOI 10.1172/JCI200215217; Kolls JK, 2004, IMMUNITY, V21, P467, DOI 10.1016/j.immuni.2004.08.018; Kolls JK, 2003, AM J RESP CELL MOL, V28, P9, DOI 10.1165/rcmb.2002-0255PS; Krisanaprakornkit S, 2002, J IMMUNOL, V168, P316, DOI 10.4049/jimmunol.168.1.316; LEHRER RI, 1993, ANNU REV IMMUNOL, V11, P105, DOI 10.1146/annurev.iy.11.040193.000541; Leung TH, 2004, CELL, V118, P453, DOI 10.1016/j.cell.2004.08.007; Liao F, 1999, J IMMUNOL, V162, P186; Liu AY, 2002, J INVEST DERMATOL, V118, P275, DOI 10.1046/j.0022-202x.2001.01651.x; Liu LD, 2003, J IMMUNOL, V170, P575, DOI 10.4049/jimmunol.170.1.575; Lyss G, 1998, J BIOL CHEM, V273, P33508, DOI 10.1074/jbc.273.50.33508; Miyamoto M, 2003, J IMMUNOL, V170, P4665, DOI 10.4049/jimmunol.170.9.4665; Moseley TA, 2003, CYTOKINE GROWTH F R, V14, P155, DOI 10.1016/S1359-6101(03)00002-9; Nelson DE, 2004, SCIENCE, V306, P704, DOI 10.1126/science.1099962; Ogushi K, 2001, J BIOL CHEM, V276, P30521, DOI 10.1074/jbc.M011618200; ROUVIER E, 1993, J IMMUNOL, V150, P5445; Singh PK, 1998, P NATL ACAD SCI USA, V95, P14961, DOI 10.1073/pnas.95.25.14961; Totzke G, 2006, J BIOL CHEM, V281, P12645, DOI 10.1074/jbc.M511956200; Tsutsumi-Ishii Y, 2003, J IMMUNOL, V170, P4226, DOI 10.4049/jimmunol.170.8.4226; Tsutsumi-Ishii Y, 2002, J LEUKOCYTE BIOL, V71, P154; Uehara N, 2003, J MED MICROBIOL, V52, P41, DOI 10.1099/jmm.0.04985-0; Wada A, 2001, CELL MICROBIOL, V3, P115, DOI 10.1046/j.1462-5822.2001.00096.x; Wahl C, 1998, J CLIN INVEST, V101, P1163, DOI 10.1172/JCI992; Yamamoto M, 2004, NATURE, V430, P218, DOI 10.1038/nature02738; Yamazaki S, 2001, J BIOL CHEM, V276, P27657, DOI 10.1074/jbc.M103426200; Yamazaki S, 2005, J BIOL CHEM, V280, P1678, DOI 10.1074/jbc.M409983200; Yang D, 2002, TRENDS IMMUNOL, V23, P291, DOI 10.1016/S1471-4906(02)02246-9; Yang D, 1999, SCIENCE, V286, P525, DOI 10.1126/science.286.5439.525; YANKASKAS JR, 1993, AM J PHYSIOL, V264, pC1219, DOI 10.1152/ajpcell.1993.264.5.C1219; Ye P, 2001, J EXP MED, V194, P519, DOI 10.1084/jem.194.4.519; Ye P, 2001, AM J RESP CELL MOL, V25, P335, DOI 10.1165/ajrcmb.25.3.4424	51	70	75	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 30	2008	283	22					15309	15318		10.1074/jbc.M708289200	http://dx.doi.org/10.1074/jbc.M708289200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	306EV	18362142	hybrid, Green Published			2022-12-27	WOS:000256232000049
